PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Simoes, BM; Santiago-Gomez, A; Chiodo, C; Moreira, T; Conole, D; Lovell, S; Alferez, D; Eyre, R; Spence, K; Sarmiento-Castro, A; Kohler, B; Morisset, L; Lanzino, M; Ando, S; Marangoni, E; Sims, AH; Tate, EW; Howell, SJ; Clarke, RB				Simoes, Bruno M.; Santiago-Gomez, Angelica; Chiodo, Chiara; Moreira, Tiago; Conole, Daniel; Lovell, Scott; Alferez, Denis; Eyre, Rachel; Spence, Katherine; Sarmiento-Castro, Aida; Kohler, Bertram; Morisset, Ludivine; Lanzino, Marilena; Ando, Sebastiano; Marangoni, Elisabetta; Sims, Andrew H.; Tate, Edward W.; Howell, Sacha J.; Clarke, Robert B.			Targeting STAT3 signaling using stabilised sulforaphane (SFX-01) inhibits endocrine resistant stem-like cells in ER-positive breast cancer	ONCOGENE			English	Article							PROMOTES TAMOXIFEN RESISTANCE; THERAPY; MAMMOSPHERE; PROGRESSION; ESTROGEN; TUMORS; GENE	Estrogen receptor (ER) positive breast cancer is frequently sensitive to endocrine therapy. Multiple mechanisms of endocrine therapy resistance have been identified, including cancer stem-like cell (CSC) activity. Here we investigate SFX-01, a stabilised formulation of sulforaphane (SFN), for its effects on breast CSC activity in ER+ preclinical models. SFX-01 reduced mammosphere formation efficiency (MFE) of ER+ primary and metastatic patient samples. Both tamoxifen and fulvestrant increased MFE and aldehyde dehydrogenase (ALDH) activity of patient-derived xenograft (PDX) tumors, which was reversed by combination with SFX-01. SFX-01 significantly reduced tumor-initiating cell frequency in secondary transplants and reduced the formation of spontaneous lung micrometastases by PDX tumors in mice. Mechanistically, we establish that both tamoxifen and fulvestrant induce STAT3 phosphorylation. SFX-01 suppressed phospho-STAT3 and SFN directly bound STAT3 in patient and PDX samples. Analysis of ALDH+ cells from endocrine-resistant patient samples revealed activation of STAT3 target genesMUC1andOSMR, which were inhibited by SFX-01 in patient samples. Increased expression of these genes after 3 months' endocrine treatment of ER+ patients (n = 68) predicted poor prognosis. Our data establish the importance of STAT3 signaling in CSC-mediated resistance to endocrine therapy and the potential of SFX-01 for improving clinical outcomes in ER+ breast cancer.	[Simoes, Bruno M.; Santiago-Gomez, Angelica; Chiodo, Chiara; Moreira, Tiago; Alferez, Denis; Eyre, Rachel; Spence, Katherine; Sarmiento-Castro, Aida; Kohler, Bertram; Howell, Sacha J.; Clarke, Robert B.] Univ Manchester, Fac Biol Med & Hlth, Div Canc Sci, Breast Biol Grp,Manchester Breast Ctr, Manchester, Lancs, England; [Chiodo, Chiara; Lanzino, Marilena; Ando, Sebastiano] Univ Calabria, Dept Pharm, Arcavacata Di Rende, Italy; [Conole, Daniel; Lovell, Scott; Tate, Edward W.] Imperial Coll, Mol Sci Res Hub, London, England; [Morisset, Ludivine; Marangoni, Elisabetta] PSL Res Univ, Inst Curie, Translat Res Dept, Paris, France; [Sims, Andrew H.] Univ Edinburgh, Appl Bioinformat Canc Grp, Canc Res UK Ctr, Edinburgh, Midlothian, Scotland; [Howell, Sacha J.] Christie NHS Fdn Trust, Dept Med Oncol, Manchester, Lancs, England	University of Manchester; University of Calabria; Imperial College London; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University of Edinburgh; Christie NHS Foundation Trust	Simoes, BM; Howell, SJ; Clarke, RB (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Div Canc Sci, Breast Biol Grp,Manchester Breast Ctr, Manchester, Lancs, England.; Howell, SJ (corresponding author), Christie NHS Fdn Trust, Dept Med Oncol, Manchester, Lancs, England.	bruno.simoes@manchester.ac.uk; sacha.howell@christie.nhs.uk; robert.clarke@manchester.ac.uk	Simoes, Bruno/AAB-2582-2019; Marangoni, Elisabetta/GSO-3945-2022; Conole, Daniel/ABA-6423-2021; Clarke, Robert/AAA-3442-2021	Simoes, Bruno/0000-0003-1253-6657; Marangoni, Elisabetta/0000-0002-3337-6448; Conole, Daniel/0000-0002-3389-8377; Clarke, Robert/0000-0001-5407-3123; Santiago Gomez, Angelica/0000-0002-2946-2669; Tate, Edward/0000-0003-2213-5814; Moreira, Tiago/0000-0003-3817-7103	National Centre for the Replacement, Refinement and Reduction of Animals in Research [NC/T001267/1] Funding Source: Medline	National Centre for the Replacement, Refinement and Reduction of Animals in Research(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs))		Alam M, 2014, ONCOTARGET, V5, P2622, DOI 10.18632/oncotarget.1848; Alam M, 2013, J BIOL CHEM, V288, P30892, DOI 10.1074/jbc.M113.477158; Bui QT, 2017, CANCER LETT, V390, P115, DOI 10.1016/j.canlet.2017.01.014; Clarke JD, 2011, PHARM RES-DORDR, V28, P3171, DOI 10.1007/s11095-011-0500-z; Clulow JA, 2017, CHEM COMMUN, V53, P5182, DOI 10.1039/c6cc08797c; Cottu P, 2012, BREAST CANCER RES TR, V133, P595, DOI 10.1007/s10549-011-1815-5; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dagan IDFA, 2008, Stabilized sulforaphane, VWO2008091608A1, A61K 31/70 (2006.01) A61K 8/00 (2006.01) A61K 31/40 (2006.01, Patent No. 2008091608; Domenici G, 2019, ONCOGENE, V38, P3151, DOI 10.1038/s41388-018-0656-7; Dustin D, 2019, CANCER-AM CANCER SOC, V125, P3714, DOI 10.1002/cncr.32345; Eyre R, 2016, J MAMMARY GLAND BIOL, V21, P99, DOI 10.1007/s10911-016-9361-8; Franklin SJ, 2014, DRUG DEV IND PHARM, V40, P494, DOI 10.3109/03639045.2013.768634; Fry DW, 2004, MOL CANCER THER, V3, P1427; Gaemers IC, 2001, J BIOL CHEM, V276, P6191, DOI 10.1074/jbc.M009449200; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hong F, 2005, CHEM RES TOXICOL, V18, P1917, DOI 10.1021/tx0502138; HOWELL SJ, 2019, ANN ONCOL, V30, pv122, DOI DOI 10.1093/annonc/mdz242.036; Kettner NM, 2019, CLIN CANCER RES, V25, P3996, DOI 10.1158/1078-0432.CCR-18-3274; Kharbanda A, 2013, MOL CANCER RES, V11, P714, DOI 10.1158/1541-7786.MCR-12-0668; Li YY, 2010, CLIN CANCER RES, V16, P2580, DOI 10.1158/1078-0432.CCR-09-2937; Lin L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082821; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Palmieri C, 2014, MOL CELL ENDOCRINOL, V382, P695, DOI 10.1016/j.mce.2013.08.001; Pan HC, 2017, NEW ENGL J MED, V377, P1836, DOI 10.1056/NEJMoa1701830; Parashar D, 2019, CELL REP, V29, P4389, DOI 10.1016/j.celrep.2019.11.085; Patnaik A, 2016, CANCER DISCOV, V6, P740, DOI 10.1158/2159-8290.CD-16-0095; Pearce D.A., 2018, CONTINUOUS BIOMARKER, DOI [10.1101/208660, DOI 10.1101/208660]; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Pitroda SP, 2009, P NATL ACAD SCI USA, V106, P5837, DOI 10.1073/pnas.0812029106; Piva M, 2014, EMBO MOL MED, V6, P66, DOI 10.1002/emmm.201303411; Sarmiento-Castro A, 2019, DORMANT SUBPOPULATIO, DOI [10.1101/821876, DOI 10.1101/821876]; Shaw FL, 2012, J MAMMARY GLAND BIOL, V17, P111, DOI 10.1007/s10911-012-9255-3; Simoes BM, 2015, CELL REP, V12, P1968, DOI 10.1016/j.celrep.2015.08.050; Simoes BM, 2011, BREAST CANCER RES TR, V129, P23, DOI 10.1007/s10549-010-1169-4; Tawara K, 2018, BREAST CANCER RES, V20, DOI 10.1186/s13058-018-0971-5; Tripathy D, 2017, CLIN CANCER RES, V23, P5658, DOI 10.1158/1078-0432.CCR-17-1819; Turnbull AK, 2015, J CLIN ONCOL, V33, P2270, DOI 10.1200/JCO.2014.57.8963; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wei W, 2014, STEM CELLS, V32, P2571, DOI 10.1002/stem.1752; West NR, 2014, ONCOGENE, V33, P1485, DOI 10.1038/onc.2013.105; West NR, 2012, ENDOCR-RELAT CANCER, V19, P181, DOI 10.1530/ERC-11-0326	42	13	13	2	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 18	2020	39	25					4896	4908		10.1038/s41388-020-1335-z	http://dx.doi.org/10.1038/s41388-020-1335-z			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LZ3HT	32472077	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000541119400009
J	Wu, QY; Xia, YT; Dai, K; Bai, PZ; Kwan, KKL; Guo, MSS; Dong, TTX; Tsim, KWK				Wu, Qiyun; Xia, Yiteng; Dai, Kun; Bai, Panzhu; Kwan, Kenneth K. L.; Guo, Maggie S. S.; Dong, Tina T. X.; Tsim, Karl W. K.			Solar light induces the release of acetylcholine from skin keratinocytes affecting melanogenesis	FASEB JOURNAL			English	Article						acetylcholine; cholinergic; keratinocyte; opsin; skin	CELL-ADHESION; NEURITE GROWTH; RECEPTOR; PHOTORECEPTOR; MECHANISM; PROTEIN; TRANSCRIPTION; EXPRESSION; GENES; CHOLINESTERASE	Cholinergic system conducts signal transmission in brain and muscle. Besides nervous system, the nonneuronal functions of cholinergic system have been proposed in various tissues. The expression of cholinergic proteins and release of acetylcholine in human skin have been reported, but its mechanism and influence on dermatological functions is not elucidated. Here, the expression profile of cholinergic markers was further investigated in skin and keratinocyte. The expression levels of choline acetyltransferase (ChAT), acetylcholinesterase (AChE), vesicular acetylcholine transporter (VAChT), and synaptophysin, were upregulated during differentiation of keratinocytes. In cultured keratinocytes, a transient exposure of solar light induced the release of acetylcholine, which was mediated by intracellular Ca2+ mobilization. The light-induced acetylcholine release was mediated by the present of opsin. The light-induced melanogenesis was inhibited by acetylcholine or AChE inhibitor in melanocyte in vitro and mouse skin ex vivo. These results indicated that the potential role of cholinergic system could be a negative regulator in skin pigmentation.	[Wu, Qiyun; Dai, Kun; Bai, Panzhu; Guo, Maggie S. S.; Dong, Tina T. X.; Tsim, Karl W. K.] Shenzhen Res Inst, Shenzhen Key Lab Edible & Med Bioresources, Shenzhen 518000, Peoples R China; [Wu, Qiyun; Xia, Yiteng; Dai, Kun; Bai, Panzhu; Kwan, Kenneth K. L.; Dong, Tina T. X.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Peoples R China; [Wu, Qiyun; Xia, Yiteng; Dai, Kun; Bai, Panzhu; Kwan, Kenneth K. L.; Dong, Tina T. X.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Ctr Chinese Med, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Tsim, KWK (corresponding author), Shenzhen Res Inst, Shenzhen Key Lab Edible & Med Bioresources, Shenzhen 518000, Peoples R China.	botsim@ust.hk			Shenzhen Science and Technology Innovation Commission [JCYJ20170413173747440, ZDSYS201707281432317, JCYJ20180306174903174]; China Postdoctoral Science Foundation [2019M653087]; Guangzhou Science and Technology Committee Research Grant [GZSTI16SC02, GZSTI17SC02]; Hong Kong RGC Theme-based Research Scheme [T13-607/12R]; Hong Kong Innovation Technology Fund [UIM/340, UIM/385, ITS/500/18FP, TCPD/17-9, HMRF18SC06, PD18SC01]; Zhongshan Municipal Bureau of Science and Technology [ZSST20SC03]	Shenzhen Science and Technology Innovation Commission; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Guangzhou Science and Technology Committee Research Grant; Hong Kong RGC Theme-based Research Scheme; Hong Kong Innovation Technology Fund; Zhongshan Municipal Bureau of Science and Technology	Shenzhen Science and Technology Innovation Commission, Grant/Award Number: JCYJ20170413173747440, ZDSYS201707281432317 and JCYJ20180306174903174; China Postdoctoral Science Foundation, Grant/Award Number: 2019M653087; Guangzhou Science and Technology Committee Research Grant, Grant/Award Number: GZSTI16SC02 and GZSTI17SC02; Hong Kong RGC Theme-based Research Scheme, Grant/Award Number: T13-607/12R; Hong Kong Innovation Technology Fund, Grant/Award Number: UIM/340, UIM/385, ITS/500/18FP, TCPD/17-9, HMRF18SC06 and PD18SC01; Zhongshan Municipal Bureau of Science and Technology, Grant/Award Number: ZSST20SC03	Arredondo J, 2003, LAB INVEST, V83, P207, DOI 10.1097/01.LAB.0000053917.46614.12; Bellono NW, 2014, J GEN PHYSIOL, V143, P203, DOI 10.1085/jgp.201311094; Bellono NW, 2013, P NATL ACAD SCI USA, V110, P2383, DOI 10.1073/pnas.1215555110; Borovansky J, 2011, MELANINS AND MELANOSOMES: BIOSYNTHESIS, BIOGENESIS, PHYSIOLOGICAL, AND PATHOLOGICAL FUNCTIONS, P1, DOI 10.1002/9783527636150; Botti SA, 1998, PROTEIN ENG, V11, P415, DOI 10.1093/protein/11.6.415; Brenner M, 2008, PHOTOCHEM PHOTOBIOL, V84, P539, DOI 10.1111/j.1751-1097.2007.00226.x; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Dedkova E N, 2000, Membr Cell Biol, V13, P357; EDELMAN GM, 1983, SCIENCE, V219, P450, DOI 10.1126/science.6823544; Eimar H, 2013, J MUSCULOSKEL NEURON, V13, P124; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Fujieda H, 2009, J NEUROCHEM, V108, P91, DOI 10.1111/j.1471-4159.2008.05739.x; Genever PG, 1999, BONE, V24, P297, DOI 10.1016/S8756-3282(98)00187-2; GORDON PR, 1988, J NUTR, V118, P1487, DOI 10.1093/jn/118.12.2187; GRANDO SA, 1995, J INVEST DERMATOL, V105, P774, DOI 10.1111/1523-1747.ep12325606; GRANDO SA, 1993, J INVEST DERMATOL, V101, P32, DOI 10.1111/1523-1747.ep12358588; Grando SA, 1997, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 2, NO 1, AUGUST 1997, P41, DOI 10.1038/jidsymp.1997.10; Haltaufderhyde K, 2015, PHOTOCHEM PHOTOBIOL, V91, P117, DOI 10.1111/php.12354; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hisatomi O, 2002, COMP BIOCHEM PHYS B, V133, P509, DOI 10.1016/S1096-4959(02)00127-6; Imai H, 1997, P NATL ACAD SCI USA, V94, P2322, DOI 10.1073/pnas.94.6.2322; Inkson CA, 2004, BONE, V35, P819, DOI 10.1016/j.bone.2004.05.026; Johnson G, 2003, NEUROSCI LETT, V337, P37, DOI 10.1016/S0304-3940(02)01298-3; KATZ B, 1965, PROC R SOC SER B-BIO, V161, P496, DOI 10.1098/rspb.1965.0017; Kehat R, 2004, INVEST OPHTH VIS SCI, V45, pU518; Kim MH, 2008, APOPTOSIS, V13, P295, DOI 10.1007/s10495-007-0160-y; Kishibe M, 2015, INT IMMUNOPHARMACOL, V29, P63, DOI 10.1016/j.intimp.2015.05.047; Klapproth H, 1997, N-S ARCH PHARMACOL, V355, P515, DOI 10.1007/PL00004977; LAYER PG, 1993, CELL TISSUE RES, V273, P219, DOI 10.1007/BF00312823; Lerner LE, 2005, J BIOL CHEM, V280, P20642, DOI 10.1074/jbc.M500957200; MASSOULIE J, 1982, ANNU REV NEUROSCI, V5, P57, DOI 10.1146/annurev.ne.05.030182.000421; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Nachmansohn D, 1943, J NEUROPHYSIOL, V6, P397, DOI 10.1152/jn.1943.6.5.397; Ndoye A, 1998, J INVEST DERMATOL, V111, P410, DOI 10.1046/j.1523-1747.1998.00299.x; Paraoanu LE, 2008, FEBS J, V275, P618, DOI 10.1111/j.1742-4658.2007.06237.x; Parsons SM, 2000, FASEB J, V14, P2423, DOI 10.1096/fj.00-0203rev; PATON WDM, 1971, J PHYSIOL-LONDON, V215, P819, DOI 10.1113/jphysiol.1971.sp009500; Peng GH, 2007, HUM MOL GENET, V16, P2433, DOI 10.1093/hmg/ddm200; Picciotto MR, 2012, NEURON, V76, P116, DOI 10.1016/j.neuron.2012.08.036; Qu L, 2009, J COMP NEUROL, V514, P343, DOI 10.1002/cne.22007; Regazzetti C, 2018, J INVEST DERMATOL, V138, P171, DOI 10.1016/j.jid.2017.07.833; Reinheimer T, 1996, AM J PHYSIOL-LUNG C, V270, pL722, DOI 10.1152/ajplung.1996.270.5.L722; Rosas-Ballina M, 2009, J INTERN MED, V265, P663, DOI 10.1111/j.1365-2796.2009.02098.x; ROSENBERRY TL, 1975, ADV ENZYMOL RAMB, V43, P103; Schlereth T, 2006, BRIT J PHARMACOL, V147, P183, DOI 10.1038/sj.bjp.0706451; Scholl FG, 2003, TRENDS NEUROSCI, V26, P618, DOI 10.1016/j.tins.2003.09.004; SCHUBERT D, 1977, P NATL ACAD SCI USA, V74, P5184, DOI 10.1073/pnas.74.11.5184; SCOTT A, 1962, BRIT J DERMATOL, V74, P317, DOI 10.1111/j.1365-2133.1962.tb13518.x; Sharma KV, 1998, J NEUROSCI RES, V53, P454, DOI 10.1002/(SICI)1097-4547(19980815)53:4<454::AID-JNR7>3.3.CO;2-E; Shi G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013216; Shichida Y, 1998, CELL MOL LIFE SCI, V54, P1299, DOI 10.1007/s000180050256; Shichida Y, 2009, PHILOS T R SOC B, V364, P2881, DOI 10.1098/rstb.2009.0051; Spieker J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170252; Spieker J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161675; Stavenga DG, 2008, PLOS BIOL, V6, P675, DOI 10.1371/journal.pbio.0060115; STEVEN DM, 1963, BIOL REV, V38, P204, DOI 10.1111/j.1469-185X.1963.tb00783.x; SUDHOF TC, 1987, SCIENCE, V238, P1142, DOI 10.1126/science.3120313; TANG A, 1994, J CELL SCI, V107, P983; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; TERAKITA A, 1993, FEBS LETT, V330, P197, DOI 10.1016/0014-5793(93)80272-V; Thangaraj G, 2016, CHEM-BIOL INTERACT, V259, P313, DOI 10.1016/j.cbi.2016.03.027; Thangaraj G, 2012, J COMP NEUROL, V520, P3181, DOI 10.1002/cne.23083; TIWARI P, 2013, ASIAN PAC J TROP DIS, V3, P413, DOI DOI 10.1016/S2222-1808(13)60094-8; TSIM KWK, 1988, P NATL ACAD SCI USA, V85, P1262, DOI 10.1073/pnas.85.4.1262; Van den Bossche K, 2006, TRAFFIC, V7, P769, DOI 10.1111/j.1600-0854.2006.00425.x; Weyand CM, 2000, ARTHRITIS RES, V2, P457, DOI 10.1186/ar128; Wu QY, 2018, J BIOL CHEM, V293, P14417, DOI 10.1074/jbc.RA118.003729; Xu ML, 2019, CHEM-BIOL INTERACT, V308, P317, DOI 10.1016/j.cbi.2019.06.006; Xu ML, 2018, J NEUROCHEM, V146, P390, DOI 10.1111/jnc.14448; Xu ML, 2017, J BIOL CHEM, V292, P12667, DOI 10.1074/jbc.M117.777581; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029	72	9	9	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					8941	8958		10.1096/fj.202000708R	http://dx.doi.org/10.1096/fj.202000708R		JUN 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32519787	Bronze			2022-12-26	WOS:000539525600001
J	Hessou, SPH; Glele-Ahanhanzo, Y; Adekpedjou, R; Ahoussinou, C; Djade, CD; Biaou, A; Johnson, CR; Boko, M; Alary, M				Hessou, Septime P. H.; Glele-Ahanhanzo, Yolaine; Adekpedjou, Rheda; Ahoussinou, Clement; Djade, Codjo D.; Biaou, Alphonse; Johnson, Christian R.; Boko, Michel; Alary, Michel			HIV incidence and risk contributing factors among men who have sex with men in Benin: A prospective cohort study	PLOS ONE			English	Article							YOUNG MEN; PREVALENCE; INFECTION	Men who have sex with Men (MSM) are a key population in the transmission of Human Immunodeficiency Virus (HIV) infection. In Benin, there is a lack of strategic information to offer appropriate interventions for these populations who live hidden due to their stigmatization and discrimination. The objective is to identify contributing factors that affect HIV incidence in the MSM population. Study of a prospective cohort of 358 HIV-negative MSM, aged 18 years and over, reporting having had at least one oral or anal relationship with another man during the last 12 months, prior to recruitment. The monitoring lasted 30 months with a follow-up visit every six months. Univariate analyses and a Cox proportional hazards multivariate regression were used to examine the association between bio-behavioral, socio-demographic and knowledge-related characteristics with HIV incidence. The retention rate for the follow-up of the 358 participants was 94.5%. On the 813.5 person-years of follow-up, 48 seroconversions with an HIV incidence of 5.91 per 100 person-years were observed (95% CI: 4.46-7.85). Factors associated with the high risk of HIV were age (HR = 0.4; 95% CI: 0.2-0.8), living in couple (HR = 0.5 95% CI: 0.2-0.96) and the lack of condom systematic use with a male partner during high-risk sex (HR = 3.9; 95% CI: 1.4-11.1). HIV incidence is high within MSM population and particularly among young people. Targeted, suitable and cost-effective interventions for the delivery of the combination prevention package in an environment free of stigma and discrimination are necessary and vital for reaching the 90x90x90 target.	[Hessou, Septime P. H.] Natl Reference Ctr AIDS Res & Care CNRRPEC CNHU B, Cotonou, Benin; [Hessou, Septime P. H.; Djade, Codjo D.; Alary, Michel] Laval Univ, Populat Hlth & Best Practices Hlth Axis Quebec Ci, Hop St Sacrement, Quebec City, PQ, Canada; [Hessou, Septime P. H.; Johnson, Christian R.; Boko, Michel] Abomey Calavi Univ UAC, Interfac Ctr Training & Res Environm Dev CIFRED, Calavi, Benin; [Glele-Ahanhanzo, Yolaine] Univ Abomey Calavi UAC, Reg Inst Publ Hlth IRSP, Ouidah, Benin; [Adekpedjou, Rheda] Univ Montreal, Ctr Rech Ctr Hosp Univ Montreal CRCHUM, Quebec City, PQ, Canada; [Ahoussinou, Clement] Inst Anal Commun & Social Grp, Misserete, Benin; [Biaou, Alphonse] Natl Program Buruli Ulcer, Cotonou, Benin	Laval University; University of Abomey Calavi; Universite de Montreal	Hessou, SPH (corresponding author), Natl Reference Ctr AIDS Res & Care CNRRPEC CNHU B, Cotonou, Benin.; Hessou, SPH (corresponding author), Laval Univ, Populat Hlth & Best Practices Hlth Axis Quebec Ci, Hop St Sacrement, Quebec City, PQ, Canada.; Hessou, SPH (corresponding author), Abomey Calavi Univ UAC, Interfac Ctr Training & Res Environm Dev CIFRED, Calavi, Benin.	shessou@yahoo.fr	Fazli, Ghazal/AAE-8320-2022	HESSOU, Pepin Septime Hector/0000-0002-8262-0355				[Anonymous], 2015, PLAN STRAT NAT LUTT; [Anonymous], 1991, DETERMINATION TAILLE; [Anonymous], 2011 2015 STRAT; [Anonymous], ACC RIP METTR EP SID; [Anonymous], 2011, 20112012 EDSDHS MACR, P2011; [Anonymous], 2012, LUTTE SIDA HOMOSEXUA; [Anonymous], [No title captured]; [Anonymous], 2006, NOUVELLES INFECT VIH; Balaji A, 2012, HIGH HIV INCIDENCE P, V27; Balaji AB, 2013, AIDS, V27, P269, DOI 10.1097/QAD.0b013e32835ad489; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Beyrer C, 2010, SEX TRANSM INFECT, V86, P323, DOI 10.1136/sti.2009.040162; Chemnasiri T, 2010, AIDS EDUC PREV, V22, P100, DOI 10.1521/aeap.2010.22.2.100; Crowell TA, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.01.21489; Davies MA, 2015, J INT AIDS SOC, V18, P1, DOI 10.7448/IAS.18.7.20745; Dong ZX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097527; Drame FM, 2013, CULT HEALTH SEX, V15, P7, DOI 10.1080/13691058.2012.748935; Ekouevi DK, 2014, REV EPIDEMIOL SANTE, V62, P127, DOI 10.1016/j.respe.2013.11.074; FB Annie Velter, 2009, 464BEH4546, V464, P45; Guedeme AEG, 2009, KIKI MEDEGAN BARUANI; Hladik W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038143; IMF, 2012, REPR COURS MAIS QUI; Keshinro B, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21270; Koblin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070413; Li Dongliang, 2012, BMJ OPEN, V2, pe001829, DOI 10.1136/bmjopen-2012-001829; Li Shu-ming, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P118; Liu GW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138232; Liu J, 2011, AIDS PATIENT CARE ST, V25, P423, DOI 10.1089/apc.2010.0333; Lloyd J, 2014, SEX TRANSM INFECT, V90, P382, DOI 10.1136/sextrans-2013-051463; Mao HY, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005351; Maroc MdlsRd, 2010, ENQUETE INTEGREE SUR; Mustanski B, 2011, HEALTH PSYCHOL, V30, P597, DOI 10.1037/a0023858; Mustanski BS, 2011, J SEX RES, V48, P218, DOI 10.1080/00224499.2011.558645; ONUSIDA, 2017, STAT MOND VIH FICH I; Park JN, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.4.18752; Roselyne PINGET JP, 2010, BILAN EPIDEMIOLOGIQU; Scheibe A, 2016, INT J DRUG POLICY, V30, P107, DOI 10.1016/j.drugpo.2016.01.004; Solomon SS, 2015, AIDS, V29, P723, DOI 10.1097/QAD.0000000000000602; Solomon SS, 2010, AIDS BEHAV, V14, P1001, DOI 10.1007/s10461-010-9711-2; Tabet SR, 1998, AIDS, V12, P2041, DOI 10.1097/00002030-199815000-00016; Vian Taryn, 2012, Open AIDS J, V6, P259, DOI 10.2174/1874613601206010259; Wade AS, 2005, AIDS, V19, P2133, DOI 10.1097/01.aids.0000194128.97640.07; Xu FJ, 2010, SEX TRANSM DIS, V37, P399, DOI 10.1097/OLQ.0b013e3181ce122b; Xu JJ, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0178-x	44	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2020	15	6							e0233624	10.1371/journal.pone.0233624	http://dx.doi.org/10.1371/journal.pone.0233624			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LZ1GC	32516307	Green Published, gold			2022-12-26	WOS:000540977000014
J	Mas, M; Brindisi, MC; Chabanet, C; Chambaron, S				Mas, Marine; Brindisi, Marie-Claude; Chabanet, Claire; Chambaron, Stephanie			Implicit food odour priming effects on reactivity and inhibitory control towards foods	PLOS ONE			English	Article							PREFRONTAL CORTEX; ATTENTIONAL BIAS; OBESITY; IMPULSIVITY; CUE; ENVIRONMENTS; PERFORMANCE; OVERWEIGHT; ADOLESCENT; ADDICTION	The food environment can interact with cognitive processing and influence eating behaviour. Our objective was to characterize the impact of implicit olfactory priming on inhibitory control towards food, in groups with different weight status. Ninety-one adults completed a modified Affective Shifting Task: they had to detect target stimuli and ignore distractor stimuli while being primed with non-attentively perceived odours. We measured reactivity and inhibitory control towards food pictures. Priming effects were observed on reactivity: participants with overweight and obesity were slower when primed with pear and pound cake odour respectively. Common inhibitory control patterns toward foods were observed between groups. We suggest that non-attentively perceived food cues influence bottom-up processing by activating distinguished mental representations according to weight status. Also, our data show that cognitive load influences inhibitory control toward foods. Those results contribute to understanding how the environment can influence eating behaviour in individuals with obesity.	[Mas, Marine; Brindisi, Marie-Claude; Chabanet, Claire; Chambaron, Stephanie] Univ Bourgogne Franche Comte, Ctr Sci Gout & Alimentat, AgroSup Dijon, CNRS,INRAE, Dijon, France; [Brindisi, Marie-Claude] Ctr Hosp Univ Dijon, Dept Diabet & Clin Nutr, Dijon, France	INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; CHU Dijon Bourgogne	Mas, M (corresponding author), Univ Bourgogne Franche Comte, Ctr Sci Gout & Alimentat, AgroSup Dijon, CNRS,INRAE, Dijon, France.	marine.mas@inrae.fr	Chambaron, Stéphanie/GYA-5524-2022; Mas, Marine/AAS-9233-2021; Chambaron-Ginhac, Stephanie/R-2478-2017	MAS, Marine/0000-0002-6914-8009; Chambaron-Ginhac, Stephanie/0000-0002-4626-8489	French National Research Agency [Agence Nationale de la Recherche (ANR): ImplicEAT project] [ANR-17-CE21-0001]	French National Research Agency [Agence Nationale de la Recherche (ANR): ImplicEAT project](French National Research Agency (ANR))	The work in this article was supported by grants from the French National Research Agency [Agence Nationale de la Recherche (ANR): ImplicEAT project ANR-17-CE21-0001], awarded to SC. https://anr.fr/Project-ANR-17-CE21-0001 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alonso M, 2015, NUTR REV, V73, P296, DOI 10.1093/nutrit/nuv002; Amiri S, 2019, NEUROPSYCHIATRIE, V33, P72, DOI 10.1007/s40211-019-0302-9; [Anonymous], 2010, Harv Health Lett, V35, P3; [Anonymous], 2018, CANC DISCOV, V8, pOF6; [Anonymous], 2014, J NURS REGUL, V5, pS3; [Anonymous], 2019, CANC DISCOV, V10, pOF5; [Anonymous], 2017, EUR GERIATR MED, V8, pS98; [Anonymous], 2012, REGEN MED S3, V7, pS14; [Anonymous], 2008, ATMOS OCEAN, V46, P229, DOI [10.3137/ao.460203, DOI 10.3137/AO.460203]; Appelhans BM, 2009, OBESITY, V17, P640, DOI 10.1038/oby.2008.638; Bailey RL, 2016, APPETITE, V107, P568, DOI 10.1016/j.appet.2016.09.001; Bargh JA, 2010, BEHAV BRAIN SCI, V33, P267, DOI 10.1017/S0140525X10000993; Barkley R.A., 2012, EXECUTIVE FUNCTIONS; Batterink L, 2010, NEUROIMAGE, V52, P1696, DOI 10.1016/j.neuroimage.2010.05.059; Berridge KC, 2015, NEURON, V86, P646, DOI 10.1016/j.neuron.2015.02.018; Bezdjian S, 2009, BRIT J DEV PSYCHOL, V27, P365, DOI 10.1348/026151008X314919; Boeka AG, 2008, ARCH CLIN NEUROPSYCH, V23, P467, DOI 10.1016/j.acn.2008.03.003; Buckland NJ, 2018, INT J BEHAV NUTR PHY, V15, DOI 10.1186/s12966-018-0698-9; Callahan S, 2003, ENCEPHALE, V29, P239; Carbine KA, 2017, PSYCHOPHYSIOLOGY, V54, P982, DOI 10.1111/psyp.12860; Chambaron S, 2015, APPETITE, V95, P74, DOI 10.1016/j.appet.2015.06.012; Chambers JM., 1992, STAT MODELS S; Childress AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001506; Coelho JS, 2009, APPETITE, V52, P517, DOI 10.1016/j.appet.2008.10.008; Cohen DA, 2008, DIABETES, V57, P1768, DOI 10.2337/db08-0163; Crewell S., 2003, RADIO SCI, V38, P1; Cserjesi R, 2009, APPETITE, V52, P535, DOI 10.1016/j.appet.2009.01.003; Dai J, 2020, LANCET PUBLIC HLTH, V5; de Oca BM, 2013, AM J PSYCHOL, V126, P287; Deux N, 2017, APPETITE, V112, P157, DOI 10.1016/j.appet.2017.01.031; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Djalalinia S, 2015, PAK J MED SCI, V31, P239, DOI 10.12669/pjms.311.7033; Dohle S, 2018, APPETITE, V124, P4, DOI 10.1016/j.appet.2017.05.041; Doolan KJ, 2014, OBESITY, V22, P2501, DOI 10.1002/oby.20884; Fergenbaum JH, 2009, OBESITY, V17, P1957, DOI 10.1038/oby.2009.161; Forwood SE, 2015, APPETITE, V89, P93, DOI 10.1016/j.appet.2015.01.018; Frank S, 2010, BRAIN RES, V1350, P159, DOI 10.1016/j.brainres.2010.04.030; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Gaillet M, 2013, FOOD QUAL PREFER, V30, P274, DOI 10.1016/j.foodqual.2013.06.008; Glanz K, 2005, AM J HEALTH PROMOT, V19, P330, DOI 10.4278/0890-1171-19.5.330; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Gomez P, 2007, J EXP PSYCHOL GEN, V136, P389, DOI 10.1037/0096-3445.136.3.389; Guerrieri R, 2012, APPETITE, V59, P96, DOI 10.1016/j.appet.2012.04.006; Hall PA, 2012, HEALTH PSYCHOL, V31, P235, DOI 10.1037/a0025407; Hoffmann-Hensel SM, 2017, CHEM SENSES, V42, P723, DOI 10.1093/chemse/bjx046; Houben K, 2014, OBESITY, V22, pE6, DOI 10.1002/oby.20670; Joyner MA, 2017, CLIN PSYCHOL SCI, V5, P1014, DOI 10.1177/2167702617718828; Junghans AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084643; Komaroff M, 2016, J OBESITY; Koster EP, 2002, OLFACTION TASTE COGN; Kulendran M, 2014, INT J OBESITY, V38, P507, DOI 10.1038/ijo.2013.198; Leleu A., 2016, 7 EUR C SENS CONS RE; Loeber S, 2012, INT J OBESITY, V36, P1334, DOI 10.1038/ijo.2011.184; Major B, 2014, J EXP SOC PSYCHOL, V51, P74, DOI 10.1016/j.jesp.2013.11.009; Marteau TM, 2012, SCIENCE, V337, P1492, DOI 10.1126/science.1226918; Marty L, 2017, FRONT NUTR, V4, DOI 10.3389/fnut.2017.00016; Meo SA, 2019, OBESITY FACTS, V12, P150, DOI 10.1159/000499386; Meule A, 2014, APPETITE, V79, P174, DOI 10.1016/j.appet.2014.04.014; Mintz LB, 1997, J COUNS PSYCHOL, V44, P63, DOI 10.1037/0022-0167.44.1.63; Mobbs O, 2011, APPETITE, V57, P263, DOI 10.1016/j.appet.2011.04.023; Munneke J, 2016, ATTEN PERCEPT PSYCHO, V78, P2213, DOI 10.3758/s13414-016-1075-x; Murphy FC, 1999, PSYCHOL MED, V29, P1307, DOI 10.1017/S0033291799001233; Nederkoorn C, 2006, APPETITE, V47, P253, DOI 10.1016/j.appet.2006.05.008; Nummenmaa L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019215; Nuttall FQ, 2015, NUTR TODAY, V50, P117, DOI [10.1097/NT.0000000000000092, DOI 10.1097/NT.0000000000000092]; Paquet C, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0540-9; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Price M, 2016, INT J OBESITY, V40, P877, DOI 10.1038/ijo.2015.235; Prickett C, 2018, OBES SURG, V28, P532, DOI 10.1007/s11695-017-2894-0; Prickett C, 2015, OBES RES CLIN PRACT, V9, P93, DOI 10.1016/j.orcp.2014.05.001; Puhl R, 2001, OBES RES, V9, P788, DOI 10.1038/oby.2001.108; R Core Team, 2018, R LANG ENV STAT COMP; Rumiati RI, 2016, PSYCHON B REV, V23, P1043, DOI 10.3758/s13423-015-0908-2; Sarwer DB, 2016, ENDOCRIN METAB CLIN, V45, P677, DOI 10.1016/j.ecl.2016.04.016; Spence C, 2016, BRAIN COGNITION, V110, P53, DOI 10.1016/j.bandc.2015.08.006; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Teslovich T, 2014, PSYCHIAT RES, V219, P166, DOI 10.1016/j.psychres.2014.04.053; Thomas-Danguin T, 2003, RHINOLOGY, V41, P142; Tiego J, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01339; Townshend T, 2017, PERSPECT PUBLIC HEAL, V137, P38, DOI 10.1177/1757913916679860; Wang GJ, 2008, OBESITY, V16, pS88, DOI 10.1038/oby.2008.469; WEGNER DM, 1994, PSYCHOL REV, V101, P34, DOI 10.1037/0033-295X.101.1.34; Wilson C, 2013, COGNITIVE THER RES, V37, P127, DOI 10.1007/s10608-012-9451-x; Zhang XC, 2009, HUM BRAIN MAPP, V30, P896, DOI 10.1002/hbm.20552; Zimmermann P, 2010, TESTS EVALUATION ATT	87	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2020	15	6							e0228830	10.1371/journal.pone.0228830	http://dx.doi.org/10.1371/journal.pone.0228830			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LZ1GC	32516338	Green Published, gold			2022-12-26	WOS:000540977000027
J	Generaal, JD; Lansdorp, CA; Boonstra, O; van Leeuwen, BL; Vanhauten, HAM; Stevenson, MG; Been, LB				Generaal, Jasmijn D.; Lansdorp, Corine A.; Boonstra, Onno; van Leeuwen, Barbara L.; Vanhauten, Hubertus A. M.; Stevenson, Marc G.; Been, Lukas B.			Hyperbaric oxygen therapy for radiation-induced tissue injury following sarcoma treatment: A retrospective analysis of a Dutch cohort	PLOS ONE			English	Article							SOFT-TISSUE; POSTOPERATIVE RADIOTHERAPY; WOUND COMPLICATIONS; OUTCOMES; SURGERY; PREDICTORS; GROWTH; TRIAL	Background and objectives Sarcomas are commonly managed by surgical resection combined with radiotherapy. Sarcoma treatment is frequently complicated by chronic wounds and late radiation tissue injury (LRTI). This study aims to gain insight in the use and results of hyperbaric oxygen therapy (HBOT) for radiation-induced complications following sarcoma treatment. Methods All sarcoma patients treated between 2006 and 2017 in one of the five centers of the Institute for Hyperbaric Oxygen in the Netherlands were included for retrospective analysis. Results Thirty patients were included, 18 (60.0%) patients were treated for chronic wounds and 12 (40.0%) for LRTI. Two patients with chronic wounds were excluded from analysis as HBOT was discontinued within five sessions. In 11 of 16 (68.8%) patients treated for chronic wounds, improved wound healing was seen. Nine of 12 (75.0%) patients treated for LRTI reported a decline in pain. Reduction of fibrosis was seen in five of eight patients (62.5%) treated for LRTI. Conclusions HBOT is safe and beneficial for treating chronic wounds and LRTI in the sarcoma population. Awaiting further prospective results, we recommend referring to HBOT centers more actively in patients experiencing impaired wound healing or symptoms of delayed radiation-induced tissue injury following multimodality sarcoma treatment.	[Generaal, Jasmijn D.; van Leeuwen, Barbara L.; Stevenson, Marc G.; Been, Lukas B.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Div Surg Oncol, Groningen, Netherlands; [Lansdorp, Corine A.; Boonstra, Onno] Inst Hyperbar Med, Rotterdam, Netherlands; [Vanhauten, Hubertus A. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiat Oncol, Groningen, Netherlands	University of Groningen; University of Groningen	Been, LB (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Div Surg Oncol, Groningen, Netherlands.	l.b.been@umcg.nl						Albertsmeier M, 2018, ANN SURG ONCOL, V25, P754, DOI 10.1245/s10434-017-6081-2; Allen S, 2012, SUPPORT CARE CANCER, V20, P2467, DOI 10.1007/s00520-012-1379-x; [Anonymous], SOFT TISS BON SARC S; [Anonymous], SOFT TISS BON SARC I; Bennett MH, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005005.pub4; Brown KR, 2011, J VASC SURG, V53, p15S, DOI 10.1016/j.jvs.2010.06.175; Clarke RE, 2008, INT J RADIAT ONCOL, V72, P134, DOI 10.1016/j.ijrobp.2007.12.048; Dalla-Favera R., 2014, CANCER CELL, V25, pe131, DOI DOI 10.1093/annonc/mdu254; Dalla-Favera R., 2014, CANCER CELL, V25, pe131, DOI DOI 10.1093/annonc/mdu256; Davis AM, 2005, RADIOTHER ONCOL, V75, P48, DOI 10.1016/j.radonc.2004.12.020; Davis AM, 2002, J CLIN ONCOL, V20, P4472, DOI 10.1200/JCO.2002.03.084; Davis AM, 2000, J SURG ONCOL, V73, P206, DOI 10.1002/(SICI)1096-9098(200004)73:4<206::AID-JSO4>3.0.CO;2-5; De Ru VJ, 1996, RADIOLOGIE STRALINGS, P25; Delanian S, 2004, RADIOTHER ONCOL, V73, P119, DOI 10.1016/j.radonc.2004.08.021; Felderhof JM, 2013, ACTA ONCOL, V52, P745, DOI 10.3109/0284186X.2012.709947; Feldmeier J, 2003, UNDERSEA HYPERBAR M, V30, P1; Feldmeier JJ, 2000, UNDERSEA HYPERBAR M, V27, P15; Feldmeier JJ, 2012, UNDERSEA HYPERBAR M, V39, P1121; Fletcher C., 2013, IARC WHO CLASSIFICAT, V5; Haas RLM, 2012, INT J RADIAT ONCOL, V84, P572, DOI 10.1016/j.ijrobp.2012.01.062; Hampson NB, 2012, CANCER-AM CANCER SOC, V118, P3860, DOI 10.1002/cncr.26637; Hills BA, 1999, MED HYPOTHESES, V52, P259, DOI 10.1054/mehy.1997.0640; MARX RE, 1990, AM J SURG, V160, P519, DOI 10.1016/S0002-9610(05)81019-0; MARX RE, 1983, J ORAL MAXIL SURG, V41, P283, DOI 10.1016/0278-2391(83)90294-X; Milovanova TN, 2009, J APPL PHYSIOL, V106, P711, DOI 10.1152/japplphysiol.91054.2008; Neovius EB, 1997, HEAD NECK-J SCI SPEC, V19, P315, DOI 10.1002/(SICI)1097-0347(199707)19:4<315::AID-HED10>3.0.CO;2-8; O'Sullivan B, 2002, LANCET, V359, P2235, DOI 10.1016/S0140-6736(02)09292-9; Stevenson MG, 2018, EJSO-EUR J SURG ONC, V44, P816, DOI 10.1016/j.ejso.2018.02.002; STINSON SF, 1991, INT J RADIAT ONCOL, V21, P1493, DOI 10.1016/0360-3016(91)90324-W; Teguh DN, 2009, INT J RADIAT ONCOL, V75, P711, DOI 10.1016/j.ijrobp.2008.11.056; Thom SR, 2006, AM J PHYSIOL-HEART C, V290, pH1378, DOI 10.1152/ajpheart.00888.2005; Tibbs MK, 1997, RADIOTHER ONCOL, V42, P99, DOI 10.1016/S0167-8140(96)01880-4	32	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2020	15	6							e0234419	10.1371/journal.pone.0234419	http://dx.doi.org/10.1371/journal.pone.0234419			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ0RE	32511259	Green Published, gold			2022-12-26	WOS:000540938100017
J	Werner, K; Sarangi, D; Nolte, S; Dotray, P; Bagavathiannan, M				Werner, Kaisa; Sarangi, Debalin; Nolte, Scott; Dotray, Peter; Bagavathiannan, Muthukumar			Late-season surveys to document seed rain potential of Palmer amaranth (Amaranthus palmeri) and waterhemp (Amaranthus tuberculatus) in Texas cotton	PLOS ONE			English	Article							ECHINOCHLOA-CRUS-GALLI; GLYPHOSATE RESISTANCE; MANAGEMENT STRATEGIES; WEED COMMUNITIES; SYSTEMS; GROWTH; EMERGENCE; RUDIS; CROP	Weed escapes are often present in large production fields prior to harvest, contributing to seed rain and species persistence. Late-season surveys were conducted in cotton (Gossypium hirsutum L.) fields in Texas in 2016 and 2017 to identify common weed species present as escapes and estimate seed rain potential of Palmer amaranth (Amaranthus palmeri S. Watson) and waterhemp [A. tuberculatus (Moq.) J.D. Sauer], two troublesome species with high fecundity. A total of 400 cotton fields across four major cotton-producing regions in Texas [High Plains (HP), Gulf Coast (GC), Central Texas, and Blacklands] were surveyed. Amaranthus palmeri, Texas millet [Urochloa texana (Buckley) R. Webster], A. tuberculatus, ragweed parthenium (Parthenium hysterophorus L.), and barnyardgrass [Echinochloa crus-galli (L.) P. Beauv.] were reported as the top five weed escapes in cotton fields. Amaranthus palmeri was the most prevalent weed in the HP and Lower GC regions, whereas A. tuberculatus escapes were predominantly observed in the Upper GC and Blacklands regions. On average, 9.4% of an individual field was infested with A. palmeri escapes in the Lower GC region; however, 5.1 to 8.1% of a field was infested in the HP region. Average A. palmeri density ranged from 405 (Central Texas) to 3,543 plants ha(-1) (Lower GC). The greatest seed rain potential by A. palmeri escapes was observed in the upper HP region (13.9 million seeds ha(-1)), whereas the seed rain potential of A. tuberculatus escapes was the greatest in the Blacklands (12.9 million seeds ha(-1)) and the upper GC regions (9.8 million seeds ha(-1)). Seed rain from late-season A. palmeri and A. tuberculatus escapes is significant in Texas cotton, and effective management of these escapes is imperative for minimizing seedbank inputs and impacting weed species persistence.	[Werner, Kaisa; Sarangi, Debalin; Nolte, Scott; Bagavathiannan, Muthukumar] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Dotray, Peter] Texas Tech Univ, Dept Plant & Soil Sci, Lubbock, TX 79409 USA; [Sarangi, Debalin] Univ Wyoming, Dept Plant Sci, Laramie, WY 82071 USA	Texas A&M University System; Texas A&M University College Station; Texas Tech University System; Texas Tech University; University of Wyoming	Bagavathiannan, M (corresponding author), Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA.	muthu@tamu.edu	Nolte, Scott/AAA-2444-2022; Sarangi, Debalin/ABC-8183-2020	Nolte, Scott/0000-0002-8719-2863; Bagavathiannan, Muthukumar/0000-0002-1107-7148	Texas Cotton Support Committee/Cotton Incorporated	Texas Cotton Support Committee/Cotton Incorporated	The research was supported in part by the Texas Cotton Support Committee/Cotton Incorporated and there was no additional external funding received for this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen C, 2011, WEED RES, V51, P214, DOI 10.1111/j.1365-3180.2010.00836.x; Bagavathiannan MV, 2018, PEST MANAG SCI, V74, P2277, DOI 10.1002/ps.4920; Bagavathiannan MV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148748; Bagavathiannan MV, 2013, WEED TECHNOL, V27, P475, DOI 10.1614/WT-D-13-00013.1; Bagavathiannan MV, 2012, WEED SCI, V60, P325, DOI 10.1614/WS-D-11-00222.1; Bajwa AA, 2018, WEED SCI, V66, P62, DOI 10.1017/wsc.2017.61; FRICK B, 1992, CAN J PLANT SCI, V72, P1337, DOI 10.4141/cjps92-166; Garetson R, 2019, WEED TECHNOL, V33, P355, DOI 10.1017/wet.2019.14; Hartzler RG, 1999, WEED SCI, V47, P578, DOI 10.1017/S0043174500092298; Jha P, 2009, WEED SCI, V57, P644, DOI 10.1614/WS-09-074.1; Jordan DL, 1997, WEED TECHNOL, V11, P354, DOI 10.1017/S0890037X00043062; KEELEY PE, 1991, WEED SCI, V39, P369, DOI 10.1017/S0043174500073082; Korres NE, 2016, AGRON SUSTAIN DEV, V36, DOI 10.1007/s13593-016-0350-5; McGinty J, 2017, WEED MANAGEMENT TEXA; Morgan GD, 2001, WEED TECHNOL, V15, P408, DOI 10.1614/0890-037X(2001)015[0408:CIOPAA]2.0.CO;2; Neve P, 2011, WEED TECHNOL, V25, P335, DOI 10.1614/WT-D-10-00171.1; Norsworthy JK, 2016, WEED SCI, V64, P540, DOI 10.1614/WS-D-15-00210.1; Norsworthy JK, 2012, WEED SCI, V60, P31, DOI 10.1614/WS-D-11-00155.1; Reed JD, 2014, WEED TECHNOL, V28, P592, DOI 10.1614/WT-D-14-00029.1; Sarangi D, 2019, WEED TECHNOL, V33, P95, DOI 10.1017/wet.2018.78; Sarangi D, 2018, WEED TECHNOL, V32, P642, DOI 10.1017/wet.2018.35; Sarangi D, 2017, WEED TECHNOL, V31, P53, DOI 10.1017/wet.2016.1; Schwartz LM, 2016, WEED TECHNOL, V30, P284, DOI 10.1614/WT-D-15-00130.1; Schwartz LM, 2016, FSA2180 U ARK COOP E; Sellers BA, 2003, WEED SCI, V51, P329, DOI 10.1614/0043-1745(2003)051[0329:CGOSAS]2.0.CO;2; Singh V, 2020, WEED TECHNOL, V34, P129, DOI 10.1017/wet.2019.78; Smith DT, 2000, WEED TECHNOL, V14, P122, DOI 10.1614/0890-037X(2000)014[0122:PAAPIO]2.0.CO;2; Smith KL, 2011, SUMMARIES ARKANSAS C, V602, P40; Sosnoskie LM, 2013, WEED SCI, V61, P283, DOI 10.1614/WS-D-12-00111.1; Steadman J, 2018, KEEPING TEXAS WEED P; Steadman KJ, 2006, AUST J AGR RES, V57, P133, DOI 10.1071/AR05122; Steckel LE, 2003, WEED SCI, V51, P898, DOI 10.1614/P2002-139; THOMAS AG, 1985, WEED SCI, V33, P34, DOI 10.1017/S0043174500083892; [USDA-APHIS] U.S. Department of Agriculture-Animal and Plant Health Inspection Service, 2018, SYST APPR US SOYB EX; Van Acker RC, 2000, CAN J PLANT SCI, V80, P963; Van Wychen L, 2016, 2015 BASELINE SURVEY; Walsh M, 2013, WEED TECHNOL, V27, P431, DOI 10.1614/WT-D-12-00181.1; Walsh MJ, 2007, WEED TECHNOL, V21, P332, DOI 10.1614/WT-06-086.1; Walsh MJ, 2017, WEED TECHNOL, V31, P178, DOI 10.1017/wet.2017.6	39	4	4	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2020	15	6							e0226054	10.1371/journal.pone.0226054	http://dx.doi.org/10.1371/journal.pone.0226054			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ0RE	32511243	gold, Green Submitted, Green Published			2022-12-26	WOS:000540938100032
J	Gemmer, MR; Richter, C; Jiang, Y; Schmutzer, T; Raorane, ML; Junker, B; Pillen, K; Maurer, A				Gemmer, Mathias Ruben; Richter, Chris; Jiang, Yong; Schmutzer, Thomas; Raorane, Manish L.; Junker, Bjoern; Pillen, Klaus; Maurer, Andreas			Can metabolic prediction be an alternative to genomic prediction in barley?	PLOS ONE			English	Article							WIDE ASSOCIATION; SELECTION; TRAITS; MARKERS	Like other crop species, barley, the fourth most important crop worldwide, suffers from the genetic bottleneck effect, where further improvements in performance through classical breeding methods become difficult. Therefore, indirect selection methods are of great interest. Here, genomic prediction (GP) based on 33,005 SNP markers and, alternatively, metabolic prediction (MP) based on 128 metabolites with sampling at two different time points in one year, were applied to predict multi-year agronomic traits in the nested association mapping (NAM) population HEB-25. We found prediction abilities of up to 0.93 for plant height with SNP markers and of up to 0.61 for flowering time with metabolites. Interestingly, prediction abilities in GP increased after reducing the number of incorporated SNP markers. The estimated effects of GP and MP were highly concordant, indicating MP as an interesting alternative to GP, being able to reflect a stable genotype-specific metabolite profile. In MP, sampling at an early developmental stage outperformed sampling at a later stage. The results confirm the value of GP for future breeding. With MP, an interesting alternative was also applied successfully. However, based on our results, usage of MP alone cannot be recommended in barley. Nevertheless, MP can assist in unravelling physiological pathways for the expression of agronomically important traits.	[Gemmer, Mathias Ruben; Schmutzer, Thomas; Pillen, Klaus; Maurer, Andreas] Martin Luther Univ Halle Wittenberg, Inst Agr & Nutr Sci, Chair Plant Breeding, Halle, Germany; [Richter, Chris; Raorane, Manish L.; Junker, Bjoern] Martin Luther Univ Halle Wittenberg, Inst Pharm, Halle, Germany; [Jiang, Yong] Leibniz Inst Plant Genet & Crop Plant Res, Dept Breeding Res, Quantitat Genet, Gatersleben, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Maurer, A (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Agr & Nutr Sci, Chair Plant Breeding, Halle, Germany.	andreas.maurer@landw.uni-halle.de	Schmutzer, Thomas/W-8705-2019; Pillen, Klaus/I-6511-2012	Schmutzer, Thomas/0000-0003-1073-6719; Pillen, Klaus/0000-0003-4646-6351; Richter, Chris/0000-0001-8615-0322; Maurer, Andreas/0000-0002-2916-7475; Jiang, Yong/0000-0002-2824-677X	European Fund for Regional Development (EFRE) within the research focus "Molecular Biosciences as a Motor of Knowledge-Based Economics"	European Fund for Regional Development (EFRE) within the research focus "Molecular Biosciences as a Motor of Knowledge-Based Economics"	This work was funded by the European Fund for Regional Development (EFRE, https://ec.europa.eu/regional_policy/en/funding/erdf/) within the research focus "Molecular Biosciences as a Motor of Knowledge-Based Economics" (awarded to KP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghnoum R, 2010, MOL PLANT MICROBE IN, V23, P91, DOI 10.1094/MPMI-23-1-0091; Arend D, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-214; Bayer MM, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01792; Bernardo R, 2008, CROP SCI, V48, P1649, DOI 10.2135/cropsci2008.03.0131; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Chan EKF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001198; Chen W, 2014, NAT GENET, V46, P714, DOI 10.1038/ng.3007; Clark SA, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-18; COVARRUBIASPAZARAN, 2016, PLOS ONE, V11, DOI DOI 10.1371/JOURNAL.PONE.0156744; Crossa J, 2014, HEREDITY, V112, P48, DOI 10.1038/hdy.2013.16; Dan ZW, 2016, SCI REP-UK, V6, DOI 10.1038/srep21732; Desta ZA, 2014, TRENDS PLANT SCI, V19, P592, DOI 10.1016/j.tplants.2014.05.006; Dixon RA, 2003, PHYTOCHEMISTRY, V62, P815, DOI 10.1016/S0031-9422(02)00712-4; Fernie AR, 2009, TRENDS GENET, V25, P39, DOI 10.1016/j.tig.2008.10.010; Friendly M, 2002, AM STAT, V56, P316, DOI 10.1198/000313002533; Goddard ME, 2007, J ANIM BREED GENET, V124, P323, DOI 10.1111/j.1439-0388.2007.00702.x; Grewal TS, 2012, MOL BREEDING, V30, P267, DOI 10.1007/s11032-011-9616-4; Hadley Wickham RF, 2018, GRAMMAR DATA MANIPUL; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Henderson C. R, 1984, APPL LINEAR MODELS A; Herzig P, 2019, PLANT SCI, V285, P151, DOI 10.1016/j.plantsci.2019.05.008; Hjorth J.U., 1993, COMPUTER INTENSIVE S; Joseph B, 2013, ELIFE, V2, DOI 10.7554/eLife.00776; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; LANCASHIRE PD, 1991, ANN APPL BIOL, V119, P561, DOI 10.1111/j.1744-7348.1991.tb04895.x; Luo J, 2015, CURR OPIN PLANT BIOL, V24, P31, DOI 10.1016/j.pbi.2015.01.006; Maurer A, 2019, 50K ILLUMINA INFINIU, DOI [10.5447/ipk/2019/20, DOI 10.5447/IPK/2019/20]; Maurer A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1459-7; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen THE, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-2; Meyer RC, 2007, P NATL ACAD SCI USA, V104, P4759, DOI 10.1073/pnas.0609709104; Perez P, 2014, GENETICS, V198, P483, DOI 10.1534/genetics.114.164442; R Core Team, 2018, R LANG ENV STAT COMP; Revelle W., 2018, USE PSYCH PACKAGE FA; Riedelsheimer C, 2012, NAT GENET, V44, P217, DOI 10.1038/ng.1033; Rowe HC, 2008, PLANT CELL, V20, P1199, DOI 10.1105/tpc.108.058131; Rutkoski JE, 2013, G3-GENES GENOM GENET, V3, P427, DOI 10.1534/g3.112.005363; Sakuma S, 2011, PLANT CELL PHYSIOL, V52, P738, DOI 10.1093/pcp/pcr025; Sallam AH, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2014.05.0020; Schauer N, 2006, NAT BIOTECHNOL, V24, P447, DOI 10.1038/nbt1192; Statista, 2019, ANB WICHT GETR WELTW; Steinfath M, 2010, PLANT BIOTECHNOL J, V8, P900, DOI 10.1111/j.1467-7652.2010.00516.x; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Werner CR, 2018, PLANT GENOME-US, V11, DOI 10.3835/plantgenome2017.09.0084; Whittaker JC, 2000, GENET RES, V75, P249, DOI 10.1017/S0016672399004462; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yang J, 2017, NAT GENET, V49, P1304, DOI 10.1038/ng.3941; Zamir D, 2001, NAT REV GENET, V2, P983, DOI 10.1038/35103590; Zhao YS, 2012, THEOR APPL GENET, V124, P769, DOI 10.1007/s00122-011-1745-y	49	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0234052	10.1371/journal.pone.0234052	http://dx.doi.org/10.1371/journal.pone.0234052			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502173	gold, Green Published			2022-12-26	WOS:000542035700043
J	Labrosse, J; Osdoit, M; Hamy, AS; Coussy, F; Pierga, JY; Reyal, F; Laas, E				Labrosse, Julie; Osdoit, Marie; Hamy, Anne-Sophie; Coussy, Florence; Pierga, Jean-Yves; Reyal, Fabien; Laas, Enora			Adjuvant chemotherapy for breast cancer after preoperative chemotherapy: A propensity score matched analysis	PLOS ONE			English	Article							RESIDUAL DISEASE; NEOADJUVANT CHEMOTHERAPY; SYSTEMIC TREATMENT; THERAPY; CAPECITABINE; RECOMMENDATIONS	Although identified to be at a higher risk of relapse, no consensus exists on the treatment of breast cancer (BC) patients with no pathological complete response after neoadjuvant chemotherapy (NAC). The benefit of adjuvant chemotherapy (ADJ) in this context has scarcely been studied. We evaluated the benefit of administrating adjuvant chemotherapy in a real life cohort of BC patients with invasive residual disease after NAC. 1199 female BC patients with T1-3NxM0 invasive tumors receiving NAC at Institut Curie from 2002 to 2012 were included in the analysis. 1061 had been treated by NAC only, whereas 138 had received additional adjuvant chemotherapy after NAC (FUN protocol: 5-FU-Vinorelbine). We compared disease-free survival (DFS) and overall survival (OS) rates between patients having received NAC only and patients having received NAC+ADJ. To ensure comparability of our populations, we used a propensity score (which defines the probability of treatment assignment conditional on observed baseline covariates) and matched each patient having received NAC+ADJ (n = 138) with a patient having received NAC only that had a similar propensity score value. Before propensity score matching, DFS and OS rates were significantly lower in the NAC+ADJ group compared to NAC only, after 3 years, 5 years and 10 years follow-up (p<0.01). After one-to-one PS matching, the two groups were comparable (n = 276 patients; 138 patients in each group). No significant difference was found regarding DFS (p = 0.87) or OS (p = 0.59) rates, neither in global population, nor by pathological subtype. Although our study did not show a benefit of administrating ADJ with FUN protocol (5-Florouracil- Vinorelbine) to BC patients with residual disease after NAC, further studies are warranted to determine the impact of other adjuvant regimens. Thereby, patients with little chance of responding to particular regimens could avoid the toxicity of futile therapy, and be study participants in evaluations of novel treatment strategies.	[Labrosse, Julie; Osdoit, Marie; Reyal, Fabien; Laas, Enora] Inst Curie, Dept Surg, Paris, France; [Hamy, Anne-Sophie; Reyal, Fabien] PSL Res Univ, Translat Res Dept, Residual Tumor & Response Treatment Lab, RT2Lab,INSERM,U932 Immun & Canc,Inst Curie, Paris, France; [Coussy, Florence; Pierga, Jean-Yves] Inst Curie, Dept Med Oncol, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Reyal, F (corresponding author), Inst Curie, Dept Surg, Paris, France.; Reyal, F (corresponding author), PSL Res Univ, Translat Res Dept, Residual Tumor & Response Treatment Lab, RT2Lab,INSERM,U932 Immun & Canc,Inst Curie, Paris, France.	fabien.reyal@curie.fr		Labrosse, Julie/0000-0002-9416-5601; Osdoit, Marie/0000-0003-1123-3400				Alberro JA, 2018, LANCET ONCOL, V19, P27, DOI 10.1016/S1470-2045(17)30777-5; [Anonymous], PEMBR TREAT PAT TRIP; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Balaton AJ, 2008, RECOMMANDATIONS EVAL; Bear HD, 2006, J CLIN ONCOL, V24, P2019, DOI 10.1200/JCO.2005.04.1665; Berry DA, 2006, JAMA-J AM MED ASSOC, V295, P1658, DOI 10.1001/jama.295.14.1658; Bollet MA, 2012, RADIOTHER ONCOL, V102, P82, DOI 10.1016/j.radonc.2011.08.017; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Chen GL, 2017, ONCOL RES, V25, P1567, DOI 10.3727/096504017X14897173032733; Cortazar P, 2014, LANCET, V384, P164, DOI 10.1016/S0140-6736(13)62422-8; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Gonzalez-Angulo AM, 2015, CLIN BREAST CANCER, V15, P325, DOI 10.1016/j.clbc.2015.03.004; Jackisch C, 2015, BREAST CARE, V10, P211, DOI 10.1159/000433590; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Kaufmann M, 2007, ANN ONCOL, V18, P1927, DOI 10.1093/annonc/mdm201; Knauer M, 2009, EJSO-EUR J SURG ONC, V35, P798, DOI 10.1016/j.ejso.2008.10.001; Labarere J, 2008, REV MED INTERNE, V29, P255, DOI 10.1016/j.revmed.2007.08.001; Lluch A, 2012, EUR J CANCER, V48, pS169; Marchand V, 2013, AM J CLIN ONCOL-CANC, V36, P425, DOI 10.1097/COC.0b013e31825466a6; Masuda N, 2017, NEW ENGL J MED, V376, P2147, DOI 10.1056/NEJMoa1612645; Mauri D, 2005, JNCI-J NATL CANCER I, V97, P188, DOI 10.1093/jnci/dji021; Mieog JSD, 2007, BRIT J SURG, V94, P1189, DOI 10.1002/bjs.5894; Patel SA, 2017, CURR ONCOL REP, V19, DOI 10.1007/s11912-017-0613-6; Penault-Llorca F, 2016, NAT REV CLIN ONCOL, V13, P487, DOI 10.1038/nrclinonc.2016.1; Perkins SM, 2000, PHARMACOEPIDEM DR S, V9, P93, DOI 10.1002/(SICI)1099-1557(200003/04)9:2<93::AID-PDS474>3.0.CO;2-I; Senkus E, 2015, ANN ONCOL, V26, pV8, DOI 10.1093/annonc/mdv298; STONE RA, 1995, MED CARE, V33, pAS56; Thomas E, 2004, J CLIN ONCOL, V22, P2294, DOI 10.1200/JCO.2004.05.207; von Minckwitz G, 2019, NEW ENGL J MED, V380, P617, DOI 10.1056/NEJMoa1814017; von Minckwitz G, 2016, EUR J CANCER, V64, P12, DOI 10.1016/j.ejca.2016.05.015; von Minckwitz G, 2012, J CLIN ONCOL, V30, P1796, DOI 10.1200/JCO.2011.38.8595; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984	32	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0234173	10.1371/journal.pone.0234173	http://dx.doi.org/10.1371/journal.pone.0234173			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502222	Green Published, gold			2022-12-26	WOS:000542035700042
J	Onarheim, KH; Moland, KM; Molla, M; Miljeteig, I				Onarheim, Kristine Husoy; Moland, Karen Marie; Molla, Mitike; Miljeteig, Ingrid			'I wanted to go, but they said wait': Mothers' bargaining power and strategies in care-seeking for ill newborns in Ethiopia	PLOS ONE			English	Article							DECISION-MAKING; HEALTH-CARE; HOUSEHOLD; ILLNESS; MALARIA; ROLES	Introduction To prevent the 2.6 million newborn deaths occurring worldwide every year, health system improvements and changes in care-taker behaviour are necessary. Mothers are commonly assumed to be of particular importance in care-seeking for ill babies; however, few studies have investigated their participation in these processes. This study explores mothers' roles in decision making and strategies in care-seeking for newborns falling ill in Ethiopia. Methods A qualitative study was conducted in Butajira, Ethiopia. Data were collected during the autumn of 2015 and comprised 41 interviews and seven focus group discussions. Participants included primary care-takers who had experienced recent newborn illness or death, health care workers and community members. Data were analysed using thematic analysis. Results Choices about whether, where and how to seek care for ill newborns were made through cooperation and negotiation among household members. Mothers were considered the ones that initially identified or recognised illness, but their actual opportunities to seek care were bounded by structural and cultural constraints. Mothers' limited bargaining power, contained by financial resources and gendered decision making, shaped their roles in care-seeking. We identified three strategies mothers took on in decision making for newborn illness: (a) acceptance and adaptation (to the lack of options), (b) negotiation and avoidance of advice from others, and (c) active care-seeking and opposition against the husband's or community's advice. Conclusion While the literature on newborn health and parenting emphasizes the key role of mothers in care-seeking, their actual opportunities to seek care are shaped by factors commonly beyond their control. Efforts to promote care-seeking for ill children should recognise that mothers' capabilities to make decisions are embedded in gendered social processes and financial power structures. Thus, policies should not only target individual mothers, but the wider decision making group, including the head of households and extended family.	[Onarheim, Kristine Husoy; Moland, Karen Marie; Miljeteig, Ingrid] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Onarheim, Kristine Husoy] UCL, Inst Global Hlth, London, England; [Onarheim, Kristine Husoy; Moland, Karen Marie] Univ Bergen, Ctr Intervent Sci Maternal & Child Hlth, Bergen, Norway; [Molla, Mitike] Addis Ababa Univ, Coll Hlth Sci, Sch Publ Hlth, Addis Ababa, Ethiopia; [Miljeteig, Ingrid] Helse Bergen Hlth Trust, Dept Res & Dev, Bergen, Norway	University of Bergen; University of London; University College London; University of Bergen; Addis Ababa University	Onarheim, KH (corresponding author), Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway.; Onarheim, KH (corresponding author), UCL, Inst Global Hlth, London, England.; Onarheim, KH (corresponding author), Univ Bergen, Ctr Intervent Sci Maternal & Child Hlth, Bergen, Norway.	kristine.onarheim@uib.no	Miljeteig, Ingrid/AAW-8728-2020	Onarheim, Kristine Husoy/0000-0001-8796-4782	University of Bergen, Norway	University of Bergen, Norway	This study was funded by the University of Bergen, Norway (personal PhD grant). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal B., 1997, FEM ECON, V3, P1, DOI [10.1080/135457097338799, DOI 10.1080/135457097338799]; Berhane Y, 2019, J ADOLESCENT HEALTH, V64, pS52, DOI 10.1016/j.jadohealth.2018.12.018; Bogale TN, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0967-9; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Central statistical agency (CSA) [Ethiopia] and ICF, 2016, ETH DEM HLTH SURV 20; Central Statistical Agency II, 2012, ETH DEM HLTH SURV 20; Colvin CJ, 2013, SOC SCI MED, V86, P66, DOI 10.1016/j.socscimed.2013.02.031; Demissie M, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-23; Ellis AA, 2013, J BIOSOC SCI, V45, P743, DOI 10.1017/S0021932013000163; Federal Democratic Republic of Ethiopia Ministry of Health, 2015, HLTH SECT DEV PROGR; Federal Democratic Republic of Ethiopia Ministry of Health, 2015, NAT NEWB CHILD SURV; Federal Democratic Republic of Ethiopia Ministry of Health, 2014, VIS ETH PATH UN HLTH; George AS, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000811; Hampshire KR, 2009, SOC SCI MED, V68, P758, DOI 10.1016/j.socscimed.2008.11.014; Hill Z, 2003, TROP MED INT HEALTH, V8, P668, DOI 10.1046/j.1365-3156.2003.01058.x; Husoy OK, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-2943-y; Institute for Health Metrics and Evaluation, 2017, GDB RES TOOL; Jeong J, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6143-9; Kassa GM, 2020, TRAUMA VIOLENCE ABUS, V21, P624, DOI 10.1177/1524838018782205; Mekonnen W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-782; Melberg A, 2018, SOC SCI MED, V215, P28, DOI 10.1016/j.socscimed.2018.09.001; Memirie ST, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000166; Moucheraud C, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S1-S4; Okoko BJ, 2006, ARCH MED RES, V37, P399, DOI 10.1016/j.arcmed.2005.07.007; Onarheim KH, 2017, SOC SCI MED, V195, P123, DOI 10.1016/j.socscimed.2017.11.003; Onarheim KH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150120; Richards E, 2013, SOC SCI MED, V95, P24, DOI 10.1016/j.socscimed.2012.06.015; Tesfahun F, 2014, MATERN CHILD HLTH J, V18, P2341, DOI 10.1007/s10995-014-1474-3; Tolhurst R, 2006, T ROY SOC TROP MED H, V100, P321, DOI 10.1016/j.trstmh.2005.05.004; Tolhurst R, 2008, SOC SCI MED, V66, P1106, DOI 10.1016/j.socscimed.2007.11.032; Wang HD, 2016, LANCET, V388, P1725, DOI 10.1016/S0140-6736(16)31575-6; World Economic Forum, 2018, GLOBAL GENDER GAP RE; World Health Organization, 2017, WORK IND FAM COMM IM; World Health Organization, 2017, WHO REC NEWB HLTH; World Health Organization, 2017, EV NEWB ACT PLAN RES	35	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0233594	10.1371/journal.pone.0233594	http://dx.doi.org/10.1371/journal.pone.0233594			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MA6QB	32502223	Green Published, gold			2022-12-26	WOS:000542035700027
J	Pineda, AM; Ramos, FM; Betting, LE; Campanharo, ASLO				Pineda, Aruane M.; Ramos, Fernando M.; Betting, Luiz Eduardo; Campanharo, Andriana S. L. O.			Quantile graphs for EEG-based diagnosis of Alzheimer's disease	PLOS ONE			English	Article							QUANTITATIVE EEG; BIOMARKERS	Known as a degenerative and progressive dementia, Alzheimer's disease (AD) affects about 25 million elderly people around the world. This illness results in a decrease in the productivity of people and places limits on their daily lives. Electroencephalography (EEG), in which the electrical brain activity is recorded in the form of time series and analyzed using signal processing techniques, is a well-known neurophysiological AD biomarker. EEG is noninvasive, low-cost, has a high temporal resolution, and provides valuable information about brain dynamics in AD. Here, we present an original approach based on the use of quantile graphs (QGs) for classifying EEG data. QGs map frequency, amplitude, and correlation characteristics of a time series (such as the EEG data of an AD patient) into the topological features of a network. The five topological network metrics used here-clustering coefficient, mean jump length, betweenness centrality, modularity, and Laplacian Estrada index-showed that the QG model can distinguish healthy subjects from AD patients, with open or closed eyes. The QG method also indicates which channels (corresponding to 19 different locations on the patients' scalp) provide the best discriminating power. Furthermore, the joint analysis of delta, theta, alpha, and beta wave results indicate that all AD patients under study display clear symptoms of the disease and may have it in its late stage, a diagnosis known a priori and supported by our study. Results presented here attest to the usefulness of the QG method in analyzing complex, nonlinear signals such as those generated from AD patients by EEGs.	[Pineda, Aruane M.; Campanharo, Andriana S. L. O.] Sao Paulo State Univ UNESP, Inst Biosci, Dept Biostat, Botucatu, SP, Brazil; [Ramos, Fernando M.] Earth Syst Sci Ctr CCST, Natl Inst Space Res INPE, Sao Jose Dos Campos, SP, Brazil; [Betting, Luiz Eduardo] Sao Paulo State Univ UNESP, Botucatu Med Sch, Inst Biosci, Dept Neurol Psychol & Psychiat, Botucatu, SP, Brazil	Universidade Estadual Paulista; Instituto Nacional de Pesquisas Espaciais (INPE); Universidade Estadual Paulista	Campanharo, ASLO (corresponding author), Sao Paulo State Univ UNESP, Inst Biosci, Dept Biostat, Botucatu, SP, Brazil.	andriana.campanharo@unesp.br	Campanharo, Andriana S L O/J-4600-2013; Mello Pineda, Aruane/H-1996-2019	Campanharo, Andriana S L O/0000-0002-0501-5303; Mello Pineda, Aruane/0000-0002-4469-5049	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]; Sao Paulo Research Foundation (FAPESP) [2018/25358-9, 2020/04989-0, 2016/17914-3]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001. L. E. B. acknowledges the support of Sao Paulo Research Foundation (FAPESP), grant 2016/17914-3. A. S. L. O. C. acknowledges the support of Sao Paulo Research Foundation (FAPESP), grants 2018/25358-9 and 2020/04989-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya R, 2005, COMPUT METH PROG BIO, V80, P37, DOI 10.1016/j.cmpb.2005.06.011; Aisen PS, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0283-5; Al-Nuaimi AHH, 2018, COMPLEXITY, DOI 10.1155/2018/8915079; Alotaiby TN, 2014, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2014-183; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; [Anonymous], 2017, MATLAB VERSION 9 3 0; Bennys K, 2001, NEUROPHYSIOL CLIN, V31, P153, DOI 10.1016/S0987-7053(01)00254-4; Boccaletti S, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.045102; Bounova G, 2011, MATLAB TOOLS NETWORK; Budson A.E., 2015, MEMORY LOSS ALZHEIME; Campanharo ASLO, 2020, NEURAL PROCESS LETT, V52, P5, DOI 10.1007/s11063-018-9936-z; Campanharo ASLO, 2017, LECT NOTES COMPUT SC, V10306, P95, DOI 10.1007/978-3-319-59147-6_9; Campanharo ASLO, 2016, PHYSICA A, V444, P43, DOI 10.1016/j.physa.2015.09.094; Campanharo ASLO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023378; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Cvetkovic D. M., 1980, SPECTRA GRAPHS, V10; Davatzikos C, 2019, NEUROIMAGE, V197, P652, DOI 10.1016/j.neuroimage.2018.10.003; Executive summary, 2007, FOOD NUTR BULL, V28, pS399; Fath-Tabar G.H., 2009, B ACAD MIE SERBE SCI, V34, P1; Feldman HH, 2005, NEUROLOGY, V65, pS10, DOI 10.1212/WNL.65.6_suppl_3.S10; Fiscon G, 2018, BMC MED INFORM DECIS, V18, DOI 10.1186/s12911-018-0613-y; Fiscon G, 2014, 2014 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE AND DATA MINING (CIDM), P105, DOI 10.1109/CIDM.2014.7008655; Fjell AM, 2014, PROG NEUROBIOL, V117, P20, DOI 10.1016/j.pneurobio.2014.02.004; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Fujii R, 2000, PIGM CELL RES, V13, P300, DOI 10.1034/j.1600-0749.2000.130502.x; GBD 2015 Eastern Mediterranean Region Collaborators, 2018, INT J PUBLIC HLTH S1, V63, pS11; Ghorbanian P, 2015, MED BIOL ENG COMPUT, V53, P843, DOI 10.1007/s11517-015-1298-3; Guimera R, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/02/P02001; Helkala EL, 1996, BEHAV NEUROSCI, V110, P1235, DOI 10.1037/0735-7044.110.6.1235; Henry J.C., 2006, NEUROLOGY, V67, P2092, DOI [DOI 10.1212/01.WNL.0000243257.85592.9A, 10.1212/01.wnl.0000243257.85592.9a]; Herrmann C. S., 2005, EVENT RELATED POTENT, P229; Horvath A, 2018, FRONT BIOSCI-LANDMRK, V23, P183, DOI 10.2741/4587; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; Insurance Institute for Highway Safety, 2010, STATUS REP, V45; Jeong JS, 2004, CLIN NEUROPHYSIOL, V115, P1490, DOI 10.1016/j.clinph.2004.01.001; Kantz H., 2003, NONLINEAR TIME SERIE; Karlawish Jason, 2017, Alzheimers Dement, V13, P374, DOI 10.1016/j.jalz.2017.02.006; Korner T.W., 1988, FOURIER ANAL; Kumar S, 2020, COMMIMITY WORK FAM, V23, P1, DOI 10.1080/13668803.2017.1365693; Locatelli T, 1998, ELECTROEN CLIN NEURO, V106, P229, DOI 10.1016/S0013-4694(97)00129-6; LOEWENSTEIN DA, 1989, ARCH NEUROL-CHICAGO, V46, P146, DOI 10.1001/archneur.1989.00520380046012; Lopez-de-Ipina K, 2018, CURR ALZHEIMER RES, V15, P139, DOI 10.2174/1567205014666171120143800; Morris A. S., 2012, MEASUREMENT INSTRUME; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Pineda AM, 2020, CODE QUANTILE GRAPHS; Pineda AM, 2019, LECT NOTES COMPUT SC, V11506, P115, DOI 10.1007/978-3-030-20521-8_10; Pritchard W.S., 1991, DEMENTIA, V2, P102, DOI DOI 10.1159/000107183; PRITCHARD WS, 1994, ELECTROEN CLIN NEURO, V91, P118, DOI 10.1016/0013-4694(94)90033-7; Ramos FM, 2020, DATA QUANTILE GRAPHS; Ridouh A, 2017, J CIRCUIT SYST COMP, V26, DOI 10.1142/S0218126617501985; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; Saramaki J, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.027105; Sharma N, 2016, J CLIN DIAGN RES, V10, pKE1, DOI 10.7860/JCDR/2016/18828.8166; Smits FM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149587; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Stam CJ, 1996, CLIN ELECTROENCEPHAL, V27, P69, DOI 10.1177/155005949602700205; Ubeyli ED, 2011, COMPUT BIOL MED, V38; Who.int, 2012, DEMENTIA; Yagneswaran S, 2002, P ANN INT IEEE EMBS, P46, DOI 10.1109/IEMBS.2002.1134380; Yang S, 2019, IEEE T BIO-MED ENG, V66, P2924, DOI 10.1109/TBME.2019.2898871; 2015, SEWAGE DISPOSAL CLOV, V15, pS1	62	6	6	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0231169	10.1371/journal.pone.0231169	http://dx.doi.org/10.1371/journal.pone.0231169			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502204	Green Submitted, gold, Green Published			2022-12-26	WOS:000542035700003
J	Wang, YP; Nakajima, T; Diao, P; Yamada, Y; Nakamura, K; Nakayama, J; Tanaka, N; Aoyama, T; Kamijo, Y				Wang, Yaping; Nakajima, Takero; Diao, Pan; Yamada, Yosuke; Nakamura, Kozo; Nakayama, Jun; Tanaka, Naoki; Aoyama, Toshifumi; Kamijo, Yuji			Polyunsaturated fatty acid deficiency affects sulfatides and other sulfated glycans in lysosomes through autophagy-mediated degradation	FASEB JOURNAL			English	Article						amyloid precursor protein; Erk1; 2; glycosaminoglycans; lysosome enzyme; mTOR; nutritional deprivation	ACTIVATED RECEPTOR-ALPHA; EARLY ALZHEIMERS-DISEASE; CHONDROITIN SULFATE; BETA-GLUCURONIDASE; HEPARAN-SULFATE; KIDNEY; BRAIN; MTOR; CELLS; GLYCOSAMINOGLYCANS	Metabolic changes in sulfatides and other sulfated glycans have been related to various diseases, including Alzheimer's disease (AD). However, the importance of polyunsaturated fatty acids (PUFA) in sulfated lysosomal substrate metabolism and its related disorders is currently unknown. We investigated the effects of deficiency or supplementation of PUFA on the metabolism of sulfatides and sulfated glycosaminoglycans (sGAGs) in sulfatide-rich organs (brain and kidney) of mice. A PUFA-deficient diet for over 5 weeks significantly reduced the sulfatide expression by increasing the sulfatide degradative enzymes arylsulfatase A and galactosylceramidase in brain and kidney. This sulfatide degradation was clearly associated with the activation of autophagy and lysosomal hyperfunction, the former of which was induced by suppression of the Erk/mTOR pathway. A PUFA-deficient diet also activated the degradation of sGAGs in the brain and kidney and that of amyloid precursor proteins in the brain, indicating an involvement in general lysosomal function and the early developmental process of AD. PUFA supplementation prevented all of the above abnormalities. Taken together, a PUFA deficiency might lead to sulfatide and sGAG degradation associated with autophagy activation and general lysosomal hyperfunction and play a role in many types of disease development, suggesting a possible benefit of prophylactic PUFA supplementation.	[Wang, Yaping; Nakajima, Takero; Diao, Pan; Yamada, Yosuke; Tanaka, Naoki; Aoyama, Toshifumi; Kamijo, Yuji] Shinshu Univ, Dept Metab Regulat, Sch Med, Matsumoto, Nagano, Japan; [Yamada, Yosuke; Kamijo, Yuji] Shinshu Univ, Dept Nephrol, Sch Med, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan; [Nakamura, Kozo] Shinshu Univ, Dept Biosci & Biotechnol, Fac Agr, Minamiminowa, Japan; [Nakayama, Jun] Shinshu Univ, Dept Mol Pathol, Sch Med, Matsumoto, Nagano, Japan	Shinshu University; Shinshu University; Shinshu University; Shinshu University	Kamijo, Y (corresponding author), Shinshu Univ, Dept Nephrol, Sch Med, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	yujibeat@shinshu-u.ac.jp		Tanaka, Naoki/0000-0002-3212-3836	 [18K08204]		Grant-in-Aid for Scientific Research (Kakenhi) in Japan, Grant/Award Number: 18K08204	Aggleton JP, 2016, BRAIN, V139, P1877, DOI 10.1093/brain/aww083; Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Ashabi G, 2013, TOXICOL IN VITRO, V27, P1780, DOI 10.1016/j.tiv.2013.05.005; Bankaitis VA, 2015, EMBO J, V34, P978, DOI 10.15252/embj.201591392; Bazinet RP, 2014, NAT REV NEUROSCI, V15, P771, DOI 10.1038/nrn3820; Belibi F, 2011, AM J PHYSIOL-RENAL, V300, pF1235, DOI 10.1152/ajprenal.00348.2010; Cheng BJ, 2018, FOOD CHEM TOXICOL, V122, P143, DOI 10.1016/j.fct.2018.10.030; Cheng H, 2013, J NEUROCHEM, V127, P733, DOI 10.1111/jnc.12368; Cheng H, 2010, J LIPID RES, V51, P1599, DOI 10.1194/jlr.D004077; DECATERINA R, 1994, AM J KIDNEY DIS, V24, P397, DOI 10.1016/S0272-6386(12)80896-1; Dehay B, 2010, J NEUROSCI, V30, P12535, DOI 10.1523/JNEUROSCI.1920-10.2010; DESHMUKH GD, 1994, J LIPID RES, V35, P1611; DONADIO JV, 1991, MAYO CLIN PROC, V66, P1018, DOI 10.1016/S0025-6196(12)61725-X; Dunlop EA, 2014, SEMIN CELL DEV BIOL, V36, P121, DOI 10.1016/j.semcdb.2014.08.006; Egan DF, 2011, AUTOPHAGY, V7, P645, DOI 10.4161/auto.7.6.15123; Fabelo N, 2011, MOL MED, V17, P1107, DOI 10.2119/molmed.2011.00119; Han XL, 2010, MOL NEUROBIOL, V41, P97, DOI 10.1007/s12035-009-8092-x; Han XL, 2002, J NEUROCHEM, V82, P809, DOI 10.1046/j.1471-4159.2002.00997.x; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Harvey SJ, 2012, METHODS MOL BIOL, V836, P259, DOI 10.1007/978-1-61779-498-8_17; He LY, 2014, NEPHRON CLIN PRACT, V127, P56, DOI 10.1159/000363677; Honke K, 2002, P NATL ACAD SCI USA, V99, P4227, DOI 10.1073/pnas.032068299; Hosono T, 2015, BRAIN RES, V1613, P92, DOI 10.1016/j.brainres.2015.04.005; Hu BL, 2015, AUTOPHAGY, V11, P503, DOI 10.1080/15548627.2015.1017184; Huang XY, 2013, J NEPHROL, V26, P960, DOI 10.5301/jn.5000284; INNIS SM, 1991, PROG LIPID RES, V30, P39, DOI 10.1016/0163-7827(91)90006-Q; Ishibashi T, 2002, J NEUROSCI, V22, P6507; Ishii M, 2015, CELL METAB, V22, P761, DOI 10.1016/j.cmet.2015.08.016; Ishizuka I, 1997, PROG LIPID RES, V36, P245, DOI 10.1016/S0163-7827(97)00011-8; Jeon SB, 2008, J IMMUNOL, V181, P8077, DOI 10.4049/jimmunol.181.11.8077; Jonsson M, 2012, DEMENT GERIATR COGN, V34, P61, DOI 10.1159/000341576; Kadomatsu K, 2014, ARCH BIOCHEM BIOPHYS, V558, P36, DOI 10.1016/j.abb.2014.06.009; Kamijo Y, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000018403.61042.56; Kamijo Y, 2007, J AM SOC NEPHROL, V18, P3089, DOI 10.1681/ASN.2007020238; Kelsey KM, 2020, CELL TISSUE RES, V379, P561, DOI 10.1007/s00441-019-03144-1; Kim IC, 2016, J MASS SPECTROM, V51, P182, DOI 10.1002/jms.3736; Kim SG, 2013, MOL CELLS, V35, P463, DOI 10.1007/s10059-013-0138-2; Kocaturk NM, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00128; Lafourcade M, 2011, NAT NEUROSCI, V14, P345, DOI 10.1038/nn.2736; Lemos CCS, 2013, BRAZ J MED BIOL RES, V46, P567, DOI 10.1590/1414-431X20132339; Lensen JFM, 2005, J AM SOC NEPHROL, V16, P1279, DOI 10.1681/ASN.2004050413; Li G, 2007, ANAL BIOCHEM, V362, P1, DOI 10.1016/j.ab.2006.12.024; Li HY, 2016, AUTOPHAGY, V12, P1472, DOI 10.1080/15548627.2016.1190071; Li XJ, 2017, ACTA HISTOCHEM, V119, P439, DOI 10.1016/j.acthis.2017.04.001; Li YL, 2015, NEUROSCI LETT, V600, P206, DOI 10.1016/j.neulet.2015.06.024; Lindahl B, 1996, J BIOL CHEM, V271, P16991, DOI 10.1074/jbc.271.29.16991; Lu J, 2003, J NUTR, V133, P180, DOI 10.1093/jn/133.1.180; Ludewig S, 2017, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00161; Maeda N, 2011, NEUROCHEM RES, V36, P1228, DOI 10.1007/s11064-010-0324-y; Marcus J, 2006, GLIA, V53, P372, DOI 10.1002/glia.20292; Marsching C, 2011, ANAL BIOANAL CHEM, V401, P53, DOI 10.1007/s00216-011-4802-0; Masola V, 2014, NEPHROL DIAL TRANSPL, V29, pI74, DOI 10.1093/ndt/gft389; McLaughlin RW, 2006, PROTEIN SCI, V15, P1710, DOI 10.1110/ps.051997606; Mehra S, 2018, J BIOL CHEM, V293, P12975, DOI 10.1074/jbc.RA118.004267; Melk A, 2016, AUTOPHAGY, V12, P596, DOI 10.1080/15548627.2015.1135284; Huynh MB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209573; Miyata S, 2016, FRONT BIOSCI-LANDMRK, V21, P1330, DOI 10.2741/4460; Moriyama T, 2018, INTERNAL MED, V57, P173, DOI 10.2169/internalmedicine.9155-17; Nakajima T, 2017, TOHOKU J EXP MED, V242, P229, DOI 10.1620/tjem.242.229; Niso-Santano M, 2015, AUTOPHAGY, V11, P575, DOI 10.1080/15548627.2015.1017222; Niso-Santano M, 2015, EMBO J, V34, P1025, DOI 10.15252/embj.201489363; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Palmieri M, 2011, HUM MOL GENET, V20, P3852, DOI 10.1093/hmg/ddr306; POLLACK SJ, 1995, NEUROSCI LETT, V197, P211, DOI 10.1016/0304-3940(95)11939-T; Puglielli L, 2003, J BIOL CHEM, V278, P19777, DOI 10.1074/jbc.M300466200; Reine TM, 2013, J HISTOCHEM CYTOCHEM, V61, P606, DOI 10.1369/0022155413494392; Ren HX, 2017, FASEB J, V31, P282, DOI 10.1096/fj.201600896; Rice HC, 2019, SCIENCE, V363, P143, DOI 10.1126/science.aao4827; Schreiber A, 2014, BBA-MOL CELL RES, V1843, P163, DOI 10.1016/j.bbamcr.2013.03.019; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Sharma A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050751; SNOW AD, 1990, AM J PATHOL, V137, P1253; Spector AA, 2015, J LIPID RES, V56, P11, DOI 10.1194/jlr.R055095; Spence Justin, 2017, Consult Pharm, V32, P412, DOI 10.4140/TCP.n.2017.412; Stettner P, 2013, P NATL ACAD SCI USA, V110, P9998, DOI 10.1073/pnas.1217775110; Su HM, 2010, J NUTR BIOCHEM, V21, P364, DOI 10.1016/j.jnutbio.2009.11.003; Su LY, 2015, AUTOPHAGY, V11, P1745, DOI 10.1080/15548627.2015.1082020; SUKEGAWA K, 1985, J INHERIT METAB DIS, V8, P145, DOI 10.1007/BF01819300; Sun YJ, 2013, FOOD CHEM TOXICOL, V51, P53, DOI 10.1016/j.fct.2012.09.012; Sun Y, 2013, AUTOPHAGY, V9, P1115, DOI 10.4161/auto.24919; Suttkus A, 2016, MOL NEUROBIOL, V53, P73, DOI 10.1007/s12035-014-8990-4; Takahashi T, 2012, J LIPID RES, V53, P1437, DOI 10.1194/jlr.R026682; Thomas J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/172801; Vogler C, 2003, P NATL ACAD SCI USA, V100, P2669, DOI 10.1073/pnas.0437941100; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xiao SY, 2013, ADV EXP MED BIOL, V991, P27, DOI 10.1007/978-94-007-6331-9_3; Xing SH, 2012, AUTOPHAGY, V8, P63, DOI 10.4161/auto.8.1.18217; Yamada Y, 2019, GLYCOCONJUGATE J, V36, P1, DOI 10.1007/s10719-018-9850-7; Yu WH, 2004, INT J BIOCHEM CELL B, V36, P2531, DOI 10.1016/j.biocel.2004.05.010; ZALC B, 1978, FEBS LETT, V92, P92, DOI 10.1016/0014-5793(78)80729-7; Zeng YC, 2008, J NEUROCHEM, V106, P1275, DOI 10.1111/j.1471-4159.2008.05481.x; Zhang BY, 2019, J VIROL, V93, DOI 10.1128/JVI.00172-19; Zhang J, 2012, J NEUROCHEM, V120, P564, DOI 10.1111/j.1471-4159.2011.07496.x; Zhang Z, 2016, NAGOYA J MED SCI, V78, P293; Zheng H, 2018, BBA-MOL BASIS DIS, V1864, P263, DOI 10.1016/j.bbadis.2017.10.028	96	2	2	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9594	9614		10.1096/fj.202000030RR	http://dx.doi.org/10.1096/fj.202000030RR		JUN 2020	21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32501606	Green Submitted, Green Published			2022-12-26	WOS:000539539500001
J	Dowarha, D; Chou, RH; Yu, C				Dowarha, Deepu; Chou, Ruey-Hwang; Yu, Chin			S100A1 blocks the interaction between p53 and mdm2 and decreases cell proliferation activity	PLOS ONE			English	Article							N-TERMINAL DOMAIN; ONCOPROTEIN MDM2; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; PROTEIN STRUCTURES; ACTIVATION DOMAIN; BINDING-AFFINITY; CHEMICAL-SHIFT; WEB SERVER; TAT	About 50% of human cancers across the globe arise due to a mutation in the p53 gene which gives rise to its functional inactive form, and in the rest of the cancer the efficacy of active p53 (wild-type) is hindered by MDM2-mediated degradation. Breakdown of the p53-MDM2 association may constitute an effective strategy to stimulate or reinstate the activity of wild type p53, thereby reviving the p53 tumor suppressor capability. S100A1 has been revealed to associate with the N-terminal domain of MDM2 and p53 protein. We utilized NMR spectroscopy to study the interface amongst the S100A1 and N-terminal domain of MDM2. Additionally, the S100A1-MDM2 complex generated through the HADDOCK program was then superimposed with the p53 (peptide) -MDM2 complex reported earlier. The overlay indicated that a segment of S100A1 could block the interaction of p53 (peptide) -MDM2 complex significantly. To further justify our assumption, we performed HSQC-NMR titration for the S100A1 and p53 N-terminal domain (p53-TAD). The data obtained indicated that the S100A1 segment comprising nearly 17 residues have some common residues that interact with both MDM2 and p53-TAD. Further, we synthesized the 17-residue peptide derived from the S100A1 protein and attached it to the cell-penetrating HIV-TAT peptide. The HSQC-NMR competitive binding experiment revealed that Peptide 1 could successfully interfere with the p53-MDM2 interaction. Furthermore, functional effects of the peptide was validated in cancer cells. The results showed that Peptide 1 effectively inhibited cell proliferation, and increased the protein levels of p53 and its downstream p21 in MCF-7 cells. Treatment of Peptide 1 resulted in cell cycle arrest at G2/M phase, and also induced apoptotic cell death at higher concentration. Taken together, the results suggest that disruption of the interaction of p53 and MDM2 by Peptide 1 could activate normal p53 functions, leading to cell cycle arrest and apoptotic cell death in cancer cells. We proposed here that S100A1 could influence the p53-MDM2 interaction credibly and possibly reactivates the wild type p53 pathway.	[Dowarha, Deepu; Yu, Chin] Natl Tsing Hua Univ, Dept Chem, Hsinchu, Taiwan; [Chou, Ruey-Hwang] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan; [Chou, Ruey-Hwang] China Med Univ, Ctr Mol Med, Taichung, Taiwan; [Chou, Ruey-Hwang] Asia Univ, Dept Biotechnol, Taichung, Taiwan	National Tsing Hua University; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan	Yu, C (corresponding author), Natl Tsing Hua Univ, Dept Chem, Hsinchu, Taiwan.; Chou, RH (corresponding author), China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan.; Chou, RH (corresponding author), China Med Univ, Ctr Mol Med, Taichung, Taiwan.; Chou, RH (corresponding author), Asia Univ, Dept Biotechnol, Taichung, Taiwan.	cyu.nthu@gmail.com; rhchou@cmu.edu.tw	Chou, Ruey-Hwang/K-8541-2013	Chou, Ruey-Hwang/0000-0002-2297-2180; Dowarha, Deepu/0000-0001-9986-368X	MOST (Ministry of Science and Technology) [MOST107B307915, MOST 108-2320-B-039-013]; China Medical University [CMU108-MF-49]	MOST (Ministry of Science and Technology); China Medical University(China Medical University)	This work was supported by a grant from MOST (Ministry of Science and Technology) Grant number MOST107B307915 (Chin Yu), MOST 108-2320-B-039-013 (Ruey-Hwang Chou), and from China Medical University, CMU108-MF-49 (Ruey-Hwang Chou). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MOST URL-https://www.most.gov.tw/?l=en CMU URLhttps://english.cmu.edu.tw/index.php.	Aroui S, 2010, BIOCHEM BIOPH RES CO, V391, P419, DOI 10.1016/j.bbrc.2009.11.073; Borcherds W, 2014, NAT CHEM BIOL, V10, P1000, DOI 10.1038/nchembio.1668; Bottger V, 1999, ONCOGENE, V18, P189, DOI 10.1038/sj.onc.1202281; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Brooks H, 2005, ADV DRUG DELIVER REV, V57, P559, DOI 10.1016/j.addr.2004.12.001; CHANG J, 1995, J BIOL CHEM, V270, P25014, DOI 10.1074/jbc.270.42.25014; Chene P, 2002, FEBS LETT, V529, P293, DOI 10.1016/S0014-5793(02)03362-8; Chi SW, 2005, J BIOL CHEM, V280, P38795, DOI 10.1074/jbc.M508578200; Dawson R, 2003, J MOL BIOL, V332, P1131, DOI 10.1016/j.jmb.2003.08.008; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Deshayes S, 2005, CELL MOL LIFE SCI, V62, P1839, DOI 10.1007/s00018-005-5109-0; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Evans SC, 2001, ONCOGENE, V20, P4041, DOI 10.1038/sj.onc.1204533; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; Fernandez-Fernandez MR, 2008, PROTEIN SCI, V17, P1663, DOI 10.1110/ps.035527.108; Fischer PM, 2001, BIOCONJUGATE CHEM, V12, P825, DOI 10.1021/bc0155115; Fischer R, 2004, J BIOL CHEM, V279, P12625, DOI 10.1074/jbc.M311461200; Freedman DA, 1999, CELL MOL LIFE SCI, V55, P96, DOI 10.1007/s000180050273; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Ganguli G, 2000, EMBO J, V19, P5135, DOI 10.1093/emboj/19.19.5135; Goddard D., 2008, SPARKY 3; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Gupta AA, 2012, BIOMOL NMR ASSIGN, V6, P213, DOI 10.1007/s12104-012-9360-7; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Heizmann CW, 1998, BIOMETALS, V11, P383, DOI 10.1023/A:1009212521172; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hu B, 2007, CANCER RES, V67, P8810, DOI 10.1158/0008-5472.CAN-07-1140; Hubbard SJ., 1993, NACCESS COMPUTER PRO, V2, P1; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Joliot A, 2004, NAT CELL BIOL, V6, P189, DOI 10.1038/ncb0304-189; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kawai H, 2003, MOL CELL BIOL, V23, P4939, DOI 10.1128/MCB.23.14.4939-4947.2003; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Leroy B, 2014, HUM MUTAT, V35, P756, DOI 10.1002/humu.22556; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Liu X, 2014, J BIOL CHEM, V289, P27571, DOI 10.1074/jbc.M114.562561; LORET EP, 1992, P NATL ACAD SCI USA, V89, P9734, DOI 10.1073/pnas.89.20.9734; Luan L, 2015, J MATER CHEM B, V3, P1068, DOI 10.1039/c4tb01353k; LUNA RMD, 1995, NATURE, V378, P203; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Marine JC, 2005, BIOCHEM BIOPH RES CO, V331, P750, DOI 10.1016/j.bbrc.2005.03.151; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Meulmeester E, 2003, MOL CELL BIOL, V23, P4929, DOI 10.1128/MCB.23.14.4929-4938.2003; Momand J, 2000, GENE, V242, P15, DOI 10.1016/S0378-1119(99)00487-4; Nag S, 2013, J BIOMED RES, V27, P254, DOI 10.7555/JBR.27.20130030; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nagata T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109163; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Oliner JD, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026336; Perry ME, 2000, J BIOL CHEM, V275, P5733, DOI 10.1074/jbc.275.8.5733; Rayburn ER, 2009, ANTI-CANCER AGENT ME, V9, P882, DOI 10.2174/187152009789124628; Royer CA, 2006, CHEM REV, V106, P1769, DOI 10.1021/cr0404390; RUBEN S, 1989, J VIROL, V63, P1; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Schrodinger L., 2020, PYMOL; Shangary S, 2008, MOL CANCER THER, V7, P1533, DOI 10.1158/1535-7163.MCT-08-0140; Shangary S, 2008, P NATL ACAD SCI USA, V105, P3933, DOI 10.1073/pnas.0708917105; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Shvarts A, 1997, ISOLATION IDENTIFICA; Snyder EL, 2004, PLOS BIOL, V2, P186, DOI 10.1371/journal.pbio.0020036; Stoll R, 2000, J BIOMOL NMR, V17, P91, DOI 10.1023/A:1008365622798; Suguitan Jr AL, 2011, PLOS ONE, V6; SUTHERLAND RL, 1983, CANCER RES, V43, P3998; Takeuchi K, 2006, CURR OPIN STRUC BIOL, V16, P109, DOI 10.1016/j.sbi.2006.01.006; Thut CJ, 1997, GENE DEV, V11, P1974, DOI 10.1101/gad.11.15.1974; Toledo F, 2007, INT J BIOCHEM CELL B, V39, P1476, DOI 10.1016/j.biocel.2007.03.022; van Dieck J, 2010, FEBS LETT, V584, P3269, DOI 10.1016/j.febslet.2010.06.024; van Dieck J, 2009, J MOL BIOL, V394, P922, DOI 10.1016/j.jmb.2009.10.002; van Dieck J, 2009, J BIOL CHEM, V284, P13804, DOI 10.1074/jbc.M901351200; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vise PD, 2005, NUCLEIC ACIDS RES, V33, P2061, DOI 10.1093/nar/gki336; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Walker KK, 1996, P NATL ACAD SCI USA, V93, P15335, DOI 10.1073/pnas.93.26.15335; Wang SM, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a026245; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Wong TS, 2009, NUCLEIC ACIDS RES, V37, P6765, DOI 10.1093/nar/gkp750; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Yu Y, 2013, PLOS ONE, V8; Zhang RW, 2000, CURR PHARM DESIGN, V6, P393, DOI 10.2174/1381612003400911; Zhao YJ, 2015, J MED CHEM, V58, P1038, DOI 10.1021/jm501092z; Zimmer DB, 2013, CELL CALCIUM, V53, P170, DOI 10.1016/j.ceca.2012.11.006	88	3	3	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0234152	10.1371/journal.pone.0234152	http://dx.doi.org/10.1371/journal.pone.0234152			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497081	Green Published, gold			2022-12-26	WOS:000542035200007
J	Barbero, AH; Rico, N; Oller-Salvia, B; Aldecoa-Bilbao, V; Macias-Munoz, L; Wijngaard, R; Figueras-Aloy, J; Salvia-Roiges, MD				Herranz Barbero, Ana; Rico, Nayra; Oller-Salvia, Benjami; Aldecoa-Bilbao, Victoria; Macias-Munoz, Laura; Wijngaard, Robin; Figueras-Aloy, Josep; Salvia-Roiges, Ma Dolors			Fortifier selection and dosage enables control of breast milk osmolarity	PLOS ONE			English	Article							NECROTIZING ENTEROCOLITIS; GASTROESOPHAGEAL-REFLUX; PRETERM INFANTS; PROTEIN-CONTENT; OSMOLALITY; FORTIFICATION; MEDICATIONS; MECHANISMS	Background Human breast milk (BM) fortification is required to feed preterm newborns with less than 32 weeks of gestation. However, addition of fortifiers increases osmolarity and osmolarity values higher than 450 mOsm/kg may be related to gastrointestinal pathology. Hence, fortifier selection and dosage are key to achieve optimal feeding. Objectives To compare the effect on osmolality of adding different fortifications, including recently developed formulations, to BM and to study evolution of osmolarity over time in supplemented BM. Methods Frozen mature BM from 10 healthy mothers of premature newborns was fortified with each of the following human milk fortifiers (HMF): AlmironFortifier (R), NANFM85 (R), or PreNANFM85 (R). In addition, fortified BMs were modified with one of the following nutritional supplements (NS): Duocal MCT (R), Nutricia (R) AminoAcids Mix, or Maxijul (R). Osmolality of BM alone, fortified and/or supplemented was measured at 1 and 22 hours after their preparation. All samples were kept at 4 degrees C throughout the study. Results Osmolality of BM alone was close to 300 mOsm/kg and did not change over 22 hours. When equicaloric amounts of HMF AlmironFortifier (R), NANFM85 (R), and PreNANFM85 (R) were added to BM, osmolality increased roughly to 480 mOsm/kg with the first two fortifiers and only to 433 +/- 6 mOsm/kg with the third one. Upon addition of any of four different NSs to BM modified with AlmironFortifier (R) and NANFM85 (R), osmolality reached values greater than 520 mOsm/kg, while osmolality of PreNANFM85 (R) with two out of the four NSs remained below 490 mOsm/kg. NSs supplementing carbohydrates and hydrolysed proteins resulted into a higher increase of BM osmolarity. Osmolality increased significantly with time and, after 22h, only BM modified with PreNANFM85 (R) remained below 450 mOsm/kg. Conclusions Upon addition of the HMFs tested, BM osmolality increases significantly and keeps raising over time. All HMFs but the recently developed PreNAN FM85 (R) at 4% exceed the AAP recommended threshold for osmolarity of 450 mOsm/kg. Addition of NSs to PreNAN FM85 (R) at 4% significantly increases osmolality above 450 mOsm/Kg. Thus, using PreNAN FM85 (R) at 5% may be preferable to adding nutritional supplements since nutritional recommendations by the ESPGHAN are reached with a lower increase in osmolality.	[Herranz Barbero, Ana; Aldecoa-Bilbao, Victoria; Figueras-Aloy, Josep; Salvia-Roiges, Ma Dolors] Univ Barcelona, Hosp Clin Hosp St Joan de Deu, BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Neonatol Deparment, Barcelona, Spain; [Rico, Nayra; Macias-Munoz, Laura; Wijngaard, Robin] Univ Barcelona, Clin Hosp, Core Lab, Barcelona, Spain; [Oller-Salvia, Benjami] Univ Ramon Llull, Inst Quim Sarria, Barcelona, Spain	University of Barcelona; University of Barcelona; Universitat Ramon Llull; Institut Quimic de Sarria	Barbero, AH (corresponding author), Univ Barcelona, Hosp Clin Hosp St Joan de Deu, BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Neonatol Deparment, Barcelona, Spain.	anaherranzbarbero@gmail.com	Oller-Salvia, Benjamí/ABH-5773-2020; Oller-Salvia, Benjamí/S-2918-2018; Aldecoa-Bilbao, Victoria/GWU-7820-2022; Macias-Muñoz, Laura/R-3210-2018; Muñoz, Laura Macías/AAV-6864-2020	Macias-Muñoz, Laura/0000-0002-8314-3087; Muñoz, Laura Macías/0000-0002-8314-3087; Herranz Barbero, Ana/0000-0003-1010-4295; Oller-Salvia, Benjami/0000-0002-8140-6111; Aldecoa-Bilbao, Victoria/0000-0002-2737-1149				Aceti A, 2009, J PEDIATR GASTR NUTR, V49, P613, DOI 10.1097/MPG.0b013e31819c0ce5; Agostoni AC, 2010, J PEDIAT GASTROENTER, V1, P85, DOI [10.1097/MPG.0b013e3181adaee0, DOI 10.1097/MPG.0B013E3181ADAEE0]; Agostoni C, 2009, J PEDIATR GASTR NUTR, V49, P112, DOI 10.1097/MPG.0b013e31819f1e05; Ahrabi AF, 2016, J PEDIATR-US, V177, P140, DOI 10.1016/j.jpeds.2016.06.024; [Anonymous], 1976, PEDIATRICS, V57, P278; Belfort MB, 2017, SEMIN FETAL NEONAT M, V22, P42, DOI 10.1016/j.siny.2016.09.001; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V316, P1688, DOI 10.1001/jama.2016.14697; BOOK LS, 1975, J PEDIATR-US, V87, P602, DOI 10.1016/S0022-3476(75)80835-3; Boyce C, 2016, BRIT J NUTR, V116, P1033, DOI 10.1017/S0007114516003007; Brown JVE, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000343.pub3; Chandran S, 2017, NEONATOLOGY, V111, P309, DOI 10.1159/000454667; Choi A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148941; De Curtis M, 1999, ARCH DIS CHILD-FETAL, V81, pF141, DOI 10.1136/fn.81.2.F141; de Halleux V, 2013, AM J CLIN NUTR, V98, p529S, DOI 10.3945/ajcn.112.042689; Donovan R, 2017, J PERINATOL, V37, P42, DOI 10.1038/jp.2016.166; Ellis ZM, 2019, ARCH DIS CHILD-FETAL, V104, pF333, DOI 10.1136/archdischild-2018-315946; Fanaro S, 2013, EARLY HUM DEV, V89, pS13, DOI 10.1016/j.earlhumdev.2013.07.013; Gupta V, 2016, INDIAN PEDIATR, V53, P167; HIBBERD CM, 1982, ARCH DIS CHILD, V57, P658, DOI 10.1136/adc.57.9.658; Lamport L, 2019, JPEN-PARENTER ENTER, V43, P809, DOI 10.1002/jpen.1470; Macias-Munoz L, 2020, QUALITY ASSURA UNPUB; Merewood A, 2006, PEDIATRICS, V118, pE1048, DOI 10.1542/peds.2005-2637; Miller J, 2012, AM J CLIN NUTR, V95, P648, DOI 10.3945/ajcn.111.026351; Mimouni FB, 2017, CLIN PERINATOL, V44, P165, DOI 10.1016/j.clp.2016.11.010; Minchinela J., BIOL VARIATION DATAB; Miyake H, 2016, PEDIATR SURG INT, V32, P1153, DOI 10.1007/s00383-016-3998-7; Morlacchi L, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0957-y; Pearson F, 2013, ARCH DIS CHILD-FETAL, V98, pF166, DOI 10.1136/adc.2011.300492; Perrella SL, 2015, J PEDIATR GASTR NUTR, V60, P264, DOI 10.1097/MPG.0000000000000596; Radmacher PG, 2012, J PERINATOL, V32, P227, DOI 10.1038/jp.2011.83; Rochow N, 2015, CURR OPIN CLIN NUTR, V18, P276, DOI 10.1097/MCO.0000000000000167; Rosas R, 2016, ACTA PAEDIATR, V105, pE555, DOI 10.1111/apa.13522; Salvia G, 2001, AM J GASTROENTEROL, V96, P1725, DOI 10.1016/S0002-9270(01)02428-5; Sauret A, 2018, ARCH PEDIATRIE, V25, P411, DOI 10.1016/j.arcped.2018.08.006; Underwood MA, 2013, PEDIATR CLIN N AM, V60, P189, DOI 10.1016/j.pcl.2012.09.008; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; WHO, GLOB STRAT INF YOUNG; WILLIS DM, 1977, PEDIATRICS, V60, P535; Ziegler EE, 2011, ANN NUTR METAB, V58, P8, DOI 10.1159/000323381	39	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0233924	10.1371/journal.pone.0233924	http://dx.doi.org/10.1371/journal.pone.0233924			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MJ2AA	32479524	Green Published, gold			2022-12-26	WOS:000547893500041
J	Schnoder, ML; Gasparoni, G; Nordstrom, K; Schottek, A; Tomic, I; Christmann, A; Schofer, KH; Menger, MD; Walter, J; Fassbender, K; Liu, Y				Schnoeder, Models Laura; Gasparoni, Gilles; Nordstroem, Karl; Schottek, Andrea; Tomic, Inge; Christmann, Anne; Schoefer, Karl H.; Menger, Michael D.; Walter, Joern; Fassbender, Klaus; Liu, Yang			Neuronal deficiency of p38 alpha-MAPK ameliorates symptoms and pathology of APP or Tau-transgenic Alzheimer's mouse models	FASEB JOURNAL			English	Article						Alzheimer's disease; calcium homeostasis; Mapk14; neurodegeneration; transcriptome analysis	DISEASE-RELATED SYMPTOMS; A-BETA; P38 KINASE; PHOSPHORYLATION; ACTIVATION; MICROGLIA; CALCIUM; OVEREXPRESSION; DEGRADATION; DYSFUNCTION	Alzheimer's disease (AD) is the leading cause of dementia with very limited therapeutic options. Amyloid beta (A beta) and phosphorylated Tau (p-Tau) are key pathogenic molecules in AD. P38 alpha-MAPK is specifically activated in AD lesion sites. However, its effects on AD pathogenesis, especially on p-Tau-associated brain pathology, and the underlying molecular mechanisms remain unclear. We mated human APP-transgenic mice and human P301S Tau-transgenic mice with mapk14-floxed and neuron-specific Cre-knock-in mice. We observed that deletion of p38 alpha-MAPK specifically in neurons improves the cognitive function of both 9-month-old APP and Tau-transgenic AD mice, which is associated with decreased A beta and p-Tau load in the brain. We further used next-generation sequencing to analyze the gene transcription in brains of p38 alpha-MAPK deficient and wild-type APP-transgenic mice, which indicated that deletion of p38 alpha-MAPK regulates the transcription of calcium homeostasis-related genes, especially downregulates the expression of grin2a, a gene encoding NMDAR subunit NR2A. Cell culture experiments further verified that deletion of p38 alpha-MAPK inhibits NMDA-triggered calcium influx and neuronal apoptosis. Our systemic studies of AD pathogenic mechanisms using both APP- and Tau-transgenic mice suggested that deletion of neuronal p38 alpha-MAPK attenuates AD-associated brain pathology and protects neurons in AD pathogenesis. This study supports p38 alpha-MAPK as a novel target for AD therapy.	[Schnoeder, Models Laura; Schottek, Andrea; Tomic, Inge; Fassbender, Klaus; Liu, Yang] Saarland Univ, Dept Neurol, Kirrberger Str, D-66421 Homburg, Germany; [Schnoeder, Models Laura; Schottek, Andrea; Tomic, Inge; Fassbender, Klaus; Liu, Yang] Saarland Univ, German Inst Dementia Prevent DIDP, Homburg, Germany; [Gasparoni, Gilles; Nordstroem, Karl; Walter, Joern] Saarland Univ, Dept Genet, Saarbrucken, Germany; [Christmann, Anne; Schoefer, Karl H.] Univ Appl Sci, Working Grp Enter Nervous Syst, Zweibrucken, Germany; [Menger, Michael D.] Saarland Univ, Dept Expt Surg, Homburg, Germany	Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; Saarland University; Universitatsklinikum des Saarlandes	Liu, Y (corresponding author), Saarland Univ, Dept Neurol, Kirrberger Str, D-66421 Homburg, Germany.; Liu, Y (corresponding author), Saarland Univ, German Inst Dementia Prevent DIDP, Homburg, Germany.	a.liu@mx.uni-saarland.de	Walter, Jörn/AFN-6428-2022; Liu, Yang/GSD-5476-2022	Walter, Jörn/0000-0003-0563-7417; Liu, Yang/0000-0002-7614-4233; Fassbender, Klaus/0000-0003-3596-868X	Deutsche Forschungsgemeinschaft (DFG) [LI1725/2-1]; German federal ministry of research and education [031L0101D]; HOMFORexcell program	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German federal ministry of research and education; HOMFORexcell program	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: LI1725/2-1; German federal ministry of research and education, Grant/Award Number: 031L0101D; HOMFORexcell program	Arbel-Ornath M, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0169-9; Bachstetter AD, 2012, J NEUROSCI, V32, P10201, DOI 10.1523/JNEUROSCI.1496-12.2012; Bachstetter AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-79; Berry KP, 2017, NEURON, V96, P43, DOI 10.1016/j.neuron.2017.08.008; Cho MH, 2014, AUTOPHAGY, V10, P1761, DOI 10.4161/auto.29647; Colie S, 2017, SCI REP-UK, V7, DOI 10.1038/srep45306; COTMAN CW, 1988, ANNU REV NEUROSCI, V11, P61, DOI 10.1146/annurev.neuro.11.1.61; DeVos SL, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0481; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; Eales KL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5701; Egan MF, 2018, NEW ENGL J MED, V378, P1691, DOI 10.1056/NEJMoa1706441; Franzen O, 2019, DATABASE-OXFORD, DOI 10.1093/database/baz046; Ghosh S, 2013, J NEUROSCI, V33, P5053, DOI 10.1523/JNEUROSCI.4361-12.2013; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Green KN, 2008, NEURON, V59, P190, DOI 10.1016/j.neuron.2008.07.013; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hensley K, 1999, J NEUROCHEM, V72, P2053, DOI 10.1046/j.1471-4159.1999.0722053.x; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Inoue K, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-48; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Keil E, 2013, CELL DEATH DIFFER, V20, P321, DOI 10.1038/cdd.2012.129; Khananshvili D, 2013, MOL ASPECTS MED, V34, P220, DOI 10.1016/j.mam.2012.07.003; Kuchibhotla KV, 2008, NEURON, V59, P214, DOI 10.1016/j.neuron.2008.06.008; Lahiri DK, 2014, ALZHEIMERS DEMENT, V10, pS411, DOI 10.1016/j.jalz.2013.11.004; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Li YK, 2003, J NEUROSCI, V23, P1605; Liu Y, 2014, J NEUROSCI, V34, P12982, DOI 10.1523/JNEUROSCI.1348-14.2014; Lucin KM, 2013, NEURON, V79, P873, DOI 10.1016/j.neuron.2013.06.046; Luo WJ, 2017, NUCLEIC ACIDS RES, V45, pW501, DOI 10.1093/nar/gkx372; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Maphis N, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0221-y; Maphis N, 2015, BRAIN, V138, P1738, DOI 10.1093/brain/awv081; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Munoz L, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-21; Nishida K, 2004, MOL CELL BIOL, V24, P10611, DOI 10.1128/MCB.24.24.10611-10620.2004; Nuzzo D, 2017, J PROTEOME RES, V16, P1526, DOI 10.1021/acs.jproteome.6b00925; Parr C, 2012, MOL CELL BIOL, V32, P4410, DOI 10.1128/MCB.00930-12; Qin YR, 2016, J IMMUNOL, V197, P3281, DOI 10.4049/jimmunol.1600873; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; Reynolds CH, 1997, J NEUROCHEM, V69, P191; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ryan SD, 2009, P NATL ACAD SCI USA, V106, P20936, DOI 10.1073/pnas.0905654106; Scheltens P, 2018, ANN CLIN TRANSL NEUR, V5, P464, DOI 10.1002/acn3.549; Schnoder L, 2016, J BIOL CHEM, V291, P2067, DOI 10.1074/jbc.M115.695916; Sheng JG, 2001, NEUROCHEM INT, V39, P341, DOI 10.1016/S0197-0186(01)00041-9; Shi YG, 2017, NAT REV MOL CELL BIO, V18, P655, DOI 10.1038/nrm.2017.86; Shimada Hitoshi, 2017, Alzheimers Dement (Amst), V6, P11, DOI 10.1016/j.dadm.2016.12.009; Soneson C, 2015, F1000 RES, V4, P1521, DOI [10.12688/f1000research.7563.1, DOI 10.12688/F1000RESEARCH.7563.2]; Srivats S, 2016, J CELL BIOL, V213, P65, DOI 10.1083/jcb.201506022; Sun AY, 2003, EXP NEUROL, V183, P394, DOI 10.1016/S0014-4886(03)00180-8; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; Texido L, 2011, CELL CALCIUM, V49, P184, DOI 10.1016/j.ceca.2011.02.001; Vossel KA, 2010, SCIENCE, V330, P198, DOI 10.1126/science.1194653; Whitehead G, 2017, NEUROPHARMACOLOGY, V112, P221, DOI 10.1016/j.neuropharm.2016.08.022; Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346; Yin J, 2015, NEUROPHARMACOLOGY, V89, P215, DOI 10.1016/j.neuropharm.2014.09.027; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhu XW, 2000, J NEUROPATH EXP NEUR, V59, P880, DOI 10.1093/jnen/59.10.880; Zott B, 2019, SCIENCE, V365, P559, DOI 10.1126/science.aay0198	65	11	11	4	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9628	9649		10.1096/fj.201902731RR	http://dx.doi.org/10.1096/fj.201902731RR		MAY 2020	22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32475008	Green Published			2022-12-26	WOS:000538127100001
J	Hosomi, A; Iida, K; Cho, T; Iida, H; Kaneko, M; Suzuki, T				Hosomi, Akira; Iida, Kazuko; Cho, Toshihiko; Iida, Hidetoshi; Kaneko, Masashi; Suzuki, Tadashi			The ER-associated protease Ste24 prevents N-terminal signal peptide-independent translocation into the endoplasmic reticulum inSaccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						signal peptide; endoplasmic reticulum; protein translocation; Ste24; Rme1; metalloendopeptidase; N-glycosylation; secretory pathway; Spc2; ER; glycosylation; yeast; cell biology	SACCHAROMYCES-CEREVISIAE; CARBOXYPEPTIDASE-Y; MEMBRANE PROTEIN; TARGETING ROUTE; DEGRADATION; IDENTIFICATION; GENE; SECRETOME; MUTANT; RETROTRANSLOCATION	Soluble proteins destined for the secretory pathway contain an N-terminal signal peptide that induces their translocation into the endoplasmic reticulum (ER). The importance of N-terminal signal peptides for ER translocation has been extensively examined over the past few decades. However, in the budding yeastSaccharomyces cerevisiae, a few proteins devoid of a signal peptide are still translocated into the ER and thenN-glycosyl-ated. Using signal peptide-truncated reporter proteins, here we report the detection of significant translocation of N-terminal signal peptide-truncated proteins in a yeast mutant strain (ste24?) that lacks the endopeptidase Ste24 at the ER membrane. Furthermore, several ER/cytosolic proteins, including Sec61, Sec66, and Sec72, were identified as being involved in the translocation process. On the basis of screening for 20 soluble proteins that may beN-glycosylated in the ER in theste24? strain, we identified the transcription factor Rme1 as a protein that is partiallyN-glycosylated despite the lack of a signal peptide. These results clearly indicate that some proteins lacking a signal peptide can be translocated into the ER and that Ste24 typically suppresses this process.	[Hosomi, Akira; Kaneko, Masashi] Shinshu Univ, Grad Sch Sci & Technol, Dept Agr, Kamiina, Nagano, Japan; [Iida, Kazuko] Tokyo Metropolitan Inst Med Sci, Lab Biomembrane, Setagaya Ku, Tokyo, Japan; [Cho, Toshihiko; Iida, Hidetoshi] Tokyo Gakugei Univ, Dept Biol, Koganei, Tokyo, Japan; [Suzuki, Tadashi] RIKEN, Cluster Pioneering Res, Glycometab Biochem Lab, Wako, Saitama, Japan	Shinshu University; Tokyo Metropolitan Institute of Medical Science; Tokyo Gakugei University; RIKEN	Hosomi, A (corresponding author), Shinshu Univ, Grad Sch Sci & Technol, Dept Agr, Kamiina, Nagano, Japan.; Suzuki, T (corresponding author), RIKEN, Cluster Pioneering Res, Glycometab Biochem Lab, Wako, Saitama, Japan.	ahosomi@shinshu-u.ac.jp; tsuzuki_gm@riken.jp	Suzuki, Tadashi/I-4536-2014; Suzuki, Tadashi/AAX-5707-2021	Suzuki, Tadashi/0000-0003-1030-7631; iida, Hidetoshi/0000-0002-3986-2615	Ministry of Education, Science, Sports and Culture of Japan [25440058, 19K06539, 25291030, 17K15089]; grant for Incentive Research Projects (RIKEN)	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); grant for Incentive Research Projects (RIKEN)	This work was supported, in part, by Grants-in-Aid for Scientific Research (C) (25440058) (to A. H.), (19K06539) (to H. I.), and (B) (25291030) (to T. S.), by a Grantin-Aid for Young Scientists (17K15089) (to A. H.) from the Ministry of Education, Science, Sports and Culture of Japan, and by a grant for Incentive Research Projects (RIKEN) (to A. H.).	Agarwal AK, 2003, HUM MOL GENET, V12, P1995, DOI 10.1093/hmg/ddg213; AMMERER G, 1986, MOL CELL BIOL, V6, P2490, DOI 10.1128/MCB.6.7.2490; Antonin W, 2000, J BIOL CHEM, V275, P34068, DOI 10.1074/jbc.M006126200; Ast T, 2016, CELL, V164, P103, DOI 10.1016/j.cell.2015.11.053; Aviram N, 2016, NATURE, V540, P134, DOI 10.1038/nature20169; Barrowman J, 2012, HUM MOL GENET, V21, P4084, DOI 10.1093/hmg/dds233; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; BLACHLYDYSON E, 1987, J CELL BIOL, V104, P1183, DOI 10.1083/jcb.104.5.1183; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; Boersema PJ, 2013, MOL CELL PROTEOMICS, V12, P158, DOI 10.1074/mcp.M112.023614; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; COVITZ PA, 1991, GENE DEV, V5, P1982, DOI 10.1101/gad.5.11.1982; de Martin PE, 2005, J CELL SCI, V118, P65, DOI 10.1242/jcs.01583; DESHAIES RJ, 1987, J CELL BIOL, V105, P633, DOI 10.1083/jcb.105.2.633; Ding Y, 2012, TRENDS PLANT SCI, V17, P606, DOI 10.1016/j.tplants.2012.06.004; Dudek J, 2015, J MOL BIOL, V427, P1159, DOI 10.1016/j.jmb.2014.06.011; FINGER A, 1993, EUR J BIOCHEM, V218, P565, DOI 10.1111/j.1432-1033.1993.tb18410.x; Fleischer TC, 2006, GENE DEV, V20, P1294, DOI 10.1101/gad.1422006; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hosomi A, 2016, BIOCHEM J, V473, P3001, DOI 10.1042/BCJ20160453; Hosomi A, 2015, BBA-GEN SUBJECTS, V1850, P612, DOI 10.1016/j.bbagen.2014.12.008; Hosomi A, 2010, J BIOL CHEM, V285, P24324, DOI 10.1074/jbc.M109.095919; IIDA H, 1994, MOL CELL BIOL, V14, P8259, DOI 10.1128/MCB.14.12.8259; Iida K, 2017, J BIOL CHEM, V292, P20570, DOI 10.1074/jbc.M117.810283; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Johnson N, 2013, BBA-MOL CELL RES, V1833, P2403, DOI 10.1016/j.bbamcr.2012.12.008; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; JUNGMANN J, 1993, NATURE, V361, P369, DOI 10.1038/361369a0; KAISER CA, 1987, SCIENCE, V235, P312, DOI 10.1126/science.3541205; Kunze M, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00259; Lehrbach NJ, 2019, CELL, V177, P737, DOI 10.1016/j.cell.2019.03.035; Li XY, 2016, ONCOTARGET, V7, P22031, DOI 10.18632/oncotarget.8247; Lin QF, 2015, PROTEOMICS, V15, P3905, DOI 10.1002/pmic.201500236; LINGAPPA VR, 1979, NATURE, V281, P117, DOI 10.1038/281117a0; Mehnert M, 2015, MOL BIOL CELL, V26, P185, DOI 10.1091/mbc.E14-07-1202; Mehnert M, 2014, NAT CELL BIOL, V16, P77, DOI 10.1038/ncb2882; Michaelis S, 2012, MICROBIOL MOL BIOL R, V76, P626, DOI 10.1128/MMBR.00010-12; Mullins C, 1996, J BIOL CHEM, V271, P29094, DOI 10.1074/jbc.271.46.29094; Murthi A, 2005, GENETICS, V170, P1553, DOI 10.1534/genetics.105.043620; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Nilsson I, 2015, J MOL BIOL, V427, P1191, DOI 10.1016/j.jmb.2014.06.014; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Nombela C, 2006, TRENDS MICROBIOL, V14, P15, DOI 10.1016/j.tim.2005.11.009; North M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002699; NOVICK P, 1979, P NATL ACAD SCI USA, V76, P1858, DOI 10.1073/pnas.76.4.1858; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Pina FJ, 2011, EUKARYOT CELL, V10, P63, DOI 10.1128/EC.00241-10; Ponpuak M, 2015, CURR OPIN CELL BIOL, V35, P106, DOI 10.1016/j.ceb.2015.04.016; RINE J, 1981, MOL CELL BIOL, V1, P958, DOI 10.1128/MCB.1.10.958; ROBINSON A, 1986, FEBS LETT, V203, P243, DOI 10.1016/0014-5793(86)80751-7; ROTHBLATT JA, 1989, J CELL BIOL, V109, P2641, DOI 10.1083/jcb.109.6.2641; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Sugahara D, 2015, PROTEOMICS, V15, P2921, DOI 10.1002/pmic.201400443; Suzuki T, 2000, J CELL BIOL, V149, P1039, DOI 10.1083/jcb.149.5.1039; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549; Tomlin FM, 2017, ACS CENTRAL SCI, V3, P1143, DOI 10.1021/acscentsci.7b00224; Usaj M, 2017, G3-GENES GENOM GENET, V7, P1539, DOI 10.1534/g3.117.040220; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; Voorhees RM, 2016, SCIENCE, V351, P88, DOI 10.1126/science.aad4992; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; WILLIAMS RS, 1985, J BIOL CHEM, V260, P3334; Yang K, 2018, J EXP MED, V215, P2600, DOI 10.1084/jem.20180783; Zhang S, 2017, CELL, V171, P346, DOI 10.1016/j.cell.2017.08.036; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015	65	7	7	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2020	295	30					10406	10419		10.1074/jbc.RA120.012575	http://dx.doi.org/10.1074/jbc.RA120.012575			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MW0BV	32513868	hybrid, Green Published			2022-12-26	WOS:000556713400023
J	Miyazaki, H; Yamanaka, T; Oyama, F; Kino, Y; Kurosawa, M; Yamada-Kurosawa, M; Yamano, R; Shimogori, T; Hattori, N; Nukina, N				Miyazaki, Haruko; Yamanaka, Tomoyuki; Oyama, Fumitaka; Kino, Yoshihiro; Kurosawa, Masaru; Yamada-Kurosawa, Mizuki; Yamano, Risa; Shimogori, Tomomi; Hattori, Nobutaka; Nukina, Nobuyuki			FACS-array?based cell purification yields a specific transcriptome of striatal medium spiny neurons in a murine Huntington disease model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Huntington disease; fluorescence-activated cell sorting (FACS); microarray; medium spiny neuron (MSN); R6; 2 mouse model; neurodegeneration; transcriptomics; DNA damage; transcription regulation; striatum	GENE-EXPRESSION; TRINUCLEOTIDE REPEAT; DECREASED EXPRESSION; DNA-DAMAGE; CAG REPEAT; APOPTOSIS; MICE; DYSREGULATION; DYSFUNCTION; ACTIVATION	Huntington disease (HD) is a neurodegenerative disorder caused by expanded CAG repeats in theHuntingtingene. Results from previous studies have suggested that transcriptional dysregulation is one of the key mechanisms underlying striatal medium spiny neuron (MSN) degeneration in HD. However, some of the critical genes involved in HD etiology or pathology could be masked in a common expression profiling assay because of contamination with non-MSN cells. To gain insight into the MSN-specific gene expression changes in presymptomatic R6/2 mice, a common HD mouse model, here we used a transgenic fluorescent protein marker of MSNs for purification via FACS before profiling gene expression with gene microarrays and compared the results of this ?FACS-array? with those obtained with homogenized striatal samples (STR-array). We identified hundreds of differentially expressed genes (DEGs) and enhanced detection of MSN-specific DEGs by comparing the results of the FACS-array with those of the STR-array. The gene sets obtained included genes ubiquitously expressed in both MSNs and non-MSN cells of the brain and associated with transcriptional regulation and DNA damage responses. We proposed that the comparative gene expression approach using the FACS-array may be useful for uncovering the gene cascades affected in MSNs during HD pathogenesis.	[Miyazaki, Haruko; Yamanaka, Tomoyuki; Yamano, Risa; Nukina, Nobuyuki] Doshisha Univ, Grad Sch Brain Sci, Lab Struct Neuropathol, Kyoto, Japan; [Miyazaki, Haruko; Yamanaka, Tomoyuki; Oyama, Fumitaka; Kino, Yoshihiro; Kurosawa, Masaru; Yamada-Kurosawa, Mizuki; Nukina, Nobuyuki] RIKEN, Lab Struct Neuropathol, Brain Sci Inst, Saitama, Japan; [Miyazaki, Haruko; Yamanaka, Tomoyuki; Shimogori, Tomomi; Nukina, Nobuyuki] RIKEN, Ctr Brain Sci, Lab Mol Mech Brain Dev, Saitama, Japan; [Miyazaki, Haruko; Yamanaka, Tomoyuki; Nukina, Nobuyuki] Juntendo Univ, Grad Sch Med, Dept Neurosci Neurodegenerat Disorders, Tokyo, Japan; [Hattori, Nobutaka] Juntendo Univ, Grad Sch Med, Dept Neurol, Tokyo, Japan; [Oyama, Fumitaka] Kogakuin Univ, Dept Chem & Life Sci, Tokyo, Japan; [Kino, Yoshihiro] Meiji Pharmaceut Univ, Dept Bioinformat & Mol Neuropathol, Tokyo, Japan; [Kurosawa, Masaru] Juntendo Univ, Inst Environm & Gender Specif Med, Grad Sch Med, Chiba, Japan	Doshisha University; RIKEN; RIKEN; Juntendo University; Juntendo University; Kogakuin University; Meiji Pharmaceutical University; Juntendo University	Nukina, N (corresponding author), Doshisha Univ, Grad Sch Brain Sci, Lab Struct Neuropathol, Kyoto, Japan.; Nukina, N (corresponding author), RIKEN, Lab Struct Neuropathol, Brain Sci Inst, Saitama, Japan.; Nukina, N (corresponding author), RIKEN, Ctr Brain Sci, Lab Mol Mech Brain Dev, Saitama, Japan.; Nukina, N (corresponding author), Juntendo Univ, Grad Sch Med, Dept Neurosci Neurodegenerat Disorders, Tokyo, Japan.	nnukina@mail.doshisha.ac.jp	Hattori, Nobutaka/ACR-0069-2022; Nukina, Nobuyuki/GPP-6265-2022; Oyama, Fumitaka/P-6186-2016	Oyama, Fumitaka/0000-0002-1095-8306; Hattori, Nobutaka/0000-0002-2034-2556; Yamanaka, Tomoyuki/0000-0002-5378-4326	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [25253066, 17H01564, 16K07005]; AMED [20ek0109310h0003]	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); AMED	This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan for 25253066 and 17H01564 (to N. N.) and 16K07005 (to H. M.) and by AMED Grant 20ek0109310h0003 (to N. N.).	Bernard A, 2012, NEURON, V73, P1083, DOI 10.1016/j.neuron.2012.03.002; Bye CR, 2015, P NATL ACAD SCI USA, V112, pE1946, DOI 10.1073/pnas.1501989112; Chan WH, 2008, IUBMB LIFE, V60, P171, DOI 10.1002/iub.30; Crotti A, 2014, NAT NEUROSCI, V17, P513, DOI 10.1038/nn.3668; Danisz K, 2013, ACTA BIOCHIM POL, V60, P503; Desplats PA, 2006, J NEUROCHEM, V96, P743, DOI 10.1111/j.1471-4159.2005.03588.x; Dragileva E, 2009, NEUROBIOL DIS, V33, P37, DOI 10.1016/j.nbd.2008.09.014; Ehrlich ME, 2012, NEUROTHERAPEUTICS, V9, P270, DOI 10.1007/s13311-012-0112-2; Ena SL, 2013, J NEUROSCI, V33, P8794, DOI 10.1523/JNEUROSCI.2989-12.2013; Enokido Y, 2010, J CELL BIOL, V189, P425, DOI 10.1083/jcb.200905138; Gervasi NM, 2016, RNA, V22, P883, DOI 10.1261/rna.053272.115; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hass DT, 2016, NEURAL REGEN RES, V11, P1197, DOI 10.4103/1673-5374.189159; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hickey MA, 2003, PROG NEURO-PSYCHOPH, V27, P255, DOI 10.1016/S0278-5846(03)00021-6; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Jia HQ, 2015, P NATL ACAD SCI USA, V112, pE56, DOI 10.1073/pnas.1415195112; Kantartzis A, 2012, CELL REP, V2, P216, DOI 10.1016/j.celrep.2012.06.020; Khromov T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048869; Kim J, 2010, HUM MOL GENET, V19, P3919, DOI 10.1093/hmg/ddq306; Kim JB, 2013, J BIOL CHEM, V288, P12014, DOI 10.1074/jbc.M112.436113; Kim MO, 2008, J NEUROSCI, V28, P3947, DOI 10.1523/JNEUROSCI.5667-07.2008; Kotliarova S, 2005, J NEUROCHEM, V93, P641, DOI 10.1111/j.1471-4159.2005.03035.x; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Langfelder P, 2016, NAT NEUROSCI, V19, P623, DOI 10.1038/nn.4256; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li GH, 2012, MED RES REV, V32, P999, DOI 10.1002/med.20231; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; Luthi-Carter R, 2002, HUM MOL GENET, V11, P1911, DOI 10.1093/hmg/11.17.1911; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Madabhushi R, 2014, NEURON, V83, P266, DOI 10.1016/j.neuron.2014.06.034; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mazarei G, 2010, HUM MOL GENET, V19, P609, DOI 10.1093/hmg/ddp527; Meade CA, 2002, J COMP NEUROL, V449, P241, DOI 10.1002/cne.10295; Merienne N, 2019, CELL REP, V26, P2477, DOI 10.1016/j.celrep.2019.02.003; Miyazaki H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6525; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Oliveira JMA, 2006, J NEUROSCI, V26, P11174, DOI 10.1523/JNEUROSCI.3004-06.2006; Oyama F, 2006, J NEUROCHEM, V98, P518, DOI 10.1111/j.1471-4159.2006.03893.x; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Roze E, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00055; Sawa A, 2001, J MOL MED, V79, P375, DOI 10.1007/s001090100223; Seredenina T, 2012, NEUROBIOL DIS, V45, P83, DOI 10.1016/j.nbd.2011.07.001; Silberberg G, 2015, CURR OPIN NEUROBIOL, V33, P182, DOI 10.1016/j.conb.2015.05.002; Suhr ST, 2001, J CELL BIOL, V153, P283, DOI 10.1083/jcb.153.2.283; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Thomas EA, 2006, J NEUROSCI RES, V84, P1151, DOI 10.1002/jnr.21046; Vashishtha M, 2013, P NATL ACAD SCI USA, V110, pE3027, DOI 10.1073/pnas.1311323110; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Xie KQ, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00049; Xu CY, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00330; Yamanaka T, 2008, EMBO J, V27, P827, DOI 10.1038/emboj.2008.23; Zeng HK, 2012, CELL, V149, P483, DOI 10.1016/j.cell.2012.02.052	56	4	4	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2020	295	29					9768	9785		10.1074/jbc.RA120.012983	http://dx.doi.org/10.1074/jbc.RA120.012983			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MR1DY	32499373	hybrid, Green Published			2022-12-26	WOS:000553333300001
J	Campos-Soto, R; Diaz-Campusano, G; Rives-Blanchard, N; Cianferoni, F; Torres-Perez, F				Campos-Soto, Ricardo; Diaz-Campusano, Gabriel; Rives-Blanchard, Ninette; Cianferoni, Franco; Torres-Perez, Fernando			Biogeographic origin and phylogenetic relationships ofMepraia(Hemiptera, Reduviidae) on islands of northern Chile	PLOS ONE			English	Article							CHAGAS-DISEASE; TRYPANOSOMA-CRUZI; MEPRAIA-SPINOLAI; POPULATION-GENETICS; WILD VECTOR; HEMIPTERA; PHYLOGEOGRAPHY; TRIATOMINAE; GAJARDOI; UPLIFT	Chagas disease is one of the main zoonoses mediated by vectors in America. The etiological agent is the protozoanTrypanosoma cruzi, transmitted mainly by hematophagous insects of the subfamily Triatominae.Mepraiaspecies are triatomines endemic to Chile that play an important role inT.cruzitransmission in the wild cycle and are potential vectors for humans. In addition to the continental distribution, populations ofMepraiagenus have been reported inhabiting islands of northern Chile. The presence of individuals ofMepraiain insular areas might be explained through passive dispersion by marine birds or by vicariance of an ancestral widespread population. To clarify the biogeographic origin and phylogenetic relationships of island individuals ofMepraia, mitochondrialCOIandcyt bgenes were sequenced in individuals from island and continental areas. Gene sequences were used to estimate phylogenetic relationships, divergence dates and migration rates between insular and continental populations. The dates of divergence estimates are congruent with sea level and tectonic changes that originated the islands during Pleistocene. Migration rates suggest symmetric historical island-continent gene flow. We suggest that the origin of island triatomines can be explained by both vicariance and dispersion. Phylogenetic relationships show that individuals from Santa Maria Island and the continent clustered in a clade different from those previously reported, indicating a new lineage ofMepraiagenus. This study will contribute to understand the origin of theT.cruziinfection in coastal islands of northern Chile.	[Campos-Soto, Ricardo; Diaz-Campusano, Gabriel; Rives-Blanchard, Ninette; Cianferoni, Franco; Torres-Perez, Fernando] Pontificia Univ Catolica Valparaiso, Fac Ciencias, Inst Biol, Valparaiso, Chile	Pontificia Universidad Catolica de Valparaiso	Campos-Soto, R (corresponding author), Pontificia Univ Catolica Valparaiso, Fac Ciencias, Inst Biol, Valparaiso, Chile.	ricardo.campos.s@pucv.cl	Torres-Perez, Fernando/B-5002-2008	Torres-Perez, Fernando/0000-0001-8655-7288; Campos-Soto, Ricardo/0000-0001-7052-0501	CONICYT Program FONDECYT [11170643]; Postdoctoral funding VRIEA PUCV; FONDECYT [1171280]	CONICYT Program FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Postdoctoral funding VRIEA PUCV; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by funds from CONICYT Program FONDECYT N degrees 11170643 (RCS), Postdoctoral funding VRIEA PUCV (FC), and partially by FONDECYT 1171280 (FT-P).	Abrahan LB, 2011, MEM I OSWALDO CRUZ, V106, P232, DOI 10.1590/S0074-02762011000200019; [Anonymous], 2014, TRACER V1 6; Arensburger P, 2004, J BIOGEOGR, V31, P557, DOI 10.1046/j.1365-2699.2003.01012.x; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Beerli Peter, 2009, V17, P42; Binnie A, 2016, QUAT GEOCHRONOL, V36, P12, DOI 10.1016/j.quageo.2016.06.005; Botto-Mahan C, 2008, ACTA TROP, V105, P166, DOI 10.1016/j.actatropica.2007.11.003; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Calleros L, 2010, INFECT GENET EVOL, V10, P221, DOI 10.1016/j.meegid.2009.12.002; Campos R, 2013, VECTOR-BORNE ZOONOT, V13, P73, DOI 10.1089/vbz.2011.0954; Campos R, 2013, INFECT GENET EVOL, V19, P280, DOI 10.1016/j.meegid.2013.04.036; Campos-Soto R, 2016, INFECT GENET EVOL, V45, P205, DOI 10.1016/j.meegid.2016.09.001; Campos-Soto R, 2016, VECTOR-BORNE ZOONOT, V16, P165, DOI 10.1089/vbz.2015.1850; Campos-Soto R, 2015, GENET MOL BIOL, V38, P390, DOI 10.1590/S1415-475738320140301; Canals M, 2001, J MED ENTOMOL, V38, P303, DOI 10.1603/0022-2585-38.2.303; Canals M, 2000, REV MED CHILE, V128, P1108; Cohen KM, 2013, EPISODES, V36, P199, DOI 10.18814/epiiugs/2013/v36i3/002; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FORATTINI O P, 1971, Revista de Saude Publica, V5, P193, DOI 10.1590/S0034-89101971000200002; Franco HS, 2000, MEM I OSWALDO CRUZ, V95, P167, DOI 10.1590/S0074-02762000000200009; Frias DA, 1998, REV CHIL HIST NAT, V71, P177; Frias-Lasserre D, 2010, NEOTROP ENTOMOL, V39, P572, DOI 10.1590/S1519-566X2010000400017; Ginestet C, 2011, J R STAT SOC A STAT, V174, P245, DOI 10.1111/j.1467-985X.2010.00676_9.x; Gourbiere S, 2012, HEREDITY, V108, P190, DOI 10.1038/hdy.2011.71; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Karesh WB, 2012, LANCET, V380, P1936, DOI 10.1016/S0140-6736(12)61678-X; KIERSZENBAUM F, 1976, IMMUNOLOGY, V30, P1; Lefort V, 2017, MOL BIOL EVOL, V34, P2422, DOI 10.1093/molbev/msx149; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345; Mazza S, 1940, MISION ESTUDIOS PATO, V44, P3; Monteiro FA, 2003, MOL ECOL, V12, P997, DOI 10.1046/j.1365-294X.2003.01802.x; Monteiro FA, 2018, ADV PARASIT, V99, P265, DOI 10.1016/bs.apar.2017.12.002; Moreno ML, 2006, INFECT GENET EVOL, V6, P228, DOI 10.1016/j.meegid.2005.06.001; Ortlieb L, 1996, QUATERNARY SCI REV, V15, P857, DOI 10.1016/S0277-3791(96)00062-5; Ortlieb L, 1996, QUATERNARY SCI REV, V15, P819, DOI 10.1016/S0277-3791(96)00066-2; Pedoja K, 2014, EARTH-SCI REV, V132, P13, DOI 10.1016/j.earscirev.2014.01.007; Perez-Losada M, 2013, INFECT GENET EVOL, V16, P38, DOI 10.1016/j.meegid.2013.01.009; Quezada J, 2007, REV GEOL CHILE, V34, P81; Rives-Blanchard N, 2017, ACTA TROP, V172, P229, DOI 10.1016/j.actatropica.2017.05.020; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Ceccarelli FS, 2017, BIOL J LINN SOC, V120, P75; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; URDANETAMORALES S, 1981, ACTA TROP, V38, P99	51	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234056	10.1371/journal.pone.0234056	http://dx.doi.org/10.1371/journal.pone.0234056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525913	Green Published, gold			2022-12-26	WOS:000542036800063
J	Shrestha, M; Garcia, JE; Burd, M; Dyer, AG				Shrestha, Mani; Garcia, Jair E.; Burd, Martin; Dyer, Adrian G.			Australian native flower colours: Does nectar reward drive bee pollinator flower preferences?	PLOS ONE			English	Article							FLORAL COLOR; BOMBUS-TERRESTRIS; HONEY-BEES; DISCRIMINATION; EVOLUTION; PHYLOGENY; VISION; INTEGRATION; CONSTRAINTS; BUMBLEBEES	Colour is an important signal that flowering plants use to attract insect pollinators like bees. Previous research in Germany has shown that nectar volume is higher for flower colours that are innately preferred by European bees, suggesting an important link between colour signals, bee preferences and floral rewards. In Australia, flower colour signals have evolved in parallel to the Northern hemisphere to enable easy discrimination and detection by the phylogenetically ancient trichromatic visual system of bees, and native Australian bees also possess similar innate colour preferences to European bees. We measured 59 spectral signatures from flowers present at two preserved native habitats in South Eastern Australia and tested whether there were any significant differences in the frequency of flowers presenting higher nectar rewards depending upon the colour category of the flower signals, as perceived by bees. We also tested if there was a significant correlation between chromatic contrast and the frequency of flowers presenting higher nectar rewards. For the entire sample, and for subsets excluding species in the Asteraceae and Orchidaceae, we found no significant difference among colour categories in the frequency of high nectar reward. This suggests that whilst such relationships between flower colour signals and nectar volume rewards have been observed at a field site in Germany, the effect is likely to be specific at a community level rather than a broad general principle that has resulted in the common signalling of bee flower colours around the world.	[Shrestha, Mani; Garcia, Jair E.; Dyer, Adrian G.] RMIT Univ, Sch Media, Bioinspired Digital Lab BIDS Lab, Melbourne, Vic, Australia; [Shrestha, Mani; Garcia, Jair E.; Dyer, Adrian G.] RMIT Univ, Sch Commun, Bioinspired Digital Lab BIDS Lab, Melbourne, Vic, Australia; [Burd, Martin] Monash Univ, Sch Biol Sci, Melbourne, Vic, Australia	Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT); Monash University	Dyer, AG (corresponding author), RMIT Univ, Sch Media, Bioinspired Digital Lab BIDS Lab, Melbourne, Vic, Australia.; Dyer, AG (corresponding author), RMIT Univ, Sch Commun, Bioinspired Digital Lab BIDS Lab, Melbourne, Vic, Australia.	adrian.dyer@rmit.edu.au	Shrestha, Mani/P-7045-2015	Shrestha, Mani/0000-0002-6165-8418; Dyer, Adrian/0000-0002-2632-9061; Burd, Martin/0000-0002-1175-2596	Monash Graduate Scholarship (MGS); Monash International Postgraduate Research Scholarship (MIPRS); Faculty of Sciences Postgraduate Publication Award (PPA); Australian Research Council [DP160100161]	Monash Graduate Scholarship (MGS)(Monash University); Monash International Postgraduate Research Scholarship (MIPRS)(Monash University); Faculty of Sciences Postgraduate Publication Award (PPA); Australian Research Council(Australian Research Council)	MS was supported by a Monash Graduate Scholarship (MGS), Monash International Postgraduate Research Scholarship (MIPRS), and Faculty of Sciences Postgraduate Publication Award (PPA) while collecting data (2009-2013). AGD was supported by Australian Research Council Discovery Projects grants DP160100161. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Parks Victoria and the Department of Sustainability and Environment (permit number 10005294) for permission to work at the field sites between 2009-2013. We thank Professor Graham H. Pyke for the suggestions and comments about nectar rewards in the previous version of manuscript. We also acknowledge two anonymous reviewers for the constructive comments and suggestions.	Ackerman J. D., 1985, Proceedings of the Eleventh World Orchid Conference, March, 1984, Miami, Florida, USA, P98; [Anonymous], 1996, ACAD RADIOL S1, V3, pS1; [Anonymous], 1994, SHAANXI SHENG ZHI SH; Arnold SEJ, 2009, ARTHROPOD-PLANT INTE, V3, P27, DOI 10.1007/s11829-009-9056-9; Avargues-Weber A, 2014, J COMP PHYSIOL A, V200, P449, DOI 10.1007/s00359-014-0909-z; Barth FG., 1985, INSECTS FLOWERS BIOL; Bischoff M, 2013, NEW ZEAL J BOT, V51, P181, DOI 10.1080/0028825X.2013.806933; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Bukovac Z., 2013, ARTIFICIAL LIFE C P, V13, P276; Bukovac Z, 2017, J COMP PHYSIOL A, V203, P369, DOI 10.1007/s00359-017-1175-7; Bukovac Z, 2017, EVOL ECOL, V31, P153, DOI 10.1007/s10682-016-9843-6; Burns JG, 2008, CURR BIOL, V18, pR953, DOI 10.1016/j.cub.2008.08.028; Chalcoff VR, 2017, EVOL ECOL, V31, P585, DOI 10.1007/s10682-017-9887-2; CHITTKA L, 1992, J COMP PHYSIOL A, V171, P171, DOI 10.1007/BF00188925; Chittka L, 1999, NATURWISSENSCHAFTEN, V86, P361, DOI 10.1007/s001140050636; Chittka L, 2001, NATURE, V411, P653, DOI 10.1038/35079676; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P533; CHITTKA L, 1994, VISION RES, V34, P1489, DOI 10.1016/0042-6989(94)90151-1; Chittka L, 1996, J THEOR BIOL, V181, P179, DOI 10.1006/jtbi.1996.0124; Chittka L, 2001, COGNITIVE ECOLOGY OF POLLINATION: ANIMAL BEHAVIOUR AND FLORAL EVOLUTION, P106, DOI 10.1017/CBO9780511542268.007; Chittka Lars, 2004, P165; Corrick M.G., 2000, WILDFLOWERS VICTORIA, P246; Darwin C., 1877, EFFECTS CROSS SELF F; Dyer AG, 2008, J COMP PHYSIOL A, V194, P617, DOI 10.1007/s00359-008-0335-1; Dyer AG, 2019, J COMP PHYSIOL A, V205, P347, DOI 10.1007/s00359-019-01346-0; Dyer AG, 2016, J COMP PHYSIOL A, V202, P603, DOI 10.1007/s00359-016-1101-4; Dyer AG, 2016, J COMP PHYSIOL A, V202, P629, DOI 10.1007/s00359-016-1107-y; Dyer AG, 2012, P ROY SOC B-BIOL SCI, V279, P3606, DOI 10.1098/rspb.2012.0827; Dyer AG, 2011, P ROY SOC B-BIOL SCI, V278, P952, DOI 10.1098/rspb.2010.2412; Dyer AG, 2004, J COMP PHYSIOL A, V190, P105, DOI 10.1007/s00359-003-0475-2; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Garcia JE, 2017, J COMP PHYSIOL A, V203, P983, DOI 10.1007/s00359-017-1208-2; Gil M, 2009, J EXP BIOL, V212, P2830, DOI 10.1242/jeb.032623; Giurfa M, 1996, J COMP PHYSIOL A, V178, P699; GIURFA M, 1995, J COMP PHYSIOL A, V177, P247; Gray M, 2018, J ECOL, V106, P1910, DOI 10.1111/1365-2745.12948; Gumbert A, 2000, BEHAV ECOL SOCIOBIOL, V48, P36, DOI 10.1007/s002650000213; de Camargo MGG, 2019, NEW PHYTOL, V222, P1112, DOI 10.1111/nph.15594; Heil M, 2015, ANNU REV ENTOMOL, V60, P213, DOI 10.1146/annurev-ento-010814-020753; HELVERSEN OV, 1972, J COMP PHYSIOL, V80, P439, DOI 10.1007/BF00696438; Howard SR, 2019, CURR ZOOL, V65, P457, DOI 10.1093/cz/zoy095; Jacobs GH, 2018, NEUROSCI BIOBEHAV R, V86, P108, DOI 10.1016/j.neubiorev.2017.12.006; Jeans J, 2006, WILD ORCHIDS VICTORI; Jones D.L., 2021, COMPLETE GUIDE NATIV, VThird ed.; JUDD DB, 1964, J OPT SOC AM, V54, P1031, DOI 10.1364/JOSA.54.001031; Kantsa A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03448-w; Kantsa A, 2017, NAT ECOL EVOL, V1, P1502, DOI 10.1038/s41559-017-0298-0; Kemp DJ, 2015, AM NAT, V185, P705, DOI 10.1086/681021; Kemp JE, 2019, FUNCT ECOL, V33, P2130, DOI 10.1111/1365-2435.13423; Kemp JE, 2019, ANN BOT-LONDON, V123, P277, DOI 10.1093/aob/mcy126; Kevan P. G., 1998, COLOR VISION PERSPEC, P163; KEVAN PG, 1985, P NATL ACAD SCI USA, V82, P4750, DOI 10.1073/pnas.82.14.4750; KIEN J, 1977, J COMP PHYSIOL, V113, P17, DOI 10.1007/BF00610451; Knight TM, 2005, ANNU REV ECOL EVOL S, V36, P467, DOI 10.1146/annurev.ecolsys.36.102403.115320; Kunze J, 1996, BUTTERFLIES BEES FLY, P109; LEHRER M, 1995, PHILOS T R SOC B, V347, P123, DOI 10.1098/rstb.1995.0017; Leonard AS, 2014, J COMP PHYSIOL A, V200, P463, DOI 10.1007/s00359-014-0904-4; Makino TT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143443; McEwen JR, 2010, P ROY SOC B-BIOL SCI, V277, P2957, DOI 10.1098/rspb.2010.0501; MENZEL R, 1967, Z VERGL PHYSIOL, V56, P22, DOI 10.1007/BF00333562; Mimicry Dafni A., 1984, ANNU REV ECOL SYST, V15, P259, DOI [10.1146/annurev.es.15.110184.001355, DOI 10.1146/ANNUREV.ES.15.110184.001355]; Morawetz L, 2013, J COMP PHYSIOL A, V199, P817, DOI 10.1007/s00359-013-0843-5; Ohashi K, 2015, FUNCT ECOL, V29, P1144, DOI 10.1111/1365-2435.12420; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paulk AC, 2008, ARTHROPOD STRUCT DEV, V37, P443, DOI 10.1016/j.asd.2008.03.002; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; Pyrzynska K, 2019, SEP PURIF REV, V48, P65, DOI 10.1080/15422119.2018.1430589; Raine N.E., 2005, ULUDAG BEE J, V5, P145; Raine NE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000556; Raine NE, 2006, ADV STUD BEHAV, V36, P305, DOI 10.1016/S0065-3454(06)36007-X; Rausher MD, 2008, INT J PLANT SCI, V169, P7, DOI 10.1086/523358; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Richardson F. J., 2011, WEEDS S E, V2; ROBERTS RB, 1979, J APICULT RES, V18, P191, DOI 10.1080/00218839.1979.11099966; Ross JH, 2000, CENSUS VASCULAR PLAN; Seeley T. D., 2009, WISDOM HIVE SOCIAL P; SEELEY TD, 1991, BEHAV ECOL SOCIOBIOL, V28, P277, DOI 10.1007/BF00175101; Shrestha M, 2020, PLANT BIOLOGY, V22, P555, DOI 10.1111/plb.13113; Shrestha M, 2019, PLANT BIOLOGY, V21, P745, DOI 10.1111/plb.12968; Shrestha M, 2019, ANN BOT-LONDON, V124, P221, DOI 10.1093/aob/mcz043; Shrestha M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200549; Shrestha M, 2014, J ECOL, V102, P126, DOI 10.1111/1365-2745.12185; Shrestha M, 2013, NEW PHYTOL, V198, P301, DOI 10.1111/nph.12135; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Spaethe J, 2001, P NATL ACAD SCI USA, V98, P3898, DOI 10.1073/pnas.071053098; Stach S, 2004, NATURE, V429, P758, DOI 10.1038/nature02594; STAVENGA DG, 1993, VISION RES, V33, P1011, DOI 10.1016/0042-6989(93)90237-Q; Stpiczynska M, 2015, PLANT SYST EVOL, V301, P1099, DOI 10.1007/s00606-014-1152-3; Suzuki MF, 2014, FUNCT ECOL, V28, P549, DOI 10.1111/1365-2435.12209; van Rijn PCJ, 2016, J APPL ECOL, V53, P925, DOI 10.1111/1365-2664.12605; WASER NM, 1985, OECOLOGIA, V67, P121, DOI 10.1007/BF00378462; Whitney HM, 2009, CURR BIOL, V19, P948, DOI 10.1016/j.cub.2009.04.051; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; WILLMER PG, 1980, OECOLOGIA, V47, P270, DOI 10.1007/BF00346832; Yang EC, 2004, J INSECT PHYSIOL, V50, P913, DOI 10.1016/j.jinsphys.2004.06.010; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; 1999, ANN PERIODONTOL, V4	98	8	8	10	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0226469	10.1371/journal.pone.0226469	http://dx.doi.org/10.1371/journal.pone.0226469			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525873	Green Published, Green Submitted, gold			2022-12-26	WOS:000542036800051
J	Shinjo, K; Hara, K; Nagae, G; Umeda, T; Katsushima, K; Suzuki, M; Murofushi, Y; Umezu, Y; Takeuchi, I; Takahashi, S; Okuno, Y; Matsuo, K; Ito, H; Tajima, S; Aburatani, H; Yamao, K; Kondo, Y				Shinjo, Keiko; Hara, Kazuo; Nagae, Genta; Umeda, Takayoshi; Katsushima, Keisuke; Suzuki, Miho; Murofushi, Yoshiteru; Umezu, Yuta; Takeuchi, Ichiro; Takahashi, Satoru; Okuno, Yusuke; Matsuo, Keitaro; Ito, Hidemi; Tajima, Shoji; Aburatani, Hiroyuki; Yamao, Kenji; Kondo, Yutaka			A novel sensitive detection method for DNA methylation in circulating free DNA of pancreatic cancer	PLOS ONE			English	Article							CELL-FREE DNA; STRUCTURAL BASIS; TUMOR DNA; PLASMA; RECOGNITION; PCDH10; DOMAIN	Despite recent advances in clinical treatment, pancreatic cancer remains a highly lethal malignancy. In order to improve the survival rate of patients with pancreatic cancer, the development of non-invasive diagnostic methods using effective biomarkers is urgently needed. Here, we developed a highly sensitive method to detect DNA methylation in cell-free (cf)DNA samples based on the enrichment of methyl-CpG binding (MBD) protein coupled with a digital PCR method (MBD-ddPCR). Five DNA methylation markers for the diagnosis of pancreatic cancer were identified through DNA methylation microarray analysis in 37 pancreatic cancers. The sensitivity and specificity of the five markers were validated in another independent cohort of pancreatic cancers (100% and 100%, respectively; n = 46) as well as in The Cancer Genome Atlas data set (96% and 90%, respectively; n = 137). MBD-ddPCR analysis revealed that DNA methylation in at least one of the five markers was detected in 23 (49%) samples of cfDNA from 47 patients with pancreatic cancer. Further, a combination of DNA methylation markers and theKRASmutation status improved the diagnostic capability of this method (sensitivity and specificity, 68% and 86%, respectively). Genome-wide MBD-sequencing analysis in cancer tissues and corresponding cfDNA revealed that more than 80% of methylated regions were overlapping; DNA methylation profiles of cancerous tissues and cfDNA significantly correlated with each other (R= 0.97). Our data indicate that newly developed MBD-ddPCR is a sensitive method to detect cfDNA methylation and that using five marker genes plusKRASmutations may be useful for the detection of pancreatic cancers.	[Shinjo, Keiko; Katsushima, Keisuke; Suzuki, Miho; Murofushi, Yoshiteru; Kondo, Yutaka] Nagoya Univ, Div Canc Biol, Grad Sch Med, Nagoya, Aichi, Japan; [Hara, Kazuo; Yamao, Kenji] Aichi Canc Ctr Hosp, Dept Gastroenterol, Nagoya, Aichi, Japan; [Nagae, Genta; Umeda, Takayoshi; Aburatani, Hiroyuki] Univ Tokyo, Res Ctr Adv Sci & Technol, Genome Sci Lab, Tokyo, Japan; [Umezu, Yuta; Takeuchi, Ichiro] Nagoya Inst Technol, Dept Comp Sci, Nagoya, Aichi, Japan; [Umezu, Yuta] Nagasaki Univ, Sch Informat & Data Sci, Nagasaki, Japan; [Takeuchi, Ichiro] RIKEN Ctr Adv Intelligence Project, Tokyo, Japan; [Takahashi, Satoru] Nagoya City Univ, Dept Expt Pathol & Tumor Biol, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Okuno, Yusuke] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan; [Matsuo, Keitaro] Aichi Canc Ctr, Div Canc Epidemiol & Prevent, Res Inst, Nagoya, Aichi, Japan; [Matsuo, Keitaro] Nagoya Univ, Dept Canc Epidemiol, Grad Sch Med, Nagoya, Aichi, Japan; [Ito, Hidemi] Aichi Canc Ctr, Div Canc Informat & Control, Res Inst, Nagoya, Aichi, Japan; [Ito, Hidemi] Nagoya Univ, Dept Descript Canc Epidemiol, Grad Sch Med, Nagoya, Aichi, Japan; [Tajima, Shoji] Osaka Univ, Inst Prot Res, Lab Epigenet, Osaka, Japan; [Yamao, Kenji] Narita Mem Hosp, Dept Gastroenterol, Toyohashi, Aichi, Japan	Nagoya University; Aichi Cancer Center; University of Tokyo; Nagoya Institute of Technology; Nagasaki University; RIKEN; Nagoya City University; Nagoya University; Aichi Cancer Center; Nagoya University; Aichi Cancer Center; Nagoya University; Osaka University	Shinjo, K (corresponding author), Nagoya Univ, Div Canc Biol, Grad Sch Med, Nagoya, Aichi, Japan.	kshinjo@med.nagoya-u.ac.jp	katsushima, keisuke/AAD-5945-2019; Nagae, Genta/H-6579-2019; Nagae, Genta/AAN-1167-2021; Matsuo, Keitaro/H-6758-2019	katsushima, keisuke/0000-0001-7770-432X; Nagae, Genta/0000-0002-2929-7990; Matsuo, Keitaro/0000-0003-1761-6314; Shinjo, Keiko/0000-0002-7797-6453	P-DIRECT from the Japan Agency for Medical Research and Development; P-CREATE from the Japan Agency for Medical Research and Development	P-DIRECT from the Japan Agency for Medical Research and Development; P-CREATE from the Japan Agency for Medical Research and Development	P-DIRECT (Y. K) and P-CREATE (K.S and Y. K) from the Japan Agency for Medical Research and Development. https://www.amed.go.jp/en/index.html.	Aguirre AJ, 2017, CANCER CELL, V32, P185, DOI 10.1016/j.ccell.2017.07.007; Aravanis AM, 2017, CELL, V168, P571, DOI 10.1016/j.cell.2017.01.030; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Church TR, 2014, GUT, V63, P317, DOI 10.1136/gutjnl-2012-304149; Collings CK, 2013, NUCLEIC ACIDS RES, V41, P2918, DOI 10.1093/nar/gks893; Curia MC, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5616-2; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; deVos T, 2009, CLIN CHEM, V55, P1337, DOI 10.1373/clinchem.2008.115808; Dubail J, 2010, CELL MOL LIFE SCI, V67, P4213, DOI 10.1007/s00018-010-0431-6; Filippakopoulos P, 2010, J MOL BIOL, V401, P389, DOI 10.1016/j.jmb.2010.06.017; Gall TMH, 2019, AM J PATHOL, V189, P71, DOI 10.1016/j.ajpath.2018.03.020; Goto Y, 2009, CANCER RES, V69, P9073, DOI 10.1158/0008-5472.CAN-09-1595; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Henriksen SD, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0286-2; Henriksen SD, 2015, PANCREAS, V44, P1036, DOI 10.1097/MPA.0000000000000487; Herreros-Villanueva M, 2013, CLIN CHIM ACTA, V418, P22, DOI 10.1016/j.cca.2012.12.025; Holdenrieder S, 2005, CLIN CHEM, V51, P1544, DOI 10.1373/clinchem.2005.049320; Jahr S, 2001, CANCER RES, V61, P1659; Janku F, 2017, ANN ONCOL, V28, P642, DOI 10.1093/annonc/mdw670; Ji LX, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00341; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Lee JY, 2012, J AM CHEM SOC, V134, P173, DOI 10.1021/ja210273w; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mishra NK, 2017, ONCOTARGET, V8, P28990, DOI 10.18632/oncotarget.15993; Morita S, 2012, INT J MOL SCI, V13, P8259, DOI 10.3390/ijms13078259; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; Ogura T, 2012, GASTROINTEST ENDOSC, V75, P769, DOI 10.1016/j.gie.2011.11.012; Otani J, 2013, J BIOL CHEM, V288, P6351, DOI 10.1074/jbc.M112.431098; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Sclafani F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19212-5; Shen SY, 2018, NATURE, V563, P579, DOI 10.1038/s41586-018-0703-0; Shinjo K, 2015, ADV DRUG DELIVER REV, V95, P56, DOI 10.1016/j.addr.2015.10.006; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Witkiewicz AK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7744; Ying J, 2006, ONCOGENE, V25, P1070, DOI 10.1038/sj.onc.1209154; Yu B, 2010, NEOPLASMA, V57, P247, DOI 10.4149/neo_2010_03_247	42	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2020	15	6							e0233782	10.1371/journal.pone.0233782	http://dx.doi.org/10.1371/journal.pone.0233782			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC0EC	32520974	Green Published, gold			2022-12-26	WOS:000542969500025
J	Thistlethwaite, FR; El-Dien, OG; Ratcliffe, B; Klapste, J; Porth, I; Chen, C; Stoehr, MU; Ingvarsson, PK; El-Kassaby, YA				Thistlethwaite, Frances R.; El-Dien, Omnia Gamal; Ratcliffe, Blaise; Klapste, Jaroslav; Porth, Ilga; Chen, Charles; Stoehr, Michael U.; Ingvarsson, Par K.; El-Kassaby, Yousry A.			Linkage disequilibrium vs. pedigree: Genomic selection prediction accuracy in conifer species	PLOS ONE			English	Article							NUCLEOTIDE DIVERSITY; QUANTITATIVE TRAITS; DEMOGRAPHIC HISTORY; RELATIONSHIP MATRIX; CLONED POPULATION; COMPLEX TRAITS; MODELS; ASSOCIATIONS; PATTERNS; VALUES	Background The presupposition of genomic selection (GS) is that predictive accuracies should be based on population-wide linkage disequilibrium (LD). However, in species with large, highly complex genomes the limitation of marker density may preclude the ability to resolve LD accurately enough for GS. Here we investigate such an effect in two conifer species with similar to 20 Gbp genomes, Douglas-fir (Pseudotsuga menziesiiMirb. (Franco)) and Interior spruce (Picea glauca(Moench) Voss xPicea engelmanniiParry ex Engelm.). Random sampling of markers was performed to obtain SNP sets with totals in the range of 200-50,000, this was replicated 10 times. Ridge Regression Best Linear Unbiased Predictor (RR-BLUP) was deployed as the GS method to test these SNP sets, and 10-fold cross-validation was performed on 1,321 Douglas-fir trees, representing 37 full-sib F(1)families and on 1,126 Interior spruce trees, representing 25 open-pollinated (half-sib) families. Both trials are located on 3 sites in British Columbia, Canada. Results As marker number increased, so did GS predictive accuracy for both conifer species. However, a plateau in the gain of accuracy became apparent around 10,000-15,000 markers for both Douglas-fir and Interior spruce. Despite random marker selection, little variation in predictive accuracy was observed across replications. On average, Douglas-fir prediction accuracies were higher than those of Interior spruce, reflecting the difference between full- and half-sib families for Douglas-fir and Interior spruce populations, respectively, as well as their respective effective population size. Conclusions Although possibly advantageous within an advanced breeding population, reducing marker density cannot be recommended for carrying out GS in conifers. Significant LD between markers and putative causal variants was not detected using 50,000 SNPS, and GS was enabled only through the tracking of relatedness in the populations studied. Dramatically increasing marker density would enable said markers to better track LD with causal variants in these large, genetically diverse genomes; as well as providing a model that could be used across populations, breeding programs, and traits.	[Thistlethwaite, Frances R.; El-Dien, Omnia Gamal; Ratcliffe, Blaise; El-Kassaby, Yousry A.] Univ British Columbia, Fac Forestry, Dept Forest & Conservat Sci, Vancouver, BC, Canada; [El-Dien, Omnia Gamal] Alexandria Univ, Fac Pharm, Pharmacognosy Dept, Alexandria, Egypt; [Klapste, Jaroslav] Scion New Zealand Forest Res Inst Ltd, Rotorua, New Zealand; [Porth, Ilga] Univ Laval, Dept Sci Bois & Foret, Quebec City, PQ, Canada; [Chen, Charles] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA; [Stoehr, Michael U.] British Columbia Minist Forests, Lands & Nat Resource Operat, Victoria, BC, Canada; [Ingvarsson, Par K.] Swedish Univ Agr Sci, Linnean Ctr Plant Biol, Dept Plant Biol, Uppsala, Sweden	University of British Columbia; Egyptian Knowledge Bank (EKB); Alexandria University; Scion; Laval University; Oklahoma State University System; Oklahoma State University - Stillwater; Swedish University of Agricultural Sciences	El-Kassaby, YA (corresponding author), Univ British Columbia, Fac Forestry, Dept Forest & Conservat Sci, Vancouver, BC, Canada.	y.el-kassaby@ubc.ca	Klapste, Jaroslav/B-6668-2016; Porth, Ilga M/N-4862-2015	Klapste, Jaroslav/0000-0001-5504-3735; Porth, Ilga M/0000-0002-9344-6348; Ingvarsson, Par/0000-0001-9225-7521	Genome British Columbia [UPP-001]; NSERC Discovery Grant	Genome British Columbia; NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Genome British Columbia (User Partnership Program (UPP-001) to YAK and MUS, NSERC Discovery Grant to YAK. We declare that the funding agencies did not participate in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.	Asoro FG, 2011, PLANT GENOME-US, V4, P132, DOI 10.3835/plantgenome2011.02.0007; Bartholome J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2879-8; Beaulieu J, 2014, HEREDITY, V113, P343, DOI 10.1038/hdy.2014.36; Beaulieu J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1048; Boyle EA, 2017, CELL, V169, P1177, DOI 10.1016/j.cell.2017.05.038; Chen C, 2013, TREE GENET GENOMES, V9, P1537, DOI 10.1007/s11295-013-0657-1; Chen ZQ, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5256-y; Dooner HK, 2008, PLANT CELL, V20, P249, DOI 10.1105/tpc.107.057596; Eckert AJ, 2010, GENETICS, V185, P969, DOI 10.1534/genetics.110.115543; El-Dien OG, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1597-y; El-Kassaby YA, 2011, TREE GENET GENOMES, V7, P553, DOI 10.1007/s11295-010-0355-1; El-Kassaby YA, 2009, GENET RES, V91, P111, DOI 10.1017/S001667230900007X; ELKASSABY YA, 1982, GENETICS, V101, P103; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Falconer DS, 2009, INTRO QUANTITATIVE G, DOI [10.1038/ng.352, DOI 10.1038/NG.352]; Fu HH, 2002, P NATL ACAD SCI USA, V99, P1082, DOI 10.1073/pnas.022635499; Gilmour AR, 2009, ASREML USER GUIDE RE; Grattapaglia D., 2017, GENOMIC SELECTION CR, P199, DOI [10.1007/978-3-319-63170-7_9, DOI 10.1007/978-3-319-63170-7_9]; GRATTAPAGLIA D, 2011, TREE GENET GENOMES, V7, P241, DOI DOI 10.1007/S11295-010-0328-4; Grattapaglia D, 2014, ADV GENOMICS PLANT G, V1, P651, DOI 10.1007/978-94-007-7572-5_26; Hayes BJ, 2009, GENET RES, V91, P47, DOI 10.1017/S0016672308009981; Heffner EL, 2010, CROP SCI, V50, P1681, DOI 10.2135/cropsci2009.11.0662; HENDERSON CR, 1976, BIOMETRICS, V32, P69, DOI 10.2307/2529339; Heuertz M, 2006, GENETICS, V174, P2095, DOI 10.1534/genetics.106.065102; Howe GT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-137; Isik F, 2016, PLANT SCI, V242, P108, DOI 10.1016/j.plantsci.2015.08.006; Isik F, 2014, NEW FOREST, V45, P379, DOI 10.1007/s11056-014-9422-z; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; Kang BY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-515; Krutovsky KV, 2004, GENETICS, V168, P447, DOI 10.1534/genetics.104.028381; Kumar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036674; Larsson H, 2013, G3-GENES GENOM GENET, V3, P795, DOI 10.1534/g3.112.005462; Lenz PRN, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3715-5; Lin Z, 2014, CROP PASTURE SCI, V65, P1177, DOI 10.1071/CP13363; Lindgren D., 1997, Forest Genetics, V4, P69; Lorenz AJ, 2012, CROP SCI, V52, P1609, DOI 10.2135/cropsci2011.09.0503; Ma YS, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0504-9; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen THE, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-35; Munoz PR, 2014, CROP SCI, V54, P1115, DOI 10.2135/cropsci2012.12.0673; Neale DB, 2004, TRENDS PLANT SCI, V9, P325, DOI 10.1016/j.tplants.2004.05.006; Neves LG, 2013, PLANT J, V75, P146, DOI 10.1111/tpj.12193; Pavy N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-21; Pavy N, 2017, PLANT J, V90, P189, DOI 10.1111/tpj.13478; Pelgas B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-145; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Pyhajarvi T, 2007, GENETICS, V177, P1713, DOI 10.1534/genetics.107.077099; Ratcliffe B, 2015, HEREDITY, V115, P547, DOI 10.1038/hdy.2015.57; Resende MFR, 2012, NEW PHYTOL, V193, P617, DOI 10.1111/j.1469-8137.2011.03895.x; Ritter E, 2002, ANN FOREST SCI, V59, P637, DOI 10.1051/forest:2002049; Shen X, 2014, PACKAGE BIGRR GENERA; Solberg TR, 2008, J ANIM SCI, V86, P2447, DOI 10.2527/jas.2007-0010; Sonesson AK, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-37; Su G, 2012, J DAIRY SCI, V95, P4657, DOI 10.3168/jds.2012-5379; Tan BY, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1059-6; Thistlethwaite FR, 2019, HEREDITY, V122, P848, DOI 10.1038/s41437-018-0172-0; Thistlethwaite FR, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4258-5; Wang QC, 2017, BMC GENET, V18, DOI 10.1186/s12863-017-0507-5; Whittaker JC, 2000, GENET RES, V75, P249, DOI 10.1017/S0016672399004462; Zapata-Valenzuela J, 2013, G3-GENES GENOM GENET, V3, P909, DOI 10.1534/g3.113.005975; Zapata-Valenzuela J, 2012, TREE GENET GENOMES, V8, P1307, DOI 10.1007/s11295-012-0516-5; Zhang Z, 2011, J DAIRY SCI, V94, P3642, DOI 10.3168/jds.2010-3917; 2013, SURG OBES RELAT DIS, V9	63	17	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2020	15	6							e0232201	10.1371/journal.pone.0232201	http://dx.doi.org/10.1371/journal.pone.0232201			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC0EC	32520936	gold, Green Published			2022-12-26	WOS:000542969500029
J	Harmsen, BJ; Foster, RJ; Quigley, H				Harmsen, Bart J.; Foster, Rebecca J.; Quigley, Howard			Spatially explicit capture recapture density estimates: Robustness, accuracy and precision in a long-term study of jaguars (Panthera onca)	PLOS ONE			English	Article							CAMERA TRAPS	Camera trapping is the standard field method of monitoring cryptic, low-density mammal populations. Typically, researchers run camera surveys for 60 to 90 days and estimate density using closed population spatially explicit capture-recapture (SCR) models. The SCR models estimate density, capture probability (g0), and a scale parameter (sigma) that reflects ranging behaviour. We used a year of camera data from 20 camera stations to estimate the density of male jaguars (Panthera onca) in the Cockscomb Basin Wildlife Sanctuary in Belize, using closed population SCR models. We subsampled the dataset into 276 90-day sessions and 186 180-day sessions. Estimated density fluctuated from 0.51 to 5.30 male jaguars / 100 km(2) between the 90-day sessions, with comparatively robust and precise estimates for the 180-day sessions (0.73 to 3.75 male jaguars / 100 km(2)). We explain the variation in density estimates from the 90-day sessions in terms of temporal variation in social behaviour, specifically male competition and mating events during the three-month wet season. Density estimates from the 90-day sessions varied with sigma, but not with the number of individuals detected, suggesting that variation in density was almost fully attributable to changes in estimated ranging behaviour. We found that the models overestimated sigma when compared to the mean ranging distance derived from GPS tracking data from two collared individuals in the camera grid. Overestimation of sigma when compared to GPS collar data was more pronounced for the 180-day sessions than the 90-day sessions. We conclude that one-off ('snap-shot') short-term, small-scale camera trap surveys do not sufficiently sample wide-ranging large carnivores. When using SCR models to estimate the density from these data, we caution against the use of poor sampling designs and/or misinterpretation of scope of inference. Although the density estimates from one-off, short-term, small-scale camera trap surveys may be statistically accurate within each short-term sampling period, the variation between density estimates from multiple sessions throughout the year illustrate that the estimates obtained should be carefully interpreted and extrapolated, because different factors, such as temporal stochasticity in behaviour of a few individuals, may have strong repercussions on density estimates. Because of temporal variation in behaviour, reliable density estimates will require larger samples of individuals and spatial recaptures than those presented in this study (mean +/- SD = 14.2 +/- 1.2 individuals, 37.7 +/- 4.7 spatial recaptures, N = 276 sessions), which are representative of, or higher than published sample sizes. To satisfy the need for larger samples, camera surveys will need to be more expansive with a higher density of stations. In the absence of this, we advocate longer sampling periods and subsampling through time as a means of understanding and describing stability or variation between density estimates.	[Harmsen, Bart J.; Foster, Rebecca J.; Quigley, Howard] Panthera, New York, NY 10018 USA; [Harmsen, Bart J.] Univ Belize, Environm Res Inst, Belmopan, Belize		Harmsen, BJ (corresponding author), Panthera, New York, NY 10018 USA.; Harmsen, BJ (corresponding author), Univ Belize, Environm Res Inst, Belmopan, Belize.	bharmsen@panthera.org	Foster, Rebecca/GSM-6886-2022		Panthera	Panthera	BJH, RJF, and HQ received funding from Panthera to carry out this work from yearly budget. https://www.panthera.org/NGO played no role in study design, data collection, analysis or decision or preparation of this manuscript. HQ Summerlee Foundation http://summerlee.org/Foundation played no role in study design, data collection, analysis or decision or preparation of this manuscript.	[Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], 2016, J HEPATOL, V64, pLB505; Borchers DL, 2008, BIOMETRICS, V64, P377, DOI 10.1111/j.1541-0420.2007.00927.x; Boron V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153973; Dupont P, 2019, METHODS ECOL EVOL, V10, P661, DOI 10.1111/2041-210X.13158; Efford M. G., 2004, Animal Biodiversity and Conservation, V27, P217; Efford MG, 2016, ECOGRAPHY, V39, P676, DOI 10.1111/ecog.01511; Figueroa O. A., 2013, THESIS U FLORIDA; Foster RJ, 2012, J WILDLIFE MANAGE, V76, P224, DOI 10.1002/jwmg.275; Foster RJ, 2010, BIOTROPICA, V42, P724, DOI 10.1111/j.1744-7429.2010.00641.x; Foster RJ, J MAMMAL UNPUB; Gerber BD, 2015, ECOL APPL, V25, P695, DOI 10.1890/14-0960.1; Glennie R, 2019, BIOMETRICS, V75, P1345, DOI 10.1111/biom.13078; Grente O, 2017, THESIS, DOI [10.13140/rg.2.2.31462.32320, DOI 10.13140/RG.2.2.31462.32320]; Harmsen BJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179505; Harmsen Bart J., 2010, P403; Harmsen BJ, 2010, BIOTROPICA, V42, P126, DOI 10.1111/j.1744-7429.2009.00544.x; Harmsen BJ, 2006, THESIS; Jedrzejewski W, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194719; Jedrzejewski W, 2017, MAMMAL RES, V62, P9, DOI 10.1007/s13364-016-0300-2; Karanth KU, 1998, ECOLOGY, V79, P2852; Karanth UK, 2002, MONITORING TIGERS TH, P111; Maffei L, 2004, J ZOOL, V262, P295, DOI 10.1017/S0952836903004655; Mateos Del Vas J, 2017, ANALISIS COMP PRODUC, P1, DOI [10.1017/S0030605316001046, DOI 10.1017/S0030605316001046]; Mohamed A, 2021, ORYX, V55, P56, DOI 10.1017/S0030605318001503; OTIS DL, 1978, WILDLIFE MONOGR, P1; Otis DL., 1982, CAPTURE RECAPTURE RE; Pickles R, 2014, PANTHERA FIELD MANUA, P91; RABINOWITZ AR, 1986, J ZOOL, V210, P149, DOI 10.1111/j.1469-7998.1986.tb03627.x; Satter CB, 2019, J WILDLIFE MANAGE, V83, P283, DOI 10.1002/jwmg.21598; Silver SC, 2004, ORYX, V38, P148, DOI 10.1017/S0030605304000286; Sollmann R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034575; Sunquist M, 2002, WILD CATS WORLD, P305; Sutherland C, 2015, METHODS ECOL EVOL, V6, P169, DOI 10.1111/2041-210X.12316; Tobler MW, 2013, BIOL CONSERV, V159, P109, DOI 10.1016/j.biocon.2012.12.009; Wooldridge RL, 2019, J MAMMAL, V100, P445, DOI 10.1093/jmammal/gyz055	36	18	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2020	15	6							e0227468	10.1371/journal.pone.0227468	http://dx.doi.org/10.1371/journal.pone.0227468			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ0RE	32511240	Green Published, gold			2022-12-26	WOS:000540938100031
J	Shelestak, J; Singhal, N; Frankle, L; Tomor, R; Sternbach, S; McDonough, J; Freeman, E; Clements, R				Shelestak, John; Singhal, Naveen; Frankle, Lana; Tomor, Riely; Sternbach, Sarah; McDonough, Jennifer; Freeman, Ernest; Clements, Robert			Increased blood-brain barrier hyperpermeability coincides with mast cell activation early under cuprizone administration	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; CORPUS-CALLOSUM; OCCLUDIN PHOSPHORYLATION; INDUCED DEMYELINATION; MICROGLIA ACTIVATION; PERMEABILITY; RECRUITMENT; ASTROCYTES; BREAKDOWN; TRYPTASE	The cuprizone induced animal model of demyelination is characterized by demyelination in many regions of the brain with high levels of demyelination in the corpus callosum as well as changes in neuronal function by 4-6 weeks of exposure. The model is used as a tool to study demyelination and subsequent degeneration as well as therapeutic interventions on these effects. Historically, the cuprizone model has been shown to contain no alterations to blood-brain barrier integrity, a key feature in many diseases that affect the central nervous system. Cuprizone is generally administered for 4-6 weeks to obtain maximal demyelination and degeneration. However, emerging evidence has shown that the effects of cuprizone on the brain may occur earlier than measurable gross demyelination. This study sought to investigate changes to blood-brain barrier permeability early in cuprizone administration. Results showed an increase in blood-brain barrier permeability and changes in tight junction protein expression as early as 3 days after beginning cuprizone treatment. These changes preceded glial morphological activation and demyelination known to occur during cuprizone administration. Increases in mast cell presence and activity were measured alongside the increased permeability implicating mast cells as a potential source for the blood-brain barrier disruption. These results provide further evidence of blood-brain barrier alterations in the cuprizone model and a target of therapeutic intervention in the prevention of cuprizone-induced pathology. Understanding how mast cells become activated under cuprizone and if they contribute to blood-brain barrier alterations may give further insight into how and when the blood-brain barrier is affected in CNS diseases. In summary, cuprizone administration causes an increase in blood-brain barrier permeability and this permeability coincides with mast cell activation.	[Shelestak, John; Frankle, Lana; Tomor, Riely; Sternbach, Sarah; McDonough, Jennifer; Freeman, Ernest; Clements, Robert] Kent State Univ, Sch Biomed Sci, Dept Biol Sci, Kent, OH 44242 USA; [Singhal, Naveen] All India Inst Med Sci, Dept Biochem, Rishikesh, Uttarakhand, India	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; All India Institute of Medical Sciences (AIIMS) Rishikesh	Shelestak, J (corresponding author), Kent State Univ, Sch Biomed Sci, Dept Biol Sci, Kent, OH 44242 USA.	jsheles1@kent.edu	Singhal, Dr.Naveen/GNW-3209-2022	Singhal, Dr.Naveen/0000-0003-4219-159X; Shelestak, John/0000-0001-8766-3461; Sternbach, Sarah/0000-0002-5761-9512				Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Acs P, 2013, J NEUROIMMUNOL, V262, P128, DOI 10.1016/j.jneuroim.2013.06.012; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Babbs RK, 2020, APPETITE, V150, DOI 10.1016/j.appet.2020.104678; Bakker DA, BLOOD BRAIN BARRIER, V13; Berghoff SA, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0497-6; Chen TH, 2018, ACS APPL BIO MATER, V1, P549, DOI 10.1021/acsabm.8b00020; Christy AL, 2013, J AUTOIMMUN, V42, P50, DOI 10.1016/j.jaut.2012.11.003; Chrzanowski U, 2019, NEUROCHEM INT, V126, P139, DOI 10.1016/j.neuint.2019.03.005; Clarner T, 2015, J IMMUNOL, V194, P3400, DOI 10.4049/jimmunol.1401459; Dong HQ, 2014, MED SCI MONIT BASIC, V20, P200, DOI 10.12659/MSMBR.893093; EDVINSSON L, 1977, NEUROLOGY, V27, P878, DOI 10.1212/WNL.27.9.878; Elieh-Ali-Komi D, 2017, CLIN REV ALLERG IMMU, V52, P436, DOI 10.1007/s12016-016-8595-y; Faizi M, 2016, TOXICOL MECH METHOD, V26, P276, DOI 10.3109/15376516.2016.1172284; Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832; Fernandez-Lopez D, 2016, J NEUROSCI, V36, P2881, DOI 10.1523/JNEUROSCI.0140-15.2016; FLATMARK T, 1980, EUR J CELL BIOL, V23, P141; Frossi B, 2003, EUR J IMMUNOL, V33, P2168, DOI 10.1002/eji.200323995; Gerwien H, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf8020; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Guerin CJ, 2001, NEUROSCIENCE, V103, P873, DOI 10.1016/S0306-4522(01)00015-X; Hirase T, 2001, J BIOL CHEM, V276, P10423, DOI 10.1074/jbc.M007136200; Hochstrasser T, 2017, J MOL NEUROSCI, V61, P617, DOI 10.1007/s12031-017-0903-3; HOFMAN FM, 1989, J EXP MED, V170, P607, DOI 10.1084/jem.170.2.607; Hogan AD, 1997, METHODS, V13, P43, DOI 10.1006/meth.1997.0494; Ibrahim MZM, 1996, J NEUROIMMUNOL, V70, P131, DOI 10.1016/S0165-5728(96)00102-6; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Jebaramya J, 2009, SENSORS, P21; KERMODE AG, 1990, BRAIN, V113, P1477, DOI 10.1093/brain/113.5.1477; Khalil M, 2007, BRAIN RES, V1171, P18, DOI 10.1016/j.brainres.2007.07.034; Komoly Samuel, 2005, Ideggyogy Sz, V58, P40; KONDO A, 1987, BRAIN RES, V425, P186, DOI 10.1016/0006-8993(87)90499-9; Lindsberg PJ, 2010, J CEREBR BLOOD F MET, V30, P689, DOI 10.1038/jcbfm.2009.282; Liu DF, 2014, NANOSCALE, V6, P15161, DOI 10.1039/c4nr03942d; Manaenko A, 2011, J NEUROSCI METH, V195, P206, DOI 10.1016/j.jneumeth.2010.12.013; McKittrick CM, 2015, J CEREBR BLOOD F MET, V35, P638, DOI 10.1038/jcbfm.2014.239; McMahon EJ, 2002, J NEUROIMMUNOL, V130, P32, DOI 10.1016/S0165-5728(02)00205-9; Mierzwa AJ, 2013, NEUROSCI LETT, V548, P280, DOI 10.1016/j.neulet.2013.05.010; Monsma PC, 2012, J NEUROSCI METH, V209, P344, DOI 10.1016/j.jneumeth.2012.06.015; Nautiyal KM, 2011, J NEUROIMMUNOL, V240, P142, DOI 10.1016/j.jneuroim.2011.09.003; Oliveira SHP, 2001, INFLAMM RES, V50, P168, DOI 10.1007/s000110050741; Ortigao-de-Sampaio MB, 1998, AIDS, V12, pF145; Pasquini LA, 2007, NEUROCHEM RES, V32, P279, DOI 10.1007/s11064-006-9165-0; PERSSON L, 1976, ACTA NEUROPATHOL, V34, P125, DOI 10.1007/BF00684663; Procaccini C, 2015, EUR J PHARMACOL, V759, P182, DOI 10.1016/j.ejphar.2015.03.042; Quinones MP, 2008, MOL CELL NEUROSCI, V37, P96, DOI 10.1016/j.mcn.2007.08.017; Rao R, 2009, ANN NY ACAD SCI, V1165, P62, DOI 10.1111/j.1749-6632.2009.04054.x; Ribatti D, 2015, EXP CELL RES, V338, P119, DOI 10.1016/j.yexcr.2015.05.013; ROZNIECKI JJ, 1995, ANN NEUROL, V37, P63, DOI 10.1002/ana.410370112; Sachs HH, 2014, ASN NEURO, V6, DOI 10.1177/1759091414551955; SARIA A, 1983, J NEUROSCI METH, V8, P41, DOI 10.1016/0165-0270(83)90050-X; SCHILLING L, 1994, BRAIN RES, V653, P289, DOI 10.1016/0006-8993(94)90403-0; Schmidt T, 2013, J MOL NEUROSCI, V49, P80, DOI 10.1007/s12031-012-9896-0; Schuh-Hofer S, 2003, BRAIN RES PROTOC, V12, P77, DOI 10.1016/j.brainresprot.2003.08.003; SCHWARTZ LB, 1987, NEW ENGL J MED, V316, P1622, DOI 10.1056/NEJM198706253162603; Secor VH, 2000, J EXP MED, V191, P813, DOI 10.1084/jem.191.5.813; Silver R, 1996, TRENDS NEUROSCI, V19, P25, DOI 10.1016/0166-2236(96)81863-7; Singhal NK, 2018, MOL NEUROBIOL, V55, P8051, DOI 10.1007/s12035-018-0971-6; Skripuletz T, 2013, BRAIN, V136, P147, DOI 10.1093/brain/aws262; Skuljec J, 2011, J NEUROPATH EXP NEUR, V70, P758, DOI 10.1097/NEN.0b013e3182294fad; Sridharan Gokul, 2012, J Oral Maxillofac Pathol, V16, P251, DOI 10.4103/0973-029X.99081; Steelman AJ, 2012, NEUROSCI RES, V72, P32, DOI 10.1016/j.neures.2011.10.002; TANDLER B, 1975, BEITR PATHOL, V156, P56, DOI 10.1016/S0005-8165(75)80085-0; TANDLER B, 1973, J CELL BIOL, V56, P266, DOI 10.1083/jcb.56.1.266; Tilling T, 1998, J NEUROCHEM, V71, P1151; TOMS R, 1990, J NEUROIMMUNOL, V30, P169, DOI 10.1016/0165-5728(90)90101-R; Vliagoftis A, 2000, J ALLERGY CLIN IMMUN, V106, P537, DOI 10.1067/mai.2000.109058; Witte ME, 2014, TRENDS MOL MED, V20, P179, DOI 10.1016/j.molmed.2013.11.007; Wolburg H, MODULATION TIGHT JUN, V11; Wolburg-Buchholz K, 2009, ACTA NEUROPATHOL, V118, P219, DOI 10.1007/s00401-009-0558-4; Wu QZ, 2008, J MAGN RESON IMAGING, V27, P446, DOI 10.1002/jmri.21111; Zhang S, 2012, CELL PHYSIOL BIOCHEM, V29, P931, DOI 10.1159/000171029; Zhuang X, 1996, J NEUROBIOL, V31, P393, DOI 10.1002/(SICI)1097-4695(199612)31:4<393::AID-NEU1>3.0.CO;2-4; Zlokovic BV, 2010, NAT MED, V16, P1370, DOI 10.1038/nm1210-1370	74	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2020	15	6							e0234001	10.1371/journal.pone.0234001	http://dx.doi.org/10.1371/journal.pone.0234001			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ0RE	32511268	Green Published, gold			2022-12-26	WOS:000540938100039
J	Rajagopal, A; Kidzinski, L; McGlaughlin, AS; Hicks, JL; Delp, SL; Schwartz, MH				Rajagopal, Apoorva; Kidzinski, Lukasz; McGlaughlin, Alec S.; Hicks, Jennifer L.; Delp, Scott L.; Schwartz, Michael H.			Pre-operative gastrocnemius lengths in gait predict outcomes following gastrocnemius lengthening surgery in children with cerebral palsy	PLOS ONE			English	Article							GROSS MOTOR FUNCTION; MULTILEVEL SURGERY; MUSCLE; CLASSIFICATION; RECESSION; PATTERNS	Equinus deformity is one of the most common gait deformities in children with cerebral palsy. We examined whether estimates of gastrocnemius length in gait could identify limbs likely to have short-term and long-term improvements in ankle kinematics following gastrocnemius lengthening surgery to correct equinus. We retrospectively analyzed data of 891 limbs that underwent a single-event multi-level surgery (SEMLS), and categorized outcomes based on the normalcy of ankle kinematics. Limbs with short gastrocnemius lengths that received a gastrocnemius lengthening surgery as part of a SEMLS (case limbs) were 2.2 times more likely than overtreated limbs (i.e., limbs who did not have short lengths, but still received a lengthening surgery) to have a good surgical outcome at the follow-up gait visit (good outcome rate of 71% vs. 33%). Case limbs were 1.2 times more likely than control limbs (i.e., limbs that had short gastrocnemius lengths but no lengthening surgery) to have a good outcome (71% vs. 59%). Three-fourths of the case limbs with a good outcome at the follow-up gait visit maintained this outcome over time, compared to only one-half of the overtreated limbs. Our results caution against over-prescription of gastrocnemius lengthening surgery and suggest gastrocnemius lengths can be used to identify good surgical candidates.	[Rajagopal, Apoorva; Delp, Scott L.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Kidzinski, Lukasz; McGlaughlin, Alec S.; Hicks, Jennifer L.; Delp, Scott L.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Schwartz, Michael H.] Gillette Childrens Specialty Healthcare, Ctr Gait & Mot Anal, St Paul, MN USA; [Schwartz, Michael H.] Univ Minnesota, Dept Orthoped Surg, Minneapolis, MN USA	Stanford University; Stanford University; University of Minnesota System; University of Minnesota Twin Cities	Rajagopal, A (corresponding author), Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA.	apoorva@alumni.stanford.edu		Hicks, Jennifer/0000-0002-2516-9334; Rajagopal, Apoorva/0000-0002-7915-7048; Delp, Scott/0000-0002-9643-7551; Schwartz, Michael/0000-0003-3388-7413	NIH [U54EB020405, R24 HD065690, P2C HD065690]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by NIH grants U54EB020405, R24 HD065690, and P2C HD065690. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsen SE, 2007, J PEDIATR ORTHOPED, V27, P658, DOI 10.1097/BPO.0b013e3180dca114; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2017, ADHD ATTENTION DE S1, V9, pS1, DOI 10.1007/s12402-017-0224-y; Arnold AS, 2006, GAIT POSTURE, V23, P273, DOI 10.1016/j.gaitpost.2005.03.003; Bell KJ, 2002, J PEDIATR ORTHOPED, V22, P677, DOI 10.1097/00004694-200209000-00020; Borton DC, 2001, J BONE JOINT SURG BR, V83B, P364, DOI 10.1302/0301-620X.83B3.10827; Boyd RN, 2000, DEV MED CHILD NEUROL, V42, P32, DOI 10.1017/S0012162200000074; DeLuca PA, 1997, J PEDIATR ORTHOPED, V17, P608, DOI 10.1097/00004694-199709000-00007; Dreher T, 2012, J BONE JOINT SURG AM, V94A, P627, DOI 10.2106/JBJS.K.00096; Gage JR, 2001, J PEDIATR ORTHOP B, V10, P265, DOI 10.1097/00009957-200110000-00001; Gough M, 2004, DEV MED CHILD NEUROL, V46, P91; Handsfield GG, 2016, MUSCLE NERVE, V53, P933, DOI 10.1002/mus.24972; Hanna SE, 2009, DEV MED CHILD NEUROL, V51, P295, DOI 10.1111/j.1469-8749.2008.03196.x; Hicks JL, 2011, GAIT POSTURE, V34, P197, DOI 10.1016/j.gaitpost.2011.04.009; Hotelling Harold, 1951, P 2 BERK S MATH STAT; Kainz H, 2016, J BIOMECH; Kay RM, 2004, J PEDIATR ORTHOP B, V13, P92, DOI 10.1097/00009957-200403000-00006; Kidziski, 2018, LONGITUDINAL DATA AN; Mathewson MA, 2015, J ORTHOP RES, V33, P33, DOI 10.1002/jor.22728; Maurer JD, 2014, GAIT POSTURE, V39, P1, DOI 10.1016/j.gaitpost.2013.08.015; Miller Rupert G., 1981, SIMULTANEOUS STAT IN, V2nd, DOI [DOI 10.1007/978-1-4613-8122-8, 10.1007/978-1-4613-8122-8_1]; Ong CF, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006993; Osborne M, 2019, GAIT POSTURE, V68, P323, DOI 10.1016/j.gaitpost.2018.11.033; Ounpuu S, 2015, GAIT POSTURE, V42, P365, DOI 10.1016/j.gaitpost.2015.07.003; Perry J, 1992, J PEDIAT ORTHOPAEDIC; Rajagopal A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33962-2; Rajagopal A, 2016, IEEE T BIO-MED ENG, V63, P2068, DOI 10.1109/TBME.2016.2586891; Rethlefsen SA, 2017, DEV MED CHILD NEUROL, V59, P79, DOI 10.1111/dmcn.13205; Rodda J, 2001, EUR J NEUROL, V8, P98, DOI 10.1046/j.1468-1331.2001.00042.x; Rose GE, 2010, GAIT POSTURE, V31, P351, DOI 10.1016/j.gaitpost.2009.12.006; ROSE SA, 1993, J PEDIATR ORTHOPED, V13, P727, DOI 10.1097/01241398-199311000-00007; Rosenbaum PL, 2002, JAMA-J AM MED ASSOC, V288, P1357, DOI 10.1001/jama.288.11.1357; Sangeux M, 2015, GAIT POSTURE, V41, P586, DOI 10.1016/j.gaitpost.2014.12.019; Scheys L, 2011, J BIOMECH, V44, P1346, DOI 10.1016/j.jbiomech.2011.01.001; Schwartz MH, 2008, GAIT POSTURE, V28, P351, DOI 10.1016/j.gaitpost.2008.05.001; Schwartz MH, 2008, J BIOMECH, V41, P1639, DOI 10.1016/j.jbiomech.2008.03.015; Schwartz MH, 2013, GAIT POSTURE, V37, P473, DOI 10.1016/j.gaitpost.2012.08.016; Seth A, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006223; Shore BJ, 2010, J CHILD ORTHOP, V4, P277, DOI 10.1007/s11832-010-0268-4; STRAYER LM, 1950, J BONE JOINT SURG AM, V32-A, P671, DOI 10.2106/00004623-195032030-00022; Theis N, 2015, CLIN BIOMECH, V30, P1071, DOI 10.1016/j.clinbiomech.2015.09.004; van der Krogt MM, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0170-5; Zwick EB, 2001, J PEDIATR ORTHOP B, V10, P226, DOI 10.1097/00009957-200107000-00013	43	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0233706	10.1371/journal.pone.0233706	http://dx.doi.org/10.1371/journal.pone.0233706			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502157	Green Published, gold			2022-12-26	WOS:000542035700012
J	Jafarpour, F; Zadegan, FG; Ostadhosseini, S; Hajian, M; Kiani-Esfahani, A; Nasr-Esfahani, MH				Jafarpour, Farnoosh; Ghazvini Zadegan, Faezeh; Ostadhosseini, Somayyeh; Hajian, Mehdi; Kiani-Esfahani, Abbas; Nasr-Esfahani, M. H.			siRNA inhibition and not chemical inhibition of Suv39h1/2 enhances pre-implantation embryonic development of bovine somatic cell nuclear transfer embryos	PLOS ONE			English	Article							IN-VITRO DEVELOPMENT; MAMMALIAN DEVELOPMENT; HISTONE; CHROMATIN; EXPRESSION; EFFICIENCY; CLONING; HETEROCHROMATIN; OOCYTES; ACID	The efficiency of somatic cell nuclear transfer (SCNT) is low due to the strong resistance of somatic donor cells to epigenetic reprogramming. Many epigenetic drugs targeting DNA methylation and histone acetylation have been used in attempts to improve the in vitro and in vivo development of SCNT embryos. H3K9me3 has been shown to be an important reprogramming barrier for generating induced pluripotent stem cells (iPSCs) and SCNT embryos in mice and humans. In this study, we examined the effects of selective siRNA and chemical inhibition of H3K9me3 in somatic donor cells on the in vitro development of bovine SCNT embryos. Chaetocin, an inhibitor of SUV39H1/H2, was supplemented during the culture of donor cells. In addition, the siRNA knockdown of SUV39H1/H2 was performed in the donor cells. The effects of chaetocin and siSUV39H1/H2 on H3K9me3 and H3K9ac were quantified using flow cytometry. Furthermore, we assessed chaetocin treatment and SUV39H1/H2 knockdown on the blastocyst formation rate. Both chaetocin and siSUV39H1/H2 significantly reduced and elevated the relative intensity level of H3K9me3 and H3K9ac in treated fibroblast cells, respectively. siSUV39H1/H2 transfection, but not chaetocin treatment, improved the in vitro development of SCNT embryos. Moreover, siSUV39H1/H2 altered the expression profile of the selected genes in the derived blastocysts, similar to those derived from in vitro fertilization (IVF). In conclusion, our results demonstrated H3K9me3 as an epigenetic barrier in the reprogramming process mediated by SCNT in bovine species, a finding which supports the role of H3K9me3 as a reprogramming barrier in mammalian species. Our findings provide a promising approach for improving the efficiency of mammalian cloning for agricultural and biomedical purposes.	[Jafarpour, Farnoosh; Ghazvini Zadegan, Faezeh; Ostadhosseini, Somayyeh; Hajian, Mehdi; Nasr-Esfahani, M. H.] ACECR, Royan Inst Biotechnol, Reprod Biomed Res Ctr, Dept Reprod Biotechnol, Esfahan, Iran; [Jafarpour, Farnoosh; Ghazvini Zadegan, Faezeh; Ostadhosseini, Somayyeh; Hajian, Mehdi; Kiani-Esfahani, Abbas; Nasr-Esfahani, M. H.] ACECR, Royan Inst Biotechnol, Cell Sci Res Ctr, Dept Cellular Biotechnol, Esfahan, Iran	Academic Center for Education, Culture & Research (ACECR); Academic Center for Education, Culture & Research (ACECR)	Jafarpour, F; Nasr-Esfahani, MH (corresponding author), ACECR, Royan Inst Biotechnol, Reprod Biomed Res Ctr, Dept Reprod Biotechnol, Esfahan, Iran.	jafarpour.farnoosh@gmail.com; mh.nasr-esfahani@royaninstitute.org	, Nasr-Esfahani/AAR-2434-2021; Nasr-Esfahani, Mohammad Hossein/AAN-2577-2020	Nasr-Esfahani, Mohammad Hossein/0000-0003-1983-3435	Royan Institute	Royan Institute	This study was funded by a grant from Royan Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors would like to express their gratitude to Royan Institute for their full support.	Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Blelloch R, 2006, STEM CELLS, V24, P2007, DOI 10.1634/stemcells.2006-0050; Bosch-Preseguee L, 2015, FEBS J, V282, P1745, DOI 10.1111/febs.13053; Bourc'his D, 2001, CURR BIOL, V11, P1542, DOI 10.1016/S0960-9822(01)00480-8; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Cherblanc FL, 2013, NAT CHEM BIOL, V9, P136, DOI 10.1038/nchembio.1187; Chung YG, 2015, CELL STEM CELL, V17, P758, DOI 10.1016/j.stem.2015.10.001; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Enright BP, 2003, BIOL REPROD, V69, P896, DOI 10.1095/biolreprod.103.017954; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Furdas SD, 2012, ARCH PHARM, V345, P7, DOI 10.1002/ardp.201100209; Greiner D, 2005, NAT CHEM BIOL, V1, P143, DOI 10.1038/nchembio721; GURDON JB, 1960, J EMBRYOL EXP MORPH, V8, P505; Hosseini SM, 2013, CELL REPROGRAM, V15, P15, DOI 10.1089/cell.2012.0033; Hosseini SM, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2264-z; Ianni A, 2017, BIOCHEM BIOPH RES CO, V492, P434, DOI 10.1016/j.bbrc.2017.08.081; Jafari S, 2011, MOL REPROD DEV, V78, P576, DOI 10.1002/mrd.21344; Jafarpour F, 2017, THERIOGENOLOGY, V89, P86, DOI 10.1016/j.theriogenology.2016.10.010; Jafarpour F, 2011, CELL REPROGRAM, V13, P483, DOI 10.1089/cell.2011.0005; Jin L, 2017, THERIOGENOLOGY, V87, P298, DOI 10.1016/j.theriogenology.2016.09.011; Kang JD, 2013, THERIOGENOLOGY, V79, P306, DOI 10.1016/j.theriogenology.2012.08.021; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Liang S, 2012, THERIOGENOLOGY, V77, P1198, DOI 10.1016/j.theriogenology.2011.10.027; Liu X, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.158261; Maleszewska M, 2014, PHARMACOL REP, V66, P107, DOI 10.1016/j.pharep.2013.08.011; Matoba S, 2014, CELL, V159, P884, DOI 10.1016/j.cell.2014.09.055; Meng Fanli, 2019, TARGETED DEMETHYLATI, DOI [10.1101/699181, DOI 10.1101/699181]; Niemann H, 2016, THERIOGENOLOGY, V86, P80, DOI 10.1016/j.theriogenology.2016.04.021; Ogura A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0329; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Pasque V, 2011, TRENDS GENET, V27, P516, DOI 10.1016/j.tig.2011.08.002; Peat JR, 2012, NAT GENET, V44, P965, DOI 10.1038/ng.2393; Pezhman M, 2017, BMC DEV BIOL, V17, DOI 10.1186/s12861-017-0152-2; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Rodriguez-Osorio N, 2012, THERIOGENOLOGY, V78, P1869, DOI 10.1016/j.theriogenology.2012.05.030; Sun HL, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15038455; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Vaute O, 2002, NUCLEIC ACIDS RES, V30, P475, DOI 10.1093/nar/30.2.475; Wells DN, 2005, REV SCI TECH OIE, V24, P251, DOI 10.20506/rst.24.1.1566; Xu P, 2016, EXPERT OPIN THER PAT, V26, P1017, DOI 10.1080/13543776.2016.1209488; Zhang TY, 2015, EMBO REP, V16, P1467, DOI 10.15252/embr.201540945; Zhu Wei-Guo, 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P187, DOI 10.2174/1568011033482440	44	3	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0233880	10.1371/journal.pone.0233880	http://dx.doi.org/10.1371/journal.pone.0233880			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497112	Green Published, gold			2022-12-26	WOS:000542035200084
J	Liu, DD; Ndongwe, TP; Puray-Chavez, M; Casey, MC; Izumi, T; Pathak, VK; Tedbury, PR; Sarafianos, SG				Liu, Dandan; Ndongwe, Tanyaradzwa P.; Puray-Chavez, Maritza; Casey, Mary C.; Izumi, Taisuke; Pathak, Vinay K.; Tedbury, Philip R.; Sarafianos, Stefan G.			Effect of P-body component Mov10 on HCV virus production and infectivity	FASEB JOURNAL			English	Article						HCV; infectivity; lipid droplets; Mov10; P-body; RNA replication	HEPATITIS-C VIRUS; INTERFERON-STIMULATED GENES; CORE PROTEIN; PEGINTERFERON ALPHA-2B; LIVER-TRANSPLANTATION; PROCESSING BODIES; PLUS RIBAVIRIN; B-VIRUS; REPLICATION; RNA	Mov10 is a processing body (P-body) protein and an interferon-stimulated gene that can affect replication of retroviruses, hepatitis B virus, and hepatitis C virus (HCV). The mechanism of HCV inhibition by Mov10 is unknown. Here, we investigate the effect of Mov10 on HCV infection and determine the virus life cycle steps affected by changes in Mov10 overexpression. Mov10 overexpression suppresses HCV RNA in both infectious virus and subgenomic replicon systems. Additionally, Mov10 overexpression decreases the infectivity of released virus, unlike control P-body protein DCP1a that has no effect on HCV RNA production or infectivity of progeny virus. Confocal imaging of uninfected cells shows endogenous Mov10 localized at P-bodies. However, in HCV-infected cells, Mov10 localizes in circular structures surrounding cytoplasmic lipid droplets with NS5A and core protein. Mutagenesis experiments show that the RNA binding activity of Mov10 is required for HCV inhibition, while its P-body localization, helicase, and ATP-binding functions are not required. Unexpectedly, endogenous Mov10 promotes HCV replication, as CRISPR-Cas9-based Mov10 depletion decreases HCV replication and infection levels. Our data reveal an important and complex role for Mov10 in HCV replication, which can be perturbed by excess or insufficient Mov10.	[Liu, Dandan; Ndongwe, Tanyaradzwa P.; Puray-Chavez, Maritza; Casey, Mary C.] Univ Missouri, Christopher Bond Life Sci Ctr, Dept Mol Microbiol & Immunol, Columbia, MO USA; [Izumi, Taisuke; Pathak, Vinay K.] Natl Canc Inst Frederick, Viral Mutat Sect, HIV Dynam & Replicat Program, Frederick, MD USA; [Tedbury, Philip R.; Sarafianos, Stefan G.] Emory Univ, Sch Med, Dept Pediat, Lab Biochem Pharmacol, Atlanta, GA 30322 USA	University of Missouri System; University of Missouri Columbia; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Emory University	Sarafianos, SG (corresponding author), Emory Univ, Sch Med, Dept Pediat, Lab Biochem Pharmacol, Atlanta, GA 30322 USA.	ssarafi@emory.edu	Tedbury, Philip/H-3945-2019; Izumi, Taisuke/GNP-1175-2022	Tedbury, Philip/0000-0001-8151-4967; Izumi, Taisuke/0000-0001-8193-0813; Pathak, Vinay/0000-0003-2441-8412	NIH [R01 AI099284 R01 AI121315]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NIH, Grant/Award Number: R01 AI099284 R01 AI121315	Abudu A, 2012, J BIOL CHEM, V287, P1220, DOI 10.1074/jbc.M111.309831; Adam P, 2003, LIVER TRANSPLANT, V9, P1231, DOI 10.1016/j.lts.2003.09.018; Adedeji AO, 2012, ANTIMICROB AGENTS CH, V56, P4718, DOI 10.1128/AAC.00957-12; Ariumi Y, 2011, J VIROL, V85, P6882, DOI 10.1128/JVI.02418-10; Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Boulant S, 2005, J VIROL, V79, P11353, DOI 10.1128/JVI.79.17.11353-11365.2005; Burdick R, 2010, J VIROL, V84, P10241, DOI 10.1128/JVI.00585-10; Cao XZ, 2015, J HEPATOL, V62, P771, DOI 10.1016/j.jhep.2014.11.007; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Conrad KD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056272; Dreux M, 2012, CELL HOST MICROBE, V12, P558, DOI 10.1016/j.chom.2012.08.010; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Furtak V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009081; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Goodier JL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002941; Gregersen LH, 2014, MOL CELL, V54, P573, DOI 10.1016/j.molcel.2014.03.017; Grunvogel O, 2015, J VIROL, V89, P10548, DOI 10.1128/JVI.01297-15; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Horner SM, 2014, J MOL BIOL, V426, P1198, DOI 10.1016/j.jmb.2013.10.032; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huys A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067437; Israelow B, 2014, HEPATOLOGY, V60, P1170, DOI 10.1002/hep.27227; Itsui Y, 2006, J VIRAL HEPATITIS, V13, P690, DOI 10.1111/j.1365-2893.2006.00732.x; Izumi T, 2013, J VIROL, V87, P11047, DOI 10.1128/JVI.02070-13; Jangra RK, 2010, J VIROL, V84, P6810, DOI 10.1128/JVI.00397-10; Jiang D, 2008, J VIROL, V82, P1665, DOI 10.1128/JVI.02113-07; Kenny PJ, 2014, CELL REP, V9, P1729, DOI 10.1016/j.celrep.2014.10.054; Kim CW, 2013, CLIN MOL HEPATOL, V19, P17, DOI 10.3350/cmh.2013.19.1.17; Kirby KA, 2012, ANTIMICROB AGENTS CH, V56, P2048, DOI 10.1128/AAC.06000-11; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Liu C, 2012, J BIOL CHEM, V287, P29373, DOI 10.1074/jbc.M112.354001; Liu DD, 2015, ANTIMICROB AGENTS CH, V59, P3482, DOI 10.1128/AAC.00223-15; Liu TT, 2019, J BIOL CHEM, V294, P19804, DOI 10.1074/jbc.RA119.009435; Lu CY, 2012, J VIROL, V86, P10517, DOI 10.1128/JVI.00868-12; Ma YX, 2015, VIRUS RES, V197, P85, DOI 10.1016/j.virusres.2014.12.011; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; McGivern DR, 2014, GASTROENTEROLOGY, V147, P453, DOI 10.1053/j.gastro.2014.04.021; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moriishi K, 2007, REV MED VIROL, V17, P343, DOI 10.1002/rmv.542; Niu JW, 2014, MOL BIOTECHNOL, V56, P681, DOI 10.1007/s12033-014-9771-z; Pager CT, 2013, VIROLOGY, V435, P472, DOI 10.1016/j.virol.2012.10.027; Pawlotsky JM, 2013, CURR TOP MICROBIOL, V369, P321, DOI 10.1007/978-3-642-27340-7_13; Perez-Vilaro G, 2012, J VIROL, V86, P8740, DOI 10.1128/JVI.07167-11; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Poenisch M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004573; Puray-Chavez MN, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11070651; Ramakrishnaiah V, 2013, P NATL ACAD SCI USA, V110, P13109, DOI 10.1073/pnas.1221899110; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roberts APE, 2014, NUCLEIC ACIDS RES, V42, P1257, DOI 10.1093/nar/gkt941; Scheller N, 2009, P NATL ACAD SCI USA, V106, P13517, DOI 10.1073/pnas.0906413106; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shimakami T, 2012, P NATL ACAD SCI USA, V109, P941, DOI 10.1073/pnas.1112263109; Sugawara Yasuhiko, 2005, Clin Gastroenterol Hepatol, V3, pS122, DOI 10.1016/S1542-3565(05)00708-1; Targett-Adams P, 2011, J VIROL, V85, P6353, DOI 10.1128/JVI.00215-11; Upadhyay A, 2013, MOL CELL PROTEOMICS, V12, P1539, DOI 10.1074/mcp.M112.017020; Wang XJ, 2010, J BIOL CHEM, V285, P14346, DOI 10.1074/jbc.M110.109314; Wiesner RH, 2003, LIVER TRANSPLANT, V9, pS1, DOI 10.1053/jlts.2003.50268; Wilson JA, 2011, J VIROL, V85, P2342, DOI 10.1128/JVI.02046-10; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Yang DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024788; Zeuzem S, 2008, NAT CLIN PRACT GASTR, V5, P610, DOI 10.1038/ncpgasthep1274; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	69	8	8	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9433	9449		10.1096/fj.201800641R	http://dx.doi.org/10.1096/fj.201800641R		JUN 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32496609	Green Accepted			2022-12-26	WOS:000538309200001
J	Georgiou, M; Chichagova, V; Hilgen, G; Dorgau, B; Sernagor, E; Armstrong, L; Lako, M				Georgiou, Maria; Chichagova, Valeria; Hilgen, Gerrit; Dorgau, Birthe; Sernagor, Evelyne; Armstrong, Lyle; Lako, Majlinda			Room temperature shipment does not affect the biological activity of pluripotent stem cell-derived retinal organoids	PLOS ONE			English	Article							CHAIN SHIPPING ENVIRONMENT; VALIDATION; TISSUE	The generation of laminated and light responsive retinal organoids from induced pluripotent stem cells (iPSCs) provides a powerful tool for the study of retinal diseases and drug discovery and a robust platform for cell-based therapies. The aim of this study is to investigate whether retinal organoids can retain their morphological and functional characteristics upon storage at room temperature (RT) conditions and shipment by air using a commercially available container that maintains the environment at ambient temperature. Morphological analysis and measurements of neuroepithelial thickness revealed no differences between control, RT incubated and shipped organoids. Similarly immunohistochemical analysis showed no differences in cell type composition and position within the laminated retinal structure. All groups showed a similar response to light, suggesting that the biological function of retinal organoids was not affected by RT storage or shipment. These findings provide an advance in transport of ready-made retinal organoids, increasing their availability to many research and pharma labs worldwide and facilitating cross-collaborative research.	[Georgiou, Maria; Chichagova, Valeria; Hilgen, Gerrit; Dorgau, Birthe; Sernagor, Evelyne; Armstrong, Lyle; Lako, Majlinda] Newcastle Univ, Fac Med Sci, Biosci Inst, Newcastle Upon Tyne, Tyne & Wear, England; [Chichagova, Valeria; Dorgau, Birthe; Armstrong, Lyle] Newcells Biotech Ltd, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK	Lako, M (corresponding author), Newcastle Univ, Fac Med Sci, Biosci Inst, Newcastle Upon Tyne, Tyne & Wear, England.	majlinda.lako@ncl.ac.uk	Hilgen, Gerrit/AAF-5649-2021	Hilgen, Gerrit/0000-0001-5008-5493; Dorgau, Birthe/0000-0003-4031-4402; Georgiou, Maria/0000-0001-7879-7003; lako, majlinda/0000-0003-1327-8573	CRACKIT23 challenge award [NC/CO16206/1]; European Research Council [614620]; MRC Confidence in Concept award [MC_PC_15030]; RP Fighting Blindness Innovation grant [GR584, GR585]; CRACKIT23 award; BBSRC [BB/T004460/1] Funding Source: UKRI; MRC [MR/T017503/1] Funding Source: UKRI	CRACKIT23 challenge award; European Research Council(European Research Council (ERC)European Commission); MRC Confidence in Concept award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); RP Fighting Blindness Innovation grant; CRACKIT23 award; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	CRACKIT23 challenge award (NC/CO16206/1), European Research Council (#614620] MRC Confidence in Concept award (MC_PC_15030), RP Fighting Blindness Innovation grant (GR584 and GR585). CRACKIT23 award to Biosciences Institute, Faculty of Medical Sciences, Newcastle University, UK. provided support in the form of salaries for authors MG, BH, VC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This work was funded by CRACKIT23 challenge award (NC/CO16206/1), the European Research Council (#614620], MRC Confidence in Concept award (MC_PC_15030) and RP Fighting Blindness Innovation grant (GR584 and GR585).	Achberger K, 2019, ADV DRUG DELIVER REV, V140, P33, DOI 10.1016/j.addr.2018.05.005; Chichagova V, 2018, EYE, V32, P946, DOI 10.1038/s41433-018-0061-z; Dorgau B, 2019, BIOMATERIALS, V199, P63, DOI 10.1016/j.biomaterials.2019.01.028; Elliott MA, 2005, INT J PHARMACEUT, V299, P49, DOI 10.1016/j.ijpharm.2005.04.032; Felemban M, 2018, ACTA BIOMATER, V74, P207, DOI 10.1016/j.actbio.2018.05.023; Gu X, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00008; Hallam D, 2018, STEM CELLS, V36, P1535, DOI 10.1002/stem.2883; Hori K, 2019, J TISSUE ENG REGEN M, V13, P459, DOI 10.1002/term.2805; Jang TH, 2017, INTEGR MED RES, V6, P12, DOI 10.1016/j.imr.2016.12.001; Kuwahara A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7286; Mellough CB, 2019, STEM CELL TRANSL MED, V8, P694, DOI 10.1002/sctm.18-0267; Mellough CB, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.169474; Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106; Miller TD, 2013, CORNEA, V32, P63, DOI 10.1097/ICO.0b013e3182685c8e; Rooney P, 2015, CELL TISSUE BANK, V16, P553, DOI 10.1007/s10561-015-9502-0; Schallenberger M, 2016, CELL TISSUE BANK, V17, P677, DOI 10.1007/s10561-016-9578-1; Singh RK, 2020, J TISSUE ENG REGEN M, V14, P388, DOI 10.1002/term.2997	17	7	7	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0233860	10.1371/journal.pone.0233860	http://dx.doi.org/10.1371/journal.pone.0233860			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MJ2AA	32479513	Green Published, Green Accepted, gold			2022-12-26	WOS:000547893500035
J	Moreno, CG; Luque, AT; Oliszewski, R; Rosa, RJ; Otero, MC				Gonzalez Moreno, Candelaria; Torres Luque, Andrea; Ruben Oliszewski; Rosa, Ramiro J.; Otero, Maria C.			Characterization of native Escherichia coli populations from bovine vagina of healthy heifers and cows with postpartum uterine disease	PLOS ONE			English	Article							VIRULENCE FACTORS; IN-VITRO; ARCANOBACTERIUM-PYOGENES; BIOFILM FORMATION; OVARIAN-FUNCTION; MULTIPLEX PCR; DAIRY-COWS; STRAINS; METRITIS; GROWTH	Even though Escherichia coli are common bacteria of the bovine vaginal microbiota, they represent an important pathogen that causes diseases in the reproductive tract and subfertility. However, the actual endometrial virulence profile of E. coli is poorly understood. The present study aims to characterize the phylogenetic structure and virulence potential of native vaginal populations of E. coli from healthy heifers (H), and cows with postpartum uterine diseases (PUD), such as metritis/endometritis (MT) or repeat breeder cows (RB). To this end, the virulence repertoire of 97 E. coli isolates was genotypically and phenotypically assessed. Most of them were assigned to phylogenetic group A (74%), followed by B1 (17%) and D (9%); RB strains were significantly (p < 0.05) more represented by B1. Seven of the 15 evaluated virulence genes (VFG) were detected and the most prevalent were fimH (87%), agn43 (41%) and csgA (35%); while traT (27%), fyuA (11%), hlyA (5%) and kpsMT II (5%) were observed in a lower proportion. Particularly, fyuA was significantly higher (p < 0.05) in MT cows whereas csgA showed the same behavior in PUD animals (p < 0.05). When comparing H and PUD strains, these last ones were associated to positive expression of biofilm, fimbriae curli/cellulose and motility; yet RB strains did not show motility. Vaginal B1 E. coli populations, that possess VFG (fyuA and csgA) as well as the expression of motility, curli fimbriae/cellulose and biofilm, may represent risk factors for endometrial disorders; specifically, those that also, have kpsMT II may have a pathogenic potential for causing the RB syndrome. Future research focusing on the detection of these strains in the vaginal microbiota of cows with postpartum uterine diseases should be done since the control of their presence in vagina could reduce the risk that they access the uterus during the postpartum period.	[Gonzalez Moreno, Candelaria; Torres Luque, Andrea; Otero, Maria C.] Consejo Nacl Invest Cient & Tecn CONICET, Inst Super Invest Biol INSIBIO, San Miguel De Tucuman, Tucuman, Argentina; [Gonzalez Moreno, Candelaria; Torres Luque, Andrea; Otero, Maria C.] Univ Nacl Tucuman UNT, Fac Bioquim Quim & Farm, Inst Biol Dr Francisco D Barbieri, San Miguel De Tucuman, Tucuman, Argentina; [Gonzalez Moreno, Candelaria; Rosa, Ramiro J.] Univ Nacl Tucuman, Fac Agron & Zootecnia, San Miguel De Tucuman, Argentina; [Ruben Oliszewski] Univ Nacl Tucuman UNT, Fac Agron & Zootecnia, Lab Calidad Lacteos LaCaLac, Consejo Nacl Invest Cient & Tecn CONICET, San Miguel De Tucuman, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de Tucuman; Universidad Nacional de Tucuman; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de Tucuman	Otero, MC (corresponding author), Consejo Nacl Invest Cient & Tecn CONICET, Inst Super Invest Biol INSIBIO, San Miguel De Tucuman, Tucuman, Argentina.; Otero, MC (corresponding author), Univ Nacl Tucuman UNT, Fac Bioquim Quim & Farm, Inst Biol Dr Francisco D Barbieri, San Miguel De Tucuman, Tucuman, Argentina.	oteromariaclaudia@gmail.com	Otero, Claudia/AAK-3262-2021	Torres Luque, Andrea/0000-0001-6981-7332; Gonzalez Moreno, Candelaria/0000-0003-4317-6172; Otero, Maria Claudia/0000-0002-1374-9286	Consejo de Investigaciones de la Universidad Nacional de Tucuman (PIUNT 2018) [26/D645]; Consejo de Investigaciones de la Universidad Nacional de Tucuman (PIUNT 2014) [D527]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2014-1334]	Consejo de Investigaciones de la Universidad Nacional de Tucuman (PIUNT 2018); Consejo de Investigaciones de la Universidad Nacional de Tucuman (PIUNT 2014); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	M. C. Otero: Consejo de Investigaciones de la Universidad Nacional de Tucuman (PIUNT 2018, 26/D645; and PIUNT 2014, D527) http://scait.ct.unt.edu.ar/programas-y-proyectos-deinvestigacion/; Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2014-1334) http://www.agencia.mincyt.gob.ar/frontend/agencia/instrumento/24.	Arun Kumar, 2009, Indian Veterinary Journal, V86, P807; Ateba CN, 2014, INT J MOL SCI, V15, P9735, DOI 10.3390/ijms15069735; Baltaci MO, 2017, GEOMICROBIOL J, V34, P53, DOI 10.1080/01490451.2015.1137662; BEJ AK, 1991, APPL ENVIRON MICROB, V57, P3529, DOI 10.1128/AEM.57.12.3529-3534.1991; Bhat Fayaz Ahmad, 2014, Vet Res Forum, V5, P177; Bicalho MLS, 2017, J DAIRY SCI, V100, P3850, DOI 10.3168/jds.2016-12058; Bicalho MLS, 2017, J DAIRY SCI, V100, P3043, DOI 10.3168/jds.2016-11623; Bicalho MLS, 2012, VET MICROBIOL, V157, P125, DOI 10.1016/j.vetmic.2011.11.034; Bicalho RC, 2010, J DAIRY SCI, V93, P5818, DOI 10.3168/jds.2010-3550; Blanco M, 2004, INT MICROBIOL, V7, P269; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; de Brito BG, 2003, INFECT IMMUN, V71, P4175, DOI 10.1128/IAI.71.7.4175-4177.2003; Dyer JG, 2007, J DAIRY SCI, V90, P193, DOI 10.3168/jds.2007-0006; Foley C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1967-5; Franck SM, 1998, J CLIN MICROBIOL, V36, P1795, DOI 10.1128/JCM.36.6.1795-1797.1998; Gustafsson H, 2002, ACTA VET SCAND, V43, P115, DOI 10.1186/1751-0147-43-115; Hancock V, 2008, MICROBIOL-SGM, V154, P167, DOI 10.1099/mic.0.2007/011981-0; Herath S, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-55; Horakova K, 2008, J APPL MICROBIOL, V105, P970, DOI 10.1111/j.1365-2672.2008.03838.x; Hufnagel DA, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0014-2014; Hussain A, 2012, ANTIMICROB AGENTS CH, V56, P6358, DOI 10.1128/AAC.01099-12; Jadhav S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018063; Jefferson KK, 2004, FEMS MICROBIOL LETT, V236, P163, DOI 10.1016/j.femsle.2004.06.005; Jeon Soo Jin, 2018, Genomics & Informatics, V16, pe21, DOI 10.5808/GI.2018.16.4.e21; Jeon SJ, 2015, APPL ENVIRON MICROB, V81, P6324, DOI 10.1128/AEM.01753-15; Johnson JR, 2005, J CLIN MICROBIOL, V43, P6064, DOI 10.1128/JCM.43.12.6064-6072.2005; Johnson JR, 2000, J INFECT DIS, V181, P261, DOI 10.1086/315217; Kafi M, 2017, THERIOGENOLOGY, V102, P29, DOI 10.1016/j.theriogenology.2017.07.011; Kao CY, 2012, HELICOBACTER, V17, P411, DOI 10.1111/j.1523-5378.2012.00974.x; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kasse FN, 2016, J DAIRY SCI, V99, P4656, DOI 10.3168/jds.2015-10094; Klemm Per, 2004, EcoSal Plus, V1, DOI 10.1128/ecosalplus.8.3.2.6; Kudinha T, 2012, APPL ENVIRON MICROB, V78, P1198, DOI 10.1128/AEM.06921-11; Ma Q, 2009, ENVIRON MICROBIOL, V11, P2735, DOI 10.1111/j.1462-2920.2009.02000.x; Magata F, 2014, J REPROD DEVELOP, V60, P280, DOI 10.1262/jrd.2013-124; Mahnani A, 2015, J DAIRY SCI, V98, P6048, DOI 10.3168/jds.2014-8862; Maurer JJ, 1998, AVIAN DIS, V42, P106, DOI 10.2307/1592582; McDougall S, 2007, ANIM REPROD SCI, V99, P9, DOI 10.1016/j.anireprosci.2006.03.017; Miller ANA, 2007, THERIOGENOLOGY, V68, P972, DOI 10.1016/j.theriogenology.2007.07.013; Miranda-CasoLuengo R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0200974; Moreno E, 2005, DIAGN MICR INFEC DIS, V53, P93, DOI 10.1016/j.diagmicrobio.2005.05.015; Moreno E, 2009, MICROBES INFECT, V11, P274, DOI 10.1016/j.micinf.2008.12.002; Nandanwar N, 2014, INT J MED MICROBIOL, V304, P835, DOI 10.1016/j.ijmm.2014.06.009; Otero C, 2000, LETT APPL MICROBIOL, V31, P251, DOI 10.1046/j.1365-2672.2000.00809.x; Peng Y, 2013, FOLIA MICROBIOL, V58, P593, DOI 10.1007/s12223-013-0238-6; Pompilio A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196260; Restieri C, 2007, APPL ENVIRON MICROB, V73, P1553, DOI 10.1128/AEM.01542-06; Romling U, 1998, J BACTERIOL, V180, P722; Runciman DJ, 2009, AUST VET J, V87, P369, DOI 10.1111/j.1751-0813.2009.00469.x; Sakoulas G, 2002, ANTIMICROB AGENTS CH, V46, P1492, DOI 10.1128/AAC.46.5.1492-1502.2002; Salasel B, 2010, THERIOGENOLOGY, V74, P1271, DOI 10.1016/j.theriogenology.2010.05.033; Schembri MA, 2000, INFECT IMMUN, V68, P2638, DOI 10.1128/IAI.68.5.2638-2646.2000; Sheldon IM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009192; Sheldon IM, 2009, BIOL REPROD, V81, P1025, DOI 10.1095/biolreprod.109.077370; Sheldon IM, 2006, THERIOGENOLOGY, V65, P1516, DOI 10.1016/j.theriogenology.2005.08.021; Sheldon IM, 2002, REPRODUCTION, V123, P837, DOI 10.1530/rep.0.1230837; Silva E, 2009, J DAIRY SCI, V92, P6000, DOI 10.3168/jds.2009-2358; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Wang X, 2013, APPL ENVIRON MICROB, V79, P5146, DOI 10.1128/AEM.01367-13; Williams EJ, 2007, THERIOGENOLOGY, V68, P549, DOI 10.1016/j.theriogenology.2007.04.056; Williams EJ, 2005, THERIOGENOLOGY, V63, P102, DOI 10.1016/j.theriogenology.2004.03.017; Williams EJ, 2008, AM J REPROD IMMUNOL, V60, P462, DOI 10.1111/j.1600-0897.2008.00645.x	62	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0228294	10.1371/journal.pone.0228294	http://dx.doi.org/10.1371/journal.pone.0228294			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MJ2AA	32479536	Green Published, gold			2022-12-26	WOS:000547893500001
J	Pandya, P; Sayers, RO; Ting, JP; Morshedian, S; Torres, C; Cudal, JS; Zhang, K; Fitchett, JR; Zhang, Q; Zhang, FYF; Wang, J; Durbin, JD; Carrillo, JJ; Espada, A; Broughton, H; Qian, YW; Afshar, S				Pandya, Priyanka; Sayers, Robert O.; Ting, Joey P.; Morshedian, Shaghayegh; Torres, Carina; Cudal, Justine S.; Zhang, Kai; Fitchett, Jonathan R.; Zhang, Qing; Zhang, Feiyu F.; Wang, Jing; Durbin, Jim D.; Carrillo, Juan J.; Espada, Alfonso; Broughton, Howard; Qian, Yuewei; Afshar, Sepideh			Integration of phage and yeast display platforms: A reliable and cost effective approach for binning of peptides as displayed on-phage	PLOS ONE			English	Article							ANTIBODIES; INTERLEUKIN-23; IL-23; FINE	Hundreds of target specific peptides are routinely discovered by peptide display platforms. However, due to the high cost of peptide synthesis only a limited number of peptides are chemically made for further analysis. Here we describe an accurate and cost effective method to bin peptides on-phage based on binding region(s), without any requirement for peptide or protein synthesis. This approach, which integrates phage and yeast display platforms, requires display of target and its alanine variants on yeast. Flow cytometry was used to detect binding of peptides on-phage to the target on yeast. Once hits were identified, they were synthesized to confirm their binding region(s) by HDX (Hydrogen deuterium exchange) and crystallography. Moreover, we have successfully shown that this approach can be implemented as part of a panning process to deplete non-functional peptides. This technique can be applied to any target that can be successfully displayed on yeast; it narrows down the number of peptides requiring synthesis; and its utilization during selection results in enrichment of peptide population against defined binding regions on the target.	[Pandya, Priyanka; Sayers, Robert O.; Ting, Joey P.; Morshedian, Shaghayegh; Torres, Carina; Cudal, Justine S.; Zhang, Kai; Fitchett, Jonathan R.; Zhang, Qing; Afshar, Sepideh] Eli Lilly Biotechnol Ctr, Dept Prot Engn, San Diego, CA 92121 USA; [Zhang, Feiyu F.; Wang, Jing] Lilly Res Labs, Discovery Chem Res & Technol, San Diego, CA USA; [Durbin, Jim D.] Eli Lilly & Co, Dept Struct Biol Discovery Chem Res & Technol, Indianapolis, IN 46285 USA; [Carrillo, Juan J.] Eli Lilly & Co, Dept Quantitat Biol Discovery Chem Res & Technol, Lilly Biotechnol Ctr, Indianapolis, IN 46285 USA; [Espada, Alfonso; Broughton, Howard] Ctr Invest Lilly, Alcobendas, Spain; [Qian, Yuewei] Lilly Res Labs, Recombinant Prot Generat, Indianapolis, IN USA	Eli Lilly; Eli Lilly; Eli Lilly; Eli Lilly; Eli Lilly	Afshar, S (corresponding author), Eli Lilly Biotechnol Ctr, Dept Prot Engn, San Diego, CA 92121 USA.	s.afshar@lilly.com		Durbin, Jim/0000-0001-8691-0352	Eli Lilly Company; U.S. DOE [DE-AC0206CH11357]	Eli Lilly Company(Eli Lilly); U.S. DOE(United States Department of Energy (DOE))	This research was funded by Eli Lilly & Company. The funder provided support in the form of salaries for authors [PP, ROS, JPT, SM, CT, JSC, KZ, JRF, QZ, FFZ, JW, JDD, JJC, AE, HB, YQ, and SA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.; The authors thank Leticia Cano for assistance with HDX, Christopher Groshong and Danalyn Manglicmot for expression and purification of IL-23 protein used in crystallization and the LRL-CAT staff for X-ray data collection. Use of the Advanced Photon Source, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under Contract No. DE-AC0206CH11357. Use of the Lilly Research Laboratories Collaborative Access Team (LRL-CAT) beamline at Sector 31 of the Advanced Photon Source was provided by Eli Lilly Company, which operates the facility. We also thank Jorge Alsina-Fernandex for chemical peptide synthesis.	Afshar S, 2016, INVENTORPHAGE DISPLA; [Anonymous], 2014, MICROBIOLOGY SPECTRU, V2015, P1; [Anonymous], 2013, OA ARTHRITIS; Beckmann C, 2005, INFECT IMMUN, V73, P444, DOI 10.1128/IAI.73.1.444-452.2005; Beyer BM, 2008, J MOL BIOL, V382, P942, DOI 10.1016/j.jmb.2008.08.001; Bidlingmaier S, 2015, METHODS MOL BIOL, V1319, P51, DOI 10.1007/978-1-4939-2748-7_3; Bloch Y, 2018, IMMUNITY, V48, P45, DOI 10.1016/j.immuni.2017.12.008; Brian K., 1998, DRUG DISCOV TODAY, V3, P370; Campa M, 2016, DERMATOLOGY THER, V6, P1, DOI 10.1007/s13555-015-0092-3; Chao G, 2004, J MOL BIOL, V342, P539, DOI 10.1016/j.jmb.2004.07.053; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Croxford AL, 2012, EUR J IMMUNOL, V42, P2263, DOI 10.1002/eji.201242598; Daniel J., 2017, J PHYS CHEM, V121, P3493; Desmet J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6237; Ferraris L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030594; Heinis C, 2009, NAT CHEM BIOL, V5, P502, DOI 10.1038/nchembio.184; Henry B., 2003, PHAGE DISPLAY; Hu XB, 2010, P NATL ACAD SCI USA, V107, P6252, DOI 10.1073/pnas.0914358107; Iwakura Y, 2006, J CLIN INVEST, V116, P1218, DOI 10.1172/JCI28508; Landon Linda A, 2004, Curr Drug Discov Technol, V1, P113, DOI 10.2174/1570163043335108; Lequn Zhao LQ, 2014, PLOS ONE, V9, P1; Levy R, 2007, J MOL BIOL, V365, P196, DOI 10.1016/j.jmb.2006.09.084; Liu SP, 2016, SCI REP-UK, V6, DOI 10.1038/srep26071; Lupardus PJ, 2008, J MOL BIOL, V382, P931, DOI 10.1016/j.jmb.2008.07.051; Mata-Fink J, 2013, J MOL BIOL, V425, P444, DOI 10.1016/j.jmb.2012.11.010; Meiring BDPS S. M., 2018, HINDAWI BIOMED RES I, V2018, P1; Molek P, 2011, MOLECULES, V16, P857, DOI 10.3390/molecules16010857; Pascal BD, 2012, J AM SOC MASS SPECTR, V23, P1512, DOI 10.1007/s13361-012-0419-6; SACHDEV S., 2000, METHOD ENZYMOL, V328, P333; Sachdev S., 2004, J MOL BIOL, V338, P299, DOI DOI 10.HTTPS://D0I.0RG/10.1016/J.JMB.2004.02.050; Sayago C, 2018, ACS MED CHEM LETT, V9, P912, DOI 10.1021/acsmedchemlett.8b00255; Tang CL, 2012, IMMUNOLOGY, V135, P112, DOI 10.1111/j.1365-2567.2011.03522.x; Ting JP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190850; Van Blarcom T, 2015, J MOL BIOL, V427, P1513, DOI 10.1016/j.jmb.2014.09.020; Zorzi A, 2017, CURR OPIN CHEM BIOL, V38, P24, DOI 10.1016/j.cbpa.2017.02.006	35	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0233961	10.1371/journal.pone.0233961	http://dx.doi.org/10.1371/journal.pone.0233961			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MJ2AA	32479512	Green Published, Green Submitted, gold			2022-12-26	WOS:000547893500043
J	Dai, SB; Holt, MV; Horton, JR; Woodcock, CB; Patel, A; Zhang, X; Young, NL; Wilkinson, AW; Cheng, XD				Dai, Shaobo; Holt, Matthew, V; Horton, John R.; Woodcock, Clayton B.; Patel, Anamika; Zhang, Xing; Young, Nicolas L.; Wilkinson, Alex W.; Cheng, Xiaodong			Characterization of SETD3 methyltransferase-mediated protein methionine methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein methylation; S-adenosylmethionine (SAM); methionine; protein structure; enzyme catalysis; actin; methionine methylation; methyltransferases; S-methylmethionine; SETD3	S-METHYLMETHIONINE; HISTONE; LYSINE; MODEL; PURIFICATION; ENZYMES; CORE; G9A	Most characterized protein methylation events encompass arginine and lysineN-methylation, and only a few cases of protein methionine thiomethylation have been reported. Newly discovered oncohistone mutations include lysine-to-methionine substitutions at positions 27 and 36 of histone H3.3. In these instances, the methionine substitution localizes to the active-site pocket of the corresponding histone lysine methyltransferase, thereby inhibiting the respective transmethylation activity. SET domain-containing 3 (SETD3) is a protein (i.e.actin) histidine methyltransferase. Here, we generated an actin variant in which the histidine target of SETD3 was substituted with methionine. As for previously characterized histone SET domain proteins, the methionine substitution substantially (76-fold) increased binding affinity for SETD3 and inhibited SETD3 activity on histidine. Unexpectedly, SETD3 was active on the substituted methionine, generatingS-methylmethionine in the context of actin peptide. The ternary structure of SETD3 in complex with the methionine-containing actin peptide at 1.9 angstrom resolution revealed that the hydrophobic thioether side chain is packed by the aromatic rings of Tyr(312)and Trp(273), as well as the hydrocarbon side chain of Ile(310). Our results suggest that placing methionine properly in the active site-within close proximity to and in line with the incoming methyl group of SAM-would allow some SET domain proteins to selectively methylate methionine in proteins.	[Dai, Shaobo; Horton, John R.; Woodcock, Clayton B.; Zhang, Xing; Cheng, Xiaodong] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Houston, TX 77030 USA; [Holt, Matthew, V; Young, Nicolas L.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Patel, Anamika] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Wilkinson, Alex W.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Emory University; Stanford University	Cheng, XD (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Houston, TX 77030 USA.; Wilkinson, AW (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	alexw2@stanford.edu; xcheng5@mdanderson.org	Horton, John R/ABB-4770-2020; Young, Nicolas/AAI-5242-2020; Dai, Shaobo/AAC-3450-2020	Young, Nicolas/0000-0002-3323-2815; Cheng, Xiaodong/0000-0002-6967-6362; Dai, Shaobo/0000-0002-1629-4483	National Institutes of Health [R01 GM133051]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Da Jia for purification of SET7 used for activity assays, members of the Cheng laboratory for discussion, and Dr. Or Gozani (Stanford University) for support under National Institutes of Health Grant R01 GM133051.	Allis CD, 2016, NAT REV GENET, V17, P487, DOI 10.1038/nrg.2016.59; Asadov Chingiz, 2017, Cardiovascular & Hematological Agents in Medicinal Chemistry, V15, P23, DOI 10.2174/1871525715666170529091921; Butler JS, 2012, EPIGENOMICS-UK, V4, P163, DOI [10.2217/EPI.12.3, 10.2217/epi.12.3]; CANTONI GL, 1952, J AM CHEM SOC, V74, P2942, DOI 10.1021/ja01131a519; Carlson SM, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026435; Clarke S, 1993, CURR OPIN CELL BIOL, V5, P977, DOI 10.1016/0955-0674(93)90080-A; Dai SB, 2020, J BIOL CHEM, V295, P2582, DOI 10.1074/jbc.RA119.012319; Dai SB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11554-6; DAOPIN S, 1991, BIOCHEMISTRY-US, V30, P11521, DOI 10.1021/bi00113a006; Diep J, 2019, NAT MICROBIOL, V4, P2523, DOI 10.1038/s41564-019-0551-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FAROOQUI JZ, 1985, J BIOL CHEM, V260, P537; Forneris F, 2007, J BIOL CHEM, V282, P20070, DOI 10.1074/jbc.C700100200; GRUNAU JA, 1991, J PLANT NUTR, V14, P653, DOI 10.1080/01904169109364232; Guo Q, 2019, ELIFE, V8, DOI 10.7554/eLife.43676; HANCK T, 1993, NUCLEIC ACIDS RES, V21, P303, DOI 10.1093/nar/21.2.303; He C, 2005, MOL CELL, V20, P117, DOI 10.1016/j.molcel.2005.08.013; Headd JJ, 2012, ACTA CRYSTALLOGR D, V68, P381, DOI 10.1107/S0907444911047834; Horowitz S, 2012, J BIOL CHEM, V287, P41576, DOI 10.1074/jbc.R112.418574; Hsiao K, 2016, EPIGENOMICS-UK, V8, P321, DOI 10.2217/epi.15.113; Hubner JM, 2019, NEURO-ONCOLOGY, V21, P878, DOI 10.1093/neuonc/noz058; Jain SU, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09981-6; Jayaram H, 2016, P NATL ACAD SCI USA, V113, P6182, DOI 10.1073/pnas.1605523113; Justin N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11316; Koh-Stenta XY, 2017, BIOCHEM J, V474, P971, DOI 10.1042/BCJ20161067; Kwiatkowski S, 2018, ELIFE, V7, DOI 10.7554/eLife.37921; Lowe BR, 2019, CANCERS, V11, DOI 10.3390/cancers11050660; Marinaki AM, 2020, XENOBIOTICA, V50, P101, DOI 10.1080/00498254.2019.1688424; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Paik WK, 2007, TRENDS BIOCHEM SCI, V32, P146, DOI 10.1016/j.tibs.2007.01.006; Pajares MA, 2006, CELL MOL LIFE SCI, V63, P2792, DOI 10.1007/s00018-006-6249-6; Patananan AN, 2013, J BIOL CHEM, V288, P14032, DOI 10.1074/jbc.M113.465765; Patel A, 2014, J BIOL CHEM, V289, P868, DOI 10.1074/jbc.M113.501064; Piunti A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax2887; Ragazzini R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11800-x; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shan CM, 2016, ELIFE, V5, DOI 10.7554/eLife.17903; Shechter D, 2019, CELL MOL LIFE SCI, V76, P2871, DOI 10.1007/s00018-019-03141-1; Siddique A, 2011, FEBS J, V278, P2055, DOI 10.1111/j.1742-4658.2011.08121.x; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Szegedi SS, 2008, J BIOL CHEM, V283, P8939, DOI 10.1074/jbc.M710449200; SZILAK L, 1994, NUCLEIC ACIDS RES, V22, P2876, DOI 10.1093/nar/22.15.2876; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tolsma TO, 2019, ESSAYS BIOCHEM, V63, P89, DOI 10.1042/EBC20180067; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Weinshilboum RM, 2006, CELL MOL NEUROBIOL, V26, P539, DOI 10.1007/s10571-006-9095-z; WEINSHILBOUM RM, 1992, XENOBIOTICA, V22, P1055, DOI 10.3109/00498259209051860; Wilkinson AW, 2019, NATURE, V565, P372, DOI 10.1038/s41586-018-0821-8; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Wysocki VH, 2000, J MASS SPECTROM, V35, P1399, DOI 10.1002/1096-9888(200012)35:12<1399::AID-JMS86>3.0.CO;2-R; Yang S, 2016, GENE DEV, V30, P1611, DOI 10.1101/gad.284323.116; Zhang L, 2012, NATURE, V481, P204, DOI 10.1038/nature10690; Zhao ZB, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1870-5	57	10	10	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2020	295	32					10901	10910		10.1074/jbc.RA120.014072	http://dx.doi.org/10.1074/jbc.RA120.014072			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE7BV	32503840	Green Published, hybrid			2022-12-26	WOS:000562757100003
J	Nakanishi, H; Irie, K; Segawa, K; Hasegawa, K; Fujiyoshi, Y; Nagata, S; Abe, K				Nakanishi, Hanayo; Irie, Katsumasa; Segawa, Katsumori; Hasegawa, Kazuya; Fujiyoshi, Yoshinori; Nagata, Shigekazu; Abe, Kazuhiro			Crystal structure of a human plasma membrane phospholipid flippase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; ATPase; crystal structure; phospholipid; plasma membrane; flippase; P-type ATPase	SARCOPLASMIC-RETICULUM CA2+-ATPASE; SIZE-EXCLUSION CHROMATOGRAPHY; P-TYPE ATPASES; PHOSPHATIDYLSERINE; TRANSPORT; ATP11C; CASPASE; COMPLEX; SYSTEM; ERYTHROCYTE	ATP11C, a member of the P4-ATPase flippase, translocates phosphatidylserine from the outer to the inner plasma membrane leaflet, and maintains the asymmetric distribution of phosphatidylserine in the living cell. We present the crystal structures of a human plasma membrane flippase, ATP11C?CDC50A complex, in a stabilized E2P conformation. The structure revealed a deep longitudinal crevice along transmembrane helices continuing from the cell surface to the phospholipid occlusion site in the middle of the membrane. We observed that the extension of the crevice on the exoplasmic side is open, and the complex is therefore in an outward-open E2P state, similar to a recently reported cryo-EM structure of yeast flippase Drs2p?Cdc50p complex. We noted extra densities, most likely bound phosphatidylserines, in the crevice and in its extension to the extracellular side. One was close to the phosphatidylserine occlusion site as previously reported for the human ATP8A1?CDC50A complex, and the other in a cavity at the surface of the exoplasmic leaflet of the bilayer. Substitutions in either of the binding sites or along the path between them impaired specific ATPase and transport activities. These results provide evidence that the observed crevice is the conduit along that phosphatidylserine traverses from the outer leaflet to its occlusion site in the membrane and suggest that the exoplasmic cavity is important for phospholipid recognition. They also yield insights into how phosphatidylserine is incorporated from the outer leaflet of the plasma membrane into the transmembrane.	[Nakanishi, Hanayo; Irie, Katsumasa; Abe, Kazuhiro] Nagoya Univ, Cellular & Struct Physiol Inst, Nagoya, Aichi, Japan; [Irie, Katsumasa; Abe, Kazuhiro] Nagoya Univ, Grad Sch Pharmaceut Sci, Nagoya, Aichi, Japan; [Segawa, Katsumori; Nagata, Shigekazu] Osaka Univ, WPI Immunol Frontier Res Ctr, Osaka, Japan; [Hasegawa, Kazuya] Japan Synchrotron Radiat Res Inst, 1-1-1 Kouto, Sayo, Japan; [Fujiyoshi, Yoshinori] Tokyo Med & Dent Univ, TMDU Adv Res Inst, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1545, Japan; [Fujiyoshi, Yoshinori] CeSPIA Inc, 2-1-1 Otemachi, Tokyo, Tokyo, Japan	Nagoya University; Nagoya University; Osaka University; Japan Synchrotron Radiation Research Institute; Tokyo Medical & Dental University (TMDU)	Abe, K (corresponding author), Nagoya Univ, Cellular & Struct Physiol Inst, Nagoya, Aichi, Japan.; Abe, K (corresponding author), Nagoya Univ, Grad Sch Pharmaceut Sci, Nagoya, Aichi, Japan.	kabe@cespi.nagoya-u.ac.jp	Abe, Kazuhiro/D-7662-2013; Irie, Katsumasa/D-7332-2013; Nagata, Shigekazu/AAG-3203-2019; Fujiyoshi, Yoshinori/E-5989-2012	Abe, Kazuhiro/0000-0003-2681-5921; Irie, Katsumasa/0000-0002-8178-1552; Nagata, Shigekazu/0000-0001-9758-8426; zhong xi, hua dai/0000-0001-8619-9513; Fujiyoshi, Yoshinori/0000-0002-8070-1493; Hasegawa, Kazuya/0000-0003-0331-1624	Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS) from the Japan Agency for Medical Research and Development (AMED); Takeda Science Foundation; Uehara Science Foundation; Naito Foundation; Core Research for Evolutional Science and Technology from JST Grant [JPMJCR14M4]; Japan New Energy and Industrial Technology Development Organization (NEDO); Japan Agency for Medical Research and Development (AMED); Platform Project for Supporting Drug Discovery and Life Science Research (BINDS) from AMED [JP18am0101070];  [17H03653];  [2018B2703];  [2019B2707]	Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS) from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Science Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Core Research for Evolutional Science and Technology from JST Grant; Japan New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Platform Project for Supporting Drug Discovery and Life Science Research (BINDS) from AMED; ; ; 	This work was supported by Grants-in-Aid for the Scientific Research Grant 17H03653 (to K. A.), grants from the Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS) from the Japan Agency for Medical Research and Development (AMED), Takeda Science Foundation, Uehara Science Foundation, The Naito Foundation (to K. A.), the Core Research for Evolutional Science and Technology from JST Grant JPMJCR14M4 (to S. N. and K. A.), Grants-in-Aid for Scientific Research (S), the Japan New Energy and Industrial Technology Development Organization (NEDO), and the Japan Agency for Medical Research and Development (AMED) (to Y. F.). This work is a part of projects 2018B2703 and 2019B2707 at SPring-8. This work was supported in part by the Platform Project for Supporting Drug Discovery and Life Science Research (BINDS) from AMED under Grant number JP18am0101070 (to K. A.).	Abe K, 2018, NATURE, V556, P214, DOI 10.1038/s41586-018-0003-8; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andersen JP, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00275; Arashiki N, 2016, HAEMATOLOGICA, V101, P559, DOI 10.3324/haematol.2016.142273; Baldridge RD, 2013, P NATL ACAD SCI USA, V110, pE358, DOI 10.1073/pnas.1216948110; BEVERS EM, 1995, BLOOD, V86, P1983, DOI 10.1182/blood.V86.5.1983.bloodjournal8651983; Bryde S, 2010, J BIOL CHEM, V285, P40562, DOI 10.1074/jbc.M110.139543; Coleman JA, 2012, P NATL ACAD SCI USA, V109, P1449, DOI 10.1073/pnas.1108862109; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; Danko S, 2001, FEBS LETT, V489, P277, DOI 10.1016/S0014-5793(01)02111-1; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dukkipati A, 2008, PROTEIN EXPRES PURIF, V62, P160, DOI 10.1016/j.pep.2008.08.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flot D, 2010, J SYNCHROTRON RADIAT, V17, P107, DOI 10.1107/S0909049509041168; Goehring A, 2014, NAT PROTOC, V9, P2574, DOI 10.1038/nprot.2014.173; Gourdon P, 2011, CRYST GROWTH DES, V11, P2098, DOI 10.1021/cg101360d; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Hiraizumi M, 2019, SCIENCE, V365, P1149, DOI 10.1126/science.aay3353; Hirata K, 2019, ACTA CRYSTALLOGR D, V75, P138, DOI 10.1107/S2059798318017795; Inesi G, 2008, J BIOL CHEM, V283, P1189, DOI 10.1074/jbc.M707189200; Jensen MS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17742-y; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; MacKenzie SH, 2012, ADV EXP MED BIOL, V747, P55, DOI 10.1007/978-1-4614-3229-6_4; Mikkelsen SA, 2019, J BIOL CHEM, V294, P5970, DOI 10.1074/jbc.RA118.007240; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Murray AN, 2015, CHEM BIOL, V22, P1052, DOI 10.1016/j.chembiol.2015.06.017; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Norimatsu Y, 2017, NATURE, V545, P193, DOI 10.1038/nature22357; Palmgren MG, 1998, BBA-BIOENERGETICS, V1365, P37, DOI 10.1016/S0005-2728(98)00041-3; Perez-Garcia V, 2018, NATURE, V555, P463, DOI 10.1038/nature26002; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pomorski T, 2006, CELL MOL LIFE SCI, V63, P2908, DOI 10.1007/s00018-006-6167-7; Pomorski TG, 2016, PROG LIPID RES, V64, P69, DOI 10.1016/j.plipres.2016.08.003; Roland BP, 2016, P NATL ACAD SCI USA, V113, pE4460, DOI 10.1073/pnas.1525730113; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Segawa K, 2018, P NATL ACAD SCI USA, V115, P12212, DOI 10.1073/pnas.1814323115; Segawa K, 2018, J BIOL CHEM, V293, P2172, DOI 10.1074/jbc.RA117.000289; Segawa K, 2016, J BIOL CHEM, V291, P762, DOI 10.1074/jbc.M115.690727; Segawa K, 2015, TRENDS CELL BIOL, V25, P639, DOI 10.1016/j.tcb.2015.08.003; Segawa K, 2014, SCIENCE, V344, P1164, DOI 10.1126/science.1252809; Shin HW, 2019, FASEB J, V33, P3087, DOI 10.1096/fj.201801873R; Siggs OM, 2011, P NATL ACAD SCI USA, V108, P7890, DOI 10.1073/pnas.1104631108; Siggs OM, 2011, NAT IMMUNOL, V12, P434, DOI 10.1038/ni.2012; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Takatsu H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01338-1; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; Timcenko M, 2019, NATURE, V571, P366, DOI 10.1038/s41586-019-1344-7; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Tsunekawa N, 2018, P NATL ACAD SCI USA, V115, P12722, DOI 10.1073/pnas.1815472115; Vestergaard AL, 2014, P NATL ACAD SCI USA, V111, pE1334, DOI 10.1073/pnas.1321165111; Williamson P., 2015, LIPID INSIGHTS S, V8s1, DOI 10.4137/LPI.S31785; Yabas M, 2014, J BIOL CHEM, V289, P19531, DOI 10.1074/jbc.C114.570267; Yabas M, 2011, NAT IMMUNOL, V12, P441, DOI 10.1038/ni.2011; Yamamoto K, 2019, ELIFE, V8, DOI 10.7554/eLife.47701; Yamashita K, 2018, ACTA CRYSTALLOGR D, V74, P441, DOI 10.1107/S2059798318004576	60	28	28	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2020	295	30					10180	10194		10.1074/jbc.RA120.014144	http://dx.doi.org/10.1074/jbc.RA120.014144			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MW0BV	32493773	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000556713400008
J	Ogura, S; Baldeosingh, R; Bhutto, IA; Kambhampati, SP; McLeod, DS; Edwards, MM; Rais, R; Schubert, W; Lutty, GA				Ogura, Shuntaro; Baldeosingh, Rajkumar; Bhutto, Imran A.; Kambhampati, Siva P.; Scott McLeod, Donald; Edwards, Malia M.; Rais, Rana; Schubert, William; Lutty, Gerard A.			A role for mast cells in geographic atrophy	FASEB JOURNAL			English	Article						48/80; age-related macular degeneration; choroid; degranulation; ketotifen fumarate; retinal pigment epithelium; tryptase	HUMAN EYES; TRYPTASE; KETOTIFEN; DEGENERATION; RPE; CHORIOCAPILLARIS; INFLAMMATION; HISTAMINE; DRUSEN; ASTHMA	Mast cells (MCs) are the initial responders of innate immunity and their degranulation contribute to various etiologies. While the abundance of MCs in the choroid implies their fundamental importance in the eye, little is known about the significance of MCs and their degranulation in choroid. The cause of geographic atrophy (GA), a progressive dry form of age-related macular degeneration is elusive and there is currently no therapy for this blinding disorder. Here we demonstrate in both human GA and a rat model for GA, that MC degranulation and MC-derived tryptase are central to disease progression. Retinal pigment epithelium degeneration followed by retinal and choroidal thinning, characteristic phenotypes of GA, were driven by continuous choroidal MC stimulation and activation in a slow release fashion in the rat. Genetic manipulation of MCs, pharmacological intervention targeting MC degranulation with ketotifen fumarate or inhibition of MC-derived tryptase with APC 366 prevented all of GA-like phenotypes following MC degranulation in the rat model. Our results demonstrate the fundamental role of choroidal MC involvement in GA disease etiology, and will provide new opportunities for understanding GA pathology and identifying novel therapies targeting MCs.	[Ogura, Shuntaro; Baldeosingh, Rajkumar; Bhutto, Imran A.; Kambhampati, Siva P.; Scott McLeod, Donald; Edwards, Malia M.; Lutty, Gerard A.] Johns Hopkins Univ Hosp, Wilmer Ophthalmol Inst, M041 Smith Bldg,400 North Broadway, Baltimore, MD 21287 USA; [Rais, Rana] Johns Hopkins Univ, Sch Med, Johns Hopkins Drug Discovery, Baltimore, MD USA; [Rais, Rana] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Schubert, William] Bayer AG Pharmaceut, Wuppertal, Germany	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University	Lutty, GA (corresponding author), Johns Hopkins Univ Hosp, Wilmer Ophthalmol Inst, M041 Smith Bldg,400 North Broadway, Baltimore, MD 21287 USA.	glutty@jhmi.edu	Kambhampati, Siva Pramodh/AAK-6269-2020	Ogura, Shuntaro/0000-0002-5191-8933	HHS \ NIH \ National Eye Institute (NEI) [EY016151, EY01765]; Bayer; Arnold and Mabel Beckman Foundation; Research to Prevent Blindness (RPB)	HHS \ NIH \ National Eye Institute (NEI); Bayer(Bayer AG); Arnold and Mabel Beckman Foundation; Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB))	HHS vertical bar NIH vertical bar National Eye Institute (NEI), Grant/Award Number: EY016151 and EY01765; Bayer; Arnold and Mabel Beckman Foundation; Research to Prevent Blindness (RPB)	Bhutto IA, 2018, INVEST OPHTH VIS SCI, V59, P143, DOI DOI 10.1167/I0VS.18-24245; Bhutto IA, 2016, BRIT J OPHTHALMOL, V100, P720, DOI 10.1136/bjophthalmol-2015-308290; Bhutto IA, 2011, BRIT J OPHTHALMOL, V95, P1323, DOI 10.1136/bjo.2010.199216; Bousquet E, 2015, AM J PATHOL, V185, P2083, DOI 10.1016/j.ajpath.2015.04.002; Bradding P, 2006, J ALLERGY CLIN IMMUN, V117, P1277, DOI 10.1016/j.jaci.2006.02.039; Cairns JA, 1996, J IMMUNOL, V156, P275; CRAPS LP, 1984, RESPIRATION, V45, P411, DOI 10.1159/000194648; Datta S, 2017, PROG RETIN EYE RES, V60, P201, DOI 10.1016/j.preteyeres.2017.03.002; Delori FC, 2000, INVEST OPHTH VIS SCI, V41, P496; Godfrey W A, 1987, Trans Am Ophthalmol Soc, V85, P557; GRANT SM, 1990, DRUGS, V40, P412, DOI 10.2165/00003495-199040030-00006; Guillonneau X, 2017, PROG RETIN EYE RES, V61, P98, DOI 10.1016/j.preteyeres.2017.06.002; Hartmann K, 1997, BLOOD, V89, P2863, DOI 10.1182/blood.V89.8.2863; Hayashi A, 1999, GRAEF ARCH CLIN EXP, V237, P668, DOI 10.1007/s004170050295; Holz FG, 2014, OPHTHALMOLOGY, V121, P1079, DOI 10.1016/j.ophtha.2013.11.023; Iddamalgoda A, 2008, ARCH DERMATOL RES, V300, pS69, DOI 10.1007/s00403-007-0806-1; Kabra SK, 2000, ANN ALLERG ASTHMA IM, V85, P46, DOI 10.1016/S1081-1206(10)62433-7; Kauppinen A, 2016, CELL MOL LIFE SCI, V73, P1765, DOI 10.1007/s00018-016-2147-8; Kidd M, 2003, BRIT J OPHTHALMOL, V87, P1206, DOI 10.1136/bjo.87.10.1206; Kinoshita M, 2005, ARTERIOSCL THROM VAS, V25, P1858, DOI 10.1161/01.ATV.0000174797.71708.97; Krishna MT, 2001, J ALLERGY CLIN IMMUN, V107, P1039, DOI 10.1067/mai.2001.115631; Krystel-Whittemore M, 2016, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00620; Lu J, 2014, INT IMMUNOPHARMACOL, V20, P352, DOI 10.1016/j.intimp.2014.04.001; Marone G, 2001, LEUKEMIA RES, V25, P583, DOI 10.1016/S0145-2126(01)00039-X; McLeod DS, 2017, INVEST OPHTH VIS SCI, V58, P5879, DOI 10.1167/iovs.17-22989; McLeod DS, 2016, INVEST OPHTH VIS SCI, V57, P5843, DOI 10.1167/iovs.16-20049; McLeod DS, 2009, INVEST OPHTH VIS SCI, V50, P4982, DOI 10.1167/iovs.09-3639; McMenamin PG, 1997, EYE, V11, P183, DOI 10.1038/eye.1997.49; NIWA Y, 1991, BLOOD, V78, P1936; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Omri S, 2011, AM J PATHOL, V179, P942, DOI 10.1016/j.ajpath.2011.04.018; Pardue MT, 2014, DOC OPHTHALMOL, V128, P77, DOI 10.1007/s10633-013-9424-8; Passante E, 2009, INFLAMM RES, V58, P737, DOI 10.1007/s00011-009-0074-y; Payne V, 2004, ANAESTHESIA, V59, P695, DOI 10.1111/j.1365-2044.2004.03757.x; Pennesi ME, 2012, MOL ASPECTS MED, V33, P487, DOI 10.1016/j.mam.2012.06.003; Ponomaryov T, 2017, CIRC RES, V121, P941, DOI 10.1161/CIRCRESAHA.117.311185; SCHWARTZ LB, 1987, ANN ALLERGY, V58, P226; SCHWARTZ LB, 1987, J IMMUNOL, V138, P2611; Soiberman U, 2017, BIOMATERIALS, V125, P38, DOI 10.1016/j.biomaterials.2017.02.016; Sun J, 2007, J CLIN INVEST, V117, P3359, DOI 10.1172/JCI31311; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; Unno K, 2012, EUR J PHARMACOL, V683, P179, DOI 10.1016/j.ejphar.2012.03.017; Valent P, 2004, J ALLERGY CLIN IMMUN, V114, P3, DOI 10.1016/j.jaci.2004.02.045; Walter P, 1999, GRAEF ARCH CLIN EXP, V237, P962, DOI 10.1007/s004170050331; Wang Q, 2019, ELIFE, V8, DOI 10.7554/eLife.39905; Weatherly LM, 2013, JOVE-J VIS EXP, DOI 10.3791/50671; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Yamada Y, 2006, EXP EYE RES, V82, P840, DOI 10.1016/j.exer.2005.10.005; Yamagishi S, 1998, DIABETOLOGIA, V41, P1435, DOI 10.1007/s001250051089	50	10	10	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2020	34	8					10117	10131		10.1096/fj.202000807R	http://dx.doi.org/10.1096/fj.202000807R		JUN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NE3EW	32525594	Green Accepted			2022-12-26	WOS:000539639000001
J	Archer, RA; Kapoor, R; Isaranuwatchai, W; Teerawattananon, Y; Giersing, B; Botwright, S; Luttjeboer, J; Hutubessy, RCW				Archer, Rachel A.; Kapoor, Ritika; Isaranuwatchai, Wanrudee; Teerawattananon, Yot; Giersing, Birgitte; Botwright, Siobhan; Luttjeboer, Jos; Hutubessy, Raymond C. W.			'It takes two to tango': Bridging the gap between country need and vaccine product innovation	PLOS ONE			English	Article							HEALTH TECHNOLOGY-ASSESSMENT; CRITERIA DECISION-ANALYSIS; CHALLENGES; DISCOVERY; MCDA	Background Despite a growing global commitment to universal health coverage, considerable vaccine coverage and uptake gaps persist in resource-constrained settings. One way of addressing the gaps is by ensuring product innovation is relevant and responsive to the needs of these contexts. Total Systems Effectiveness (TSE) framework has been developed to characterize preferred vaccine attributes from the perspective of country decision-makers to inform research and development (R&D) of products. A proof of concept pilot study took place in Thailand in 2018 to examine the feasibility and usefulness of the TSE approach using a rotavirus hypothetical test-case. Methods The excel-based model used multiple-criteria decision analysis (MCDA) to compare and evaluate five hypothetical rotavirus vaccine products. The model was populated with local data and products were ranked against decision criteria identified by Thai stakeholders. A one-way sensitivity analysis was performed to identify criteria that influenced vaccine ranking. Self-assessment forms were distributed to R&D stakeholders on the usability of the approach and were subsequently analysed. Results The model identified significant parameters that impacted on MCDA rankings. Self-assessment forms revealed that TSE was perceived as being able to encourage closer collaboration between country decision makers and vaccine developers. Conclusions The pilot study demonstrates that it is feasible to use an MCDA approach to elicit stakeholder preferences and determine influential parameters to help identify the preferred product characteristics for R&D from the perspective of country decision-makers. It found that TSE can help steer manufacturers to develop products that are better aligned with country need. Findings will guide further development of the TSE concept.	[Archer, Rachel A.; Isaranuwatchai, Wanrudee; Teerawattananon, Yot] Minist Publ Hlth, Hlth Intervent & Technol Assessment Program, Nonthaburi, Thailand; [Kapoor, Ritika; Teerawattananon, Yot] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Isaranuwatchai, Wanrudee] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Giersing, Birgitte; Botwright, Siobhan; Hutubessy, Raymond C. W.] WHO, Immunizat Vaccines & Biolog Dept, Geneva, Switzerland; [Luttjeboer, Jos] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [Luttjeboer, Jos] Asc Acad, Groningen, Netherlands	Ministry of Public Health - Thailand; National University of Singapore; University of Toronto; World Health Organization; University of Groningen	Archer, RA (corresponding author), Minist Publ Hlth, Hlth Intervent & Technol Assessment Program, Nonthaburi, Thailand.	Rachel.a@hitap.net		Teerawattananon, Yot/0000-0003-2217-2930; Archer, Rachel/0000-0003-0951-9020	Bill and Melinda Gates Foundation; Thailand Research Fund [RTA5980011]; Bill & Melinda Gates Foundation [OPP1202541]; United Kingdom's Department for International Development; Rockefeller Foundation; International Decision Support Initiative (iDSI)	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Thailand Research Fund(Thailand Research Fund (TRF)); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); United Kingdom's Department for International Development; Rockefeller Foundation; International Decision Support Initiative (iDSI)	This pilot study was funded by the Bill and Melinda Gates Foundation. The Health Intervention and Technology Assessment Program (HITAP) is funded by the Thailand Research Fund under a grant for Senior Research Scholar (RTA5980011). HITAP's International Unit is supported by the International Decision Support Initiative (iDSI) to provide technical assistance on health intervention and technology assessment to governments in low-and middle-income countries. iDSI is funded by the Bill & Melinda Gates Foundation [OPP1202541], the United Kingdom's Department for International Development, and the Rockefeller Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. HITAP's International Unit collaborates with The Access and Delivery Partnership.	Angelis A, 2017, SOC SCI MED, V188, P137, DOI 10.1016/j.socscimed.2017.06.024; [Anonymous], 2016, METAL AM, V2, P61; Botwright S, 2020, COUNTRY LED ASSESSME; Brooks A, 2012, GLOB PUBLIC HEALTH, V7, P931, DOI 10.1080/17441692.2012.699088; Ford AQ, 2016, VACCINE, V34, P1489, DOI 10.1016/j.vaccine.2015.11.038; Frazao TDC, 2018, BMC MED INFORM DECIS, V18, DOI 10.1186/s12911-018-0663-1; Giersing BK, 2017, VACCINE, V35, P6793, DOI 10.1016/j.vaccine.2017.04.063; IJzerman MJ, 2017, PHARMACOECONOMICS, V35, P727, DOI 10.1007/s40273-017-0509-1; Inotai A, 2018, EXPERT REV PHARM OUT, V18, P585, DOI 10.1080/14737167.2018.1508345; Knobler S, 2017, VACCINE, V35, pA43, DOI 10.1016/j.vaccine.2016.10.086; Kristensen DD, 2016, VACCINE, V34, P6236, DOI 10.1016/j.vaccine.2016.10.057; Lee J, 2017, TECHNOL FORECAST SOC, V119, P53, DOI [10.1016/j.techfore2017.03.011, 10.1016/j.techfore.2017.03.011]; Madhavan G, 2015, VACCINE, V33, pB34, DOI 10.1016/j.vaccine.2015.02.032; Marsh K, 2018, COST EFFECT RESOUR A, V16, DOI 10.1186/s12962-018-0125-8; Marsh K, 2016, VALUE HEALTH, V19, P125, DOI 10.1016/j.jval.2015.12.016; Plotkin S, 2017, VACCINE, V35, P4064, DOI 10.1016/j.vaccine.2017.06.003; Popova O, 2016, CURR MED RES OPIN, V32, P177, DOI 10.1185/03007995.2015.1108910; Rattanavipapong W, 2020, INT J HEALTH POLICY, Vx, P1; Sheerin D, 2017, EUR J IMMUNOL, V47, P2017, DOI 10.1002/eji.201746942; Strategic Group of Experts in Immunization, 2018, 2018 ASS REP GLOB VA; Wahlster P, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0930-0; WHO, HLTH SYST FIN PATH U; World Health Organization, 2014, PRINC CONS ADD VACC; World Health Organization, UN HLTH COV UHC	24	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2020	15	6							e0233950	10.1371/journal.pone.0233950	http://dx.doi.org/10.1371/journal.pone.0233950			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC0EC	32520934	Green Published, gold			2022-12-26	WOS:000542969500032
J	Bert, D; Lebourgeois, F; Ponton, S; Musch, B; Ducousso, A				Bert, Didier; Lebourgeois, Francois; Ponton, Stephane; Musch, Brigitte; Ducousso, Alexis			Which oak provenances for the 22nd century in Western Europe? Dendroclimatology in common gardens	PLOS ONE			English	Article							QUERCUS-PETRAEA LIEBL.; SESSILE OAK; GROWTH RELATIONSHIPS; PEDUNCULATE OAK; STAND DENSITY; RADIAL GROWTH; NORWAY SPRUCE; SOCIAL-STATUS; MIXED STANDS; TIME-SERIES	The current distribution area of the two sympatric oaksQuercus petraeaandQ.roburcovers most of temperate Western Europe. Depending on their geographic location, populations of these trees are exposed to different climate constraints, to which they are adapted. Comparing the performances of trees from contrasting populations provides the insight into their expected resilience to future climate change required for forest management. In this study, the descendants of 24Q.petraeaand twoQ.roburprovenances selected from sites throughout Europe were grown for 20 years in three common gardens with contrasting climates. The 2420 sampled trees allowed the assessments of the relationship between radial growth and climate. An analysis of 15-year chronologies of ring widths, with different combinations of climate variables, revealed different response patterns between provenances and between common gardens. As expected, provenances originating from sites with wet summers displayed the strongest responses to summer drought, particularly in the driest common garden. All provenances displayed positive significant relationships between the temperature of the previous winter and radial growth when grown in the common garden experiencing the mildest winter temperatures. Only eastern provenances from continental cold climates also clearly expressed this limitation of growth by cold winter temperatures in the other two common gardens. However, ecological distance, calculated on the basis of differences in climate between the site of origin and the common garden, was not clearly related to the radial growth responses of the provenances. This suggests that the gradient of genetic variability among the selected provenances was not strictly structured according to climate gradients. Based on these results, we provide guidelines for forest managers for the assisted migration ofQuercus petraeaandQ.roburprovenances.	[Bert, Didier; Ducousso, Alexis] Univ Bordeaux, BIOGECO, INRAE, Cestas, France; [Lebourgeois, Francois; Ponton, Stephane] Univ Lorraine, UMR Silva, INRAE, AgroParisTech, Nancy, France; [Musch, Brigitte] INRAE, CGAF ONF, Orleans, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux; AgroParisTech; INRAE; Universite de Lorraine; INRAE	Bert, D (corresponding author), Univ Bordeaux, BIOGECO, INRAE, Cestas, France.	didier.bert@inrae.fr		Bert, Didier/0000-0002-7475-6367; Lebourgeois, Francois/0000-0002-2040-6150	 [H2Oak ANR 14-CE02-0013-02]		This work was made possible by H2Oak ANR 14-CE02-0013-02 funding and an ONF convention "Convention de recherche 2013-2016 ONF-INRA Variabilite genetique des Fagacees".	Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Alberto FJ, 2013, GLOBAL CHANGE BIOL, V19, P1645, DOI 10.1111/gcb.12181; [Anonymous], 2006, POSTSCRIPTS, V2, P47; [Anonymous], 1996, MINIUS REV DEP HIST, V5, P167; BACILIERI R, 1994, HEREDITY, V73, P130, DOI 10.1038/hdy.1994.112; BARATAUD F, 1995, PLANT SOIL, V172, P29, DOI 10.1007/BF00020856; BARZDAJN W, 1993, ANN SCIENC FOR VOL, pS222; BECKER M, 1982, ANN SCI FOREST, V39, P439, DOI 10.1051/forest:19820407; BECKER M, 1994, ANN SCI FOREST, V51, P477, DOI 10.1051/forest:19940504; Berges L, 2010, EUR J FOREST RES, V129, P199, DOI 10.1007/s10342-009-0315-1; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; BREDA N, 1993, ANN SCI FOREST, V50, P571, DOI 10.1051/forest:19930606; Breda N, 2008, CR GEOSCI, V340, P651, DOI 10.1016/j.crte.2008.08.003; Briffa K.R., 1990, METHODS DENDROCHRONO, P137, DOI DOI 10.1007/978-94-015-7879-0; Bunn AG, 2008, DENDROCHRONOLOGIA, V26, P115, DOI 10.1016/j.dendro.2008.01.002; Burianek V., 2011, Journal of Forest Science (Prague), V57, P153, DOI 10.17221/117/2010-JFS; Cavender-Bares J, 2000, OECOLOGIA, V124, P8, DOI 10.1007/PL00008865; Chakraborty D, 2019, SCI TOTAL ENVIRON, V654, P393, DOI 10.1016/j.scitotenv.2018.11.093; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Delmas B., 1996, STAT DESCRIPTIVE; Deque M, 2007, GLOBAL PLANET CHANGE, V57, P16, DOI 10.1016/j.gloplacha.2006.11.030; Dimopoulos P., 2013, Englera, V31; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Ducousso A, 2004, RENDEZ VOUS TECHNIQU, VN1, P33; Ducousso A., 1993, ANN SCIENC FOR VOL, V50, p91s, DOI 10.1051/forest:19930708; Duursma RA, 2012, GEOSCI MODEL DEV, V5, P919, DOI 10.5194/gmd-5-919-2012; Dyderski MK, 2018, GLOBAL CHANGE BIOL, V24, P1150, DOI 10.1111/gcb.13925; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Fisher D. K., 2013, Agricultural Sciences, V4, P51; Friedrichs DA, 2009, TREE PHYSIOL, V29, P39, DOI 10.1093/treephys/tpn003; Garzon MB, 2019, NEW PHYTOL, V222, P1757, DOI 10.1111/nph.15716; GRACAN J, 1993, ANNALES DES SCIENCES FORESTIERES, VOL 50, SUPPLEMENT 1, 1993, pS215; Grotehusmann H, 2011, SILVAE GENET, V60, P186, DOI 10.1515/sg-2011-0025; GUAY R, 1992, FOREST CHRON, V68, P138, DOI 10.5558/tfc68138-1; Guillemot J, 2015, BIOGEOSCIENCES, V12, P2773, DOI 10.5194/bg-12-2773-2015; Guiot J., 1991, Tree-Ring Bulletin, V51, P39; Hardtle W, 2013, PLANT ECOL, V214, P1147, DOI 10.1007/s11258-013-0239-1; Hanewinkel M, 2013, NAT CLIM CHANGE, V3, P203, DOI [10.1038/nclimate1687, 10.1038/NCLIMATE1687]; Housset JM, 2018, NEW PHYTOL, V218, P630, DOI 10.1111/nph.14968; IGN, 2013, PORT I GEOGR NAT RES; JENSEN JS, 1993, ANN SCI FOR S1, V50, P203; Kapeller S, 2012, FOREST ECOL MANAG, V271, P46, DOI 10.1016/j.foreco.2012.01.039; Kleinschmit J, 1993, ANN FOR SCI S1, V50, P166, DOI DOI 10.1051/FOREST:19930716; Kremer A, 2002, FOREST ECOL MANAG, V156, P75, DOI 10.1016/S0378-1127(01)00635-1; Kremer A., 1993, ANN SCI FOR S1, V50, P186, DOI DOI 10.1051/F0REST:19930717; Lebourgeois F, 2004, ANN FOREST SCI, V61, P361, DOI 10.1051/forest:2004029; Lebourgeois F, 2014, FOREST ECOL MANAG, V328, P209, DOI 10.1016/j.foreco.2014.05.038; Lebourgeois F, 2013, FOREST ECOL MANAG, V303, P61, DOI 10.1016/j.foreco.2013.04.003; Lebourgeois Francois, 2006, Revue Forestiere Francaise (Nancy), V58, P29; Lebourgeois Francois, 2008, Revue Forestiere Francaise (Nancy), V60, P411; Lebourgeois Francois, 2017, Revue Forestiere Francaise (Nancy), V69, P11; Lebourgeois Francois, 2002, Revue Forestiere Francaise (Nancy), V54, P17; Madsen SF, 1990, INT PROVENANCE TRIAL; Matyas C., 2010, Forstarchiv, V81, P130; MATYAS C, 1994, TREE PHYSIOL, V14, P797, DOI 10.1093/treephys/14.7-8-9.797; Matyas C, 2014, DILEMMA SILVICULTURA; Matyas C, 2018, FORESTS, V9, DOI 10.3390/f9080489; Merian P, 2011, CAN J FOREST RES, V41, P2413, DOI [10.1139/x11-149, 10.1139/X11-149]; Merian P, 2011, PLANT ECOL, V212, P1855, DOI 10.1007/s11258-011-9959-2; Murtagh F, 2014, J CLASSIF, V31, P274, DOI 10.1007/s00357-014-9161-z; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Petit RJ, 2008, SCIENCE, V320, P1450, DOI 10.1126/science.1155457; PETIT RJ, 1993, THEOR APPL GENET, V87, P122, DOI 10.1007/BF00223755; Piedallu C, 2011, GEODERMA, V160, P355, DOI 10.1016/j.geoderma.2010.10.004; Polge H., 1966, ANN SCI FOREST, V23, P1, DOI DOI 10.1051/FOREST/19660101; Ponton S, 2001, PLANT CELL ENVIRON, V24, P861, DOI 10.1046/j.0016-8025.2001.00733.x; Pritzkow C, 2016, PALAEOGEOGR PALAEOCL, V449, P520, DOI 10.1016/j.palaeo.2016.02.046; Saenz-Romero C, 2017, GLOBAL CHANGE BIOL, V23, P2831, DOI 10.1111/gcb.13576; Schweingruber F. H., 1990, Dendrochronologia, V8, P9; Seynave I, 2018, ANN FOREST SCI, V75, DOI 10.1007/s13595-018-0692-z; Sofletea N, 2015, NOT BOT HORTI AGROBO, V43, P265, DOI 10.15835/nbha4319861; Stephane P, 2019, FOREST ECOL MANAG, V432, P923, DOI 10.1016/j.foreco.2018.10.027; Taeger S, 2013, FOREST ECOL MANAG, V307, P30, DOI 10.1016/j.foreco.2013.06.053; Trouve R, 2017, TREES-STRUCT FUNCT, V31, P517, DOI 10.1007/s00468-016-1479-1; Trouve R, 2015, TREE PHYSIOL, V35, P1035, DOI 10.1093/treephys/tpv067; Veras L, 2016, ASIA PAC J CLIN ONCO, V12, pe196, DOI 10.1111/ajco.12129; Wang T, 2006, GLOBAL CHANGE BIOL, V12, P2404, DOI 10.1111/j.1365-2486.2006.01271.x; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Williams G. C., 1966, P307; WORRELL R, 1992, FORESTRY, V65, P253, DOI 10.1093/forestry/65.3.253; Yule GU, 1926, J R STAT SOC, V89, P1, DOI 10.2307/2341482; Zang C, 2013, DENDROCHRONOLOGIA, V31, P68, DOI 10.1016/j.dendro.2012.08.001	83	11	11	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2020	15	6							e0234583	10.1371/journal.pone.0234583	http://dx.doi.org/10.1371/journal.pone.0234583			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC0EC	32520978	Green Published, gold			2022-12-26	WOS:000542969500038
J	Orrego, RC; Rios-Osorio, LA; Keynan, Y; Rueda, ZV; Gutierrez, LA				Cabrera Orrego, Ruth; Alberto Rios-Osorio, Leonardo; Keynan, Yoav; Vanessa Rueda, Zulma; Andrea Gutierrez, Lina			Molecular detection ofCoxiella burnetiiin livestock farmers and cattle from Magdalena Medio in Antioquia, Colombia	PLOS ONE			English	Article							COXIELLA-BURNETII; Q-FEVER; RISK-FACTORS; DAIRY; PREVALENCE; SEROPREVALENCE; INFECTION; HISTORY; MILK	Coxiella burnetiicauses Q fever in humans and coxiellosis in animals. In humans, it causes acute febrile illnesses like influenza, pneumonia, hepatitis, and chronic illnesses such as endocarditis, vascular infection, and post-infectious fatigue syndrome. It is widely distributed worldwide, and its main reservoirs are sheep, goats, and cattle. This study aimed to determine the frequency ofC.burnetiiinfection using molecular detection and to identify the associated factors in livestock farmers and cattle from the Magdalena Medio region of Antioquia, Colombia. Using real-time polymerase chain reaction (PCR), molecular detection was performed for the IS1111 insertion sequence ofC.burnetiiusing genomic DNA collected from the peripheral blood of 143 livestock farmers and 192 cattle from 24 farms located in Puerto Berrio, Puerto Nare, and Puerto Triunfo. To confirm the results, bidirectional amplicon sequencing of16S rRNAwas performed in four of the positive samples. Additionally, factors associated withC.burnetiiwere identified using a Poisson regression with cluster effect adjustment. Real-time PCR showed positive results in 25.9% and 19.5% of livestock farmer samples and cattle samples, respectively. For livestock farmers, factors associated withC.burnetiiwere the area where the farm was located [Puerto Berrio, adjusted prevalence ratio (aPR): 2.13, 95% confidence interval (CI): 1.10-4.11], presence of hens (aPR: 1.47, 95% CI: 1.21-1.79), horses (aPR: 1.61, 95% CI: 1.54-1.67), and ticks (aPR: 2.36, 95% CI: 1.03-5.42) in the residence, and consumption of raw milk (aPR: 1.47, 95% CI: 1.26-1.72). For cattle, the factors associated withCoxiellagenus were municipality (Puerto Nare; aPR: 0.39, 95% CI: 0.37-0.41) and time of residence on the farm (>= 49 months; aPR: 2.28, 95% CI: 1.03-5.20). By analyzing sequences of the16S rRNAmolecular marker,C.burnetiiinfection was confirmed in livestock farmers. However, in cattle, only the presence ofCoxiella-type bacteria was identified. Further research is necessary to determine the potential role that these types of bacteria have as etiological agents for disease in livestock farmers and cattle from the study area.	[Cabrera Orrego, Ruth; Andrea Gutierrez, Lina] Univ Pontificia Bolivariana, Fac Med, Escuela Ciencias Salud, Grp Biol Sistemas, Medellin, Antioquia, Colombia; [Alberto Rios-Osorio, Leonardo] Univ Antioquia, Grp Invest Microbiol Vet, Escuela Microbiol, Medellin, Colombia; [Keynan, Yoav] Univ Manitoba, Dept Internal Med, Med Microbiol & Infect Dis & Community Hlth Sci, Winnipeg, MB, Canada; [Vanessa Rueda, Zulma] Univ Pontificia Bolivariana, Fac Med, Escuela Ciencias Salud, Grp Invest Salud Publ, Medellin, Antioquia, Colombia	Universidad Pontificia Bolivariana; Universidad de Antioquia; University of Manitoba; Universidad Pontificia Bolivariana	Gutierrez, LA (corresponding author), Univ Pontificia Bolivariana, Fac Med, Escuela Ciencias Salud, Grp Biol Sistemas, Medellin, Antioquia, Colombia.	lina.gutierrezb@upb.edu.co	Rueda, Zulma Vanessa/AAH-4650-2019; Builes, Lina Andrea Gutierrez/AAS-4137-2021	Rueda, Zulma Vanessa/0000-0001-6342-1812; Builes, Lina Andrea Gutierrez/0000-0002-5336-6984; Keynan, Yoav/0000-0003-4948-4707	Ministerio de Ciencia Tecnologia e Innovacion (Minciencias) [653-2013, CIDI UPB 211B-02/14-65]; Grant Extendiendo Fronteras Educativas from Sapiencia: Agencia de Educacion Superior de Medellin, Alcaldia de Medellin [2017-2]; Minciencias [692-2017]; CIDI UPB [020C-01/18-65]	Ministerio de Ciencia Tecnologia e Innovacion (Minciencias); Grant Extendiendo Fronteras Educativas from Sapiencia: Agencia de Educacion Superior de Medellin, Alcaldia de Medellin; Minciencias; CIDI UPB	This study was supported by the Ministerio de Ciencia Tecnologia e Innovacion (Minciencias) (grant contract 653-2013, CIDI UPB 211B-02/14-65 to LAG). RCO such as a master's student was supported by Grant Extendiendo Fronteras Educativas 2017-2 from Sapiencia: Agencia de Educacion Superior de Medellin, Alcaldia de Medellin and by Minciencias grant contract 692-2017 and CIDI UPB number 020C-01/18-65. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalii F, 2018, IRAN J MICROBIOL, V10, P220; Alvarez J, 2012, VET J, V194, P102, DOI 10.1016/j.tvjl.2012.02.022; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2009, J AVIATION MED SCI, V23, P127; [Anonymous], 2011, ANIMAL, DOI DOI 10.1097/ADM.0B013E31820C23FA; Ayres JG, 1998, QJM-MON J ASSOC PHYS, V91, P105, DOI 10.1093/qjmed/91.2.105; Betancur Carlos Alberto, 2015, Acta Med Colomb, V40, P20; Betancur Carlos Alberto, 2012, Acta Med Colomb, V37, P31; Bottcher J, 2011, VET MICROBIOL, V151, P291, DOI 10.1016/j.vetmic.2011.03.007; Brooke RJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-488; Carbonero A, 2015, PREV VET MED, V118, P427, DOI 10.1016/j.prevetmed.2015.01.007; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Delsing CE, 2010, NETH J MED, V68, P382; Desjardins I, 2018, VET MICROBIOL, V215, P49, DOI 10.1016/j.vetmic.2017.11.012; Duron O, 2015, TRENDS PARASITOL, V31, P536, DOI 10.1016/j.pt.2015.06.014; Duron O, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004892; Duron O, 2014, TICKS TICK-BORNE DIS, V5, P557, DOI 10.1016/j.ttbdis.2014.04.003; Eldin C, 2017, CLIN MICROBIOL REV, V30, P115, DOI 10.1128/CMR.00045-16; Esmaeili S, 2019, COMP IMMUNOL MICROB, V63, P127, DOI 10.1016/j.cimid.2019.01.015; Georgiev M., 2013, EUROSURVEILLANCE, V18, P8; Guatteo R, 2007, VET RES, V38, P849, DOI 10.1051/vetres:2007038; Guo HP, 2019, TICKS TICK-BORNE DIS, V10, P875, DOI 10.1016/j.ttbdis.2019.04.008; Hirschmann JV, 2019, AM J MED SCI, V358, P3, DOI 10.1016/j.amjms.2019.04.006; Kampschreur LM, 2015, EMERG INFECT DIS, V21, P1183, DOI 10.3201/eid2107.130955; Korner S, 2020, PARASITE VECTOR, V13, DOI 10.1186/s13071-020-3956-z; Machado-Ferreira E, 2016, PARASITOL RES, V115, P4691, DOI 10.1007/s00436-016-5230-z; Marrie TJ, 2003, EUR RESPIR J, V21, P713, DOI 10.1183/09031936.03.00099703; Máttar Salim, 2006, Rev.MVZ Cordoba, V11, P781; Mattar Salim, 2014, Rev. salud pública, V16, P958, DOI 10.15446/rsap.v16n6.40086; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; MEZA-CARDONA JUAN CARLOS, 2012, CES Med., V26, P201; Mori M, 2018, ARCH PUBLIC HEALTH, V76, DOI 10.1186/s13690-017-0248-y; Mostafavi E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211781; Muskens J, 2011, Vet Rec, V168, P79, DOI 10.1136/vr.c6106; Nokhodian Z, 2018, COMP IMMUNOL MICROB, V61, P34, DOI 10.1016/j.cimid.2018.11.003; PARK J, 2018, J KOREAN MED SCI, V33; Eraso-Cadena MP, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311x00193617, 10.1590/0102-311X00193617]; Paul S, 2014, PREV VET MED, V113, P504, DOI 10.1016/j.prevetmed.2014.01.018; Pexara A, 2018, TRENDS FOOD SCI TECH, V71, P65, DOI 10.1016/j.tifs.2017.11.004; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Riera Mario Alejandro, 2010, Rev. cienc. tecnol., P4; Roest HIJ, 2013, EMERG INFECT DIS, V19, P834, DOI 10.3201/eid1905.121489; Rozental T, 2017, ACTA TROP, V168, P64, DOI 10.1016/j.actatropica.2017.01.003; Schneeberger PM, 2014, MED MALADIES INFECT, V44, P339, DOI 10.1016/j.medmal.2014.02.006; Signs KA, 2012, CLIN INFECT DIS, V55, P1387, DOI 10.1093/cid/cis690; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Sobotta K, 2018, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00543; Sun WW, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7059196; Szymaska-Czerwiska M, 2019, PLOS ONE, V14; Tatsumi N, 2006, ANN NY ACAD SCI, V1078, P502, DOI 10.1196/annals.1374.096; The Gene Ontology Consortium, 2019, NUCLEIC ACIDS RES, V47, pD330; Vidal S, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1294-y; Wiethoelter AK, 2015, P NATL ACAD SCI USA, V112, P9662, DOI 10.1073/pnas.1422741112; Woldehiwet Z, 2004, RES VET SCI, V77, P93, DOI 10.1016/j.rvsc.2003.09.001	54	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2020	15	6							e0234360	10.1371/journal.pone.0234360	http://dx.doi.org/10.1371/journal.pone.0234360			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC0EC	32520958	gold, Green Published			2022-12-26	WOS:000542969500040
J	Verma, M; Kathirvel, S; Das, M; Aggarwal, R; Goel, S				Verma, Madhur; Kathirvel, Soundappan; Das, Milan; Aggarwal, Ramnika; Goel, Sonu			Trends and patterns of second-hand smoke exposure amongst the non-smokers in India-A secondary data analysis from the Global Adult Tobacco Survey (GATS) I & II	PLOS ONE			English	Article							SECONDHAND SMOKE; DISEASE; WORK; HOME	Objectives The primary objective of the present study was to compare the prevalence and patterns of second-hand smoke (SHS) exposure in the home, workplace, public places, and at all three places amongst the non-smoker respondents between the two rounds of Global Adult Tobacco Survey (GATS) in India. The secondary objectives were to assess the differences in various factors associated with SHS exposure among non-smokers. Study design This secondary data analysis incorporated data generated from the previous two rounds of the cross-sectional, nationally representative GATS India, which covered 69,296 and 74,037 individuals aged 15 years and above. Exposure to the SHS at home, workplace, and public places amongst the non-smokers were the primary outcome variables. Standard definitions of the surveys were used. Results The overall weighted prevalence of exposure to SHS amongst the non-smokers inside the home and public places reduced. In contrast, the prevalence in the workplace increased marginally in round II compared to I. The proportion of adults who were exposed to SHS at all three places did not change much in two rounds of surveys. A decrease in the knowledge of the respondents exposed to SHS at home and public places was observed about the harmful effects of smoking in round II. Age, gender, occupation, place, and region of respondents were found to be significant determinants of SHS exposure at all the three places on multinomial logistic regression analysis. Conclusions The study calls for focused interventions in India and stringent implementation of anti-tobacco legislation, especially in the workplaces for reducing the exposure to SHS amongst the non-smokers and to produce encouraging and motivating results by next round of the survey.	[Verma, Madhur; Aggarwal, Ramnika] All India Inst Med Sci, Dept Community & Family Med, Bathinda, Punjab, India; [Kathirvel, Soundappan; Goel, Sonu] Post Grad Inst Med Educ & Res, Dept Community Med, Chandigarh, India; [Kathirvel, Soundappan; Goel, Sonu] Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India; [Das, Milan] Int Inst Populat Sci, Mumbai, Maharashtra, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; International Institute for Population Sciences	Goel, S (corresponding author), Post Grad Inst Med Educ & Res, Dept Community Med, Chandigarh, India.; Goel, S (corresponding author), Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India.	sonugoel007@yahoo.co.in	; Goel, Sonu/F-7956-2010	Kathirvel, Soundappan/0000-0002-4839-0138; Goel, Sonu/0000-0001-5231-7083				Abdullah AS, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-117; Adda J, 2010, AM ECON J-APPL ECON, V2, P1, DOI 10.1257/app.2.1.1; Agrawal Deepika, 2015, J Family Med Prim Care, V4, P293, DOI 10.4103/2249-4863.161300; American Cancer Society, 2015, HLTH RISKS SEC SMOK; [Anonymous], 2014, CANC DISCOV, V4, pOF5; [Anonymous], 2014, IEEE T NEUR SYS REH, V23, P308; Apelberg BJ, 2013, TOB CONTROL, V22, P147, DOI 10.1136/tobaccocontrol-2011-050301; Asma S, 2015, THE GATS ATLAS, P128; Avila-Tang E, 2013, TOB CONTROL, V22, P156, DOI 10.1136/tobaccocontrol-2011-050296; Barnoya J, 2005, CIRCULATION, V111, P2684, DOI 10.1161/CIRCULATIONAHA.104.492215; Bhatt G, 2018, INDIAN J PUBLIC HLTH, V62, P128, DOI 10.4103/ijph.IJPH_442_16; BHAUMIK S, 2013, BMJ-BRIT MED J, V346, DOI DOI 10.1136/BMJ.F2186; Chaouachi K, 2009, INT J ENV RES PUB HE, V6, P798, DOI 10.3390/ijerph6020798; COST Action B13 working group, 2006, EUROPEAN SPINE J S2, V15, pS1; Dinas PC, 2014, INT J ENVIRON HEAL R, V24, P56, DOI 10.1080/09603123.2013.782603; Global Adult Tobacco Survey (GATS), 2017, PUBL US DAT FIL IND; Goel S, 2018, INT J NONCOMMUNICABL, V3, P9; Gu DF, 2004, AM J PUBLIC HEALTH, V94, P1972, DOI 10.2105/AJPH.94.11.1972; Ho SY, 2010, TOB CONTROL, V19, P129, DOI 10.1136/tc.2009.032003; Hughes SC, ASIAN PAC J CANC PRE, V9, P247; King BA, 2013, TOB CONTROL, V22, P362, DOI 10.1136/tobaccocontrol-2012-050582corr1; Levy DT, 2004, TOB CONTROL, V13, P258, DOI 10.1136/tc.2003.006056; Lim KH, 2018, TOB INDUC DIS, V16, DOI 10.18332/tid/95188; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Mckay AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122610; Ministry of Health & Family Welfare Government of India, 2017, GLOB AD TOB SURV 201; Ministry of Law and Justice, 2003, COTPA 2003; Mohan P., 2018, INDIAN J CLIN MED, V9, P1, DOI [10.1177/1179916118759289, DOI 10.1177/1179916118759289]; Nebot M, 2004, TOB CONTROL, V13, P95, DOI 10.1136/tc.2003.006221; Newsletter A.E.R.B., 2010, GOV IND, V23, P9; Singh A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003542; Singh Rana J, 2011, Indian J Public Health, V55, P192, DOI 10.4103/0019-557X.89950; Tobacco-Free Initiative (TFI), 2018, GLOB AD TOB SURV GAT; Tripathy JP, 2020, ENVIRON SCI POLLUT R, V27, P6033, DOI 10.1007/s11356-019-07341-x; Wang CP, 2009, TOB CONTROL, V18, P121, DOI 10.1136/tc.2008.024836; World Health Organization, 2019, WHO REP GLOB TOB EP; World Health Organization, 2008, WHO REP GLOB TOB EP; World Health Organization, 2007, PROT EXP 2 HAND TOB; World Health Organization, 2019, WHO DOC WHO EMTFI196; World Health Organization, 2020, REV SOK FREE; World Health Organization, 2003, WHO FRAM CONV TOB CO	41	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2020	15	6							e0233861	10.1371/journal.pone.0233861	http://dx.doi.org/10.1371/journal.pone.0233861			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC0EC	32520979	gold, Green Published			2022-12-26	WOS:000542969500023
J	Vikal, Y; Kaur, A; Jindal, J; Kaur, K; Pathak, D; Garg, T; Singh, A; Singh, P; Yadav, I				Vikal, Yogesh; Kaur, Arshpreet; Jindal, Jawala; Kaur, Kirandeep; Pathak, Dharminder; Garg, Tosh; Singh, Ashanpreet; Singh, Princepal; Yadav, Inderjit			Identification of genomic regions associated with shoot fly resistance in maize and their syntenic relationships in the sorghum genome	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; BORER OSTRINIA-NUBILALIS; MEDITERRANEAN CORN-BORER; FALL ARMYWORM; WEEVIL RESISTANCE; BLIGHT RESISTANCE; TROPICAL MAIZE; QTL; BIOSYNTHESIS; TOLERANCE	Shoot fly (Atherigona naqvii) is one of the major insects affecting spring maize in North India and can cause yield loss up to 60 per cent. The genetics of insect resistance is complex as influenced by genotypic background, insect population and climatic conditions. Therefore, quantitative trait loci (QTL) mapping is a highly effective approach for studying genetically complex forms of insect resistance. The objective of the present study was to dissect the genetic basis of resistance and identification of genomic regions associated with shoot fly resistance. A total of 107 F-2 population derived from the cross CM143 (resistant) x CM144 (susceptible) was genotyped with 120 SSR markers. Phenotypic data were recorded on replicated F-2:3 progenies for various component traits imparting resistance to shoot fly at different time intervals. Resistance to shoot fly was observed to be under polygenic control as evidenced by the identification of 19 putative QTLs governed by overdominance to partial dominance and additive gene actions. The major QTLs conditioning shoot fly resistance viz., qDH9.1 (deadheart) and qEC9.1 (oviposition) explaining 15.03 and 18.89 per cent phenotypic variance, respectively were colocalized on chromosome 9. These QTLs are syntenic to regions of chromosome 10 of sorghum which were also accounted for deadheart and oviposition suggesting that the same gene block may be responsible for shoot fly resistance. The candidate genes such as cysteine protease, subtilisin-chymotrypsin inhibitor, cytochrome P450 involved in synthesis of alleochemicals, receptor kinases, glossy15 and ubiquitin-proteasome degradation pathway were identified within the predicted QTL regions. This is the first reported mapping of QTLs conferring resistance to shoot fly in maize, and the markers identified here will be a valuable resource for developing elite maize cultivars with resistance to shoot fly.	[Vikal, Yogesh; Kaur, Arshpreet; Kaur, Kirandeep; Singh, Ashanpreet; Singh, Princepal; Yadav, Inderjit] Punjab Agr Univ, Sch Agr Biotechnol, Ludhiana, Punjab, India; [Jindal, Jawala; Pathak, Dharminder; Garg, Tosh] Punjab Agr Univ, Dept Plant Breeding & Genet, Ludhiana, Punjab, India	Punjab Agricultural University; Punjab Agricultural University	Vikal, Y (corresponding author), Punjab Agr Univ, Sch Agr Biotechnol, Ludhiana, Punjab, India.	yvikal-soab@pau.edu		yadav, inderjit/0000-0001-9988-945X; Vikal, Yogesh/0000-0001-5821-9345; Singh, Prince Pal/0000-0001-7053-0347	Punjab Agricultural University	Punjab Agricultural University	Funding provided by the Punjab Agricultural University is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding provided by the Punjab Agricultural University is gratefully acknowledged. Mention of a specific product by Punjab Agricultural University does not constitute an endorsement and does not imply recommendation of products.	Ai X., 2005, CHEM BIOL HEPARIN HE, P245; Alheit KV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-380; Andre A. M., 2003, South African Journal of Plant and Soil, V20, P64; Ankala A, 2009, MOL PLANT MICROBE IN, V22, P1555, DOI 10.1094/MPMI-22-12-1555; [Anonymous], 2006, NORBA REV HIST, V19, P105; [Anonymous], 2011, PSYCHOLOGIST, V24, P86; [Anonymous], 2008, AUSTR NZ SPORTS LAW, V3, P119; Apotikar DB, 2011, J GENET, V90, P59, DOI 10.1007/s12041-011-0046-1; Badji A, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00895; Balbi V, 2008, NEW PHYTOL, V177, P301, DOI 10.1111/j.1469-8137.2007.02292.x; Barriere Y, 2008, PLANT SCI, V175, P585, DOI 10.1016/j.plantsci.2008.06.009; Barros J, 2011, PLANT BREEDING, V130, P268, DOI 10.1111/j.1439-0523.2010.01789.x; Basten C.J., 2005, QTL CARTOGRAPHER REF; Baumbach J, 2012, PLANT SCI, V195, P151, DOI 10.1016/j.plantsci.2012.07.003; Becraft PW, 2002, ANNU REV CELL DEV BI, V18, P163, DOI 10.1146/annurev.cellbio.18.012502.083431; Bohn M, 2000, THEOR APPL GENET, V101, P907, DOI 10.1007/s001220051561; Bowman JL, 2000, TRENDS PLANT SCI, V5, P110, DOI 10.1016/S1360-1385(00)01569-7; Brooks TD, 2005, CROP SCI, V45, P2430, DOI 10.2135/cropsci2004.0656; Brooks TD, 2007, J ECON ENTOMOL, V100, P1470, DOI 10.1603/0022-0493(2007)100[1470:GBORTF]2.0.CO;2; Butron A, 2010, THEOR APPL GENET, V120, P721, DOI 10.1007/s00122-009-1192-1; Cardinal AJ, 2006, MAYDICA, V51, P93; Castro-Alvarez FF, 2015, THEOR APPL GENET, V128, P411, DOI 10.1007/s00122-014-2440-6; Dhillon MK, 2005, EUPHYTICA, V144, P301, DOI 10.1007/s10681-005-7400-4; Ferry N, 2004, CURR OPIN BIOTECH, V15, P155, DOI 10.1016/j.copbio.2004.01.008; Finka A, 2012, PLANT CELL, V24, P3333, DOI 10.1105/tpc.112.095844; Garcia-Lara S, 2010, CROP SCI, V50, P815, DOI 10.2135/cropsci2009.07.0415; Garcia-Lara S, 2009, CROP SCI, V49, P139, DOI 10.2135/cropsci2007.06.0326; Go YS, 2014, PLANT CELL, V26, P1666, DOI 10.1105/tpc.114.123307; Golldack D, 2011, PLANT CELL REP, V30, P1383, DOI 10.1007/s00299-011-1068-0; Groh S, 1998, CROP SCI, V38, P1062, DOI 10.2135/cropsci1998.0011183X003800040030x; Guelette BS, 2012, J EXP BOT, V63, P3603, DOI 10.1093/jxb/ers028; Gullner G, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01836; HALLALI MS, 1982, SABRAO J, V14, P165; Henrissat B, 2000, PLANT PHYSIOL, V124, P1515, DOI 10.1104/pp.124.4.1515; Jimenez-Galindo JC, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00698; Jindal J, 2013, THESIS; Jindal Jawala, 2007, Crop Improvement, V34, P160; Kaur M, 2019, J PHYTOPATHOL, V167, P591, DOI 10.1111/jph.12849; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lakhssassi N, 2012, PLANT PHYSIOL, V158, P1252, DOI 10.1104/pp.111.188920; Lorieux M, 2012, MOL BREEDING, V30, P1231, DOI 10.1007/s11032-012-9706-y; McMullen MD, 1995, MOL PLANT MICROBE IN, V8, P811, DOI 10.1094/MPMI-8-0811; Meihls L N, 2012, Cold Spring Harb Symp Quant Biol, V77, P269, DOI 10.1101/sqb.2012.77.014662; Miller G, 2009, J BIOL CHEM, V284, P26482, DOI 10.1074/jbc.M109.009340; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Ng CY, 2016, ENVIRON IMPACT ASSES, V61, P1, DOI 10.1016/j.eiar.2016.06.006; Nimbalkar V. S., 1992, Journal of Maharashtra Agricultural Universities, V17, P93; PANWAR V P S, 1985, Journal of Entomological Research (New Delhi), V9, P207; Pechan T, 2000, PLANT CELL, V12, P1031, DOI 10.1105/tpc.12.7.1031; Pu YY, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-215; Raffaele S, 2008, PLANT CELL, V20, P752, DOI 10.1105/tpc.107.054858; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; SANDHU G S, 1976, Entomologist's Record and Journal of Variation, V88, P27; Satish K, 2009, THEOR APPL GENET, V119, P1425, DOI 10.1007/s00122-009-1145-8; Schuler MA, 1996, PLANT PHYSIOL, V112, P1411, DOI 10.1104/pp.112.4.1411; Sessa G, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124047; Sharma H. C., 1992, ICRISAT Information Bulletin; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; STUBER CW, 1987, CROP SCI, V27, P639, DOI 10.2135/cropsci1987.0011183X002700040006x; Szalma SJ, 2002, CROP SCI, V42, P1679, DOI 10.2135/cropsci2002.1679; Tamayo MC, 2000, PLANTA, V211, P62, DOI 10.1007/s004250000258; Vikal Y, 2014, INDIAN J GENET PL BR, V74, P589, DOI 10.5958/0975-6906.2014.00895.5; Zhang XJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085007, 10.1186/1748-717X-9-64]; [No title captured]	64	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2020	15	6							e0234335	10.1371/journal.pone.0234335	http://dx.doi.org/10.1371/journal.pone.0234335			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ1GC	32516348	gold, Green Published			2022-12-26	WOS:000540977000008
J	Pantoja, IEM; Smith, MD; Rajbhandari, L; Cheng, LZ; Gao, YX; Mahairaki, V; Venkatesan, A; Calabresi, PA; Fitzgerald, KC; Whartenby, KA				Morales Pantoja, Itzy E.; Smith, Matthew D.; Rajbhandari, Labchan; Cheng, Linzhao; Gao, Yongxing; Mahairaki, Vasiliki; Venkatesan, Arun; Calabresi, Peter A.; Fitzgerald, Kathryn C.; Whartenby, Katharine A.			iPSCs from people with MS can differentiate into oligodendrocytes in a homeostatic but not an inflammatory milieu	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; MULTIPLE-SCLEROSIS; INTERFERON-GAMMA; PROGENITOR CELLS; BLOOD-CELLS; REMYELINATION; ADULT; EXPRESSION; PATHWAY; GENERATION	Multiple sclerosis (MS) is an inflammatory and demyelinating disease of the central nervous system (CNS) that results in variable severities of neurodegeneration. The understanding of MS has been limited by the inaccessibility of the affected cells and the lengthy timeframe of disease development. However, recent advances in stem cell technology have facilitated the bypassing of some of these challenges. Towards gaining a greater understanding of the innate potential of stem cells from people with varying degrees of disability, we generated induced pluripotent stem cells (iPSCs) from peripheral blood mononuclear cells derived from stable and progressive MS patients, and then further differentiated them into oligodendrocyte (OL) lineage cells. We analyzed differentiation under both homeostatic and inflammatory conditions via sustained exposure to low-dose interferon gamma (IFN gamma), a prominent cytokine in MS. We found that all iPSC lines differentiated into mature myelinating OLs, but chronic exposure to IFN gamma dramatically inhibited differentiation in both MS groups, particularly if exposure was initiated during the pre-progenitor stage. Low-dose IFN gamma was not toxic but led to an early upregulation of interferon response genes in OPCs followed by an apparent redirection in lineage commitment from OL to a neuron-like phenotype in a significant portion of the treated cells. Our results reveal that a chronic low-grade inflammatory environment may have profound effects on the efficacy of regenerative therapies.	[Morales Pantoja, Itzy E.; Whartenby, Katharine A.] Johns Hopkins Univ, Sch Med, Program Cellular & Mol Med, Baltimore, MD 21218 USA; [Smith, Matthew D.; Rajbhandari, Labchan; Mahairaki, Vasiliki; Venkatesan, Arun; Calabresi, Peter A.; Fitzgerald, Kathryn C.; Whartenby, Katharine A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Cheng, Linzhao; Gao, Yongxing] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD USA; [Calabresi, Peter A.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Fitzgerald, Kathryn C.] Johns Hopkins Univ, Sch Med, Dept Epidemiol, Baltimore, MD USA; [Whartenby, Katharine A.] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Whartenby, KA (corresponding author), Johns Hopkins Univ, Sch Med, Program Cellular & Mol Med, Baltimore, MD 21218 USA.; Whartenby, KA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.; Whartenby, KA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA.	whartenby@jhmi.edu		Smith, Matthew/0000-0001-6614-569X; Morales Pantoja, Itzy/0000-0002-8808-2789; Fitzgerald, Kathryn/0000-0003-3137-0322	Maryland Stem Cell Research Foundation; Race to Erase MS; NIH/NINDS [R37NS041435]	Maryland Stem Cell Research Foundation; Race to Erase MS; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	(Maryland Stem Cell Research Foundation, the Race to Erase MS, and NIH/NINDS R37NS041435).	Andrews HE, 2005, MED HYPOTHESES; [Anonymous], 2019, CJEM; [Anonymous], 2011, CANC DISCOV; Baerwald KD, 1998, J NEUROSCI RES, V52, P230, DOI 10.1002/(SICI)1097-4547(19980415)52:2<230::AID-JNR11>3.3.CO;2-P; Butovsky O, 2007, MOL CELL NEUROSCI; Cadavid D, 2019, LANCET NEUROL; CHAMBERS SM, 2009, NAT BIOTECHNOL; Chari DM, 2007, INT REV NEUROBIOL, V79, P589, DOI 10.1016/S0074-7742(07)79026-8; Chew LJ, 2005, GLIA, V52, P127, DOI 10.1002/glia.20232; Chou BK, 2015, STEM CELL TRANSL MED, V4, P320, DOI 10.5966/sctm.2014-0214; Chou BK, 2011, CELL RES, V21, P518, DOI 10.1038/cr.2011.12; Cui QQ, 2016, CELL MOL NEUROBIOL, V36, P683, DOI 10.1007/s10571-015-0248-9; Douvaras P, 2014, STEM CELL REPORTS; Douvaras P, 2015, NAT PROTOC, V10, P1143, DOI 10.1038/nprot.2015.075; Dowey SN, 2012, NAT PROTOC, V7, P2013, DOI 10.1038/nprot.2012.121; Falcao AM, 2018, NAT MED, V24, P1837, DOI 10.1038/s41591-018-0236-y; Goldenberg Marvin M, 2012, P T, V37, P175; Goldschmidt T, 2009, NEUROLOGY, V72, P1914, DOI 10.1212/WNL.0b013e3181a8260a; Haider L, 2011, BRAIN, V134, P1914, DOI 10.1093/brain/awr128; Hajihosseini M, 1996, J NEUROSCI, V16, P7981; Hammond TR, 2014, NEURON; Horiuchi M, 2006, J BIOL CHEM; Hosmane S, 2012, J NEUROSCI, V32, P7745, DOI 10.1523/JNEUROSCI.0203-12.2012; Karumbayaram S, 2009, STEM CELLS, V27, P806, DOI 10.1002/stem.31; Khaibullin T, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00531; Kirby L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11638-3; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kuai XL, 2009, DIFFERENTIATION; Lee HK, 2012, DEV CELL; Lee HK, 2015, NEURON, V85, P1227, DOI 10.1016/j.neuron.2015.02.024; Leipzig ND, 2010, J BIOMED MATER RES A, V93A, P625, DOI 10.1002/jbm.a.32573; Lentferink DH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19934-6; Lin G, 2009, J NEUROSCI RES, V87, P3390, DOI 10.1002/jnr.22065; Lin W, 2010, J NEUROSCI RES; Lin WS, 2006, BRAIN, V129, P1306, DOI 10.1093/brain/awl044; Link H, 1998, MULT SCLER, V4, P12, DOI 10.1191/135245898678909141; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Luchtman DW, 2014, CYTOKINE GROWTH FACT; Mahairaki V, 2014, STEM CELLS DEV, V23, P2996, DOI 10.1089/scd.2013.0511; Mali P, 2008, STEM CELLS, V26, P1998, DOI 10.1634/stemcells.2008-0346; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; Miron VE, 2011, BIOCH BIOPHYSICA ACT; Munzel EJ, 2013, DRUGS, V73, P2017, DOI 10.1007/s40265-013-0146-8; Navikas V, 1996, J NEUROSCIENCE RES; Nicaise AM, 2019, P NATL ACAD SCI USA, V116, P9030, DOI 10.1073/pnas.1818348116; Nicaise AM, 2017, EXP NEUROL, V288, P114, DOI 10.1016/j.expneurol.2016.11.012; Patrikios P, 2006, BRAIN, V129, P3165, DOI 10.1093/brain/awl217; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Piao JH, 2015, CELL STEM CELL, V16, P198, DOI 10.1016/j.stem.2015.01.004; Reich DS, 2018, NEW ENGL J MED, V378, P169, DOI 10.1056/NEJMra1401483; Sandrine Pouly, 2000, J NEUROPATHOLOGY EXP, V59, P2015; Scolding N, 1998, BRAIN, V121, P2221, DOI 10.1093/brain/121.12.2221; Scovil Watson AE, 2019, NEUROSCI LETT; Soneson C, 2015, F1000 RES, V4, P1521, DOI [10.12688/f1000research.7563.1, DOI 10.12688/F1000RESEARCH.7563.2]; Steinman L, 2009, EUR J IMMUNOL, V39, P2358, DOI 10.1002/eji.200939814; Su KG, 2009, CURR NEUROL NEUROSCI, V9, P411, DOI 10.1007/s11910-009-0060-3; Torkildsen O, 2016, EUR J NEUROL, V23, P18, DOI 10.1111/ene.12883; Wang Y, 2010, GLIA, V58, P195, DOI 10.1002/glia.20912; Wang Y, 2014, ANN BIOMED ENG, V42, P1357, DOI 10.1007/s10439-013-0921-4; Windrem MS, 2004, NAT MED; Wojkowska DW, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051000; Wolswijk G, 2002, BRAIN; Zhang SC, 1999, P NATL ACAD SCI USA, V96, P4089, DOI 10.1073/pnas.96.7.4089	64	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2020	15	6							e0233980	10.1371/journal.pone.0233980	http://dx.doi.org/10.1371/journal.pone.0233980			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ0RE	32511247	gold, Green Published			2022-12-26	WOS:000540938100028
J	Murao, A; Arif, A; Brenner, M; Denning, NL; Jin, H; Takizawa, S; Nicastro, B; Wang, P; Aziz, M				Murao, Atsushi; Arif, Adnan; Brenner, Max; Denning, Naomi-Liza; Jin, Hui; Takizawa, Satoshi; Nicastro, Benjamin; Wang, Ping; Aziz, Monowar			Extracellular CIRP and TREM-1 axis promotes ICAM-1-Rho-mediated NETosis in sepsis	FASEB JOURNAL			English	Article						eCIRP; ICAM-1; NETs; sepsis; TREM-1	INFLAMMATORY RESPONSES; SIGNALING PATHWAYS; CUTTING EDGE; RECEPTOR; NEUTROPHILS; ICAM-1; TRAPS; ACTIVATION; ADHESION; IDENTIFICATION	Extracellular cold-inducible RNA-binding protein (eCIRP) is a damage-associated molecular pattern (DAMP). Intercellular adhesion molecule-1 (ICAM-1) expressing neutrophils produce excessive amounts of neutrophil extracellular traps (NETs). We reveal that eCIRP generates ICAM-1(+) neutrophils through triggering receptor expressed on myeloid cells-1 (TREM-1) and the ICAM-1(+) neutrophils involve Rho GTPase to promote NETosis. Treatment of BMDN with rmCIRP increased the frequency of ICAM-1(+) BMDN, while rmCIRP-treated TREM-1(-/-) BMDN or pretreatment of BMDN with TREM-1 inhibitor LP17 significantly decreased the frequency of ICAM-1(+) neutrophils. The frequencies of ICAM-1(+) neutrophils in blood and lungs were markedly decreased in rmCIRP-injected mice or septic mice treated with LP17. Coculture of ICAM-1(-/-) neutrophils or wild-type (WT) neutrophils with WT macrophages in the presence of a peptidylarginine deiminase 4 (PAD4) inhibitor reduced TNF-alpha and IL-6 compared to WT neutrophils treated with rmCIRP. Treatment of ICAM-1(-/-) neutrophils with rmCIRP resulted in reduced quantities of NETs compared to WT rmCIRP-treated neutrophils. Treatment of BMDN with rmCIRP-induced Rho activation, while blockade of ICAM-1 significantly decreased Rho activation. Inhibition of Rho significantly decreased rmCIRP-induced NET formation in BMDN. TREM-1 plays a critical role in the eCIRP-mediated increase of ICAM-1 expression in neutrophils, leading to the increased NET formation via Rho activation to exaggerate inflammation.	[Murao, Atsushi; Arif, Adnan; Brenner, Max; Denning, Naomi-Liza; Jin, Hui; Takizawa, Satoshi; Nicastro, Benjamin; Wang, Ping; Aziz, Monowar] Feinstein Inst Med Res, Ctr Immunol & Inflammat, 350 Community Dr, Manhasset, NY 11030 USA; [Brenner, Max; Wang, Ping] Hofstra Northwell, Zucker Sch Med, Dept Mol Med, Manhasset, NY USA; [Denning, Naomi-Liza; Wang, Ping; Aziz, Monowar] Elmezzi Grad Sch Mol Med, Manhasset, NY USA; [Denning, Naomi-Liza; Wang, Ping] Hofstra Northwell, Zucker Sch Med, Dept Surg, Manhasset, NY USA	Northwell Health; Northwell Health; Northwell Health; Northwell Health	Wang, P; Aziz, M (corresponding author), Feinstein Inst Med Res, Ctr Immunol & Inflammat, 350 Community Dr, Manhasset, NY 11030 USA.	pwang@northwell.edu; Maziz1@northwell.edu		Brenner, Max/0000-0002-8010-148X; Wang, Ping/0000-0002-1557-0394; Aziz, Monowar/0000-0002-8195-4505	National Institutes of Health (NIH) [R35GM118337, R01GM129633]; Shock Society's Faculty Research	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shock Society's Faculty Research	National Institutes of Health (NIH), Grant/Award Number: R35GM118337 and R01GM129633; Shock Society's Faculty Research	Adamson P, 1999, J IMMUNOL, V162, P2964; Allingham MJ, 2007, J IMMUNOL, V179, P4053, DOI 10.4049/jimmunol.179.6.4053; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Arts RJW, 2013, J LEUKOCYTE BIOL, V93, P209, DOI 10.1189/jlb.0312145; Arts RJW, 2011, EUR CYTOKINE NETW, V22, P11, DOI 10.1684/ecn.2011.0274; Aziz M, 2019, J LEUKOCYTE BIOL, V106, P133, DOI 10.1002/JLB.3MIR1118-443R; Aziz M, 2017, J IMMUNOL, V199, P750, DOI 10.4049/jimmunol.1602056; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; Biron BM, 2017, J INNATE IMMUN, V9, P22, DOI 10.1159/000448808; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Cen C, 2017, SURGERY, V162, P915, DOI 10.1016/j.surg.2017.06.004; Claushuis TAM, 2018, J IMMUNOL, V201, P1241, DOI 10.4049/jimmunol.1800314; Colon DF, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2407-8; Denning NL, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.134172; Denning NL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02536; Dower K, 2008, J IMMUNOL, V180, P3520, DOI 10.4049/jimmunol.180.5.3520; Dragoni S, 2017, J IMMUNOL, V198, P4074, DOI 10.4049/jimmunol.1600823; Ericsson AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116704; Etienne S, 1998, J IMMUNOL, V161, P5755; Etienne-Manneville S, 2000, J IMMUNOL, V165, P3375, DOI 10.4049/jimmunol.165.6.3375; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fu L, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00917; Gavillet M, 2015, AM J HEMATOL, V90, P1155, DOI 10.1002/ajh.24185; Gibot S, 2004, J EXP MED, V200, P1419, DOI 10.1084/jem.20040708; Gurien SD, 2020, EMBO REP, V21, DOI 10.15252/embr.201948075; Hidalgo A, 2019, TRENDS IMMUNOL, V40, P584, DOI 10.1016/j.it.2019.04.013; Kaplan MJ, 2012, J IMMUNOL, V189, P2689, DOI 10.4049/jimmunol.1201719; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Ng LG, 2019, NAT REV IMMUNOL, V19, P255, DOI 10.1038/s41577-019-0141-8; Luo Y, 2006, BIOCHEMISTRY-US, V45, P11727, DOI 10.1021/bi061180d; Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921; Neubert E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06263-5; Ode Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42762-1; Ode Y, 2018, J LEUKOCYTE BIOL, V103, P693, DOI 10.1002/JLB.3A0817-327RR; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; Qiang XL, 2013, NAT MED, V19, P1489, DOI 10.1038/nm.3368; Rasmussen TS, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11050435; Read CB, 2015, J IMMUNOL, V194, P1417, DOI 10.4049/jimmunol.1402303; Silvestre-Roig C, 2016, BLOOD, V127, P2173, DOI 10.1182/blood-2016-01-688887; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Warnatsch A, 2017, IMMUNITY, V46, P421, DOI 10.1016/j.immuni.2017.02.013; Wong SL, 2018, FASEB J, V32, P6358, DOI 10.1096/fj.201800691R; Woodfin A, 2016, BLOOD, V127, P898, DOI 10.1182/blood-2015-08-664995; Wu J, 2012, CANCER RES, V72, P3977, DOI 10.1158/0008-5472.CAN-12-0938; Yang H, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00302; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942; Zhou YS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116095	50	21	22	3	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9771	9786		10.1096/fj.202000482R	http://dx.doi.org/10.1096/fj.202000482R		JUN 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32506691	Bronze, Green Accepted			2022-12-26	WOS:000539606200001
J	Heynckes, M; De Weerd, P; Valente, G; Formisano, E; De Martino, F				Heynckes, Miriam; De Weerd, Peter; Valente, Giancarlo; Formisano, Elia; De Martino, Federico			Behavioral effects of rhythm, carrier frequency and temporal cueing on the perception of sound sequences	PLOS ONE			English	Article							CORTICAL OSCILLATIONS; NEURONAL OSCILLATIONS; AMPLITUDE-MODULATION; EXPECTATIONS; ENTRAINMENT; MECHANISM; ATTENTION; TIME	Regularity of acoustic rhythms allows predicting a target embedded within a stream thereby improving detection performance and reaction times in spectral detection tasks. In two experiments we examine whether temporal regularity enhances perceptual sensitivity and reduces reaction times using a temporal shift detection task. Participants detected temporal shifts embedded at different positions within a sequence of quintet-sounds. Narrowband quintets were centered around carrier frequencies of 200 Hz, 1100 Hz, or 3100 Hz and presented at presentation rates between 1-8 Hz. We compared rhythmic sequences to control conditions where periodicity was reduced or absent and tested whether perceptual benefits depend on the presentation rate, the spectral content of the sounds, and task difficulty. We found that (1) the slowest rate (1 Hz) led to the largest behavioral effect on sensitivity. (2) This sensitivity improvement is carrier-dependent, such that the largest improvement is observed for low-frequency (200 Hz) carriers compared to 1100 Hz and 3100 Hz carriers. (3) Moreover, we show that the predictive value of a temporal cue and that of a temporal rhythm similarly affect perceptual sensitivity. That is, both the cue and the rhythm induce confident temporal expectancies in contrast to an aperiodic rhythm, and thereby allow to effectively prepare and allocate attentional resources in time. (4) Lastly, periodic stimulation reduces reaction times compared to aperiodic stimulation, both at perceptual threshold as well as above threshold. Similarly, a temporal cue allowed participants to optimally prepare and thereby respond fastest. Overall, our results are consistent with the hypothesis that periodicity leads to optimized predictions and processing of forthcoming input and thus to behavioral benefits. Predictable temporally cued sounds provide a similar perceptual benefit to periodic rhythms, despite an additional uncertainty of target position within periodic sequences. Several neural mechanisms may underlie our findings, including the entrainment of oscillatory activity of neural populations.	[Heynckes, Miriam; De Weerd, Peter; Valente, Giancarlo; Formisano, Elia; De Martino, Federico] Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands; [Formisano, Elia] Maastricht Univ, Maastricht Ctr Syst Biol, Maastricht, Netherlands	Maastricht University; Maastricht University	Heynckes, M (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands.	miriam.heynckes@maastrichtuniversity.nl	De Martino, Federico/ABF-9850-2021; De Martino, Federico/I-1817-2012	De Martino, Federico/0000-0002-0352-0648; De Martino, Federico/0000-0002-0352-0648; Heynckes, Miriam/0000-0001-5532-8044; Formisano, Elia/0000-0001-5008-2460	Netherlands Organization for Scientific Research (NWO) Research Talent Grant [406.17.200]	Netherlands Organization for Scientific Research (NWO) Research Talent Grant(Netherlands Organization for Scientific Research (NWO))	This work was funded by The Netherlands Organization for Scientific Research (NWO) Research Talent Grant 406.17.200 awarded to MH, EF and PdW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Jacek Chudy and Louisa Zielke for help with data collection. We thank Sanne ten Oever for feedback on the manuscript and the reviewers for their valuable comments that helped improve this work. This work was funded by The Netherlands Organization for Scientific Research (NWO) Research Talent Grant 406.17.200 awarded to MH, EF and PdW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrikanova Tatiana, 2013, PLoS One, V8, pe54166, DOI 10.1371/journal.pone.0054166; Andreou LV, 2011, HEARING RES, V280, P228, DOI 10.1016/j.heares.2011.06.001; Arnal LH, 2012, TRENDS COGN SCI, V16, P390, DOI 10.1016/j.tics.2012.05.003; Badanoiu AI, 2015, INT J MINER PROCESS, V135, P1, DOI 10.1016/j.minpro.2014.12.002; Barnes R, 2000, COGNITIVE PSYCHOL, V41, P254, DOI 10.1006/cogp.2000.0738; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Breska A, 2018, P NATL ACAD SCI USA, V115, P12283, DOI 10.1073/pnas.1810596115; Breska A, 2014, J COGNITIVE NEUROSCI, V26, P1555, DOI 10.1162/jocn_a_00564; Chang A, 2019, NEUROIMAGE, V198, P31, DOI 10.1016/j.neuroimage.2019.05.007; Correa A, 2006, EXP BRAIN RES, V169, P58, DOI 10.1007/s00221-005-0131-x; Dau T, 1997, J ACOUST SOC AM, V102, P2892, DOI 10.1121/1.420344; Ding N, 2017, NEUROSCI BIOBEHAV R, V81, P181, DOI 10.1016/j.neubiorev.2017.02.011; Ding N, 2013, J NEUROSCI, V33, P5728, DOI 10.1523/JNEUROSCI.5297-12.2013; DRAKE C, 1993, PERCEPT PSYCHOPHYS, V54, P277, DOI 10.3758/BF03205262; Ellis RJ, 2010, ATTEN PERCEPT PSYCHO, V72, P2274, DOI 10.3758/APP.72.8.2274; European Food Safety Authority, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.5077; Friedman M.P., 1974, HDB PERCEPTION, V2, P299; Giraud AL, 2012, NAT NEUROSCI, V15, P511, DOI 10.1038/nn.3063; Henry M.J., 2014, TIMING TIME PERCEPT, V2, P62, DOI [10.1163/22134468-00002011, DOI 10.1163/22134468-00002011]; Henry MJ, 2012, P NATL ACAD SCI USA, V109, P20095, DOI 10.1073/pnas.1213390109; Herbst SK, 2019, NEUROIMAGE, V203, DOI 10.1016/j.neuroimage.2019.116198; Herbst SK, 2017, NEUROPSYCHOLOGIA, V101, P141, DOI 10.1016/j.neuropsychologia.2017.05.019; Hickok G, 2015, PSYCHOL SCI, V26, P1006, DOI 10.1177/0956797615576533; Jones MR, 2002, PSYCHOL SCI, V13, P313, DOI 10.1111/1467-9280.00458; Knoblauch K, 2012, MODELING PSYCHOPHYSI, DOI DOI 10.1007/978-0-387-78171-6; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lakatos P, 2013, NEURON, V77, P750, DOI 10.1016/j.neuron.2012.11.034; Lange K, 2009, BRAIN COGNITION, V69, P127, DOI 10.1016/j.bandc.2008.06.004; Los SA, 2001, ACTA PSYCHOL, V106, P121, DOI 10.1016/S0001-6918(00)00029-9; McAuley JD, 2006, J EXP PSYCHOL GEN, V135, P348, DOI 10.1037/0096-3445.135.3.348; MOORE BCJ, 1990, J ACOUST SOC AM, V88, P132, DOI 10.1121/1.399960; MOORE BCJ, 1993, J ACOUST SOC AM, V93, P1563, DOI 10.1121/1.406815; Moore BCJ, 2001, J ACOUST SOC AM, V110, P1067, DOI 10.1121/1.1385177; Moore BCJ, 2003, BOST ACAD PRESS, V3, P413; Morillon B, 2019, NEUROSCI BIOBEHAV R, V107, P136, DOI 10.1016/j.neubiorev.2019.09.012; Morillon B, 2016, J NEUROSCI, V36, P2342, DOI 10.1523/JNEUROSCI.0836-15.2016; Morillon B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6255; Ng BSW, 2012, J NEUROSCI, V32, P12268, DOI 10.1523/JNEUROSCI.1877-12.2012; NIEMI P, 1981, PSYCHOL BULL, V89, P133, DOI 10.1037/0033-2909.89.1.133; Nobre AC, 2018, NAT REV NEUROSCI, V19, P34, DOI 10.1038/nrn.2017.141; Nourski KV, 2013, J NEUROPHYSIOL, V109, P1283, DOI 10.1152/jn.00718.2012; O'Connell MN, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00655; O'Connell MN, 2014, J NEUROSCI, V34, P16496, DOI 10.1523/JNEUROSCI.2055-14.2014; O'Connor KN, 2011, HEARING RES, V277, P37, DOI 10.1016/j.heares.2011.03.014; Pek J, 2018, PSYCHOL METHODS, V23, P208, DOI 10.1037/met0000126; Poeppel D, 2020, NAT REV NEUROSCI, V21, P322, DOI 10.1038/s41583-020-0304-4; Ren Y, 2019, PERCEPTION; Rimmele J, 2011, J COGNITIVE NEUROSCI, V23, P1136, DOI 10.1162/jocn.2010.21437; Rimmele JM, 2018, TRENDS COGN SCI, V22, P870, DOI 10.1016/j.tics.2018.08.003; Rohenkohl G, 2012, J NEUROSCI, V32, P8424, DOI 10.1523/JNEUROSCI.0804-12.2012; Sanabria D, 2011, J EXP PSYCHOL HUMAN, V37, P236, DOI 10.1037/a0019956; Schmidt-Kassow M, 2009, NEUROREPORT, V20, P31, DOI 10.1097/WNR.0b013e32831b4287; Schroeder CE, 2010, CURR OPIN NEUROBIOL, V20, P172, DOI 10.1016/j.conb.2010.02.010; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; ten Oever S, 2015, J NEUROSCI; ten Oever S, 2017, J NEUROSCI, V37, P4903, DOI 10.1523/JNEUROSCI.3658-16.2017; ten Oever S, 2014, NEUROPSYCHOLOGIA, V63, P43, DOI 10.1016/j.neuropsychologia.2014.08.008; Teng X, 2019, THETA GAMMA BANDS EN, DOI DOI 10.1101/547125V1; VIEMEISTER NF, 1979, J ACOUST SOC AM, V66, P1364, DOI 10.1121/1.383531; Wilsch A, 2015, PSYCHOPHYSIOLOGY, V52, P910, DOI 10.1111/psyp.12413; Wollman I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31878-5	61	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0234251	10.1371/journal.pone.0234251	http://dx.doi.org/10.1371/journal.pone.0234251			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MA6QB	32502187	Green Published, gold			2022-12-26	WOS:000542035700044
J	Radwan, A; Mahrous, GM				Radwan, Awwad; Mahrous, Gamal M.			Docking studies and molecular dynamics simulations of the binding characteristics of waldiomycin and its methyl ester analog toStaphylococcus aureushistidine kinase	PLOS ONE			English	Article							2-COMPONENT SIGNAL-TRANSDUCTION; REGULATORY SYSTEMS; INSIGHTS	Bacterial histidine kinases (HKs) are considered attractive drug targets because of their ability to govern adaptive responses coupled with their ubiquity. There are several classes of HK inhibitors; however, they suffer from drug resistance, poor bioavailability, and a lack of selectivity. The 3D structure ofStaphylococcus aureusHK was not isolated in high-resolution coordinates, precluding further disclosure of structure-dependent binding to the specific antibiotics. To elucidate structure-dependent binding, the 3D structure of the catalytic domain WalK ofS.aureusHK was constructed using homology modeling to investigate the WalK-ligand binding mechanisms through molecular docking studies and molecular dynamics simulations. The binding free energies of the waldiomycin and its methyl ester analog were calculated using molecular mechanics/generalized born surface area scoring. The key residues for protein-ligand binding were postulated. The structural divergence responsible for the 7.4-fold higher potency of waldiomycin than that of its ester analog was clearly observed. The optimized 3D macromolecule-ligand binding modes shed light on theS.aureusHK/WalK-ligand interactions that afford a means to assess binding affinity to design new HK/WalK inhibitors.	[Radwan, Awwad; Mahrous, Gamal M.] King Saud Univ, Coll Pharm, Kayyali Chair, Riyadh, Saudi Arabia; [Radwan, Awwad] Assiut Univ, Dept Organ Pharmaceut Chem, Fac Pharm, Assiut, Egypt	King Saud University; Egyptian Knowledge Bank (EKB); Assiut University	Radwan, A (corresponding author), King Saud Univ, Coll Pharm, Kayyali Chair, Riyadh, Saudi Arabia.; Radwan, A (corresponding author), Assiut Univ, Dept Organ Pharmaceut Chem, Fac Pharm, Assiut, Egypt.	dhna_2001@hotmail.com	Mahrous, Gamal/GZB-1966-2022; Radwan, Awwad/AFH-0279-2022	Radwan, Awwad/0000-0003-0269-7123	Deanship of the Scientific Research at King Saud University [RG-1435-080]	Deanship of the Scientific Research at King Saud University	A A Radwan. RG-1435-080. Deanship of the Scientific Research at King Saud University. dsrs.ksu.edu.sa/en The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WJ, 2015, J COMPUT CHEM, V36, P1132, DOI 10.1002/jcc.23905; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barrett JF, 1998, P NATL ACAD SCI USA, V95, P5317, DOI 10.1073/pnas.95.9.5317; Bem AE, 2015, ACS CHEM BIOL, V10, P213, DOI 10.1021/cb5007135; Bronner S, 2004, FEMS MICROBIOL REV, V28, P183, DOI 10.1016/j.femsre.2003.09.003; Cai YF, 2017, ACTA CRYSTALLOGR D, V73, P793, DOI 10.1107/S2059798317013043; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Cheng TJ, 2012, AAPS J, V14, P133, DOI 10.1208/s12248-012-9322-0; Darden T.A., 2018, AMBER 2018; Fabret C, 1998, J BACTERIOL, V180, P6375; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Gotoh Y, 2010, CURR OPIN MICROBIOL, V13, P232, DOI 10.1016/j.mib.2010.01.008; Hancock L, 2002, J BACTERIOL, V184, P5819, DOI 10.1128/JB.184.21.5819-5825.2002; Heitz F, 2002, BBA-PROTEIN STRUCT M, V1597, P1, DOI 10.1016/S0167-4838(02)00273-X; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Hynes NE, 2006, J MAMMARY GLAND BIOL, V11, P53, DOI 10.1007/s10911-006-9012-6; Hynes NE, 2000, BREAST CANCER RES, V2, P154, DOI 10.1186/bcr48; Igarashi M, 2013, J ANTIBIOT, V66, P459, DOI 10.1038/ja.2013.33; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee VS, 2010, MOL IMMUNOL, V47, P982, DOI 10.1016/j.molimm.2009.11.021; Li WH, 2011, PROTEINS, V79, P271, DOI 10.1002/prot.22880; Macielag MJ, 1998, J MED CHEM, V41, P2939, DOI 10.1021/jm9803572; Martin PK, 1999, J BACTERIOL, V181, P3666, DOI 10.1128/JB.181.12.3666-3673.1999; Nigri F, 2016, SURG NEUROL INT S31, V7, pS785; Nikolaev DM, 2018, ACS OMEGA, V3, P7555, DOI 10.1021/acsomega.8b00721; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Shen J, 2009, J PHYS CHEM B, V113, P10436, DOI 10.1021/jp903785h; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sui ZH, 1998, BIOORG MED CHEM LETT, V8, P1929, DOI 10.1016/S0960-894X(98)00325-4; Szurmant H, 2007, CURR OPIN STRUC BIOL, V17, P706, DOI 10.1016/j.sbi.2007.08.019; Turner M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217992; Vadloori Bharadwaja, 2018, BMC Res Notes, V11, P246, DOI 10.1186/s13104-018-3354-1; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Weiser J, 1999, J COMPUT CHEM, V20, P217, DOI 10.1002/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A; Wilke KE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006670; 2014, REG ANESTH PAIN MED, V9	41	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0234215	10.1371/journal.pone.0234215	http://dx.doi.org/10.1371/journal.pone.0234215			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502195	Green Published, gold			2022-12-26	WOS:000542035700036
J	Stephens, JH; Alizadeh, F; Bamwine, JB; Baganizi, M; Chaw, GF; Cohen, MY; Patel, A; Schaefle, KJ; Mangat, JS; Mukiza, J; Paccione, GA				Stephens, Joseph H.; Alizadeh, Faraz; Bamwine, John Bosco; Baganizi, Michael; Chaw, Gloria Fung; Cohen, Morgen Yao; Patel, Amit; Schaefle, K. J.; Mangat, Jasdeep Singh; Mukiza, Joel; Paccione, Gerald A.			Managing hypertension in rural Uganda: Realities and strategies 10 years of experience at a district hospital chronic disease clinic	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; CARDIOVASCULAR-DISEASES; MANAGEMENT; BURDEN; COST	The literature on the global burden of noncommunicable diseases (NCDs) contrasts a spiraling epidemic centered in low-income countries with low levels of awareness, risk factor control, infrastructure, personnel and funding. There are few data-based reports of broad and interconnected strategies to address these challenges where they hit hardest. Kisoro district in Southwest Uganda is rural, remote, over-populated and poor, the majority of its population working as subsistence farmers. This paper describes the 10-year experience of a tri-partite collaboration between Kisoro District Hospital, a New York teaching hospital, and a US-based NGO delivering hypertension services to the district. Using data from patient and pharmacy registers and a random sample of charts reviewed manually, we describe both common and often-overlooked barriers to quality care (clinic overcrowding, drug stockouts, provider shortages, visit non-adherence, and uninformative medical records) and strategies adopted to address these barriers (locally-adapted treatment guidelines, patient-clinic-pharmacy cost sharing, appointment systems, workforce development, patient-provider continuity initiatives, and ongoing data monitoring). We find that: 1) although following CVD risk-based treatment guidelines could safely allocate scarce medications to the highest-risk patients first, national guidelines emphasizing treatment at blood pressures over 140/90 mmHg ignore the reality of "stockouts" and conflict with this goal; 2) often-overlooked barriers to quality care such as poor quality medical records, clinic disorganization and local employment practices are surmountable; 3) cost-sharing initiatives partially fill the gap during stockouts of government supplied medications, but still may be insufficient for the poorest patients; 4) frequent prolonged lapses in care may be the norm for most known hypertensives in rural SSA, and 5) ongoing data monitoring can identify local barriers to quality care and provide the impetus to ameliorate them. We anticipate that our 10-year experience adapting to the complex challenges of hypertension management and a granular description of the solutions we devised will be of benefit to others managing chronic disease in similar rural African communities.	[Stephens, Joseph H.; Alizadeh, Faraz; Bamwine, John Bosco; Baganizi, Michael; Chaw, Gloria Fung; Cohen, Morgen Yao; Patel, Amit; Schaefle, K. J.; Mangat, Jasdeep Singh; Mukiza, Joel; Paccione, Gerald A.] Kisoro Dist Hosp, Kisoro, Uganda; [Stephens, Joseph H.; Alizadeh, Faraz; Bamwine, John Bosco; Chaw, Gloria Fung; Cohen, Morgen Yao; Patel, Amit; Schaefle, K. J.; Mangat, Jasdeep Singh; Mukiza, Joel; Paccione, Gerald A.] Doctors Global Hlth, Kisoro, Uganda; [Stephens, Joseph H.; Chaw, Gloria Fung; Cohen, Morgen Yao; Patel, Amit; Schaefle, K. J.; Paccione, Gerald A.] Albert Einstein Coll Med, Montefiore Med Ctr, New York, NY 10461 USA; [Alizadeh, Faraz] Harvard Med Sch, Boston Childrens Hosp, Boston, MA 02115 USA; [Alizadeh, Faraz] Boston Univ, Boston Med Ctr, Boston, MA 02215 USA	Montefiore Medical Center; Yeshiva University; Harvard University; Boston Children's Hospital; Harvard Medical School; Boston Medical Center; Boston University	Stephens, JH (corresponding author), Kisoro Dist Hosp, Kisoro, Uganda.; Stephens, JH (corresponding author), Doctors Global Hlth, Kisoro, Uganda.; Stephens, JH (corresponding author), Albert Einstein Coll Med, Montefiore Med Ctr, New York, NY 10461 USA.	jossteph@montefiore.org		Alizadeh, Faraz/0000-0001-9452-4566; Stephens, Joseph/0000-0001-5543-7056				Alizadeh F, 2019, GLOB HEALTH-SCI PRAC, V7, P103, DOI 10.9745/GHSP-D-18-00394; [Anonymous], 2016, OUT POCK EXP CURR HL; Gaziano TA, 2008, HEART, V94, P140, DOI 10.1136/hrt.2007.128785; Gaziano TA, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P645; Guwatudde D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138991; Health UMo, 2014, UG NONC DIS RISK FAC; Health UMo, 2012, NAT GUID MAN COMM CO; Health UMo, 2018, ANN HLTH SECT PERF R; Ilesanmi OS, 2012, PAN AFR MED J, V12; Iwelunmor J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130193; Katende D, 2015, TROP MED INT HEALTH, V20, P1385, DOI 10.1111/tmi.12560; Lancet Global Health, 2019, LANCET GLOB HEALTH, V7, pe1, DOI DOI 10.1016/S2214-109X(19)30318-3; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Musinguzi G, 2018, INT J HYPERTENS, V2018, DOI 10.1155/2018/8307591; Musinguzi G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142312; Ngalesoni F, 2015, HEALTH POLICY PLANN, V30, P875, DOI 10.1093/heapol/czu088; Nulu S, 2016, CARDIOL REV, V24, P30, DOI 10.1097/CRD.0000000000000083; O'Neil DS, 2016, HLTH POLICY PLANNING; Poulter NR, 2015, LANCET, V386, P801, DOI 10.1016/S0140-6736(14)61468-9; Rajbhandari R, 2020, NEW ENGL J MED, V382, P397, DOI 10.1056/NEJMp1911298; Rogers HE, 2014, ASSESSMENT CAPACITY; Schwartz JI, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/s12992-014-0077-5; Statistics UBo, 2014, KIS DISTR PROF; Statistics UBo, 2014, NAT POP HOUS CENS PR; Thanassoulis G, 2018, JAMA CARDIOL, V3, P1090, DOI 10.1001/jamacardio.2018.3476; Twagirumukiza M, 2011, J HYPERTENS, V29, P1243, DOI 10.1097/HJH.0b013e328346995d; WHO, 2014, WORLD HLTH STAT; WHO, 2007, INT ASCVD RISK GUID	28	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0234049	10.1371/journal.pone.0234049	http://dx.doi.org/10.1371/journal.pone.0234049			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502169	Green Published, gold			2022-12-26	WOS:000542035700016
J	Jaganath, D; Rajan, J; Yoon, C; Ravindran, R; Andama, A; Asege, L; Mwebe, SZ; Katende, J; Nakaye, M; Semitala, FC; Khan, IH; Cattamanchi, A				Jaganath, Devan; Rajan, Jayant; Yoon, Christina; Ravindran, Resmi; Andama, Alfred; Asege, Lucy; Mwebe, Sandra Z.; Katende, Jane; Nakaye, Martha; Semitala, Fred C.; Khan, Imran H.; Cattamanchi, Adithya			Evaluation of multi-antigen serological screening for active tuberculosis among people living with HIV	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; SIMULTANEOUS SERODETECTION; SERODIAGNOSIS; ANTIBODIES; PERFORMANCE; VALIDATION; BIOMARKERS; DIAGNOSIS; PROFILES	Better triage tests for screening tuberculosis (TB) disease are needed for people living with HIV (PLHIV). We performed the first evaluation of a previously-validated 8-antigen serological panel to screen PLHIV for pulmonary TB in Kampala, Uganda. We selected a random 1:1 sample with and without TB (defined by sputum culture) from a cohort of PLHIV initiating antiretroviral therapy. We used a multiplex microbead immunoassay and an ensemble machine learning classifier to determine the area under the receiver operating characteristic curve (AUC) for Ag85A, Ag85B, Ag85C, Rv0934-P38, Rv3881, Rv3841-BfrB, Rv3873, and Rv2878c. We then assessed the performance with the addition of four TB-specific antigens ESAT-6, CFP-10, Rv1980-MPT64, and Rv2031-HSPX, and every antigen combination. Of 262 participants (median CD4 cell-count 152 cells/mu L [IQR 65-279]), 138 (53%) had culture-confirmed TB. The 8-antigen panel had an AUC of 0.53 (95% CI 0.40-0.66), and the additional 4 antigens did not improve performance (AUC 0.51, 95% CI 0.39-0.64). When sensitivity was restricted to >= 90% for the 8- and 12-antigen panel, specificity was 2.2% (95% CI 0-17.7%) and 8.1% (95% CI 0-23.9%), respectively. A three-antigen combination (Rv0934-P38, Ag85A, and Rv2031-HSPX) outperformed both panels, with an AUC of 0.60 (95% CI 0.48-0.73), 90% sensitivity (95% CI 78.2-96.7%) and 29.7% specificity (95% CI 15.9-47%). The multi-antigen panels did not achieve the target accuracy for a TB triage test among PLHIV. We identified a new combination that improved performance for TB screening in an HIV-positive sample compared to an existing serological panel in Uganda, and suggests an approach to identify novel antigen combinations specifically for screening TB in PLHIV.	[Jaganath, Devan] Univ Calif San Francisco, Dept Pediat, Div Pediat Infect Dis, San Francisco, CA 94143 USA; [Jaganath, Devan; Yoon, Christina; Cattamanchi, Adithya] Univ Calif San Francisco, Dept Med, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Jaganath, Devan; Yoon, Christina; Cattamanchi, Adithya] Univ Calif San Francisco, Dept Med, Ctr TB, San Francisco, CA 94143 USA; [Rajan, Jayant] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA 94143 USA; [Ravindran, Resmi; Khan, Imran H.] Univ Calif San Francisco, Dept Pathol & Lab Med, Davis, CA USA; [Andama, Alfred; Asege, Lucy; Mwebe, Sandra Z.; Katende, Jane; Nakaye, Martha; Semitala, Fred C.] Infect Dis Res Collaborat, Kampala, Uganda; [Andama, Alfred; Semitala, Fred C.] Makerere Univ, Dept Med, Coll Hlth Sci, Kampala, Uganda; [Semitala, Fred C.] Makerere Univ Joint Aids Program MJAP, Kampala, Uganda; [Cattamanchi, Adithya] Univ Calif San Francisco, Dept Med, Ctr Vulnerable Populat, San Francisco, CA 94143 USA; [Cattamanchi, Adithya] Univ Calif San Francisco, Curry Int TB Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Makerere University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Jaganath, D (corresponding author), Univ Calif San Francisco, Dept Pediat, Div Pediat Infect Dis, San Francisco, CA 94143 USA.; Jaganath, D (corresponding author), Univ Calif San Francisco, Dept Med, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA.; Jaganath, D (corresponding author), Univ Calif San Francisco, Dept Med, Ctr TB, San Francisco, CA 94143 USA.	Devan.jaganath@ucsf.edu	Khan, imran/GQQ-2176-2022; Khan, Imran Ali/GVT-0232-2022	Khan, Imran Ali/0000-0002-8774-2896	National Institute of Health [NIH/NIAID K23 AI114363, NICHD K12 HD000850]; NIH [P30 AI027763]; University of California, San Francisco-Gladstone Institute of Virology and Immunology (UCSF-GIVI) Center for AIDS Research (CFAR) [P30 AI027763]; NIH/NIAID-President's Emergency Plan for AIDS Relief (PEPFAR) CFAR Administrative Supplement [P30 A120163]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Francisco-Gladstone Institute of Virology and Immunology (UCSF-GIVI) Center for AIDS Research (CFAR); NIH/NIAID-President's Emergency Plan for AIDS Relief (PEPFAR) CFAR Administrative Supplement	This work was supported by the National Institute of Health (NIH/NIAID K23 AI114363 to CY and NICHD K12 HD000850 to DJ), NIH and University of California, San Francisco-Gladstone Institute of Virology and Immunology (UCSF-GIVI) Center for AIDS Research (CFAR; P30 AI027763 to CY), and NIH/NIAID-President's Emergency Plan for AIDS Relief (PEPFAR) CFAR Administrative Supplement (P30 A120163 to AC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190989; Ahmad R, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw8287; [Anonymous], 2019, GLOB TUB REP 2018; [Anonymous], 2017, EUR UROL SUPPL, V16, pe1; [Anonymous], 2011, GUID INT TUB CAS FIN; Araujo Z, 2013, MEM I OSWALDO CRUZ, V108, P131, DOI 10.1590/0074-0276108022013001; Babaki MKZ, 2017, MICROB PATHOGENESIS, V112, P20, DOI 10.1016/j.micpath.2017.08.040; Bajema KL, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-018-3614-7; BARRERA L, 1992, TUBERCLE LUNG DIS, V73, P187, DOI 10.1016/0962-8479(92)90084-W; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; Collins GS, 2015, CIRCULATION, V131, P211, DOI [10.1016/j.jclinepi.2014.11.010, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.7326/M14-0697, 10.1016/j.eururo.2014.11.025, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594, 10.1038/bjc.2014.639, 10.7326/M14-0698]; De Milito A, 2004, BLOOD, V103, P2180, DOI 10.1182/blood-2003-07-2375; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Gutlapalli R, 2016, J CLIN DIAGN RES, V10, pKC1, DOI 10.7860/JCDR/2016/16559.7322; Hamada Y, 2018, LANCET HIV, V5, pE515, DOI 10.1016/S2352-3018(18)30137-1; Ivanyi J, 2012, TUBERCULOSIS, V92, P31, DOI 10.1016/j.tube.2011.09.001; Kaforou M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001538; Khaliq A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173359; Khan IH, 2005, CLIN DIAGN LAB IMMUN, V12, P513, DOI 10.1128/CDLI.12.4.513-519.2005; Khan IH, 2006, CLIN VACCINE IMMUNOL, V13, P45, DOI 10.1128/CVI.13.1.45-52.2006; Khan IH, 2008, CLIN VACCINE IMMUNOL, V15, P433, DOI 10.1128/CVI.00354-07; Khan IH, 2011, CLIN VACCINE IMMUNOL, V18, P2148, DOI 10.1128/CVI.05304-11; Kunnath-Velayudhan S, 2010, P NATL ACAD SCI USA, V107, P14703, DOI 10.1073/pnas.1009080107; MacLean E, 2019, NAT MICROBIOL, V4, P748, DOI 10.1038/s41564-019-0380-2; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Mushtaq K, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00351; Nathavitharana RR, 2019, J INFECT DIS, V220, pS116, DOI 10.1093/infdis/jiz243; Oni T, 2011, THORAX, V66, P669, DOI 10.1136/thx.2011.160168; Polley Eric, 2019, SUPER LEARNER PREDIC; Pukazhvanthen P, 2014, TUBERCULOSIS, V94, P622, DOI 10.1016/j.tube.2014.09.006; Rajan JV, 2018, CLIN INFECT DIS; Rao PVR, 2009, INT J INFECT DIS, V13, P613, DOI 10.1016/j.ijid.2008.09.022; Ravindran R, 2010, J IMMUNOL METHODS, V363, P51, DOI 10.1016/j.jim.2010.10.003; Rekha RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016425; SALTINI C, 1993, J INFECT DIS, V168, P1409, DOI 10.1093/infdis/168.6.1409; Sartain MJ, 2006, MOL CELL PROTEOMICS, V5, P2102, DOI 10.1074/mcp.M600089-MCP200; Shete PB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180122; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Steingart KR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001062; Steingart KR, 2009, CLIN VACCINE IMMUNOL, V16, P260, DOI 10.1128/CVI.00355-08; Sutherland JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074080; Wilkinson RJ, 1997, J CLIN MICROBIOL, V35, P553, DOI 10.1128/JCM.35.3.553-557.1997; World Health Organization, 2019, COMM SER TESTS DIAGN; World Health Organization, 2019, CONS M 2019 9 MAY; Yoon C, 2017, LANCET INFECT DIS, V17, P1285, DOI 10.1016/S1473-3099(17)30488-7; Yu X, 2012, CLIN VACCINE IMMUNOL, V19, P198, DOI 10.1128/CVI.05550-11	46	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0234130	10.1371/journal.pone.0234130	http://dx.doi.org/10.1371/journal.pone.0234130			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497095	gold, Green Published			2022-12-26	WOS:000542035200039
J	Liao, YQ; Gose, JW; Arruda, EM; Liu, AP; Merajver, SD; Young, YL				Liao, Yingqian; Gose, James W.; Arruda, Ellen M.; Liu, Allen P.; Merajver, Sofia D.; Young, Yin Lu			Shock wave impact on the viability of MDA-MB-231 cells	PLOS ONE			English	Article							MOLECULAR DELIVERY; FIELDS	Shock waves are gaining interests in biological and medical applications. In this work, we investigated the mechanical characteristics of shock waves that affect cell viability. In vitro testing was conducted using the metastatic breast epithelial cell line MDA-MB-231. Shock waves were generated using a high-power pulse laser. Two different coating materials and different laser energy levels were used to vary the peak pressure, decay time, and the strength of subsequent peaks of the shock waves. Within the testing capability of the current study, it is shown that shock waves with a higher impulse led to lower cell viability, a higher detached cell ratio, and a higher cell death ratio, while shock waves with the same peak pressure could lead to different levels of cell damage. The results also showed that the detached cells had a higher cell death ratio compared to the attached cells. Moreover, a critical shock impulse of 5 Pa center dot s was found to cause the cell death ratio of the detached cells to exceed 50%. This work has demonstrated that, within the testing range shown here, the impulse, rather than the peak pressure, is the governing shock wave parameter for the damage of MDA-MB-231 breast cancer cells. The result suggests that a lower-pressure shock wave with a longer duration, or multiple sequential low amplitude shock waves can be applied over a duration shorter than the fundamental response period of the cells to achieve the same impact as shock waves with a high peak pressure but a short duration. The finding that cell viability is better correlated with shock impulse rather than peak pressure has potential significant implications on how shock waves should be tailored for cancer treatments, enhanced drug delivery, and diagnostic techniques to maximize efficacy while minimizing potential side effects.	[Liao, Yingqian; Gose, James W.; Young, Yin Lu] Univ Michigan, Dept Naval Architecture & Marine Engn, Ann Arbor, MI 48109 USA; [Arruda, Ellen M.; Liu, Allen P.; Young, Yin Lu] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Arruda, Ellen M.; Liu, Allen P.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Arruda, Ellen M.] Univ Michigan, Program Macromol Sci & Engn, Ann Arbor, MI 48109 USA; [Liu, Allen P.] Univ Michigan, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA; [Liu, Allen P.] Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA; [Merajver, Sofia D.] Univ Michigan, Dept Internal Med, Div Hematol & Oncol, Ann Arbor, MI 48109 USA; [Young, Yin Lu] Univ Michigan, Dept Aerosp Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Young, YL (corresponding author), Univ Michigan, Dept Naval Architecture & Marine Engn, Ann Arbor, MI 48109 USA.; Young, YL (corresponding author), Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.; Young, YL (corresponding author), Univ Michigan, Dept Aerosp Engn, Ann Arbor, MI 48109 USA.	ylyoung@umich.edu		Liu, Allen/0000-0002-0309-7018; Liao, Yingqian/0000-0001-6904-8844; Young, Yin Lu/0000-0001-6388-9140	MCubed project, University of Michigan [826]; Mcubed Seed Funding Program by the University of Michigan	MCubed project, University of Michigan; Mcubed Seed Funding Program by the University of Michigan	This work was supported by MCubed project (Project ID: 826), University of Michigan. The grant was received by Prof. Yin Lu Young, Prof. Ellen Arruda, and Prof. Sofia Merajver. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Shue Wang, Luciana Rosselli-Murai, Kenneth Ho, Jonathan Estrada, and Andrea Poli for their help with cellular analysis, data analysis, and experiment design. The authors also thank Mathew Boban for his help on the well plate treatment and Professor Anish Tuteja for providing the lab facilities used for the well plate treatment. The authors would also like to acknowledge funding from Mcubed Seed Funding Program provided by the University of Michigan.	Boustie M, 2008, P 1 INT S LAS ULTR, P1; CARSTENSEN EL, 1990, ULTRASOUND MED BIOL, V16, P687, DOI 10.1016/0301-5629(90)90102-I; Chen HJ, 2014, DRUG DISCOV TODAY, V19, P502, DOI 10.1016/j.drudis.2014.01.010; Chen PY, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0451-y; COLEMAN AJ, 1993, ULTRASONICS, V31, P75, DOI 10.1016/0041-624X(93)90037-Z; Delius M, 1999, CANC RES; DOUKAS AG, 1993, ULTRASOUND MED BIOL, V19, P137, DOI 10.1016/0301-5629(93)90006-A; DOUKAS AG, 1995, ULTRASOUND MED BIOL, V21, P961, DOI 10.1016/0301-5629(95)00027-O; Etame AB, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2011.10.FOCUS11252; Fabbro R, 1998, J LASER APPL, V10, P265, DOI 10.2351/1.521861; GAMARRA F, 1993, INT J CANCER, V55, P153, DOI 10.1002/ijc.2910550127; Gamarra F, 1993, CANC RES; HARTMAN C, 1990, ULTRASOUND MED BIOL, V16, P581, DOI 10.1016/0301-5629(90)90023-6; Jagadeesh G, 2011, CLIN VACCINE IMMUNOL, V18, P539, DOI 10.1128/CVI.00494-10; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; Kodama T, 2000, BIOPHYS J, V79, P1821, DOI 10.1016/S0006-3495(00)76432-0; Kodama T, 2002, BBA-MOL CELL RES, V1542, P186, DOI 10.1016/S0167-4889(01)00177-X; Lee LM, 2015, LAB CHIP, V15, P264, DOI 10.1039/c4lc01218f; Li QY, 2013, J APPL MECH-T ASME, V80, DOI 10.1115/1.4007586; Limame R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046536; Liu ZK, 2008, J APPL MECH-T ASME, V75, DOI 10.1115/1.2871129; Maloney E, 2015, INT J HYPERTHER, V31, P302, DOI 10.3109/02656736.2014.969789; Meyers MA., 1982, J APPL MECH, V49, P683, DOI [10.1115/1.3162565, DOI 10.1115/1.3162565]; Ogden JA, 2001, CLIN ORTHOP RELAT R, P8; Ohl CD, 2003, BBA-GEN SUBJECTS, V1624, P131, DOI 10.1016/j.bbagen.2003.10.005; Park K, 2008, LAB CHIP, V8, P1034, DOI 10.1039/b803601b; Rahimzadeh T, 2015, J MECH PHYS SOLIDS, V85, P98, DOI 10.1016/j.jmps.2015.09.009; Schmidt M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03849; Steinhauser M., 2016, OPEN J, V1, P60; Steinhauser MO, 2014, SOFT MATTER, V10, P4778, DOI 10.1039/c4sm00407h; Swift DC, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.2052593; VEESER LR, 1978, PHYS REV LETT, V40, P1391, DOI 10.1103/PhysRevLett.40.1391; Wang CJ, 2012, J ORTHOP SURG RES, V7, DOI 10.1186/1749-799X-7-11; WEISS N, 1990, ULTRASOUND MED BIOL, V16, P595, DOI 10.1016/0301-5629(90)90025-8	34	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0234138	10.1371/journal.pone.0234138	http://dx.doi.org/10.1371/journal.pone.0234138			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497154	Green Published, gold			2022-12-26	WOS:000542035200032
J	Pereira, WJ; Pappas, MDR; Grattapaglia, D; Pappas, GJ				Pereira, Wendell Jacinto; Pappas, Marilia de Castro Rodrigues; Grattapaglia, Dario; Pappas, Georgios Joannis, Jr.			A cost-effective approach to DNA methylation detection by Methyl Sensitive DArT sequencing	PLOS ONE			English	Article							CYTOSINE METHYLATION; GENOME; PACKAGE; SITES; OPTIMIZATION; ORGANIZATION; EXPRESSION; PATTERNS; PLANTS; SEQ	Several studies suggest the relation of DNA methylation to diseases in humans and important phenotypes in plants drawing attention to this epigenetic mark as an important source of variability. In the last decades, several methodologies were developed to assess the methylation state of a genome. However, there is still a lack of affordable and precise methods for genome wide analysis in large sample size studies. Methyl sensitive double digestion MS-DArT sequencing method emerges as a promising alternative for methylation profiling. We developed a computational pipeline for the identification of DNA methylation using MS-DArT-seq data and carried out a pilot study using the Eucalyptus grandis tree sequenced for the species reference genome. Using a statistic framework as in differential expression analysis, 72,515 genomic sites were investigated and 5,846 methylated sites identified, several tissue specific, distributed along the species 11 chromosomes. We highlight a bias towards identification of DNA methylation in genic regions and the identification of 2,783 genes and 842 transposons containing methylated sites. Comparison with WGBS, DNA sequencing after treatment with bisulfite, data demonstrated a precision rate higher than 95% for our approach. The availability of a reference genome is useful for determining the genomic context of methylated sites but not imperative, making this approach suitable for any species. Our approach provides a cost effective, broad and reliable examination of DNA methylation profile on MspI/HpaII restriction sites, is fully reproducible and the source code is available on GitHub (https://github.com/wendelljpereira/ms-dart-seq).	[Pereira, Wendell Jacinto; Pappas, Georgios Joannis, Jr.] Univ Brasilia, Dept Cell Biol, Brasilia, DF, Brazil; [Pappas, Marilia de Castro Rodrigues; Grattapaglia, Dario] Embrapa Genet Resources & Biotechnol, Brasilia, DF, Brazil; [Grattapaglia, Dario] Univ Catolica Brasilia, Brasilia, DF, Brazil; [Pereira, Wendell Jacinto] Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA	Universidade de Brasilia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Catolica de Brasilia; State University System of Florida; University of Florida	Pappas, GJ (corresponding author), Univ Brasilia, Dept Cell Biol, Brasilia, DF, Brazil.	gpappas@unb.br	Pappas, Georgios J./N-8071-2019; Grattapaglia, Dario/AAB-6805-2020; Grattapaglia, Dario/B-5864-2014; Pereira, Wendell/C-3330-2016	Pappas, Georgios J./0000-0002-1100-976X; Grattapaglia, Dario/0000-0002-0050-970X; Grattapaglia, Dario/0000-0002-0050-970X; Pereira, Wendell/0000-0003-1019-6281	CNPq (Brazilian National Council for Scientific and Technological Development) [140374/2016-7, 404144/2013-6]	CNPq (Brazilian National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Both the PhD scholarship for WJP, grant number: 140374/2016-7, and research funding, grant number: 404144/2013-6 (coordinated by DG), were provided by CNPq (Brazilian National Council for Scientific and Technological Development; http://www.cnpq.br/).Embrapa Genetic Resources and Biotechnology provided support in the form of salaries for authors MRP and DG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderman MH, 2019, CELL MOL LIFE SCI, V76, P2957, DOI 10.1007/s00018-019-03146-w; Allis CD, 2016, NAT REV GENET, V17, P487, DOI 10.1038/nrg.2016.59; Bahin M, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5624-2; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Barros-Silva D, 2018, GENES-BASEL, V9, DOI 10.3390/genes9090429; Baubec T, 2014, EMBO REP, V15, P446, DOI 10.1002/embr.201337915; Bewick AJ, 2019, G3-GENES GENOM GENET, V9, P2441, DOI 10.1534/g3.119.400365; Bewick AJ, 2017, CURR OPIN PLANT BIOL, V36, P103, DOI 10.1016/j.pbi.2016.12.007; Bitonti MB, 2002, J EXP BOT, V53, P1047, DOI 10.1093/jexbot/53.371.1047; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boskovic A, 2018, ANNU REV GENET, V52, P21, DOI 10.1146/annurev-genet-120417-031404; Brinkman AB, 2010, METHODS, V52, P232, DOI 10.1016/j.ymeth.2010.06.012; Brunner AL, 2009, GENOME RES, V19, P1044, DOI 10.1101/gr.088773.108; Chwialkowska K, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02056; Colaneri A, 2011, P NATL ACAD SCI USA, V108, P9715, DOI 10.1073/pnas.1105713108; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Courtois B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078037; Cruz VMV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064062; Deichmann U, 2016, DEV BIOL, V416, P249, DOI 10.1016/j.ydbio.2016.06.005; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; Doyle J. J., 1987, PHYTOCHEM B, P11; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Ferre Q, 2019, BIOINFORMATICS, DOI [10.1093/bioinformatics/btz810, DOI 10.1093/BIOINF0RMATICS/BTZ810]; Finnegan EJ, 1998, ANNU REV PLANT PHYS, V49, P223, DOI 10.1146/annurev.arplant.49.1.223; Flutre T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016526; Fraga MF, 2002, TREE PHYSIOL, V22, P813, DOI 10.1093/treephys/22.11.813; Fulnecek J, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-2; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Greally JM, 2018, NAT REV MOL CELL BIO, V19, P207, DOI 10.1038/nrm.2017.135; Inacio V, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01194; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kawakatsu T, 2016, NAT PLANTS, V2, DOI [10.1038/nplants.2016.58, 10.1038/NPLANTS.2016.58]; Kilian Andrzej, 2012, Methods Mol Biol, V888, P67, DOI 10.1007/978-1-61779-870-2_5; Kim KD, 2014, BRIEF FUNCT GENOMICS, V13, P318, DOI 10.1093/bfgp/elu003; Klemm SL, 2019, NAT REV GENET, V20, P207, DOI 10.1038/s41576-018-0089-8; Koster J, 2012, BIOINFORMATICS, V28, P2520, DOI 10.1093/bioinformatics/bts480; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kurdyukov Sergey, 2016, Biology-Basel, V5, DOI 10.3390/biology5010003; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Li N, 2010, METHODS, V52, P203, DOI 10.1016/j.ymeth.2010.04.009; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; LINDSAY S, 1987, NATURE, V327, P336, DOI 10.1038/327336a0; Lister R, 2009, GENOME RES, V19, P959, DOI 10.1101/gr.083451.108; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Mayne BT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19655-w; MCCLELLAND M, 1994, NUCLEIC ACIDS RES, V22, P3640, DOI 10.1093/nar/22.17.3640; MESSEGUER R, 1991, PLANT MOL BIOL, V16, P753, DOI 10.1007/BF00015069; Myburg AA, 2014, NATURE, V510, P356, DOI 10.1038/nature13308; Niederhuth CE, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1059-0; Nishibuchi G, 2017, CHROMOSOME RES, V25, P77, DOI 10.1007/s10577-016-9547-3; Oda M, 2009, NUCLEIC ACIDS RES, V37, P3829, DOI 10.1093/nar/gkp260; Osabe K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086049; Paun O, 2019, NEW PHYTOL, V221, P738, DOI 10.1111/nph.15388; Pootakham W, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0572-x; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raman H, 2014, PLANT BIOTECHNOL J, V12, P851, DOI 10.1111/pbi.12186; Rivera CM, 2013, CELL, V155, P39, DOI 10.1016/j.cell.2013.09.011; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ruiz-Garcia L, 2005, PLANTA, V222, P301, DOI 10.1007/s00425-005-1524-6; Schmitz RJ, 2019, TRENDS GENET, V35, P818, DOI 10.1016/j.tig.2019.07.007; Schultz MD, 2015, NATURE, V523, P212, DOI 10.1038/nature14465; Sekhon JS, 2011, J STAT SOFTW, V42, P1; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Umer M, 2013, ANTIOXID REDOX SIGN, V18, P1972, DOI 10.1089/ars.2012.4923; Xing XY, 2018, METHODS MOL BIOL, V1708, P209, DOI 10.1007/978-1-4939-7481-8_12; Xu YM, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01048; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zeng H, 2019, CHEMBIOCHEM, V20, P1898, DOI 10.1002/cbic.201900035	72	11	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0233800	10.1371/journal.pone.0233800	http://dx.doi.org/10.1371/journal.pone.0233800			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497070	Green Published, gold			2022-12-26	WOS:000542035200079
J	Zhu, LF; Nazeri, A; Pacia, CP; Yue, YM; Chen, H				Zhu, Lifei; Nazeri, Arash; Pacia, Christopher Pham; Yue, Yimei; Chen, Hong			Focused ultrasound for safe and effective release of brain tumor biomarkers into the peripheral circulation	PLOS ONE			English	Article							BARRIER DISRUPTION; LIQUID BIOPSIES; DRUG-DELIVERY; MICROBUBBLES; GLIOMA; SIZE	The development of noninvasive approaches for brain tumor diagnosis and monitoring continues to be a major medical challenge. Although blood-based liquid biopsy has received considerable attention in various cancers, limited progress has been made for brain tumors, at least partly due to the hindrance of tumor biomarker release into the peripheral circulation by the blood-brain barrier. Focused ultrasound (FUS) combined with microbubbles induced BBB disruption has been established as a promising technique for noninvasive and localized brain drug delivery. Building on this established technique, we propose to develop FUS-enabled liquid biopsy technique (FUS-LBx) to enhance the release of brain tumor biomarkers (e.g., DNA, RNA, and proteins) into the circulation. The objective of this study was to demonstrate that FUS-LBx could sufficiently increase plasma levels of brain tumor biomarkers without causing hemorrhage in the brain. Mice with orthotopic implantation of enhanced green fluorescent protein (eGFP)-transfected murine glioma cells were treated using magnetic resonance (MR)-guided FUS system in the presence of systemically injected microbubbles at three peak negative pressure levels (0.59, 1.29, and 1.58 MPa). Plasma eGFP mRNA levels were quantified with the quantitative polymerase chain reaction (qPCR). Contrast-enhanced MR images were acquired before and after the FUS sonication. FUS at 0.59 MPa resulted in an increased plasma eGFP mRNA level, comparable to those at higher acoustic pressures (1.29 MPa and 1.58 MPa). Microhemorrhage density associated with FUS at 0.59 MPa was significantly lower than that at higher acoustic pressures and not significantly different from the control group. MRI analysis revealed that post-sonication intratumoral and peritumoral hyperenhancement had strong correlations with the level of FUS-induced biomarker release and the extent of hemorrhage. This study suggests that FUS-LBx could be a safe and effective brain-tumor biomarker release technique, and MRI could be used to develop image-guided FUS-LBx.	[Zhu, Lifei; Pacia, Christopher Pham; Yue, Yimei; Chen, Hong] Washington Univ, Dept Biomed Engn, St Louis, MO 63110 USA; [Nazeri, Arash] Washington Univ, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA; [Chen, Hong] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Chen, H (corresponding author), Washington Univ, Dept Biomed Engn, St Louis, MO 63110 USA.; Chen, H (corresponding author), Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO 63110 USA.	hongchen@wustl.edu	Zhu, Lifei/L-6461-2016	Zhu, Lifei/0000-0003-1417-985X; Nazeri, Arash/0000-0001-6983-0641; Chen, Hong/0000-0003-1904-0857	National Institutes of Health (NIH) [R01MH116981, R01EB27223]; NIH/National Center for Advancing Translational Sciences (NCATS) [UL1TR002345]; Office of the Vice Chancellor for Research Seed Grant of Washington University in Saint Louis	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Office of the Vice Chancellor for Research Seed Grant of Washington University in Saint Louis	This work was in part supported by the National Institutes of Health (NIH) grants R01MH116981 (PI: HC) and R01EB27223 (PI: HC). This publication was also partially supported by the NIH/National Center for Advancing Translational Sciences (NCATS) grant UL1TR002345 (PI: HC) and the Office of the Vice Chancellor for Research Seed Grant of Washington University in Saint Louis (PI: HC). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahao A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12426-9; Aldiabat H., 2018, J ACOUST SOC AM, V143, P1731; Alli S, 2018, J CONTROL RELEASE, V281, P29, DOI 10.1016/j.jconrel.2018.05.005; [Anonymous], 2014, DIABETES CARE SUPPL, V37, pS5; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2017, COMMUN MATH STAT, V5, P1, DOI DOI 10.1007/S40304-017-0103-Z; Arvanitis CD, 2017, IEEE T MED IMAGING, V36, P983, DOI 10.1109/TMI.2016.2643565; Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5; Bardelli A, 2017, CANCER CELL, V31, P172, DOI 10.1016/j.ccell.2017.01.002; Baseri B, 2010, ULTRASOUND MED BIOL, V36, P1445, DOI 10.1016/j.ultrasmedbio.2010.06.005; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Bronkhorst Abel Jacobus, 2019, Biomol Detect Quantif, V17, P100087, DOI 10.1016/j.bdq.2019.100087; Carpentier A, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6086; Chen H, 2014, J CEREBR BLOOD F MET, V34, P1197, DOI 10.1038/jcbfm.2014.71; Chevillet JR, 2017, RADIOLOGY, V283, P158, DOI 10.1148/radiol.2016160024; Choi JJ, 2011, P NATL ACAD SCI USA, V108, P16539, DOI 10.1073/pnas.1105116108; Choi JJ, 2010, IEEE T BIO-MED ENG, V57, P145, DOI 10.1109/TBME.2009.2034533; Couture O, 2014, TRANSL CANCER RES, V3, P494, DOI 10.3978/j.issn.2218-676X.2014.10.01; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Downs ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125911; El Kaffas A, 2015, FUTURE ONCOL, V11, P1093, DOI 10.2217/fon.15.19; Figueroa JM, 2017, NEURO-ONCOLOGY, V19, P1494, DOI 10.1093/neuonc/nox085; Fisher JL, 2007, NEUROL CLIN, V25, P867, DOI 10.1016/j.ncl.2007.07.002; Huang YX, 2017, RADIOLOGY, V282, P123, DOI 10.1148/radiol.2016152154; Idbaih A, 2019, CLIN CANCER RES, V25, P3793, DOI 10.1158/1078-0432.CCR-18-3643; Jones RM, 2018, THERANOSTICS, V8, P2909, DOI 10.7150/thno.24911; Karakatsani ME, 2019, J CONTROL RELEASE, V303, P289, DOI 10.1016/j.jconrel.2019.03.030; Kinoshita M, 2006, P NATL ACAD SCI USA, P103; Konofagou EE, 2012, THERANOSTICS, V2, P1223, DOI 10.7150/thno.5576; Kothapalli SVVN, 2018, J THER ULTRASOUND, V6, DOI 10.1186/s40349-018-0113-7; Kothapalli SVVN, 2017, MED PHYS, V44, P4890, DOI 10.1002/mp.12412; Lee EJ, 2019, J KOREAN NEUROSURG S, V62, P10, DOI 10.3340/jkns.2018.0180; Leinenga G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2512; Lipsman N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04529-6; Liu HL, 2010, RADIOLOGY, V255, P415, DOI 10.1148/radiol.10090699; Mainprize T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36340-0; Malone H, 2015, WORLD NEUROSURG, V84, P1084, DOI 10.1016/j.wneu.2015.05.025; Meng Y, 2018, CAN J NEUROL SCI, V8, P1; Meng Y, 2019, J CONTROL RELEASE, V309, P25, DOI 10.1016/j.jconrel.2019.07.023; Merker JD, 2018, ARCH PATHOL LAB MED, V142, P1242, DOI 10.5858/arpa.2018-0901-SA; Miller AM, 2019, NATURE, V565, P654, DOI 10.1038/s41586-019-0882-3; Morel DR, 2000, INVEST RADIOL, V35, P80, DOI 10.1097/00004424-200001000-00009; Mornstein V, 1997, EUR J ULTRASOUND, V5, P101, DOI [10.1016/S0929-8266(97)00214-0, DOI 10.1016/S0929-8266(97)00214-0]; O'Reilly MA, 2017, THERANOSTICS, V7, P3573, DOI 10.7150/thno.20621; Omuro AMP, 2006, LANCET NEUROL, V5, P937, DOI 10.1016/S1474-4422(06)70597-X; Paproski RJ, 2017, CANCER RES, V77, P3, DOI 10.1158/0008-5472.CAN-15-3231; Park J, 2012, J CONTROL RELEASE, V162, P134, DOI 10.1016/j.jconrel.2012.06.012; Park SH, 2021, J NEUROSURG, V134, P475, DOI 10.3171/2019.10.JNS192206; Ragel BT, 2015, J NEURO-ONCOL, V125, P481, DOI 10.1007/s11060-015-1866-2; Stride Eleanor, 2009, Cerebrovasc Dis, V27 Suppl 2, P1, DOI 10.1159/000203122; Sun T, 2017, P NATL ACAD SCI USA, V114, pE10281, DOI 10.1073/pnas.1713328114; Taylor SC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02217-x; Ting CY, 2012, BIOMATERIALS, V33, P704, DOI 10.1016/j.biomaterials.2011.09.096; van Tellingen O, 2015, DRUG RESIST UPDATE, V19, P1, DOI 10.1016/j.drup.2015.02.002; Wood AKW, 2015, ULTRASOUND MED BIOL, V41, P905, DOI 10.1016/j.ultrasmedbio.2014.11.019; Wu SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep37094; Xi Xiaochen, 2017, Non-Coding RNA, V3, P9, DOI 10.3390/ncrna3010009; Ye DZ, 2018, J CONTROL RELEASE, V283, P143, DOI 10.1016/j.jconrel.2018.05.039; Zachariah MA, 2018, NEURO-ONCOLOGY, V20, P1155, DOI 10.1093/neuonc/noy074; Zhu LF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24516-7	60	12	13	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2020	15	6							e0234182	10.1371/journal.pone.0234182	http://dx.doi.org/10.1371/journal.pone.0234182			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LW6ZP	32492056	Green Published, gold			2022-12-26	WOS:000539293000039
J	Canovas, CP; Valenzuela, J; Carrion, DA; Olza, I; Ramscar, M				Pagan Canovas, Cristobal; Valenzuela, Javier; Alcaraz Carrion, Daniel; Olza, Ines; Ramscar, Michael			Quantifying the speech-gesture relation with massive multimodal datasets: Informativity in time expressions	PLOS ONE			English	Article							LANGUAGE; CONSTRUALS; FREQUENCY; MARKING; FUTURE; DESIGN; BODY	The development of large-scale corpora has led to a quantum leap in our understanding of speech in recent years. By contrast, the analysis of massive datasets has so far had a limited impact on the study of gesture and other visual communicative behaviors. We utilized the UCLA-Red Hen Lab multi-billion-word repository of video recordings, all of them showing communicative behavior that was not elicited in a lab, to quantify speech-gesture co-occurrence frequency for a subset of linguistic expressions in American English. First, we objectively establish a systematic relationship in the high degree of co-occurrence between gesture and speech in our subset of expressions, which consists of temporal phrases. Second, we show that there is a systematic alignment between the informativity of co-speech gestures and that of the verbal expressions with which they co-occur. By exposing deep, systematic relations between the modalities of gesture and speech, our results pave the way for the data-driven integration of multimodal behavior into our understanding of human communication.	[Pagan Canovas, Cristobal; Valenzuela, Javier; Alcaraz Carrion, Daniel] Univ Murcia, Dept English Philol, Murcia, Spain; [Pagan Canovas, Cristobal; Ramscar, Michael] Eberhard Karls Univ Tubingen, Dept Quantitat Linguist, Tubingen, Baden Wurttembe, Germany; [Olza, Ines] Univ Navarra, Inst Culture & Soc, Navarra, Spain	University of Murcia; Eberhard Karls University of Tubingen; University of Navarra	Canovas, CP (corresponding author), Univ Murcia, Dept English Philol, Murcia, Spain.; Canovas, CP (corresponding author), Eberhard Karls Univ Tubingen, Dept Quantitat Linguist, Tubingen, Baden Wurttembe, Germany.	cpcanovas@um.es	Alcaraz-Carrion, Daniel/AAF-2990-2021; Pagan Canovas, Cristobal/S-8861-2016	Alcaraz-Carrion, Daniel/0000-0001-5325-431X; Valenzuela, Javier/0000-0002-0007-7943; Pagan Canovas, Cristobal/0000-0003-2341-0128	Spain's Ministry of Science and Innovation [PGC2018-097658-B-I00, PGC2018-095703-B-I00]; FEDER/UE funds [PGC2018-097658-B-I00, PGC2018-095703-B-I00]; EURIAS Fellowship from NetIAS; Netherlands Institute for Advanced Study; Ramon y Cajal grant; Arts and Humanities Research Council doctoral scheme scholarship; SRUK On the move postdoctoral research program	Spain's Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER/UE funds; EURIAS Fellowship from NetIAS; Netherlands Institute for Advanced Study; Ramon y Cajal grant(Spanish Government); Arts and Humanities Research Council doctoral scheme scholarship(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); SRUK On the move postdoctoral research program	Funding support was provided by two I + D Knowledge Generation Grants from Spain's Ministry of Science and Innovation and FEDER/UE funds, one to C.P.C. and J.V. (ref. PGC2018-097658-B-I00) and another to I.O. (ref. PGC2018-095703-B-I00); a EURIAS Fellowship from NetIAS and the Netherlands Institute for Advanced Study (C.P.C.); a Ramon y Cajal grant (C.P.C.); an Arts and Humanities Research Council doctoral scheme scholarship (D.A.C.); a fellowship from the SRUK On the move postdoctoral research program (D.A. C.).	Alibali MW, 2001, J MEM LANG, V44, P169, DOI 10.1006/jmla.2000.2752; Baayen RH, 2016, APHASIOLOGY, V30, P1174, DOI 10.1080/02687038.2016.1147767; Bavelas J, 2008, J MEM LANG, V58, P495, DOI 10.1016/j.jml.2007.02.004; BAVELAS JB, 1992, DISCOURSE PROCESS, V15, P469, DOI 10.1080/01638539209544823; Boroditsky L, 2002, PSYCHOL SCI, V13, P185, DOI 10.1111/1467-9280.00434; Chu MY, 2014, J EXP PSYCHOL GEN, V143, P694, DOI 10.1037/a0033861; Cienki A, 2017, LINGUIST VANGUARD, V3, DOI 10.1515/lingvan-2016-0048; Cooperrider K., 2014, BODY LANGUAGE COMMUN, V2, P1781; Cooperrider K, 2009, GESTURE, V9, P181, DOI 10.1075/gest.9.2.02coo; Davies M, 2009, INT J CORPUS LINGUIS, V14, P159, DOI 10.1075/ijcl.14.2.02dav; Dye M, 2018, TOP COGN SCI, V10, P209, DOI 10.1111/tops.12316; Estoup JB., 1916, GAMMES STENOGRAPHIQU; Gibson E, 2019, TRENDS COGN SCI, V23, P389, DOI 10.1016/j.tics.2019.02.003; Halevy A, 2009, IEEE INTELL SYST, V24, P8, DOI 10.1109/MIS.2009.36; Hannun A, 2014, ARXIV14125567CS; Hinnell J, 2018, COGN LINGUIST, V29, P773, DOI 10.1515/cog-2017-0009; Hoffmann T, 2017, LINGUIST VANGUARD, V3, DOI 10.1515/lingvan-2016-0042; Holler J, 2019, TRENDS COGN SCI; Iverson JM, 1998, NATURE, P396; Kelly S, 2015, PSYCHON B REV, V22, P517, DOI 10.3758/s13423-014-0681-7; Kendon A., 2004, GESTURE VISIBLE ACTI, DOI DOI 10.1017/CBO9780511807572; Kendon A., 1980, RELATIONSHIP VERBAL, P207, DOI [10.1515/9783110813098.207, DOI 10.1515/9783110813098.207]; Kita S, 2009, LANG COGNITIVE PROC, V24, P761, DOI 10.1080/01690960802327971; Lanwer JP, 2017, LINGUIST VANGUARD, V3, DOI 10.1515/lingvan-2016-0071; Le Guen O, 2011, COGNITIVE SCI, V35, P905, DOI 10.1111/j.1551-6709.2011.01183.x; Levinson SC, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0302; Linke M., ENTROPY, V22, P90; Mayberry RI, 2000, GESTURE PRODUCTION S, P199, DOI DOI 10.1017/CB09780511620850.013; McNeill D., 1982, SPEECH PLACE ACTION, P271; Mittelberg I, 2017, LINGUIST VANGUARD, V3, DOI 10.1515/lingvan-2016-0047; Ningelgen J, 2017, LINGUIST VANGUARD, V3, DOI 10.1515/lingvan-2016-0051; Nunez R, 2013, TRENDS COGN SCI, V17, P220, DOI 10.1016/j.tics.2013.03.008; Nunez R, 2012, COGNITION, V124, P25, DOI 10.1016/j.cognition.2012.03.007; Nunez RE, 2006, COGNITIVE SCI, V30, P401, DOI 10.1207/s15516709cog0000_62; Ozyurek A, 2007, BENJAMINS CURRENT TO, P197; Canovas CP, 2017, LINGUIST VANGUARD, V3, DOI 10.1515/lingvan-2016-0087; Radden G., 2004, UEBERSETZEN INTERKUL, P226; Ramscar M, 2016, LANG SCI, V53, P58, DOI 10.1016/j.langsci.2015.08.002; Schoonjans S, 2017, LINGUIST VANGUARD, V3, DOI 10.1515/lingvan-2016-0050; So WC, 2010, LANG COGNITIVE PROC, V25, P1335, DOI 10.1080/01690961003694268; Steen F., 2013, LANGUAGE CREATIVE MI; Steen FF, 2018, LINGUIST VANGUARD, V4, DOI 10.1515/lingvan-2017-0041; Szyurek A., 2014, PHIL T R SOC B, V369; Tessendorf S., 2013, HDB LINGUISTICS COMM, P837; Turchyn S, 2018, 30 AAAI C INN APPL A; Walker E, 2016, COGNITIVE SCI, V40, P481, DOI 10.1111/cogs.12254; Walker TJ, 2011, FORBES; Ziem A, 2017, LINGUIST VANGUARD, V3, DOI 10.1515/lingvan-2016-0095; Zima E, 2017, LINGUISTICS VANGUARD, V3; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	50	9	9	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2020	15	6							e0233892	10.1371/journal.pone.0233892	http://dx.doi.org/10.1371/journal.pone.0233892			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MT4VF	32484842	Green Published, gold			2022-12-26	WOS:000554969700020
J	Shukla, AK; Behera, SK; Singh, VK; Prakash, C; Sachan, AK; Dhaliwal, SS; Srivastava, PC; Pachauri, SP; Tripathi, A; Pathak, J; Nayak, AK; Kumar, A; Tripathi, R; Dwivedi, BS; Datta, SP; Meena, MC; Das, S; Trivedi, V				Shukla, A. K.; Behera, S. K.; Singh, V. K.; Prakash, C.; Sachan, A. K.; Dhaliwal, S. S.; Srivastava, P. C.; Pachauri, S. P.; Tripathi, A.; Pathak, J.; Nayak, A. K.; Kumar, A.; Tripathi, R.; Dwivedi, B. S.; Datta, S. P.; Meena, M. C.; Das, S.; Trivedi, V			Pre-monsoon spatial distribution of available micronutrients and sulphur in surface soils and their management zones in Indian Indo-Gangetic Plain	PLOS ONE			English	Article							ELECTRICAL-CONDUCTIVITY; ORGANIC-MATTER; CULTIVATED AREA; PARENT MATERIAL; CARBON CONTENT; SODIC SOILS; VARIABILITY; DELINEATION; RICE; REGION	The efficient (site-specific) management of soil nutrients is possible by understanding the spatial variability in distribution of phyto-available nutrients (here after called available nutrients) and identifying the soil management zones (MZs) of agricultural landscapes. There is need for delineating soil MZs of agricultural landscapes of the world for efficient management of soil nutrients in order to obtain sustainability in crop yield. The present study was, therefore, undertaken to understand the spatial distribution pattern of available micronutrients (zinc (Zn), boron (B), iron (Fe), manganese (Mn) and copper (Cu)), available sulphur (S), and soil properties (soil acidity (pH), electrical conductivity (EC) and organic carbon (SOC) content) in soils of intensively cultivated Indo-Gangetic Plain (IGP) of India and to delineate soil MZs for efficient management of soil nutrients. Totally, 55101 soil samples from 0-15 cm depth were obtained from 167 districts of IGP during 2014 to 2017 and were analysed for different soil parameters. Soil pH, EC and SOC content varied from 4.44 to 9.80, 0.02 to 2.13 dS m(-1) and 0.10 to 1.99%, respectively. The concentration of available Zn, B, Fe, Mn, Cu and S varied from 0.01 to 3.27, 0.01 to 3.51, 0.19 to 55.7, 0.05 to 49.0, 0.01 to 5.29 and 1.01 to 108 mg kg(-1), respectively. Geostatistical analysis resulted in varied distribution pattern of studied soil parameters with moderate to strong spatial dependence. The extent (% area) of nutrient deficiencies in IGP followed the order: S > Zn > B > Mn > Cu > Fe. Principal component analysis and fuzzy c-means clustering produced six distinctly different soil MZs of IGP for implementation of zone-specific soil nutrient management strategies for attaining sustainability in crop yield. The developed MZ maps could also be utilized for prioritization and rationalization of nutrients supply in IGP of India.	[Shukla, A. K.; Behera, S. K.; Prakash, C.; Tripathi, A.] ICAR Indian Inst Soil Sci, Bhopal, Madhya Pradesh, India; [Singh, V. K.; Dwivedi, B. S.; Datta, S. P.; Meena, M. C.; Trivedi, V] ICAR Indian Agr Res Inst, New Delhi, India; [Sachan, A. K.] Chandra Sekhar Azad Univ Agr & Technol, Kanpur, Uttar Pradesh, India; [Dhaliwal, S. S.] Punjab Agr Univ, Ludhiana, Punjab, India; [Srivastava, P. C.; Pachauri, S. P.] Govind Ballabh Pant Univ Agr & Technol, Udham Singh Nagar, Uttarakhand, India; [Pathak, J.] Banda Univ Agr & Technol, Banda, Uttar Pradesh, India; [Nayak, A. K.; Tripathi, R.] ICAR Natl Rice Res Inst, Cuttack, Odisha, India; [Kumar, A.] ICAR Indian Agr Stat Res Inst, New Delhi, India; [Das, S.] Int Zinc Assoc, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Soil Sciences; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Punjab Agricultural University; Govind Ballabh Pant University of Agriculture Technology; Indian Council of Agricultural Research (ICAR); ICAR - National Rice Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Statistics Research Institute	Behera, SK (corresponding author), ICAR Indian Inst Soil Sci, Bhopal, Madhya Pradesh, India.	sanjibkumarbehera123@gmail.com	Shukla, Arvind K/U-6063-2017; Behera, Sanjib Kumar/ABI-8143-2020; Shukla, Arvind K/ABI-8102-2020; Datta, SP/AAA-5541-2022	Shukla, Arvind K/0000-0001-7867-8717; Nayak, A. K./0000-0002-2257-3243; Behera, Sanjib Kumar/0000-0003-1105-6782	Indian Council of Agricultural Research (ICAR), New Delhi	Indian Council of Agricultural Research (ICAR), New Delhi(Indian Council of Agricultural Research (ICAR))	The authors duly acknowledge the support of Indian Council of Agricultural Research (ICAR), New Delhi through All India Coordinated Research Project on Micro and Secondary Nutrients and Pollutant Elements in Soils and Plants, for conducting the study.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari P, 2012, SOIL SCI, V177, P458, DOI 10.1097/SS.0b013e318257c331; Aggarwal PK, 2004, ENVIRON SCI POLICY, V7, P487, DOI 10.1016/j.envsci.2004.07.006; Alloway Brian J., 2008, P1, DOI 10.1007/978-1-4020-6860-7_1; ANDERSON DW, 1988, BIOGEOCHEMISTRY, V5, P71, DOI 10.1007/BF02180318; Behera S.K., 2016, J INDIAN SOC SOIL SC, V64, P183, DOI [10.5958/0974-0228.2016.00024.4, DOI 10.5958/0974-0228.2016.00024.4]; Behera SK, 2018, CATENA, V165, P251, DOI 10.1016/j.catena.2018.02.008; Behera SK, 2015, LAND DEGRAD DEV, V26, P71, DOI 10.1002/ldr.2306; Behera SK., 2013, J INDIAN SOC SOIL SC, V61, P244; Bhattacharyya T, 2007, AGR ECOSYST ENVIRON, V122, P84, DOI 10.1016/j.agee.2007.01.010; Bogunovic I, 2017, SCI TOTAL ENVIRON, V584, P535, DOI 10.1016/j.scitotenv.2017.01.062; Brady N, 2002, NATURE PROPERTIES SO, P249, DOI [10.1023/A:1016012810895, DOI 10.1023/A:1016012810895]; CAMBARDELLA CA, 1994, SOIL SCI SOC AM J, V58, P1501, DOI 10.2136/sssaj1994.03615995005800050033x; CHANDI KS, 1982, PLANT SOIL, V69, P423, DOI 10.1007/BF02372463; Corwin DL, 2005, COMPUT ELECTRON AGR, V46, P11, DOI 10.1016/j.compag.2004.10.005; Davatgar N, 2012, GEODERMA, V173, P111, DOI 10.1016/j.geoderma.2011.12.005; De Bona FD, 2010, SOIL SCI SOC AM J, V74, P1248, DOI 10.2136/sssaj2009.0228; Ferreira V, 2015, SOLID EARTH, V6, P383, DOI 10.5194/se-6-383-2015; Fertilizer Association of India, 2017, SPEC FERT MICR STAT, P207; FRENEY JR, 1975, SOIL BIOL BIOCHEM, V7, P217, DOI 10.1016/0038-0717(75)90041-3; Fu WJ, 2010, SOIL TILL RES, V106, P185, DOI 10.1016/j.still.2009.12.001; Ghosh P. K., 2019, Proceedings of the Indian National Science Academy Part B Biological Sciences, V89, P429, DOI 10.1007/s40011-017-0953-x; Goovaerts P, 1998, BIOL FERT SOILS, V27, P315, DOI 10.1007/s003740050439; Goovaerts P., 1997, GEOSTATISTICS NATURA, DOI DOI 10.2307/1270969; Gruba P, 2016, CATENA, V140, P90, DOI 10.1016/j.catena.2016.01.020; GUPTA UC, 1967, SOIL SCI, V103, P424, DOI 10.1097/00010694-196706000-00009; Jackson ML, 2005, SOIL CHEM ANAL ADV C; Jat HS, 2018, ARCH AGRON SOIL SCI, V64, P531, DOI 10.1080/03650340.2017.1359415; KATYAL JC, 1985, FERT RES, V7, P69, DOI 10.1007/BF01048996; Katyal JC, 2001, NUTR CYCL AGROECOSYS, V61, P77, DOI 10.1023/A:1013320502810; Kerry R, 2010, GEOSTATISTICAL APPLICATIONS FOR PRECISION AGRICULTURE, P35, DOI 10.1007/978-90-481-9133-8_2; Kertesz MA, 2004, J EXP BOT, V55, P1939, DOI 10.1093/jxb/erh176; Khurana M. P. S., 2008, Sulfur: a missing link between soils, crops and nutrition, P11; Kumar P, 2002, AGR EC RES REPORT, V2; Lal R, 2004, CLIMATIC CHANGE, V65, P277, DOI 10.1023/B:CLIM.0000038202.46720.37; LINDSAY WL, 1978, SOIL SCI SOC AM J, V42, P421, DOI 10.2136/sssaj1978.03615995004200030009x; Lopez-Granados F, 2002, PLANT SOIL, V246, P97, DOI 10.1023/A:1021568415380; Minasny B, 2006, COMPUT GEOSCI-UK, V32, P1378, DOI 10.1016/j.cageo.2005.12.009; Mueller TG, 2003, AGRON J, V95, P496, DOI 10.2134/agronj2003.0496; NEILSEN D, 1986, CAN J SOIL SCI, V66, P445; Nielsen D. R., 1985, Soil spatial variability.; Ortega RA, 2007, COMPUT ELECTRON AGR, V58, P49, DOI 10.1016/j.compag.2006.12.011; Pal DK, 2009, CURR SCI INDIA, V96, P1193; Pal DK, 2003, CATENA, V51, P3, DOI 10.1016/S0341-8162(02)00092-9; Pingali PL, 2012, P NATL ACAD SCI USA, V109, P12302, DOI 10.1073/pnas.0912953109; Peralta NR, 2015, COMPUT ELECTRON AGR, V110, P103, DOI 10.1016/j.compag.2014.10.017; Rengel Z, 2015, J SOIL SCI PLANT NUT, V15, P397; Sahrawat KL, 2012, COMMUN SOIL SCI PLAN, V43, P948, DOI 10.1080/00103624.2012.653030; SAS Institute, 2011, SAS SYST WIND; Scherer HW, 2009, J PLANT NUTR SOIL SC, V172, P326, DOI 10.1002/jpln.200900037; Shukla A. K., 2019, Indian Journal of Fertilisers, V15, P522; Shukla A.K., 2016, COORDINATORS REPORT, P1; Shukla AK, 2017, FAI ANN SEM NEW DELH; Shukla AK, 2017, LAND DEGRAD DEV, V28, P959, DOI 10.1002/ldr.2673; Shukla AK, 2016, SOIL TILL RES, V163, P282, DOI 10.1016/j.still.2016.07.004; Shukla AK, 2018, LAND DEGRAD DEV, V29, P2449, DOI 10.1002/ldr.2992; SINGH B, 2012, ARCH AGRON SOIL SCI, V58, pS33, DOI DOI 10.1080/03650340.2012.693600; Singh VK, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9010001; Singh VK, 2015, AGR RES, V4, P76, DOI 10.1007/s40003-015-0149-7; Singh YP, 2016, FIELD CROP RES, V190, P82, DOI 10.1016/j.fcr.2016.02.007; Soil Survey Staff, 2014, KEYS SOIL TAXONOMY; Srivastava P, 2015, EARTH-SCI REV, V140, P54, DOI 10.1016/j.earscirev.2014.10.010; Takkar P. N., 1996, Journal of the Indian Society of Soil Science, V44, P562; Takkar PN., 1989, 20 YEARS COORDINATED; Tandon H L S., 2011, SULPHUR SOILS CROPS, p204 + X; Tesfahunegn GB, 2011, SOIL TILL RES, V117, P124, DOI 10.1016/j.still.2011.09.005; Tripathi R, 2015, CATENA, V133, P128, DOI 10.1016/j.catena.2015.05.009; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Wang L, 2009, PEDOSPHERE, V19, P748, DOI 10.1016/S1002-0160(09)60170-3; Wang XZ, 2009, COMPUT ELECTRON AGR, V65, P168, DOI 10.1016/j.compag.2008.08.008; Warrick A. W., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P53; Wei XR, 2006, SOIL TILL RES, V91, P120, DOI 10.1016/j.still.2005.11.009; White JG, 1997, SOIL SCI SOC AM J, V61, P185, DOI 10.2136/sssaj1997.03615995006100010027x; WILLIAMS C. H., 1959, AUSTRALIAN JOUR AGRIC RES, V10, P340, DOI 10.1071/AR9590340; Zhang YY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218563	74	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2020	15	6							e0234053	10.1371/journal.pone.0234053	http://dx.doi.org/10.1371/journal.pone.0234053			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MT4VF	32484834	Green Published, gold			2022-12-26	WOS:000554969700031
J	Restan, AZ; Camacho, AA; Cerqueira, JA; Zacche, E; Kirnew, MD; Loureiro, BA; Silva, SB; Moranza, HG; Ferraz, GC				Restan, Alejandro Z.; Camacho, Aparecido A.; Cerqueira, Juliana A.; Zacche, Evandro; Kirnew, Murillo D.; Loureiro, Bruna A.; Silva, Samara B.; Moranza, Henriette G.; Ferraz, Guilherme C.			Effect of a lactate-guided conditioning program on heart rate variability obtained using 24-Holter electrocardiography in Beagle dogs	PLOS ONE			English	Article							MITRAL-VALVE DISEASE; ENDURANCE EXERCISE; TRAINING ADAPTATION; PARAMETERS; PERFORMANCE; RESPONSES; MUSCLE	The dogs' responses to training exercise are seldom monitored using physiological variables, and cardiac autonomic regulation (CAR) is a relevant determinant of endurance-training adaptation. There are studies in the literature establishing that regular exercise could interfere with CAR in dogs, measured by heart rate and vagal-derived indexes of heart-rate-variability (HRV). However, few studies were found using a prescribed training program based on the lactate threshold (LT) to determine HRV by a 24-h Holter analysis. The purpose of this study was to test whether an endurance-training program (ETP) guided individually by LT raises time-domain measures of HRV in healthy Beagle dogs. Twenty dogs were assigned to two groups: control (C) and trained (T). The dogs from group T underwent an incremental exercise test (IET) to determine their LT. Both LT and velocity corresponding to the LT (VLT) was determined by visual inspection. T group performed an eight-week endurance-training program consisting of treadmill runs set to 70-80% of the VLT. Next, dogs from the group T have submitted to IET again. The maximal velocities (Vmax) at which achieved by the trained dogs in both IETs were determined. The group S did not undergo IETs or ETP. HRV was determined by the 24-hour-Holter at rest, before and on the 2 degrees, 4 degrees, 6 degrees and 8 degrees training weeks. To examine the HR impact on HRV, standard HRV variables were normalized to prevailing HR. VLT and Vmax rose in group T, indicating an improvement of dogs' aerobic and anaerobic capacity. The normalized standard HRV indexes were relatively attenuated since these variables had a reduction in the degree of correlation concerning an average HR. The ETP resulted in decreased resting heart rate and increased time-domain indices, highlighting the log-transformed square root of the mean sum of the squared differences between R-R intervals (Ln rMSSD). The lactate-guided endurance-training program could lead to better parasympathetic cardiac modulation in Beagle dogs.	[Restan, Alejandro Z.; Cerqueira, Juliana A.; Silva, Samara B.; Moranza, Henriette G.; Ferraz, Guilherme C.] Sao Paulo State Univ UNESP, Sch Agr & Vet Sci FCAV, Dept Anim Morphol & Physiol, Lab Pharmacol & Equine Exercise Physiol LAFEQ, Jaboticabal, SP, Brazil; [Camacho, Aparecido A.; Zacche, Evandro; Kirnew, Murillo D.] Sao Paulo State Univ, Sch Agr & Vet Sci, Dept Vet Med & Surg, Coll Agr & Vet Sci FCAV,Univ Estadual Paulista,UN, Jaboticabal, SP, Brazil; [Loureiro, Bruna A.] Univ Fed Paraiba, Ctr Ciencias Agr, Dept Anim Sci, Areia, Paraiba, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Federal da Paraiba	Ferraz, GC (corresponding author), Sao Paulo State Univ UNESP, Sch Agr & Vet Sci FCAV, Dept Anim Morphol & Physiol, Lab Pharmacol & Equine Exercise Physiol LAFEQ, Jaboticabal, SP, Brazil.	guilherme.c.ferraz@unesp.br	Loureiro, Bruna Agy/M-9615-2015; Zamora Restan, Wilmer Alejandro/GYD-4745-2022; Ferraz, Guilherme/ADE-4760-2022; Ferraz, Guilherme/G-4954-2012	Loureiro, Bruna Agy/0000-0002-4163-6414; Zamora Restan, Wilmer Alejandro/0000-0003-3609-315X; Ferraz, Guilherme/0000-0002-6463-6628; Gellert Moranza, Henriette/0000-0002-1562-7223	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]; FAPESP [2015/26738-1]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001. Financial support was also given by FAPESP (grant no. 2015/26738-1) to GCF. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albinet CT, 2010, EUR J APPL PHYSIOL, V109, P617, DOI 10.1007/s00421-010-1393-y; Allen KJ, 2016, EQUINE VET EDUC, V28, P89, DOI 10.1111/eve.12410; Atkins CE, 2012, J VET CARDIOL, V14, P165, DOI 10.1016/j.jvc.2012.02.002; Aubert AE, 2003, SPORTS MED, V33, P889, DOI 10.2165/00007256-200333120-00003; Belardinelli R, 2012, J AM COLL CARDIOL, V60, P1521, DOI 10.1016/j.jacc.2012.06.036; Berkman C, 2016, COMP EXERC PHYSIOL, V12, P75, DOI 10.3920/CEP160002; Billman GE, 2007, J APPL PHYSIOL, V102, P231, DOI 10.1152/japplphysiol.00793.2006; Billman GE, 2015, J APPL PHYSIOL, V118, P1344, DOI 10.1152/japplphysiol.01111.2014; Billman GE, 2013, FRONT PHYSIOL, V4, DOI [10.3389/fphys.2013.00222, 10.3389/fphys.2013.00026]; Billman GE, 2009, AM J PHYSIOL-HEART C, V297, pH1171, DOI 10.1152/ajpheart.00534.2009; Blake RR, 2018, J VET CARDIOL, V20, P20, DOI 10.1016/j.jvc.2017.10.006; Burr RL, 2006, BIOL RES NURS, V7, P256, DOI 10.1177/1099800405285268; Camm AJ, 1996, EUR HEART J, V17, P354; Carter JB, 2003, SPORTS MED, V33, P33, DOI 10.2165/00007256-200333010-00003; Cerqueira JA, 2018, RES VET SCI, V121, P31, DOI 10.1016/j.rvsc.2018.10.004; Constable PD, 2000, AM J VET RES, V61, P582, DOI 10.2460/ajvr.2000.61.582; Coyle E F, 1995, Exerc Sport Sci Rev, V23, P25; De Maeyer C, 2013, THER ADV CHRONIC DIS, V4, P105, DOI 10.1177/2040622313480382; Dempsey JA., 2011, COMPR PHYSIOL, P448, DOI [DOI 10.1002/CPHY.CP120111, 10.1002/cphy.cp120111]; Dong JG, 2016, EXP THER MED, V11, P1531, DOI 10.3892/etm.2016.3104; Ferraz GC, 2008, ARQ BRAS MED VET ZOO, V60, P256, DOI 10.1590/S0102-09352008000100035; HAMLIN RL, 1966, AM J PHYSIOL, V210, P321, DOI 10.1152/ajplegacy.1966.210.2.321; HETTS S, 1992, APPL ANIM BEHAV SCI, V34, P137, DOI 10.1016/S0168-1591(05)80063-2; Katayama M, 2016, BEHAV PROCESS, V128, P108, DOI 10.1016/j.beproc.2016.04.015; Keene BW, 2019, J VET INTERN MED, V33, P1127, DOI 10.1111/jvim.15488; Manzo A, 2009, LAB ANIM-UK, V43, P41, DOI 10.1258/la.2007.007085; Melanson EL, 2001, EUR J APPL PHYSIOL, V85, P442, DOI 10.1007/s004210100479; Moraes VS, 2017, COMP EXERC PHYSIOL, V13, P217, DOI 10.3920/CEP170007; National Research Council, 2006, NUTR REQ DOGS CATS, P260; Nummela A, 2016, BIOL SPORT, V33, P7, DOI 10.5604/20831862.1180171; Oliveira MS, 2012, VET REC, V170, P622, DOI 10.1136/vr.100202; Pirintr P, 2012, VET RES COMMUN, V36, P207, DOI 10.1007/s11259-012-9531-0; Plews DJ, 2013, INT J SPORT PHYSIOL, V8, P688, DOI 10.1123/ijspp.8.6.688; Plews DJ, 2013, SPORTS MED, V43, P773, DOI 10.1007/s40279-013-0071-8; Pouchelon JL, 2015, J SMALL ANIM PRACT, V56, P537, DOI 10.1111/jsap.12387; Queiroz RW, 2018, J ANIM PHYSIOL AN N, V102, P122, DOI 10.1111/jpn.12667; Rasmussen CE, 2011, J VET INTERN MED, V25, P460, DOI 10.1111/j.1939-1676.2011.0707.x; Restan AZ, 2019, AM J VET RES, V80, P284, DOI 10.2460/ajvr.80.3.284; Rovira S, 2010, REV MED VET-TOULOUSE, V161, P307; Sacha J, 2013, INT J CARDIOL, V168, P1660, DOI 10.1016/j.ijcard.2013.03.038; SCHER AM, 1972, FED PROC, V31, P1219; Schneider C, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00582; Shaffer F, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00258; Shaffer F, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01040; Stein PK, 2005, J CARDIOVASC ELECTR, V16, P13, DOI 10.1046/j.1540-8167.2005.04358.x; Stepien RL, 1998, J APPL PHYSIOL, V85, P1368, DOI 10.1152/jappl.1998.85.4.1368; Stewart GM, 2015, AM J PHYSIOL-HEART C, V308, pH875, DOI 10.1152/ajpheart.00917.2014; Ulmer CS, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy174; Vrachimis A., 2016, Health, V8, P144, DOI 10.4236/health.2016.82017; Wolpern AE, 2015, BMC SPORTS SCI MED R, V7, DOI 10.1186/s13102-015-0011-z; Zacche E, 2017, CIENC RURAL, V47, DOI 10.1590/0103-8478cr20160740; Zanesco A, 2007, PHARMACOL THERAPEUT, V114, P307, DOI 10.1016/j.pharmthera.2007.03.010; Zupan M, 2016, PHYSIOL BEHAV, V155, P102, DOI 10.1016/j.physbeh.2015.11.027	53	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0233264	10.1371/journal.pone.0233264	http://dx.doi.org/10.1371/journal.pone.0233264			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MJ2AA	32479554	Green Published, gold			2022-12-26	WOS:000547893500009
J	Quirino, TD; Ortolan, LD; Sercundes, MK; Marinho, CRF; Turato, WM; Epiphanio, S				Quirino, Thatyane de Castro; Ortolan, Luana dos Santos; Sercundes, Michelle Klein; Farias Marinho, Claudio Romero; Turato, Walter Miguel; Epiphanio, Sabrina			Lung aeration in experimental malaria-associated acute respiratory distress syndrome by SPECT/CT analysis	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; MOUSE MODEL; CT; INJURY; SCAN; ARDS; RADIOPHARMACEUTICALS; SEGMENTATION; VOLUMES; CHEST	Malaria-associated acute respiratory distress syndrome (ARDS) is an inflammatory disease causing alveolar-pulmonary barrier lesion and increased vascular permeability characterized by severe hypoxemia. Computed tomography (CT), among other imaging techniques, allows the morphological and quantitative identification of lung lesions during ARDS. This study aims to identify the onset of malaria-associated ARDS development in an experimental model by imaging diagnosis. Our results demonstrated that ARDS-developing mice presented decreased gaseous exchange and pulmonary insufficiency, as shown by the SPECT/CT technique. The pulmonary aeration disturbance in ARDS-developing mice on the 5th day post infection was characterized by aerated tissues decrease and nonaerated tissue accumulation, demonstrating increased vascular permeability and pleural effusion. The SPECT/CT technique allowed the early diagnosis in the experimental model, as well as the identification of the pulmonary aeration. Notwithstanding, despite the fact that this study contributes to better understand lung lesions during malaria-associated ARDS, further imaging studies are needed.	[Quirino, Thatyane de Castro; Sercundes, Michelle Klein; Turato, Walter Miguel; Epiphanio, Sabrina] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin & Toxicol, Sao Paulo, Brazil; [Ortolan, Luana dos Santos] Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, Sao Paulo, Brazil; [Farias Marinho, Claudio Romero] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, Sao Paulo, Brazil; [Turato, Walter Miguel] Inst Pesquisas Energet & Nucl, Ctr Radiofarmacia, Sao Paulo, Brazil; [Ortolan, Luana dos Santos] Seattle Childrens Res Inst, Seattle, WA USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Comissao Nacional de Energia Nuclear (CNEN); Instituto de Pesquisas Energeticas e Nucleares (IPEN); Seattle Children's Hospital	Epiphanio, S (corresponding author), Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin & Toxicol, Sao Paulo, Brazil.	sabrinae@usp.br	Marinho, Claudio Romero Farias/F-7507-2012; dos Santos Ortolan, Luana/AAU-3092-2021; Epiphanio, Sabrina/C-7572-2012	Marinho, Claudio Romero Farias/0000-0002-1227-3845; Epiphanio, Sabrina/0000-0001-6094-9750; dos Santos Ortolan, Luana/0000-0003-1153-9987	Sao Paulo Research Foundation (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo: FAPESP, Brazil); Coordination of Improvement of Higher Level Personnel; (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior: CAPES); National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico: CNPq, Brazil); CAPES; CAPES/PNPD;  [CNPq 131431/2017-0];  [FAPESP 2013/20718-3];  [FAPESP 2016/07030-3];  [FAPESP 2017/05782-8]	Sao Paulo Research Foundation (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo: FAPESP, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination of Improvement of Higher Level Personnel; (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior: CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico: CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES/PNPD(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); ; ; ; 	Sao Paulo Research Foundation (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo: FAPESP, Brazil), the Coordination of Improvement of Higher Level Personnel; (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior: CAPES) and the National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico: CNPq, Brazil) supported this research. TCQ (CNPq 131431/2017-0), LSO (CAPES and FAPESP 2013/20718-3), MKS (CAPES/PNPD), CRFM (FAPESP 2016/07030-3), SE (FAPESP 2017/05782-8) received fellowship grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeffner F, 2015, TOXICOL PATHOL, V43, P1074, DOI 10.1177/0192623315598399; Aguirre-Bermeo H, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0183-z; Akbar MU, 2016, J RADIOANAL NUCL CH, V310, P477, DOI 10.1007/s10967-016-5019-7; Al A, 2018, NEW MECH VENTILATION, P1, DOI [10.4103/1110-2098.234223, DOI 10.4103/1110-2098.234223]; AMATO M, 2007, J BRAS PNEUMOL, V33, P128, DOI [10.1590/S0004-27301999000400002, DOI 10.1590/S0004-27301999000400002]; Anan K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45063-9; Andrade JG., 1994, REV PATOL TROP, V23, P181; [Anonymous], 2019, WORLD MALARIA REPORT; Bachmann MC, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2195-6; Bajc Marika, 2011, Int J Mol Imaging, V2011, P682949, DOI 10.1155/2011/682949; Bates J, 2002, CORRES USE MISUSE PE; Bellani G, 2012, CURR OPIN CRIT CARE, V18, P29, DOI 10.1097/MCC.0b013e32834eb47d; Bello G, 2019, J ULTRAS MED, V38, P27, DOI 10.1002/jum.14671; Brasil P, 2017, LANCET GLOB HEALTH, V5, pE1038, DOI 10.1016/S2214-109X(17)30333-9; Calderaro A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-321; Chen IC, 2016, J CHIN MED ASSOC, V79, P17, DOI 10.1016/j.jcma.2015.10.001; Chiumello D, 2013, CRIT CARE, V17, DOI 10.1186/cc13114; Christmann Wawrzeniak I, 2018, WEANING MECH VENTILA, V2018, DOI [10.1155/2018/5423639, DOI 10.1155/2018/5423639]; Conway J, 2012, ADV DRUG DELIVER REV, V64, P357, DOI 10.1016/j.addr.2012.01.013; Dakin O, 2012, RESPIROLOGY, V16, P1265, DOI [10.1111/j.1440-1843.2011.02048.x.Changes, DOI 10.1111/J.1440-1843.2011.02048.X.CHANGES]; Davison CA, 2013, CURR MOL MED, V13, P368; De Freitas ERFS, 2007, VENTILACAO MECANICA, P53; De Matos GFJ, 2011, PULMAO RJ, V20, P13; Elzein F, 2017, RESPIR MED CASE REP, V22, P83, DOI 10.1016/j.rmcr.2017.06.014; Epiphanio S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000916; Fanelli V, 2013, J THORAC DIS, V5, P326, DOI 10.3978/j.issn.2072-1439.2013.04.05; Franca TCC, 2008, QUIM NOVA, V31, P1271, DOI 10.1590/S0100-40422008000500060; Gattinoni L, 2001, AM J RESP CRIT CARE, V164, P1701, DOI 10.1164/ajrccm.164.9.2103121; GATTINONI L, 1991, ACTA ANAESTH SCAND, V35, P87, DOI 10.1111/j.1399-6576.1991.tb03404.x; Gattinoni L MD, 1986, J THORACIC IMAGING; Gattinoni L, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1905-9; Ghazanfari N, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02016; Guerrero T, 2007, INT J RADIAT ONCOL, V67, P879, DOI 10.1016/j.ijrobp.2006.10.037; Hochhegger B, 2010, HOCHHEGGER RUA MEASU, V43, P260, DOI [10.1590/S0100-39842010000400011, DOI 10.1590/S0100-39842010000400011]; HOUNDFIELD GN, 1973, BRIT J RADIOL, V46, P1016, DOI 10.1259/0007-1285-46-552-1016; Irion Klaus Loureiro, 2007, J. bras. pneumol., V33, P720, DOI 10.1590/S1806-37132007000600017; Jacene HA, 2004, CLIN NUCL MED, V29, P786, DOI 10.1097/00003072-200412000-00002; Jobse BN, 2013, J NUCL MED, V54, P616, DOI 10.2967/jnumed.112.111419; Karmrodt J, 2006, BRIT J ANAESTH, V97, P883, DOI 10.1093/bja/ael275; Khalil Magdy M, 2011, Int J Mol Imaging, V2011, P796025, DOI 10.1155/2011/796025; Klapsing P, 2017, J CRIT CARE, V42, P184, DOI 10.1016/j.jcrc.2016.11.001; Kniess T, 2017, DALTON T, V46, P14435, DOI 10.1039/c7dt01735a; Loya DE, 2017, HHS PUBLIC ACCESS, V78, P401, DOI [10.1002/ana.24447.Olfactory, DOI 10.1002/ANA.24447.OLFACTORY]; Lundblad LKA, 2007, EUR RESPIR J, V30, P805, DOI 10.1183/09031936.00091307; Ma H, 2016, J THORAC DIS, V8, P1443, DOI 10.21037/jtd.2016.05.15; Malhotra A, 2007, NEW ENGL J MED, V357, P1113, DOI 10.1056/NEJMct074213; Markstaller K, 2001, BRIT J ANAESTH, V87, P459, DOI 10.1093/bja/87.3.459; Mercat A, 2001, CRIT CARE MED, V29, P40, DOI 10.1097/00003246-200101000-00011; Negrin LL, 2017, J CRIT CARE, V37, P211, DOI 10.1016/j.jcrc.2016.10.003; Ochiai R, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-015-0091-6; Ong PK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003444; Ortolan LD, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/3105817; Ortolan LS, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/872464; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Patroniti N, 2003, CRIT CARE, V7, P105, DOI 10.1186/cc1883; Pelosi P, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0014-z; Pereira MLM, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/4158698; Pesenti A, 2001, INTENS CARE MED, V27, P631, DOI 10.1007/s001340100877; Puybasset L, 2000, INTENS CARE MED, V26, P857, DOI 10.1007/s001340051274; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; RC B, 1993, JAMA-J AM MED ASSOC, P16; Reske AW, 2011, CRIT CARE, V15, DOI 10.1186/cc10563; Rios Fernando, 2017, Rev. bras. ter. intensiva, V29, P354, DOI [10.5935/0103-507x.20170044, 10.5935/0103-507X.20170044]; Rotta Alexandre Tellechea, 2015, Rev. bras. ter. intensiva, V27, P266, DOI 10.5935/0103-507X.20150035; Routly JJ, 2003, CRIT CARE MED, V31, pS285, DOI 10.1097/01.CCM.0000057905.74813.BC; Sahetya SK, 2017, AM J RESP CRIT CARE, V196, P1519, DOI 10.1164/rccm.201708-1629CI; Saleri N, 2006, J TRAVEL MED, V13, P112, DOI 10.1111/j.1708-8305.2006.00024.x; SCHWOCHAU K, 1994, ANGEW CHEM INT EDIT, V33, P2258, DOI 10.1002/anie.199422581; Sercundes MK, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006054; Sheard S, 2012, RESP CARE, V57, P607, DOI 10.4187/respcare.01731; Simon M, 2016, RESP CARE, V61, P316, DOI 10.4187/respcare.04308; Siqueira-Batista Rodrigo, 2012, Rev. bras. ter. intensiva, V24, P394, DOI 10.1590/S0103-507X2012000400017; Souza MC, 2013, RESP PHYSIOL NEUROBI, V186, P65, DOI 10.1016/j.resp.2012.12.008; Sun XJ, 2006, ACAD RADIOL, V13, P670, DOI 10.1016/j.acra.2006.02.039; Tauil PL, 2006, REV SOC BRAS MED TRO, V39, P275, DOI 10.1590/S0037-86822006000300010; Van den Steen PE, 2010, AM J RESP CRIT CARE, V181, P957, DOI 10.1164/rccm.200905-0786OC; Vergani G, 2020, J INTENSIVE CARE MED, V35, P284, DOI 10.1177/0885066617743477; Verheijden KAT, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00190; Wolf S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123533; Worsley DF, 2003, SEMIN NUCL MED, V33, P259, DOI 10.1016/S0001-2998(03)00031-X; Zompatori M, 2014, EUR RESPIR REV, V23, P519, DOI 10.1183/09059180.00001314	81	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2020	15	5							e0233864	10.1371/journal.pone.0233864	http://dx.doi.org/10.1371/journal.pone.0233864			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1WS	32470082	Green Published, gold			2022-12-26	WOS:000537552800199
J	Wang, QQ; Bian, XL; Zeng, L; Pan, F; Liu, LZ; Liang, JY; Wang, LY; Zhou, KF; Lee, WH; Xiang, Y; Li, SA; Teng, MK; Li, X; Guo, XL; Zhang, Y				Wang, Qiquan; Bian, Xianling; Zeng, Lin; Pan, Fei; Liu, Lingzhen; Liang, Jinyang; Wang, Lingyan; Zhou, Kaifeng; Lee, Wenhui; Xiang, Yang; Li, Sheng'an; Teng, Maikun; Li, Xu; Guo, Xiaolong; Zhang, Yun			A cellular endolysosome-modulating pore-forming protein from a toad is negatively regulated by its paralog under oxidizing conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pore-forming protein; aerolysin-like protein (ALP); redox regulation; endolysosomes; bacterial toxin; disulfide; dimerization; ??-CAT; BmALP3; vesicles	TREFOIL FACTOR COMPLEX; BETA-GAMMA-CRYSTALLIN; STRUCTURE REFINEMENT; HOST; ACTIVATION; AEROLYSIN; FAMILY; PHENIX; SKIN	Endolysosomes are key players in cell physiology, including molecular exchange, immunity, and environmental adaptation. They are the molecular targets of some pore-forming aerolysin-like proteins (ALPs) that are widely distributed in animals and plants and are functionally related to bacterial toxin aerolysins. ??-CAT is a complex of an ALP (BmALP1) and a trefoil factor (BmTFF3) in the firebelly toad (Bombina maxima). It is the first example of a secreted endogenous pore-forming protein that modulates the biochemical properties of endolysosomes by inducing pore formation in these intracellular vesicles. Here, using a large array of biochemical and cell biology methods, we report the identification of BmALP3, a paralog of BmALP1 that lacks membrane pore-forming capacity. We noted that both BmALP3 and BmALP1 contain a conserved cysteine in their C-terminal regions. BmALP3 was readily oxidized to a disulfide bond-linked homodimer, and this homodimer then oxidized BmALP1 via disulfide bond exchange, resulting in the dissociation of ??-CAT subunits and the elimination of biological activity. Consistent with its behaviorin vitro, BmALP3 sensed environmental oxygen tensionin vivo, leading to modulation of ??-CAT activity. Interestingly, we found that this C-terminal cysteine site is well conserved in numerous vertebrate ALPs. These findings uncover the existence of a regulatory ALP (BmALP3) that modulates the activity of an active ALP (BmALP1) in a redox-dependent manner, a property that differs from those of bacterial toxin aerolysins.	[Wang, Qiquan; Bian, Xianling; Zeng, Lin; Pan, Fei; Liu, Lingzhen; Liang, Jinyang; Wang, Lingyan; Zhou, Kaifeng; Lee, Wenhui; Xiang, Yang; Li, Sheng'an; Guo, Xiaolong; Zhang, Yun] Chinese Acad Sci, Kunming Inst Zool, Key Lab Bioact Peptides Yunnan Prov, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China; [Bian, Xianling; Teng, Maikun; Li, Xu] Univ Sci & Technol China, Innovat Ctr Cell Signaling Network, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei, Anhui, Peoples R China; [Wang, Qiquan; Pan, Fei; Liu, Lingzhen; Liang, Jinyang] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Yunnan, Peoples R China; [Zhang, Yun] Chinese Acad Sci, Ctr Excellence Anim Evolut & Genet, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences	Guo, XL; Zhang, Y (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Key Lab Bioact Peptides Yunnan Prov, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China.; Li, X (corresponding author), Univ Sci & Technol China, Innovat Ctr Cell Signaling Network, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei, Anhui, Peoples R China.; Zhang, Y (corresponding author), Chinese Acad Sci, Ctr Excellence Anim Evolut & Genet, Kunming, Yunnan, Peoples R China.	sachem@ustc.edu.cn; guoxiaolong@mail.kiz.ac.cn; zhangy@mail.kiz.ac.cn		Lee, Wen-Hui/0000-0003-2621-5782; Zhang, Yun/0000-0002-8636-183X	National Natural Science Foundation of China [31572268, U1602225, 31872226]; Yunling Scholar Program; Light of West China Talents Training Program of the Chinese Academy of Sciences; Project of Applied Basic Research of Yunnan Province [2018FB049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunling Scholar Program; Light of West China Talents Training Program of the Chinese Academy of Sciences; Project of Applied Basic Research of Yunnan Province	This work was supported by grants from the National Natural Science Foundation of China (Grants 31572268, U1602225, and 31872226) and the Yunling Scholar Program to Y.Z., the Light of West China Talents Training Program of the Chinese Academy of Sciences, and the Project of Applied Basic Research of Yunnan Province (Grant 2018FB049) to X.G.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afghah Z, 2020, NEUROBIOL DIS, V134, DOI 10.1016/j.nbd.2019.104670; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Bharadwaj P, 2017, J ALZHEIMERS DIS, V59, P421, DOI 10.3233/JAD-161192; Bischofberger M, 2012, CELL HOST MICROBE, V12, P266, DOI 10.1016/j.chom.2012.08.005; Bischofberger M, 2009, CURR OPIN CELL BIOL, V21, P589, DOI 10.1016/j.ceb.2009.04.003; Brodersen DE, 2000, ACTA CRYSTALLOGR D, V56, P431, DOI 10.1107/S0907444900000834; Buckley JT, 1995, BIOCHEMISTRY-US, V34, P16450, DOI 10.1021/bi00050a028; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cirauqui N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13714-4; Dal Peraro M, 2016, NAT REV MICROBIOL, V14, P77, DOI 10.1038/nrmicro.2015.3; Dang LY, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01368; Demori I, 2019, MOLECULES, V24, DOI 10.3390/molecules24020347; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Fivaz M, 2001, CURR TOP MICROBIOL, V257, P35; Galvin BD, 2008, GENETICS, V179, P403, DOI 10.1534/genetics.108.087221; Gao Q, 2011, BIOCHIMIE, V93, P1865, DOI 10.1016/j.biochi.2011.07.013; Gao ZH, 2019, FASEB J, V33, P782, DOI 10.1096/fj.201800087R; Guo XL, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0304-y; Heneka MT, 2018, NAT REV NEUROSCI, V19, P610, DOI 10.1038/s41583-018-0055-7; Jared SR, 2017, ADV PHYSIOL EDUC, V41, P444, DOI 10.1152/advan.00115.2016; Jia N, 2016, EMBO REP, V17, P235, DOI 10.15252/embr.201540851; Knapp O, 2010, OPEN TOXINOL J, V3, P53, DOI DOI 10.2174/1875414701003010053; Li SA, 2017, J INFECT DIS, V215, P1753, DOI 10.1093/infdis/jix183; Liu SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001770; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00262; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ogawa M, 1998, DEV GROWTH DIFFER, V40, P465; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; PARKER MW, 1994, NATURE, V367, P292, DOI 10.1038/367292a0; Perrin P, 2019, CURR OPIN IMMUNOL, V58, P1, DOI 10.1016/j.coi.2018.12.004; Salvador-Gallego R, 2016, EMBO J, V35, P389, DOI 10.15252/embj.201593384; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Shen H, 2016, SCI REP-UK, V6, DOI 10.1038/srep33905; Siddiqui WA, 2015, ARCH TOXICOL, V89, P289, DOI 10.1007/s00204-014-1448-7; Szczesny P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020349; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Wang FJ, 2018, TRAFFIC, V19, P918, DOI 10.1111/tra.12613; Wang QS, 2018, NUCL SCI TECH, V29, DOI 10.1007/s41365-018-0398-9; Wang S, 2019, INT IMMUNOPHARMACOL, V67, P458, DOI 10.1016/j.intimp.2018.12.019; Wang YJ, 2014, BBA-MOL CELL RES, V1843, P1393, DOI 10.1016/j.bbamcr.2014.04.005; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xiang Y, 2014, P NATL ACAD SCI USA, V111, P6702, DOI 10.1073/pnas.1321317111; Xu XQ, 2015, CHEM REV, V115, P1760, DOI 10.1021/cr4006704; Zeng L, 2012, TOXICON, V60, P290, DOI 10.1016/j.toxicon.2012.04.344; Zhang Y, 2012, J THROMB HAEMOST, V10, P411, DOI 10.1111/j.1538-7836.2011.04607.x; Zhang Y, 2011, CELL MOL LIFE SCI, V68, P3771, DOI 10.1007/s00018-011-0678-6; Zhang Yun, 2015, Zoological Research, V36, P183, DOI 10.13918/j.issn.2095-8137.2015.4.183; Zhao F, 2014, DNA RES, V21, P1, DOI 10.1093/dnares/dst035	53	8	8	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2020	295	30					10293	10306		10.1074/jbc.RA120.013556	http://dx.doi.org/10.1074/jbc.RA120.013556			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MW0BV	32499370	Green Published, hybrid			2022-12-26	WOS:000556713400016
J	Edsinger, E; Pnini, R; Ono, N; Yanagisawa, R; Dever, K; Miller, J				Edsinger, Eric; Pnini, Reuven; Ono, Natsumi; Yanagisawa, Ryoko; Dever, Kathryn; Miller, Jonathan			Social tolerance inOctopus laqueus-A maximum entropy model	PLOS ONE			English	Article							ABDOPUS-ACULEATUS DORBIGNY; OCTOPUS-CYANEA; BEHAVIOR; OCCUPANCY; VULGARIS; JOUBINI	Octopus laqueusis a small tropical octopus found in Okinawa, Japan and the greater Indo-Pacific. Octopus are often viewed as solitary animals butO. laqueuslive in close proximity in the wild, and will potentially encounter one another on a regular basis, raising the possibility of social tolerance. Adopting shared den occupancy in aquaria as a potential measure of social tolerance inO. laqueus, we studied the animals' preference for shared dens over solitude. We characterized dependence of sharing preference on sex, den availability and den occupancy density. We designed two simple social tolerance assays in aquaria with a total of 45 daily measurements: (i) Pots Equal, with equal numbers of octopuses and dens and (ii) Pots Limited, with a 3:1 ratio of octopuses to dens. We found thatO. laqueuswill socially tolerate other individuals by sharing tanks and dens and with typically no loss to cannibalism or escape. However, animals also exhibit significant levels of social repulsion, and individuals often chose a solitary den when given the option. The patterns of den occupancy are observed to be consistent with a maximum entropy model that balances seeking shelter against avoiding other animals. The model accurately captures and predicts the data and can be generalized to other organisms and their social interactions. Overall, inO. laqueusthe preference for a den is stronger than the preference to be solitary. The animals are tolerant of others with a mixture of sizes in the tank and even in a den, a reported first for octopuses outside mating. The relaxed disposition and social tolerance ofO. laqueusmake it a promising species to work with in the lab to explore social and potentially other behaviors in octopuses.	[Edsinger, Eric] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; [Edsinger, Eric; Dever, Kathryn] Univ Chicago, Marine Biol Lab, Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Woods Hole, MA 02543 USA; [Edsinger, Eric; Pnini, Reuven; Miller, Jonathan] Okinawa Inst Sci & Technol Grad Univ, Onna Son, Okinawa, Japan; [Ono, Natsumi] Okinawa Enetech, Urasoe City, Okinawa, Japan; [Yanagisawa, Ryoko] Okinawa Fisheries High Sch, Itoman, Okinawa, Japan	Salk Institute; Marine Biological Laboratory - Woods Hole; Okinawa Institute of Science & Technology Graduate University	Edsinger, E (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA.; Edsinger, E (corresponding author), Univ Chicago, Marine Biol Lab, Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Woods Hole, MA 02543 USA.; Edsinger, E (corresponding author), Okinawa Inst Sci & Technol Grad Univ, Onna Son, Okinawa, Japan.	eedsinger@salk.edu		Pnini, Reuven/0000-0002-2812-2232; Edsinger, Eric/0000-0002-1012-1506	Vetlesen Foundation grant; Human Frontiers In Science Program Research Grant [RGP0060/2017]; Okinawa Institute of Science and Technology Graduate University; National Science Foundation [PHY-1607611]	Vetlesen Foundation grant; Human Frontiers In Science Program Research Grant; Okinawa Institute of Science and Technology Graduate University(Okinawa Institute of Science & Technology Graduate University); National Science Foundation(National Science Foundation (NSF))	EE was funded as a Research Fellow under a Vetlesen Foundation grant (http://www.vetlesenfoundation.org/) and by Human Frontiers In Science Program Research Grant RGP0060/2017 (http://www.hfsp.org/).JM was funded by the Okinawa Institute of Science and Technology Graduate University (https://www.oist.jp/).Part of this work was performed by JM at the Aspen Center for Physics, which is supported by National Science Foundation grant PHY-1607611 (https://www.nsf.gov/).NO was employed by Okinawa Enetech Inc. The funders or employer provided support in the form of salaries for authors EE, JM, and NO but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Altman J. S., 1967, Report Underwater Association, V1966-67, P77; Boal JG, 2006, VIE MILIEU, V56, P69; Boal JG, 2011, VIE MILIEU, V61, P203; BOYLE PR, 1980, ANIM BEHAV, V28, P1123, DOI 10.1016/S0003-3472(80)80101-1; Caldwell RL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134152; Domingues P, 2012, AQUAC RES, V43, P26, DOI 10.1111/j.1365-2109.2011.02797.x; Edsinger E, 2018, CURR BIOL, V28, P3136, DOI 10.1016/j.cub.2018.07.061; Forsythe J.W, 1988, MALACOLOGIA; GERSCH HA, 1963, PHYS REV, V129, P959, DOI 10.1103/PhysRev.129.959; Hanlon R., 2018, OCTOPUS SQUID CUTTLE, P184; Hanlon RT, 2008, MAR FRESHW BEHAV PHY, V41, P19, DOI 10.1080/10236240701661123; Hernandez-Urcera J, 2014, J COMP PSYCHOL, V128, P427, DOI 10.1037/a0036883; Huffard CL, 2008, MAR BIOL, V154, P353, DOI 10.1007/s00227-008-0930-2; Huffard CL, 2007, J MOLLUS STUD, V73, P185, DOI 10.1093/mollus/eym015; Huffard CL, 2015, MOLLUSCAN RES, V35, P12, DOI 10.1080/13235818.2014.909558; Huffard CL, 2010, J COMP PSYCHOL, V124, P38, DOI 10.1037/a0017230; Ikeda Y, 2009, JPN PSYCHOL RES, V51, P146, DOI 10.1111/j.1468-5884.2009.00401.x; JAYNES ET, 1982, P IEEE, V70, P939, DOI 10.1109/PROC.1982.12425; Kaneko Natsumi, 2005, Bulletin of the National Science Museum Series A (Zoology), V31, P7; KAYES R J, 1974, Marine Behaviour and Physiology, V2, P337; Leite TS, 2009, FISH RES, V98, P85, DOI 10.1016/j.fishres.2009.04.001; Mangold-Wirz K., 1959, VIE MILIEU S, V13, P1; MATHER J, 1980, B MAR SCI, V30, P848; MATHER JA, 1982, ANIM BEHAV, V30, P1166, DOI 10.1016/S0003-3472(82)80207-8; MATHER JA, 1982, MAR BEHAV PHYSIOL, V8, P285, DOI 10.1080/10236248209387025; Mezard M., 2009, INFORM PHYS COMPUTAT, P32; Savoie W, 2018, ARTIF LIFE ROBOT, V23, P459, DOI 10.1007/s10015-018-0473-7; Scheel D, 2016, CURR BIOL, V26, P377, DOI 10.1016/j.cub.2015.12.033; Seltman H.J, 2018, EXPT DESIGN ANAL, P294; Stasyuk IV, 2017, PHYSICA B, V511, P109, DOI 10.1016/j.physb.2017.02.004; Thomas J. A., 2006, ELEMENTS INFORM THEO, P792; Tricarico E., 2014, BIOCOMMUNICATION ANI, P337, DOI [10.1007/978-94-007-7414-8_19, DOI 10.1007/978-94-007-7414-8_19]; Tricarico E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018710; VANHEUKELEM WF, 1977, LAB ANIM SCI, V27, P852; YARNALL JL, 1969, ANIM BEHAV, V17, P747, DOI 10.1016/S0003-3472(69)80022-9; Yasumuro H, 2015, MAR BIOL, V162, P763, DOI 10.1007/s00227-015-2622-z; Zeeh KM, 2009, FISH RES, V95, P362, DOI 10.1016/j.fishres.2008.08.002; ZWANZIG R, 1969, PHYS REV, V182, P280, DOI 10.1103/PhysRev.182.280	38	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2020	15	6							e0233834	10.1371/journal.pone.0233834	http://dx.doi.org/10.1371/journal.pone.0233834			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC0EC	32520975	Green Published, gold			2022-12-26	WOS:000542969500035
J	Martinez-Cava, A; Hernandez-Belmonte, A; Courel-Ibanez, J; Moran-Navarro, R; Gonzalez-Badillo, JJ; Pallares, JG				Martinez-Cava, Alejandro; Hernandez-Belmonte, Alejandro; Courel-Ibanez, Javier; Moran-Navarro, Ricardo; Gonzalez-Badillo, Juan Jose; Pallares, Jesus G.			Reliability of technologies to measure the barbell velocity: Implications for monitoring resistance training	PLOS ONE			English	Article							MOVEMENT VELOCITY; PERFORMANCE; REPRODUCIBILITY; VALIDITY	This study investigated the inter- and intra-device agreement of four new devices marketed for barbell velocity measurement. Mean, mean propulsive and peak velocity outcomes were obtained for bench press and full squat exercises along the whole load-velocity spectrum (from light to heavy loads). Measurements were simultaneously registered by two linear velocity transducers T-Force, two linear position transducers Speed4Lifts, two smartphone video-based systems My Lift, and one 3D motion analysis system STT. Calculations included infraclass correlation coefficient (ICC), Bland-Altman Limits of Agreement (LoA), standard error of measurement (SEM), smallest detectable change (SDC) and maximum errors (MaxError). Results were reported in absolute (m/s) and relative terms (%1RM). Three velocity segments were differentiated according to the velocity-load relationships for each exercise: heavy (>= 80% 1RM), medium (50% < 1RM < 80%) and light loads (<= 50% 1RM). Criteria for acceptable reliability were ICC > 0.990 and SDC < 0.07 m/s (similar to 5% 1RM). The T-Force device shown the best intra-device agreement (SDC = 0.01-0.02 m/s, LoA <0.01m/s, MaxError = 1.3-2.2%1RM). The Speed4Lifts and STT were found as highly reliable, especially against lifting velocities <= 1.0 m/s (Speed4Lifts, SDC = 0.01-0.05 m/s; STT, SDC = 0.02-0.04 m/s), whereas the My Lift app showed the worst results with errors well above the acceptable levels (SDC = 0.26-0.34 m/s, MaxError = 18.9-24.8%1RM). T-Force stands as the preferable option to assess barbell velocity and to identify technical errors of measurement for emerging monitoring technologies. Both the Speed4Lifts and STT are fine alternatives to T-Force for measuring velocity against high-medium loads (velocities <= 1.0 m/s), while the excessive errors of the newly updated My Lift app advise against the use of this tool for velocity-based resistance training.	[Martinez-Cava, Alejandro; Hernandez-Belmonte, Alejandro; Courel-Ibanez, Javier; Moran-Navarro, Ricardo; Pallares, Jesus G.] Univ Murcia, Human Performance & Sports Sci Lab, Fac Sport Sci, Murcia, Spain; [Gonzalez-Badillo, Juan Jose] Pablo de Olavide Univ, Fac Sport, Seville, Spain	University of Murcia; Universidad Pablo de Olavide	Pallares, JG (corresponding author), Univ Murcia, Human Performance & Sports Sci Lab, Fac Sport Sci, Murcia, Spain.	jgpallares@um.es	Hernández-Belmonte, Alejandro/M-9674-2019; Pallarés, Jesús G/J-3054-2016; PALLARES, JESUS G./AAW-3182-2020; Courel-Ibáñez, Javier/I-4264-2015	Hernández-Belmonte, Alejandro/0000-0002-0638-5859; Pallarés, Jesús G/0000-0002-6087-1583; PALLARES, JESUS G./0000-0002-6087-1583; Courel-Ibáñez, Javier/0000-0003-2446-1875				[Anonymous], 2019, DTBI S, V1, P1, DOI DOI 10.36811/RJCSE.2019.110001; Appleby BB, 2020, J STRENGTH COND RES, V34, P3118, DOI 10.1519/JSC.0000000000002803; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Balsalobre-Fernandez C, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00649; Balsalobre-Fernandez C, 2018, J SPORT SCI, V36, P64, DOI 10.1080/02640414.2017.1280610; Banyard HG, 2019, INT J SPORT PHYSIOL, V14, P246, DOI 10.1123/ijspp.2018-0147; Banyard HG, 2018, INT J SPORT PHYSIOL, V13, P763, DOI 10.1123/ijspp.2017-0610; Banyard HG, 2017, INT J SPORT PHYSIOL, V12, P1170, DOI 10.1123/ijspp.2016-0627; Beckerman H, 2001, QUAL LIFE RES, V10, P571, DOI 10.1023/A:1013138911638; Cormie P, 2011, SPORTS MED, V41, P125, DOI 10.2165/11538500-000000000-00000; Courel-Ibanez J, 2020, ANN BIOMED ENG, V48, P6, DOI 10.1007/s10439-019-02305-1; Courel-Ibanez J, 2019, ANN BIOMED ENG, V47, P1523, DOI 10.1007/s10439-019-02265-6; Dorrell HF, 2020, J STRENGTH COND RES, V34, P46, DOI 10.1519/JSC.0000000000003089; Franco-Marquez F, 2015, INT J SPORTS MED, V36, P906, DOI 10.1055/s-0035-1548890; Garcia-Ramos A, 2018, INT J SPORTS SCI COA, V13, P737, DOI 10.1177/1747954118791525; Garnacho-Castano MV, 2015, J SPORT SCI MED, V14, P128; Gentil P, 2018, APPL PHYSIOL NUTR ME, V43, P833, DOI 10.1139/apnm-2018-0011; Giavarina D, 2015, BIOCHEM MEDICA, V25, P141, DOI 10.11613/BM.2015.015; Gonzalez-Badillo JJ, 2010, INT J SPORTS MED, V31, P347, DOI 10.1055/s-0030-1248333; Gonzalez-Badillo JJ, 2014, EUR J SPORT SCI, V14, P772, DOI 10.1080/17461391.2014.905987; Mann JB, 2015, STRENGTH COND J, V37, P52, DOI 10.1519/SSC.0000000000000177; Martinez-Cava A, 2019, J SPORT SCI, V37, P1088, DOI 10.1080/02640414.2018.1544187; Martins WP, 2014, ULTRASOUND OBST GYN, V43, P479, DOI 10.1002/uog.13320; Orange ST, 2020, J STRENGTH COND RES, V34, P728, DOI 10.1519/JSC.0000000000002715; Ortega-Becerra M, 2018, J STRENGTH COND RES, V32, P1778, DOI 10.1519/JSC.0000000000002050; Pallares JG, 2015, SCAND J MED SCI SPOR, V25, pE603, DOI 10.1111/sms.12385; Pallares JG, 2020, EUR J SPORT SCI, V20, P115, DOI 10.1080/17461391.2019.1612952; Pallares JG, 2014, J SPORT SCI, V32, P1165, DOI 10.1080/02640414.2014.889844; Perez-Castilla A, 2019, J STRENGTH COND RES, V33, P1258, DOI 10.1519/JSC.0000000000003118; Randell AD, 2011, J STRENGTH COND RES, V25, P87, DOI 10.1519/JSC.0b013e3181fee634; Revicki D, 2008, J CLIN EPIDEMIOL, V61, P102, DOI 10.1016/j.jclinepi.2007.03.012; Sanchez-Medina L, 2014, INT J SPORTS MED, V35, P209, DOI 10.1055/s-0033-1351252; Sanchez-Medina L, 2010, INT J SPORTS MED, V31, P123, DOI 10.1055/s-0029-1242815; Sanchez-Medina Luis, 2017, Sports Med Int Open, V1, pE80, DOI 10.1055/s-0043-102933; Sanchez-Medina L, 2011, MED SCI SPORT EXER, V43, P1725, DOI 10.1249/MSS.0b013e318213f880; Sanchez-Pay A, 2019, MEASUREMENT, V137, P355, DOI 10.1016/j.measurement.2019.01.006; Tomasevicz CL, 2020, J SCI MED SPORT, V23, P7, DOI 10.1016/j.jsams.2019.07.014; Vas S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059809, 10.1371/journal.pone.0073990]	38	31	31	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2020	15	6							e0232465	10.1371/journal.pone.0232465	http://dx.doi.org/10.1371/journal.pone.0232465			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC0EC	32520952	gold, Green Published			2022-12-26	WOS:000542969500030
J	Lazarini, JG; Franchin, M; Soares, JC; Nani, BD; Massarioli, AP; de Alencar, SM; Rosalen, PL				Lazarini, Josy Goldoni; Franchin, Marcelo; Soares, Jackeline Cintra; Nani, Bruno Dias; Massarioli, Adna Prado; de Alencar, Severino Matias; Rosalen, Pedro Luiz			Anti-inflammatory and antioxidant potential, in vivo toxicity, and polyphenolic composition of Eugenia selloi BDJacks. (pitangatuba), a Brazilian native fruit	PLOS ONE			English	Article							DAD-ESI-MS/MS; NF-KAPPA-B; PHENOLIC-COMPOUNDS; REACTIVE OXYGEN; IDENTIFICATION; INFLAMMATION; QUANTIFICATION; CHROMATOGRAPHY; BRASILIENSIS; EXTRACTION	Brazilian native fruits are a rich source of polyphenolic compounds that can act as anti-inflammatory and antioxidant agents. Here, we determined the polyphenolic composition, anti-inflammatory mechanism of action, antioxidant activity and systemic toxicity in Galleria mellonella larvae of Eugenia selloi B.D.Jacks. (synonym Eugenia neonitida Sobral) extract (Ese) and its polyphenol-rich fraction (F3) obtained through bioassay-guided fractionation. Phenolic compounds present in Ese and F3 were identified by LC-ESI-QTOF-MS. The anti-inflammatory activity of Ese and F3 was tested in vitro and in vivo through NF-kappa B activation, cytokine release and neutrophil migration assays. The samples were tested for their effects against reactive species (ROO center dot, O2 center dot-, HOCl and NO center dot) and for their toxicity in Galleria mellonella larvae model. The presence of hydroxybenzoic acid, ellagitannins and flavonoids was identified. Ese and F3 reduced NF-kappa B activation, cytokine release and neutrophil migration, with F3 being three-fold more potent. Overall, F3 exhibited strong antioxidant effects against biologically relevant radicals, and neither Ese nor F3 were toxic to G. mellonella larvae. In conclusion, Ese and F3 revealed the presence of phenolic compounds that decreased the inflammatory parameters evaluated and inhibited reactive oxygen/nitrogen species. E. selloi is a novel source of bioactive compounds that may provide benefits for human health.	[Lazarini, Josy Goldoni; Franchin, Marcelo; Nani, Bruno Dias; Rosalen, Pedro Luiz] Univ Estadual Campinas, Piracicaba Dent Sch, Dept Physiol Sci, Piracicaba, SP, Brazil; [Franchin, Marcelo] Fed Univ Alfenas UNIFAL, Fac Dent, Alfenas, MG, Brazil; [Soares, Jackeline Cintra; Massarioli, Adna Prado; de Alencar, Severino Matias] Univ Sao Paulo, Luiz de Queiroz Coll Agr, Dept Agrifood Ind Food & Nutr, Piracicaba, SP, Brazil; [Rosalen, Pedro Luiz] Fed Univ Alfenas UNIFAL, Biol Sci Grad Program, Alfenas, MG, Brazil	Universidade Estadual de Campinas; Universidade Federal de Alfenas; Universidade de Sao Paulo; Universidade Federal de Alfenas	Franchin, M; Rosalen, PL (corresponding author), Univ Estadual Campinas, Piracicaba Dent Sch, Dept Physiol Sci, Piracicaba, SP, Brazil.; Franchin, M (corresponding author), Fed Univ Alfenas UNIFAL, Fac Dent, Alfenas, MG, Brazil.; Rosalen, PL (corresponding author), Fed Univ Alfenas UNIFAL, Biol Sci Grad Program, Alfenas, MG, Brazil.	marcelo.franchin@yahoo.com; rosalen@fop.unicamp.br	Alencar, Severino Matias/B-7743-2012; Massarioli, Adna Prado/I-4840-2013; Franchin, Marcelo/M-7636-2017; Soares, Jackeline/L-5019-2018	Alencar, Severino Matias/0000-0002-6637-7973; Massarioli, Adna Prado/0000-0002-2747-0788; Franchin, Marcelo/0000-0001-5613-2756; Rosalen, Pedro Luiz/0000-0003-0812-4027; Soares, Jackeline/0000-0003-2552-0494	Sao Paulo Research Foundation (FAPESP) [2016/02926-6, 2017/09898-0]; National Council for Scientific and Technological Development (CNPq) [310522/2015-3, 307893/2016-2]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES) [001]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by the Sao Paulo Research Foundation (FAPESP, grant numbers 2016/02926-6 to JGL and 2017/09898-0 to PLR); the National Council for Scientific and Technological Development (CNPq, Grant #310522/2015-3 to PLR and 307893/2016-2 to SMdA); and part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES) - Finance Code 001 to JGL. There was no additional external funding for this study.	Aaby K, 2013, LWT-FOOD SCI TECHNOL, V54, P257, DOI 10.1016/j.lwt.2013.05.031; Aguirre L., 2011, OPEN NUTRACEUTICALS, V4, P189, DOI [10.2174/1876396001104010189, DOI 10.2174/1876396001104010189]; Barros L, 2012, PLANT FOOD HUM NUTR, V67, P229, DOI 10.1007/s11130-012-0307-z; Baskaran R, 2016, FOOD RES INT, V82, P121, DOI 10.1016/j.foodres.2016.02.001; Campbell TF, 2017, J FUNCT FOODS, V37, P49, DOI 10.1016/j.jff.2017.07.040; Chang SK, 2019, CRIT REV FOOD SCI, V59, P1580, DOI 10.1080/10408398.2017.1422111; Chekalina N, 2018, INDIAN HEART J, V70, P593, DOI 10.1016/j.ihj.2018.04.006; Crasci L, 2018, DRUG RES, V68, P132, DOI 10.1055/s-0043-120662; de Araujo FF, 2019, FOOD RES INT, V121, P57, DOI 10.1016/j.foodres.2019.03.018; de Souza AM, 2018, PLANTA MED, V84, P1232, DOI 10.1055/a-0656-7262; Essid C., 2017, ENTOMOPHAGY W WORLD; Figueiroa ED, 2013, SCI WORLD J, DOI 10.1155/2013/125027; Fracassetti D, 2013, FOOD CHEM, V139, P578, DOI 10.1016/j.foodchem.2013.01.121; Fraige K, 2018, PHYTOCHEM ANALYSIS, V29, P196, DOI 10.1002/pca.2734; Freires IA, 2017, PHARM RES-DORDR, V34, P681, DOI 10.1007/s11095-016-2069-z; Fumagalli M, 2016, PHARMACOL RES, V111, P703, DOI 10.1016/j.phrs.2016.07.028; Grace MH, 2014, FOOD CHEM, V158, P229, DOI 10.1016/j.foodchem.2014.02.117; Huang DJ, 2005, J AGR FOOD CHEM, V53, P1841, DOI 10.1021/jf030723c; Infante J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152974; Kadioglu O, 2015, ANTICANCER RES, V35, P2645; Kelebek H, 2016, FOOD CHEM, V204, P227, DOI 10.1016/j.foodchem.2016.02.132; Kolniak-Ostek J, 2016, J FOOD COMPOS ANAL, V49, P65, DOI 10.1016/j.jfca.2016.04.004; Lavecchia T, 2013, CRIT REV FOOD SCI, V53, P198, DOI 10.1080/10408398.2010.520829; Lazarini JG, 2018, BIOMED PHARMACOTHER, V102, P132, DOI 10.1016/j.biopha.2018.03.034; Lazarini JG, 2016, J FUNCT FOODS, V26, P249, DOI 10.1016/j.jff.2016.08.001; Liew SS, 2018, PEERJ, V6, DOI 10.7717/peerj.5331; Martinez-Las Heras R, 2016, J FUNCT FOODS, V23, P370, DOI 10.1016/j.jff.2016.02.048; Melo PS, 2015, FOOD CHEM, V181, P160, DOI 10.1016/j.foodchem.2015.02.087; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Moukette BM, 2015, BIOL RES, V48, DOI 10.1186/s40659-015-0003-1; Negri T.C., 2016, BIOS, V18, P83; Sardi JDO, 2017, MICROB PATHOGENESIS, V105, P280, DOI 10.1016/j.micpath.2017.02.044; Pietrovski EF, 2008, J PHARM PHARMACOL, V60, P479, DOI 10.1211/jpp.60.4.0011; Pinho-Ribeiro FA, 2016, INFLAMMOPHARMACOLOGY, V24, P97, DOI 10.1007/s10787-016-0266-3; Regueiro J, 2014, FOOD CHEM, V152, P340, DOI 10.1016/j.foodchem.2013.11.158; Rodrigues E, 2013, J AGR FOOD CHEM, V61, P3022, DOI 10.1021/jf3054214; Saldanha LL, 2013, MOLECULES, V18, P8402, DOI 10.3390/molecules18078402; Sharma D, 2019, BIOMED PHARMACOTHER, V109, P1610, DOI 10.1016/j.biopha.2018.10.195; Soares JC, 2019, FOOD CHEM, V281, P178, DOI 10.1016/j.foodchem.2018.12.106; Sousa JAC, 2017, ENVIRON MONIT ASSESS, V189, DOI 10.1007/s10661-017-5854-1; Taniguchi K, 2018, NAT REV IMMUNOL, V18, P309, DOI 10.1038/nri.2017.142; Thulasingam S, 2011, MOL CELL BIOCHEM, V352, P181, DOI 10.1007/s11010-011-0752-2	42	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2020	15	6							e0234157	10.1371/journal.pone.0234157	http://dx.doi.org/10.1371/journal.pone.0234157			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ1GC	32516332	Green Published, gold			2022-12-26	WOS:000540977000021
J	Muller, C; Hethke, M; Riedel, F; Helle, G				Mueller, Carolina; Hethke, Manja; Riedel, Frank; Helle, Gerhard			Inter- and intra-tree variability of carbon and oxygen stable isotope ratios of modern pollen from nine European tree species	PLOS ONE			English	Article							OAK QUERCUS-ROBUR; LEAF PHENOLOGY; PINUS-SYLVESTRIS; POACEAE POLLEN; RINGS; TEMPERATURE; CLIMATE; DISCRIMINATION; DELTA-C-13; RESPONSES	Stable carbon and oxygen isotope ratios of raw pollen sampled from nine abundant tree species growing in natural habitats of central and northern Europe were investigated to understand the intra- and inter-specific variability of pollen-isotope values. All species yielded specific delta C-13(pollen) and delta O-18(pollen) values and patterns, which can be ascribed to their physiology and habitat preferences. Broad-leaved trees flowering early in the year before leaf proliferation (Alnus glutinosa and Corylus avellana) exhibited on average 2.6 parts per thousand lower delta C-13(pollen) and 3.1 parts per thousand lower delta O-18(pollen) values than broad-leaved and coniferous trees flowering during mid and late spring (Acer pseudoplatanus, Betula pendula, Carpinus betulus, Fagus sylvatica, Picea abies, Pinus sylvestris and Quercus robur). Mean species-specific delta C-13(pollen) values did not change markedly over time, whereas delta O-18(pollen) values of two consecutive years were often statistically distinct. An intra-annual analysis of B. pendula and P. sylvestris pollen revealed increasing delta O-18(pollen) values during the final weeks of pollen development. However, the delta C-13(pollen) values remained consistent throughout the pollen-maturation process. Detailed intra-individual analysis yielded circumferential and height-dependent variations within carbon and oxygen pollen-isotopes and the sampling position on a tree accounted for differences of up to 3.5 parts per thousand for delta C-13(pollen) and 2.1 parts per thousand for delta O-18(pollen). A comparison of isotope ranges from different geographic settings revealed gradients between maritime and continental as well as between high and low altitudinal study sites. The results of stepwise regression analysis demonstrated, that carbon and oxygen pollen-isotopes also reflect local non-climate environmental conditions. A detailed understanding of isotope patterns and ranges in modern pollen is necessary to enhance the accuracy of palaeoclimate investigations on delta C-13 and delta O-18 of fossil pollen. Furthermore, pollen-isotope values are species-specific and the analysis of species growing during different phenophases may be valuable for palaeoweather reconstructions of different seasons.	[Mueller, Carolina; Hethke, Manja; Riedel, Frank; Helle, Gerhard] Free Univ Berlin, Inst Geol Sci, Palaeontol, Berlin, Germany; [Mueller, Carolina; Helle, Gerhard] GFZ German Res Ctr Geosci, Sect Climate Dynam & Landscape Evolut 4 3, Potsdam, Germany	Free University of Berlin; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences	Muller, C (corresponding author), Free Univ Berlin, Inst Geol Sci, Palaeontol, Berlin, Germany.; Muller, C (corresponding author), GFZ German Res Ctr Geosci, Sect Climate Dynam & Landscape Evolut 4 3, Potsdam, Germany.	carolina.mueller@fu-berlin.de	Hethke, Manja/ABG-3254-2020	Hethke, Manja/0000-0002-0220-8492	Deutsche Forschungsgesellschaft (DFG) [RI 809/33-1]	Deutsche Forschungsgesellschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgesellschaft (DFG) [grant number RI 809/33-1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are thankful to the students who helped duringfieldwork and sample preparation in the laboratory: Julian Hennig, Camilla Brunello, Franziska Pritzke, Alena Zippel, Hendrik Schultz and Vanessa Skiba. Also, we thank Maike Glos (Freie Universitat Berlin) for discussion, support and consultations concerning laboratory methods. We also acknowledge Raffella Dibona and all colleagues from the Centro Studi Ambiente Alpino in San Vito Di Cadore for accommodation during fieldwork in Italy and discussions about the biogeography in the adjoining Dolomite Mountains. Additionally, we are very grateful to Vincent Duponcheel (Foret d'Anlier), Nils Altvater, Ralf Pauli (both Muritz NP) and Pawel Czarnota (Gorczaski NP) for regional information about the national parks, local phenology and seasonality as well as pollinator behaviour. We also thank two anonymous reviewers for many positive comments and suggestions to improve an earlier version of the manuscript.	Ahas R, 2002, INT J CLIMATOL, V22, P1727, DOI 10.1002/joc.818; Amundson R, 1997, REV PALAEOBOT PALYNO, V99, P17, DOI 10.1016/S0034-6667(97)00031-6; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Archetti M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057373; Bell BA, 2019, J QUATERNARY SCI, V34, P323, DOI 10.1002/jqs.3103; Bell BA, 2017, REV PALAEOBOT PALYNO, V244, P128, DOI 10.1016/j.revpalbo.2017.04.008; BENNETT KD, 1990, J QUATERNARY SCI, V5, P123, DOI 10.1002/jqs.3390050204; Beug H.J, 2004, LEITFADEN POLLENBEST; Bezrukova EV, 2010, PALAEOGEOGR PALAEOCL, V296, P185, DOI 10.1016/j.palaeo.2010.07.020; Birks H.J.B., 1980, QUATERNARY PALAEOECO; Blackmore S, 2007, NEW PHYTOL, V174, P483, DOI 10.1111/j.1469-8137.2007.02060.x; BRETT D. W., 1964, NEW PHYTOL, V63, P96, DOI 10.1111/j.1469-8137.1964.tb07363.x; BURK RL, 1981, SCIENCE, V211, P1417, DOI 10.1126/science.211.4489.1417; Cheddadi R, 2006, GLOBAL ECOL BIOGEOGR, V15, P271, DOI [10.1111/j.1466-822x.2006.00226.x, 10.1111/j.1466-822X.2006.00226.x]; Chesson LA, 2011, FOOD CHEM, V125, P576, DOI 10.1016/j.foodchem.2010.09.050; Chesson LA, 2013, GRANA, V52, P305, DOI 10.1080/00173134.2013.841751; Chuine I, 2000, J ECOL, V88, P561, DOI 10.1046/j.1365-2745.2000.00468.x; Crepinsek Z, 2012, INT J BIOMETEOROL, V56, P681, DOI 10.1007/s00484-011-0469-7; Datta R, 2002, PLANT PHYSIOL, V130, P1645, DOI 10.1104/pp.006908; Dawson TE, 2002, ANNU REV ECOL SYST, V33, P507, DOI 10.1146/annurev.ecolsys.33.020602.095451; Demske D, 2013, QUATERN INT, V290, P164, DOI 10.1016/j.quaint.2012.02.002; Descolas-Gros C, 2007, NEW PHYTOL, V176, P390, DOI 10.1111/j.1469-8137.2007.02176.x; DONGMANN G, 1974, RADIAT ENVIRON BIOPH, V11, P41, DOI 10.1007/BF01323099; EHLERINGER JR, 1992, PLANT CELL ENVIRON, V15, P1073, DOI 10.1111/j.1365-3040.1992.tb01657.x; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Flanagan LB, 2014, PLANT CELL ENVIRON, V37, P425, DOI 10.1111/pce.12165; Gallinat AS, 2015, TRENDS ECOL EVOL, V30, P169, DOI 10.1016/j.tree.2015.01.004; Gaudinski JB, 2009, GLOBAL CHANGE BIOL, V15, P992, DOI 10.1111/j.1365-2486.2008.01736.x; George E, 1997, TREE PHYSIOL, V17, P39; Gessler A, 2014, TREE PHYSIOL, V34, P796, DOI 10.1093/treephys/tpu040; Graham HV, 2014, GEOCHIM COSMOCHIM AC, V144, P82, DOI 10.1016/j.gca.2014.08.032; Griener KW, 2013, PALAEOGEOGR PALAEOCL, V383, P72, DOI 10.1016/j.palaeo.2013.05.004; Helle G, 2004, PLANT CELL ENVIRON, V27, P367, DOI 10.1111/j.0016-8025.2003.01159.x; Hultine KR, 2000, OECOLOGIA, V123, P32, DOI 10.1007/s004420050986; INGESTAD T, 1979, PHYSIOL PLANTARUM, V45, P373, DOI 10.1111/j.1399-3054.1979.tb02599.x; Jahren AH, 2004, REV PALAEOBOT PALYNO, V132, P291, DOI 10.1016/j.revpalbo.2004.08.001; Jones PD, 2009, HOLOCENE, V19, P3, DOI 10.1177/0959683608098952; Kamenik C, 2009, J QUATERNARY SCI, V24, P529, DOI 10.1002/jqs.1266; Kampstra P., 2008, J STAT SOFTW, V28, P1, DOI [10.18637/jss.v028.c01, DOI 10.18637/JSS.V028.C01]; KIKUZAWA K, 1995, CAN J BOT, V73, P158, DOI 10.1139/b95-019; King DC, 2012, RAPID COMMUN MASS SP, V26, P2165, DOI 10.1002/rcm.6333; KORNER C, 1991, OECOLOGIA, V88, P30, DOI 10.1007/BF00328400; Kramer K., 1996, PHENOLOGY GROWTH EUR; Krizo M, 1997, B POLISH ACAD SCI BI, V45, P2; Leavitt SW, 2010, SCI TOTAL ENVIRON, V408, P5244, DOI 10.1016/j.scitotenv.2010.07.057; LEAVITT SW, 1984, NATURE, V311, P145, DOI 10.1038/311145a0; LEAVITT SW, 1986, ECOLOGY, V67, P1002, DOI 10.2307/1939823; LEJOLY-GABRIEL M, 1983, Grana, V22, P59; Loader NJ, 2004, QUATERNARY SCI REV, V23, P893, DOI 10.1016/j.quascirev.2003.06.015; Loader NJ, 2001, HOLOCENE, V11, P587, DOI 10.1191/095968301680223530; Lockheart MJ, 1997, ORG GEOCHEM, V26, P137, DOI 10.1016/S0146-6380(96)00135-0; LOESCHER WH, 1990, HORTSCIENCE, V25, P274, DOI 10.21273/HORTSCI.25.3.274; Luomajoki A, 1986, ACTA FOR FENN, V196; McCarroll D, 2004, QUATERNARY SCI REV, V23, P771, DOI 10.1016/j.quascirev.2003.06.017; MCVEAN DN, 1953, J ECOL, V41, P447, DOI 10.2307/2257070; Michelot A, 2012, TREE PHYSIOL, V32, P1033, DOI 10.1093/treephys/tps052; Moore P.D., 1991, BLACKWELL SCI PUBLI; Morecroft MD, 2003, INT J BIOMETEOROL, V47, P221, DOI 10.1007/s00484-003-0173-3; Morecroft MD, 1999, FUNCT ECOL, V13, P332, DOI 10.1046/j.1365-2435.1999.00327.x; Muller C, 2017, QUATERN INT, V444, P1, DOI 10.1016/j.quaint.2017.05.058; Myszkowska D, 2010, AEROBIOLOGIA, V26, P209, DOI 10.1007/s10453-010-9157-z; Nelson DM, 2008, EARTH PLANET SC LETT, V269, P11, DOI 10.1016/j.epsl.2008.03.001; Nelson DM, 2006, HOLOCENE, V16, P819, DOI 10.1191/0959683606hol974rp; Nelson DM, 2012, NEW PHYTOL, V195, P787, DOI 10.1111/j.1469-8137.2012.04219.x; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; Panagos P, 2012, LAND USE POLICY, V29, P329, DOI 10.1016/j.landusepol.2011.07.003; Paul D, 2007, RAPID COMMUN MASS SP, V21, P3006, DOI 10.1002/rcm.3185; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; R Studio Team, 2016, RSTUDIO INT DEV ENV; Richardson AD, 2013, NEW PHYTOL, V197, P850, DOI 10.1111/nph.12042; Rotzer T, 2001, CLIM RES, V18, P249, DOI 10.3354/cr018249; Rowley JR, 2000, PLANT SYST EVOL, V225, P201, DOI 10.1007/BF00985468; Saurer M., 1989, Dendrochronologia, V7, P9; Saurer M, 1997, TELLUS B, V49, P80, DOI 10.1034/j.1600-0889.49.issue1.6.x; Scheifinger H, 2002, INT J CLIMATOL, V22, P1739, DOI 10.1002/joc.817; SCHLESER GH, 1999, FOSSIL PLANTS SPORES, P306; Schonwiese C, 2013, KLIMAANDERUNGEN DATE; Schuster C, 2014, INT J BIOMETEOROL, V58, P485, DOI 10.1007/s00484-013-0709-0; Schwarz DM, 2016, THESIS; SPARKS TH, 1995, J ECOL, V83, P321, DOI 10.2307/2261570; Speer JH, 2010, FUNDAMENTALS TREE RI; Stach A, 2008, INT J BIOMETEOROL, V52, P311, DOI 10.1007/s00484-007-0127-2; Traverse A., 2007, TOPICS GEOBIOLOGY; Treydte K, 2001, TELLUS B, V53, P593, DOI 10.1034/j.1600-0889.2001.530505.x; Urban MA, 2016, PALAEOGEOGR PALAEOCL, V443, P10, DOI 10.1016/j.palaeo.2015.11.012; Urban MA, 2013, GEOCHIM COSMOCHIM AC, V121, P168, DOI 10.1016/j.gca.2013.07.019; van der Sleen P, 2017, FUNCT ECOL, V31, P1674, DOI 10.1111/1365-2435.12889; van Roij L, 2017, RAPID COMMUN MASS SP, V31, P47, DOI 10.1002/rcm.7769; Vitasse Y, 2009, OECOLOGIA, V161, P187, DOI 10.1007/s00442-009-1363-4; Vitasse Y, 2009, AGR FOREST METEOROL, V149, P735, DOI 10.1016/j.agrformet.2008.10.019; Warren CR, 2001, OECOLOGIA, V127, P476, DOI 10.1007/s004420000609; Wilczek AM, 2010, PHILOS T R SOC B, V365, P3129, DOI 10.1098/rstb.2010.0128; Willis CG, 2008, P NATL ACAD SCI USA, V105, P17029, DOI 10.1073/pnas.0806446105	93	3	3	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2020	15	6							e0234315	10.1371/journal.pone.0234315	http://dx.doi.org/10.1371/journal.pone.0234315			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ1GC	32516353	Green Published, gold			2022-12-26	WOS:000540977000003
J	Fundisi, E; Musakwa, W; Ahmed, FB; Tesfamichael, SG				Fundisi, Emmanuel; Musakwa, Walter; Ahmed, Fethi B.; Tesfamichael, Solomon G.			Estimation of woody plant species diversity during a dry season in a savanna environment using the spectral and textural information derived from WorldView-2 imagery	PLOS ONE			English	Article							STRUCTURAL DIVERSITY; ECOSYSTEM SERVICES; SATELLITE IMAGERY; BETA-DIVERSITY; SOUTH-AFRICA; VEGETATION; CLASSIFICATION; BIODIVERSITY; LANDSCAPE; NDVI	Remote sensing techniques are useful in the monitoring of woody plant species diversity in different environments including in savanna vegetation types. However, the performance of satellite imagery in assessing woody plant species diversity in dry seasons has been understudied. This study aimed to assess the performance of multiple Gray Level Co-occurrence Matrices (GLCM) derived from individual bands of WorldView-2 satellite imagery to quantify woody plant species diversity in a savanna environment during the dry season. Woody plant species were counted in 220 plots (20 m radius) and subsequently converted to a continuous scale of the Shannon species diversity index. The index regressed against the GLCMs using the all-possible-subsets regression approach that builds competing models to choose from. Entropy GLCM yielded the best overall accuracy (adjusted R-2: 0.41-0.46; Root Mean Square Error (RMSE): 0.60-0.58) in estimating species diversity. The effect of the number of predicting bands on species diversity estimation was also explored. Accuracy generally increased when three-five bands were used in models but stabilised or gradually decreased as more than five bands were used. Despite the peak accuracies achieved with three-five bands, performances still fared well for models that used fewer bands, showing the relevance of few bands for species diversity estimation. We also assessed the effect of GLCM window size (3x3, 5x5 and 7x7) on species diversity estimation and generally found inconsistent conclusions. These findings demonstrate the capability of GLCMs combined with high spatial resolution imagery in estimating woody plants species diversity in a savanna environment during the dry period. It is important to test the performance of species diversity estimation of similar environmental set-ups using widely available moderate-resolution imagery.	[Fundisi, Emmanuel; Tesfamichael, Solomon G.] Univ Johannesburg, Dept Geog Environm Management & Energy Studies, Johannesburg, South Africa; [Musakwa, Walter] Univ Johannesburg, Dept Urban & Reg Planning, Future Earth & Ecosyst Serv Res Grp, Doornfontein Campus, Johannesburg, South Africa; [Ahmed, Fethi B.] Univ Witwatersrand, Sch Geog Archaeol & Environm Studies, Johannesburg, South Africa	University of Johannesburg; University of Johannesburg; University of Witwatersrand	Fundisi, E; Tesfamichael, SG (corresponding author), Univ Johannesburg, Dept Geog Environm Management & Energy Studies, Johannesburg, South Africa.	sgtesfamichael@uj.ac.za; fundisye@icloud.com		FUNDISI, EMMANUEL/0000-0002-1609-1029; Musakwa, Walter/0000-0003-2173-0072; Ahmed, Fethi/0000-0001-5947-9835; , Solomon/0000-0002-4754-5732	University of Johannesburg (South Africa); National Research Foundation (NRF) of South Africa [SFH150803134516, 110778, 119288]	University of Johannesburg (South Africa); National Research Foundation (NRF) of South Africa(National Research Foundation - South Africa)	The University of Johannesburg (South Africa) provided the necessary financial and material support to undertake the study. We thank the National Research Foundation (NRF) of South Africa for supporting the first author through student scholarship programme (Reference SFH150803134516) and the second author through Grants No 110778 and 119288.	Adler-Golden SM, 1999, PROC SPIE, V3753, P61, DOI 10.1117/12.366315; Akaike H., 1973, P 2 INT S INF THEOR; Almeida DRA, 2019, FOREST ECOL MANAG, V438, P34, DOI 10.1016/j.foreco.2019.02.002; [Anonymous], 2003, LITURGY, V18, P33; Arekhi M, 2017, ENVIRON MONIT ASSESS, V189, DOI 10.1007/s10661-017-6295-6; Bernstein LS, 2005, P SOC PHOTO-OPT INS, V5806, P668, DOI 10.1117/12.603359; Bommarco R, 2013, TRENDS ECOL EVOL, V28, P230, DOI 10.1016/j.tree.2012.10.012; Brehaut L, 2018, ECOL INDIC, V91, P698, DOI 10.1016/j.ecolind.2018.04.052; Bunting P, 2006, REMOTE SENS ENVIRON, V101, P230, DOI 10.1016/j.rse.2005.12.015; Burnham K. P., 2002, ECOLOGICAL MODELLING, V172, DOI [10.1016/j.ecolmodel.2003.11.004, DOI 10.1016/J.ECOLMODEL.2003.11.004]; Campos VE, 2018, ECOL INDIC, V88, P63, DOI 10.1016/j.ecolind.2018.01.032; Carleo G, 2019, SOFTWAREX, V10, DOI 10.1016/j.softx.2019.100311; Carrijo TF, 2009, J INSECT CONSERV, V13, P575, DOI 10.1007/s10841-008-9205-y; Castillo-Riffart I, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9070681; Chaluvadi Mahesh, 2012, IETE Journal of Education, V53, P9; Chavez PS, 1996, PHOTOGRAMMETRIC ENG; Cho MA, 2015, INT J APPL EARTH OBS, DOI [10.1016/j.jag.2015.11.001, DOI 10.1016/J.JAG.2015.11.001]; Cleland EE, 2012, ECOLOGY, V93, P1765, DOI 10.1890/11-1912.1; Coburn CA, 2004, INT J REMOTE SENS, V25, P4287, DOI 10.1080/0143116042000192367; Silveira EMD, 2019, FOREST ECOL MANAG, V452, DOI 10.1016/j.foreco.2019.117575; Deng W, 2018, PALGR SER ASIA PAC, P1, DOI 10.1007/978-981-10-8345-7; Dieler J, 2017, EUR J FOREST RES, V136, P739, DOI 10.1007/s10342-017-1056-1; Gao JL, 2019, ISPRS J PHOTOGRAMM, V147, P104, DOI 10.1016/j.isprsjprs.2018.11.015; George-Chacon SP, 2019, ECOL INDIC, V101, P975, DOI 10.1016/j.ecolind.2019.02.015; Gholizadeh H, 2019, REMOTE SENS ENVIRON, V221, P38, DOI 10.1016/j.rse.2018.10.037; Gillon D, 2004, AGR FOREST METEOROL, V124, P51, DOI 10.1016/j.agrformet.2004.01.004; Gonzalez RC, 1992, DIGITAL IMAGE PROCES, P1; Graf W, 2019, REMOTE SENS ENVIRON, V232, DOI 10.1016/j.rse.2019.111305; Hall-Beyer M, 2017, INT J REMOTE SENS, V38, P1312, DOI 10.1080/01431161.2016.1278314; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; He KS, 2009, ACTA OECOL, V35, P14, DOI 10.1016/j.actao.2008.07.006; HOCKING RR, 1967, TECHNOMETRICS, V9, P531, DOI 10.2307/1266192; Ibrahim S, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11080898; Jawak SD, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11161909; Kadane JB, 2004, J AM STAT ASSOC, V99, P279, DOI 10.1198/016214504000000269; Karlson M, 2015, REMOTE SENSING, DOI [10.1080/01431161.2015.1101505, DOI 10.1080/01431161.2015.1101505]; Kruger AC, 2017, WATER SA, V43, P285, DOI 10.4314/wsa.v43i2.12; Lillesand T.M., 2015, REMOTE SENSING IMAGE, V7th; Loranty MM, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10111686; Lu D, 2007, INT J REMOTE SENS, V28, P823, DOI 10.1080/01431160600746456; Lu DS, 2014, GISCI REMOTE SENS, V51, P695, DOI 10.1080/15481603.2014.983338; Lu DS, 2010, PHOTOGRAMM ENG REM S, V76, P1159, DOI 10.14358/PERS.76.10.1159; Ludwig M, 2019, REMOTE SENS ENVIRON, V222, P195, DOI 10.1016/j.rse.2018.12.019; Luize Bruno Garcia, 2018, PLoS One, V13, pe0198130, DOI 10.1371/journal.pone.0198130; Macintyre P, 2020, INT J APPL EARTH OBS, V85, DOI 10.1016/j.jag.2019.101980; MacKellar N, 2014, S AFR J SCI, V110, P51, DOI 10.1590/sajs.2014/20130353; Madonsela S, 2018, INT J APPL EARTH OBS, V66, P106, DOI 10.1016/j.jag.2017.11.005; Madonsela S, 2017, ISPRS J PHOTOGRAMM, V133, P116, DOI 10.1016/j.isprsjprs.2017.10.008; Madonsela S, 2017, INT J APPL EARTH OBS, V58, P65, DOI 10.1016/j.jag.2017.01.018; Mapfumo RB, 2017, GEOCARTO INT, V32, P514, DOI 10.1080/10106049.2016.1161074; Marks CO, 2016, ECOL LETT, V19, P743, DOI 10.1111/ele.12608; Medeiros ESES, 2019, J ARID ENVIRON, V166, P43, DOI 10.1016/j.jaridenv.2019.03.001; Meng JH, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8020125; Molezzi MG, 2019, TECTONOPHYSICS, V761, P65, DOI 10.1016/j.tecto.2019.04.004; Momeni R, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8020088; Mucina L., 2006, STRELITZIA, V19, P616; Munyati C, 2018, INT J REMOTE SENS, V39, P5997, DOI 10.1080/01431161.2018.1508922; Ouma YO, 2008, INT J REMOTE SENS, DOI [10.1080/01431160701474545, DOI 10.1080/01431160701474545]; Ozkan UY, 2017, J FORESTRY RES, V28, P805, DOI 10.1007/s11676-016-0353-8; R Core Team, 2019, R LANG ENV STAT COMP; Rocchini D, 2016, REMOTE SENS ECOL CON, DOI [10.1002/rse2.32, DOI 10.1002/RSE2.32]; Rocchini D, 2018, METHODS ECOL EVOL, V9, P1787, DOI 10.1111/2041-210X.12941; Rocchini D, 2010, ECOL INFORM, V5, P318, DOI 10.1016/j.ecoinf.2010.06.001; Rouse J.W, 1973, 3 EARTH RES TECHN SA, V1, P309; Saatchi S, 2008, REMOTE SENS ENVIRON, V112, P2000, DOI 10.1016/j.rse.2008.01.008; Sandifer PA, 2015, ECOSYST SERV, V12, P1, DOI 10.1016/j.ecoser.2014.12.007; Sarbjit G, 2018, WILEY INTERDISCIPL R, V7, pe286, DOI 10.1002/WENE.286; Schwartz NB, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2677; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shannon CE, 1997, MATH THEORY COMMUNIC, DOI [10.2307/410457, DOI 10.2307/410457]; Sharma RP, 2017, TREES-STRUCT FUNCT, V31, P1875, DOI 10.1007/s00468-017-1593-8; Silver M, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11192308; Sobrino JA, 2000, INT J REMOTE SENS, V21, P353, DOI 10.1080/014311600210876; Sosef MSM, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0356-8; Stych P, 2019, GEOSCIENCES, V9, DOI 10.3390/geosciences9090396; Tehrany MS, 2017, J NAT CONSERV, V40, P12, DOI 10.1016/j.jnc.2017.08.004; Trimble, 2007, ECOGNITION DEV 7 REF; Verrelst J, 2008, REMOTE SENS ENVIRON, V112, P2341, DOI 10.1016/j.rse.2007.11.001; Wang K, 2018, ADV MECH ENG, V10, P1, DOI DOI 10.3390/f10010001; Warren SD, 2014, ECOL INFORM, V24, P160, DOI 10.1016/j.ecoinf.2014.08.006; Waser LT, 2014, REMOTE SENS-BASEL, V6, P4515, DOI 10.3390/rs6054515; Wolf AF, 2012, PROC SPIE, V8390, DOI 10.1117/12.917717; Wood EM, 2012, REMOTE SENS ENVIRON, V121, P516, DOI 10.1016/j.rse.2012.01.003; Xie YC, 2008, J PLANT ECOL, V1, P9, DOI 10.1093/jpe/rtm005; Xue JR, 2017, J SENSORS, V2017, DOI 10.1155/2017/1353691; Zhang C, 2016, REMOTE SENS ENVIRON, V175, P271, DOI 10.1016/j.rse.2016.01.002; Zhang SQ, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11030864	87	6	7	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2020	15	6							e0234158	10.1371/journal.pone.0234158	http://dx.doi.org/10.1371/journal.pone.0234158			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ0RE	32511261	gold, Green Published			2022-12-26	WOS:000540938100025
J	Ke, LY; Chan, HC; Chen, CC; Chang, CF; Lu, PL; Chu, CS; Lai, WT; Shin, SJ; Liu, FT; Chen, CH				Ke, Liang-Yin; Chan, Hua-Chen; Chen, Chih-Chieh; Chang, Chuan-Fa; Lu, Po-Liang; Chu, Chih-Sheng; Lai, Wen-Ter; Shin, Shyi-Jang; Liu, Fu-Tong; Chen, Chu-Huang			Increased APOE glycosylation plays a key role in the atherogenicity of L5 low-density lipoprotein	FASEB JOURNAL			English	Article						APOE; atherosclerosis; electronegative low-density lipoproteins; glycosylation; L5 LDL	APOLIPOPROTEIN-E; ELECTRONEGATIVE LDL; MYOCARDIAL-INFARCTION; BINDING DOMAIN; NO EVIDENCE; CHOLESTEROL; DISEASE; PROTEIN; DESIALYLATION; SUBFRACTIONS	Low-density lipoprotein (LDL) is heterogeneous, composed of particles with variable atherogenicity. Electronegative L5 LDL exhibits atherogenic properties in vitro and in vivo, and its levels are elevated in patients with increased cardiovascular risk. Apolipoprotein E (APOE) content is increased in L5, but what role APOE plays in L5 function remains unclear. Here, we characterized the contributions of APOE posttranslational modification to L5's atherogenicity. Using two-dimensional electrophoresis and liquid chromatography-mass spectrometry, we studied APOE's posttranslational modification in L5 from human plasma. APOE structures with various glycan residues were predicted. Molecular docking and molecular dynamics simulation were performed to examine the functional changes of APOE resulting from glycosylation. We also examined the effects of L5 deglycosylation on endothelial cell apoptosis. The glycan sequence N-acetylgalactosamine, galactose, and sialic acid was consistently expressed on serine 94, threonine 194, and threonine 289 of APOE in L5 and was predicted to contribute to L5's negative surface charge and hydrophilicity. The electrostatic force between the negatively charged sialic acid-containing glycan residue of APOE and positively charged amino acids at the receptor-binding area suggested that glycosylation interferes with APOE's attraction to receptors, lipid-binding ability, and lipid transportation and metabolism functions. Importantly, L5 containing glycosylated APOE induced apoptosis in cultured endothelial cells through lectin-like oxidized LDL receptor-1 (LOX-1) signaling, and glycosylation removal from L5 attenuated L5-induced apoptosis. APOE glycosylation may contribute to the atherogenicity of L5 and be a useful biomarker for rapidly quantifying L5.	[Ke, Liang-Yin; Chan, Hua-Chen; Chen, Chu-Huang] Texas Heart Inst, Vasc & Med Res, 6770 Bertner Ave, Houston, TX 77030 USA; [Ke, Liang-Yin; Chan, Hua-Chen; Lu, Po-Liang; Chu, Chih-Sheng] Kaohsiung Med Univ, Lipid Sci & Aging Res Ctr, Kaohsiung Med Univ Hosp, Ctr Lipid Biosci, Kaohsiung, Taiwan; [Ke, Liang-Yin; Chang, Chuan-Fa] Kaohsiung Med Univ, Coll Hlth Sci, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan; [Ke, Liang-Yin; Lai, Wen-Ter; Shin, Shyi-Jang] Kaohsiung Med Univ, Drug Dev & Value Creat Res Ctr, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Chen, Chih-Chieh] Natl Sun Yat Sen Univ, Inst Med Sci & Technol, Kaohsiung, Taiwan; [Chang, Chuan-Fa] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan, Taiwan; [Chu, Chih-Sheng; Lai, Wen-Ter; Shin, Shyi-Jang] Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Liu, Fu-Tong] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Liu, Fu-Tong] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA; [Chen, Chu-Huang] New York Heart Res Fdn, New York, NY USA	Texas Heart Institute; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; National Sun Yat Sen University; National Cheng Kung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Academia Sinica - Taiwan; University of California System; University of California Davis	Chen, CH (corresponding author), Texas Heart Inst, Vasc & Med Res, 6770 Bertner Ave, Houston, TX 77030 USA.; Ke, LY (corresponding author), Kaohsiung Med Univ, Med Lab Sci & Biotechnol, 100 Tzyou Rd,Int Res Bldg 11F Ctr Lipid Biosci, Kaohsiung 807, Taiwan.	kly@gap.kmu.edu.tw; cchen@texasheart.org	Liu, FU-TONG/A-5749-2019; Ke, Liang-Yin/A-2778-2009; Chang, Chuan-Fa/F-8660-2011	Liu, FU-TONG/0000-0002-3354-1001; Ke, Liang-Yin/0000-0002-2547-0987; Chang, Chuan-Fa/0000-0003-2404-1248	Vascular and Medicinal Research Fund, Texas Heart Institute [765-64050]; KMU [KMU-TP105D14, KMU-DK107012, KMU-TC108A03-0]; Taiwan Ministry of Science and Technology [105-2320-B-037-004-MY3, 106-2314-B-037-069-]	Vascular and Medicinal Research Fund, Texas Heart Institute; KMU; Taiwan Ministry of Science and Technology	This work was supported in part by grants from the Vascular and Medicinal Research Fund, Texas Heart Institute (#765-64050) to C-HC; KMU (KMU-TP105D14, KMU-DK107012, KMU-TC108A03-0) to L-YK; and Taiwan Ministry of Science and Technology (105-2320-B-037-004-MY3 and 106-2314-B-037-069-) to L-YK and C-HC	Akyol S, 2017, TRENDS CARDIOVAS MED, V27, P239, DOI 10.1016/j.tcm.2016.11.002; AVIRAM M, 1983, BIOCHEM MED METAB B, V30, P111, DOI 10.1016/0006-2944(83)90013-3; AVOGARO P, 1988, ARTERIOSCLEROSIS, V8, P79, DOI 10.1161/01.ATV.8.1.79; Bancells C, 2010, J LIPID RES, V51, P3508, DOI 10.1194/jlr.M009258; Chan HC, 2013, BLOOD, V122, P3632, DOI 10.1182/blood-2013-05-504639; Chappey B, 1995, BBA-LIPID LIPID MET, V1259, P261, DOI 10.1016/0005-2760(95)00172-7; Chappey B, 1998, ARTERIOSCL THROM VAS, V18, P876, DOI 10.1161/01.ATV.18.6.876; Chen CH, 2003, CIRCULATION, V107, P2102, DOI 10.1161/01.CIR.0000065220.70220.F7; Chen CH, 2012, DIABETES CARE, V35, P648, DOI 10.2337/dc11-1623; Chen HH, 2007, J LIPID RES, V48, P177, DOI 10.1194/jlr.M500481-JLR200; Chen JL, 2011, P NATL ACAD SCI USA, V108, P14813, DOI 10.1073/pnas.1106420108; Chu CS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30243-w; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; De Castellarnau C, 2000, ARTERIOSCL THROM VAS, V20, P2281; Demuth K, 1996, ARTERIOSCL THROM VAS, V16, P773, DOI 10.1161/01.ATV.16.6.773; Fernandes CL, 2010, CARBOHYD RES, V345, P663, DOI 10.1016/j.carres.2009.12.018; Ferretti G, 2018, J CELL PHYSIOL, V233, P2966, DOI 10.1002/jcp.26050; Flowers SA, 2020, NEUROBIOL DIS, V136, DOI 10.1016/j.nbd.2019.104724; Flowers SA, 2020, GLYCOBIOLOGY, V30, P74, DOI 10.1093/glycob/cwz084; Gerber PA, 2017, CURR OPIN CARDIOL, V32, P454, DOI 10.1097/HCO.0000000000000410; Geromanos SJ, 2009, PROTEOMICS, V9, P1683, DOI 10.1002/pmic.200800562; Grundy SM, 2019, J AM COLL CARDIOL, V73, pE285, DOI 10.1016/j.jacc.2018.11.003; Hsu KC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S33; Huang TT, 2015, NUCLEIC ACIDS RES, V43, pW338, DOI 10.1093/nar/gkv454; INNERARITY TL, 1983, J BIOL CHEM, V258, P2341; Ivanova EA, 2015, VASC HEALTH RISK MAN, V11, P525, DOI 10.2147/VHRM.S74697; Kandt C, 2007, METHODS, V41, P475, DOI 10.1016/j.ymeth.2006.08.006; Ke LY, 2017, J CLIN ENDOCR METAB, V102, P4615, DOI 10.1210/jc.2017-01657; Ke LY, 2016, J MED CHEM, V59, P1032, DOI 10.1021/acs.jmedchem.5b01534; Ke LY, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0428-y; Ke LY, 2011, PURE APPL CHEM, V83, P1731, DOI 10.1351/PAC-CON-10-12-07; Krahenbuhl S, 2016, DRUGS, V76, P1175, DOI 10.1007/s40265-016-0613-0; Lemkul JA, 2010, J CHEM INF MODEL, V50, P2221, DOI 10.1021/ci100335w; Libby P, 2018, J AM COLL CARDIOL, V72, P2071, DOI 10.1016/j.jacc.2018.08.1043; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; LOHSE P, 1991, J BIOL CHEM, V266, P10479; Lu J, 2008, DIABETES, V57, P158, DOI 10.2337/db07-1287; Lu J, 2009, CIRC RES, V104, P619, DOI 10.1161/CIRCRESAHA.108.190116; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Mbeunkui F, 2011, PROTEOMICS, V11, P898, DOI 10.1002/pmic.200900698; OREKHOV AN, 1989, BIOCHEM BIOPH RES CO, V162, P206, DOI 10.1016/0006-291X(89)91982-7; Pendse AA, 2009, J LIPID RES, V50, pS178, DOI 10.1194/jlr.R800070-JLR200; Rivas-Urbina A, 2019, CURR MED CHEM, V26, P1665, DOI 10.2174/0929867325666180330093953; Savinova OV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104833; Shen MY, 2016, BLOOD, V127, P1336, DOI 10.1182/blood-2015-05-646117; Sobenin IA, 1998, J LIPID RES, V39, P2293; Solanki A, 2018, PHARMACOL THERAPEUT, V187, P1, DOI 10.1016/j.pharmthera.2018.02.002; Swarnakar S, 1998, J BIOL CHEM, V273, P12140, DOI 10.1074/jbc.273.20.12140; Tang D, 2008, J LIPID RES, V49, P33, DOI 10.1194/jlr.M700305-JLR200; Varki A., 2017, ESSENTIALS GLYCOBIOL; Vedhachalam C, 2007, BIOCHEMISTRY-US, V46, P2583, DOI 10.1021/bi602407r; Wadhera RK, 2016, J CLIN LIPIDOL, V10, P472, DOI 10.1016/j.jacl.2015.11.010; Wilson Nicole, 2009, V534, P205, DOI 10.1007/978-1-59745-022-5_15; Winklhofer-Roob BM, 2017, FREE RADICAL BIO MED, V111, P38, DOI 10.1016/j.freeradbiomed.2017.04.345; Yang CY, 2003, ARTERIOSCL THROM VAS, V23, P1083, DOI 10.1161/01.ATV.0000071350.78872.C4; Zhu CH, 2019, J PROTEOME RES, V18, P3977, DOI 10.1021/acs.jproteome.9b00450	57	12	12	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9802	9813		10.1096/fj.202000659R	http://dx.doi.org/10.1096/fj.202000659R		JUN 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32501643				2022-12-26	WOS:000539538400001
J	Xu, Y; Yu, XD; Wang, T; Xu, ZZ				Xu, Ye; Yu, Xiaodong; Wang, Tian; Xu, Zezhong			Pooling region learning of visual word for image classification using bag-of-visual-words model	PLOS ONE			English	Article							IMPROVE	In the problem where there is not enough data to use Deep Learning, Bag-of-Visual-Words (BoVW) is still a good alternative for image classification. In BoVW model, many pooling methods are proposed to incorporate the spatial information of local feature into the image representation vector, but none of the methods devote to making each visual word have its own pooling regions. The practice of designing the same pooling regions for all the words restrains the discriminability of image representation, since the spatial distributions of the local features indexed by different visual words are not same. In this paper, we propose to make each visual word have its own pooling regions, and raise a simple yet effective method for learning pooling region. Concretely, a kind of small window named observation window is used to obtain its responses to each word over the whole image region. The pooling regions of each word are organized by a kind of tree structure, in which each node indicates a pooling region. For each word, its pooling regions are learned by constructing a tree with its labelled coordinate data. The labelled coordinate data consist of the coordinates of responses and image class labels. The effectiveness of our method is validated by observing if there is an obvious classification accuracy improvement after applying our method. Our experimental results on four small datasets (i.e., Scene-15, Caltech-101, Caltech-256 and Corel-10) show that, the classification accuracy is improved by about 1% to 2.5%. We experimentally demonstrate that the practice of making each word have its own pooling regions is beneficial to image classification task, which is the significance of our work.	[Xu, Ye] Wuxi Inst Technol, Sch IoT Technol, Wuxi, Jiangsu, Peoples R China; [Yu, Xiaodong; Wang, Tian; Xu, Zezhong] Changzhou Inst Technol, Sch Comp Informat & Engn, Changzhou, Jiangsu, Peoples R China	Wuxi Institute of Technology; Changzhou Institute of Technology	Xu, Y (corresponding author), Wuxi Inst Technol, Sch IoT Technol, Wuxi, Jiangsu, Peoples R China.	xuye@wxit.edu.cn		Xu, Ye/0000-0002-3361-0177				Anwar H, 2014, LECT NOTES COMPUT SC, V8753, P443, DOI 10.1007/978-3-319-11752-2_36; Boureau Y, 2011, P INT C COMP VIS; Boureau YL, 2008, P INT C COMP VIS PAT; Cheplygina V, 2019, CURR OPIN BIOMED ENG, V9, P21, DOI 10.1016/j.cobme.2018.12.005; Dammak M, 2015, IET IMAGE PROCESS, V9, P184, DOI 10.1049/iet-ipr.2014.0189; Du B, 2017, IEEE T CYBERNETICS, V47, P1017, DOI 10.1109/TCYB.2016.2536638; Duchenne O, 2011, P INT C COMP VIS; Farhangi MM, 2014, IET IMAGE PROCESS, V8, P310, DOI 10.1049/iet-ipr.2013.0449; Fei-Fei L, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P1134, DOI 10.1109/ICCV.2003.1238476; Goh H, 2014, IEEE T NEUR NET LEAR, V25, P2212, DOI 10.1109/TNNLS.2014.2307532; Goh H, 2012, LECT NOTES COMPUT SC, V7576, P298, DOI 10.1007/978-3-642-33715-4_22; Griffin G., 2007, 120 CAL I TECHN; Harada T, 2011, PROC CVPR IEEE, P1617, DOI 10.1109/CVPR.2011.5995691; Huang YZ, 2014, NEUROCOMPUTING, V129, P225, DOI 10.1016/j.neucom.2013.09.037; Hussain M, 2019, ADV INTELL SYST, V840, P191, DOI 10.1007/978-3-319-97982-3_16; Jia Y, 2013, P C COMP VIS PATT RE, P3370; Jiashi Feng, 2011, 2011 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P2697, DOI 10.1109/CVPR.2011.5995370; Kavukcuoglu K, 2009, P INT C COMP VIS PAT; Khan R, 2015, COMPUT VIS IMAGE UND, V132, P102, DOI 10.1016/j.cviu.2014.09.005; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Lazebnik S, 2006, COMPUTER VISION PATT, P2169, DOI [10.1109/CVPR.2006.68, DOI 10.1109/CVPR.2006.68]; LeCun Y, 1995, HDB BRAIN THEORY NEU, V3361, P1995, DOI DOI 10.1007/S13398-014-0173-7.2; Lee H., 2009, P ANN INT C MACH LEA, P609; Li T, 2011, IEEE T CIRC SYST VID, V21, P381, DOI 10.1109/TCSVT.2010.2041828; Liu L, 2001, P INT C COMP VIS, P2486; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Morioka N., 2010, P BRIT MACH VIS C, P1; Oquab M, 2014, PROC CVPR IEEE, P1717, DOI 10.1109/CVPR.2014.222; Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191; Penatti OAB, 2014, PATTERN RECOGN, V47, P705, DOI 10.1016/j.patcog.2013.08.012; Sadeghi F, 2012, LECT NOTES COMPUT SC, V7576, P228, DOI 10.1007/978-3-642-33715-4_17; Schlegl T, 2014, LECT NOTES COMPUT SC, V8848, P82, DOI 10.1007/978-3-319-13972-2_8; Sharma G, 2012, PROC CVPR IEEE, P3506, DOI 10.1109/CVPR.2012.6248093; Silva FB, 2013, IEEE IMAGE PROC, P4312, DOI 10.1109/ICIP.2013.6738888; Simonyan K., 2014, P INT C COMP VIS PAT; Sohn K, 2011, P INT C COMP VIS; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Tuytelaars T, 2011, P INT C COMP VIS; Vedaldi A, 2010, P 18 ACM INT C MULT, P1469, DOI DOI 10.1145/1873951.1874249; Wang J, 2010, P INT C COMP VIS PAT; Wang JZ, 2001, IEEE T PATTERN ANAL, V23, P947, DOI 10.1109/34.955109; Wu Z, 2012, P C AS C COMP VIS, P716; Yang JC, 2009, PROC CVPR IEEE, P1794, DOI 10.1109/CVPRW.2009.5206757; Yu K, 2011, P INT C COMP VIS PAT; Zafar B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198175; Zeiler Matthew D, 2010, P INT C COMP VIS PAT; Zhang E., 2010, Proceedings 2010 International Conference on Digital Image Computing: Techniques and Applications (DICTA 2010), P208, DOI 10.1109/DICTA.2010.46; Zhang H, 2013, IEEE IMAGE PROC, P265, DOI 10.1109/ICIP.2013.6738055; Zhang SL, 2011, IEEE T IMAGE PROCESS, V20, P2664, DOI 10.1109/TIP.2011.2128333	49	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0234144	10.1371/journal.pone.0234144	http://dx.doi.org/10.1371/journal.pone.0234144			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502224	gold, Green Published			2022-12-26	WOS:000542035700076
J	Zhu, H; Peng, B; Klausen, C; Yi, YY; Li, Y; Xiong, SY; von Dadelszen, P; Leung, PCK				Zhu, Hua; Peng, Bo; Klausen, Christian; Yi, Yuyin; Li, Yan; Xiong, Siyuan; von Dadelszen, Peter; Leung, Peter C. K.			NPFF increases fusogenic proteins syncytin 1 and syncytin 2 via GCM1 in first trimester primary human cytotrophoblast cells	FASEB JOURNAL			English	Article						hCG; Neuropeptide FF; NPFFR2; placenta; trophoblast	W ENV GLYCOPROTEIN; NEUROPEPTIDE-FF; HERV-W; SPINAL-CORD; FUNCTIONAL-CHARACTERIZATION; NERVOUS-SYSTEM; HUMAN PLACENTA; EXPRESSION; RECEPTOR; TROPHOBLAST	Neuropeptide FF (NPFF) is well-known for its roles in the central nervous system. Despite studies demonstrating that NPFF receptor 2 (NPFFR2) mRNA is highest in placenta, nothing is known about NPFF-NPFFR2 functions in placental development. Here, we investigated the effects of NPFF-NPFFR2 on expression of syncytial [human chorionic gonadotropin (hCG) beta] and fusogenic [syncytin 1, syncytin 2, and glial cells missing 1 (GCM1)] genes in first trimester primary human cytotrophoblast cells. By analyzing two publicly available microarray data sets, we found that NPFF is consistently expressed throughout gestation whereas NPFFR2 increases in first trimester and is elevated in placenta samples from women with preeclampsia. Immunohistochemistry showed that NPFFR2, syncytin 1/2, and GCM1 each displayed unique patterns of expression among different trophoblast populations in first trimester placenta. Treatment of primary human cytotrophoblast cells with NPFF increased the mRNA and protein levels of hCG beta, syncytin 1, syncytin 2, and GCM1; and knockdown of NPFFR2 abolished these effects. Interestingly, GCM1 mediated NPFF-induced upregulation of syncytin 1 and syncytin 2, but not hCG beta, in primary human cytotrophoblasts. Our results demonstrate that NPFF acts via NPFFR2 to enhance production of hCG beta and promote GCM1-dependent expression of syncytin 1 and 2 in human cytotrophoblasts.	[Zhu, Hua; Peng, Bo; Klausen, Christian; Yi, Yuyin; Li, Yan; Xiong, Siyuan; Leung, Peter C. K.] Univ British Columbia, BC Childrens Hosp Res Inst, Dept Obstet & Gynaecol, Room 317,950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada; [von Dadelszen, Peter] Kings Coll London, Global Womens Hlth, London, England	University of British Columbia; University of London; King's College London	Leung, PCK (corresponding author), Univ British Columbia, BC Childrens Hosp Res Inst, Dept Obstet & Gynaecol, Room 317,950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada.	peter.leung@ubc.ca	von Dadelszen, Peter/AAP-7480-2021	von Dadelszen, Peter/0000-0003-4136-3070; Leung, Peter/0000-0003-3152-3800; Peng, Bo/0000-0002-3142-547X; Li, Yan/0000-0003-1813-8115	Canadian Institute of Health Research Foundation [143317]	Canadian Institute of Health Research Foundation(Canadian Institutes of Health Research (CIHR))	Canadian Institute of Health Research Foundation, Grant/Award Number: 143317	Akiyama Y, 1996, P NATL ACAD SCI USA, V93, P14912, DOI 10.1073/pnas.93.25.14912; ALLARD M, 1991, NEUROSCIENCE, V40, P81, DOI 10.1016/0306-4522(91)90176-O; Anko ML, 2006, J NEUROCHEM, V96, P573, DOI 10.1111/j.1471-4159.2005.03581.x; Bjerregaard B, 2006, CELL MOL LIFE SCI, V63, P1906, DOI 10.1007/s00018-006-6201-9; Bjerregaard B, 2014, J ASSIST REPROD GEN, V31, P533, DOI 10.1007/s10815-014-0224-1; Blond JL, 2000, J VIROL, V74, P3321, DOI 10.1128/JVI.74.7.3321-3329.2000; Blond JL, 1999, J VIROL, V73, P1175, DOI 10.1128/JVI.73.2.1175-1185.1999; Bonini JA, 2000, J BIOL CHEM, V275, P39324, DOI 10.1074/jbc.M004385200; Chen CP, 2008, BIOL REPROD, V79, P815, DOI 10.1095/biolreprod.108.069765; Cheng YH, 2005, BIOL REPROD, V73, P500, DOI 10.1095/biolreprod.105.039941; Cheong ML, 2016, MOL CELL BIOL, V36, P197, DOI 10.1128/MCB.00655-15; Cole LA, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-8; DAMSKY CH, 1992, J CLIN INVEST, V89, P210, DOI 10.1172/JCI115565; Elshourbagy NA, 2000, J BIOL CHEM, V275, P25965, DOI 10.1074/jbc.M004515200; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Gherardi N, 1997, PEPTIDES, V18, P577, DOI 10.1016/S0196-9781(97)00071-5; Gimenez J, 2009, DNA RES, V16, P195, DOI 10.1093/dnares/dsp011; Gouarderes C, 2007, NEUROPHARMACOLOGY, V52, P376, DOI 10.1016/j.neuropharm.2006.07.034; GOUARDERES C, 1993, EUR J PHARMACOL, V237, P73, DOI 10.1016/0014-2999(93)90095-Y; Grandi N, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00462; Huang Q, 2013, CELL SIGNAL, V25, P1027, DOI 10.1016/j.cellsig.2013.01.008; Kim JS, 1998, P NATL ACAD SCI USA, V95, P12364, DOI 10.1073/pnas.95.21.12364; KIVIPELTO L, 1989, J COMP NEUROL, V286, P269, DOI 10.1002/cne.902860211; Knerr I, 2005, FEBS LETT, V579, P3991, DOI 10.1016/j.febslet.2005.06.029; Knerr I, 2007, APOPTOSIS, V12, P37, DOI 10.1007/s10495-006-0329-9; Kotani M, 2001, BRIT J PHARMACOL, V133, P138, DOI 10.1038/sj.bjp.0704038; Leavey K, 2016, HYPERTENSION, V68, P137, DOI 10.1161/HYPERTENSIONAHA.116.07293; LEE CH, 1993, EUR J NEUROSCI, V5, P1339, DOI 10.1111/j.1460-9568.1993.tb00920.x; Liang CY, 2010, BIOL REPROD, V83, P387, DOI 10.1095/biolreprod.110.083915; Lu XY, 2017, CELL REP, V21, P1150, DOI 10.1016/j.celrep.2017.10.019; MAJANE EA, 1993, ENDOCRINOLOGY, V133, P1578, DOI 10.1210/en.133.4.1578; MAJANE EA, 1989, BRAIN RES, V494, P1, DOI 10.1016/0006-8993(89)90137-6; MAJANE EA, 1990, PEPTIDES, V11, P345, DOI 10.1016/0196-9781(90)90091-I; Malassine A, 2007, PLACENTA, V28, P185, DOI 10.1016/j.placenta.2006.03.001; Malassine A, 2005, PLACENTA, V26, P556, DOI 10.1016/j.placenta.2004.09.002; MALIN DH, 1990, PEPTIDES, V11, P277, DOI 10.1016/0196-9781(90)90082-G; Mangeney M, 2007, P NATL ACAD SCI USA, V104, P20534, DOI 10.1073/pnas.0707873105; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Panula P, 1996, PROG NEUROBIOL, V48, P461, DOI 10.1016/0301-0082(96)00001-9; Perry SJ, 1997, FEBS LETT, V409, P426, DOI 10.1016/S0014-5793(97)00557-7; PRICE DA, 1977, SCIENCE, V197, P670, DOI 10.1126/science.877582; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Schreiber J, 1997, P NATL ACAD SCI USA, V94, P4739, DOI 10.1073/pnas.94.9.4739; Smallwood A, 2003, BIOL REPROD, V69, P286, DOI 10.1095/biolreprod.102.013078; Soe K, 2011, BONE, V48, P837, DOI 10.1016/j.bone.2010.11.011; Soncin F, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.156273; Stenqvist AC, 2008, AM J REPROD IMMUNOL, V60, P33, DOI 10.1111/j.1600-0897.2008.00588.x; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; TANG J, 1984, P NATL ACAD SCI-BIOL, V81, P5002, DOI 10.1073/pnas.81.15.5002; Toufaily C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121468; Turco MY, 2018, NATURE, V564, P263, DOI 10.1038/s41586-018-0753-3; Vargas A, 2009, J MOL BIOL, V392, P301, DOI 10.1016/j.jmb.2009.07.025; Vilim FS, 1999, MOL PHARMACOL, V55, P804; YANG HYT, 1985, P NATL ACAD SCI USA, V82, P7757, DOI 10.1073/pnas.82.22.7757; Yu CC, 2002, J BIOL CHEM, V277, P50062, DOI 10.1074/jbc.M209316200	55	7	7	3	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9419	9432		10.1096/fj.201902978R	http://dx.doi.org/10.1096/fj.201902978R		JUN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32501590	Bronze			2022-12-26	WOS:000539537700001
J	Birhanu, BT; Lee, EB; Park, SC				Birhanu, Biruk Tesfaye; Lee, Eon-Bee; Park, Seung-Chun			Evaluation of the pharmacokinetic-pharmacodynamic integration of marbofloxacin in combination with methyl gallate against Salmonella Typhimurium in rats	PLOS ONE			English	Article							MUTANT-PREVENTION CONCENTRATION; FLUOROQUINOLONE RESISTANCE; ESCHERICHIA-COLI; CIPROFLOXACIN; EXPOSURE; ANIMALS; RHOIS; ACID	Fluoroquinolone resistance inSalmonellaTyphimurium is becoming a major concern. Hence, an intervention to limit the growth in resistance is inevitable. One way to combat this challenge is through combination therapy. The combination of antibiotics with phytochemicals has become an ideal means of preventing antimicrobial resistance. Recently, in anin vitrostudy, the combination of methyl gallate (MG) with marbofloxacin (MAR) has shown to preventSalmonellaTyphimurium invasion. It is also worth to study the effects of plant extracts on the pharmacokinetics of antibiotics. Hence, the objective of this study was to determine the effect of MG on the pharmacokinetics of MAR and pharmacokinetics/pharmacodynamics integration of MG and MAR. The micro-broth dilution method was used to obtain the minimum inhibitory concentration (MIC), and fractional inhibitory concentration (FIC) of MAR and MG. Whereas, the pharmacokinetic was conducted in rats by administering either MAR alone or combined with MG through oral and/or intravenous routes. The results indicated that the MIC of MAR and MG against standard strainSalmonellaTyphimurium (ATCC 14028) was 0.031 and 500 mu g/mL, respectively. The FIC(index)of the combination of MAR and MG was 0.5. For orally administered drugs, the C(max)and AUC(24h)of MAR were 1.04 and 0.78 mu g/mL and 5.98 and 6.11 h.mu g/mL when MAR was given alone and in combination with MG, respectively. The intravenous administration of MAR showed a half-life of 3.8 and 3.9 h; a clearance rate of 1.1 and 0.73 L/h/kg and a volume of distribution of 5.98 and 4.13 L/kg for MAR alone and in combination with MG, respectively. The AUC(24)/MIC for MAR alone and in combination with MG was 192.8 and 381.9 h, respectively. In conclusion, MG has shown to increase the antimicrobial activity of MARin vitroandex vivoexperiments without affecting the pharmacokinetics of MAR in rats.	[Birhanu, Biruk Tesfaye; Lee, Eon-Bee; Park, Seung-Chun] Kyungpook Natl Univ, Coll Vet Med, Lab Vet Pharmacokinet & Pharmacodynam, Daegu, South Korea	Kyungpook National University	Park, SC (corresponding author), Kyungpook Natl Univ, Coll Vet Med, Lab Vet Pharmacokinet & Pharmacodynam, Daegu, South Korea.	parksch@knu.ac.kr	Park, Seung-Chun/AAV-3388-2021; Birhanu, Biruk Tesfaye/F-1622-2017	Birhanu, Biruk Tesfaye/0000-0002-5261-8406	National Research Foundation of Korea (NRF) - Ministry of Education [2016R1A2B4013507, 2019R1A2C2006277]	National Research Foundation of Korea (NRF) - Ministry of Education	SCP received funds from National Research Foundation of Korea (NRF) funded by the Ministry of Education under Grant [No. 2016R1A2B4013507 and 2019R1A2C2006277]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2015, J MED MICROBIOL, V64, P901, DOI 10.1099/jmm.0.000107; Ahmed Mohammed Dahiru, 2017, Natural Product Sciences, V23, P5, DOI 10.20307/nps.2017.23.1.5; [Anonymous], 2015, M100S25 CLSI; Anu Rahal, 2014, Journal of Biological Sciences, V14, P1; Asin-Prieto E, 2015, J INFECT CHEMOTHER, V21, P319, DOI 10.1016/j.jiac.2015.02.001; Baroni EE, 2011, VET REC, V169, DOI 10.1136/vr.d4012; Birhanu BT, 2018, VET RES, V49, DOI 10.1186/s13567-018-0597-8; Choi JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102697; Choi JG, 2009, MOLECULES, V14, P1773, DOI 10.3390/molecules14051773; Choi JG, 2008, J MICROBIOL BIOTECHN, V18, P1848, DOI 10.4014/jmb.0800.025; Correa LB, 2016, J NAT PROD, V79, P1554, DOI 10.1021/acs.jnatprod.5b01115; Fang FC, 2015, J CLIN MICROBIOL, V53, P3401, DOI 10.1128/JCM.02270-15; FDA, 2015, AN PROC METH VAL DRU; Gebru E, 2011, J MED MICROBIOL, V60, P1512, DOI 10.1099/jmm.0.028654-0; Hossain MA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10997-5; Hossain MA, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/2469826; Izumiya H, 2005, J CLIN MICROBIOL, V43, P5074, DOI 10.1128/JCM.43.10.5074-5079.2005; Jiamboonsri P, 2015, J CHROMATOGR B, V986, P12, DOI 10.1016/j.jchromb.2015.02.006; Kang MS, 2008, J MICROBIOL, V46, P744, DOI 10.1007/s12275-008-0235-7; Leber AL, 2016, CLIN MICROBIOLOGY PR; Lee SJ, 2017, VET MICROBIOL, V207, P29, DOI 10.1016/j.vetmic.2017.05.026; Lees P, 2002, INT J ANTIMICROB AG, V19, P269, DOI 10.1016/S0924-8579(02)00025-0; Mechesso AF, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221386; Haritova AM, 2006, ANTIMICROB AGENTS CH, V50, P3779, DOI 10.1128/AAC.00711-05; Olofsson SK, 2006, J ANTIMICROB CHEMOTH, V57, P1116, DOI 10.1093/jac/dkl135; Olsen SJ, 2001, NEW ENGL J MED, V344, P1572, DOI 10.1056/NEJM200105243442102; Papich MG, 2013, CANINE FELINE GASTRO, P471; Rathi Chetan, 2016, Drug Discov Today Technol, V21-22, P41, DOI 10.1016/j.ddtec.2016.08.004; Redgrave LS, 2014, TRENDS MICROBIOL, V22, P438, DOI 10.1016/j.tim.2014.04.007; Sanchez E, 2013, J APPL MICROBIOL, V115, P1307, DOI 10.1111/jam.12328; Schentag JJ, 2001, CLIN INFECT DIS, V32, pS39, DOI 10.1086/319375; Sidhu PK, 2010, VET J, V184, P219, DOI 10.1016/j.tvjl.2009.02.009; Southwood RL, 2018, CONCEPTS CLIN PHARMA; Toutain PL, 2002, AAPS PHARMSCI, V4; Toutain PL, 2003, VET J, V165, P98, DOI 10.1016/S1090-0233(02)00271-X; Urso R, 2002, Eur Rev Med Pharmacol Sci, V6, P33; Werle M, 2006, AMINO ACIDS, V30, P351, DOI 10.1007/s00726-005-0289-3; Wise R, 2003, J ANTIMICROB CHEMOTH, V51, P37, DOI 10.1093/jac/dkg210; Worthington RJ, 2013, TRENDS BIOTECHNOL, V31, P177, DOI 10.1016/j.tibtech.2012.12.006; Yohannes S, 2015, XENOBIOTICA, V45, P264, DOI 10.3109/00498254.2014.969794	40	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0234211	10.1371/journal.pone.0234211	http://dx.doi.org/10.1371/journal.pone.0234211			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497083	gold, Green Published			2022-12-26	WOS:000542035200085
J	Mukherjeel, M; Ratnayake, I; Janga, M; Fogarty, E; Scheidt, S; Grassmeyer, J; DeRiso, J; Chandrasekar, I; Ahrenkiel, SP; Kopan, R; Surendran, K				Mukherjeel, Malini; Ratnayake, Ishara; Janga, Madhusudhana; Fogarty, Eric; Scheidt, Shania; Grassmeyer, Justin; DeRiso, Jennifer; Chandrasekar, Indra; Ahrenkiel, S. Phil; Kopan, Raphael; Surendran, Kameswaran			Notch signaling regulates Akap12 expression and primary cilia length during renal tubule morphogenesis	FASEB JOURNAL			English	Article						Akap12; Alagille; cilia; Notch; tubule morphogenesis	MITOTIC SPINDLE ORIENTATION; POLYCYSTIC KIDNEY-DISEASE; PLANAR CELL POLARITY; BRANCHING MORPHOGENESIS; NEPHRON SEGMENTATION; ALAGILLE-SYNDROME; GENE HES1; AURORA; FATE; RELEASE	Alagille syndrome patients present with loss of function mutations in either JAG1 or NOTCH2. About 40%-50% of patients have kidney abnormalities, and frequently display multicystic, dysplastic kidneys. Additionally, gain-of-function mutations in NOTCH2 are associated with cystic kidneys in Hajdu-Cheney syndrome patients. How perturbations in Notch signaling cause renal tubular cysts remains unclear. Here, we have determined that reduced Notch signaling mediated transcription by ectopic expression of dominant-negative mastermind-like (dnMaml) peptide in the nephrogenic epithelia from after the s-shaped body formation and in the developing collecting ducts results in proximal tubular and collecting duct cysts, respectively. An acute inhibition of Notch signaling for two days during kidney development is sufficient to disrupt tubule formation, and significantly increases Akap12 expression. Ectopic expression of Akap12 in renal epithelia results in abnormally long primary cilia similar to that observed in Notch-signaling-deficient epithelia. Both loss of Notch signaling and elevated Akap12 expression disrupt the ability of renal epithelial cells to form spherical structures with a single lumen when grown embedded in matrix. Interestingly, Akap12 can inhibit Notch signaling mediated transcription, which likely explains how both loss of Notch signaling and ectopic expression of Akap12 result in similar renal epithelial abnormalities. We conclude that Notch signaling regulates Akap12 expression while also ensuring normal primary cilia length and renal epithelial morphogenesis, and suggest that one aspect of diseases associated with defective Notch signaling, such as Alagille syndrome, maybe mechanistically related to ciliopathies.	[Mukherjeel, Malini; Janga, Madhusudhana; Scheidt, Shania; DeRiso, Jennifer; Chandrasekar, Indra; Surendran, Kameswaran] Sanford Res, Pediat & Rare Dis Grp, 2301 East 60th St North, Sioux Falls, SD 57104 USA; [Ratnayake, Ishara; Ahrenkiel, S. Phil] South Dakota Sch Mines & Technol, Dept Nanosci & Nanoengn, Rapid City, SD USA; [Fogarty, Eric] Univ South Dakota, Div Basic Biomed Sci, Sanford Sch Med, Vermillion, SD USA; [Grassmeyer, Justin] Univ Nebraska Med Ctr, Omaha, NE USA; [Chandrasekar, Indra] Sanford Res, Enabling Technol Grp, Sioux Falls, SD USA; [Kopan, Raphael] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Surendran, Kameswaran] Univ South Dakota, Sanford Sch Med, Dept Pediat, Sioux Falls, SD USA	Sanford Health; South Dakota School Mines & Technology; University of South Dakota; University of Nebraska System; University of Nebraska Medical Center; Sanford Health; Cincinnati Children's Hospital Medical Center; University of South Dakota	Surendran, K (corresponding author), Sanford Res, Pediat & Rare Dis Grp, 2301 East 60th St North, Sioux Falls, SD 57104 USA.	kameswaran.surendran@sanfordhealth.org	Kopan, Raphael/AFG-3275-2022; Kopan, Raphael/AAF-1357-2022; Mukherjee, Malini/ABG-1341-2020	Surendran, Kameswaran/0000-0001-5693-4409; Grassmeyer, Justin/0000-0001-9624-9027	NIH [R01DK106135, P20GM10358, P20GM121341, P20GM103620]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NIH, Grant/Award Number: R01DK106135, P20GM10358, P20GM121341 and P20GM103620	Arnett KL, 2010, NAT STRUCT MOL BIOL, V17, P1312, DOI 10.1038/nsmb.1938; Bateman NW, 2015, J PROTEOME RES, V14, P1900, DOI 10.1021/pr5012894; Bell GP, 2015, CURR BIOL, V25, P61, DOI 10.1016/j.cub.2014.10.052; Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; Bettencourt-Dias M, 2011, TRENDS GENET, V27, P307, DOI 10.1016/j.tig.2011.05.004; Bonegio RGB, 2011, KIDNEY INT, V79, P1099, DOI 10.1038/ki.2010.553; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Carvalho CA, 2015, CURR BIOL, V25, P53, DOI 10.1016/j.cub.2014.10.053; Cebrian C, 2004, DEV DYNAM, V231, P601, DOI 10.1002/dvdy.20143; Chen LH, 2017, P NATL ACAD SCI USA, V114, pE9989, DOI 10.1073/pnas.1710964114; Cheng HT, 2007, DEVELOPMENT, V134, P801, DOI 10.1242/dev.02773; Chung E, 2017, DEVELOPMENT, V144, P4530, DOI 10.1242/dev.156661; Chung E, 2016, DEVELOPMENT, V143, P3907, DOI 10.1242/dev.143503; Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Ezratty EJ, 2011, CELL, V145, P1129, DOI 10.1016/j.cell.2011.05.030; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Gelman IH, 2002, FRONT BIOSCI-LANDMRK, V7, pD1782, DOI 10.2741/gelman; Gelman Irwin H, 2010, Genes Cancer, V1, P1147, DOI 10.1177/1947601910392984; Grisanti L, 2016, DEVELOPMENT, V143, P2160, DOI 10.1242/dev.132704; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Gunay-Aygun M, 2009, AM J MED GENET C, V151C, P296, DOI 10.1002/ajmg.c.30225; Habbig Sandra, 2015, Mol Cell Pediatr, V2, P8, DOI 10.1186/s40348-015-0019-1; Han B, 2015, PFLUG ARCH EUR J PHY, V467, P2401, DOI 10.1007/s00424-015-1718-0; Hartman HA, 2007, DEV BIOL, V310, P379, DOI 10.1016/j.ydbio.2007.08.021; Hartman TR, 2009, HUM MOL GENET, V18, P151, DOI 10.1093/hmg/ddn325; Hehnly H, 2015, ELIFE, V4, DOI 10.7554/eLife.09384; Hildebrandt F, 2007, J AM SOC NEPHROL, V18, P1855, DOI 10.1681/ASN.2006121344; Hopp K, 2012, J CLIN INVEST, V122, P4257, DOI 10.1172/JCI64313; Ilagan MXG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001656; Ishikawa T, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028076; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; Jouve C, 2000, DEVELOPMENT, V127, P1421; Kamath BM, 2013, NAT REV NEPHROL, V9, P409, DOI 10.1038/nrneph.2013.102; Kamath BM, 2012, AM J MED GENET A, V158A, P85, DOI 10.1002/ajmg.a.34369; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lienkamp SS, 2012, NAT GENET, V44, P1382, DOI 10.1038/ng.2452; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Little MH, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008300; Liu Y, 2007, DEVELOPMENT, V134, P1111, DOI 10.1242/dev.02806; Liu ZY, 2013, DEV CELL, V25, P585, DOI 10.1016/j.devcel.2013.05.022; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Martin SR, 1996, ARCH DIS CHILD, V74, P232, DOI 10.1136/adc.74.3.232; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; Menezes LF, 2009, METHOD CELL BIOL, V94, P273, DOI 10.1016/S0091-679X(08)94014-0; Morimoto M, 2010, J CELL SCI, V123, P213, DOI 10.1242/jcs.058669; Nakajima Y, 2015, CURR BIOL, V25, pR43, DOI 10.1016/j.cub.2014.11.052; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nishimura M, 1998, GENOMICS, V49, P69, DOI 10.1006/geno.1998.5213; Pan JM, 2013, CELL MOL LIFE SCI, V70, P1849, DOI 10.1007/s00018-012-1052-z; Park J, 2018, SCIENCE, V360, P758, DOI 10.1126/science.aar2131; Pazour GJ, 2004, J AM SOC NEPHROL, V15, P2528, DOI 10.1097/01.ASN.0000141055.57643.E0; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rajagopalan R, 2016, AM J MED GENET A, V170, P750, DOI 10.1002/ajmg.a.37512; Regan JL, 2013, CELL REP, V4, P110, DOI 10.1016/j.celrep.2013.05.044; Reiter JF, 2017, NAT REV MOL CELL BIO, V18, P533, DOI 10.1038/nrm.2017.60; Rodriguez-Fraticelli AE, 2010, J CELL BIOL, V189, P725, DOI 10.1083/jcb.201002047; Satir P, 2008, HISTOCHEM CELL BIOL, V129, P687, DOI 10.1007/s00418-008-0416-9; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; SOROKIN S, 1962, J CELL BIOL, V15, P363, DOI 10.1083/jcb.15.2.363; Stratman JL, 2003, TRANSGENIC RES, V12, P521, DOI 10.1023/A:1024225408961; Stubbs JL, 2012, NAT CELL BIOL, V14, P140, DOI 10.1038/ncb2406; Surendran K, 2010, J AM SOC NEPHROL, V21, P819, DOI 10.1681/ASN.2009090925; Surendran K, 2010, DEV BIOL, V337, P386, DOI 10.1016/j.ydbio.2009.11.017; Thoma CR, 2007, NAT CELL BIOL, V9, P588, DOI 10.1038/ncb1579; Tomita K, 1999, GENE DEV, V13, P1203, DOI 10.1101/gad.13.9.1203; Traykova-Brauch M, 2008, NAT MED, V14, P979, DOI 10.1038/nm.1865; Watanabe T, 2004, DEV BIOL, V271, P98, DOI 10.1016/j.ydbio.2004.03.025; Xia W, 2001, CANCER RES, V61, P5644; Yoder BK, 2007, J AM SOC NEPHROL, V18, P1381, DOI 10.1681/ASN.2006111215; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	75	9	9	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9512	9530		10.1096/fj.201902358RR	http://dx.doi.org/10.1096/fj.201902358RR		MAY 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32474964	Green Submitted, Green Accepted			2022-12-26	WOS:000538128000001
J	Krambs, JR; Abou Ezzi, G; Yao, JC; Link, DC				Krambs, Joseph Ryan; Abou Ezzi, Grazia; Yao, Juo-Chin; Link, Daniel C.			Canonical signaling by TGF family members in mesenchymal stromal cells is dispensable for hematopoietic niche maintenance under basal and stress conditions	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; BONE-MARROW; G-CSF; PHOSPHATIDYLINOSITOL 3-KINASE; INEFFECTIVE ERYTHROPOIESIS; II RECEPTOR; STEM-CELLS; DIFFERENTIATION; ACTIVATION; EXPRESSION	Mesenchymal stromal cells are an important component of the bone marrow hematopoietic niche. Prior studies showed that signaling from members of the transforming growth factor (TGF) superfamily in mesenchymal stromal cells is required for normal niche development. Here, we assessed the impact of TGF family signaling on niche maintenance and stress responses by deleting Smad4 in mesenchymal stromal cells at birth, thereby abrogating canonical TGF signaling. No alteration in the number or spatial organization of CXCL12-abundant reticular (CAR) cells, osteoblasts, or adipocytes was observed in Osx-Cre, Smad4(fl/fl) mice, and expression of key niche factors was normal. Basal hematopoiesis and stress erythropoiesis responses to acute hemolytic anemia were normal. TGF-beta potently inhibits stromal CXCL12 expression in vitro; however, G-CSF induced decreases in bone marrow CXCL12 expression and subsequent hematopoietic stem/progenitor cell mobilization were normal in Osx-Cre, Tgfbr2(fl/fl) mice, in which all TGF-beta signaling in mesenchymal stromal is lost. Finally, although a prior study showed that TGF-beta enhances recovery from myeloablative therapy, hematopoietic recovery following single or multiple doses of 5-flurauracil were normal in Osx-Cre, Tgfbr2(fl/fl) mice. Collectively, these data suggest that TGF family member signaling in mesenchymal stromal cells is dispensable for hematopoietic niche maintenance under basal and stress conditions.	[Krambs, Joseph Ryan; Abou Ezzi, Grazia; Yao, Juo-Chin; Link, Daniel C.] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA	Washington University (WUSTL)	Link, DC (corresponding author), Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA.	danielclink@wusti.edu		Link, Daniel/0000-0002-3170-7581; Yao, Juo-Chin/0000-0002-2041-9867	National Institutes of Health [RO1HL131655]; National Cancer Institute [F31CA247136]; NCI Cancer Center Support Grant [P30 CA091842]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Institutes of Health grant RO1HL131655 (DCL) and by the National Cancer Institute grant F31CA247136 (JRK). The Siteman Cancer Center is supported in part by an NCI Cancer Center Support Grant #P30 CA091842. https://grants.nih.gov/grants/oer.htm.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulkadyrov KM, 2014, BRIT J HAEMATOL, V165, P814, DOI 10.1111/bjh.12835; Abou-Ezzi G, 2019, STEM CELL REPORTS; Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bhowmick NA, 2001, J BIOL CHEM, V276, P46707, DOI 10.1074/jbc.M106176200; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Brenet F, 2013, J EXP MED, V210, P623, DOI 10.1084/jem.20121610; BURT DW, 1992, BIOCHEM BIOPH RES CO, V184, P590, DOI 10.1016/0006-291X(92)90630-4; Carrancio S, 2014, BRIT J HAEMATOL, V165, P870, DOI 10.1111/bjh.12838; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Christopher MJ, 2008, J BONE MINER RES, V23, P1765, DOI 10.1359/JBMR.080612; Christopher MJ, 2009, BLOOD, V114, P1331, DOI 10.1182/blood-2008-10-184754; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Dominici M, 2009, BLOOD, V114, P2333, DOI 10.1182/blood-2008-10-183459; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Dussiot M, 2014, NAT MED, V20, P398, DOI 10.1038/nm.3468; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; Engel ME, 1999, J BIOL CHEM, V274, P37413, DOI 10.1074/jbc.274.52.37413; Frey RS, 1997, CANCER RES, V57, P628; Galliher AJ, 2007, CANCER RES, V67, P3752, DOI 10.1158/0008-5472.CAN-06-3851; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Hanafusa H, 1999, J BIOL CHEM, V274, P27161, DOI 10.1074/jbc.274.38.27161; HARTSOUGH MT, 1995, J BIOL CHEM, V270, P7117, DOI 10.1074/jbc.270.13.7117; Herpin A, 2004, DEV COMP IMMUNOL, V28, P461, DOI 10.1016/j.dci.2003.09.007; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; Iancu-Rubin C, 2013, EXP HEMATOL, V41, P155, DOI 10.1016/j.exphem.2012.12.002; IGNOTZ RA, 1985, P NATL ACAD SCI USA, V82, P8530, DOI 10.1073/pnas.82.24.8530; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kaygusuz MA, 2006, LIFE SCI, V80, P67, DOI 10.1016/j.lfs.2006.08.023; Khurana S, 2014, STEM CELLS, V32, P3012, DOI 10.1002/stem.1794; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Leveen P, 2002, BLOOD, V100, P560, DOI 10.1182/blood.V100.2.560; Levesque JP, 2003, J CLIN INVEST, V111, P187, DOI 10.1172/JCI200315994; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; MULDER KM, 1992, J BIOL CHEM, V267, P5029; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Peters SB, 2017, BONE, V97, P54, DOI 10.1016/j.bone.2016.12.017; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Semerad CL, 2005, BLOOD, V106, P3020, DOI 10.1182/blood-2004-01-0272; Shin I, 2001, MOL BIOL CELL, V12, P3328, DOI 10.1091/mbc.12.11.3328; SPARKS RL, 1992, J CELL PHYSIOL, V150, P568, DOI 10.1002/jcp.1041500318; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Suragani RNVS, 2014, BLOOD, V123, P3864, DOI 10.1182/blood-2013-06-511238; Suragani RNVS, 2014, NAT MED, V20, P408, DOI 10.1038/nm.3512; Tikhonova AN, 2019, NATURE, V572, pE6, DOI 10.1038/s41586-019-1394-x; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Wilkes MC, 2005, CANCER RES, V65, P10431, DOI 10.1158/0008-5472.CAN-05-1522; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Wright N, 2003, BLOOD, V102, P1978, DOI 10.1182/blood-2002-10-3190; Yang X, 2002, GENESIS, V32, P80, DOI 10.1002/gene.10029; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Yu VWC, 2015, J EXP MED, V212, P759, DOI 10.1084/jem.20141843; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhou BO, 2017, NAT CELL BIOL, V19, P891, DOI 10.1038/ncb3570; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384	60	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2020	15	5							e0233751	10.1371/journal.pone.0233751	http://dx.doi.org/10.1371/journal.pone.0233751			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1WS	32470079	Green Published, gold			2022-12-26	WOS:000537552800164
J	Shulami, S; Zehavi, A; Belakhov, V; Salama, R; Lansky, S; Baasov, T; Shoham, G; Shoham, Y				Shulami, Smadar; Zehavi, Arie; Belakhov, Valery; Salama, Rachel; Lansky, Shifra; Baasov, Timor; Shoham, Gil; Shoham, Yuval			Cross-utilization of beta-galactosides and cellobiose in Geobacillus stearothermophilus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoside hydrolases; 6-phospho-beta-galactosidase; 6-phospho-beta-glucosidase; PTS system; G; stearothermophilus; galactose; galactosyl-glycerol; lactose; ABC transport system; bacterial metabolism; cellobiose; glycoside hydrolase; ABC transporter; bacteria; thermophile; cellobiose	STRUCTURE-SPECIFICITY RELATIONSHIPS; RESPONSE REGULATOR PROTEINS; BIOCHEMICAL-CHARACTERIZATION; PHOSPHOTRANSFERASE SYSTEM; CLOSTRIDIUM-THERMOCELLUM; ALPHA-GLUCURONIDASE; CATALYTIC RESIDUES; GENE; PATHWAY; FAMILY	Strains of the Gram-positive, thermophilic bacteriumGeobacillus stearothermophiluspossess elaborate systems for the utilization of hemicellulolytic polysaccharides, including xylan, arabinan, and galactan. These systems have been studied extensively in strains T-1 and T-6, representing microbial models for the utilization of soil polysaccharides, and many of their components have been characterized both biochemically and structurally. Here, we characterized routes by whichG. stearothermophilusutilizes mono- and disaccharides such as galactose, cellobiose, lactose, and galactosyl-glycerol. TheG. stearothermophilusgenome encodes a phosphoenolpyruvate carbohydrate phosphotransferase system (PTS) for cellobiose. We found that the cellobiose-PTS system is induced by cellobiose and characterized the corresponding GH1 6-phospho-beta-glucosidase, Cel1A. The bacterium also possesses two transport systems for galactose, a galactose-PTS system and an ABC galactose transporter. The ABC galactose transport system is regulated by a three-component sensing system. We observed that both systems, the sensor and the transporter, utilize galactose-binding proteins that also bind glucose with the same affinity. We hypothesize that this allows the cell to control the flux of galactose into the cell in the presence of glucose. Unexpectedly, we discovered thatG. stearothermophilusT-1 can also utilize lactose and galactosyl-glycerol via the cellobiose-PTS system together with a bifunctional 6-phospho-beta-gal/glucosidase, Gan1D. Growth curves of strain T-1 growing in the presence of cellobiose, with either lactose or galactosyl-glycerol, revealed initially logarithmic growth on cellobiose and then linear growth supported by the additional sugars. We conclude that Gan1D allows the cell to utilize residual galactose-containing disaccharides, taking advantage of the promiscuity of the cellobiose-PTS system.	[Shulami, Smadar; Zehavi, Arie; Salama, Rachel; Shoham, Yuval] Technion Israel Inst Technol, Dept Biotechnol & Food Engn, Haifa, Israel; [Belakhov, Valery; Baasov, Timor] Technion Israel Inst Technol, Schulich Fac Chem, Haifa, Israel; [Lansky, Shifra; Shoham, Gil] Hebrew Univ Jerusalem, Inst Chem, Jerusalem, Israel; [Lansky, Shifra; Shoham, Gil] Hebrew Univ Jerusalem, Lab Struct Chem & Biol, Jerusalem, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Shoham, Y (corresponding author), Technion Israel Inst Technol, Dept Biotechnol & Food Engn, Haifa, Israel.; Shoham, G (corresponding author), Hebrew Univ Jerusalem, Inst Chem, Jerusalem, Israel.; Shoham, G (corresponding author), Hebrew Univ Jerusalem, Lab Struct Chem & Biol, Jerusalem, Israel.	yshoham@technion.ac.il; gil2@mail.huji.ac.il		Lansky, Shifra/0000-0002-2037-7388	United States-Israel Binational Science Foundation (BSF) Jerusalem, Israel [96-178]; Israel Science Foundation [500/10, 152/11, 1905/15]; Israel Ministry of Science and Technology [3-12484]; I-CORE Program of the Planning and Budgeting Committee; Ministry of Environmental Protection; Grand Technion Energy Program (GTEP); Russell Berrie Nanotechnology Institute; Lorry I. Lokey Interdisciplinary Center for Life Science and Engineering, Technion; Azrieli Foundation; Ministry of Immigration Absorption; Ministry of Science and Technology, Israel (Kamea Program)	United States-Israel Binational Science Foundation (BSF) Jerusalem, Israel(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); Israel Ministry of Science and Technology(Ministry of Science, Technology and Space (MOST), Israel); I-CORE Program of the Planning and Budgeting Committee; Ministry of Environmental Protection; Grand Technion Energy Program (GTEP); Russell Berrie Nanotechnology Institute; Lorry I. Lokey Interdisciplinary Center for Life Science and Engineering, Technion; Azrieli Foundation; Ministry of Immigration Absorption; Ministry of Science and Technology, Israel (Kamea Program)	This work was supported by United States-Israel Binational Science Foundation (BSF) Jerusalem, Israel Grant 96-178 (to Y. S.), Israel Science Foundation Grants 500/10 and 152/11 (to Y. S.) and 1905/15 (to G. S.); Israel Ministry of Science and Technology Grant 3-12484 (to Y. S. and G. S.), the I-CORE Program of the Planning and Budgeting Committee, and the Ministry of Environmental Protection and the Grand Technion Energy Program (GTEP) and comprises part of the Leona M. and Harry B. Helmsley Charitable Trust Reports on Alternative Energy series of the Technion, Israel Institute of Technology and the Weizmann Institute of Science. Y. S. was supported in part by the Russell Berrie Nanotechnology Institute and The Lorry I. Lokey Interdisciplinary Center for Life Science and Engineering, Technion. S. L. was supported in part by an Azrieli Fellowship from the Azrieli Foundation. V. B. acknowledges the financial support by the Ministry of Immigration Absorption and the Ministry of Science and Technology, Israel (Kamea Program). Y. S. holds the Erwin and Rosl Pollak Chair in Biotechnology at the Technion.	Alalouf O, 2011, J BIOL CHEM, V286, P41993, DOI 10.1074/jbc.M111.301051; Aleksandrzak-Piekarczyk T, 2005, APPL ENVIRON MICROB, V71, P6060, DOI 10.1128/AEM.71.10.6060-6069.2005; Barnard A, 2004, CURR OPIN MICROBIOL, V7, P102, DOI 10.1016/j.mib.2004.02.011; Blanco AG, 2002, STRUCTURE, V10, P701, DOI 10.1016/S0969-2126(02)00761-X; Bogel G, 2007, FEBS J, V274, P3900, DOI 10.1111/j.1742-4658.2007.05923.x; Bordi C, 2004, J BACTERIOL, V186, P4502, DOI 10.1128/JB.186.14.4502-4509.2004; Bravman T, 2001, FEBS LETT, V495, P115, DOI 10.1016/S0014-5793(01)02371-7; Buschiazzo A, 2019, ANNU REV MICROBIOL, V73, P507, DOI 10.1146/annurev-micro-091018-054627; Cateni F, 2007, BIOORG MED CHEM LETT, V17, P1971, DOI 10.1016/j.bmcl.2007.01.019; Cuskin F, 2015, NATURE, V517, P165, DOI 10.1038/nature13995; Czjzek M, 2005, J MOL BIOL, V353, P838, DOI 10.1016/j.jmb.2005.09.003; Danchin A, 2009, BIOESSAYS, V31, P769, DOI 10.1002/bies.200900024; Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007; Frey PA, 1996, FASEB J, V10, P461, DOI 10.1096/fasebj.10.4.8647345; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Golan G, 2004, J BIOL CHEM, V279, P3014, DOI 10.1074/jbc.M310098200; GOUNARIS K, 1983, TRENDS BIOCHEM SCI, V8, P378, DOI 10.1016/0968-0004(83)90366-3; Himmel S, 2012, ACTA CRYSTALLOGR F, V68, P751, DOI 10.1107/S1744309112020635; HONEYMAN AL, 1993, J GEN MICROBIOL, V139, P2685, DOI 10.1099/00221287-139-11-2685; Hovel K, 2003, EMBO J, V22, P4922, DOI 10.1093/emboj/cdg494; JAGUSZTYNKRYNICKA EK, 1992, J BACTERIOL, V174, P6152, DOI 10.1128/JB.174.19.6152-6158.1992; Janwitayanuchit W, 2003, PHYTOCHEMISTRY, V64, P1253, DOI 10.1016/j.phytochem.2003.09.008; Jarmer H, 2001, MICROBIOL-SGM, V147, P2417, DOI 10.1099/00221287-147-9-2417; Johnson J. L., 1981, MANUAL METHODS GEN B, P450; Kenney LJ, 2000, TRENDS MICROBIOL, V8, P155, DOI 10.1016/S0966-842X(00)01708-X; Knezevic I, 2000, MICROBIOL-SGM, V146, P2333, DOI 10.1099/00221287-146-9-2333; Lansky S, 2017, FEBS J, V284, P3931, DOI 10.1111/febs.14283; Lansky S, 2014, ACTA CRYSTALLOGR D, V70, P2994, DOI 10.1107/S139900471401863X; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; Mechaly A, 1997, CARBOHYD RES, V304, P111, DOI 10.1016/S0008-6215(97)00209-7; Mokhtari A, 2013, MOL MICROBIOL, V88, P234, DOI 10.1111/mmi.12183; Nataf Y, 2010, P NATL ACAD SCI USA, V107, P18646, DOI 10.1073/pnas.1012175107; Rhodius VA, 1998, CURR OPIN MICROBIOL, V1, P152, DOI 10.1016/S1369-5274(98)80005-2; ROSEY EL, 1991, J BACTERIOL, V173, P5992, DOI 10.1128/jb.173.19.5992-5998.1991; Saier MH, 1996, RES MICROBIOL, V147, P482, DOI 10.1016/S0923-2508(96)90150-3; Saier MH, 2015, J MOL MICROB BIOTECH, V25, P73, DOI 10.1159/000381215; Salama R, 2012, FEBS LETT, V586, P2436, DOI 10.1016/j.febslet.2012.05.062; Sambrook J, 2001, MOL CLONING LAB MANU; Sand A, 2015, FEBS LETT, V589, P3133, DOI 10.1016/j.febslet.2015.08.026; Sastry P S, 1974, Adv Lipid Res, V12, P251; Schulte D, 2000, PROTEIN ENG, V13, P515, DOI 10.1093/protein/13.7.515; Shallom D, 2005, BIOCHEMISTRY-US, V44, P387, DOI 10.1021/bi048059w; Shallom D, 2002, J BIOL CHEM, V277, P43667, DOI 10.1074/jbc.M208285200; Shulami S, 1999, J BACTERIOL, V181, P3695, DOI 10.1128/JB.181.12.3695-3704.1999; Shulami S, 2007, APPL ENVIRON MICROB, V73, P874, DOI 10.1128/AEM.02367-06; Shulami S, 2014, J BIOL CHEM, V289, P25957, DOI 10.1074/jbc.M114.592873; Shulami S, 2011, J BACTERIOL, V193, P2838, DOI 10.1128/JB.00222-11; Solomon HV, 2015, ACTA CRYSTALLOGR D, V71, P2433, DOI 10.1107/S1399004715018672; Solomon V, 2007, ACTA CRYSTALLOGR D, V63, P845, DOI 10.1107/S0907444907024845; Sun Z, 2015, MOL MICROBIOL, V95, P576, DOI 10.1111/mmi.12894; Tabachnikov O, 2013, FEBS J, V280, P950, DOI 10.1111/febs.12089; Teplitsky A, 2004, ACTA CRYSTALLOGR D, V60, P836, DOI 10.1107/S0907444904004123; Thompson J, 2002, J BIOL CHEM, V277, P34310, DOI 10.1074/jbc.M206397200; Van der Heiden E, 2013, APPL ENVIRON MICROB, V79, P3511, DOI 10.1128/AEM.03918-12; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Yu WL, 2013, J BIOL CHEM, V288, P14949, DOI 10.1074/jbc.M113.454751; Zaide G, 2001, EUR J BIOCHEM, V268, P3006, DOI 10.1046/j.1432-1327.2001.02193.x	60	1	1	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2020	295	31					10766	10780		10.1074/jbc.RA120.014029	http://dx.doi.org/10.1074/jbc.RA120.014029			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB3HM	32493770	Green Published, hybrid			2022-12-26	WOS:000560405600020
J	Strasser, T; Wagner, S; Zrenner, E				Strasser, Torsten; Wagner, Sandra; Zrenner, Eberhart			Review of the application of the open-source software CilOCT for semi-automatic segmentation and analysis of the ciliary muscle in OCT images	PLOS ONE			English	Review							AGE-RELATED-CHANGES; CRYSTALLINE LENS; ACCOMMODATION; THICKNESS; PRESBYOPIA; MORPHOLOGY	Presbyopia and myopia research shows a growing interest in ciliary muscle biometry using optical coherence tomography (OCT). Until now, segmentation of the ciliary muscle is often performed manually using either custom-developed programs or image processing software. Here we present a novel software for semi-automatic segmentation of the ciliary muscle. It provides direct import of OCT images in DICOM format, a standardized procedure for segmentation, image distortion correction, the export of anatomical ciliary muscle landmarks, like ciliary muscle apex and scleral spur, as well as a continuous thickness profile of the ciliary muscle as a novel way of analysis. All processing steps are stored as XML files, fostering documentation and reproducibility of research through the possibility of replicating the analysis. Additionally, CilOCT supports batch processing for the automated analysis of large numbers of images and the respective data export to tabulated text files based on the stored XML files. CilOCT was successfully applied in several studies and their results will be summarized in this paper.	[Strasser, Torsten; Wagner, Sandra; Zrenner, Eberhart] Univ Tubingen, Inst Ophthalm Res, Ctr Ophthalmol, Tubingen, Germany; [Zrenner, Eberhart] Univ Tubingen, Werner Reichardt Ctr Integrat Neurosci CIN, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen	Strasser, T (corresponding author), Univ Tubingen, Inst Ophthalm Res, Ctr Ophthalmol, Tubingen, Germany.	torsten.strasser@uni-tuebingen.de	Straßer, Torsten/AAJ-6644-2020	Straßer, Torsten/0000-0001-7725-7961; Wagner, Sandra/0000-0001-6681-1998	Hector Fellow Academy; German Research Council in the Excellence Center Program [EXC307]	Hector Fellow Academy; German Research Council in the Excellence Center Program	SW acknowledges support from the Hector Fellow Academy (https://www.hectorfellow-academy.de/).EZ was supported by the German Research Council in the Excellence Center Program (EXC307) (https://www.dfg.de).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey MD, 2008, INVEST OPHTH VIS SCI, V49, P4353, DOI 10.1167/iovs.08-2008; Buckhurst H, 2013, OPHTHAL PHYSL OPT, V33, P294, DOI 10.1111/opo.12039; Chang YC, 2018, BIOMED OPT EXPRESS, V9, P791, DOI 10.1364/BOE.9.000791; Dostal M, 2010, ADV DATA NETW COMMUN, P143; Esteve-Taboada JJ, 2017, GRAEF ARCH CLIN EXP, V255, P1385, DOI 10.1007/s00417-017-3663-4; Glasser A, 1998, VISION RES, V38, P209, DOI 10.1016/S0042-6989(97)00102-8; Goodman SN, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf5027; Gualdi L, 2017, J REFRACT SURG, V33, P578, DOI 10.3928/1081597X-20170621-05; Holden BA, 2016, OPHTHALMOLOGY, V123, P1036, DOI 10.1016/j.ophtha.2016.01.006; Kao CY, 2011, OPTOMETRY VISION SCI, V88, P275, DOI 10.1097/OPX.0b013e3182044b94; Laughton DS, 2015, CONTACT LENS ANTERIO, V38, P402, DOI 10.1016/j.clae.2015.05.007; Lewis HA, 2012, OPTOMETRY VISION SCI, V89, P727, DOI 10.1097/OPX.0b013e318253de7e; Massol V, 2007, BETTER BUILDS MAVEN; Monsalvez-Romin D, 2019, ARQ BRAS OFTALMOL, V82, P207, DOI 10.5935/0004-2749.20190041; Nemati B, 1997, APPL OPTICS, V36, P416, DOI 10.1364/AO.36.000416; Pardue MT, 2000, OPTOMETRY VISION SCI, V77, P204, DOI 10.1097/00006324-200004000-00013; Peng RD, 2011, SCIENCE, V334, P1226, DOI 10.1126/science.1213847; Richdale K, 2013, INVEST OPHTH VIS SCI, V54, P1095, DOI 10.1167/iovs.12-10619; Ruggeri M, 2014, PROC SPIE, V8930, DOI 10.1117/12.2044309; Sheppard AL, 2011, INVEST OPHTH VIS SCI, V52, P1809, DOI 10.1167/iovs.10-6447; Sheppard AL, 2010, INVEST OPHTH VIS SCI, V51, P6882, DOI 10.1167/iovs.10-5787; Shi JL, 2020, INT OPHTHALMOL, V40, P917, DOI 10.1007/s10792-019-01264-9; Stachs O, 2002, GRAEF ARCH CLIN EXP, V240, P906, DOI 10.1007/s00417-002-0551-2; Strenk SA, 1999, INVEST OPHTH VIS SCI, V40, P1162; Strenk SA, 2010, J CATARACT REFR SURG, V36, P235, DOI 10.1016/j.jcrs.2009.08.029; Wagner S, 2019, VISION RES, V163, P42, DOI 10.1016/j.visres.2019.08.002; Wagner S, 2019, EXP EYE RES, V186, DOI 10.1016/j.exer.2019.107741; Wagner S, 2018, BIOMED OPT EXPRESS, V9, P5100, DOI 10.1364/BOE.9.005100; Warnock MJ, 2007, J DIGIT IMAGING, V20, P125, DOI 10.1007/s10278-007-9064-1; ZIMMERMAN JB, 1988, IEEE T MED IMAGING, V7, P304, DOI 10.1109/42.14513	30	2	2	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2020	15	6							e0234330	10.1371/journal.pone.0234330	http://dx.doi.org/10.1371/journal.pone.0234330			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ1GC	32516331	Green Published, gold			2022-12-26	WOS:000540977000016
J	Boyer, S; Marcombe, S; Yean, S; Fontenille, D				Boyer, Sebastien; Marcombe, Sebastien; Yean, Sony; Fontenille, Didier			High diversity of mosquito vectors in Cambodian primary schools and consequences for arbovirus transmission	PLOS ONE			English	Article							JAPANESE ENCEPHALITIS; DIPTERA-CULICIDAE; FEEDING PATTERNS; DENGUE; SURVEILLANCE; CHECKLIST; TRENDS	Only few data exist in Cambodia on mosquito diversity and their potential role as vectors. Many arboviruses, such as dengue and Japanese encephalitis, are endemic and mostly affect children in the country. This research sets out to evaluate vector relative abundance and diversity in primary schools in Cambodia in an attempt to explain the apparent burden of dengue fever, severe dengue (DEN), Japanese encephalitis (JE), other arboviral diseases and malaria among children, 15 years and under, attending selected primary schools through vector surveys. Entomological surveys were implemented in primary schools in two provinces of Cambodia to assess the potential risk of exposure of schoolchildren to mosquito vector species. Light traps and BG traps were used to collect adult mosquitoes in 24 schools during the rainy and dry seasons of 2017 and 2018 in Kampong Cham and Tboung Khmum provinces. A total of 61 species were described, including Aedes, Culex and Anopheles species. The relative abundance and biodiversity of mosquito species were dependent on the month and school. Of the 37,725 mosquitoes caught during the study, three species accounted for three-quarters of the relative abundance: Culex vishnui, Anopheles indefinitus and Culex quinquefasciatus. More importantly, nearly 90% of the mosquitoes caught in the schools were identified as potential vectors of pathogens including Japanese encephalitis, dengue, and malaria parasites. Our results showed that schools in Cambodia represent a risk for vector-borne disease transmission and highlight the importance of implementing vector control in schools in Cambodia to decrease the risk of transmission.	[Boyer, Sebastien; Yean, Sony; Fontenille, Didier] Inst Pasteur Cambodge, Med & Vet Entomol Unit, Blvd Monivong, Phnom Penh, Cambodia; [Marcombe, Sebastien] Inst Pasteur Laos, Med Entomol Unit, Minist Hlth, Viangchan, Laos	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia	Boyer, S (corresponding author), Inst Pasteur Cambodge, Med & Vet Entomol Unit, Blvd Monivong, Phnom Penh, Cambodia.	sboyer@pasteur-kh.org		FONTENILLE, didier/0000-0002-0544-3885; Boyer, Sebastien/0000-0002-2946-586X	ECOMORE 2 project; AFD (Agence Francaise pour le De'veloppement)	ECOMORE 2 project; AFD (Agence Francaise pour le De'veloppement)	The study was supported by ECOMORE 2 project, coordinated by Institut Pasteur and financially supported by AFD (Agence Francaise pour le De ' veloppement). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Olano VA, 2015, J AM MOSQUITO CONTR, V31, P212, DOI 10.2987/moco-31-03-212-222.1; Arima Y, 2011, WEST PAC SURVEILL RE, V2, P4, DOI [10.5365/wpsar.2011.2.2.005, 10.5365/WPSAR.2011.2.2.005]; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Boyer S, 2018, ASIA-PAC J PUBLIC HE, V30, P158, DOI 10.1177/1010539517753876; Bui P, 2008, J AM MOSQUITO CONTR, V24, P187, DOI 10.2987/5665.1; Delacollette C, 2009, SE ASIAN J TROP MED, V40, P674; HURLBUT HERBERT S., 1964, J MED ENTOMOL, V1, P301, DOI 10.1093/jmedent/1.3.301; Huy R, 2010, B WORLD HEALTH ORGAN, V88, P650, DOI 10.2471/BLT.09.073908; Levin M. L., 2014, EMERG INFECT DIS, V20, P1428, DOI DOI 10.3201/eid2008.131738; MITCHELL CJ, 1973, B WORLD HEALTH ORGAN, V49, P293; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Motoki MT, 2019, J VECTOR ECOL, V44, P76, DOI 10.1111/jvec.12331; Mwandawiro C, 2000, T ROY SOC TROP MED H, V94, P238, DOI 10.1016/S0035-9203(00)90303-1; Ratanawong P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161895; Rattanarithikul Rampa, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1; REUBEN R, 1992, AM J TROP MED HYG, V46, P654, DOI 10.4269/ajtmh.1992.46.654; Roiz D, 2012, AM J TROP MED HYG, V86, P642, DOI 10.4269/ajtmh.2012.11-0326; Rozo-Lopez P, 2015, BIODIVERS DATA J, V3, DOI 10.3897/BDJ.3.e4567; Rueda Leopoldo M, 2015, US Army Med Dep J, P25; St Laurent B, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1488-y; Stojanovich CHS, 1965, ILLUSTRATED KEY MOSQ; Suaya JA, 2007, TROP MED INT HEALTH, V12, P1026, DOI 10.1111/j.1365-3156.2007.01889.x; Touch S, 2009, TROP MED INT HEALTH, V14, P1365, DOI 10.1111/j.1365-3156.2009.02380.x; Tsukamoto M., 1987, Japanese Journal of Tropical Medicine and Hygiene, V15, P291; Turner P, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2915-6; Vantaux A, 2018, J INFECT DIS, V217, P1561, DOI 10.1093/infdis/jiy060; Vong S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000903; WHO, 2019, WORLD MAL REP 2018; World Health Organization, 2019, WORLD DENG REP 2018	29	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0233669	10.1371/journal.pone.0233669	http://dx.doi.org/10.1371/journal.pone.0233669			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502226	gold, Green Published			2022-12-26	WOS:000542035700004
J	Izquierdo-Rodriguez, E; Fernandez-Alvarez, A; Martin-Carrillo, N; Marchand, B; Feliu, C; Miquel, J; Foronda, P; Quilichini, Y				Izquierdo-Rodriguez, Elena; Fernandez-Alvarez, Angela; Martin-Carrillo, Natalia; Marchand, Bernard; Feliu, Carlos; Miquel, Jordi; Foronda, Pilar; Quilichini, Yann			Pathogenic Leptospira species in rodents from Corsica (France)	PLOS ONE			English	Article							CATTLE; URINE; SPP.	Leptospirosis is a worldwide emerging zoonotic disease caused byLeptospiraspecies, that in some patients develop severe forms with high mortality. In France, Corsica is the area where the highest incidences have been reported. The present study was focused on the analysis of pathogenicLeptospiraspecies in rodents of Corsica, as these micromammals are the main natural reservoirs of the bacteria, in order to identify the circulating species and to locate possible risk focuses of transmission, as no previous study on the presence ofLeptospiraspecies has been carried out in the island.Rattus rattus,Rattus norvegicus,Apodemus sylvaticusandMus musculus domesticuswere captured in the proximity of water sources along Corsica, the detection of pathogenicLeptospiraspecies was carried out by amplification of the LipL32 gene. The bacteria were found in all the rodent species analyzed and widely. The general prevalence was 10.4%, reaching the maximum value in Bastia (45%).Leptospira interrogansandLeptospira borgpeterseniiwere identified by phylogenetic analysis, but also two sequences which corresponded to an unnamedLeptospiraspecies, only previously found in rodents of New Caledonia. The high incidence of human leptospirosis in Corsica could be partially explained by the wide distribution of pathogenicLeptospiraspecies identified in this study. Also, the presence of an unknown pathogenic species ofLeptospirain an area with high prevalence, may be involved in the higher incidence ofLeptospirosisin this island, however, the zoonotic capacity of this species remains unknown. The results obtained are interesting for public health since all positive samples were found near water sources and one of the routes of transmission of leptospirosis is contact with contaminated water. This information could help the competent entities to take preventive measures, reducing the incidence of human leptospirosis in Corsica.	[Izquierdo-Rodriguez, Elena; Fernandez-Alvarez, Angela; Martin-Carrillo, Natalia; Foronda, Pilar] Univ La Laguna, Inst Univ Enfermedades Trop & Salud Publ Canarias, San Cristobal la Laguna, Canary Islands, Spain; [Izquierdo-Rodriguez, Elena; Martin-Carrillo, Natalia; Foronda, Pilar] Univ La Laguna, Fac Farm, Dept Obstet & Ginecol, Pediat Med Prevent & Salud Publ,Toxicol Med Legal, San Cristobal la Laguna, Canary Islands, Spain; [Fernandez-Alvarez, Angela; Marchand, Bernard; Quilichini, Yann] CNRS Univ Corse, Projet GEM, UMR SPE 6134, F-20250 Corte, France; [Feliu, Carlos; Miquel, Jordi] Univ Barcelona, Fac Farm & Ciencies Alimentacio, Dept Biol Sanitat & Medi Ambient, Seccio Parasitol, Barcelona, Spain; [Feliu, Carlos; Miquel, Jordi] Univ Barcelona, Fac Biol, IRBio, Barcelona, Spain	Universidad de la Laguna; Universidad de la Laguna; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); University of Barcelona; University of Barcelona	Foronda, P (corresponding author), Univ La Laguna, Inst Univ Enfermedades Trop & Salud Publ Canarias, San Cristobal la Laguna, Canary Islands, Spain.; Foronda, P (corresponding author), Univ La Laguna, Fac Farm, Dept Obstet & Ginecol, Pediat Med Prevent & Salud Publ,Toxicol Med Legal, San Cristobal la Laguna, Canary Islands, Spain.	pforonda@ull.edu.es	Miquel, Jordi/J-7186-2017; Foronda, Pilar/H-4680-2015	Miquel, Jordi/0000-0003-1132-3772; Foronda, Pilar/0000-0001-9526-5113	Collectivite Territoriale de Corse-Direction de L'Enseignement Superieur et de la Recherche [CE/03/2015]; Proyectos I + D de la Consejeria de Economia, Industria, Comercio y Conocimiento de la Comunidad Autonoma de Canarias [ProID2017010092]; FEDER 2014-2020; Spanish Ministry of Health, Consumer Affairs and Social Welfare of Spain [RD16/0027/0001]	Collectivite Territoriale de Corse-Direction de L'Enseignement Superieur et de la Recherche(Region Corse); Proyectos I + D de la Consejeria de Economia, Industria, Comercio y Conocimiento de la Comunidad Autonoma de Canarias; FEDER 2014-2020; Spanish Ministry of Health, Consumer Affairs and Social Welfare of Spain	This work was funded by post-doctoral fellowship (AFA) CE/03/2015 "Collectivite Territoriale de Corse-Direction de L'Enseignement Superieur et de la Recherche"; ProID2017010092 "Proyectos I + D de la Consejeria de Economia, Industria, Comercio y Conocimiento de la Comunidad Autonoma de Canarias"; FEDER 2014-2020; RD16/0027/0001 Spanish Ministry of Health, Consumer Affairs and Social Welfare of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abgueguen P, 2008, J INFECTION, V57, P171, DOI 10.1016/j.jinf.2008.06.010; Brockmann S, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-91; Centre National de Reference de la Leptospirose, 2018, RAPP ANN ACT ANN EX, P38; Cosson JF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002902; Foronda P, 2011, EMERG INFECT DIS, V17, P1781, DOI 10.3201/eid1709.101470; Institut National de la Statistique et des Etudes Economiques, 2018, PORTR INT CORS, V8, p[17, 41]; Institut National de la Statistique et des Etudes Economiques, 2018, BIL ANN TOUR, P5; Jaujou C., 1954, B ORGANISME MONDIAL, V11, P635; Levett PN, 2005, J MED MICROBIOL, V54, P45, DOI 10.1099/jmm.0.45860-0; Ministere des solidarites et la sante, 2019, CAND VACC REC VACC, V19; Morgan J, 2002, CLIN INFECT DIS, V34, P1593, DOI 10.1086/340615; Mwachui MA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003843; Perez J, 2011, PLOS NEGLECT TROP D, V5, P1371; Bomfim MRQ, 2006, VET MICROBIOL, V118, P278, DOI 10.1016/j.vetmic.2006.07.020; Bomfim MRQ, 2008, VET J, V178, P251, DOI 10.1016/j.tvjl.2007.07.029; Radl C, 2011, WIEN KLIN WOCHENSCHR, V123, P751, DOI 10.1007/s00508-011-0100-2; Sejvar J, 2003, EMERG INFECT DIS, V9, P702; Vedhagiri K, 2010, BRAZ J MICROBIOL, V41, P150, DOI [10.1590/S1517-83822010000100022, 10.1590/S1517-838220100001000022]; Yang CW, 2002, J AM SOC NEPHROL, V13, P2037, DOI 10.1097/01.ASN.0000022007.91733.62	19	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0233776	10.1371/journal.pone.0233776	http://dx.doi.org/10.1371/journal.pone.0233776			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502160	Green Published, gold			2022-12-26	WOS:000542035700053
J	Sell, SL; Widen, SG; Prough, DS; Hellmich, HL				Sell, Stacy L.; Widen, Steven G.; Prough, Donald S.; Hellmich, Helen L.			Principal component analysis of blood microRNA datasets facilitates diagnosis of diverse diseases	PLOS ONE			English	Article							UP-REGULATION; ENDOTHELIAL-CELLS; BURKITT-LYMPHOMA; INFLAMMATION; EXPRESSION; INJURY; BIOMARKERS; TARGETS; BETA; ATHEROSCLEROSIS	Early, ideally pre-symptomatic, recognition of common diseases (e.g., heart disease, cancer, diabetes, Alzheimer's disease) facilitates early treatment or lifestyle modifications, such as diet and exercise. Sensitive, specific identification of diseases using blood samples would facilitate early recognition. We explored the potential of disease identification in high dimensional blood microRNA (miRNA) datasets using a powerful data reduction method: principal component analysis (PCA). Using Qlucore Omics Explorer (QOE), a dynamic, interactive visualization-guided bioinformatics program with a built-in statistical platform, we analyzed publicly available blood miRNA datasets from the Gene Expression Omnibus (GEO) maintained at the National Center for Biotechnology Information at the National Institutes of Health (NIH). The miRNA expression profiles were generated from real time PCR arrays, microarrays or next generation sequencing of biologic materials (e.g., blood, serum or blood components such as platelets). PCA identified the top three principal components that distinguished cohorts of patients with specific diseases (e.g., heart disease, stroke, hypertension, sepsis, diabetes, specific types of cancer, HIV, hemophilia, subtypes of meningitis, multiple sclerosis, amyotrophic lateral sclerosis, Alzheimer's disease, mild cognitive impairment, aging, and autism), from healthy subjects. Literature searches verified the functional relevance of the discriminating miRNAs. Our goal is to assemble PCA and heatmap analyses of existing and future blood miRNA datasets into a clinical reference database to facilitate the diagnosis of diseases using routine blood draws.	[Sell, Stacy L.; Prough, Donald S.; Hellmich, Helen L.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Widen, Steven G.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Hellmich, HL (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.	hhellmic@utmb.edu						An Z, 2018, J CELL BIOCHEM, V119, P3451, DOI 10.1002/jcb.26517; [Anonymous], 2015, PHARM COMMERCE, V10, P21; [Anonymous], 2012, DIABETES CARE S1, V35, pS12; [Anonymous], 2018, NAT BIOMED ENG, V2, P139; AR HL S, 2019, PAEDIAT PULMONOL, V54, pS302; Bao Y, 2019, DRUG DES DEV THER, V13, P3465, DOI 10.2147/DDDT.S210511; Baulina N, 2018, J NEUROIMMUNOL, V317, P67, DOI 10.1016/j.jneuroim.2018.01.005; Bellan C, 2009, HEMATOL ONCOL, V27, P182, DOI 10.1002/hon.914; Bras JP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188530; Busch A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010081; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Caserta S, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01977; Cheng C, 2013, J BIOL CHEM, V288, P13748, DOI 10.1074/jbc.M112.381392; Cheng XY, 2020, J CEREBR BLOOD F MET, V40, P775, DOI 10.1177/0271678X19839501; Correale J, 2017, BRAIN, V140, P527, DOI 10.1093/brain/aww258; Das SG, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0699-z; Ding M, 2018, CANCER RES, V78, P6771, DOI 10.1158/0008-5472.CAN-18-1662; Drummond MJ, 2011, PHYSIOL GENOMICS, V43, P595, DOI 10.1152/physiolgenomics.00148.2010; Du XJ, 2020, J CELL PHYSIOL, V235, P563, DOI 10.1002/jcp.28995; Ehtesham N, 2017, J MOL NEUROSCI, V61, P16, DOI 10.1007/s12031-016-0851-3; Emon MAEK, 2017, J ALZHEIMERS DIS, V56, P677, DOI 10.3233/JAD-160222; Ferguson DC, 2018, PHARM RES-DORDR, V35, DOI 10.1007/s11095-017-2294-0; Ferlay J, 2019, INT J CANCER, V144, P1941, DOI 10.1002/ijc.31937; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Filip D, 2020, LEUKEMIA LYMPHOMA, V61, P510, DOI 10.1080/10428194.2019.1675877; Foggin S, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00578; Giuliani A, 2017, DRUG DISCOV TODAY, V22, P1069, DOI 10.1016/j.drudis.2017.01.005; Goutman SA, 2018, MUSCLE NERVE, V57, P1, DOI 10.1002/mus.25740; Hamburg MA, 2010, NEW ENGL J MED, V363, P301, DOI 10.1056/NEJMp1006304; Han B, 2018, EXP THER MED, V16, P1935, DOI 10.3892/etm.2018.6389; Han YY, 2019, INT IMMUNOPHARMACOL, V76, DOI 10.1016/j.intimp.2019.105878; Haneklaus M, 2013, J INTERN MED, V274, P215, DOI 10.1111/joim.12099; Hariharan M, 2005, BIOCHEM BIOPH RES CO, V337, P1214, DOI 10.1016/j.bbrc.2005.09.183; He KJ, 2017, HEREDITAS, V155, P1, DOI 10.1186/s41065-017-0044-2; He PP, 2019, BIOCHEM BIOPH RES CO, V508, P97, DOI 10.1016/j.bbrc.2018.11.075; Hemond CC, 2019, NEUROL-NEUROIMMUNOL, V6, DOI 10.1212/NXI.0000000000000530; Uribe JH, 2016, VET RES, V47, DOI 10.1186/s13567-015-0286-9; Hulsen T, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00034; Jakaria M, 2019, MOL NEUROBIOL, V56, P5799, DOI 10.1007/s12035-019-1487-4; Jiang L, 2020, J CELL PHYSIOL, V235, P380, DOI 10.1002/jcp.28979; Jiang M, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00098; Jiang X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05560-1; Jiao YN, 2016, NEUROPHARMACOLOGY, V108, P332, DOI 10.1016/j.neuropharm.2016.04.046; Jolliffe IT, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0202; Jones D, 2012, ARTERIOSCL THROM VAS, V32, P633, DOI 10.1161/ATVBAHA.111.243576; Kang YC, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00154; Karolina DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022839; Kayano M, 2016, BIOMARK RES, V4, DOI 10.1186/s40364-016-0076-1; Keller A, 2011, NAT METHODS, V8, P841, DOI [10.1038/nmeth.1682, 10.1038/NMETH.1682]; Keller A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007440; Kokiko-Cochran ON, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00672; Kumar S, 2017, PROG MOL BIOL TRANSL, V146, P47, DOI 10.1016/bs.pmbts.2016.12.013; Lai ZM, 2018, BIOMED PHARMACOTHER, V97, P162, DOI 10.1016/j.biopha.2017.10.062; Lavin KM, 2020, J APPL PHYSIOL, V128, P87, DOI 10.1152/japplphysiol.00495.2019; Lee SA, 2018, J KOREAN MED SCI, V33, DOI 10.3346/jkms.2018.33.e201; Leidinger P, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r78; Lenze D, 2011, LEUKEMIA, V25, P1869, DOI 10.1038/leu.2011.156; Li L, 2019, J CELL PHYSIOL, V234, P13649, DOI 10.1002/jcp.28045; Ligthart S, 2018, AM J HUM GENET, V103, P691, DOI 10.1016/j.ajhg.2018.09.009; Lin HY, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101298; Liu W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6684; Lodes MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006229; Lou J, 2017, EXP CELL RES, V358, P120, DOI 10.1016/j.yexcr.2017.06.007; Lu ZG, 2014, MOL PHARMACOL, V85, P368, DOI 10.1124/mol.113.089292; Lv JL, 2019, VIRUS RES, V260, P1, DOI 10.1016/j.virusres.2018.11.001; Lv ZY, 2018, METAB BRAIN DIS, V33, P1711, DOI 10.1007/s11011-018-0279-2; Ma E, 2018, METAB SYNDR RELAT D, V16, P82, DOI 10.1089/met.2017.0101; Maes M, 2019, CURR PHARM DESIGN, V25, P4405, DOI 10.2174/1381612825666191102165459; Mariconti M, 2019, IMMUNOL RES, V67, P93, DOI 10.1007/s12026-018-9041-4; McKeever PM, 2018, MOL NEUROBIOL, V55, P8826, DOI 10.1007/s12035-018-1032-x; Mishra PK, 2009, CELL BIOCHEM BIOPHYS, V55, P153, DOI 10.1007/s12013-009-9063-6; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Nandakumar P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176734; Ontaneda D, 2017, LANCET, V389, P1357, DOI 10.1016/S0140-6736(16)31320-4; Organista-Juarez D, 2019, EPILEPSY RES, V157, DOI 10.1016/j.eplepsyres.2019.106188; Sheinerman KS, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00150; Pan LP, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00323; Pan TY, 2019, THERANOSTICS, V9, P405, DOI 10.7150/thno.29832; Patsopoulos NA, 2019, SCIENCE, V365, P1417, DOI 10.1126/science.aav7188; Price NL, 2017, CELL REP, V21, P1317, DOI 10.1016/j.celrep.2017.10.023; Ryan B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170407; Sand IK, 2015, CURR OPIN NEUROL, V28, P193, DOI 10.1097/WCO.0000000000000206; Schultz NA, 2014, JAMA-J AM MED ASSOC, V311, P392, DOI 10.1001/jama.2013.284664; Shang J, 2019, J CELL PHYSIOL, V234, P9746, DOI 10.1002/jcp.27660; Sheinerman KS, 2012, AGING-US, V4, P590, DOI 10.18632/aging.100486; Shigemizu D, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0324-7; Sonoda T, 2019, STROKE, V50, P1510, DOI 10.1161/STROKEAHA.118.023648; Srivastava AK, 2019, CANCER RES, V79, P2314, DOI 10.1158/0008-5472.CAN-18-3668; Stefan-Lifshitz M, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126663; Su Q, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1341-7; Sun HX, 2018, NEUROSCI LETT, V662, P233, DOI 10.1016/j.neulet.2017.10.046; Swindell WR, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1909-0; Takahashi I, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0161-7; Tang B, 2018, PATHOL RES PRACT, V214, P1686, DOI 10.1016/j.prp.2018.08.024; Tran Khanh-Van, 2019, J Clin Transl Res, V5, P33; Tremblay-Servier M, 2019, METABOLISM, V100; Nonaka CKV, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20164064; Vegter EL, 2017, CLIN RES CARDIOL, V106, P598, DOI 10.1007/s00392-017-1096-z; Vinuesa CG, 2009, INT REV IMMUNOL, V28, P112, DOI 10.1080/08830180902934909; Wang J, 2020, J CLIN LAB ANAL, V34, DOI 10.1002/jcla.23006; Wang L, 2019, J CELL PHYSIOL, V234, P5319, DOI 10.1002/jcp.27340; Wang M, 2019, J CANCER, V10, P4603, DOI 10.7150/jca.32065; Wei XJ, 2017, EUR REV MED PHARMACO, V21, P3886; Weisz H, 2019, THESIS; Xing TJ, 2014, INT J MOL SCI, V15, P14411, DOI 10.3390/ijms150814411; Xu HX, 2019, MOL MED REP, V20, P719, DOI 10.3892/mmr.2019.10266; Xu TT, 2019, CHEM RES TOXICOL, V32, P2192, DOI 10.1021/acs.chemrestox.9b00194; Xu YY, 2020, MOL THER, V28, P202, DOI 10.1016/j.ymthe.2019.09.008; Yang LS, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0805-5; Yang TS, 2018, REDOX BIOL, V15, P159, DOI 10.1016/j.redox.2017.11.025; Yuan Y, 2019, TECHNOL CANCER RES T, V18, DOI 10.1177/1533033819886867; Zhang XF, 2018, THROMB RES, V171, P55, DOI 10.1016/j.thromres.2018.09.043; Zhang YP, 2018, THER APHER DIAL, V22, P649, DOI 10.1111/1744-9987.12720; Zheng Y, 2018, EXP THER MED, V15, P338, DOI 10.3892/etm.2017.5355; Zheng Y, 2015, LAB INVEST, V95, P1387, DOI 10.1038/labinvest.2015.112; Zheng ZJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep37492; Zhong RL, 2019, CELL CYCLE, V18, P990, DOI 10.1080/15384101.2019.1608127; Zhou YL, 2018, BIOMED PHARMACOTHER, V106, P1751, DOI 10.1016/j.biopha.2018.07.141; Zhu Y, 2019, EUR REV MED PHARMACO, V23, P37, DOI 10.26355/eurrev_201901_16745; Zhu YN, 2015, INT J GYNECOL OBSTET, V130, P49, DOI 10.1016/j.ijgo.2015.01.010; Zou SB, 2019, BIOTECHNOL APPL BIOC, V66, P763, DOI 10.1002/bab.1767; 2018, EUROPEAN J LEGAL HIS, V15, P99	122	11	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0234185	10.1371/journal.pone.0234185	http://dx.doi.org/10.1371/journal.pone.0234185			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502186	gold, Green Published			2022-12-26	WOS:000542035700067
J	Atarsaikhan, G; Iwana, BK; Uchida, S				Atarsaikhan, Gantugs; Iwana, Brian Kenji; Uchida, Seiichi			Guided neural style transfer for shape stylization	PLOS ONE			English	Article							FONTS	Designing logos, typefaces, and other decorated shapes can require professional skills. In this paper, we aim to produce new and unique decorated shapes by stylizing ordinary shapes with machine learning. Specifically, we combined parametric and non-parametric neural style transfer algorithms to transfer both local and global features. Furthermore, we introduced a distance-based guiding to the neural style transfer process, so that only the foreground shape will be decorated. Lastly, qualitative evaluation and ablation studies are provided to demonstrate the usefulness of the proposed method.	[Atarsaikhan, Gantugs; Iwana, Brian Kenji; Uchida, Seiichi] Kyushu Univ, Dept Adv Informat Technol, Fukuoka, Japan	Kyushu University	Atarsaikhan, G (corresponding author), Kyushu Univ, Dept Adv Informat Technol, Fukuoka, Japan.	gantugs.atarsaikhan@human.ait.kyushu-u.ac.jp		Iwana, Brian Kenji/0000-0002-5146-6818	MEXT-Japan [J17H06100]	MEXT-Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Our work was supported by MEXT-Japan (Grant No. J17H06100). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2017, PROCEEDINGS 2017 4TH IAPR ASIAN CONFERENCE ON PATTERN RECOGNITION (ACPR), P232, DOI 10.1109/ACPR.2017.99; Anderson AG, 2016, DEEPMOVIE USING OPTI; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Atarsaikhan G, 2018, 2018 13TH IAPR INTERNATIONAL WORKSHOP ON DOCUMENT ANALYSIS SYSTEMS (DAS), P317, DOI 10.1109/DAS.2018.78; Atarsaikhan G, 2017, PROC INT CONF DOC, P51, DOI 10.1109/ICDAR.2017.328; Azadil S, 2018, PROC CVPR IEEE, P7564, DOI 10.1109/CVPR.2018.00789; CAMPBELL NDF, 2014, TOG, V33, P4, DOI DOI 10.1145/2601097.2601212; Champandard A. J., 2016, SEMANTIC STYLE TRANS; Chen T. Q., 2016, FAST PATCH BASED STY; Chen YX, 2016, CANCERS, V8, DOI 10.3390/cancers8040040; Emplemmatic. Mark Maker, MARK MAK; Gatys L A, 2016, PRESERVING COLOR NEU; GATYS LA, 2016, PROC CVPR IEEE, P2414, DOI DOI 10.1109/CVPR.2016.265; Gatys LA, 2015, TEXTURE SYNTHESIS CO; Gatys LA, 2017, PROC CVPR IEEE, P3730, DOI 10.1109/CVPR.2017.397; Goodfellow IJ, 2014, ADV NEUR IN, V27, P2672, DOI 10.1145/3422622; Gretton A, 2012, J MACH LEARN RES, V13, P723; Huang X., 2017, ARBITRARY STYLE TRAN; Jiang SH, 2017, PROCEEDINGS OF THE TWENTY-SIXTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P3721; Jing Y, 2020, AAAI; Jing Yongcheng, 2019, IEEE T VISUALIZATION; Johnson Justin, 2016, Computer Vision - ECCV 2016. 14th European Conference. Proceedings: LNCS 9906, P694, DOI 10.1007/978-3-319-46475-6_43; Joshi B., 2017, ACM SIGGRAPH DIGITAL, DOI DOI 10.1145/3105692.3105697; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Li C, 2016, PROC CVPR IEEE, P2479, DOI 10.1109/CVPR.2016.272; Li C, 2016, LECT NOTES COMPUT SC, V9907, P702, DOI 10.1007/978-3-319-46487-9_43; Li SH, 2017, PROCEEDINGS OF THE 2017 ACM MULTIMEDIA CONFERENCE (MM'17), P1716, DOI 10.1145/3123266.3123425; Li YH, 2017, PROCEEDINGS OF THE TWENTY-SIXTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P2230; Li Yijun, 2017, ARXIV170508086; Liao J, 2017, ACM T GRAPHIC, V36, DOI 10.1145/3072959.3073683; Logojoy, IT WORKS DES LOH YOU; Lu M, 2017, IEEE I CONF COMP VIS, P2488, DOI 10.1109/ICCV.2017.270; Luan FJ, 2017, PROC CVPR IEEE, P6997, DOI 10.1109/CVPR.2017.740; Lyu PY, 2017, PROC INT CONF DOC, P1095, DOI 10.1109/ICDAR.2017.181; Mechrez R, 2018, CONTEXTUAL LOSS IMAG; Mechrez SERoey, 2017, BRIT MACH VIS C; Mino A, 2018, 2018 17TH IEEE INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS (ICMLA), P965, DOI 10.1109/ICMLA.2018.00157; Risser E., 2017, STABLE CONTROLLABLE; Ruder M., 2018, INT J COMPUT VISION, V126, P1199, DOI DOI 10.1007/s11263-018-1089-z; Ruder M, 2016, LECT NOTES COMPUT SC, V9796, P26, DOI 10.1007/978-3-319-45886-1_3; Sage A, 2018, PROC CVPR IEEE, P5879, DOI 10.1109/CVPR.2018.00616; Saputra RA, 2019, IEEE T VISUALIZATION; Selim A, 2016, ACM T GRAPHIC, V35, DOI 10.1145/2897824.2925968; Sun D, 2018, PYRAMID EMBEDDED GEN; Suveeranont R, 2010, LECT NOTES COMPUT SC, V6133, P127, DOI 10.1007/978-3-642-13544-6_12; Uchida S, 2015, PROC INT CONF DOC, P441, DOI 10.1109/ICDAR.2015.7333800; Ulyanov D, 2017, P IEEE C COMP VIS PA, P6; Ulyanov D, 2016, PR MACH LEARN RES, V48; Wang Z, 2018, GLSTYLENET HIGHER QU; Yang S, 2018, TET GAN TEXT EFFECTS; Yang S, 2018, COMPUT VIS IMAGE UND, V174, P43, DOI 10.1016/j.cviu.2018.07.004; Yang S, 2017, PROC CVPR IEEE, P2886, DOI 10.1109/CVPR.2017.308; Yin R, 2016, CONTENT AWARE NEURAL; Yong JW, 2014, 2014 IEEE INTERNATIONAL CONFERENCE ON INFORMATION AND AUTOMATION (ICIA), P35, DOI 10.1109/ICInfA.2014.6932622; Zhao NX, 2018, COMPUT GRAPH FORUM, V37, P385, DOI 10.1111/cgf.13576	56	3	3	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0233489	10.1371/journal.pone.0233489	http://dx.doi.org/10.1371/journal.pone.0233489			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497055	gold, Green Published			2022-12-26	WOS:000542035200077
J	Hendriks, T; McGregor, S; Rakesh, S; Robinson, J; Ho, KM; Baker, R				Hendriks, Thomas; McGregor, Scott; Rakesh, Shilpa; Robinson, Julie; Ho, Kwok M.; Baker, Ross			Patient satisfaction after conversion from warfarin to direct oral anticoagulants for patients on extended duration of anticoagulation for venous thromboembolism - The SWAN Study	PLOS ONE			English	Article							REPORTED TREATMENT SATISFACTION; VITAMIN-K ANTAGONIST; QUALITY-OF-LIFE; ATRIAL-FIBRILLATION; COST-EFFECTIVENESS; STANDARD THERAPY; RIVAROXABAN; APIXABAN; PREVENTION; STROKE	Background Warfarin is an anticoagulant medication proven effective in the initial treatment and secondary prevention of venous thromboembolism. Anti-Xa direct oral anticoagulants are alternatives to warfarin; however there is limited data assessing satisfaction after switching from warfarin to an anti-Xa direct oral anticoagulant in patients for treatment of venous thromboembolism. Objectives To assess medication satisfaction in patients requiring anticoagulation for venous thromboembolism after conversion from warfarin to an anti-Xa direct oral anticoagulant. Methods A retrospective cohort study with prospective assessment of satisfaction and review of adverse events following anti-Xa direct oral anticoagulant replacement of warfarin for treatment of venous thromboembolism. Out of 165 patients who had switched from warfarin to rivaroxaban or apixaban from an outpatient haematology practice, 126 patients consented for a survey of patient's relative satisfaction of anti-Xa direct oral anticoagulant therapy compared with previous warfarin therapy using the Anti-Clot Burden and Benefits Treatment Scale and SWAN Score. Results The mean Anti-Clot Burden and Benefits and SWAN Score was 93% (56/60) and 83% (24.8/30) respectively reflecting high satisfaction with anti-Xa direct oral anticoagulants. 120 patients stated preference for anti-Xa direct oral anticoagulants over warfarin. Leading perceptions driving this was the reduction in frequency of medical contact and fewer bleeding side effects. Thirteen patients (10.3%) experienced an adverse event after the anti-Xa direct oral anticoagulant switch (majority were non-major bleeding) but most remained on anti-Xa direct oral anticoagulant treatment after management options were implemented with continued high satisfaction scores. Conclusions Patient satisfaction with anti-Xa direct oral anticoagulant therapy for the treatment and prevention of venous thromboembolism after switching from warfarin in routine clinical practice appeared high. Improved patient convenience including reduced frequency of medical contact and fewer unpredictable side effects were perceived as significant advantages of anti-Xa direct oral anticoagulants compared to warfarin.	[Hendriks, Thomas; McGregor, Scott; Robinson, Julie; Baker, Ross] Hollywood Private Hosp, Perth Blood Inst, Perth, WA, Australia; [Hendriks, Thomas; McGregor, Scott; Rakesh, Shilpa; Baker, Ross] Murdoch Univ, Western Australian Ctr Thrombosis & Haemostasis, Murdoch, WA, Australia; [Ho, Kwok M.] Royal Perth Hosp, Dept Intens Care Med, Perth, WA, Australia; [Ho, Kwok M.] Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA, Australia	Murdoch University; Royal Perth Hospital; University of Western Australia; Murdoch University	Hendriks, T (corresponding author), Hollywood Private Hosp, Perth Blood Inst, Perth, WA, Australia.; Hendriks, T (corresponding author), Murdoch Univ, Western Australian Ctr Thrombosis & Haemostasis, Murdoch, WA, Australia.	thomas.hendriks@health.wa.gov.au	Baker, Ross/AAG-5798-2021; Ho, Kwok M./E-3546-2010	Baker, Ross/0000-0002-2728-6788; Ho, Kwok M./0000-0002-6705-6004				Ageno W, 2012, CHEST, V141, pE44S, DOI 10.1378/chest.11-2292; Agnelli G, 2013, NEW ENGL J MED, V369, P799, DOI 10.1056/NEJMoa1302507; Agnelli G, 2013, NEW ENGL J MED, V368, P699, DOI 10.1056/NEJMoa1207541; Bamber L, 2013, THROMB HAEMOSTASIS, V110, P732, DOI 10.1160/TH13-03-0243; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Bellinge JW, 2018, MED J AUSTRALIA, V208, P18, DOI 10.5694/mja17.00132; Beyer-Westendorf J, 2016, LANCET HAEMATOL, V3, pE480, DOI 10.1016/S2352-3026(16)30111-9; Buller HR, 2012, NEW ENGL J MED, V366, P1287, DOI 10.1056/NEJMoa1113572; Cano SJ, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-120; Coleman CI, 2016, CLIN CARDIOL, V39, P565, DOI 10.1002/clc.22565; Coyle D, 2013, VALUE HEALTH, V16, P498, DOI 10.1016/j.jval.2013.01.009; Fareau S, 2015, GERIATR PSYCHOL NEUR, V13, P45, DOI 10.1684/pnv.2015.0516; Fumagalli S, 2015, AGING CLIN EXP RES, V27, P99, DOI 10.1007/s40520-014-0243-x; Harenberg J, 2012, THROMB RES, V129, pS106, DOI 10.1016/S0049-3848(12)70028-2; Keita I, 2017, PATIENT PREFER ADHER, V11, P1625, DOI 10.2147/PPA.S131157; Pinyol C, 2016, CARDIOL THER, V5, P171, DOI 10.1007/s40119-016-0066-2; Pratt NL, 2016, MED J AUSTRALIA, V204, P104, DOI [10.5694/mja15.01000, DOI 10.5694/MJA15.0100026866544]; Prins MH, 2015, THROMB RES, V135, P281, DOI 10.1016/j.thromres.2014.11.008; Scheme PB, 2017, EXPENDITURE PRESCRIP; Singh SM, 2015, CURR CARDIOL REP, V17, DOI 10.1007/s11886-015-0618-4; Wan D, 2018, CAN J CARDIOL, V34, P1412, DOI 10.1016/j.cjca.2018.07.476; Weitz JI, 2017, NEW ENGL J MED, V376, P1211, DOI 10.1056/NEJMoa1700518	22	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0234048	10.1371/journal.pone.0234048	http://dx.doi.org/10.1371/journal.pone.0234048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497116	Green Published, gold			2022-12-26	WOS:000542035200021
J	McCulloch, KA; Zhou, K; Jin, YS				McCulloch, Katherine A.; Zhou, Kingston; Jin, Yishi			Neuronal transcriptome analyses reveal novel neuropeptide modulators of excitation and inhibition imbalance inC.elegans	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; GENE FAMILIES; C. ELEGANS; EXPRESSION; RESISTANCE; REQUIRES	Neuropeptides are secreted molecules that have conserved roles modulating many processes, including mood, reproduction, and feeding. Dysregulation of neuropeptide signaling is also implicated in neurological disorders such as epilepsy. However, much is unknown about the mechanisms regulating specific neuropeptides to mediate behavior. Here, we report that the expression levels of dozens of neuropeptides are up-regulated in response to circuit activity imbalance inC.elegans.acr-2encodes a homolog of human nicotinic receptors, and functions in the cholinergic motoneurons. A hyperactive mutation,acr-2(gf), causes an activity imbalance in the motor circuit. We performed cell-type specific transcriptomic analysis and identified genes differentially expressed inacr-2(gf), compared to wild type. The most over-represented class of genes are neuropeptides, with insulin-like-peptides (ILPs) the most affected. Moreover, up-regulation of neuropeptides occurs in motoneurons, as well as sensory neurons. In particular, the induced expression of the ILPins-29occurs in the BAG neurons, which were previously shown to function in gas-sensing. We also show that this up-regulation ofins-29inacr-2(gf)animals is activity-dependent. Our genetic and molecular analyses support cooperative effects for ILPs and other neuropeptides in promoting motor circuit activity in theacr-2(gf)background. Together, this data reveals that a major transcriptional response to motor circuit dysregulation is in up-regulation of multiple neuropeptides, and suggests that BAG sensory neurons can respond to intrinsic activity states to feedback on the motor circuit.	[McCulloch, Katherine A.; Zhou, Kingston; Jin, Yishi] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Jin, YS (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.	yijin@ucsd.edu		Jin, Yishi/0000-0002-9371-9860	National Institutes of Health [T32 NS007220, T32 AG000216, R37 NS035546]; NIH Office of Research Infrastructure Programs [P40 OD010440]; National Bioresource Project of Japan	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Bioresource Project of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	K.A.M. was a trainee on National Institutes of Health institutional training grants (T32 NS007220 and T32 AG000216). This work was supported by a National Institutes of Health grant to Y. J. (R37 NS035546). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank our lab members for helpful discussions, and Matt Andrusiak and Ngang Heok Tang for comments on the manuscript. We also thank Rachel Kaletsky and Coleen Murphy for sharing advice on neuron isolation, Martin Hudson for the XA2260 strain, and Niels Ringstad for discussion. Some strains were provided by the Caenorhabditis Genetics Center, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440) and the National Bioresource Project of Japan.	Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Blazie SM, 2018, ACS CHEM NEUROSCI, V9, P1963, DOI 10.1021/acschemneuro.7b00509; Chalasani SH, 2010, NAT NEUROSCI, V13, P615, DOI 10.1038/nn.2526; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Cohen S, 2011, NEURON, V72, P72, DOI 10.1016/j.neuron.2011.08.022; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Evans TC, 2006, TRANSFORMATION MICRO; Frazier HN, 2019, EXP NEUROL, V313, P79, DOI 10.1016/j.expneurol.2018.12.007; Guillermin ML, 2017, CURR BIOL, V27, P2630, DOI 10.1016/j.cub.2017.07.023; Guillermin ML, 2011, GENETICS, V189, P1327, DOI 10.1534/genetics.111.133835; Hallem EA, 2008, P NATL ACAD SCI USA, V105, P8038, DOI 10.1073/pnas.0707469105; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Hung WL, 2014, DEVELOPMENT, V141, P1767, DOI 10.1242/dev.103846; Husson SJ, 2007, J NEUROCHEM, V102, P246, DOI 10.1111/j.1471-4159.2007.04474.x; Husson SJ, 2006, J NEUROCHEM, V98, P1999, DOI 10.1111/j.1471-4159.2006.04014.x; Jospin M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000265; Kaletsky R, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007559; Kaletsky R, 2016, NATURE, V529, P92, DOI 10.1038/nature16483; Kim K, 2004, J COMP NEUROL, V475, P540, DOI 10.1002/cne.20189; Kovac S, 2013, NEUROPEPTIDES, V47, P467, DOI 10.1016/j.npep.2013.10.015; Kroetz MB, 2015, G3-GENES GENOM GENET, V5, P2831, DOI 10.1534/g3.115.022517; LEWIS JA, 1980, GENETICS, V95, P905; Li C, 1999, ANN NY ACAD SCI, V897, P239, DOI 10.1111/j.1749-6632.1999.tb07895.x; Liu TW, 2007, J NEUROSCI, V27, P7174, DOI 10.1523/JNEUROSCI.1405-07.2007; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Mahoney TR, 2006, NAT PROTOC, V1, P1772, DOI 10.1038/nprot.2006.281; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; Paix A, 2015, GENETICS, V201, P47, DOI 10.1534/genetics.115.179382; Phillips HA, 2001, AM J HUM GENET, V68, P225, DOI 10.1086/316946; Qi YB, 2013, J NEUROSCI, V33, P5319, DOI 10.1523/JNEUROSCI.4017-12.2013; Reichmann F, 2016, NEUROPEPTIDES, V55, P99, DOI 10.1016/j.npep.2015.09.008; Richards J. P., 2005, SUPER PORPHYRY COPPE, V1, P7; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Ringstad N, 2008, NAT NEUROSCI, V11, P1168, DOI 10.1038/nn.2186; Serrano-Saiz E, 2013, CELL, V155, P659, DOI 10.1016/j.cell.2013.09.052; Song YC, 2016, SCI REP-UK, V6, DOI 10.1038/srep21389; Speese S, 2007, J NEUROSCI, V27, P6150, DOI 10.1523/JNEUROSCI.1466-07.2007; Spencer WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112102; Stawicki TM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003472; Stawicki TM, 2011, CURR BIOL, V21, P883, DOI 10.1016/j.cub.2011.03.070; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Von Stetina SE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r135; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384; Zhang SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019505; Zheng Fei, 2012, Int J Physiol Pathophysiol Pharmacol, V4, P188	48	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0233991	10.1371/journal.pone.0233991	http://dx.doi.org/10.1371/journal.pone.0233991			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497060	Green Submitted, Green Published, gold			2022-12-26	WOS:000542035200023
J	El-Rewaidy, H; Neisius, U; Nakamori, S; Ngo, L; Rodriguez, J; Manning, WJ; Nezafat, R				El-Rewaidy, Hossam; Neisius, Ulf; Nakamori, Shiro; Ngo, Long; Rodriguez, Jennifer; Manning, Warren J.; Nezafat, Reza			Characterization of interstitial diffuse fibrosis patterns using texture analysis of myocardial native T-1 mapping	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; HYPERTROPHIC CARDIOMYOPATHY; EUROPEAN-SOCIETY; IMAGES; TIME; REGISTRATION; VALIDATION	Background The pattern of myocardial fibrosis differs significantly between different cardiomyopathies. Fibrosis in hypertrophic cardiomyopathy (HCM) is characteristically as patchy and regional but in dilated cardiomyopathy (DCM) as diffuse and global. We sought to investigate if texture analyses on myocardial native T-1 mapping can differentiate between fibrosis patterns in patients with HCM and DCM. Methods We prospectively acquired native myocardial T-1 mapping images for 321 subjects (55 +/- 15 years, 70% male): 65 control, 116 HCM, and 140 DCM patients. To quantify different fibrosis patterns, four sets of texture descriptors were used to extract 152 texture features from native T-1 maps. Seven features were sequentially selected to identify HCM- and DCM-specific patterns in 70% of data (training dataset). Pattern reproducibility and generalizability were tested on the rest of data (testing dataset) using support vector machines (SVM) and regression models. Results Pattern-derived texture features were capable to identify subjects in HCM, DCM, and controls cohorts with 202/237(85.2%) accuracy of all subjects in the training dataset using 10-fold cross-validation on SVM (AUC = 0.93, 0.93, and 0.93 for controls, HCM and DCM, respectively), while pattern-independent global native T-1 mapping was poorly capable to identify those subjects with 121/237(51.1%) accuracy (AUC = 0.78, 0.51, and 0.74) (P<0.001 for all). The pattern-derived features were reproducible with excellent intra- and inter-observer reliability and generalizable on the testing dataset with 75/84(89.3%) accuracy. Conclusion Texture analysis of myocardial native T-1 mapping can characterize fibrosis patterns in HCM and DCM patients and provides additional information beyond average native T-1 values.	[El-Rewaidy, Hossam; Neisius, Ulf; Nakamori, Shiro; Ngo, Long; Rodriguez, Jennifer; Manning, Warren J.; Nezafat, Reza] Beth Israel Deaconess Med Ctr, Dept Med, Cardiovasc Div, Boston, MA 02215 USA; [El-Rewaidy, Hossam; Neisius, Ulf; Nakamori, Shiro; Ngo, Long; Rodriguez, Jennifer; Manning, Warren J.; Nezafat, Reza] Harvard Med Sch, Boston, MA 02215 USA; [El-Rewaidy, Hossam] Tech Univ Munich, Dept Comp Sci, Munich, Germany; [Manning, Warren J.] Beth Israel Deaconess Med Ctr, Dept Radiol, 330 Brookline Ave, Boston, MA 02215 USA; [Manning, Warren J.] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Technical University of Munich; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Nezafat, R (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Cardiovasc Div, Boston, MA 02215 USA.; Nezafat, R (corresponding author), Harvard Med Sch, Boston, MA 02215 USA.	rnezafat@bidmc.harvard.edu	Nakamori, Shiro/GQP-8013-2022	Nakamori, Shiro/0000-0001-8165-5268; El-Rewaidy, Hossam/0000-0002-5266-8702	National Institutes of Health [5R01HL129185, 1R01HL129157-01A1, 5R01HL127015-02]; American Heart Association (AHA) (Dallas, TX, USA) [15EIA22710040]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA) (Dallas, TX, USA)(American Heart Association)	This study is supported in part by grants received by the corresponding author (RN) from: 1-National Institutes of Health: Grants number 5R01HL129185 and 1R01HL129157-01A1 2-The American Heart Association (AHA) (Dallas, TX, USA): Grant number 15EIA22710040. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.The corresponding author (RN) also receive other grant from National Institutes of Health: Grants number 5R01HL127015-02 which is not in support of this study.	Ahonen T, 2009, LECT NOTES COMPUT SC, V5575, P61, DOI 10.1007/978-3-642-02230-2_7; Baessler B, 2018, RADIOLOGY, V289, P357, DOI 10.1148/radiol.2018180411; Baessler B, 2018, EUR J RADIOL, V102, P61, DOI 10.1016/j.ejrad.2018.03.013; Baessler B, 2018, RADIOLOGY, V286, P103, DOI 10.1148/radiol.2017170213; Child N, 2018, EUR HEART J-CARD IMG, V19, P768, DOI 10.1093/ehjci/jex309; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Dass S, 2012, CIRC-CARDIOVASC IMAG, V5, P726, DOI 10.1161/CIRCIMAGING.112.976738; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dietterich TG, 1994, J ARTIF INTELL RES, V2, P263; El-Rewaidy H, 2018, MAGN RESON MED, V80, P780, DOI 10.1002/mrm.27068; Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342; Elliott PM, 2014, EUR HEART J, V35, P2733, DOI 10.1093/eurheartj/ehu284; Fahmy AS, 2018, JACC-CARDIOVASC IMAG, V11, P1917, DOI 10.1016/j.jcmg.2018.04.030; Flett AS, 2010, CIRCULATION, V122, P138, DOI 10.1161/CIRCULATIONAHA.109.930636; Galloway M., 1975, COMPUTER GRAPHICS IM, V4, P172, DOI DOI 10.1016/S0146-664X(75)80008-6; Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169; Goebel J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155591; Haralick R.M., 1992, COMPUTER ROBOT VISIO, VVolume 1; Hastie T, 2009, ELEMENTS, V27, P337, DOI DOI 10.1007/B94608; Hinojar R, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.115.003285; Iles LM, 2015, EUR HEART J-CARD IMG, V16, P14, DOI 10.1093/ehjci/jeu182; Kather JN, 2016, SCI REP-UK, V6, DOI 10.1038/srep27988; Kato S, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-016-0301-y; Kato S, 2016, AM J CARDIOL, V118, P1057, DOI 10.1016/j.amjcard.2016.07.010; Kawel-Boehm N, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0111-7; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Liu JM, 2017, J CARDIOVASC MAGN R, V19, DOI 10.1186/s12968-017-0386-y; Messroghli DR, 2017, J CARDIOVASC MAGN R, V19, DOI 10.1186/s12968-017-0389-8; Nakamori S, 2018, J MAGN RESON IMAGING, V47, P779, DOI 10.1002/jmri.25811; Nakamori S, 2018, JACC-CARDIOVASC IMAG, V11, P48, DOI 10.1016/j.jcmg.2017.04.006; Neisius U, 2019, JACC-CARDIOVASC IMAG, V12, P1946, DOI 10.1016/j.jcmg.2018.11.024; Plana JC, 2014, J AM SOC ECHOCARDIOG, V27, P911, DOI [10.1016/j.echo.2014.07.012, 10.1093/ehjci/jeu192]; PUDIL P, 1994, PATTERN RECOGN LETT, V15, P1119, DOI 10.1016/0167-8655(94)90127-9; Puntmann VO, 2016, JACC-CARDIOVASC IMAG, V9, P40, DOI 10.1016/j.jcmg.2015.12.001; Puntmann VO, 2013, JACC-CARDIOVASC IMAG, V6, P475, DOI 10.1016/j.jcmg.2012.08.019; Rayatzadeh H, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-31; Roes SD, 2009, CIRC-CARDIOVASC IMAG, V2, P183, DOI 10.1161/CIRCIMAGING.108.826529; Roujol S, 2015, MAGN RESON MED, V73, P1469, DOI 10.1002/mrm.25270; Salton CJ, 2002, J AM COLL CARDIOL, V39, P1055, DOI 10.1016/S0735-1097(02)01712-6; Shah RV, 2016, AM J CARDIOL, V117, P282, DOI 10.1016/j.amjcard.2015.10.046; Shao XN, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012246; Tang XO, 1998, IEEE T IMAGE PROCESS, V7, P1602, DOI 10.1109/83.725367; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579	43	7	7	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0233694	10.1371/journal.pone.0233694	http://dx.doi.org/10.1371/journal.pone.0233694			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MJ2AA	32479518	gold, Green Published			2022-12-26	WOS:000547893500021
J	Zhang, XZ; Shi, SD; Su, Y; Yang, XL; He, SN; Yang, XY; Wu, J; Zhang, J; Rao, F				Zhang, Xiaozhe; Shi, Shaodong; Su, Yang; Yang, Xiaoli; He, Sining; Yang, Xiuyan; Wu, Jing; Zhang, Jian; Rao, Feng			Suramin and NF449 are IP5K inhibitors that disrupt inositol hexakisphosphate?mediated regulation of cullin?RING ligase and sensitize cancer cells to MLN4924/pevonedistat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inositol phosphate; inhibitor; E3 ubiquitin ligase; cancer chemoprevention; protein degradation; COP9 signalosome; cullin?RING ligase; IP5K; neddylation; suramin	1,3,4,5,6-PENTAKISPHOSPHATE 2-KINASE; CRYSTAL-STRUCTURE; COP9 SIGNALOSOME; BINDING-SITE; IP6; REVEALS; KINASES; PATHWAY; CORE	Inositol hexakisphosphate (IP6) is an abundant metabolite synthesized from inositol 1,3,4,5,6-pentakisphosphate (IP5) by the single IP(5)2-kinase (IP5K). Genetic and biochemical studies have shown that IP(6)usually functions as a structural cofactor in protein(s) mediating mRNA export, DNA repair, necroptosis, 3D genome organization, HIV infection, and cullin?RING ligase (CRL) deneddylation. However, it remains unknown whether pharmacological perturbation of cellular IP(6)levels affects any of these processes. Here, we performed screening for small molecules that regulate human IP5K activity, revealing that the antiparasitic drug and polysulfonic compound suramin efficiently inhibits IP5Kin vitroandin vivo. The results from docking experiments and biochemical validations suggested that the suramin targets IP5K in a distinct bidentate manner by concurrently binding to the ATP- and IP5-binding pockets, thereby inhibiting both IP(5)phosphorylation and ATP hydrolysis. NF449, a suramin analog with additional sulfonate moieties, more potently inhibited IP5K. Both suramin and NF449 disrupted IP6-dependent sequestration of CRL by the deneddylase COP9 signalosome, thereby affecting CRL activity cycle and component dynamics in an IP5K-dependent manner. Finally, nontoxic doses of suramin, NF449, or NF110 exacerbate the loss of cell viability elicited by the neddylation inhibitor and clinical trial drug MLN4924/pevonedistat, suggesting synergistic ef-fects. Suramin and its analogs provide structural templates for designing potent and specific IP5K inhibitors, which could be used in combination therapy along with MLN4924/pevonedistat. IP5K is a potential mechanistic target of suramin, accounting for suramin's therapeutic effects.	[Zhang, Xiaozhe] China Agr Univ, Coll Biol Sci, Beijing, Peoples R China; [Zhang, Xiaozhe; Shi, Shaodong; Su, Yang; Yang, Xiaoli; He, Sining; Yang, Xiuyan; Rao, Feng] Southern Univ Sci & Technol, Dept Biol, Shenzhen, Guangdong, Peoples R China; [Wu, Jing; Zhang, Jian] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Pathophysiol,Sch Med, Key Lab Cell Differentiat & Apoptosis,Minist Educ, Shanghai, Peoples R China	China Agricultural University; Southern University of Science & Technology; Shanghai Jiao Tong University	Rao, F (corresponding author), Southern Univ Sci & Technol, Dept Biol, Shenzhen, Guangdong, Peoples R China.	raof@sustech.edu.cn	Zhang, Jian/GXA-1303-2022	Zhang, Jian/0000-0002-6558-791X	Science and Technology Innovation Commission of Shenzhen Municipal Government [KQJSCX20180322152418316, JCYJ20170412153517422, JCYJ20170817104311912]; National Science Foundation of China [31872798, 91853129, 81925034]; Department of Science and Technology of Guangdong Province [2018A030313207]	Science and Technology Innovation Commission of Shenzhen Municipal Government; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Guangdong Province	This work was supported by Grants KQJSCX20180322152418316, JCYJ20170412153517422, and JCYJ20170817104311912 from the Science and Technology Innovation Commission of Shenzhen Municipal Government (to F. R.), Grants 31872798 and 91853129 (to F. R.) and 81925034 (to J. Z.) from the National Science Foundation of China, and Grant 2018A030313207 from the Department of Science and Technology of Guangdong Province (to F. R.).	Alcazar-Roman AR, 2006, NAT CELL BIOL, V8, P711, DOI 10.1038/ncb1427; Brehm MA, 2019, BIOCHEM PHARMACOL, V163, P206, DOI 10.1016/j.bcp.2019.02.024; Cheng J, 2019, BBA-REV CANCER, V1871, P138, DOI 10.1016/j.bbcan.2018.11.007; Cope Gregory A., 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-1; DECLERCQ E, 1987, ANTIVIR RES, V7, P1, DOI 10.1016/0166-3542(87)90034-9; Desfougeres Y, 2019, P NATL ACAD SCI USA, V116, P24551, DOI 10.1073/pnas.1911431116; Dick RA, 2018, NATURE, V560, P509, DOI 10.1038/s41586-018-0396-4; Franco-Echevarria E, 2017, J BIOL CHEM, V292, P10534, DOI 10.1074/jbc.M117.780395; Gonzalez B, 2004, MOL CELL, V15, P689, DOI 10.1016/j.molcel.2004.08.004; Gonzalez B, 2010, P NATL ACAD SCI USA, V107, P9608, DOI 10.1073/pnas.0912979107; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Gu CF, 2019, J MED CHEM, V62, P1443, DOI 10.1021/acs.jmedchem.8b01593; Hanakahi LA, 2000, CELL, V102, P721, DOI 10.1016/S0092-8674(00)00061-1; Hatch AJ, 2010, CELL, V143, P1030, DOI 10.1016/j.cell.2010.11.045; Huang ZM, 2018, NAT CHEM BIOL, V14, P1118, DOI 10.1038/s41589-018-0150-0; Ives EB, 2000, J BIOL CHEM, V275, P36575, DOI 10.1074/jbc.M007586200; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Lin H, 2020, P NATL ACAD SCI USA, V117, P4117, DOI 10.1073/pnas.1911998117; Liu J, 2020, ADV EXP MED BIOL, V1217, P123, DOI 10.1007/978-981-15-1025-0_9; Losito O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005580; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Mallery DL, 2019, CELL REP, V29, P3983, DOI 10.1016/j.celrep.2019.11.050; Mayr GW, 2005, J BIOL CHEM, V280, P13229, DOI 10.1074/jbc.M500545200; Melhorn H., 2008, ENCY PARASITOLOGY, P475; Miller GJ, 2004, MOL CELL, V15, P703, DOI 10.1016/j.molcel.2004.08.005; Ouyang ZQ, 2016, MOL CELL, V62, P248, DOI 10.1016/j.molcel.2016.02.033; Padmanabhan U, 2009, J BIOL CHEM, V284, P10571, DOI 10.1074/jbc.M900752200; Puhl-Rubio AC, 2018, SLAS DISCOV, V23, P982, DOI 10.1177/2472555218775323; Rao F, 2020, ADV EXP MED BIOL, V1217, P47, DOI 10.1007/978-981-15-1025-0_4; Rao F, 2014, P NATL ACAD SCI USA, V111, P16005, DOI 10.1073/pnas.1417900111; Rao F, 2014, MOL CELL, V54, P119, DOI 10.1016/j.molcel.2014.02.020; Rao F, 2010, J BIOL CHEM, V285, P473, DOI 10.1074/jbc.M109.040238; Reitsma JM, 2017, CELL, V171, P1326, DOI 10.1016/j.cell.2017.10.016; Russo GL, 2014, FOOD FUNCT, V5, P2393, DOI [10.1039/c4fo00413b, 10.1039/C4FO00413B]; Scherer PC, 2016, P NATL ACAD SCI USA, V113, P3503, DOI 10.1073/pnas.1525580113; Schlierf A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13166; Schroder D, 2015, BIOCHEM PHARMACOL, V96, P143, DOI 10.1016/j.bcp.2015.05.004; Schroder D, 2013, BIOCHEM BIOPH RES CO, V439, P228, DOI 10.1016/j.bbrc.2013.08.053; Scott DC, 2020, P NATL ACAD SCI USA, V117, P6292, DOI 10.1073/pnas.2001683117; Sekeres M. A., 2018, J CLIN ONCOL, V36, P7077; Shears SB, 2001, CELL SIGNAL, V13, P151, DOI 10.1016/S0898-6568(01)00129-2; Shears Stephen B., 2019, Advances in Biological Regulation, V71, P118, DOI 10.1016/j.jbior.2018.10.006; Tan SY, 2019, J BIOL CHEM, V294, P13740, DOI 10.1074/jbc.RA118.006797; Verbsky J, 2005, J BIOL CHEM, V280, P29263, DOI 10.1074/jbc.M503366200; Verbsky J, 2005, P NATL ACAD SCI USA, V102, P8448, DOI 10.1073/pnas.0503656102; Vogelzang NJ, 2004, CANCER, V100, P65, DOI 10.1002/cncr.11867; Wee S, 2005, NAT CELL BIOL, V7, P387, DOI 10.1038/ncb1241; Whitfield H, 2018, J MED CHEM, V61, P8838, DOI 10.1021/acs.jmedchem.8b01022; Wilson MSC, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.2959; Windhorst S, 2013, BIOCHEM J, V450, P115, DOI 10.1042/BJ20121524; Wolf DA, 2003, NAT CELL BIOL, V5, P1029, DOI 10.1038/ncb1203-1029; Wormald M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188852; Wu K, 2016, P NATL ACAD SCI USA, V113, pE2011, DOI 10.1073/pnas.1601089113; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; Zhang XZ, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9080349; Zhao YC, 2013, CURR PHARM DESIGN, V19, P3215, DOI 10.2174/13816128113199990300	57	3	5	2	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2020	295	30					10281	10292		10.1074/jbc.RA120.014375	http://dx.doi.org/10.1074/jbc.RA120.014375			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MW0BV	32493769	hybrid, Green Published			2022-12-26	WOS:000556713400015
J	Badego, B; Yoseph, A; Astatkie, A				Badego, Bedilu; Yoseph, Amanuel; Astatkie, Ayalew			Prevalence and risk factors of hypertension among civil servants in Sidama Zone, south Ethiopia	PLOS ONE			English	Article							BLOOD-PRESSURE; GLOBAL BURDEN	Introduction Hypertension is the leading cause of death and disability in adult populations globally. Its prevalence is increasing rapidly in Ethiopia. Studies conducted to date address different population categories. However, there is lack of data on the prevalence and risk factors of hypertension among civil servants working in various sectors and levels. Objective To assess the prevalence and risk factors of hypertension among civil servants in Sidama Zone, south Ethiopia. Methods and materials An institution-based cross-sectional study was conducted from March 1-30, 2019 on a sample of 546 civil servants selected randomly from different departments of Sidama Zone Administration. Data were collected using structured, face-to-face interviewer-administered questionnaire and standard physical measurements. The data were entered using Epi Data 3.1 and analyzed using SPSS version 20. Multivariable logistic regression analysis was used to identify factors associated with hypertension. Adjusted odds ratios (AORs) with 95% confidence interval (CI) were computed to assess the presence and strength of associations. Results A total of 546 civil servants responded resulting in a response rate of 94.9%. The prevalence of hypertension was 24.5% [95% CI: 23.3% - 25.6%]. The identified risk factors of hypertension were male sex (AOR 4.31[95% CI: 1.84-10.09]), moderate current alcohol consumption (AOR: 4.85; [95% CI: 1.73-13.61]), current khat chewing (AOR 2.97[95% CI: 1.38-6.40]), old age (AOR: 4.41[95% CI: 1.19-16.26]), being obese (AOR 5.94 [95% CI: 1.26-27.86]) and central obesity (AOR 3.57 [95% CI: 1.80-7.07]). Conclusions One in four civil servants are hypertensive. Different demographic, behavioral and metabolic factors increase the odds of hypertension among civil servants. Prevention and control of hypertension shall involve promotion of healthy lifestyles such as weight management, regular physical activity and quitting or cutting down on harmful use of substances such as alcohol and khat.	[Badego, Bedilu] Sidama Zone Hlth Dept, Hawassa, Ethiopia; [Yoseph, Amanuel; Astatkie, Ayalew] Hawassa Univ, Sch Publ Hlth, Coll Med & Hlth Sci, Hawassa, Ethiopia	Hawassa University	Badego, B (corresponding author), Sidama Zone Hlth Dept, Hawassa, Ethiopia.	baynbadego@gmail.com	Astatkie, Ayalew/I-1167-2019	Astatkie, Ayalew/0000-0002-4840-9601; Badego, Bedilu/0000-0002-2824-3800				Abdissa SG, 2015, ETHIOP J HEALTH DEV, V29, P22; Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Agyemang C, 2006, PUBLIC HEALTH, V120, P525, DOI 10.1016/j.puhe.2006.02.002; Angaw K, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0062-9; [Anonymous], 2011, GLOBAL STATUS REPORT; [Anonymous], 2017, LANCET, V389, P10064; Anteneh ZA, 2015, INT J GEN MED, V8, P175, DOI 10.2147/IJGM.S81513; Asresahegn Henok, 2017, BMC Res Notes, V10, P629, DOI 10.1186/s13104-017-2966-1; Awoke A, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-113; Bayray A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204879; Bell M, 2011, STATE ALASKA MEASURI; Bonsa F, 2014, ETHIOP J HEALTH SCI, V24, P21, DOI 10.4314/ejhs.v24i1.3; Bosu WK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-418; de Vijver SV, 2013, PAN AFR MED J, V16, DOI 10.11604/pamj.2013.16.38.3100; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Ethiopian Public Health Association (EPHA), 2012, EM PUBL HLTH PROBL E; Fikadu G, 2016, INT J HYPERTENS, V2016, DOI 10.1155/2016/4143962; Forouzanfar MH, 2017, JAMA-J AM MED ASSOC, V317, P165, DOI 10.1001/jama.2016.19043; Gao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065938; Gaziano TA, 2009, J HYPERTENS, V27, P1472, DOI 10.1097/HJH.0b013e32832a9ba3; Guchiye B., 2014, PREVALENCE ASS FACTO; Gudina EK, 2013, INTEGR BLOOD PRESS C, V6, P111, DOI 10.2147/IBPC.S47298; Hall J. E., 2011, GUYTON HALL TXB MED; Hassan NAGM, 2000, TROP DOCT, V30, P107, DOI 10.1177/004947550003000219; Helelo TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112790; Jima SB, 2015, SCI J PUBL HLTH, V3, P650; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Kibret KT, 2015, PUBLIC HEALTH REV, V36, DOI 10.1186/s40985-015-0014-z; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Marpillat NL, 2013, J HYPERTENS, V31, P1073, DOI 10.1097/HJH.0b013e3283603f53; NCCN Clinical Practice, 2018, ACUTE MYELOID LEUKEM, VV2, pMS28; Opie LH, 2005, CIRCULATION, V112, P3562, DOI 10.1161/CIRCULATIONAHA.105.539569; Organization (WHO), 2014, GLOB STAT REOPR NONC; Qiao Q, 2010, EUR J CLIN NUTR, V64, P23, DOI 10.1038/ejcn.2009.92; Rahmouni K, 2005, HYPERTENSION, V45, P9, DOI 10.1161/01.HYP.0000151325.83008.b4; Singh S, 2017, INT J HYPERTENS, V2017, DOI 10.1155/2017/5491838; Tadesse T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-937; Takeoka A, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005361; Tesfaye F, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-39; The Lancet Global Health, 2018, LANCET GLOB HLTH, V6, pE593; Tran A, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/193719; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339; Worl Health Organization (WHO), 2015, WHO STEPWISE APPR CH; World Health Organization, 2008, WAIST CIRCUMFERENCE; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454; World Health Organization, 2020, GLOBAL STATUS REPORT, DOI DOI 10.1037/COU0000248; Yoon Sung Sug Sarah, 2015, NCHS Data Brief, P1; Zimmerman MA, 2013, PHYSIOLOGY, V28, P234, DOI 10.1152/physiol.00013.2013	49	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234485	10.1371/journal.pone.0234485	http://dx.doi.org/10.1371/journal.pone.0234485			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525916	Green Published, gold			2022-12-26	WOS:000542036800048
J	Crawford, LJ; Campbell, DC; Morgan, JJ; Lawson, MA; Down, JM; Chauhan, D; McAvera, RM; Morris, TC; Hamilton, C; Krishnan, A; Rajalingam, K; Chantry, AD; Irvine, AE				Crawford, Lisa J.; Campbell, David C.; Morgan, Jonathan J.; Lawson, Michelle A.; Down, Jennifer M.; Chauhan, Dharminder; McAvera, Roisin M.; Morris, Treen C.; Hamilton, Claudia; Krishnan, Aswini; Rajalingam, Krishnaraj; Chantry, Andrew D.; Irvine, Alexandra E.			The E3 ligase HUWE1 inhibition as a therapeutic strategy to target MYC in multiple myeloma	ONCOGENE			English	Article							UBIQUITIN LIGASES; DOWN-REGULATION; BORTEZOMIB; CANCER; CELLS; APOPTOSIS; GROWTH; ARF	Proteasome inhibitors have provided a significant advance in the treatment of multiple myeloma (MM). Consequently, there is increasing interest in developing strategies to target E3 ligases, de-ubiquitinases, and/or ubiquitin receptors within the ubiquitin proteasome pathway, with an aim to achieve more specificity and reduced side-effects. Previous studies have shown a role for the E3 ligase HUWE1 in modulating c-MYC, an oncogene frequently dysregulated in MM. Here we investigated HUWE1 in MM. We identified elevated expression of HUWE1 in MM compared with normal cells. Small molecule-mediated inhibition of HUWE1 resulted in growth arrest of MM cell lines without significantly effecting the growth of normal bone marrow cells, suggesting a favorable therapeutic index. Studies using a HUWE1 knockdown model showed similar growth inhibition. HUWE1 expression positively correlated with MYC expression in MM bone marrow cells and correspondingly, genetic knockdown and biochemical inhibition of HUWE1 reduced MYC expression in MM cell lines. Proteomic identification of HUWE1 substrates revealed a strong association of HUWE1 with metabolic processes in MM cells. Intracellular glutamine levels are decreased in the absence of HUWE1 and may contribute to MYC degradation. Finally, HUWE1 depletion in combination with lenalidomide resulted in synergistic anti-MM activity in both in vitro and in vivo models. Taken together, our data demonstrate an important role of HUWE1 in MM cell growth and provides preclinical rationale for therapeutic strategies targeting HUWE1 in MM.	[Crawford, Lisa J.; Campbell, David C.; Morgan, Jonathan J.; McAvera, Roisin M.; Morris, Treen C.; Hamilton, Claudia; Irvine, Alexandra E.] Queens Univ Belfast, Patrick G Johnston Ctr Canc Res, Belfast, Antrim, North Ireland; [Lawson, Michelle A.; Down, Jennifer M.; Chantry, Andrew D.] Univ Sheffield, Sch Med, Sheffield Myeloma Res Team, Dept Oncol & Metab, Sheffield, S Yorkshire, England; [Chauhan, Dharminder] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, LeBow Inst Myeloma Therapeut, Boston, MA 02115 USA; [Chauhan, Dharminder] Harvard Med Sch, Dana Farber Canc Inst, Jerome Lipper Myeloma Ctr, Boston, MA 02115 USA; [Krishnan, Aswini; Rajalingam, Krishnaraj] Univ Med Ctr Mainz, Cell Biol Unit, Mainz, Germany	Queens University Belfast; University of Sheffield; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Johannes Gutenberg University of Mainz	Crawford, LJ (corresponding author), Queens Univ Belfast, Patrick G Johnston Ctr Canc Res, Belfast, Antrim, North Ireland.	lisa.crawford@qub.ac.uk	Lawson, Michelle/M-6095-2019	Lawson, Michelle/0000-0002-5446-923X; Morgan, Jonathan/0000-0002-9062-1542; Crawford, Lisa/0000-0001-5162-1809; McAvera, Roisin/0000-0002-1222-3047	Blood Cancer UK; Leukemia Lymphoma NI	Blood Cancer UK; Leukemia Lymphoma NI	This work was supported by a grant from Blood Cancer UK and funding from Leukemia & Lymphoma NI.	Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5; Bosshard M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15380-y; Chang Xiu-Bao, 2011, Int J Biochem Mol Biol, V2, P287; Chauhan D, 2012, CANCER CELL, V22, P345, DOI 10.1016/j.ccr.2012.08.007; Choe KN, 2016, EMBO REP, V17, P874, DOI 10.15252/embr.201541685; Confalonieri S, 2009, ONCOGENE, V28, P2959, DOI 10.1038/onc.2009.156; Crawford LJ, 2016, ONCOTARGET, V7, P70481, DOI 10.18632/oncotarget.12026; Effenberger M, 2017, ONCOTARGET, V8, P85858, DOI 10.18632/oncotarget.20691; El Arfani C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041200; Groen K, 2019, CANCER MANAG RES, V11, P2663, DOI 10.2147/CMAR.S150653; Guerrero-Garcia TA, 2018, EXPERT REV PROTEOMIC, V15, P1033, DOI 10.1080/14789450.2018.1543595; Hao ZY, 2012, J EXP MED, V209, P173, DOI 10.1084/jem.20111363; Horenstein AL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00760; Inoue S, 2013, GENE DEV, V27, P1101, DOI 10.1101/gad.214577.113; Jang ER, 2014, MOL CELL BIOL, V34, P3579, DOI 10.1128/MCB.00811-14; Jovanovic KK, 2018, LEUKEMIA, V32, P1295, DOI 10.1038/s41375-018-0036-x; Kao SH, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0470-0; Krishnan A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15955-w; Lawson MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119546; Lee HJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10374-y; Leleu X, 2019, CL LYMPH MYELOM LEUK, V19, P9, DOI 10.1016/j.clml.2018.08.016; Liu P, 2019, EPIGENET CHROMATIN, V12, DOI 10.1186/s13072-019-0322-5; Nguyen L, 2017, GENES-BASEL, V8, DOI 10.3390/genes8040116; Mansour MA, 2018, INT J BIOCHEM CELL B, V101, P80, DOI 10.1016/j.biocel.2018.06.001; Michel MA, 2017, MOL CELL, V68, P233, DOI 10.1016/j.molcel.2017.08.020; Moortgat S, 2018, EUR J HUM GENET, V26, P64, DOI 10.1038/s41431-017-0038-6; Myant KB, 2017, EMBO MOL MED, V9, P181, DOI 10.15252/emmm.201606684; Ohtake F, 2016, MOL CELL, V64, P251, DOI 10.1016/j.molcel.2016.09.014; Pandya RK, 2010, J BIOL CHEM, V285, P5664, DOI 10.1074/jbc.M109.051805; Peter S, 2014, EMBO MOL MED, V6, P1525, DOI 10.15252/emmm.201403927; Poulsen EG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050548; Qi CF, 2013, LEUKEMIA RES, V37, P1680, DOI 10.1016/j.leukres.2013.09.009; Qi CF, 2012, INT J MOL SCI, V13, P6204, DOI 10.3390/ijms13056204; Rajkumar SV, 2019, HEMATOL ONCOL, V37, P62, DOI 10.1002/hon.2586; Richardson PG, 2018, EXPERT OPIN PHARMACO, V19, P1949, DOI 10.1080/14656566.2018.1528229; Rizzieri D, 2019, J CANC METASTASIS TR, V5, P26, DOI 10.20517/2394-4722.2019.05; Sander B, 2017, ELIFE, V6, DOI 10.7554/eLife.21036; Song Y, 2017, ONCOGENE, V36, P5631, DOI 10.1038/onc.2017.172; Vaughan L, 2015, CELL REP, V10, P88, DOI 10.1016/j.celrep.2014.12.012; Velasco R, 2019, J PERIPHER NERV SYST, V24, pS52, DOI 10.1111/jns.12338; Walker BA, 2018, BLOOD, V132, P587, DOI 10.1182/blood-2018-03-840132; Wallington-Beddoe CT, 2018, BRIT J HAEMATOL, V182, P11, DOI 10.1111/bjh.15210; Wang D, 2017, CANCER METAST REV, V36, P683, DOI 10.1007/s10555-017-9703-z; Wang SSS, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.18; Yang D, 2018, THERANOSTICS, V8, P3517, DOI 10.7150/thno.24401; Yang D, 2017, CANCER RES, V77, P4773, DOI 10.1158/0008-5472.CAN-16-2597; Zaal EA, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00500; Zhang ZB, 2016, BLOOD, V127, P1676, DOI 10.1182/blood-2015-07-658203	49	14	15	3	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 2	2020	39	27					5001	5014		10.1038/s41388-020-1345-x	http://dx.doi.org/10.1038/s41388-020-1345-x		JUN 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ME5NL	32523091	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000539515400001
J	Krauss, A; Colombo, M				Krauss, Alexander; Colombo, Matteo			Explaining public understanding of the concepts of climate change, nutrition, poverty and effective medical drugs: An international experimental survey	PLOS ONE			English	Article							SCIENCE; HEALTH; ATTITUDES; ILLUSION	Climate change, nutrition, poverty and medical drugs are widely discussed and pressing issues in science, policy and society. Despite these issues being of great importance for the quality of our lives it remains unclear how well people understand them. Specifically, do particular demographic and socioeconomic factors explain variation in public understanding of these four concepts? To what extent are people's changes in understanding associated with changes in their behaviour? Do people judge scientific practices relying on the more descriptive concepts ofclimate changeandeffective medical drugsto be more objective (less controversial) than practices relying on the more value-laden concepts ofpovertyandhealthy nutrition? To address these questions, an experimental survey and regression analyses are conducted using data collected from about one thousand participants across different continents. The study finds that public understanding of science is generally low. A smaller proportion of people were able to correctly identify the common explanation accepted internationally among the scientific community for climate change and effectiveness of medical drugs (42% and 43% of participants in the study, respectively) than for poverty and healthy nutrition (61% and 65% of participants, respectively). Older age and political non-conservativeness were the strongest predictors of correctly understanding these four concepts. Greater levels of education and political non-conservativeness were in turn the strongest predictors of people's reported changes in their behaviour based on their improved understanding of these concepts. Because climate change is among the least understood scientific concepts but is arguably the greatest challenge of our time, better efforts are needed to improve how media, awareness campaigns and education systems mediate information on the topic in order to tackle the large knowledge deficits that constrain behavioural change.	[Krauss, Alexander] London Sch Econ, London, England; [Krauss, Alexander] Univ Barcelona, Barcelona, Spain; [Colombo, Matteo] Tilburg Univ, Tilburg, Netherlands	University of London; London School Economics & Political Science; University of Barcelona; Tilburg University	Krauss, A (corresponding author), London Sch Econ, London, England.; Krauss, A (corresponding author), Univ Barcelona, Barcelona, Spain.	a.krauss@lse.ac.uk		Krauss, Alexander/0000-0002-1783-2765	Marie Curie programme of the European Commission; Beatriu de Pinos programme of the Government of Catalonia; Alexander von Humboldt research fellowship (Matteo Colombo)	Marie Curie programme of the European Commission(European Commission); Beatriu de Pinos programme of the Government of Catalonia; Alexander von Humboldt research fellowship (Matteo Colombo)	This research was funded through the Marie Curie programme of the European Commission and the Beatriu de Pinos programme of the Government of Catalonia (Alexander Krauss) and through an Alexander von Humboldt research fellowship (Matteo Colombo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alicke M. D., 2005, SELF SOCIAL JUDGMENT, P85, DOI DOI 10.1111/J.1559-1816.2011.00752.X; Allum N, 2008, PUBLIC UNDERST SCI, V17, P35, DOI 10.1177/0963662506070159; [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; [Anonymous], 2013, OXFORD HDB POLITICAL; Astin JA, 1998, JAMA-J AM MED ASSOC, V279, P1548, DOI 10.1001/jama.279.19.1548; Bisogni CA, 2012, J NUTR EDUC BEHAV, V44, P282, DOI 10.1016/j.jneb.2011.11.009; Blake CE, 2007, APPETITE, V49, P500, DOI 10.1016/j.appet.2007.03.009; Blancke S, 2018, PERSPECTIVES SCI CUL, P223, DOI DOI 10.2307/J.CTT2204RXR.16; Bolitho FH, 2007, INT J NONPROFIT VOLU, V12, P13, DOI 10.1002/nvsm.220; Bromme R, 2014, EDUC PSYCHOL-US, V49, P59, DOI 10.1080/00461520.2014.921572; Brulle RJ, 2012, CLIMATIC CHANGE, V114, P169, DOI 10.1007/s10584-012-0403-y; Clayton S, 2015, NAT CLIM CHANGE, V5, P640, DOI [10.1038/NCLIMATE2622, 10.1038/nclimate2622]; Cochrane, GLOSSARY; Colgan S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008915; Colombo M, 2016, REV PHILOS PSYCHOL, V7, P743, DOI 10.1007/s13164-015-0282-z; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Corner A, 2014, WIRES CLIM CHANGE, V5, P411, DOI 10.1002/wcc.269; Croll JK, 2001, J NUTR EDUC, V33, P193, DOI 10.1016/S1499-4046(06)60031-6; Douglas HE, 2009, SCI POLICY VALUE FRE, DOI [DOI 10.2307/J.CTT6WRC78, 10.2307/j.ctt6wrc78]; Dupre John, 2007, VALUE FREE SCI IDEAL, P21; Elliott K.C., 2017, TAPESTRY VALUES INTR; European Commission, 2010, POV SOC EXCL; Falk LW, 2001, HEALTH EDUC BEHAV, V28, P425, DOI 10.1177/109019810102800405; Fernbach PM, 2013, PSYCHOL SCI, V24, P939, DOI 10.1177/0956797612464058; FURNHAM A, 1993, BRIT J CLIN PSYCHOL, V32, P237, DOI 10.1111/j.2044-8260.1993.tb01051.x; Hornsey MJ, 2016, NAT CLIM CHANGE, V6, P622, DOI [10.1038/nclimate2943, 10.1038/NCLIMATE2943]; Hughner RS, 2008, QUAL HEALTH RES, V18, P1687, DOI 10.1177/1049732308327354; IPCC International Panel on Climate Change, CLIMATE CHANGE; Irwin A, 2003, MISUNDERSTANDING SCI; Isacson D, 2002, PHARM WORLD SCI, V24, P104, DOI 10.1023/A:1016127320051; Jukola S, 2019, STUD HIST PHI PART C, V73, P1, DOI 10.1016/j.shpsc.2018.05.007; Kincaid H., 2007, VALUE FREE SCI; Kitcher P., 2011, SCI DEMOCRATIC SOC; Krauss A, 2018, ANN MED, V50, P312, DOI 10.1080/07853890.2018.1453233; Kroh M, 2007, PUBLIC OPIN QUART, V71, P204, DOI 10.1093/poq/nfm009; Lewandowsky S, 2012, PSYCHOL SCI PUBL INT, V13, P106, DOI 10.1177/1529100612451018; Longino H. E., 1990, SCI SOCIAL KNOWLEDGE, DOI [10.1515/9780691209753, DOI 10.2307/J.CTVX5WBFZ]; Lorenzoni I, 2006, CLIMATIC CHANGE, V77, P73, DOI 10.1007/s10584-006-9072-z; Maynard JL, 2013, J POLIT IDEOL, V18, P299, DOI 10.1080/13569317.2013.831589; McCredie MN, 2019, ASSESSMENT, V26, P759, DOI 10.1177/1073191118760709; MERTON Robert King., 1973, THEORETICAL SOCIOLOG; Noel A, 2008, LEFT AND RIGHT IN GLOBAL POLITICS, P1, DOI 10.1017/CBO9780511790751; Oreskes Naomi, 2011, MERCHANTS DOUBT HAND; Panadero S, 2008, SOC BEHAV PERSONAL, V36, P571, DOI 10.2224/sbp.2008.36.4.571; Paquette MC, 2005, CAN J PUBLIC HEALTH, V96, pS15, DOI 10.1007/BF03405196; Parsons S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006420; Roberts D, 2013, PHILOS COMPASS, V8, P677, DOI 10.1111/phc3.12055; Roman S, 2017, TRENDS FOOD SCI TECH, V67, P44, DOI 10.1016/j.tifs.2017.06.010; Ronteltap A, 2012, APPETITE, V59, P333, DOI 10.1016/j.appet.2012.05.023; Rozenblit L, 2002, COGNITIVE SCI, V26, P521, DOI 10.1016/S0364-0213(02)00078-2; Sturgis P, 2004, PUBLIC UNDERST SCI, V13, P55, DOI 10.1177/0963662504042690; UNFCC, UN FRAM CONV CLIM CH; Vermeire E, 2001, J CLIN PHARM THER, V26, P331, DOI 10.1046/j.1365-2710.2001.00363.x; Voelkel J.G., 2018, COMPREHENSIVE RESULT, V3, P56, DOI [10.1080/23743603.2018.1464881, DOI 10.1080/23743603.2018.1464881]; Walters K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198835; Whitmarsh L, 2011, GLOBAL ENVIRON CHANG, V21, P690, DOI 10.1016/j.gloenvcha.2011.01.016; Whitmarsh L, 2009, PUBLIC UNDERST SCI, V18, P401, DOI 10.1177/0963662506073088; WILL JA, 1993, SOC SCI RES, V22, P312, DOI 10.1006/ssre.1993.1016; World Bank, 1990, WORLD DEV REP 1990 P; World Bank, 2001, WORLD DEV REP 2000 2; World Health Organization, NUTR; Yarar N, 2018, APPETITE, V120, P145, DOI 10.1016/j.appet.2017.08.026	62	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2020	15	6							e0234036	10.1371/journal.pone.0234036	http://dx.doi.org/10.1371/journal.pone.0234036			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC0EC	32520971	Green Published, Green Accepted, gold			2022-12-26	WOS:000542969500019
J	Wu, YH; Juan, YS; Shen, JT; Wang, HS; Jhan, JH; Lee, YC; Geng, JH				Wu, Yi-Hsuan; Juan, Yung-Shun; Shen, Jung-Tsung; Wang, Hsun-Shuan; Jhan, Jhen-Hao; Lee, Yung-Chin; Geng, Jiun-Hung			Lower urinary tract symptoms-Benign prostatic hyperplasia may increase the risk of subsequent inguinal hernia in a Taiwanese population: A nationwide population-Based cohort study	PLOS ONE			English	Article							OCCUPATIONAL MECHANICAL EXPOSURES; GROIN HERNIA; MEN; GUIDELINES	Introduction & objectives It has been suggested that lower urinary tract symptoms-benign prostatic hyperplasia (LUTS-BPH) may be a risk factor for inguinal hernia (IH). The aim of this study was to examine the emergence of a subsequent IH diagnosis in men with and without LUTS-BPH. Methods From a database derived from the National Health Insurance Program covering 99% of the population in Taiwan, 22,310 men with LUTS-BPH and 22,310 matched men without LUTS-BPH were identified and followed for IH from 1997 to 2013. Both IH and LUTS-BPH were defined by the ninth revision of the International Classification of Diseases code (ICD9). Subjects younger than 20 years of age and with IH diagnosed before the index date were excluded. We used Cox proportional hazards regression models to estimate hazard ratios (HRs) for subsequent IH, controlling for potential confounders. Results Men with and without LUTS-BPH had similar age and comorbidity distributions. During the 10 years of follow-up, 1,303 (5.84%) men with LUTS-BPH and 735 (2.53%) men without LUTS-BPH developed IH. The mean time to IH was 4.02 years and 4.44 years, respectively. After adjusting for age and comorbidities, LUTS-BPH was associated with a two-fold increased risk of IH (HR:2.25, 95% CI = 2.04-2.49). Conclusion This nation-wide population-based cohort study showed that LUTS-BPH increased the risk of subsequent IH in a Taiwanese Population.	[Wu, Yi-Hsuan; Shen, Jung-Tsung; Wang, Hsun-Shuan; Jhan, Jhen-Hao; Lee, Yung-Chin; Geng, Jiun-Hung] Kaohsiung Municipal Hsiaokang Hosp, Dept Urol, Kaohsiung, Taiwan; [Wu, Yi-Hsuan; Juan, Yung-Shun; Wang, Hsun-Shuan; Jhan, Jhen-Hao; Lee, Yung-Chin; Geng, Jiun-Hung] Kaohsiung Med Univ Hosp, Dept Urol, Kaohsiung, Taiwan; [Wu, Yi-Hsuan; Juan, Yung-Shun; Wang, Hsun-Shuan; Jhan, Jhen-Hao; Lee, Yung-Chin; Geng, Jiun-Hung] Kaohsiung Med Univ, Kaohsiung, Taiwan; [Juan, Yung-Shun] Kaohsiung Municipal Tatung Hosp, Dept Urol, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital	Geng, JH (corresponding author), Kaohsiung Municipal Hsiaokang Hosp, Dept Urol, Kaohsiung, Taiwan.; Geng, JH (corresponding author), Kaohsiung Med Univ Hosp, Dept Urol, Kaohsiung, Taiwan.; Geng, JH (corresponding author), Kaohsiung Med Univ, Kaohsiung, Taiwan.	u9001090@hotmail.com	GENG, JIUNHUNG/AAB-2322-2022	GENG, JIUNHUNG/0000-0003-0610-1278; Jhan, Jhen-Hao/0000-0003-3239-0712; Wu, Yi Hsuan/0000-0003-2366-8268	Kaohsiung Municipal Hsiao-Kang Hospital [NHIRD_1060904 (N-106-03)]	Kaohsiung Municipal Hsiao-Kang Hospital	Hung Geng, receives research support fees from Kaohsiung Municipal Hsiao-Kang Hospital (NHIRD_1060904 (N-106-03).	Abrahamson J, 1998, SURG CLIN N AM, V78, P953, DOI 10.1016/S0039-6109(05)70364-9; [Anonymous], 2011, J AM COLL CARDIOL, V58, pe44, DOI 10.1016/j.jacc.2011.08.007; [Anonymous], 2014, OIL GAS J, V112, P13; [Anonymous], 2015, B DE LIAISON, V15, P17; Aren A, 2011, HERNIA, V15, P667, DOI 10.1007/s10029-011-0846-5; BERRY SJ, 1984, J UROLOGY, V132, P474, DOI 10.1016/S0022-5347(17)49698-4; Bittner James G 4th, 2016, Adv Surg, V50, P67, DOI 10.1016/j.yasu.2016.03.006; Bosch JLHR, 2008, EUR UROL, V53, P819, DOI 10.1016/j.eururo.2007.08.042; Burcharth J, 2013, HERNIA, V17, P183, DOI 10.1007/s10029-013-1060-4; CARBONELL JF, 1993, EUR J SURG, V159, P481; Carrieri P., 1998, Annali Italiani di Chirurgia, V69, P795; Cheng TM, 2015, HEALTH AFFAIR, V34, P502, DOI 10.1377/hlthaff.2014.1332; Claus Christiano Marlo Paggi, 2019, Rev Col Bras Cir, V46, pe20192226, DOI 10.1590/0100-6991e-20192226; de Goede B, 2015, SURGERY, V157, P540, DOI 10.1016/j.surg.2014.09.029; dos Reis RB, 2011, ACTA CIR BRAS, V26, P125, DOI 10.1590/S0102-86502011000800023; Fitzgibbons RJ, 2015, NEW ENGL J MED, V372, P756, DOI 10.1056/NEJMcp1404068; Flament J B, 1997, Rev Prat, V47, P252; Foster HE, 2019, J UROLOGY, V202, P593, DOI 10.1097/JU.0000000000000319; Hellspong G, 2017, LANGENBECK ARCH SURG, V402, P219, DOI 10.1007/s00423-016-1519-8; Henriksen NA, 2015, SURGERY, V157, P312, DOI 10.1016/j.surg.2014.09.006; Jansen PL, 2009, BMC SURG, V9, DOI 10.1186/1471-2482-9-18; Klinge U, 1999, EUR SURG RES, V31, P480, DOI 10.1159/000008728; Kupelian V, 2006, ARCH INTERN MED, V166, P2381, DOI 10.1001/archinte.166.21.2381; Lau H, 2007, SURGERY, V141, P262, DOI 10.1016/j.surg.2006.04.014; Lee CL, 2017, TZU CHI MED J, V29, P6, DOI 10.4103/tcmj.tcmj_3_17; Liem MSL, 1997, AM J EPIDEMIOL, V146, P721; Linder S, 2019, HERNIA, V23, P131, DOI 10.1007/s10029-018-1862-5; Lyass S, 1997, AM J GASTROENTEROL, V92, P700; Madersbacher S, 2004, EUR UROL, V46, P547, DOI 10.1016/j.eururo.2004.07.016; Oberg S, 2017, FRONT SURG, V4, DOI 10.3389/fsurg.2017.00052; Petro CC, 2019, AM J SURG, V217, P59, DOI 10.1016/j.amjsurg.2018.10.020; Schroeder Alexander D, 2019, Adv Surg, V53, P293, DOI 10.1016/j.yasu.2019.04.014; Senturk AB, 2016, ARCH ITAL UROL ANDRO, V88, P262, DOI 10.4081/aiua.2016.4.262; Simons MP, 2009, HERNIA, V13, P343, DOI 10.1007/s10029-009-0529-7; STOPPA R, 1987, J CHIR-PARIS, V124, P125; THOMPSON IM, 1982, SOUTHERN MED J, V75, P1342, DOI 10.1097/00007611-198211000-00009; Unal Y, 2019, LUTS, V11, P99, DOI 10.1111/luts.12239; Vad MV, 2017, OCCUP ENVIRON MED, V74, P769, DOI 10.1136/oemed-2016-104160; Vad MV, 2012, OCCUP ENVIRON MED, V69, P802, DOI 10.1136/oemed-2012-100787; Villemain F, 2002, NEPHROLOGIE, V23, P237; WATSON DS, 1994, SOUTHERN MED J, V87, P23, DOI 10.1097/00007611-199401000-00005; Zendejas B, 2014, HERNIA, V18, P283, DOI 10.1007/s10029-013-1185-5	42	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2020	15	6							e0234329	10.1371/journal.pone.0234329	http://dx.doi.org/10.1371/journal.pone.0234329			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ0RE	32511262	gold, Green Published			2022-12-26	WOS:000540938100036
J	Dovgan, E; Gradisek, A; Lustrek, M; Uddin, M; Nursetyo, AA; Annavarajula, SK; Li, YC; Syed-Abdul, S				Dovgan, Erik; Gradisek, Anton; Lustrek, Mitja; Uddin, Mohy; Nursetyo, Aldilas Achmad; Annavarajula, Sashi Kiran; Li, Yu-Chuan; Syed-Abdul, Shabbir			Using machine learning models to predict the initiation of renal replacement therapy among chronic kidney disease patients	PLOS ONE			English	Article							COHORT; HEALTH; RISK	Starting renal replacement therapy (RRT) for patients with chronic kidney disease (CKD) at an optimal time, either with hemodialysis or kidney transplantation, is crucial for patient's well-being and for successful management of the condition. In this paper, we explore the possibilities of creating forecasting models to predict the onset of RRT 3, 6, and 12 months from the time of the patient's first diagnosis with CKD, using only the comorbidities data from National Health Insurance from Taiwan. The goal of this study was to see whether a limited amount of data (including comorbidities but not considering laboratory values which are expensive to obtain in low- and medium-income countries) can provide a good basis for such predictive models. On the other hand, in developed countries, such models could allow policy-makers better planning and allocation of resources for treatment. Using data from 8,492 patients, we obtained the area under the receiver operating characteristic curve (AUC) of 0.773 for predicting RRT within 12 months from the time of CKD diagnosis. The results also show that there is no additional advantage in focusing only on patients with diabetes in terms of prediction performance. Although these results are not as such suitable for adoption into clinical practice, the study provides a strong basis and a variety of approaches for future studies of forecasting models in healthcare.	[Dovgan, Erik; Gradisek, Anton; Lustrek, Mitja] Jozef Stefan Inst, Dept Intelligent Syst, Ljubljana, Slovenia; [Uddin, Mohy] King Saud bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Execut Off, Minist Natl Guard Hlth Affairs, Riyadh, Saudi Arabia; [Nursetyo, Aldilas Achmad; Li, Yu-Chuan; Syed-Abdul, Shabbir] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Biomed Informat, Taipei, Taiwan; [Annavarajula, Sashi Kiran] Yashoda Hosp, Dept Nephrol, Hyderabad, India	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); Ministry of National Guard - Health Affairs; Taipei Medical University	Dovgan, E (corresponding author), Jozef Stefan Inst, Dept Intelligent Syst, Ljubljana, Slovenia.; Syed-Abdul, S (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Biomed Informat, Taipei, Taiwan.	erik.dovgan@ijs.si; drshabbir@tmu.edu.tw	li, JACK/HHC-6755-2022; Gradišek, Anton/AAU-3981-2021	Gradišek, Anton/0000-0001-6480-9587; Dovgan, Erik/0000-0003-4671-8627; Nursetyo, Aldilas Achmad/0000-0002-0572-0424	Slovenian Research Agency [P2-0209]; European Union's Horizon 2020 research and innovation program [727560]; Ministry of Science and Technology [106-3805-018-110]; NVIDIA Corporation	Slovenian Research Agency(Slovenian Research Agency - Slovenia); European Union's Horizon 2020 research and innovation program; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); NVIDIA Corporation	E. D., A. G., M. L.; P2-0209; Slovenian Research Agency; https://www.arrs.si/en/E.D., A. G., M. L.; 727560; European Union's Horizon 2020 research and innovation program; https://ec.europa.eu/programmes/horizon2020/en A. A. N., Y.-C. L., S. S.-A., 106-3805-018-110; Ministry of Science and Technology; https://www.most.gov.tw/?l=en E. D.; NVIDIA Corporation; https://www.nvidia.com/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, INT ENCY SOCIAL BEHA; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; COLECTIVO DE AUTORES, 2009, REV CUBANA ANTROPOLO, V10, P8; Cook NR, 2008, CLIN CHEM, V54, P17, DOI 10.1373/clinchem.2007.096529; Cooper BA, 2010, NEW ENGL J MED, V363, P609, DOI 10.1056/NEJMoa1000552; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Daugirdas JT, 2015, AM J KIDNEY DIS, V66, P884, DOI 10.1053/j.ajkd.2015.07.015; Eknoyan G, 2004, KIDNEY INT, V66, P1310, DOI 10.1111/j.1523-1755.2004.00894.x; Escoli R, 2017, THER APHER DIAL, V21, P606, DOI 10.1111/1744-9987.12582; Evans M, 2005, AM J KIDNEY DIS, V46, P863, DOI 10.1053/j.ajkd.2005.07.040; Gjoreski M, 2018, PROCEEDINGS OF THE 2018 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING AND PROCEEDINGS OF THE 2018 ACM INTERNATIONAL SYMPOSIUM ON WEARABLE COMPUTERS (UBICOMP/ISWC'18 ADJUNCT), P1488, DOI 10.1145/3267305.3267515; GLAROS AG, 1988, J CLIN PSYCHOL, V44, P1013, DOI 10.1002/1097-4679(198811)44:6<1013::AID-JCLP2270440627>3.0.CO;2-Z; Goldberger J, 2005, ADV NEURAL INFORM PR, P513, DOI DOI 10.5555/2976040.2976105; Goransson LG, 2001, J INTERN MED, V250, P154, DOI 10.1046/j.1365-2796.2001.00869.x; Haghshenas A.M, 2014, PHONETICS; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765; Hsu CY, 2002, J AM SOC NEPHROL, V13, P504, DOI 10.1681/ASN.V132504; Huang CW, 2015, J AM MED INFORM ASSN, V22, P290, DOI 10.1093/jamia/ocu044; Iseki K, 1996, KIDNEY INT, V49, P800, DOI 10.1038/ki.1996.111; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Lea J, 2005, ARCH INTERN MED, V165, P947, DOI 10.1001/archinte.165.8.947; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Li XY, 2018, NANOSCALE RES LETT, V13, DOI 10.1186/s11671-018-2434-4; Lin LY, 2018, EPIDEMIOL HEALTH, V40, DOI 10.4178/epih.e2018062; Mehrotra R, 2013, SEMIN DIALYSIS, V26, P644, DOI 10.1111/sdi.12127; Mohamadlou H, 2018, CANADIAN J KIDNEY HL, V5, P9, DOI 10.1177/2054358118776326; Norouzi J, 2016, COMPUT MATH METHOD M, V2016, DOI 10.1155/2016/6080814; Park N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199839; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Provenzano M, 2020, NEPHROL DIAL TRANSPL, V35, P138, DOI 10.1093/ndt/gfy217; Roderick P, 2002, NEPHROL DIAL TRANSPL, V17, P1252, DOI 10.1093/ndt/17.7.1252; Saran R, 2017, AM J KIDNEY DIS, V69, DOI 10.1053/j.ajkd.2016.12.004; Shalev-Shwartz S, 2011, MATH PROGRAM, V127, P3, DOI 10.1007/s10107-010-0420-4; Tomasev N, 2019, NATURE, V572, P116, DOI 10.1038/s41586-019-1390-1; Tsai MH, 2018, NEPHRON, V140, P175, DOI 10.1159/000491708; United States Renal Data System, 2015, 2015 USRDS ANN DAT R; Wu MY, 2018, NEPHROLOGY, V23, P112, DOI 10.1111/nep.13460; YERUSHALMY J, 1947, PUBLIC HEALTH REP, V62, P1432, DOI 10.2307/4586294; Zhang H., 2004, AA, P6; Zhang ZZ, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2411-z	42	19	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0233976	10.1371/journal.pone.0233976	http://dx.doi.org/10.1371/journal.pone.0233976			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MA6QB	32502209	Green Published, gold			2022-12-26	WOS:000542035700058
J	Garcia-Dominguez, DJ; Hontecillas-Prieto, L; Leon, EA; Sanchez-Molina, S; Rodriguez-Nunez, P; Moron, FJ; Hajji, N; Mackintosh, C; de Alava, E				Garcia-Dominguez, Daniel J.; Hontecillas-Prieto, Lourdes; Andres Leon, Eduardo; Sanchez-Molina, Sara; Rodriguez-Nunez, Pablo; Moron, Francisco J.; Hajji, Nabil; Mackintosh, Carlos; de Alava, Enrique			An inducible ectopic expression system of EWSR1-FLI1 as a tool for understanding Ewing sarcoma oncogenesis	PLOS ONE			English	Article							GENE; EWS-FLI1; DIFFERENTIATION; TUMORIGENESIS; HETEROGENEITY; ONCOPROTEIN; REPRESSION; INITIATION; PROGRAM; GROWTH	The presence of the chimeric EWSR1-FLI1 oncoprotein is the main and initiating event defining Ewing sarcoma (ES). The dysregulation of epigenomic and proteomic homeostasis induced by the oncoprotein contributes to a wide variety of events involved in oncogenesis and tumor progression. Attempts at studying the effects of EWSR1-FLI1 in non-tumor cells to understand the mechanisms underlying sarcomagenesis have been unsuccessful to date, as ectopic expression of EWSR1-FLI1 blocks cell cycle progression and induces apoptosis in the tested cell lines. Therefore, it is essential to find a permissive cell type for EWSR1-FLI1 expression that allows its endogenous molecular functions to be studied. Here we have demonstrated that HeLa cell lines are permissive to EWSR1-FLI1 ectopic expression, and that our model substantially recapitulates the endogenous activity of the EWSR1-FLI1 fusion protein. This model could contribute to better understanding ES sarcomagenesis by helping to understand the molecular mechanisms induced by the EWSR1-FLI1 oncoprotein.	[Garcia-Dominguez, Daniel J.; Hontecillas-Prieto, Lourdes; Rodriguez-Nunez, Pablo; de Alava, Enrique] Univ Seville, Inst Biomed Seville IBiS, Hosp Univ Virgen del Rocio, CIBERONC,CSIC, Seville, Spain; [Andres Leon, Eduardo] Consejo Super Invest Cient IPBLN CSIC, Bioinformat Unit, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Sanchez-Molina, Sara] Hosp St Joan Deu, Dev Tumor Biol Lab, Inst Recerca Pediat, Barcelona, Spain; [Moron, Francisco J.] Univ Seville, Inst Biomed Sevilla IBiS, Genom Core Facil, Hosp Univ Virgen Rocio,CSIC, Seville, Spain; [Hajji, Nabil] Imperial Coll London, Div Brain Sci, John Fulcher Mol Neurooncol, London, England; [Mackintosh, Carlos] Vitro SA, Granada, Spain; [de Alava, Enrique] Univ Seville, Sch Med, Dept Normal & Pathol Cytol & Histol, Seville, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Imperial College London; University of Sevilla	Garcia-Dominguez, DJ; de Alava, E (corresponding author), Univ Seville, Inst Biomed Seville IBiS, Hosp Univ Virgen del Rocio, CIBERONC,CSIC, Seville, Spain.; de Alava, E (corresponding author), Univ Seville, Sch Med, Dept Normal & Pathol Cytol & Histol, Seville, Spain.	dgarcia-ibis@us.es; enrique.alava.sspa@juntadeandalucia.es	Andrés-León., Eduardo/K-8944-2014; hajji, nabil/AAV-1435-2020; de Alava, Enrique/GOH-0368-2022; Garcia, Daniel Jose/B-5366-2016; Sanchez-Molina, Sara/B-2148-2017	Andrés-León., Eduardo/0000-0002-0621-9914; de Alava, Enrique/0000-0001-8400-046X; Garcia, Daniel Jose/0000-0001-8150-2747; Sanchez-Molina, Sara/0000-0002-1430-131X; Mackintosh, Carlos/0000-0002-6786-9558	Asociacion Espanola Contra el Cancer (AECC); Ministry of Economy and Competitiveness of Spain-FEDER (CIBERONC) [PI11700464, RD06/0020/0059]; European Commission (FP7HEALTH-2011-two-stage) [ID278742 EUROSARC]; CIBERONC [CB16/12/00361]; Consejeria de Salud, Junta de Andalucia [PI-0197-2016, PI-0013-2018]	Asociacion Espanola Contra el Cancer (AECC); Ministry of Economy and Competitiveness of Spain-FEDER (CIBERONC); European Commission (FP7HEALTH-2011-two-stage)(European Commission); CIBERONC; Consejeria de Salud, Junta de Andalucia(Junta de Andalucia)	Research in the EDA lab is supported by Asociacion Espanola Contra el Cancer (AECC). Enrique de Alava's lab is also supported by the Ministry of Economy and Competitiveness of Spain-FEDER (CIBERONC, PI11700464, RD06/0020/0059) and the European Commission (FP7HEALTH-2011-two-stage, Project ID278742 EUROSARC). DGD and LHP are supported by CIBERONC (CB16/12/00361). DGD is a PhD researcher funded by the Consejeria de Salud, Junta de Andalucia (PI-0197-2016). LHP is a PhD researcher funded by the Consejeria de Salud, Junta de Andalucia (PI-0013-2018). The funder Vitro SA provided support in the form of salaries for the author CM but had no additional roles in the study design, data collection, data analyses, decision to publish or manuscript preparation. The specific roles of this author (CM) are articulated in the `author contributions' section.	Anderson ND, 2018, SCIENCE, V361, DOI 10.1126/science.aam8419; Arvand A, 2001, ONCOGENE, V20, P5747, DOI 10.1038/sj.onc.1204598; Arvand A, 2001, CANCER RES, V61, P5311; Deneen B, 2001, ONCOGENE, V20, P6731, DOI 10.1038/sj.onc.1204875; Franzetti GA, 2017, ONCOGENE, V36, P3505, DOI 10.1038/onc.2016.498; Garcia-Dominguez Daniel Jose, 2018, Oncotarget, V9, P31397, DOI 10.18632/oncotarget.25829; Gierisch ME, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37264-5; Giraud G, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku869; Gordon DJ, 2016, ONCOGENE, V35, P3092, DOI 10.1038/onc.2015.368; Herrero-Martin D, 2009, BRIT J CANCER, V101, P80, DOI 10.1038/sj.bjc.6605104; Howarth MM, 2014, J CLIN INVEST, V124, P5275, DOI 10.1172/JCI72124; Jully B, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-513; Kauer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005415; Kovar H, 2016, ONCOTARGET, V7, P8613, DOI 10.18632/oncotarget.6937; Lessnick SL, 2002, CANCER CELL, V1, P393, DOI 10.1016/S1535-6108(02)00056-9; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; MAY WA, 1993, MOL CELL BIOL, V13, P7393, DOI 10.1128/MCB.13.12.7393; Mendiola M, 2006, INT J CANCER, V118, P1381, DOI 10.1002/ijc.21578; Richter GHS, 2009, P NATL ACAD SCI USA, V106, P5324, DOI 10.1073/pnas.0810759106; Riggi N, 2008, CANCER RES, V68, P2176, DOI 10.1158/0008-5472.CAN-07-1761; Riggi N, 2014, CANCER CELL, V26, P668, DOI 10.1016/j.ccell.2014.10.004; Rorie CJ, 2004, CANCER RES, V64, P1266, DOI 10.1158/0008-5472.CAN-03-3274; Sankar S, 2013, ONCOGENE, V32, P5089, DOI 10.1038/onc.2012.525; Sankar S, 2011, CANCER GENET-NY, V204, P351, DOI 10.1016/j.cancergen.2011.07.008; Selvanathan SP, 2015, P NATL ACAD SCI USA, V112, pE1307, DOI 10.1073/pnas.1500536112; Sheffield NC, 2017, NAT MED, V23, P386, DOI 10.1038/nm.4273; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Surdez D, 2012, CANCER RES, V72, P4494, DOI 10.1158/0008-5472.CAN-12-0371; Tomazou EM, 2015, CELL REP, V10, P1082, DOI 10.1016/j.celrep.2015.01.042; Torchia EC, 2003, CANCER RES, V63, P3464	30	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0234243	10.1371/journal.pone.0234243	http://dx.doi.org/10.1371/journal.pone.0234243			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502203	Green Published, gold			2022-12-26	WOS:000542035700026
J	Ciavarella, C; Buzzi, M; Bergantin, E; Di Marco, S; Giannaccare, G; Campos, E; Bisti, S; Versura, P				Ciavarella, Carmen; Buzzi, Marina; Bergantin, Elisa; Di Marco, Stefano; Giannaccare, Giuseppe; Campos, Emilio; Bisti, Silvia; Versura, Piera			Effects of Cord Blood Serum (CBS) on viability of retinal Muller glial cells under in vitro injury	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; CILIARY NEUROTROPHIC FACTOR; OPEN-ANGLE GLAUCOMA; EYE DROPS; NEUROPROTECTION; APOPTOSIS; ALPHA	Oxidative stress and inflammation determine retinal ganglion cell degeneration, leading to retinal impairment and vision loss. Muller glial cells regulate retinal repair under injury, through gliosis. Meanwhile, reactive gliosis can turn in pathological effects, contributing to neurodegeneration. In the present study, we tested whether Cord Blood Serum (CBS), rich of growth factors, might improve the viability of Muller cells under in vitro damage. BDNF, NGF, TGF-alpha, GDNF and EGF levels were measured in CBS samples by Human Magnetic Luminex Assay. CBS effects were evaluated on rat (rMC-1) and human (MIO-M1) Muller cells, under H2O2 and IL-1 beta damage. Cells grown with FBS or CBS both at 5% were exposed to stress and analyzed in terms of cell viability, GFAP, IL-6 and TNF-alpha expression. CBS was also administrated after treatment with K252a, inhibitor of the neurotrophin receptor Trk. Cell viability of rMC-1 and MIO-M1 resulted significantly improved when pretreated with CBS and exposed to H2O2 and IL-1 beta, in comparison to the standard culture with FBS. Accordingly, the gliosis marker GFAP resulted down-regulated following CBS priming. In parallel, we observed a lower expression of the inflammatory mediators in rMC-1 (TNF-alpha) and MIO-M1 (IL-6, TNF- alpha), especially in presence of inflammatory damage. Trk inhibition through K252a administration impaired the effects of CBS under stress conditions on MIO-M1 and rMC-1 viability, not significantly different from FBS condition. CBS is enriched with neurotrophins and its administration to rMC-1 and MIO-M1 attenuates the cytotoxic effects of H2O2 and IL-1 beta. Moreover, the decrease of the main markers of gliosis and inflammation suggests a promising use of CBS for neuroprotection aims. This study is a preliminary basis that prompts future investigations to deeply explore and confirm the CBS potential.	[Ciavarella, Carmen; Giannaccare, Giuseppe; Campos, Emilio; Versura, Piera] Alma Mater Studiorum Univ Bologna, S Orsola Malpighi Teaching Hosp, Ophthalmol Unit, DIMES, Bologna, Italy; [Buzzi, Marina; Bergantin, Elisa] S Orsola Malpighi Teaching Hosp, Emilia Romagna Cord Blood Bank Transfus Serv, Bologna, Italy; [Di Marco, Stefano; Bisti, Silvia] Univ Aquila, Vis Lab, DISCAB, Laquila, Italy; [Bisti, Silvia] Ist Italiano Tecnol IIT, Genoa, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of L'Aquila; Istituto Italiano di Tecnologia - IIT	Versura, P (corresponding author), Alma Mater Studiorum Univ Bologna, S Orsola Malpighi Teaching Hosp, Ophthalmol Unit, DIMES, Bologna, Italy.	piera.versura@unibo.it	Buzzi, Marina/AAC-8681-2022; Versura, P/J-1361-2019; Ciavarella, Carmen/K-9870-2016	Buzzi, Marina/0000-0002-3711-5886; Versura, P/0000-0002-2951-5337; 	Fondazione Cassa di Risparmio Bologna; Beneficientia Stiftung, Vaduz, Liechtenstein	Fondazione Cassa di Risparmio Bologna; Beneficientia Stiftung, Vaduz, Liechtenstein	Authors acknowledge the support from Fondazione Cassa di Risparmio Bologna (unrestricted grant to GG), and Beneficientia Stiftung, Vaduz, Liechtenstein (unrestricted grant to EC).	Belecky-Adams T.L., 2013, NEURAL STEM CELLS NE, P73; Birch DG, 2016, AM J OPHTHALMOL, V170, P10, DOI 10.1016/j.ajo.2016.07.013; Bringmann A, 2000, GLIA, V29, P35, DOI 10.1002/(SICI)1098-1136(20000101)29:1<35::AID-GLIA4>3.0.CO;2-A; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Bringmann A, 2012, OPHTHALMOLOGICA, V227, P1, DOI 10.1159/000328979; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Buzzi M, 2018, TRANSFUS APHER SCI, V57, P549, DOI 10.1016/j.transci.2018.06.001; Campos E, 2018, CASE REP OPHTHALMOL, V2018, DOI 10.1155/2018/2381296; Cerri E, 2015, TRANSL VIS SCI TECHN, V4, DOI 10.1167/tvst.4.6.1; Datta S, 2017, PROG RETIN EYE RES, V60, P201, DOI 10.1016/j.preteyeres.2017.03.002; de Hoz R, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2954721; Domenici L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115579; Eastlake K, 2020, CURR EYE RES, V45, P339, DOI 10.1080/02713683.2019.1648831; Falsini B, 2016, BRAIN, V139, P404, DOI 10.1093/brain/awv366; Falsini B, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-015-0750-3; Giannaccare G, 2017, TRANSFUS APHER SCI, V56, P595, DOI 10.1016/j.transci.2017.07.023; Kimura A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091584; Kolomeyer AM, 2014, SURV OPHTHALMOL, V59, P134, DOI 10.1016/j.survophthal.2013.09.004; Lambiase A, 2009, P NATL ACAD SCI USA, V106, P13469, DOI 10.1073/pnas.0906678106; LAVAIL MM, 1992, P NATL ACAD SCI USA, V89, P11249, DOI 10.1073/pnas.89.23.11249; Limb GA, 2002, INVEST OPHTH VIS SCI, V43, P864; Marangoni D, 2012, ACTA OPHTHALMOL, V90, pE288, DOI 10.1111/j.1755-3768.2011.02340.x; Nguyen TLX, 2010, EXP MOL MED, V42, P583, DOI 10.3858/emm.2010.42.8.060; Ooto S, 2004, P NATL ACAD SCI USA, V101, P13654, DOI 10.1073/pnas.0402129101; Pardue MT, 2018, PROG RETIN EYE RES, V65, P50, DOI 10.1016/j.preteyeres.2018.02.002; Payne AJ, 2014, INT J MOL SCI, V15, P1865, DOI 10.3390/ijms15021865; Reichenbach A, 2013, GLIA, V61, P651, DOI 10.1002/glia.22477; Rocco ML, 2018, GRAEF ARCH CLIN EXP, V256, P729, DOI 10.1007/s00417-018-3931-y; Rohowetz LJ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113362; Shpak AA, 2018, CURR EYE RES, V43, P224, DOI 10.1080/02713683.2017.1396617; Shpak AA, 2017, MOL VIS, V23, P799; Takeda M, 2008, INVEST OPHTH VIS SCI, V49, P1142, DOI 10.1167/iovs.07-0434; Tezel G, 2000, J NEUROSCI, V20, P8693; Vecino E, 2016, PROG RETIN EYE RES, V51, P1, DOI 10.1016/j.preteyeres.2015.06.003	34	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0234145	10.1371/journal.pone.0234145	http://dx.doi.org/10.1371/journal.pone.0234145			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497126	gold, Green Published			2022-12-26	WOS:000542035200053
J	McDonald, SD; Yu, ZM; van Blyderveen, S; Schmidt, L; Sword, W; Vanstone, M; Biringer, A; McDonald, H; Beyene, J				McDonald, Sarah D.; Yu, Zhijie Michael; van Blyderveen, Sherry; Schmidt, Louis; Sword, Wendy; Vanstone, Meredith; Biringer, Anne; McDonald, Helen; Beyene, Joseph			Prediction of excess pregnancy weight gain using psychological, physical, and social predictors: A validated model in a prospective cohort study	PLOS ONE			English	Article							MULTIPLE IMPUTATION; EMOTION REGULATION; PSYCHOSOCIAL RISK; CONTROLLED-TRIAL; BIRTH OUTCOMES; LIFE-STYLE; BEHAVIOR; WOMEN; COMPLICATIONS; INTERVENTION	Objective To develop and validate a prediction model for excess pregnancy weight gain using early pregnancy factors. Design Prospective cohort study Setting We recruited from 12 obstetrical, family medicine, and midwifery centers in Ontario, Canada Participants We recruited English-speaking women with singleton pregnancies between 8(+0)-20(+6) weeks. Of 1296 women approached, 1050 were recruited (81%). Of those, 970 women had complete data (970/1050, 92%) and were recruited at a mean of 14.8 weeks. Primary outcome measure We collected data on psychological, physical, and social factors and used stepwise logistic regression analysis to develop a multivariable model predicting our primary outcome of excess pregnancy weight gain, with random selection of 2/3 of women for training data and 1/3 for testing data. Results Nine variables were included in the final model to predict excess pregnancy weight gain. These included nulliparity, being overweight, planning excessive gain, eating in front of a screen, low self-efficacy regarding pregnancy weight gain, thinking family or friends believe pregnant women should eat twice as much as before pregnancy, being agreeable, and having emotion control difficulties. Training and testing data yielded areas under the receiver operating characteristic curve of 0.76 (95% confidence interval, 0.72 to 0.80) and 0.62 (95% confidence interval 0.56 to 0.68), respectively. Conclusions In this first validated prediction model in early pregnancy, we found that nine psychological, physical, and social factors moderately predicted excess pregnancy weight gain in the final model. This research highlights the importance of several predictors, including relatively easily modifiable ones such as appropriate weight gain plans and mindfulness during eating, and lays an important methodological foundation for other future prediction models.	[McDonald, Sarah D.; Yu, Zhijie Michael] McMaster Univ, Dept Obstet & Gynecol, Div Maternal Fetal Med, Hamilton, ON, Canada; [McDonald, Sarah D.] McMaster Univ, Dept Radiol, Hamilton, ON, Canada; [McDonald, Sarah D.; Beyene, Joseph] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [van Blyderveen, Sherry] Eating Disorders Program Homewood Hlth Ctr, Guelph, ON, Canada; [Schmidt, Louis] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada; [Sword, Wendy] McMaster Univ, Sch Nursing, Hamilton, ON, Canada; [Vanstone, Meredith] McMaster Univ, Dept Family Med, Hamilton, ON, Canada; [Biringer, Anne] Mt Sinai Hosp, Ray D Wolfe Dept Family Med, Toronto, ON, Canada; [McDonald, Helen] McMaster Univ, Midwifery Educ Program, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; McMaster University	McDonald, SD (corresponding author), McMaster Univ, Dept Obstet & Gynecol, Div Maternal Fetal Med, Hamilton, ON, Canada.; McDonald, SD (corresponding author), McMaster Univ, Dept Radiol, Hamilton, ON, Canada.; McDonald, SD (corresponding author), McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada.	mcdonals@mcmaster.ca		McDonald, Sarah/0000-0002-4461-2178	Canadian Instituties of Health Research [MOP-142253]; Tier II Canada Research Chair Sponsor Award [950-229920]; Ada Slaight and Slaight Family Maternity Care Directorship	Canadian Instituties of Health Research(Canadian Institutes of Health Research (CIHR)); Tier II Canada Research Chair Sponsor Award; Ada Slaight and Slaight Family Maternity Care Directorship	This research was supported by a Canadian Instituties of Health Research grant #MOP-142253 (http://www.cihr-irsc.gc.ca/e/193.html).SDM is supported by a Tier II Canada Research Chair Sponsor Award #950-229920 (https://www.chairs-chaires.gc.ca/home-accueil-eng.aspx).AB is supported by the Ada Slaight and Slaight Family Maternity Care Directorship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi N, 2013, OBES REV, V14, P68, DOI 10.1111/j.1467-789X.2012.01059.x; Block G, 1990, Epidemiology, V1, P58, DOI 10.1097/00001648-199001000-00013; Canada Health, 2010, CAN GEST WEIGHT REC; Cedergren M, 2006, INT J GYNECOL OBSTET, V93, P269, DOI 10.1016/j.ijgo.2006.03.002; Cogswell ME, 1999, OBSTET GYNECOL, V94, P616, DOI 10.1016/S0029-7844(99)00375-0; Collins GS, 2015, CIRCULATION, V131, P211, DOI [10.1016/j.jclinepi.2014.11.010, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.7326/M14-0697, 10.1016/j.eururo.2014.11.025, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Criss S, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1118-2; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dzakpasu S, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0452-0; Ekeus C, 2006, BJOG-INT J OBSTET GY, V113, P925, DOI 10.1111/j.1471-0528.2006.01012.x; Fowles ER, 2004, WESTERN J NURS RES, V26, P429, DOI 10.1177/0193945904263281; Gardner B, 2011, OBES REV, V12, pE602, DOI 10.1111/j.1467-789X.2011.00884.x; GARNER DM, 1983, INT J EAT DISORDER, V2, P15, DOI 10.1002/1098-108X(198321)2:2<15::AID-EAT2260020203>3.0.CO;2-6; Goldstein RF, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1128-1; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9; Gratz KL, 2004, J PSYCHOPATHOL BEHAV, V26, P41, DOI 10.1023/B:JOBA.0000007455.08539.94; Gray-Donald K, 2000, CAN MED ASSOC J, V163, P1247; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Guelinckx I, 2010, AM J CLIN NUTR, V91, P373, DOI 10.3945/ajcn.2009.28166; Hales D, 2010, AM J HEALTH BEHAV, V34, P387; Hartley E, 2015, WOMEN BIRTH, V28, pE99, DOI 10.1016/j.wombi.2015.04.004; Herman C. P., 1980, OBESITY, P208; Hill B, 2017, OBES REV, V18, P755, DOI 10.1111/obr.12538; Hill B, 2013, OBES REV, V14, P435, DOI 10.1111/obr.12022; Hill B, 2013, MIDWIFERY, V29, P110, DOI 10.1016/j.midw.2011.12.001; Hosmer DW, 2013, WILEY SER PROBAB ST, P89; Hosmer DW, 2013, WILEY SER PROBAB ST, P1, DOI 10.1002/9781118548387; Kapadia MZ, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0535-y; Kendall A, 2001, ANN BEHAV MED, V23, P50, DOI 10.1207/S15324796ABM2301_8; Kinnunen TI, 2007, EUR J CLIN NUTR, V61, P884, DOI 10.1038/sj.ejcn.1602602; Lee KJ, 2010, AM J EPIDEMIOL, V171, P624, DOI 10.1093/aje/kwp425; Lundahl B, 2013, PATIENT EDUC COUNS, V93, P157, DOI 10.1016/j.pec.2013.07.012; Maggard MA, 2008, JAMA-J AM MED ASSOC, V300, P2286, DOI 10.1001/jama.2008.641; McDonald SD, 2018, CAN J PUBLIC HEALTH, V109, P527, DOI 10.17269/s41997-018-0086-x; McDonald SD, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-205; McDonald SD, 2013, J OBSTET GYNAECOL CA, V35, P1071, DOI 10.1016/S1701-2163(15)30757-X; McDonald SD, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.05.039; Metz CE, 1978, SEMIN NUCL MED; Muktabhant B, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007145.pub3; O'Brien EC, 2018, J PUBLIC HEALTH-UK, V40, P41, DOI 10.1093/pubmed/fdx038; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Park C, 2015, J OBSTET GYNEOCLOGY; Park CK, 2015, J OBSTET GYNAECOL CA, V37, P225, DOI 10.1016/S1701-2163(15)30308-X; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Public Health Agency of Canada, 2009, WHAT MOTH SAY CAN MA; Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1; Rini CK, 1999, HEALTH PSYCHOL, V18, P333, DOI 10.1037/0278-6133.18.4.333; Samura Tirah, 2016, Glob Adv Health Med, V5, P87, DOI 10.7453/gahmj.2015.094; Schmidt MD, 2006, MED SCI SPORT EXER, V38, P42, DOI 10.1249/01.mss.0000181301.07516.d6; Scott C, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-167; Siega-Riz AM, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.07.002; Skouteris H, 2010, OBES REV, V11, P757, DOI 10.1111/j.1467-789X.2010.00806.x; Statistics Canada, 2018, STAT CAN TABL 13 10; Swann RA, 2009, INT J EAT DISORDER, V42, P394, DOI 10.1002/eat.20632; Thangaratinam S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2088; The Government of Ontario, 2013, ONT REG BOUND; Thomas DM, 2012, AM J CLIN NUTR, V95, P115, DOI 10.3945/ajcn.111.024307; Thorsdottir I, 2002, OBSTET GYNECOL, V99, P799, DOI 10.1016/S0029-7844(02)01946-4; Tragea C, 2014, COMPLEMENT THER MED, V22, P203, DOI 10.1016/j.ctim.2014.01.006; VANSTRIEN T, 1986, INT J EAT DISORDER, V5, P295, DOI 10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Whitaker KM, 2016, J BEHAV MED, V39, P41, DOI 10.1007/s10865-015-9672-z; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Williamson DA, 2000, INT J OBESITY, V24, P1326, DOI 10.1038/sj.ijo.0801363; Wilson A, 2015, EUR J OBSTET GYN R B, V191, P72, DOI 10.1016/j.ejogrb.2015.05.010; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454; ZWEIG MH, 1993, CLIN CHEM, V39, P561	69	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2020	15	6							e0233774	10.1371/journal.pone.0233774	http://dx.doi.org/10.1371/journal.pone.0233774			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MT4VF	32484813	Green Published, gold			2022-12-26	WOS:000554969700017
J	Zilio, M; Motta, S; Tambone, F; Scaglia, B; Boccasile, G; Squartini, A; Adani, F				Zilio, Massimo; Motta, Silvia; Tambone, Fulvia; Scaglia, Barbara; Boccasile, Gabriele; Squartini, Andrea; Adani, Fabrizio			The distribution of functional N-cycle related genes and ammonia and nitrate nitrogen in soil profiles fertilized with mineral and organic N fertilizer	PLOS ONE			English	Article							OXIDIZING BACTERIA; COMMUNITY COMPOSITION; MICROBIAL BIOMASS; NITRIFICATION; RATES; TRANSFORMATIONS; DENITRIFICATION; PROKARYOTES; POPULATION; GRASSLAND	Nitrogen transformation in soil is a complex process and the soil microbial population can regulate the potential for N mineralization, nitrification and denitrification. Here we show that agricultural soils under standard agricultural N-management are consistently characterized by a high presence of gene copies for some of the key biological activities related to the N-cycle. This led to a strong NO3- reduction (75%) passing from the soil surface (15.38 +/- 11.36 g N-NO3 kg(-1) on average) to the 1 m deep layer (3.92 +/- 4.42 g N-NO3 kg(-1) on average), and ensured low nitrate presence in the deepest layer. Under these circumstances the other soil properties play a minor role in reducing soil nitrate presence in soil. However, with excessive N fertilization, the abundance of bacterial gene copies is not sufficient to explain N leaching in soil and other factors, i.e. soil texture and rainfall, become more important in controlling these aspects.	[Zilio, Massimo; Tambone, Fulvia; Scaglia, Barbara; Adani, Fabrizio] Univ Milan, DiSAA, Grp Ricicla Labs, Milan, Italy; [Motta, Silvia] Ente Reg & Servizi Agr & Foreste, Milan, Regione Lombard, Italy; [Boccasile, Gabriele] DG Agr, Milan, Regione Lombard, Italy; [Squartini, Andrea] Univ Padua, Agripolis, DAFNAE, Padua, Italy	University of Milan; University of Padua	Adani, F (corresponding author), Univ Milan, DiSAA, Grp Ricicla Labs, Milan, Italy.	fabrizio.adani@unimi.it	Squartini, Andrea/AAX-9942-2020; Adani, fabrizio/I-6319-2017	Squartini, Andrea/0000-0002-1961-1165; Adani, fabrizio/0000-0003-0250-730X; SCAGLIA, BARBARA/0000-0003-2207-1232; ZILIO, MASSIMO/0000-0001-5007-4540	University of Milan CONVENZIONE QUADRO Regione Lombardia - ERSAF, Italy [15-3-3014000-218, 15-3-3014000-219]; Gruppo Ricicla lab. Universita degli Studi di Milano, Italy [1705]; CONVENZIONE QUADRO Regione Lombardia-ERSAF, Italy [15-3-3014000-218, 15-3-3014000-219]	University of Milan CONVENZIONE QUADRO Regione Lombardia - ERSAF, Italy; Gruppo Ricicla lab. Universita degli Studi di Milano, Italy; CONVENZIONE QUADRO Regione Lombardia-ERSAF, Italy	Grant recieved by Fabrizio Adani -University of Milan CONVENZIONE QUADRO Regione Lombardia - ERSAF, Italy: Supporto tecnico per l'applicazione e il monitoraggio della direttiva nitrati (ARMOSA) + rapporto ambientale per VAS, piano triennale 2014 - 2016, Agreement Collaborazione tecnico-scientifica per azioni finalizzate a valutare la sostenibilita complessiva della gestione". Project N. 15-3-3014000-218 and 15-3-3014000-219. Gruppo Ricicla lab. Universita degli Studi di Milano, Italy, Project N. 1705, 2011: RV_ATT_COM16FADAN_M.; CONVENZIONE QUADRO Regione Lombardia-ERSAF, Italy: Supporto tecnico per l'applicazione e il monitoraggio della direttiva nitrati (ARMOSA) + rapporto ambientale per VAS, piano triennale 2014-2016, Agreement Collaborazione tecnico-scientifica per azioni finalizzate a valutare la sostenibilita complessiva della gestione". Project N. 15-3-3014000-218 and 15-3-3014000-219. Gruppo Ricicla lab. Universita degli Studi di Milano, Italy, Project N. 1705, 2011: RV_ATT_COM16FADAN_M.	Balser TC, 2005, BIOGEOCHEMISTRY, V73, P395, DOI 10.1007/s10533-004-0372-y; Banning N. C., 2015, SCI REP, V5, P1, DOI DOI 10.1038/; Barton L, 1999, AUST J SOIL RES, V37, P1073, DOI 10.1071/SR99009; Bodirsky BL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4858; Brenzinger K, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00961; Cameron KC, 2013, ANN APPL BIOL, V162, P145, DOI 10.1111/aab.12014; Canfield DE, 2010, SCIENCE, V330, P192, DOI 10.1126/science.1186120; Compton JE, 2002, SOIL BIOL BIOCHEM, V34, P933, DOI 10.1016/S0038-0717(02)00025-1; Daims H, 2015, NATURE, V528, P504, DOI 10.1038/nature16461; DAVIDSON EA, 1992, ECOLOGY, V73, P1148, DOI 10.2307/1940665; Delgado JA, 2002, J SOIL WATER CONSERV, V57, P389; Delgado JA, 2010, J SOIL WATER CONSERV, V65, p111A, DOI 10.2489/jswc.65.5.111A; Di HJ, 2002, NUTR CYCL AGROECOSYS, V64, P237, DOI 10.1023/A:1021471531188; Domeignoz-Horta LA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00971; Fagodiya R.K., 2017, SCI REP, V7, P1, DOI [10.1038/srep44928, DOI 10.1038/SREP44928.]; Faithfull N.T., 2002, METHODS AGR CHEM ANA; Fierer N, 2017, NAT REV MICROBIOL, V15, P579, DOI 10.1038/nrmicro.2017.87; Fowler D, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0164; GAINES TP, 1994, COMMUN SOIL SCI PLAN, V25, P2561, DOI 10.1080/00103629409369207; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Gee G.W., 1986, METHODS SOIL ANAL PA, P383; Goulding K, 2000, SOIL USE MANAGE, V16, P145, DOI 10.1111/j.1475-2743.2000.tb00218.x; Graf DRH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114118; Grenon F, 2004, SOIL BIOL BIOCHEM, V36, P1465, DOI 10.1016/j.soilbio.2004.04.021; Hallin S, 2009, ISME J, V3, P597, DOI 10.1038/ismej.2008.128; Hayatsu M, 2008, SOIL SCI PLANT NUTR, V54, P33, DOI 10.1111/j.1747-0765.2007.00195.x; Hermansson A, 2001, APPL ENVIRON MICROB, V67, P972, DOI 10.1128/AEM.67.2.972-976.2001; Huang ZQ, 2013, SOIL BIOL BIOCHEM, V62, P68, DOI 10.1016/j.soilbio.2013.03.008; Ingebritsen SE, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/9/091002; Jarvis SC, 2000, SOIL USE MANAGE, V16, P152, DOI 10.1111/j.1475-2743.2000.tb00219.x; Kuypers MMM, 2018, NAT REV MICROBIOL, V16, P263, DOI 10.1038/nrmicro.2018.9; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Ma L, 2013, ENVIRON SCI TECHNOL, V47, P7260, DOI 10.1021/es400456u; McLean EO, 1982, METHODS SOIL ANAL, V9, P199, DOI DOI 10.2134/AGR0NM0N0GR9.2.2ED.C12; Mendum TA, 1999, APPL ENVIRON MICROB, V65, P4155; Moeller K, 2009, EUR J AGRON, V30, P1, DOI 10.1016/j.eja.2008.06.003; Okano Y, 2004, APPL ENVIRON MICROB, V70, P1008, DOI 10.1128/AEM.70.2.1008-1016.2004; Ollivier J, 2011, FEMS MICROBIOL ECOL, V78, P3, DOI 10.1111/j.1574-6941.2011.01165.x; Rhoades J. D., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P149; Riva C, 2016, SCI TOTAL ENVIRON, V547, P206, DOI 10.1016/j.scitotenv.2015.12.156; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; RYDEN JC, 1984, NATURE, V311, P50, DOI 10.1038/311050a0; Sanford RA, 2012, P NATL ACAD SCI USA, V109, P19709, DOI [10.1073/pnas., 10.1073/pnas.1211238109]; Sebilo M, 2013, P NATL ACAD SCI USA, V110, P18185, DOI 10.1073/pnas.1305372110; SEXSTONE AJ, 1985, SOIL SCI SOC AM J, V49, P99, DOI 10.2136/sssaj1985.03615995004900010020x; Shan J, 2016, ENVIRON SCI TECHNOL, V50, P9972, DOI 10.1021/acs.est.6b01765; Springmann M, 2018, NATURE, V562, P519, DOI 10.1038/s41586-018-0594-0; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; Steinheimer TR, 1998, ENVIRON SCI TECHNOL, V32, P1039, DOI 10.1021/es970598j; Tambone F, 2017, BIORESOURCE TECHNOL, V243, P1251, DOI 10.1016/j.biortech.2017.07.130; Templer PH, 2003, SOIL BIOL BIOCHEM, V35, P607, DOI 10.1016/S0038-0717(03)00006-3; Wakelin SA, 2008, SOIL BIOL BIOCHEM, V40, P803, DOI 10.1016/j.soilbio.2007.10.015; Wang JC, 2019, SCI TOTAL ENVIRON, V668, P224, DOI 10.1016/j.scitotenv.2019.02.427; Wang Y, 2016, J SOIL SEDIMENT, V16, P1046, DOI 10.1007/s11368-015-1320-2; Wang Y, 2014, J BASIC MICROB, V54, P190, DOI 10.1002/jobm.201200671; WATANABE F. S., 1965, SOIL SCI SOC AMER PROC, V29, P677; Wild A., 1980, International Atomic Energy Agency: Soil nitrogen as fertilizer or pollutant. (Proceedings and report of a research coordination meeting Piracicaba, 3-7 July, 1978)., P289; Zanardo M, 2016, EUR J SOIL BIOL, V76, P83, DOI 10.1016/j.ejsobi.2016.08.002	59	6	6	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2020	15	6							e0228364	10.1371/journal.pone.0228364	http://dx.doi.org/10.1371/journal.pone.0228364			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MT4VF	32484823	Green Published, gold			2022-12-26	WOS:000554969700002
J	Li, SW; Wright, M; Healey, JF; Hutchinson, JM; O'Rourke, S; Mesa, KA; Lollar, P; Berman, PW				Li, Sophia W.; Wright, Meredith; Healey, John F.; Hutchinson, Jennie M.; O'Rourke, Sara; Mesa, Kathryn A.; Lollar, Pete; Berman, Phillip W.			Gene editing in CHO cells to prevent proteolysis and enhance glycosylation: Production of HIV envelope proteins as vaccine immunogens	PLOS ONE			English	Article							BROADLY NEUTRALIZING ANTIBODIES; COAGULATION-FACTOR-VIII; SUBSTRATE-SPECIFICITY; STRUCTURAL BASIS; RECOMBINANT; POTENT; COMPLEMENT; GLYCOPROTEINS; PROTEASE; GP120	Several candidate HIV subunit vaccines based on recombinant envelope (Env) glycoproteins have been advanced into human clinical trials. To facilitate biopharmaceutical production, it is necessary to produce these in CHO (Chinese Hamster Ovary) cells, the cellular substrate used for the manufacturing of most recombinant protein therapeutics. However, previous studies have shown that when recombinant Env proteins from Glade B viruses, the major subtype represented in North America, Europe, and other parts of the world, are expressed in CHO cells, they are proteolyzed and lack important glycan-dependent epitopes present on virions. Previously, we identified Cis, a serine protease in the complement pathway, as the endogenous CHO protease responsible for the cleavage of Glade B laboratory isolates of -recombinant gp120s (rgp120s) expressed in stable CHO-S cell lines. In this paper, we describe the development of two novel CHOK1 cell lines with the C1s gene inactivated by gene editing, that are suitable for the production of any protein susceptible to C1s proteolysis. One cell line, C1s(-/-)CHOK1 2.E7, contains a deletion in the C1s gene. The other cell line, C1s(-/)-MGAT1-CHOK1 1.A1, contains a deletion in both the C1s gene and the MGAT1 gene, which limits glycosylation to mannose-5 or earlier intermediates in the N-linked glycosylation pathway. In addition, we compare the substrate specificity of C1s with thrombin on the cleavage of both rgp120 and human Factor VIII, two recombinant proteins known to undergo unintended proteolysis (clipping) when expressed in CHO cells. Finally, we demonstrate the utility and practicality of the C1s(-/-) MGAT1-CHOK1 1.A1 cell line for the expression of clinical isolates of Glade B Envs from rare individuals that possess broadly neutralizing antibodies and are able to control virus replication without anti-retroviral drugs (elite neutralizer/controller phenotypes). The Envs represent unique HIV vaccine immunogens suitable for further immunogenicity and efficacy studies.	[Li, Sophia W.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Li, Sophia W.; Wright, Meredith; Hutchinson, Jennie M.; O'Rourke, Sara; Mesa, Kathryn A.; Berman, Phillip W.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Healey, John F.; Lollar, Pete] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Emory University	Li, SW (corresponding author), Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA.; Li, SW (corresponding author), Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA.	sli140@uesc.edu		Li, Sophia/0000-0002-5873-1602	National Institute of Drug Abuse [R01DA036335]; National Institute of Allergy and Infectious Diseases [R01AI113893]	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by the National Institute of Drug Abuse through Grant R01DA036335 to Phillip W. Berman. Funding was also provided by the National Institute of Allergy and Infectious Diseases through Grant R01AI113893 to Phillip W. Berman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara U, 2010, J IMMUNOL, V185, P5628, DOI 10.4049/jimmunol.0903678; Bale S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01116; Bandres JC, 1998, J VIROL, V72, P2500, DOI 10.1128/JVI.72.3.2500-2504.1998; Bonomelli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023521; Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515; Byrne G, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005817; Chiang AWT, 2019, SCI REPORTS, V9, P1; CLEMENTS GJ, 1991, AIDS RES HUM RETROV, V7, P3, DOI 10.1089/aid.1991.7.3; Clincke M.-F., 2011, BMC P, V5, pP115; Conway EM, 2015, J THROMB HAEMOST, V13, pS121, DOI 10.1111/jth.12950; Dey AK, 2018, BIOTECHNOL BIOENG, V115, P885, DOI 10.1002/bit.26498; Doores KJ, 2010, P NATL ACAD SCI USA, V107, P13800, DOI 10.1073/pnas.1006498107; Dorai H, 2011, BIOTECHNOL PROGR, V27, P220, DOI 10.1002/btpr.537; Doran RC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02313; Doran RC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196370; Du SX, 2008, PROTEIN EXPRES PURIF, V59, P223, DOI 10.1016/j.pep.2008.02.002; Eggink D, 2010, VIROLOGY, V401, P236, DOI 10.1016/j.virol.2010.02.019; Fan LC, 2012, BIOTECHNOL BIOENG, V109, P1007, DOI 10.1002/bit.24365; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Foley B, 1996, GLOBAL VARIATION HIV, VIII, P77; Gaboriaud C, 2000, EMBO J, V19, P1755, DOI 10.1093/emboj/19.8.1755; Gallwitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031756; Gosalia DN, 2005, MOL CELL PROTEOMICS, V4, P626, DOI 10.1074/mcp.M500004-MCP200; Hammond S, 2012, BIOTECHNOL BIOENG, V109, P1353, DOI 10.1002/bit.24374; Huang YM, 2010, BIOTECHNOL PROGR, V26, P1400, DOI 10.1002/btpr.436; HULTIN MB, 1981, BLOOD, V57, P476; Hutchinson JM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01021; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; KAUFMAN RJ, 1988, J BIOL CHEM, V263, P6352; Kerr FK, 2005, J BIOL CHEM, V280, P39510, DOI 10.1074/jbc.M506131200; Kong L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12040; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Krem MM, 2002, TRENDS BIOCHEM SCI, V27, P67, DOI 10.1016/S0968-0004(01)02007-2; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; LAURENTCRAWFORD AG, 1993, AIDS RES HUM RETROV, V9, P761, DOI 10.1089/aid.1993.9.761; Laux H, 2018, BIOTECHNOL BIOENG, V115, P2530, DOI 10.1002/bit.26731; Lenting PJ, 1998, BLOOD, V92, P3983, DOI 10.1182/blood.V92.11.3983.423k51_3983_3996; Li SW, 2019, BIOTECHNOL BIOENG, V116, P2130, DOI 10.1002/bit.27016; Lim A, 2018, BIOTECHNOL PROGR, V34, P120, DOI 10.1002/btpr.2530; LIND P, 1995, EUR J BIOCHEM, V232, P19, DOI 10.1111/j.1432-1033.1995.tb20776.x; Luo HB, 2019, BIOTECHNOL PROGR, V35, DOI 10.1002/btpr.2732; Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; Mesa KA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213409; MORALES D, 2014, J BIOL CHEM, V28; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; O'Rourke SM, 2019, J IMMUNOL METHODS, V465, P31, DOI 10.1016/j.jim.2018.11.015; O'Rourke SM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197656; Pang SS, 2017, J IMMUNOL, V199, P3883, DOI 10.4049/jimmunol.1700158; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pipe SW, 2009, HAEMOPHILIA, V15, P1187, DOI 10.1111/j.1365-2516.2009.02026.x; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Ponomarenko EA, 2016, INT J ANAL CHEM, V2016, DOI 10.1155/2016/7436849; Pugach P, 2015, J VIROL, V89, P3380, DOI 10.1128/JVI.03473-14; Quesada V, 2009, NUCLEIC ACIDS RES, V37, pD239, DOI 10.1093/nar/gkn570; Raska M, 2010, J BIOL CHEM, V285, P20860, DOI 10.1074/jbc.M109.085472; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Robert F, 2009, BIOTECHNOL BIOENG, V104, P1132, DOI 10.1002/bit.22494; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; Robinson HL, 2018, CLIN PHARMACOL THER, V104, P1062, DOI 10.1002/cpt.1208; SCHULZ TF, 1993, AIDS RES HUM RETROV, V9, P159, DOI 10.1089/aid.1993.9.159; Shapiro AD, 2007, VASC HEALTH RISK MAN, V3, P555; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Sinacore MS, 2000, MOL BIOTECHNOL, V15, P249, DOI 10.1385/MB:15:3:249; Sok D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008104; SRINIVASAN A, 1989, AIDS RES HUM RETROV, V5, P121, DOI 10.1089/aid.1989.5.121; Stolfa G, 2018, BIOTECHNOL J, V13, DOI 10.1002/biot.201700227; STUBBS MT, 1994, CURR OPIN STRUC BIOL, V4, P823, DOI 10.1016/0959-440X(94)90263-1; Sullivan JT, 2017, J VIROL, V91, DOI 10.1128/JVI.00862-17; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Walport MJ, 1998, IMMUNOBIOLOGY, V199, P265, DOI 10.1016/S0171-2985(98)80032-6; Warren DL, 1999, BIOCHEMISTRY-US, V38, P6529, DOI 10.1021/bi983033o; Weissman D, 1997, NATURE, V389, P981, DOI 10.1038/40173; Wen YX, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194266; WORTON RG, 1977, SOMAT CELL GENET, V3, P27, DOI 10.1007/BF01550985; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Wurm FM, 2017, CLONING CHO CELLS PR; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zolla-Pazner S, 2004, AIDS RES HUM RETROV, V20, P1254, DOI 10.1089/aid.2004.20.1254	82	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2020	15	5							e0233866	10.1371/journal.pone.0233866	http://dx.doi.org/10.1371/journal.pone.0233866			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1WS	32470085	Green Published, gold			2022-12-26	WOS:000537552800200
J	Raisi-Estabragh, Z; Cooper, J; Judge, R; Khanji, MY; Munroe, PB; Cooper, C; Harvey, NC; Petersen, SE				Raisi-Estabragh, Zahra; Cooper, Jackie; Judge, Rebekah; Khanji, Mohammed Y.; Munroe, Patricia B.; Cooper, Cyrus; Harvey, Nicholas C.; Petersen, Steffen E.			Age, sex and disease-specific associations between resting heart rate and cardiovascular mortality in the UK BIOBANK	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; FOLLOW-UP; RISK-FACTOR; DEATH; WOMEN; MEN; POPULATION	Objective To define the sex, age, and disease-specific associations of resting heart rate (RHR) with cardiovascular and mortality outcomes in 502,534 individuals from the UK Biobank over 7-12 years of prospective follow-up. Methods The main outcomes were all-cause, cardiovascular, and ischaemic heart disease mortality. Additional outcomes included incident acute myocardial infarction (AMI), fatal AMI, and cancer mortality. We considered a wide range of confounders and the effects of competing hazards. Results are reported as hazard ratios (HR) for all-cause mortality and sub-distribution hazard ratios (SHR) for other outcomes with corresponding 95% confidence intervals (CI) per 10bpm increment of RHR. Results In men, for every 10bpm increase of RHR there was 22% (HR 1.22, CI 1.20 to 1.24, p = 3x10(-123)) greater hazard of all-cause and 17% (SHR 1.17, CI 1.13 to 1.21, p = 5.6x10(-18)) greater hazard of cardiovascular mortality; for women, corresponding figures were 19% (HR 1.19, CI 1.16 to 1.22, p = 8.9x10(-45)) and 14% (SHR 1.14, CI 1.07 to 1.22, p = 0.00008). Associations between RHR and ischaemic outcomes were of greater magnitude amongst men than women, but with similar magnitude of association for non-cardiovascular cancer mortality [men (SHR 1.18, CI 1.15-1.21, p = 5.2x10(-46)); women 15% (SHR 1.15, CI 1.11-1.18, p = 3.1x10(-18))]. Associations with all-cause, incident AMI, and cancer mortality were of greater magnitude at younger than older ages. Conclusions RHR is an independent predictor of mortality, with variation by sex, age, and disease. Ischaemic disease appeared a more important driver of this relationship in men, and associations were more pronounced at younger ages.	[Raisi-Estabragh, Zahra; Cooper, Jackie; Khanji, Mohammed Y.; Munroe, Patricia B.; Petersen, Steffen E.] Queen Mary Univ London, William Harvey Res Inst, NIHR Barts Biomed Res Ctr, London, England; [Raisi-Estabragh, Zahra; Cooper, Jackie; Khanji, Mohammed Y.; Petersen, Steffen E.] St Bartholomews Hosp, Barts Heart Ctr, Barts Hlth NHS Trust, London, England; [Judge, Rebekah] Imperial Coll Healthcare Trust, St Marys Hosp, London, England; [Cooper, Cyrus; Harvey, Nicholas C.] MRC Lifecourse Epidemiol Unit MRCLEU, Southampton, Hants, England; [Cooper, Cyrus; Harvey, Nicholas C.] Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Cooper, Cyrus; Harvey, Nicholas C.] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England; [Cooper, Cyrus] Univ Oxford, NIHR Oxford Biomed Res Ctr, Oxford, England	University of London; Queen Mary University London; Barts Health NHS Trust; University of London; Queen Mary University London; Imperial College London; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Oxford	Petersen, SE (corresponding author), Queen Mary Univ London, William Harvey Res Inst, NIHR Barts Biomed Res Ctr, London, England.; Petersen, SE (corresponding author), St Bartholomews Hosp, Barts Heart Ctr, Barts Hlth NHS Trust, London, England.	s.e.petersen@qmul.ac.uk	Petersen, Steffen E/A-8389-2011	Petersen, Steffen E/0000-0003-4622-5160; Judge, Rebekah/0000-0003-3288-8297; Munroe, Patricia/0000-0002-4176-2947; Raisi-Estabragh, Zahra/0000-0002-7757-5465	British Heart Foundation Clinical Research Training Fellowship [FS/17/81/33318]; Medical Research Council [MR/L016311/1]; National Institute for Health Research (NIHR) Cardiovascular Biomedical Research Centre at Barts; European Union's Horizon 2020 research and innovation programme [825903]; MRC [G0400491, MC_UU_12011/2, MC_U147585827, MR/L016311/1, MC_U147585819, MC_UP_A620_1015] Funding Source: UKRI	British Heart Foundation Clinical Research Training Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Cardiovascular Biomedical Research Centre at Barts(National Institute for Health Research (NIHR)); European Union's Horizon 2020 research and innovation programme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	ZRE is supported by British Heart Foundation Clinical Research Training Fellowship no. FS/17/81/33318. This project was enabled through access to the MRC eMedLab Medical Bioinformatics infrastructure, supported by the Medical Research Council (www.mrc.ac.uk; MR/L016311/1). Data access was granted through UK Biobank access application 2964. SEP acknowledges support from the National Institute for Health Research (NIHR) Cardiovascular Biomedical Research Centre at Barts and received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 825903. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, BLOOD PRESSURE; Aune D, 2017, NUTR METAB CARDIOVAS, V27, P504, DOI 10.1016/j.numecd.2017.04.004; Benetos A, 1999, HYPERTENSION, V33, P44, DOI 10.1161/01.HYP.33.1.44; Chen XJ, 2019, OPEN HEART, V6, DOI 10.1136/openhrt-2018-000856; Cooney MT, 2010, AM HEART J, V159, P612, DOI 10.1016/j.ahj.2009.12.029; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Custodis F, 2016, CLIN RES CARDIOL, V105, P601, DOI 10.1007/s00392-015-0956-7; Diaz A, 2005, EUR HEART J, V26, P967, DOI 10.1093/eurheartj/ehi190; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fox K, 2007, J AM COLL CARDIOL, V50, P823, DOI 10.1016/j.jacc.2007.04.079; Garcia M, 2016, CIRC RES, V118, P1273, DOI 10.1161/CIRCRESAHA.116.307547; GILLUM RF, 1991, AM HEART J, V121, P172, DOI 10.1016/0002-8703(91)90970-S; Goldberg RJ, 1996, ARCH INTERN MED, V156, P505, DOI 10.1001/archinte.156.5.505; Greenland P, 1999, AM J EPIDEMIOL, V149, P853; Hsia Judith, 2009, BMJ, V338, pb219, DOI 10.1136/bmj.b219; Jensen MT, 2013, HEART, V99, P882, DOI 10.1136/heartjnl-2012-303375; KANNEL WB, 1987, AM HEART J, V113, P1489, DOI 10.1016/0002-8703(87)90666-1; Kristal-Boneh E, 2000, EUR HEART J, V21, P116, DOI 10.1053/euhj.1999.1741; Li KB, 2017, J AM GERIATR SOC, V65, P989, DOI 10.1111/jgs.14714; Littlejohns TJ, 2019, EUR HEART J, V40, P1158, DOI 10.1093/eurheartj/ehx254; Nanchen D, 2013, EUR J HEART FAIL, V15, P581, DOI 10.1093/eurjhf/hfs195; Palatini P, 2013, CURR HYPERTENS REP, V15, P253, DOI 10.1007/s11906-013-0342-7; Palatini P, 2009, PROG CARDIOVASC DIS, V52, P46, DOI 10.1016/j.pcad.2009.05.005; Raisi-Estabragh Z, 2019, CARDIOVASC RES, DOI [10.1093/cvr/cvz294/5645361, DOI 10.1093/CVR/CVZ294/5645361]; Reil JC, 2007, CLIN RES CARDIOL, V96, P585, DOI 10.1007/s00392-007-0537-5; Roth GA, 2018, LANCET, V392, P1736, DOI [10.1016/S0140-6736(18)32203-7, 10.1016/s0140-6736(18)32203-7]; Seviiri M, 2018, HEART, V104, P1076, DOI 10.1136/heartjnl-2017-312251; Sharashova E, 2016, J EPIDEMIOL COMMUN H, V70, P902, DOI 10.1136/jech-2015-206663; Sudlow C, 2017, DEFINITIONS ACUTE MY; Tverdal A, 2008, EUR HEART J, V29, P2772, DOI 10.1093/eurheartj/ehn435; Woodward M, 2014, EUR J PREV CARDIOL, V21, P719, DOI 10.1177/2047487312452501; Zhang DF, 2016, CAN MED ASSOC J, V188, pE53, DOI 10.1503/cmaj.150535	32	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2020	15	5							e0233898	10.1371/journal.pone.0233898	http://dx.doi.org/10.1371/journal.pone.0233898			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1WS	32470091	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000537552800210
J	Shi, XQ; Long, W; Li, YY; Deng, DS				Shi, Xiaoqiu; Long, Wei; Li, Yanyan; Deng, Dingshan			Multi-population genetic algorithm with ER network for solving flexible job shop scheduling problems	PLOS ONE			English	Article							SEARCH ALGORITHM; TABU SEARCH; OPTIMIZATION; MODELS	A genetic algorithm (GA) cannot always avoid premature convergence, and multi-population is usually used to overcome this limitation by dividing the population into several sub-populations (sub-population number) with the same number of individuals (sub-population size). In previous research, the questions of how a network structure composed of sub-populations affects the propagation rate of advantageous genes among sub-populations and how it affects the performance of GA have always been ignored. Therefore, we first propose a multi-population GA with an ER network (MPGA-ER). Then, by using the flexible job shop scheduling problem (FJSP) as an example and considering the total individual number (TIN), we study how the sub-population number and size and the propagation rate of advantageous genes affect the performance of MPGA-ER, wherein the performance is evaluated by the average optimal value and success rate based on TIN. The simulation results indicate the following regarding the performance of MPGA-ER: (i) performance shows considerable improvement compared with that of traditional GA; (ii) for an increase in the sub-population number for a certain TIN, the performance first increases slowly, and then decreases rapidly; (iii) for an increase in the sub-population size for a certain TIN, the performance of MPGA-ER first increases rapidly and then tends to remain stable; and (iv) with an increase in the propagation rate of advantageous genes, the performance first increases rapidly and then decreases slowly. Finally, we use a parameter-optimized MPGA-ER to solve for more FJSP instances and demonstrate its effectiveness by comparing it with that of other algorithms proposed in other studies.	[Shi, Xiaoqiu] Southwest Univ Sci & Technol, Sch Mfg Sci & Engn, Mianyang, Sichuan, Peoples R China; [Long, Wei; Li, Yanyan; Deng, Dingshan] Sichuan Univ, Sch Mech Engn, Chengdu, Peoples R China	Southwest University of Science & Technology - China; Sichuan University	Li, YY (corresponding author), Sichuan Univ, Sch Mech Engn, Chengdu, Peoples R China.	yyl_scu@163.com	邓, 丁山/ABF-7645-2020	邓, 丁山/0000-0001-7553-8655	Science and Technology Department of Sichuan Province [20CXRC0097]	Science and Technology Department of Sichuan Province	This research was funded by the Science and Technology Department of Sichuan Province (Grant No. 20CXRC0097) to YL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bardoscia M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163825; Birgin EG, 2014, OPTIM LETT, V8, P1417, DOI 10.1007/s11590-013-0669-7; BRUCKER P, 1990, COMPUTING, V45, P369, DOI 10.1007/BF02238804; Bryden KM, 2006, IEEE T EVOLUT COMPUT, V10, P550, DOI 10.1109/TEVC.2005.863128; Cantu-Paz E, 2000, IEEE T EVOLUT COMPUT, V4, P216, DOI 10.1109/4235.873233; Demir Y, 2013, APPL MATH MODEL, V37, P977, DOI 10.1016/j.apm.2012.03.020; Deng ZH, 2018, CHAOS SOLITON FRACT, V114, P151, DOI 10.1016/j.chaos.2018.06.036; Erdos P., 1959, PUBL MATH-DEBRECEN, V6, P290; Fattahi P, 2007, J INTELL MANUF, V18, P331, DOI 10.1007/s10845-007-0026-8; Garey M. R., 1976, Mathematics of Operations Research, V1, P117, DOI 10.1287/moor.1.2.117; Giacobini M, 2005, IEEE T EVOLUT COMPUT, V9, P489, DOI 10.1109/TEVC.2005.850298; Giacobini M, 2006, LECT NOTES COMPUT SC, V3906, P86; Goli A, 2019, PROD MANUF RES, V7, P294, DOI 10.1080/21693277.2019.1620651; Golpira H, 2019, COMPUT IND ENG, V137, DOI 10.1016/j.cie.2019.106007; Goto H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185712; Han ZL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181747; Herrera F, 2000, IEEE T EVOLUT COMPUT, V4, P43, DOI 10.1109/4235.843494; Ichinose G, 2018, NEW J PHYS, V20, DOI 10.1088/1367-2630/aac2a7; Kacem I, 2002, IEEE T SYST MAN CY C, V32, P1, DOI 10.1109/TSMCC.2002.1009117; Kirley M, 2007, GECCO 2007: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOL 1 AND 2, P845; Li JQ, 2010, COMPUT IND ENG, V59, P647, DOI 10.1016/j.cie.2010.07.014; Li MX, 2019, IEEE ACCESS, V7, P29236, DOI 10.1109/ACCESS.2019.2892181; Li XY, 2016, INT J PROD ECON, V174, P93, DOI 10.1016/j.ijpe.2016.01.016; Ma C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198931; Mateo PM, 2018, APPL SOFT COMPUT, V62, P619, DOI 10.1016/j.asoc.2017.10.042; Newman M.E.J., 2010, NETWORKS INTRO; Payne JL, 2009, IEEE T EVOLUT COMPUT, V13, P895, DOI 10.1109/TEVC.2009.2019825; Shi XQ, 2018, COMPUT INTEL NEUROSC, V2018, DOI 10.1155/2018/4617816; Shi XQ, 2020, SOFT COMPUT, V24, P13441, DOI 10.1007/s00500-020-04759-1; Shi Xiaoqiu, 2019, Journal of Mechanical Engineering, V55, P223, DOI 10.3901/JME.2019.06.223; Tirkolaee EB, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10051366; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yuan Y, 2013, APPL SOFT COMPUT, V13, P3259, DOI 10.1016/j.asoc.2013.02.013; Zhang GH, 2009, COMPUT IND ENG, V56, P1309, DOI 10.1016/j.cie.2008.07.021; Zhang W, 2017, INT J SIMUL MODEL, V16, P313, DOI 10.2507/IJSIMM16(2)CO6	36	13	15	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2020	15	5							e0233759	10.1371/journal.pone.0233759	http://dx.doi.org/10.1371/journal.pone.0233759			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1WS	32470077	Green Published, gold			2022-12-26	WOS:000537552800168
J	Darlot, B; Eaton, JRO; Geis-Asteggiante, L; Yakala, GK; Karuppanan, K; Davies, G; Robinson, CV; Kawamura, A; Bhattacharya, S				Darlot, Benoit; Eaton, James R. O.; Geis-Asteggiante, Lucia; Yakala, Gopala K.; Karuppanan, Kalimuthu; Davies, Graham; Robinson, Carol, V; Kawamura, Akane; Bhattacharya, Shoumo			Engineered anti-inflammatory peptides inspired by mapping an evasin-chemokine interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chemokine; C-C motif chemokine ligand (CCL); chemotaxis; mass spectrometry; inflammation; protein-protein interaction; evasin; tick; immune response; innate immunity; hydrogen exchange mass spectrometry; protein structure; host-pathogen interaction; peptide interaction; peptides	PROTEIN-PROTEIN INTERACTIONS; CC-CHEMOKINE; HOT-SPOTS; BINDING; EXPRESSION; MODULATION; TARGETS	Chemokines mediate leukocyte migration and homeostasis and are key targets in inflammatory diseases including atherosclerosis, cytokine storm, and chronic autoimmune disease. Chemokine redundancy and ensuing network robustness has frustrated therapeutic development. Salivary evasins from ticks bind multiple chemokines to overcome redundancy and are effective in several preclinical disease models. Their clinical development has not progressed because of concerns regarding potential immunogenicity, parenteral delivery, and cost. Peptides mimicking protein activity can overcome the perceived limitations of therapeutic proteins. Here we show that peptides possessing multiple chemokine-binding and anti-inflammatory activities can be developed from the chemokine-binding site of an evasin. We used hydrogen-deuterium exchange MS to map the binding interface of the evasin P672 that physically interacts with C-C motif chemokine ligand (CCL) 8 and synthesized a 16-mer peptide (BK1.1) based on this interface region in evasin P672. Fluorescent polarization and native MS approaches showed that BK1.1 binds CCL8, CCL7, and CCL18 and disrupts CCL8 homodimerization. We show that a BK1.1 derivative, BK1.3, has substantially improved ability to disrupt P672 binding to CCL8, CCL2, and CCL3 in an AlphaScreen assay. Using isothermal titration calorimetry, we show that BK1.3 directly binds CCL8. BK1.3 also has substantially improved ability to inhibit CCL8, CCL7, CCL2, and CCL3 chemotactic functionin vitro. We show that local as well as systemic administration of BK1.3 potently blocks inflammationin vivo. Identification and characterization of the chemokine-binding interface of evasins could thus inspire the development of novel anti-inflammatory peptides that therapeutically target the chemokine network in inflammatory diseases.	[Darlot, Benoit; Eaton, James R. O.; Geis-Asteggiante, Lucia; Robinson, Carol, V; Kawamura, Akane] Univ Oxford, Dept Chem, Chem Res Lab, Oxford, England; [Eaton, James R. O.; Yakala, Gopala K.; Karuppanan, Kalimuthu; Davies, Graham; Kawamura, Akane; Bhattacharya, Shoumo] Univ Oxford, Radcliffe Dept Med, Div Cardiovasc Med, Oxford, England; [Kawamura, Akane] Newcastle Univ, Sch Nat & Environm Sci, Newcastle Upon Tyne, Tyne & Wear, England	University of Oxford; University of Oxford; Newcastle University - UK	Kawamura, A (corresponding author), Univ Oxford, Dept Chem, Chem Res Lab, Oxford, England.; Kawamura, A; Bhattacharya, S (corresponding author), Univ Oxford, Radcliffe Dept Med, Div Cardiovasc Med, Oxford, England.; Kawamura, A (corresponding author), Newcastle Univ, Sch Nat & Environm Sci, Newcastle Upon Tyne, Tyne & Wear, England.	akane.kawamura@nd.ac.uk; sbhattac@well.ox.ac.uk	Bhattacharya, Shoumo/F-4127-2010; Kawamura, Akane/I-4047-2018	Bhattacharya, Shoumo/0000-0002-5571-0478; Darlot, Benoit/0000-0002-3679-4071; Kawamura, Akane/0000-0003-1169-5082	British Heart Foundation Chair Award [CH/09/003/26631]; British Heart Foundation Program Grant [RG/18/1/33351]; Oxford British Heart Foundation Centre of Research Excellence Grant [RE/13/1/30181]; Medical Research Council [MR/N020413/1]; Engineering and Physical Sciences Research Council Centre for Doctoral Training in Synthesis for Biology and Medicine [EP/L015838/1]; Oxford British Heart Foundation Centre of Research Excellence; Royal Society Dorothy Hodgkin Fellowship; MRC [MR/N020413/1] Funding Source: UKRI	British Heart Foundation Chair Award; British Heart Foundation Program Grant; Oxford British Heart Foundation Centre of Research Excellence Grant; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council Centre for Doctoral Training in Synthesis for Biology and Medicine; Oxford British Heart Foundation Centre of Research Excellence; Royal Society Dorothy Hodgkin Fellowship(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by British Heart Foundation Chair Award CH/09/003/26631 (to S. B.), British Heart Foundation Program Grant RG/18/1/33351 (to S. B. and A. K.) and the Oxford British Heart Foundation Centre of Research Excellence Grant RE/13/1/30181 (to J. R. O. E., A. K., and S. B.). C. V. R. is supported by Medical Research Council Grant MR/N020413/1. B. D. is supported by Grant EP/L015838/1 from the Engineering and Physical Sciences Research Council Centre for Doctoral Training in Synthesis for Biology and Medicine. J. R. O. E. is supported by a studentship from the Oxford British Heart Foundation Centre of Research Excellence, A. K. is supported by a Royal Society Dorothy Hodgkin Fellowship.	Achour L, 2009, BLOOD, V113, P1938, DOI 10.1182/blood-2008-02-141275; Alenazi Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24568-9; Antosova Z, 2009, TRENDS BIOTECHNOL, V27, P628, DOI 10.1016/j.tibtech.2009.07.009; Beck CG, 2001, J BIOL CHEM, V276, P43270, DOI 10.1074/jbc.M106305200; Bhusal RP, 2020, TRENDS BIOCHEM SCI, V45, P108, DOI 10.1016/j.tibs.2019.10.003; Blaszczyk J, 2000, BIOCHEMISTRY-US, V39, P14075, DOI 10.1021/bi0009340; Boehncke WH, 2018, EXPERT REV CLIN IMMU, V14, P513, DOI 10.1080/1744666X.2018.1468753; Bonvin P, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00208; Brandes M, 2013, CELL, V154, P197, DOI 10.1016/j.cell.2013.06.013; Brown KA, 2017, ANALYST, V142, P2874, DOI 10.1039/c7an00662d; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; Coates NJ, 2001, J IMMUNOL, V166, P5176, DOI 10.4049/jimmunol.166.8.5176; Dias JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008514; Duarte Djane B, 2016, Curr Protoc Pharmacol, V72, DOI 10.1002/0471141755.ph0506s72; Eaton JRO, 2018, J BIOL CHEM, V293, P6134, DOI 10.1074/jbc.RA117.000487; El-Achkar GA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216405; Ezerzer C, 2009, PEPTIDES, V30, P1296, DOI 10.1016/j.peptides.2009.03.016; Garin A, 2011, EXP CELL RES, V317, P602, DOI 10.1016/j.yexcr.2010.12.021; Gault J, 2016, NAT METHODS, V13, P333, DOI [10.1038/NMETH.3771, 10.1038/nmeth.3771]; Girrbach M, 2014, PHYS CHEM CHEM PHYS, V16, P8036, DOI 10.1039/c3cp53850h; Harding SD, 2018, NUCLEIC ACIDS RES, V46, pD1091, DOI 10.1093/nar/gkx1121; Hayward J, 2017, J BIOL CHEM, V292, P15670, DOI 10.1074/jbc.M117.807255; Heidarieh H, 2015, VIRUS RES, V209, P67, DOI 10.1016/j.virusres.2015.02.028; Horuk R, 2009, NAT REV DRUG DISCOV, V8, P23, DOI 10.1038/nrd2734; Houimel M, 2013, IMMUNOL LETT, V149, P19, DOI 10.1016/j.imlet.2012.11.006; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Kawamura A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14773; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Kufareva I, 2016, CURR OPIN PHARMACOL, V30, P27, DOI 10.1016/j.coph.2016.07.006; Larive CK, 1997, APPL SPECTROSC, V51, P1531, DOI 10.1366/0003702971939055; Lau JL, 2018, BIOORGAN MED CHEM, V26, P2700, DOI 10.1016/j.bmc.2017.06.052; Lee AW, 2019, J BIOL CHEM, V294, P11199, DOI 10.1074/jbc.RA119.008817; Lua RC, 2014, PROG BIOPHYS MOL BIO, V116, P194, DOI 10.1016/j.pbiomolbio.2014.05.004; Ludeman JP, 2014, BRIT J PHARMACOL, V171, P1167, DOI 10.1111/bph.12455; Ma B, 2007, CURR TOP MED CHEM, V7, P999, DOI 10.2174/156802607780906717; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; Maizels RM, 2018, IMMUNITY, V49, P801, DOI 10.1016/j.immuni.2018.10.016; Mantovani A, 2018, SEMIN IMMUNOL, V36, P28, DOI 10.1016/j.smim.2017.12.006; Marcsisin SR, 2010, ANAL BIOANAL CHEM, V397, P967, DOI 10.1007/s00216-010-3556-4; McAllister TE, 2018, CHEM SCI, V9, P4569, DOI 10.1039/c8sc00286j; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Parker LC, 2004, J IMMUNOL, V172, P4977, DOI 10.4049/jimmunol.172.8.4977; Schmidpeter PAM, 2015, BBA-GEN SUBJECTS, V1850, P1973, DOI 10.1016/j.bbagen.2014.12.019; Seet BT, 2001, P NATL ACAD SCI USA, V98, P9008, DOI 10.1073/pnas.171069398; Sharif S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168007; Singh K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05204-4; Skelton NJ, 1999, STRUCTURE, V7, P157, DOI 10.1016/S0969-2126(99)80022-7; Szekanecz Z, 2016, NAT REV RHEUMATOL, V12, P5, DOI 10.1038/nrrheum.2015.157; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Velazquez-Campoy A, 2015, METHODS MOL BIOL, V1278, P183, DOI 10.1007/978-1-4939-2425-7_11; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; von Hundelshausen P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah6650; Zernecke A, 2014, ARTERIOSCL THROM VAS, V34, P742, DOI 10.1161/ATVBAHA.113.301655; Zhao YG, 2011, J STRUCT BIOL, V175, P209, DOI 10.1016/j.jsb.2011.04.017; Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008	59	5	5	3	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2020	295	32					10926	10939		10.1074/jbc.RA120.014103	http://dx.doi.org/10.1074/jbc.RA120.014103			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE7BV	32471866	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000562757100005
J	Wang, JW; Zhao, CZ; Zhao, LC; Wen, J; Li, Q				Wang, Jiwei; Zhao, Chengzhang; Zhao, Lianchun; Wen, Jun; Li, Qun			Effects of grazing on the allocation of mass of soil aggregates and aggregate-associated organic carbon in an alpine meadow	PLOS ONE			English	Article							TIBETAN PLATEAU; SWAMP MEADOW; STABILITY; MATTER; NITROGEN; STORAGE; RESPIRATION; CULTIVATION; MECHANISMS; PROTECTION	Soil aggregation is closely related to the soil organic carbon sequestration, both of which plays an important role in the stability of the soil carbon pool. However, the results of the impact of yak grazing intensity on the soil carbon process in alpine meadows have been unclear. With the marsh meadow as the research object in the Gahai wetland of the east Qinghai-Tibet Plateau, we analyzed the influence of different grazing intensities on the allocation of mass, stability and aggregate-associated organic carbon content of aggregates in the surface soil (0-20cm) of pasture by the Le Bissonnais method. The results showed that the mass of aggregates in the particle size class of > 0.2-mm was the highest among the pastures with different grazing intensities. Compared with the no grazing grassland, light grazing promoted the formation of macro aggregates in the particle size class of > 1-mm and improved the stability of soil aggregates. The degree of soil agglomerations and stability of aggregates decreased, and the macro aggregates gradually transformed into micro aggregates (< 0.05-mm class) in moderately and heavily grazed pastures. The > 2-mm and < 0.05-mm classes of particle size had a strong fixation effect on organic carbon. Light grazing promoted the accumulation of organic carbon in this particle size aggregate, and moderate and heavy grazing accelerated the decomposition of organic carbon. There was no significant difference in organic carbon in other particle size aggregates among different grasslands (P > 0.05). This result shows that light grazing, which is a reasonable yak grazing intensity in the study area, is conducive to the formation of a good soil structure in the area and improves the soil carbon sequestration capacity.	[Wang, Jiwei; Zhao, Chengzhang; Zhao, Lianchun; Wen, Jun; Li, Qun] Northwest Normal Univ, Coll Geog & Environm Sci, Lanzhou, Peoples R China	Northwest Normal University - China	Zhao, CZ (corresponding author), Northwest Normal Univ, Coll Geog & Environm Sci, Lanzhou, Peoples R China.	zhaocz601@163.com						Abiven S, 2009, SOIL BIOL BIOCHEM, V41, P1, DOI 10.1016/j.soilbio.2008.09.015; American Academy of Pediatric Dentistry Reference Manual, 2004, PEDIAT DENT S, V26, P14; Amezketa E, 1999, J SUSTAIN AGR, V14, P83, DOI 10.1300/J064v14n02_08; Bao S.D, 2000, SOIL AGRO CHEM ANAL, P49; Bird SB, 2002, ENVIRON POLLUT, V116, P445, DOI 10.1016/S0269-7491(01)00222-6; Briedis C, 2012, GEODERMA, V170, P80, DOI 10.1016/j.geoderma.2011.10.011; Chen JB, 2015, RANGELAND ECOL MANAG, V68, P48, DOI 10.1016/j.rama.2014.12.002; Chen Ning, 2018, Chinese Journal of Plant Ecology, V42, P50, DOI 10.17521/cjpe.2017.0252; Dorfer C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057024; Dorrepaal E, 2009, NATURE, V460, P616, DOI 10.1038/nature08216; ELLIOTT ET, 1991, AGR ECOSYST ENVIRON, V34, P407, DOI 10.1016/0167-8809(91)90124-G; ELLIOTT ET, 1986, SOIL SCI SOC AM J, V50, P627, DOI 10.2136/sssaj1986.03615995005000030017x; [侯扶江 Hou Pujiang], 2004, [生态学报, Acta Ecologica Sinica], V24, P784; Jastrow JD, 1998, SOIL BIOL BIOCHEM, V30, P905, DOI 10.1016/S0038-0717(97)00207-1; Karlen DL, 1999, J SOIL WATER CONSERV, V54, P439; Le Bissonnais Y, 2018, PLANT SOIL, V424, P303, DOI 10.1007/s11104-017-3423-6; LeBissonnais Y, 1996, EUR J SOIL SCI, V47, P425, DOI 10.1111/j.1365-2389.1996.tb01843.x; Li W, 2011, J SOIL SCI PLANT NUT, V11, P27, DOI 10.4067/S0718-95162011000400003; Li XG, 2007, SOIL TILL RES, V95, P172, DOI 10.1016/j.still.2006.12.005; Li XD, 2013, SOIL SCI PLANT NUTR, V59, P877, DOI 10.1080/00380768.2013.862157; [刘帆 Liu Fan], 2013, [科学通报, Chinese Science Bulletin], V58, P1332; Ma Wei-wei, 2014, Yingyong Shengtai Xuebao, V25, P738; [马维伟 Ma Weiwei], 2015, [水土保持学报, Journal of Soil and Water Conservation], V29, P254; Marquez CO, 2004, SOIL SCI SOC AM J, V68, P725, DOI 10.2136/sssaj2004.0725; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; MILCHUNAS DG, 1993, ECOL MONOGR, V63, P327, DOI 10.2307/2937150; Mrabet R, 2002, SOIL TILL RES, V66, P119, DOI 10.1016/S0167-1987(02)00020-X; Niu Ben, 2017, Journal of Resources and Ecology, V8, P57, DOI 10.5814/j.issn.1674-764x.2017.01.008; Puget P, 2000, EUR J SOIL SCI, V51, P595, DOI 10.1046/j.1365-2389.2000.00353.x; Rui YC, 2011, J SOIL SEDIMENT, V11, P903, DOI 10.1007/s11368-011-0388-6; SHARIFF AR, 1994, J RANGE MANAGE, V47, P444, DOI 10.2307/4002994; Shi XM, 2010, BIOL FERT SOILS, V46, P103, DOI 10.1007/s00374-009-0414-7; Sinsabaugh RL, 2013, ECOL LETT, V16, P930, DOI 10.1111/ele.12113; Six J, 1998, SOIL SCI SOC AM J, V62, P1367, DOI 10.2136/sssaj1998.03615995006200050032x; Six J, 2004, SOIL TILL RES, V79, P7, DOI 10.1016/j.still.2004.03.008; Six J, 2014, SOIL BIOL BIOCHEM, V68, pA4, DOI 10.1016/j.soilbio.2013.06.014; SK AZ, 2016, DIABETOL STOFFWECHS, V11, pS01; Steffens M, 2011, PLANT SOIL, V338, P63, DOI 10.1007/s11104-010-0594-9; TISDALL JM, 1982, J SOIL SCI, V33, P141, DOI 10.1111/j.1365-2389.1982.tb01755.x; Wang GX, 2002, SCI TOTAL ENVIRON, V291, P207, DOI 10.1016/S0048-9697(01)01100-7; Wiesmeier M, 2012, EUR J SOIL SCI, V63, P22, DOI 10.1111/j.1365-2389.2011.01418.x; Wu GL, 2010, PLANT SOIL, V332, P331, DOI 10.1007/s11104-010-0299-0; [薛冉 Xue Ran], 2014, [水土保持通报, Bulletin of Soil and Water Conservation], V34, P82; Yang YH, 2008, GLOBAL CHANGE BIOL, V14, P1592, DOI 10.1111/j.1365-2486.2008.01591.x; [于宝政 Yu Baozheng], 2017, [草地学报, Acta Agrestia Sinica], V25, P1212; Zhang WX, 2017, INT J ADV ROBOT SYST, V14, P1, DOI 10.1177/1729881417705845; Zhang YL, 2010, J GEOGR SCI, V20, P375, DOI 10.1007/s11442-010-0375-7; Zhao L, 2010, BIOGEOSCIENCES, V7, P1207, DOI 10.5194/bg-7-1207-2010	48	12	13	16	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234477	10.1371/journal.pone.0234477	http://dx.doi.org/10.1371/journal.pone.0234477			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525934	Green Published, gold			2022-12-26	WOS:000542036800025
J	Mitchell, WG; Pande, R; Robinson, TE; Jones, GD; Hou, I; Celi, LA				Mitchell, William Greig; Pande, Rohit; Robinson, Tom Edward; Jones, Gabriel Davis; Hou, Isabella; Celi, Leo Anthony			The weekend effect for stroke patients admitted to intensive care: A retrospective cohort analysis	PLOS ONE			English	Article							IN-HOSPITAL MORTALITY; ADMISSION; OUTCOMES; ICU; ASSOCIATION; SEVERITY; UNITS	Objectives To examine the effect of weekend admission on short and long-term morbidity and mortality, for patients admitted to intensive care after suffering a cerebrovascular accident (stroke). Design, setting, and participants A hospital-wide, retrospective cohort study of 3,729 adult stroke patients admitted to the Beth Israel Deaconess Medical Centre (BIDMC) intensive care unit (ICU) between 2001 and 2012, using the Medical Information Mart for Intensive Care III (MIMIC-III) database. Primary outcome measures Primary outcome measures were ICU length-of-stay and mortality, hospital length-of-stay and mortality, proportions of patients discharged home after admission, and 6-month mortality. Results Overall, 23% of BIDMC ICU stroke admissions occurred over the weekend. Those admitted over the weekend were likelier to have suffered haemorrhagic stroke than those admitted during the week (60.6% vs 47.9%). Those admitted on the weekend were younger, and likelier to be male and unmarried, with similar ethnic representation. The OASIS severity of illness (32.5 vs. 32) and lowest day-one GCS (12.6 vs. 12.9) were similar between groups. Unadjusted ICU-mortality was significantly higher for patients admitted over the weekend (OR 1.32, CI 1.08-1.61), but when adjusted for type of stroke, became non-significant (OR 1.17, CI 0.95-1.44). In-hospital mortality was significantly higher for patients admitted to ICU over the weekend in both unadjusted (OR 1.45, CI 1.22-1.73) and adjusted (OR 1.31, CI 1.09-1.58) analyses. There was no significant difference in ICU or hospital length of stay. While patients admitted on the weekend appeared less likely to be discharged back to home and more at risk of 6-month mortality compared to weekday admissions, results were non-significant. Conclusions The effect of weekend ICU-admission for stroke patients appears to be significant for in-hospital mortality. There were no significant differences in adjusted ICU-mortality, ICU or hospital length-of-stay, or longer-term morbidity and mortality measures.	[Mitchell, William Greig] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Pande, Rohit] Whitireia Community Polytech, Porirua, New Zealand; [Robinson, Tom Edward] Univ Auckland, Auckland, New Zealand; [Jones, Gabriel Davis] Univ Oxford, Oxford, England; [Hou, Isabella] Southern Cross Hlth Soc, Auckland, New Zealand; [Celi, Leo Anthony] MIT, Harvard Med Sch, Beth Israel Deaconess Med Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Harvard University; Harvard T.H. Chan School of Public Health; Whitireia Community Polytechnic; University of Auckland; University of Oxford; Harvard University; Beth Israel Deaconess Medical Center; Massachusetts Institute of Technology (MIT)	Mitchell, WG (corresponding author), Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.	william.greig.mitchell@gmail.com		Pande, Rohit/0000-0002-2598-4689; Mitchell, William/0000-0002-2122-6741				Andersen KK, 2009, STROKE, V40, P2068, DOI 10.1161/STROKEAHA.108.540112; [Anonymous], 2019, CANC DISCOV, V9, pOF3, DOI 10. 1158/2159-8290. CD-NB2018-158; [Anonymous], 2020, TYP STROK AM STROK A; Barnett MJ, 2002, MED CARE, V40, P530, DOI 10.1097/00005650-200206000-00010; Bell CM, 2001, NEW ENGL J MED, V345, P663, DOI 10.1056/NEJMsa003376; Black N, 2016, JAMA-J AM MED ASSOC, V316, P2593, DOI 10.1001/jama.2016.16410; Cavallazzi R, 2010, CHEST, V138, P68, DOI 10.1378/chest.09-3018; Crowley RW, 2009, STROKE, V40, P2387, DOI 10.1161/STROKEAHA.108.546572; Ensminger SA, 2004, CHEST, V126, P1292, DOI 10.1378/chest.126.4.1292; Galloway M, 2018, CRIT CARE MED, V46, P290, DOI 10.1097/CCM.0000000000002837; Hoh BL, 2010, STROKE, V41, P2323, DOI 10.1161/STROKEAHA.110.591081; Inoue T, 2015, J STROKE CEREBROVASC, V24, P2787, DOI 10.1016/j.jstrokecerebrovasdis.2015.08.010; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; Johnson AEW, 2013, CRIT CARE MED, V41, P1711, DOI 10.1097/CCM.0b013e31828a24fe; Laupland KB, 2008, J CRIT CARE, V23, P317, DOI 10.1016/j.jcrc.2007.09.001; Levy MM, 2008, ANN INTERN MED, V148, P801, DOI 10.7326/0003-4819-148-11-200806030-00002; Luyt CE, 2007, CRIT CARE MED, V35, P3, DOI 10.1097/01.CCM.0000249832.36518.11; Meynaar IA, 2009, CRIT CARE, V13, DOI 10.1186/cc7904; Patel AA, 2016, NEUROHOSPITALIST, V6, P51, DOI 10.1177/1941874415601164; Pronovost PJ, 1999, JAMA-J AM MED ASSOC, V281, P1310, DOI 10.1001/jama.281.14.1310; Pronovost PJ, 2002, JAMA-J AM MED ASSOC, V288, P2151, DOI 10.1001/jama.288.17.2151; Uematsu H, 2016, RESPIROLOGY, V21, P905, DOI 10.1111/resp.12788; Uusaro A, 2003, INTENS CARE MED, V29, P2144, DOI 10.1007/s00134-003-2035-1; Zampieri FG, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018541	24	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2020	15	6							e0234521	10.1371/journal.pone.0234521	http://dx.doi.org/10.1371/journal.pone.0234521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC0EC	32520977	gold, Green Published			2022-12-26	WOS:000542969500046
J	Schwefel, K; Spiegler, S; Kirchmaier, BC; Dellweg, PKE; Much, CD; Pane-Farre, J; Strom, TM; Riedel, K; Felbor, U; Rath, M				Schwefel, Konrad; Spiegler, Stefanie; Kirchmaier, Bettina C.; Dellweg, Patricia K. E.; Much, Christian D.; Pane-Farre, Jan; Strom, Tim M.; Riedel, Katharina; Felbor, Ute; Rath, Matthias			Fibronectin rescues aberrant phenotype of endothelial cells lacking either CCM1, CCM2 or CCM3	FASEB JOURNAL			English	Article						cerebral cavernous malformations; CRISPR; Cas9 genome editing; extracellular matrix	CEREBRAL CAVERNOUS MALFORMATIONS; VASCULAR MORPHOGENESIS; INTEGRIN ALPHA-5-BETA-1; EXTRACELLULAR-MATRIX; BINDING DOMAIN; RHO KINASE; MUTATIONS; PROTEINS; BARRIER; ANGIOGENESIS	Loss-of-function variants in CCM1/KRIT1, CCM2, and CCM3/PDCD10 are associated with autosomal dominant cerebral cavernous malformations (CCMs). CRISPR/Cas9-mediated CCM3 inactivation in human endothelial cells (ECs) has been shown to induce profound defects in cell-cell interaction as well as actin cytoskeleton organization. We here show that CCM3 inactivation impairs fibronectin expression and consequently leads to reduced fibers in the extracellular matrix. Despite the complexity and high molecular weight of fibronectin fibrils, our in vitro model allowed us to reveal that fibronectin supplementation restored aberrant spheroid formation as well as altered EC morphology, and suppressed actin stress fiber formation. Yet, fibronectin replacement neither enhanced the stability of tube-like structures nor inhibited the survival advantage of CCM3(-/-) ECs. Importantly, CRISPR/Cas9-mediated introduction of biallelic loss-of-function variants into either CCM1 or CCM2 demonstrated that the impaired production of a functional fibronectin matrix is a common feature of CCM1-, CCM2-, and CCM3-deficient ECs.	[Schwefel, Konrad; Spiegler, Stefanie; Dellweg, Patricia K. E.; Much, Christian D.; Felbor, Ute; Rath, Matthias] Univ Med Greifswald, Dept Human Genet, Fleischmannstr 43, D-17475 Greifswald, Germany; [Schwefel, Konrad; Spiegler, Stefanie; Dellweg, Patricia K. E.; Much, Christian D.; Felbor, Ute; Rath, Matthias] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Kirchmaier, Bettina C.] Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, Frankfurt, Germany; [Kirchmaier, Bettina C.] Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci, Frankfurt, Germany; [Pane-Farre, Jan; Riedel, Katharina] Ernst Moritz Arndt Univ Greifswald, Inst Microbiol, Dept Microbial Physiol & Mol Biol, Greifswald, Germany; [Strom, Tim M.] Tech Univ Munich, Inst Human Genet, Munich, Germany; [Strom, Tim M.] Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Pane-Farre, Jan] Philipps Univ Marburg, Ctr Synthet Microbiol SYNMIKRO, Marburg, Germany; [Pane-Farre, Jan] Philipps Univ Marburg, Dept Chem, Marburg, Germany	Greifswald Medical School; Ernst Moritz Arndt Universitat Greifswald; Goethe University Frankfurt; Goethe University Frankfurt; Ernst Moritz Arndt Universitat Greifswald; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Philipps University Marburg; Philipps University Marburg	Rath, M (corresponding author), Univ Med Greifswald, Dept Human Genet, Fleischmannstr 43, D-17475 Greifswald, Germany.	matthias.rath@med.uni-greifswald.de		Rath, Matthias/0000-0002-7834-4650	Deutsche Forschungsgemeinschaft (DFG) [DFG RA2876/2-2]; Research Network Molecular Medicine of the University Medicine Greifswald [FOVB-2019-01]; Gerhard Domagk program of the University Medicine Greifswald	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Research Network Molecular Medicine of the University Medicine Greifswald; Gerhard Domagk program of the University Medicine Greifswald	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: DFG RA2876/2-2; Research Network Molecular Medicine of the University Medicine Greifswald, Grant/Award Number: FOVB-2019-01; Gerhard Domagk program of the University Medicine Greifswald	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; Bauman E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18431-6; Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952; Boon RA, 2010, BLOOD, V115, P2533, DOI 10.1182/blood-2009-06-228726; Borikova AL, 2010, J BIOL CHEM, V285, P11760, DOI 10.1074/jbc.C109.097220; Boulday G, 2011, J EXP MED, V208, P1835, DOI 10.1084/jem.20110571; Brenner KA, 2000, ONCOGENE, V19, P3156, DOI 10.1038/sj.onc.1203626; Burridge K, 2013, J CELL BIOL, V200, P9, DOI 10.1083/jcb.201210090; Carpentier GMM, 2012, 4 IMAGEJ USER DEV C, P198; Castro M, 2019, CIRC RES, V124, P1240, DOI 10.1161/CIRCRESAHA.118.314300; Cigoli MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110438; Cseh B, 2010, J CELL SCI, V123, P3989, DOI 10.1242/jcs.073346; Cuttano R, 2016, EMBO MOL MED, V8, P6, DOI 10.15252/emmm.201505433; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Denier C, 2004, AM J HUM GENET, V74, P326, DOI 10.1086/381718; Detter MR, 2018, CIRC RES, V123, P1143, DOI 10.1161/CIRCRESAHA.118.313970; Draheim KM, 2015, J CELL BIOL, V208, P987, DOI 10.1083/jcb.201407129; Draheim KM, 2014, J CELL SCI, V127, P701, DOI 10.1242/jcs.138388; Faurobert E, 2013, J CELL BIOL, V202, P545, DOI 10.1083/jcb.201303044; Fidalgo M, 2010, J CELL SCI, V123, P1274, DOI 10.1242/jcs.061341; Fischer A, 2013, TRENDS MOL MED, V19, P302, DOI 10.1016/j.molmed.2013.02.004; GILNAGEL A, 1995, EPILEPSY RES, V21, P27, DOI 10.1016/0920-1211(95)00005-U; Glading A, 2007, J CELL BIOL, V179, P247, DOI 10.1083/jcb.200705175; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; GUNEL M, 1995, P NATL ACAD SCI USA, V92, P6620, DOI 10.1073/pnas.92.14.6620; Hocking DC, 1998, J CELL BIOL, V141, P241, DOI 10.1083/jcb.141.1.241; Huveneers S, 2008, J CELL SCI, V121, P2452, DOI 10.1242/jcs.033001; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Jansen KA, 2017, SEMIN CELL DEV BIOL, V71, P75, DOI 10.1016/j.semcdb.2017.07.027; Jilkova ZM, 2014, BIOL OPEN, V3, P1228, DOI 10.1242/bio.201410132; Kim S, 2000, AM J PATHOL, V156, P1345, DOI 10.1016/S0002-9440(10)65005-5; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; Koval M, 2010, AM J RESP CELL MOL, V42, P172, DOI 10.1165/rcmb.2008-0270OC; Laberge-le Couteulx S, 1999, NAT GENET, V23, P189, DOI 10.1038/13815; Lampugnani MG, 2010, J CELL SCI, V123, P1073, DOI 10.1242/jcs.059329; Liquori CL, 2003, AM J HUM GENET, V73, P1459, DOI 10.1086/380314; Liu WY, 2012, CNS NEUROSCI THER, V18, P609, DOI 10.1111/j.1755-5949.2012.00340.x; Liu WZ, 2013, MOL CELL, V49, P719, DOI 10.1016/j.molcel.2012.12.005; Liu YQ, 2004, FASEB J, V18, P457, DOI 10.1096/fj.03-0948com; Lopez-Ramirez MA, 2017, J EXP MED, V214, P3331, DOI 10.1084/jem.20171178; Lorenz L, 2018, NATURE, V562, P128, DOI 10.1038/s41586-018-0522-3; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maddaluno L, 2013, NATURE, V498, P492, DOI 10.1038/nature12207; Malinyerno M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10707-x; Marchuk DA, 2003, HUM MOL GENET, V12, pR97, DOI 10.1093/hmg/ddg103; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; NICOSIA RF, 1993, J CELL PHYSIOL, V154, P654, DOI 10.1002/jcp.1041540325; Otten C, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201809155; Perruzzi CA, 2003, J INVEST DERMATOL, V120, P1100, DOI 10.1046/j.1523-1747.2003.12236.x; Renz M, 2015, DEV CELL, V32, P181, DOI 10.1016/j.devcel.2014.12.016; Sabbagh MF, 2018, ELIFE, V7, DOI 10.7554/eLife.36187; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; Sarelius IH, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.985954; Schneider H, 2011, J NEUROPATH EXP NEUR, V70, P417, DOI 10.1097/NEN.0b013e31821bc40e; Schwefel K, 2019, J CELL MOL MED, V23, P1771, DOI 10.1111/jcmm.14075; Senger DR, 1996, BBA-MOL CELL RES, V1314, P13, DOI 10.1016/S0167-4889(96)00067-5; Shenkar R, 2015, GENET MED, V17, P188, DOI 10.1038/gim.2014.97; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Spiegler S, 2019, MOL GENET GENOM MED, V7, DOI 10.1002/mgg3.755; Spiegler S, 2018, MOL SYNDROMOL, V9, P60, DOI 10.1159/000486292; Stahl S, 2008, HUM MUTAT, V29, P709, DOI 10.1002/humu.20712; Stamatovic SM, 2015, ACTA NEUROPATHOL, V130, P731, DOI 10.1007/s00401-015-1479-z; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Stockton RA, 2010, J EXP MED, V207, P881, DOI 10.1084/jem.20091258; Sun ZQ, 2016, J CELL BIOL, V215, P445, DOI 10.1083/jcb.201609037; Tilling T, 1998, J NEUROCHEM, V71, P1151; Tin A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06620-4; Turner CJ, 2017, ANGIOGENESIS, V20, P519, DOI 10.1007/s10456-017-9563-8; Voss K, 2007, NEUROGENETICS, V8, P249, DOI 10.1007/s10048-007-0098-9; Weber GF, 2011, J CELL SCI, V124, P1183, DOI 10.1242/jcs.064618; Wei S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020675; Whelan MC, 2003, J BIOL CHEM, V278, P327, DOI 10.1074/jbc.M207554200; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Whitehead KJ, 2004, DEVELOPMENT, V131, P1437, DOI 10.1242/dev.01036; Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670; Wu MH, 2005, J PHYSIOL-LONDON, V569, P359, DOI 10.1113/jphysiol.2005.096537; Yoruk B, 2012, DEV BIOL, V362, P121, DOI 10.1016/j.ydbio.2011.12.006; Zhou HJ, 2016, NAT MED, V22, P1033, DOI 10.1038/nm.4169; Zhou ZN, 2016, NATURE, V532, P122, DOI 10.1038/nature17178; Zhou ZN, 2015, DEV CELL, V32, P168, DOI 10.1016/j.devcel.2014.12.009	81	4	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9018	9033		10.1096/fj.201902888R	http://dx.doi.org/10.1096/fj.201902888R		JUN 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32515053	hybrid			2022-12-26	WOS:000539691200001
J	Yang, YH; Lin, ZW; Cheng, JW; Ding, S; Mao, WW; Shi, S; Liang, BR; Jiang, LS				Yang, Yuehua; Lin, Zunwen; Cheng, Jiangwei; Ding, Sheng; Mao, Wei-wei; Shi, Sheng; Liang, Biru; Jiang, Leisheng			The roles of autophagy in osteogenic differentiation in rat ligamentum fibroblasts: Evidence and possible implications	FASEB JOURNAL			English	Article						autophagy; ligamentum fibroblasts; OPLL; osteogenic differentiation	POSTERIOR LONGITUDINAL LIGAMENT; MESENCHYMAL STEM-CELLS; OSSIFICATION; MINERALIZATION; SUSCEPTIBILITY; ASSOCIATION; OSTEOBLASTS; DETERMINES; EXPRESSION; APOPTOSIS	Autophagy, a macromolecular degradation process, plays a pivotal role in cell differentiation and survival. This study was designed to investigate the role of autophagy in the osteogenic differentiation in ligamentum fibroblasts. Rat ligamentum fibroblasts were isolated from the posterior longitudinal ligament and cultured in osteogenic induction medium. Ultrastructural analysis, immunofluorescence assay, western blot, flow cytometry, and lysosomal activity assessment were performed to determine the presence and activity of autophagy in the cells. The mineralization deposit and osteogenic gene expressions were evaluated to classify the association between autophagy activity and the bone formation ability of the spinal ligament cells. The influence of leptin and endothelin-1 on the autophagy activity was also evaluated. Our study demonstrated that autophagy was present and increased in the ligament cells under osteogenic induction. Inhibition of autophagy with either pharmacologic inhibitors (Bafilomycin A and 3-methyladenine) or Belcin1 (BECN1) knocking down weakened the mineralization capacity, decreased the gene expressions of COL1A1, osteocalcin (Ocn), and runt-related transcription factor 2 (Runx2) in the ligamentum fibroblasts and increased cell apoptosis. The Adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK)-BECN1 autophagic pathway was activated in the osteogenic differentiating ligamentum fibroblasts. Leptin significantly increased the autophagy activity in the ligament cells under osteogenic induction. These discoveries might improve our understanding for the mechanism of ossification of the posterior longitudinal ligament (OPLL) and provide new approaches on the prevention and treatment of this not uncommon disease.	[Yang, Yuehua; Jiang, Leisheng] Shanghai Jiao Tong Univ, Xinhua Hosp, Spine Ctr, Sch Med, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China; [Yang, Yuehua; Liang, Biru] Southern Med Univ, Affiliated Hosp 5, Dept Orthopaed, Guangzhou, Guangdong, Peoples R China; [Lin, Zunwen; Cheng, Jiangwei] Nanchang Univ, Dept Orthoped Surg, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China; [Ding, Sheng] Shanghai Jiao Tong Univ, Dept Stomatol, Sch Med, Xinhua Hosp, Shanghai, Peoples R China; [Mao, Wei-wei] Shanghai Jiao Tong Univ, Dept Pediat Neurosurg, Sch Med, Xinhua Hosp, Shanghai, Peoples R China; [Shi, Sheng] Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Orthoped, Shanghai, Peoples R China	Shanghai Jiao Tong University; Southern Medical University - China; Nanchang University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Tongji University	Yang, YH; Jiang, LS (corresponding author), Shanghai Jiao Tong Univ, Xinhua Hosp, Spine Ctr, Sch Med, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China.	yuesjtu@outlook.com; jiangleisheng@xinhuamed.com.cn	yang, yuehua/AHE-1426-2022; Shi, Sheng/AAF-8784-2020	yang, yuehua/0000-0001-7632-9871	National Natural Science Foundation of China [81501196, 81572092]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 81501196 and 81572092	Asari T, 2012, BIOCHEM BIOPH RES CO, V417, P1193, DOI 10.1016/j.bbrc.2011.12.106; Boya P, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.146506; Chen HH, 2018, MOL MED REP, V17, P3267, DOI 10.3892/mmr.2017.8242; Chen S, 2018, EUR SPINE J, V27, P1757, DOI 10.1007/s00586-018-5663-4; Chen XH, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/9131397; Chen YT, 2011, SPINE, V36, pE1193, DOI 10.1097/BRS.0b013e3182053f58; Cheng M, 2018, INT J CLIN EXP PATHO, V11, P1610; Di YQ, 2021, AUTOPHAGY, V17, P1170, DOI 10.1080/15548627.2020.1752497; Feng B, 2018, J ORTHOP SURG RES, V13, DOI 10.1186/s13018-018-0864-4; Feng L, 2020, INT J MOL MED, V45, P1464, DOI 10.3892/ijmm.2020.4534; Guan JL, 2013, AUTOPHAGY, V9, P830, DOI 10.4161/auto.24132; Han IB, 2013, GENET MOL RES, V12, P4807, DOI 10.4238/2013.February.28.26; Harris L, 2018, SPINE, V43, pE545, DOI 10.1097/BRS.0000000000002401; Ho TT, 2017, NATURE, V543, P205, DOI 10.1038/nature21388; Ikeda Y, 2011, EUR SPINE J, V20, P1450, DOI 10.1007/s00586-011-1688-7; Iwasawa T, 2006, CALCIFIED TISSUE INT, V79, P422, DOI 10.1007/s00223-006-0147-7; Jaber FA, 2019, J CELL PHYSIOL, V234, P12105, DOI 10.1002/jcp.27071; Jia JJ, 2011, FASEB J, V25, P3366, DOI 10.1096/fj.11-182519; Jung KH, 2012, HEPATOLOGY, V56, P644, DOI 10.1002/hep.25699; Kim KH, 2014, GENET MOL RES, V13, P2240, DOI 10.4238/2014.March.31.4; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kristjansson B, 2016, SPINE, V41, pE1, DOI 10.1097/BRS.0000000000001178; Lian WS, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0970-6; Nam DC, 2019, BIOMOL THER, V27, P342, DOI 10.4062/biomolther.2019.043; Nelson ER, 2012, J BURN CARE RES, V33, P463, DOI 10.1097/BCR.0b013e31825af547; Nollet M, 2014, AUTOPHAGY, V10, P1965, DOI 10.4161/auto.36182; Pantovic A, 2013, BONE, V52, P524, DOI 10.1016/j.bone.2012.10.024; Settembre C, 2008, GENE DEV, V22, P2645, DOI 10.1101/gad.1711308; Song YJ, 2013, CANCER LETT, V339, P70, DOI 10.1016/j.canlet.2013.07.021; Sotthibundhu A, 2018, CELL TISSUE RES, V374, P205, DOI 10.1007/s00441-018-2829-7; Steppan CM, 2000, REGUL PEPTIDES, V92, P73, DOI 10.1016/S0167-0115(00)00152-X; Sugita D, 2013, SPINE, V38, pE1388, DOI 10.1097/BRS.0b013e3182a40489; Suvorova II, 2019, CELL DEATH DISCOV, V5, DOI 10.1038/s41420-019-0137-y; Thomas N, 2019, CALCIFIED TISSUE INT, V105, P518, DOI 10.1007/s00223-019-00593-2; Vidoni C, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0414-7; WHITE MF, 1994, J BIOL CHEM, V269, P1; Whitehouse CA, 2010, P NATL ACAD SCI USA, V107, P12913, DOI 10.1073/pnas.0913058107; Wu WX, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107547; Wu XT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10533; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Yan L, 2017, AGING DIS, V8, P570, DOI 10.14336/AD.2017.0201; Yang YH, 2013, APOPTOSIS, V18, P1363, DOI 10.1007/s10495-013-0867-x; Yang YH, 2014, BIOCHEM BIOPH RES CO, V451, P86, DOI 10.1016/j.bbrc.2014.07.069; Zahm AM, 2011, CELLS TISSUES ORGANS, V194, P274, DOI 10.1159/000324647	44	5	5	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					8876	8886		10.1096/fj.201903216RR	http://dx.doi.org/10.1096/fj.201903216RR		JUN 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32510740	Bronze			2022-12-26	WOS:000539575300001
J	Cartland, SP; Lin, RCY; Genner, S; Patil, MS; Martinez, GJ; Barraclough, JY; Gloss, B; Misra, A; Patel, S; Kavurma, MM				Cartland, Sian P.; Lin, Ruby C. Y.; Genner, Scott; Patil, Manisha S.; Martinez, Gonzalo J.; Barraclough, Jennifer Y.; Gloss, Brian; Misra, Ashish; Patel, Sanjay; Kavurma, Mary M.			Vascular transcriptome landscape of Trail(-/-) mice: Implications and therapeutic strategies for diabetic vascular disease	FASEB JOURNAL			English	Article						differentially expressed genes; transcriptome; TRAIL; vascular	APOPTOSIS-INDUCING-LIGAND; SMOOTH-MUSCLE-CELLS; HIGH-FAT DIET; NF-KAPPA-B; SP1 PHOSPHORYLATION; VSMC PROLIFERATION; INSULIN-RESISTANCE; DOPAMINE-RECEPTOR; P200 FAMILY; EXPRESSION	Circulating plasma TRAIL levels are suppressed in patients with cardiovascular and diabetic diseases. To identify novel targets in vascular metabolic diseases, genome-wide transcriptome of aortic tissue from Trail(-/-) versus Trail(+/+) mice were interrogated. We found 861 genes differentially expressed with TRAIL deletion. Gene enrichment analyses showed many of these genes were related to inflammation, cell-to-cell cytoskeletal interactions, and transcriptional modulation. We identified vascular protective and pathological gene clusters, with Ifi205 as the most significantly reduced vascular protective gene, whereas Glut1, the most significantly increased pathological gene with TRAIL deletion. We hypothesized that therapeutic targets could be devised from such integrated analysis and validated our findings from vascular tissues of diabetic mice. From the differentially expressed gene targets, enriched transcription factor (TF) and microRNA binding motifs were identified. The top two TFs were Elk1 and Sp1, with enrichment to eight gene targets common to both. miR-520d-3p and miR-377-3p were the top enriched microRNAs with TRAIL deletion; with four overlapping genes enriched for both microRNAs. Our findings offer an alternate in silico approach for therapeutic target identification and present a deeper understanding of gene signatures and pathways altered with TRAIL suppression in the vasculature.	[Cartland, Sian P.; Genner, Scott; Patil, Manisha S.; Barraclough, Jennifer Y.; Misra, Ashish; Patel, Sanjay; Kavurma, Mary M.] Heart Res Inst, Sydney, NSW, Australia; [Cartland, Sian P.; Lin, Ruby C. Y.; Patil, Manisha S.; Martinez, Gonzalo J.; Barraclough, Jennifer Y.; Misra, Ashish; Patel, Sanjay; Kavurma, Mary M.] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia; [Lin, Ruby C. Y.] Univ New South Wales, Sch Med Sci, Sydney, NSW, Australia; [Lin, Ruby C. Y.; Martinez, Gonzalo J.; Gloss, Brian] Westmead Inst Med Res, Sydney, NSW, Australia; [Martinez, Gonzalo J.] Pontificia Univ Catolica Chile, Div Enfermedades Cardiovasc, Santiago, Chile; [Martinez, Gonzalo J.] Millennium Nucleus Cardiovasc Magnet Resonance, Santiago, Chile; [Barraclough, Jennifer Y.; Patel, Sanjay] Royal Prince Alfred Hosp, Dept Cardiol, Sydney, NSW, Australia	University of Sydney; Heart Research Institute; University of Sydney; University of New South Wales Sydney; University of Sydney; Westmead Institute for Medical Research; Pontificia Universidad Catolica de Chile; University of Sydney	Kavurma, MM (corresponding author), Univ Sydney, Heart Res Inst, 7 Eliza St, Newtown, NSW 2042, Australia.; Lin, RCY (corresponding author), Westmead Inst Med Res, 176 Hawkesbury Rd, Westmead, NSW 2145, Australia.	ruby.lin@sydney.edu.au; mary.kavurma@hri.org.au	Lin, Ruby CY/A-1636-2009	Lin, Ruby CY/0000-0003-4163-511X; Barraclough, jennifer/0000-0002-5093-9900; Gloss, Brian/0000-0001-7695-4394; Cartland, Sian/0000-0003-1723-2679				Adhikari N, 2011, ARTERIOSCL THROM VAS, V31, P86, DOI 10.1161/ATVBAHA.110.215004; Amenta F, 2000, CLIN EXP HYPERTENS, V22, P277, DOI 10.1081/CEH-100100077; Arik HO, 2013, MED SCI MONITOR, V19, P712, DOI [10.12659/MSM.889514, 10.12659/MSM.889304]; Asefa B, 2004, BLOOD CELL MOL DIS, V32, P155, DOI 10.1016/j.bcmd.2003.10.002; Azahri NSM, 2012, J CELL BIOCHEM, V113, P2597, DOI 10.1002/jcb.24135; Bernardo BC, 2016, J PHYSIOL-LONDON, V594, P5959, DOI 10.1113/JP272512; Bernardo BC, 2012, P NATL ACAD SCI USA, V109, P17615, DOI 10.1073/pnas.1206432109; Bisgin A, 2012, DIABETES RES CLIN PR, V96, pE84, DOI 10.1016/j.diabres.2012.02.028; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Cannavo A, 2016, J PHARMACOL EXP THER, V356, P503, DOI 10.1124/jpet.115.228411; Cartland SP, 2019, ISCIENCE, V12, P41, DOI 10.1016/j.isci.2018.12.037; Cartland SP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01721-4; Cartland SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092952; Castells MC, 2001, NAT IMMUNOL, V2, P436, DOI 10.1038/87749; Cat AND, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21087-5; Chalmers JA, 2008, AM J PHYSIOL-REG I, V295, pR1529, DOI 10.1152/ajpregu.90572.2008; Chan J, 2010, CIRC RES, V106, P1061, DOI 10.1161/CIRCRESAHA.109.206029; Chen YB, 2019, ARTERIOSCL THROM VAS, V39, P1911, DOI 10.1161/ATVBAHA.119.312192; Chmielewski S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113318; Cholan PM, 2018, FREE RADICAL BIO MED, V126, P341, DOI 10.1016/j.freeradbiomed.2018.08.031; Cholan PM, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6030056; Di Bartolo BA, 2011, DIABETOLOGIA, V54, P3157, DOI 10.1007/s00125-011-2308-0; Di Bartolo BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074211; Di Bartolo BA, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002527; Ehrlich S, 2003, CYTOKINE, V24, P244, DOI 10.1016/S1043-4666(03)00094-2; Falschlehner C, 2009, IMMUNOLOGY, V127, P145, DOI 10.1111/j.1365-2567.2009.03058.x; Fanger NA, 1999, J EXP MED, V190, P1155, DOI 10.1084/jem.190.8.1155; Freemerman AJ, 2014, J BIOL CHEM, V289, P7884, DOI 10.1074/jbc.M113.522037; Gaither K, 1999, J CLIN ENDOCR METAB, V84, P695, DOI 10.1210/jc.84.2.695; Galasso G, 2013, CIRC RES, V112, P1026, DOI 10.1161/CIRCRESAHA.111.300152; Gao F, 2010, AM J PHYSIOL-HEART C, V298, pH921, DOI 10.1152/ajpheart.00135.2009; Gariglio M, 2011, J INTERF CYTOK RES, V31, P159, DOI 10.1089/jir.2010.0106; Ghosh S, 2017, J IMMUNOL, V199, P3249, DOI 10.4049/jimmunol.1700823; Giudicelli W, 2005, NUCLEIC ACIDS RES, V33, pD256, DOI 10.1093/nar/gki010; Harith HH, 2016, J DIABETES, V8, P568, DOI 10.1111/1753-0407.12339; Harith HH, 2013, TRENDS ENDOCRIN MET, V24, P578, DOI 10.1016/j.tem.2013.07.001; Hoffmann O, 2007, J CLIN INVEST, V117, P2004, DOI 10.1172/JCI30356; Hsu PH, 2016, FEBS OPEN BIO, V6, P349, DOI 10.1002/2211-5463.12045; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang KN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089190; Hyvarinen K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-709; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; Jones RD, 2013, DRUG METAB DISPOS, V41, P40, DOI 10.1124/dmd.112.048397; KASAHARA M, 1977, J BIOL CHEM, V252, P7384; Kavurma MM, 2008, BIOCHEM PHARMACOL, V75, P1441, DOI 10.1016/j.bcp.2007.10.020; Kavurma MM, 2008, J BIOL CHEM, V283, P7754, DOI 10.1074/jbc.M706927200; Kayagaki N, 1999, J IMMUNOL, V163, P1906; Kreth S, 2018, ANESTH ANALG, V126, P670, DOI 10.1213/ANE.0000000000002444; Lamhamedi-Cherradi SE, 2003, DIABETES, V52, P2274, DOI 10.2337/diabetes.52.9.2274; Leon-Villapalos J, 2005, BRIT J PLAST SURG, V58, P348, DOI 10.1016/j.bjps.2004.05.029; LEWIS JL, 1994, ANAT REC, V239, P55, DOI 10.1002/ar.1092390107; Li H, 2016, TRANSPORT RES REC, P92, DOI 10.3141/2575-10; Li R, 2014, 2014 2ND INTERNATIONAL CONFERENCE ON SYSTEMS AND INFORMATICS (ICSAI), P520, DOI 10.1109/ICSAI.2014.7009342; Li RF, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0209-0; Li Y, 2015, CLIN EXP HYPERTENS, V37, P288, DOI 10.3109/10641963.2014.960971; Lin RCY, 2010, ARTERIOSCL THROM VAS, V30, P724, DOI 10.1161/ATVBAHA.109.201988; Liu FH, 2014, MOL CELL ENDOCRINOL, V392, P80, DOI 10.1016/j.mce.2014.05.009; Liu WY, 2018, J CELL BIOCHEM, V119, P2124, DOI 10.1002/jcb.26374; Lu LL, 2013, J CELL PHYSIOL, V228, P251, DOI 10.1002/jcp.24133; Mann GE, 2003, PHYSIOL REV, V83, P183, DOI 10.1152/physrev.00022.2002; Mantovani A, 2016, CELL METAB, V24, P653, DOI 10.1016/j.cmet.2016.10.016; Martinez GJ, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002128; Massberg D, 2018, PHYSIOL REV, V98, P1739, DOI 10.1152/physrev.00013.2017; Moon DO, 2012, TOXICOL APPL PHARM, V259, P87, DOI 10.1016/j.taap.2011.12.010; Ng SF, 2014, FASEB J, V28, P1830, DOI 10.1096/fj.13-244046; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Nilsson M, 2007, NUCLEIC ACIDS RES, V35, P4858, DOI 10.1093/nar/gkm492; Nyman E, 2014, J BIOL CHEM, V289, P33215, DOI 10.1074/jbc.M114.608927; Oh YT, 2012, J BIOL CHEM, V287, P257, DOI 10.1074/jbc.M111.304006; Ooi JYY, 2017, RNA BIOL, V14, P500, DOI 10.1080/15476286.2016.1181251; Pati P, 2016, HYPERTENSION, V67, P661, DOI 10.1161/HYPERTENSIONAHA.115.06194; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; Richards J, 2014, LIFE SCI, V118, P255, DOI 10.1016/j.lfs.2014.03.028; Rothman A, 2017, PULM CIRC, V7, P455, DOI 10.1177/2045893217704206; Sarrazy V, 2016, CIRC RES, V118, P1062, DOI 10.1161/CIRCRESAHA.115.307599; Schoppet M, 2006, ATHEROSCLEROSIS, V184, P446, DOI 10.1016/j.atherosclerosis.2005.10.028; Secchiero P, 2004, CELL MOL LIFE SCI, V61, P1965, DOI 10.1007/s00018-004-4197-6; Secchiero P, 2004, NEOPLASIA, V6, P364, DOI 10.1593/neo.03421; Secchiero P, 2006, CIRCULATION, V114, P1522, DOI 10.1161/CIRCULATIONAHA.106.643841; Shantikumar S, 2012, CARDIOVASC RES, V93, P583, DOI 10.1093/cvr/cvr300; Song KM, 2000, J EXP MED, V191, P1095, DOI 10.1084/jem.191.7.1095; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Tornese G, 2014, ACTA DIABETOL, V51, P239, DOI 10.1007/s00592-013-0507-5; Tsokos GC, 2003, J CLIN INVEST, V112, P1315, DOI 10.1172/JCI200320297; Vogel H, 2012, HUM MOL GENET, V21, P3845, DOI 10.1093/hmg/dds213; Volpato S, 2011, ATHEROSCLEROSIS, V215, P452, DOI 10.1016/j.atherosclerosis.2010.11.004; Wang YL, 2010, AM J PHYSIOL-RENAL, V299, pF99, DOI 10.1152/ajprenal.00466.2009; Wu KK, 2005, ATHEROSCLEROSIS, V181, P251, DOI 10.1016/j.atherosclerosis.2005.01.029; Yang CH, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0530-7; Yang JJ, 2016, INT J CLIN EXP MED, V9, P5574; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zauli G, 2010, DIABETES, V59, P1261, DOI 10.2337/db09-1771; Zhou SS, 2018, ACTA PHARMACOL SIN, V39, P1073, DOI 10.1038/aps.2018.30	97	4	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9547	9562		10.1096/fj.201902785R	http://dx.doi.org/10.1096/fj.201902785R		JUN 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32501591	Bronze			2022-12-26	WOS:000539541400001
J	Martinez-Sanchez, M; Moctezuma-Davila, M; Hernandez-Monge, J; Rangel-Charqueno, M; Olivares-Illana, V				Martinez-Sanchez, Mayra; Moctezuma-Davila, Mariana; Hernandez-Monge, Jesus; Rangel-Charqueno, Martha; Olivares-Illana, Vanesa			Analysis of the p53 pathway in peripheral blood of retinoblastoma patients; potential biomarkers	PLOS ONE			English	Article							CANCER; GENES; MDM2; MUTATION; KNOCKOUT; MODEL	Loss of retinoblastoma (RB) function in the cone cells during retina development is necessary but not sufficient for retinoblastoma development. It has been reported that in the absence of RB activity, a retinoma is generated, and the onset of retina cancer occurs until the p53 pathway is altered. Unlike other types of cancer, in retinoblastoma the p53 tumour suppressor is mostly wild type, although its two primary regulators, MDMX and MDM2, are commonly dysregulated. A mutated RB form is inherited in around 35% of the cases, but normally two, somatic mutations are needed to alter the RB function. Here we investigated the mRNA levels of RB, p53, MDMX and MDM2 in peripheral blood samples of retinoblastoma patients to monitor the pathway status of p53 in somatic cells. We sought to investigate the involvement of these genes in the development of retina cancer, with the aim of identifying biomarkers for early diagnosis of this disease.	[Martinez-Sanchez, Mayra; Moctezuma-Davila, Mariana; Olivares-Illana, Vanesa] Univ Autonoma San Luis Potosi, Inst Fis, Lab Interacc Biomol & Canc, San Luis Potosi, San Luis Potosi, Mexico; [Hernandez-Monge, Jesus] Univ Autonoma San Luis Potosi, Lab Interacc Biomol & Canc, Catedra CONACyT, Inst Fis, San Luis Potosi, San Luis Potosi, Mexico; [Rangel-Charqueno, Martha] Univ Autonoma San Luis Potosi, Hosp Cent Ignacio Morones Prieto, Dept Oftalmol, Div Cirugia, San Luis Potosi, San Luis Potosi, Mexico	Universidad Autonoma de San Luis Potosi; Universidad Autonoma de San Luis Potosi; Hospital Central Dr. Ignacio Morones Prieto; Universidad Autonoma de San Luis Potosi	Olivares-Illana, V (corresponding author), Univ Autonoma San Luis Potosi, Inst Fis, Lab Interacc Biomol & Canc, San Luis Potosi, San Luis Potosi, Mexico.	vanesa@ifisica.uaslp.mx	Olivares-Illana, Vanesa/AAF-9710-2021; Martinez Sanchez, Mayra/GPS-4462-2022	Moctezuma Davila, Mariana/0000-0002-1931-307X; Olivares-Illana, Vanesa/0000-0001-6949-5986	Conacyt [CB-256637]; L'oreal-UNESCO-AMC	Conacyt(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); L'oreal-UNESCO-AMC(L'Oreal Group)	This work was supported by Conacyt CB-256637. This work, including the efforts of Vanesa Olivares-Illana, was funded by L'oreal-UNESCO-AMC. JH-M Catedras CONACyT program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts I, 2016, ARCH PEDIATRIE, V23, P112, DOI 10.1016/j.arcped.2015.09.025; Amozorrutia-Alegria V, 2002, PAEDIATR PERINAT EP, V16, P370, DOI 10.1046/j.1365-3016.2002.t01-1-00442.x; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Dyer MA, 2005, PLOS MED, V2, P971, DOI 10.1371/journal.pmed.0020332; Gaikwad N, 2015, ASIA-PAC J CLIN ONCO, V11, P299, DOI 10.1111/ajco.12401; Golabchi K, 2018, J CELL PHYSIOL, V233, P3016, DOI 10.1002/jcp.26070; Guo J, 2019, LUNG CANCER, V135, P47, DOI 10.1016/j.lungcan.2019.07.008; Guo K, 2015, MOL MED REP, V12, P7673, DOI 10.3892/mmr.2015.4350; Hernandez-Monge Jesus, 2016, Genes Cancer, V7, P278, DOI 10.18632/genesandcancer.120; Kato MV, 1996, CANCER LETT, V106, P75, DOI 10.1016/0304-3835(96)04305-4; Kivela T, 2009, BRIT J OPHTHALMOL, V93, P1129, DOI 10.1136/bjo.2008.150292; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Laurie NA, 2007, CURR CANCER DRUG TAR, V7, P689, DOI 10.2174/156800907782418266; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; Lin SCJ, 1996, SEMIN CANCER BIOL, V7, P279, DOI 10.1006/scbi.1996.0036; Luo X, 2015, TURK J MED SCI, V45, P1256, DOI 10.3906/sag-1402-144; McEvoy J, 2011, CANCER CELL, V20, P260, DOI 10.1016/j.ccr.2011.07.005; Medina-Medina I, 2016, MOL CELL BIOL; Medina-Medina I, 2018, PROTEIN SCI, V27, P976, DOI 10.1002/pro.3405; MORGENBESSER SD, 1994, NATURE, V371, P72, DOI 10.1038/371072a0; Perez-Cuevas R, 2013, PEDIATR BLOOD CANCER, V60, P196, DOI 10.1002/pbc.24265; Qi DL, 2017, ONCOGENE, V36, P1760, DOI 10.1038/onc.2016.350; Steliarova-Foucher E, 2017, LANCET ONCOL, V18, P719, DOI 10.1016/S1470-2045(17)30186-9; Sun J, 2020, INT J OPHTHALMOL-CHI, V13, P325, DOI 10.18240/ijo.2020.02.18; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Xie F., 2012, PLANT MOL BIOL; Xu XLL, 2009, CELL, V137, P1018, DOI 10.1016/j.cell.2009.03.051; Zhang JK, 2004, CELL CYCLE, V3, P952	28	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0234337	10.1371/journal.pone.0234337	http://dx.doi.org/10.1371/journal.pone.0234337			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502182	gold, Green Published			2022-12-26	WOS:000542035700032
J	Smit, PW; Cornelissen, AR; Bruisten, SM				Smit, Pieter Willem; Cornelissen, Akke Rosanne; Bruisten, Sylvia Maria			Reduction of non-typeable results using a plasmid oriented Lymfogranuloma venereum PCR for typing ofChlamydia trachomatispositive samples	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS; LYMPHOGRANULOMA-VENEREUM; COPY NUMBER; POPULATION; DYNAMICS; STRAINS; MEN; SEX	Objectives Typing ofChlamydia trachomatis(CT) is traditionally performed by characterising theompAgene, resulting in more than a dozen different genovars, A to L. Type L is associated with Lymphogranuloma venereum (LGV) and commonly screened for using PCR, targeting the chromosomalpmpHgene. We aimed to develop and validate a new CT/LGV plasmid-based typing assay targeting thepgp3gene, to increase sensitivity and thus reduce the number of non-typeable results. Methods The newpgp3PCR assay using LNA probes to detect point mutations was analytically and prospectively validated in a routine diagnostic laboratory setting. For the analytical tests, quantified nucleotide constructs (gBlocks) were used to perform limit of detection analyses. Quality control panel samples from 2018 and 2019 for CT were also tested. For the clinical study patient samples which were collected in two months in 2018 were tested simultaneously using thepmpHPCR and thepgp3PCR. Results Analytically, the assay proved to be 100% specific relative to the previously used LGV typing assay targeting the single copypmpHgene but it was much more sensitive to detect non-LGV CT. In the quality control panel 2 nonLGV samples and 7 LGV samples were solely positive with thepgp3PCR and not with thepmpHPCR. None of the samples from analytical specificity panels were positive, indicating 100% specificity. In a prospective panel of 152 clinical samples, 142 (93%) were successfully typed with thepgp3PCR compared to 78% with thepmpHPCR. Thepgp3PCR was fully concordant with thepmpHPCR to identify all LGV subtypes and detected an increased number of clinical samples of non-LGV subtype. Conclusion We developed and validated a sensitive and specific plasmid-based typing assay to discriminate LGV from non-LGV CT subtypes. This is useful in a clinical setting to quickly determine the optimal treatment forChlamydia trachomatisinfections.	[Smit, Pieter Willem; Cornelissen, Akke Rosanne; Bruisten, Sylvia Maria] Publ Hlth Lab GGD Amsterdam, Dept Infect Dis, Amsterdam, Netherlands; [Smit, Pieter Willem] Maasstad Ziekenhuis, Med Microbiol Lab, Rotterdam, Netherlands; [Bruisten, Sylvia Maria] Univ Amsterdam, Amsterdam UMC, Amsterdam Infect & Immun Inst AI&II, Amsterdam, Netherlands	Maasstad Hospital; University of Amsterdam	Bruisten, SM (corresponding author), Publ Hlth Lab GGD Amsterdam, Dept Infect Dis, Amsterdam, Netherlands.; Bruisten, SM (corresponding author), Univ Amsterdam, Amsterdam UMC, Amsterdam Infect & Immun Inst AI&II, Amsterdam, Netherlands.	sbruisten@ggd.amsterdam.nl						[Anonymous], 2018, LANCET ONCOL, V19, pe581; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2018, PLOS ONE, V13, P1, DOI DOI 10.3171/2018.1.JNS172645; [Anonymous], 2006, J HLTH COMMUN, V11, pS1; [Anonymous], 2016, CANC DISCOV; Borges V, 2019, MICROB GENOMICS, V5, DOI 10.1099/mgen.0.000313; Chernesky M, 2006, J CLIN MICROBIOL, V44, P1084, DOI 10.1128/JCM.44.3.1084-1086.2006; de Vries HJC, 2019, J EUR ACAD DERMATOL, V33, P1821, DOI 10.1111/jdv.15729; de Vries HJC, 2015, CURR OPIN INFECT DIS, V28, P61, DOI 10.1097/QCO.0000000000000129; Dean D, 2009, EMERG INFECT DIS, V15, P1385, DOI 10.3201/eid1509.090272; Ferreira R, 2013, MICROBIOL RES, V168, P333, DOI 10.1016/j.micres.2013.02.001; Geisler WM, 2008, SEX TRANSM DIS, V35, P856, DOI 10.1097/OLQ.0b013e3181788313; Guangming Zhong, 2016, PHYSIOL BEHAV, V176, P139; Hadfield J, 2017, GENOME RES, V27, P1220, DOI 10.1101/gr.212647.116; Herrmann B, 2008, EMERG INFECT DIS, V14, P1462, DOI 10.3201/eid1409.080153; Holt DC, 2019, METHODS MOL BIOL; Hou SP, 2019, MICROBES INFECT, V21, P50, DOI 10.1016/j.micinf.2018.06.003; Joseph SJ, 2012, MOL BIOL EVOL, V29, P3933, DOI 10.1093/molbev/mss198; Lancet Global Health, 2019, LANCET GLOBAL HLTH, V7, pe1; Lanjouw E, 2016, INT J STD AIDS, V27, P333, DOI 10.1177/0956462415618837; Last AR, 2014, J CLIN MICROBIOL, V52, P324, DOI 10.1128/JCM.02618-13; Lehr S, 2018, MICROBES INFECT, V20, P284, DOI 10.1016/j.micinf.2018.02.007; Lopez-Pintor J, 2019, ECCMID; Morre SA, 2005, EMERG INFECT DIS, V11, P1311, DOI 10.3201/eid1108.050535; Nigri F, 2016, SURG NEUROL INT S31, V7, pS785; Peipert JF, 2003, NEW ENGL J MED, V349, P2424, DOI 10.1056/NEJMcp030542; Pickett MA, 2005, MICROBIOL-SGM, V151, P893, DOI 10.1099/mic.0.27625-0; Quint KD, 2010, MOL CELL PROBE, V24, P266, DOI 10.1016/j.mcp.2010.04.007; Rantakokko-Jalava K, 2019, EURO SURVEILL, V24; Song LH, 2013, INFECT IMMUN, V81, P636, DOI 10.1128/IAI.01305-12; Van der Bij AK, 2006, CLIN INFECT DIS, V42, P186, DOI 10.1086/498904; van Houdt R, 2007, J MED VIROL, V79, P895, DOI 10.1002/jmv.20820; Versteeg B, 2015, SEX TRANSM INFECT, V91, P415, DOI 10.1136/sextrans-2014-051790; WHO, 2019, WHO REP GLOB SEX TRA	34	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0233990	10.1371/journal.pone.0233990	http://dx.doi.org/10.1371/journal.pone.0233990			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497069	Green Published, gold			2022-12-26	WOS:000542035200022
J	Adcock, SJJ; Tucker, CB				Adcock, Sarah J. J.; Tucker, Cassandra B.			The effect of early burn injury on sensitivity to future painful stimuli in dairy heifers	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; AUTONOMIC NERVOUS-SYSTEM; INFRARED THERMOGRAPHY; IMMUNE CHALLENGE; TAIL DOCKING; EARLY-LIFE; STRESS; LONG; CALVES; MODEL	Animals that experience painful procedures as neonates are more sensitive to pain later in life. We evaluated whether disbudding with a heated iron at 3 (n = 12), 35 (n = 9), or 56 (n = 20) d of age affected heifers' pain responses to vaccine injections at 11 mo of age. Heifers responded to the injection procedure with struggling and changes in eye temperature and heart rate variability compared to a sham procedure the day before, and still had a heightened response 6 d later, regardless of disbudding age. However, some heart rate variability indices suggested increased sympathetic dominance in heifers disbudded at 35 d, compared to the other 2 age groups, independent of the injection procedure. We also found that heifers disbudded at 3 or 35 d had a higher mean heart rate after the injection procedure compared to those disbudded at 56 d. We conclude that: (1) heifers find injections aversive; and (2) there is some evidence that disbudding age influences autonomic nervous system activity later in life.	[Adcock, Sarah J. J.; Tucker, Cassandra B.] Univ Calif Davis, Dept Anim Sci, Ctr Anim Welf, Davis, CA 95616 USA; [Adcock, Sarah J. J.] Univ Calif Davis, Anim Behav Grad Grp, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Tucker, CB (corresponding author), Univ Calif Davis, Dept Anim Sci, Ctr Anim Welf, Davis, CA 95616 USA.	cbtucker@ucdavis.edu			USDA Multistate Research Project [NC1029]; National Sciences and Engineering Research Council PGS-D	USDA Multistate Research Project; National Sciences and Engineering Research Council PGS-D	This study was supported by USDA Multistate Research Project NC1029 (C.B.T) and a National Sciences and Engineering Research Council PGS-D (S.J.J.A).	Adcock SJJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60260-7; Adcock SJJ, 2018, J DAIRY SCI, V101, P10361, DOI 10.3168/jds.2018-14987; Al-Chaer ED, 2000, GASTROENTEROLOGY, V119, P1276, DOI 10.1053/gast.2000.19576; Alboni Paolo, 2014, J Atr Fibrillation, V7, P1035, DOI 10.4022/jafib.1035; American Association of Bovine Practitioners, 2018, CASTR DEH GUID 2014; American Veterinary Medical Association, 2018, CASTR DEH CATTL 2018; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 2014, HYG MED, V39, P344; [Anonymous], 2014, ALZHEIMERS DEMENT J, V10, pe47; Batchinsky AI, 2007, CRIT CARE MED, V35, P519, DOI 10.1097/01.CCM.0000254065.44990.77; Beggs S, 2015, CAN J PSYCHIAT, V60, P176, DOI 10.1177/070674371506000404; Beggs S, 2012, BRAIN, V135, P404, DOI 10.1093/brain/awr288; Boisse L, 2005, PAIN, V119, P133, DOI 10.1016/j.pain.2005.09.022; Brazeau GA, 1998, J PHARM SCI-US, V87, P667, DOI 10.1021/js970315l; Burke NN, 2017, J NEUROSCI RES, V95, P1257, DOI 10.1002/jnr.23802; Byrd CJ, 2020, ANIMAL, V14, P379, DOI 10.1017/S1751731119001630; Byrd CJ, 2019, NONLINEAR ANAL HEART; Casoni D, 2019, PHYSIOL BEHAV, V199, P47, DOI 10.1016/j.physbeh.2018.11.010; Chapman CR, 2008, J PAIN, V9, P122, DOI 10.1016/j.jpain.2007.09.006; Chase CCL, 2008, VET CLIN N AM-FOOD A, V24, P87, DOI 10.1016/j.cvfa.2007.11.001; Ede T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27669-7; Evans S, 2013, J PAIN RES, V6, P449, DOI 10.2147/JPR.S43849; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Friard O, 2016, METHODS ECOL EVOL, V7, P1325, DOI 10.1111/2041-210X.12584; Gilchrist PT, 2015, BIOL PSYCHOL, V104, P28, DOI 10.1016/j.biopsycho.2014.11.006; Gilchrist PT, 2012, PSYCHOPHYSIOLOGY, V49, P815, DOI 10.1111/j.1469-8986.2012.01359.x; Goffaux P, 2008, EUR J PAIN, V12, P945, DOI 10.1016/j.ejpain.2008.01.003; HALLIDAY R, 1957, PROC R SOC SER B-BIO, V146, P431, DOI 10.1098/rspb.1957.0022; Hulbert LE, 2016, J DAIRY SCI, V99, P3199, DOI 10.3168/jds.2015-10198; Jimenez RE, 2019, J DAIRY SCI, V102, P3431, DOI 10.3168/jds.2018-15445; Karrow NA, 2006, BRAIN BEHAV IMMUN, V20, P144, DOI 10.1016/j.bbi.2005.05.003; Kovacs L, 2015, PHYSIOL BEHAV, V139, P281, DOI 10.1016/j.physbeh.2014.11.039; Kovacs L, 2014, ANIMAL, V8, P316, DOI 10.1017/S1751731113002140; Lenth R., 2018, EMMEANS ESTIMATED MA; Marco EM, 2011, NEUROTOX RES, V19, P286, DOI 10.1007/s12640-010-9205-z; McCracken L, 2010, VET ANAESTH ANALG, V37, P375, DOI 10.1111/j.1467-2995.2010.00547.x; Mohr E, 2002, PHYSIOL BEHAV, V75, P251, DOI 10.1016/S0031-9384(01)00651-5; Morin M, 2014, PAIN RES TREAT, V2014, DOI 10.1155/2014/121289; National Milk Producers Federation, 2016, FARM AN CAR REF MAN; Parois SP, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00223; Peters JWB, 2005, PAIN, V114, P444, DOI 10.1016/j.pain.2005.01.014; Pieler D, 2013, J DAIRY SCI, V96, P6378, DOI 10.3168/jds.2013-6683; Pinheiro J., 2017, LINEAR NONLINEAR MIX, DOI DOI 10.1186/1742-9994-4-11; Ren K, 2004, PAIN, V110, P588, DOI 10.1016/j.pain.2004.04.006; Ruda MA, 2000, SCIENCE, V289, P628, DOI 10.1126/science.289.5479.628; RUSHEN J, 1986, APPL ANIM BEHAV SCI, V15, P315, DOI 10.1016/0168-1591(86)90124-3; SchwartzkopfGenswein KS, 1997, J ANIM SCI, V75, P2064; Sgoifo A, 2015, STRESS, V18, P343, DOI 10.3109/10253890.2015.1045868; Sominsky L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057700; Spencer SJ, 2011, AM J PHYSIOL-ENDOC M, V300, pE11, DOI 10.1152/ajpendo.00516.2010; Spencer SJ, 2006, NEUROPSYCHOPHARMACOL, V31, P1910, DOI 10.1038/sj.npp.1301004; Stewart M, 2008, ANIM WELFARE, V17, P387; Stewart M, 2008, PHYSIOL BEHAV, V93, P789, DOI 10.1016/j.physbeh.2007.11.044; Stewart M, 2007, PHYSIOL BEHAV, V92, P520, DOI 10.1016/j.physbeh.2007.04.034; Stewart M, 2005, ANIM WELFARE, V14, P319; Stewart M, 2010, J DAIRY SCI, V93, P3602, DOI 10.3168/jds.2010-3114; Stock ML, 2013, VET CLIN N AM-FOOD A, V29, P103, DOI 10.1016/j.cvfa.2012.11.001; Sutherland MA, 2011, APPL ANIM BEHAV SCI, V135, P179, DOI 10.1016/j.applanim.2011.10.015; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; USDA, 2018, DAIR 2014 HLTH MAN P; USDA, 2016, DAIR CATTL MAN PRACT; Vega-Avelaira D, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-30; von Borell E, 2007, PHYSIOL BEHAV, V92, P293, DOI 10.1016/j.physbeh.2007.01.007; Walker SM, 2017, PAIN, V158, pS29, DOI 10.1097/j.pain.0000000000000784; Walker SM, 2016, EXP NEUROL, V275, P253, DOI 10.1016/j.expneurol.2015.06.020; Wang JY, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-34; Wang KC, 2011, TOXICOLOGY, V279, P123, DOI 10.1016/j.tox.2010.10.002; Wollgarten-Hadamek I, 2009, PAIN, V141, P165, DOI 10.1016/j.pain.2008.11.008; Wulsin L, 2018, NEUROSCI BIOBEHAV R, V86, P12, DOI 10.1016/j.neubiorev.2017.12.010; Zouikr I, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0879-8	71	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2020	15	6							e0233711	10.1371/journal.pone.0233711	http://dx.doi.org/10.1371/journal.pone.0233711			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LW6ZP	32492026	Green Published, gold			2022-12-26	WOS:000539293000014
J	Rodrigues, DR; Briggs, W; Duff, A; Chasser, K; Murugesan, R; Pender, C; Ramirez, S; Valenzuela, L; Bielke, L				Rodrigues, Denise R.; Briggs, Whitney; Duff, Audrey; Chasser, Kaylin; Murugesan, Raj; Pender, Chasity; Ramirez, Shelby; Valenzuela, Luis; Bielke, Lisa			Cecal microbiome composition and metabolic function in probiotic treated broilers	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; PERFORMANCE; BACTERIA; CHICKENS	Probiotics have become increasingly popular in the poultry industry as a promising nutritional intervention to promote the modulation of intestinal microbial communities and their metabolic activities as a means of improving health and performance. This study aimed to determine the influence of different probiotic formulations on the taxonomic and metabolic profiling of cecal microbial communities, as well as to define associations between cecal microbiota and growth parameters in 21 and 42-day-old broilers. Probiotics investigated included a synbiotic (SYNBIO), a yeast-based probiotic (YEAST), and three single-strain formulations of spore-forming Bacillus amyloliquefaciens (SINGLE1), B. subtilis (SINGLE2) and B. licheniformis (SINGLE3). Dietary inclusion of SYNBIO, YEAST, SINGLE2, and SINGLE3 into the diets supported a significant stimulation of BW and BWG by 7 days of age. Besides, SYNBIO reduced the overall mortality rate by 42d (p<0.05). No significant variation was observed among different probiotic-based formulations for cecal microbiota composition. However, there was a treatment-specific effect on the metabolic profiles, with a particular beneficial metabolic adaptation by the microbiota when supplemented by SYNBIO and SINGLE2. Furthermore, the population of Lactobacillales was identified to be strongly associated with lower Enterobacteriales colonization, higher BW means, and lower mortality rate of growing broilers. Overall, the results emphasize that probiotic supplementation may enhance the microbial energy metabolism in the ceca of young broilers.	[Rodrigues, Denise R.; Briggs, Whitney; Duff, Audrey; Chasser, Kaylin; Bielke, Lisa] Ohio State Univ, Dept Anim Sci, Columbus, OH 43210 USA; [Murugesan, Raj; Pender, Chasity; Ramirez, Shelby] BIOMIN Amer Inc, Overland Pk, KS USA; [Valenzuela, Luis] BIOMIN Holding GmbH, Getzersdorf, Austria	University System of Ohio; Ohio State University; BIOMIN GmbH	Bielke, L (corresponding author), Ohio State Univ, Dept Anim Sci, Columbus, OH 43210 USA.	bielke.1@osu.edu		Murugesan, Raj/0000-0002-1285-2126; Rodrigues, Denise/0000-0001-8591-5514	BIOMIN	BIOMIN	This work was supported by BIOMIN (http://www.biomin.net). The funder provided support in the form of salaries for authors RM, CP, SR, LV and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions'. There was no additional external funding received for this study.	Aliakbarpour HR, 2012, ASIAN AUSTRAL J ANIM, V25, P1285, DOI 10.5713/ajas.2012.12110; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 1994, NUTR REQ POULTR, DOI [10.17226/2114, DOI 10.17226/2114]; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Baldwin S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194825; Ballou AL, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00002; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caspi R, 2018, NUCLEIC ACIDS RES, V46, pD633, DOI 10.1093/nar/gkx935; Clavijo V, 2018, POULTRY SCI, V97, P1006, DOI 10.3382/ps/pex359; De Cesare A, 2019, POULTRY SCI, V98, P3963, DOI 10.3382/ps/pez132; Ding BY, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01398; Douglas G.M., 2020, PICURUST2 IMPROVED E, DOI [10.1101/672295, 672295, 10.1101/672295, DOI 10.1101/672295]; Eckert NH, 2010, J APPL POULTRY RES, V19, P59, DOI 10.3382/japr.2009-00084; Ezema C, 2015, MICROBIOL MONOGR, V29, P59, DOI 10.1007/978-3-319-23183-9_4; Haldar S, 2011, ANIM FEED SCI TECH, V168, P61, DOI 10.1016/j.anifeedsci.2011.03.007; Kabir SML, 2009, INT J MOL SCI, V10, P3531, DOI 10.3390/ijms10083531; Kogut MH, 2019, ANIM FEED SCI TECH, V250, P32, DOI 10.1016/j.anifeedsci.2018.10.008; Kubasova T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212446; LeBlanc JG, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0691-z; Luoma A, 2017, POULTRY SCI, V96, P4208, DOI 10.3382/ps/pex251; Markowiak P, 2017, NUTRIENTS, V9, DOI 10.3390/nu9091021; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Oakley BB, 2014, FEMS MICROBIOL LETT, V360, P100, DOI 10.1111/1574-6968.12608; Pandit RJ, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0501-9; Pender CM, 2017, POULTRY SCI, V96, P1052, DOI 10.3382/ps/pew381; Pessione E, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00086; Rajakovich LJ, 2019, NAT PROD REP, V36, P593, DOI 10.1039/c8np00074c; Ritzi MM, 2014, POULTRY SCI, V93, P2772, DOI 10.3382/ps.2014-04207; Rodrigues DR, 2020, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02858; Roto SM, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00063; Rubio LA, 2019, POULTRY SCI, V98, P695, DOI 10.3382/ps/pey416; Schoenhofen IC, 2009, GLYCOBIOLOGY, V19, P715, DOI 10.1093/glycob/cwp039; Stanley D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084290; Teague KD, 2017, POULTRY SCI, V96, P2074, DOI 10.3382/ps/pew494; Terpou A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071591; Wilson KM, 2019, POULTRY SCI, V98, P5949, DOI 10.3382/ps/pez388; Xu JQ, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02011; Yalcin S, 2013, J APPL POULTRY RES, V22, P55, DOI 10.3382/japr.2012-00577; Yan W, 2017, SCI REP-UK, V7, DOI 10.1038/srep45308	42	14	14	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2020	15	6							e0225921	10.1371/journal.pone.0225921	http://dx.doi.org/10.1371/journal.pone.0225921			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LW6ZP	32492021	Green Published, gold			2022-12-26	WOS:000539293000040
J	Takahashi, S; Hara, K; Sano, I; Onoda, K; Nagai, A; Yamaguchi, S; Tanito, M				Takahashi, Satsuki; Hara, Katsunori; Sano, Ichiya; Onoda, Keiichi; Nagai, Atsushi; Yamaguchi, Shuhei; Tanito, Masaki			Systemic factors associated with intraocular pressure among subjects in a health examination program in Japan	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; AGE-RELATED-CHANGES; CORNEAL THICKNESS; NERVOUS-SYSTEM; RISK; POPULATION; PREVALENCE; RESISTANCE; VARIABLES; EYE	Background To elucidate the possible effect of various systemic factors on intraocular pressure (IOP) using a dataset from a health examination program database in Japan. Methods This cross-sectional study included 1569 subjects selected from the 2287 subjects who comprised the database. Various systemic parameters including age, sex, height, body weight, waist circumference, percent body fat, blood pressure (BP), pulse rate, body mass index, 28 blood examination values, intimal medial thicknesses of both carotid arteries, and intraocular pressure (IOP) values measured by non-contact tonometry in both eyes were collected. The possible correlation between the IOP and other parameters was assessed initially by univariate analyses followed by multivariate analyses. Results Stepwise multivariate analyses, which included all parameters extracted by the univariate analyses (p<0.1) and sex, identified the same six parameters as indicators of the IOP values for each right and left IOP model. Among the parameters, age (r = -0.05 and -0.04/year for right and left IOPs, respectively) was associated negatively and the percent body fat (r = 0.06 and 0.05/%), systolic BP (r = 0.02 and 0.03/mmHg), pulse rate (r = 0.03 and 0.03/counts/minutes), albumin (r = 1.12 and 1.00/g/dL), and hemoglobin A1c (r = 0.38 and 0.44/%) were associated positively with the IOP in each eye. Conclusions Older age was associated with low IOP, while factors reflecting the metabolic syndrome were associated with high IOP in our study population.	[Takahashi, Satsuki; Hara, Katsunori; Sano, Ichiya; Tanito, Masaki] Shimane Univ, Fac Med, Dept Ophthalmol, Izumo, Shimane, Japan; [Onoda, Keiichi; Nagai, Atsushi; Yamaguchi, Shuhei] Shimane Univ, Fac Med, Dept Neurol, Izumo, Shimane, Japan; [Takahashi, Satsuki] Chiba Univ, Grad Sch Med, Dept Gastroenterol, Chiba, Japan	Shimane University; Shimane University; Chiba University	Tanito, M (corresponding author), Shimane Univ, Fac Med, Dept Ophthalmol, Izumo, Shimane, Japan.	tanito-oph@umin.ac.jp	Onoda, Keiichi/N-2944-2019	Onoda, Keiichi/0000-0002-3882-3446				Acott TS, 2008, EXP EYE RES, V86, P543, DOI 10.1016/j.exer.2008.01.013; Al Owaifeer AM, 2018, OPHTHALMOL THER, V7, P19, DOI 10.1007/s40123-018-0120-3; BELMONTE C, 1987, INVEST OPHTH VIS SCI, V28, P1649; BLOOM JN, 1976, ARCH OPHTHALMOL-CHIC, V94, P435, DOI 10.1001/archopht.1976.03910030211008; Bonomi L, 1998, OPHTHALMOLOGY, V105, P209, DOI 10.1016/S0161-6420(98)92665-3; BRUBAKER RF, 1981, OPHTHALMOLOGY, V88, P283; BULPITT CJ, 1975, BRIT J OPHTHALMOL, V59, P717, DOI 10.1136/bjo.59.12.717; Chang YC, 2010, EYE, V24, P1037, DOI 10.1038/eye.2009.247; Chopra V, 2008, OPHTHALMOLOGY, V115, P227, DOI 10.1016/j.ophtha.2007.04.049; Civan MM, 2004, EXP EYE RES, V78, P625, DOI 10.1016/j.exer.2003.09.021; dos Santos MG, 1998, OPHTHALMOLOGY, V105, P2260, DOI 10.1016/S0161-6420(98)91226-X; Doughty MJ, 2000, SURV OPHTHALMOL, V44, P367, DOI 10.1016/S0039-6257(00)00110-7; Fukuoka S, 2008, ACTA OPHTHALMOL, V86, P434, DOI 10.1111/j.1600-0420.2007.01068.x; Hennis A, 2003, OPHTHALMOLOGY, V110, P908, DOI 10.1016/S0161-6420(03)00075-7; Kim HT, 2017, AM J OPHTHALMOL, V173, P23, DOI 10.1016/j.ajo.2016.09.031; Kim YW, 2019, BRIT J OPHTHALMOL; KLEIN BEK, 1992, INVEST OPHTH VIS SCI, V33, P2224; KUPFER C, 1973, AM J OPHTHALMOL, V75, P193, DOI 10.1016/0002-9394(73)91013-1; Lee JY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176894; Lee JS, 2002, CLIN EXP OPHTHALMOL, V30, P237, DOI 10.1046/j.1442-9071.2002.00527.x; Lee MK, 2012, OPHTHALMOLOGY, V119, P450, DOI 10.1016/j.ophtha.2011.09.016; Lee YW, 2008, J KOREAN MED SCI, V23, P31, DOI 10.3346/jkms.2008.23.1.31; LESKE MC, 1983, AM J EPIDEMIOL, V118, P280, DOI 10.1093/oxfordjournals.aje.a113634; Lin CP, 2012, EUR J INTERN MED, V23, P76, DOI 10.1016/j.ejim.2011.06.002; Mancia G, 2007, J HYPERTENS, V25, P909, DOI 10.1097/HJH.0b013e328048d004; MAPSTONE R, 1985, BRIT MED J, V291, P93, DOI 10.1136/bmj.291.6488.93; MCLEOD SD, 1990, INVEST OPHTH VIS SCI, V31, P2361; Memarzadeh F, 2008, AM J OPHTHALMOL, V146, P69, DOI 10.1016/j.ajo.2008.03.015; Mitaki S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194182; Mitchell P, 1997, OPHTHALMOLOGY, V104, P712, DOI 10.1016/S0161-6420(97)30247-4; MIYAZAKI M, 1987, JPN J OPHTHALMOL, V31, P558; Mori K, 2000, INT J EPIDEMIOL, V29, P661, DOI 10.1093/ije/29.4.661; Nomura H, 1999, OPHTHALMOLOGY, V106, P2016, DOI 10.1016/S0161-6420(99)90417-7; Oh SW, 2005, DIABETES-METAB RES, V21, P434, DOI 10.1002/dmrr.529; Overby DR, 2009, EXP EYE RES, V88, P656, DOI 10.1016/j.exer.2008.11.033; Park Sang-shin, 2010, J Prev Med Public Health, V43, P125, DOI 10.3961/jpmph.2010.43.2.125; Perez CI, 2019, CURR OPIN OPHTHALMOL, V30, P82, DOI 10.1097/ICU.0000000000000553; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rochtchina E, 2002, CLIN EXP OPHTHALMOL, V30, P173, DOI 10.1046/j.1442-9071.2002.00519.x; SCHTEING.DE, 1965, ANN NY ACAD SCI, V131, P388, DOI 10.1111/j.1749-6632.1965.tb34805.x; SHIOSE Y, 1990, SURV OPHTHALMOL, V34, P413, DOI 10.1016/0039-6257(90)90122-C; SHIOSE Y, 1984, ARCH OPHTHALMOL-CHIC, V102, P883; SHIOSE Y, 1986, AM J OPHTHALMOL, V101, P714, DOI 10.1016/0002-9394(86)90776-2; Su DHW, 2008, OPHTHALMOLOGY, V115, P964, DOI 10.1016/j.ophtha.2007.08.021; Tan GS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1354, DOI 10.1001/archophthalmol.2009.268; Toyoda G, 2015, CEREBROVASC DIS EXTR, V5, P22, DOI 10.1159/000373916; Xu L, 2005, AM J OPHTHALMOL, V140, P913, DOI 10.1016/j.ajo.2005.04.050; Yasuda K, 2006, TRENDS ENDOCRIN MET, V17, P269, DOI 10.1016/j.tem.2006.07.001; Yazici A, 2009, EUR J OPHTHALMOL, V19, P61, DOI 10.1177/112067210901900109; Zhao D, 2015, OPHTHALMOLOGY, V122, P72, DOI 10.1016/j.ophtha.2014.07.051	50	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2020	15	6							e0234042	10.1371/journal.pone.0234042	http://dx.doi.org/10.1371/journal.pone.0234042			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LW6ZP	32492062	gold, Green Published			2022-12-26	WOS:000539293000025
J	Zheng, LX; Liang, QC; Yu, M; Cao, Y; Chen, WS				Zheng, Lixia; Liang, Qichun; Yu, Ming; Cao, Yi; Chen, Wensheng			Morphological characterization of antennae and antennal sensilla of Diaphorina citri Kuwayama (Hemiptera: Liviidae) nymphs	PLOS ONE			English	Article							SENSE ORGANS; HONEY-BEE; ULTRASTRUCTURE; HYMENOPTERA; HOMOPTERA; INSECT; PSYLLIDAE; VOLATILES; RESPONSES; DISEASE	Diaphorina citri Kuwayama is the most economically important citrus pest which is the primary vector of Candidatus Liberibacter spp. causing citrus greening (huanglongbing, HLB) disease. To better understand the developmental and structural changes of antennae and antennal sensilla in D. citri nymphs, we investigated the antennal morphology, structure and sensilla distribution of the five nymphal stages of D. citri using scanning electron microscopy. The antennae of the five different nymphal stages of D. citri were filiform in shape, which consisted of two segments in the first-, second- and third-instar nymphs; three segments in the fourth- and fifth-instar nymphs. The length of their antennae was significantly increased with the increase of the nymphal instar, as well as the total number of antennal sensilla. Ten morphological sensilla types were recorded altogether. They were the long terminal hair (TH1), short terminal hair (TH2), sensilla trichoidea (ST), cavity sensillum 1 (CvS1), cavity sensillum 2 (CvS2), sensilla basiconica 1-3 (SB1-3), sensilla campaniform (SCA) and partitioned sensory organ (PSO). Also, the distribution of antennal sensilla in each nymphal stage of D. citri was asymmetrical. The SBs only occurred on the antennae of the third-, fourth- and fifth-instar nymphs. Only one CvS2 was found in the third- and fifth-instar nymphs, and one SCA in the fourth- and fifth-instar nymphs, respectively. The possible roles of the nymphal antennal sensilla in D. citri were discussed. The results could contribute to a better understanding of the development of the sensory system, and facilitate future studies on the antennal functions in D. citri nymphs.	[Zheng, Lixia; Liang, Qichun; Yu, Ming; Cao, Yi; Chen, Wensheng] Foshan Univ, Dept Hort, Foshan, Peoples R China; [Zheng, Lixia] Jiangxi Agr Univ, Coll Agron, Nanchang, Jiangxi, Peoples R China	Foshan University; Jiangxi Agricultural University	Chen, WS (corresponding author), Foshan Univ, Dept Hort, Foshan, Peoples R China.	cjf0000@163.com			National Natural Science Foundation of China [31660517]; Natural Science Foundation of Jiangxi Province, China [20161BAB214172]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangxi Province, China(Natural Science Foundation of Jiangxi Province)	This research was supported by the National Natural Science Foundation of China (31660517) and the Natural Science Foundation of Jiangxi Province, China (20161BAB214172).	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Altner H., 1980, International Review of Cytology, V67, P69, DOI 10.1016/S0074-7696(08)62427-4; Ammar ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064938; [Anonymous], 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-018-0474-7; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 1999, J MOD GREEK STUD, V17, P416; Arras J, 2012, SOUTHWEST ENTOMOL, V37, P1, DOI 10.3958/059.037.0101; BLAND RG, 1989, ANN ENTOMOL SOC AM, V82, P368, DOI 10.1093/aesa/82.3.368; Blaney WM, 1989, BIOL GRASSHOPPERS, P1; Boina DR, 2010, PEST MANAG SCI, V66, P349, DOI 10.1002/ps.1880; Bove JM, 2006, J PLANT PATHOL, V88, P7; BROMLEY AK, 1979, CELL TISSUE RES, V203, P427; Cen YJ, 2012, ENTOMOL EXP APPL, V143, P13, DOI 10.1111/j.1570-7458.2012.01222.x; Chapman R.F., 1998, INSECTS STRUCTURE FU, V4th ed.; Coutinho-Abreu IV, 2014, CHEM SENSES, V39, P539, DOI 10.1093/chemse/bju023; Dagulo L, 2010, J FOOD SCI, V75, pC199, DOI 10.1111/j.1750-3841.2009.01495.x; Dethier VG., 1963, PHYSL INSECT SENSES; DIETZ A, 1971, ANN ENTOMOL SOC AM, V64, P919, DOI 10.1093/aesa/64.4.919; George J, 2016, CHEM SENSES, V41, P325, DOI 10.1093/chemse/bjw005; Gharaei AM, 2014, J APPL ENTOMOL, V138, P500, DOI 10.1111/jen.12107; Grafton-Cardwell EE, 2013, ANNU REV ENTOMOL, V58, P413, DOI 10.1146/annurev-ento-120811-153542; Gullan PJ, 2004, INSECTS OUTLINE ENTO, P86; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; HASHIMOTO Y, 1990, APPL ENTOMOL ZOOL, V25, P491, DOI 10.1303/aez.25.491; Hung TH, 2004, PLANT PATHOL, V53, P96, DOI 10.1111/j.1365-3059.2004.00948.x; Imms AD, 1970, GEN TXB ENTOMOLOGY; Kleineidam C, 2000, ARTHROPOD STRUCT DEV, V29, P43, DOI 10.1016/S1467-8039(00)00012-8; Kristoffersen L, 2006, ARTHROPOD STRUCT DEV, V35, P85, DOI 10.1016/j.asd.2006.04.001; Liang AP, 2002, AUST J ENTOMOL, V41, P39, DOI 10.1046/j.1440-6055.2002.00266.x; McCLEAN A. P. D., 1970, Phytophylactica, V2, P177; McIver S.B., 1985, P71; MELLOR HE, 1995, INT J INSECT MORPHOL, V24, P133, DOI 10.1016/0020-7322(94)00021-H; MORAN V C, 1973, Journal of the Entomological Society of Southern Africa, V36, P191; MORAN VC, 1975, ENTOMOL EXP APPL, V18, P96, DOI 10.1007/BF00342405; Ochieng SA, 2000, ARTHROPOD STRUCT DEV, V29, P231, DOI 10.1016/S1467-8039(01)00008-1; OLSON DM, 1993, INT J INSECT MORPHOL, V22, P507, DOI 10.1016/0020-7322(93)90037-2; Onagbola EO, 2008, MICRON, V39, P1184, DOI 10.1016/j.micron.2008.05.002; Onagbola EO, 2008, MICRON, V39, P526, DOI 10.1016/j.micron.2007.08.001; Patti JM, 2010, ENVIRON ENTOMOL, V39, P618, DOI 10.1603/EN09216; SCHNEIDER D, 1964, ANNU REV ENTOMOL, V9, P103, DOI 10.1146/annurev.en.09.010164.000535; SINGLETONSMITH J, 1978, CAN J ZOOL, V56, P1576, DOI 10.1139/z78-219; SLIFER EH, 1961, J MORPHOL, V109, P351, DOI 10.1002/jmor.1051090308; SLIFER EH, 1970, ANNU REV ENTOMOL, V15, P121, DOI 10.1146/annurev.en.15.010170.001005; SLIFER EH, 1964, Q J MICROSC SCI, V105, P21; Steinbrecht R.A., 1984, BIOL INTEGUMENT, V1, P523, DOI DOI 10.1007/978-3-642-51593-4_28; STORT AC, 1981, J KANSAS ENTOMOL SOC, V54, P352; Wenninger EJ, 2008, ENTOMOL EXP APPL, V128, P450, DOI 10.1111/j.1570-7458.2008.00738.x; Wenninger EJ, 2007, FLA ENTOMOL, V90, P715, DOI 10.1653/0015-4040(2007)90[715:DTOMAA]2.0.CO;2; Wu ZZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159372; Zacharuk R.Y., 1985, COMPREHENSIVE INSECT, P1; ZACHARUK RY, 1980, ANNU REV ENTOMOL, V25, P27, DOI 10.1146/annurev.en.25.010180.000331; ZACHARUK RY, 1991, ANNU REV ENTOMOL, V36, P331, DOI 10.1146/annurev.en.36.010191.001555; Zanardi OZ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18986-4; Zheng LX, 2014, B ENTOMOL RES, V104, P622, DOI 10.1017/S000748531400039X; Zheng Li-Xia, 2010, Kunchong Zhishi, V47, P525; Zheng LiXia, 2011, Journal of Fruit Science, V28, P344; Zheng YH, 2016, MICROSC RES TECHNIQ, V79, P374, DOI 10.1002/jemt.22640	57	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2020	15	6							e0234030	10.1371/journal.pone.0234030	http://dx.doi.org/10.1371/journal.pone.0234030			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LW6ZP	32492065	Green Published, gold			2022-12-26	WOS:000539293000009
J	Diarz, EJ; Leyaro, BJ; Kivuyo, SL; Ngowi, BJ; Msuya, SE; Mfinanga, SG; Bonfoh, B; Mahande, MJ				Diarz, Ester J.; Leyaro, Beatrice J.; Kivuyo, Sokoine L.; Ngowi, Bernard J.; Msuya, Sia E.; Mfinanga, Sayoki G.; Bonfoh, Bassirou; Mahande, Michael J.			Red meat consumption and its association with hypertension and hyperlipidaemia among adult Maasai pastoralists of Ngorongoro Conservation Area, Tanzania	PLOS ONE			English	Article							RISK-FACTORS; DISEASE; PREVALENCE; OBESITY; STROKE; DIET	Background Red meat is an important dietary source of protein and other essential nutrients. Its high intake has been associated with an increased risk of cardiovascular morbidity and mortality, including hypertension (HTN) and hyperlipidaemia (HLP). Despite being physically active, the Maasai at Ngorongoro Conservation Area (NCA) depend heavily on animals' products as their staple food with fewer intakes of vegetables or fruits due to restriction from carrying out agricultural activities within the NCA. This study aimed at determining the prevalence of HTN and HLP and their association with red meat consumption among adult Maasai of NCA. Methods A community-based cross-sectional study was conducted in October 2018 using multistage sampling technique. Eight hundred and ninety-four (894) participants enrolled from seven villages in three wards within NCA Data were collected using a modified WHO NCDs-STEPS tool. Anthropometric measurements, blood pressure (BP) measurements, and blood samples for glucose and cholesterol tests were obtained from the study participants. Crude and adjusted prevalence ratio (PR) for factors associated with HTN and HLP were estimated using Ordinal and Bayesian logistic regression models, respectively. Results The prevalence of HLP was 23.7 percent. The levels were higher among males than were among the females (29.0% vs. 20.1%, p = 0.002). The prevalence of HTN and pre-HTN (elevated BP) were 9.8 and 37.0 percent, respectively. Both HTN and elevated BP were higher among males than were among females (hypertensive [10.9% vs. 9.0%]; elevated BP [44.0% vs. 32.1%], p<0.001). The prevalence of HLP was significantly associated with level II (PR = 1.56, 95%CrI: 1.10-2.09) and level III (PR = 1.64, 95%CrI: 1.08-2.41) of red meat consumption as opposed to level I. Conclusion The prevalence of hyperlipidaemia and elevated BP were high among NCA Maasai. We found a significant association between red meat consumption and hyperlipidaemia. Further follow-up studies are warranted to establish a temporal relationship between red meat consumption and both conditions.	[Diarz, Ester J.; Leyaro, Beatrice J.; Msuya, Sia E.; Mahande, Michael J.] Kilimanjaro Christian Med Univ Coll, Inst Publ Hlth, Dept Epidemiol & Appl Biostat, Kilimanjaro, Tanzania; [Diarz, Ester J.; Kivuyo, Sokoine L.; Ngowi, Bernard J.; Mfinanga, Sayoki G.] Natl Inst Med Res, Muhimbili Med Res Ctr, Dar Es Salaam, Tanzania; [Ngowi, Bernard J.] Univ Dar Es Salaam, Mbeya Coll Hlth & Allied Sci, Mbeya, Tanzania; [Msuya, Sia E.] Kilimanjaro Christian Med Univ Coll, Inst Publ Hlth, Dept Community Hlth, Kilimanjaro, Tanzania; [Msuya, Sia E.] Kilimanjaro Christian Med Ctr, Dept Community Med, Kilimanjaro, Tanzania; [Mfinanga, Sayoki G.] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania; [Mfinanga, Sayoki G.] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Bonfoh, Bassirou] Ctr Suisse Rech Sci Cote Ivoire, Abidjan, Cote Ivoire	National Institute of Medical Research; University of Dar es Salaam; Kilimanjaro Christian Medical Centre; Muhimbili University of Health & Allied Sciences; Liverpool School of Tropical Medicine	Diarz, EJ (corresponding author), Kilimanjaro Christian Med Univ Coll, Inst Publ Hlth, Dept Epidemiol & Appl Biostat, Kilimanjaro, Tanzania.; Diarz, EJ (corresponding author), Natl Inst Med Res, Muhimbili Med Res Ctr, Dar Es Salaam, Tanzania.	diarzester@gmail.com		Diarz, Ester Jacob/0000-0002-3463-5229; Kivuyo, Sokoine Lesikari/0000-0003-2257-5254; Leyaro, Beatrice/0000-0002-8525-0281	AfriqueOne ASPIRE; DELTAS Africa Initiative [Afrique OneASPIRE/DEL-15-008]; African Academy of Sciences (AAS) Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating (NEPAD) Agency; Welcome Trust [107753/A/15/Z]; UK government	AfriqueOne ASPIRE; DELTAS Africa Initiative; African Academy of Sciences (AAS) Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating (NEPAD) Agency; Welcome Trust(Wellcome Trust); UK government	EJD sponsored by AfriqueOne ASPIRE and the study was conducted within the framework of the DELTAS Africa Initiative [Afrique OneASPIRE/DEL-15-008]. Afrique One-ASPIRE is funded by a consortium of donor including the African Academy of Sciences (AAS) Alliance for Accelerating Excellence in Science in Africa (AESA), the New Partnership for Africa's Development Planning and Coordinating (NEPAD) Agency, the Welcome Trust [107753/A/15/Z] and the UK government. http://afriqueoneaspire.org The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellavia A, 2016, AM J CLIN NUTR, V104, P1137, DOI 10.3945/ajcn.116.135335; Brady R, 2008, CALIF POLYTECH HONOR, V1, P17; Christensen DL, 2008, ANN HUM BIOL, V35, P232, DOI 10.1080/03014460801949870; Cocate P. G., 2013, EUROPEAN J PREVENTIV, V22, P1; Edwards R, 2000, J HYPERTENS, V18, P145, DOI 10.1097/00004872-200018020-00003; Fogelholm M, 2015, EUR J CLIN NUTR, V69, P1060, DOI 10.1038/ejcn.2015.63; Forstater M., 2002, REV POLITICAL EC, V14, P47; Glew RH, 2001, AM J CLIN NUTR, V74, P730; Kaluza J, 2012, RED MEAT CONSUMPTION, P2556; Lajous M, 2014, AM J CLIN NUTR; Laltaika E., 2013, OREGON REV INT LAW, V15; LEONARD WR, 1994, AM J HUM BIOL, V6, P329, DOI 10.1002/ajhb.1310060308; Torman VBL, 2015, EMERG THEMES EPIDEMI, V12, DOI 10.1186/s12982-015-0030-y; Lukmanji Z, 2008, MUHIMBILI U ALLIED S, V259; Lwanga SK, 1991, SAMPLE SIZE DETERMIN, P15; Mandha J, 2015, ARCH CURR RES INT, V2; Martin H, 2014, AM J RES COMMUN, V2, P10; Mayige M., 2013, TANZANIA STEPS SURVE; McAfee AJ, 2010, MEAT SCI; Melita AW, 2014, RELATIONSHIP TOURISM, V2, P78; Micha R, 2010, CIRCULATION, V121, P2271, DOI 10.1161/CIRCULATIONAHA.109.924977; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; NCAA, 2019, CRATER TANZ AS; Ngoye A, 2014, INT J LIFE SCI, V1, P17; Ngoye A, 2014, J APPL LIFE SCI INT, V1, P17; Njelekela M, 2002, J NUTR SCI VITAMINOL, V48, P352, DOI 10.3177/jnsv.48.352; Nkwame, 2013, TANZANIA DAILY N OCT; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Poulter NR, 2015, LANCET, V386, P801, DOI 10.1016/S0140-6736(14)61468-9; Rose CE, 2015, BAYESIAN LOGISTIC RE, V6; Saneei P, PUBLIC HLTH NUT; Sarki AM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001959; Serneels S, 2009, STUD HUM ECOL ADAPT, V5, P43, DOI 10.1007/978-0-387-87492-0_2; Tanzania Mushi D., 2013, TANZANIA WHY FARMING; UNESCO, 2010, NGOR CONS AR; WHO, 2015, RAIS CHOL; WHO. World Health Organization-Noncommunicable Diseases (NCD), 2018, WHO NONC DIS NCD UN, P199; Wilson R.T., 2015, RED MEAT VALUE CHAIN; World Health Organization, 2009, GLOB HLTH RISKS; Wyness L, 2016, P NUTR SOC, V75, P227, DOI 10.1017/S0029665115004267; Yao XG, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-91	41	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0233777	10.1371/journal.pone.0233777	http://dx.doi.org/10.1371/journal.pone.0233777			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MJ2AA	32479535	Green Published, gold, Green Accepted			2022-12-26	WOS:000547893500027
J	Hu, L; Li, HY; Chi, ZP; He, JB				Hu, Liang; Li, Hongyan; Chi, Zhiping; He, Jianbo			Loss of the RNA-binding protein Rbm15 disrupts liver maturation in zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA-binding motif protein 15 (Rbm15); liver organogenesis; liver maturation; mTORC1; hepatocyte nuclear factor 4alpha (Hnf4a); RNA-binding protein; gene regulation; post-transcriptional regulation; zebrafish hepatocyte nuclear factor 4 (HNF-4)	TRANSCRIPTION; PATHWAY; CELL	Liver organogenesis begins with hepatic precursors in the foregut endoderm, followed by hepatoblast specification, differentiation, outgrowth, and maturation for the formation of functional hepatocytes. Although several signaling pathways and critical factors that regulate liver specification, differentiation, and proliferation have been identified, little is known about how liver maturation is regulated. Here, we used a screen for mutations affecting liver development in zebrafish and identified acq96mutant that exhibits a specific defect in liver maturation. Results from positional cloning revealed thatcq96encodes an RNA-binding protein, Rbm15, which is an evolutionarily conserved Spen family protein and known to play a crucial role in RNA m6A modification, nuclear export, and alternative splicing. However, a function of Rbm15 in embryonic liver development has not been reported. We found thatRbm15is specifically expressed in the liver after its differentiation. CRISPR/Cas9-mediated loss ofrbm15repressed hepatic maturation, but did not affect hepatoblast specification, differentiation, and hepatocyte proliferation and apoptosis. Additional experiments disclosed that the mTOR complex 1 (mTORC1) pathway is highly activated inrbm15-deficient hepatocytes. Moreover, rapamycin treatment partially restored normal hepatic gene expression as well as the nuclear location of the transcription factor Hnf4a. Taken together, these results reveal an unexpected role of Rbm15 in liver maturation.	[Hu, Liang; Li, Hongyan; Chi, Zhiping; He, Jianbo] Southwest Univ, Inst Dev Biol & Regenerat Med, Chongqing, Peoples R China	Southwest University - China	He, JB (corresponding author), Southwest Univ, Inst Dev Biol & Regenerat Med, Chongqing, Peoples R China.	hejianbo@swu.edu.cn		he, jianbo/0000-0002-2551-8186	National Key RAMP;D Program of China [2019YFA0802703]; National Natural Science Foundation of China [31970784, 31801214]	National Key RAMP;D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key R&D Program of China Grant 2019YFA0802703 (to J. H.) and National Natural Science Foundation of China Grants 31970784 and 31801214 (to J. H.).	Berasain C, 2015, CELL MOL LIFE SCI, V72, P3831, DOI 10.1007/s00018-015-1970-7; Calmont A, 2006, DEV CELL, V11, P339, DOI 10.1016/j.devcel.2006.06.015; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Chaturantabut S, 2020, HEPATOLOGY, V72, P1786, DOI 10.1002/hep.31184; Chaturantabut S, 2019, GASTROENTEROLOGY, V156, P1788, DOI 10.1053/j.gastro.2019.01.010; Chu J, 2009, HEPATOLOGY, V50, P1656, DOI 10.1002/hep.23157; Colletti M, 2009, GASTROENTEROLOGY, V137, P660, DOI 10.1053/j.gastro.2009.05.038; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Goessling W, 2015, GASTROENTEROLOGY, V149, P1361, DOI 10.1053/j.gastro.2015.08.034; Gordillo M, 2015, DEVELOPMENT, V142, P2094, DOI 10.1242/dev.114215; Hang HL, 2017, EXP CELL RES, V360, P81, DOI 10.1016/j.yexcr.2017.08.020; He J, 2017, J GENET GENOMICS, V44, P567, DOI 10.1016/j.jgg.2017.09.013; He JB, 2014, GASTROENTEROLOGY, V146, P789, DOI 10.1053/j.gastro.2013.11.045; Knuckles P, 2018, GENE DEV, V32, P415, DOI 10.1101/gad.309146.117; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Ludtke THW, 2009, HEPATOLOGY, V49, P969, DOI 10.1002/hep.22700; Ma XY, 2007, MOL CELL BIOL, V27, P3056, DOI 10.1128/MCB.01339-06; Tran NT, 2016, EMBO REP, V17, P887, DOI 10.15252/embr.201541970; Niu C, 2009, BLOOD, V114, P2087, DOI 10.1182/blood-2009-01-197921; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Patil DP, 2016, NATURE, V537, P369, DOI 10.1038/nature19342; Shin D, 2007, DEVELOPMENT, V134, P2041, DOI 10.1242/dev.000281; Sosa-Pineda B, 2000, NAT GENET, V25, P254, DOI 10.1038/76996; Tan XP, 2006, GASTROENTEROLOGY, V131, P1561, DOI 10.1053/j.gastro.2006.08.042; Wang ZK, 2018, BIOCHEM BIOPH RES CO, V505, P378, DOI 10.1016/j.bbrc.2018.09.133; Watanabe H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090791; Yimlamai D, 2014, CELL, V157, P1324, DOI 10.1016/j.cell.2014.03.060; Zhang L, 2015, ELIFE, V4, DOI 10.7554/eLife.07938; Zhao RO, 2005, MOL CELL BIOL, V25, P2622, DOI 10.1128/MCB.25.7.2622-2631.2005; Zhu Q, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0894-1; Zolotukhin AS, 2009, NUCLEIC ACIDS RES, V37, P7151, DOI 10.1093/nar/gkp782; Zong YW, 2009, DEVELOPMENT, V136, P1727, DOI 10.1242/dev.029140	33	3	4	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2020	295	33					11466	11472		10.1074/jbc.RA120.014080	http://dx.doi.org/10.1074/jbc.RA120.014080			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NG3YV	32518161	hybrid, Green Published			2022-12-26	WOS:000563922500009
J	Liu, MJ; Zhu, YR; Xing, F; Liu, S; Xia, Y; Jiang, Q; Qin, JZ				Liu, Mengjie; Zhu, Yaru; Xing, Fei; Liu, Shuang; Xia, Yin; Jiang, Qing; Qin, Jinzhong			The polycomb group protein PCGF6 mediates germline gene silencing by recruiting histone-modifying proteins to target gene promoters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						polycomb group ring finger 6 (Pcgf6); knockout mice; embryonic stem cells; germline gene silencing; G9A histone methyltransferase; G9a-like protein 1 (Glp); histone deacetylase 1; 2 (Hdac1; 2); PRC1; 6; epigenetic regulation; gene regulation; polycomb; embryonic stem cell; histone deacetylase (HDAC); gene knockout; histone methylation; G9a; Glp; Pcgf6	SPERM MOTILITY; VARIANT PRC1; COMPLEX; METHYLATION; FAMILY; MICE; G9A; METHYLTRANSFERASE; DIFFERENTIATION; TRANSCRIPTION	Polycomb group (PcG) proteins are essential for maintenance of lineage fidelity by coordinating developmental gene expression programs. Polycomb group ring finger 6 (PCGF6) has been previously reported to repress expression of lineage-specific genes, especially germ cell?related genes in mouse embryonic stem cells (ESCs) via the noncanonical polycomb repressive complex PRC1.6. However, the molecular mechanism of this repression remains largely unknown. Here, using RNA-Seq, real-time RT-PCR, immunohistochemistry, immunoprecipitation, and ChIP analyses, we demonstrate that PCGF6 plays an essential role in embryonic development, indicated by the partially penetrant embryonic lethality in homozygous PCGF6 (Pcgf6(?/?))-deficient mice. We also found that survivingPcgf6-deficient mice exhibit reduced fertility. Using thePcgf6-deficient mice, we observed that ablation ofPcgf6in somatic tissues robustly derepresses germ cell?related genes. We further provide evidence that these genes are direct targets of PCGF6 in ESCs and that endogenous PCGF6 co-localizes with the histone-modifying proteins G9A histone methyltransferase (G9A)/G9a-like protein (GLP) and histone deacetylase 1/2 (HDAC1/2) on the promoters of the germ cell?related genes. Moreover, the binding of these proteins to their target genes correlated with methylation of Lys-9 of histone 3 and with the status of histone acetylation at these genes. Moreover, the recruitment of G9A/GLP and HDAC1/2 to target promoters depended on the binding of PCGF6. Our findings indicate that PCGF6 has a critical role in safeguarding lineage decisions and in preventing aberrant expression of germ cell?related genes.	[Liu, Mengjie; Zhu, Yaru; Liu, Shuang; Qin, Jinzhong] Nanjing Univ, Model Anim Res Ctr, State Key Lab Pharmaceut Biotechnol, Nanjing, Peoples R China; [Liu, Mengjie; Zhu, Yaru; Liu, Shuang; Qin, Jinzhong] Nanjing Univ, MOE Key Lab Model Anim Dis Study, Model Anim Res Ctr, Nanjing, Peoples R China; [Xing, Fei] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Peoples R China; [Xia, Yin] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China; [Jiang, Qing] Nanjing Univ, Dept Sports Med & Adult Reconstruct Surg, Nanjing Drum Tower Hosp, Med Sch, Nanjing, Peoples R China	Nanjing University; Nanjing University; Nanjing Agricultural University; Chinese University of Hong Kong; Nanjing University	Qin, JZ (corresponding author), Nanjing Univ, Model Anim Res Ctr, State Key Lab Pharmaceut Biotechnol, Nanjing, Peoples R China.; Qin, JZ (corresponding author), Nanjing Univ, MOE Key Lab Model Anim Dis Study, Model Anim Res Ctr, Nanjing, Peoples R China.	qinjz@nicemice.cn	Xia, Yin/M-5440-2018	Xia, Yin/0000-0003-0315-7532	National Natural Science Foundation of China [31671532, 31970810]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 31671532 and 31970810 (to J. Q.).	Akasaka T, 2002, GENES CELLS, V7, P835, DOI 10.1046/j.1365-2443.2002.00565.x; Boulias K, 2004, NUCLEIC ACIDS RES, V32, P6096, DOI 10.1093/nar/gkh947; Brand M, 2019, CELL STEM CELL, V24, P518, DOI 10.1016/j.stem.2019.03.005; Chang YF, 2011, BIOTECHNIQUES, V51, P341, DOI 10.2144/000113764; Choi H, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.130252; Cohen I, 2018, CELL STEM CELL, V22, P726, DOI 10.1016/j.stem.2018.04.005; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Da Ros M, 2019, JOVE-J VIS EXP, DOI 10.3791/60271; Da Ros VG, 2008, DEV BIOL, V320, P12, DOI 10.1016/j.ydbio.2008.03.015; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Duan ZJ, 2005, MOL CELL BIOL, V25, P10338, DOI 10.1128/MCB.25.23.10338-10351.2005; Endoh M, 2017, ELIFE, V6, DOI 10.7554/eLife.21064; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Fuks F, 2005, CURR OPIN GENET DEV, V15, P490, DOI 10.1016/j.gde.2005.08.002; Fursova NA, 2019, MOL CELL, V74, P1020, DOI 10.1016/j.molcel.2019.03.024; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Gaubatz S, 1998, P NATL ACAD SCI USA, V95, P9190, DOI 10.1073/pnas.95.16.9190; Goodson SG, 2011, BIOL REPROD, V84, P1207, DOI 10.1095/biolreprod.110.088989; Gyory I, 2004, NAT IMMUNOL, V5, P299, DOI 10.1038/ni1046; Harris T, 2007, BIOL REPROD, V77, P376, DOI 10.1095/biolreprod.106.058669; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Huang YK, 2018, CELL REP, V22, P3032, DOI 10.1016/j.celrep.2018.02.072; Hurlin PJ, 1999, EMBO J, V18, P7019, DOI 10.1093/emboj/18.24.7019; Jalkanen J, 2006, BIOCHEM BIOPH RES CO, V349, P245, DOI 10.1016/j.bbrc.2006.08.023; Jeong J, 2019, GENE EXPR PATTERNS, V31, P18, DOI 10.1016/j.gep.2018.12.001; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li SH, 2005, BIOL REPROD, V73, P546, DOI 10.1095/biolreprod.105.039651; Lin MH, 2008, REPRODUCTION, V136, P559, DOI 10.1530/REP-07-0375; Maeda I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2780; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; Meng CL, 2019, CELL DEATH DIFFER, V26, P2194, DOI 10.1038/s41418-019-0283-z; Nishio H, 2004, P NATL ACAD SCI USA, V101, P11257, DOI 10.1073/pnas.0401343101; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Pohlers M, 2005, CURR BIOL, V15, P1051, DOI 10.1016/j.cub.2005.04.060; Qin JZ, 2012, CELL STEM CELL, V11, P319, DOI 10.1016/j.stem.2012.06.002; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Sapiro R, 2002, MOL CELL BIOL, V22, P6298, DOI 10.1128/MCB.22.17.6298-6305.2002; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Suzuki A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11056; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Trojer P, 2011, MOL CELL, V42, P438, DOI 10.1016/j.molcel.2011.04.004; Turner SA, 2013, CELL STEM CELL, V12, P145, DOI 10.1016/j.stem.2013.01.014; van den Boom V, 2016, CELL REP, V14, P332, DOI 10.1016/j.celrep.2015.12.034; Westmuckett AD, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.116863; Yokobayashi S, 2013, NATURE, V495, P236, DOI 10.1038/nature11918; Zdzieblo D, 2014, STEM CELLS, V32, P3112, DOI 10.1002/stem.1826; Zhao WK, 2017, J BIOL CHEM, V292, P21527, DOI 10.1074/jbc.M117.804054; Zhao WK, 2017, J BIOL CHEM, V292, P2773, DOI 10.1074/jbc.M116.763961	54	13	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9712	9724		10.1074/jbc.RA119.012121	http://dx.doi.org/10.1074/jbc.RA119.012121			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32482889	hybrid, Green Published			2022-12-26	WOS:000552758600035
J	Shen, SL; Sun, FJ; Zhu, MC; Chen, S; Guan, MW; Chen, R; Tang, F; Yin, NW; Xu, XF; Tang, ZL; Li, JN; Lu, K; Qu, CM				Shen, Shulin; Sun, Fujun; Zhu, Meichen; Chen, Si; Guan, Mingwei; Chen, Rui; Tang, Fang; Yin, Nengwen; Xu, Xinfu; Tang, Zhanglin; Li, Jiana; Lu, Kun; Qu, Cunmin			Genome-wide identification AINTEGUMENTA-like (AIL) genes in Brassica species and expression patterns during reproductive development in Brassica napus L.	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; ARABIDOPSIS FLOWER; APETALA2-LIKE GENE; ROOT; PLETHORA; EVOLUTION; PROTEINS; FAMILY; GROWTH; DIVERSIFICATION	The AINTEGUMENTA-like (AIL) proteins, which belong to the AP2 family, play important roles in regulating the growth and development of plant organs. The AIL family has not yet been comprehensively studied in rapeseed (Brassica napus), an allotetraploid and model organism for the study of polyploid evolution. In the present study, 99 AIL family genes were identified and characterized from B. rapa, B. oleracea, B. napus, B. juncea, and B. nigra using a comprehensive genome-wide study, including analyses of phylogeny, gene structure, chromosomal localization, and expression pattern. Using a phylogenetic analysis, the AIL genes were divided into eight groups, which were closely related to the eight AtAIL genes, and which shared highly conserved structural features within the same subfamily. The non-synonymous/synonymous substitution ratios of the paralogs and orthologs were less than 1, suggesting that the AIL genes mainly experienced purifying selection during evolution. In addition, the RNA sequencing data and qRT-PCR analysis revealed that the B. napus AIL genes exhibited organ- and developmental stage-specific expression patterns. Certain genes were highly expressed in the developing seeds (BnaAIL1, BnaAIL2, BnaAIL5, and BnaAIL6), the roots (BnaANT, BnaAIL5, and BnaAIL6), and the stem (BnaAIL7B). Our results provide valuable information for further functional analysis of the AIL family in B. napus and related Brassica species.	[Shen, Shulin; Sun, Fujun; Zhu, Meichen; Chen, Si; Guan, Mingwei; Chen, Rui; Tang, Fang; Yin, Nengwen; Xu, Xinfu; Tang, Zhanglin; Li, Jiana; Lu, Kun; Qu, Cunmin] Southwest Univ, Chongqing Rapeseed Engn Res Ctr, Coll Agron & Biotechnol, Chongqing, Peoples R China; [Shen, Shulin; Sun, Fujun; Zhu, Meichen; Chen, Si; Guan, Mingwei; Chen, Rui; Tang, Fang; Yin, Nengwen; Xu, Xinfu; Tang, Zhanglin; Li, Jiana; Lu, Kun; Qu, Cunmin] Southwest Univ, Acad Agr Sci, Chongqing, Peoples R China	Southwest University - China; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Southwest University - China	Lu, K; Qu, CM (corresponding author), Southwest Univ, Chongqing Rapeseed Engn Res Ctr, Coll Agron & Biotechnol, Chongqing, Peoples R China.; Lu, K; Qu, CM (corresponding author), Southwest Univ, Acad Agr Sci, Chongqing, Peoples R China.	drlukun@swu.edu.cn; drqucunmin@swu.edu.cn	Yin, Nengwen/ABF-1384-2021; Lu, Kun/C-2597-2008	Lu, Kun/0000-0003-1370-8633; Shen, Shulin/0000-0002-7690-9769	National Major Science and Technology Projects of China [2018ZX08020001]; National Natural Science Foundation of China [31830067]; Fundamental Research Funds for Central Universities of the Central South University [XDJK2020B030, XDJK2019C099]; Chongqing Postdoctoral Research Foundation (CN) [XmT2018057]; 111 project (CN) [B12006]; Modern Agro-industry Technology Research System (CN) [CARS-12]	National Major Science and Technology Projects of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Central Universities of the Central South University; Chongqing Postdoctoral Research Foundation (CN); 111 project (CN); Modern Agro-industry Technology Research System (CN)	This study was funded by the National Major Science and Technology Projects of China (2018ZX08020001), National Natural Science Foundation of China (31830067), Fundamental Research Funds for Central Universities of the Central South University (XDJK2019C099), Fundamental Research Funds for Central Universities of the Central South University (XDJK2020B030), Chongqing Postdoctoral Research Foundation (CN) (XmT2018057), 111 project (CN) (B12006), and Modern Agro-industry Technology Research System (CN) (CARS-12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Africa Confidential, 2006, AFRICA CONFIDENTIAL, V47, P1; Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arias T, 2014, AM J BOT, V101, P86, DOI 10.3732/ajb.1300312; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bandupriya HDD, 2013, TREE GENET GENOMES, V9, P813, DOI 10.1007/s11295-013-0600-5; Cao YP, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01750; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Chen B, 2010, AGR SCI CHINA, V9, P488, DOI 10.1016/S1671-2927(09)60121-8; Cheng F, 2016, NAT GENET, V48, P1218, DOI 10.1038/ng.3634; Chialva C, 2016, PLANT MOL BIOL, V91, P67, DOI 10.1007/s11103-016-0443-1; Confalonieri M, 2014, PLANT MOL BIOL REP, V32, P957, DOI 10.1007/s11105-014-0706-4; Dash M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-98; Ding Q, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28606-4; Dona DH, 2010, IN VITRO CELL DEV-AN, V46, pS123; Du YJ, 2017, P NATL ACAD SCI USA, V114, P11709, DOI 10.1073/pnas.1714410114; Elliott RC, 1996, PLANT CELL, V8, P155, DOI 10.1105/tpc.8.2.155; Galinha C, 2007, NATURE, V449, P1053, DOI 10.1038/nature06206; Han H, 2016, PLANT MOL BIOL, V92, P597, DOI 10.1007/s11103-016-0535-y; Horstman A, 2014, TRENDS PLANT SCI, V19, P146, DOI 10.1016/j.tplants.2013.10.010; Hu YX, 2003, PLANT CELL, V15, P1951, DOI 10.1105/tpc.013557; JOFUKU KD, 1994, PLANT CELL, V6, P1211, DOI 10.1105/tpc.6.9.1211; Kim S, 2006, MOL BIOL EVOL, V23, P107, DOI 10.1093/molbev/msj014; Klucher KM, 1996, PLANT CELL, V8, P137, DOI 10.1105/tpc.8.2.137; Krizek BA, 2012, PLANT MOL BIOL, V78, P199, DOI 10.1007/s11103-011-9844-3; Krizek Beth A, 2011, BMC Res Notes, V4, P176, DOI 10.1186/1756-0500-4-176; Krizek BA, 2009, PLANT PHYSIOL, V150, P1916, DOI 10.1104/pp.109.141119; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Ma JQ, 2017, GENE, V620, P36, DOI 10.1016/j.gene.2017.03.030; Manchado-Rojo M, 2014, PLANT BIOTECHNOL J, V12, P1053, DOI 10.1111/pbi.12212; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; Mizukami Y, 2000, P NATL ACAD SCI USA, V97, P942, DOI 10.1073/pnas.97.2.942; Morcillo F, 2007, PLANTA, V226, P1353, DOI 10.1007/s00425-007-0574-3; Mudunkothge JS, 2012, PLANT J, V71, P108, DOI 10.1111/j.1365-313X.2012.04975.x; NCBI Resource Coordinators, 2018, NUCLEIC ACIDS RES, V46, pD8; Nole-Wilson S, 2005, PLANT MOL BIOL, V57, P613, DOI 10.1007/s11103-005-0955-6; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Pan Y, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082181; Qu CM, 2013, J EXP BOT, V64, P2885, DOI 10.1093/jxb/ert148; Rigal A, 2012, PLANT PHYSIOL, V160, P1996, DOI 10.1104/pp.112.204453; Scheres B, 2018, CURR OPIN PLANT BIOL, V41, P95, DOI 10.1016/j.pbi.2017.10.002; Shigyo M, 2006, GENE, V366, P256, DOI 10.1016/j.gene.2005.08.009; Shigyo M, 2004, DEV GENES EVOL, V214, P105, DOI 10.1007/s00427-004-0385-5; Subramanian B, 2019, NUCLEIC ACIDS RES, V47, pW270, DOI 10.1093/nar/gkz357; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tsuwamoto R, 2010, PLANT MOL BIOL, V73, P481, DOI 10.1007/s11103-010-9634-3; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang Dapeng, 2010, Genomics Proteomics & Bioinformatics, V8, P77, DOI 10.1016/S1672-0229(10)60008-3; Wang FD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-807; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; Wu G, 2010, J AGR FOOD CHEM, V58, P2812, DOI 10.1021/jf904255b; Yu JY, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3844-x; ZUBAY G, 1959, J MOL BIOL, V1, P1, DOI 10.1016/S0022-2836(59)80002-4	55	4	4	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2020	15	6							e0234411	10.1371/journal.pone.0234411	http://dx.doi.org/10.1371/journal.pone.0234411			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ0RE	32511257	gold, Green Published			2022-12-26	WOS:000540938100026
J	Seernani, D; Ioannou, C; Damania, K; Spindler, K; Hill, H; Foulsham, T; Smyrnis, N; Bender, S; Fleischhaker, C; Biscaldi, M; Ebner-Priemer, U; Klein, C				Seernani, D.; Ioannou, C.; Damania, K.; Spindler, K.; Hill, H.; Foulsham, T.; Smyrnis, N.; Bender, S.; Fleischhaker, C.; Biscaldi, M.; Ebner-Priemer, U.; Klein, C.			Studying global processing in autism and attention-deficit/hyperactivity disorder with gaze movements: The example of a copying task	PLOS ONE			English	Article							REACTION-TIME VARIABILITY; SPECTRUM DISORDERS; WEAK COHERENCE; VISUAL-SEARCH; INTRAINDIVIDUAL VARIABILITY; CHILDREN; ADHD; ASD; DEFICIT; STRATEGIES	Recent discussions in the literature, along with the revision of the Diagnostic and Statistical Manual (DSM) (American Psychiatric Association 2013), suggest aetiological commonalities between the highly comorbid Attention-Deficit/Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD). Addressing this discussion requires studying these disorders together by comparing constructs typical to each of them. In the present study, we investigate global processing, known to be difficult for participants with ASD, and Intra-Subject Variability (ISV), known to be consistently increased in participants with ADHD, in groups, aged 10-13 years, with ADHD (n = 25), ASD without comorbid ADHD (ASD-) (n = 13) and ASD with ADHD (ASD+) (n = 18) in comparison with a typically developing group (n = 22). A Copying task, typically requiring global processing and in this case particularly designed using equally complex stimuli to also measure ISV across trials, was selected. Oculomotor measures in this task proved to be particularly sensitive to group differences. While increased ISV was not observed in the present task in participants with ADHD, both ASD groups looked longer on the figure to be drawn, indicating that global processing takes longer in ASD. However, the ASD+ group fixated on the figure only between drawing movements, whereas the ASD- group did this throughout the drawing process. The present study provides evidence towards ASD and ADHD being separate, not-overlapping, disorders. Since the pure ASD- group was affected more by central coherence problems than the ASD+ group, it may suggest that neuropsychological constructs interact differently in different clinical groups and sub-groups.	[Seernani, D.; Ioannou, C.; Spindler, K.; Fleischhaker, C.; Biscaldi, M.; Klein, C.] Univ Freiburg, Med Fac, Clin Child & Adolescent Psychiat Psychotherapy &, Freiburg, Germany; [Hill, H.; Ebner-Priemer, U.] Karlsruhe Inst Technol, Inst Sports & Sports Sci, Karlsruhe, Germany; [Foulsham, T.] Univ Essex, Dept Psychol, Colchester, Essex, England; [Smyrnis, N.; Klein, C.] Natl & Kapodistrian Univ Athens, Dept Psychiat, Athens, Greece; [Bender, S.; Klein, C.] Univ Cologne, Med Fac, Dept Child & Adolescent Psychiat, Cologne, Germany	University of Freiburg; Helmholtz Association; Karlsruhe Institute of Technology; University of Essex; National & Kapodistrian University of Athens; University of Cologne	Klein, C (corresponding author), Univ Freiburg, Med Fac, Clin Child & Adolescent Psychiat Psychotherapy &, Freiburg, Germany.; Klein, C (corresponding author), Natl & Kapodistrian Univ Athens, Dept Psychiat, Athens, Greece.; Klein, C (corresponding author), Univ Cologne, Med Fac, Dept Child & Adolescent Psychiat, Cologne, Germany.	christoph.klein.kip@uniklinik-freiburg.de	Bender, Stephan/AAT-1266-2021	Seernani, Divya/0000-0002-7125-9058	Research Commission of the Medical Faculty of the University of Freiburg [KLE1076/16]; State Funded Doctoral Scholarship of Baden-Wuerttemberg; German Research Foundation (DFG); University of Freiburg	Research Commission of the Medical Faculty of the University of Freiburg; State Funded Doctoral Scholarship of Baden-Wuerttemberg; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Freiburg	This study was funded by a grant from the Research Commission of the Medical Faculty of the University of Freiburg (KLE1076/16) and by the State Funded Doctoral Scholarship of Baden-Wuerttemberg. The Article Processing Charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding programme Open Access Publishing. Author SB has received support from Shire, Actelion and Medice for scientific symposia, has served on an Advisory Board for Roche, and received an honorary from Medice for an expert panel discussion. Author UEP has received consultant fees from Boehringer Ingelheim. The specific roles of these authors are articulated in the `author contributions' section.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE, P16; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Biscaldi M, 2015, EUR CHILD ADOLES PSY, V24, P1497, DOI 10.1007/s00787-015-0753-x; Bolte S, 2006, J CHILD PSYCHOL PSYC, V47, P639, DOI 10.1111/j.1469-7610.2006.01603.x; Bolte S., 2007, GERMAN VERSION SOCIA; Booth R, 2003, PHILOS T ROY SOC B, V358, P387, DOI 10.1098/rstb.2002.1204; Booth R, 2010, J EXP CHILD PSYCHOL, V107, P377, DOI 10.1016/j.jecp.2010.06.003; Booth RDL, 2018, J AUTISM DEV DISORD, V48, P1397, DOI 10.1007/s10803-016-2724-6; Chamberlain R, 2017, VISION RES, V141, P247, DOI 10.1016/j.visres.2017.01.008; Dopfner M, 2008, DIAGNOSTIK SYSTEM PS, V3; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Fletcher-Watson S., 2019, AUTISM NEW INTRO PSY, DOI DOI 10.4324/9781315101699; Geurts HM, 2008, NEUROPSYCHOLOGIA, V46, P3030, DOI 10.1016/j.neuropsychologia.2008.06.013; Gonen-Yaacovi G, 2016, CORTEX, V81, P50, DOI 10.1016/j.cortex.2016.04.010; Gottesman I. I., 2003, AM J PSYCHIAT, P16; Happe F, 1999, TRENDS COGN SCI, V3, P216, DOI 10.1016/S1364-6613(99)01318-2; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; Happe FGE, 2008, Q J EXP PSYCHOL, V61, P50, DOI 10.1080/17470210701508731; Horlin C, 2014, RES AUTISM SPECT DIS, V8, P463, DOI 10.1016/j.rasd.2014.01.006; Jobs EN, 2018, J AUTISM DEV DISORD, V48, P2249, DOI 10.1007/s10803-018-3470-8; Joseph RM, 2009, DEVELOPMENTAL SCI, V12, P1083, DOI 10.1111/j.1467-7687.2009.00855.x; Karalunas SL, 2014, J CHILD PSYCHOL PSYC, V55, P685, DOI 10.1111/jcpp.12217; Keehn B, 2009, J AUTISM DEV DISORD, V39, P383, DOI 10.1007/s10803-008-0608-0; Klein C., EYE MOVEMENT RES INT; Klein C, 2006, BIOL PSYCHIAT, V60, P1088, DOI 10.1016/j.biopsych.2006.04.003; Kofler MJ, 2013, CLIN PSYCHOL REV, V33, P795, DOI 10.1016/j.cpr.2013.06.001; Kuschner ES, 2009, AUTISM RES, V2, P348, DOI 10.1002/aur.101; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Losh M, 2009, ARCH GEN PSYCHIAT, V66, P518, DOI 10.1001/archgenpsychiatry.2009.34; McLoughlin G, 2014, BIOL PSYCHIAT, V75, P238, DOI 10.1016/j.biopsych.2013.07.020; Mottron L, 2006, J AUTISM DEV DISORD, V36, P27, DOI 10.1007/s10803-005-0040-7; O'Riordan MA, 2001, J EXP PSYCHOL HUMAN, V27, P719, DOI 10.1037//0096-1523.27.3.719; Rajendran G, 2007, DEV REV, V27, P224, DOI 10.1016/j.dr.2007.02.001; Rommelse NNJ, 2011, NEUROSCI BIOBEHAV R, V35, P1363, DOI 10.1016/j.neubiorev.2011.02.015; Rstudio T, 2020, RSTUDIO INT DEV R; Salunkhe G, 2021, J ATTEN DISORD, V25, P217, DOI 10.1177/1087054718778114; Saville CWN, 2015, J CHILD PSYCHOL PSYC, V56, P801, DOI 10.1111/jcpp.12348; Schlooz WAJM, 2012, RES AUTISM SPECT DIS, V6, P326, DOI 10.1016/j.rasd.2011.06.006; Schlooz WAJM, 2006, J AUTISM DEV DISORD, V36, P1025, DOI 10.1007/s10803-006-0140-z; Smith AD, 2016, J AUTISM DEV DISORD, V46, P3481, DOI 10.1007/s10803-016-2889-z; Stevens T, 2016, RES AUTISM SPECT DIS, V31, P11, DOI 10.1016/j.rasd.2016.07.003; Tchalenko J, 2009, CORTEX, V45, P368, DOI 10.1016/j.cortex.2007.12.012; Tokuyama, 1994, PHYS REV E, V50, pR16; Tsatsanis KD, 2011, J AUTISM DEV DISORD, V41, P135, DOI 10.1007/s10803-010-1139-z; Tye C, 2017, DEV COGN NEUROS-NETH, V26, P84, DOI 10.1016/j.dcn.2017.06.002; Tye C, 2014, PSYCHOL MED, V44, P1101, DOI 10.1017/S0033291713001049; Tye C, 2016, J CHILD PSYCHOL PSYC, V57, P1414, DOI 10.1111/jcpp.12608; Tye C, 2014, BIOL PSYCHOL, V103, P125, DOI 10.1016/j.biopsycho.2014.08.013; Unterrainer JM, 2016, AUTISM RES, V9, P739, DOI 10.1002/aur.1574; van Belle J, 2015, J CHILD PSYCHOL PSYC, V56, P1316, DOI 10.1111/jcpp.12417; Van der Hallen R, 2015, PSYCHOL BULL, V141, P549, DOI 10.1037/bul0000004; Van Eylen L, 2018, J AUTISM DEV DISORD, V48, P1359, DOI 10.1007/s10803-015-2526-2; Weiss RH., 2006, GRUNDINTELLIGENZTEST	53	1	1	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0224186	10.1371/journal.pone.0224186	http://dx.doi.org/10.1371/journal.pone.0224186			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MA6PX	32497045	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000542035200001
J	Stahl, B; Gawron, B; Regenbrecht, F; Floel, A; Kotz, SA				Stahl, Benjamin; Gawron, Bianca; Regenbrecht, Frank; Floeel, Agnes; Kotz, Sonja A.			Formulaic Language Resources May Help Overcome Difficulties in Speech-Motor Planning after Stroke	PLOS ONE			English	Article							SYLLABLE FREQUENCY; APRAXIA; RECOVERY; APHASIA; EXPRESSIONS; MECHANISMS; REGRESSION	Purpose Decades of research have explored communication in cerebrovascular diseases by focusing on formulaic expressions (e.g., "Thank you"-"You're welcome"). This category of utterances is known for engaging primarily right-hemisphere frontotemporal and bilateral subcortical neural networks, explaining why left-hemisphere stroke patients with speech-motor planning disorders often produce formulaic expressions comparatively well. The present proof-of-concept study aims to confirm that using verbal cues derived from formulaic expressions can alleviate word-onset difficulties, one major symptom in apraxia of speech. Methods In a cross-sectional repeated-measures design, 20 individuals with chronic post-stroke apraxia of speech were asked to produce (i) verbal cues (e.g., /guMODIFIER LETTER TRIANGULAR COLON/) and (ii) subsequent German target words (e.g., "Tanz") with critical onsets (e.g., /t/). Cues differed, most notably, in aspects of formulaicity (e.g., stereotyped prompt: /guMODIFIER LETTER TRIANGULAR COLON/, based on formulaic phrase "Guten Morgen"; unstereotyped prompt: /muMODIFIER LETTER TRIANGULAR COLON/, based on non-formulaic control word "Mutig"). Apart from systematic variation in stereotypy and communicative-pragmatic embeddedness possibly associated with holistic language processing, cues were matched for consonant-vowel structure, syllable-transition frequency, noun-verb classification, meter, and articulatory tempo. Results Statistical analyses revealed significant increases in correctly produced word onsets after verbal cues with distinct features of formulaicity (e.g., stereotyped versus unstereotyped prompts: p < 0.001), as reflected in large effect sizes (Cohen's d(z) <= 2.2). Conclusions The current results indicate that using preserved formulaic language skills can relieve word-onset difficulties in apraxia of speech. This finding is consistent with a dynamic interplay of left perilesional and right intact language networks in post-stroke rehabilitation and may inspire new treatment strategies for individuals with apraxia of speech.	[Stahl, Benjamin; Floeel, Agnes] Univ Med Greifswald, Dept Neurol, Greifswald, Germany; [Stahl, Benjamin; Floeel, Agnes] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany; [Stahl, Benjamin; Kotz, Sonja A.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Stahl, Benjamin] Psychol Hsch Berlin, Berlin, Germany; [Gawron, Bianca] Martin Luther Univ Halle Wittenberg, Dept Speech Sci, Halle, Germany; [Regenbrecht, Frank] Univ Hosp Leipzig, Clin Cognit Neurol, Leipzig, Germany; [Floeel, Agnes] German Ctr Neurodegenerat Dis, Rostock, Germany; [Floeel, Agnes] German Ctr Neurodegenerat Dis, Greifswald, Germany; [Kotz, Sonja A.] Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands	Greifswald Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Martin Luther University Halle Wittenberg; Leipzig University; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Maastricht University	Stahl, B (corresponding author), Univ Med Greifswald, Dept Neurol, Greifswald, Germany.; Stahl, B (corresponding author), Charite Univ Med Berlin, Dept Neurol, Berlin, Germany.; Stahl, B (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.; Stahl, B (corresponding author), Psychol Hsch Berlin, Berlin, Germany.	benjamin.stahl@charite.de			Else Kroner-Fresenius-Stiftung [2016_A51]; University of Greifswald; German Research Foundation [393148499]	Else Kroner-Fresenius-Stiftung; University of Greifswald; German Research Foundation(German Research Foundation (DFG))	The present study was supported by the Else Kroner-Fresenius-Stiftung (to BS, AF, and SAK; grant number: 2016_A51; www.ekfs.de).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The article processing charge was supported by Open-Access Publication Funds provided by the University of Greifswald and the German Research Foundation (grant number: 393148499).	Aichert I, 2004, BRAIN LANG, V88, P148, DOI 10.1016/S0093-934X(03)00296-7; Aichert I, 2016, NEUROPSYCHOLOGIA, V82, P171, DOI 10.1016/j.neuropsychologia.2016.01.009; ALAJOUANINE T, 1960, J NEUROL NEUROSUR PS, V23, P191, DOI 10.1136/jnnp.23.3.191; Baayen R. H., 1993, CELEX LEXICAL DATABA; Ballard KJ, 2015, AM J SPEECH-LANG PAT, V24, P316, DOI 10.1044/2015_AJSLP-14-0118; Bannard C, 2008, PSYCHOL SCI, V19, P241, DOI 10.1111/j.1467-9280.2008.02075.x; Brendel B, 2008, APHASIOLOGY, V22, P77, DOI 10.1080/02687030600965464; CANTER GJ, 1985, BRAIN LANG, V24, P204, DOI 10.1016/0093-934X(85)90131-2; CARAMAZZA A, 1991, NATURE, V349, P788, DOI 10.1038/349788a0; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; GRAVES R, 1985, ARCH NEUROL-CHICAGO, V42, P249, DOI 10.1001/archneur.1985.04060030067011; Heiss WD, 1999, ANN NEUROL, V45, P430, DOI 10.1002/1531-8249(199904)45:4<430::AID-ANA3>3.0.CO;2-P; Huber W, 1984, Adv Neurol, V42, P291; Hughlings-Jackson J., 1879, BRAIN, V2, P203, DOI 10.1093/brain/2.3.323; Hustad KC, 2003, J SPEECH LANG HEAR R, V46, P462, DOI 10.1044/1092-4388(2003/038); Mitchell AJ, 2017, GEN HOSP PSYCHIAT, V47, P48, DOI 10.1016/j.genhosppsych.2017.04.001; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Rammell CS, 2017, MENT LEX, V12, P234, DOI 10.1075/ml.16019.ram; Riecker A, 2008, BRAIN LANG, V107, P102, DOI 10.1016/j.bandl.2008.01.008; Rosen HJ, 2000, NEUROLOGY, V55, P1883, DOI 10.1212/WNL.55.12.1883; Sidtis DV, 2006, APHASIOLOGY, V20, P411, DOI 10.1080/02687030500538148; Sidtis JJ, 2018, BRAIN CONNECT, V8, P189, DOI 10.1089/brain.2017.0573; SPEEDIE LJ, 1993, NEUROLOGY, V43, P1768, DOI 10.1212/WNL.43.9.1768; Stahl B, 2016, CORTEX, V85, P90, DOI 10.1016/j.cortex.2016.09.021; Stahl B, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01526; Stahl B, 2011, BRAIN, V134, P3083, DOI 10.1093/brain/awr240; Tabossi P, 2009, MEM COGNITION, V37, P529, DOI 10.3758/MC.37.4.529; Tremblay Antoine, 2010, PERSPECTIVES FORMULA, P151; Van Lancker-Sidtis D, 2004, LANG COMMUN, V24, P207, DOI 10.1016/j.langcom.2004.02.003; Warburton E, 1999, J NEUROL NEUROSUR PS, V66, P155, DOI 10.1136/jnnp.66.2.155; Wertz R., 1984, APRAXIA SPEECH ADULT; Ziegler W, 2012, J SPEECH LANG HEAR R, V55, pS1485, DOI 10.1044/1092-4388(2012/12-0128)	32	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0233608	10.1371/journal.pone.0233608	http://dx.doi.org/10.1371/journal.pone.0233608			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MA6PX	32497064	Green Published, gold			2022-12-26	WOS:000542035200044
J	Albert, H; Purcell, R; Wang, YY; Kao, K; Mareka, M; Katz, Z; Maama, BL; Mots'oane, T				Albert, Heidi; Purcell, Ryan; Wang, Ying Ying; Kao, Kekeletso; Mareka, Mathabo; Katz, Zachary; Maama, Bridget Llang; Mots'oane, Tsietso			Designing an optimized diagnostic network to improve access to TB diagnosis and treatment in Lesotho	PLOS ONE			English	Article							PATIENT-PATHWAY ANALYSIS; TUBERCULOSIS; INFORM; CARE	Background To reach WHO End tuberculosis (TB) targets, countries need a quality-assured laboratory network equipped with rapid diagnostics for tuberculosis diagnosis and drug susceptibility testing. Diagnostic network analysis aims to inform instrument placement, sample referral, staffing, geographical prioritization, integration of testing enabling targeted investments and programming to meet priority needs. Methods Supply chain modelling and optimization software was used to map Lesotho's TB diagnostic network using available data sources, including laboratory and programme reports and health and demographic surveys. Various scenarios were analysed, including current network configuration and inclusion of additional GeneXpert and/or point of care instruments. Different levels of estimated demand for testing services were modelled (current [30,000 tests/year], intermediate [41,000 tests/year] and total demand needed to find all TB cases [88,000 tests/year]). Results Lesotho's GeneXpert capacity is largely well-located but under-utilized (19/24 sites use under 50% capacity). The network has sufficient capacity to meet current and near-future demand and 70% of estimated total demand. Relocation of 13 existing instruments would deliver equivalent access to services, maintain turnaround time and reduce costs compared with planned procurement of 7 more instruments. Gaps exist in linking people with positive symptom screens to testing; closing this gap would require extra 11,000 tests per year and result in 1000 additional TB patients being treated. Closing the gap in linking diagnosed patients to treatment would result in a further 629 patients being treated. Scale up of capacity to meet total demand will be best achieved using a point-of-care platform in addition to the existing GeneXpert footprint. Conclusions Analysis of TB diagnostic networks highlighted key gaps and opportunities to optimize services. Network mapping and optimization should be considered an integral part of strategic planning. By building efficient and patient-centred diagnostic networks, countries will be better equipped to meet End TB targets.	[Albert, Heidi] FIND, Cape Town, South Africa; [Purcell, Ryan; Wang, Ying Ying] LLamasoft Inc, St Ann Arbor, MI USA; [Kao, Kekeletso; Katz, Zachary] FIND, Geneva, Switzerland; [Mareka, Mathabo] Minist Hlth, Natl TB Reference Lab, Maseru, Lesotho; [Maama, Bridget Llang] Minist Hlth, Natl TB Programme, Maseru, Lesotho; [Mots'oane, Tsietso] Minist Hlth, Directorate Lab Serv, Maseru, Lesotho	Foundation For Innovative New Diagnostics; Foundation For Innovative New Diagnostics	Albert, H (corresponding author), FIND, Cape Town, South Africa.	heidi.albert@finddx.org	wang, yan/GSE-6489-2022; wang, yingying/GRS-3058-2022; wang, yi/GVT-8516-2022	Albert, Heidi/0000-0002-8595-4123	UK Aid from the UK government; Ministry of Health of Lesotho; FIND	UK Aid from the UK government(CGIAR); Ministry of Health of Lesotho; FIND	This study was funded by UK Aid from the UK government through a grant to the Foundation for Innovative New Diagnostics (FIND). FIND provided support for this study in the form of salaries for HA, KK and ZK and provided funding to Llamasoft through a consulting services agreement which covered consultancy fees for RP and YW. The specific roles of these authors are articulated in the 'author contributions' section. FIND participated in the development, evaluation and demonstration of the Xpert MTB/RIF assay, and provides technical assistance to countries for roll out. LLamasoft Inc. is a private supply chain management software company that developed and provides consulting services for use of the software used in the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the leadership and support of the Ministry of Health of Lesotho to conduct this work and for their assistance with data collection and analysis. The authors are grateful to Mathabo Lebina and Brendan Witherspoon for assistance with data collection and to Holynne Steppe for figure preparation. We thank Riders for Health and Clinton Health Access Initiative for providing data on sample transportation services and costs and health facility data. Editorial assistance for later drafts was provided by Rachel Wright, PhD, funded by FIND, according to Good Publication Practice guidelines. Publication of this article was funded by FIND.	Albert H, 2019, 50 UN WORLD C LUNG H; [Anonymous], 2014, PLOS ONE, V9, P1, DOI [10.1371/journal.pone.0109970, DOI 10.1371/JOURNAL.PONE.0109970, DOI 10.1371/J0URNAL.P0NE.0109970]; [Anonymous], 2017, J HEAR LUNG TRANSPLA, V36, pS99; Fatima R, 2017, J INFECT DIS, V216, pS733, DOI 10.1093/infdis/jix380; Garfin C, 2017, J INFECT DIS, V216, pS740, DOI 10.1093/infdis/jix391; Hanson C, 2017, J INFECT DIS, V216, pS686, DOI 10.1093/infdis/jix388; Hanson CL, 2017, J INFECT DIS, V216, pS679, DOI 10.1093/infdis/jix387; Katende B, 2020, SCI REP, V10, P1, DOI [10.1038/s41598-019-56847-4, DOI 10.1038/S41598-019-56847-4]; Langley I, 2014, LANCET GLOB HEALTH, V2, pE581, DOI 10.1016/S2214-109X(14)70291-8; Lesotho Ministry of Health and Social Welfare Services, 2016, NAT HLTH STRAT PLAN, V2022, P1; Masini E, 2017, J INFECT DIS, V216, pS714, DOI 10.1093/infdis/jix381; Minsitry of Health Republic of Kenya, KEN NAT STRAT PLAN T, P21019; Ogoro J, 2019, 50 UN WORLD C LUNG H; Osberg M, 2017, PATIENT PATHWAY ANAL; Sistoso E, 2019, 50 UN WORLD C LUNG H; Surya A, 2017, J INFECT DIS, V216, pS724, DOI 10.1093/infdis/jix379; The World Bank, 2016, WORLD BANK DAT LES; The World Bank, 2017, LES PUBL HLTH SECT E; United Nations Statistics Division, 2012, DEM YB; Wang ZX, 2009, INT J INF SYST SUPPL, V2, P81, DOI 10.4018/jisscm.2009010106; WHO, 2019, GLOB TUB REP; WHO, 2015, END TB STRATEGY; Williams H., 2009, INT SERIES OPERATION; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2020, POL STAT TB DIAGN LA; World Health Organization, 2020, GLOBAL TUBERCULOSIS; World Health Organization, 2017, TUB COUNTR PROF LES; World Health Organization, 2016, LES HIV COUNTR PROF	28	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2020	15	6							e0233620	10.1371/journal.pone.0233620	http://dx.doi.org/10.1371/journal.pone.0233620			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LW6ZP	32492022	Green Published, gold			2022-12-26	WOS:000539293000005
J	Basoulis, D; Liatis, S; Skouloudi, M; Makrilakis, K; Daikos, GL; Sfikakis, PP				Basoulis, Dimitrios; Liatis, Stavros; Skouloudi, Marina; Makrilakis, Konstantinos; Daikos, Georgios L.; Sfikakis, Petros P.			Survival predictors after intubation in medical wards: A prospective study in 151 patients	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; CHRONIC HEALTH EVALUATION; MECHANICAL VENTILATION; HOSPITAL MORTALITY; ACUTE PHYSIOLOGY; APACHE; OUTCOMES; FUTILE; SCORE; MODEL	Introduction In health care systems in need of additional intensive care unit (ICU) beds, the decision to mechanically ventilate critically ill patients in Internal Medicine (IM) Department wards needs to balance patients' health outcomes, possible futility, and logistics. We aimed to examine the survival rates and predictors in these patients. Methods We prospectively enrolled consecutive patients receiving mechanical ventilation during their care in the IM wards of a tertiary University hospital between April 2016 and December 2018. Primary outcome was 90-day mortality and secondary outcomes were in-hospital mortality and ICU transfer. Results Our cohort consisted of 151 unique patient intubations, of whom 74 (49%) patients were transferred to ICU within a median of 0 days (range 0-7). Compared to patients who remained in the wards, patients transferred to ICU had lower in-hospital and 90-day mortality (65% vs. 97%, and 70% vs. 99%, respectively, p<0.001 for both). Amongst several possible predictors of survival in the ICU, sequential organ failure assessment (SOFA) score at the time of intubation had the best prognostic accuracy with an AUROC of 0.818 and 0.855 for in-hospital and 90-day mortality, respectively. A baseline SOFA score <= 8 had a 100% sensitivity for survival prediction in ICU. However, out of 26 patients with SOFA score.8 who remained in the wards, only one survived, whereas 19 patients with SOFA score > 8 who were transferred to ICUs received futile care. Conclusion Mortality for patients receiving mechanical ventilation in IM wards is almost inevitable when ICU availability is lacking. Therefore, applying additional transfer criteria beyond the SOFA score is imperative.	[Basoulis, Dimitrios; Liatis, Stavros; Sfikakis, Petros P.] Natl & Kapodistrian Univ Athens, Laiko Gen Hosp, Dept Propaedeut Internal Med 1, Athens, Greece; [Basoulis, Dimitrios; Skouloudi, Marina; Makrilakis, Konstantinos; Daikos, Georgios L.] Natl & Kapodistrian Univ Athens, Laiko Gen Hosp, Dept Internal Med 1, Athens, Greece	Laiko General Hospital; National & Kapodistrian University of Athens; Laiko General Hospital; National & Kapodistrian University of Athens	Basoulis, D (corresponding author), Natl & Kapodistrian Univ Athens, Laiko Gen Hosp, Dept Propaedeut Internal Med 1, Athens, Greece.; Basoulis, D (corresponding author), Natl & Kapodistrian Univ Athens, Laiko Gen Hosp, Dept Internal Med 1, Athens, Greece.	dimitris.basoulis@gmail.com	Liatis, Stavros/CAA-4315-2022					Bosslet GT, 2015, AM J RESP CRIT CARE, V191, P1318, DOI 10.1164/rccm.201505-0924ST; Capuzzo M, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0551-8; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Esteban A, 2002, JAMA-J AM MED ASSOC, V287, P345, DOI 10.1001/jama.287.3.345; Fedosiuk Roman N, 2018, Wiad Lek, V71, P1320; Fernandez R, 2015, MED INTENSIVA, V39, P537, DOI 10.1016/j.medin.2014.11.002; Hersch M, 2007, J CRIT CARE, V22, P13, DOI 10.1016/j.jcrc.2006.06.004; Hersch M, 2012, J CRIT CARE, V27, P694, DOI 10.1016/j.jcrc.2012.08.020; Higgins TL, 2007, CRIT CARE MED, V35, P827, DOI 10.1097/01.CCM.0000257337.63529.9F; Huynh TN, 2013, JAMA INTERN MED, V173, P1887, DOI 10.1001/jamainternmed.2013.10261; Karabatsou D, 2016, INTENS CRIT CARE NUR, V35, P66, DOI 10.1016/j.iccn.2016.01.001; Kelley MA, 2004, CHEST, V125, P1514, DOI 10.1378/chest.125.4.1514; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Kranidiotis G, 2010, CRIT CARE, V14, DOI 10.1186/cc9380; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; LEMESHOW S, 1993, JAMA-J AM MED ASSOC, V270, P2478, DOI 10.1001/jama.270.20.2478; Lieberman D, 2010, CRIT CARE, V14, DOI 10.1186/cc8935; Moreno RP, 2005, INTENS CARE MED, V31, P1345, DOI 10.1007/s00134-005-2763-5; Opgenorth D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201524; Pintado MC, 2013, SCI WORLD J, DOI 10.1155/2013/590837; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Saric L, 2017, J BIOETHIC INQ, V14, P329, DOI 10.1007/s11673-017-9793-x; Sprung CL, 1999, CRIT CARE MED, V27, P1073, DOI 10.1097/00003246-199906000-00021; Tang WM, 2012, HONG KONG MED J, V18, P284; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wongsurakiat Phunsup, 2016, Journal of the Medical Association of Thailand, V99, P772; Zimmerman JE, 2006, CRIT CARE MED, V34, P1297, DOI 10.1097/01.CCM.0000215112.84523.F0	28	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0234181	10.1371/journal.pone.0234181	http://dx.doi.org/10.1371/journal.pone.0234181			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MJ2AA	32479534	Green Published, gold			2022-12-26	WOS:000547893500057
J	Tu, HM				Tu, Hung-Ming			Does active leisure participation promote psychological capital through peer support in economically disadvantaged children?	PLOS ONE			English	Article							QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; SELF-DETERMINATION; SOCIAL SUPPORT; PLS-SEM; POVERTY; HEALTH; SATISFACTION; EXPERIENCE; IMPACTS	This study's main purpose was to explore the effects of active leisure participation on poor children's psychological capital, while also investigating the mediated effect of peer support. The sample consisted of 483 economically disadvantaged children, selected and analysed from the Taiwan Database of Children and Youth in Poverty (fifth wave). The study employed partial least squares-structural equation modelling to analyse the relationship between the variables: active leisure participation (exercise and nature travel), peer support, and psychological capital in economically disadvantaged children. The results showed that active leisure participation improved psychological capital and peer support in economically disadvantaged students; and peer support was an important mediator between the other two variables.	[Tu, Hung-Ming] Natl Chung Hsing Univ, Dept Hort, Taichung, Taiwan	National Chung Hsing University	Tu, HM (corresponding author), Natl Chung Hsing Univ, Dept Hort, Taichung, Taiwan.	hmtu@dragon.nchu.edu.tw	Tu, Hung-Ming/AAA-4892-2021	Tu, Hung-Ming/0000-0002-0436-0789				Abraham A, 2010, INT J PUBLIC HEALTH, V55, P59, DOI 10.1007/s00038-009-0069-z; Adelman L., 2003, BRITAINS POOREST CHI; Allington RL, 2010, READ PSYCHOL, V31, P411, DOI 10.1080/02702711.2010.505165; Baumgardner R, 2009, POSITIVE PSYCHOL; Bittman M, 2002, SOC POLICY ADMIN, V36, P408, DOI 10.1111/1467-9515.t01-1-00262; Breslin G, 2017, MENT HEALTH PHYS ACT, V13, P9, DOI 10.1016/j.mhpa.2017.06.001; Brooks R., 2004, POWER RESILIENCE; BrooksGunn J, 1997, FUTURE CHILD, V7, P55, DOI 10.2307/1602387; Burton NW, 2003, HEALTH EDUC BEHAV, V30, P225, DOI 10.1177/1090198102251036; Carr A., 2013, POSITIVE PSYCHOL SCI, DOI [10.4324/9780203156629, DOI 10.4324/9780203156629]; CHAO CT, 2017, SCAND J TRAUMA RESUS, V25, DOI DOI 10.6151/CERQ.2017.2504.01; Chen CY, 2018, APPETITE, V121, P41, DOI 10.1016/j.appet.2017.10.027; Coffey J.K., 2018, POSITIVE PSYCHOL SCI; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 1988, STAT POWER ANAL BEHA, V2, P1, DOI DOI 10.4324/9780203771587; COLEMAN D, 1993, J LEISURE RES, V25, P111, DOI 10.1080/00222216.1993.11969913; COLLINS M.F., 2003, SPORT SOC, P67, DOI 10.4135/9781446278833.n5; CRAWFORD DW, 1991, LEISURE SCI, V13, P309, DOI 10.1080/01490409109513147; Crews DJ, 2004, PERCEPT MOTOR SKILL, V98, P319; Deci E.L., 2004, HDB SELF DETERMINATI; Dixon J, 2011, POVERTY PUBLIC POLIC, V3, DOI 10.2202/1944-2858.1158; Duncan JM, 2018, LEISURE STUD, V37, P343, DOI 10.1080/02614367.2017.1411968; Eamon MK, 2001, SOC WORK, V46, P256, DOI 10.1093/sw/46.3.256; Hair JF, 2012, J ACAD MARKET SCI, V40, P414, DOI 10.1007/s11747-011-0261-6; Hair JF, 2011, J MARKET THEORY PRAC, V19, P139, DOI 10.2753/MTP1069-6679190202; Hair JF, 2014, EUR BUS REV, V26, P106, DOI 10.1108/EBR-10-2013-0128; Hair Jr J.F., 2016, PRIMER PARTIAL LEAST; Haushofer J, 2014, SCIENCE, V344, P862, DOI 10.1126/science.1232491; Henderson KA, 2005, LEISURE SCI, V27, P355, DOI 10.1080/01490400500225559; Huang I. C., 2001, THESIS; Hughes H. L., 1991, Tourism Management, V12, P193, DOI 10.1016/0261-5177(91)90003-C; IsoAhola SE, 1996, J LEISURE RES, V28, P169, DOI 10.1080/00222216.1996.11949769; Ivory T, 2018, INT DEV EDUC, P31, DOI 10.1007/978-3-319-98666-1_3; Korpela KM, 2001, ENVIRON BEHAV, V33, P572, DOI 10.1177/00139160121973133; Lee EY, 2017, LEISURE SCI, V39, P355, DOI 10.1080/01490400.2016.1209139; Lloyd K, 2010, LEISURE SCI, V32, P369, DOI 10.1080/01490400.2010.488603; Luthans F, 2002, J ORGAN BEHAV, V23, P695, DOI 10.1002/job.165; Luthans F., 2006, PSYCHOL CAPITAL DEV, DOI [10.1093/acprof:oso/9780195187526.001.0001, DOI 10.1093/ACPROF:OSO/9780195187526.001.0001]; Luthans F., 2004, BUS HORIZONS, V47, P45, DOI [10.1016/j.bushor.2003.11.007, DOI 10.1016/J.BUSHOR.2003.11.007]; Martin KD, 2012, J CONSUM RES, V38, P1155, DOI 10.1086/661528; Milteer RM, 2012, PEDIATRICS, V129, pE204, DOI 10.1542/peds.2011-2953; ORTHNER DK, 1990, J LEISURE RES, V22, P125, DOI 10.1080/00222216.1990.11969820; Park J, 2002, EXCEPT CHILDREN, V68, P151, DOI 10.1177/001440290206800201; PATTERSON CJ, 1991, J SOC PERS RELAT, V8, P347, DOI 10.1177/0265407591083003; Quarmby T, 2019, LEISURE STUD, V38, P28, DOI 10.1080/02614367.2018.1535614; Ravallion M., 2017, POVERTY COMP; Ringle C.M., 2015, SMARTPLS VERSION 3 S; Salvini M, 2018, QUAL LIFE RES, V27, P205, DOI 10.1007/s11136-017-1707-1; Sedgley D, 2012, TOURISM MANAGE, V33, P951, DOI 10.1016/j.tourman.2011.10.001; Seeland K, 2009, FOREST POLICY ECON, V11, P10, DOI 10.1016/j.forpol.2008.07.005; Shin K, 2013, J PAC RIM PSYCHOL, V7, P53, DOI 10.1017/prp.2013.6; Shoukri MM., 2018, ANAL CORRELATED DATA, DOI [10.1201/9781315277738, DOI 10.1201/9781315277738]; Sletten MA, 2010, J YOUTH STUD, V13, P291, DOI 10.1080/13676260903520894; Stewart B, 2013, LEISURE STUD, V32, P542, DOI 10.1080/02614367.2012.697183; The World Bank, PRINC PRACT MEAS GLO; Vadala CE, 2007, J ENVIRON EDUC, V39, P3, DOI 10.3200/JOEE.39.1.3-18; Votsi NEP, 2014, TOUR MANAG PERSPECT, V11, P10, DOI 10.1016/j.tmp.2014.02.001; Zhao XS, 2010, J CONSUM RES, V37, P197, DOI 10.1086/651257	58	5	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0234143	10.1371/journal.pone.0234143	http://dx.doi.org/10.1371/journal.pone.0234143			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MJ2AA	32479528	gold, Green Published			2022-12-26	WOS:000547893500054
J	Chen, XX; Zheng, Y; Lei, AM; Zhang, HX; Niu, HM; Li, XL; Zhang, PF; Liao, MZ; Lv, YH; Zhu, ZD; Pan, CY; Dong, WZ; Chen, H; Wu, D; Liu, WS; Hamer, G; Zeng, SM; Zeng, WX				Chen, Xiaoxu; Zheng, Yi; Lei, Anmin; Zhang, Hanxue; Niu, Huimin; Li, Xueliang; Zhang, Pengfei; Liao, Mingzhi; Lv, Yinghua; Zhu, Zhendong; Pan, Chuanying; Dong, Wuzi; Chen, Hong; Wu, De; Liu, Wansheng; Hamer, Geert; Zeng, Shenming; Zeng, Wenxian			Early cleavage of preimplantation embryos is regulated by tRNA(Gln-TTG)-derived small RNAs present in mature spermatozoa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tRNA-derived small RNAs (tsRNAs); spermatogenesis; sperm maturation; embryo development; fertility; exosome; preimplantation; tRNAGln-TTG; epigenetics; embryo cleavage; embryo; sperm; RNA; development	MEIOTIC MATURATION; SPERM; FERTILIZATION; INHERITANCE; FRAGMENTS; LINE-1; CELLS	tRNA-derived small RNAs (tsRNAs) from spermatozoa could act as acquired epigenetic factors and contribute to offspring phenotypes. However, the roles of specific tsRNAs in early embryo development remain to be elucidated. Here, using pigs as a research model, we probed the tsRNA dynamics during spermatogenesis and sperm maturation and demonstrated the delivery of tsRNAs from semen-derived exosomes to spermatozoa. By microinjection of antisense sequences intoin vitrofertilized oocytes and subsequent single-cell RNA-seq of embryos, we identified a specific functional tsRNA group (termed here Gln-TTGs) that participate in the early cleavage of porcine preimplantation embryos, probably by regulating cell cycle-associated genes and retrotransposons. We conclude that specific tsRNAs present in mature spermatozoa play significant roles in preimplantation embryo development.	[Chen, Xiaoxu; Zheng, Yi; Li, Xueliang; Zhang, Pengfei; Zhu, Zhendong; Pan, Chuanying; Dong, Wuzi; Chen, Hong; Zeng, Wenxian] Northwest A&F Univ, Key Lab Anim Genet Breeding & Reprod Shaanxi Prov, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Lei, Anmin; Niu, Huimin] Northwest A&F Univ, Coll Vet Med, Shaanxi Stem Cell Engn & Technol Ctr, Yangling, Shaanxi, Peoples R China; [Liao, Mingzhi] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Lv, Yinghua] Northwest A&F Univ, Coll Chem & Pharm, Yangling, Shaanxi, Peoples R China; [Zhang, Hanxue; Zeng, Shenming] China Agr Univ, Coll Anim Sci & Technol, Lab Anim Embryon Biotechnol,Minist Agr, Natl Engn Lab Anim Breeding,Key Lab Anim Genet Br, Beijing, Peoples R China; [Wu, De] Sichuan Agr Univ, Inst Anim Nutr, Key Lab Anim Dis Resistance Nutr, Minist Educ China, Yaan Chengdu, Peoples R China; [Liu, Wansheng] Penn State Univ, Dept Anim Sci, Ctr Reprod Biol & Hlth, Coll Agr Sci, University Pk, PA 16802 USA; [Hamer, Geert] Univ Amsterdam, Reprod Biol Lab, Ctr Reprod Med, Amsterdam Reprod & Dev Res Inst,Amsterdam UMC, Amsterdam, Netherlands	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China; China Agricultural University; Ministry of Agriculture & Rural Affairs; Ministry of Education, China; Sichuan Agricultural University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Amsterdam	Zheng, Y; Zeng, WX (corresponding author), Northwest A&F Univ, Key Lab Anim Genet Breeding & Reprod Shaanxi Prov, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.; Zeng, SM (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Lab Anim Embryon Biotechnol,Minist Agr, Natl Engn Lab Anim Breeding,Key Lab Anim Genet Br, Beijing, Peoples R China.	y.zheng@nwafu.edu.cn; zengsm@cau.edu.cn; zengwenxian2015@126.com	Zeng, Wen/GPS-8058-2022; pan, chuanying/AAM-7092-2021	Zheng, Yi/0000-0003-0152-2671; LEI, An-min/0000-0002-5066-8709; Hamer, Geert/0000-0002-9583-6796	National Key R&D Program of China [2018YFD0501000]; First-classUniversity andAcademic ProgramfromNorthwest A&F University Grant [Z102021906]; Open Fund of Farm Animal Genetic Resources Exploration and Innovation Key Laboratory of Sichuan Province [SNDK-KF-201804]	National Key R&D Program of China; First-classUniversity andAcademic ProgramfromNorthwest A&F University Grant; Open Fund of Farm Animal Genetic Resources Exploration and Innovation Key Laboratory of Sichuan Province	This work was supported in part by National Key R&D Program of China Grant 2018YFD0501000 (toW. Z.), First-classUniversity andAcademic ProgramfromNorthwest A&F University Grant Z102021906 (to W. Z.), and Open Fund of Farm Animal Genetic Resources Exploration and Innovation Key Laboratory of Sichuan Province Grant SNDK-KF-201804 (to Y. Z.).	Cao SY, 2012, MOL REPROD DEV, V79, P413, DOI 10.1002/mrd.22044; Chen C, 2017, REPRODUCTION, V153, P785, DOI 10.1530/REP-17-0014; Chen Q, 2016, NAT REV GENET, V17, P733, DOI 10.1038/nrg.2016.106; Chen Q, 2016, SCIENCE, V351, P397, DOI 10.1126/science.aad7977; Chen XX, 2017, REPRODUCTION, V154, P789, DOI [10.1530/rep-17-0441, 10.1530/REP-17-0441]; Conine CC, 2019, DEV CELL, V50, P7, DOI 10.1016/j.devcel.2019.06.007; Conine CC, 2018, DEV CELL, V46, P470, DOI 10.1016/j.devcel.2018.06.024; Du J, 2016, ONCOTARGET, V7, P58832, DOI 10.18632/oncotarget.11315; Fadloun A, 2013, NAT STRUCT MOL BIOL, V20, P332, DOI 10.1038/nsmb.2495; Gervasi MG, 2017, ANDROLOGY-US, V5, P204, DOI 10.1111/andr.12320; Goke J, 2015, CELL STEM CELL, V16, P135, DOI 10.1016/j.stem.2015.01.005; Goodarzi H, 2015, CELL, V161, P790, DOI 10.1016/j.cell.2015.02.053; Groh S, 2017, CELL MOL LIFE SCI, V74, P2055, DOI 10.1007/s00018-017-2454-8; HOAGLAND MB, 1958, J BIOL CHEM, V231, P241; Hosseini HM, 2014, TUMOR BIOL, V35, P3699, DOI 10.1007/s13277-013-1489-1; Hua MM, 2019, CELL DISCOV, V5, DOI 10.1038/s41421-019-0087-9; Jachowicz JW, 2017, NAT GENET, V49, P1502, DOI 10.1038/ng.3945; Jan SZ, 2012, BBA-MOL BASIS DIS, V1822, P1838, DOI 10.1016/j.bbadis.2012.02.008; Kaupp UB, 2017, TRENDS CELL BIOL, V27, P101, DOI 10.1016/j.tcb.2016.10.002; Li HG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034566; Li Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep20850; Luo SQ, 2018, NUCLEIC ACIDS RES, V46, P5250, DOI 10.1093/nar/gky189; Ma MY, 2008, J PROTEOME RES, V7, P4821, DOI 10.1021/pr800392s; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Mincheva-Nilsson L., 2016, CURR PROTOC IMMUNOL, V115, P14421; Mistry BV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060611; Peaston AE, 2004, DEV CELL, V7, P597, DOI 10.1016/j.devcel.2004.09.004; Peng HY, 2012, CELL RES, V22, P1609, DOI 10.1038/cr.2012.141; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Romar R, 2016, THERIOGENOLOGY, V85, P125, DOI 10.1016/j.theriogenology.2015.07.017; Schorn AJ, 2017, CELL, V170, P61, DOI 10.1016/j.cell.2017.06.013; Schulz KN, 2019, NAT REV GENET, V20, P221, DOI 10.1038/s41576-018-0087-x; Schuster A, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.142190; Sharma U, 2018, DEV CELL, V46, P481, DOI 10.1016/j.devcel.2018.06.023; Sharma U, 2016, SCIENCE, V351, P391, DOI 10.1126/science.aad6780; Shi JM, 2009, J PINEAL RES, V47, P318, DOI 10.1111/j.1600-079X.2009.00717.x; Shi JC, 2018, GENOM PROTEOM BIOINF, V16, P144, DOI 10.1016/j.gpb.2018.04.004; Sullivan R, 2013, REPRODUCTION, V146, pR21, DOI 10.1530/REP-13-0058; Swindle MM, 2012, VET PATHOL, V49, P344, DOI 10.1177/0300985811402846; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Vojtech L, 2014, NUCLEIC ACIDS RES, V42, P7290, DOI 10.1093/nar/gku347; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yun Y, 2015, ZYGOTE, V23, P416, DOI 10.1017/S0967199414000021; Zhang YF, 2018, NAT CELL BIOL, V20, P535, DOI 10.1038/s41556-018-0087-2; Zhou DJ, 2019, DEV CELL, V50, P5, DOI 10.1016/j.devcel.2019.05.012; Zhou W, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00059; Zigo M, 2020, CELL TISSUE RES, V380, P237, DOI 10.1007/s00441-020-03181-1; Zuidema D, 2020, CELL TISSUE RES, V380, P263, DOI 10.1007/s00441-019-03100-z	48	18	22	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2020	295	32					10885	10900		10.1074/jbc.RA120.013003	http://dx.doi.org/10.1074/jbc.RA120.013003			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE7BV	32487749	Green Published, hybrid			2022-12-26	WOS:000562757100002
J	Armbruster, KM; Komazin, G; Meredith, TC				Armbruster, Krista M.; Komazin, Gloria; Meredith, Timothy C.			Bacterial lyso-form lipoproteins are synthesized via an intramolecular acyl chain migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipoproteins; Firmicutes; Toll-like receptor; acyl transfer; Enterococcus; Mut-Seq; immune evasion; virulence factor; membrane protein; intramolecular transferase; TLR2; lipoprotein; acyltransferase; Toll-like receptor (TLR); microbiology	APOLIPOPROTEIN N-ACYLTRANSFERASE; FATTY-ACID BIOSYNTHESIS; TRANSMEMBRANE PROTEIN TOPOLOGY; OUTER-MEMBRANE LIPOPROTEIN; GRAM-POSITIVE BACTERIA; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; ESSENTIAL RESIDUES; CARRIER PROTEIN; PREDICTION	All bacterial lipoproteins share a variably acylated N-terminal cysteine residue. Gram-negative bacterial lipoproteins are triacylated with a thioether-linked diacylglycerol moiety and anN-acyl chain. The latter is transferred from a membrane phospholipid donor to the ?-amino terminus by the enzyme lipoproteinN-acyltransferase (Lnt), using an active-site cysteine thioester covalent intermediate. Many Gram-positive Firmicutes also haveN-acylated lipoproteins, but the enzymes catalyzingN-acylation remain uncharacterized. The integral membrane protein Lit (lipoproteinintramoleculartransacylase) from the opportunistic nosocomial pathogenEnterococcus faecalissynthesizes a specific lysoform lipoprotein (N-acylS-monoacylglycerol) chemotype by an unknown mechanism that helps this bacterium evade immune recognition by the Toll-like receptor 2 family complex. Here, we used a deuterium-labeled lipoprotein substrate with reconstituted Lit to investigate intramolecular acyl chain transfer. We observed that Lit transfers thesn-2 ester-linked lipid from the diacylglycerol moiety to the ?-amino terminus without forming a covalent thioester intermediate. Utilizing Mut-Seq to analyze an alanine scan library of Lit alleles, we identified two stretches of functionally important amino acid residues containing two conserved histidines. Topology maps based on reporter fusion assays and cysteine accessibility placed both histidines in the extracellular half of the cytoplasmic membrane. We propose a general acid base?promoted catalytic mechanism, invoking direct nucleophilic attack by the substrate ?-amino group on thesn-2 ester to form a cyclic tetrahedral intermediate that then collapses to produce lyso-lipoprotein. Lit is a unique example of an intramolecular transacylase differentiated from that catalyzed by Lnt, and provides insight into the heterogeneity of bacterial lipoprotein biosynthetic systems.	[Armbruster, Krista M.; Komazin, Gloria; Meredith, Timothy C.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Meredith, Timothy C.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Armbruster, Krista M.] Univ Michigan, Med Sch, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Michigan System; University of Michigan	Meredith, TC (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.; Meredith, TC (corresponding author), Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA.	txm50@psu.edu	Meredith, Timothy/X-2713-2019	Meredith, Timothy/0000-0002-1901-6841	National Institutes of Health Grant NIGMS [R01GM127482]	National Institutes of Health Grant NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grant NIGMS R01GM127482 (to T. C. M.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adamian L, 2001, J MOL BIOL, V311, P891, DOI 10.1006/jmbi.2001.4908; Anderson CM, 2001, PLANT MOL BIOL, V47, P197, DOI 10.1023/A:1010691701578; [Anonymous], 2019, SUBCELL BIOCHEM; Armbruster KM, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00195-19; Armbruster KM, 2018, JOVE-J VIS EXP, DOI 10.3791/56842; Armbruster KM, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00099-17; Asanuma M, 2011, FEBS J, V278, P716, DOI 10.1111/j.1742-4658.2010.07990.x; BLACK PN, 1991, J BACTERIOL, V173, P435, DOI 10.1128/jb.173.2.435-442.1991; BLACK PN, 1992, J BIOL CHEM, V267, P25513; Bogdanov M, 2005, METHODS, V36, P148, DOI 10.1016/j.ymeth.2004.11.002; BRAUN V, 1975, BIOCHIM BIOPHYS ACTA, V415, P335, DOI 10.1016/0304-4157(75)90013-1; Buddelmeijer N, 2015, FEMS MICROBIOL REV, V39, P246, DOI 10.1093/femsre/fuu006; Buddelmeijer N, 2010, BIOCHEMISTRY-US, V49, P341, DOI 10.1021/bi9020346; Campbell JW, 2002, J BACTERIOL, V184, P3759, DOI 10.1128/JB.184.13.3759-3764.2002; Chaturvedi KS, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00003; Cronan JE, 1998, MOL MICROBIOL, V29, P937, DOI 10.1046/j.1365-2958.1998.00917.x; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; Dalecki AG, 2017, ADV MICROB PHYSIOL, V70, P193, DOI 10.1016/bs.ampbs.2017.01.007; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DIRUSSO CC, 1993, MOL MICROBIOL, V7, P311, DOI 10.1111/j.1365-2958.1993.tb01122.x; Dobson L, 2015, NUCLEIC ACIDS RES, V43, pW408, DOI 10.1093/nar/gkv451; Drew D, 2002, P NATL ACAD SCI USA, V99, P2690, DOI 10.1073/pnas.052018199; Entova S, 2018, ELIFE, V7, DOI 10.7554/eLife.40889; Fiore E, 2019, MICROBIOL SPECTR, V7, DOI 10.1128/microbiolspec.GPP3-0053-2018; Ford TJ, 2015, PEERJ, V3, DOI 10.7717/peerj.1040; Fukuda A, 2002, J BIOL CHEM, V277, P43512, DOI 10.1074/jbc.M206816200; Gelis-Jeanvoine S, 2015, MOL MICROBIOL, V95, P692, DOI 10.1111/mmi.12897; Grabowicz M, 2017, P NATL ACAD SCI USA, V114, P4769, DOI 10.1073/pnas.1702248114; Guo MS, 2014, GENE DEV, V28, P1620, DOI 10.1101/gad.243485.114; GUPTA SD, 1991, FEMS MICROBIOL LETT, V78, P37; Hillmann F, 2011, J BIOL CHEM, V286, P27936, DOI 10.1074/jbc.M111.243519; HOMMA H, 1981, BIOCHIM BIOPHYS ACTA, V663, P1, DOI 10.1016/0005-2760(81)90189-2; HUSSAIN M, 1982, J BIOL CHEM, V257, P5177; JACKOWSKI S, 1986, J BIOL CHEM, V261, P1328; Juretic D, 2002, J CHEM INF COMP SCI, V42, P620, DOI 10.1021/ci010263s; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; KLEIN K, 1971, EUR J BIOCHEM, V19, P442, DOI 10.1111/j.1432-1033.1971.tb01334.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kurokawa K, 2012, J BIOL CHEM, V287, P13170, DOI 10.1074/jbc.M111.292235; Lang MM, 2001, LETT APPL MICROBIOL, V33, P65, DOI 10.1046/j.1472-765X.2001.00949.x; Lin YB, 2018, J BIOL CHEM, V293, P3386, DOI 10.1074/jbc.RA117.001231; MANOIL C, 1991, METHOD CELL BIOL, V34, P61; Meeske AJ, 2016, NATURE, V537, P634, DOI 10.1038/nature19331; Milo R, 2013, BIOESSAYS, V35, P1050, DOI 10.1002/bies.201300066; Nguyen MT, 2016, MICROBIOL MOL BIOL R, V80, P891, DOI 10.1128/MMBR.00028-16; Nakayama H, 2012, FEBS J, V279, P4247, DOI 10.1111/febs.12041; Narita S, 2017, BBA-MOL CELL BIOL L, V1862, P1414, DOI 10.1016/j.bbalip.2016.11.009; Narita Shin-Ichiro, 2010, EcoSal Plus, V4, DOI 10.1128/ecosalplus.4.3.7; Narita S, 2011, J BACTERIOL, V193, P4832, DOI 10.1128/JB.05013-11; NUNN WD, 1983, J BACTERIOL, V154, P554, DOI 10.1128/JB.154.2.554-560.1983; Oliveira-Nascimento L, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00079; RAINES LJ, 1968, J BACTERIOL, V96, P2175, DOI 10.1128/JB.96.6.2175-2177.1968; Rashid R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175886; Ray LC, 2018, NAT CHEM BIOL, V14, P538, DOI 10.1038/s41589-018-0054-z; Ridder A, 2005, J MOL BIOL, V354, P894, DOI 10.1016/j.jmb.2005.09.084; Robichon C, 2005, J BIOL CHEM, V280, P974, DOI 10.1074/jbc.M411059200; Robins WP, 2013, P NATL ACAD SCI USA, V110, pE848, DOI 10.1073/pnas.1222538110; ROCK CO, 1981, J BIOL CHEM, V256, P736; ROCK CO, 1984, J BIOL CHEM, V259, P6188; Rottig A, 2013, MICROBIOL MOL BIOL R, V77, P277, DOI 10.1128/MMBR.00010-13; Sal-Man N, 2007, J BIOL CHEM, V282, P19753, DOI 10.1074/jbc.M610368200; SANKARAN K, 1994, J BIOL CHEM, V269, P19701; Silva-Rocha R, 2013, NUCLEIC ACIDS RES, V41, pD666, DOI 10.1093/nar/gks1119; Swoboda JG, 2009, ACS CHEM BIOL, V4, P875, DOI 10.1021/cb900151k; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; Ulmschneider MB, 2001, BBA-BIOMEMBRANES, V1512, P1, DOI 10.1016/S0005-2736(01)00299-1; Unterreitmeier S, 2007, J MOL BIOL, V374, P705, DOI 10.1016/j.jmb.2007.09.056; Vidal-Ingigliardi D, 2007, J BACTERIOL, V189, P4456, DOI 10.1128/JB.00099-07; Viklund H, 2008, BIOINFORMATICS, V24, P1662, DOI 10.1093/bioinformatics/btn221; WEEKS G, 1969, J BACTERIOL, V97, P827, DOI 10.1128/JB.97.2.827-836.1969; WELTZIEN HU, 1979, BIOCHIM BIOPHYS ACTA, V559, P259, DOI 10.1016/0304-4157(79)90004-2; Wiktor M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15952; Wiseman B, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57419-7; Yachdav G, 2014, NUCLEIC ACIDS RES, V42, pW337, DOI 10.1093/nar/gku366; Yakushi T, 2000, NAT CELL BIOL, V2, P212, DOI 10.1038/35008635; Yakushi T, 1997, J BACTERIOL, V179, P2857, DOI 10.1128/jb.179.9.2857-2862.1997; Yao ZZ, 2012, P NATL ACAD SCI USA, V109, pE2561, DOI 10.1073/pnas.1209742109; Yuan YQ, 2012, J BACTERIOL, V194, P5171, DOI 10.1128/JB.00792-12; Yuan YQ, 2012, J BACTERIOL, V194, P5185, DOI 10.1128/JB.00860-12; Zhang YM, 2008, J LIPID RES, V49, P1867, DOI 10.1194/jlr.R800005-JLR200; Zheng L, 2017, BBA-MOL CELL BIOL L, V1862, P1404, DOI 10.1016/j.bbalip.2016.11.015; Zuckert WR, 2014, BBA-MOL CELL RES, V1843, P1509, DOI 10.1016/j.bbamcr.2014.04.022	82	5	5	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2020	295	30					10195	10211		10.1074/jbc.RA120.014000	http://dx.doi.org/10.1074/jbc.RA120.014000			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MW0BV	32471867	Green Published, hybrid			2022-12-26	WOS:000556713400009
J	Elbaz, M; Ruiz, A; Nicolay, S; Tupini, C; Bachmann, C; Eckhardt, J; Benucci, S; Pelczar, P; Treves, S; Zorzato, F				Elbaz, Moran; Ruiz, Alexis; Nicolay, Sven; Tupini, Chiara; Bachmann, Christoph; Eckhardt, Jan; Benucci, Sofia; Pelczar, Pawel; Treves, Susan; Zorzato, Francesco			Bi-allelic expression of the RyR1 p.A4329D mutation decreases muscle strength in slow-twitch muscles in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ryanodine receptor (RyR); mutations; slow-twitch muscles; monoallelic versus bi-allelic; muscle strength; myopathy; skeletal muscle disease; calcium release channel; multiminicore disease (MmD)	SKELETAL-MUSCLE; SARCOPLASMIC-RETICULUM; CONGENITAL MYOPATHIES; HISTONE DEACETYLASES; STRUCTURAL BASIS; COMMON-CAUSE; RYANODINE; ACTIVATION; CHANNEL; DISORDERS	Mutations in the ryanodine receptor 1 (RYR1) gene are associated with several human congenital myopathies, including the dominantly inherited central core disease and exercise-induced rhabdomyolysis, and the more severe recessive phenotypes, including multiminicore disease, centronuclear myopathy, and congenital fiber type disproportion. Within the latter group, those carrying a hypomorphic mutation in one allele and a missense mutation in the other are the most severely affected. Because of nonsense-mediated decay, most hypomorphic alleles are not expressed, resulting in homozygous expression of the missense mutation allele. This should result in 50% reduced expression of the ryanodine receptor in skeletal muscle, but its observed content is even lower. To study in more detail the biochemistry and pathophysiology of recessiveRYR1myopathies, here we investigated a mouse model we recently generated by analyzing the effect of bi-allelicversusmono-allelic expression of the RyR1 p.A4329D mutation. Our results revealed that the expression of two alleles carrying the same mutation or of one allele with the mutation in combination with a hypomorphic allele does not result in functionally equal outcomes and impacts skeletal muscles differently. In particular, the bi-allelic RyR1 p.A4329D mutation caused a milder phenotype than its mono-allelic expression, leading to changes in the biochemical properties and physiological function only of slow-twitch muscles and largely sparing fast-twitch muscles. In summary, bi-allelic expression of the RyR1 p.A4329D mutation phenotypically differs from mono-allelic expression of this mutation in a compound heterozygous carrier.	[Elbaz, Moran; Ruiz, Alexis; Nicolay, Sven; Bachmann, Christoph; Eckhardt, Jan; Benucci, Sofia; Treves, Susan; Zorzato, Francesco] Basel Univ Hosp, Dept Biomed, Basel, Switzerland; [Tupini, Chiara; Treves, Susan; Zorzato, Francesco] Univ Ferrara, Dept Life Sci & Biotechnol, Ferrara, Italy; [Pelczar, Pawel] Univ Basel, Ctr Transgen Models, Basel, Switzerland	University of Basel; University of Ferrara; University of Basel	Zorzato, F (corresponding author), Basel Univ Hosp, Dept Biomed, Basel, Switzerland.; Zorzato, F (corresponding author), Univ Ferrara, Dept Life Sci & Biotechnol, Ferrara, Italy.	zor@unife.it		Bachmann, Christoph/0000-0003-1391-9860; Treves, Susan/0000-0002-0007-9631; Tupini, Chiara/0000-0002-2855-9290	Swiss National Science Foundation [SNF 31003A-169316, SNF 310030-184765]; Swiss muscle foundation (FSRMM); Botnar Stiftung [OOG-19-001]; PRIN 2015; NeRAB	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss muscle foundation (FSRMM); Botnar Stiftung; PRIN 2015(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); NeRAB	This work was supported by Grants SNF 31003A-169316 and SNF 310030-184765 from the Swiss National Science Foundation, a grant from the Swiss muscle foundation (FSRMM), a grant from NeRAB, Botnar Stiftung (OOG-19-001), and PRIN 2015 to F. Z.	ANDERSON K, 1994, AM J PHYSIOL, V266, pC462, DOI 10.1152/ajpcell.1994.266.2.C462; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Baylor SM, 2012, J GEN PHYSIOL, V139, P261, DOI 10.1085/jgp.201210773; BERS DM, 1993, AM J PHYSIOL, V264, pC1587, DOI 10.1152/ajpcell.1993.264.6.C1587; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; Clarke NF, 2010, HUM MUTAT, V31, pE1544, DOI 10.1002/humu.21278; des Georges A, 2016, CELL, V167, P145, DOI 10.1016/j.cell.2016.08.075; Du GG, 2004, J BIOL CHEM, V279, P37566, DOI 10.1074/jbc.M406637200; Eckhardt J, 2020, HUM MOL GENET, V29, P1330, DOI 10.1093/hmg/ddaa056; Elbaz M, 2019, HUM MOL GENET, V28, P2987, DOI 10.1093/hmg/ddz092; FRANZINIARMSTRONG C, 1994, ANNU REV PHYSIOL, V56, P509, DOI 10.1146/annurev.ph.56.030194.002453; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Han AD, 2005, J MOL BIOL, V345, P91, DOI 10.1016/j.jmb.2004.10.033; ISAACSON A, 1970, AM J PHYSIOL, V218, P33, DOI 10.1152/ajplegacy.1970.218.1.33; Jungbluth H, 2018, NAT REV NEUROL, V14, P151, DOI 10.1038/nrneurol.2017.191; Klein A, 2012, HUM MUTAT, V33, P981, DOI 10.1002/humu.22056; LAMB GD, 1992, J MUSCLE RES CELL M, V13, P394, DOI 10.1007/BF01738035; Meissner G, 2017, J GEN PHYSIOL, V149, P1065, DOI 10.1085/jgp.201711878; MELZER W, 1995, BBA-REV BIOMEMBRANES, V1241, P59, DOI 10.1016/0304-4157(94)00014-5; Monnier N, 2008, HUM MUTAT, V29, P670, DOI 10.1002/humu.20696; Mosca B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2496; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; RIOS E, 1991, PHYSIOL REV, V71, P849, DOI 10.1152/physrev.1991.71.3.849; Robinson R, 2006, HUM MUTAT, V27, P977, DOI 10.1002/humu.20356; Rokach O, 2015, HUM MOL GENET, V24, P4636, DOI 10.1093/hmg/ddv195; SALVIATI G, 1988, AM J PHYSIOL, V254, pC459, DOI 10.1152/ajpcell.1988.254.3.C459; Schulz RA, 2004, DEV BIOL, V266, P1, DOI 10.1016/j.ydbio.2003.10.008; Treves S, 2008, CURR OPIN PHARMACOL, V8, P319, DOI 10.1016/j.coph.2008.01.005; Treves S, 2009, J PHYSIOL-LONDON, V587, P3071, DOI 10.1113/jphysiol.2009.171876; Wilmshurst JM, 2010, ANN NEUROL, V68, P717, DOI 10.1002/ana.22119; Zhou H, 2007, BRAIN, V130, P2024, DOI 10.1093/brain/awm096	32	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2020	295	30					10331	10339		10.1074/jbc.RA120.013846	http://dx.doi.org/10.1074/jbc.RA120.013846			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MW0BV	32499372	hybrid, Green Published			2022-12-26	WOS:000556713400018
J	Roehrkasse, AM; Warner, ML; Booe, JM; Pioszak, AA				Roehrkasse, Amanda M.; Warner, Margaret L.; Booe, Jason M.; Pioszak, Augen A.			Biochemical characterization of G protein coupling to calcitonin gene?related peptide and adrenomedullin receptors using a native PAGE assay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); G protein; hormone receptor; molecular pharmacology; peptide hormone; receptor structure; function; hrCNE; thermostability; mini-G; in-gel fluorescence	SIZE-EXCLUSION CHROMATOGRAPHY; N-GLYCOSYLATION; FLUORESCENCE; CGRP; PHARMACOLOGY; MODULATION; INTERMEDIN; BINDING; FAMILY; GPCR	Calcitonin gene-related peptide (CGRP), adrenomedullin (AM), and adrenomedullin 2/intermedin (AM2/IMD) have overlapping and unique functions in the nervous and circulatory systems including vasodilation, cardioprotection, and pain transmission. Their actions are mediated by the class B calcitonin-like G protein?coupled receptor (CLR), which heterodimerizes with three receptor activity?modifying proteins (RAMP1?3) that determine its peptide ligand selectivity. How the three agonists and RAMPs modulate CLR binding to transducer proteins remains poorly understood. Here, we biochemically characterized agonist-promoted G protein coupling to each CLR?RAMP complex. We adapted a native PAGE method to assess the formation and thermostabilities of detergent-solubilized fluorescent protein?tagged CLR?RAMP complexes expressed in mammalian cells. Addition of agonist and the purified G(s)protein surrogate mini-G(s)(mG(s)) yielded a mobility-shifted agonist?CLR?RAMP?mG(s)quaternary complex gel band that was sensitive to antagonists. Measuring the apparent affinities of the agonists for the mG(s)-coupled receptors and of mG(s)for the agonist-occupied receptors revealed that both ligand and RAMP control mG(s)coupling and defined how agonist engagement of the CLR extracellular and transmembrane domains affects transducer recruitment. Using mini-G(sq)and -G(si)chimeras, we observed a coupling rank order of mG(s)> mG(sq)> mG(si)for each receptor. Last, we demonstrated the physiological relevance of the native gel assays by showing that they can predict the cAMP-signaling potencies of AM and AM2/IMD chimeras. These results highlight the power of the native PAGE assay for membrane protein biochemistry and provide a biochemical foundation for understanding the molecular basis of shared and distinct signaling properties of CGRP, AM, and AM2/IMD.	[Roehrkasse, Amanda M.; Warner, Margaret L.; Booe, Jason M.; Pioszak, Augen A.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Pioszak, AA (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA.	augen-pioszak@ouhsc.edu			National Institutes of Health [R01GM104251, 1F30 HL142232]; Presbyterian Health Foundation; American Heart Association Predoctoral Fellowship [18PRE33990152]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Presbyterian Health Foundation; American Heart Association Predoctoral Fellowship(American Heart Association)	This work was supported by National Institutes of Health Grant R01GM104251 (to A. A. P.), a Presbyterian Health Foundation seed grant (to A. A. P.), American Heart Association Predoctoral Fellowship 18PRE33990152 (to J. M. B.), and National Institutes of Health Predoctoral M.D./Ph.D. Fellowship 1F30 HL142232 (to A. M. R.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexandrov AI, 2008, STRUCTURE, V16, P351, DOI 10.1016/j.str.2008.02.004; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Booe J. M., 2020, BIORXIV, DOI 10.110/2020.2002.2028.970301; Booe JM, 2018, MOL PHARMACOL, V93, P355, DOI 10.1124/mol.117.110916; Booe JM, 2015, MOL CELL, V58, P1040, DOI 10.1016/j.molcel.2015.04.018; Caron KM, 2001, P NATL ACAD SCI USA, V98, P615, DOI 10.1073/pnas.021548898; Carpenter B, 2018, AIMS BIOENG, V5, P209, DOI 10.3934/bioeng.2018.4.209; Carpenter B, 2016, PROTEIN ENG DES SEL, V29, P583, DOI 10.1093/protein/gzw049; Carpenter B, 2016, NATURE, V536, P104, DOI 10.1038/nature18966; Christopoulos A, 2003, J BIOL CHEM, V278, P3293, DOI 10.1074/jbc.C200629200; Edvinsson L, 2018, NAT REV NEUROL, V14, P338, DOI 10.1038/s41582-018-0003-1; Furness SGB, 2016, CELL, V167, P739, DOI 10.1016/j.cell.2016.09.021; Garcia-Ponce A, 2016, TISSUE BARRIERS, V4, DOI 10.1080/21688370.2016.1228439; Garelja ML, 2020, ACS PHARMACOL TRANSL, V3, P246, DOI 10.1021/acsptsci.9b00083; Geven C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00292; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Hay DL, 2018, BRIT J PHARMACOL, V175, P3, DOI 10.1111/bph.14075; Hay DL, 2016, ANNU REV PHARMACOL, V56, P469, DOI 10.1146/annurev-pharmtox-010715-103120; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Holmes D, 2013, CURR PROTEIN PEPT SC, V14, P294, DOI 10.2174/13892037113149990049; Kato J, 2015, EUR J PHARMACOL, V764, P140, DOI 10.1016/j.ejphar.2015.06.061; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kee Z, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01249; Klein KR, 2015, CELL MOL LIFE SCI, V72, P3115, DOI 10.1007/s00018-015-1921-3; Lee SM, 2020, J MOL BIOL, V432, P1996, DOI 10.1016/j.jmb.2020.01.028; Liang YL, 2020, ACS PHARMACOL TRANSL, V3, P263, DOI 10.1021/acsptsci.9b00080; Liang YL, 2018, NATURE, V561, P492, DOI 10.1038/s41586-018-0535-y; Lorenzen E, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw2778; Mackie DI, 2019, P NATL ACAD SCI USA, V116, P24093, DOI 10.1073/pnas.1905561116; Mackie DI, 2018, J EXP MED, V215, P2339, DOI 10.1084/jem.20180528; Magnani F, 2016, NAT PROTOC, V11, P1554, DOI 10.1038/nprot.2016.088; McRae SR, 2005, PROTEIN EXPRES PURIF, V41, P121, DOI 10.1016/j.pep.2004.12.030; Moad HE, 2013, PROTEIN SCI, V22, P1775, DOI 10.1002/pro.2377; Musa H, 2019, BIOCHEMISTRY-US, V58, P3468, DOI 10.1021/acs.biochem.9b00571; Nehme R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175642; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Roehrkasse AM, 2018, J BIOL CHEM, V293, P15840, DOI 10.1074/jbc.RA118.005062; Russell FA, 2014, PHYSIOL REV, V94, P1099, DOI 10.1152/physrev.00034.2013; ter Haar E, 2010, STRUCTURE, V18, P1083, DOI 10.1016/j.str.2010.05.014; Tsuruda T, 2019, PEPTIDES, V111, P47, DOI 10.1016/j.peptides.2018.03.012; Voors AA, 2019, EUR J HEART FAIL, V21, P163, DOI 10.1002/ejhf.1366; Walker CS, 2010, TRENDS PHARMACOL SCI, V31, P476, DOI 10.1016/j.tips.2010.06.006; Wan QW, 2018, J BIOL CHEM, V293, P7466, DOI 10.1074/jbc.RA118.001975; Wang LJ, 2018, ARTERIOSCL THROM VAS, V38, P398, DOI 10.1161/ATVBAHA.117.310317; Weston C, 2016, J BIOL CHEM, V291, P21925, DOI 10.1074/jbc.M116.751362; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Zhang SY, 2018, BRIT J PHARMACOL, V175, P1230, DOI 10.1111/bph.13814	47	2	2	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9736	9751		10.1074/jbc.RA120.013854	http://dx.doi.org/10.1074/jbc.RA120.013854			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32487746	Green Published, hybrid			2022-12-26	WOS:000552758600037
J	Ghanima, MMA; Abd El-Aziz, AH; Noreldin, AE; Atta, MS; Mouse, SA; El-Far, AH				Ghanima, Mahmoud M. Abo; Abd El-Aziz, Ayman H.; Noreldin, Ahmed E.; Atta, Mustafa S.; Mouse, Shaker A.; El-Far, Ali H.			beta-glucan administration improves growth performance and gut health in New Zealand White and APRI rabbits with different breed responses	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; IMMUNE-RESPONSES; BLOOD PROFILE; MEAT QUALITY; SUPPLEMENTATION; MORPHOLOGY; CARCASS; DIGESTIBILITY; CYTOKINE; CHICKS	This study investigated the effects of oral administration of beta-glucan 1,3 (pharmaceutical grade 10%) on growth performance and carcass traits in two breeds of weanling rabbits adapted to survive in Egypt, New Zealand White (NZW) and Animal Production Research Institute (APRI) rabbits, with special attention to relative mRNA expression of interleukins and antioxidant enzyme genes, biochemical, and histological alterations. Oral administration of beta-glucan with doses 0.25 and 0.5 ml per one-liter of drinking water significantly accelerated body weight gain (BWG) in both rabbits' breeds, reduced total feed consumption (FC), and reduced feed conversion ratio (FCR), especially the 0.5 ml per one-liter dose in both rabbit breeds. There are remarkable differences in all the growth performance traits due to breed effect. The interaction effect between beta-glucan and breed significantly improved BWG, FC, and FCR. There were non-significant differences in all carcass traits studied due to oral administration of beta-glucan with both doses, except in dressing percentages. The highest of the dressing percentages were observed at doses 0.25 ml per one-liter (51%) and 0.5 ml per one-liter (52%) compared with control (50%). Our findings show significant variations in the final BW, total daily gain, feed consumption, and total feed conversion ratio between NZW and APRI rabbits. Absence of significant differences in the hot carcass weight and dressing percentage between the genetic groups had been reported in this study. Supplementing NZW and APRI rabbits with beta-glucan increased blood total protein and globulin. The duodenal villi dimensions, splenic lymphoid diameter, muscular fiber diameter, and muscular glycogen areas were significantly increased by beta-glucan administration. Expression of intestinal interleukin-18 (IL-18) in NZW rabbits treated with 0.25 and 0.5 doses of beta-glucan was significantly upregulated and enhanced the immune response. beta-glucan upregulated the expression of intestinaloccludinmRNA particularly at dose 0.5 beta-glucan as well as upregulated intestinal superoxide dismutase 1 (SOD1) and glutathione peroxidase 1 (GPx1), which modulates anti-inflammatory and antioxidant properties. In conclusion, oral administration of beta-glucan at a dose of 0.25 or 0.5 ml per one-liter drinking water provided beneficial effects in the growth performance and health status of rabbits.	[Ghanima, Mahmoud M. Abo; Abd El-Aziz, Ayman H.] Damanhour Univ, Fac Vet Med, Dept Anim Husb & Anim Wealth Dev, Damanhour, Egypt; [Noreldin, Ahmed E.] Damanhour Univ, Fac Vet Med, Dept Histol & Cytol, Damanhour, Egypt; [Atta, Mustafa S.] Kafrelsheikh Univ, Fac Vet Med, Dept Physiol, Kafrelsheikh, Egypt; [Mouse, Shaker A.] Albany Coll Pharm & Hlth Sci, Pharmaceut Res Inst, Rensselaer, NY USA; [El-Far, Ali H.] Damanhour Univ, Fac Vet Med, Dept Biochem, Damanhour, Egypt	Egyptian Knowledge Bank (EKB); Damanhour University; Egyptian Knowledge Bank (EKB); Damanhour University; Egyptian Knowledge Bank (EKB); Kafrelsheikh University; Albany College of Pharmacy & Health Sciences; Egyptian Knowledge Bank (EKB); Damanhour University	El-Far, AH (corresponding author), Damanhour Univ, Fac Vet Med, Dept Biochem, Damanhour, Egypt.	ali.elfar@damanhour.edu.eg	Ghanima, Mahmoud Abo/AAU-8401-2020; Noreldin, Ahmed E./S-1130-2017; El-Far, Prof Dr/Ali H./L-7946-2017; Abd El-Aziz, Ayman H./AAG-5126-2019	Ghanima, Mahmoud Abo/0000-0002-1788-5082; Noreldin, Ahmed E./0000-0002-8344-0807; El-Far, Prof Dr/Ali H./0000-0001-9721-4360; Abd El-Aziz, Ayman H./0000-0002-8306-0011; Shukry, Mustafa/0000-0003-2722-2466				Abd El-Hack ME, 2018, ENVIRON SCI POLLUT R, V25, P31971, DOI 10.1007/s11356-018-3197-2; [Anonymous], 2017, J ADOLESC HLTH S, V61, pS1; Attia YA, 2015, ANIM SCI PAP REP, V33, P85; Attia YA, 2011, J ANIM PHYSIOL AN N, V95, P17, DOI 10.1111/j.1439-0396.2009.00967.x; Aydogan M.S, 2016, MED SCI INT MED J, V5, P539; Azevedo JL, 1998, EUR J APPL PHYSIOL, V78, P479, DOI 10.1007/s004210050449; Bancroft JD., 2013, THEORY PRACTICE HIST, V4; Bedirli A, 2007, SHOCK, V27, P397, DOI 10.1097/01.shk.0000245030.24235.f1; Belhassen T, 2016, WORLD RABBIT SCI, V24, P191, DOI 10.4995/wrs.2016.3991; Bhatt RS, 2017, J APPL ANIM RES, V45, P304, DOI 10.1080/09712119.2016.1174126; Blasco A., 2010, WORLD RABBIT SCI, V4, P93, DOI 10.4995/wrs.1996.278; Brown GD, 2005, CELL MICROBIOL, V7, P471, DOI 10.1111/j.1462-5822.2005.00505.x; Chen KL, 2008, POULTRY SCI, V87, P2242, DOI 10.3382/ps.2008-00147; Chen TC, 2003, INT J POULT SCI; Cox CM, 2010, POULTRY SCI, V89, P2597, DOI 10.3382/ps.2010-00987; Cox CM, 2010, POULTRY SCI, V89, P1924, DOI 10.3382/ps.2010-00865; Dalle Zotte A, 2011, MEAT SCI, V88, P319, DOI 10.1016/j.meatsci.2011.02.017; DeBlas C, 2010, NUTRITION OF THE RABBIT, 2ND EDITION, P1; DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478; Ebeid TA, 2013, LIVEST SCI, DOI [10.1016/j.livsci.2013.11.004, DOI 10.1016/J.LIVSCI.2013.11.004]; El-Badawi AY, 2018, AGR ENG INT CIGR J, V19, P220; El-Sawy A. E. F., 2015, Alexandria Journal of Veterinary Sciences, V44, P23; Ezema C., 2012, Comparative Clinical Pathology, V21, P1145, DOI 10.1007/s00580-011-1250-3; Falcao-e-Cunha L, 2007, WORLD RABBIT SCI, V15, P127; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Guo YM, 2003, IMMUNOPHARM IMMUNOT, V25, P461, DOI 10.1081/IPH-120024513; Hahn TW, 2006, J ANIM SCI, V84, P1422, DOI 10.2527/2006.8461422x; Harrison OJ, 2015, MUCOSAL IMMUNOL, V8, P1226, DOI 10.1038/mi.2015.13; Heywood JL, 2005, J MUSCLE RES CELL M, V26, P49, DOI 10.1007/s10974-005-9007-8; Hong YH, 2006, VET IMMUNOL IMMUNOP, V114, P209, DOI 10.1016/j.vetimm.2006.07.007; Ighodaro OM, 2018, ALEX J MED, V54, P287, DOI 10.1016/j.ajme.2017.09.001; Jaeschke H, 2003, AM J PHYSIOL-GASTR L, V284, pG15, DOI 10.1152/ajpgi.00342.2002; Khanna S., 2014, Haryana Veterinarian, V53, P23; Kiczorowska B, 2016, LIVEST SCI, V191, P117, DOI 10.1016/j.livsci.2016.07.019; Krakowski L, 1999, VET IMMUNOL IMMUNOP, V68, P1, DOI 10.1016/S0165-2427(99)00006-9; Krizkova L, 2003, ANTICANCER RES, V23, P2751; Lambert W.V., 1936, AM RES SOC ANIM PROD, V29, P236; Li J, 2005, ARCH ANIM NUTR, V59, P303, DOI 10.1080/17450390500247832; Miyamoto J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196579; Moon SH, 2016, ASIAN AUSTRAL J ANIM, V29, P384, DOI 10.5713/ajas.15.0141; NRC, 1977, NUTR REQ RABB; Petracci M, 2009, NUTRIENTS, V1, P111, DOI 10.3390/nu1020111; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prats C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077774; Resta-Lenert S, 2003, GUT, V52, P988, DOI 10.1136/gut.52.7.988; Saeed M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020462; Seyidoglu N, 2015, INDIAN J ANIM RES, V49, P602, DOI 10.18805/ijar.5570; Shao YJ, 2013, POULTRY SCI, V92, P1764, DOI 10.3382/ps.2013-03029; Shehata S. A., 2012, Egyptian Journal of Nutrition and Feeds, V15, P75; Teng PY, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00245; Tian XY, 2016, ANIM FEED SCI TECH, V215, P144, DOI 10.1016/j.anifeedsci.2016.03.009; Tizard I. R., 2013, VET IMMUNOLOGY; Tsukada C, 2003, CELL IMMUNOL, V221, P1, DOI 10.1016/S0008-8749(03)00061-3; Vetvicka V, 2007, INT J BIOL MACROMOL, V40, P291, DOI 10.1016/j.ijbiomac.2006.08.009; Xu C, 2013, CARBOHYD POLYM, V92, P1159, DOI 10.1016/j.carbpol.2012.10.023; Zhang AW, 2005, POULTRY SCI, V84, P1015, DOI 10.1093/ps/84.7.1015; Zotte AD, 2002, LIVEST PROD SCI, V75, P11, DOI 10.1016/S0301-6226(01)00308-6	57	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2020	15	6							e0234076	10.1371/journal.pone.0234076	http://dx.doi.org/10.1371/journal.pone.0234076			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC0EC	32520965	Green Published, gold			2022-12-26	WOS:000542969500013
J	Hayashi, H; Wang, T; Tanaka, M; Ogiwara, S; Okada, C; Ito, M; Fukunishi, N; Iida, Y; Nakamura, A; Sasaki, A; Amano, S; Yoshida, K; Otomo, A; Ohtsuka, M; Hadano, S				Hayashi, Hideki; Wang, Ting; Tanaka, Masayuki; Ogiwara, Sanae; Okada, Chisa; Ito, Masatoshi; Fukunishi, Nahoko; Iida, Yumi; Nakamura, Ayaka; Sasaki, Ayumi; Amano, Shunji; Yoshida, Kazuhiro; Otomo, Asako; Ohtsuka, Masato; Hadano, Shinji			Monitoring the autophagy-endolysosomal system using monomeric Keima-fused MAP1LC3B	PLOS ONE			English	Article							TRANSGENIC MICE; H+-ATPASE; PROTEIN; MATURATION; PATHWAY; CANCER; FLUX; PH	The autophagy-endolysosomal pathway is an evolutionally conserved degradation system that is tightly linked to a wide variety of physiological processes. Dysfunction of this system is associated with many pathological conditions such as cancer, inflammation and neurodegenerative diseases. Therefore, monitoring the cellular autophagy-endolysosomal activity is crucial for studies on the pathogenesis as well as therapeutics of such disorders. To this end, we here sought to create a novel means exploiting Keima, an acid-stable fluorescent protein possessing pH-dependent fluorescence excitation spectra, for precisely monitoring the autophagy-endolysosomal system. First, we generated three lines of transgenic (tg) mouse expressing monomeric Keima-fused MAP1LC3B (mKeima-LC3B). Then, these tg mice were subjected to starvation by food-restriction, and also challenged to neurodegeneration by genetically crossing with a mouse model of amyotrophic lateral sclerosis; i.e., SOD1(H46R) transgenic mouse. Unexpectedly, despite that a lipidated-form of endogenous LC3 (LC3-II) was significantly increased, those of mKeima-LC3B (mKeima-LC3B-II) were not changed under both stressed conditions. It was also noted that mKeima-LC3B-positive aggregates were progressively accumulated in the spinal cord of SOD1(H46R);mKeima-LC3B double-tg mice, suggestive of acid-resistance and aggregate-prone natures of long-term overexpressed mKeima-LC3B in vivo. Next, we characterized mouse embryonic fibroblasts (MEFs) derived from mKeima-LC3B-tg mice. In contrast with in vivo, levels of mKeima-LC3B-I were decreased under starved conditions. Furthermore, when starved MEFs were treated with chloroquine (CQ), the abundance of mKeima-LC3B-II was significantly increased. Remarkably, when cultured medium was repeatedly changed between DMEM (nutrient-rich) and EBSS (starvation), acidic/neutral signal ratios of mKeima-LC3B-positive compartments were rapidly and reversibly shifted, which were suppressed by the CQ treatment, indicating that intraluminal pH of mKeima-LC3B-positive vesicles was changeable upon nutritional conditions of culture media. Taken together, although mKeima-LC3B-tg mice may not be an appropriate tool to monitor the autophagy-endolysosomal system in vivo, mKeima-LC3B must be one of the most sensitive reporter molecules for monitoring this system under in vitro cultured conditions.	[Hayashi, Hideki; Wang, Ting; Tanaka, Masayuki; Ogiwara, Sanae; Okada, Chisa; Ito, Masatoshi; Fukunishi, Nahoko; Iida, Yumi; Nakamura, Ayaka; Sasaki, Ayumi; Amano, Shunji; Yoshida, Kazuhiro] Tokai Univ, Isehara Res Promot Div, Support Ctr Med Res & Educ, Isehara, Kanagawa, Japan; [Otomo, Asako; Hadano, Shinji] Tokai Univ, Sch Med, Dept Mol Life Sci, Mol Neuropathobiol Lab, Isehara, Kanagawa, Japan; [Otomo, Asako; Hadano, Shinji] Tokai Univ, Inst Med Sci, Isehara, Kanagawa, Japan; [Otomo, Asako; Hadano, Shinji] Tokai Univ, Micro Nano Technol Ctr, Hiratsuka, Kanagawa, Japan; [Ohtsuka, Masato] Tokai Univ, Sch Med, Dept Mol Life Sci, Genet Engn & Genome Editing Lab, Isehara, Kanagawa, Japan; [Hadano, Shinji] Tokai Univ, Grad Sch Med, Res Ctr Brain & Nervous Dis, Isehara, Kanagawa, Japan	Tokai University; Tokai University; Tokai University; Tokai University; Tokai University; Tokai University	Hadano, S (corresponding author), Tokai Univ, Sch Med, Dept Mol Life Sci, Mol Neuropathobiol Lab, Isehara, Kanagawa, Japan.; Hadano, S (corresponding author), Tokai Univ, Inst Med Sci, Isehara, Kanagawa, Japan.; Hadano, S (corresponding author), Tokai Univ, Micro Nano Technol Ctr, Hiratsuka, Kanagawa, Japan.; Hadano, S (corresponding author), Tokai Univ, Grad Sch Med, Res Ctr Brain & Nervous Dis, Isehara, Kanagawa, Japan.	shinji@is.icc.u-tokai.ac.jp	Otomo, Asako/AAA-6374-2019; Hadano, Shinji/ABA-5052-2021	Otomo, Asako/0000-0002-7849-4309; Hadano, Shinji/0000-0002-4997-3968; Ohtsuka, Masato/0000-0002-6952-4238; Tanaka, Masayuki/0000-0002-8682-8719	Japanese Society for Promotion of Science (JSPS) [24650189, 23300129, 26290018]	Japanese Society for Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant-in-Aid for Challenging Exploratory Research (24650189 to S.H.) and partly by a Grant-in-Aid for Scientific Research (B) (23300129, 26290018 to S. H.) from the Japanese Society for Promotion of Science (JSPS).	Alirezaei M, 2010, AUTOPHAGY, V6, P702, DOI 10.4161/auto.6.6.12376; [Anonymous], 2014, ANN ONCOL         S4, V25, piv305; BRIGHT GR, 1987, J CELL BIOL, V104, P1019, DOI 10.1083/jcb.104.4.1019; Ghislat G, 2012, J BIOL CHEM, V287, P38625, DOI 10.1074/jbc.M112.365767; Hadano S, 2016, HUM MOL GENET, V25, P3321, DOI 10.1093/hmg/ddw180; Hadano S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009805; Heckmann BL, 2019, CELL, V178, P536, DOI 10.1016/j.cell.2019.05.056; Heckmann BL, 2017, J MOL BIOL, V429, P3561, DOI 10.1016/j.jmb.2017.08.012; Hyttinen JMT, 2013, BBA-MOL CELL RES, V1833, P503, DOI 10.1016/j.bbamcr.2012.11.018; Ilie A, 2020, J BIOL CHEM, V295, P7075, DOI 10.1074/jbc.RA120.012614; Kaizuka T, 2016, MOL CELL, V64, P835, DOI 10.1016/j.molcel.2016.09.037; Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kogure T, 2006, NAT BIOTECHNOL, V24, P577, DOI 10.1038/nbt1207; Lafourcade C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002758; Leidal AM, 2020, NAT CELL BIOL, V22, P187, DOI 10.1038/s41556-019-0450-y; Leidal AM, 2018, NAT CELL BIOL, V20, P1338, DOI 10.1038/s41556-018-0235-8; Luningschror P, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00689-z; Mauvezin C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8007; Maxson ME, 2014, J CELL SCI, V127, P4987, DOI 10.1242/jcs.158550; Mitsui S, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0373-8; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2018, NAT CELL BIOL, V20, P521, DOI 10.1038/s41556-018-0092-5; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Ohtsuka M, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq860; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Porcelli AM, 2005, BIOCHEM BIOPH RES CO, V326, P799, DOI 10.1016/j.bbrc.2004.11.105; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Runwal G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46657-z; Rybstein MD, 2018, NAT CELL BIOL, V20, P243, DOI 10.1038/s41556-018-0042-2; Sahani MH, 2014, AUTOPHAGY, V10, P431, DOI 10.4161/auto.27344; Sasaki S, 2007, J NEUROPATH EXP NEUR, V66, P517, DOI 10.1097/01.jnen.0000263868.84188.3b; Stransky LA, 2015, J BIOL CHEM, V290, P27360, DOI 10.1074/jbc.M115.659128; Tanida I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110600; Tian FF, 2011, AUTOPHAGY, V7, P985, DOI 10.4161/auto.7.9.16012; Tooze SA, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018358; US Foodlink, 2016, US FOODLINK, V12, P1, DOI DOI 10.1016/j.jalz.2016.03.001; Yoshii SR, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091865; Zhong ZY, 2016, CELL, V166, P288, DOI 10.1016/j.cell.2016.05.051; Zhou CH, 2012, AUTOPHAGY, V8, P1215, DOI 10.4161/auto.20284	41	1	1	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2020	15	6							e0234180	10.1371/journal.pone.0234180	http://dx.doi.org/10.1371/journal.pone.0234180			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ0RE	32511278	gold, Green Published			2022-12-26	WOS:000540938100029
J	Ledberg, A				Ledberg, Anders			Exponential increase in mortality with age is a generic property of a simple model system of damage accumulation and death	PLOS ONE			English	Article							DNA-REPAIR; LIFE-SPAN; FRAILTY; HETEROGENEITY; FITNESS; IMPACT	The risk of dying increases exponentially with age, in humans as well as in many other species. This increase is often attributed to the "accumulation of damage" known to occur in many biological structures and systems. The aim of this paper is to describe a generic model of damage accumulation and death in which mortality increases exponentially with age. The damage-accumulation process is modeled by a stochastic process know as a queue, and risk of dying is a function of the accumulated damage, i.e., length of the queue. The model has four parameters and the main characteristics of the model are: (i) damage occurs at random times with a constant high rate; (ii) the damage is repaired at a limited rate, and consequently damage can accumulate; (iii) the efficiency of the repair mechanism decays linearly with age; (iv) the risk of dying is a function of the accumulated damage. Using standard results from the mathematical theory of queues it is shown that there is an exponential dependence between risk of dying and age in these models, and that this dependency holds irrespective of how the damage-accumulation process is modeled. Furthermore, the ways in which this exponential dependence is shaped by the model parameters are also independent of the details of the damage accumulation process. These generic features suggest that the model could be useful when interpreting changes in the relation between age and mortality in real data. To exemplify, historical mortality data from Sweden are interpreted in the light of the model. The decrease in mortality seen between cohorts born in 1905, compared to those born in 1885, can be accounted for by higher threshold to damage. This fits well with the many advances made in public health during the 20th century.	[Ledberg, Anders] Stockholm Univ, Dept Publ Hlth Sci, Stockholm, Sweden	Stockholm University	Ledberg, A (corresponding author), Stockholm Univ, Dept Publ Hlth Sci, Stockholm, Sweden.	anders.ledberg@su.se		Ledberg, Anders/0000-0003-3827-8721	Statens institutionsstyrelse [2.6.1-1134-2017]	Statens institutionsstyrelse	This research was partly financed by a grant from Statens institutionsstyrelse with number 2.6.1-1134-2017. There was no additional external funding received for this study.	Abate J., 1987, Queueing Systems Theory and Applications, V2, P41, DOI 10.1007/BF01182933; [Anonymous], 2021, LANG ENV STAT COMP; BROWN KS, 1974, J GERONTOL, V29, P46, DOI 10.1093/geronj/29.1.46; Burger O, 2016, J THEOR BIOL, V408, P34, DOI 10.1016/j.jtbi.2016.08.002; Comfort A, 1964, TIME CELLS AND AGING; Economos A C, 1982, Arch Gerontol Geriatr, V1, P3; Gavrilov LA, 2001, J THEOR BIOL, V213, P527, DOI 10.1006/jtbi.2001.2430; Gavrilov LA, 2019, GERONTOLOGY, V65, P451, DOI 10.1159/000500141; Gompertz B., 1825, PHILOS T ROYAL SOC L, V115, P515, DOI [DOI 10.1098/RSTL.1825.0026, 10.1098/rstl.1825.0026]; Gorbunova V, 2007, NUCLEIC ACIDS RES, V35, P7466, DOI 10.1093/nar/gkm756; Gross D, 2008, FUNDAMENTALS QUEUEIN; HEMMINKI E, 1976, AM J PUBLIC HEALTH, V66, P1180, DOI 10.2105/AJPH.66.12.1180; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042; Hjelmborg JV, 2006, HUM GENET, V119, P312, DOI 10.1007/s00439-006-0144-y; JOHNSON TE, 1990, SCIENCE, V249, P908, DOI 10.1126/science.2392681; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Kirkwood TBL, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0379; Ledberg A, 2020, LARGE DECREASE MAGNI; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Mitnitski A, 2005, J AM GERIATR SOC, V53, P2184, DOI 10.1111/j.1532-5415.2005.00506.x; Mitnitski A, 2015, INTERD T GERONT GERI, V40, P85, DOI 10.1159/000364933; Mitnitski A, 2013, BIOGERONTOLOGY, V14, P709, DOI 10.1007/s10522-013-9446-3; Newell G.F., 1982, APPL QUEUEING THEORY; NEWELL GF, 1968, J APPL PROBAB, V5, P436, DOI 10.2307/3212264; Nicolai S, 2015, AGING-US, V7, P1050, DOI 10.18632/aging.100858; Ogrodnik M, 2019, AGING CELL, V18, DOI 10.1111/acel.12841; Olshansky SJ, 1997, DEMOGRAPHY, V34, P1, DOI 10.2307/2061656; Rau R, 2007, DEMOGR RES MONOGR, P1, DOI 10.1007/978-3-540-44902-7; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; SACHER GA, 1962, ANN NY ACAD SCI, V96, P985, DOI 10.1111/j.1749-6632.1962.tb54116.x; SAYMOUR M, 1994, PHILOS STUD, V74, P1; Socialstyrelsenc, 1986, 19869 SOC, V9; Statistics Sweden, 2010, COH MORT SWED MORT S; Strehler B.L, 1977, TIME CELLS AND AGING, V2nd; STREHLER BL, 1960, SCIENCE, V132, P14, DOI 10.1126/science.132.3418.14; Svenska Gallup Institutet AB, 1955, SVENSK FOLK TOB; Vaupel JW, 2014, DEMOGR RES, V31, P659, DOI 10.4054/DemRes.2014.31.22; VAUPEL JW, 1979, DEMOGRAPHY, V16, P439, DOI 10.2307/2061224; WOODBURY MA, 1977, THEOR POPUL BIOL, V11, P37, DOI 10.1016/0040-5809(77)90005-3	40	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0233384	10.1371/journal.pone.0233384	http://dx.doi.org/10.1371/journal.pone.0233384			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MA6PX	32497107	Green Submitted, gold, Green Published			2022-12-26	WOS:000542035200056
J	Maphumulo, A; Mahomed, O; Vennervald, B; Gundersen, SG; Taylor, M; Kjetland, EF				Maphumulo, A.; Mahomed, O.; Vennervald, B.; Gundersen, S. G.; Taylor, M.; Kjetland, E. F.			The cost of a school based mass treatment of schistosomiasis in Ugu District, KwaZulu Natal, South Africa in 2012	PLOS ONE			English	Article							CHILDREN	Introduction The Neglected Tropical Diseases Roadmap of the WHO set targets for potential elimination as a "public health problem" for the period 2012-2020 in multiple countries in Africa, with the aim of global elimination of schistosomiasis as a "public health problem" by 2025. Aim The purpose of the study was to estimate the cost from a provider's perspective of the Department of Health's Schistosomiasis Mass Drug Administration (MDA) in Ugu District, KwaZulu-Natal in 2012, with a view to project the costs for the entire KwaZulu Natal Province. Methods A total of 491 public schools and 16 independent schools in Ugu District, a predominantly rural district in KwaZulu-Natal with a total of 218 242 learners, were included in the schistosomiasis control programme. They were randomly selected from schools situated below an altitude of 300 meters, where schistosomiasis is endemic. A retrospective costing study was conducted using the provider's perspective to cost. Cost data were collected by reviewing existing records including financial statements, invoices, receipts, transport log books, equipment inventories, and information from personnel payroll, existing budget, and the staff diaries. Results A total of 15571 children were treated in 2012, resulting in a total cost of the MDA programme of ZAR 2 137 143 and a unit cost of ZAR 137. The three main cost components were Medication Costs (37%), Human Resources Cost (36%) and Capital items (16%). The total cost for treating all eligible pupils in KwaZulu-Natal will be ZAR 149 031 888. However, should the capital cost be excluded, then the unit cost will be ZAR 112 per patient and this will translate to a total cost of ZAR 121 836 288. Conclusions Low coverage exacerbates the cost of the programme and makes a decision to support such a programme difficult. However, a normative costing study based on the integration of the programme within the Department of Health should be conducted.	[Maphumulo, A.; Mahomed, O.; Taylor, M.; Kjetland, E. F.] Univ KwaZulu Natal, Publ Hlth Dept, Durban, South Africa; [Vennervald, B.] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Gundersen, S. G.] Oslo Univ Hosp, Sorlandet Sykehus HF, Oslo, Norway; [Gundersen, S. G.] Univ Agder, Dept Global Dev & Planning, Kristiansand, Norway; [Kjetland, E. F.] Norwergian Ctr Imported & Trop Dis, Oslo, Norway	University of Kwazulu Natal; University of Copenhagen; University of Oslo; University of Agder	Mahomed, O (corresponding author), Univ KwaZulu Natal, Publ Hlth Dept, Durban, South Africa.	ozayr411@gmail.com	Mahomed, Ozayr/L-7570-2019	Mahomed, Ozayr/0000-0001-8076-0453; Maphumulo, Andile/0000-0002-5518-4113; Kjetland, Eyrun Floerecke/0000-0002-5552-1095; Vennervald, Birgitte/0000-0001-5721-3494	South-Eastern Regional Health Authority, Norway [2016055]; European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant [PIRSES-GA-2010-269245]	South-Eastern Regional Health Authority, Norway; European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant(European Research Council (ERC))	The research leading to these results has received funding from the South-Eastern Regional Health Authority, Norway no. 2016055 and European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no. PIRSES-GA-2010-269245. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Ahmed SH, 2016, SCHISTOSOMIASIS; [Anonymous], 2010, LIDER POSLOVNI TJEDN, V25, P30; Appleton C. C., 2006, Southern African Journal of Epidemiology & Infection, V21, P55; Brooker S, 2008, HEALTH POLICY PLANN, V23, P24, DOI 10.1093/heapol/czm041; Corcoran C, 2016, DIAGNOSING SCHISTOSO; Fenwick A, 2009, PARASITOLOGY, V136, P1719, DOI 10.1017/S0031182009990400; Fu SH, 2011, PLOS NEGL TROP DIS, V5, pe1231; Gabrielli AF, 2006, ACTA TROP, V99, P234, DOI 10.1016/j.actatropica.2006.08.008; Hill AM, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000571; Hotez PJ, 2010, LANCET, V376, P496, DOI 10.1016/S0140-6736(10)60879-3; Jinabhai CC, 2001, ANN TROP PAEDIATR, V21, P50, DOI 10.1080/02724930020028920; Jordan P, 2000, ACTA TROP, V77, P9, DOI 10.1016/S0001-706X(00)00121-2; Kjetland EF, 2006, AIDS, V20, P593, DOI 10.1097/01.aids.0000210614.45212.0a; Lothe A, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3102-0; Magaisa K, 2015, S AFRICAN J SCI, V111; Magaisa K, 2015, S AFR J SCI, V111, P32, DOI 10.17159/sajs.2015/20140427; Moodley I, 2003, MODELLING SCHISTOSOM; [National Department of Health Health NDo], 2008, POL IMPL GUID 2008 R; National Institute of Communicable Diseases, 2014, SCHIST BILH FAQS; Randjelovic A, 2015, S AFR FAM PRACT, V57, P57, DOI 10.1080/20786190.2014.978121; Turner HC, 2018, CLIN INFECT DIS, V66, P1298, DOI 10.1093/cid/cix1001; uGu District Municipality, 2019, 2018 19 INT DEV PLAN; WHO, 2011, HELMINTH CONTROL IN SCHOOL-AGE CHILDREN: A GUIDE FOR MANAGERS OF CONTROL PROGRAMMES, SECOND EDITION, P1; WHO, 2011, WHO REP 2011 HELM CO; World Health Organization, 2017, SCIST FACT SHEET; World Health Organization (WHO), 2012, LOND DECL NEGL TROP	26	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0232867	10.1371/journal.pone.0232867	http://dx.doi.org/10.1371/journal.pone.0232867			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497049	Green Published, gold			2022-12-26	WOS:000542035200068
J	Wang, MQ; Strand, MJ; Lanser, BJ; Santos, C; Bendelja, K; Fish, J; Esterl, EA; Ashino, S; Abbott, JK; Knight, V; Gelfand, EW				Wang, Meiqin; Strand, Matthew J.; Lanser, Bruce J.; Santos, Carah; Bendelja, Kreso; Fish, Jennifer; Esterl, Elizabeth A.; Ashino, Shigeru; Abbott, Jordan K.; Knight, Vijaya; Gelfand, Erwin W.			Expression and activation of the steroidogenic enzyme CYP11A1 is associated with IL-13 production in T cells from peanut allergic children	PLOS ONE			English	Article							GENE-EXPRESSION; FOOD CHALLENGES; TRANSCRIPTIONAL REGULATION; DIAGNOSIS; RESPONSES; RISK	Activation of the steroidogenic enzyme CYP11A1 was shown to be necessary for the development of peanut-induced intestinal anaphylaxis and IL-13 production in allergic mice. We determined if levels of CYP11A1 in peripheral blood T cells from peanut-allergic (PA) children compared to non-allergic controls were increased and if levels correlated to IL-13 production and oral challenge outcomes to peanut. CYP11A1 mRNA and protein levels were significantly increased in activated CD4(+) T cells from PA patients. In parallel, IL-13 production was significantly increased; IFN gamma levels were not different between groups. There were significant correlations between expression levels of CYP11A1 mRNA and levels of IL13 mRNA and protein, levels of serum IgE anti-Ara h 2 and to outcomes of peanut challenge. The importance of CYP11A1 on cytokine production was tested using a CYP11A1 CRISPR/Cas9 KO plasmid or an inhibitor of enzymatic CYP11A1 activity. Inhibition of CYP11A1 activation in patient cells treated with the inhibitor, aminoglutethimide, or CD4(+) T cell line transfected with the CYP11A1 KO plasmid resulted in reduced IL-13 production. These data suggest that the CYP11A1-CD4(+)Tcell-IL-13 axis in activated CD4(+) T cells from PA children is associated with development of PA reactions. CYP11A1 may represent a novel target for therapeutic intervention in PA children.	[Wang, Meiqin; Lanser, Bruce J.; Santos, Carah; Bendelja, Kreso; Fish, Jennifer; Esterl, Elizabeth A.; Ashino, Shigeru; Abbott, Jordan K.; Gelfand, Erwin W.] Natl Jewish Hlth, Div Cell Biol, Dept Pediat, Denver, CO 80206 USA; [Strand, Matthew J.] Natl Jewish Hlth, Div Biostat & Bioinformat, Denver, CO USA; [Knight, Vijaya] Natl Jewish Hlth, Adv Diagnost Labs, Denver, CO USA	National Jewish Health; National Jewish Health; National Jewish Health	Gelfand, EW (corresponding author), Natl Jewish Hlth, Div Cell Biol, Dept Pediat, Denver, CO 80206 USA.	erwin3460@gmail.com	Strand, Matt/AAU-3762-2021; Lanser, Bruce/GVU-1927-2022; Abbott, Jordan K/P-2509-2016	Strand, Matt/0000-0002-9083-5989; Lanser, Bruce/0000-0002-3422-8658; Abbott, Jordan K/0000-0001-6334-5266; Bendelja, Kreso/0000-0002-6017-3355	NIH [AI-77609]; Colorado Advanced Industries Grant; Eugene F. and Easton M. Crawford Charitable Lead Unitrust; Dreiseszun Fund	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Colorado Advanced Industries Grant; Eugene F. and Easton M. Crawford Charitable Lead Unitrust; Dreiseszun Fund	This work was supported by NIH grant AI-77609 (to EWG), Colorado Advanced Industries Grant (to MW), Eugene F. and Easton M. Crawford Charitable Lead Unitrust (to EWG), and the Dreiseszun Fund (to EWG).	Appay V, 2007, J IMMUNOL, V179, P7406, DOI 10.4049/jimmunol.179.11.7406; Asai Y, 2018, J ALLERGY CLIN IMMUN, V141, P991, DOI 10.1016/j.jaci.2017.09.015; Bernstein IL, 2008, ANN ALLERG ASTHMA IM, V100, pS1, DOI 10.1016/S1081-1206(10)60305-5; Bock SA, 2001, J ALLERGY CLIN IMMUN, V107, P191, DOI 10.1067/mai.2001.112031; Bublin M, 2014, INT ARCH ALLERGY IMM, V165, P179, DOI 10.1159/000369340; Caffarelli C, 2001, LANCET, V358, P1871, DOI 10.1016/S0140-6736(01)06897-0; Celik-Bilgili S, 2005, CLIN EXP ALLERGY, V35, P268, DOI 10.1111/j.1365-2222.2005.02150.x; Cima I, 2004, J EXP MED, V200, P1635, DOI 10.1084/jem.20031958; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Hill DJ, 2001, CLIN EXP ALLERGY, V31, P1031, DOI 10.1046/j.1365-2222.2001.01113.x; Jeon SM, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0038-9; Jia Y, 2013, P NATL ACAD SCI USA, V110, P8152, DOI 10.1073/pnas.1216671110; Jimenez P, 2003, ENDOCRINOLOGY, V144, P4285, DOI 10.1210/en.2003-0472; LaVoie HA, 2009, EXP BIOL MED, V234, P880, DOI 10.3181/0903-MR-97; Mahata B, 2014, CELL REP, V7, P1130, DOI 10.1016/j.celrep.2014.04.011; Pazirandeh A, 1999, FASEB J, V13, P893, DOI 10.1096/fasebj.13.8.893; Pochard P, 2010, J ALLERGY CLIN IMMUN, V126, P92, DOI 10.1016/j.jaci.2010.04.003; Prussin C, 1995, J IMMUNOL METHODS, V188, P117, DOI 10.1016/0022-1759(95)00209-X; Sampson HA, 1997, J ALLERGY CLIN IMMUN, V100, P444, DOI 10.1016/S0091-6749(97)70133-7; Sampson HA, 2012, J ALLERGY CLIN IMMUN, V130, P1260, DOI 10.1016/j.jaci.2012.10.017; Samy TSA, 2001, ENDOCRINOLOGY, V142, P3519, DOI 10.1210/en.142.8.3519; Schedel M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10213; Sher N, 2007, MOL ENDOCRINOL, V21, P948, DOI 10.1210/me.2006-0226; Shih MC, 2008, MOL ENDOCRINOL, V22, P915, DOI 10.1210/me.2007-0222; Shih MCM, 2011, MOL CELL ENDOCRINOL, V336, P80, DOI 10.1016/j.mce.2010.12.017; Sicherer SH, 2014, J ALLERGY CLIN IMMUN, V133, P291, DOI 10.1016/j.jaci.2013.11.020; Sicherer SH, 2000, J ALLERGY CLIN IMMUN, V106, P53, DOI [10.1067/mai.2000.108105, 10.1067/mai.2000.110158]; Turcanu V, 2003, J CLIN INVEST, V111, P1065, DOI 10.1172/JCI200316142; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Wang MQ, 2013, J ALLERGY CLIN IMMUN, V132, P1174, DOI 10.1016/j.jaci.2013.05.027; Wang MQ, 2010, J ALLERGY CLIN IMMUN, V126, P306, DOI 10.1016/j.jaci.2010.05.017; Weisse K, 2013, ALLERGY, V68, P220, DOI 10.1111/all.12081; Yu W, 2016, NAT REV IMMUNOL, V16, P751, DOI 10.1038/nri.2016.111	33	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0233563	10.1371/journal.pone.0233563	http://dx.doi.org/10.1371/journal.pone.0233563			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497050	Green Published, gold			2022-12-26	WOS:000542035200040
J	Broleze, DF; Souza, LL; Zorzetto, MF; Savegnago, RP; Negrao, JA; Bonilha, SFM; Mercadante, MEZ				Broleze, Danielly Fernanda; Souza, Luana Lelis; Zorzetto, Mariana Furtado; Savegnago, Rodrigo Pelicioni; Negrao, Joao Alberto; Bonilha, Sarah Figueiredo Martins; Mercadante, Maria Eugenia Zerlotti			Feed efficiency and maternal productivity of Bos indicus beef cows	PLOS ONE			English	Article							GROWTH; PERFORMANCE; ANGUS; TRAITS; ULTRASOUND; PROGENY; HEIFERS; DAIRY; MILK	This study evaluated 53 primiparous cows (36.8 +/- 1.23 months old and 484 +/- 40.9 kg of body weight) performance tested (GrowSafe (R) System) from 22 +/- 5 to 190 +/- 13 days of lactation in order to obtain daily dry matter intake (DMI). The animals received a high-forage diet (forage-to-concentrate ratio of 90:10). Milk production of the cows was evaluated three times by mechanical milking and the energy-corrected milk yield (ECMY) was calculated. Energy status (through the indicators glucose, cholesterol, triglycerides, and beta-hydroxybutyrate), protein status (indicators albumin, urea, and creatinine), mineral status (indicators calcium, phosphorus, and magnesium), and hormonal status (indicators insulin and cortisol) were estimated four times throughout lactation. The residual feed intake (RFI) of cows was calculated considering DMI, average daily gain (ADG) and mid-test metabolic weight (BW0.75) obtained in early lactation (from 22 +/- 5 to 102 +/- 7 days), and the animals were classified as negative (most efficient) or positive RFI (least efficient). The RFI model explained 53% of the variation in DMI. The mean DMI, ADG, ECMY, and calf weight as a percentage of cow weight were 12.47 +/- 2.70 kg DM/day, 0.632 +/- 0.323 kg/day, 10.47 +/- 3.23 kg/day, and 36.6 +/- 5.39%, respectively. Negative RFI cows consumed 11.5% less DM than positive RFI cows, with performance and metabolic profile being similar to those of positive RFI cows, except for a lower milk protein content and higher blood cholesterol concentration. In conclusion, negative (most efficient) and positive RFI (least efficient) Nellore cows, fed an ad libitum high-forage diet, produced similar amounts of milk, fat and lactose and had similar subcutaneous fat thickness, weight, calf weight as a percentage of cow weight, and blood metabolite concentrations (except for cholesterol). Therefore, there are economic benefits to utilizing RFI in a cow herd since cattle had decreased DMI with similar overall performance, making them more profitable due to lower input costs.	[Broleze, Danielly Fernanda; Souza, Luana Lelis; Zorzetto, Mariana Furtado; Savegnago, Rodrigo Pelicioni; Bonilha, Sarah Figueiredo Martins; Mercadante, Maria Eugenia Zerlotti] Ctr Avancado Pesquisa Bovinos Corte, Inst Zootecnia IZ, Sertaozinho, SP, Brazil; [Negrao, Joao Alberto] Univ Sao Paulo, Fac Zootecnia & Engn Alimentos, Pirassununga, SP, Brazil	Instituto de Zootecnia; Universidade de Sao Paulo	Mercadante, MEZ (corresponding author), Ctr Avancado Pesquisa Bovinos Corte, Inst Zootecnia IZ, Sertaozinho, SP, Brazil.	mezmercadante@gmail.com	Bonilha, Sarah F M/D-1043-2012; Savegnago, Rodrigo Pelicioni/H-7396-2012; Negrao, Joao/M-3819-2017	Bonilha, Sarah F M/0000-0002-8055-4112; Savegnago, Rodrigo Pelicioni/0000-0002-6551-2168; Negrao, Joao/0000-0003-3510-411X	Sao Paulo Research Foundation (FAPESP) [2015/02066-4, 2016/24423-6]; Coordination for the Improvement of Higher Education Personnel (CAPES) [001]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Sao Paulo Research Foundation (FAPESP, grant #2015/02066-4) for financial support and for providing grant to MFZ (FAPESP, grant #2016/24423-6), and Coordination for the Improvement of Higher Education Personnel (CAPES, Finance Code 001) for providing grants to DFB, LLS, and RPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Archer JA, 1997, J ANIM SCI, V75, P2024; Arthur PF, 2005, AUST J EXP AGR, V45, P985, DOI 10.1071/EA05052; Basarab JA, 2007, CAN J ANIM SCI, V87, P489, DOI 10.4141/CJAS07026; Berry DP, 2013, J ANIM SCI, V91, P1594, DOI 10.2527/jas.2012-5862; Black TE, 2013, J ANIM SCI, V91, P2254, DOI [10.2527/jas.2012-5242, 10.2527/jas2012-5242]; Cerdotes L, 2004, REV BRAS ZOOTECN, V33, P610, DOI 10.1590/S1516-35982004000300010; Council N-NR, 1996, NUTR REQ BEEF CATTL; Council NR, 2001, NUTR REQUIREMENTS DA; Cundiff LV, 2010, GUIDELINES UNIFORM B, P17; da Silva AG, 2017, TROP ANIM HEALTH PRO, V49, P383, DOI 10.1007/s11250-016-1204-5; de Almeida DM, 2018, TROP ANIM HEALTH PRO, V50, P1771, DOI 10.1007/s11250-018-1617-4; Detmann E, 2016, NUTR REQUIREMENTS ZE, V2, P45; DiGiacomo K, 2018, J DAIRY SCI, V101, P6474, DOI 10.3168/jds.2017-12569; Gibb D, 1999, P 20 W NUTR C MARK 2; Kenny DA, 2018, ANIMAL, V12, P1815, DOI [10.1017/S1751731118000976, 10.1017/s1751731118000976]; Lamb GC, 1999, J ANIM SCI, V77, P2207; Lawrence P, 2013, LIVEST SCI, V152, P154, DOI 10.1016/j.livsci.2012.12.024; Lawrence P, 2011, J ANIM SCI, V89, P3248, DOI 10.2527/jas.2010-3774; Macdonald KA, 2014, J DAIRY SCI, V97, P1427, DOI [10.31, 10.3168/jds.2013-7227]; Mao F, 2013, J ANIM SCI, V91, P2067, DOI 10.2527/jas.2012-5470; Montanholi YR, 2013, CAN J ANIM SCI, V93, P487, DOI [10.4141/CJAS2013-054, 10.4141/cjas2013-054]; Montanholi YR, 2017, ACTA VET SCAND, V59, DOI 10.1186/s13028-017-0292-1; Morris ST, 2014, ANIM PROD SCI, V54, P1428, DOI 10.1071/AN14220; Rauw WM, 2007, ANIMAL, V1, P865, DOI 10.1017/S1751731107000018; Richardson EC, 2004, AUST J EXP AGR, V44, P441, DOI 10.1071/EA02219; Richardson EC, 2002, AUST J EXP AGR, V42, P901, DOI 10.1071/EA01098; Rose S, 2018, CANCER DISCOV, V8, P133, DOI 10.1158/2159-8290.CD-NB2017-177; Santana MHA, 2014, LIVEST SCI, V167, P80, DOI 10.1016/j.livsci.2014.06.002; Scapini S, 2019, VOZ ESCR, P1; Schwager-Suter R, 2000, ANIM SCI, V71, P465, DOI 10.1017/S1357729800055375; Siqueira JGd, 2007, REV BRASILEIRA ZOOTE; Taylor MS, 2007, CALCIUM PHOSPHORUS M; Walker RS, 2015, J ANIM SCI, V93, P672, DOI 10.2527/jas.2014-7702; Wood KM, 2014, CAN J ANIM SCI, V94, P499, DOI 10.4141/CJAS2013-165	35	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2020	15	6							e0233926	10.1371/journal.pone.0233926	http://dx.doi.org/10.1371/journal.pone.0233926			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LW6ZP	32492042	gold, Green Published			2022-12-26	WOS:000539293000042
J	Calvo, A; Roddy, DW; Coughlan, H; Kelleher, I; Healy, C; Harley, M; Clarke, M; Leemans, A; Frodl, T; O'Hanlon, E; Cannon, M				Calvo, Ana; Roddy, Darren W.; Coughlan, Helen; Kelleher, Ian; Healy, Colm; Harley, Michelle; Clarke, Mary; Leemans, Alexander; Frodl, Thomas; O'Hanlon, Erik; Cannon, Mary			Reduced hippocampal volume in adolescents with psychotic experiences: A longitudinal population-based study	PLOS ONE			English	Article							ULTRA-HIGH RISK; SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; CHILDHOOD TRAUMA; BRAIN STRUCTURE; 1ST-EPISODE SCHIZOPHRENIA; COMMUNITY SAMPLE; SYMPTOMS; DISORDERS; YOUNG	Aims Smaller hippocampal volumes are among the most consistently reported neuroimaging findings in schizophrenia. However, little is known about hippocampal volumes in people who report psychotic experiences. This study investigated differences in hippocampal volume between young people without formal diagnoses who report psychotic experiences (PEs) and those who do not report such experiences. This study also investigated if any differences persisted over two years. Methods A nested case-control study of 25 adolescents (mean age 13.5 years) with reported PEs and 25 matched controls (mean age 13.36 years) without PEs were drawn from a sample of 100 local schoolchildren. High-resolution T1-weighted anatomical imaging and subsequent automated cortical segmentation (Freesurfer 6.0) was undertaken to determine total hippocampal volumes. Comprehensive semi-structured clinical interviews were also performed including information on PEs, mental diagnoses and early life stress (bullying). Participants were invited for a second scan at two years. Results 19 adolescents with PEs and 19 controls completed both scans. Hippocampal volumes were bilaterally lower in the PE group compared to the controls with moderate effects sizes both at baseline [left hippocampus p = 0.024 d = 0.736, right hippocampus p = 0.018, d = 0.738] and at 2 year follow up [left hippocampus p = 0.027 d = 0.702, right = 0.048 d = 0.659] throughout. These differences survived adjustment for co-morbid mental disorders and early life stress. Conclusions Psychotic experiences are associated with total hippocampal volume loss in young people and this volume loss appears to be independent of possible confounders such as co-morbid disorders and early life stress.	[Calvo, Ana; Roddy, Darren W.; Coughlan, Helen; Kelleher, Ian; Healy, Colm; Harley, Michelle; Clarke, Mary; O'Hanlon, Erik; Cannon, Mary] Royal Coll Surgeons Ireland, Dept Psychiat, Dublin, Ireland; [Calvo, Ana] Univ Int Rioja UNIR, Fac Hlth Sci, Madrid, Spain; [Calvo, Ana] Univ Complutense, Hosp Gen Univ Gregorio Maranon, Dept Child & Adolescent Psychiat, CIBERSAM,IiSGM,Sch Med, Madrid, Spain; [Roddy, Darren W.; Frodl, Thomas; O'Hanlon, Erik; Cannon, Mary] Trinity Coll Dublin, Trinity Coll Inst Neurosci, Dublin, Ireland; [Leemans, Alexander] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [Frodl, Thomas] Otto von Guericke Univ Mageburg, Dept & Hosp Psychiat & Psychotherapy, Mageburg, Germany; [Frodl, Thomas] German Ctr Neurodegenerat Dis DZNE, Site Magdeburg, Magdeburg, Germany	Royal College of Surgeons - Ireland; Universidad Internacional de La Rioja (UNIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Complutense University of Madrid; General University Gregorio Maranon Hospital; Trinity College Dublin; Utrecht University; Utrecht University Medical Center; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Calvo, A; Cannon, M (corresponding author), Royal Coll Surgeons Ireland, Dept Psychiat, Dublin, Ireland.; Calvo, A (corresponding author), Univ Int Rioja UNIR, Fac Hlth Sci, Madrid, Spain.; Calvo, A (corresponding author), Univ Complutense, Hosp Gen Univ Gregorio Maranon, Dept Child & Adolescent Psychiat, CIBERSAM,IiSGM,Sch Med, Madrid, Spain.; Cannon, M (corresponding author), Trinity Coll Dublin, Trinity Coll Inst Neurosci, Dublin, Ireland.	anabelen.calvo@unir.net; marycannon@rcsi.ie	Cannon, Mary/D-8227-2012; Frodl, Thomas Stefan/GQZ-9107-2022; Frodl, Thomas/D-8118-2012; Calvo, Ana/AAD-7944-2020; Coughlan, Helen/P-3462-2014	Cannon, Mary/0000-0002-0910-299X; Frodl, Thomas Stefan/0000-0002-8113-6959; Frodl, Thomas/0000-0002-8113-6959; Calvo, Ana/0000-0002-7953-2629; Coughlan, Helen/0000-0002-8494-2884; Kelleher, Ian/0000-0003-1484-651X	European Research Council Consolidator Award [724809 iHEAR]; Health Research Board Ireland [HRA/PHS/2-012/28]; Alicia Koplowitz Foundation; Interdisciplinary Capacity Enhancement Award from the Health Research Board [ICE/2012/11]; VIDI Grant from the Netherlands Organization for Scientific Research (NWO) [639.072.411]; Royal College of Surgeons in Ireland; Science Foundation Ireland	European Research Council Consolidator Award(European Research Council (ERC)); Health Research Board Ireland; Alicia Koplowitz Foundation; Interdisciplinary Capacity Enhancement Award from the Health Research Board; VIDI Grant from the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Royal College of Surgeons in Ireland; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This study was funded by a European Research Council Consolidator Award [724809 iHEAR] to MCannon and by the Health Research Board Ireland [HRA/PHS/2-012/28 (EO'H)]. AC was supported through Alicia Koplowitz grant for Short-Term Placements from the Alicia Koplowitz Foundation. HC was supported by an Interdisciplinary Capacity Enhancement Award from the Health Research Board (ICE/2012/11) to M Cannon and M Clarke. The research of AL. is supported by VIDI Grant 639.072.411 from the Netherlands Organization for Scientific Research (NWO). IK is funded by a STaR lectureship from the Royal College of Surgeons in Ireland.; We acknowledge the use of the facilities of the Clinical Research Centre in the RCSI Education and Research Centre and Trinity College High-Performance Computing support and infrastructure funded by Science Foundation Ireland. We thank Mr. Ciaran Conneely, Administrator, Trinity College Institute of Neuroscience (TCIN) and Mr. Sojo Joseph, TCIN MRI Radiographer. We would particularly like to thank all the young participants and their parents for giving their time to this study.	Allen P, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00298; Allen P, 2016, AM J PSYCHIAT, V173, P392, DOI 10.1176/appi.ajp.2015.15040485; Anacker C, 2016, BIOL PSYCHIAT, V79, P840, DOI 10.1016/j.biopsych.2015.08.009; Armando M, 2010, SCHIZOPHR RES, V119, P258, DOI 10.1016/j.schres.2010.03.001; Arseneault L, 2011, AM J PSYCHIAT, V168, P65, DOI 10.1176/appi.ajp.2010.10040567; Baumann PS, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.117; Bendall S, 2008, SCHIZOPHRENIA BULL, V34, P568, DOI 10.1093/schbul/sbm121; Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; Blanchard MM, 2010, SCHIZOPHR RES, V123, P71, DOI 10.1016/j.schres.2010.05.028; Brugger SP, 2017, JAMA PSYCHIAT, V74, P1104, DOI 10.1001/jamapsychiatry.2017.2663; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Calvo A, 2018, J AFFECT DISORD; Cohen J., 1998, STAT POWER ANAL BEHA; Corp I, 2012, IBM SPSS STAT WIND V; Cristobal-Narvaez P, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0153557, 10.1176/appi.focus.140301]; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Drakesmith M, 2015, HUM BRAIN MAPP, V36, P2629, DOI 10.1002/hbm.22796; Dubovyk V, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00098; Iglesias JE, 2015, NEUROIMAGE, V115, P117, DOI 10.1016/j.neuroimage.2015.04.042; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Frodl T, 2017, J PSYCHIATR RES, V86, P58, DOI 10.1016/j.jpsychires.2016.11.010; Frodl T, 2013, NEUROBIOL DIS, V52, P24, DOI 10.1016/j.nbd.2012.03.012; Harrisberger F, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.143; Heckers S, 2010, CURR TOP BEHAV NEURO, V4, P529, DOI 10.1007/7854_2010_43; Ho BC, 2011, ARCH GEN PSYCHIAT, V68, P128, DOI 10.1001/archgenpsychiatry.2010.199; Hoy K, 2012, SCHIZOPHRENIA BULL, V38, P1162, DOI 10.1093/schbul/sbr085; Jacobson S, 2010, NEUROIMAGE, V49, P1875, DOI 10.1016/j.neuroimage.2009.09.015; Kaufman J, 2000, BIOL PSYCHIAT, V48, P778, DOI 10.1016/S0006-3223(00)00998-7; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kaymaz N, 2010, PSYCHOL MED, V40, P1963, DOI 10.1017/S0033291710000358; Kelleher I, 2012, PSYCHOL MED, V42, P1857, DOI 10.1017/S0033291711002960; Kelleher I, 2013, JAMA PSYCHIAT, V70, P940, DOI 10.1001/jamapsychiatry.2013.140; Kelleher I, 2013, SCHIZOPHRENIA BULL, V39, P1018, DOI 10.1093/schbul/sbs086; Kelleher I, 2013, AM J PSYCHIAT, V170, P734, DOI 10.1176/appi.ajp.2012.12091169; Kelleher I, 2012, SCHIZOPHRENIA BULL, V38, P239, DOI 10.1093/schbul/sbr164; Linscott RJ, 2013, PSYCHOL MED, V43, P1133, DOI 10.1017/S0033291712001626; Mamah Daniel, 2012, Front Psychiatry, V3, P96, DOI 10.3389/fpsyt.2012.00096; McGrath JJ, 2016, AM J PSYCHIAT; Nansel TR, 2001, JAMA-J AM MED ASSOC, V285, P2094, DOI 10.1001/jama.285.16.2094; Nenadic I, 2015, SCHIZOPHR RES, V161, P169, DOI 10.1016/j.schres.2014.10.041; O'Hanlon E, 2015, JAMA PSYCHIAT, V72, P668, DOI 10.1001/jamapsychiatry.2015.0137; Poulton R, 2000, ARCH GEN PSYCHIAT, V57, P1053, DOI 10.1001/archpsyc.57.11.1053; Qiu A, 2013, PSYCHOL MED, V43, P1353, DOI 10.1017/S0033291712002218; Rao U, 2010, BIOL PSYCHIAT, V67, P357, DOI 10.1016/j.biopsych.2009.10.017; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Roddy D., 2019, CHRONIC STRESS 1000, V3; Roddy DW, 2019, BIOL PSYCHIAT, V85, P487, DOI 10.1016/j.biopsych.2018.08.021; Rutigliano G, 2016, J AFFECT DISORDERS, V203, P101, DOI 10.1016/j.jad.2016.05.053; Satterthwaite TD, 2015, MOL PSYCHIATR, V20, P1508, DOI 10.1038/mp.2015.66; Satterthwaite TD, 2016, JAMA PSYCHIAT, V73, P515, DOI 10.1001/jamapsychiatry.2015.3463; Schalinski I, 2015, PSYCHIAT RES, V228, P633, DOI 10.1016/j.psychres.2015.04.052; Sheline YI, 2019, BIOL PSYCHIAT, V85, P436, DOI 10.1016/j.biopsych.2019.01.011; Simard R, 2011, J STAT SOFTW, V39, P1, DOI 10.18637/jss.v039.i11; Smeets F, TESTING HYPOTHESIS P; Spauwen J, 2006, EPIDEMIOL PSICHIAT S, V15, P252, DOI 10.1017/S1121189X00002128; van Erp TGM, 2016, MOL PSYCHIATR, V21, P585, DOI 10.1038/mp.2015.118; Van Leemput K, 2009, IEEE T MED IMAGING, V28, P822, DOI 10.1109/TMI.2008.2010434; Watson DR, 2012, BRAIN IMAGING BEHAV, V6, P49, DOI 10.1007/s11682-011-9141-4; Weininger J, 2019, FRONT NEUROANAT, V13, DOI 10.3389/fnana.2019.00014; Welham J, 2009, PSYCHOL MED, V39, P625, DOI 10.1017/S0033291708003760; Werbeloff N, 2012, ARCH GEN PSYCHIAT, V69, P467, DOI 10.1001/archgenpsychiatry.2011.1580; Wigman JTW, 2012, SCHIZOPHRENIA BULL, V38, P247, DOI 10.1093/schbul/sbr196; Wolf DH, 2015, JAMA PSYCHIAT, V72, P456, DOI 10.1001/jamapsychiatry.2014.3169; Wolke D, 2001, BRIT J PSYCHOL, V92, P673, DOI 10.1348/000712601162419; Wood SJ, 2010, NEUROIMAGE, V52, P62, DOI 10.1016/j.neuroimage.2010.04.012; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16; Zammit S, 2013, AM J PSYCHIAT, V170, P742, DOI 10.1176/appi.ajp.2013.12060768	72	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2020	15	6							e0233670	10.1371/journal.pone.0233670	http://dx.doi.org/10.1371/journal.pone.0233670			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LW6ZP	32492020	gold, Green Published			2022-12-26	WOS:000539293000023
J	Chase, RP; Kerac, M; Grant, A; Manary, M; Briend, A; Opondo, C; Bailey, J				Chase, Rachel P.; Kerac, Marko; Grant, Angeline; Manary, Mark; Briend, Andre; Opondo, Charles; Bailey, Jeanette			Acute malnutrition recovery energy requirements based on mid-upper arm circumference: Secondary analysis of feeding program data from 5 countries, Combined Protocol for Acute Malnutrition Study (ComPAS) Stage 1	PLOS ONE			English	Article							MODERATE ACUTE MALNUTRITION; CHILDREN; RATES; RISK	Background Severe and moderate acute malnutrition (SAM and MAM) are currently treated with different food products in separate treatment programs. The development of a unified and simplified treatment protocol using a single food product aims to increase treatment program efficiency and effectiveness. This study, the first stage of the ComPAS trial, sought to assess rate of growth and energy requirements among children recovering from acute malnutrition in order to design a simplified, MUAC-based dosage protocol. Methods We obtained secondary data from patient cards of children aged 6-59 months recovering from SAM in outpatient therapeutic feeding programs (TFPs) and from MAM in supplementary feeding programs (SFPs) in five countries in Africa and Asia. We used local polynomial smoothing to assess changes in MUAC and proportional weight gain between clinic visits and assessed their normalized differences for a non-zero linear trend. We estimated energy needs to meet or exceed the growth observed in 95% of visits. Results This analysis used data from 5518 patients representing 33942 visits. Growth trends in MUAC and proportional weight gain were not significantly different, each lower at higher MUAC values: MUAC growth averaged 2mm/week at lower MUACs (100 to <110mm) and 1mm/week at higher MUACs (120mm to <125mm); and proportional weight gain declined from 3.9g/kg/day to 2.4g/kg/day across the same MUAC values. In 95% of visits by children with a MUAC 100mm to <125mm who were successfully treated, energy needs could be met or exceeded with 1,000 kilocalories a day. Conclusion Two 92g sachets of Ready-to-Use Therapeutic Food (RUTF) (1,000kcal total) is proposed to meet the estimated total energy requirements of children with a MUAC 100mm to <115mm, and one 92g sachet of RUTF (500kcal) is proposed to meet half the energy requirements of children with a MUAC of 115 to <125mm. A simplified, combined protocol may enable a more holistic continuum of care, potentially contributing to increased coverage for children suffering from acute malnutrition.	[Chase, Rachel P.] Johns Hopkins Univ, Dept Int Hlth, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Kerac, Marko; Bailey, Jeanette] London Sch Hyg & Trop Med, Dept Populat Hlth, London, England; [Kerac, Marko; Bailey, Jeanette] London Sch Hyg & Trop Med, Ctr Maternal Adolescent & Child Hlth MARCH, London, England; [Grant, Angeline] Act Hunger USA, New York, NY USA; [Manary, Mark] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Briend, Andre] Univ Tampere, Sch Med, Ctr Child Hlth Res, Tampere, Finland; [Briend, Andre] Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen, Denmark; [Opondo, Charles] London Sch Hyg & Trop Med, Dept Med Stat, London, England; [Bailey, Jeanette] Int Rescue Comm, New York, NY USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Washington University (WUSTL); Tampere University; University of Copenhagen; University of London; London School of Hygiene & Tropical Medicine	Chase, RP (corresponding author), Johns Hopkins Univ, Dept Int Hlth, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	rachelp.chase@gmail.com	Kerac, Marko/G-1777-2010; Kerac, Marko/GQR-1136-2022	Kerac, Marko/0000-0002-3745-7317; Bailey, Jeanette/0000-0002-4343-4939; Opondo, Charles/0000-0001-8155-4117; Chase, Rachel/0000-0002-1503-4954	Office of US Foreign Disaster Assistance [AID-OFDA-G-14-00208]	Office of US Foreign Disaster Assistance	ComPAS Stage 1 was funded by Office of US Foreign Disaster Assistance (OFDA website: https://www.usaid.gov/who-we-are/organization/bureaus/bureau-democracy-conflict-and-humanitarian-assistance/office-us), grant number AID-OFDA-G-14-00208, awarded to the International Rescue Committee (JB's affiliation). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Ackatia-Armah RS, 2015, AM J CLIN NUTR, V101, P632, DOI 10.3945/ajcn.113.069807; [Anonymous], 2012, REGEN MED S3, V7, pS14; [Anonymous], 2014, PEERJ, V2, pe447; [Anonymous], 2017, GUID ASS MAN CHILDR; ASHWORTH A, 1969, BRIT J NUTR, V23, P835, DOI 10.1079/BJN19690094; Bailey J, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2643-2; Bhutta ZA, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.67; Binns P, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0103-y; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Bliss J, 2018, GLOB HEALTH-SCI PRAC, V6, P552, DOI 10.9745/GHSP-D-18-00105; Briend A., 2016, BMC NUTR, V2, P63, DOI [10.1186/s40795-016-0101-7, DOI 10.1186/S40795-016-0101-7, 10.1186/s40795-016, DOI 10.1186/S40795-016]; Briend A, 2012, MATERN CHILD NUTR, V8, P130, DOI 10.1111/j.1740-8709.2011.00340.x; Burrell A, 2017, INT HEALTH, V9, P226, DOI 10.1093/inthealth/ihx022; Chang CY, 2013, J NUTR, V143, P215, DOI 10.3945/jn.112.168047; Dale NM, 2017, PUBLIC HEALTH NUTR, V20, P1362, DOI 10.1017/S1368980016003578; Daures M, 2019, BR J NUTR; Daures M, 2020, BRIT J NUTR, V123, P756, DOI 10.1017/S0007114519003258; Dolan C., 2013, MANAGING ACUTE MALNU; Eleanor Crook Foundation, 2018, MIND UND EV GAP FIND; 2019, J AM COLL RADIOL, V16, pS141, DOI 10.1016/j.jacr.2019.02.015; Food and Agricutural Organization, 2001, FAO FOOD NUTR TECH R, P96; Global Nutrition Cluster MAM Task Force, 2017, MOD AC MALN DEC MAK; Golden MH, 2012, PROTOCOLE PRISE CHAR; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hure A, 2016, AM J EPIDEMIOL, V184, P870, DOI 10.1093/aje/kww131; Isanaka S, 2019, MATERN CHILD NUTR, V15, DOI 10.1111/mcn.12688; Isanaka S, 2016, AM J EPIDEMIOL, V184, P861, DOI 10.1093/aje/kww129; James P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153530; James PT, 2015, MATERN CHILD NUTR, V11, P859, DOI 10.1111/mcn.12192; Kangas ST, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002887; Kenya Ministry of Health, 2009, NAT GUID INT MAN AC; Lazzerini M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009584.pub2; Lelijveld N, 2018, F EXCH, P64; Lelijveld N, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2594-7; Leroy J.L., 2011, ZSCORE06 STATA MODUL; Matilsky DK, 2009, J NUTR, V139, P773, DOI 10.3945/jn.108.104018; Maust A, 2015, J NUTR, V145, P2604, DOI 10.3945/jn.115.214957; Morales-Velazquez L, 2010, J SYST ARCHITECT, V56, P407, DOI 10.1016/j.sysarc.2010.04.009; Olofin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064636; Patel MP, 2005, J HEALTH POPUL NUTR, V23, P351; Prost A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002934; Saboya M, 2015, REV NATL PRISE CHARG; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; SPADY DW, 1976, AM J CLIN NUTR, V29, P1073, DOI 10.1093/ajcn/29.10.1073; StataCorp, 2013, STAT REL 13; Suri DJ, 2016, FOOD NUTR BULL, V37, P176, DOI 10.1177/0379572116633327; The Council of Research and Technical Advice on Acute Malnutrition (CORTASAM), 2018, RES AG ACT NO WAST L; The Lancet Global Health, 2016, LANCET GLOB HEALTH, V4, pe427; UNICEF, 2012, NAT GUID MAN AC MALN; Unicef/ UN Populations Division, STAT WORLDS CHILDR; United Nations Children's Fund World Health Organization World Bank, 2018, LEV TRENDS CHILD MAL; Valid International Concern Worldwide, 2006, WORLDW COMM BAS THER; Wegner CW, 2015, FOOD NUTR BULL, V36, pS3, DOI 10.1177/15648265150361S101; WHO, 2019, JOINT UN COMM SIMPL; Woodhead S., 2019, Field Exchange - Emergency Nutrition Network ENN, P33; World Health Organization, 2012, TECHN NOT SUPPL FOOD; World Health Organization, 1999, MAN SEV MALN MAN PHY; Yemen Ministry of Public Health and Population Primary Health Care Sector Nutrition Department, 2013, INT GUID COMM BAS MA; 2006, CLIN BIOCH REV, V27, pS49; 2006, CLIN BIOCH REV, V27, pS24	61	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2020	15	6							e0230452	10.1371/journal.pone.0230452	http://dx.doi.org/10.1371/journal.pone.0230452			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LW6ZP	32492023	Green Published, gold			2022-12-26	WOS:000539293000033
J	Abd Elkader, NA; Emam, IA; Farghali, HA; Daghash, SM; Salem, NY				Abd Elkader, Naglaa A.; Emam, Ibrahim A.; Farghali, Haithem A.; Daghash, S. M.; Salem, Noha Y.			Oesophageal foreign bodies in cats: Clinical and anatomic findings	PLOS ONE			English	Article							BODY; DOGS	Background Anatomical feline models can aid in understanding the relationships between clinical findings and anatomical features and the course of foreign bodies passing through the oesophagus. This study has two goals 1) to assess feline oesophageal foreign bodies in feline patients using physical, radiologic and endoscopic examination and, how their location influences treatment plans and complications. 2) How the anatomical sharp angle of the oesophagus contribute to foreign body lodgement. Thirty-five cats were enrolled in this study; 30 of them were clinically ill, and five cats were used for anatomical study. Results Cats with clinical signs underwent complete clinical and radiologic examination. Endoscopy was performed in only five cases. The site with the highest occurrence of foreign body lodgement was the oesophageal entrance, caudal to the pharynx (63.3%), followed by the thoracic inlet (26.7%) and the mid-cervical region of the oesophagus (10%). Two types of foreign bodies were identified: sewing needles (25/30) and bone (5/30). Radiography was able to identify the location and nature of the foreign body in all 30 affected cats. Therapeutic regimens were applied according to the nature and location of the foreign body and any associated complications. Removal of the foreign body was achieved using Rochester pean artery forceps in 17/30 cases, using full surgical intervention in 8/30 cases, and during endoscopy in 5/30 cases. Conclusion The results suggest that the location of the foreign body is strongly related to combination of consumed foreign body type and anatomic features of the cat oesophagus. The feline oesophagus has a variety of sharp angles that facilitate the entrapment of rigid linear and angular foreign bodies. Radiographic imaging remains the most frequently used diagnostic modality for determining the lodgement site and nature of radiopaque foreign bodies. Over all complication rate was low (6/30).	[Abd Elkader, Naglaa A.; Emam, Ibrahim A.; Farghali, Haithem A.] Cairo Univ, Fac Vet Med, Surg Anesthesiol & Radiol Dept, Giza, Egypt; [Daghash, S. M.] Cairo Univ, Fac Vet Med, Anat & Embryol Dept, Giza, Egypt; [Salem, Noha Y.] Cairo Univ, Fac Vet Med, Internal Med & Infect Dis Dept, Giza, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University	Abd Elkader, NA (corresponding author), Cairo Univ, Fac Vet Med, Surg Anesthesiol & Radiol Dept, Giza, Egypt.	naglaa_abd.elkader@cu.edu.eg	Farghali, Haithem/AAH-8288-2021	Daghash, Samer/0000-0002-1319-8613				Aiello SE, 2016, MERCK VET MANUAL, V11th; Allouch M, 2018, DAIRY VET SCI J, V5, P1; Alloush GM, 2001, THESIS; Binvel M, 2018, J SMALL ANIM PRACT, V59, P45, DOI 10.1111/jsap.12794; Brinster CJ, 2004, ANN THORAC SURG, V77, P1475, DOI 10.1016/j.athoracsur.2003.08.037; Cote, 2015, CLINCAL VET ADVISOR; Deroy C, 2015, J SMALL ANIM PRACT, V56, P613, DOI 10.1111/jsap.12386; Dyce K.M., 2010, TXB VET ANATOMY, V4th ed.; Gugjoo M. B., 2012, Journal of Advanced Veterinary Research, V2, P299; Hayes G, 2009, J SMALL ANIM PRACT, V50, P576, DOI 10.1111/j.1748-5827.2009.00783.x; Hildebrand M, 1968, ANATOMICAL PREPARATI; Kealy J.K., 2011, DIAGNOSTIC RADIOLOGY, V5th ed., P351; Konig HE, 2014, VET ANATOMY DOMESTIC; Leib M. S., 2005, Small animal and exotics. Proceedings of the North American Veterinary Conference, Volume 19, Orlando, Florida, USA, 8-12 January, 2005, P341; Leib MS, 2008, JAVMA-J AM VET MED A, V232, P1021, DOI 10.2460/javma.232.7.1021; McKelvey D K, 2000, WHOLLINGSHEAD SMALL; MICHELS GM, 1995, J AM VET MED ASSOC, V207, P1194; Nelson R., 2019, SMALL ANIMAL INTERNA; Pratt CL, 2014, JAVMA-J AM VET MED A, V245, P302, DOI 10.2460/javma.245.3.302; Runge JJ, 2013, SMALL ANIMAL SOFT TISSUE SURGERY, P304; Sterman AA, 2018, JAVMA-J AM VET MED A, V253, P1053, DOI 10.2460/javma.253.8.1053; Tams TR, 2003, HDB SMALL ANIMAL GAS; Tams TR., 2011, SMALL ANIMAL ENDOSCO; Tyrrell D, 2006, VET RADIOL ULTRASOUN, V47, P404, DOI 10.1111/j.1740-8261.2006.00160.x; Webb J, 2014, REGISTERED VET TECH, V38, P6; Zoran DL, 2005, ESOPHAGEAL FOREIGN B	26	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2020	15	6							e0233983	10.1371/journal.pone.0233983	http://dx.doi.org/10.1371/journal.pone.0233983			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MT4VF	32484841	gold, Green Published			2022-12-26	WOS:000554969700024
J	Zmora, O; Gutzeit, O; Segal, L; Boulos, S; Millo, Z; Ginsberg, Y; Khatib, N; Dabbah-Assad, F; Fainaru, O; Weiner, Z; Beloosesky, R				Zmora, Osnat; Gutzeit, Ola; Segal, Linoy; Boulos, Sari; Millo, Zvika; Ginsberg, Yuval; Khatib, Nizar; Dabbah-Assad, Fadwa; Fainaru, Ofer; Weiner, Zeev; Beloosesky, Ron			Prophylactic antenatal N-Acetyl Cysteine administration combined with postnatal administration can decrease mortality and injury markers associated with necrotizing enterocolitis in a rat model	PLOS ONE			English	Article							INTESTINAL EPITHELIAL APOPTOSIS; NITRIC-OXIDE; ACETYLCYSTEINE; EXPRESSION; CYTOKINES; PROTECTS; COHORT	Background Necrotizing enterocolitis (NEC) is a devastating gastrointestinal disease of neonates, especially premature neonates. To date, there is no prophylactic treatment against NEC, except breast milk and slow increase in enteral feeding, and there is no antenatal prophylaxis. Aims To assess possible protective effects of antenatal N-Acetyl Cysteine (NAC) against the intestinal pathophysiological changes associated with NEC in a rat model of NEC and against its associated mortality. Methods Newborn Sprague-Dawley rats were divided into 5 groups: control (n = 33); NEC (n = 32)subjected to hypoxia and formula feeding for 4 days to induce NEC; NEC-NAC (n = 34)-with induced NEC and concomitant postnatal NAC administration; NAC-NEC (n = 33)-born to dams treated with NAC for the last 3 days of pregnancy starting at gestational age of 18 days, and then subjected to induced NEC after birth; NAC-NEC-NAC (n = 36)-subjected to induced NEC with both prenatal and postnatal NAC treatment. At day of life 5, weight and survival of pups in the different groups were examined, and pups were euthanized. Ileal TNF-alpha, IL-6, IL-1 beta, IL-10, NFkB p65, iNOS and cleaved caspase 3 protein levels (western blot) and mRNA expression (RT-PCR) were compared between groups. Results Pup mortality was significantly reduced in the NAC-NEC-NAC group compared to NEC (11% vs. 34%, P<0.05). Ileal protein levels and mRNA expression of all injury markers tested except IL-10 were significantly increased in NEC compared to control. These markers were significantly reduced in all NAC treatment groups (NEC-NAC, NAC-NEC, and NAC-NEC-NAC) compared to NEC. The most pronounced decrease was observed in the NAC-NEC NAC group. Conclusions Antenatal NAC decreases injury markers and mortality associated with NEC in a rat model. Antenatal administration of NAC may present a novel approach for NEC prophylaxis in pregnancies with risk for preterm birth.	[Zmora, Osnat] Shamir Med Ctr, Dept Pediat Surg, Zerifin, Israel; [Gutzeit, Ola; Segal, Linoy; Boulos, Sari; Millo, Zvika; Ginsberg, Yuval; Khatib, Nizar; Dabbah-Assad, Fadwa; Fainaru, Ofer; Weiner, Zeev; Beloosesky, Ron] Rambam Med Ctr, Dept Obstet & Gynecol, Haifa, Israel	Shamir Medical Center (Assaf Harofeh); Rambam Health Care Campus; Technion Israel Institute of Technology	Zmora, O (corresponding author), Shamir Med Ctr, Dept Pediat Surg, Zerifin, Israel.	zmora.osnat@gmail.com		Zmora, Osnat/0000-0003-2999-5438				Aceti A, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7397659; Beloosesky R, 2012, J MATERN-FETAL NEO M, V25, P1324, DOI 10.3109/14767058.2011.632793; Beloosesky R, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.032; Berk M, 2013, TRENDS PHARMACOL SCI, V34, P167, DOI 10.1016/j.tips.2013.01.001; Blakely ML, 2005, ANN SURG, V241, P984, DOI 10.1097/01.sla.0000164181.67862.7f; Buhimschi IA, 2003, AM J OBSTET GYNECOL, V188, P203, DOI 10.1067/mob.2003.112; CAPLAN MS, 1993, PEDIATR PATHOL, V13, P357, DOI 10.3109/15513819309048223; CAPLAN MS, 1990, J PEDIATR-US, V117, pS47, DOI 10.1016/S0022-3476(05)81130-8; De Plaen IG, 2013, CLIN PERINATOL, V40, P109, DOI 10.1016/j.clp.2012.12.008; Ford H, 1997, J PEDIATR SURG, V32, P275, DOI 10.1016/S0022-3468(97)90194-9; Fu D, 2019, AGING-US, V11, P8294, DOI 10.18632/aging.102320; Janvier A, 2014, J PEDIATR-US, V164, P980, DOI 10.1016/j.jpeds.2013.11.025; Jenkins DD, 2016, J PEDIAT, V168; Jilling T, 2004, PEDIATR RES, V55, P622, DOI 10.1203/01.PDR.0000113463.70435.74; Jing Y, 2018, EXP THER MED, V16, P5280, DOI 10.3892/etm.2018.6871; Jones IH, 2020, J PEDIAT; KANTO WP, 1994, CLIN PERINATOL, V21, P335, DOI 10.1016/S0095-5108(18)30349-X; Kelly N, 2004, SURGERY, V136, P557, DOI 10.1016/j.surg.2004.05.034; KLIEGMAN RM, 1979, PEDIATR CLIN N AM, V26, P327; Lappas M, 2003, J CLIN ENDOCR METAB, V88, P1723, DOI 10.1210/jc.2002-021677; Liu DP, 2020, INT J SURG, V76, P79, DOI 10.1016/j.ijsu.2020.02.031; Lucas A, LANCET LONDON ENGLAN, V336, P1519; Maheshwari A, 2014, PEDIATR RES, V76, P100, DOI 10.1038/pr.2014.48; McElroy SJ, 2014, AM J PATHOL, V184, P2768, DOI 10.1016/j.ajpath.2014.06.015; Nadler EP, 2000, J SURG RES, V92, P71, DOI 10.1006/jsre.2000.5877; Neu J, 1996, PEDIATR CLIN N AM, V43, P409, DOI 10.1016/S0031-3955(05)70413-2; Ozdemir R, 2012, J PEDIATR SURG, V47, P1652, DOI 10.1016/j.jpedsurg.2012.02.016; Paterson RL, 2003, CRIT CARE MED, V31, P2574, DOI 10.1097/01.CCM.0000089945.69588.18; Ramiro-Cortijo D, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020534; RIGGS BS, 1989, OBSTET GYNECOL, V74, P247; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Schanler RJ, 2000, J NUTR, V130, p417S, DOI 10.1093/jn/130.2.417S; Seo S, 2019, J PEDIATR SURG, V54, P2520, DOI 10.1016/j.jpedsurg.2019.08.038; Tayman C, 2012, J PEDIATR SURG, V47, P540, DOI 10.1016/j.jpedsurg.2011.09.051; Turitz AL, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.05.004; van den Akker C, 2020, J PEDIAT GASTROENTER, V1; Wiest DB, 2014, J PEDIAT, V165	37	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0233612	10.1371/journal.pone.0233612	http://dx.doi.org/10.1371/journal.pone.0233612			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MJ2AA	32479520	Green Published, gold			2022-12-26	WOS:000547893500018
J	Chan, MH; Aminzai, S; Hu, TF; Taran, A; Li, S; Kim, C; Pilz, RB; Casteel, DE				Chan, Matthew H.; Aminzai, Sahar; Hu, Tingfei; Taran, Amatya; Li, Sheng; Kim, Choel; Pilz, Renate B.; Casteel, Darren E.			A substitution in cGMP-dependent protein kinase 1 associated with aortic disease induces an active conformation in the absence of cGMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein kinase G (PKG); cyclic GMP (cGMP); mutant; mutagenesis; autophosphorylation; enzyme structure; hydrogen; deuterium exchange; thoracic aortic aneurysm and dissection (TAAD); kinase signaling; cardiovascular system; hydrogen exchange mass spectrometry	I-BETA; PHOSPHORYLATION; ACTIVATION; BINDING; MUTATIONS; REVEALS; VITRO; IDENTIFICATION; AUTOINHIBITION; INHIBITORS	Type 1 cGMP-dependent protein kinases (PKGs) play important roles in human cardiovascular physiology, regulating vascular tone and smooth-muscle cell phenotype. A mutation in the human PRKG1 gene encoding cGMP-dependent protein kinase 1 (PKG1) leads to thoracic aortic aneurysms and dissections. The mutation causes an arginine-to-glutamine (RQ) substitution within the first cGMP-binding pocket in PKG1. This substitution disrupts cGMP binding to the pocket, but it also unexpectedly causes PKG1 to have high activity in the absence of cGMP via an unknown mechanism. Here, we identified the molecular mechanism whereby the RQ mutation increases basal kinase activity in the human PKG1? and PKG1? isoforms. Although we found that the RQ substitution (R177Q in PKG1? and R192Q in PKG1?) increases PKG1? and PKG1? autophosphorylationin vitro, we did not detect increased autophosphorylation of the PKG1? or PKG1? RQ variant isolated from transiently transfected 293T cells, indicating that increased basal activity of the RQ variants in cells was not driven by PKG1 autophosphorylation. Replacement of Arg-177 in PKG1? with alanine or methionine also increased basal activity. PKG1 exists as a parallel homodimer linked by an N-terminal leucine zipper, and we show that the WT chain in WT-RQ heterodimers partly reduces basal activity of the RQ chain. Using hydrogen/deuterium-exchange MS, we found that the RQ substitution causes PKG1? to adopt an active conformation in the absence of cGMP, similar to that of cGMP-bound WT enzyme. We conclude that the RQ substitution in PKG1 increases its basal activity by disrupting the formation of an inactive conformation.	[Chan, Matthew H.; Aminzai, Sahar; Hu, Tingfei; Taran, Amatya; Li, Sheng; Pilz, Renate B.; Casteel, Darren E.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Kim, Choel] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Kim, Choel] Baylor Coll Med, Dept Pharmacol & Chem Biol, Houston, TX 77030 USA	University of California System; University of California San Diego; Baylor College of Medicine; Baylor College of Medicine	Casteel, DE (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	dcasteel@ucsd.edu		Chan, Matthew/0000-0002-6953-7960	National Institutes of Health [R01-HL132141, R01-GM090161, 1U19AI117905, R01-GM020501]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health grants R01-HL132141 (to R. B. P.), R01-GM090161 (to C. K.), and 1U19AI117905, R01-GM020501 (to S. L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AITKEN A, 1984, BIOCHIM BIOPHYS ACTA, V790, P219, DOI 10.1016/0167-4838(84)90025-6; Alverdi V, 2008, J MOL BIOL, V375, P1380, DOI 10.1016/j.jmb.2007.11.053; Badireddy Suguna, 2011, Mol Cell Proteomics, V10, DOI 10.1074/mcp.M110.004390; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Busch JL, 2002, J BIOL CHEM, V277, P34048, DOI 10.1074/jbc.M202761200; BUTT E, 1994, J BIOL CHEM, V269, P14509; Casteel DE, 2002, J BIOL CHEM, V277, P32003, DOI 10.1074/jbc.M112332200; DEJONGE HR, 1977, J BIOL CHEM, V252, P2780; FEIL R, 1993, MOL CELL BIOCHEM, V128, P71, DOI 10.1007/BF01076758; Francis SH, 2008, INT J IMPOT RES, V20, P333, DOI 10.1038/ijir.2008.4; Francis SH, 1996, J BIOL CHEM, V271, P20748, DOI 10.1074/jbc.271.34.20748; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; Friebe A, 2017, N-S ARCH PHARMACOL, V390, P1177, DOI 10.1007/s00210-017-1429-5; Guo DC, 2013, AM J HUM GENET, V93, P398, DOI 10.1016/j.ajhg.2013.06.019; HALBRUGGE M, 1990, J BIOL CHEM, V265, P3088; Han Xinbing, 2014, Adv Pharmacol, V70, P265, DOI 10.1016/B978-0-12-417197-8.00009-2; HERBERG FW, 1994, BIOCHEMISTRY-US, V33, P7485, DOI 10.1021/bi00189a057; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hofmann Franz, 2009, V191, P137, DOI 10.1007/978-3-540-68964-5_8; Kato M, 2012, J BIOL CHEM, V287, P41342, DOI 10.1074/jbc.M112.421040; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kim JJ, 2016, STRUCTURE, V24, P710, DOI 10.1016/j.str.2016.03.009; Malik RU, 2013, J BIOL CHEM, V288, P17167, DOI 10.1074/jbc.M113.464065; Marsh JJ, 2013, BIOCHEMISTRY-US, V52, P5491, DOI 10.1021/bi4007995; Osborne BW, 2011, STRUCTURE, V19, P1317, DOI 10.1016/j.str.2011.06.012; Pires DEV, 2014, NUCLEIC ACIDS RES, V42, pW314, DOI 10.1093/nar/gku411; Pires DEV, 2014, BIOINFORMATICS, V30, P335, DOI 10.1093/bioinformatics/btt691; Ruth P, 1997, J BIOL CHEM, V272, P10522; RUTH P, 1991, EUR J BIOCHEM, V202, P1339, DOI 10.1111/j.1432-1033.1991.tb16509.x; Schlossmann J, 2000, NATURE, V404, P197, DOI 10.1038/35004606; Schwaerzer GK, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11389-1; Schwappacher R, 2013, J CELL SCI, V126, P1626, DOI 10.1242/jcs.118190; Simanshu DK, 2017, CELL, V170, P17, DOI 10.1016/j.cell.2017.06.009; Smith JA, 1996, J BIOL CHEM, V271, P20756, DOI 10.1074/jbc.271.34.20756; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Taylor MS, 2004, MOL PHARMACOL, V65, P1111, DOI 10.1124/mol.65.5.1111; Vallur R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098946; Valtcheva N, 2009, J BIOL CHEM, V284, P556, DOI 10.1074/jbc.M806161200; Wolfertstetter S, 2013, PHARMACEUTICALS, V6, P269, DOI 10.3390/ph6020269; Worth CL, 2011, NUCLEIC ACIDS RES, V39, pW215, DOI 10.1093/nar/gkr363; Yuasa K, 1999, J BIOL CHEM, V274, P37429, DOI 10.1074/jbc.274.52.37429; Yuasa K, 2000, J BIOL CHEM, V275, P4897, DOI 10.1074/jbc.275.7.4897; Zhuang SH, 2004, J BIOL CHEM, V279, P10397, DOI 10.1074/jbc.M313048200	44	4	4	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2020	295	30					10394	10405		10.1074/jbc.RA119.010984	http://dx.doi.org/10.1074/jbc.RA119.010984			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MW0BV	32506052	Green Published, hybrid			2022-12-26	WOS:000556713400022
J	Bin Abdullah, MFIL; Tan, KL; Isa, SM; Yusoff, NS; Chear, NJY; Singh, D				Bin Abdullah, Mohammad Farris Iman Leong; Kok Leng Tan; Isa, Salbiah Mohd; Yusoff, Nur Sabrina; Chear, Nelson Jeng Yeou; Singh, Darshan			Lipid profile of regular kratom (Mitragyna speciosaKorth.) users in the community setting	PLOS ONE			English	Article							TISSUE CHOLESTEROL; PARAMETERS; PLASMA; ABUSE	Background and aim Kratom, orMitragyna speciosaKorth., is a tropical plant that has been reported to exhibit opioid-like effects. Although opioids have been demonstrated to alter the lipid profile of regular users, data on the lipid-altering effects of kratom are scarce. This study aimed to compare the fasting lipid profile of regular kratom users to that of healthy subjects who do not use kratom. It also determined the association between various characteristics of kratom users and the serum triglycerides, total cholesterol, low-density lipoprotein (LDL), and high-density lipoprotein (HDL) levels of regular kratom users. Methods A total of 200 participants (n = 100 kratom users and n = 100 healthy subjects who do not use kratom) were recruited for this analytical cross-sectional study. Data on sociodemographic status, kratom use characteristics, cigarette smoking, physical activity, body mass index (BMI), fasting serum lipid profile, and liver function were collected from all participants. Results The liver parameters of the study participants were within normal range. The serum total cholesterol and LDL of kratom users were significantly lower than those of healthy subjects who do not use kratom. There were no significant differences in the serum triglyceride and HDL levels. However, higher average daily frequency of kratom use and increasing age were associated with increased serum total cholesterol among kratom users. Other kratom use characteristics such as age of first kratom intake, duration of kratom use, and quantity of daily kratom intake were not associated with increased serum triglyceride, total cholesterol, LDL, and HDL levels. Conclusions Our findings suggest regular kratom consumption was not linked to elevated serum lipids, except when there is a higher frequency of daily kratom intake. However, the study was limited by the small sample size, and hence a more comprehensive study with larger sample size is warranted to confirm the findings.	[Bin Abdullah, Mohammad Farris Iman Leong; Isa, Salbiah Mohd] Univ Sains Malaysia, Adv Med & Dent Inst, Lifestyle Sci Cluster, Kepala Batas, Pulau Pinang, Malaysia; [Kok Leng Tan] Univ Sains Malaysia, Adv Med & Dent Inst, Regenerat Med Cluster, Kepala Batas, Pulau Pinang, Malaysia; [Yusoff, Nur Sabrina; Chear, Nelson Jeng Yeou; Singh, Darshan] Univ Sains Malaysia, Ctr Drug Res, Minden, Pulau Pinang, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia; Universiti Sains Malaysia	Bin Abdullah, MFIL (corresponding author), Univ Sains Malaysia, Adv Med & Dent Inst, Lifestyle Sci Cluster, Kepala Batas, Pulau Pinang, Malaysia.	farris@usm.my	Singh, Darshan/ABB-9359-2020; Leong Abdullah, Mohammad Farris Iman/I-9583-2017; Chear, Nelson/AAA-8621-2022; Chear, Nelson Jeng-Yeou/P-8222-2018; KokLeng, Tan/E-4949-2016	Leong Abdullah, Mohammad Farris Iman/0000-0002-7762-4052; Chear, Nelson/0000-0001-5050-8230; Chear, Nelson Jeng-Yeou/0000-0001-5050-8230; KokLeng, Tan/0000-0001-8798-4855	Fundamental Research Grant Scheme of the Ministry of Education Malaysia [203. CIPPT.6711626]	Fundamental Research Grant Scheme of the Ministry of Education Malaysia	Grant receiver: Mohammad Farris Iman Leong Bin Abdullah Grant number: 203. CIPPT.6711626 Full name of the funder: Fundamental Research Grant Scheme of the Ministry of Education Malaysia URL of the funder website: http://jpt.moe.gov.my Role of funder: The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghadavoudi Omid, 2015, Adv Biomed Res, V4, P12, DOI 10.4103/2277-9175.148294; Agongo G, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213233; ALBERS JJ, 1978, LIPIDS, V13, P926, DOI 10.1007/BF02533852; Aljandali A., 2017, MULTIVARIATE METHODS; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; Anwar M, 2016, MMWR-MORBID MORTAL W, V65, P748, DOI 10.15585/mmwr.mm6529a4; BRYANT HU, 1988, BIOCHEM PHARMACOL, V37, P3777, DOI 10.1016/0006-2952(88)90415-7; BRYANT HU, 1987, LIFE SCI, V41, P545, DOI 10.1016/0024-3205(87)90406-1; Bush MA, REPEATED DOSES KEY P; Coe MA, 2019, DRUG ALCOHOL DEPEN, V202, P24, DOI 10.1016/j.drugalcdep.2019.05.005; Corkery JM, 2019, J PSYCHOPHARMACOL, V33, P1102, DOI 10.1177/0269881119862530; Dorman C, 2015, HEPATOLOGY, V61, P1086, DOI 10.1002/hep.27612; Fernandes CT, 2019, J INVEST MED HIGH IM, V7, DOI 10.1177/2324709619836138; Garcia-Romeu A, 2020, DRUG ALCOHOL DEPEN, V208, DOI 10.1016/j.drugalcdep.2020.107849; Grundmann O, 2017, DRUG ALCOHOL DEPEN, V176, P63, DOI 10.1016/j.drugalcdep.2017.03.007; Hassan Z, 2013, NEUROSCI BIOBEHAV R, V37, P138, DOI 10.1016/j.neubiorev.2012.11.012; Johnson R, 1997, CLIN CHEM, V43, P2183; Kapp FG, 2011, J MED TOXICOL, V7, P227, DOI 10.1007/s13181-011-0155-5; Kouros D, 2010, AM J DRUG ALCOHOL AB, V36, P135, DOI 10.3109/00952991003734277; Kronstrand R, 2011, J ANAL TOXICOL, V35, P242, DOI 10.1093/anatox/35.4.242; Kruegel AC, 2016, J AM CHEM SOC, V138, P6754, DOI 10.1021/jacs.6b00360; Langsted A, 2019, PATHOLOGY, V51, P131, DOI 10.1016/j.pathol.2018.09.062; Lecubrier Y., 1998, J CLIN PSYCHIAT S20, V59, P22; Mitchell BD, 2019, J CLIN LIPIDOL, V13, P109, DOI 10.1016/j.jacl.2018.11.006; Najafipour H, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00436; Ni WQ, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0073-7; Osborne CS, 2019, J INVEST MED HIGH IM, V7, DOI 10.1177/2324709619826167; Post S, 2019, CLIN TOXICOL, V57, P847, DOI 10.1080/15563650.2019.1569236; Prozialeck WC, 2019, INT J DRUG POLICY, V70, P70, DOI 10.1016/j.drugpo.2019.05.003; Qasini A, 2013, ESCULAPIO, V9, P163; Rahimi Najmeh, 2014, Addict Health, V6, P1; Singh D, 2018, J ETHNOPHARMACOL, V214, P197, DOI 10.1016/j.jep.2017.12.017; Singh D, 2016, BRAIN RES BULL, V126, P41, DOI 10.1016/j.brainresbull.2016.05.004; SUWANLERT S, 1975, B NARCOTICS, V27, P21; Szapary Philippe O, 2003, Curr Cardiol Rep, V5, P488, DOI 10.1007/s11886-003-0112-2; Tabachnick B.G., 2013, USING MULTIVARIATE S, V6th ed; Tayabali K, 2018, J COMMUNITY HOSP INT, V8, P107, DOI 10.1080/20009666.2018.1468693; Tietz N.W., 1990, CLIN GUIDE LAB TESTS, V2nd; U.S. Department of Health and Human Services, 2018, PHYS ACT GUID AM; U. S. Food and Drug Administration, 2019, FDA ISS WARN CO SELL; Vicknasingam B, 2010, INT J DRUG POLICY, V21, P283, DOI 10.1016/j.drugpo.2009.12.003; World Health Organization, 2018, PHYS ACTIVITY; Ya K, 2019, ASIAN J PSYCHIATR, V43, P73, DOI 10.1016/j.ajp.2019.05.016; 2010, ZHONGGUO YIXUE QIANY, V4, P50	44	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234639	10.1371/journal.pone.0234639	http://dx.doi.org/10.1371/journal.pone.0234639			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525924	Green Published, gold			2022-12-26	WOS:000542036800015
J	Chen, MM; Jahn, JL; Barber, JR; Han, M; Stampfer, MJ; Platz, EA; Penney, KL				Chen, Maxine M.; Jahn, Jaquelyn L.; Barber, John R.; Han, Misop; Stampfer, Meir J.; Platz, Elizabeth A.; Penney, Kathryn L.			Clinical stage provides useful prognostic information even after pathological stage is known for prostate cancer in the PSA era	PLOS ONE			English	Article							RADICAL RETROPUBIC PROSTATECTOMY; GLEASON PATTERN 5; RADIATION-THERAPY; RISK-ASSESSMENT; SURVIVAL RATES; RECURRENCE; ANTIGEN; IMPACT; SCORE; PREDICTOR	Background Pathological and clinical stage are associated with prostate cancer-specific survival after prostatectomy. With PSA screening, the post-surgery prognostic utility of clinical stage is debatable in studies seeking to identify new biomarkers. Few studies have investigated clinical stage and lethal prostate cancer association after accounting for pathological stage. We hypothesize that clinical stage provides prognostic information beyond pathological stage in the PSA era. Methods Cox regression models tested associations between clinical and pathological stage and lethal prostate cancer among 3,064 participants from the Health Professionals Follow-Up Study and Physicians' Health Study (HPFS/PHS) who underwent prostatectomy. Likelihood ratio tests and c-statistics were used to assess the models' prognostic utility. Equivalent analyses were performed in 16,134 men who underwent prostatectomy at Johns Hopkins. Results Independently, clinical and pathological stage were associated (p<0.0001 for both) with rate of lethal prostate cancer in HPFS/PHS. The model with clinical and pathological stage fit significantly better than the model with only pathological stage in all men (p = 0.01) and in men diagnosed during the PSA era (p = 0.04). The mutually adjusted model also improved discriminatory ability. In the Johns Hopkins cohort, the model with clinical and pathological stage improved discriminatory ability and fit significantly better overall (p<0.0001) and in the PSA era (p<0.0001). Conclusions Despite stage migration resulting from widespread PSA screening, clinical stage remains associated with progression to lethal prostate cancer independent of pathological stage. Future studies evaluating associations between new factors and poor outcome following prostatectomy should consider including both clinical and pathological stages since the data is already available.	[Chen, Maxine M.; Jahn, Jaquelyn L.; Stampfer, Meir J.; Penney, Kathryn L.] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Chen, Maxine M.; Jahn, Jaquelyn L.; Stampfer, Meir J.; Penney, Kathryn L.] Harvard Med Sch, Boston, MA 02115 USA; [Chen, Maxine M.; Stampfer, Meir J.; Penney, Kathryn L.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Jahn, Jaquelyn L.] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA; [Barber, John R.; Han, Misop; Platz, Elizabeth A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Han, Misop; Platz, Elizabeth A.] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA; [Han, Misop; Platz, Elizabeth A.] Johns Hopkins Univ, Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD USA; [Stampfer, Meir J.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Platz, Elizabeth A.] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Penney, KL (corresponding author), Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.; Penney, KL (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Penney, KL (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	kpenney@hsph.harvard.edu		Chen, Maxine/0000-0001-7138-6228	National Cancer Institute (NCI) [5T32CA009001-38]; NCI [P30CA006973, P50CA58236];  [CA141298];  [CA34944];  [CA40360];  [CA097193];  [HL26490];  [HL34595];  [P01CA055075];  [CA133891];  [UM1CA167552]	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; ; ; ; ; ; ; 	M.M.C. is supported by training grant 5T32CA009001-38 from the National Cancer Institute (NCI). This study was supported by CA141298. The Physicians' Health Study was supported by grants CA34944, CA40360, CA097193, HL26490 and HL34595. The Health Professionals Follow-up Study was supported by grants P01CA055075, CA133891, CA141298, and UM1CA167552. This study was also supported by the NCI grants P30CA006973 and P50CA58236 (Johns Hopkins). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NCI: https://www.cancer.gov/.	Angulo J C, 1995, Urol Oncol, V1, P199, DOI 10.1016/1078-1439(95)00066-6; [Anonymous], 1989, NEW ENGL J MED, V321, P129, DOI DOI 10.1056/NEJM198907203210301; Bostwick DG, 1997, EUR UROL, V32, P2; Bryant RJ, 2015, J CLIN PATHOL, V68, P465, DOI 10.1136/jclinpath-2014-202661; Busch J, 2012, J UROLOGY, V188, P2165, DOI 10.1016/j.juro.2012.07.106; Catalona WJ, 1998, J UROLOGY, V160, P2428, DOI 10.1016/S0022-5347(01)62204-3; Cooperberg MR, 2005, J UROLOGY, V173, P1938, DOI 10.1097/01.ju.0000158155.33890.e7; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Fossati N, 2016, BJU INT, V117, P740, DOI 10.1111/bju.13125; Freedland SJ, 2011, CANCER-AM CANCER SOC, V117, P1123, DOI 10.1002/cncr.25477; GIOVANNUCCI E, 1993, JAMA-J AM MED ASSOC, V269, P873, DOI 10.1001/jama.269.7.873; Howlader N, 2011, SEER CANC STAT REV 1; Jackson W, 2013, CANCER-AM CANCER SOC, V119, P3287, DOI 10.1002/cncr.28215; Jani AB, 2001, INT J CANCER, V96, P363, DOI 10.1002/ijc.1035; Kremers WK, 2007, TECHNICAL REPORT SER; Mithal P, 2015, INT J UROL, V22, P362, DOI 10.1111/iju.12704; PARTIN AW, 1993, J UROLOGY, V150, P110, DOI 10.1016/S0022-5347(17)35410-1; Ramos CG, 1999, J UROLOGY, V161, P1525, DOI 10.1016/S0022-5347(05)68944-6; Reese AC, 2010, J UROLOGY, V184, P114, DOI 10.1016/j.juro.2010.03.025; Roehl KA, 2004, J UROLOGY, V172, P910, DOI 10.1097/01.ju.0000134888.22332.bb; Sabolch A, 2011, INT J RADIAT ONCOL, V81, pE351, DOI 10.1016/j.ijrobp.2011.01.063; Tejada-Vera B., 2010, NATL VITAL STAT REPO, V58, P1; Tollefson MK, 2013, J UROLOGY, V189, P1707, DOI 10.1016/j.juro.2012.11.065; Uchio EM, 2010, ARCH INTERN MED, V170, P1390, DOI 10.1001/archinternmed.2010.262	25	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234391	10.1371/journal.pone.0234391	http://dx.doi.org/10.1371/journal.pone.0234391			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525914	Green Published, gold			2022-12-26	WOS:000542036800001
J	Lenti, MV; Klersy, C; Brera, AS; Musella, V; Benedetti, I; Padovini, L; Ciola, M; Croce, G; Ballesio, A; Gorgone, MF; Bertolino, G; Di Sabatino, A; Corazza, GR				Lenti, Marco Vincenzo; Klersy, Catherine; Brera, Alice Silvia; Musella, Valeria; Benedetti, Irene; Padovini, Lucia; Ciola, Mariella; Croce, Gabriele; Ballesio, Alessia; Gorgone, Maria Fortunata; Bertolino, Giampiera; Di Sabatino, Antonio; Corazza, Gino Roberto			Clinical complexity and hospital admissions in the December holiday period	PLOS ONE			English	Article							PATIENT COMPLEXITY; VECTOR MODEL; MORTALITY; CARE; DEPRIVATION; CHRISTMAS; SCIENCE; TIME	Background Christmas and New Year's holidays are risk factors for hospitalization, but the causes of this "holiday effect" are uncertain. In particular, clinical complexity (CC) has never been assessed in this setting. We therefore sought to determine whether patients admitted to the hospital during the December holiday period had greater CC compared to those admitted during a contiguous non-holiday period. Methods This is a prospective, longitudinal study conducted in an academic ward of internal medicine in 2017-2019. Overall, 227 consecutive adult patients were enrolled, including 106 cases (mean age 79.4 +/- 12.8 years, 55 females; 15 December-15 January) and 121 controls (mean age 74.3 +/- 16.6 years, 56 females; 16 January-16 February). Demographic characteristics, CC, length of stay, and early mortality rate were assessed. Logistic regression analyses for the evaluation of independent correlates of being a holiday case were computed. Results Cases displayed greater CC (17.7 +/- 5.5 vs 15.2 +/- 5.9; p = 0.001), with greater impact of socioeconomic (3.51 +/- 1.7 vs 2.9 +/- 1.7; p = 0.012) and behavioral (2.36 +/- 1.6 vs 1.9 +/- 1.8; p = 0.01) CC components. Cases were also significantly frailer according to the Edmonton Frail Scale (8.0 +/- 2.8 vs 6.4 +/- 3.1; p<0.001), whilst having similar disease burden, as measured by the CIRS comorbidity index. Age (OR 1.02; p = 0.039), low income (OR 1.97, 95% CI 1.10-3.55; p = 0.023), and total CC (OR 1.06; p = 0.014) independently correlated with the cases. Also, cases showed a longer length of stay (median 15.5vs11 days; p = 0.0016) and higher in-hospital (12 vs 4 events; p = 0.021) and 30-day (14 vs 6 events; p = 0.035) mortality. Conclusions Patients hospitalized during the December holiday period had worse health outcomes, and this could be attributable to the grater CC, especially related to socioeconomic (social deprivation, low income) and behavioral factors (inappropriate diet). The evaluation of all CC components could potentially represent a useful tool for a more rational resource allocation over this time of the year.	[Lenti, Marco Vincenzo; Brera, Alice Silvia; Benedetti, Irene; Padovini, Lucia; Ciola, Mariella; Croce, Gabriele; Ballesio, Alessia; Bertolino, Giampiera; Di Sabatino, Antonio; Corazza, Gino Roberto] Univ Pavia, Fdn IRCCS Policlin San Matteo, Dept Internal Med, Pavia, Italy; [Klersy, Catherine; Musella, Valeria] Univ Pavia, Fdn IRCCS Policlin San Matteo, Biometry & Clin Epidemiol, Pavia, Italy; [Gorgone, Maria Fortunata] Univ Pavia, Fdn IRCCS Policlin San Matteo, Direz Med Presidio, Pavia, Italy	IRCCS Fondazione San Matteo; University of Pavia; IRCCS Fondazione San Matteo; University of Pavia; IRCCS Fondazione San Matteo; University of Pavia	Corazza, GR (corresponding author), Univ Pavia, Fdn IRCCS Policlin San Matteo, Dept Internal Med, Pavia, Italy.	gr.corazza@smatteo.pv.it	Musella, Valeria/H-4458-2016; klersy, catherine/AAA-3003-2019; Lenti, Marco Vincenzo/F-9044-2018	Musella, Valeria/0000-0001-9517-2670; klersy, catherine/0000-0003-0314-8548; Lenti, Marco Vincenzo/0000-0002-6654-4911; Croce, Gabriele/0000-0002-3562-5321	San Matteo Hospital Foundation - Italian Ministry of Health	San Matteo Hospital Foundation - Italian Ministry of Health	This research is part of a project for the study of clinical complexity (SMAC study) funded by San Matteo Hospital Foundation - Italian Ministry of Health (Progetto di Ricerca Corrente 2017 - PI Prof. Gino Roberto Corazza). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Champagne CM, 2007, J AM DIET ASSOC, V107, P1886, DOI 10.1016/j.jada.2007.08.003; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Conway R, 2013, QJM-INT J MED, V106, P245, DOI 10.1093/qjmed/hcs233; Conway Richard, 2016, Acute Med, V15, P124; Corazza GR, 2019, EUR J INTERN MED, V61, P9, DOI 10.1016/j.ejim.2018.11.009; Corazza GR, 2017, INTERN EMERG MED, V12, P1313, DOI 10.1007/s11739-017-1709-6; Cournane S, 2015, EUR J INTERN MED, V26, P766, DOI 10.1016/j.ejim.2015.09.019; Dragano N, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-255; Dugravot A, 2020, LANCET PUBLIC HEALTH, V5, pE42, DOI 10.1016/S2468-2667(19)30226-9; EPSTEIN AM, 1990, NEW ENGL J MED, V322, P1122, DOI 10.1056/NEJM199004193221606; Grant RW, 2011, ANN INTERN MED, V155, P797, DOI 10.7326/0003-4819-155-12-201112200-00001; Hong CS, 2015, J GEN INTERN MED, V30, P1741, DOI 10.1007/s11606-015-3357-8; KATZMAN R, 1983, AM J PSYCHIAT, V140, P734; Knight J, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.005098; Lang IA, 2009, J AM GERIATR SOC, V57, P1776, DOI 10.1111/j.1532-5415.2009.02480.x; Lapointe-Shaw L, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4481; Lee TA, 2007, J GEN INTERN MED, V22, P403, DOI 10.1007/s11606-007-0277-2; Lenti MV, 2019, J GEN INTERN MED, V34, P2316, DOI 10.1007/s11606-019-05228-8; LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x; Luck J, 2007, J GEN INTERN MED, V22, P396, DOI 10.1007/s11606-007-0293-2; Magid DJ, 2005, JAMA-J AM MED ASSOC, V294, P803, DOI 10.1001/jama.294.7.803; MAHONEY F I, 1965, Md State Med J, V14, P61; Phillips D, 2010, SOC SCI MED, V71, P1463, DOI 10.1016/j.socscimed.2010.07.024; Phillips DP, 2004, CIRCULATION, V110, P3781, DOI 10.1161/01.CIR.0000151424.02045.F7; Pushparajah S, 2006, Chron Respir Dis, V3, P187, DOI 10.1177/1479972306070371; Rolfson DB, 2006, AGE AGEING, V35, P526, DOI 10.1093/ageing/afl041; Safford MM, 2007, J GEN INTERN MED, V22, P382, DOI 10.1007/s11606-007-0307-0; Stanaway JD, 2018, LANCET, V392, P1923, DOI 10.1016/s0140-6736(18)32225-6; Trzeciak S, 2003, EMERG MED J, V20, P402, DOI 10.1136/emj.20.5.402; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Walker AS, 2017, LANCET, V390, P62, DOI [10.1016/S0140-6736(17)30782-1, 10.1016/s0140-6736(17)30782-1]	33	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234112	10.1371/journal.pone.0234112	http://dx.doi.org/10.1371/journal.pone.0234112			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MA6QL	32525896	Green Published, gold			2022-12-26	WOS:000542036800029
J	Soroko, M; Zaborski, D				Soroko, Maria; Zaborski, Daniel			Investigation of the effects of probiotic, Bacillus subtilis on stress reactions in laying hens using infrared thermography	PLOS ONE			English	Article							GUT-BRAIN AXIS; TONIC IMMOBILITY; FEATHER PECKING; DOMESTIC-FOWL; RESPONSES; FEAR; TEMPERATURE; MICROBIOME; SUPPLEMENTATION; PERFORMANCE	The goal of the study was to assess whether tonic immobility (TI)-induced stress reactions in laying hens can be reduced by probiotic supplementation and if the changes in body surface temperature, as a stress indicator, are genetically dependent and can be detected using infrared thermography (IRT). Seventy-one white and 70 brown hens were used. Hens were randomly assigned to three treatments at 1-day-old: beak trimmed and fed a regular diet; non-beak trimmed and fed a regular diet; and non-beak trimmed and fed a diet supplemented with probiotics, Bacillus subtilis. At 40 weeks of age, hens were tested for TI reactions. Eye and face temperatures were measured with IRT immediately before and after TI testing. Results revealed that the probiotic supplementation did not affect hens' stress responses to TI testing; the left and right eye temperatures increased by 0.26s degrees C and 0.15 degrees C, respectively, while right face temperature tended to increase following TI testing. However, the right eye (32.60 degrees C for white, and 32.35 degrees C for brown) and face (39.51 degrees C for white, and 39.36 degrees C for brown) temperatures differed significantly among genetic lines. There was a positive correlation between TI duration and the changes of the left and right eye temperatures after TI testing in white hens. Based on these results, hens experienced TI-induced surface temperature changes that were detectable using IRT. White hens experienced greater stress reactions in response to TI than brown hens. However, supplementation with Bacillus subtilis did not attenuate hens' reaction to TI testing.	[Soroko, Maria] Wroclaw Univ Environm & Life Sci, Inst Anim Breeding, Dept Horse Breeding & Equestrian Studies, Wroclaw, Poland; [Zaborski, Daniel] West Pomeranian Univ Technol, Dept Ruminants Sci, Szczecin, Poland	Wroclaw University of Environmental & Life Sciences; West Pomeranian University of Technology	Soroko, M (corresponding author), Wroclaw Univ Environm & Life Sci, Inst Anim Breeding, Dept Horse Breeding & Equestrian Studies, Wroclaw, Poland.	kontakt@eqma.pl	Soroko-Dubrovina, Maria/AEA-3348-2022	Soroko-Dubrovina, Maria/0000-0002-8585-8000	Fulbright Scholarship (Fulbright Senior Award); USDA National Institute of Food and Agriculture, Foundation program of the Agriculture and Food Research Initiative Competitive Grants Program [2017-67015-26567]	Fulbright Scholarship (Fulbright Senior Award); USDA National Institute of Food and Agriculture, Foundation program of the Agriculture and Food Research Initiative Competitive Grants Program	This research was supported by a Fulbright Scholarship (Fulbright Senior Award) to conduct thermographic examination on birds at Purdue University. Rest of the research on poultry was supported by the USDA National Institute of Food and Agriculture, Foundation program of the Agriculture and Food Research Initiative Competitive Grants Program under the Award No: 2017-67015-26567. Mention of trade names or commercial products in this article is solely for the purpose of providing specific information and does not imply recommendation or endorsement of the USDA. The USDA is an equal opportunity provider and employer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abautret-Daly A, 2018, ACTA NEUROPSYCHIATR, V30, P275, DOI 10.1017/neu.2017.3; Albentosa MJ, 2003, BRIT POULTRY SCI, V44, P333, DOI 10.1080/00071660310001598085; Alverdy J, 2005, CURR OPIN CLIN NUTR, V8, P205, DOI 10.1097/00075197-200503000-00016; Bedanova I, 2007, POULTRY SCI, V86, P1065, DOI 10.1093/ps/86.6.1065; BEUVING G, 1989, BRIT POULTRY SCI, V30, P175, DOI 10.1080/00071668908417135; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Buijs S, 2018, APPL ANIM BEHAV SCI, V199, P17, DOI 10.1016/j.applanim.2017.10.017; Busnardo C, 2010, AUTON NEUROSCI-BASIC, V158, P51, DOI 10.1016/j.autneu.2010.06.003; Campo JL, 2002, POULTRY SCI, V81, P1099, DOI 10.1093/ps/81.8.1099; Cary VA, 2010, J CLIN NURS, V19, P904, DOI 10.1111/j.1365-2702.2009.03123.x; Chaucheyras-Durand F, 2010, BENEF MICROBES, V1, P3, DOI 10.3920/BM2008.1002; Choi Y, 2018, ASIAN AUSTRAL J ANIM, V31, P1654, DOI 10.5713/ajas.17.0921; Cryan J, 2014, INT J NEUROPSYCHOPH, V17, P27; Cryan JF, 2015, EUR NEUROPSYCHOPHARM, V25, pS140, DOI 10.1016/S0924-977X(15)30096-1; Cryan J, 2015, NEUROTOXICOL TERATOL, V49, P140, DOI 10.1016/j.ntt.2015.04.126; de Haas EN, 2013, POULTRY SCI, V92, P2259, DOI 10.3382/ps.2012-02996; Donatti AF, 2011, BEHAV BRAIN RES, V225, P23, DOI 10.1016/j.bbr.2011.06.027; EDDY TJ, 1990, PHYSIOL BEHAV, V47, P641, DOI 10.1016/0031-9384(90)90071-B; Edgar JL, 2013, PHYSIOL BEHAV, V119, P195, DOI 10.1016/j.physbeh.2013.06.020; El-Lethey H, 2000, BRIT POULTRY SCI, V41, P22, DOI 10.1080/00071660086358; Forsyth CB, 2009, ALCOHOL, V43, P163, DOI 10.1016/j.alcohol.2008.12.009; Fraisse F., 2006, BR POULT SCI, V47, P1; GENTLE MJ, 1989, PHYSIOL BEHAV, V46, P843, DOI 10.1016/0031-9384(89)90046-2; Ghareeb K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087727; Glatz PC, 2001, ASIAN AUSTRAL J ANIM, V14, P553, DOI 10.5713/ajas.2001.553; Herborn KA, 2018, PHYSIOL BEHAV, V191, P47, DOI 10.1016/j.physbeh.2018.04.004; Herborn KA, 2015, PHYSIOL BEHAV, V152, P225, DOI 10.1016/j.physbeh.2015.09.032; Hester PY, 2015, POULTRY SCI, V94, P860, DOI 10.3382/ps/pev066; Higgins SE, 2008, POULTRY SCI, V87, P27, DOI 10.3382/ps.2007-00210; Hosseini A, 2012, EXPERT OPIN BIOL TH, V12, P1323, DOI 10.1517/14712598.2012.707179; Humphreys RK, 2018, BEHAV ECOL SOCIOBIOL, V72, DOI 10.1007/s00265-017-2436-8; Johnson SR, 2011, J EQUINE VET SCI, V31, P63, DOI 10.1016/j.jevs.2010.12.004; JONES RB, 1981, BEHAV PROCESS, V6, P47, DOI 10.1016/0376-6357(81)90015-2; JONES RB, 1983, BEHAV PROCESS, V8, P243; Kurtoglu V, 2004, FOOD ADDIT CONTAM, V21, P817, DOI 10.1080/02652030310001639530; LAUNAY F, 1993, THESIS U RENNES 1, P167; Lay DC, 2011, POULTRY SCI, V90, P278, DOI 10.3382/ps.2010-00962; Logan AC, 2005, MED HYPOTHESES, V64, P533, DOI 10.1016/j.mehy.2004.08.019; Maldague XPV, 2001, NONDESTRUCTIVE HDB I, P15; Markowiak P, 2018, GUT PATHOG, V10, DOI 10.1186/s13099-018-0250-0; Messaoudi M, 2011, BRIT J NUTR, V105, P755, DOI 10.1017/S0007114510004319; Mingmongkolchai S, 2018, J APPL MICROBIOL, V124, P1334, DOI 10.1111/jam.13690; Moe RO, 2017, PHYSIOL BEHAV, V179, P42, DOI 10.1016/j.physbeh.2017.05.025; Mohammed AA, 2018, POULTRY SCI, V97, P1101, DOI 10.3382/ps/pex421; MURPHY LB, 1977, APPL ANIM ETHOL, V3, P335, DOI 10.1016/0304-3762(77)90058-X; NASH RF, 1976, PHYSIOL BEHAV, V17, P413, DOI 10.1016/0031-9384(76)90100-1; Patterson JA, 2003, POULTRY SCI, V82, P627, DOI 10.1093/ps/82.4.627; Prieto MT, 2010, POULTRY SCI, V89, P2071, DOI 10.3382/ps.2010-00716; Rao S, 2009, ARCH PEDIAT ADOL MED, V163, P755, DOI 10.1001/archpediatrics.2009.94; Roelofs K, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0206; Sherwin E, 2016, CURR OPIN GASTROEN, V32, P96, DOI 10.1097/MOG.0000000000000244; Soroko M, 2018, J EQUINE VET SCI, V60, P90, DOI 10.1016/j.jevs.2016.11.002; Stewart M, 2007, PHYSIOL BEHAV, V92, P520, DOI 10.1016/j.physbeh.2007.04.034; Tayeri V, 2018, VET RES COMMUN, V42, P195, DOI 10.1007/s11259-018-9724-2; Taylor AM, 2020, NUTR NEUROSCI, V23, P237, DOI 10.1080/1028415X.2018.1493808; Vuong HE, 2017, ANNU REV NEUROSCI, V40, P21, DOI 10.1146/annurev-neuro-072116-031347; Wang HX, 2016, CHINESE MED J-PEKING, V129, P2373, DOI 10.4103/0366-6999.190667; Wang WC, 2018, J ANIM SCI, V96, P1654, DOI 10.1093/jas/sky092; Whelan K, 2011, CURR OPIN CLIN NUTR, V14, P581, DOI 10.1097/MCO.0b013e32834b8082; Wilcox CS, 2009, POULTRY SCI, V88, P1176, DOI 10.3382/ps.2008-00446; Wiley NC, 2017, J ANIM SCI, V95, P3225, DOI 10.2527/jas.2016.1256	61	4	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234117	10.1371/journal.pone.0234117; 10.1371/journal.pone.0234117.r001; 10.1371/journal.pone.0234117.r002; 10.1371/journal.pone.0234117.r003; 10.1371/journal.pone.0234117.r004	http://dx.doi.org/10.1371/journal.pone.0234117; 10.1371/journal.pone.0234117.r001; 10.1371/journal.pone.0234117.r002; 10.1371/journal.pone.0234117.r003; 10.1371/journal.pone.0234117.r004			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MA6QL	32525895	gold, Green Published			2022-12-26	WOS:000542036800007
J	Consolazio, D; Koster, A; Sarti, S; Schram, MT; Stehouwer, CDA; Timmermans, EJ; Wesselius, A; Bosma, H				Consolazio, David; Koster, Annemarie; Sarti, Simone; Schram, Miranda T.; Stehouwer, Coen D. A.; Timmermans, Erik J.; Wesselius, Anke; Bosma, Hans			Neighbourhood property value and type 2 diabetes mellitus in the Maastricht study: A multilevel study	PLOS ONE			English	Article								Objective Low individual socioeconomic status (SES) is known to be associated with a higher risk of type 2 diabetes mellitus (T2DM), but the extent to which the local context in which people live may influence T2DM rates remains unclear. This study examines whether living in a low property value neighbourhood is associated with higher rates of T2DM independently of individual SES. Research design and methods Using cross-sectional data from the Maastricht Study (2010-2013) and geographical data from Statistics Netherlands, multilevel logistic regression was used to assess the association between neighbourhood property value and T2DM. Individual SES was based on education, occupation and income. Of the 2,056 participants (aged 40-75 years), 494 (24%) were diagnosed with T2DM. Results Individual SES was strongly associated with T2DM, but a significant proportion of the variance in T2DM was found at the neighbourhood level (VPC = 9.2%; 95% CI = 5.0%-16%). Participants living in the poorest neighbourhoods had a 2.38 times higher odds ratio of T2DM compared to those living in the richest areas (95% CI = 1.58-3.58), independently of individual SES. Conclusions Neighbourhood property value showed a significant association with T2DM, suggesting the usefulness of area-based programmes aimed at improving neighbourhood characteristics in order to tackle inequalities in T2DM.	[Consolazio, David; Koster, Annemarie; Bosma, Hans] Maastricht Univ, Dept Social Med, Maastricht, Netherlands; [Consolazio, David; Koster, Annemarie; Bosma, Hans] Maastricht Univ, CAPHRI Care & Publ Hlth Res Inst, Maastricht, Netherlands; [Consolazio, David] Univ Milano Bicocca, Dept Sociol & Social Res, Milan, Italy; [Sarti, Simone] Univ Milan, Dept Polit & Social Sci, Milan, Italy; [Schram, Miranda T.; Stehouwer, Coen D. A.] Maastricht Univ, Med Ctr, Dept Internal Med, Maastricht, Netherlands; [Schram, Miranda T.; Stehouwer, Coen D. A.] Maastricht Univ, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands; [Schram, Miranda T.] Maastricht Univ, Med Ctr, Heart & Vasc Ctr, Maastricht, Netherlands; [Timmermans, Erik J.] Vrije Univ Amsterdam, Med Ctr, Amsterdam Publ Hlth Res Inst, Amsterdam UMC,Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Wesselius, Anke] Maastricht Univ, Dept Complex Genet, Maastricht, Netherlands; [Wesselius, Anke] Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands	Maastricht University; Maastricht University; University of Milano-Bicocca; University of Milan; Maastricht University; Maastricht University; Maastricht University; University of Amsterdam; Vrije Universiteit Amsterdam; Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC)	Consolazio, D (corresponding author), Maastricht Univ, Dept Social Med, Maastricht, Netherlands.; Consolazio, D (corresponding author), Maastricht Univ, CAPHRI Care & Publ Hlth Res Inst, Maastricht, Netherlands.; Consolazio, D (corresponding author), Univ Milano Bicocca, Dept Sociol & Social Res, Milan, Italy.	d.consolazio@maastrichtuniversity.nl	Stehouwer, Coen/AAB-3435-2021; Bosma, Hans/A-6184-2013; Koster, Annemarie/E-7438-2010; SARTI, SIMONE/G-2964-2017	Koster, Annemarie/0000-0003-1583-7391; SARTI, SIMONE/0000-0001-5791-8793; Consolazio, David/0000-0002-5363-3691; Stehouwer, Coen/0000-0001-8752-3223	European Regional Development Fund; province of Limburg; department of Economic Affairs of the Netherlands [310.041]; Stichting Weijerhorst; Pearl String Initiative Diabetes; Cardiovascular Research Institute Maastricht (CARIM), School for Nutrition, Toxicology and Metabolism (NUTRIM); Stichting Annadal; Health Foundation Limburg; Janssen; Novo Nordisk; Sanofi	European Regional Development Fund(European Commission); province of Limburg; department of Economic Affairs of the Netherlands; Stichting Weijerhorst; Pearl String Initiative Diabetes; Cardiovascular Research Institute Maastricht (CARIM), School for Nutrition, Toxicology and Metabolism (NUTRIM); Stichting Annadal; Health Foundation Limburg; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Novo Nordisk(Novo Nordisk); Sanofi	This study has been supported by the European Regional Development Fund as part of OP-ZUID, the province of Limburg, the department of Economic Affairs of the Netherlands (grant 310.041), Stichting Weijerhorst, the Pearl String Initiative Diabetes, the Cardiovascular Center Maastricht, Cardiovascular Research Institute Maastricht (CARIM), School for Nutrition, Toxicology and Metabolism (NUTRIM), Stichting Annadal, Health Foundation Limburg and by unrestricted grants from Janssen, Novo Nordisk and Sanofi. The regional association of General Practitioners (Zorg in Ontwikkeling (ZIO)) is gratefully acknowledged for its contribution to The Maastricht Study, enabling the invitation of individuals with T2DM by using information from its web-based electronic health record.	A. D. American Diabetes Association, 2018, DIABETES CARE; Adler N., 2006, SOC SCI MED; Agardh E, 2011, INT J EPIDEMIOL; [Anonymous], 2012, LANCET; Astell-Burt T., 2014, DIABETES CARE; Auchincloss A. H., 2009, ARCH INTERN MED; Auchincloss A. H., 2008, EPIDEMIOLOGY; Bocquier A., 2011, DIABETES METAB; Booth G. L., 2013, DIABETES CARE; Bourassa S. C., 2003, J HOUS EC; Braveman P. A., 2005, JAMA; Butterfield M. C., 2011, J EPIDEMIOL COMMUNIT; Chichlowska K. L., 2008, PSYCHOSOM MED; Christine P, 2015, JAMA INT MED; Coffee NT, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-22; Connolly V., 2000, J EPIDEMIOL COMMUNIT; Cox M., 2007, SOC SCI MED; den Braver NR, 2018, BMC MED, V16, DOI 10.1186/s12916-017-0997-z; DREWNOWSKI A, 2007, SOC SCI MED; Ganzeboom H. B., 2010, ANN C INT SOC SURV P; Goembiewska E., 2004, ANN ACAD MED STETIN; Goldstein H., 2011, MULTILEVEL STAT MODE, V4th; Goldthorpe J. H., 2010, EUR SOCIOL REV; Jager K. J., 2008, KIDNEY INT; Kern D. M., 2018, PREV MED BALTIM; Knol F., STATUSONTWIKKELING W; Kroger H., 2015, EUR J PUBLIC HLTH; Lovasi G. S., 2009, EPIDEMIOL REV; Lynch J. W., 2000, BMJ; Macintyre S., 2002, SOCIAL SCI MED; Macleod J., 2005, SOC SCI MED; Meadows P., 1995, DIABET MED; Mellor J. M., 2011, INT J PEDIAT OBES; Mezuk B., 2016, AM J EPIDEMIOL; OECD, WHAT AR EQ SCAL; Pickett K. E., 2005, J EPIDEMIOL COMMUNIT; Qi Y., 2019, INT J ENV RES PUBLIC; Rehm C. D., 2012, SOC SCI MED; Sarti S., 2018, J PUBLIC HLTH BANGKO; Schram MT., 2014, EUR J EPIDEMIOL; The Netherlands Institute of Social Research, SOC CULT PLANB STAT; Vernez Moudon A., 2011, AM J PREV MED; Wilkinson R. G., 1997, AM J PUBLIC HLTH; Wilkinson R. G., 1992, BMJ	44	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2020	15	6							e0234324	10.1371/journal.pone.0234324	http://dx.doi.org/10.1371/journal.pone.0234324			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LZ0RE	32511267	Green Published, gold			2022-12-26	WOS:000540938100033
J	Iwaki, A; Moriwaki, K; Sobajima, T; Taniguchi, M; Yoshimura, SI; Kunii, M; Kanda, S; Kamada, Y; Miyoshi, E; Harada, A				Iwaki, Ayano; Moriwaki, Kenta; Sobajima, Tomoaki; Taniguchi, Manabu; Yoshimura, Shin-ichiro; Kunii, Masataka; Kanda, Satoshi; Kamada, Yoshihiro; Miyoshi, Eiji; Harada, Akihiro			Loss of Rab6a in the small intestine causes lipid accumulation and epithelial cell death from lactation	FASEB JOURNAL			English	Article						cell polarity; membrane trafficking; Rab protein	MICROVILLUS INCLUSION DISEASE; APICAL PROTEIN LOCALIZATION; RETROGRADE TRANSPORT; GOLGI; ER; PATHWAY; TRAFFICKING; REVEALS; RAB11A; RAB8A	Intestinal epithelial cells (IECs) are not only responsible for the digestion and absorption of dietary substrates but also function as a first line of host defense against commensal and pathogenic luminal bacteria. Disruption of the epithelial layer causes malnutrition and enteritis. Rab6 is a small GTPase localized to the Golgi, where it regulates anterograde and retrograde transport by interacting with various effector proteins. Here, we generated mice with IEC-specific deletion of Rab6a (Rab6a( increment IEC) mice). While Rab6a(Delta IEC) mice were born at the Mendelian ratio, they started to show IEC death, inflammation, and bleeding in the small intestine shortly after birth, and these changes culminated in early postnatal death. We further found massive lipid accumulation in the IECs of Rab6a( increment IEC) neonates. In contrast to Rab6a( increment IEC) neonates, knockout embryos did not show any of these abnormalities. Lipid accumulation and IEC death became evident when Rab6a( increment IEC) embryos were nursed by a foster mother, suggesting that dietary milk-derived lipids accumulated in Rab6a-deficient IECs and triggered IEC death. These results indicate that Rab6a plays a crucial role in regulating the lipid transport and maintaining tissue integrity.	[Iwaki, Ayano; Moriwaki, Kenta; Sobajima, Tomoaki; Taniguchi, Manabu; Yoshimura, Shin-ichiro; Kunii, Masataka; Kanda, Satoshi; Harada, Akihiro] Osaka Univ, Dept Cell Biol, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Iwaki, Ayano; Sobajima, Tomoaki; Kamada, Yoshihiro; Miyoshi, Eiji] Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Invest, Suita, Osaka, Japan; [Moriwaki, Kenta] Toho Univ, Dept Biochem, Sch Med, Tokyo, Japan; [Sobajima, Tomoaki] Univ Oxford, Dept Biochem, Oxford, England	Osaka University; Osaka University; Toho University; University of Oxford	Moriwaki, K; Harada, A (corresponding author), Osaka Univ, Dept Cell Biol, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kenta.moriwaki@med.toho-u.ac.jp; aharada@acb.med.osaka-u.ac.jp	Kamada, Yoshihiro/GQA-8854-2022; Kamada, Yoshihiro/AHC-1613-2022	Kamada, Yoshihiro/0000-0001-5485-902X; Kanda, Satoshi/0000-0002-1123-1205; Moriwaki, Kenta/0000-0002-8724-4715	Japan Society for the Promotion of Science KAKENHI [15H04668, 16H06280, 17H06422, 18H02594, 17K15547]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Japan Society for the Promotion of Science KAKENHI, Grant/Award Number: 15H04668, 16H06280, 17H06422, 18H02594 and 17K15547	Banfalvi G, 2017, APOPTOSIS, V22, P306, DOI 10.1007/s10495-016-1333-3; Bardin S, 2015, BIOL CELL, V107, P427, DOI 10.1111/boc.201400083; Blander JM, 2018, CURR OPIN GASTROEN, V34, P413, DOI 10.1097/MOG.0000000000000481; Coutelis JB, 2007, DEVELOPMENT, V134, P1419, DOI 10.1242/dev.02821; Echard A, 2000, MOL BIOL CELL, V11, P3819, DOI 10.1091/mbc.11.11.3819; Feng Q, 2017, J CELL SCI, V130, P2491, DOI 10.1242/jcs.201897; Fourriere L, 2019, J CELL BIOL, V218, P2215, DOI 10.1083/jcb.201805002; Garcia-Hernandez V, 2017, ANN NY ACAD SCI, V1397, P66, DOI 10.1111/nyas.13360; Gordon SM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40296-0; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; Grigoriev I, 2007, DEV CELL, V13, P305, DOI 10.1016/j.devcel.2007.06.010; Han J, 2016, J LIPID RES, V57, P1329, DOI 10.1194/jlr.R067595; Homma Y, 2019, J CELL BIOL, V218, P2035, DOI 10.1083/jcb.201810134; Hussain MM, 2014, CURR OPIN LIPIDOL, V25, P200, DOI 10.1097/MOL.0000000000000084; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Iwanami N, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005828; Januschke J, 2007, DEVELOPMENT, V134, P3419, DOI 10.1242/dev.008078; Klunder LJ, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a027888; Leng CS, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000531; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Mansbach CM, 2010, ANNU REV PHYSIOL, V72, P315, DOI 10.1146/annurev-physiol-021909-135801; Matanis T, 2002, NAT CELL BIOL, V4, P986, DOI 10.1038/ncb891; Miserey-Lenkei S, 2007, TRAFFIC, V8, P1385, DOI 10.1111/j.1600-0854.2007.00612.x; Mizuta R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080223; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Odenwald MA, 2017, NAT REV GASTRO HEPAT, V14, P9, DOI 10.1038/nrgastro.2016.169; Opdam FJM, 2000, J CELL SCI, V113, P2725; Piccolis M, 2019, MOL CELL, V74, P32, DOI 10.1016/j.molcel.2019.01.036; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; Sato T, 2014, J CELL SCI, V127, P422, DOI 10.1242/jcs.136903; Schneeberger K, 2015, P NATL ACAD SCI USA, V112, P12408, DOI 10.1073/pnas.1516672112; Shafaq-Zadah M, 2016, NAT CELL BIOL, V18, P54, DOI 10.1038/ncb3287; Sobajima T, 2015, BIOL OPEN, V4, P86, DOI 10.1242/bio.20148532; Wallach D, 2014, NAT REV IMMUNOL, V14, P51, DOI 10.1038/nri3561; Weis VG, 2016, CELL MOL GASTROENTER, V2, P131, DOI 10.1016/j.jcmgh.2015.11.009; White J, 1999, J CELL BIOL, V147, P743, DOI 10.1083/jcb.147.4.743; Yoshimura S, 2004, J BIOCHEM, V135, P201, DOI 10.1093/jb/mvh024; Yu SY, 2014, EMBO J, V33, P1882, DOI 10.15252/embj.201487888; ZAHRAOUI A, 1989, J BIOL CHEM, V264, P12394; Zhen Y, 2015, J CELL SCI, V128, P3171, DOI 10.1242/jcs.166074	40	1	1	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9450	9465		10.1096/fj.202000028R	http://dx.doi.org/10.1096/fj.202000028R		JUN 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32496646	Bronze			2022-12-26	WOS:000538309300001
J	Wu, BL; Yuan, YC; Han, X; Wang, QC; Shang, HT; Liang, XT; Jing, H; Cheng, W				Wu, Bolin; Yuan, Yanchi; Han, Xue; Wang, Qiucheng; Shang, Haitao; Liang, Xitian; Jing, Hui; Cheng, Wen			Structure of LINC00511-siRNA-conjugated nanobubbles and improvement of cisplatin sensitivity on triple negative breast cancer	FASEB JOURNAL			English	Article						drug resistance; gene transfection; nanobubbles; RNA-Seq; triple negative breast cancer	RNA-SEQ; EXPRESSION; DELIVERY; RESISTANCE; KEGG	The drug resistance of triple negative breast cancer (TNBC) is considered as a major obstacle for the curative effect of chemotherapy. Long intergenic noncoding RNA 00511 (LINC00511) has been considered as a target gene of drug resistance. A novel theranostic agent loaded with LINC00511-siRNA to deliver siRNA was structured, and the responses of drug sensitivity in TNBC were detected. Next-generation high-throughput RNA sequencing (RNA-Seq) was performed to accurately analyze the differential expression of mRNAs and lncRNA targets after LINC00511-siRNA transfection with low-frequency ultrasound (LFUS). The LINC00511-siRNA conjugated nanobubble complexes showed appropriate characterization, with a mean diameter of 516.1 +/- 24.7 nm and a zeta potential of -38.05 +/- 0.24 mV. The transfection efficiency of nanobubble complexes was approximately 50% with LFUS. By RNA-Seq, the differential expressions of lncRNA transcripts and mRNA transcripts were identified, and then analyzed. The GO and KEGG enrichment analyses revealed the TNBC drug resistance related target genes and pathways. The combination of LFUS irradiation and nanobubble complexes is regarded as an efficient and safe method for siRNA transfection. The TNBC drug resistance occurs as a result of synergistic reactions between a variety of genes and a variety of pathways.	[Wu, Bolin; Yuan, Yanchi; Han, Xue; Wang, Qiucheng; Shang, Haitao; Liang, Xitian; Jing, Hui; Cheng, Wen] Harbin Med Univ, Dept Ultrasound, Canc Hosp, 150 Haping Rd, Harbin 150081, Heilongjiang, Peoples R China; [Wu, Bolin; Cheng, Wen] Harbin Med Univ, Dept Intervent Ultrasound, Canc Hosp, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Jing, H; Cheng, W (corresponding author), Harbin Med Univ, Dept Ultrasound, Canc Hosp, 150 Haping Rd, Harbin 150081, Heilongjiang, Peoples R China.	jinghui@hrbmu.edu.cn; chengwen@hrbmu.edu.cn	Jing, Hui/GXM-4109-2022	Jing, Hui/0000-0002-8389-8252	National Natural Science Foundation of China (NSFC) [81801709, 81873900]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81801709 and 81873900	Anastasiadi Z, 2017, UPDATES SURG, V69, P313, DOI 10.1007/s13304-017-0424-1; Barone I, 2020, SEMIN CANCER BIOL, V60, P274, DOI 10.1016/j.semcancer.2019.09.001; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Chen SY, 2018, GENE THER, V25, P497, DOI 10.1038/s41434-018-0036-5; Chen ZY, 2013, CARDIOVASC ULTRASOUN, V11, DOI 10.1186/1476-7120-11-11; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Frazee AC, 2015, NAT BIOTECHNOL, V33, P243, DOI 10.1038/nbt.3172; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Johnstone TC, 2016, CHEM REV, V116, P3436, DOI 10.1021/acs.chemrev.5b00597; Kaczmarek E, 2019, BREAST CANCER RES TR, V178, P505, DOI 10.1007/s10549-019-05423-5; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kang YJ, 2017, NUCLEIC ACIDS RES, V45, pW12, DOI 10.1093/nar/gkx428; Krupka TM, 2010, MOL PHARMACEUT, V7, P49, DOI 10.1021/mp9001816; Lee KL, 2019, CANCERS, V11, DOI 10.3390/cancers11091334; Liang XT, 2018, ONCOL LETT, V16, P2893, DOI 10.3892/ol.2018.8994; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Liu L, 2019, EUR REV MED PHARMACO, V23, P7457, DOI 10.26355/eurrev_201909_18855; Liu YY, 2006, J CONTROL RELEASE, V114, P89, DOI 10.1016/j.jconrel.2006.05.018; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Meng L, 2019, ADV SCI, V6, DOI 10.1002/advs.201900557; Miansari M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47295-1; Moiseenko Fedor, 2017, F1000Res, V6, P288, DOI 10.12688/f1000research.10992.1; Omata D, 2019, J CONTROL RELEASE, V311, P65, DOI 10.1016/j.jconrel.2019.08.023; Poggio F, 2018, ANN ONCOL, V29, P1497, DOI 10.1093/annonc/mdy127; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Ren HX, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2365-3; Shang HT, 2019, DRUG DELIV, V26, P944, DOI 10.1080/10717544.2019.1667450; Sirsi SR, 2012, J CONTROL RELEASE, V157, P224, DOI 10.1016/j.jconrel.2011.09.071; Song QL, 2019, ADV MATER, V31, DOI 10.1002/adma.201903793; Sun L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt646; Sun SJ, 2018, NANOSCALE, V10, P19945, DOI 10.1039/c8nr03074j; Szablowski JO, 2019, ACCOUNTS CHEM RES, V52, P2427, DOI 10.1021/acs.accounts.9b00277; Tayier B, 2019, NANOSCALE, V11, P14757, DOI 10.1039/c9nr03402a; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tray N, 2019, CANCER TREAT REV, V79, DOI 10.1016/j.ctrv.2019.08.004; Wang HY, 2019, NANOSCALE, V11, P17018, DOI 10.1039/c9nr04655k; Wang X, 2019, NANO LETT, V19, P2251, DOI 10.1021/acs.nanolett.8b04632; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wayteck L, 2017, J CONTROL RELEASE, V267, P154, DOI 10.1016/j.jconrel.2017.08.002; Wein L, 2017, BREAST, V34, pS27, DOI 10.1016/j.breast.2017.06.023; Wu BL, 2019, FASEB J, V33, P14129, DOI 10.1096/fj.201900716RR; Wu BL, 2016, TUMOR BIOL, V37, P12113, DOI 10.1007/s13277-016-5082-2; Wu Q, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0778-6; Xu SP, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0696-6; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	47	22	22	2	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9713	9726		10.1096/fj.202000481R	http://dx.doi.org/10.1096/fj.202000481R		JUN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32497336				2022-12-26	WOS:000538309000001
J	Liu, B; Wei, H; Ren, YJ; Zou, DB; Zhang, KN; Ma, QW; Xiao, X				Liu, Bo; Wei, Hong; Ren, Yan-Jun; Zou, Debo; Zhang, Kaining; Ma, Qingwei; Xiao, Xing			Clinicopathological characteristics and survival of malignant fibrous histiocytoma of the bone: A population-based study using the SEER database	PLOS ONE			English	Article							NEOADJUVANT CHEMOTHERAPY; CANCER; LUNG	Malignant fibrous histiocytoma of the bone (MFH-B) is an extremely rare and aggressive malignancy. The clinicopathological characteristics and prognosis of patients with MFH-B have not been defined. We conducted a retrospective study using the data of all MFH-B patients from the Surveillance, Epidemiology and End Results (SEER) database between 1975 and 2016. Initially, the clinicopathological characteristics were described. The difference in prognosis between patients with MFH-B and those with osteosarcoma was compared using propensity score matching analysis. Then, the features affecting the prognosis of patients with MFH-B were further determined using Cox regression analysis. A total of 318 patients with MFH-B were identified. The median overall survival (mOS) of all 318 patients with MFH-B was 29.0 months. The 1-, 3-, 5-, and 10- year survival rates were 67.4%, 53.6%, 38.7%, and 28.7%, respectively. The multivariate Cox regression analysis showed that older age, distant metastases, and flat bone lesion were independent factors for worse prognosis, whereas surgery was an independent factor for favorable survival, and this intervention could decrease risk of death by 61% (HR = 0.39, 95% CI 0.28-0.54). Apart from this, the prognosis of patients with MFH-B was significantly worse than that of patients with osteosarcoma in both unmatched and matched cohorts. In conclusion, MFH-B is a rare malignant bone cancer, with relatively worse prognosis than osteosarcoma. Older age, distant metastases, flat bone lesion, and surgery were independently associated with prognosis. In order to understand this disease more thoroughly and accurately, more cases with adequate information are required in the future.	[Liu, Bo] Linyi Cent Hosp, Dept Orthoped, Yishui, Shandong, Peoples R China; [Wei, Hong; Ren, Yan-Jun; Zou, Debo; Zhang, Kaining; Ma, Qingwei; Xiao, Xing] Shandong First Med Univ, Affiliated Hosp 1, Dept Orthoped, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences	Xiao, X (corresponding author), Shandong First Med Univ, Affiliated Hosp 1, Dept Orthoped, Jinan, Shandong, Peoples R China.	xiaoxbone@163.com						Bielack SS, 1999, ACTA ORTHOP SCAND, V70, P353, DOI 10.3109/17453679908997824; Bramwell VHC, 1999, J CLIN ONCOL, V17, P3260, DOI 10.1200/JCO.1999.17.10.3260; CAPANNA R, 1984, CANCER-AM CANCER SOC, V54, P177, DOI 10.1002/1097-0142(19840701)54:1<177::AID-CNCR2820540133>3.0.CO;2-C; Gu XB, 2018, CANCER MANAG RES, V10, P1061, DOI 10.2147/CMAR.S157442; HUVOS AG, 1985, AM J SURG PATHOL, V9, P853, DOI 10.1097/00000478-198512000-00002; Ke SJ, 2019, CANCER MANAG RES, V11, P1003, DOI 10.2147/CMAR.S187370; Koplas MC, 2010, SKELETAL RADIOL, V39, P791, DOI 10.1007/s00256-009-0822-7; Kubo T, 2008, J AM ACAD DERMATOL, V59, pS88, DOI 10.1016/j.jaad.2008.06.039; Li Guang-xue, 2011, Zhonghua Wai Ke Za Zhi, V49, P733; Natarajan M V, 2007, J Orthop Surg (Hong Kong), V15, P352; Nishida J, 1997, CANCER, V79, P482; OBRIEN JE, 1964, CANCER, V17, P1445, DOI 10.1002/1097-0142(196411)17:11<1445::AID-CNCR2820171112>3.0.CO;2-G; Papagelopoulos PJ, 2000, ORTHOPEDICS, V23, P59; PAPAGELOPOULOS PJ, 2000, ORTHOPEDICS, V23, P66; Picci P, 1997, ANN ONCOL, V8, P1107, DOI 10.1023/A:1008283516969; Rogers S J, 2000, Sarcoma, V4, P125, DOI 10.1080/13577140020008093; Sun J, 2017, ADV CLIN EXP MED, V26, P781, DOI 10.17219/acem/63744; Wang HY, 2017, ONCOTARGET, V8, P34923, DOI 10.18632/oncotarget.16823	18	4	5	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2020	15	6							e0232466	10.1371/journal.pone.0232466	http://dx.doi.org/10.1371/journal.pone.0232466			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LW6ZP	32492019	gold, Green Published			2022-12-26	WOS:000539293000013
J	Sultana, S; Stewart, J; van der Spoel, AC				Sultana, Saki; Stewart, Jacklyn; van der Spoel, Aarnoud C.			Truncated mutants of beta-glucosidase 2 (GBA2) are localized in the mitochondrial matrix and cause mitochondrial fragmentation	PLOS ONE			English	Article							HEREDITARY SPASTIC PARAPLEGIA; NONLYSOSOMAL GLUCOSYLCERAMIDASE; ELECTRON-MICROSCOPY; HUMAN INTERACTOME; IMINO SUGAR; RARE CAUSES; PROTEIN; GENES; MUTATIONS; ATAXIA	The enzyme beta-glucosidase 2 (GBA2) is clinically relevant because it is targeted by the drug miglustat (Zavesca(R)) and because it is involved in inherited diseases. Mutations in the GBA2 gene are associated with two neurological diseases on the ataxia-spasticity spectrum, hereditary spastic paraplegia 46 (SPG46) and Marinesco-Sjogren-like syndrome (MSS). To establish how GBA2 mutations give rise to neurological pathology, we have begun to investigate mutant forms of GBA2 encoded by disease-associated GBA2 alleles. Previously, we found that five GBA2 missense mutants and five C-terminally truncated mutants lacked enzyme activity. Here we have examined the cellular locations of wild-type (WT) and mutant forms of GBA2 by confocal and electron microscopy, using transfected cells. Similar to GBA2-WT, the D594H and M510Vfs*17 GBA2 mutants were located at the plasma membrane, whereas the C-terminally truncated mutants terminating after amino acids 233 and 339 (GBA2-233 and -339) were present in the mitochondrial matrix, induced mitochondrial fragmentation and loss of mitochondrial transmembrane potential. Deletional mutagenesis indicated that residues 161-200 are critical for the mitochondrial fragmentation of GBA2-233 and -339. Considering that the mitochondrial fragmentation induced by GBA2-233 and -339 is consistently accompanied by their localization to the mitochondrial matrix, our deletional analysis raises the possibility that that GBA2 residues 161-200 harbor an internal targeting sequence for transport to the mitochondrial matrix. Altogether, our work provides new insights into the behaviour of GBA2-WT and disease-associated forms of GBA2.	[Sultana, Saki; van der Spoel, Aarnoud C.] Dalhousie Univ, Atlantic Res Ctr, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Stewart, Jacklyn] Dalhousie Univ, Biomed Sci Program, Halifax, NS, Canada; [van der Spoel, Aarnoud C.] Dalhousie Univ, Atlantic Res Ctr, Dept Pediat, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Dalhousie University	van der Spoel, AC (corresponding author), Dalhousie Univ, Atlantic Res Ctr, Dept Biochem & Mol Biol, Halifax, NS, Canada.; van der Spoel, AC (corresponding author), Dalhousie Univ, Atlantic Res Ctr, Dept Pediat, Halifax, NS, Canada.	spoela@dal.ca		van der Spoel, Aarnoud/0000-0002-2338-5316	Natural Sciences and Engineering Research Council of Canada [RGPIN/386633]; Research Nova Scotia [MED-DI-2017-1276]; Dalhousie University Medical Research Development Office; Dalhousie University Department of Pediatrics; Research Nova Scotia; Health Centre Halifax; Dalhousie University Faculty of Graduate Studies	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Research Nova Scotia; Dalhousie University Medical Research Development Office; Dalhousie University Department of Pediatrics; Research Nova Scotia; Health Centre Halifax; Dalhousie University Faculty of Graduate Studies	ACvdS received grant RGPIN/386633 from the Natural Sciences and Engineering Research Council of Canada, https://portal-portail.nserc-crsng.gc.ca/s/login.aspx; ACvdS received grant MED-DI-2017-1276 from Research Nova Scotia (previously the Nova Scotia Health Research Foundation), https://researchns.ca/; ACvdS received funding from the Dalhousie University Medical Research Development Office, https://medicine.dal.ca/research-dal-med/people/office-staff.html; ACvdS received funding from Dalhousie University Department of Pediatrics, https://medicine.dal.ca/departments/department-sites/pediatrics.html; SS received funding from Research Nova Scotia (previously the Nova Scotia Health Research Foundation), https://researchns.ca/; SS & IWK received funding from Health Centre Halifax, http://www.iwk.nshealth.ca/; SS received funding from the Dalhousie University Faculty of Graduate Studies, https://www.dal.ca/faculty/gradstudies/funding/appprocres/scholarshiprefs/nsgs.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2020, J BIOL CHEM, V295, P5257, DOI 10.1074/jbc.RA119.012502; Akiyama H, 2013, BIOCHEM BIOPH RES CO, V441, P838, DOI 10.1016/j.bbrc.2013.10.145; Amory JK, 2007, HUM REPROD, V22, P702, DOI 10.1093/humrep/del414; [Anonymous], 2015, DABIQ, V12, P51; Ariotti N, 2015, DEV CELL, V35, P513, DOI 10.1016/j.devcel.2015.10.016; Bone W, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-1; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Citterio A, 2014, J NEUROL, V261, P373, DOI 10.1007/s00415-013-7206-6; Coarelli G, 2019, NEUROLOGY, V92, pE2679, DOI 10.1212/WNL.0000000000007606; Coarelli G, 2018, CLIN NEUROL NEUROSUR, V168, P60, DOI 10.1016/j.clineuro.2018.02.042; EHRENBERG B, 1988, BIOPHYS J, V53, P785, DOI 10.1016/S0006-3495(88)83158-8; FARKAS DL, 1989, BIOPHYS J, V56, P1053, DOI 10.1016/S0006-3495(89)82754-7; Hammer MB, 2013, AM J HUM GENET, V92, P245, DOI 10.1016/j.ajhg.2012.12.012; Harbauer AB, 2014, CELL METAB, V19, P357, DOI 10.1016/j.cmet.2014.01.010; Haugarvoll K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169309; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Huttlin EL, 2017, NATURE, V545, P505, DOI 10.1038/nature22366; Kancheva D, 2016, GENET MED, V18, P600, DOI 10.1038/gim.2015.139; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Kervestin S, 2012, NAT REV MOL CELL BIO, V13, P700, DOI 10.1038/nrm3454; Korschen HG, 2013, J BIOL CHEM, V288, P3381, DOI 10.1074/jbc.M112.414714; Marques ARA, 2016, J LIPID RES, V57, P451, DOI 10.1194/jlr.M064923; Martell JD, 2017, NAT PROTOC, V12, P1792, DOI 10.1038/nprot.2017.065; Martin E, 2013, AM J HUM GENET, V92, P238, DOI 10.1016/j.ajhg.2012.11.021; Matz J, 2010, P NATL ACAD SCI USA, V107, P8836, DOI 10.1073/pnas.0906087107; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Morais S, 2017, EUR J HUM GENET, V25, P1217, DOI 10.1038/ejhg.2017.124; Oko R, 2011, CELL TISSUE RES, V346, P119, DOI 10.1007/s00441-011-1248-9; Raju D, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005063; Ridley CM, 2013, J BIOL CHEM, V288, P26052, DOI 10.1074/jbc.M113.463562; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Sultana S, 2016, ZEBRAFISH, V13, P177, DOI 10.1089/zeb.2015.1152; Sultana S, 2015, BIOCHEM BIOPH RES CO, V465, P35, DOI 10.1016/j.bbrc.2015.07.112; Tulli S, 2019, J MED GENET, V56, P499, DOI 10.1136/jmedgenet-2018-105766; van der Spoel AC, 2008, PHARMACOGENOMICS, V9, P717, DOI 10.2217/14622416.9.6.717; van der Spoel AC, 2002, P NATL ACAD SCI USA, V99, P17173, DOI 10.1073/pnas.262586099; van der Spoel AC, 2019, MOL BIOL CELL, V30, P553; VANWEELY S, 1993, BIOCHIM BIOPHYS ACTA, V1181, P55, DOI 10.1016/0925-4439(93)90090-N; Villeneuve LM, 2014, J PROTEOMICS, V109, P228, DOI 10.1016/j.jprot.2014.07.011; Votsi C, 2014, ANN HUM GENET, V78, P13, DOI 10.1111/ahg.12045; Walden CM, 2007, J BIOL CHEM, V282, P32655, DOI 10.1074/jbc.M702387200; Walden CM, 2006, HUM REPROD, V21, P1309, DOI 10.1093/humrep/dei463; Wei Q, 2019, TRANSL NEURODEGENER, V8, DOI 10.1186/s40035-019-0157-9; Woeste MA, 2019, J BIOL CHEM, V294, P3853, DOI 10.1074/jbc.RA118.006311; Woeste MA, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00386; Wu ATH, 2007, DEV BIOL, V312, P471, DOI 10.1016/j.ydbio.2007.08.051; Yang YJ, 2016, J NEUROL, V263, P2136, DOI 10.1007/s00415-016-8256-3; Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224	49	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2020	15	6							e0233856	10.1371/journal.pone.0233856	http://dx.doi.org/10.1371/journal.pone.0233856			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LW6ZP	32492073	gold, Green Published			2022-12-26	WOS:000539293000047
J	Mao, SF; Pachter, L; Tse, D; Kannan, S				Mao, Shunfu; Pachter, Lior; Tse, David; Kannan, Sreeram			RefShannon: A genome-guided transcriptome assembler using sparse flow decomposition	PLOS ONE			English	Article							RNA-SEQ; RECONSTRUCTION; GENERATION; DISCOVERY; REVEALS; GENES	High throughput sequencing of RNA (RNA-Seq) has become a staple in modern molecular biology, with applications not only in quantifying gene expression but also in isoform-level analysis of the RNA transcripts. To enable such an isoform-level analysis, a transcriptome assembly algorithm is utilized to stitch together the observed short reads into the corresponding transcripts. This task is complicated due to the complexity of alternative splicing a mechanism by which the same gene may generate multiple distinct RNA transcripts. We develop a novel genome-guided transcriptome assembler, RefShannon, that exploits the varying abundances of the different transcripts, in enabling an accurate reconstruction of the transcripts. Our evaluation shows RefShannon is able to improve sensitivity effectively (up to 22%) at a given specificity in comparison with other state-of-the-art assemblers. RefShannon is written in Python and is available from Github (https://github.com/shunfumao/RefShannon).	[Mao, Shunfu; Kannan, Sreeram] Univ Washington, Dept Elect & Comp Engn, Seattle, WA 98195 USA; [Pachter, Lior] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Tse, David] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA	University of Washington; University of Washington Seattle; California Institute of Technology; Stanford University	Kannan, S (corresponding author), Univ Washington, Dept Elect & Comp Engn, Seattle, WA 98195 USA.	ksreeram@ece.uw.edu		Pachter, Lior/0000-0002-9164-6231	NIH [1R01HG008164]; NSF [CIF-1703403, CCF-1651236]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF))	Y This project is funded by NIH award 1R01HG008164, NSF CCF-1651236, and NSF CIF-1703403.	Alberts B., 2019, ESSENTIAL CELL BIOL; [Anonymous], 2018, NAT BIOTECHNOL, V36, P287, DOI 10.1038/nbt.4125; Au KF, 2013, P NATL ACAD SCI USA, V110, pE4821, DOI 10.1073/pnas.1320101110; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; BREITBART RE, 1987, ANNU REV BIOCHEM, V56, P467, DOI 10.1146/annurev.bi.56.070187.002343; De Maio N, 2019, MICROB GENOMICS, V5, DOI 10.1099/mgen.0.000294; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Deutsch M, 1999, NUCLEIC ACIDS RES, V27, P3219, DOI 10.1093/nar/27.15.3219; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Gatter T, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2786-5; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Hayer KE, 2015, BIOINFORMATICS, V31, P3938, DOI 10.1093/bioinformatics/btv488; Kannan S, 2016, INFORM OPTIMAL NOVO; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Krizanovic K, 2018, BIOINFORMATICS, V34, P748, DOI 10.1093/bioinformatics/btx668; Leonelli S, 2013, ENDEAVOUR, V37, P209, DOI 10.1016/j.endeavour.2013.06.001; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Liu JT, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1074-1; Liu RL, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005851; Maitra RD, 2012, ELECTROPHORESIS, V33, P3418, DOI 10.1002/elps.201200272; Mao S., 2017, 17 INT WORK ALGORITH, V15, p[14, 1]; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Meister G, 2011, RNA BIOL INTRO; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Roberts RJ, 2013, GENOME BIOL, V14, DOI [10.1186/gb-2013-14-7-405, 10.1186/gb-2013-14-6-405]; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Sakharkar Meena Kishore, 2004, In Silico Biology, V4, P387; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Song L, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw158; Steijger T, 2013, NAT METHODS, V10, P1177, DOI [10.1038/nmeth.2714, 10.1038/NMETH.2714]; Tilgner H, 2014, P NATL ACAD SCI USA, V111, P9869, DOI 10.1073/pnas.1400447111; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WITKOWSKI JA, 1988, TRENDS BIOCHEM SCI, V13, P110, DOI 10.1016/0968-0004(88)90052-7; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Xie YL, 2014, BIOINFORMATICS, V30, P1660, DOI 10.1093/bioinformatics/btu077; Zimin AV, 2013, BIOINFORMATICS, V29, P2669, DOI 10.1093/bioinformatics/btt476	41	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2020	15	6							e0232946	10.1371/journal.pone.0232946	http://dx.doi.org/10.1371/journal.pone.0232946			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MT4VF	32484809	Green Published, Green Accepted, gold			2022-12-26	WOS:000554969700006
J	Blanckenberg, M; Mlambo, MC; Parker, D; Motitsoe, SN; Reed, C				Blanckenberg, Michelle; Mlambo, Musa C.; Parker, Denham; Motitsoe, Samuel N.; Reed, Cecile			Protected and un-protected urban wetlands have similar aquatic macroinvertebrate communities: A case study from the Cape Flats Sand Fynbos region of southern Africa	PLOS ONE			English	Article							TEMPORARY WETLANDS; WESTERN CAPE; PONDS; URBANIZATION; BIODIVERSITY; PANS; LANDSCAPE; DIVERSITY; ECOLOGY	Rapid urbanisation has led to major landscape alterations, affecting aquatic ecosystems' hydrological and biogeochemical cycles, and biodiversity. Thus, habitat alteration is considered a major driver of aquatic biodiversity loss and related aquatic ecosystem goods and services. This study aimed to investigate and compare aquatic macroinvertebrate richness, diversity and community structure between urban temporary wetlands, located within protected and un-protected areas. The latter were found within an open public space or park with no protection or conservation status, whereas the former were inaccessible to the public and had formal protected, conservation status. We hypothesised that; (1) protected urban wetlands will harbour higher aquatic macroinvertebrate biodiversity (both dry and wet) as compared to un-protected urban wetlands, and (2) that the community composition between the two urban wetlands types will be significantly different. Contrary to our hypothesis, our results revealed no major differences between protected and un-protected urban wetlands, based on the measures investigated (i.e. taxon richness, Shannon-Weiner diversity, Pielou's evenness and community composition) during the dry and wet phase. The only exception was community composition, which revealed significant differences between these urban wetland types. These results suggest that human activities (potential littering and polluting) in the un-protected urban wetlands have not yet resulted in drastic change in macroinvertebrate richness and composition, at least from the dry phase. This suggests a potential for un-protected urban wetlands suffering from minimal human impact to act as important reservoirs of biodiversity and ecosystem services.	[Blanckenberg, Michelle; Reed, Cecile] Univ Cape Town, Dept Biol Sci, Cape Town, South Africa; [Mlambo, Musa C.] Rhodes Univ, Dept Freshwater Invertebrates, Albany Museum, Affiliated Res Inst, Grahamstown, South Africa; [Mlambo, Musa C.] Rhodes Univ, Dept Zool & Entomol, Grahamstown, South Africa; [Parker, Denham] Branch Fisheries Management Res & Dev, Dept Environm Affairs, Cape Town, South Africa; [Motitsoe, Samuel N.] Rhodes Univ, Dept Zool & Entomol, Ctr Biol Control, Grahamstown, South Africa	University of Cape Town; Rhodes University; Rhodes University; Department of Environment, Forestry & Fisheries; Rhodes University	Mlambo, MC (corresponding author), Rhodes Univ, Dept Freshwater Invertebrates, Albany Museum, Affiliated Res Inst, Grahamstown, South Africa.; Mlambo, MC (corresponding author), Rhodes Univ, Dept Zool & Entomol, Grahamstown, South Africa.	musa.miambo@gmail.com	Motitsoe, Samuel/GFN-9052-2022	Motitsoe, Samuel/0000-0002-6592-3725; Mlambo, Musa C./0000-0001-7624-5686	Foundational Biodiversity Information Programme (FBIP) of DST-NRF [10492]	Foundational Biodiversity Information Programme (FBIP) of DST-NRF	Foundational Biodiversity Information Programme (FBIP) of DST-NRF (Grant No 10492) to MCM.	Anderson PML, 2014, LANDSCAPE URBAN PLAN, V127, P104, DOI 10.1016/j.landurbplan.2014.03.007; [Anonymous], 2018, UN WORLD URB PROSP 2; [Anonymous], 2006, BIOL TEMPORARY WATER; Bird MS, 2016, HYDROBIOLOGIA, V782, P169, DOI 10.1007/s10750-016-2804-9; Bird MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088935; Bird MS, 2013, HYDROBIOLOGIA, V711, P115, DOI 10.1007/s10750-013-1470-4; Blanckenberg M, 2019, AUSTRAL ECOL, V44, P1225, DOI 10.1111/aec.12800; Blaustein L, 2001, ISR J ZOOL, V47, P303, DOI 10.1560/CKMU-Q2PM-HTGC-P9C8; Boix D, 2001, WETLANDS, V21, P577, DOI 10.1672/0277-5212(2001)021[0577:TFCOEP]2.0.CO;2; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brendonck L, 1997, P S DIAP CRUS INV CO; Brock MA, 2005, FRESHWATER BIOL, V50, P1376, DOI 10.1111/j.1365-2427.2005.01408.x; Calhoun AJK, 2017, BIOL CONSERV, V211, P3, DOI 10.1016/j.biocon.2016.11.024; Chamberlain DE, 2019, GLOBAL CHANGE BIOL, V25, P3045, DOI 10.1111/gcb.14682; COLLINSON NH, 1995, BIOL CONSERV, V74, P125, DOI 10.1016/0006-3207(95)00021-U; Dalu T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08026-6; Day J, 2010, TT43409 WAT RES COMM; De Roeck ER, 2007, WETLANDS, V27, P162, DOI 10.1672/0277-5212(2007)27[162:CSOLBI]2.0.CO;2; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; Deacon C, 2019, FRESHWATER BIOL, V64, P1643, DOI 10.1111/fwb.13360; Dietz-Brantley SE, 2002, WETLANDS, V22, P767, DOI 10.1672/0277-5212(2002)022[0767:ITAIDB]2.0.CO;2; Escalera-Vazquez LH, 2010, FRESHWATER BIOL, V55, P2557, DOI 10.1111/j.1365-2427.2010.02486.x; Fynn RWS, 2015, WETL ECOL MANAG, V23, P559, DOI 10.1007/s11273-015-9430-6; Gal B, 2019, ECOL INDIC, V104, P357, DOI 10.1016/j.ecolind.2019.05.012; Gehrke B., 2011, VELD FLORA, V97, P32; GOUDIE AS, 1995, EARTH-SCI REV, V38, P1, DOI 10.1016/0012-8252(94)00066-6; Grimm NB, 2008, FRONT ECOL ENVIRON, V6, P264, DOI 10.1890/070147; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Groffman PM, 2014, FRONT ECOL ENVIRON, V12, P74, DOI 10.1890/120374; HARMSE JT, 1994, LANDSCAPE URBAN PLAN, V28, P217; Hassall C, 2015, HYDROBIOLOGIA, V745, P137, DOI 10.1007/s10750-014-2100-5; Henri AJ, 2014, HYDROBIOLOGIA, V738, P35, DOI 10.1007/s10750-014-1913-6; Hill MJ, 2016, BIOL CONSERV, V201, P50, DOI 10.1016/j.biocon.2016.06.027; Hill MJ, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12447; Johnson PTJ, 2013, J APPL ECOL, V50, P34, DOI 10.1111/1365-2664.12022; Kowarik I, 2011, ENVIRON POLLUT, V159, P1974, DOI 10.1016/j.envpol.2011.02.022; Liefferink SL, 2014, AFR J AQUAT SCI, V39, P417, DOI 10.2989/16085914.2014.975778; Martinez-Sanz C, 2012, AQUAT CONSERV, V22, P155, DOI 10.1002/aqc.2227; Measey GJ, 2011, SANBI BIODIVERS SER, P1; Mlambo MC, 2011, AFR J AQUAT SCI, V36, P299, DOI 10.2989/16085914.2011.636903; Muzon J, 2019, AQUATIC INSECTS; Oksanen J, 2019, R PROJ, V256, P1; Otto FEL, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aae9f9; Pickett STA, 2011, J ENVIRON MANAGE, V92, P331, DOI 10.1016/j.jenvman.2010.08.022; Pinheiro J, 2000, MIXED EFFECTS MODELS; R Core Team, 2021, R LANGUAGE ENV STAT; Rebelo A. G., 2006, VEGETATION S AFRICA, P53, DOI DOI 10.1007/S; Schael DM, 2015, 2181115 WAT RES COMM; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Silver CA, 2012, ACTA OECOL, V39, P1, DOI 10.1016/j.actao.2011.10.001; Strachan SR., 2015, SPRINGER SCI REV, V3, P57, DOI [10.1007/s40362-015-0031-9, DOI 10.1007/S40362-015-0031-9]; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Zacharias I, 2007, J ENVIRON BIOL, V28, P1	53	4	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2020	15	5							e0233889	10.1371/journal.pone.0233889	http://dx.doi.org/10.1371/journal.pone.0233889			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1WS	32470075	gold, Green Published			2022-12-26	WOS:000537552800207
J	Remzso, G; Nemeth, J; Varga, V; Kovacs, V; Toth-Szuki, V; Kaila, K; Voipio, J; Domoki, F				Remzso, Gabor; Nemeth, Janos; Varga, Viktoria; Kovacs, Viktoria; Toth-Szuki, Valeria; Kaila, Kai; Voipio, Juha; Domoki, Ferenc			Brain interstitial pH changes in the subacute phase of hypoxic-ischemic encephalopathy in newborn pigs	PLOS ONE			English	Article							NEONATAL ENCEPHALOPATHY; ENERGY-METABOLISM; INTRACELLULAR PH; PLASMA-GLUCOSE; BLOOD-FLOW; PIGLET; INFANTS; MODEL; PCO2; ASPHYXIA	Brain interstitial pH (pH(brain)) alterations play an important role in the mechanisms of neuronal injury in neonatal hypoxic-ischemic encephalopathy (HIE) induced by perinatal asphyxia. The newborn pig is an established large animal model to study HIE, however, only limited information on pH(brain) alterations is available in this species and it is restricted to experimental perinatal asphyxia (PA) and the immediate reventilation. Therefore, we sought to determine pH(brain) over the first 24h of HIE development in piglets. Anaesthetized, ventilated newborn pigs (n = 16) were instrumented to control major physiological parameters. pHbrain was determined in the parietal cortex using a pH -selective microelectrode. PA was induced by ventilation with a gas mixture containing 6%O-2-20%CO2 for 20 min, followed by reventilation with air for 24h, then the brains were processed for histopathology assessment. The core temperature was maintained unchanged during PA (38.4 0.1 vs 38.3 0.1 degrees C, at baseline versus the end of PA, respectively; mean SEM). In the arterial blood, PA resulted in severe hypoxia (PaO2: 65 +/- 4 vs 23 1*mmHg, *p<0.05) as well as acidosis (pH(a): 7.53 +/- 0.03 vs 6.79 +/- 0.02*) that is consistent with the observed hypercapnia (PaCO2: 37 +/- 3 vs 160 +/- 6*mmHg) and lactacidemia (1.6 +/- 0.3 vs 10.3 +/- 0.7*mmol/L). Meanwhile, pHbrain decreased progressively from 7.21 +/- 0.03 to 5.94 +/- 0.11*. Reventilation restored pH(a), blood gases and metabolites within 4 hours except for PaCO2 that remained slightly elevated. pH(brain) returned to 7.0 in 29.4 +/- 5.5 min and then recovered to its baseline level without showing secondary alterations during the 24 h observation period. Neuropathological assessment also confirmed neuronal injury. In conclusion, in spite of the severe acidosis and alterations in blood gases during experimental PA, pH(brain) recovered rapidly and notably, there was no post asphyxia hypocapnia that is commonly observed in many HIE babies. Thus, the neuronal injury in our piglet model is not associated with abnormal pHbrain or low PaCO2 over the first 24 h after PA.	[Remzso, Gabor; Nemeth, Janos; Varga, Viktoria; Kovacs, Viktoria; Toth-Szuki, Valeria; Domoki, Ferenc] Univ Szeged, Dept Physiol, Fac Med, Szeged, Hungary; [Kaila, Kai; Voipio, Juha] Univ Helsinki, Fac Biol & Environm Sci Mol & Integrat Biosci, Helsinki, Finland; [Kaila, Kai] Univ Helsinki, Neurosci Ctr HiLIFE, Helsinki, Finland	Szeged University; University of Helsinki; University of Helsinki	Remzso, G (corresponding author), Univ Szeged, Dept Physiol, Fac Med, Szeged, Hungary.	remzso.gabor@med.u-szeged.hu	Domoki, Ferenc/K-5336-2012; Kaila, Kai/R-8528-2016	Kovacs, Viktoria/0000-0001-7474-7148; Remzso, Gabor/0000-0002-3448-3835; Kaila, Kai/0000-0003-0668-5955; Voipio, Juha/0000-0001-7096-1286	Hungarian Brain Research Program [2.0 1.3 2017 1,2.1 NKP 2017 00002]; EU [EFOP-3.6.1-16-2016-00014]; GINOP [GINOP 2.3.2. 15 2016 00034]	Hungarian Brain Research Program; EU(European Commission); GINOP	JN,GR,VTSZ,VV,VK,FD; 2.0 1.3 2017 1,2.1 NKP 2017 00002; Hungarian Brain Research Program JN,GR,VTSZ,VV,VK,FD; EFOP-3.6.1-16-2016-00014; EU-funded Hungarian grant EFOP JN, GR,VTSZ,VV,VK,FD; GINOP 2.3.2. 15 2016 00034; GINOP The funders had no role in study design, data collection and analysis, decision t\o publish, or preparation of the manuscript.	AZZOPARDI D, 1989, PEDIATR RES, V25, P445, DOI 10.1203/00006450-198905000-00004; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Bender TM, 2003, RESUSCITATION, V59, P243, DOI 10.1016/S0300-9572(03)00207-7; BOOK SA, 1974, J ANIM SCI, V38, P997, DOI 10.2527/jas1974.385997x; BUSIJA DW, 1994, HUMAN BRAIN CIRCULATION, P259; BUSTAD LK, 1966, SCIENCE, V152, P1526, DOI 10.1126/science.152.3728.1526; Conrad MS, 2015, ANNU REV ANIM BIOSCI, V3, P245, DOI 10.1146/annurev-animal-022114-111049; CORBETT RJT, 1988, MAGNET RESON MED, V6, P99, DOI 10.1002/mrm.1910060112; CORBETT RJT, 1988, J NEUROCHEM, V51, P1501, DOI 10.1111/j.1471-4159.1988.tb01118.x; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Engle WD, 1999, RESUSCITATION, V42, P11; Foster KA, 2001, BRAIN RES, V919, P122, DOI 10.1016/S0006-8993(01)03011-6; Helmy MM, 2011, ANN NEUROL, V69, P493, DOI 10.1002/ana.22223; HOPE PL, 1984, LANCET, V2, P366; LAPTOOK A, 1982, EARLY HUM DEV, V6, P99, DOI 10.1016/0378-3782(82)90063-9; LAPTOOK AR, 1983, BRAIN RES, V276, P51, DOI 10.1016/0006-8993(83)90547-4; LAPTOOK AR, 1990, STROKE, V21, P435, DOI 10.1161/01.STR.21.3.435; Lawn Joy E, 2007, Health Res Policy Syst, V5, P4, DOI 10.1186/1478-4505-5-4; LI PA, 1995, NEUROBIOL DIS, V2, P97, DOI 10.1006/nbdi.1995.0010; Lingappan K, 2016, PEDIATR RES, V80, P204, DOI 10.1038/pr.2016.62; LOREK A, 1994, PEDIATR RES, V36, P699, DOI 10.1203/00006450-199412000-00003; Mortola JP, 1999, RESP PHYSIOL, V116, P95, DOI 10.1016/S0034-5687(99)00038-9; Nemeth J, 2016, J PHYSIOL PHARMACOL, V67, P677; Olah O, 2013, NEONATOLOGY, V104, P79, DOI 10.1159/000348445; Pappas A, 2011, J PEDIATR-US, V158, P752, DOI 10.1016/j.jpeds.2010.10.019; Pospelov AS, 2020, ACTA PHYSIOL, V229, DOI 10.1111/apha.13467; RANDALL GCB, 1971, CAN J COMPARAT MED, V35, P141; RANDALL GCB, 1979, BIOL NEONATE, V36, P63, DOI 10.1159/000241208; RANDALL GCB, 1972, BIOL NEONATE, V20, P68, DOI 10.1159/000240447; Ringer SK, 2019, PEDIATR ANESTH, V29, P1114, DOI 10.1111/pan.13736; Robertson NJ, 1999, PEDIATR RES, V46, P287, DOI 10.1203/00006450-199909000-00007; Robertson NJ, 2002, ANN NEUROL, V52, P732, DOI 10.1002/ana.10365; SIESJO BK, 1985, PROG BRAIN RES, V63, P121; STONESTREET BS, 1992, BRAIN RES, V590, P263, DOI 10.1016/0006-8993(92)91104-M; Thoresen M, 2015, SEMIN FETAL NEONAT M, V20, P66, DOI 10.1016/j.siny.2015.01.002; VOIPIO J, 1993, PFLUG ARCH EUR J PHY, V423, P193, DOI 10.1007/BF00374394; Voipio J., 1994, MICROELECTRODE TECHN, V2, P275; Volpe JJ, 2012, ANN NEUROL, V72, P156, DOI 10.1002/ana.23647; Yager JY, 2009, PEDIATR NEUROL, V40, P156, DOI 10.1016/j.pediatrneurol.2008.10.025	39	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2020	15	5							e0233851	10.1371/journal.pone.0233851	http://dx.doi.org/10.1371/journal.pone.0233851			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1WS	32470084	Green Accepted, gold, Green Published			2022-12-26	WOS:000537552800194
J	Sztwiertnia, I; Schenz, J; Bomans, K; Schaack, D; Ohnesorge, J; Tamulyte, S; Weigand, MA; Uhle, F				Sztwiertnia, Isabella; Schenz, Judith; Bomans, Katharina; Schaack, Dominik; Ohnesorge, Johanna; Tamulyte, Sandra; Weigand, Markus A.; Uhle, Florian			Sevoflurane depletes macrophages from the melanoma microenvironment	PLOS ONE			English	Article							FATE; ACTIVATION; EXPRESSION	Background With more than 18 million annual new cases, cancer belongs to the major challenges of modern healthcare. Surgical resection of solid tumours under general anaesthesia is the prime therapy. Different aspects of anaesthesia are under discussion to independently influence the long-term outcome of cancer patients. Most recently, the commonly used volatile anaesthetics like sevoflurane have entered the spotlight, as retrospective studies suggest a detrimental outcome in certain cancer aetiologies with sparse mechanistic understanding. Our objective was to investigate this concept in a murine melanoma model, herein comparing the consequence of inhalative and injection anesthesia on tumour composition and growth. Methods We used a murine model of malignant melanoma in male, adult C57BU6 mice (n = 92), induced by the subcutaneous injection of B16-F10 cells. We either exposed the melanoma cells to sevoflurane before implantation or subjected the animals to single or double anaesthesia with either volatile or injection drugs. After a maximum follow-up of 4 weeks, leucocytes within the tumour microenvironment (TME) were comprehensively analysed by flow cytometry with focus on tumor-associated macrophages (TAM). Results We found that exposure of melanoma cells to sevoflurane before implantation induced longlasting transcriptome changes and aggravated tumour growth, without extensive changes of the TME. Contrastingly, both a single and double anaesthesia with sevoflurane led to a significant reduction of TAMs (injection vs. sevoflurane: 2,0 vs. 0.3% and 1.2 vs. 0.6%, respectively), whilst increasing PD-L1 expression on the remaining cells (mean fluorescent intensity injection vs. sevoflurane: 3,804 vs. 7,143 and 9,090 vs. 32,228, respectively). No changes in tumour growth were observed in these groups. Conclusion In sharp contrast to the detrimental impact of sevoflurane on patients' outcome reported in retrospective clinical studies, we propose here that sevoflurane might actually exert a beneficial effect by decreasing TAMs within the TME, rendering the tumour again susceptible for cytotoxic T cells and immunotherapies. Further research is warranted to delineate, how these results translate into the clinic.	[Sztwiertnia, Isabella; Schenz, Judith; Schaack, Dominik; Ohnesorge, Johanna; Tamulyte, Sandra; Weigand, Markus A.; Uhle, Florian] Heidelberg Univ Hosp, Dept Anesthesiol, Heidelberg, Germany; [Bomans, Katharina] Eberhard Karls Univ Tubingen, Dept Anesthesiol & Intens Care Med, Univ Hosp Tubingen, Tubingen, Germany	Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Uhle, F (corresponding author), Heidelberg Univ Hosp, Dept Anesthesiol, Heidelberg, Germany.	florian.uhle@med.uni-heidelberg.de		Schenz, Judith/0000-0002-6771-8864; Glosse, Katharina/0000-0002-5517-5786; Schaack, Dominik/0000-0003-4829-5197	Foundation for Cancer and Scarlet Research Mannheim; Estate of Herbert Dauss; Estate of Carlo Chiappini; Estate of Sabine Krichbaum	Foundation for Cancer and Scarlet Research Mannheim; Estate of Herbert Dauss; Estate of Carlo Chiappini; Estate of Sabine Krichbaum	The work was financially supported by a combined grant of the "Foundation for Cancer and Scarlet Research Mannheim", "Estate of Herbert Dauss", "Estate of Carlo Chiappini", and "Estate of Sabine Krichbaum", administered by the University of Heidelberg and provided to FU.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arlauckas SP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3604; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brioni JD, 2017, J ANESTH, V31, P764, DOI 10.1007/s00540-017-2375-6; Cakmakkaya OS, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008877.pub2; Cassetta L, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00038; da Silva JL, 2019, CANCER CHEMOTH PHARM, V84, P227, DOI 10.1007/s00280-019-03894-3; de Rossi LW, 2003, ACTA ANAESTH SCAND, V47, P559, DOI 10.1034/j.1399-6576.2003.00107.x; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Gordon SR, 2017, NATURE, V545, P495, DOI 10.1038/nature22396; Hoves S, 2018, J EXP MED, V215, P859, DOI 10.1084/jem.20171440; Iwasaki M, 2016, ONCOTARGET, V7, P26042, DOI 10.18632/oncotarget.8304; Jenkins RW, 2018, BRIT J CANCER, V118, P9, DOI 10.1038/bjc.2017.434; Jung KY, 2015, J PATHOL TRANSL MED, V49, P318, DOI 10.4132/jptm.2015.06.01; Kleffel S, 2015, CELL, V162, P1242, DOI 10.1016/j.cell.2015.08.052; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Leonardi GC, 2018, INT J ONCOL, V52, P1071, DOI 10.3892/ijo.2018.4287; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu ZY, 2019, CELL, V178, P1509, DOI 10.1016/j.cell.2019.08.009; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Meier A, 2018, ANESTH ANALG, V126, P1910, DOI 10.1213/ANE.0000000000002902; Neubert NJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan3311; Noman MZ, 2014, J EXP MED, V211, P781, DOI 10.1084/jem.20131916; Overwijk W W, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2001s39; Passarelli A, 2017, ONCOTARGET, V8, P106132, DOI 10.18632/oncotarget.22190; Patel AA, 2017, J EXP MED, V214, P1913, DOI 10.1084/jem.20170355; Peranzoni E, 2018, P NATL ACAD SCI USA, V115, pE4041, DOI 10.1073/pnas.1720948115; Petrova V, 2018, ONCOGENESIS, V7, DOI 10.1038/s41389-017-0011-9; Shi QY, 2015, BRIT J ANAESTH, V114, P825, DOI 10.1093/bja/aeu402; Stollings LM, 2016, ANESTHESIOLOGY, V125, P399, DOI 10.1097/ALN.0000000000001195; Tucci M, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01148; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Wall T, 2019, BRIT J ANAESTH, V123, P135, DOI 10.1016/j.bja.2019.04.062; Wang ZC, 2019, J CANCER, V10, P3112, DOI 10.7150/jca.30406; Yang L, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0430-2; Yap A, 2019, CAN J ANESTH, V66, P546, DOI 10.1007/s12630-019-01330-x; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhang QW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050946; Zhu Y, 2017, IMMUNITY, V47, P323, DOI 10.1016/j.immuni.2017.07.014	42	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2020	15	5							e0233789	10.1371/journal.pone.0233789	http://dx.doi.org/10.1371/journal.pone.0233789			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1WS	32470095	Green Published, gold			2022-12-26	WOS:000537552800178
J	Bandara, AY; Weerasooriya, DK; Conley, SP; Bradley, CA; Allen, TW; Esker, PD				Bandara, Ananda Y.; Weerasooriya, Dilooshi K.; Conley, Shawn P.; Bradley, Carl A.; Allen, Tom W.; Esker, Paul D.			Modeling the relationship between estimated fungicide use and disease-associated yield losses of soybean in the United States I: Foliar fungicides vs foliar diseases	PLOS ONE			English	Article							FROGEYE LEAF-SPOT; STROBILURIN KRESOXIM-METHYL; CERCOSPORA-SOJINA; INHIBITOR FUNGICIDES; WINTER-WHEAT; CAUSAL AGENT; 1ST REPORT; RUST; RESISTANCE; QUINONE	Fungicide use in the United States to manage soybean diseases has increased in recent years. The ability of fungicides to reduce disease-associated yield losses varies greatly depending on multiple factors. Nonetheless, historical data are useful to understand the broad sense and long-term trends related to fungicide use practices. In the current study, the relationship between estimated soybean yield losses due to selected foliar diseases and foliar fungicide use was investigated using annual data from 28 soybean growing states over the period of 2005 to 2015. For national and regional (southern and northern United States) scale data, mixed effects modeling was performed considering fungicide use as a fixed and state and year as random factors to generate generalized R(2)values for marginal (R-GLMM(m)(2); contains only fixed effects) and conditional (R-GLMM(c)(2); contains fixed and random effects) models. Similar analyses were performed considering soybean production data to see how fungicide use affected production. Analyses at both national and regional scales showed thatR(GLMM(m))(2)values were significantly smaller compared toR(GLMM(c))(2)values. The large difference between R(2)values for conditional and marginal models indicated that the variation of yield loss as well as production were predominantly explained by the state and year rather than the fungicide use, revealing the general lack of fit between fungicide use and yield loss/production at national and regional scales. Therefore, regression models were fitted across states and years to examine their importance in combination with fungicide use on yield loss or yield. In the majority of cases, the relationship was nonsignificant. However, the relationship between soybean yield and fungicide use was significant and positive for majority of the years in the study. Results suggest that foliar fungicides conferred yield benefits in most of the years in the study. Furthermore, the year-dependent usefulness of foliar fungicides in mitigating soybean yield losses suggested the possible influence of temporally fluctuating abiotic factors on the effectiveness of foliar fungicides and/or target disease occurrence and associated loss magnitudes.	[Bandara, Ananda Y.; Weerasooriya, Dilooshi K.; Esker, Paul D.] Penn State Univ, Dept Plant Pathol & Environm Microbiol, University Pk, PA 16802 USA; [Conley, Shawn P.] Univ Wisconsin, Dept Agron, 1575 Linden Dr, Madison, WI 53706 USA; [Bradley, Carl A.] Univ Kentucky, Res & Educ Ctr, Dept Plant Pathol, Princeton, KY USA; [Allen, Tom W.] Mississippi State Univ, Delta Res & Extens Ctr, Stoneville, MS USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Wisconsin System; University of Wisconsin Madison; University of Kentucky; Mississippi State University	Esker, PD (corresponding author), Penn State Univ, Dept Plant Pathol & Environm Microbiol, University Pk, PA 16802 USA.	pde6@psu.edu	Allen, Tom/ABC-8705-2020; Esker, Paul/L-4266-2019	Esker, Paul/0000-0002-7753-3476; Bradley, Carl/0000-0002-8334-0750	United Soybean Board [1420-532-5637]; USDA National Institute of Food and Federal Appropriations [PEN04660, 1016474];  [2215];  [1520-532-5637];  [1620-532-5637]	United Soybean Board; USDA National Institute of Food and Federal Appropriations; ; ; 	Yield loss data originated from the parent project that began in 2009 with funding from the United Soybean Board under code 1420-532-5637, awarded to J. Allen Wrather and Steve Koennig. From 2012 to 2016, further funding under the original parent project was received primarily by Carl Bradely, with Paul Esker and Tom Allen also members of the project under codes: 2215 (2012), 1420-532-5637 (2014), 1520-532-5637 (2015), and 1620-532-5637 (2016). This project was also supported by the USDA National Institute of Food and Federal Appropriations under Project PEN04660 and Accession number 1016474. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKEM CN, 1995, EUR J PLANT PATHOL, V101, P183, DOI 10.1007/BF01874764; Allen T. W., 2014, Outlooks on Pest Management, V25, P167, DOI 10.1564/v25_apr_05; Allen TW, 2017, PLANT HLTH PROG, V18, P19, DOI 10.1094/PHP-RS-16-0066; Bandara AY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231141; Bartlett DW, 2002, PEST MANAG SCI, V58, P649, DOI 10.1002/ps.520; BARTO K, 2009, MUMIN MULTIMODEL INF; BASF, 2009, HEADL; Bates D., 2011, LME4 LINEAR MIXEDEFF; Bayles RA, 2000, PROC BRIGHTON CROP, V1-3, P731; Begliomini E, 2007, P NAT SOYB RUST S LO; Bradley KW, 2008, AGRON J, V100, P1360, DOI 10.2134/agronj2007.0329; Bryson RJ, 2000, PROC BRIGHTON CROP, V1-3, P739; Butkute B, 2008, CEREAL RES COMMUN, V36, P671, DOI 10.1556/CRC.36.2008.Suppl.B.58; COOPER RL, 1989, AGRON J, V81, P847; Cruz CD, 2010, PLANT DIS, V94, P820, DOI 10.1094/PDIS-94-7-0820; DASHIELL KE, 1991, CROP PROT, V10, P465, DOI 10.1016/S0261-2194(91)80134-2; Davis MW, 2010, FISH FISH, V11, P1, DOI 10.1111/j.1467-2979.2009.00331.x; Fagan Evandro Binotto, 2010, Bragantia, V69, P771, DOI 10.1590/S0006-87052010000400001; FRAC, 2016, FUNG RES ACT COMM CO; Galloway J, 2008, CROP PROT, V27, P566, DOI 10.1016/j.cropro.2007.08.014; Gelman A, 2018, PACKAGE ARM R PACKAG; Grossmann K, 1997, PESTIC SCI, V50, P11, DOI 10.1002/(SICI)1096-9063(199705)50:1&lt;11::AID-PS556&gt;3.0.CO;2-8; Grossmann K, 1999, J PLANT PHYSIOL, V154, P805, DOI 10.1016/S0176-1617(99)80262-4; Hanna SO, 2008, AGRON J, V100, P1488, DOI 10.2134/agronj2007.0135; Hartman G. L., 2015, COMPENDIUM SOYBEAN D, V5th; Hershman D, 2004, KENTUCKY PEST NEWSLE; Joshi J, 2014, PESTIC BIOCHEM PHYS, V114, P61, DOI 10.1016/j.pestbp.2014.07.002; KA Wise, 2016, PURDUE EXT B; Kandel Y.R., 2016, PLANT HLTH PROG, V17, P232, DOI [10.1094/PHP-RS-16-0038, DOI 10.1094/PHP-RS-16-0038]; Klingelfuss Luiza Helena, 2001, Acta Scientiarum Universidade Estadual de Maringa, V23, P1287; Kohle H., 2002, MODERN FUNGICIDES AN, P61; Lal R, 2009, FOOD SECUR, V1, P45, DOI 10.1007/s12571-009-0009-z; Mahoney KJ, 2015, CAN J PLANT SCI, V95, P285, DOI [10.4141/CJPS-2014-125, 10.4141/cjps-2014-125]; Mathew FM, 2019, PLANT HLTH PROG, V20, P104, DOI 10.1094/PHP-02-19-0014-BR; Mian MAR, 2008, CROP SCI, V48, P14, DOI 10.2135/cropsci2007.08.0432; Miles MR, 2007, PLANT DIS, V91, P1450, DOI 10.1094/PDIS-91-11-1450; Mourtzinis S, 2017, CROP SCI, V57, P983, DOI 10.2135/cropsci2016.10.0876; Mueller DS., 2013, FUNGICIDES FIELD CRO; Mueller TA, 2009, PLANT DIS, V93, P243, DOI 10.1094/PDIS-93-3-0243; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nelson KA, 2011, AGRON J, V103, P1359, DOI [10.2134/agronj2011.0090, 10.2134/agronj2011.0112]; Orlowski JM, 2016, CROP SCI, V56, P1988, DOI 10.2135/cropsci2015.10.0620; Padwick GW, 1956, PAPERS, V1; PIPER EL, 1989, J PROD AGRIC, V2, P250, DOI 10.2134/jpa1989.0250; PP J, 2004, REV STAT APPL, V52, P93; Price PP, 2015, PLANT DIS, V99, P1596, DOI 10.1094/PDIS-07-14-0782-RE; Ruske RE, 2003, J AGR SCI, V140, P395, DOI 10.1017/S0021859603003228; Schneider RW, 2005, PLANT DIS, V89, P774, DOI 10.1094/PD-89-0774A; Sikora EJ, 2014, PLANT DIS, V98, P864, DOI 10.1094/PDIS-02-14-0121-FE; Standish JR, 2015, PLANT DIS, V99, P1347, DOI 10.1094/PDIS-02-15-0157-RE; Strange RN, 2005, ANNU REV PHYTOPATHOL, V43, P83, DOI 10.1146/annurev.phyto.43.113004.133839; Swoboda C, 2009, AGRON J, V101, P352, DOI 10.2134/agronj2008.0150; Syngenta, 2009, QUADR; VENANCIO WS, 2003, AGRARIAN SCI ENG, V9, P59; Ward JMJ, 1997, PLANT DIS, V81, P41, DOI 10.1094/PDIS.1997.81.1.41; Wise K.A., 2015, COMPENDIUM SOYBEAN D, P43; Wrather JA, 2001, CAN J PLANT PATHOL, V23, P115; Wrather JA., 2009, PLANT HLTH PROGR, V10, P1, DOI DOI 10.1094/PHP-2009-0401-01-RS; Yorinori MA, 2004, J PHYTOPATHOL, V152, P129, DOI 10.1111/j.1439-0434.2003.00810.x; Zeng F, 2015, PLANT DIS, V99, P544, DOI 10.1094/PDIS-05-14-0460-RE; Zhang GR, 2012, PLANT DIS, V96, P767, DOI 10.1094/PDIS-10-11-0915-PDN; Zhang GR, 2018, PLANT HLTH PROG, V19, P295, DOI 10.1094/PHP-04-18-0016-RS	62	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234390	10.1371/journal.pone.0234390	http://dx.doi.org/10.1371/journal.pone.0234390			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525917	gold, Green Published, Green Submitted			2022-12-26	WOS:000542036800004
J	Sun, Y; Sun, HP; Chen, LZ; Taghizadeh-Hesary, F; Zhao, GM				Sun, Yu; Sun, Huaping; Chen, Lizhen; Taghizadeh-Hesary, Farhad; Zhao, Guimei			Impact of natural-resource dependence on foreign contracting projects of China: A spatial panel threshold approach	PLOS ONE			English	Article							DOMESTIC FIRMS; DIRECT-INVESTMENT; PRODUCTIVITY; FINANCE; DECOMPOSITION; SPILLOVERS	The proposal of the "Belt and Road" initiative has had a positive and far-reaching impact on the economic and social development of countries and regions along the route and has provided good opportunities and conditions for the development of China's foreign contracted projects. In the present study, in view of the heterogeneous characteristics and spatial correlation of countries along the Belt and Road, panel data of 46 contracted projects in China along the Belt and Road from 2008 to 2017 were used to empirically study the spatial characteristics of resource heterogeneity and outsourcing projects in the host country from the perspectives of spatial correlation and spatial heterogeneity. The results indicated that China had significant spatial agglomeration effects, natural restraining effects, and spatial spillover effects on the contracting projects along the Belt and Road, and the marginal impact in low-income countries exhibited a "broken line" relationship. Corresponding suggestions were provided for Chinese enterprises contracting projects involving Belt and Road countries. The databases of BRI need to be established, and ensure green investment efficiency.	[Sun, Yu; Sun, Huaping; Chen, Lizhen; Zhao, Guimei] Jiangsu Univ, Sch Finance & Econ, Zhenjiang, Jiangsu, Peoples R China; [Taghizadeh-Hesary, Farhad] Tokai Univ, Tokyo, Japan	Jiangsu University; Tokai University	Sun, HP (corresponding author), Jiangsu Univ, Sch Finance & Econ, Zhenjiang, Jiangsu, Peoples R China.	shp@ujs.edu.cn	Taghizadeh-Hesary, Farhad/R-5136-2018	Taghizadeh-Hesary, Farhad/0000-0001-5446-7093; huaping, sun/0000-0002-9328-7850	National Natural Science Foundation of China [71774071]; Key Project of Jiangsu Social Science Fund [20ZLA007]; Young Academic Leader Project of Jiangsu University [5521380003]; Postgraduate Research & Practice Innovation Program of Jiangsu Province [SJK19_2517]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Jiangsu Social Science Fund; Young Academic Leader Project of Jiangsu University; Postgraduate Research & Practice Innovation Program of Jiangsu Province	We are grateful for the financial support provided by the National Natural Science Foundation of China (71774071), the Key Project of Jiangsu Social Science Fund (20ZLA007), the Young Academic Leader Project of Jiangsu University (5521380003), and Postgraduate Research & Practice Innovation Program of Jiangsu Province (SJK19_2517).	Aitken BJ, 1999, AM ECON REV, V89, P605, DOI 10.1257/aer.89.3.605; [Anonymous], 2013, AM J D, V25; [Anonymous], 2003, THE REVENGERS TRAGED, V6.2, P34; [Anonymous], 2014, 56194 MPRA; Ayhan KM, 2006, 12484 NBER; BUCKLEY PJ, 2004, J CHINESE EC BUSINES, V2, P1, DOI DOI 10.1080/14765280310001631354; CASSON M, 1987, FIRM MARKET; Chakrabarti A, 2001, KYKLOS, V54, P89, DOI 10.1111/1467-6435.00142; Chen W., 2014, ASIAN DEV REV, V31, P109, DOI DOI 10.1162/ADEV_A_00032; Cheng L. K., 2008, CHINAS OUTWARD FDI F; Enderwick P, 1989, SOME EC SERVICE SECT; Erdal F., 2002, MULTINATL BUS REV, V10, P21; FRIEDMAN L, 1956, OPER RES, V4, P104, DOI 10.1287/opre.4.1.104; Hall S, 2018, APPL ENERG, V222, P772, DOI 10.1016/j.apenergy.2018.04.007; Javorcik BS, 2004, AM ECON REV, V94, P605, DOI 10.1257/0002828041464605; Ma SZ, 2016, INT TRADE ISSUES, P72; Marcin K, 2008, J INT TRADE ECON DEV, V17, P155, DOI 10.1080/09638190701728131; Miao Z, 2019, ENERG ECON, V83, P501, DOI 10.1016/j.eneco.2019.07.002; Miao Z, 2019, ENERG POLICY, V132, P665, DOI 10.1016/j.enpol.2019.06.019; Morck R, 2008, J INT BUS STUD, V39, P337, DOI 10.1057/palgrave.jibs.8400366; Pollio G, 1998, ENERG POLICY, V26, P687, DOI 10.1016/S0301-4215(98)00028-7; Qin QD, 2020, COMPUT ECON, V55, P1249, DOI 10.1007/s10614-018-9862-1; Robert BY, 2007, GLOBAL PROJECT MANAG, V50, P113; Sun CW, 2020, ENERG ECON, V86, DOI 10.1016/j.eneco.2019.104654; Sun HP, 2019, ENERG POLICY, V135, DOI 10.1016/j.enpol.2019.111002; Sun Y, 2020, FINANC RES LETT, V2020, P101491; Taghizadeh-Hesary F, 2019, FINANC RES LETT, V31, P98, DOI 10.1016/j.frl.2019.04.016; Wang MA, 2010, SHANXI ARCHITECURE, V16, P284; Wang WZ, 2014, WORLD EC STUDY, V7, P67; Zhang CH, 2019, WORLD J MICROB BIOT, V35, DOI 10.1007/s11274-019-2741-7; Zhang N, 2012, GANSU SCI TECHNOLOGY, V41, P69; Zhao LT, 2018, J CLEAN PROD, V171, P1429, DOI 10.1016/j.jclepro.2017.10.117; Zhao XM, 2020, ENERG ECON, V86, DOI 10.1016/j.eneco.2019.104631	33	4	4	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234057	10.1371/journal.pone.0234057	http://dx.doi.org/10.1371/journal.pone.0234057			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MA6QL	32525886	gold, Green Published			2022-12-26	WOS:000542036800068
J	Yang, LS; Pierce, S; Chatterjee, I; Craviso, GL; Leblanc, N				Yang, Lisha; Pierce, Sophia; Chatterjee, Indira; Craviso, Gale L.; Leblanc, Normand			Paradoxical effects on voltage-gated Na+ conductance in adrenal chromaffin cells by twin vs single high intensity nanosecond electric pulses	PLOS ONE			English	Article							NA(V)1.7 SODIUM-CHANNELS; LIPID RAFTS; PLASMA-MEMBRANE; ION CHANNELS; CHOLESTEROL; CALCIUM; BIPOLAR; PROTEIN; PERMEABILIZATION; LOCALIZATION	We previously reported that a single 5 ns high intensity electric pulse (NEP) caused an E-field-dependent decrease in peak inward voltage-gated Na+ current (I-Na) in isolated bovine adrenal chromaffin cells. This study explored the effects of a pair of 5 ns pulses on I-Na recorded in the same cell type, and how varying the E-field amplitude and interval between the pulses altered its response. Regardless of the E-field strength (5 to 10 MV/m), twin NEPs having interpulse intervals >= than 5 s caused the inhibition of TTX-sensitive I-Na to approximately double relative to that produced by a single pulse. However, reducing the interval from 1 s to 10 ms between twin NEPs at E-fields of 5 and 8 MV/m but not 10 MV/m decreased the magnitude of the additive inhibitory effect by the second pulse in a pair on I-Na. The enhanced inhibitory effects of twin vs single NEPs on I-Na were not due to a shift in the voltage-dependence of steady-state activation and inactivation but were associated with a reduction in maximal Na+ conductance. Paradoxically, reducing the interval between twin NEPs at 5 or 8 MV/m but not 10 MV/m led to a progressive interval-dependent recovery of I-Na, which after 9 min exceeded the level of I-Na reached following the application of a single NEP. Disrupting lipid rafts by depleting membrane cholesterol with methyl-beta-cyclodextrin enhanced the inhibitory effects of twin NEPs on I-Na and ablated the progressive recovery of this current at short twin pulse intervals, suggesting a complete dissociation of the inhibitory effects of twin NEPs on this current from their ability to stimulate its recovery. Our results suggest that in contrast to a single NEP, twin NEPs may influence membrane lipid rafts in a manner that enhances the trafficking of newly synthesized and/or recycling of endocytosed voltage-gated Na+ channels, thereby pointing to novel means to regulate ion channels in excitable cells.	[Yang, Lisha; Pierce, Sophia; Craviso, Gale L.; Leblanc, Normand] Univ Nevada, Reno Sch Med, Dept Pharmacol, Reno, NV 89557 USA; [Chatterjee, Indira] Univ Nevada, Coll Engn, Dept Elect & Biomed Engn, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno	Leblanc, N (corresponding author), Univ Nevada, Reno Sch Med, Dept Pharmacol, Reno, NV 89557 USA.	nleblanc@unr.edu	YANG, LISHA/AAA-1663-2019	YANG, LISHA/0000-0001-6318-4298; Leblanc, Normand/0000-0002-1090-9432	Air Force Office of Scientific Research (AFOSR) [FA9550-14-1-0018, FA9550-15-1-0517]	Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	The work was supported by grants to GLC and NL from the Air Force Office of Scientific Research (AFOSR Grant #FA9550-14-1-0018 and FA9550-15-1-0517). AFOSR URL: https://www.wpafb.af.mil/afrl/afosr/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shawaf E, 2010, ARTERIOSCL THROM VAS, V30, P1453, DOI 10.1161/ATVBAHA.110.205666; [Anonymous], 2017, SAF HLTH, V09, P36; Bagalkot TR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47929-4; Barrantes FJ, 2015, BBA-BIOMEMBRANES, V1848, P1796, DOI 10.1016/j.bbamem.2015.03.028; Bergdahl A, 2003, CIRC RES, V93, P839, DOI 10.1161/01.RES.0000100367.45446.A3; Brisson L, 2011, ONCOGENE, V30, P2070, DOI 10.1038/onc.2010.574; Cantu JC, 2016, BBA-BIOMEMBRANES, V1858, P2636, DOI 10.1016/j.bbamem.2016.07.006; Casciola M, 2019, CELL MOL LIFE SCI, V76, P4539, DOI 10.1007/s00018-019-03126-0; Casciola M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10282-5; Chattopadhyay M, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-17; Chattopadhyay M, 2011, EUR J PAIN, V15, P913, DOI 10.1016/j.ejpain.2011.03.007; Choi E, 2010, FASEB J, V24, P1518, DOI 10.1096/fj.09-145219; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Coyan FC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093255; Craviso GL, 2015, BIOELECTROCHEMISTRY, V103, P98, DOI 10.1016/j.bioelechem.2014.08.006; Craviso GL, 2012, BIOELECTROCHEMISTRY, V87, P244, DOI 10.1016/j.bioelechem.2011.11.016; Craviso GL, 2010, CELL MOL NEUROBIOL, V30, P1259, DOI 10.1007/s10571-010-9573-1; Craviso GL, 2009, IEEE T DIELECT EL IN, V16, P1294, DOI 10.1109/TDEI.2009.5293941; Craviso GL, 2004, J NEUROSCI METH, V137, P275, DOI 10.1016/j.jneumeth.2004.02.031; Dauter Z, 2016, PROTEIN PEPTIDE LETT, V23, P201, DOI 10.2174/0929866523666160106153524; Ganapathi SB, 2010, AM J PHYSIOL-CELL PH, V299, pC74, DOI 10.1152/ajpcell.00462.2009; Gianulis EC, 2018, BIOELECTROCHEMISTRY, V119, P10, DOI 10.1016/j.bioelechem.2017.08.005; Gianulis EC, 2015, SCI REP-UK, V5, DOI 10.1038/srep13818; Gueguinou M, 2015, BBA-BIOMEMBRANES, V1848, P2603, DOI 10.1016/j.bbamem.2014.10.036; Hassan N, 2002, IEEE T PLASMA SCI, V30, P1516, DOI 10.1109/TPS.2002.804210; Herrera JL, 2011, J NEUROCHEM, V116, P820, DOI 10.1111/j.1471-4159.2010.06987.x; Hille B, 2015, BBA-MOL CELL BIOL L, V1851, P844, DOI 10.1016/j.bbalip.2014.09.010; Ibey BL, 2014, BIOCHEM BIOPH RES CO, V443, P568, DOI 10.1016/j.bbrc.2013.12.004; Jiang N, 2011, BIOELECTROMAGNETICS, V32, P148, DOI 10.1002/bem.20620; Jiang QX, 2019, ADV EXP MED BIOL, V1115, P167, DOI 10.1007/978-3-030-04278-3_8; Jiang QX, 2012, CURR OPIN STRUC BIOL, V22, P529, DOI 10.1016/j.sbi.2012.03.009; KIMITSUKI T, 1990, AM J PHYSIOL, V258, pH247, DOI 10.1152/ajpheart.1990.258.1.H247; KLUGBAUER N, 1995, EMBO J, V14, P1084, DOI 10.1002/j.1460-2075.1995.tb07091.x; Fernandez ML, 2012, BIOCHEM BIOPH RES CO, V423, P325, DOI 10.1016/j.bbrc.2012.05.122; Lee Anthony G., 2009, Journal of Biology (London), V8, P86, DOI 10.1186/jbiol178; Levine ZA, 2010, J MEMBRANE BIOL, V236, P27, DOI 10.1007/s00232-010-9277-y; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lockwich TP, 2000, J BIOL CHEM, V275, P11934, DOI 10.1074/jbc.275.16.11934; Maguy A, 2006, CARDIOVASC RES, V69, P798, DOI 10.1016/j.cardiores.2005.11.013; Marra G, 2017, COMPUT STAT DATA AN, V112, P99, DOI 10.1016/j.csda.2017.03.004; Martens JR, 2004, TRENDS PHARMACOL SCI, V25, P16, DOI 10.1016/j.tips.2003.11.007; Martens JR, 2001, J BIOL CHEM, V276, P8409, DOI 10.1074/jbc.M009948200; Merla C, 2017, BBA-BIOMEMBRANES, V1859, P1282, DOI 10.1016/j.bbamem.2017.04.014; Nesin OM, 2011, BBA-BIOMEMBRANES, V1808, P792, DOI 10.1016/j.bbamem.2010.12.012; Nesin V, 2012, BIOELECTROMAGNETICS, V33, P443, DOI 10.1002/bem.21703; Nesin V, 2012, BIOELECTROMAGNETICS, V33, P394, DOI 10.1002/bem.21696; O'Connell KMS, 2004, TRENDS CARDIOVAS MED, V14, P37, DOI 10.1016/j.tcm.2003.10.002; Pakhomov AG, 2007, BIOELECTROMAGNETICS, V28, P655, DOI 10.1002/bem.20354; Pakhomov AG, 2018, BIOELECTROCHEMISTRY, V122, P123, DOI 10.1016/j.bioelechem.2018.03.014; Pakhomov AG, 2009, BIOCHEM BIOPH RES CO, V385, P181, DOI 10.1016/j.bbrc.2009.05.035; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; Practice Committee of the American Society for Reproductive Medicine, 2015, FERTIL STERIL, V103, P44; Pristera A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040079; Purcell EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026289; Rems L., 2019, PULSED ELECT FIELDS, DOI [10.1101/838474, DOI 10.1101/838474]; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Sones WR, 2010, CARDIOVASC RES, V87, P476, DOI 10.1093/cvr/cvq057; Sozer EB, 2019, BBA-BIOMEMBRANES, V1861, P1228, DOI 10.1016/j.bbamem.2019.03.019; Sozer EB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00092-0; Su XD, 2015, CRYSTALLOGR REV, V21, P122, DOI 10.1080/0889311X.2014.973868; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Tamura R, 2014, ANESTH ANALG, V118, P318, DOI 10.1213/ANE.0000000000000085; Tolstykh GP, 2014, BIOELECTROCHEMISTRY, V100, P80, DOI 10.1016/j.bioelechem.2014.01.006; Valdez CM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16142-6; Vandael DHF, 2015, J PHYSIOL-LONDON, V593, P905, DOI 10.1113/jphysiol.2014.283374; Vernier PT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-37; Vernier PT, 2006, J AM CHEM SOC, V128, P6288, DOI 10.1021/ja0588306; Wada A, 2008, ACTA PHYSIOL, V192, P221, DOI 10.1111/j.1748-1716.2007.01810.x; Wada A, 2004, FRONT BIOSCI-LANDMRK, V9, P1954, DOI 10.2741/1314; Weaver AK, 2007, J BIOL CHEM, V282, P31558, DOI 10.1074/jbc.M702866200; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Yang LS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181002; YATANI A, 1985, CIRC RES, V56, P868, DOI 10.1161/01.RES.56.6.868; Yoon J, 2016, J MEMBRANE BIOL, V249, P633, DOI 10.1007/s00232-016-9902-5; Zaklit J, 2017, J MEMBRANE BIOL, V250, P535, DOI 10.1007/s00232-017-9983-9; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	76	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2020	15	6							e0234114	10.1371/journal.pone.0234114	http://dx.doi.org/10.1371/journal.pone.0234114			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ1GC	32516325	Green Published, gold			2022-12-26	WOS:000540977000023
J	Mogaji, HO; Dedeke, GA; Bada, BS; Bankole, S; Adeniji, A; Fagbenro, MT; Omitola, OO; Oluwole, AS; Odoemene, NS; Abe, EM; Mafiana, CF; Ekpo, UF				Mogaji, Hammed Oladeji; Dedeke, Gabriel Adewunmi; Bada, Babatunde Saheed; Bankole, Samuel; Adeniji, Adejuwon; Fagbenro, Mariam Tobi; Omitola, Olaitan Olamide; Oluwole, Akinola Stephen; Odoemene, Nnayere Simon; Abe, Eniola Micheal; Mafiana, Chiedu Felix; Ekpo, Uwem Friday			Distribution of ascariasis, trichuriasis and hookworm infections in Ogun State, Southwestern Nigeria	PLOS ONE			English	Article								Background Ascariasis, Trichuriasis and Hookworm infections poses a considerable public health burden in Sub-Saharan Africa, and a sound understanding of their spatial distribution facilitates to better target control interventions. This study, therefore, assessed the prevalence of the trio, and mapped their spatial distribution in the 20 administrative regions of Ogun State, Nigeria. Methods Parasitological surveys were carried out in 1,499 households across 33 spatially selected communities. Fresh stool samples were collected from 1,027 consenting participants and processed using ether concentration method. The locations of the communities were georeferenced using a GPS device while demographic data were obtained using a standardized form. Data were analysed using SPSS software and visualizations and plotting maps were made in ArcGIS software. Results Findings showed that 19 of the 20 regions were endemic for one or more kind of the three infections, with an aggregated prevalence of 17.2%. Ascariasis was the most frequently observed parasitic infection in 28 communities with a prevalence of 13.6%, followed by hookworm infections with a prevalence of 4.6% while Trichuriasis was the least encountered with a prevalence of 1.7%. The spatial distribution of infections ranges between 5.3-49.2% across the regions. The highest and lowest distribution of overall helminth infections was recorded in Egbado South and Egbado North respectively. Nine regions had infection status between 20.0%-49.2%, while 10 regions had infection status between 5.3%-15.8%. Conclusion This study provides epidemiological data on the prevalence and spatial distribution of ascariasis, trichuriasis and hookworm infections which will add to the baseline data and guide the public health officers in providing appropriate control strategies in the endemic communities.	[Mogaji, Hammed Oladeji] Fed Univ Oye Ekiti, Dept Anim & Environm Biol, Ekiti, Nigeria; [Dedeke, Gabriel Adewunmi; Bankole, Samuel; Adeniji, Adejuwon; Fagbenro, Mariam Tobi; Omitola, Olaitan Olamide; Ekpo, Uwem Friday] Fed Univ Agr, Dept Pure & Appl Zool, Abeokuta, Nigeria; [Bada, Babatunde Saheed] Fed Univ Agr, Dept Environm Management & Toxicol, Abeokuta, Nigeria; [Oluwole, Akinola Stephen] Nigeria Country Off, Sightsavers, COUNTDOWN Project, Kaduna, Nigeria; [Odoemene, Nnayere Simon] Adeleke Univ, Dept Biol Sci, Ede, Osun State, Nigeria; [Abe, Eniola Micheal] 14 China Ctr Dis Control, Natl Inst Parasit Dis & Control, Beijing, Peoples R China; [Mafiana, Chiedu Felix] Natl Open Univ Nigeria, Directorate Res & Innovat, Abuja, Nigeria	University of Agriculture, Abeokuta; University of Agriculture, Abeokuta	Mogaji, HO (corresponding author), Fed Univ Oye Ekiti, Dept Anim & Environm Biol, Ekiti, Nigeria.	mogajihammed@gmail.com	Mogaji, Hammed/ABB-2114-2021; Dedeke, Gabriel Adewunmi/GOE-5725-2022	Mogaji, Hammed/0000-0001-7330-2892; Mafiana, Chiedu/0000-0001-8444-3682; OLUWOLE, AKINOLA/0000-0002-0050-3463				ANDERSON RM, 1985, T ROY SOC TROP MED H, V79, P812, DOI 10.1016/0035-9203(85)90128-2; Anderson R, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0435; [Anonymous], 2018, DIABETES CARE S1, V4, pS4, DOI 10.2337/dc18-Srev01; Clarke NE, 2017, LANCET, V389, P287, DOI 10.1016/S0140-6736(16)32123-7; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; Dunn JC, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2306-2; Endriss Y., 2005, METHODS PARASITOLOGY; Ezeamama AE, 2005, AM J TROP MED HYG, V72, P540, DOI 10.4269/ajtmh.2005.72.540; Fafunwa T. S., 2017, Journal of Water Resource and Protection, V9, P99, DOI 10.4236/jwarp.2017.92008; Gemechu TL, 2020, PARASITE VECTOR, DOI [10.21203/rs.2.20657/v1, DOI 10.21203/RS.2.20657/V1]; Grantham-McGregor S, 2001, J NUTR, V131, p649S, DOI 10.1093/jn/131.2.649S; Karagiannis-Voules DA, 2014, ACTA TROP, V141, P2014; Luka SA., 2018, RES J PARASITOL, V13, P35, DOI [10.3923/jp.2018.19.35, DOI 10.3923/JP.2018.19.35]; Mogaji H. O., 2017, Parasitology Open, V3, pe16, DOI 10.1017/pao.2017.18; Molyneux DH, 2017, LANCET, V389, P312, DOI 10.1016/S0140-6736(16)30171-4; Mwinzi PNM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-182; Oluwole AS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003740; Pullan RL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000958; SAMWOBO SO, 2012, J ENTOMOL NEMATOL, V4, P7, DOI DOI 10.5897/JEN11.019; Schur N, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001194; WHO, 2018, NEGLECTED TROPICAL D; WHO, 2012, EL SOIL TRANSM HELM; World Health Organ Tech Rep Ser, 2002, WHO TECHN REP SER, V912, p[1, 1]	23	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2020	15	6							e0233423	10.1371/journal.pone.0233423	http://dx.doi.org/10.1371/journal.pone.0233423			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ0RE	32511237	Green Published, gold			2022-12-26	WOS:000540938100015
J	Azman, NZM; Zainal, PNS; Ahmad, SAA				Azman, Nor Zawani Mohamed; Zainal, Putri Nur Syafieqah; Alang Ahmad, Shahrul Ainliah			Enhancement the electrochemical conductivity of a modified reduced graphene oxide/calixarene screen-printed electrode using response surface methodology	PLOS ONE			English	Article							OXIDE; OPTIMIZATION; REDUCTION	In this paper, Response Surface Methodology with central composite design (RSM/CCD) was used to optimize a modified electrode for improved electron transfer rate and electrochemical performance. The modification was done on a screen-printed carbon electrode (SPCE) with reduced graphene oxide (ERGO)/calix [4] arene (ERGOC4-SPCE). The properties of the modified electrodes were analyzed via cyclic voltammetry, Raman spectroscopy, and Fourier-Transform Infrared (FT-IR) spectroscopy. Then, different variables were optimized, namely, the concentration of graphene oxide, GO (A), the number of scan cycles of graphene oxide (B), and the deposition time (C). The effect of the optimized variables on the reduction-oxidation peak current response of the potassium ferricyanide redox system was analyzed. By using statistical analysis, it shows a significant effect of the concentration of GO, the deposition time, and the number of scans cycles on the peak current response. The coefficient of determination (R-2) value of 0.9987 produced indicated a good fit of the model with experimental finding.	[Azman, Nor Zawani Mohamed; Zainal, Putri Nur Syafieqah; Alang Ahmad, Shahrul Ainliah] Univ Putra Malaysia, Dept Chem, Fac Sci, Upm Serdang, Selangor, Malaysia; [Alang Ahmad, Shahrul Ainliah] Univ Putra Malaysia, Inst Adv Technol, Upm Serdang, Selangor, Malaysia; [Alang Ahmad, Shahrul Ainliah] Univ Putra Malaysia, Res Ctr Water Treatment Technol TeRAS, Upm Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Ahmad, SAA (corresponding author), Univ Putra Malaysia, Dept Chem, Fac Sci, Upm Serdang, Selangor, Malaysia.; Ahmad, SAA (corresponding author), Univ Putra Malaysia, Inst Adv Technol, Upm Serdang, Selangor, Malaysia.; Ahmad, SAA (corresponding author), Univ Putra Malaysia, Res Ctr Water Treatment Technol TeRAS, Upm Serdang, Selangor, Malaysia.	ainliah@upm.edu.my		Alang Ahmad, Shahrul/0000-0002-5745-5300	Universiti Putra Malaysia [9557800, 9642700]	Universiti Putra Malaysia	Shahrul GP-IPB [9557800] and GP-IPS [9642700]. Universiti Putra Malaysia https://rmc.upm.edu.my No.	Ahmad R, 2018, J COLLOID INTERF SCI, V516, P67, DOI 10.1016/j.jcis.2018.01.052; Alam MZ, 2007, J ENVIRON SCI-CHINA, V19, P674, DOI 10.1016/S1001-0742(07)60113-2; Balandin AA, 2008, NANO LETT, V8, P902, DOI 10.1021/nl0731872; Bezerra MA, 2008, TALANTA, V76, P965, DOI 10.1016/j.talanta.2008.05.019; Bonaccorso F, 2015, SCIENCE, V347, DOI 10.1126/science.1246501; De Benedetto GE, 2019, BIOSENSORS-BASEL, V9, DOI 10.3390/bios9010026; Guex LG, 2017, NANOSCALE, V9, P9562, DOI 10.1039/c7nr02943h; Jian JM, 2013, SENSORS-BASEL, V13, P13063, DOI 10.3390/s131013063; Lundstedt T, 1998, CHEMOMETR INTELL LAB, V42, P3, DOI 10.1016/S0169-7439(98)00065-3; Mangili I, 2015, CHEMOMETR INTELL LAB, V144, P1, DOI 10.1016/j.chemolab.2015.03.003; Mirmoghtadaie L, 2013, MAT SCI ENG C-MATER, V33, P1753, DOI 10.1016/j.msec.2012.12.090; Mohan VB, 2015, MATER SCI ENG B-ADV, V193, P49, DOI 10.1016/j.mseb.2014.11.002; Saleem H, 2018, MATER CHEM PHYS, V204, P1, DOI 10.1016/j.matchemphys.2017.10.020; Si K, 2018, ANAL METHODS-UK, V10, P3660, DOI 10.1039/c8ay00664d; Talib NAA, 2018, RSC ADV, V8, P15522, DOI 10.1039/c8ra00109j; Tong H, 2013, J SOLID STATE ELECTR, V17, P2857, DOI 10.1007/s10008-013-2195-z; Xu Z, 2015, MATER TODAY, V18, P480, DOI 10.1016/j.mattod.2015.06.009; Zainal PNS, 2019, J ELECTROCHEM SOC, V166, pB110, DOI 10.1149/2.1141902jes	18	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0234148	10.1371/journal.pone.0234148	http://dx.doi.org/10.1371/journal.pone.0234148			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502185	gold, Green Accepted, Green Published			2022-12-26	WOS:000542035700054
J	Nakano, K; Yanobu-Takanashi, R; Shimizu, Y; Takahashi, Y; Hiura, K; Watanabe, M; Sasaki, H; Okamura, T; Sasaki, N				Nakano, Kenta; Yanobu-Takanashi, Rieko; Shimizu, Yukiko; Takahashi, Yuki; Hiura, Koki; Watanabe, Masaki; Sasaki, Hayato; Okamura, Tadashi; Sasaki, Nobuya			Genetic locus responsible for diabetic phenotype in the insulin hyposecretion (ihs) mouse	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; SUSCEPTIBILITY LOCUS; OPTIC ATROPHY; TYPE-2; SECRETION; SLC25A46; MODEL; SENSITIVITY; MUTATIONS; JAPANESE	Diabetic animal models have made significant contributions to understanding the etiology of diabetes and to the development of new medications. Our research group recently developed a novel diabetic mouse strain, the insulin hyposecretion (ihs)mouse. The strain involves neither obesity nor insulitis but exhibits notable pancreatic beta-cell dysfunction, distinguishing it from other well-characterized animal models. In ihs mice, severe impairment of insulin secretion from pancreas has been elicited by glucose or potassium chloride stimulation. To clarify the genetic basis of impaired insulin secretion, beginning with identifying the causative gene, genetic linkage analysis was performed using [(C57BL/6 x ihs) F-1 x ihs] backcross progeny. Genetic linkage analysis and quantitative trait loci analysis for blood glucose after oral glucose loading indicated that a recessively acting locus responsible for impaired glucose tolerance was mapped to a 14.9-Mb region of chromosome 18 between D18Mit233 and D18Mit235 (the ihs locus). To confirm the gene responsible for the ihs locus, a congenic strain harboring the ihs locus on the C57BL/6 genetic background was developed. Phenotypic analysis of B6.ihs-(D18Mit233-D18Mit235) mice showed significant glucose tolerance impairment and markedly lower plasma insulin levels during an oral glucose tolerance test. Whole-genome sequencing and Sanger sequencing analyses on the ihs genome detected two ihs-specific variants changing amino acids within the ihs locus; both variants in Slc25a46 and Tcerg1 were predicted to disrupt the protein function. Based on information regarding gene functions involving diabetes mellitus and insulin secretion, reverse-transcription quantitative polymerase chain reaction analysis revealed that the relative abundance of Reep2 and Sil1 transcripts from ihs islets was significantly decreased whereas that of Syt4 transcripts were significantly increased compared with those of control C57BL/6 mice. Thus, Slc25a46, Tcerg1, Syt4, Reep2 and Sil1 are potential candidate genes for the ihs locus. This will be the focus of future studies in both mice and humans.	[Nakano, Kenta; Yanobu-Takanashi, Rieko; Shimizu, Yukiko; Okamura, Tadashi] Natl Ctr Global Hlth & Med NCGM, Res Inst, Dept Lab Anim Med, Shinjuku Ku, Tokyo, Japan; [Nakano, Kenta; Takahashi, Yuki; Hiura, Koki; Watanabe, Masaki; Sasaki, Hayato; Sasaki, Nobuya] Kitasato Univ, Sch Vet Med, Lab Lab Anim Sci & Med, Towada, Aomori, Japan; [Shimizu, Yukiko] Juntendo Univ, Dept Pediat & Adolescent Med, Grad Sch Med, Bunkyo Ku, Tokyo, Japan; [Okamura, Tadashi] Natl Ctr Global Hlth & Med, Res Inst, Dept Infect Dis, Sect Anim Models, Tokyo, Japan	Kitasato University; Juntendo University; National Center for Global Health & Medicine - Japan	Okamura, T (corresponding author), Natl Ctr Global Hlth & Med NCGM, Res Inst, Dept Lab Anim Med, Shinjuku Ku, Tokyo, Japan.; Sasaki, N (corresponding author), Kitasato Univ, Sch Vet Med, Lab Lab Anim Sci & Med, Towada, Aomori, Japan.; Okamura, T (corresponding author), Natl Ctr Global Hlth & Med, Res Inst, Dept Infect Dis, Sect Anim Models, Tokyo, Japan.	okamurat@ri.ncgm.go.jp; nobsasa@vmas.kitasato-u.ac.jp		OKAMURA, TADASHI/0000-0001-8457-1561	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [16K07094, 26430101, 20K15708]; National Center for Global Health and Medicine [26105, 29-1001]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan)	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT); Grants-in-Aid for Scientific Research, KAKENHI (16K07094, 26430101 and 20K15708) to NS, TO and KN, and was partially supported by Grants-in-Aid for Research from the National Center for Global Health and Medicine (26105 and 29-1001) to TO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Abrams AJ, 2015, NAT GENET, V47, P926, DOI 10.1038/ng.3354; Al-awar A, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/9051426; Charlesworth G, 2016, MOVEMENT DISORD, V31, P1249, DOI 10.1002/mds.26716; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dingreville F, 2019, DIABETES, V68, P1778, DOI 10.2337/db18-1112; Fuhlendorff J, 1998, DIABETES, V47, P345, DOI 10.2337/diabetes.47.3.345; Fukushima M, 2004, DIABETES RES CLIN PR, V66, pS37, DOI 10.1016/j.diabres.2003.11.024; Gilon P, 2014, CELL CALCIUM, V56, P340, DOI 10.1016/j.ceca.2014.09.001; Goldstrohm AC, 2001, MOL CELL BIOL, V21, P7617, DOI 10.1128/MCB.21.22.7617-7628.2001; Huang C, 2018, DEV CELL, V45, P347, DOI 10.1016/j.devcel.2018.03.013; Hurt CM, 2014, BRAIN RES, V1545, P12, DOI 10.1016/j.brainres.2013.12.008; Ichhaporia VP, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.033043; Ittner AA, 2014, DIABETOLOGIA, V57, P1410, DOI 10.1007/s00125-014-3230-z; Janer A, 2016, EMBO MOL MED, V8, P1019, DOI 10.15252/emmm.201506159; Kaja S, 2011, INVEST OPHTH VIS SCI, V52, P5605, DOI 10.1167/iovs.10-7114; Kitada M, 2016, INT J NEPHROL RENOV, V9, P279, DOI 10.2147/IJNRD.S103784; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Leiter EH, 1998, DIABETES, V47, P1287, DOI 10.2337/diabetes.47.8.1287; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu JX, 2013, J BIOL CHEM, V288, P10890, DOI 10.1074/jbc.M113.460238; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Moller JB, 2014, J CLIN ENDOCR METAB, V99, P4273, DOI 10.1210/jc.2014-1724; Moller JB, 2014, DIABETES CARE, V37, P796, DOI 10.2337/dc13-0598; Nakagawa Y, 2014, ENDOCR J, V61, P119, DOI 10.1507/endocrj.EJ13-0431; Nakano K, 2019, J DIABETES INVEST, V10, P227, DOI 10.1111/jdi.12895; O'Rahilly S, 2005, SCIENCE, V307, P370, DOI 10.1126/science.1104346; Ohara-Imaizumi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015553; Olokoba Abdulfatai B, 2012, Oman Med J, V27, P269, DOI 10.5001/omj.2012.68; Palmieri F, 2016, BBA-MOL CELL RES, V1863, P2362, DOI 10.1016/j.bbamcr.2016.03.007; Pearson JL, 2008, J BIOL CHEM, V283, P7949, DOI 10.1074/jbc.M709402200; Plum L, 2000, DIABETES, V49, P1590, DOI 10.2337/diabetes.49.9.1590; Plum L, 2002, DIABETOLOGIA, V45, P823, DOI 10.1007/s00125-002-0796-7; Sasaki H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099602; Schmidt C, 2008, PHYSIOL GENOMICS, V34, P42, DOI 10.1152/physiolgenomics.00267.2007; Shimizu Y, 2019, MAMM GENOME, V30, P23, DOI 10.1007/s00335-018-9790-3; Terzenidou ME, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006656; Ueda H, 1999, DIABETES, V48, P1168, DOI 10.2337/diabetes.48.5.1168; Volk T, 2003, CARDIOVASC RES, V58, P76, DOI 10.1016/S0008-6363(02)00858-1; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang S, 2012, WINDOWS QTL CARTOGRA; Xu H, 2018, ONCOTARGETS THER, V11, P3775, DOI 10.2147/OTT.S167552; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1	43	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0234132	10.1371/journal.pone.0234132	http://dx.doi.org/10.1371/journal.pone.0234132			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502168	Green Published, gold			2022-12-26	WOS:000542035700041
J	Ndwiga, C; Odwe, G; Pooja, S; Ogutu, O; Osoti, A; Warren, CE				Ndwiga, Charity; Odwe, George; Pooja, Sripad; Ogutu, Omondi; Osoti, Alfred; Warren, E. Charlotte			Clinical presentation and outcomes of pre-eclampsia and eclampsia at a national hospital, Kenya: A retrospective cohort study	PLOS ONE			English	Article							PERINATAL OUTCOMES; ONSET PREECLAMPSIA; RISK-FACTORS; MANAGEMENT; HYPERTENSION; IMPACT; FETAL	Background Hypertensive disorders in pregnancy including pre-eclampsia are associated with maternal and newborn mortality and morbidity. Early detection is vital for effective treatment and management of pre-eclampsia. This study examines and compares the clinical presentation and outcomes between early- and late-onset pre-eclampsia over a two year period. Methods A retrospective cohort study design which examines socio-demographic characteristics, treatment, outcomes, and fetal and maternal complications among women with early onset of pre-eclampsia (EO-PE) and late onset of pre-eclampsia (LO-PE). De-identified records of women who attended antenatal, intrapartum and postnatal care services and experienced pre-eclampsia at Kenyatta National teaching and referral hospital were reviewed. We used chi square, t-test, and calculated odds ratio to determine any significant differences between the EO-PE and LO-PE cohorts. Results Out of 620 pre-eclamptic and eclamptic patients' records analyzed; 44 percent (n = 273) exhibited EO-PE, while 56 percent had late onset. Women with EO-PE compared to LO-PE had greater odds of adverse maternal and perinatal outcomes including hemolysis elevated liver enzymes and low platelets (HELLP) syndrome (OR: 4.3; CI 2.0-10.2; p<0.001), renal dysfunction (OR; 1.7; CI 0.7-4.1; p = 0.192), stillbirth (OR = 4.9; CI 3.1-8.1; p<0.001), and neonatal death (OR: 8.5; CI 3.8-21.3; p<0.001). EO-PE was also associated with higher odds of prolonged maternal hospitalization, beyond seven days (OR = 5.8; CI 3.9-8.4; p<0.001), and antepartum hemorrhage (OR = 5.8; CI 1.1-56.4; p<0.001). Neonates born after early onset of pre-eclampsia had increased odds of respiratory distress (OR = 17.0; CI 9.0-32.3, p<0.001) and birth asphyxia (OR: 1.9; CI 0.7-4.8; p = 0.142). Conclusions The profiles and outcomes of women with EO-PE (compared to late onset) suggest that seriousness of morbidity increases with earlier onset. To reduce adverse neonatal and maternal outcomes, it is critical to identify, manage, referral and closely follow-up pregnant women with pre-eclampsia throughout the pregnancy continuum. Ethical approval This study protocol was approved by Population Council's research ethics Institutional Review Board, Protocol 813, and KNH-UoN Ethics and Research Committee, Protocol 293/06/2017.	[Ndwiga, Charity; Odwe, George] Populat Council, Nairobi, Kenya; [Pooja, Sripad; Warren, E. Charlotte] Populat Council, Washington, DC USA; [Ogutu, Omondi; Osoti, Alfred] Univ Nairobi, OBGyn Dept, Nairobi, Kenya	Population Council; University of Nairobi	Ndwiga, C (corresponding author), Populat Council, Nairobi, Kenya.	cndwiga@popcouncil.org			United States Agency for International Development (USAID) [USAID APS-OAA-14-00048]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR)	The study is made possible by the generous support of the American people through the United States Agency for International Development (USAID) under the terms of USAID APS-OAA-14-00048. The contents of this manuscript are the sole responsibility of the authors, Ending Eclampsia project and Population Council and do not necessarily reflect the views of USAID or the United States Government.	Agha Khan, 2007, PREVALENCE HYPERTENS; Alanis MC, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.076; Andrea A, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8020027; [Anonymous], 2015, JMIR MED INF, V3, pe22; [Anonymous], 2018, HYPERTENSION, V72, P24, DOI [10.1161/HYPERTENSIONAHA.117.10803, DOI 10.1161/HYPERTENSIONAHA.117.10803]; Barros FC, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S3; Berzan E, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0473-5; Bilano VL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091198; Bohren MA, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0603-x; Bramham K, 2013, BMJ; Brownbc Gerda G, 2013, COMMUNICATION, DOI [10.1016/j.preghy.2012.11.001, DOI 10.1016/J.PREGHY.2012.11.001]; Dadelszen P, 2013, PREGNANCY HYPERTENS, V3, P199, DOI 10.1016/j.preghy.2013.06.002; DONNER A, 1984, STAT MED, V3, P199, DOI 10.1002/sim.4780030302; Dora SK., 2017, INT J RES MED SCI, V5, P1785, DOI [10.18203/2320-6012.ijrms20171483, DOI 10.18203/2320-6012.IJRMS20171483]; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Duley L, 2006, BMJ-BRIT MED J, V332, P463, DOI 10.1136/bmj.332.7539.463; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Edgar M Ndaboine, 2012, AFRICAN J REPROD HLT; Gomathy E, 2018, EARLY ONSET LATE ONS; Gulec UK, 2013, J MATERN-FETAL NEO M, V26, P1228, DOI 10.3109/14767058.2013.776533; Hutcheon JA, 2011, SCIENCEDIRECT; Iacobelli S, 2017, J REPROD IMMUNOL, V123, P12, DOI 10.1016/j.jri.2017.08.005; James PR, 2004, HEART, V90, P1499, DOI 10.1136/hrt.2004.035444; Janani Fatemeh, 2017, J Family Med Prim Care, V6, P766, DOI 10.4103/jfmpc.jfmpc_132_17; Kiondo, 2014, BMC PREGNANCY CHILDB; KNH, 2007, PREV HYP DIS PREGN K; Kovo M, 2015, REPROD SCI, V22, P316, DOI 10.1177/1933719114542024; Lisonkova S, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.08.019; Madazli R, 2014, ARCH GYNECOL OBSTET, V290, P53, DOI 10.1007/s00404-014-3176-x; Magee L, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004351.pub3; MARKIN L, 2017, LVIV CLIN B, V4, P30, DOI DOI 10.25040/LKV2017.04.030; Mbarak B, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2395-3; Ministry of Health Kenya, 2017, SAV MOTH LIV 2017 1; Ndwiga Charity, 2018, ENDING ECLAMPSIA PRO; Paruk F, 2000, Semin Neonatol, V5, P197, DOI 10.1053/siny.2000.0023; Paruk F, 2000, SEMIN NEONATOL; Pauli JM, 2017, CLIN OBSTET GYNECOL, V60, P141, DOI 10.1097/GRF.0000000000000247; Ramesh K, 2018, SOCIODEMOGRAPHIC OTH; Renfrew J. Mary, 2014, SCIENCEDIRECT; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; s NA, 2018, LANCET INFECT DIS, V18, pe228; Sarbjit G, 2018, WILEY INTERDISCIPL R, V7, pe286, DOI 10.1002/WENE.286; Sibai BM, 2012, AM J OBSTET GYNECOL, V206, P470, DOI 10.1016/j.ajog.2011.09.002; Silvia Iacobelli, 2017, SCIENCEDIRECT; Smith M, 2013, OBSTET GYNAECOL, V15, P45, DOI 10.1111/j.1744-4667.2012.00144.x; Sri Sulistyowati, 2017, EARLY LATE ONSET PRE; Tessema GA, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0502-7; Townsend R, 2016, INTEGR BLOOD PRESS C, V9, P79, DOI 10.2147/IBPC.S77344; Urassa DP, 2006, ACTA OBSTET GYN SCAN, V85, P571, DOI 10.1080/00016340600604880; van Esch JJA, 2017, J MATERN-FETAL NEO M, V30, P2789, DOI 10.1080/14767058.2016.1263295; W Szymonowicz V, ARCH DIS CHILDHOOD; WHO, 2022, WHO RECOMMENDATIONS; World Health Organization, 2011, WHO REC PREV TREAM P; Xiong X, 2002, AM J EPIDEMIOL, V155, P203, DOI 10.1093/aje/155.3.203	54	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0233323	10.1371/journal.pone.0233323	http://dx.doi.org/10.1371/journal.pone.0233323			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502144	gold, Green Published			2022-12-26	WOS:000542035700033
J	Yet, B; Lamanna, C; Shepherd, KD; Rosenstock, TS				Yet, Barbaros; Lamanna, Christine; Shepherd, Keith D.; Rosenstock, Todd S.			Evidence-based investment selection: Prioritizing agricultural development investments under climatic and socio-political risk using Bayesian networks	PLOS ONE			English	Article							MODELS; BELIEF; METAANALYSIS; MANAGEMENT; FRAMEWORK; IMPACTS; POLICY; TOOLS	Agricultural development projects have a poor track record of success mainly due to risks and uncertainty involved in implementation. Cost-benefit analysis can help allocate resources more effectively, but scarcity of data and high uncertainty makes it difficult to use standard approaches. Bayesian Networks (BN) offer a suitable modelling technology for this domain as they can combine expert knowledge and data. This paper proposes a systematic methodology for creating a general BN model for evaluating agricultural development projects. Our approach adapts the BN model to specific projects by using systematic review of published evidence and relevant data repositories under the guidance of domain experts. We evaluate a large-scale agricultural investment in Africa to provide a proof of concept for this approach. The BN model provides decision support for project evaluation by predicting the value-measured as net present value and return on investment-of the project under different risk scenarios.	[Yet, Barbaros] Hacettepe Univ, Ankara, Turkey; [Lamanna, Christine; Shepherd, Keith D.] World Agroforestry ICRAF, Nairobi, Kenya; [Shepherd, Keith D.] CGIAR Res Program Water Land & Ecosyst, Nairobi, Kenya; [Rosenstock, Todd S.] World Agroforestry ICRAF, Kinshasa, DEM REP CONGO; [Rosenstock, Todd S.] CGIAR Res Program Climate Change Agr & Food Secur, Kinshasa, DEM REP CONGO	Hacettepe University; CGIAR; World Agroforestry (ICRAF); CGIAR; CGIAR	Yet, B (corresponding author), Hacettepe Univ, Ankara, Turkey.	barbarosyet@gmail.com	Yet, Barbaros/L-8355-2018	Yet, Barbaros/0000-0003-4058-2677	CGIAR Trust Fund; CGIAR; World Bank; International Center for Tropical Agriculture (CIAT)	CGIAR Trust Fund(CGIAR); CGIAR(CGIAR); World Bank(The World Bank India); International Center for Tropical Agriculture (CIAT)	The research was implemented under the Adaptation of African Agriculture Initiative as part of the CGIAR Research Program on Climate Change, Agriculture, and Food Security (CCAFS) and its Partnerships for Scaling Climate-Smart Agriculture (P4S) project. CCAFS is carried out with support from the CGIAR Trust Fund and through bilateral funding agreements. For details please visit https://ccafs.cgiar.org/donors.Part of this research was also carried out under the CGIAR Research Program on Water, Land and Ecosystems with support from CGIAR Fund Donors (http://www.cgiar.org/about-us/ourfunders/).This work specifically was developed in collaboration with and supported financially by the World Bank and the International Center for Tropical Agriculture (CIAT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research was implemented under the Adaptation of African Agriculture Initiative as part of the CGIAR Research Program on Climate Change, Agriculture, andFood Security (CCAFS) and its Partnerships for Scaling Climate-Smart Agriculture (P4S) project. CCAFS is carried out with support from the CGIAR Trust Fund and through bilateral funding agreements. For details please visit https://ccafs.cgiar.org/donors.Part of this research was also carried out under the CGIAR Research Program on Water, Land and Ecosystems with support from CGIAR Fund Donors (http://www.cgiar.org/about-us/our-funders/).This work specifically was developed in collaboration with and supported financially by the World Bank and the International Center for Tropical Agriculture (CIAT).	AgenaRisk, 2020, AGENARISK BAYES NETW; AGRA, 2019, AGRA ANN REP; Bojke L, 2010, VALUE HEALTH, V13, P557, DOI 10.1111/j.1524-4733.2010.00709.x; CEPII, 2019, I PROF DAT; Constantinou AC, 2012, KNOWL-BASED SYST, V36, P322, DOI 10.1016/j.knosys.2012.07.008; Constantinou AC, 2016, EXPERT SYST APPL, V56, P197, DOI 10.1016/j.eswa.2016.02.050; Constantinou AC, 2016, ARTIF INTELL MED, V67, P75, DOI 10.1016/j.artmed.2016.01.002; Crouch L, 2017, DEV CLIMATE SMART AG, DOI [10.3768/rtipress.2017.op.0034.1701, DOI 10.3768/RTIPRESS.2017.OP.0034.1701]; Drury B, 2017, ENG APPL ARTIF INTEL, V65, P29, DOI 10.1016/j.engappai.2017.07.003; EBIS BN, EV BAS INV SEL BAYES; Egger M, 1997, BMJ-BRIT MED J, V315, P1533, DOI 10.1136/bmj.315.7121.1533; FAO, 2019, FAO LOC WATCH; Fenton NE, 2007, IEEE T KNOWL DATA EN, V19, P1420, DOI [10.1109/TKDE.2007.1073, 10.1109/TKDE.2007.1068]; Florin MJ, 2013, AGR SYST, V121, P81, DOI 10.1016/j.agsy.2013.07.002; Hallegatte S, 2017, NAT CLIM CHANGE, V7, P250, DOI 10.1038/NCLIMATE3253; IFAD, 2016, AD SMALLH AGR PROGR, P1; KLEIJNEN JPC, 1994, PREDICTABILITY AND NONLINEAR MODELLING IN NATURAL SCIENCES AND ECONOMICS, P322; Lagnado DA, 2013, ARGUM COMPUT, V4, P46, DOI 10.1080/19462166.2012.682656; Lanzanova D, 2019, ENVIRON MODELL SOFTW, V115, P164, DOI 10.1016/j.envsoft.2019.01.016; Laskey KB, 2000, IEEE T KNOWL DATA EN, V12, P487, DOI 10.1109/69.868902; LAURITZEN SL, 1988, J ROY STAT SOC B MET, V50, P157; Luedeling E., 2016, SOLUTIONS, P46; Nash D, 2011, ENVIRON MODELL SOFTW, V26, P1079, DOI 10.1016/j.envsoft.2011.03.009; Neil M, 2000, KNOWL ENG REV, V15, P257, DOI 10.1017/S0269888900003039; Neil M, 2007, STAT COMPUT, V17, P219, DOI 10.1007/s11222-007-9018-y; PEARL J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Perez-Minana E, 2012, ENVIRON MODELL SOFTW, V35, P132, DOI 10.1016/j.envsoft.2012.02.016; Raggi M, 2010, 118 SEM EUR ASS AGR, P297; Rasmussen S, 2013, BAYESIAN NETWORK MOD; Richards R, 2013, ENVIRON MODELL SOFTW, V44, P113, DOI 10.1016/j.envsoft.2012.07.008; Rosenstock T.S., 2016, SCI BASIS CLIMATE SM; Shepherd K, 2015, NATURE, V523, P152, DOI 10.1038/523152a; Smid JH, 2010, INT J FOOD MICROBIOL, V139, pS57, DOI 10.1016/j.ijfoodmicro.2009.12.015; Smith J., 2015, CROPS CROP PESTS CLI; Spinoni J, 2014, INT J CLIMATOL, V34, P2792, DOI 10.1002/joc.3875; Tari F, 1996, COMPUT ELECTRON AGR, V15, P111, DOI 10.1016/0168-1699(96)00011-7; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; UNDRR, 2019, PREVENTIONWEB; Villordon A, 2011, HORTSCIENCE, V46, P1588, DOI 10.21273/HORTSCI.46.12.1588; Wafula J., 2018, FRONT APPL MATH STAT, V4, P6, DOI [10.3389/fams.2018.00006, DOI 10.3389/FAMS.2018.00006]; Whitney CW, 2018, EARTHS FUTURE, V6, P359, DOI 10.1002/2017EF000765; World Bank, 2010, COST BEN AN WORLD BA; World Bank, 2011, IMP EV AGR ASS EV; World Bank, 2015, FIN CLIM ACT; World Bank, 2019, WORLDWIDE GOVERNANCE; World Bank, 2018, WORLD BANK GROUP ANN; Yet B, 2018, IEEE ACCESS, V6, P7802, DOI 10.1109/ACCESS.2018.2799527; Yet B, 2016, EXPERT SYST APPL, V60, P141, DOI 10.1016/j.eswa.2016.05.005; Yet B, 2014, J BIOMED INFORM, V52, P373, DOI 10.1016/j.jbi.2014.07.018; Yet B, 2014, J BIOMED INFORM, V48, P28, DOI 10.1016/j.jbi.2013.10.012; Zhang HY, 2018, P I MECH ENG O-J RIS, V232, P505, DOI 10.1177/1748006X17742765; 1997, MONUMENTS FOLKLORE P, V15, P82	52	7	7	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0234213	10.1371/journal.pone.0234213	http://dx.doi.org/10.1371/journal.pone.0234213			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502217	Green Published, gold			2022-12-26	WOS:000542035700046
J	Awasthi, S; Kesarwani, N; Verma, RK; Agarwal, GG; Tewari, LS; Mishra, RK; Shukla, L; Raut, AK; Qazi, SA; Aboubaker, S; Bin Nisar, Y; Bahl, R; Agarwal, M				Awasthi, Shally; Kesarwani, Naveen; Verma, Raj Kumar; Agarwal, Girdhar Gopal; Tewari, Luxmi Shanker; Mishra, Ravi Krishna; Shukla, Lalji; Raut, Arun Kumar; Qazi, Shamim Ahmad; Aboubaker, Samira; Bin Nisar, Yasir; Bahl, Rajiv; Agarwal, Monika			Identification and management of young infants with possible serious bacterial infection where referral was not feasible in rural Lucknow district of Uttar Pradesh, India: An implementation research	PLOS ONE			English	Article							BENZYLPENICILLIN PLUS GENTAMICIN; COMMUNITY-HEALTH WORKERS; OPEN-LABEL; NEWBORNS; CARE	Background Based on World Health Organization guidelines, Government of India recommended management of possible serious bacterial infection (PSBI) in young infants up to two months of age on an outpatient basis where referral is not feasible. We implemented the guideline in program setting to increase access to treatment with high treatment success and low resultant mortality. Methods Implementation research was conducted in four rural blocks of Lucknow district in Uttar Pradesh, India. It included policy dialogues with the central and state government and district level officials. A Technical Support Unit was established. Thereafter, capacity building across all cadres of health workers in the implementation area was done for strengthening of home based newborn care (HBNC) program, skills enhancement for identification and management of PSBI, logistics management to ensure availability of necessary supplies, monitoring and evaluation as well as providing feedback. Data was collected by the research team. Results From June 2017 to February 2019 there were 24,448 live births in a population of 856106. We identified 1302 infants, aged 0-59 days, with any sign of PSBI leading to a coverage of 53% (1302/2445), assuming an incidence of 10%. However, in the establishment phase the coverage was 33%, while it was 85% in the implementation phase. Accredited social health activists (ASHAs) identified 81.2% (1058/1302) cases while rest were identified by families. ASHAs increased home visits within first 7 days of life in home based newborn care program from 74.3% (2781/3738) to 89.0% (3128/3513) and detection of cases of PSBI from 1.6% (45/2781) to 8.7% (275/3128) in the first and last quarter of the project, respectively. Of these 18.7% (244/1302) refused referral to government health system and 6.7% (88/1302) were treated in a hospital. Among cases of PSBI, there were 13.3% (173/1302) cases of fast breathing in young infant aged 7-59 days in whom referral was not needed. Of these 147 were treated by oral amoxicillin and 95.2% (140/147) were cured. Among those who needed referral, simplified treatment was given when referral was refused. There were 2.9% (37/1302) cases of fast breathing at ages of 0-6 days of which 34 were treated by simplified treatment with100% (34/34) cured;66.5% (866/1302) were cases of clinical severe infection of which 685 treated by simplified treatment with94.2% (645/685)cured and 09 died;17.3% (226/1302) cases of critical illness of which 93 were treated by simplified treatment, as a last resort, 72% (67/93) cured and 16 died. Among 255 cases who either did not seek formal treatment or sought it at private facilities, 96 died. Conclusion Simplified treatment for PSBI is feasible in public program settings in northern India with good cure rates. It required system strengthening and supportive supervision.	[Awasthi, Shally; Kesarwani, Naveen; Verma, Raj Kumar; Tewari, Luxmi Shanker; Mishra, Ravi Krishna; Shukla, Lalji; Raut, Arun Kumar] King Georges Med Univ, Dept Pediat, Lucknow, Uttar Pradesh, India; [Agarwal, Girdhar Gopal] Univ Lucknow, Dept Stat, Lucknow, Uttar Pradesh, India; [Qazi, Shamim Ahmad; Aboubaker, Samira] WHO, Dept Maternal Newborn Child & Adolescent Hlth, Geneva, Switzerland; [Bin Nisar, Yasir; Bahl, Rajiv] WHO, Dept Maternal Newborn Child & Adolescent Hlth & A, Geneva, Switzerland; [Agarwal, Monika] King Georges Med Univ, Dept Social & Prevent Med, Lucknow, Uttar Pradesh, India	King George's Medical University; Lucknow University; World Health Organization; World Health Organization; King George's Medical University	Awasthi, S (corresponding author), King Georges Med Univ, Dept Pediat, Lucknow, Uttar Pradesh, India.	shally07@gmail.com	Nisar, Yasir Bin/AFO-2407-2022	Awasthi, Shally/0000-0003-1254-9802	World Health Organization Geneva, Switzerland (World Health Organization: WHO) [MCA00415]	World Health Organization Geneva, Switzerland (World Health Organization: WHO)	The study was supported by World Health Organization Geneva, Switzerland (World Health Organization: WHO www.who.int) via Project ID: MCA00415. The funders had role in study conceptualization and review and editing of the manuscript.	[Anonymous], 2017, LANCET GLOB HEALTH, V5, pe428; [Anonymous], 2015, JMIR MED INF, V3, pe22; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Baqui AH, 2009, PEDIATR INFECT DIS J, V28, P304, DOI 10.1097/INF.0b013e31819069e8; Boys MC, 2013, THEOL STUD, V74, P73, DOI 10.1177/004056391307400104; Census of India, 2011, CENS IND BAS TERMS; Fadel SA, 2017, LANCET, V390, P1972, DOI 10.1016/S0140-6736(17)32162-1; Government of India, 2014, DISTR CENS HDB CENS; Government of India, IND PUBL HLTH STAND; Government of India. Indian Public Health Standards (IPHS), IND PUBL HLTH STAND; Government of India. Indian Public Health Standards (IPHS), GUID SUB; Khanal S, 2011, J HEALTH POPUL NUTR, V29, P255, DOI 10.3329/jhpn.v29i3.7873; Kozuki N, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2330-0; Ministry of Health and Family Welfare, 2014, US GETN ANMS MAN SEP; Ministry of Health and Family Welfare, 2014, REV HOM BAS NEWB CAR; Ministry of Health and Familyl Welfare Government of India, ACCR SOC HLTH ACT AS; National Health Mission, 2018, ADDENDUM OPERATIONAL; Office of the Registrar General and Census Commissioner India, 2017, SAMPL REG SYST STAT; Owais A, 2011, J PERINATOL, V31, P586, DOI 10.1038/jp.2010.191; Seale AC, 2014, LANCET INFECT DIS, V14, P731, DOI 10.1016/S1473-3099(14)70804-7; SPSS Inc, 2009, REL 2009 SPSS WIND S; Tshefu A, 2015, LANCET, V385, P1767, DOI 10.1016/S0140-6736(14)62284-4; Tshefu A, 2015, LANCET, V385, P1758, DOI 10.1016/S0140-6736(14)62285-6; Wang ME, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3688-3; World Health Organization, 2014, INTEGRATED MANAGEMEN; World Health Organization, 2008, TRIAN MID LEV MAN ML; World Health Organization, GUID MAN POSS SER BA; World Health Organization, 2013, POCK BOOK HOSP CAR C; World Health Organization Department of Maternal N, 2013, WHO REC POSTN CAR MO; Zaidi AKM, 2012, PEDIATR INFECT DIS J, V31, P667, DOI 10.1097/INF.0b013e318256f86c	30	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0234212	10.1371/journal.pone.0234212	http://dx.doi.org/10.1371/journal.pone.0234212			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497092	Green Published, gold			2022-12-26	WOS:000542035200083
J	Molinari, GS; McCracken, VJ; Wojno, M; Rimoldi, S; Terova, G; Kwasek, K				Molinari, Giovanni S.; McCracken, Vance J.; Wojno, Michal; Rimoldi, Simona; Terova, Genciana; Kwasek, Karolina			Can intestinal absorption of dietary protein be improved through early exposure to plant-based diet?	PLOS ONE			English	Article							FAMILY GROWTH-RESPONSE; SOYBEAN-MEAL; REPRODUCTIVE-PERFORMANCE; SEA BASS; FISH-MEAL; ZEBRAFISH; EXPRESSION; BROODSTOCK; QUALITY; FABP2	Nutritional Programming (NP) has been studied as a means of mitigating the negative effects of dietary plant protein (PP), but the optimal timing and mechanism behind NP are still unknown. The objectives of this study were: 1) To determine whether zebrafish (Danio rerio) can be programmed to soybean meal (SBM) through early feeding and broodstock exposure to improve SBM utilization; 2) To determine if NP in zebrafish affects expression of genes associated with intestinal nutrient uptake; 3) To determine if early stage NP and/or broodstock affects gene expression associated with intestinal inflammation or any morphological changes in the intestinal tract that might improve dietary SBM utilization. Two broodstocks were used to form the six experimental groups. One broodstock group received fishmeal (FM) diet (FMBS), while the other was fed ("programmed with") SBM diet (PPBS). The first ((+) Control) and the second group ((-) Control) received FM and SBM diet for the entire study, respectively, and were progeny of FMBS. The last four groups consisted of a non-programmed (FMBS-X-PP and PPBS-X-PP) and a programmed group (FMBS-NP-PP and PPBS-NP-PP) from each of the broodstocks. The programming occurred through feeding with SBM diet during 13-23 dph. The non-control groups underwent a PP-Challenge, receiving SBM diet during 36-60 dph. During the PP-Challenge, both PPBS groups experienced significantly lower weight gains than the (+) Control group. NP in early life stages significantly increased the expression of PepT1 in PPBS-NP-PP, compared to PPBS-X-PP. NP also tended to increase the expression of fabp2 in the programmed vs. non-programmed groups of both broodstocks. The highest distal villus length-to-width ratio was observed in the dual-programmed group, suggesting an increase in surface area for nutrient absorption within the intestine. The results of this study suggest that NP during early life stages may increase intestinal absorption of nutrients from PP-based feeds.	[Molinari, Giovanni S.; Wojno, Michal; Kwasek, Karolina] Southern Illinois Univ, Ctr Fisheries Aquaculture & Aquat Sci, Carbondale, IL 62901 USA; [McCracken, Vance J.] Southern Illinois Univ Edwardsville, Dept Biol Sci, Edwardsville, IL USA; [Rimoldi, Simona; Terova, Genciana] Univ Insubria, Dept Biotechnol & Life Sci, Varese, Italy	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University Edwardsville; University of Insubria	Kwasek, K (corresponding author), Southern Illinois Univ, Ctr Fisheries Aquaculture & Aquat Sci, Carbondale, IL 62901 USA.	karolina.kwasek@siu.edu	Terova, Genciana/AAL-6412-2021	Terova, Genciana/0000-0002-7532-7951; McCracken, Vance/0000-0002-8533-5808; Rimoldi, Simona/0000-0002-1995-263X	AGER project Fine Feed for Fish (4F) [2016-01-01]	AGER project Fine Feed for Fish (4F)	The AGER project Fine Feed for Fish (4F), Rif. No. 2016-01-01 (https://acquacoltura.progettoager.it). The funding was awarded to GT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	[Anonymous], 2015, DIABETOL KLIN SA, V4, pA1; [Anonymous], 2012, P NATL ACAD SCI USA, V109, pE1377; [Anonymous], 2016, THE TOTAL AUDIENCE R; [Anonymous], 2014, J VISUAL COMMUNICATI; Bagheri T, 2013, ANIM REPROD SCI, V139, P136, DOI 10.1016/j.anireprosci.2013.02.003; Brugman S, 2016, DEV COMP IMMUNOL, V64, P82, DOI 10.1016/j.dci.2016.02.020; CERDA J, 1994, AQUACULTURE, V128, P345, DOI 10.1016/0044-8486(94)90322-0; Chadzinska M, 2008, IMMUNOLOGY, V125, P601, DOI 10.1111/j.1365-2567.2008.02874.x; Chen WT, 2013, MOL REPROD DEV, V80, P384, DOI 10.1002/mrd.22172; Dabrowski K, 2018, ZEBRAFISH, V15, P295, DOI 10.1089/zeb.2017.1515; de Francesco M, 2004, AQUACULTURE, V236, P413, DOI 10.1016/j.aquaculture.2004.01.006; Fernandes H, 2016, ZEBRAFISH, V13, P548, DOI 10.1089/zeb.2016.1303; Fowler LA, 2020, AM COLL LAB, P379, DOI 10.1016/B978-0-12-812431-4.00033-6; Furuita H, 2000, AQUACULTURE, V187, P387, DOI 10.1016/S0044-8486(00)00319-7; Geurden I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083162; Hedrera MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069983; Izquierdo MS, 2015, AQUACULTURE, V449, P18, DOI 10.1016/j.aquaculture.2015.03.032; Izquierdo MS, 2001, AQUACULTURE, V197, P25, DOI 10.1016/S0044-8486(01)00581-6; Jakowski S., 1999, LOGIC LOGICAL PHILOS, V7, P57, DOI [10.12775/LLP.1999.004, DOI 10.12775/LLP.1999.004]; Kemski M, 2018, AQUACULTURE, V497, P452, DOI 10.1016/j.aquaculture.2018.07.001; Kwasek K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0225917; Kwasek K, 2012, REV FISH BIOL FISHER, V22, P797, DOI 10.1007/s11160-012-9266-6; Marjara IS, 2012, CYTOKINE, V60, P186, DOI 10.1016/j.cyto.2012.05.027; Moghadam H, 2015, J MAR SCI ENG, V3, P175, DOI 10.3390/jmse3020175; National Research Council, 2011, NUTR REQ FISH SHRIMP; Overturf K, 2013, AQUAC RES, V44, P604, DOI 10.1111/j.1365-2109.2011.03065.x; Palti Y, 2006, AQUACULTURE, V255, P548, DOI 10.1016/j.aquaculture.2005.11.029; Pedersen ME, 2015, MATRIX BIOL, V44-46, P86, DOI 10.1016/j.matbio.2015.01.009; Perera E, 2016, ZEBRAFISH, V13, P61, DOI 10.1089/zeb.2015.1131; Pierce LR, 2008, AQUACULTURE, V278, P37, DOI 10.1016/j.aquaculture.2008.03.017; Stockhammer OW, 2009, J IMMUNOL, V182, P5641, DOI 10.4049/jimmunol.0900082; Szyf M, 2008, ENVIRON MOL MUTAGEN, V49, P46, DOI 10.1002/em.20357; Terova G, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-17; Terova G, 2009, AQUACULTURE, V294, P288, DOI 10.1016/j.aquaculture.2009.06.014; Turkmen S, 2017, BRIT J NUTR, V118, P500, DOI [10.1017/s0007114517002434, 10.1017/S0007114517002434]; Ulloa PE, 2011, REV FISH BIOL FISHER, V21, P649, DOI 10.1007/s11160-011-9203-0; Uran PA, 2008, FISH SHELLFISH IMMUN, V25, P751, DOI 10.1016/j.fsi.2008.02.013; Venkatachalam AB, 2013, GENE, V520, P14, DOI 10.1016/j.gene.2013.02.034; Venold FF, 2013, COMP BIOCHEM PHYS A, V164, P229, DOI 10.1016/j.cbpa.2012.09.009; Venold FF, 2012, AQUACULTURE, V364, P281, DOI 10.1016/j.aquaculture.2012.08.035; Verri T, 2003, FEBS LETT, V549, P115, DOI 10.1016/S0014-5793(03)00759-2; Verri T, 2011, BIOL LETTERS, V7, P597, DOI 10.1098/rsbl.2010.1164; Wang YZ, 2017, EARTH SURF DYNAM, V5, P1, DOI 10.5194/esurf-5-145-2017; WATANABE T, 1984, B JPN SOC SCI FISH, V50, P495; Yossa R, 2011, COMP BIOCHEM PHYS B, V160, P150, DOI 10.1016/j.cbpb.2011.07.005; Zambonino-Infante JL, 2019, AQUACULTURE, V501, P441, DOI 10.1016/j.aquaculture.2018.11.056	46	8	8	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0228758	10.1371/journal.pone.0228758	http://dx.doi.org/10.1371/journal.pone.0228758			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497052	Green Published, Green Submitted, gold			2022-12-26	WOS:000542035200087
J	Kristensen, PK; Perez-Vicente, R; Leckie, G; Johnsen, SP; Merlo, J				Kristensen, Pia Kjaer; Perez-Vicente, Raquel; Leckie, George; Johnsen, Soren Paaske; Merlo, Juan			Disentangling the contribution of hospitals and municipalities for understanding patient level differences in one-year mortality risk after hip-fracture: A cross-classified multilevel analysis in Sweden	PLOS ONE			English	Article							LEAGUE TABLES; REGIONAL DIFFERENCES; PERFORMANCE; LIMITATIONS; SURGERY; LENGTH; RATES; STAY	Background One-year mortality after hip-fracture is a widely used outcome measure when comparing hospital care performance. However, traditional analyses do not explicitly consider the referral of patients to municipality care after just a few days of hospitalization. Furthermore, traditional analyses investigates hospital (or municipality) variation in patient outcomes in isolation rather than as a component of the underlying patient variation. We therefore aimed to extend the traditional approach to simultaneously estimate both case-mix adjusted hospital and municipality comparisons in order to disentangle the amount of the total patient variation in clinical outcomes that was attributable to the hospital and municipality level, respectively. Methods We determined 1-year mortality risk in patients aged 65 or above with hip fractures registered in Sweden between 2011 and 2014. We performed cross-classified multilevel analysis with 54,999 patients nested within 54 hospitals and 290 municipalities. We adjusted for individual demographic, socioeconomic and clinical characteristics. To quantify the size of the hospital and municipality variation we calculated the variance partition coefficient (VPC) and the area under the receiver operator characteristic curve (AUC). Results The overall 1-year mortality rate was 25.1%. The case-mix adjusted rates varied from 21.7% to 26.5% for the 54 hospitals, and from 18.9% to 29.5% for the 290 municipalities. The VPC was just 0.2% for the hospital and just 0.1% for the municipality level. Patient sociodemographic and clinical characteristics were strong predictors of 1-year mortality (AUC = 0.716), but adding the hospital and municipality levels in the cross-classified model had a minor influence (AUC = 0.718). Conclusions Overall in Sweden, one-year mortality after hip-fracture is rather high. However, only a minor part of the patient variation is explained by the hospital and municipality levels. Therefore, a possible intervention should be nation-wide rather than directed to specific hospitals or municipalities.	[Kristensen, Pia Kjaer] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark; [Kristensen, Pia Kjaer] Reg Hosp Horsens, Dept Orthoped Surg, Horsens, Denmark; [Perez-Vicente, Raquel; Merlo, Juan] Lund Univ, Fac Med, Clin Res Ctr, Res Unit Social Epidemiol, Malmo, Sweden; [Leckie, George] Univ Bristol, Ctr Multilevel Modelling, Sch Educ, Bristol, Avon, England; [Johnsen, Soren Paaske] Aalborg Univ, Danish Ctr Clin Hlth Serv Res, Dept Clin Med, Aalborg, Denmark	Aarhus University; Lund University; University of Bristol; Aalborg University	Kristensen, PK (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark.; Kristensen, PK (corresponding author), Reg Hosp Horsens, Dept Orthoped Surg, Horsens, Denmark.	pkkr@clin.au.dk	Merlo, Juan/E-2136-2011	Merlo, Juan/0000-0001-8379-9708; Kristensen, Pia Kjaer/0000-0001-5473-9386	Swedish Research Council (i.e., Vetenskapsradet) [2017-01321]; Health Research Fund of Central Denmark Region [A869]	Swedish Research Council (i.e., Vetenskapsradet); Health Research Fund of Central Denmark Region	Juan Merlo - Swedish Research Council (i.e., Vetenskapsradet) project-id: 2017-01321. https://www.swecris.se/betasearch/details/project/201701321VR Pia Kjaer Kristensen- The Health Research Fund of Central Denmark Region A869. https://www.rm.dk/sundhed/faginfo/forskning/region-midtjyllands-sundhedsvidenskabelige-forskningsfond/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel G, 2019, BMJ QUAL SAF, V28, P1032, DOI 10.1136/bmjqs-2018-009165; Abel G, 2015, BMJ QUAL SAF, V24, P554, DOI 10.1136/bmjqs-2015-004366; Adab P, 2002, BRIT MED J, V324, P95, DOI 10.1136/bmj.324.7329.95; Ash A., 2011, STAT ISSUES ASSESSIN; Bergman J, 2019, OSTEOPOROSIS INT, V30, P1973, DOI 10.1007/s00198-019-05097-1; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Brooke HL, 2017, EUR J EPIDEMIOL, V32, P765, DOI 10.1007/s10654-017-0316-1; Bungener M, 1994, TRAJECTOIRES SOCIALE; Clarke A, 2001, EUR J PUBLIC HEALTH, V11, P166, DOI 10.1093/eurpub/11.2.166; Corallo AN, 2014, HEALTH POLICY, V114, P5, DOI 10.1016/j.healthpol.2013.08.002; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Ghith N, 2019, BMJ OPEN QUAL, V8, DOI 10.1136/bmjoq-2018-000449; Ghith N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189050; Ghith N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148187; Goldstein H, 1996, J ROY STAT SOC A STA, V159, P385, DOI 10.2307/2983325; Hakkinen U, 2015, HEALTH ECON, V24, P116, DOI 10.1002/hec.3270; Hekkert K, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3761-y; Hjerpe P, 2011, EUR J CLIN PHARMACOL, V67, P415, DOI 10.1007/s00228-010-0973-4; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Hu FK, 2012, INJURY, V43, P676, DOI 10.1016/j.injury.2011.05.017; Jantzen C, 2020, HIP INT, V30, P101, DOI 10.1177/1120700019832603; Kristensen PK, 2019, CLIN EPIDEMIOL, V11, P605, DOI 10.2147/CLEP.S213898; Leckie G., 2013, LEMMA VLE MODULE, V12, P1; Leyland AH, 1998, LANCET, V351, P555, DOI 10.1016/S0140-6736(97)09362-8; Ludvigsson JF, 2016, EUR J EPIDEMIOL, V31, P125, DOI 10.1007/s10654-016-0117-y; Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; Medin E, 2015, HEALTH ECON, V24, P53, DOI 10.1002/hec.3278; Merlo J, 2005, EUR J EPIDEMIOL, V20, P737, DOI 10.1007/s10654-005-2065-9; Merlo J, 2001, J EPIDEMIOL COMMUN H, V55, P323, DOI 10.1136/jech.55.5.323; Merlo J, 2019, HEALTH PLACE, V58, DOI 10.1016/j.healthplace.2019.102145; Merlo J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153778; Nordstrom P, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h696; Ohlsson H, 2011, MED CARE, V49, P327, DOI 10.1097/MLR.0b013e31820325c5; Paula FD, 2016, REV SAUDE PUBL, V50, DOI 10.1590/S1518-8787.2016050005947; Pedersen AB, 2017, EPIDEMIOLOGY, V28, P898, DOI [10.1097/EDE.0000000000000729, 10.1097/ede.0000000000000729]; Peng J, 2016, PAK J MED SCI, V32, P499, DOI 10.12669/pjms.322.9435; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Rogmark C, 2020, ACTA ORTHOP, V91, P123, DOI 10.1080/17453674.2019.1706936; Saez-Lopez P, 2017, OSTEOPOROSIS INT, V28, P1157, DOI 10.1007/s00198-016-3834-x; Schousboe JT, 2017, OSTEOPOROSIS INT, V28, P889, DOI 10.1007/s00198-016-3803-4; Tomioka S, 2019, TOHOKU J EXP MED, V247, P161, DOI 10.1620/tjem.247.161; Turesson E, 2019, BMC MUSCULOSKEL DIS, V20, DOI 10.1186/s12891-019-3007-0; van Dishoeck AM, 2011, BMJ QUAL SAF, V20, P869, DOI 10.1136/bmjqs.2010.048058; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294	46	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2020	15	6							e0234041	10.1371/journal.pone.0234041; 10.1371/journal.pone.0234041.r001; 10.1371/journal.pone.0234041.r002; 10.1371/journal.pone.0234041.r003; 10.1371/journal.pone.0234041.r004	http://dx.doi.org/10.1371/journal.pone.0234041; 10.1371/journal.pone.0234041.r001; 10.1371/journal.pone.0234041.r002; 10.1371/journal.pone.0234041.r003; 10.1371/journal.pone.0234041.r004			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LW6ZP	32492053	Green Published, gold			2022-12-26	WOS:000539293000024
J	Singh, R; Das, S; Datta, S; Mazumdar, A; Biswas, NK; Maitra, A; Majumder, PP; Ghose, S; Roy, B				Singh, Richa; Das, Shreya; Datta, Sila; Mazumdar, Anjana; Biswas, Nidhan K.; Maitra, Arindam; Majumder, Partha P.; Ghose, Sandip; Roy, Bidyut			Study of Caspase 8 mutation in oral cancer and adjacent precancer tissues and implication in progression	PLOS ONE			English	Article							MALIGNANT-TRANSFORMATION; LEUKOPLAKIA; GENE	It is hypothesized that same driver gene mutations should be present in both oral leukoplakia and cancer tissues. So, we attempted to find out mutations at one of the driver genes, CASP8, in cancer and adjacent leukoplakia tissues. Patients (n = 27), affected by both of cancer and adjacent leukoplakia, were recruited for the study. Blood and tissue DNA samples were used to identify somatic mutations at CASP8 by next generation sequencing method. In total, 56% (15 out of 27) cancer and 30% (8 out of 27) leukoplakia tissues had CASP8 somatic mutations. In 8 patients, both cancer and adjacent leukoplakia tissues, located within 2-5 cm of tumor sites, had identical somatic mutations. But, in 7 patients, cancer samples had somatic mutations but none of the leukoplakia tissues, located beyond 5cm of tumor sites, had somatic mutations. Mutated allele frequencies at CASP8 were found to be more in cancer compared to adjacent leukoplakia tissues. This study provides mutational evidence that oral cancer might have progressed from previously grown leukoplakia lesion. Leukoplakia tissues, located beyond 5cm of cancer sites, were free from mutation. The study implies that CASP8 mutation could be one of the signatures for some of the leukoplakia to progress to oral cancer.	[Singh, Richa; Roy, Bidyut] Indian Stat Inst, Human Genet Unit, Kolkata, India; [Das, Shreya; Datta, Sila; Mazumdar, Anjana; Ghose, Sandip] Dr R Ahmed Dent Coll & Hosp, Kolkata, India; [Biswas, Nidhan K.; Maitra, Arindam; Majumder, Partha P.] Natl Inst Biomed Genom, Kalyani, W Bengal, India; [Singh, Richa] Weill Cornell Med, Pathol & Lab Med, New York, NY USA	Indian Statistical Institute; Indian Statistical Institute Kolkata; Department of Biotechnology (DBT) India; National Institute of Biomedical Genomics (NIBMG); Cornell University	Roy, B (corresponding author), Indian Stat Inst, Human Genet Unit, Kolkata, India.; Ghose, S (corresponding author), Dr R Ahmed Dent Coll & Hosp, Kolkata, India.	broy@isical.ac.in; sanindra1967@gmail.com	; Biswas, Nidhan K./A-4383-2009	Roy, Bidyut/0000-0003-4117-5838; Biswas, Nidhan K./0000-0001-7960-3290				AGOMELATINE (Valdoxan/ Thymanax), 2013, DRUG SAFETY UPDATE, V6, pA1; [Anonymous], 2014, NUCLEIC ACIDS RES, V42, pD7; Arunkumar G, 2017, ORAL DIS, V23, P669, DOI 10.1111/odi.12655; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Ferlay J, 2019, INT J CANCER, V144, P1941, DOI 10.1002/ijc.31937; Fischer JM, 2014, CARCINOGENESIS, V35, P237, DOI 10.1093/carcin/bgt296; Hayes TF, 2016, CANCER LETT, V383, P106, DOI 10.1016/j.canlet.2016.09.014; Kim HS, 2003, GASTROENTEROLOGY, V125, P708, DOI 10.1016/S0016-5085(03)01059-X; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ma J, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4481-8; Maitra A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3873; MEHTA FS, 1972, ORAL SURG ORAL MED O, V34, P426, DOI 10.1016/0030-4220(72)90319-2; Menon Uthara, 2015, Asian Pac J Cancer Prev, V16, P4589; Pickering CR, 2013, CANCER DISCOV, V3, P770, DOI 10.1158/2159-8290.CD-12-0537; PINDBORG JJ, 1968, J AM DENT ASSOC, V76, P767, DOI 10.14219/jada.archive.1968.0127; Robbins KT, 2019, AURIS NASUS LARYNX, V46, P10, DOI 10.1016/j.anl.2018.08.011; Schepman KP, 1998, ORAL ONCOL, V34, P270, DOI 10.1016/S1368-8375(98)80007-9; SILVERMAN S, 1976, CANCER-AM CANCER SOC, V38, P1790, DOI 10.1002/1097-0142(197610)38:4<1790::AID-CNCR2820380456>3.0.CO;2-I; Soung YH, 2005, CANCER RES, V65, P815; Soung YH, 2005, ONCOGENE, V24, P141, DOI 10.1038/sj.onc.1208244; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Tomasetti C, 2015, P NATL ACAD SCI USA, V112, P118, DOI 10.1073/pnas.1421839112; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Winters IP, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01519-y; Yang EC, 2018, OR SURG OR MED OR PA, V125, P670, DOI 10.1016/j.oooo.2018.02.020	26	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2020	15	6							e0233058	10.1371/journal.pone.0233058	http://dx.doi.org/10.1371/journal.pone.0233058			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LW6ZP	32492030	Green Published, gold			2022-12-26	WOS:000539293000051
J	Peixoto, GM; De Fraga, R; Araujo, MC; Kaefer, IL; Lima, AP				Peixoto, Gabriela Marques; De Fraga, Rafael; Araujo, Maria C.; Kaefer, Igor Luis; Lima, Albertina Pimentel			Hierarchical effects of historical and environmental factors on lizard assemblages in the upper Madeira River, Brazilian Amazonia	PLOS ONE			English	Article							LIFE-HISTORY; RIPARIAN CORRIDORS; RAIN-FOREST; PATTERNS; ECOLOGY; DIVERSIFICATION; DIVERSITY; SNAKE; SOIL; DISPERSAL	Investigating the role of historical and ecological factors structuring assemblages is relevant to understand mechanisms and processes affecting biodiversity across heterogeneous habitats. Considering that community assembly often involves scale-dependent processes, different spatial scales may reveal distinct factors structuring assemblages. In this study we use arboreal and leaf-litter lizard abundance data from 83 plots to investigate assemblage spatial structure at two distinct scales in southwestern Brazilian Amazonia. At a regional scale, we test the general hypothesis that the Madeira River acts as a barrier to dispersal of some lizard species, which results in distinct assemblages between river banks. At a local scale, we test the hypothesis that assemblages are not evenly distributed across heterogeneous habitats but respond to a continuum of inadequate-to-optimal portions of environmental predictors. Our results show that regional lizard assemblages are structured by the upper Madeira River acting as a regional barrier to 29.62% of the species sampled. This finding suggests species have been historically isolated at one of the river banks, or that distinct geomorphological features influence species occurrence at each river bank. At a local scale, different sets of environmental predictors affected assemblage composition between river banks or even along a river bank. These findings indicate that environmental filtering is a major cause of lizard assemblage spatial structure in the upper Madeira River, but predictor variables cannot be generalized over the extensive (nearly 500 km) study area. Based on a single study system we demonstrate that lizard assemblages along the forests near the banks of the upper Madeira River are not randomly structured but respond to multiple factors acting at different and hierarchical spatial scales.	[Peixoto, Gabriela Marques; Araujo, Maria C.; Kaefer, Igor Luis; Lima, Albertina Pimentel] Inst Nacl de Pesquisas da Amazonia, Posgrad Ecol, Manaus, Amazonas, Brazil; [De Fraga, Rafael] Univ Fed Oeste, Posgrad Recursos Nat Amazon, Santarem, Para, Brazil; [Kaefer, Igor Luis] Univ Fed Amazonas, Inst Ciencias Biol, Manaus, Amazonas, Brazil	Universidade Federal do Oeste do Para; Universidade Federal de Amazonas	Peixoto, GM (corresponding author), Inst Nacl de Pesquisas da Amazonia, Posgrad Ecol, Manaus, Amazonas, Brazil.	gabriela.marquespd@gmail.com	Kaefer, Igor/AAP-2418-2021; Kaefer, Igor L/A-3413-2009	Kaefer, Igor/0000-0001-6515-0278; Kaefer, Igor L/0000-0001-6515-0278; Marques Peixoto, Gabriela/0000-0002-1509-0817	Programa de Conservacao da Vida Selvagem da Santo Antonio Energia S.A.; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); CAPES; CNPq	Programa de Conservacao da Vida Selvagem da Santo Antonio Energia S.A.; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Data collection was financially supported by Programa de Conservacao da Vida Selvagem da Santo Antonio Energia S.A.; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) granted PhD scholarships to GMP. CAPES provided a PNPD postdoc grant to RF and CNPq provided productivity grants to ILK and APL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Stefan Lotters and an anonymous reviewer for insightful suggestions on this manuscript. Data collection was logistically supported by Programa de Pesquisas em Biodiversidade (PPBio), Centro de Estudos Integrados da Biodiversidade Amazonica (INCTCENBAM), and Programa de Conservacao da Vida Selvagem da Santo Antonio Energia S. A. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) granted PhD scholarships	Aleixo A., AREAS IMPORTANTES AV; Amazonia Central, 2008, THESIS; [Anonymous], 2019, R LANG ENV STAT COMP; Ansari MH, 2019, MOL PHYLOGENET EVOL, V133, P107, DOI 10.1016/j.ympev.2018.12.014; Antonelli A, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P386; Avila-Pires TCS, 2012, HERPETOLOGICA, V68, P272; Avila-Pires Teresa Cristina Sauer, 2009, Boletim do Museu Paraense Emilio Goeldi Ciencias Naturais, V4, P99; AYRES JM, 1992, AM NAT, V140, P531, DOI 10.1086/285427; BALLINGER RE, 1979, ECOLOGY, V60, P901, DOI 10.2307/1936858; Barros OG, 2009, ZOOLOGIA-CURITIBA, V26, P85, DOI 10.1590/S1984-46702009000100014; Bernardi JVE, 2012, GEOCHIM BRASILIENSIS, V23, P79; Bezerra RB, 2006, GEOGRAFIA, V15, P65; Bobrowiec PED, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183036; Boubli JP, 2015, MOL PHYLOGENET EVOL, V82, P400, DOI 10.1016/j.ympev.2014.09.005; Brandt R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020040; Bueno AS, 2012, ECOL APPL, V22, P722, DOI 10.1890/11-0789.1; Buhrnheim CM, 2003, COPEIA, P255, DOI 10.1643/0045-8511(2003)003[0255:SOFAIA]2.0.CO;2; Cavalcante M.M.A., 2012, THESIS; Cintra BBL, 2013, BIOGEOSCIENCES, V10, P7759, DOI 10.5194/bg-10-7759-2013; Cole EM, 2014, GLOB ECOL CONSERV, V1, P60, DOI 10.1016/j.gecco.2014.06.002; Costa FRC, 2005, J ECOL, V93, P863, DOI 10.1111/j.1365-2745.2005.01020.x; Dambros CS., 2016, ECOGRAPHY COP, V39, P1, DOI DOI 10.6084/M9.FIGSHARE; Daws MI, 2002, PLANT SOIL, V238, P79, DOI 10.1023/A:1014289930621; de Fraga R, 2018, PEERJ, V6, DOI 10.7717/peerj.5628; de Fraga R, 2017, J HERED, V108, P524, DOI 10.1093/jhered/esx051; de Fraga R, 2011, HERPETOL J, V21, P51; Dexter KG, 2012, P NATL ACAD SCI USA, V109, P7787, DOI 10.1073/pnas.1203523109; Dias-Terceiro RG, 2015, BIOTROPICA, V47, P259, DOI 10.1111/btp.12197; Dixo M., 2001, THESIS; Driscoll DA, 2004, ECOL APPL, V14, P220, DOI 10.1890/02-5248; Drucker DP, 2008, J TROP ECOL, V24, P65, DOI 10.1017/S0266467407004701; Emilio T, 2014, PLANT ECOL DIVERS, V7, P215, DOI 10.1080/17550874.2013.772257; Faria AS, 2019, AUSTRAL ECOL, V44, P850, DOI 10.1111/aec.12754; FAUTH JE, 1989, BIOTROPICA, V21, P178, DOI 10.2307/2388708; Fearnside PM, 2014, WATER ALTERN, V7, P256; Fischer J, 2005, DIVERS DISTRIB, V11, P225, DOI 10.1111/j.1366-9516.2005.00139.x; Fouquet A, 2015, J TROP ECOL, V31, P361, DOI 10.1017/S0266467415000206; Franklin E, 2005, APPL SOIL ECOL, V29, P259, DOI 10.1016/j.apsoil.2004.12.004; Gascon C, 2000, P NATL ACAD SCI USA, V97, P13672, DOI 10.1073/pnas.230136397; Gascon C, 1996, BIOTROPICA, V28, P376, DOI 10.2307/2389201; Gaston Kevin J., 2003, P345; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; Gibbs HL, 2018, BIOL J LINN SOC, V123, P651, DOI 10.1093/biolinnean/blx158; Hangartner S, 2012, EVOLUTION, V66, P867, DOI 10.1111/j.1558-5646.2011.01472.x; Haugaasen T, 2005, J TROP ECOL, V21, P133, DOI 10.1017/s026646740400207X; Hayes FE, 2004, J BIOGEOGR, V31, P1809, DOI 10.1111/j.1365-2699.2004.01139.x; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Kaefer IL, 2013, EVOL BIOL, V40, P228, DOI 10.1007/s11692-012-9205-4; Kinupp VF, 2005, J TROP ECOL, V21, P363, DOI 10.1017/S0266467405002440; Kraft NJB, 2015, FUNCT ECOL, V29, P592, DOI 10.1111/1365-2435.12345; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lamborot M, 1997, J ZOOL SYST EVOL RES, V35, P105; Lieberman SS, 1986, BIOL REV, V81, P1; Magnusson W.E., 2013, BIODIVERSIDADE MONIT; Maia GF, 2017, BIOL J LINN SOC, V121, P95, DOI 10.1093/biolinnean/blw017; Mariac C, 2011, MOL ECOL, V20, P80, DOI 10.1111/j.1365-294X.2010.04893.x; Masseli GS, 2019, AN ACAD BRAS CIENC, V91, DOI 10.1590/0001-3765201920190080; Maximiano MFD, 2020, BIOTROPICA, V52, P946, DOI 10.1111/btp.12793; Menger J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171540; Menin M, 2011, HERPETOL J, V21, P255; Miller DAW, 2012, ECOL APPL, V22, P1665; Moraes LJCL, 2016, J BIOGEOGR, V43, P2113, DOI 10.1111/jbi.12756; Moraes LFP, 2008, THESIS; NAIMAN RJ, 1993, ECOL APPL, V3, P209, DOI 10.2307/1941822; Oksanen J., 2013, R PACKAGE VERSION 2, P292; Pansonato MP, 2013, BIOTROPICA, V45, P299, DOI 10.1111/btp.12008; PATTON JL, 1994, EVOLUTION, V48, P1314, DOI 10.1111/j.1558-5646.1994.tb05315.x; Pianka E., 1986, ECOLOGY NATURAL HIST; Pinto M.G.M., 2006, THESIS; Pomara LY, 2014, J BIOGEOGR, V41, P784, DOI 10.1111/jbi.12247; Pringle RM, 2003, ECOLOGY, V84, P2668, DOI 10.1890/02-0482; Ribas CC, 2012, P ROY SOC B-BIOL SCI, V279, P681, DOI 10.1098/rspb.2011.1120; Ribeiro JW, 2012, COPEIA, P375, DOI 10.1643/CE-11-117; Ribeiro MA, 2015, ZOOTAXA, V3983, P1, DOI 10.11646/zootaxa.3983.1.1; Richardson JL, 2012, MOL ECOL, V21, P4437, DOI 10.1111/j.1365-294X.2012.05708.x; Rocha CFD, 1994, HERPETOLOGIA BRASIL, P1; Rojas-Ahumada DP, 2012, AUSTRAL ECOL, V37, P865, DOI 10.1111/j.1442-9993.2011.02330.x; Schietti J, 2016, J ECOL, V104, P1335, DOI 10.1111/1365-2745.12596; Schneider DC, 2001, BIOSCIENCE, V51, P545, DOI 10.1641/0006-3568(2001)051[0545:TROTCO]2.0.CO;2; Simoes PI, 2008, BIOTROPICA, V40, P607, DOI 10.1111/j.1744-7429.2008.00416.x; Smith AL, 2014, MOL ECOL, V23, P2428, DOI 10.1111/mec.12757; Souza SM, 2013, J HERPETOL, V47, P511, DOI 10.1670/12-124; Souza-Filho PWM., 1999, BRASIL REV BRAS GEOC, V29, P469, DOI DOI 10.25249/0375-7536.1999294469476; Tabarelli M, 2005, CONSERV BIOL, V19, P695, DOI 10.1111/j.1523-1739.2005.00694.x; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Tikuka MM., 2012, REV ANTROP, V4, P252; Vaz, 1997, REC NAT MEIO AMB VIS, V1, P55; Vellend M, 2010, Q REV BIOL, V85, P183, DOI 10.1086/652373; vila-Pires TC, 1992, ZOOL MEDED, V66, P453; Vitt LJ, 1997, J TROP ECOL, V13, P199, DOI 10.1017/S0266467400010415; VITT LJ, 1991, COPEIA, P916, DOI 10.2307/1446087; VITT LJ, 1992, CAN J ZOOL, V70, P1995, DOI 10.1139/z92-270; Vitt LJ, 1999, OIKOS, V87, P286, DOI 10.2307/3546743; Wallace A.R., 1854, ANN MAG NAT HIST, V14, P451, DOI [10.1080/037454809494374, DOI 10.1080/037454809494374]; Webb JK, 1997, BIOL CONSERV, V81, P21, DOI 10.1016/S0006-3207(96)00160-7; WILLIAMS BK, 2002, ANAL MANAGEMENT WILD	97	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2020	15	6							e0233881	10.1371/journal.pone.0233881	http://dx.doi.org/10.1371/journal.pone.0233881			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MT4VF	32484844	Green Published, gold			2022-12-26	WOS:000554969700018
J	Ng, S; Strunk, T; Lee, AH; Gill, EE; Falsafi, R; Woodman, T; Hibbert, J; Hancock, REW; Currie, A				Ng, Sherrianne; Strunk, Tobias; Lee, Amy H.; Gill, Erin E.; Falsafi, Reza; Woodman, Tabitha; Hibbert, Julie; Hancock, Robert E. W.; Currie, Andrew			Whole blood transcriptional responses of very preterm infants during late-onset sepsis	PLOS ONE			English	Article							C-REACTIVE PROTEIN; PROLIFERATOR-ACTIVATED RECEPTOR; NECROSIS-FACTOR-ALPHA; NEONATAL SEPSIS; LIPOPROTEIN METABOLISM; ORGAN DYSFUNCTION; DENDRITIC CELLS; INNATE IMMUNITY; HUMAN MONOCYTES; I INTERFERON	Background Host immune responses during late-onset sepsis (LOS) in very preterm infants are poorly characterised due to a complex and dynamic pathophysiology and challenges in working with small available blood volumes. We present here an unbiased transcriptomic analysis of whole peripheral blood from very preterm infants at the time of LOS. Methods RNA-Seq was performed on peripheral blood samples (6-29 days postnatal age) taken at the time of suspected LOS from very preterm infants < 30 weeks gestational age. Infants were classified based on blood culture positivity and elevated C-reactive protein concentrations as having confirmed LOS (n = 5), possible LOS (n = 4) or no LOS (n = 9). Bioinformatics and statistical analyses performed included pathway over-representation and protein-protein interaction network analyses. Plasma cytokine immunoassays were performed to validate differentially expressed cytokine pathways. Results The blood leukocyte transcriptional responses of infants with confirmed LOS differed significantly from infants without LOS (1,317 differentially expressed genes). However, infants with possible LOS could not be distinguished from infants with no LOS or confirmed LOS. Transcriptional alterations associated with LOS included genes involved in pathogen recognition (mainly TLR pathways), cytokine signalling (both pro-inflammatory and inhibitory responses), immune and haematological regulation (including cell death pathways), and metabolism (altered cholesterol biosynthesis). At the transcriptional-level cytokine responses during LOS were characterised by over-representation of IFN-alpha/beta, IFN-gamma, IL-1 and IL-6 signalling pathways and up-regulation of genes for inflammatory responses. Infants with confirmed LOS had significantly higher levels of IL-1 alpha and IL-6 in their plasma. Conclusions Blood responses in very preterm infants with LOS are characterised by altered host immune responses that appear to reflect unbalanced immuno-metabolic homeostasis.	[Ng, Sherrianne; Woodman, Tabitha; Currie, Andrew] Murdoch Univ, Med Mol & Forens Sci, Perth, WA, Australia; [Ng, Sherrianne] Imperial Coll London, Imperial Coll Parturit Res Grp, Div Inst Reprod & Dev Biol, London, England; [Ng, Sherrianne] Imperial Coll London, March Dimes European Prematur Res Ctr, London, England; [Strunk, Tobias] King Edward Mem Hosp, Dept Hlth, Child & Adolescent Hlth Serv, Neonatal Directorate, Perth, WA, Australia; [Strunk, Tobias; Woodman, Tabitha; Hibbert, Julie; Currie, Andrew] Telethon Kids Inst, Wesfarmers Ctr Vaccine & Infect Dis, Neonatal Infect & Immun Team, Perth, WA, Australia; [Lee, Amy H.; Gill, Erin E.; Falsafi, Reza; Hancock, Robert E. W.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC, Canada; [Lee, Amy H.; Gill, Erin E.; Falsafi, Reza; Hancock, Robert E. W.] Univ British Columbia, Ctr Microbial Dis & Immun Res, Vancouver, BC, Canada	Murdoch University; Imperial College London; Imperial College London; King Edward Memorial Hospital; Telethon Kids Institute; Wesfarmers Limited; University of British Columbia; University of British Columbia	Currie, A (corresponding author), Murdoch Univ, Med Mol & Forens Sci, Perth, WA, Australia.; Currie, A (corresponding author), Telethon Kids Inst, Wesfarmers Ctr Vaccine & Infect Dis, Neonatal Infect & Immun Team, Perth, WA, Australia.	a.currie@murdoch.edu.au	Strunk, Tobias/AIE-3407-2022; Hancock, Robert E. W./E-1145-2013	Strunk, Tobias/0000-0001-7079-2339; Hancock, Robert E. W./0000-0001-5989-8503; Hibbert, Julie/0000-0002-8839-3966; Gill, Erin/0000-0002-4943-610X; Currie, Andrew/0000-0002-5193-3404; Woodman, Tabitha/0000-0002-9214-8066; Ng, Sherrianne/0000-0002-4262-7587; Lee, Amy/0000-0003-3250-3246	NH&MRC of Australia Centre of Research Excellence Scholarship; Canadian Institutes for Health Research [FDN-154287]; Canada Research Chair in Health and Genomics	NH&MRC of Australia Centre of Research Excellence Scholarship(National Health and Medical Research Council (NHMRC) of Australia); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Health and Genomics	SN is supported by a NH&MRC of Australia Centre of Research Excellence Scholarship. The work in REWH's lab is supported by the Canadian Institutes for Health Research grant #FDN-154287 and he holds a Canada Research Chair in Health and Genomics and a UBC Killam Professorship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aken BL, 2017, NUCLEIC ACIDS RES, V45, pD635, DOI 10.1093/nar/gkw1104; Alexander WS, 2002, NAT REV IMMUNOL, V2, P410, DOI 10.1038/nri818; Andrews S., 2010, FASTQC QUALITY CONTR; Annema W, 2010, J LIPID RES, V51, P743, DOI 10.1194/jlr.M000323; [Anonymous], 2010, R LANG ENV STAT COMP; Atici A, 1996, ACTA PAEDIATR, V85, P371, DOI 10.1111/j.1651-2227.1996.tb14036.x; Benjamin JT, 2018, J IMMUNOL, V201, P2873, DOI 10.4049/jimmunol.1801089; Bermudes ACG, 2018, NUTRITION, V47, P104, DOI 10.1016/j.nut.2017.09.015; Bone RC, 1996, ANN INTERN MED, V125, P680, DOI 10.7326/0003-4819-125-8-199610150-00009; Boxx GM, 2016, CELL HOST MICROBE, V19, P760, DOI 10.1016/j.chom.2016.05.016; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045; Carow B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00058; Cernada M, 2014, PEDIATRICS, V133, pE1203, DOI 10.1542/peds.2013-2552; CHRISTENSEN RD, 1980, J PEDIATR-US, V96, P316, DOI 10.1016/S0022-3476(80)80837-7; Currie AJ, 2011, INFECT IMMUN, V79, P1588, DOI 10.1128/IAI.00535-10; DEBONT ESJM, 1993, PEDIATR RES, V33, P380; Dinarello CA, 2018, IMMUNOL REV, V281, P8, DOI 10.1111/imr.12621; Dobin Alexander, 2015, Curr Protoc Bioinformatics, V51, DOI 10.1002/0471250953.bi1114s51; Dong Y, 2015, ARCH DIS CHILD-FETAL, V100, pF257, DOI 10.1136/archdischild-2014-306213; Duncan SA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02431; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; Fanos V, 2014, EARLY HUM DEV, V90, pS78, DOI 10.1016/S0378-3782(14)70024-6; FEINGOLD KR, 1993, J LIPID RES, V34, P2147; Fleischmann-Struzek C, 2018, LANCET RESP MED, V6, P223, DOI 10.1016/S2213-2600(18)30063-8; Flores C, 2017, LANCET RESP MED, V5, P767, DOI 10.1016/S2213-2600(17)30297-7; Foell D, 2013, AM J RESP CRIT CARE, V187, P1324, DOI 10.1164/rccm.201209-1602OC; Foroushani ABK, 2013, PEERJ, V1, DOI 10.7717/peerj.229; Fumery M, 2017, EMBO MOL MED, V9, P1471, DOI 10.15252/emmm.201707795; Ghazal P, 2013, CURR OPIN INFECT DIS, V26, P213, DOI 10.1097/QCO.0b013e32835fb8bf; Guirgis FW, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1579-8; Hanna N, 2005, PEDIATR RES, V57, P56, DOI 10.1203/01.PDR.0000147568.14392.F0; Harbeson D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01077; Hibbert JE, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00357; Hilgendorff A, 2017, J MOL MED, V95, P169, DOI 10.1007/s00109-016-1466-4; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hotchkiss RS, 1999, J IMMUNOL, V162, P4148; Hotoura E, 2012, INFLAMMATION, V35, P1094, DOI 10.1007/s10753-011-9416-3; ITOH K, 1990, Pediatric Pathology, V10, P757; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Kan B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07215-9; Kan B, 2016, TRENDS MOL MED, V22, P290, DOI 10.1016/j.molmed.2016.02.001; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Kurt ANC, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/31397; Lai MY, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1069-7; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Layseca-Espinosa E, 2002, PEDIAT ALLERG IMM-UK, V13, P319, DOI 10.1034/j.1399-3038.2002.01064.x; LEE SH, 2015, BIOMED RES INT, V2015, DOI DOI 10.1155/2015/789298; Liu ZH, 2014, INT J CLIN EXP PATHO, V7, P870; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Machado JR, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/269681; Marchant EA, 2015, PEDIATR RES, V78, P492, DOI 10.1038/pr.2015.132; Mayer-Barber KD, 2017, CELL MOL IMMUNOL, V14, P22, DOI 10.1038/cmi.2016.25; Melville JM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00079; Netea MG, 1996, J CLIN INVEST, V97, P1366, DOI 10.1172/JCI118556; Ng PC, 1997, ARCH DIS CHILD-FETAL, V77, pF221, DOI 10.1136/fn.77.3.F221; Ng PC, 2003, ARCH DIS CHILD-FETAL, V88, P209; Ng S, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00070; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Peck-Palmer OM, 2009, SHOCK, V31, P359, DOI 10.1097/SHK.0b013e31818ba2a2; Pena OM, 2014, EBIOMEDICINE, V1, P64, DOI 10.1016/j.ebiom.2014.10.003; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Peyssonnaux C, 2005, J CLIN INVEST, V115, P1806, DOI 10.1172/JCI23865; Rakesh K, 2005, BIOCHEM PHARMACOL, V70, P649, DOI 10.1016/j.bcp.2005.04.042; Ravnskov U, 2003, QJM-INT J MED, V96, P927, DOI 10.1093/qjmed/hcg150; Reboldi A, 2014, SCIENCE, V345, P679, DOI 10.1126/science.1254790; Reyes CS, 2003, ACTA PAEDIATR, V92, P221, DOI 10.1111/j.1651-2227.2003.tb00530.x; Romagnoli C, 2001, EUR J PEDIATR, V160, P345, DOI 10.1007/PL00008445; Rudd KE, 2020, LANCET, V395, P200, DOI 10.1016/S0140-6736(19)32989-7; Shalova IN, 2015, IMMUNITY, V42, P484, DOI 10.1016/j.immuni.2015.02.001; Sharma AA, 2015, EUR J IMMUNOL, V45, P238, DOI 10.1002/eji.201444707; Sharma AA, 2014, NEONATOLOGY, V106, P1, DOI 10.1159/000358550; Sharma AA, 2012, CLIN IMMUNOL, V145, P61, DOI 10.1016/j.clim.2012.08.006; Simon A, 2014, NEW ENGL J MED, V371, P1933, DOI 10.1056/NEJMcibr1412016; Skibsted S, 2013, CRIT CARE, V17, DOI 10.1186/cc12693; Smith CL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5649; Strunk T, 2011, J MATERN-FETAL NEO M, V24, P25, DOI 10.3109/14767058.2010.482605; Suetrong B, 2016, CHEST, V149, P252, DOI 10.1378/chest.15-1703; Suzuki M, 2010, CIRCULATION, V122, P1919, DOI 10.1161/CIRCULATIONAHA.110.961193; Tall AR, 2015, NAT REV IMMUNOL, V15, P104, DOI 10.1038/nri3793; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Tosson AMS, 2020, J MATERN-FETAL NEO M, V33, P2768, DOI 10.1080/14767058.2018.1560411; Toti P, 2004, AM J CLIN PATHOL, V122, P765, DOI 10.1309/RV6E9BMC9954A2WU; Tsai MH, 2014, PEDIATR INFECT DIS J, V33, pE7, DOI 10.1097/INF.0b013e3182a72ee0; Tsujimoto Y, 1998, GENES CELLS, V3, P697, DOI 10.1046/j.1365-2443.1998.00223.x; Tyagi S, 2011, J ADV PHARM TECHNOL, V2, P236, DOI 10.4103/2231-4040.90879; Ucar B, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/737141; Unsinger J, 2010, J IMMUNOL, V184, P3768, DOI 10.4049/jimmunol.0903151; van Leeuwen HJ, 2003, CRIT CARE MED, V31, P1359, DOI 10.1097/01.CCM.0000059724.08290.51; Van Wyngene L, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708712; Venet F, 2012, J IMMUNOL, V189, P5073, DOI 10.4049/jimmunol.1202062; Wendel M, 2007, INTENS CARE MED, V33, P25, DOI 10.1007/s00134-006-0433-x; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wynn JL, 2020, PEDIATR RES, V88, P85, DOI 10.1038/s41390-019-0517-2; Wynn JL, 2015, MOL MED, V21, P496, DOI 10.2119/molmed.2015.00064; Xia JG, 2015, NAT PROTOC, V10, P823, DOI 10.1038/nprot.2015.052; Yildiz B, 2009, SCAND J INFECT DIS, V41, P263, DOI 10.1080/00365540902767056	102	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0233841	10.1371/journal.pone.0233841	http://dx.doi.org/10.1371/journal.pone.0233841			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MJ2AA	32479514	Green Published, gold			2022-12-26	WOS:000547893500031
J	Raymond, CK; Raymond, FC; Hill, K				Raymond, Christopher K.; Raymond, Fenella C.; Hill, Kay			UltraPrep is a scalable, cost-effective, bead-based method for purifying cell-free DNA	PLOS ONE			English	Article							PURIFICATION	UltraPrep is an open-source, two-step method for purification of cell-free DNA that entails extraction of total DNA followed by size-selective enrichment of the smaller fragments that are characteristic of DNA originating from fragmentation between nucleosome. The advantages of the two related protocols that are described are that they can easily accommodate a wide range of sample input volumes, they rely on simple, magnetic bead-based technology, the yields of cfDNA are directly comparable to the most popular methods for cfDNA purification, and they dramatically reduce the cost of cfDNA isolation relative to currently available commercial methods. We provide a framework for physical and molecular quality analysis of purified cfDNA and demonstrate that the cfDNA generated by UltraPrep meets or exceeds the quality metrics of the most commonly used procedure. In addition, our method removes high molecular weight genomic DNA (hmwgDNA) that can interfere with downstream assay results, thereby addressing one of the primary concerns for preanalytical collection of blood samples.	[Raymond, Christopher K.; Raymond, Fenella C.] Ripple Biosolut, Seattle, WA 98115 USA; [Hill, Kay] PlasmaLab Int, Everett, WA USA		Raymond, CK (corresponding author), Ripple Biosolut, Seattle, WA 98115 USA.	craymond@ripplebiosol.com		Raymond, Christopher/0000-0002-1417-4568	Ripple Biosolutions; PlasmaLab International	Ripple Biosolutions; PlasmaLab International	Funding for this study was provided jointly by Ripple Biosolutions and by PlasmaLab International. These entities provided the resources necessary to conduct this study in the form of materials, supplies and salaries. All of the authors are employees and/or owners of these entities, as detailed below. CKR and FCR are co-founders and employees of Ripple Biosolutions, and both have an ownership stake in RB. KH is an owner and director of Plasma Lab International and has an ownership stake in PLI. The funder provided support in the form of salaries for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Blauwkamp TA, 2019, NAT MICROBIOL, V4, P663, DOI 10.1038/s41564-018-0349-6; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Borgstrom E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019119; Chandrananda D, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0107-z; Cohen JD, 2018, SCIENCE, V359, P926, DOI 10.1126/science.aar3247; Jennings LJ, 2017, J MOL DIAGN, V19, P341, DOI 10.1016/j.jmoldx.2017.01.011; Katevatis C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176848; Marullo M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r9; Oberacker P, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000107; Quail M. A., 2009, CURRENT PROTOCOLS HU, V18, P18, DOI DOI 10.1002/0471142905.HG1802S62; Raymond CK, 2019, BIOTECHNIQUES, V67, P188, DOI 10.2144/btn-2019-0071; Raymond CK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176241; Raymond CK, EARLY DETECTION CANC; Razavi P, 2019, NAT MED, V25, P1928, DOI 10.1038/s41591-019-0652-7; Rohland N, 2012, GENOME RES, V22, P939, DOI 10.1101/gr.128124.111; Snyder MW, 2016, CELL, V164, P57, DOI 10.1016/j.cell.2015.11.050; Stetson D, 2019, JCO PRECIS ONCOL, V3, DOI 10.1200/PO.18.00191; Vandeventer PE, 2012, J PHYS CHEM B, V116, P5661, DOI 10.1021/jp3017776; VOGELSTEIN B, 1979, P NATL ACAD SCI USA, V76, P615, DOI 10.1073/pnas.76.2.615	19	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0231854	10.1371/journal.pone.0231854	http://dx.doi.org/10.1371/journal.pone.0231854			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MJ2AA	32479545	Green Published, gold, Green Submitted			2022-12-26	WOS:000547893500004
J	Szostaczuk, N; van Schothorst, EM; Sanchez, J; Priego, T; Palou, M; Bekkenkamp-Grovenstein, M; Faustmann, G; Obermayer-Pietsch, B; Tiran, B; Roob, JM; Winklhofer-Roob, B; Keijer, J; Palou, A; Pico, C				Szostaczuk, Nara; van Schothorst, Evert M.; Sanchez, Juana; Priego, Teresa; Palou, Mariona; Bekkenkamp-Grovenstein, Melissa; Faustmann, Gernot; Obermayer-Pietsch, Barbara; Tiran, Beate; Roob, Johannes M.; Winklhofer-Roob, Brigitte; Keijer, Jaap; Palou, Andreu; Pico, Catalina			Identification of blood cell transcriptome-based biomarkers in adulthood predictive of increased risk to develop metabolic disorders using early life intervention rat models	FASEB JOURNAL			English	Article						gestational calorie restriction; metabolic health; metabolic programing; NPC1; PBMCs; predictive biomarkers	MODERATE CALORIC RESTRICTION; A(2) GROUP IIA; MONONUCLEAR-CELLS; ADIPOSE-TISSUE; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; SYMPATHETIC DRIVE; PREVENTS OBESITY; FOOD PREFERENCES; MICROARRAY DATA	Calorie restriction during gestation in rats has long-lasting adverse effects in the offspring. It induces metabolic syndrome-related alterations, which are partially reversed by leptin supplementation during lactation. We employed these conditions to identify transcript-based nutrient sensitive biomarkers in peripheral blood mononuclear cells (PBMCs) predictive of later adverse metabolic health. The best candidate was validated in humans. Transcriptome analysis of PBMCs from adult male Wistar rats of three experimental groups was performed: offspring of control dams (CON), and offspring of 20% calorie-restricted dams during gestation without (CR) and with leptin supplementation throughout lactation (CR-LEP). The expression of 401 genes was affected by gestational calorie restriction and reversed by leptin. The changes preceded metabolic syndrome-related phenotypic alterations. Of these genes, Npc1 mRNA levels were lower in CR vs CON, and normalized to CON in CR-LEP. In humans, NPC1 mRNA levels in peripheral blood cells (PBCs) were decreased in subjects with mildly impaired metabolic health compared to healthy subjects. Therefore, a set of potential transcript-based biomarkers indicative of a predisposition to metabolic syndrome-related alterations were identified, including NPC1, which was validated in humans. Low NPC1 transcript levels in PBCs are a candidate biomarker of increased risk for impaired metabolic health in humans.	[Szostaczuk, Nara; Sanchez, Juana; Priego, Teresa; Palou, Mariona; Palou, Andreu; Pico, Catalina] Univ Balearic Isl, CIBER Fisiopatol Obesidad & Nut CIBERobn, Grp Nutrigen & Obes, Lab Mol Biol Nutr & Biotechnol, Palma De Mallorca, Spain; [van Schothorst, Evert M.; Bekkenkamp-Grovenstein, Melissa; Keijer, Jaap] Wageningen Univ, Human & Anim Physiol, Wageningen, Netherlands; [Sanchez, Juana; Palou, Mariona; Palou, Andreu; Pico, Catalina] Inst Invest Sanit Illes Balears IdISBa, Palma De Mallorca, Spain; [Faustmann, Gernot; Winklhofer-Roob, Brigitte] Karl Franzens Univ Graz, Human Nutr & Metab Res & Training Ctr, Inst Mol Biosci, Graz, Austria; [Faustmann, Gernot; Roob, Johannes M.] Med Univ Graz, Dept Internal Med, Clin Div Nephrol, Graz, Austria; [Obermayer-Pietsch, Barbara] Med Univ Graz, Dept Internal Med, Div Endocrinol, Graz, Austria; [Tiran, Beate] Med Univ Graz, Clin Inst Med & Clin Lab Diagnost, Graz, Austria	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universitat de les Illes Balears; Wageningen University & Research; Institut Investigacio Sanitaria Illes Balears (IdISBa); University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz	Palou, A (corresponding author), Univ Balearic Isl, Lab Mol Biol Nutr & Biotechnol Nutrigen, Cra Valldemossa Km 7-5, Palma De Mallorca 07122, Balearic Island, Spain.	andreu.palou@uib.es	Palou, Mariona/S-2098-2018; Palou, Andreu/K-9881-2014; Sanchez, Juana/K-9675-2014; Pico, Catalina/H-7115-2015	Palou, Mariona/0000-0001-9918-3764; Palou, Andreu/0000-0002-0295-4452; Sanchez, Juana/0000-0002-9176-8060; Pico, Catalina/0000-0001-6759-5844	EC \ Seventh Framework Programme (FP7) [244995]; Ministerio de Economia y Competitividad (MINECO) [AGL2015-67019-P]; Ministerio de Ciencia, innovacion y universidades [PGC2018-097436-B-I00]; Federal Ministry of Science, Research and Economy of Austria [BMWF651.483/0001-II/2/2010, BMWF-651.484/0001-II/2/2010]	EC \ Seventh Framework Programme (FP7); Ministerio de Economia y Competitividad (MINECO); Ministerio de Ciencia, innovacion y universidades; Federal Ministry of Science, Research and Economy of Austria	EC vertical bar Seventh Framework Programme (FP7), Grant/Award Number: 244995; Ministerio de Economia y Competitividad (MINECO), Grant/Award Number: AGL2015-67019-P; Ministerio de Ciencia, innovacion y universidades, Grant/Award Number: PGC2018-097436-B-I00; Federal Ministry of Science, Research and Economy of Austria, Grant/Award Number: BMWF651.483/0001-II/2/2010 and BMWF-651.484/0001-II/2/2010	Afman L, 2014, MOL NUTR FOOD RES, V58, P1708, DOI 10.1002/mnfr.201300559; Al-Daghri NM, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-140; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; [Anonymous], 2019, DIABETES CARE, V42, pS1, DOI [10.2337/dc19-Sint01, 10.2337/dc19-SINT01]; Augustin R, 2004, J BIOL CHEM, V279, P16229, DOI 10.1074/jbc.M312226200; Caimari A, 2010, INT J OBESITY, V34, P831, DOI 10.1038/ijo.2010.17; Carobbio S, 2013, DIABETES, V62, P3697, DOI 10.2337/db12-1748; Casabiell X, 1997, J CLIN ENDOCR METAB, V82, P4270, DOI 10.1210/jc.82.12.4270; de Mello VDF, 2012, MOL NUTR FOOD RES, V56, P1160, DOI 10.1002/mnfr.201100685; DeBosch BJ, 2014, J BIOL CHEM, V289, P10989, DOI 10.1074/jbc.M113.527002; DeBosch BJ, 2012, ENDOCRINOLOGY, V153, P4181, DOI 10.1210/en.2012-1541; Denarie N, 2000, ATHEROSCLEROSIS, V148, P297, DOI 10.1016/S0021-9150(99)00276-2; Desai M, 2007, AM J PHYSIOL-REG I, V293, pR2306, DOI 10.1152/ajpregu.00783.2006; Diaz-Rua R, 2015, J NUTR BIOCHEM, V26, P398, DOI 10.1016/j.jnutbio.2014.11.013; Engelking LJ, 2004, J CLIN INVEST, V113, P1168, DOI 10.1172/JCI200420978; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Faustmann G, 2016, BIOFACTORS, V42, P376, DOI 10.1002/biof.1281; Fletcher R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095598; Garcia AP, 2010, DIABETES OBES METAB, V12, P403, DOI 10.1111/j.1463-1326.2009.01174.x; Gertow K, 2004, DIABETOLOGIA, V47, P1118, DOI 10.1007/s00125-004-1417-4; Gluckman PD, 2005, MATERN CHILD NUTR, V1, P130, DOI 10.1111/j.1740-8709.2005.00020.x; Gorovits N, 2003, ENDOCRINOLOGY, V144, P1703, DOI 10.1210/en.2002-220968; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Hartford M, 2006, INT J CARDIOL, V108, P55, DOI 10.1016/j.ijcard.2005.04.004; Ikenasio-Thorpe BA, 2007, J ENDOCRINOL, V193, P31, DOI 10.1677/joe.1.07017; Iyer A, 2012, DIABETES, V61, P2320, DOI 10.2337/db11-1179; Jelinek D, 2011, HUM MOL GENET, V20, P312, DOI 10.1093/hmg/ddq466; Keijer J, 2010, MOL NUTR FOOD RES, V54, P240, DOI 10.1002/mnfr.200900304; KELLER H, 1993, P NATL ACAD SCI USA, V90, P2160, DOI 10.1073/pnas.90.6.2160; Kiani A, 2011, INT J ENDOCRINOL MET, V9, P409, DOI 10.5812/Kowsar.1726913X.3366; Konieczna J, 2015, INT J OBESITY, V39, P959, DOI 10.1038/ijo.2015.22; Konieczna J, 2014, GENES NUTR, V9, DOI 10.1007/s12263-013-0366-2; Konieczna J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081906; Kugiyama K, 1999, CIRCULATION, V100, P1280, DOI 10.1161/01.CIR.100.12.1280; Lamant M, 2006, J BIOL CHEM, V281, P36289, DOI 10.1074/jbc.M510861200; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Liu RX, 2017, DIABETES, V66, P935, DOI 10.2337/db16-0877; Mariman ECM, 2015, PHYSIOL GENOMICS, V47, P225, DOI 10.1152/physiolgenomics.00006.2015; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Musaad S, 2007, EPIDEMIOL REV, V29, P98, DOI 10.1093/epirev/mxm005; Oliver P, 2013, PFLUG ARCH EUR J PHY, V465, P459, DOI 10.1007/s00424-013-1246-8; Palou A, 2009, APPETITE, V52, P249, DOI 10.1016/j.appet.2008.09.013; Palou M, 2011, BRIT J NUTR, V106, P769, DOI 10.1017/S0007114511000973; Palou M, 2018, NUTR REV, V76, P875, DOI 10.1093/nutrit/nuy046; Palou M, 2012, J NUTR BIOCHEM, V23, P1627, DOI 10.1016/j.jnutbio.2011.11.005; Palou M, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-69; Palou M, 2010, ENDOCRINOLOGY, V151, P1030, DOI 10.1210/en.2009-0934; Patel KM, 2015, CIRC RES, V116, P789, DOI 10.1161/CIRCRESAHA.116.305811; Garcia AP, 2013, PEPTIDES, V39, P59, DOI 10.1016/j.peptides.2012.11.005; Garcia AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017313; Pavlovic Z, 2013, INT J MOL SCI, V14, P2529, DOI 10.3390/ijms14022529; Pellis L, 2003, PHYSIOL GENOMICS, V16, P99, DOI 10.1152/physiolgenomics.00111.2003; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Philip-Couderc P, 2003, HYPERTENSION, V41, P414, DOI 10.1161/01.HYP.0000057573.32425.95; Pico C, 2007, INT J OBESITY, V31, P1199, DOI 10.1038/sj.ijo.0803585; Pico C, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00436; Roder K, 2007, FEBS LETT, V581, P2715, DOI 10.1016/j.febslet.2007.05.022; Ruiz A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00476; Sanchez J, 2017, INT J OBESITY, V41, P1481, DOI 10.1038/ijo.2017.132; Sanchez J, 2008, ENDOCRINOLOGY, V149, P733, DOI 10.1210/en.2007-0630; Sanchez J, 2012, J CLIN ENDOCR METAB, V97, pE648, DOI 10.1210/jc.2011-2209; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Smith EM, 2010, J LIPID RES, V51, P701, DOI 10.1194/jlr.M001404; Stark K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001948; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Szostaczuk N, 2017, INT J OBESITY, V41, P360, DOI 10.1038/ijo.2016.241; Szostaczuk N, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00256; Turkieh A, 2014, J CLIN INVEST, V124, P2277, DOI 10.1172/JCI74668; van Schothorst EM, 2007, ANAL BIOCHEM, V363, P315, DOI 10.1016/j.ab.2007.01.016; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Xing SC, 2015, CELL BIOCHEM BIOPHYS, V71, P1335, DOI 10.1007/s12013-014-0353-2; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	74	6	6	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9003	9017		10.1096/fj.202000071RR	http://dx.doi.org/10.1096/fj.202000071RR		MAY 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32474969				2022-12-26	WOS:000538127700001
J	Dent, AT; Wilks, A				Dent, Alecia T.; Wilks, Angela			Contributions of the heme coordinating ligands of thePseudomonas aeruginosaouter membrane receptor HasR to extracellular heme sensing and transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heme coordination; heme assimilation system (Has); cell surface signaling; transcriptional activation; heme uptake; HasR; iron uptake; Pseudomonasheme utilization (Phu); extracytoplasmic function (ECF); outer membrane; heme; bacterial signal transduction; bacterial transcription; cell surface receptor; heme assimilation system	PSEUDOMONAS-AERUGINOSA; OUTER-MEMBRANE; SERRATIA-MARCESCENS; IRON TRANSPORT; ACQUISITION; OXYGENASE; SYSTEM; PHUR	Pseudomonas aeruginosaexhibits a high requirement for iron, which it can acquire via several mechanisms, including the acquisition and utilization of heme. TheP. aeruginosagenome encodes two heme uptake systems, the heme assimilation system (Has) and thePseudomonasheme utilization (Phu) system. Extracellular heme is sensed via the Has system, which encodes an extracytoplasmic function (ECF) ? factor system. Previous studies have shown that the transfer of heme from the extracellular hemophore HasAp to the outer membrane receptor HasR is required for activation of the ? factor HasI and upregulation ofhasoperon expression. Here, employing site-directed mutagenesis, allelic exchange, quantitative PCR analyses, immunoblotting, and(13)C-heme uptake experiments, we delineated the differential contributions of the extracellular FRAP/PNPNL loop residue His-624 in HasR and of His-221 in its N-terminal plug domain required for heme capture to heme transport and signaling, respectively. Specifically, we show that substitution of the N-terminal plug His-221 disrupts both signaling and transport, leading to dysregulation of both the Has and Phu uptake systems. Our results are consistent with a model wherein heme release from HasAp to the N-terminal plug of HasR is required to initiate signaling, whereas His-624 is required for simultaneously closing off the heme transport channel from the extracellular medium and triggering heme transport. Our results provide critical insight into heme release, signaling, and transport inP. aeruginosaand suggest a functional link between the ECF ? factor and Phu heme uptake system.	[Dent, Alecia T.; Wilks, Angela] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Wilks, A (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA.	awilks@rx.umaryland.edu		Dent, Alecia/0000-0002-6376-7482	National Institutes of Health [R01 AI134886]; National Institutes of Health Ruth L. Kirschstein (NRSA) Individual Predoctoral Fellowship [GM126860]; Chemistry/Biology Interface Training Program [NIGMS/NIH T32GM066706]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Ruth L. Kirschstein (NRSA) Individual Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chemistry/Biology Interface Training Program	This work was supported by National Institutes of Health grant R01 AI134886 (to A. W.). A. T. D. was funded by National Institutes of Health Ruth L. Kirschstein (NRSA) Individual Predoctoral Fellowship GM126860. A. T. D. also acknowledges previous support from a Chemistry/Biology Interface Training Program (NIGMS/NIH T32GM066706). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], 2020, PYMOL MOL GRAPH SYST; Biville F, 2004, MOL MICROBIOL, V53, P1267, DOI 10.1111/j.1365-2958.2004.04207.x; Caillet-Saguy C, 2012, J BIOL CHEM, V287, P26932, DOI 10.1074/jbc.M112.366385; Contreras H, 2014, CURR OPIN CHEM BIOL, V19, P34, DOI 10.1016/j.cbpa.2013.12.014; Dent AT, 2019, J BIOL CHEM, V294, P2771, DOI 10.1074/jbc.RA118.006185; Fuhrhop J-H., 1975, LAB METHODS PORPHYRI; Ganz T, 2009, CURR OPIN IMMUNOL, V21, P63, DOI 10.1016/j.coi.2009.01.011; Ghigo JM, 1997, J BACTERIOL, V179, P3572, DOI 10.1128/jb.179.11.3572-3579.1997; HEINRICHS DE, 1991, INFECT IMMUN, V59, P3680, DOI 10.1128/IAI.59.10.3680-3684.1991; Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Huang WL, 2017, ANNU REV BIOCHEM, V86, P799, DOI 10.1146/annurev-biochem-060815-014214; Hunter RC, 2013, MBIO, V4, DOI 10.1128/mBio.00557-13; Krieg S, 2009, P NATL ACAD SCI USA, V106, P1045, DOI 10.1073/pnas.0809406106; Llamas MA, 2008, MOL MICROBIOL, V67, P458; Llamas MA, 2014, FEMS MICROBIOL REV, V38, P569, DOI 10.1111/1574-6976.12078; Mascher T, 2013, CURR OPIN MICROBIOL, V16, P148, DOI 10.1016/j.mib.2013.02.001; Mourino S, 2016, J BIOL CHEM, V291, P20503, DOI 10.1074/jbc.M116.728527; Nguyen AT, 2014, J BACTERIOL, V196, P2265, DOI 10.1128/JB.01491-14; O'Neill MJ, 2013, ACS CHEM BIOL, V8, P1794, DOI 10.1021/cb400165b; Ochsner UA, 2000, MICROBIOL-UK, V146, P185, DOI 10.1099/00221287-146-1-185; Potvin E, 2008, FEMS MICROBIOL REV, V32, P38, DOI 10.1111/j.1574-6976.2007.00092.x; Ratliff M, 2001, J BACTERIOL, V183, P6394, DOI 10.1128/JB.183.21.6394-6403.2001; RIVERA M, 1995, ANAL BIOCHEM, V230, P295, DOI 10.1006/abio.1995.1477; Royt P W, 1990, Biol Met, V3, P28, DOI 10.1007/BF01141174; Sheldon JR, 2015, FEMS MICROBIOL REV, V39, P592, DOI 10.1093/femsre/fuv009; Smith AD, 2015, BIOCHEMISTRY-US, V54, P2601, DOI 10.1021/acs.biochem.5b00017; Smith AD, 2015, J BIOL CHEM, V290, P7756, DOI 10.1074/jbc.M114.633495; TEALE FWJ, 1959, BIOCHIM BIOPHYS ACTA, V35, P543, DOI 10.1016/0006-3002(59)90407-X; Vanderpool CK, 2003, J BACTERIOL, V185, P909, DOI 10.1128/JB.185.3.909-917.2003	30	9	9	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2020	295	30					10456	10467		10.1074/jbc.RA120.014081	http://dx.doi.org/10.1074/jbc.RA120.014081			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MW0BV	32522817	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000556713400027
J	Brogna, R; Oldenhof, H; Sieme, H; Figueiredo, C; Kerrinnes, T; Wolkers, WF				Brogna, Raffaele; Oldenhof, Harriette; Sieme, Harald; Figueiredo, Constana; Kerrinnes, Tobias; Wolkers, Willem F.			Increasing storage stability of freeze-dried plasma using trehalose	PLOS ONE			English	Article							STABILIZATION; PROTEINS; FORMULATION; ANTIBODY; SUCROSE; SUGARS; CELLS; STATE	Preservation of blood plasma in the dried state would facilitate long-term storage and transport at ambient temperatures, without the need of to use liquid nitrogen tanks or freezers. The aim of this study was to investigate the feasibility of dry preservation of human plasma, using sugars as lyoprotectants, and evaluate macromolecular stability of plasma components during storage. Blood plasma from healthy donors was freeze dried using 0-10% glucose, sucrose, or trehalose, and stored at various temperatures. Differential scanning calorimetry was used to measure the glass transition temperatures of freeze-dried samples. Protein aggregation, the overall protein secondary structure, and oxidative damage were studied under different storage conditions. Differential scanning calorimetry measurements showed that plasma freeze-dried with glucose, sucrose and trehalose have glass transition temperatures of respectively 72 +/- 3.4 degrees C, 46 +/- 11 degrees C, 15 +/- 2.4 degrees C. It was found that sugars diminish freeze-drying induced protein aggregation in a dose-dependent manner, and that a 10% (w/v) sugar concentration almost entirely prevents protein aggregation. Protein aggregation after rehydration coincided with relatively high contents of beta-sheet structures in the dried state. Trehalose reduced the rate of protein aggregation during storage at elevated temperatures, and plasma that is freeze- dried plasma with trehalose showed a reduced accumulation of reactive oxygen species and protein oxidation products during storage. In conclusion, freeze-drying plasma with trehalose provides an attractive alternative to traditional cryogenic preservation.	[Brogna, Raffaele; Oldenhof, Harriette; Sieme, Harald; Wolkers, Willem F.] Univ Vet Med Hannover, Unit Reprod Med, Clin Horses, Hannover, Germany; [Brogna, Raffaele; Wolkers, Willem F.] Univ Vet Med Hannover, Biostabilizat Lab, Lower Saxony Ctr Biomed Engn Implant Res & Dev, Hannover, Germany; [Figueiredo, Constana] Hannover Med Sch, Inst Transfus Med, Hannover, Germany; [Kerrinnes, Tobias] Helmholtz Ctr Infect Res, Braunschweig, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research	Wolkers, WF (corresponding author), Univ Vet Med Hannover, Unit Reprod Med, Clin Horses, Hannover, Germany.; Wolkers, WF (corresponding author), Univ Vet Med Hannover, Biostabilizat Lab, Lower Saxony Ctr Biomed Engn Implant Res & Dev, Hannover, Germany.	willem.wolkers@tiho-hannover.de	Wolkers, Wim/AAT-1110-2021	Wolkers, Willem/0000-0002-7406-4651	German Center for Infection Research (DZIF); Maschmeyer Group; German Research Foundation (DFG) REBIRTH-excellence cluster; Deutsche Forschungsgemeinschaft; University of Veterinary Medicine Hannover	German Center for Infection Research (DZIF); Maschmeyer Group; German Research Foundation (DFG) REBIRTH-excellence cluster(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Veterinary Medicine Hannover	The work described in this study was financially supported via funds provided by the German Center for Infection Research (DZIF) and the Maschmeyer Group. The Maschmeyer group is a commercial funder. This does not alter our adherence to PLOS ONE policies on sharing data and materials. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The initial phase of this work was performed at the Institute of Multiphase Processes at the Leibniz University Hannover, funded via the German Research Foundation (DFG) REBIRTH-excellence cluster. This publication was supported by the Deutsche Forschungsgemeinschaft and the University of Veterinary Medicine Hannover, Foundation within the funding programme Open Access Publishing.	Bakaltcheva I, 2007, THROMB RES, V120, P105, DOI 10.1016/j.thromres.2006.07.005; Bonnier F, 2012, ANALYST, V137, P322, DOI 10.1039/c1an15821j; Buckley L, 2019, TRANSFUSION, V59, P837, DOI 10.1111/trf.14985; Burnouf T., 2018, ANN BLOOD, V3, P33, DOI [DOI 10.21037/AOB.2018.05.03, 10.21037/aob.2018.05.03]; CARPENTER JF, 1987, CRYOBIOLOGY, V24, P455, DOI 10.1016/0011-2240(87)90049-6; Crowe JH, 2005, INTEGR COMP BIOL, V45, P810, DOI 10.1093/icb/45.5.810; CROWE JH, 1990, CRYOBIOLOGY, V27, P219, DOI 10.1016/0011-2240(90)90023-W; Dufresne J, 2017, CLIN PROTEOM, V14, DOI 10.1186/s12014-017-9170-0; Garbett NC, 2015, METHODS, V76, P41, DOI 10.1016/j.ymeth.2014.10.030; Hawe A, 2009, EUR J PHARM SCI, V38, P79, DOI 10.1016/j.ejps.2009.06.001; Heljo VP, 2013, EUR J PHARM BIOPHARM, V85, P752, DOI 10.1016/j.ejpb.2013.03.033; Horn J, 2019, EUR J PHARM BIOPHARM, V134, P185, DOI 10.1016/j.ejpb.2018.12.001; Kaushik JK, 2003, J BIOL CHEM, V278, P26458, DOI 10.1074/jbc.M300815200; Kitamura Y, 2017, NEUROL RES, V39, P231, DOI 10.1080/01616412.2017.1281195; Kudo C, 2012, J DENT RES, V91, P1190, DOI 10.1177/0022034512461796; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Loi P, 2013, TRENDS BIOTECHNOL, V31, P688, DOI 10.1016/j.tibtech.2013.09.004; Luo Y, 2008, ENVIRON EXP BOT, V63, P378, DOI 10.1016/j.envexpbot.2007.11.016; Mensink MA, 2017, EUR J PHARM BIOPHARM, V114, P288, DOI 10.1016/j.ejpb.2017.01.024; Murthy UMN, 2000, J EXP BOT, V51, P1221, DOI 10.1093/jexbot/51.348.1221; O'Neill MK, 2017, PURE APPL CHEM, V89, P1223, DOI 10.1515/pac-2016-1025; Ohtake S, 2011, J PHARM SCI-US, V100, P2020, DOI 10.1002/jps.22458; Ozgyin Lilla, 2018, Oncotarget, V9, P31312, DOI 10.18632/oncotarget.25764; Page C, 2000, J PHARM PHARMACOL, V52, P19, DOI 10.1211/0022357001773643; Pinto J, 2014, ANALYST, V139, P1168, DOI 10.1039/c3an02188b; Poe A, 2018, J VIROL METHODS, V253, P53, DOI 10.1016/j.jviromet.2017.12.004; Potter DR, 2015, J TRAUMA ACUTE CARE, V78, pS7, DOI 10.1097/TA.0000000000000630; Pusateri AE, 2016, TRANSFUSION, V56, pS128, DOI 10.1111/trf.13580; Qualman SJ, 2004, BRIT J CANCER, V90, P1115, DOI 10.1038/sj.bjc.6601678; Randolph T, 2004, FREEZE DRYING LYOPHI, P167, DOI [10.1201/9780203021323.ch5, DOI 10.1201/9780203021323.CH5]; Shabihkhani M, 2014, CLIN BIOCHEM, V47, P258, DOI 10.1016/j.clinbiochem.2014.01.002; Simperler A, 2006, J PHYS CHEM B, V110, P19678, DOI 10.1021/jp063134t; Steil L, 2008, TRANSFUSION, V48, P2356, DOI 10.1111/j.1537-2995.2008.01856.x; Sydykov B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199867; TAKAHASHI R, 1995, PATHOL RES PRACT, V191, P420, DOI 10.1016/S0344-0338(11)80729-6; Vaughan H, 2006, J CLIN VIROL, V35, P135, DOI 10.1016/j.jcv.2005.06.001; Watanabe M, 2006, APPL ENTOMOL ZOOL, V41, P15, DOI 10.1303/aez.2006.15; Weber D, 2015, REDOX BIOL, V5, P367, DOI 10.1016/j.redox.2015.06.005; Weng LD, 2019, ANNU REV BIOMED ENG, V21, P1, DOI 10.1146/annurev-bioeng-060418-052130; Wolkers W. F., 2003, CELL PRESERV TECHNOL, V1, P175, DOI DOI 10.1089/153834402765035617; Xu YJ, 2002, CLIN CHIM ACTA, V325, P127, DOI 10.1016/S0009-8981(02)00277-2; Zhang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06542-z; Zur M, 2019, TRANSFUSION, V59, P3485, DOI 10.1111/trf.15533	43	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234502	10.1371/journal.pone.0234502	http://dx.doi.org/10.1371/journal.pone.0234502			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525915	Green Published, gold			2022-12-26	WOS:000542036800071
J	Nili, H; Walther, A; Alink, A; Kriegeskorte, N				Nili, Hamed; Walther, Alexander; Alink, Arjen; Kriegeskorte, Nikolaus			Inferring exemplar discriminability in brain representations	PLOS ONE			English	Article							OBJECT REPRESENTATIONS; RESPONSE PATTERNS; INFORMATION; CATEGORY; FACES; POPULATION; IDENTITY; CORTEX	Representational distinctions within categories are important in all perceptual modalities and also in cognitive and motor representations. Recent pattern-information studies of brain activity have used condition-rich designs to sample the stimulus space more densely. To test whether brain response patterns discriminate among a set of stimuli (e.g. exemplars within a category) with good sensitivity, we can pool statistical evidence over all pairwise comparisons. Here we describe a wide range of statistical tests of exemplar discriminability and assess the validity (specificity) and power (sensitivity) of each test. The tests include previously used and novel, parametric and nonparametric tests, which treat subject as a random or fixed effect, and are based on different dissimilarity measures, different test statistics, and different inference procedures. We use simulated and real data to determine which tests are valid and which are most sensitive. A popular test statistic reflecting exemplar information is theexemplar discriminability index (EDI), which is defined as the average of the pattern dissimilarity estimates between different exemplars minus the average of the pattern dissimilarity estimates between repetitions of identical exemplars. The popular across-subjectttest of the EDI (typically using correlation distance as the pattern dissimilarity measure) requires the assumption that the EDI is 0-mean normal under H-0. Although this assumption is not strictly true, our simulations suggest that the test controls the false-positives rate at the nominal level, and is thus valid, in practice. However, test statistics based on average Mahalanobis distances or average linear-discriminanttvalues (both accounting for the multivariate error covariance among responses) are substantially more powerful for both random- and fixed-effects inference. Unlike average cross-validated distances, the EDI is sensitive to differences between the distributions associated with different exemplars (e.g. greater variability for some exemplars than for others), which complicates its interpretation. We suggest preferred procedures for safely and sensitively detecting subtle pattern differences between exemplars.	[Nili, Hamed] Univ Oxford, Wellcome Ctr Integrat Neuroimaging, Oxford, England; [Walther, Alexander] MRC Cognit & Brain Sci Unit, Cambridge, England; [Alink, Arjen] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany; [Kriegeskorte, Nikolaus] Columbia Univ, Zuckerman Inst, New York, NY USA	University of Oxford; University of Hamburg; University Medical Center Hamburg-Eppendorf; Columbia University	Nili, H (corresponding author), Univ Oxford, Wellcome Ctr Integrat Neuroimaging, Oxford, England.	nili.hamed@gmail.com		Nili, Hamed/0000-0002-6629-7957; Kriegeskorte, Nikolaus/0000-0001-7433-9005	UK Medical Research Council; European Research Council [261352]; Wellcome Trust [WT091540MA]; Cambridge Overseas Trust scholarship; Gates Cambridge Scholarship; British Academy postdoctoral fellowship	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Cambridge Overseas Trust scholarship; Gates Cambridge Scholarship; British Academy postdoctoral fellowship	This work was supported by the UK Medical Research Council and by a European Research Council Starting Grant (261352) and Wellcome Trust Project Grant (WT091540MA) to NK, a Cambridge Overseas Trust scholarship to HN, a Gates Cambridge Scholarship to AW and a British Academy postdoctoral fellowship to AA.	Alink A., 2015, 032391 BIORXIV; Allefeld C, 2016, NEUROIMAGE, V141, P378, DOI 10.1016/j.neuroimage.2016.07.040; [Anonymous], 2013, CLIN TRANSL GASTROEN, V4, pe39; Anzellotti S., 2013, CEREB CORTEX; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chan AWY, 2010, NAT NEUROSCI, V13, P417, DOI 10.1038/nn.2502; Cichy RM, 2014, NAT NEUROSCI, V17, P455, DOI 10.1038/nn.3635; DIXON WJ, 1946, J AM STAT ASSOC, V41, P557, DOI 10.2307/2280577; Efron B., 1994, INTRO BOOTSTRAP; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Hebart MN, 2018, NEUROIMAGE, V180, P4, DOI 10.1016/j.neuroimage.2017.08.005; Henriksson L., 2014, 008961 BIORXIV; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; Jozwik KM, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01726; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Khaligh-Razavi SM, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003915; Kiani R, 2007, J NEUROPHYSIOL, V97, P4296, DOI 10.1152/jn.00024.2007; Kravitz DJ, 2010, CEREB CORTEX, V20, P2916, DOI 10.1093/cercor/bhq042; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Kriegeskorte N, 2012, COMPUT NEUROSCI-MIT, P1; Kriegeskorte N, 2007, P NATL ACAD SCI USA, V104, P20600, DOI 10.1073/pnas.0705654104; Kriegeskorte N, 2013, TRENDS COGN SCI, V17, P401, DOI 10.1016/j.tics.2013.06.007; Kriegeskorte N, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.004.2008; Kriegeskorte N, 2008, NEURON, V60, P1126, DOI 10.1016/j.neuron.2008.10.043; Ledoit O., 2003, J EMPIR FINANCE, V10, P603, DOI [10.1016/S0927-5398(03)00007-0, DOI 10.1016/S0927-5398(03)00007-0]; Lee SH, 2012, NEUROIMAGE, V59, P4064, DOI 10.1016/j.neuroimage.2011.10.055; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Liu N, 2013, J NEUROSCI, V33, P11346, DOI 10.1523/JNEUROSCI.4180-12.2013; Luyckx F, 2019, ELIFE, V8, DOI 10.7554/eLife.42816; Misaki M, 2010, NEUROIMAGE, V53, P103, DOI 10.1016/j.neuroimage.2010.05.051; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Mumford JA, 2014, NEUROIMAGE, V103, P130, DOI 10.1016/j.neuroimage.2014.09.026; Mur M, 2009, SOC COGN AFFECT NEUR, V4, P101, DOI 10.1093/scan/nsn044; Nestor A, 2011, P NATL ACAD SCI USA, V108, P9998, DOI 10.1073/pnas.1102433108; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nili H, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003553; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Sayres R, 2008, J NEUROPHYSIOL, V100, P249, DOI 10.1152/jn.01383.2007; Schwarzlose RF, 2008, P NATL ACAD SCI USA, V105, P4447, DOI 10.1073/pnas.0800431105; Spitzer B, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-017-0145; Walther A, 2016, NEUROIMAGE, V137, P188, DOI 10.1016/j.neuroimage.2015.12.012; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269	45	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2020	15	6							e0232551	10.1371/journal.pone.0232551	http://dx.doi.org/10.1371/journal.pone.0232551			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC0EC	32520962	Green Submitted, Green Published, gold			2022-12-26	WOS:000542969500024
J	Qu, Z; Dong, WQ; Chen, Y; Dong, G; Zhu, SY; Yu, Y; Bian, DJ				Qu, Zhan; Dong, Wenqing; Chen, Yu; Dong, Ge; Zhu, Suiyi; Yu, Yang; Bian, Dejun			Upcycling of groundwater treatment sludge to magnetic Fe/Mn-bearing nanorod for chromate adsorption from wastewater treatment	PLOS ONE			English	Article							HEXAVALENT CHROMIUM; AQUEOUS-SOLUTION; HEAVY-METALS; REMOVAL; ADSORBENT; CR(VI); FERRIHYDRITE; DISSOLUTION; GOETHITE; HEMATITE	Groundwater treatment sludge is a Fe/Mn-bearing waste that is mass produced in groundwater treatment plant. In this study, sludge was converted to a magnetic adsorbent (MA) by adding ascorbate. The sludge was weakly magnetised in the amorphous form with Fe and Mn contents of 28.8% and 8.1%, respectively. After hydrothermal treatment, Fe/Mn oxides in the sludge was recrystallised to siderite and rhodochrosite, with jacobsite as the intermediate in the presence of ascorbate. With an increment in ascorbate dosage, the obtained magnetic adsorbent had a significant increase in chromate adsorption but a decrease in magnetisation. When the M-ascorbate/M(Fe)molar ratio was 10, the produced MA-10 was a dumbbell-shaped nanorod with a length of 2-5 mu m and a diameter of 0.5-1 mu m. This MA-10 showed 183.2 mg/g of chromate adsorption capacity and 2.81 emu/g of magnetisation. The mechanism of chromate adsorption was surface coprecipitation of the generated Cr(3+)and Fe3+/Mn(4+)from redox reaction between chromate and siderite/rhodochrosite on MA-10, separately. This study demonstrated an efficient recycling route of waste sludge from groundwater treatment to produce MA for treating chromate-bearing wastewater.	[Qu, Zhan; Dong, Wenqing; Dong, Ge; Zhu, Suiyi; Bian, Dejun] Northeast Normal Univ, Sch Environm, Changchun, Peoples R China; [Chen, Yu] Jilin Inst Forestry Survey & Design, Changchun, Peoples R China; [Yu, Yang] Longdong Univ, Sch Chem Sci & Engn, Qingyang, Peoples R China	Northeast Normal University - China; Longdong University	Zhu, SY (corresponding author), Northeast Normal Univ, Sch Environm, Changchun, Peoples R China.	papermanuscript@126.com	Zhu, Suiyi/AAD-7613-2021	Suiyi, Zhu/0000-0002-9784-2698	National Natural Science Foundation of China [51578118, 51678273, 51878134, 51878133]; Fundamental Research Funds for the Central Universities [2412017QD021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was partially funded by the National Natural Science Foundation of China (Grant Nos. 51578118, 51678273, 51878134, and 51878133), the Fundamental Research Funds for the Central Universities (Grant No. 2412017QD021).	Ahmed MA, 2013, MATER SCI ENG B-ADV, V178, P744, DOI 10.1016/j.mseb.2013.03.011; Alizadeh A, 2017, RSC ADV, V7, P14876, DOI 10.1039/c7ra01536d; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Aslibeiki B, 2016, J MAGN MAGN MATER, V399, P236, DOI 10.1016/j.jmmm.2015.09.081; Bajpai VK, 2019, ACS APPL MATER INTER, V11, P43949, DOI 10.1021/acsami.9b16989; Ban T, 1999, INT J INORG MATER, V1, P243, DOI 10.1016/S1466-6049(99)00037-9; Bao JB, 2002, INTEGR FERROELECTR, V45, P31, DOI 10.1080/10584580190043921; Barrera-Diaz CE, 2012, J HAZARD MATER, V223, P1, DOI 10.1016/j.jhazmat.2012.04.054; Bhaumik M, 2011, J HAZARD MATER, V190, P381, DOI 10.1016/j.jhazmat.2011.03.062; Bolobajev J, 2015, CHEM ENG J, V281, P566, DOI 10.1016/j.cej.2015.06.115; Brinza L, 2015, CRYST GROWTH DES, V15, P4768, DOI 10.1021/acs.cgd.5b00173; Cheung KH, 2007, INT BIODETER BIODEGR, V59, P8, DOI 10.1016/j.ibiod.2006.05.002; CORNELL RM, 1987, CLAY CLAY MINER, V35, P21, DOI 10.1346/CCMN.1987.0350103; Cudennec Y, 2006, J SOLID STATE CHEM, V179, P716, DOI 10.1016/j.jssc.2005.11.030; Dong WQ, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9081519; Du YC, 2018, PARTICUOLOGY, V40, P123, DOI 10.1016/j.partic.2017.11.005; Duan SB, 2017, J TAIWAN INST CHEM E, V80, P835, DOI 10.1016/j.jtice.2017.07.002; Hou XJ, 2016, J HAZARD MATER, V310, P170, DOI 10.1016/j.jhazmat.2016.01.020; Hu J, 2005, LANGMUIR, V21, P11173, DOI 10.1021/la051076h; Jaafar AR, 2008, WIT TRANS ECOL ENVIR, V111, P247, DOI 10.2495/WP080241; Kaur N, 2010, CLAY CLAY MINER, V58, P415, DOI 10.1346/CCMN.2010.0580311; Li DL, 2015, ENVIRON TECHNOL, V36, P1084, DOI 10.1080/09593330.2014.975286; Madhumita B., 2011, J HAZARD MATER, V190, P381, DOI DOI 10.1016/J.JHAZMAT.2011.03.062; Mungray AA, 2012, CENT EUR J CHEM, V10, P27, DOI 10.2478/s11532-011-0134-3; Murphy V, 2009, CHEM ENG J, V148, P425, DOI 10.1016/j.cej.2008.09.029; Myung  Y., 2019, ACS SUSTAINABLE CHEM; Ngatenah S.N.I., 2010, CIVIL ENG, V2010, P1; Ong DC, 2017, J ENVIRON CHEM ENG, V5, P5746, DOI 10.1016/j.jece.2017.10.046; Owlad M, 2009, WATER AIR SOIL POLL, V200, P59, DOI 10.1007/s11270-008-9893-7; Paul Wersin, 1989, GEOCHIMICA COSMOCHIM; Pisarev OA, 2018, REACT FUNCT POLYM, V130, P98, DOI 10.1016/j.reactfunctpolym.2018.06.002; Pradhan J, 1999, J COLLOID INTERF SCI, V217, P137, DOI 10.1006/jcis.1999.6288; Qu Z, 2020, J CLEAN PROD, V257, DOI 10.1016/j.jclepro.2020.120462; Qu Z, 2019, ENGINEERING-PRC, V5, P880, DOI 10.1016/j.eng.2019.06.001; Ramesh K, 2008, CATAL TODAY, V131, P477, DOI 10.1016/j.cattod.2007.10.061; Setshedi KZ, 2013, CHEM ENG J, V222, P186, DOI 10.1016/j.cej.2013.02.061; Shukla S, 2019, ACS APPL MATER INTER, V11, P18165, DOI 10.1021/acsami.9b02857; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Tang YZ, 2011, GEOCHIM COSMOCHIM AC, V75, P4951, DOI 10.1016/j.gca.2011.06.024; Tashauoei HR, 2010, INT J ENVIRON RES, V4, P491; Villinski JE, 2001, ENVIRON SCI TECHNOL, V35, P1157, DOI 10.1021/es001356d; Wang SB, 2005, WATER RES, V39, P129, DOI 10.1016/j.watres.2004.09.011; Wei Z, 2010, IND WATER TREATMENT; Wen Y, 2011, CHEM ENG J, V175, P110, DOI 10.1016/j.cej.2011.09.066; Xiao YZ, 2013, MATER RES BULL, V48, P3910, DOI 10.1016/j.materresbull.2013.05.099; Yang YQ, 2018, COLLOID SURFACE A, V556, P201, DOI 10.1016/j.colsurfa.2018.08.035; Zhang Y, 2017, J COLLOID INTERF SCI; ZHAO JM, 1994, CLAY CLAY MINER, V42, P737, DOI 10.1346/CCMN.1994.0420610; Zheng CF, 2018, BIORESOURCE TECHNOL, V267, P1, DOI 10.1016/j.biortech.2018.06.113; Zhu SY, 2020, J CLEAN PROD, V247, DOI 10.1016/j.jclepro.2019.119140; Zhu SY, 2019, J ENVIRON MANAGE, V236, P446, DOI 10.1016/j.jenvman.2019.01.117; Zhu SY, 2018, ENVIRON SCI POLLUT R, V25, P22710, DOI 10.1007/s11356-018-2378-3; Zhu SY, 2015, J HAZARD MATER, V292, P173, DOI 10.1016/j.jhazmat.2015.03.028	53	4	5	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2020	15	6							e0234136	10.1371/journal.pone.0234136	http://dx.doi.org/10.1371/journal.pone.0234136			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC0EC	32520947	Green Published, gold			2022-12-26	WOS:000542969500022
J	Liu, Y; Zhang, YY; Wang, SQ; Li, M; Long, YH; Li, YF; Liu, YK; Li, YH; Wang, YQ; Mi, JS; Yu, CH; Li, DY; Zhang, JH; Zhang, XJ				Liu, Yan; Zhang, Yuan-Yue; Wang, Shu-Qing; Li, Min; Long, Yue-Hong; Li, Yu-Feng; Liu, Yan-Kun; Li, Yu-Hui; Wang, Ya-Qi; Mi, Jiang-Sheng; Yu, Cheng-Hua; Li, De-Yan; Zhang, Jing-Hua; Zhang, Xiao-Jun			WSTF acetylation by MOF promotes WSTF activities and oncogenic functions	ONCOGENE			English	Article							SYNDROME TRANSCRIPTION FACTOR; HISTONE H3; CANCER CELLS; TARGETS; PROTEIN; COMPLEXES	Williams syndrome transcription factor (WSTF) is a transcription factor and tyrosine kinase. WSTF overexpression promotes migration and proliferation of various cancers, and Ser158 (WSTFS158) phosphorylation plays an important role in this process. However, the role of the other posttranslational modifications of WSTF is unknown. Here, we report that lysine (K) 426 on WSTF is acetylated by MOF and deacetylated by SIRT1. Mechanistically, male-specific lethal (MSL) 1v1 interaction with WSTF facilitates its interaction with MOF for WSTF acetylation, which in turn promotes WSTF(S158)phosphorylation. The kinase and transcriptional regulatory activity of WSTF were enhanced by acetylation. WSTF(K426ac)levels positively and significantly correlated with tumor size, histological grade, and age. Moreover, we demonstrated that acetylated WSTF promotes cancer cell proliferation, migration, invasion, and tumor formation. In conclusion, we identified the enzymes regulating WSTF K426 acetylation, and demonstrated an acetylation-dependent mechanism that modulates the activities of WSTF and contributes to tumorigenesis. Our findings provide new clues to study WSTF-mediated normal development and disease.	[Liu, Yan; Zhang, Yuan-Yue; Long, Yue-Hong] North China Univ Sci & Technol, Coll Life Sci, Tangshan, Peoples R China; [Liu, Yan; Zhang, Yuan-Yue; Li, Yu-Feng; Liu, Yan-Kun; Wang, Ya-Qi; Zhang, Jing-Hua] North China Univ Sci & Technol, Affiliated Tangshan Peoples Hosp, Canc Inst, Tangshan, Peoples R China; [Zhang, Yuan-Yue] North China Univ Sci & Technol, Grad Sch, Tangshan, Peoples R China; [Wang, Shu-Qing] Hosp North China Univ Sci & Technol, Tangshan, Peoples R China; [Li, Min] North China Univ Sci & Technol, Affiliated Hosp, Orthopaed Surg, Tangshan, Peoples R China; [Li, Yu-Hui] North China Univ Sci & Technol, Affiliated Tangshan Peoples Hosp, Neurosurg, Tangshan, Peoples R China; [Mi, Jiang-Sheng; Yu, Cheng-Hua; Li, De-Yan; Zhang, Xiao-Jun] Zunhua Peoples Hosp, Zunhua, Peoples R China	North China University of Science & Technology; North China University of Science & Technology; North China University of Science & Technology; North China University of Science & Technology; North China University of Science & Technology	Li, YF; Zhang, JH (corresponding author), North China Univ Sci & Technol, Affiliated Tangshan Peoples Hosp, Canc Inst, Tangshan, Peoples R China.; Zhang, XJ (corresponding author), Zunhua Peoples Hosp, Zunhua, Peoples R China.	yfli_renmin@qq.com; jhzhang_te@163.com; tech_ol@foxmail.com	zhang, jin/GXV-9154-2022; Li, yu/HHZ-5236-2022		National Natural Science Foundation of China [81772834]; Natural Science Foundation of Hebei Province [H2019105034]; Science Fund for Distinguished Young Scholars of North China University of Science and Technology [JQ201704]; Doctoral Research Project of North China University of Science and Technology; Program for Innovation Research Team (in Science and Technology) of Tangshan [17130205D]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province); Science Fund for Distinguished Young Scholars of North China University of Science and Technology; Doctoral Research Project of North China University of Science and Technology; Program for Innovation Research Team (in Science and Technology) of Tangshan	This work was supported by the National Natural Science Foundation of China (grant number 81772834); Natural Science Foundation of Hebei Province (grant number H2019105034); Science Fund for Distinguished Young Scholars of North China University of Science and Technology (JQ201704); Doctoral Research Project of North China University of Science and Technology; the Program for Innovation Research Team (in Science and Technology) of Tangshan (17130205D).	Barnett C, 2011, BIOCHEM CELL BIOL, V89, P12, DOI 10.1139/O10-114; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Guo JP, 2019, NAT CELL BIOL, V21, P226, DOI 10.1038/s41556-018-0261-6; Kahali B, 2014, ONCOGENE, V33, P653, DOI 10.1038/onc.2012.613; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Li XZ, 2009, MOL CELL, V36, P290, DOI 10.1016/j.molcel.2009.07.031; Liu Y, 2019, ONCOGENE, V38, P980, DOI 10.1038/s41388-018-0466-y; Liu Y, 2016, ONCOTARGET, V7, P53153, DOI 10.18632/oncotarget.10625; Liu Y, 2014, FEBS J, V281, P3315, DOI 10.1111/febs.12863; Liu Y, 2013, FEBS LETT, V587, P847, DOI 10.1016/j.febslet.2013.02.023; Liu Y, 2012, J BIOL CHEM, V287, P41469, DOI 10.1074/jbc.M112.367847; Lundqvist J, 2018, J STEROID BIOCHEM, V177, P171, DOI 10.1016/j.jsbmb.2017.06.003; Meng J, 2016, CELL SIGNAL, V28, P1673, DOI 10.1016/j.cellsig.2016.07.008; Pfister S, 2008, INT J CANCER, V122, P1207, DOI 10.1002/ijc.23283; Su JM, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010099; Wan JH, 2016, NUCLEIC ACIDS RES, V44, P10662, DOI 10.1093/nar/gkw808; Wang YQ, 2016, INT J CLIN EXP PATHO, V9, P1668; Xiao A, 2009, NATURE, V457, P57, DOI 10.1038/nature07668; Yang XJ, 2004, NUCLEIC ACIDS RES, V32, P959, DOI 10.1093/nar/gkh252	21	7	7	2	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 2	2020	39	27					5056	5067		10.1038/s41388-020-1350-0	http://dx.doi.org/10.1038/s41388-020-1350-0		JUN 2020	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ME5NL	32518374				2022-12-26	WOS:000539201700001
J	Tomioka, K; Kurumatani, N; Saeki, K				Tomioka, Kimiko; Kurumatani, Norio; Saeki, Keigo			Longitudinal association between lifetime workforce participation and risk of self-reported cognitive decline in community-dwelling older adults	PLOS ONE			English	Article							LEISURE ACTIVITIES; MEMORY COMPLAINTS; HEALTH OUTCOMES; AGE; IMPAIRMENT; MIDLIFE; WORK; TRAJECTORIES; OCCUPATION; DEMENTIA	Background Although many governments are promoting workforce participation (WP) by older people, evidence of WP's effects on active aging is inadequate. We examined whether there is a gender-specific beneficial effect of lifetime WP from adulthood though old age against self-reported cognitive decline (CD) among community-dwelling older adults. Methods We used data from a community-based prospective study of 2,422 men and 2,852 women aged >= 65 with neither poor cognition nor disability in basic activities of daily living at baseline. Self-reported CD was measured using the Cognitive Performance Scale. Lifetime WP evaluated the presence or absence of WP at baseline, the longest-held occupation, and lifetime working years (total working years throughout lifetime). Generalized estimating equations of the multivariable Poisson regression model were applied to evaluate a cumulative incidence ratio (CIR) for self-reported CD and a 95% confidence interval (CI), controlled for age, education, self-perceived economic status, chronic medical conditions, smoking history, physical activity, depression, and instrumental activities of daily living. To examine any gender-specific association, stratified analyses by gender were performed. Results The 33-month cumulative incidence of self-reported CD was 15.7% in men and 14.4% in women. After covariate adjustments and mutual adjustment for three items of lifetime WP, men who had their longest held job in a white-collar occupation reported significantly decreased self-reported CD compared to men engaged in blue-collar jobs (CIR 0.72; 95% CI, 0.57-0.91), and women had a significant dose-response relationship between longer lifetime working years and less decline in subjective cognitive functioning (P for trend <0.029). Among both genders, WP at baseline was not associated with self-reported CD. Conclusions Our results suggest that lifetime WP, especially lifetime principal occupation in men and lifetime working years in women, may play a more prominent role in preventing self-reported CD than later-life WP.	[Tomioka, Kimiko; Kurumatani, Norio; Saeki, Keigo] Nara Med Univ, Nara Prefectural Hlth Res Ctr, Kashihara, Nara, Japan	Nara Medical University	Tomioka, K (corresponding author), Nara Med Univ, Nara Prefectural Hlth Res Ctr, Kashihara, Nara, Japan.	tkimiko@naramed-u.ac.jp	SAEKI, KEIGO/GWU-5723-2022		JSPS KAKENHI [JP17K09209]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Financial support for this study was provided by JSPS KAKENHI Grant Number JP17K09209 to KT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimer's Association, 10 EARL SIGNS SYMPT; Amariglio RE, 2011, J AM GERIATR SOC, V59, P1612, DOI 10.1111/j.1532-5415.2011.03543.x; [Anonymous], 2002, Aging Male, V5, P1; Anton SD, 2015, AGEING RES REV, V24, P304, DOI 10.1016/j.arr.2015.09.005; Baldivia Beatriz, 2008, Dement. neuropsychol., V2, P173, DOI 10.1590/S1980-57642009DN20300003; Baumgart M, 2015, ALZHEIMERS DEMENT, V11, P718, DOI 10.1016/j.jalz.2015.05.016; Bosma H, 2003, EXP AGING RES, V29, P33, DOI 10.1080/03610730303710; Bretsky P, 2003, NEUROLOGY, V60, P1077, DOI 10.1212/01.WNL.0000055875.26908.24; DARTIGUES JF, 1992, AM J EPIDEMIOL, V135, P981, DOI 10.1093/oxfordjournals.aje.a116410; DENNEY NW, 1984, DEV REV, V4, P171, DOI 10.1016/0273-2297(84)90006-6; Di Gessa G, 2017, J EPIDEMIOL COMMUN H, V71, P431, DOI 10.1136/jech-2016-208086; Fei M, 2009, ALZ DIS ASSOC DIS, V23, P130, DOI 10.1097/WAD.0b013e318190a59d; Fujiwara Y, 2016, GERIATR GERONTOL INT, V16, P126, DOI 10.1111/ggi.12441; Gross AL, 2011, J GERONTOL B-PSYCHOL, V66, P557, DOI 10.1093/geronb/gbr033; HARTMAIER SL, 1995, J GERONTOL A-BIOL, V50, pM128, DOI 10.1093/gerona/50A.2.M128; Hoyl MT, 1999, J AM GERIATR SOC, V47, P873, DOI 10.1111/j.1532-5415.1999.tb03848.x; Jokela M, 2010, EPIDEMIOLOGY, V21, P284, DOI 10.1097/EDE.0b013e3181d61f53; Kajitani S, 2011, JPN WORLD ECON, V23, P153, DOI 10.1016/j.japwor.2011.06.001; Kobayashi LC, 2019, J EPIDEMIOL COMMUN H, V73, P232, DOI 10.1136/jech-2018-211153; KOYANO W, 1991, ARCH GERONTOL GERIAT, V13, P103, DOI 10.1016/0167-4943(91)90053-S; Koyano W, 1987, JPN J PUBLIC HLTH, V34, P109; Li YW, 2014, GERONTOLOGIST, V54, P784, DOI 10.1093/geront/gnt106; Maciejewski ML, 2019, JAMA-J AM MED ASSOC, V321, P2124, DOI 10.1001/jama.2019.5646; Mein G, 2003, J EPIDEMIOL COMMUN H, V57, P46, DOI 10.1136/jech.57.1.46; Minami U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144069; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; Muscari A, 2018, EXP GERONTOL, V108, P69, DOI 10.1016/j.exger.2018.03.021; Nishiguchi S, 2013, DEMENT GER COGN D EX, V3, P312, DOI 10.1159/000354962; Opdebeeck C, 2016, AGING NEUROPSYCHOL C, V23, P40, DOI 10.1080/13825585.2015.1041450; Organization for Economic Cooperation and Development, 2006, AG EMPL LIV LONG WOR; Prakash KC, 2016, INT ARCH OCC ENV HEA, V89, P997, DOI 10.1007/s00420-016-1133-7; Qiu CX, 2003, AM J IND MED, V43, P204, DOI 10.1002/ajim.10159; Salthouse TA, 1991, THEORETICAL PERSPECT, P173; Salthouse T, 2012, ANNU REV PSYCHOL, V63, P201, DOI 10.1146/annurev-psych-120710-100328; Statistics Bureau Ministry of Internal Affairs and Communication Japan, LAB FORC SURV; Staudinger UM, 2016, GERONTOLOGIST, V56, pS281, DOI 10.1093/geront/gnw032; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; Stern Y, 2013, FOLIA PHONIATR LOGO, V65, P49, DOI 10.1159/000353443; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Stone J, 2015, J EPIDEMIOL COMMUN H, V69, P873, DOI 10.1136/jech-2014-204777; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Sugihara Y, 2008, J GERONTOL B-PSYCHOL, V63, pP227, DOI 10.1093/geronb/63.4.P227; Tomioka K, 2019, J EPIDEMIOL, V29, P407, DOI 10.2188/jea.JE20180113; Verdelho A, 2011, J ALZHEIMERS DIS, V27, P491, DOI 10.3233/JAD-2011-110494; Verghese J, 2003, NEW ENGL J MED, V348, P2508, DOI 10.1056/NEJMoa022252; von Bonsdorff MB, 2017, AGE AGEING, V46, P108, DOI 10.1093/ageing/afw178; Wang HX, 2013, J GERONTOL A-BIOL, V68, P205, DOI 10.1093/gerona/gls153; Welsh J, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3478-y; Westerlund H, 2009, LANCET, V374, P1889, DOI 10.1016/S0140-6736(09)61570-1; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Yamauchi K, 1999, JPN J GERIATR PSYCHI, V10, P943	51	1	1	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2020	15	6							e0234392	10.1371/journal.pone.0234392	http://dx.doi.org/10.1371/journal.pone.0234392			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LZ0RE	32511273	Green Published, gold			2022-12-26	WOS:000540938100002
J	Shim, JT; Schmidt, N; Nogales, P; Larsen, T; Sorensen, CB; Bentzon, JF				Shim, Jeong T.; Schmidt, Nikolaj; Nogales, Paula; Larsen, Torben; Sorensen, Charlotte B.; Bentzon, Jacob F.			Effects of castration on atherosclerosis in Yucatan minipigs with genetic hypercholesterolemia	PLOS ONE			English	Article							ANDROGEN-DEPRIVATION THERAPY; PROSTATE-CANCER; TESTOSTERONE; DISEASE; RISK; ESTRADIOL	Background Low plasma testosterone, either spontaneous or as a result of androgen deprivation therapy for prostate cancer, is associated with an increased risk of cardiovascular events. The underlying mechanism in humans is not understood. Experimental studies in mice have shown that castration facilitates atherogenesis and may increase signs of plaque vulnerability. Pigs used for translational atherosclerosis research have frequently been castrated for practical or commercial reasons, but the effect of castration on atherosclerosis has never been systematically evaluated in pigs. Objective To study the effect of castration on atherosclerotic plaque burden and type in genetically modified minipigs with hypercholesterolemia. Methods Newborn male Yucatan minipigs with transgenic overexpression of a human gain-of-function mutant of proprotein convertase subtilisin/kexin type 9 were randomized to undergo orchiectomy (n = 8) or serve as controls (n = 6). Minipigs were started on high-fat diet at 3 months of age and the amount and composition of atherosclerotic lesions were analyzed at 12 months of age. Plasma lipid profiles and behavioral parameters were also assessed. Results Plasma lipids were slightly affected to a more atherogenic profile by orchiectomy, but atherosclerotic lesion size was unaltered in the LAD, thoracic aorta, abdominal aorta, and iliac arteries. The distribution of lesion types (xanthomas, pathological intimal thickening and fibroatheromas) were also not statistically different between groups in any of the examined vascular territories. The abdominal aorta developed the most advanced stages of disease with reproducible fibroatheroma formation, and here it was found that the area of necrotic core was significantly increased in orchiectomized pigs compared with controls. Orchiectomy also reduced aggressive behavior. Conclusions Castration does not alter the burden of atherosclerosis in hypercholesterolemic Yucatan minipigs, but may increase necrotic core area in fibroatheromas.	[Shim, Jeong T.; Schmidt, Nikolaj; Sorensen, Charlotte B.; Bentzon, Jacob F.] Aarhus Univ, Dept Clin Med, Heart Dis, Aarhus, Denmark; [Shim, Jeong T.; Nogales, Paula; Bentzon, Jacob F.] Ctr Nacl Invest Cardiovasc Carlos III CNIC, Madrid, Spain; [Larsen, Torben] Aarhus Univ, Dept Anim Sci, Aarhus, Denmark	Aarhus University; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Aarhus University	Bentzon, JF (corresponding author), Aarhus Univ, Dept Clin Med, Heart Dis, Aarhus, Denmark.; Bentzon, JF (corresponding author), Ctr Nacl Invest Cardiovasc Carlos III CNIC, Madrid, Spain.	jfbentzon@clin.au.dk	Nogales, Paula/T-4274-2018; Bentzon, Jacob/B-5302-2016; Bentzon, Jacob Fog/ABC-4460-2021	Nogales, Paula/0000-0002-6965-6724; Bentzon, Jacob/0000-0002-3020-5002; Bentzon, Jacob Fog/0000-0002-3020-5002; Sorensen, Charlotte Brandt/0000-0002-4469-8696	Danish Independent Research Council (Sapere Aude Programme) [4004-00459B]; Graduate School of Health, Aarhus University, Aarhus, Denmark; Instituto de Salud Carlos III (ISCIII); Ministerio de Ciencia e Innovacion (MCIN); Pro CNIC Foundation	Danish Independent Research Council (Sapere Aude Programme); Graduate School of Health, Aarhus University, Aarhus, Denmark; Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Ciencia e Innovacion (MCIN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Pro CNIC Foundation	The study was funded by a grant from the Danish Independent Research Council (Sapere Aude Programme, 4004-00459B) and a fellowship from The Graduate School of Health, Aarhus University, Aarhus, Denmark. The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovacion (MCIN) and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV-2015-0505). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mashhadi RH, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004853; Albertsen PC, 2014, EUR UROL, V65, P565, DOI 10.1016/j.eururo.2013.10.032; Alexandersen P, 1999, CIRC RES, V84, P813; Bourghardt J, 2010, ENDOCRINOLOGY, V151, P5428, DOI 10.1210/en.2010-0663; Christoffersen BO, 2010, STEROIDS, V75, P676, DOI 10.1016/j.steroids.2010.04.004; Freeman BM, 2014, J SURG RES, V190, P319, DOI 10.1016/j.jss.2014.03.017; Hu JR, 2020, ARTERIOSCL THROM VAS, V40, pE55, DOI 10.1161/ATVBAHA.119.313046; Huang CK, 2016, J ENDOCRINOL, V229, pR1, DOI 10.1530/JOE-15-0518; Knutsson A, 2016, SCI REP-UK, V6, DOI 10.1038/srep26220; Langer C, 2002, BIOCHEM BIOPH RES CO, V296, P1051, DOI 10.1016/S0006-291X(02)02038-7; Levine GN, 2010, CIRCULATION, V121, P833, DOI 10.1161/CIRCULATIONAHA.109.192695; Ludvigsen TP, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0670-2; Nathan L, 2001, P NATL ACAD SCI USA, V98, P3589, DOI 10.1073/pnas.051003698; Neeb ZP, 2010, COMPARATIVE MED, V60, P300; O'Farrell S, 2015, J CLIN ONCOL, V33, P1243, DOI 10.1200/JCO.2014.59.1792; Poulsen CB, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002800; Shim J, 2016, J PATHOL, V238, P257, DOI 10.1002/path.4646; Tivesten A, 2015, UROL ONCOL-SEMIN ORI, V33, P464, DOI 10.1016/j.urolonc.2015.05.030; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Wilhelmson AS, 2018, ARTERIOSCL THROM VAS, V38, P1519, DOI 10.1161/ATVBAHA.118.311252; Yuan F, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.006207	21	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0234131	10.1371/journal.pone.0234131	http://dx.doi.org/10.1371/journal.pone.0234131			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502216	gold, Green Published			2022-12-26	WOS:000542035700038
J	Nepveu, JF; Mikhail, Y; Pion, CH; Gossard, JP; Barthelemy, D				Nepveu, Jean-Francois; Mikhail, Youstina; Pion, Charlotte H.; Gossard, Jean-Pierre; Barthelemy, Dorothy			Assessment of vestibulocortical interactions during standing in healthy subjects	PLOS ONE			English	Article							GALVANIC VESTIBULAR STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; SOLEUS H-REFLEX; MOTOR CORTEX STIMULATION; SPINAL-CORD; DESCENDING PATHWAYS; BRAIN-STIMULATION; POSTURAL REACTIONS; BALANCE RESPONSES; TIBIALIS ANTERIOR	The vestibular system is essential to produce adequate postural responses enabling voluntary movement. However, how the vestibular system influences corticospinal output during postural tasks is still unknown. Here, we examined the modulation exerted by the vestibular system on corticospinal output during standing. Healthy subjects (n = 25) maintained quiet standing, head facing forward with eyes closed. Galvanic vestibular stimulation (GVS) was applied bipolarly and binaurally at different delays prior to transcranial magnetic stimulation (TMS) which triggered motor evoked potentials (MEPs). With the cathode right/anode left configuration, MEPs in right Soleus (SOL) muscle were significantly suppressed when GVS was applied at ISI = 40 and 130ms before TMS. With the anode right/cathode left configuration, no significant changes were observed. Changes in the MEP amplitude were then compared to changes in the ongoing EMG when GVS was applied alone. Only the decrease in MEP amplitude at ISI = 40ms occurred without change in the ongoing EMG, suggesting that modulation occurred at a premotoneuronal level. We further investigated whether vestibular modulation could occur at the motor cortex level by assessing changes in the direct corticospinal pathways using the short-latency facilitation of the SOL Hoffmann reflex (H-reflex) by TMS. None of the observed modulation occurred at the level of motor cortex. Finally, using the long-latency facilitation of the SOL H-reflex, we were able to confirm that the suppression of MEP at ISI = 40ms occurred at a premotoneuronal level. The data indicate that vestibular signals modulate corticospinal output to SOL at both premotoneuronal and motoneuronal levels during standing.	[Nepveu, Jean-Francois; Mikhail, Youstina; Pion, Charlotte H.; Barthelemy, Dorothy] CRIR, Ctr Interdisciplinary Res Rehabil Greater Montrea, Montreal, PQ, Canada; [Nepveu, Jean-Francois; Gossard, Jean-Pierre] Univ Montreal, Dept Neurosci, Montreal, PQ, Canada; [Mikhail, Youstina; Pion, Charlotte H.; Barthelemy, Dorothy] Univ Montreal, Sch Rehabil, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Barthelemy, D (corresponding author), CRIR, Ctr Interdisciplinary Res Rehabil Greater Montrea, Montreal, PQ, Canada.; Barthelemy, D (corresponding author), Univ Montreal, Sch Rehabil, Montreal, PQ, Canada.	dorothy.barthelemy@umontreal.ca		Nepveu, Jean-Francois/0000-0002-2364-0794	National Science and Engineering Research Council (NSERC)	National Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research is supported by the National Science and Engineering Research Council (NSERC) grant to DB. http://www.nserc-crsng.gc.ca/index_eng.asp The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allum J H, 1994, J Vestib Res, V4, P49; Barthelemy D, 2015, PROG BRAIN RES, V218, P79, DOI 10.1016/bs.pbr.2014.12.012; Barthelemy D, 2010, J PHYSIOL-LONDON, V588, P967, DOI 10.1113/jphysiol.2009.185520; Bawa P, 2002, J NEUROPHYSIOL, V88, P124, DOI 10.1152/jn.2002.88.1.124; Beloozerova IN, 2003, J NEUROSCI, V23, P7844; Brandt T, 2015, J NEUROL, V262, P214, DOI 10.1007/s00415-014-7548-8; BRITTON TC, 1993, EXP BRAIN RES, V94, P143; Carpenter MG, 2001, EXP BRAIN RES, V140, P95, DOI 10.1007/s002210100802; College national des gynecologues et obstetriciens francais, 2006, J GYNECOL OBST BIO R, V35, pS7; CRONE C, 1990, EXP BRAIN RES, V81, P35; Dakin CJ, 2007, J PHYSIOL-LONDON, V583, P1117, DOI 10.1113/jphysiol.2007.133264; DAVIES HE, 1994, J PHYSIOL-LONDON, V479, P463, DOI 10.1113/jphysiol.1994.sp020310; Day BL, 2007, J PHYSIOL-LONDON, V582, P153, DOI 10.1113/jphysiol.2007.132092; de Waele C, 2001, EXP BRAIN RES, V141, P541, DOI 10.1007/s00221-001-0894-7; Di Lazzaro V, 2004, CLIN NEUROPHYSIOL, V115, P255, DOI 10.1016/j.clinph.2003.10.009; Di Lazzaro V, 2001, J PHYSIOL-LONDON, V537, P1047, DOI 10.1113/jphysiol.2001.012572; Dieterich M, 2003, CEREB CORTEX, V13, P994, DOI 10.1093/cercor/13.9.994; Dieterich Marianne, 2018, Handb Clin Neurol, V151, P119, DOI 10.1016/B978-0-444-63622-5.00006-1; Dieterich M, 2015, ANN NY ACAD SCI, V1343, P10, DOI 10.1111/nyas.12585; Dieterich M, 2010, RESTOR NEUROL NEUROS, V28, P47, DOI 10.3233/RNN-2010-0505; Fernandez L, 2018, NEUROSCI BIOBEHAV R, V86, P176, DOI 10.1016/j.neubiorev.2017.11.018; FITZPATRICK R, 1994, J PHYSIOL-LONDON, V478, P363, DOI 10.1113/jphysiol.1994.sp020257; Fitzpatrick RC, 2004, J APPL PHYSIOL, V96, P2301, DOI 10.1152/japplphysiol.00008.2004; Fukushima K, 1997, EXP BRAIN RES, V117, P1, DOI 10.1007/PL00005786; Ghanim Z, 2009, J APPL PHYSIOL, V106, P893, DOI 10.1152/japplphysiol.90594.2008; Gossard JP, 1996, EXP BRAIN RES, V109, P277; Grillner S, 1972, Prog Brain Res, V37, P243, DOI 10.1016/S0079-6123(08)63906-0; Guldin WO, 1998, TRENDS NEUROSCI, V21, P254, DOI 10.1016/S0166-2236(97)01211-3; Guzman-Lopez J, 2011, EXP BRAIN RES, V214, P37, DOI 10.1007/s00221-011-2804-y; Hanna-Boutros B, 2014, J NEUROPHYSIOL, V111, P1865, DOI 10.1152/jn.00838.2013; HAYES K C, 1976, Electromyography and Clinical Neurophysiology, V16, P251; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hof AL, 2018, HUM MOVEMENT SCI, V57, P69, DOI 10.1016/j.humov.2017.11.009; Hof AL, 2010, J EXP BIOL, V213, P2655, DOI 10.1242/jeb.042572; Horak FB, 2009, PHYS THER, V89, P484, DOI 10.2522/ptj.20080071; Horak FB, 2009, ANN NY ACAD SCI, V1164, P76, DOI 10.1111/j.1749-6632.2008.03708.x; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; HULTBORN H, 1976, ACTA PHYSIOL SCAND, V96, P351, DOI 10.1111/j.1748-1716.1976.tb10205.x; ILES JF, 1992, J PHYSIOL-LONDON, V455, P407, DOI 10.1113/jphysiol.1992.sp019308; ILES JF, 1992, J PHYSIOL-LONDON, V455, P425, DOI 10.1113/jphysiol.1992.sp019309; Ilic TV, 2002, J PHYSIOL-LONDON, V545, P153, DOI 10.1113/jphysiol.2002.030122; INGLIS JT, 1995, J NEUROPHYSIOL, V73, P1181, DOI 10.1152/jn.1995.73.3.1181; Jankowska E, 2008, BRAIN RES REV, V57, P46, DOI 10.1016/j.brainresrev.2007.06.022; Kammermeier S, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00587; Kennedy PM, 2004, CAN J PHYSIOL PHARM, V82, P675, DOI 10.1139/Y04-080; Kennedy PM, 2004, MUSCLE NERVE, V30, P188, DOI 10.1002/mus.20074; Kennedy PM, 2002, CLIN NEUROPHYSIOL, V113, P1709, DOI 10.1016/S1388-2457(02)00238-9; Kennedy PM, 2001, CLIN NEUROPHYSIOL, V112, P2159, DOI 10.1016/S1388-2457(01)00665-4; Kirsch V, 2016, BRAIN STRUCT FUNCT, V221, P1291, DOI 10.1007/s00429-014-0971-x; Knikou M, 2008, J NEUROSCI METH, V171, P1, DOI 10.1016/j.jneumeth.2008.02.012; Laakso I, 2014, PHYS MED BIOL, V59, P203, DOI 10.1088/0031-9155/59/1/203; Lackmy A, 2010, CLIN NEUROPHYSIOL, V121, P612, DOI 10.1016/j.clinph.2009.12.011; LAJOIE Y, 1993, EXP BRAIN RES, V97, P139; Leblond H, 2001, EXP BRAIN RES, V138, P173, DOI 10.1007/s002210100696; Liechti M, 2008, CLIN NEUROPHYSIOL, V119, P2804, DOI 10.1016/j.clinph.2008.05.033; Lowrey CR, 2009, MUSCLE NERVE, V40, P213, DOI 10.1002/mus.21275; Macpherson JM, 2007, J NEUROPHYSIOL, V97, P4357, DOI 10.1152/jn.01338.2006; Marsden JF, 2002, J PHYSIOL-LONDON, V542, P323, DOI 10.1113/jphysiol.2002.019513; Matsugi A, 2017, NEUROREPORT, V28, P439, DOI 10.1097/WNR.0000000000000776; Morita H, 1999, EXP BRAIN RES, V128, P557, DOI 10.1007/s002210050881; Morita H, 2000, ACTA PHYSIOL SCAND, V170, P65, DOI 10.1046/j.1365-201x.2000.00762.x; Mullick AA, 2018, EXP BRAIN RES, V236, P381, DOI 10.1007/s00221-017-5133-y; Nepveu J. F., 2015, ISPGR ABSTR; NIELSEN J, 1993, J PHYSIOL-LONDON, V471, P223, DOI 10.1113/jphysiol.1993.sp019899; NIELSEN J, 1995, J PHYSIOL-LONDON, V484, P791, DOI 10.1113/jphysiol.1995.sp020704; NIELSEN J, 1995, J PHYSIOL-LONDON, V486, P779, DOI 10.1113/jphysiol.1995.sp020853; Nielsen J, 1997, J PHYSIOL-LONDON, V501, P473, DOI 10.1111/j.1469-7793.1997.473bn.x; Okada Y, 2018, NEUROREPORT, V29, P1135, DOI 10.1097/WNR.0000000000001086; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Petersen N, 1998, J PHYSIOL-LONDON, V513, P599, DOI 10.1111/j.1469-7793.1998.599bb.x; Petersen NT, 2001, J PHYSIOL-LONDON, V537, P651, DOI 10.1111/j.1469-7793.2001.00651.x; Petersen TH, 2009, EXP BRAIN RES, V193, P161, DOI 10.1007/s00221-008-1603-6; Pierrot-Deseilligny E, 2000, NEUROPHYSIOL CLIN, V30, P67, DOI 10.1016/S0987-7053(00)00062-9; PierrotDeseilligny E, 2005, CIRCUITRY OF THE HUMAN SPINAL CORD: ITS ROLE IN MOTOR CONTROL AND MOVEMENT DISORDERS, P1, DOI 10.1017/CBO9780511545047; Richter L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060358, 10.1371/journal.pone.0081647]; Riddle CN, 2010, J NEUROPHYSIOL, V103, P2821, DOI 10.1152/jn.00491.2009; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rossini PM, 2015, CLIN NEUROPHYSIOL, V126, P1071, DOI 10.1016/j.clinph.2015.02.001; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rothwell JC, 1997, J NEUROSCI METH, V74, P113, DOI 10.1016/S0165-0270(97)02242-5; ROTHWELL JC, 1987, BRAIN, V110, P1173, DOI 10.1093/brain/110.5.1173; Roy FD, 2009, EXP BRAIN RES, V193, P477, DOI 10.1007/s00221-009-1704-x; Sarkisian VH, 2000, ARCH ITAL BIOL, V138, P295; Sidhu SK, 2012, J NEUROPHYSIOL, V107, P306, DOI 10.1152/jn.00212.2011; Smith MC, 2017, BRAIN RES, V1655, P10, DOI 10.1016/j.brainres.2016.11.004; Suzuki S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175131; Taube W, 2006, J APPL PHYSIOL, V101, P420, DOI 10.1152/japplphysiol.01447.2005; Terao Y, 2000, BRAIN RES, V859, P137, DOI 10.1016/S0006-8993(00)01975-2; Wardman DL, 2002, ADV EXP MED BIOL, V508, P119; Watson SRD, 2003, CLIN NEUROPHYSIOL, V114, P1456, DOI 10.1016/S1388-2457(03)00121-4; Welgampola MS, 2002, CLIN NEUROPHYSIOL, V113, P528, DOI 10.1016/S1388-2457(02)00020-2; Zhang L, 2018, J NEUROPHYSIOL, V120, P3026, DOI 10.1152/jn.00483.2018	92	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0233843	10.1371/journal.pone.0233843	http://dx.doi.org/10.1371/journal.pone.0233843			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497147	gold, Green Published			2022-12-26	WOS:000542035200030
J	Pullen, MY; Weihl, CC; True, HL				Pullen, Melanie Y.; Weihl, Conrad C.; True, Heather L.			Client processing is altered by novel myopathy-causing mutations in the HSP40 J domain	PLOS ONE			English	Article							YEAST PSI(+) PRION; PROPAGATION; HSP70; SIS1; PSI+; SPECIFICITY; CHAPERONES; TRANSMISSION; MAINTENANCE; REVEALS	The misfolding and aggregation of proteins is often implicated in the development and progression of degenerative diseases. Heat shock proteins (HSPs), such as the ubiquitously expressed Type II Hsp40 molecular chaperone, DNAJB6, assist in protein folding and disaggregation. Historically, mutations within the DNAJB6 G/F domain have been associated with Limb-Girdle Muscular Dystrophy type 1D, now referred to as LGMDD1, a dominantly inherited degenerative disease. Recently, novel mutations within the J domain of DNAJB6 have been reported in patients with LGMDD1. Since novel myopathy-causing mutations in the Hsp40 J domain have yet to be characterized and both the function of DNAJB6 in skeletal muscle and the clients of this chaperone are unknown, we set out to assess the effect of these mutations on chaperone function using the genetically tractable yeast system. The essential yeast Type II Hsp40, Sis1, is homologous to DNAJB6 and is involved in the propagation of yeast prions. Using phenotypic, biochemical, and functional assays we found that homologous mutations in the Sis1 J domain differentially alter the processing of specific yeast prion strains, as well as a non-prion substrate. These data suggest that the newly-identified mutations in the J domain of DNAJB6 cause aberrant chaperone function that leads to the pathogenesis in LGMDD1.	[Pullen, Melanie Y.; True, Heather L.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Weihl, Conrad C.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	True, HL (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.	heather.true@wustl.edu			National Institutes of Health [K24AR073317, R01AR068797]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by: National Institutes of Health Grant R01AR068797 to CCW and HLT; National Institutes of Health Grant K24AR073317 to CCW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams JL, 2013, JOVE-J VIS EXP, DOI 10.3791/50432; Alberti S, 2010, METHOD ENZYMOL, V470, P709, DOI 10.1016/S0076-6879(10)70030-6; [Anonymous], PYMOL MOL GRAPHICS S; [Anonymous], 2013, THYROID S1, V23, pA13; [Anonymous], SYST SHUTTL VECT YEA; Aron R, 2007, EMBO J, V26, P3794, DOI 10.1038/sj.emboj.7601811; Bardill JP, 2009, PRION, V3, P151, DOI 10.4161/pri.3.3.9662; Berger SE, 2019, CURR GENET; Bohlega Saeed A, 2018, Acta Myol, V37, P221; Bradley ME, 2003, GENETICS, V165, P1675; Bradley ME, 2002, P NATL ACAD SCI USA, V99, P16392, DOI 10.1073/pnas.152330699; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chernoff YO, 2007, FEBS LETT, V581, P3695, DOI 10.1016/j.febslet.2007.04.075; Chernova TA, 2019, MOLECULES, V24, DOI 10.3390/molecules24183388; Couthouis J, 2014, NEUROMUSCULAR DISORD, V24, P431, DOI 10.1016/j.nmd.2014.01.014; Crist CG, 2006, BIOCHIMIE, V88, P485, DOI 10.1016/j.biochi.2005.10.008; Derkatch IL, 1996, GENETICS, V144, P1375; Derkatch IL, 2000, EMBO J, V19, P1942, DOI 10.1093/emboj/19.9.1942; Dulle JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087521; Dulle JE, 2013, J CELL BIOL, V203, P197, DOI 10.1083/jcb.201307040; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; Guinan E, 2009, PROTEIN PEPTIDE LETT, V16, P582, DOI 10.2174/092986609788490168; Guthrie C, 1991, GUIDE YEAST GENETICS; Hall T, 1999, NUCL ACIDS S SER, V41, P1979; Hall T., 2011, GERF B BIOSCI, V2, P60; Harms MB, 2012, ANN NEUROL, V71, P407, DOI 10.1002/ana.22683; Hennessy F, 2005, PROTEIN SCI, V14, P1697, DOI 10.1110/ps.051406805; Higurashi T, 2008, P NATL ACAD SCI USA, V105, P16596, DOI 10.1073/pnas.0808934105; Hipp MS, 2019, NAT REV MOL CELL BIO, V20, P421, DOI 10.1038/s41580-019-0101-y; Huang VJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079582; Inge-Vechtomov SG, 2011, RUSS J DEV BIOL+, V42, P293, DOI 10.1134/S1062360411020068; Jee H, 2016, J EXERC REHABIL, V12, P255, DOI 10.12965/jer.1632642.321; Johnson JL, 2001, J CELL BIOL, V152, P851, DOI 10.1083/jcb.152.4.851; Jones GW, 2003, GENETICS, V163, P495; Jung G, 2000, GENETICS, V156, P559; Kaschner LA, 2015, BBA-MOL CELL RES, V1853, P1035, DOI 10.1016/j.bbamcr.2015.01.014; Killian AN, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040349; Kryndushkin D, 2007, MOL BIOL CELL, V18, P2149, DOI 10.1091/mbc.E07-02-0128; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Lee S, 2002, J BIOL CHEM, V277, P21675, DOI 10.1074/jbc.M111075200; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; Liebman SW, 1999, J BIOL CHEM, V274, P1181, DOI 10.1074/jbc.274.3.1181; Lindstrom M, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00218; Loovers HM, 2007, GENETICS, V175, P621, DOI 10.1534/genetics.106.066019; Lopez N, 2003, MOL BIOL CELL, V14, P1172, DOI 10.1091/mbc.E02-09-0593; LUKE MM, 1991, J CELL BIOL, V114, P623, DOI 10.1083/jcb.114.4.623; Masison DC, 2009, PRION, V3, P65, DOI 10.4161/pri.3.2.9134; Matveenko AG, 2018, CURR GENET, V64, P317, DOI 10.1007/s00294-017-0750-3; Monahan ZT, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00453; Muranova LK, 2019, BIOCHEMISTRY-MOSCOW+, V84, P1256, DOI 10.1134/S000629791911004X; Nathan DF, 1997, P NATL ACAD SCI USA, V94, P12949, DOI 10.1073/pnas.94.24.12949; Needham PG, 2008, ARCH BIOCHEM BIOPHYS, V478, P167, DOI 10.1016/j.abb.2008.07.023; Pal E, 2019, EUR J MED GENET, V62, DOI 10.1016/j.ejmg.2019.05.001; Palmio J, 2019, NEUROMUSCUL DISORD; Pinheiro GMS, 2019, ARCH BIOCHEM BIOPHYS, V669, P71, DOI 10.1016/j.abb.2019.05.020; Ramos CHI, 2008, J MOL BIOL, V383, P155, DOI 10.1016/j.jmb.2008.08.019; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ruggieri A, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmoll.2016.00063; Sarparanta J, 2012, NAT GENET, V44, P450, DOI 10.1038/ng.1103; Sato T, 2013, NEUROMUSCULAR DISORD, V23, P269, DOI 10.1016/j.nmd.2012.12.010; Savarese M, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0100-3; Schilke BA, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007084; Sharma J, 2012, MOL MICROBIOL, V86, P866, DOI 10.1111/mmi.12024; Sondheimer N, 2001, EMBO J, V20, P2435, DOI 10.1093/emboj/20.10.2435; Sporn ZA, 2015, PRION, V9, P80, DOI 10.1080/19336896.2015.1020268; Stein KC, 2014, J BIOL CHEM, V289, P21120, DOI 10.1074/jbc.M114.572461; Straub V, 2018, NEUROMUSCULAR DISORD, V28, P702, DOI 10.1016/j.nmd.2018.05.007; Summers DW, 2009, PRION, V3, P59, DOI 10.4161/pri.3.2.9062; Sweeny EA, 2008, PRION, V2, P135, DOI 10.4161/pri.2.4.7952; Tamadaddi CA, 2016, CELL STRESS CHAPERON, V21, P563, DOI 10.1007/s12192-016-0697-1; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Tenreiro S, 2017, CURR OPIN GENET DEV, V44, P74, DOI 10.1016/j.gde.2017.01.013; Tipton KA, 2008, MOL CELL, V32, P584, DOI 10.1016/j.molcel.2008.11.003; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Tuite MF, 2004, MOL CELL, V14, P541, DOI 10.1016/j.molcel.2004.05.012; Westergard L, 2014, MOL MICROBIOL, V92, P698, DOI 10.1111/mmi.12579; Winkler J, 2012, J STRUCT BIOL, V179, P152, DOI 10.1016/j.jsb.2012.05.002; Xu LN, 2018, PRION, V12, P170, DOI 10.1080/19336896.2018.1507579; Yan W, 1999, MOL CELL BIOL, V19, P7751; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yu HY, 2015, J MOL BIOL, V427, P1632, DOI 10.1016/j.jmb.2015.02.007; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	86	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0234207	10.1371/journal.pone.0234207	http://dx.doi.org/10.1371/journal.pone.0234207			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497100	Green Submitted, gold, Green Published			2022-12-26	WOS:000542035200019
J	Ceasar, SA; Ramakrishnan, M; Vinod, KK; Roch, GV; Upadhyaya, HD; Baker, A; Ignacimuthu, S				Ceasar, S. Antony; Ramakrishnan, M.; Vinod, K. K.; Roch, G. Victor; Upadhyaya, Hari D.; Baker, Alison; Ignacimuthu, S.			Phenotypic responses of foxtail millet (Setaria italica) genotypes to phosphate supply under greenhouse and natural field conditions	PLOS ONE			English	Article							PHOSPHORUS-USE EFFICIENCY; HAIRLESS BARLEY MUTANT; ROOT HAIRS; ARABIDOPSIS-THALIANA; GENOME SEQUENCE; SOIL-PHOSPHORUS; LOW-P; DEFICIENCY; TOLERANCE; NITROGEN	Food insecurity is a looming threat for the burgeoning world population. Phosphorus (P), which is absorbed from soil as inorganic phosphate (Pi), is an essential macronutrient for the growth of all agricultural crops. This study reports phenotype analysis for P responses in natural field and greenhouse conditions, using 54 genotypes of foxtail millet (Setaria italica) representing wide geographic origins. The genotype responses were assessed in natural field conditions in two different seasons (monsoon and summer) under Pi-fertilized (P+) and unfertilized (P-) soil for eight above-ground traits. Enormous variations were seen among the genotypes in phenotypic responses for all the measured parameters under low P stress conditions. Variations were significant for plant height, leaf number and length, tillering ability and seed yield traits. Genotypes ISe 1234 and ISe 1541 were P+ responders, and the genotypes ISe 1181, ISe 1655, ISe 783 and ISe 1892 showed tolerance to low P for total seed yield. Genotypes that performed well under P- conditions were almost as productive as genotypes that performed well under P+ conditions suggesting some genotypes are well adapted to nutrient-poor soils. In the greenhouse, most of the genotypes produced changes in root architecture that are characteristic of P- stress, but to differing degrees. Significant variation was seen in root hair density and root hair number and in fresh and dry weight of shoot and root under P- stress. However, there was not much difference in the shoot and root total P and Pi levels of five selected high and low responding genotypes. We noticed contrasting responses in the greenhouse and natural field experiments for most of these genotypes. The leads from the study form the basis for breeding and improvement of foxtail millet for better Pi-use efficiency.	[Ceasar, S. Antony; Ramakrishnan, M.; Roch, G. Victor] Loyola Coll, Entomol Res Inst, Div Plant Biotechnol, Chennai, Tamil Nadu, India; [Ceasar, S. Antony; Baker, Alison] Univ Leeds, Fac Biol Sci, Ctr Plant Sci, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England; [Ramakrishnan, M.] Zhejiang A&F Univ, State Key Lab Subtrop Silviculture, Hangzhou, Zhejiang, Peoples R China; [Vinod, K. K.] ICAR Indian Agr Res Inst, Div Genet, New Delhi, India; [Upadhyaya, Hari D.] Univ Georgia, Athens, GA 30602 USA; [Ignacimuthu, S.] St Xaviers Coll, Xavier Res Fdn, Palayankottai, India	Loyola College - Chennai; University of Leeds; Zhejiang A&F University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; University System of Georgia; University of Georgia	Ceasar, SA (corresponding author), Loyola Coll, Entomol Res Inst, Div Plant Biotechnol, Chennai, Tamil Nadu, India.; Ceasar, SA; Baker, A (corresponding author), Univ Leeds, Fac Biol Sci, Ctr Plant Sci, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England.	antony_sm2003@yahoo.co.in; a.baker@leeds.ac.uk	CEASAR, STANISLAUS ANTONY/P-2479-2017; Ramakrishnan, Muthusamy/AAM-6865-2021; Ignacimuthu, S/ABH-3983-2020; K K, Vinod/H-2938-2019	CEASAR, STANISLAUS ANTONY/0000-0003-4106-1531; Ramakrishnan, Muthusamy/0000-0001-7819-339X; Ignacimuthu, S/0000-0002-8467-789X; K K, Vinod/0000-0001-8927-4590	European Union through a Marie Curie International Incoming Fellowship [921672]; University Grant Commission (UGC) through Rajiv Gandhi National Fellowship for Students [F./2014-15/RGNF-2014-15D-OBC-TAM-74226]	European Union through a Marie Curie International Incoming Fellowship; University Grant Commission (UGC) through Rajiv Gandhi National Fellowship for Students(University Grants Commission, India)	This work was supported by the European Union through a Marie Curie International Incoming Fellowship to Dr S. Antony Ceasar (Ref No: FP7-People-2-11-IIF-Acronym IMPACT-No: 921672) and by the University Grant Commission (UGC) through Rajiv Gandhi National Fellowship for Students with Disability to Dr M. Ramakrishnan (No. F./2014-15/RGNF-2014-15D-OBC-TAM-74226).	Ahmad Z, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01367; Andersson MX, 2003, FEBS LETT, V537, P128, DOI 10.1016/S0014-5793(03)00109-1; Baker A, 2015, J EXP BOT, V66, P3523, DOI 10.1093/jxb/erv210; Bates TR, 2000, AM J BOT, V87, P964, DOI 10.2307/2656995; BATTEN GD, 1986, ANN BOT-LONDON, V58, P49, DOI 10.1093/oxfordjournals.aob.a087187; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Borch K, 1999, PLANT CELL ENVIRON, V22, P425, DOI 10.1046/j.1365-3040.1999.00405.x; Bray MA, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/giw014; Carswell C, 1996, PLANT PHYSIOL, V110, P105, DOI 10.1104/pp.110.1.105; Ceasar SA, 2019, PLANT GENOME-US, V12, DOI 10.3835/plantgenome2018.04.0019; Ceasar SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14447-0; Ceasar SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108459; Ceasar SA, 2009, BIOTECHNOL LETT, V31, P779, DOI 10.1007/s10529-009-9933-4; Chiou TJ, 2006, PLANT CELL, V18, P412, DOI 10.1105/tpc.105.038943; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; Diao XM, 2017, PLANT GENET GENOMICS, V19, P61, DOI 10.1007/978-3-319-45105-3_4; Dinkelaker Barbara, 1995, Botanica Acta, V108, P183; Gahoonia TS, 2004, PLANT SOIL, V262, P55, DOI 10.1023/B:PLSO.0000037020.58002.ac; Gahoonia TS, 2003, PLANT CELL ENVIRON, V26, P1759, DOI 10.1046/j.1365-3040.2003.01093.x; Gahoonia TS, 2001, PLANT SOIL, V235, P211, DOI 10.1023/A:1011993322286; Gemenet DC, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01389; Gemenet DC, 2014, CROP SCI, V54, P2574, DOI 10.2135/cropsci2014.04.0277; Gilmour AR, 1995, BIOMETRICS, V51, P1440, DOI 10.2307/2533274; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; He Y, 2003, PLANT SOIL, V248, P247, DOI 10.1023/A:1022351203545; Heuer S, 2017, PLANT J, V90, P868, DOI 10.1111/tpj.13423; Huang P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01781; Huehn M., 1996, GENOTYPE ENV INTERAC, P213; Jin J, 2012, PLANT SOIL, V358, P86, DOI 10.1007/s11104-012-1270-z; Kalaghatagi SB, 2000, ANN ARID ZONE, V39, P169; KANG MS, 1988, CEREAL RES COMMUN, V16, P113; Kim HJ, 2008, PLANT CELL ENVIRON, V31, P1744, DOI 10.1111/j.1365-3040.2008.01886.x; Lambers H, 2011, PLANT PHYSIOL, V156, P1058, DOI 10.1104/pp.111.174318; Lehmann A, 2012, PLANT SOIL, V355, P231, DOI 10.1007/s11104-011-1095-1; Leiser WL, 2014, PLANT SOIL, V377, P383, DOI 10.1007/s11104-013-1978-4; Li PH, 2011, J EXP BOT, V62, P3031, DOI 10.1093/jxb/err096; Lopez-Arredondo DL, 2014, ANNU REV PLANT BIOL, V65, P95, DOI 10.1146/annurev-arplant-050213-035949; Lynch Jonathan P., 2008, V7, P83; Lynch JP, 2005, PLANT SOIL, V269, P45, DOI 10.1007/s11104-004-1096-4; Lynch JP, 2001, PLANT SOIL, V237, P225, DOI 10.1023/A:1013324727040; Maharajan T, 2019, PLANTA, V250, P1433, DOI 10.1007/s00425-019-03237-9; Mollier A, 1999, J EXP BOT, V50, P487, DOI 10.1093/jexbot/50.333.487; Muthamilarasan M, 2015, THEOR APPL GENET, V128, P1, DOI 10.1007/s00122-014-2399-3; Nadeem F, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00205; Ni JJ, 1998, NUTR CYCL AGROECOSYS, V51, P95, DOI 10.1023/A:1009716330296; Niu YF, 2013, ANN BOT-LONDON, V112, P391, DOI 10.1093/aob/mcs285; Peret B, 2014, PLANT PHYSIOL, V166, P1713, DOI 10.1104/pp.114.244541; Peret B, 2011, TRENDS PLANT SCI, V16, P442, DOI 10.1016/j.tplants.2011.05.006; Ramakrishnan M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183261; Rouached H, 2010, MOL PLANT, V3, P288, DOI 10.1093/mp/ssp120; Sattari SZ, 2012, P NATL ACAD SCI USA, V109, P6348, DOI 10.1073/pnas.1113675109; Schachtman DP, 1998, PLANT PHYSIOL, V116, P447, DOI 10.1104/pp.116.2.447; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Shimodaira H, 2004, ANN STAT, V32, P2616, DOI 10.1214/009053604000000823; Slabaugh E, 2011, PLANT J, V67, P395, DOI 10.1111/j.1365-313X.2011.04602.x; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Upadhyaya Hari D., 2009, Plant Genetic Resources Characterization and Utilization, V7, P177, DOI 10.1017/S1479262108178042; Veneklaas EJ, 2012, NEW PHYTOL, V195, P306, DOI 10.1111/j.1469-8137.2012.04190.x; Vinod KK, 2012, AOB PLANTS, DOI 10.1093/aobpla/pls028; Vinod KK, 2015, GENETIC MANIPULATION, DOI [10.1007/978-81-322-2662-8_6, DOI 10.1007/978-81-322-2662-8_6]; Wang LD, 2004, PLANT SOIL, V261, P77, DOI 10.1023/B:PLSO.0000035552.94249.6a; Wang XR, 2010, PLANT SCI, V179, P302, DOI 10.1016/j.plantsci.2010.06.007; Wiel CCM, 2015, EUPHYTICA, V207, P1; Wissuwa M, 2005, J EXP BOT, V56, P1943, DOI 10.1093/jxb/eri189; Wissuwa M, 2003, PLANT PHYSIOL, V133, P1947, DOI 10.1104/pp.103.029306; Wissuwa M, 2001, PLANT BREEDING, V120, P43, DOI 10.1046/j.1439-0523.2001.00561.x; Yan XL, 2004, PLANT SOIL, V265, P17, DOI 10.1007/s11104-005-0693-1; Yoneyama K, 2007, PLANTA, V227, P125, DOI 10.1007/s00425-007-0600-5; York LM, 2015, J EXP BOT, V66, P5493, DOI 10.1093/jxb/erv241; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zhu JM, 2005, FUNCT PLANT BIOL, V32, P749, DOI 10.1071/FP05005; Zou XJ, 2019, CROP PASTURE SCI, V70, P234, DOI 10.1071/CP18269	73	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2020	15	6							e0233896	10.1371/journal.pone.0233896	http://dx.doi.org/10.1371/journal.pone.0233896			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LW6ZP	32492057	Green Published, gold			2022-12-26	WOS:000539293000045
J	Jaen-Sanchez, N; Gonzalez-Azpeitia, G; Saavedra-Santana, P; Saavedra-Sanjuan, E; Manguiza, AA; Manwere, N; Carranza-Rodriguez, C; Perez-Arellano, JL; Serra-Majem, L				Jaen-Sanchez, Nieves; Gonzalez-Azpeitia, Gloria; Saavedra-Santana, Pedro; Saavedra-Sanjuan, Esther; Manguiza, Aniceto-Alberto; Manwere, Nicholas; Carranza-Rodriguez, Cristina; Luis Perez-Arellano, Jose; Serra-Majem, Lluis			Adolescent motherhood in Mozambique. Consequences for pregnant women and newborns	PLOS ONE			English	Article							MATERNAL MORTALITY	Introduction In sub-Saharan Mozambique, high adolescent fertility rates are a significant public health problem. Understanding the consequences of teenage pregnancies facilitates effective strategies for improving the quality of care of both mother and the newborn. Aims To identify the factors associated with adolescent motherhood in Tete (Mozambique). Methods This was a cross-sectional study including 821 pregnant women (255 teenagers) admitted to the general maternity ward of the Provincial Hospital between March and October 2016. The survey included clinical data of the mother and newborn. Results The overall prevalence of adolescent deliveries was 31.8% (95% CI 27.9% - 34.2%). Multivariate analysis showed that independent factors associated with teenage motherhood were: number of pregnancies (OR 0.066; 95% CI 0.040-0.110), pregnancy follow-up (OR 0.29; CI 0.173-0.488) and previous abortions (OR 4.419; 95% CI 1.931-10.112). When the age of the mother was analysed as a continuous variable, positively associated factors were body mass index, arterial hypertension, HIV infection, previous abortions, pregnancy follow-up, and the weight of the newborn. Negatively associated factors were episiotomy and respiratory distress in the newborn. Conclusion Teenage motherhood is a serious public health problem in Mozambique. Intensive sexual and reproductive health planning for adolescents is needed.	[Jaen-Sanchez, Nieves; Carranza-Rodriguez, Cristina; Luis Perez-Arellano, Jose] Complejo Hosp Univer Sitario Insular Materno Infa, Infect Dis & Trop Med Div, Las Palmas Gran Canaria, Spain; [Jaen-Sanchez, Nieves; Gonzalez-Azpeitia, Gloria; Carranza-Rodriguez, Cristina; Luis Perez-Arellano, Jose; Serra-Majem, Lluis] Univ Las Palmas Gran Canaria, Las Palmas Gran Canaria, Spain; [Gonzalez-Azpeitia, Gloria] Complejo Hosp Univ Insular Materno Infantil, Pediat Div, Las Palmas Gran Canaria, Spain; [Gonzalez-Azpeitia, Gloria; Carranza-Rodriguez, Cristina; Luis Perez-Arellano, Jose; Serra-Majem, Lluis] Univ Las Palmas Gran Canaria, Res Inst Biomed & Hlth Sci, Dept Clin Sci iUIBS, Las Palmas Gran Canaria, Spain; [Saavedra-Santana, Pedro; Saavedra-Sanjuan, Esther] Univ Las Palmas Gran Canaria, Dept Math, Las Palmas Gran Canaria, Spain; [Manguiza, Aniceto-Alberto; Manwere, Nicholas] Univ Zambeze, Beira, Mozambique; [Serra-Majem, Lluis] Spanish Govt, Ciber OBN CB06 03, Inst Carlos III, Madrid, Spain	Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Carranza-Rodriguez, C (corresponding author), Complejo Hosp Univer Sitario Insular Materno Infa, Infect Dis & Trop Med Div, Las Palmas Gran Canaria, Spain.; Carranza-Rodriguez, C (corresponding author), Univ Las Palmas Gran Canaria, Las Palmas Gran Canaria, Spain.; Carranza-Rodriguez, C (corresponding author), Univ Las Palmas Gran Canaria, Res Inst Biomed & Hlth Sci, Dept Clin Sci iUIBS, Las Palmas Gran Canaria, Spain.	cristinacarranzarodriguez@gmail.com	Carranza, Cristina/K-9578-2016	Saavedra-Santana, Pedro/0000-0003-1681-7165; Carranza rodriguez, Cristina/0000-0002-2768-0072	University Center for International Cooperation for Development (CUCID) of the University of Las Palmas de Gran Canaria (ULPGC); ULPGC; Faculty of Health Sciences of the University Zambeze	University Center for International Cooperation for Development (CUCID) of the University of Las Palmas de Gran Canaria (ULPGC); ULPGC; Faculty of Health Sciences of the University Zambeze	This work was supported by the University Center for International Cooperation for Development (CUCID) of the University of Las Palmas de Gran Canaria (ULPGC), key project of the Program of Medical Training that imparts the ULPGC in Mozambique (the specific agreement of collaboration between ULPGC and the Faculty of Health Sciences of the University Zambeze to strengthen institutional capacities and training). We would like to thank Ms. Janet Dawson for her help in revising the English version of the manuscript.	[Anonymous], 1997, JAMA-J AM MED ASSOC, V277, P925; [Anonymous], 2019, R LANG ENV STAT COMP; Central Intelligence Agency, WORLD FACTBOOK; Frederico M, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15020329; Gonzalez R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132053; Gunn JKL, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20605; Instituto nacional de estadistica, 2017, APPR RES PREL 4 REC; Instituto Nacional de Estatistica, 2013, MO AMBIQUE INQU RITO; Kongnyuy EJ, 2008, MATERN CHILD HLTH J, V12, P149, DOI 10.1007/s10995-007-0235-y; Long Q, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0686-x; Ministerio da Saude (MISAU) Instituto Nacional de Estatistica (INE) e ICF, 2019, INQ IND IM MAL HIV S; Mombo-Ngoma G, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011783; Munguambe K, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0141-0; Njim Tsi, 2017, BMC Res Notes, V10, P227, DOI 10.1186/s13104-017-2555-3; Norte G, 2013, GRAVIDEZ ADOLESCENCI; Nove A, 2014, LANCET GLOB HEALTH, V2, pE155, DOI 10.1016/S2214-109X(13)70179-7; ONUSIDA, 2017, MOZ 2017; Osman N B, 2000, Afr J Reprod Health, V4, P110, DOI 10.2307/3583248; Pizzol D, 2018, AJAR-AFR J AIDS RES, V17, P32, DOI 10.2989/16085906.2017.1405825; Ramaiya Astha, 2014, BMC Res Notes, V7, P750, DOI 10.1186/1756-0500-7-750; Sacoor C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0184249; Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5; Tebeu PM, 2007, W INDIAN MED J, V56, P502; UNICEF, 2010, STRENGTH BIRTH REG A; UNICEF, 2016, UNICEF ANN REP 2016; UNICEF, 2015, CHILD MARR AD PREGN; United Nations, 2018, TRANSF OUR WORLD 203; United Nations Population Fund (UNPF), 2013, ADOLESCENT PREGNANCY; WHO, 2020, ADOLESCENT PREGNANCY; World Health Organization, 2016, PREGN WOM MUST BE AB; World Health Organization, GLOB ACC ACT HLTH AD	31	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2020	15	6							e0233985	10.1371/journal.pone.0233985	http://dx.doi.org/10.1371/journal.pone.0233985			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LW6ZP	32492055	Green Published, gold			2022-12-26	WOS:000539293000002
J	Donald, S; Sharples, K; Barson, D; Horsburgh, S; Parkin, L				Donald, Sarah; Sharples, Katrina; Barson, David; Horsburgh, Simon; Parkin, Lianne			Patterns of prescription medicine dispensing before and during pregnancy in New Zealand, 2005-2015	PLOS ONE			English	Article							DRUG-USE; MEDICATION USE; TERATOGENIC RISK; PRIMARY-CARE; WOMEN; PERCEPTION; COHORT; ASSOCIATION; INFORMATION; PREVALENCE	Objective To describe prescription medicine dispensing before and during pregnancy in New Zealand, 2005-2015. Methods Members of the New Zealand Pregnancy Cohort were linked with their dispensing records in a national database of prescription products dispensed from community pharmacies. We identified the proportion of pregnancies during which at least one prescription medicine was dispensed, the number of different medicines used and the most commonly dispensed medicine groups both during pregnancy and in the 270 days before conception. Dispensing during pregnancy was assessed by several maternal characteristics. Results 874,884 pregnancies were included. Over the study timeframe, the proportion of pregnancies exposed to a non-supplement prescription medicine increased from 38.5% to 67.2%. The mean number of different non-supplement medicines dispensed during pregnancy increased from 2.5 to 3.2. Dispensing during pregnancy was weakly associated with body mass index, smoking status and ethnicity. Pregnancy exposure was highest for Antibacterials (26.0%), Analgesics (16.7%) and Antinausea & Vertigo Agents (11.0%). Conclusions From 2005-2015, both the proportion of exposed pregnancies and the number of different medicines dispensed to pregnant women in New Zealand increased.	[Donald, Sarah; Sharples, Katrina; Barson, David; Horsburgh, Simon; Parkin, Lianne] Pharmacoepidemiol Res Network, Dunedin, New Zealand; [Donald, Sarah; Barson, David; Horsburgh, Simon; Parkin, Lianne] Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Dunedin, New Zealand; [Sharples, Katrina] Univ Otago, Dept Math & Stat, Dunedin, New Zealand; [Sharples, Katrina] Univ Otago, Dept Med, Dunedin, New Zealand	University of Otago; University of Otago; University of Otago	Donald, S (corresponding author), Pharmacoepidemiol Res Network, Dunedin, New Zealand.; Donald, S (corresponding author), Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Dunedin, New Zealand.	sarah.donald@otago.ac.nz	Horsburgh, Simon/C-9861-2009	Horsburgh, Simon/0000-0002-1011-7996; Donald, Sarah/0000-0002-7189-3200; Parkin, Lianne/0000-0002-6824-6176	Health Research Council of New Zealand [16/072]	Health Research Council of New Zealand(Health Research Council of New Zealand)	This research was supported by a Clinical Research Training Fellowship (SD) from the Health Research Council of New Zealand (grant number 16/072) (https://www.hrc.govt.nz/).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam MP, 2011, AM J MED GENET C, V157C, P175, DOI 10.1002/ajmg.c.30313; Andrade SE, 2004, AM J OBSTET GYNECOL, V191, P398, DOI 10.1016/j.ajog.2004.04.025; Artama M, 2011, PHARMACOEPIDEM DR S, V20, P729, DOI 10.1002/pds.2159; Bakker MK, 2006, BJOG-INT J OBSTET GY, V113, P559, DOI 10.1111/j.1471-0528.2006.00927.x; Berard A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093870; Bjorn Anne-Mette Bay, 2011, Clin Epidemiol, V3, P149, DOI 10.2147/CLEP.S17747; Charlton RA, 2014, PHARMACOEPIDEM DR S, V23, P586, DOI 10.1002/pds.3613; Cheung K, 2017, PHARMACOEPIDEM DR S, V26, P1119, DOI 10.1002/pds.4264; Cleary BJ, 2010, PHARMACOEPIDEM DR S, V19, P408, DOI 10.1002/pds.1906; Colvin L, 2009, PHARMACOEPIDEM DR S, V18, P211, DOI 10.1002/pds.1705; Daw JR, 2012, CLIN THER, V34, P239, DOI 10.1016/j.clinthera.2011.11.025; Daw JR, 2011, PHARMACOEPIDEM DR S, V20, P895, DOI 10.1002/pds.2184; de Jonge L, 2015, DRUG SAFETY, V38, P737, DOI 10.1007/s40264-015-0302-z; Demailly R, 2017, PHARMACOEPIDEM DR S, V26, P1126, DOI 10.1002/pds.4265; Dillon P, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0489-0; Donald S, 2018, PHARMACOEPIDEM DR S, V27, P1335, DOI 10.1002/pds.4671; Engeland A, 2008, BRIT J CLIN PHARMACO, V65, P653, DOI 10.1111/j.1365-2125.2008.03102.x; Gagne JJ, 2008, EUR J CLIN PHARMACOL, V64, P1125, DOI 10.1007/s00228-008-0546-y; Hardy JR, 2006, PHARMACOEPIDEM DR S, V15, P555, DOI 10.1002/pds.1269; Houghton LA, 2008, BEST PRACTICE J, P42; Huybrechts KF, 2019, PHARMACOEPIDEM DR S, V28, P906, DOI 10.1002/pds.4789; Huybrechts KF, 2018, JAMA-J AM MED ASSOC, V320, P2429, DOI 10.1001/jama.2018.18307; Irvine L, 2010, DRUG SAFETY, V33, P593, DOI 10.2165/11532330-000000000-00000; Jones MR, 2018, PAIN THER, V7, P13, DOI 10.1007/s40122-018-0097-6; Kantor ED, 2015, JAMA-J AM MED ASSOC, V314, P1818, DOI 10.1001/jama.2015.13766; Kaplan YC, 2019, REPROD TOXICOL, V86, P1, DOI 10.1016/j.reprotox.2019.03.001; Lacroix I, 2009, EUR J CLIN PHARMACOL, V65, P839, DOI 10.1007/s00228-009-0647-2; Lo WY, 2002, OBSTET GYNECOL, V100, P465, DOI 10.1016/S0029-7844(02)02122-1; Lumley T, 2006, UW BIOSTATISTICS WOR; Lupattelli A, 2014, PATIENT EDUC COUNS, V96, P171, DOI 10.1016/j.pec.2014.04.014; Malm H, 2003, EUR J CLIN PHARMACOL, V59, P127, DOI 10.1007/s00228-003-0584-4; Ministry of Health, 2018, HELPFUL ADVICE PREGN; Ministry of Health, 2018, PHARM COLL; Ministry of Health, 2018, BARR ACC HLTH CAR; MITCHELL AA, 1986, AM J EPIDEMIOL, V123, P670, DOI 10.1093/oxfordjournals.aje.a114286; Mitchell AA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.02.029; National Centre for Classification in Health, 2002, INT STAT CLASS DIS R; Nordeng H, 2010, EUR J CLIN PHARMACOL, V66, P207, DOI 10.1007/s00228-009-0744-2; Olesen C, 2001, EPIDEMIOLOGY, V12, P497, DOI 10.1097/00001648-200109000-00006; Olesen C, 2006, EUR J CLIN PHARMACOL, V62, P547, DOI 10.1007/s00228-006-0119-x; Palmsten K, 2015, OBSTET GYNECOL, V126, P465, DOI 10.1097/AOG.0000000000000982; Pisa FE, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0745-3; Riley EH, 2005, J WOMENS HEALTH, V14, P401, DOI 10.1089/jwh.2005.14.401; Sanz E, 2001, EUR J OBSTET GYN R B, V95, P127, DOI 10.1016/S0301-2115(00)00375-4; Sarangarm P, 2012, BIRTH DEFECTS RES A, V94, P153, DOI 10.1002/bdra.22888; Schirm E, 2004, EUR J OBSTET GYN R B, V114, P182, DOI 10.1016/j.ejogrb.2003.10.024; Singh S, 2010, STUD FAMILY PLANN, V41, P241, DOI 10.1111/j.1728-4465.2010.00250.x; Skurtveit S, 2014, NORWEGIAN J EPIDEMIO, V24, P209; Smolina K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128312; Stephansson Olof, 2011, Clin Epidemiol, V3, P43, DOI 10.2147/CLEP.S16305; White IR, 2010, STAT MED, V29, P2920, DOI 10.1002/sim.3944; Widnes SF, 2013, DRUG SAFETY, V36, P481, DOI 10.1007/s40264-013-0035-9; Zambelli-Weiner A, 2019, REPROD TOXICOL, V83, P14, DOI 10.1016/j.reprotox.2018.10.010; Zhang F, 2016, PHARMACOEPIDEM DR S, V25, P628, DOI 10.1002/pds.3947	54	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2020	15	6							e0234153	10.1371/journal.pone.0234153	http://dx.doi.org/10.1371/journal.pone.0234153			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MT4VF	32484824	Green Published, gold			2022-12-26	WOS:000554969700035
J	Krammel, M; Lobmeyr, E; Sulzgruber, P; Winnisch, M; Weidenauer, D; Poppe, M; Datler, P; Zeiner, S; Keferboeck, M; Eichelter, J; Hamp, T; Uray, T; Schnaubelt, S; Nuernberger, A				Krammel, Mario; Lobmeyr, Elisabeth; Sulzgruber, Patrick; Winnisch, Markus; Weidenauer, David; Poppe, Michael; Datler, Philip; Zeiner, Sebastian; Keferboeck, Markus; Eichelter, Jakob; Hamp, Thomas; Uray, Thomas; Schnaubelt, Sebastian; Nuernberger, Alexander			The impact of a high-quality basic life support police-based first responder system on outcome after out-of-hospital cardiac arrest	PLOS ONE			English	Article							RESUSCITATION COUNCIL GUIDELINES; SURVIVAL; DEFIBRILLATION; BYSTANDER; CITY	Background Laypersons' efforts to initiate basic life support (BLS) in witnessed Out-of-Hospital Cardiac Arrest (OHCA) remain comparably low within western society. Therefore, in order to shorten no-flow times in cardiac arrest, several police-based first responder systems equipped with automated external defibrillators (Pol-AED) were established in urban areas, which subsequently allow early BLS and AED administration by police officers. However, data on the quality of BLS and AED use in such a system and its impact on patient outcome remain scarce and inconclusive. Methods A total of 85 Pol-AED cases were randomly assigned to a gender, age and first rhythm matched non-Pol-AED control group (n = 170) in a 1:2 ratio. Data on quality of BLS were extracted via trans-thoracic impedance tracings of used AED devices. Results Comparing Pol-AED cases and the control group, we observed a similar compression rate per minute (p = 0.677) and compression ratio (p = 0.651), mirroring an overall high quality of BLS administered by police officers. Time to the first shock was significantly shorter in Pol-AED cases (6 minutes [IQR: 2-10] vs. 12 minutes [IQR: 8-17]; p<0.001). While Pol-AED was not associated with increased sustained return of spontaneous circulation (p = 0.564), a strong and independent impact on survival until hospital discharge (adj. OR: 1.85 [95%CI: 1.06-3.23; p = 0.030]) and a borderline significance for the association with favorable neurological outcome (adj. OR: 1.58 [95%CI: 0.96-2.89; p = 0.052) were observed. Conclusion We were able to demonstrate an early start and a high quality of BLS and AED use in Pol-AED assessed OHCA cases. Moreover, the presence of Pol-AED care was associated with better patient survival and borderline significance for favorable neurological outcome.	[Krammel, Mario; Datler, Philip; Zeiner, Sebastian; Hamp, Thomas] Med Univ Vienna, Dept Anesthesiol Intens Care & Pain Med, Vienna, Austria; [Krammel, Mario; Lobmeyr, Elisabeth; Sulzgruber, Patrick; Winnisch, Markus; Weidenauer, David; Eichelter, Jakob; Hamp, Thomas; Schnaubelt, Sebastian] PULS Austrian Cardiac Arrest Awareness Assoc, Vienna, Austria; [Krammel, Mario; Eichelter, Jakob] Emergency Med Serv, Vienna, Austria; [Lobmeyr, Elisabeth; Poppe, Michael; Keferboeck, Markus; Uray, Thomas; Schnaubelt, Sebastian; Nuernberger, Alexander] Med Univ Vienna, Dept Emergency Med, Vienna, Austria; [Sulzgruber, Patrick; Weidenauer, David] Med Univ Vienna, Dept Med 2, Div Cardiol, Vienna, Austria; [Winnisch, Markus] Med Univ Vienna, Dept Trauma Surg, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Krammel, M (corresponding author), Med Univ Vienna, Dept Anesthesiol Intens Care & Pain Med, Vienna, Austria.; Krammel, M; Schnaubelt, S (corresponding author), PULS Austrian Cardiac Arrest Awareness Assoc, Vienna, Austria.; Krammel, M (corresponding author), Emergency Med Serv, Vienna, Austria.; Schnaubelt, S (corresponding author), Med Univ Vienna, Dept Emergency Med, Vienna, Austria.	sebastian.schnaubelt@meduniwien.ac.at	Lobmeyr, Elisabeth/AAX-5988-2020	Zeiner, Sebastian/0000-0001-8329-6940; Poppe, Michael/0000-0003-4656-6010; Sulzgruber, Patrick/0000-0001-5146-0099; Uray, Thomas/0000-0002-8869-1912				Berdowski J, 2011, CIRCULATION, V124, P2225, DOI 10.1161/CIRCULATIONAHA.110.015545; Hansen CM, 2015, JAMA-J AM MED ASSOC, V314, P255, DOI 10.1001/jama.2015.7938; Hubner P, 2017, RESUSCITATION, V120, P38, DOI 10.1016/j.resuscitation.2017.08.235; Husain S, 2013, RESUSCITATION, V84, P1184, DOI 10.1016/j.resuscitation.2013.03.040; Kragholm K, 2017, NEW ENGL J MED, V376, P1737, DOI 10.1056/NEJMoa1601891; Krammel M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198918; Lin CC, 2016, AM J EMERG MED, V34, P20, DOI 10.1016/j.ajem.2015.09.001; Nurnberger A, 2013, RESUSCITATION, V84, P42, DOI 10.1016/j.resuscitation.2012.07.002; Perkins GD, 2018, RESUSCITATION, V123, P43, DOI 10.1016/j.resuscitation.2017.12.007; Perkins GD, 2015, RESUSCITATION, V95, P81, DOI 10.1016/j.resuscitation.2015.07.015; Perkins GD, 2015, RESUSCITATION, V96, P328, DOI 10.1016/j.resuscitation.2014.11.002; Ross P, 2001, RESUSCITATION, V50, P141, DOI 10.1016/S0300-9572(01)00343-4; Saner H, 2013, RESUSCITATION, V84, P1197, DOI 10.1016/j.resuscitation.2013.02.023; Schnaubelt S, 2018, RESUSCITATION, V126, pE4, DOI 10.1016/j.resuscitation.2018.02.028; Schober A, 2016, RESUSCITATION, V106, P42, DOI 10.1016/j.resuscitation.2016.06.021; Soar J, 2015, RESUSCITATION, V95, P100, DOI 10.1016/j.resuscitation.2015.07.016; Stein P, 2017, RESUSCITATION, V118, P27, DOI 10.1016/j.resuscitation.2017.06.017; Vukmir RB, 2006, RESUSCITATION, V69, P229, DOI 10.1016/j.resuscitation.2005.08.014; White RD, 1996, ANN EMERG MED, V28, P480, DOI 10.1016/S0196-0644(96)70109-9; Zhan L, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010134.pub2	20	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2020	15	6							e0233966	10.1371/journal.pone.0233966	http://dx.doi.org/10.1371/journal.pone.0233966			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MT4VF	32484818	Green Published, gold			2022-12-26	WOS:000554969700023
J	Lillesand, M; Kvikstad, V; Mangrud, OM; Gudlaugsson, E; Van Diermen-Hidle, B; Skaland, I; Baak, JPA; Janssen, EAM				Lillesand, Melinda; Kvikstad, Vebjorn; Mangrud, Ok Malfrid; Gudlaugsson, Einar; Van Diermen-Hidle, Bianca; Skaland, Ivar; Baak, Jan P. A.; Janssen, Emiel A. M.			Mitotic activity index and CD25+lymphocytes predict risk of stage progression in non-muscle invasive bladder cancer	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; UROTHELIAL CARCINOMAS; PROGNOSTIC VALUE; CELL CARCINOMAS; MICROENVIRONMENT; ASSOCIATION; RECURRENCE; SURVIVAL; NUCLEAR; MARKERS	In urothelial cell type non-muscle invasive urinary bladder carcinoma, TNM stage and WHO grade are widely used to classify patients into low and high-risk groups for prognostic and therapeutic decision-making. However, stage and grade reproducibility and prediction accuracy are wanting. This may lead to suboptimal treatment. We evaluated whether proliferation features, nuclear area of the epithelial cancer cells and the composition of stromal and tumor infiltrating lymphocytes have independent prognostic value. In 183 primary non-muscle invasive bladder cancer patients with long follow-up (median for stage progression cohort: 119 months, range 5-173; median for tumor recurrence cohort: 82, range 3-165) proliferation features Ki67, PPH3 and Mitotic Activity Index (MAI), Mean Nuclear Area (MNA), lymphocyte subsets (CD8+, CD4+, CD25+) and plasma cells (CD138+) were assessed on consecutive sections. Post-resection instillation treatments (none, mitomycin, BCG) were strictly standardized during the intake period. Risk of recurrence was associated with expression of Ki67 (<= 39 vs. > 39) and Multifocality (p = 0.01). Patients with low Ki67 had a higher recurrence rate than those with high Ki67. Lymphocyte composition did not predict recurrence. Stage progression was strongly associated with high values for MAI (> 15) and CD25+ (> 0.2%). In a multivariate analysis the combination of MAI and CD25+ was the single most prognostic feature (p<0.001). Validation of these results in additional, independent studies is warranted.	[Lillesand, Melinda; Kvikstad, Vebjorn; Gudlaugsson, Einar; Van Diermen-Hidle, Bianca; Skaland, Ivar; Baak, Jan P. A.; Janssen, Emiel A. M.] Stavanger Univ Hosp, Dept Pathol, Stavanger, Norway; [Kvikstad, Vebjorn; Janssen, Emiel A. M.] Univ Stavanger, Dept Math & Nat Sci, Stavanger, Norway; [Mangrud, Ok Malfrid] Innlandet Hosp, Dept Pathol, Lillehammer, Norway; [Baak, Jan P. A.] Jan Baak AS, Tananger, Norway	Stavanger University Hospital; Universitetet i Stavanger; Innlandet Hospital Trust	Lillesand, M (corresponding author), Stavanger Univ Hosp, Dept Pathol, Stavanger, Norway.	melinda.lillesand@sus.no		Lillesand, Melinda/0000-0001-8898-1330	Department of Pathology at the Stavanger University Hospital	Department of Pathology at the Stavanger University Hospital	We would like to thank Marit Nordhus for excellent technical assistance, Emma Rewcastle for the great discussions and proofreading the article. Furthermore, we are grateful for all the support from the Department of Pathology at the Stavanger University Hospital. Bianca van Diermen Hidle passed away before the submission of the final version of this manuscript.	Bol MGW, 2002, UROLOGY, V60, P1124, DOI 10.1016/S0090-4295(02)01906-4; Bol MGW, 2001, J CLIN PATHOL, V54, P854, DOI 10.1136/jcp.54.11.854; Bunimovich-Mendrazitsky S, 2011, J THEOR BIOL, V277, P27, DOI 10.1016/j.jtbi.2011.02.008; Cambier S, 2016, EUR UROL, V69, P60, DOI 10.1016/j.eururo.2015.06.045; Decaestecker K, 2015, RES REP UROL, V7, P157, DOI 10.2147/RRU.S63448; Faraj SF, 2015, UROLOGY, V85, DOI 10.1016/j.urology.2014.10.020; Grivas PD, 2011, AM J TRANSL RES, V3, P362; Horn T, 2016, WORLD J UROL, V34, P181, DOI 10.1007/s00345-015-1615-3; Huang HS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25944-1; Ko K, 2017, ONCOTARGET, V8, P100614, DOI 10.18632/oncotarget.21899; Krpina K, 2012, CROAT MED J, V53, P598, DOI 10.3325/cmj.2012.53.598; Kvikstad V, 2019, DIAGN PATHOL, V14, DOI 10.1186/s13000-019-0868-3; Loskog A, 2007, J UROLOGY, V177, P353, DOI 10.1016/j.juro.2006.08.078; Mangrud O., 2014, PLOS ONE, V9, P1, DOI DOI 10.1371/J0URNAL.P0NE.0083192; Mangrud OM, 2014, HUM PATHOL, V45, P1496, DOI 10.1016/j.humpath.2014.03.001; Miyazaki J, 2017, INT J UROL, V24, P730, DOI 10.1111/iju.13376; Ovestad IT, 2010, MODERN PATHOL, V23, P1231, DOI 10.1038/modpathol.2010.109; Parodi A, 2016, ONCOTARGET, V7, P6424, DOI 10.18632/oncotarget.7024; Pichler R, 2016, ONCOTARGET, V7, P39916, DOI 10.18632/oncotarget.9537; Sharma P, 2007, P NATL ACAD SCI USA, V104, P3967, DOI 10.1073/pnas.0611618104; Sievert KD, 2009, WORLD J UROL, V27, P295, DOI 10.1007/s00345-009-0395-z; Skaland I, 2009, BREAST CANCER RES TR, V114, P39, DOI 10.1007/s10549-008-9980-x; Soukup V, 2017, EUR UROL, V72, P801, DOI 10.1016/j.eururo.2017.04.015; Taube JM, 2018, MODERN PATHOL, V31, P214, DOI 10.1038/modpathol.2017.156; van Kessel KEM, 2018, CLIN CANCER RES, V24, P1586, DOI 10.1158/1078-0432.CCR-17-2719; Wang B, 2015, J UROLOGY, V194, P556, DOI 10.1016/j.juro.2015.02.2941; Winerdal ME, 2011, BJU INT, V108, P1672, DOI 10.1111/j.1464-410X.2010.10020.x; Zhang QL, 2015, INT J CLIN EXP PATHO, V8, P11510; Zhang SQ, 2017, PEERJ, V5, DOI 10.7717/peerj.3921; Zhu X, 2009, J CLIN LAB ANAL, V23, P197, DOI 10.1002/jcla.20331; Zuiverloon TCM, 2012, EUR UROL, V61, P128, DOI 10.1016/j.eururo.2011.09.026	31	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2020	15	6							e0233676	10.1371/journal.pone.0233676	http://dx.doi.org/10.1371/journal.pone.0233676			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MT4VF	32484812	Green Published, gold			2022-12-26	WOS:000554969700013
J	Saqib, F; Mujahid, K; Aslam, MA; Modhi, A; Moga, MA; Bobescu, E; Marceanu, L				Saqib, Fatima; Mujahid, Khizra; Aslam, Muhammad Arif; Modhi, Alotaibi; Moga, Marius Alexandru; Bobescu, Elena; Marceanu, Luigi			Ex vivo and in vivo studies of Viola tricolor Linn. as potential cardio protective and hypotensive agent: Inhibition of voltage-gated Ca++ ion channels	FASEB JOURNAL			English	Article						calcium channel blocker; cardiac depressant; histopathology; in vitro; in vivo; invasive blood pressure; Vasodilator; VDLCs	MYOCARDIAL INFARCTED RATS; ISOPROTERENOL; HYPERTROPHY; HYPERTENSION; EXTRACT; GEL	Viola tricolor Linn. is used as cardio-protective and anti-hypertensive agent in traditional medicine. Current study objective was to evaluate cardio-protective and hypotensive effects of Viola tricolor L. in vitro and in vivo studies. Viola tricolor L. crude extract (Vt.Cr) and its fractions (Aqueous and organic) were tested at rabbit atria and aorta coupled to Power Lab Data Acquisition System for cardio depressant and vasorelaxant effects in vitro whereas in vivo Blood Pressure was checked by invasive method in normotensive ketamine-diazepam anesthetized rats. Isoproterenol was employed for acute myocardial infarction (AMI) and left ventricular hypertrophy (LVH) development and cardioprotective effects of Vt.Cr were evaluated hemodynamically and histopathologically. Vt.Cr and its fractions decreased heart rate and contractile force in paired atria and relaxed Phenylephrine (1 mu M) and K+ (80 mM) stimulated contractions in aorta possibly mediated through Voltage dependent L-type calcium channels blockage supported by in vivo hypotensive action. In LVH, Vt.Cr lowered Angiotensin Converting Enzymes and renin, increased cyclic Guanosine Monophosphate and nitric oxide levels, decreased cardiomyocytes size and fibrosis attributed to Gallic acid as detected by High Performance Liquid Chromatography. Partial positive results were seen hemodynamically and histologically in AMI Viola tricolor L. showed vasorelaxant, cardio-relaxant, hypotensive, and cardio protective effect validating traditional practice in cardiovascular disorders.	[Saqib, Fatima; Mujahid, Khizra; Aslam, Muhammad Arif] Bahauddin Zakariya Univ, Fac Pharm, Multan, Pakistan; [Modhi, Alotaibi] Princess Nourah bint Abdulrahman Univ, Dept Biol, Coll Sci, Riyadh, Saudi Arabia; [Moga, Marius Alexandru; Bobescu, Elena; Marceanu, Luigi] Transilvania Univ Brasov, Fac Med, 56 Balcescu Nicolae St, Brasov 500019, Romania	Bahauddin Zakariya University; Princess Nourah bint Abdulrahman University; Transylvania University of Brasov	Bobescu, E (corresponding author), Transilvania Univ Brasov, Fac Med, 56 Balcescu Nicolae St, Brasov 500019, Romania.	elena.bobescu@gmail.com	MOGA, MARIUS ALEXANDRU/AHC-2310-2022; Aslam, Muhammad Arif/AAS-4577-2020; Bobescu, Elena/AAC-6840-2021; Bobescu, Elena/ABD-6951-2020	Aslam, Muhammad Arif/0000-0001-9747-658X; Bobescu, Elena/0000-0002-0945-9067	Deanship of Scientific Research at Princess Nourah bint Abdurrahman University through the Fast-track Research Funding Program	Deanship of Scientific Research at Princess Nourah bint Abdurrahman University through the Fast-track Research Funding Program(Princess Nourah bint Abdulrahman University)	This research was funded by the Deanship of Scientific Research at Princess Nourah bint Abdurrahman University through the Fast-track Research Funding Program	Aman Upaganlawar, 2011, Journal of Pharmacology and Toxicology, V6, P1; Ardjmand A, 2019, LIFE SCI, V227, P187, DOI 10.1016/j.lfs.2019.04.056; Bao D, 2015, DIS MODEL MECH, V8, P795, DOI 10.1242/dmm.021303; Cheng YL, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/274025; Doggrell SA, 1998, CARDIOVASC RES, V39, P89, DOI 10.1016/S0008-6363(98)00076-5; Fan Y, 2019, PHARMACOLOGY, V103, P291, DOI 10.1159/000496800; FOSTER RW, 1984, BRIT J PHARMACOL, V81, P499, DOI 10.1111/j.1476-5381.1984.tb10103.x; Ghorbani A, 2012, AFR J PHARM PHARMACO, V6, P2503, DOI 10.5897/AJPP10.721; Gilani AH, 2005, J ETHNOPHARMACOL, V98, P127, DOI 10.1016/j.jep.2005.01.017; Grzeszczuk M, 2016, ACTA SCI POL-HORTORU, V15, P109; Hellinger R, 2014, J ETHNOPHARMACOL, V151, P299, DOI 10.1016/j.jep.2013.10.044; Jahantab E., 2018, IRAN ADV HERB, V3, P12; Janbaz KH, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0697-1; Jin L., 2017, SCI REP-UK, V7, P1; Jin L, 2017, J HYPERTENS, V35, P1502, DOI 10.1097/HJH.0000000000001327; JIN LI, 2018, SCI REP-UK, V8, P1, DOI DOI 10.1038/S41598-018-27599-4; Kang N, 2015, ENVIRON TOXICOL PHAR, V39, P764, DOI 10.1016/j.etap.2015.02.006; Kim HY, 2011, J ETHNOPHARMACOL, V133, P315, DOI 10.1016/j.jep.2010.09.024; Kirichenko TV, 2016, PHYTOMEDICINE, V23, P1198, DOI 10.1016/j.phymed.2015.12.002; Lin PP, 2013, INT J MOL MED, V32, P1319, DOI 10.3892/ijmm.2013.1524; Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015; Lu L, 2015, CELL BIOCHEM BIOPHYS, V72, P865, DOI 10.1007/s12013-015-0553-4; Meeran MFN, 2016, CHEM-BIOL INTERACT, V244, P159, DOI 10.1016/j.cbi.2015.12.006; Meeran MFN, 2012, EUR J PHARMACOL, V677, P116, DOI 10.1016/j.ejphar.2011.11.043; Mradu G., 2012, INT J PHARMACOGN PHY, V4, P162; Murugesan S, 2019, J ETHNOPHARMACOL, V237, P108, DOI 10.1016/j.jep.2019.03.049; NAGANO M, 1992, HYPERTENSION, V19, P708, DOI 10.1161/01.HYP.19.6.708; Ocaranza MP, 2002, J CARDIOVASC PHARM, V40, P246, DOI 10.1097/00005344-200208000-00010; Odigie IP, 2003, J ETHNOPHARMACOL, V86, P181, DOI 10.1016/S0378-8741(03)00078-3; Panda S, 2014, EUR J PHARMACOL, V723, P451, DOI 10.1016/j.ejphar.2013.10.049; Piana M, 2013, J ETHNOPHARMACOL, V150, P458, DOI 10.1016/j.jep.2013.08.040; Piana M, 2013, J CHROMATOGR SCI, V51, P406, DOI 10.1093/chromsci/bms155; Prince PSM, 2009, EUR J PHARMACOL, V615, P139, DOI 10.1016/j.ejphar.2009.05.003; Rahimi VB, 2019, IRAN J MED SCI, V44, P220; Ryu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep34790; Saqib F, 2019, B LATINOAM CARIBE PL, V18, P204; Saqib F, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0837-7; Seguro Luis Fernando Bernal da Costa, 2009, Arq Bras Cardiol, V93, P652; Sudhakumari A., 2012, INT J BASIC MED SCI, V2, P53; Syed AA, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00510; Takami T, 2003, CLIN EXP HYPERTENS, V25, P525, DOI 10.1081/CEH-120025336; TSE J, 1979, ENDOCRINOLOGY, V105, P246, DOI 10.1210/endo-105-1-246; Vukics V, 2008, J CHROMATOGR SCI, V46, P823, DOI 10.1093/chromsci/46.9.823; Vukics V, 2009, ANTIOXIDANT FLAVONOI, P222; Witkowska-Banaszczak E, 2005, FITOTERAPIA, V76, P458, DOI 10.1016/j.fitote.2005.03.005; World Health Organization, 2019, SAN; YIN FCP, 1982, AM J PHYSIOL, V243, pH941, DOI 10.1152/ajpheart.1982.243.6.H941; Yoon Na Young, 2013, Fisheries and Aquatic Sciences, V16, P237, DOI 10.5657/FAS.2013.0237; Zhang GX, 2005, CARDIOVASC RES, V65, P230, DOI 10.1016/j.cardiores.2004.08.013	49	4	4	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9102	9119		10.1096/fj.202000658R	http://dx.doi.org/10.1096/fj.202000658R		MAY 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32475023				2022-12-26	WOS:000538126200001
J	Margaryan, S; Kriegova, E; Fillerova, R; Kraiczova, VS; Manukyan, G				Margaryan, Sona; Kriegova, Eva; Fillerova, Regina; Kraiczova, Veronika Smotkova; Manukyan, Gayane			Hypomethylation of IL1RN and NFKB1 genes is linked to the dysbalance in IL1 beta/1L-1Ra axis in female patients with type 2 diabetes mellitus	PLOS ONE			English	Article							NF-KAPPA-B; BETA-CELL; RECEPTOR ANTAGONIST; ISLET INFLAMMATION; MACROPHAGES; IL-1-BETA; CYTOKINES; IL-1; LIPOPOLYSACCHARIDE; INTERLEUKIN-1	Inflammation has received considerable attention in the pathogenesis of type 2 diabetes mellitus (T2DM). Supporting this concept, enhanced expression of interleukin (IL)-1 beta and increased infiltration of macrophages are observed in pancreatic islets of patients with T2DM. Although IL-1 receptor antagonist (IL-1Ra) plays a major role in controlling of IL-1 beta mediated inflammation, its counteraction effects and epigenetic alterations in T2DM are less studied. Thus, we aimed to analyze the DNA methylation status in IL1RN, RELA (p65) and NFKB1 (p50) genes in peripheral blood mononuclear cells (PBMCs) from treated T2DM patients (n = 35) and age-/sex-matched healthy controls (n = 31). Production of IL-1 beta and IL-1Ra was analyzed in plasma and supernatants from LPS-induced PBMCs. Immunomodulatory effects of IL-1 beta and IL-1Ra were studied on THP-1 cells. Average DNA methylation level of IL1RN and NFKB1 gene promoters was significantly decreased in T2DM patients in comparison with healthy controls (P < 0.05), which was associated with the increased IL-1Ra (P < 0.001) and IL-1 beta (P = 0.039) plasma levels in T2DM patients. Negative association between average methylation of IL1RN gene and IL-1Ra plasma levels were observed in female T2DM patients. Methylation of NFKB1 gene was negatively correlated with IL-1Ra levels in the patients and positively with IL-1 beta levels in female patients. LPS-stimulated PBMCs from female patients failed to raise IL-1 beta production, while the cells from healthy females increased IL-1 beta production in comparison with unstimulated cells (P < 0.001). Taken together, the findings suggest that hypomethylation of IL1RN and NFKB1 gene promoters may promote the increased IL-113/1L-1Ra production and regulate chronic inflammation in T2DM. Further studies are necessary to elucidate the causal direction of these associations and potential role of IL-1Ra in anti-inflammatory processes in treated patients with T2DM.	[Margaryan, Sona; Kriegova, Eva; Fillerova, Regina; Kraiczova, Veronika Smotkova; Manukyan, Gayane] Palacky Univ, Fac Med & Dent, Dept Immunol, Olomouc, Czech Republic; [Margaryan, Sona; Kriegova, Eva; Fillerova, Regina; Kraiczova, Veronika Smotkova; Manukyan, Gayane] Univ Hosp Olomouc, Olomouc, Czech Republic; [Margaryan, Sona; Manukyan, Gayane] Russian Armenian Slavon Univ, Yerevan, Armenia; [Margaryan, Sona; Manukyan, Gayane] Inst Mol Biol, Lab Mol & Cellular Immunol, Yerevan, Armenia	Palacky University Olomouc; University Hospital Olomouc; Russian Armenian Slavonic University; National Academy of Sciences of Armenia; Institute of Molecular Biology - NAS RA	Manukyan, G (corresponding author), Palacky Univ, Fac Med & Dent, Dept Immunol, Olomouc, Czech Republic.; Manukyan, G (corresponding author), Univ Hosp Olomouc, Olomouc, Czech Republic.; Manukyan, G (corresponding author), Russian Armenian Slavon Univ, Yerevan, Armenia.; Manukyan, G (corresponding author), Inst Mol Biol, Lab Mol & Cellular Immunol, Yerevan, Armenia.	gaya.manukyan@gmail.com	Manukyan, Gayane/AAR-7421-2020	Manukyan, Gayane/0000-0001-7541-5743	Internal grant agency of Palacky University [IGA UP_2020_016]; Ministry of Health Czech Republic MH CZ-DRO (FNOL) [00098892]; Russian-Armenian University of the Ministry of Education and Science of the Russian Federation	Internal grant agency of Palacky University; Ministry of Health Czech Republic MH CZ-DRO (FNOL); Russian-Armenian University of the Ministry of Education and Science of the Russian Federation	Internal grant agency of Palacky University (IGA UP_2020_016), Ministry of Health Czech Republic MH CZ-DRO (FNOL, 00098892) as well as Russian-Armenian University within the framework of the grant of the Ministry of Education and Science of the Russian Federation.	Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Andre P, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081887; Andreasen AS, 2010, INTENS CARE MED, V36, P1548, DOI 10.1007/s00134-010-1845-1; Pinzon-Cortes JA, 2017, ENDOCR CONNECT, V6, P708, DOI 10.1530/EC-17-0199; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Bissonnette S, 2015, NUTR DIABETES, V5, DOI 10.1038/nutd.2015.30; Boni-Schnetzler M, 2009, ENDOCRINOLOGY, V150, P5218, DOI 10.1210/en.2009-0543; Boni-Schnetzler M, 2008, J CLIN ENDOCR METAB, V93, P4065, DOI 10.1210/jc.2008-0396; Boni-Schnetzler M, 2019, SEMIN IMMUNOPATHOL, V41, P501, DOI 10.1007/s00281-019-00745-4; Butcher MJ, 2014, DIABETOLOGIA, V57, P491, DOI 10.1007/s00125-013-3116-5; Cao SJ, 2006, J BIOL CHEM, V281, P26041, DOI 10.1074/jbc.M602222200; Cartwright T, 2016, FEBS J, V283, P1812, DOI 10.1111/febs.13627; Cavallone L, 2003, MECH AGEING DEV, V124, P533, DOI 10.1016/S0047-6374(03)00033-2; Chan C, 2005, J IMMUNOL, V175, P461, DOI 10.4049/jimmunol.175.1.461; Chen SY, 2020, CELL MOL IMMUNOL, V17, P36, DOI 10.1038/s41423-019-0315-0; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; de Groot Amber E, 2018, Oncotarget, V9, P20908, DOI 10.18632/oncotarget.24556; Dinarello CA, 2018, IMMUNOL REV, V281, P8, DOI 10.1111/imr.12621; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Donath MY, 2008, ENDOCR REV, V29, P334, DOI 10.1210/er.2007-0033; Eguchi K, 2013, DIABETES OBES METAB, V15, P152, DOI 10.1111/dom.12168; Ehrich M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1134; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Garcia-Calzon S, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0400-0; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Hanson MA, 2015, NAT REV ENDOCRINOL, V11, P261, DOI 10.1038/nrendo.2015.31; Hawkesworth S, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.24; Isoda K, 2006, ARTERIOSCL THROM VAS, V26, P611, DOI 10.1161/01.ATV.0000201938.78044.75; Jayashree B, 2014, MOL CELL BIOCHEM, V388, P203, DOI 10.1007/s11010-013-1911-4; Khondkaryan L, 2018, INT J INFLAMM, V2018, DOI 10.1155/2018/2157434; La EH, 2001, J IMMUNOL, V166, P6149, DOI 10.4049/jimmunol.166.10.6149; Lin YS, 2009, DIS MARKERS, V27, P23, DOI [10.1155/2009/529253, 10.3233/DMA-2009-0643]; Luttmer R, 2013, OBES RES CLIN PRACT, V7, pE106, DOI 10.1016/j.orcp.2012.06.001; Madej MP, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00335; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Mantovani A, 2019, IMMUNITY, V50, P778, DOI 10.1016/j.immuni.2019.03.012; Matsha TE, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/8738072; Mauvais-Jarvis F, 2017, ENDOCR REV, V38, P173, DOI 10.1210/er.2016-1146; Mo D, 2019, DRUG DES DEV THER, V13, P2769, DOI 10.2147/DDDT.S208327; Morris MC, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00680; Nackiewicz D, 2014, DIABETOLOGIA, V57, P1645, DOI 10.1007/s00125-014-3249-1; Nardini C, 2018, SEMIN IMMUNOL, V40, P49, DOI 10.1016/j.smim.2018.10.009; Saccani A, 2006, CANCER RES, V66, P11432, DOI 10.1158/0008-5472.CAN-06-1867; Seeley JJ, 2017, J LEUKOCYTE BIOL, V101, P107, DOI 10.1189/jlb.3MR0316-118RR; Sobowale OA, 2016, STROKE, V47, P2160, DOI 10.1161/STROKEAHA.115.010001; Sommese L, 2017, EPIGENETICS-US, V12, P401, DOI 10.1080/15592294.2016.1278097; Kuwabara WMT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35809-2; Tong X, 2004, MOL CELL BIOCHEM, V265, P171, DOI 10.1023/B:MCBI.0000044394.66951.4d; van den Biggelaar AHJ, 2004, FASEB J, V18, P1022, DOI 10.1096/fj.03-1162fje; Walker CG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131681; Westwell-Roper CY, 2014, DIABETES, V63, P1698, DOI 10.2337/db13-0863; Wiesner P, 2010, CIRC RES, V107, P56, DOI 10.1161/CIRCRESAHA.110.218420; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Willmer T, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00744; Ybarra J, 2008, DIABETES METAB, V34, P75, DOI 10.1016/j.diabet.2007.10.006; Zhang Q, 2017, CELL, V168, P37, DOI 10.1016/j.cell.2016.12.012	57	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2020	15	5							e0233737	10.1371/journal.pone.0233737	http://dx.doi.org/10.1371/journal.pone.0233737			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1WS	32470060	gold, Green Published			2022-12-26	WOS:000537552800159
J	Fischer, J; Song, YS; Yosef, N; di Iulio, J; Churchman, LS; Choder, M				Fischer, Jonathan; Song, Yun S.; Yosef, Nir; di Iulio, Julia; Churchman, L. Stirling; Choder, Mordechai			The yeast exoribonuclease Xrn1 and associated factors modulate RNA polymerase II processivity in 5' and 3' gene regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mRNA buffering; native elongating transcript sequencing (NET-seq); transcription regulation; transcriptional profiling; yeast; mRNA decay; Xrn1; transcription factor; transcriptomics; gene regulation	NONCODING RNA; TRANSCRIPTION TERMINATION; PERVASIVE TRANSCRIPTION; NASCENT TRANSCRIPTION; CCR4-NOT COMPLEX; RPB4 SUBUNIT; REVEALS; DECAY; ELONGATION; GENOME	mRNA levels are determined by the balance between mRNA synthesis and decay. Protein factors that mediate both processes, including the 5'-3' exonuclease Xrn1, are responsible for a cross-talk between the two processes that buffers steady-state mRNA levels. However, the roles of these proteins in transcription remain elusive and controversial. Applying native elongating transcript sequencing (NET-seq) to yeast cells, we show that Xrn1 functions mainly as a transcriptional activator and that its disruption manifests as a reduction of RNA polymerase II (Pol II) occupancy downstream of transcription start sites. By combining our sequencing data and mathematical modeling of transcription, we found that Xrn1 modulates transcription initiation and elongation of its target genes. Furthermore, Pol II occupancy markedly increased near cleavage and polyadenylation sites inxrn1 Delta cells, whereas its activity decreased, a characteristic feature of backtracked Pol II. We also provide indirect evidence that Xrn1 is involved in transcription termination downstream of polyadenylation sites. We noted that two additional decay factors, Dhh1 and Lsm1, seem to function similarly to Xrn1 in transcription, perhaps as a complex, and that the decay factors Ccr4 and Rpb4 also perturb transcription in other ways. Interestingly, the decay factors could differentiate between SAGA- and TFIID-dominated promoters. These two classes of genes responded differently toXRN1deletion in mRNA synthesis and were differentially regulated by mRNA decay pathways, raising the possibility that one distinction between these two gene classes lies in the mechanisms that balance mRNA synthesis with mRNA decay.	[Fischer, Jonathan; Song, Yun S.] Univ Calif Berkeley, Div Comp Sci, Berkeley, CA 94720 USA; [Fischer, Jonathan; Song, Yun S.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Song, Yun S.; Yosef, Nir] Chan Zuckerberg BioHub, San Francisco, CA USA; [Yosef, Nir] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Yosef, Nir] Ragon Inst MGH MIT & Harvard, Cambridge, MA USA; [di Iulio, Julia; Churchman, L. Stirling] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Choder, Mordechai] Technion Israel Inst Technol, Rappaport Fac Med, Dept Mol Microbiol, Haifa, Israel	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard Medical School; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Choder, M (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, Dept Mol Microbiol, Haifa, Israel.	choder@technion.ac.il		Fischer, Jonathan/0000-0002-1165-9930	Israel Science Foundation [1472/15]; National Institutes of Health [T32-HG000047, R01-GM094402]; Packard Fellowship for Science and Engineering	Israel Science Foundation(Israel Science Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Fellowship for Science and Engineering	This work was supported in part by Israel Science Foundation Grant 1472/15, National Institutes of Health Training Grants T32-HG000047 and R01-GM094402, and a Packard Fellowship for Science and Engineering. N. Y. and Y. S. S. are Chan Zuckerberg Biohub Investigators. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Baptista T, 2017, MOL CELL, V68, P130, DOI 10.1016/j.molcel.2017.08.016; Bartman CR, 2019, MOL CELL, V73, P519, DOI 10.1016/j.molcel.2018.11.004; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Begley V., 2020, BIORXIV, DOI [10.1101/2020.06.02.129171, DOI 10.1101/2020.06.02.129171]; Begley V, 2019, NUCLEIC ACIDS RES, V47, P9524, DOI 10.1093/nar/gkz660; Bentley DL, 2014, NAT REV GENET, V15, P163, DOI 10.1038/nrg3662; Blasco-Moreno B, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09199-6; Bonnet J, 2014, GENE DEV, V28, P1999, DOI 10.1101/gad.250225.114; Braun KA, 2014, MOL CELL BIOL, V34, P4078, DOI 10.1128/MCB.00535-14; Bregman A, 2011, CELL, V147, P1473, DOI 10.1016/j.cell.2011.12.005; Bumgarner SL, 2009, P NATL ACAD SCI USA, V106, P18321, DOI 10.1073/pnas.0909641106; Chen FX, 2018, NAT REV MOL CELL BIO, V19, P464, DOI 10.1038/s41580-018-0010-5; Choder M, 2004, TRENDS BIOCHEM SCI, V29, P674, DOI 10.1016/j.tibs.2004.10.007; Churchman L.S., 2011, GSE25107; Churchman L Stirling, 2012, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0414s98; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; CLEVELAND WS, 1981, AM STAT, V35, P54, DOI 10.2307/2683591; Collart MA, 2016, WIRES RNA, V7, P438, DOI 10.1002/wrna.1332; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Costanzo M, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1420; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; de Jonge WJ, 2017, EMBO J, V36, P274, DOI 10.15252/embj.201695621; Duek L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206161; Dutta A, 2015, MOL CELL BIOL, V35, P1915, DOI 10.1128/MCB.00044-15; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Ehrensberger AH, 2013, CELL, V154, P713, DOI 10.1016/j.cell.2013.07.032; Erdmann-Pham DD, 2020, CELL SYST, V10, P183, DOI 10.1016/j.cels.2019.12.003; Feldman JL, 2019, CELL REP, V27, P2978, DOI 10.1016/j.celrep.2019.05.009; Fischer J., 2020, EMTAB8749; Garcia-Martinez J, 2004, MOL CELL, V15, P303, DOI 10.1016/j.molcel.2004.06.004; Garcia-Martinez J, 2016, NUCLEIC ACIDS RES, V44, P3643, DOI 10.1093/nar/gkv1512; Goler-Baron V, 2008, GENE DEV, V22, P2022, DOI 10.1101/gad.473608; Gomez-Herreros F, 2012, FEBS LETT, V586, P2820, DOI 10.1016/j.febslet.2012.07.030; Grosso AR, 2012, GENOME RES, V22, P1447, DOI 10.1101/gr.138057.112; Gupta I, 2016, CELL REP, V15, P1782, DOI 10.1016/j.celrep.2016.04.055; Haimovich G., 2013, GSE44312; Haimovich G, 2013, CELL, V153, P1000, DOI 10.1016/j.cell.2013.05.012; He F., 2017, GSE107841; He F, 2018, ELIFE, V7, DOI 10.7554/eLife.34409; Hobson DJ, 2012, MOL CELL, V48, P365, DOI 10.1016/j.molcel.2012.08.027; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; HYMAN LE, 1993, MOL CELL BIOL, V13, P5159, DOI 10.1128/MCB.13.9.5159; Iyer V.R., 2014, GSE49026; Jonkers I, 2014, ELIFE, V3, DOI 10.7554/eLife.02407; Jordan-Pla A., 2014, GSE58859; Jordan-Pla A, 2016, METHODS MOL BIOL, V1361, P125, DOI 10.1007/978-1-4939-3079-1_8; Jordan-Pla A, 2015, NUCLEIC ACIDS RES, V43, P787, DOI 10.1093/nar/gku1349; Kazerouninia A, 2010, RNA, V16, P197, DOI 10.1261/rna.1622010; Kruk JA, 2011, GENE DEV, V25, P581, DOI 10.1101/gad.2020911; Kubik S, 2015, MOL CELL, V60, P422, DOI 10.1016/j.molcel.2015.10.002; Kuehner JN, 2011, NAT REV MOL CELL BIO, V12, P283, DOI 10.1038/nrm3098; Kuzmin E, 2018, SCIENCE, V360, DOI 10.1126/science.aao1729; Larson DR, 2011, SCIENCE, V332, P475, DOI 10.1126/science.1202142; Le Martelot G, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001442; Lotan R, 2005, GENE DEV, V19, P3004, DOI 10.1101/gad.353205; Lotan R, 2007, J CELL BIOL, V178, P1133, DOI 10.1083/jcb.200701165; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mayer A, 2017, CURR OPIN CELL BIOL, V46, P72, DOI 10.1016/j.ceb.2017.03.002; Medina DA, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00001; Mi HY, 2019, NUCLEIC ACIDS RES, V47, pD419, DOI 10.1093/nar/gky1038; Miller JE, 2018, G3-GENES GENOM GENET, V8, P315, DOI 10.1534/g3.117.300415; Mischo HE, 2013, BBA-GENE REGUL MECH, V1829, P174, DOI 10.1016/j.bbagrm.2012.10.003; Murray SC, 2015, NUCLEIC ACIDS RES, V43, P7823, DOI 10.1093/nar/gkv666; Park D, 2014, NUCLEIC ACIDS RES, V42, P3736, DOI 10.1093/nar/gkt1366; Perez-Ortin J.E., 2015, GSE57467; Perez-Ortin J.E., 2013, GSE29619; Perez-Ortin JE, 2019, RNA BIOL, V16, P1659, DOI 10.1080/15476286.2019.1655352; Perl K., 2015, RRIDSCR018776; Porrua O, 2016, TRENDS GENET, V32, P508, DOI 10.1016/j.tig.2016.05.007; Richard P, 2009, GENE DEV, V23, P1247, DOI 10.1101/gad.1792809; Rodriguez-Molina JB, 2016, MOL CELL, V63, P433, DOI 10.1016/j.molcel.2016.06.036; Runner VM, 2008, MOL CELL BIOL, V28, P1883, DOI 10.1128/MCB.01714-07; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schulz D, 2014, J BIOL CHEM, V289, P17446, DOI 10.1074/jbc.M114.568014; Schulz D, 2013, CELL, V155, P1075, DOI 10.1016/j.cell.2013.10.024; Shalem O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002273; Sheridan RM, 2019, MOL CELL, V73, P107, DOI 10.1016/j.molcel.2018.10.031; Srivas R, 2016, MOL CELL, V63, P514, DOI 10.1016/j.molcel.2016.06.022; Sun M., 2014, EMTAB1525; Sun M, 2013, MOL CELL, V52, P52, DOI 10.1016/j.molcel.2013.09.010; Sun M, 2012, GENOME RES, V22, P1350, DOI 10.1101/gr.130161.111; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tian B, 2017, NAT REV MOL CELL BIO, V18, P18, DOI 10.1038/nrm.2016.116; Tirosh I, 2007, TRENDS GENET, V23, P318, DOI 10.1016/j.tig.2007.03.015; Tisseur M, 2011, BIOCHIMIE, V93, P1889, DOI 10.1016/j.biochi.2011.07.001; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Trcek T, 2011, CELL, V147, P1484, DOI 10.1016/j.cell.2011.11.051; Tuck A.C., 2013, GSE46742; Tuck AC, 2013, CELL, V154, P996, DOI 10.1016/j.cell.2013.07.047; van Dijk EL, 2011, NATURE, V475, P114, DOI 10.1038/nature10118; Verma-Gaur J, 2008, EUKARYOT CELL, V7, P1009, DOI 10.1128/EC.00057-08; Warfield L, 2017, MOL CELL, V68, P118, DOI 10.1016/j.molcel.2017.08.014; Wery M, 2018, RNA, V24, P196, DOI 10.1261/rna.063446.117; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012; Wissink EM, 2019, NAT REV GENET, V20, P705, DOI 10.1038/s41576-019-0159-6; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728	100	10	10	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2020	295	33					11435	11454		10.1074/jbc.RA120.013426	http://dx.doi.org/10.1074/jbc.RA120.013426			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NG3YV	32518159	hybrid, Green Published			2022-12-26	WOS:000563922500007
J	Zaccor, NW; Sumner, CJ; Snyder, SH				Zaccor, Nicholas W.; Sumner, Charlotte J.; Snyder, Solomon H.			The nonselective cation channel TRPV4 inhibits angiotensin II receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transient receptor potential vanilloid 4 (TRPV4); angiotensin II receptor type 1 (AT1R); G-protein?coupled receptor (GPCR); ?-arrestin; phosphorylation; desensitization; calcineurin; cell signaling; cell sensor; receptor desensitization; transient receptor potential channels (TRP channels); beta-arrestin	ACTIVATION; PROTEIN; CALCINEURIN; CALCIUM; CELLS; FORMS; DESENSITIZATION; SPECIFICITY; SECRETION; INFLUX	G-protein?coupled receptors (GPCRs) are a ubiquitously expressed family of receptor proteins that regulate many physiological functions and other proteins. They act through two dissociable signaling pathways: the exchange of GDP to GTP by linked G-proteins and the recruitment of ?-arrestins. GPCRs modulate several members of the transient receptor potential (TRP) channel family of nonselective cation channels. How TRP channels reciprocally regulate GPCR signaling is less well-explored. Here, using an array of biochemical approaches, including immunoprecipitation and fluorescence, calcium imaging, phosphate radiolabeling, and a ?-arrestin?dependent luciferase assay, we characterize a GPCR?TRP channel pair, angiotensin II receptor type 1 (AT1R), and transient receptor potential vanilloid 4 (TRPV4), in primary murine choroid plexus epithelial cells and immortalized cell lines. We found that AT1R and TRPV4 are binding partners and that activation of AT1R by angiotensin II (ANGII) elicits ?-arrestin?dependent inhibition and internalization of TRPV4. Activating TRPV4 with endogenous and synthetic agonists inhibited angiotensin II?mediated G-protein?associated second messenger accumulation, AT1R receptor phosphorylation, and ?-arrestin recruitment. We also noted that TRPV4 inhibits AT1R phosphorylation by activating the calcium-activated phosphatase calcineurin in a Ca2+/calmodulin?dependent manner, preventing ?-arrestin recruitment and receptor internalization. These findings suggest that when TRP channels and GPCRs are co-expressed in the same tissues, many of these channels can inhibit GPCR desensitization.	[Zaccor, Nicholas W.; Sumner, Charlotte J.; Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Sumner, Charlotte J.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.; Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.; Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	ssnyder@jhmi.edu		Zaccor, Nicholas/0000-0003-0002-3328; Sumner, Charlotte/0000-0001-5088-6012	National Institutes of Health [DA044123-1A1, MH018501-48, MH100024-05, NS062869, NS087579, OD016374, GM007309]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants DA044123-1A1 (to S. H. S.), MH018501-48 (to S. H. S.), MH100024-05 (to S. H. S.), NS062869 (to C. J. S.), NS087579 (to C. J. S.), OD016374 (to S. Kuo), and GM007309 (to N. W. Z.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arniges M, 2006, J BIOL CHEM, V281, P1580, DOI 10.1074/jbc.M511456200; Bahouth SW, 1996, MOL PHARMACOL, V49, P1049; Basso L., 2018, TRPV1 REGULATES OPIO, DOI [10.1101/274233, DOI 10.1101/274233]; Bihzad S. M., 2017, Autonomic & Autacoid Pharmacology, V37, P3, DOI 10.1111/aap.12052; BODDEKE HWGM, 1993, N-S ARCH PHARMACOL, V348, P221; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Chen J, 2015, N-S ARCH PHARMACOL, V388, P451, DOI 10.1007/s00210-015-1088-3; Crabtree GR, 2001, J BIOL CHEM, V276, P2313, DOI 10.1074/jbc.R000024200; Damkier HH, 2013, PHYSIOL REV, V93, P1847, DOI 10.1152/physrev.00004.2013; Filosa JA, 2013, J CARDIOVASC PHARM, V61, P113, DOI 10.1097/FJC.0b013e318279ba42; Gaborik Z, 2003, ENDOCRINOLOGY, V144, P2220, DOI 10.1210/en.2002-0135; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Hannan MA, 2008, BBA-BIOMEMBRANES, V1778, P974, DOI 10.1016/j.bbamem.2008.01.011; Hilger D, 2018, NAT STRUCT MOL BIOL, V25, P4, DOI 10.1038/s41594-017-0011-7; Hughes TE, 2001, J BIOL CHEM, V276, P4227, DOI 10.1074/jbc.M007608200; Hunton DL, 2005, MOL PHARMACOL, V67, P1229, DOI 10.1124/mol.104.006270; Kim SJ, 2003, NATURE, V426, P285, DOI 10.1038/nature02162; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Kusudo T, 2012, J APPL PHYSIOL, V112, P1223, DOI 10.1152/japplphysiol.01070.2011; Liu CH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14335; Luft FC, 2015, J MOL MED, V93, P1283, DOI 10.1007/s00109-015-1347-2; MAJERUS PW, 1992, ANNU REV BIOCHEM, V61, P225, DOI 10.1146/annurev.bi.61.070192.001301; Masuyama R, 2008, CELL METAB, V8, P257, DOI 10.1016/j.cmet.2008.08.002; Matsusaka T, 1997, ANNU REV PHYSIOL, V59, P395, DOI 10.1146/annurev.physiol.59.1.395; Meixiong J, 2019, ELIFE, V8, DOI 10.7554/eLife.44116; Mendoza SA, 2010, AM J PHYSIOL-HEART C, V298, pH466, DOI 10.1152/ajpheart.00854.2009; Millar Ian D, 2007, Cerebrospinal Fluid Res, V4, P8, DOI 10.1186/1743-8454-4-8; Mizuno N, 2009, NEUROSIGNALS, V17, P42, DOI 10.1159/000186689; Monnot Andrew D, 2013, Methods Mol Biol, V945, P13, DOI 10.1007/978-1-62703-125-7_2; Orlandi C, 2013, INVEST OPHTH VIS SCI, V54, P7153, DOI 10.1167/iovs.13-12907; Preston D, 2018, AM J PHYSIOL-CELL PH, V315, pC357, DOI 10.1152/ajpcell.00312.2017; SANDERSBUSH E, 1991, PSYCHOPHARMACOLOGY, V105, P340, DOI 10.1007/BF02244428; Scherer PC, 2017, P NATL ACAD SCI USA, V114, P13561, DOI 10.1073/pnas.1717005114; Segal MB, 2000, CELL MOL NEUROBIOL, V20, P183, DOI 10.1023/A:1007045605751; Shapovalov G, 2013, CELL REP, V4, P504, DOI 10.1016/j.celrep.2013.07.002; Shukla AK, 2010, J BIOL CHEM, V285, P30115, DOI 10.1074/jbc.M110.141549; Swingle Mark, 2007, V365, P23; Takayama Y, 2014, FASEB J, V28, P2238, DOI 10.1096/fj.13-243436; Thomas W. G., 2009, G PROTEIN COUPLED RE; Vasavda C, 2017, JOVE-J VIS EXP, DOI 10.3791/55561; Vetter I, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-22; Vinuela-Fernandez I, 2014, NEUROPHARMACOLOGY, V79, P136, DOI 10.1016/j.neuropharm.2013.11.006; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; Wisler JW, 2014, CURR OPIN CELL BIOL, V27, P18, DOI 10.1016/j.ceb.2013.10.008; Zhang DX, 2009, HYPERTENSION, V53, P532, DOI 10.1161/HYPERTENSIONAHA.108.127100; Zhao LM, 2014, AM J RESP CELL MOL, V50, P1064, DOI 10.1165/rcmb.2013-0416OC; Zheng J, 2013, COMPR PHYSIOL, V3, P221, DOI 10.1002/cphy.c120001	48	4	4	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2020	295	29					9986	9997		10.1074/jbc.RA120.014325	http://dx.doi.org/10.1074/jbc.RA120.014325			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MR1DY	32493776	hybrid, Green Published			2022-12-26	WOS:000553333300017
J	Huff, A; Reed, MD; Iceman, KE; Howland, DR; Pitts, T				Huff, Alyssa; Reed, Mitchell D.; Iceman, Kimberly E.; Howland, Dena R.; Pitts, Teresa			Sex-specific vagal and spinal modulation of swallow and its coordination with breathing	PLOS ONE			English	Article							LARYNGEAL NERVE-STIMULATION; VOLUNTARY COUGH; LUNG-VOLUME; ASPIRATION RISK; PHARYNGEAL; MOTONEURONS; DYSFUNCTION; NEURONS; REFLEX; DEGLUTITION	Swallow-breathing coordination is influenced by changes in lung volume, which is modulated by feedback from both vagal and spinal sensory afferents. The purpose of this study was to manipulate feedback from these afferents, with and without a simultaneous mechanical challenge (chest compression), in order to assess the influence of each sensory pathway on swallow in rats. We hypothesized that manipulation of afferent feedback would shift the occurrence of swallow toward the inspiratory phase of breathing. Afferent feedback was perturbed by lidocaine nebulization, extra-thoracic vagotomy, or lidocaine administration to the pleural space in sodium pentobarbital anesthetized rats (N= 43). These different afferent perturbations were performed both in control conditions (no chest compression), and with chest compression. Manipulating pulmonary stretch receptor-mediated volume feedback in male animals decreased swallow occurrence. Female rats appear to rely more on spinal afferent feedback, as swallow occurrence shifted to late expiration with chest compression and vagotomy or lidocaine injections. Results suggest that sex-specific mechanisms modulate swallow-breathing coordination, and that vagal feedback is inhibitory to swallow-related muscles, while spinal feedback from pleural afferents has excitatory effects. This study supports the theory that a balance of vagal and spinal afferent feedback is necessary to maintain an optimal swallow pattern and swallow-breathing coordination.	[Huff, Alyssa] Univ Louisville, Dept Physiol, Louisville, KY 40292 USA; [Huff, Alyssa; Reed, Mitchell D.; Iceman, Kimberly E.; Howland, Dena R.; Pitts, Teresa] Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Dept Neurol Surg, Louisville, KY 40292 USA; [Howland, Dena R.] Robley Rex Vet Affairs Med Ctr, Res Serv, Louisville, KY USA; [Huff, Alyssa] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA USA	University of Louisville; University of Louisville; Seattle Children's Hospital	Pitts, T (corresponding author), Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Dept Neurol Surg, Louisville, KY 40292 USA.	t.pitts@louisville.edu		Huff, Alyssa/0000-0003-2817-251X; Iceman, Kimberly/0000-0002-9004-3893	NIH [HL 111215, HL 103415, OT2OD023854]; Craig F. Neilson Foundation Pilot Research Grant [546714]; Kentucky Spinal Cord and Head Injury Research Trust; Commonwealth of Kentucky Challenge for Excellence; Rebecca F Hammond Endowment	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Craig F. Neilson Foundation Pilot Research Grant; Kentucky Spinal Cord and Head Injury Research Trust; Commonwealth of Kentucky Challenge for Excellence; Rebecca F Hammond Endowment	NIH grants HL 111215, HL 103415 and OT2OD023854: TP. The Craig F. Neilson Foundation Pilot Research Grant 546714: TP. Kentucky Spinal Cord and Head Injury Research Trust: TP. Commonwealth of Kentucky Challenge for Excellence: TP. Rebecca F Hammond Endowment: DH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN ML, 1986, J APPL PHYSIOL, V60, P1894, DOI 10.1152/jappl.1986.60.6.1894; Bailey EF, 2006, J APPL PHYSIOL, V101, P609, DOI 10.1152/japplphysiol.00204.2006; BASMAJIAN JV, 1962, J APPL PHYSIOL, V17, P849, DOI 10.1152/jappl.1962.17.5.849; Baum DM, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00788; Bautista TG, 2014, J PHYSIOL-LONDON, V592, P2605, DOI 10.1113/jphysiol.2014.272468; Bellemare F, 2003, AM J RESP CRIT CARE, V168, P305, DOI 10.1164/rccm.200208-876OC; Black R, 2020, DISABIL REHABIL, V42, P2083, DOI 10.1080/09638288.2018.1552326; Bolser DC, 2013, OTOLARYNG CLIN N AM, V46, P957, DOI 10.1016/j.otc.2013.09.013; Brodsky MB, 2010, HEAD NECK-J SCI SPEC, V32, P481, DOI 10.1002/hed.21209; Campbell E, 1962, CIBA F S PULMONARY S, P29; Carey MA, 2007, TRENDS ENDOCRIN MET, V18, P308, DOI 10.1016/j.tem.2007.08.003; Castro J, 2014, P NATL ACAD SCI USA, V111, P9941, DOI 10.1073/pnas.1311685111; CHIAO GZ, 1994, EXP BRAIN RES, V100, P29; DICK TE, 1993, J PHYSIOL-LONDON, V465, P715, DOI 10.1113/jphysiol.1993.sp019702; DURON B, 1980, Z MIKROSK ANAT FORSC, V94, P257; Feroah TR, 2002, J APPL PHYSIOL, V92, P1923, DOI 10.1152/japplphysiol.01079.2000; Gargaglioni LH, 2019, COMP BIOCHEM PHYS A, V238, DOI 10.1016/j.cbpa.2019.110543; Gestreau C, 1996, EXP BRAIN RES, V108, P247; Gestreau C, 2000, EXP BRAIN RES, V130, P27, DOI 10.1007/s002210050003; GREET DG, 1984, J MORPHOL, V179, P95, DOI 10.1002/jmor.1051790109; Hammond CAS, 2009, CHEST, V135, P769, DOI 10.1378/chest.08-1122; Hammond CAS, 2001, NEUROLOGY, V56, P502, DOI 10.1212/WNL.56.4.502; Harada H, 2005, NEUROSCI RES, V51, P395, DOI 10.1016/j.neures.2004.12.007; Hashimoto K, 2019, LARYNGOSCOPE, V129, pE72, DOI 10.1002/lary.27401; Hegland KMW, 2009, J SPEECH LANG HEAR R, V52, P178, DOI 10.1044/1092-4388(2008/07-0165); Hegland KW, 2014, LUNG, V192, P601, DOI 10.1007/s00408-014-9584-7; Hegland KW, 2011, J SPEECH LANG HEAR R, V54, P777, DOI [10.1044/1092-4388(2010/09-0237), 10.1044/1092-4388(2010/09-0237]; HILDEBRAND MILTON U., 1959, JOUR MAMMAL, V40, P481, DOI 10.2307/1376265; Horton KK, 2018, FASEB J, V32; Huff A, 2018, RESP PHYSIOL NEUROBI; Huff A, 2018, LUNG, V196, P601, DOI 10.1007/s00408-018-0133-7; Huff ARM, 2020, PLOS ONE; Hutchinson J, 1846, Med Chir Trans, V29, P137; Ihalainen T, 2017, SPINAL CORD, V55, P979, DOI 10.1038/sc.2017.71; JEAN A, 1984, J AUTONOM NERV SYST, V10, P225, DOI 10.1016/0165-1838(84)90017-1; Joseph V, 2013, RESP PHYSIOL NEUROBI, V185, P75, DOI 10.1016/j.resp.2012.07.001; KESSLER JP, 1985, EXP BRAIN RES, V57, P256; Kogo M, 2002, BRAIN RES, V955, P24, DOI 10.1016/S0006-8993(02)03339-5; Kronecker H, 1880, ARCH F PHYSL, V446; Kronecker H, 1882, P ROY SOC LONDON, V33, P27; Li HF, 2009, AM J PHYSIOL-REG I, V297, pR853, DOI 10.1152/ajpregu.00013.2009; LoMauro A, 2018, BREATHE, V14, P131, DOI 10.1183/20734735.000318; Lust RM, 2007, CONTROL RESPIRATION; Magendie F, 1817, PRECIS ELEMENTAIRE P, V1816, P2; Mantilla CB, 2009, J NEUROSCI METH, V182, P244, DOI 10.1016/j.jneumeth.2009.06.016; Marckwald M, 1888, SUPPLEMENT RELATION; Martin-Harris B, 2003, J APPL PHYSIOL, V94, P1735, DOI 10.1152/japplphysiol.00806.2002; McFarland DH, 2016, RESP PHYSIOL NEUROBI, V234, P89, DOI 10.1016/j.resp.2016.09.004; MCFARLAND DH, 1993, J NEUROPHYSIOL, V69, P95, DOI 10.1152/jn.1993.69.1.95; MCNAMARA JA, 1973, ARCH ORAL BIOL, V18, P995, DOI 10.1016/0003-9969(73)90181-7; Ouahchi Y, 2011, RESP PHYSIOL NEUROBI, V176, P98, DOI 10.1016/j.resp.2011.01.013; Patten Samuel, 1800, Lond Med J, V10, P356; Pitts T, 2008, DYSPHAGIA, V23, P297, DOI 10.1007/s00455-007-9144-x; Pitts T, 2015, LUNG, V193, P129, DOI 10.1007/s00408-014-9662-x; Pitts T, 2013, RESP PHYSIOL NEUROBI, V189, P543, DOI 10.1016/j.resp.2013.08.009; Pitts T, 2012, EXP PHYSIOL, V97, P469, DOI 10.1113/expphysiol.2011.063362; Pitts T, 2010, CHEST, V138, P1426, DOI 10.1378/chest.10-0342; Reed MD, 2019, LUNG; Sang Q, 2001, AM J PHYSIOL-GASTR L, V280, pG191, DOI 10.1152/ajpgi.2001.280.2.G191; Sherrington C.S., 1915, EXP PHYSIOL, V9, P147, DOI [10.1113/expphysiol.1915.sp000201, DOI 10.1113/EXPPHYSIOL.1915.SP000201]; SHIMAZU I, 1962, J NEUROPHYSIOL, V25, P309; Spearman DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106121; SUMI T, 1963, J NEUROPHYSIOL, V26, P466, DOI 10.1152/jn.1963.26.3.466; Suzuki T, 2010, NEUROSCI RES, V67, P327, DOI 10.1016/j.neures.2010.04.011; Thexton AJ, 2007, J APPL PHYSIOL, V102, P587, DOI 10.1152/japplphysiol.00456.2006; Troche MS, 2010, NEUROLOGY, V75, P1912, DOI 10.1212/WNL.0b013e3181fef115; Troche MS, 2016, DYSPHAGIA, V31, P757, DOI 10.1007/s00455-016-9734-6; UCHIDA K, 1994, PHYSIOL BEHAV, V55, P795, DOI 10.1016/0031-9384(94)90062-0; VANLUNTEREN E, 1989, J APPL PHYSIOL, V67, P2296, DOI 10.1152/jappl.1989.67.6.2296; VANLUNTEREN E, 1989, J CLIN INVEST, V84, P577, DOI 10.1172/JCI114201; Wassilieff N, 1887, WO WIRD SCHLUCKREFLE; Wenninger JM, 2009, J APPL PHYSIOL, V106, P1522, DOI 10.1152/japplphysiol.90802.2008; Zabka AG, 2001, J PHYSIOL-LONDON, V531, P509, DOI 10.1111/j.1469-7793.2001.0509i.x; Zechman Jr FW, 2011, COMPREHENSIVE PHYSL, P449	74	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234194	10.1371/journal.pone.0234194	http://dx.doi.org/10.1371/journal.pone.0234194			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525920	Green Published, gold			2022-12-26	WOS:000542036800002
J	Wu, FP; Wang, GY; Wang, J; Zhou, CX; Yang, CR; Niu, WB; Zhang, JF; Wang, GL; Yang, YF				Wu, Fengpeng; Wang, Guiying; Wang, Jun; Zhou, Chaoxi; Yang, Congrong; Niu, Wenbo; Zhang, Jianfeng; Wang, Guanglin; Yang, Yafan			Analysis of influencing factors of no/low response to preoperative concurrent chemoradiotherapy in locally advanced rectal cancer	PLOS ONE			English	Article							PATHOLOGICAL COMPLETE RESPONSE; TOTAL MESORECTAL EXCISION; RADIATION-THERAPY; RISK-FACTORS; ANASTOMOTIC LEAKAGE; INITIATING CELLS; TUMOR RESPONSE; BREAST-CANCER; CD44; EXPRESSION	The aim of this study is to investigate the influencing factors associated with no/low response to preoperative concurrent chemoradiotherapy (CCRT) for locally advanced rectal cancer (LARC) patients. A total of 79 patients were included in this prospective study. Fifteen factors that might affect the resistance to CCRT were included in this logistic regression analysis, these factors include the general clinical data of patients, the expression status of tumor stem cell marker CD44v6 and the volumetric imaging parameters of primary tumor lesions. We found that the no/low response status to preoperative CCRT was positively correlated with the real tumor volume (RTV), the total surface area of tumor (TSA), and CD44v6 expression, whereas negatively correlated with the tumor compactness (TC). According to the results of logistic regression analysis, two formulas that could predict whether or not no/low response to preoperative CCRT were established. The Area Under Curve (AUC) of the two formulas and those significant measurement data (RTV, TC, TSA) were 0.900, 0.858, 0.771, 0.754, 0.859, the sensitivity were 95.8%, 79.17%, 62.50%, 95.83%, 62.5%, the specificity were 70.9%, 74.55%, 83.64%,47.27%, 96.36%, the positive predictive values were 58.96%, 57.58%, 62.51%,44.23%, 88.23%, the negative predictive values were 97.48%, 89.13%, 83.64%, 96.29%, and 85.48%, respectively.	[Wu, Fengpeng; Wang, Jun; Yang, Congrong] Hebei Med Univ, Dept Radiat Oncol, Affiliated Hosp 4, Shijiazhuang, Hebei, Peoples R China; [Wu, Fengpeng; Wang, Guiying; Wang, Jun; Zhou, Chaoxi; Yang, Congrong; Niu, Wenbo; Zhang, Jianfeng; Wang, Guanglin; Yang, Yafan] Hebei Prov Tumor Hosp, Shijiazhuang, Hebei, Peoples R China; [Wang, Guiying; Zhou, Chaoxi; Niu, Wenbo; Zhang, Jianfeng; Wang, Guanglin; Yang, Yafan] Hebei Med Univ, Dept Gastrointestinal Surg, Affiliated Hosp 4, Shijiazhuang, Hebei, Peoples R China	Hebei Medical University; Hebei Medical University	Wang, GY (corresponding author), Hebei Prov Tumor Hosp, Shijiazhuang, Hebei, Peoples R China.; Wang, GY (corresponding author), Hebei Med Univ, Dept Gastrointestinal Surg, Affiliated Hosp 4, Shijiazhuang, Hebei, Peoples R China.	wgywfp@163.com			Science and Technology Department of Hebei Province [17277750D]	Science and Technology Department of Hebei Province	This work was supported by the Science and Technology Department of Hebei Province ((Grant Number 17277750D), http://kjt.hebei.gov.cn/www/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Agner SC, 2014, RADIOLOGY, V272, P91, DOI 10.1148/radiol.14121031; Alison MR, 2011, J PATHOL, V223, P147, DOI 10.1002/path.2793; [Anonymous], 2015, ALBANIA INT J DISTRI, V6, P28; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barbaro B, 2009, RADIOLOGY, V250, P730, DOI 10.1148/radiol.2503080310; Chen Y, 2016, J THORAC DIS, V8, DOI 10.21037/jtd.2016.04.08; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Crane CH, 2003, INT J RADIAT ONCOL, V57, P84, DOI 10.1016/S0360-3016(03)00532-7; Diaz LK, 2005, CLIN CANCER RES, V11, P3309, DOI 10.1158/1078-0432.CCR-04-2184; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Du L, 2008, CLIN CANCER RES, V14, P6751, DOI 10.1158/1078-0432.CCR-08-1034; Fave X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00665-z; Francesca D, 2016, ONCOTARGET, V7, P33374, DOI 10.18632/oncotarget.8133; Frieboes HB, 2006, CANCER RES, V66, P1597, DOI 10.1158/0008-5472.CAN-05-3166; Gao XF, 2013, CANCER RES, V73, P1481, DOI 10.1158/0008-5472.CAN-12-3429; Garland ML, 2014, INT J COLORECTAL DIS, V29, P301, DOI 10.1007/s00384-013-1821-7; Gentile M, 2003, Ann Ital Chir, V74, P555; Guillem JG, 2005, ANN SURG, V241, P829, DOI 10.1097/01.sla.0000161980.46459.96; Guy JB, 2016, B CANCER, V103, P41, DOI 10.1016/j.bulcan.2015.10.016; Hasan S, 2020, ANN SURG, V271, P716, DOI 10.1097/SLA.0000000000003051; Hsu CY, 2017, ONCOTARGET, V8, P7921, DOI 10.18632/oncotarget.13855; Huh JW, 2014, ANN SURG, V259, P508, DOI 10.1097/SLA.0b013e31829b3916; Jacobs PP, 2011, FEBS LETT, V585, P3148, DOI 10.1016/j.febslet.2011.07.039; Jaggupilli A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/708036; Jestin P, 2008, COLORECTAL DIS, V10, P715, DOI 10.1111/j.1463-1318.2007.01466.x; Kim H, 2016, CLIN RADIOL, V71, P250, DOI 10.1016/j.crad.2015.11.011; Lagadec C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2479; Lee WS, 2008, WORLD J SURG, V32, P1124, DOI 10.1007/s00268-007-9451-2; Leijenaar RTH, 2015, ACTA ONCOL, V54, P1423, DOI 10.3109/0284186X.2015.1061214; Maretto I, 2007, ANN SURG ONCOL, V14, P455, DOI 10.1245/s10434-006-9269-4; MILAS L, 1994, CANCER RES, V54, P3506; Nancy Y.L., 2013, TARGET VOLUME DELINE, DOI [10.1007/978-3-642-28860-9, DOI 10.1007/978-3-642-28860-9]; Ni J, 2014, PROSTATE, V74, P602, DOI 10.1002/pros.22775; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Read TE, 2001, DIS COLON RECTUM, V44, P513, DOI 10.1007/BF02234323; Sagawa K, 2016, J LARYNGOL OTOL, V130, P843, DOI 10.1017/S0022215116008525; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Schulenburg A, 2007, J PATHOL, V213, P152, DOI 10.1002/path.2220; Sinclair WK, 2012, RADIAT RES, V178, pAV112, DOI 10.1667/RRAV09.1; Strauss R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016186; Uzcudun AE, 2002, DIS COLON RECTUM, V45, P1349, DOI 10.1007/s10350-004-6424-5; Vliegen RFA, 2008, RADIOLOGY, V246, P454, DOI 10.1148/radiol.2462070042; Wheeler JMD, 2002, DIS COLON RECTUM, V45, P1051, DOI 10.1007/s10350-004-6359-x; Wu FP, 2019, J RADIAT RES, V60, P666, DOI 10.1093/jrr/rrz035; Xiao WW, 2012, CLIN EXP METASTAS, V29, P1, DOI 10.1007/s10585-011-9423-7; Xing XF, 2009, HISTOPATHOLOGY, V54, P309, DOI 10.1111/j.1365-2559.2009.03226.x; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137; Zoccali MB, 2015, INT J COLORECTAL DIS, V30, P87, DOI 10.1007/s00384-014-2062-0	49	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2020	15	6							e0234310	10.1371/journal.pone.0234310	http://dx.doi.org/10.1371/journal.pone.0234310			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC0EC	32520954	gold, Green Published			2022-12-26	WOS:000542969500026
J	Harmon, JB; Gray, HK; Young, CC; Schwab, KJ				Harmon, J. Brian; Gray, Hannah K.; Young, Charles C.; Schwab, Kellogg J.			Microfluidic droplet application for bacterial surveillance in fresh-cut produce wash waters	PLOS ONE			English	Article							UNITED-STATES; CROSS-CONTAMINATION; FOODBORNE OUTBREAKS; PUBLIC-HEALTH; SAFETY; SALMONELLA; CHLORINE; QUALITY; HACCP; ULTRAFILTRATION	Foodborne contamination and associated illness in the United States is responsible for an estimated 48 million cases per year. Increased food demand, global commerce of perishable foods, and the growing threat of antibiotic resistance are driving factors elevating concern for food safety. Foodborne illness is often associated with fresh-cut, ready-to-eat produce commodities due to the perishable nature of the product and relatively minimal processing from farm to the consumer. The research presented here optimizes and evaluates the utility of microfluidic droplets, also termed ultra-miniaturized bioreactors, for rapid detection of viable Salmonella enterica ser. Typhimurium in a shredded lettuce wash water acquired from a major Mid-Atlantic produce processing facility (denoted as Producer) in the U.S. Using a fluorescently-labeled anti-S. Typhimurium antibody and relative fluorescence intensities, paired with in-droplet incubation, S. Typhimurium was detected and identified with 100% specificity in less than 5 h. In initial optimization experiments using S. Typhimurium-spiked sterile water, the relative fluorescence intensity of S. Typhimurium was approximately two times that of the observed relative intensities of five non-S. Typhimurium negative controls at 4-h incubation in droplets containing Rappaport-Vasiliadis (RV) broth at 37 degrees C: relative fluorescence intensity for S. Typhimurium = 2.36 (95% CI: 2.15-2.58), Enterobacter aerogens 1.12 (95% CI: 1.09-1.16), Escherichia coli 700609 = 1.13 (95% CI: 1.09-1.17), E. coli 13706 1.13 (95% CI: 1.07-1.19), E. coli 700891 1.05 (95% CI: 1.03-1.07) and Citrobacter freundii 1.04 (95% CI: 1.03-1.05). S. Typhimurium- and E. aerogens-spiked shredded lettuce wash waters acquired from the Producer were then incubated 4 h in-droplet at 37 degrees C with RV broth. The observed relative fluorescence of S. Typhimurium was significantly higher than that of E. aerogens, 1.56 (95% CI: 1.42-1.71) and 1.10 (95% CI: 1.08-1.12), respectively. While further optimization focusing on compatible concentration methodologies for highly-dilute produce water samples is needed, this application of droplet microfluidics shows great promise in dramatically shortening the time necessary-from days to hours-to confirm viable bacterial contamination in ready-to-eat produce wash waters used throughout the domestic and international food industry.	[Harmon, J. Brian; Gray, Hannah K.; Young, Charles C.; Schwab, Kellogg J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth & Engn, Baltimore, MD 21205 USA; [Harmon, J. Brian; Young, Charles C.] Johns Hopkins Univ, Appl Phys Lab, Asymmetr Operat Sect, Laurel, MD 20723 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	Harmon, JB (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth & Engn, Baltimore, MD 21205 USA.; Harmon, JB (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Asymmetr Operat Sect, Laurel, MD 20723 USA.	jbrianharmon@gmail.com			National Institute for Occupational Safety and Health [T42 OH0008428]; National Institutes of Health [T32 ES007141]	National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the National Institute for Occupational Safety and Health (T42 OH0008428) (https://www.cdc.gov/niosh/index.htm) to the Johns Hopkins University Education and Research Center for Occupational Safety and Health, the National Institutes of Health (T32 ES007141) (https://www.nih.gov/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Osprey Foundation of Maryland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We would like to thank the major Mid-Atlantic ready-to-eat produce processing facility (denoted as Producer) for providing wash water. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoston R, 2009, J FOOD PROTECT, V72, P666; Agresti JJ, 2010, P NATL ACAD SCI USA, V107, P4004, DOI 10.1073/pnas.0910781107; Al-Kady AS, 2011, SPECTROCHIM ACTA A, V79, P1540, DOI 10.1016/j.saa.2011.05.013; Aroonnual A, 2017, ESSAYS BIOCHEM, V61, P91, DOI 10.1042/EBC20160059; Banach JL, 2015, INT J ENV RES PUB HE, V12, P8658, DOI 10.3390/ijerph120808658; Bonilauri P, 2016, ITAL J FOOD SAF, V5, DOI 10.4081/ijfs.2016.5641; Callejon RM, 2015, FOODBORNE PATHOG DIS, V12, P32, DOI 10.1089/fpd.2014.1821; Chiou PY, 2005, NATURE, V436, P370, DOI [10.1038/nature03831, 10.1038/nature0383l]; Churski K, 2012, LAB CHIP, V12, P1629, DOI 10.1039/c2lc21284f; Decol LT, 2017, FOOD MICROBIOL, V65, P105, DOI 10.1016/j.fm.2017.02.003; DIEHL H, 1989, TALANTA, V36, P416, DOI 10.1016/0039-9140(89)80213-9; Dong L., 2017, CLIM PAST, V13, P1, DOI [10. 5194/cp-2016-139, DOI 10.5194/CP-2016-139]; Francis GA, 2012, CRIT REV FOOD SCI, V52, P595, DOI 10.1080/10408398.2010.503685; Francy DS, 2013, APPL ENVIRON MICROB, V79, P1342, DOI 10.1128/AEM.03117-12; Gil MI, 2009, INT J FOOD MICROBIOL, V134, P37, DOI 10.1016/j.ijfoodmicro.2009.05.021; Gould LH, 2013, MMWR SURVEILL SUMM, V62, P1; Havelaar AH, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001923; Herman KM, 2015, EPIDEMIOL INFECT, V143, P3011, DOI 10.1017/S0950268815000047; Huys GRB, 2018, CURR OPIN MICROBIOL, V44, P1, DOI 10.1016/j.mib.2018.05.002; Hyde R, 2016, ADMIN SOC, V48, P962, DOI 10.1177/0095399714548266; Ismail IA, 2017, CHLORINE ANAL TEST E; Iwamoto M, 2015, MMWR-MORBID MORTAL W, V64, P252; Jensen DA, 2017, J FOOD PROTECT, V80, P213, DOI [10.4315/0362-028x.jfp-16-240, 10.4315/0362-028X.JFP-16-240]; Keays MC, 2016, BIOENGINEERED, V7, P79, DOI 10.1080/21655979.2016.1156824; Kim HS, 2017, ANALYST, V142, P1054, DOI 10.1039/c6an02221a; Kirk MD, 2015, PLOS MED, V12, DOI [10.1371/journal.pmed.1001921, 10.1371/journal.pmed.1001940]; Kozak GK, 2013, J FOOD PROTECT, V76, P173, DOI 10.4315/0362-028X.JFP-12-126; Liu PB, 2012, J MICROBIOL METH, V88, P155, DOI 10.1016/j.mimet.2011.11.007; Liu X, 2016, LAB CHIP, V16, P1636, DOI 10.1039/c6lc00180g; Liu ZZ, 2017, TRENDS BIOTECHNOL, V35, P1129, DOI 10.1016/j.tibtech.2017.07.008; Lopez-Galvez F, 2009, INT J FOOD MICROBIOL, V133, P167, DOI 10.1016/j.ijfoodmicro.2009.05.017; Luo YG, 2012, INT J FOOD MICROBIOL, V158, P133, DOI 10.1016/j.ijfoodmicro.2012.07.008; Ma LY, 2004, SPECTROCHIM ACTA A, V60, P1865, DOI 10.1016/j.saa.2003.10.004; Mahler L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31263-2; Marcoux PR, 2011, COLLOID SURFACE A, V377, P54, DOI 10.1016/j.colsurfa.2010.12.013; Mazutis L, 2013, NAT PROTOC, V8, P870, DOI 10.1038/nprot.2013.046; Moon HS, 2018, LAB CHIP, V18, P775, DOI 10.1039/c7lc01284e; Mortimore S, 2001, FOOD CONTROL, V12, P209, DOI 10.1016/S0956-7135(01)00017-2; Munther D, 2015, FOOD MICROBIOL, V51, P101, DOI 10.1016/j.fm.2015.05.010; Olaimat AN, 2012, FOOD MICROBIOL, V32, P1, DOI 10.1016/j.fm.2012.04.016; Ottesen EA, 2006, SCIENCE, V314, P1464, DOI 10.1126/science.1131370; Painter JA, 2013, EMERG INFECT DIS, V19, P407, DOI 10.3201/eid1903.111866; Panisello PJ, 2000, INT J FOOD MICROBIOL, V59, P221, DOI 10.1016/S0168-1605(00)00376-7; Polaczyk AL, 2008, J MICROBIOL METH, V73, P92, DOI 10.1016/j.mimet.2008.02.014; Powell MR, 2016, RISK ANAL, V36, P1589, DOI 10.1111/risa.12530; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Scharff RL, 2015, J FOOD PROTECT, V78, P1064, DOI 10.4315/0362-028X.JFP-14-505; Tauxe RV, 2010, INT J FOOD MICROBIOL, V139, pS16, DOI 10.1016/j.ijfoodmicro.2009.10.014; Tauxe RV, 2002, FOOD CONTROL, V13, P363, DOI 10.1016/S0956-7135(01)00091-3; The Lancet Planetary Health, 2017, LANCET PLANET HLTH, V1, pe209; Theberge AB, 2010, ANGEW CHEM INT EDIT, V49, P5846, DOI 10.1002/anie.200906653; U.S. Food and Drug Administration C for FS and A, LABORATORY METHODS B; Van Haute S, 2013, APPL ENVIRON MICROB, V79, P2850, DOI 10.1128/AEM.03283-12; Weng SC, 2016, FOOD CONTROL, V60, P543, DOI 10.1016/j.foodcont.2015.08.031; Winfield MD, 2003, APPL ENVIRON MICROB, V69, P3687, DOI 10.1128/AEM.69.7.3687-3694.2003; Zhang GD, 2011, APPL ENVIRON MICROB, V77, P6495, DOI 10.1128/AEM.00520-11; Zhang Q, 2017, SCI REP-UK, V7, DOI 10.1038/srep41192	57	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2020	15	6							e0233239	10.1371/journal.pone.0233239	http://dx.doi.org/10.1371/journal.pone.0233239			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ1GC	32516315	gold, Green Published			2022-12-26	WOS:000540977000034
J	Mody, K; Lerch, D; Muller, AK; Simons, NK; Bluthgen, N; Harnisch, M				Mody, Karsten; Lerch, Doris; Mueller, Ann-Kathrin; Simons, Nadja K.; Bluethgen, Nico; Harnisch, Matthias			Flower power in the city: Replacing roadside shrubs by wildflower meadows increases insect numbers and reduces maintenance costs	PLOS ONE			English	Article							URBAN GREEN SPACES; LAND-USE; ARTHROPOD COMMUNITIES; GRASSLAND MANAGEMENT; BEETLE COMMUNITIES; HABITAT COMPLEXITY; FUNCTIONAL TRAITS; MOWING FREQUENCY; ABUNDANCE; BIODIVERSITY	Massive declines in insect biodiversity and biomass are reported from many regions and habitats. In urban areas, creation of native wildflower meadows is one option to support insects and reduce maintenance costs of urban green spaces. However, benefits for insect conservation may depend on previous land use, and the size and location of new wildflower meadows. We show effects of conversion of roadside plantings-from exotic shrubs into wildflower meadows-on (1) the abundance of 13 arthropod taxa-Opiliones, Araneae, Isopoda, Collembola, Orthoptera, Aphidoidea, Auchenorrhyncha, Heteroptera, Coleoptera, Nematocera, Brachycera, Apocrita, Formicidae-and (2) changes in maintenance costs. We assessed the influence of vegetation type (meadow vs. woody), meadow age, size, location (distance to city boundary), and mowing regime. We found many, but not all, arthropod taxa profiting from meadows in terms of arthropod activity abundance in pitfall traps and arthropod density in standardized suction samples. Arthropod number in meadows was 212% higher in pitfall traps and 260% higher in suction samples compared to woody vegetation. The increased arthropod number in meadows was independent of the size and isolation of green spaces for most taxa. However, mowing regime strongly affected several arthropod taxa, with an increase of 63% of total arthropod density in unmown compared to mown meadow spots. Costs of green space maintenance were fivefold lower for meadows than for woody vegetation. Our study shows that (1) many different arthropod taxa occur in roadside vegetation in urban areas, (2) replacement of exotic woody vegetation by native wildflower meadows can significantly increase arthropod abundance, especially if meadow management permits temporarily unmown areas, and (3) maintenance costs can be considerably reduced by converting woody plantings into wildflower meadows. Considering many groups of arthropods, our study provides new insights into possible measures to support arthropods in urban environments.	[Mody, Karsten; Lerch, Doris; Mueller, Ann-Kathrin; Simons, Nadja K.; Bluethgen, Nico] Tech Univ Darmstadt, Ecol Networks, Darmstadt, Germany; [Harnisch, Matthias] Magistrat Stadt Riedstadt, Riedstadt, Germany; [Mody, Karsten] Hsch Geisenheim Univ, Dept Appl Ecol, Geisenheim, Germany	Technical University of Darmstadt	Mody, K (corresponding author), Tech Univ Darmstadt, Ecol Networks, Darmstadt, Germany.; Mody, K (corresponding author), Hsch Geisenheim Univ, Dept Appl Ecol, Geisenheim, Germany.	Karsten.Mody@hs-gm.de	Simons, Nadja K./H-4227-2019; Blüthgen, Nico/F-5983-2010	Simons, Nadja K./0000-0002-2718-7050; 	German Research Foundation; Open Access Publishing Fund of Technical University of Darmstadt	German Research Foundation(German Research Foundation (DFG)); Open Access Publishing Fund of Technical University of Darmstadt	We acknowledge support by the German Research Foundation and the Open Access Publishing Fund of Technical University of Darmstadt.	Achtziger R., 2014, INSECTA, V14, P37; Ahmed DA, 2019, METHODS ECOL EVOL, V10, P1246, DOI 10.1111/2041-210X.13207; Akre RD, 1982, SOCIAL INSECTS, VIV, P1; Andersson E, 2014, AMBIO, V43, P445, DOI 10.1007/s13280-014-0506-y; [Anonymous], 2019, J INORG ORGANOMET PO, V29, P1; [Anonymous], 1996, FOOD CANADA, V56, P10; Apfelbeck B, 2020, LANDSCAPE URBAN PLAN, V200, DOI 10.1016/j.landurbplan.2020.103817; Aronson MFJ, 2017, FRONT ECOL ENVIRON, V15, P189, DOI 10.1002/fee.1480; Attwood SJ, 2008, GLOBAL ECOL BIOGEOGR, V17, P585, DOI 10.1111/j.1466-8238.2008.00399.x; Barratt BIP, 2015, INSECT CONSERV DIVER, V8, P428, DOI 10.1111/icad.12120; Baxter-Gilbert JH, 2015, J INSECT CONSERV, V19, P1029, DOI 10.1007/s10841-015-9808-z; Becker N, 1997, PARASITOL TODAY, V13, P485, DOI 10.1016/S0169-4758(97)01154-X; Beninde J, 2015, ECOL LETT, V18, P581, DOI 10.1111/ele.12427; Biedermann Robert, 2005, Journal of Insect Conservation, V9, P229, DOI 10.1007/s10841-005-0531-z; Biedermann Robert, 2002, Denisia, V4, P523; Birkhofer K, 2019, FRONT SUSTAIN FOOD S, V3, DOI 10.3389/fsufs.2019.00107; Blackmore LM, 2014, INSECT CONSERV DIVER, V7, P480, DOI 10.1111/icad.12071; Boetzl FA, 2018, PEERJ, V6, DOI 10.7717/peerj.5078; Bolger DT, 2000, ECOL APPL, V10, P1230, DOI 10.1890/1051-0761(2000)010[1230:AIUHFI]2.0.CO;2; Bowler DE, 2019, CONSERV BIOL, V33, P1120, DOI 10.1111/cobi.13307; Braaker S, 2017, J ANIM ECOL, V86, P521, DOI 10.1111/1365-2656.12648; Braman SK, 2002, ENVIRON ENTOMOL, V31, P564, DOI 10.1603/0046-225X-31.3.564; Bretzel F, 2016, URBAN FOR URBAN GREE, V20, P428, DOI 10.1016/j.ufug.2016.10.008; Brown GR, 2016, ECOL EVOL, V6, P3953, DOI 10.1002/ece3.2176; Bucharova A, 2016, BASIC APPL ECOL, V17, P688, DOI 10.1016/j.baae.2016.09.001; Buchholz S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137723; Buczkowski G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041729; Burghardt KT, 2013, DIVERS DISTRIB, V19, P1553, DOI 10.1111/ddi.12122; Burghardt KT, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00032.1; Burghardt KT, 2009, CONSERV BIOL, V23, P219, DOI 10.1111/j.1523-1739.2008.01076.x; Buri P, 2016, INSECT CONSERV DIVER, V9, P536, DOI 10.1111/icad.12186; Buri P, 2013, AGR ECOSYST ENVIRON, V181, P22, DOI 10.1016/j.agee.2013.09.003; Chalker-Scott Linda, 2015, Arboriculture & Urban Forestry, V41, P173; Chiste MN, 2018, OECOLOGIA, V186, P529, DOI 10.1007/s00442-017-4031-0; Chiste MN, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1545; Chong KY, 2014, BIOL CONSERV, V171, P299, DOI 10.1016/j.biocon.2014.01.037; Daniels GD, 2006, BIOL CONSERV, V133, P326, DOI 10.1016/j.biocon.2006.06.011; de Jonga FMW, 2008, J ENVIRON MANAGE, V86, P721, DOI 10.1016/j.jenvman.2006.12.031; Denys C, 1998, OECOLOGIA, V113, P269, DOI 10.1007/s004420050378; Di Giulio M, 2001, J APPL ECOL, V38, P310, DOI 10.1046/j.1365-2664.2001.00605.x; Dunlop J.A., 2007, HARVESTMEN BIOL OPIL, DOI [10.4159/9780674276833-007, DOI 10.4159/9780674276833-007]; Durka W., 2019, Natur und Landschaft, V94, P146; Everwand G, 2014, BMC ECOL, V14, DOI 10.1186/1472-6785-14-1; Forbes AA, 2018, BMC ECOL, V18, DOI 10.1186/s12898-018-0176-x; Frank K, 2017, AGR ECOSYST ENVIRON, V243, P114, DOI 10.1016/j.agee.2017.04.010; Frank SD, 2019, PEERJ, V7, DOI 10.7717/peerj.6531; Garbuzov M, 2015, INSECT CONSERV DIVER, V8, P107, DOI 10.1111/icad.12085; Gardiner MM, 2014, URBAN ECOSYST, V17, P101, DOI 10.1007/s11252-013-0303-6; Gardiner Tim, 2005, Journal of Insect Conservation, V9, P151, DOI 10.1007/s10841-005-2854-1; Gaston KJ, 2005, BIODIVERS CONSERV, V14, P3327, DOI 10.1007/s10531-004-9513-9; Gibb H, 2002, BIOL CONSERV, V106, P91, DOI 10.1016/S0006-3207(01)00232-4; Habel JC, 2019, BIODIVERS CONSERV, P1; Hall B, 2002, J BIOGEOGR, V29, P1319, DOI 10.1046/j.1365-2699.2002.00790.x; Hall DM, 2017, CONSERV BIOL, V31, P24, DOI 10.1111/cobi.12840; Hallmann CA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185809; Hallmann CA, 2014, NATURE, V511, P341, DOI 10.1038/nature13531; Happe AK, 2019, AGR ECOSYST ENVIRON, V273, P141, DOI 10.1016/j.agee.2018.12.012; Hardie J, 2017, APHIDS AS CROP PESTS, 2ND EDITION, P81, DOI 10.1079/9781780647098.0081; Heiniger C, 2015, SOIL BIOL BIOCHEM, V86, P181, DOI 10.1016/j.soilbio.2015.04.003; Helbing F, 2017, AGR ECOSYST ENVIRON, V246, P94, DOI 10.1016/j.agee.2017.05.024; Helden AJ, 2012, URBAN ECOSYST, V15, P611, DOI 10.1007/s11252-012-0231-x; Hicks DM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158117; HODGSON C, 1991, B ENTOMOL RES, V81, P417, DOI 10.1017/S0007485300031989; Hornung E, 2018, ZOOKEYS, P371, DOI 10.3897/zookeys.801.22829; Horton DR, 2003, ENTOMOL EXP APPL, V106, P135, DOI 10.1046/j.1570-7458.2003.00018.x; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hoyle H, 2017, URBAN FOR URBAN GREE, V25, P139, DOI 10.1016/j.ufug.2017.05.009; Humbert JY, 2012, BIOL CONSERV, V152, P96, DOI 10.1016/j.biocon.2012.03.015; Humbert JY, 2009, AGR ECOSYST ENVIRON, V130, P1, DOI 10.1016/j.agee.2008.11.014; Hunter MR, 2008, INSECT CONSERV DIVER, V1, P189, DOI 10.1111/j.1752-4598.2008.00024.x; Janzen DH, 2019, BIOL CONSERV, V233, P102, DOI 10.1016/j.biocon.2019.02.030; JOERN A, 1993, ENVIRON ENTOMOL, V22, P352, DOI 10.1093/ee/22.2.352; Jones EL, 2012, EUR J ENTOMOL, V109, P463, DOI 10.14411/eje.2012.060; Kendle AD, 2000, LANDSCAPE URBAN PLAN, V47, P19, DOI 10.1016/S0169-2046(99)00070-5; KENNEDY CEJ, 1984, J ANIM ECOL, V53, P455, DOI 10.2307/4528; KEVAN PG, 1983, ANNU REV ENTOMOL, V28, P407, DOI 10.1146/annurev.en.28.010183.002203; Klimesova J, 2008, PRESLIA, V80, P245; Kouakou L. M. M., 2018, Journal of Animal and Plant Sciences (JAPS), V36, P5793; KROMP B, 1992, AGR ECOSYST ENVIRON, V40, P71, DOI 10.1016/0167-8809(92)90085-P; Kuehne Isabel, 2015, Conservation Evidence, V12, P25; Kuhsel S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8989; Kuznetsova N., 1995, Fragmenta Faunistica (Warsaw), V37, P413; Kuznetsova NA, 2006, PEDOBIOLOGIA, V50, P157, DOI 10.1016/j.pedobi.2005.12.004; Landau KI, 2012, J VECTOR ECOL, V37, P407, DOI 10.1111/j.1948-7134.2012.00245.x; Lassau SA, 2004, ECOGRAPHY, V27, P157, DOI 10.1111/j.0906-7590.2004.03675.x; LAWTON JH, 1983, ANNU REV ENTOMOL, V28, P23, DOI 10.1146/annurev.en.28.010183.000323; Lepczyk CA, 2017, BIOSCIENCE, V67, P799, DOI 10.1093/biosci/bix079; Lerman SB, 2018, BIOL CONSERV, V221, P160, DOI 10.1016/j.biocon.2018.01.025; Lister BC, 2018, P NATL ACAD SCI USA, V115, pE10397, DOI 10.1073/pnas.1722477115; Loreth A, 2019, THESIS; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Martin AE, 2018, INSECT CONSERV DIVER, V11, P608, DOI 10.1111/icad.12300; McIntyre NE, 2000, ANN ENTOMOL SOC AM, V93, P825, DOI 10.1603/0013-8746(2000)093[0825:EOUAAR]2.0.CO;2; Medeiros-Sousa AR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18208-x; Meyer S, 2017, AGR ECOSYST ENVIRON, V239, P376, DOI 10.1016/j.agee.2017.01.037; Michael ED, 1986, TRANSPN RES REC, V1075, P19; Mody K, 2003, ARTHROPODS OF TROPICAL FORESTS, P198; Montgomery GA, 2019, BIOL CONSERV; MORAN VC, 1982, J ANIM ECOL, V51, P289, DOI 10.2307/4325; Narango DL, 2018, P NATL ACAD SCI USA, V115, P11549, DOI 10.1073/pnas.1809259115; Lescano MN, 2011, ECOL RES, V26, P827, DOI 10.1007/s11284-011-0842-3; New T. R., 2015, INSECT CONSERVATION, DOI DOI 10.1007/978-3-319-21224-1; Nguyen MN, 2010, PLOS ONE, V5, pe9907; Nickel Herbert, 2002, Denisia, V4, P279; Niemel? J., 1999, URBAN ECOSYST, V3, P57, DOI [10.1023/A:1009595932440, DOI 10.1023/A:1009595932440]; Noordijk J, 2008, P NETH ENT SOC M, V19, P75; Noordijk J, 2009, BIOL CONSERV, V142, P2097, DOI 10.1016/j.biocon.2009.04.009; Nooten SS, 2019, MYRMECOL NEWS, V29, P67, DOI 10.25849/myrmecol.news_029:067; Norton BA, 2014, URBAN ECOSYST, V17, P77, DOI 10.1007/s11252-013-0297-0; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; PAOLETTI MG, 1992, AGR ECOSYST ENVIRON, V40, P3, DOI 10.1016/0167-8809(92)90080-U; Pape T, 2015, BIODIVERS DATA J, V3, DOI 10.3897/BDJ.3.e4187; Penone C, 2013, INSECT CONSERV DIVER, V6, P319, DOI 10.1111/j.1752-4598.2012.00217.x; Philpott SM, 2014, URBAN ECOSYST, V17, P513, DOI 10.1007/s11252-013-0333-0; Pinheiro J., 2020, NLME LINEAR NONLINEA; R Foundation for Statistical Computing, 2019, R LANG ENV STAT COMP; Randlkofer B, 2009, ENTOMOL EXP APPL, V132, P134, DOI 10.1111/j.1570-7458.2009.00872.x; Raupp MJ, 2010, ANNU REV ENTOMOL, V55, P19, DOI 10.1146/annurev-ento-112408-085351; ROITBERG BD, 1979, J ANIM ECOL, V48, P111, DOI 10.2307/4104; Rousselin A, 2017, AGRON SUSTAIN DEV, V37, DOI 10.1007/s13593-017-0444-8; Sabais ACW, 2011, ACTA OECOL, V37, P195, DOI 10.1016/j.actao.2011.02.002; Salisbury A, 2017, BIODIVERS CONSERV, V26, P2657, DOI 10.1007/s10531-017-1377-x; Salmon S, 2014, SOIL BIOL BIOCHEM, V75, P73, DOI 10.1016/j.soilbio.2014.04.002; Sanchez-Bayo F, 2019, BIOL CONSERV, V232, P8, DOI 10.1016/j.biocon.2019.01.020; Sattler T, 2010, LANDSCAPE ECOL, V25, P941, DOI 10.1007/s10980-010-9473-2; Savard JPL, 2000, LANDSCAPE URBAN PLAN, V48, P131, DOI 10.1016/S0169-2046(00)00037-2; Seibold S, 2019, NATURE, V574, P671, DOI 10.1038/s41586-019-1684-3; Seto KC, 2012, P NATL ACAD SCI USA, V109, P16083, DOI 10.1073/pnas.1211658109; Skorka P, 2013, BIOL CONSERV, V159, P148, DOI 10.1016/j.biocon.2012.12.028; Smith Jo, 2006, Urban Ecosystems, V9, P337, DOI 10.1007/s11252-006-0001-8; Smith RM, 2006, BIODIVERS CONSERV, V15, P2415, DOI 10.1007/s10531-004-5014-0; Snep RPH, 2006, BIOL CONSERV, V127, P345, DOI 10.1016/j.biocon.2005.06.034; Soanes K, 2019, CONSERV BIOL, V33, P300, DOI 10.1111/cobi.13193; Sobek S, 2009, ECOL ENTOMOL, V34, P772, DOI 10.1111/j.1365-2311.2009.01132.x; Southon GE, 2017, LANDSCAPE URBAN PLAN, V158, P105, DOI 10.1016/j.landurbplan.2016.08.003; Stork NE, 2001, ECOL ENTOMOL, V26, P302, DOI 10.1046/j.1365-2311.2001.00323.x; SWEET MERRILL H., 1960, ANN ENT SOC AMER, V53, P317; Munoz PT, 2015, BIODIVERS CONSERV, V24, P659, DOI 10.1007/s10531-014-0831-2; Thiele H. -U., 1977, CARABID BEETLES THEI, DOI 10.1007/978-3-642-81154-8; Thomas CD, 2019, GLOBAL CHANGE BIOL, V25, P1891, DOI 10.1111/gcb.14608; Threlfall CG, 2016, LANDSCAPE URBAN PLAN, V153, P28, DOI 10.1016/j.landurbplan.2016.04.011; TUMLINSON JH, 1993, SCI AM, V268, P100; Uetz G.W., 1976, Journal Arachnol, V3, P101; Uno Shinsuke, 2010, Urban Ecosystems, V13, P425, DOI 10.1007/s11252-010-0136-5; Unterweger Philipp Andreas, 2018, BioRisk, V13, P1; Unterweger Philipp Andreas, 2017, Heteropteron, V48, P7; van de Poel D, 2014, HDB NATURSCHUTZ LAND, P1; van Heezik Y, 2016, LANDSCAPE URBAN PLAN, V151, P79, DOI 10.1016/j.landurbplan.2016.02.013; van Klink R, 2020, SCIENCE, V368, P417, DOI 10.1126/science.aax9931; van Klink R, 2019, ECOL APPL, V29, DOI 10.1002/eap.1900; van Strien AJ, 2019, BIOL CONSERV, V234, P116, DOI 10.1016/j.biocon.2019.03.023; Vergnes A, 2012, BIOL CONSERV, V145, P171, DOI 10.1016/j.biocon.2011.11.002; Vezzani D, 2007, TROP MED INT HEALTH, V12, P299, DOI [10.1111/j.1365-3165.2006.01781.x, 10.1111/j.1365-3156.2006.01781.x]; Wagner DL, 2019, ANN REV ENTOMOL, V65; Watson CJ, 2020, J APPL ECOL, V57, P436, DOI 10.1111/1365-2664.13542; Weiss N, 2013, BIODIVERS CONSERV, V22, P2167, DOI 10.1007/s10531-012-0398-8; Wenzel A, 2019, BIOL CONSERV; Wilson MC, 2016, LANDSCAPE ECOL, V31, P219, DOI 10.1007/s10980-015-0312-3; Wong GKL, 2018, LANDSCAPE ECOL, V33, P475, DOI 10.1007/s10980-018-0616-1; Wong SK, 2013, BIOL CONTROL, V64, P45, DOI 10.1016/j.biocontrol.2012.09.015; Woschke N., 2013, CHEM ECOLOGY INSECT, P37, DOI [10.1002/9781118409589.ch3, DOI 10.1002/9781118409589.CH3]; Yang LH, 2014, CURR OPIN INSECT SCI, V2, P26, DOI 10.1016/j.cois.2014.06.004; Yong TH, 2003, ANN ENTOMOL SOC AM, V96, P643, DOI 10.1603/0013-8746(2003)096[0643:NBAPAB]2.0.CO;2; Zajac G, 2017, 102017 KGST	164	13	13	10	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2020	15	6							e0234327	10.1371/journal.pone.0234327	http://dx.doi.org/10.1371/journal.pone.0234327			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LZ1GC	32516354	Green Published, gold			2022-12-26	WOS:000540977000030
J	Ting, HY; Cesar, JA				Ting, Hsu Yuan; Cesar, Juraci A.			Urinary incontinence among pregnant women in Southern Brazil: A population-based cross-sectional survey	PLOS ONE			English	Article							QUALITY-OF-LIFE; RISK-FACTORS; FECAL INCONTINENCE; MUSCLE; PRIMIGRAVIDAE; EPIDEMIOLOGY; PREVALENCE; POSTPARTUM; DELIVERY; AGE	Urinary incontinence (UI) is a common condition that causes significant harm to the well-being and quality of life of pregnant women. This cross-sectional population-based study aimed to estimate the prevalence and identify factors associated with the occurrence of UI during pregnancy in women living in the municipality of Rio Grande (RS), Southern Brazil, between January 1 and December 31 of 2016, and included all puerperae living in this municipality that had a child in one of the two local maternity hospitals. The previously trained interviewers used a single standardized questionnaire, within 48 hours after delivery to retrieve information on maternal demographic, behavioral and reproductive/obstetric history, as well as socioeconomic status of the household and care received during pregnancy and childbirth. The multivariate analysis followed a previously defined hierarchical model using Poisson regression with robust variance adjustment and prevalence ratio (PR) as a measure of effect. As a result, 2,716 puerperae were identified, of which 2,694 (99.2%) participated in this study. The prevalence of urinary incontinence in the gestational period was 14.7% (95%CI: 13.4%-16.1%). After adjusted analysis, the likelihood of UI occurring varied significantly as per women's characteristics. For example, the PR for the occurrence of UI among women over 30 years of age was 2.05 (95% CI: 1.39-3.01) compared to adolescents. In two other groups of women who had their first pregnancy before the age of 20 or after the age of 30, the PR for UI was 1.36 (95% CI: 1.04-1.76) and 1.59 (95% CI: 1.01-2.51), respectively, when compared to those who became pregnant for the first time between 20 and 29 years of age. Finally, in two other groups of women, namely, those who reached 90 kg and over at the end of pregnancy and those who performed regular physical exercise and reported frequent urinary urgency, the PR was 2.49 (95% CI: 1.74-3.57), and 2.90 (95% CI: 2.10-4.00) compared to those who did not exercise and did not report urinary urgency, respectively. The authors concluded that UI showed a high prevalence in the study population. The identified risk factors can be well administered at primary health care level. The recommendation of regular physical exercise in pregnancy must be reviewed and better investigated with more robust designs because of possible facilitators for the occurrence of UI in this period.	[Ting, Hsu Yuan] Fed Univ Rio Grande FURG, Postgrad Program Hlth Sci, Rio Grande, RS, Brazil; [Cesar, Juraci A.] Fed Univ Rio Grande FURG, Postgrad Program Hlth Sci, Postgrad Program Publ Hlth, Rio Grande, RS, Brazil	Universidade Federal do Rio Grande; Universidade Federal do Rio Grande	Ting, HY (corresponding author), Fed Univ Rio Grande FURG, Postgrad Program Hlth Sci, Rio Grande, RS, Brazil.	hsuriogrande@gmail.com		Hsu, Yuan Ting/0000-0001-9676-6235				Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Adaji SE, 2010, EUR J OBSTET GYN R B, V150, P19, DOI 10.1016/j.ejogrb.2010.02.008; Artal R, 2003, BRIT J SPORT MED, V37, P6, DOI 10.1136/bjsm.37.1.6; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bo K, 2011, NEUROUROL URODYNAM, V30, P370, DOI 10.1002/nau.21006; Boyle R, 2014, NEUROUROL URODYNAM, V33, P269, DOI 10.1002/nau.22402; Cerruto MA, 2013, UROL INT, V90, P1, DOI 10.1159/000339929; Corp Stata, 2011, STAT STAT SOFTW REL; de Oliveira C, 2013, REV ASSOC MED BRAS, V59, P460, DOI [10.1016/j.ramb.2013.08.002, 10.1016/S2255-4823(13)70505-8]; Dean A, 2011, EPI INFO DATABASE ST; Dietz HP, 2013, AUST NZ J OBSTET GYN, V53, P220, DOI 10.1111/ajo.12059; Dolan LM, 2004, INT UROGYNECOL J, V15, P160, DOI 10.1007/s00192-004-1128-x; Du YH, 2015, INT UROGYNECOL J, V26, P1415, DOI 10.1007/s00192-015-2654-4; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Horng SS, 2013, NEUROUROL URODYNAM, V32, P371, DOI 10.1002/nau.22302; Hunskaar S, 2000, INT UROGYNECOL J, V11, P301, DOI 10.1007/s001920070021; Hunskaar S, 2008, NEUROUROL URODYNAM, V27, P749, DOI 10.1002/nau.20635; Kirkwood BR, 2003, ESSENTIAL MED STAT; Lewicky-Gaupp C, 2008, J PEDIATR ADOL GYNEC, V21, P21, DOI 10.1016/j.jpag.2007.05.003; Marecki M, 2010, J PERINAT NEONAT NUR, V24, P330, DOI 10.1097/JPN.0b013e3181ec0d9b; Martins G, 2010, INT UROGYNECOL J, V21, P1271, DOI 10.1007/s00192-010-1185-2; Perucchini D, 2002, AM J OBSTET GYNECOL, V186, P351, DOI 10.1067/mob.2002.121089; Rortveit G, 2006, AM J OBSTET GYNECOL, V195, P433, DOI 10.1016/j.ajog.2006.01.023; RUD T, 1980, ACTA OBSTET GYN SCAN, V59, P331, DOI 10.3109/00016348009154090; Sangsawang B, 2014, EUR J OBSTET GYN R B, V178, P27, DOI 10.1016/j.ejogrb.2014.04.010; Scarpa Katia Pary, 2006, Rev. Assoc. Med. Bras., V52, P153, DOI 10.1590/S0104-42302006000300015; Scarpa KP, 2006, INT UROGYNECOL J, V17, P219, DOI 10.1007/s00192-005-1361-y; Sievert KD, 2012, NEUROUROL URODYNAM, V31, P390, DOI 10.1002/nau.22225; Subak LL, 2009, J UROLOGY, V182, pS2, DOI 10.1016/j.juro.2009.08.071; Thyssen HH, 2002, INT UROGYNECOL J PEL, V13, P15, DOI 10.1007/s001920200003; Valeton CT, 2011, INT UROGYNECOL J, V22, P813, DOI 10.1007/s00192-011-1365-8; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Viktrup L, 2000, INT UROGYNECOL J PEL, V11, P336, DOI 10.1007/s001920070002; Wesnes SL, 2013, INT UROGYNECOL J, V24, P889, DOI 10.1007/s00192-012-2017-3	34	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2020	15	6							e0234338	10.1371/journal.pone.0234338	http://dx.doi.org/10.1371/journal.pone.0234338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ0RE	32511254	gold, Green Submitted, Green Published			2022-12-26	WOS:000540938100007
J	Abduelkarem, AR; Sharif, SI; Bankessli, FG; Kamal, SA; Kulhasan, NM; Hamrouni, AM				Abduelkarem, Abduelmula R.; Sharif, Suleiman I.; Bankessli, Farah G.; Kamal, Sherin A.; Kulhasan, Nahed M.; Hamrouni, Amar M.			Obesity and its associated risk factors among school-aged children in Sharjah, UAE	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; CHILDHOOD OBESITY; OVERWEIGHT; PREVALENCE	Background The most prevalent nutritional disorders worldwide are childhood overweight or obesity. Various factors clearly contribute to the childhood obesity epidemic. The aim of this study is to investigate the prevalence of childhood obesity in children of primary schools, and determine the influence of eating behavior and lifestyle in such a condition. Methods The study based on a cross sectional survey including school children aged 6-11 years. Pupils were from different schools in Sharjah, UAE. Outcome measures used in this study covered health characteristics; child habits and lifestyle; disease status and medication. Results The number of pre-validated surveys distributed was 932 and those returned counted to 678, giving a response rate of 72.8%. More than half (379; 55.9%) of the participants were females and 191 (28.2%) of the children were obese or overweight. Almost one quarter (162; 23.9%) of the children was physically inactive. Additionally, candy and fast food consumption was significantly high (370; 54.6%) and (324; 47.8%) respectively. Participant's food, age and time spent on TV were significantly associated with body mass index (BMI). Conclusion Prevalence of overweight and obesity in the Emirate of Sharjah is high in both genders and across all ages of the study population. Contributing factors may include; sedentary lifestyle, consumption of unhealthy food and family history. There is a need for an immediate attention and measures to reduce the prevalence of obesity and associated diseases.	[Abduelkarem, Abduelmula R.; Sharif, Suleiman I.; Bankessli, Farah G.; Kamal, Sherin A.; Kulhasan, Nahed M.] Univ Sharjah, Pharm Practice & Pharmacoetherapeut Dept, Coll Pharm, Sharjah, U Arab Emirates; [Hamrouni, Amar M.] Al Ain Univ, Coll Pharm, Al Ain, U Arab Emirates	University of Sharjah	Abduelkarem, AR (corresponding author), Univ Sharjah, Pharm Practice & Pharmacoetherapeut Dept, Coll Pharm, Sharjah, U Arab Emirates.	aabdelkarim@Sharjah.ac.ae	Abduelkarem, Abduelmula/AIB-6938-2022	Abduelkarem, Abduelmula/0000-0003-4481-7779; Hamrouni, Amar/0000-0002-8283-5364				Al Junaibi A, 2012, INT J OBES LOND, V37, P68, DOI DOI 10.1038/IJ0.2012.131; Al-Haddad FH, 2005, ANN HUM BIOL, V32, P72, DOI 10.1080/03014460400027425; Al-Shehhi E, 2017, WORLD FAM MED, V15, P61, DOI 10.5742/MEWFM.2017.93103; AlBlooshi A, 2016, OBES SCI PRACT, V2, P196, DOI 10.1002/osp4.37; [Anonymous], 2017, CHILD OV; [Anonymous], 2017, OB FACTS HLTH SCH; [Anonymous], 2005, GAZETTE STATE COUNCI, V17, P36; Carvalhal MM, 2007, EUR J PUBLIC HEALTH, V17, P42, DOI 10.1093/eurpub/ckl093; Chung AE, 2012, CLIN PEDIATR, V51, P122, DOI 10.1177/0009922811417291; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Dehghan M, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-24; Goldstein D. Jordi, 2001, NUTR RENAL DIS NUTR; Keykhaei F, 2016, FOOD NUTR BULL, V37, P364, DOI 10.1177/0379572116657225; Koletzko B, 2016, AM J CLIN NUTR, V103, P303, DOI 10.3945/ajcn.115.128009; Krebs NF, 2003, PEDIATRICS, V112, P424, DOI 10.1542/peds.112.2.424; Lloyd LJ, 2010, INT J OBESITY, V34, P18, DOI 10.1038/ijo.2009.61; Mony Prem K, 2016, Indian J Community Med, V41, P98, DOI 10.4103/0970-0218.173499; Musaiger AO, 2011, J OBES, V2011, DOI 10.1155/2011/407237; Pradinuk M, 2011, CAN FAM PHYSICIAN, V57, P779; Radwan H, 2018, J OBES, V2018, DOI 10.1155/2018/2185942; Raosoft, ONL SAMPL SIZ CALC; Rogers R, 2015, CHILD OBES, V11, P691, DOI 10.1089/chi.2015.0029; Strauch I, 2017, OBESITY CAUSES RISK; Szajewska H, 2010, CRIT REV FOOD SCI, V50, P113, DOI 10.1080/10408390903467514; WHO, 2017, WHAT IS OV OB	25	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0234244	10.1371/journal.pone.0234244	http://dx.doi.org/10.1371/journal.pone.0234244			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502178	Green Published, gold			2022-12-26	WOS:000542035700028
J	Teulings, NEWD; Garrud, TAC; Niu, YG; Skeffington, KL; Beck, C; Itani, N; Conlon, FG; Botting, KJ; Nicholas, LM; Ashmore, TJ; Blackmore, HL; Tong, W; Camm, EJ; Derks, JB; Logan, A; Murphy, MP; Ozanne, SE; Giussani, DA				Teulings, Noor E. W. D.; Garrud, Tessa A. C.; Niu, Youguo; Skeffington, Katie L.; Beck, Christian; Itani, Nozomi; Conlon, Fiona G.; Botting, Kimberley J.; Nicholas, Lisa M.; Ashmore, Thomas J.; Blackmore, Heather L.; Tong, Wen; Camm, Emily J.; Derks, Jan B.; Logan, Angela; Murphy, Michael P.; Ozanne, Susan E.; Giussani, Dino A.			Isolating adverse effects of glucocorticoids on the embryonic cardiovascular system	FASEB JOURNAL			English	Article						antenatal glucocorticoid therapy; cardiac function; cellular senescence; oxidative stress	DEXAMETHASONE TREATMENT; CARDIAC-FUNCTION; FETAL SHEEP; PRESSURE; HEART; BASAL; SENESCENCE; ENDOCRINE; MORTALITY; ADULTHOOD	Antenatal glucocorticoid therapy reduces mortality in the preterm infant, but evidence suggests off-target adverse effects on the developing cardiovascular system. Whether deleterious effects are direct on the offspring or secondary to alterations in uteroplacental physiology is unclear. Here, we isolated direct effects of glucocorticoids using the chicken embryo, a model system in which the effects on the developing heart and circulation of therapy can be investigated, independent of effects on the mother and/or the placenta. Fertilized chicken eggs were incubated and divided randomly into control (C) or dexamethasone (Dex) treatment at day 14 out of the 21-day incubation period. Combining functional experiments at the isolated organ, cellular and molecular levels, embryos were then studied close to term. Chicken embryos exposed to dexamethasone were growth restricted and showed systolic and diastolic dysfunction, with an increase in cardiomyocyte volume but decreased cardiomyocyte nuclear density in the left ventricle. Underlying mechanisms included a premature switch from tissue accretion to differentiation, increased oxidative stress, and activated signaling of cellular senescence. These findings, therefore, demonstrate that dexamethasone treatment can have direct detrimental off-target effects on the cardiovascular system in the developing embryo, which are independent of effects on the mother and/or placenta.	[Teulings, Noor E. W. D.; Nicholas, Lisa M.; Ashmore, Thomas J.; Blackmore, Heather L.; Ozanne, Susan E.] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Cambridge, England; [Garrud, Tessa A. C.; Niu, Youguo; Skeffington, Katie L.; Beck, Christian; Itani, Nozomi; Conlon, Fiona G.; Botting, Kimberley J.; Tong, Wen; Camm, Emily J.; Giussani, Dino A.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Derks, Jan B.] Univ Med Ctr, Dept Perinatal Med, Utrecht, Netherlands; [Logan, Angela; Murphy, Michael P.] Univ Cambridge, Mitochondrial Biol Unit, Med Res Council, Cambridge, England; [Murphy, Michael P.] Univ Cambridge, Dept Med, Cambridge, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; Utrecht University; Utrecht University Medical Center; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; University of Cambridge	Giussani, DA (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England.	dag26@cam.ac.uk	Garrud, Tess/AAJ-2564-2021; Skeffington, Katie/AAJ-8756-2021	Garrud, Tess/0000-0002-7900-7939; Skeffington, Katie/0000-0001-5252-6459; Teulings, Noor/0000-0001-8176-179X; Tong, Wen/0000-0003-1647-4166; Nicholas, Lisa/0000-0003-1976-1953; Ozanne, Susan/0000-0001-8753-5144	British Heart Foundation [PG/14/5/30547, RG/17/8/32924, PG/10/99/28656] Funding Source: Medline; Medical Research Council [MC_U105663142] Funding Source: Medline; Wellcome Trust [110159, 110159/A/15/Z, 110158, 110158/Z/15/Z] Funding Source: Medline; MRC [MC_U105663142] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adler A, 2010, NEONATOLOGY, V98, P73, DOI 10.1159/000275561; Aiken CE, 2013, REPRODUCTION, V145, pR1, DOI 10.1530/REP-11-0489; Bal MP, 2008, J APPL PHYSIOL, V104, P446, DOI 10.1152/japplphysiol.00951.2007; Botting KJ, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000531; Chapman K, 2013, PHYSIOL REV, V93, P1139, DOI 10.1152/physrev.00020.2012; CROWLEY P, 1990, BRIT J OBSTET GYNAEC, V97, P11, DOI 10.1111/j.1471-0528.1990.tb01711.x; Derks JB, 1997, J PHYSIOL-LONDON, V499, P217, DOI 10.1113/jphysiol.1997.sp021922; Figueroa JP, 2005, PEDIATR RES, V58, P510, DOI 10.1203/01.PDR.0000179410.57947.88; Fletcher AJW, 2002, J PHYSIOL-LONDON, V545, P649, DOI 10.1113/jphysiol.2001.015693; Fowden AL, 2015, EXP PHYSIOL, V100, P1477, DOI 10.1113/EP085212; Fowden AL, 1998, P NUTR SOC, V57, P113, DOI 10.1079/PNS19980017; Garrud TAC, 2019, TRENDS ENDOCRIN MET, V30, P258, DOI 10.1016/j.tem.2019.02.003; Gay MS, 2016, J PHARMACOL EXP THER, V358, P190, DOI 10.1124/jpet.116.234104; Gay MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125033; Guioli S, 2014, SEX DEV, V8, P227, DOI 10.1159/000358406; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; Itani N, 2018, J PHYSIOL-LONDON, V596, P2991, DOI 10.1113/JP274111; Iuchi T, 2003, CIRC RES, V92, P81, DOI 10.1161/01.RES.0000050588.35034.3C; Jellyman JK, 2004, AM J OBSTET GYNECOL, V190, P825, DOI 10.1016/j.ajog.2003.09.046; Jellyman JK, 2020, TRENDS MOL MED, V26, P170, DOI 10.1016/j.molmed.2019.09.005; Jobe AH, 1998, PEDIATRICS, V102, P1116, DOI 10.1542/peds.102.5.1116; Kelly BA, 2012, PEDIATRICS, V129, pE1282, DOI 10.1542/peds.2011-3175; KREAM J, 1983, J CLIN ENDOCR METAB, V56, P127, DOI 10.1210/jcem-56-1-127; Levkau B, 2008, CIRCULATION, V117, P1583, DOI 10.1161/CIRCULATIONAHA.107.734160; Li FQ, 1997, AM J PHYSIOL-REG I, V273, pR518, DOI 10.1152/ajpregu.1997.273.2.R518; Louey S, 2007, J PHYSIOL-LONDON, V580, P639, DOI 10.1113/jphysiol.2006.122200; McKinlay CJD, 2015, J DEV ORIG HLTH DIS, V6, P127, DOI 10.1017/S2040174414000579; Morrison JL, 2007, AM J PHYSIOL-REG I, V293, pR306, DOI 10.1152/ajpregu.00798.2006; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Niu YG, 2013, J PHYSIOL-LONDON, V591, P5083, DOI 10.1113/jphysiol.2013.258210; Osterman H, 2015, AM J PHYSIOL-REG I, V309, pR1204, DOI 10.1152/ajpregu.00499.2014; Paolini M, 1997, BRIT J PHARMACOL, V122, P344, DOI 10.1038/sj.bjp.0701352; Pappas JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111135; Paradis AN, 2014, DRUG DISCOV TODAY, V19, P602, DOI 10.1016/j.drudis.2013.10.019; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; PETERSEN MC, 1980, EUR J CLIN PHARMACOL, V18, P245, DOI 10.1007/BF00563006; Puente BN, 2014, CELL, V157, P565, DOI 10.1016/j.cell.2014.03.032; Razaz N, 2015, OBSTET GYNECOL, V125, P288, DOI 10.1097/AOG.0000000000000629; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Salem R, 2006, BRIT J ANAESTH, V97, P292, DOI 10.1093/bja/ael140; Sedmera D, 2003, J MOL CELL CARDIOL, V35, P301, DOI 10.1016/S0022-2828(03)00011-7; Skeffington KL, 2018, J DEV ORIG HLTH DIS, V9, P460, DOI 10.1017/S2040174418000247; Smith CA, 2001, J EXP ZOOL, V290, P691, DOI 10.1002/jez.1119; Tang JI, 2011, J HYPERTENS, V29, P282, DOI 10.1097/HJH.0b013e328340aa18; Thornburg K, 2011, PROG BIOPHYS MOL BIO, V106, P289, DOI 10.1016/j.pbiomolbio.2010.11.010; Tijsseling D, 2013, PEDIATR RES, V74, P639, DOI 10.1038/pr.2013.152; Whitworth JA, 2002, J HYPERTENS, V20, P1035, DOI 10.1097/00004872-200206000-00003; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019	50	4	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9664	9677		10.1096/fj.202000697R	http://dx.doi.org/10.1096/fj.202000697R		JUN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32502311	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000539540500001
J	An, PP; Chen, F; Li, ZH; Ling, YY; Peng, YX; Zhang, HS; Li, JX; Chen, ZJ; Wang, HS				An, Panpan; Chen, Feng; Li, Zihan; Ling, Yuyi; Peng, Yanxi; Zhang, Haisheng; Li, Jiexin; Chen, Zhuojia; Wang, Hongsheng			HDAC8 promotes the dissemination of breast cancer cells via AKT/GSK-3 beta/Snail signals	ONCOGENE			English	Article							CARDIAC HYPERTROPHIC RESPONSE; GLYCOGEN-SYNTHASE KINASE-3; HISTONE DEACETYLASE; MESENCHYMAL TRANSITION; PROTEIN; SNAIL; PHOSPHORYLATION; ACETYLATION; INHIBITION; SUPPRESSES	The mechanistic action of histone deacetylase 8 (HDAC8) in cancer motility, including epithelial-mesenchymal transition (EMT), remains largely undefined. We found that the expression of HDAC8 was upregulated in breast cancer (BC) cells and tissues as compared to the controls. Further, BC tissues had the highest values of HDAC8 expression among 31 kinds of cancers. Cellular study indicated that HDAC8 can positively regulate the dissemination and EMT of BC cells. It increased the protein stability of Snail, an important regulator of EMT, by phosphorylation of its motif 2 in serine-rich regions. There are 21 factors that have been reported to regulate the protein stability of Snail. Among them, HDAC8 can decrease the expression of GSK-3 beta through increasing its Ser9-phosphorylation. Mass spectrum analysis indicated that HDAC8 interact with AKT1 to decrease its acetylation while increase its phosphorylation, which further increased Ser9-phosphorylation of GSK-3 beta. The C-terminal of AKT1 was responsible for the interaction between HDAC8 and AKT1. Further, Lys426 was the key residue for HDAC8-regulated deacetylation of AKT1. Moreover, HDAC8/Snail axis acted as adverse prognosis factors for in vivo progression and overall survival (OS) rate of BC patients. Collectively, we found that HDAC8 can trigger the dissemination of BC cells via AKT/GSK-3 beta/Snail signals, which imposed that inhibition of HDAC8 is a potential approach for BC treatment.	[An, Panpan; Chen, Feng; Li, Zihan; Ling, Yuyi; Peng, Yanxi; Zhang, Haisheng; Li, Jiexin; Wang, Hongsheng] Sun Yat Sen Univ, Guangdong Key Lab Chiral Mol & Drug Discovery, Sch Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China; [Chen, Zhuojia] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Wang, HS (corresponding author), Sun Yat Sen Univ, Guangdong Key Lab Chiral Mol & Drug Discovery, Sch Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China.; Chen, ZJ (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Peoples R China.	chenzhj@sysucc.org.cn; whongsh@mail.sysu.edu.cn		Wang, Hong-Sheng/0000-0001-5729-6074	National Natural Science Foundation of China [81973343, 81673454, 81672608, 31801197]; Fundamental Research Funds for the Central Universities (Sun Yat-sen University) [19ykzd24, 19ykpy130]; Guangdong Provincial Key Laboratory of Construction Foundation [2017B030314030]; Guangdong Provincial Key Laboratory of Chiral Molecule and Drug Discovery [2019B030301005]; Natural Science Foundation of Guangdong Province [2020A1515010291]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities (Sun Yat-sen University); Guangdong Provincial Key Laboratory of Construction Foundation; Guangdong Provincial Key Laboratory of Chiral Molecule and Drug Discovery; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This research was supported by the National Natural Science Foundation of China (Grant Nos. 81973343, 81673454, 81672608, and 31801197), the Fundamental Research Funds for the Central Universities (Sun Yat-sen University) (19ykzd24, 19ykpy130), the Guangdong Provincial Key Laboratory of Construction Foundation (No. 2017B030314030), the Guangdong Provincial Key Laboratory of Chiral Molecule and Drug Discovery (2019B030301005), and the Natural Science Foundation of Guangdong Province (No. 2020A1515010291).	Balasubramanian S, 2008, LEUKEMIA, V22, P1026, DOI 10.1038/leu.2008.9; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Chang R, 2017, THORAC CANCER, V8, P131, DOI 10.1111/1759-7714.12408; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Deardorff MA, 2012, NATURE, V489, P313, DOI 10.1038/nature11316; Domoto T, 2016, CANCER SCI, V107, P1363, DOI 10.1111/cas.13028; Du C, 2010, CANCER RES, V70, P7810, DOI 10.1158/0008-5472.CAN-09-4481; Ecker Jonas, 2013, CNS Oncol, V2, P359, DOI 10.2217/cns.13.24; Gupta M, 2009, BLOOD, V114, P2926, DOI 10.1182/blood-2009-05-220889; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Haberland M, 2009, GENE DEV, V23, P1625, DOI 10.1101/gad.1809209; Higuchi T, 2013, BLOOD, V121, P3640, DOI 10.1182/blood-2012-07-441022; Hojfeldt JW, 2013, NAT REV DRUG DISCOV, V12, P917, DOI 10.1038/nrd4154; Hsu DSS, 2014, CANCER CELL, V26, P534, DOI 10.1016/j.ccell.2014.09.002; Hu E, 2000, J BIOL CHEM, V275, P15254, DOI 10.1074/jbc.M908988199; Hua WK, 2017, BLOOD, V130, P2619, DOI 10.1182/blood-2017-03-771386; Iaconelli J, 2017, ACS CHEM BIOL, V12, P2139, DOI 10.1021/acschembio.6b01014; Kvaratskhelia Mamuka, 2008, V488, P213, DOI 10.1007/978-1-60327-475-3_15; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lee H, 2006, MOL CELL BIOL, V26, P5259, DOI 10.1128/MCB.01971-05; Lin XY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09865-9; Liu Q, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0654-3; Long J, 2017, LEUKEMIA, V31, P2761, DOI 10.1038/leu.2017.130; Lopez JE, 2017, J AM CHEM SOC, V139, P16222, DOI 10.1021/jacs.7b07603; Lu LL, 2020, CELL DEATH DIFFER, V27, P255, DOI 10.1038/s41418-019-0353-2; Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346; Narita T, 2019, NAT REV MOL CELL BIO, V20, P156, DOI 10.1038/s41580-018-0081-3; Nieuwenhuis J, 2019, TRENDS CELL BIOL, V29, P80, DOI 10.1016/j.tcb.2018.08.003; Oehme I, 2009, CLIN CANCER RES, V15, P91, DOI 10.1158/1078-0432.CCR-08-0684; Pallet N, 2012, J TRANSPLANT, V2012, DOI 10.1155/2012/348604; Park SY, 2011, ONCOL REP, V25, P1677, DOI 10.3892/or.2011.1236; Qi J, 2015, CELL STEM CELL, V17, P597, DOI 10.1016/j.stem.2015.08.004; Rodriguez MI, 2011, ONCOGENE, V30, P4365, DOI 10.1038/onc.2011.153; Somoza JR, 2004, STRUCTURE, V12, P1325, DOI 10.1016/j.str.2004.04.012; Sundaresan NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001465; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Vannini A, 2007, EMBO REP, V8, P879, DOI 10.1038/sj.embor.7401047; Vasaikar SV, 2018, NUCLEIC ACIDS RES, V46, pD956, DOI 10.1093/nar/gkx1090; von Burstin J, 2009, GASTROENTEROLOGY, V137, P361, DOI 10.1053/j.gastro.2009.04.004; Yan MW, 2015, CARDIOVASC RES, V105, P340, DOI 10.1093/cvr/cvu254; Yan W, 2013, ONCOGENE, V32, P599, DOI 10.1038/onc.2012.81; Zhang K, 2013, NAT CELL BIOL, V15, P677, DOI 10.1038/ncb2743; Zhang K, 2012, EMBO J, V31, P29, DOI 10.1038/emboj.2011.357; Zheng HQ, 2014, CANCER CELL, V26, P358, DOI 10.1016/j.ccr.2014.07.022; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173; Zhou Y, 2019, CELL DEATH DIFFER, V26, P1442, DOI 10.1038/s41418-018-0222-4	48	19	20	3	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 25	2020	39	26					4956	4969		10.1038/s41388-020-1337-x	http://dx.doi.org/10.1038/s41388-020-1337-x		JUN 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	MQ2YO	32499521				2022-12-26	WOS:000537994200001
J	Dunstan, A; Robertson, K; Fitzpatrick, R; Pickford, J; Meager, J				Dunstan, Andrew; Robertson, Katharine; Fitzpatrick, Richard; Pickford, Jeffrey; Meager, Justin			Use of unmanned aerial vehicles (UAVs) for mark-resight nesting population estimation of adult female green sea turtles at Raine Island	PLOS ONE			English	Article							VISUAL-SEARCH; RECAPTURE; ABUNDANCE; SIZE	Nester abundance is a key measure of the performance of the world's largest green turtle rookery at Raine Island, Australia, and has been estimated by mark-resight counts since 1984. Nesters are first marked by painting their carapace with a longitudinal white stripe. Painted and unpainted turtles are then counted by a surface observer on a small boat in waters adjacent to the reef. Unmanned aerial vehicles (UAV) and underwater video may provide more cost-effective and less biased alternatives to this approach, but estimates must be comparable with historical estimates. Here we compare and evaluate the three methods. We found comparatively little variation in resighting probabilities between consecutive days of sampling or time of day, which supports an underlying assumption of the method (i.e. demographic closure during sampling). This lack of bias in the location availability for detection of painted versus unpainted turtles and further supported by a parallel satellite tracking study of 40 turtles at Raine Island. Our results demonstrated that surface observers consistently reported higher proportions of marked turtles than either the UAV or underwater video method. This in turn yielded higher population estimates with UAV or underwater video compared to the historical surface observer method, which suggested correction factors of 1.53 and 1.73 respectively. We attributed this to observer search error because a white marked turtle is easier to spot than the non-marked turtle. In contrast, the UAV and underwater video methods allowed subsequent frame-by-frame review, thus reducing observer search error. UAVs were the most efficient in terms of survey time, personnel commitment and weather tolerance compared to the other methods. However, underwater video may also be a useful alternative for in-water mark-resight surveys of turtles.	[Dunstan, Andrew; Robertson, Katharine; Meager, Justin] Queensland Dept Environm & Sci, Brisbane, Qld, Australia; [Fitzpatrick, Richard] James Cook Univ, Biopixel Oceans Fdn, Smithfield, Qld, Australia; [Pickford, Jeffrey] Queensland Dept Nat Resources Mines & Energy, Brisbane, Qld, Australia	James Cook University	Dunstan, A (corresponding author), Queensland Dept Environm & Sci, Brisbane, Qld, Australia.	andrew.dunstan@des.qld.gov.au		Meager, Justin/0000-0002-3349-1841; Pickford, Jeffrey/0000-0001-8285-7259; Dunstan, Andrew/0000-0002-3976-5030				Bell IP, 2019, SCI TOTAL ENVIRON, V652, P1040, DOI 10.1016/j.scitotenv.2018.10.150; Dunstan AJ, 2018, 2017 18 SEASON TECHN; Dunstan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016716; Eckstein MP, 2000, PERCEPT PSYCHOPHYS, V62, P425, DOI 10.3758/BF03212096; Einhauser W, 2003, EUR J NEUROSCI, V17, P1089, DOI 10.1046/j.1460-9568.2003.02508.x; Fuentes MMPB, 2015, J EXP MAR BIOL ECOL, V471, P77, DOI 10.1016/j.jembe.2015.05.003; Fuentes MMPB, 2011, GLOBAL CHANGE BIOL, V17, P140, DOI 10.1111/j.1365-2486.2010.02192.x; Graysona J., 2010, CONSERV SOC, V8, P73, DOI DOI 10.4103/0972-4923.62673; Hazel J, 2006, WILDLIFE RES, V33, P149, DOI 10.1071/WR04097; Hollings T, 2018, METHODS ECOL EVOL, V9, P881, DOI 10.1111/2041-210X.12973; Jackson RM, 2006, WILDLIFE SOC B, V34, P772, DOI 10.2193/0091-7648(2006)34[772:ESLPAU]2.0.CO;2; Jensen MP, 2018, CURR BIOL, V28, P154, DOI 10.1016/j.cub.2017.11.057; Lardner B, 2019, WILDLIFE RES, V46, P127, DOI 10.1071/WR18016; Lee KA, 2014, BIODIVERS CONSERV, V23, P2781, DOI 10.1007/s10531-014-0748-9; Limpus C, 2000, ATMOS OCEAN SCI LIB, V21, P399; Limpus C., 2007, BIOLOGICAL REV AUSTR; Limpus CJ, 2003, MEM QUEENSLAND MUS, V49, P339; McClintock BT, 2009, ECOLOGY, V90, P313, DOI 10.1890/08-0973.1; PALMER J, 1994, VISION RES, V34, P1703, DOI 10.1016/0042-6989(94)90128-7; Peel D, 2015, ECOL APPL, V25, P1003, DOI 10.1890/14-1169.1; Rees AF, 2018, ENDANGER SPECIES RES, V35, P81, DOI 10.3354/esr00877; Schofield G, 2019, BIOL CONSERV, V238, DOI 10.1016/j.biocon.2019.108214; Schofield G, 2017, FUNCT ECOL, V31, P2310, DOI 10.1111/1365-2435.12930; Schuyler Q, 2014, CONSERV BIOL, V28, P129, DOI 10.1111/cobi.12126; Seminoff J.A., 2015, SHORT CREEPY HIST HO; Sorrell KJ, 2019, ECOSPHERE, V10, DOI 10.1002/ecs2.2812; Sykora-Bodie ST, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17719-x; Wilcox C, 2015, CONSERV BIOL, V29, P198, DOI 10.1111/cobi.12355; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Witt MJ, 2009, BIOL CONSERV, V142, P1719, DOI 10.1016/j.biocon.2009.03.009; Zuur Alain F., 2009, P1	31	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0228524	10.1371/journal.pone.0228524	http://dx.doi.org/10.1371/journal.pone.0228524			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497041	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000542035200074
J	Lehmann, S; Dominguez-Ferreras, A; Huang, WJ; Denby, K; Ntoukakis, V; Schafer, P				Lehmann, Silke; Dominguez-Ferreras, Ana; Huang, Wei-Jie; Denby, Katherine; Ntoukakis, Vardis; Schafer, Patrick			Novel markers for high-throughput protoplast-based analyses of phytohormone signaling	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; PLANT HORMONES; ABSCISIC-ACID; ARABIDOPSIS; AUXIN; EXPRESSION; CYTOKININ; GENE; ACTIVATION; CASCADE	Phytohormones mediate most diverse processes in plants, ranging from organ development to immune responses. Receptor protein complexes perceive changes in intracellular phytohormone levels and trigger a signaling cascade to effectuate downstream responses. The in planta analysis of elements involved in phytohormone signaling can be achieved through transient expression in mesophyll protoplasts, which are a fast and versatile alternative to generating plant lines that stably express a transgene. While promoter-reporter constructs have been used successfully to identify internal or external factors that change phytohormone signaling, the range of available marker constructs does not meet the potential of the protoplast technique for large scale approaches. The aim of our study was to provide novel markers for phytohormone signaling in the Arabidopsis mesophyll protoplast system. We validated 18 promoter::luciferase constructs towards their phytohormone responsiveness and specificity and suggest an experimental setup for high-throughput analyses. We recommend novel markers for the analysis of auxin, abscisic acid, cytokinin, salicylic acid and jasmonic acid responses that will facilitate future screens for biological elements and environmental stimuli affecting phytohormone signaling.	[Lehmann, Silke; Dominguez-Ferreras, Ana; Huang, Wei-Jie; Denby, Katherine; Ntoukakis, Vardis; Schafer, Patrick] Univ Warwick, Sch Life Sci, Coventry, W Midlands, England; [Lehmann, Silke; Dominguez-Ferreras, Ana; Huang, Wei-Jie; Denby, Katherine; Ntoukakis, Vardis; Schafer, Patrick] Univ Warwick, Warwick Integrat Synthet Biol Ctr, Coventry, W Midlands, England; [Huang, Wei-Jie] John Innes Ctr, Norwich, England; [Denby, Katherine] Univ York, Dept Biol, York, N Yorkshire, England; [Schafer, Patrick] Univ Ulm, Mol Bot, Ulm, Germany	University of Warwick; University of Warwick; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of York - UK; Ulm University	Lehmann, S; Ntoukakis, V; Schafer, P (corresponding author), Univ Warwick, Sch Life Sci, Coventry, W Midlands, England.; Lehmann, S; Ntoukakis, V; Schafer, P (corresponding author), Univ Warwick, Warwick Integrat Synthet Biol Ctr, Coventry, W Midlands, England.; Schafer, P (corresponding author), Univ Ulm, Mol Bot, Ulm, Germany.	patrick-1.schaefer@uni-ulm.de; v.ntoukakis@warwick.ac.uk; s.lehmann@warwick.ac.uk	Dominguez-Ferreras, Ana/Y-4855-2018; Ntoukakis, Vardis/C-6296-2012	Dominguez Ferreras, Ana/0000-0003-0822-2145; Huang, Weijie/0000-0001-5208-6713; Ntoukakis, Vardis/0000-0003-0069-6004	Biotechnological and Biological Research Council (BBSRC)/Engineering and Physical Sciences Research Council Grant (EPSRC) of the United Kingdom [BB/M017982/1]; BBSRC [BB/L019345/1, BB/M017982/1, BB/K018612/2, BB/K018612/1] Funding Source: UKRI	Biotechnological and Biological Research Council (BBSRC)/Engineering and Physical Sciences Research Council Grant (EPSRC) of the United Kingdom; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by research grant BB/M017982/1 (PS, VN, KD) from Biotechnological and Biological Research Council (BBSRC)/Engineering and Physical Sciences Research Council Grant (EPSRC) of the United Kingdom. https://bbsrc.ukri.org https://epsrc.ukri.org The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL S, 1995, J MOL BIOL, V251, P533, DOI 10.1006/jmbi.1995.0454; Antoniadi I, 2015, PLANT CELL, V27, P1955, DOI 10.1105/tpc.15.00176; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Brandstatter I, 1998, PLANT CELL, V10, P1009, DOI 10.1105/tpc.10.6.1009; Brenner WG, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00008; Brown RL, 2003, PLANT PHYSIOL, V132, P1020, DOI 10.1104/pp.102.017814; Caillaud MC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001732; Chen ZY, 2007, P NATL ACAD SCI USA, V104, P20131, DOI 10.1073/pnas.0704901104; Cho YH, 2006, CELL, V127, P579, DOI 10.1016/j.cell.2006.09.028; Choi J, 2012, PLANT CELL PHYSIOL, V53, P1334, DOI 10.1093/pcp/pcs079; Cruz TMD, 2014, INT J MOL SCI, V15, P17541, DOI 10.3390/ijms151017541; D'Agostino IB, 2000, PLANT PHYSIOL, V124, P1706, DOI 10.1104/pp.124.4.1706; He P, 2006, CELL, V125, P563, DOI 10.1016/j.cell.2006.02.047; Hejatko J, 2009, PLANT CELL, V21, P2008, DOI 10.1105/tpc.109.066696; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Huang ZL, 2005, PLANT PHYSIOL, V137, P1147, DOI 10.1104/pp.104.056028; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Kinkema M, 2000, PLANT CELL, V12, P2339, DOI 10.1105/tpc.12.12.2339; Komarova NY, 2012, TRAFFIC, V13, P1090, DOI 10.1111/j.1600-0854.2012.01370.x; Koornneef A, 2008, PLANT PHYSIOL, V147, P1358, DOI 10.1104/pp.108.121392; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Kovtun Y, 1998, NATURE, V395, P716, DOI 10.1038/27240; Kunihiro A, 2011, PLANT CELL PHYSIOL, V52, P1315, DOI 10.1093/pcp/pcr076; LANG V, 1992, PLANT MOL BIOL, V20, P951, DOI 10.1007/BF00027165; Li J, 2004, PLANT CELL, V16, P319, DOI 10.1105/tpc.016980; Lomin SN, 2011, J EXP BOT, V62, P5149, DOI 10.1093/jxb/err220; Lu YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057171; McSteen P, 2008, DEV CELL, V14, P467, DOI 10.1016/j.devcel.2008.03.013; Mellor N, 2016, P NATL ACAD SCI USA, V113, P11022, DOI 10.1073/pnas.1604458113; Mueller K, 2012, PLANT CELL, V24, P2213, DOI 10.1105/tpc.112.096073; Negin B, 2019, PLANT PHYSIOL, V180, P910, DOI 10.1104/pp.18.01334; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; Noutoshi Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00705; Okushima Y, 2007, PLANT CELL, V19, P118, DOI 10.1105/tpc.106.047761; Paponov IA, 2008, MOL PLANT, V1, P321, DOI 10.1093/mp/ssm021; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Qi TC, 2011, PLANT CELL, V23, P1795, DOI 10.1105/tpc.111.083261; Quareshy M, 2018, ACS CHEM BIOL, V13, P2585, DOI 10.1021/acschembio.8b00527; Samodelov SL, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601266; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Sebastian J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004973; Sehr EM, 2010, PLANT J, V63, P811, DOI 10.1111/j.1365-313X.2010.04283.x; Shan QW, 2014, NAT PROTOC, V9, P2395, DOI 10.1038/nprot.2014.157; Spoel SH, 2003, PLANT CELL, V15, P760, DOI 10.1105/tpc.009159; Sun JQ, 2013, PLANT CELL, V25, P2102, DOI 10.1105/tpc.113.112417; Takei K, 2004, J BIOL CHEM, V279, P41866, DOI 10.1074/jbc.M406337200; Toufighi K, 2005, PLANT J, V43, P153, DOI 10.1111/j.1365-313X.2005.02437.x; Van der Does D, 2013, PLANT CELL, V25, P744, DOI 10.1105/tpc.112.108548; Villarino GH, 2016, PLANT PHYSIOL, V171, P42, DOI 10.1104/pp.15.01845; Wang L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000301; Wang SC, 2005, PLANT CELL, V17, P1979, DOI 10.1105/tpc.105.031096; Wehner N, 2011, PLANT J, V68, P560, DOI 10.1111/j.1365-313X.2011.04704.x; Wend S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02052; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Worley CK, 2000, PLANT J, V21, P553, DOI 10.1046/j.1365-313x.2000.00703.x; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; YAMAGUCHISHINOZAKI K, 1993, MOL GEN GENET, V236, P331, DOI 10.1007/BF00277130; Yan YX, 2007, PLANT CELL, V19, P2470, DOI 10.1105/tpc.107.050708; Yanagisawa S, 2003, NATURE, V425, P521, DOI 10.1038/nature01984; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yu SM, 2015, TRENDS PLANT SCI, V20, P844, DOI 10.1016/j.tplants.2015.10.009; YU TF, 2018, FRONT PLANT SCI, V9, DOI DOI 10.3389/FPLS.2018.0065130093908; Zander M, 2014, PLANT PHYSIOL, V165, P1671, DOI 10.1104/pp.114.243360	63	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0234154	10.1371/journal.pone.0234154	http://dx.doi.org/10.1371/journal.pone.0234154			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497144	Green Published, gold, Green Accepted			2022-12-26	WOS:000542035200005
J	van Dammen, L; de Rooij, SR; Behnsen, PM; Huizink, AC				van Dammen, Lotte; de Rooij, Susanne R.; Behnsen, Pia M.; Huizink, Anja C.			Sex-specific associations between person and environment-related childhood adverse events and levels of cortisol and DHEA in adolescence	PLOS ONE			English	Article							STRESSFUL LIFE EVENTS; DIURNAL CORTISOL; HAIR CORTISOL; DEHYDROEPIANDROSTERONE DHEA; HPA-AXIS; SALIVARY; DEPRESSION; GIRLS; PSYCHOPATHOLOGY; RELIABILITY	Background Person and environment-related childhood adverse events have been demonstrated to increase the risk of impaired mental health in later life differently for boys and girls. Altered hypothalamic pituitary adrenal (HPA)-axis functioning has been suggested as a key mechanism underlying this association. Cortisol and dehydroepiandrosterone (DHEA) are both output hormones of the HPA-axis. DHEA may have a protective function against long-term exposure to increased levels of cortisol, but has been little investigated in relation to childhood adversity. Objective We aimed to test the associations between person-, and environment-related childhood adversity and levels of cortisol, DHEA and cortisol/DHEA ratio in adolescent boys and girls. Methods A total of 215 Dutch adolescents participated in the study and filled out the 27-item Adverse Life Events Questionnaire for the assessment of childhood adversity, which was split up in separate scores for person-related and environment-related events. Cortisol and DHEA concentrations and cortisol/DHEA ratio were determined in proximal 3 cm long hair segments. Additionally, saliva samples were collected immediately and 30 minutes after waking up, at noon and at 8 pm. Multiple linear regression analyses were used to test associations between childhood adversity and cortisol and DHEA concentrations, for boys and girls separately, with age, BMI and pubertal development as covariates. Results Data were available for 74 boys and 116 girls with a mean age of 15.7 years (SD = 2.0). Higher levels of person-related childhood adversity were associated with higher hair DHEA levels in girls and with higher hair cortisol levels in boys. A trend towards a significant association was observed between higher levels of environment-related childhood adversity and higher DHEA levels in boys. Neither person- nor environment related childhood adversity was associated with cortisol/DHEA ratio. A trend was observed for environment-related childhood adversity and lower daily cortisol output in boys. Conclusion We found differential associations between childhood adversity and cortisol and DHEA levels in girls and boys, for respectively person-related and environment-related childhood adversity. Our findings suggest that different types of childhood adversity are not only linked to levels of cortisol, but also to DHEA concentrations, in a sex-specific manner, with possible future implications for mental health.	[van Dammen, Lotte] Iowa State Univ, Dept Human Dev & Family Studies, Ames, IA 50011 USA; [van Dammen, Lotte] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynaecol, Groningen, Netherlands; [van Dammen, Lotte] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [de Rooij, Susanne R.] Amsterdam UMC, Locat AMC, Dept Clin Epidemiol Biostat & Bioinformat, Amsterdam, Netherlands; [de Rooij, Susanne R.; Behnsen, Pia M.; Huizink, Anja C.] Vrije Univ Amsterdam, Dept Dev Psychol, Amsterdam, Netherlands; [Huizink, Anja C.] Univ Skovde, Sch Hlth & Learning, Skovde, Sweden	Iowa State University; University of Groningen; University of Groningen; University of Amsterdam; Vrije Universiteit Amsterdam; University of Skovde	van Dammen, L (corresponding author), Iowa State Univ, Dept Human Dev & Family Studies, Ames, IA 50011 USA.; van Dammen, L (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynaecol, Groningen, Netherlands.; van Dammen, L (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.	lotte@iastate.edu		de Rooij, Susanne Rosalie/0000-0001-7382-5749				Amato P R, 1994, Future Child, V4, P143, DOI 10.2307/1602482; Amone-P'olak K, 2009, J AM ACAD CHILD PSY, V48, P1031, DOI 10.1097/CHI.0b013e3181b39595; Anacker C, 2014, DIALOGUES CLIN NEURO, V16, P321; [Anonymous], 2016, STATUSSCORE; BAILEY SL, 1991, BIOL PSYCHOL, V32, P181, DOI 10.1016/0301-0511(91)90009-6; Barendse MEA, 2018, PSYCHONEUROENDOCRINO, V97, P156, DOI 10.1016/j.psyneuen.2018.07.020; BARON JA, 1995, J PHARMACOL EXP THER, V272, P151; BENDIXEN M, 1994, CHILD ABUSE NEGLECT, V18, P837, DOI 10.1016/0145-2134(94)90063-9; Bernard K, 2015, DEV PSYCHOBIOL, V57, P935, DOI 10.1002/dev.21324; Biederman J, 2002, AM J PSYCHIAT, V159, P1556, DOI 10.1176/appi.ajp.159.9.1556; Black SR, 2017, BIOL PSYCHOL; BROOKSGUNN J, 1987, CHILD DEV, V58, P829, DOI 10.2307/1130220; BRUGHA TS, 1990, ACTA PSYCHIAT SCAND, V82, P77, DOI 10.1111/j.1600-0447.1990.tb01360.x; Busso DS, 2017, PSYCHOSOM MED, V79, P162, DOI 10.1097/PSY.0000000000000369; Carpenter T, 2017, J DEV ORIG HLTH DIS, V8, P244, DOI 10.1017/S204017441600074X; CARSKADON MA, 1993, J ADOLESCENT HEALTH, V14, P190, DOI 10.1016/1054-139X(93)90004-9; D'Anna-Hernandez KL, 2011, PHYSIOL BEHAV, V104, P348, DOI 10.1016/j.physbeh.2011.02.041; Dieleman GC, 2015, PSYCHONEUROENDOCRINO, V51, P135, DOI 10.1016/j.psyneuen.2014.09.002; Doom JR, 2013, PSYCHONEUROENDOCRINO, V38, P1442, DOI 10.1016/j.psyneuen.2012.12.019; DRESSENDORFER RA, 1992, J STEROID BIOCHEM, V43, P683, DOI 10.1016/0960-0760(92)90294-S; Ehlert U, 2001, BIOL PSYCHOL, V57, P141, DOI 10.1016/S0301-0511(01)00092-8; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Fraser R, 1999, HYPERTENSION, V33, P1364, DOI 10.1161/01.HYP.33.6.1364; Gao W, 2013, J CHROMATOGR B, V928, P1, DOI 10.1016/j.jchromb.2013.03.008; Gonzalez A, 2009, PSYCHONEUROENDOCRINO, V34, P76, DOI 10.1016/j.psyneuen.2008.08.012; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Kendler KS, 1999, PSYCHOL MED, V29, P1455, DOI 10.1017/S0033291798008198; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Kessler RC, 2010, BRIT J PSYCHIAT, V197, P378, DOI 10.1192/bjp.bp.110.080499; Kimonides VG, 1999, NEUROSCIENCE, V89, P429, DOI 10.1016/S0306-4522(98)00347-9; Kuhlman KR, 2017, NEUROSCI BIOBEHAV R, V80, P166, DOI 10.1016/j.neubiorev.2017.05.020; Kurita H, 2013, J AFFECT DISORDERS, V146, P205, DOI 10.1016/j.jad.2012.09.004; Lovallo WR, 2013, INT J PSYCHOPHYSIOL, V90, P8, DOI 10.1016/j.ijpsycho.2012.10.006; Lu HJ, 2011, 2011 INTERNATIONAL CONFERENCE ON ELECTRONICS, COMMUNICATIONS AND CONTROL (ICECC), P132; Matchock RL, 2007, CHRONOBIOL INT, V24, P969, DOI 10.1080/07420520701649471; Michael A, 2000, BIOL PSYCHIAT, V48, P989, DOI 10.1016/S0006-3223(00)00955-0; Olff M, 2006, PSYCHONEUROENDOCRINO, V31, P1220, DOI 10.1016/j.psyneuen.2006.09.003; Pham S, 2018, AM J PSYCHIAT; SANDLER IN, 1992, J CLIN CHILD PSYCHOL, V21, P240, DOI 10.1207/s15374424jccp2103_5; Segerstrom SC, 2014, PSYCHONEUROENDOCRINO, V49, P299, DOI 10.1016/j.psyneuen.2014.07.022; Shonkoff JP, 2012, PEDIATRICS, V129, pE232, DOI 10.1542/peds.2011-2663; Short SJ, 2016, PSYCHONEUROENDOCRINO, V71, P12, DOI 10.1016/j.psyneuen.2016.05.007; Simmons JG, 2016, PSYCHONEUROENDOCRINO, V63, P276, DOI 10.1016/j.psyneuen.2015.10.004; Stalder T, 2012, BRAIN BEHAV IMMUN, V26, P1019, DOI 10.1016/j.bbi.2012.02.002; Technow JR, 2015, J ABNORM CHILD PSYCH, V43, P489, DOI 10.1007/s10802-014-9922-5; Uh D, 2017, CLIN PSYCHOPHARM NEU, V15, P163, DOI 10.9758/cpn.2017.15.2.163; Van Voorhees Elizabeth, 2004, Trauma Violence Abuse, V5, P333, DOI 10.1177/1524838004269486; Van Voorhees EE, 2014, INT CLIN PSYCHOPHARM, V29, P56, DOI 10.1097/YIC.0b013e328364ecd1; Vanaelst B, 2012, PSYCHOPHYSIOLOGY, V49, P1072, DOI 10.1111/j.1469-8986.2012.01396.x; WILLIAMSON DE, 1995, J AM ACAD CHILD PSY, V34, P591, DOI 10.1097/00004583-199505000-00011; Yadid G, 2010, NEUROSCI BIOBEHAV R, V35, P303, DOI 10.1016/j.neubiorev.2010.03.003; Yehuda R, 2006, ACTA PSYCHIAT SCAND, V114, P187, DOI 10.1111/j.1600-0447.2006.00801.x; Zhang Q, 2018, LIFE SCI, V193, P57, DOI 10.1016/j.lfs.2017.11.037; Zilioli S, 2016, PSYCHOL SCI, V27, P1249, DOI 10.1177/0956797616658287	54	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0233718	10.1371/journal.pone.0233718	http://dx.doi.org/10.1371/journal.pone.0233718			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MA6PX	32497103	Green Published, gold			2022-12-26	WOS:000542035200024
J	Crandon, LE; Boenisch, KM; Harper, BJ; Harper, SL				Crandon, Lauren E.; Boenisch, Kylie M.; Harper, Bryan J.; Harper, Stacey L.			Adaptive methodology to determine hydrophobicity of nanomaterials in situ	PLOS ONE			English	Article							OCTANOL-WATER DISTRIBUTION; SURFACE HYDROPHOBICITY; TIO2 NANOPARTICLES; CONTACT-ANGLE; ADSORPTION; TRANSPORT; MODEL; HETEROAGGREGATION; AGGREGATION; ATTACHMENT	The hydrophobicity of nanoparticles (NPs) is a key property determining environmental fate, biological partitioning and toxicity. However, methods to characterize surface hydrophobicity are not uniformly applied to NPs and cannot quantify surface changes in complex environments. Existing methods designed to evaluate the hydrophobicity of bulk solids, chemicals, and proteins have significant limitations when applied to NPs. In this study, we modified and evaluated two methods to determine the hydrophobicity of NPs, hydrophobic interaction chromatography (HIC) and dye adsorption, and compared them to the standard octanol-water partitioning protocol for chemicals. Gold, copper oxide, silica, and amine-functionalized silica NPs were used to evaluate methods based on their applicability to NPs that agglomerate and have surface coatings. The octanol water partitioning and HIC methods both measured Au NPs as hydrophilic, but despite having a small size and stable suspension, NPs could not be fully recovered from the HIC column. For the dye adsorption method, hydrophobic (Rose Bengal) and hydrophilic (Nile Blue) dyes were adsorbed to the NP surface, and linear isotherm parameters were used as a metric for hydrophobicity. CuO was determined to be slightly hydrophilic, while SiO2 was hydrophilic and Ami-SiO2 was hydrophobic. The advantages and limitations of each method are discussed, and the dye adsorption method is recommended as the most suitable for application across broad classes of nanomaterials. The dye assay method was further used to measure changes in the surface hydrophobicity of TiO2 NPs after being suspended in natural water collected from the Alsea Rivers watershed in Oregon. TiO2 NPs adsorbed Rose Bengal when suspended in ultrapure water, but adsorbed Nile Blue after being incubated in natural water samples, demonstrating a shift from hydrophobic to hydrophilic properties on the outer surface. The dye adsorption method can be applied to characterize surface hydrophobicity of NPs and quantify environmental transformations, potentially improving environmental fate models.	[Crandon, Lauren E.; Boenisch, Kylie M.; Harper, Stacey L.] Oregon State Univ, Sch Chem Biol & Environm Engn, Corvallis, OR 97331 USA; [Harper, Bryan J.; Harper, Stacey L.] Oregon State Univ, Dept Environm & Mol Toxicol, Corvallis, OR 97331 USA; [Harper, Stacey L.] Oregon Nanosci & Microtechnol Inst, Corvallis, OR 97330 USA	Oregon State University; Oregon State University	Harper, SL (corresponding author), Oregon State Univ, Sch Chem Biol & Environm Engn, Corvallis, OR 97331 USA.; Harper, SL (corresponding author), Oregon State Univ, Dept Environm & Mol Toxicol, Corvallis, OR 97331 USA.; Harper, SL (corresponding author), Oregon Nanosci & Microtechnol Inst, Corvallis, OR 97330 USA.	stacey.harper@oregonstate.edu		Crandon, Lauren/0000-0001-6521-0226; Harper, Stacey/0000-0001-7043-7097	NSF [1762245]	NSF(National Science Foundation (NSF))	This work was partially supported by NSF Grant #1762245 awarded to Stacey Harper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Aggarwal P, 2009, ADV DRUG DELIVER REV, V61, P428, DOI 10.1016/j.addr.2009.03.009; AKSOY B.S., 1989, PROCESSING COMPLEX O, P19; Alvarez PJJ, 2009, ACS NANO, V3, P1616, DOI 10.1021/nn9006835; Arnaudov LN, 2010, PHYS CHEM CHEM PHYS, V12, P328, DOI 10.1039/b917353f; Ayawei N, 2017, J CHEM-NY, V2017, DOI 10.1155/2017/3039817; Azimi G, 2013, NAT MATER, V12, P315, DOI [10.1038/NMAT3545, 10.1038/nmat3545]; Barton LE, 2014, ENVIRON ENG SCI, V31, P421, DOI 10.1089/ees.2013.0472; BCCResearch, 2017, GLOB MARK NAN NAN NA; CARSTENSEN H, 1991, INT J PHARM, V67, P29, DOI 10.1016/0378-5173(91)90262-M; Cestari AR, 2007, J COLLOID INTERF SCI, V309, P402, DOI 10.1016/j.jcis.2006.11.049; ChemAxon, 2017, CHEM; Chowdhury I, 2011, J COLLOID INTERF SCI, V360, P548, DOI 10.1016/j.jcis.2011.04.111; Deak A, 2007, PHYS CHEM CHEM PHYS, V9, P6359, DOI 10.1039/b702937n; des Rieux A, 2005, EUR J PHARM SCI, V25, P455, DOI 10.1016/j.ejps.2005.04.015; Doktorovova S, 2012, EUR J PHARM SCI, V45, P606, DOI 10.1016/j.ejps.2011.12.016; Finizio A, 1997, CHEMOSPHERE, V34, P131, DOI 10.1016/S0045-6535(96)00355-4; Geitner NK, 2017, ENVIRON SCI TECHNOL, V51, P13288, DOI 10.1021/acs.est.7b04612; Hou WC, 2012, ENVIRON SCI TECHNOL, V46, P1869, DOI 10.1021/es203661k; Hristovski KD, 2011, J ENVIRON SCI HEAL A, V46, P636, DOI 10.1080/10934529.2011.562859; Hu YQ, 2013, CHEM ENG J, V228, P392, DOI 10.1016/j.cej.2013.04.116; Jafvert CT, 2008, ENVIRON SCI TECHNOL, V42, P5945, DOI 10.1021/es702809a; Jones MC, 2014, J CONTROL RELEASE, V183, P94, DOI 10.1016/j.jconrel.2014.03.022; Keller AA, 2010, ENVIRON SCI TECHNOL, V44, P1962, DOI 10.1021/es902987d; Kim ST, 2013, ACCOUNTS CHEM RES, V46, P681, DOI 10.1021/ar3000647; Li SH, 2015, BIOMATERIALS, V52, P312, DOI 10.1016/j.biomaterials.2015.02.043; Li XQ, 2004, ENVIRON SCI TECHNOL, V38, P5616, DOI 10.1021/es049154v; Li Y, 2008, J PHYS CHEM B, V112, P16647, DOI 10.1021/jp8051906; Liu XL, 2010, SURF COAT TECH, V204, P3200, DOI 10.1016/j.surfcoat.2010.03.012; Lowry GV, 2010, J ENVIRON QUAL, V39, P1867, DOI 10.2134/jeq2010.0297; Maestro A, 2014, CURR OPIN COLLOID IN, V19, P355, DOI 10.1016/j.cocis.2014.04.008; Meylan WM, 1999, ENVIRON TOXICOL CHEM, V18, P664, DOI 10.1002/etc.5620180412; Moyano DF, 2014, ACS NANO, V8, P6748, DOI 10.1021/nn5006478; Mudunkotuwa IA, 2015, ENVIRON SCI-NANO, V2, P429, DOI 10.1039/c4en00215f; Muller RH, 1997, PHARMACEUT RES, V14, P18, DOI 10.1023/A:1012043131081; O. Guideline, 1995, OECD GUIDEL, V107, P1, DOI [10.1787/9789264069626-en, DOI 10.1787/9789264069626-EN]; Petersen EJ, 2010, ENVIRON TOXICOL CHEM, V29, P1106, DOI 10.1002/etc.149; Praetorius A, 2014, ENVIRON SCI-NANO, V1, P317, DOI 10.1039/c4en00043a; Praetorius A, 2014, ENVIRON SCI TECHNOL, V48, P10690, DOI 10.1021/es501655v; Praetorius A, 2012, ENVIRON SCI TECHNOL, V46, P6705, DOI 10.1021/es204530n; Queiroz JA, 2001, J BIOTECHNOL, V87, P143, DOI 10.1016/S0168-1656(01)00237-1; SMITH T, 1980, J COLLOID INTERF SCI, V75, P51, DOI 10.1016/0021-9797(80)90348-3; Song JE, 2011, ENVIRON SCI TECHNOL, V45, P5988, DOI 10.1021/es200547c; Stark WJ, 2015, CHEM SOC REV, V44, P5793, DOI 10.1039/c4cs00362d; Thomas DN, 1999, WATER RES, V33, P1579, DOI 10.1016/S0043-1354(98)00392-3; Topuz E, 2014, ENVIRON POLLUT, V193, P37, DOI 10.1016/j.envpol.2014.05.029; Tufenkji N, 2005, LANGMUIR, V21, P841, DOI 10.1021/la048102g; Valsesia A, 2018, COMMUN CHEM, V1, DOI 10.1038/s42004-018-0054-7; Velmurugan P, 2016, RES CHEM INTERMEDIAT, V42, P5937, DOI 10.1007/s11164-015-2415-5; Vencalek BE, 2016, ENVIRON SCI TECH LET, V3, P375, DOI 10.1021/acs.estlett.6b00252; Wu F, 2019, INTEGR ENV ASSESS MA, P107; Xia TA, 2011, ACS NANO, V5, P1223, DOI 10.1021/nn1028482; Xia XR, 2011, ACS NANO, V5, P9074, DOI 10.1021/nn203303c; Xiao Y, 2012, J HAZARD MATER, V215, P146, DOI 10.1016/j.jhazmat.2012.02.043; Zhu MT, 2013, ACCOUNTS CHEM RES, V46, P622, DOI 10.1021/ar300031y	54	11	11	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2020	15	6							e0233844	10.1371/journal.pone.0233844	http://dx.doi.org/10.1371/journal.pone.0233844			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LW6ZP	32492068	gold, Green Published			2022-12-26	WOS:000539293000036
J	Perryman, CR; Wirsing, J; Bennett, KA; Brennick, O; Perry, AL; Williamson, N; Ernakovich, JG				Perryman, Clarice R.; Wirsing, Jochen; Bennett, Kathryn A.; Brennick, Owen; Perry, Apryl L.; Williamson, Nicole; Ernakovich, Jessica G.			Heavy metals in the Arctic: Distribution and enrichment of five metals in Alaskan soils	PLOS ONE			English	Article							FRESH-WATER FISH; TRACE-METALS; SPATIAL-PATTERNS; INUIT CHILDREN; CLIMATE-CHANGE; MERCURY; LEAD; CONTAMINATION; CARBON; PLANT	Metal contamination of food and water resources is a known public health issue in Arctic and sub-Arctic communities due to the proximity of many communities to mining and drilling sites. In addition, permafrost thaw may release heavy metals sequestered in previously frozen soils, potentially contaminating food and water resources by increasing the concentration of metals in freshwater, plants, and wildlife. Here we assess the enrichment of selected heavy metals in Alaskan soils by synthesizing publicly available data of soil metal concentrations. We analyzed data of soil concentrations of arsenic, chromium, mercury, nickel, and lead from over 1,000 samples available through the USGS Alaskan Geochemical Database to evaluate 1) the spatial distribution of sampling locations for soil metal analysis, 2) metal concentrations in soils from different land cover types and depths, and 3) the occurrence of soils in Alaska with elevated metal concentrations relative to other soils. We found substantial clustering of sample sites in the southwestern portion of Alaska in discontinuous and sporadic permafrost, while the continuous permafrost zone in Northern Alaska and the more populous Interior are severely understudied. Metal concentration varied by land cover type but lacked consistent patterns. Concentrations of chromium, mercury, and lead were higher in soils below 10 cm depth, however these deeper soils are under-sampled. Arsenic, chromium, mercury, nickel and lead concentrations exceeded average values for US soils by one standard deviation or more in 3.7% to 18.7% of the samples in this dataset. Our analysis highlights critical gaps that impede understanding of how heavy metals in thawing permafrost soils may become mobilized and increase exposure risk for Arctic communities.	[Perryman, Clarice R.; Bennett, Kathryn A.; Perry, Apryl L.] Univ New Hampshire, Dept Earth Sci, Durham, NH 03824 USA; [Perryman, Clarice R.; Bennett, Kathryn A.; Perry, Apryl L.] Univ New Hampshire, Inst Study Earth Oceans & Space, Durham, NH 03824 USA; [Wirsing, Jochen] Univ New Hampshire, Dept Sociol, Durham, NH 03824 USA; [Brennick, Owen; Ernakovich, Jessica G.] Univ New Hampshire, Dept Nat Resources & Environm, Durham, NH 03824 USA; [Williamson, Nicole] Towson Univ, Environm Sci & Studies Program, Towson, MD USA; [Williamson, Nicole] Towson Univ, Dept Biol Sci, Towson, MD USA	University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire; University System of Maryland; Towson University; University System of Maryland; Towson University	Perryman, CR (corresponding author), Univ New Hampshire, Dept Earth Sci, Durham, NH 03824 USA.; Perryman, CR (corresponding author), Univ New Hampshire, Inst Study Earth Oceans & Space, Durham, NH 03824 USA.	crp1006@wildcats.unh.edu	; Ernakovich, Jessica/E-4864-2016	Perryman, Clarice/0000-0002-5086-6684; Ernakovich, Jessica/0000-0002-4493-2489; Brennick, Owen/0000-0002-9916-6718; Wirsing, Jochen/0000-0002-8457-8170; Bennett, Kathryn/0000-0001-7563-2537; Perry, Apryl/0000-0003-1617-557X	Arctic Science IntegrAtion Quest (ASIAQ)	Arctic Science IntegrAtion Quest (ASIAQ)	We would like to thank the members of the New England Arctic Network (NEAN) for their feedback throughout the development of this work, especially NEAN members Jack Dibb, Katherine Duderstadt, Robyn Barbato, Ruth Varner, Julie Bryce, Florencia Fahnestock, and Stacey Doherty. We would also like to thank the Arctic Science IntegrAtion Quest (ASIAQ) for their support and the academic editor and 5 reviewers of this manuscript for their time and thoughtful feedback. Database searches, data analysis, and preliminary manuscript preparation was conducted through a course offered by the UNH Department of Natural Resources and the Environment, and we thank the department for their support of the course.	Abass K, 2018, ENVIRON SCI POLLUT R, V25, P28834, DOI 10.1007/s11356-018-2936-8; Abbott BW, 2015, BIOGEOSCIENCES, V12, P3725, DOI 10.5194/bg-12-3725-2015; [Alaska Department of Natural Resources Clearinghouse AKSGD], 2019, SPAT DAT; Allen-Gil SM, 2003, SCI TOTAL ENVIRON, V301, P119, DOI 10.1016/S0048-9697(02)00295-4; AllenGil SM, 1997, ENVIRON TOXICOL CHEM, V16, P733, DOI [10.1002/etc.5620160418, 10.1897/1551-5028(1997)016&lt;0733:HMAISA&gt;2.3.CO;2]; Amundsen PA, 1997, SCI TOTAL ENVIRON, V201, P211, DOI 10.1016/S0048-9697(97)84058-2; [Anonymous], 2011, NLCD 2011 LAND COV A; [Anonymous], 2012, AGENCY TOXIC SUBSTAN; [Anonymous], 2019, AL CONT SIT DAT; Antcibor I, 2014, BIOGEOSCIENCES, V11, P1, DOI 10.5194/bg-11-1-2014; Barker AJ, 2014, CHEM GEOL, V381, P180, DOI 10.1016/j.chemgeo.2014.05.012; BELKIN HE, 1993, ENVIRON GEOL, V22, P106, DOI 10.1007/BF00789322; Boucher O, 2012, ENVIRON HEALTH PERSP, V120, P1456, DOI 10.1289/ehp.1204976; Burger J, 2007, SCI TOTAL ENVIRON, V387, P175, DOI 10.1016/j.scitotenv.2007.07.049; Dornblaser MM, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007546; Dudarev AA, 2012, INT J CIRCUMPOL HEAL, V71, DOI 10.3402/ijch.v71i0.18592; Elberling B, 1998, CAN GEOTECH J, V35, P895, DOI 10.1139/cgj-35-5-895; Eubig PA, 2010, ENVIRON HEALTH PERSP, V118, P1654, DOI 10.1289/ehp.0901852; Evengard B, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.8449; Fahnestock MF, 2019, GEOCHEM PERSPECT LET, V11, P33, DOI 10.7185/geochemlet.1922; Farquharson LM, 2019, GEOPHYS RES LETT, V46, P6681, DOI 10.1029/2019GL082187; Fay M., 2005, TOXICOLOGICAL PROFIL; Frugal C, 2003, NO CONTAMINANTS PROG; Gibson CM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05457-1; Granitto M., 2013, ALASKAN GEOCHEMICAL; Greenwald MJ, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000549; Halbach K, 2017, CHEMOSPHERE, V188, P567, DOI 10.1016/j.chemosphere.2017.09.012; Hasselbach L, 2005, SCI TOTAL ENVIRON, V348, P211, DOI 10.1016/j.scitotenv.2004.12.084; Jorgenson MT, 2010, CAN J FOREST RES, V40, P1219, DOI 10.1139/X10-060; Jorgenson T., 2008, 9 INT C PERM FAIRB A; Kamunda C, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13070663; Kenny TA, 2018, PUBLIC HEALTH NUTR, V21, P1319, DOI 10.1017/S1368980017003810; Kim S, 2011, WATER AIR SOIL POLL, V219, P365, DOI 10.1007/s11270-010-0713-5; Lee S, 2018, KOREAN J ANESTHESIOL, V71; Liu CW, 2007, CHEMOSPHERE, V69, P128, DOI 10.1016/j.chemosphere.2007.04.038; Loiko SV, 2017, CHEM GEOL, V471, P153, DOI 10.1016/j.chemgeo.2017.10.002; Loseto LL, 2004, ENVIRON TOXICOL CHEM, V23, P17, DOI 10.1897/02-644; Lu ZB, 2013, ENVIRON GEOCHEM HLTH, V35, P257, DOI 10.1007/s10653-012-9481-z; Natali SM, 2009, ECOSYSTEMS, V12, P715, DOI 10.1007/s10021-009-9251-7; Neitlich PN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177936; Obrist D, 2016, SCI TOTAL ENVIRON, V568, P522, DOI 10.1016/j.scitotenv.2015.11.104; Pearson C, 2019, ATMOS CHEM PHYS, V19, P6913, DOI 10.5194/acp-19-6913-2019; Pithan F, 2014, NAT GEOSCI, V7, P181, DOI [10.1038/ngeo2071, 10.1038/NGEO2071]; R Core Team, 2018, R LANG ENV STAT COMP; Rajkumar M, 2013, ENVIRON INT, V53, P74, DOI 10.1016/j.envint.2012.12.009; Reimann C, 2005, SCI TOTAL ENVIRON, V337, P91, DOI 10.1016/j.scitotenv.2004.06.011; Romanovsky VE, 2010, PERMAFROST PERIGLAC, V21, P106, DOI 10.1002/ppp.689; Schuster PF, 2018, GEOPHYS RES LETT, V45, P1463, DOI 10.1002/2017GL075571; Schuur EAG, 2015, NATURE, V520, P171, DOI 10.1038/nature14338; Simonetti A, 2003, ATMOS ENVIRON, V37, P2853, DOI 10.1016/S1352-2310(03)00210-3; Smith D.B., 2013, DATA SERIES, V801; St Pierre KA, 2018, ENVIRON SCI TECHNOL, V52, P14099, DOI 10.1021/acs.est.8b05348; Trust KA, 2000, ARCH ENVIRON CON TOX, V38, P107, DOI 10.1007/s002449910013; United States Census Bureau, 2017, TIGER LIN SHAP; Valera B, 2012, NEUROTOXICOLOGY, V33, P1067, DOI 10.1016/j.neuro.2012.05.005; Valette-Silver N, 1999, MAR POLLUT BULL, V38, P702, DOI 10.1016/S0025-326X(99)00034-X; van Gestel CAM, 2008, SCI TOTAL ENVIRON, V406, P385, DOI 10.1016/j.scitotenv.2008.05.050; Walker DA, 2005, J VEG SCI, V16, P267, DOI 10.1111/j.1654-1103.2005.tb02365.x; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	59	13	13	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2020	15	6							e0233297	10.1371/journal.pone.0233297	http://dx.doi.org/10.1371/journal.pone.0233297			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LW6ZP	32492035	Green Published, gold			2022-12-26	WOS:000539293000052
J	Pan, ZN; Pan, MH; Sun, MH; Li, XH; Zhang, Y; Sun, SC				Pan, Zhen-Nan; Pan, Meng-Hao; Sun, Ming-Hong; Li, Xiao-Han; Zhang, Yu; Sun, Shao-Chen			RAB7 GTPase regulates actin dynamics for DRP1-mediated mitochondria function and spindle migration in mouse oocyte meiosis	FASEB JOURNAL			English	Article						actin; meiosis; oocyte; RAB7; spindle	CYTOSKELETAL ORGANIZATION; MATURATION; TRANSPORT; PROTEINS; FISSION; REARRANGEMENT; DIVISION	RAB7 is a small GTPase that belongs to the Rab family, and as a vesicle trafficking factor it is shown to regulate the transport to late endocytic compartments, autophagosome maturation and organelle function. In present study, we showed the critical roles of RAB7 GTPase on actin dynamics and mitochondria function in oocyte meiosis. RAB7 mainly accumulated at cortex and spindle periphery during oocyte maturation. RAB7 depletion caused the failure of polar body extrusion and asymmetric division, and Rab7 exogenous mRNA supplement could rescue the defects caused by RAB7 RNAi. Based on mass spectrometry analysis, we found that RAB7 associated with several actin nucleation factors and mitochondria-related proteins in oocytes. The depletion of RAB7 caused the decrease of actin dynamics, which further affected meiotic spindle migration to the oocyte cortex. In addition, we found that RAB7 could maintain mitochondrial membrane potential and the mitochondrial distribution in mouse oocytes, and this might be due to its effects on the phosphorylation of DRP1 at Ser616 domain. Taken together, our data indicated that RAB7 transported actin nucleation factor for actin polarization, which further affected the phosphorylation of DRP1 for mitochondria dynamics and the meiotic spindle migration in mouse oocytes.	[Pan, Zhen-Nan; Pan, Meng-Hao; Sun, Ming-Hong; Li, Xiao-Han; Zhang, Yu; Sun, Shao-Chen] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing 210095, Peoples R China	Nanjing Agricultural University	Sun, SC (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing 210095, Peoples R China.	sunsc@njau.edu.cn			National Key Research and Development Program of China [2018YFC1003802, 2018YFC1004003]	National Key Research and Development Program of China	National Key Research and Development Program of China, Grant/Award Number: 2018YFC1003802 and 2018YFC1004003	Almonacid M, 2014, J CELL SCI, V127, P477, DOI 10.1242/jcs.142711; Azoury J, 2009, BIOL CELL, V101, P69, DOI 10.1042/BC20080003; Babayev E, 2015, CURR OPIN OBSTET GYN, V27, P175, DOI 10.1097/GCO.0000000000000164; Brunet S, 2011, HUM REPROD UPDATE, V17, P68, DOI 10.1093/humupd/dmq044; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Dalton CM, 2013, J CELL SCI, V126, P2955, DOI 10.1242/jcs.128744; Desai SP, 2013, BIOPHYS J, V104, P2077, DOI 10.1016/j.bpj.2013.03.025; Duan X, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14068-3; Duan X, 2019, BIOL REPROD, V100, P15, DOI 10.1093/biolre/ioy163; Duan X, 2018, BBA-MOL CELL RES, V1865, P455, DOI 10.1016/j.bbamcr.2017.11.016; Emmanuel M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004666; Feng JX, 2019, FISH SHELLFISH IMMUN, V88, P1, DOI 10.1016/j.fsi.2019.02.053; FitzHarris G, 2007, DEV BIOL, V305, P133, DOI 10.1016/j.ydbio.2007.02.006; Frederick RL, 2007, TRAFFIC, V8, P1668, DOI 10.1111/j.1600-0854.2007.00644.x; Goody RS, 2017, BIOL CHEM, V398, P565, DOI 10.1515/hsz-2016-0274; Guerra F, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5030034; Haile Y, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0788-z; Hatch AL, 2016, MOL BIOL CELL, V27, P3109, DOI 10.1091/mbc.E16-03-0193; Holubcova Z, 2013, NAT CELL BIOL, V15, P937, DOI 10.1038/ncb2802; Hu CX, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010144; Hyttinen JMT, 2013, BBA-MOL CELL RES, V1833, P503, DOI 10.1016/j.bbamcr.2012.11.018; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Jin RU, 2014, J CELL SCI, V127, P1018, DOI 10.1242/jcs.138776; Kjos I, 2018, BBA-MOL CELL RES, V1865, P1397, DOI 10.1016/j.bbamcr.2018.07.009; Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360; Landry MC, 2014, J BIOL CHEM, V289, P2230, DOI 10.1074/jbc.M113.516351; Levi M, 2011, MOL HUM REPROD, V17, P328, DOI 10.1093/molehr/gar025; Li Guangpu, 2015, Methods Mol Biol, V1298, P1, DOI 10.1007/978-1-4939-2569-8_1; Lopez-Domenech G, 2018, EMBO J, V37, P321, DOI 10.15252/embj.201696380; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Ma RJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23560; Manor U, 2015, ELIFE, V4, DOI 10.7554/eLife.08828; Mao LN, 2014, REPROD BIOMED ONLINE, V28, P284, DOI 10.1016/j.rbmo.2013.10.016; Mascia A, 2016, J CELL PHYSIOL, V231, P1695, DOI 10.1002/jcp.25267; Miller HE, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007005; Moore AS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12886; Pan MH, 2018, J CELL PHYSIOL, V233, P2270, DOI 10.1002/jcp.26099; Pan ZN, 2019, BIOL REPROD, V100, P711, DOI 10.1093/biolre/ioy217; Pfender S, 2011, CURR BIOL, V21, P955, DOI 10.1016/j.cub.2011.04.029; Qiu D, 2019, CELL CYCLE, V18, P1; Rehklau K, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.448; Sakane A, 2012, J BIOL CHEM, V287, P42455, DOI 10.1074/jbc.M112.383653; Shi P, 2019, J CELL SCI, V132, DOI 10.1242/jcs.226506; Sun Y, 2005, J BIOL CHEM, V280, P32356, DOI 10.1074/jbc.M414213200; Udagawa O, 2014, CURR BIOL, V24, P2451, DOI 10.1016/j.cub.2014.08.060; Van Blerkom J, 2007, MOL HUM REPROD, V13, P759, DOI 10.1093/molehr/gam068; Van Blerkom J, 2011, MITOCHONDRION, V11, P797, DOI 10.1016/j.mito.2010.09.012; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Wong YC, 2018, NATURE, V554, P382, DOI 10.1038/nature25486; Yang CS, 2019, NAT CELL BIOL, V21, P603, DOI 10.1038/s41556-019-0313-6; Yi KX, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0002; Zhang Y, 2019, MOL HUM REPROD, V25, P359, DOI 10.1093/molehr/gaz027; Zhang Y, 2014, CELL CYCLE, V13, P3390, DOI 10.4161/15384101.2014.952967; Zhu H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.441	54	17	17	2	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9615	9627		10.1096/fj.201903013R	http://dx.doi.org/10.1096/fj.201903013R		MAY 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32472654				2022-12-26	WOS:000538118800001
J	Miras, K; Ferrante, E; Eiben, AE				Miras, Karine; Ferrante, Eliseo; Eiben, A. E.			Environmental influences on evolvable robots	PLOS ONE			English	Article								The field of Evolutionary Robotics addresses the challenge of automatically designing robotic systems. Furthermore, the field can also support biological investigations related to evolution. In this paper, we evolve (simulated) modular robots under diverse environmental conditions and analyze the influences that these conditions have on the evolved morphologies, controllers, and behavior. To this end, we introduce a set of morphological, controller, and behavioral descriptors that together span a multi-dimensional trait space. Using these descriptors, we demonstrate how changes in environmental conditions induce different levels of differentiation in this trait space. Our main goal is to gain deeper insights into the effect of the environment on a robotic evolutionary process.	[Miras, Karine; Ferrante, Eliseo; Eiben, A. E.] Vrije Univ Amsterdam, Computat Intelligence Grp, Comp Sci Dept, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Miras, K (corresponding author), Vrije Univ Amsterdam, Computat Intelligence Grp, Comp Sci Dept, Amsterdam, Netherlands.	k.dasilvamirasdearaujo@vu.nl	Ferrante, Eliseo/S-7877-2017	Ferrante, Eliseo/0000-0002-2213-8356; Miras, Karine/0000-0003-4942-3488				Auerbach JE, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003399; Auerbach JE, 2014, ALIFE 2014: THE FOURTEENTH INTERNATIONAL CONFERENCE ON THE SYNTHESIS AND SIMULATION OF LIVING SYSTEMS, P136, DOI [10.7551/978-0-262-32621-6-ch022, 10.1061/9780784412480.012]; Bongard JC, 2013, COMMUN ACM, V56, P74, DOI [10.1145/2493883, 10.1145/2492007.2493883]; Darwin C., 2004, ORIGIN SPECIES 1859; Daudelin J, 2018, SCI ROBOT, V3, DOI 10.1126/scirobotics.aat4983; Doncieux S, 2015, FRONTIERS ROBOTICS A, V2, P4, DOI [10.3389/frobt.2015.00004, DOI 10.3389/FR0BT.2015.00004]; Eiben A.E., 2015, INTRO EVOLUTIONARY C, V2nd; Eiben AE, 2015, NATURE, V521, P476, DOI 10.1038/nature14544; Farina M, 2012, BRAIN BODY ENV SHAPE; Ferrante E, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004273; Ferrante E, 2013, GECCO'13: PROCEEDINGS OF THE 2013 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P17; Hart Adam G., 2002, Acta Ethologica, V5, P1, DOI 10.1007/s10211-002-0062-5; Hornby G., 2001, P 3 ANN C GENETIC EV, P868; Howard D, 2019, NAT MACH INTELL, V1, P12, DOI 10.1038/s42256-018-0009-9; Hupkes E, 2018, LECT NOTES COMPUT SC, V10784, P687, DOI 10.1007/978-3-319-77538-8_46; Jacob C, 1994, LECT NOTES COMPUT SC, V866, P334; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kriegman S, 2018, ARXIV180402257; Kriegman S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31868-7; Methenitis G, 2015, GECCO'15: PROCEEDINGS OF THE 2015 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P193, DOI 10.1145/2739480.2754731; Miras K, 2019, PROCEEDINGS OF THE 2019 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE (GECCO'19), P125, DOI 10.1145/3321707.3321811; Miras K, 2019, ALIFE 2019: THE 2019 CONFERENCE ON ARTIFICIAL LIFE, P396; Miras K, 2018, 2018 CONFERENCE ON ARTIFICIAL LIFE (ALIFE 2018), P224; Miras K, 2018, 2018 IEEE SYMPOSIUM SERIES ON COMPUTATIONAL INTELLIGENCE (IEEE SSCI), P867, DOI 10.1109/SSCI.2018.8628662; Miras K, 2018, LECT NOTES COMPUT SC, V10784, P703, DOI 10.1007/978-3-319-77538-8_47; Payne JL, 2019, NAT REV GENET, V20, P24, DOI 10.1038/s41576-018-0069-z; Pfeifer R., 2006, BODY SHAPES WAY WE T; Pfeifer R, 2005, CREATING BRAIN INTEL, V5436, P130; Roli A, 2019, FRONT ROBOT AI, V6, DOI 10.3389/frobt.2019.00130; Samuelsen E, 2014, GECCO'14: PROCEEDINGS OF THE 2014 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P721, DOI 10.1145/2576768.2598325; Sapolsky R.M., 2017, BEHAV BIOL HUMANS OU; Sims K., 1994, Artificial Life IV. Proceedings of the Fourth International Workshop on the Synthesis and Simulation of Living Systems, P28; SOUTHWOOD TRE, 1977, J ANIM ECOL, V46, P337; Stern DL, 2013, NAT REV GENET, V14, P751, DOI 10.1038/nrg3483; Vargas PA, 2014, INTEL ROBOT AUTON AG, P1; Wang IJ, 2010, MOL ECOL, V19, P447, DOI 10.1111/j.1365-294X.2009.04465.x; Weigmann K, 2012, EMBO REP, V13, P1066, DOI 10.1038/embor.2012.170; Zamudio KR, 2016, P NATL ACAD SCI USA, V113, P8041, DOI 10.1073/pnas.1602237113	38	11	11	6	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2020	15	5							e0233848	10.1371/journal.pone.0233848	http://dx.doi.org/10.1371/journal.pone.0233848			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1WS	32470076	gold, Green Published			2022-12-26	WOS:000537552800193
J	Sarker, AR; Sultana, M				Sarker, Abdur Razzaque; Sultana, Marufa			Cost-effective analysis of childhood malaria vaccination in endemic hotspots of Bangladesh	PLOS ONE			English	Article							ROTAVIRUS VACCINATION; ECONOMIC-BENEFITS; ORAL CHOLERA; VACCINES; BURDEN; DISEASE; POPULATION; RTS,S/AS01; STRATEGIES; COUNTRIES	Introduction Bangladesh has a history of endemic malaria transmission, with 17.5 million people at risk. The objective of this study was to assess the cost-effectiveness of universal childhood malaria vaccination in Chittagong Hill Tracts (CHT) of Bangladesh with newly developed RTS,S/AS01 malaria vaccines. Methods A decision model was been developed using Microsoft (R) Excel to examine the potential impact of future vaccination in Bangladesh. We estimated the economic and health burden due to malaria and the cost-effectiveness of malaria vaccination from the health system and societal perspective. The primary outcomes include the incremental cost per Disability-Adjusted Life Year (DALY) averted, incremental cost per case averted, and the incremental cost per death averted. Results Introducing childhood malaria vaccination in CHT in Bangladesh for a single birth cohort could prevent approximately 500 malaria cases and at least 30 deaths from malaria during the first year of vaccination. The cost per DALY averted of introducing the malaria vaccine compared to status quo is US$ 2,629 and US$ 2,583 from the health system and societal perspective, respectively. Conclusions Introduction of malaria vaccination in CHT region is estimated to be a cost-effective preventive intervention and would offer substantial future benefits particularly for young children vaccinated today. Policies should, thus, consider the operational advantages of targeting these populations, particularly in the CHT area, with the vaccine along with other malaria control initiatives.	[Sarker, Abdur Razzaque] Bangladesh Inst Dev Studies BIDS, Populat Studies Div, Dhaka, Bangladesh; [Sarker, Abdur Razzaque; Sultana, Marufa] Bangladesh Icddr b, Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh; [Sultana, Marufa] Deakin Univ, Sch Hlth & Social Dev, Melbourne, Vic, Australia	Bangladesh Institute of Development Studies (BIDS); International Centre for Diarrhoeal Disease Research (ICDDR); Deakin University	Sarker, AR (corresponding author), Bangladesh Inst Dev Studies BIDS, Populat Studies Div, Dhaka, Bangladesh.; Sarker, AR (corresponding author), Bangladesh Icddr b, Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh.	razzaque@bids.org.bdn		Sarker, Abdur Razzaque/0000-0002-2022-7590				Alam MS, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1603-0; [Anonymous], 2016, Wkly Epidemiol Rec, V91, P33; [Anonymous], 2004, COCHRANE DB SYST REV; Atherly D, 2009, J INFECT DIS, V200, pS28, DOI 10.1086/605033; BBS, 2015, POPULATION PROJECTIO; BBS (Bangladesh Bureau of Statistics), 2015, REP BANGL SAMPL VIT; Burchett HED, 2012, HEALTH POLICY PLANN, V27, pII62, DOI 10.1093/heapol/czr049; Chen IT, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0569-7; Cook J, 2008, VACCINE, V26, P6305, DOI 10.1016/j.vaccine.2008.09.040; Drummond MF, 2015, METHODS EC EVALUATIO; Etiaba E, 2015, NIGER J CLIN PRACT, V18, P22, DOI 10.4103/1119-3077.146974; Ezeoke OP, 2012, AM J TROP MED HYG, V86, P52, DOI 10.4269/ajtmh.2012.11-0090; Fischer TK, 2005, J INFECT DIS, V192, P1720, DOI 10.1086/497339; Galactionova K, 2017, VACCINE, V35, P53, DOI 10.1016/j.vaccine.2016.11.042; Gold MR, 1996, COST EFFECTIVENESS H, DOI [10.1002/(SICI)1099-176X(199906)2<91::AID, DOI 10.1002/(SICI)1099-176X(199906)2<91::AID]; Gosling R, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001994; Greenwood B, 2006, TROP MED INT HEALTH, V11, P983, DOI 10.1111/j.1365-3156.2006.01657.x; Greenwood B, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0433; Hague U, 2013, AM J TROP MED HYG, V88, P727, DOI 10.4269/ajtmh.12-0456; Han L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07533-w; Haque U, 2014, LANCET GLOB HEALTH, V2, pE98, DOI 10.1016/S2214-109X(13)70176-1; Haque U, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-367; Haque U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018908; Haque U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006737; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P3, DOI 10.1596/978-0-8213-6179-5/Chpt-1; Jeuland M, 2009, WORLD BANK ECON REV, V23, P1; Jeuland M, 2009, VALUE HEALTH, V12, P899, DOI 10.1111/j.1524-4733.2009.00562.x; Jin H, 2011, VACCINE, V29, P7801, DOI 10.1016/j.vaccine.2011.07.104; Kyu HH, 2018, LANCET, V392, P1859, DOI 10.1016/s0140-6736(18)32335-3; Lindstrand A, 2008, GLOBAL HLTH INTRO TX; Longini IM, 2007, PLOS MED, V4, P1776, DOI 10.1371/journal.pmed.0040336; Lugner AK, 2010, HEALTH ECON, V19, P518, DOI 10.1002/hec.1485; Mahoney RT, 2007, VACCINE, V25, P4003, DOI 10.1016/j.vaccine.2007.02.047; McKenna MT, 2005, AM J PREV MED, V28, P415, DOI 10.1016/j.amepre.2005.02.009; Megiddo I, 2014, VACCINE, V32, pA151, DOI 10.1016/j.vaccine.2014.04.080; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; MOHFW, 2010, COMPR MULT PLAN 2011; Murray C.J, 1996, GLOBAL BURDEN DIS CO; Murray J, 1998, B WORLD HEALTH ORGAN, V76, P343; National Institute of Population Research and Training Mitra and Associates ICF International, 2015, BANGLADESH DEMOGRAPH, V34; Neafsey DE, 2015, NEW ENGL J MED, V373, P2025, DOI 10.1056/NEJMoa1505819; Onwujekwe O, 2010, TROP MED INT HEALTH, V15, P18, DOI 10.1111/j.1365-3156.2009.02418.x; Ozawa S, 2012, VACCINE, V31, P96, DOI 10.1016/j.vaccine.2012.10.103; Pecenka C, 2017, VACCINE, V35, P3982, DOI 10.1016/j.vaccine.2017.05.087; Penny MA, 2016, LANCET, V387, P367, DOI 10.1016/S0140-6736(15)00725-4; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Qadri F, 2015, LANCET, V386, P1362, DOI 10.1016/S0140-6736(15)61140-0; Romore I, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1197-6; S.C.T.P. RTS, 2017, LANCET, V386, P31, DOI 10.1016/s0140-6736(15)60721-8; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Sarker AR, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028020; Sarker AR, 2015, VACCINE, V33, P4916, DOI 10.1016/j.vaccine.2015.07.042; Sinclair D, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007483.pub2; Stack ML, 2011, HEALTH AFFAIR, V30, P1021, DOI 10.1377/hlthaff.2011.0382; Starzengruber P, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-16; Tan-Torres E, 2003, WHO GUIDE COSTEFFECT; Troeger C, 2014, AM J TROP MED HYG, V91, P1181, DOI 10.4269/ajtmh.14-0159; UCSF Global Health Group, 2017, INV CAS EL MAL BANGL; Uddin J, 2013, J HEALTH POPUL NUTR, V31, P211; White MT, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-337; WHO, 2016, MALARIA; WHO, 2014, WORLD MAL RE 2014, DOI [10.1002/(SICI)1096-987X(19981115)19:14%3C1639::AID-JCC10%3E3.0.CO;2-B%5Cn, DOI 10.1002/(SICI)1096-987X(19981115)19:14%3C1639::AID-JCC10%3E3.0.CO;2-B%5CN]; WHO &VERBAR; World Health Organization, 2016, FACT SHEET WORLD MAL; Winskill P, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000090; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; World Health Organization, 2015, WORLD MAL REP 2015	66	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2020	15	5							e0233902	10.1371/journal.pone.0233902	http://dx.doi.org/10.1371/journal.pone.0233902			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU1WS	32470101	Green Published, gold			2022-12-26	WOS:000537552800211
J	Chen, XC; Shang, L; Deng, SW; Li, P; Chen, K; Gao, T; Zhang, X; Chen, ZL; Zeng, J				Chen, Xiaocui; Shang, Lin; Deng, Senwen; Li, Ping; Chen, Kai; Gao, Ting; Zhang, Xiao; Chen, Zhilan; Zeng, Jia			Peroxisomal oxidation of erucic acid suppresses mitochondrial fatty acid oxidation by stimulating malonyl-CoA formation in the rat liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						erucic acid; mitochondrial fatty acid oxidation; malonyl-CoA; peroxisome; peroxisome proliferator activator receptor ?; fatty liver; steatosis; metabolic disorder; canola oil; fatty acid oxidation; mitochondrial metabolism; peroxisome proliferator-activated receptor (PPAR); insulin resistance	ACTIVATED RECEPTOR-ALPHA; BETA-OXIDATION; ACETYL-COA; CARNITINE ACYLTRANSFERASES; LIPID-METABOLISM; PROTEIN-KINASE; RAPESEED OIL; SHORT-CHAIN; LOCALIZATION; ACCUMULATION	Feeding of rapeseed (canola) oil with a high erucic acid concentration is known to cause hepatic steatosis in animals. Mitochondrial fatty acid oxidation plays a central role in liver lipid homeostasis, so it is possible that hepatic metabolism of erucic acid might decrease mitochondrial fatty acid oxidation. However, the precise mechanistic relationship between erucic acid levels and mitochondrial fatty acid oxidation is unclear. Using male Sprague?Dawley rats, along with biochemical and molecular biology approaches, we report here that peroxisomal ?-oxidation of erucic acid stimulates malonyl-CoA formation in the liver and thereby suppresses mitochondrial fatty acid oxidation. Excessive hepatic uptake and peroxisomal ?-oxidation of erucic acid resulted in appreciable peroxisomal release of free acetate, which was then used in the synthesis of cytosolic acetyl-CoA. Peroxisomal metabolism of erucic acid also remarkably increased the cytosolic NADH/NAD(+)ratio, suppressed sirtuin 1 (SIRT1) activity, and thereby activated acetyl-CoA carboxylase, which stimulated malonyl-CoA biosynthesis from acetyl-CoA. Chronic feeding of a diet including high-erucic-acid rapeseed oil diminished mitochondrial fatty acid oxidation and caused hepatic steatosis and insulin resistance in the rats. Of note, administration of a specific peroxisomal ?-oxidation inhibitor attenuated these effects. Our findings establish a cross-talk between peroxisomal and mitochondrial fatty acid oxidation. They suggest that peroxisomal oxidation of long-chain fatty acids suppresses mitochondrial fatty acid oxidation by stimulating malonyl-CoA formation, which might play a role in fatty acid?induced hepatic steatosis and related metabolic disorders.	[Chen, Xiaocui; Shang, Lin; Deng, Senwen; Li, Ping; Chen, Kai; Gao, Ting; Zhang, Xiao; Chen, Zhilan; Zeng, Jia] Hunan Univ Sci & Technol, Sch Life Sci, Xiangtan, Hunan, Peoples R China	Hunan University of Science & Technology	Zeng, J (corresponding author), Hunan Univ Sci & Technol, Sch Life Sci, Xiangtan, Hunan, Peoples R China.	zengj@hnu.edu.cn			National Natural Science Fund of China [30900024]; Hunan Education Department Scientific Research Project [16C0656]; Distinguished Professor Funds from Hunan University of Science and Technology; Project of Graduate Innovation in Hunan Province Grant [CX20190814]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Hunan Education Department Scientific Research Project; Distinguished Professor Funds from Hunan University of Science and Technology; Project of Graduate Innovation in Hunan Province Grant	This work was supported by National Natural Science Fund of China Grant 30900024, Hunan Education Department Scientific Research Project 16C0656, Distinguished Professor Funds from Hunan University of Science and Technology, and Project of Graduate Innovation in Hunan Province Grant CX20190814.	Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Antonenkov VD, 2006, BBA-MOL CELL RES, V1763, P1697, DOI 10.1016/j.bbamcr.2006.08.044; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bloom K, 2018, J INHERIT METAB DIS, V41, P49, DOI 10.1007/s10545-017-0013-y; BREMER J, 1982, J LIPID RES, V23, P243; CAPUZZI DM, 1974, BIOCHEM BIOPH RES CO, V60, P1499, DOI 10.1016/0006-291X(74)90367-2; Carre P, 2014, OCL OILS FAT CROP LI, V21, DOI 10.1051/ocl/2013054; CEDERBAUM AI, 1974, BIOCHEM PHARMACOL, V23, P1985, DOI 10.1016/0006-2952(74)90257-3; CHIEN KR, 1983, AM J PATHOL, V112, P68; CHOI YR, 1977, J BIOL CHEM, V252, P7930; CHRISTOPHERSEN BO, 1972, BIOCHIM BIOPHYS ACTA, V280, P506, DOI 10.1016/0005-2760(72)90130-0; Cotter DG, 2014, J CLIN INVEST, V124, P5175, DOI 10.1172/JCI76388; DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; Ellinghaus P, 1999, J BIOL CHEM, V274, P2766, DOI 10.1074/jbc.274.5.2766; FERRE P, 1983, BIOCHEM J, V214, P937, DOI 10.1042/bj2140937; Fujino T, 2001, J BIOL CHEM, V276, P11420, DOI 10.1074/jbc.M008782200; GALLIKIENLE M, 1976, LIPIDS, V11, P670, DOI 10.1007/BF02532884; HORIE S, 1986, J BIOCHEM, V99, P1345, DOI 10.1093/oxfordjournals.jbchem.a135602; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; HOVIK R, 1991, J LIPID RES, V32, P993; Hui AY, 2005, ALIMENT PHARM THER, V21, P407, DOI 10.1111/j.1365-2036.2005.02334.x; IMESCH E, 1984, INT J BIOCHEM, V16, P875, DOI 10.1016/0020-711X(84)90146-0; Ishaq M, 2017, J SCI FOOD AGR, V97, P1924, DOI 10.1002/jsfa.7997; Islinger M, 2018, HISTOCHEM CELL BIOL, V150, P443, DOI 10.1007/s00418-018-1722-5; Jin YH, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-0233-6; KING MT, 1988, METHOD ENZYMOL, V166, P70; KNUDSEN CT, 1992, EUR J BIOCHEM, V204, P359, DOI 10.1111/j.1432-1033.1992.tb16644.x; Knutsen H. K., 2016, EFSA; KRAMER JKG, 1979, J NUTR, V109, P202, DOI 10.1093/jn/109.2.202; Krebs H A, 1967, Adv Enzyme Regul, V5, P409, DOI 10.1016/0065-2571(67)90029-5; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Latruffe N, 2000, BIOCHEM PHARMACOL, V60, P1027, DOI 10.1016/S0006-2952(00)00416-0; Lazarow P B, 1981, Methods Enzymol, V72, P315; LAZAROW PB, 1976, P NATL ACAD SCI USA, V73, P2043, DOI 10.1073/pnas.73.6.2043; Lee YH, 2015, J AGR FOOD CHEM, V63, P7361, DOI 10.1021/acs.jafc.5b02876; LEIGHTON F, 1984, BIOCHEM BIOPH RES CO, V120, P505, DOI 10.1016/0006-291X(84)91283-X; LEIGHTON F, 1989, J BIOL CHEM, V264, P10347; Li D, 1999, J AM CHEM SOC, V121, P9034, DOI 10.1021/ja991908w; LIEBER CS, 1961, J CLIN INVEST, V40, P394, DOI 10.1172/JCI104266; McClelland GB, 2003, BIOCHEM BIOPH RES CO, V304, P130, DOI 10.1016/S0006-291X(03)00550-3; MCGARRY JD, 1977, J CLIN INVEST, V60, P265, DOI 10.1172/JCI108764; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; NEAT CE, 1980, BIOCHEM J, V186, P369, DOI 10.1042/bj1860369; NEAT CE, 1981, BIOCHEM J, V196, P149, DOI 10.1042/bj1960149; NORSETH J, 1978, FEBS LETT, V88, P353, DOI 10.1016/0014-5793(78)80210-5; OSMUNDSEN H, 1977, BIOCHEM J, V164, P621, DOI 10.1042/bj1640621; OSMUNDSEN H, 1979, FEBS LETT, V99, P292, DOI 10.1016/0014-5793(79)80975-8; Park H, 2002, J BIOL CHEM, V277, P32571, DOI 10.1074/jbc.M201692200; PEARSON DJ, 1964, NATURE, V202, P91, DOI 10.1038/202091a0; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Prip-Buus C, 1998, FEBS LETT, V429, P173, DOI 10.1016/S0014-5793(98)00584-5; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; SCHOLTE HR, 1975, BIOCHIM BIOPHYS ACTA, V409, P283, DOI 10.1016/0005-2760(75)90024-7; THOMASSEN MS, 1985, BIOCHEM J, V225, P301, DOI 10.1042/bj2250301; THOMASSEN MS, 1982, BIOCHEM J, V206, P195, DOI 10.1042/bj2060195; THOMASSON HJ, 1955, J NUTR, V57, P17, DOI 10.1093/jn/57.1.17; THORPE C, 1979, BIOCHEMISTRY-US, V18, P331, DOI 10.1021/bi00569a016; TOLBERT NE, 1981, ANNU REV BIOCHEM, V50, P133, DOI 10.1146/annurev.bi.50.070181.001025; TUBBS PK, 1964, BIOCHEM J, V93, P550, DOI 10.1042/bj0930550; Vetter W., 2020, NFS Journal, V19, P9, DOI 10.1016/j.nfs.2020.03.002; Violante S, 2010, BBA-MOL BASIS DIS, V1802, P728, DOI 10.1016/j.bbadis.2010.06.002; WANDERS RJA, 1987, J CLIN INVEST, V80, P1778, DOI 10.1172/JCI113271; Wanders RJA, 2001, BIOCHEM SOC T, V29, P250, DOI 10.1042/0300-5127:0290250; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Westin MAK, 2008, CELL MOL LIFE SCI, V65, P982, DOI 10.1007/s00018-008-7576-6; WILLIAMSON DH, 1962, BIOCHEM J, V82, P90, DOI 10.1042/bj0820090; Zeng J, 2008, ORG LETT, V10, P4287, DOI 10.1021/ol801571n; Zeng J, 2017, J BIOL CHEM, V292, P3800, DOI 10.1074/jbc.M116.763532	68	9	9	3	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2020	295	30					10168	10179		10.1074/jbc.RA120.013583	http://dx.doi.org/10.1074/jbc.RA120.013583			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MW0BV	32493774	Green Published, hybrid			2022-12-26	WOS:000556713400007
J	Vishwanath, N; Monis, WJ; Hoffmann, GA; Ramachandran, B; DiGiacomo, V; Wong, JY; Smith, ML; Layne, MD				Vishwanath, Neya; Monis, William J.; Hoffmann, Gwendolyn A.; Ramachandran, Bhavana; DiGiacomo, Vincent; Wong, Joyce Y.; Smith, Michael L.; Layne, Matthew D.			Mechanisms of aortic carboxypeptidase-like protein secretion and identification of an intracellularly retained variant associated with Ehlers?Danlos syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						extracellular matrix (ECM); collagen; glycosylation; genetic disease; endoplasmic reticulum stress (ER stress); post-translational modification (PTM); Ehlers-Danlos syndrome; aortic carboxypeptidase-like protein (ACLP); glycoprotein secretion	ALZHEIMERS-DISEASE; DANLOS-SYNDROME; COLLAGEN V; GLYCOSYLATION; DENSITY; LACKING; AEBP1; LUNG	Aortic carboxypeptidase-like protein (ACLP) is a collagen-binding extracellular matrix protein that has important roles in wound healing and fibrosis. ACLP contains thrombospondin repeats, a collagen-binding discoidin domain, and a catalytically inactive metallocarboxypeptidase domain. Recently, mutations in the ACLP-encoding gene, AE-binding protein 1 (AEBP1), have been discovered, leading to the identification of a new variant of Ehlers?Danlos syndrome causing connective tissue disruptions in multiple organs. Currently, little is known about the mechanisms of ACLP secretion or the role of post-translational modifications in these processes. We show here that the secreted form of ACLP containsN-linked glycosylation and that inhibition of glycosylation results in its intracellular retention. Using site-directed mutagenesis, we determined that glycosylation of Asn-471 and Asn-1030 is necessary for ACLP secretion and identified a specific N-terminal proteolytic ACLP fragment. To determine the contribution of secreted ACLP to extracellular matrix mechanical properties, we generated and mechanically tested wet-spun collagen ACLP composite fibers, finding that ACLP enhances the modulus (or stiffness), toughness, and tensile strength of the fibers. SomeAEBP1mutations were null alleles, whereas others resulted in expressed proteins. We tested the hypothesis that a recently discovered 40-amino acid mutation and insertion in the ACLP discoidin domain regulates collagen binding and assembly. Interestingly, we found that this protein variant is retained intracellularly and induces endoplasmic reticulum stress identified with an XBP1-based endoplasmic reticulum stress reporter. Our findings highlight the importance ofN-linked glycosylation of ACLP for its secretion and contribute to our understanding of ACLP-dependent disease pathologies.	[Vishwanath, Neya; Monis, William J.; Ramachandran, Bhavana; DiGiacomo, Vincent; Layne, Matthew D.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Hoffmann, Gwendolyn A.; Wong, Joyce Y.; Smith, Michael L.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Monis, William J.] Sanofi, Cambridge, MA USA; [DiGiacomo, Vincent] DeepBiome Therapeut, Cambridge, MA USA	Boston University; Boston University; Sanofi-Aventis	Layne, MD (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.	mlayne@bu.edu	Wong, Joyce Y./AAF-5759-2019	Wong, Joyce Y./0000-0002-3526-6381; Smith, Michael/0000-0003-3757-2726; Hoffmann, Gwendolyn/0000-0001-7492-4503	National Institutes of Health [HL078869, T32 GM008764, F31 HL151082]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health Grant HL078869 (to M. D. L.). G. A. H. was supported by National Institutes of Health Graining Grants T32 GM008764 and F31 HL151082. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abderrahim-Ferkoune A, 2004, EXP CELL RES, V293, P219, DOI 10.1016/j.yexcr.2003.10.020; Alazami AM, 2016, HUM GENET, V135, P525, DOI 10.1007/s00439-016-1660-z; Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; Blackburn PR, 2018, AM J HUM GENET, V102, P696, DOI 10.1016/j.ajhg.2018.02.018; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Boot-Handford RP, 2010, CELL TISSUE RES, V339, P197, DOI 10.1007/s00441-009-0877-8; Bradshaw MJ, 2019, ACTA BIOMATER, V88, P78, DOI 10.1016/j.actbio.2019.02.022; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Connizzo BK, 2015, J ORTHOP RES, V33, P882, DOI 10.1002/jor.22893; den Dunnen JT, 1998, HUM MOL GENET, V7, P1185; Didangelos A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008128; Finch-Edmondson M, 2016, CELL MOL BIOL LETT, V21, DOI 10.1186/s11658-016-0028-7; Fuentes-Prior P, 2002, CURR PROTEIN PEPT SC, V3, P313, DOI 10.2174/1389203023380639; Gerhard GS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219764; HE GP, 1995, NATURE, V378, P92, DOI 10.1038/378092a0; Hebebrand M, 2019, AM J MED GENET A, V179, P50, DOI 10.1002/ajmg.a.60679; Hoosdally SJ, 2009, J BIOL CHEM, V284, P16277, DOI 10.1074/jbc.M109.007849; Hopkins DR, 2007, MATRIX BIOL, V26, P508, DOI 10.1016/j.matbio.2007.05.004; Hynes RO, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a004903; Ith B, 2005, GENE EXPR PATTERNS, V5, P533, DOI 10.1016/j.modgep.2004.11.002; Jacobsen MM, 2017, SCI REP-UK, V7, DOI 10.1038/srep45653; Jager M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197777; Lampi MC, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao0475; Layne MD, 2002, CIRC RES, V90, P728, DOI 10.1161/01.RES.0000013289.97650.C8; Layne MD, 2001, MOL CELL BIOL, V21, P5256, DOI 10.1128/MCB.21.15.5256-5261.2001; Layne MD, 1998, J BIOL CHEM, V273, P15654, DOI 10.1074/jbc.273.25.15654; Li SC, 2019, ONCOL LETT, V17, P55, DOI 10.3892/ol.2018.9623; Li SC, 2019, FRAT INTEGRITA STRUT, P1, DOI 10.3221/IGF-ESIS.47.01; Liu JY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29878-6; Malfait F, 2017, AM J MED GENET C, V175, P8, DOI 10.1002/ajmg.c.31552; Malfait F, 2014, ADV EXP MED BIOL, V802, P129, DOI 10.1007/978-94-007-7893-1_9; Merksamer PI, 2010, J CELL SCI, V123, P1003, DOI 10.1242/jcs.035832; Pepin M, 2000, NEW ENGL J MED, V342, P673, DOI 10.1056/NEJM200003093421001; Piras IS, 2019, BRAIN RES, V1719, P217, DOI 10.1016/j.brainres.2019.06.004; Price NPJ, 2007, J ANTIBIOT, V60, P485, DOI 10.1038/ja.2007.62; Reznik SE, 2001, CELL MOL LIFE SCI, V58, P1790, DOI 10.1007/PL00000819; Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978; Ritelli M, 2019, GENES-BASEL, V10, DOI 10.3390/genes10020135; ROBERTSON WV, 1953, J BIOL CHEM, V201, P689; Schissel SL, 2009, AM J PATHOL, V174, P818, DOI 10.2353/ajpath.2009.080856; Shijo M, 2018, BRAIN PATHOL, V28, P58, DOI 10.1111/bpa.12475; Sun M, 2011, J CELL SCI, V124, P4096, DOI 10.1242/jcs.091363; Suzuki N, 1996, DEVELOPMENT, V122, P3587; Syx D, 2019, HUM MOL GENET, V28, P1853, DOI 10.1093/hmg/ddz024; Teratani T, 2018, J CLIN INVEST, V128, P1581, DOI 10.1172/JCI92863; Teule F, 2009, NAT PROTOC, V4, P341, DOI 10.1038/nprot.2008.250; Trackman PC, 2005, J CELL BIOCHEM, V96, P927, DOI 10.1002/jcb.20605; Tschumperlin DJ, 2018, J CLIN INVEST, V128, P74, DOI 10.1172/JCI93561; Tumelty K. E., 2013, HDB PROTEOLYTIC ENZY, P1352; Tumelty KE, 2014, J BIOL CHEM, V289, P2526, DOI 10.1074/jbc.M113.502617; Vanakker O, 2015, ANNU REV GENOM HUM G, V16, P229, DOI 10.1146/annurev-genom-090314-050039; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Xing YW, 2019, MOL CARCINOGEN, V58, P1795, DOI 10.1002/mc.23066; Yoneda A, 2020, MOL CANCER RES, V18, P847, DOI 10.1158/1541-7786.MCR-19-0673	54	3	3	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9725	9735		10.1074/jbc.RA120.013902	http://dx.doi.org/10.1074/jbc.RA120.013902			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32482891	Green Published, hybrid			2022-12-26	WOS:000552758600036
J	DiScala, M; Najor, MS; Yung, TM; Morgan, D; Abukhdeir, AM; Cobleigh, MA				DiScala, Molly; Najor, Matthew S.; Yung, Timothy; Morgan, Deri; Abukhdeir, Abde M.; Cobleigh, Melody A.			Loss of STAT6 leads to anchorage-independent growth and trastuzumab resistance in HER2+breast cancer cells	PLOS ONE			English	Article								Approximately 20% of breast cancers are HER2-positive. Trastuzumab has improved patient outcomes significantly for these cancers. However, acquired resistance remains a major hurdle in the clinical management of these patients. Therefore, identifying molecular changes that cause trastuzumab resistance is worthwhile. STAT6 is a transcription factor that regulates a variety of genes involved in cell cycle regulation, growth inhibition, and apoptosis. STAT6 expression is lost in approximately 3% of breast cancers, but little work has been done in the context of trastuzumab resistance in breast cancer. In isogenic cell line pairs, we observed that trastuzumab-resistant cells expressed significantly lower levels of STAT6 compared to trastuzumab-sensitive cells. Therefore, in order to study the consequences of STAT6 loss in HER2+ breast cancer, we knocked out both alleles of the STAT6 gene using somatic cell gene targeting. Interestingly, loss of STAT6 resulted in anchorage-independent growth and changes in several genes involved in epithelial to mesenchymal transition. This study suggests that STAT6 may play a role in the pathophysiology of HER2+ human breast cancer.	[DiScala, Molly; Najor, Matthew S.; Yung, Timothy; Abukhdeir, Abde M.; Cobleigh, Melody A.] Rush Univ, Med Ctr, Dept Med, Div Hematol Oncol & Cell Therapy, Chicago, IL 60612 USA; [Morgan, Deri] Univ Kansas, Med Ctr, Dept Radiat Oncol, Kansas City, MO USA	Rush University; University of Kansas	Abukhdeir, AM (corresponding author), Rush Univ, Med Ctr, Dept Med, Div Hematol Oncol & Cell Therapy, Chicago, IL 60612 USA.	abde_abukhdeir@rush.edu		Abukhdeir, Abde/0000-0003-1172-5819	MAC Bears Care	MAC Bears Care	AMA and MAC Bears Care https://www.chicagobears.com/community/bears-care Sponsor did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, P T, V39, P213; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Ciotlos S, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0113-x; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Grigoriadis A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1604; Gustin JP, 2009, P NATL ACAD SCI USA, V106, P2835, DOI 10.1073/pnas.0813351106; Januchowski R, 2016, J CANCER, V7, P1295, DOI 10.7150/jca.15371; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Li J, 2016, P NATL ACAD SCI USA, V113, P13015, DOI 10.1073/pnas.1611228113; Li J, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-1056-5; Majewski IJ, 2015, J CLIN ONCOL, V33, P1334, DOI 10.1200/JCO.2014.55.2158; Paoli P, 2013, BBA-MOL CELL RES, V1833, P3481, DOI 10.1016/j.bbamcr.2013.06.026; Pinello L, 2016, NAT BIOTECHNOL, V34, P695, DOI 10.1038/nbt.3583; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ranstam J, 2016, OSTEOARTHR CARTILAGE, V24, P763, DOI 10.1016/j.joca.2016.01.008; Rondon-Lagos M, 2014, MOL CYTOGENET, V7, DOI 10.1186/1755-8166-7-8; Seidel HM, 2000, ONCOGENE, V19, P2645, DOI 10.1038/sj.onc.1203550; Seo Y, 2018, J BREAST CANCER, V21, P382, DOI 10.4048/jbc.2018.21.e48; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Starczynski J, 2012, AM J CLIN PATHOL, V137, P595, DOI 10.1309/AJCPATBZ2JFN1QQC; Thaci B, 2014, NEURO-ONCOLOGY, V16, P1304, DOI 10.1093/neuonc/nou045; ThermoFisherScientific, TM CALC; Vu T, 2017, CANCERS, V9, DOI 10.3390/cancers9120171; Wallet MA, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00276; Wu HT, 2017, ONCOTARGET, V8, P36279, DOI 10.18632/oncotarget.16748; Yuste L, 2005, CANCER RES, V65, P6801, DOI 10.1158/0008-5472.CAN-04-4023; Zhang JT, 2013, BBA-MOL CELL RES, V1833, P2961, DOI 10.1016/j.bbamcr.2013.07.021; Zhang Lab M, 2015, CRISPR DES	30	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234146	10.1371/journal.pone.0234146	http://dx.doi.org/10.1371/journal.pone.0234146			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525891	Green Published, gold			2022-12-26	WOS:000542036800088
J	Patil, A; Elwitigala, JP; Rajapaksa, L; Gangakhedkar, R; Chaturbhuj, D; Pendse, R; Rajapaksha, DI; Rewari, BB; Malliawadu, N; Jayamanna, K; Dombawela, D; Kurle, S				Patil, Ajit; Elwitigala, Jayanthi P.; Rajapaksa, Lilani; Gangakhedkar, Raman; Chaturbhuj, Devidas; Pendse, Razia; Rajapaksha, Dharshani Iruka; Rewari, B. B.; Malliawadu, Nilmini; Jayamanna, Kanchana; Dombawela, Dammika; Kurle, Swarali			HIV-1polgene diversity and molecular dating of subtype C from Sri Lanka	PLOS ONE			English	Article								Background The first case of HIV infection in Sri Lanka was reported in 1987 and at the end of 2018 there were 3500 people living with HIV. There have been commendable efforts made towards the detection, treatment, and prevention of HIV in the country. Even though the genetic diversity of HIV has been shown to affect the parameters ranging from detection to vaccine development, there is no data available with respect to the molecular epidemiology of HIV-1 in Sri Lanka. Methods In this report we have performed the ancillary analysis ofpolgene region sequences (n = 85) obtained primarily for the purpose of HIV-1 drug resistance genotyping. Briefly, dried blood spot specimens (DBS) collected from HIV-1 infected individuals between December 2015 and August 2018 were subjected topolgene amplification and sequencing. Thesepolgene sequences were used to interpret the drug resistance mutation profiles. Further, sequences were subjected to HIV-1 subtyping using REGA 3.0, COMET, jPHMM and, RIP online subtyping tools. Moreover, Bayesian phylogenetic analysis was employed to estimate the evolutionary history of HIV-1 subtype C in Sri Lanka. Results Our analysis revealed that the majority (51.8%) ofpolgene sequences were subtype C. Other than subtype C, there were sequences categorized as subtypes A1, B, D and G. In addition to pure subtypes there were sequences which were observed to be circulating recombinant forms (CRFs) and a few of the recombinants were identified as potential unique recombinants (URFs). We also observed the presence of drug resistance mutations in 56 (65.9%) out of 85 sequences. Estimates of the Bayesian evolutionary analysis suggested that the HIV-1 subtype C was introduced to Sri Lanka during the early 1970s (1972.8). Conclusion The findings presented here indicate the presence of multiple HIV-1 subtypes and the prevalence of drug resistance mutations in Sri Lanka. The majority of the sequences were subtype C, having their most recent common ancestor traced back to the early 1970s. Continuous molecular surveillance of HIV-1 molecular epidemiology will be crucial to keep track of drug resistance, genetic diversity, and evolutionary history of HIV-1 in Sri Lanka.	[Patil, Ajit; Kurle, Swarali] Natl AIDS Res Inst, HIV Drug Resistance Lab, Pune, Maharashtra, India; [Elwitigala, Jayanthi P.; Rajapaksa, Lilani; Rajapaksha, Dharshani Iruka; Malliawadu, Nilmini; Jayamanna, Kanchana; Dombawela, Dammika] Natl STD AIDS Control Programme, Colombo, Sri Lanka; [Gangakhedkar, Raman] Indian Council Med Res, New Delhi, India; [Chaturbhuj, Devidas] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY USA; [Pendse, Razia] WHO, Colombo, Sri Lanka; [Rewari, B. B.] World Hlth Org South East Asia Reg, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); Indian Council of Medical Research (ICMR); Cornell University; World Health Organization; World Health Organization	Kurle, S (corresponding author), Natl AIDS Res Inst, HIV Drug Resistance Lab, Pune, Maharashtra, India.	skurle@nariindia.org		Patil, Ajit/0000-0002-6976-0978; Chaturbhuj, Devidas/0000-0003-0276-0671	World Health Organization Indian Council of Medical Research, New Delhi, India National STD/AIDS Control Programme, Colombo, Sri Lanka	World Health Organization Indian Council of Medical Research, New Delhi, India National STD/AIDS Control Programme, Colombo, Sri Lanka	World Health Organization Indian Council of Medical Research, New Delhi, India National STD/AIDS Control Programme, Colombo, Sri Lanka.	[Anonymous], ANN REP 2018; [Anonymous], 2005, GUID ANT THER; [Anonymous], 2016, GUID ANT THER; [Anonymous], 2018, COUNTR HIV FACTSH; [Anonymous], 2016, LANCET INFECT DIS, V16, P565, DOI [10.1016/S1473-3099(15)00536-8, DOI 10.1016/S1473-3099(15)00536-8]; [Anonymous], 2014, GUID US ANT DRUGS TR; [Anonymous], 2017, NAT HIV STI STRAT PL; [Anonymous], CENS POP HOUS; [Anonymous], 2018, NAT SIZ EST MOST RIS; [Anonymous], 2010, REP HIV EST PROJ 200; [Anonymous], 2010, WHO MANUAL HIV DRUG; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bozicevic I, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227689; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Deng W, 2007, BIOINFORMATICS, V23, P2334, DOI 10.1093/bioinformatics/btm331; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Gunthard HF, 2019, CLIN INFECT DIS, V68, P177, DOI 10.1093/cid/ciy463; Hemelaar J, 2019, LANCET INFECT DIS, V19, P143, DOI 10.1016/S1473-3099(18)30647-9; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Moradigaravand D, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004439; Neogi U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039819; Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032; Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007; Schultz AK, 2009, NUCLEIC ACIDS RES, V37, pW647, DOI 10.1093/nar/gkp371; SIEPEL AC, 1995, AIDS RES HUM RETROV, V11, P1413, DOI 10.1089/aid.1995.11.1413; Struck D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku739; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Trifinopoulos J, 2016, NUCLEIC ACIDS RES, V44, pW232, DOI 10.1093/nar/gkw256	30	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234133	10.1371/journal.pone.0234133	http://dx.doi.org/10.1371/journal.pone.0234133			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525892	gold, Green Published			2022-12-26	WOS:000542036800066
J	Price, JC; Azizi, E; Naiche, LA; Parvani, JG; Shukla, P; Kim, S; Slack-Davis, JK; Peer, D; Kitajewski, JK				Price, Jessica C.; Azizi, Elham; Naiche, L. A.; Parvani, Jenny G.; Shukla, Priyanka; Kim, Seoyeon; Slack-Davis, Jill K.; Peer, Dana; Kitajewski, Jan K.			Notch3 signaling promotes tumor cell adhesion and progression in a murine epithelial ovarian cancer model	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; GENE-EXPRESSION; MOUSE MODEL; METASTASIS; SURVIVAL; GROWTH; APOPTOSIS; PROLIFERATION; AMPLIFICATION; ANGIOGENESIS	High grade serous ovarian cancer (HGSC) is the most common and deadly type of ovarian cancer, largely due to difficulties in early diagnosis and rapid metastasis throughout the peritoneal cavity. Previous studies have shown that expression of Notch3 correlates with worse prognosis and increased tumorigenic cell behaviors in HGSC. We investigated the mechanistic role of Notch3 in a model of metastatic ovarian cancer using the murine ovarian surface epithelial cell line, ID8 IP2. Notch3 was activated in ID8 IP2 cells via expression of the Notch3 intracellular domain (Notch3IC). Notch3IC ID8 IP2 cells injected intraperitoneally caused accelerated ascites and reduced survival compared to control ID8 IP2, particularly in early stages of disease. We interrogated downstream targets of Notch3IC in ID8 IP2 cells by RNA sequencing and found significant induction of genes that encode adhesion and extracellular matrix proteins. Notch3IC ID8 IP2 showed increased expression of ITGA1 mRNA and cell-surface protein. Notch3IC-mediated increase of ITGA1 was also seen in two human ovarian cancer cells. Notch3IC ID8 IP2 cells showed increased adhesion to collagens I and IVin vitro. We propose that Notch3 activation in ovarian cancer cells causes increased adherence to collagen-rich peritoneal surfaces. Thus, the correlation between increased Notch3 signaling and poor prognosis may be influenced by increased metastasis of HGSC via increased adherence of disseminating cells to new metastatic sites in the peritoneum.	[Price, Jessica C.] Columbia Univ, Integrated Program Cellular Mol & Biomed Studies, New York, NY 10027 USA; [Azizi, Elham; Peer, Dana] Mem Sloan Kettering Canc Ctr, Parker Inst Canc Immunotherapy, Sloan Kettering Inst, Program Computat & Syst Biol, 1275 York Ave, New York, NY 10021 USA; [Naiche, L. A.; Parvani, Jenny G.; Shukla, Priyanka; Kim, Seoyeon; Kitajewski, Jan K.] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60680 USA; [Slack-Davis, Jill K.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA USA	Columbia University; Memorial Sloan Kettering Cancer Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Virginia	Kitajewski, JK (corresponding author), Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60680 USA.	kitaj@uic.edu		Naiche, L. A./0000-0002-5031-4804	NCI [F31 CA192891, R01 CA142783, DP1-HD084071, R01CA164729, U54 CA209975]; American Cancer Society -Fairfield County Roast Committee Postdoctoral Fellowship [PF-17-243-01-RMC, K99CA230195]; Cancer Center Support Grant [P30 CA008748]; Hilton-Ludwig Cancer Prevention Initiative; NHLBI [R01 HL112626]	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society -Fairfield County Roast Committee Postdoctoral Fellowship(American Cancer Society); Cancer Center Support Grant; Hilton-Ludwig Cancer Prevention Initiative; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by the following support: NCI F31 CA192891 (JP), American Cancer Society -Fairfield County Roast Committee Postdoctoral Fellowship PF-17-243-01-RMC (EA), K99CA230195 (EA), NCI R01 CA142783 (JKSD), DP1-HD084071 (DP), R01CA164729 (DP), U54 CA209975 (DP), Cancer Center Support Grant P30 CA008748 (DP), the Hilton-Ludwig Cancer Prevention Initiative (DP), and NHLBI R01 HL112626 (JKK).; We thank the UIC flow cytometry core facility for assisting with flow cytometer reading and raw data, in particular Dr. Balaji Ganesh and Dr. Suresh Ramasamy, and the JP Sulzberger Columbia Genome Center for the RNAseq data generation. We thank Dr. Joanna Burdette and Dr. Alexandra Naba for informative discussions and helpful critiques.	ALBINI A, 1987, CANCER RES, V47, P3239; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2016, THE TOTAL AUDIENCE R; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Barbolina MV, 2009, CANCER TREAT RES, V149, P319, DOI 10.1007/978-0-387-98094-2_15; Beatus P, 2001, MECH DEVELOP, V104, P3, DOI 10.1016/S0925-4773(01)00373-2; Beatus P, 1999, DEVELOPMENT, V126, P3925; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berns EMJJ, 2012, CANCER RES, V72, P2701, DOI 10.1158/0008-5472.CAN-11-3911; Bowtell DD, 2015, NAT REV CANCER, V15, P668, DOI 10.1038/nrc4019; Brown CW, 2015, MOL CANCER RES, V13, P78, DOI 10.1158/1541-7786.MCR-14-0334; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Capaccione KM, 2013, CARCINOGENESIS, V34, P1420, DOI 10.1093/carcin/bgt127; Casey RC, 2001, AM J PATHOL, V159, P2071, DOI 10.1016/S0002-9440(10)63058-1; Chen X, 2010, ONCOTARGET, V1, P210, DOI 10.18632/oncotarget.127; Cheon DJ, 2014, CLIN CANCER RES, V20, P711, DOI 10.1158/1078-0432.CCR-13-1256; Cho S, 2013, ANTICANCER RES, V33, P1317; Choi JH, 2008, CANCER RES, V68, P5716, DOI 10.1158/0008-5472.CAN-08-0001; Choy L, 2017, CANCER RES, V77, P1439, DOI 10.1158/0008-5472.CAN-16-1022; Gerber SA, 2006, AM J PATHOL, V169, P1739, DOI 10.2353/ajpath.2006.051222; Greenaway J, 2008, GYNECOL ONCOL, V108, P385, DOI 10.1016/j.ygyno.2007.10.035; Groeneweg JW, 2014, J OVARIAN RES, V7, DOI 10.1186/s13048-014-0095-1; Gupta N, 2013, GYNECOL ONCOL, V130, P200, DOI 10.1016/j.ygyno.2013.03.019; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Hass MR, 2015, MOL CELL, V59, P685, DOI 10.1016/j.molcel.2015.07.008; Hu W, 2014, CANCER RES, V74, P3282, DOI 10.1158/0008-5472.CAN-13-2066; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Iwanicki MP, 2011, CANCER DISCOV, V1, P144, DOI 10.1158/2159-8274.CD-11-0010; Jung JG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004751; Jung SG, 2010, CANCER SCI, V101, P1977, DOI 10.1111/j.1349-7006.2010.01641.x; Kangsamaksin T, 2015, CANCER DISCOV, V5, P182, DOI 10.1158/2159-8290.CD-14-0650; Kawazu M, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006853; Kenny HA, 2011, CANCER DISCOV, V1, P100, DOI 10.1158/2159-8290.CD-11-0117; Kenny HA, 2009, CANCER TREAT RES, V149, P335, DOI 10.1007/978-0-387-98094-2_16; Kimbrel EA, 2009, MOL IMAGING, V8, P140, DOI 10.2310/7290.2009.00007; Klymenko Y, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.034199; Kofler NM, 2015, SCI REP-UK, V5, DOI 10.1038/srep16449; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007; Lu CH, 2007, CANCER RES, V67, P1757, DOI 10.1158/0008-5472.CAN-06-3700; Lu KH, 2004, CLIN CANCER RES, V10, P3291, DOI 10.1158/1078-0432.CCR-03-0409; Martinez RLMC, 2010, METRON, V68, P111, DOI 10.1007/BF03263529; Matulonis UA, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.61; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nakayama J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120071; Nakayama K, 2007, INT J CANCER, V120, P2613, DOI 10.1002/ijc.22609; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; NIEDBALA MJ, 1985, EXP CELL RES, V160, P499, DOI 10.1016/0014-4827(85)90197-1; Nyberg P, 2005, CANCER RES, V65, P3967, DOI 10.1158/0008-5472.CAN-04-2427; Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071; Park JT, 2006, CANCER RES, V66, P6312, DOI 10.1158/0008-5472.CAN-05-3610; Pradeep S, 2014, CANCER CELL, V26, P77, DOI 10.1016/j.ccr.2014.05.002; Puls LE, 1996, GYNECOL ONCOL, V61, P109, DOI 10.1006/gyno.1996.0106; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Rosen DG, 2009, FRONT BIOSCI-LANDMRK, V14, P2089, DOI 10.2741/3364; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen YF, 2012, INT J GYNECOL CANCER, V22, P1316, DOI 10.1097/IGC.0b013e318263ef34; Sher I, 2009, INT J CANCER, V124, P553, DOI 10.1002/ijc.23963; Shih IM, 2011, MODERN PATHOL, V24, P638, DOI 10.1038/modpathol.2010.230; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sodek KL, 2012, CANCER METAST REV, V31, P397, DOI 10.1007/s10555-012-9351-2; Sorensen EW, 2009, IMMUNOL RES, V45, P185, DOI 10.1007/s12026-009-8100-2; Steg AD, 2011, CLIN CANCER RES, V17, P5674, DOI 10.1158/1078-0432.CCR-11-0432; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TARIN D, 1984, CANCER RES, V44, P3584; TARONE RE, 1977, BIOMETRIKA, V64, P156, DOI 10.1093/biomet/64.1.156; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tucker Gordon C, 2006, Curr Oncol Rep, V8, P96, DOI 10.1007/s11912-006-0043-3; Ullman-Cullere MH, 1999, LAB ANIM SCI, V49, P319; Walton J, 2016, CANCER RES, V76, P6118, DOI 10.1158/0008-5472.CAN-16-1272; White EA, 2014, ADV DRUG DELIVER REV, V79-80, P184, DOI 10.1016/j.addr.2014.07.003; Witz CA, 2001, J SOC GYNECOL INVEST, V8, P299, DOI 10.1016/S1071-5576(01)00122-8; Zhang J, 2015, EUR REV MED PHARMACO, V19, P818; Zhang X, 2012, GYNECOL ONCOL, V124, P606, DOI 10.1016/j.ygyno.2011.11.044	76	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0233962	10.1371/journal.pone.0233962	http://dx.doi.org/10.1371/journal.pone.0233962			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525899	Green Published, gold			2022-12-26	WOS:000542036800054
J	Rogers, CM; Scott, EM; Sarawichitr, B; Arnold, C; Suchodolski, JS				Rogers, Callie M.; Scott, Erin M.; Sarawichitr, Benjamin; Arnold, Carolyn; Suchodolski, Jan S.			Evaluation of the bacterial ocular surface microbiome in ophthalmologically normal dogs prior to and following treatment with topical neomycin-polymyxin-bacitracin	PLOS ONE			English	Article							CLINICALLY NORMAL DOGS; CONJUNCTIVAL SAC; ANTIMICROBIAL SUSCEPTIBILITY; ULCERATIVE KERATITIS; CANINE; HEALTHY; PHARMACOKINETICS; MICROORGANISMS; DELIVERY; IMPACT	The ocular surface microbiome of veterinary species has not been thoroughly characterized using molecular-based techniques, such as next generation sequencing (NGS), as the vast majority of studies have utilized traditional culture-based techniques. To date, there is one pilot study evaluating the ocular surface of healthy dogs using NGS. Furthermore, alterations in the ocular surface microbiome over time and after topical antibiotic treatment are unknown. The objectives of this study were to describe the bacterial composition of the ocular surface microbiome in clinically normal dogs, and to determine if microbial community changes occur over time or following topical antibiotic therapy. Topical neomycin-polymyxin-bacitracin ophthalmic ointment was applied to one eye each of 13 adult dogs three times daily for seven days, while contralateral eyes served as untreated controls. The inferior conjunctival fornix of both eyes was sampled via swabbing at baseline prior to antibiotic therapy (day 0), after 1 week of treatment (day 7), and 4 weeks after discontinuing treatment (day 35). Genomic DNA was extracted from the conjunctival swabs and primers targeting the V4 region of bacterial 16S rRNA genes were used to generate amplicon libraries, which were then sequenced on an Illumina platform. Data were analyzed using Quantitative Insights Into Molecular Ecology (QIIME 2.0). At baseline, the most relatively abundant phyla sequenced were Proteobacteria (49.7%), Actinobacteria (25.5%), Firmicutes (12%), Bacteroidetes (7.5%), and Fusobacteria (1.4%). The most common families detected were Pseudomonadaceae (13.2%), Micrococcaceae (12%), Pasteurellaceae (6.9%), Microbacteriaceae (5.2%), Enterobacteriaceae (3.9%), Neisseriaceae (3.5%), and Corynebacteriaceae (3.3%). Alpha and beta diversity measurements did not differ in both control and treatment eyes over time. This report examines the temporal stability of the canine ocular surface microbiome. The major bacterial taxa on the canine ocular surface remained consistent over time and following topical antibiotic therapy.	[Rogers, Callie M.; Scott, Erin M.; Sarawichitr, Benjamin; Suchodolski, Jan S.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Small Anim Clin Sci, College Stn, TX 77843 USA; [Arnold, Carolyn] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Large Anim Clin Sci, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Scott, EM (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Small Anim Clin Sci, College Stn, TX 77843 USA.	escott@cvm.tamu.edu		Scott, Erin/0000-0002-9702-7298; Rogers, Callie/0000-0002-0684-7283; Sarawichitr, Benjamin/0000-0001-8616-5137	Texas AM	Texas AM	The authors received no external funding for this work. Internal funding from Texas A&M in the form of start-up for EMS were received.	[Anonymous], 2018, PEER J PREPRINTS; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Clode A, 2013, VET OPHTHALMOLOGY; Darden JE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223859; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dey S, 2004, J PHARMACOL EXP THER, V311, P246, DOI 10.1124/jpet.104.069583; Doan T, 2016, INVEST OPHTH VIS SCI, V57, P5116, DOI 10.1167/iovs.16-19803; Dong QF, 2011, INVEST OPHTH VIS SCI, V52, P5408, DOI 10.1167/iovs.10-6939; Eisenhofer R, 2019, TRENDS MICROBIOL, V27, P105, DOI 10.1016/j.tim.2018.11.003; FRANGIE JP, 1995, CLIN PHARMACOKINET, V29, P130, DOI 10.2165/00003088-199529020-00006; Furiani N, 2011, VET DERMATOL, V22, P490, DOI 10.1111/j.1365-3164.2011.00979.x; GERDING PA, 1990, VET CLIN N AM-SMALL, V20, P615, DOI 10.1016/S0195-5616(90)50053-4; GERDING PA, 1988, J AM VET MED ASSOC, V193, P242; Gilger BC, 2008, VET CLIN N AM-SMALL, V38, P223, DOI 10.1016/j.cvsm.2007.11.004; Gloor GB, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02224; Huang Y, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.04.008; Isaiah A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184899; Kugadas Abirami, 2016, Ocul Surf, V14, P342, DOI 10.1016/j.jtos.2016.04.004; Langdon A, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0294-z; Leis ML, 2019, VET OPHTHALMOL, V22, P337, DOI 10.1111/vop.12599; Lin CT, 2007, J SMALL ANIM PRACT, V48, P271, DOI 10.1111/j.1748-5827.2007.00348.x; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lu Louise J., 2016, Yale Journal of Biology and Medicine, V89, P325; Mauger T., 1994, HAVENERS OCULAR PHAR; McDermott AM, 2013, EXP EYE RES, V117, P53, DOI 10.1016/j.exer.2013.07.014; MCDONALD PJ, 1976, J SMALL ANIM PRACT, V17, P809, DOI 10.1111/j.1748-5827.1976.tb06947.x; Meason-Smith C, 2017, VET DERMATOL, V28, P71, DOI 10.1111/vde.12373; Meason-Smith C, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv139; MURPHY JM, 1978, J AM VET MED ASSOC, V172, P66; Older CE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178555; Ozkan J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10494-9; Prado MR, 2005, VET OPHTHALMOL, V8, P33, DOI 10.1111/j.1463-5224.2005.04061.x; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Sandmeyer LS, 2017, AM J VET RES, V78, P207, DOI 10.2460/ajvr.78.2.207; Sasaki H, 1996, PROG RETIN EYE RES, V15, P583, DOI 10.1016/1350-9462(96)00014-6; Scott EM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214877; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shin H, 2016, MBIO, V7, DOI 10.1128/mBio.00198-16; Suchodolski JS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-210; Tolar EL, 2006, JAVMA-J AM VET MED A, V228, P80, DOI 10.2460/javma.228.1.80; Tress B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176736; Varges R, 2009, VET OPHTHALMOL, V12, P216, DOI 10.1111/j.1463-5224.2009.00701.x; Wang L, 2008, VET OPHTHALMOL, V11, P145, DOI 10.1111/j.1463-5224.2008.00579.x; Weese JS, 2013, VET DERMATOL, V24, P137, DOI 10.1111/j.1365-3164.2012.01076.x; Weese SJ, 2015, VET RES, V46, DOI 10.1186/s13567-014-0140-5; Whitley RD, 2000, VET CLIN N AM-SMALL, V30, P1151, DOI 10.1016/S0195-5616(00)05012-9; Willcox MDP, 2013, EXP EYE RES, V117, P99, DOI 10.1016/j.exer.2013.06.003; Zakrzewski M, 2017, BIOINFORMATICS, V33, P782, DOI 10.1093/bioinformatics/btw725; Zegans ME, 2014, AM J OPHTHALMOL, V158, P420, DOI 10.1016/j.ajo.2014.06.014; 2014, REG ANESTH PAIN MED, V9	51	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2020	15	6							e0234313	10.1371/journal.pone.0234313	http://dx.doi.org/10.1371/journal.pone.0234313			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ1GC	32516320	Green Published, gold			2022-12-26	WOS:000540977000007
J	Haile, D; Kondale, M; Andarge, E; Tunje, A; Fikadu, T; Boti, N				Haile, Dereje; Kondale, Mekdes; Andarge, Eshetu; Tunje, Abayneh; Fikadu, Teshale; Boti, Nigussie			Level of completion along continuum of care for maternal and newborn health services and factors associated with it among women in Arba Minch Zuria woreda, Gamo zone, Southern Ethiopia: A community based cross-sectional study	PLOS ONE			English	Article								Background Completion along continuum of care for maternal and newborn health (MNH) services like antenatal care, skilled birth attendance and postnatal care services is advantageous over each segment of services. It is one of the currently recommended strategies to reduce both maternal and neonatal mortality and achieve the global target of ending preventable maternal and under-five children's mortality. Although studies on factors affecting each segment of MNH services have been well documented in Ethiopia, there is a dearth of evidence about the level of continuum of care and factors associated with it. This study was intended to fill this gap in evidence in the study area so that interventions could be taken to improve maternal and newborn health. Methods A community-basedcross-sectional study was conducted among 432 postnatal women who gave birth in the previous year in Arba Minch Health and Demographic Surveillance System (HDSS) site. Women were selected by computer generated random numbers from a list of women who stayed at least 6 weeks after birth. A pre-tested, structured, and interviewer-administered questionnaire was used for data collection. Data were entered and coded in Epi-data and analyzed using SPSS software version 23. Binary logistic regression model was fitted to identify factors associated with the dependent variable. Bivariate and multivariable analyses were fitted in steps to select candidate variables for multivariable analysis and to control for potential confounding effect respectively. Results The overall completion along the continuum of care was 42(9.7%). The factors significantly associated with completion of care along the continuumwere timely initiation of antenatalcare (before16weeks) [AOR: 10.7, CI (5.1, 22.7], birth preparedness and complication readiness [AOR: 2.9, CI (1.4, 6.1), pre-pregnancy contraception utilization [AOR: 3.9, CI: 1.4, 11.0], being employed [AOR: 2.6 CI:(1.3, 5.4)], and having a planned pregnancy [AOR:3.5 CI: (1.1, 11.4)]. Conclusion and recommendation Completion along the continuum of care for MNH services was low in the study area. Thus, efforts to improve the completion of care should focus on interventions that enhance early initiation of antenatal care, planned pregnancy, and birth preparedness and complication readiness.	[Haile, Dereje] Duguna Fango Hlth Off, Wolaita Zone Hlth Dept, Wolaita Sodo, Wolaita Zone, Ethiopia; [Kondale, Mekdes; Andarge, Eshetu; Boti, Nigussie] Arba Minch Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Reprod Hlth Unit, Arba Minch, Ethiopia; [Tunje, Abayneh; Fikadu, Teshale] Arba Minch Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Epidemiol & Biostat Unit, Arba Minch, Ethiopia	Arba Minch University; Arba Minch University	Andarge, E (corresponding author), Arba Minch Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Reprod Hlth Unit, Arba Minch, Ethiopia.	andeshe7@gmail.com	Boti, Negussie/X-7354-2019; Haile, Dereje/AAA-4418-2021; Zeleke, Eshetu Andarge/GLT-2605-2022	Boti, Negussie/0000-0001-8949-573X; Fikadu, Teshale/0000-0002-4177-9159				Abdella M, 2017, GLOB J FERTILRES; Abota TL, 2018, ETHIOP J HEALTH SCI, V28, P267, DOI 10.4314/ejhs.v28i3.4; Agha S, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0979-8; Andarge E, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1582-3; [Anonymous], 2014, PREV CHRONIC DIS, V11, pE62; [Anonymous], 2016, SENSORS, V16, pC1, DOI 10.1109/JSEN.2016.2517933; [Anonymous], 2014, PEERJ, V2, pe447; [Anonymous], 2007, COTTON STAT B, V36, P1; [Anonymous], GLOB REV KEY INT REL; [Anonymous], 2018, LEVELS TRENDS CHILD; [Anonymous], 2016, WASHINGTON TRAD 0615, V25, P2, DOI DOI 10.1002/pds.3891; Asefa A, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024783; Basha GW, 2019, OBSTET GYNECOL INT, V2019, DOI 10.1155/2019/5036783; Chaka EE, 2019, INT J MED SCI PUBLIC, DOI 10.4103%2Fijpvm.IJPVM_26_19; de l I, 2018, J CLIN GASTROENTEROL, V52, pe63; Demilew YM, 2016, AFR HEALTH SCI, V16, P10, DOI 10.4314/ahs.v16i1.2; Every Woman Every Child, 2015, GLOBAL STRATEGY WOME; Ewunetie AA, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1748-7; Fadel SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140448; FMOH, 2015, ETH HLTH SECT TRANSF; FMoH of Ethiopia, 2015, MAT NEWB CHILD CAR Q; Gebremeskel F, 2015, J ENVIRON PUBLIC HEA, V2015, DOI 10.1155/2015/971506; Hamed A. F., 2018, International Journal of Medical Science and Public Health, V7, P417; ICF CSA (CSA), 2016, ETH DEM HLTH SURV 20; Islam S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197693; Kapoor D, 2006, 2006 IEEE WORKSHOP ON MICROELECTRONICS AND ELECTRON DEVICES, P23, DOI 10.1109/WMED.2006.1678289; Kaso M, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-55; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Khatib N, 2009, INDIAN J MED SCI, V63, P10; Kikuchi K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198829; Kikuchi K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164965; Kikuchi K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139288; Kuhnt J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017122; Lemeshow S., 1990, TITLE ADEQUACY SAMPL; Leyandowski BA, 2012, INT J GYNECOL OBSTET, V118, pS167, DOI 10.1016/S0020-7292(12)60017-4; Limenih Miteku Andualem, 2016, Int J Reprod Med, V2016, P7095352, DOI 10.1155/2016/7095352; McDougal L, 2016, ASIA-PAC J PUBLIC HE, V28, P423, DOI 10.1177/1010539516654539; Mohan D, 2017, HEALTH POLICY PLANN, V32, P791, DOI 10.1093/heapol/czx005; Muchie KF, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1488-0; Nawal D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060957; Onyiapat JL, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1689-0; Oyerinde K, 2013, J COMMUNITY MED HLTH, V3, DOI 10.4172/2161-0711.1000e116; Pambe M. W., 2014, African Population Studies, V28, P1146; Sado L, 2014, SOC SCI MED, V114, P169, DOI 10.1016/j.socscimed.2014.05.047; Samari G, 2015, INDIVIDUAL HOUSEHOLD, P004; Sharma B, 2018, EFFECT WOMENS EMPOWE, V46, P95; Shibanuma A, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000786; Singh K, 2016, MATERN CHILD HLTH J, V20, P281, DOI 10.1007/s10995-015-1827-6; Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X; Tafere TE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192428; Tsegay Y, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-30; UN-DESA, 2017, SUSTAINABLE DEV GOAL; UNICEF, 2019, PAK KEY DEM IND; UNICEF WHO and the World Bank Group, 2020, LEVELS TRENDS CHILD; UNICEF World Health Organization World Bank Group United Nations, 2017, LEV TRENDS CHILD MOR; USAID and CDC. Maternal and child survival programme, 2016, MAT CHILD SURV PROGR; Wang WJ, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0497-0; WHO, 2015, WHO REC HLTH PROM IN; Workineh YG, 2014, SCI J PUBLIC HLTH, V2, P169, DOI [10.11648/j.sjph.20140203.15, DOI 10.11648/J.SJPH.20140203.15]; World Health Organization, 2013, PROGR STRAT POSTP FA; Yaya S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184934; Yeji F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142849	62	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2020	15	6							e0221670	10.1371/journal.pone.0221670	http://dx.doi.org/10.1371/journal.pone.0221670			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LZ0RE	32511230	Green Published, Green Submitted, gold			2022-12-26	WOS:000540938100004
J	Ayuso, M; Michiels, J; Wuyts, S; Yan, HL; Degroote, J; Lebeer, S; Le Bourgot, C; Apper, E; Majdeddin, M; Van Noten, N; Vanden Hole, C; Van Cruchten, S; Van Poucke, M; Peelman, L; Van Ginneken, C				Ayuso, Miriam; Michiels, Joris; Wuyts, Sander; Yan, Honglin; Degroote, Jeroen; Lebeer, Sarah; Le Bourgot, Cindy; Apper, Emmanuelle; Majdeddin, Maryam; Van Noten, Noemie; Vanden Hole, Charlotte; Van Cruchten, Steven; Van Poucke, Mario; Peelman, Luc; Van Ginneken, Chris			Short-chain fructo-oligosaccharides supplementation to suckling piglets: Assessment of pre- and post-weaning performance and gut health	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; MESSENGER-RNA EXPRESSION; BIRTH-WEIGHT; DIETARY FRUCTOOLIGOSACCHARIDES; BODY-WEIGHT; PIG; MICROBIOTA; MATURATION; IMPACT; CELL	Farmers face difficulties in redeeming their investment in larger litter sizes since this comes with larger litter heterogenicity, lower litter resilience and risk of higher mortality. Dietary oligosaccharides, given to the sow, proved beneficial for the offspring's performance. However, giving oligosaccharides to the suckling piglet is poorly explored. Therefore, this field trial studied the effect of dietary short-chain fructo-oligosaccharides (scFOS; 1g/day; drenched) supplementation to low (LBW, lower quartile), normal (NBW, two intermediate quartiles) and high (HBW, upper quartile) birth weight piglets from birth until 7 or 21 days of age. Performance parameters, gut microbiome and short-chain fatty acids profile of feces and digesta were assessed at birth (d 0), d 7, weaning (d 21.5) and 2 weeks post-weaning (d 36.5). Additional parameters reflecting gut health (intestinal integrity and morphology, mucosal immune system) were analysed at d 36.5. Most parameters changed with age or differed with the piglet's birth weight. Drenching with scFOS increased body weight by 1 kg in NBW suckling piglets and reduced the post-weaning mortality rate by a 100%. No clear difference in the IgG level, the microbiota composition and fermentative activity between the treatment groups was observed. Additionnally, intestinal integrity, determined by measuring intestinal permeability and regenerative capacity, was similar between the treatment groups. Also, intestinal architecture (villus lenght, crypt depth) was not affected by scFOS supplementation. The density of intra-epithelial lymphocytes and the expression profiles (real-time qPCR) for immune system-related genes (IL-10, IL-1ss, IL-6, TNF alpha and IFN gamma) were used to assess mucosal immunity. Only IFN gamma expression, was upregulated in piglets that received scFOS for 7 days. The improved body weight and the reduced post-weaning mortality seen in piglets supplemented with scFOS support the view that scFOS positively impact piglet's health and resilience. However, the modes of action for these effects are not yet fully elucidated and its potential to improve other performance parameters needs further investigation.	[Ayuso, Miriam; Vanden Hole, Charlotte; Van Cruchten, Steven; Van Ginneken, Chris] Univ Antwerp, Fac Pharmaceut Biomed & Vet Sci, Dept Vet Med, Antwerp, Belgium; [Michiels, Joris; Yan, Honglin; Degroote, Jeroen; Majdeddin, Maryam; Van Noten, Noemie] Univ Ghent, Fac Biosci Engn, Dept Anim Sci & Aquat Ecol, Lab Anim Prod & Anim Prod Qual, Ghent, Belgium; [Wuyts, Sander; Lebeer, Sarah] Univ Antwerp, Fac Sci, Dept Bioengn, Antwerp, Belgium; [Le Bourgot, Cindy; Apper, Emmanuelle] Tereos, R&D Dept, Moussy Le Vieux, France; [Van Poucke, Mario; Peelman, Luc] Univ Ghent, Fac Vet Med, Dept Nutr Genet & Ethol, Merelbeke, Belgium	University of Antwerp; Ghent University; University of Antwerp; Ghent University	Ayuso, M (corresponding author), Univ Antwerp, Fac Pharmaceut Biomed & Vet Sci, Dept Vet Med, Antwerp, Belgium.	Miriam.ayusohernando@uantwerpen.be	ayuso, miriam/GPX-8386-2022; Hernando, Miriam Ayuso/AAY-3751-2020	ayuso, miriam/0000-0001-6045-394X; Van Poucke, Mario/0000-0002-4316-8984	 [34543]		Feed and supplements were provided by TEREOS (https://tereos.com), under the project ID 34543. The funder also provided support in the form of salaries for authors [CLB, EA], who participated in the conceptualisation of the experiment and reviewed the manuscript, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Andersen AD, 2019, J NUTR, V149, P36, DOI 10.1093/jn/nxy243; Andersen IL, 2011, BEHAV ECOL SOCIOBIOL, V65, P1159, DOI 10.1007/s00265-010-1128-4; [Anonymous], 2017, J MOL BIOMARKERS DIA, V8, P1, DOI [10.4172/2155-9929.S2-026, DOI 10.4172/2155-9929.S2-026, DOI 10.5334/LABPHON.19]; [Anonymous], 2011, MED SCI MONITOR, V17, pCR577; Apper E, 2016, J ANIM RES NUTR, V1, P19, DOI [10.21767/2572-5459.100019, DOI 10.21767/2572-5459.100019]; Bassonga E, 2001, CYTOKINE, V14, P243, DOI 10.1006/cyto.2001.0872; Bian GR, 2016, ENVIRON MICROBIOL, V18, P1566, DOI 10.1111/1462-2920.13272; Bornet FRJ, 2002, DIGEST LIVER DIS, V34, pS111, DOI 10.1016/S1590-8658(02)80177-3; Buske B., 2006, INVESTIGATION CANDID; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Canfora EE, 2015, NAT REV ENDOCRINOL, V11, P577, DOI 10.1038/nrendo.2015.128; Chen TT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02995-4; Collins CL, 2017, ANIM NUTR, V3, P372, DOI 10.1016/j.aninu.2017.01.001; Comstock SS, 2017, J NUTR, V147, P1041, DOI 10.3945/jn.116.243774; Conway EJ, 1957, MICRODIFFUSION ANAL, P277; D'Inca R, 2011, NEONATOLOGY, V99, P208, DOI 10.1159/000314919; D'Inca R, 2010, J NUTR, V140, P925, DOI 10.3945/jn.109.116822; Davani-Davari D, 2019, FOODS, V8, DOI 10.3390/foods8030092; Dou S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169851; Douglas SL, 2013, J ANIM SCI, V91, P4123, DOI 10.2527/jas.2012-5915; Estrada A, 2001, CAN J ANIM SCI, V81, P141, DOI 10.4141/A00-037; Everaert N, 2017, ANIM FEED SCI TECH, V233, P89, DOI 10.1016/j.anifeedsci.2017.06.011; Fraser D., 1995, P287; Fukasawa T, 2007, J AGR FOOD CHEM, V55, P3174, DOI 10.1021/jf062814q; Genda T, 2018, J NUTR SCI VITAMINOL, V64, P357, DOI 10.3177/jnsv.64.357; Gibson GR, 2005, BRIT J NUTR, V93, pS31, DOI 10.1079/BJN20041343; Grela ER, 2006, MED WETER, V62, P762; Guevarra RB, 2019, J ANIM SCI BIOTECHNO, V10, DOI 10.1186/s40104-018-0308-3; Haarman M, 2005, APPL ENVIRON MICROB, V71, P2318, DOI 10.1128/AEM.71.5.2318-2324.2005; Halas Veronika, 2012, Animals (Basel), V2, P261, DOI 10.3390/ani2020261; Hayen SM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00923; Hernot DC, 2009, J AGR FOOD CHEM, V57, P1354, DOI 10.1021/jf802484j; Hidaka H., 1986, Bifidobacteria and Microflora, V5, P37; Hosono A, 2003, BIOSCI BIOTECH BIOCH, V67, P758, DOI 10.1271/bbb.67.758; HOWARD MD, 1995, J PEDIATR GASTR NUTR, V21, P297, DOI 10.1097/00005176-199510000-00007; Huting AMS, 2018, PORCINE HEALTH MANAG, V4, DOI 10.1186/s40813-018-0098-1; Inman CF, 2010, CLIN EXP IMMUNOL, V160, P431, DOI 10.1111/j.1365-2249.2010.04090.x; Jacobi SK, 2012, ADV NUTR, V3, P687, DOI 10.3945/an.112.002683; Kaplan H, 2003, APPL ENVIRON MICROB, V69, P2217, DOI 10.1128/AEM.69.4.2217-2222.2003; Kim HB, 2011, VET MICROBIOL, V153, P124, DOI 10.1016/j.vetmic.2011.05.021; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Lalles J. P., 2005, Animals and environment, Volume 1: Proceedings of the XIIth ISAH Congress on Animal Hygiene, Warsaw, Poland, 4-8 September 2005, P405; Larriestra AJ, 2006, CAN VET J, V47, P560; Le Bourgot C, 2019, FASEB J, V33, P301, DOI 10.1096/fj.201800108R; Le Bourgot C, 2018, NUTR METAB, V15, DOI 10.1186/s12986-018-0245-3; Le Bourgot C, 2017, BRIT J NUTR, V117, P83, DOI 10.1017/S0007114516004268; Le Bourgot C, 2016, J FUNCT FOODS, V24, P307, DOI 10.1016/j.jff.2016.04.018; Le Bourgot C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107508; Leblois J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07228-2; Leijdekkers AGM, 2014, J AGR FOOD CHEM, V62, P1079, DOI 10.1021/jf4049676; Manhart N, 2003, NUTRITION, V19, P657, DOI 10.1016/S0899-9007(03)00059-5; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Michiels J, 2013, BRIT J NUTR, V109, P65, DOI 10.1017/S0007114512000670; Mickiewicz M, 2012, J PHYSIOL PHARMACOL, V63, P225; Milligan BN, 2002, LIVEST PROD SCI, V76, P181, DOI 10.1016/S0301-6226(02)00012-X; Morise A, 2008, ANIMAL, V2, P73, DOI 10.1017/S175173110700095X; Nakamura Y, 2004, CLIN EXP IMMUNOL, V137, P52, DOI 10.1111/j.1365-2249.2004.02487.x; Paredes SP, 2012, J ANIM SCI, V90, P3243, DOI 10.2527/jas.2011-4574; Pluske JR, 2018, ANIM NUTR, V4, P187, DOI 10.1016/j.aninu.2017.12.004; Pompei A, 2008, ANAEROBE, V14, P280, DOI 10.1016/j.anaerobe.2008.07.002; Quiniou N, 2002, LIVEST PROD SCI, V78, P63, DOI 10.1016/S0301-6226(02)00181-1; Sabater-Molina M, 2011, J CLIN BIOCHEM NUTR, V48, P230, DOI 10.3164/jcbn.10-100; Schokker D, 2018, J ANIM SCI, V96, P2139, DOI 10.1093/jas/sky110; Shim SB, 2005, ARCH ANIM NUTR, V59, P419, DOI 10.1080/17450390500353234; Shoaf K, 2006, INFECT IMMUN, V74, P6920, DOI 10.1128/IAI.01030-06; Smit MN, 2013, ANIMAL, V7, P1681, DOI 10.1017/S1751731113001249; Stiverson J, 2014, APPL ENVIRON MICROB, V80, P7388, DOI 10.1128/AEM.02200-14; Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005; Theil PK, 2014, J ANIM SCI, V92, P5507, DOI 10.2527/jas.2014-7841; Thorburn AN, 2014, IMMUNITY, V40, P833, DOI 10.1016/j.immuni.2014.05.014; Tsukahara T, 2003, J NUTR SCI VITAMINOL, V49, P414, DOI 10.3177/jnsv.49.414; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang W, 2016, FASEB J, V30, P863, DOI 10.1096/fj.15-274779	73	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0233910	10.1371/journal.pone.0233910	http://dx.doi.org/10.1371/journal.pone.0233910			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502215	Green Published, gold			2022-12-26	WOS:000542035700019
J	Bedaso, A; Abraham, Y; Temesgen, A; Mekonnen, N				Bedaso, Asres; Abraham, Yacob; Temesgen, Abdi; Mekonnen, Nibretie			Quality of sleep and associated factors among people living with HIV/AIDS attending ART clinic at Hawassa University comprehensive specialized Hospital, Hawassa, SNNPR, Ethiopia	PLOS ONE			English	Article							RISK-FACTORS; HIV; PREVALENCE; DISTURBANCES	Background Sleep is a natural, restorative, physiological process that is characterized by perceptual disengagement from and unresponsiveness to whatever going around, which is reversible. Sleep quality refers to a sense of being rested and refreshed after waking up from sleep. People living with HIV/AIDS (PLWHA) are vulnerable to poor sleep quality as they suffer from social stigma and Anti-Retroviral drug side effects. The study aimed to examine the quality of sleep and its associated factors among people living with HIV/AIDS attending Anti-Retroviral Therapy (ART) clinic at Hawassa University comprehensive specialized hospital. Method Institutional based cross-sectional study was conducted among PLWHA attending ART clinic at Hawassa University comprehensive specialized hospital from May 1-30, 2019. A systematic random sampling technique was used to select an estimated 422 study participants and data was collected using interviewer-administered technique. Sleep Quality was assessed using the Pittsburgh Sleep Quality Index (PSQI). Data were entered and analyzed using SPSS 22 software. Bivariable and multivariable logistic regression model was fitted to identify factors associated with quality of sleep. An adjusted odds ratio with a 95% confidence interval was computed to determine the level of significance with P-value less than 0.05. Result Out of 422 respondents, 389 participated in the study giving a response rate of 92.1%. The prevalence of poor quality of sleep among study participants was found to be 57.6% (95% CI: 54.72, 60.48). 31.9% (124) and 30.6% (119) of study participants had anxiety and depression respectively. Being between the age of 55-64 years (AOR = 5.7, 95% CI (1.9, 17.8), Age >= 65 (AOR:6.6, 95% CI (1.2, 36.9), Monthly income <1656 Ethiopian Birr (ETB) (AOR = 2.17, 95% CI (1.06, 4.4), having anxiety (AOR = 4.4, 95% CI (2.12, 9.2), having depression (AOR = 4.97, 95% CI (2.28, 10) and poor social support (AOR = 2.9, 95% CI (1.16, 7.3) were factors associated with poor quality of sleep. Conclusion The prevalence of poor quality of sleep among PLWHA was significantly high. Average monthly income, age, anxiety, depression, and social support were found to be significantly associated with poor sleep quality. Health care professionals working at the ART clinic need to assess the sleep pattern of ART clients, give psychoeducation on the prevention and management of sleep pattern problems.	[Bedaso, Asres; Abraham, Yacob] Hawassa Univ, Coll Med & Hlth Sci, Sch Nursing, Hawassa, Ethiopia; [Bedaso, Asres] Univ Technol Sydney, Fac Hlth, Australian Ctr Publ & Populat Hlth Res, Sydney, NSW, Australia; [Temesgen, Abdi] Hawassa Univ Comprehens Specialized Hosp, Psychiat Unit, Hawassa, Ethiopia; [Mekonnen, Nibretie] Hawassa Univ, Coll Med & Hlth Sci, Fac Med, Physiol Unit, Hawassa, Ethiopia	Hawassa University; University of Technology Sydney; Hawassa University	Bedaso, A (corresponding author), Hawassa Univ, Coll Med & Hlth Sci, Sch Nursing, Hawassa, Ethiopia.; Bedaso, A (corresponding author), Univ Technol Sydney, Fac Hlth, Australian Ctr Publ & Populat Hlth Res, Sydney, NSW, Australia.	asresbedaso@gmail.com	Tilahune, Asres Bedaso/AAP-9118-2020; Tilahune, Asres Bedaso/AAP-9464-2020	Tilahune, Asres Bedaso/0000-0001-7859-0264				Afkham Ebrahimi Azizeh, 2010, MED J ISLAMIC REPUBL, V23, P144; Allavena C, 2016, AIDS BEHAV, V20, P339, DOI 10.1007/s10461-015-1160-5; [Anonymous], DOES IT SEEM HARD SL; [Anonymous], 2016, PREV CHRONIC DIS, V13, pE40; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2014, J CLIN DIAGN RES, V8; [Anonymous], 2006, SLEEP WAK CYCL ITS P; Babson KA, 2013, AIDS PATIENT CARE ST, V27, P544, DOI 10.1089/apc.2013.0221; Barlow DH, 2014, CLIN HDB PSYCHOL DIS; Bisong E, 2017, RECENT ADV BIOL MED, V2017, P2747; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carckadon MA, 2005, PRINCIPLES PRACTICES, DOI [10.1016/s1389-9457(05)80005-x, DOI 10.1016/S1389-9457(05)80005-X]; Centers for Disease Control and Prevention, 2015, INS SLEEP IS PUBL HL; Chai-Coetzer CL, 2015, LANCET RESP MED, V3, P337, DOI [10.1016/s2213-2600(15)00141-1, 10.1016/S2213-2600(15)00141-1]; Chen YC, 2017, SLEEP MED, V36, P38, DOI 10.1016/j.sleep.2017.04.005; Christopher M, 2015, PRIORITIZING SLEEP H, V10, P733; Country/Regional Operational Plan, 2017, STRAT DIR SUMM; Crum-Cianflone NF, 2012, CLIN INFECT DIS, V54, P1485, DOI 10.1093/cid/cis192; Dabaghzadeh Fatemeh, 2013, Iran J Psychiatry, V8, P160; Dahl RE, 2007, J FAM PSYCHOL, V21, P1, DOI 10.1037/0893-3200.21.1.1; Dalgard O., 2009, SOCIAL SUPPORT CONSE; Evelyn E, 2018, FACTORS ASS POOR SLE; Gamaldo CE, 2013, AIDS BEHAV, V17, P2808, DOI 10.1007/s10461-012-0401-0; Huang XJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03968-3; Irwin MR, 2016, BIOL PSYCHIAT, V80, P40, DOI 10.1016/j.biopsych.2015.05.014; Johnston L, 2017, HIV AIDS RISK PROTEC; Ferreira LTK, 2012, REV ESC ENFERM USP, V46, P890; Mahoney JJ, 2014, PSYCHIAT RES, V219, P367, DOI 10.1016/j.psychres.2014.05.026; McDaniel Janelle, 2011, SLEEP QUALITY HABITS; MELLINGER GD, 1985, ARCH GEN PSYCHIAT, V42, P225, DOI 10.1001/archpsyc.1985.01790260019002; National sleep foundation, 2019, SLEEP ALZH DIS MOR E; Oshinaike O, 2014, NEUROL RES INT, V2014, DOI 10.1155/2014/298703; Reda AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016049; Redman Kirsten, 2016, WITS I REPOSITORY EN; Tedaldi EM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/641913; UNAIDS, 2020, GLOB HIV AIDS STAT F; WINKLEBY MA, 1992, AM J PUBLIC HEALTH, V82, P816, DOI 10.2105/AJPH.82.6.816; Wu WW, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15092055; 2018, ARTERIANA HIPERTENZI, V4, P28	39	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0233849	10.1371/journal.pone.0233849	http://dx.doi.org/10.1371/journal.pone.0233849			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MA6PX	32497153	Green Published, gold			2022-12-26	WOS:000542035200045
J	Garrett-Thomson, SC; Massimi, A; Fedorov, EV; Bonanno, JB; Scandiuzzi, L; Hillerich, B; Seidel, RD; Love, JD; Garforth, SJ; Guha, C; Almo, SC				Garrett-Thomson, Sarah C.; Massimi, Aldo; Fedorov, Elena V.; Bonanno, Jeffrey B.; Scandiuzzi, Lisa; Hillerich, Brandan; Seidel, Ronald D., III; Love, James D.; Garforth, Scott J.; Guha, Chandan; Almo, Steven C.			Mechanistic dissection of the PD-L1:B7-1 co-inhibitory immune complex	PLOS ONE			English	Article							T-CELL-ACTIVATION; CRYSTAL-STRUCTURE; SOLUBLE FORM; LIGAND; IPILIMUMAB; B7-1; PEMBROLIZUMAB; TOLERANCE; PATHWAY; BINDING	The B7 family represents one of the best-studied subgroups within the Ig superfamily, yet new interactions continue to be discovered. However, this binding promiscuity represents a major challenge for defining the biological contribution of each specific interaction. We developed a strategy for addressing these challenges by combining cell microarray and high-throughput FACS methods to screen for promiscuous binding events, map binding interfaces, and generate functionally selective reagents. Applying this approach to the interactions of mPD-L1 with its receptor mPD-1 and its ligand mB7-1, we identified the binding interface of mB7-1 on mPD-L1 and as a result generated mPD-L1 mutants with binding selectivity for mB7-1 or mPD-1. Next, using a panel of mB7-1 mutants, we mapped the binding sites of mCTLA-4, mCD28 and mPD-L1. Surprisingly, the mPD-L1 binding site mapped to the dimer interface surface of mB7-1, placing it distal from the CTLA-4/CD28 recognition surface. Using two independent approaches, we demonstrated that mPD-L1 and mB7-1 bind in cis, consistent with recent reports from Chaudhri A et al. and Sugiura D et al. We further provide evidence that while CTLA-4 and CD28 do not directly compete with PD-L1 for binding to B7-1, they can disrupt the cis PD-L1:B7-1 complex by reorganizing B7-1 on the cell surface. These observations offer new functional insights into the regulatory mechanisms associated with this group of B7 family proteins and provide new tools to elucidate their function in vitro and in vivo.	[Garrett-Thomson, Sarah C.; Massimi, Aldo; Fedorov, Elena V.; Bonanno, Jeffrey B.; Love, James D.; Garforth, Scott J.; Almo, Steven C.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA; [Scandiuzzi, Lisa; Guha, Chandan] Albert Einstein Coll Med, Dept Radiat Oncol, Bronx, NY 10467 USA; [Hillerich, Brandan; Seidel, Ronald D., III] Cue BioPharma Inc, Cambridge, MA USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Garrett-Thomson, SC; Almo, SC (corresponding author), Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA.	steven.almo@einsteinmed.org; sarah.garrett@einsteinmed.org		Massimi, Aldo/0000-0002-1549-386X	SCA - HG008325 - NIH - National Human Genome Research Institute	SCA - HG008325 - NIH - National Human Genome Research Institute	SCA - HG008325 - NIH - National Human Genome Research Institute. The authors RDS and BH contributed to this manuscript prior to their employment with Cue Biopharma, Inc. Cue Biopharma, Inc. continues to employ authors RDS and BH, and did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	[Anonymous], 2004, PROBLEMI IZKUSTVOTO, V1, P37, DOI DOI 10.1504/WRSTSD.2004.004854; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Bagcchi S, 2014, LANCET ONCOL, V15, pE419, DOI 10.1016/S1470-2045(14)70348-1; Bhatia S, 2006, IMMUNOL LETT, V104, P70, DOI 10.1016/j.imlet.2005.11.019; Bhatia S, 2005, P NATL ACAD SCI USA, V102, P15569, DOI 10.1073/pnas.0507257102; Bhatia S, 2010, J IMMUNOL, V184, P1821, DOI 10.4049/jimmunol.0902869; Bluestone JA, 2006, IMMUNITY, V24, P233, DOI 10.1016/j.immuni.2006.03.001; Bour-Jordan H, 2011, IMMUNOL REV, V241, P180, DOI 10.1111/j.1600-065X.2011.01011.x; Butte MJ, 2008, MOL IMMUNOL, V45, P3567, DOI 10.1016/j.molimm.2008.05.014; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Chattopadhyay K, 2009, IMMUNOL REV, V229, P356, DOI 10.1111/j.1600-065X.2009.00778.x; Chaudhri A, 2018, CANCER IMMUNOL RES, V6, P921, DOI 10.1158/2326-6066.CIR-17-0316; Di Giacomo AM, 2009, CANCER IMMUNOL IMMUN, V58, P1297, DOI 10.1007/s00262-008-0642-y; Evans EJ, 2005, NAT IMMUNOL, V6, P271, DOI 10.1038/ni1170; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Ganesan A, 2018, BBA-GEN SUBJECTS, V1862, P2764, DOI 10.1016/j.bbagen.2018.08.010; Ghiotto M, 2010, INT IMMUNOL, V22, P651, DOI 10.1093/intimm/dxq049; Gianchecchi E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02374; Haile ST, 2014, CANCER IMMUNOL RES, V2, P610, DOI 10.1158/2326-6066.CIR-13-0204; Haile ST, 2013, J IMMUNOL, V191, P2829, DOI 10.4049/jimmunol.1202777; Haile ST, 2011, J IMMUNOL, V186, P6822, DOI 10.4049/jimmunol.1003682; Ikemizu S, 2000, IMMUNITY, V12, P51, DOI 10.1016/S1074-7613(00)80158-2; Larsen CP, 2005, AM J TRANSPLANT, V5, P443, DOI 10.1111/j.1600-6143.2005.00749.x; Lin DYW, 2008, P NATL ACAD SCI USA, V105, P3011, DOI 10.1073/pnas.0712278105; Mansh Matthew, 2011, Yale Journal of Biology and Medicine, V84, P381; MUKHERJEE S, 2017, BLOOD S1, V130; Ni X, 2017, J CLIN INVEST, V127, P1960, DOI 10.1172/JCI91138; Nurieva RI, 2009, IMMUNOL REV, V229, P88, DOI 10.1111/j.1600-065X.2009.00769.x; Paterson AM, 2011, J IMMUNOL, V187, P1097, DOI 10.4049/jimmunol.1003496; Postow MA, 2015, J CLIN ONCOLOGY; Ramani SR, 2012, ANAL BIOCHEM, V420, P127, DOI 10.1016/j.ab.2011.09.017; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2014, LANCET, V384, P1109, DOI 10.1016/S0140-6736(14)60958-2; Rollins MR, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/7659462; Sanchez-Lockhart M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089263; Shen M, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317695013; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; Sugiura D, 2019, SCIENCE, V364, P558, DOI 10.1126/science.aav7062; Vincenti F, 2011, NAT REV DRUG DISCOV, V10, P655, DOI 10.1038/nrd3536; Weber J, 2007, ONCOLOGIST, V12, P864, DOI 10.1634/theoncologist.12-7-864; Wu RZ, 2002, TRENDS CELL BIOL, V12, P485, DOI 10.1016/S0962-8924(02)02354-1; Xiao YP, 2014, J EXP MED, V211, P943, DOI 10.1084/jem.20130790; Yang J, 2011, J IMMUNOL, V187, P1113, DOI 10.4049/jimmunol.1100056; Yao S, 2011, IMMUNITY, V34, P729, DOI 10.1016/j.immuni.2011.03.014; Zak KM, 2015, STRUCTURE, V23, P2341, DOI 10.1016/j.str.2015.09.010; Zang XX, 2007, CLIN CANCER RES, V13, P5271, DOI 10.1158/1078-0432.CCR-07-1030; Ziauddin J, 2001, NATURE, V411, P107, DOI 10.1038/35075114	47	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0233578	10.1371/journal.pone.0233578	http://dx.doi.org/10.1371/journal.pone.0233578			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497097	Green Published, gold			2022-12-26	WOS:000542035200046
J	Jangtarwan, K; Kamsongkram, P; Subpayakom, N; Sillapaprayoon, S; Muangmai, N; Kongphoemph, A; Wongsodchuen, A; Intapan, S; Chamchumroon, W; Safoowong, M; Peyachoknagu, S; Duengkae, P; Srikulnath, K				Jangtarwan, Kornsuang; Kamsongkram, Peerapong; Subpayakom, Navapong; Sillapaprayoon, Siwapech; Muangmai, Narongrit; Kongphoemph, Adisorn; Wongsodchuen, Apinya; Intapan, Sanya; Chamchumroon, Wiyada; Safoowong, Mongkol; Peyachoknagu, Surin; Duengkae, Prateep; Srikulnath, Kornsorn			Predictive genetic plan for a captive population of the Chinese goral (Naemorhedus griseus) and prescriptive action forex situandin situconservation management in Thailand	PLOS ONE			English	Article							COMPUTER-PROGRAM; SIZE; REINTRODUCTION; SOFTWARE; RELATEDNESS; VARIABILITY; DIVERSITY; CAUDATUS	Captive breeding programs for endangered species can increase population numbers for eventual reintroduction to the wild. Captive populations are typically small and isolated, which results in inbreeding and reduction of genetic variability, and may lead to an increased risk of extinction. The Omkoi Wildlife Breeding Center maintains the only Thai captive Chinese goral (Naemorhedus griseus) population, and has plans to reintroduce individuals into natural isolated populations. Genetic variability was assessed within the captive population using microsatellite data. Although no bottleneck was observed, genetic variability was low (allelic richness = 7.091 +/- 0.756,H-e= 0.455 +/- 0.219;H-e<H-o) and 11 microsatellite loci were informative that likely reflect inbreeding. Estimates of small effective population size and limited numbers of founders, combined with wild-born individuals within subpopulations, tend to cause reduction of genetic variability over time in captive programs. This leads to low reproductive fitness and limited ability to adapt to environmental change, thereby increasing the risk of extinction. Management of captive populations as evolutionarily significant units with diverse genetic backgrounds offers an effective strategy for population recovery. Relocation of individuals among subpopulations, or introduction of newly captured wild individuals into the captive program will help to ensure the future security of Chinese goral. Implications for future conservation actions for the species are discussed herein.	[Jangtarwan, Kornsuang; Kamsongkram, Peerapong; Subpayakom, Navapong; Sillapaprayoon, Siwapech; Peyachoknagu, Surin; Srikulnath, Kornsorn] Kasetsart Univ, Fac Sci, Dept Genet, Lab Anim Cytogenet & Comparat Genom ACCG, Bangkok, Thailand; [Jangtarwan, Kornsuang; Kamsongkram, Peerapong; Subpayakom, Navapong; Sillapaprayoon, Siwapech; Duengkae, Prateep; Srikulnath, Kornsorn] Kasetsart Univ, Fac Forestry, Dept Forest Biol, Special Res Unit Wildlife Genom SRUWG, Bangkok, Thailand; [Muangmai, Narongrit] Kasetsart Univ, Fac Fisheries, Dept Fishery Biol, Bangkok, Thailand; [Kongphoemph, Adisorn; Wongsodchuen, Apinya; Intapan, Sanya; Chamchumroon, Wiyada; Safoowong, Mongkol] Minist Nat Resources & Environm, Dept Natl Pk Wildlife & Plant Conservat, Bangkok, Thailand; [Duengkae, Prateep; Srikulnath, Kornsorn] Kasetsart Univ, Natl Res Univ, Ctr Adv Studies Trop Nat Resources, Bangkok, Thailand; [Duengkae, Prateep; Srikulnath, Kornsorn] NRU KU, CASTNAR, Bangkok, Thailand; [Srikulnath, Kornsorn] Ctr Excellence Agr Biotechnol AG BIO PERDO CHE, Bangkok, Thailand; [Srikulnath, Kornsorn] Hiroshima Univ, Amphibian Res Ctr, Higashihiroshima, Japan	Kasetsart University; Kasetsart University; Kasetsart University; Kasetsart University; Hiroshima University	Srikulnath, K (corresponding author), Kasetsart Univ, Fac Sci, Dept Genet, Lab Anim Cytogenet & Comparat Genom ACCG, Bangkok, Thailand.; Srikulnath, K (corresponding author), Kasetsart Univ, Fac Forestry, Dept Forest Biol, Special Res Unit Wildlife Genom SRUWG, Bangkok, Thailand.; Srikulnath, K (corresponding author), Kasetsart Univ, Natl Res Univ, Ctr Adv Studies Trop Nat Resources, Bangkok, Thailand.; Srikulnath, K (corresponding author), NRU KU, CASTNAR, Bangkok, Thailand.; Srikulnath, K (corresponding author), Ctr Excellence Agr Biotechnol AG BIO PERDO CHE, Bangkok, Thailand.; Srikulnath, K (corresponding author), Hiroshima Univ, Amphibian Res Ctr, Higashihiroshima, Japan.	kornsorn.s@ku.ac.th			National Research Council of Thailand [0404639]; Faculty of Science, Kasetsart University [6501.0901/0775]; Center for Advanced Studies in Tropical Natural Resources, National Research University-Kasetsart University (CASTNAR, NRU-KU, Thailand); Center of Excellence on Agricultural Biotechnology, Science and Technology Postgraduate Education and Research Development Office, Office of Higher Education Commission, Ministry of Education (AG-BIO/PERDO-CHE)	National Research Council of Thailand(National Research Council of Thailand (NRCT)); Faculty of Science, Kasetsart University; Center for Advanced Studies in Tropical Natural Resources, National Research University-Kasetsart University (CASTNAR, NRU-KU, Thailand); Center of Excellence on Agricultural Biotechnology, Science and Technology Postgraduate Education and Research Development Office, Office of Higher Education Commission, Ministry of Education (AG-BIO/PERDO-CHE)	This study was financially supported by a Government Budget Grant from the National Research Council of Thailand (No. 0404639) awarded to KJ, NS, WC, NM, SP, PD and KS, an Undergraduate Research Matching Fund (6501.0901/0775) from the Faculty of Science, Kasetsart University awarded to PK and KS, the Center for Advanced Studies in Tropical Natural Resources, National Research University-Kasetsart University (CASTNAR, NRU-KU, Thailand) awarded to PD and KS, and the Center of Excellence on Agricultural Biotechnology, Science and Technology Postgraduate Education and Research Development Office, Office of Higher Education Commission, Ministry of Education (AG-BIO/PERDO-CHE) awarded to KS. The funding agencies did not play a role in the design of the study or in the collection, analysis, and interpretation of data, or in writing the manuscript.	Allendorf F. W., 1986, CONSERVATION BIOL SC, P58; An J, 2005, MOL ECOL NOTES, V5, P421, DOI 10.1111/j.1471-8286.2005.00948.x; An J, 2010, J VET SCI, V11, P351, DOI 10.4142/jvs.2010.11.4.351; [Anonymous], 2015, ENSEMBLE MODERN, V42, P31; [Anonymous], 2009, J APPL SPORT PSYC S1, V21, pS116; [Anonymous], 2013, INT UNION CONSERVATI; Arif IA, 2011, SAUDI J BIOL SCI, V18, P219, DOI 10.1016/j.sjbs.2011.03.002; Ballou JD, 2010, WILD MAMMALS CAPTIVI, V219; Buranapim N, 2014, THAI J VET MED, V44, P75; Ceballos G, 2017, P NATL ACAD SCI USA, V114, pE6089, DOI 10.1073/pnas.1704949114; Chaiyarat Rattanawat, 1999, Natural History Bulletin of the Siam Society, V47, P191; Choi SK, 2015, GENES GENET SYST, V90, P31, DOI 10.1266/ggs.90.31; Cohas A, 2006, BEHAV ECOL SOCIOBIOL, V59, P597, DOI 10.1007/s00265-005-0086-8; Cornuet JM, 1996, GENETICS, V144, P2001; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Duckworth JW, 2008, NAEMORHEDUS GRISEUS, DOI [10.2305/IUCN.UK.2008.RLTS.T14303A4430834.en, DOI 10.2305/IUCN.UK.2008.RLTS.T14303A4430834.EN]; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frankham R., 2010, INTRO CONSERVATION G, DOI [10. 1017/CBO9780511809002, DOI 10.1017/CB09780511809002]; Galbusera Peter, 2000, Conservation Genetics, V1, P163, DOI 10.1023/A:1026587024065; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Gilpin M.E., 1986, P19; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Greenbaum G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115203; Guan TL, 2009, BIOCHEM SYST ECOL, V37, P166, DOI 10.1016/j.bse.2009.04.001; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hunter P, 2007, EMBO REP, V8, P316, DOI 10.1038/sj.embor.7400951; Jangtarwan K, 2019, J WILD THAI, V26; Jangtarwan K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223726; Keller L.K., 2012, REINTRODUCTION BIOL, P360, DOI DOI 10.1002/9781444355833.CH11; Khonmee J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091633; Kirkwood J. K., 2003, International Zoo Yearbook, V38, P124, DOI 10.1111/j.1748-1090.2003.tb02072.x; Kongprempoon A., 2003, GORAL BEHAV SEMICAPT; Lacy RC, 1997, J MAMMAL, V78, P320, DOI 10.2307/1382885; Lapbenjakul S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184526; Lin LF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204056; Lynch M, 1999, GENETICS, V152, P1753; Masanja GF, 2014, J SUSTAINABLE DEV ST, V23, P5; Park SDE, 2001, THESIS; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pelletier F, 2009, TRENDS ECOL EVOL, V24, P263, DOI 10.1016/j.tree.2008.11.013; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2018, R LANG ENV STAT COMP; RALLS K, 1986, TRENDS ECOL EVOL, V1, P19, DOI 10.1016/0169-5347(86)90062-5; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rees PA, 2001, ORYX, V35, P216, DOI 10.1046/j.1365-3008.2001.00178.x; Rico C, 2017, PEERJ, V5, DOI 10.7717/peerj.3188; Schadt S, 2002, J APPL ECOL, V39, P189, DOI 10.1046/j.1365-2664.2002.00700.x; Shen FJ, 2009, MOL ECOL, V18, P1061, DOI 10.1111/j.1365-294X.2009.04086.x; Smith Andrew T., 2008, P1; Soultan A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37851-6; State Forestry Administration (SFA), 2009, PEOPL REP CHIN FOR O; Stiver JR, 2008, BIOL CONSERV, V141, P472, DOI 10.1016/j.biocon.2007.10.018; Supikamolseni A, 2015, GENET MOL RES, V14, P13981, DOI 10.4238/2015.October.29.18; Theodorou K, 2015, HEREDITY, V114, P38, DOI 10.1038/hdy.2014.63; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wang J., 2018, USERS GUIDE SOFTWARE; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Wildlife Research Division, 2018, POP STAT DISTR CHIN; WILLIS K, 1993, ZOO BIOL, V12, P535, DOI 10.1002/zoo.1430120605; Zeng Y, 2007, CONSERV GENET, V8, P1051, DOI 10.1007/s10592-006-9256-0	65	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0234064	10.1371/journal.pone.0234064	http://dx.doi.org/10.1371/journal.pone.0234064			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497115	Green Published, gold			2022-12-26	WOS:000542035200095
J	Wadepohl, K; Muller, A; Seinige, D; Rohn, K; Blaha, T; Meemken, D; Kehrenberg, C				Wadepohl, Katharina; Mueller, Anja; Seinige, Diana; Rohn, Karl; Blaha, Thomas; Meemken, Diana; Kehrenberg, Corinna			Association of intestinal colonization of ESBL-producing Enterobacteriaceae in poultry slaughterhouse workers with occupational exposure-A German pilot study	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; (ESBL)-PRODUCING ESCHERICHIA-COLI; GENETIC DIVERSITY; PIG FARMERS; E.-COLI; ANIMALS; PREVALENCE; FOOD; CAMPYLOBACTER; RESISTANCE	Background Bacteria that have acquired antimicrobial resistance, in particular ESBL-producingEnterobacteriaceae, are an important healthcare concern. Therefore, transmission routes and risk factors are of interest, especially for the carriage of ESBL-producingE.coli. Since there is an enhanced risk for pig slaughterhouse employees to carry ESBL-producingEnterobacteriaceae, associated with animal contact as potential risk factor, the present study investigated the occurrence of ESBL-producingEnterobacteriaceaein poultry slaughterhouse employees. Due to the higher level of resistantEnterobacteriaceaein primary poultry production than in pig production, a higher risk of intestinal colonization of poultry slaughterhouse employees was expected. Results ESBL-producingEnterobacteriaceaewere detected in 5.1% (5 of 99) of the fecal samples of slaughterhouse workers. The species of these isolates was confirmed asE.coli. PCR assays revealed the presence of the genesbla(CTX-M-15)(n = 2) andbla(SHV-12)(n = 3) in these isolates, partly in combination with the beta-lactamase genebla(TEM-135). Participants were divided into two groups according to their occupational exposure and results indicated an increased probability of colonization with ESBL-producingEnterobacteriaceaefor the group of 'higher exposure' (OR 3.7, exact 95% CI 0.6-23.5; p = 0.4). For intestinal colonization with ESBL-producingEnterobacteriaceae, a prevalence of 10% (3/30) was observed in the group of 'higher exposure' versus 2.9% (2/69) in the group of 'lower exposure'. Employees in working steps such as 'hanging' poultry in the process of slaughter and 'evisceration' seemed to have a higher risk for intestinal colonization with ESBL-producingEnterobacteriaceaecompared to the group of 'lower exposure'. Conclusion This study is the first of its kind to collect data on the occupational exposure of slaughterhouse workers to ESBL-producingEnterobacteriaceaein Europe. The results suggested that colonization with ESBL-producingEnterobacteriaceaeis associated with occupational exposure in poultry slaughterhouses. However, the presence of ESBL-producingE.coliisolates in only 5.1% (5/99) of the tested employees in poultry slaughterhouses suggests a lower transmission risk than in pig slaughterhouses.	[Wadepohl, Katharina; Blaha, Thomas] Univ Vet Med Hannover, Field Stn Epidemiol, Bakum, Germany; [Mueller, Anja; Seinige, Diana] Univ Vet Med Hannover, Inst Food Qual & Food Safety, Hannover, Germany; [Rohn, Karl] Univ Vet Med Hannover, Inst Biometry Epidemiol & Informat Proc IBEI, Hannover, Germany; [Meemken, Diana] Free Univ Berlin, Inst Food Safety & Food Hyg, Dept Vet Med, Sect Meat Hyg, Berlin, Germany; [Mueller, Anja; Kehrenberg, Corinna] Justus Liebig Univ, Fac Vet Med, Inst Vet Food Sci, Giessen, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; Free University of Berlin; Justus Liebig University Giessen	Wadepohl, K (corresponding author), Univ Vet Med Hannover, Field Stn Epidemiol, Bakum, Germany.	Katharina.Wadepohl@tiho-hannover.de	Kehrenberg, Corinna/GSI-9835-2022; Müller, Anja/AAM-3406-2021	Wadepohl, Katharina/0000-0002-1350-6794; Muller, Anja/0000-0002-3179-6684	EU [FP7-KBBE-2013-7, 613754]; Deutsche Forschungsgemeinschaft; University of Veterinary Medicine Hannover, Foundation	EU(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Veterinary Medicine Hannover, Foundation	The EFFORT project (www.effort-againstamr.eu) and the study presented here are supported by EU, FP7-KBBE-2013-7, grant agreement 613754. This publication was supported by Deutsche Forschungsgemeinschaft and University of Veterinary Medicine Hannover, Foundation within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 1999, MICROBES INFECT, V1, P639, DOI 10.1016/S1286-4579(99)80064-1; [Anonymous], 2012, HEPATOLOGY, V56, pE1; Cassini A, 2019, LANCET INFECT DIS, V19, P56, DOI 10.1016/S1473-3099(18)30605-4; Chmelnitsky I, 2005, ANTIMICROB AGENTS CH, V49, P4745, DOI 10.1128/AAC.49.11.4745-4750.2005; Cole MJ, 2015, J ANTIMICROB CHEMOTH, V70, P3238, DOI 10.1093/jac/dkv260; Dahms C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143326; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; Dierikx C, 2013, J ANTIMICROB CHEMOTH, V68, P60, DOI 10.1093/jac/dks349; Dohmen W, 2015, CLIN MICROBIOL INFEC, V21, P917, DOI 10.1016/j.cmi.2015.05.032; Dorado-Garcia A, 2018, J ANTIMICROB CHEMOTH, V73, P339, DOI 10.1093/jac/dkx397; European Centre for Disease Prevention and Control (ECDC), 2009, ANN EP REP COMM DIS; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Friese A, 2013, BERL MUNCH TIERARZTL, V126, P175, DOI 10.2376/0005-9366-126-175; Geser N, 2011, J FOOD PROTECT, V74, P446, DOI 10.4315/0362-028X.JFP-10-372; Geser N, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-21; Graveland H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010990; Hammerum AM, 2014, J ANTIMICROB CHEMOTH, V69, P2650, DOI 10.1093/jac/dku180; Hering J, 2016, PREV VET MED, V125, P154, DOI 10.1016/j.prevetmed.2016.01.003; Institute. CaLS, 2012, M100S222012 S, P2162; Kaesbohrer A, 2019, VET MICROBIOL, V233, P52, DOI 10.1016/j.vetmic.2019.03.025; Kennedy K, 2010, EUR J CLIN MICROBIOL, V29, P1501, DOI 10.1007/s10096-010-1031-y; Kola A, 2012, J ANTIMICROB CHEMOTH, V67, P2631, DOI 10.1093/jac/dks295; Lubbert C, 2015, INT J MED MICROBIOL, V305, P148, DOI 10.1016/j.ijmm.2014.12.001; Monstein HJ, 2007, APMIS, V115, P1400, DOI 10.1111/j.1600-0463.2007.00722.x; Muloi D, 2018, FOODBORNE PATHOG DIS, V15, P467, DOI 10.1089/fpd.2017.2411; Otter JA, 2019, CLIN MICROBIOL INFEC, V25, P1259, DOI 10.1016/j.cmi.2019.02.026; Pacholewicz E, 2015, INT J FOOD MICROBIOL, V205, P119, DOI 10.1016/j.ijfoodmicro.2015.04.006; Price LB, 2007, ENVIRON HEALTH PERSP, V115, P1738, DOI 10.1289/ehp.10191; Pruller S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135703; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Saladin M, 2002, FEMS MICROBIOL LETT, V209, P161, DOI 10.1016/S0378-1097(02)00484-6; Schmithausen RM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138173; Singer RS, 2003, LANCET INFECT DIS, V3, P47, DOI 10.1016/S1473-3099(03)00490-0; Sogaard M, 2017, CLIN MICROBIOL INFEC, V23, P952, DOI 10.1016/j.cmi.2017.03.026; Valentin L, 2014, INT J MED MICROBIOL, V304, P805, DOI 10.1016/j.ijmm.2014.07.015; Valenza G, 2017, VET MICROBIOL, V200, P138, DOI 10.1016/j.vetmic.2015.10.008; Zweifel C, 2015, FOOD CONTROL, V51, P37, DOI 10.1016/j.foodcont.2014.11.002	37	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0232326	10.1371/journal.pone.0232326	http://dx.doi.org/10.1371/journal.pone.0232326			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497054	Green Published, gold			2022-12-26	WOS:000542035200092
J	Eun, K; Hong, N; Jeong, YW; Park, MG; Hwang, SU; Jeong, YIK; Choi, EJ; Olsson, PO; Hwang, WS; Hyun, SH; Kim, H				Eun, Kiyoung; Hong, Nayoung; Jeong, Yeon Woo; Park, Min Gi; Hwang, Seon-Ung; Jeong, Yeon I. K.; Choi, Eun Ji; Olsson, P. Olof; Hwang, Woo Suk; Hyun, Sang-Hwan; Kim, Hyunggee			Transcriptional activities of human elongation factor-1 alpha and cytomegalovirus promoter in transgenic dogs generated by somatic cell nuclear transfer	PLOS ONE			English	Article							EPIGENETIC REGULATION; EXPRESSION; MODEL; METHYLATION; PREGNANCY; VERSATILE; PATTERNS; VECTORS	Recent advances in somatic cell nuclear transfer (SCNT) in canines facilitate the production of canine transgenic models. Owing to the importance of stable and strong promoter activity in transgenic animals, we tested human elongation factor 1 alpha (hEF1 alpha) and cytomegalovirus (CMV) promoter sequences in SCNT transgenic dogs. After transfection, transgenic donor fibroblasts with the hEF1 alpha-enhanced green fluorescence protein (EGFP) transgene were successfully isolated using fluorescence-activated cell sorting (FACS). We obtained four puppies, after SCNT, and identified three puppies as being transgenic using PCR analysis. Unexpectedly, EGFP regulated by hEF1 alpha promoter was not observed at the organismal and cellular levels in these transgenic dogs. EGFP expression was rescued by the inhibition of DNA methyltransferases, implying that the hEF1 alpha promoter is silenced by DNA methylation. Next, donor cells with CMV-EGFP transgene were successfully established and SCNT was performed. Three puppies of six born puppies were confirmed to be transgenic. Unlike hEF1 alpha-regulated EGFP, CMV-regulated EGFP was strongly detectable at both the organismal and cellular levels in all transgenic dogs, even after 19 months. In conclusion, our study suggests that the CMV promoter is more suitable, than the hEF1 alpha promoter, for stable transgene expression in SCNT-derived transgenic canine model.	[Eun, Kiyoung; Hong, Nayoung; Park, Min Gi; Kim, Hyunggee] Korea Univ, Coll Life Sci & Biotechnol, Dept Biotechnol, Seoul, South Korea; [Eun, Kiyoung; Hong, Nayoung; Park, Min Gi; Kim, Hyunggee] Korea Univ, Inst Anim Mol Biotechnol, Seoul, South Korea; [Jeong, Yeon Woo; Jeong, Yeon I. K.; Choi, Eun Ji; Olsson, P. Olof; Hwang, Woo Suk] Sooam Biotech Res Fdn, Seoul, South Korea; [Hwang, Seon-Ung; Hyun, Sang-Hwan] Chungbuk Natl Univ, Coll Vet Med, Lab Vet Embryol & Biotechnol, Cheongju, South Korea; [Hwang, Seon-Ung; Hyun, Sang-Hwan] Chungbuk Natl Univ, Inst Stem Cell & Regenerat Med, Cheongju, South Korea	Korea University; Korea University; Chungbuk National University; Chungbuk National University	Kim, H (corresponding author), Korea Univ, Coll Life Sci & Biotechnol, Dept Biotechnol, Seoul, South Korea.; Kim, H (corresponding author), Korea Univ, Inst Anim Mol Biotechnol, Seoul, South Korea.; Hyun, SH (corresponding author), Chungbuk Natl Univ, Coll Vet Med, Lab Vet Embryol & Biotechnol, Cheongju, South Korea.; Hyun, SH (corresponding author), Chungbuk Natl Univ, Inst Stem Cell & Regenerat Med, Cheongju, South Korea.	shhyun@cbu.ac.kr; hg-kim@korea.ac.kr		Olsson, P. Olof/0000-0002-1048-0832	Next-Generation BioGreen21 Program [PJ01107701]; Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries(IPET) through Agri-Bio industry Technology Development Program from Ministry of Agriculture, Food and Rural Affairs [318016-5]	Next-Generation BioGreen21 Program(Rural Development Administration (RDA), Republic of Korea); Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries(IPET) through Agri-Bio industry Technology Development Program from Ministry of Agriculture, Food and Rural Affairs	This work was supported by grants from the Next-Generation BioGreen21 Program (PJ01107701) and Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries(IPET) through Agri-Bio industry Technology Development Program from Ministry of Agriculture, Food and Rural Affairs (Grant number: 318016-5).	Abdelmegeed SM, 2018, ONCOL LETT, V15, P8195, DOI 10.3892/ol.2018.8411; [Anonymous], 2013, ORAL HIST REV, V40, P67; Bouabe H, 2013, METHODS MOL BIOL, V1064, P315, DOI 10.1007/978-1-62703-601-6_23; Caldin M, 2019, RES VET SCI, V125, P305, DOI 10.1016/j.rvsc.2019.07.006; Calero-Nieto FJ, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-3; Eun K, 2019, BMC BIOTECHNOL, V19, DOI 10.1186/s12896-018-0491-5; Eun K, 2017, BIOL PROCED ONLINE, V19, DOI 10.1186/s12575-017-0061-6; FOECKING MK, 1986, GENE, V45, P101, DOI 10.1016/0378-1119(86)90137-X; Gardner HL, 2016, ANNU REV ANIM BIOSCI, V4, P199, DOI 10.1146/annurev-animal-022114-110911; Haruyama Naoto, 2009, Curr Protoc Cell Biol, VChapter 19, DOI 10.1002/0471143030.cb1910s42; Hodges Craig A, 2003, Reprod Biol Endocrinol, V1, P81, DOI 10.1186/1477-7827-1-81; Hofmann A, 2006, MOL THER, V13, P59, DOI 10.1016/j.ymthe.2005.07.685; Hong S, 2007, MOL THER, V15, P1630, DOI 10.1038/sj.mt.6300251; Hsu CC, 2010, BIOCHEM BIOPH RES CO, V402, P228, DOI 10.1016/j.bbrc.2010.09.131; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Jeong YW, 2016, THERIOGENOLOGY, V86, P1865, DOI 10.1016/j.theriogenology.2015.10.026; Jeong YW, 2012, INT J MOL MED, V30, P321, DOI 10.3892/ijmm.2012.993; Johnston S.D., 2001, CANINE FELINE THERIO; Kelly WG, 1998, DEVELOPMENT, V125, P2451; KIM DW, 1990, GENE, V91, P217, DOI 10.1016/0378-1119(90)90091-5; Kim JJ, 2017, ANIM REPROD SCI, V185, P75, DOI 10.1016/j.anireprosci.2017.08.004; Kong QR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107945; Kong QR, 2011, MOL CELL BIOCHEM, V355, P157, DOI 10.1007/s11010-011-0849-7; Kong QR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006679; Kues WA, 2006, FASEB J, V20, P1200, DOI 10.1096/fj.05-5415fje; Lloyd VK, 2003, GENOME, V46, P1104, DOI 10.1139/G03-070; Ma DY, 2015, GENOM PROTEOM BIOINF, V13, P336, DOI 10.1016/j.gpb.2015.12.001; Matzke MA, 2000, PLANT MOL BIOL, V43, P401, DOI 10.1023/A:1006484806925; Mehta AK, 2009, GENE, V428, P20, DOI 10.1016/j.gene.2008.09.033; Miao XY, 2013, CELL MOL LIFE SCI, V70, P815, DOI 10.1007/s00018-012-1081-7; Mukai HY, 2006, MOL CELL BIOL, V26, P7953, DOI 10.1128/MCB.00718-06; Nathanson JL, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.019.2009; Nguyen MN, 2010, PLOS ONE, V5, pe9907; Niemann H, 2012, REPROD DOMEST ANIM, V47, P2, DOI 10.1111/j.1439-0531.2012.02121.x; Norrman K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012413; Petters RM, 2000, TRANSGENIC RES, V9, P347, DOI 10.1023/A:1008926303533; Qin JZ, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0058-4; Rajeevkumar S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00693; Schumacher A, 2000, J BIOL CHEM, V275, P37915, DOI 10.1074/jbc.M004839200; Tolmachov O. E., 2013, GENE THERAPY TOOLS P, P49; Tratar UL, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00268; Whitelaw CBA, 2016, J PATHOL, V238, P247, DOI 10.1002/path.4648; Xia XF, 2007, STEM CELLS DEV, V16, P167, DOI 10.1089/scd.2006.0057; Zheng CY, 2005, MOL THER, V12, P528, DOI 10.1016/j.ymthe.2005.03.008	44	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2020	15	6							e0233784	10.1371/journal.pone.0233784	http://dx.doi.org/10.1371/journal.pone.0233784			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LW6ZP	32492024	Green Published, gold			2022-12-26	WOS:000539293000011
J	Moschos, MM; Dettoraki, M; Karekla, A; Lamprinakis, I; Damaskos, C; Gouliopoulos, N; Tibilis, M; Gazouli, M				Moschos, Marilita M.; Dettoraki, Maria; Karekla, Aggela; Lamprinakis, Ioannis; Damaskos, Christos; Gouliopoulos, Nikolaos; Tibilis, Marios; Gazouli, Maria			Polymorphism analysis of miR182 and CDKN2B genes in Greek patients with primary open angle glaucoma	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; BEHCETS-DISEASE; BINDING-SITES; VARIANTS; RISK; 9P21; MUTATION; CHINESE; RATIO	Glaucoma is a progressive optic neuropathy resulting from retinal ganglion cells death; it represents one of the leading causes of irreversible blindness worldwide. Although, primary open angle glaucoma (POAG) is the most common type of the disease, the pathogenesis of POAG and the genetic factors contributing to disease development remain poorly understood. The aim of this study was to investigate whether the polymorphisms rs76481776 in miR182 gene and rs3217992 in cyclin-dependent kinase inhibitor-2B (CDKN2B) gene are risk factors for POAG in a series of patients of Greek origin. A case-control study was conducted including 120 patients with POAG and 113 unaffected healthy controls of Greek origin, surveyed for polymorphisms with potential correlation to POAG. DNA from each individual was tested for the miR182 rs76481776 and CDKN2B rs3217992 polymorphisms. Regarding the miR182 rs76481776 polymorphism, the T allele occurred with significantly higher frequency in POAG patients compared to controls (OR: 2.62, 95% CI: 1.56-4.39; p = 0.0002). The CDKN2B rs3217992 A allele frequency was found significantly increased in POAG patients compared to healthy individuals (OR: 1.72, 95% CI: 1.18-2.49; p = 0.005). Therefore, both rs76481776 polymorphism in miR182 gene and rs3217992 polymorphism in CDKN2B gene seem to be associated with the development of POAG in a Greek population. The carriers of the T allele of rs76481776 in miR182 and the carriers of the A allele of rs3217992 in CDKN2B have an increased risk of developing POAG.	[Moschos, Marilita M.; Dettoraki, Maria; Gouliopoulos, Nikolaos; Tibilis, Marios] Natl & Kapodistrian Univ Athens, Med Sch, Dept Ophthalmol 1, G Gennimatas Gen Hosp, Athens, Greece; [Karekla, Aggela; Lamprinakis, Ioannis] Evangelismos Gen Hosp, Dept Ophthalmol, Athens, Greece; [Damaskos, Christos] Natl & Kapodistrian Univ Athens, Laiko Gen Hosp, Med Sch, Dept Propedeut Surg 2, Athens, Greece; [Gazouli, Maria] Natl & Kapodistrian Univ Athens, Med Sch, Dept Basic Med Sci, Lab Biol, Athens, Greece	National & Kapodistrian University of Athens; Evangelismos Hospital; Laiko General Hospital; National & Kapodistrian University of Athens; National & Kapodistrian University of Athens	Moschos, MM (corresponding author), Natl & Kapodistrian Univ Athens, Med Sch, Dept Ophthalmol 1, G Gennimatas Gen Hosp, Athens, Greece.	moschosmarilita@yahoo.fr	Gouliopoulos, Nikolaos/AAV-8128-2021	Gouliopoulos, Nikolaos/0000-0002-4154-1597				Abu-Amero KK, 2016, GENET TEST MOL BIOMA, V20, P637, DOI 10.1089/gtmb.2016.0140; Alward WLM, 2003, AM J OPHTHALMOL, V136, P904, DOI 10.1016/S0002-9394(03)00577-4; Bailey JNC, 2016, NAT GENET, V48, P189, DOI 10.1038/ng.3482; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cao D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039278; Chatzikyriakidou A, 2018, OPHTHALMIC GENET, V39, P603, DOI 10.1080/13816810.2018.1509352; Chen YH, 2015, INVEST OPHTH VIS SCI, V56, P2595, DOI 10.1167/iovs.14-16269; Dimasi DP, 2012, AM J OPHTHALMOL, V154, P833, DOI 10.1016/j.ajo.2012.04.023; Fingert JH, 1999, HUM MOL GENET, V8, P899, DOI 10.1093/hmg/8.5.899; Ghanbari M, 2017, INVEST OPHTH VIS SCI, V58, P5831, DOI 10.1167/iovs.17-22410a; Ghanbari M, 2016, HUM MUTAT, V37, P292, DOI 10.1002/humu.22943; Ghanbari M, 2015, CIRC-CARDIOVASC GENE, V8, P473, DOI 10.1161/CIRCGENETICS.114.000968; Ghanbari M, 2015, OBESITY, V23, P495, DOI 10.1002/oby.20975; Greene LA, 2007, BBA-MOL BASIS DIS, V1772, P392, DOI 10.1016/j.bbadis.2006.12.003; Gutierrez-Camino A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177421; Hewitt AW, 2006, AM J OPHTHALMOL, V142, P324, DOI 10.1016/j.ajo.2006.02.041; Horswell SD, 2013, J LIPID RES, V54, P3491, DOI 10.1194/jlr.M041814; Hu ZX, 2017, ONCOTARGET, V8, P21167, DOI 10.18632/oncotarget.15504; Hughes AE, 2011, AM J HUM GENET, V89, P628, DOI 10.1016/j.ajhg.2011.09.014; Iglesias AI, 2014, HUM MOL GENET, V23, P1320, DOI 10.1093/hmg/ddt522; Li GR, 2010, J BIOL CHEM, V285, P5461, DOI 10.1074/jbc.M109.037127; Li GR, 2009, MECH AGEING DEV, V130, P731, DOI 10.1016/j.mad.2009.09.002; Li K, 2020, OPHTHALMIC GENET, V13, P1; Li WQ, 2014, CARCINOGENESIS, V35, P2698, DOI 10.1093/carcin/bgu203; Liu YT, 2016, INVEST OPHTH VIS SCI, V57, P4528, DOI 10.1167/iovs.16-19688; Liu YT, 2011, EXP EYE RES, V93, P331, DOI 10.1016/j.exer.2011.08.007; Loomis SJ, 2014, OPHTHALMOLOGY, V121, P508, DOI 10.1016/j.ophtha.2013.09.012; Luna C, 2009, MOL VIS, V15, P2488; Mabuchi F, 2012, OPHTHALMOLOGY, V119, P1819, DOI 10.1016/j.ophtha.2012.02.044; Meola Nicola, 2009, Pathogenetics, V2, P7, DOI 10.1186/1755-8417-2-7; Micheal S, 2014, MOL VIS, V20, P1471; Moschos MM, 2016, CORNEA, V35, P631, DOI 10.1097/ICO.0000000000000769; Ng SK, 2014, CLIN EXP OPHTHALMOL, V42, P25, DOI 10.1111/ceo.12234; Osman W, 2012, HUM MOL GENET, V21, P2836, DOI 10.1093/hmg/dds103; Pasquale LR, 2013, AM J OPHTHALMOL, V155, P342, DOI 10.1016/j.ajo.2012.07.023; Philomenadin FS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119703; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rong SS, 2019, EXP EYE RES, V180, P129, DOI 10.1016/j.exer.2018.12.014; Saus E, 2010, HUM MOL GENET, V19, P4017, DOI 10.1093/hmg/ddq316; Shiga Y, 2018, HUM MOL GENET, V27, P1486, DOI 10.1093/hmg/ddy053; Vithana EN, 2010, MOL VIS, V16, P1640; Wang XJ, 2015, ACTA DIABETOL, V52, P951, DOI 10.1007/s00592-015-0768-2; Wang YS, 2016, MOL MED REP, V14, P5746, DOI 10.3892/mmr.2016.5938; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Wiggs JL, 2017, HUM MOL GENET, V26, pR21, DOI 10.1093/hmg/ddx184; Worley A, 2011, AUST J PRIM HEALTH, V17, P233, DOI 10.1071/PY10042; Yu HS, 2014, J MOL MED, V92, P961, DOI 10.1007/s00109-014-1159-9; Zhang QL, 2018, INT J BIOL MACROMOL, V120, P801, DOI 10.1016/j.ijbiomac.2018.08.166; Zhang QL, 2015, BIOMED PHARMACOTHER, V75, P19, DOI 10.1016/j.biopha.2015.08.028; Zhou QY, 2014, ANN RHEUM DIS, V73, P170, DOI 10.1136/annrheumdis-2012-201627	50	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2020	15	6							e0233692	10.1371/journal.pone.0233692	http://dx.doi.org/10.1371/journal.pone.0233692			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LW6ZP	32492046	gold, Green Published			2022-12-26	WOS:000539293000048
J	Shawer, H; Aiyelaagbe, E; Clowes, C; Lean, SC; Lu, YH; Kadler, KE; Kerby, A; Dilworth, MR; Hentges, KE; Heazell, AEP				Shawer, Heba; Aiyelaagbe, Esther; Clowes, Christopher; Lean, Samantha C.; Lu, Yinhui; Kadler, Karl E.; Kerby, Alan; Dilworth, Mark R.; Hentges, Kathryn E.; Heazell, Alexander E. P.			A missense mutation of ErbB2 produces a novel mouse model of stillbirth associated with a cardiac abnormality but lacking abnormalities of placental structure	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; LONG-QT SYNDROME; UNITED-STATES; FETAL-DEATH; DEFECTS; CLASSIFICATION; EXPRESSION; DIAGNOSIS; CHILDREN; MICE	Background In humans, stillbirth describes the death of a fetus before birth after 28 weeks gestation, and accounts for approximately 2.6 million deaths worldwide annually. In high-income countries, up to half of stillbirths have an unknown cause and are described as "unexplained stillbirths"; this lack of understanding impairs efforts to prevent stillbirth. There are also few animal models of stillbirth, but those that have been described usually have significant placental abnormalities. This study describes a novel mutant murine model of fetal death with atrial conduction block due to an ErbB2 missense mutation which is not associated with abnormal placental morphology. Methods Phenotypic characterisation and histological analysis of the mutant mouse model was conducted. The mRNA distribution of the early cardiomyocyte marker Nkx2-5 was assessed via in situ hybridisation. Cardiac structure was quantified and cellular morphology evaluated by electron microscopy. Immunostaining was employed to quantify placental structure and cell characteristics on matched heterozygous and homozygous mutant placental samples. Results There were no structural abnormalities observed in hearts of mutant embryos. Comparable Nkx2-5 expression was observed in hearts of mutants and controls, suggesting normal cardiac specification. Additionally, there was no significant difference in the weight, placenta dimensions, giant cell characteristics, labyrinth tissue composition, levels of apoptosis, proliferation or vascularisation between placentas of homozygous mutant mice and controls. Conclusion Embryonic lethality in the ErbB2 homozygous mutant mouse cannot be attributed to placental pathology. As such, we conclude the ErbB2(M802R) mutant is a model of stillbirth with a non-placental cause of death. The mechanism of the atrial block resulting from ErbB2 mutation and its role in embryonic death is still unclear. Studying this mutant mouse model could identify candidate genes involved in stillbirth associated with structural or functional cardiac defects.	[Shawer, Heba; Clowes, Christopher; Hentges, Kathryn E.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Sch Biol Sci,Div Evolut & Genom Sci, Manchester, Lancs, England; [Aiyelaagbe, Esther; Lean, Samantha C.; Kerby, Alan; Dilworth, Mark R.; Heazell, Alexander E. P.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Div Dev Biol & Med,Sch Med Sci, Manchester, Lancs, England; [Lu, Yinhui; Kadler, Karl E.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Wellcome Trust Ctr Cell Matrix Res,Div Cell Matri, Manchester, Lancs, England; [Heazell, Alexander E. P.] Manchester Univ NHS Fdn Trust, St Marys Hosp, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Clowes, Christopher] Univ Hosp North Midlands NHS Trust, Royal Stoke Univ Hosp, Res & Dev Dept, Stoke On Trent, Staffs, England	University of Manchester; University of Manchester; University of Manchester; University of Manchester; Royal Stoke University Hospital	Heazell, AEP (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Div Dev Biol & Med,Sch Med Sci, Manchester, Lancs, England.; Heazell, AEP (corresponding author), Manchester Univ NHS Fdn Trust, St Marys Hosp, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England.	alexander.heazell@manchester.ac.uk	KADLER, KARL/ABI-2403-2020	KADLER, KARL/0000-0003-4977-4683; Heazell, Alexander/0000-0002-4303-7845; Kerby, Alan/0000-0002-2358-1966; Hentges, Kathryn/0000-0001-8917-3765; Shawer, Heba/0000-0003-1813-427X	Holly Martin Stillbirth Research Fund; British Heart Foundation [PG/08/007/24400]; Tommy's - the baby charity; National Institute for Health Research (NIHR) Clinician Scientist Fellowship [CS-2013-0009]; Wellcome Trust [203128/Z/16/Z, 110126/Z/15/Z]	Holly Martin Stillbirth Research Fund; British Heart Foundation(British Heart Foundation); Tommy's - the baby charity; National Institute for Health Research (NIHR) Clinician Scientist Fellowship(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)	This study was funded by a donation from Dr Grace Jorgensen and the Holly Martin Stillbirth Research Fund to AEPH, and by British Heart Foundation Project Grant PG/08/007/24400 to KEH. Prof Alexander Heazell is supported by funding from Tommy's - the baby charity and the National Institute for Health Research (NIHR) Clinician Scientist Fellowship CS-2013-0009. The electron microscopy in KEK's laboratory was funded by the Wellcome Trust (203128/Z/16/Z and 110126/Z/15/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of NIHR, NHS or the Department of Health.	ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955; Andescavage N, 2015, PLACENTA, V36, P1024, DOI 10.1016/j.placenta.2015.06.013; [Anonymous], 2017, EUR GERIATR MED, V8, pS98; [Anonymous], 2007, DIASPORA, V16, P416; Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Blencowe H, 2016, LANCET GLOB HEALTH, V4, pE98, DOI 10.1016/S2214-109X(15)00275-2; Brero A, 2010, CARDIOVASC RES, V88, P443, DOI 10.1093/cvr/cvq238; Canty EG, 2004, J CELL BIOL, V165, P553, DOI 10.1083/jcb.200312071; Chan R, 2002, MOL CELL BIOL, V22, P1073, DOI 10.1128/MCB.22.4.1073-1078.2002; Crotti L, 2013, JAMA-J AM MED ASSOC, V309, P1473, DOI 10.1001/jama.2013.3219; de Moraes LV, 2016, INFECT IMMUN, V84, P1761, DOI 10.1128/IAI.01207-15; Desjardins P., 2010, J VIS EXP, V45, P2565; Dolk H, 2011, CIRCULATION, V123, P841, DOI 10.1161/CIRCULATIONAHA.110.958405; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Froen JF, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-22; Gardosi J, 2005, BMJ-BRIT MED J, V331, P1113, DOI 10.1136/bmj.38629.587639.7C; Gilboa SM, 2010, CIRCULATION, V122, P2254, DOI 10.1161/CIRCULATIONAHA.110.947002; Govindaraj S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171089; Guo WN, 2002, CIRC RES, V90, P586, DOI 10.1161/01.RES.0000012664.05949.E0; Hardy J, 2012, PEDIATR RES, V71, P539, DOI 10.1038/pr.2012.2; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Holmgren D, 2003, EUR HEART J, V24, P280, DOI 10.1016/S0195-668X(02)00387-1; Hugel B, 2005, PHYSIOLOGY, V20, P22, DOI 10.1152/physiol.00029.2004; Ishikawa S, 2013, FETAL DIAGN THER, V33, P1, DOI 10.1159/000339150; Jones HN, 2015, PLACENTA, V36, P1078, DOI 10.1016/j.placenta.2015.08.003; Jorgensen M, 2014, AM J MED GENET A, V164, P691, DOI 10.1002/ajmg.a.36366; Kile BT, 2003, NATURE, V425, P81, DOI 10.1038/nature01865; Koenig MK, 2008, PEDIATR NEUROL, V38, P305, DOI 10.1016/j.pediatrneurol.2007.12.001; Lai D, 2010, CIRC RES, V107, P715, DOI 10.1161/CIRCRESAHA.110.218693; Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5; Lean SC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09814-w; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Leisher SH, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1071-0; Linask KK, 2013, J PREGNANCY, V2013, DOI 10.1155/2013/320413; Linask KK, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00390; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Majamaa-Voltti Kirsi, 2002, BMC Cardiovasc Disord, V2, P12; Matthiesen NB, 2016, CIRCULATION, V134, P1546, DOI 10.1161/CIRCULATIONAHA.116.021793; Miller TE, 2004, CIRCULATION, V109, P3029, DOI 10.1161/01.CIR.0000130666.81539.9E; Mu J, 2003, BIOL REPROD, V68, P1968, DOI 10.1095/biolreprod.102.008029; Nerbonne JM, 2004, TRENDS CARDIOVAS MED, V14, P83, DOI 10.1016/j.tcm.2003.12.006; Perez-Garcia V, 2018, NATURE, V555, P463, DOI 10.1038/nature26002; Ptacek I, 2014, PLACENTA, V35, P552, DOI 10.1016/j.placenta.2014.05.011; Ptacek I, 2016, BMC CLIN PATHOL, V16, DOI 10.1186/s12907-016-0023-y; Rahman A, 2017, AM J OBSTET GYNECOL, V217, DOI 10.1016/j.ajog.2017.06.009; Rentschler S, 2002, P NATL ACAD SCI USA, V99, P10464, DOI 10.1073/pnas.162301699; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Samsioe A, 2008, BIRTH DEFECTS RES B, V83, P507, DOI 10.1002/bdrb.20169; Schwartz PJ, 2004, CIRCULATION, V109, P2930, DOI 10.1161/01.CIR.0000133180.77213.43; Schwartz PJ, 2001, LANCET, V358, P1342, DOI 10.1016/S0140-6736(01)06450-9; Schwartz PJ, 1998, NEW ENGL J MED, V338, P1709, DOI 10.1056/NEJM199806113382401; Tenin G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107041; Thornburg KL, 2010, PLACENTA, V31, pS54, DOI 10.1016/j.placenta.2010.01.002; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Varli IH, 2008, ACTA OBSTET GYN SCAN, V87, P1202, DOI 10.1080/00016340802460271; Xu HD, 1999, J GEN PHYSIOL, V113, P661, DOI 10.1085/jgp.113.5.661; Yang QH, 2006, BIRTH DEFECTS RES A, V76, P706, DOI 10.1002/bdra.20308	58	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2020	15	6							e0233007	10.1371/journal.pone.0233007	http://dx.doi.org/10.1371/journal.pone.0233007			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LW6ZP	32492036	gold, Green Published			2022-12-26	WOS:000539293000035
J	Hata, T; Furusawa-Horie, T; Arai, Y; Takahashi, T; Seishima, M; Ichihara, K				Hata, Taketoshi; Furusawa-Horie, Takako; Arai, Yasuko; Takahashi, Tomoko; Seishima, Mariko; Ichihara, Kenji			Studies of royal jelly and associated cross-reactive allergens in atopic dermatitis patients	PLOS ONE			English	Article							HONEY-BEE; ANAPHYLAXIS; ASTHMA; VENOM; TROPOMYOSIN; INGESTION; PROTEINS; BLIND	Royal jelly (RJ), a creamy substance secreted by honeybees, is the exclusive diet for queen bee differentiation and life maintenance. RJ has been used in cosmetics, beverages, medicines, and supplements worldwide. However, allergy is a concerning issue for RJ, especially in atopic dermatitis (AD) and asthma patients. In some cases, allergic reactions are seen after the first intake of RJ, suggesting the existence of allergens cross-reactive with RJ. Information about the cross-reactive allergens is very important for the safe application of RJ; however, study of this cross-reactivity is quite limited. In this study, we attempted to identify allergens cross-reactive with RJ by using serum samples from 30 AD patients who had never been exposed to RJ. In an enzyme-linked immunosorbent assay (ELISA) experiment, RJ-binding IgE antibodies were detected in the serum of 10 out of 30 patients, and their antibody titers ranged from 4- to 2,048-fold dilution ratios. Additionally, 3 AD patients were determined to be positive in a skin-prick test (SPT) with an RJ solution. Significant correlations were observed between the anti-RJ antibody titer and nonspecific IgE and between the anti-RJ antibody titer and the Eczema Area and Severity Index score. We further examined the cross-reactivity between RJ and 14 typical allergens by using an ELISA-inhibition assay and demonstrated that the following 6 allergens showed cross-reactivity with RJ: the European house dust mite (HDM) (Dermatophagoides pteronyssinus), American HDM (Dermatophagoides farinae), snow crab (Chionocetes spp.), edible crab (Cancer pagurus), German cockroach (Blatella germanica), and honeybee venom (Apis mellifera). In conclusion, people with a history of allergic diseases, including AD, asthma, and allergic rhinitis, should be cautioned against consuming RJ products because of the potential for cross-reactive responses to ensure the safe and successful use of RJ supplements.	[Hata, Taketoshi; Furusawa-Horie, Takako; Arai, Yasuko; Ichihara, Kenji] API Co Ltd, Nagaragawa Res Ctr, Gifu, Japan; [Hata, Taketoshi; Takahashi, Tomoko; Seishima, Mariko] Gifu Univ, Dept Dermatol, Grad Sch Med, Gifu, Japan	Gifu University	Hata, T (corresponding author), API Co Ltd, Nagaragawa Res Ctr, Gifu, Japan.; Hata, T (corresponding author), Gifu Univ, Dept Dermatol, Grad Sch Med, Gifu, Japan.	hata-taketoshi@api3838.co.jp			"Initiative for the implementation of the diversity research environment (Collaboration Type)" of the Ministry of Education, Culture, Sports, Science, and Technology	"Initiative for the implementation of the diversity research environment (Collaboration Type)" of the Ministry of Education, Culture, Sports, Science, and Technology	This research was financially supported by "Initiative for the implementation of the diversity research environment (Collaboration Type)" of the Ministry of Education, Culture, Sports, Science, and Technology to FHT, YA, TH, TT, MS, and KI(http://www.jst.go.jp/shincho/josei_shien/).The funder provided support in the form of purchasing equipment for authors FHT, YA, TH, TT, MS, and KI, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	[Anonymous], 2016, 12824 ISO; Blank S, 2012, CLIN EXP ALLERGY, V42, P976, DOI 10.1111/j.1365-2222.2012.03966.x; BULLOCK RJ, 1994, MED J AUSTRALIA, V160, P44, DOI 10.5694/j.1326-5377.1994.tb138207.x; BUTLER CG, 1966, NATURE, V212, P530, DOI 10.1038/212530a0; Buttstedt A, 2014, BIOL REV, V89, P255, DOI 10.1111/brv.12052; Celakovska J, 2017, FOOD AGR IMMUNOL, V28, P933, DOI 10.1080/09540105.2017.1320358; CHAPMAN MD, 1983, J ALLERGY CLIN IMMUN, V72, P27, DOI 10.1016/0091-6749(83)90048-9; Furusawa T, 2008, J PROTEOME RES, V7, P3194, DOI 10.1021/pr800061j; Harada Susumu, 2011, Arerugi, V60, P708; Harwood M, 1996, NEW ZEAL MED J, V109, P325; Hashimoto T, 2011, HIFUBYOU SHINRYOU, V33, P511; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; Kariya N, 2005, NIHON HIFU ARERUGI G, V13, P144; Katayama M, 2008, J DERMATOL, V35, P222, DOI 10.1111/j.1346-8138.2008.00448.x; Laporte JR, 1996, ALLERGY, V51, P440, DOI 10.1111/j.1398-9995.1996.tb00157.x; Leung R, 1995, J ALLERGY CLIN IMMUN, V96, P1004, DOI 10.1016/S0091-6749(95)70242-3; Leung R., 1997, Hong Kong Medical Journal, V3, P211; Li LS, 2016, CHINESE MED J-PEKING, V129, P2888, DOI 10.4103/0366-6999.194650; Lombardi C, 1998, Allergol Immunopathol (Madr), V26, P288; Mizutani Y, 2011, J DERMATOL, V38, P1079, DOI 10.1111/j.1346-8138.2010.01179.x; Morita H, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-77; Nakashima C, 2018, EUR J DERMATOL, V28, P563, DOI 10.1684/ejd.2018.3352; Page RE, 2001, EXP GERONTOL, V36, P695, DOI 10.1016/S0531-5565(00)00236-9; Paola F, 2014, CASE REP MED, V2014, DOI 10.1155/2014/941248; PEACOCK S, 1995, BRIT MED J, V311, P1472; Peiren N, 2005, BBA-PROTEINS PROTEOM, V1752, P1, DOI 10.1016/j.bbapap.2005.07.017; Peiren N, 2008, TOXICON, V52, P72, DOI 10.1016/j.toxicon.2008.05.003; Reese G, 1999, INT ARCH ALLERGY IMM, V119, P247, DOI 10.1159/000024201; Ribbands CR, 1953, BEHAV SOCIAL LIFE HO, P247; Rosmilah M, 2008, TROP BIOMED, V25, P243; Rueff F, 2011, Pneumologie, V65, P484, DOI 10.1055/s-0030-1256476; Shintani H, 1998, ARERUGI, V47, P292; Sidenius KE, 2001, ALLERGY, V56, P723, DOI 10.1034/j.1398-9995.2001.056008723.x; Suzuki S, 2011, SHOUWA IGAKU GAKKAI, V71, P416; Taavoni S, 2014, COMPLEMENT THER MED, V22, P601, DOI 10.1016/j.ctim.2014.05.004; Takahama H, 2006, J DERMATOL, V33, P424, DOI 10.1111/j.1346-8138.2006.00100.x; Takahashi T, 2008, JPN J DERMATOL, V118, P43; Testi S, 2007, J INVEST ALLERG CLIN, V17, P281; THIEN FCK, 1993, MED J AUSTRALIA, V159, P639, DOI 10.5694/j.1326-5377.1993.tb138070.x; Thien FCK, 1996, CLIN EXP ALLERGY, V26, P216, DOI 10.1111/j.1365-2222.1996.tb00082.x; Vila L, 2013, J ALLER CL IMM-PRACT, V1, P200, DOI 10.1016/j.jaip.2013.01.003; WHEELER DE, 1986, AM NAT, V128, P13, DOI 10.1086/284536; WITTEMAN AM, 1994, INT ARCH ALLERGY IMM, V105, P56, DOI 10.1159/000236803; Zhang L, 2012, J PROTEOMICS, V75, P5327, DOI 10.1016/j.jprot.2012.06.008	44	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2020	15	6							e0233707	10.1371/journal.pone.0233707	http://dx.doi.org/10.1371/journal.pone.0233707			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MT4VF	32484810	Green Published, gold			2022-12-26	WOS:000554969700014
J	Yeo, IC; Devarenne, TP				Yeo, In-Cheol; Devarenne, Timothy P.			Screening for potential nuclear substrates for the plant cell death suppressor kinase Adi3 using peptide microarrays	PLOS ONE			English	Article							RNA-POLYMERASE-II; DISEASE-RESISTANCE; ELONGATION-FACTORS; PROTEIN-KINASES; TOMATO; GENE; AKT; ACTIVATION; SURVIVAL; SUBUNIT	The tomato AGC protein kinase Adi3 is a Ser/Thr kinase that functions as a negative regulator of programmed cell death through cell death suppression (CDS) activity in the nucleus. In this study, to understand the mechanism of Adi3 CDS, peptide microarrays containing random Ser- and Thr-peptide phosphorylation substrates were used to screen for downstream phosphorylation substrates. In the microarray phosphorylation assay, Adi3 showed promiscuous kinase activity more toward Ser-peptides compared to Thr-peptides, and a preference for aromatic and cyclic amino acids on both Ser- and Thr-peptides was seen. The 63 highest phosphorylated peptide sequences from the Ser-peptide microarray were selected as queries for a BLAST search against the tomato proteome. As a result, 294 candidate nuclear Adi3 substrates were selected and categorized based on their functions. Many of these proteins were classified as DNA/RNA polymerases or regulators involved in transcription and translation events. The list of potential Adi3 substrates was narrowed to eleven and four candidates were tested for phosphorylation by Adi3. Two of these candidates, RNA polymerase II 2nd largest subunit (RPB2) and the pathogen defense related transcription factor Pti5, were confirmed as Adi3 phosphorylation substrates by in vitro kinase assays. Using a mutational approach two residues, Thr675 and Thr676, were identified as Adi3 phosphorylation sites on RPB2. This study provides the foundation for understanding Adi3 CDS mechanisms in the nucleus as well as other cellular functions.	[Yeo, In-Cheol; Devarenne, Timothy P.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Devarenne, TP (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	tpd8@tamu.edu			United States Department of Agriculture-National Institute of Food and Agriculture-Agriculture and Food Research Initiative grant [2014-67013-21560]; National Science Foundation-Molecular and Cellular Biology-Systems and Synthetic Biology grant [1244068]	United States Department of Agriculture-National Institute of Food and Agriculture-Agriculture and Food Research Initiative grant; National Science Foundation-Molecular and Cellular Biology-Systems and Synthetic Biology grant	This work was supported by the United States Department of Agriculture-National Institute of Food and Agriculture-Agriculture and Food Research Initiative grant #2014-67013-21560 and National Science Foundation-Molecular and Cellular Biology-Systems and Synthetic Biology grant #1244068 to TPD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antosz W, 2017, PLANT CELL, V29, P854, DOI 10.1105/tpc.16.00735; Avila J, 2013, BIOCHEM BIOPH RES CO, V430, P119, DOI 10.1016/j.bbrc.2012.11.043; Avila J, 2012, PLANT PHYSIOL, V159, P1277, DOI 10.1104/pp.112.198432; Bago R, 2016, EMBO J, V35, P2263, DOI 10.15252/embj.201670010; Blanvillain R, 2011, EMBO J, V30, P3812, DOI 10.1038/emboj.2011.270; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Buratowski S, 2005, CURR OPIN CELL BIOL, V17, P257, DOI 10.1016/j.ceb.2005.04.003; Chen L, 2016, DEVELOPMENT, V143, P1600, DOI 10.1242/dev.129098; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cui YJ, 2003, MOL CELL BIOL, V23, P7887, DOI 10.1128/MCB.23.21.7887-7901.2003; Devarenne TP, 2011, BIOCHEM BIOPH RES CO, V412, P699, DOI 10.1016/j.bbrc.2011.08.031; Devarenne TP, 2007, PLANT SIGNAL BEHAV, V2, P188, DOI 10.4161/psb.2.3.4150; Devarenne TP, 2006, EMBO J, V25, P255, DOI 10.1038/sj.emboj.7600910; Dittrich ACN, 2012, BBA-PROTEINS PROTEOM, V1824, P269, DOI 10.1016/j.bbapap.2011.10.004; Dominy Clifford N, 2003, Methods Mol Biol, V235, P209; Ek-Ramos MJ, 2010, J BIOL CHEM, V285, P17584, DOI 10.1074/jbc.M110.117416; Ek-Ramos MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110807; Frederick RD, 1998, MOL CELL, V2, P241, DOI 10.1016/S1097-2765(00)80134-3; Friant S, 2001, EMBO J, V20, P6783, DOI 10.1093/emboj/20.23.6783; Gray JW, 2013, BBA-PROTEINS PROTEOM, V1834, P1099, DOI 10.1016/j.bbapap.2013.03.006; Greenberg JT, 1997, ANNU REV PLANT PHYS, V48, P525, DOI 10.1146/annurev.arplant.48.1.525; Gu YQ, 2002, PLANT CELL, V14, P817, DOI 10.1105/tpc.000794; Hajheidari M, 2013, TRENDS PLANT SCI, V18, P633, DOI 10.1016/j.tplants.2013.07.001; Halford NG, 2009, BIOCHEM J, V419, P247, DOI 10.1042/BJ20082408; Hawley SA, 2014, BIOCHEM J, V459, P275, DOI 10.1042/BJ20131344; He LL, 2016, PLANT PHYSIOL, V171, P1675, DOI 10.1104/pp.16.00220; He P, 2001, MOL PLANT MICROBE IN, V14, P1453, DOI 10.1094/MPMI.2001.14.12.1453; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Hochman A, 1997, CRIT REV MICROBIOL, V23, P207, DOI 10.3109/10408419709115136; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Jeronimo C, 2016, J MOL BIOL, V428, P2607, DOI 10.1016/j.jmb.2016.02.006; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kaplan CD, 2005, J BIOL CHEM, V280, P913, DOI 10.1074/jbc.M411108200; KOLODZIEJ PA, 1990, MOL CELL BIOL, V10, P1915, DOI 10.1128/MCB.10.5.1915; Kozma SC, 2002, BIOESSAYS, V24, P65, DOI 10.1002/bies.10031; Kubicek CE, 2013, G3-GENES GENOM GENET, V3, P167, DOI 10.1534/g3.112.004531; Lam E, 2004, NAT REV MOL CELL BIO, V5, P305, DOI 10.1038/nrm1358; Langelier MF, 2005, NUCLEIC ACIDS RES, V33, P2629, DOI 10.1093/nar/gki570; Liu GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055185; LOH YT, 1995, PLANT PHYSIOL, V108, P1735, DOI 10.1104/pp.108.4.1735; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Morel C, 2009, MOL CELL BIOL, V29, P3845, DOI 10.1128/MCB.00279-09; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Palangat M, 2011, MOL CELL BIOL, V31, P3312, DOI 10.1128/MCB.05318-11; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Reape TJ, 2008, NEW PHYTOL, V180, P13, DOI 10.1111/j.1469-8137.2008.02549.x; SALMERON JM, 1993, MOL GEN GENET, V239, P6, DOI 10.1007/BF00281595; Salmeron JM, 1996, CELL, V86, P123, DOI 10.1016/S0092-8674(00)80083-5; Smolka B, 2003, APPL KERNEL DENSITY; STAAL SP, 1987, P NATL ACAD SCI USA, V84, P5034, DOI 10.1073/pnas.84.14.5034; Sun JQ, 2007, PLANT CELL PHYSIOL, V48, P1148, DOI 10.1093/pcp/pcm088; Thara VK, 1999, PLANT J, V20, P475, DOI 10.1046/j.1365-313x.1999.00619.x; Trinh V, 2006, MICROBIOL MOL BIOL R, V70, P12, DOI 10.1128/MMBR.70.1.12-36.2006; Uppala JK, 2018, FEBS LETT, V592, P3116, DOI 10.1002/1873-3468.13214; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; YOUNG RA, 1991, ANNU REV BIOCHEM, V60, P689, DOI 10.1146/annurev.biochem.60.1.689; Yudushkin I, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9020067; ZHANG SH, 1994, J BIOL CHEM, V269, P17586; Zhou JM, 1997, EMBO J, V16, P3207, DOI 10.1093/emboj/16.11.3207	61	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2020	15	6							e0234011	10.1371/journal.pone.0234011	http://dx.doi.org/10.1371/journal.pone.0234011			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MT4VF	32484825	Green Published, gold			2022-12-26	WOS:000554969700027
J	Lyu, IJ; Han, JC; Oh, SY				Lyu, In Jeong; Han, Jong Chul; Oh, Sei Yeul			Long-term results of augmented unilateral lateral rectus muscle recession for dissociated horizontal deviation	PLOS ONE			English	Article							OUTCOMES	We report the long-term surgical results of augmented lateral rectus muscle (LR) recession for dissociated horizontal deviation (DHD) without concomitant exotropia (XT) or esotropia (ET). This retrospective review included patients with DHD without XT or ET who underwent augmented LR recession and were followed-up for >= 12 months. Each patient's medical records were evaluated to identify their demographics, preoperative angle of deviation, surgical procedure, success rate, and reoperation rate. A total of 11 patients with DHD were included (median patient age at surgery, 6 years; interquartile range [IQR], 5 to 10 years). Four patients (36.4%) had a history of infantile ET while three patients (27.3%) had a history of unilateral cataract surgery for congenital cataract. The median preoperative angle of DHD in the unilateral eye was 20 prism diopters (PD) (IQR, 15 to 25 PD). The median amount of LR recession was 8.0 mm (IQR, 7.5 to 8.0 mm). Three patients (27.3%) underwent simultaneous surgery for dissociated vertical deviation. At the final examination after a median follow-up period of 32 months (IQR, 24 to 58 months), 10 patients (91%) showed successful alignment. The long-term successful alignment rate after augmented LR recession for DHD was good; thus, application of this technique is appropriate in patients with DHD.	[Lyu, In Jeong] Korea Inst Radiol & Med Sci, Korea Canc Ctr Hosp, Dept Ophthalmol, Seoul, South Korea; [Lyu, In Jeong; Han, Jong Chul; Oh, Sei Yeul] Sungkyunkwan Univ, Samsung Med Ctr, Dept Ophthalmol, Sch Med, Seoul, South Korea	Korea Institute of Radiological & Medical Sciences; National Cancer Center - Korea (NCC); Sungkyunkwan University (SKKU); Samsung Medical Center	Oh, SY (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Dept Ophthalmol, Sch Med, Seoul, South Korea.	syoh@skku.edu			Korea Institute of Radiological and Medical Sciences (KIRAMS) - Ministry of Science and ICT (MSIT), Republic of Korea [50543-2020]	Korea Institute of Radiological and Medical Sciences (KIRAMS) - Ministry of Science and ICT (MSIT), Republic of Korea	Receiver: IJL. Grant number: This work was supported by the Korea Institute of Radiological and Medical Sciences (KIRAMS), funded by the Ministry of Science and ICT (MSIT), Republic of Korea (No. 50543-2020). The funder had no role in the design or conduct of this research.	Biglan AW, 1996, J PEDIATR OPHTHALMOL, V33, P79; Brodsky MC, 2005, ARCH OPHTHALMOL-CHIC, V123, P1083, DOI 10.1001/archopht.123.8.1083; Brodsky MC, 2007, ARCH OPHTHALMOL-CHIC, V125, P1683, DOI 10.1001/archopht.125.12.1683; Christoff A, 2014, J AAPOS, V18, P378, DOI 10.1016/j.jaapos.2014.03.009; David TW, 1996, BINOC VISION STRABIS, V11, P258; Helveston E M, 1980, Trans Am Ophthalmol Soc, V78, P734; Lyu IJ, 2016, BRIT J OPHTHALMOL, V100, P1433, DOI 10.1136/bjophthalmol-2015-307970; Romero-Apis D, 1992, BINOCUL VIS STRABISM, V7, P173; Von Noorden G K, 1972, Trans Am Acad Ophthalmol Otolaryngol, V76, P1465; Wilson M E, 1991, J Pediatr Ophthalmol Strabismus, V28, P90; Wilson ME, 2000, J AAPOS, V4, P94, DOI 10.1067/mpa.2000.103437; Zubcov A A, 1990, J Pediatr Ophthalmol Strabismus, V27, P59; Zubcov AA, 1990, J PEDIATR OPHTHALMOL, V27, P5; 2010, ESSENT OPHTHALMOL, P1	14	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0234017	10.1371/journal.pone.0234017	http://dx.doi.org/10.1371/journal.pone.0234017			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MJ2AA	32479558	Green Published, gold			2022-12-26	WOS:000547893500048
J	Stark, JE; Opoka, AM; Fei, L; Zang, HY; Davies, SM; Wong, HR; Alder, MN				Stark, Julie E.; Opoka, Amy M.; Fei, Lin; Zang, Huaiyu; Davies, Stella M.; Wong, Hector R.; Alder, Matthew N.			Longitudinal characterization of olfactomedin-4 expressing neutrophils in pediatric patients undergoing bone marrow transplantation	PLOS ONE			English	Article							SEPTIC SHOCK; CHILDREN; SEPSIS; MARKER	Sepsis is an important cause of morbidity and mortality in pediatric patients. Increased expression of olfactomedin-4 (OLFM4), a glycoprotein contained within a subpopulation of neutrophils, has been associated with complicated course in sepsis. The factors that regulate OLFM4 expression are unknown. Here, we followed children undergoing bone marrow transplantation (BMT) to document the percentage of neutrophils that express OLFM4 over time. This population was selected because of the ability to observe nascent neutrophils following engraftment, perform frequent blood sampling, and the children are at high risk for clinical complications that may associate with changes in percentage of OLFM4+ neutrophils. We found a surprising degree of variability of OLFM4 expression between patients. In the weeks following initial neutrophil recovery we also saw great variability in OLFM4 expression within individual patients, indicating that multiple external factors may modify OLFM4 expression. We identified decreased expression of CD64 (a marker associated with response to infection), in OLFM4+ neutrophils. This is the first study to demonstrate fluctuation in OLFM4 expression within patients and provides insight into possible mechanisms for OLFM4 regulation in nascent neutrophils.	[Stark, Julie E.; Opoka, Amy M.; Wong, Hector R.; Alder, Matthew N.] Univ Cincinnati, Coll Med, Dept Pediat, Div Crit Care Med,Cincinnati Childrens Hosp Med C, Cincinnati, OH 45267 USA; [Fei, Lin; Zang, Huaiyu] Univ Cincinnati, Dept Biostat & Epidemiol, Cincinnati, OH USA; [Davies, Stella M.] Cincinnati Childrens Hosp Med Ctr, Div Bone Marrow Transplant & Immune Deficiency, Canc & Blood Dis Inst, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Alder, MN (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, Div Crit Care Med,Cincinnati Childrens Hosp Med C, Cincinnati, OH 45267 USA.	matthew.alder@cchmc.org	Stark, Julie/GOE-5507-2022; Zang, Huaiyu/AAY-6603-2021	Alder, Matthew/0000-0003-2879-6576; Opoka, Amy/0000-0003-4759-008X	NIGMS [R35GM126943]	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	MNA was supported by grant K08GM124298 from NIGMS (https://www.nigms.nih.gov/) HRW was supported by grant R35GM126943 from NIGMS (https://www.nigms.nih.gov/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder MN, 2016, CRIT CARE MED; Beyrau M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120134; Brand HK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131927; Clemmensen SN, 2015, J CELL MOL MED, V19, P2865, DOI 10.1111/jcmm.12679; Clemmensen SN, 2012, J LEUKOCYTE BIOL, V91, P495, DOI 10.1189/jlb.0811417; Deniset JF, 2018, J LEUKOCYTE BIOL, V103, P829, DOI 10.1002/JLB.3RI0917-361R; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Fitzgerald JC, 2016, PEDIATR CRIT CARE ME, V17, P1073, DOI 10.1097/PCC.0000000000000942; Hoffmeyer F, 1997, IMMUNOLOGY, V92, P544, DOI 10.1046/j.1365-2567.1997.00381.x; Kangelaris KN, 2015, AM J PHYSIOL-LUNG C, V308, pL1102, DOI 10.1152/ajplung.00380.2014; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Matics TJ, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2017.2352; Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921; Rudensky B, 2008, PEDIATR EMERG CARE, V24, P745, DOI 10.1097/PEC.0b013e31818c2679; Schlapbach LJ, 2015, LANCET INFECT DIS, V15, P46, DOI 10.1016/S1473-3099(14)71003-5; Stark JE, 2020, AM J PHYSIOL-RENAL, V318, pF809, DOI 10.1152/ajprenal.00443.2019; Welin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069575; Wong HR, 2007, PHYSIOL GENOMICS, V30, P146, DOI 10.1152/physiolgenomics.00024.2007; Wong HR, 2014, AM J RESP CRIT CARE, V189, P940, DOI 10.1164/rccm.201401-0171OC; Yu L, 2011, NEOPLASMA, V58, P9, DOI 10.4149/neo_2011_01_9	20	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2020	15	5							e0233738	10.1371/journal.pone.0233738	http://dx.doi.org/10.1371/journal.pone.0233738			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1WS	32470072	gold, Green Published			2022-12-26	WOS:000537552800160
J	Peshenko, IV; Dizhoor, AM				Peshenko, Igor V.; Dizhoor, Alexander M.			Two clusters of surface-exposed amino acid residues enable high-affinity binding of retinal degeneration-3 (RD3) protein to retinal guanylyl cyclase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						guanylate cyclase (guanylyl cyclase); retinal degeneration; cyclic GMP (cGMP); signal transduction; photoreceptor; calcium-binding protein; retina; phototransduction; GCAP; RD3; RetGC	1 RETGC1; ACTIVATING PROTEIN-2; CRYSTAL-STRUCTURE; CALCIUM; GCAPS; SENSITIVITY; CLONING; IDENTIFICATION; LOCALIZATION; TRAFFICKING	Retinal degeneration-3 (RD3) protein protects photoreceptors from degeneration by preventing retinal guanylyl cyclase (RetGC) activation via calcium-sensing guanylyl cyclase-activating proteins (GCAP), and RD3 truncation causes severe congenital blindness in humans and other animals. The three-dimensional structure of RD3 has recently been established, but the molecular mechanisms of its inhibitory binding to RetGC remain unclear. Here, we report the results of probing 133 surface-exposed residues in RD3 by single substitutions and deletions to identify side chains that are critical for the inhibitory binding of RD3 to RetGC. We tested the effects of these substitutions and deletionsin vitroby reconstituting purified RD3 variants with GCAP1-activated human RetGC1. Although the vast majority of the surface-exposed residues tolerated substitutions without loss of RD3's inhibitory activity, substitutions in two distinct narrow clusters located on the opposite sides of the molecule effectively suppressed RD3 binding to the cyclase. The first surface-exposed cluster included residues adjacent to Leu(63)in the loop connecting helices 1 and 2. The second cluster surrounded Arg(101)on a surface of helix 3. Single substitutions in those two clusters drastically,i.e.up to 245-fold, reduced the IC(50)for the cyclase inhibition. Inactivation of the two binding sites completely disabled binding of RD3 to RetGC1 in living HEK293 cells. In contrast, deletion of 49 C-terminal residues did not affect the apparent affinity of RD3 for RetGC. Our findings identify the functional interface on RD3 required for its inhibitory binding to RetGC, a process essential for protecting photoreceptors from degeneration.	[Peshenko, Igor V.; Dizhoor, Alexander M.] Salus Univ, Penn Coll Optometry, Elkins Pk, PA 19027 USA		Dizhoor, AM (corresponding author), Salus Univ, Penn Coll Optometry, Elkins Pk, PA 19027 USA.	adizhoor@salus.edu			NEI, National Institutes of Health [EY011522]; Pennsylvania Department of Health CURE formula grant; Salus University Research Fund	NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Pennsylvania Department of Health CURE formula grant; Salus University Research Fund	This work was supported by NEI, National Institutes of Health Grant EY011522 (to A. M. D.), by Pennsylvania Department of Health CURE formula grant (to A. M. D.), and Salus University Research Fund (to I. V. P.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ames JB, 1999, J BIOL CHEM, V274, P19329, DOI 10.1074/jbc.274.27.19329; Azadi S, 2010, P NATL ACAD SCI USA, V107, P21158, DOI 10.1073/pnas.1010460107; Dizhoor AM, 2019, J BIOL CHEM, V294, P13729, DOI 10.1074/jbc.RA119.009948; Dizhoor AM, 2016, J BIOL CHEM, V291, P24504, DOI 10.1074/jbc.M116.755553; Dizhoor AM, 2010, MOL CELL BIOCHEM, V334, P117, DOI 10.1007/s11010-009-0328-6; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Ermilov AN, 2001, J BIOL CHEM, V276, P48143, DOI 10.1074/jbc.M107539200; Friedman JS, 2006, AM J HUM GENET, V79, P1059, DOI 10.1086/510021; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; Horton R. M., 1991, DIRECTED MUTAGENESIS, P217; Imanishi Y, 2004, J MOL EVOL, V59, P204, DOI 10.1007/s00239-004-2614-y; Koch KW, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00067; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; KOCH KW, 1991, J BIOL CHEM, V266, P8634; Kukekova AV, 2009, MAMM GENOME, V20, P109, DOI 10.1007/s00335-008-9163-4; Liu Y, 1997, P NATL ACAD SCI USA, V94, P13414, DOI 10.1073/pnas.94.25.13414; LOWE DG, 1995, P NATL ACAD SCI USA, V92, P5535, DOI 10.1073/pnas.92.12.5535; Makino CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047637; Martinez-Velazquez LA, 2018, P NATL ACAD SCI USA, V115, pE438, DOI 10.1073/pnas.1712302115; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; Molday LL, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00044; Molday LL, 2013, HUM MOL GENET, V22, P3894, DOI 10.1093/hmg/ddt244; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Perrault I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051622; Peshenko IV, 2008, J BIOL CHEM, V283, P21747, DOI 10.1074/jbc.M801899200; Peshenko IV, 2006, J BIOL CHEM, V281, P23830, DOI 10.1074/jbc.M600257200; Peshenko IV, 2019, J BIOL CHEM, V294, P3476, DOI 10.1074/jbc.RA118.006180; Peshenko IV, 2019, J BIOL CHEM, V294, P2318, DOI 10.1074/jbc.RA118.006106; Peshenko IV, 2016, J BIOL CHEM, V291, P19713, DOI 10.1074/jbc.M116.742288; Peshenko IV, 2015, J BIOL CHEM, V290, P19584, DOI 10.1074/jbc.M115.661371; Peshenko IV, 2015, J BIOL CHEM, V290, P6913, DOI 10.1074/jbc.M114.629642; Peshenko IV, 2014, J BIOL CHEM, V289, P10140, DOI 10.1074/jbc.M113.540716; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P9511, DOI 10.1021/bi201342b; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P5590, DOI 10.1021/bi200491b; Peshenko IV, 2004, BIOCHEMISTRY-US, V43, P13796, DOI 10.1021/bi048943m; Peshenko IV, 2004, J BIOL CHEM, V279, P16903, DOI 10.1074/jbc.C400065200; Plana-Bonamaiso A, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2255-0; Preising MN, 2012, INVEST OPHTH VIS SCI, V53, P3463, DOI 10.1167/iovs.12-9519; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; Sakurai K, 2011, J NEUROSCI, V31, P7991, DOI 10.1523/JNEUROSCI.6650-10.2011; Stephen R, 2007, STRUCTURE, V15, P1392, DOI 10.1016/j.str.2007.09.013; Stephen R, 2006, J MOL BIOL, V359, P266, DOI 10.1016/j.jmb.2006.03.042; Tucker CL, 1998, P NATL ACAD SCI USA, V95, P5993, DOI 10.1073/pnas.95.11.5993; Wimberg H, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00052; YANG RB, 1995, P NATL ACAD SCI USA, V92, P602, DOI 10.1073/pnas.92.2.602; Zinchuk V., 2011, CURR PROTOC CELL BIO, V52, P419; Zulliger R, 2015, J BIOL CHEM, V290, P3488, DOI 10.1074/jbc.M114.616656	48	3	3	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2020	295	31					10781	10793		10.1074/jbc.RA120.013789	http://dx.doi.org/10.1074/jbc.RA120.013789			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB3HM	32493772	Green Published, hybrid			2022-12-26	WOS:000560405600021
J	Chen, R; Zeng, Z; Zhang, YY; Cao, C; Liu, HM; Li, W; Wu, Y; Xia, ZY; Ma, DQ; Meng, QT				Chen, Rong; Zeng, Zi; Zhang, Yun-yan; Cao, Chen; Liu, Hui-min; Li, Wei; Wu, Yang; Xia, Zhong-yuan; Ma, Daqing; Meng, Qing-tao			Ischemic postconditioning attenuates acute kidney injury following intestinal ischemia-reperfusion through Nrf2-regulated autophagy, anti-oxidation, and anti-inflammation in mice	FASEB JOURNAL			English	Article						acute kidney injury; autophagy; intestinal ischemia-reperfusion; ischemic postconditioning; Nrf2; HO-1 pathway	ACUTE LUNG INJURY; CEREBRAL-ISCHEMIA; CARDIAC-SURGERY; NRF2; PROTECTS; DAMAGE; DEFENSE; CANCER; RATS	Intestinal ischemia-reperfusion (IIR) often occurs during and following major cardiovascular or gut surgery and causes significant organ including kidney injuries. This study was to investigate the protective effect of intestinal ischemic postconditioning (IPo) on IIR-induced acute kidney injury (AKI) and the underling cellular signaling mechanisms with focus on the Nrf2/HO-1. Adult C57BL/6J mice were subjected to IIR with or without IPo. IIR was established by clamping the superior mesenteric artery (SMA) for 45 minutes followed by 120 minutes reperfusion. Outcome measures were: (i) Intestinal and renal histopathology; (ii) Renal function; (iii) Cellular signaling changes; (iv) Oxidative stress and inflammatory responses. IPo significantly attenuated IIR-induced kidney injury. Furthermore, IPo significantly increased both nuclear Nrf2 and HO-1 expression in the kidney, upregulated autophagic flux, inhibited IIR-induced inflammation and reduced oxidative stress. The protective effect of IPo was abolished by the administration of Nrf2 inhibitor (Brusatol) or Nrf2 siRNA. Conversely, a Nrf2 activator t-BHQ has a similar protective effect to that of IPo. Our data indicate that IPo protects the kidney injury induced by IIR, which was likely mediated through the Nrf2/HO-1 cellular signaling activation.	[Chen, Rong; Zeng, Zi; Zhang, Yun-yan; Liu, Hui-min; Li, Wei; Wu, Yang; Xia, Zhong-yuan; Meng, Qing-tao] Wuhan Univ, Dept Anesthesiol, Renmin Hosp, Wuhan 430060, Peoples R China; [Cao, Chen] 3rd Hosp Wuhan, Dept Endocrinol, Wuhan, Peoples R China; [Ma, Daqing] Imperial Coll London, Chelsea & Westminster Hosp, Div Anaesthet Pain Med & Intens Care, Dept Surg & Canc,Fac Med, London, England	Wuhan University; Imperial College London	Meng, QT (corresponding author), Wuhan Univ, Dept Anesthesiol, Renmin Hosp, Wuhan 430060, Peoples R China.	mengqingtao2018@126.com	Ma, Daqing/GLT-2735-2022	Ma, Daqing/0000-0003-1235-0537; xia, zhongyuan/0000-0002-5807-9554	National Natural Science Foundation of China (NSFC) [81671948, 81400698, 81401574]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (NSFC) (grand number 81671948, 81400698, 81401574)	Bell RM, 2014, EUR HEART J, V35, P138, DOI 10.1093/eurheartj/eht478; Chapple SJ, 2012, INT J BIOCHEM CELL B, V44, P1315, DOI 10.1016/j.biocel.2012.04.021; Chen R, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/6954764; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; Decuypere JP, 2015, AM J KIDNEY DIS, V66, P699, DOI 10.1053/j.ajkd.2015.05.021; Diez ER, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20235927; Guo C, 2017, MOL NEUROBIOL, V54, P833, DOI 10.1007/s12035-016-9690-z; He F, 2020, CARCINOGENESIS, V41, P405, DOI 10.1093/carcin/bgaa039; Hess DC, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2015.223; Hobel S, 2010, J GENE MED, V12, P287, DOI 10.1002/jgm.1431; Jeong WS, 2006, ANTIOXID REDOX SIGN, V8, P99, DOI 10.1089/ars.2006.8.99; Jiang Y, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/843721; Kazantzidou D, 2010, MINERVA CHIR, V65, P515; Levy JMM, 2017, NAT REV CANCER, V17, P528, DOI 10.1038/nrc.2017.53; Li N, 2004, J IMMUNOL, V173, P3467, DOI 10.4049/jimmunol.173.5.3467; Li S, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9040354; Liu L, 2013, WORLD J GASTROENTERO, V19, P9439, DOI 10.3748/wjg.v19.i48.9439; Liu TQ, 2015, FREE RADICAL BIO MED, V81, P170, DOI 10.1016/j.freeradbiomed.2014.10.509; Souza JRM, 2008, ARQ BRAS CARDIOL, V90, P94, DOI 10.1590/S0066-782X2008000200004; Meng QT, 2017, INT J MOL MED, V40, P1731, DOI 10.3892/ijmm.2017.3170; Meng QT, 2016, LAB INVEST, V96, P1087, DOI 10.1038/labinvest.2016.87; Myles PS, 2019, BRIT J ANAESTH, V122, P726, DOI 10.1016/j.bja.2019.01.010; Ologunde R, 2014, INT UROL NEPHROL, V46, P2337, DOI 10.1007/s11255-014-0766-2; Pac-Soo CK, 2015, BRIT J ANAESTH, V114, P204, DOI 10.1093/bja/aeu302; Piantadosi CA, 2008, FREE RADICAL BIO MED, V45, P562, DOI 10.1016/j.freeradbiomed.2008.05.013; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Ren DM, 2011, P NATL ACAD SCI USA, V108, P1433, DOI 10.1073/pnas.1014275108; Shih AY, 2005, J NEUROSCI, V25, P10321, DOI 10.1523/JNEUROSCI.4014-05.2005; Shokeir AA, 2014, ACTA PHYSIOL, V210, P342, DOI 10.1111/apha.12164; Spandou E, 2006, NEPHROL DIAL TRANSPL, V21, P330, DOI 10.1093/ndt/gfi177; Stiermaier T, 2019, CIRC RES, V124, P1482, DOI 10.1161/CIRCRESAHA.118.314500; Tan KP, 2008, FREE RADICAL BIO MED, V45, P1663, DOI 10.1016/j.freeradbiomed.2008.09.010; Teke Z, 2008, AM J SURG, V195, P861, DOI 10.1016/j.amjsurg.2007.06.025; Vaziri ND, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114881; Venditti P, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21062173; Vollmar B, 2011, LANGENBECK ARCH SURG, V396, P13, DOI 10.1007/s00423-010-0727-x; Xiao LY, 2020, PHYTOMEDICINE, V70, DOI 10.1016/j.phymed.2020.153219; Yun N, 2014, FREE RADICAL BIO MED, V68, P168, DOI 10.1016/j.freeradbiomed.2013.12.014; Yurdakan G, 2012, KAOHSIUNG J MED SCI, V28, P16, DOI 10.1016/j.kjms.2011.06.030; Zarbock A, 2017, ANESTHESIOLOGY, V126, P787, DOI 10.1097/ALN.0000000000001598; Zarbock A, 2015, JAMA-J AM MED ASSOC, V313, P2133, DOI 10.1001/jama.2015.4189; Zhang MH, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/463815; Zhang YX, 2011, ANTIOXID REDOX SIGN, V15, P2867, DOI 10.1089/ars.2010.3685; Zhao HL, 2019, BRIT J ANAESTH, V123, P519, DOI 10.1016/j.bja.2019.05.041; Zhao HL, 2017, AM J PHYSIOL-LUNG C, V312, pL155, DOI 10.1152/ajplung.00449.2016; Zhao HL, 2013, FASEB J, V27, P4076, DOI 10.1096/fj.13-232173; Zhao HP, 2014, STROKE, V45, P2417, DOI 10.1161/STROKEAHA.114.006135; Zhao QF, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/231351; Zhao ZQ, 2010, CARDIOVASC DRUG THER, V24, P265, DOI 10.1007/s10557-010-6240-1; Zhong ZY, 2016, CELL, V166, P288, DOI 10.1016/j.cell.2016.05.051; Zhou B, 2017, CLIN SCI, V131, P1161, DOI 10.1042/CS20170052	51	9	9	2	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					8887	8901		10.1096/fj.202000274R	http://dx.doi.org/10.1096/fj.202000274R		JUN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32519766	Bronze			2022-12-26	WOS:000541521500001
J	Dobbie, F; Uny, I; Eadie, D; Duncan, E; Stead, M; Bauld, L; Angus, K; Hassled, L; MacInnes, L; Clegg, G				Dobbie, Fiona; Uny, Isa; Eadie, Douglas; Duncan, Edward; Stead, Martine; Bauld, Linda; Angus, Kathryn; Hassled, Liz; MacInnes, Lisa; Clegg, Gareth			Barriers to bystander CPR in deprived communities: Findings from a qualitative study	PLOS ONE			English	Article							HOSPITAL CARDIAC-ARREST; SOCIOECONOMIC-STATUS; SURVIVAL RATES; KNOWLEDGE	Study aim Rates of out of hospital cardiac arrest are higher in deprived communities. Bystander Cardiopulmonary Resuscitation (BCPR) can double the chance of survival but occurs less often in these communities in comparison to more affluent communities. People living in deprived communities are, therefore, doubly disadvantaged and there is limited evidence to explain why BCPR rates are lower. The aim of this paper is to examine the barriers to administering BCPR in deprived communities. Method Mixed method qualitative study with ten single sex focus groups (n = 61) conducted in deprived communities across central Scotland and 18 semi-structured interviews with stakeholders from the UK, Europe and the USA. Results Two key themes related to confidence and environmental factors were identified to summarise the perceived barriers to administering BCPR in deprived communities. Barriers related to confidence included: self-efficacy; knowledge and awareness of how, and when, to administer CPR; accessing CPR training; having previous experience of administering BCPR; who required CPR; and whether the bystander was physically fit to give CPR. Environmental barriers focused on the safety of the physical environment in which people lived, and fear of reprisal from gangs or the police. Conclusions Barriers to administering BCPR identified in the general population are relevant to people living in deprived communities but are exacerbated by a range of contextual, individual and environmental factors. A one-size-fits-all approach is not sufficient to promote 'CPR readiness' in deprived communities. Future approaches to working with disadvantaged communities should be tailored to the local community.	[Dobbie, Fiona; Bauld, Linda] Univ Edinburgh, Coll Med & Vet Med, Usher Inst, Edinburgh, Midlothian, Scotland; [Uny, Isa; Eadie, Douglas; Stead, Martine; Angus, Kathryn] Univ Stirling, Sch Hlth Sci, Inst Social Mkt & Hlth, Stirling, Scotland; [Duncan, Edward] Univ Stirling, Fac Hlth Sci & Sport, Nursing Midwifery & Allied Hlth Professionals Res, Stirling, Scotland; [Hassled, Liz; MacInnes, Lisa; Clegg, Gareth] Univ Edinburgh, Resuscitat Res Grp, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Stirling; University of Stirling; University of Edinburgh	Dobbie, F (corresponding author), Univ Edinburgh, Coll Med & Vet Med, Usher Inst, Edinburgh, Midlothian, Scotland.	fiona.dobbie@ed.ac.uk	; Dobbie, Fiona/L-5858-2016	Stead, Martine/0000-0002-3066-4604; Clegg, Gareth/0000-0002-4314-611X; Uny, Isabelle/0000-0002-9548-5332; Dobbie, Fiona/0000-0002-8294-8203	Chief Scientist Office [HIPS/17/10]	Chief Scientist Office	FD received funding for this study from the Chief Scientist Office HIPS/17/10 https://www.cso.scot.nhs.uk/outputs/cso-funded-research/hips2017/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	2011ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS, 2011, CIRCULATION, V124, pe54; Aaberg AMR, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-24; [Anonymous], 2014, REG ANESTH PAIN MED; [Anonymous], 2017, ONCOGENESIS, V6, pe345; Becker TK, 2019, EMERGENCY MED J; Berdowski J, 2010, RESUSCITATION, V81, P1479, DOI 10.1016/j.resuscitation.2010.08.006; Chen KY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211792; Craig P, 2013, INT J NURS STUD, V50, P585, DOI 10.1016/j.ijnurstu.2012.09.009; Dobbie F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193391; Frohlich KL, TAKING ACCOUNT CONTE; Global Resuscitation Alliance, 2016, IMPROVING SURVIVAL O; Jakubowski A, 2018, SUBST ABUS, V39, P233, DOI 10.1080/08897077.2017.1387213; Kanstad BK, 2011, RESUSCITATION, V82, P1053, DOI 10.1016/j.resuscitation.2011.03.033; Kramer CE, 2015, RESUSCITATION, V86, P82, DOI 10.1016/j.resuscitation.2014.10.016; Mathiesen WT, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2017-x; Mitchell MJ, 2009, PREHOSP EMERG CARE, V13, P478, DOI 10.1080/10903120903144833; Moore G, 2014, J EPIDEMIOL COMMUN H, V68, P101, DOI 10.1136/jech-2013-202869; Nadarajan GD, 2018, RESUSCITATION, V132, P85, DOI 10.1016/j.resuscitation.2018.08.022; Nicholls M.C., 2014, QUALITATIVE RES PRAC, P177, DOI DOI 10.1186/1745-6215-14-166; O'Brien BC, 2014, ACAD MED, V89, P1245, DOI 10.1097/ACM.0000000000000388; Reinier K, 2011, CAN MED ASSOC J, V183, P1705, DOI 10.1503/cmaj.101512; Riegel B, 2006, RESUSCITATION, V70, P98, DOI 10.1016/j.resuscitation.2005.10.029; Riva G, 2019, CIRCULATION, V139, P2600, DOI 10.1161/CIRCULATIONAHA.118.038179; Sasson C, 2015, ANN EMERG MED, V65, P545, DOI [10.1016/j.annemergmed.2014.10.028, DOI 10.1016/J.ANNEMERGMED.2014.10.02825481112]; Sasson C, 2013, CIRC-CARDIOVASC QUAL, V6, P550, DOI 10.1161/CIRCOUTCOMES.111.000097; Sasson C, 2012, ACAD EMERG MED, V19, P139, DOI 10.1111/j.1553-2712.2011.01284.x; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; Scottish Government The Scottish G, 2015, OUT HOSP CARD ARR ST; Scottish Government The Scottish G, 2018, IN RES SCOTT OUT HOS; Smeeding Timothy., 2016, OXFORD HDB SOCIAL SC; Uny I, 2019, LETS BE CPR READY DE; Vaillancourt C, 2008, RESUSCITATION, V79, P417, DOI 10.1016/j.resuscitation.2008.07.012; Vaillancourt C, 2008, CAN J EMERG MED, V10, P51, DOI 10.1017/S1481803500010010; 2018, EUR UROL SUPPL, V17	34	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2020	15	6							e0233675	10.1371/journal.pone.0233675	http://dx.doi.org/10.1371/journal.pone.0233675			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC0EC	32520938	Green Published, gold, Green Accepted			2022-12-26	WOS:000542969500031
J	Kozinc, Z; Sarabon, N				Kozinc, Ziga; Sarabon, Nejc			Shear-wave elastography for assessment of trapezius muscle stiffness: Reliability and association with low-level muscle activity	PLOS ONE			English	Article							ELASTIC-MODULUS; NECK PAIN; SHOULDER; SEX; AGE	Purpose Shear-wave elastography has been recognized a useful tool for quantifying muscle stiffness, commonly reported as shear modulus, however the reports on reliability are often limited to test-retest correlations. In this study, we explored the reliability of shear-wave elastography for assessment of the trapezius muscle stiffness and its relationship with low-level muscle activity. Methods Twenty participants were included in a two-session experiment. Measurements of shear modulus and muscle activity were performed at rest and during low-level activity, induced by shoulder abduction without additional external resistance. Results Good to excellent intra-session repeatability (ICC > 0.80) and moderate inter-rater and inter-session reproducibility (ICC = 0.66-0.74) were observed. Typical errors were acceptable (7.6% of the mean value) only for intra-session measurements in resting conditions, but not acceptable for all conditions with low-level muscle activity (10.2-16.6% of the mean value). Inverse relationships between shear modulus and muscle activity at 40 degrees and 60 degrees of shoulder abduction (r = -0.53 and -0.57) were observed on a group level. We also found higher shear modulus in males compared to females, for the parallel probe position compared to the perpendicular position (in relation to muscle fiber orientation), and for the dominant side of the body compared to the non-dominant side. Conclusions This study showed an inverse relationship between muscle activity in low-level range and shear modulus on a group level, suggesting inherent passive stiffness could account for a larger portion of the variance (compared to muscle activity) in shear modulus when the muscle activity is low. Our results imply that shear-wave elastography can be used in research exploring muscle stiffness, however, caution is needed since only intra-session examination in resting conditions showed acceptable within-participant typical errors. The secondary analyses of the study showed higher shear modulus for males, for the non-dominant side of the body and for the parallel orientation of the ultrasound probe.	[Kozinc, Ziga; Sarabon, Nejc] Univ Primorska, Fac Hlth Sci, Polje, Izola, Slovenia; [Kozinc, Ziga] Univ Primorska, Andrej Marusic Inst, Koper, Slovenia; [Sarabon, Nejc] Sci Practice Ltd, S2P, Lab Motor Control & Motor Behav, Tehnoloski Pk, Ljubljana, Slovenia; [Sarabon, Nejc] InnoRenew CoE, Human Hlth Dept, Livade, Izola, Slovenia	University of Primorska; University of Primorska	Sarabon, N (corresponding author), Univ Primorska, Fac Hlth Sci, Polje, Izola, Slovenia.; Sarabon, N (corresponding author), Sci Practice Ltd, S2P, Lab Motor Control & Motor Behav, Tehnoloski Pk, Ljubljana, Slovenia.; Sarabon, N (corresponding author), InnoRenew CoE, Human Hlth Dept, Livade, Izola, Slovenia.	nejc.sarabon@fvz.upr.si		Sarabon, Nejc/0000-0003-0747-3735	Horizon 2020 Framework Programme of the European Union; H2020 WIDESPREAD-2-Teaming [739574]	Horizon 2020 Framework Programme of the European Union; H2020 WIDESPREAD-2-Teaming	The authors gratefully acknowledge the Horizon 2020 Framework Programme of the European Union; H2020 WIDESPREAD-2-Teaming: #739574 and the. The funding body was not involved in study conception, design, data collection or analysis, nor in preparation of the manuscript. The funder only provided resources for author salaries and will provide submission fees in case the article is accepted.	Akagi R, 2015, ULTRASOUND MED BIOL, V41, P2906, DOI 10.1016/j.ultrasmedbio.2015.07.011; Akoglu H, 2018, TURK J EMERG MED, V18, P91, DOI 10.1016/j.tjem.2018.08.001; Alfuraih AM, 2018, J CLIN ULTRASOUND, V46, P108, DOI 10.1002/jcu.22534; [Anonymous], 2015, DIABETOL KLIN SA, V4, pA1; Baker R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081678; Bouillard K, 2012, J APPL PHYSIOL, V113, P1353, DOI 10.1152/japplphysiol.00858.2012; Brandenburg JE, 2016, DEV MED CHILD NEUROL, V58, P1288, DOI 10.1111/dmcn.13179; Chen J, 2017, CLIN IMAG, V45, P26, DOI 10.1016/j.clinimag.2017.05.017; Creze M, 2018, SKELETAL RADIOL, V47, P457, DOI 10.1007/s00256-017-2843-y; Cui A, 2020, APPL ERGON, V82, DOI 10.1016/j.apergo.2019.102957; Dieterich AV, 2017, EUR J APPL PHYSIOL, V117, P171, DOI 10.1007/s00421-016-3509-5; Du LJ, 2016, CLIN IMAG, V40, P1075, DOI 10.1016/j.clinimag.2016.05.008; Dubois G, 2015, ULTRASOUND MED BIOL, V41, P2284, DOI 10.1016/j.ultrasmedbio.2015.04.020; Eby SF, 2015, CLIN BIOMECH, V30, P22, DOI 10.1016/j.clinbiomech.2014.11.011; Eby SF, 2013, J BIOMECH, V46, P2381, DOI 10.1016/j.jbiomech.2013.07.033; Enderlein G., 2007, BIOMETRICAL J, V30, P304, DOI [10.1002/bimj.4710300308, DOI 10.1002/BIMJ.4710300308]; Ewertsen C, 2018, ULTRASOUND INT OPEN, V4, pE23, DOI 10.1055/s-0044-102013; Hatta T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155102; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Januario LB, 2018, WORK, V61, P295, DOI 10.3233/WOR-182800; Kim K, 2018, CLIN ORTHOP RELAT R, V476, P1276, DOI 10.1097/01.blo.0000533628.06091.0a; Le Sant G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139272; Leonard JH, 2010, CLIN TER, V161, P29; MacDonald D, 2016, ULTRASOUND MED BIOL, V42, P1018, DOI 10.1016/j.ultrasmedbio.2015.12.002; Marker RJ, 2016, ERGONOMICS, V59, P1205, DOI 10.1080/00140139.2015.1130860; Mendes B, 2018, EUR J APPL PHYSIOL, V118, P2403, DOI 10.1007/s00421-018-3967-z; Morales-Artacho AJ, 2017, SCAND J MED SCI SPOR, V27, P1959, DOI 10.1111/sms.12832; Nakamura M, 2014, ULTRASOUND MED BIOL, V40, P1991, DOI 10.1016/j.ultrasmedbio.2014.03.024; Nicoletti C, 2017, IND HEALTH, V55, P162, DOI 10.2486/indhealth.2016-0189; Norkin CC, 2009, MEASUREMENT JOINT MO; Ostensvik T, 2009, ERGONOMICS, V52, P1556, DOI 10.1080/00140130903199889; Sarvazyan AP, 1998, ULTRASOUND MED BIOL, V24, P1419, DOI 10.1016/S0301-5629(98)00110-0; Tas S, 2018, J MANIP PHYSIOL THER, V41, P580, DOI 10.1016/j.jmpt.2018.01.007; Tas S, 2017, J ULTRAS MED, V36, P565, DOI 10.7863/ultra.16.03032; Umegaki H, 2015, MANUAL THER, V20, P610, DOI 10.1016/j.math.2015.02.006; Vasseljen O, 1997, CLIN BIOMECH, V12, P22, DOI 10.1016/S0268-0033(97)00048-X; Xie YF, 2019, J ELECTROMYOGR KINES, V48, P94, DOI 10.1016/j.jelekin.2019.06.009; Yamamoto A, 2018, J MED ULTRASON, V45, P129, DOI 10.1007/s10396-017-0803-8	39	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2020	15	6							e0234359	10.1371/journal.pone.0234359	http://dx.doi.org/10.1371/journal.pone.0234359			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC0EC	32520959	gold, Green Published			2022-12-26	WOS:000542969500003
J	Morkholt, AS; Oklinski, MK; Larsen, A; Bockermann, R; Issazadeh-Navikas, S; Nieland, JGK; Kwon, TH; Corthals, A; Nielsen, S; Nieland, JDV				Morkholt, Anne Skottrup; Oklinski, Michal Krystian; Larsen, Agnete; Bockermann, Robert; Issazadeh-Navikas, Shohreh; Nieland, Jette Goller Kloth; Kwon, Tae-Hwan; Corthals, Angelique; Nielsen, Soren; Nieland, John Dirk Vestergaard			Pharmacological inhibition of carnitine palmitoyl transferase 1 inhibits and reverses experimental autoimmune encephalitis in rodents	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; INTERFERON-BETA; PROTEIN; METABOLISM; DEPRESSION; DISEASE; MODEL	Multiple sclerosis (MS) is a neurodegenerative disease characterized by demyelination and inflammation. Dysregulated lipid metabolism and mitochondrial dysfunction are hypothesized to play a key role in MS. Carnitine Palmitoyl Transferase 1 (CPT1) is a rate-limiting enzyme for beta-oxidation of fatty acids in mitochondria. The therapeutic effect of pharmacological CPT1 inhibition with etomoxir was investigated in rodent models of myelin oligodendrocyte glycoprotein- and myelin basic protein-induced experimental autoimmune encephalitis (EAE). Mice receiving etomoxir showed lower clinical score compared to placebo, however this was not significant. Rats receiving etomoxir revealed significantly lower clinical score and lower body weight compared to placebo group. When comparing etomoxir with interferon-beta (IFN-beta), IFN-beta had no significant therapeutic effects, whereas etomoxir treatment starting at day 1 and 5 significantly improved the clinical scores compared to the IFN-beta and the placebo group. Immunohistochemistry and image assessments of brain sections from rats with EAE showed higher myelination intensity and decreased expression of CPT1A in etomoxir-treated rats compared to placebo group. Moreover, etomoxir mediated increased interleukin-4 production and decreased interleukin-17 alpha production in activated T cells. In conclusion, CPT1 is a key protein in the pathogenesis of EAE and MS and a crucial therapeutic target for the treatment.	[Morkholt, Anne Skottrup; Oklinski, Michal Krystian; Nielsen, Soren; Nieland, John Dirk Vestergaard] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark; [Larsen, Agnete] Aarhus Univ, Dept Biomed, Aarhus C, Denmark; [Bockermann, Robert; Issazadeh-Navikas, Shohreh] Univ Copenhagen, Biotech Res & Innovat Ctr, Copehage N, Denmark; [Nieland, Jette Goller Kloth; Nielsen, Soren] ApS, Meta IQ, Aarhus C, Denmark; [Kwon, Tae-Hwan] Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Taegu, South Korea; [Corthals, Angelique] CUNY, Dept Sci, John Jay Coll Criminal Justice, New York, NY 10021 USA	Aalborg University; Aarhus University; University of Copenhagen; Kyungpook National University; City University of New York (CUNY) System	Nieland, JDV (corresponding author), Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark.	jdn@hst.aau.dk	Oklinski, Michal K./AAT-9152-2020; Oklinski, Michal Krystian/S-9651-2017; Issazadeh-Navikas, Shohreh/AAI-7900-2021; Kwon, Tae-Hwan/ABA-1981-2020	Oklinski, Michal K./0000-0002-7713-4731; Nieland, John/0000-0001-7423-0122; Corthals, Angelique/0000-0002-5610-2992; Morkholt, Anne Skottrup/0000-0002-7718-6312	Lundbeckfonden [R191-2015-1118]	Lundbeckfonden(Lundbeckfonden)	A grant from Lundbeckfonden, R191-2015-1118, financed the studies. J.G.K.N. and S.N. disclose being employed and have financial interest in Meta-IQ. The funders provided support in the form of the drug Etomoxir used in the animal study as well as know-how on the drug, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	ABERG JA, 1990, J CLIN LAB ANAL, V4, P246, DOI 10.1002/jcla.1860040403; Acharya NK, 2012, J AUTOIMMUN, V38, P369, DOI 10.1016/j.jaut.2012.03.004; Adibhatla RM, 2007, FUTURE LIPIDOL, V2, P403, DOI 10.2217/17460875.2.4.403; [Anonymous], 2011, ACTUALIDAD LABORAL S, V1, P6; Bennett MJ, 2004, MOL GENET METAB, V82, P59, DOI 10.1016/j.ymgme.2004.02.004; Bizzozero OA, 1999, J NEUROCHEM, V72, P2610, DOI 10.1046/j.1471-4159.1999.0722610.x; BIZZOZERO OA, 1991, J BIOL CHEM, V266, P17092; Blinkenberg M, 2000, NEUROLOGY, V54, P558, DOI 10.1212/WNL.54.3.558; Cannella B, 2004, ANN NEUROL, V55, P46, DOI 10.1002/ana.10764; Cantaert T, 2013, ARTHRITIS RHEUM-US, V65, P939, DOI 10.1002/art.37839; Carrillo-Vico A, 2010, J IMMUNOL, V184, P2839, DOI 10.4049/jimmunol.0903639; Chen CC, 2001, PSYCHIAT RES, V102, P153, DOI 10.1016/S0165-1781(01)00231-1; Constantinescu CS, 2011, BRIT J PHARMACOL, V164, P1079, DOI 10.1111/j.1476-5381.2011.01302.x; Corthals AP, 2011, Q REV BIOL, V86, P287, DOI 10.1086/662453; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Faria DD, 2014, MULT SCLER J, V20, P1443, DOI 10.1177/1352458514526941; Gonzalo H, 2012, J NEUROCHEM, V123, P622, DOI 10.1111/j.1471-4159.2012.07934.x; Greenberg CR, 2009, MOL GENET METAB, V96, P201, DOI 10.1016/j.ymgme.2008.12.018; Kidd BA, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2523; Lieury A, 2014, GLIA, V62, P1645, DOI 10.1002/glia.22705; Lundberg K, 2005, ARTHRITIS RES THER, V7, pR458, DOI 10.1186/ar1697; Maier K, 2006, AM J PATHOL, V169, P1353, DOI 10.2353/ajpath.2006.060159; McNamara RK, 2014, PSYCHIAT RES, V215, P560, DOI 10.1016/j.psychres.2013.12.022; Moreira LS, 2009, BBA-MOL CELL BIOL L, V1791, P156, DOI 10.1016/j.bbalip.2009.01.003; Morkholt AS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25391-y; Morkholt AS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02343-6; MOrkholt AS, 2019, SCI REP, P1; Newell M Karen, 2006, J Immune Based Ther Vaccines, V4, P1, DOI 10.1186/1476-8518-4-1; Oklinski MK, 2014, J HISTOCHEM CYTOCHEM, V62, P598, DOI 10.1369/0022155414537495; Prasad C, 2001, MOL GENET METAB, V73, P55, DOI 10.1006/mgme.2001.3149; ROSS RT, 1995, J CLIN EPIDEMIOL, V48, P1319, DOI 10.1016/0895-4356(95)00046-1; Saeedi J, 2012, MULT SCLER J, V18, P1239, DOI 10.1177/1352458512436595; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Schneider A, 2005, J CELL SCI, V118, P2415, DOI 10.1242/jcs.02365; Tomioka R, 2014, INTERNAL MED, V53, P361, DOI 10.2169/internalmedicine.53.1246; Urrutia PJ, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00038; Van der Aa A, 2003, J NEUROIMMUNOL, V137, P164, DOI 10.1016/S0165-5728(03)00048-1; Weinstock-Guttman B, 2013, J NEUROL NEUROSUR PS, V84, P1186, DOI 10.1136/jnnp-2012-304740; Weinstock-Guttman B, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-127; Weissert R., 2015, METHOD MOL BIOL, V1304, P161; Willner P, 2013, NEUROSCI BIOBEHAV R, V37, P2331, DOI 10.1016/j.neubiorev.2012.12.007; Wiskin AE, 2011, ARCH DIS CHILD, V96, P567, DOI 10.1136/adc.2009.158303; WOELK H, 1973, EUR NEUROL, V10, P250, DOI 10.1159/000114281; Yang HK, 2013, NEUROSCI RES, V77, P1, DOI 10.1016/j.neures.2013.07.005; Zunszain PA, 2011, PROG NEURO-PSYCHOPH, V35, P722, DOI 10.1016/j.pnpbp.2010.04.011	45	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2020	15	6							e0234493	10.1371/journal.pone.0234493	http://dx.doi.org/10.1371/journal.pone.0234493			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC0EC	32520953	Green Published, gold			2022-12-26	WOS:000542969500017
J	Hasyim, H; Firdaus, F; Prabawa, A; Dale, P; Harapan, H; Groneberg, DA; Kuch, U; Muller, R				Hasyim, Hamzah; Firdaus, Firdaus; Prabawa, Artha; Dale, Pat; Harapan, Harapan; Groneberg, David A.; Kuch, Ulrich; Mueller, Ruth			Potential for a web-based management information system to improve malaria control: An exploratory study in the Lahat District, South Sumatra Province, Indonesia	PLOS ONE			English	Article							SURVEILLANCE	Background A web-based malaria reporting information system (MRIS) has the potential to improve malaria reporting and management. The aim of this study was to evaluate the existing manual paper-based MRIS and to provide a way to overcome the obstacles by developing a web-based MRIS in Indonesia. Methods An exploratory study was conducted in 2012 in Lahat District, South Sumatra Province of Indonesia. We evaluated the current reporting system and identified the potential benefits of using a web-based MRIS by in-depth interviews on selected key informants. Feasibility study was then conducted to develop a prototype system. A web-based MRIS was developed, integrated and synchronized, with suitability ranging from Primary Healthcare Centres (PHCs) to the Lahat District Health Office. Results The paper-based reporting system was sub-optimal due to a lack of transportation, communication, and human capacity. We developed a web-based MRIS to replace the current one. Although the web-based system has the potential to improve the malaria reporting information system, there were some barriers to its implementation, including lack of skilled operators, computer availability and lack of internet access. Recommended ways to overcome the obstacles are by training operators, making the application in an offline mode and able to be operated by mobile phone text messaging for malaria reporting. Conclusion The web-based MRIS has the potential to be implemented as an enhanced malaria reporting information system and investment in the system to support timely management responses is essential for malaria elimination. The developed application can be cloned to other areas that have similar characteristics and MRIS with a built-in web base to aid its application in the 5G future.	[Hasyim, Hamzah; Groneberg, David A.; Kuch, Ulrich; Mueller, Ruth] Goethe Univ, Inst Occupat Med Social Med & Environm Med, Fac Med, Frankfurt, Germany; [Hasyim, Hamzah] Sriwijaya Univ, Fac Publ Hlth, Indralaya, South Sumatra P, Indonesia; [Firdaus, Firdaus] Sriwijaya Univ, Fac Comp Sci, Intelligence Syst Res Grp, Indralaya, South Sumatra P, Indonesia; [Prabawa, Artha] Univ Indonesia, Fac Publ Hlth, Dept Biostat & Populat, Depok, Indonesia; [Dale, Pat] Griffith Univ, Environm Futures Res Inst EFRI, Sch Environm & Sci, Nathan, Qld, Australia; [Harapan, Harapan] Univ Syiah Kuala, Sch Med, Med Res Unit, Banda Aceh, Indonesia; [Mueller, Ruth] Inst Trop Med, Unit Entomol, Antwerp, Belgium	Goethe University Frankfurt; Universitas Sriwijaya; Universitas Sriwijaya; University of Indonesia; Griffith University; Universitas Syiah Kuala; Institute of Tropical Medicine (ITM)	Hasyim, H (corresponding author), Goethe Univ, Inst Occupat Med Social Med & Environm Med, Fac Med, Frankfurt, Germany.; Hasyim, H (corresponding author), Sriwijaya Univ, Fac Publ Hlth, Indralaya, South Sumatra P, Indonesia.	hamzah.hasyim@stud.uni-frankfurt.de	hasyim, hamzah/AAO-1249-2020; Groneberg, David/A-5132-2018; Prabawa, Artha/HCJ-0708-2022; , Firdaus/J-1824-2015; Muller, Ruth/GXA-1300-2022; Harapan, Harapan/I-8741-2016	hasyim, hamzah/0000-0002-2780-8902; Groneberg, David/0000-0001-8551-6556; , Firdaus/0000-0003-2791-3486; Harapan, Harapan/0000-0001-7630-8413				Badan Perencanaan Pembangunan Nasional, 2007, VIS DAN ARAH RENC PE; Bentley L.D., 2000, SYSTEMS ANAL DESIGN; Caulfield LE, 2004, AM J TROP MED HYG, V71, P55, DOI 10.4269/ajtmh.2004.71.55; Deek F. P., 2005, STRATEGIC SOFTWARE E; Dinas Kesehatan Provinsi Sumatera Selatan, 2013, PROF KES PROV SUM SE, P19; Erhart A, 2007, T ROY SOC TROP MED H, V101, P216, DOI 10.1016/j.trstmh.2006.07.003; Feng J, 2016, AM J TROP MED HYG, V95, P806, DOI 10.4269/ajtmh.15-0888; Gallup JL, 2001, AM J TROP MED HYG, V64, P85, DOI 10.4269/ajtmh.2001.64.85; Handaga B, 2009, APLIKASI SISTEM INFO; Hasyim H, 2014, DETERMINAN KEJADIAN, P291; Hasyim H, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2230-8; Kamanga A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-96; Kementerian Kesehatan Republik Indonesia, 2012, ROADM SIST INF KES T, P10; Merkord CL, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1735-x; Murhandarwati EEH, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0828-7; Noor AM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-100; Ochtavian Putra Y, 2011, PEMBANGUNAN SISTEM I; Ohrt C, 2015, AM J TROP MED HYG, V93, P145, DOI 10.4269/ajtmh.14-0257; Ratnaningrum D, 2011, PENGEMBANGAN SISTEM; Rosewell A, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1910-0; Salda?a J., 2009, INTRO CODES CODING C, V3; Santoso LW, 2012, SEMINAR SENTIA; Shirayama Y, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-217; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Thomsen EK, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004342; Tobgay T, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1105-0; Wangdi K, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1235-4; World Health Organization, 2012, DIS SURV MAL CONTR O; World Health Organization, THIS YEARS WORLD MAL; World Health Organization, EP APPR MAL CONTR 20; Yeh EC, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1501645; 2013, WORLD MAL REP 2013, P1	32	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2020	15	6							e0229838	10.1371/journal.pone.0229838	http://dx.doi.org/10.1371/journal.pone.0229838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ1GC	32516344	Green Published, gold			2022-12-26	WOS:000540977000001
J	Itani, M; Al Zein, M; Nasralla, N; Talhouk, SN				Itani, M.; Al Zein, M.; Nasralla, N.; Talhouk, S. N.			Biodiversity conservation in cities: Defining habitat analogues for plant species of conservation interest	PLOS ONE			English	Article							URBAN ECOSYSTEMS; FUNCTIONAL TYPES; VEGETATION; ECOLOGY; DIVERSITY; RICHNESS; PATTERNS; EXTINCTION; TRAITS; URBANIZATION	Urban green spaces, both unmanaged and managed, include novel ecosystems that may be suitable habitat analogues for native plant species of conservation interest. The objective of this study was to define habitat analogues in the Mediterranean city of Beirut for Matthiola crassifolia, a Lebanese steno-endemic only present in urban habitats. We adopted a stepwise method that integrates two vegetation assessments, floristics, and life form. We placed seventy-eight quadrats (1m x 1m) in 12 study sites following a deliberate biased approach to capture habitat diversity. In every quadrat, we performed taxonomic identification and recorded life forms of each species. We pooled species that shared the same life form and estimated area cover for each life form accordingly. We performed TWINSPAN analyses on both floristic and life form data, then combined these findings to generate a description of habitat analogues suitable for M. crassifolia. TWINSPAN analysis of floristic data clustered the 78 quadrats under 17 quadrat groups, while life form data assembled the quadrats under 11 quadrat groups. The integration of floristic and life-form classification results into one matrix generated 30 quadrat groups, 8, which were highly favorable to M. crassifolia, and 12, which excluded it. The stepwise method unveiled similarities between vegetation assemblages, which appeared distinct due to the high presence of ruderals. We found that habitat analogues favorable to M. crassifolia include green spaces dominated by palms, low-lying succulents, or shrubs with scale-like leaves. In contrast, areas dominated by turf grass, canopy trees, or vegetation that produces significant litter were not favorable to M. crassifolia's persistence. Based on these findings, we generated a plant palette of life forms which guides designs of urban habitats favorable to M. crassifolia. Synthesis and applications The stepwise method was useful in producing informative plant lists and assemblages for planting designs and landscape management; it generated a plant selection palette that is not restrictive and does not enforce a native only policy. It also offered a wide range of potential habitat analogues for M. crassifolia.	[Itani, M.; Talhouk, S. N.] Amer Univ Beirut, Dept Landscape Design & Ecosyst Management, Fac Agr & Food Sci, Beirut, Lebanon; [Itani, M.; Nasralla, N.; Talhouk, S. N.] Amer Univ Beirut, Nat Conservat Ctr, Beirut, Lebanon; [Al Zein, M.] Amer Univ Beirut, Fac Arts & Sci, Dept Biol, Beirut, Lebanon	American University of Beirut; American University of Beirut; American University of Beirut	Talhouk, SN (corresponding author), Amer Univ Beirut, Dept Landscape Design & Ecosyst Management, Fac Agr & Food Sci, Beirut, Lebanon.; Talhouk, SN (corresponding author), Amer Univ Beirut, Nat Conservat Ctr, Beirut, Lebanon.	ntsalma@aub.edu.lb	Itani, Moustapha/AAO-5244-2021	Itani, Moustapha/0000-0001-9372-3715; Talhouk, Salma N./0000-0002-4797-4342; Nasrallah, Nivine/0000-0001-5103-8162				Alberti Marina, 2001, P89; [Anonymous], 2012, NEUROGASTROENTEROL M, V24, pe147; [Anonymous], 2002, PHILOSOPHIQUES, V29, P81; Beninde J, 2015, ECOL LETT, V18, P581, DOI 10.1111/ele.12427; Bergstedt J, 2009, PLANT ECOL, V204, P271, DOI 10.1007/s11258-009-9590-7; Blackwood J, 2010, ECOL ECON, V69, P519, DOI 10.1016/j.ecolecon.2009.08.029; Boissier E., 1867, FLORA ORIENTALIS SIV, Vprimum; Box EO, 1996, J VEG SCI, V7, P309, DOI 10.2307/3236274; Brandes D., 1992, TUEXENIA, V12, P315; Bretzel F, 2016, URBAN FOR URBAN GREE, V20, P428, DOI 10.1016/j.ufug.2016.10.008; Breuste JH, 2013, URBAN ECOSYST, V16, P801, DOI 10.1007/s11252-012-0255-2; Brown RN, 2012, NORTHEAST NAT, V19, P25, DOI 10.1656/045.019.0102; Catalano C, 2016, LANDSCAPE URBAN PLAN, V149, P11, DOI 10.1016/j.landurbplan.2016.01.003; CAUSTON D. R, 1988, INTRO VEGETATION ANA; Caynes RJC, 2016, URBAN ECOSYST, V19, P1749, DOI 10.1007/s11252-016-0571-z; Chmaitelly Hala, 2009, International Journal of Environmental Studies, V66, P169, DOI 10.1080/00207230902859820; Clements F.E., 1916, PLANT SUCCESSION ANA; Clements F.E., 1928, PLANT SUCCESSION IND; Colla S.H.R., 2009, CITIES ENV CATE, V2, P4; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Dallimer M, 2012, DIVERS DISTRIB, V18, P742, DOI 10.1111/j.1472-4642.2012.00891.x; DANSEREAU P, 1951, ECOLOGY, V32, P172, DOI 10.2307/1930415; DANSEREAU P, 1957, BIOGEOGRAPHY ECOLOGI; DAVIS B N K, 1976, Biological Conservation, V10, P249, DOI 10.1016/0006-3207(76)90002-1; Diekmann M, 2007, FOLIA GEOBOT, V42, P179, DOI 10.1007/BF02893884; Dinsdale J, 1997, J BIOGEOGR, V24, P153, DOI 10.1046/j.1365-2699.1997.00077.x; Dinsdale JM, 1996, THESIS; DOING H, 1985, VEGETATIO, V61, P65, DOI 10.1007/BF00039811; DOWN C G, 1973, Environmental Pollution, V5, P19, DOI 10.1016/0013-9327(73)90052-9; Dubertret L, 1940, COMPTE RENDU SOC GEO, V8, P83; Duncan RP, 2011, GLOBAL ECOL BIOGEOGR, V20, P509, DOI 10.1111/j.1466-8238.2010.00633.x; Ellenberg H, 1974, INDICATOR VALUES VAS, V9, DOI DOI 10.5586/ASBP.1992.001; Ellenberg H., 1967, KEY RAUNKIAER PLANT, V37, P56; Elton C., 1966, PATTERN ANIMAL COMMU; ELTON CS, 1954, J ECOL, V42, P460, DOI 10.2307/2256872; European Council, 1999, OFF J EUR COMMUNITIE, V42, P1; Faber-Langendoen D, 2014, ECOL MONOGR, V84, P533, DOI 10.1890/13-2334.1; Fosberg FR, 1961, TROPICAL ECOLOGY, V2, P1; Garcia-Mora MR, 1999, J VEG SCI, V10, P27, DOI 10.2307/3237157; Gaston KJ, 2005, PROG PHYS GEOG, V29, P239, DOI 10.1191/0309133305pp445pr; Gilbert OL, 1989, ECOLOGY URBAN HABITA, P68; GLEASON H. A., 1939, AMER MIDLAND NAT, V21, P92, DOI 10.2307/2420377; Gleason H. A, 1917, B TORREY BOTANICAL C, V44, P463, DOI DOI 10.2307/2479596; Gleason H.A., 1926, B TORREY BOT CLUB, V53, P7, DOI DOI 10.2307/2479933; GOLDSMITH F B, 1974, Biological Conservation, V6, P3, DOI 10.1016/0006-3207(74)90034-2; Gowler Z.R., 1998, THESIS; Grime J.P., 2006, PLANT STRATEGIES VEG; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; GRIME JP, 1974, NATURE, V250, P26, DOI 10.1038/250026a0; GRIME JP, 1993, OIKOS, V68, P385, DOI 10.2307/3544906; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Hahs AK, 2009, ECOL LETT, V12, P1165, DOI 10.1111/j.1461-0248.2009.01372.x; HAIGH MJ, 1980, URBAN ECOL, V4, P329, DOI 10.1016/0304-4009(80)90004-2; Hall L., 2004, ROMAN BERYTUS BEIRUT; Harper J. L, 1977, POPULATION BIOL PLAN; Hill M.O., 1979, TWINSPAN FORTRAN PRO; Hobbs RJ, 2009, TRENDS ECOL EVOL, V24, P599, DOI 10.1016/j.tree.2009.05.012; HUENNEKE LF, 1995, CONSERV BIOL, V9, P416, DOI 10.1046/j.1523-1739.1995.9020416.x; Itani MA, 2015, THESIS; Ives CD, 2016, GLOBAL ECOL BIOGEOGR, V25, P117, DOI 10.1111/geb.12404; Jim CY, 2013, URBAN ECOSYST, V16, P741, DOI 10.1007/s11252-012-0268-x; Jim CY, 2010, URBAN FOR URBAN GREE, V9, P169, DOI 10.1016/j.ufug.2010.02.004; JOGER H G, 1988, Zoologische Jahrbuecher Abteilung fuer Systematik Oekologie und Geographie der Tiere, V115, P69; Kantsa A, 2013, LANDSCAPE URBAN PLAN, V120, P129, DOI 10.1016/j.landurbplan.2013.08.013; Kassir S., 2003, HIST BEYROUTH; Kaupp Andreas, 2004, Entomologische Blaetter fuer Biologie und Systematik der Kaefer, V100, P47; KENNEDY KA, 1987, J ECOL, V75, P151, DOI 10.2307/2260541; Kent M, 1999, J BIOGEOGR, V26, P1281, DOI 10.1046/j.1365-2699.1999.00350.x; Kent M., 2011, VOODOO PILCHARD, V2nd ed.; Kent M., 2012, VEGETATION DESCRIPTI, V2nd ed.; Knapp S, 2009, DIVERS DISTRIB, V15, P533, DOI 10.1111/j.1472-4642.2009.00561.x; Knapp S, 2008, PRESLIA, V80, P375; Kostler, 2003, BIOTOPTYPEN BERLINS; Kowarik I, 2018, J APPL ECOL, V55, P2354, DOI 10.1111/1365-2664.13144; Kuchler AW, 1967, VEGETATION MAPPING V; Lavorel S, 1997, TRENDS ECOL EVOL, V12, P474, DOI 10.1016/S0169-5347(97)01219-6; Lebanese Ministry of Environment, 2019, 6 NAT REP LEB CONV B; Loram A, 2008, J VEG SCI, V19, P321, DOI 10.3170/2008-8-18373; Lundholm JT, 2010, J APPL ECOL, V47, P966, DOI 10.1111/j.1365-2664.2010.01857.x; Marzluff J. M., 2001, AVIAN CONSERV ECOL, P1, DOI DOI 10.1007/978-1-4615-1531-9; Masri R., 1997, Journal of Developing Societies, V13, P73; McDermott CJ, 2015, LANCET NEUROL, V14, P883, DOI 10.1016/S1474-4422(15)00152-0; MCDONNELL MJ, 1990, ECOLOGY, V71, P1232, DOI 10.2307/1938259; Meiners SJ, 2014, PLANT ECOL, V215, P661, DOI 10.1007/s11258-014-0331-1; Miller JR, 2005, TRENDS ECOL EVOL, V20, P430, DOI 10.1016/j.tree.2005.05.013; Misgav A, 2000, LANDSCAPE URBAN PLAN, V48, P143, DOI 10.1016/S0169-2046(00)00038-4; Miura N, 2010, UTILITY LIDAR LANDSC; MOE/LEDO/ECODIT, 2001, LEB STAT ENV REP; MOUTERDE P., 1966, NOUVELLE FLORE LIBAN; Mouterde P, 1935, PETITE FLORE ENV BEY; Mouterde Rene, 1966, REGARDS BEYROUTH PHE; Nassauer J. I., 1995, LANDSCAPE J, V14, P161, DOI [10.3368/lj.14.2.161., DOI 10.3368/LJ.14.2.161]; Nature Conservancy Council, 1979, NAT CONS URB AR CHAL; Nazzal M., 2018, J PUBLIC SPACE, V3, P119, DOI [10.5204/jps.v3i1.323, DOI 10.5204/JPS.V3I1.323]; Nelis LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042906; Planchuelo G, 2019, LANDSCAPE URBAN PLAN, V189, P320, DOI 10.1016/j.landurbplan.2019.05.007; Population and Development Strategies Programme, 2014, DEM CHAR RES; Post G. E., 1932, FLORA SYRIA PALESTIN; Pysek P, 2004, J VEG SCI, V15, P781, DOI 10.1111/j.1654-1103.2004.tb02321.x; Raunkiaer C., 1937, PLANT LIFE FORMS; Raunkiaer C, 1934, LIFE FORMS PLANTS ST; Rebele F, LANDSCHAFT STADT, V20, P49; Rosenzweig M. L., 2003, WIN WIN ECOLOGY EART; Rowntree R., 1997, URBAN ECOSYST, V1, P185, DOI [10.1023/A:1018531712889, DOI 10.1023/A:1018531712889]; Rteil HH, 2002, THESIS; Salisbury EJ, 1943, FLORA BOMBED AREAS; Schmidt KJ, 2014, URBAN ECOSYST, V17, P427, DOI 10.1007/s11252-013-0319-y; Shenstone J., 1912, J BOT, V50, P117; Shwartz A, 2014, GLOBAL ENVIRON CHANG, V28, P39, DOI 10.1016/j.gloenvcha.2014.06.002; Siddiqui MF, 2009, PAK J BOT, V41, P2357; Silvertown J., 2001, INTRO PLANT POPULATI; Snavely RA, 2019, INT J REMOTE SENS, V40, P4384, DOI 10.1080/01431161.2018.1562588; Solon J., 2004, STUDIA EKOLOGICZNO K, V13, P49; Talhouk SN, 2005, BIODIVERS CONSERV, V14, P903, DOI 10.1007/s10531-004-0650-y; Thompson K, 2004, J VEG SCI, V15, P373, DOI 10.1111/j.1654-1103.2004.tb02274.x; Threlfall CG, 2017, J APPL ECOL, V54, P1874, DOI 10.1111/1365-2664.12876; Tilman D., 1982, Monographs in Population Biology, pi; TILMAN D, 1988; Tohme G., 2014, ILLUSTRATED FLORA LE; Van der Maarel E., 2005, VEG ECOL, V3, P1; Vestergaard P, 2004, NORD J BOT, V24, P309, DOI 10.1111/j.1756-1051.2004.tb00847.x; Westoby M, 2006, TRENDS ECOL EVOL, V21, P261, DOI 10.1016/j.tree.2006.02.004; WHITNEY GG, 1980, J APPL ECOL, V17, P431, DOI 10.2307/2402338; Wilkes P, 2018, CARBON BAL MANAGE, V13, DOI 10.1186/s13021-018-0098-0; Williams NSG, 2015, PERSPECT PLANT ECOL, V17, P78, DOI 10.1016/j.ppees.2014.10.002; Williams NSG, 2009, J ECOL, V97, P4, DOI 10.1111/j.1365-2745.2008.01460.x; Winter M, THESIS; Yassin N, 2012, CITIES, V29, P64, DOI 10.1016/j.cities.2011.02.001	128	6	6	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2020	15	6							e0220355	10.1371/journal.pone.0220355; 10.1371/journal.pone.0220355.r001; 10.1371/journal.pone.0220355.r002; 10.1371/journal.pone.0220355.r003; 10.1371/journal.pone.0220355.r004; 10.1371/journal.pone.0220355.r005; 10.1371/journal.pone.0220355.r006	http://dx.doi.org/10.1371/journal.pone.0220355; 10.1371/journal.pone.0220355.r001; 10.1371/journal.pone.0220355.r002; 10.1371/journal.pone.0220355.r003; 10.1371/journal.pone.0220355.r004; 10.1371/journal.pone.0220355.r005; 10.1371/journal.pone.0220355.r006			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LZ1GC	32516335	Green Published, Green Submitted, gold			2022-12-26	WOS:000540977000024
J	Sewda, A; Agopian, AJ; Goldmuntz, E; Hakonarson, H; Morrow, BE; Musfee, F; Taylor, D; Mitchell, LE				Sewda, Anshuman; Agopian, A. J.; Goldmuntz, Elizabeth; Hakonarson, Hakon; Morrow, Bernice E.; Musfee, Fadi; Taylor, Deanne; Mitchell, Laura E.		Pediat Cardiac Genomics Consortium	Gene-based analyses of the maternal genome implicate maternal effect genes as risk factors for conotruncal heart defects	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; BIRTH-DEFECTS; WIDE ASSOCIATION; PREECLAMPSIA; FREQUENCY; PREGNANCY; DYNAMICS; DISEASE; LINKS; RARE	Congenital heart defects (CHDs) affect approximately 1% of newborns. Epidemiological studies have identified several genetically-mediated maternal phenotypes (e.g., pregestational diabetes, chronic hypertension) that are associated with the risk of CHDs in offspring. However, the role of the maternal genome in determining CHD risk has not been defined. We present findings from gene-level, genome-wide studies that link CHDs to maternal effect genes as well as to maternal genes related to hypertension and proteostasis. Maternal effect genes, which provide the mRNAs and proteins in the oocyte that guide early embryonic development before zygotic gene activation, have not previously been implicated in CHD risk. Our findings support a role for and suggest new pathways by which the maternal genome may contribute to the development of CHDs in offspring.	[Sewda, Anshuman; Agopian, A. J.; Musfee, Fadi; Mitchell, Laura E.] UTHlth Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA; [Goldmuntz, Elizabeth; Hakonarson, Hakon; Taylor, Deanne] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Goldmuntz, Elizabeth] Childrens Hosp Philadelphia, Div Cardiol, 34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Morrow, Bernice E.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Taylor, Deanne] Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA; [Sewda, Anshuman] IIHMR Univ, Inst Hlth Management Res, Jaipur, Rajasthan, India	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Yeshiva University; Albert Einstein College of Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Mitchell, LE (corresponding author), UTHlth Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA.	Laura.E.Mitchell@uth.tmc.edu	Sewda, Anshuman/ABH-6847-2020; Taylor, Deanne/AAY-6296-2020	Sewda, Anshuman/0000-0002-2272-5382; Taylor, Deanne/0000-0002-3302-4610; Morrow, Bernice/0000-0002-8076-4726; Mitchell, Laura/0000-0003-1151-5096	Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01HD070454, R21HD097347, R03HD098552]; National Heart, Lung, and Blood Institute [P50-HL74731, U01HL098188, U01HL131003, U01-HL098147, U01HL098153, U01-HL098163, U01-HL098123, U01HL098162, U01HL098166]; National Human Genome Research Institute [U54HG006504]; National Center for Research Resources [M01-RR-000240]; Children's Hospital of Philadelphia; National Center for Advancing Translational Sciences [UL1TR000003]	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Children's Hospital of Philadelphia; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (P01HD070454, AJA, EG, BM, LEM, FM, AS, DT; R21HD097347, AJA, LEM; R03HD098552, LEM) (https://www.nichd.nih.gov/), the National Heart, Lung, and Blood Institute (P50-HL74731) (https://www.nhlbi.nih.gov/), including the PCGC (U01HL098188, U01HL131003, U01-HL098147, U01HL098153, U01-HL098163, U01-HL098123, U01HL098162) (https://benchtobassinet.com) and the Cardiovascular Development Consortium (U01HL098166) (https://benchtobassinet.com/?page_ id=1644), as well as the National Human Genome Research Institute (U54HG006504) (https://www.genome.gov), and the National Center for Research Resources (M01-RR-000240, RR024134, which is now the National Center for Advancing Translational Sciences (UL1TR000003) (https://ncats.nih.gov).The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding sources. Array genotyping of the CHOP cohorts was funded by an Institutional Development Fund to The Center for Applied Genomics from The Children's Hospital of Philadelphia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Members of the PCGC include (listed alphabetically, by institution): Boston Children's Hospital, Boston, Massachusetts (Jane Newburger and Amy Roberts), Children's Hospital of Los Angeles, Los Angeles, California (Richard Kim), Children's Hospital of Philadelphia (Elizabeth Goldmuntz)*, Cincinnati Children's Hospital, Cincinnati, Ohio (Eileen C. King), Columbia University Medical School, New York, New York (Wendy Chung), Harvard Medical School, Boston, Massachusetts (Christine Seidman and Jonathan Seidman), Icahn School of Medicine at Mount Sinai, New York, New York (Bruce Gelb), J. David Gladstone Institutes, San Francisco, California (Deepak Srivastava and Daniel Bernstein), New England Research Institutes, Watertown, Massachusetts (Sharon Tennstedt, Kimberly Dandreo, and Julie Miller), Stanford University, Stanford, California (Daniel Bernstein), Steve and Alexandra Cohen Children's Medical Center of New York, New Hyde Park, New York (Angela Romano-Adesman), University of Rochester School of Medicine and Dentistry, Rochester, New York (George Porter), University of Utah, Salt Lake City, Utah (Martin Tristani-Firouzi and H. Joseph Yost), Yale School of Medicine, New Haven, Connecticut (Martina Brueckner and Richard Lifton).	Agopian AJ, 2017, CIRC-CARDIOVASC GENE, V10, DOI 10.1161/CIRCGENETICS.116.001449; Agopian AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096057; [Anonymous], 1932, STAT METHODS RES WOR; [Anonymous], 2015, NUCLEIC ACIDS RES, V43, pD204; [Anonymous], 2018, DIABETES CARE, V40, pS1; Arth AC, 2017, MMWR-MORBID MORTAL W, V66, P41, DOI 10.15585/mmwr.mm6602a1; Becker M, 2005, MOL BIOL CELL, V16, P3887, DOI 10.1091/mbc.E05-04-0350; Begemann M, 2018, J MED GENET, V55, P497, DOI 10.1136/jmedgenet-2017-105190; Bellizzi S, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0987-8; Birthplace in England Collaborative Group, 2011, BMJ-BRIT MED J, V343, pd7400; Boyd HA, 2017, CIRCULATION, V136, P39, DOI 10.1161/CIRCULATIONAHA.116.024600; Boyles AL, 2009, GENET EPIDEMIOL, V33, P247, DOI 10.1002/gepi.20376; Brody LC, 2002, AM J HUM GENET, V71, P1207, DOI 10.1086/344213; Condic ML, 2016, STEM CELL REV REP, V12, P276, DOI 10.1007/s12015-016-9648-6; Docherty LE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9086; Fuentes R, 2018, MECH DEVELOP, V154, P259, DOI 10.1016/j.mod.2018.08.001; Funaya S, 2018, FEBS LETT, V592, P2414, DOI 10.1002/1873-3468.13175; Goldmuntz E, 1998, J AM COLL CARDIOL, V32, P492, DOI 10.1016/S0735-1097(98)00259-9; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; Hoang TT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191319; Hobbs CA, 2011, BIRTH DEFECTS RES A, V91, P195, DOI 10.1002/bdra.20784; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Ionita-Laza I, 2013, AM J HUM GENET, V92, P841, DOI 10.1016/j.ajhg.2013.04.015; Jamsai D, 2011, INT J ANDROL, V34, P624, DOI 10.1111/j.1365-2605.2010.01127.x; Jamsai D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056955; Jenkins KJ, 2007, CIRCULATION, V115, P2995, DOI 10.1161/CIRCULATIONAHA.106.183216; Johnson TR, 2010, PEDIATR CARDIOL, V31, P430, DOI 10.1007/s00246-010-9668-y; Juan T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04284-8; Kaplinski M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216477; Kim B, 2014, DEV BIOL, V386, P331, DOI 10.1016/j.ydbio.2013.12.025; Kim Kyeoung-Hwa, 2014, Clin Exp Reprod Med, V41, P47, DOI 10.5653/cerm.2014.41.2.47; Kloesel B, 2016, ANESTH ANALG, V123, P551, DOI 10.1213/ANE.0000000000001451; Lucotte EA, 2016, GENOME BIOL EVOL, V8, P1489, DOI 10.1093/gbe/evw090; Lupo PJ, 2012, AM J EPIDEMIOL, V176, P1101, DOI 10.1093/aje/kws190; Mahadevan S, 2017, SCI REP-UK, V7, DOI 10.1038/srep44667; Marlow FL, 2018, F1000RES, P7, DOI [10.12688/f1000research.13350.2, DOI 10.12688/F1000RESEARCH.13350.2]; Mitchell LE, 2015, HUM MOL GENET, V24, P265, DOI 10.1093/hmg/ddu420; Nelson DB, 2015, J MATERN-FETAL NEO M, V28, P2135, DOI 10.3109/14767058.2014.980808; Patel SS, 2013, PEDIATR CARDIOL, V34, P1535, DOI 10.1007/s00246-013-0775-4; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qian JH, 2018, EUR J HUM GENET, V26, P1007, DOI 10.1038/s41431-018-0141-3; Ramakrishnan A, 2015, PEDIATR CARDIOL, V36, P1442, DOI 10.1007/s00246-015-1182-9; Reichmann J, 2018, SCIENCE, V361, P189, DOI 10.1126/science.aar7462; Santorico SA, 2016, BMC GENET, V17, DOI 10.1186/s12863-015-0316-7; Sewda A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219926; Sheriff FR, 2019, BIRTH DEFECTS RES, V111, P9, DOI 10.1002/bdr2.1415; Shi M, 2012, AM J MED GENET A, V158A, P784, DOI 10.1002/ajmg.a.35257; Soellner L, 2018, J PERINAT MED, V46, P169, DOI 10.1515/jpm-2016-0405; Stelzer Gil, 2016, Curr Protoc Bioinformatics, V54, DOI 10.1002/cpbi.5; van der Vaart B, 2011, J CELL BIOL, V193, P1083, DOI 10.1083/jcb.201012179; Weber KA, 2018, AM J EPIDEMIOL, V187, P668, DOI 10.1093/aje/kwx269; Yang QH, 2006, BIRTH DEFECTS RES A, V76, P706, DOI 10.1002/bdra.20308; Zhang K, 2015, REPROD FERT DEVELOP, V27, P880, DOI 10.1071/RD14441	55	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2020	15	6							e0234357	10.1371/journal.pone.0234357	http://dx.doi.org/10.1371/journal.pone.0234357			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ1GC	32516339	Green Published, gold			2022-12-26	WOS:000540977000005
J	Jankovic, J; Slijepcevic, V; Miletic, V				Jankovic, Janko; Slijepcevic, Vesna; Miletic, Vladimir			Depression and suicidal behavior in LGB and heterosexual populations in Serbia and their differences: Cross-sectional study	PLOS ONE			English	Article							INTERPERSONAL-PSYCHOLOGICAL THEORY; SEXUAL ORIENTATION; MENTAL-HEALTH; RISK-FACTORS; IDEATION; MINORITY; ADULTS; GAY; EPIDEMIOLOGY; HOPELESSNESS	Background Sexual identity is a significant risk factor for triggering symptoms of depression, as well as for suicide attempts in lesbian, gay and bisexual (LGB) population compared to the heterosexual population. To the best of our knowledge, data on the mental health of LGB persons in Serbia are lacking, and this is the first study to address this problem. The aim of the study was to examine the association between selected determinants and depression, and selected determinants and suicide attempts in LGB and heterosexual populations in the Republic of Serbia, as well as, their differences. Methods We conducted a cross-sectional study in 2015 of 264 heterosexual and LGB respondents using the "snowball sampling" method. We used linear regression analyses to investigate the relationship between socio-demographic variables and different sexual identity categories with PHQ-9 scores. We assessed associations between suicide attempts, and socio-demographic characteristics, sexual identity, depression, and suicidal thoughts using logistic regression. Results Depression symptoms were higher in female relative to male participants, in participants who were single, divorced or widowed in comparison to currently married, among people with a middle level of education compared to highly educated, and in respondents identified as bisexual or homosexual in comparison to heterosexual. Homosexual and bisexual participants reported suicidal attempts 27 [Odds Ratio (OR) = 27.31] and six times (OR = 6.40) more often than did heterosexual respondents, respectively. Suicide attempts were less frequently reported by single, divorced or widowed participants in comparison to married (OR = 0.25) and those with middle education (OR = 0.38) compared to highly educated. Conclusions The present study showed that LGB persons in Serbia have significantly more symptoms of depression and suicide attempts compared to heterosexuals. Public health interventions should focus on the early detection of depression and on overcoming prejudicial and discriminatory attitudes. Also, intervention should emphasize that homosexuality and bisexuality are normal, equal and morally acceptable expressions of human sexuality.	[Jankovic, Janko] Univ Belgrade, Inst Social Med, Fac Med, Belgrade, Serbia; [Slijepcevic, Vesna] Inst Publ Hlth Belgrade, Belgrade, Serbia; [Miletic, Vladimir] Assoc Mental Hlth Promot, Belgrade, Serbia	University of Belgrade	Jankovic, J (corresponding author), Univ Belgrade, Inst Social Med, Fac Med, Belgrade, Serbia.	drjankojankovic@yahoo.com		Jankovic, Janko/0000-0002-2387-6596	Association for Mental Health Promotion; Ministry of Education, Science and Technological Development of the Republic of Serbia [175025]	Association for Mental Health Promotion; Ministry of Education, Science and Technological Development of the Republic of Serbia	The study was funded by the Association for Mental Health Promotion. Funding for this work was obtained from the Ministry of Education, Science and Technological Development of the Republic of Serbia (project No. 175025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amnesty International, 2018, SERB STILL FAIL DEL; [Anonymous], 2013, PSYCHOL ASS PHILIPPI; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2017, DIABETES CARE S1, V39, pS33; Arnarsson A, 2015, SCAND J PUBLIC HEALT, V43, P497, DOI 10.1177/1403494815585402; Baams L, 2015, DEV PSYCHOL, V51, P688, DOI 10.1037/a0038994; Bagley C, 2000, Crisis, V21, P111, DOI 10.1027//0227-5910.21.3.111; BECK AT, 1985, AM J PSYCHIAT, V142, P559; Brown CR, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4371-z; Canetto SS, 2008, AM J ORTHOPSYCHIAT, V78, P259, DOI 10.1037/a0013973; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; Gilbert P., 1992, DEPRESSION EVOLUTION; Grozdanov J, 2013, RESULTS NATL HLTH SU; Hafeez H, 2017, CUREUS, V9, DOI 10.7759/cureus.1184; Hill RM, 2012, SUICIDE LIFE-THREAT, V42, P567, DOI 10.1111/j.1943-278X.2012.00113.x; Hottes TS, 2016, AM J PUBLIC HEALTH, V106, pE1, DOI 10.2105/AJPH.2016.303088; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; ILGA-Europe, RAINB COUNTR RANK; Joiner TE, 2009, J ABNORM PSYCHOL, V118, P634, DOI 10.1037/a0016500; Kalmar Sandor, 2013, Neuropsychopharmacol Hung, V15, P27; Keilp JG, 2010, NEUROPSYCHOPHARMACOL, V35, P1063, DOI 10.1038/npp.2008.28; Kerr M., 2016, DEPRESSION LGBT POPU; Kessler RC, 2013, ANNU REV PUBL HEALTH, V34, P119, DOI 10.1146/annurev-publhealth-031912-114409; King M, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-70; Klein DN, 2000, AM J PSYCHIAT, V157, P931, DOI 10.1176/appi.ajp.157.6.931; Koh AS, 2006, J HOMOSEXUAL, V51, P33, DOI 10.1300/J082v51n01_03; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Maji S, 2018, INT J SOC PSYCHIATR, V64, P396, DOI 10.1177/0020764018765023; Marshal MP, 2011, J ADOLESCENT HEALTH, V49, P115, DOI 10.1016/j.jadohealth.2011.02.005; Marver JE, 2017, SUICIDE LIFE-THREAT, V47, P660, DOI 10.1111/sltb.12329; Miletic V, 2015, HDB PSYCHOTHERAPY WO; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; Nock MK, 2007, J CONSULT CLIN PSYCH, V75, P707, DOI 10.1037/0022-006X.75.5.707; O'Connor RC, 2013, J CONSULT CLIN PSYCH, V81, P1137, DOI 10.1037/a0033751; Pitts M, 2006, PRIVATE LIVES REPORT; Ribeiro JD, 2018, BRIT J PSYCHIAT, V212, P279, DOI 10.1192/bjp.2018.27; Riggs D.W., 2010, LESBIAN GAY BISEXUAL; Roberts SJ, 2004, J GAY LESBIAN SOCIAL, V17, P1, DOI DOI 10.1300/J041V17N04_; Santacruz E., 2017, LGBT PSYCHOL MENTAL; Seeman MV, 1997, AM J PSYCHIAT, V154, P1641, DOI 10.1176/ajp.154.12.1641; Sher L, 2006, BIPOLAR DISORD, V8, P543, DOI 10.1111/j.1399-5618.2006.00319.x; Shilo G, 2012, J RES ADOLESCENCE, V22, P310, DOI 10.1111/j.1532-7795.2011.00772.x; Shittu Rasaki O, 2014, Int J MCH AIDS, V2, P174; Silenzio VMB, 2007, AM J PUBLIC HEALTH, V97, P2017, DOI 10.2105/AJPH.2006.095943; Stojisavljevic S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179101; Van Orden KA, 2008, J CONSULT CLIN PSYCH, V76, P72, DOI 10.1037/0022-006X.76.1.72; Wang J, 2015, J NERV MENT DIS, V203, P499, DOI 10.1097/NMD.0000000000000319; Weissman MM, 1996, JAMA-J AM MED ASSOC, V276, P293, DOI 10.1001/jama.276.4.293; Whittier AB, 2016, J AFFECT DISORDERS, V197, P58, DOI 10.1016/j.jad.2016.02.052; Woodward E.N., 2014, PSYCHOL SEX ORIENTAT, V1, P234, DOI [10.1037/sgd0000046, DOI 10.1037/SGD0000046]; World Federation for Mental health, 2010, DEPR GLOB CRIS, P140; World Health Organization, 2018, SUICIDE; World Health Organization, 2018, DEPRESSION	53	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2020	15	6							e0234188	10.1371/journal.pone.0234188	http://dx.doi.org/10.1371/journal.pone.0234188			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LZ0RE	32511283	gold, Green Published			2022-12-26	WOS:000540938100040
J	Martin-Frances, L; Martinon-Torres, M; de Pinillos, MM; Garcia-Campos, C; Zanolli, C; Bayle, P; Modesto-Mata, M; Arsuaga, JL; de Castro, JMB				Martin-Frances, Laura; Martinon-Torres, Maria; Martinez de Pinillos, Marina; Garcia-Campos, Cecilia; Zanolli, Clement; Bayle, Priscilla; Modesto-Mata, Mario; Arsuaga, Juan Luis; Bermudez de Castro, Jose Maria			Crown tissue proportions and enamel thickness distribution in the Middle Pleistocene hominin molars from Sima de los Huesos (SH) population (Atapuerca, Spain)	PLOS ONE			English	Article							GEOMETRIC MORPHOMETRIC-ANALYSIS; DENTAL REMAINS; HOMO-ERECTUS; COMPUTED-TOMOGRAPHY; SIZE-REDUCTION; MODERN HUMANS; NEANDERTHAL; TOOTH; MORPHOLOGY; PERMANENT	Dental enamel thickness, topography, growth and development vary among hominins. In Homo, the thickness of dental enamel in most Pleistocene hominins display variations from thick to hyper-thick, while Neanderthals exhibit proportionally thinner enamel. The origin of the thin trait remains unclear. In this context, the Middle Pleistocene human dental assemblage from Atapuerca-Sima de los Huesos (SH) provides a unique opportunity to trace the evolution of enamel thickness in European hominins. In this study, we aim to test the hypothesis if the SH molar sample approximates the Neanderthal condition for enamel thickness and/or distribution. This study includes 626 molars, both original and comparative data. We analysed the molar inner structural organization of the original collections (n = 124), belonging to SH(n = 72) and modern humans from Spanish origin (n = 52). We compared the SH estimates to those of extinct and extant populations of the genus Homo from African, Asian and European origin (estimates extracted from literature n = 502). The comparative sample included maxillary and mandibular molars belonging to H. erectus, East and North African Homo, European Middle Pleistocene Homo, Neanderthals, and fossil and extant H. sapiens. We used high-resolution images to investigate the endostructural configuration of SH molars (tissue proportions, enamel thickness and distribution). The SH molars exhibit on average thick absolute and relative enamel in 2D and 3D estimates, both in the complete crown and the lateral enamel. This primitive condition is shared with the majority of extinct and extant hominin sample, except for Neanderthals and some isolated specimens. On the contrary, the SH molar enamel distribution maps reveal a distribution pattern similar to the Neanderthal signal (with thicker enamel on the lingual cusps and more peripherally distributed), compared to H. antecessor and modern humans. Due to the phylogenetic position of the SH population, the thick condition in molars could represent the persistence of the plesiomorphic condition in this group. Still, more data is needed on other Early and Middle Pleistocene populations to fully understand the evolutionary meaning of this trait.	[Martin-Frances, Laura; Zanolli, Clement; Bayle, Priscilla] Univ Bordeaux, CNRS, UMR 5199, MCC,PACEA, Bordeaux, France; [Martin-Frances, Laura; Martinon-Torres, Maria; Martinez de Pinillos, Marina; Garcia-Campos, Cecilia; Bermudez de Castro, Jose Maria] Ctr Nacl Invest Evoluc Humana, Burgos, Spain; [Martin-Frances, Laura; Martinon-Torres, Maria; Martinez de Pinillos, Marina; Garcia-Campos, Cecilia; Bermudez de Castro, Jose Maria] UCL, Anthropol Dept, London, England; [Modesto-Mata, Mario] Casa Cultura Rodriguez Monino, Equipo Primeros Pobladores Extremadura, Caceres, Spain; [Arsuaga, Juan Luis] Ctr Mixto Univ Complutense Madrid, Inst Salud Carlos III Evoluc & Comportamiento Hum, Madrid, Spain; [Arsuaga, Juan Luis] Univ Complutense Madrid, Fac Ciencias Geol, Dept Paleontol, Madrid, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); University of London; University College London; Complutense University of Madrid	Martin-Frances, L (corresponding author), Univ Bordeaux, CNRS, UMR 5199, MCC,PACEA, Bordeaux, France.; Martin-Frances, L (corresponding author), Ctr Nacl Invest Evoluc Humana, Burgos, Spain.; Martin-Frances, L (corresponding author), UCL, Anthropol Dept, London, England.	lauramartinfrancesmf@gmail.com	Garcia-Campos, Cecilia/L-3757-2016; Martínez de Pinillos, Marina/D-9631-2018; de Pinillos, Marina Martínez/N-7595-2019	Garcia-Campos, Cecilia/0000-0002-0310-6973; Martínez de Pinillos, Marina/0000-0002-8035-337X; de Pinillos, Marina Martínez/0000-0002-8035-337X; Zanolli, Clement/0000-0002-5617-1613; Martin-Frances Martin de la Fuente, Laura/0000-0001-5853-5014; Bermudez de Castro, Jose Maria/0000-0003-1314-3273; Arsuaga, Juan Luis/0000-0001-5361-2295	Direccion General de Universidades e Investigacion [PGC2018-093925-B-C31]; Consejeria de Cultura y Turismo de la Junta de Castilla y Leon; Initiative d'Excellence [ANR-10-IDEX-03-02]; British Academy [PM160019]; Leakey Foundation	Direccion General de Universidades e Investigacion; Consejeria de Cultura y Turismo de la Junta de Castilla y Leon; Initiative d'Excellence(Centre National de la Recherche Scientifique (CNRS)); British Academy; Leakey Foundation	This study received financial support from Direccion General de Universidades e Investigacion in the form of a grant awarded to JMBC and MM-T (PGC2018-093925-B-C31) and Consejeria de Cultura y Turismo de la Junta de Castilla y Leon. This study also received financial support from Initiative d'Excellence in the form of a grant awarded to LM-F (ANR-10-IDEX-03-02), from the British Academy in the form of a grant awarded to MM-T (International Partnership and Mobility Scheme PM160019), and from the Leakey Foundation through the personal support of Gordon Getty (2013) and Dub Crook (2014-2016, 2018, 2019) to MM-T. Further support was provided in the form of Fundacion Atapuerca Post-Doctoral Research Grants awarded to MM-P and CG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud J, 2016, QUATERN INT, V425, P437, DOI 10.1016/j.quaint.2016.09.009; Arnold LJ, 2014, J HUM EVOL, V67, P85, DOI 10.1016/j.jhevol.2013.12.001; Arsuaga JL, 2014, SCIENCE, V344, P1358, DOI 10.1126/science.1253958; ARSUAGA JL, 1991, J HUM EVOL, V20, P191, DOI 10.1016/0047-2484(91)90073-5; ARSUAGA JL, 1993, NATURE, V362, P534, DOI 10.1038/362534a0; Arsuaga JL, 1997, J HUM EVOL, V33, P219, DOI 10.1006/jhev.1997.0133; Bayle P., 2017, PEOPLE PALOMAS NEAND, P115; Bayle P, 2012, SPY CAVE 125 YEARS M; Bayle P, 2010, P NATL ACAD SCI USA, V107, P1338, DOI 10.1073/pnas.0914202107; Bayle P, 2009, J HUM EVOL, V56, P66, DOI 10.1016/j.jhevol.2008.09.002; Been E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03025-z; Buck LT, 2014, CURR BIOL, V24, pR214, DOI 10.1016/j.cub.2013.12.048; Buti L, 2017, J HUM EVOL, V113, P162, DOI 10.1016/j.jhevol.2017.08.009; Coleman MN, 2007, AM J PHYS ANTHROPOL, V133, P723, DOI 10.1002/ajpa.20583; Daura J, 2017, P NATL ACAD SCI USA, V114, P3397, DOI 10.1073/pnas.1619040114; De Castro JMB, 2004, EVOL ANTHROPOL, V13, P25, DOI 10.1002/evan.10130; de Lumley MA, 2015, ANTHROPOLOGIE, V119, P303, DOI 10.1016/j.anthro.2015.06.001; Dean C, 2001, NATURE, V414, P628, DOI 10.1038/414628a; Dean D, 1998, J HUM EVOL, V34, P485, DOI 10.1006/jhev.1998.0214; DECASTRO JMB, 1988, J HUM EVOL, V17, P279; DECASTRO JMB, 1993, J HUM EVOL, V24, P339, DOI 10.1006/jhev.1993.1027; DECASTRO JMB, 1995, AM J PHYS ANTHROPOL, V96, P335, DOI 10.1002/ajpa.1330960403; Demuro M, 2019, J HUM EVOL, V131, P76, DOI 10.1016/j.jhevol.2018.12.003; Dennell RW, 2011, QUATERNARY SCI REV, V30, P1511, DOI 10.1016/j.quascirev.2009.11.027; Fajardo RJ, 2002, AM J PHYS ANTHROPOL, V118, P1, DOI 10.1002/ajpa.10086; Garcia-Campos C, 2019, CR PALEVOL, V18, P72, DOI 10.1016/j.crpv.2018.06.004; Goldberg Michel, 2011, Front Biosci (Elite Ed), V3, P711, DOI 10.2741/e281; Gomez-Robles A, 2007, J HUM EVOL, V53, P272, DOI 10.1016/j.jhevol.2007.02.002; Gomez-Robles A, 2008, J HUM EVOL, V55, P627, DOI 10.1016/j.jhevol.2008.03.011; Gomez-Robles A, 2015, J HUM EVOL, V82, P34, DOI 10.1016/j.jhevol.2015.02.013; Grine FE, 2005, AM J PHYS ANTHROPOL, V126, P14, DOI 10.1002/ajpa.10277; Grine FE, 2002, S AFR J SCI, V98, P503; Harvati K., 2007, MITT GESEL URGESCH, V16, P85; Horvath JE, 2014, J HUM EVOL, V73, P75, DOI 10.1016/j.jhevol.2014.01.005; Hublin JJ, 1998, NEANDERTALS AND MODERN HUMANS IN WESTERN ASIA, P295; Kono RT, 2004, ANTHROPOL SCI, V112, P121, DOI 10.1537/ase.03106; Kupczik K, 2010, J HUM EVOL, V59, P525, DOI 10.1016/j.jhevol.2010.05.009; Le Cabec A, 2013, J HUM EVOL, V64, P169, DOI 10.1016/j.jhevol.2012.08.011; Lieberman DE, 2011, EVOLUTION HUMAN HEAD; Lucas PW, 2008, J ANAT, V212, P486, DOI 10.1111/j.1469-7580.2008.00877.x; Macchiarelli R., 2013, ANTHR PERSPECTIVES T, P250, DOI DOI 10.1017/CBO9780511984464.011; Macchiarelli R, 2006, NATURE, V444, P748, DOI 10.1038/nature05314; de Castro JMB, 2019, QUATERNARY SCI REV, V217, P45, DOI 10.1016/j.quascirev.2018.04.003; de Castro JMB, 2013, QUATERN INT, V295, P102, DOI 10.1016/j.quaint.2012.02.036; MARTIN L, 1985, NATURE, V314, P260, DOI 10.1038/314260a0; Martin LB, 1983, RELATIONSHIPS LATE M; Martin-Albaladejo M, 2017, QUATERN INT, V433, P156, DOI 10.1016/j.quaint.2015.11.126; Martin-Frances L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203334; Martinez de Pinillos Gonzalez M, J HUMAN EVOLUT UNPUB; de Pinillos MM, 2014, CR PALEVOL, V13, P205, DOI 10.1016/j.crpv.2013.10.008; Martinon-Torres M, 2007, VERTEBR PALEOBIOL PA, P65, DOI 10.1007/978-1-4020-5845-5_5; Martinon-Torres M, 2018, CR PALEVOL, V17, P33, DOI 10.1016/j.crpv.2015.09.011; Martinon-Torres M, 2014, CR PALEVOL, V13, P223, DOI 10.1016/j.crpv.2013.12.002; Martinon-Torres M, 2012, J HUM EVOL, V62, P7, DOI 10.1016/j.jhevol.2011.08.007; Meyer M, 2016, NATURE, V531, P504, DOI 10.1038/nature17405; Meyer M, 2014, NATURE, V505, P403, DOI 10.1038/nature12788; MOLNAR S, 1971, AM J PHYS ANTHROPOL, V34, P175, DOI 10.1002/ajpa.1330340204; Olejniczak AJ, 2008, BIOL LETTERS, V4, P406, DOI 10.1098/rsbl.2008.0223; Olejniczak AJ, 2008, J HUM EVOL, V55, P12, DOI 10.1016/j.jhevol.2007.11.004; Pablos A, 2017, QUATERN INT, V433, P103, DOI 10.1016/j.quaint.2015.08.044; Rightmire GP, 2013, J HUM EVOL, V65, P223, DOI 10.1016/j.jhevol.2013.04.008; Rosas A, 2001, AM J PHYS ANTHROPOL, V114, P74, DOI 10.1002/1096-8644(200101)114:1<74::AID-AJPA1007>3.3.CO;2-L; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Skinner MM, 2016, J HUM EVOL, V93, P63, DOI 10.1016/j.jhevol.2016.01.010; Skinner MM, 2015, J HUM EVOL, V85, P35, DOI 10.1016/j.jhevol.2015.03.012; Smith TM, 2006, ARCH ORAL BIOL, V51, P974, DOI 10.1016/j.archoralbio.2006.04.012; Smith TM, 2007, P NATL ACAD SCI USA, V104, P20220, DOI 10.1073/pnas.0707051104; Smith TM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204737; Smith TM, 2012, J HUM EVOL, V62, P395, DOI 10.1016/j.jhevol.2011.12.004; Smith TM, 2010, P NATL ACAD SCI USA, V107, P20923, DOI 10.1073/pnas.1010906107; Sorenti M, 2019, AM J PHYS ANTHROPOL, V169, P332, DOI 10.1002/ajpa.23822; SPOOR CF, 1993, AM J PHYS ANTHROPOL, V91, P469, DOI 10.1002/ajpa.1330910405; Stringer C, 2012, EVOL ANTHROPOL, V21, P101, DOI 10.1002/evan.21311; Suwa G, 2005, ANTHROPOL SCI, V113, P273, DOI 10.1537/ase.050118; Toussaint M, 2010, J HUM EVOL, V58, P56, DOI 10.1016/j.jhevol.2009.09.006; Tuniz C, 2013, NUCL INSTRUM METH A, V711, P106, DOI 10.1016/j.nima.2013.01.046; Weber GW, 2011, VIRTUAL ANTHROPOLOGY: GUIDE TO A NEW INTERDISCIPLINARY FIELD, P1, DOI 10.1007/978-3-211-49347-2; Xing S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114265; Zanolli C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189773; Zanolli C, 2018, J HUM EVOL, V116, P1, DOI 10.1016/j.jhevol.2017.11.002; Zanolli C, 2017, CR PALEVOL, V16, P702, DOI 10.1016/j.crpv.2017.05.002; Zanolli C, 2015, AM J PHYS ANTHROPOL, V156, P148, DOI 10.1002/ajpa.22611; Zanolli C, 2014, J HUM EVOL, V74, P96, DOI 10.1016/j.jhevol.2014.04.005; Zanolli C, 2013, CR PALEVOL, V12, P293, DOI 10.1016/j.crpv.2013.06.004	84	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2020	15	6							e0233281	10.1371/journal.pone.0233281	http://dx.doi.org/10.1371/journal.pone.0233281			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LZ0RE	32511250	gold, Green Published, Green Accepted			2022-12-26	WOS:000540938100001
J	Huang, CS; Chen, CY; Huang, LK; Wang, WS; Yang, SH				Huang, Chih-Sheng; Chen, Chin-Yau; Huang, Li-Kuo; Wang, Wei-Shu; Yang, Shung-Haur			Prognostic value of postoperative serum carcinoembryonic antigen levels in colorectal cancer patients who smoke	PLOS ONE			English	Article							CIGARETTE-SMOKING; ELDERLY-PATIENTS; CEA; SURVIVAL; STAGE; ASSOCIATIONS; INFLAMMATION; DISEASE	Serum carcinoembryonic antigen (CEA) levels can help predict the prognosis of colorectal cancer patients. Accordingly, high preoperative CEA levels that is not restored after surgery are indicative of a worse outcome. On the other hand, smoking can increase serum CEA levels independently of the disease status. Thus, we aimed to evaluate the impact of smoking on the prognostic value of serum CEA levels. This retrospective cohort study included 273 patients who underwent curative resection for stage I-III colorectal adenocarcinoma at a single institution, between January 2010 and December 2017. Patients were grouped as follows: group A, normal preoperative and postoperative CEA levels (n = 152); group B, elevated preoperative CEA levels that returned to reference values after surgery (n = 69); and group C, elevated postoperative serum CEA levels (n = 52). Patients were also grouped according to their smoking history: group S (current smokers, n = 79) and group NS (never and former smokers, n = 194). Group A showed a higher 3-year disease-free survival (DFS) rate (84.9%) than groups B (75.4%) and C (62.0%) (p < 0.001). Postoperative serum CEA levels were significantly higher in the S group than in the NS group (2.6 vs. 3.1 ng/mL, p = 0.009), whereas preoperative levels were similar (3.8 vs. 4.1, p = 0.182). Further, smokers showed higher 3 year-DFS rates than nonsmokers in group C (83.3% vs. 43.9%, p = 0.029). This suggests that while elevated postoperative CEA levels are associated with lower DFS rates in never and former smokers, they are not associated with lower DFS rates in current smokers. We conclude that persistent smoking alters the prognostic value of postoperative serum CEA levels in colorectal cancer patients and that, consequently, alternative surveillance strategies need to be developed for colon cancer patients with smoking habits.	[Huang, Chih-Sheng; Chen, Chin-Yau; Yang, Shung-Haur] Natl Yang Ming Univ Hosp, Dept Surg, Yilan, Taiwan; [Huang, Chih-Sheng; Chen, Chin-Yau; Huang, Li-Kuo; Wang, Wei-Shu; Yang, Shung-Haur] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Huang, Li-Kuo] Natl Yang Ming Univ Hosp, Dept Radiol, Yilan, Taiwan; [Wang, Wei-Shu] Natl Yang Ming Univ Hosp, Dept Internal Med, Div Oncol, Yilan, Taiwan; [Yang, Shung-Haur] Taipei Vet Gen Hosp, Dept Surg, Div Colon & Rectal Surg, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Huang, CS (corresponding author), Natl Yang Ming Univ Hosp, Dept Surg, Yilan, Taiwan.; Huang, CS (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.	imalive20@hotmail.com		Huang, Chih-Sheng/0000-0001-7215-2589	National Yang-Ming University Hospital	National Yang-Ming University Hospital	National Yang-Ming University Hospital The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER JC, 1976, JAMA-J AM MED ASSOC, V235, P1975; [Anonymous], 2008, INT WOUND J S4, V5, piii, DOI DOI 10.1111/J.1742-1481X.2008.00537.X; ARNAUD JP, 1991, DIS COLON RECTUM, V34, P896, DOI 10.1007/BF02049704; Bhatti I, 2015, INT J SURG, V16, P123, DOI 10.1016/j.ijsu.2015.03.002; Boyle T, 2013, BRIT J CANCER, V109, P814, DOI 10.1038/bjc.2013.310; Carriquiry LA, 1999, DIS COLON RECTUM, V42, P921, DOI 10.1007/BF02237104; Chen CC, 2005, J SURG RES, V124, P169, DOI 10.1016/j.jss.2004.08.013; Choi Jin Sub, 1997, Yonsei Medical Journal, V38, P1; Compton C, 2000, CANCER-AM CANCER SOC, V88, P1739, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1739::AID-CNCR30>3.0.CO;2-T; Doat S, 2014, EUR J CANCER, V50, P1276, DOI 10.1016/j.ejca.2013.12.026; Edge SB, 2010, AJCC CANC STAGING MA; Fukuda I, 1998, J MED SYST, V22, P89, DOI 10.1023/A:1022643102208; Hermans E, 2010, J ONCOL, V2010, DOI 10.1155/2010/865908; Huang CS, 2014, AM J SURG, V208, P99, DOI 10.1016/j.amjsurg.2013.08.054; Japuntich SJ, 2019, NICOTINE TOB RES, V21, P497, DOI 10.1093/ntr/nty012; Jayasekara H, 2018, INT J CANCER, V142, P238, DOI 10.1002/ijc.31049; Konishi T, 2018, JAMA ONCOL, V4, P309, DOI 10.1001/jamaoncol.2017.4420; Lee J, 2012, J DENT RES, V91, P142, DOI 10.1177/0022034511421200; Lin JK, 2011, INT J COLORECTAL DIS, V26, P1135, DOI 10.1007/s00384-011-1209-5; Locker GY, 2006, J CLIN ONCOL, V24, P5313, DOI 10.1200/JCO.2006.08.2644; LOEWENSTEIN MS, 1978, CANCER, V42, P1412, DOI 10.1002/1097-0142(197809)42:3+<1412::AID-CNCR2820420805>3.0.CO;2-8; Lu J, 2018, DIABETES THER, V9, P209, DOI 10.1007/s13300-017-0356-2; McCleary NJ, 2010, CANCER-AM CANCER SOC, V116, P957, DOI 10.1002/cncr.24866; National Comprehensive Cancer Network, COL CANC VERS 1 2020; Pezzuto A, 2013, J COMP EFFECT RES, V2, P335, DOI [10.2217/cer.13.25, 10.2217/CER.13.25]; Phipps AI, 2013, J CLIN ONCOL, V31, P2016, DOI 10.1200/JCO.2012.46.2457; Phipps AI, 2011, CANCER-AM CANCER SOC, V117, P4948, DOI 10.1002/cncr.26114; ROHAN TE, 2000, COLORECTAL DIS, V2, P298; Simmonds P, 2000, LANCET, V356, P968, DOI 10.1016/S0140-6736(00)02713-6; SLENTZ K, 1994, AM SURGEON, V60, P528; STOCKLEY RA, 1986, THORAX, V41, P17, DOI 10.1136/thx.41.1.17; Tarantino I, 2012, BRIT J CANCER, V107, P266, DOI 10.1038/bjc.2012.267; Thirunavukarasu P, 2011, JNCI-J NATL CANCER I, V103, P689, DOI 10.1093/jnci/djr078; Wang JY, 2007, EUR SURG RES, V39, P245, DOI 10.1159/000101952	34	17	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0233687	10.1371/journal.pone.0233687	http://dx.doi.org/10.1371/journal.pone.0233687			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502149	gold, Green Published			2022-12-26	WOS:000542035700035
J	Pircher, M; Pitono, E; Pierre-Francois, S; Molcard, S; Brunier-Agot, L; Fagour, L; Napoullah, F; Cesaire, R; Abel, S; Cuzin, L; Cabie, A				Pircher, Mathilde; Pitono, Edwin; Pierre-Francois, Sandrine; Molcard, Sabine; Brunier-Agot, Lauren; Fagour, Laurence; Napoullah, Fatiha; Cesaire, Raymond; Abel, Sylvie; Cuzin, Lise; Cabie, Andre			The effects of chikungunya virus infection on people living with HIV during the 2014 Martinique outbreak	PLOS ONE			English	Article								Our objective was to describe the clinical presentation of chikungunya virus (CHIKV) infection in patients living with HIV (PLHIV) during the 2014 Martinique outbreak. During the outbreak and the 6 following months, all PLHIV coming in our unit for a medical evaluation answered questions about potential CHIKV related symptoms, and had blood tests to assess the diagnosis. For patients coming in at the acute phase of infection, we are able to provide and analyze CD4+, CD8+ T-cells and HIV viral load evolution before, during and after CHIK infection. Among the 1 003 PLHIV in care in the center at the time of the outbreak, 188 (94 men and 94 women) had confirmed (following the WHO definition) CHIKV infection. Clinical presentation was common in 63% of the cases, severe and atypical forms were scarce. During the acute phase, CD4+ and CD8+ T-cells (evaluated in 30 PLHIV, 15 men and 15 women) absolute numbers dropped significantly, but returned to pre-CHIKV values after the acute phase. Reassuringly, CD4 and CD8 T cells proportions did not decrease during the acute phase. CHIKV infection had no significant impact on this anti-retroviral treated population.	[Pircher, Mathilde; Pitono, Edwin; Pierre-Francois, Sandrine; Abel, Sylvie; Cuzin, Lise; Cabie, Andre] Univ Hosp Martinique, Infect Dis & Trop Med Unit, Fort De France, Martinique, France; [Molcard, Sabine] Univ Hosp Martinique, Unit Phys & Rehabil Med, Fort De France, Martinique, France; [Brunier-Agot, Lauren] Univ Hosp Martinique, Dept Rheumatol, Fort De France, Martinique, France; [Fagour, Laurence; Napoullah, Fatiha; Cesaire, Raymond] Univ Hosp Martinique, Virol Lab, Fort De France, Martinique, France; [Fagour, Laurence; Napoullah, Fatiha; Cesaire, Raymond; Abel, Sylvie; Cabie, Andre] Antilles Univ, EA 7524, Fort De France, Martinique, France; [Cuzin, Lise] Toulouse III Univ, INSERM, UMR1017, Toulouse, France; [Cabie, Andre] INSERM CIC1424, Fort De France, Martinique, France	CHU Martinique; CHU Martinique; CHU Martinique; CHU Martinique; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm)	Cuzin, L (corresponding author), Univ Hosp Martinique, Infect Dis & Trop Med Unit, Fort De France, Martinique, France.; Cuzin, L (corresponding author), Toulouse III Univ, INSERM, UMR1017, Toulouse, France.	lise.cuzin@chu-martinique.fr	Cuzin, Lise/AAF-8812-2020	Cuzin, Lise/0000-0002-6345-497X; Cabie, Andre/0000-0003-0117-3061; pitono, edwin/0000-0002-2511-0420				[Anonymous], 2014, DIABETES CARE, V1, pS14; [Anonymous], 2015, WKLY EPIDEMIOL REC, V90, P410; [Anonymous], 2009, EPIDEMIOLOGY INFECT, V137, P534; Couzigou B, 2018, AM J TROP MED HYG, V99, P182, DOI 10.4269/ajtmh.17-0543; Dorleans F, 2018, AM J TROP MED HYG, V98, P1819, DOI 10.4269/ajtmh.16-0719; Gerardin P, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-5; Ghiglione Y, 2016, AIDS, V30, P1905, DOI 10.1097/QAD.0000000000001129; HEATH CJ, 2018, OPEN FORUM INFECT DI, V5, DOI DOI 10.1093/OFID/OFX234; Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255; Pugliese P, 2009, HIV MED, V10, P504, DOI 10.1111/j.1468-1293.2009.00719.x; Sissoko D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000389; Wauquier N, 2011, J INFECT DIS, V204, P115, DOI 10.1093/infdis/jiq006; World Health Organization, GUID CLIN MAN CHIK F; Yactayo S, 2016, J INFECT DIS, V214, pS441, DOI 10.1093/infdis/jiw390	14	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0234267	10.1371/journal.pone.0234267	http://dx.doi.org/10.1371/journal.pone.0234267			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32503031	Green Published, gold			2022-12-26	WOS:000542035700068
J	Schumann, H; Rubagumya, K; Rubaihayo, J; Harms, G; Wanyenze, RK; Theuring, S				Schumann, Hannah; Rubagumya, Kenyonyozi; Rubaihayo, John; Harms, Gundel; Wanyenze, Rhoda K.; Theuring, Stefanie			The incidence of HIV and associated risk factors among pregnant women in Kabarole District, Uganda	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; TO-CHILD TRANSMISSION; ACQUISITION; PREVENTION; HIV/AIDS; PROPHYLAXIS; INFECTIONS; ALCOHOL; RAKAI; DRUGS	Objectives The study attempted to determine the incidence of HIV among pregnant women in Kabarole District, Uganda, and to identify socio-demographic and behavioral risk factors for seroconversion during pregnancy. Methods We carried out a retrospective cohort study among women for whom a documented HIV-negative test result from the first pregnancy trimester could be confirmed using available records, and who were HIV-retested in the third trimester or during delivery. In total, 1610 pregnant women from three different healthcare settings took part in the study. We captured the results of repeated HIV tests and conducted semi-structured interviews to explore participants' socio-demographic characteristics and sexual risk behavior. For HIV incidence rates, we calculated the number of seroconversions per 100 person-years. We used Fisher's exact test to test for potential associations. Penalized maximum likelihood logistic regression and Poisson regression were applied to adjust for potential confounders. Results The overall HIV incidence rate among participants was 2.9/100 women-years. Among socio-demographic characteristics, the multivariable analysis showed a significant association of marital status with HIV incidence in pregnancy (IRR 8.78, 95%CI [1.13-68.33]). Risky sexual behaviors including higher number of sexual partners in pregnancy (IRR 2.78 [1.30-5.94]), unprotected sex with unknown persons (IRR 14.25 [4.52-44.93]), alcohol abuse (IRR 12.08 [4.18-34.90]) and sex under the influence of drugs or alcohol (IRR 6.33 [1.36-29.49]) were significantly associated with seroconversion in pregnancy (similar results in logistic regression). Conclusions HIV incidence was three times higher among our pregnant study population compared to the general female population in Uganda. This underlines the importance of HIV prevention and repeat testing during pregnancy. Identified risk groups should be considered for pre-exposure prophylaxis.	[Schumann, Hannah; Harms, Gundel; Theuring, Stefanie] Charite Univ Med Berlin, Inst Trop Med & Int Hlth, Berlin, Germany; [Schumann, Hannah; Harms, Gundel; Theuring, Stefanie] Free Univ Berlin, Berlin, Germany; [Schumann, Hannah; Harms, Gundel; Theuring, Stefanie] Humboldt Univ, Berlin, Germany; [Schumann, Hannah; Harms, Gundel; Theuring, Stefanie] Berlin Inst Hlth, Berlin, Germany; [Rubagumya, Kenyonyozi; Rubaihayo, John] Mt Moon Univ, Sch Hlth Sci, Ft Portal, Uganda; [Wanyenze, Rhoda K.] Makerere Univ, Sch Publ Hlth, Kampala, Uganda	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Makerere University	Theuring, S (corresponding author), Charite Univ Med Berlin, Inst Trop Med & Int Hlth, Berlin, Germany.; Theuring, S (corresponding author), Free Univ Berlin, Berlin, Germany.; Theuring, S (corresponding author), Humboldt Univ, Berlin, Germany.; Theuring, S (corresponding author), Berlin Inst Hlth, Berlin, Germany.	stefanie.theuring@charite.de	Rubaihayo, John/HDO-2747-2022	Rubaihayo, Prof. John/0000-0002-3421-2242	H.W. & J. Hector Foundation, Germany	H.W. & J. Hector Foundation, Germany	The study was funded by the H.W. & J. Hector Foundation, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, NAT POP HOUS CENS 20; [Anonymous], 2016, UG HIV AIDS COUNTR P; [Anonymous], 2016, THE TOTAL AUDIENCE R; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baliunas D, 2010, INT J PUBLIC HEALTH, V55, P159, DOI 10.1007/s00038-009-0095-x; Campbell JC, 2008, INT J INJ CONTROL SA, V15, P221, DOI 10.1080/17457300802423224; Chetty T, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1421-6; Drake AL, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001608; Durevall D, 2015, LANCET GLOB HEALTH, V3, pE34, DOI 10.1016/S2214-109X(14)70343-2; Fatti G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181691; Friedman H, 2003, CLIN MICROBIOL REV, V16, P209, DOI 10.1128/CMR.16.2.209-219.2003; Friedman H, 2006, FEMS IMMUNOL MED MIC, V47, P330, DOI 10.1111/j.1574-695X.2006.00097.x; Grabowski MK, 2017, NEW ENGL J MED, V377, P2154, DOI [10.1056/NEJMoa1702150, 10.1056/nejmoa1702150]; Gray RH, 2005, LANCET, V366, P1182, DOI 10.1016/S0140-6736(05)67481-8; Health UMo, 2018, CONSOLIDATED GUIDELI, P1; Johnson LF, 2012, JAIDS-J ACQ IMM DEF, V59, P417, DOI 10.1097/QAI.0b013e3182432f27; Kharsany Ayesha B M, 2016, Open AIDS J, V10, P34, DOI 10.2174/1874613601610010034; Kinuthia J, 2015, AIDS, V29, P2025, DOI 10.1097/QAD.0000000000000793; Kouyoumdjian FG, 2013, AIDS, V27, P1331, DOI 10.1097/QAD.0b013e32835fd851; Marston M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082219; Ministry of Health, 2016, CONS GUID PREV TREAT; Moodley D, 2009, AIDS, V23, P1255, DOI 10.1097/QAD.0b013e32832a5934; Pandrea I, 2010, ALCOHOL RES HEALTH, V33, P203; Rehm J, 2017, POPUL HEALTH METR, V15, DOI 10.1186/s12963-017-0121-9; Rubaihayo J, 2010, INFECT DIS REP, V2, P40, DOI [10.4081/idr.2010.e13, 10.4081/idr.2010.1585]; Schnack A, 2016, AIDS PATIENT CARE ST, V30, P110, DOI 10.1089/apc.2015.0318; Shuper PA, 2014, AIDS BEHAV, V18, P398, DOI 10.1007/s10461-013-0554-5; Shuper PA, 2010, ALCOHOL ALCOHOLISM, V45, P159, DOI 10.1093/alcalc/agp091; Society for Endocrinology MaDoSAS, 2017, J ENDOCRINOL METAB D, V21, pS1; Taha TE, 1998, AIDS, V12, P1699, DOI 10.1097/00002030-199813000-00019; The Joint United Nations Programme on HIV/AIDS (UNAIDS), UNAIDS DAT 2018; Uganda Ministry of Health, 2016, NAT HIV TEST SERV PO; United Nations Population Fund (UNFPA), STAT HIV PREV 2017; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; World Health Organization, 2017, PREV HIV PREGN BREAS; World Health Organization (WHO), 2015, DAT GUID START ANT T; World Health Organization (WHO), 2015, HIV TEST SERV 2015; World Health Organization (WHO), 2012, HIV AIDS PROGR PROGR; Zablotska IB, 2006, AIDS, V20, P1191, DOI 10.1097/01.aids.0000226960.25589.72	39	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0234174	10.1371/journal.pone.0234174	http://dx.doi.org/10.1371/journal.pone.0234174			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502227	Green Published, gold			2022-12-26	WOS:000542035700045
J	Donegan, JJ; Boley, AM; Glenn, JP; Carless, MA; Lodge, DJ				Donegan, Jennifer J.; Boley, Angela M.; Glenn, Jeremy P.; Carless, Melanie A.; Lodge, Daniel J.			Developmental alterations in the transcriptome of three distinct rodent models of schizophrenia	PLOS ONE			English	Article							PRENATAL PROTEIN-MALNUTRITION; GENE-EXPRESSION; WORKING-MEMORY; IMMUNE ACTIVATION; BIPOLAR DISORDER; METHYLAZOXYMETHANOL ACETATE; INTERNEURON TRANSPLANTS; COGNITIVE DEFICITS; PREFRONTAL CORTEX; POSTMORTEM-BRAIN	Schizophrenia is a debilitating disorder affecting just under 1% of the population. While the symptoms of this disorder do not appear until late adolescence, pathological alterations likely occur earlier, during development in utero. While there is an increasing literature examining transcriptome alterations in patients, it is not possible to examine the changes in gene expression that occur during development in humans that will develop schizophrenia. Here we utilize three distinct rodent developmental disruption models of schizophrenia to examine potential overlapping alterations in the transcriptome, with a specific focus on markers of interneuron development. Specifically, we administered either methylazoxymethanol acetate (MAM), Polyinosinic:polycytidylic acid (Poly I:C), or chronic protein malnutrition, on GD 17 and examined mRNA expression in the developing hippocampus of the offspring 18 hours later. Here, we report alterations in gene expression that may contribute to the pathophysiology of schizophrenia, including significant alterations in interneuron development and ribosome function.	[Donegan, Jennifer J.; Boley, Angela M.; Lodge, Daniel J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Donegan, Jennifer J.; Boley, Angela M.; Lodge, Daniel J.] Univ Texas Hlth Sci Ctr San Antonio, Ctr Biomed Neurosci, San Antonio, TX 78229 USA; [Glenn, Jeremy P.; Carless, Melanie A.] Texas Biomed Res Inst, Populat Hlth Program, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Texas Biomedical Research Institute	Donegan, JJ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA.; Donegan, JJ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Ctr Biomed Neurosci, San Antonio, TX 78229 USA.	Donegan@uthscsa.edu		Boley, Angela/0000-0003-0253-1481; Donegan, Jennifer/0000-0002-7828-2429; Carless, Melanie/0000-0001-8350-2302	Owens Foundation; National Institute for Mental Health [R01 MH090067]; National Center for Advancing Translational Science [TL1TR002647]; National Institute of Mental Health [K99MH121355]	Owens Foundation; National Institute for Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Center for Advancing Translational Science; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Owens Foundation (DJL), R01 MH090067 (DJL) from the National Institute for Mental Health, by TL1TR002647 (JJD) from the National Center for Advancing Translational Science, and by K99MH121355 (JJD) from the National Institute of Mental Health. This content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Owens Foundation: NA NIMH: https://www.nimh.nih.gov/index.shtml NCATS: https://ncats.nih.gov/.	Aguilar DD, 2015, INCREASING ENDOCANNA; AKBARIAN S, 1995, ARCH GEN PSYCHIAT, V52, P258, DOI 10.1001/archpsyc.1995.03950160008002; Almeida SS, 1996, PHYSIOL BEHAV, V60, P197, DOI 10.1016/0031-9384(95)02236-8; [Anonymous], 2012, REGEN MED S3, V7, pS14; [Anonymous], 2015, DIABETOL KLIN SA, V4, pA1; Arnold SE, 2000, ANN NY ACAD SCI, V911, P275; Arnsten AFT, 2004, PSYCHOPHARMACOLOGY, V174, P25, DOI 10.1007/s00213-003-1724-3; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bendikov I, 2007, SCHIZOPHR RES, V90, P41, DOI 10.1016/j.schres.2006.10.010; Benes FM, 2007, P NATL ACAD SCI USA, V104, P10164, DOI 10.1073/pnas.0703806104; Boley AM, 2014, SCHIZOPHR RES, V157, P238, DOI 10.1016/j.schres.2014.05.005; Brown AS, 2008, SCHIZOPHRENIA BULL, V34, P1054, DOI 10.1093/schbul/sbn096; Brown AS, 2011, PROG NEUROBIOL, V93, P23, DOI 10.1016/j.pneurobio.2010.09.003; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; Brown AS, 2006, SCHIZOPHRENIA BULL, V32, P200, DOI 10.1093/schbul/sbj052; Brown AS, 2004, ARCH GEN PSYCHIAT, V61, P774, DOI 10.1001/archpsyc.61.8.774; Buka SL, 2001, ARCH GEN PSYCHIAT, V58, P1032, DOI 10.1001/archpsyc.58.11.1032; BUTLER PD, 1994, NEUROPSYCHOPHARMACOL, V11, P227, DOI 10.1038/sj.npp.1380109; Chevassus-au-Louis N, 1999, CELL MOL LIFE SCI, V55, P1206, DOI 10.1007/s000180050367; Corfas G, 2004, NAT NEUROSCI, V7, P575, DOI 10.1038/nn1258; Cruz-Rizzolo RJ, 2017, IBRO REP, V3, P65, DOI 10.1016/j.ibror.2017.08.002; Donegan JJ, 2017, MOL PSYCHIATR, V22, P1492, DOI 10.1038/mp.2016.121; Donegan JJ, 2018, NEUROPSYCHOPHARMACOL, V43, P1789, DOI 10.1038/s41386-018-0021-0; FEINBERG I, 1983, J PSYCHIAT RES, V17, P319, DOI 10.1016/0022-3956(82)90038-3; Flagstad P, 2005, NEUROPSYCHOPHARMACOL, V30, P250, DOI 10.1038/sj.npp.1300625; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Galehdari H, 2009, J MOL NEUROSCI, V38, P178, DOI 10.1007/s12031-008-9148-5; Giovanoli S, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.38; Glantz LA, 1997, ARCH GEN PSYCHIAT, V54, P943; Gourevitch R, 2004, BEHAV PHARMACOL, V15, P287, DOI 10.1097/01.fbp.0000135703.48799.71; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061; Guilmatre A, 2009, ARCH GEN PSYCHIAT, V66, P947, DOI 10.1001/archgenpsychiatry.2009.80; Harrison PJ, 2006, BIOL PSYCHIAT, V60, P132, DOI 10.1016/j.biopsych.2005.11.002; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Hashimoto T, 2003, J NEUROSCI, V23, P6315; Heckers S, 1998, NAT NEUROSCI, V1, P318, DOI 10.1038/1137; Heckers S, 2002, ARCH GEN PSYCHIAT, V59, P521, DOI 10.1001/archpsyc.59.6.521; Joseph Altman SAB, 1994, ATLAS PRENATAL RAT B; Joshi D, 2012, BIOL PSYCHIAT, V72, P725, DOI 10.1016/j.biopsych.2012.06.021; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Konradi C, 2011, SCHIZOPHR RES, V131, P165, DOI 10.1016/j.schres.2011.06.007; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kromkamp M, 2003, ARCH GEN PSYCHIAT, V60, P869, DOI 10.1001/archpsyc.60.9.869; Labrie V, 2009, HUM MOL GENET, V18, P3227, DOI 10.1093/hmg/ddp261; Le Pen G, 2006, NEUROSCIENCE, V143, P395, DOI 10.1016/j.neuroscience.2006.08.004; Linklaters Oppenhoff & Radler, 2002, BETRIEB, V55, P1; Lodge DJ, 2007, J NEUROSCI, V27, P11424, DOI 10.1523/JNEUROSCI.2847-07.2007; Lodge DJ, 2009, BEHAV BRAIN RES, V204, P306, DOI 10.1016/j.bbr.2009.01.031; Malaspina D, 1999, BIOL PSYCHIAT, V46, P89, DOI 10.1016/S0006-3223(98)00306-0; Maletic V, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00042; Mangale VS, 2008, SCIENCE, V319, P304, DOI 10.1126/science.1151695; Medoff DR, 2001, HIPPOCAMPUS, V11, P543; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Meyer U, 2012, NEUROPHARMACOLOGY, V62, P1308, DOI 10.1016/j.neuropharm.2011.01.009; Mirnics K, 2001, TRENDS NEUROSCI, V24, P479, DOI 10.1016/S0166-2236(00)01862-2; Mizukami K, 2000, NEUROSCI LETT, V283, P101, DOI 10.1016/S0304-3940(00)00939-3; Moghaddam B, 2012, NEUROPSYCHOPHARMACOL, V37, P4, DOI 10.1038/npp.2011.181; Moore H, 2006, BIOL PSYCHIAT, V60, P253, DOI 10.1016/j.biopsych.2006.01.003; Moreno-Kustner B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195687; Murray BG, 2017, NEUROBIOL LEARN MEM, V141, P150, DOI 10.1016/j.nlm.2017.04.005; Nam JW, 2014, MOL CELL, V53, P1031, DOI 10.1016/j.molcel.2014.02.013; Nelson MD, 1998, ARCH GEN PSYCHIAT, V55, P433, DOI 10.1001/archpsyc.55.5.433; Nishioka M, 2013, J HUM GENET, V58, P91, DOI 10.1038/jhg.2012.140; Niwa M, 2010, NEURON, V65, P480, DOI 10.1016/j.neuron.2010.01.019; NOPOULOS PC, 1995, PSYCHIAT RES-NEUROIM, V61, P11, DOI 10.1016/0925-4927(95)02573-G; Osborne AL, 2017, NEUROPSYCHOPHARMACOL, V42, P1447, DOI 10.1038/npp.2017.40; Osimo EF, 2018, MOL PSYCHIAT; Palmer AA, 2004, BRAIN RES, V996, P193, DOI 10.1016/j.brainres.2003.09.077; Perez SM, 2013, MOL PSYCHIATR, V18, P1193, DOI 10.1038/mp.2013.111; Perez SM, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0603-6; Perez SM, 2018, J NEUROSCI, V38, P10607, DOI 10.1523/JNEUROSCI.2629-16.2018; Piontkewitz Y, 2009, BIOL PSYCHIAT, V66, P1038, DOI 10.1016/j.biopsych.2009.07.005; Reisinger S, 2015, PHARMACOL THERAPEUT, V149, P213, DOI 10.1016/j.pharmthera.2015.01.001; Rossignol E, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/649325; Sanuki R, 2011, NAT NEUROSCI, V14, P1125, DOI 10.1038/nn.2897; Schobel SA, 2009, SCHIZOPHR RES, V114, P110, DOI 10.1016/j.schres.2009.07.016; Schobel SA, 2009, ARCH GEN PSYCHIAT, V66, P938, DOI 10.1001/archgenpsychiatry.2009.115; Shen YC, 2012, SCHIZOPHR RES, V137, P14, DOI 10.1016/j.schres.2012.01.028; Shi LM, 2003, J NEUROSCI, V23, P297, DOI 10.1523/jneurosci.23-01-00297.2003; St Clair D, 2005, JAMA-J AM MED ASSOC, V294, P557, DOI 10.1001/jama.294.5.557; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Sussel L, 1999, DEVELOPMENT, V126, P3359; Susser E, 1996, ARCH GEN PSYCHIAT, V53, P25; SUSSER ES, 1992, ARCH GEN PSYCHIAT, V49, P983; TONKISS J, 1990, BEHAV BRAIN RES, V40, P95, DOI 10.1016/0166-4328(90)90002-V; Topol A, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.118; Tyson JA, 2014, TRENDS NEUROSCI, V37, P169, DOI 10.1016/j.tins.2014.01.003; Vawter MP, 1999, MOL PSYCHIATR, V4, P467, DOI 10.1038/sj.mp.4000547; Volk DW, 2014, SCHIZOPHRENIA BULL, V40, P1053, DOI 10.1093/schbul/sbu068; Volk DW, 2012, AM J PSYCHIAT, V169, P1082, DOI 10.1176/appi.ajp.2012.12030305; Volk DW, 2000, ARCH GEN PSYCHIAT, V57, P237, DOI 10.1001/archpsyc.57.3.237; Volk DW, 2015, SCHIZOPHRENIA RES; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wassef A, 2003, J CLIN PSYCHOPHARM, V23, P601, DOI 10.1097/01.jcp.0000095349.32154.a5; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Zuckerman L, 2003, NEUROPSYCHOPHARMACOL, V28, P1778, DOI 10.1038/sj.npp.1300248	100	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0232200	10.1371/journal.pone.0232200	http://dx.doi.org/10.1371/journal.pone.0232200			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MA6PX	32497066	Green Published, gold			2022-12-26	WOS:000542035200097
J	Kim , H; Yi, JY; Kim, BG; Song, JE; Jeong, HJ; Kim, HR				Kim, Hyunjin; Yi, Joon-Yeop; Kim, Byung-Gee; Song, Ji Eun; Jeong, Hee-Jin; Kim, Hye Rim			Development of cellulose-based conductive fabrics with electrical conductivity and flexibility	PLOS ONE			English	Article							CARBON NANOTUBE NANOCOMPOSITES; BACTERIAL CELLULOSE; EMULSION POLYMERIZATION; MICELLE POLYMERIZATION; METHYLCELLULOSE; COMPOSITES; NANOCRYSTALS; DBSA; ROUTE; YARNS	This study aimed to produce cellulose-based conductive fabrics with electrical conductivity and flexibility. Bacterial cellulose (BC) and three chemical cellulose (CC), namely methyl cellulose (MC), hydroxypropyl cellulose (HPMC) and carboxymethyl cellulose (CMC) were in situ polymerized with aniline and the four conductive cellulose fabrics were compared and evaluated. Matrix-assisted laser desorption/ionization time-of-flight mass spectroscopy analysis confirmed that three CC-PANI composites displayed longer and more stable polymerization pattern than BC-PANI because of the different polymerization method: bulk polymerization for BC-PANI and emulsion polymerization for CC-PANI, respectively. The electrical conductivity of BC-PANI and CC-PANI were ranging from 0.962 x 10(-2) S/cm to 2.840 x 10(-2) S/cm. MC-PANI showed the highest electrical conductivity among the four conductive cellulose fabrics. The flexibility and crease recovery results showed that MC-PANI had the highest flexibility compared to BC-PANI, HPMC-PANI, and CMC-PANI. These results have confirmed that the electrical conductivity and flexibility were influenced by the type of cellulose, and MC-PANI was found to have the best performance in the electrical conductivity and flexibility.	[Kim, Hyunjin; Kim, Hye Rim] Sookmyung Womens Univ, Dept Clothing & Text, Seoul, South Korea; [Yi, Joon-Yeop; Kim, Byung-Gee] Seoul Natl Univ, Interdisciplinary Program Bioengn, Seoul, South Korea; [Yi, Joon-Yeop; Kim, Byung-Gee] Seoul Natl Univ, Inst Mol Biol & Genet, Seoul, South Korea; [Kim, Byung-Gee] Seoul Natl Univ, Sch Chem & Biol Engn, Seoul, South Korea; [Song, Ji Eun] Korea Inst Ind Technol, Human Convergence Technol Grp, Ansan, South Korea; [Jeong, Hee-Jin] Hongik Univ, Dept Biol & Chem Engn, Sejong, South Korea	Sookmyung Women's University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Korea Institute of Industrial Technology (KITECH); Hongik University	Kim, HR (corresponding author), Sookmyung Womens Univ, Dept Clothing & Text, Seoul, South Korea.; Jeong, HJ (corresponding author), Hongik Univ, Dept Biol & Chem Engn, Sejong, South Korea.	heejinjeong@hongik.ac.kr; khyerim@sookmyung.ac.kr	Jeong, Hee-Jin/AGR-3650-2022; kim, byung-gee/AAR-1933-2020	Jeong, Hee-Jin/0000-0001-5897-1756; Kim, Hyunjin/0000-0003-2445-7016	National Research Foundation of Korea (NRF) - Korean government (MSIT) [2019R1A2C1009217]; NRF - Ministry of Science, ICT & Future Planning [NRF-2017R1E1A1A01073523, NRF-2017M3A9B6062989, NRF-2016S1A5A2A03926786]; NRF - Korean government (MSIT) [2018R1C1B5044988]; 2019 Hongik University Research Fund, Korea	National Research Foundation of Korea (NRF) - Korean government (MSIT)(National Research Foundation of Korea); NRF - Ministry of Science, ICT & Future Planning; NRF - Korean government (MSIT)(National Research Foundation of Korea); 2019 Hongik University Research Fund, Korea	HJK and HRK were funded by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (Grant No. 2019R1A2C1009217). BGK was funded by the NRF grant funded by the Ministry of Science, ICT & Future Planning (NRF-2017R1E1A1A01073523, NRF-2017M3A9B6062989, NRF-2016S1A5A2A03926786), HJJ was funded by the NRF grant funded by the Korean government (MSIT) (Grant No. 2018R1C1B5044988), and the 2019 Hongik University Research Fund, Korea.	[Anonymous], 2010, SHANGHAI URBAN PLANN, V2010, P1; Arboleya JC, 2005, FOOD HYDROCOLLOID, V19, P485, DOI 10.1016/j.foodhyd.2004.10.013; Ashjaran A, 2013, ASIAN J CHEM, V25, P783, DOI 10.14233/ajchem.2013.12898; Ashjaran A, 2013, J TEXT I, V104, P121, DOI 10.1080/00405000.2012.703796; Barakzehi M, 2019, ELECTROCHIM ACTA, V305, P187, DOI 10.1016/j.electacta.2019.03.058; Bhadra J, 2017, ARAB J CHEM, V10, P664, DOI 10.1016/j.arabjc.2015.04.017; Butoi B, 2017, POLYMERS-BASEL, V9, DOI 10.3390/polym9120732; Chang CY, 2011, CARBOHYD POLYM, V84, P40, DOI 10.1016/j.carbpol.2010.12.023; Chattopadhyay D, 1996, LANGMUIR, V12, P1585, DOI 10.1021/la950523y; Chen T, 2009, POLYM DEGRAD STABIL, V94, P1788, DOI 10.1016/j.polymdegradstab.2009.06.011; Cho MS, 2004, MAT SCI ENG C-BIO S, V24, P15, DOI 10.1016/j.msec.2003.09.003; Ciric-Marjanovic G, 2013, SYNTHETIC MET, V177, P1, DOI 10.1016/j.synthmet.2013.06.004; Cochis A, 2017, SCI REP-UK, V7, DOI 10.1038/srep45018; Cochrane C, 2007, SENSORS-BASEL, V7, P473, DOI 10.3390/s7040473; Fei GQ, 2019, ACS SUSTAIN CHEM ENG, V7, P8215, DOI 10.1021/acssuschemeng.8b06306; George J, 2015, NANOTECHNOL SCI APPL, V8, P45, DOI 10.2147/NSA.S64386; George J, 2014, CARBOHYD POLYM, V105, P285, DOI 10.1016/j.carbpol.2014.01.057; Guo GZ, 2019, INT J ELECTROCHEM SC, V14, P5899, DOI 10.20964/2019.06.220; Han DX, 2005, COLLOID SURFACE A, V259, P179, DOI 10.1016/j.colsurfa.2005.02.017; Han J, 2019, TEXT RES J, V89, P1094, DOI 10.1177/0040517518763989; Han YG, 2009, SYNTHETIC MET, V159, P123, DOI 10.1016/j.synthmet.2008.08.011; Hebeish A, 2013, CARBOHYD POLYM, V92, P407, DOI 10.1016/j.carbpol.2012.08.094; Huang QY, 2016, ADV ENERGY MATER, V6, DOI 10.1002/aenm.201600783; Jafari Y, 2017, IRAN J CHEM CHEM ENG, V36, P23; Jeevananda T, 2008, POLYM ADVAN TECHNOL, V19, P1754, DOI 10.1002/pat.1191; Ji YX, 2015, DYES PIGMENTS, V117, P72, DOI 10.1016/j.dyepig.2015.01.026; Jia B, 2007, REACT FUNCT POLYM, V67, P836, DOI 10.1016/j.reactfunctpolym.2007.01.005; KAKDE K, 2017, INDIAN J SCI TECHNOL, V10, P1; Karaoglan N, 2018, ENG SCI TECHNOL, V21, P1152, DOI 10.1016/j.jestch.2018.09.010; Kaur G, 2015, RSC ADV, V5, P37553, DOI 10.1039/c5ra01851j; Khan RA, 2012, RADIAT PHYS CHEM, V81, P927, DOI 10.1016/j.radphyschem.2012.02.044; Khan RA, 2012, J APPL POLYM SCI, V123, P1690, DOI 10.1002/app.34655; Kim B, 2006, J APPL POLYM SCI, V101, P1252, DOI 10.1002/app.22799; Kim H, 2020, TEXT RES J, V90, P1517, DOI 10.1177/0040517519893717; Kizildag N, 2013, INT IST TEXT C 2013, P1; Lee YH, 2013, NANO LETT, V13, P5753, DOI 10.1021/nl403860k; Liu L, 2007, ADV FUNCT MATER, V17, P2343, DOI 10.1002/adfm.200600785; Maity D, 2012, CARBOHYD POLYM, V90, P1818, DOI 10.1016/j.carbpol.2012.07.082; Majumder S, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17010130; Micusik M, 2007, SYNTHETIC MET, V157, P914, DOI 10.1016/j.synthmet.2007.09.001; Mokhtar N, 2017, POLYM POLYM COMPOS, V25, P545, DOI 10.1177/096739111702500706; Mostafaei A, 2012, PROG NAT SCI-MATER, V22, P273, DOI 10.1016/j.pnsc.2012.07.002; Mu B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05755-6; Oh M, 2012, ELECTROCHIM ACTA, V59, P196, DOI 10.1016/j.electacta.2011.10.058; Palaniappan S, 2008, PROG POLYM SCI, V33, P732, DOI 10.1016/j.progpolymsci.2008.02.002; Park JS, 2001, CARBOHYD POLYM, V46, P373, DOI 10.1016/S0144-8617(00)00336-2; Petersson L, 2006, COMPOS SCI TECHNOL, V66, P2187, DOI 10.1016/j.compscitech.2005.12.010; Radhakrishnan S, 2011, J APPL POLYM SCI, V122, P1510, DOI 10.1002/app.34236; Rahman MA, 2008, SENSORS-BASEL, V8, P118, DOI 10.3390/s8010118; Rao PS, 2002, SYNTHETIC MET, V128, P311, DOI 10.1016/S0379-6779(02)00016-4; Salama A, 2018, INT J BIOL MACROMOL, V106, P940, DOI 10.1016/j.ijbiomac.2017.08.097; Sambasevam KP, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.41746; Singh RK, 2013, J THERM ANAL CALORIM, V114, P809, DOI 10.1007/s10973-013-3032-4; Song JE, 2017, ENG LIFE SCI, V17, P1108, DOI 10.1002/elsc.201700085; Swamy TMM, 2009, J APPL POLYM SCI, V112, P2235, DOI 10.1002/app.29738; Tang SJ, 2011, POLYM J, V43, P667, DOI 10.1038/pj.2011.43; Trache D, 2017, NANOSCALE, V9, P1763, DOI 10.1039/c6nr09494e; Trivedi M.K., 2015, INT J BIOMEDICAL MAT, V3, P83, DOI 10.11648/j.ijbmr.20150306.12; Yoon SB, 2011, J POWER SOURCES, V196, P10791, DOI 10.1016/j.jpowsour.2011.08.107; Yue LN, 2017, COMPOS SCI TECHNOL, V145, P122, DOI 10.1016/j.compscitech.2017.04.002; Yun YJ, 2013, ADV MATER, V25, P5701, DOI 10.1002/adma.201303225; Zhou NY, 1998, TEXT RES J, V68, P533	62	3	3	15	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0233952	10.1371/journal.pone.0233952	http://dx.doi.org/10.1371/journal.pone.0233952			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32498075	Green Published, gold			2022-12-26	WOS:000542035200064
J	Resende-Lara, PT; Perahia, D; Scott, AL; Braz, ANSK				Resende-Lara, Pedro Tulio; Perahia, David; Scott, Ana Ligia; Braz, Antonio Sergio Kimus			Unveiling functional motions based on point mutations in biased signaling systems: A normal mode study on nerve growth factor bound to TrkA	PLOS ONE			English	Article							IMMUNOGLOBULIN-LIKE DOMAIN; MOLECULAR-DYNAMICS; RECEPTOR-BINDING; CRYSTAL-STRUCTURE; ALLOSTERIC NETWORKS; CARBOXYL-TERMINUS; NGF; AGONISM; COMPLEX; NEUROTROPHIN	Many receptors elicit signal transduction by activating multiple intracellular pathways. This transduction can be triggered by a non-specific ligand, which simultaneously activates all the signaling pathways of the receptors. However, the binding of one biased ligand preferentially trigger one pathway over another, in a process called biased signaling. The identification the functional motions related to each of these distinct pathways has a direct impact on the development of new effective and specific drugs. We show here how to detect specific functional motions by considering the case of the NGF/TrkA-Ig2 complex. NGF-mediated TrkA receptor activation is dependent on specific structural motions that trigger the neuronal growth, development, and survival of neurons in nervous system. The R221W mutation in the ngf gene impairs nociceptive signaling. We discuss how the large-scale structural effects of this mutation lead to the suppression of collective motions necessary to induce TrkA activation of nociceptive signaling. Our results suggest that subtle changes in the NGF interaction network due to the point mutation are sufficient to inhibit the motions of TrkA receptors putatively linked to nociception. The methodological approach presented in this article, based jointly on the normal mode analysis and the experimentally observed functional alterations due to point mutations provides an essential tool to reveal the structural changes and motions linked to the disease, which in turn could be necessary for a drug design study.	[Resende-Lara, Pedro Tulio; Scott, Ana Ligia; Braz, Antonio Sergio Kimus] Univ Fed ABC, Lab Biol Computac & Bioinformat, Santo Andre, SP, Brazil; [Resende-Lara, Pedro Tulio; Perahia, David] Ecole Normale Super Paris Saclay, LabBiol & Pharmacol Appl, Cachan, Ile De France, France	Universidade Federal do ABC (UFABC); UDICE-French Research Universities; Universite Paris Saclay	Braz, ANSK (corresponding author), Univ Fed ABC, Lab Biol Computac & Bioinformat, Santo Andre, SP, Brazil.	antonio.braz@ufabc.edu.br	SCOTT, ANA LIGIA/AAF-5939-2021; de Resende-Lara, Pedro Túlio/AAE-2325-2019	SCOTT, ANA LIGIA/0000-0002-8053-1834; de Resende-Lara, Pedro Túlio/0000-0001-8197-3899; perahia, david/0000-0001-7480-3349	Centre Nationale de Recherche Scientifique (CNRS, France); Region Ile-de-France; Universidade Federal do ABC (UFABC); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [88881.133141/201601]	Centre Nationale de Recherche Scientifique (CNRS, France); Region Ile-de-France(Region Ile-de-France); Universidade Federal do ABC (UFABC); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was performed using HPC resources from the "Mesocentre" computing center of Centrale Supelec andE cole Normale Superieure Paris-Saclay supported by Centre Nationale de Recherche Scientifique (CNRS, France) and Region Ile-de-France (http://mesocentre.centralesupelec.fr/).We gratefully acknowledge financial support from Universidade Federal do ABC (UFABC) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), process number: 88881.133141/201601 to PTRL.	[Anonymous], 2021, LANG ENV STAT COMP; Arevalo JC, 2000, MOL CELL BIOL, V20, P5908, DOI 10.1128/MCB.20.16.5908-5916.2000; Arevalo JC, 2001, ONCOGENE, V20, P1229, DOI 10.1038/sj.onc.1204215; BENOVIC JL, 1986, P NATL ACAD SCI USA, V83, P2797, DOI 10.1073/pnas.83.9.2797; Bradshaw R. A., 2013, Advances in Biological Regulation, V53, P87, DOI 10.1016/j.jbior.2012.10.006; Brahimi F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089617; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Capsoni S, 2014, EUR J NEUROSCI, V39, P392, DOI 10.1111/ejn.12461; Capsoni S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017321; Carleton LA, 2018, BIOCHEM BIOPH RES CO, V495, P700, DOI 10.1016/j.bbrc.2017.11.003; Carvalho OP, 2011, J MED GENET, V48, P131, DOI 10.1136/jmg.2010.081455; Costa MGS, 2015, J CHEM THEORY COMPUT, V11, P2755, DOI 10.1021/acs.jctc.5b00003; Covaceuszach S, 2010, BIOCHEM BIOPH RES CO, V391, P824, DOI 10.1016/j.bbrc.2009.11.146; DRINKWATER CC, 1993, J BIOL CHEM, V268, P23202; Ehlert FJ, 2015, TRENDS PHARMACOL SCI, V36, P596, DOI 10.1016/j.tips.2015.05.008; Einarsdottir E, 2004, HUM MOL GENET, V13, P799, DOI 10.1093/hmg/ddh096; Floquet N, 2009, J MOL BIOL, V385, P653, DOI 10.1016/j.jmb.2008.10.032; Freed DM, 2017, CELL, V171, P683, DOI 10.1016/j.cell.2017.09.017; Fribourg M, 2011, CELL, V147, P1011, DOI 10.1016/j.cell.2011.09.055; Gasper PM, 2012, P NATL ACAD SCI USA, V109, P21216, DOI 10.1073/pnas.1218414109; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gong Y, 2008, NATURE, V454, P789, DOI 10.1038/nature07089; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Griffin JH, 2015, BLOOD, V125, P2898, DOI 10.1182/blood-2015-02-355974; Guarnera E, 2016, CURR OPIN STRUC BIOL, V37, P1, DOI 10.1016/j.sbi.2015.10.004; Guo MH, 1996, PROTEIN SCI, V5, P447; Gur M, 2013, BIOPHYS J, V105, P1643, DOI 10.1016/j.bpj.2013.07.058; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Houlden H, 2001, ANN NEUROL, V49, P521; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IBANEZ CF, 1993, EMBO J, V12, P2281, DOI 10.1002/j.1460-2075.1993.tb05882.x; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; IBANEZ CF, 1990, EMBO J, V9, P1477, DOI 10.1002/j.1460-2075.1990.tb08265.x; Ikeda Y, 2015, INT HEART J, V56, P485, DOI 10.1536/ihj.15-256; Khajehali E, 2015, MOL PHARMACOL, V88, P368, DOI 10.1124/mol.115.099192; Kruttgen A, 1997, J BIOL CHEM, V272, P29222, DOI 10.1074/jbc.272.46.29222; Larsson E, 2009, NEUROBIOL DIS, V33, P221, DOI 10.1016/j.nbd.2008.10.012; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Leach K, 2015, TRENDS PHARMACOL SCI, V36, P215, DOI 10.1016/j.tips.2015.02.004; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Livnah O, 1998, NAT STRUCT BIOL, V5, P993, DOI 10.1038/2965; Longo Frank M., 2005, Current Medicinal Chemistry - Central Nervous System Agents, V5, P29; Longo FM, 2013, NAT REV DRUG DISCOV, V12, P507, DOI 10.1038/nrd4024; Mantyh PW, 2011, ANESTHESIOLOGY, V115, P189, DOI 10.1097/ALN.0b013e31821b1ac5; Marlin MC, 2015, INT REV CEL MOL BIO, V314, P239, DOI 10.1016/bs.ircmb.2014.10.002; Maruyama IN, 2014, CELLS-BASEL, V3, P304, DOI 10.3390/cells3020304; McGibbon RT, 2015, BIOPHYS J, V109, P1528, DOI 10.1016/j.bpj.2015.08.015; Mehta HM, 2012, J NEUROSCI RES, V90, P2259, DOI 10.1002/jnr.23116; Mischel PS, 2002, BIOPHYS J, V83, P968, DOI 10.1016/S0006-3495(02)75222-3; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; O'Connell L, 2000, J BIOL CHEM, V275, P7870, DOI 10.1074/jbc.275.11.7870; Oksanen J, 2015, VEGAN COMMUNITY ECOL, V2, P2; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Pattarawarapan M, 2003, J MED CHEM, V46, P5277, DOI 10.1021/jm030221q; PERAHIA D, 1995, COMPUT CHEM, V19, P241, DOI 10.1016/0097-8485(95)00011-G; Rankovic Z, 2016, BIOORG MED CHEM LETT, V26, P241, DOI 10.1016/j.bmcl.2015.12.024; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Reyes CM, 2001, BIOPHYS J, V80, P2833, DOI 10.1016/S0006-3495(01)76250-9; Rizzi C, 2018, GLIA, V66, P1395, DOI 10.1002/glia.23312; Scarabelli G, 2014, BIOPHYS J, V107, P2204, DOI 10.1016/j.bpj.2014.09.019; Scarpi D, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.80; Schrodinger L.L.C., 2015, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S13398-014-0173-7.2; Sengmany K, 2017, NEUROPHARMACOLOGY, V115, P60, DOI 10.1016/j.neuropharm.2016.07.001; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Settanni G, 2003, BIOPHYS J, V84, P2282, DOI 10.1016/S0006-3495(03)75034-6; Shen JY, 2011, FEBS LETT, V585, P295, DOI 10.1016/j.febslet.2010.12.031; SHIH A, 1994, J BIOL CHEM, V269, P27679; Stolzenberg S, 2016, BBA-BIOMEMBRANES, V1858, P1652, DOI 10.1016/j.bbamem.2016.01.010; Sung KJ, 2018, J NEUROSCI, V38, P3394, DOI 10.1523/JNEUROSCI.1686-17.2018; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; Thompson GL, 2015, MOL PHARMACOL, V88, P335, DOI 10.1124/mol.115.098848; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; Urfer R, 1998, J BIOL CHEM, V273, P5829, DOI 10.1074/jbc.273.10.5829; URFER R, 1995, EMBO J, V14, P2795, DOI 10.1002/j.1460-2075.1995.tb07279.x; Van Wart AT, 2014, J CHEM THEORY COMPUT, V10, P511, DOI 10.1021/ct4008603; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wiesmann C, 1999, NATURE, V401, P184, DOI 10.1038/43705; Wisler JW, 2014, CURR OPIN CELL BIOL, V27, P18, DOI 10.1016/j.ceb.2013.10.008; Yao XQ, 2016, J PHYS CHEM B, V120, P8276, DOI 10.1021/acs.jpcb.6b01991; Yao XQ, 2016, J BIOL CHEM, V291, P4742, DOI 10.1074/jbc.M115.702605; Zhang Q, 2014, J ALZHEIMERS DIS, V40, P605, DOI 10.3233/JAD-130017	83	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0231542	10.1371/journal.pone.0231542	http://dx.doi.org/10.1371/journal.pone.0231542			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497034	gold, Green Published, Green Submitted			2022-12-26	WOS:000542035200028
J	Frangez, Z; Fernandez-Marrero, Y; Stojkov, D; Jafari, SMS; Hunger, RE; Djonov, V; Riether, C; Simon, HU				Frangez, Ziva; Fernandez-Marrero, Yuniel; Stojkov, Darko; Jafari, S. Morteza Seyed; Hunger, Robert E.; Djonov, Valentin; Riether, Carsten; Simon, Hans-Uwe			BIF-1 inhibits both mitochondrial and glycolytic ATP production: its downregulation promotes melanoma growth	ONCOGENE			English	Article							INTERACTING FACTOR-I; BAX; METABOLISM; PROTEIN; DOMAIN; EXPRESSION; GENERATION; CURVATURE; MEMBRANES; METFORMIN	Endophilin B1, also known as BAX-interacting protein 1 (BIF-1), is part of the endophilin B protein family, and is a multifunctional protein involved in the regulation of apoptosis, autophagy, and mitochondrial morphology. The role of BIF-1 in cancer is controversial since previous reports indicated to both tumor-promoting and tumor-suppressive roles, perhaps depending on the cancer cell type. In the present study, we report that BIF-1 is significantly downregulated in both primary and metastatic melanomas, and that patients with high levels of BIF-1 expression exhibited a better overall survival. Depleting BIF-1 using CRISPR/Cas9 technology in melanoma cells resulted in higher proliferation rates both in vitro and in vivo, a finding that was associated with increased ATP production, metabolic acidification, and mitochondrial respiration. We also observed mitochondrial hyperpolarization, but no increase in the mitochondrial content of BIF-1-knockout melanoma cells. In contrast, such knockout melanoma cells were equally sensitive to anticancer drug- or UV irradiation-induced cell death, and exhibited similar autophagic activities as compared with control cells. Taken together, it appears that downregulation of BIF-1 contributes to tumorigenesis in cutaneous melanoma by upregulating mitochondrial respiration and metabolism, independent of its effect on apoptosis and autophagy.	[Frangez, Ziva; Fernandez-Marrero, Yuniel; Stojkov, Darko; Simon, Hans-Uwe] Univ Bern, Inst Pharmacol, Bern, Switzerland; [Jafari, S. Morteza Seyed; Hunger, Robert E.] Univ Bern, Bern Univ Hosp, Dept Dermatol, Inselspital, Bern, Switzerland; [Djonov, Valentin] Univ Bern, Inst Anat, Bern, Switzerland; [Riether, Carsten] Univ Bern, Dept Biomed Res, Tumor Immunol, Bern, Switzerland; [Riether, Carsten] Univ Bern, Bern Univ Hosp, Dept Med Oncol, Inselspital, Bern, Switzerland; [Simon, Hans-Uwe] Sechenov Univ, Dept Clin Immunol & Allergol, Moscow, Russia	University of Bern; University of Bern; University Hospital of Bern; University of Bern; University of Bern; University of Bern; University Hospital of Bern; Sechenov First Moscow State Medical University	Simon, HU (corresponding author), Univ Bern, Inst Pharmacol, Bern, Switzerland.; Simon, HU (corresponding author), Sechenov Univ, Dept Clin Immunol & Allergol, Moscow, Russia.	hus@pki.unibe.ch	Jafari, S. Morteza Seyed/AAV-9160-2020; Simon, Hans-Uwe/AAU-7410-2020; Riether, Carsten/ABC-7699-2021; Riether, Carsten/K-8603-2013	Jafari, S. Morteza Seyed/0000-0002-6466-2199; Simon, Hans-Uwe/0000-0002-9404-7736; Riether, Carsten/0000-0001-7512-513X; Riether, Carsten/0000-0001-7512-513X; Frangez, Ziva/0000-0002-9164-7656	Swiss National Science Foundation [310030_184816]; European Union [642295]; Microscopy Imaging Center of the University of Bern	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission); Microscopy Imaging Center of the University of Bern	This work was supported by the Swiss National Science Foundation (310030_184816 to H.U.S.) and the European Union Horizon 2020 Research and Innovation Program (Marie Sklodowska-Curie grant No. 642295; MEL-PLEX). Z.F. is a PhD student of the Graduate School of Cellular and Biomedical Sciences of the University of Bern. Images were acquired on equipment supported by the Microscopy Imaging Center of the University of Bern.	Amini P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05387-y; Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5; Coppola D, 2008, CANCER-AM CANCER SOC, V113, P2665, DOI 10.1002/cncr.23892; Cuddeback SM, 2001, J BIOL CHEM, V276, P20559, DOI 10.1074/jbc.M101527200; Diepart C, 2012, CANCER RES, V72, P482, DOI 10.1158/0008-5472.CAN-11-1755; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Fan RG, 2012, ONCOL LETT, V3, P851, DOI 10.3892/ol.2012.562; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Giachino C, 1997, GENOMICS, V41, P427, DOI 10.1006/geno.1997.4645; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huttner WB, 2000, CURR OPIN NEUROBIOL, V10, P543, DOI 10.1016/S0959-4388(00)00126-4; Jiao L, 2018, AUTOPHAGY, V14, P671, DOI 10.1080/15548627.2017.1381804; Karbowski M, 2004, J CELL BIOL, V166, P1027, DOI 10.1083/jcb.200407046; Kim SY, 2008, PATHOLOGY, V40, P553, DOI 10.1080/00313020802320440; Kjaerulff O, 2011, CELL BIOCHEM BIOPHYS, V60, P137, DOI 10.1007/s12013-010-9137-5; Koritzinsky M, 2015, INT J RADIAT ONCOL, V93, P454, DOI 10.1016/j.ijrobp.2015.06.003; Liu H, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005864; Loll PJ, 2008, ACTA CRYSTALLOGR F, V64, P243, DOI 10.1107/S1744309108007574; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Mauthe M, 2018, AUTOPHAGY, V14, P1435, DOI 10.1080/15548627.2018.1474314; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Pierrat B, 2001, GENOMICS, V71, P222, DOI 10.1006/geno.2000.6378; Rozman S, 2015, CELL DEATH DIFFER, V22, P445, DOI 10.1038/cdd.2014.169; Schlauder SM, 2009, J CUTAN PATHOL, V36, P21, DOI 10.1111/j.1600-0560.2007.00945.x; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Simon N, 1998, FEBS LETT, V435, P25, DOI 10.1016/S0014-5793(98)01033-3; Takahashi Y, 2005, MOL CELL BIOL, V25, P9369, DOI 10.1128/MCB.25.21.9369-9382.2005; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Takahashi Y, 2011, AUTOPHAGY, V7, P61, DOI 10.4161/auto.7.1.14015; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang DB, 2014, J NEUROSCI, V34, P2674, DOI 10.1523/JNEUROSCI.4074-13.2014; Weinberg SE, 2015, NAT CHEM BIOL, V11, P9, DOI 10.1038/nchembio.1712; Wheaton WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02242; Xu L, 2016, ONCOL REP, V36, P3513, DOI 10.3892/or.2016.5172; Yamaguchi H, 2008, J BIOL CHEM, V283, P19112, DOI 10.1074/jbc.M709882200; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Zannella VE, 2013, CLIN CANCER RES, V19, P6741, DOI 10.1158/1078-0432.CCR-13-1787	39	5	6	2	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 25	2020	39	26					4944	4955		10.1038/s41388-020-1339-8	http://dx.doi.org/10.1038/s41388-020-1339-8		JUN 2020	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	MQ2YO	32493957				2022-12-26	WOS:000537926600001
J	Albakheet, SS; Yoon, H; Shin, HJ; Koh, H; Kim, S; Lee, MJ				Albakheet, Salman S.; Yoon, Haesung; Shin, Hyun Joo; Koh, Hong; Kim, Seung; Lee, Mi-Jung			Bone marrow fat change in pediatric patients with non-alcoholic fatty liver disease	PLOS ONE			English	Article							INSULIN-RESISTANCE; MINERAL DENSITY; ADOLESCENTS; CHILDREN; PREVALENCE; MUSCLES	Objectives To investigate changes of fat in bone marrow (BM) and paraspinal muscle (PSM) associated with the degree of fatty liver in pediatric patients with non-alcoholic fatty liver disease (NAFLD) in consideration of age and body mass index (BMI). Methods Hepatic fat, BM fat, and PSM fat from proton density fat fraction of liver MRI between June 2015 and April 2019 were quantitatively evaluated on axial images of the fat map at the midlevel of T11-L2 vertebral bodies for BM fat and at the mid-level of L2 for PSM fat. Age, height, and weight at the time of MRI were recorded and BMI was calculated. Correlation analysis was performed. Results A total of 147 patients (114 male) were included with a mean age of 13.3 +/- 2.9 years (range 7-18 years). The mean fat fractions were 24.3 +/- 13.0% (2-53%) in liver, 37.4 +/- 8.6% (17.356%) in vertebral BM, and 2.7 +/- 1.1% (1.0-6.9%) in PSM. Age, height, weight, and BMI were not correlated with liver fat or BM fat. However, weight (rho = 0.174, p = 0.035) and BMI (rho = 0.247, p = 0.003) were positively correlated with PSM fat. Liver fat showed positive correlation with BM fat when adjusting age and BMI (rho = 0.309, p< 0.001), but not with PSM fat. Conclusions BM fat positively correlates with liver fat, but not with age or BMI in pediatric NAFLD patients.	[Albakheet, Salman S.; Yoon, Haesung; Shin, Hyun Joo; Lee, Mi-Jung] Yonsei Univ, Res Inst Radiol Sci, Severance Pediat Liver Dis Res Grp, Dept Radiol,Severance Hosp,Coll Med, Seoul, South Korea; [Albakheet, Salman S.] King Faisal Gen Hosp, Dept Radiol, Al Hufuf, Saudi Arabia; [Koh, Hong; Kim, Seung] Yonsei Univ, Div Gastroenterol Hepatol & Nutr, Severance Pediat Liver Dis Res Grp, Dept Pediat,Severance Childrens Hosp,Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, MJ (corresponding author), Yonsei Univ, Res Inst Radiol Sci, Severance Pediat Liver Dis Res Grp, Dept Radiol,Severance Hosp,Coll Med, Seoul, South Korea.	mjl1213@yuhs.ac	Albakheet, Salman S./AAE-6554-2019	Kim, Seung/0000-0003-4373-9828; Yoon, Haesung/0000-0003-0581-8656; Shin, Hyun Joo/0000-0002-7462-2609; Lee, Mi-Jung/0000-0003-3244-9171; Albakheet, Salman/0000-0001-5998-0355				Bredella MA, 2013, RADIOLOGY, V269, P533, DOI 10.1148/radiol.13130375; Bush H, 2017, CHILDREN-BASEL, V4, DOI 10.3390/children4060048; Carr RM, 2016, GASTROENTEROL CLIN N, V45, P639, DOI 10.1016/j.gtc.2016.07.003; Chan Y H, 2003, Singapore Med J, V44, P614; Cordes C, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00074; Crawford RJ, 2016, AM J NEURORADIOL, V37, P742, DOI 10.3174/ajnr.A4596; D'Adamo E, 2010, DIABETES CARE, V33, P1817, DOI 10.2337/dc10-0284; Dahlqvist JR, 2017, MED SCI SPORT EXER, V49, P595, DOI 10.1249/MSS.0000000000001119; Deivanayagam S, 2008, AM J CLIN NUTR, V88, P257, DOI 10.1093/ajcn/88.2.257; Fonvig CE, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0513-6; Fonvig CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135018; Giorgio V, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-40; Hawkes CP, 2019, BONE, V119, P57, DOI 10.1016/j.bone.2018.03.012; Jimenez-Rivera C, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0867-z; Knight JA, 2011, ANN CLIN LAB SCI, V41, P107; Lionetti L, 2009, NUTR METAB CARDIOVAS, V19, P146, DOI 10.1016/j.numecd.2008.10.010; Lomonaco R, 2011, THER ADV ENDOCRINOL, V2, P211, DOI 10.1177/2042018811419157; Mantovani A, 2019, HEPATOLOGY, V70, P812, DOI 10.1002/hep.30538; Pardee PE, 2012, ALIMENT PHARM THER, V35, P248, DOI 10.1111/j.1365-2036.2011.04924.x; Razek AAKA, 2018, CLIN IMAG, V51, P318, DOI 10.1016/j.clinimag.2018.06.011; RICCI C, 1990, RADIOLOGY, V177, P83, DOI 10.1148/radiology.177.1.2399343; Schwimmer JB, 2006, PEDIATRICS, V118, P1388, DOI 10.1542/peds.2006-1212; Schwimmer JB, 2008, CIRCULATION, V118, P277, DOI 10.1161/CIRCULATIONAHA.107.739920; Selvakumar PKC, 2017, PEDIATR CLIN N AM, V64, P659, DOI 10.1016/j.pcl.2017.01.008; Shin HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117480; Singhal V, 2018, BONE, V116, P203, DOI 10.1016/j.bone.2018.08.009; Sun Y, 2019, DIABET METAB SYND OB, V12, P199, DOI 10.2147/DMSO.S192256; Surowska A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010209; Vajro P, 2012, J PEDIATR GASTR NUTR, V54, P700, DOI 10.1097/MPG.0b013e318252a13f; Xanthakos SA, 2015, GASTROENTEROLOGY, V149, P623, DOI 10.1053/j.gastro.2015.05.039; Yu EL, 2019, J PEDIATR-US, V207, P64, DOI 10.1016/j.jpeds.2018.11.021; Yu NY, 2017, CLIN RADIOL, V72, DOI 10.1016/j.crad.2016.11.017	32	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2020	15	6							e0234096	10.1371/journal.pone.0234096	http://dx.doi.org/10.1371/journal.pone.0234096			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MT4VF	32484830	Green Published, gold			2022-12-26	WOS:000554969700034
J	Sun, FH; Lai, XP; Shen, JQ; Nie, LB; Gao, X				Sun, Fuhua; Lai, Xiuping; Shen, Juqin; Nie, Libing; Gao, Xin			Initial allocation of flood drainage rights based on a PSR model and entropy-based matter-element theory in the Sunan Canal, China	PLOS ONE			English	Article							HEALTH-ASSESSMENT; RIVER-BASIN; RISK; CLIMATE; REDUCTION; FRAMEWORK; PRESSURE; PATHWAYS; SECURITY; STATE	The pursuit of flood prevention safety and the mitigation of drainage contradiction against an unnecessary influx of floodwater require a modern and efficient model to optimize the management of the initial allocation of flood drainage rights. We attempted to formulate a framework for initial flood drainage rights allocation to promote the sustainable drainage of the Sunan Canal, China. The Pressure-State-Response (PSR) model was constructed using a literature review and interviews with experts and directors using 18 key indicators being determined from field surveys and library studies. We then assessed the flood status of Zhenjiang City, Changzhou City, Wuxi City and Suzhou City in the Sunan Canal zone using an entropy-based matter-element model. The flood drainage rights for a total of 400m(3)/s was allocated to the four cities in accordance with their flood status. Our research demonstrated that, overall, the four cities may gain the flood drainage rights of 106.67m(3)/s,120.40m(3)/s, 118.22m(3)/s and 54.71m(3)/s, respectively. Specifically, the calculation of the flood drainage for Wuxi was very close to the actual allocation in 2016, whereas there were differences in the other cities that should not be neglected.	[Sun, Fuhua; Shen, Juqin] Hohai Univ, Coll Agr Sci Engn, Nanjing, Jiangsu, Peoples R China; [Lai, Xiuping; Gao, Xin] Hohai Univ, Business Sch, Nanjing, Jiangsu, Peoples R China; [Nie, Libing] Wuhan Univ, Econ & Management Sch, Wuhan, Hubei, Peoples R China	Hohai University; Hohai University; Wuhan University	Lai, XP (corresponding author), Hohai Univ, Business Sch, Nanjing, Jiangsu, Peoples R China.	laixiup@163.com			Fundamental Research Funds for the Central Universities [2018B58814]; Water Conservancy Science and Technology Project of Jiangsu Province, China [2019013]; Social Science Foundation of Jiangsu Province of China [19GLD002]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Water Conservancy Science and Technology Project of Jiangsu Province, China; Social Science Foundation of Jiangsu Province of China	FS, XL, and JS are supported by the research grants from "the Fundamental Research Funds for the Central Universities" No. 2018B58814 (http://hhbs.hhu.edu.cn/2018/1102/c6691a180735/page.htm), "Water Conservancy Science and Technology Project of Jiangsu Province, China" No. 2019013 (http://zrkxc.yzu.edu.cn/) and "Social Science Foundation of Jiangsu Province of China"No. 19GLD002 (http://jspopss.jschina.com.cn/).None of the sponsors or funders play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, except the "Water Conservancy Science and Technology Project of Jiangsu Province, China", who helped to collect data.	Bates B.C., 2008, CLIMATE CHANGE WATER; Brombach H., 2002, URBAN STORM WATER PR, P1; Cai W, 1999, CHINESE SCI BULL, V44, P1538, DOI 10.1007/BF02886090; CAI W, 1983, SCI EXPLORATION, V3, P83; Cave RR, 2003, SCI TOTAL ENVIRON, V314, P31, DOI 10.1016/S0048-9697(03)00093-7; Deng XJ, 2015, ECOL INDIC, V57, P85, DOI 10.1016/j.ecolind.2015.04.020; Eckart K, 2018, J HYDROL, V562, P564, DOI 10.1016/j.jhydrol.2018.04.068; Ellis JB, 2014, CLEAN-SOIL AIR WATER, V42, P153, DOI 10.1002/clen.201300225; [范子武 Fan Ziwu], 2010, [水利水运工程学报, Hydro-Science and Engineering], P22; Fang H, 2012, DISASTER ADV, V5, P855; Han GY, 2011, INT J DISAST RISK SC, V2, P21, DOI 10.1007/s13753-011-0013-8; He YH, 2018, STOCH ENV RES RISK A, V32, P3083, DOI 10.1007/s00477-018-1526-0; Hellmers S, 2018, J FLOOD RISK MANAG, V11, pS5, DOI 10.1111/jfr3.12146; Kundzewicz ZW, 2019, ADV WATER RESOUR, V130, P37, DOI 10.1016/j.advwatres.2019.05.020; Kundzewicz ZW, 2018, P NATL ACAD SCI USA, V115, P12321, DOI 10.1073/pnas.1818227115; Kundzewicz ZW, 1999, HYDROLOG SCI J, V44, P559, DOI 10.1080/02626669909492252; Lai XP, J EC WATER RES; Li B, 2009, IN C IND ENG ENG MAN, P2458, DOI 10.1109/IEEM.2009.5373514; Li DD, 2011, ADV RES AUTOMATION C, P225; Liu C, 2007, CHINESE GEOGR SCI, V17, P99, DOI 10.1007/s11769-007-0099-5; Men BH, 2018, WATER SCI TECH-W SUP, V18, P1956, DOI 10.2166/ws.2018.017; Meyar-Naimi H, 2012, ENERG POLICY, V43, P351, DOI 10.1016/j.enpol.2012.01.012; Ministry of Water Resources of the People's Republic of China, 2018, CHIN FLOOD DROUGHT D; Newton A, 2014, ESTUAR COAST SHELF S, V140, P123, DOI 10.1016/j.ecss.2013.10.010; Office of Flood Control and Drought Relief Headquarters in Jiangsu Province, 2016, COMP FLOOD DROUGHT P, P182; Office of National Flood Control and Drought Relief Headquarters Nanjing Institute of Hydrological and Water Resources of the Ministry of Water Resources, 1997, WAT DROUGHT CHIN DIS; Sahoo MM, 2017, EUR J ENVIRON CIV EN, V21, P730, DOI 10.1080/19648189.2016.1150895; Salemi M, 2019, INT J SUST DEV WORLD, V26, P354, DOI 10.1080/13504509.2019.1570379; Seo JP, 2015, J HYDROINFORM, V17, P211, DOI 10.2166/hydro.2014.058; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shen J., 2019, RESOUR IND, V21, P39; Shi PJ, 2005, INT J WATER RESOUR D, V21, P613, DOI 10.1080/07900620500258455; Sun BD, 2019, OCEAN COAST MANAGE, V168, P41, DOI 10.1016/j.ocecoaman.2018.10.026; Trenberth KE, 1998, CLIMATIC CHANGE, V39, P667, DOI 10.1023/A:1005319109110; WANG W, 2019, WATER-SUI, V11, DOI DOI 10.3390/W11081537; Wu X, 2019, ECOL INDIC, V102, P469, DOI 10.1016/j.ecolind.2019.02.057; Wu YN, 2017, STOCH ENV RES RISK A, V31, P935, DOI 10.1007/s00477-016-1262-2; Yong X, 2019, CONCURR COMP-PRACT E, V31, DOI 10.1002/cpe.5010; [于凤存 Yu Fengcun], 2014, [灌溉排水学报, Journal of Irrigation and Drainage], V33, P134; Yu FC, 2013, APPL MECH MATER, V405-408, P2208, DOI 10.4028/www.scientific.net/AMM.405-408.2208; Zhang DD, 2019, WATER-SUI, V11, DOI 10.3390/w11091769; [张劲松 Zhang Jinsong], 2019, [水资源保护, Water Resources Protection], V35, P25; Zhang K.Z., 2019, J HENAN U SOCIAL SCI, V59, P21; Zhang KZ, 2019, WATER-SUI, V11, DOI 10.3390/w11061190; [张雷 Zhang Lei], 2019, [中国人口·资源与环境, China Population Resources and Environment], V29, P110; Zhao YW, 2019, ECOL INDIC, V99, P324, DOI 10.1016/j.ecolind.2018.12.023; Zhou QQ, 2014, WATER-SUI, V6, P976, DOI 10.3390/w6040976; Zhu FL, 2016, J HYDROINFORM, V18, P531, DOI 10.2166/hydro.2015.055	48	8	8	8	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0233570	10.1371/journal.pone.0233570	http://dx.doi.org/10.1371/journal.pone.0233570			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MJ2AA	32479523	Green Published, gold			2022-12-26	WOS:000547893500016
J	Petersen, J; Kontsevaya, A; McKee, M; Kudryavtsev, AV; Malyutina, S; Cook, S; Leon, DA				Petersen, Jakob; Kontsevaya, Anna; McKee, Martin; Kudryavtsev, Alexander V.; Malyutina, Sofia; Cook, Sarah; Leon, David A.			Untreated hypertension in Russian 35-69 year olds - a cross-sectional study	PLOS ONE			English	Article							QUESTIONNAIRE	Background The Russian Federation has among the highest rates of cardiovascular disease (CVD) in the world and a high rate of untreated hypertension remains an important risk factor. Understanding who is at greatest risk is important to inform approaches to primary prevention. Methods 2,353 hypertensive 35-69 year olds were selected from a population-based study, Know Your Heart, conducted in Arkhangelsk and Novosibirsk, Russian Federation, 2015-2018. The associations between untreated hypertension and a range of co-variates related to socio-demographics, health, and health behaviours were examined. Results The age-standardised prevalence of untreated hypertension was 51.1% (95% CI 47.8-54.5) in males, 28.8% (25.4-32.5) in females, and 40.0% (37.5-42.5) overall. The factors associated with untreated hypertension relative to treated hypertension were younger ages, self-rated general health as very good-excellent, not being obese, no history of CVD events, no evidence of diabetes or chronic kidney disease, and not seeing a primary care doctor in the past year as well as problem drinking for women and working full time, lower education, and smoking for men. Conclusion The study found relatively high prevalence of untreated hypertension, especially, in men. Recent initiatives to strengthen primary care provision and implementation of a general health check programme (dispansarisation) are promising, although further studies should evaluate other, potentially more effective strategies tailored to the particular circumstances of this population.	[Petersen, Jakob; McKee, Martin; Leon, David A.] London Sch Hyg & Trop Med, London, England; [Kontsevaya, Anna] Minist Healthcare, Natl Res Ctr Prevent Med, Moscow, Russia; [Kudryavtsev, Alexander V.] Northern State Med Univ, Arkhangelsk, Russia; [Malyutina, Sofia] Russian Acad Sci, Branch Inst Cytol & Genet, Siberian Branch, Res Inst Internal & Prevent Med, Novosibirsk, Russia; [Malyutina, Sofia] Novosibirsk State Med Univ, Russian Minist Hlth, Novosibirsk, Russia; [Cook, Sarah; Leon, David A.] UiT Arctic Univ Norway, Dept Community Med, Tromso, Norway	University of London; London School of Hygiene & Tropical Medicine; National Medical Research Center for Therapy & Preventive Medicine; Northern State Medical University; Russian Academy of Sciences; Ministry of Health of the Russian Federation; Novosibirsk State Medical University; UiT The Arctic University of Tromso	Petersen, J (corresponding author), London Sch Hyg & Trop Med, London, England.	j.petersen@ucl.ac.uk	Kudryavtsev, Alexander V./C-8817-2013; Malyutina, Sofia/J-1651-2018; Petersen, Jakob/AAQ-4677-2021	Kudryavtsev, Alexander V./0000-0001-8902-8947; Malyutina, Sofia/0000-0001-6539-0466; Petersen, Jakob/0000-0002-6659-7028; Cook, Sarah/0000-0003-1250-2967	Wellcome Trust Strategic Award [100217]; UiT The Arctic University of Norway (UiT); Norwegian Institute of Public Health; Norwegian Ministry of Health and Care Services; ESRC [ES/L011840/1] Funding Source: UKRI	Wellcome Trust Strategic Award(Wellcome Trust); UiT The Arctic University of Norway (UiT); Norwegian Institute of Public Health; Norwegian Ministry of Health and Care Services; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Know Your Heat (KYH) is a component of International Project on Cardiovascular Disease in Russia (IPCDR) and funded by Wellcome Trust Strategic Award [100217; received by DAL], UiT The Arctic University of Norway (UiT), Norwegian Institute of Public Health, and Norwegian Ministry of Health and Care Services. URLs (Accessed 12 November 2019): https://wellcome.ac.uk/https://en.uit.no/startsida https://www.fhi.no/en/https://www.regjeringen.no/en/dep/hod/id421/.	Babor T.F., 2001, ALCOHOL USE DISORDER; Balanova YA, 2019, RATION PHARMACOTHER, V15, P450, DOI 10.20996/1819-6446-2019-15-4-450-466; Beaney T, 2019, EUR HEART J, V40, P2006, DOI 10.1093/eurheartj/ehz300; Bland M, 2015, INTRO MED STAT; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; Cook Sarah, 2018, Wellcome Open Res, V3, P67, DOI [10.12688/wellcomeopenres.14619.2, 10.12688/wellcomeopenres.14619.3]; de Waard AKM, 2018, EUR J PREV CARDIOL, V25, P1326, DOI 10.1177/2047487318780751; Dryden R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-723; Eurostat, 2013, REV EUR STAND POP; Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Kontsevaya AV, 2015, RATION PHARMACOTHER, V11, P238, DOI 10.20996/1819-6446-2015-11-3-238-246; Marshall IJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e3953; Mills KT, 2018, ANN INTERN MED, V168, P110, DOI 10.7326/M17-1805; Moody A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010155; Morgan KE, 2019, INT J EPIDEMIOL, V48, P1721, DOI 10.1093/ije/dyz055; Peters T, 2012, EUR J EPIDEMIOL, V27, P15, DOI 10.1007/s10654-011-9625-y; Petersen Jakob, 2016, Prev Med Rep, V4, P81, DOI 10.1016/j.pmedr.2016.05.007; Pogosova N, 2018, EUR J PREV CARDIOL, V25, P1725, DOI 10.1177/2047487318768030; Pogosova N, 2017, CARDIOVASC DIAGN THE, V7, pS48, DOI 10.21037/cdt.2017.03.01; Russian Ministry of Health, 2019, APPR PREV MED EX PRO; SabatU E., 2003, ADHERENCE LONG TERM; Schwalm JD, 2019, LANCET, V394, P1231, DOI 10.1016/S0140-6736(19)31949-X; Sheiman I, 2018, RISK MANAG HEALTHC P, V11, P209, DOI 10.2147/RMHP.S168399; Spring B, 2012, J PUBLIC HEALTH-UK, V34, pI3, DOI 10.1093/pubmed/fdr111; StataCorp, 2017, STAT STAT SOFTW REL; Tillmann T, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002459; Victor RG, 2018, NEW ENGL J MED, V378, P1291, DOI 10.1056/NEJMoa1717250; WHOCC, 2019, ATC DDD IND 2019; Williams B, 2018, BLOOD PRESSURE, V27, P314, DOI [10.1080/08037051.2018.1527177, 10.1097/HJH.0000000000001961]; Zhou B, 2019, LANCET, V394, P639, DOI 10.1016/S0140-6736(19)31145-6	31	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2020	15	5							e0233801	10.1371/journal.pone.0233801	http://dx.doi.org/10.1371/journal.pone.0233801			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1WS	32470073	Green Published, gold			2022-12-26	WOS:000537552800185
J	Inoda, S; Hayashi, T; Takahashi, H; Oyakawa, I; Yokogawa, H; Kobayashi, A; Kato, N; Kawashima, H				Inoda, Satoru; Hayashi, Takahiko; Takahashi, Hidenori; Oyakawa, Itaru; Yokogawa, Hideaki; Kobayashi, Akira; Kato, Naoko; Kawashima, Hidetoshi			Factors associated with endothelial cell density loss post Descemet membrane endothelial keratoplasty for bullous keratopathy in Asia	PLOS ONE			English	Article							GRAFT-SURVIVAL; PENETRATING KERATOPLASTY; CORNEAL ENDOTHELIUM; SURGICAL INDICATION; RISK-FACTORS; EYES; OUTCOMES	Purpose To investigate the factors associated with endothelial survival after Descemet's membrane endothelial keratoplasty (DMEK) in eyes of Asian patients with bullous keratopathy (BK). Methods In this retrospective, consecutive interventional case series, 72 eyes of 72 patients who underwent DMEK were evaluated. Best corrected visual acuity (BCVA) and corneal endothelial cell density (ECD) were assessed at 12 months postoperatively. Multiple regression analysis was performed to assess parameters such as age, sex, axial length, preoperative visual acuity, re-bubbling, the ratio of graft to cornea area, iris damage scores, types of filling gases, air or SF(6)volume in the anterior chamber (AC) on postoperative day 1, and ECD loss rates at 12 months postoperatively. Results BCVA improved significantly at 12 months after DMEK (P< .001). The rate of ECD loss at 12 months after DMEK was 54.4 +/- 16.1%. Multiple linear regression analysis showed that a larger ratio of graft to corneal area (P= 0.0061) and higher donor ECD (P= 0.042) were the primary factors for a lower ECD loss rate at 12 months after DMEK. Conclusion A relatively larger graft size compared to the host cornea and more donor ECD might help endothelial survival in patients with BK. Moreover, for such patients, the surgeon should attempt to use a relatively larger graft size when performing DMEK, particularly in Asian eyes.	[Inoda, Satoru; Hayashi, Takahiko; Takahashi, Hidenori] Jichi Med Univ, Dept Ophthalmol, Shimotsuke, Tochigi, Japan; [Hayashi, Takahiko] Univ Cologne, Dept Ophthalmol, Cologne, Germany; [Hayashi, Takahiko; Kato, Naoko] Yokohama Minami Kyosai Hosp, Dept Ophthalmol, Yokohama, Kanagawa, Japan; [Oyakawa, Itaru] Heart Life Hosp, Dept Ophthalmol, Nakagusuku, Okinawa, Japan; [Oyakawa, Itaru] Univ Ryukyus, Dept Ophthalmol, Nishihara, Okinawa, Japan; [Yokogawa, Hideaki; Kobayashi, Akira; Kawashima, Hidetoshi] Kanazawa Univ, Grad Sch Med Sci, Dept Ophthalmol, Kanazawa, Ishikawa, Japan; [Kato, Naoko] Minamiaoyama Eye Clin, Tokyo, Japan	Jichi Medical University; University of Cologne; University of the Ryukyus; Kanazawa University	Hayashi, T (corresponding author), Jichi Med Univ, Dept Ophthalmol, Shimotsuke, Tochigi, Japan.; Hayashi, T (corresponding author), Univ Cologne, Dept Ophthalmol, Cologne, Germany.; Hayashi, T (corresponding author), Yokohama Minami Kyosai Hosp, Dept Ophthalmol, Yokohama, Kanagawa, Japan.	takamed@gmail.com	Hayashi, Takahiko/ABB-7168-2020	Hayashi, Takahiko/0000-0001-8704-680X; Kato, Naoko/0000-0002-6670-2043; Takahashi, Hidenori/0000-0001-5331-4730; Inoda, Satoru/0000-0003-4577-8169	Japan Eye Bank Association	Japan Eye Bank Association	Minamiaoyama Eye Clinic provided support in the form of salaries for author NK, and this work was supported by the Japan Eye Bank Association (http://www.j-eyebank.or.jp).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldave AJ, 2014, CORNEA, V33, P223, DOI 10.1097/ICO.0000000000000028; Ang M, 2016, OPHTHALMOLOGY, V123, P1646, DOI 10.1016/j.ophtha.2016.04.049; Anshu A, 2012, OPHTHALMOLOGY, V119, P1982, DOI 10.1016/j.ophtha.2012.04.031; Baydoun L, 2015, JAMA OPHTHALMOL, V133, P1277, DOI 10.1001/jamaophthalmol.2015.3064; Birbal RS, 2020, AM J OPHTHALMOL, V212, P79, DOI 10.1016/j.ajo.2019.12.011; Borkar DS, 2016, CORNEA, V35, P1267, DOI 10.1097/ICO.0000000000000915; Dirisamer M, 2011, AM J OPHTHALMOL, V152, P543, DOI 10.1016/j.ajo.2011.03.031; Eye Bank Association of America, 2018 EYE BANK STAT R; Eye bank Association of America, 2016 EYE BANKING STA; Ezon I, 2013, OPHTHALMOLOGY, V120, P1360, DOI 10.1016/j.ophtha.2012.12.036; Giasson CJ, 2007, OPHTHALMOLOGY, V114, P1469, DOI 10.1016/j.ophtha.2006.11.022; Gov N, 2011, NAT MATER, V10, P412, DOI 10.1038/nmat3036; Heinzelmann S, 2016, GRAEF ARCH CLIN EXP, V254, P515, DOI 10.1007/s00417-015-3248-z; Hoppenreijs VPT, 1996, SURV OPHTHALMOL, V41, P155, DOI 10.1016/S0039-6257(96)80005-1; Hos D, 2017, OPHTHALMOLOGY, V124, P512, DOI 10.1016/j.ophtha.2016.12.017; Inoue T, 2016, JPN J OPHTHALMOL, V60, P349, DOI 10.1007/s10384-016-0459-8; Ishii N, 2016, SCI REP-UK, V6, DOI 10.1038/srep25276; Jacobi C, 2011, AM J OPHTHALMOL, V152, P537, DOI 10.1016/j.ajo.2011.04.005; Kang JJ, 2016, CORNEA, V35, P1520, DOI 10.1097/ICO.0000000000001058; Koizumi N, 2014, CORNEA, V33, pS25, DOI 10.1097/ICO.0000000000000240; Nahum Y, 2015, CORNEA, V34, P876, DOI 10.1097/ICO.0000000000000455; Patel HY, 2011, CORNEA, V30, P760, DOI 10.1097/ICO.0b013e3182014668; Romano V, 2015, BRIT J OPHTHALMOL, V99, P784, DOI 10.1136/bjophthalmol-2014-305648; Schrittenlocher S, 2019, ACTA OPHTHALMOL, V97, pE618, DOI 10.1111/aos.13943; Shimizu T, 2018, CORNEA, V37, P1355, DOI 10.1097/ICO.0000000000001698; Siggel R, 2015, GRAEF ARCH CLIN EXP, V253, P817, DOI 10.1007/s00417-014-2850-9; Tambe DT, 2011, NAT MATER, V10, P469, DOI [10.1038/NMAT3025, 10.1038/nmat3025]; Tan GS, 2012, BMC MED IMAGING, V12, DOI 10.1186/1471-2342-12-19; Varadaraj V, 2017, J GLAUCOMA, V26, P566, DOI 10.1097/IJG.0000000000000669	29	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234202	10.1371/journal.pone.0234202	http://dx.doi.org/10.1371/journal.pone.0234202			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525919	Green Published, gold			2022-12-26	WOS:000542036800045
J	Wang, CD; Li, YQ; MaiTiSaiYiDi, T; Yang, HJ; Yang, KL				Wang, CaiDie; Li, YuQi; MaiTiSaiYiDi, TunNiSa; Yang, HongJian; Yang, KaiLun			Effect of dietary gossypol supplement on fermentation characteristics and bacterial diversity in the rumen of sheep	PLOS ONE			English	Article							IN-VITRO; COTTONSEED; DETOXIFICATION; SEQUENCES; GROWTH; ACID	The tolerance of ruminants to gossypol, a natural phenolic compound derived from the cotton plant, is greater than that of monogastric animals, partially because of the gossypol-degrading bacteria in the rumen of the ruminants. In this study, we aimed to examine the effect of gossypol supplementation on fermentation characteristics, bacterial alpha-diversity and community structure in the rumen fluid of sheep to analyse the change of bacterial in response to gossypol. 8 sheep with permanent fistula were randomly divided into 2 groups, a control and gossypol acetate supplementation groups. Sheep in the latter group were supplemented with gossypol acetate at the levels of 600 mg and 1,200 mg/animal per day during the first (S1, days 1 to 27) and subsequent (S2, days 28 to 47) stages. Gossypol supplementation significantly increased the molar proportion of acetate, and decreased the molar proportion of isobutyric acid, butyric acid, and isovaleric acid in the rumen fluid. Gossypol supplementation have no significant effect on bacterial diversity in the rumen fluid. At the phylum level, gossypol had no effect on bacterial community. At the genus level, gossypol supplementation significantly increased the relative abundance ofTreponema_2. However, there were no significant differences in the relative abundance of dominant bacterial genera. In conclusion, gossypol supplementation had an effect on molar proportion of acetate, isobutyric acid, butyric acid, and isovaleric acid, but had no significant effect on the bacterial diversity and relative abundance of dominant bacteria in rumen fluid of sheep.	[Wang, CaiDie; Li, YuQi; MaiTiSaiYiDi, TunNiSa; Yang, KaiLun] Xinjiang Agr Univ, Xinjiang Key Lab Meat & Milk Prod Herbivore Nutr, Coll Anim Sci, Urumqi, Xinjiang, Peoples R China; [Yang, HongJian] China Agr Univ, State Key Lab Anim Nutr, Coll Anim Sci & Technol, Beijing, Peoples R China	Xinjiang Agricultural University; China Agricultural University	Yang, KL (corresponding author), Xinjiang Agr Univ, Xinjiang Key Lab Meat & Milk Prod Herbivore Nutr, Coll Anim Sci, Urumqi, Xinjiang, Peoples R China.	ykl@xjau.edu.cn			China Agricultural University [2017TC002]; Xinjiang Agricultural University [2017TC002]	China Agricultural University; Xinjiang Agricultural University	This work was funded by the Joint Fund of China Agricultural University and Xinjiang Agricultural University (2017TC002).	Acamovic T, 1993, P BRIT SOC ANIM PROD, V1993, P171; [Anonymous], 2017, EUR GERIATR MED, V8, pS98; Chetima A, 2018, PROCESSES, V6, DOI 10.3390/pr6030022; China general administration of quality supervision inspection and quarantine, 2017, 130782017 GB CHIN GE; Clayton EH, 2005, APPL ENVIRON MICROB, V71, P2206, DOI 10.1128/AEM.71.4.2206-2207.2005; DUNCAN AJ, 1992, J SCI FOOD AGR, V58, P15, DOI 10.1002/jsfa.2740580104; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; GAD A, 1977, UPSALA J MED SCI, V82, P49, DOI 10.3109/03009737709179059; GONZALEZGARZA MT, 1988, EXP PARASITOL, V66, P253, DOI 10.1016/0014-4894(88)90097-5; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Ismartoyo M, 2017, BANGLADESH J ANIMAL, V46, P239; Lin J, 2013, ONCOL REP, V30, P731, DOI 10.3892/or.2013.2489; LIN TS, 1993, BIOCHEM PHARMACOL, V46, P251, DOI 10.1016/0006-2952(93)90411-O; Camara ACL, 2016, TROP ANIM HEALTH PRO, V48, P1037, DOI 10.1007/s11250-016-1039-0; Ma MT, 2018, FOOD CHEM, V240, P856, DOI 10.1016/j.foodchem.2017.08.030; Malmuthuge N, 2014, APPL ENVIRON MICROB, V80, P2021, DOI 10.1128/AEM.03864-13; MARGALIT.P, 1967, APPL MICROBIOL, V15, P952, DOI 10.1128/AEM.15.4.952-953.1967; Marsh KJ, 2006, J CHEM ECOL, V32, P1247, DOI 10.1007/s10886-006-9082-3; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mena H, 2001, J DAIRY SCI, V84, P2231, DOI 10.3168/jds.S0022-0302(01)74670-X; Miller AW, 2016, APPL ENVIRON MICROB, V82, P2669, DOI 10.1128/AEM.00216-16; Miron J, 2001, J DAIRY SCI, V84, P1294, DOI 10.3168/jds.S0022-0302(01)70159-2; MONTAMAT EE, 1982, SCIENCE, V218, P288, DOI 10.1126/science.6750791; Gadelha ICN, 2014, SCI WORLD J, DOI 10.1155/2014/986184; Palmquist DL, 1995, ANIM FEED SCI TECH, V56, P231, DOI 10.1016/0377-8401(95)00830-6; Piwosz K, 2018, ISME J, V12, P2640, DOI 10.1038/s41396-018-0213-y; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; REISER R, 1962, J NUTR, V76, P215, DOI 10.1093/jn/76.2.215; SMITH GS, 1992, J RANGE MANAGE, V45, P25, DOI 10.2307/4002521; Souza NKP, 2013, ARQ BRAS MED VET ZOO, V65, P1752, DOI 10.1590/S0102-09352013000600024; STACKEBRANDT E, 1986, SYST APPL MICROBIOL, V8, P204, DOI 10.1016/S0723-2020(86)80078-9; Stipanovic RD, 2006, J CHEM ECOL, V32, P959, DOI 10.1007/s10886-006-9052-9; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359; Lima PDT, 2014, TROP ANIM HEALTH PRO, V46, P285, DOI 10.1007/s11250-013-0491-3; TOMPKINS DS, 1982, BMJ-BRIT MED J, V284, P52, DOI 10.1136/bmj.284.6308.52-b; VADEHRA DV, 1985, IRCS MED SCI-BIOCHEM, V13, P10; Wang CaiDie, 2019, Chinese Journal of Animal Nutrition, V31, P3374; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WANG W., 2016, SYSTEMS ENG THEORY P, V1, P006, DOI DOI 10.1038/SREP27604; Yildirim-Aksoy M, 2004, J APPL MICROBIOL, V97, P87, DOI 10.1111/j.1365-2672.2004.02273.x; Zhang YH, 2018, ASIAN AUSTRAL J ANIM, V31, P63, DOI 10.5713/ajas.17.0018; Zhong S, 2019, APPL MICROBIOL BIOT, V103, P3193, DOI 10.1007/s00253-019-09673-7	43	4	5	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2020	15	6							e0234378	10.1371/journal.pone.0234378	http://dx.doi.org/10.1371/journal.pone.0234378			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC0EC	32520963	Green Published, gold			2022-12-26	WOS:000542969500021
J	Hessel, P; Rodriguez-Lesmes, P; Torres, D				Hessel, Philipp; Rodriguez-Lesmes, Paul; Torres, David			Socio-economic inequalities in high blood pressure and additional risk factors for cardiovascular disease among older individuals in Colombia: Results from a nationally representative study	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; NONCOMMUNICABLE DISEASES; LATIN-AMERICA; ADULTS; POPULATION; TRANSITION; MORTALITY; HEALTH; POLICY	Background Studies in high-income countries have documented a consistent gradient between socio-economic status (SES) and high blood pressure (HBP), a key risk factor for cardiovascular disease (CVD). However, evidence from Latin American countries (LA) remains comparatively scarce and inconclusive. Data Data for 3,984 individuals came from a nationally representative survey of individuals aged 60 years or above in Colombia (Encuesta de Salud, Bienestar y Envejecimiento) (SABE) conducted in 2015. SES was measured by educational achievement and household assets. CVD risk factors included objectively measured HBP and body mass index (BMI), as well as behaviors (smoking, alcohol consumption, fruit and vegetables intake, and physical activity). Methods Bivariate methods and multivariate regression models were used to assess associations between SES with HBP as well as additional risk factors for CVD. Results Individuals with lower SES have significantly higher risk of suffering from HBP. Compared to those with no formal education, individuals with secondary or post-secondary education have a 37% lower risk of HBP (odds ratio [OR] = 0.63, P-value<0.001). Being in the highest asset quartile (most affluent) is associated with a 44% lower risk (OR = 56, P-value = 0.001) of HBP compared to those in the lowest asset quartile (most deprived). Individuals with lower SES are more likely to smoke, not engage in regular physical activity and not regularly consume fruits or vegetables. In contrast, individuals with higher SES are more likely to consume alcohol and, those with more assets, more likely to be obese. Conclusions Among older Colombians there exists a marked SES gradient in HBP as well as several additional risk factors for CVD. The results highlight the importance of a public health approach towards HBP and additional CVD risk factors that takes into account the specific conditions of older individuals, especially among disadvantaged groups.	[Hessel, Philipp; Torres, David] Univ Andes, Alberto Lleras Camargo Sch Govt, Bogota, Colombia; [Rodriguez-Lesmes, Paul] Univ Rosario, Fac Econ, Bogota, Colombia	Universidad de los Andes (Colombia); Universidad del Rosario	Hessel, P (corresponding author), Univ Andes, Alberto Lleras Camargo Sch Govt, Bogota, Colombia.	p.hessel@uniandes.edu.co	Hessel, Philipp/AAU-6761-2020; Rodriguez-Lesmes, Paul/S-1357-2017	Hessel, Philipp/0000-0002-8754-5710; Rodriguez-Lesmes, Paul/0000-0003-1058-3062	GADC project from CIHR/IDRC [108442-001]	GADC project from CIHR/IDRC	None of the authors did not receive any specific funding for this study. We are grateful with Maria Fernanda Garcia for her research assistance, which was funded by the GADC project from CIHR/IDRC [grant number 108442-001].	Allen L, 2017, LANCET GLOB HEALTH, V5, pE277, DOI 10.1016/s2214-109x(17)30058-x; Alves L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037158; Barcelo A, 2006, LANCET, V368, P625, DOI 10.1016/S0140-6736(06)69223-4; Centro Nacional de Investigacion en Evidencia y Tecnologias en Salud, 2013, GUIA PRACT CLIN HIP; Crimmins Eileen M., 2005, Genus, V61, P163; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; Dinsa GD, 2012, OBES REV, V13, P1067, DOI 10.1111/j.1467-789X.2012.01017.x; Lima-Costa MF, 2012, AM J PUBLIC HEALTH, V102, P1535, DOI 10.2105/AJPH.2012.300765; Fernando L, 2014, PROG CARDIOVASC DIS, V57, P262, DOI 10.1016/j.pcad.2014.07.007; Fillenbaum GG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073930; Gomez Fernando, 2016, Curr Gerontol Geriatr Res, V2016, P7910205; Guevara PE, 2015, REV PANAM SALUD PUBL, V38, P226; Havranek EP, 2015, CIRCULATION, V132, P873, DOI 10.1161/CIR.0000000000000228; Miranda JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054056; Jones A, 2014, CURR SOCIOL, V62, P1055, DOI 10.1177/0011392114537003; Kankeu HT, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-31; Lee J.H., 2011, IMPROVING EQUITY HLT; Lloyd-Sherlock P, 2002, INT J EPIDEMIOL, V31, P754, DOI 10.1093/ije/31.4.754; Lloyd-Sherlock P, 2000, WORLD DEV, V28, P2157, DOI 10.1016/S0305-750X(00)00077-2; Lloyd-Sherlock P, 2014, INT J EPIDEMIOL, V43, P116, DOI 10.1093/ije/dyt215; Mackenbach JP, 2000, EUR HEART J, V21, P1141, DOI 10.1053/euhj.1999.1990; Ministerio de Salud y Proteccion Social de Colombia, 2015, SABE COL 2015 EST NA; Murray CJL, 1996, GLOBAL BURDEN DIS CO; Ocampo-Chaparro JM, 2019, COLOMB MEDICA, V50, P89, DOI 10.25100/cm.v50i2.4121; Ortega-Lenis D, 2019, COLOMB MEDICA, V50, P128, DOI 10.25100/cm.v50i2.4557; Perel P, 2006, PLOS MED, V3, P1448, DOI 10.1371/journal.pmed.0030344; Quispe R, 2016, GLOB HEART, V11, P121, DOI 10.1016/j.gheart.2015.12.005; Rehkopf DH, 2010, J EPIDEMIOL COMMUN H, V64, P821, DOI 10.1136/jech.2009.086926; Rosero-Bixby L, 2016, P NATL ACAD SCI USA, V113, P1130, DOI 10.1073/pnas.1521917112; Rosero-Bixby L, 2009, J GERONTOL B-PSYCHOL, V64, P105, DOI 10.1093/geronb/gbn004; Ruilope L M, 2017, Hipertens Riesgo Vasc, V34, P50, DOI 10.1016/j.hipert.2016.11.005; Stringhini S, 2017, LANCET GLOB HEALTH, V5, pE230, DOI 10.1016/S2214-109X(17)30054-2; Stringhini S, 2013, INT J EPIDEMIOL, V42, P1429, DOI 10.1093/ije/dyt084; Webber L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039589; World Health Organization, 2011, RIO POL DECL WORLD C; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487	36	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2020	15	6							e0234326	10.1371/journal.pone.0234326	http://dx.doi.org/10.1371/journal.pone.0234326			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LZ1GC	32516351	Green Published, gold			2022-12-26	WOS:000540977000029
J	Peroutka, RJ; Buzza, MS; Mukhopadhyay, S; Johnson, TA; Driesbaugh, KH; Antalis, TM				Peroutka, Raymond J.; Buzza, Marguerite S.; Mukhopadhyay, Subhradip; Johnson, Tierra A.; Driesbaugh, Kathryn H.; Antalis, Toni M.			Testisin/Prss21 deficiency causes increased vascular permeability and a hemorrhagic phenotype during luteal angiogenesis	PLOS ONE			English	Article							PROTEINASE-ACTIVATED RECEPTOR-2; ANCHORED SERINE PROTEASES; TESTICULAR GERM-CELLS; VE-CADHERIN; TYROSINE PHOSPHORYLATION; ENDOTHELIAL-CADHERIN; TIGHT JUNCTIONS; BETA-CATENIN; GENE; MOUSE	Testisin (encoded by PRSS21) is a membrane anchored serine protease, which is tethered to the cell surface via a glycosylphosphatidylinositol (GPI)-anchor. While testisin is found in abundance in spermatozoa, it is also expressed in microvascular endothelial cells where its function is unknown. Here we identify testisin as a novel regulator of physiological hormone-induced angiogenesis and microvascular endothelial permeability. Using a murine model of rapid physiological angiogenesis during corpus luteal development in the ovary, we found that mice genetically deficient in testisin (Prss21(-/-)) show a substantially increased incidence of hemorrhages which are significantly more severe than in littermate control Prss21(+/+) mice. This phenotype was associated with increased vascular leakiness, demonstrated by a greater accumulation of extravasated Evans blue dye in Prss21(-/-) ovaries. Live cell imaging of in vitro cultured microvascular endothelial cells depleted of testisin by siRNA knockdown revealed that loss of testisin markedly impaired reorganization and tubule-like formation on Matrigel basement membranes. Moreover testisin siRNA knockdown increased the paracellular permeability to FITC-albumin across endothelial cell monolayers, which was associated with decreased expression of the adherens junction protein VE-cadherin and increased levels of phospho(Tyr658)-VE-cadherin, without affecting the levels of the tight junction proteins occludin and claudin-5, or ZO-1. Decreased expression of VE-cadherin in the neovasculature of Prss21(-/-) ovaries was also observed without marked differences in endothelial cell content, vascular claudin-5 expression or pericyte recruitment. Together, these data identify testisin as a novel regulator of VE-cadherin adhesions during angiogenesis and indicate a potential new target for regulating neovascular integrity and associated pathologies.	[Peroutka, Raymond J.; Buzza, Marguerite S.; Mukhopadhyay, Subhradip; Johnson, Tierra A.; Driesbaugh, Kathryn H.; Antalis, Toni M.] Univ Maryland, Sch Med, Dept Physiol, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Buzza, Marguerite S.; Mukhopadhyay, Subhradip; Johnson, Tierra A.; Antalis, Toni M.] VA Maryland Hlth Care Syst, Baltimore, MD USA; [Buzza, Marguerite S.; Antalis, Toni M.] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA; [Mukhopadhyay, Subhradip; Antalis, Toni M.] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Antalis, TM (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA.; Antalis, TM (corresponding author), VA Maryland Hlth Care Syst, Baltimore, MD USA.; Antalis, TM (corresponding author), Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA.; Antalis, TM (corresponding author), Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA.	tantalis@som.umaryland.edu			National Institutes of Health [R01 CA196988, R01 HL118390, T32 HL007698]; VA Maryland Health Care System Merit Award [I01 BX001921]; American Cancer Society [IRG-16-123-13]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Maryland Health Care System Merit Award; American Cancer Society(American Cancer Society)	The study was supported by grants from the National Institutes of Health R01 CA196988 (T. M.A.), R01 HL118390 (T.M.A.) and T32 HL007698 (T.A.J.); VA Maryland Health Care System Merit Award I01 BX001921 (T.M.A.) and an Institutional Research Grant IRG-16-123-13 from the American Cancer Society (M.S.B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Aimes RT, 2003, THROMB HAEMOSTASIS, V89, P561, DOI 10.1055/s-0037-1613388; Akhtar N, 2001, ENDOTHELIUM-NEW YORK, V8, P221; Allingham MJ, 2007, J IMMUNOL, V179, P4053, DOI 10.4049/jimmunol.179.6.4053; Antalis TM, 2011, PROG MOL BIOL TRANSL, V99, P1, DOI 10.1016/S1877-1173(11)99001-2; Bach TL, 1998, EXP CELL RES, V238, P324, DOI 10.1006/excr.1997.3844; Bazzoni G, 2006, THROMB HAEMOSTASIS, V95, P36, DOI 10.1160/TH05-07-0488; Cao JH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02373-8; Carpentier G., 2012, IMAGEJ NEWS; Cattelino A, 2003, J CELL BIOL, V162, P1111, DOI 10.1083/jcb.200212157; Chi JT, 2003, P NATL ACAD SCI USA, V100, P10623, DOI 10.1073/pnas.1434429100; Conway GD, 2019, J MOL MED, V97, P691, DOI 10.1007/s00109-019-01763-3; Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Driesbaugh KH, 2015, J BIOL CHEM, V290, P3529, DOI 10.1074/jbc.M114.628560; Fraser Hamish M, 2003, Reprod Biol Endocrinol, V1, P88, DOI 10.1186/1477-7827-1-88; Gavard J, 2008, NAT CELL BIOL, V10, P883, DOI 10.1038/ncb0808-883; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gavard J, 2013, CELL ADHES MIGR, V7, P455, DOI 10.4161/cam.27330; Giampietro C, 2012, BLOOD, V119, P2159, DOI 10.1182/blood-2011-09-381012; Gu Y, 2012, PLACENTA, V33, P803, DOI 10.1016/j.placenta.2012.06.020; Harris ES, 2010, CURR OPIN CELL BIOL, V22, P651, DOI 10.1016/j.ceb.2010.07.006; Head BP, 2014, BBA-BIOMEMBRANES, V1838, P532, DOI 10.1016/j.bbamem.2013.07.018; Hooper JD, 1999, CANCER RES, V59, P3199; Hooper JD, 2000, BBA-GENE STRUCT EXPR, V1492, P63, DOI 10.1016/S0167-4781(00)00071-3; Inoue M, 1999, BIOCHEM BIOPH RES CO, V266, P564, DOI 10.1006/bbrc.1999.1870; Kuhnert F, 2008, P NATL ACAD SCI USA, V105, P10185, DOI 10.1073/pnas.0803194105; Manaenko A, 2014, STROKE, V45, P828, DOI 10.1161/STROKEAHA.113.003754; Manton KJ, 2005, BRIT J CANCER, V92, P760, DOI 10.1038/sj.bjc.6602373; Nagy JA, 2008, ANGIOGENESIS, V11, P109, DOI 10.1007/s10456-008-9099-z; Nakamura Yasuo, 2003, Journal of Medical Investigation, V50, P78; Netzel-Arnett S, 2009, BIOL REPROD, V81, P921, DOI 10.1095/biolreprod.109.076273; Orsenigo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2199; Park-Windhol C, 2016, ANNU REV PATHOL-MECH, V11, P251, DOI 10.1146/annurev-pathol-012615-044506; Pepper Michael S., 1997, Cytokine and Growth Factor Reviews, V8, P21, DOI 10.1016/S1359-6101(96)00048-2; Pepper MS, 2001, ARTERIOSCL THROM VAS, V21, P1104, DOI 10.1161/hq0701.093685; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; Ribatti D, 2011, INT J DEV BIOL, V55, P261, DOI 10.1387/ijdb.103167dr; Roy R, 2006, EXP CELL RES, V312, P608, DOI 10.1016/j.yexcr.2005.11.022; Schwartz MA, 2018, SCIENCE, V360, P270, DOI 10.1126/science.aat3470; Sendo T, 2003, CELL SIGNAL, V15, P773, DOI 10.1016/S0898-6568(03)00014-7; Shigemasa K, 2000, J SOC GYNECOL INVEST, V7, P358, DOI 10.1016/S1071-5576(00)00086-1; Shoeibi S, 2018, MICROVASC RES, V117, P1, DOI 10.1016/j.mvr.2017.12.002; Sidibe A, 2014, AM J PHYSIOL-HEART C, V307, pH455, DOI 10.1152/ajpheart.00774.2013; Swegen A, 2019, ANDROLOGY-US, V7, P199, DOI 10.1111/andr.12569; Szabo R, 2011, ANNU REV CELL DEV BI, V27, P213, DOI 10.1146/annurev-cellbio-092910-154247; Tang T, 2005, CANCER RES, V65, P868; Wallez Y, 2008, BBA-BIOMEMBRANES, V1778, P794, DOI 10.1016/j.bbamem.2007.09.003; Wang HL, 2014, SCI REP-UK, V4, DOI 10.1038/srep06588; Welti J, 2013, J CLIN INVEST, V123, P3190, DOI 10.1172/JCI70212; Wong GW, 2001, J BIOL CHEM, V276, P20648, DOI 10.1074/jbc.M010422200; Yamashita M, 2008, GENES CELLS, V13, P1001, DOI 10.1111/j.1365-2443.2008.01222.x; Zhang R, 2017, J CELL BIOCHEM, V118, P4587, DOI 10.1002/jcb.26123	54	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2020	15	6							e0234407	10.1371/journal.pone.0234407	http://dx.doi.org/10.1371/journal.pone.0234407			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ0RE	32511276	gold, Green Published			2022-12-26	WOS:000540938100034
J	Bishop, CA; Schulze, MB; Klaus, S; Weitkunat, K				Bishop, Christopher A.; Schulze, Matthias B.; Klaus, Susanne; Weitkunat, Karolin			The branched-chain amino acids valine and leucine have differential effects on hepatic lipid metabolism	FASEB JOURNAL			English	Article						fatty acid metabolism; leucine; liver; OCFA; valine	DAIRY PRODUCT INTAKE; INSULIN SENSITIVITY; FATTY-ACIDS; ODD-CHAIN; PPAR-ALPHA; GLUCOSE-METABOLISM; IMPROVES GLUCOSE; PROTEIN; SUPPLEMENTATION; OBESE	Dairy intake, as a source of branched-chain amino acids (BCAA), has been linked to a lower incidence of type-2-diabetes and increased circulating odd-chain fatty acids (OCFA). To understand this connection, we aimed to investigate differences in BCAA metabolism of leucine and valine, a possible source of OCFA, and their role in hepatic metabolism. Male mice were fed a high-fat diet supplemented with leucine and valine for 1 week and phenotypically characterized with a focus on lipid metabolism. Mouse primary hepatocytes were treated with the BCAA or a Ppar alpha activator WY-14643 to systematically examine direct hepatic effects and their mechanisms. Here, we show that only valine supplementation was able to increase hepatic and circulating OCFA levels via two pathways; a PPAR alpha-dependent induction of alpha-oxidation and an increased supply of propionyl-CoA for de novo lipogenesis. Meanwhile, we were able to confirm leucine-mediated effects on the inhibition of food intake and transport of fatty acids, as well as induction of S6 ribosomal protein phosphorylation. Taken together, these data illustrate differential roles of the BCAA in lipid metabolism and provide preliminary evidence that exclusively valine contributes to the endogenous formation of OCFA which is important for a better understanding of these metabolites in metabolic health.	[Bishop, Christopher A.; Klaus, Susanne; Weitkunat, Karolin] German Inst Human Nutr Potsdam Rehbruecke DIfE, Dept Physiol Energy Metab, Arthur Scheunert Allee 114-116, D-14558 Nuthetal, Germany; [Bishop, Christopher A.; Schulze, Matthias B.; Klaus, Susanne] Univ Potsdam, Inst Nutr Sci, Nuthetal, Germany; [Schulze, Matthias B.] German Inst Human Nutr Potsdam Rehbruecke DIfE, Dept Mol Epidemiol, Nuthetal, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of Potsdam; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Weitkunat, K (corresponding author), German Inst Human Nutr Potsdam Rehbruecke DIfE, Dept Physiol Energy Metab, Arthur Scheunert Allee 114-116, D-14558 Nuthetal, Germany.	Karolin.Weitkunat@dife.de	Schulze, Matthias B/AAH-6906-2021; Klaus, Susanne/P-9299-2018	Schulze, Matthias B/0000-0002-0830-5277; Bishop, Christopher/0000-0003-2247-3602; Klaus, Susanne/0000-0001-8726-185X	Deutsche Forschungsgemeinschaft (DFG) [WE6488/1-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: WE6488/1-1	Akiyama Taro E, 2005, Curr Diab Rep, V5, P45, DOI 10.1007/s11892-005-0067-3; Al-Majdoub M, 2017, DIABETES METAB, V43, P475, DOI 10.1016/j.diabet.2016.12.008; Anthony TG, 2001, J NUTR, V131, P1171, DOI 10.1093/jn/131.4.1171; Arakawa M, 2011, ENDOCR J, V58, P161, DOI 10.1507/endocrj.K10E-221; Bianchi G, 2005, CURR OPIN CLIN NUTR, V8, P83, DOI 10.1097/00075197-200501000-00013; Binder E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074705; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Brunetta HS, 2018, AMINO ACIDS, V50, P1663, DOI 10.1007/s00726-018-2658-8; Chan SMH, 2013, DIABETES, V62, P2095, DOI 10.2337/db12-1397; Chu RY, 2004, MOL CELL BIOL, V24, P6288, DOI 10.1128/MCB.24.14.6288-6297.2004; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Crown SB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145850; Dongol B, 2007, J LIPID RES, V48, P1781, DOI 10.1194/jlr.M700119-JLR200; Forouhi NG, 2014, LANCET DIABETES ENDO, V2, P810, DOI 10.1016/S2213-8587(14)70146-9; Franklin MP, 2017, DIABETES, V66, P2112, DOI 10.2337/db16-1519; Freudenberg A, 2013, AMINO ACIDS, V44, P519, DOI 10.1007/s00726-012-1363-2; Freudenberg A, 2012, J NUTR BIOCHEM, V23, P1524, DOI 10.1016/j.jnutbio.2011.10.005; Guerre-Millo M, 2000, J BIOL CHEM, V275, P16638, DOI 10.1074/jbc.275.22.16638; Guillou Herve, 2008, V49, P3, DOI 10.1007/978-1-4020-8831-5_1; Halton TL, 2004, J AM COLL NUTR, V23, P373, DOI 10.1080/07315724.2004.10719381; Higuchi N, 2011, J CELL BIOCHEM, V112, P30, DOI 10.1002/jcb.22688; Ijichi C, 2003, BIOCHEM BIOPH RES CO, V303, P59, DOI 10.1016/S0006-291X(03)00295-X; Jenkins B, 2017, MOLECULES, V22, DOI 10.3390/molecules22101718; Jenkins B, 2015, MOLECULES, V20, P2425, DOI 10.3390/molecules20022425; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Klaus S, 2005, J NUTR, V135, P1854, DOI 10.1093/jn/135.8.1854; Layman DK, 2006, J NUTR, V136, p319S, DOI 10.1093/jn/136.1.319S; Li CH, 2003, J BIOL CHEM, V278, P2853, DOI 10.1074/jbc.M210577200; Li HL, 2012, AM J PHYSIOL-ENDOC M, V303, pE1234, DOI 10.1152/ajpendo.00198.2012; Li WC, 2010, METHODS MOL BIOL, V633, P185, DOI 10.1007/978-1-59745-019-5_13; Lotta LA, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002179; Macotela Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021187; Matthan NR, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000764; Meijer AJ, 2004, BIOCHEM BIOPH RES CO, V313, P397, DOI 10.1016/j.bbrc.2003.07.012; Nepokroeff C M, 1975, Methods Enzymol, V35, P37, DOI 10.1016/0076-6879(75)35136-7; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nilsson M, 2007, AM J CLIN NUTR, V85, P996, DOI 10.1093/ajcn/85.4.996; O'Connor LM, 2014, DIABETOLOGIA, V57, P909, DOI 10.1007/s00125-014-3176-1; Pertiwi K, 2019, NUTR METAB, V16, DOI 10.1186/s12986-019-0407-y; Proud CG, 2002, EUR J BIOCHEM, V269, P5338, DOI 10.1046/j.1432-1033.2002.03292.x; Santaren ID, 2014, AM J CLIN NUTR, V100, P1532, DOI 10.3945/ajcn.114.092544; Veiga FM, 2017, BIOCHIMIE, V140, P106, DOI 10.1016/j.biochi.2017.07.003; Sluijs I, 2012, AM J CLIN NUTR, V96, P382, DOI 10.3945/ajcn.111.021907; Solon-Biet SM, 2019, NAT METAB, V1, P532, DOI 10.1038/s42255-019-0059-2; Son SM, 2019, CELL METAB, V29, P192, DOI 10.1016/j.cmet.2018.08.013; Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72; Titchenell PM, 2017, TRENDS ENDOCRIN MET, V28, P497, DOI 10.1016/j.tem.2017.03.003; Tournissac Marine, 2018, Alzheimers Dement (N Y), V4, P677, DOI 10.1016/j.trci.2018.10.005; Vessby B, 2013, BRIT J NUTR, V110, P871, DOI 10.1017/S0007114512005934; Vlaeminck B, 2006, ANIM FEED SCI TECH, V131, P389, DOI 10.1016/j.anifeedsci.2006.06.017; Weitkunat K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06447-x; Weitkunat K, 2017, AM J CLIN NUTR, V105, P1544, DOI 10.3945/ajcn.117.152702; Weitkunat K, 2016, MOL NUTR FOOD RES, V60, P2611, DOI 10.1002/mnfr.201600305; Weitkunat K, 2015, J NUTR BIOCHEM, V26, P929, DOI 10.1016/j.jnutbio.2015.03.010; Westerterp-Plantenga MS, 2009, ANNU REV NUTR, V29, P21, DOI 10.1146/annurev-nutr-080508-141056; Xiao F, 2014, METABOLISM, V63, P841, DOI 10.1016/j.metabol.2014.03.006; Xiao F, 2011, DIABETES, V60, P746, DOI 10.2337/db10-1246; Yakoob MY, 2016, CIRCULATION, V133, P1645, DOI 10.1161/CIRCULATIONAHA.115.018410; Yan X, 2018, MOL METAB, V18, P15, DOI 10.1016/j.molmet.2018.10.003; Yang JC, 2010, NUTR REV, V68, P270, DOI 10.1111/j.1753-4887.2010.00282.x; Ye JM, 2001, DIABETES, V50, P411, DOI 10.2337/diabetes.50.2.411; Yoshizawa F, 2013, BIOSCI BIOTECH BIOCH, V77, P839, DOI 10.1271/bbb.120737; Zarfeshani A, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-27; Zhang YY, 2007, DIABETES, V56, P1647, DOI 10.2337/db07-0123	65	18	19	8	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9727	9739		10.1096/fj.202000195R	http://dx.doi.org/10.1096/fj.202000195R		JUN 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32506644	Green Published			2022-12-26	WOS:000539607600001
J	Qu, FN; Palte, IC; Gontarz, PM; Zhang, B; Guilak, F				Qu, Feini; Palte, Ilan C.; Gontarz, Paul M.; Zhang, Bo; Guilak, Farshid			Transcriptomic analysis of bone and fibrous tissue morphogenesis during digit tip regeneration in the adult mouse	FASEB JOURNAL			English	Article						amputation; blastema; osteogenesis; regenerative medicine; RNA-seq; wound repair	GENE-EXPRESSION; ROLES; DIFFERENTIATION; AMPUTATION; CELLS; FETAL; MSX1	Humans have limited regenerative potential of musculoskeletal tissues following limb or digit loss. The murine digit has been used to study mammalian regeneration, where stem/progenitor cells (the "blastema") completely regenerate the digit tip after distal, but not proximal, amputation. However, the molecular mechanisms responsible for this response remain to be determined. Here, we evaluated the spatiotemporal formation of bone and fibrous tissues after level-dependent amputation of the murine terminal phalanx and quantified the transcriptome of the repair tissue. Distal (regenerative) and proximal (non-regenerative) amputations showed significant differences in temporal gene expression and tissue regrowth over time. Genes that direct skeletal system development and limb morphogenesis are transiently upregulated during blastema formation and differentiation, including distal Hox genes. Overall, our results suggest that digit tip regeneration is controlled by a gene regulatory network that recapitulates aspects of limb development, and that failure to activate this developmental program results in fibrotic wound healing.	[Qu, Feini; Palte, Ilan C.; Guilak, Farshid] Washington Univ, Dept Orthopaed Surg, Couch Biomed Res Bldg,Room 3121,Campus Box 8233, St Louis, MO 63110 USA; [Qu, Feini; Palte, Ilan C.; Gontarz, Paul M.; Zhang, Bo; Guilak, Farshid] Washington Univ, Ctr Regenerat Med, St Louis, MO 63110 USA; [Qu, Feini; Palte, Ilan C.; Guilak, Farshid] Shriners Hosp Children St Louis, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	Guilak, F (corresponding author), Washington Univ, Dept Orthopaed Surg, Couch Biomed Res Bldg,Room 3121,Campus Box 8233, St Louis, MO 63110 USA.	guilak@wustl.edu			National Institutes of Health [T32 AR060719, F32 AR074895, R25 DA027995, AG15768, AG46927, P30 AR073752, P30 AR074992]; Arthritis Foundation; Nancy Taylor Foundation for Chronic Diseases; Shriners Hospitals for Children	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; Nancy Taylor Foundation for Chronic Diseases; Shriners Hospitals for Children	This work was supported by the National Institutes of Health (T32 AR060719 and F32 AR074895 to F. Qu, R25 DA027995 to B. Zhang, AG15768 and AG46927 to F. Guilak, P30 AR073752, P30 AR074992), the Arthritis Foundation, the Nancy Taylor Foundation for Chronic Diseases, and the Shriners Hospitals for Children	Agrawal V, 2011, TISSUE ENG PT A, V17, P2435, DOI [10.1089/ten.TEA.2011.0036, 10.1089/ten.tea.2011.0036]; Avouac J, 2012, ARTHRITIS RHEUM-US, V64, P1642, DOI 10.1002/art.33501; Bauer O, 2015, MOL CELL BIOL, V35, P1097, DOI 10.1128/MCB.01106-14; Carr MJ, 2019, CELL STEM CELL, V24, P240, DOI 10.1016/j.stem.2018.10.024; Chadwick RB, 2007, WOUND REPAIR REGEN, V15, P275, DOI 10.1111/j.1524-475X.2007.00216.x; Chamberlain CS, 2017, WOUND REPAIR REGEN, V25, P443, DOI 10.1111/wrr.12544; Chen Y, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.46; Cheng CH, 2013, PHYSIOL GENOMICS, V45, P409, DOI 10.1152/physiolgenomics.00142.2012; Corada M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3609; Dawson LA, 2018, WOUND REPAIR REGEN, V26, P263, DOI 10.1111/wrr.12666; Dawson LA, 2017, REGENERATION, V4, P140, DOI 10.1002/reg2.81; Fernando WA, 2011, DEV BIOL, V350, P301, DOI 10.1016/j.ydbio.2010.11.035; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; Gabory A, 2009, DEVELOPMENT, V136, P3413, DOI 10.1242/dev.036061; Gerber T, 2018, SCIENCE, V362, P421, DOI 10.1126/science.aaq0681; Giannandrea M, 2014, DIS MODEL MECH, V7, P193, DOI 10.1242/dmm.012062; Han M, 2008, DEV BIOL, V315, P125, DOI 10.1016/j.ydbio.2007.12.025; Han MJ, 2003, DEVELOPMENT, V130, P5123, DOI 10.1242/dev.00710; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang YH, 2015, 2015 12TH WEB INFORMATION SYSTEM AND APPLICATION CONFERENCE (WISA), P3, DOI [10.1109/WISA.2015.16, 10.1109/PPC.2015.7296864]; Johnson GL, 2020, DEV CELL, V52, P525, DOI 10.1016/j.devcel.2020.01.026; Johnston APW, 2016, CELL STEM CELL, V19, P433, DOI 10.1016/j.stem.2016.06.002; Komori T, 2010, ADV EXP MED BIOL, V658, P43, DOI 10.1007/978-1-4419-1050-9_5; Kuijper S, 2005, DEV BIOL, V285, P533, DOI 10.1016/j.ydbio.2005.06.017; Lehoczky JA, 2011, P NATL ACAD SCI USA, V108, P20609, DOI 10.1073/pnas.1118017108; Leigh ND, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07604-0; Li XY, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00855; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu QC, 2018, INFLAMMATION, V41, P896, DOI 10.1007/s10753-018-0744-4; Marrero L, 2017, REGENERATION, V4, P69, DOI 10.1002/reg2.75; Martin TJ, 2009, CRIT REV EUKAR GENE, V19, P73, DOI 10.1615/CritRevEukarGeneExpr.v19.i1.40; Meyer MB, 2014, J BIOL CHEM, V289, P16016, DOI 10.1074/jbc.M114.552216; Miller MJ, 2017, CONTEMP CLIN TRIALS, V55, P10, DOI 10.1016/j.cct.2017.01.008; Mu XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059105; Neufeld Daniel A., 1995, Wound Repair and Regeneration, V3, P461, DOI 10.1046/j.1524-475X.1995.30410.x; Nik AM, 2016, DEV BIOL, V415, P14, DOI 10.1016/j.ydbio.2016.05.013; Owings MF, 1998, VITAL HLTH STAT, V139, P1; Pineault KM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11100-4; Qu FN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01955-w; Qu FN, 2015, BIOMATERIALS, V39, P85, DOI 10.1016/j.biomaterials.2014.10.067; REGINELLI AD, 1995, DEVELOPMENT, V121, P1065; Rinkevich Y, 2015, DEV DYNAM, V244, P641, DOI 10.1002/dvdy.24265; Rinkevich Y, 2014, P NATL ACAD SCI USA, V111, P9846, DOI 10.1073/pnas.1410097111; Rinkevich Y, 2011, NATURE, V476, P409, DOI 10.1038/nature10346; Rux DR, 2016, DEV CELL, V39, P653, DOI 10.1016/j.devcel.2016.11.008; Sheeba CJ, 2017, CURR TOP DEV BIOL, V122, P355, DOI 10.1016/bs.ctdb.2016.08.009; Sheth R, 2016, CELL REP, V17, P2913, DOI 10.1016/j.celrep.2016.11.039; Simkin J, 2017, DEVELOPMENT, V144, P3907, DOI 10.1242/dev.150086; Simkin J, 2015, REGENERATION, V2, P106, DOI 10.1002/reg2.34; Stadler HS, 2001, DEVELOPMENT, V128, P4177; Storer MA, 2020, DEV CELL, V52, P509, DOI 10.1016/j.devcel.2019.12.004; Taghiyar L, 2017, J BIOL CHEM, V292, P10520, DOI 10.1074/jbc.M116.774265; Takeo M, 2013, NATURE, V499, P228, DOI 10.1038/nature12214; ten Berge D, 1998, DEVELOPMENT, V125, P3831; Varma P, 2014, PHYS MED REH CLIN N, V25, P1, DOI 10.1016/j.pmr.2013.09.001; Villavicencio-Lorini P, 2010, J CLIN INVEST, V120, P1994, DOI 10.1172/JCI41554; Volk SW, 2011, CELLS TISSUES ORGANS, V194, P25, DOI 10.1159/000322399; Wu YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054764; Yu L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08278-4; Yu L, 2010, DEVELOPMENT, V137, P551, DOI 10.1242/dev.042424; Zakany J, 1999, CELL TISSUE RES, V296, P19, DOI 10.1007/s004410051262	61	6	6	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9740	9754		10.1096/fj.202000330R	http://dx.doi.org/10.1096/fj.202000330R		JUN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32506623	Green Submitted, Green Accepted			2022-12-26	WOS:000539605700001
J	LeMasters, K; Dussault, J; Barrington, C; Bengtson, A; Gaynes, B; Go, V; Hosseinipour, MC; Kulisewa, K; Kutengule, A; Meltzer-Brody, S; Midiani, D; Mphonda, S; Udedi, M; Pence, B				LeMasters, Katherine; Dussault, Josee; Barrington, Clare; Bengtson, Angela; Gaynes, Bradley; Go, Vivian; Hosseinipour, Mina C.; Kulisewa, Kazione; Kutengule, Anna; Meltzer-Brody, Samantha; Midiani, Dalitso; Mphonda, Steve; Udedi, Michael; Pence, Brian			"Pain in my heart": Understanding perinatal depression among women living with HIV in Malawi	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; SEROPOSITIVE WOMEN; MENTAL-ILLNESS; SYMPTOMS; HEALTH; EXPERIENCES; PREVALENCE; PREGNANCY; ANXIETY	Background Perinatal depression (PND) can interfere with HIV care engagement and outcomes. We examined experiences of PND among women living with HIV (WLWH) in Malawi. Methods We screened 73 WLWH presenting for perinatal care in Lilongwe, Malawi using the Edinburgh Postnatal Depression Scale (EPDS). We conducted qualitative interviews with 24 women experiencing PND and analyzed data using inductive and deductive coding and narrative analysis. Results Women experienced a double burden of physical and mental illness, expressed as pain in one's heart. Receiving an HIV diagnosis unexpectedly during antenatal care was a key contributor to developing PND. This development was influenced by stigmatization and social support. Conclusions These findings highlight the need to recognize the mental health implications of routine screening for HIV and to routinely screen and treat PND among WLWH. Culturally appropriate mental health interventions are needed in settings with a high HIV burden.	[LeMasters, Katherine; Dussault, Josee; Pence, Brian] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [LeMasters, Katherine; Barrington, Clare] Carolina Populat Ctr, Chapel Hill, NC 27516 USA; [Barrington, Clare; Go, Vivian] Univ N Carolina, Dept Hlth Behav, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [Bengtson, Angela] Brown Univ, Brown Sch Publ Hlth, Dept Epidemiol, Providence, RI 02912 USA; [Gaynes, Bradley; Meltzer-Brody, Samantha] Univ N Carolina, Dept Psychiat, UNC Sch Med, Chapel Hill, NC 27515 USA; [Hosseinipour, Mina C.; Kutengule, Anna; Mphonda, Steve] UNC Project Malawi, Lilongwe, Malawi; [Hosseinipour, Mina C.] Univ N Carolina, Dept Med, UNC Sch Med, Chapel Hill, NC 27515 USA; [Kulisewa, Kazione; Udedi, Michael] Univ Malawi, Coll Med, Lilongwe, Malawi; [Midiani, Dalitso; Udedi, Michael] Minist Hlth, Lilongwe, Malawi	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Brown University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Malawi	LeMasters, K (corresponding author), Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA.	katherine.lemasters@unc.edu	Dussault, Josée/ABC-1098-2021; Barrington, Clare/AAM-4909-2021; Udedi, Michael/V-6147-2017	Dussault, Josée/0000-0001-7434-2159; Udedi, Michael/0000-0001-8769-4313; LeMasters, Katherine/0000-0002-1754-1730; Bengtson, Angela/0000-0003-1305-8132	National Institute of Mental health (NIMH) [R34 MH 116806, R00 MH 112413]; UNC Center for AIDS Research (CFAR), an NIH [P30 AI 050410]; Fogarty International Center through the Malawi HIV implementation research scientist training program [D43-D43TW010060]	National Institute of Mental health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); UNC Center for AIDS Research (CFAR), an NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center through the Malawi HIV implementation research scientist training program	This research was supported by grant R34 MH 116806 and R00 MH 112413 from the National Institute of Mental health (NIMH) and by a developmental grant from the UNC Center for AIDS Research (CFAR), an NIH-funded program (P30 AI 050410). This work was also supported by the Fogarty International Center through the Malawi HIV implementation research scientist training program (D43-D43TW010060). This paper does not reflect the views of the NIMH, NIH, or Fogarty.	Accortt EE, 2015, MATERN CHILD HLTH J, V19, P1306, DOI 10.1007/s10995-014-1637-2; [Anonymous], 2016, NAT PHOTONICS, V10, P1, DOI 10.1038/nphoton.2015.265; [Anonymous], 2012, DRUG DISCOV TODAY TE; Bek Cox J., 1987, BRIT J PSYCHIAT, V150, P191; Bhatia R, 2011, AIDS BEHAV, V15, P1161, DOI 10.1007/s10461-010-9778-9; Brittain K, 2017, AIDS BEHAV, V21, P274, DOI 10.1007/s10461-016-1389-7; Chibanda D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-828; Davies T, 2016, TRANSCULT PSYCHIATRY, V53, P286, DOI 10.1177/1363461516632389; Dow A, 2014, JAIDS-J ACQ IMM DEF, V65, P359, DOI 10.1097/QAI.0000000000000050; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Gibbs G, 2007, ANAL QUALITATIVE DAT, P56; Gibbs G, 2013, ANAL QUALITATIVE DAT, P38; Glaser B.G., 1968, DISCOV GROUNDED THEO; Harrington BJ, 2018, AIDS; Harrington BJ, 2018, J MENT HEAL; Ickovics JR, 2001, JAMA-J AM MED ASSOC, V285, P1466, DOI 10.1001/jama.285.11.1466; Kagee A, 2010, AIDS CARE, V22, P159, DOI 10.1080/09540120903111445; Kamen C, 2015, AJAR-AFR J AIDS RES, V14, P67, DOI 10.2989/16085906.2015.1016987; Kapetanovic S, 2014, AIDS BEHAV, V18, P1152, DOI 10.1007/s10461-014-0728-9; Kidia K, 2015, TROP MED INT HEALTH, V20, P903, DOI 10.1111/tmi.12502; Luzuriaga K, 2016, NEW ENGL J MED, V374, P761, DOI 10.1056/NEJMra1505256; Malqvist M, 2016, J COMMUN HEALTH, V41, P946, DOI 10.1007/s10900-016-0175-9; Martinez-Mesa J, 2016, AN BRAS DERMATOL, V91, P326, DOI 10.1590/abd1806-4841.20165254; Maxwell JosephA., 2008, HDB EMERGENT METHODS, P461; Meunier A, 2014, ELECTROCHIM ACTA, V126, P74, DOI 10.1016/j.electacta.2013.07.110; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; O'Hara MW, 2014, BEST PRACT RES CL OB, V28, P3, DOI 10.1016/j.bpobgyn.2013.09.002; Orza L, 2015, J INT AIDS SOC, V18, P1; QSR International Pty Ltd, 2018, NVIVO VERS 12; Reissman C.K., 2008, NARRATIVE METHODS HU, P53; Saldana J, 2014, CODING MANUAL QUALIT, P32; SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P371, DOI 10.1002/nur.4770180411; Sorsdahl KR, 2010, AIDS CARE, V22, P1418, DOI 10.1080/09540121003758655; Sowa NA, 2015, J CLIN PSYCHIAT, V76, P1385, DOI 10.4088/JCP.14r09186; Stewart RC, 2013, J AFFECT DISORDERS, V150, P1041, DOI 10.1016/j.jad.2013.05.036; Stringer EM, 2014, LANCET PSYCHIAT, V1, P159, DOI 10.1016/S2215-0366(14)70273-1; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; Wong JPH, 2010, J TRANSCULT NURS, V21, P151, DOI 10.1177/1043659609357637; Woody CA, 2017, J AFFECT DISORDERS, V219, P86, DOI 10.1016/j.jad.2017.05.003; World Health Organization, 2012, PROGR UPD US ANT DRU; 2007, CID S2, V44	41	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0227935	10.1371/journal.pone.0227935	http://dx.doi.org/10.1371/journal.pone.0227935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MA6QB	32502150	Green Published, gold, Green Submitted			2022-12-26	WOS:000542035700001
J	Zhang, RC; Qiu, ZY				Zhang, Runchi; Qiu, Zhiyi			Optimizing hyper-parameters of neural networks with swarm intelligence: A novel framework for credit scoring	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; BANKRUPTCY PREDICTION; GENETIC ALGORITHM; CLASSIFICATION; OPTIMIZATION; MODEL; RISK; CLASSIFIERS; ENSEMBLE; ACCURACY	Neural networks are widely used in automatic credit scoring systems with high accuracy and outstanding efficiency. However, in the absence of prior knowledge, it is difficult to determine the set of hyper-parameters, which makes its application limited in practice. This paper presents a novel framework of credit-scoring model based on neural networks trained by the optimal swarm intelligence (SI) algorithm. This framework incorporates three procedures. Step 1, pre-processing, including imputation, normalization, and re-ordering of the samples. Step 2, training, where SI algorithms optimize hyper-parameters of back-propagation artificial neural networks (BP-ANN) with the area under curve (AUC) as the evaluation function. Step 3, test, applying the optimized model in Step 2 to predict new samples. The results show that the framework proposed in this paper searches the hyper-parameter space efficiently and finds the optimal set of hyper parameters with appropriate time complexity, which enhances the fitting and generalization ability of BP-ANN. Compared with existing credit-scoring models, the model in this paper predicts with a higher accuracy. Additionally, the model enjoys a greater robustness, for the difference of performance between training and testing phases.	[Zhang, Runchi] Bank Jiangsu Co Ltd, Postdoctoral Work Stn, Nanjing, Jiangsu, Peoples R China; [Zhang, Runchi] Nanjing Univ, Postdoctoral Res Stn, Nanjing, Jiangsu, Peoples R China; [Qiu, Zhiyi] Shanghai Univ Finance & Econ, Sch Publ Econ & Adm, Shanghai, Peoples R China	Nanjing University; Shanghai University of Finance & Economics	Qiu, ZY (corresponding author), Shanghai Univ Finance & Econ, Sch Publ Econ & Adm, Shanghai, Peoples R China.	zyqiu1789@hotmail.com			China Postdoctoral Science Foundation [2019M651760]; Graduates Innovation Foundation of Shanghai University of Finance and Economics [CXJJ2016-443]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Graduates Innovation Foundation of Shanghai University of Finance and Economics	R.Z. is financed by China Postdoctoral Science Foundation (http://jj.chinapostdoctor.org.cn/V1/Program3/Default.aspx), grant number 2019M651760. Z.Q. is financed by the Graduates Innovation Foundation of Shanghai University of Finance and Economics (https://gs.sufe.edu.cn/Home/NewsDetail/1467), grant number CXJJ2016-443. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdou H, 2008, EXPERT SYST APPL, V35, P1275, DOI 10.1016/j.eswa.2007.08.030; Adebayo J., 2016, YALE J LAW TECH, V18, P148; Akkoc S, 2012, EUR J OPER RES, V222, P168, DOI 10.1016/j.ejor.2012.04.009; Ala'raj M, 2016, EXPERT SYST APPL, V64, P36, DOI 10.1016/j.eswa.2016.07.017; ALTMAN EI, 1994, J BANK FINANC, V18, P505, DOI 10.1016/0378-4266(94)90007-8; Anderson R., 2007, CREDIT SCORING TOOLK; [Anonymous], 2011, PERPECTIVES REV U HE, V18, P59; [Anonymous], 2000, COMPUTERS OPERATIONS, V27, P1131; Arundina T, 2015, PAC-BASIN FINANC J, V34, P273, DOI 10.1016/j.pacfin.2015.03.002; Banasik J, 2007, EUR J OPER RES, V183, P1582, DOI 10.1016/j.ejor.2006.06.072; Barba Navaretti G., 2017, EUROPEAN EC, V2, P9; Bennell JA, 2006, EXPERT SYST APPL, V30, P415, DOI 10.1016/j.eswa.2005.10.002; Berkson J, 1944, J AM STAT ASSOC, V39, P357, DOI 10.2307/2280041; Blanco A, 2013, EXPERT SYST APPL, V40, P356, DOI 10.1016/j.eswa.2012.07.051; Breiman L., 2001, MACH LEARN, V45, P5; Brill J., 1998, BUSINESS CREDIT, V100, P16; Brown I, 2012, EXPERT SYST APPL, V39, P3446, DOI 10.1016/j.eswa.2011.09.033; Chuang CL, 2011, EXPERT SYST, V28, P185, DOI 10.1111/j.1468-0394.2010.00565.x; Chuang CL, 2009, EXPERT SYST APPL, V36, P1685, DOI 10.1016/j.eswa.2007.11.067; COATS PK, 1993, FINANC MANAGE, V22, P142, DOI 10.2307/3665934; Cortina Lorente J.J., 2018, WORLD BANK RES POLIC; Danenas P, 2015, EXPERT SYST APPL, V42, P3194, DOI 10.1016/j.eswa.2014.12.001; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; FRYDMAN H, 1985, J FINANC, V40, P269, DOI 10.2307/2328060; Gandomi AH, 2013, COMMUN NONLINEAR SCI, V18, P89, DOI 10.1016/j.cnsns.2012.06.009; Goldstein I, 2019, REV FINANC STUD, V32, P1647, DOI 10.1093/rfs/hhz025; Goonatilake S, 1995, INTELLIGENT SYSTEMS; Gup B. E., 2005, COMMERCIAL BANKING M; Hand D.J., PATTERN RECOGNITION, V40, P41; Hand DJ, 2005, J OPER RES SOC, V56, P1109, DOI 10.1057/palgrave.jors.2601932; Harris T, 2015, EXPERT SYST APPL, V42, P741, DOI 10.1016/j.eswa.2014.08.029; Hassanien A.E., 2018, SWARM INTELLIGENCE P; Hastie T., 2009, ELEMENTS STAT LEARNI, P587; Henley WE, 1996, J ROY STAT SOC D-STA, V45, P77, DOI 10.2307/2348414; Hens AB, 2012, EXPERT SYST APPL, V39, P6774, DOI 10.1016/j.eswa.2011.12.057; Hjort N, 1996, PATTERN RECOGNITION; Hoffmann F, 2007, EUR J OPER RES, V177, P540, DOI 10.1016/j.ejor.2005.09.044; Huang CL, 2007, EXPERT SYST APPL, V33, P847, DOI 10.1016/j.eswa.2006.07.007; Huang Z, 2004, DECIS SUPPORT SYST, V37, P543, DOI 10.1016/S0167-9236(03)00086-1; Khashman A, 2010, EXPERT SYST APPL, V37, P6233, DOI 10.1016/j.eswa.2010.02.101; Kijsipongse E, 2012, 2012 9 INT C COMP SC; Lawrence S, 1997, AAAI IAAI; Leong CK, 2016, COMPUT ECON, V47, P423, DOI 10.1007/s10614-015-9505-8; Li HG, 2002, J OPER RES SOC, V53, P647, DOI 10.1057/palgrave.jors.2601346; Lisboa PJG, 2009, IEEE T NEURAL NETWOR, V20, P1403, DOI 10.1109/TNN.2009.2023654; Louzada F, 2011, EXPERT SYST APPL, V38, P12717, DOI 10.1016/j.eswa.2011.04.059; Mahmoudi N, 2015, EXPERT SYST APPL, V42, P2510, DOI 10.1016/j.eswa.2014.10.037; Marcano-Cedeno A, 2011, INT J NEURAL SYST, V21, P311, DOI 10.1142/S0129065711002857; Mavrovouniotis M, 2017, SWARM EVOL COMPUT, V33, P1, DOI 10.1016/j.swevo.2016.12.005; Mello C, 1999, ANALYST, V124, P1669, DOI 10.1039/a905570c; Mirjalili S, 2016, ADV ENG SOFTW, V95, P51, DOI 10.1016/j.advengsoft.2016.01.008; Mirjalili S, 2014, ADV ENG SOFTW, V69, P46, DOI 10.1016/j.advengsoft.2013.12.007; Nanni L, 2009, EXPERT SYST APPL, V36, P3028, DOI 10.1016/j.eswa.2008.01.018; Oreski S, 2012, EXPERT SYST APPL, V39, P12605, DOI 10.1016/j.eswa.2012.05.023; Paliwal M, 2009, EXPERT SYST APPL, V36, P2, DOI 10.1016/j.eswa.2007.10.005; Pavlidis NG, 2012, J OPER RES SOC, V63, P1645, DOI 10.1057/jors.2012.15; Plawiak P, 2019, APPL SOFT COMPUT, V84, DOI 10.1016/j.asoc.2019.105740; Rashedi E, 2009, INFORM SCIENCES, V179, P2232, DOI 10.1016/j.ins.2009.03.004; SALCHENBERGER LM, 1992, DECISION SCI, V23, P899, DOI 10.1111/j.1540-5915.1992.tb00425.x; Sermpinis G, 2015, EUR J FINANC, V21, P316, DOI 10.1080/1351847X.2012.744763; Siddiqi N, 2012, CREDIT RISK SCORECAR, V3; Singh K., 2011, IJCEM INT J COMPUTAT, V12, P105; Stulz R.M., 2019, NBER WORKING PAPER; Sustersic M, 2009, EXPERT SYST APPL, V36, P4736, DOI 10.1016/j.eswa.2008.06.016; TAM KY, 1992, MANAGE SCI, V38, P926, DOI 10.1287/mnsc.38.7.926; Thomas LC, 2002, CREDIT SCORING ITS A; Tkac M, 2016, APPL SOFT COMPUT, V38, P788, DOI 10.1016/j.asoc.2015.09.040; Trelea IC, 2003, INFORM PROCESS LETT, V85, P317, DOI 10.1016/S0020-0190(02)00447-7; Trinkle BS, 2016, INTELL SYST ACCOUNT, V23, P240, DOI 10.1002/isaf.1394; Tripathi D, 2018, J INTELL FUZZY SYST, V34, P1543, DOI 10.3233/JIFS-169449; Tsai CF, 2008, EXPERT SYST APPL, V34, P2639, DOI 10.1016/j.eswa.2007.05.019; Van Gestel T, 2006, EUR J OPER RES, V172, P979, DOI 10.1016/j.ejor.2004.11.009; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Wang G, 2011, EXPERT SYST APPL, V38, P223, DOI 10.1016/j.eswa.2010.06.048; White C, BANANAS BAYESIAN OPT; Xia YF, 2017, EXPERT SYST APPL, V78, P225, DOI 10.1016/j.eswa.2017.02.017; Xu DY, 2019, INT J FINANC ECON, V24, P903, DOI 10.1002/ijfe.1698; Yang XS, 2014, NEURAL COMPUT APPL, V24, P169, DOI 10.1007/s00521-013-1367-1; Yang XS, 2012, ENG COMPUTATION, V29, P464, DOI 10.1108/02644401211235834; Yap BW, 2011, EXPERT SYST APPL, V38, P13274, DOI 10.1016/j.eswa.2011.04.147; Yeh IC, 2009, EXPERT SYST APPL, V36, P2473, DOI 10.1016/j.eswa.2007.12.020; Yu JJQ, 2015, APPL SOFT COMPUT, V30, P614, DOI 10.1016/j.asoc.2015.02.014; Zhang DF, 2010, EXPERT SYST APPL, V37, P7838, DOI 10.1016/j.eswa.2010.04.054; Zhang WY, 2019, EXPERT SYST APPL, V121, P221, DOI 10.1016/j.eswa.2018.12.020; Zhao ZY, 2015, EXPERT SYST APPL, V42, P3508, DOI 10.1016/j.eswa.2014.12.006; Zhou LG, 2009, INT J INF TECH DECIS, V8, P677, DOI 10.1142/S0219622009003582; Zhou LG, 2010, EXPERT SYST APPL, V37, P127, DOI 10.1016/j.eswa.2009.05.024; 2018, INT J COMMUN SYST, V31	89	5	5	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0234254	10.1371/journal.pone.0234254	http://dx.doi.org/10.1371/journal.pone.0234254			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MA6QB	32502197	Green Published, gold			2022-12-26	WOS:000542035700047
J	Burke, LM; Sharma, AP; Heikura, IA; Forbes, SF; Holloway, M; McKay, AKA; Bone, JL; Leckey, JJ; Welvaert, M; Ross, ML				Burke, Louise M.; Sharma, Avish P.; Heikura, Ida A.; Forbes, Sara F.; Holloway, Melissa; McKay, Alannah K. A.; Bone, Julia L.; Leckey, Jill J.; Welvaert, Marijke; Ross, Megan L.			Crisis of confidence averted: Impairment of exercise economy and performance in elite race walkers by ketogenic low carbohydrate, high fat (LCHF) diet is reproducible	PLOS ONE			English	Article							ENDURANCE PERFORMANCE; RESPIRATORY QUOTIENT; ENHANCED ENDURANCE; ADAPTATION; METABOLISM; PERIODIZATION; INTENSITY; FUEL; OXIDATION; CYCLISTS	Introduction We repeated our study of intensified training on a ketogenic low-carbohydrate (CHO), high-fat diet (LCHF) in world-class endurance athletes, with further investigation of a "carryover" effect on performance after restoring CHO availability in comparison to high or periodised CHO diets. Methods After Baseline testing (10,000 m IAAF-sanctioned race, aerobic capacity and submaximal walking economy) elite male and female race walkers undertook 25 d supervised training and repeat testing (Adapt) on energy-matched diets: High CHO availability (8.6 g.kg(-1).d(-1) CHO, 2.1 g.kg(-1).d(-1) protein; 1.2 g.kg(-1).d(-1) fat) including CHO before/during/after workouts (HCHO, n = 8): similar macronutrient intake periodised within/between days to manipulate low and high CHO availability at various workouts (PCHO, n = 8); and LCHF (<50 g.d(-1) CHO; 78% energy as fat; 2.1 g.kg(-1).d(-1) protein; n = 10). After Adapt, all athletes resumed HCHO for 2.5 wk before a cohort (n = 19) completed a 20 km race. Results All groups increased VO(2)peak (ml.kg(-1).min(-1)) at Adapt (p = 0.02, 95%CI: [0.35-2.74]). LCHF markedly increased whole-body fat oxidation (from 0.6 g.min(-1) to 1.3 g.min(-1)), but also the oxygen cost of walking at race-relevant velocities. Differences in 10,000 m performance were clear and meaningful: HCHO improved by 4.8% or 134 s (95% CI: [207 to 62 s]; p < 0.001), with a trend for a faster time (2.2%, 61 s [-18 to +144 s]; p = 0.09) in PCHO. LCHF were slower by 2.3%, -86 s ([-18 to -144 s]; p < 0.001), with no evidence of superior "rebound" performance over 20 km after 2.5 wk of HCHO restoration and taper. Conclusion Our previous findings of impaired exercise economy and performance of sustained high-intensity race walking following keto-adaptation in elite competitors were repeated. Furthermore, there was no detectable benefit from undertaking an LCHF intervention as a periodised strategy before a 2.5-wk race preparation/taper with high CHO availability.	[Burke, Louise M.; Sharma, Avish P.; Heikura, Ida A.; Forbes, Sara F.; Holloway, Melissa; McKay, Alannah K. A.; Bone, Julia L.; Welvaert, Marijke; Ross, Megan L.] Australian Inst Sport, Canberra, ACT, Australia; [Burke, Louise M.; Heikura, Ida A.; Bone, Julia L.; Leckey, Jill J.; Ross, Megan L.] Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Melbourne, Vic, Australia; [Sharma, Avish P.] Griffith Univ, Sch Allied Hlth Sci, Griffith Sports Physiol & Performance, Gold Coast, Australia; [McKay, Alannah K. A.] Univ Western Australia, Sch Human Sci Exercise & Sport Sci, Crawley, WA, Australia; [McKay, Alannah K. A.] Western Australian Inst Sport, Mt Claremont, WA, Australia; [Welvaert, Marijke] Univ Canberra, Res Inst Sport & Exercise, Canberra, ACT, Australia	Australian Institute of Sport; Australian Catholic University; Griffith University; University of Western Australia; University of Canberra	Burke, LM (corresponding author), Australian Inst Sport, Canberra, ACT, Australia.; Burke, LM (corresponding author), Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Melbourne, Vic, Australia.	louise.burke@ausport.gov.au	Burke, Louise/ABC-5691-2020; McKay, Alannah/AAH-3738-2021; Forbes, Sara/AHE-6669-2022; Welvaert, Marijke/GOE-6151-2022; Welvaert, Marijke/K-8486-2013	Forbes, Sara/0000-0001-6726-9328; Welvaert, Marijke/0000-0002-0802-8134; McKay, Alannah/0000-0002-4184-3886; Heikura, Ida/0000-0002-1088-428X; Burke, Louise M/0000-0001-8866-5637	Australian Catholic University Research Funds [2017000034]; Australian Institute of Sport	Australian Catholic University Research Funds; Australian Institute of Sport	This study was funded by a Program Grant from the Australian Catholic University Research Funds to Professor Louise Burke (ACURF, 2017000034).; Studies of this magnitude require incredible support from a large team. We thank our research colleagues and supporters: Laura Garvican-Lewis, Amelia Carr, Brent Vallance, Rita Civil, Alice Wallett, Nicolin Tee, Victor Vuong, Nikki Jeacocke, Reid Reale, Chris Fonda, Rebekah Alcock, Michelle Minehan, Bronwen Charlesson, Bronwen Lundy, Mark Howard, Toni Franklin, Ben Parker, Aki Kawamura, Susan Boegman, Kiara Carmody, Rachel McCormick, Ned Brophy-Williams, Peter Peeling, Philo Saunders, Damon Arezzollo, Jamie Whitfield, Sarah Taylor, Sacha Tee, James Tee, Stephan Praet, Claire Tallent, Phil Reading and Lynne Mercer. The support and environment of the Australian Institute of Sport were crucial in allowing this study to be completed. Finally, the generosity and commitment to sports science of the Supernova race walkers continues to inspire us. This study would not have happened without their blood, sweat, tears and good humour.	Achten J, 2002, MED SCI SPORT EXER, V34, P92, DOI 10.1097/00005768-200201000-00015; [Anonymous], IMPR REPR EMP SCI; B Spiriev, IAAF SCORING TABLES; Badenhorst CE, 2015, EUR J APPL PHYSIOL, V115, P2521, DOI 10.1007/s00421-015-3252-3; Bartlett JD, 2015, EUR J SPORT SCI, V15, P3, DOI 10.1080/17461391.2014.920926; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benardot D, 2016, MED SCI SPORT EXER, V48, P543; Burke LM, 2006, J APPL PHYSIOL, V100, P7, DOI 10.1152/japplphysiol.01238.2005; Burke LM, 2002, MED SCI SPORT EXER, V34, P83, DOI 10.1097/00005768-200201000-00014; Burke LM, 2000, J APPL PHYSIOL, V89, P2413, DOI 10.1152/jappl.2000.89.6.2413; Burke LM, J PHYSL; Burke LM, 2021, J PHYSIOL-LONDON, V599, P819, DOI 10.1113/JP278928; Burke LM, 2019, INT J SPORT NUTR EXE, V29, P117, DOI 10.1123/ijsnem.2019-0004; Burke LM, 2018, SCIENCE, V362, P781, DOI 10.1126/science.aau2093; Burke LM, 2018, INT J SPORT NUTR EXE, V28, P451, DOI 10.1123/ijsnem.2018-0289; Burke LM, 2017, J PHYSIOL-LONDON, V595, P2993, DOI 10.1113/JP274011; Burke LM, 2017, J PHYSIOL-LONDON, V595, P2785, DOI 10.1113/JP273230; Carlino Elisa, 2014, Handb Exp Pharmacol, V225, P149, DOI 10.1007/978-3-662-44519-8_9; Cole M, 2014, INT J SPORTS MED, V35, P265, DOI 10.1055/s-0033-1348254; Cox PJ, 2016, CELL METAB, V24, P256, DOI 10.1016/j.cmet.2016.07.010; Coyle EF, 1991, J SPORT SCI, V9, P29, DOI 10.1080/02640419108729865; DANIELS J, 1992, MED SCI SPORT EXER, V24, P483; Evans M, 2019, MED SCI SPORT EXER, V51, P2506, DOI 10.1249/MSS.0000000000002065; Evans M, 2018, MED SCI SPORT EXER, V50, P2330, DOI 10.1249/MSS.0000000000001700; Evans M, 2017, J PHYSIOL-LONDON, V595, P2857, DOI 10.1113/JP273185; Ewing L, RACEWALKER E DUNFEES; Frandsen J, 2017, INT J SPORTS MED, V38, P975, DOI 10.1055/s-0043-117178; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; Gejl KD, 2017, MED SCI SPORT EXER, V49, P2486, DOI 10.1249/MSS.0000000000001377; Goedecke JH, 1999, METABOLISM, V48, P1509, DOI 10.1016/S0026-0495(99)90238-X; Havemann L, 2006, J APPL PHYSIOL, V100, P194, DOI 10.1152/japplphysiol.00813.2005; Heikura IA, 2020, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00880; Hoogkamer W, 2018, SPORTS MED, V48, P1009, DOI 10.1007/s40279-017-0811-2; Huebsch T, EYE OPENING SPLITS 5; IAP: Interacademy Partnership for Health, 2016, CALL ACT IMPR REPR B; Impey SG, 2018, SPORTS MED, V48, P1031, DOI 10.1007/s40279-018-0867-7; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Iqbal SA, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002333; Jones AM, 2018, ANNU REV NUTR, V38, P303, DOI 10.1146/annurev-nutr-082117-051622; Joyner MJ, 2008, J PHYSIOL-LONDON, V586, P35, DOI 10.1113/jphysiol.2007.143834; Karelis AD, 2010, SPORTS MED, V40, P747, DOI 10.2165/11533080-000000000-00000; Kipp S, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00079; Krogh A, 1920, BIOCHEM J, V14, P290, DOI 10.1042/bj0140290; LAMBERT EV, 1994, EUR J APPL PHYSIOL O, V69, P287, DOI 10.1007/BF00392032; Larsen HB, 2003, COMP BIOCHEM PHYS A, V136, P161, DOI 10.1016/S1095-6433(03)00227-7; Leckey JJ, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00806; Leckey JJ, 2018, FASEB J, pfj201700993R; Leverve Xavier, 2007, Novartis Found Symp, V280, P108; Lindseth I, 2017, J PHYSIOL-LONDON, V595, P2989, DOI 10.1113/JP273990; Louis JB, 2020, J APPL PHYSIOL, V128, P440, DOI 10.1152/japplphysiol.00819.2019; Marquet LA, 2016, MED SCI SPORT EXER, V48, P663, DOI 10.1249/MSS.0000000000000823; Maunder E, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00599; Maunder E, 2018, SPORTS MED, V48, P2219, DOI 10.1007/s40279-018-0938-9; McKay AKA, 2019, J SPORT SCI, V37, P553, DOI 10.1080/02640414.2018.1521712; McSwiney FT, 2018, METABOLISM, V81, P25, DOI 10.1016/j.metabol.2017.10.010; Mirtschin JG, 2018, INT J SPORT NUTR EXE, V28, P480, DOI 10.1123/ijsnem.2017-0249; Munafo MR, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-016-0021; Murtaza N, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030614; Noakes TD, 1990, J SPORT SCI, V8, P35, DOI 10.1080/02640419008732129; Noakes T, 2014, BRIT J SPORT MED, V48, P1077, DOI 10.1136/bjsports-2014-093824; Peake JM, 2017, J APPL PHYSIOL, V122, P1077, DOI 10.1152/japplphysiol.00622.2016; PERONNET F, 1991, CAN J SPORT SCI, V16, P23; Petersson J, 2009, FREE RADICAL BIO MED, V46, P1068, DOI 10.1016/j.freeradbiomed.2009.01.011; PHINNEY SD, 1983, METABOLISM, V32, P769, DOI 10.1016/0026-0495(83)90106-3; R Core Team, R LANG ENV STAT COMP; Robertson EY, 2010, MED SCI SPORT EXER, V42, P394, DOI 10.1249/MSS.0b013e3181b34b57; ROMIJN JA, 1992, AM J PHYSIOL, V263, pE64, DOI 10.1152/ajpendo.1992.263.1.E64; Saunders PU, 2010, INT J SPORT PHYSIOL, V5, P521, DOI 10.1123/ijspp.5.4.521; Saunders PU, 2012, PHYSL TESTS ELITE AT, P397; Scott BE, 2018, J SCI MED SPORT; Shaw DM, 2020, SPORTS MED, V50, P641, DOI 10.1007/s40279-019-01246-y; Shaw DM, 2019, MED SCI SPORT EXER, V51, P2135, DOI 10.1249/MSS.0000000000002008; Spriet LL, 2014, SPORTS MED, V44, P87, DOI 10.1007/s40279-014-0154-1; Stellingwerff T, 2006, AM J PHYSIOL-ENDOC M, V290, pE380, DOI 10.1152/ajpendo.00268.2005; The Academy of Medical Sciences, 2015, REPR REL BIOM RES IM; Tucker R., 2020, RUNNING SHOE TECH EM; Volek JS, 2016, METABOLISM, V65, P100, DOI 10.1016/j.metabol.2015.10.028; Volek JS, 2015, EUR J SPORT SCI, V15, P13, DOI 10.1080/17461391.2014.959564; Volek JS, 2012, ART SCI LOW CARBOHYD; Webster CC, 2018, SPORTS MED, V48, P2421, DOI 10.1007/s40279-018-0972-7; Webster CC, 2018, INT J SPORT PHYSIOL, V13, P957, DOI 10.1123/ijspp.2017-0392; Webster CC, 2016, J PHYSIOL-LONDON, V594, P4389, DOI 10.1113/JP271934; Zuntz N., 1901, STUDIEN PHYSIOLOGIE, P361	83	38	38	5	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0234027	10.1371/journal.pone.0234027	http://dx.doi.org/10.1371/journal.pone.0234027			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497061	Green Published, gold			2022-12-26	WOS:000542035200047
J	Linher-Melville, K; Zhu, YF; Sidhu, J; Parzei, N; Shahid, A; Seesankar, G; Ma, D; Wang, Z; Zacal, N; Sharma, M; Parihar, V; Zacharias, R; Singh, G				Linher-Melville, Katja; Zhu, Yong Fang; Sidhu, Jesse; Parzei, Natalka; Shahid, Ayesha; Seesankar, Gireesh; Ma, Danny; Wang, Zhi; Zacal, Natalie; Sharma, Manu; Parihar, Vikas; Zacharias, Ramesh; Singh, Gurmit			Evaluation of the preclinical analgesic efficacy of naturally derived, orally administered oil forms of Delta 9-tetrahydrocannabinol (THC), cannabidiol (CBD), and their 1:1 combination	PLOS ONE			English	Article							CHRONIC CONSTRICTION INJURY; PERIPHERAL-NERVE INJURY; T-CELL INFILTRATION; NEUROPATHIC PAIN; SCIATIC-NERVE; GERMINAL-CENTERS; GENE-EXPRESSION; SPINAL-CORD; IFN-GAMMA; CYTOKINES	Chronic neuropathic pain (NP) is a growing clinical problem for which effective treatments, aside from non-steroidal anti-inflammatory drugs and opioids, are lacking. Cannabinoids are emerging as potentially promising agents to manage neuroimmune effects associated with nociception. In particular, Delta 9-tetrahydrocannabinol (THC), cannabidiol (CBD), and their combination are being considered as therapeutic alternatives for treatment of NP. This study aimed to examine whether sex affects long-term outcomes on persistent mechanical hypersensitivity 7 weeks after ceasing cannabinoid administration. Clinically relevant low doses of THC, CBD, and a 1:1 combination of THC:CBD extracts, in medium chain triglyceride (MCT) oil, were orally gavaged for 14 consecutive days to age-matched groups of male and female sexually mature Sprague Dawley rats. Treatments commenced one day after surgically inducing a pro-nociceptive state using a peripheral sciatic nerve cuff. The analgesic efficacy of each phytocannabinoid was assessed relative to MCT oil using hind paw mechanical behavioural testing once a week for 9 weeks. In vivo intracellular electrophysiology was recorded at endpoint to characterize soma threshold changes in primary afferent sensory neurons within dorsal root ganglia (DRG) innervated by the affected sciatic nerve. The thymus, spleen, and DRG were collected post-sacrifice and analyzed for long-term effects on markers associated with T lymphocytes at the RNA level using qPCR. Administration of cannabinoids, particularly the 1:1 combination of THC, elicited a sustained mechanical anti-hypersensitive effect in males with persistent peripheral NP, which corresponded to beneficial changes in myelinated A beta mechanoreceptive fibers. Specific immune cell markers associated with T cell differentiation and pro-inflammatory cytokines, previously implicated in repair processes, were differentially up-regulated by cannabinoids in males treated with cannabinoids, but not in females, warranting further investigation into sexual dimorphisms that may underlie treatment outcomes.	[Linher-Melville, Katja; Zhu, Yong Fang; Singh, Gurmit] McMaster Univ, Michael G DeGroote Inst Pain Res & Care, Hamilton, ON, Canada; [Linher-Melville, Katja; Zhu, Yong Fang; Sidhu, Jesse; Parzei, Natalka; Shahid, Ayesha; Seesankar, Gireesh; Ma, Danny; Wang, Zhi; Zacal, Natalie; Sharma, Manu; Singh, Gurmit] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Parihar, Vikas; Zacharias, Ramesh] McMaster Univ Med Ctr, Michael G DeGroote Pain Clin, Med Ctr, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Singh, G (corresponding author), McMaster Univ, Michael G DeGroote Inst Pain Res & Care, Hamilton, ON, Canada.; Singh, G (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.	gsingh@mcmaster.ca	nusratjahan, Dr./AAA-9051-2022	nusratjahan, Dr./0000-0002-3972-3009; Linher-Melville, Katja/0000-0001-8243-0212	CIHR Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR))		[Anonymous], 2017, LANCET HIV, V2, pe115; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; [Anonymous], 2016, LANCET ONCOL, V17, pe198; Arneth B, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0715-6; Banczyk D, 2014, EUR J IMMUNOL, V44, P93, DOI 10.1002/eji.201343811; Baron EP, 2018, HEADACHE, V58, P1139, DOI 10.1111/head.13345; Bertin S, 2014, NAT IMMUNOL, V15, P1055, DOI 10.1038/ni.3009; Bode U, 1997, EUR J IMMUNOL, V27, P2087, DOI 10.1002/eji.1830270837; Bolbecker AR, 2018, DRUG ALCOHOL DEPEN, V190, P54, DOI 10.1016/j.drugalcdep.2018.05.012; Brandsborg B, 2007, ANESTHESIOLOGY, V106, P1003, DOI 10.1097/01.anes.0000265161.39932.e8; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen WM, 2012, J LEUKOCYTE BIOL, V92, P1093, DOI 10.1189/jlb.0212082; Colloca L, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.2; Costa B, 2005, PAIN, V116, P52, DOI 10.1016/j.pain.2005.03.043; Costa B, 2007, EUR J PHARMACOL, V556, P75, DOI 10.1016/j.ejphar.2006.11.006; Costigan M, 2009, J NEUROSCI, V29, P14415, DOI 10.1523/JNEUROSCI.4569-09.2009; Dableh Liliane J, 2011, J Pain Res, V4, P91, DOI 10.2147/JPR.S17009; DALTON WS, 1976, CLIN PHARMACOL THER, V19, P300; De Petrocellis L, 2011, BRIT J PHARMACOL, V163, P1479, DOI 10.1111/j.1476-5381.2010.01166.x; De Vry J, 2004, EUR J PHARMACOL, V491, P137, DOI 10.1016/j.ejphar.2004.03.051; DEVOR M, 1991, BRIT MED BULL, V47, P619, DOI 10.1093/oxfordjournals.bmb.a072496; Dhital S, 2017, CELL IMMUNOL, V312, P25, DOI 10.1016/j.cellimm.2016.11.006; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Djouhri L, 1998, J PHYSIOL-LONDON, V513, P857, DOI 10.1111/j.1469-7793.1998.857ba.x; Draleau Ks, 2014, J Pain Relief, VSuppl 3, P003; EDIN BB, 1995, J PHYSIOL-LONDON, V487, P243, DOI 10.1113/jphysiol.1995.sp020875; Fairweather D, 2004, EMERG INFECT DIS, V10, P2005, DOI 10.3201/eid1011.040367; FERRELL WR, 1987, J PHYSIOL-LONDON, V386, P63, DOI 10.1113/jphysiol.1987.sp016522; Gallego A, 2003, CYTOM PART B-CLIN CY, V56B, P23, DOI 10.1002/cyto.b.10052; GOODWIN GM, 1972, SCIENCE, V175, P1382, DOI 10.1126/science.175.4028.1382; Gui JG, 2012, AGING DIS, V3, P280; Hu P, 2007, BRAIN BEHAV IMMUN, V21, P599, DOI 10.1016/j.bbi.2006.10.013; Inyang KE, 2019, PHARMACOL RES, V139, P1, DOI 10.1016/j.phrs.2018.10.027; Jan TR, 2001, J LEUKOCYTE BIOL, V69, P841; Jungen MJ, 2019, BMC MUSCULOSKEL DIS, V20, DOI 10.1186/s12891-019-2541-0; Kalies K, 2008, J IMMUNOL, V180, P5457, DOI 10.4049/jimmunol.180.8.5457; Kaminski NE, 1998, J NEUROIMMUNOL, V83, P124, DOI 10.1016/S0165-5728(97)00228-2; Kaplan BLF, 2008, BIOCHEM PHARMACOL, V76, P726, DOI 10.1016/j.bcp.2008.06.022; Kaplan BLF, 2003, J PHARMACOL EXP THER, V306, P1077, DOI 10.1124/jpet.103.051961; KARNIOL IG, 1974, EUR J PHARMACOL, V28, P172, DOI 10.1016/0014-2999(74)90129-0; Kassiotis G, 2004, J IMMUNOL, V173, P7292, DOI 10.4049/jimmunol.173.12.7292; Kirby L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11638-3; Kissick HT, 2014, P NATL ACAD SCI USA, V111, P9887, DOI 10.1073/pnas.1402468111; Klein TW, 2004, J NEUROIMMUNOL, V147, P91, DOI 10.1016/j.jneuroim.2003.10.019; Kleinschnitz C, 2006, EXP NEUROL, V200, P480, DOI 10.1016/j.expneurol.2006.03.014; Kozela E, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0603-x; Lawson SN, 1997, J PHYSIOL-LONDON, V505, P177, DOI 10.1111/j.1469-7793.1997.00177.x; LEMBERGER L, 1976, ANN NY ACAD SCI, V281, P219, DOI 10.1111/j.1749-6632.1976.tb27933.x; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Liu Hai-hong, 2006, Zhonghua Nan Ke Xue, V12, P330; Liu HH, 2006, ZHONGHUA NAN KE XUE, V12, P336; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lotsch J, 2018, EUR J PAIN, V22, P471, DOI 10.1002/ejp.1148; MacLeod AS, 2013, J CLIN INVEST, V123, P4364, DOI 10.1172/JCI70064; Manzanares J, 2006, CURR NEUROPHARMACOL, V4, P239, DOI 10.2174/157015906778019527; McLeod GA, 2001, ANAESTHESIA, V56, P75, DOI 10.1046/j.1365-2044.2001.01763-7.x; Meng H, 2017, ANESTH ANALG, V125, P1638, DOI 10.1213/ANE.0000000000002110; Moalem G, 2004, NEUROSCIENCE, V129, P767, DOI 10.1016/j.neuroscience.2004.08.035; Mosconi T, 1996, PAIN, V64, P37, DOI 10.1016/0304-3959(95)00077-1; Nadeau S, 2011, J NEUROSCI, V31, P12533, DOI 10.1523/JNEUROSCI.2840-11.2011; Nave KA, 2014, ANNU REV CELL DEV BI, V30, P503, DOI 10.1146/annurev-cellbio-100913-013101; Neil Michael Je, 2009, Rev Pain, V3, P6, DOI 10.1177/204946370900300203; Nichols JM, 2020, CANNABIS CANNABINOID, V5, P12, DOI 10.1089/can.2018.0073; Nikolajsen L, 2004, ACTA ANAESTH SCAND, V48, P111, DOI 10.1111/j.1399-6576.2004.00271.x; Nurmikko TJ, 2007, PAIN, V133, P210, DOI 10.1016/j.pain.2007.08.028; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Parkitny L, 2013, NEUROLOGY, V80, P106, DOI 10.1212/WNL.0b013e31827b1aa1; Perkins NM, 2000, NEUROSCIENCE, V101, P745, DOI 10.1016/S0306-4522(00)00396-1; Pertwee RG, 2002, EUR J PHARMACOL, V456, P99, DOI 10.1016/S0014-2999(02)02624-9; Pitcher GM, 2002, EUR J NEUROSCI, V15, P1509, DOI 10.1046/j.1460-9568.2002.01984.x; Rodrigues PC, 2009, LATERALITY, V14, P395, DOI 10.1080/13576500802469607; Rohr LE, 2006, J MOTOR BEHAV, V38, P431, DOI 10.3200/JMBR.38.6.431-137; ROLL JP, 1982, EXP BRAIN RES, V47, P177; Russell C, 2018, INT J DRUG POLICY, V52, P87, DOI 10.1016/j.drugpo.2017.11.008; Russo EB, 2005, NEUROCHEM RES, V30, P1037, DOI 10.1007/s11064-005-6978-1; Russo EB, 2011, BRIT J PHARMACOL, V163, P1344, DOI 10.1111/j.1476-5381.2011.01238.x; Saucier D, 2007, J INT NEUROPSYCH SOC, V13, P683, DOI 10.1017/S1355617707070865; Schaible H. -G., 2007, V177, P3; Schinkel C, 2006, CLIN J PAIN, V22, P235, DOI 10.1097/01.ajp.0000169669.70523.f0; Sorge RE, 2017, J NEUROSCI RES, V95, P1271, DOI 10.1002/jnr.23841; Sorge RE, 2015, NAT NEUROSCI, V18, P1081, DOI 10.1038/nn.4053; Tanabe S, 2018, NAT NEUROSCI, V21, P506, DOI 10.1038/s41593-018-0106-4; Trigunaite A, 2015, CELL IMMUNOL, V294, P87, DOI 10.1016/j.cellimm.2015.02.004; Tsai YC, 2001, PAIN, V92, P63, DOI 10.1016/S0304-3959(00)00472-3; Uceyler N, 2006, ARTHRITIS RHEUM-US, V54, P2656, DOI 10.1002/art.22026; Ungard RG, 2020, CAN J PAIN, V4, P39, DOI 10.1080/24740527.2020.1724776; Vafadar AK, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0731-y; van den Elsen GAH, 2017, J PSYCHOPHARMACOL, V31, P184, DOI 10.1177/0269881116665357; van der Heiden M, 2016, SCI REP-UK, V6, DOI 10.1038/srep26892; Verri WA, 2006, PHARMACOL THERAPEUT, V112, P116, DOI 10.1016/j.pharmthera.2006.04.001; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; Wu Q, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-37; Yuan W, 2016, IRAN J BASIC MED SCI, V19, P794; ZHU YF, 2018, J CANCER RES THER, V14, DOI DOI 10.1177/1744806918810099; Zhu YF, 2020, BRIT J PHARM; Zhu YF, 2020, MOL PAIN, V16, DOI 10.1177/1744806920911536; Zhu Yong Fang, 2012, J Pain Res, V5, P175, DOI 10.2147/JPR.S26367; Zhu YF, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-15	98	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0234176	10.1371/journal.pone.0234176	http://dx.doi.org/10.1371/journal.pone.0234176			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497151	gold, Green Published			2022-12-26	WOS:000542035200081
J	Nawaz, SA; Li, JB; Bhatti, UA; Mehmood, A; Shoukat, MU; Bhatti, MA				Nawaz, Saqib Ali; Li, Jingbing; Bhatti, Uzair Aslam; Mehmood, Anum; Shoukat, Muhammad Usman; Bhatti, Mughair Aslam			Advance hybrid medical watermarking algorithm using speeded up robust features and discrete cosine transform	PLOS ONE			English	Article							IMAGES; SURF	In the continuous development of computer network technology, multimedia technology and information technology, digitization has become the main means of displaying information, thus facilitating the storage, copying and dissemination of digital multimedia information. In this context, there are no restrictions on arbitrary editing, copying, modification, and dissemination of digital images, music, etc., which leads to various social problems such as information security, copyright disputes, and piracy. With the advancement of networks and multimedia, digital watermarking technology has received worldwide attention as an effective method of copyright protection. Improving the anti-geometric attack ability of digital watermarking algorithms using image feature-based algorithms have received extensive attention. This paper proposes a novel robust watermarking algorithm based on SURF-DCT perceptual hashing (Speeded Up Robust Features and Discrete Cosine Transform), namely blind watermarking. The algorithm firstly uses the affine transformation with a feature matrix and chaotic encryption technology to preprocess the watermark image, enhance the confidentiality of the watermark, and perform block and DCT coefficients extraction on the carrier image, and then uses the positive and negative quantization rules to modify the DCT coefficients. The embedding of the watermark is completed, and the blind extraction of the watermark realized. Experiments show that the algorithm has good invisibility and strong robustness against conventional and geometric attacks and can effectively protect the security of images with NC value more than 90%.	[Nawaz, Saqib Ali; Li, Jingbing] Hainan Univ, Coll Informat & Commun Engn, Haikou, Hainan, Peoples R China; [Nawaz, Saqib Ali; Li, Jingbing] Hainan Univ, State Key Lab Marine Resource Utilizat South Chin, Haikou, Hainan, Peoples R China; [Bhatti, Uzair Aslam] Nanjing Normal Univ, Sch Geog, Nanjing, Peoples R China; [Mehmood, Anum] Hainan Univ, Coll Biol, Inst Trop Agr & Forestry, Haikou, Hainan, Peoples R China; [Mehmood, Anum] Hainan Univ, Lab Biotechnol & Mol Pharmacol, Hainan Key Lab Sustainable Utilizat Trop Bioresou, Haikou, Hainan, Peoples R China; [Shoukat, Muhammad Usman] Sichuan Univ Sci & Engn, Sch Automat & Informat, Yibin, Peoples R China; [Bhatti, Mughair Aslam] Hamdard Univ, Karachi, Pakistan	Hainan University; Hainan University; Nanjing Normal University; Hainan University; Hainan University; Sichuan University of Science & Engineering; Hamdard University	Li, JB (corresponding author), Hainan Univ, Coll Informat & Commun Engn, Haikou, Hainan, Peoples R China.; Li, JB (corresponding author), Hainan Univ, State Key Lab Marine Resource Utilizat South Chin, Haikou, Hainan, Peoples R China.	jingbingli2008@hotmail.com		Bhatti, Uzair/0000-0002-8743-2783	Hainan Provincial Natural Science Foundation of China [2019RC018]; Natural Science Foundation of Hainan [617048, 2018CXTD333]; Science and Technology Research Project of Chongqing Education Commission [KJQN201800442]; Special Scientific Research Project of Philosophy and Social Sciences of Chongqing Medical University [201703]	Hainan Provincial Natural Science Foundation of China; Natural Science Foundation of Hainan; Science and Technology Research Project of Chongqing Education Commission; Special Scientific Research Project of Philosophy and Social Sciences of Chongqing Medical University	This work is supported by Hainan Provincial Natural Science Foundation of China [No. 2019RC018], and by the Natural Science Foundation of Hainan[617048, 2018CXTD333], and by the Science and Technology Research Project of Chongqing Education Commission [KJQN201800442] and by the Special Scientific Research Project of Philosophy and Social Sciences of Chongqing Medical University [201703].	Aggoun A, 2003, IEE P-COMPUT DIG T, V150, P2, DOI 10.1049/ip-cdt:20030063; Agrwal Shubh Lakshmi, 2016, 2016 5 INT C REL INF; AHMED N, 1974, IEEE T COMPUT, VC 23, P90, DOI 10.1109/T-C.1974.223784; Al-Haj Ali, 2007, Journal of Computer Sciences, V3, P740, DOI 10.3844/jcssp.2007.740.746; Alotaibi Reem A., 2019, Applied Computing and Informatics, V15, P191, DOI 10.1016/j.aci.2018.06.003; [Anonymous], 2008, WORKSH VER VAL SHIP, V1, pB7; [Anonymous], 2008, J FUEL CELL SCI TECH, V5, P12; Bahrami Z, 2018, MULTIMED TOOLS APPL, V77, P327, DOI 10.1007/s11042-016-4226-0; Bay Herbert, 2006, EUR C COMP VIS; Berghel H, 1996, COMPUTER, V29, P101, DOI 10.1109/2.511977; Byun SW, 2019, IEEE ACCESS, V7, P100706, DOI 10.1109/ACCESS.2019.2931039; Cedillo-Hernandez M, 2013, RADIOENGINEERING, V22, P1057; Chu WC, 2003, IEEE T MULTIMEDIA, V5, P34, DOI 10.1109/TMM.2003.808816; Hernandez JR, 2000, IEEE T IMAGE PROCESS, V9, P55, DOI 10.1109/83.817598; Hsu LY, 2020, EXPERT SYST APPL, V149, DOI 10.1016/j.eswa.2020.113225; Ken Cabeen, 1998, TECH REP; Lin SD, 2000, IEEE T CONSUM ELECTR, V46, P415, DOI 10.1109/30.883387; Liu Jialing, 2018, INT C CLOUD COMP SEC; Liu JW, 2019, AIP ADV, V9, DOI 10.1063/1.5094516; Liu J, 2019, J MED IMAG HEALTH IN, V9, P188, DOI 10.1166/jmihi.2019.2559; Lu JF, 2010, PROCEEDINGS OF THE ASME 29TH INTERNATIONAL CONFERENCE ON OCEAN, OFFSHORE AND ARCTIC ENGINEERING, 2010, VOL 1, P883; Manu VT, 2016, ADV INTELL SYST COMP, V425, P645, DOI 10.1007/978-3-319-28658-7_55; Mohanty S. P., 1999, 7 ACM INT MULT C ACM, P49; Mohanty SP, 2018, IEEE ACCESS, V6, P5939, DOI 10.1109/ACCESS.2018.2795478; Mohanty Saraju P., 2012, ARXIV12054489; Nguyen D., 2011, CELL DEATH DIS, V2, pe240; Roy S, 2017, AEU-INT J ELECTRON C, V72, P149, DOI 10.1016/j.aeue.2016.12.003; Shivakumar BL, 2011, IJCSI INT J COMPUTER, V8, P4; Singh AK, 2015, J MED IMAG HEALTH IN, V5, P607, DOI 10.1166/jmihi.2015.1432; Suaib NM, 2014, IEEE REGION 10 SYMP, P200, DOI 10.1109/TENCONSpring.2014.6863025; Sverdlov Alexander, 2005, 2005 13 EUR SIGN PRO; Thanki R, 2017, ENG SCI TECHNOL, V20, P1366, DOI 10.1016/j.jestch.2017.06.001; Wang W, 2013, APPL MECH MATER, V303-306, P2117, DOI 10.4028/www.scientific.net/AMM.303-306.2117; Yuan XC, 2018, SIGNAL PROCESS, V149, P103, DOI 10.1016/j.sigpro.2018.03.007; Zear A, 2018, MULTIMED TOOLS APPL, V77, P4863, DOI 10.1007/s11042-016-3862-8	35	8	8	7	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0232902	10.1371/journal.pone.0232902	http://dx.doi.org/10.1371/journal.pone.0232902			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497047	Green Published, gold			2022-12-26	WOS:000542035200025
J	Spasibionek, S; Mikolajczyk, K; Cwiek-Kupczynska, H; Pietka, T; Krotka, K; Matuszczak, M; Nowakowska, J; Michalski, K; Bartkowiak-Broda, I				Spasibionek, Stanislaw; Mikolajczyk, Katarzyna; Cwiek-Kupczynska, Hanna; Pietka, Teresa; Krotka, Krystyna; Matuszczak, Marcin; Nowakowska, Joanna; Michalski, Krzysztof; Bartkowiak-Broda, Iwona			Marker assisted selection of new high oleic and low linolenic winter oilseed rape (Brassica napusL.) inbred lines revealing good agricultural value	PLOS ONE			English	Article							VEGETABLE-OIL; CANOLA; ACIDS	Development of oilseed rape (Brassica napusL.) breeding lines producing oil characterized by high oleic and low linolenic acid content is an important goal of rapeseed breeding programs worldwide. Such kind of oil is ideal for deep frying and can also be used as a raw material for biodiesel production. By performing chemical mutagenesis using ethyl methanesulfonate, we obtained mutant winter rapeseed breeding lines that can produce oil with a high content of oleic acid (C18:1, more than 75%) and a low content of linolenic acid (C18:3, less than 3%). However, the mutant lines revealed low agricultural value as they were characterized by low seed yield, low wintering, and high content of glucosinolates in seed meal. The aim of this work was to improve the mutant lines and develop high-oleic and low-linolenic recombinants exhibiting both good oil quality and high agronomic value. The plant materials used in this study included high-oleic and low-linolenic mutant breeding lines and high-yielding domestic canola-type breeding lines of good agricultural value with high oleic acid content and extremely low glucosinolates content. Field trials were conducted in four environments, in a randomized complete block design. Phenotyping was performed for wintering, yield of seed and oil, and seed quality traits. Genotype x environment interaction was investigated with respect to the content of C18:1 and C18:3 acids in seed oil. Genotyping was done for the selection of homozygous high oleic and low linolenic lines using allele-specific CAPS markers and SNaPshot assay, respectively. Finally, new high oleic and low linolenic winter rapeseed recombinant lines were obtained for use as a starting material for the development of new varieties that may be of high value on the oil crop market.	[Spasibionek, Stanislaw; Mikolajczyk, Katarzyna; Pietka, Teresa; Krotka, Krystyna; Matuszczak, Marcin; Nowakowska, Joanna; Michalski, Krzysztof; Bartkowiak-Broda, Iwona] Plant Breeding & Acclimatizat Inst Natl Res Inst, Dept Genet & Breeding Oilseed Crops, Poznan, Greater Poland, Poland; [Cwiek-Kupczynska, Hanna] Polish Acad Sci, Inst Plant Genet, Poznan, Greater Poland, Poland	Institute of Plant Breeding & Acclimatization; Polish Academy of Sciences; Institute of Plant Genetics of the Polish Academy of Sciences	Mikolajczyk, K (corresponding author), Plant Breeding & Acclimatizat Inst Natl Res Inst, Dept Genet & Breeding Oilseed Crops, Poznan, Greater Poland, Poland.	kamik@nico.ihar.poznan.pl	Ćwiek-Kupczyńska, Hanna/W-1810-2018	Ćwiek-Kupczyńska, Hanna/0000-0001-9113-567X; Matuszczak, Marcin/0000-0003-0712-7568; Mikolajczyk, Katarzyna/0000-0002-5874-2213	Polish Ministry of Agriculture and Rural Development, grant 'Biological Progress' [4201701]	Polish Ministry of Agriculture and Rural Development, grant 'Biological Progress'	This work was funded by the Polish Ministry of Agriculture and Rural Development (https://www.gov.pl/web/rolnictwo), grant 'Biological Progress' No. 4201701, task 53 (20142020). Initial of authors who received the award: SS, KM, TP, KK, MM, JN. The funders had no role in stugy design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, AIR FORCE TIMES, V75, P24; [Anonymous], 2015, J CROHNS COLITIS S1, V9, pS15; Barret P., 1999, P 10 INT RAP C, P26; Barth CA, 2009, EUR J LIPID SCI TECH, V111, P953, DOI 10.1002/ejlt.200900019; Bocianowski J, 2012, J APPL GENET, V53, P27, DOI 10.1007/s13353-011-0062-0; Calinski T., 1997, Advances in biometrical genetics. Proceedings of the tenth meeting of the EUCARPIA Section Biometrics in Plant Breeding, Poznan, Poland, 14-16 May 1997., P3; Calinski T, 1998, SERGEN STAT METHODOL, P1; Delourme R, 2006, THEOR APPL GENET, V113, P1331, DOI 10.1007/s00122-006-0386-z; Downey R. K., 1987, PRINCIPLES PLANT BRE, P437; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Eskin N. A., 1996, BAILEYS IND OIL FAT, P1; Falentin C, 2007, International Patent Application Publication, Patent No. [WO 2007/138444, 2007138444]; Fitzpatrick K, 1998, P B I B, P15; Friedt W., 1999, P 10 INT RAP C CANB; Friedt W, 2009, HANDB PLANT BREED, V4, P91, DOI 10.1007/978-0-387-77594-4_4; Gauthier M, 2017, FIELD CROP RES, V212, P165, DOI 10.1016/j.fcr.2017.07.013; Hansson SO, 2018, TRENDS FOOD SCI TECH, V80, P131, DOI 10.1016/j.tifs.2018.07.023; Harwood JL, 1996, BBA-LIPID LIPID MET, V1301, P7, DOI 10.1016/0005-2760(95)00242-1; Hu XY, 2006, THEOR APPL GENET, V113, P497, DOI 10.1007/s00122-006-0315-1; Javed N, 2014, CAN J PLANT SCI, V94, P1103, DOI [10.4141/CJPS2013-142, 10.4141/cjps2013-142]; Jourdren C, 1996, THEOR APPL GENET, V93, P512, DOI 10.1007/BF00417942; Kaczmarek Z., 1986, ROCZ AR POZNAN, V155, P1; KRZYMANSKI J, 1970, Hodowla Roslin Aklimatyzacja i Nasiennictwo, V14, P95; Leckband G, 2002, FOOD RES INT, V35, P273, DOI 10.1016/S0963-9969(01)00196-X; Long WH, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00399; MAHER L, 2007, P 12 INT RAP C, V0005, P00022; Mailer R, 2009, CANOLA BEST PRACTICE, P7; Matthaus B, 2006, EUR J LIPID SCI TECH, V108, P200, DOI 10.1002/ejlt.200500249; Michalski K., 1995, P 9 INT RAP C 4 7 JU, V3, P911; Mikolajczyk K, 2010, PLANT BREEDING, V129, P502, DOI 10.1111/j.1439-0523.2009.01730.x; Mikolajczyk K, 2011, PLANT BREEDING, P185; Nath U. K., 2016, Plant Breeding and Biotechnology, V4, P123, DOI 10.9787/PBB.2016.4.2.123; Nelson MN, 2016, CROP PASTURE SCI, V67, P284, DOI 10.1071/CP15320; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Ostergaard L, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-10; Pinzi S, 2009, ENERG FUEL, V23, P2325, DOI 10.1021/ef801098a; Rakopoulos DC, 2015, FUEL, V156, P1, DOI 10.1016/j.fuel.2015.04.021; Rakow G, 2004, BIOTECHNOL AGRIC FOR, V54, P3; RAKOW G, 1973, Z PFLANZENZUCHT, V69, P62; Raney J. P., 1990, P OIL CROPS NETW SHA; Scarth R, 2006, CROP SCI, V46, P1225, DOI 10.2135/cropsci2005.08-0245; SCARTH R, 1988, CAN J PLANT SCI, V68, P509, DOI 10.4141/cjps88-061; Scarth R, 1999, P 10 INT RAP C CANB, V1, P57; Schierholt A, 2000, THEOR APPL GENET, V101, P897, DOI 10.1007/s001220051559; Simopoulos AP, 2000, POULTRY SCI, V79, P961, DOI 10.1093/ps/79.7.961; Singer SD, 2016, PLANT SCI, V243, P1, DOI 10.1016/j.plantsci.2015.11.003; Singer SD, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0094-7; Snowdon R., 2007, GENOME MAPPING MOL B, V2, P55, DOI DOI 10.1007/978-3-540-34388-2_; Spasibionek S, 2006, PLANT BREEDING, V125, P259, DOI 10.1111/j.1439-0523.2006.01213.x; Spasibionek S., 2004, Rosliny Oleiste, V25, P383; Spasibionek S., 2016, Rosliny Oleiste, V37, P21; Spasibionek S, 2013, MONOGRAPHS SCI DISSE, P47; TOPFER R, 1995, SCIENCE, V268, P681, DOI 10.1126/science.268.5211.681; Wittkop B, 2009, EUPHYTICA, V170, P131, DOI 10.1007/s10681-009-9940-5; Yang QY, 2012, THEOR APPL GENET, V125, P715, DOI 10.1007/s00122-012-1863-1	55	9	10	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0233959	10.1371/journal.pone.0233959	http://dx.doi.org/10.1371/journal.pone.0233959			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497146	Green Published, gold			2022-12-26	WOS:000542035200027
J	Bracker, LB; Gong, XY; Schmid, C; Dawid, C; Ulrich, D; Phung, T; Leonhard, A; Ainsworth, J; Olbricht, K; Parniske, M; Gompel, N				Braecker, Lasse B.; Gong, Xiaoyun; Schmid, Christian; Dawid, Corinna; Ulrich, Detlef; Tuyen Phung; Leonhard, Alexandra; Ainsworth, Julia; Olbricht, Klaus; Parniske, Martin; Gompel, Nicolas			A strawberry accession with elevated methyl anthranilate fruit concentration is naturally resistant to the pest fly Drosophila suzukii	PLOS ONE			English	Article							QUANTIFICATION; DRIVES	During the past decade, Drosophila suzukii has established itself as a global invasive fruit pest, enabled by its ability to lay eggs into fresh, ripening fruit. In a previous study, we investigated the impact of different strawberry accessions on the development of D. suzukii eggs, in the search of natural resistance. We identified several accessions that significantly reduced adult fly emergence from infested fruit. In the present study, we aimed at understanding the chemical basis of this effect. We first noted that one of the more resistant accessions showed an unusual enrichment of methyl anthranilate within its fruit, prompting us to investigate this fruit compound as a possible cause limiting fly development. We found that methyl anthranilate alone triggers embryo lethality in a concentration-dependent manner, unlike another comparable organic fruit compound. We also showed that a chemical fraction of the resistant strawberry accession that contains methyl anthranilate carries some activity toward the egg hatching rate. Surprisingly, in spite of the lethal effect of this compound to their eggs, adult females are not only attracted to methyl anthranilate at certain concentrations, but they also display a concentration-dependent preference to lay on substrates enriched in methyl anthranilate. This study demonstrates that methyl anthranilate is a potent agonist molecule against D. suzukii egg development. Its elevated concentration in a specific strawberry accession proven to reduce the fly development may explain, at least in part the fruit resistance. It further illustrates how a single, natural compound, non-toxic to humans could be exploited for biological control of a pest species.	[Braecker, Lasse B.; Tuyen Phung; Leonhard, Alexandra; Ainsworth, Julia; Gompel, Nicolas] Ludwig Maximilians Univ Munchen, Fac Biol, Chair Evolutionry Ecol, Planegg Martinsried, Germany; [Gong, Xiaoyun; Parniske, Martin] Ludwig Maximilians Univ Munchen, Fac Biol, Chair Genet, Planegg Martinsried, Germany; [Schmid, Christian; Dawid, Corinna] Tech Univ Munich, Chair Food Chem & Mol Sensory Sci, Freising Weihenstephan, Germany; [Ulrich, Detlef] Julius Kuhn Inst, Fed Res Ctr Cultivated Plants, Quedlinburg, Germany; [Olbricht, Klaus] Hansabred GmbH & Co KG, Dresden, Germany; [Olbricht, Klaus] Humboldt Univ, Fac Life Sci, Albrecht Daniel Thaer Inst Agr & Hort Sci, Berlin, Germany	University of Munich; University of Munich; Technical University of Munich; Julius Kuhn-Institut; Humboldt University of Berlin	Gompel, N (corresponding author), Ludwig Maximilians Univ Munchen, Fac Biol, Chair Evolutionry Ecol, Planegg Martinsried, Germany.; Parniske, M (corresponding author), Ludwig Maximilians Univ Munchen, Fac Biol, Chair Genet, Planegg Martinsried, Germany.; Olbricht, K (corresponding author), Hansabred GmbH & Co KG, Dresden, Germany.; Olbricht, K (corresponding author), Humboldt Univ, Fac Life Sci, Albrecht Daniel Thaer Inst Agr & Hort Sci, Berlin, Germany.	k.olbricht@hansabred.org; parniske@lmu.de; gompel@bio.lmu.de	Parniske, Martin/F-2202-2011	Parniske, Martin/0000-0001-8561-747X	Ludwig-Maximilians University of Munich	Ludwig-Maximilians University of Munich	The present work has been financed with funding from the Ludwig-Maximilians University of Munich (NG and MP). KO is an employee of Hansabred GmbH. The funder provided support in the form of salaries for author KO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the author contributions' section.	Atallah J, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2840; Bonneau P, 2019, INSECTS, V10, DOI 10.3390/insects10030068; Bourne A, 2019, PEST MANAG SCI, V75, P3340, DOI 10.1002/ps.5459; Bracker LB, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00118; Buchman A, 2018, P NATL ACAD SCI USA, V115, P4725, DOI 10.1073/pnas.1713139115; Farnsworth D, 2017, PEST MANAG SCI, V73, P1083, DOI 10.1002/ps.4497; Fraimout A, 2017, MOL BIOL EVOL, V34, P980, DOI 10.1093/molbev/msx050; Frank O, 2014, J AGR FOOD CHEM, V62, P2506, DOI 10.1021/jf405529b; Gong XY, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01880; Green JE, 2019, CURR BIOL, V29, P2075, DOI 10.1016/j.cub.2019.05.020; Hussain A, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002454; Jetti RR, 2007, J FOOD SCI, V72, pS487, DOI 10.1111/j.1750-3841.2007.00445.x; Jones CD, 2001, GENET RES, V78, P225, DOI 10.1017/S0016672301005298; Joseph RM, 2009, P NATL ACAD SCI USA, V106, P11352, DOI 10.1073/pnas.0901419106; Karageorgi M, 2017, CURR BIOL, V27, P847, DOI 10.1016/j.cub.2017.01.055; LACHAISE D, 1988, EVOL BIOL, V22, P159; Pillet J, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1088-1; Rendon D, 2020, PEST MANAG SCI, V76, P55, DOI 10.1002/ps.5512; Salmon B., 1996, Flavour and Fragrance Journal, V11, P353, DOI [10.1002/(SICI)1099-1026(199611)11:6<353::AID-FFJ596>3.3.CO;2-0, 10.1002/(SICI)1099-1026(199611)11:6&lt;353::AID-FFJ596&gt;3.0.CO;2-9]; Shrader ME, 2019, J ECON ENTOMOL, V112, P139, DOI 10.1093/jee/toy305; Ulrich D, 1997, Z LEBENSM UNTERS F A, V205, P218, DOI 10.1007/s002170050154; Ulrich D, 2014, J BERRY RES, V4, P11, DOI 10.3233/JBR-140067	22	4	4	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2020	15	6							e0234040	10.1371/journal.pone.0234040	http://dx.doi.org/10.1371/journal.pone.0234040			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MT4VF	32484826	gold, Green Published			2022-12-26	WOS:000554969700030
J	Kolarz, B; Ciesla, M; Dryglewska, M; Rosenthal, AK; Majdan, M				Kolarz, Bogdan; Ciesla, Marek; Dryglewska, Magdalena; Rosenthal, Ann K.; Majdan, Maria			Hypermethylation of the miR-155 gene in the whole blood and decreased plasma level of miR-155 in rheumatoid arthritis	PLOS ONE			English	Article							ALTERED EXPRESSION; HOST GENE; MICRORNA-155; INFLAMMATION; CONTRIBUTES; METHYLATION; LYMPHOMA; ROLES; ALPHA	Objectives miR-155 plays a critical role in the inflammatory process and in diseases such as rheumatoid arthritis (RA). miR155 gene expression is regulated by its gene promoter region CpG island methylation. Previous studies have shown inconsistent changes in circulating levels of mir-155 in RA patients. The aims of our study were to evaluate miR-155 levels in plasma, to investigate its gene methylation level, and to correlate these levels with RA disease activity. Methods One hundred and twenty-five patients with RA, and 30 age and sex-matched healthy controls (HC) were enrolled. Whole blood and plasma samples were collected and stored at -80 degrees C until analysis. DAS28 score at the time of the blood draw was used to assess RA disease activity. The methylation status of miR-155 host gene was determined in whole blood by quantitative real-time methylation-specific PCR (qPCR). miR-155 expression levels were evaluated by quantitative reverse transcription PCR. Results We found significantly lower circulating miR155 levels in RA patients compared to HC. Interestingly, the miR-155 gene methylation level was significantly higher in RA patients than in HC. miR-155 levels did not correlate with ACPA or RF positivity or disease activity. Conclusions We show here higher miR-155 methylation in whole blood and lower plasma miR155 expression in RA patients in comparison to HC. The evaluation of miR-155 host gene methylation status or miR155 plasma level might be a potentially useful marker in RA determination.	[Kolarz, Bogdan; Ciesla, Marek] Univ Rzeszow, Coll Med Sci, Rzeszow, Poland; [Dryglewska, Magdalena; Majdan, Maria] Med Univ Lublin, Dept Rheumatol & Connect Tissue Dis, Lublin, Poland; [Rosenthal, Ann K.] Med Coll Wisconsin, Dept Med, Div Rheumatol, Wauwatosa, WI USA	University of Rzeszow; Medical University of Lublin; Medical College of Wisconsin	Kolarz, B (corresponding author), Univ Rzeszow, Coll Med Sci, Rzeszow, Poland.	kolbo@wp.pl	Kolarz, Bogdan/AAO-7369-2020; Kolarz, Bogdan/M-7774-2016	Majdan, Maria/0000-0002-4345-1675; Dryglewska, Magdalena/0000-0001-9937-8158; Kolarz, Bogdan/0000-0001-8496-6846				Alivernini S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12970; Anaparti V, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1459-x; Angiolilli C, 2018, NAT REV RHEUMATOL, V14, P657, DOI 10.1038/s41584-018-0099-0; Asquith DL, 2015, CURR OPIN RHEUMATOL, V27, P204, DOI 10.1097/BOR.0000000000000150; Assmann TS, 2017, ENDOCR CONNECT, V6, P773, DOI 10.1530/EC-17-0248; Atarod Sadaf, 2014, F1000Res, V3, P183, DOI 10.12688/f1000research.4884.4; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Bluml S, 2011, ARTHRITIS RHEUM-US, V63, P1281, DOI 10.1002/art.30281; Chen X-M, 2015, MED BALTIMORE, V94; Churov AV, 2015, AUTOIMMUN REV, V14, P1029, DOI 10.1016/j.autrev.2015.07.005; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Daniunaite K, 2017, HUM MOL GENET, V26, P2451, DOI 10.1093/hmg/ddx138; Elmesmari A, 2016, RHEUMATOLOGY, V55, P2056, DOI 10.1093/rheumatology/kew272; Elton TS, 2013, GENE, V532, P1, DOI 10.1016/j.gene.2012.12.009; Filkova M, 2014, ANN RHEUM DIS, V73, P1898, DOI 10.1136/annrheumdis-2012-202815; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Klein K, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4074; Kolarz B, 2017, SEMIN ARTHRITIS RHEU, V46, P724, DOI 10.1016/j.semarthrit.2017.01.003; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Krzeminski P, 2015, BBA-GENE REGUL MECH, V1849, P353, DOI 10.1016/j.bbagrm.2014.12.002; Kurowska-Stolarska M, 2011, P NATL ACAD SCI USA, V108, P11193, DOI 10.1073/pnas.1019536108; Leonardo TR, 2012, NAT CELL BIOL, V14, P1114, DOI 10.1038/ncb2613; Li XC, 2013, INT J MOL SCI, V14, P23910, DOI 10.3390/ijms141223910; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long L, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/296139; Mashima R, 2015, IMMUNOLOGY, V145, P323, DOI 10.1111/imm.12468; Menigatti M, 2009, ONCOGENE, V28, P899, DOI 10.1038/onc.2008.444; Mookherjee N, 2013, J IMMUNOL METHODS, V400, P106, DOI 10.1016/j.jim.2013.10.001; Murata K, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3013; Niimoto T, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-209; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rajasekhar M, 2017, J AUTOIMMUN, V79, P53, DOI 10.1016/j.jaut.2017.01.002; Sharma AR, 2016, MED RES REV, V36, P425, DOI 10.1002/med.21384; Spoerl D, 2013, CLIN IMMUNOL, V148, P56, DOI 10.1016/j.clim.2013.03.010; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vigorito E, 2013, IMMUNOL REV, V253, P146, DOI 10.1111/imr.12057; Yim RL, 2014, ONCOTARGET, V5, P9770, DOI 10.18632/oncotarget.2390; Zhou QH, 2015, ANN RHEUM DIS, V74, P1265, DOI 10.1136/annrheumdis-2013-204377	41	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2020	15	6							e0233897	10.1371/journal.pone.0233897	http://dx.doi.org/10.1371/journal.pone.0233897			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MT4VF	32484820	Green Published, gold			2022-12-26	WOS:000554969700021
J	Adachi-Fukunaga, S; Tomitaka, Y; Sakurai, T				Adachi-Fukunaga, Shuhei; Tomitaka, Yasuhiro; Sakurai, Tamito			Effects of melon yellow spot orthotospovirus infection on the preference and developmental traits of melon thrips, Thrips palmi, in cucumber	PLOS ONE			English	Article							POPULATION ECOLOGY; INSECT VECTORS; VIRUS ATTRACT; PLANT-VIRUS; TOSPOVIRUS; TRANSMISSION; MANIPULATION; JASMONATE; BENEFITS; KARNY	Melon yellow spot orthotospovirus (MYSV), a member of the genus Orthotospovirus, is an important virus in cucurbits. Thrips palmi is considered the most serious pest of cucurbits because it directly damages and indirectly transmits MYSV to the plant. The effects of MYSV-infected plants on the development time, fecundity, and preference of the thrips were analyzed in this study. Our results showed that the development time of male and female thrips did not differ significantly between MYSV-infected and non-infected cucumbers. The survival rate of thrips in non-infected and MYSV-infected cucumbers were not significantly different. In a non-choice assay, T. palmi adults were released on non-infected and MYSV-infected cucumbers and allowed to lay eggs. The number of hatched larvae did not significantly differ between non-infected and MYSV-infected cucumbers. In a choice assay, MYSV had no detectable effect on the number of adult thrips and preceding hatched larvae. In a pull assay, the settling rate of thrips on the released plant did not differ significantly when the adult thrips were released to non-infected or MYSV infected cucumbers for any cucumber cultivar. Based on our results, we propose that the effects of MYSV-infected cucumbers on the development time, fecundity, or preference of T. palmi may not be an important factor in MYSV spread between cucumbers.	[Adachi-Fukunaga, Shuhei; Tomitaka, Yasuhiro] Natl Agr & Food Res Org, Kyushu Okinawa Agr Res Ctr, Kumamoto, Japan; [Sakurai, Tamito] Natl Agr & Food Res Org, Agr Res Ctr, Ibaraki, Japan	National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan	Sakurai, T (corresponding author), Natl Agr & Food Res Org, Agr Res Ctr, Ibaraki, Japan.	tsakurai@affrc.go.jp		Adachi, Shuhei/0000-0002-7314-4676				Abe H, 2008, PLANT CELL PHYSIOL, V49, P68, DOI 10.1093/pcp/pcm168; Abe H, 2012, PLANT CELL PHYSIOL, V53, P204, DOI 10.1093/pcp/pcr173; Abe H, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-97; Belliure B, 2005, ECOL LETT, V8, P70, DOI 10.1111/j.1461-0248.2004.00699.x; Belliure B, 2008, OECOLOGIA, V156, P797, DOI 10.1007/s00442-008-1027-9; Belliure B, 2010, BASIC APPL ECOL, V11, P162, DOI 10.1016/j.baae.2009.09.004; Cannon RJC, 2007, CROP PROT, V26, P1089, DOI 10.1016/j.cropro.2006.10.023; Chakraborty R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199404; Chen WT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102021; Daimei G, 2017, PHYTOPATHOLOGY, V107, P1440, DOI 10.1094/PHYTO-08-16-0296-R; Eigenbrode SD, 2018, ANNU REV ENTOMOL, V63, P169, DOI 10.1146/annurev-ento-020117-043119; Eigenbrode SD, 2002, P ROY SOC B-BIOL SCI, V269, P455, DOI 10.1098/rspb.2001.1909; GERMAN TL, 1992, ANNU REV PHYTOPATHOL, V30, P315, DOI 10.1146/annurev.py.30.090192.001531; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Hurd H, 2003, ANNU REV ENTOMOL, V48, P141, DOI 10.1146/annurev.ento.48.091801.112722; IWAKI M, 1984, PLANT DIS, V68, P1006, DOI 10.1094/PD-69-1006; Jensen Sten E., 2000, Integrated Pest Management Reviews, V5, P131, DOI 10.1023/A:1009600426262; Jones DR, 2005, EUR J PLANT PATHOL, V113, P119, DOI 10.1007/s10658-005-2334-1; Karny HH, 1925, B DELI PROEFSTATION, V23, P3; Kato K, 2000, PHYTOPATHOLOGY, V90, P422, DOI 10.1094/PHYTO.2000.90.4.422; Kato Kimihiko, 1999, Annals of the Phytopathological Society of Japan, V65, P624; KAWAI A, 1986, JPN J APPL ENTOMOL Z, V30, P12, DOI 10.1303/jjaez.30.12; Kawai A, 2001, JPN J APPL ENTOMOL Z, V45, P39, DOI 10.1303/jjaez.2001.39; KAWAI A, 1986, JPN J APPL ENTOMOL Z, V30, P7, DOI 10.1303/jjaez.30.7; KAWAI A, 1990, JARQ-JPN AGR RES Q, V23, P282; KENNEDY JS, 1951, NATURE, V168, P825, DOI 10.1038/168825a0; Leon-Reyes A, 2009, PLANT PHYSIOL, V149, P1797, DOI 10.1104/pp.108.133926; Maris PC, 2004, PHYTOPATHOLOGY, V94, P706, DOI 10.1094/PHYTO.2004.94.7.706; Mauck KE, 2010, P NATL ACAD SCI USA, V107, P3600, DOI 10.1073/pnas.0907191107; Mayer CJ, 2008, J CHEM ECOL, V34, P1045, DOI 10.1007/s10886-008-9516-1; Mirnezhad M, 2010, PHYTOCHEM ANALYSIS, V21, P110, DOI 10.1002/pca.1182; MURPHY FA, 1995, ARCH VIROL, V140, P391, DOI 10.1007/BF01309873; Pappu HR, 2009, VIRUS RES, V141, P219, DOI 10.1016/j.virusres.2009.01.009; Parker B, 1995, THRIPS BIOL MANAGEME, P7; Reitz SR, 2020, ANNU REV ENTOMOL, V65, P17, DOI 10.1146/annurev-ento-011019-024947; Riley DG, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10020; Rotenberg D, 2015, CURR OPIN VIROL, V15, P80, DOI 10.1016/j.coviro.2015.08.003; Shalileh S, 2016, ENVIRON ENTOMOL, V45, P1235, DOI 10.1093/ee/nvw102; Stafford-Banks CA, 2014, OIKOS, V123, P1384, DOI 10.1111/oik.01148; Stumpf CF, 2007, ENTOMOL EXP APPL, V123, P139, DOI 10.1111/j.1570-7458.2007.00541.x; Sugiyama M, 2009, PLANT BREEDING, V128, P696, DOI 10.1111/j.1439-0523.2008.01617.x; Sugiyama M, 2016, VEGETABLE BREEDING G, V15, P1; Suzuki M., 2010, Annual Report of the Kanto-Tosan Plant Protection Society, P119; Takeuchi S., 2001, Japanese Journal of Phytopathology, V67, P46; Takeuchi S, 2008, JAPANESE J PHYTOPATH, V74, P225; Tomitaka Y, 2015, J APPL ENTOMOL, V139, P250, DOI 10.1111/jen.12165; Whitfield AE, 2005, ANNU REV PHYTOPATHOL, V43, P459, DOI 10.1146/annurev.phyto.43.040204.140017; Yamasaki S, 2012, EUR J PLANT PATHOL, V132, P169, DOI 10.1007/s10658-011-9860-9	48	0	0	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0233722	10.1371/journal.pone.0233722	http://dx.doi.org/10.1371/journal.pone.0233722			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MJ2AA	32479526	Green Published, gold			2022-12-26	WOS:000547893500023
J	Kumpula, EK; Norris, P; Pomerleau, AC				Kumpula, Eeva-Katri; Norris, Pauline; Pomerleau, Adam C.			Stocks of paracetamol products stored in urban New Zealand households: A cross-sectional study	PLOS ONE			English	Article							MEDICINES; STORAGE; IMPUTATION; EXPOSURE	Background Intentional self-harm is a common cause of hospital presentations in New Zealand and across the world, and self-poisoning is the most common method of self-harm. Paracetamol (acetaminophen) is frequently used in impulsive intentional overdoses, where ease of access may determine the choice of substance. Objective This cross-sectional study aimed to determine how much paracetamol is present and therefore accessible in urban New Zealand households, and sources from where it has been obtained. This information is not currently available through any other means, but could inform New Zealand drug policy on access to paracetamol. Methods Random cluster-sampling of households was performed in major urban areas of two cities in New Zealand, and the paracetamol-containing products, quantities, and sources were recorded. Population estimates of proportions of various types of paracetamol products were calculated. Results A total of 174 of the 201 study households (86.6%) had at least one paracetamol product. Study households had mostly prescription products (78.2% of total mass), and a median of 24.0 g paracetamol present per household (inter-quartile range 6.0-54.0 g). Prescribed paracetamol was the main source of large stock. Based on the study findings, 53% of New Zealand households had 30 g or more paracetamol present, and 36% had 30 g or more of prescribed paracetamol, specifically. Conclusions This study highlights the importance of assessing whether and how much paracetamol is truly needed when prescribing and dispensing it. Convenience of appropriate access to therapeutic paracetamol needs to be balanced with preventing unnecessary accumulation of paracetamol stocks in households and inappropriate access to it. Prescribers and pharmacists need to be aware of the risks of such accumulation and assess the therapeutic needs of their patients. Public initiatives should be rolled out at regular intervals to encourage people to return unused or expired medicines to pharmacies for safe disposal.	[Kumpula, Eeva-Katri; Pomerleau, Adam C.] Univ Otago, Natl Poisons Ctr, Dept Prevent & Social Med, Dunedin, New Zealand; [Norris, Pauline] Univ Otago, Ctr Pacific Hlth Vaa Tautai, Div Hlth Sci, Dunedin, New Zealand	University of Otago; University of Otago	Kumpula, EK (corresponding author), Univ Otago, Natl Poisons Ctr, Dept Prevent & Social Med, Dunedin, New Zealand.	eeva-katri.kumpula@otago.ac.nz		Kumpula, Eeva-Katri/0000-0003-0455-5161	Oakley Mental Health Research Foundation	Oakley Mental Health Research Foundation	This study was funded by a research grant from Oakley Mental Health Research Foundation (http://www.oakleymentalhealth.co.nz/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the study participants, research assistants Timothy Burrell, Jocelyn Ooi, Daniel Paterson, and Erika Sequeda for collecting the data, Andrew Gray for assistance in study design and sample size determinations, and Benoit Auvray (Airmed Ltd) for the adjusted stock proportions calculations.	Abushanab Amani S, 2013, Int J Pharm Pract, V21, P185, DOI 10.1111/j.2042-7174.2012.00250.x; Atkinson J., 2014, NZDEP2013 INDEX DEPR; Bateman DN, 2009, CLIN TOXICOL, V47, P536, DOI 10.1080/15563650903093192; Bettington E, 2018, AUST PRESCR, V41, P78, DOI 10.18773/austprescr.2018.015; Blieden M, 2014, EXPERT REV CLIN PHAR, V7, P341, DOI 10.1586/17512433.2014.904744; Braund R, 2009, PHARM WORLD SCI, V31, P664, DOI 10.1007/s11096-009-9325-9; Buykx P, 2010, AUST NZ J PUBL HEAL, V34, P401, DOI 10.1111/j.1753-6405.2010.00573.x; Cairns R, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026001; Chiew AL, 2020, MED J AUSTRALIA, V212, P175, DOI 10.5694/mja2.50428; Daly C, 2018, EUR J PUBLIC HEALTH, V28, P681, DOI 10.1093/eurpub/cky031; Foroutan B, 2014, E MEDITERR HEALTH J, V20, P547, DOI 10.26719/2014.20.9.547; Gedeborg R, 2017, PHARMACOEPIDEM DR S, V26, P518, DOI 10.1002/pds.4166; Gilley M, 2020, CLIN TOXICOL, V58, P711, DOI 10.1080/15563650.2019.1687900; Griffin E, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005557; Gummin DD, 2019, CLIN TOXICOL, V57, P1220, DOI 10.1080/15563650.2019.1677022; Gwini SM, 2011, EMERG MED J, V28, P892, DOI 10.1136/emj.2009.086140; HAWTON K, 1995, BRIT MED J, V310, P164, DOI 10.1136/bmj.310.6973.164; Hawton K, 1996, BRIT J PSYCHIAT, V168, P43, DOI 10.1192/bjp.168.1.43; Hawton K, 2001, BRIT MED J, V322, P1, DOI DOI 10.1136/BMJ.322.7296.1203; Hawton K, 2012, EUR CHILD ADOLES PSY, V21, P369, DOI 10.1007/s00787-012-0269-6; Hewson C, 2013, J PRIM HEALTH CARE, V5, P146, DOI 10.1071/HC13146; Huynh A, 2018, MED J AUSTRALIA, V209, P74, DOI 10.5694/mja17.01063; Janssen L, 2018, PHARMACY, V6, DOI 10.3390/pharmacy6030074; Kelly JP, 2018, J AM PHARM ASSOC, V58, P492, DOI 10.1016/j.japh.2018.06.012; KESSEL N, 1966, P ROY SOC MED, V59, P89, DOI 10.1177/003591576605900206; Kumpula EK, 2017, AUST NZ J PUBL HEAL, V41, P535, DOI 10.1111/1753-6405.12702; Martinez RM, 2012, J COMMUN HEALTH, V37, P1249, DOI 10.1007/s10900-012-9563-y; Martins RR, 2017, REV SAUDE PUBL, V51, DOI [10.11606/S1518-8787.2017051000053, 10.11606/s1518-8787.2017051000053]; Mikhail A, 2019, CRISIS, V40, P166, DOI 10.1027/0227-5910/a000545; Ministry of Health, 2019, SUIC FACTS DAT TABL; National Ethics Advisory Committee, 2019, NAT ETH STAND HLTH D; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Peiris-John R, 2014, INTERN MED J, V44, P273, DOI 10.1111/imj.12364; Perry IJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031663; Rubin D. B., 2004, MULTIPLE IMPUTATION; Samuelsen PJ, 2015, BMC PHARMACOL TOXICO, V16, DOI 10.1186/s40360-015-0016-y; Sarganas G, 2015, BMC PHARMACOL TOXICO, V16, DOI 10.1186/s40360-015-0028-7; Statistics New Zealand, 2016, STAT STAND MESHBL; Stekhoven DJ, 2012, BIOINFORMATICS, V28, P112, DOI 10.1093/bioinformatics/btr597; University of Otago, NZDEP2013 MESHBL DAT; van Buuren S, 2011, J STAT SOFTW, V45, P1; Wastesson JW, 2018, BASIC CLIN PHARMACOL, V123, P301, DOI 10.1111/bcpt.13003; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Wondimu A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135650; Wright MN, 2017, J STAT SOFTW, V77, P1, DOI 10.18637/jss.v077.i01	45	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0233806	10.1371/journal.pone.0233806	http://dx.doi.org/10.1371/journal.pone.0233806			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MJ2AA	32479539	gold, Green Published			2022-12-26	WOS:000547893500028
J	Leon-Lozano, MZ; Arnaez, J; Valls, A; Arca, G; Agut, T; Alarcon, A; Garcia-Alix, A				Leon-Lozano, Marisol-Zulema; Arnaez, Juan; Valls, Ana; Arca, Gemma; Agut, Thais; Alarcon, Ana; Garcia-Alix, Alfredo			Cerebrospinal fluid levels of neuron-specific enolase predict the severity of brain damage in newborns with neonatal hypoxic-ischemic encephalopathy treated with hypothermia	PLOS ONE			English	Article							NEUROBIOCHEMICAL MARKERS; THERAPEUTIC HYPOTHERMIA; TERM INFANTS; BIOMARKERS; SERUM; PROTEINS; INJURY; MRI; DYSFUNCTION; INCREASE	Objectives To investigate whether cerebrospinal fluid levels of neuron-specific enolase (CSF-NSE) during the first 72 hours correlate with other tools used to assess ongoing brain damage, including clinical grading of hypoxic-ischemic encephalopathy (HIE), abnormal patterns in amplitude integrated electroencephalography (aEEG), and magnetic resonance imaging (MRI), as well as with the neurodevelopmental outcomes at two years of age. Material and methods Prospective observational study performed in two hospitals between 2009 and 2011. Forty-three infants diagnosed with HIE within 6 hours of life were included. HIE was severe in 20 infants, moderate in 12, and mild in 11. Infants with moderate-to-severe HIE received whole-body cooling. Both the HIE cohort and a control group of 59 infants with suspected infection underwent measurement of CSF-NSE concentrations at between 12 and 72 hours after birth. aEEG monitoring was started at admission and brain MRI was performed within the first 2 weeks. Neurodevelopment was assessed at 24 months. Results The HIE group showed higher levels of CSF-NSE than the control group: median 70 ng/ml (29; 205) vs 10.6 ng/ml (7.7; 12.9); p < 0.001. Median levels of CSF-NSE in infants with severe, moderate, and mild HIE were 220.5 ng/ml (120.5; 368.8), 45.5 ng/ml (26, 75.3), and 26 ng/ml (18, 33), respectively. CSF-NSE levels correlated were significantly higher in infants with seizures, abnormal aEEG, or abnormal MRI, compared to those without abnormalities. Infants with an adverse outcome showed higher CSF-NSE levels than those with normal findings (p<0.001), and the most accurate CSF-NSE cutoff level for predicting adverse outcome in the whole cohort was 108 ng/ml and 50ng/ml in surviving infants. Conclusions In the era of hypothermia, CSF-NSE concentrations provides valuable information as a clinical surrogate of the severity of hypoxic-ischemic brain damage, and this information may be predictive of abnormal outcome at two years of age.	[Leon-Lozano, Marisol-Zulema] Assistencial Univ Manresa, Althaia Xarxa, Barcelona, Spain; [Leon-Lozano, Marisol-Zulema; Garcia-Alix, Alfredo] Univ Barcelona, Barcelona, Spain; [Arnaez, Juan] Hosp Univ Burgos, Dept Neonatol, Burgos, Spain; [Arnaez, Juan; Arca, Gemma; Agut, Thais; Garcia-Alix, Alfredo] NeNe Fdn, Madrid, Spain; [Valls, Ana; Garcia-Alix, Alfredo] Hosp St Joan de Deu, Inst Recerca St Joan de Deu, Barcelona, Spain; [Arca, Gemma] IDIBAPS, Dept Neonatol, Hosp Clin, Barcelona, Spain; [Agut, Thais; Alarcon, Ana] Hosp St Joan de Deu, Dept Neonatol, Barcelona, Spain; [Garcia-Alix, Alfredo] CIBER Enfermedades Raras, Madrid, Spain	University of Barcelona; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Garcia-Alix, A (corresponding author), Univ Barcelona, Barcelona, Spain.; Garcia-Alix, A (corresponding author), NeNe Fdn, Madrid, Spain.; Garcia-Alix, A (corresponding author), Hosp St Joan de Deu, Inst Recerca St Joan de Deu, Barcelona, Spain.; Garcia-Alix, A (corresponding author), CIBER Enfermedades Raras, Madrid, Spain.	alfredoalix@gmail.com	Arnaez, Juan/ABF-4338-2020	Arnaez, Juan/0000-0001-8883-5181; Agut, Thais/0000-0002-5673-0016; Alarcon Allen, Ana/0000-0001-7223-2028				Agut T, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-177; Alsina M, 2017, PEDIATR CRIT CARE ME, V18, P234, DOI 10.1097/PCC.0000000000001068; Arca G, 2020, ARCH DIS CHILD-FETAL, V105, pF132, DOI 10.1136/archdischild-2018-316680; Arnaez J, 2018, THER HYPOTHERMIA TEM, V8, P24, DOI 10.1089/ther.2017.0024; BARONE FC, 1993, BRAIN RES, V623, P77, DOI 10.1016/0006-8993(93)90012-C; Bennet L, 2010, SEMIN FETAL NEONAT M, V15, P253, DOI 10.1016/j.siny.2010.05.007; Berger RP, 2010, DEV NEUROSCI-BASEL, V32, P396, DOI 10.1159/000316803; Blennow M, 2001, ACTA PAEDIATR, V90, P1171, DOI 10.1080/080352501317061594; Bonifacio SL, 2015, SEMIN FETAL NEONAT M, V20, P122, DOI 10.1016/j.siny.2014.12.011; Boudes E, 2015, ARCH DIS CHILD-FETAL, V100, pF238, DOI 10.1136/archdischild-2014-306550; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x; Carreras N, 2018, J PEDIAT-BRAZIL, V94, P251, DOI 10.1016/j.jped.2017.05.009; Celtik C, 2004, BRAIN DEV-JPN, V26, P398, DOI 10.1016/j.braindev.2003.12.007; Chalak LF, 2014, J PEDIATR-US, V164, P468, DOI 10.1016/j.jpeds.2013.10.067; Chang T, 2012, CURR NEUROL NEUROSCI, V12, P145, DOI 10.1007/s11910-012-0254-y; Charon V, 2016, EUR J RADIOL, V85, P1366, DOI 10.1016/j.ejrad.2016.05.005; del Rio R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165744; Douglas-Escobar M, 2015, JAMA PEDIATR, V169, P397, DOI 10.1001/jamapediatrics.2014.3269; Ezgu FS, 2002, J CHILD NEUROL, V17, P824, DOI 10.1177/08830738020170111301; Garca-Alix A, 2001, ACTA PAEDIATR, V90, P1103, DOI 10.1080/080352501317061459; Garcia-Alix A, 2013, ACTA PAEDIATR, V102, P1137, DOI 10.1111/apa.12420; GARCIAALIX A, 1994, PEDIATRICS, V93, P234; Gunn AJ, 2008, J PEDIATR-US, V152, P55, DOI 10.1016/j.jpeds.2007.06.003; HAIMOTO H, 1987, LAB INVEST, V57, P489; Hellstrom-Westas L., 2008, ATLAS AMPLITUDE INTE, V2nd; HORN M, 1995, STROKE, V26, P290, DOI 10.1161/01.STR.26.2.290; Isgro MA, 2015, ADV EXP MED BIOL, V867, P125, DOI 10.1007/978-94-017-7215-0_9; KAISER E, 1989, CLIN CHIM ACTA, V183, P13, DOI 10.1016/0009-8981(89)90268-4; Kelen D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184593; Lv HY, 2015, CLIN CHIM ACTA, V450, P282, DOI 10.1016/j.cca.2015.08.021; Echeverria-Palacio CM, 2019, PEDIATR NEUROL, V101, P71, DOI 10.1016/j.pediatrneurol.2019.02.020; Martinez-Biarge M, 2011, NEUROLOGY, V76, P2055, DOI 10.1212/WNL.0b013e31821f442d; Massaro AN, 2018, J PEDIATR-US, V194, P67, DOI 10.1016/j.jpeds.2017.10.060; Massaro AN, 2014, PEDIATR CRIT CARE ME, V15, P615, DOI 10.1097/PCC.0000000000000155; Massaro AN, 2012, J PEDIATR-US, V161, P434, DOI 10.1016/j.jpeds.2012.02.047; Merchant N, 2015, DEV MED CHILD NEUROL, V57, P8, DOI 10.1111/dmcn.12726; Merhar SL, 2016, CLIN PERINATOL, V43, P511, DOI 10.1016/j.clp.2016.04.009; Nagdyman N, 2003, PEDIATR RES, V54, P270, DOI 10.1203/01.PDR.0000072518.98189.A0; Nanavati T, 2015, PEDIATR NEONATOL, V56, P307, DOI 10.1016/j.pedneo.2014.12.005; Natarajan N, 2017, SEMIN PERINATOL, V41, P117, DOI 10.1053/j.semperi.2016.11.008; Pelinka LE, 2005, SHOCK, V24, P119, DOI 10.1097/01.shk.0000168876.68154.43; Polat M, 2013, EUR J PAEDIATR NEURO, V17, P288, DOI 10.1016/j.ejpn.2012.11.004; Polglase GR, 2016, CLIN PERINATOL, V43, P469, DOI 10.1016/j.clp.2016.04.006; Ramaswamy V, 2009, PEDIATR NEUROL, V40, P215, DOI 10.1016/j.pediatrneurol.2008.09.026; Ramont L, 2005, CLIN CHEM LAB MED, V43, P1215, DOI 10.1515/CCLM.2005.210; Rasmussen LA, 2019, J PERINATOL, V39, P278, DOI 10.1038/s41372-018-0296-3; Rescorla LA, 2005, MENT RETARD DEV D R, V11, P226, DOI 10.1002/mrdd.20071; Roka A, 2012, ACTA PAEDIATR, V101, P319, DOI 10.1111/j.1651-2227.2011.02480.x; Rundgren Malin, 2014, BMC Res Notes, V7, P726, DOI 10.1186/1756-0500-7-726; Rundgren M, 2009, RESUSCITATION, V80, P784, DOI 10.1016/j.resuscitation.2009.03.025; Rutherford M., 2002, MRI NEONATAL BRAIN; Selakovic V, 2005, J CLIN NEUROSCI, V12, P542, DOI 10.1016/j.jocn.2004.07.019; Shankaran S, 2012, J PEDIATR-US, V160, P567, DOI 10.1016/j.jpeds.2011.09.018; Shellhaas RA, 2015, J CHILD NEUROL, V30, P1526, DOI 10.1177/0883073815573319; Sun JQ, 2012, ACTA PAEDIATR, V101, pe316, DOI 10.1111/j.1651-2227.2012.02679.x; Tagin MA, 2012, ARCH PEDIAT ADOL MED, V166, P558, DOI 10.1001/archpediatrics.2011.1772; Tekgul H, 2004, PEDIATR NEUROL, V31, P326, DOI 10.1016/j.pediatrneurol.2004.05.004; THORNBERG E, 1995, ARCH DIS CHILD-FETAL, V72, pF39, DOI 10.1136/fn.72.1.F39; van Laerhoven H, 2013, PEDIATRICS, V131, P88, DOI 10.1542/peds.2012-1297; Weeke LC, 2016, EUR J PAEDIATR NEURO, V20, P855, DOI 10.1016/j.ejpn.2016.06.003; Wilkinson D, 2011, ARCH PEDIAT ADOL MED, V165, P211, DOI 10.1001/archpediatrics.2011.4; Wunderlich MT, 2006, CLIN NEUROL NEUROSUR, V108, P558, DOI 10.1016/j.clineuro.2005.12.006; Wunderlich MT, 1999, STROKE, V30, P1190, DOI 10.1161/01.STR.30.6.1190	63	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0234082	10.1371/journal.pone.0234082	http://dx.doi.org/10.1371/journal.pone.0234082			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MJ2AA	32479533	Green Published, gold			2022-12-26	WOS:000547893500052
J	Luszczki, JJ; Panasiuk, A; Zagaja, M; Karwan, S; Bojar, H; Plewa, Z; Florek-Luszczki, M				Luszczki, Jarogniew J.; Panasiuk, Anna; Zagaja, Miroslaw; Karwan, Slawomir; Bojar, Hubert; Plewa, Zbigniew; Florek-Luszczki, Magdalena			Polygonogram and isobolographic analysis of interactions between various novel antiepileptic drugs in the 6-Hz corneal stimulation-induced seizure model in mice	PLOS ONE			English	Article							CB1 RECEPTOR AGONIST; ELECTROSHOCK-INDUCED SEIZURES; DOSE-RESPONSE; CANNABINOID CB1; 6 HZ; SYNERGISTIC INTERACTION; PROTECTIVE ACTION; WIN 55,212-2; PHARMACOLOGICAL CHARACTERIZATION; PHARMACOKINETIC INTERACTION	Pharmacotherapy with two antiepileptic drugs in combination is usually prescribed to epilepsy patients with refractory seizures. The choice of antiepileptic drugs in combination should be based on synergistic cooperation of the drugs with respect to suppression of seizures. The selection of synergistic interactions between antiepileptic drugs is challenging issue for physicians, especially, if 25 antiepileptic drugs are currently available and approved to treat epilepsy patients. The aim of this study was to determine all possible interactions among 5 second-generation antiepileptic drugs (gabapentin (GBP), lacosamide (LCM), levetiracetam (LEV), pregabalin (PGB) and retigabine (RTG)) in the 6-Hz corneal stimulation-induced seizure model in adult male albino Swiss mice. The anticonvulsant effects of 10 various two-drug combinations of antiepileptic drugs were evaluated with type I isobolographic analysis associated with graphical presentation of polygonogram to visualize the types of interactions. Isobolographic analysis revealed that 7 two-drug combinations of LEV+RTG, LEV+LCM, GBP+RTG, PGB+LEV, GBP+LEV, PGB+RTG, PGB+LCM were synergistic in the 6-Hz corneal stimulation-induced seizure model in mice. The additive interaction was observed for the combinations of GBP+LCM, GBP+PGB, and RTG+LCM in this seizure model in mice. The most beneficial combination, offering the highest level of synergistic suppression of seizures in mice was that of LEV+RTG, whereas the most additive combination that protected the animals from seizures was that reporting additivity for RTG +LCM. The strength of interaction for two-drug combinations can be arranged from the synergistic to the additive, as follows: LEV+RTG > LEV+LCM > GBP+RTG > PGB+LEV > GBP+LEV > PGB+RTG > PGB+LCM > GBP+LCM > GBP+PGB > RTG+LCM.	[Luszczki, Jarogniew J.; Panasiuk, Anna] Med Univ Lublin, Dept Pathophysiol, Lublin, Poland; [Luszczki, Jarogniew J.; Zagaja, Miroslaw] Inst Rural Hlth, Isobolog Anal Lab, Lublin, Poland; [Panasiuk, Anna] Med Univ Lublin, Dept Anesthesiol & Intens Care, Lublin, Poland; [Karwan, Slawomir] Reg Specialized Childrens Hosp, Olsztyn, Poland; [Bojar, Hubert] Inst Rural Hlth, Dept Toxicol & Food Safety, Lublin, Poland; [Plewa, Zbigniew] 1st Mil Clin Hosp, Dept Gen Oncol & Minimally Invas Surg, Lublin, Poland; [Florek-Luszczki, Magdalena] Inst Rural Hlth, Dept Med Anthropol, Lublin, Poland	Medical University of Lublin; Institute of Rural Health in Lublin, Poland; Medical University of Lublin; Institute of Rural Health in Lublin, Poland; Institute of Rural Health in Lublin, Poland	Luszczki, JJ (corresponding author), Med Univ Lublin, Dept Pathophysiol, Lublin, Poland.; Luszczki, JJ (corresponding author), Inst Rural Hlth, Isobolog Anal Lab, Lublin, Poland.	jarogniew.luszczki@umlub.pl	Luszczki, Jarogniew/AAB-1113-2020; Karwan, Sławomir/ABB-7133-2020; Bojar, Hubert/AAZ-3694-2020; Zagaja, Miroslaw/T-8459-2018; FLOREK-LUSZCZKI, MAGDALENA/S-9487-2018	Luszczki, Jarogniew/0000-0002-3059-0393; Bojar, Hubert/0000-0003-4887-7541; Zagaja, Miroslaw/0000-0002-0079-0490; FLOREK-LUSZCZKI, MAGDALENA/0000-0003-1489-2399	Medical University of Lublin, Poland [DS 474/2017-2018]	Medical University of Lublin, Poland	This work was supported by the Medical University of Lublin, Poland [DS 474/2017-2018] (J.J.L.).	Alles SRA, 2018, PHARMACOL REV, V70, P315, DOI 10.1124/pr.117.014399; Andres-Mach M, 2014, PHARMACOLOGY, V93, P172, DOI 10.1159/000360640; Andres-Mach M, 2012, PROG NEURO-PSYCHOPH, V39, P301, DOI 10.1016/j.pnpbp.2012.07.001; AVMA, 2020, AVMA GUID EUTH AN; Barton ME, 2003, EPILEPSY RES, V56, P17, DOI 10.1016/j.eplepsyres.2003.08.001; Barton ME, 2001, EPILEPSY RES, V47, P217, DOI 10.1016/S0920-1211(01)00302-3; BERENBAUM MC, 1989, PHARMACOL REV, V41, P93; Blaszczyk B, 2018, EXPERT REV CLIN PHAR, P1; Boivin GP, 2017, J AM ASSOC LAB ANIM, V56, P491; Calandre EP, 2016, EXPERT REV NEUROTHER, V16, P1263, DOI 10.1080/14737175.2016.1202764; Carter R J, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0812s15; Carver CM, 2020, HIPPOCAMPUS, V30, P435, DOI 10.1002/hipo.23163; CHOU TC, 1994, JNCI-J NATL CANCER I, V86, P1517, DOI 10.1093/jnci/86.20.1517; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2008, LEUKEMIA LYMPHOMA, V49, P2059, DOI 10.1080/10428190802353591; Chroscinska-Krawczyk M, 2016, PHARMACOL REP, V68, P680, DOI 10.1016/j.pharep.2016.03.011; Clark S, 2015, THER ADV DRUG SAF, V6, P15, DOI 10.1177/2042098614560736; Deacon RMJ, 2013, JOVE-J VIS EXP, DOI 10.3791/2609; Deckers CLP, 2000, EPILEPSIA, V41, P1364, DOI 10.1111/j.1528-1157.2000.tb00111.x; Doggett SL, 2012, CLIN MICROBIOL REV, V25, P164, DOI 10.1128/CMR.05015-11; Fattore C, 2011, DRUGS, V71, P2151, DOI 10.2165/11594640-000000000-00000; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fitzi-Rathgen J, 2019, ALTEX-ALTERN ANIM EX, V36, P671, DOI 10.14573/altex.1909261; Florek-Luszczki M, 2015, FUND CLIN PHARMACOL, V29, P382, DOI 10.1111/fcp.12123; Florek-Luszczki M, 2015, PHARMACOL BIOCHEM BE, V130, P53, DOI 10.1016/j.pbb.2015.01.003; Florek-Luszczki M, 2014, J NEURAL TRANSM, V121, P707, DOI 10.1007/s00702-014-1173-7; Florek-Luszczki M, 2014, EUR J PHARMACOL, V723, P410, DOI 10.1016/j.ejphar.2013.10.063; Gessner PK, 1995, TOXICOLOGY, V105, P161, DOI 10.1016/0300-483X(95)03210-7; Giordano C, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00281; Giordano C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141221; Grabovsky Y, 2004, J PHARMACOL EXP THER, V310, P981, DOI 10.1124/jpet.104.067264; Kaminski RM, 2009, EPILEPSIA, V50, P387, DOI 10.1111/j.1528-1167.2008.01713.x; Kanner AM, 2018, NEUROLOGY, V91, P82, DOI 10.1212/WNL.0000000000005756; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1113/expphysiol.2010.053793, 10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Kraeuter AK, 2019, METHODS MOL BIOL, V1916, P69, DOI 10.1007/978-1-4939-8994-2_4; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Kwok CS, 2017, CNS DRUGS, V31, P959, DOI 10.1007/s40263-017-0480-6; LITCHFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99; Liu Y, 2019, HANDB EXP PHARMACOL, V260, P187, DOI 10.1007/164_2019_333; Loscher W, 2006, EPILEPSIA, V47, P1253, DOI 10.1111/j.1528-1167.2006.00607.x; LOEWE S, 1953, ARZNEIMITTEL-FORSCH, V3, P285; LOSCHER W, 1990, EPILEPSY RES, V7, P173, DOI 10.1016/0920-1211(90)90013-L; LOSCHER W, 1991, EPILEPSY RES, V9, P1, DOI 10.1016/0920-1211(91)90041-D; Loscher W, 2000, EPILEPSIA, V41, P1499; Lucchi C, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10040082; Lucchi C, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00676; Luszczki J., 2009, J PRECLIN CLIN RES, V3, P103; Luszczki JJ, 2010, ADV MED SCI-POLAND, V55, P43, DOI 10.2478/v10039-010-0005-8; Luszczki JJ, 2009, ADV MED SCI-POLAND, V54, P75, DOI 10.2478/v10039-009-0006-7; Luszczki JJ, 2008, N-S ARCH PHARMACOL, V378, P483, DOI 10.1007/s00210-008-0305-8; Luszczki JJ, 2008, EUR J PHARMACOL, V595, P13, DOI 10.1016/j.ejphar.2008.07.051; Luszczki JJ, 2007, N-S ARCH PHARMACOL, V375, P105, DOI 10.1007/s00210-007-0144-z; Luszczki JJ, 2007, PROG NEURO-PSYCHOPH, V31, P529, DOI 10.1016/j.pnpbp.2006.11.020; Luszczki JJ, 2006, PHARMACOL REP, V58, P944; Luszczki JJ, 2006, EPILEPSIA, V47, P1841, DOI 10.1111/j.1528-1167.2006.00825.x; Luszczki JJ, 2006, PHARMACOL REP, V58, P660; Luszczki JJ, 2006, N-S ARCH PHARMACOL, V374, P51, DOI 10.1007/s00210-006-0100-3; Luszczki JJ, 2006, EUR J PHARMACOL, V547, P65, DOI 10.1016/j.ejphar.2006.07.037; Luszczki JJ, 2018, EPILEPSY RES, V145, P116, DOI 10.1016/j.eplepsyres.2018.06.003; Luszczki JJ, 2018, PHARMACOLOGY, V101, P22, DOI 10.1159/000480019; Luszczki JJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183873; Luszczki JJ, 2016, PHARMACOLOGY, V97, P259, DOI 10.1159/000444452; Luszczki JJ, 2015, PHARMACOLOGY, V96, P11, DOI 10.1159/000430822; Luszczki JJ, 2012, PHARMACOL REP, V64, P723; Luszczki JJ, 2012, EPILEPSY RES, V98, P148, DOI 10.1016/j.eplepsyres.2011.09.002; Luszczki JJ, 2010, EPILEPSY RES, V91, P166, DOI 10.1016/j.eplepsyres.2010.07.009; Luszczki JJ, 2010, EPILEPSY RES, V90, P188, DOI 10.1016/j.eplepsyres.2010.04.006; Luszczki JJ, 2010, EPILEPSY RES, V89, P207, DOI 10.1016/j.eplepsyres.2010.01.001; Luszczki JJ, 2010, PROG NEURO-PSYCHOPH, V34, P18, DOI 10.1016/j.pnpbp.2009.09.005; Luszczki JJ, 2006, N-S ARCH PHARMACOL, V373, P169, DOI 10.1007/s00210-006-0055-4; Luszczki JJ, 2005, EPILEPSIA, V46, P344, DOI 10.1111/j.0013-9580.2005.34704.x; Luszczki JJ, 2005, EUR NEUROPSYCHOPHARM, V15, P133, DOI 10.1016/j.euroneuro.2004.06.002; Luszczki JJ, 2005, EUR NEUROPSYCHOPHARM, V15, P609, DOI 10.1016/j.euroneuro.2005.03.005; Luszczki JJ, 2005, EUR J PHARMACOL, V515, P54, DOI 10.1016/j.ejphar.2005.03.046; Luszczki JJ, 2005, NEUROPSYCHOPHARMACOL, V30, P958, DOI 10.1038/sj.npp.1300602; Luszczki JJ, 2004, N-S ARCH PHARMACOL, V370, P369, DOI 10.1007/s00210-004-0983-9; Luszczki JJ, 2004, EPILEPSIA, V45, P895, DOI 10.1111/j.0013-9580.2004.05104.x; Luszczki JJ, 2004, N-S ARCH PHARMACOL, V369, P434, DOI 10.1007/s00210-004-0867-z; Luszczki JJ, 2003, NEUROPSYCHOPHARMACOL, V28, P1817, DOI 10.1038/sj.npp.1300243; Luszczki JJ, 2003, EPILEPSIA, V44, P1003, DOI 10.1046/j.1528-1157.2003.10003.x; Luszczki JJ, 2003, EPILEPSIA, V44, P489, DOI 10.1046/j.1528-1157.2003.32702.x; Matsumura N, 2014, EUR J PHARMACOL, V741, P237, DOI 10.1016/j.ejphar.2014.08.001; Mesraoua B, 2019, EPILEPSY BEHAV, V97, P282, DOI 10.1016/j.yebeh.2019.04.042; Metcalf CS, 2017, EPILEPSIA, V58, P1073, DOI 10.1111/epi.13764; Meyer O A, 1979, Neurobehav Toxicol, V1, P233; Parker RMA, 2014, ILAR J, V55, P477, DOI 10.1093/ilar/ilu044; Patsalos PN, 2018, THER DRUG MONIT, V40, P526, DOI 10.1097/FTD.0000000000000546; Patsalos PN, 2003, LANCET NEUROL, V2, P473, DOI 10.1016/S1474-4422(03)00483-6; Patsalos PN, 2003, LANCET NEUROL, V2, P347, DOI 10.1016/S1474-4422(03)00409-5; Perez-Perez D, 2021, EPILEPSY BEHAV, V121, DOI 10.1016/j.yebeh.2019.07.031; PERUCCA E, 1995, ACTA NEUROL SCAND, V92, P31; POCH G, 1990, J PHARMACOL METHOD, V24, P311, DOI 10.1016/0160-5402(90)90015-D; POCH G, 1982, METHOD FIND EXP CLIN, V4, P371; POCH G, 1990, CAN J PHYSIOL PHARM, V68, P1338; POCH G, 1980, J PHARMACOL METHOD, V4, P179, DOI 10.1016/0160-5402(80)90036-4; Premoli I, 2019, ANN CLIN TRANSL NEUR, V6, P2164, DOI 10.1002/acn3.50896; Rogawski MA, 2008, CURR NEUROL NEUROSCI, V8, P345, DOI 10.1007/s11910-008-0053-7; Santulli L, 2016, PHARMACOL RES, V107, P211, DOI 10.1016/j.phrs.2016.03.016; Shafer SL, 2008, ANESTH ANALG, V107, P507, DOI 10.1213/ane.0b013e31817b7140; Shandra A, 2013, EPILEPSIA, V54, P1167, DOI 10.1111/epi.12237; Shkolnik TG, 2014, JAMA DERMATOL, V150, P984, DOI 10.1001/jamadermatol.2013.8895; Singh VP, 2019, ALTEX-ALTERN ANIM EX, V36, P322, DOI 10.14573/altex.1901041; Stephen LJ, 2012, EPILEPSY RES, V98, P194, DOI 10.1016/j.eplepsyres.2011.09.008; Stephen LJ, 2002, SEIZURE-EUR J EPILEP, V11, P349, DOI 10.1053/seiz.2002.0711; Tallarida RJ, 1997, LIFE SCI, V61, pPL417, DOI 10.1016/S0024-3205(97)01030-8; Tallarida RJ, 2002, PAIN, V98, P163, DOI 10.1016/S0304-3959(02)00041-6; TALLARIDA RJ, 1989, LIFE SCI, V45, P947, DOI 10.1016/0024-3205(89)90148-3; Tallarida RJ., 2000, DRUG SYNERGISM DOSE; Tallarida RJ, 2007, PHARMACOL THERAPEUT, V113, P197, DOI 10.1016/j.pharmthera.2006.08.002; Tallarida RJ, 2006, J PHARMACOL EXP THER, V319, P1, DOI 10.1124/jpet.106.104117; Tallarida Ronald J, 2016, Curr Protoc Pharmacol, V72, DOI 10.1002/0471141755.ph0919s72; Tallarida Ronald J, 2011, Genes Cancer, V2, P1003, DOI 10.1177/1947601912440575; Tallarida RJ, 2012, J PHARMACOL EXP THER, V342, P2, DOI 10.1124/jpet.112.193474; Thackaberry EA, 2010, TOXICOL SCI, V117, P485, DOI 10.1093/toxsci/kfq207; VERROTTI A, 2019, EXPERT REV NEUR 1227, DOI DOI 10.1080/14737175.2020; Vigil FA, 2020, J CEREBR BLOOD F MET, V40, P1256, DOI 10.1177/0271678X19857818; Wojda E, 2009, EPILEPSY RES, V86, P163, DOI 10.1016/j.eplepsyres.2009.06.003; Zaccara G, 2014, EPILEPTIC DISORD, V16, P409, DOI 10.1684/epd.2014.0714; Zadroniak A, 2009, PHARMACOL REP, V61, P737, DOI 10.1016/S1734-1140(09)70128-8	120	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0234070	10.1371/journal.pone.0234070	http://dx.doi.org/10.1371/journal.pone.0234070			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MJ2AA	32479532	Green Published, gold			2022-12-26	WOS:000547893500050
J	Sayed, IM; Sahan, AZ; Venkova, T; Chakraborty, A; Mukhopadhyay, D; Bimczok, D; Beswick, EJ; Reyes, VE; Pinchuk, I; Sahoo, D; Ghosh, P; Hazra, TK; Das, S				Sayed, Ibrahim M.; Sahan, Ayse Z.; Venkova, Tatiana; Chakraborty, Anirban; Mukhopadhyay, Dibyabrata; Bimczok, Diane; Beswick, Ellen J.; Reyes, Victor E.; Pinchuk, Irina; Sahoo, Debashis; Ghosh, Pradipta; Hazra, Tapas K.; Das, Soumita			Helicobacter pyloriinfection downregulates the DNA glycosylase NEIL2, resulting in increased genome damage and inflammation in gastric epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Helicobacter pylori; DNA damage; base excision repair; gastric cancer; bacterial infection; inflammation; Nei-like DNA glycosylase 2 (NEIL2); cytokine response; oxidative stress; gastric organoid; infection; DNA repair; stem cells; enteroids; Nei-like DNA glycosylase	BASE-EXCISION-REPAIR; PYLORI INFECTION; OXIDATIVE STRESS; IN-VITRO; REACTIVE OXYGEN; FREE-RADICALS; CANCER RISK; STEM-CELLS; MECHANISMS; ANTIOXIDANTS	Infection with the Gram-negative, microaerophilic bacteriumHelicobacter pyloriinduces an inflammatory response and oxidative DNA damage in gastric epithelial cells that can lead to gastric cancer (GC). However, the underlying pathogenic mechanism is largely unclear. Here, we report that the suppression of Nei-like DNA glycosylase 2 (NEIL2), a mammalian DNA glycosylase that specifically removes oxidized bases, is one mechanism through whichH. pyloriinfection may fuel the accumulation of DNA damage leading to GC. Using cultured cell lines, gastric biopsy specimens, primary cells, and human enteroid-derived monolayers from healthy human stomach, we show thatH. pyloriinfection greatly reduces NEIL2 expression. TheH. pyloriinfection-induced downregulation of NEIL2 was specific, asCampylobacter jejunihad no such effect. Using gastric organoids isolated from the murine stomach in coculture experiments with live bacteria mimicking the infected stomach lining, we found thatH. pyloriinfection is associated with the production of various inflammatory cytokines. This response was more pronounced inNeil2knockout (KO) mouse cells than in WT cells, suggesting that NEIL2 suppresses inflammation under physiological conditions. Notably, theH. pylori-infectedNeil2-KO murine stomach exhibited more DNA damage than the WT. Furthermore,H. pylori-infectedNeil2-KO mice had greater inflammation and more epithelial cell damage. Computational analysis of gene expression profiles of DNA glycosylases in gastric specimens linked the reducedNeil2level to GC progression. Our results suggest that NEIL2 downregulation is a plausible mechanism by whichH. pyloriinfection impairs DNA damage repair, amplifies the inflammatory response, and initiates GC.	[Sayed, Ibrahim M.; Sahan, Ayse Z.; Mukhopadhyay, Dibyabrata; Das, Soumita] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Venkova, Tatiana; Chakraborty, Anirban; Hazra, Tapas K.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Bimczok, Diane] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA; [Beswick, Ellen J.] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; [Reyes, Victor E.] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA; [Pinchuk, Irina] Penn State Hlth Milton S Hershey Med Ctr, Coll Med, Hershey, PA USA; [Sahoo, Debashis] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA; [Sahoo, Debashis] Jacobs Sch Engn, Dept Comp Sci & Engn, San Diego, CA USA; [Ghosh, Pradipta] Univ Calif San Diego, Dept Med & Cellular & Mol Med, John & Rebecca Moore Canc Ctr, San Diego, CA 92103 USA; [Sayed, Ibrahim M.] Assiut Univ, Fac Med, Dept Med Microbiol & Immunol, Assiut, Egypt; [Venkova, Tatiana] Fox Chase Canc Ctr, Res & Dev Alliances, 7701 Burholme Ave, Philadelphia, PA 19111 USA	University of California System; University of California San Diego; University of Texas System; University of Texas Medical Branch Galveston; Montana State University System; Montana State University Bozeman; Utah System of Higher Education; University of Utah; University of Texas System; University of Texas Medical Branch Galveston; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of California System; University of California San Diego; University of California System; University of California San Diego; Egyptian Knowledge Bank (EKB); Assiut University; Fox Chase Cancer Center	Das, S (corresponding author), Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA.; Hazra, TK (corresponding author), Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA.	tkhazra@utmb.edu; sodas@ucsd.edu	Sayed, Ibrahim M./AAB-6973-2021; CHAKRABORTY, ANIRBAN/ABC-6552-2020	Sayed, Ibrahim M./0000-0001-8207-6401; Bimczok, Diane/0000-0002-8817-7243; Sahan, Ayse/0000-0003-4661-035X; CHAKRABORTY, ANIRBAN/0000-0002-6558-0179	National Institutes of Health [DK107585, DK099275]; DoD [CA150375]; C3 Padre Pedal MCC pilot grant [R01 NS073976, R01HL145477, W81XWH-18-10743, R01 AI141630, R01-GM138385]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoD(United States Department of Defense); C3 Padre Pedal MCC pilot grant	This work was supported, in whole or in part, by National Institutes of Health grants DK107585 and DK099275, C3 Padre Pedal MCC pilot grant (to S. D.), R01 NS073976 (to T. H.), R01HL145477 (T. K. H.), W81XWH-18-10743 (to T. K. H.), R01 AI141630 (to P. G.), R01-GM138385 (to D. S.), and DoD CA150375 (to V. E. R.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abadi ATB, 2017, WORLD J GASTROENTERO, V23, P6379, DOI 10.3748/wjg.v23.i35.6379; Aguilera-Aguirre L, 2015, FREE RADICAL BIO MED, V89, P20, DOI 10.1016/j.freeradbiomed.2015.07.007; Alzahrani S, 2014, WORLD J GASTROENTERO, V20, P12767, DOI 10.3748/wjg.v20.i36.12767; Anurag M, 2018, CLIN CANCER RES, V24, P4887, DOI 10.1158/1078-0432.CCR-17-3702; Ba XQ, 2018, REDOX BIOL, V14, P669, DOI 10.1016/j.redox.2017.11.008; Ba X, 2014, INT J MOL SCI, V15, P16975, DOI 10.3390/ijms150916975; Banerjee D, 2011, J BIOL CHEM, V286, P6006, DOI 10.1074/jbc.M110.198796; Rodrigues DGB, 2017, TOXICOL IN VITRO, V42, P47, DOI 10.1016/j.tiv.2017.04.006; Beswick EJ, 2005, J IMMUNOL, V175, P171, DOI 10.4049/jimmunol.175.1.171; Beswick EJ, 2006, J IMMUNOL, V176, P6794, DOI 10.4049/jimmunol.176.11.6794; Bhattacharyya A, 2010, AM J PHYSIOL-GASTR L, V299, pG1177, DOI 10.1152/ajpgi.00372.2010; Butcher LD, 2017, CELL MOL GASTROENTER, V3, P316, DOI 10.1016/j.jcmgh.2017.02.002; Chakraborty A, 2015, J BIOL CHEM, V290, P24636, DOI 10.1074/jbc.M115.658146; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Companioni O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176043; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; D'Errico M, 2009, EUR J CANCER, V45, P461, DOI 10.1016/j.ejca.2008.10.032; Das S, 2007, J BIOL CHEM, V282, P28474, DOI 10.1074/jbc.M704672200; DAVIES GR, 1994, GUT, V35, P179, DOI 10.1136/gut.35.2.179; de Vries AC, 2008, GASTROENTEROLOGY, V134, P945, DOI 10.1053/j.gastro.2008.01.071; den Hartog G, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005382; Dey S, 2012, DNA REPAIR, V11, P570, DOI 10.1016/j.dnarep.2012.03.005; Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200; Ebule IA, 2013, AFR HEALTH SCI, V13, P112, DOI 10.4314/ahs.v13i1.15; Flores-Trevino S, 2018, EXPERT REV GASTROENT, V12, P819, DOI 10.1080/17474124.2018.1496017; Fumagalli M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110969; Gao X, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42596-x; Handa O, 2010, INFLAMM RES, V59, P997, DOI 10.1007/s00011-010-0245-x; Hazra TK, 2007, DNA REPAIR, V6, P470, DOI 10.1016/j.dnarep.2006.10.011; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kadaja M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000397; Kiraly O, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004901; Koeppel M, 2015, CELL REP, V11, P1703, DOI 10.1016/j.celrep.2015.05.030; Lina TT, 2013, J IMMUNOL, V191, P3838, DOI 10.4049/jimmunol.1300524; Liou Jyh-Ming, 2018, Gastroenterology, V155, P1109, DOI 10.1053/j.gastro.2018.06.047; Maddocks ODK, 2013, MBIO, V4, DOI 10.1128/mBio.00152-13; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Maynard S, 2009, CARCINOGENESIS, V30, P2, DOI 10.1093/carcin/bgn250; Miftahussurur M, 2017, EXPERT REV MOL MED, V19, DOI 10.1017/erm.2017.4; Miyoshi H, 2013, NAT PROTOC, V8, P2471, DOI 10.1038/nprot.2013.153; Moran AP, 2010, SUBCELL BIOCHEM, V53, P209, DOI 10.1007/978-90-481-9078-2_10; Mou XB, 2015, J BIOMED NANOTECHNOL, V11, P2057, DOI 10.1166/jbn.2015.2113; Nookaew I, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-41; Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106; Pan L, 2016, J BIOL CHEM, V291, P25553, DOI 10.1074/jbc.M116.751453; Ronchetti L, 2017, INT J CANCER, V140, P2587, DOI 10.1002/ijc.30668; Sahan AZ, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00663; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sarker AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090261; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Savoldi A, 2018, GASTROENTEROLOGY, V155, P1372, DOI 10.1053/j.gastro.2018.07.007; Scharer OD, 2001, BIOESSAYS, V23, P270, DOI 10.1002/1521-1878(200103)23:3<270::AID-BIES1037>3.0.CO;2-J; Sebrell TA, 2018, CELL TISSUE RES, V371, P293, DOI 10.1007/s00441-017-2726-5; Sebrell TA, 2019, CELL MOL GASTROENTER, V8, P157, DOI 10.1016/j.jcmgh.2019.02.010; Shinmura K, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1546392; Suarez K., 2018, 280172 BIORXIV; Sutton P, 2001, GUT, V49, P467, DOI 10.1136/gut.49.4.467; Szendroi A, 2016, ONCOTARGET, V7, P42086, DOI 10.18632/oncotarget.9669; Touati E, 2006, HELICOBACTER, V11, P494, DOI 10.1111/j.1523-5378.2006.00442.x; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wang G, 2005, FREE RADICAL RES, V39, P1183, DOI 10.1080/10715760500194018; Wang G, 2006, INFECT IMMUN, V74, P6839, DOI 10.1128/IAI.00991-06; Wang LJ, 2016, ANAL CHEM, V88, P7523, DOI 10.1021/acs.analchem.6b00664; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017; Wong BCY, 2004, JAMA-J AM MED ASSOC, V291, P187, DOI 10.1001/jama.291.2.187; World Health Organization, 2018, GLOB CANC OBS; Yamaoka Y, 2002, GASTROENTEROLOGY, V123, P1992, DOI 10.1053/gast.2002.37074; Zhai XD, 2008, CLIN CANCER RES, V14, P4345, DOI 10.1158/1078-0432.CCR-07-5282	72	18	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2020	295	32					11082	11098		10.1074/jbc.RA119.009981	http://dx.doi.org/10.1074/jbc.RA119.009981			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE7BV	32518160	Green Published, hybrid			2022-12-26	WOS:000562757100015
J	Prasad, N; Newbern, EC; Trenholme, AA; Thompson, MG; McArthur, C; Wong, CA; Jelley, L; Aminisani, N; Huang, QS; Grant, CC				Prasad, Namrata; Newbern, E. Claire; Trenholme, Adrian A.; Thompson, Mark G.; McArthur, Colin; Wong, Conroy A.; Jelley, Lauren; Aminisani, Nayyereh; Huang, Q. Sue; Grant, Cameron C.			The health and economic burden of respiratory syncytial virus associated hospitalizations in adults	PLOS ONE			English	Article							HUMAN METAPNEUMOVIRUS; INFLUENZA; SURVEILLANCE; INFECTIONS; PCR	Background Respiratory syncytial virus (RSV) is increasingly recognized as an important cause of illness in adults; however, data on RSV disease and economic burden in this age group remain limited. We aimed to provide comprehensive estimates of RSV disease burden among adults aged >= 18 years. Methods During 2012-2015, population-based, active surveillance of acute respiratory infection (ARI) hospitalizations enabled estimation of the seasonal incidence of RSV hospitalizations and direct health costs in adults aged >= 18 years in Auckland, New Zealand. Results Of 4,600 ARI hospitalizations tested for RSV, 348 (7.6%) were RSV positive. The median (interquartile range) length of hospital stay for RSV positive patients was 4 (2-6) days. The seasonal incidence rate (IR) of RSV hospitalizations, corrected for non-testing, was 23.6 (95% confidence intervals [CI] 21.0-26.1) per 100,000 adults aged >= 18 years. Hospitalization risk increased with age with the highest incidence among adults aged >= 80 years (IR 190.8 per 100,000, 95% CI 137.6-244.0). Being of Maori or Pacific ethnicity or living in a neighborhood with low socioeconomic status (SES) were independently associated with increased RSV hospitalization rates. We estimate RSV-associated hospitalizations among adults aged >= 18 years to cost on average NZD $4,758 per event. Conclusions RSV infection is associated with considerable disease and economic cost in adults. RSV disproportionally affects adult sub-groups defined by age, ethnicity, and neighborhood SES. An effective RSV vaccine or RSV treatment may offer benefits for older adults.	[Prasad, Namrata; Newbern, E. Claire; Jelley, Lauren; Aminisani, Nayyereh; Huang, Q. Sue] Inst Environm Sci & Res, Wellington, New Zealand; [Prasad, Namrata; Grant, Cameron C.] Univ Auckland, Dept Paediat Child & Youth Hlth, Auckland, New Zealand; [Trenholme, Adrian A.; Wong, Conroy A.] Counties Manukau Dist Hlth Board, Auckland, New Zealand; [Thompson, Mark G.] US Ctr Dis Control & Prevent, Atlanta, GA USA; [McArthur, Colin] Auckland City Hosp, Dept Crit Care Med, Auckland, New Zealand; [Aminisani, Nayyereh] Neyshabur Univ Med Sci, Noncommunicable Dis Res Ctr, Neyshabur, Iran; [Grant, Cameron C.] Starship Childrens Hosp, Gen Paediat, Auckland, New Zealand	Institute of Environmental Science & Research (ESR) - New Zealand; University of Auckland; Centers for Disease Control & Prevention - USA; Auckland City Hospital; Starship Children's Hospital	Prasad, N; Newbern, EC (corresponding author), Inst Environm Sci & Res, Wellington, New Zealand.; Prasad, N (corresponding author), Univ Auckland, Dept Paediat Child & Youth Hlth, Auckland, New Zealand.	Namrata.Prasad@esr.cri.nz; Claire.Newbern@esr.cri.nz		Huang, Q. Sue/0000-0002-3923-5195; Prasad, Namrata/0000-0002-2268-279X	US Centers of Disease Control and Prevention [1U01IP000480-01]; Pacific Health Research scholarship by the New Zealand Health Research Council; New Zealand Ministry of Health	US Centers of Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Pacific Health Research scholarship by the New Zealand Health Research Council; New Zealand Ministry of Health	This work was supported by the US Centers of Disease Control and Prevention funded (cooperative agreement number 1U01IP000480-01) and a Pacific Health Research scholarship by the New Zealand Health Research Council to NP. Support in kind was provided by the New Zealand Ministry of Health.	Atkinson J., 2014, NZDEP2013 INDEX DEPR; Colosia AD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182321; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Falsey AR, 2002, J CLIN MICROBIOL, V40, P817, DOI 10.1128/JCM.40.3.817-820.2002; Fleming DM, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1218-z; Fowlkes A, 2014, J INFECT DIS, V209, P1715, DOI 10.1093/infdis/jit806; Groenwold RHH, 2012, AM J EPIDEMIOL, V175, P210, DOI 10.1093/aje/kwr302; Huang QS, 2014, WEST PAC SURVEILL RE, V5, P23, DOI [10.5365/WPSAR.2014.5.1.004, 10.5365/wpsar.2014.5.1.004]; Huang QS, 2015, INFLUENZA OTHER RESP, V9, P179, DOI 10.1111/irv.12315; Institute of Environmental Science and Research Limited, 2017, INFL SURV NZ ANN REP; Karron RA, 1999, J INFECT DIS, V180, P41, DOI 10.1086/314841; Kim C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021610; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Mazur NI, 2018, LANCET INFECT DIS, V18, pE295, DOI 10.1016/S1473-3099(18)30292-5; Ministry of Health New Zealand. New Zealand Ministry of Health, 2019, NAT COLL SURV; New Zealand Ministry of Health, 2017, NZ CAS FRAM PUBL FUN; Royston P, 2011, J STAT SOFTW, V45, P1, DOI 10.18637/jss.v045.i04; Schanzer DL, 2018, INFLUENZA OTHER RESP, V12, P113, DOI 10.1111/irv.12497; Shi T, 2020, J INFECT DIS, V222, pS577, DOI 10.1093/infdis/jiz059; Shi T, 2020, J INFECT DIS, V222, pS563, DOI 10.1093/infdis/jiy662; Shu B, 2011, J CLIN MICROBIOL, V49, P2614, DOI 10.1128/JCM.02636-10; Statistics New Zealand, 2016, SUBN POP EST AG SEX; Statistics New Zealand, 2019, NZ PERIOD LIFE TABLE; Szewczuk E, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-113; The Lancet HIV, 2016, LANCET HIV, V3, pe191; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Tobias M, 2008, AUST NZ J PUBL HEAL, V32, P431, DOI 10.1111/j.1753-6405.2008.00275.x; Widmer K, 2014, INFLUENZA OTHER RESP, V8, P347, DOI 10.1111/irv.12234; Widmer K, 2012, J INFECT DIS, V206, P56, DOI 10.1093/infdis/jis309; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211	30	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234235	10.1371/journal.pone.0234235	http://dx.doi.org/10.1371/journal.pone.0234235			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525898	Green Published, gold			2022-12-26	WOS:000542036800024
J	Wang, JN; Hou, J; Zhong, JY; Cao, GP; Yu, ZY; Wu, YY; Li, TQ; Liu, QM; Gong, ZY				Wang, Jin-Na; Hou, Juan; Zhong, Jian-Yue; Cao, Guo-Ping; Yu, Zhang-You; Wu, Yu-Yan; Li, Tian-Qi; Liu, Qin-Mei; Gong, Zhen-Yu			Relationships between traditional larval indices and meteorological factors with the adult density ofAedes albopictus captured by BG-mosquito trap	PLOS ONE			English	Article							AEDES-AEGYPTI; DENGUE; SURVEILLANCE; TRANSMISSION; TEMPERATURE; VARIABILITY; GUANGZHOU; FEVER; EGG	Objectives Larval indices have been used forAe.albopictussurveillance for many years, while there is limited use in assessing dengue transmission risk and adult mosquito emergence. This study is aimed to explore the relationships between larval indices and theAe.albopictusdensity captured by BG-mosquito trap (BG-trap) method, with considering the meteorological factors. Methods Data on larval density, adult mosquito density and meteorology factors were collected in an entomological survey carried out in Quzhou City, Zhejiang Province of China in 2018. The Spearman's rank correlation and Pearson correlation were used for the analysis on the correlation of density indices. Generalized additive models were established to analyze the influencing factors of mosquito density. Results Breteau index (BI), House index (HI) and Container index (CI) were highly correlated with each other (r>0.7, p<0.05). TheAe.albopictusdensity was significantly correlated with CI (rs = 0.260, p<0.05), CI pre one week (rs = 0.259, p<0.05), and CI pre three weeks (rs = 0.329, p<0.05). BI was correlated with femaleAe.albopictusdensity pre 4 weeks (r = -0.299, p<0.05). FemaleAe.albopictusdensity was correlated with CI pre 3 weeks (rs = 0.303, p<0.05). The influencing factors of BI were average wind speed pre 1 week, average temperature and femaleAe.albopictusdensity pre 4 weeks. The influencing factors of CI were average humidity pre 3 weeks and average temperature. The influencing factors of HI were average temperature and precipitation pre 4 weeks. The influencing factor ofAe.albopictusdensity and femaleAe.albopictusdensity was temperature. Conclusions The adultAe.albopictusdensity had low correlation with certain larval indices. Some of the meteorology factors played significant roles in the density of adultAe.albopictusand larva with or without a time lag.	[Wang, Jin-Na; Hou, Juan; Wu, Yu-Yan; Li, Tian-Qi; Liu, Qin-Mei; Gong, Zhen-Yu] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Peoples R China; [Zhong, Jian-Yue; Cao, Guo-Ping; Yu, Zhang-You] Quzhou Ctr Dis Control & Prevent, Quzhou, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention	Gong, ZY (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Peoples R China.	gongzy12345@163.com		Gong, Zhen-Yu/0000-0001-9550-7370	National Critical Project for Science and Technology on Infectious Diseases of China [2017ZX10303404]	National Critical Project for Science and Technology on Infectious Diseases of China	This work was supported by grant from the National Critical Project for Science and Technology on Infectious Diseases of China (no. 2017ZX10303404) and the grant receiver was ZYG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhalala H, 2009, J AM MOSQUITO CONTR, V25, P134, DOI 10.2987/08-5821.1; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003; Carrington LB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00290; Chang FS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004043; Chen SC, 2010, SCI TOTAL ENVIRON, V408, P4069, DOI 10.1016/j.scitotenv.2010.05.021; Codeco CT, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003475; Couret J, 2014, BMC ECOL, V14, DOI 10.1186/1472-6785-14-3; Couret J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087468; Crepeau TN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060524; Endo N, 2018, LANCET PLANET HEALTH, V2, pE406, DOI 10.1016/S2542-5196(18)30175-X; Estallo EL, 2008, J AM MOSQUITO CONTR, V24, P368, DOI 10.2987/5705.1; Farjana T, 2012, MED VET ENTOMOL, V26, P210, DOI 10.1111/j.1365-2915.2011.00971.x; Gao Q, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3053-8; Gouagna LC, 2015, ACTA TROP, V143, P89, DOI 10.1016/j.actatropica.2014.12.011; Jimenez-Alejo A, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4294-8; Johnson PH, 2012, J MED ENTOMOL, V49, P29, DOI 10.1603/ME11116; Le TDP, 2016, AIMS PUBLIC HEALTH, V3, P769, DOI 10.3934/publichealth.2016.4.769; Lequime S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005548; Li YJ, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1724-x; Luo L, 2015, J VECTOR ECOL, V40, P240, DOI 10.1111/jvec.12160; Manrique-Saide P, 2014, MED VET ENTOMOL, V28, P264, DOI 10.1111/mve.12046; Nagao Y, 2003, TROP MED INT HEALTH, V8, P650, DOI 10.1046/j.1365-3156.2003.01075.x; Pan American Health Organization, 1995, DENG DENG HEM FEV AM, V116; Pena-Garcia VH, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13070734; Rivas AV, 2018, REV SOC BRAS MED TRO, V51, P71, DOI 10.1590/0037-8682-0228-2017; Roiz D, 2010, VECTOR-BORNE ZOONOT, V10, P811, DOI 10.1089/vbz.2009.0098; Romero-Vivas CME, 2005, J AM MOSQUITO CONTR, V21, P15, DOI 10.2987/8756-971X(2005)21[15:IORBAA]2.0.CO;2; Sang SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102755; Shen JC, 2015, BIOMED ENVIRON SCI, V28, P321, DOI 10.3967/bes2015.046; Sivagnaname N, 2012, INDIAN J MED RES, V136, P739; Tsai CH, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2493-x; Tuladhar R, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3304-3; Udayanga L, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2961-y; Urquhart C, 2016, J AM MOSQUITO CONTR, V32, P24, DOI 10.2987/8756-971X-32.1.24; Wijayanti SPM, 2016, PLOS NEGLECT TROP D, V10, DOI [10.1371/journal.pntd.0004964, 10.1371/journal.pntd.0004500]; Wijegunawardana NDAD, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/2950216; Yin QQ, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3715-1	38	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234555	10.1371/journal.pone.0234555	http://dx.doi.org/10.1371/journal.pone.0234555			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525905	gold, Green Published			2022-12-26	WOS:000542036800011
J	Xia, TT; Wang, YJ; He, YJ; Wu, CB; Shen, KP; Tan, QY; Kang, LL; Guo, Y; Wu, BL; Han, X				Xia, Tingting; Wang, Yongjian; He, Yuejun; Wu, Changbang; Shen, Kaiping; Tan, Qiyu; Kang, Liling; Guo, Yun; Wu, Bangli; Han, Xu			An invasive plant experiences greater benefits of root morphology from enhancing nutrient competition associated with arbuscular mycorrhizae in karst soil than a native plant	PLOS ONE			English	Article							NETWORKS AMPLIFY COMPETITION; BELOW-GROUND COMPETITION; PHOSPHORUS; NITROGEN; GROWTH; FUNGI; ACQUISITION; EVOLUTION; ALIEN; WATER	The Eupatorium adenophorum have widespread invaded the karst ecosystem of southwest China and threatened the regional native community stability. Arbuscular mycorrhizae (AM) plays an important role in promoting growth for host plants via root external mycelia. However, whether AM regulates plant root traits underlying competition between invasive and native species via mycorrhizal networks in karst habitats, remains unclear. An experiment was conducted in a microcosm composed of two planting compartments flanking a competition compartment. The invasive E. adenophorum and native Artemisia annua were each placed in one of the two planting compartments with or without Glomus etunicatum fungus. The nutrient access treatments included the competitive utilization (Cu), single utilization (Su) and non-utilization (Nu) by using different nylon meshes allowed or prevented mycelium passing to acquire nutrients from the competition compartment. Root traits and nutrients of the two species were analyzed. The results showed that AM fungi had differential effects on root traits and nutrients of E. adenophorum and A. annua seedlings, which increased dry weight, length, surface area, volume, tips and branching points in roots, specific root length and volume, root nitrogen (N) and phosphorus (P) contents under Cu, Su and Nu treatments. AM fungus was also associated with decreases in the average diameter for both species. Under the Cu treatment, E. adenophorum had significantly greater length, surface area, volume, tips and branching points of roots, specific root traits, and root N and P than A. annua. AM fungi changed root phenotypes and nutrient uptake for both invasive and native plant species via interconnected mycorrhizal networks. Overall, our results suggest that through mycorrhizal networks, the invasive plant experiences greater benefits than the native plant in the nutrient competition, which fosters root morphological developments in karst soil.	[Xia, Tingting; He, Yuejun; Wu, Changbang; Shen, Kaiping; Tan, Qiyu; Kang, Liling; Guo, Yun; Wu, Bangli; Han, Xu] Guizhou Univ, Coll Forestry, Res Ctr Forest Ecol, Inst Forest Resources & Environm Guizhou, Guiyang, Peoples R China; [Wang, Yongjian] Huazhong Agr Univ, Coll Hort & Forestry Sci, Hubei Engn Technol Res Ctr Forestry Informat, Wuhan, Peoples R China	Guizhou University; Huazhong Agricultural University	He, YJ (corresponding author), Guizhou Univ, Coll Forestry, Res Ctr Forest Ecol, Inst Forest Resources & Environm Guizhou, Guiyang, Peoples R China.	hyj1358@163.com	He, Yuejun/AAX-9561-2021	He, Yuejun/0000-0002-7653-0265; Wang, Yong-Jian/0000-0002-2027-2084	National Natural Science Foundation of China [NSFC: 31366156, 31360106]; First-class Disciplines Progam on Ecology of Guizhou Province [GNYL [2017]007]; High Level Innovative Talents Project Science and Technology Program from Guizhou Province [Qiankehe-talent-platform [2020] 6004, [2017]5788, [2018]5781]; Key Technologies RD program [NY[2014]3029, [2016]-2805]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); First-class Disciplines Progam on Ecology of Guizhou Province; High Level Innovative Talents Project Science and Technology Program from Guizhou Province; Key Technologies RD program(National Key Technology R&D Program)	This study was supported by the National Natural Science Foundation of China (NSFC: 31366156; 31360106), the First-class Disciplines Progam on Ecology of Guizhou Province (GNYL [2017]007),the High Level Innovative Talents Project Science and Technology Program from Guizhou Province (Qiankehe-talent-platform [2020] 6004; [2017]5788; [2018]5781) and the Key Technologies R&D program (NY[2014]3029; [2016]-2805).	[Anonymous], 2012, PEDIAT DENT, V34, P33; [Anonymous], 2019, DIABETES CARE, V40, pS13; Awaydul A, 2019, MYCORRHIZA, V29, P29, DOI 10.1007/s00572-018-0873-5; Bao S.D, 2000, SOIL AGRO CHEM ANAL, P49; Berntson GM, 2000, ECOLOGY, V81, P1072, DOI 10.1890/0012-9658(2000)081[1072:CTSDOR]2.0.CO;2; Cahill JF, 2000, OIKOS, V90, P311, DOI 10.1034/j.1600-0706.2000.900211.x; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.1890/1540-9295(2004)002[0436:NWISAT]2.0.CO;2; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; CAMPBELL BD, 1991, OECOLOGIA, V87, P532, DOI 10.1007/BF00320417; Casper BB, 1997, ANNU REV ECOL SYST, V28, P545, DOI 10.1146/annurev.ecolsys.28.1.545; Chen D, 2019, SCI TOTAL ENVIRON, V657, P1568, DOI 10.1016/j.scitotenv.2018.12.099; Craine JM, 2013, FUNCT ECOL, V27, P833, DOI 10.1111/1365-2435.12081; Dai ZC, 2015, BIOCHEM SYST ECOL, V61, P19, DOI 10.1016/j.bse.2015.05.004; De Kroon H, 2013, ROOT ECOLOGY; FITTER AH, 1994, EXPLOITATION ENV HET, P305, DOI DOI 10.1016/B978-0-12-155070-7.50016-0; Fitter Alastair H, 2004, New Phytol, V164, P15, DOI 10.1111/j.1469-8137.2004.01193.x; Harner MJ, 2010, BIOL INVASIONS, V12, P1481, DOI 10.1007/s10530-009-9559-4; Henke M, 2014, PLANT SOIL, V385, P49, DOI 10.1007/s11104-014-2221-7; Hodge A, 2006, J EXP BOT, V57, P401, DOI 10.1093/jxb/eri280; Hodge A, 2004, NEW PHYTOL, V162, P9, DOI 10.1111/j.1469-8137.2004.01015.x; Hodge A, 2001, NATURE, V413, P297, DOI 10.1038/35095041; Hu Chao-Chen, 2016, Chinese Journal of Plant Ecology, V40, P1145, DOI 10.17521/cjpe.2016.0052; Huang Jing-hua, 2011, Yingyong Shengtai Xuebao, V22, P1443; [皇甫超河 HUANGFU Chaohe], 2010, [生态环境学报, Ecology and Environmental Sciences], V19, P672; Jiang ZC, 2014, EARTH-SCI REV, V132, P1, DOI 10.1016/j.earscirev.2014.01.005; Lee MR, 2014, BIOL INVASIONS, V16, P1083, DOI 10.1007/s10530-013-0562-4; Lin ShuangShuang, 2013, Acta Prataculturae Sinica, V22, P310; Liu J, 2016, EMIR J FOOD AGR, V28, P251, DOI 10.9755/ejfa.2015-11-1044; Liu SC, 2010, J ANHUI AGR SCI, DOI [10.3969/j.issn.0517-6611.2010.12.036, DOI 10.3969/J.ISSN.0517-6611.2010.12.036]; LuLiHui, 2017, Biotechnology, V16, P34; Majewska ML, 2017, MYCORRHIZA, V27, P83, DOI 10.1007/s00572-016-0729-9; Malamy JE, 2005, PLANT CELL ENVIRON, V28, P67, DOI 10.1111/j.1365-3040.2005.01306.x; McPhee CS, 2001, PLANT ECOL, V152, P119, DOI 10.1023/A:1011471719799; Merrild MP, 2013, NEW PHYTOL, V200, P229, DOI 10.1111/nph.12351; Mommer L, 2011, PLANT SOIL, V344, P347, DOI 10.1007/s11104-011-0752-8; Nottingham AT, 2013, FEMS MICROBIOL ECOL, V85, P37, DOI 10.1111/1574-6941.12096; Osmont KS, 2007, ANNU REV PLANT BIOL, V58, P93, DOI 10.1146/annurev.arplant.58.032806.104006; Pharmacovigilance Programme of India, 2018, WHO DRUG INFORM, V32, P10; Pregitzer KS, 2002, ECOL MONOGR, V72, P293, DOI 10.1890/0012-9615(2002)072[0293:FRAONN]2.0.CO;2; [许静静 Xu Jingjing], 2019, [生态学报, Acta Ecologica Sinica], V39, P2071; Rubio G, 2001, ANN BOT-LONDON, V88, P929, DOI 10.1006/anbo.2001.1530; Ryan MH, 2012, PLANT CELL ENVIRON, V35, P2170, DOI 10.1111/j.1365-3040.2012.02547.x; Schussler A., 2010, GLOMEROMYCOTA SPECIE; Shao YD, 2018, PLANT SOIL ENVIRON, V64, P283, DOI 10.17221/126/2018-PSE; Simard SW, 2009, FOREST ECOL MANAG, V258, pS95, DOI 10.1016/j.foreco.2009.05.001; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Su Liang, 2018, Yingyong Shengtai Xuebao, V29, P783, DOI 10.13287/j.1001-9332.201803.006; Su Liang, 2018, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V38, P150, DOI 10.7606/j.issn.1000-4025.2018.01.0150; Suri VK, 2013, COMMUN SOIL SCI PLAN, V44, P2587, DOI 10.1080/00103624.2013.803569; Tan K.H., 2005, SOIL SAMPLING PREPAR, Vsecond, DOI [10.1201/9781482274769, DOI 10.1201/9781482274769]; Valerio Miguel, 2016, AFRO HISPANIC REV, V35, P79; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Wang B, 2006, MYCORRHIZA, V16, P299, DOI 10.1007/s00572-005-0033-6; Wang Peng, 2012, Chinese Journal of Plant Ecology, V36, P1184, DOI 10.3724/SP.J.1258.2012.01184; [王晓燕 Wang Xiaoyan], 2016, [生态学报, Acta Ecologica Sinica], V36, P5204; [王艳 Wang Yan], 2018, [生态学报, Acta Ecologica Sinica], V38, P2271; Wang YJ, 2017, NEW PHYTOL, V216, P1072, DOI 10.1111/nph.14820; Weremijewicz J, 2016, NEW PHYTOL, V212, P461, DOI 10.1111/nph.14041; Weremijewicz J, 2013, NEW PHYTOL, V198, P203, DOI 10.1111/nph.12125; WILSON JB, 1988, J APPL ECOL, V25, P279, DOI 10.2307/2403626; Yang GW, 2014, J ECOL, V102, P1072, DOI 10.1111/1365-2745.12249; [杨应 Yang Ying], 2017, [植物生理学报, Plant Physiology Journal], V53, P2078; [杨应 Yang Ying], 2017, [生态学报, Acta Ecologica Sinica], V37, P8477; Yao Q, 2005, J PLANT NUTR, V28, P2179, DOI 10.1080/01904160500323537; Yu WQ, 2014, J BIOSAFETY, V23, P156, DOI DOI 10.3969/j.issn.2095-1787.2014.03.004; Zabinski CA, 2002, FUNCT ECOL, V16, P758, DOI 10.1046/j.1365-2435.2002.00676.x; Zhang FJ, 2018, MYCORRHIZA, V28, P703, DOI 10.1007/s00572-018-0866-4; Zhang W, 2015, PLANT SOIL, V391, P77, DOI 10.1007/s11104-015-2406-8; Zhang Zhong-feng, 2015, Shengtaixue Zazhi, V34, P1198	69	6	8	11	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2020	15	6							e0234410	10.1371/journal.pone.0234410	http://dx.doi.org/10.1371/journal.pone.0234410			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ1GC	32516341	Green Published, gold			2022-12-26	WOS:000540977000020
J	Fang, WQ; Deng, ZY; Benadjaoud, F; Yang, DF; Yang, CZ; Shi, GP				Fang, Wenqian; Deng, Zhiyong; Benadjaoud, Feriel; Yang, Dafeng; Yang, Chongzhe; Shi, Guo-Ping			Regulatory T cells promote adipocyte beiging in subcutaneous adipose tissue	FASEB JOURNAL			English	Article						epididymal white adipose tissue; gonadal white adipose tissue; macrophage polarization; regulatory T cell; subcutaneous adipose tissue; uncoupling protein-1	NICOTINAMIDE RIBOSIDE; THERMOGENIC ADIPOCYTES; METABOLIC HOMEOSTASIS; FAT DEVELOPMENT; BROWN; ACTIVATION; DISTINCT; POPULATION; GLUCOSE; ENERGY	Regulatory T cells (Tregs) play essential roles in obesity and diabetes. Here, we report a role of Tregs in enhancing beta 3-adrenergic receptor agonist CL316243 (CL)-stimulated thermogenic program in subcutaneous adipose tissue (SAT), but not in visceral fat. CL treatment for 7 days increased SAT adipocyte beiging and thermogenic gene expression in male or female mice. Adoptive transfer of Tregs enhanced this CL activity. Such Treg activity lost in male epididymal white adipose tissue (eWAT) and female gonadal gWAT. Adipocyte culture yielded the same conclusion. Tregs enhanced the expression of CL-induced thermogenic genes in SAT from male and female mice. This activity of Tregs reduced or disappeared in adipocytes from eWAT or gWAT. Both CL and Tregs induced much higher UCP-1 (uncoupling protein-1) expression in SAT from females than that from males. A mechanistic study demonstrated a role of Tregs in suppressing the expression of M1 macrophage markers (Tnfa, Il6, iNos, Ip10) and promoting the expression of M2 macrophage markers (Mrc1, Arg1, Il10) in bone-marrow-derived macrophages or in SAT from male or female mice. In female mice with pre-established obesity, Treg adoptive transfer reduced the gWAT weight in 2 weeks. Together with CL treatment, Treg adoptive transfer reduced the SAT weight and further improved CL-induced glucose metabolism and insulin sensitivity in female obese mice, but did not affect CL-induced body weight loss in male or female obese mice. This study revealed a predominant role of Tregs in female mice in promoting adipocyte beiging and thermogenesis in SAT, in part by slanting M2 macrophage polarization.	[Fang, Wenqian; Deng, Zhiyong; Benadjaoud, Feriel; Yang, Dafeng; Shi, Guo-Ping] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Fang, Wenqian; Deng, Zhiyong; Benadjaoud, Feriel; Yang, Dafeng; Shi, Guo-Ping] Harvard Med Sch, Boston, MA 02115 USA; [Fang, Wenqian] Shanghai Univ, Cardiac Regenerat & Ageing Lab, Sch Life Sci, Inst Cardiovasc Sci, Shanghai, Peoples R China; [Deng, Zhiyong; Yang, Chongzhe] South China Univ Technol, Natl Key Clin Specialty, Guangzhou Peoples Hosp 1, Dept Geriatr,Sch Med, Guangzhou, Peoples R China	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Shanghai University; South China University of Technology	Yang, CZ (corresponding author), Guangzhou First Peoples Hosp, Dept Geriatr, 1 Panfu Rd,Pansong Bldg 7, Guangzhou 510180, Guangdong, Peoples R China.; Shi, GP (corresponding author), Brigham & Womens Hosp, Cardiovasc Med, 77 Ave Louis Pasteur,NRB-7, Boston, MA 02115 USA.	eyyangchongzhe@scut.edu.cn; gshi@bwh.harvard.edu	Yang, Dafeng/HIK-2106-2022; Shi, Guoping/AAI-9946-2021	Yang, Dafeng/0000-0002-8320-8215; Fang, Wenqian/0000-0001-8929-6423; Yang, Chongzhe/0000-0002-0338-8245	National Heart, Lung, and Blood Institute (NHLBI) [HL123568, HL60942]; National Institute of Neurological Disorders and Stroke (NINDS) [AG063839]	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL123568 and HL60942; National Institute of Neurological Disorders and Stroke (NINDS), Grant/Award Number: AG063839	Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Bacher P, 2016, CELL, V167, P1067, DOI 10.1016/j.cell.2016.09.050; Brestoff JR, 2015, CELL, V161, P146, DOI 10.1016/j.cell.2015.02.022; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Cereijo R, 2018, CELL METAB, V28, P750, DOI 10.1016/j.cmet.2018.07.015; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Chu DT, 2016, J PHYSIOL BIOCHEM, V73, P315, DOI 10.1007/s13105-017-0567-z; Chu DT, 2017, BIOCHIMIE, V138, P102, DOI 10.1016/j.biochi.2017.04.017; Chu DT, 2017, J PHYSIOL BIOCHEM, V73, P1, DOI 10.1007/s13105-016-0536-y; Chu DT, 2014, J BIOL CHEM, V289, P18478, DOI 10.1074/jbc.M114.555821; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fried SK, 2015, OBESITY, V23, P1345, DOI 10.1002/oby.21133; Grinberg-Bleyer Y, 2017, CELL, V170, P1096, DOI 10.1016/j.cell.2017.08.004; Hao L, 2018, J PHARMACOL EXP THER, V365, P467, DOI 10.1124/jpet.117.246256; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Jiang YW, 2017, ELIFE, V6, DOI 10.7554/eLife.30329; Kalin S, 2017, CELL METAB, V26, P475, DOI 10.1016/j.cmet.2017.08.008; Kajimura S, 2014, ANNU REV PHYSIOL, V76, P225, DOI 10.1146/annurev-physiol-021113-170252; Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943; Kim SN, 2016, BIOL SEX DIFFER, V7, DOI 10.1186/s13293-016-0121-7; Klein J, 1999, J BIOL CHEM, V274, P34795, DOI 10.1074/jbc.274.49.34795; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Liu PS, 2015, ADIPOCYTE, V4, P146, DOI 10.4161/21623945.2014.981428; Liu PS, 2015, ADIPOCYTE, V4, P123, DOI 10.4161/21623945.2014.981438; Merlin J, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00249; Min SY, 2016, NAT MED, V22, P312, DOI 10.1038/nm.4031; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Ooi JD, 2017, NATURE, V545, P243, DOI 10.1038/nature22329; Peirce V, 2014, NATURE, V510, P76, DOI 10.1038/nature13477; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Rao RR, 2014, CELL, V157, P1279, DOI 10.1016/j.cell.2014.03.065; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Sakamoto T, 2016, AM J PHYSIOL-ENDOC M, V310, pE676, DOI 10.1152/ajpendo.00028.2015; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Sidossis L, 2015, J CLIN INVEST, V125, P478, DOI 10.1172/JCI78362; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Tiemessen MM, 2007, P NATL ACAD SCI USA, V104, P19446, DOI 10.1073/pnas.0706832104; Traba J, 2015, J CLIN INVEST, V125, P4592, DOI 10.1172/JCI83260; Trammell SAJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26933; Tseng YH, 2004, MOL CELL BIOL, V24, P1918, DOI 10.1128/MCB.24.5.1918-1929.2004; Varghese M, 2017, ADV EXP MED BIOL, V1043, P65, DOI 10.1007/978-3-319-70178-3_5; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang H, 2016, CELL METAB, V24, P835, DOI 10.1016/j.cmet.2016.10.005; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Ying W, 2013, JOVE-J VIS EXP, DOI 10.3791/50323; Zeng Q, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02075; Zheng XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063967; Zhou Y, 2015, CELL METAB, V22, P1045, DOI 10.1016/j.cmet.2015.09.013	54	10	11	4	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9755	9770		10.1096/fj.201902518R	http://dx.doi.org/10.1096/fj.201902518R		JUN 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32510702				2022-12-26	WOS:000539575900001
J	Smith-Norowitz, TA; Huang, Y; Loeffler, J; Klein, E; Norowitz, YM; Hammerschlag, MR; Joks, R; Kohlhoff, S				Smith-Norowitz, Tamar A.; Huang, Yvonne; Loeffler, Jeffrey; Klein, Elliot; Norowitz, Yitzchok M.; Hammerschlag, Margaret R.; Joks, Rauno; Kohlhoff, Stephan			Azithromycin decreases Chlamydia pneumoniae-mediated Interleukin-4 responses but not Immunoglobulin E responses	PLOS ONE			English	Article							MYCOPLASMA-PNEUMONIAE; INFECTION; ASTHMA; CLARITHROMYCIN; ASSAY	Background Chlamydia pneumoniae is an obligate intracellular bacterium that causes respiratory infection. There may exist an association between C. pneumoniae, asthma, and production of immunoglobulin (Ig) E responses in vitro. Interleukin (IL-4) is required for IgE production. Objective We previously demonstrated that doxycycline suppresses C. pneumoniae-induced production of IgE and IL-4 responses in peripheral blood mononuclear cells (PBMC) from asthmatic subjects. Whereas macrolides have anti-chlamydial activity, their effect on in vitro anti-inflammatory (IgE) and IL-4 responses to C. pneumoniae have not been studied. Methods PBMC from IgE- adult atopic subjects (N = 5) were infected +/- C. pneumoniae BAL69, +/- azithromycin (0.1, 1.0 ug/mL) for 10 days. IL-4 and IgE levels were determined in supernatants by ELISA. IL-4 and IgE were detected in supernatants of PBMC (day 10). Results When azithromycin (0.1, 1.0 ug/ml) was added, IL-4 levels decreased. At low dose, IgE levels increased and at high dose, IgE levels decreased. When PBMC were infected with C. pneumoniae, both IL-4 and IgE levels decreased. Addition of azithromycin (0.1, 1.0 ug/mL) decreased IL-4 levels and had no effect on IgE levels. Conclusions These findings indicate that azithromycin decreases IL-4 responses but has a bimodal effect on IgE responses in PBMC from atopic patients in vitro.	[Smith-Norowitz, Tamar A.; Huang, Yvonne; Loeffler, Jeffrey; Klein, Elliot; Norowitz, Yitzchok M.; Hammerschlag, Margaret R.; Kohlhoff, Stephan] SUNY Hlth Sci Univ, Div Infect Dis, Dept Pediat, Brooklyn, NY USA; [Joks, Rauno] SUNY Downstate Hlth Sci Univ, Dept Med, Brooklyn, NY USA	State University of New York (SUNY) System	Smith-Norowitz, TA (corresponding author), SUNY Hlth Sci Univ, Div Infect Dis, Dept Pediat, Brooklyn, NY USA.	tamar.smith-norowitz@downstate.edu						Apfalter P, 2003, J CLIN MICROBIOL, V41, P592, DOI 10.1128/JCM.41.2.592-600.2003; Bouwman JJM, 2004, J LAB CLIN MED, V144, P18, DOI 10.1016/j.lab.2004.03.012; Cowen MK, 2007, J ASTHMA, V44, P711, DOI 10.1080/02770900701595576; Daoud A, 2008, ALLERGY ASTHMA PROC, V29, P286, DOI 10.2500/aap.2008.29.3121; Dzhindzhikhashvili MS, 2013, J ANTIMICROB CHEMOTH, V68, P2363, DOI 10.1093/jac/dkt179; EMRE U, 1994, ARCH PEDIAT ADOL MED, V148, P727, DOI 10.1001/archpedi.1994.02170070065013; HAMMERSCHLAG MR, 1992, CLIN INFECT DIS, V14, P178, DOI 10.1093/clinids/14.1.178; Hammerschlag MR., 2014, PRINCIPLES PRACTICE, V8th ed., P2174; Ikezawa Shigeru, 2001, Kurume Medical Journal, V48, P165, DOI 10.2739/kurumemedj.48.165; Johnston SL, 2005, AM J RESP CRIT CARE, V172, P1078, DOI 10.1164/rccm.200412-1743PP; Khan AA, 1999, INT J ANTIMICROB AG, V11, P121, DOI 10.1016/S0924-8579(98)00091-0; Kohlhoff SA, 2015, EXPERT OPIN PHARMACO, V16, P205, DOI 10.1517/14656566.2015.999041; Kutlin A, 2002, ANTIMICROB AGENTS CH, V46, P409, DOI 10.1128/AAC.46.2.409-412.2002; Martin RJ, 2001, J ALLERGY CLIN IMMUN, V107, P595, DOI 10.1067/mai.2001.113563; Richeldi L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002997.pub3; ROBLIN PM, 1992, J CLIN MICROBIOL, V30, P1968, DOI 10.1128/JCM.30.8.1968-1971.1992; Smith-Norowitz TA, 2018, J INFECT CHEMOTHER, V24, P470, DOI 10.1016/j.jiac.2018.02.004; Vanaudenaerde BM, 2007, AM J TRANSPLANT, V7, P76, DOI 10.1111/j.1600-6143.2006.01586.x; Wang SP, 1986, CHLAMYDIAL INFECTION, P329; Waring AL, 2001, J CLIN MICROBIOL, V39, P1385, DOI 10.1128/JCM.39.4.1385-1390.2001	20	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2020	15	6							e0234413	10.1371/journal.pone.0234413	http://dx.doi.org/10.1371/journal.pone.0234413			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ0RE	32511255	Green Published, gold			2022-12-26	WOS:000540938100013
J	Zeidan, H; Kawagoe, M; Kajiwara, Y; Harada, K; Nishida, Y; Yamada, K; Kawabe, R; Yokota, J; Yamashiro, C; Odake, Y; Takeda, M; Doi, N; Negoro, K; Matsumura, N; Morino, T; Yoshioka, CKB; Chen, CY; Aoyama, T				Zeidan, Hala; Kawagoe, Mirei; Kajiwara, Yuu; Harada, Keiko; Nishida, Yurika; Yamada, Keisuke; Kawabe, Rika; Yokota, Junpei; Yamashiro, Chiaki; Odake, Yu; Takeda, Masakatsu; Doi, Naoki; Negoro, Kaho; Matsumura, Natsuki; Morino, Tappei; Yoshioka, Clemence Kiho Bourgeois; Chen, Chang Yu; Aoyama, Tomoki			The shape of the transverse arch in high heels while standing	PLOS ONE			English	Article							PLANTAR PRESSURE; FOOT; WALKING; SHOES; MECHANICS	Introduction High heeled shoes have long been worn in society and they are known to cause biomechanical imbalances to not only the foot, but the whole musculoskeletal system. This study aims to show the detailed changes that happen to the shape of the transverse arch of the foot in high heels, using two different inclination degrees. Methods 68 women participated in this study. Two custom-made high heels were made with inclinations of 15 degrees and 30 degrees (cm). A weight-bearing ultrasound was used to assess the coronal view of the transverse arch in standing. ANOVA and Tuckey tests were used to compare the results between 0 degrees, 15 degrees and 30 degrees inclinations. Results The transverse arch height was slightly increased as the heel height increased (0DI-15DI: p = 0.5852 / 15DI-30DI: p = 0.395 / 0DI-30DI: p = 0.0593). The transverse arch length (0DI-15DI: p = 0.0486 / 15DI-30DI: p = 0.0004 / 0DI-30DI: p = 0.1105) and the area under the metatarsal heads (0DI-15DI: p = 0.0422 / 15DI-30DI: p = 0.0180 / 0DI-30DI: p = 0.9463) significantly decreased as the heel height increased. Discussion The main changes were viewed in the 30 degrees inclinations compared to 0 degrees inclination. When the toes are dorsiflexed in high heels, it stimulates the Windlass mechanism which in turn stiffens the plantar fascia and adducts the metatarsal heads, while the soft tissues shrink in response to loads. Conclusion High heels affected the shape of the transverse arch even in short term standing, and these effects increased as the height of the heel increased.	[Zeidan, Hala; Kawagoe, Mirei; Kajiwara, Yuu; Harada, Keiko; Nishida, Yurika; Yamada, Keisuke; Kawabe, Rika; Yokota, Junpei; Yamashiro, Chiaki; Odake, Yu; Takeda, Masakatsu; Doi, Naoki; Negoro, Kaho; Matsumura, Natsuki; Morino, Tappei; Yoshioka, Clemence Kiho Bourgeois; Chen, Chang Yu; Aoyama, Tomoki] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Dept Phys Therapy, Kyoto, Japan; [Kajiwara, Yuu] Kio Univ, Dept Phys Therapy, Fac Hlth Sci, Koryo, Japan; [Zeidan, Hala; Aoyama, Tomoki] Kyoto Univ, Fac Human Hlth Sci, Sakyo Ku, Kawahara Cho, Kyoto, Japan	Kyoto University; Kyoto University	Zeidan, H (corresponding author), Kyoto Univ, Grad Sch Med, Human Hlth Sci, Dept Phys Therapy, Kyoto, Japan.; Zeidan, H (corresponding author), Kyoto Univ, Fac Human Hlth Sci, Sakyo Ku, Kawahara Cho, Kyoto, Japan.	hala-zeidan@hotmail.com						Bae YH, 2015, J PHYS THER SCI, V27, P1129, DOI 10.1589/jpts.27.1129; Barnish MS, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010053; Borchgrevink GE, 2016, FOOT ANKLE SURG, V22, P239, DOI 10.1016/j.fas.2015.10.004; Cernekova M., 2008, CLIN BIOMECH, V23, P662, DOI [10.1016/j.clinbiomech.2008.03.008, DOI 10.1016/J.CLINBIOMECH.2008.03.008]; Chibi-Ogbolu N, 2018, FRONT PHYSIOL, V9, P1834, DOI [10.3389/fphys.2018.01834, DOI 10.3389/FPHYS.2018.01834]; Cronin NJ, 2014, J ELECTROMYOGR KINES, V24, P258, DOI 10.1016/j.jelekin.2014.01.004; Dalal S, 2015, INT WOUND J, V12, P636, DOI 10.1111/iwj.12173; EBBELING CJ, 1994, J ORTHOP SPORT PHYS, V19, P190, DOI 10.2519/jospt.1994.19.4.190; Gougoulias N, 2019, EFORT OPEN REV, V4, P14, DOI 10.1302/2058-5241.4.180025; Hamandi Sadiq J., 2020, IOP Conference Series: Materials Science and Engineering, V671, DOI 10.1088/1757-899X/671/1/012063; Hsue BJ, 2009, J ELECTROMYOGR KINES, V19, P1071, DOI 10.1016/j.jelekin.2008.09.005; Japanese Gastr Canc Assoc, 2021, GASTRIC CANCER, V24, P1, DOI [10.1007/s10120-020-01042-y, 10.1007/s10120-016-0622-4]; Kelly LA, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1188; Kim Y, 2013, FOOT ANKLE INT, V34, P414, DOI 10.1177/1071100712468562; Ko PH, 2009, FOOT ANKLE INT, V30, P1111, DOI 10.3113/FAI.2009.1111; Kwan RLC, 2010, CLIN BIOMECH, V25, P601, DOI 10.1016/j.clinbiomech.2010.04.003; Lee CM, 2001, INT J IND ERGONOM, V28, P321, DOI 10.1016/S0169-8141(01)00038-5; Liu XX, 2018, ROBOT AUTON SYST, V110, P85, DOI 10.1016/j.robot.2018.09.006; Lucas Rachel, 2017, Foot (Edinb), V30, P38, DOI 10.1016/j.foot.2017.01.005; Luximon Y, 2015, HUM MOVEMENT SCI, V41, P307, DOI 10.1016/j.humov.2015.04.003; Matsubara K, 2017, J FOOT ANKLE RES, V10, DOI 10.1186/s13047-017-0198-1; Matsushita T, 2017, CLIN RES FOOT ANKLE, V5, P1; Nakayama Yasuaki, 2018, J Phys Ther Sci, V30, P630, DOI 10.1589/jpts.30.630; Naraghi R, 2018, FOOT ANKLE INT, V39, P829, DOI 10.1177/1071100718766553; Sanchez N, 2018, INT J APPL ENG, V13, P13258; Silva Anniele Martins, 2013, Rev. paul. pediatr., V31, P265; Sims AL, 2014, WORLD J ORTHOP, V5, P146, DOI 10.5312/wjo.v5.i2.146; Webster J., 2018, ATLAS ORTHOSES ASSIS, V5th ed., P216; Welte L, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2018.0270; Wilkerson R D, 2000, Iowa Orthop J, V20, P46; Winiarski S, 2017, ACTA BIOENG BIOMECH, V19, P107, DOI 10.5277/ABB-00671-2016-04; Zeidan H, 2019, APPL SYST INNOV, V2, DOI 10.3390/asi2010003; Zhao DY, 2016, INT J GREENH GAS CON, V49, P192, DOI 10.1016/j.ijggc.2016.03.005	33	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2020	15	6							e0233958	10.1371/journal.pone.0233958	http://dx.doi.org/10.1371/journal.pone.0233958			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ0RE	32511246	Green Published, gold			2022-12-26	WOS:000540938100003
J	Rumora, L; Hlapcic, I; Popovic-Grle, S; Rako, I; Rogic, D; Cepelak, I				Rumora, Lada; Hlapcic, Iva; Popovic-Grle, Sanja; Rako, Ivana; Rogic, Dunja; Cepelak, Ivana			Uric acid and uric acid to creatinine ratio in the assessment of chronic obstructive pulmonary disease: Potential biomarkers in multicomponent models comprising IL-1beta	PLOS ONE			English	Article							XANTHINE-OXIDASE; UP-REGULATION; HEALTH CHECK; RISK; EXACERBATIONS; INHIBITION; ACTIVATION; EXPRESSION; MORTALITY; CELLS	Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous disease, with oxidative stress and inflammation implicated in its development. Uric acid (UA) could exert anti-oxidative, pro-oxidative or pro-inflammatory effects, depending on the specific context. It was recently shown that soluble UA, and not just its crystals, could activate the nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome, leading to interleukin (IL)-1 beta secretion. We aimed to assess the differences in blood levels of UA and its ratio with creatinine (UCR) between COPD patients and healthy subjects, as well as their association with disease severity, smoking status, common COPD comorbidities and therapy regimes. The diagnostic characteristics of UA and UCR were also explored. This study included 109 stable COPD patients and 95 controls and measured white blood cells (WBC), C-reactive protein (CRP), fibrinogen (Fbg), IL-1 beta, creatinine (CREAT) and UA. All of the parameters were increased in COPD patients, except for CREAT. UA and UCR were positively associated with WBC, CRP and IL-1 beta. COPD smokers had lower UA and UCR values. Common COPD therapy did not affect UA or UCR, while patients with cardiovascular diseases (CVD) had higher UA, but not UCR, levels. Patients with higher UCR values showed worse disease-related outcomes (lung function, symptoms, quality of life, history of exacerbations, BODCAT and BODEx). Also, UCR differentiated patients with different severity of airflow limitation as well as symptoms and exacerbations. The great individual predictive potential of UCR and IL-1 beta was observed with their odds ratios (OR) being 2.09 and 5.53, respectively. Multiparameter models of UA and UCR that included IL-1 beta were able to correctly classify 86% and 90% of cases, respectively. We suggest that UA might be a useful biomarker when combined with IL-1 beta, while UCR might be even more informative and useful in overall COPD assessments.	[Rumora, Lada; Hlapcic, Iva; Cepelak, Ivana] Univ Zagreb, Fac Pharm & Biochem, Dept Med Biochem & Hematol, Zagreb, Croatia; [Popovic-Grle, Sanja] Univ Hosp Ctr Zagreb, Clin Dept Lung Dis Jordanovac, Zagreb, Croatia; [Popovic-Grle, Sanja] Univ Zagreb, Sch Med, Zagreb, Croatia; [Rako, Ivana; Rogic, Dunja] Univ Hosp Ctr Zagreb, Clin Inst Lab Diagnost, Zagreb, Croatia	University of Zagreb; University of Zagreb; University of Zagreb; University of Zagreb	Rumora, L (corresponding author), Univ Zagreb, Fac Pharm & Biochem, Dept Med Biochem & Hematol, Zagreb, Croatia.	lrumora@pharma.hr			Croatian Science Foundation [IP-2014-09-1247]; "Young researchers' career development project training of doctoral students" of the Croatian Science Foundation - European Union from the European Social Fund	Croatian Science Foundation; "Young researchers' career development project training of doctoral students" of the Croatian Science Foundation - European Union from the European Social Fund	This work has been fully supported by the Croatian Science Foundation under the project number IP-2014-09-1247. The work of PhD student Iva Hlapcic has been fully supported by the "Young researchers' career development project training of doctoral students" of the Croatian Science Foundation funded by the European Union from the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal T, 2018, ARCH PHYSIOL BIOCHEM, V124, P226, DOI 10.1080/13813455.2017.1387796; Agusti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037483; Aida Y, 2011, INT J MED SCI, V8, P470, DOI 10.7150/ijms.8.470; Alhibrii M. H., 2013, Asian Journal of Biomedical and Pharmaceutical Sciences, V3, P17; [Anonymous], 2018, NAT REV GENET, V19, P1, DOI 10.1038/nrg.2017.141; [Anonymous], 2012, NEC NEXT, V7, P3; [Anonymous], 2019, J INORG ORGANOMET PO, V29, P1; [Anonymous], 2018, IUVA NEWS, V20, P1, DOI DOI 10.1007/S42341-018-00089-0; [Anonymous], 2017, KIDNEY INT S, V7, p[1, 1], DOI DOI 10.1016/j.kisu.2017.04.001; Bartziokas K, 2014, EUR RESPIR J, V43, P43, DOI 10.1183/09031936.00209212; Cortese F, 2019, VASC PHARMACOL, V120, DOI 10.1016/j.vph.2019.106565; Crisan TO, 2016, ANN RHEUM DIS, V75, P755, DOI 10.1136/annrheumdis-2014-206564; Dishan PY, 2019, IP INDIAN J IMMUNOL, V4, P109; Duan X. C., 2015, AM J PHYSIOL-HEART C, V308, pH603; El Ridi R, 2017, J ADV RES, V8, P487, DOI 10.1016/j.jare.2017.03.003; ELSAYED NM, 1993, ARCH BIOCHEM BIOPHYS, V302, P228, DOI 10.1006/abbi.1993.1204; Eltom S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112829; Faner R., 2016, ERJ OPEN RES, V2, P1, DOI DOI 10.1183/; Foreman KJ, 2018, LANCET, V392, P2052, DOI [10.1016/S0140-6736(18)31694-5, 10.1016/s0140-6736(18)31694-5]; Fukuhara A, 2017, INT J CHRONIC OBSTR, V12, P1213, DOI 10.2147/COPD.S126249; Garcia-Pachon E, 2007, LUNG, V185, P21, DOI 10.1007/s00408-006-0076-2; GOLD. Global Initiative for Chronic Obstructive Lung Disease, 2020, GLOB STRAT DIAGN MAN; Hageman GJ, 2003, FREE RADICAL BIO MED, V35, P140, DOI 10.1016/S0891-5849(03)00237-5; Hanna Bassam E, 2008, Oman Med J, V23, P269; Hassoun PM, 1998, AM J RESP CRIT CARE, V158, P299, DOI 10.1164/ajrccm.158.1.9709116; Hlapcic I, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51855-w; Hlapi I, 2020, BIOCHEM MEDICA, V30, P60; Ichinose M, 2003, EUR RESPIR J, V22, P457, DOI 10.1183/09031936.03.00052002; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Kim SK, 2019, MEDICINE, V98, DOI [10.1097/MD.0000000000014507, 10.1097/md.0000000000014507]; Kobylecki CJ, 2018, THORAX, V73, P748, DOI 10.1136/thoraxjnl-2017-210273; Kocak ND, 2016, MED SCI MONITOR, V22, P4169, DOI 10.12659/MSM.897759; Komaki Y, 2005, PULM PHARMACOL THER, V18, P297, DOI 10.1016/j.pupt.2005.01.002; Kopcinovic LM, 2016, BIOMARKERS, V21, P692, DOI 10.3109/1354750X.2016.1172110; Kutzing MK, 2008, J PHARMACOL EXP THER, V324, P1, DOI 10.1124/jpet.107.129031; Laxmi P, 2017, INT J MED HEAL RES, V3, P55; Lee H, 2018, CHRON RESP DIS, V15, P138, DOI 10.1177/1479972317736293; MASSEY V, 1970, J BIOL CHEM, V245, P6595; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Ndrepepa G, 2018, CLIN CHIM ACTA, V484, P150, DOI 10.1016/j.cca.2018.05.046; Nicks ME, 2011, COPD, V8, P264, DOI 10.3109/15412555.2011.579202; QUANJER PH, 1983, B EUR PHYSIOPATH RES, V19, P1; Sarangi R, 2017, J CLIN DIAGN RES, V11, pBC9, DOI 10.7860/JCDR/2017/29300.10605; Sautin YY, 2008, NUCLEOS NUCLEOT NUCL, V27, P608, DOI 10.1080/15257770802138558; Simundic AM, 2018, CLIN CHEM LAB MED, V56, P2015, DOI 10.1515/cclm-2018-0602; Song JU, 2017, MOD RHEUMATOL, V27, P1057, DOI 10.1080/14397595.2017.1285981; Stiburkova B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097646; Swanson KV, 2019, NAT REV IMMUNOL, V19, P477, DOI 10.1038/s41577-019-0165-0; Teng GG, 2016, ARTHRIT CARE RES, V68, P1135, DOI 10.1002/acr.22821; Woodruff PG, 2015, LANCET, V385, P1789, DOI 10.1016/S0140-6736(15)60693-6; Xiao J, 2015, MOL IMMUNOL, V66, P310, DOI 10.1016/j.molimm.2015.03.250; Xiao J, 2015, INT J MOL MED, V35, P1347, DOI 10.3892/ijmm.2015.2148; Yang QM, 2019, INT J MOL MED, V43, P1542, DOI 10.3892/ijmm.2019.4072; Yang Y, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1413-8; Zhang X, 2015, INT J CHRONIC OBSTR, V10, P2519, DOI 10.2147/COPD.S87202	56	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0234363	10.1371/journal.pone.0234363	http://dx.doi.org/10.1371/journal.pone.0234363			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502184	Green Published, gold			2022-12-26	WOS:000542035700020
J	Abdelrazek, S; Simon, P; Colley, M; Mengiste, T; Hoagland, L				Abdelrazek, Sahar; Simon, Philipp; Colley, Micaela; Mengiste, Tesfaye; Hoagland, Lori			Crop management system and carrot genotype affect endophyte composition andAlternaria daucisuppression	PLOS ONE			English	Article							ALTERNARIA LEAF-BLIGHT; BACTERIAL ENDOPHYTES; RHIZOSPHERE MICROBIOME; GROWTH PROMOTION; PLANT PATHOGEN; SOIL QUALITY; IN-VITRO; RESISTANCE; ROOT; DIVERSITY	Managing pests in carrot production is challenging. Endophytic microbes have been demonstrated to improve the health and productivity of many crops, but factors affecting endophyte dynamics in carrot is still not well understood. The goal of this study was to determine how crop management system and carrot genotype interact to affect the composition and potential of endophytes to mitigate disease caused byAlternaria dauci, an important carrot pathogen. Twenty-eight unique isolates were collected from the taproots of nine diverse genotypes of carrot grown in a long-term trial comparing organic and conventional management. Antagonistic activity was quantified using anin vitroassay, and potential for individual isolates to mitigate disease was evaluated in greenhouse trials using two carrot cultivars. Results confirm that carrot taproots are colonized by an abundant and diverse assortment of bacteria and fungi representing at least distinct 13 genera. Soils in the organic system had greater total organic matter, microbial biomass and activity than the conventional system and endophyte composition in taproots grown in this system were more abundant and diverse, and had greater antagonistic activity. Carrot genotype also affected endophyte abundance as well as potential for individual isolates to affect seed germination, seedling growth and tolerance toA.dauci. The benefits of endophytes on carrot growth were greatest when plants were subject toA.daucistress, highlighting the importance of environmental conditions in the functional role of endophytes. Results of this study provide evidence that endophytes can play an important role in improving carrot performance and mediating resistance toA.dauci, and it may someday be possible to select for these beneficial plant-microbial relationships in carrot breeding programs. Implementing soil-building practices commonly used in organic farming systems has potential to promote these beneficial relationships and improve the health and productivity of carrot crops.	[Abdelrazek, Sahar; Hoagland, Lori] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA; [Simon, Philipp] USDA ARS Agr Res Serv, Madison, WI USA; [Colley, Micaela] Organ Seed Alliance, Port Townsend, WA USA; [Mengiste, Tesfaye] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Hoagland, L (corresponding author), Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA.	lhoaglan@purdue.edu		Abdelrazek, Sahar/0000-0002-6435-3660; Hoagland, Lori/0000-0003-3812-0748	USDA National Institute of Food and Agriculture [2016-51300-25721]; USDA National Institute of Food and Agriculture, Hatch project [1007553, 1015999]	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); USDA National Institute of Food and Agriculture, Hatch project	This research was funded by the following sources: -USDA National Institute of Food and Agriculture, Grant Project Award #2016-51300-25721 (P. Simon, M. Colley, J. Dawson, L. duToit, L. Hoagland, P. Roberts, E. Silva) https://nifa.usda.gov/funding-opportunity/organicagriculture-research-and-extension-initiative USDA National Institute of Food and Agriculture, Hatch project 1007553 https://nifa.usda.gov/program/hatch-act-1887-multistate-research-fund -USDA National Institute of Food and Agriculture, Hatch project 1015999 https://nifa.usda.gov/program/hatch-act-1887-multistate-research-fund The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Abdelrazek S., 2019, CARROT ENDOPHYTES DI; AGRIOS GN, 2005, INTRO PLANT PATHOLOG; Andreote FD, 2010, ANTON LEEUW INT J G, V97, P389, DOI 10.1007/s10482-010-9421-9; [Anonymous], 2009, TANZAN J HLTH RES, V11, piii; Arenz BE, 2015, J MICROBIOL METH, V117, P1, DOI 10.1016/j.mimet.2015.07.003; Arscott SA, 2010, COMPR REV FOOD SCI F, V9, P223, DOI 10.1111/j.1541-4337.2009.00103.x; BARRATT RW, 1945, PHYTOPATHOLOGY, V35, P654; Bassler BL, 1999, CURR OPIN MICROBIOL, V2, P582, DOI 10.1016/S1369-5274(99)00025-9; Ben Hamed K, 2005, J PLANT PHYSIOL, V162, P599, DOI 10.1016/j.jplph.2004.11.010; Bender SF, 2016, TRENDS ECOL EVOL, V31, P440, DOI 10.1016/j.tree.2016.02.016; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Berg G, 2005, FEMS MICROBIOL ECOL, V51, P215, DOI 10.1016/j.femsec.2004.08.006; Berg G, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00241; BILOFSKY HS, 1988, NUCLEIC ACIDS RES, V16, P1861, DOI 10.1093/nar/16.5.1861; Black J.G., 2008, MICROBIOLOGY PRINCIP; Boedo C, 2010, PLANT PATHOL, V59, P368, DOI 10.1111/j.1365-3059.2009.02218.x; Boedo C, 2008, EUR J PLANT PATHOL, V121, P55, DOI 10.1007/s10658-007-9241-6; Bowen GD, 1999, ADV AGRON, V66, P1, DOI 10.1016/S0065-2113(08)60425-3; Brader G, 2017, ANNU REV PHYTOPATHOL, V55, P61, DOI 10.1146/annurev-phyto-080516-035641; Brown J.R, 1998, RECOMMENDED CHEM SOI; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Bulgari D, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-198; Bulluck LR, 2002, APPL SOIL ECOL, V19, P147, DOI 10.1016/S0929-1393(01)00187-1; Busby PE, 2016, PLANT MOL BIOL, V90, P645, DOI 10.1007/s11103-015-0412-0; Buyer JS, 2012, APPL SOIL ECOL, V61, P127, DOI 10.1016/j.apsoil.2012.06.005; Campanile G, 2007, EUR J PLANT PATHOL, V117, P237, DOI 10.1007/s10658-006-9089-1; Carlucci A, 2012, PERSOONIA, V28, P34, DOI 10.3767/003158512X638251; Chaparro JM, 2012, BIOL FERT SOILS, V48, P489, DOI 10.1007/s00374-012-0691-4; Cherif H, 2015, ENV MICROBIOL REP, V7, P668, DOI 10.1111/1758-2229.12304; Colla G, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02202; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; Correa-Galeote D, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00484; Corry J.E.T., 2011, HDB CULTURE MEDIA FO, V3rd; D Egel, 2018, SYN SUST P 9 ORG SEE; DALAL RC, 1991, SOIL BIOL BIOCHEM, V23, P435, DOI 10.1016/0038-0717(91)90006-6; Dalton DA, 2004, FEMS MICROBIOL ECOL, V49, P469, DOI 10.1016/j.femsec.2004.04.010; Pereira GVDM, 2012, MICROB ECOL, V63, P405, DOI 10.1007/s00248-011-9919-3; DRINKWATER LE, 1995, ECOL APPL, V5, P1098, DOI 10.2307/2269357; du Toit LJ, 2005, PLANT DIS, V89, P896, DOI 10.1094/PD-89-0896; Estendorfer J, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00930; Farrar JJ, 2004, PLANT DIS, V88, P776, DOI 10.1094/PDIS.2004.88.8.776; Fulthorpe R, 2020, PHYTOBIOMES J, V4, P27, DOI 10.1094/PBIOMES-04-19-0021-R; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; Gaube C, 2004, PHM REV TECHNIQUE PE, pXV; Cabanas CGL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00427; Green VS, 2006, SOIL BIOL BIOCHEM, V38, P693, DOI 10.1016/j.soilbio.2005.06.020; GRIBANOVKISASSU O, 1967, PHYTOCHEMISTRY, V6, P907, DOI 10.1016/S0031-9422(00)86041-0; Hallmann J, 2006, MICROBIAL ROOT ENDOP, V9, P15, DOI DOI 10.1007/3-540-33526-9_2; Hardoim PR, 2015, MICROBIOL MOL BIOL R, V79, P293, DOI 10.1128/MMBR.00050-14; Hardoim PR, 2011, FEMS MICROBIOL ECOL, V77, P154, DOI 10.1111/j.1574-6941.2011.01092.x; Hartmann M, 2015, ISME J, V9, P1177, DOI 10.1038/ismej.2014.210; Hillebrand H, 2008, ECOLOGY, V89, P1510, DOI 10.1890/07-1053.1; Hiruma K, 2016, CELL, V165, P464, DOI 10.1016/j.cell.2016.02.028; Hoagland L, 2012, STRENGTH COMM SEED S; Hoagland L, 2015, HORTSCIENCE, V50, P1301, DOI 10.21273/HORTSCI.50.9.1301; Horton MW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6320; Institute S, 2000, JMP STAT GRAPH GUID; Ishak HD, 2011, MICROB ECOL, V61, P821, DOI 10.1007/s00248-010-9793-4; Jitendra Dalal, 2015, American Journal of Agricultural and Biological Sciences, V10, P99; Johnston-Monje D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020396; Kandel SL, 2015, CROP SCI, V55, P1765, DOI 10.2135/cropsci2014.08.0570; Khalaf EM, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0743-2; Kim H, 2014, MYCOBIOLOGY, V42, P100, DOI 10.5941/MYCO.2014.42.2.100; Koiv V, 2015, SCI REP-UK, V5, DOI 10.1038/srep11606; Kwak MJ, 2018, NAT BIOTECHNOL, V36, P1100, DOI 10.1038/nbt.4232; Kwak YS, 2011, APPL ENVIRON MICROB, V77, P1770, DOI 10.1128/AEM.02151-10; Lanna R, 2017, TROP PLANT PATHOL, V42, P96, DOI 10.1007/s40858-017-0141-9; Larena I, 2005, BIOL CONTROL, V32, P305, DOI 10.1016/j.biocontrol.2004.10.010; Larena I, 1999, J BIOTECHNOL, V75, P187, DOI 10.1016/S0168-1656(99)00154-6; Le Clerc V, 2009, THEOR APPL GENET, V118, P1251, DOI 10.1007/s00122-009-0978-5; Lecomte M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101008; Li XJ, 2012, J AGR FOOD CHEM, V60, P3424, DOI 10.1021/jf300146n; Li Y, 2017, IEEE C EVOL COMPUTAT, P89, DOI 10.1109/CEC.2017.7969300; Liotti RG, 2018, MICROBIOL RES, V207, P8, DOI 10.1016/j.micres.2017.10.011; Liu B, 2007, APPL SOIL ECOL, V37, P202, DOI 10.1016/j.apsoil.2007.06.007; Liu HY, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00038; Liu H, 2017, J PLANT INTERACT, V12, P264, DOI 10.1080/17429145.2017.1333635; Liu Y, 2017, PLANT GROWTH REGUL, V82, P403, DOI 10.1007/s10725-017-0265-4; Louarn S, 2013, POSTHARVEST BIOL TEC, V76, P26, DOI 10.1016/j.postharvbio.2012.08.011; Marques JM, 2015, APPL SOIL ECOL, V96, P273, DOI 10.1016/j.apsoil.2015.08.020; Martinez-Medina A, 2016, TRENDS PLANT SCI, V21, P818, DOI 10.1016/j.tplants.2016.07.009; MASEL A, 1990, CURR GENET, V18, P81, DOI 10.1007/BF00321120; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Moronta-Barrios F, 2018, MICROORGANISMS, V6, DOI 10.3390/microorganisms6010014; Muller K, 2009, REMOTE SENSING SIMUL; Narayanasamy P, 2001, BOOK SOIL P, DOI 10.1201/9781482270952; NASS U, 2016, STAT AGR OV; Niones JT, 2014, J GEN PLANT PATHOL, V80, P337, DOI 10.1007/s10327-014-0521-7; Pan F, 2017, SCI REP-UK, V7, DOI 10.1038/srep42008; Pancher M, 2012, APPL ENVIRON MICROB, V78, P4308, DOI 10.1128/AEM.07655-11; Parsons J, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0309-2; Pawelec A, 2006, PLANT PATHOL, V55, P68, DOI 10.1111/j.1365-3059.2006.01290.x; Peiffer J, DIVERSITY HERITABILI; Peiffer JA, 2013, P NATL ACAD SCI USA, V110, P6548, DOI 10.1073/pnas.1302837110; Peters RD, 2003, SOIL TILL RES, V72, P181, DOI 10.1016/S0167-1987(03)00087-4; Petrini O, 1991, MICROBIAL ECOLOGY LE, P179, DOI DOI 10.1007/978-1-4612-3168-4_9; Philippot L, 2013, NAT REV MICROBIOL, V11, P789, DOI 10.1038/nrmicro3109; Pili NN, 2016, PLANT SOIL, V405, P371, DOI 10.1007/s11104-015-2590-6; Raja HA, 2017, J NAT PROD, V80, P756, DOI 10.1021/acs.jnatprod.6b01085; REASONER DJ, 1985, APPL ENVIRON MICROB, V49, P1; Reeve JR, 2016, ADV AGRON, V137, P319, DOI 10.1016/bs.agron.2015.12.003; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Rodriguez-Blanco A, 2015, BIOL FERT SOILS, V51, P391, DOI 10.1007/s00374-014-0986-8; Rolli E, 2015, ENVIRON MICROBIOL, V17, P316, DOI 10.1111/1462-2920.12439; Rudisill MA, 2015, HORTSCIENCE, V50, P461, DOI 10.21273/HORTSCI.50.3.461; Sadrati Nouari, 2013, Journal of Plant Protection Research, V53, P128, DOI 10.2478/jppr-2013-0019; Sessitsch A, 2004, CAN J MICROBIOL, V50, P239, DOI [10.1139/w03-118, 10.1139/W03-118]; Shen SY, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00427; Souza R. T., 2001, Fitopatologia Brasileira, V26, P614, DOI 10.1590/S0100-41582001000300006; STRANDBERG JO, 1988, PLANT DIS, V72, P522, DOI 10.1094/PD-72-0522; STRANDBERG JO, 1987, PHYTOPATHOLOGY, V77, P1008, DOI 10.1094/Phyto-77-1008; Sturz AV, 1998, CAN J MICROBIOL, V44, P162, DOI 10.1139/cjm-44-2-162; Surette MA, 2003, PLANT SOIL, V253, P381, DOI 10.1023/A:1024835208421; Thomma BPHJ, 2005, MOL PLANT PATHOL, V6, P379, DOI 10.1111/J.1364-3703.2005.00292.X; Timmusk S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096086; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; Turner TR, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-209; Tyvaert L, 2014, J APPL MICROBIOL, V116, P1563, DOI 10.1111/jam.12481; Upreti R, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00255; Vandenkoornhuyse P, 2015, NEW PHYTOL, V206, P1196, DOI 10.1111/nph.13312; Walitang DI, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1117-0; Walters WA, 2018, P NATL ACAD SCI USA, V115, P7368, DOI 10.1073/pnas.1800918115; Wang FW, 2007, WORLD J MICROB BIOT, V23, P79, DOI 10.1007/s11274-006-9195-4; Weil R. R., 2003, American Journal of Alternative Agriculture, V18, P3, DOI 10.1079/AJAA2003003; Xia Y, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00490; Yao HY, 2010, FEMS MICROBIOL ECOL, V72, P456, DOI 10.1111/j.1574-6941.2010.00859.x; Young CA, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00095; Zhao J, 2010, CURRENT RES TECHNOLO, P567, DOI DOI 10.1016/J.PHYTOCHEM.2012.07.021	129	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0233783	10.1371/journal.pone.0233783	http://dx.doi.org/10.1371/journal.pone.0233783			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497087	Green Published, gold			2022-12-26	WOS:000542035200058
J	Salajegheh, R; Nemergut, EC; Rice, TM; Joseph, R; Tsang, S; Sarosiek, BM; Muthusubramanian, CP; Hipwell, KM; Horton, KB; Naik, BI				Salajegheh, Reza; Nemergut, Edward C.; Rice, Terran M.; Joseph, Roy; Tsang, Siny; Sarosiek, Bethany M.; Muthusubramanian, C. Paige; Hipwell, Katelyn M.; Horton, Kate B.; Naik, Bhiken, I			Impact of a perioperative oral opioid substitution protocol during the nationwide intravenous opioid shortage: A single center, interrupted time series with segmented regression analysis	PLOS ONE			English	Article							PAIN MANAGEMENT; CONSUMPTION	Introduction To mitigate the recent nationwide shortage of intravenous opioids, we developed a standardized perioperative oral opioid guideline anchored with appropriate use of nonopioid analgesia, neuraxial and loco-regional techniques. We hypothesize that adoption of this new guideline was associated with: 1) equivalent patient reported pain scores in the post-anesthesia care unit (PACU); and 2) equivalent total opioid use (oral and parenteral) during the perioperative period. Methods Cases performed from July 1, 2017 to May 31, 2019 were screened. All opioids administered were converted to intravenous morphine milligram equivalents. Segmented regression analyses of interrupted time series were performed examining the change in opioid use, PACU pain scores and number of non-opioid analgesic medications used before and after the protocol implementation in April 2018. Results After exclusions, 29, 621 cases were included in the analysis. No significant differences in demographic, ASA status, case length and surgical procedure type were present in the pre and post-intervention period. A significant decrease in total (Estimate: -39.9 mg, SE: 6.9 mg, p < 0.001) and parenteral (Estimate: -51.6 mg, SE: 7.1 mg, p < 0.001) opioid use with a significant increase in oral opioid use (Estimate: 9.4 mg, SE: 1.1 mg, p < 0.001) was noted after the intervention. Pain scores were not significantly different between the pre- and post-intervention period (Estimate: 0.05, SE: 0.13, p = 0.69). Conclusion We report our experience with a primary perioperative oral based opioid regimen that is associated with decreased total opioid consumption and equivalent patient reported pain scores.	[Salajegheh, Reza; Nemergut, Edward C.; Naik, Bhiken, I] Univ Virginia, Dept Anesthesiol, Charlottesville, VA 22904 USA; [Nemergut, Edward C.; Naik, Bhiken, I] Univ Virginia, Dept Neurol Surg, Charlottesville, VA 22904 USA; [Rice, Terran M.; Joseph, Roy; Hipwell, Katelyn M.; Horton, Kate B.] Univ Virginia, Dept Pharm, Charlottesville, VA USA; [Joseph, Roy] Rady Childrens Hosp San Diego, Dept Pharm, San Diego, CA USA; [Tsang, Siny] Washington State Univ, Dept Nutr & Exercise Physiol, Spokane, WA USA; [Sarosiek, Bethany M.; Muthusubramanian, C. Paige] Univ Virginia, Dept Perioperat Serv, Charlottesville, VA USA	University of Virginia; University of Virginia; University of Virginia; Rady Childrens Hospital San Diego; Washington State University; University of Virginia	Naik, BI (corresponding author), Univ Virginia, Dept Anesthesiol, Charlottesville, VA 22904 USA.; Naik, BI (corresponding author), Univ Virginia, Dept Neurol Surg, Charlottesville, VA 22904 USA.	bin4n@virginia.edu		Naik, Bhiken/0000-0001-8223-4078				Ackerman AL, 2018, JAMA INTERN MED, V178, P759, DOI 10.1001/jamainternmed.2018.1044; [Anonymous], 2010, COMPUTER BUSINESS WE, V2, P41; Blaudszun G, 2012, ANESTHESIOLOGY, V116, P1312, DOI 10.1097/ALN.0b013e31825681cb; Bruera E, 2018, NEW ENGL J MED, V379, P601, DOI 10.1056/NEJMp1807117; Colvin LA, 2019, LANCET, V393, P1558, DOI 10.1016/S0140-6736(19)30430-1; Davis MP, 2018, AM J HOSP PALLIAT ME, V35, P1118, DOI 10.1177/1049909118771374; Dunn LK, 2018, ANESTH ANALG, V127, P591, DOI 10.1213/ANE.0000000000003400; Fabritius ML, 2016, ACTA ANAESTH SCAND, V60, P1188, DOI 10.1111/aas.12766; Farag E, 2013, ANESTHESIOLOGY, V119, P932, DOI 10.1097/ALN.0b013e318297d4a5; Goucke CR, 2018, ANESTH ANALG, V126, P1283, DOI 10.1213/ANE.0000000000002736; Hah J, 2018, JAMA SURG, V153, P303, DOI [10.1001/jamasurg.2017.4915, 10.1001/jamasurg.2022.1392]; Hollingsworth Hanna, 2018, J Opioid Manag, V14, P81, DOI 10.5055/jom.2018.0434; Loftus RW, 2010, ANESTHESIOLOGY, V113, P639, DOI 10.1097/ALN.0b013e3181e90914; Ogden J, 2008, HEALTH-LONDON, V12, P419, DOI 10.1177/1363459308094417; Size M, 2007, ANAESTHESIA, V62, P38, DOI 10.1111/j.1365-2044.2007.05296.x; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Yu S, 2020, J ARTHROPLASTY, V35, P89, DOI 10.1016/j.arth.2019.08.013	17	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0234199	10.1371/journal.pone.0234199	http://dx.doi.org/10.1371/journal.pone.0234199			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497141	Green Published, gold			2022-12-26	WOS:000542035200061
J	Mathiesen, L; Bay-Richter, C; Wegener, G; Liebenberg, N; Knudsen, LE				Mathiesen, Line; Bay-Richter, Cecilie; Wegener, Gregers; Liebenberg, Nico; Knudsen, Lisbeth E.			Maternal stress and placental function; ex vivo placental perfusion studying cortisol, cortisone, tryptophan and serotonin	PLOS ONE			English	Article							FETAL; INHIBITION; METABOLISM; MECHANISMS	Background Exposure to maternal stress during pregnancy can have adverse effects on the fetus, which has potential long-term effects on offspring ' s development and health. We investigated the kinetics and metabolism of the hormones and amino acids: cortisol, cortisone, tryptophan and serotonin in the term placenta in an ex vivo human placental perfusion model. The placentas used in the experiments were donated from families participating in the Maternal Stress and Placental Function project with a known maternal stress background. Method Cortisol, cortisone, tryptophan and serotonin were added simultaneously to the maternal side in the 6 hour ex vivo term human recirculating placental perfusion model, in four experimental set-ups: without inhibitors, with carbenoxolone -that inhibits cortisol metabolism into cortisone, with fluoxetine that inhibits the serotonin transporter, and with PCPA that inhibits metabolism of tryptophan into serotonin. The concentration of cortisol and cortisone, and tryptophan and serotonin were quantified using UPLC and HPLC-MS respectively. Results Cortisol was rapidly metabolized into cortisone in the placenta, to a somewhat lesser degree when adding the inhibitor carbenoxolone, resulting in higher fetal exposure to cortisol. Serotonin was also rapidly metabolized in the placenta. When adding fluoxetine a peak of fetal serotonin levels was seen in the first hour of the perfusion. No effect was seen of the maternal stress levels on placental transport kinetics in this study. Conclusion Inhibiting the metabolism of cortisol in the placenta increased fetal exposure to cortisol as expected. Unexpectedly we saw an increased fetal exposure to serotonin when inhibiting the serotonin transporter, which may be related to the increased serotonin concentration on the maternal side of the placenta. No effect on placental kinetics were evident on maternal stress levels during the pregnancy as the majority of participating mothers had normal stress levels.	[Mathiesen, Line; Knudsen, Lisbeth E.] Univ Copenhagen, Dept Publ Hlth, Environm Hlth Sect, Copenhagen, Denmark; [Bay-Richter, Cecilie; Wegener, Gregers; Liebenberg, Nico] Univ Aarhus, Dept Clin Med, Translat Neuropsychiat Unit, Aarhus, Denmark	University of Copenhagen; Aarhus University	Mathiesen, L (corresponding author), Univ Copenhagen, Dept Publ Hlth, Environm Hlth Sect, Copenhagen, Denmark.	lima@sund.ku.dk	Bay-Richter, Cecilie/AAX-2712-2020; Wegener, Gregers/A-1019-2011; Knudsen, Lisbeth E./W-9392-2018	Wegener, Gregers/0000-0002-0081-0068; Knudsen, Lisbeth E./0000-0002-9576-1202; Mathiesen, Line/0000-0002-3210-159X; Bay-Richter, Cecilie/0000-0002-2254-4020	AFAAR/NEAVS (the American Fund for Alternatives to Animal Research/New England Anti-Vivisection Society Fellowship Grant for Alternatives to Animal Research in Women's Health and Sex Differences); University of Copenhagen; Alternativfondet; Laege Sofus Carl Emil Friis og Hustru Olga Doris Friis' Legat; University of Aarhus	AFAAR/NEAVS (the American Fund for Alternatives to Animal Research/New England Anti-Vivisection Society Fellowship Grant for Alternatives to Animal Research in Women's Health and Sex Differences); University of Copenhagen; Alternativfondet; Laege Sofus Carl Emil Friis og Hustru Olga Doris Friis' Legat; University of Aarhus	The Maternal Stress and Placental Function project was funded by AFAAR/NEAVS (the American Fund for Alternatives to Animal Research/New England Anti-Vivisection Society Fellowship Grant for Alternatives to Animal Research in Women's Health and Sex Differences) (LM), and internal funding from the University of Copenhagen. HPLC used to quantify antipyrine in perfusion samples was funded by Alternativfondet (LM). Analysis of cortisol and cortisone in perfusion samples was funded by Laege Sofus Carl Emil Friis og Hustru Olga Doris Friis' Legat (LM). Analysis of serotonin, serotonin metabolites and tryptophan in perfusion samples was funded by internal funding from University of Aarhus (GW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beijers R, 2014, EUR CHILD ADOLES PSY, V23, P943, DOI 10.1007/s00787-014-0566-3; Blakeley PM, 2013, J PSYCHOSOM RES, V75, P341, DOI 10.1016/j.jpsychores.2013.07.002; Bonnin A, 2011, NEUROSCIENCE, V197, P1, DOI 10.1016/j.neuroscience.2011.10.005; Bonnin A, 2011, NATURE, V472, P347, DOI 10.1038/nature09972; Busada JT, 2017, CURR TOP DEV BIOL, V125, P147, DOI 10.1016/bs.ctdb.2016.12.004; Dahlerup BR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207184; Dodds HM, 1997, J STEROID BIOCHEM, V62, P337, DOI 10.1016/S0960-0760(97)00039-3; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Heussner K, 2016, PLACENTA, V37, P79, DOI 10.1016/j.placenta.2015.11.009; HUMPHREYS CJ, 1988, MOL PHARMACOL, V33, P657; Kliman HJ, 2018, ENDOCRINOLOGY, V159, P1609, DOI 10.1210/en.2017-03025; Mathiesen L, 2010, REPROD TOXICOL, V30, P138, DOI 10.1016/j.reprotox.2010.01.006; MURPHY BEP, 1974, AM J OBSTET GYNECOL, V118, P538, DOI 10.1016/S0002-9378(16)33697-3; Myllynen P, 2010, REPROD TOXICOL, V30, P94, DOI 10.1016/j.reprotox.2010.04.006; O'Donnell K, 2009, DEV NEUROSCI-BASEL, V31, P285, DOI 10.1159/000216539; Oberlander TF, 2012, J ADOLESCENT HEALTH, V51, pS9, DOI 10.1016/j.jadohealth.2012.04.009; Sedlmayr P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00230; Stirrat LI, 2018, J CLIN ENDOCR METAB, V103, P640, DOI 10.1210/jc.2017-02140; Sun K, 1999, PLACENTA, V20, P13, DOI 10.1053/plac.1998.0352; TODRICK A, 1969, J PHARM PHARMACOL, V21, P751, DOI 10.1111/j.2042-7158.1969.tb08164.x	20	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2020	15	6							e0233979	10.1371/journal.pone.0233979; 10.1371/journal.pone.0233979.r001; 10.1371/journal.pone.0233979.r002; 10.1371/journal.pone.0233979.r003; 10.1371/journal.pone.0233979.r004	http://dx.doi.org/10.1371/journal.pone.0233979; 10.1371/journal.pone.0233979.r001; 10.1371/journal.pone.0233979.r002; 10.1371/journal.pone.0233979.r003; 10.1371/journal.pone.0233979.r004			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LW6ZP	32492052	Green Published, gold			2022-12-26	WOS:000539293000046
J	Wong, KK; Hussain, FA				Wong, Kah Keng; Hussain, Faezahtul Arbaeyah			TRPM4 is overexpressed in breast cancer associated with estrogen response and epithelial-mesenchymal transition gene sets	PLOS ONE			English	Article							PROSTATE-CANCER; PROTEIN EXPRESSION; CHANNEL TRPM4; ION-CHANNEL; METASTASIS; SIGNATURES; RECEPTOR; ANDROGEN; SURVIVAL; MIGRATION	Ion channels form an important class of drug targets in malignancies. Transient receptor potential cation channel subfamily M member 4 (TRPM4) plays oncological roles in various solid tumors. Herein, we examined TRPM4 protein expression profile by immunohistochemistry (IHC) in breast cancer cases compared with normal breast ducts, its association with clinico-demographical parameters, and its potential function in breast cancers by Gene Set Enrichment Analysis (GSEA). Data-mining demonstrated that TRPM4 transcript levels were significantly higher in The Cancer Genome Atlas series of breast cancer cases (n = 1,085) compared with normal breast tissues (n = 112) (p = 1.03 x 10(-11)). Our IHC findings in tissue microarrays showed that TRPM4 protein was overexpressed in breast cancers (n = 83/99 TRPM4(+); 83.8%) compared with normal breast ducts (n = 5/10 TRPM4(+); 50%) (p = 0.022). Higher TRPM4 expression (median frequency cut-off) was significantly associated with higher lymph node status (N1-N2 vs N0; p = 0.024) and higher stage (IIb-IIIb vs I-IIa; p = 0.005). GSEA evaluation in three independent gene expression profiling (GEP) datasets of breast cancer cases (GSE54002, n = 417; GSE20685, n = 327; GSE23720, n = 197) demonstrated significant association of TRPM4 transcript expression with estrogen response and epithelial-mesenchymal transition (EMT) gene sets (p<0.01 and false discovery rate<0.05). These gene sets were not enriched in GEP datasets of normal breast epithelium cases (GSE10797, n = 5; GSE9574, n = 15; GSE20437, n = 18). In conclusion, TRPM4 protein expression is upregulated in breast cancers associated with worse clinico-demographical parameters, and TRPM4 potentially regulates estrogen receptor signaling and EMT progression in breast cancer.	[Wong, Kah Keng] Univ Sains Malaysia, Sch Med Sci, Dept Immunol, Kubang Kerian, Kelantan, Malaysia; [Hussain, Faezahtul Arbaeyah] Univ Sains Malaysia, Sch Med Sci, Dept Pathol, Kubang Kerian, Kelantan, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia	Wong, KK (corresponding author), Univ Sains Malaysia, Sch Med Sci, Dept Immunol, Kubang Kerian, Kelantan, Malaysia.	kahkeng@usm.my	Hussain, Faezahtul Arbaeyah/AAF-5141-2021; Wong, Kah Keng/AAC-2807-2022	Hussain, Faezahtul Arbaeyah/0000-0003-3899-8833; Wong, Kah Keng/0000-0001-7359-6202	Bridging Grant by Universiti Sains Malaysia [304.PPSP.6316332]	Bridging Grant by Universiti Sains Malaysia(Universiti Sains Malaysia)	This research project was supported by the Bridging Grant (304.PPSP.6316332) by Universiti Sains Malaysia awarded to KKW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almangush A, 2019, HISTOPATHOLOGY, V74, P536, DOI 10.1111/his.13793; Autzen HE, 2018, SCIENCE, V359, P228, DOI 10.1126/science.aar4510; Barbet G, 2008, NAT IMMUNOL, V9, P1148, DOI 10.1038/ni.1648; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bekhouche I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016950; Berg KD, 2016, VIRCHOWS ARCH, V468, P345, DOI 10.1007/s00428-015-1880-y; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brown PJ, 2016, LEUKEMIA, V30, P605, DOI 10.1038/leu.2015.299; Burris SK, 2015, BRIT J PHARMACOL, V172, P2459, DOI 10.1111/bph.13077; Cao L, 2018, HISTOPATHOLOGY, V73, P819, DOI 10.1111/his.13699; Casey T, 2009, BREAST CANCER RES TR, V114, P47, DOI 10.1007/s10549-008-9982-8; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen B, 2019, PFLUG ARCH EUR J PHY, V471, P1455, DOI 10.1007/s00424-019-02326-8; Cheng H, 2007, CELL CALCIUM, V41, P51, DOI 10.1016/j.ceca.2006.04.032; Cochrane DR, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3599; Collins LC, 2005, CANCER-AM CANCER SOC, V103, P1778, DOI 10.1002/cncr.20979; Dobrescu Andrei, 2011, ISRN Oncol, V2011, P673790, DOI 10.5402/2011/673790; Earley S, 2004, CIRC RES, V95, P922, DOI 10.1161/01.RES.0000147311.54833.03; Espina V, 2011, NAT REV CANCER, V11, P618, DOI 10.1038/nrc2950-c2; Finan C, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag1166; Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gao YH, 2019, CANCER LETT, V454, P66, DOI 10.1016/j.canlet.2019.04.012; Georges LMC, 2018, ADV EXP MED BIOL, V1110, P101, DOI 10.1007/978-3-030-02771-1_7; Giovannelli P, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00492; Gomez-Contreras P, 2017, CLIN EXP METASTAS, V34, P37, DOI 10.1007/s10585-016-9827-5; Graham K, 2010, BRIT J CANCER, V102, P1284, DOI 10.1038/sj.bjc.6605576; Grand T, 2008, BRIT J PHARMACOL, V153, P1697, DOI 10.1038/bjp.2008.38; Guo JT, 2017, NATURE, V552, P205, DOI 10.1038/nature24997; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Harris JR, 2004, DIS BREAST; Holzmann C, 2015, ONCOTARGET, V6, P41783, DOI 10.18632/oncotarget.6157; Hong X, 2019, AM J PHYSIOL-CELL PH, V316, pC463, DOI 10.1152/ajpcell.00142.2018; Kao KJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-143; Kappel S, 2019, MOL ONCOL, V13, P2393, DOI 10.1002/1878-0261.12566; Karousou E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/606458; Kim Hae-Young, 2017, Restor Dent Endod, V42, P152, DOI 10.5395/rde.2017.42.2.152; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koelzer VH, 2016, HUM PATHOL, V47, P4, DOI 10.1016/j.humpath.2015.08.007; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Leanza L, 2016, BBA-MOL CELL RES, V1863, P1385, DOI 10.1016/j.bbamcr.2015.11.032; Lee KM, 2015, ONCOGENE, V34, P6055, DOI 10.1038/onc.2015.54; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liu J, 2018, DISCOV MED, V25, P211; Loo SK, 2017, HISTOPATHOLOGY, V71, P98, DOI 10.1111/his.13204; Loo SK, 2018, PATHOL RES PRACT, V214, P134, DOI 10.1016/j.prp.2017.10.005; Narayan G, 2007, GENE CHROMOSOME CANC, V46, P373, DOI 10.1002/gcc.20418; Need EF, 2012, MOL ENDOCRINOL, V26, P1941, DOI 10.1210/me.2011-1314; Nilius B, 2005, J BIOL CHEM, V280, P22899, DOI 10.1074/jbc.M501686200; Onitilo AA, 2009, CLIN MED RES, V7, P4, DOI 10.3121/cmr.2009.825; Oshilaja O, 2018, APPL IMMUNOHISTO M M, DOI [10.1097/PAI, DOI 10.1097/PAI]; Ozhathil LC, 2018, BRIT J PHARMACOL, V175, P2504, DOI 10.1111/bph.14220; Prevarskaya N, 2010, TRENDS MOL MED, V16, P107, DOI 10.1016/j.molmed.2010.01.005; Ravaioli S, 2019, APPL IMMUNOHISTO M M, V27, P301, DOI 10.1097/PAI.0000000000000582; Ravaioli S, 2017, INT J EXP PATHOL, V98, P289, DOI 10.1111/iep.12253; Rivas J, 2020, FASEB J, V34, P7847, DOI 10.1096/fj.201901195RRR; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Sagredo AI, 2019, J CELL PHYSIOL, V234, P2037, DOI 10.1002/jcp.27371; Sagredo AI, 2018, MOL ONCOL, V12, P151, DOI 10.1002/1878-0261.12100; Salvi S, 2020, SEMIN CANCER BIOL, V60, P132, DOI 10.1016/j.semcancer.2019.04.002; Santos R, 2017, NAT REV DRUG DISCOV, V16, P19, DOI 10.1038/nrd.2016.230; Schmitz C, 2005, CURR PHARM DESIGN, V11, P2765, DOI 10.2174/1381612054546851; Shimizu T, 2009, CELL CALCIUM, V45, P226, DOI 10.1016/j.ceca.2008.10.005; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sumoza-Toledo A, 2011, J PHYSIOL-LONDON, V589, P1515, DOI 10.1113/jphysiol.2010.201855; Tan TZ, 2014, EMBO MOL MED, V6, P1279, DOI 10.15252/emmm.201404208; Tang ZF, 2019, NUCLEIC ACIDS RES, V47, pW556, DOI 10.1093/nar/gkz430; Tripathi A, 2008, INT J CANCER, V122, P1557, DOI 10.1002/ijc.23267; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vennekens R., 2007, V179, P269; Wang C, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7060062; Weber KS, 2010, J IMMUNOL, V185, P2836, DOI 10.4049/jimmunol.1000880; Winkler PA, 2017, NATURE, V552, P200, DOI 10.1038/nature24674; Wong KK, 2019, J CELL PHYSIOL, V234, P14556, DOI 10.1002/jcp.28168; Wong KK, 2016, ONCOTARGET, V7, P52940, DOI 10.18632/oncotarget.9507; Wong KK, 2015, EXP MOL PATHOL, V99, P537, DOI 10.1016/j.yexmp.2015.08.019	76	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2020	15	6							e0233884	10.1371/journal.pone.0233884	http://dx.doi.org/10.1371/journal.pone.0233884			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MT4VF	32484822	gold, Green Published			2022-12-26	WOS:000554969700019
J	Guo, ZY; Tong, LB; Xu, S; Li, B; Wang, Z; Liu, YD				Guo, Zuiyuan; Tong, Libo; Xu, Shuang; Li, Bing; Wang, Zhuo; Liu, Yuandong			Epidemiological analysis of an outbreak of an adenovirus type 7 infection in a boot camp in China	PLOS ONE			English	Article							RESPIRATORY ILLNESS; MILITARY RECRUITS; INFLUENZA; TRANSMISSION; HOUSEHOLD	Background An outbreak of respiratory disease associated with adenovirus type 7 occurred in a boot camp in China and was characterized by many cases, severe symptoms, and intrapulmonary infection in many patients. Methods We implemented a series of comprehensive preventive and control measures. We analyzed the incubation period and generation time by using the maximum likelihood method, assessed the symptom period and hospitalization duration using the Kaplan-Meier method, and estimated the basic reproductive number and dormitory transmission rate by using established methods. Results The epidemic lasted for 30 days, and 375 individuals were affected. Overall, 109 patients were hospitalized, and 266 individuals were isolated and treated. The median incubation period was 5.2 days (95% confidence interval [CI]: 5.0 to 5.4 days). The median generation time was 7.3 days (95% CI: 7.1 to 7.6 days). The median symptom period was 6 days (95% CI: 6 to 7 days). The median hospitalization duration was 9 days (95% CI: 9 to 11 days). The basic reproductive number was 5.1 (95% CI: 4.6 to 5.6), and the dormitory transmission rate was 0.15 (95% CI: 0.12 to 0.18). Conclusion Patients in the early stage of the epidemic were treated as having a regular cold and were not isolated; therefore, the virus continued to be transmitted to other susceptible individuals.	[Guo, Zuiyuan; Tong, Libo; Xu, Shuang; Li, Bing; Wang, Zhuo; Liu, Yuandong] Ctr Dis Control & Prevent Northern Theater Comman, Dept Dis Control, Shenyang, Liaoning, Peoples R China		Liu, YD (corresponding author), Ctr Dis Control & Prevent Northern Theater Comman, Dept Dis Control, Shenyang, Liaoning, Peoples R China.	LyDCDC@163.com			National Science and Technology Major Project [2018ZX10713003]	National Science and Technology Major Project	The work was supported by National Science and Technology Major Project [2018ZX10713003].	Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912; Centers for Disease Control and Prevention, ADENOVIRUSES; Cheng J, 2016, AM J TRANSL RES, V8, P2331; Delevaux I, 2013, REV MED INTERNE, V34, P487, DOI 10.1016/j.revmed.2012.10.366; Fu YX, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-018-3651-2; HIERHOLZER JC, 1974, AM J EPIDEMIOL, V99, P434, DOI 10.1093/oxfordjournals.aje.a121632; HORWITZ MS, 2001, FIELDS VIROLOGY, P2301; Huang XD, 2016, IEEE T DEVICE MAT RE, V16, P38, DOI 10.1109/TDMR.2015.2508153; Jeon K, 2007, EUR J CLIN MICROBIOL, V26, P481, DOI 10.1007/s10096-007-0312-6; Lessler J, 2007, J R SOC INTERFACE, V4, P755, DOI 10.1098/rsif.2007.0228; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; Liu X., 2012, SURVIVAL ANAL MODELS; Nishiura Hiroshi, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P1075; Radin JM, 2014, CLIN INFECT DIS, V59, P962, DOI 10.1093/cid/ciu507; Reich NG, 2009, STAT MED, V28, P2769, DOI 10.1002/sim.3659; Scott MK, 2016, EMERG INFECT DIS, V22, P1044, DOI 10.3201/eid2206.151898; Vynnycky E, 2007, INT J EPIDEMIOL, V36, P881, DOI 10.1093/ije/dym071; WADELL G, 1980, AM J EPIDEMIOL, V112, P619, DOI 10.1093/oxfordjournals.aje.a113034; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Yang XX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172519; Yu PB, 2013, MICROBIOL IMMUNOL, V57, P553, DOI 10.1111/1348-0421.12074; Yusof MA, 2012, EMERG INFECT DIS, V18, P852, DOI 10.3201/eid1805.110865; Zhao SH, 2014, SCI REP-UK, V4, DOI 10.1038/srep07365	24	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0232948	10.1371/journal.pone.0232948	http://dx.doi.org/10.1371/journal.pone.0232948			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MJ2AA	32479490	gold, Green Published			2022-12-26	WOS:000547893500008
J	Nam, HK; Vesela, I; Schutte, SD; Hatch, NE				Nam, Hwa Kyung; Vesela, Iva; Schutte, Sara Dean; Hatch, Nan E.			Viral delivery of tissue nonspecific alkaline phosphatase diminishes craniosynostosis in one of two FGFR2(C342Y/+) mouse models of Crouzon syndrome	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR-2; ENZYME-REPLACEMENT THERAPY; MUTATIONS; BONE; ACTIVATION; EXPRESSION; MANAGEMENT; OUTCOMES; VECTORS; FGFR2	Craniosynostosis is the premature fusion of cranial bones. The goal of this study was to determine if delivery of recombinant tissue nonspecific alkaline phosphatase (TNAP) could prevent or diminish the severity of craniosynostosis in a C57BL/6 FGFR2(C342Y/+) model of neonatal onset craniosynostosis or a BALB/c FGFR2(C342Y/+) model of postnatal onset craniosynostosis. Mice were injected with a lentivirus encoding a mineral targeted form of TNAP immediately after birth. Cranial bone fusion as well as cranial bone volume, mineral content and density were assessed by micro CT. Craniofacial shape was measured with calipers. Alkaline phosphatase, alanine amino transferase (ALT) and aspartate amino transferase (AST) activity levels were measured in serum. Neonatal delivery of TNAP diminished craniosynostosis severity from 94% suture obliteration in vehicle treated mice to 67% suture obliteration in treated mice, p<0.02) and the incidence of malocclusion from 82.4% to 34.7% (p<0.03), with no effect on cranial bone in C57BL/6 FGFR2(C342Y/+) mice. In contrast, treatment with TNAP increased cranial bone volume (p < 0.01), density (p < 0.01) and mineral content (p < 0.01) as compared to vehicle treated controls, but had no effect on craniosynostosis or malocclusion in BALB/c FGFR2(C342Y/+) mice. These results indicate that postnatal recombinant TNAP enzyme therapy diminishes craniosynostosis severity in the C57BL/6 FGFR2(C342Y/+) neonatal onset mouse model of Crouzon syndrome, and that effects of exogenous TNAP are genetic background dependent.	[Nam, Hwa Kyung; Vesela, Iva; Schutte, Sara Dean; Hatch, Nan E.] Univ Michigan, Sch Dent, Dept Orthodont & Pediat Dent, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Hatch, NE (corresponding author), Univ Michigan, Sch Dent, Dept Orthodont & Pediat Dent, Ann Arbor, MI 48109 USA.	nhatch@umich.edu	Hatch, Nan/AAQ-8465-2020; Hatch, Nan/ABC-9177-2020	Hatch, Nan/0000-0002-2632-0841; Vesela, Iva/0000-0001-5751-0130	National Institute of Dental and Craniofacial Research (NIDCR) [R01DE02582701]	National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grant R01DE02582701. to N.E.H. from the National Institute of Dental and Craniofacial Research (NIDCR). The funders played no role in the study design, data collection, data analysis, decision to publish, or preparation of the manuscript.	ABE H, 1985, CHILD NERV SYST, V1, P53, DOI 10.1007/BF00706732; Baird LC, 2012, CHILD NERV SYST, V28, P411, DOI 10.1007/s00381-011-1615-6; Chen L, 2003, BONE, V33, P169, DOI 10.1016/S8756-3282(03)00222-9; Collmann H, 2009, CHILD NERV SYST, V25, P217, DOI 10.1007/s00381-008-0708-3; Franca RFD, 2010, EXP MOL PATHOL, V89, P321, DOI 10.1016/j.yexmp.2010.07.007; DeWeerdt S, 2018, NATURE, V564, pS6, DOI 10.1038/d41586-018-07643-z; Eswarakumar VP, 2004, P NATL ACAD SCI USA, V101, P12555, DOI 10.1073/pnas.0405031101; Flapper WJ, 2009, J CRANIOFAC SURG, V20, P1252, DOI 10.1097/SCS.0b013e3181acdf9a; FRASER D, 1957, AM J MED, V22, P730, DOI 10.1016/0002-9343(57)90124-9; Galvin BD, 1996, P NATL ACAD SCI USA, V93, P7894, DOI 10.1073/pnas.93.15.7894; Hanawa H, 2009, MOL THER, V17, P667, DOI 10.1038/mt.2009.1; Hatch NE, 2009, J BONE MINER RES, V24, P652, DOI 10.1359/JBMR.081213; Hatch NE, 2005, CONNECT TISSUE RES, V46, P184, DOI 10.1080/03008200500237203; Huang F, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-93; Liu J, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/292506; Liu J, 2015, BONE, V78, P203, DOI 10.1016/j.bone.2015.05.005; Liu J, 2014, BONE, V67, P81, DOI 10.1016/j.bone.2014.06.040; Liu J, 2013, CALCIFIED TISSUE INT, V92, P451, DOI 10.1007/s00223-013-9701-2; McCarthy JG, 2012, CLEFT PALATE-CRAN J, V49, p1S, DOI 10.1597/11-138; Meganck JA, 2009, BONE, V45, P1104, DOI 10.1016/j.bone.2009.07.078; Millan JL, 2008, J BONE MINER RES, V23, P777, DOI 10.1359/JBMR.071213; Morriss-Kay GM, 2005, J ANAT, V207, P637, DOI 10.1111/j.1469-7580.2005.00475.x; Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205; Nam HK, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00161; Nam HK, 2019, BONE, V120, P125, DOI 10.1016/j.bone.2018.10.013; NEILSON KM, 1995, J BIOL CHEM, V270, P26037, DOI 10.1074/jbc.270.44.26037; Nishioka T, 2006, MOL GENET METAB, V88, P244, DOI 10.1016/j.ymgme.2006.02.012; Okajima K, 1999, AM J MED GENET, V85, P160, DOI 10.1002/(SICI)1096-8628(19990716)85:2<160::AID-AJMG11>3.0.CO;2-R; Perlyn CA, 2006, CLEFT PALATE-CRAN J, V43, P740, DOI 10.1597/05-212; Pfaff MJ, 2016, DEV BIOL, V415, P242, DOI 10.1016/j.ydbio.2016.03.026; Rasmussen SA, 2007, AM J MED GENET A, V143A, P2896, DOI 10.1002/ajmg.a.32077; REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98; Renier D, 2000, CHILD NERV SYST, V16, P645, DOI 10.1007/s003810000320; Richtsmeier JT, 2000, DEV DYNAM, V217, P137, DOI 10.1002/(SICI)1097-0177(200002)217:2<137::AID-DVDY1>3.0.CO;2-N; Robertson SC, 1998, P NATL ACAD SCI USA, V95, P4567, DOI 10.1073/pnas.95.8.4567; Seruya M, 2011, J NEUROSURG-PEDIATR, V8, P40, DOI 10.3171/2011.4.PEDS1160; Umoh JU, 2009, PHYS MED BIOL, V54, P2147, DOI 10.1088/0031-9155/54/7/020; Wang E, 2015, ORTHOD CRANIOFAC RES, V18, P196, DOI 10.1111/ocr.12080; Warren SM, 2012, PLAST RECONSTR SURG, V129, P731, DOI 10.1097/PRS.0b013e3182412a50; Whyte MP, 2019, LANCET DIABETES ENDO, V7, P93, DOI 10.1016/S2213-8587(18)30307-3; Whyte MP, 2012, NEW ENGL J MED, V366, P904, DOI 10.1056/NEJMoa1106173; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165; Yadav MC, 2011, BONE, V49, P250, DOI 10.1016/j.bone.2011.03.770; Yamamoto S, 2011, J BONE MINER RES, V26, P135, DOI 10.1002/jbmr.201; Zheng CX, 2018, ANAT REC, V301, P825, DOI 10.1002/ar.23723	45	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2020	15	5							e0234073	10.1371/journal.pone.0234073	http://dx.doi.org/10.1371/journal.pone.0234073			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1WS	32470062	gold, Green Published, Green Submitted			2022-12-26	WOS:000537552800228
J	Lu, W; Ai, H; Xue, FS; Luan, YF; Zhang, B				Lu, Wen; Ai, Heng; Xue, Fusheng; Luan, Yifei; Zhang, Bin			The Noonan syndrome-associated D61G variant of the protein tyrosine phosphatase SHP2 prevents synaptic down-scaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphatase; phosphorylation; Src homology 2 domain (SH2 domain); ?-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPA receptor); phosphotyrosine signaling; SHP2; postsynaptic density protein 95 (PSD95); synaptic scaling; protein tyrosine phosphatase non-receptor type 11 (PTPN11)	NMDA RECEPTOR; PLASTICITY; PHOSPHORYLATION; EXPRESSION; SUBUNIT; BINDING; PSD-95	Homeostatic scaling of the synapse, such as synaptic down-scaling, has been proposed to offset deleterious effects induced by sustained synaptic strength enhancement. Proper function and subcellular distribution of Src homology 2 domain-containing nonreceptor protein tyrosine phosphatase (SHP2) are required for synaptic plasticity. However, the role of SHP2 in synaptic down-scaling remains largely unknown. Here, using biochemical assays and cell-imaging techniques, we found that synaptic SHP2 levels are temporally regulated during synaptic down-scaling in cultured hippocampal neurons. Furthermore, we observed that a Noonan syndrome-associated mutation of SHP2, resulting in a D61G substitution, prevents synaptic down-scaling. We further show that this effect is due to an inability of the SHP2-D61G variant to properly disassociate from postsynaptic density protein 95, leading to impaired SHP2 dispersion from synaptic sites after synaptic down-scaling. Our findings reveal a molecular mechanism of the Noonan syndrome-associated genetic variant SHP2-D61G that contributes to deficient synaptic down-scaling.	[Lu, Wen] Hainan Med Univ, Dept Biochem & Mol Biol, Haikou, Hainan, Peoples R China; [Lu, Wen] Hainan Med Univ, Minist Educ, Key Lab Emergency & Trauma, Haikou, Hainan, Peoples R China; [Ai, Heng; Luan, Yifei] Hangzhou Med Coll, Dept Physiol, Hangzhou, Zhejiang, Peoples R China; [Xue, Fusheng; Zhang, Bin] Hangzhou Normal Univ, Inst Life Sci, Zhejiang Key Lab Organ Dev & Regenerat, Hangzhou, Zhejiang, Peoples R China	Hainan Medical University; Hainan Medical University; Hangzhou Medical College; Hangzhou Normal University	Zhang, B (corresponding author), Hangzhou Normal Univ, Inst Life Sci, Zhejiang Key Lab Organ Dev & Regenerat, Hangzhou, Zhejiang, Peoples R China.	zhangbin890124@163.com		Lu, Wen/0000-0003-1826-5720	National Natural Science Foundation of China [31700882, 31600863]; Zhejiang Provincial Natural Science Foundation of China [LY20C090004, LY18H090010]; Hainan Medical University; Tri-Five Cultivating Project from Hangzhou Normal University [2017XJSGWXM209]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Hainan Medical University; Tri-Five Cultivating Project from Hangzhou Normal University	This work was supported by National Natural Science Foundation of China (Grant 31700882 to B. Z. and Grant 31600863 to W. L.), the Zhejiang Provincial Natural Science Foundation of China (Grant LY20C090004 to B. Z. and Grant LY18H090010 to H. A.), the start-up fund of Hainan Medical University (to W. L.), and the Tri-Five Cultivating Project from Hangzhou Normal University (Grant 2017XJSGWXM209 to B. Z.).	Araki T, 2009, P NATL ACAD SCI USA, V106, P4736, DOI 10.1073/pnas.0810053106; Chowdhury D, 2018, EMBO J, V37, P122, DOI 10.15252/embj.201695829; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; Diering GH, 2018, NEURON, V100, P314, DOI 10.1016/j.neuron.2018.10.018; Diering GH, 2014, NEURON, V84, P790, DOI 10.1016/j.neuron.2014.09.024; Fragale A, 2004, HUM MUTAT, V23, P267, DOI 10.1002/humu.20005; Huber KM, 2018, NAT NEUROSCI, V21, P774, DOI 10.1038/s41593-018-0159-4; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; Keilhack H, 2005, J BIOL CHEM, V280, P30984, DOI 10.1074/jbc.M504699200; Kusakari S, 2015, MOL CELL BIOL, V35, P1557, DOI 10.1128/MCB.01339-14; Lee YS, 2014, NAT NEUROSCI, V17, P1736, DOI 10.1038/nn.3863; Levy AD, 2018, CELL REP, V24, P1523, DOI 10.1016/j.celrep.2018.07.006; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Lu W, 2015, J BIOL CHEM, V290, P22945, DOI 10.1074/jbc.M115.663450; Oh JY, 2017, NEUROSCI LETT, V649, P41, DOI 10.1016/j.neulet.2017.03.036; Pagani MR, 2009, CELL, V139, P186, DOI 10.1016/j.cell.2009.08.033; Peng HY, 2012, PAIN, V153, P1042, DOI 10.1016/j.pain.2012.02.006; Ran H, 2017, P NATL ACAD SCI USA, V114, P4816, DOI 10.1073/pnas.1700978114; Romano AA, 2010, PEDIATRICS, V126, P746, DOI 10.1542/peds.2009-3207; Ryu HH, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aau5755; Sun Q, 2011, J NEUROSCI, V31, P6800, DOI 10.1523/JNEUROSCI.5616-10.2011; Tajan M, 2015, EUR J MED GENET, V58, P509, DOI 10.1016/j.ejmg.2015.08.005; Tartaglia M, 2011, BEST PRACT RES CL EN, V25, P161, DOI 10.1016/j.beem.2010.09.002; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005736; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Wu TR, 2002, J BIOL CHEM, V277, P47572, DOI 10.1074/jbc.M207536200; Yan XY, 2017, MOL NEUROBIOL, V54, P7235, DOI 10.1007/s12035-016-0222-7; Zhang B, 2017, J BIOL CHEM, V292, P15481, DOI 10.1074/jbc.M117.775239; Zhang B, 2016, J BIOL CHEM, V291, P18856, DOI 10.1074/jbc.M116.714501; Zhang XM, 2015, CELL RES, V25, P818, DOI 10.1038/cr.2015.75	32	3	3	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2020	295	29					10023	10031		10.1074/jbc.RA119.010331	http://dx.doi.org/10.1074/jbc.RA119.010331			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MR1DY	32499374	hybrid, Green Published			2022-12-26	WOS:000553333300020
J	Choudhury, M; Yin, XQ; Schaefbauer, KJ; Kang, JH; Roy, B; Kottom, TJ; Limper, AH; Leof, EB				Choudhury, Malay; Yin, Xueqian; Schaefbauer, Kyle J.; Kang, Jeong-Han; Roy, Bhaskar; Kottom, Theodore J.; Limper, Andrew H.; Leof, Edward B.			SIRT7-mediated modulation of glutaminase 1 regulates TGF-beta-induced pulmonary fibrosis	FASEB JOURNAL			English	Article						bleomycin; FOXO4; GLS1; glutamine metabolism; pulmonary fibrosis; SIRT7; TGF-beta signaling	GROWTH-FACTOR-BETA; RECEPTOR; GLUTAMINOLYSIS; METABOLISM; EXPRESSION; GLUTAMATE; CANCER; ACTIVATION; MECHANISMS; RESPONSES	In the current work we show that the profibrotic actions of TGF-beta are mediated, at least in part, through a metabolic maladaptation in glutamine metabolism and how the inhibition of glutaminase 1 (GLS1) reverses pulmonary fibrosis. GLS1 was found to be highly expressed in fibrotic vs normal lung fibroblasts and the expression of profibrotic targets, cell migration, and soft agar colony formation stimulated by TGF-beta required GLS1 activity. Moreover, knockdown of SMAD2 or SMAD3 as well as inhibition of PI3K, mTORC2, and PDGFR abrogated the induction of GLS1 by TGF-beta. We further demonstrated that the NAD-dependent protein deacetylase, SIRT7, and the FOXO4 transcription factor acted as endogenous brakes for GLS1 expression, which are inhibited by TGF-beta. Lastly, administration of the GLS1 inhibitor CB-839 attenuated bleomycin-induced pulmonary fibrosis. Our study points to an exciting and unexplored connection between epigenetic and transcriptional processes that regulate glutamine metabolism and fibrotic development in a TGF-beta-dependent manner.	[Choudhury, Malay; Yin, Xueqian; Schaefbauer, Kyle J.; Kang, Jeong-Han; Kottom, Theodore J.; Limper, Andrew H.; Leof, Edward B.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Thorac Dis Res Unit,Div Pulm & Crit Care Med, Rochester, MN 55905 USA; [Roy, Bhaskar] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN USA; [Yin, Xueqian] Mayo Clin, Coll Med, Dept Mol Med, Rochester, MN USA; [Kang, Jeong-Han] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Choudhury, M; Limper, AH (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Thorac Dis Res Unit,Div Pulm & Crit Care Med, Rochester, MN 55905 USA.	Choudhury.Malay@mayo.edu; limper.andrew@mayo.edu	Kang, Jeong-Han/J-3541-2019	Kang, Jeong-Han/0000-0002-9693-0696; Choudhury, Malay/0000-0003-3051-9084	HHS | NIH | National Institute of General Medical Sciences (NIGMS) [GM-54200, GM-55816]	HHS | NIH | National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	HHS | NIH | National Institute of General Medical Sciences (NIGMS), Grant/Award Number: GM-54200 and GM-55816	Akamata K, 2016, ONCOTARGET, V7, P69321, DOI 10.18632/oncotarget.12504; Altman BJ, 2016, NAT REV CANCER, V16, P619, DOI 10.1038/nrc.2016.71; Andrianifahanana M, 2013, FASEB J, V27, P4444, DOI 10.1096/fj.12-224907; Andrianifahanana M, 2010, CANCER RES, V70, P7421, DOI 10.1158/0008-5472.CAN-10-0232; BASSING CH, 1994, SCIENCE, V263, P87, DOI 10.1126/science.8272871; BERGSTROM J, 1974, J APPL PHYSIOL, V36, P693, DOI 10.1152/jappl.1974.36.6.693; Bernard K, 2018, J BIOL CHEM, V293, P1218, DOI 10.1074/jbc.RA117.000444; Canestaro WJ, 2016, CHEST, V149, P756, DOI 10.1016/j.chest.2015.11.013; Coloff JL, 2016, CELL METAB, V23, P867, DOI 10.1016/j.cmet.2016.03.016; Csibi A, 2013, CELL, V153, P840, DOI 10.1016/j.cell.2013.04.023; Cui HC, 2019, AM J RESP CELL MOL, V61, P492, DOI 10.1165/rcmb.2019-0051OC; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; Daniels CE, 2004, J CLIN INVEST, V114, P1308, DOI 10.1175/JCI200419603; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; dos Reis LM, 2019, J BIOL CHEM, V294, P9342, DOI 10.1074/jbc.RA119.008180; Duran RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Eng CH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000911; Esnault S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170207; Fernandez Isis E, 2012, Proc Am Thorac Soc, V9, P111, DOI 10.1513/pats.201203-023AW; Foskett AM, 2014, AM J PHYSIOL-LUNG C, V306, pL120, DOI 10.1152/ajplung.00240.2013; Galan-Cobo A, 2019, CANCER RES, V79, P3251, DOI 10.1158/0008-5472.CAN-18-3527; Ge J, 2018, AM J RESP CELL MOL, V58, P378, DOI 10.1165/rcmb.2017-0238OC; Gregory MA, 2019, CLIN CANCER RES, V25, P4079, DOI 10.1158/1078-0432.CCR-18-3223; Grinde MT, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-019-1141-0; Gross MI, 2014, MOL CANCER THER, V13, P890, DOI 10.1158/1535-7163.MCT-13-0870; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jacque N, 2015, BLOOD, V126, P1346, DOI 10.1182/blood-2015-01-621870; Jeong SM, 2013, CANCER CELL, V23, P450, DOI 10.1016/j.ccr.2013.02.024; Jin L, 2016, ONCOGENE, V35, P3619, DOI 10.1038/onc.2015.447; Jin LT, 2015, CANCER CELL, V27, P257, DOI 10.1016/j.ccell.2014.12.006; Kang JH, 2017, J CLIN INVEST, V127, P2541, DOI 10.1172/JCI88696; Katt WP, 2012, MOL CANCER THER, V11, P1269, DOI 10.1158/1535-7163.MCT-11-0942; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Kurotsu S, 2014, J PHARMACOL EXP THER, V350, P79, DOI 10.1124/jpet.114.213009; Lee JS, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.404; Lee YZ, 2014, ONCOTARGET, V5, P6087, DOI 10.18632/oncotarget.2173; LEOF EB, 1986, P NATL ACAD SCI USA, V83, P2453, DOI 10.1073/pnas.83.8.2453; Li J, 2019, CELL BIOL INT, V43, P921, DOI 10.1002/cbin.11182; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; Liu PS, 2017, NAT IMMUNOL, V18, P985, DOI 10.1038/ni.3796; Liu RQ, 2019, CANCER LETT, V443, P34, DOI 10.1016/j.canlet.2018.11.030; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Michaeloudes C, 2011, AM J PHYSIOL-LUNG C, V300, pL295, DOI 10.1152/ajplung.00134.2010; MOREADITH RW, 1984, J BIOL CHEM, V259, P6215; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Nakerakanti Sashidhar, 2012, Open Rheumatol J, V6, P156, DOI 10.2174/1874312901206010156; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Pilewski JM, 2005, AM J PATHOL, V166, P399, DOI 10.1016/S0002-9440(10)62263-8; Prud'homme GJ, 2007, LAB INVEST, V87, P1077, DOI 10.1038/labinvest.3700669; Raghu G, 2015, AM J RESP CRIT CARE, V191, P252, DOI 10.1164/rccm.201411-2044ED; Rahimi RA, 2009, CANCER RES, V69, P84, DOI 10.1158/0008-5472.CAN-08-2146; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; RUBIN AL, 1990, CANCER RES, V50, P2832; Sanjabi S, 2005, GENE DEV, V19, P2138, DOI 10.1101/gad.1329805; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shah R, 2019, CANCER RES, V79, P1799, DOI 10.1158/0008-5472.CAN-18-1500; Sosulski ML, 2017, J GERONTOL A-BIOL, V72, P595, DOI 10.1093/gerona/glw151; Steele MP, 2013, ANNU REV MED, V64, P265, DOI 10.1146/annurev-med-042711-142004; Todd NW, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-11; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; van der Vos KE, 2012, AUTOPHAGY, V8, P1862, DOI 10.4161/auto.22152; Verhoeven D, 2009, VIROLOGY, V390, P151, DOI 10.1016/j.virol.2009.05.004; Wang DC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166423; Wei J, 2015, ARTHRITIS RHEUMATOL, V67, P1323, DOI 10.1002/art.39061; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wilkes MC, 2003, MOL CELL BIOL, V23, P8878, DOI 10.1128/MCB.23.23.8878-8889.2003; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; WU MC, 1978, INT J CANCER, V22, P728, DOI 10.1002/ijc.2910220615; Wyman AE, 2018, CURR RHEUMATOL REP, V20, DOI 10.1007/s11926-018-0724-6; Wyman AE, 2017, AM J PHYSIOL-LUNG C, V312, pL945, DOI 10.1152/ajplung.00473.2016; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xiang LS, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1291-5; Xin ZL, 2018, AGEING RES REV, V41, P42, DOI 10.1016/j.arr.2017.11.002; Yang J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41523-4; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099; Zerr P, 2016, ANN RHEUM DIS, V75, P226, DOI 10.1136/annrheumdis-2014-205740; Zhai XX, 2017, MOL MED REP, V15, P3467, DOI 10.3892/mmr.2017.6437; Zhang J, 2014, MOL CELL, V56, P205, DOI 10.1016/j.molcel.2014.08.018; Zhang L, 2013, TRENDS BIOCHEM SCI, V38, P612, DOI 10.1016/j.tibs.2013.10.001; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	86	14	15	3	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					8920	8940		10.1096/fj.202000564R	http://dx.doi.org/10.1096/fj.202000564R		JUN 2020	21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32519817	Bronze			2022-12-26	WOS:000541521900001
J	Dias, DD; Bernardes, N; Stoyell-Conti, FF; dos Santos, CP; de Araujo, AA; Llesuy, S; Ingoyen, MC; De Angelis, K				Dias, Danielle da Silva; Bernardes, Nathalia; Stoyell-Conti, Filipe Fernandes; dos Santos, Camila Paixao; de Araujo, Amanda Aparecida; Llesuy, Susana; Ingoyen, Maria Claudia; De Angelis, Katie			Impact of combined exercise training on the development of cardiometabolic and neuroimmune complications induced by fructose consumption in hypertensive rats	PLOS ONE			English	Article							OXIDATIVE STRESS; INSULIN-RESISTANCE; METABOLIC SYNDROME; BLOOD-PRESSURE; GLUTATHIONE; DYSFUNCTION; MECHANISMS; BEVERAGES; LIVER; MODEL	This study evaluated the impact of combined exercise training on the development of cardiovascular and neuroimmune complications induced by fructose consumption (10% in the drinking water) in hypertensive rats (SHR). After weaning, SHR were divided into 3 groups: SHR (H), SHR+fructose (HF) and SHR+fructose+combined exercise training (treadmill+ladder, 40-60% of maximum capacity) (HFTC). Metabolic, hemodynamic, autonomic, inflammatory and oxidative stress parameters were evaluated in the subgroups (n = 6 group/time) at 7, 15, 30 and 60 days of protocol. Fructose consumption (H vs. HF groups) decreased spontaneous baroreflex sensitivity and total variance of pulse interval at day 7 (7 to 60); increased IL-6 and TNF alpha in the heart (at day 15, 30 and 60) and NADPH oxidase activity and cardiac lipoperoxidation (LPO) (day 60); increased white adipose tissue weight, reduced insulin sensitivity and increased triglycerides (day 60); induced an additional increase in mean arterial pressure (MAP) (days 30 and 60). Combined exercise training prevented such dysfunctions and sustained increased cardiac IL-10 (day 7) and glutathione redox balance (GSH/GSSG) for the entire protocol. In conclusion, combined exercise training performed simultaneously with exacerbated fructose consumption prevented early cardiovascular autonomic dysfunction, probably trigging positive changes in inflammation and oxidative stress, resulting in a better cardiometabolic profile in rats genetically predisposed to hypertension.	[Dias, Danielle da Silva; Bernardes, Nathalia; Llesuy, Susana; De Angelis, Katie] Univ Nove Julho UNINOVE, Lab Translat Physiol, Sao Paulo, SP, Brazil; [Dias, Danielle da Silva; dos Santos, Camila Paixao; de Araujo, Amanda Aparecida; De Angelis, Katie] Fed Univ Sao Paulo UNIFESP, Dept Physiol, Sao Paulo, SP, Brazil; [Stoyell-Conti, Filipe Fernandes] Univ Miami, Dept Surg, Miami, FL USA; [Llesuy, Susana] Hosp Italiano Buenos Aires, Inst Univ Hosp Italiano, Buenos Aires, DF, Argentina; [Ingoyen, Maria Claudia] Univ Sao Paulo, Sch Med, Heart Inst InCor, Hypertens Unit, Sao Paulo, SP, Brazil	Universidade Nove de Julho; Universidade Federal de Sao Paulo (UNIFESP); University of Miami; Hospital Italiano de Buenos Aires; University of Buenos Aires; Universidade de Sao Paulo	De Angelis, K (corresponding author), Univ Nove Julho UNINOVE, Lab Translat Physiol, Sao Paulo, SP, Brazil.; De Angelis, K (corresponding author), Fed Univ Sao Paulo UNIFESP, Dept Physiol, Sao Paulo, SP, Brazil.	prof.kangelis@yahoo.com.br			CNPq [457200/2014-6, 309292/2014-0]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2020/07482-4, 2015/11223-6]; CAPES [88881.062178/2014-01]; CNPq Fellowship (CNPq-BPQ) [5/29, SFDC 06651800]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq Fellowship (CNPq-BPQ)	This study was supported by CNPq (457200/2014-6; 309292/2014-0) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (2020/07482-4; 2015/11223-6); CAPES (88881.062178/2014-01). Katia De Angelis and Maria-Claudia Irigoyen are recipients of CNPq Fellowship (CNPq-BPQ)"(GJ, 5/29, SFDC 06651800).	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Alikhani M., 2007, AM J PHYSIOL, V292, pC850, DOI 10.1152/ajpce11.00356.2006; ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; [Anonymous], 2015, AM J PHYSIOL-HEART C, V309, pH532; Basciano Heather, 2005, Nutr Metab (Lond), V2, P5, DOI 10.1186/1743-7075-2-5; Bernardes N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26816-4; Bernardes N, 2017, CAN J PHYSIOL PHARM, V95, P1078, DOI 10.1139/cjpp-2016-0663; Brito JO, 2008, BRAZ J MED BIOL RES, V41, P804, DOI 10.1590/S0100-879X2008005000030; Castro MC, 2015, LIFE SCI, V137, P1, DOI 10.1016/j.lfs.2015.07.010; Conti FF, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-185; da Luz PL, 2008, CLINICS, V63, P427, DOI 10.1590/S1807-59322008000400003; da Palma RK, 2016, J APPL PHYSIOL, V121, P1032, DOI 10.1152/japplphysiol.00130.2016; De Angelis K, 2012, AM J PHYSIOL-REG I, V302, pR950, DOI 10.1152/ajpregu.00450.2011; Egli L, 2013, DIABETES, V62, P2259, DOI 10.2337/db12-1651; FLECHA BG, 1991, FREE RADICAL BIO MED, V10, P93; Francisqueti FV, 2016, SAGE OPEN MED, V4, DOI 10.1177/2050312116684294; Giris M, 2014, J PHYSIOL BIOCHEM, V70, P385, DOI 10.1007/s13105-014-0314-7; Hulsmans M, 2012, CURR ATHEROSCLER REP, V14, P264, DOI 10.1007/s11883-012-0237-0; KIHLSTROM M, 1990, J APPL PHYSIOL, V68, P1672, DOI 10.1152/jappl.1990.68.4.1672; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Malik AH, 2014, AM J CARDIOL, V113, P1574, DOI 10.1016/j.amjcard.2014.01.437; MANITIUS J, 1995, J PHYSIOL PHARMACOL, V46, P179; MARKLUND SL, 1985, MUTAT RES, V148, P129, DOI 10.1016/0027-5107(85)90216-7; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Moraes-Silva IC, 2013, J APPL PHYSIOL, V114, P786, DOI 10.1152/japplphysiol.00586.2012; Pavlov VA, 2017, NAT NEUROSCI, V20, P156, DOI 10.1038/nn.4477; Pescatello LS, 2019, BRIT J SPORT MED, V53, P849, DOI 10.1136/bjsports-2018-100359; PICK E, 1980, J IMMUNOL METHODS, V38, P161, DOI 10.1016/0022-1759(80)90340-3; Ratamess NA, 2009, MED SCI SPORT EXER, V41, P687, DOI 10.1249/MSS.0b013e3181915670; Renna NF, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/420979; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; Rodrigues B, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-38; Sanches IC, 2014, INT J SPORTS MED, V35, P323, DOI 10.1055/s-0033-1351254; Sanches IC, 2012, MENOPAUSE, V19, P562, DOI 10.1097/gme.0b013e3182358c9c; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Training Technical, 2006, COMMUNIST POSTCOMMUN, V39, P39; Tran LT, 2009, MOL CELL BIOCHEM, V332, P145, DOI 10.1007/s11010-009-0184-4; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Wu KLH, 2017, J NUTR BIOCHEM, V41, P73, DOI 10.1016/j.jnutbio.2016.11.013; 2014, REG ANESTH PAIN MED, V9	42	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2020	15	6							e0233785	10.1371/journal.pone.0233785	http://dx.doi.org/10.1371/journal.pone.0233785			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC0EC	32521542	Green Published, gold			2022-12-26	WOS:000542969500008
J	Lewis, A; McCrossan, ZA; Manville, RW; Popa, MO; Cuello, LG; Goldstein, SAN				Lewis, Anthony; McCrossan, Zoe A.; Manville, Rian W.; Popa, M. Oana; Cuello, Luis G.; Goldstein, Steve A. N.			TOK channels use the two gates in classical K(+)channels to achieve outward rectification	FASEB JOURNAL			English	Article						Aspergillus; Candida; Cryptococcus; gating; potassium; selectivity	C-TYPE INACTIVATION; YEAST K+ CHANNEL; POTASSIUM-CHANNEL; PLASMA-MEMBRANE; SELECTIVITY FILTER; PORE DOMAINS; KILLER TOXIN; CRYSTAL-STRUCTURE; LEAK CHANNEL; ION	TOKs are outwardly rectifying K(+)channels in fungi with two pore-loops and eight transmembrane spans. Here, we describe the TOKs from four pathogens that cause the majority of life-threatening fungal infections in humans. These TOKs pass large currents only in the outward direction like the canonical isolate fromSaccharomyces cerevisiae(ScTOK), and distinct from other K(+)channels. ScTOK, AfTOK1 (Aspergillus fumigatus), and H99TOK (Cryptococcus neoformans grubii) are K+-selective and pass current above the K(+)reversal potential. CaTOK (Candida albicans) and CnTOK (Cryptococcus neoformans neoformans) pass both K(+)and Na(+)and conduct above a reversal potential reflecting the mixed permeability of their selectivity filter. Mutations in CaTOK and ScTOK at sites homologous to those that open the internal gates in classical K(+)channels are shown to produce inward TOK currents. A favored model for outward rectification is proposed whereby the reversal potential determines ion occupancy, and thus, conductivity, of the selectivity filter gate that is coupled to an imperfectly restrictive internal gate, permitting the filter to sample ion concentrations on both sides of the membrane.	[Lewis, Anthony] Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth, Hants, England; [McCrossan, Zoe A.] Univ Southampton, NIHR Evaluat Trials & Studies Coordinating Ctr NE, Southampton, Hants, England; [Manville, Rian W.] Univ Brighton, Sch Pharm & Biomol Sci, Brighton, E Sussex, England; [Popa, M. Oana] Univ Sussex, Sch Life Sci, Sussex Drug Discovery Ctr, Brighton, E Sussex, England; [Cuello, Luis G.] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Ctr Membrane Prot Res, Lubbock, TX 79430 USA; [Goldstein, Steve A. N.] Univ Calif Irvine, Dept Physiol & Biophys, Sch Med, Samueli Coll Hlth Sci, Irvine, CA 92717 USA; [Goldstein, Steve A. N.] Univ Calif Irvine, Dept Pediat, Sch Med, Samueli Coll Hlth Sci, Irvine, CA 92717 USA	University of Portsmouth; University of Southampton; University of Brighton; University of Sussex; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; University of California System; University of California Irvine; University of California System; University of California Irvine	Goldstein, SAN (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Sch Med, Susan & Henry Samueli Coll Hlth Sci, Irvine, CA 92697 USA.; Goldstein, SAN (corresponding author), Univ Calif Irvine, Dept Pediat, Sch Med, Susan & Henry Samueli Coll Hlth Sci, Irvine, CA 92697 USA.; Lewis, A (corresponding author), Univ Portsmouth, Sch Pharm & Biomed Sci, Inst Biol & Biomed Sci, Portsmouth PO1 2DT, Hants, England.	anthony.lewis@port.ac.uk; sgoldst2@uci.edu	; Goldstein, Steven A./E-9817-2015	Manville, Rian/0000-0002-0057-3541; Goldstein, Steven A./0000-0001-5207-5061; Popa, Mariana Oana/0000-0002-2766-6801	HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) [RO1NS58505]; HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [RO1HL61657]; Biotechnology and Biological Sciences Research Council [BB/J006114/1]; HHS NIH National Institute of General Medical Sciences (NIGMS) [RO1GM097159]; BBSRC [BB/J006114/1] Funding Source: UKRI	HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS); HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); HHS NIH National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS), Grant/Award Number: RO1NS58505; HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: RO1HL61657; Biotechnology and Biological Sciences Research Council, Grant/Award Number: BB/J006114/1; HHS NIH National Institute of General Medical Sciences (NIGMS), Grant/Award Number: RO1GM097159	Ahmed A, 1999, CELL, V99, P283, DOI 10.1016/S0092-8674(00)81659-1; Ando H, 2005, J GEN PHYSIOL, V126, P529, DOI 10.1085/jgp.200509377; Aryal P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5377; Baev D, 2003, INFECT IMMUN, V71, P3251, DOI 10.1128/IAI.71.6.3251-3260.2003; Bagriantsev SN, 2011, EMBO J, V30, P3594, DOI 10.1038/emboj.2011.230; Ben Soussia I, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08710-3; Ben-Abu Y, 2009, NAT STRUCT MOL BIOL, V16, P71, DOI 10.1038/nsmb.1525; Berneche S, 2005, STRUCTURE, V13, P591, DOI 10.1016/j.str.2004.12.019; Bertl A, 1998, J MEMBRANE BIOL, V162, P67, DOI 10.1007/s002329900343; Bichet D, 2006, P NATL ACAD SCI USA, V103, P14355, DOI 10.1073/pnas.0606660103; Brettmann JB, 2015, P NATL ACAD SCI USA, V112, P15366, DOI 10.1073/pnas.1515965112; Brohawn SG, 2013, P NATL ACAD SCI USA, V110, P2129, DOI 10.1073/pnas.1218950110; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Brown S, 2008, CELL PHYSIOL BIOCHEM, V22, P601, DOI 10.1159/000185544; Coonen L, 2020, BIOPHYS J, V118, P2612, DOI 10.1016/j.bpj.2020.03.032; Cuello LG, 2017, ELIFE, V6, DOI 10.7554/eLife.28032; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; DEMO SD, 1992, BIOPHYS J, V61, P639, DOI 10.1016/S0006-3495(92)81869-6; Diaz-Franulic I, 2015, J GEN PHYSIOL, V146, P133, DOI 10.1085/jgp.201411353; Dong YY, 2015, SCIENCE, V347, P1256, DOI 10.1126/science.1261512; Flynn GE, 2001, NEURON, V30, P689, DOI 10.1016/S0896-6273(01)00324-5; Goldstein SAN, 1998, J MOL MED-JMM, V76, P13, DOI 10.1007/s109-1998-8100-0; Goldstein SAN, 1996, P NATL ACAD SCI USA, V93, P13256, DOI 10.1073/pnas.93.23.13256; Guerrero-Galan C, 2018, ENVIRON MICROBIOL, V20, P1873, DOI 10.1111/1462-2920.14122; Heer FT, 2017, ELIFE, V6, DOI 10.7554/eLife.25844.001; Iwamoto M, 2011, J NEUROSCI, V31, P12180, DOI 10.1523/JNEUROSCI.1377-11.2011; Jensen MO, 2013, J GEN PHYSIOL, V141, P619, DOI 10.1085/jgp.201210820; Jia ZG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05970-3; Jiang YX, 2000, J GEN PHYSIOL, V115, P269, DOI 10.1085/jgp.115.3.269; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; KETCHUM KA, 1995, NATURE, V376, P690, DOI 10.1038/376690a0; Kopfer DA, 2014, SCIENCE, V346, P352, DOI 10.1126/science.1254840; Kollewe A, 2009, J GEN PHYSIOL, V134, P53, DOI 10.1085/jgp.200910235; Labro AJ, 2018, P NATL ACAD SCI USA, V115, P5426, DOI 10.1073/pnas.1800559115; Lengyel M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197622; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; Lesage F, 1996, J BIOL CHEM, V271, P4183; Li J, 2018, J GEN PHYSIOL, V150, P1408, DOI 10.1085/jgp.201812082; Lolicato M, 2014, NEURON, V84, P1198, DOI 10.1016/j.neuron.2014.11.017; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; Loukin SH, 1999, BIOPHYS J, V77, P3060, DOI 10.1016/S0006-3495(99)77137-7; Loukin SH, 2002, P NATL ACAD SCI USA, V99, P1926, DOI 10.1073/pnas.042538599; Loukin SH, 1997, EMBO J, V16, P4817, DOI 10.1093/emboj/16.16.4817; Ma XY, 2011, J BIOL CHEM, V286, P39813, DOI 10.1074/jbc.M111.264788; Maresova L, 2006, FEMS YEAST RES, V6, P1039, DOI 10.1111/j.1567-1364.2006.00140.x; Matulef K, 2016, STRUCTURE, V24, P750, DOI 10.1016/j.str.2016.02.021; Matulef K, 2013, P NATL ACAD SCI USA, V110, P17886, DOI 10.1073/pnas.1314356110; MILLER C, 1982, BIOPHYS J, V38, P227, DOI 10.1016/S0006-3495(82)84552-9; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Pan AC, 2011, J GEN PHYSIOL, V138, P571, DOI 10.1085/jgp.201110670; Piechotta PL, 2011, EMBO J, V30, P3607, DOI 10.1038/emboj.2011.268; Prole DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042404; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Rapedius M, 2012, CHANNELS, V6, P473, DOI 10.4161/chan.22153; Roberts SK, 2003, EUKARYOT CELL, V2, P181, DOI 10.1128/EC.2.1.181-190.2003; Roller A, 2005, PFLUG ARCH EUR J PHY, V451, P362, DOI 10.1007/s00424-005-1418-2; Roller A, 2008, PFLUG ARCH EUR J PHY, V456, P883, DOI 10.1007/s00424-008-0446-0; Schewe M, 2016, CELL, V164, P937, DOI 10.1016/j.cell.2016.02.002; Sesti F, 2001, CELL, V105, P637, DOI 10.1016/S0092-8674(01)00376-2; Sesti F, 2001, BIOPHYS J, V80, p446A; Shiraki Y, 2006, J MED MICROBIOL, V55, P1175, DOI 10.1099/jmm.0.46632-0; Squeo RF, 1998, J AM ACAD DERMATOL, V39, P379, DOI 10.1016/S0190-9622(98)70396-2; Thompson AN, 2009, NAT STRUCT MOL BIOL, V16, P1317, DOI 10.1038/nsmb.1703; Tilegenova C, 2019, P NATL ACAD SCI USA, V116, P16829, DOI 10.1073/pnas.1901888116; Tsukamoto H, 2018, J BIOL CHEM, V293, P6969, DOI 10.1074/jbc.RA118.001817; Ye S, 2010, NAT STRUCT MOL BIOL, V17, P1019, DOI 10.1038/nsmb.1865; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; Zheng J, 1997, J GEN PHYSIOL, V110, P101, DOI 10.1085/jgp.110.2.101; ZHOU XL, 1995, FEBS LETT, V373, P170, DOI 10.1016/0014-5793(95)01035-D; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zilberberg N, 2001, NEURON, V32, P635, DOI 10.1016/S0896-6273(01)00503-7	74	1	1	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					8902	8919		10.1096/fj.202000545R	http://dx.doi.org/10.1096/fj.202000545R		JUN 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32519783	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000539526300001
J	Jones, SI; Hunt, MR; Vodkin, LO				Jones, Sarah I.; Hunt, Matt R.; Vodkin, Lila O.			An embryo lethal transgenic line manifests global expression changes and elevated protein/oil ratios in heterozygous soybean plants	PLOS ONE			English	Article							BOVINE BETA-CASEIN; SOY PROTEIN; BIOLISTIC TRANSFORMATION; GENE FAMILY; MAIZE; ORGANIZATION; SEQUENCE; MUTANTS	Understanding the molecular processes of seed development is important especially in agronomic crops that produce large amounts of nutrient reserves. Because soybean is a vital source of vegetable protein worldwide, producers are concerned about increasing the total amount of protein in the seed without substantially lowering the amount of oil, another economically important product. Here we describe a transgenic soybean line with increased protein and protein/oil ratio, containing an average of 42.2% protein vs. 38.5% in controls and with a protein/oil ratio of 2.02 vs. 1.76 in controls over several generations of greenhouse growth. Other phenotypic data show that the seeds are heavier, although there are overall lower yields per plant. We postulate these effects result from insertion site mutagenesis by the transgenic construct. As this line never achieves homozygosity and appears to be embryo lethal when homozygous, one functional copy of the gene is most likely essential for normal seed development. Global transcript analyses using RNA-Seq for 88,000 gene models over two stages of cotyledon development revealed that more genes are over-expressed in the transgenic line including ribosomal protein related genes and those in the membrane protein and transporters families. Localization of the insertion site should reveal the genes and developmental program that has been perturbed by the transgenic construct, resulting in this economically interesting increase in protein and the protein/oil ratio.	[Jones, Sarah I.; Hunt, Matt R.; Vodkin, Lila O.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Vodkin, LO (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	l-vodkin@illinois.edu			United Soybean Board; University of Illinois Foundation through the Charles Adlai Ewing Chair; Illinois Soybean Association; University of Illinois Foundation	United Soybean Board; University of Illinois Foundation through the Charles Adlai Ewing Chair; Illinois Soybean Association; University of Illinois Foundation	Funded by grants from the United Soybean Board (https://www.unitedsoybean.org/to LV and by University of Illinois Foundation support to LV through the Charles Adlai Ewing Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the High Throughput Sequencing Center at the University of Illinois (Dr. Alvaro Hernandez and staff) for the RNA-Seq and small RNA sequencing and Dr. Mark Band of the Keck Functional Genomics Unit for assistance with the digital PCR. We acknowledge financial support from United Soybean Board, Illinois Soybean Association, and the University of Illinois Foundation.	Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Barakat A, 2001, PLANT PHYSIOL, V127, P398, DOI 10.1104/pp.010265; Beilinson V, 2002, THEOR APPL GENET, V104, P1132, DOI 10.1007/s00122-002-0884-6; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brunelle DC, 2017, G3-GENES GENOM GENET, V7, P3559, DOI 10.1534/g3.117.300293; Carranco R, 2010, P NATL ACAD SCI USA, V107, P21908, DOI 10.1073/pnas.1014856107; Chien KB, 2014, J BIOMATER APPL, V28, P1085, DOI 10.1177/0885328213497413; COATES JB, 1985, ARCH BIOCHEM BIOPHYS, V243, P184, DOI 10.1016/0003-9861(85)90787-8; Dellaporta S., 1994, MAIZE HDB, P776, DOI [10.1007/978-1-4612-2694-9, DOI 10.1007/978-1-4612-2694-9]; Dong XL, 2004, NUCLEIC ACIDS RES, V32, pW660, DOI 10.1093/nar/gkh410; Dreher KA, 2006, PLANT CELL, V18, P699, DOI 10.1105/tpc.105.039172; Dresselhaus T, 1999, MOL GEN GENET, V261, P416, DOI 10.1007/s004380050983; Dube S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002876; Finer JJ., 1991, IN VITRO CELL DEV-PL, V27, P175, DOI [10.1007/bf02632213, DOI 10.1007/BF02632213, 10.2307/4292952]; Forrest KL, 2007, FUNCT INTEGR GENOMIC, V7, P263, DOI 10.1007/s10142-007-0049-4; GORDONKAMM WJ, 1990, PLANT CELL, V2, P603, DOI 10.1105/tpc.2.7.603; Hamasaki H, 2012, MOL PLANT, V5, P461, DOI 10.1093/mp/ssr088; Herman EM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00437; Heuze V., 2017, SOYBEAN MEAL; Hu TT, 2018, PLANT CELL REP, V37, P1667, DOI 10.1007/s00299-018-2338-x; Hunt MR, 2009, THESIS; Jones SI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059270; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LARKIN JC, 1989, GENE DEV, V3, P500, DOI 10.1101/gad.3.4.500; Linzey, 1995, PACE ENV LAW REV, V13, P255; Liu JN, 2019, PLANT CELL, V31, P368, DOI 10.1105/tpc.18.00613; Luo J, 2018, INT J MOL SCI, V19; Maughan PJ, 1999, IN VITRO CELL DEV-PL, V35, P344; McALISTER DEAN F., 1958, AGRON JOUR, V50, P674; McCarty DR, 1986, MAIZE GEN COOP NEWSL, V60, P61; Meinke D, 2008, TRENDS PLANT SCI, V13, P483, DOI 10.1016/j.tplants.2008.06.003; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muralla R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028398; NEUFFER MG, 1980, GENETICS, V95, P929; NIELSEN NC, 1989, PLANT CELL, V1, P313, DOI 10.1105/tpc.1.3.313; PARROTT WA, 1994, IN VITRO CELL DEV-PL, V30P, P144; Paul G, 2015, J AM COLL NUTR, V34, P56, DOI 10.1080/07315724.2015.1080531; Pelletier JM, 2017, P NATL ACAD SCI USA, V114, pE6710, DOI 10.1073/pnas.1707957114; Philip R, 2001, PLANT SCI, V161, P323, DOI 10.1016/S0168-9452(01)00420-4; Ploense SE, 2009, DEVELOPMENT, V136, P1509, DOI 10.1242/dev.025932; Prieto-Dapena P, 2006, PLANT PHYSIOL, V142, P1102, DOI 10.1104/pp.106.087817; Rotundo JL, 2009, FIELD CROP RES, V112, P90, DOI 10.1016/j.fcr.2009.02.004; Santarem ER, 1999, IN VITRO CELL DEV-PL, V35, P451, DOI 10.1007/s11627-999-0067-0; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schuurmans JAMJ, 2003, PLANT MOL BIOL, V53, P655, DOI 10.1023/B:PLAN.0000019070.60954.77; Sha AH, 2012, MOL BIOL REP, V39, P2867, DOI 10.1007/s11033-011-1046-1; Shamimuzzaman M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194596; Singh P, 2008, COMPR REV FOOD SCI F, V7, P14, DOI 10.1111/j.1541-4337.2007.00025.x; Su LY, 2014, PLANT CELL PHYSIOL, V55, P1969, DOI 10.1093/pcp/pcu124; Tan XY, 2017, BIOCHEM BIOPH RES CO, V491, P794, DOI 10.1016/j.bbrc.2017.07.059; UNITED STATES DEPARTMENT OF AGRICULTURE NATIONAL AGRICULTURAL STATISTICS SERVICE-USDA, 2019, CROP PRODUCTION; USDA, 2015, USDA COEX FACT SHEET; USDA, 2019, CROP VAL 2018 SUMM; VANLIJSEBETTENS M, 1994, EMBO J, V13, P3378, DOI 10.1002/j.1460-2075.1994.tb06640.x; WILLIAMS ME, 1995, PLANT J, V8, P65, DOI 10.1046/j.1365-313X.1995.08010065.x; Zhang J, 2013, ACTA BIOCH BIOPH SIN, V45, P104, DOI 10.1093/abbs/gms096	56	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2020	15	6							e0233721	10.1371/journal.pone.0233721	http://dx.doi.org/10.1371/journal.pone.0233721			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ1GC	32516314	Green Published, gold			2022-12-26	WOS:000540977000002
J	Osorio, CRWD; Teixeira, GCM; Barreto, RF; Campos, CNS; Leal, AJF; Teodoro, PE; Prado, RD				de Souza Osorio, Christian Rones Wruck; Marques Teixeira, Gelza Carliane; Barreto, Rafael Ferreira; Silva Campos, Cid Naudi; Freitas Leal, Aguinaldo Jose; Teodoro, Paulo Eduardo; de Mello Prado, Renato			Macronutrient deficiency in snap bean considering physiological, nutritional, and growth aspects	PLOS ONE			English	Article							NITROGEN APPLICATION; GAS-EXCHANGE; PHOTOSYNTHESIS; CHLOROPHYLLS; RESPONSES; CALCIUM; LEAVES; SULFUR	Nutritional deficiencies limit the growth of snap bean plants, therefore knowing the biological mechanisms involved in it is fundamental. This study is aimed to evaluate the damage caused by a deficiency of macronutrients in physiological variables that cause decreased growth and the appearance of visual symptoms in snap bean. Thus, we design a hydroponic system of snap bean cultivation in order to test the effect of macronutrient deficiencies in a controlled environment. The treatments consisted in evaluate the effects of lack of one macronutrient in time. To perform this, we used Hoagland and Arnon solution in its complete formulation (control) or without N, P; K; Mg, Ca or S in each treatment. Physiological, nutritional, and growth analyses were performed when visual deficiency symptoms of each omitted nutrient appeared. Thus, the omissions of N and P in the nutrient solution led to lower accumulations of all macronutrients in the shoot. And the K, Ca, Mg, and S omissions decreased the amounts of K, Ca, Mg, P, and S in the shoot of the snap bean plants when compared with the plants grown in the complete nutrient solution. With the lowest accumulation of macronutrients, the content of photosynthetic pigments and the photosynthetic rate were reduced, with harmful effects on plant growth. Thus, from the losses in dry matter production of the shoot, the order of limiting of macronutrients in bean plants was N < P < Ca < S < Mg < K, with a decrease of up to 86.2%, 80.1%, 51.2%, 46.5%, 25.6%, and 19.3%, respectively. The nitrogen deficiency is more evident, proven by symptoms such as chlorosis in the lower and upper third leaves and necrosis of the lower third leaves.	[de Souza Osorio, Christian Rones Wruck; Silva Campos, Cid Naudi; Teodoro, Paulo Eduardo] Fed Univ Mato Grosso Sul UFMS, Chapadao Do Sul, MS, Brazil; [Marques Teixeira, Gelza Carliane; Barreto, Rafael Ferreira; de Mello Prado, Renato] Sao Paulo State Univ UNESP, Dept Soils & Fertilizers, Lab Plant Nutr, Jaboticabal, SP, Brazil; [Freitas Leal, Aguinaldo Jose] Fed Univ Triangulo Mineiro UFTM, Iturama, MG, Brazil	Universidade Federal de Mato Grosso do Sul; Universidade Estadual Paulista; Universidade Federal do Triangulo Mineiro	Teodoro, PE (corresponding author), Fed Univ Mato Grosso Sul UFMS, Chapadao Do Sul, MS, Brazil.	eduteodoro@hotmail.com	Teixeira, Gelza Carliane Marques/ABG-9313-2020; Campos, Cid Naudi Silva/I-7063-2015; Barreto, Rafael Ferreira/N-1215-2015; de Mello Prado, Renato/K-9947-2015	Teixeira, Gelza Carliane Marques/0000-0002-8062-482X; Campos, Cid Naudi Silva/0000-0001-6810-885X; Barreto, Rafael Ferreira/0000-0002-1170-5386; de Mello Prado, Renato/0000-0003-1998-6343; TEODORO, PAULO/0000-0002-8236-542X	UFMS (Federal University of Mato Grosso do Sul); CAPES [001]; CNPq (National Council for Scientific and Technological Development)	UFMS (Federal University of Mato Grosso do Sul); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors thank UFMS (Federal University of Mato Grosso do Sul), CAPES Financial Code 001 (Brazilian Federal Agency for Support and Evaluation of Graduate Education) and CNPq (National Council for Scientific and Technological Development) for their financial support.	Akram M, 2011, RUSS J PLANT PHYSL+, V58, P394, DOI 10.1134/S1021443711030022; Barbosa J, 2020, AGROSTAT SISTEMA ANA; Bataglia O. C., 1983, METODOS ANALISE QUIM; Beshir H. M., 2015, African Journal of Agricultural Research, V10, P3157; Cakmak I., 2010, Better Crops with Plant Food, V94, P23; Calderon-Vazquez C, 2011, PLANT PHYSIOL, V156, P1067, DOI 10.1104/pp.111.174987; Cavalcante VS, 2019, HORTSCIENCE, V54, P738, DOI 10.21273/HORTSCI13807-18; Favaro SP, 2007, SCI AGR, V64, P616, DOI 10.1590/S0103-90162007000600009; Havaux M, 2014, PLANT J, V79, P597, DOI 10.1111/tpj.12386; Hepler PK, 2010, J INTEGR PLANT BIOL, V52, P147, DOI 10.1111/j.1744-7909.2010.00923.x; Hoagland D.R., 1950, WATER CULTURE METHOD, V347, P29; Imsande J, 1998, PHYSIOL PLANTARUM, V103, P139, DOI 10.1034/j.1399-3054.1998.1030117.x; Jin XL, 2016, J PLANT PHYSIOL, V198, P103, DOI 10.1016/j.jplph.2016.04.011; Leal R. M., 2008, Revista Brasileira de Ciencias Agrarias, V3, P301, DOI 10.5039/agraria.v3i4a322; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Mak M, 2014, ENVIRON EXP BOT, V98, P1, DOI 10.1016/j.envexpbot.2013.10.003; Prado R de M., 2020, NUTR PLANTAS; Reis AR, 2009, COMMUN SOIL SCI PLAN, V40, P1512, DOI 10.1080/00103620902820373; Santos KR, 2015, AQUAT BOT, V122, P47, DOI 10.1016/j.aquabot.2015.01.007; Seif Y. I. A., 2016, Annals of Agricultural Science (Cairo), V61, P187; Sun LL, 2016, J EXP BOT, V67, P3655, DOI 10.1093/jxb/erw188; Takahashi H, 2011, ANNU REV PLANT BIOL, V62, P157, DOI 10.1146/annurev-arplant-042110-103921; Verbruggen N, 2013, PLANT SOIL, V368, P87, DOI 10.1007/s11104-013-1589-0; Vicosi KA, 2020, J SOIL SCI PLANT NUT, V20, P917, DOI 10.1007/s42729-020-00178-1; Vysotskaya LB, 2016, ACTA PHYSIOL PLANT, V38, DOI 10.1007/s11738-016-2127-5; Winkler U, 2010, ANN BOT-LONDON, V106, P421, DOI 10.1093/aob/mcq120; Zhang XC, 2013, PHOTOSYNTHETICA, V51, P593, DOI 10.1007/s11099-013-0059-5	27	7	7	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2020	15	6							e0234512	10.1371/journal.pone.0234512	http://dx.doi.org/10.1371/journal.pone.0234512			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ0RE	32511280	gold, Green Published			2022-12-26	WOS:000540938100014
J	Shannon, AH; Elder, CT; Lu, GY; Su, G; Mast, A; Salmon, MD; Montgomery, WG; Spinosa, MD; Upchurch, GR; Sharma, AK				Shannon, Alexander H.; Elder, Craig T.; Lu, Guanyi; Su, Gang; Mast, Alexis; Salmon, Morgan D.; Montgomery, William G.; Spinosa, Michael D.; Upchurch, Gilbert R., Jr.; Sharma, Ashish K.			Pharmacologic inhibition of transient receptor channel vanilloid 4 attenuates abdominal aortic aneurysm formation	FASEB JOURNAL			English	Article						abdominal aortic aneurysms; aortic smooth muscle cells; endothelial cells; inflammation; TRPV4 channels	TRP CHANNELS; PRACTICE GUIDELINES; ACTIVATION; MODEL; INFLAMMATION; PROGRESSION; EXPRESSION; MORTALITY; DILATION; ARTERIAL	Abdominal aortic aneurysm (AAA) formation is characterized by inflammation, leukocyte infiltration, and vascular remodeling. This study investigates the role of TRPV4 channels, which are transmembrane calcium channels that can regulate vascular tone, in modulating AAA formation. The elastase-treatment model of AAA in C57BL6 (WT) mice and Angiotensin II treatment model in ApoE(-/-) mice were used to confirm our hypotheses. The administration of a specific TRPV4 antagonist, GSK2193874, in elastase-treated WT mice and in AngII-treated ApoE(-/-) mice caused a significant attenuation of aortic diameter, decrease in pro-inflammatory cytokines (IL-1 beta, IL-6, IL-17, MCP-1, MIP-1 alpha, MIP-2, RANTES, and TNF-alpha), inflammatory cell infiltration (CD3 + T cells, macrophages, and neutrophils), elastic fiber disruption, and an increase in smooth muscle cell alpha-actin expression compared to untreated mice. Similarly, elastase-treated TRPV4(-/-) mice had a significant decrease in AAA formation, aortic inflammation, and vascular remodeling compared to elastase-treated WT mice on Day 14. In vitro studies demonstrated that the inhibition of TRPV4 channels mitigates aortic smooth muscle cell-dependent inflammatory cytokine production as well as decreases neutrophil transmigration through aortic endothelial cells. Therefore, our results suggest that TRPV4 antagonism can attenuate aortic inflammation and remodeling via decreased smooth muscle cell activation and neutrophil transendothelial migration during AAA formation.	[Shannon, Alexander H.; Salmon, Morgan D.; Montgomery, William G.; Spinosa, Michael D.] Univ Virginia, Dept Surg, Charlottesville, VA USA; [Elder, Craig T.; Lu, Guanyi; Su, Gang; Mast, Alexis; Upchurch, Gilbert R., Jr.; Sharma, Ashish K.] Univ Florida, Dept Surg, POB 100128, Gainesville, FL 32610 USA	University of Virginia; State University System of Florida; University of Florida	Sharma, AK (corresponding author), Univ Florida, Dept Surg, POB 100128, Gainesville, FL 32610 USA.	ashish.sharma@surgery.ufl.edu		Sharma, Ashish/0000-0002-1234-6039	National Institutes of Health [RO1 HL081629, RO1 HL138931]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health, Grant/Award Number: RO1 HL081629 and RO1 HL138931	Anguita E, 2017, BBA-MOL CELL RES, V1864, P915, DOI 10.1016/j.bbamcr.2016.10.022; Azar D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192032; BICKERSTAFF LK, 1982, SURGERY, V92, P1103; Brady AR, 2004, CIRCULATION, V110, P16, DOI 10.1161/01.CIR.0000133279.07468.9F; Brophy C M, 1991, Ann Vasc Surg, V5, P229, DOI 10.1007/BF02329378; Cao RY, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00009; Chaikof EL, 2018, J VASC SURG, V67, P2, DOI 10.1016/j.jvs.2017.10.044; Chaikof EL, 2009, J VASC SURG, V50, P880, DOI 10.1016/j.jvs.2009.07.001; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Colonnello JS, 2003, J VASC SURG, V38, P138, DOI 10.1016/S0741-5214(03)00125-3; Cullen JM, 2019, J VASC SURG, V70, P252, DOI 10.1016/j.jvs.2018.09.057; Earley S, 2005, CIRC RES, V97, P1270, DOI 10.1161/01.RES.0000194321.60300.d6; Earley S, 2009, AM J PHYSIOL-HEART C, V297, pH1096, DOI 10.1152/ajpheart.00241.2009; Fashandi AZ, 2018, SURGERY, V163, P397, DOI 10.1016/j.surg.2017.10.003; Firth AL, 2007, BBA-MOL BASIS DIS, V1772, P895, DOI 10.1016/j.bbadis.2007.02.009; FREESTONE T, 1995, ARTERIOSCL THROM VAS, V15, P1145, DOI 10.1161/01.ATV.15.8.1145; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Ihara M, 1999, HYPERTENSION, V33, P1399, DOI 10.1161/01.HYP.33.6.1399; Johnston WF, 2014, CIRCULATION, V130, pS51, DOI 10.1161/CIRCULATIONAHA.113.006800; Johnston WF, 2013, ARTERIOSCL THROM VAS, V33, P294, DOI 10.1161/ATVBAHA.112.300432; Karthikesalingam A, 2014, LANCET, V383, P963, DOI 10.1016/S0140-6736(14)60109-4; Laser A, 2012, J SURG RES, V178, P1038, DOI 10.1016/j.jss.2012.04.073; Lederle FA, 2000, ARCH INTERN MED, V160, P1425, DOI 10.1001/archinte.160.10.1425; Lu GY, 2017, J VASC SURG, V66, P232, DOI 10.1016/j.jvs.2016.07.105; Mittal M, 2017, CIRC RES, V121, P1081, DOI 10.1161/CIRCRESAHA.117.311747; Moll FL, 2011, EUR J VASC ENDOVASC, V41, pS1, DOI 10.1016/j.ejvs.2010.09.011; NEWMAN KM, 1994, CIRCULATION, V90, P224; Nilius B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-218; Nordon IM, 2011, NAT REV CARDIOL, V8, P92, DOI 10.1038/nrcardio.2010.180; Norman PE, 2004, BRIT MED J, V329, P1259, DOI 10.1136/bmj.38272.478438.55; Orandi BJ, 2014, CURRENT SURG THERAPY, P777; Pope NH, 2016, FASEB J, V30, P4192, DOI 10.1096/fj.201600144RR; Pope NH, 2015, ANN THORAC SURG, V100, P1620, DOI 10.1016/j.athoracsur.2015.05.009; Powell JT, 1998, LANCET, V352, P1649; Sharma AK, 2016, ARTERIOSCL THROM VAS, V36, P908, DOI 10.1161/ATVBAHA.116.307373; Sharma AK, 2012, CIRCULATION, V126, pS38, DOI 10.1161/CIRCULATIONAHA.111.083451; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Sonkusare SK, 2012, SCIENCE, V336, P597, DOI 10.1126/science.1216283; Spinosa M, 2018, CIRCULATION, V138; Spinosa M, 2018, FASEB J, V32, P6038, DOI 10.1096/fj.201701138RR; Sullivan MN, 2013, AM J PHYSIOL-CELL PH, V305, pC999, DOI 10.1152/ajpcell.00273.2013; Thorneloe KS, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004276; Tykocki T, 2015, ASIAN J NEUROSURG, V2, P1031; VanderLaan PA, 2005, J LIPID RES, V46, P829, DOI 10.1194/jlr.R500003-JLR200; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Yang XR, 2006, AM J PHYSIOL-LUNG C, V290, pL1267, DOI 10.1152/ajplung.00515.2005; Yin J, 2008, CIRC RES, V102, P966, DOI 10.1161/CIRCRESAHA.107.168724; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Yue ZC, 2015, AM J PHYSIOL-HEART C, V308, pH157, DOI 10.1152/ajpheart.00457.2014; Zhang DX, 2011, J CARDIOVASC PHARM, V57, P133, DOI 10.1097/FJC.0b013e3181fd35d1; Zhang DX, 2009, HYPERTENSION, V53, P532, DOI 10.1161/HYPERTENSIONAHA.108.127100; Zhang P, 2018, HYPERTENSION, V71, P134, DOI 10.1161/HYPERTENSIONAHA.117.09767; Zhang Z, 2012, CIRC RES, V111, P1137, DOI 10.1161/CIRCRESAHA.112.273755	53	3	3	3	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9787	9801		10.1096/fj.202000251R	http://dx.doi.org/10.1096/fj.202000251R		JUN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32506673	Bronze, Green Accepted			2022-12-26	WOS:000539604700001
J	Katz, DC; Aponte, JD; Liu, W; Green, RM; Mayeux, JM; Pollard, KM; Pomp, D; Munger, SC; Murray, SA; Roseman, CC; Percival, CJ; Cheverud, J; Marcucio, RS; Hallgrimsson, B				Katz, David C.; Aponte, J. David; Liu, Wei; Green, Rebecca M.; Mayeux, Jessica M.; Pollard, K. Michael; Pomp, Daniel; Munger, Steven C.; Murray, Stephen A.; Roseman, Charles C.; Percival, Christopher J.; Cheverud, James; Marcucio, Ralph S.; Hallgrimsson, Benedikt			Facial shape and allometry quantitative trait locus intervals in the Diversity Outbred mouse are enriched for known skeletal and facial development genes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PRADER-WILLI-SYNDROME; CRANIOFACIAL MORPHOLOGY; BONE-DEVELOPMENT; GEOMETRIC SHAPE; MIXED-MODEL; EXPRESSION; GROWTH; MICE; SIZE	The biology of how faces are built and come to differ from one another is complex. Discovering normal variants that contribute to differences in facial morphology is one key to untangling this complexity, with important implications for medicine and evolutionary biology. This study maps quantitative trait loci (QTL) for skeletal facial shape using Diversity Outbred (DO) mice. The DO is a randomly outcrossed population with high heterozygosity that captures the allelic diversity of eight inbred mouse lines from three subspecies. The study uses a sample of 1147 DO animals (the largest sample yet employed for a shape QTL study in mouse), each characterized by 22 three-dimensional landmarks, 56,885 autosomal and X-chromosome markers, and sex and age classifiers. We identified 37 facial shape QTL across 20 shape principal components (PCs) using a mixed effects regression that accounts for kinship among observations. The QTL include some previously identified intervals as well as new regions that expand the list of potential targets for future experimental study. Three QTL characterized shape associations with size (allometry). Median support interval size was 3.5 Mb. Narrowing additional analysis to QTL for the five largest magnitude shape PCs, we found significant overrepresentation of genes with known roles in growth, skeletal and facial development, and sensory organ development. For most intervals, one or more of these genes lies within 0.25 Mb of the QTL's peak. QTL effect sizes were small, with none explaining more than 0.5% of facial shape variation. Thus, our results are consistent with a model of facial diversity that is influenced by key genes in skeletal and facial development and, simultaneously, is highly polygenic.	[Katz, David C.; Aponte, J. David; Liu, Wei; Green, Rebecca M.; Hallgrimsson, Benedikt] Univ Calgary, Alberta Childrens Hosp, Res Inst, Dept Cell Biol & Anat, Calgary, AB, Canada; [Katz, David C.; Aponte, J. David; Liu, Wei; Green, Rebecca M.; Hallgrimsson, Benedikt] Univ Calgary, Cumming Sch Med, McCaig Bone & Joint Inst, Calgary, AB, Canada; [Mayeux, Jessica M.; Pollard, K. Michael] Scripps Res Inst, Dept Mol Med, La Jolla, CA USA; [Pomp, Daniel] Univ N Carolina, Dept Genet, Sch Med, Chapel Hill, NC 27515 USA; [Munger, Steven C.; Murray, Stephen A.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Roseman, Charles C.] Univ Illinois, Dept Evolut Ecol & Behav, Urbana, IL USA; [Percival, Christopher J.] SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA; [Cheverud, James] Loyola Univ, Dept Biol, Chicago, IL 60626 USA; [Marcucio, Ralph S.] Univ Calif San Francisco, Sch Med, Dept Orthopaed Surg, San Francisco, CA USA	Alberta Childrens Hospital; University of Calgary; University of Calgary; Scripps Research Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Jackson Laboratory; University of Illinois System; University of Illinois Urbana-Champaign; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Loyola University Chicago; University of California System; University of California San Francisco	Katz, DC; Hallgrimsson, B (corresponding author), Univ Calgary, Alberta Childrens Hosp, Res Inst, Dept Cell Biol & Anat, Calgary, AB, Canada.; Katz, DC; Hallgrimsson, B (corresponding author), Univ Calgary, Cumming Sch Med, McCaig Bone & Joint Inst, Calgary, AB, Canada.	david.katz@ucalgary.ca; bhallgri@ucalgary.ca	Roseman, Charles/AAL-6141-2021	Roseman, Charles/0000-0002-4589-0401; Katz, David/0000-0002-0827-5602	National Institutes of Health National Institute of Dental and Craniofacial Research [U01DE020054, R01DE019638, R01DE021708]; National Sciences and Engineering Research Council [238992-17]; National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [DK076050, DK087346, DK056350]; National Institutes of Health, National Institute of Environmental Research [R21ES024485]; March of Dimes [414-01]; Alberta Innovates Health Solutions; Alberta Children's Hospital Research Institute; Eyes High Doctoral Recruitment Scholarship	National Institutes of Health National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health, National Institute of Environmental Research; March of Dimes(March of Dimes); Alberta Innovates Health Solutions; Alberta Children's Hospital Research Institute; Eyes High Doctoral Recruitment Scholarship	To BH and RSM, National Institutes of Health National Institute of Dental and Craniofacial Research (https://www.nidcr.nih.gov/), Awards U01DE020054, R01DE019638, R01DE021708. To BH, National Sciences and Engineering Research Council (http://www.nserc-crsng.gc.ca/index_eng.asp), Award 238992-17. To DP, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (https://www.niddk.nih.gov/), Awards DK076050, DK087346, DK056350. To KMP, National Institutes of Health, National Institute of Environmental Research (https://www.niehs.nih.gov/), Award R21ES024485. To SAM, March of Dimes (https://www.marchofdimes.ca/EN/Pages/default.aspx), Award 414-01. To CJP, a postgraduate fellowship from Alberta Innovates Health Solutions (https://albertainnovates.ca/).To DCK, a postgraduate fellowship from Alberta Children's Hospital Research Institute (https://research4kids.ucalgary.ca/).To JDA, an Eyes High Doctoral Recruitment Scholarship (https://iac01.ucalgary.ca/FGSA/Public/SpecificAward.aspx?AwardID=5461).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11616; Adler D, **DATA OBJECT**; Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; [Anonymous], 2019, J ASIAN AM STUDIES, V22, P207; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2011, NUCLEIC ACIDS RES, V39, pD214; Barton NH, 2002, NAT REV GENET, V3, P11, DOI 10.1038/nrg700; Baud A, 2013, NAT GENET, V45, P767, DOI 10.1038/ng.2644; Bookstein FL, 2017, AM J PHYS ANTHROPOL, V164, P221, DOI 10.1002/ajpa.23277; Bressler J, 2001, NAT GENET, V28, P232, DOI 10.1038/90067; Broman KW, 2019, G3-GENES GENOM GENET, V9, P1571, DOI 10.1534/g3.119.400165; Broman KW, 2019, GENETICS, V211, P495, DOI 10.1534/genetics.118.301595; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Cerny R, 2010, P NATL ACAD SCI USA, V107, P17262, DOI 10.1073/pnas.1009304107; Cha S, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4865-9; Cheng RY, 2013, G3-GENES GENOM GENET, V3, P1861, DOI 10.1534/g3.113.007948; Chesler EJ, 2016, G3-GENES GENOM GENET, V6, P3893, DOI 10.1534/g3.116.035527; Cheverud JM, 2008, P NATL ACAD SCI USA, V105, P4253, DOI 10.1073/pnas.0706562105; Cheverud JM, 1997, EVOLUTION, V51, P2006, DOI [10.1111/j.1558-5646.1997.tb05122.x, 10.2307/2411021]; CHEVERUD JM, 1982, AM J PHYS ANTHROPOL, V59, P139, DOI 10.1002/ajpa.1330590204; CHURCHILL GA, 1994, GENETICS, V138, P963; Churchill GA, 2012, MAMM GENOME, V23, P713, DOI 10.1007/s00335-012-9414-2; Claes P, 2018, NAT GENET, V50, P414, DOI 10.1038/s41588-018-0057-4; Clayton-Smith J, 2011, AM J HUM GENET, V89, P675, DOI 10.1016/j.ajhg.2011.10.008; Cole J, 2017, ELS; Cole JB, 2017, GENETICS, V205, P967, DOI 10.1534/genetics.116.193185; Cole JB, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006174; Crouch DJM, 2018, P NATL ACAD SCI USA, V115, pE676, DOI 10.1073/pnas.1708207114; de Koning DJ, 2002, GENETICS, V161, P931; de los Campos G, 2018, TRENDS GENET, V34, P746, DOI 10.1016/j.tig.2018.07.004; Didion JP, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004850; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Falconer DS, 2009, INTRO QUANTITATIVE G, DOI [10.1038/ng.352, DOI 10.1038/NG.352]; Flint J, 2012, NAT REV GENET, V13, P807, DOI 10.1038/nrg3335; Francis-West P, 2016, ELS, P1; French JE, 2015, ENVIRON HEALTH PERSP, V123, P237, DOI 10.1289/ehp.1408202; Gatti DM, 2014, G3-GENES GENOM GENET, V4, P1623, DOI 10.1534/g3.114.013748; Goios A, 2007, GENOME RES, V17, P293, DOI 10.1101/gr.5941007; Gray TA, 1999, P NATL ACAD SCI USA, V96, P5616, DOI 10.1073/pnas.96.10.5616; Green RM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02037-7; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Hallgrimsson B, 2020, FACIAL SHAPE ALLOMET, DOI [10.25550/1-731C, DOI 10.25550/1-731C]; Hallgrimsson B, 2019, INTEGRATIVE COMP BIO; Hallgrimsson BA, 2019, AM J HUMAN GENETICS; Hallgrimsson B, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004724; Hallgrimsson B, 2009, EVOL BIOL, V36, P355, DOI 10.1007/s11692-009-9076-5; HOLM VA, 1993, PEDIATRICS, V91, P398; Hooper JE, 2017, DEV BIOL, V426, P97, DOI 10.1016/j.ydbio.2017.03.025; Hu D, 2009, DEVELOPMENT, V136, P107, DOI 10.1242/dev.026583; Huang W, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006421; Huh A, 2013, AM J ORTHOD DENTOFAC, V144, P568, DOI 10.1016/j.ajodo.2013.06.016; Iraqi FA, 2012, GENETICS, V190, P389, DOI 10.1534/genetics.111.132639; Jeong J, 2012, DEV DYNAM, V241, P1757, DOI 10.1002/dvdy.23867; JOLICOEUR PIERRE, 1960, GROWTH, V24, P339; Katz DC, 2017, P NATL ACAD SCI USA, V114, P9050, DOI 10.1073/pnas.1702586114; Katz DC, 2016, AM J PHYS ANTHROPOL, V160, P593, DOI 10.1002/ajpa.22896; Kawai S, 2018, J BONE MINER METAB, V36, P640, DOI 10.1007/s00774-017-0885-9; Kenney-Hunt JP, 2008, GENETICS, V178, P2275, DOI 10.1534/genetics.107.084434; Kim S, 2003, GENE DEV, V17, P1979, DOI 10.1101/gad.1119303; Klingenberg CP, 2004, GENETICS, V166, P1909, DOI 10.1534/genetics.166.4.1909; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Klingenberg CP, 2001, EVOLUTION, V55, P2342; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; Kobayashi S, 2002, BIOCHEM BIOPH RES CO, V290, P403, DOI 10.1006/bbrc.2001.6160; Krzanowski WJ, 2005, PRINCIPLES MULTIVARI; Lander, 1989, GENETICS, V121, P185; Larson JR, 2018, AM J PHYS ANTHROPOL, V165, P327, DOI 10.1002/ajpa.23356; Le Fevre AK, 2013, AM J MED GENET A, V161, P3166, DOI 10.1002/ajmg.a.36174; Le N, 2005, NAT NEUROSCI, V8, P932, DOI 10.1038/nn1490; Leamy LJ, 2008, HEREDITY, V101, P518, DOI 10.1038/hdy.2008.79; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Listgarten J, 2012, NAT METHODS, V9, P525, DOI 10.1038/nmeth.2037; Liu F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002932; Logan RW, 2013, GENES BRAIN BEHAV, V12, P424, DOI 10.1111/gbb.12029; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Maga AM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00092; Manichaikul A, 2006, GENETICS, V174, P481, DOI 10.1534/genetics.106.061549; Mardia KV, 2000, BIOMETRIKA, V87, P285, DOI 10.1093/biomet/87.2.285; Marroig G, 2012, EVOLUTION, V66, P1506, DOI 10.1111/j.1558-5646.2011.01555.x; Martin KM, 2001, MECH DEVELOP, V103, P149, DOI 10.1016/S0925-4773(01)00343-4; Mic FA, 2000, MECH DEVELOP, V97, P227, DOI 10.1016/S0925-4773(00)00434-2; Mitteroecker P, 2004, J HUM EVOL, V46, P679, DOI 10.1016/j.jhevol.2004.03.006; Mitteroecker P, 2007, SYST BIOL, V56, P818, DOI 10.1080/10635150701648029; Mitteroecker P, 2016, GENETICS, V202, P1345, DOI 10.1534/genetics.115.181339; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Morgan AP, 2016, G3-GENES GENOM GENET, V6, P263, DOI 10.1534/g3.115.022087; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; MOSIMANN JE, 1970, J AM STAT ASSOC, V65, P930, DOI 10.2307/2284599; Mrode R.A, 2014, LINEAR MODELS PREDIC; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nakashima M, 1998, ARCH ORAL BIOL, V43, P745, DOI 10.1016/S0003-9969(98)00046-6; Pacheco-Costa R, 2017, BONE, V97, P105, DOI 10.1016/j.bone.2017.01.010; Pallares LF, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005607; Pallares LF, 2014, MOL ECOL, V23, P5756, DOI 10.1111/mec.12968; Paternoster L, 2012, AM J HUM GENET, V90, P478, DOI 10.1016/j.ajhg.2011.12.021; Percival CJ, 2018, EVODEVO, V9, DOI 10.1186/s13227-018-0092-3; R Development Core Team, R LANG ENV STAT COMP; Rhee SY, 2008, NAT REV GENET, V9, P509, DOI 10.1038/nrg2363; Richmond S, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00462; Robinson G.K., 1991, STAT SCI, P15, DOI DOI 10.1214/SS/1177011926; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rohlf FJ, 1999, J CLASSIF, V16, P197, DOI 10.1007/s003579900054; Runcie DE, 2013, GENETICS, V194, P753, DOI 10.1534/genetics.113.151217; Sahni M, 1999, GENE DEV, V13, P1361, DOI 10.1101/gad.13.11.1361; Schlager S., 2017, STAT SHAPE DEFORMATI, P217; Sena K, 2003, J DENT RES, V82, P166, DOI 10.1177/154405910308200304; Shaffer JR, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006149; Shi C, 2008, BLOOD, V112, P4699, DOI 10.1182/blood-2008-01-137018; Shorter JR, 2018, MAMM GENOME, V29, P80, DOI 10.1007/s00335-017-9730-7; Smallwood TL, 2014, G3-GENES GENOM GENET, V4, P2353, DOI 10.1534/g3.114.014704; So PL, 1999, MECH DEVELOP, V84, P157, DOI 10.1016/S0925-4773(99)00058-1; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Svenson KL, 2012, GENETICS, V190, P437, DOI 10.1534/genetics.111.132597; Sybert VP, 2004, NEW ENGL J MED, V351, P1227, DOI 10.1056/NEJMra030360; Szabo-Rogers HL, 2010, DEV BIOL, V341, P84, DOI 10.1016/j.ydbio.2009.11.021; Tian J, 2010, AM J HUM GENET, V87, P768, DOI 10.1016/j.ajhg.2010.11.005; Tsagkrasoulis D, 2017, SCI REP-UK, V7, DOI 10.1038/srep45885; Unda FJ, 2003, HISTOL HISTOPATHOL, V18, P27, DOI 10.14670/HH-18.27; Varon-Gonzalez C, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00064; Varon-Gonzalez C, 2019, HEREDITY, V122, P501, DOI 10.1038/s41437-018-0140-8; Vecchione L, 2007, J DENT RES, V86, P1068, DOI 10.1177/154405910708601109; Vecchione L, 2010, ANAT REC, V293, P32, DOI 10.1002/ar.21024; Vimalraj S, 2015, INT J BIOL MACROMOL, V78, P202, DOI 10.1016/j.ijbiomac.2015.04.008; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Wilderman A, 2018, CELL REP, V23, P1581, DOI 10.1016/j.celrep.2018.03.129; Wilson DG, 2012, DEV BIOL, V363, P413, DOI 10.1016/j.ydbio.2012.01.005; Wolf JB, 2005, GENETICS, V171, P683, DOI 10.1534/genetics.104.038885; Xiao LP, 2004, J BIOL CHEM, V279, P27743, DOI 10.1074/jbc.M314323200; Xing WRR, 2017, BONE RES, V5, DOI 10.1038/boneres.2017.3; Yalcin B, 2005, GENETICS, V171, P673, DOI 10.1534/genetics.104.028902; Yang HN, 2011, NAT GENET, V43, P648, DOI 10.1038/ng.847; Yang J, 2014, NAT GENET, V46, P100, DOI 10.1038/ng.2876; Yokoyama S, 2009, DEV CELL, V17, P836, DOI 10.1016/j.devcel.2009.10.011; Yoshida T, 2010, DEV DYNAM, V239, P2558, DOI 10.1002/dvdy.22395; Young NM, 2010, DEVELOPMENT, V137, P3405, DOI 10.1242/dev.052340; Zelzer E, 2002, DEVELOPMENT, V129, P1893; Zhao HX, 2015, DEV BIOL, V398, P242, DOI 10.1016/j.ydbio.2014.12.007	137	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0233377	10.1371/journal.pone.0233377	http://dx.doi.org/10.1371/journal.pone.0233377			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502155	Green Submitted, gold, Green Published			2022-12-26	WOS:000542035700072
J	Lant, NJ; Hayward, AS; Peththawadu, MMD; Sheridan, KJ; Dean, JR				Lant, Neil J.; Hayward, Adam S.; Peththawadu, Madusha M. D.; Sheridan, Kelly J.; Dean, John R.			Microfiber release from real soiled consumer laundry and the impact of fabric care products and washing conditions	PLOS ONE			English	Article							MICROPLASTIC RELEASE; WASTE-WATER; FIBERS; POLYESTER; CONTAMINATION; TEXTILES; COTTON	Fiber release during domestic textile washing is a cause of marine microplastic pollution, but better understanding of the magnitude of the issue and role of fabric care products, appliances and washing cycles is needed. Soiled consumer wash loads from U.K. households were found to release a mean of 114 +/- 66.8 ppm (mg microfiber per kg fabric) (n = 79) fibers during typical washing conditions and these were mainly composed of natural fibers. Microfiber release decreased with increasing wash load size and hence decreasing water to fabric ratio, with mean microfiber release from wash loads in the mass range 1.0-3.5 kg (n = 57) found to be 132.4 +/- 68.6 ppm, significantly (p = 3.3 x 10(-8)) higher than the 66.3 +/- 27.0 ppm of those in the 3.5-6.0 kg range (n = 22). In further tests with similar soiled consumer wash loads, moving to colder and quicker washing cycles (i.e. 15 degrees C for 30 mins, as opposed to 40 degrees C for 85 mins) significantly reduced microfiber generation by 30% (p = 0.036) and reduced whiteness loss by 42% (p = 0.000) through reduced dye transfer and soil re-deposition, compared to conventional 40 degrees C cycles. In multicycle technical testing, detergent pods were selected for investigation and found to have no impact on microfiber release compared to washing in water alone. Fabric softeners were also found to have no direct impact on microfiber release in testing under both European and North American washing conditions. Extended testing of polyester fleece garments up to a 48-wash cycle history under European conditions found that microfiber release significantly reduced to a consistent low level of 28.7 +/- 10.9 ppm from eight through 64 washes. Emerging North American High-Efficiency top-loading washing machines generated significantly lower microfiber release than traditional top-loading machines, likely due to their lower water fill volumes and hence lower water to fabric ratio, with a 69.7% reduction observed for polyester fleece (n = 32, p = 7.9 x 10(-6)) and 37.4% reduction for polyester T-shirt (n = 32, p = 0.0032). These results conclude that consumers can directly reduce the levels of microfibers generated per wash during domestic textile washing by using colder and quicker wash cycles, washing complete (but not overfilled) loads, and (in North America) converting to High-Efficiency washing machines. Moving to colder and quicker cycles will also indirectly reduce microfiber release by extending the lifetime of clothing, leading to fewer new garments being purchased and hence lower incidence of the high microfiber release occurring during the first few washes of a new item.	[Lant, Neil J.; Hayward, Adam S.] Procter & Gamble, Newcastle Innovat Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Peththawadu, Madusha M. D.; Sheridan, Kelly J.; Dean, John R.] Northumbria Univ, Dept Appl Sci, Newcastle Upon Tyne, Tyne & Wear, England	Procter & Gamble; Northumbria University	Lant, NJ (corresponding author), Procter & Gamble, Newcastle Innovat Ctr, Newcastle Upon Tyne, Tyne & Wear, England.	lant.n@pg.com		Dean, John/0000-0001-5729-356X; Sheridan, Kelly/0000-0002-9389-3578; Lant, Neil/0000-0002-5939-0125	Procter Gamble	Procter Gamble(Procter & Gamble)	This work was sponsored by Procter & Gamble, a manufacturer of detergents and fabric softeners. The funder provided support in the form of salaries for N.J.L. and A.S.H. and decision to publish but did not have any additional role in the study design, data collection and analysis or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	A.I.S.E, 2013, CAS A I S E LOW TEMP; A.S.T.M, D62915 ASTM; Almroth BMC, 2018, ENVIRON SCI POLLUT R, V25, P1191, DOI 10.1007/s11356-017-0528-7; [Anonymous], 2018, LANCET HAEMATOL, V5, P378; Boucher J., 2017, PRIMARY MICROPLASTIC, P1; Browne MA, 2011, ENVIRON SCI TECHNOL, V45, P9175, DOI 10.1021/es201811s; Cesa FS, 2020, ENVIRON POLLUT, V257, DOI 10.1016/j.envpol.2019.113553; Cesa FS, 2017, SCI TOTAL ENVIRON, V598, P1116, DOI 10.1016/j.scitotenv.2017.04.172; De Falco F, 2019, POLYM DEGRAD STABIL, V165, P110, DOI 10.1016/j.polymdegradstab.2019.05.001; De Falco F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43023-x; De Falco F, 2018, EUR PHYS J PLUS, V133, DOI 10.1140/epjp/i2018-12123-x; De Falco F, 2018, ENVIRON POLLUT, V236, P916, DOI 10.1016/j.envpol.2017.10.057; Francesca D, 2018, CARBOHYD POLYM, V198, P175, DOI 10.1016/j.carbpol.2018.06.062; Hartline NL, 2016, ENVIRON SCI TECHNOL, V50, P11532, DOI 10.1021/acs.est.6b03045; Hernandez E, 2017, ENVIRON SCI TECHNOL, V51, P7036, DOI 10.1021/acs.est.7b01750; Hussain D, 2019, MAIL ONLINE; Jonsson C, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10072457; Kelly MR, 2019, ENVIRON SCI TECHNOL, V53, P11735, DOI 10.1021/acs.est.9b03022; Laitala K, 2015, INT J DES, V9, P93; McIlwraith HK, 2019, MAR POLLUT BULL, V139, P40, DOI 10.1016/j.marpolbul.2018.12.012; Michielssen MR, 2016, ENVIRON SCI-WAT RES, V2, P1064, DOI [10.1039/c6ew00207b, 10.1039/C6EW00207B]; Mishra S, 2019, MAR POLLUT BULL, V140, P188, DOI 10.1016/j.marpolbul.2019.01.039; Napper IE, 2016, MAR POLLUT BULL, V112, P39, DOI 10.1016/j.marpolbul.2016.09.025; Pirc U, 2016, ENVIRON SCI POLLUT R, V23, P22206, DOI 10.1007/s11356-016-7703-0; Sanchez-Vidal A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207033; Schopel B, 2019, TENSIDE SURFACT DET, V56, P94, DOI 10.3139/113.110610; Sharma G, 2005, COLOR RES APPL, V30, P21, DOI 10.1002/col.20070; Sillanpaa M, 2017, ENVIRON SCI POLLUT R, V24, P19313, DOI 10.1007/s11356-017-9621-1; Talvitie J, 2017, WATER RES, V109, P164, DOI 10.1016/j.watres.2016.11.046; Taylor ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep33997; Turner A, 2019, SCI TOTAL ENVIRON, V665, P568, DOI 10.1016/j.scitotenv.2019.02.025; Watt R, 2005, SCI JUSTICE, V45, P75, DOI 10.1016/S1355-0306(05)71632-4; Williams GH, 2017, CLINICAL AND TRANSLATIONAL SCIENCE: PRINCIPLES OF HUMAN RESEARCH, 2ND EDITION, P3, DOI 10.1016/B978-0-12-802101-9.00001-6; Woodall LC, 2015, MAR POLLUT BULL, V95, P40, DOI 10.1016/j.marpolbul.2015.04.044; Yang LB, 2019, ENVIRON POLLUT, V249, P136, DOI 10.1016/j.envpol.2019.03.011; Zambrano MC, 2019, MAR POLLUT BULL, V142, P394, DOI 10.1016/j.marpolbul.2019.02.062	36	19	19	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0233332	10.1371/journal.pone.0233332	http://dx.doi.org/10.1371/journal.pone.0233332			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502152	Green Accepted, gold, Green Published			2022-12-26	WOS:000542035700069
J	Allen, KL; Cann, J; Zhao, WG; Peterson, N; Lazzaro, M; Zhong, HH; Wu, HR; Dall'Acqua, WF; Borrok, MJ; Damschroder, MM; Tsui, P; Li, Q				Allen, Kevin L.; Cann, Jennifer; Zhao, Weiguang; Peterson, Norman; Lazzaro, Michelle; Zhong, Haihong; Wu, Herren; Dall'Acqua, William F.; Borrok, M. Jack; Damschroder, Melissa M.; Tsui, Ping; Li, Qing			Upregulation of annexin A1 protein expression in the intratumoral vasculature of human non-small-cell lung carcinoma and rodent tumor models	PLOS ONE			English	Article							GROWTH-FACTOR; IN-VIVO; TISSUE MICROENVIRONMENT; MEMBRANE ANTIGEN; PROSTATE-CANCER; A2 SYSTEM; ANTIBODY; ANGIOGENESIS; METASTASIS; DISRUPTION	Annexin A1 (anxA1) is an immunomodulatory protein that has been proposed as a tumor vascular target for antitumor biologic agents, yet to date the vascular expression of anxA1 in specific tumor indications has not been systematically assessed. Attempts to evaluate vascular anxA1 expression by immunohistochemistry are complicated by a lack of available antibodies that are both specific for anxA1 and bind the N-terminal-truncated form of anxA1 that has previously been identified in tumor vasculature. To study the vascular expression pattern of anxA1 in non-small-cell lung carcinoma (NSCLC), we isolated an antibody capable of binding N-terminal-truncated anxA1(27-346) and employed it in immunohistochemical studies of human lung specimens. Lung tumor specimens evaluated with this antibody revealed vascular (endothelial) anxA1 expression in five of eight tumor samples studied, but no vascular anxA1 expression was observed in normal lung tissue. Tumor microarray analysis further demonstrated positive vascular staining for anxA1 in 30 of 80 NSCLC samples, and positive staining of neoplastic cells was observed in 54 of 80 samples. No correlation was observed between vascular and parenchymal anxA1 expression. Two rodent tumor models, B16-F10 and Py230, were determined to have upregulated anxA1 expression in the intratumoral vasculature. These data validate anxA1 as a potential vascular anti-tumor target in a subset of human lung tumors and identify rodent models which demonstrate anxA1 expression in tumor vasculature.	[Allen, Kevin L.; Wu, Herren; Dall'Acqua, William F.; Borrok, M. Jack; Damschroder, Melissa M.; Tsui, Ping; Li, Qing] AstraZeneca Plc, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA; [Cann, Jennifer; Zhao, Weiguang; Peterson, Norman] AstraZeneca Plc, Dept Clin Pharmacol & Safety Sci, Gaithersburg, MD USA; [Lazzaro, Michelle; Zhong, Haihong] AstraZeneca Plc, AstraZeneca, Dept Oncol, Gaithersburg, MD USA	AstraZeneca	Li, Q (corresponding author), AstraZeneca Plc, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA.	qing.li@astrazeneca.com		, Michelle/0000-0001-7874-7428; Peterson, Norman/0000-0003-0568-0052	AstraZeneca	AstraZeneca(AstraZeneca)	AstraZeneca financed the submitted work. The funder provided support in the form of salaries for authors, however, did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alldridge LC, 2003, EXP CELL RES, V290, P93, DOI 10.1016/S0014-4827(03)00310-0; Alves VAF, 2008, HISTOPATHOLOGY, V53, P715, DOI 10.1111/j.1365-2559.2008.03186.x; [Anonymous], 2019, FRONTIERS PLANT SCI; Bander NH, 2003, SEMIN ONCOL, V30, P667, DOI 10.1016/S0093-7754(03)00358-0; Bao L, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0615-y; Belvedere R, 2016, SCI REP-UK, V6, DOI 10.1038/srep29660; Belvedere R, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-961; Bizzarro V, 2015, ONCOTARGET, V6, P25074, DOI 10.18632/oncotarget.4725; Borgstrom Per, 2013, F1000Res, V2, P129, DOI 10.12688/f1000research.2-129.v2; Boudhraa Z, 2014, ARCH DERMATOL RES, V306, P903, DOI 10.1007/s00403-014-1517-z; Boudhraa Z, 2016, CLIN SCI, V130, P205, DOI 10.1042/CS20150415; Boudhraa Z, 2014, CLIN EXP METASTAS, V31, P749, DOI 10.1007/s10585-014-9665-2; Brekken RA, 1998, CANCER RES, V58, P1952; Bridgeman VL, 2017, J PATHOL, V241, P362, DOI 10.1002/path.4845; Cano P, 2007, CANCER RES, V67, P511, DOI 10.1158/0008-5472.CAN-06-1478; Carson-Walter EB, 2001, CANCER RES, V61, P6649; Chang SS, 1999, CANCER RES, V59, P3192; Chatterjee BE, 2005, J LEUKOCYTE BIOL, V78, P639, DOI 10.1189/jlb.0405206; Chen F, 2014, SMALL, V10, P1887, DOI 10.1002/smll.201303627; Cheng TY, 2012, CANCER-AM CANCER SOC, V118, P5757, DOI 10.1002/cncr.27565; Chrenek MA, 2001, BREAST CANCER RES, V3, P224, DOI 10.1186/bcr300; Christensen MV, 2018, INT J ONCOL, V52, P5, DOI 10.3892/ijo.2017.4197; CHRISTMAS P, 1991, J BIOL CHEM, V266, P2499; D'Acquisto F, 2008, BRIT J PHARMACOL, V155, P152, DOI 10.1038/bjp.2008.252; de Graauw M, 2010, P NATL ACAD SCI USA, V107, P6340, DOI 10.1073/pnas.0913360107; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Elkin Michael, 2001, Curr Protoc Cell Biol, VChapter 19, DOI 10.1002/0471143030.cb1902s12; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Flood EC, 2011, VASC PHARMACOL, V54, P59, DOI 10.1016/j.vph.2011.03.003; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Foo SL, 2019, TRENDS MOL MED, V25, P315, DOI 10.1016/j.molmed.2019.02.004; Freites JA, 2004, LANGMUIR, V20, P11674, DOI 10.1021/la049713b; Gao YS, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-520; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Hayhoe RPG, 2006, BLOOD, V107, P2123, DOI 10.1182/blood-2005-08-3099; Hong H, 2012, ACS NANO, V6, P2361, DOI 10.1021/nn204625e; Kerbel RS, 2000, CARCINOGENESIS, V21, P505, DOI 10.1093/carcin/21.3.505; LIN Y, 2014, MED ONCOL, V31, DOI DOI 10.1007/S12032-014-0327-725412936; Lindskog C, 2015, EXPERT REV MOL DIAGN, V15, P471, DOI 10.1586/14737159.2015.1002772; Liu W, 2016, BIOL CHEM, V397, P1005, DOI 10.1515/hsz-2016-0166; Liu ZF, 2008, DRUG DEVELOP RES, V69, P329, DOI 10.1002/ddr.20265; Neri D, 2005, NAT REV CANCER, V5, P436, DOI 10.1038/nrc1627; Oh P, 2004, NATURE, V429, P629, DOI 10.1038/nature02580; Oh P, 2014, NAT MED, V20, P1062, DOI 10.1038/nm.3623; Patton KT, 2005, HISTOPATHOLOGY, V47, P597, DOI 10.1111/j.1365-2559.2005.02300.x; Paweletz CP, 2000, CANCER RES, V60, P6293; Pedrero JMG, 2004, AM J PATHOL, V164, P73, DOI 10.1016/S0002-9440(10)63098-2; Poeter M, 2013, BBA-MOL CELL RES, V1833, P1700, DOI 10.1016/j.bbamcr.2012.12.006; Rong BX, 2017, INT J BIOL MARKER, V32, pE132, DOI 10.5301/jbm.5000243; Rong BX, 2014, AM J TRANSL RES, V6, P558; Rong BX, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-70; Rosengarth A, 2001, J MOL BIOL, V306, P489, DOI 10.1006/jmbi.2000.4423; Sakaguchi M, 2007, J BIOL CHEM, V282, P35679, DOI 10.1074/jbc.M707538200; Sato Y, 2011, EXP THER MED, V2, P239, DOI 10.3892/etm.2011.210; Schmeichel KL, 1998, J MAMMARY GLAND BIOL, V3, P201, DOI 10.1023/A:1018751124382; Seaman S, 2017, CANCER CELL, V31, P501, DOI [10.1016/j.ccell.2017.03.005, DOI 10.1016/J.CCELL.2017.03.00528399408]; Seaman S, 2007, CANCER CELL, V11, P539, DOI 10.1016/j.ccr.2007.04.017; Seon BK, 2011, CURR DRUG DELIV, V8, P135; Siemann DW, 2011, CANCER TREAT REV, V37, P63, DOI 10.1016/j.ctrv.2010.05.001; Spurr L, 2011, INT IMMUNOPHARMACOL, V11, P55, DOI 10.1016/j.intimp.2010.10.006; St Croix B, 2000, SCIENCE, V289, P1197; Szabo V, 2015, J PATHOL, V235, P384, DOI 10.1002/path.4464; Thurber GM, 2008, ADV DRUG DELIVER REV, V60, P1421, DOI 10.1016/j.addr.2008.04.012; Vaughan TJ, 1996, NAT BIOTECHNOL, V14, P309, DOI 10.1038/nbt0396-309; Wernicke AG, 2011, ARCH PATHOL LAB MED, V135, P1486, DOI 10.5858/arpa.2010-0740-OA; Williams SL, 2010, J IMMUNOL, V185, P3057, DOI 10.4049/jimmunol.1000119; Yi M, 2009, P NATL ACAD SCI USA, V106, P17886, DOI 10.1073/pnas.0901324106; Zhang L, 2009, J ORAL PATHOL MED, V38, P362, DOI 10.1111/j.1600-0714.2008.00678.x; Zhang ZQ, 2013, WORLD J GASTROENTERO, V19, P7795, DOI 10.3748/wjg.v19.i43.7795	69	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0234268	10.1371/journal.pone.0234268	http://dx.doi.org/10.1371/journal.pone.0234268			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497150	Green Published, gold			2022-12-26	WOS:000542035200052
J	Chu, YW; Chien, CH; Sung, MI; Chen, CW; Chen, YT				Chu, Yen-Wei; Chien, Ching-Hsuan; Sung, Mei-, I; Chen, Chi-Wei; Chen, Yu-Ting			dBMHCC: A comprehensive hepatocellular carcinoma (HCC) biomarker database provides a reliable prediction system for novel HCC phosphorylated biomarkers	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE; CANCER; LIVER; GENE; CELL; PROLIFERATION; REARRANGEMENT; COMPLEX; PROTEIN; TARGET	Hepatocellular carcinoma (HCC), which is associated with an absence of obvious symptoms and poor prognosis, is the second leading cause of cancer death worldwide. Genome-wide molecular biology studies should provide biological insights into HCC development. Based on the importance of phosphorylation for signal transduction, several protein kinase inhibitors have been developed that improve the survival of cancer patients. However, a comprehensive database of HCC-related phosphorylated biomarkers (HCCPMs) and novel HCCPMs prediction platform has been lacking. We have thus constructed the dBMHCC databases to provide expression profiles, phosphorylation and drug information, and evidence type; gathered information on HCC-related pathways and their involved genes as candidate HCC biomarkers; and established a system for evaluating protein phosphorylation and HCC-related biomarkers to improve the reliability of biomarker prediction. The resulting dBMHCC contains 611 notable HCC-related genes, 234 HCC-related pathways, 17 phosphorylation-related motifs and their 255 corresponding protein kinases, 5955 HCC biomarkers, and 1077 predicted HCCPMs. Methionine adenosyltransferase 2B (MAT2B) and acireductone dioxygenase 1 (ADI1), which regulate HCC development and hepatitis C virus infection, respectively, were among the top 10 HCCPMs predicted by dBMHCC. Platelet-derived growth factor receptor alpha (PDGFRA), which had the highest evaluation score, was identified as the target of one HCC drug (Regorafenib), five cancer drugs, and four non-cancer drugs. dBMHCC is an open resource for HCC phosphorylated biomarkers, which supports researchers investigating the development of HCC and designing novel diagnosis methods and drug treatments. Database URL: http://predictor.nchu.edu.tw/dBMHCC.	[Chu, Yen-Wei; Chien, Ching-Hsuan; Sung, Mei-, I; Chen, Chi-Wei; Chen, Yu-Ting] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung, Taiwan; [Chu, Yen-Wei; Chen, Yu-Ting] Natl Chung Hsing Univ, Biotechnol Ctr, Taichung, Taiwan; [Chu, Yen-Wei; Chen, Yu-Ting] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung, Taiwan; [Chu, Yen-Wei] Natl Chung Hsing Univ, Inst Mol Biol, Taichung, Taiwan; [Chu, Yen-Wei; Chien, Ching-Hsuan; Chen, Yu-Ting] Natl Chung Hsing Univ, PhD Program Med Biotechnol, Taichung, Taiwan; [Chen, Chi-Wei] Natl Chung Hsing Univ, Dept Comp Sci & Engn, Taichung, Taiwan	National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University	Chen, YT (corresponding author), Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung, Taiwan.; Chen, YT (corresponding author), Natl Chung Hsing Univ, Biotechnol Ctr, Taichung, Taiwan.; Chen, YT (corresponding author), Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung, Taiwan.; Chen, YT (corresponding author), Natl Chung Hsing Univ, PhD Program Med Biotechnol, Taichung, Taiwan.	yuting@dragon.nchu.edu.tw		Chu, Yen-Wei/0000-0002-5525-4011; Chen, Chi-Wei/0000-0002-3026-634X; Chen, Chi-Wei/0000-0002-5799-9017	Ministry of Science and Technology, Taiwan, ROC [MOST 106-2313-B-005-035-MY2, 108-2321-B-005-008, 108-2634-F-005 -002]; National Chung Hsing University [NCHU-CSMU-10811]; Chung-Shan Medical University [NCHU-CSMU-10811]	Ministry of Science and Technology, Taiwan, ROC(Ministry of Science and Technology, Taiwan); National Chung Hsing University; Chung-Shan Medical University	This research was supported by (a) Ministry of Science and Technology, Taiwan, ROC under grant number MOST 106-2313-B-005-035-MY2, 108-2321-B-005-008 and 108-2634-F-005 -002. This funding is supported for the salaries on research assistants and graduate students; (b) National Chung Hsing University and Chung-Shan Medical University under grant number NCHU-CSMU-10811. This funding is applied to research equipment, stationery, and printing fee. This funding is supported for English editing and publication fee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, NUCLEIC ACIDS RES, V41, pD43; [Anonymous], 2015, DIABETOL KLIN SA, V4, pA1; [Anonymous], 2011, NUCLEIC ACIDS RES, V39, pD214; [Anonymous], 2012, NUCLEIC ACIDS RES, V40, pD71; [Anonymous], 2010, EUR J CARDIO-THORAC, V38, pS1; [Anonymous], 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/glan290; [Anonymous], 2011, DIABETOLOGIA PRAKTYC, V12, pA28; [Anonymous], 2015, NUCLEIC ACIDS RES, V43, pD204; [Anonymous], 2012, NUCLEIC ACIDS RES, V40, pD71; Armstrong F, 2004, ONCOGENE, V23, P6071, DOI 10.1038/sj.onc.1207813; Baughman G, 1997, BIOCHEM BIOPH RES CO, V232, P437, DOI 10.1006/bbrc.1997.6307; Chang ML, 2016, J VIRAL HEPATITIS, V23, P256, DOI 10.1111/jvh.12486; Chen Y, 2014, ANTICANCER RES, V34, P1595; Chi HC, 2016, AUTOPHAGY, V12, P2271, DOI 10.1080/15548627.2016.1230583; Cotan D, 2016, CURR DRUG TARGETS, V17, P921, DOI 10.2174/1389450117666160112110204; Delire B, 2015, EUR J CLIN INVEST, V45, P609, DOI 10.1111/eci.12441; Dey S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088040; Eglen R, 2011, PHARMACOL THERAPEUT, V130, P144, DOI 10.1016/j.pharmthera.2011.01.007; Fujibuchi W, 1998, Pac Symp Biocomput, P683; GRECO A, 1995, MOL CELL BIOL, V15, P6118; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hsu CN, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-66; HUBBARD MJ, 1993, TRENDS BIOCHEM SCI, V18, P172, DOI 10.1016/0968-0004(93)90109-Z; ITSB, 2016, J SCI ENG RES, V3, P63; Li L, 2011, BRIT J CANCER, V104, P19, DOI 10.1038/sj.bjc.6606014; Liu M, 2016, CANCER LETT, V377, P97, DOI 10.1016/j.canlet.2016.04.034; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; Minguez P, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.31; NCBI Resource Coordinators, 2018, NUCLEIC ACIDS RES, V46, pD8; Ni L, 2010, MOL CELL BIOL, V30, P1243, DOI 10.1128/MCB.01891-08; Ouyang J, 2016, BBA-GEN SUBJECTS, V1860, P2688, DOI 10.1016/j.bbagen.2016.02.017; Peng H, 2015, AM J PATHOL, V185, P1135, DOI 10.1016/j.ajpath.2014.12.016; Schwaller J, 2001, BLOOD, V97, P3910, DOI 10.1182/blood.V97.12.3910; Sexauer AN, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00248; Sia D, 2017, GASTROENTEROLOGY, V152, P745, DOI 10.1053/j.gastro.2016.11.048; SOMAN NR, 1991, P NATL ACAD SCI USA, V88, P4892, DOI 10.1073/pnas.88.11.4892; Sun WJ, 2018, J GASTROINTEST CANC, V49, P107, DOI 10.1007/s12029-018-0065-8; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Upadhya D, 2013, DEVELOPMENT, V140, P1573, DOI 10.1242/dev.081042; Wieczorek E, 2014, INT J UROL, V21, P744, DOI 10.1111/iju.12431; Xu SL, 2009, SEMIN CELL DEV BIOL, V20, P620, DOI 10.1016/j.semcdb.2009.03.003; Xuan JJ, 2015, BIOMED REP, V3, P395, DOI 10.3892/br.2015.420; Zhang HT, 2012, APOPTOSIS, V17, P325, DOI 10.1007/s10495-011-0685-y; Zhao JG, 2012, FEBS LETT, V586, P4257, DOI 10.1016/j.febslet.2012.10.029	45	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0234084	10.1371/journal.pone.0234084	http://dx.doi.org/10.1371/journal.pone.0234084			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497121	Green Published, gold			2022-12-26	WOS:000542035200062
J	Han, LL; Gao, LT; Hao, ZR; Zhao, KJ; Zhang, WN; Chen, J; Xiao, JF; Zhang, AN; Shi, ZH; Zhu, L				Han, Lanlan; Gao, Litong; Hao, Ziru; Zhao, Kuijun; Zhang, Wenlin; Chen, Juan; Xiao, Jianfei; Zhang, Aonan; Shi, Zhenghao; Zhu, Lin			Effect of rotenone-induced stress on physiologically active substances in adultAphis glycines	PLOS ONE			English	Article							RESISTANCE	The aim of this study was to determine the effect of rotenone stress onAphis glycinesMatsumura (Hemiptera: Aphididae) populations in different habitats of Northeast China. The changes in kinase expression activity of endogenous substances (proteins, total sugars, trehalose, cholesterol, and free amino acids), detoxifying enzymes (cytochrome P450 and glutathione S-transferase), and metabolic enzymes (proteases and phosphofructokinases) in specimens from three populations were compared before and after stress with rotenone at median lethal concentration (LC50) and their response mechanisms were analyzed. Following a 24 h treatment with rotenone, the average LC(50)rotenone values inA.glycinesspecimens from field populations A and B, and a laboratory population were 4.39, 4.61, and 4.03 mg/L, respectively. The degree of changes in the kinase expression activity of endogenous substances also differed, which indicated a difference in the response ofA.glycinesspecimens from varying habitats to LC(50)rotenone stress. The content of endogenous substances, detoxifying enzymes, and metabolic enzymes, except for that of free amino acids, changed significantly in all populations treated with rotenone at LC(50)compared with that in the control (P< 0.05). The decrease in protein and trehalose content, and the obstruction of cholesterol transportation owing to decreased feeding in stressed individuals were the causes ofA.glycinesdeath after rotenone treatment.Aphis glycinesresistance to rotenone may be related to cytochrome P450 expression.	[Han, Lanlan; Gao, Litong; Hao, Ziru; Zhao, Kuijun; Zhang, Wenlin; Chen, Juan; Xiao, Jianfei; Zhang, Aonan; Shi, Zhenghao; Zhu, Lin] Northeast Agr Univ, Coll Agr, Agr Insect & Pest Control Task Grp, Harbin, Heilongjiang, Peoples R China	Northeast Agricultural University - China	Zhao, KJ (corresponding author), Northeast Agr Univ, Coll Agr, Agr Insect & Pest Control Task Grp, Harbin, Heilongjiang, Peoples R China.	kjzhao@neau.edu.cn			Special Fund for Construction of Modern Agricultural Industry Technology System [CARS-04]; Heilongjiang Science Foundation Project [C2018011]	Special Fund for Construction of Modern Agricultural Industry Technology System; Heilongjiang Science Foundation Project	This work was supported by Special Fund for Construction of Modern Agricultural Industry Technology System (grant number CARS-04); Heilongjiang Science Foundation Project (grant number C2018011).	Alexnat RK, 2009, J INVERTEBR PATHOL, V100, P169, DOI [10.1016/j.jip.2009.01.003, DOI 10.1016/J.JIP.2009.01.003]; [Anonymous], 2005, CRIT CARE, V9, pR32; Becker A, 1996, EXPERIENTIA, V52, P433, DOI 10.1007/BF01919312; Behmer ST, 2003, ADV INSECT PHYSIOL, V31, P1, DOI 10.1016/S0065-2806(03)31001-X; BRATTSTEN LB, 1986, SCIENCE, V231, P1255, DOI 10.1126/science.231.4743.1255; Cao XL, 2018, INSECT BIOCHEM MOLEC, V103, P53, DOI 10.1016/j.ibmb.2018.10.006; Cheng Wei-xia, 2005, Zoological Research, V26, P545; Gilbert L. I, 1970, P229; Hua Rui-Xiang, 2014, Acta Entomologica Sinica, V57, P265; Jing XiangFeng, 2013, Chinese Journal of Applied Entomology, V50, P575; Liang J.L., 2015, AGR DISASTER RES, V5, P13; Liu Chang-Li, 2013, Acta Entomologica Sinica, V56, P1509; Liu Jian, 2007, Chinese Bulletin of Entomology, V44, P179; NAWROT J, 1989, BIOCHEM SYST ECOL, V17, P55, DOI 10.1016/0305-1978(89)90043-4; [潘怡欧 Pan Yiou], 2010, [大豆科学, Soybean Science], V29, P483; Qin Jia-Min, 2015, Huanjing Kunchong Xuebao, V37, P163; Satyavathi VV, 2018, J INVERTEBR PATHOL, V154, P102, DOI 10.1016/j.jip.2018.04.006; Tomilova OG, 2016, J INVERTEBR PATHOL, V140, P8, DOI 10.1016/j.jip.2016.08.008; Wang CL, 2005, CHINA SURF ENG, P19; [王洪亮 WANG Hongliang], 2006, [干旱地区农业研究, Agricultural Research in the Arid Areas], V24, P218; Wang Y, 2019, IEEE T PARALL DISTR, V30, P589, DOI 10.1109/TPDS.2018.2868062; Yu CH, 2008, INSECT KNOWLEDGE, P832; Zhang Hui, 2017, Scientia Agricultura Sinica, V50, P591; Zhang J, 2011, J SUN YS U NAT SCI E, V50, P88; Zhang N, 2016, INSECT SCI, V23, P675, DOI 10.1111/1744-7917.12202; Zhou Jiao, 2013, Chinese Journal of Applied Entomology, V50, P1413, DOI 10.7679/j.issn.2095-1353.2013.194; Zhu F, 2010, P NATL ACAD SCI USA, V107, P8557, DOI 10.1073/pnas.1000059107	27	1	1	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0234137	10.1371/journal.pone.0234137	http://dx.doi.org/10.1371/journal.pone.0234137			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497152	Green Published, gold			2022-12-26	WOS:000542035200031
J	Wright, E; Galbany, J; McFarlin, SC; Ndayishimiye, E; Stoinski, TS; Robbins, MM				Wright, Edward; Galbany, Jordi; McFarlin, Shannon C.; Ndayishimiye, Eric; Stoinski, Tara S.; Robbins, Martha M.			Dominance rank but not body size influences female reproductive success in mountain gorillas	PLOS ONE			English	Article							LONG-TAILED MACAQUES; LIFE-HISTORY; AGGRESSIVE COMPETITION; SOCIAL RELATIONSHIPS; MATERNAL INVESTMENT; CONTEST COMPETITION; BERINGEI-BERINGEI; SEXUAL DIMORPHISM; ENERGY-BALANCE; SELECTION	According to life history theory, natural selection has shaped trade-offs for allocating energy among growth, reproduction and maintenance to maximize individual fitness. In social mammals body size and dominance rank are two key variables believed to influence female reproductive success. However, few studies have examined these variables together, particularly in long-lived species. Previous studies found that female dominance rank correlates with reproductive success in mountain gorillas (Gorilla beringei beringei), which is surprising given they have weak dominance relationships and experience seemingly low levels of feeding competition. It is not currently known whether this relationship is primarily driven by a positive correlation between rank and body size. We used the non-invasive parallel laser method to measure two body size variables (back breadth and body length) of 34 wild adult female mountain gorillas, together with long-term dominance and demography data to investigate the interrelationships among body size, dominance rank and two measures of female reproductive success (inter-birth interval N = 29 and infant mortality N = 64). Using linear mixed models, we found no support for body size to be significantly correlated with dominance rank or female reproductive success. Higher-ranking females had significantly shorter inter-birth intervals than lower-ranking ones, but dominance rank was not significantly correlated with infant mortality. Our results suggest that female dominance rank is primarily determined by factors other than linear body dimensions and that high rank provides benefits even in species with weak dominance relationships and abundant year-round food resources. Future studies should focus on the mechanisms behind heterogeneity in female body size in relation to trade-offs in allocating energy to growth, maintenance and lifetime reproductive success.	[Wright, Edward; Robbins, Martha M.] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Galbany, Jordi; McFarlin, Shannon C.] George Washington Univ, Ctr Adv Study Human Paleobiol, Dept Anthropol, Washington, DC USA; [Galbany, Jordi] Univ Barcelona, Dept Clin Psychol & Psychobiol, Barcelona, Spain; [Ndayishimiye, Eric; Stoinski, Tara S.] Dian Fossey Gorilla Fund Int, Atlanta, GA USA	Max Planck Society; George Washington University; University of Barcelona	Wright, E (corresponding author), Max Planck Inst Evolutionary Anthropol, Leipzig, Germany.	edward.wright@eva.mpg.de	Galbany, Jordi/K-8609-2017	Galbany, Jordi/0000-0001-6724-3451	Max Planck Society; National Geographic Society; Columbian College of the George Washington University; Wenner Gren Foundation [ICRG-123]; National Science Foundation [BCS 1520221]; Leakey foundation	Max Planck Society(Max Planck SocietyFoundation CELLEX); National Geographic Society(National Geographic Society); Columbian College of the George Washington University; Wenner Gren Foundation; National Science Foundation(National Science Foundation (NSF)); Leakey foundation	This research was funded by the Max Planck Society, National Geographic Society, The Columbian College of the George Washington University, The Wenner Gren Foundation (ICRG-123), The National Science Foundation (BCS 1520221) and The Leakey foundation.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Albers PCH, 2001, ANIM BEHAV, V61, P489, DOI 10.1006/anbe.2000.1571; Altmann J, 2005, BEHAV ECOL SOCIOBIOL, V57, P490, DOI 10.1007/s00265-004-0870-x; Andersson Malte, 1994; [Anonymous], 2018, LANG ENV STAT COMP; Archie EA, 2006, ANIM BEHAV, V71, P117, DOI 10.1016/j.anbehav.2005.03.023; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, 2015, FITTING LINEAR MIXED, V4; Beauplet G, 2007, P R SOC B, V274, P1877, DOI 10.1098/rspb.2007.0454; Bergeron P, 2007, J WILDLIFE MANAGE, V71, P289, DOI 10.2193/2006-290; Blomquist GE, 2011, J HUM EVOL, V60, P677, DOI 10.1016/j.jhevol.2010.05.010; Bowen WD, 2001, CAN J ZOOL, V79, P1088, DOI 10.1139/cjz-79-6-1088; Brooks ME, 2017, R J, V9, P378, DOI 10.32614/RJ-2017-066; Charnov Eric L., 1993, Evolutionary Anthropology, V1, P191, DOI 10.1002/evan.1360010604; Cheney DL, 2004, INT J PRIMATOL, V25, P401, DOI 10.1023/B:IJOP.0000019159.75573.13; Clutton-Brock T, 2013, J ZOOL, V289, P151, DOI 10.1111/jzo.12023; Clutton-Brock TH, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0074; Clutton-Brock TH, 2006, NATURE, V444, P1065, DOI 10.1038/nature05386; Clutton-Brock T.H., 1988, P325; Clutton-Brock T, 2012, EVOL ANTHROPOL, V21, P136, DOI 10.1002/evan.21316; CluttonBrock TH, 1996, J ANIM ECOL, V65, P675, DOI 10.2307/5667; CLUTTONBROCK TH, 1984, NATURE, V308, P358, DOI 10.1038/308358a0; Cote SD, 2000, BEHAVIOUR, V137, P1541, DOI 10.1163/156853900502718; Eckardt W, 2016, BEHAV ECOL SOCIOBIOL, V70, P493, DOI 10.1007/s00265-016-2066-6; Thompson ME, 2017, HORM BEHAV, V91, P84, DOI 10.1016/j.yhbeh.2016.08.009; Favre M, 2008, ANIM BEHAV, V76, P1373, DOI 10.1016/j.anbehav.2008.07.003; Festa-Bianchet M, 1998, ECOL LETT, V1, P91; Festa-Bianchet M, 1998, AM NAT, V152, P367, DOI 10.1086/286175; Foerster S, 2016, SCI REP-UK, V6, DOI 10.1038/srep35404; Forstmeier W, 2011, BEHAV ECOL SOCIOBIOL, V65, P47, DOI 10.1007/s00265-010-1038-5; Fox J., 2019, R COMPANION APPL REG, V.; Galbany J, 2017, AM J PHYS ANTHROPOL, V163, P570, DOI 10.1002/ajpa.23232; Galbany J, 2016, AM J PRIMATOL, V78, P418, DOI 10.1002/ajp.22511; Gesquiere LR, 2018, AM J PHYS ANTHROPOL, V166, P107, DOI 10.1002/ajpa.23407; Gordon AD, 2006, INT J PRIMATOL, V27, P27, DOI 10.1007/s10764-005-9003-2; Grueter CC, 2016, BEHAV ECOL, V27, P766, DOI 10.1093/beheco/arv212; Grueter CC, 2014, PHYSIOL BEHAV, V127, P13, DOI 10.1016/j.physbeh.2014.01.009; Hamel S, 2009, J ANIM ECOL, V78, P143, DOI 10.1111/j.1365-2656.2008.01459.x; Hamel S, 2009, ECOLOGY, V90, P1981, DOI 10.1890/08-0596.1; Harcourt A H, 1980, J Reprod Fertil Suppl, VSuppl 28, P59; HARCOURT AH, 1979, ANIM BEHAV, V27, P251, DOI 10.1016/0003-3472(79)90145-3; Hodge SJ, 2008, J ANIM ECOL, V77, P92, DOI 10.1111/j.1365-2656.2007.01318.x; Holekamp KE, 1996, J REPROD FERTIL, V108, P229; Johnson SE, 2003, AM J PHYS ANTHROPOL, V120, P83, DOI 10.1002/ajpa.10139; Jones JH, 2010, J ANIM ECOL, V79, P1262, DOI 10.1111/j.1365-2656.2010.01687.x; Jonsson KI, 1997, OIKOS, V78, P57, DOI 10.2307/3545800; Key C, 1999, P ROY SOC B-BIOL SCI, V266, P2479, DOI 10.1098/rspb.1999.0949; Kingsolver JG, 2004, EVOLUTION, V58, P1608; Knott CD, 1998, INT J PRIMATOL, V19, P1061, DOI 10.1023/A:1020330404983; Koenig A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0348; LANDE R, 1980, EVOLUTION, V34, P292, DOI [10.2307/2407393, 10.1111/j.1558-5646.1980.tb04817.x]; Lea AJ, 2014, ANIM BEHAV, V94, P87, DOI 10.1016/j.anbehav.2014.05.019; LEIGH SR, 1995, AM J PRIMATOL, V36, P37, DOI 10.1002/ajp.1350360104; Lindenfors P, 2002, J EVOLUTION BIOL, V15, P595, DOI 10.1046/j.1420-9101.2002.00422.x; Majolo B, 2012, AM J PHYS ANTHROPOL, V147, P652, DOI 10.1002/ajpa.22031; McLean EM, 2019, AM NAT, V194, P745, DOI 10.1086/705810; Murray CM, 2006, BEHAV ECOL, V17, P1020, DOI 10.1093/beheco/arl042; Neumann C, 2011, ANIM BEHAV, V82, P911, DOI 10.1016/j.anbehav.2011.07.016; Ostner J, 2018, ADV STUD BEHAV, V50, P127, DOI 10.1016/bs.asb.2017.12.001; PACKER C, 1995, NATURE, V373, P60, DOI 10.1038/373060a0; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; Plavcan JM, 2012, HUM NATURE-INT BIOS, V23, P45, DOI 10.1007/s12110-012-9130-3; Plavcan JM, 2001, YEARB PHYS ANTHROPOL, V44, P25, DOI 10.1002/ajpa.10011; Pusey A, 1997, SCIENCE, V277, P828, DOI 10.1126/science.277.5327.828; Pusey AE, 2005, INT J PRIMATOL, V26, P3, DOI 10.1007/s10764-005-0721-2; Pusey Anne, 2012, P343; REITER J, 1981, ANIM BEHAV, V29, P670, DOI 10.1016/S0003-3472(81)80002-4; Robbins AM, 2007, ETHOLOGY, V113, P235, DOI 10.1111/j.1439-0310.2006.01319.x; Robbins AM, 2006, AM J PHYS ANTHROPOL, V131, P511, DOI 10.1002/ajpa.20474; Robbins AM, 2011, AM J PHYS ANTHROPOL, V146, P582, DOI 10.1002/ajpa.21605; Robbins AM, 2009, BEHAVIOUR, V146, P525, DOI 10.1163/156853909X426354; Robbins MM, 2007, BEHAV ECOL SOCIOBIOL, V61, P919, DOI 10.1007/s00265-006-0321-y; Robbins MM, 2018, EVOL ANTHROPOL, V27, P218, DOI 10.1002/evan.21721; Robbins MM, 2005, BEHAVIOUR, V142, P779, DOI 10.1163/1568539054729123; Roff Derek, 2002, pi; Rothman JM, 2008, AM J PRIMATOL, V70, P1191, DOI 10.1002/ajp.20611; RUTBERG AT, 1990, ANIM BEHAV, V40, P322, DOI 10.1016/S0003-3472(05)80927-3; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; Setchell JM, 2004, AM J PHYS ANTHROPOL, V125, P73, DOI 10.1002/ajpa.10375; Setchell JM, 2002, INT J PRIMATOL, V23, P51, DOI 10.1023/A:1013245707228; Silk JB, 2003, SCIENCE, V302, P1231, DOI 10.1126/science.1088580; Silk JB, 2010, CURR BIOL, V20, P1359, DOI 10.1016/j.cub.2010.05.067; Stearns S.C., 1992, pi; Sterck EHM, 1997, BEHAV ECOL SOCIOBIOL, V41, P291, DOI 10.1007/s002650050390; Stockley P, 2011, BIOL REV, V86, P341, DOI 10.1111/j.1469-185X.2010.00149.x; Therneau TM, 2001, MODELING SURVIVAL DA; Tung J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11181; van Noordwijk MA, 1999, PRIMATES, V40, P105, DOI 10.1007/BF02557705; VANNOORDWIJK MA, 1987, ANIM BEHAV, V35, P577, DOI 10.1016/S0003-3472(87)80284-1; Vogel ER, 2005, BEHAV ECOL SOCIOBIOL, V58, P333, DOI 10.1007/s00265-005-0960-4; Wasser SK, 2004, BEHAV ECOL SOCIOBIOL, V56, P338, DOI 10.1007/s00265-004-0797-2; Watts D P., 2001, MOUNTAIN GORILLAS 3, P215; WATTS DP, 1991, ETHOLOGY, V89, P135; WATTS DP, 1994, BEHAV ECOL SOCIOBIOL, V34, P347, DOI 10.1007/BF01209781; WHITTEN PL, 1983, AM J PRIMATOL, V5, P139, DOI 10.1002/ajp.1350050205; WRANGHAM RW, 1980, BEHAVIOUR, V75, P262, DOI 10.1163/156853980X00447; Wright E, 2019, ANIM BEHAV, V151, P87, DOI 10.1016/j.anbehav.2019.03.011; Wright E, 2014, BEHAV ECOL SOCIOBIOL, V68, P1785, DOI 10.1007/s00265-014-1788-6; Wright E, 2014, BEHAV ECOL SOCIOBIOL, V68, P957, DOI 10.1007/s00265-014-1708-9	99	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2020	15	6							e0233235	10.1371/journal.pone.0233235	http://dx.doi.org/10.1371/journal.pone.0233235			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LW6ZP	32492071	Green Published, gold			2022-12-26	WOS:000539293000015
J	Ishida, T; Kotani, T; Serada, S; Fujimoto, M; Takeuchi, T; Makino, S; Naka, T				Ishida, Takaaki; Kotani, Takuya; Serada, Satoshi; Fujimoto, Minoru; Takeuchi, Tohru; Makino, Shigeki; Naka, Tetsuji			Correlation of increased serum leucine-rich alpha 2-glycoprotein levels with disease prognosis, progression, and activity of interstitial pneumonia in patients with dermatomyositis: A retrospective study	PLOS ONE			English	Article							LONG-TERM PROGNOSIS; ALPHA-2 GLYCOPROTEIN; LUNG-DISEASE; ANTI-MDA5 ANTIBODY; USEFUL BIOMARKER; POLYMYOSITIS; ALPHA(2)-GLYCOPROTEIN	Objective To investigate whether leucine-rich alpha 2-glycoprotein (LRG) can be a biomarker for the disease activity, progression, and prognosis of interstitial pneumonia (IP) in patients with dermatomyositis (DM). Methods Correlations between the clinical findings and serum LRG levels were investigated in 46 patients with DM-IP (33 with acute/subacute IP [A/SIP] and 13 patients with chronic IP [CIP], including 10 fatal cases of IP). Results The median serum LRG level of 18.4 (14.6-25.2) mu g/mL in DM-IP patients was higher than that in healthy control subjects. The median levels of serum LRG at baseline and at 2 and 4 weeks after the initiation of treatment in the patients who died were significantly higher than those in the surviving patients (P = 0.026, 0.029, and 0.008, respectively). The median level of serum LRG in the DM-A/SIP patients was significantly higher than that in the DM-CIP patients (P = 0.0004), and that in the anti-MDA5-Ab-positive group was slightly higher than that in the anti-ARS-Ab-positive group. The serum LRG levels correlated significantly with the serum levels of LDH, C-reactive protein, ferritin, AaDO(2), %DLco, and total ground-glass opacity score. The survival rate after 24 weeks in patients with an initial LRG level >= 17.6 mu g/mL (survival rate: 40%) was significantly lower than that in patients with an initial LRG level < 17.6 mu g/mL (100%) (P = 0.0009). Conclusion The serum LRG level may be a promising marker of disease activity, progression, and prognosis in patients with DM-IP.	[Ishida, Takaaki; Kotani, Takuya; Takeuchi, Tohru; Makino, Shigeki] Osaka Med Coll, Dept Internal Med 4, Takatsuki, Osaka, Japan; [Serada, Satoshi; Fujimoto, Minoru; Naka, Tetsuji] Kochi Univ, Ctr Intractable Immune Dis, Kochi Med Sch, Nankoku, Kochi, Japan	Osaka Medical College; Kochi University	Kotani, T (corresponding author), Osaka Med Coll, Dept Internal Med 4, Takatsuki, Osaka, Japan.	in1242@osaka-med.ac.jp		Ishida, Takaaki/0000-0002-3289-0867				Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; BENBASSAT J, 1985, ARTHRITIS RHEUM-US, V28, P249, DOI 10.1002/art.1780280303; BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Druhan LJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170261; Fujiki Y, 2018, MOD RHEUMATOL, V28, P133, DOI 10.1080/14397595.2017.1318468; Fujimoto M, 2015, ARTHRITIS RHEUMATOL, V67, P2056, DOI 10.1002/art.39164; Gerami P, 2006, J AM ACAD DERMATOL, V54, P597, DOI 10.1016/j.jaad.2005.10.041; Gono T, 2014, RHEUMATOLOGY, V53, P2196, DOI 10.1093/rheumatology/keu258; Gono T, 2012, RHEUMATOLOGY, V51, P1563, DOI 10.1093/rheumatology/kes102; Gono T, 2010, RHEUMATOLOGY, V49, P1713, DOI 10.1093/rheumatology/keq149; Ha YJ, 2015, SCAND J RHEUMATOL, V44, P399, DOI 10.3109/03009742.2015.1016103; HAUPT H, 1977, H-S Z PHYSIOL CHEM, V358, P639, DOI 10.1515/bchm2.1977.358.1.639; Hayashi S, 2008, J RHEUMATOL, V35, P260; Honda H, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13556; Honda H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162672; Horai Y, 2015, MOD RHEUMATOL, V25, P85, DOI 10.3109/14397595.2014.900843; Isoda K, 2017, RHEUMATOL INT, V37, P1335, DOI 10.1007/s00296-017-3729-y; Isoda K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089610; Kawasumi H, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/815245; Kazerooni EA, 1997, AM J ROENTGENOL, V169, P977, DOI 10.2214/ajr.169.4.9308447; Kimura Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep43732; Koreeda Y, 2010, INTERNAL MED, V49, P361, DOI 10.2169/internalmedicine.49.2889; Maugars YM, 1996, CLIN EXP RHEUMATOL, V14, P263; Oda K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01685-5; Sato S, 2018, RHEUMATOLOGY, V57, P1212, DOI 10.1093/rheumatology/key060; Serada S, 2012, INFLAMM BOWEL DIS, V18, P2169, DOI 10.1002/ibd.22936; Serada S, 2010, ANN RHEUM DIS, V69, P770, DOI 10.1136/ard.2009.118919; Shinzaki S, 2017, J CROHNS COLITIS, V11, P84, DOI 10.1093/ecco-jcc/jjw132; Shirai R, 2009, BIOCHEM BIOPH RES CO, V382, P776, DOI 10.1016/j.bbrc.2009.03.104; Sontheimer RD, 2002, DERMATOL CLIN, V20, P387, DOI 10.1016/S0733-8635(02)00021-9; TAKAHASHI N, 1985, P NATL ACAD SCI USA, V82, P1906, DOI 10.1073/pnas.82.7.1906; Takemoto N, 2015, ONCOTARGET, V6, P11009, DOI 10.18632/oncotarget.3557; Wang XM, 2013, NATURE, V499, P306, DOI 10.1038/nature12345	34	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0234090	10.1371/journal.pone.0234090	http://dx.doi.org/10.1371/journal.pone.0234090			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MJ2AA	32479560	Green Published, gold			2022-12-26	WOS:000547893500053
J	Gabrovsek, L; Collins, KB; Aggarwal, S; Saunders, LM; Lau, HT; Suh, D; Sancak, Y; Trapnell, C; Ong, SE; Smith, FD; Scott, JD				Gabrovsek, Laura; Collins, Kerrie B.; Aggarwal, Stacey; Saunders, Lauren M.; Lau, Ho-Tak; Suh, Danny; Sancak, Yasemin; Trapnell, Cole; Ong, Shao-En; Smith, F. Donelson; Scott, John D.			A-kinase-anchoring protein 1 (dAKAP1)-based signaling complexes coordinate local protein synthesis at the mitochondrial surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein kinase A (PKA); A-kinase anchoring proteins (AKAPs); mitochondria; RNA-protein interaction; mitochondrial respiratory chain complex; translation regulation; protein kinases; local signaling complexes; intracellular compartmentalization; molecular scaffold	MESSENGER-RNA; P-BODIES; BINDING; REVEALS; SPACE; TRANSLATION; CONTAIN; MUSCLE; DOMAIN; TOOL	Compartmentalization of macromolecules is a ubiquitous molecular mechanism that drives numerous cellular functions. The appropriate organization of enzymes in space and time enables the precise transmission and integration of intracellular signals. Molecular scaffolds constrain signaling enzymes to influence the regional modulation of these physiological processes. Mitochondrial targeting of protein kinases and protein phosphatases provides a means to locally control the phosphorylation status and action of proteins on the surface of this organelle. Dual-specificity protein kinase A anchoring protein 1 (dAKAP1) is a multivalent binding protein that targets protein kinase A (PKA), RNAs, and other signaling enzymes to the outer mitochondrial membrane. Many AKAPs recruit a diverse set of binding partners that coordinate a broad range of cellular processes. Here, results of MS and biochemical analyses reveal that dAKAP1 anchors additional components, including the ribonucleoprotein granule components La-related protein 4 (LARP4) and polyadenylate-binding protein 1 (PABPC1). Local translation of mRNAs at organelles is a means to spatially control the synthesis of proteins. RNA-Seq data demonstrate that dAKAP1 binds mRNAs encoding proteins required for mitochondrial metabolism, including succinate dehydrogenase. Functional studies suggest that the loss of dAKAP1-RNA interactions reduces mitochondrial electron transport chain activity. Hence, dAKAP1 plays a previously unappreciated role as a molecular interface between second messenger signaling and local protein synthesis machinery.	[Gabrovsek, Laura; Collins, Kerrie B.; Aggarwal, Stacey; Lau, Ho-Tak; Suh, Danny; Sancak, Yasemin; Ong, Shao-En; Smith, F. Donelson; Scott, John D.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Gabrovsek, Laura; Saunders, Lauren M.] Univ Washington, Program Mol & Cellular Biol, Seattle, WA 98195 USA; [Saunders, Lauren M.; Trapnell, Cole] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Scott, JD (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	scottjdw@uw.edu		Saunders, Lauren/0000-0003-4377-4252; Collins, Kerrie/0000-0001-9553-1928	PHS NRSA from NIGMS [T32GM007270]; Department of Molecular and Cellular Biology at the University of Washington; NIH [DP2 HD088158, DK105542, DK119192]; Paul G. Allen Frontiers Group-Allen Discovery Center grant; Alfred P. Sloan Foundation Research Fellowship; W. M. Keck Foundation Grant; DOD [CA150370]; NIH NIAMS [AR065459]	PHS NRSA from NIGMS; Department of Molecular and Cellular Biology at the University of Washington; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul G. Allen Frontiers Group-Allen Discovery Center grant; Alfred P. Sloan Foundation Research Fellowship(Alfred P. Sloan Foundation); W. M. Keck Foundation Grant; DOD(United States Department of Defense); NIH NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	L. G., S. A., and L. M. S. were supported in part by PHS NRSA T32GM007270 from NIGMS. L. G. and L. M. S. were supported in part by the Department of Molecular and Cellular Biology at the University of Washington. C. T. is supported by NIH DP2 HD088158, Paul G. Allen Frontiers Group-Allen Discovery Center grant, W. M. Keck Foundation Grant, and the Alfred P. Sloan Foundation Research Fellowship. S.-E. O., H.-T. L., and F. D. S. were supported by DOD CA150370 and NIH NIAMS AR065459. J. D. S. is supported by DK105542 and DK119192 from the NIH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aggarwal S, 2019, J BIOL CHEM, V294, P3152, DOI 10.1074/jbc.RA118.006741; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Bardella C, 2011, BBA-BIOENERGETICS, V1807, P1432, DOI 10.1016/j.bbabio.2011.07.003; Besse F, 2008, NAT REV MOL CELL BIO, V9, P971, DOI 10.1038/nrm2548; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Boeynaems S, 2018, TRENDS CELL BIOL, V28, P420, DOI 10.1016/j.tcb.2018.02.004; Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Cardaci Simone, 2012, Int J Cell Biol, V2012, P161837, DOI 10.1155/2012/161837; Cardone L, 2004, MOL CELL BIOL, V24, P4613, DOI 10.1128/MCB.24.11.4613-4626.2004; Carnegie GK, 2004, MOL CELL, V15, P889, DOI 10.1016/j.molcel.2004.09.015; Carnegie GK, 2008, MOL CELL, V32, P169, DOI 10.1016/j.molcel.2008.08.030; CARR DW, 1991, J BIOL CHEM, V266, P14188; Chekulaeva M, 2016, MOL CELL, V63, P918, DOI 10.1016/j.molcel.2016.08.031; Chen C, 2011, NAT REV MOL CELL BIO, V12, P629, DOI 10.1038/nrm3185; Clayton David A, 2014, Cold Spring Harb Protoc, V2014, DOI 10.1101/pdb.prot080002; David A, 2012, J CELL BIOL, V197, P45, DOI 10.1083/jcb.201112145; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Fazal FM, 2019, CELL, V178, P473, DOI 10.1016/j.cell.2019.05.027; Galera-Ruiz H, 2008, ANAL QUANT CYTOL, V30, P119; Ginsberg MD, 2003, J MOL BIOL, V327, P885, DOI 10.1016/S0022-2836(03)00173-6; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Grozdanov PN, 2012, MOL ENDOCRINOL, V26, P2104, DOI 10.1210/me.2012-1123; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Hoffman NJ, 2015, CELL METAB, V22, P922, DOI 10.1016/j.cmet.2015.09.001; Hollingworth D, 2012, NUCLEIC ACIDS RES, V40, P6873, DOI 10.1093/nar/gks368; Huang LJS, 1997, J BIOL CHEM, V272, P8057, DOI 10.1074/jbc.272.12.8057; Hwang MS, 2014, MITOCHONDRION, V19, P20, DOI 10.1016/j.mito.2014.06.001; Jain S, 2016, CELL, V164, P487, DOI 10.1016/j.cell.2015.12.038; Jin MY, 2017, CELL REP, V20, P895, DOI 10.1016/j.celrep.2017.06.082; Jung H, 2014, CELL, V157, P26, DOI 10.1016/j.cell.2014.03.005; Kaewsapsak P, 2017, ELIFE, V6, DOI [10.7554/elife.29224, 10.7554/eLife.29224]; Kershaw CJ, 2017, MOL CELL, V68, P3, DOI 10.1016/j.molcel.2017.09.032; Khong A, 2017, MOL CELL, V68, P808, DOI 10.1016/j.molcel.2017.10.015; Kozlov G, 2010, J BIOL CHEM, V285, P13599, DOI 10.1074/jbc.M109.089540; Lau HT, 2014, J PROTEOME RES, V13, P4164, DOI 10.1021/pr500630a; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lefkimmiatis K, 2014, PHARMACOL THERAPEUT, V143, P295, DOI 10.1016/j.pharmthera.2014.03.008; Lesnik C, 2015, RNA BIOL, V12, P801, DOI 10.1080/15476286.2015.1058686; LIN RY, 1995, J BIOL CHEM, V270, P27804, DOI 10.1074/jbc.270.46.27804; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu YT, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0708-5; Lussey-Lepoutre C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9784; Markmiller S, 2018, CELL, V172, P590, DOI 10.1016/j.cell.2017.12.032; Means CK, 2011, P NATL ACAD SCI USA, V108, pE1227, DOI 10.1073/pnas.1107182108; Merrill RA, 2014, INT J BIOCHEM CELL B, V48, P92, DOI 10.1016/j.biocel.2013.12.012; Merrill RA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000612; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Nygren PJ, 2017, ELIFE, V6, DOI 10.7554/eLife.30872; Pidoux G, 2011, EMBO J, V30, P4371, DOI 10.1038/emboj.2011.365; Rogne M, 2006, BIOCHEMISTRY-US, V45, P14980, DOI 10.1021/bi061418y; Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; SCHWERZMANN K, 1989, P NATL ACAD SCI USA, V86, P1583, DOI 10.1073/pnas.86.5.1583; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Smith FD, 2018, P NATL ACAD SCI USA, V115, pE11465, DOI 10.1073/pnas.1816614115; Smith FD, 2017, SCIENCE, V356, P1288, DOI 10.1126/science.aaj1669; Smith FD, 2013, ELIFE, V2, DOI 10.7554/eLife.01319; Srinivasan S, 2017, BBA-BIOENERGETICS, V1858, P602, DOI 10.1016/j.bbabio.2017.01.004; Stavraka C, 2015, BIOMOLECULES, V5, P2701, DOI 10.3390/biom5042701; Steen RL, 2000, J CELL BIOL, V150, P1251, DOI 10.1083/jcb.150.6.1251; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Tingley WG, 2007, P NATL ACAD SCI USA, V104, P8461, DOI 10.1073/pnas.0610393104; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Van Treeck B, 2018, P NATL ACAD SCI USA, V115, P2734, DOI 10.1073/pnas.1800038115; Wang JT, 2014, ELIFE, V3, DOI 10.7554/eLife.04591; WARBURG O, 1956, SCIENCE, V124, P269; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wu B, 2017, BBA-MOL BASIS DIS, V1863, P2307, DOI 10.1016/j.bbadis.2017.06.011; Yu SB, 2018, J MOL BIOL, V430, P3922, DOI 10.1016/j.jmb.2018.07.027; Zhang Y, 2016, EMBO J, V35, P1045, DOI 10.15252/embj.201592994	77	6	6	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2020	295	31					10749	10765		10.1074/jbc.RA120.013454	http://dx.doi.org/10.1074/jbc.RA120.013454			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB3HM	32482893	Green Published, hybrid			2022-12-26	WOS:000560405600019
J	Ruben, E; Planer, W; Chinnaraj, M; Chen, ZW; Zuo, XB; Pengo, V; De Filippis, V; Alluri, RK; McCrae, KR; Macor, P; Tedesco, F; Pozzi, N				Ruben, Eliza; Planer, William; Chinnaraj, Mathivanan; Chen, Zhiwei; Zuo, Xiaobing; Pengo, Vittorio; De Filippis, Vincenzo; Alluri, Ravi K.; McCrae, Keith R.; Macor, Paolo; Tedesco, Francesco; Pozzi, Nicola			The J-elongated conformation of beta(2)-glycoprotein I predominates in solution: implications for our understanding of antiphospholipid syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta-2 glycoprotein I; single-molecule biophysics; X-ray crystallography; structure-function; autoimmunity; thrombosis; antiphospholipid syndrome; complement system; coagulation; lipid-protein interaction; structural biology; autoimmune disease; protein-protein interaction	ENDOTHELIAL-CELL ACTIVATION; BETA(2) GLYCOPROTEIN I; SINGLE-MOLECULE FRET; DOMAIN-I; ANTICARDIOLIPIN ANTIBODIES; PHOSPHOLIPID-BINDING; CRYSTAL-STRUCTURE; IMMUNE-COMPLEXES; LIPID-BINDING; BETA-2-GLYCOPROTEIN-I	beta(2)-Glycoprotein I (beta(2)GPI) is an abundant plasma protein displaying phospholipid-binding properties. Because it binds phospholipids, it is a target of antiphospholipid antibodies (aPLs) in antiphospholipid syndrome (APS), a life-threatening autoimmune thrombotic disease. Indeed, aPLs prefer membrane-bound beta(2)GPI to that in solution. beta(2)GPI exists in two almost equally populated redox states: oxidized, in which all the disulfide bonds are formed, and reduced, in which one or more disulfide bonds are broken. Furthermore, beta(2)GPI can adopt multiple conformations (i.e.J-elongated, S-twisted, and O-circular). While strong evidence indicates that the J-form is the structure bound to aPLs, which conformation exists and predominates in solution remains controversial, and so is the conformational pathway leading to the bound state. Here, we report that human recombinant beta(2)GPI purified under native conditions is oxidized. Moreover, under physiological pH and salt concentrations, this oxidized form adopts a J-elongated, flexible conformation, not circular or twisted, in which the N-terminal domain I (DI) and the C-terminal domain V (DV) are exposed to the solvent. Consistent with this model, binding kinetics and mutagenesis experiments revealed that in solution the J-form interacts with negatively charged liposomes and with MBB2, a monoclonal anti-DI antibody that recapitulates most of the features of pathogenic aPLs. We conclude that the preferential binding of aPLs to phospholipid-bound beta(2)GPI arises from the ability of its preexisting J-form to accumulate on the membranes, thereby offering an ideal environment for aPL binding. We propose that targeting the J-form of beta(2)GPI provides a strategy to block pathogenic aPLs in APS.	[Ruben, Eliza; Planer, William; Chinnaraj, Mathivanan; Chen, Zhiwei; Pozzi, Nicola] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Zuo, Xiaobing] Argonne Natl Lab, Xray Sci Div, 9700 S Cass Ave, Argonne, IL 60439 USA; [Pengo, Vittorio] Univ Padua, Thrombosis Res Lab, Dept Cardiac Thorac & Vasc Sci & Publ Hlth, Padua, Italy; [Pengo, Vittorio] Arianna Fdn Anticoagulat, Bologna, Italy; [De Filippis, Vincenzo] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy; [Alluri, Ravi K.; McCrae, Keith R.] Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44106 USA; [Macor, Paolo] Univ Trieste, Dept Life Sci, Trieste, Italy; [Tedesco, Francesco] IRCCS, Lab Immunorheumatol, Ist Auxol Italiano, Milan, Italy	Saint Louis University; United States Department of Energy (DOE); Argonne National Laboratory; University of Padua; University of Padua; Cleveland Clinic Foundation; University of Trieste; IRCCS Istituto Auxologico Italiano	Pozzi, N (corresponding author), St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA.	nicola.pozzi@health.slu.edu	Pozzi, Nicola/AAV-4876-2021; Chinnaraj, Mathivanan/O-4873-2014	Pozzi, Nicola/0000-0003-2309-7100; Chinnaraj, Mathivanan/0000-0002-7749-7364	CaRiPaRo Foundation Excellence Research Grant 2018 [BPiTA-52012]; National Institutes of Health [HL049413, HL139554, HL147821, HL150146]; Saint Louis University; DOE Office of Science [DE-AC02-06CH11357]	CaRiPaRo Foundation Excellence Research Grant 2018; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saint Louis University; DOE Office of Science(United States Department of Energy (DOE))	This work was supported in part by the CaRiPaRo Foundation Excellence Research Grant 2018 BPiTA-52012 (V. D. F.), the National Institutes of Health Research Grant HL150146 (N. P.), and President's Research Fund, Saint Louis University (N. P.). Z. C. was supported in part by the National Institutes of Health Research Grants HL049413, HL139554, and HL147821 to E. D. C. This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract no. DE-AC02-06CH11357. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acquasaliente L, 2016, BIOCHEM J, V473, P4629, DOI 10.1042/BCJ20160603; Agar C, 2011, BLOOD, V117, P6939, DOI 10.1182/blood-2010-12-325951; Agar C, 2010, BLOOD, V116, P1336, DOI 10.1182/blood-2009-12-260976; Agostinis C, 2014, BLOOD, V123, P3478, DOI 10.1182/blood-2013-11-537704; Allen KL, 2012, BLOOD, V119, P884, DOI 10.1182/blood-2011-03-344671; Arad A, 2011, BLOOD, V117, P3453, DOI 10.1182/blood-2010-08-300715; Banzato A, 2012, LUPUS, V21, P784, DOI 10.1177/0961203312440347; Banzato A, 2011, THROMB RES, V128, P583, DOI 10.1016/j.thromres.2011.04.021; Bevers EM, 2004, CLIN IMMUNOL, V112, P150, DOI 10.1016/j.clim.2004.02.009; BEVERS EM, 1990, LANCET, V336, P952; Biasiolo A, 1999, LUPUS, V8, P121, DOI 10.1191/096120399678847506; Bouma B, 1999, EMBO J, V18, P5166, DOI 10.1093/emboj/18.19.5166; Buchholz I, 2018, PHYS CHEM CHEM PHYS, V20, P26819, DOI 10.1039/c8cp03234c; Chinnaraj M, 2019, BLOOD ADV, V3, P1738, DOI 10.1182/bloodadvances.2019030932; Chinnaraj M, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00281; Chinnaraj M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21304-1; de Groot PG, 2011, J THROMB HAEMOST, V9, P1275, DOI 10.1111/j.1538-7836.2011.04327.x; de Laat B, 2006, BLOOD, V107, P1916, DOI 10.1182/blood-2005-05-1943; de Laat B, 2005, BLOOD, V105, P1540, DOI 10.1182/blood-2004-09-3387; de Laat B, 2011, ARTHRITIS RHEUM-US, V63, P3960, DOI 10.1002/art.30633; De Michele C, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004752; Dienava-Verdoold I, 2011, J THROMB HAEMOST, V9, P738, DOI 10.1111/j.1538-7836.2011.04212.x; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Durigutto P, 2019, HAEMATOLOGICA, V104, P819, DOI 10.3324/haematol.2018.198119; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischetti F, 2005, BLOOD, V106, P2340, DOI 10.1182/blood-2005-03-1319; Forneris F, 2016, EMBO J, V35, P1133, DOI 10.15252/embj.201593673; GALLI M, 1990, LANCET, V335, P1544, DOI 10.1016/0140-6736(90)91374-J; Giannakopoulos B, 2013, NEW ENGL J MED, V368, P1033, DOI 10.1056/NEJMra1112830; Gopich IV, 2007, J PHYS CHEM B, V111, P12925, DOI 10.1021/jp075255e; Hadzhieva M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03942-z; Hammel M, 2002, J MOL BIOL, V321, P85, DOI 10.1016/S0022-2836(02)00621-6; Hammel M, 2001, BIOCHEMISTRY-US, V40, P14173, DOI 10.1021/bi0114372; HUNT J, 1994, J IMMUNOL, V152, P653; HUNT JE, 1993, P NATL ACAD SCI USA, V90, P2141, DOI 10.1073/pnas.90.6.2141; Ioannou Y, 2011, ARTHRITIS RHEUM-US, V63, P2774, DOI 10.1002/art.30383; Ivanov I, 2017, BLOOD, V129, P1527, DOI 10.1182/blood-2016-10-744110; Iverson GM, 2002, J IMMUNOL, V169, P7097, DOI 10.4049/jimmunol.169.12.7097; Iverson GM, 1998, P NATL ACAD SCI USA, V95, P15542, DOI 10.1073/pnas.95.26.15542; Kapanidis AN, 2004, P NATL ACAD SCI USA, V101, P8936, DOI 10.1073/pnas.0401690101; Kikhney AG, 2015, FEBS LETT, V589, P2570, DOI 10.1016/j.febslet.2015.08.027; Koike T, 1996, LUPUS, V5, P156, DOI 10.1177/096120339600500213; Kolyada A, 2017, ANTIBODIES, V6, DOI 10.3390/antib6020008; Kolyada A, 2013, BBA-PROTEINS PROTEOM, V1834, P2080, DOI 10.1016/j.bbapap.2013.06.009; Law RHP, 2012, CELL REP, V1, P185, DOI 10.1016/j.celrep.2012.02.012; Lee CJ, 2010, STRUCTURE, V18, P366, DOI 10.1016/j.str.2009.12.013; Lee NK, 2005, BIOPHYS J, V88, P2939, DOI 10.1529/biophysj.104.054114; Lehtinen MJ, 2004, J MOL BIOL, V344, P1385, DOI 10.1016/j.jmb.2004.10.017; Lerner E, 2018, SCIENCE, V359, P288, DOI 10.1126/science.aan1133; Levine JS, 2002, NEW ENGL J MED, V346, P752, DOI 10.1056/NEJMra002974; LOZIER J, 1984, P NATL ACAD SCI-BIOL, V81, P3640, DOI 10.1073/pnas.81.12.3640; Lutters BCH, 2003, J BIOL CHEM, V278, P33831, DOI 10.1074/jbc.M212655200; MCNEIL HP, 1990, P NATL ACAD SCI USA, V87, P4120, DOI 10.1073/pnas.87.11.4120; Meroni PL, 2011, NAT REV RHEUMATOL, V7, P330, DOI 10.1038/nrrheum.2011.52; Muia J, 2014, P NATL ACAD SCI USA, V111, P18584, DOI 10.1073/pnas.1413282112; Muller BK, 2005, BIOPHYS J, V89, P3508, DOI 10.1529/biophysj.105.064766; Nir E, 2006, J PHYS CHEM B, V110, P22103, DOI 10.1021/jp063483n; Ohkura N, 1998, BLOOD, V91, P4173, DOI 10.1182/blood.V91.11.4173.411k35_4173_4179; OOSTING JD, 1992, THROMB HAEMOSTASIS, V67, P499; Osborne AJ, 2018, J BIOL CHEM, V293, P17166, DOI 10.1074/jbc.RA118.004767; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Passam FH, 2010, BLOOD, V116, P1995, DOI 10.1182/blood-2010-02-271494; Pedersen DV, 2017, EMBO J, V36, P1084, DOI 10.15252/embj.201696173; Pengo V, 2018, THROMB RES, V172, P172, DOI 10.1016/j.thromres.2018.11.003; Pierangeli SS, 2007, ANN RHEUM DIS, V66, P1327, DOI 10.1136/ard.2006.065037; Pierangeli SS, 1996, LUPUS, V5, P451, DOI 10.1177/096120339600500524; Pozzi N, 2016, J BIOL CHEM, V291, P18107, DOI 10.1074/jbc.M116.738310; Pozzi N, 2010, PROTEIN SCI, V19, P1065, DOI 10.1002/pro.387; Schrimpf W, 2018, BIOPHYS J, V114, P1518, DOI 10.1016/j.bpj.2018.02.035; SCHULTZE HE, 1961, NATURWISSENSCHAFTEN, V48, P719, DOI 10.1007/BF00620967; Schwarzenbacher R, 1999, EMBO J, V18, P6228, DOI 10.1093/emboj/18.22.6228; Sheng YH, 1998, J IMMUNOL, V161, P2038; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Van Os GMA, 2011, J THROMB HAEMOST, V9, P2447, DOI 10.1111/j.1538-7836.2011.04532.x; Zhang JW, 2005, BLOOD, V105, P1964, DOI 10.1182/blood-2004-05-1708	76	9	9	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2020	295	31					10794	10806		10.1074/jbc.RA120.013939	http://dx.doi.org/10.1074/jbc.RA120.013939			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB3HM	32518155	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000560405600022
J	Chaudhari, K; Wang, JM; Xu, Y; Winters, A; Wang, LS; Dong, XW; Cheng, EY; Liu, R; Yang, SH				Chaudhari, Kiran; Wang, Jianmei; Xu, Yong; Winters, Ali; Wang, Linshu; Dong, Xiaowei; Cheng, Eric Y.; Liu, Ran; Yang, Shao-Hua			Determination of metformin bio-distribution by LC-MS/MS in mice treated with a clinically relevant paradigm	PLOS ONE			English	Article							EXTENDS LIFE-SPAN; GENDER-DIFFERENCES; CRYSTAL-STRUCTURE; HUMAN PLASMA; DRUG; PHARMACOKINETICS; VALIDATION; EXPRESSION; THERAPY; CANCER	Metformin, an anti-diabetes drug, has been recently emerging as a potential "anti-aging" intervention based on its reported beneficial actions against aging in preclinical studies. Nonetheless, very few metformin studies using mice have determined metformin concentrations and many effects of metformin have been observed in preclinical studies using doses/concentrations that were not relevant to therapeutic levels in human. We developed a liquid chromatography-tandem mass spectrometry protocol for metformin measurement in plasma, liver, brain, kidney, and muscle of mice. Young adult male and female C57BL/6 mice were voluntarily treated with metformin of 4 mg/ml in drinking water which translated to the maximum dose of 2.5 g/day in humans. A clinically relevant steady-state plasma metformin concentrations were achieved at 7 and 30 days after treatment in male and female mice. Metformin concentrations were slightly higher in muscle than in plasma, while, similar to 3 and 6-fold higher in the liver and kidney than in plasma, respectively. Low metformin concentration was found in the brain at similar to 20% of the plasma level. Furthermore, gender difference in steady-state metformin bio-distribution was observed. Our study established steady-state metformin levels in plasma, liver, muscle, kidney, and brain of normoglycemic mice treated with a clinically relevant dose, providing insight into future metformin preclinical studies for potential clinical translation.	[Chaudhari, Kiran; Xu, Yong; Winters, Ali; Wang, Linshu; Liu, Ran; Yang, Shao-Hua] Univ North Texas, Hlth Sci Ctr, Inst Hlth Aging, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA; [Wang, Jianmei] Univ North Texas, Hlth Sci Ctr, Pharmaceut Anal Core Lab, Coll Pharm, Ft Worth, TX USA; [Dong, Xiaowei; Cheng, Eric Y.] Univ North Texas, Hlth Sci Ctr, Pharmaceut Sci, Coll Pharm, Ft Worth, TX USA	University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton	Yang, SH (corresponding author), Univ North Texas, Hlth Sci Ctr, Inst Hlth Aging, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA.	shaohua.yang@unthsc.edu	Chaudhari, Kiran/G-9031-2015; Wang, Jianmei/HHZ-0585-2022	Cheng, Eric/0000-0001-9336-2593	National Institutes of Health [R01NS088596, R01NS109583]; American Heart Association [17POST33670981]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was partly supported by the National Institutes of Health grants R01NS088596 (SY), R01NS109583 (SY), and American Heart Association Grant 17POST33670981 (KC)	Al Bratty M, 2017, CHROMATOGRAPHIA, V80, P891, DOI 10.1007/s10337-017-3288-0; Alfaras I, 2017, NPJ AGING MECH DIS, V3, DOI 10.1038/s41514-017-0018-7; Anisimov VN, 2008, CELL CYCLE, V7, P2769, DOI 10.4161/cc.7.17.6625; Anisimov VN, 2010, AGING-US, V2, P945, DOI 10.18632/aging.100245; Anisimov VN, 2010, CELL CYCLE, V9, P188, DOI 10.4161/cc.9.1.10407; [Anonymous], 2018, BIOANALYTICAL METHOD, V44; [Anonymous], 2016, CLIN REP, V9, P1, DOI DOI 10.3823/1909; Antonopoulos N, 2018, MOLECULES, V23, DOI 10.3390/molecules23071548; Bailey CJ, 2017, DIABETOLOGIA, V60, P1566, DOI 10.1007/s00125-017-4318-z; Barini E, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0082-7; Chandel NS, 2016, CELL METAB, V23, P569, DOI 10.1016/j.cmet.2016.03.010; Chen XY, 2004, J CHROMATOGR B, V802, P377, DOI 10.1016/j.jchromb.2003.12.017; Chen YM, 2009, P NATL ACAD SCI USA, V106, P3907, DOI 10.1073/pnas.0807991106; DeFronzo R, 2016, METABOLISM, V65, P20, DOI 10.1016/j.metabol.2015.10.014; Duca FA, 2015, NAT MED, V21, P506, DOI 10.1038/nm.3787; Elgawish MS, 2019, J CHROMATOGR B, V1124, P47, DOI 10.1016/j.jchromb.2019.05.036; Freire AC, 2011, INT J PHARMACEUT, V415, P15, DOI 10.1016/j.ijpharm.2011.04.069; Gergov M, 2015, J ANAL TOXICOL, V39, P359, DOI 10.1093/jat/bkv020; Ghasemi F, 2019, J MOL STRUCT, V1193, P310, DOI 10.1016/j.molstruc.2019.05.040; Glossmann HH, 2019, EUR J PHARMACOL, V865, DOI 10.1016/j.ejphar.2019.172782; Gormsen LC, 2016, J NUCL MED, V57, P1920, DOI 10.2967/jnumed.116.177774; Govender K, 2018, J CHROMATOGR B, V1095, P127, DOI 10.1016/j.jchromb.2018.07.041; Graham GG, 2011, CLIN PHARMACOKINET, V50, P81, DOI 10.2165/11534750-000000000-00000; He L, 2015, CELL METAB, V21, P159, DOI 10.1016/j.cmet.2015.01.003; Hess C, 2018, FORENSIC SCI INT, V286, P106, DOI 10.1016/j.forsciint.2018.03.003; Higgins JW, 2012, DRUG METAB DISPOS, V40, P1170, DOI 10.1124/dmd.112.044875; Hou M, 2010, BIOCHEM BIOPH RES CO, V397, P537, DOI 10.1016/j.bbrc.2010.05.152; Iversen AB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10010-z; Jensen JB, 2016, DIABETES, V65, P1724, DOI 10.2337/db16-0032; Kajbaf F, 2016, CLIN PHARMACOKINET, V55, P439, DOI 10.1007/s40262-015-0323-x; Kaneb HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024189; Kathuria D, 2018, J MOL STRUCT, V1152, P61, DOI 10.1016/j.molstruc.2017.08.100; Kickstein E, 2010, P NATL ACAD SCI USA, V107, P21830, DOI 10.1073/pnas.0912793107; Kimura Naoko, 2005, Drug Metab Pharmacokinet, V20, P379, DOI 10.2133/dmpk.20.379; Lalau JD, 2011, CLIN DRUG INVEST, V31, P435, DOI 10.2165/11588310-000000000-00000; Levin AV, 2005, CAN J OPHTHALMOL, V40, P685, DOI 10.1016/S0008-4182(05)80084-5; Li WJ, 2019, AGING DIS, V10, P949, DOI 10.14336/AD.2019.0120; Dias BCL, 2019, BIOMED CHROMATOGR, V33, DOI 10.1002/bmc.4663; Ma TC, 2007, NEUROSCI LETT, V411, P98, DOI 10.1016/j.neulet.2006.10.039; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Malinska H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150924; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; Matthes F, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-017-0003-8; Mohamed D, 2019, BMC CHEM, V13, DOI 10.1186/s13065-019-0597-4; Mondal S, 2018, J PHYS CHEM B, V122, P2227, DOI 10.1021/acs.jpcb.7b11928; Moussa BA, 2019, J PHARMACEUT BIOMED, V163, P153, DOI 10.1016/j.jpba.2018.09.052; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Ningrum VDA, 2018, J CLIN TRANSL ENDOCR, V12, P42, DOI 10.1016/j.jcte.2018.05.001; Overgaard MD, 2019, CONTRAST MEDIA MOL I, DOI 10.1155/2019/9787340; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Paleari L, 2018, GASTROENTEROLOGY, V154, P1543, DOI 10.1053/j.gastro.2017.12.040; Paul D, 2017, J PHARMACEUT BIOMED, V143, P1, DOI 10.1016/j.jpba.2017.05.026; Sambol NC, 1996, J CLIN PHARMACOL, V36, P1012, DOI 10.1177/009127009603601105; Scherf-Clavel O, 2019, J PHARMACEUT BIOMED, V175, DOI 10.1016/j.jpba.2019.07.002; Sengupta P, 2009, CHROMATOGRAPHIA, V69, P1243, DOI 10.1365/s10337-009-1056-5; Shah PA, 2019, J PHARMACEUT BIOMED, V175, DOI 10.1016/j.jpba.2019.112790; Shah PA, 2016, J PHARMACEUT BIOMED, V131, P64, DOI 10.1016/j.jpba.2016.08.011; Slitt AL, 2002, DRUG METAB DISPOS, V30, P212, DOI 10.1124/dmd.30.2.212; Soukas AA, 2019, TRENDS ENDOCRIN MET, V30, P745, DOI 10.1016/j.tem.2019.07.015; Thangthaeng N, 2017, AGING DIS, V8, P17, DOI 10.14336/AD.2016.1010; Urakami Y, 1999, FEBS LETT, V461, P339, DOI 10.1016/S0014-5793(99)01491-X; Urakami Y, 2000, FEBS LETT, V473, P173, DOI 10.1016/S0014-5793(00)01525-8; Walton RG, 2019, AGING CELL, V18, DOI 10.1111/acel.13039; Wang JM, 2013, BIOMED CHROMATOGR, V27, P1463, DOI 10.1002/bmc.2945; Wei XD, 2014, B KOREAN CHEM SOC, V35, P3495, DOI 10.5012/bkcs.2014.35.12.3495; Wu B, 2019, LIFE SCI, V226, P185, DOI 10.1016/j.lfs.2019.04.009; Zabielski P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25397-6; Zhang XY, 2014, J CHROMATOGR SCI, V52, P52, DOI 10.1093/chromsci/bms204; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zi FM, 2018, ONCOL LETT, V15, P683, DOI 10.3892/ol.2017.7412	70	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234571	10.1371/journal.pone.0234571	http://dx.doi.org/10.1371/journal.pone.0234571			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525922	Green Published, gold			2022-12-26	WOS:000542036800058
J	Martin, S; Youngentob, KN; Clark, RG; Foley, WJ; Marsh, KJ				Martin, Sarah; Youngentob, Kara N.; Clark, Robert G.; Foley, William J.; Marsh, Karen J.			The distribution and abundance of an unusual resource for koalas (Phascolarctos cinereus) in a sodium-poor environment	PLOS ONE			English	Article							SALT TOLERANCE; EUCALYPTUS; SALINITY; LIMITATION; DYNAMICS; GEOPHAGY	Environmentally available sodium tends to decrease with increasing elevation, and sodium resources in these sodium-poor environments are critical for the survival of herbivores. Eucalypt leaves in the subalpine Monaro region of NSW, Australia contain much less sodium than eucalypt leaves at lower elevations, and subalpine koalas obtain this much needed resource by eating the bark from someEucalyptus manniferatrees. To better understand the availability of salty-barked trees, we searched for evidence of koala bark chewing at 100 randomly generated locations in the region. We found 318E.manniferatrees with koala chew marks. We also analysed sodium concentrations in the bark of three unchewedE.manniferatrees from each site to determine whether there were trees with high bark sodium content that had not yet been utilized by koalas. Although 90% of unchewed trees had sodium concentrations less than 225.4 mg.kg(-1)DM, some unchewed trees contained high sodium concentrations (up to 1213.1 mg.kg(-1)DM). From the random survey, we can extrapolate that 11% of trees in this area have bark sodium above 300 mg.kg(-1)DM, which is based on the concentration of bark sodium observed in at least moderately chewed trees. We would expect to find 0.24 of these trees per 200 m(2), or 720,000 salty-barked trees in the 30 km by 20 km study area. Bark chewing by koalas is widespread in the area, and trees with salty bark are more common than initially thought. We discuss correlations with the occurrence of salty-barked trees and other landscape attributes; however, questions remain about why someE.manniferatrees have much more bark sodium than others. Studies such as this one should be expanded to identify sodium resources and their availability for other herbivorous species, since many are predicted to move to higher elevations in response to climate change.	[Martin, Sarah; Youngentob, Kara N.; Foley, William J.; Marsh, Karen J.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Clark, Robert G.] Australian Natl Univ, Res Sch Finance Actuarial Studies & Stat, Canberra, ACT, Australia	Australian National University; Australian National University	Youngentob, KN (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia.	kara.youngentob@anu.edu.au	Marsh, Karen/AED-4842-2022; Foley, William J/C-8069-2009; Marsh, Karen/AFQ-2818-2022; Youngentob, Kara/N-1501-2013	Marsh, Karen/0000-0002-9699-8033; Foley, William J/0000-0001-8587-1814; Marsh, Karen/0000-0002-9699-8033; Youngentob, Kara/0000-0002-4295-9784; Clark, Robert/0000-0003-4368-5145	New South Wales (NSW) Office of Environment and Heritage (OEH); Australian Government Biodiversity Fund [LSP945029-1202]; Australian National University, Research School of Biology	New South Wales (NSW) Office of Environment and Heritage (OEH); Australian Government Biodiversity Fund; Australian National University, Research School of Biology	KNY received funding to support this work from the New South Wales (NSW) Office of Environment and Heritage (OEH). This came from a grant to NSW OEH from the Australian Government Biodiversity Fund (Grant number LSP945029-1202). https://www.anao.gov.au/work/performance-audit/administration-biodiversityfund-program WJF received financial support from the Australian National University, Research School of Biology. https://biology.anu.edu.au/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MA, 2005, PLANT CELL ENVIRON, V28, P772, DOI 10.1111/j.1365-3040.2005.01328.x; Allen C, 2010, ISLAMOPHOBIA, P1; Andrew RL, 2007, ECOLOGY, V88, P716, DOI 10.1890/05-1858; Au J, 2017, J MAMMAL, V98, P1185, DOI 10.1093/jmammal/gyx045; Banks SC, 2011, P ROY SOC B-BIOL SCI, V278, P2768, DOI 10.1098/rspb.2010.2657; BELOVSKY GE, 1981, J MAMMAL, V62, P613, DOI 10.2307/1380408; Best EC, 2013, J MAMMAL, V94, P1237, DOI 10.1644/13-MAMM-A-054.1; BLAIRWEST JR, 1967, AUST J EXP BIOL MED, V45, P1, DOI 10.1038/icb.1967.1; Boland DJ, 2006, FOREST TREES AUSTR; Bolker B, 2008, ECOLOGICAL MODELS DA; Borger GA, 1973, DEV SHEDDING BARK; Burchfield E, 2006, AUSTR J ZOOLOGY, V56, P395, DOI [10.1071/ZO05045, DOI 10.1071/Z005045]; Canty A, 2019, R PACKAGE BOOT; Costin AB, 1954, STUDY ECOSYSTEMS MON; Denton D.A., 1982, HUNGER SALT ANTHR PH; FLOWERS TJ, 1981, NEW PHYTOL, V88, P363, DOI 10.1111/j.1469-8137.1981.tb01731.x; FREELAND WJ, 1985, BIOCHEM SYST ECOL, V13, P195, DOI 10.1016/0305-1978(85)90079-1; Grieve CM, 1999, HORTSCIENCE, V34, P867, DOI 10.21273/HORTSCI.34.5.867; HASTINGS JJ, 1991, J MAMMAL, V72, P641, DOI 10.2307/1381825; HEBERT D, 1971, CAN J ZOOLOG, V49, P605, DOI 10.1139/z71-097; Kaspari M, 2008, P NATL ACAD SCI USA, V105, P17848, DOI 10.1073/pnas.0804528105; Marsh KJ, 2019, PHYTOCHEMISTRY, V160, P31, DOI 10.1016/j.phytochem.2019.01.005; Marsh KJ, 2017, PHYTOCHEMISTRY, V144, P197, DOI 10.1016/j.phytochem.2017.09.014; Meterology ABo, 2016, CLIM DAT 2016; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; National Atmospheric Deposition Program/National Trends Network, SOD ION WET DEP; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Pecl GT, 2017, SCIENCE, V355, DOI 10.1126/science.aai9214; R Core Team, 2019, R LANG ENV STAT COMP; Rodushkin I, 1999, ANAL CHIM ACTA, V378, P191, DOI 10.1016/S0003-2670(98)00635-7; Rothman JM, 2006, BIOL LETTERS, V2, P321, DOI 10.1098/rsbl.2006.0480; Stace HCT, 1961, MORPHOLOGICAL CHEM C; TAYLOR G, 1990, PALAEOGEOGR PALAEOCL, V78, P109, DOI 10.1016/0031-0182(90)90207-N; Tucker DJ, 2010, J CHEM ECOL, V36, P727, DOI 10.1007/s10886-010-9803-5; Wallis IR, 2004, ROLE NUTR CONSERVATI; WILLIAMS WD, 1970, AUST J MAR FRESH RES, V21, P103; Worker SB, 2015, CAN J ZOOL, V93, P323, DOI 10.1139/cjz-2014-0237	38	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234515	10.1371/journal.pone.0234515	http://dx.doi.org/10.1371/journal.pone.0234515			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525918	Green Published, gold			2022-12-26	WOS:000542036800017
J	Chang, SX; Chen, KK; Liu, XT; Xia, N; Xiong, PS; Cai, YM				Chang, Shu-Xia; Chen, Kang-Kang; Liu, Xiao-Ting; Xia, Nan; Xiong, Pei-Sheng; Cai, Yu-Mao			Cross-sectional study of asymptomatic Neisseria gonorrhoeae and Chlamydia trachomatis infections in sexually transmitted disease related clinics in Shenzhen, China	PLOS ONE			English	Article							RISK-FACTORS; UNITED-STATES; SYNDROMIC MANAGEMENT; PREVALENCE; WOMEN; COST	The aims of this study were to investigate the prevalence and proportion of laboratory-confirmed urethral Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections that were asymptomatic among individuals presenting to clinics in Shenzhen and the risk factors related to asymptomatic CT infection. In a cross-sectional study, eligible individuals were invited to participate in the questionnaire, and urine specimens were collected to identify CT and NG infections using a nucleic acid amplification test (NAAT). Considering the differences in the presentation of symptoms between men and women, this study was stratified by gender. Corresponding outcomes were analyzed by Chi-square test and multivariate logistic regression. A total of 2,871 participants were asymptomatic and included in our analyses: 1120 (39.0%) men and 1751 (61.0%) women. The prevalence of asymptomatic NG and CT infections was 0.9% and 6.2% in men, and 0.4% and 7.9% in women, respectively. The proportion of asymptomatic urethral CT among men with urethral CT was 28.3%; for women, it was 34.2%. For asymptomatic men with CT, 3 independent risk factors were identified: (1) men under the age of 30 (aOR, 1.83; 95% CI, 1.11-3.03); (2) being employed in the commercial service work (2.82; 1.36-5.84); and (3) being recruited through the urological department (2.12; 1.19-3.79). For asymptomatic women with urethral CT, age less than 30 years was a risk factor. In conclusion, a substantial prevalence of asymptomatic CT infections was found among men and women presenting to clinics in Shenzhen. The significant correlation between asymptomatic CT infection and these risk factors could help identify high-risk populations and guide screening.	[Chang, Shu-Xia] Shenzhen Longgang Ctr Chron Dis Control, Shenzhen, Peoples R China; [Chen, Kang-Kang; Xiong, Pei-Sheng] Shantou Univ, Dept Prevent Med, Coll Med, Shantou, Peoples R China; [Liu, Xiao-Ting] Shantou Univ, Dept Nursing, Coll Med, Shantou, Peoples R China; [Xia, Nan] Cent South Univ, Dept Prevent Med, Changsha, Peoples R China; [Cai, Yu-Mao] Shenzhen Ctr Chron Dis Control, Shenzhen, Peoples R China	Shantou University; Shantou University; Central South University	Cai, YM (corresponding author), Shenzhen Ctr Chron Dis Control, Shenzhen, Peoples R China.	caiyumao@163.com	Xia, Nan/ABG-4600-2021	xiong, peisheng/0000-0002-6686-0113	Sanming Project of Medicine in Shenzhen [SZSM201611077]	Sanming Project of Medicine in Shenzhen	This work was supported by [Sanming Project of Medicine in Shenzhen] grant number [SZSM201611077] to SC.	[Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2002, GYNECOL ONCOL 2, V78, pS1; Barry MS, 2018, TROP MED INT HEALTH, V23, P541, DOI 10.1111/tmi.13046; Cai WD, 2010, SEX TRANSM INFECT, V86, P15, DOI 10.1136/sti.2009.037440; Datta SD, 2012, SEX TRANSM DIS, V39, P92, DOI 10.1097/OLQ.0b013e31823e2ff7; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Harder E, 2016, SEX TRANSM DIS, V43, P113, DOI 10.1097/OLQ.0000000000000394; Honey E, 2002, SEX TRANSM INFECT, V78, P406, DOI 10.1136/sti.78.6.406; Kaida A, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3380-6; Lanjouw E, 2016, INT J STD AIDS, V27, P333, DOI 10.1177/0956462415618837; Lewis DA, 1999, INT J STD AIDS, V10, P588, DOI 10.1258/0956462991914717; Mlisana K, 2012, J INFECT DIS, V206, P6, DOI 10.1093/infdis/jis298; Ong JJ, 2017, CLIN MICROBIOL INFEC, V23, P555, DOI 10.1016/j.cmi.2017.02.020; Otieno FO, 2014, INT J STD AIDS, V25, P851, DOI 10.1177/0956462414523260; Owusu-Edusei K, 2013, SEX TRANSM DIS, V40, P197, DOI 10.1097/OLQ.0b013e318285c6d2; Parish WL, 2003, JAMA-J AM MED ASSOC, V289, P1265, DOI 10.1001/jama.289.10.1265; Priest D, 2017, SEX TRANSM INFECT, V93, P478, DOI 10.1136/sextrans-2016-052950; Rowley J, 2019, B WORLD HEALTH ORGAN, V97, P548, DOI 10.2471/BLT.18.228486; Skjeldestad FE, 2009, SEX TRANSM DIS, V36, P273, DOI 10.1097/OLQ.0b013e3181924386; Sonnenberg P, 2013, LANCET, V382, P1795, DOI 10.1016/S0140-6736(13)61947-9; Soriano V, 2018, AIDS REV, V20, P187, DOI 10.24875/AIDSRev.18000034; Tao GY, 2012, SEX TRANSM DIS, V39, P605, DOI 10.1097/OLQ.0b013e318254c837; Tsoumanis A, 2018, SEX TRANSM DIS, V45, P615, DOI [10.1097/OLQ.0000000000000824, 10.1097/olq.0000000000000824]; US Preventive Services Task Force, 2007, ANN INTERN MED, V147, P128, DOI 10.7326/0003-4819-147-2-200707170-00172; van der Eem L, 2016, TROP MED INT HEALTH, V21, P1138, DOI 10.1111/tmi.12742; White RG, 2008, SEX TRANSM INFECT, V84, P528, DOI 10.1136/sti.2008.032011; Wong WCW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172561; Wu D, 2019, SEX TRANSM DIS, V46, P260, DOI [10.1097/OLQ.0000000000000963, 10.1097/olq.0000000000000963]; Zhang JJ, 2012, SEX TRANSM INFECT, V88, P272, DOI 10.1136/sextrans-2011-050163	29	7	9	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2020	15	6							e0234261	10.1371/journal.pone.0234261	http://dx.doi.org/10.1371/journal.pone.0234261			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ1GC	32516318	Green Published, gold			2022-12-26	WOS:000540977000036
J	Chen, L; Zhang, LY; Wang, WD; Qiu, W; Liu, L; Ning, AH; Cao, J; Huang, M; Zhong, MT				Chen, Lei; Zhang, Liangyu; Wang, Wendong; Qiu, Wei; Liu, Lei; Ning, Anhong; Cao, Jing; Huang, Min; Zhong, Mintao			Polysaccharides isolated from Cordyceps Sinensis contribute to the progression of NASH by modifying the gut microbiota in mice fed a high-fat diet	PLOS ONE			English	Article							LIVER-DISEASE; LIPID-METABOLISM; INDUCED OBESITY; FIBER; SUPPLEMENTATION; INTERVENTION; SREBP; RISK; L.	Various dietary fibers are considered to prevent obesity by modulating the gut microbiota. Cordyceps sinensis polysaccharide (CSP) is a soluble dietary fiber known to have protective effects against obesity and related diseases, but whether these effects induce any side effects remains unknown. The function and safety of CSP were tested in high-fat diet (HFD)-feding C57BL/6J mice. The results revealed that even though CSP supplementation could prevent an increase in body weight, it aggravated liver fibrosis and steatosis as evidenced by increased inflammation, lipid metabolism markers, insulin resistance (IR) and alanine aminotransferase (ALT) in HFD-induced obesity. 16S rDNA gene sequencing was used to analyze the gut microbiota composition, and the relative abundance of the Actinobacteria phylum, including the Olsenella genus, was significantly higher in CSP-treated mice than in HFD-fed mice. CSP supplementation may increase the proportion of Actinobacteria, which can degrade CSP. The high level of Actinobacteria aggravated the disorder of the intestinal flora and contributed to the progression from obesity to nonalcoholic steatohepatitis (NASH) and related diseases.	[Chen, Lei; Zhang, Liangyu; Qiu, Wei; Liu, Lei; Ning, Anhong; Cao, Jing; Huang, Min; Zhong, Mintao] Dalian Med Univ, Dept Microbiol, Coll Basic Med Sci, Dalian, PR, Peoples R China; [Wang, Wendong] Dalian Med Univ, Affiliated Hosp 1, Dalian, Peoples R China	Dalian Medical University; Dalian Medical University	Zhong, MT (corresponding author), Dalian Med Univ, Dept Microbiol, Coll Basic Med Sci, Dalian, PR, Peoples R China.	dalianzhongmintao@163.com		Zhong, Mintao/0000-0001-6846-3253				Aby ES, 2019, JAMA INTERN MED, V179, P1308, DOI 10.1001/jamainternmed.2019.1240; Aleixandre A, 2008, CRIT REV FOOD SCI, V48, P905, DOI 10.1080/10408390701761886; [Anonymous], 2017, J ADOLESC HLTH S, V61, pS1; [Anonymous], 2017, ADHD ATTENTION DE S1, V9, pS1, DOI 10.1007/s12402-017-0224-y; BHIVA/ BASHH, 2019, HIV MED S2, V20, ps2; Canfora EE, 2019, NAT REV ENDOCRINOL, V15, P261, DOI 10.1038/s41574-019-0156-z; Carlucci C, 2016, EBIOMEDICINE, V13, P37, DOI 10.1016/j.ebiom.2016.09.029; Caussy C, 2018, HEPATOLOGY; Caussy C, 2018, NAT REV GASTRO HEPAT, V15, P719, DOI 10.1038/s41575-018-0058-x; Chen GJ, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700485; Chen J, 2018, J NUTR BIOCHEM, V61, P17, DOI 10.1016/j.jnutbio.2018.06.009; Choi Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep15878; Chu HK, 2019, GUT, V68, P359, DOI 10.1136/gutjnl-2018-316307; Crusell MKW, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0472-x; Di Lorenzo F, 2019, FEMS MICROBIOL REV, V43, P257, DOI 10.1093/femsre/fuz002; Downes J, 2013, INT J SYST EVOL MICR, V63, P1214, DOI 10.1099/ijs.0.041376-0; Eid HM, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00387; Fan SH, 2019, BIOSCI BIOTECH BIOCH, V83, P2334, DOI 10.1080/09168451.2019.1650635; Farzanegi P, 2019, EUR J SPORT SCI, V19, P994, DOI 10.1080/17461391.2019.1571114; Font-Burgada J, 2016, CELL METAB, V23, P48, DOI 10.1016/j.cmet.2015.12.015; Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9; Gao H, 2018, CARBOHYD POLYM, V201, P624, DOI 10.1016/j.carbpol.2018.08.075; Guo BB, 2019, MOL NUTR FOOD RES, V63, DOI [10.1002/mnfr.201800808, 10.1002/mnfr.201970007]; Hassan NF, 2019, INFLAMMATION, V42, P1056, DOI 10.1007/s10753-019-00967-6; Hersoug LG, 2018, NUTR RES REV, V31, P153, DOI [10.1017/S0954422417000269, 10.1017/s0954422417000269]; Jiao XY, 2019, J NUTR BIOCHEM, V64, P88, DOI 10.1016/j.jnutbio.2018.07.008; Kang YB, 2019, INT J OBESITY, V43, P1631, DOI 10.1038/s41366-018-0187-x; Kelly TN, 2016, CIRC RES, V119, P956, DOI 10.1161/CIRCRESAHA.116.309219; Khan I, 2018, J FUNCT FOODS, V41, P191, DOI 10.1016/j.jff.2017.12.046; Kim S, 2018, CLIN SCI, V132, P701, DOI [10.1042/CS20180087, 10.1042/cs20180087]; Kolodziejczyk AA, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809302; Komaroff AL, 2017, JAMA-J AM MED ASSOC, V317, P355, DOI 10.1001/jama.2016.20099; Lakhani HV, 2018, INT J MED SCI, V15, P1591, DOI 10.7150/ijms.27953; Lean MEJ, 2019, NAT REV ENDOCRINOL, V15, P251, DOI 10.1038/s41574-019-0186-6; Li L, 2019, FOOD FUNCT, V10, P2560, DOI [10.1039/c9fo00075e, 10.1039/C9FO00075E]; Li WF, 2018, J AGR FOOD CHEM, V66, P8015, DOI 10.1021/acs.jafc.8b02979; Li Y, 2018, MOL PHARMACEUT, V15, P3860, DOI 10.1021/acs.molpharmaceut.8b00347; Liu M, 2018, J FUNCT FOODS, V48, P220, DOI 10.1016/j.jff.2018.07.006; Makki K, 2018, CELL HOST MICROBE, V23, P705, DOI 10.1016/j.chom.2018.05.012; McCullough AJ, 2006, J CLIN GASTROENTEROL, V40, pS17; Miles JP, 2017, INFLAMM BOWEL DIS, V23, P1133, DOI 10.1097/MIB.0000000000001155; Mokhtari Z, 2017, ADV NUTR, V8, P240, DOI 10.3945/an.116.013151; Mouries J., 2019, J HEPATOL; Nguyen SG, 2016, FOOD FUNCT, V7, P4193, DOI [10.1039/C6FO00929H, 10.1039/c6fo00929h]; Nie QX, 2019, FOOD HYDROCOLLOID, V86, P34, DOI 10.1016/j.foodhyd.2017.12.026; Ohashi T, 2018, FOOD CHEM TOXICOL, V118, P190, DOI 10.1016/j.fct.2018.05.006; Pedret A, 2019, INT J OBESITY, V43, P1863, DOI 10.1038/s41366-018-0220-0; Ponziani FR, 2019, HEPATOLOGY, V69, P107, DOI 10.1002/hep.30036; Porras D, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201800930; Quan HY, 2013, BIOCHEM PHARMACOL, V85, P1330, DOI 10.1016/j.bcp.2013.02.007; Rangan KJ, 2017, TRENDS BIOCHEM SCI, V42, P887, DOI 10.1016/j.tibs.2017.08.005; Ren ZG, 2019, GUT, V68, P1014, DOI 10.1136/gutjnl-2017-315084; Reynolds A, 2019, LANCET, V393, P434, DOI 10.1016/S0140-6736(18)31809-9; Sato H, 2016, GASTROENTEROLOGY, V151, P923, DOI 10.1053/j.gastro.2016.07.009; Schachter J, 2018, BRAIN BEHAV IMMUN, V69, P1, DOI 10.1016/j.bbi.2017.08.026; Schuster S, 2018, NAT REV GASTRO HEPAT, V15, P349, DOI 10.1038/s41575-018-0009-6; Schwalm ND, 2017, TRENDS MICROBIOL, V25, P1005, DOI 10.1016/j.tim.2017.06.009; Schweinlin A, 2018, Z GASTROENTEROL, V56, P1247, DOI 10.1055/a-0668-2891; Schwimmer J.B., 2019, GASTROENTEROLOGY; Shanahan F, 2017, GUT, V66, P1709, DOI 10.1136/gutjnl-2017-313872; Shen T, 2019, GASTROENTEROLOGY, V156, P2230, DOI 10.1053/j.gastro.2019.02.002; Singh V, 2018, CELL, V175, P679, DOI 10.1016/j.cell.2018.09.004; Sun LJ, 2018, PROTEIN CELL, V9, P397, DOI 10.1007/s13238-018-0546-3; Tang WHW, 2019, NAT REV CARDIOL, V16, P137, DOI 10.1038/s41569-018-0108-7; Toscano M, 2017, WORLD J GASTROENTERO, V23, P2696, DOI 10.3748/wjg.v23.i15.2696; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2017, CELL HOST MICROBE, V21, P278, DOI 10.1016/j.chom.2017.02.021; Urnov FD, 2018, NAT MED, V24, P899, DOI 10.1038/s41591-018-0110-y; Wang L, 2018, J FOOD SCI, V83, P864, DOI 10.1111/1750-3841.14058; Weiss GA, 2014, BRIT J NUTR, V111, P1602, DOI 10.1017/S0007114513004200; Wu TR, 2019, GUT, V68, P248, DOI 10.1136/gutjnl-2017-315458; Xiao X, 2013, ACTA BIOCH BIOPH SIN, V45, P2, DOI 10.1093/abbs/gms112; Xie RX, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02608; Xu PF, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12399; Yan SM, 2019, FOOD FUNCT, V10, P1747, DOI 10.1039/c8fo02163e; Yue Y, 2014, FOOD CHEM TOXICOL, V74, P76, DOI 10.1016/j.fct.2014.09.006; Zarei M, 2019, BRIT J PHARMACOL, V176, P2292, DOI 10.1111/bph.14678; Zhao JB, 2018, J AGR FOOD CHEM, V66, P7995, DOI 10.1021/acs.jafc.8b02545; Zhao LP, 2013, NAT REV MICROBIOL, V11, P639, DOI 10.1038/nrmicro3089; Zhong L., 2019, J CELL BIOCH; Zhou YL, 2018, CELL PHYSIOL BIOCHEM, V51, P2123, DOI 10.1159/000495830; Zhu ZJ, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201800446	82	14	15	6	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2020	15	6							e0232972	10.1371/journal.pone.0232972	http://dx.doi.org/10.1371/journal.pone.0232972			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ0RE	32512581	Green Published, gold			2022-12-26	WOS:000540938100005
J	Spinelli, M; Boucard, C; Di Nicuolo, F; Haesler, V; Castellani, R; Pontecorvi, A; Scambia, G; Granieri, C; Barnea, ER; Surbek, D; Mueller, M; Di Simone, N				Spinelli, Marialuigia; Boucard, Celine; Di Nicuolo, Fiorella; Haesler, Valerie; Castellani, Roberta; Pontecorvi, Alfredo; Scambia, Giovanni; Granieri, Chiara; Barnea, Eytan R.; Surbek, Daniel; Mueller, Martin; Di Simone, Nicoletta			Synthetic PreImplantation Factor (sPIF) reduces inflammation and prevents preterm birth	PLOS ONE			English	Article							FETAL-GROWTH RESTRICTION; CYTOKINE; DISEASE; INJURY; NEUROPROTECTION; ACTIVATION; MODEL; CELL	Preterm birth (PTB) is the leading cause of neonatal morbidity and mortality and spontaneous PTB is a major contributor. The preceding inflammation/infection contributes not only to spontaneous PTB but is associated with neonatal morbidities including impaired brain development. Therefore, control of exaggerated immune response during pregnancy is an attractive strategy. A potential candidate is synthetic PreImplantation Factor (sPIF) as sPIF prevents inflammatory induced fetal loss and has neuroprotective properties. Here, we tested maternal sPIF prophylaxis in pregnant mice subjected to a lipopolysaccharides (LPS) insult, which results in PTB. Additionally, we evaluated sPIF effects in placental and microglial cell lines. Maternal sPIF application reduced the LPS induced PTB rate significantly. Consequently, sPIF reduced microglial activation (Iba-1 positive cells) and preserved neuronal migration (Cux-2 positive cells) in fetal brains. In fetal brain lysates sPIF decreased IL-6 and INF gamma concentrations. In-vitro, sPIF reduced Iba1 and TNF alpha expression in microglial cells and reduced the expression of pro-apoptotic (Bad and Bax) and inflammatory (IL-6 and NLRP4) genes in placental cell lines. Together, maternal sPIF prophylaxis prevents PTB in part by controlling exaggerated immune response. Given the sPIF`FDA Fast Track approval in non-pregnant subjects, we envision sPIF therapy in pregnancy.	[Spinelli, Marialuigia; Boucard, Celine; Haesler, Valerie; Surbek, Daniel; Mueller, Martin] Univ Bern, Univ Hosp Bern, Dept Obstet & Gynecol, Bern, Switzerland; [Spinelli, Marialuigia; Boucard, Celine; Haesler, Valerie; Surbek, Daniel; Mueller, Martin] Univ Bern, Univ Hosp Bern, Dept Biomed Res, Bern, Switzerland; [Di Nicuolo, Fiorella; Castellani, Roberta; Pontecorvi, Alfredo; Scambia, Giovanni; Granieri, Chiara; Di Simone, Nicoletta] Univ Cattolica Sacro Cuore, Ist Clin Ostetr & Ginecol, Rome, Italy; [Di Nicuolo, Fiorella] Univ Cattolica Sacro Cuore, A Gemelli Univ Hosp, Int Sci Inst Paolo VI, Rome, Italy; [Pontecorvi, Alfredo] Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Sci Gastroenterol Endocrinometab & N, UOC Endocrinol & Diabetol, Rome, Italy; [Scambia, Giovanni] Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Sci Salute Donna Bambino & Sanita Pu, UOC Ginecol Oncol, Rome, Italy; [Barnea, Eytan R.] Soc Invest Early Pregnancy SIEP, Cherry Hill, NJ USA; [Barnea, Eytan R.] BioIncept LLC, Cherry Hill, NJ USA; [Di Simone, Nicoletta] Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Sci Salute Donna & Bambino, UOC Ostetricia & Patol Ostetr, Rome, Italy	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Mueller, M (corresponding author), Univ Bern, Univ Hosp Bern, Dept Obstet & Gynecol, Bern, Switzerland.; Mueller, M (corresponding author), Univ Bern, Univ Hosp Bern, Dept Biomed Res, Bern, Switzerland.; Di Simone, N (corresponding author), Univ Cattolica Sacro Cuore, Ist Clin Ostetr & Ginecol, Rome, Italy.; Di Simone, N (corresponding author), Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Sci Salute Donna & Bambino, UOC Ostetricia & Patol Ostetr, Rome, Italy.	martin.mueller@insel.ch; nicoletta.disimone@unicatt.it	Mueller, Martin/J-9682-2019; Barnea, Eytan/AAK-9467-2021; Spinelli, Marialuigia/HHM-4415-2022	Mueller, Martin/0000-0001-5594-0532; Barnea, Eytan/0000-0003-4677-4370; Surbek, Daniel/0000-0001-7705-1584; DI SIMONE, NICOLETTA/0000-0003-1273-3335	BioIncept; Universita Cattolica del Sacro Cuore [D1 2015: 70201356]; Instituto Scientifico Internazionale, Paolo VI Institute, Universita Cattolica del Sacro Cuore, Rome, Italy; University Hospital Bern [2019-00431]	BioIncept; Universita Cattolica del Sacro Cuore; Instituto Scientifico Internazionale, Paolo VI Institute, Universita Cattolica del Sacro Cuore, Rome, Italy; University Hospital Bern	NDS and MM received an unrestricted fund from BioIncept. BioIncept provided sPIF. ERB is CSO of BioIncept. The specific roles of this authors are articulated in the 'author contributions' section. In addition, the following grants helped fund this research: Universita Cattolica del Sacro Cuore (D1 2015: 70201356), Instituto Scientifico Internazionale, Paolo VI Institute, Universita Cattolica del Sacro Cuore, Rome, Italy to NDS, and University Hospital Bern (2019-00431) to MS and MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, FRONT IMMUNOL; Azar Y, 2013, BIOL BLOOD MARROW TR, V19, P519, DOI 10.1016/j.bbmt.2012.12.011; Barnea ER, 2016, J REPROD IMMUNOL, V114, P58, DOI 10.1016/j.jri.2015.06.002; Barnea ER, 2015, PHARMACOL THERAPEUT, V156, P10, DOI 10.1016/j.pharmthera.2015.10.008; Barnea ER, 2007, ANN NY ACAD SCI, V1110, P602, DOI 10.1196/annals.1423.064; Barnea ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100263; Barnea ER, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.07.017; Barnea ER, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-50; Baron JC, 2014, J CEREBR BLOOD F MET, V34, P2, DOI 10.1038/jcbfm.2013.188; Been JV, 2013, J PEDIATR-US, V162, P236, DOI 10.1016/j.jpeds.2012.07.012; Boyle AK, 2019, FASEB J, V33, P2743, DOI 10.1096/fj.201801104R; Boyle AK, 2017, J REPROD IMMUNOL, V119, P62, DOI 10.1016/j.jri.2016.11.008; Chen YC, 2016, THROMB HAEMOSTASIS, V115, P1010, DOI 10.1160/TH15-08-0640; Chu DM, 2018, BEST PRACT RES CL OB, V52, P103, DOI 10.1016/j.bpobgyn.2018.03.006; Clark DA, 2008, AM J REPROD IMMUNOL, V59, P277, DOI 10.1111/j.1600-0897.2008.00580.x; Clark DA, 2016, J REPROD IMMUNOL, V116, P60, DOI 10.1016/j.jri.2016.04.288; Cubelos B, 2010, NEURON, V66, P523, DOI 10.1016/j.neuron.2010.04.038; D'Ippolito S, 2016, FERTIL STERIL, V105, P111, DOI 10.1016/j.fertnstert.2015.09.027; Di Simone N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180642; Doyle LW, 2014, JAMA-J AM MED ASSOC, V312, P1105, DOI 10.1001/jama.2014.11189; Dunn AB, 2017, BIOL RES NURS, V19, P295, DOI 10.1177/1099800416687648; Dunne A, 2011, BIOCHEM SOC T, V39, P669, DOI 10.1042/BST0390669; Duzyj CM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.060; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Fernandez-Calle R, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0823-8; Fregoso SP, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.170068; Gomez-Lopez N, 2019, J IMMUNOL, V203, P2757, DOI 10.4049/jimmunol.1900901; Hagberg H, 2012, ANN NEUROL, V71, P444, DOI 10.1002/ana.22620; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Hansen-Pupp I, 2005, PEDIATR RES, V58, P946, DOI 10.1203/01.PDR.0000182592.76702.E8; Harrison MS, 2016, SEMIN FETAL NEONAT M, V21, P74, DOI 10.1016/j.siny.2015.12.007; Hayrabedyan S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48473-x; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Jellema RK, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-13; Kubo KI, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.88609; Lappas M, 2018, MOL HUM REPROD, V24, P94, DOI 10.1093/molehr/gax067; Li J, 2018, MOL MED REP, V18, P2581, DOI 10.3892/mmr.2018.9274; Lu HY, 2016, PEDIATR NEUROL, V61, P94, DOI [10.1016/j.pediatrneurol.2016.05.001, DOI 10.1016/J.PEDIATRNEUR0L.2016.05.001]; Migliara G, 2017, ONCOTARGET, V8, P21834, DOI 10.18632/oncotarget.15662; Moffett-King A, 2002, NAT REV IMMUNOL, V2, P656, DOI 10.1038/nri886; Moindjie H, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119156; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Mueller M, 2015, CELL DEATH DIFFER, V22, P2078, DOI 10.1038/cdd.2015.55; Mueller M, 2014, P NATL ACAD SCI USA, V111, P13882, DOI 10.1073/pnas.1411674111; Ofengeim D, 2012, NAT NEUROSCI, V15, P574, DOI 10.1038/nn.3054; Ortinau C, 2015, CLIN ANAT, V28, P168, DOI 10.1002/ca.22430; Padilla N, 2015, CEREB CORTEX; Paidas MJ, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.03.024; Park HW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138114; PrabhuDas M, 2015, NAT IMMUNOL, V16, P328, DOI 10.1038/ni.3131; Ramu S, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-105; Robertson RC, 2019, TRENDS MICROBIOL, V27, P131, DOI 10.1016/j.tim.2018.09.008; Robertson SA, 2007, BIOL REPROD, V76, P738, DOI 10.1095/biolreprod.106.056143; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20; Roussev RG, 2013, REPROD BIOMED ONLINE, V26, P79, DOI 10.1016/j.rbmo.2012.09.017; Shainer R, 2016, ONCOTARGET; Silver RM, 1997, AM J OBSTET GYNECOL, V176, P544, DOI 10.1016/S0002-9378(97)70545-3; Sizonenko SV, 2005, PEDIATR RES, V57, P865, DOI 10.1203/01.PDR.0000157673.36848.67; Sizonenko SV, 2003, PEDIATR RES, V54, P263, DOI 10.1203/01.PDR.0000072517.01207.87; Smith AL, 2014, EXP NEUROL, V254, P54, DOI 10.1016/j.expneurol.2014.01.003; Stamatkin CW, 2011, REPROD BIOMED ONLINE, V23, P517, DOI 10.1016/j.rbmo.2011.06.009; Weiss L, 2012, J NEUROL SCI, V312, P146, DOI 10.1016/j.jns.2011.07.050; Weiss L, 2011, ENDOCRINE, V40, P41, DOI 10.1007/s12020-011-9438-5; Yamada M, 2015, HIPPOCAMPUS, V25, P253, DOI 10.1002/hipo.22370	64	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2020	15	6							e0232493	10.1371/journal.pone.0232493	http://dx.doi.org/10.1371/journal.pone.0232493			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ0RE	32511256	Green Published, gold			2022-12-26	WOS:000540938100022
J	Li, J; Feng, YH; Wang, XK; Peng, JF; Yang, DH; Xu, GL; Luo, QX; Wang, LL; Ou, D; Su, W; Xue, B; Xue, B; Xue, B				Li, Jie; Feng, Yuehua; Wang, Xiaoke; Peng, Jinfeng; Yang, Dinghua; Xu, Guiling; Luo, Qiangxin; Wang, Lingli; Ou, Da; Su, Wei; Xue, Bing; Xue, Bing; Xue, Bing			Stability and applicability of the leaf value model for variable nitrogen application based on SPAD value in rice	PLOS ONE			English	Article							CHLOROPHYLL METER; FERTILIZER; MANAGEMENT; PLANT; REQUIREMENTS; EFFICIENCY; CORN	Many fertilization models have been created to scientifically determine the amount of fertilization. With the same purpose, we constructed a nitrogen (N) application model, the leaf value model, which can make N fertilizer decisions in a timely, fast and nondestructive manner during rice planting. However, only one area (A(1), Jiuzhou Town, Xixiu District, Guizhou Province) and one cultivar (Qyou6) were involved in the construction of the leaf value model. Its stability and applicability could not be well evaluated. Thus, we chose another area (A(2), Jiuzhou Town, Huangping County, Guizhou Province) in Guizhou Province and carried out the experiment by using four cultivars (Nie5you5399, Qyou6, Yixiangyou2115 and Zhongzheyou8) for the leaf value model construction. Compared with the average value of apparent total N uptake (Nz) obtained in 2 years in the A1 area, that in the Qyou6 leaf value model in the A2 area increased by 12%, reaching 635.72 kg ha(-1), whereas the corresponding target yield changed slightly, reaching 10,999.90 kg ha(-1). Simultaneously, the linear relationship between several good SPAD value-derived indexes (Ys) and apparent N supply of the field (Nx) was still significant or extremely significant in the Qyou6 leaf value model. Compared with the A(1) area, it slightly differed, and the R-2 of SPAD(L1) was higher than that of SPAD(L3xL4/mean). In the leaf value model of the other three cultivars, the relationship between yield and Nx and that between Ys and Nx were significant or extremely significant. The Nz of Yixiangyou2115 and Zhongzheyou8 (618.33 and 617.76 kg ha(-1)) were close to that of Qyou6 and the corresponding target yields were 10313.36 and 10301.99 kg ha(-1), respectively. The Nz and target yield of Nie5you5399 were lowest at 546.63 and 10680.24 kg ha(-1), respectively. In general, this study showed that relationships used in the construction of leaf value model had certain stability and applicability to difference areas and cultivars. The leaf value model can be considered in N fertilizer decision-making of rice planting management.	[Li, Jie; Feng, Yuehua; Wang, Xiaoke; Peng, Jinfeng; Xu, Guiling; Luo, Qiangxin; Wang, Lingli; Ou, Da; Su, Wei] Guizhou Univ, Coll Agron, Guiyang, Peoples R China; [Li, Jie; Yang, Dinghua] Qiandongnan Vocat & Tech Coll Nationalities, Kaili, Peoples R China; [Feng, Yuehua] Guizhou Univ, Minist Educ, Lab Plant Resource Conservat & Germplasm Innovat, Guiyang, Peoples R China; [Xue, Bing; Xue, Bing; Xue, Bing] Inst Adv Sustainabil Studies, Potsdam, Germany	Guizhou University; Guizhou University	Feng, YH (corresponding author), Guizhou Univ, Coll Agron, Guiyang, Peoples R China.; Feng, YH (corresponding author), Guizhou Univ, Minist Educ, Lab Plant Resource Conservat & Germplasm Innovat, Guiyang, Peoples R China.	fengyuehua2006@126.com		feng, yuehua/0000-0003-2315-518X	National Natural Science Foundation of China [31360311, 31160263]; Subproject of Special fund project for Scientific Research of Public Welfare Industry (Agriculture) [201503118-03]; Scientific and Technological Innovative Talents Team for Cultivation and Eco-Physiology Research of Featured Grain and Oil Crops in Guizhou Province [Qiankehe Platform Talents [2019] 5613]; Talents Program of High Level and Innovative in Guizhou Province [Qiankehe Platform Talents [2018]5632]; Construction Program of Biology First-class Discipline in Guizhou Province [GNYL [2017]009]; Agricultural Scientific and Technological Project in Guizhou Province [Qiankehe NY[2013] 3005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Subproject of Special fund project for Scientific Research of Public Welfare Industry (Agriculture); Scientific and Technological Innovative Talents Team for Cultivation and Eco-Physiology Research of Featured Grain and Oil Crops in Guizhou Province; Talents Program of High Level and Innovative in Guizhou Province; Construction Program of Biology First-class Discipline in Guizhou Province; Agricultural Scientific and Technological Project in Guizhou Province	This work was supported by the National Natural Science Foundation of China (31360311, 31160263), the Subproject of Special fund project for Scientific Research of Public Welfare Industry (Agriculture) (201503118-03), the Scientific and Technological Innovative Talents Team for Cultivation and Eco-Physiology Research of Featured Grain and Oil Crops in Guizhou Province (Grant no. Qiankehe Platform Talents [2019] 5613), the Talents Program of High Level and Innovative in Guizhou Province (Grant no. Qiankehe Platform Talents [2018]5632), the Construction Program of Biology First-class Discipline in Guizhou Province (GNYL [2017]009) and the Agricultural Scientific and Technological Project in Guizhou Province (Qiankehe NY[2013] 3005).	Afzal S, 2014, COMMUN SOIL SCI PLAN, V45, P1636, DOI 10.1080/00103624.2014.907911; [Anonymous], 2017, EUR GERIATR MED, V8, pS98; [白由路 Bai Youlu], 2015, [中国农业科学, Scientia Agricultura Sinica], V48, P3477; Balasubramanian V., 2000, International Rice Research Notes, V25, P4; Bullock DG, 1998, J PLANT NUTR, V21, P741, DOI 10.1080/01904169809365439; Chen PF, 2010, REMOTE SENS ENVIRON, V114, P1987, DOI 10.1016/j.rse.2010.04.006; Dobermann A, 2002, FIELD CROP RES, V74, P37, DOI 10.1016/S0378-4290(01)00197-6; Dong C, 2019, SPECTROSC SPECT ANAL, V39, P3599, DOI 10.3964/j.issn.1000-0593(2019)11-3599-07; FOLLETT RH, 1992, COMMUN SOIL SCI PLAN, V23, P687, DOI 10.1080/00103629209368619; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Huang JL, 2008, FIELD CROP RES, V105, P70, DOI 10.1016/j.fcr.2007.07.006; Huang ZhiPing, 2014, Journal of Agricultural Resources and Environment, V31, P495; Li GangHua, 2007, Scientia Agricultura Sinica, V40, P1127; [李刚华 Li Ganghua], 2005, [植物营养与肥料学报, Plant nutrition and fertitizer science], V11, P412; Li Jie, 2017, Scientia Agricultura Sinica, V50, P4714; Miransari M, 2011, J PLANT NUTR, V34, P762, DOI 10.1080/01904167.2011.540922; Moral FJ, 2011, COMPUT ELECTRON AGR, V75, P223, DOI 10.1016/j.compag.2010.10.014; PELTONEN J, 1995, J AGRON CROP SCI, V174, P309, DOI 10.1111/j.1439-037X.1995.tb01118.x; Peng S, 1996, FIELD CROP RES, V47, P243, DOI 10.1016/0378-4290(96)00018-4; PENG SB, 1993, AGRON J, V85, P987, DOI 10.2134/agronj1993.00021962008500050005x; REEVES DW, 1993, J PLANT NUTR, V16, P781, DOI 10.1080/01904169309364574; Rodrigues MA, 2004, COMMUN SOIL SCI PLAN, V35, P2067, DOI 10.1081/LCSS-200026837; Walsh OS, 2013, PRECIS AGRIC, V14, P343, DOI 10.1007/s11119-012-9299-9; Wang SH, 2006, FIELD CROP RES, V96, P224, DOI 10.1016/j.fcr.2005.07.008; Wang ShaoHua, 2003, Scientia Agricultura Sinica, V36, P1261; Wang Y, 2014, ACM T SENSOR NETWORK, V10, DOI 10.1145/2505767; Wang Y, 2020, FIELD CROP RES, V245, DOI 10.1016/j.fcr.2019.107664; Wang Y, 2016, FIELD CROP RES, V198, P93, DOI 10.1016/j.fcr.2016.08.032; Wu FB, 1998, FIELD CROP RES, V56, P309, DOI 10.1016/S0378-4290(97)00108-1; Zhou QF, 2003, J PLANT NUTR, V26, P607, DOI 10.1081/PLN-120017668	31	1	1	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0233735	10.1371/journal.pone.0233735	http://dx.doi.org/10.1371/journal.pone.0233735			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497128	Green Published, gold			2022-12-26	WOS:000542035200050
J	Breiding, PS; Kellner-Weldon, F; Grunder, L; Scutelnic, A; Fischer, U; Meinel, TR; Slavova, N; Gralla, J; El-Koussy, M; Denier, N				Breiding, Philipe Sebastian; Kellner-Weldon, Frauke; Grunder, Lorenz; Scutelnic, Adrian; Fischer, Urs; Meinel, Thomas Raphael; Slavova, Nedelina; Gralla, Jan; El-Koussy, Marwan; Denier, Niklaus			Quantification of cerebral veins in patients with acute migraine with aura: A fully automated quantification algorithm using susceptibility-weighted imaging	PLOS ONE			English	Article							CLINICAL-APPLICATIONS; BRAIN; SEGMENTATION	Introduction Susceptibility weighted imaging (SWI) is a very sensitive technique that often depicts prominent focal veins (PFV) in patients with acute migraine with aura (MwA). Interpretation of visual venous asymmetry (VVA) between brain hemispheres on SWI may help support the clinical diagnosis of MwA. Our goal was to develop an automated algorithm for segmentation and quantification of cerebral veins using SWI. Materials and methods Expert readers visually evaluated SWI of patients with acute MwA for VVA. Subsequently a fully automated algorithm based on 3D normalization and 2D imaging processing using SPM and MATLAB image processing software including top-hat transform was used to quantify cerebral veins and to calculate volumetric differences between hemispheres. Results Fifty patients with MwA were examined with SWI. VVA was present in 20 of 50 patients (40%). In 95% of patients with VVA, the fully automated calculation agreed with the side that visually harboured more PFV. Our algorithm showed a sensitivity of 95%, specificity of 90% and accuracy of 92% for detecting VVA. Patients with VVA had significantly larger vein volume on the hemisphere with more PFV compared to patients without (15.90 +/- 5.38 ml vs 11.93 +/- 5.31 ml; p = 0.013). The mean difference in venous volume between hemispheres in patients with VVA was larger compared to patients without VVA (16.34 +/- 7.76% vs 4.31 +/- 3.26% p < 1E-10). The average time between aura onset and SWI correlated negatively with venous volume of the dominant brain hemisphere (r = -0.348; p = 0.038). Conclusion A fully automated algorithm can accurately identify and quantify cerebral venous distribution on SWI. Absolute quantification may be useful for the future assessment of patients with suspected diseases, which may be associated with a unilateral abnormal degree of venous oxygenation.	[Breiding, Philipe Sebastian] Spital Thurgau AG, Inst Diagnost & Intervent Radiol, Cantonal Hosp Frauenfeld, Frauenfeld, Switzerland; [Kellner-Weldon, Frauke] Cantonal Hosp Luzern, Inst Diagnost & Intervent Radiol, Luzern, Switzerland; [Kellner-Weldon, Frauke; Slavova, Nedelina; El-Koussy, Marwan; Denier, Niklaus] Univ Bern, Univ Inst Diagnost & Intervent Neuroradiol, Support Ctr Adv Neuroimaging SCAN, Inselspital, Bern, Switzerland; [Grunder, Lorenz] Univ Bern, Univ Inst Diagnost & Intervent Radiol, Inselspital, Bern, Switzerland; [Scutelnic, Adrian; Fischer, Urs; Meinel, Thomas Raphael] Univ Bern, Dept Neurol, Inselspital, Bern, Switzerland; [Slavova, Nedelina; Gralla, Jan; El-Koussy, Marwan] Univ Bern, Univ Inst Diagnost & Intervent Neuroradiol, Inselspital, Bern, Switzerland; [Denier, Niklaus] Univ Bern, Dept Psychiat & Psychotherapy, Bern, Switzerland	Lucerne Cantonal Hospital; University of Bern; University of Bern; University of Bern; University of Bern; University of Bern	Breiding, PS (corresponding author), Spital Thurgau AG, Inst Diagnost & Intervent Radiol, Cantonal Hosp Frauenfeld, Frauenfeld, Switzerland.	philipeb@gmail.com		Breiding, Philipe/0000-0002-6985-0332; Denier, Niklaus/0000-0002-3996-9148; Fischer, Urs/0000-0003-0521-4051; Kellner-Weldon, Frauke/0000-0002-6019-0147				Bazin P.-L, VESSEL SEGMENTATION; Chang K, 2014, AM J NEURORADIOL, V35, P1091, DOI 10.3174/ajnr.A3818; Cobb-Pitstick KM, 2018, AM J NEURORADIOL, V39, P1751, DOI 10.3174/ajnr.A5693; de Vis JB, 2015, HUM BRAIN MAPP, V36, P3973, DOI 10.1002/hbm.22891; Dempfle AK, 2018, CLIN NEURORADIOL, V28, P493, DOI 10.1007/s00062-017-0602-z; Egger K, 2016, NEURORADIOLOGY, V58, P937, DOI 10.1007/s00234-016-1712-z; Fedak EM, 2013, CEPHALALGIA, V33, P1258, DOI 10.1177/0333102413491027; Fushimi Y, 2010, J NEUROIMAGING, V20, P255, DOI 10.1111/j.1552-6569.2008.00348.x; Gonzalez R.C., 2009, DIGITAL IMAGE PROCES, V2nd; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Karaarslan E, 2011, AJNR Am J Neuroradiol, V32, pE5, DOI 10.3174/ajnr.A1973; Monti S, 2017, IEEE T MED IMAGING, V36, P1054, DOI 10.1109/TMI.2016.2645286; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pollock JM, 2008, AM J NEURORADIOL, V29, P1494, DOI 10.3174/ajnr.A1115; Reichenbach JR, 2000, J COMPUT ASSIST TOMO, V24, P949, DOI 10.1097/00004728-200011000-00023; Sedlacik J, 2008, NEUROIMAGE, V40, P11, DOI 10.1016/j.neuroimage.2007.11.046; Sehgal V, 2005, J MAGN RESON IMAGING, V22, P439, DOI 10.1002/jmri.20404; Serra J, 1983, IMAGE ANAL MATH MORP; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Thomas B, 2008, NEURORADIOLOGY, V50, P105, DOI 10.1007/s00234-007-0316-z; Tong KA, 2008, AM J NEURORADIOL, V29, P9, DOI 10.3174/ajnr.A0786; Ward PGD, 2018, NEUROIMAGE, V165, P294, DOI 10.1016/j.neuroimage.2017.10.049; Zuiderveld K.J., 1994, GRAPHICS GEMS, P474, DOI DOI 10.1016/B978-0-12-336156-1.50061-6	23	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2020	15	6							e0233992	10.1371/journal.pone.0233992	http://dx.doi.org/10.1371/journal.pone.0233992			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LW6ZP	32492059	Green Published, gold			2022-12-26	WOS:000539293000026
J	Qin, H; Liu, Y; Cao, XY; Jiang, J; Lian, WS; Qiao, DR; Xu, H; Cao, Y				Qin, Han; Liu, Ying; Cao, Xiyue; Jiang, Jia; Lian, Weishao; Qiao, Dairong; Xu, Hui; Cao, Yi			RpoS is a pleiotropic regulator of motility, biofilm formation, exoenzymes, siderophore and prodigiosin production, and trade-off during prolonged stationary phase in Serratia marcescens	PLOS ONE			English	Article							GGDEF/EAL DOMAIN PROTEIN; ESCHERICHIA-COLI; SIGMA-FACTOR; BIOSYNTHESIS; CARBAPENEM; VIRULENCE; STRAIN; ANTIBIOTICS; SYSTEM; ADVANTAGE	Prodigiosin is an important secondary metabolite produced by Serratia marcescens. It can help strains resist stresses from other microorganisms and environmental factors to achieve self-preservation. Prodigiosin is also a promising secondary metabolite due to its pharmacological characteristics. However, pigmentless S. marcescens mutants always emerge after prolonged starvation, which might be a way for the bacteria to adapt to starvation conditions, but it could be a major problem in the industrial application of S. marcescens. To identify the molecular mechanisms of loss of prodigiosin production, two mutants were isolated after 16 days of prolonged incubation of wild-type (WT) S. marcescens 1912768R; one mutant (named 1912768WR) exhibited reduced production of prodigiosin, and a second mutant (named 1912768W) was totally defective. Comparative genomic analysis revealed that the two mutants had either mutations or deletions in rpoS. Knockout of rpoS in S. marcescens 1912768R had pleiotropic effects. Complementation of rpoS in the.rpoS mutant further confirmed that RpoS was a positive regulator of prodigiosin production and that its regulatory role in prodigiosin biosynthesis was opposite that in Serratia sp. ATCC 39006, which had a different type of pig cluster; further, rpoS from Serratia sp. ATCC 39006 and other strains complemented the prodigiosin defect of the.rpoS mutant, suggesting that the pig promoters are more important than the genes in the regulation of prodigiosin production. Deletion of rpoS strongly impaired the resistance of S. marcescens to stresses but increased membrane permeability for nutritional competence; competition assays in rich and minimum media showed that the.rpoS mutant outcompeted its isogenic WT strain. All these data support the idea that RpoS is pleiotropic and that the loss of prodigiosin biosynthesis in S. marcescens 1912768R during prolonged incubation is due to a mutation in rpoS, which appears to be a self-preservation and nutritional competence (SPANC) trade-off.	[Qin, Han; Liu, Ying; Cao, Xiyue; Jiang, Jia; Lian, Weishao; Qiao, Dairong; Xu, Hui; Cao, Yi] Sichuan Univ, Coll Life Sci, Microbiol & Metab Engn Key Lab Sichuan Prov, Chengdu, Peoples R China	Sichuan University	Xu, H; Cao, Y (corresponding author), Sichuan Univ, Coll Life Sci, Microbiol & Metab Engn Key Lab Sichuan Prov, Chengdu, Peoples R China.	xuhui_scu@scu.edu.cn; geneium@scu.edu.cn			National Natural Science Foundation of China [31670078]; Sichuan Science and Technology Program [2018GZ0375, 2018TJPT0004]; Chengdu Science and Technology Program [2017-GH02-00071-HZ, 2018-YF05-00738-SN]; National Infrastructure of Natural Resources for Science and Technology Program of China [NIMR-2018-8]; Science and Technology Program of Sichuan University [2018SCUH0072]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Science and Technology Program; Chengdu Science and Technology Program; National Infrastructure of Natural Resources for Science and Technology Program of China; Science and Technology Program of Sichuan University	This work was supported by National Natural Science Foundation of China (31670078); Sichuan Science and Technology Program (2018GZ0375 and 2018TJPT0004); Chengdu Science and Technology Program (2017-GH02-00071-HZ and 2018-YF05-00738-SN); National Infrastructure of Natural Resources for Science and Technology Program of China (NIMR-2018-8); Science and Technology Program of Sichuan University (2018SCUH0072).	BERGER LR, 1958, BIOCHIM BIOPHYS ACTA, V29, P522; Chen HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088658; Chib S, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00059-17; Corsaro MM, 2009, J BIOCHEM, V146, P231, DOI 10.1093/jb/mvp062; Coulthurst SJ, 2005, NAT REV MICROBIOL, V3, P295, DOI 10.1038/nrmicro1128; Coulthurst SJ, 2004, MICROBIOL-SGM, V150, P1901, DOI 10.1099/mic.0.26946-0; Delcour AH, 1794, BIOCHIM BIOPHYS ACTA, P808; Farrell MJ, 2003, J BACTERIOL, V185, P7044, DOI 10.1128/JB.185.24.7044-7052.2003; Ferenci T, 2005, MOL MICROBIOL, V57, P1, DOI 10.1111/j.1365-2958.2005.04649.x; Ferenci T, 2016, TRENDS MICROBIOL, V24, P209, DOI 10.1016/j.tim.2015.11.009; Fineran PC, 2007, J BACTERIOL, V189, P7653, DOI 10.1128/JB.00671-07; Finkel SE, 2006, NAT REV MICROBIOL, V4, P113, DOI 10.1038/nrmicro1340; Girard G, 2006, MICROBIOL-SGM, V152, P43, DOI 10.1099/mic.0.28284-0; Gulani C, 2012, MALAYS J MICROBIOL, V8, P116, DOI 10.21161/mjm.03612; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hardjito Linawati, 2002, Biotechnology and Bioprocess Engineering, V7, P100, DOI 10.1007/BF02935887; Harris AKP, 2004, MICROBIOL-SGM, V150, P3547, DOI 10.1099/mic.0.27222-0; Horng YT, 2010, INT J MED MICROBIOL, V300, P304, DOI 10.1016/j.ijmm.2010.01.003; Iguchi A, 2014, GENOME BIOL EVOL, V6, P2096, DOI 10.1093/gbe/evu160; Kalivoda EJ, 2008, APPL ENVIRON MICROB, V74, P3461, DOI 10.1128/AEM.02733-07; Kalivoda EJ, 2010, RES MICROBIOL, V161, P158, DOI 10.1016/j.resmic.2009.12.004; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kram KE, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00192-16; Lee CM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01678; Liu X, 2010, WORLD J MICROB BIOT, V26, P1465, DOI 10.1007/s11274-010-0321-y; Liu X, MICROBIOLOGY, V147, P2981; Liu XX, 2018, INT J FOOD MICROBIOL, V270, P31, DOI 10.1016/j.ijfoodmicro.2018.02.011; Liu XQ, 1998, J BACTERIOL, V180, P3917, DOI 10.1128/JB.180.15.3917-3922.1998; Monteil V, 2010, J BACTERIOL, V192, P6401, DOI 10.1128/JB.00801-10; Nikaido H., 2003, MOL BASIS BACTERIAL; Pages J-M, PORIN PERMEATING ANT, V6, P893, DOI [10.1038/nrmicro1994, DOI 10.1038/NRMICRO1994]; Pan XW, 2020, APPL ENVIRON MICROB, V86, DOI 10.1128/AEM.02241-19; Patten CL, 2004, MOL GENET GENOMICS, V272, P580, DOI 10.1007/s00438-004-1089-2; Phan K, 2013, ISME J, V7, P2034, DOI 10.1038/ismej.2013.82; Poulter S, 2010, ENV MICROBIOL REP, V2, P322, DOI 10.1111/j.1758-2229.2010.00140.x; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Shanks RMQ, 2007, J BACTERIOL, V189, P7262, DOI 10.1128/JB.00859-07; Shanks RMQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057634; Shanks RMQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036398; Mata GMSC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180381; Slater H, 2003, MOL MICROBIOL, V47, P303, DOI 10.1046/j.1365-2958.2003.03295.x; Stankovic N, APPL MICROBIOLOGY BI, V98, P3841; Stella NA, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02575-17; Stella NA, 2015, J BACTERIOL, V197, P2468, DOI 10.1128/JB.00136-15; Su C, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3171-7; Tanikawa T, 2013, MICROBIOL IMMUNOL, V50, P587, DOI [10.1007/s00438-004-1089-2, DOI 10.1007/S00438-004-1089-2]; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Thomson NR, 2000, MOL MICROBIOL, V36, P539, DOI 10.1046/j.1365-2958.2000.01872.x; Verhamme DT, 2007, MOL MICROBIOL, V65, P554, DOI 10.1111/j.1365-2958.2007.05810.x; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Wilf NM, 2012, MICROBIOL-SGM, V158, P648, DOI 10.1099/mic.0.055780-0; Wilf NM, 2011, ENVIRON MICROBIOL, V13, P2649, DOI 10.1111/j.1462-2920.2011.02532.x; Williamson NR, 2008, ENVIRON MICROBIOL, V10, P1202, DOI 10.1111/j.1462-2920.2007.01536.x; Williamson NR, 2006, NAT REV MICROBIOL, V4, P887, DOI 10.1038/nrmicro1531; Wong GT, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00755-16; Yang K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08132-5; Yip CH, 2019, APPL MICROBIOL BIOT, V103, P1667, DOI 10.1007/s00253-018-09611-z; ZAMBRANO MM, 1993, SCIENCE, V259, P1757, DOI 10.1126/science.7681219; Zhang HJ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00999; Zhao KL, 2016, SCI REP-UK, V6, DOI 10.1038/srep34925; Zhao S, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0616-9; Zhou W, 2016, J INVERTEBR PATHOL, V136, P92, DOI 10.1016/j.jip.2016.03.011; Zinser ER, 2000, J BACTERIOL, V182, P4361, DOI 10.1128/JB.182.15.4361-4365.2000	63	9	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2020	15	6							e0232549	10.1371/journal.pone.0232549	http://dx.doi.org/10.1371/journal.pone.0232549			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MT4VF	32484808	Green Published, gold			2022-12-26	WOS:000554969700003
J	Baulin, EF; Kulakovskiy, IV; Roytberg, MA; Astakhova, TV				Baulin, Eugene F.; Kulakovskiy, Ivan V.; Roytberg, Mikhail A.; Astakhova, Tatiana V.			Brain-related genes are specifically enriched with long phase 1 introns	PLOS ONE			English	Article							SIGNAL PEPTIDES; EVOLUTION; INSERTION	Intronic gene regions are mostly considered in the scope of gene expression regulation, such as alternative splicing. However, relations between basic statistical properties of introns are much rarely studied in detail, despite vast available data. Particularly, little is known regarding the relationship between the intron length and the intron phase. Intron phase distribution is significantly different at different intron length thresholds. In this study, we performed GO enrichment analysis of gene sets with a particular intron phase at varying intron length thresholds using a list of 13823 orthologous human-mouse gene pairs. We found a specific group of 153 genes with phase 1 introns longer than 50 kilobases that were specifically expressed in brain, functionally related to synaptic signaling, and strongly associated with schizophrenia and other mental disorders. We propose that the prevalence of long phase 1 introns arises from the presence of the signal peptide sequence and is connected with 1-1 exon shuffling.	[Baulin, Eugene F.; Kulakovskiy, Ivan V.; Roytberg, Mikhail A.; Astakhova, Tatiana V.] Russian Acad Sci, Branch Keldysh Inst Appl Math, Inst Math Problems Biol RAS, Pushchino, Moscow Region, Russia; [Baulin, Eugene F.; Roytberg, Mikhail A.] Natl Res Univ, Moscow Inst Phys & Technol, Phystech Sch Appl Math & Informat, Dolgoprudnyi, Moscow Region, Russia; [Kulakovskiy, Ivan V.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia	Russian Academy of Sciences; Moscow Institute of Physics & Technology; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS	Baulin, EF (corresponding author), Russian Acad Sci, Branch Keldysh Inst Appl Math, Inst Math Problems Biol RAS, Pushchino, Moscow Region, Russia.; Baulin, EF (corresponding author), Natl Res Univ, Moscow Inst Phys & Technol, Phystech Sch Appl Math & Informat, Dolgoprudnyi, Moscow Region, Russia.	baulin@ipm.org.ru	Kulakovskiy, Ivan/A-1462-2014; Astakhova, Tatiana/AAC-4957-2022; Baulin, Eugene F/B-2933-2014	Kulakovskiy, Ivan/0000-0002-6554-8128; Baulin, Eugene F/0000-0003-4694-9783				[Астахова Т.В. Astakhova T.V.], 2014, [Математическая биология и биоинформатика, Mathematical Biology and Bioinformatics, Matematicheskaya biologiya i bioinformatika], V9, P482; Basu MK, 2008, GENOME RES, V18, P449, DOI 10.1101/gr.6943508; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Boutet Emmanuel, 2007, V406, P89; Bradnam KR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003093; Eppig JT, 2017, METHODS MOL BIOL, V1488, P47, DOI 10.1007/978-1-4939-6427-7_3; Franca GS, 2012, GENETICA, V140, P249, DOI 10.1007/s10709-012-9676-3; Frankish A, 2019, NUCLEIC ACIDS RES, V47, pD766, DOI 10.1093/nar/gky955; Gorlova O, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-50; Harr B, 2010, MOL ECOL, V19, P228, DOI 10.1111/j.1365-294X.2009.04490.x; Haynes W., 2013, ENCY SYSTEMBIOL, P78, DOI [10.1007/978-1-4419-9863-7_1215, DOI 10.1007/978-1-4419-9863-7_1215]; Julenius K, 2006, MOL BIOL EVOL, V23, P2039, DOI 10.1093/molbev/msl081; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Kolkman JA, 2001, NAT BIOTECHNOL, V19, P423, DOI 10.1038/88084; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Lee Byungwook, 2009, Genomics & Informatics, V7, P131; Long MY, 1995, P NATL ACAD SCI USA, V92, P12495, DOI 10.1073/pnas.92.26.12495; Long MY, 1999, MOL BIOL EVOL, V16, P1528, DOI 10.1093/oxfordjournals.molbev.a026065; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nielsen H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-256; Palazzo AF, 2007, PLOS BIOL, V5, P2862, DOI 10.1371/journal.pbio.0050322; Patthy L, 1999, GENE, V238, P103, DOI 10.1016/S0378-1119(99)00228-0; PATTHY L, 1985, CELL, V41, P657, DOI 10.1016/S0092-8674(85)80046-5; ROGERS J, 1985, NATURE, V315, P458, DOI 10.1038/315458a0; Rose AB, 2008, CURR TOP MICROBIOL, V326, P277; Ruvinsky A, 2006, J MOL EVOL, V63, P136, DOI 10.1007/s00239-005-0261-6; Sprent Peter., 2011, INT ENCY STAT SCI, P524, DOI DOI 10.1007/978-3-642-04898-2_253; Tordai H, 2004, FEBS LETT, V575, P109, DOI 10.1016/j.febslet.2004.08.045; Vibranovski MD, 2006, FEBS LETT, V580, P1621, DOI 10.1016/j.febslet.2006.01.094; Vinogradov AE, 2006, GENOME RES, V16, P347, DOI 10.1101/gr.4318206; Wang X., 2017, SUSTAINABILITY, V9, P1; Zhao CY, 2007, J BIOL CHEM, V282, P20230, DOI 10.1074/jbc.M700180200; Zhu SY, 2013, DEV COMP IMMUNOL, V39, P79, DOI 10.1016/j.dci.2012.02.011	33	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2020	15	5							e0233978	10.1371/journal.pone.0233978	http://dx.doi.org/10.1371/journal.pone.0233978			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1WS	32470086	gold, Green Published			2022-12-26	WOS:000537552800218
J	Murata, T; Kyozuka, H; Fukuda, T; Yasuda, S; Yamaguchi, A; Sato, A; Ogata, Y; Kuse, M; Hosoya, M; Yasumura, S; Hashimoto, K; Nishigori, H; Fujimori, K				Murata, Tsuyoshi; Kyozuka, Hyo; Fukuda, Toma; Yasuda, Shun; Yamaguchi, Akiko; Sato, Akiko; Ogata, Yuka; Kuse, Masahito; Hosoya, Mitsuaki; Yasumura, Seiji; Hashimoto, Koichi; Nishigori, Hidekazu; Fujimori, Keiya		Japan Environm & Children's Stud	Risk of adverse obstetric outcomes in Japanese women with systemic lupus erythematosus: The Japan Environment and Children's Study	PLOS ONE			English	Article							BIRTH-WEIGHT; PREGNANCY COMPLICATIONS; PRETERM BIRTH; PREVALENCE; PREDICTORS	Systemic lupus erythematosus, simply known as lupus, is associated with adverse obstetric outcomes. This study evaluated the incidence of preterm births (before 37 and 34 weeks), low birthweight infants (<2500 g and <1500 g), small-for-gestational age infants, preterm premature rupture of membranes, and gestational hypertension in mothers with lupus and compared them with those of the Japanese general population. Data from participants in the Japan Environment and Children's Study who gave birth between 2011 and 2014 were collected. Only participants with singleton pregnancies were included. Adjusted odds ratios for the variables were calculated using a logistic regression model, with a general population as the reference. In total, 88,017 participants were included in the analysis, and 63 of them had lupus. The adjusted odds ratios of preterm births before 37 and 34 weeks, low birthweight infants <2500 g and <1500 g, small-for-gestational age infants, and preterm premature rupture of membranes in the systemic lupus erythematosus group were 8.1 (95% CI, 4.7-14.1), 5.2 (1.6-16.5), 6.5 (3.9-10.8), 5.4 (1.3-22.4), 2.9 (1.4-5.9), and 12.1 (5.7-25.5), respectively. The adjusted odds ratio of gestational hypertension was 1.4 (0.4-4.5). This study revealed increased risk of preterm births, low birthweight infants, small-for-gestational age infants, and preterm premature rupture of membranes in patients with lupus when compared with those in the general population.	[Murata, Tsuyoshi; Kyozuka, Hyo; Fukuda, Toma; Yasuda, Shun; Yamaguchi, Akiko; Sato, Akiko; Ogata, Yuka; Kuse, Masahito; Hosoya, Mitsuaki; Yasumura, Seiji; Hashimoto, Koichi; Nishigori, Hidekazu; Fujimori, Keiya] Fukushima Reg Ctr Japan Environm & Childrens Stud, Fukushima, Japan; [Murata, Tsuyoshi; Kyozuka, Hyo; Fukuda, Toma; Yasuda, Shun; Yamaguchi, Akiko; Fujimori, Keiya] Fukushima Med Univ, Dept Obstet & Gynecol, Sch Med, Fukushima, Japan; [Hosoya, Mitsuaki; Hashimoto, Koichi] Fukushima Med Univ, Dept Pediat, Sch Med, Fukushima, Japan; [Yasumura, Seiji] Fukushima Med Univ, Dept Publ Hlth, Sch Med, Fukushima, Japan; [Nishigori, Hidekazu] Fukushima Med Univ, Fukushima Med Ctr Children & Women, Sch Med, Fukushima, Japan	Fukushima Medical University; Fukushima Medical University; Fukushima Medical University; Fukushima Medical University	Murata, T (corresponding author), Fukushima Reg Ctr Japan Environm & Childrens Stud, Fukushima, Japan.; Murata, T (corresponding author), Fukushima Med Univ, Dept Obstet & Gynecol, Sch Med, Fukushima, Japan.	tuyoshim@fmu.ac.jp	Murata, Tsuyoshi/GMW-4256-2022	Murata, Tsuyoshi/0000-0001-9506-117X	Ministry of the Environment, Japan	Ministry of the Environment, Japan(Ministry of the Environment, Japan)	This research was supported by funding from the Ministry of the Environment, Japan for the JECS. The findings and conclusions of this article are solely the responsibility of the authors and do not represent the official views of the Japanese government.	Andreoli L, 2017, ANN RHEUM DIS, V76, P476, DOI 10.1136/annrheumdis-2016-209770; Buyon JP, 2015, ANN INTERN MED, V163, P153, DOI 10.7326/M14-2235; Cetin I, 2013, CURR OPIN CLIN NUTR, V16, P310, DOI 10.1097/MCO.0b013e32835e8d9c; Chakravarty EF, 2007, ARTHRITIS RHEUM, V56, P2092, DOI 10.1002/art.22641; Chen DY, 2019, CLIN RHEUMATOL, V38, P3501, DOI 10.1007/s10067-019-04696-x; Clowse MEB, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.03.012; Duley L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000025.pub2; El-Sayed YY, 2017, OBSTET GYNECOL, V130, pE102; Haberman RH, 2020, ARTHRITIS RHEUMATOL, V72, P1981, DOI 10.1002/art.41456; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Itabashi K, 2014, PEDIATR INT, V56, P702, DOI 10.1111/ped.12331; Jarde A, 2019, BJOG-INT J OBSTET GY, V126, P556, DOI 10.1111/1471-0528.15566; Kawamoto T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-25; Kolstad KD, 2020, BJOG-INT J OBSTET GY, V127, P70, DOI 10.1111/1471-0528.15970; Kyozuka H, 2019, J EPIDEMIOL, V29, P187, DOI 10.2188/jea.JE20170283; Lateef A, 2017, RHEUM DIS CLIN N AM, V43, P215, DOI 10.1016/j.rdc.2016.12.009; Lopez Bernal Andres, 2007, BMC Pregnancy Childbirth, V7 Suppl 1, pS2, DOI 10.1186/1471-2393-7-S1-S2; Luke B, 2007, HUM REPROD, V22, P1264, DOI 10.1093/humrep/del522; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; Meyer O, 2004, JOINT BONE SPINE, V71, P178, DOI 10.1016/S1297-319X(03)00155-6; Michikawa T, 2018, J EPIDEMIOL, V28, P99, DOI 10.2188/jea.JE20170018; Ostensen M, 2013, CURR OPIN RHEUMATOL, V25, P591, DOI 10.1097/BOR.0b013e328363ebf7; Park J S, 2005, Minerva Ginecol, V57, P349; Pastore DEA, 2019, LUPUS, V28, P1417, DOI 10.1177/0961203319877247; de Jesus GR, 2015, AUTOIMMUN DIS, V2015, DOI 10.1155/2015/943490; Rees F, 2017, RHEUMATOLOGY, V56, P1945, DOI 10.1093/rheumatology/kex260; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Sammaritano LR, 2020, ARTHRIT CARE RES, V72, P461, DOI [10.1002/art.41191, 10.1002/acr.24130]; Skorpen CG, 2018, ANN RHEUM DIS, V77, P264, DOI 10.1136/annrheumdis-2017-211641; Smyth Andrew, 2010, Clin J Am Soc Nephrol, V5, P2060, DOI 10.2215/CJN.00240110; Suzuki K, 2016, J EPIDEMIOL, V26, P371, DOI 10.2188/jea.JE20150185; Voltolini C, 2013, REPROD SCI, V20, P1274, DOI 10.1177/1933719113477496; Wen Shi Wu, 2004, Semin Fetal Neonatal Med, V9, P429, DOI 10.1016/j.siny.2004.04.002	33	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2020	15	5							e0233883	10.1371/journal.pone.0233883	http://dx.doi.org/10.1371/journal.pone.0233883			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1WS	32470103	Green Published, gold			2022-12-26	WOS:000537552800205
J	Seguin, A; Jia, X; Earl, AM; Li, LT; Wallace, J; Qiu, AD; Bradley, T; Shrestha, R; Troadec, MB; Hockin, M; Titen, S; Warner, DE; Dowdle, PT; Wohlfahrt, ME; Hillas, E; Firpo, MA; Phillips, JD; Kaplan, J; Paw, BH; Barasch, J; Ward, DM				Seguin, Alexandra; Jia, Xuan; Earl, Aubree M.; Li, Liangtao; Wallace, Jared; Qiu, Andong; Bradley, Thomas; Shrestha, Rishna; Troadec, Marie-Berengere; Hockin, Matt; Titen, Simon; Warner, Dave E.; Dowdle, P. Tom; Wohlfahrt, Martin E.; Hillas, Elaine; Firpo, Matthew A.; Phillips, John D.; Kaplan, Jerry; Paw, Barry H.; Barasch, Jonathan; Ward, Diane M.			The mitochondrial metal transporters mitoferrin1 and mitoferrin2 are required for liver regeneration and cell proliferation in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell proliferation; gene knockout; iron metabolism; liver; membrane transport; mitochondria; mitoferrin (Mfrn); solute carrier family 25 member 37 (Slc25a37); Slc25a28; metal homeostasis	HISTONE H4; IRON; DYSFUNCTION; DEPLETION; YEAST; METABOLISM; TURNOVER; MODELS; FAMILY; GENES	Mitochondrial iron import is essential for iron-sulfur cluster formation and heme biosynthesis. Two nuclear-encoded vertebrate mitochondrial high-affinity iron importers, mitoferrin1 (Mfrn1) and Mfrn2, have been identified in mammals. In mice, the gene encoding Mfrn1,solute carrier family 25 member 37(Slc25a37), is highly expressed in sites of erythropoiesis, and whole-bodySlc25a37deletion leads to lethality. Here, we report that mice with a deletion ofSlc25a28(encoding Mfrn2) are born at expected Mendelian ratios, but show decreased male fertility due to reduced sperm numbers and sperm motility.Mfrn2(-/-)mice placed on a low-iron diet exhibited reduced mitochondrial manganese, cobalt, and zinc levels, but not reduced iron. Hepatocyte-specific loss ofSlc25a37(encoding Mfrn1) inMfrn2(-/-)mice did not affect animal viability, but resulted in a 40% reduction in mitochondrial iron and reduced levels of oxidative phosphorylation proteins. Placing animals on a low-iron diet exaggerated the reduction in mitochondrial iron observed in liver-specificMfrn1/2-knockout animals.Mfrn1(-/-)/Mfrn2(-/-)bone marrow-derived macrophages or skin fibroblastsin vitrowere unable to proliferate, and overexpression of Mfrn1-GFP or Mfrn2-GFP prevented this proliferation defect. Loss of both mitoferrins in hepatocytes dramatically reduced regeneration in the adult mouse liver, further supporting the notion that both mitoferrins transport iron and that their absence limits proliferative capacity of mammalian cells. We conclude that Mfrn1 and Mfrn2 contribute to mitochondrial iron homeostasis and are required for high-affinity iron import during active proliferation of mammalian cells.	[Seguin, Alexandra; Jia, Xuan; Earl, Aubree M.; Li, Liangtao; Wallace, Jared; Bradley, Thomas; Shrestha, Rishna; Warner, Dave E.; Dowdle, P. Tom; Kaplan, Jerry; Ward, Diane M.] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84112 USA; [Qiu, Andong; Barasch, Jonathan] Columbia Univ, New York, NY USA; [Troadec, Marie-Berengere] Univ Brest, GGB, EFS, UMR 1078,INSERM, F-29200 Brest, France; [Troadec, Marie-Berengere] CHRU Brest, Serv Genet, Lab Chromosome Genet, Brest, France; [Hockin, Matt; Titen, Simon] Fred Hutchinson Canc Res Ctr, Dept Human Genet, 1124 Columbia St, Seattle, WA 98104 USA; [Wohlfahrt, Martin E.] Fred Hutchinson Canc Res Ctr, Clin Res Div, 1124 Columbia St, Seattle, WA 98104 USA; [Hillas, Elaine; Firpo, Matthew A.] Univ Utah, Sch Med, Dept Gen Surg, Salt Lake City, UT USA; [Phillips, John D.] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT USA; [Paw, Barry H.] Harvard Med Sch, Childrens Hosp, Boston, MA 02115 USA	Utah System of Higher Education; University of Utah; Columbia University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Harvard University; Boston Children's Hospital; Harvard Medical School	Ward, DM (corresponding author), Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84112 USA.	diane.mcveyward@path.utah.edu	Qiu, Andong/AAY-1179-2021	TROADEC, Marie-Berengere/0000-0003-2668-9670	National Institutes of Health [DK052830, R01DK073462, R01DK092684, U54DK110858, DK070838, P01 HL032262, 28349, U54DK106829]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health Grant DK052830 (to D. M. W.), Grants R01DK073462 and R01DK092684 (to J. B.), U54DK110858 (to J. D. P. and D. M. W.), Grants DK070838 and P01 HL032262 (to B. H. P.) (deceased), University of Utah Pathology Seed Grant 28349 (to D. M. W.), and Grant U54DK106829 (to M. E. W. and B. Torok-Storb.) from the Co-operative Center of Excellence in Hematology. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bashir K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1326; Chen W, 2009, P NATL ACAD SCI USA, V106, P16263, DOI 10.1073/pnas.0904519106; Chen YC, 2015, FREE RADICAL RES, V49, P1285, DOI 10.3109/10715762.2015.1067695; Christenson ET, 2018, J BIOL CHEM, V293, P3819, DOI 10.1074/jbc.M117.817478; Di Noia MA, 2014, J BIOL CHEM, V289, P33137, DOI 10.1074/jbc.M114.610808; Diebold LP, 2019, NAT METAB, V1, P158, DOI 10.1038/s42255-018-0011-x; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Foury F, 2002, J BIOL CHEM, V277, P24475, DOI 10.1074/jbc.M111789200; Froschauer EM, 2013, BIOCHEM J, V455, P57, DOI 10.1042/BJ20130144; Grillo AS, 2017, SCIENCE, V356, P608, DOI 10.1126/science.aah3862; Gutierrez-Aguilar M, 2013, BIOCHEM J, V454, P371, DOI 10.1042/BJ20121753; HARE JF, 1982, J BIOL CHEM, V257, P3575; Hopkinson BM, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5080128; Hung HI, 2013, J BIOL CHEM, V288, P677, DOI 10.1074/jbc.M112.422667; Kumfu S, 2012, BIOMETALS, V25, P1167, DOI 10.1007/s10534-012-9579-x; Li LT, 2004, J BIOL CHEM, V279, P33653, DOI 10.1074/jbc.M403146200; Llorens JV, 2015, J BIOL INORG CHEM, V20, P1229, DOI 10.1007/s00775-015-1302-2; Metzendorf C, 2010, BIOCHEM BIOPH RES CO, V400, P442, DOI 10.1016/j.bbrc.2010.08.100; Metzendorf C, 2009, BIOCHEM J, V421, P463, DOI 10.1042/BJ20082231; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Moullan N, 2015, CELL REP, V10, P1681, DOI 10.1016/j.celrep.2015.02.034; Muhlenhoff U, 2003, J BIOL CHEM, V278, P40612, DOI 10.1074/jbc.M307847200; Nelson DM, 2002, MOL CELL BIOL, V22, P7459, DOI 10.1128/MCB.22.21.7459-7472.2002; Palmieri F, 2014, J INHERIT METAB DIS, V37, P565, DOI 10.1007/s10545-014-9708-5; Paradkar PN, 2008, BLOOD, V112, P866, DOI 10.1182/blood-2007-12-126854; Paradkar PN, 2009, MOL CELL BIOL, V29, P1007, DOI 10.1128/MCB.01685-08; PARSONS DF, 1966, ANN NY ACAD SCI, V137, P643, DOI 10.1111/j.1749-6632.1966.tb50188.x; Prado F, 2005, MOL CELL BIOL, V25, P1526, DOI 10.1128/MCB.25.4.1526-1536.2005; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Ren YG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029666; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; Serwas NK, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00588; Severgnini M, 2012, CYTOTECHNOLOGY, V64, P187, DOI 10.1007/s10616-011-9407-0; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Shyamsunder P, 2019, BLOOD, V133, P2507, DOI 10.1182/blood.2018886077; Shyamsunder P, 2018, HAEMATOLOGICA, V103, P1269, DOI 10.3324/haematol.2018.190280; Sripetchwandee J, 2014, ACTA PHYSIOL, V210, P330, DOI 10.1111/apha.12162; Sripetchwandee J, 2013, LIFE SCI, V92, P298, DOI 10.1016/j.lfs.2013.01.004; Studd JB, 2019, LEUKEMIA, V33, P1, DOI 10.1038/s41375-018-0184-z; Troadec MB, 2011, BLOOD, V117, P5494, DOI 10.1182/blood-2010-11-319483; Weisend CM, 2009, GENESIS, V47, P789, DOI 10.1002/dvg.20568; Yien YY, 2014, J CLIN INVEST, V124, P4294, DOI 10.1172/JCI76979; Yin J, 2019, CHEM-BIOL INTERACT, V304, P73, DOI 10.1016/j.cbi.2019.03.002; Yoon H, 2011, BIOCHEM J, V440, P137, DOI 10.1042/BJ20111036; Zhang AS, 2004, BLOOD, V103, P1509, DOI 10.1182/blood-2003-07-2378; Zhang J, 2017, EMBO J, V36, P1302, DOI 10.15252/embj.201696151; Zhang YY, 2011, MOL BIOL CELL, V22, P2165, DOI 10.1091/mbc.E10-11-0912; Zorn A. M., 2008, STEMBOOK, DOI [10.3824/stembook.1.25.1, DOI 10.3824/STEMBOOK.1.25.1]; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	49	15	15	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2020	295	32					11002	11020		10.1074/jbc.RA120.013229	http://dx.doi.org/10.1074/jbc.RA120.013229			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE7BV	32518166	hybrid, Green Published			2022-12-26	WOS:000562757100010
J	Doan, ND; Hosseini, AS; Bikovtseva, AA; Huang, MS; DiChiara, AS; Papa, LJ; Koller, A; Shoulders, MD				Ngoc-Duc Doan; Hosseini, Azade S.; Bikovtseva, Agata A.; Huang, Michelle S.; DiChiara, Andrew S.; Papa, Louis J., III; Koller, Antonius; Shoulders, Matthew D.			Elucidation of proteostasis defects caused by osteogenesis imperfecta mutations in the collagen-?2(I) C-propeptide domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						procollagen; endoplasmic reticulum proteostasis; protein quality control; mass spectrometry-based interactome; extracellular matrix; protein folding; protein secretion; osteogenesis imperfecta; triple-helix assembly; C1163R C-Pro?2(I); proteostasis; collagen; ER quality control	CARBOXYL-TERMINAL PROPEPTIDE; I COLLAGEN; ENDOPLASMIC-RETICULUM; PRO-ALPHA-1(I) CHAIN; TRIMERIZATION; TRAFFICKING; PEPTIDES; PROTEINS; CELLS; MODEL	Intracellular collagen assembly begins with the oxidative folding of ?30-kDa C-terminal propeptide (C-Pro) domains. Folded C-Pro domains then template the formation of triple helices between appropriate partner strands. Numerous C-Pro missense variants that disrupt or delay triple-helix formation are known to cause disease, but our understanding of the specific proteostasis defects introduced by these variants remains immature. Moreover, it is unclear whether or not recognition and quality control of misfolded C-Pro domains is mediated by recognizing stalled assembly of triple-helical domains or by direct engagement of the C-Pro itself. Here, we integrate biochemical and cellular approaches to illuminate the proteostasis defects associated with osteogenesis imperfecta-causing mutations within the collagen-?2(I) C-Pro domain. We first show that ?C-Pro-only? constructs recapitulate key aspects of the behavior of full-length Col?2(I) constructs. Of the variants studied, perhaps the most severe assembly defects are associated with C1163R C-Pro?2(I), which is incapable of forming stable trimers and is retained within cells. We find that the presence or absence of an unassembled triple-helical domain is not the key feature driving cellular retentionversussecretion. Rather, the proteostasis network directly engages the misfolded C-Pro domain itself to prevent secretion and initiate clearance. Using MS-based proteomics, we elucidate how the endoplasmic reticulum (ER) proteostasis network differentially engages misfolded C1163R C-Pro?2(I) and targets it for ER-associated degradation. These results provide insights into collagen folding and quality control with the potential to inform the design of proteostasis network-targeted strategies for managing collagenopathies.	[Ngoc-Duc Doan; Hosseini, Azade S.; Bikovtseva, Agata A.; Huang, Michelle S.; DiChiara, Andrew S.; Papa, Louis J., III; Shoulders, Matthew D.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Koller, Antonius] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Shoulders, MD (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	mshoulde@mit.edu		/0000-0002-9438-0643; Huang, Michelle/0000-0002-1814-7786	National Institutes of Health [1R01AR071443]; G. Harold and Leila Y. Mathers Foundation; Dreyfus Foundation Teacher-Scholar Award; Canadian Institutes of Health Research; Fonds de Recherche du Quebec-Sante; National Science Foundation; Johnson and Johnson UROP Scholar Program; NIH Ruth L. Kirschstein predoctoral fellowship [F31AR067615]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Foundation; Dreyfus Foundation Teacher-Scholar Award; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); National Science Foundation(National Science Foundation (NSF)); Johnson and Johnson UROP Scholar Program; NIH Ruth L. Kirschstein predoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (Grant 1R01AR071443), a Research Grant from the G. Harold and Leila Y. Mathers Foundation, and a Dreyfus Foundation Teacher-Scholar Award (all toM. D. S.). N.-D. D. was supported by Canadian Institutes of Health Research and Fonds de Recherche du Quebec-Sante postdoctoral fellowships. L. J. P. was supported by a National Science Foundation Graduate Research Fellowship. A. A. B. was supported by the Johnson and Johnson UROP Scholar Program. A. S. D. was supported by an NIH Ruth L. Kirschstein predoctoral fellowship (Grant F31AR067615). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BACHINGER HP, 1980, EUR J BIOCHEM, V106, P619, DOI 10.1111/j.1432-1033.1980.tb04610.x; Barnes AM, 2019, BBA-MOL BASIS DIS, V1865, P2210, DOI 10.1016/j.bbadis.2019.04.018; Bateman JF, 2019, J CELL MOL MED, V23, P1735, DOI 10.1111/jcmm.14072; Bonfanti L, 1998, CELL, V95, P993, DOI 10.1016/S0092-8674(00)81723-7; Boudko SP, 2012, INT J BIOCHEM CELL B, V44, P21, DOI 10.1016/j.biocel.2011.09.009; Bourhis JM, 2012, NAT STRUCT MOL BIOL, V19, P1031, DOI 10.1038/nsmb.2389; Buehler MJ, 2006, P NATL ACAD SCI USA, V103, P12285, DOI 10.1073/pnas.0603216103; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; CHESSLER SD, 1993, J BIOL CHEM, V268, P18226; Dewal MB, 2015, CHEM BIOL, V22, P1301, DOI 10.1016/j.chembiol.2015.09.006; DiChiara AS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06185-2; DiChiara AS, 2016, ACS CHEM BIOL, V11, P1408, DOI 10.1021/acschembio.5b01083; Doan ND, 2019, METHODS MOL BIOL, V1944, P95, DOI 10.1007/978-1-4939-9095-5_7; DOEGE KJ, 1986, J BIOL CHEM, V261, P8924; EYRE DR, 1980, SCIENCE, V207, P1315, DOI 10.1126/science.7355290; Fitzgerald J, 1999, J BIOL CHEM, V274, P27392, DOI 10.1074/jbc.274.39.27392; Forlino A, 2011, NAT REV ENDOCRINOL, V7, P540, DOI 10.1038/nrendo.2011.81; Graham LV, 2010, J BIOL CHEM, V285, P7067, DOI 10.1074/jbc.M109.006841; HAYASHI T, 1980, J BIOCHEM, V87, P803, DOI 10.1093/oxfordjournals.jbchem.a132809; Hulmes DJS, 2002, J STRUCT BIOL, V137, P2, DOI 10.1006/jsbi.2002.4450; Ishida Y, 2009, MOL BIOL CELL, V20, P2744, DOI 10.1091/mbc.E08-11-1092; Ishikawa Y, 2013, BBA-MOL CELL RES, V1833, P2479, DOI 10.1016/j.bbamcr.2013.04.008; Jobling R, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-013-0394-3; Khoshnoodi J, 2006, J BIOL CHEM, V281, P38117, DOI 10.1074/jbc.R600025200; LAMANDE SR, 1995, J BIOL CHEM, V270, P8642, DOI 10.1074/jbc.270.15.8642; LEES JF, 1994, J BIOL CHEM, V269, P24354; LEUNG MKK, 1979, J BIOL CHEM, V254, P224; Lindahl K, 2011, HUM MUTAT, V32, P598, DOI 10.1002/humu.21475; Lisse TS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040007; Makareeva E, 2011, TRENDS CELL BIOL, V21, P168, DOI 10.1016/j.tcb.2010.11.007; Mirigian LS, 2016, J BONE MINER RES, V31, P1608, DOI 10.1002/jbmr.2824; Nabavi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046265; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Oliver JE, 1996, HUM MUTAT, V7, P318, DOI 10.1002/(SICI)1098-1004(1996)7:4<318::AID-HUMU5>3.3.CO;2-S; OLSEN BR, 1977, BIOCHEMISTRY-US, V16, P3030, DOI 10.1021/bi00632a034; Pace JM, 2008, J BIOL CHEM, V283, P16061, DOI 10.1074/jbc.M801982200; Pace JM, 2001, J MED GENET, V38, P443, DOI 10.1136/jmg.38.7.443; PROCKOP DJ, 1979, NEW ENGL J MED, V301, P13, DOI 10.1056/NEJM197907053010104; Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978; Schellenberger V, 2009, NAT BIOTECHNOL, V27, P1186, DOI 10.1038/nbt.1588; Sebastian RM, 2020, ANNU REV BIOCHEM, V89, P529, DOI 10.1146/annurev-biochem-013118-111552; Sharma U, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14671; Shoulders MD, 2013, CELL REP, V3, P1279, DOI 10.1016/j.celrep.2013.03.024; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Symoens S, 2014, HUM MUTAT, V35, P1330, DOI 10.1002/humu.22677; Wong MY, 2019, CURR OPIN CHEM BIOL, V50, P80, DOI 10.1016/j.cbpa.2019.02.021; Wong MY, 2018, P NATL ACAD SCI USA, V115, pE10089, DOI 10.1073/pnas.1805425115; Wong MY, 2018, CURR TOP MICROBIOL, V414, P1, DOI 10.1007/82_2017_56	48	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2020	295	29					9959	9973		10.1074/jbc.RA120.014071	http://dx.doi.org/10.1074/jbc.RA120.014071			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MR1DY	32482890	Green Published, hybrid			2022-12-26	WOS:000553333300015
J	Daddali, R; Ojaniemi, M; Hallman, M; Ramet, M; Haapalainen, AM				Daddali, Ravindra; Ojaniemi, Marja; Hallman, Mikko; Ramet, Mika; Haapalainen, Antti M.			CPPED1-targeting microRNA-371a-5p expression in human placenta associates with spontaneous delivery	PLOS ONE			English	Article							TARGET PREDICTION; MICRORNAS; GROWTH; AKT; TROPHOBLAST; PHOSPHORYLATION; RESOURCE; BINDING; IMMUNE; CANCER	MicroRNAs (miRNAs) are important regulators of gene expression, and their expression is associated with many physiological conditions. Here, we investigated potential associations between expression levels of miRNAs in human placenta and the onset of spontaneous term birth. Using RNA sequencing, we identified 54 miRNAs differentially expressed during spontaneous term labor compared to elective term births. Expression levels of 23 miRNAs were upregulated, whereas 31 were downregulated at least 1.5-fold. The upregulated miRNA miR-371a-5p putatively targetsCPPED1, expression of which decreases during spontaneous birth. We used a luciferase reporter-based assay to test whether a miR-371a-5p mimic affected translation when it bound to the 3 ' untranslated region ofCPPED1. In this setting, the miR-371a-5p mimic resulted in lower luciferase activity, which suggests that miR-371a-5p regulates levels of CPPED1. In conclusion, inversely correlated levels of miR-371a-5p andCPPED1suggest a role for both in spontaneous delivery.	[Daddali, Ravindra; Ojaniemi, Marja; Hallman, Mikko; Ramet, Mika; Haapalainen, Antti M.] Univ Oulu, PEDEGO Res Unit, Oulu, Finland; [Daddali, Ravindra; Ojaniemi, Marja; Hallman, Mikko; Ramet, Mika; Haapalainen, Antti M.] Univ Oulu, Med Res Ctr Oulu, Oulu, Finland; [Daddali, Ravindra; Ojaniemi, Marja; Hallman, Mikko; Ramet, Mika; Haapalainen, Antti M.] Oulu Univ Hosp, Dept Children & Adolescents, Oulu, Finland; [Ramet, Mika] Univ Tampere, BioMediTech, Inst & Fac Med & Life Sci, Tampere, Finland	University of Oulu; University of Oulu; University of Oulu; Tampere University	Haapalainen, AM (corresponding author), Univ Oulu, PEDEGO Res Unit, Oulu, Finland.; Haapalainen, AM (corresponding author), Univ Oulu, Med Res Ctr Oulu, Oulu, Finland.; Haapalainen, AM (corresponding author), Oulu Univ Hosp, Dept Children & Adolescents, Oulu, Finland.	antti.haapalainen@oulu.fi	Hallman, Niilo/AHD-9810-2022		Jane and Aatos Erkko Foundation; Sigrid Juse'lius Foundation; Competitive State Research Financing of the Expert Responsibility Area of Oulu University Hospital; Pediatric Research Foundation	Jane and Aatos Erkko Foundation; Sigrid Juse'lius Foundation(Sigrid Juselius Foundation); Competitive State Research Financing of the Expert Responsibility Area of Oulu University Hospital; Pediatric Research Foundation	This work was supported by the Jane and Aatos Erkko Foundation (MH and MR), Sigrid Juse ' lius Foundation (MH), Competitive State Research Financing of the Expert Responsibility Area of Oulu University Hospital (MR), and Pediatric Research Foundation (AMH).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; Bischof P, 2000, HUM REPROD, V15, P51; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Casey ML, 1997, ANN NY ACAD SCI, V828, P273, DOI 10.1111/j.1749-6632.1997.tb48548.x; Chang GJ, 2017, FASEB J, V31, P2760, DOI 10.1096/fj.201601146R; Chou CH, 2018, NUCLEIC ACIDS RES, V46, pD296, DOI 10.1093/nar/gkx1067; Du E, 2019, REPROD SCI, p1933719119828051; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elovitz MA, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.01.023; Elovitz MA, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.12.043; Fu GD, 2013, INT J MOL SCI, V14, P5519, DOI 10.3390/ijms14035519; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Gracie S, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-71; Gray C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00713-8; Gu Y, 2013, AM J PHYSIOL-ENDOC M, V304, pE836, DOI 10.1152/ajpendo.00660.2012; Haapalainen AM, 2018, J CELL MOL MED, V22, P968, DOI 10.1111/jcmm.13402; Hemmings BA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011189; Hess AP, 2007, BIOL REPROD, V76, P102, DOI 10.1095/biolreprod.106.054791; Holtan SG, 2009, MAYO CLIN PROC, V84, P985, DOI 10.1016/S0025-6196(11)60669-1; Hromadnikova I, 2013, MEDIAT INFLAMM, V2013, DOI DOI 10.1155/2013/186041; Hromadnikova I, 2015, DNA CELL BIOL, V34, P437, DOI 10.1089/dna.2014.2687; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Janas MM, 2012, EMBO J, V31, P2446, DOI 10.1038/emboj.2012.119; Johnson ME, 2014, BMJ OPEN DIAB RES CA, V2, DOI 10.1136/bmjdrc-2014-000052; Kacerovsky M, 2014, REPROD SCI, V21, P283, DOI 10.1177/1933719113503415; Karjalainen MK, 2015, J IMMUNOL, V195, P2187, DOI 10.4049/jimmunol.1501174; Kim JJ, 2005, BIOL REPROD, V73, P833, DOI 10.1095/biolreprod.105.043182; Kiss H, 2000, ACTA OBSTET GYN SCAN, V79, P3, DOI 10.1034/j.1600-0412.2000.079001003.x; Kotlabova K, 2011, J REPROD IMMUNOL, V89, P185, DOI 10.1016/j.jri.2011.02.006; Lam EWF, 2012, J ENDOCRINOL, V212, P13, DOI 10.1530/JOE-10-0480; Leung TN, 2001, BRIT J OBSTET GYNAEC, V108, P527, DOI 10.1016/S0306-5456(00)00112-1; Lim R, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.108126; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Medeiros LA, 2011, P NATL ACAD SCI USA, V108, P14163, DOI 10.1073/pnas.1111241108; Morales-Prieto DM, 2012, PLACENTA, V33, P725, DOI 10.1016/j.placenta.2012.05.009; Morales-Prieto DM, 2013, J REPROD IMMUNOL, V97, P51, DOI 10.1016/j.jri.2012.11.001; Nair RR, 2016, GEN COMP ENDOCRINOL; Ngo TTM, 2018, SCIENCE, V360, P1133, DOI 10.1126/science.aar3819; Paikari A, 2017, DEVELOPMENT, V144, P3731, DOI 10.1242/dev.151654; Pfaff N, 2012, J MOL MED, V90, P747, DOI 10.1007/s00109-012-0922-z; Prieto DMM, 2011, J REPROD IMMUNOL, V88, P106, DOI 10.1016/j.jri.2011.01.004; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Schumacher A, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00196; Sheridan R, 2015, HISTOL HISTOPATHOL, V30, P213, DOI 10.14670/HH-30.213; Smith R, 2007, NEW ENGL J MED, V356, P271, DOI 10.1056/NEJMra061360; Suguitan Jr AL, 2011, PLOS ONE, V6; Tsukerman P, 2014, ONCOTARGET, V5, P12141, DOI 10.18632/oncotarget.2559; Vaittinen M, 2013, DIABETES, V62, P3747, DOI 10.2337/db13-0830; Vasquez YM, 2015, MOL ENDOCRINOL, V29, P421, DOI 10.1210/me.2014-1292; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang XW, 2016, BIOINFORMATICS, V32, P1316, DOI 10.1093/bioinformatics/btw002; Winger EE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180124; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Wu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108519; Yan L, 2015, AM J CANCER RES, V5, P1447; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200; Zhang XB, 2011, BBA-MOL CELL RES, V1813, P1978, DOI 10.1016/j.bbamcr.2011.03.010; Zhao JR, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0108-2; Zhu XM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.045; Zhuo DX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065679; Zhuo DX, 2019, EXP CELL RES, V380, P80, DOI 10.1016/j.yexcr.2019.04.019	64	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2020	15	6							e0234403	10.1371/journal.pone.0234403	http://dx.doi.org/10.1371/journal.pone.0234403			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC0EC	32520951	gold, Green Published			2022-12-26	WOS:000542969500028
J	Rao, AR; Chatterjee, P; Thakral, M; Dwivedi, SN; Dey, AB				Rao, Abhijith Rajaram; Chatterjee, Prasun; Thakral, Meenal; Dwivedi, S. N.; Dey, Aparajit Ballav			Behavioural issues in late life may be the precursor of dementia- A cross sectional evidence from memory clinic of AIIMS, India	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; NEUROPSYCHIATRIC SYMPTOMS; URINARY-INCONTINENCE; RISK-FACTORS; POPULATION; PREVALENCE; DISORDERS; ANXIETY; DECLINE; ASSOCIATION	Background Mild Behavioural Impairment (MBI), an "at risk" state for incident cognitive declin, is characterized by late onset, sustained neuropsychiatric symptoms of any severity which cannot be accounted for by other formal medical and psychiatric nosology. There is no study related to MBI from India. Methods and findings In this cross-sectional observational study 124 subjects 60 years and above were recruited between March 2017 to October 2018, from memory clinic of department of Geriatric medicine with memory or behavioural complains. Subjects with major neurocognitive impairment (CDR score of 1 or more), major depressive disorder, generalized anxiety disorder and impaired activities of daily living (ADL) were excluded. Subjects with Mild Cognitive impairment (MCI) (CDR- 0.5), and Subjective cognitive impairment (SCI) (CDR- 0) were included. Neuropsychiatric Inventory Questionnaire (NPI-Q) was used to identify the presence of NPS. The ISTAART-MBI (International Society of Advance Alzheimer's Research and Treatment-Alzheimer's Association) diagnostic criteria was used to diagnose MBI. All the participants underwent a geriatric assessment using standardised screening. The objectives of this study was to determine the frequency of mild behavioural impairment (MBI), and its domains, in MCI or SCI and its association with comorbidities and geriatric syndromes. The mean age of the participants was 69.21, 71.77% (89) were male and 28.23% (35) were female. 41.13% (51) of these individuals were diagnosed with MBI. The MBI and non MBI group differed significantly in marital status, cognitive status and MCI subtype. The proportion of domains involved are as follows: decreased motivation 60.78%(31), emotional dysregulation 54.90% (28), impulse dyscontrol 68.63% (35), social inappropriateness 21.57%(11), abnormal perception 2 (3.93%). Presence of multi-morbidity, and diabetes, were statistically significant between the groups. Conclusion This study presents the first clinic-based prevalence estimates of MBI from Asia. Findings indicate a relatively high prevalence of MBI in predementia clinical states, impulse dyscontrol was the most commonly involved MBI domain. Multimorbidity, diabetes, urinary incontinence were other determinants of MBI.	[Rao, Abhijith Rajaram; Chatterjee, Prasun; Thakral, Meenal; Dey, Aparajit Ballav] All India Inst Med Sci, Dept Geriatr Med, New Delhi, India; [Dwivedi, S. N.] All India Inst Med Sci, Dept Biostat, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Chatterjee, P (corresponding author), All India Inst Med Sci, Dept Geriatr Med, New Delhi, India.	drprasun.geriatrics@gmail.com	Rao, Abhijith Rajaram/EYM-5234-2022	Rao, Abhijith Rajaram/0000-0002-3904-4372; Chatterjee, Prasun/0000-0002-3260-2458				Acosta I, 2018, ALZHEIMERS DEMENT, V14, P271, DOI 10.1016/j.jalz.2017.08.015; [Anonymous], 2014, ALZHEIMERS DEMENT J, V10, pe47; Bogner HR, 2011, J ANXIETY DISORD, V25, P203, DOI 10.1016/j.janxdis.2010.09.003; Bogner HR, 2002, J AM GERIATR SOC, V50, P489, DOI 10.1046/j.1532-5415.2002.50115.x; Creese B, 2019, AM J GERIAT PSYCHIAT, V27, P823, DOI 10.1016/j.jagp.2019.01.215; Davies-Kershaw HR, 2018, J AM GERIATR SOC, V66, P1823, DOI 10.1111/jgs.15456; Dumurgier J, 2017, J GERONTOL A-BIOL, V72, P655, DOI 10.1093/gerona/glw110; Garand L, 2007, WESTERN J NURS RES, V29, P976, DOI 10.1177/0193945907303086; Geda YE, 2008, ARCH GEN PSYCHIAT, V65, P1193, DOI 10.1001/archpsyc.65.10.1193; Gulpers B, 2016, AM J GERIAT PSYCHIAT, V24, P823, DOI 10.1016/j.jagp.2016.05.015; Gurgel RK, 2014, OTOL NEUROTOL, V35, P775, DOI 10.1097/MAO.0000000000000313; Ismail Z, 2018, INT PSYCHOGERIATR, V30, P185, DOI 10.1017/S1041610217001880; Ismail Z, 2016, ALZHEIMERS DEMENT, V12, P195, DOI 10.1016/j.jalz.2015.05.017; Jayaraman A, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0476-2; Lanctot KL, 2017, ALZHEIMERS DEMENT, V13, P84, DOI 10.1016/j.jalz.2016.05.008; Lyketsos CG, 2002, JAMA-J AM MED ASSOC, V288, P1475, DOI 10.1001/jama.288.12.1475; Mallo SC, 2018, J ALZHEIMERS DIS, V66, P83, DOI 10.3233/JAD-180131; Mortby ME, 2018, INT PSYCHOGERIATR, V30, P221, DOI 10.1017/S1041610217001909; Mortby ME, 2017, J ALZHEIMERS DIS, V59, P141, DOI 10.3233/JAD-170050; Peters ME, 2013, AM J GERIAT PSYCHIAT, V21, P1116, DOI 10.1016/j.jagp.2013.01.049; Rosenberg PB, 2013, AM J GERIAT PSYCHIAT, V21, P685, DOI 10.1016/j.jagp.2013.01.006; Sathianathan R, 2018, INDIAN J PSYCHIAT, V60, P165, DOI 10.4103/psychiatry.IndianJPsychiatry_261_18; Sheikh F, 2018, INT PSYCHOGERIATR, V30, P233, DOI 10.1017/S104161021700151X; Steers WD, 2001, WORLD J UROL, V19, P351, DOI 10.1007/s003450100227; Tamam L, 2014, COMPR PSYCHIAT, V55, P1022, DOI 10.1016/j.comppsych.2013.12.003; Taragano FE, 2009, J CLIN PSYCHIAT, V70, P584, DOI 10.4088/JCP.08m04181	26	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2020	15	6							e0234514	10.1371/journal.pone.0234514	http://dx.doi.org/10.1371/journal.pone.0234514			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC0EC	32520946	Green Published, gold			2022-12-26	WOS:000542969500006
J	Feng, X; Sun, BL; Zhang, HH; Yu, PQ				Feng, Xin; Sun, Baoli; Zhang, Huihua; Yu, Peiqiang			Using advanced vibrational molecular spectroscopy to detect moist heating induced protein structure changes in cool-climate adapted barley grain	PLOS ONE			English	Article							IN-VITRO; MICROWAVE IRRADIATION; INTESTINAL DIGESTION; CARBOHYDRATE; DEGRADATION; STARCH; RUMEN; DEGRADABILITY; DIGESTIBILITY; FERMENTATION	Different techniques have been applied in feed processing to improve ruminal degradation and nutrient utilization in ruminant. There are limited studies investigating how moist heating process impacts barley protein utilization and internal molecular structures. The objectives of this study were to investigate: 1) how moist heating affects barley protein chemical profiles and Cornell Net Carbohydrate and Protein System (CNCPS) subfractions, in situ rumen degradation parameters, and predicted intestinal protein supply and feed milk value; 2) how moist heating affects protein molecular spectral features; and 3) the relationship between protein molecular structure spectral features and protein chemical profiles and metabolic characteristics. The barley variety CDC cowboy samples collected from the research farm during two consecutive years were used. Half of each sample was kept as raw and the other half underwent moist heating. The advanced molecular spectroscopy (attenuated total reflectance-fourier transform infrared, ATR-FTIR) was used to detect the barley protein molecular structure spectral features. It was found that moist heating decreased the fractions of soluble protein and increased the moderately degradable protein and ingestible protein fractions. This further resulted in the changes of in situ rumen degradation parameters and intestinal protein digestion characteristics. The protein molecular structure spectral features detected by using ATR-FTIR spectroscopy can be used as potential predictors for protein related chemical and metabolic parameters.	[Feng, Xin; Sun, Baoli; Yu, Peiqiang] Univ Saskatchewan, Coll Agr & Bioresources, Dept Anim & Poultry Sci, Saskatoon, SK, Canada; [Feng, Xin; Zhang, Huihua] Foshan Univ, Sch Life Sci & Engn, Foshan, Peoples R China; [Sun, Baoli] South China Agr Univ, Coll Anim Sci, Guangzhou, Peoples R China	University of Saskatchewan; Foshan University; South China Agricultural University	Yu, PQ (corresponding author), Univ Saskatchewan, Coll Agr & Bioresources, Dept Anim & Poultry Sci, Saskatoon, SK, Canada.	peiqiang.yu@usask.ca	weixian, zhang/H-4046-2013	weixian, zhang/0000-0002-0250-4013	Ministry of Agriculture Strategic Research Chair; Agricultural Development Fund (ADF); Saskatchewan Pulse Growers (SPG); SaskCanola; Natural Sciences and Engineering Research Council of Canada (NSERC-Individual Discovery Grant); Natural Sciences and Engineering Research Council of Canada (NSERC-CRD Grant); Saskatchewan Agriculture Strategic Research Chair Program; SaskMilk; Saskatchewan Forage Network (SNK); Western Grain Research Foundation (WGRF); Prairie Oat Grower Associations (POGA)	Ministry of Agriculture Strategic Research Chair; Agricultural Development Fund (ADF); Saskatchewan Pulse Growers (SPG); SaskCanola; Natural Sciences and Engineering Research Council of Canada (NSERC-Individual Discovery Grant)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council of Canada (NSERC-CRD Grant)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Saskatchewan Agriculture Strategic Research Chair Program; SaskMilk; Saskatchewan Forage Network (SNK); Western Grain Research Foundation (WGRF); Prairie Oat Grower Associations (POGA)	This work was supported by The Ministry of Agriculture Strategic Research Chair (to PY), Programs fund from the Agricultural Development Fund (ADF), the Saskatchewan Pulse Growers (SPG), the SaskCanola, the Natural Sciences and Engineering Research Council of Canada (NSERC-Individual Discovery Grant and NSERC-CRD Grant), the Saskatchewan Agriculture Strategic Research Chair Program, the SaskMilk, the Saskatchewan Forage Network (SNK), the Western Grain Research Foundation (WGRF), and the Prairie Oat Grower Associations (POGA).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOAC, 2007, OFFICIAL METHODS ANA, V18th; CALSAMIGLIA S, 1995, J ANIM SCI, V73, P1459; Canadian Council on Animal Care, 2009, TEACHING TESTING, VII, P103; Dehghan-Banadaky M, 2007, ANIM FEED SCI TECH, V137, P1, DOI 10.1016/j.anifeedsci.2006.11.021; England S, 1990, METHODS ENZYMOL, V182; Goelema JO, 1999, ANIM FEED SCI TECH, V78, P109, DOI 10.1016/S0377-8401(98)00266-1; Kennelly J, 1995, ADV DAIRY TECHNOL, V7, P259; Khan NA, 2015, J AGR FOOD CHEM, V63, P1057, DOI 10.1021/jf503575y; KHORASANI GR, 1994, J DAIRY SCI, V77, P813, DOI 10.3168/jds.S0022-0302(94)77016-8; Licitra G, 1996, ANIM FEED SCI TECH, V57, P347, DOI 10.1016/0377-8401(95)00837-3; Mathison GW, 1996, ANIM FEED SCI TECH, V58, P113, DOI 10.1016/0377-8401(95)00878-0; MCCARTHY RD, 1989, J DAIRY SCI, V72, P2002, DOI 10.3168/jds.S0022-0302(89)79324-3; MCNIVEN MA, 1994, ANIM FEED SCI TECH, V47, P31, DOI 10.1016/0377-8401(94)90157-0; NASEM (National Academies of Science Engineering and Medicine), 2001, NUTR REQ DAIR CATTL, V7th, DOI 10.17226/9825; Nikkhah A, 2006, J ANIM SCI, V84, P369; Nikkhah A, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-22; ORSKOV ER, 1981, ANIM FEED SCI TECH, V6, P273, DOI 10.1016/0377-8401(81)90006-7; ORSKOV ER, 1979, J AGR SCI, V92, P499, DOI 10.1017/S0021859600063048; Peng QH, 2014, J DAIRY SCI, V97, P446, DOI 10.3168/jds.2013-7298; Prestlokken E, 1999, ANIM FEED SCI TECH, V82, P157, DOI 10.1016/S0377-8401(99)00110-8; ROE MB, 1990, PROCEEDINGS 1990 : CORNELL NUTRITION CONFERENCE FOR FEED MANUFACTURERS, P81; RUSSELL JB, 1983, J DAIRY SCI, V66, P763, DOI 10.3168/jds.S0022-0302(83)81856-6; Sadeghi AA, 2005, ANIM SCI, V80, P369, DOI 10.1079/ASC40820369; TAMMINGA S, 1994, LIVEST PROD SCI, V40, P139, DOI 10.1016/0301-6226(94)90043-4; VALENTINE S C, 1980, Proceedings of the Australian Society of Animal Production, V13, P397; Van Amburgh ME, 2015, J DAIRY SCI, V98, P6361, DOI 10.3168/jds.2015-9378; Voragen AGJ, 1995, REC ADV AN, P93; Xin HS, 2013, SPECTROCHIM ACTA A, V112, P318, DOI 10.1016/j.saa.2013.04.073; Yu GQ, 2015, SPECTROCHIM ACTA A, V151, P980, DOI 10.1016/j.saa.2015.06.050; Yu P., 2007, AM J BIOCH BIOTECHNO, V3, P66, DOI DOI 10.3844/AJBBSP.2007.66.86	30	1	1	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0234126	10.1371/journal.pone.0234126	http://dx.doi.org/10.1371/journal.pone.0234126			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502162	Green Published, gold			2022-12-26	WOS:000542035700017
J	Collins, DP; Hapke, JH; Aravalli, RN; Steer, CJ				Collins, Daniel P.; Hapke, Joel H.; Aravalli, Rajagopal N.; Steer, Clifford J.			Development of immortalized human hepatocyte-like hybrid cells by fusion of multi-lineage progenitor cells with primary hepatocytes	PLOS ONE			English	Article							MULTIPOTENT STEM-CELLS; LONG-TERM CULTURE; BONE-MARROW; LIVER; DIFFERENTIATION; THERAPY; TISSUE; MICE	Human primary hepatocytes (PHs) are critical to studying liver functions, drug metabolism and toxicity. PHs isolated from livers that are unacceptable for transplantation have limited expansion and culture viability in vitro, in addition to rapidly deteriorating enzymatic functions. The unsuitability of immortalized hepato-carcinoma cell lines for this function has prompted studies to develop hepatocyte-like cells from alternative sources like ESC, iPS, and other stem cell types using differentiation protocols. This study describes a novel technique to produce expandable and functional hepatocyte-like cells from the fusion of an immortalized human umbilical cord blood derived cell line (E12 MLPC) to normal human primary hepatocytes. Multi-lineage progenitor cells (MLPC) comprise a small subset of mesenchymal-like cells isolated from human umbilical cord blood. MLPC are distinguishable from other mesenchymal-like cells by their extended expansion capacity (up to 80 cell doublings before senescence) and the ability to be differentiated into cells representative of endo-, meso- and ectodermal origins. Transfection of MLPC with the gene for telomerase reverse transcriptase (TERT) resulted in clonal cell lines that were capable of differentiation to different cellular outcomes while maintaining their functional immortality. A methodology for the development of immortalized hepatocyte-like hybrid cells by the in vitro fusion of human MLPC with normal human primary hepatocytes is reported. The resultant hybrid cells exhibited homology with hepatocytes by morphology, immunohistochemistry, urea and albumin production and gene expression. A medium that allows stable long-term expansion of hepatocyte-like fusion cells is described.	[Collins, Daniel P.; Hapke, Joel H.] CMDG LLC, St Paul, MN 55127 USA; [Aravalli, Rajagopal N.] Univ Minnesota, Coll Sci & Engn, Dept Elect & Comp Engn, Minneapolis, MN USA; [Steer, Clifford J.] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; [Steer, Clifford J.] Univ Minnesota, Sch Med, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Collins, DP (corresponding author), CMDG LLC, St Paul, MN 55127 USA.	dc@cmdgiic.com		Collins, Daniel/0000-0003-2488-1108	CytoMedical Design Group, LLC (CMDG); BioE, LLC	CytoMedical Design Group, LLC (CMDG); BioE, LLC	CytoMedical Design Group, LLC (CMDG) provided funding for this study in the form of salaries for DPC and JHH. Additionally, funding was provided by BioE, LLC. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2005, BIOCHEM BIOPH RES CO, V326, P527, DOI 10.1016/j.bbrc.2004.11.059; Berger MJ, 2006, CYTOTHERAPY, V8, P480, DOI 10.1080/14653240600941549; Cadet P, 2007, J IMMUNOL, V179, P5839, DOI 10.4049/jimmunol.179.9.5839; Chen HL, 1998, J BIOMED SCI, V5, P435, DOI 10.1007/BF02255932; Chen ML, 2010, WORLD J GASTROENTERO, V16, P5092, DOI 10.3748/wjg.v16.i40.5092; Collins DP, 2006, BIOL BLOOD MARROW TR, V12, P1227, DOI 10.1016/j.bbmt.2006.08.028; Collins DP, 2007, STEM CELLS WORLD C; Dahlke MH, 2004, LIVER TRANSPLANT, V10, P471, DOI 10.1002/lt.20121; Deguchi S, 2019, DRUG METAB DISPOS, V47, P632, DOI 10.1124/dmd.119.086322; Deurholt T, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-89; Hay DC, 2008, STEM CELLS, V26, P894, DOI 10.1634/stemcells.2007-0718; Huang CJ, 2011, DIABETOLOGIA, V54, P1066, DOI 10.1007/s00125-011-2071-2; Ishikawa F, 2003, ANN NY ACAD SCI, V996, P174, DOI 10.1111/j.1749-6632.2003.tb03245.x; Katsura N, 2002, J SURG RES, V106, P115, DOI 10.1006/jsre.2002.6446; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Martinez JJG, 2018, ANN INTENSIVE CARE, V8, DOI 10.1186/s13613-018-0453-z; McKenna DH, 2010, US Patent, Patent No. [7,727,763, 7727763]; Medvinsky A, 2003, NATURE, V422, P823, DOI 10.1038/422823a; Mowbray C., 2015, EUR PHARM REV, V20, P8; Newsome PN, 2003, GASTROENTEROLOGY, V124, P1891, DOI 10.1016/S0016-5085(03)00401-3; Okamoto R, 2018, CELL TRANSPLANT, V27, P299, DOI 10.1177/0963689717751734; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Sakai K, 2015, ONCOL LETT, V9, P405, DOI 10.3892/ol.2014.2702; Sato Y, 2005, BLOOD, V106, P756, DOI 10.1182/blood-2005-02-0572; Sen S, 2003, SEMIN LIVER DIS, V23, P283; Sprague SL, 2010, United State patent, Patent No. [7,670,596, 7670596]; Sprague SL, 2009, United States patent, Patent No. [7,622,108, 7622108]; Stefano GB, 2008, SEMIN CANCER BIOL, V18, P199, DOI 10.1016/j.semcancer.2007.12.003; Theise ND, 2003, SCIENCE, V299, p1317A, DOI 10.1126/science.1078412; van de Ven C, 2007, EXP HEMATOL, V35, P1753, DOI 10.1016/j.exphem.2007.08.017; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Wang XL, 2003, BLOOD, V101, P4201, DOI 10.1182/blood-2002-05-1338; Wege H, 2003, GASTROENTEROLOGY, V124, P432, DOI 10.1053/gast.2003.50064	35	4	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0234002	10.1371/journal.pone.0234002	http://dx.doi.org/10.1371/journal.pone.0234002			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497071	gold, Green Published			2022-12-26	WOS:000542035200072
J	McCabe, RA; Receveur, JP; Houtz, JL; Thomas, KL; Benbow, ME; Pechal, JL; Wallace, JR				McCabe, Rebecca A.; Receveur, Joseph P.; Houtz, Jennifer L.; Thomas, Kayli L.; Benbow, M. Eric; Pechal, Jennifer L.; Wallace, John R.			Characterizing the microbiome of ectoparasitic louse flies feeding on migratory raptors	PLOS ONE			English	Article							WOHLFAHRTIA-MAGNIFICA DIPTERA; BACTERIAL COMMUNITIES; VECTOR COMPETENCE; TICK MICROBIOME; GUT MICROBIOTA; WILD BIRDS; GEN-NOV; FLY; DIVERSITY; ARSENOPHONUS	Louse flies (Diptera: Hippoboscidae) are obligate ectoparasites that often cause behavioral, pathogenic, and evolutionary effects on their hosts. Interactions between ectoparasites and avian hosts, especially migrating taxa, may influence avian pathogen spread in tropical and temperate ecosystems and affect long-term survival, fitness and reproductive success. The purpose of this study was to characterize the vector-associated microbiome of ectoparasitic louse flies feeding on migrating raptors over the fall migration period. Surveys for louse flies occurred during fall migration (2015-2016) at a banding station in Pennsylvania, United States; flies were collected from seven species of migrating raptors, and we sequenced their microbial (bacteria and archaea) composition using high-throughput targeted amplicon sequencing of the 16S rRNA gene (V4 region). All louse flies collected belonged to the same species, Icosta americana. Our analysis revealed no difference in bacterial communities of louse flies retrieved from different avian host species. The louse fly microbiome was dominated by a primary endosymbiont, suggesting that louse flies maintain a core microbial structure despite receiving blood meals from different host species. Thus, our findings highlight the importance of characterizing both beneficial and potentially pathogenic endosymbionts when interpreting how vector-associated microbiomes may impact insect vectors and their avian hosts.	[McCabe, Rebecca A.] McGill Univ, Dept Nat Resource Sci, Ste Anne De Bellevue, PQ, Canada; [Receveur, Joseph P.; Benbow, M. Eric; Pechal, Jennifer L.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Houtz, Jennifer L.; Thomas, Kayli L.; Wallace, John R.] Millersville Univ Pennsylvania, Dept Biol, Millersville, PA USA; [Houtz, Jennifer L.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA	McGill University; Michigan State University; Pennsylvania State System of Higher Education (PASSHE); Millersville University of Pennsylvania; Cornell University	McCabe, RA (corresponding author), McGill Univ, Dept Nat Resource Sci, Ste Anne De Bellevue, PQ, Canada.; Wallace, JR (corresponding author), Millersville Univ Pennsylvania, Dept Biol, Millersville, PA USA.	rebecca.mccabe@mail.mcgill.ca; john.wallace@millersville.edu		McCabe, Rebecca/0000-0001-7761-6020	Commonwealth of Pennsylvania University Biologists [2-2016]; Millersville University [6033009967]; Niemeyer-Hodgson Undergraduate Research Grant [6033009969]; Department of Entomology at Michigan State University; Merritt Endowed Fellowship in Entomology at Michigan State University	Commonwealth of Pennsylvania University Biologists; Millersville University; Niemeyer-Hodgson Undergraduate Research Grant; Department of Entomology at Michigan State University; Merritt Endowed Fellowship in Entomology at Michigan State University	The authors received funding for this work including: The Commonwealth of Pennsylvania University Biologists (http://academics.sru.edu/cpub/index.php?content=main) Student Research Grant (#2-2016), Millersville University's Biology Student Investigator (#6033009967) and Niemeyer-Hodgson Undergraduate Research Grant (#6033009969)-awarded to KLT, and the Department of Entomology and Merritt Endowed Fellowship in Entomology at Michigan State University (https://www.canr.msu.edu/ent/students/funding_ opportunities/index) awarded to JPR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, STROKE, V49, pe233; [Anonymous], 2006, YB INT LAW COMMISSIO, VII; BAKER JR, 1967, J PARASITOL, V53, P412, DOI 10.2307/3276603; Barber I, 2010, PHILOS T R SOC B, V365, P4077, DOI 10.1098/rstb.2010.0182; Beard CB, 2001, INT J PARASITOL, V31, P621, DOI 10.1016/S0020-7519(01)00165-5; Behar A, 2008, J INSECT PHYSIOL, V54, P1377, DOI 10.1016/j.jinsphys.2008.07.011; BEQUAERT J. C., 1953, Entomologica Americana, V32, P1; BEQUAERT JOSEPH C., 1954, ENT AMER, V34, P1; BERGER DANIEL D., 1962, JOUR WILDLIFE MANAGEMENT JOUR WILDLIFE MANAGEMENT, V26, P203, DOI 10.2307/3798603; Bildstein K. L., 2006, MIGRATING RAPTORS WO; Bjoersdorff A, 2001, EMERG INFECT DIS, V7, P877; Bokulich NA, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0470-z; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Brown CR, 1995, P ROY SOC B-BIOL SCI, V262, P313, DOI 10.1098/rspb.1995.0211; Budachetri K, 2017, TICKS TICK-BORNE DIS, V8, P170, DOI 10.1016/j.ttbdis.2016.10.014; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Coon KL, 2014, MOL ECOL, V23, P2727, DOI 10.1111/mec.12771; Crespo R, 2019, BACTERIAL DIVERSITY; Dale C, 2006, APPL ENVIRON MICROB, V72, P2997, DOI 10.1128/AEM.72.4.2997-3004.2006; Davidsson PR, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00191; DeLiberto TJ, 2009, INTEGR ZOOL, V4, P426, DOI 10.1111/j.1749-4877.2009.00180.x; Dennison NJ, 2014, CURR OPIN INSECT SCI, V3, P6, DOI 10.1016/j.cois.2014.07.004; Descamps S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065374; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Farajollahi A, 2005, J AM MOSQUITO CONTR, V21, P474, DOI 10.2987/8756-971X(2006)21[474:DOWNVR]2.0.CO;2; Fuller T, 2012, ECOHEALTH, V9, P80, DOI 10.1007/s10393-012-0750-1; Gancz AY, 2004, EMERG INFECT DIS, V10, P2135; Gerlach H, 1994, AVIAN MED PRINCIPLES, P951; GHERNA RL, 1991, INT J SYST BACTERIOL, V41, P563, DOI 10.1099/00207713-41-4-563; Goodrich LJ, 2014, BIRDS N AM, DOI [10.2173/bna.218, DOI 10.2173/BNA.218]; Goodrich LJ, 2008, STATE N AM BIRDS PRE; Grindle N, 2003, J INVERTEBR PATHOL, V83, P264, DOI 10.1016/S0022-2011(03)00080-6; Guernier V, 2004, PLOS BIOL, V2, P740, DOI 10.1371/journal.pbio.0020141; Gurung K, 2019, ENTOMOL EXP APPL, V167, P156, DOI 10.1111/eea.12768; Hernandez-Garcia JA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14031-6; Hunter DB, 1997, J WILDLIFE DIS, V33, P486, DOI 10.7589/0090-3558-33.3.486; Ioannou I, 2009, CLIN MICROBIOL INFEC, V15, P158, DOI 10.1111/j.1469-0691.2008.02207.x; Ishii Y, 2013, APPL ENVIRON MICROB, V79, P5013, DOI 10.1128/AEM.01527-13; Jahantigh M, 2016, J Parasit Dis, V40, P1548; Junqueira ACM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16353-x; Jupatanakul N, 2014, VIRUSES-BASEL, V6, P4294, DOI 10.3390/v6114294; Kaltenpoth M, 2014, MOL ECOL, V23, P1251, DOI 10.1111/mec.12469; Kasana RC, 2018, CRIT REV BIOTECHNOL, V38, P141, DOI 10.1080/07388551.2017.1312273; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kim CH, 2015, J MED ENTOMOL, V52, P63, DOI 10.1093/jme/tju011; Klaassen RHG, 2014, J ANIM ECOL, V83, P176, DOI 10.1111/1365-2656.12135; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Levin II, 2014, MOL ECOL, V23, P947, DOI 10.1111/mec.12587; Levin II, 2011, INT J PARASITOL, V41, P1019, DOI 10.1016/j.ijpara.2011.03.014; Maa T. C., 1969, Pacific Insects Monograph, V20, P261; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; McWilliams SR, 2004, J AVIAN BIOL, V35, P377, DOI 10.1111/j.0908-8857.2004.03378.x; Moller AP, 2010, GLOBAL CHANGE BIOL, V16, P1158, DOI 10.1111/j.1365-2486.2009.02035.x; Narasimhan S, 2015, TRENDS PARASITOL, V31, P315, DOI 10.1016/j.pt.2015.03.010; Narasimhan S, 2014, CELL HOST MICROBE, V15, P58, DOI 10.1016/j.chom.2013.12.001; Newton I., 1979, POPULATION ECOLOGY R; Novakova E, 2016, STAND GENOMIC SCI, V11, DOI 10.1186/s40793-016-0195-1; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Peterson AT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000261; Philips J. R., 1990, Wildlife rehabilitation. Volume 8. Selected papers presented at the Eighth Symposium of the National Wildlife Rehabilitators Association, Ithaca, New York, March 21-25, 1990., P155; Philips James R., 2007, P311; Pitt TL, 2007, CLIN MICROBIOL INFEC, V13, P946, DOI 10.1111/j.1469-0691.2007.01779.x; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; R Core Team, 2021, R LANGUAGE ENV STAT; Remple JD, 2004, J AVIAN MED SURG, V18, P75, DOI 10.1647/2003-008; Rizzi A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/420287; Roggenbuck M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6498; Russell JA, 2003, MOL ECOL, V12, P1061, DOI 10.1046/j.1365-294X.2003.01780.x; RVACHEV LA, 1985, MATH BIOSCI, V75, P3, DOI 10.1016/0025-5564(85)90064-1; Sehgal RNM, 2015, INT J PARASITOL-PAR, V4, P421, DOI 10.1016/j.ijppaw.2015.09.001; Singh B, 2015, APPL MICROBIOL BIOT, V99, P869, DOI 10.1007/s00253-014-6115-7; Liebana MS, 2011, J RAPTOR RES, V45, P335, DOI 10.3356/JRR-11-26.1; Sonawane M. S., 2018, Proceedings of the Indian National Science Academy Part B Biological Sciences, V88, P567, DOI 10.1007/s40011-016-0785-0; Subandiyah S, 2000, ZOOL SCI, V17, P983, DOI 10.2108/zsj.17.983; Swei A, 2017, ISME J, V11, P813, DOI 10.1038/ismej.2016.152; Taylor MJ, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1413-y; Thao MLL, 2004, CURR MICROBIOL, V48, P140, DOI 10.1007/s00284-003-4157-7; TITUS K, 1982, Wilson Bulletin, V94, P176; Toth E, 2001, INT J SYST EVOL MICR, V51, P401, DOI 10.1099/00207713-51-2-401; Toth EM, 2006, MICROB ECOL, V51, P13, DOI 10.1007/s00248-005-0090-6; Tsuchida T, 2002, MOL ECOL, V11, P2123, DOI 10.1046/j.1365-294X.2002.01606.x; Turrell M, 2009, J MED VET ENTOMOLOGY, P55; VARMA MGR, 1964, B WORLD HEALTH ORGAN, V31, P411; Waite DW, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00223; Weiss B, 2011, TRENDS PARASITOL, V27, P514, DOI 10.1016/j.pt.2011.05.001; Weiss S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0237-y; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Zheng LY, 2013, J MED ENTOMOL, V50, P647, DOI 10.1603/ME12199	90	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0234050	10.1371/journal.pone.0234050	http://dx.doi.org/10.1371/journal.pone.0234050			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497084	Green Published, gold			2022-12-26	WOS:000542035200073
J	Piasecki, P; Ziecina, P; Brzozowski, K; Wierzbicki, M; Narloch, J				Piasecki, Piotr; Ziecina, Piotr; Brzozowski, Krzysztof; Wierzbicki, Marek; Narloch, Jerzy			Intra-aneurysmal pressure changes during stent-assisted coiling	PLOS ONE			English	Article							NECKED INTRACRANIAL ANEURYSMS; ENDOVASCULAR RECONSTRUCTION; FLOW DIVERSION; IN-VITRO; HEMODYNAMICS; MANAGEMENT; PLACEMENT; DYNAMICS	We aimed to examine aneurysm hemodynamics with intra-saccular pressure measurement, and compare the effects of coiling, stenting and stent-assisted coiling in proximal segments of intracranial circulation. A cohort of 45 patients underwent elective endovascular coil embolization (with or without stent) for intracranial aneurysm at our department. Arterial pressure transducer was used for all measurements. It was attached to proximal end of the microcatheter. Measurements were taken in the parent artery before and after embolization, at the aneurysm dome before embolization, after stent implantation, and after embolization. Stent-assisted coiling was performed with 4 different stents: LVIS and LVIS Jr (Microvention, Tustin, CA, USA), Leo (Balt, Montmorency, France), Barrel VRD (Medtronic/ Covidien, Irvine, CA, USA). Presence of the stent showed significant reverse correlation with intra-aneurysmal pressure-both systolic and diastolic-after its implantation (r = -0.70 and r = -0.75, respectively), which was further supported by correlations with stent cell size-r = 0.72 and r = 0.71, respectively (P<0.05). Stent implantation resulted in significant decrease in diastolic intra-aneurysmal pressure (p = 0.046). Systolic or mean intra-aneurysmal pressure did not differ significantly. Embolization did not significantly change the intra-aneurysmal pressure in matched pairs, regardless of the use of stent (p>0.05). In conclusion, low-profile braided stents show a potential to divert blood flow, there was significant decrease in diastolic pressure after stent placement. Flow-diverting properties were related to stent porosity. Coiling does not significantly change the intra-aneurysmal pressure, regardless of packing density.	[Piasecki, Piotr; Ziecina, Piotr; Brzozowski, Krzysztof; Wierzbicki, Marek; Narloch, Jerzy] Mil Inst Med, Dept Intervent Radiol, Warsaw, Poland	Military Institute of Aviation Medicine	Narloch, J (corresponding author), Mil Inst Med, Dept Intervent Radiol, Warsaw, Poland.	jerzy.narloch@gmail.com	Narloch, Jerzy/AAS-2826-2020	Narloch, Jerzy/0000-0001-6856-111X				Akpek S, 2005, AM J NEURORADIOL, V26, P1223; [Anonymous], 2015, AM J PHARM BENEFITS, V7, pe141; [Anonymous], 2014, SARTRE STUDIES INT 2, V20, P45; Aydin K, 2017, AM J NEURORADIOL, V38, P2131, DOI 10.3174/ajnr.A5362; Babiker MH, 2013, IEEE T BIO-MED ENG, V60, P1150, DOI 10.1109/TBME.2012.2228002; Behme D, 2015, J NEUROINTERV SURG, V7, P281, DOI 10.1136/neurintsurg-2014-011157; Boecher-Schwarz HG, 2000, AM J NEURORADIOL, V21, P1532; Canton G, 2005, AM J NEURORADIOL, V26, P904; Cohen JE, 2014, J CLIN NEUROSCI, V21, P664, DOI 10.1016/j.jocn.2013.09.003; Corriveau M, 2019, J CLIN NEUROSCI, V59, P339, DOI 10.1016/j.jocn.2018.10.093; Darsaut TE, 2013, INTERV NEURORADIOL, V19, P180, DOI 10.1177/159101991301900206; Duong DH, 1998, STROKE, V29, P1167, DOI 10.1161/01.STR.29.6.1167; Feng ZZ, 2015, J STROKE CEREBROVASC, V24, P1357, DOI 10.1016/j.jstrokecerebrovasdis.2015.02.016; Fiorella D, 2006, NEUROSURGERY, V59, P291, DOI 10.1227/01.NEU.0000223650.11954.6C; FLEISCHER LH, 1993, STROKE, V24, P1897, DOI 10.1161/01.STR.24.12.1897; FogartyMack P, 1996, AM J NEURORADIOL, V17, P1443; Groden C, 2001, J CEREBR BLOOD F MET, V21, P1464, DOI 10.1097/00004647-200112000-00011; Hayakawa M, 2000, J NEUROSURG, V93, P561, DOI 10.3171/jns.2000.93.4.0561; Larrabide I, 2015, J NEUROINTERV SURG, V7, P272, DOI 10.1136/neurintsurg-2014-011171; Li YP, 2019, NEUROSURGERY, V84, P1261, DOI 10.1093/neuros/nyy182; Lylyk P, 2002, J NEUROSURG, V97, P1306, DOI 10.3171/jns.2002.97.6.1306; Meng H, 2006, AM J NEURORADIOL, V27, P1861; Molyneux AJ, 2005, LANCET, V366, P809, DOI 10.1016/S0140-6736(05)67214-5; Morales HG, 2011, AM J NEURORADIOL, V32, P1935, DOI 10.3174/ajnr.A2635; Nguyen TN, 2007, SURG NEUROL, V68, P19, DOI 10.1016/j.surneu.2006.10.021; Roszelle BN, 2013, NEURORADIOLOGY, V55, P751, DOI 10.1007/s00234-013-1169-2; Schirmer CM, 2010, NEUROSURGERY, V67, P1692, DOI 10.1227/NEU.0b013e3181f9a93b; Schneiders J J, 2013, AJNR Am J Neuroradiol, V34, pE1, DOI 10.3174/ajnr.A2613; Seshadhri S, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004410; Shobayashi Y, 2013, J NEUROINTERV SURG, V5, pIII38, DOI 10.1136/neurintsurg-2012-010488; Song J, 2016, ACTA NEUROCHIR, V158, P803, DOI 10.1007/s00701-016-2721-8; Tateshima S, 2009, J NEUROSURG, V111, P22, DOI 10.3171/2009.2.JNS081324; Wanke I, 2003, AM J NEURORADIOL, V24, P1192; Wanke I, 2008, NEURORADIOLOGY, V50, P991, DOI 10.1007/s00234-008-0460-0; Wu YF, 2012, J CLIN NEUROSCI, V19, P1520, DOI 10.1016/j.jocn.2011.10.015; Zanaty M, 2015, J CLIN NEUROSCI, V22, P105, DOI 10.1016/j.jocn.2014.05.033; Zenteno MA, 2008, J NEUROSURG, V108, P1104, DOI 10.3171/JNS/2008/108/6/1104	37	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0233981	10.1371/journal.pone.0233981	http://dx.doi.org/10.1371/journal.pone.0233981			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497124	gold, Green Published			2022-12-26	WOS:000542035200008
J	Wisgerhof, W; Ruijgrok, C; den Braver, NR; Borgonjen-van den Berg, KJ; van der Heijden, AAWA; Elders, PJM; Beulens, JWJ; Alssema, M				Wisgerhof, Willem; Ruijgrok, Carolien; den Braver, Nicole R.; Borgonjen-van den Berg, Karin J.; van der Heijden, Amber A. W. A.; Elders, Petra J. M.; Beulens, Joline W. J.; Alssema, Marjan			Phenotypic and lifestyle determinants of HbA(1c)in the general population-The Hoorn Study	PLOS ONE			English	Article							GLYCATED HEMOGLOBIN; CARDIOVASCULAR-DISEASE; ALCOHOL-CONSUMPTION; HIP CIRCUMFERENCES; VITAMIN-C; ASSOCIATION; ADULTS; A(1C); A1C; MANAGEMENT	Aim To investigate the relative contribution of phenotypic and lifestyle factors to HbA(1c), independent of fasting plasma glucose (FPG) and 2h post-load glucose (2hPG), in the general population. Methods The study populations included 2309 participants without known diabetes from the first wave of the Hoorn Study (1989) and 2619 from the second wave (2006). Multivariate linear regression models were used to analyze the relationship between potential determinants and HbA(1c)in addition to FPG and 2hPG. The multivariate model was derived in the first wave of the Hoorn Study, and replicated in the second wave. Results In both cohorts, independent of FPG and 2hPG, higher age, female sex, larger waist circumference, and smoking were associated with a higher HbA(1c)level. Larger hip circumference, higher BMI, higher alcohol consumption and vitamin C intake were associated with a lower HbA(1c)level. FPG and 2hPG together explained 41.0% (first wave) and 53.0% (second wave) of the total variance in HbA(1c). The combination of phenotypic and lifestyle determinants additionally explained 5.7% (first wave) and 3.9% (second wave). Conclusions This study suggests that, independent of glucose, phenotypic and lifestyle factors are associated with HbA(1c), but the contribution is relatively small. These findings contribute to a better understanding of the low correlation between glucose levels and HbA(1c)in the general population.	[Wisgerhof, Willem; Ruijgrok, Carolien; den Braver, Nicole R.; Beulens, Joline W. J.; Alssema, Marjan] Vrije Univ Amsterdam Med Ctr, Amsterdam Publ Hlth Res Inst, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Borgonjen-van den Berg, Karin J.] Wageningen Univ, Dept Agrotechnol & Food Sci, Div Human Nutr, Wageningen, Netherlands; [van der Heijden, Amber A. W. A.; Elders, Petra J. M.] Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Dept Gen Practice & Elderly Care Med, Med Ctr, Amsterdam, Netherlands; [Beulens, Joline W. J.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Alssema, Marjan] Hlth Council Netherlands, The Hague, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Wageningen University & Research; University of Amsterdam; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center	Wisgerhof, W (corresponding author), Vrije Univ Amsterdam Med Ctr, Amsterdam Publ Hlth Res Inst, Dept Epidemiol & Biostat, Amsterdam, Netherlands.	willemwisgerhof@gmail.com	den Braver, Nicole/ABB-9190-2021	den Braver, Nicole/0000-0002-6345-251X; Beulens, Joline/0000-0002-4181-0937; Elders, Petra/0000-0002-5907-7219	Unilever R&D Vlaardingen, the Netherlands; Amsterdam Public Health Research Institute, Amsterdam, the Netherlands	Unilever R&D Vlaardingen, the Netherlands(Netherlands Government); Amsterdam Public Health Research Institute, Amsterdam, the Netherlands(Netherlands Government)	This study was financially supported by a grant from Unilever R&D Vlaardingen, the Netherlands (https://www.unilever.com/) and a grant from the Amsterdam Public Health Research Institute, Amsterdam, the Netherlands (https://www.amsterdamresearch.org/web/public-health/home.htm).Unilever also provided support in the form of a salary for MA, who was an employee at the time this article was written. The specific role of this author is articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://www.amsterdamresearch.org/web/publichealth/home.htm The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; [Anonymous], 2012, REGEN MED S3, V7, pS14; Boeing H, 2000, AM J CLIN NUTR, V71, P1115; Danaei G, 2015, LANCET DIABETES ENDO, V3, P624, DOI 10.1016/S2213-8587(15)00129-1; DAVIE SJ, 1992, DIABETES, V41, P167, DOI 10.2337/diabetes.41.2.167; Di Angelantonio E, 2014, JAMA-J AM MED ASSOC, V311, P1225, DOI 10.1001/jama.2014.1873; Florez JC, 2010, DIABETES, V59, P332, DOI 10.2337/db09-1636; Gallagher EJ, 2009, J DIABETES, V1, P9, DOI 10.1111/j.1753-0407.2009.00009.x; Genuth S, 2005, DIABETES CARE, V28, P233, DOI 10.2337/diacare.28.1.233; GROOTENHUIS PA, 1995, J CLIN EPIDEMIOL, V48, P859, DOI 10.1016/0895-4356(95)00013-T; Gulliford MC, 2001, EUR J CLIN NUTR, V55, P615, DOI 10.1038/sj.ejcn.1601233; Harding AH, 2002, EUR J CLIN NUTR, V56, P882, DOI 10.1038/sj.ejcn.1601408; Henry RMA, 2002, KIDNEY INT, V62, P1402, DOI 10.1046/j.1523-1755.2002.00571.x; Jansen H, 2013, J INTERN MED, V273, P283, DOI 10.1111/joim.12010; Khaw KT, 2004, ANN INTERN MED, V141, P413, DOI 10.7326/0003-4819-141-6-200409210-00006; Kilpatrick ES, 2009, DIABETES CARE, V32, P1901, DOI [10.2337/dc09-0109, 10.2337/dc09-1231]; Marshall A, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-57; Monnier L, 2003, DIABETES CARE, V26, P881, DOI 10.2337/diacare.26.3.881; NAKASHIMA K, 1993, CLIN CHIM ACTA, V215, P111, DOI 10.1016/0009-8981(93)90254-2; Nathan DM, 2007, DIABETOLOGIA, V50, P2239, DOI 10.1007/s00125-007-0803-0; Nevo, 2006, DUTCH FOOD COMP DAT; NEVO Tabel, 1989, NEV TABL DUTCH FOOD; Pani LN, 2008, DIABETES CARE, V31, P1991, DOI 10.2337/dc08-0577; Rubin D. B., 2004, MULTIPLE IMPUTATION; Rutters F, 2018, INT J EPIDEMIOL, V47, P396, DOI 10.1093/ije/dyx227; Schindhelm RK, 2007, ATHEROSCLEROSIS, V191, P391, DOI 10.1016/j.atherosclerosis.2006.04.006; Schrieks IC, 2015, DIABETES CARE, V38, P723, DOI 10.2337/dc14-1556; Seidell JC, 2001, AM J CLIN NUTR, V74, P315; Selvin E, 2009, DIABETES CARE, V32, P828, DOI 10.2337/dc08-1699; SHOFF SM, 1993, AM J CLIN NUTR, V58, P412, DOI 10.1093/ajcn/58.3.412; Siebelink E, 2011, BRIT J NUTR, V106, P274, DOI 10.1017/S0007114511000067; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Snijder MB, 2004, INT J OBESITY, V28, P402, DOI 10.1038/sj.ijo.0802567; van 't Riet E, 2010, DIABETES CARE, V33, P61, DOI 10.2337/dc09-0677; Welsh KJ, 2016, DIABETES CARE, V39, P1299, DOI 10.2337/dc15-2727; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Willett W., 2012, OVERVIEW NUTR EPIDEM, P1; Yang YC, 1997, DIABETES CARE, V20, P988, DOI 10.2337/diacare.20.6.988; YUDKIN JS, 1990, DIABETOLOGIA, V33, P208, DOI 10.1007/BF00404798; Ziemer DC, 2010, ANN INTERN MED, V152, P770, DOI 10.7326/0003-4819-152-12-201006150-00004	40	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0233769	10.1371/journal.pone.0233769	http://dx.doi.org/10.1371/journal.pone.0233769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497119	Green Published, gold			2022-12-26	WOS:000542035200078
J	Schrinner, K; Veiter, L; Schmideder, S; Doppler, P; Schrader, M; Munch, N; Althof, K; Kwade, A; Briesen, H; Herwig, C; Krull, R				Schrinner, Kathrin; Veiter, Lukas; Schmideder, Stefan; Doppler, Philipp; Schrader, Marcel; Muench, Nadine; Althof, Kristin; Kwade, Arno; Briesen, Heiko; Herwig, Christoph; Krull, Rainer			Morphological and physiological characterization of filamentous Lentzea aerocolonigenes: Comparison of biopellets by microscopy and flow cytometry	PLOS ONE			English	Article							PENICILLIUM-CHRYSOGENUM PELLETS; PHASE-II TRIAL; REBECCAMYCIN ANALOG; METABOLIC-ACTIVITY; FUNGAL MORPHOLOGY; OXYGEN; MICROORGANISMS; CULTIVATIONS; DESIGN; GROWTH	Cell morphology of filamentous microorganisms is highly interesting during cultivations as it is often linked to productivity and can be influenced by process conditions. Hence, the characterization of cell morphology is of major importance to improve the understanding of industrial processes with filamentous microorganisms. For this purpose, reliable and robust methods are necessary. In this study, pellet morphology and physiology of the rebeccamycin producing filamentous actinomycete Lentzea aerocolonigenes were investigated by microscopy and flow cytometry. Both methods were compared regarding their applicability. To achieve different morphologies, a cultivation with glass bead addition (o = 969 mu m, 100 g L-1) was compared to an unsupplemented cultivation. This led to two different macro-morphologies. Furthermore, glass bead addition increased rebeccamycin titers after 10 days of cultivation (95 mg L-1 with glass beads, 38 mg L-1 without glass beads). Macro-morphology and viability were investigated through microscopy and flow cytometry. For viability assessment fluorescent staining was used additionally. Smaller, more regular pellets were found for glass bead addition. Pellet diameters resulting from microscopy followed by image analysis were 172 mu m without and 106 mu m with glass beads, diameters from flow cytometry were 170 and 100 mu m, respectively. These results show excellent agreement of both methods, each considering several thousand pellets. Furthermore, the pellet viability obtained from both methods suggested an enhanced metabolic activity in glass bead treated pellets during the exponential production phase. However, total viability values differ for flow cytometry (0.32 without and 0.41 with glass beads) and confocal laser scanning microscopy of single stained pellet slices (life ratio in production phase of 0.10 without and 0.22 with glass beads), which is probably caused by the different numbers of investigated pellets. In confocal laser scanning microscopy only one pellet per sample could be investigated while flow cytometry considered at least 50 pellets per sample, resulting in an increased statistical reliability.	[Schrinner, Kathrin; Althof, Kristin; Krull, Rainer] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Engn, Braunschweig, Germany; [Schrinner, Kathrin; Schrader, Marcel; Kwade, Arno; Krull, Rainer] Tech Univ Carolo Wilhelmina Braunschweig, Ctr Pharmaceut Engn, Braunschweig, Germany; [Veiter, Lukas; Doppler, Philipp; Herwig, Christoph] Tech Univ Wien, Inst Chem Environm & Biosci Engn, Res Area Biochem Engn, Vienna, Austria; [Veiter, Lukas] Competence Ctr CHASE GmbH, Linz, Austria; [Schmideder, Stefan; Muench, Nadine; Briesen, Heiko] Tech Univ Munich, Sch Life Sci, Chair Proc Syst Engn, Freising Weihenstephan, Germany; [Schrader, Marcel; Kwade, Arno] Tech Univ Carolo Wilhelmina Braunschweig, Inst Particle Technol, Braunschweig, Germany	Braunschweig University of Technology; Braunschweig University of Technology; Technische Universitat Wien; Technical University of Munich; Braunschweig University of Technology	Krull, R (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Engn, Braunschweig, Germany.; Krull, R (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Ctr Pharmaceut Engn, Braunschweig, Germany.	r.krull@tu-braunschweig.de	Kwade, Arno/AAV-7782-2021; Briesen, Heiko/C-3244-2009	Kwade, Arno/0000-0002-6348-7309; Briesen, Heiko/0000-0001-7725-5907; Schmideder, Stefan/0000-0003-4328-9724; Doppler, Philipp/0000-0002-8027-4655; Krull, Rainer/0000-0003-2821-8610; Schrader, Marcel/0000-0002-5880-615X	German Research Foundation (DFG) [1934 DiSPBiotech, SPP 1934 DiSPBiotech - 315384307, 315457657]; Austrian Research Promotion Agency (FFG) [844608]; Competence Center CHASE GmbH - Austrian Research Promotion Agency as part of the COMET programCompetence Centers for Excellent Technologies by BMVIT [868615]; BMDW; Federal Province of Upper Austria; Federal Province of Vienna; Technische Universitat Braunschweig	German Research Foundation (DFG)(German Research Foundation (DFG)); Austrian Research Promotion Agency (FFG); Competence Center CHASE GmbH - Austrian Research Promotion Agency as part of the COMET programCompetence Centers for Excellent Technologies by BMVIT; BMDW; Federal Province of Upper Austria; Federal Province of Vienna; Technische Universitat Braunschweig	The authors (KS, SS, MS, AK, HB, RK) gratefully acknowledge financial support by the German Research Foundation (DFG) in the Priority Programme 1934 DiSPBiotech - Dispersity, structural and phase modifications of proteins and biological agglomerates in biotechnological processes (SPP 1934 DiSPBiotech - 315384307 (HB) and 315457657 (RK/AK)). The work of LV and CH was supported by the Austrian Research Promotion Agency (FFG) (Grant number: 844608) and within the framework of the Competence Center CHASE GmbH, funded by the Austrian Research Promotion Agency (grant number 868615) as part of the COMET programCompetence Centers for Excellent Technologies by BMVIT, BMDW, the Federal Provinces of Upper Austria and Vienna. The funders provided support in the form of salaries for authors (KS, LV, SS, MS), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. We also acknowledge support by the Open Access Publication Funds of the Technische Universitat Braunschweig.	Antecka A, 2016, BIOTECHNOL LETT, V38, P667, DOI 10.1007/s10529-015-2019-6; BELMARBEINY MT, 1991, BIOTECHNOL BIOENG, V37, P456, DOI 10.1002/bit.260370507; Bizukojc M, 2010, WORLD J MICROB BIOT, V26, P41, DOI 10.1007/s11274-009-0140-1; Bizukojc M, 2015, BIOPROC BIOSYST ENG, V38, P1251, DOI 10.1007/s00449-015-1366-y; Burstein HJ, 2007, INVEST NEW DRUG, V25, P161, DOI 10.1007/s10637-006-9007-6; BUSH JA, 1987, J ANTIBIOT, V40, P668, DOI 10.7164/antibiotics.40.668; Cairns TC, 2019, BIOTECHNOL BIOFUELS, V12, DOI 10.1186/s13068-019-1473-0; CRONENBERG CCH, 1994, BIOPROCESS ENG, V10, P209, DOI 10.1007/s004490050045; Cui YQ, 1998, BIOTECHNOL BIOENG, V57, P409, DOI 10.1002/(SICI)1097-0290(19980220)57:4<409::AID-BIT4>3.0.CO;2-Q; Dobson LF, 2008, APPL MICROBIOL BIOT, V79, P859, DOI 10.1007/s00253-008-1493-3; Doyle T.W., 1985, [No title captured], Patent No. [US 4552842 A, 4552842]; Driouch H, 2012, BIOTECHNOL BIOENG, V109, P462, DOI 10.1002/bit.23313; Dubelaar GBJ, 1999, CYTOMETRY, V37, P247, DOI 10.1002/(SICI)1097-0320(19991201)37:4<247::AID-CYTO1>3.0.CO;2-9; Ehgartner D, 2017, APPL MICROBIOL BIOT, V101, P7675, DOI 10.1007/s00253-017-8475-2; Ehgartner D, 2017, CHEM ENG SCI, V172, P32, DOI 10.1016/j.ces.2017.06.020; Gerlach SR, 1998, PROCESS BIOCHEM, V33, P601, DOI 10.1016/S0032-9592(98)00016-8; Goel S, 2003, INVEST NEW DRUG, V21, P103, DOI 10.1023/A:1022980613420; Gonciarz J, 2014, ENG LIFE SCI, V14, P190, DOI 10.1002/elsc.201300055; Hellendoorn L, 1998, BIOTECHNOL BIOENG, V58, P478, DOI 10.1002/(SICI)1097-0290(19980605)58:5<478::AID-BIT3>3.0.CO;2-A; Hille A, 2005, BIOTECHNOL BIOENG, V92, P614, DOI 10.1002/bit.20628; Holtmann D, 2017, SUSTAIN CHEM PHARM, V5, P67, DOI 10.1016/j.scp.2016.09.001; Kaup JA, 2008, BIOTECHNOL BIOENG, V99, P491, DOI 10.1002/bit.21713; Krull R, 2013, J BIOTECHNOL, V163, P112, DOI 10.1016/j.jbiotec.2012.06.024; Lestan D, 1996, J IND MICROBIOL, V16, P286, DOI 10.1007/BF01570036; Li J, 2011, PHYCOL RES, V59, P200, DOI 10.1111/j.1440-1835.2011.00618.x; Lin PJ, 2010, BIOCHEM ENG J, V49, P213, DOI 10.1016/j.bej.2009.12.016; Moreau P, 1999, J MED CHEM, V42, P1816, DOI 10.1021/jm980702n; Nieminen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054316; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Papagianni M., 2014, J MICROB BIOCH TECHN, V6, DOI [10.4172/1948-5948.1000142, DOI 10.4172/1948-5948.1000142]; Pekarsky A, 2018, MICROB CELL FACT, V17, DOI 10.1186/s12934-018-1032-6; PIRT SJ, 1966, PROC R SOC SER B-BIO, V166, P369, DOI 10.1098/rspb.1966.0105; Pommerehne K, 2019, APPL MICROBIOL BIOT, V103, P3627, DOI 10.1007/s00253-019-09741-y; Ronnest NP, 2011, J IND MICROBIOL BIOT, V38, P1679, DOI 10.1007/s10295-011-0957-0; Saruyama N, 2013, ANAL BIOCHEM, V441, P58, DOI 10.1016/j.ab.2013.06.005; Schmideder S, 2019, BIOTECHNOL BIOENG, V116, P3360, DOI 10.1002/bit.27166; Schmideder S, 2019, BIOTECHNOL BIOENG, V116, P1355, DOI 10.1002/bit.26956; Schrader M, 2019, BIOCHEM ENG J, V148, P116, DOI 10.1016/j.bej.2019.04.014; Schwandt A, 2012, J THORAC ONCOL, V7, P751, DOI 10.1097/JTO.0b013e31824abca2; Silva EME, 2001, BIOTECHNOL PROGR, V17, P95, DOI 10.1021/bp0001361; Stocks SM, 2004, CYTOM PART A, V61A, P189, DOI 10.1002/cyto.a.20069; Veiter L, 2019, APPL MICROBIOL BIOT, V103, P6725, DOI 10.1007/s00253-019-09943-4; Veiter L, 2018, APPL MICROBIOL BIOT, V102, P2997, DOI 10.1007/s00253-018-8818-7; Walisko J, 2017, PROCESS BIOCHEM, V53, P1, DOI 10.1016/j.procbio.2016.11.017; Walisko R, 2015, ADV BIOCHEM ENG BIOT, V149, P1, DOI 10.1007/10_2015_322; Wardell JN, 2002, BIOTECHNOL BIOENG, V78, P141, DOI 10.1002/bit.10210; Willemse J, 2018, ANTON LEEUW INT J G, V111, P171, DOI 10.1007/s10482-017-0939-y; WITTLER R, 1986, BIOTECHNOL BIOENG, V28, P1024, DOI 10.1002/bit.260280713; Wucherpfennig T, 2010, ADV APPL MICROBIOL, V72, P89, DOI 10.1016/S0065-2164(10)72004-9; Yang YK, 1996, J FERMENT BIOENG, V81, P7, DOI 10.1016/0922-338X(96)83111-4; Zacchetti B, 2018, BIOTECHNOL ADV, V36, P2138, DOI 10.1016/j.biotechadv.2018.10.002; Zacchetti B, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00943	52	11	11	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2020	15	6							e0234125	10.1371/journal.pone.0234125	http://dx.doi.org/10.1371/journal.pone.0234125			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LW6ZP	32492063	Green Published, gold			2022-12-26	WOS:000539293000027
J	Sennoune, SR; Nelius, T; Jarvis, C; Pruitt, K; Kottapalli, KR; Filleur, S				Sennoune, Souad R.; Nelius, Thomas; Jarvis, Courtney; Pruitt, Kevin; Kottapalli, Kameswara Rao; Filleur, Stephanie			The Wnt non-canonical signaling modulates cabazitaxel sensitivity in prostate cancer cells	PLOS ONE			English	Article							PLUS PREDNISONE; RESISTANT; DOCETAXEL; RECEPTOR; TAXANE; NANOPARTICLES; CHEMOTHERAPY; MITOXANTRONE; PATHWAY; TRIAL	Background Despite new drugs, metastatic prostate cancer remains fatal. Growing interest in the latest approved cabazitaxel taxane drug has markedly increased due to the survival benefits conferred when used at an earlier stage of the disease, its promising new therapeutic combination and formulation, and its differential toxicity. Still cabazitaxel's mechanisms of resistance are poorly characterized. The goal of this study was thus to generate a new model of acquired resistance against cabazitaxel in order to unravel cabazitaxel's resistance mechanisms. Methods Du145 cells were cultured with increasing concentrations of cabazitaxel, docetaxel/ taxane control or placebo/age-matched control. Once resistance was reached, Epithelial-to-Mesenchymal Translation (EMT) was tested by cell morphology, cell migration, and E/M markers expression profile. Cell transcriptomics were determined by RNA sequencing; related pathways were identified using IPA, PANTHER or KEGG software. The Wnt pathway was analyzed by western blotting, pharmacological and knock-down studies. Results While age-matched Du145 cells were sensitive to both taxane drugs, docetaxel-resistant cells were only resistant to docetaxel and cabazitaxel-resistant cells showed a partial crossresistance to both drugs concomitant to EMT. Using RNA-sequencing, the Wnt non-canonical pathway was identified as exclusively activated in cabazitaxel resistant cells while the Wnt canonical pathway was restricted to docetaxel-resistant cells. Cabazitaxel-resistant cells showed a minimal crossover in the Wnt-pathway-related genes linked to docetaxel resistance validating our unique model of acquired resistance to cabazitaxel. Pharmacological and western blot studies confirmed these findings and suggest the implication of the Tyrosine kinase Ror2 receptor in cabazitaxel resistant cells. Variation in Ror2 expression level altered the sensitivity of prostate cancer cells to both drugs identifying a possible new target for taxane resistance. Conclusion Our study represents the first demonstration that while Wnt pathway seems to play an important role in taxanes resistance, Wnt effectors responsible for taxane specificity remain un-identified prompting the need for more studies.	[Sennoune, Souad R.; Nelius, Thomas; Filleur, Stephanie] Texas Tech Univ, Hlth Sci Ctr, Dept Urol, Lubbock, TX 79430 USA; [Jarvis, Courtney; Pruitt, Kevin; Filleur, Stephanie] Texas Tech Univ, Hlth Sci Ctr, Dept Immunol & Mol Microbiol, Lubbock, TX 79430 USA; [Kottapalli, Kameswara Rao] Amer Univ Antigua, Coll Med, West Indies, Antigua, West Indies, Antigua & Barbu	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Filleur, S (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Urol, Lubbock, TX 79430 USA.; Filleur, S (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Immunol & Mol Microbiol, Lubbock, TX 79430 USA.	Stephanie.filleur@ttuhsc.edu		Filleur, Stephanie/0000-0002-3420-5536	School of Medicine at TTUHSC; Laura W. Bush Institute for Women's Health; South Plains Foundation (Lubbock, TX); CH Foundation	School of Medicine at TTUHSC; Laura W. Bush Institute for Women's Health; South Plains Foundation (Lubbock, TX); CH Foundation	The present study was performed with the financial support of the School of Medicine at TTUHSC, the Laura W. Bush Institute for Women's Health, The CH Foundation and the South Plains Foundation (Lubbock, TX).	Al-Mansouri L, 2019, ASIA-PAC J CLIN ONCO, V15, P288, DOI 10.1111/ajco.13193; Climent MA, 2017, EUR J CANCER, V87, P30, DOI 10.1016/j.ejca.2017.09.028; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Bordonaro M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027308; Bteich J, 2018, BIOCONJUGATE CHEM, V29, P2009, DOI 10.1021/acs.bioconjchem.8b00220; Carthon BC, 2016, TRANSL CANCER RES, V5, pS485, DOI 10.21037/tcr.2016.09.08; Chen RG, 2018, AM J CANCER RES, V8, P1297; Cheng YZ, 2019, MOL MED REP, V19, P490, DOI 10.3892/mmr.2018.9689; Corn PG, 2019, LANCET ONCOL; Darshan MS, 2011, CANCER RES, V71, P6019, DOI 10.1158/0008-5472.CAN-11-1417; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; de Leeuw R, 2015, CLIN CANCER RES, V21, P795, DOI 10.1158/1078-0432.CCR-14-1358; de Morree E, 2016, PROSTATE; de Morree ES, 2016, BRIT J CANCER, V115, P674, DOI 10.1038/bjc.2016.251; Du WJ, 2014, J CELL MOL MED, V18, P1712, DOI 10.1111/jcmm.12340; Duchartre Y, 2016, CRIT REV ONCOL HEMAT, V99, P141, DOI 10.1016/j.critrevonc.2015.12.005; Duran GE, 2018, CANCER CHEMOTH PHARM, V81, P1095, DOI 10.1007/s00280-018-3572-1; Duran GE, 2017, BRIT J CANCER, V116, P1318, DOI 10.1038/bjc.2017.102; Duran GE, 2015, MOL CANCER THER, V14, P193, DOI 10.1158/1535-7163.MCT-14-0155; Feng CC, 2018, J BIOMAT SCI-POLYM E, V29, P1729, DOI 10.1080/09205063.2018.1483616; Garrido MF, 2019, CLIN CANCER RES, V25, P710, DOI 10.1158/1078-0432.CCR-18-0704; Gdowski AS, 2017, NANOMEDICINE-UK, V12, P2083, DOI 10.2217/nnm-2017-0190; Gerwing M, 2016, J CANCER RES CLIN, V142, P1979, DOI 10.1007/s00432-016-2204-6; Ghoochani A, 2016, ONCOTARGET, V7, P38306, DOI 10.18632/oncotarget.9439; Heidenreich A, 2012, EUR UROL, V62, P1201, DOI 10.1016/j.eururo.2012.08.048; Henry CE, 2018, GYNECOL ONCOL, V148, P576, DOI 10.1016/j.ygyno.2018.01.025; Hirsch J, 2011, CYTOKINE, V55, P202, DOI 10.1016/j.cyto.2011.04.010; Hoang B, 2017, CANCER LETT, V410, P169, DOI 10.1016/j.canlet.2017.09.029; Hongo H, 2018, CANCER SCI, V109, P2937, DOI 10.1111/cas.13729; Howard S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023899; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; Jarvis C, 2018, PROSTATE, V78, P905, DOI 10.1002/pros.23647; Kaefer M, 1996, J STEROID BIOCHEM, V58, P195, DOI 10.1016/0960-0760(96)00020-9; Kam Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004580; Kampan NC, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/413076; Karanika S, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0395-0; Karvonen H, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080812; Khoeeniha MK, 2017, CURR DRUG DELIV, V14, P1120, DOI 10.2174/1567201814666161122150302; Kim JY, 2013, INT J MOL MED, V31, P1388, DOI 10.3892/ijmm.2013.1333; Kommineni N, 2018, CHEM PHYS LIPIDS; Kommineni N, 2019, PHARMACEUTICS, V11, DOI 10.3390/pharmaceutics11030141; Kroon J, 2016, TRENDS PHARMACOL SCI, V37, P451, DOI 10.1016/j.tips.2016.03.003; Laird DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002428; Lombard AP, 2017, MOL CANCER THER, V16, P2257, DOI 10.1158/1535-7163.MCT-17-0179; Lombard AP, 2018, MOL CANC THER; Machioka Kazuaki, 2018, Oncotarget, V9, P16185, DOI 10.18632/oncotarget.24609; Mahira S, 2019, BIOMED PHARMACOTHER, V110, P803, DOI 10.1016/j.biopha.2018.11.145; Massard C, 2017, ANN ONCOL, V28, P90, DOI 10.1093/annonc/mdw441; Medzihradszky KF, 2004, MOL CELL PROTEOMICS, V3, P429, DOI 10.1074/mcp.M300140-MCP200; Mellado B, 2016, CLIN GENITOURIN CANC, V14, P265, DOI 10.1016/j.clgc.2015.12.030; Miyamoto DT, 2015, SCIENCE, V349, P1351, DOI 10.1126/science.aab0917; Morioka K, 2009, CANCER SCI, V100, P1227, DOI 10.1111/j.1349-7006.2009.01165.x; Nair RR, 2018, LEUKEMIA RES, V72, P59, DOI 10.1016/j.leukres.2018.08.002; Natsagdorj A, 2019, CANCER SCI, V110, P279, DOI 10.1111/cas.13876; Nelius T, 2013, PROSTATE, V73, P549, DOI 10.1002/pros.22595; Nemcova-Furstova V, 2016, TOXICOL APPL PHARM, V310, P215, DOI 10.1016/j.taap.2016.09.020; Neshasteh-Riz A, 2018, CELL BIOL INT, V42, P815, DOI 10.1002/cbin.10940; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Novellasdemunt L, 2015, AM J PHYSIOL-CELL PH, V309, pC511, DOI 10.1152/ajpcell.00117.2015; Oprea-Lager DE, 2013, ANTICANCER RES, V33, P387; Oudard S, 2017, J CLIN ONCOL, V35, P3189, DOI 10.1200/JCO.2016.72.1068; Petrova IM, 2014, MOL NEUROBIOL, V49, P303, DOI 10.1007/s12035-013-8520-9; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Poh S, 2015, SINGLE CELL BIOL; Qu N, 2016, INT J NANOMED, V11, P3451, DOI 10.2147/IJN.S105420; Rabelo FD, 2010, AUTOIMMUN REV, V9, P207, DOI 10.1016/j.autrev.2009.08.003; Ramachandran K, 2016, ANTICANCER RES, V36, P161; Ramachandran K, 2009, CANCER RES, V69, P1527, DOI 10.1158/0008-5472.CAN-08-3609; Ren TY, 2018, MOL PHARMACEUT, V15, P2870, DOI 10.1021/acs.molpharmaceut.8b00357; Rojo JU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171677; Sekino Y, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20163936; Seruga B, 2011, NAT REV CLIN ONCOL, V8, P12, DOI 10.1038/nrclinonc.2010.136; Sharma M, 2018, CELL SIGNAL, V47, P52, DOI 10.1016/j.cellsig.2018.03.004; Shiota M, 2019, MED ONCOL, V36, DOI 10.1007/s12032-019-1257-1; Su F, 2019, ONCOGENE, V38, P1979, DOI 10.1038/s41388-018-0558-8; Sun YT, 2019, INT J NANOMED, V14, P135, DOI 10.2147/IJN.S181296; Sweeney CJ, 2015, NEW ENGL J MED, V373, P737, DOI 10.1056/NEJMoa1503747; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Terada N, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5342-9; Thibault C, 2018, EUR J CANCER, V97, P41, DOI 10.1016/j.ejca.2018.03.008; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; van Dodewaard-de Jong JM, 2017, CLIN NUCL MED, V42, P415, DOI 10.1097/RLU.0000000000001604; von Wahlde MK, 2015, GYNECOL ENDOCRINOL, V31, P160, DOI 10.3109/09513590.2014.971235; Wang WC, 2017, CHIN J CANCER, V36, DOI 10.1186/s40880-017-0203-x; Wu CC, 2012, J PROTEOME RES, V11, P3829, DOI 10.1021/pr300314d; Zhang ZZ, 2018, CANCER RES, V78, P3147, DOI 10.1158/0008-5472.CAN-17-3006	87	1	1	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2020	15	6							e0234078	10.1371/journal.pone.0234078	http://dx.doi.org/10.1371/journal.pone.0234078			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MT4VF	32484838	Green Published, gold			2022-12-26	WOS:000554969700033
J	Wang, Y; Wang, C; Rajaofera, MJN; Zhu, L; Liu, WB; Zheng, FC; Miao, WG				Wang, Yi; Wang, Chen; Rajaofera, Mamy Jayne Nelly; Zhu, Li; Liu, Wenbo; Zheng, Fucong; Miao, Weiguo			WY7 is a newly identified promoter from the rubber powdery mildew pathogen that regulates exogenous gene expression in both monocots and dicots	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; DISEASE RESISTANCE; INDUCIBLE PROMOTER; LEAF-SPOT; TRANSFORMATION; ARABIDOPSIS; PATHWAY; PLANTS; HARPIN(XOO); GROWTH	Promoters are very important for transcriptional regulation and gene expression, and have become invaluable tools for genetic engineering. Owing to the characteristics of obligate bio-trophs, molecular research into obligate biotrophic fungi is seriously lagging behind, and very few of their endogenous promoters have been developed. In this study, a WY7 fragment was predicted in the genome of Oidium heveae Steinmann using PromoterScan. Its promoter function was verified with transient transformations (Agrobacterium tumefaciens-mediated transformation, ATMT) in Nicotiana tabacum cv. Xanthi nc. The analysis of the transcription range showed that WY7 could regulate GUS expression in both monocots (Zea mays Linn and Oryza sativa L. spp. Japonica cv. Nipponbare) and dicots (N. tabacum and Hylocereus undulates Britt). The results of the quantitative detection showed that the GUS transient expression levels when regulated by WY7 was more than 11.7 times that of the CaMV 35S promoter in dicots (N. tabacum) and 5.13 times that of the ACT1 promoter in monocots (O. sativa). GUS staining was not detected in the T1 generation of the WY7-GUS transgenic N. tabacum. This showed that WY7 is an inducible promoter. The cis elements of WY7 were predicted using PlantCARE, and further experiments indicated that WY7 was a low temperature- and salt-inducible promoter. Soluble proteins produced by WY7-hpa1Xoo transgenic tobacco elicited hypersensitive responses (HR) in N. tabacum leaves. N. tabacum transformed with pBI121-WY7-hpa1Xoo exhibited enhanced resistance to the tobacco mosaic virus (TMV). The WY7 promoter has a lot of potential as a tool for plant genetic engineering. Further in-depth studies will help to better understand the transcriptional regulation mechanisms of O. heveae.	[Wang, Yi; Wang, Chen; Rajaofera, Mamy Jayne Nelly; Zhu, Li; Liu, Wenbo; Zheng, Fucong; Miao, Weiguo] Hainan Univ, Key Lab Green Prevent & Control Trop Plant Dis &, Minist Educ, Haikou, Hainan, Peoples R China; [Wang, Yi; Wang, Chen; Rajaofera, Mamy Jayne Nelly; Zhu, Li; Liu, Wenbo; Zheng, Fucong; Miao, Weiguo] Hainan Univ, Coll Plant Protect, Haikou, Hainan, Peoples R China	Hainan University; Hainan University	Zheng, FC; Miao, WG (corresponding author), Hainan Univ, Key Lab Green Prevent & Control Trop Plant Dis &, Minist Educ, Haikou, Hainan, Peoples R China.; Zheng, FC; Miao, WG (corresponding author), Hainan Univ, Coll Plant Protect, Haikou, Hainan, Peoples R China.	zhengfucong@126.com; miao@hainu.edu.cn			Key Research and Development Program of Hainan Province [ZDYF2018240]; National Key R&D Program of China [2018YFD0201105]; National Natural Science Foundation of China [31660033, 31560495, 31760499]; National Key Basic Research Plan of China [2011CB111612]; Innovation Team of Hainan Natural Science Foundation of China [2016CXTD002]; China Agriculture Research System [CARS-34-BC1]; scientific research beginning project of Hainan University [kyqd1535]	Key Research and Development Program of Hainan Province; National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Plan of China(National Basic Research Program of China); Innovation Team of Hainan Natural Science Foundation of China; China Agriculture Research System; scientific research beginning project of Hainan University	This study received financial support from Key Research and Development Program of Hainan Province (No. ZDYF2018240), National Key R&D Program of China (No. 2018YFD0201105), the National Natural Science Foundation of China (No. 31660033), the National Key Basic Research Plan of China (No.2011CB111612), the Innovation Team of Hainan Natural Science Foundation of China (2016CXTD002), the National Natural Science Foundation of China (No. 31560495, No.31760499), China Agriculture Research System (No.CARS-34-BC1), and the scientific research beginning project of Hainan University (No. kyqd1535) to WM.	ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Adnan M, 2011, MOL CELL BIOCHEM, V357, P275, DOI 10.1007/s11010-011-0898-y; Anil K, 2012, MICROBIOL RES, V167, P194, DOI 10.1016/j.micres.2011.07.002; Antunes MS, 2016, APPL MICROBIOL BIOT, V100, P5479, DOI 10.1007/s00253-016-7373-3; Arocho A, 2006, DIAGN MOL PATHOL, V15, P56, DOI 10.1097/00019606-200603000-00009; Bajic V B, 2000, Brief Bioinform, V1, P214, DOI 10.1093/bib/1.3.214; Blatzer M, 2014, J BIOTECHNOL, V169, P82, DOI 10.1016/j.jbiotec.2013.11.003; Divya K, 2019, MOL BIOL REP, V46, P6039, DOI 10.1007/s11033-019-05039-4; Dong H, 2000, PHYTOPATHOLOGY, V90, P801, DOI 10.1094/PHYTO.2000.90.8.801; Dong HP, 2004, PLANT PHYSIOL, V136, P3628, DOI 10.1104/pp.104.048900; Dong HS, 1999, PLANT J, V20, P207, DOI 10.1046/j.1365-313x.1999.00595.x; Dong Q, 2015, APPL BIOCHEM BIOTECH, V175, P1344, DOI 10.1007/s12010-014-1277-4; Dong YL, 2016, BOT STUD, V57, DOI 10.1186/s40529-016-0132-z; Fanhong M, 2007, J NANJING AGR U; Gilmour SJ, 2000, PLANT PHYSIOL, V124, P1854, DOI 10.1104/pp.124.4.1854; GUILLEY H, 1982, CELL, V30, P763, DOI 10.1016/0092-8674(82)90281-1; Gurr SJ, 2005, TRENDS BIOTECHNOL, V23, P283, DOI 10.1016/j.tibtech.2005.04.009; HE SY, 1993, CELL, V73, P1255, DOI 10.1016/0092-8674(93)90354-S; HINTZ WE, 1995, CAN J BOT, V73, pS876; HOLSTERS M, 1978, MOL GEN GENET, V163, P181, DOI 10.1007/BF00267408; Ioshikhes IP, 2000, NAT GENET, V26, P61, DOI 10.1038/79189; Katiyar-Agarwal S, 2006, P NATL ACAD SCI USA, V103, P18002, DOI 10.1073/pnas.0608258103; Kausch AP, 2001, PLANT MOL BIOL, V45, P1, DOI 10.1023/A:1006487326533; Khurana N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054418; Kumar M, 2009, J BIOTECHNOL, V140, P143, DOI 10.1016/j.jbiotec.2009.01.005; Lee JE, 1997, INT COLLOQ PROC SIM, P23; Li J., 2006, LETT BIOTECHNOLOGY, V17, P658; Li L, 2017, PLOS ONE, V12, P1, DOI DOI 10.1371/J0URNAL.P0NE.0182592; Li Zhongming, 2012, Weishengwu Xuebao, V52, P44; Liu Gen-Qi, 2005, Zhi Wu Sheng Li Yu Fen Zi Sheng Wu Xue Xue Bao, V31, P327; MargollesClark E, 1996, APPL ENVIRON MICROB, V62, P2152, DOI 10.1128/AEM.62.6.2152-2155.1996; Mattanovich D, 2015, CONSTITUTIVE PROMOTE; MCELROY D, 1990, PLANT CELL, V2, P163, DOI 10.1105/tpc.2.2.163; Miao W. G., 2009, THESIS; Miao WeiGuo, 2010, Scientia Agricultura Sinica, V43, P313; Mur LA, 2007, HYPERSENSITIVE RESPO; Pederson P., 1998, PROTEIN-STRUCT FUNCT, V28, P140; Peng JL, 2004, PHYTOPATHOLOGY, V94, P1048, DOI 10.1094/PHYTO.2004.94.10.1048; PUNT PJ, 1990, GENE, V93, P101, DOI 10.1016/0378-1119(90)90142-E; Qu D, 2011, GENET MOL RES, V10, P621, DOI 10.4238/vol10-2gmr1088; RYALS J, 1985, CELL, V41, P497, DOI 10.1016/S0092-8674(85)80023-4; SCHLEDZEWSKI K, 1994, TRANSGENIC RES, V3, P249, DOI 10.1007/BF02336778; Strobel NE, 1996, PLANT J, V9, P431, DOI 10.1046/j.1365-313X.1996.09040431.x; Thomashow MF, 1997, PLANT COLD HARDINESS, P29; Wang J, 2003, PLANT CELL REP, V22, P129, DOI 10.1007/s00299-003-0657-y; Wei XU, 2003, J SHENYANG PHARM U, V6; WEI ZM, 1992, J BACTERIOL, V174, P1875, DOI 10.1128/jb.174.6.1875-1882.1992; Wen WeiGang, 2001, Acta Phytopathologica Sinica, V31, P295; West A, 2001, J NEUROCHEM, V78, P1146, DOI 10.1046/j.1471-4159.2001.00512.x; Xu GJ, 2010, RUSS J PLANT PHYSL+, V57, P548, DOI 10.1134/S1021443710040138; Xu ZW, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133326; Yi N, 2011, TRANSGENIC RES, V20, P153, DOI 10.1007/s11248-010-9400-y; Yin X, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.03222-16; Zambanini Thiemo, 2017, Fungal Biol Biotechnol, V4, P11, DOI 10.1186/s40694-017-0040-3; Zhang ZP, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-99; Zheng HuiQuan, 2007, Forestry Studies in China, V9, P95, DOI 10.1007/s11632-007-0015-1	56	4	4	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0233911	10.1371/journal.pone.0233911	http://dx.doi.org/10.1371/journal.pone.0233911			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MJ2AA	32479550	Green Published, gold			2022-12-26	WOS:000547893500039
J	Dassanayake, RP; Falkenberg, SM; Stasko, JA; Shircliff, AL; Lippolis, JD; Briggs, RE				Dassanayake, Rohana P.; Falkenberg, Shollie M.; Stasko, Judith A.; Shircliff, Adrienne L.; Lippolis, John D.; Briggs, Robert E.			Identification of a reliable fixative solution to preserve the complex architecture of bacterial biofilms for scanning electron microscopy evaluation	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; PASTEURELLA-HAEMOLYTICA; MANNHEIMIA-HAEMOLYTICA; BOVINE MASTITIS; ANTIMICROBIAL SUSCEPTIBILITY; RESPIRATORY-DISEASE; CARNOY FIXATION; PATHOGENESIS; RESISTANCE; PNEUMONIA	Bacterial biofilms are organized sessile communities of bacteria enclosed in extracellular polymeric substances (EPS). To analyze organization of bacteria and EPS in high resolution and high magnification by scanning electron microscopy (SEM), it is important to preserve the complex architecture of biofilms. Therefore, fixation abilities of formalin, glutaraldehyde, and Methacarn (methanol/chloroform/acetic acid -6:3:1) fixatives were evaluated to identify which fixative would best preserve the complex structure of bacterial biofilms. Economically important Gram-negative Mannheimia haemolytica, the major pathogen associated with bovine respiratory disease complex, and Gram-positive Staphylococcus aureus, the major cause of chronic mastitis in cattle, bacteria were selected since both form biofilms on solid liquid interface. For SEM analysis, round glass coverslips were placed into the wells of 24-well plates and diluted M. haemolytica or S. aureus cultures were added, and incubated at 37 degrees C for 48-72 h under static growth conditions. Culture media were aspirated and biofilms were fixed with an individual fixative for 48 h. SEM examination revealed that all three fixatives were effective preserving the bacterial cell morphology, however only Methacarn fixative could consistently preserve the complex structure of biofilms. EPS layers were clearly visible on the top, in the middle, and in the bottom of the biofilms with Methacarn fixative. Biomass and three-dimensional structure of the biofilms were further confirmed spectrophotometrically following crystal violet staining and by confocal microscopy after viability staining. These findings demonstrate that Methacarn fixative solution is superior to the other fixatives evaluated to preserve the complex architecture of biofilms grown on glass coverslips for SEM evaluation.	[Dassanayake, Rohana P.; Falkenberg, Shollie M.; Lippolis, John D.; Briggs, Robert E.] ARS, Ruminant Dis & Immunol Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50010 USA; [Stasko, Judith A.; Shircliff, Adrienne L.] ARS, Microscopy Serv Lab, Natl Anim Dis Ctr, USDA, Ames, IA USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Dassanayake, RP (corresponding author), ARS, Ruminant Dis & Immunol Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50010 USA.	rohana.dassanayake@usda.gov			USDA/ARS National Animal Disease Center [5030-32000-116-00D]	USDA/ARS National Animal Disease Center	This research was conducted at a USDA research facility and all funding was provided through internal USDA research dollars. This project is an intramural project of the USDA/ARS National Animal Disease Center (5030-32000-116-00D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi RD, 2018, FOODBORNE PATHOG DIS, V15, P449, DOI 10.1089/fpd.2017.2362; Ames TR, 1997, VET CLIN N AM-FOOD A, V13, P379, DOI 10.1016/S0749-0720(15)30303-0; Arciola CR, 2018, NAT REV MICROBIOL, V16, P397, DOI 10.1038/s41579-018-0019-y; Boukahil I, 2016, VET MICROBIOL, V197, P129, DOI 10.1016/j.vetmic.2016.11.012; Boukahil I, 2015, VET MICROBIOL, V175, P114, DOI 10.1016/j.vetmic.2014.11.012; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Castilho IG, 2017, J DAIRY SCI, V100, P6414, DOI 10.3168/jds.2017-12700; Caswell JL, 2014, VET PATHOL, V51, P393, DOI 10.1177/0300985813502821; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; Cucarella C, 2004, INFECT IMMUN, V72, P2177, DOI 10.1128/IAI.72.4.2177-2185.2004; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Drago L, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030293; Fish KE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115824; FRANK GH, 1992, AM J VET RES, V53, P481; Gonzalez-Machado C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200011; Griffin D, 1997, VET CLIN N AM-FOOD A, V13, P367, DOI 10.1016/S0749-0720(15)30302-9; GUDDING R, 1984, AM J VET RES, V45, P2525; Hebert A, 2000, FEMS MICROBIOL LETT, V193, P57, DOI 10.1016/S0378-1097(00)00455-9; Hensen SM, 2000, J DAIRY SCI, V83, P1966, DOI 10.3168/jds.S0022-0302(00)75073-9; Howat WJ, 2014, METHODS, V70, P12, DOI 10.1016/j.ymeth.2014.01.022; Jahn A, 1998, WATER SCI TECHNOL, V37, P17, DOI 10.2166/wst.1998.0006; Kong C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21141-2; Linder M., 2013, BERL MUNCH TIERARZTL, V6, P291, DOI [10.2376/0005-9366-126-10, DOI 10.2376/0005-9366-126-10]; Lopez ADR, 2019, ACTA BIOMATER, V93, P50, DOI 10.1016/j.actbio.2019.02.047; Marti Sara, 2011, BMC Res Notes, V4, P5, DOI 10.1186/1756-0500-4-5; MASON JT, 1991, J HISTOCHEM CYTOCHEM, V39, P225, DOI 10.1177/39.2.1987266; Melchior MB, 2007, VET MICROBIOL, V125, P141, DOI 10.1016/j.vetmic.2007.05.019; Melchior MB, 2006, J VET MED B, V53, P326, DOI 10.1111/j.1439-0450.2006.00962.x; Melchior MB, 2006, VET J, V171, P398, DOI 10.1016/j.tvjl.2005.01.006; Melchior MB, 2009, VET MICROBIOL, V137, P83, DOI 10.1016/j.vetmic.2008.12.004; Mishra M, 2005, J BACTERIOL, V187, P1474, DOI 10.1128/JB.187.4.1474-1484.2005; Monistero V, 2018, TOXINS, V10, DOI 10.3390/toxins10060247; MORCK DW, 1989, CAN J VET RES, V53, P167; Nicholson TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049166; PRASAD LBM, 1968, CANADIAN VET J, V9, P107; PUCHTLER H, 1968, HISTOCHEMISTRY, V16, P361, DOI 10.1007/BF00306359; PUCHTLER H, 1970, HISTOCHEMISTRY, V21, P97, DOI 10.1007/BF00306176; Putz EJ, 2019, J DAIRY SCI, V102, P9268, DOI 10.3168/jds.2019-16448; Reichhardt C, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00677; Rice J. A., 2007, Animal Health Research Reviews, V8, P117, DOI 10.1017/S1466252307001375; Ruegg PL, 2017, J DAIRY SCI, V100, P10381, DOI 10.3168/jds.2017-13023; Schlafer S, 2017, J MICROBIOL METH, V138, P50, DOI 10.1016/j.mimet.2016.03.002; SHOO MK, 1990, RES VET SCI, V48, P383, DOI 10.1016/S0034-5288(18)31033-6; SMITH KL, 1985, J DAIRY SCI, V68, P1531, DOI 10.3168/jds.S0022-0302(85)80993-0; Stewart PS, 2001, TRENDS MICROBIOL, V9, P204, DOI 10.1016/S0966-842X(01)01983-7; STOODLEY P, 1994, APPL ENVIRON MICROB, V60, P2711, DOI 10.1128/AEM.60.8.2711-2716.1994; Sutherland IW, 2001, TRENDS MICROBIOL, V9, P222, DOI 10.1016/S0966-842X(01)02012-1; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Tatum FM, 1998, MICROB PATHOGENESIS, V24, P37, DOI 10.1006/mpat.1997.0181; Thiran E, 2018, J DAIRY SCI, V101, P1000, DOI 10.3168/jds.2017-13696; WHITELEY LO, 1992, J VET INTERN MED, V6, P11, DOI 10.1111/j.1939-1676.1992.tb00980.x; Winther B, 2009, ARCH OTOLARYNGOL, V135, P1239, DOI 10.1001/archoto.2009.186	53	9	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2020	15	5							e0233973	10.1371/journal.pone.0233973	http://dx.doi.org/10.1371/journal.pone.0233973			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1WS	32470063	Green Published, gold			2022-12-26	WOS:000537552800217
J	Fernandez-Ruiz, N; Estrada-Pena, A				Fernandez-Ruiz, Natalia; Estrada-Pena, Agustin			Could climate trends disrupt the contact rates between lxodes ricinus (Acari, Ixodidae) and the reservoirs of Borrelia burgdorferi s.I.?	PLOS ONE			English	Article							IXODES-RICINUS; SENSU-LATO; DIVERSITY; HABITAT; VECTOR; MODEL	This study addresses the modifications that future climate conditions could impose on the transmission cycles of Borrelia burgdorferi s.l. by the tick Ixodes ricinus in Europe. Tracking the distribution of foci of a zoonotic agent transmitted by vectors as climate change shapes its spatial niche is necessary to issue self-protection measures for the human population. We modeled the current distribution of the tick and its predicted contact rates with 18 species of vertebrates known to act as reservoirs of the pathogen. We approached an innovative way for estimating the possibility of permanent foci of Borrelia afzelii or Borrelia garinii tracking separately the expected spatial overlap among ticks and reservoirs for these pathogens in Europe. Environmental traits were obtained from MODIS satellite images for the years 2002-2017 (baseline) and projected on scenarios for the years 2030 and 2050. The ratio between MODIS baseline/current interpolated climatologies (WorldClim), and the ratio between MODIS-projected year 2050 with five climate change scenarios for that year (WorldClim) revealed no significant differences, meaning that projections from MODIS are reliable. Models predict that contact rates between the tick and reservoirs of either B. garinii or B. afzeliiare spatially different because those have different habitats overlap. This is expected to promote different distribution patterns because of the different responses of both groups of reservoirs to environmental variables. Models for 2030 predict an increase in latitude, mainly in the circulation of B. garinii, with large areas of expected permanent contact between vector and reservoirs in Nordic countries and central Europe. However, climate projections for the year 2050 predict an unexpected scenario of contact disruption. Though large areas in Europe would be suitable for circulation of the pathogens, the predicted lack of niche overlap among ticks and reservoirs could promote a decrease in permanent foci. This development represents a proof-of-concept for the power of jointly modeling both the vector and reservoirs in a common framework. A deeper understanding of the unanticipated result regarding the year 2050 is needed.	[Fernandez-Ruiz, Natalia; Estrada-Pena, Agustin] Univ Zaragoza, Fac Vet Med, Dept Anim Hlth, Zaragoza, Spain; [Estrada-Pena, Agustin] Inst Agroalimentario Aragon IA2, Emerging Zoonoses Res Grp, Zaragoza, Spain	University of Zaragoza	Estrada-Pena, A (corresponding author), Univ Zaragoza, Fac Vet Med, Dept Anim Hlth, Zaragoza, Spain.; Estrada-Pena, A (corresponding author), Inst Agroalimentario Aragon IA2, Emerging Zoonoses Res Grp, Zaragoza, Spain.	aestrada@unizar.es		Estrada Pena, Agustin/0000-0001-7483-046X; Fernandez-Ruiz, Natalia/0000-0001-5205-1908	European Union; COST Action [TD1202]; Research Program of the Regional Government of Aragon (Spain) [218376]	European Union(European Commission); COST Action(European Cooperation in Science and Technology (COST)); Research Program of the Regional Government of Aragon (Spain)	Parts of this study were funded by the European Union under the FP7 program, and the COST Action TD1202. Parts of this study were funded by the Research Program of the Regional Government of Aragon (Spain), funding strategic research groups, under the contract 218376. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study has been conducted under the initiative "World Scientists' Warning to Humanity: A Second Notice" led by William J. Ripple (University of Oregon, USA). Most of the I. ricinus records were collected by AEP under the ICTTD initiative led by Frans Jongejan (University of Utrecht, the Netherlands). Additional data were provided by Thomas G.T. Jaenson and his team (University of Uppsala, Sweden) and Tero Klemola and his team (University of Helsinki, Finland). Andrei D. Mihalca (University of Cluj-Napoca, Romania) coordinated the efforts to improve the dataset on I. ricinus in Europe.	Alkishe AA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189092; [Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], 1995, B AM MUS NAT HIST, DOI DOI 10.1002/joc.5086; Baranton Guy, 2009, V37, P1, DOI 10.1159/000213066; Busetto L, 2016, COMPUT GEOSCI-UK, V97, P40, DOI 10.1016/j.cageo.2016.08.020; Danielova V, 2010, VECTOR-BORNE ZOONOT, V10, P223, DOI 10.1089/vbz.2009.0020; Dennis David T., 2002, P251, DOI 10.1079/9780851996325.0251; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Estrada-Pena A, 2014, MED VET ENTOMOL, V28, P35, DOI 10.1111/mve.12009; Estrada-Pena A, RETROSPECTIVE ASSESS; Estrada-Pena A, 2018, INT J HEALTH GEOGR, V17, DOI 10.1186/s12942-018-0163-7; Estrada-Pena A, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00234; Estrada-Pena A, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.56; Estrada-Pena A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-302; Estrada-Pena A, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00029; Funk CC, 2006, REMOTE SENS ENVIRON, V101, P249, DOI 10.1016/j.rse.2005.12.014; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hofmeester TR, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/4/043001; Huang ZYX, 2016, PARASITOLOGY, V143, P1075, DOI 10.1017/S0031182016000536; Jaenson TGT, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-8; Jaenson TGT, 2011, TICKS TICK-BORNE DIS, V2, P44, DOI 10.1016/j.ttbdis.2010.10.006; Jore S, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-84; Julien Y, 2006, REMOTE SENS ENVIRON, V103, P43, DOI 10.1016/j.rse.2006.03.011; Leighton PA, 2012, J APPL ECOL, V49, P457, DOI 10.1111/j.1365-2664.2012.02112.x; Li S, 2019, ENVIRON HEALTH PERSP, V127, DOI 10.1289/EHP4615; Merckx B, 2011, ECOL MODEL, V222, P588, DOI 10.1016/j.ecolmodel.2010.11.016; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Mucher CA, 2010, ECOL INDIC, V10, P87, DOI 10.1016/j.ecolind.2009.03.018; Ogden NH, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-24; Pawelczyk A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38755-9; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Richman R, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2832-6; Scharlemann JPW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001408; Semenza J.C., 2017, FEMS MICROBIOL LETT, V365; Song D, 2008, PIERS ONLINE, V4, P191, DOI DOI 10.2529/PIERS070907105158; Strnad M, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.00609-17, 10.1128/aem.00609-17]; Tack W, 2012, FOREST ECOL MANAG, V265, P30, DOI 10.1016/j.foreco.2011.10.028; Tokarevich NK, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.8448; Tsao JL, 2009, VET RES, V40, P1; van den Wijngaard CC, 2017, EUROSURVEILLANCE, V22, P15, DOI 10.2807/1560-7917.ES.2017.22.27.30569; Velasco JA, 2019, ECOL INFORM, V51, P25, DOI 10.1016/j.ecoinf.2019.02.005; Weber EU, 2010, WIRES CLIM CHANGE, V1, P332, DOI 10.1002/wcc.41; Xu G, 2003, J PARASITOL, V89, P452, DOI 10.1645/0022-3395(2003)089[0452:MPAITT]2.0.CO;2	43	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2020	15	5							e0233771	10.1371/journal.pone.0233771	http://dx.doi.org/10.1371/journal.pone.0233771			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1WS	32470102	Green Published, gold			2022-12-26	WOS:000537552800172
J	Leon, J; Escobar, JJ; Ortiz, A; Ortega, J; Gonzalez, J; Martin-Smith, P; Gan, JQ; Damas, M				Leon, Javier; Jose Escobar, Juan; Ortiz, Andres; Ortega, Julio; Gonzalez, Jesus; Martin-Smith, Pedro; Gan, John Q.; Damas, Miguel			Deep learning for EEG-based Motor Imagery classification: Accuracy-cost trade-off	PLOS ONE			English	Article							MULTIOBJECTIVE FEATURE-SELECTION; TESTS	Electroencephalography (EEG) datasets are often small and high dimensional, owing to cumbersome recording processes. In these conditions, powerful machine learning techniques are essential to deal with the large amount of information and overcome the curse of dimensionality. Artificial Neural Networks (ANNs) have achieved promising performance in EEG-based Brain-Computer Interface (BCI) applications, but they involve computationally intensive training algorithms and hyperparameter optimization methods. Thus, an awareness of the quality-cost trade-off, although usually overlooked, is highly beneficial. In this paper, we apply a hyperparameter optimization procedure based on Genetic Algorithms to Convolutional Neural Networks (CNNs), Feed-Forward Neural Networks (FFNNs), and Recurrent Neural Networks (RNNs), all of them purposely shallow. We compare their relative quality and energy-time cost, but we also analyze the variability in the structural complexity of networks of the same type with similar accuracies. The experimental results show that the optimization procedure improves accuracy in all models, and that CNN models with only one hidden convolutional layer can equal or slightly outperform a 6-layer Deep Belief Network. FFNN and RNN were not able to reach the same quality, although the cost was significantly lower. The results also highlight the fact that size within the same type of network is not necessarily correlated with accuracy, as smaller models can and do match, or even surpass, bigger ones in performance. In this regard, overfitting is likely a contributing factor since deep learning approaches struggle with limited training examples.	[Leon, Javier; Jose Escobar, Juan; Ortega, Julio; Gonzalez, Jesus; Martin-Smith, Pedro; Damas, Miguel] Univ Granada, Dept Comp Architecture & Technol, Granada, Spain; [Ortiz, Andres] Univ Malaga, Dept Commun Engn, Malaga, Spain; [Gan, John Q.] Univ Essex, Sch Comp Sci & Elect Engn, Colchester, Essex, England	University of Granada; Universidad de Malaga; University of Essex	Leon, J (corresponding author), Univ Granada, Dept Comp Architecture & Technol, Granada, Spain.	jaleon@correo.ugr.es	Damas-Hermoso, Miguel/D-9979-2012; González, Jesús/D-9923-2012	Damas-Hermoso, Miguel/0000-0003-2599-8076; González, Jesús/0000-0002-0415-1821; Leon, Javier/0000-0003-4698-1089	Spanish Ministerio de Ciencia, Innovacion y Universidades [PGC2018-098813-B-C31, PGC2018-098813-B-C32, PSI201565848-R]	Spanish Ministerio de Ciencia, Innovacion y Universidades(Spanish Government)	Javier Leo ' n, Julio Ortega, Jesu ' s Gonza ' lez, Miguel Damas, Pedro Marti ' n-Smith, Juan Jose ' Escobar Pe ' rez: Grant number PGC2018-098813-B-C31 (Spanish Ministerio de Ciencia, Innovacion y Universidades, http://www.ciencia.gob.es/portal/site/MICINN/) Andre ' s Ortiz: Grant numbers PGC2018-098813-B-C32 and PSI201565848-R (Spanish Ministerio de Ciencia, Innovacion y Universidades, http://www.ciencia.gob.es/portal/site/MICINN/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi M., 2016, TENSORFLOW LARGE SCA; Abootalebi V, 2009, COMPUT METH PROG BIO, V94, P48, DOI 10.1016/j.cmpb.2008.10.001; Acharya UR, 2018, COMPUT BIOL MED, V100, P270, DOI 10.1016/j.compbiomed.2017.09.017; Amaldi E, 1998, THEOR COMPUT SCI, V209, P237, DOI 10.1016/S0304-3975(97)00115-1; Amin SU, 2019, FUTURE GENER COMP SY, V101, P542, DOI 10.1016/j.future.2019.06.027; [Anonymous], 2017, INT J MOL SCI, V18, pE961; [Anonymous], 2013, EC J WATCH, V10, pA1; Back T., 1994, Proceedings of the First IEEE Conference on Evolutionary Computation. IEEE World Congress on Computational Intelligence (Cat. No.94TH0650-2), P57, DOI 10.1109/ICEC.1994.350042; Bajaj V, 2012, IEEE T INF TECHNOL B, V16, P1135, DOI 10.1109/TITB.2011.2181403; Benavoli A, 2016, J MACH LEARN RES, V17; Benavoli A, 2017, J MACH LEARN RES, V18; BENGIO Y, 1994, IEEE T NEURAL NETWOR, V5, P157, DOI 10.1109/72.279181; Buhlmann P, 2011, SPRINGER SER STAT, P1, DOI 10.1007/978-3-642-20192-9; Calvo B, 2016, R J, V8, P248; Carrasco J, 2017, LECT NOTES ARTIF INT, V10334, P281, DOI 10.1007/978-3-319-59650-1_24; Chiarelli AM, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aaaf82; Cho K., 2014, EMNLP 2014 2014 C EM, DOI DOI 10.3115/V1/D14-1179; Chollet F., 2015, KERAS; Clevert D.-A., 2015, P 4 INT C LEARNING R; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Corralejo R, 2011, IEEE ENG MED BIO, P7703, DOI 10.1109/IEMBS.2011.6091898; Davidson PR, 2007, IEEE T BIO-MED ENG, V54, P832, DOI 10.1109/TBME.2007.893452; Demsar J, 2006, J MACH LEARN RES, V7, P1; Derrac J, 2011, SWARM EVOL COMPUT, V1, P3, DOI 10.1016/j.swevo.2011.02.002; Eiben A., 2015, INTRO EVOLUTIONARY C, V53; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Escobar JJ, 2017, CLUSTER COMPUT, V20, P1881, DOI 10.1007/s10586-017-0980-7; Expert Panel on Women's I, 2018, J AM COLL RADIOL, V15, pS365, DOI DOI 10.1016/J.JACR.2018.09.023; Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372; Friedman M, 1940, ANN MATH STAT, V11, P86, DOI 10.1214/aoms/1177731944; Gaur P, 2018, EXPERT SYST APPL, V95, P201, DOI 10.1016/j.eswa.2017.11.007; Gers FA, 2000, NEURAL COMPUT, V12, P2451, DOI 10.1162/089976600300015015; Giampapa VC, 2012, RIVER PUB S RES BUS, P175; Glorot X., 2011, P 14 INT C ART INT S, P315; Graves A, 2005, NEURAL NETWORKS, V18, P602, DOI 10.1016/j.neunet.2005.06.042; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; HOLM S, 1979, SCAND J STAT, V6, P65; Hotson G, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/2/026017; Jiao Y, 2019, IEEE J BIOMED HEALTH, V23, P631, DOI 10.1109/JBHI.2018.2832538; Kee CY, 2015, NEUROCOMPUTING, V161, P120, DOI 10.1016/j.neucom.2015.02.057; Kimovski D, 2015, CONCURR COMP-PRACT E, V27, P5476, DOI 10.1002/cpe.3594; Kumar S, 2019, SCI REP, V9, P1, DOI [10.1038/s41598-018-37186-2, DOI 10.1038/S41598-018-37186-2]; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Leon J, 2019, LECT NOTES COMPUT SC, V11506, P883, DOI 10.1007/978-3-030-20521-8_72; Martin-Smith P, 2017, NEUROCOMPUTING, V250, P45, DOI 10.1016/j.neucom.2016.09.123; O'Brien K, 2017, ACM COMPUT SURV, V50, DOI 10.1145/3078811; Oghabian A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090801; Oliphant T.E., 2006, A GUIDE TO NUMPY, V1; Ortega J, 2017, LECT NOTES COMPUT SC, V10305, P28, DOI 10.1007/978-3-319-59153-7_3; Ortega J, 2016, BIOMED ENG ONLINE, V15, DOI 10.1186/s12938-016-0178-x; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; RAUDYS SJ, 1991, IEEE T PATTERN ANAL, V13, P252, DOI 10.1109/34.75512; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sakhavi S, 2018, IEEE T NEUR NET LEAR, V29, P5619, DOI 10.1109/TNNLS.2018.2789927; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Stingl K, 2015, VISION RES, V111, P149, DOI 10.1016/j.visres.2015.03.001; Stingl K, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0077; Tayeb Z, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19010210; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Wang P, 2018, IEEE T NEUR SYS REH, V26, P2086, DOI 10.1109/TNSRE.2018.2876129; Weiss G, 2018, PROCEEDINGS OF THE 56TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 2, P740; Yanagisawa T, 2011, J NEUROSURG, V114, P1715, DOI 10.3171/2011.1.JNS101421	66	25	25	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234178	10.1371/journal.pone.0234178	http://dx.doi.org/10.1371/journal.pone.0234178			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525885	gold, Green Accepted, Green Published			2022-12-26	WOS:000542036800067
J	Hitchens, RT; Blakeslee, AMH				Hitchens, Rosemary T.; Blakeslee, April M. H.			Trends in illegal wildlife trade: Analyzing personal baggage seizure data in the Pacific Northwest	PLOS ONE			English	Article							TRAFFICKING; GUIDE; PETS	The illegal import of wildlife and wildlife products is a growing concern, and the U.S. is one of the world's leading countries in the consumption and transit of illegal wildlife and their derivatives. Yet, few U.S. studies have analyzed the illegal wildlife trade (IWT) on a national or local scale. Moreover, to our knowledge, no studies have specifically examined the trends associated with IWT moving through personal baggage. This work aimed to better understand the magnitude of illegal wildlife importation into U.S. ports of entry by determining trends associated with illegal wildlife products from personal baggage seizures, using the Pacific Northwest (PNW) as a specific case study. To identify the most influential factors determining the numbers and types of personal baggage seizures into PNW, we analyzed 1,731 records between 1999 and 2016 from the Fish and Wildlife Service's (FWS) Law Enforcement Management Information System (LEMIS) database. We found five significant contributors: taxonomic classification of wildlife, categorical import date, wildlife product, source region, and the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES) status. While wildlife seizures across taxonomic categories have generally decreased in the PNW since 2008, other findings provide a reason for concern. More specifically, mammals were identified as the largest animal group of seized wildlife, and temporal trends indicate increases in seizures for this and several other taxonomic groups. Many of the seizures originated from overseas, with East Asia serving as the largest source. Our PNW case study can be a model for how large-scale geographical seizure data can be used to inform about the major factors that have historically and presently contribute to IWT, with conservation implications globally.	[Hitchens, Rosemary T.] Miami Univ, Dept Biol, Oxford, OH 45056 USA; [Blakeslee, April M. H.] East Carolina Univ, Dept Biol, Greenville, NC 27858 USA	University System of Ohio; Miami University; University of North Carolina; East Carolina University	Hitchens, RT (corresponding author), Miami Univ, Dept Biol, Oxford, OH 45056 USA.	hitchert@miamioh.edu		Hitchens, Rosemary/0000-0002-9012-3498; Blakeslee, April/0000-0001-9667-2175	Miami University's Project Dragonfly	Miami University's Project Dragonfly	This work would not have been possible without the support of Miami University's Project Dragonfly. We thank Dr. Laura Avila and R.H.'s graduate peers for assisting with the final editing and publication of this article. We acknowledge the FWS personnel that provided the inspiration and means for this research, particularly Michael Jenkins, USFWS Management Analyst. RH also thanks John Goldman, Supervisory Wildlife Inspector at the OLE in the PNW, for his continued guidance, support, and expertise throughout the process. This research was not funded by any specific grant from any funding agency, or commercial or not-for-profit sectors.	Ando AW, 1999, J LAW ECON, V42, P29, DOI 10.1086/467417; [Anonymous], 2007, GUARDIAN; [Anonymous], 2017, AIR CARGO NEWS; Banse T., 2015, WHATS POACHING AFRIC; Barringer F, 2005, US BAN IMPORTS BELUG; Boratto R, 2021, EUR J CRIMINOL, V18, P777, DOI 10.1177/1477370819887512; Bronzi P, 2019, J APPL ICHTHYOL, V35, P257, DOI 10.1111/jai.13870; Burgess E.A., 2014, BROUGHT BEAR ANAL SE; Bush ER, 2014, CONSERV BIOL, V28, P663, DOI 10.1111/cobi.12240; Campbell Charlie., 2019, TIME; Challender DWS, 2015, GLOB ECOL CONSERV, V3, P129, DOI 10.1016/j.gecco.2014.11.010; Collis A.H., 2011, MODERN US REPTILE IN; Community Attributes Inc, 2018, SEA TAC INT AIRP EC; Cooney R, 2017, CONSERV LETT, V10, P367, DOI 10.1111/conl.12294; Cooper ME, 2002, REV SCI TECH OIE, V21, P103, DOI 10.20506/rst.21.1.1329; Craig V, 2011, REV TRADE ORNAMENTAL; D'Cruze N, 2016, NAT CONSERV-BULGARIA, P47, DOI 10.3897/natureconservation.15.10005; D'Cruze N, 2015, NAT CONSERV-BULGARIA, P1, DOI 10.3897/natureconservation.13.5625; Deines T, 2018, ANIMALS; Deines T, 2017, NATL GEOGRAPHIC NEWS; Deines T, 2018, NATL GEOGRAPHIC; Dell'Amore C, 2018, HAVE PARROTS BECOME; Dishon G, 2020, SCI REPORTS, V10, P1, DOI [10.1038/s41598-019-56847-4, DOI 10.1038/S41598-019-56847-4]; Ebersole R, 2017, NATL GEOGRAPHIC; EIA International, 2019, WHO URG COND TRAD CH; Ellis Richard, 2005, TIGER BONE RHINO HOR; Expert Panel on Women's I, 2018, J AM COLL RADIOL, V15, pS365; Felbab-Brown V., 2011, FOREIGN POLICY BROOK; Felson M, 1999, OPPORTUNITY MAKES TH; Ferrier P., 2009, 81 USDAERS; Garcia-Diaz P, 2017, CONSERV LETT, V10, P690, DOI 10.1111/conl.12301; Goyenechea A., 2015, COMBATING WILDLIFE T; H-r L, 2016, SPINE, V41, pE116, DOI 10.1097/BRS.0000000000001139; International Union for Conservation of Nature and Natural Resources, 2012, 31 WORLD CONS UN; Janssen J, 2018, J ASIA-PAC BIODIVERS, V11, P476, DOI 10.1016/j.japb.2018.09.003; Karesh WB, 2005, EMERG INFECT DIS, V11, P1000; KRC Research, 2016, AM SUPPORT WILDL CON; Krishnasamy K., 2016, REDUCED SKIN BONES R; Kurland J, 2017, DEVIANT BEHAV, V38, P375, DOI 10.1080/01639625.2016.1197009; Lavorgna A., 2014, CRIME SCI, V3, P1, DOI 10.1186/s40163-014-0005-2; Lawson K, 2014, ROYAL I INT AFFAIRS; Lemieux AM, 2014, CRIM SCI SER, V15, P1; Martin E, 2008, IVORY MARKETS US; Mofson P, 1996, BEHAV STATES INT WIL; Moseley J., 2016, AIRLINEGEEKS; Naidoo R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13379; Nijman V, 2019, J ETHNOBIOL, V39, P282, DOI 10.2993/0278-0771-39.2.282; Nijman V, 2010, BIODIVERS CONSERV, V19, P1101, DOI 10.1007/s10531-009-9758-4; Ocampo-Penuela N, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601367; Office of Congressional and Legislative Affairs, 2008, IMP ILL WILDL TRAD T; Petrossian GA, 2016, GLOB CRIME, V17, P181, DOI 10.1080/17440572.2016.1152548; Petrossian GA, 2014, BRIT J CRIMINOL, V54, P73, DOI 10.1093/bjc/azt061; Pires SF, 2012, GLOB CRIME, V13, P176, DOI 10.1080/17440572.2012.700180; Pires SF, 2011, BRIT J CRIMINOL, V51, P314, DOI 10.1093/bjc/azq074; Reardon JT, 2012, NEW ZEAL J ECOL, V36, P141; Reuter P, 2017, GLOB CRIME, V18, P77, DOI 10.1080/17440572.2016.1179633; Rhyne AL, 2017, PEERJ, V5, DOI 10.7717/peerj.2949; Rhyne AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035808; Rice Susan M., 2008, Marine Turtle Newsletter, P1; Roe D, 2007, TRADING NATURE REPOR; Rosen GE, 2010, ECOHEALTH, V7, P24, DOI 10.1007/s10393-010-0317-y; Rosser AM, 2002, CONSERV BIOL, V16, P584, DOI 10.1046/j.1523-1739.2002.01635.x; ROUTES Partnership C4ADS, 2018, PLANE SIGHT WILDL TR; Sas-Rolfes M't., 1997, 0255364423 IEA ENV U; Schloegel LM, 2009, BIOL CONSERV, V142, P1420, DOI 10.1016/j.biocon.2009.02.007; Shariati A, 2017, ADV PREVENTION SCI, P261, DOI 10.1007/978-3-319-44124-5_22; Sheeler A, 2019, THE SACRAMENTO BEE; Sina S, 2016, WILDLIFE CRIME ECOLO; Souviron-Priego L, 2015, TRAFFIC B; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Tensen L, 2016, GLOB ECOL CONSERV, V6, P286, DOI 10.1016/j.gecco.2016.03.007; The Northwest Seaport Alliance, 2019, CARG STATS; Todd D., 2011, VANCOUVER SUN; Todd D., 2017, VANCOUVER SUN; TRAFFIC, 2005, WILDL TRAD S E AS, V20; Tricorache P, 2018, BIODIVER WORL CONS, P191, DOI 10.1016/B978-0-12-804088-1.00014-9; U.S. Department of Justice, 2014, SNOH COUNT MAN WHO S; U.S. Fish and Wildlife Service Office of Law Enforcement, 2018, ANN REP FY 2017; U.S. Fish and Wildlife Service Office of Law Enforcement, ANN REP FY 2001; U.S. Fish and Wildlife Service Office of Law Enforcement, 2001, ANN REP FY 2000; U.S. Fish and Wildlife Service Office of Law Enforcement, 2002, ANN REP FY 2008; U.S. Government Accountability Office (GAO), 2017, GAO187; United Nations Office on Drugs and Crime, 2016, WORLD WILDLIFE CRIME; UNWTO, 2020, UNWTO WORLD TOUR BAR, V18, DOI 10.18111/wtobarometereng.2020.18.1.1; Utermohlen M, 2017, USAID REDUCING OPPOR; Van Uhm D, 2016, J TRAFFICKING ORG CR, V2, P36; van Uhm D, 2019, QUANTITATIVE STUDIES; van Uhm D, 2016, TRENDS ORGAN CRIME, V19, P67, DOI 10.1007/s12117-016-9264-5; van Uhm DP, 2018, THEOR CRIMINOL, V22, P384, DOI 10.1177/1362480618787170; Washington State Office of Financial Management, 2017, POP GROWTH WASH REM; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Wilcox P, 2018, ANNU REV CRIMINOL, V1, P123, DOI 10.1146/annurev-criminol-032317-092421; World Wildlife Fund, 2016, LIV PLAN REP 2016 RI; World Wildlife Fund, 2004, MUSK DEER THREAT RUS; Wu S, 2018, SEATTLE TIMES; Wyatt T, 2009, GLOB CRIME, V10, P144, DOI 10.1080/17440570902783947; Wyatt Tanya, 2016, J TRAFFICKING ORG CR, V2, P62, DOI DOI 10.1108/17410391111097438; Zabyelina YG, 2014, TRENDS ORGAN CRIME, V17, P181, DOI 10.1007/s12117-014-9214-z; Zhang L, 2009, BREAST CARE, V4, P379, DOI 10.1159/000266759; Zimmerman, 2003, VANDERBILT J TRANSNA, V36, P1657	100	7	7	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2020	15	6							e0234197	10.1371/journal.pone.0234197	http://dx.doi.org/10.1371/journal.pone.0234197			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC0EC	32520961	Green Published, gold			2022-12-26	WOS:000542969500012
J	Lee, CH; Choi, SW; Jun, SW; Hwang, J; Kim, IC; Cho, YK; Park, HS; Yoon, HJ; Kim, H; Nam, CW; Han, W; Kim, KB; Hur, SH				Lee, Cheol Hyun; Choi, Sang-Woong; Jun, Seung-Woon; Hwang, Jongmin; Kim, In-Cheol; Cho, Yun-Kyeong; Park, Hyoung-Seob; Yoon, Hyuck-Jun; Kim, Hyungseop; Nam, Chang-Wook; Han, Seongwook; Kim, Kwon-Bae; Hur, Seung-Ho			Clinical impact of diabetes mellitus on 2-year clinical outcomes following PCI with second-generation drug-eluting stents; Landmark analysis findings from patient registry: Pooled analysis of the Korean multicenter drug-eluting stent registry	PLOS ONE			English	Article							CORONARY; EVEROLIMUS; IMPLANTATION; THROMBOSIS; LESIONS; TERM	Background Patients with diabetes mellitus are at an increased risk for adverse clinical events following percutaneous coronary interventions (PCI). However, the clinical impact of diabetes mellitus (DM) on second-generation drug-eluting stent (DES) implantation is not well-known. The aim of the current analysis was to examine the clinical impact of DM on clinical outcomes and the time sequence of associated risks in patients treated with second-generation DES. Methods Using patient-level data from two stent-specific, all-comer, prospective DES registries, we evaluated 1,913 patients who underwent PCI with second-generation DES between Feb 2009 and Dec 2013. The primary outcomes assessed were two-year major cardiac adverse events (MACE), composite endpoints of death from any cause, myocardial infarction (MI), and any repeat revascularization. We classified 0-1 year as the early period and 1-2 years as the late period. Landmark analyses were performed according to diabetes mellitus status. Results There were 1,913 patients with 2,614 lesions included in the pooled dataset. The median duration of clinical follow-up in the overall population was 2.0 years (interquartile range 1.9-2.1). Patients with DM had more cardiovascular risk factors than patients without DM. In multivariate analyses, the presence of DM and renal failure were strong predictors of MACE and target-vessel revascularization (TVR). After inverse probability of treatment weighting (IPTW) analyses, patients with DM had significantly increased rates of 2-year MACE (HR 2.07, 95% CI; 1.50-2.86; P <0.001). In landmark analyses, patients with DM had significantly higher rates of MACE in the early period (0-1 year) (HR 3.04, 95% CI; 1.97-4.68; P < 0.001) after IPTW adjustment, but these findings or trends were not observed in the late period (1-2 year) (HR 1.24, 95% CI; 0.74-2.07; P = 0.41). Conclusions In the second-generation DES era, the clinical impact of DM significantly increased the 2-year event rate of MACE, mainly caused by clinical events in the early period (0-1 year). Careful observation of patients with DM is advised in the early period following PCI with second-generation DES.	[Lee, Cheol Hyun; Choi, Sang-Woong; Jun, Seung-Woon; Hwang, Jongmin; Kim, In-Cheol; Cho, Yun-Kyeong; Park, Hyoung-Seob; Yoon, Hyuck-Jun; Kim, Hyungseop; Nam, Chang-Wook; Han, Seongwook; Kim, Kwon-Bae; Hur, Seung-Ho] Keimyung Univ, Dept Internal Med, Div Cardiol, Dongsan Hosp, Daegu, South Korea	Keimyung University	Hur, SH (corresponding author), Keimyung Univ, Dept Internal Med, Div Cardiol, Dongsan Hosp, Daegu, South Korea.	shur@dsmc.or.kr		Lee, Cheol Hyun/0000-0003-4203-1457	Korea Health Industry Development Institute (KR) Grant [HI17C2594]	Korea Health Industry Development Institute (KR) Grant	Korea Health Industry Development Institute (KR) Grant nr. HI17C2594 Dr. Seongwook Han.	Elezi S, 1998, J AM COLL CARDIOL, V32, P1866, DOI 10.1016/S0735-1097(98)00467-7; Jensen JK, 2013, CATHETER CARDIO INTE, V81, P260, DOI 10.1002/ccd.24398; Kedhi E, 2010, LANCET, V375, P201, DOI 10.1016/S0140-6736(09)62127-9; Kereiakes DJ, 2010, J AM COLL CARDIOL, V56, P2084, DOI 10.1016/j.jacc.2010.10.006; Kim WJ, 2011, CIRCULATION, V124, P886, DOI 10.1161/CIRCULATIONAHA.110.015453; Laskey WK, 2007, CIRCULATION, V115, P2352, DOI 10.1161/CIRCULATIONAHA.107.688416; Lee SW, 2011, JACC-CARDIOVASC INTE, V4, P310, DOI 10.1016/j.jcin.2010.12.006; Mehran R, 2004, J AM COLL CARDIOL, V43, P1348, DOI 10.1016/j.jacc.2003.04.004; Morice MC, 2007, J AM COLL CARDIOL, V50, P1299, DOI 10.1016/j.jacc.2007.06.029; Moussa I, 2004, CIRCULATION, V109, P2273, DOI 10.1161/01.CIR.0000129767.45513.71; Nakatsuma K, 2018, CARDIOVASC INTERV TH, V33, P125, DOI 10.1007/s12928-017-0458-9; Ortolani P, 2008, CIRCULATION, V117, P923, DOI 10.1161/CIRCULATIONAHA.107.730416; Park KW, 2014, JACC-CARDIOVASC INTE, V7, P471, DOI 10.1016/j.jcin.2013.12.201; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Sabate M, 2005, CIRCULATION, V112, P2175, DOI 10.1161/CIRCULATIONAHA.105.562421; Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5; Stone GW, 2010, NEW ENGL J MED, V362, P1663, DOI 10.1056/NEJMoa0910496; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011	18	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2020	15	6							e0234362	10.1371/journal.pone.0234362	http://dx.doi.org/10.1371/journal.pone.0234362			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC0EC	32520973	gold, Green Published			2022-12-26	WOS:000542969500037
J	Li, M; Zhao, QY; Chen, R; He, JJ; Peng, T; Deng, WB; Che, YL; Wang, ZQ				Li, Meng; Zhao, Qiongyao; Chen, Rong; He, Jiajun; Peng, Tao; Deng, Wenbo; Che, Yanli; Wang, Zongqing			Species diversity revealed in Sigmella Hebard, 1929 (Blattodea, ectobiidae) based on morphology and four molecular species delimitation methods	PLOS ONE			English	Article							BIOLOGICAL IDENTIFICATIONS; DNA; MITOCHONDRIAL; DICTYOPTERA; EVOLUTION; ISOPTERA; TAXONOMY	Cockroaches are one of the major decomposers involved in biogeochemical cycles. Cockroaches have an amazing amount of diversity, but most of them remain unknown due to the shortage of the trained taxonomists and the limitations of morphology-based identification. We obtained 49 COI sequences (including 42 novel sequences) and 32 novel 28S sequences for 5Sigmellamorphospecies collected from 11 localities. Three are new to science:Sigmella digitalissp. nov.,Sigmella exsertasp. nov. andSigmella normalissp. nov. Based on four species delimitation methods (ABGD, GMYC, BINs and bPTP), a total of 6 molecular operational taxonomic units (MOTUs) were recovered for 5 morphospecies. These were then confirmed by tree building methods using COI and combined data (COI and 28S). We detected more than one MOTU in the morphospeciesS.digitalissp. nov., which can indicate genetic diversity. Detailed morphological evidence for each MOTU is provided to confirm these slight variations and we conclude that natural barriers are likely the main cause of genetic diversity.	[Li, Meng; Zhao, Qiongyao; Chen, Rong; He, Jiajun; Peng, Tao; Deng, Wenbo; Che, Yanli; Wang, Zongqing] Southwest Univ, Inst Entomol, Coll Plant Protect, Chongqing, Peoples R China	Southwest University - China	Wang, ZQ (corresponding author), Southwest Univ, Inst Entomol, Coll Plant Protect, Chongqing, Peoples R China.	zqwang2006@126.com			National Natural Science Foundation of China [31872271, 31472026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by the National Natural Science Foundation of China (Nos. 31872271 to ZW, and 31472026 to YC).	[Anonymous], 2016, INT J DIABETES, V1, P12; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bai QK, 2018, INVERTEBR SYST, V32, P69, DOI 10.1071/IS17003; Ball SL, 2005, J N AM BENTHOL SOC, V24, P508, DOI 10.1899/04-142.1; Bell WJ, 2007, COCKROACHES ECOLOGY; BEY BIYENKO G. YA., 1957, ENT OBOZRENIE, V36, P895; Bey-Bienko GY, 1959, ZOOL ZH, V38, P1813; Bey-Bienko GY, 1958, ENTOMOL OBOZR, V37, P670; Bey-Bienko GY, 1954, T ZOOLOGICHESKOGO I, V15, P5; BRUIJNING C. F. A., 1948, ZOOL MEDEDEEL LEYDEN, V29, P1; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evangelista DA, 2014, SYST ENTOMOL, V39, P150, DOI 10.1111/syen.12043; Ezard T, 2009, PACKAGE SPLITS SPECI; Fisk FW, 1983, T AM ENTOMOL SOC, V108, P479; Foottit RG, 2009, MOL ECOL RESOUR, V9, P188, DOI 10.1111/j.1755-0998.2009.02644.x; Foster BT, 2004, J ECON ENTOMOL, V97, P95, DOI 10.1603/0022-0493-97.1.95; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Giangrande A, 2003, AQUAT CONSERV, V13, P451, DOI 10.1002/aqc.584; HEBARD MORGAN, 1940, ENT NEWS, V51, P236; HEBARD MORGAN, 1929, PROC ACAD NAT SCI PHILADELPHIA, V81, P1; Hebert PDN, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0333; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Kim SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171394; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Legendre F, 2008, MOL PHYLOGENET EVOL, V48, P615, DOI 10.1016/j.ympev.2008.04.017; Legendre F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130127; Legendre F, 2014, BIOL J LINN SOC, V111, P58, DOI 10.1111/bij.12199; Monaghan MT, 2005, PHILOS T R SOC B, V360, P1925, DOI 10.1098/rstb.2005.1724; Morard R, 2016, SYST BIOL, V65, P925, DOI 10.1093/sysbio/syw031; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Princis K, 1969, ORTHOPTERORUM CATALO, P712, DOI DOI 10.1002/MMNZ.4830400108; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rach J, 2008, P ROY SOC B-BIOL SCI, V275, P237, DOI 10.1098/rspb.2007.1290; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; von Beeren C, 2015, SCI REP-UK, V5, DOI 10.1038/srep08297; Wang XD, 2014, ZOOKEYS, P59, DOI 10.3897/zookeys.412.7134; Wang ZQ, 2010, ZOOTAXA, P37; Yue QY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106789; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	46	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2020	15	6							e0232821	10.1371/journal.pone.0232821	http://dx.doi.org/10.1371/journal.pone.0232821			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC0EC	32520927	gold, Green Published			2022-12-26	WOS:000542969500033
J	Kang, J; Cho, YJ; Choi, S				Kang, Jiyeon; Cho, Young-Jae; Choi, Seunghye			State anxiety, uncertainty in illness, and needs of family members of critically ill patients and their experiences with family-centered multidisciplinary rounds: A mixed model study	PLOS ONE			English	Article							DECISION-MAKING; OF-LIFE; CARE; SATISFACTION; ICU; COMMUNICATION; RELATIVES	This study aimed to determine whether family-centered multidisciplinary rounds could alleviate anxiety and uncertainty in illness and meet needs for critically ill patients' families. A family-centered multidisciplinary rounds protocol was developed identifying needs of critically ill patients' families, and family experiences were reviewed through in-depth interviews. A sequential mixed-methods study was utilized, combining survey data and semi-structured interviews in a tertiary medical intensive care unit in South Korea. A structured questionnaire assessed needs, anxiety, and uncertainty in illness for 50 participants. Interview data of 10 participants were analyzed using grounded theory. Assurance was the highest family need, followed by information need. Family needs differed according to gender, relationship to the patient, and length of intensive care unit stay. Participants reported family-centered multidisciplinary rounds provided a sense of relief, a chance to listen to medical staff, and a chance to provide medical staff with comprehensive information about patient care. Proximity needs were found to have a positive correlation with state anxiety, while comfort needs had a negative correlation with uncertainty in illness. Families reported family-centered multidisciplinary rounds were positive, useful experiences. Thus, standardization of family-centered multidisciplinary rounds is needed to meet families' various needs.	[Kang, Jiyeon] Univ Virginia, Dept Anthropol, Charlottesville, VA USA; [Cho, Young-Jae] Seoul Natl Univ, Bundang Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Seongnam, South Korea; [Choi, Seunghye] Gachon Univ, Coll Nursing, Incheon, South Korea	University of Virginia; Seoul National University (SNU); Gachon University	Choi, S (corresponding author), Gachon Univ, Coll Nursing, Incheon, South Korea.	hera0511@gmail.com	Cho, Young-Jae/D-5528-2012	Cho, Young-Jae/0000-0001-6943-4462; Kang, Jiyeon/0000-0003-3987-4656	National Research Foundation of Korea [NRF2017R1C1B5076726]	National Research Foundation of Korea(National Research Foundation of Korea)	This study was funded by the National Research Foundation of Korea (Project #: NRF2017R1C1B5076726) to SH Choi. http://www.nrf.re.kr The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SR, 2017, J TRAUMA ACUTE CARE, V82, P582, DOI 10.1097/TA.0000000000001332; Andresen M, 2015, J CRIT CARE, V30, DOI 10.1016/j.jcrc.2015.06.009; Baharoon S, 2017, J PATIENT SAF, V13, P169, DOI 10.1097/PTS.0000000000000140; Barclay JS, 2007, J PALLIAT MED, V10, P958, DOI 10.1089/jpm.2007.9929; Bogue TL, 2017, CRIT CARE NURS CLIN, V29, P233, DOI 10.1016/j.cnc.2017.01.009; Browning AM, 2009, DIMENS CRIT CARE NUR, V28, P18, DOI 10.1097/01.DCC.0000325092.39154.4a; Cao V, 2018, CRIT CARE MED, V46, P85, DOI 10.1097/CCM.0000000000002807; Choi Y. J., 2018, THESIS; Curtis JR, 2008, CHEST, V134, P835, DOI 10.1378/chest.08-0235; Evans LR, 2009, AM J RESP CRIT CARE, V179, P48, DOI 10.1164/rccm.200806-969OC; Hetland B, 2018, INTENS CRIT CARE NUR, V44, P67, DOI 10.1016/j.iccn.2017.08.008; Huffines M, 2013, CRIT CARE NURSE, V33, P56, DOI 10.4037/ccn2013354; Im Mihae, 2016, Child Health Nursing Research, V22, P107, DOI 10.4094/chnr.2016.22.2.107; Jang S.-H., 2007, THESIS; Johnson CC, 2019, ANN AM THORAC SOC, V16, P894, DOI 10.1513/AnnalsATS.201808-540SR; Jongerden IP, 2013, INTENS CARE MED, V39, P1626, DOI 10.1007/s00134-013-2966-0; Jung Yu Sun, 2019, [Journal of Music and Human Behavior, 인간행동과 음악연구], V16, P25, DOI 10.21187/jmhb.2019.16.1.025; Kim IK, 2015, THESIS; Kim JT, 1978, J HUMAN UNDERST COUN, V1, P16; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kuo DZ, 2012, PEDIATRICS, V130, P299, DOI 10.1542/peds.2011-2623; Kynoch Kate, 2016, JBI Database System Rev Implement Rep, V14, P181, DOI 10.11124/JBISRIR-2016-2477; Lee EJ, 2015, WORK, V52, P777, DOI 10.3233/WOR-152205; Lee，Ji-Won, 2014, [The Journal of the Korea Contents Association, 한국콘텐츠학회 논문지], V14, P421, DOI 10.5392/JKCA.2014.14.02.421; Leske J S, 1991, AACN Clin Issues Crit Care Nurs, V2, P220; Levin AB, 2015, PEDIATR CRIT CARE ME, V16, P801, DOI 10.1097/PCC.0000000000000486; Fumis RRL, 2015, J CRIT CARE, V30, P440, DOI 10.1016/j.jcrc.2014.11.022; Meyers TA, 2000, AM J NURS, V100, P32, DOI 10.2307/3521954; MISHEL MH, 1981, NURS RES, V30, P258; Mitchell M, 2019, INTENS CRIT CARE NUR, V50, P11, DOI 10.1016/j.iccn.2018.08.009; Mittal V, 2014, PEDIATR CLIN N AM, V61, P663, DOI 10.1016/j.pcl.2014.04.003; MOLTER NC, 1979, HEART LUNG, V8, P332; Monteiro F, 2014, RESP CARE, V59, P411, DOI 10.4187/respcare.02695; Park IK, 2018, HLTH INSUR REV ASSES, V12, P15; Park Y. O., 2005, THESIS; Paul F, 2008, J ADV NURS, V62, P276, DOI 10.1111/j.1365-2648.2007.04568.x; Sarafis Pavlos, 2013, Glob J Health Sci, V6, P128, DOI 10.5539/gjhs.v6n2p128; Sisterhen LL, 2007, TEACH LEARN MED, V19, P319, DOI 10.1080/10401330701366812; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Strauss A, 1997, GROUNDED THEORY PRAC; Sung H. Y., 2003, CHUNG ANG J NURSING, V7, P1; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; van den Born-van Zanten SA, 2016, REHABIL PSYCHOL, V61, P173, DOI 10.1037/rep0000081; Van Keer RL, 2019, PATIENT EDUC COUNS, V102, P2199, DOI 10.1016/j.pec.2019.06.017; Wesson J S, 1997, Intensive Crit Care Nurs, V13, P111, DOI 10.1016/S0964-3397(97)80271-6	45	7	7	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2020	15	6							e0234296	10.1371/journal.pone.0234296	http://dx.doi.org/10.1371/journal.pone.0234296			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LZ1GC	32516349	gold, Green Published			2022-12-26	WOS:000540977000015
J	Nasrollahi, SM; Meale, SJ; Morgavi, DP; Schiphorst, AM; Robins, RJ; Ortigues-Marty, I; Cantalapiedra-Hijar, G				Nasrollahi, Sayyed Mahmoud; Meale, Sarah Jade; Morgavi, Diego P.; Schiphorst, Anne Marie; Robins, Richard J.; Ortigues-Marty, Isabelle; Cantalapiedra-Hijar, Gonzalo			The origin of N isotopic discrimination and its relationship with feed efficiency in fattening yearling bulls is diet-dependent	PLOS ONE			English	Article							NITROGEN ISOTOPES; FRACTIONATION; RUMEN; COWS; METABOLISM; SYSTEM; FIBER	Nitrogen (N) isotopic discrimination (i.e. the difference in natural N-15 abundance between the animal proteins and the diet; Delta N-15) is known to correlate with N use efficiency (NUE) and feed conversion efficiency (FCE) in ruminants. However, results from the literature are not always consistent across studies, likely due to isotopic discrimination pathways that may differ with the nature of diets. The objective of the present study was to assess at which level, from rumen to tissues, Delta N-15 originates and becomes related to NUE and FCE in fattening yearling bulls when they are fed two contrasted diets. Twenty-four Charolais yearling bulls were randomly divided into two groups and fed during 8 months, from weaning to slaughter, either 1) a high starch diet based on corn silage supplying a balanced N to energy ratio at the rumen level (starch) or 2) a high fiber diet based on grass silage supplying an excess of rumen degradable N (fiber). All animals were slaughtered and samples of different digestive pools (ruminal, duodenal, ileal and fecal contents), animal tissues (duodenum, liver and muscle), blood and urine were collected for each animal. Ruminal content was further used to isolate liquid-associated bacteria (LAB), protozoa and free ammonia, while plasma proteins were obtained from blood. All samples along with feed were analyzed for their N isotopic composition. For both diets, the digestive contribution (i.e. the N isotopic discrimination occurring before absorption) to the Delta N-15 observed in animal tissues accounted for 65 +/- 11%, leaving only one third to the contribution of post-absorptive metabolism. Concerning the Delta N-15 in digestive pools, the majority of these changes occurred in the rumen (av. Delta N-15 = 2.12 +/- 0.66 parts per thousand), with only minor N-15 enrichments thereafter (av. Delta N-15 = 2.24 +/- 0.41 parts per thousand), highlighting the key role of the rumen on N isotopic discrimination. A strong, significant overall relationship (n = 24) between Delta N-15 and FCE or NUE was found when using any post-absorptive metabolic pool (duodenum, liver, or muscle tissues, or plasma proteins; 0.52 < r < 0.73; P <= 0.01), probably as these pools reflect both digestive and post-absorptive metabolic phenomena. Fiber diet compared to starch diet had a lower feed efficiency and promoted higher (P <= 0.05) Delta N-15 values across all post-absorptive metabolic pools and some digestive pools (ruminal, duodenal, and ileal contents). The within-diet relationship (n = 12) between Delta N-15 and feed efficiency was not as strong and consistent as the overall relationship, with contrasted responses between the two diets for specific pools (diet x pool interaction; P <= 0.01). Our results highlight the contrasted use of N at the rumen level between the two experimental diets and suggests the need for different equations to predict FCE or NUE from Delta N-15 according to the type of diet. In conclusion, rumen digestion and associated microbial activity can play an important role on N isotopic discrimination so rumen effect related to diet may interfere with the relationship between Delta N-15 and feed efficiency in fattening yearling bulls.	[Nasrollahi, Sayyed Mahmoud; Morgavi, Diego P.; Ortigues-Marty, Isabelle; Cantalapiedra-Hijar, Gonzalo] Univ Clermont Auvergne, INRAE, Vetagro Sup, UMRH, St Genes Champanelle, France; [Meale, Sarah Jade] Univ Queensland, Sch Agr & Food Sci, Gatton Campus, Gatton, Australia; [Schiphorst, Anne Marie; Robins, Richard J.] Univ Nantes, CNRS, CEISAM, UMR 6230, Nantes, France	INRAE; Universite Clermont Auvergne (UCA); VetAgro Sup; University of Queensland; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Nantes Universite	Cantalapiedra-Hijar, G (corresponding author), Univ Clermont Auvergne, INRAE, Vetagro Sup, UMRH, St Genes Champanelle, France.	gonzalo.cantalapiedra@inrae.fr	Morgavi, Diego P./C-2191-2013	Morgavi, Diego P./0000-0002-3883-0937; CANTALAPIEDRA-HIJAR, Gonzalo/0000-0001-9486-8238; Meale, Sarah/0000-0002-8417-1186	French regional funding "CASDAR" [016]; SmartCow - European Union's Horizon 2020 research and innovation program [730924]; European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant [658126]; CNRS	French regional funding "CASDAR"; SmartCow - European Union's Horizon 2020 research and innovation program; European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant; CNRS(Centre National de la Recherche Scientifique (CNRS))	We thank the French regional funding "CASDAR" for financial support for this project (Effi-J; 2015 No016). S.M. Nasrollahi received funding from SmartCow, a project supported by the European Union's Horizon 2020 research and innovation program under grant agreement No 730924. S.J. Meale received funding from the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement no. 658126. R.J. Robins acknowledges core funding from the CNRS.	AOAC, 2007, OFFICIAL METHODS ANA, V18th; AUFRERE J, 1988, ANN ZOOTECH, V37, P255, DOI 10.1051/animres:19880403; Bahar B, 2009, J ANIM SCI, V87, P905, DOI 10.2527/jas.2008-1360; BAUCHART D, 1990, BRIT J NUTR, V63, P563, DOI 10.1079/BJN19900143; Cantalaiedra-Hijar G, 2018, ANIMAL, V12, P1827, DOI [10.1017/S1751731117003391, 10.1017/s1751731117003391]; Cantalapiedra-Hijar G, 2016, ANIMAL, V10, P221, DOI 10.1017/S1751731115002025; Cantalapiedra-Hijar G, 2015, BRIT J NUTR, V113, P1158, DOI 10.1017/S0007114514004449; Cantalapiedra-Hijar G, 2014, J DAIRY SCI, V97, P5151, DOI 10.3168/jds.2014-8019; Cheng L, 2013, J ANIM SCI, V91, P5785, DOI 10.2527/jas.2012-5378; Conway E. J., 1947, MICRODIFFUSION ANAL; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; FAISANT N, 1995, SCI ALIMENT, V15, P83; Gannes LZ, 1998, COMP BIOCHEM PHYS A, V119, P725, DOI 10.1016/S1095-6433(98)01016-2; Garcia F, 2008, J AGR SCI-CAMBRIDGE, V146, P251, DOI 10.1017/S002185960800779X; HOCH MP, 1992, LIMNOL OCEANOGR, V37, P1447, DOI 10.4319/lo.1992.37.7.1447; Huhtanen P, 2015, J DAIRY SCI, V98, P3182, DOI 10.3168/jds.2014-8215; Institut National de la Recherche Agronomique (INRA), 2018, INRA FEEDING SYSTEM, DOI 10.3920/978-90-8686-292-4; Macko S.A., 1984, ORG GEOCHEM, V6, P787, DOI DOI 10.1016/0146-6380(84)90100-1; MACKO SA, 1986, GEOCHIM COSMOCHIM AC, V50, P2143, DOI 10.1016/0016-7037(86)90068-2; MARTIN C, 1993, CURR MICROBIOL, V27, P223, DOI 10.1007/BF01692880; MARTIN C, 1994, J ANIM SCI, V72, P2962, DOI 10.2527/1994.72112962x; Michalet-Doreau B, 2001, REPROD NUTR DEV, V41, P187, DOI 10.1051/rnd:2001122; Murray R. K., 2009, HARPERS ILLUSTRATED; OLDHAM JD, 1984, J DAIRY SCI, V67, P1090, DOI 10.3168/jds.S0022-0302(84)81410-1; Ouellet DR, 2002, J DAIRY SCI, V85, P3013, DOI 10.3168/jds.S0022-0302(02)74387-7; Robelin J, 1975, B TECH CRZV THEIX IN, V22, P41; RUSSELL JB, 1992, J ANIM SCI, V70, P3551, DOI 10.2527/1992.70113551x; Shinoda K, 2019, MICROBES ENVIRON, V34, P5, DOI 10.1264/jsme2.ME18082; Sick H, 1997, Z ERNAHRUNGSWISS, V36, P340, DOI 10.1007/BF01617819; SUTOH M, 1987, Radioisotopes, V36, P74, DOI 10.3769/radioisotopes.36.2_74; Van Soest PJ, 2018, NUTR ECOLOGY RUMINAN, DOI DOI 10.7591/9781501732355; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Vo J, 2013, P NATL ACAD SCI USA, V110, P8696, DOI 10.1073/pnas.1216683110; WATTIAUX MA, 1995, J ANIM SCI, V73, P257; WEISS PM, 1988, BIOCHEMISTRY-US, V27, P4814, DOI 10.1021/bi00413a035; Wheadon NM, 2014, BRIT J NUTR, V111, P1705, DOI 10.1017/S0007114513004078; WILDMAN EE, 1982, J DAIRY SCI, V65, P495, DOI 10.3168/jds.S0022-0302(82)82223-6	37	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0234344	10.1371/journal.pone.0234344	http://dx.doi.org/10.1371/journal.pone.0234344			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502191	Green Published, gold			2022-12-26	WOS:000542035700070
J	Cheng, Y; Huang, ZM; Liao, Q; Yu, XC; Jiang, HY; He, YT; Yao, S; Nie, SF; Liu, L				Cheng, Yao; Huang, Ziming; Liao, Qing; Yu, Xingchen; Jiang, Hongyu; He, Yangting; Yao, Shuang; Nie, Shaofa; Liu, Li			Risk of second primary breast cancer among cancer survivors: Implications for prevention and screening practice	PLOS ONE			English	Article							PRIMARY MALIGNANCIES; BRCA2 MUTATIONS; THYROID-CANCER; SKIN-CANCER; DIAGNOSIS; POPULATION; OVARIAN; EPIDEMIOLOGY	Second primary breast cancer (SPBC) is becoming one of the major obstacles to breast cancer (BC) control. This study was aimed to determine the trend of SPBC incidence over time and the risk of developing SPBC in site-specific primary cancer survivors in the United States. The Surveillance, Epidemiology, and End Results (SEER) 13 registry (1992-2015) was used to identify SPBC patients with previous malignancies. Standardized incidence ratio (SIR) was computed to compare the incidence rates of the observed cases of SPBC in cancer survivors over the expected cases in the general population. Elevated risk of SPBC was observed in women with previous BC (SIR = 1.74) or thyroid cancer (SIR = 1.17). Women with initial skin melanoma in older age (>= 50 years) (SIR = 1.11), or White race (SIR = 1.11) presented an elevated incidence of SPBC than the general female population. Besides, Asian/Pacific Islander (API) women with cancer of corpus uteri, ovary, bladder, or kidney were prone to developing SPBC when compared with the general population, with SIRs of 1.61, 1.35, 1.48, and 1.70, respectively. Male BC patients showed profound risk of developing SPBC (SIR = 34.86). Male leukemia patients also presented elevated risk of developing SPBC (SIR = 2.06). Our study suggests significant increase of SPBC in both sexes in the United States. Elevated risk of SPBC exists in survivors with primary BC, female thyroid cancer, male leukemia, and API female cancer patients with primary genitourinary cancer. Our study is helpful in developing strategies for BC control and prevention on specific first primary cancer survivors with an elevated risk of SPBC.	[Cheng, Yao; Huang, Ziming] Huazhong Univ Sci & Technol, Tongji Med Coll, Maternal & Child Hlth Hosp Hubei Prov, Wuhan, Hubei, Peoples R China; [Liao, Qing; Yu, Xingchen; Jiang, Hongyu; He, Yangting; Yao, Shuang; Nie, Shaofa; Liu, Li] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat,Minist Educ,Key Lab Envi, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Nie, SF; Liu, L (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat,Minist Educ,Key Lab Envi, Wuhan, Hubei, Peoples R China.	liul2012@hust.edu.cn; sf_nie@hust.edu.cn						[Anonymous], 2009, SEER STAT DAT; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Auvinen A, 2002, J NATL CANCER I, V94, P1330; BERGFELDT K, 1995, ACTA ONCOL, V34, P771, DOI 10.3109/02841869509127185; Bevers TB, 2018, J NATL COMPR CANC NE, V16, P1362, DOI 10.6004/jnccn.2018.0083; Bluhm EC, 2008, BLOOD, V111, P4014, DOI 10.1182/blood-2007-08-106021; Borg A, 2000, J NATL CANCER I, V92, P1260, DOI 10.1093/jnci/92.15.1260; Caini S, 2014, J DERMATOL SCI, V75, P3, DOI 10.1016/j.jdermsci.2014.02.007; Clegg LX, 2009, CANCER CAUSE CONTROL, V20, P417, DOI 10.1007/s10552-008-9256-0; Daly MB, 2014, J NATL COMPR CANC NE, V12, P1326, DOI 10.6004/jnccn.2014.0127; Farr DE, 2017, ONCOLOGIST, V22, P895, DOI 10.1634/theoncologist.2016-0460; Gao YM, 2018, RADIOGRAPHICS, V38, P1289, DOI 10.1148/rg.2018180013; Hultborn R, 1997, ANTICANCER RES, V17, P4293; Hung YP, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001626; Joseph KR, 2015, BREAST CANCER RES TR, V152, P173, DOI 10.1007/s10549-015-3456-6; Keegan THM, 2017, JAMA ONCOL, V3, P1554, DOI 10.1001/jamaoncol.2017.0465; Kim HJ, 2008, J STAT COMPUT SIM, V78, P1087, DOI 10.1080/00949650701528461; Kwon WA, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4530-3; Lee KD, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1426-3; Lehtonen HJ, 2006, J MED GENET, V43, P523, DOI 10.1136/jmg.2005.036400; Levi F, 2008, INT J CANCER, V123, P2899, DOI 10.1002/ijc.23816; Lynch HT, 1999, CANCER-AM CANCER SOC, V86, P744, DOI 10.1002/(SICI)1097-0142(19990901)86:5<744::AID-CNCR4>3.3.CO;2-7; Manole D, 2001, J CLIN ENDOCR METAB, V86, P1072, DOI 10.1210/jc.86.3.1072; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Moskowitz CS, 2014, J CLIN ONCOL, V32, P2217, DOI 10.1200/JCO.2013.54.4601; MURAKAMI R, 1987, JPN J CLIN ONCOL, V17, P293; Murray KS, 2016, WORLD J UROL, V34, P1667, DOI 10.1007/s00345-016-1832-4; Nielsen SM, 2016, CANCER EPIDEM BIOMAR, V25, P231, DOI 10.1158/1055-9965.EPI-15-0833; Noone AM, 2018, SEER CANC STAT REV 1; Ricceri F, 2015, INT J CANCER, V137, P940, DOI 10.1002/ijc.29462; Sadler C, 2015, CANCER-AM CANCER SOC, V121, P1295, DOI 10.1002/cncr.29200; Saraiva PP, 2005, BRAZ J MED BIOL RES, V38, P761, DOI 10.1590/S0100-879X2005000500014; Satram-Hoang S, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1643; Shanmughapriya S, 2013, ONCOLOGY-BASEL, V84, P226, DOI 10.1159/000346593; Soerjomataram I, 2008, AM J EPIDEMIOL, V167, P1421, DOI 10.1093/aje/kwn077; Soerjomataram I, 2005, EUR J CANCER, V41, P2331, DOI 10.1016/j.ejca.2005.01.029; Spanogle JP, 2010, J AM ACAD DERMATOL, V62, P757, DOI 10.1016/j.jaad.2009.07.039; STEDMAN KE, 1980, ARCH SURG-CHICAGO, V115, P244; Utada M, 2014, CANCER SCI, V105, P890, DOI 10.1111/cas.12433; Wassberg C, 1999, INT J CANCER, V83, P314, DOI 10.1002/(SICI)1097-0215(19991029)83:3<314::AID-IJC5>3.0.CO;2-9	40	6	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0232800	10.1371/journal.pone.0232800	http://dx.doi.org/10.1371/journal.pone.0232800			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497148	gold, Green Published			2022-12-26	WOS:000542035200049
J	Shen, J; Guo, MJ; Wang, YG; Yuan, XY; Dong, SQ; Song, XE; Guo, PY				Shen, Jie; Guo, Meijun; Wang, Yuguo; Yuan, Xiangyang; Dong, Shuqi; Song, Xi-e; Guo, Pingyi			An investigation into the beneficial effects and molecular mechanisms of humic acid on foxtail millet under drought conditions	PLOS ONE			English	Article							SEQ ANALYSIS; RNA-SEQ; GROWTH; SOIL; YIELD; WHEAT; EDGER; WELL	The aim of this study was to determine the effects and underlying molecular mechanisms of humic acid (HA) on foxtail millet (Setaria italica Beauv.) under drought conditions. The rainless climate of the Shanxi Province (37 degrees 42'N, 112 degrees 58'E) in China provides a natural simulation of drought conditions. Two foxtail millet cultivars, Jingu21 and Zhangza10, were cultivated in Shanxi for two consecutive years (2017-2018) based on a split-plot design. Plant growth, grain quality, and mineral elements were analyzed in foxtail millet treated with HA (50, 100, 200, 300, and 400 mg L-1) and those treated with clear water. Transcriptome sequencing followed by bioinformatics analysis was performed on plants in the normal control (CK), drought treatment (D), and drought + HA treatment (DHA) groups. Results were verified using real-time quantitative PCR (RT-qPCR). HA at a concentration of 100-200 mg L-1 caused a significant increase in the yield of foxtail millet and had a positive effect on dry weight and root-shoot ratio. HA also significantly increased P, Fe, Cu, Zn, and Mg content in grains. Moreover, a total of 1098 and 409 differentially expressed genes (DEGs) were identified in group D vs. CK and D vs. DHA, respectively. A protein-protein interaction network and two modules were constructed based on DEGs (such as SETIT_016654mg) between groups D and DHA. These DEGs were mainly enriched in the metabolic pathway. In conclusion, HA (100 mg L-1) was found to promote the growth of foxtail millet under drought conditions. Furthermore, SETIT_016654mg may play a role in the effect of HA on foxtail millet via control of the metabolic pathway. This study lays the foundation for research into the molecular mechanisms that underlie the alleviating effects of HA on foxtail millet under drought conditions.	[Shen, Jie; Guo, Meijun; Wang, Yuguo; Yuan, Xiangyang; Dong, Shuqi; Song, Xi-e; Guo, Pingyi] Shanxi Agr Univ, Coll Agr, Dept Agron, Jinzhong, Shanxi, Peoples R China	Shanxi Agricultural University	Guo, PY (corresponding author), Shanxi Agr Univ, Coll Agr, Dept Agron, Jinzhong, Shanxi, Peoples R China.	pyguo126@126.com			Scientific and Technological Innovation Project of Colleges and Universities in Shanxi Province [201802056]; Program for the Technical System of National Foxtail Millet and Sorghum Industry in the 13th Five-Year [CARS-06-13.5-A28]; Key Scientific and Technological Project of Shanxi Province [2015-TN-09]; Key Innovation Team of "1331" Project from Shanxi Province	Scientific and Technological Innovation Project of Colleges and Universities in Shanxi Province; Program for the Technical System of National Foxtail Millet and Sorghum Industry in the 13th Five-Year; Key Scientific and Technological Project of Shanxi Province; Key Innovation Team of "1331" Project from Shanxi Province	This study was funded by Scientific and Technological Innovation Project of Colleges and Universities in Shanxi Province (grant number 201802056) to JS; Program for the Technical System of National Foxtail Millet and Sorghum Industry in the 13th Five-Year (grant number CARS-06-13.5-A28) to XY; Key Scientific and Technological Project of Shanxi Province (grant number 2015-TN-09) to PG; and the Key Innovation Team of "1331" Project from Shanxi Province to PG.	Alcazar R, 2006, PHYSIOL PLANTARUM, V128, P448, DOI 10.1111/j.1399-3054.2006.00780.x; Andrews S., 2015, BABRAHAM BIOINFORMAT; Atiyeh RM, 2002, BIORESOURCE TECHNOL, V84, P7, DOI 10.1016/S0960-8524(02)00017-2; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bandettini WP, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-83; Celik H, 2011, COMMUN SOIL SCI PLAN, V42, P29, DOI 10.1080/00103624.2011.528490; Cheng YQ, 2013, PLANT MOL BIOL REP, V31, P607, DOI 10.1007/s11105-012-0533-4; DAVID PP, 1994, J PLANT NUTR, V17, P173, DOI 10.1080/01904169409364717; El-Nemr M. A., 2012, Australian Journal of Basic and Applied Sciences, V6, P630; Fallahi HR, 2017, J CROP IMPROV, V31, P192, DOI 10.1080/15427528.2016.1269378; Fan GY, 2014, ACTA AGR BOREALI SIN, V01, P114; FOSTER SA, 1991, PHYSIOL PLANTARUM, V82, P185; Hseu YC, 2014, TOXICOL APPL PHARM, V274, P249, DOI 10.1016/j.taap.2013.11.002; Kalaichelvi K., 2006, AGRIC REV, V27, P276; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kersey PJ, 2018, NUCLEIC ACIDS RES, V46, pD802, DOI 10.1093/nar/gkx1011; Khan RU, 2018, J PLANT NUTR, V41, P453, DOI 10.1080/01904167.2017.1385807; Li H, 2015, IRRIG DRAIN, V64, P193, DOI 10.1002/ird.1901; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma YH, RUSSIAN J PLANT PHYS, V65, P278; Maji D, 2017, APPL SOIL ECOL, V110, P97, DOI 10.1016/j.apsoil.2016.10.008; Nandakumar R, 2015, ACTA AGRON HUNG, V52, P227; Nikolayeva O, 2014, METHODS MOL BIOL, V1150, P45, DOI 10.1007/978-1-4939-0512-6_3; Olaetxea M, 2015, PLANT PHYSIOL; Oliveros J.C., 2007, INTERACTIVE TOOL COM; Paradikovic N, 2011, J SCI FOOD AGR, V91, P2146, DOI 10.1002/jsfa.4431; Peng YF, 2011, 2011 INTERNATIONAL CONFERENCE ON APPLIED SOCIAL SCIENCE (ICASS 2011), VOL III, P116; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saruhan V, 2011, SCI RES ESSAYS, V6, P663; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stevenson FJ, 1982, SOIL SCI, V135, P129, DOI 10.1097/00010694-198302000-00014; TEBBE CC, 1993, APPL ENVIRON MICROB, V59, P2657, DOI 10.1128/AEM.59.8.2657-2665.1993; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsai KJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep35076; Vaccaro S, 2015, CHEM BIOL TECHNOL AG, V2, DOI 10.1186/s40538-015-0033-5; Wu JM, 2006, NUCLEIC ACIDS RES, V34, pW720, DOI 10.1093/nar/gkl167	37	4	4	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2020	15	6							e0234029	10.1371/journal.pone.0234029	http://dx.doi.org/10.1371/journal.pone.0234029			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MT4VF	32484836	gold, Green Published			2022-12-26	WOS:000554969700029
J	Fentaw, S; Abubeker, R; Asamene, N; Assefa, M; Bekele, Y; Tigabu, E				Fentaw, Surafel; Abubeker, Rajiha; Asamene, Negga; Assefa, Meseret; Bekele, Yonas; Tigabu, Eyasu			Antimicrobial susceptibility profile of Gonococcal isolates obtained from men presenting with urethral discharge in Addis Ababa, Ethiopia: Implications for national syndromic treatment guideline	PLOS ONE			English	Article							NEISSERIA-GONORRHOEAE; SOUTH-AFRICA; RESISTANCE	Background Neisseria gonorrhoeae (gonococcus) is the etiologic agent for the sexually transmitted Infection gonorrhea, a disease with a significant global public health impact. The treatment regimen for gonorrhea has been changed frequently over the past few decades due to the organism's propensity for developing antibiotic resistance. This study investigated antimicrobial susceptibility patterns of quinolones, third-generation cephalosporin, and other relevant antimicrobials found in N. gonorrhoeae isolated from men presenting with urethral discharge at selected healthcare facilities in Addis Ababa, Ethiopia, with the aim of revising the national treatment regimen based on the information generated from this study. Methods A total of 599 male patients presenting with urethral discharge were included in the current study. Urethral discharge specimens were cultured on Modified Thayer Marti ' n media and suspected gonococcal colonies were confirmed using Oxidase and Superoxol tests followed by identification through a commercial kit (API-NHR). Antimicrobial susceptibility testing was performed by the Kirby-Bauer disc diffusion method using ciprofloxacin (5 mu g), ceftriaxone (30 mu g), cefixime (5 mu g), cefoxitin (30 mu g), penicillin (10 mu g) and spectinomycin (100 mu g) on enriched GC agar. Minimum Inhibitory Concentration (MIC) was also carried out using concentration gradient strips (E-tests) of the same antimicrobial agents. Results The prevalence of gonococcal isolates in the current study was 69%. Out of the 361 gonococcal isolates, close to 68% were fluoroquinolone non-susceptible, with 60% resistant and 7% having an intermediate status. However, all tested isolates were susceptible to ceftriax-one. In addition, all of the isolates have shown reduced non-susceptibility to spectinomycin and cefoxitin. Conclusion The prevalence of gonococcal isolates in men presenting with urethral discharge at selected healthcare facilities in Addis Ababa, Ethiopia was found to be high. The high level of fluoroquinolone resistance observed in gonococcal isolates recovered in this study necessitates revision of the national syndromic treatment guideline.	[Fentaw, Surafel; Abubeker, Rajiha; Asamene, Negga; Assefa, Meseret; Tigabu, Eyasu] Ethiopian Publ Hlth Inst Ethiopia, Clin Bacteriol & Mycol, Addis Ababa, Ethiopia; [Bekele, Yonas] NCI, Ctr Canc Res, NIH, Bethesda, MD USA; [Tigabu, Eyasu] Ohio State Univ, Global One Hlth Initiat, Columbus, OH 43210 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Ohio; Ohio State University	Fentaw, S (corresponding author), Ethiopian Publ Hlth Inst Ethiopia, Clin Bacteriol & Mycol, Addis Ababa, Ethiopia.	sura4f@gmail.com	Bekele, Yonas/AAN-6710-2021		CDC Atlanta through PEPFAR 1045 Cooperation	CDC Atlanta through PEPFAR 1045 Cooperation	The fund was from CDC Atlanta through PEPFAR 1045 Cooperation agreement to Ethiopia. Specifically, the fund for STI ethological study to SF. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed VNS, 2017, INT J RES MED SCI, V5, P3960; Ali Seada, 2016, BMC Res Notes, V9, P439, DOI 10.1186/s13104-016-2247-4; [Anonymous], 2016, GUIDELINES TREATMENT; Apalata T, 2006, SEX TRANSM DIS, V6, P341; Araneta CMP, 2017, TROP MED INFECT DIS, V2, DOI 10.3390/tropicalmed2030045; Buder S, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2944-9; Cao V, 2008, SEX TRANSM DIS, V35, P941, DOI 10.1097/OLQ.0b013e31818318d8; Centers for Disease Control and Prevention, 2017, SEX TRANSM DIS SURV; Clinical and Laboratory Standards Institute, 2014, M39A4 CLSI; Cristillo AD, 2019, SEX TRANSM DIS, V46, pE18, DOI [10.1097/OLQ.0000000000000929, 10.1097/olq.0000000000000929]; De Jongh M, 2007, INT J STD AIDS, V18, P697, DOI 10.1258/095646207782193768; Duncan S, 2011, SEX TRANSM INFECT, V87, P231, DOI 10.1136/sti.2010.048777; Emily JW, 2017, EMERGING INFECT DI S; Federal Democratic Republic of Ethiopia Ministry of Health (MOH), 2006, NAT GUID MAN SEX TRA; Federal Democratic Republic of Ethiopia Ministry of Health (MOH), 2015, NAT GUID MAN SEX TRA; Yeshanew AG, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0376-3; Hailemariam M, 2013, ETHIOP J HEALTH SCI, V23, P10; HUGHES H, 2014, SEX TRANSM DIS, P41, DOI DOI 10.1136/STI.2010.048777; Kularatne R, 2018, ANTIBIOTICS-BASEL, V7, DOI 10.3390/antibiotics7030058; Kulkarni SV, 2018, J MED MICROBIOL, V67, P22, DOI 10.1099/jmm.0.000662; Lewis DA, 2008, SEX TRANSM INFECT, V84, P371, DOI 10.1136/sti.2008.029751; Mehta SD, 2011, ANTIMICROB AGENTS CH, V55, P3882, DOI 10.1128/AAC.00155-11; da Costa-Lourenco APR, 2017, BRAZ J MICROBIOL, V48, P617, DOI 10.1016/j.bjm.2017.06.001; Ranmini Kularatne, 2016, COMMUNICABLE DIS SUR, V14; Sarwal S, 2003, CAN MED ASSOC J, V168, P872; Tibebu M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-415; Unemo M, 2014, CLIN MICROBIOL REV, V27, P587, DOI 10.1128/CMR.00010-14; Wi T, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002344; Workowski KA, 2008, ANN INTERN MED, V148, P606, DOI 10.7326/0003-4819-148-8-200804150-00005; World Health Organization, 2006, SURV ANT RES NEISS G	30	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0233753	10.1371/journal.pone.0233753	http://dx.doi.org/10.1371/journal.pone.0233753			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MJ2AA	32479537	gold, Green Published			2022-12-26	WOS:000547893500025
J	Pan, YL; Sun, YL; Wang, YL; Mang, ZP				Pan, Yinlai; Sun, Yulong; Wang, Yilei; Mang, Ziping			Barcode sequence could be a good target for developing a species-specific anti-parasite agent based on CRISPR-Cas9	FASEB JOURNAL			English	Article						CRISPR-Cas9; Cryptocaryon irritans; DNA barcode; quantitative real-time PCR; species-specific anti-parasitic drug	CRYPTOCARYON-IRRITANS CILIOPHORA; ORANGE-SPOTTED GROUPER; RNA-GUIDED ENDONUCLEASE; EPINEPHELUS-COIOIDES; PROTECTIVE IMMUNITY; MOLECULAR-CLONING; PARASITE; CILIATE; LIFE; IMMUNIZATION	Parasitic infections are a severe issue in many regions of the world. We assume that if a chemical can destroy a DNA barcode sequence, then this chemical could be developed as a species-specific parasiticidal agent. To test this hypothesis, we designed sgRNAs that target the sequences of both a DNA barcode (ITS-2) and a control (5.8S rDNA) in Cryptocaryon irritans. In in vivo tests, we found that exposure to Cas9 mRNA mixed with sgRNAs was able to significantly reduce the hatching rate of tomont and the survival rate of theront. Quantitative Real-time PCR demonstrated that the DNAs of tomont and theront exposed to sgRNAs and Cas9 mRNA were significantly disrupted, no matter whether they were exposed to a single sgRNA or a mixture of two sgRNAs. DNA sequencing also suggested the test group that was exposed to a single sgRNA mixed with Cas9-induced mutation at sgRNA targeted fragments and the test group exposed to two sgRNAs combined with Cas9-induced deletion of large pieces. The findings and principles provided by this study contribute to the development of novel nucleic acid therapeutic drugs for cryptocaryoniasis and other parasitic diseases and provide insight into the development of species-specific parasiticidal agents.	[Pan, Yinlai; Sun, Yulong; Mang, Ziping] Fujian Agr & Forestry Univ, Coll Anim Sci, Fuzhou 350002, Fujian, Peoples R China; [Pan, Yinlai; Mang, Ziping] Fujian Agr & Forestry Univ, Inst Oceanol, Key Lab Marine Biotechnol Fujian Prov, Fuzhou, Peoples R China; [Sun, Yulong] Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Peoples R China; [Wang, Yilei] Jimei Univ, Coll Fisheries, Xiamen, Peoples R China; [Wang, Yilei; Mang, Ziping] State Key Lab Large Yellow Croaker Breeding, Ningde, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Jimei University	Mang, ZP (corresponding author), Fujian Agr & Forestry Univ, Coll Anim Sci, Fuzhou 350002, Fujian, Peoples R China.	zhangziping@hotmail.com			Major Projects of Industry-University Cooperation in Science and Technology of Department of Science and Technology of Fujian Province [2017N5002]; Municipal University (Institute) Science and Technology Cooperation Project of Fuzhou Science and Technology Bureau [2018-G-43]; Research Fund of State Key Laboratory of Large Yellow Croaker Breeding [LYC2018RS05]; Special Fund for Marine Economic Development of Fujian Province [ZHHY-2019-3]; 13th Five-year Plan on Fuzhou Marine Economic Innovation and Development Demonstration City Project [FZHJ17]	Major Projects of Industry-University Cooperation in Science and Technology of Department of Science and Technology of Fujian Province; Municipal University (Institute) Science and Technology Cooperation Project of Fuzhou Science and Technology Bureau; Research Fund of State Key Laboratory of Large Yellow Croaker Breeding; Special Fund for Marine Economic Development of Fujian Province; 13th Five-year Plan on Fuzhou Marine Economic Innovation and Development Demonstration City Project	This research was funded by Major Projects of Industry-University Cooperation in Science and Technology of Department of Science and Technology of Fujian Province (2017N5002), Municipal University (Institute) Science and Technology Cooperation Project of Fuzhou Science and Technology Bureau (2018-G-43), Research Fund of State Key Laboratory of Large Yellow Croaker Breeding (LYC2018RS05), Special Fund for Marine Economic Development of Fujian Province (ZHHY-2019-3), 13th Five-year Plan on Fuzhou Marine Economic Innovation and Development Demonstration City Project (FZHJ17).	Adams A, 2019, FISH SHELLFISH IMMUN, V90, P210, DOI 10.1016/j.fsi.2019.04.066; Agnew P, 2000, MICROBES INFECT, V2, P891, DOI 10.1016/S1286-4579(00)00389-0; [Anonymous], J MICROBIOL EXP, DOI DOI 10.1007/s00436-007-0766-6; [Anonymous], SUISANZOSHOKU; [Anonymous], 1937, SUISANGAKUKAI HO; [Anonymous], KAIYO MON; [Anonymous], DRUM CROAKER, DOI DOI 10.1126/science.1247997; Bai JS, 2008, PARASITOL RES, V102, P307, DOI 10.1007/s00436-007-0766-6; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beneke T, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170095; Bondad-Reantaso MG, 2005, VET PARASITOL, V132, P249, DOI 10.1016/j.vetpar.2005.07.005; BURGESS PJ, 1995, FISH SHELLFISH IMMUN, V5, P459, DOI 10.1006/fsim.1995.0043; COLORNI A, 1987, AQUACULTURE, V67, P236, DOI 10.1016/0044-8486(87)90041-X; Colorni Angelo, 1997, Aquarium Sciences and Conservation, V1, P217, DOI 10.1023/A:1018360323287; Crampton A, 2007, INFECT GENET EVOL, V7, P664, DOI 10.1016/j.meegid.2007.06.004; Crawford ED, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178163; Dalby B, 2004, METHODS, V33, P95, DOI 10.1016/j.ymeth.2003.11.023; Dan XM, 2013, FISH SHELLFISH IMMUN, V34, P885, DOI 10.1016/j.fsi.2012.12.011; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Dickerson HW, 2006, FISH DISEASES AND DISORDERS, VOL 1: PROTOZOAN AND METAZOAN INFECTIONS, 2ND EDITION, P116, DOI 10.1079/9780851990156.0116; Gang SS, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006675; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Geary TG, 2012, CURR OPIN INFECT DIS, V25, P709, DOI 10.1097/QCO.0b013e328359f04a; Good MF, 2004, IMMUNOL REV, V201, P254, DOI 10.1111/j.0105-2896.2004.00178.x; Goto T, 2015, AQUACULTURE, V435, P173, DOI 10.1016/j.aquaculture.2014.09.007; Hatanaka A, 2008, PARASITOLOGY, V135, P1043, DOI 10.1017/S0031182008004617; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hewitson JP, 2014, EXPERT REV VACCINES, V13, P473, DOI 10.1586/14760584.2014.893195; Hirazawa N, 2003, AQUACULTURE, V223, P1, DOI 10.1016/S0044-8486(03)00167-4; Hirazawa N, 2001, AQUACULTURE, V198, P219, DOI 10.1016/S0044-8486(01)00503-8; Hoang TTT, 2011, ENVIRON SCI POLLUT R, V18, P835, DOI 10.1007/s11356-011-0475-7; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huang XH, 2012, EXP PARASITOL, V130, P189, DOI 10.1016/j.exppara.2012.01.012; HUFF JA, 1981, AQUACULTURE, V22, P181, DOI 10.1016/0044-8486(81)90144-7; Isah MB, 2016, PARASITOLOGY, V143, P1219, DOI 10.1017/S0031182016000718; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kawano F, 2012, AQUACULTURE, V344, P35, DOI 10.1016/j.aquaculture.2012.02.028; Kawano F, 2012, AQUACULTURE, V330, P1, DOI 10.1016/j.aquaculture.2011.11.037; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Kress WJ, 2008, P NATL ACAD SCI USA, V105, P2761, DOI 10.1073/pnas.0800476105; Li YW, 2012, FISH SHELLFISH IMMUN, V32, P476, DOI 10.1016/j.fsi.2011.11.021; Li YW, 2011, FISH SHELLFISH IMMUN, V30, P1230, DOI 10.1016/j.fsi.2011.04.012; Luo XC, 2008, PARASITOL RES, V102, P1269, DOI 10.1007/s00436-008-0904-9; Luo XC, 2007, FISH SHELLFISH IMMUN, V22, P427, DOI 10.1016/j.fsi.2006.04.011; Ma R, 2017, PARASITOLOGY, V144, P720, DOI [10.1017/S0031182016002651, 10.1017/s0031182016002651]; MATTHEWS BF, 1993, J FISH DIS, V16, P339, DOI 10.1111/j.1365-2761.1993.tb00867.x; Minet C, 2018, INFECT GENET EVOL, V63, P326, DOI 10.1016/j.meegid.2018.02.030; Misumi I, 2012, PARASITOL RES, V110, P363, DOI 10.1007/s00436-011-2500-7; Misumi I, 2011, FISH SHELLFISH IMMUN, V30, P1152, DOI 10.1016/j.fsi.2011.03.004; Mo ZQ, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1919-1; Mo ZQ, 2015, FISH SHELLFISH IMMUN, V43, P142, DOI 10.1016/j.fsi.2014.12.023; Okazaki T, 2012, INT CONF EMERG TR, P253, DOI 10.1109/ICETET.2012.44; Peng D, 2015, MBIO, V6, DOI 10.1128/mBio.02097-14; Picon-Camacho SM, 2011, DIS AQUAT ORGAN, V94, P167, DOI 10.3354/dao02315; Priya TAJ, 2012, VACCINE, V30, P893, DOI 10.1016/j.vaccine.2011.11.102; Seng LeongTak, 2006, Aqua Culture Asia Pacific, V2, P14; Shen B, 2014, MBIO, V5, DOI 10.1128/mBio.01114-14; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/nmeth.2857, 10.1038/NMETH.2857]; Shrivastava R, 2019, MSPHERE, V4, DOI 10.1128/mSphere.00450-19; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Vinayak S, 2015, NATURE, V523, P477, DOI 10.1038/nature14651; Wang GX, 2009, AQUACULTURE, V297, P38, DOI 10.1016/j.aquaculture.2009.09.012; Watanabe Y, 2019, AQUACULTURE, V512, DOI 10.1016/j.aquaculture.2019.734311; WILKIE DW, 1969, CALIF FISH GAME, V55, P227; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Yambot AV, 2006, AQUACULTURE, V260, P1, DOI 10.1016/j.aquaculture.2006.05.055; YANG RZ, 1988, ECON BOT, V42, P376, DOI 10.1007/BF02860162; Yoshinaga T, 2001, FISH PATHOL, V36, P231, DOI 10.3147/jsfp.36.231; Yu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098282; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zheng J, 2015, INT J PARASITOL, V45, P141, DOI 10.1016/j.ijpara.2014.09.003	73	4	4	1	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9393	9404		10.1096/fj.202000118RR	http://dx.doi.org/10.1096/fj.202000118RR		MAY 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32474999				2022-12-26	WOS:000538126600001
J	Abskharon, R; Seidler, PM; Sawaya, MR; Cascio, D; Yang, TXP; Philipp, S; Williams, CK; Newell, KL; Ghetti, B; DeTure, MA; Dickson, DW; Vinters, HV; Felgner, PL; Nakajima, R; Glabe, CG; Eisenberg, DS				Abskharon, Romany; Seidler, Paul M.; Sawaya, Michael R.; Cascio, Duilio; Yang, Tianxiao P.; Philipp, Stephan; Williams, Christopher Kazu; Newell, Kathy L.; Ghetti, Bernardino; DeTure, Michael A.; Dickson, Dennis W.; Vinters, Harry V.; Felgner, Philip L.; Nakajima, Rie; Glabe, Charles G.; Eisenberg, David S.			Crystal structure of a conformational antibody that binds tau oligomers and inhibits pathological seeding by extracts from donors with Alzheimer's disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; tau; prion; inhibitor; fibril; protein structure; antibody; neurodegeneration; tauopathy; protein aggregation; neurodegenerative disease; oligomerization; Alzheimer disease; antibody engineering; protein crystallization; inhibitor; tau	IN-VITRO; PROTEIN; BETA; AGGREGATION; IDENTIFICATION; MECHANISM; DEMENTIA; SPINES; TRENDS	Soluble oligomers of aggregated tau accompany the accumulation of insoluble amyloid fibrils, a histological hallmark of Alzheimer disease (AD) and two dozen related neurodegenerative diseases. Both oligomers and fibrils seed the spread of Tau pathology, and by virtue of their low molecular weight and relative solubility, oligomers may be particularly pernicious seeds. Here, we report the formation ofin vitrotau oligomers formed by an ionic liquid (IL15). Using IL15-induced recombinant tau oligomers and a dot blot assay, we discovered a mAb (M204) that binds oligomeric tau, but not tau monomers or fibrils. M204 and an engineered single-chain variable fragment (scFv) inhibited seeding by IL15-induced tau oligomers and pathological extracts from donors with AD and chronic traumatic encephalopathy. This finding suggests that M204-scFv targets pathological structures that are formed by tau in neurodegenerative diseases. We found that M204-scFv itself partitions into oligomeric forms that inhibit seeding differently, and crystal structures of the M204-scFv monomer, dimer, and trimer revealed conformational differences that explain differences among these forms in binding and inhibition. The efficiency of M204-scFv antibodies to inhibit the seeding by brain tissue extracts from different donors with tauopathies varied among individuals, indicating the possible existence of distinct amyloid polymorphs. We propose that by binding to oligomers, which are hypothesized to be the earliest seeding-competent species, M204-scFv may have potential as an early-stage diagnostic for AD and tauopathies, and also could guide the development of promising therapeutic antibodies.	[Abskharon, Romany; Seidler, Paul M.; Sawaya, Michael R.; Cascio, Duilio; Yang, Tianxiao P.; Eisenberg, David S.] Univ Calif Los Angeles, Dept Chem & Biochem, UCLA DOE Inst, 405 Hilgard Ave, Los Angeles, CA 90024 USA; [Abskharon, Romany; Seidler, Paul M.; Sawaya, Michael R.; Cascio, Duilio; Yang, Tianxiao P.; Eisenberg, David S.] Univ Calif Los Angeles, Dept Biol Chem, UCLA DOE Inst, Los Angeles, CA 90024 USA; [Abskharon, Romany; Seidler, Paul M.; Sawaya, Michael R.; Cascio, Duilio; Yang, Tianxiao P.; Eisenberg, David S.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90024 USA; [Philipp, Stephan; Glabe, Charles G.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA; [Williams, Christopher Kazu; Vinters, Harry V.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Newell, Kathy L.; Ghetti, Bernardino] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [DeTure, Michael A.; Dickson, Dennis W.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Vinters, Harry V.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Felgner, Philip L.; Nakajima, Rie] Univ Calif Irvine, Dept Physiol & Biophys, Vaccine Res & Dev Ctr, Irvine, CA 92717 USA	United States Department of Energy (DOE); University of California System; University of California Los Angeles; United States Department of Energy (DOE); University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Irvine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Indiana University System; Indiana University Bloomington; Mayo Clinic; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Irvine	Eisenberg, DS (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, UCLA DOE Inst, 405 Hilgard Ave, Los Angeles, CA 90024 USA.; Eisenberg, DS (corresponding author), Univ Calif Los Angeles, Dept Biol Chem, UCLA DOE Inst, Los Angeles, CA 90024 USA.; Eisenberg, DS (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90024 USA.	david@mbi.ucla.edu		Sawaya, Michael/0000-0003-0874-9043; Yang, Tianxiao/0000-0002-4479-5154	NIA National Institutes of Health [1R01 AG029430, RF1 AG054022, RF1AG056507, PHS P30-AG010133]; NINDS, National Institutes of Health [1F32 NS095661]; BrightFocus Foundation [A2016588F]; Howard Hughes Medical Institute	NIA National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); BrightFocus Foundation(BrightFocus Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by Grants 1R01 AG029430 (to D. S. E.), RF1 AG054022 (to D. S. E.), RF1AG056507 (to C. G. G.), and PHS P30-AG010133 (to B. G.) from the NIA National Institutes of Health, Grant 1F32 NS095661 from the NINDS, National Institutes of Health (to P. M. S.), Grant A2016588F from the BrightFocus Foundation (to P. M. S.), and the Howard Hughes Medical Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abskharon RNN, 2014, J AM CHEM SOC, V136, P937, DOI 10.1021/ja407527p; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arai H, 2012, BBA-GEN SUBJECTS, V1820, P1908, DOI 10.1016/j.bbagen.2012.08.016; Arndt KM, 1998, BIOCHEMISTRY-US, V37, P12918, DOI 10.1021/bi9810407; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379; Brier MR, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2362; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Castillo-Carranza DL, 2014, J NEUROSCI, V34, P4260, DOI 10.1523/JNEUROSCI.3192-13.2014; Combs B, 2017, METHOD CELL BIOL, V141, P45, DOI 10.1016/bs.mcb.2017.06.005; Cova I, 2017, J NEUROL SCI, V379, P259, DOI 10.1016/j.jns.2017.06.030; d'Abramo C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135774; Day ES, 2012, BIOCHEMISTRY-US, V51, P9124, DOI 10.1021/bi301039t; Cardenas-Aguayo MD, 2014, ACS CHEM NEUROSCI, V5, P1178, DOI 10.1021/cn500148z; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fa M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19393; Falcon B, 2019, NATURE, V568, P420, DOI 10.1038/s41586-019-1026-5; Falcon B, 2018, NATURE, V561, P137, DOI 10.1038/s41586-018-0454-y; Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882; Gao YL, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.04.23; Ghetti B, 2015, NEUROPATH APPL NEURO, V41, P24, DOI 10.1111/nan.12213; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; Goedert M, 2017, ANNU REV NEUROSCI, V40, P189, DOI 10.1146/annurev-neuro-072116-031153; GRIFFITHS AD, 1993, EMBO J, V12, P725, DOI 10.1002/j.1460-2075.1993.tb05706.x; GUSTKE N, 1992, FEBS LETT, V307, P199, DOI 10.1016/0014-5793(92)80767-B; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hatami A, 2014, J BIOL CHEM, V289, P32131, DOI 10.1074/jbc.M114.594846; Jackson SJ, 2016, J NEUROSCI, V36, P762, DOI 10.1523/JNEUROSCI.3542-15.2016; James BD, 2012, JAMA-J AM MED ASSOC, V307, P1798, DOI 10.1001/jama.2012.3556; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karikari TK, 2019, ANAL BIOCHEM, V566, P67, DOI 10.1016/j.ab.2018.10.013; Kaufman SK, 2018, ACTA NEUROPATHOL, V136, P57, DOI 10.1007/s00401-018-1855-6; Kaufman SK, 2016, NEURON, V92, P796, DOI 10.1016/j.neuron.2016.09.055; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kayed R, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-57; Krotee P, 2018, J BIOL CHEM, V293, P2888, DOI 10.1074/jbc.M117.806109; Krotee P, 2017, ELIFE, V6, DOI 10.7554/eLife.19273; Lasagna-Reeves CA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00700; Lasagna-Reeves CA, 2012, FASEB J, V26, P1946, DOI 10.1096/fj.11-199851; Lasagna-Reeves CA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-39; Li Z, 2016, MABS-AUSTIN, V8, P113, DOI 10.1080/19420862.2015.1111497; Liu C, 2012, P NATL ACAD SCI USA, V109, P20913, DOI 10.1073/pnas.1218792109; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nelson AL, 2009, NAT BIOTECHNOL, V27, P331, DOI 10.1038/nbt0409-331; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Patterson KR, 2011, J BIOL CHEM, V286, P23063, DOI 10.1074/jbc.M111.237974; Saerens D, 2008, J MOL BIOL, V377, P478, DOI 10.1016/j.jmb.2008.01.022; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seidler PM, 2018, NAT CHEM, V10, P170, DOI [10.1038/nchem.2889, 10.1038/NCHEM.2889]; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Sievers SA, 2011, NATURE, V475, P96, DOI 10.1038/nature10154; Sutton KA, 2013, ACTA CRYSTALLOGR D, V69, P2381, DOI 10.1107/S0907444913022117; TABATON M, 1989, ANN NEUROL, V26, P771, DOI 10.1002/ana.410260614; Takekiyo Takahiro, 2018, Biophys Rev, V10, P853, DOI 10.1007/s12551-018-0421-8; Takekiyo T, 2013, J PHYS CHEM B, V117, P10142, DOI 10.1021/jp405834n; Usenovic M, 2015, J NEUROSCI, V35, P14234, DOI 10.1523/JNEUROSCI.1523-15.2015; Wang RZ, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00072; Weaver KD, 2012, PHYS CHEM CHEM PHYS, V14, P790, DOI 10.1039/c1cp22965f; Weik M, 2000, P NATL ACAD SCI USA, V97, P623, DOI 10.1073/pnas.97.2.623; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6; Zheng J, 2011, J AM CHEM SOC, V133, P3144, DOI 10.1021/ja110545h	64	7	7	6	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2020	295	31					10662	10676		10.1074/jbc.RA120.013638	http://dx.doi.org/10.1074/jbc.RA120.013638			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB3HM	32493775	hybrid, Green Published			2022-12-26	WOS:000560405600013
J	Bouza, AA; Philippe, JM; Edokobi, N; Pinsky, AM; Offord, J; Calhoun, JD; Lopez-Floran, M; Lopez-Santiago, LF; Jenkins, PM; Isom, LL				Bouza, Alexandra A.; Philippe, Julie M.; Edokobi, Nnamdi; Pinsky, Alexa M.; Offord, James; Calhoun, Jeffrey D.; Lopez-Floran, Mariana; Lopez-Santiago, Luis F.; Jenkins, Paul M.; Isom, Lori L.			Sodium channel?1 subunits are post-translationally modified by tyrosine phosphorylation,S-palmitoylation, and regulated intramembrane proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						voltage-gated sodium channels; post-translational modification (PTM); protein palmitoylation; ?-secretase 1 (BACE1); ?-secretase; intramembrane proteolysis; membrane trafficking; FYN proto-oncogene Src family tyrosine kinase; cell signaling; sodium channel	BETA-1 SUBUNITS; CELL-ADHESION; NEURONAL EXCITABILITY; NEURITE OUTGROWTH; BRUGADA-SYNDROME; MULTIPLE NAV1.5; SITE; EXPRESSION; BRAIN; PALMITOYLATION	Voltage-gated sodium channel (VGSC) ?1 subunits are multifunctional proteins that modulate the biophysical properties and cell-surface localization of VGSC ? subunits and participate in cell?cell and cell?matrix adhesion, all with important implications for intracellular signal transduction, cell migration, and differentiation. Human loss-of-function variants inSCN1B, the gene encoding the VGSC ?1 subunits, are linked to severe diseases with high risk for sudden death, including epileptic encephalopathy and cardiac arrhythmia. We showed previously that ?1 subunits are post-translationally modified by tyrosine phosphorylation. We also showed that ?1 subunits undergo regulated intramembrane proteolysis via the activity of ?-secretase 1 and ?-secretase, resulting in the generation of a soluble intracellular domain, ?1-ICD, which modulates transcription. Here, we report that ?1 subunits are phosphorylated by FYN kinase. Moreover, we show that ?1 subunits areS-palmitoylated. Substitution of a single residue in ?1, Cys-162, to alanine prevented palmitoylation, reduced the level of ?1 polypeptides at the plasma membrane, and reduced the extent of ?1-regulated intramembrane proteolysis, suggesting that the plasma membrane is the site of ?1 proteolytic processing. Treatment with the clathrin-mediated endocytosis inhibitor, Dyngo-4a, re-stored the plasma membrane association of ?1-p.C162A to WT levels. Despite these observations, palmitoylation-null ?1-p.C162A modulated sodium current and sorted to detergent-resistant membrane fractions normally. This is the first demonstration ofS-palmitoylation of a VGSC ? subunit, establishing precedence for this post-translational modification as a regulatory mechanism in this protein family.	[Bouza, Alexandra A.; Philippe, Julie M.; Edokobi, Nnamdi; Pinsky, Alexa M.; Offord, James; Calhoun, Jeffrey D.; Lopez-Floran, Mariana; Lopez-Santiago, Luis F.; Jenkins, Paul M.; Isom, Lori L.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Jenkins, Paul M.] Univ Michigan, Sch Med, Dept Psychiat, Ann Arbor, MI USA; [Isom, Lori L.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Isom, Lori L.] Univ Michigan, Dept Neurol, Med Sch, Ann Arbor, MI 48109 USA; [Calhoun, Jeffrey D.] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Northwestern University; Feinberg School of Medicine	Isom, LL (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA.; Isom, LL (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.; Isom, LL (corresponding author), Univ Michigan, Dept Neurol, Med Sch, Ann Arbor, MI 48109 USA.	lisom@umich.edu	Jenkins, Paul/C-9098-2015	Jenkins, Paul/0000-0002-4207-5823; Philippe, Julie/0000-0002-3517-4284; Isom, Lori/0000-0002-9479-6729; Pinsky, Alexa/0000-0001-8430-0171; Edokobi, Nnamdi/0000-0002-7253-2503	National Institutes of Health [T32-GM008322, T32-GM00776737, T32-HL125242, R37-NS076752, F31-HL144047]; Charles W. Edmunds Predoctoral Fellowship from the University of Michigan Department of Pharmacology	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles W. Edmunds Predoctoral Fellowship from the University of Michigan Department of Pharmacology	This work was supported by National Institutes of Health Grant R37-NS076752 (to L. L. I.) National Institutes of Health Grant F31-HL144047 (to A. A. B.). This work was also supported by National Institutes of Health Predoctoral Fellowships T32-GM008322 (to A. A. B.), T32-GM00776737 and T32-HL125242 (to N. E.), and T32-GM00776737 (to J. M. P.) and a Charles W. Edmunds Predoctoral Fellowship from the University of Michigan Department of Pharmacology (to J. M. P.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abriel H, 2010, J MOL CELL CARDIOL, V48, P2, DOI 10.1016/j.yjmcc.2009.08.025; Aeby A, 2019, ANN CLIN TRANSL NEUR, V6, P2354, DOI 10.1002/acn3.50921; BHARADWAJ M, 1995, J NEUROCHEM, V65, P1805; Bhattacharyya R, 2013, J NEUROSCI, V33, P11169, DOI 10.1523/JNEUROSCI.4704-12.2013; Bouza A. A., 2019, AES 2019 ANN M DAT; Bouza AA, 2018, HANDB EXP PHARMACOL, V246, P423, DOI 10.1007/164_2017_48; Brackenbury WJ, 2008, J NEUROSCI, V28, P3246, DOI 10.1523/JNEUROSCI.5446-07.2008; Brackenbury WJ, 2013, P NATL ACAD SCI USA, V110, P1089, DOI 10.1073/pnas.1208767110; Brackenbury WJ, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00053; Brackenbury WJ, 2010, P NATL ACAD SCI USA, V107, P2283, DOI 10.1073/pnas.0909434107; Brigidi GS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9200; Brigidi GS, 2014, NAT NEUROSCI, V17, P522, DOI 10.1038/nn.3657; Calhoun Jeffrey D, 2014, Handb Exp Pharmacol, V221, P51, DOI 10.1007/978-3-642-41588-3_4; Chen CL, 2004, J NEUROSCI, V24, P4030, DOI 10.1523/JNEUROSCI.4139-03.2004; Cole SL, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-22; Davis TH, 2004, J BIOL CHEM, V279, P51424, DOI 10.1074/jbc.M410830200; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Giri B, 2007, EUR J IMMUNOL, V37, P2104, DOI 10.1002/eji.200636680; Gray B, 2018, HEART RHYTHM, V15, P1051, DOI 10.1016/j.hrthm.2018.03.015; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Hull JM, 2018, NEUROPHARMACOLOGY, V132, P43, DOI 10.1016/j.neuropharm.2017.09.018; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; ISOM LL, 1995, CELL, V83, P433, DOI 10.1016/0092-8674(95)90121-3; Kim DY, 2005, J BIOL CHEM, V280, P23251, DOI 10.1074/jbc.M412938200; Kruger LC, 2016, J NEUROSCI, V36, P6213, DOI 10.1523/JNEUROSCI.0405-16.2016; Lemaillet G, 2003, J BIOL CHEM, V278, P27333, DOI 10.1074/jbc.M303327200; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Lin XM, 2015, J PHYSIOL-LONDON, V593, P1389, DOI 10.1113/jphysiol.2014.277699; Lopez-Santiago Luis F, 2007, J Mol Cell Cardiol, V43, P636, DOI 10.1016/j.yjmcc.2007.07.062; Malhotra JD, 2000, J BIOL CHEM, V275, P11383, DOI 10.1074/jbc.275.15.11383; Malhotra JD, 2004, J BIOL CHEM, V279, P40748, DOI 10.1074/jbc.M407243200; Malhotra JD, 2002, J BIOL CHEM, V277, P26681, DOI 10.1074/jbc.M202354200; Marionneau C, 2012, J NEUROSCI, V32, P5716, DOI 10.1523/JNEUROSCI.6450-11.2012; McEwen DP, 2004, J BIOL CHEM, V279, P16044, DOI 10.1074/jbc.M400856200; McEwen DP, 2004, J BIOL CHEM, V279, P52744, DOI 10.1074/jbc.M405990200; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; O'Malley HA, 2015, ANNU REV PHYSIOL, V77, P481, DOI 10.1146/annurev-physiol-021014-071846; Olesen MS, 2012, HEART RHYTHM, V9, P770, DOI 10.1016/j.hrthm.2011.12.005; Patino GA, 2011, J NEUROSCI, V31, P14577, DOI 10.1523/JNEUROSCI.0361-11.2011; Patino GA, 2009, J NEUROSCI, V29, P10764, DOI 10.1523/JNEUROSCI.2475-09.2009; Percher A, 2016, P NATL ACAD SCI USA, V113, P4302, DOI 10.1073/pnas.1602244113; Pischedda F, 2014, MOL CELL PROTEOMICS, V13, P733, DOI 10.1074/mcp.M113.031716; Reverter M, 2011, MOL BIOL CELL, V22, P4108, DOI 10.1091/mbc.E11-04-0332; Ricci MT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06470; SRINIVASAN Y, 1992, J BIOL CHEM, V267, P7483; Veeraraghavan R, 2018, ELIFE, V7, DOI 10.7554/eLife.37610; Wang J, 2018, INT J MOL MED, V41, P915, DOI 10.3892/ijmm.2017.3286; Wang J, 2017, MOL MED REP, V16, P719, DOI 10.3892/mmr.2017.6654; Watanabe H, 2008, J CLIN INVEST, V118, P2260, DOI [10.1172/JC133891, 10.1172/JCI33891]; Watanabe H, 2009, CIRC-ARRHYTHMIA ELEC, V2, P268, DOI 10.1161/CIRCEP.108.779181; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Xiao ZC, 1999, J BIOL CHEM, V274, P26511, DOI 10.1074/jbc.274.37.26511; Xing DG, 2014, ONCOL REP, V31, P2692, DOI 10.3892/or.2014.3143; Zhang ST, 2017, J NEUROSCI, V37, P6915, DOI 10.1523/JNEUROSCI.0340-17.2017	55	6	6	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2020	295	30					10380	10393		10.1074/jbc.RA120.013978	http://dx.doi.org/10.1074/jbc.RA120.013978			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MW0BV	32503841	hybrid, Green Published			2022-12-26	WOS:000556713400021
J	Das, S; Banerjee, A; Kamran, M; Ejazi, SA; Asad, M; Ali, N; Chakrabarti, S				Das, Sonali; Banerjee, Anindyajit; Kamran, Mohd; Ejazi, Sarfaraz Ahmad; Asad, Mohammad; Ali, Nahid; Chakrabarti, Saikat			A chemical inhibitor of heat shock protein 78 (HSP78) fromLeishmania donovanirepresents a potential antileishmanial drug candidate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Leishmania; transgenic parasite; molecular modeling; high-throughput virtual screening; heat shock protein 78 (HSP78); Ap5A; caseinolytic protease; kinase signaling; macrophage; innate immunity; drug screening	LEISHMANIA-DONOVANI INFECTION; NITRIC-OXIDE; CHAPERONE; TEMPERATURE; ACTIVATION; PATHOGEN; ANALOGS; TARGETS; IL-10; MODEL	The emergence of resistance to available antileishmanial drugs advocates identification of new drug targets and their inhibitors for visceral leishmaniasis. Here, we identifiedLeishmania donovaniheat shock protein 78 (LdHSP78), a putative caseinolytic protease, as important for parasite infection of host macrophages and a potential therapeutic target. Enrichment of LdHSP78 in infected humans, hamsters, and parasite amastigotes suggested its importance for disease persistence. Heterozygous knockouts ofL. donovaniHSP78 (LdHSP78+/?) andLeishmania mexicanaHSP78 (LmxHSP78+/?) were generated using a flanking UTR-based multifragment ligation strategy and the CRISPR-Cas9 technique, respectively to investigate the significance of HSP78 for disease manifestation. TheLdHSP78+/? parasite burden was dramatically reduced in both murine bone marrow-derived macrophages and hamsters, in association with enrichment of proinflammatory cytokines and NO. This finding implies thatLdHSP78+/? parasites cannot suppress immune activation and escape NO-mediated toxicity in macrophages. Furthermore, phosphorylation of the mitogen-activated protein kinase p38 was enhanced and phosphorylation of extracellular signal-regulated kinase 1/2 was decreased in cells infected withLdHSP78+/? parasites, compared with WT parasites. Virulence of theLdHSP78+/? strain was restored by episomal addition of theLdHSP78gene. Finally, using high-throughput virtual screening, we identifiedP(1),P-5-di(adenosine-5?)-pentaphosphate (Ap5A) ammonium salt as an LdHSP78 inhibitor. It selectively induced amastigote death at doses similar to amphotericin B doses, while exhibiting much less cytotoxicity to healthy macrophages than amphotericin B. In summary, using both a genetic knockout approach and pharmacological inhibition, we establish LdHSP78 as a drug target and Ap5A as a potential lead for improved antileishmanial agents.	[Das, Sonali; Kamran, Mohd; Ejazi, Sarfaraz Ahmad; Asad, Mohammad; Ali, Nahid] CSIR Indian Inst Chem Biol, Infect Dis & Immunol Div, Kolkata, W Bengal, India; [Banerjee, Anindyajit; Chakrabarti, Saikat] CSIR Indian Inst Chem Biol, Struct Biol & Bioinformat Div, Kolkata, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Ali, N (corresponding author), CSIR Indian Inst Chem Biol, Infect Dis & Immunol Div, Kolkata, W Bengal, India.; Chakrabarti, S (corresponding author), CSIR Indian Inst Chem Biol, Struct Biol & Bioinformat Div, Kolkata, W Bengal, India.	nali@iicb.res.in; saikat@iicb.res.in	Ejazi, Sarfaraz/AAS-8580-2021; KAMRAN, MOHD/ABF-8235-2021	Ejazi, Sarfaraz/0000-0001-7312-1549; KAMRAN, MOHD/0000-0001-9007-6735; Asad, Mohammad/0000-0003-3078-200X	CSIR Network Project [BSC-0114]; Systems Medicine Cluster Grant from the Department of Biotechnology [GAP357]; High-Risk High-Reward Grant from the Department of Science and Technology [HRR/2016/000093]; J. C. Bose National Fellowship; UK Research and Innovation via the Global Challenges Research Fund [MR/P027989/1]; MRC [MR/P027989/1] Funding Source: UKRI	CSIR Network Project(Council of Scientific & Industrial Research (CSIR) - India); Systems Medicine Cluster Grant from the Department of Biotechnology; High-Risk High-Reward Grant from the Department of Science and Technology; J. C. Bose National Fellowship; UK Research and Innovation via the Global Challenges Research Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	S. C. acknowledges CSIRIICB for infrastructure support, CSIR Network Project BSC-0114, Systems Medicine Cluster Grant GAP357 from the Department of Biotechnology, and High-Risk High-Reward Grant HRR/2016/000093 from the Department of Science and Technology for financial support. N. A. acknowledges the J. C. Bose National Fellowship and UK Research and Innovation via the Global Challenges Research Fund (Grant MR/P027989/1) for financial support.	Anderson CF, 2008, J IMMUNOL, V180, P4090, DOI 10.4049/jimmunol.180.6.4090; Ansari NA, 2011, J IMMUNOL, V186, P3977, DOI 10.4049/jimmunol.1003588; Asad M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00616; Bhattacharya P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024141; Bhattacharya P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004422; Callahan HL, 1996, EXP PARASITOL, V84, P400, DOI 10.1006/expr.1996.0128; Chandra D, 2008, CLIN EXP IMMUNOL, V154, P224, DOI 10.1111/j.1365-2249.2008.03741.x; Chio CC, 2004, CELL SIGNAL, V16, P565, DOI 10.1016/j.cellsig.2003.10.003; Crocker MJ, 2004, TRANSPORT RES REC, P16; Castro MD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005515; Dixon SL, 2006, CHEM BIOL DRUG DES, V67, P370, DOI 10.1111/j.1747-0285.2006.00384.x; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Goulhen F, 1998, INFECT IMMUN, V66, P5307, DOI 10.1128/IAI.66.11.5307-5313.1998; Hombach A, 2014, J CELL SCI, V127, P4762, DOI 10.1242/jcs.157297; Hombach A, 2013, CELL MICROBIOL, V15, P585, DOI 10.1111/cmi.12057; Hubel A, 1997, MOL CELL BIOL, V17, P5987; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Junghae M, 2002, INFECT IMMUN, V70, P5026, DOI 10.1128/IAI.70.9.5026-5035.2002; Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951; Krett NL, 2004, MOL CANCER THER, V3, P1411; Krobitsch S, 1999, CELL STRESS CHAPERON, V4, P191; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lecka J, 2013, J MED CHEM, V56, P8308, DOI 10.1021/jm400918s; Lee S, 2004, J STRUCT BIOL, V146, P99, DOI 10.1016/j.jsb.2003.11.016; LEONHARDT SA, 1993, MOL CELL BIOL, V13, P6304, DOI 10.1128/MCB.13.10.6304; Medina-Colorado AA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169496; Melby PC, 2001, J IMMUNOL, V166, P1912, DOI 10.4049/jimmunol.166.3.1912; Monkkonen H, 2008, ANTI-CANCER DRUG, V19, P391, DOI 10.1097/CAD.0b013e3282f632bf; Loria-Cervera EN, 2014, REV INST MED TROP SP, V56, P1, DOI 10.1590/S0036-46652014000100001; Neckers L, 2008, CELL HOST MICROBE, V4, P519, DOI 10.1016/j.chom.2008.10.011; Pallavi R, 2010, J BIOL CHEM, V285, P37964, DOI 10.1074/jbc.M110.155317; Ponte-Sucre A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006052; Saha S, 2007, J IMMUNOL, V179, P5592, DOI 10.4049/jimmunol.179.8.5592; Samsel M, 2011, PHARMACOL REP, V63, P601, DOI 10.1016/S1734-1140(11)70573-4; Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787; Singh OP, 2019, NANOMEDICINE-UK, V14, P1911, DOI 10.2217/nnm-2018-0448; Sosa EJ, 2018, NUCLEIC ACIDS RES, V46, pD413, DOI 10.1093/nar/gkx1015; Stempin CC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/683485; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Weibezahn J, 2003, J BIOL CHEM, V278, P32608, DOI 10.1074/jbc.M303653200; World Health Organization, 2020, LEISHMANIASIS; ZILBERSTEIN D, 1994, ANNU REV MICROBIOL, V48, P449, DOI 10.1146/annurev.mi.48.100194.002313	43	7	7	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2020	295	29					9934	9947		10.1074/jbc.RA120.014587	http://dx.doi.org/10.1074/jbc.RA120.014587			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MR1DY	32471865	hybrid, Green Published			2022-12-26	WOS:000553333300013
J	Al-Dahshan, A; Al-Kubiasi, N; Al-Zaidan, M; Saeed, W; Kehyayan, V; Bougmiza, I				Al-Dahshan, Ayman; Al-Kubiasi, Noora; Al-Zaidan, Manal; Saeed, Wael; Kehyayan, Vahe; Bougmiza, Iheb			Prevalence of polypharmacy and the association with non-communicable diseases in Qatari elderly patients attending primary healthcare centers: A cross-sectional study	PLOS ONE			English	Article							OLDER-ADULTS; DRUG-TREATMENT; RISK	Background Polypharmacy has become a global public health concern particularly in the elderly population. The elderly population is the most susceptible to the negative effects of polypharmacy due to their altered pharmacokinetics and decreased drug clearance. Therefore, polypharmacy can lead to poor health status and higher rates of morbidity and mortality. Objective The objective of this study was to determine the prevalence of polypharmacy (>= 5 drugs) and its association with non-communicable diseases (NCDs) in elderly (>= 65 years) Qatari patients attending Primary Healthcare (PHC) centers in Qatar. Methods A retrospective cross-sectional analysis was conducted using the Electronic Medical Record (EMR) database of all PHC centers in Qatar for six months (April-September 2017). Results Out of 5639 patients screened, 75.5% (95% CI: 74.3-76.6) were exposed to polypharmacy. Females were 1.18 times more likely to have polypharmacy compared to males (95% CI: 1.03-1.34). The multivariate analysis identified having hypertension (AOR 1.71; 95% CI: 1.38-2.13), diabetes (AOR 2.38; 95% CI: 1.97-2.87), dyslipidemia (AOR 1.29; 95% CI: 1.06-1.56), cardiovascular disease (AOR 1.56; 95% CI: 1.25-1.95) and asthma (AOR 1.39; 95% CI: 1.13-1.72) to be independent parameters associated with polypharmacy. Also, the Body Mass Index (BMI) and number of NCDs were found to be significant independent parameters associated with polypharmacy. Conclusions The prevalence of polypharmacy among Qatari elderly attending PHC Centers is very high. Our findings confirm the strong relationship between polypharmacy and BMI, and certain NCDs. Healthcare professionals should be educated about the magnitude of polypharmacy, its negative effects, and its associated factors. Best practice guidelines should be developed for improved medical practice in the prescription of medications for such a vulnerable population.	[Al-Dahshan, Ayman] Hamad Med Corp, Community Med Residency Program, Doha, Qatar; [Al-Kubiasi, Noora; Bougmiza, Iheb] Primary Hlth Care Corp, Community Med Residency Program, Doha, Qatar; [Al-Zaidan, Manal; Saeed, Wael] Primary Hlth Care Corp, Clin Affairs Dept, Doha, Qatar; [Kehyayan, Vahe] Univ Calgary Qatar, Doha, Qatar	Hamad Medical Corporation; Hamad Medical Corporation; Primary Health Care Corporation (PHCC); Hamad Medical Corporation; Primary Health Care Corporation (PHCC)	Al-Dahshan, A (corresponding author), Hamad Med Corp, Community Med Residency Program, Doha, Qatar.	Ayman.aldahshan@hotmail.com	al-dahshan, ayman/AAR-4635-2021	AL DAHSHAN, AYMAN/0000-0001-6132-3223				Al-Hashar Amna, 2016, Oman Med J, V31, P421, DOI 10.5001/omj.2016.85; Alsuwaidan A, 2019, GERIATRICS-BASEL, V4, DOI 10.3390/geriatrics4020036; Alwhaibi M, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020852; Badawy NA, 2020, MED PRIN PRACT, V29, P166, DOI 10.1159/000503298; Charlesworth CJ, 2015, J GERONTOL A-BIOL, V70, P989, DOI 10.1093/gerona/glv013; Cusack Barry J, 2004, Am J Geriatr Pharmacother, V2, P274, DOI 10.1016/j.amjopharm.2004.12.005; Frazier Susan C, 2005, J Gerontol Nurs, V31, P4; Fried TR, 2014, J AM GERIATR SOC, V62, P2261, DOI 10.1111/jgs.13153; Gnjidic D, 2012, CLIN PHARMACOL THER, V91, P521, DOI 10.1038/clpt.2011.258; Gomez C, 2015, GERONTOLOGY, V61, P301, DOI 10.1159/000365328; Hu T, 2017, CAN FAM PHYSICIAN, V63, P45; Hughes LD, 2012, AGE AGEING, V41, P24; Institute for Healthcare Improvement, 2020, MED REC PREV DRUG EV; Jyrkka J, 2009, DRUG AGING, V26, P493, DOI 10.2165/00002512-200926060-00006; Kann Inger Cathrine, 2015, Drugs Real World Outcomes, V2, P193; Kim HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098043; Maher RL, 2014, EXPERT OPIN DRUG SAF, V13, P57, DOI 10.1517/14740338.2013.827660; Carmona-Torres JM, 2018, J CLIN NURS, V27, P2942, DOI 10.1111/jocn.14371; Masnoon N, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0621-2; Ministry of Public Health, 2018, HLTH AG; Morin L, 2018, CLIN EPIDEMIOL, V10, P289, DOI 10.2147/CLEP.S153458; Pereira Karine Gonçalves, 2017, Rev. bras. epidemiol., V20, P335, DOI 10.1590/1980-5497201700020013; Primary Health Care Corporation, 2013, NAT PRIM HLTH CAR ST; Primary Health Care Corporation, 2018, HLTH CTR; Primary Health Care Corporation, 2019, CORP STRAT PLAN 2019; Rochon PA, 1997, BMJ-BRIT MED J, V315, P1096, DOI 10.1136/bmj.315.7115.1096; Salisbury C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X548929; Slabaugh SL, 2010, DRUG AGING, V27, P1019, DOI 10.2165/11584990-000000000-00000; Slater N, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020270; Syed Mohamed A, 2019, BMJ Nutr Prev Health, V2, P20, DOI 10.1136/bmjnph-2018-000014; Weng MC, 2013, QJM-INT J MED, V106, P1009, DOI 10.1093/qjmed/hct141; WHO, AN THER CHEM CLASS S; World Health Organization, 2018, AG HLTH; Wynne HA, 2010, MATURITAS, V66, P246, DOI 10.1016/j.maturitas.2010.03.004; Zidan A, 2018, PHARMACY-BASEL, V6, DOI 10.3390/pharmacy6030085; 2016, EUR HEART J, V50	36	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234386	10.1371/journal.pone.0234386	http://dx.doi.org/10.1371/journal.pone.0234386			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MA6QL	32525902	Green Published, gold			2022-12-26	WOS:000542036800091
J	Kim, Y; Barber, AV; Lee, S				Kim, Yunhwan; Barber, Ana Vivas; Lee, Sunmi			Modeling influenza transmission dynamics with media coverage data of the 2009 H1N1 outbreak in Korea	PLOS ONE			English	Article							EPIDEMIC MODEL; INFECTIOUS-DISEASES; INFORMATION; VACCINATION; BEHAVIOR	Recurrent outbreaks of the influenza virus continue to pose a serious health threat all over the world. The role of mass media becomes increasingly important in modeling infectious disease transmission dynamics since it can provide public health information that influences risk perception and health behaviors. Motivated by the recent 2009 H1N1 influenza pandemic outbreak in South Korea, a mathematical model has been developed. In this work, a previous influenza transmission model is modified by incorporating two distinct media effect terms in the transmission rate function; (1) a theory-based media effect term is defined as a function of the number of infected people and its rage of change and (2) a data-based media effect term employs the real-world media coverage data during the same period of the 2009 influenza outbreak. The transmission rate and the media parameters are estimated through the least-squares fitting of the influenza model with two media effect terms to the 2009 H1N1 cumulative number of confirmed cases. The impacts of media effect terms are investigated in terms of incidence and cumulative incidence. Our results highlight that the theory-based and data-based media effect terms have almost the same influence on the influenza dynamics under the parameters obtained in this study. Numerical simulations suggest that the media can have a positive influence on influenza dynamics; more media coverage leads to a reduced peak size and final epidemic size of influenza.	[Kim, Yunhwan] Hankuk Univ Foreign Studies, Div Media Commun, Seoul, South Korea; [Barber, Ana Vivas] Norfolk State Univ, Dept Math, Norfolk, VA USA; [Lee, Sunmi] Kyung Hee Univ, Dept Appl Math, Yongin, South Korea; [Lee, Sunmi] Kyung Hee Univ, Inst Nat Sci, Yongin, South Korea	Hankuk University Foreign Studies; Norfolk State University; Kyung Hee University; Kyung Hee University	Lee, S (corresponding author), Kyung Hee Univ, Dept Appl Math, Yongin, South Korea.; Lee, S (corresponding author), Kyung Hee Univ, Inst Nat Sci, Yongin, South Korea.	sunmilee@khu.ac.kr	Kim, Yunhwan/HDO-7627-2022; Kim, Yunhwan/AAP-5825-2021	Kim, Yunhwan/0000-0003-1138-6802; Kim, Yunhwan/0000-0003-1138-6802	National Research Foundation of Korea (NRF) - Korean government (MSIP) [NRF-2018R1A2B6007668]	National Research Foundation of Korea (NRF) - Korean government (MSIP)	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (NRF-2018R1A2B6007668).	[Anonymous], 2014, J Grad Med Educ, V6, P47, DOI 10.4300/JGME-06-01s1-03; [Anonymous], 2006, PLAST RECONSTR SURG, V117, p45S; Aster RC, 2019, PARAMETER ESTIMATION AND INVERSE PROBLEMS, 3RD EDITION; Bauch CT, 2013, SCIENCE, V342, P47, DOI 10.1126/science.1244492; Bauch CT, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002452; Brauer F., 2000, MATH MODELS POPULATI; Buonomo B, 2008, MATH BIOSCI, V216, P9, DOI 10.1016/j.mbs.2008.07.011; Chavent G, 2009, SCI COMPUT, P1; Conn AR., 2000, TRUST REGION METHODS, DOI [10.1137/1.9780898719857, DOI 10.1137/1.9780898719857]; Cui JA, 2008, ROCKY MT J MATH, V38, P1323, DOI 10.1216/RMJ-2008-38-5-1323; Cui JG, 2008, J DYN DIFFER EQU, V20, P31, DOI 10.1007/s10884-007-9075-0; d'Onofrio A, 2007, MATH MODEL NAT PHENO, V2, P26, DOI 10.1051/mmnp:2008009; d'Onofrio A, 2007, THEOR POPUL BIOL, V71, P301, DOI 10.1016/j.tpb.2007.01.001; Dantas E, 2018, APPL MATH COMPUT, V338, P249, DOI 10.1016/j.amc.2018.06.024; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Funk S, 2010, J THEOR BIOL, V264, P501, DOI 10.1016/j.jtbi.2010.02.032; Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142; Kiss IZ, 2010, MATH BIOSCI, V225, P1, DOI 10.1016/j.mbs.2009.11.009; Korea Centers for Disease Control & Prevention, 2010, INF DIS SURV YB 2010; Leung NHL, 2015, EPIDEMIOLOGY, V26, P862, DOI 10.1097/EDE.0000000000000340; Li YF, 2009, COMMUN NONLINEAR SCI, V14, P2353, DOI 10.1016/j.cnsns.2008.06.024; Liu R., 2007, COMP MATH MATH PHYS, V8, P153, DOI [10.1080/17486700701425870, DOI 10.1080/17486700701425870]; Misra AK, 2011, MATH COMPUT MODEL, V53, P1221, DOI 10.1016/j.mcm.2010.12.005; Mummert A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071692; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Sun CJ, 2011, MATH BIOSCI, V230, P87, DOI 10.1016/j.mbs.2011.01.005; Tchuenche J. M., 2012, ISRN BIOMATH, V2012, P1, DOI [10.5402/2012/581274, DOI 10.5402/2012/581274]; Tchuenche JM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S5; Xiao DM, 2007, MATH BIOSCI, V208, P419, DOI 10.1016/j.mbs.2006.09.025; Xiao YN, 2013, MATH BIOSCI ENG, V10, P445, DOI 10.3934/mbe.2013.10.445; Yaman F, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/976837; Yoo BK, 2010, HEALTH SERV RES, V45, P1287, DOI 10.1111/j.1475-6773.2010.01127.x	32	8	8	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0232580	10.1371/journal.pone.0232580	http://dx.doi.org/10.1371/journal.pone.0232580			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525907	gold, Green Published			2022-12-26	WOS:000542036800040
J	Quinlan, J; Subramanian, V; Yohay, J; Poziembo, B; Fatone, S				Quinlan, Julia; Subramanian, Vasanth; Yohay, Jessica; Poziembo, Brad; Fatone, Stefania			Using mechanical testing to assess texturing of prosthetic sockets to improve suspension in the transverse plane and reduce rotation	PLOS ONE			English	Article							TRANSTIBIAL AMPUTEES; GAIT; BIOMECHANICS; INTERFACE; MOMENTS; SYSTEMS	Creating a secure and comfortable linkage between the residual limb and prosthetic socket in persons with lower limb amputation is a critical factor for successful rehabilitation, including ambulation and other activities of daily living. Unwanted rotation within the socket can be a clinical problem for prosthesis users. One way of addressing issues experienced with transverse plane control of the socket may be through increased friction interface forces. It has been proposed that friction at the residual limb/socket interface may be increased by adding texture to interface components. Three-dimensional (3D) printing may be used to fabricate sockets with texture patterns added to the inner socket surface. Hence, the aim of this study was to investigate the effects of socket texturing on transverse plane rotation of the socket on a mock residual limb under two suspension conditions: passive suction and active vacuum. To conduct this study, we developed a mechanical testing protocol as no standardized tests currently exist to assess prosthetic sockets. Sockets with 14 different texture patterns were fabricated using the Squirt-Shape((TM))3D printer. Textured sockets were compared to an Original Squirt-Shape (OSS) socket and a smooth thermoformed socket. Sockets were fitted with a mock residual limb and bi-axially loaded to 350 N compression with simultaneous rotation (2.5 degrees, 5 degrees and 7.5 degrees) using a custom rotation assembly attached to a uniaxial hydraulic material testing system. There was a statistically significant three-way interaction between suspension, angle and texture (p < 0.0005). Torques between textured and reference sockets, for all rotation angles and both suspension conditions, were significantly different (p < 0.0005). Using newly developed testing protocols, it was demonstrated that some texture patterns significantly increased torque (i.e., resistance against unwanted rotation) in the transverse plane compared to both OSS and smooth sockets, especially for passive suction. Rotation testing of sockets may provide insight into socket design to improve suspension in the transverse plane.	[Quinlan, Julia; Subramanian, Vasanth; Yohay, Jessica; Fatone, Stefania] Northwestern Univ, Dept Phys Med & Rehabil, Prosthet Orthot Ctr, Chicago, IL 60611 USA; [Poziembo, Brad] Prosthet Design Inc, Dayton, OH USA	Northwestern University	Fatone, S (corresponding author), Northwestern Univ, Dept Phys Med & Rehabil, Prosthet Orthot Ctr, Chicago, IL 60611 USA.	s-fatone@northwestern.edu		Quinlan, Julia/0000-0001-9089-7322	Office of the Assistant Secretary for Health Affairs, through the Neuromusculoskeletal Injuries Research Award [W81XWH-16-1-0485]; DOD; National Institute on Disability, Independent Living and Rehabilitation Research of the U.S. Department of Health and Human Services, Administration for Community Living [90AR5010, 90AR5031]	Office of the Assistant Secretary for Health Affairs, through the Neuromusculoskeletal Injuries Research Award; DOD(United States Department of Defense); National Institute on Disability, Independent Living and Rehabilitation Research of the U.S. Department of Health and Human Services, Administration for Community Living	This work was supported by the Office of the Assistant Secretary for Health Affairs, through the Neuromusculoskeletal Injuries Research Award under Award No. W81XWH-16-1-0485. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense (DOD). Prosthetic Design Inc. were funded by the DOD as a collaborative partner on this study. As a collaborative partner they provided support in the form of research materials (primarily printing of sockets). Additional roles in this study included developing the texture patterns, validating 3D printing processes, and contributing to preparation of the manuscript. Brad Poziembo is an employee of Prosthetic Design Inc., the commercial manufacturer of the Squirt-ShapeT 3D Printer used in this study. The DOD award provided support in the form of salaries for authors SF, BP, JY, and VS, but the funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author JQ was supported on a training grant from National Institute on Disability, Independent Living and Rehabilitation Research of the U.S. Department of Health and Human Services, Administration for Community Living (grants 90AR5010 and 90AR5031). Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the U.S. Department of Health and Human Services. The specific roles of all authors are articulated in the 'author contributions' section.	Ali S, 2012, ARCH PHYS MED REHAB, V93, P1919, DOI 10.1016/j.apmr.2012.04.024; [Anonymous], 103282016 ISO; ASTM, D189414 ASTM; Cagle JC, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4035917; Caspers C, 2010, USA patent, Patent No. [US 8114167B2, 8114167]; Castellano J, 2011, THESIS; Chui K., 2019, ORTHOTICS PROSTHETIC; Covey S., 2000, JPO, V12, P15; Current TA, 1999, PROSTHET ORTHOT INT, V23, P113; Edwards WB, 2012, P I MECH ENG H, V226, P729, DOI 10.1177/0954411912452996; Eshraghi A, 2012, AM J PHYS MED REHAB, V91, P1028, DOI 10.1097/PHM.0b013e318269d82a; Flick KC, 2005, PROSTHET ORTHOT INT, V29, P73, DOI 10.1080/03093640500088120; Gerschutz MJ, 2012, J REHABIL RES DEV, V49, P405, DOI 10.1682/JRRD.2011.05.0091; Gholizadeh H, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-1; Graebner RH., 2009, JPO J PROSTHET ORTHO, V19, P67, DOI [DOI 10.1097/JP0.0B013E3180CFE8DA, 10.1097/JPO.0b013e3180cfe8da]; Hashimoto H, 2018, GAIT POSTURE, V65, P8, DOI 10.1016/j.gaitpost.2018.06.119; Heitzmann DWW, 2016, PROSTHET ORTHOT INT, V40, P558, DOI 10.1177/0309364615592698; Instron, M2115041EN INSTR, P1; Lamoureux L W, 1977, Prosthet Orthot Int, V1, P114; Legro MW, 1999, J REHABIL RES DEV, V36, P155; Lenz AL, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4040125; Lie W, 2011, WEAR, V271, P2804, DOI 10.1016/j.wear.2011.05.032; Lyon CC, 2000, J AM ACAD DERMATOL, V42, P501, DOI 10.1016/S0190-9622(00)90227-5; Mak AFT, 2001, J REHABIL RES DEV, V38, P161; McGrath MP, 2017, P I MECH ENG H, V231, P235, DOI 10.1177/0954411917690764; Meulenbelt HE, 2009, ARCH PHYS MED REHAB, V90, P74, DOI 10.1016/j.apmr.2008.07.015; Neo LD, 2000, PROSTHET ORTHOT INT, V24, P241, DOI 10.1080/03093640008726554; Neumann ES, 2014, PROSTHET ORTHOT INT, V38, P253, DOI 10.1177/0309364613497048; Pew C, 2019, J BIOMECH, V96, DOI 10.1016/j.jbiomech.2019.109330; Quinlan J, 2018, J PROSTHET ORHOT, V30, P39; Quinlan J, 2019, J PROSTHET ORTHOT, V31, P32; Richardson A, 2017, PROSTHET ORTHOT INT, V41, P6, DOI 10.1177/0309364616631343; Rovick J, 1992, 7 WORLD C INT SOC PR, P24; Rovick J, 1993, THESIS; Segal AD, 2011, GAIT POSTURE, V33, P41, DOI 10.1016/j.gaitpost.2010.09.021; Segal AD, 2009, J REHABIL RES DEV, V46, P375, DOI 10.1682/JRRD.2008.06.0070; Swiss Re Report, 2018, SIGMA, V3148, DOI DOI 10.2218/PIHPH.3.2018.2602; Templeton GF, 2011, COMMUN ASSOC INF SYS, V28, P41; Trotta T, 2013, United States patent, Patent No. [US 20130192741A1, 2013019274]; Twiste M, 2003, J REHABIL RES DEV, V40, P9, DOI 10.1682/JRRD.2003.01.0009; Van der Linden ML, 2002, PROSTHET ORTHOT INT, V26, P35, DOI 10.1080/03093640208726619; Ventura JD, 2011, GAIT POSTURE, V34, P307, DOI 10.1016/j.gaitpost.2011.05.014; Wernke MM, 2017, ADV WOUND CARE, V6, P233, DOI 10.1089/wound.2016.0719	43	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0233148	10.1371/journal.pone.0233148	http://dx.doi.org/10.1371/journal.pone.0233148			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MA6QL	32525868	Green Published, gold			2022-12-26	WOS:000542036800013
J	Rhea, S; Jones, K; Endres-Dighe, S; Munoz, B; Weber, DJ; Hilscher, R; MacFarquhar, J; Sickbert-Bennett, E; DiBiase, L; Marx, A; Rineer, J; Lewis, J; Bobashev, G				Rhea, Sarah; Jones, Kasey; Endres-Dighe, Stacy; Munoz, Breda; Weber, David J.; Hilscher, Rainer; MacFarquhar, Jennifer; Sickbert-Bennett, Emily; DiBiase, Lauren; Marx, Ashley; Rineer, James; Lewis, James; Bobashev, Georgiy		CDC MInD-Healthcare Network	Modeling inpatient and outpatient antibiotic stewardship interventions to reduce the burden ofClostridioides difficileinfection in a regional healthcare network	PLOS ONE			English	Article							INFECTIOUS-DISEASES SOCIETY; CLOSTRIDIUM-DIFFICILE; ANTIMICROBIAL USE; TRANSMISSION; EPIDEMIOLOGY; GUIDELINES; RISK; VALIDATION; CAMPAIGN; AMERICA	Antibiotic exposure can lead to unintended outcomes, including drug-drug interactions, adverse drug events, and healthcare-associated infections likeClostridioides difficileinfection (CDI). Improving antibiotic use is critical to reduce an individual's CDI risk. Antibiotic stewardship initiatives can reduce inappropriate antibiotic prescribing (e.g., unnecessary antibiotic prescribing, inappropriate antibiotic selection), impacting both hospital (healthcare)-onset (HO)-CDI and community-associated (CA)-CDI. Previous computational and mathematical modeling studies have demonstrated a reduction in CDI incidence associated with antibiotic stewardship initiatives in hospital settings. Although the impact of antibiotic stewardship initiatives in long-term care facilities (LTCFs), including nursing homes, and in outpatient settings have been documented, the effects of specific interventions on CDI incidence are not well understood. We examined the relative effectiveness of antibiotic stewardship interventions on CDI incidence using a geospatially explicit agent-based model of a regional healthcare network in North Carolina. We simulated reductions in unnecessary antibiotic prescribing and inappropriate antibiotic selection with intervention scenarios at individual and network healthcare facilities, including short-term acute care hospitals (STACHs), nursing homes, and outpatient locations. Modeled antibiotic prescription rates were calculated using patient-level data on antibiotic length of therapy for the 10 modeled network STACHs. By simulating a 30% reduction in antibiotics prescribed across all inpatient and outpatient locations, we found the greatest reductions on network CDI incidence among tested scenarios, namely a 17% decrease in HO-CDI incidence and 7% decrease in CA-CDI. Among intervention scenarios of reducing inappropriate antibiotic selection, we found a greater impact on network CDI incidence when modeling this reduction in nursing homes alone compared to the same intervention in STACHs alone. These results support the potential importance of LTCF and outpatient antibiotic stewardship efforts on network CDI burden and add to the evidence that a coordinated approach to antibiotic stewardship across multiple facilities, including inpatient and outpatient settings, within a regional healthcare network could be an effective strategy to reduce network CDI burden.	[Rhea, Sarah; Jones, Kasey; Endres-Dighe, Stacy; Munoz, Breda; Hilscher, Rainer; Rineer, James; Bobashev, Georgiy] RTI Int, Res Triangle Pk, NC 27709 USA; [Weber, David J.; Sickbert-Bennett, Emily; DiBiase, Lauren; Marx, Ashley] UNC Hlth Care, Chapel Hill, NC USA; [MacFarquhar, Jennifer; Lewis, James] North Carolina Dept Hlth & Human Serv, Raleigh, NC USA; [MacFarquhar, Jennifer] Ctr Dis Control & Prevent, Career Epidemiol Field Officer Program, Div State & Local Readiness, Ctr Preparedness & Response, Atlanta, GA USA; [Marx, Ashley] UNC Eshelman Sch Pharm, Chapel Hill, NC USA	Research Triangle Institute; Centers for Disease Control & Prevention - USA	Rhea, S (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	srhea@rti.org		Endres-Dighe, Stacy/0000-0002-4192-2234; Rineer, James/0000-0002-1398-5908; Rhea, Sarah/0000-0002-6183-1620; Jones, K/0000-0002-9154-9079; Hilscher, Rainer/0000-0002-5004-4584	Centers for Disease Control and Prevention (CDC) [U01CK000527]	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by Centers for Disease Control and Prevention (CDC) Cooperative Agreement number U01CK000527. The funder provided support in the form of salaries for authors (Sarah Rhea, Kasey Jones, Stacy Endres-Dighe, Breda Munoz, Rainer Hilscher, Lauren DiBiase, James Rineer, Georgiy Bobashev) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The conclusions, findings, and opinions expressed do not necessarily reflect the official position of the CDC.	American Hospital Association Health Research & Educational Trust, 2018, HRET HIIN MEAS MATT; Ashraf Muhammad Salman, 2016, N C Med J, V77, P346, DOI 10.18043/ncm.77.5.346; Bintz J, 2017, B MATH BIOL, V79, P36, DOI 10.1007/s11538-016-0224-7; Brown KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105454; Cecil G, 2017, PATIENT COUNTY RESID; Cecil G, 2017, SHORT TERM ACUTE CAR; Centers for Disease Control and Prevention, 2019, NAT HEALTHC SAF NETW; Centers for Disease Control and Prevention, 2017, NURS HOM ASS LIV LON; Centers for Disease Control and Prevention, HEALTHC ASS INF COMM; Centers for Disease Control and Prevention, 2013, ANT RES THREATS US; Centers for Disease Control and Prevention, 2019, NHSN STAND INF RAT S; Centers for Disease Control and Prevention, 2019, MULT RES ORG CLOSTR; Centers for Disease Control and Prevention, 2016, 2016 ANN REP; Centers for Disease Control and Prevention, 2018, ANT PRESCR US; Centers for Medicare & Medicaid Services, 2015, NURS HOM DAT COMP 20; Cohen AL, 2008, INFECT CONT HOSP EP, V29, P901, DOI 10.1086/591741; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Diazi M-A., 2009, Abstracts of the General Meeting of the American Society for Microbiology, V109; Dubberke ER, 2014, INFECT CONT HOSP EP, V35, P628, DOI [10.1086/676023, 10.1017/S0899823X00193857]; Dubberke ER, 2011, INFECT CONT HOSP EP, V32, P360, DOI 10.1086/658944; Durham DP, 2016, EMERG INFECT DIS, V22, P608, DOI 10.3201/eid2204.150455; Feazel LM, 2014, J ANTIMICROB CHEMOTH, V69, P1748, DOI 10.1093/jac/dku046; Fleming-Dutra KE, 2016, JAMA-J AM MED ASSOC, V315, P1864, DOI 10.1001/jama.2016.4151; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; Fridkin S, 2014, MMWR-MORBID MORTAL W, V63, P194; Hensgens MPM, 2012, J ANTIMICROB CHEMOTH, V67, P742, DOI 10.1093/jac/dkr508; Hersh AL, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2017-0027; Hicks LA, 2015, CLIN INFECT DIS, V60, P1308, DOI 10.1093/cid/civ076; Ingram PR, 2012, INTERN MED J, V42, P719, DOI 10.1111/j.1445-5994.2012.02809.x; Jones K, 2019, P 2019 WINT SIM C HL; Kahn JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139742; Kutty PK, 2010, EMERG INFECT DIS, V16, P197, DOI 10.3201/eid1602.090953; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Levin PD, 2012, J HOSP MED, V7, P672, DOI 10.1002/jhm.1964; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; McLure A, 2017, B MATH BIOL, V79, P2242, DOI 10.1007/s11538-017-0328-8; MedPac, 2016, REP C MED PAYM POL, P288; NC Communicable Disease Branch, 2016, HEALTHC ASS INF N CA; NC Department of Health and Human Services, 2015, N CAR HLTH STAT POCK; NC Department of Health and Human Services Division of Health Service Regulation, 2018, NURS HOM COUNT 2018; NC Department of Health and Human Services Division of Health Service Regulation, 2018, HOSP COUNT 2018; Or Nick H. K., 2017, POLICY STUD J, V45, pS67; Patel SJ, 2009, PEDIATR INFECT DIS J, V28, P1047, DOI 10.1097/INF.0b013e3181b12484; Rhea S, HLTH SECURITY; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; Rubin MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080671; Schwartz DN, 2011, INFECT CONT HOSP EP, V32, P472, DOI 10.1086/659760; Simmering JE, 2015, INFECT CONT HOSP EP, V36, P1031, DOI 10.1017/ice.2015.130; Slayton RB, 2015, MMWR-MORBID MORTAL W, V64, P826, DOI 10.15585/mmwr.mm6430a4; Slimings C, 2014, J ANTIMICROB CHEMOTH, V69, P881, DOI 10.1093/jac/dkt477; Society for Healthcare Epidemiology of America (SHEA), 2019, ANT STEW; Toth DJA, 2017, CLIN INFECT DIS, V65, P581, DOI 10.1093/cid/cix370; UNC Health Care, 2017, UNC HLTH CAR 2017 AN; US Census Bureau, B01001 TOT POP 2012; Vardakas KZ, 2016, INT J ANTIMICROB AG, V48, P1, DOI 10.1016/j.ijantimicag.2016.03.008	57	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234031	10.1371/journal.pone.0234031	http://dx.doi.org/10.1371/journal.pone.0234031			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525887	Green Published, gold			2022-12-26	WOS:000542036800023
J	Li, Y; Li, T; Tang, YJ; Zhan, ZY; Ding, LX; Song, LL; Yu, TT; Yang, Y; Ma, J; Zhang, YW; Zhou, Y; Gu, S; Xu, M; Gao, YJ; Li, YX				Li, Yang; Li, Ting; Tang, Yuejia; Zhan, Zhiyan; Ding, Lixia; Song, Lili; Yu, Tingting; Yang, Yi; Ma, Jing; Zhang, Yingwen; Zhou, Ying; Gu, Song; Xu, Min; Gao, Yijin; Li, Yanxin			The function of a heterozygous p53 mutation in a Li-Fraumeni syndrome patient	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; MOUSE MODEL; EXPRESSION; FIBROBLASTS; EFFICIENCY; GAIN	p53 is one of the most extensively studied proteins in cancer research. Mutations in p53 generally abolish normal p53 function, and some mutants can gain new oncogenic functions. However, the mechanisms underlying p53 mutation-driven cancer remains to be elucidated. Our study investigated the function of a heterozygous p53 mutation (p.Asn268Glufs*4) in a Li-Fraumeni syndrome (LFS) patient. We used episomal technology to perform somatic reprogramming, and used molecular and cell biology methods to determine the p53 mutation levels in patient-originated induced pluripotent stem (iPS) cells at the RNA and protein levels. We found that p53 protein expression was not increased in this patient's somatic cells compared with those of a healthy control. p53 mutation facilitates the proliferation of tumor cells by inhibiting apoptosis and promoting cell division. It can inhibit the efficiency of somatic reprogramming by inhibiting OCT4 expression during reprogramming stage. Moreover, not all p53 mutant iPS cell lines have mutant p53 RNA sequences. A small percentage of mutant p53 mRNA is present in the somatic cells from the patient and his mother. In summary, this p53 mutation can promote tumor cell proliferation, inhibit somatic reprogramming, and exhibit random p53 allelic expression of heterozygous mutations in the patient and iPS cells which may be one of the reasons why the people with p53 mutations develop cancer at random. This finding suggested that mutant p53 allelic expression should be added to the risk forecasting of cancer.	[Li, Yang; Li, Ting; Tang, Yuejia; Zhan, Zhiyan; Ding, Lixia; Song, Lili; Yang, Yi; Zhang, Yingwen; Gao, Yijin; Li, Yanxin] Shanghai Jiao Tong Univ, Shanghai Childrens Med Ctr, Key Lab Pediat Hematol & Oncol, Dept Hematol & Oncol,Minist Hlth,Sch Med, Shanghai, Peoples R China; [Yu, Tingting] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Mol Biol Diagnost Lab, Shanghai, Peoples R China; [Ma, Jing] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Pathol, Shanghai, Peoples R China; [Zhou, Ying] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Radiol, Shanghai, Peoples R China; [Gu, Song; Xu, Min] Shanghai Jiao Tong Univ, Shanghai Childrens Med Ctr, Sch Med, Dept Gen Surg,Surg Oncol Ctr, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Gao, YJ; Li, YX (corresponding author), Shanghai Jiao Tong Univ, Shanghai Childrens Med Ctr, Key Lab Pediat Hematol & Oncol, Dept Hematol & Oncol,Minist Hlth,Sch Med, Shanghai, Peoples R China.; Xu, M (corresponding author), Shanghai Jiao Tong Univ, Shanghai Childrens Med Ctr, Sch Med, Dept Gen Surg,Surg Oncol Ctr, Shanghai, Peoples R China.	liyanxin@scmc.com.cn; gaoyijin@scmc.com.cn; xumin@scmc.com.cn			National Key R&D Program of China [2018YFC1313000/2018YFC1313005 Y. L]; National Natural Science Foundation of China [81470315, 81972341]; Shanghai Jiao Tong University Medical Engineering Cross Fund [YG2017MS32]; Local High Level University Construction Project of Shanghai Jiao Tong University School of Medicine; Commission of Shanghai Municipality [17441903200, 17411950402]; Pudong New Area Science & Technology Development Fund [PKJ2018-Y47]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Jiao Tong University Medical Engineering Cross Fund; Local High Level University Construction Project of Shanghai Jiao Tong University School of Medicine; Commission of Shanghai Municipality; Pudong New Area Science & Technology Development Fund	This work was supported in part by the National Key R&D Program of China (2018YFC1313000/2018YFC1313005 Y. L and Y. G); the National Natural Science Foundation of China (No.81470315 and No. 81972341 to Y. L.); the Shanghai Jiao Tong University Medical Engineering Cross Fund (No. YG2017MS32); the Local High Level University Construction Project of Shanghai Jiao Tong University School of Medicine; the Commission of Shanghai Municipality (No. 17441903200 to S. G and No. 17411950402 to M. X.); and the Pudong New Area Science & Technology Development Fund (PKJ2018-Y47) to Y. L.	[Anonymous], 2012, REGEN MED S3, V7, pS14; [Anonymous], 2014, INT J LAW CONTEXT, V10, P98; Belmonte JCI, 2009, NAT REV GENET, V10, P878, DOI 10.1038/nrg2700; Bougeard G, 2015, J CLIN ONCOL, V33, P2345, DOI 10.1200/JCO.2014.59.5728; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; Chou BK, 2011, CELL RES, V21, P518, DOI 10.1038/cr.2011.12; CROSS SM, 1995, SCIENCE, V267, P1353, DOI 10.1126/science.7871434; Doyle B, 2010, J PATHOL, V222, P129, DOI 10.1002/path.2748; Dudley AC, 2008, BRIT J CANCER, V99, P118, DOI 10.1038/sj.bjc.6604465; Eckersiey-Maslin MA, 2014, TRENDS GENET, V30, P237, DOI 10.1016/j.tig.2014.03.003; Escamilla-Del-Arenal M, 2011, HUM GENET, V130, P307, DOI 10.1007/s00439-011-1029-2; EU, 2016, FAZ, P1, DOI DOI 10.5194/ACP16-150752016; Gendre AV, 2014, DEV CELL, V28, P366, DOI 10.1016/j.devcel.2014.01.016; Gong L, 2016, SCI REP-UK, V6, DOI 10.1038/srep37281; Gu HH, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0908-z; Hohenstein P, 2004, PLOS BIOL, V2, P165, DOI 10.1371/journal.pbio.0020040; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; IGGO R, 1990, LANCET, V335, P675, DOI 10.1016/0140-6736(90)90801-B; James LA, 1999, BRIT J CANCER, V81, P300, DOI 10.1038/sj.bjc.6990691; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Krizhanovsky V, 2009, NATURE, V460, P1085, DOI 10.1038/4601085a; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Li YX, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3174; Liu G, 2004, NAT GENET, V36, P63, DOI 10.1038/ng1282; Mack AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027956; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Martos SN, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.38; Michalak EM, 2008, CELL DEATH DIFFER, V15, P1019, DOI 10.1038/cdd.2008.16; MICHALOVITZ D, 1991, J CELL BIOCHEM, V45, P22, DOI 10.1002/jcb.240450108; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Takahashi K, 2006, NATURE PROTOCOLS, V51, P3081; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tang YJ, 2019, J PEDIAT HEMATOL ONC, V41, P399, DOI 10.1097/MPH.0000000000001205; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang HR, 2018, CELL REPROGRAM, V20, P27, DOI 10.1089/cell.2017.0031; Xue YZ, 2019, J PATHOL, V249, P274, DOI 10.1002/path.5328; Zhang J, 2011, NEW ENGL J MED, V373, P2336; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002; Zwemer LM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r10	44	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2020	15	6							e0234262	10.1371/journal.pone.0234262	http://dx.doi.org/10.1371/journal.pone.0234262			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ1GC	32516327	gold, Green Published			2022-12-26	WOS:000540977000037
J	Ghandour, LA; Anouti, S; Afifi, RA				Ghandour, Lilian A.; Anouti, Sirine; Afifi, Rima A.			The impact of DSM classification changes on the prevalence of alcohol use disorder and 'diagnostic orphans' in Lebanese college youth: Implications for epidemiological research, health practice, and policy	PLOS ONE			English	Article							SUBSTANCE USE DISORDERS; MENTAL-HEALTH; UNITED-STATES; DEPENDENCE CRITERIA; HAZARDOUS USE; YOUNG-ADULTS; ABUSE; IV; DRINKING; TOBACCO	Background Studies comparing prevalence of alcohol use disorder (AUD) using DSM-IV and DSM-5 diagnostic criteria in college students are limited. This study examines changes in AUD prevalence estimates using DSM-IV versus DSM-5 and characterizes the profile of DSM-5 "diagnostic orphans." Methods and findings A college student sample (n = 1,155; mean age: 21 +/- 1.97) selected conveniently from six large private and public universities in Greater Beirut, Lebanon completed an anonymous survey in May 2016. The study response rate was 83.1%. Data on DSM-IV and DSM-5 AUD criteria were gathered from 582 past-year drinkers, of which 377 (65%) were screened to have DSM-IV abuse/dependence, and 203 (35%) to have any DSM-5 AUD (58% mild, 21% moderate, and 21% severe). Overall percent agreement between measures was 68% (kappa = 0.41). One hundred and ninety-one students met one DSM-5 AUD criterion only (i.e. "diagnostic orphans," herein DOs), of which the majority (82%) endorsed "hazardous use." Compared to past-year drinkers with zero-endorsed DSM-5 criteria, DOs were more likely to be aged 21 or above [OR = 1.57(1.21-2.03)], less likely to perceive their socioeconomic status (SES) as poorer vs. same as others [OR = 0.17(0.07-0.43)], more likely to drink 1-2 times/week vs. <= 3 times per month [OR = 2.24(1.44-3.49)], and more likely to report past-year cigarette smoking [OR = 2.16(1.10-4.24)]. When compared to past-year drinkers with DSM-5 AUD, DOs were more likely to be pursuing a graduate or medical degree (vs. undergraduate degree) [2.06 (1.09-3.89)], and to be living with parents most of the time vs. not [OR = 2.68(1.14-6.31)]. DOs (versus drinkers with AUD) were less likely to drink at a high frequency (3-4 times /week or more vs.<= 3 times per month) [OR = 0.15(0.05-0.48)], and to report past-year waterpipe smoking [OR = 0.54(0.34-0.85)], but more likely to report past-year marijuana use [1.89(1.10-3.23)]. The findings are subject to recall bias and under-reporting and the study could not infer causality because temporality of associations cannot be established in a cross-sectional study design. Conclusions DSM-IV abuse/dependence prevalence rate was higher than DSM-5 AUD prevalence mainly due to the high percentage of students who engaged in "hazardous use". The DO screen might capture a young person in transition between non-drinking/occasional drinking to drinking frequently/developing an AUD. The prevention, identification, and management of DOs may be critical components of a national alcohol harm-reduction policy.	[Ghandour, Lilian A.; Anouti, Sirine] Amer Univ Beirut, Fac Hlth Sci, Dept Epidemiol & Populat Hlth, Beirut, Lebanon; [Afifi, Rima A.] Univ Iowa, Coll Publ Hlth, Dept Community & Behav Hlth, Iowa City, IA USA; [Afifi, Rima A.] Amer Univ Beirut, Fac Hlth Sci, Dept Hlth Promot & Community Hlth, Beirut, Lebanon	American University of Beirut; University of Iowa; American University of Beirut	Ghandour, LA (corresponding author), Amer Univ Beirut, Fac Hlth Sci, Dept Epidemiol & Populat Hlth, Beirut, Lebanon.	lg01@aub.edu.lb	Afifi, Rima/M-5615-2016	Afifi, Rima/0000-0003-3154-3617	International Development Research Centre, Canada [107201-001]	International Development Research Centre, Canada(CGIAR)	This study was supported by the International Development Research Centre (https://www.idrc.ca/en/funding), Canada [grant number 107201-001]. L.G received the funding award. The funding source had no involvement in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	Agrawal A, 2010, J STUD ALCOHOL DRUGS, V71, P857, DOI 10.15288/jsad.2010.71.857; Althouse AD, 2016, ANN THORAC SURG, V101, P1644, DOI 10.1016/j.athoracsur.2015.11.024; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Babor TF, 2008, ADDICTION, V103, P1057, DOI 10.1111/j.1360-0443.2008.02263.x; Babor TF, 2010, ADDICTION, V105, P769, DOI 10.1111/j.1360-0443.2010.02945.x; Baley JW, 2015, SUBST USE MISUSE, V50, P1747, DOI 10.3109/10826084.2015.1027923; Bartoli F, 2015, ADDICT BEHAV, V41, P46, DOI 10.1016/j.addbeh.2014.09.029; Billieux J, 2015, J BEHAV ADDICT, V4, P119, DOI 10.1556/2006.4.2015.009; BUKSTEIN OG, 1989, AM J PSYCHIAT, V146, P1131; Carney T, 2012, SUBST ABUSE TREAT PR, V7, DOI 10.1186/1747-597X-7-25; Casswell S, 2014, ALCOHOL CLIN EXP RES, V38, P1425, DOI 10.1111/acer.12359; Casswell S, 2012, ALCOHOL CLIN EXP RES, V36, P1462, DOI 10.1111/j.1530-0277.2012.01738.x; Casswell S, 2009, LANCET, V373, P2247, DOI 10.1016/S0140-6736(09)60745-5; Davoren MP, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006045; De Bruijn C, 2005, ALCOHOL ALCOHOLISM, V40, P441, DOI 10.1093/alcalc/agh183; DeWit DJ, 2000, AM J PSYCHIAT, V157, P745, DOI 10.1176/appi.ajp.157.5.745; Ehlke SJ, 2012, SUBST USE MISUSE, V47, P1073, DOI 10.3109/10826084.2012.676698; Erke A, 2009, ACCIDENT ANAL PREV, V41, P914, DOI 10.1016/j.aap.2009.05.005; Fong GT, 2006, TOB CONTROL, V15, P3, DOI 10.1136/tc.2005.015438; Francis JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140041; Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8; Ghandour L, 2016, INT J DRUG POLICY, V28, P10, DOI 10.1016/j.drugpo.2015.09.013; Ghandour L, 2015, SUBST USE MISUSE, V50, P1826, DOI 10.3109/10826084.2015.1073320; Gilbert PA, 2018, SUBST USE MISUSE, V53, P1239, DOI 10.1080/10826084.2017.1402057; Glantz MD, 2014, AM J ADDICTION, V23, P145, DOI 10.1111/j.1521-0391.2013.12082.x; Grant BF, 1997, J SUBST ABUSE, V9, P103, DOI 10.1016/S0899-3289(97)90009-2; Grant BF, 2017, JAMA PSYCHIAT, V74, P911, DOI 10.1001/jamapsychiatry.2017.2161; Griswold MG, 2018, LANCET, V392, P1015, DOI [10.1016/s0140-6736(18)31310-2, 10.1136/bmj.l94, 10.1016/S0140-6736(18)31310-2]; Gureje O, 2007, DRUG ALCOHOL DEPEN, V91, P1, DOI 10.1016/j.drugalcdep.2007.04.010; Hagman BT, 2018, ADDICT DISORD TREAT, V17, P1, DOI 10.1097/ADT.0000000000000116; Hagman BT, 2014, AM J ADDICTION, V23, P378, DOI 10.1111/j.1521-0391.2014.12120.x; Hagman BT, 2011, DRUG ALCOHOL DEPEN, V118, P202, DOI 10.1016/j.drugalcdep.2011.03.021; Harford TC, 2005, ALCOHOL CLIN EXP RES, V29, P810, DOI 10.1097/01.ALC.0000164381.67723.76; Harford TC, 2010, J STUD ALCOHOL DRUGS, V71, P410, DOI 10.15288/jsad.2010.71.410; Hasin D, 1998, DRUG ALCOHOL DEPEN, V50, P19, DOI 10.1016/S0376-8716(98)00007-6; Hingson R, 2017, J STUD ALCOHOL DRUGS, V78, P540, DOI 10.15288/jsad.2017.78.540; Hingson RW, 2006, ARCH PEDIAT ADOL MED, V160, P739, DOI 10.1001/archpedi.160.7.739; Jane-Llopis E, 2006, DRUG ALCOHOL REV, V25, P515, DOI 10.1080/09595230600944461; Jeanblanc J., 2015, CURRENT ADDICTION RE, V2, P293, DOI [10.1007/s40429-015-0076-5, DOI 10.1007/S40429-015-0076-5]; Johnston LD, 2019, MONITORING FUTURE NA, DOI DOI 10.3998/2027.42/148123; Keyes KM, 2008, ADDICTION, V103, P1120, DOI 10.1111/j.1360-0443.2008.02218.x; Knight JR, 2002, J STUD ALCOHOL, V63, P263, DOI 10.15288/jsa.2002.63.263; Lipari RN, 2013, DAY LIFE COLL STUDEN; Martin CS, 2011, J STUD ALCOHOL DRUGS, V72, P685, DOI 10.15288/jsad.2011.72.685; Martineau F, 2013, PREV MED, V57, P278, DOI 10.1016/j.ypmed.2013.06.019; McBride O, 2010, ADDICT BEHAV, V35, P586, DOI 10.1016/j.addbeh.2010.01.014; Mewton L, 2011, ALCOHOL ALCOHOLISM, V46, P185, DOI 10.1093/alcalc/agq091; Mohler-Kuo M, 2015, ADDICTION, V110, P429, DOI 10.1111/add.12800; Nakkash R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15092006; NIH, 2014, ALC US DIS COMP DSM; Patel V, 2007, ANN EPIDEMIOL, V17, pS87, DOI 10.1016/j.annepidem.2007.01.019; Pollock NK, 1999, AM J PSYCHIAT, V156, P897, DOI 10.1176/ajp.156.6.897; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; Richter L, 2017, AM J DRUG ALCOHOL AB, V43, P132, DOI 10.1080/00952990.2016.1193511; Schulenberg JE, 2017, MONITORING FUTURE NA, VII; Seo S, 2015, HEALTH POLICY, V119, P33, DOI 10.1016/j.healthpol.2014.10.016; Silveira CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108355; Slade T, 2016, ALCOHOL CLIN EXP RES, V40, P1728, DOI 10.1111/acer.13134; Slade T, 2013, ALCOHOL CLIN EXP RES, V37, P1001, DOI 10.1111/acer.12063; StataCorp L, 2013, STAT 13; Takahashi T, 2017, ADDICT SCI CLIN PRAC, V12, DOI 10.1186/s13722-017-0082-0; Weitzman ER, 2005, J EPIDEMIOL COMMUN H, V59, P1065, DOI 10.1136/jech.2005.033183	62	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0233657	10.1371/journal.pone.0233657	http://dx.doi.org/10.1371/journal.pone.0233657			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MA6QB	32502221	Green Published, gold			2022-12-26	WOS:000542035700059
J	Chatterjee, N; Nigam, P; Habib, B				Chatterjee, Nilanjan; Nigam, Parag; Habib, Bilal			Population density and habitat use of two sympatric small cats in a central Indian reserve	PLOS ONE			English	Article							RUSTY-SPOTTED CAT; ACTIVITY PATTERNS; SMALL CARNIVORES; TIGER RESERVE; FOREST; RECORDS; TADOBA	Despite appreciable advances in carnivore ecology, studies on small cats remain limited with carnivore research in India being skewed towards large cats. Small cats are more specialized than their larger cousins in terms of resource selection. Studies on small cat population and habitat preference are critical to evaluate their status to ensure better management and conservation. We estimated abundance of two widespread small cats, the jungle cat, and the rusty-spotted cat, and investigated their habitat associations based on camera trap captures from a central Indian tiger reserve. We predicted fine-scale habitat segregation between these sympatric species as a driver of coexistence. We used an extension of the spatial count model in a Bayesian framework approach to estimate the population density of jungle cat and rusty-spotted cat and used generalized linear models to explore their habitat associations. Densities of rusty-spotted cat and jungle cat were estimated as 6.67 (95% CI 4.07-10.74) and 4.01 (95% CI 2.65-6.12) individuals/100 km(2) respectively. Forest cover and evapotranspiration were positively associated with rusty-spotted cat occurrence whereas both factors had a significant negative relation with jungle cat occurrence. The results directed habitat segregation between these small cats with affinities of rusty-spotted cat and jungle cat towards well-forested and open scrubland areas respectively. Our estimates highlight the widespread applicability of this model for density estimation of species with no individual identification. Moreover, the study outcomes can aid in targeted management decisions and serve as the baseline for species conservation as these models allow robust population estimation of elusive species along with predicting their habitat preferences.	[Chatterjee, Nilanjan; Nigam, Parag; Habib, Bilal] Wildlife Inst India, Dehra Dun, Uttarakhand, India	Wildlife Institute of India	Habib, B (corresponding author), Wildlife Inst India, Dehra Dun, Uttarakhand, India.	bh@wii.gov.in	Chatterjee, Nilanjan/ABB-1234-2021	Chatterjee, Nilanjan/0000-0002-7932-0191; Habib, Bilal/0000-0003-0040-6214	Maharashtra Forest Department; National Tiger Conservation Authority	Maharashtra Forest Department; National Tiger Conservation Authority(Ministry of Environment, Forest and Climate Change (MoEFCC), Government of IndiaNational Tiger Conservation Authority, Government of India)	The project was jointly funded by Maharashtra Forest Department and National Tiger Conservation Authority to BH. The funders play no role in the study design, data collection, analysis and preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 2018, PLOS ONE, V13, P1, DOI DOI 10.3171/2018.1.JNS172645; Champion H., 1968, REVISED STUDY FOREST; Chandler RB, 2013, ANN APPL STAT, V7, P936, DOI 10.1214/12-AOAS610; Chen MT, 2009, MAMMALIA, V73, P20, DOI 10.1515/MAMM.2009.006; D'Cruze N, 2015, BIODIVERS CONSERV, V24, P3505, DOI 10.1007/s10531-015-1010-9; Davate Madhura, 2015, Cat News, V62, P22; Di Bitetti MS, 2008, J TROP ECOL, V24, P189, DOI 10.1017/S0266467408004847; Dickman AJ, 2015, CONSERV BIOL, V29, P854, DOI 10.1111/cobi.12494; Dillon A, 2007, ORYX, V41, P469, DOI 10.1017/S0030605307000518; Efford M, 2004, OIKOS, V106, P598, DOI 10.1111/j.0030-1299.2004.13043.x; Evans BE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217543; GARLAND T, 1983, AM NAT, V121, P571, DOI 10.1086/284084; Geweke J., 1992, BAYESIAN STAT, V4, P169, DOI DOI 10.21034/SR.148; Gray T.N.E., 2016, IUCN RED LIST THREAT; Habib B., 2015, STATUS TIGERS COPRED, P62; Hearn AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151046; Johnson A, 2009, ORYX, V43, P626, DOI 10.1017/S0030605309990238; Johnson WE, 2006, SCIENCE, V311, P73, DOI 10.1126/science.1122277; Kalle R, 2014, J TROP ECOL, V30, P469, DOI 10.1017/S0266467414000340; Kalle R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079295; Kendall WL, 1999, ECOLOGY, V80, P2517, DOI 10.1890/0012-9658(1999)080[2517:ROCCRM]2.0.CO;2; Khawarey K. N., 1997, MANAGEMENT PLAN TADO; Kitchener A.C., 2017, Cat News, P3; Kolowski JM, 2010, BIOL CONSERV, V143, P917, DOI 10.1016/j.biocon.2009.12.039; Lotze HK, 2009, TRENDS ECOL EVOL, V24, P254, DOI 10.1016/j.tree.2008.12.004; Macdonald David W., 2010, P471; Macdonald David W., 2010, P3; Majumder Aniruddha, 2011, Journal of Threatened Taxa, V3, P2221; Mali Sumant, 2015, Cat News, V62, P20; McClintock BT, 2009, BIOMETRICS, V65, P237, DOI 10.1111/j.1541-0420.2008.01047.x; Mohamed A, 2013, J MAMMAL, V94, P82, DOI 10.1644/11-MAMM-A-394.1; Mukherjee S., 2016, IUCN RED LIST THREAT; Nguyen MN, 2010, PLOS ONE, V5, pe9907; Nowell K., 1996, WILD CATS STATUS SUR; Paliwal A, 2014, J FORESTRY RES, V25, P185, DOI 10.1007/s11676-014-0444-3; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Rajaratnam R, 2007, J TROP ECOL, V23, P209, DOI 10.1017/S0266467406003841; Ramsey David S.L., 2015, Journal of Wildlife Management, V79, P491; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Roemer GW, 2009, BIOSCIENCE, V59, P165, DOI 10.1525/bio.2009.59.2.9; Singh P, 2017, J MAMMAL, V98, P1453, DOI 10.1093/jmammal/gyx104; Srivathsa A, 2015, J MAMMAL, V96, P742, DOI 10.1093/jmammal/gyv079; Weber W, 1996, CONSERV BIOL, V10, P1046, DOI 10.1046/j.1523-1739.1996.10041046.x	44	5	7	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0233569	10.1371/journal.pone.0233569	http://dx.doi.org/10.1371/journal.pone.0233569			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497053	gold, Green Published			2022-12-26	WOS:000542035200038
J	Milligan, MC; Berkeley, LI; McNew, LB				Milligan, Megan C.; Berkeley, Lorelle I.; McNew, Lance B.			Habitat selection of female sharp-tailed grouse in grasslands managed for livestock production	PLOS ONE			English	Article							GREATER SAGE-GROUSE; RANGELAND MANAGEMENT; RESOURCE SELECTION; HOME-RANGE; FUNCTIONAL-RESPONSES; COMMUNITY RESPONSE; NESTING ECOLOGY; PYRIC-HERBIVORY; PRAIRIE; HETEROGENEITY	Habitat selection links individual behavior to population abundance and dynamics, so evaluation of habitat selection is necessary for conservation and management. Land management can potentially alter both the structure and composition of habitats, thus influencing habitat selection and population size. Livestock grazing is the dominant land use worldwide and, while overstocking has been linked to the decline of many wildlife species, properly managed grazing could improve habitat quality and maintain native rangeland habitats. We evaluated breeding season habitat selection of female sharp-tailed grouse, an indicator species for grassland ecosystems, in relation to grazing management and landscape features in eastern Montana and western North Dakota. At broad spatial scales, females selected for multiple landscape features, including grassland, but exhibited no selection for either landscape or management variables when selecting habitat at smaller spatial scales. Females selected for pastures managed with rest-rotation grazing when choosing a home range, but selection did not equate to improved fitness. Moreover, we observed strong individual variation in both home range size and third-order habitat selection. While the high variability among individuals makes specific management recommendations difficult, selection for grassland habitats at broad scales suggests that strategies that maintain intact native rangelands are important for the conservation of sharp-tailed grouse.	[Milligan, Megan C.; McNew, Lance B.] Montana State Univ, Dept Anim & Range Sci, Bozeman, MT 59717 USA; [Berkeley, Lorelle I.] Montana Dept Fish Wildlife & Parks, Helena, MT USA	Montana State University System; Montana State University Bozeman	Milligan, MC (corresponding author), Montana State Univ, Dept Anim & Range Sci, Bozeman, MT 59717 USA.	megan.milligan11@gmail.com		Milligan, Megan/0000-0001-8466-7803	Federal Aid in Wildlife Restoration [W-161-R1]	Federal Aid in Wildlife Restoration	This research was supported by the general sale of hunting and fishing licenses in Montana and matching funds under Federal Aid in Wildlife Restoration grant W-161-R1 awarded to LIB and LBM.	Alkemade R, 2013, P NATL ACAD SCI USA, V110, P20900, DOI 10.1073/pnas.1011013108; Allen AM, 2014, EUR J WILDLIFE RES, V60, P411, DOI 10.1007/s10344-014-0797-0; [Anonymous], 2017, EUR GERIATR MED, V8, pS98; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Bergerud A.T., 1988, P473; Beyer HL, 2010, PHILOS T R SOC B, V365, P2245, DOI 10.1098/rstb.2010.0083; Boisvert JH, 2005, WEST N AM NATURALIST, V65, P36; Boyce MS, 2016, J ANIM ECOL, V85, P11, DOI 10.1111/1365-2656.12359; Boyd C.S., 2014, J RANGELAND APPL, V1, P58; Briske DD, 2008, RANGELAND ECOL MANAG, V61, P3, DOI 10.2111/06-159R.1; Burnham K.P, 2002, PRACTICAL INFORM THE; Christenson C. D., 1970, THESIS; Cope M. G., 1992, THESIS; Coppedge BR, 2008, BIOL CONSERV, V141, P1196, DOI 10.1016/j.biocon.2008.02.015; Curtin CG, 2002, ENVIRON SCI POLICY, V5, P55, DOI 10.1016/S1462-9011(02)00020-5; Dettenmaier SJ, 2017, ECOL EVOL, V7, P7620, DOI 10.1002/ece3.3287; Dinkins JB, 2014, CONDOR, V116, P629, DOI 10.1650/CONDOR-13-163.1; Engle DM, 2008, RANGELAND ECOL MANAG, V61, P55, DOI 10.2111/06-149R2.1; FLEISCHNER TL, 1994, CONSERV BIOL, V8, P629, DOI 10.1046/j.1523-1739.1994.08030629.x; Fong YY, 2010, BIOSTATISTICS, V11, P397, DOI 10.1093/biostatistics/kxp053; Frisina M.R., 1991, Rangelands, V13, P291; Fuhlendorf SD, 2010, RANGELAND ECOL MANAG, V63, P670, DOI 10.2111/REM-D-10-00044.1; Fuhlendorf SD, 2001, BIOSCIENCE, V51, P625, DOI 10.1641/0006-3568(2001)051[0625:RHOREM]2.0.CO;2; Gillies CS, 2006, J ANIM ECOL, V75, P887, DOI 10.1111/j.1365-2656.2006.01106.x; Goddard AD, 2009, CAN J ZOOL, V87, P326, DOI 10.1139/Z09-016; Hagen CA, 2011, STUD AVIAN BIOL, P63; Hagen CA, 2009, J WILDLIFE MANAGE, V73, P1325, DOI 10.2193/2008-225; Hebblewhite M, 2009, ECOLOGY, V90, P3445, DOI 10.1890/08-2090.1; Hillman C. N., 1973, SHARP TAILED GROUSE; Holechek J.L., 1999, RANGELANDS, V21, P12; Holloran MJ, 2010, J WILDLIFE MANAGE, V74, P65, DOI 10.2193/2008-291; Hormay A. L., 1970, PRINCIPLES REST ROTA; HORMAY AL, 1958, REST ROTATION GRAZIN; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Johnson MD, 2007, CONDOR, V109, P489, DOI 10.1650/8347.1; Jones J, 2001, AUK, V118, P557, DOI 10.1642/0004-8038(2001)118[0557:HSSIAE]2.0.CO;2; Kraft J.D., 2016, THESIS KANSAS STATE; Krausman Paul R., 2009, Rangelands, V31, P15; Laforge MP, 2016, LANDSCAPE ECOL, V31, P855, DOI 10.1007/s10980-015-0298-x; Laforge MP, 2015, ECOL MODEL, V305, P10, DOI 10.1016/j.ecolmodel.2015.03.003; LANDFIRE, 2013, EXIST VEG TYP LAY; Lautenbach JM, 2017, RANGELAND ECOL MANAG, V70, P78, DOI 10.1016/j.rama.2016.07.008; Leclerc M, 2014, OECOLOGIA, V176, P297, DOI 10.1007/s00442-014-3012-9; Limb RF, 2011, RANGELAND ECOL MANAG, V64, P659, DOI 10.2111/REM-D-10-00192.1; Lipsey MK, 2017, RANGELAND ECOL MANAG, V70, P331, DOI 10.1016/j.rama.2016.10.010; Manly B.F.J., 2002, RESOURCE SELECTION A; Manzer DL, 2004, THESIS; Marks JS, 1987, HABITAT SELECTION CO; Matthews TW, 2011, STUD AVIAN BIOL, P179; McDonald L., 2012, WILDLIFE TECHNIQUES, V1, P410; McGarigal K., 2012, TECH REP; McLoughlin PD, 2006, P ROY SOC B-BIOL SCI, V273, P1449, DOI 10.1098/rspb.2006.3486; McLoughlin PD, 2010, J ANIM ECOL, V79, P4, DOI 10.1111/j.1365-2656.2009.01613.x; Mcnew LB, 2015, RANGELAND ECOL MANAG, V68, P298, DOI 10.1016/j.rama.2015.03.009; Mcnew LB, 2013, J WILDLIFE MANAGE, V77, P791, DOI 10.1002/jwmg.493; Milligan MC, J WILDL MANAGE; Milligan MC, 2019, THESIS; Milligan MC, 2020, RANGELAND ECOL MANAG, V73, P128, DOI 10.1016/j.rama.2019.08.009; Montana Department of Fish Wildlife and Parks, 2011, UPL GAM BIRD ENH PRO; Montana UNRCS-, 1983, TECHN GUID R058AE001; Muff S, 2020, J ANIM ECOL, V89, P80, DOI 10.1111/1365-2656.13087; Mysterud A, 1998, ECOLOGY, V79, P1435, DOI 10.1890/0012-9658(1998)079[1435:FRIHUA]2.0.CO;2; Niemuth ND, 2003, WILDLIFE SOC B, V31, P145; Northrup JM, 2013, ECOLOGY, V94, P1456, DOI 10.1890/12-1688.1; Patten MA, 2011, STUD AVIAN BIOL, P51; Poiani KA, 2001, CONSERV BIOL, V15, P513, DOI 10.1046/j.1523-1739.2001.015002513.x; Reale D, 2010, PHILOS T R SOC B, V365, P3937, DOI 10.1098/rstb.2010.0222; Roersma S.J., 2001, THESIS; Ryan MR, 1998, AM MIDL NAT, V140, P111, DOI 10.1674/0003-0031(1998)140[0111:BEOGPC]2.0.CO;2; SAAB VA, 1992, GREAT BASIN NAT, V52, P166; Schieltz JM, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/11/113003; Seaman DE, 1999, J WILDLIFE MANAGE, V63, P739, DOI 10.2307/3802664; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sih A, 2012, ECOL LETT, V15, P278, DOI 10.1111/j.1461-0248.2011.01731.x; Sliwinski MS, 2018, ECOL SOC, V23, DOI [10.5751/es-10660-230445, 10.5751/ES-10660-230445]; Stonehouse KF, 2015, J WILDLIFE MANAGE, V79, P1308, DOI 10.1002/jwmg.990; Thomas DL, 2006, J WILDLIFE MANAGE, V70, P404, DOI 10.2193/0022-541X(2006)70[404:ABREDM]2.0.CO;2; Wang X, 2018, CH CRC COMP SCI DATA, P1, DOI 10.1201/9781351165761; Wiens JA, 1989, LANDSCAPE ECOL, V3, P87, DOI 10.1007/BF00131172; Winder VL, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00206.1; Winder VL, 2018, J WILDLIFE MANAGE, V82, P113, DOI 10.1002/jwmg.21331; Winder VL, 2017, RANGELAND ECOL MANAG, V70, P165, DOI 10.1016/j.rama.2016.08.004; Winder VL, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00536.1; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	84	3	3	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0233756	10.1371/journal.pone.0233756	http://dx.doi.org/10.1371/journal.pone.0233756			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497098	Green Published, gold			2022-12-26	WOS:000542035200018
J	Negesa, LB; Magarey, J; Rasmussen, P; Hendriks, JML				Negesa, Lemma B.; Magarey, Judy; Rasmussen, Philippa; Hendriks, Jeroen M. L.			Patients' knowledge on cardiovascular risk factors and associated lifestyle behaviour in Ethiopia in 2018: A cross-sectional study	PLOS ONE			English	Article							NONCOMMUNICABLE DISEASES; HEART-FAILURE; HEALTH; POPULATION; HYPERTENSION; PREVALENCE; AWARENESS; PERCEPTION; CARDIOLOGY	Background Cardiovascular disease (CVD) is posing a major public health challenge globally. Evidence reports significant gaps in knowledge of cardiovascular risk factors among patients with CVD. Despite the growing burden of cardiovascular disease in developing countries, there is limited data available to improve the awareness of this area, which is crucial for the implementation of prevention programs. Methods A cross-sectional survey was conducted in two referral hospitals in Eastern Ethiopia from June-September 2018. Outpatients with a confirmed diagnosis cardiovascular conditions were eligible for participation in the study. A convenience sampling technique was used. The primary outcome of the study was knowledge of cardiovascular risk factors among patients with cardiovascular disease. The knowledge of cardiovascular disease risk factors was measured using a validated instrument (heart disease fact questionnaire). A score less than 70% was defined as suboptimal knowledge. Multivariable linear regression was used to examine the relationship between knowledge of cardiovascular risk factors and explanatory variables. Results A total of 287 patients were enrolled in the study. Mean age was 47 +/- 11yrs and 56.4% of patients were females. More than half of patients (54%) had good knowledge on cardiovascular risk factors (scored>70%), whilst 46% demonstrated suboptimal knowledge levels in this area. Urban residency was associated with higher cardiovascular risk factors knowledge scores, whereas, never married and no formal education or lower education were identified as predictors of lower knowledge scores. There was no statistically significant association between knowledge of cardiovascular risk factors and actual cumulative risk behaviour. Conclusion Almost half of CVD patients in Ethiopia have suboptimal knowledge regarding cardiovascular risk factors. Residence, education level and marital status were associated with knowledge of cardiovascular risk factors. Implementation of innovative interventions and structured, nurse-led lifestyle counselling would be required to effectively guide patients in developing lifestyle modification and achieve sustainable behaviour change.	[Negesa, Lemma B.; Magarey, Judy; Rasmussen, Philippa] Univ Adelaide, Adelaide Nursing Sch, Adelaide, SA, Australia; [Negesa, Lemma B.] Haramaya Univ, Coll Hlth & Med Sci, Harar, Ethiopia; [Hendriks, Jeroen M. L.] Flinders Univ S Australia, Coll Nursing & Hlth Sci, Royal Adelaide Hosp, Adelaide, SA, Australia; [Hendriks, Jeroen M. L.] Ctr Heart Rhythm Disorders, Adelaide, SA, Australia; [Hendriks, Jeroen M. L.] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden	University of Adelaide; Haramaya University; Flinders University South Australia; Royal Adelaide Hospital; Linkoping University	Negesa, LB (corresponding author), Univ Adelaide, Adelaide Nursing Sch, Adelaide, SA, Australia.; Negesa, LB (corresponding author), Haramaya Univ, Coll Hlth & Med Sci, Harar, Ethiopia.	lemma.bulto@adelaide.edu.au	Hendriks, Jeroen/T-5329-2019; Hendriks, Jeroen/G-9538-2015	Hendriks, Jeroen/0000-0003-4326-9256; Hendriks, Jeroen/0000-0003-4326-9256; Negesa Bulto, Lemma/0000-0001-9528-5595	University of Adelaide	University of Adelaide	The study was supported by University of Adelaide.; The authors would like to thank the University of Adelaide for supporting this study. We are also grateful to the study participants, data collectors and health care workers who were directly or indirectly involved in this study. We are thankful to Suzzane Edwards for her statistical advice.	Aaby A, 2017, EUR J PREV CARDIOL, V24, P1880, DOI 10.1177/2047487317729538; Abed MA, 2015, HEART LUNG, V44, P183, DOI 10.1016/j.hrtlng.2015.02.008; Akintunde Adeseye Abiodun, 2015, Niger Med J, V56, P91, DOI 10.4103/0300-1652.150688; Alzaman N, 2013, SOUTH MED J, V106, P606, DOI 10.1097/SMJ.0000000000000013; Aminde LN, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4477-3; Andhuvan G, 2017, ASIAN J PHARM CLIN R, V10, P99, DOI [10.22159/ajpcr.2017.v10i1.14180, DOI 10.22159/AJPCR.2017.V10I1.14180]; Andrus B, 2014, J AM COLL CARDIOL, V63, P2886, DOI 10.1016/j.jacc.2014.02.606; [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; [Anonymous], 2010, NEW YORK TIMES 1007, VZ, P1; Baruth M, 2012, HEALTH EDUC J, V71, P565, DOI 10.1177/0017896911411761; Bloch MJ, 2016, J AM SOC HYPERTENS, V10, P753, DOI 10.1016/j.jash.2016.08.006; Bloomfield GS, 2013, HEART, V99, P1323, DOI 10.1136/heartjnl-2013-303913; Boateng D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189264; Booth M, 2000, Res Q Exerc Sport, V71 Suppl 2, P114, DOI 10.1080/02701367.2000.11082794; Buda Eyasu Siyum, 2017, Clin Hypertens, V23, P26, DOI 10.1186/s40885-017-0081-1; Burger A, 2016, HEALTH SA GESONDHEID, V21, DOI 10.1016/j.hsag.2016.07.003; Chinju G, 2014, INDIAN J PHARM PRACT, V7, P2; Cohen DL, 2014, J CLIN HYPERTENS, V16, P624, DOI 10.1111/jch.12384; De Smedt D, 2014, EUR J PREV CARDIOL, V21, P796, DOI 10.1177/2047487312473846; Elzawy M., 2017, J EGYPTIAN MATH SOC, V25, P53, DOI DOI 10.1016/J.JOEMS.2016.04.008; Glanz K, HLTH BELIEF MODEL HL, P1997; Glanz K, 2010, ANNU REV PUBL HEALTH, V31, P399, DOI 10.1146/annurev.publhealth.012809.103604; Gonzalez B, 2014, EUR J CARDIOVASC NUR, V13, P459, DOI 10.1177/1474515113510810; Haregu TN, 2015, GLOBAL HEALTH ACTION, V8, P1, DOI 10.3402/gha.v8.28697; Harting J, 2006, EUR J CARDIOV PREV R, V13, P214, DOI 10.1097/01.hjr.0000194416.39508.e9; Hos CJ, 2015, J LOSS PREVENT PROC, V36, P1, DOI 10.1016/j.jlp.2015.04.011; Ike SO, 2010, T ROY SOC TROP MED H, V104, P55, DOI 10.1016/j.trstmh.2009.07.029; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Khan Muhammad S, 2006, BMC Cardiovasc Disord, V6, P18, DOI 10.1186/1471-2261-6-18; Kirchhof P, 2017, REV ESPANOLA CARDIOL, V70, P50, DOI [10.1016/j.rec.2016, DOI 10.1016/J.REC.2016.11.033]; Leuner CJ, 2018, EUR HEART J, V39, P2699, DOI 10.1093/eurheartj/ehy373; Leuner CJ, 2018, EUR HEART J, V39, P1666, DOI 10.1093/eurheartj/ehy198; Saffi MAL, 2014, EUR J CARDIOVASC NUR, V13, P436, DOI 10.1177/1474515113505396; Manfredini R, 2017, J WOMENS HEALTH, V26, P624, DOI 10.1089/jwh.2016.6103; Minicuci N, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.21292; Misganaw A, 2017, POPUL HEALTH METR, V15, DOI 10.1186/s12963-017-0145-1; Mondo CK, 2013, CARDIOVASC J AFR, V24, P52, DOI 10.5830/CVJA-2012-081; Negesa LB, 2019, EUR J CARDIOVASC NUR, V18, P679, DOI 10.1177/1474515119861772; Oluyombo R, 2016, CARDIOVASC J AFR, V27, P322, DOI 10.5830/CVJA-2016-024; Perumareddi P, 2019, PRIMARY CARE, V46, P27, DOI 10.1016/j.pop.2018.10.005; Pi KJ, 2010, KOREAN J REMOTE SENS, V26, P537; Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052; Surka S, 2015, AFR J PRIM HEALTH CA, V7, DOI 10.4102/phcfm.v7i1.891; Tchicaya A, 2018, EUR J CARDIOVASC NUR, V17, P136, DOI 10.1177/1474515117720789; Tibebu A, 2017, PATIENT PREFER ADHER, V11, P323, DOI 10.2147/PPA.S126382; Tran DMT, 2017, J AM COLL HEALTH, V65, P158, DOI 10.1080/07448481.2016.1266638; Tsega TA, 2018, J CARDIOVASC MED, V19, P91, DOI 10.2459/JCM.0000000000000617; Twagirumukiza M, 2011, J HYPERTENS, V29, P1243, DOI 10.1097/HJH.0b013e328346995d; Wagner J, 2005, PATIENT EDUC COUNS, V58, P82, DOI 10.1016/j.pec.2004.07.004; World Health Organisation, 2017, STEPS SURV MAN, P260; Yeates K, 2015, CAN J CARDIOL, V31, P1081, DOI 10.1016/j.cjca.2015.06.035; Zuhaid Muhammad, 2014, J Ayub Med Coll Abbottabad, V26, P364	52	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0234198	10.1371/journal.pone.0234198	http://dx.doi.org/10.1371/journal.pone.0234198			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MA6PX	32497079	Green Published, gold			2022-12-26	WOS:000542035200055
J	Rosen, E; Kryndushkin, D; Aryal, B; Gonzalez, Y; Chehab, L; Dickey, J; Rao, VA				Rosen, Elliot; Kryndushkin, Dmitry; Aryal, Baikuntha; Gonzalez, Yanira; Chehab, Leena; Dickey, Jennifer; Rao, V. Ashutosh			Acute total body ionizing gamma radiation induces long-term adverse effects and immediate changes in cardiac protein oxidative carbonylation in the rat	PLOS ONE			English	Article							TROPONIN-T; HEART-DISEASE; MECHANISM; IDENTIFICATION; DEGRADATION; IRRADIATION; DOXORUBICIN; DAMAGE; SERUM	Radiation-induced heart disease presents a significant challenge in the event of an accidental radiation exposure as well as to cancer patients who receive acute doses of irradiation as part of radiation therapy. We utilized the spontaneously hypertensive Wistar-Kyoto rat model, previously shown to demonstrate drug-induced cardiomyopathy, to evaluate the acute and long-term effects of sub-lethal total body gamma irradiation at two, four, and fifty-two weeks. We further examined irreversible oxidative protein carbonylation in the heart immediately following irradiation in the normotensive Wistar-Kyoto rat. Both males and females sustained weight loss and anemic conditions compared to untreated controls over a one-year period as reflected by reduced body weight and low red blood cell count. Increased inflammation was detected by elevated IL-6 serum levels selectively in males at four weeks. Serum cardiac troponin T and I analyses revealed signs of cardiomyopathy at earlier timepoints, but high variability was observed, especially at one year. Echocardiography at two weeks following 5.0Gy treatment revealed a significant decrease in cardiac output in females and a significant decrease in both diastolic and systolic volumes in males. Following 10.0Gy irradiation in the normotensive Wistar-Kyoto rat, the heart tissue showed an increase in total protein oxidative carbonylation accompanied by DNA damage indicated by an increase in gamma-H2AX. Using proteomic analyses, we identified several novel proteins which showed a marked difference in carbonylation including those of mitochondrial origin and most notably, cardiac troponin T, one of the key proteins involved in cardiomyocyte contractility. Overall, we present findings of acute oxidative protein damage, DNA damage, cardiac troponin T carbonylation, and long-term cardiomyopathy in the irradiated animals.	[Rosen, Elliot; Kryndushkin, Dmitry; Aryal, Baikuntha; Gonzalez, Yanira; Chehab, Leena; Dickey, Jennifer; Rao, V. Ashutosh] US FDA, Ctr Drug Evaluat & Res, Off Biotechnol Prod, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Rao, VA (corresponding author), US FDA, Ctr Drug Evaluat & Res, Off Biotechnol Prod, Silver Spring, MD 20993 USA.	ashutosh.rao@fda.hhs.gov	Rao, V Ashutosh/A-3569-2013	Rao, V Ashutosh/0000-0001-6817-8049	FDA Medical Countermeasures Initiative (MCMi) Challenge Grant	FDA Medical Countermeasures Initiative (MCMi) Challenge Grant	This project was supported in part by the FDA Medical Countermeasures Initiative (MCMi) Challenge Grant (VAR) and an appointment to the Research Participation Program at the Office of Biotechnology Products, Center for Drug Evaluation and Research at the U.S. FDA (DJ, YG, LC), administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. DOE and FDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuelhija M, 2013, ANDROLOGY-US, V1, P206, DOI 10.1111/j.2047-2927.2012.00034.x; Achimovicova M, 2011, ACTA MONTAN SLOVACA, V16, P123; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 1996, RADIAT RES, V146, P1; Aryal B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194164; Aryal B, 2014, P NATL ACAD SCI USA, V111, P2011, DOI 10.1073/pnas.1321783111; Augustyniak E, 2015, REDOX BIOL, V4, P149, DOI 10.1016/j.redox.2014.12.014; Azimzadeh O, 2017, ONCOTARGET, V8, P9067, DOI 10.18632/oncotarget.10424; Azimzadeh O, 2013, J PROTEOME RES, V12, P2700, DOI 10.1021/pr400071g; Azimzadeh O, 2011, PROTEOMICS, V11, P3299, DOI 10.1002/pmic.201100178; Azzam EI, 2012, CANCER LETT, V327, P48, DOI 10.1016/j.canlet.2011.12.012; Babuin L, 2005, CAN MED ASSOC J, V173, P1191, DOI 10.1503/cmaj/051291; Barjaktarovic Z, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205239; Barjaktarovic Z, 2015, J RADIAT RES, V56, P623, DOI 10.1093/jrr/rrv014; Barjaktarovic Z, 2013, RADIOTHER ONCOL, V106, P404, DOI 10.1016/j.radonc.2013.01.017; Dickey JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070575; Fedorova M, 2010, PROTEOMICS, V10, P2692, DOI 10.1002/pmic.201000147; Fedorova M, 2009, BBA-MOL BASIS DIS, V1792, P1185, DOI 10.1016/j.bbadis.2009.09.011; Filopei J, 2012, CARDIOL REV, V20, P184, DOI 10.1097/CRD.0b013e3182431c23; Gaze DC, 2008, ANN CLIN BIOCHEM, V45, P349, DOI 10.1258/acb.2007.007229; Giraud P, 2004, B CANCER, V91, pS147; Gorbunov NV, 2015, ANTIOXIDANTS, V4, P134, DOI 10.3390/antiox4010134; HERMAN EH, 1985, TOXICOL APPL PHARM, V78, P202, DOI 10.1016/0041-008X(85)90284-4; Janssens JV, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33886-x; Kashcheev VV, 2017, HEALTH PHYS, V113, P23, DOI 10.1097/HP.0000000000000670; Kim YC, 2014, PROTEOMES, V2, P291, DOI 10.3390/proteomes2030291; Kiscsatari L, 2016, IN VIVO, V30, P623; Labugger R, 2000, CIRCULATION, V102, P1221, DOI 10.1161/01.CIR.102.11.1221; LAUK S, 1988, INT J RADIAT ONCOL, V14, P109, DOI 10.1016/0360-3016(88)90058-2; LEIPER AD, 1995, ARCH DIS CHILD, V72, P382, DOI 10.1136/adc.72.5.382; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Little MP, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000539; Magherini F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071839; Mansour HH, 2012, EUR J PHARMACOL, V692, P46, DOI 10.1016/j.ejphar.2012.06.037; Michos ED, 2014, AHRQ COMP EFFECTIVEN; Mirzaei H, 2008, J CHROMATOGR B, V873, P8, DOI 10.1016/j.jchromb.2008.04.025; Muller AM, 2016, CLIN IMMUNOL, V173, P64, DOI 10.1016/j.clim.2016.09.003; Murase K, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.009486; NOVI AM, 1969, VIRCHOWS ARCH B, V2, P24; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; Pistevou-Gompaki Kyriaki, 2008, Ther Clin Risk Manag, V4, P1359; Pradeep K, 2012, J MED FOOD, V15, P419, DOI 10.1089/jmf.2011.1737; Skytta T, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0436-2; Slezak J, 2017, CAN J PHYSIOL PHARM, V95, P1190, DOI 10.1139/cjpp-2017-0121; Starnberg K, 2014, CLIN CHEM, V60, P1098, DOI 10.1373/clinchem.2013.217943; Streng AS, 2018, J APPL LAB MED, V2, P857, DOI 10.1373/jalm.2017.024224; Streng AS, 2016, BIOCHEM BIOPH RES CO, V481, P165, DOI 10.1016/j.bbrc.2016.10.149; Thomas O, 2001, INT J RADIAT ONCOL, V49, P125, DOI 10.1016/S0360-3016(00)01373-0; Weng SL, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1472-8; Wu AHB., 2017, FRONT LAB MED, V1, P144, DOI [10.1016/j.flm.2017.09.003, DOI 10.1016/J.FLM.2017.09.003]; 2014, REG ANESTH PAIN MED, V9	51	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0233967	10.1371/journal.pone.0233967	http://dx.doi.org/10.1371/journal.pone.0233967			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497067	gold, Green Published			2022-12-26	WOS:000542035200035
J	Rosenblum, U; Kribus-Shmiel, L; Zeilig, G; Bahat, Y; Kimel-Naor, S; Melzer, I; Plotnik, M				Rosenblum, Uri; Kribus-Shmiel, Lotem; Zeilig, Gabi; Bahat, Yotam; Kimel-Naor, Shani; Melzer, Itshak; Plotnik, Meir			Novel methodology for assessing total recovery time in response to unexpected perturbations while walking	PLOS ONE			English	Article							POSTURAL STABILITY; BALANCE PERTURBATIONS; TREADMILL; GAIT; DETERMINANTS; VELOCITY; MUSCLES; TALKING; PELVIS; MOTION	Walking stability is achieved by adjusting the medio-lateral and anterior-posterior dimensions of the base of support (step length and step width, respectively) to contain an extrapolated center of mass. We aimed to calculate total recovery time after different types of perturbations during walking, and use it to compare young and older adults following different types of perturbations. Walking trials were performed in 12 young (age 26.92 +/- 3.40 years) and 12 older (age 66.83 +/- 1.60 years) adults. Perturbations were introduced at different phases of the gait cycle, on both legs and in anterior-posterior or medio-lateral directions, in random order. A novel algorithm was developed to determine total recovery time values for regaining stable step length and step width parameters following the different perturbations, and compared between the two participant groups under low and high cognitive load conditions, using principal component analysis (PCA). We analyzed 829 perturbations each for step length and step width. The algorithm successfully estimated total recovery time in 91.07% of the runs. PCA and statistical comparisons showed significant differences in step length and step width recovery times between anterior-posterior and medio-lateral perturbations, but no age-related differences. Initial analyses demonstrated the feasibility of comparisons based on total recovery time calculated using our algorithm.	[Rosenblum, Uri; Kribus-Shmiel, Lotem; Bahat, Yotam; Kimel-Naor, Shani; Plotnik, Meir] Sheba Med Ctr, Ctr Adv Technol Rehabil, Tel Hashomer, Israel; [Rosenblum, Uri; Melzer, Itshak] Ben Gurion Univ Negev, Fac Hlth Sci, Recanati Sch Community Hlth Profess, Dept Phys Therapy, Beer Sheva, Israel; [Zeilig, Gabi] Sheba Med Ctr, Dept Neurol Rehabil, Tel Hashomer, Israel; [Zeilig, Gabi] Tel Aviv Univ, Sackler Fac Med, Dept Phys & Rehabil Med, Tel Aviv, Israel; [Plotnik, Meir] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, Tel Aviv, Israel; [Plotnik, Meir] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel	Chaim Sheba Medical Center; Ben Gurion University; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Plotnik, M (corresponding author), Sheba Med Ctr, Ctr Adv Technol Rehabil, Tel Hashomer, Israel.; Plotnik, M (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, Tel Aviv, Israel.; Plotnik, M (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel.	meir.plontik@sheba.health.gov.il		Rosenblum, Uri/0000-0002-0744-2739; Plotnik, Meir/0000-0003-2637-3457	Israeli Ministry of Science and Technology [312072]; Israel Science Fund [3-14527]; Ben-Gurion University of the Negev	Israeli Ministry of Science and Technology(Ministry of Science, Technology and Space (MOST), Israel); Israel Science Fund(Israel Science Foundation); Ben-Gurion University of the Negev	The author MP funding for this work from the Israeli Ministry of Science and Technology - https://www.gov.il/en/Departments/Units/most_planning_and_control, grant #312072, and from the Israel Science Fund - https://www.isf.org.il/#/, grant #3-14527. The author UR is supported by a stipend from Ben-Gurion University of the Negev - https://in.bgu.ac.il/en/pages/default.aspx, as part of a PhD scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer C, 2010, ARCH GERONTOL GERIAT, V51, pE100, DOI 10.1016/j.archger.2010.01.009; Beauchet O, 2009, EUR J NEUROL, V16, P786, DOI 10.1111/j.1468-1331.2009.02612.x; Berger L, 2005, J MOTOR BEHAV, V37, P359, DOI 10.3200/JMBR.37.5.359-366; Borg FG, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-38; Bowen A, 2001, AGE AGEING, V30, P319, DOI 10.1093/ageing/30.4.319; Brauer SG, 2001, J GERONTOL A-BIOL, V56, pM489, DOI 10.1093/gerona/56.8.M489; Brown LA, 1999, J GERONTOL A-BIOL, V54, pM165, DOI 10.1093/gerona/54.4.M165; Byrne JE, 2002, PERCEPT MOTOR SKILL, V94, P265, DOI 10.2466/PMS.94.1.265-280; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Centers for Disease Control and Prevention, WEB BAS INJ STAT QUE; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Donelan JM, 2001, P ROY SOC B-BIOL SCI, V268, P1985, DOI 10.1098/rspb.2001.1761; Fino PC, 2016, ANN BIOMED ENG, V44, P1636, DOI 10.1007/s10439-015-1479-0; Florence CS, 2018, J AM GERIATR SOC, V66, P693, DOI 10.1111/jgs.15304; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ghai S, 2017, CLIN INTERV AGING, V12, P557, DOI 10.2147/CIA.S125201; GRONWALL D, 1974, LANCET, V2, P605; Hof AL, 2018, HUM MOVEMENT SCI, V57, P69, DOI 10.1016/j.humov.2017.11.009; Hof AL, 2013, EXP BRAIN RES, V230, P301, DOI 10.1007/s00221-013-3655-5; Hof AL, 2010, J EXP BIOL, V213, P2655, DOI 10.1242/jeb.042572; Hof AL, 2005, J BIOMECH, V38, P1, DOI 10.1016/j.jbiomech.2004.03.025; Hof AL, 2008, HUM MOVEMENT SCI, V27, P112, DOI 10.1016/j.humov.2007.08.003; Hof AL, 2007, J BIOMECH, V40, P451, DOI 10.1016/j.jbiomech.2005.12.016; Joshi M., 2018, IEEE T SERV COMPUT, P1, DOI 10.1080/23335432.2018.1512375; Lee BC, 2017, IEEE T NEUR SYS REH, V25, P235, DOI 10.1109/TNSRE.2016.2556690; Liau BY, 2019, ENTROPY-SWITZ, V21, DOI 10.3390/e21111128; LICHTENSTEIN MJ, 1988, J AM GERIATR SOC, V36, P996, DOI 10.1111/j.1532-5415.1988.tb04365.x; Lin MIB, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00092; Liu J, 2009, GAIT POSTURE, V30, P276, DOI 10.1016/j.gaitpost.2009.04.005; Madehkhaksar F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195902; MAKI BE, 1991, J GERONTOL, V46, pM123, DOI 10.1093/geronj/46.4.M123; McIlroy WE, 1996, J GERONTOL A-BIOL, V51, pM289, DOI 10.1093/gerona/51A.6.M289; O'Connor SM, 2012, J NEUROPHYSIOL, V107, P2549, DOI 10.1152/jn.00866.2011; Plotnik M, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0002-z; Pluijm SMF, 2006, OSTEOPOROSIS INT, V17, P417, DOI 10.1007/s00198-005-0002-0; Shumway-Cook A, 2009, PHYS THER, V89, P324, DOI 10.2522/ptj.20070107; Snaterse M, 2011, J APPL PHYSIOL, V110, P1682, DOI 10.1152/japplphysiol.00536.2010; Stevens JA, 2005, J SAFETY RES, V36, P409, DOI 10.1016/j.jsr.2005.08.001; Tanahashi S, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-39; Tang PF, 1998, EXP BRAIN RES, V119, P141, DOI 10.1007/s002210050327; Thelen DG, 2000, J ELECTROMYOGR KINES, V10, P93, DOI 10.1016/S1050-6411(99)00028-0; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Vlutters M, 2016, J EXP BIOL, V219, P1514, DOI 10.1242/jeb.129338; Wojcik LA, 1999, J GERONTOL A-BIOL, V54, pM44, DOI 10.1093/gerona/54.1.M44; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Yang F, 2014, J BIOMECH, V47, P2797, DOI 10.1016/j.jbiomech.2014.06.001; Zadravec M, 2017, TECHNOL HEALTH CARE, V25, P781, DOI 10.3233/THC-160798; ZARRUGH MY, 1978, EUR J APPL PHYSIOL O, V38, P215, DOI 10.1007/BF00430080; Zeni JA, 2008, GAIT POSTURE, V27, P710, DOI 10.1016/j.gaitpost.2007.07.007; Zwergal A, 2012, NEUROBIOL AGING, V33, P1073, DOI 10.1016/j.neurobiolaging.2010.09.022	50	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2020	15	6							e0233510	10.1371/journal.pone.0233510; 10.1371/journal.pone.0233510.r001; 10.1371/journal.pone.0233510.r002; 10.1371/journal.pone.0233510.r003; 10.1371/journal.pone.0233510.r004	http://dx.doi.org/10.1371/journal.pone.0233510; 10.1371/journal.pone.0233510.r001; 10.1371/journal.pone.0233510.r002; 10.1371/journal.pone.0233510.r003; 10.1371/journal.pone.0233510.r004			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LW6ZP	32492029	Green Submitted, Green Published, gold			2022-12-26	WOS:000539293000016
J	Tanaka, M; Yamasaki, T; Hasebe, R; Suzuki, A; Horiuchi, M				Tanaka, Misaki; Yamasaki, Takeshi; Hasebe, Rie; Suzuki, Akio; Horiuchi, Motohiro			Enhanced phosphorylation of PERK in primary cultured neurons as an autonomous neuronal response to prion infection	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; ABNORMAL ISOFORM; DISEASE; ACTIVATION; RESISTANT; NEUROTOXICITY; TRANSLATION; MICROGLIA; CELLS	Conversion of cellular prion protein (PrPC) into the pathogenic isoform of prion protein (PrPSc) in neurons is one of the key pathophysiological events in prion diseases. However, the molecular mechanism of neurodegeneration in prion diseases has yet to be fully elucidated because of a lack of suitable experimental models for analyzing neuron-autonomous responses to prion infection. In the present study, we used neuron-enriched primary cultures of cortical and thalamic mouse neurons to analyze autonomous neuronal responses to prion infection. PrPSc levels in neurons increased over the time after prion infection; however, no obvious neuronal losses or neurite alterations were observed. Interestingly, a finer analysis of individual neurons co-stained with PrPSc and phosphorylated protein kinase RNA-activated-like endoplasmic reticulum (ER) kinase (p-PERK), the early cellular response of the PERK-eukaryotic initiation factor 2 (eIF2 alpha) pathway, demonstrated a positive correlation between the number of PrPSc granular stains and p-PERK granular stains, in cortical neurons at 21 dpi. Although the phosphorylation of PERK was enhanced in prion-infected cortical neurons, there was no sign of subsequent translational repression of synaptic protein synthesis or activations of downstream unfolded protein response (UPR) in the PERK-eIF2 alpha pathway. These results suggest that PrPSc production in neurons induces ER stress in a neuron-autonomous manner; however, it does not fully activate UPR in prion-infected neurons. Our findings provide insights into the autonomous neuronal responses to prion propagation and the involvement of neuron-non-autonomous factor(s) in the mechanisms of neurodegeneration in prion diseases.	[Tanaka, Misaki; Yamasaki, Takeshi; Hasebe, Rie; Suzuki, Akio; Horiuchi, Motohiro] Hokkaido Univ, Fac Vet Med, Lab Vet Hyg, Sapporo, Hokkaido, Japan; [Horiuchi, Motohiro] Hokkaido Univ, Global Inst Collaborat Res & Educ, Global Stn Zoonosis Control, Sapporo, Hokkaido, Japan; [Yamasaki, Takeshi; Hasebe, Rie] Hokkaido Univ, Inst Genet Med, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Horiuchi, M (corresponding author), Hokkaido Univ, Fac Vet Med, Lab Vet Hyg, Sapporo, Hokkaido, Japan.; Horiuchi, M (corresponding author), Hokkaido Univ, Global Inst Collaborat Res & Educ, Global Stn Zoonosis Control, Sapporo, Hokkaido, Japan.	horiuchi@vetmed.hokudai.ac.jp		HASEBE, Rie/0000-0003-2009-0595	Program for Leading Graduate Schools (F01) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labour and Welfare of Japan [H29-Shokuhin-Ippan-004]; JSPS KAKENHI Grant [JP 15H02475];  [JP18J12535]	Program for Leading Graduate Schools (F01) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); 	This work was supported by Grant-in-aid for JSPS Research Fellow Grant Number JP18J12535 (M.T.). This work was also supported by a Grant-in-Aid for Science Research (A) (JSPS KAKENHI Grant Number JP 15H02475) (M.H.) and a grant from the Program for Leading Graduate Schools (F01) (M.H.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. This work was also supported by grants for TSE research (H29-Shokuhin-Ippan-004) (M.H.) from the Ministry of Health, Labour and Welfare of Japan.	Alleaume-Butaux A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005073; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; Campeau JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081776; Carroll JA, 2018, J VIROL, V92, DOI 10.1128/JVI.00549-18; Challis RC, 2019, NAT PROTOC, V14, P379, DOI 10.1038/s41596-018-0097-3; Chan KY, 2017, NAT NEUROSCI, V20, P1172, DOI 10.1038/nn.4593; Chiti Z, 2006, NEUROBIOL DIS, V22, P363, DOI 10.1016/j.nbd.2005.12.002; Ciccotosto GD, 2017, METHODS MOL BIOL, V1658, P147, DOI 10.1007/978-1-4939-7244-9_12; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; Cronier S, 2004, P NATL ACAD SCI USA, V101, P12271, DOI 10.1073/pnas.0402725101; Cronier S, 2012, FASEB J, V26, P3854, DOI 10.1096/fj.11-201772; Cunningham C, 2003, EUR J NEUROSCI, V17, P2147, DOI 10.1046/j.1460-9568.2003.02662.x; Fang C, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007283; Fang C, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005623; Foliaki ST, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007214; Galehdar Z, 2010, J NEUROSCI, V30, P16938, DOI 10.1523/JNEUROSCI.1598-10.2010; Garden GA, 2012, NEURON, V73, P886, DOI 10.1016/j.neuron.2012.02.017; Gomez-Nicola D, 2013, J NEUROSCI, V33, P2481, DOI 10.1523/JNEUROSCI.4440-12.2013; Hannaoui S, 2013, J VIROL, V87, P2535, DOI 10.1128/JVI.03082-12; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hartmann K, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0735-1; Hetz C, 2003, EMBO J, V22, P5435, DOI 10.1093/emboj/cdg537; Hilton KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068062; Hollister JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115351; Hoozemans JJM, 2007, BIOCHEM BIOPH RES CO, V354, P707, DOI 10.1016/j.bbrc.2007.01.043; Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Kerschensteiner M, 2009, NEUROSCIENCE, V158, P1122, DOI 10.1016/j.neuroscience.2008.09.009; Kim CL, 2004, VIROLOGY, V320, P40, DOI 10.1016/j.virol.2003.10.026; Kimball SR, 1999, INT J BIOCHEM CELL B, V31, P25, DOI 10.1016/S1357-2725(98)00128-9; Krejciova Z, 2017, J EXP MED, V214, P3481, DOI 10.1084/jem.20161547; Luo SZ, 2003, J BIOL CHEM, V278, P37375, DOI 10.1074/jbc.M303619200; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mallucci GR, 2007, NEURON, V53, P325, DOI 10.1016/j.neuron.2007.01.005; Mallucci GR, 2009, PRION, V3, P195, DOI 10.4161/pri.3.4.9981; MANSON JC, 1994, NEURODEGENERATION, V3, P331; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Masujin K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058013; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Moreno JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006767; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; Nakagaki T, 2013, AUTOPHAGY, V9, P1386, DOI 10.4161/auto.25381; Nakamitsu S, 2010, J GEN VIROL, V91, P563, DOI 10.1099/vir.0.016287-0; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; RACE RE, 1988, J VIROL, V62, P2845, DOI 10.1128/JVI.62.8.2845-2849.1988; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roussel BD, 2013, LANCET NEUROL, V12, P105, DOI 10.1016/S1474-4422(12)70238-7; Sandberg MK, 2011, NATURE, V470, P540, DOI 10.1038/nature09768; Schatzl HM, 1997, J VIROL, V71, P8821; Schultz J, 2004, AM J PATHOL, V165, P671, DOI 10.1016/S0002-9440(10)63331-7; Shindoh R, 2009, J VIROL, V83, P3852, DOI 10.1128/JVI.01740-08; Siskova Z, 2009, AM J PATHOL, V175, P1610, DOI 10.2353/ajpath.2009.090372; Smith HL, 2020, NEURON, V105, P855, DOI 10.1016/j.neuron.2019.12.014; Tanaka M, 2016, J GEN VIROL, V97, P2030, DOI 10.1099/jgv.0.000514; Uryu M, 2007, MICROBIOL IMMUNOL, V51, P661, DOI 10.1111/j.1348-0421.2007.tb03954.x; Victoria GS, 2016, SCI REP-UK, V6, DOI 10.1038/srep20762; Yamasaki T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106516; Yamasaki T, 2012, J GEN VIROL, V93, P668, DOI 10.1099/vir.0.037101-0; Yoo BC, 2002, NEUROSCI LETT, V334, P196, DOI 10.1016/S0304-3940(02)01071-6; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhu CH, 2016, J EXP MED, V213, P1047, DOI 10.1084/jem.20151000; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	68	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0234147	10.1371/journal.pone.0234147	http://dx.doi.org/10.1371/journal.pone.0234147			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MJ2AA	32479530	Green Published, gold			2022-12-26	WOS:000547893500055
J	de Leon, DG; Vahter, T; Zobel, M; Koppel, M; Edesi, L; Davison, J; Al-Quraishy, S; Hozzein, WN; Moora, M; Oja, J; Vasar, M; Opik, M				Garcia de Leon, David; Vahter, Tanel; Zobel, Martin; Koppel, Mati; Edesi, Liina; Davison, John; Al-Quraishy, Saleh; Hozzein, Wael N.; Moora, Mari; Oja, Jane; Vasar, Martti; Opik, Maarja			Different wheat cultivars exhibit variable responses to inoculation with arbuscular mycorrhizal fungi from organic and conventional farms	PLOS ONE			English	Article							DIVERSITY; COMMUNITIES; MANAGEMENT; CONTRIBUTE; FIELD	The present study aimed to investigate the effects of arbuscular mycorrhizal (AM) fungal communities originating from organic and conventional agriculture on wheat growth and yield. Six different spring wheat cultivars released in different years in north and central European countries were considered. We hypothesised that AM fungal inoculum collected from organic agricultural fields would elicit a greater positive growth response than inoculum collected from conventional agricultural fields; and that older cultivars, which were developed under conditions of low fertilizer input, would exhibit overall greater growth responses to the presence of AM fungi, compared with more recent cultivars, and that AM fungal inoculum from conventional fields might have the most beneficial effect on the growth and yield of recent cultivars. The results showed that the overall effects on the growth and yield of spring wheat grown with organic and conventional AM fungal inocula did not differ greatly. However, the inoculation growth response, showing the difference of the effects of organic and conventional inocula, varied between particular wheat cultivars. Inoculation growth response of the cultivar Pikker (released in 1959) was the most positive, while that of the cultivar Arabella (released in 2012) was the most negative. The use of AM fungal inoculum from organic fields resulted in slightly taller plant individuals. Pikker showed relatively higher yield and stronger growth when the organic AM fungal inoculum was used. Arabella exhibited relatively lower yield and weaker growth when the organic inoculum was used. Whether the positive response of Pikker to Estonian organic inoculation reflects adaptation to the locally occurring AM fungal community needs to be established by further studies of the communities of AM fungi colonizing wheat roots.	[Garcia de Leon, David] Univ Alcala, Dept Life Sci, Technol Sci Campus, Alcala De Henares, Spain; [Garcia de Leon, David; Vahter, Tanel; Davison, John; Moora, Mari; Oja, Jane; Vasar, Martti; Opik, Maarja] Univ Tartu, Inst Ecol & Earth Sci, Tartu, Estonia; [Zobel, Martin; Al-Quraishy, Saleh; Hozzein, Wael N.] King Saud Univ, Zool Dept, Coll Sci, Riyadh, Saudi Arabia; [Zobel, Martin] Univ Tartu, Dept Bot, Tartu, Estonia; [Koppel, Mati; Edesi, Liina] Estonian Crop Res Inst, Jageva, Estonia; [Hozzein, Wael N.] Beni Suef Univ, Bot & Microbiol Dept, Fac Sci, Bani Suwayf, Egypt	Universidad de Alcala; University of Tartu; Tartu University Institute of Ecology & Earth Sciences; King Saud University; University of Tartu; Egyptian Knowledge Bank (EKB); Beni Suef University	de Leon, DG (corresponding author), Univ Alcala, Dept Life Sci, Technol Sci Campus, Alcala De Henares, Spain.; de Leon, DG (corresponding author), Univ Tartu, Inst Ecol & Earth Sci, Tartu, Estonia.	david.garcialh@uah.es	Zobel, Martin/H-1336-2015; García de León, David/I-2398-2018; Moora, Mari/D-1961-2009; Öpik, Maarja/A-1765-2008; Edesi, Liina/AAI-7190-2020	Zobel, Martin/0000-0001-7957-6704; García de León, David/0000-0001-8165-6965; Moora, Mari/0000-0002-4819-7506; Öpik, Maarja/0000-0001-8025-7460; Edesi, Liina/0000-0002-8871-1071	European Regional Development Fund [Centre of Excellence EcolChange]; ERA-NET Cofund BiodivERsA3 [SoilMan]; Madrid Regional Government [REMEDINAL] [TE-CM S2018/EMT-4 338]; University of Alcala [CM/JIN/2019-023, 2018-T2/BIO-10995]; Madrid Regional Government [2018-T2/BIO-10995]	European Regional Development Fund [Centre of Excellence EcolChange]; ERA-NET Cofund BiodivERsA3 [SoilMan]; Madrid Regional Government [REMEDINAL]; University of Alcala; Madrid Regional Government	This study was supported by the European Regional Development Fund [Centre of Excellence EcolChange], ERA-NET Cofund BiodivERsA3 [SoilMan], Madrid Regional Government [REMEDINAL, ref. TE-CM S2018/EMT-4 338], and University of Alcala [CM/JIN/2019-023]. DGL is grateful to Madrid Regional Government and University of Alcala ' for grant number 2018-T2/BIO-10995.	Auge RM, 2001, MYCORRHIZA, V11, P3, DOI 10.1007/s005720100097; Banerjee S, 2019, ISME J, V13, P1722, DOI 10.1038/s41396-019-0383-2; Bender SF, 2016, TRENDS ECOL EVOL, V31, P440, DOI 10.1016/j.tree.2016.02.016; Blaszkowski J, 2009, BOTANY, V87, P260, DOI 10.1139/B08-138; Brundrett M, 1996, WORKING MYCORRHIZAS; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cavagnaro TR, 2015, TRENDS PLANT SCI, V20, P283, DOI 10.1016/j.tplants.2015.03.004; Dai M, 2014, SOIL BIOL BIOCHEM, V74, P156, DOI 10.1016/j.soilbio.2014.03.016; Davison J, 2015, SCIENCE, V349, P970, DOI 10.1126/science.aab1161; de Vries FT, 2017, J ECOL, V105, P913, DOI 10.1111/1365-2745.12783; DELEON DG, 2018, J TROP ECOL 3, V34, P186, DOI DOI 10.1017/S0266467418000184; DIBLE WT, 1954, ANAL CHEM, V26, P418, DOI 10.1021/ac60086a047; Dumbrell AJ, 2011, NEW PHYTOL, V190, P794, DOI 10.1111/j.1469-8137.2010.03636.x; Elliott AJ, 2021, PLANTS PEOPLE PLANET, V3, P588, DOI 10.1002/ppp3.10094; FAOSTAT, WORLD FOOD SITUATION; Gianinazzi S, 2010, MYCORRHIZA, V20, P519, DOI 10.1007/s00572-010-0333-3; Gottshall CB, 2017, AGR ECOSYST ENVIRON, V241, P142, DOI 10.1016/j.agee.2017.03.011; Graham JH, 2000, PLANT SOIL, V220, P207, DOI 10.1023/A:1004709209009; HETRICK BAD, 1993, CAN J BOT, V71, P512, DOI 10.1139/b93-056; Jordan-Meille L, 2012, SOIL USE MANAGE, V28, P419, DOI 10.1111/j.1475-2743.2012.00453.x; Jung SC, 2012, J CHEM ECOL, V38, P651, DOI 10.1007/s10886-012-0134-6; KOIDE RT, 1989, NEW PHYTOL, V111, P35, DOI 10.1111/j.1469-8137.1989.tb04215.x; KOSKE RE, 1989, MYCOL RES, V92, P486, DOI 10.1016/S0953-7562(89)80195-9; Lee J, 2008, FEMS MICROBIOL ECOL, V65, P339, DOI 10.1111/j.1574-6941.2008.00531.x; Lehmann A, 2012, PLANT SOIL, V355, P231, DOI 10.1007/s11104-011-1095-1; Li HY, 2006, NEW PHYTOL, V172, P536, DOI 10.1111/j.1469-8137.2006.01846.x; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Mao L, 2014, PLANT SOIL, V374, P949, DOI 10.1007/s11104-013-1943-2; Mironiuk M, 2016, ACCREDIT QUAL ASSUR, V21, P409, DOI 10.1007/s00769-016-1240-x; Moora M, 2014, FEMS MICROBIOL ECOL, V90, P609, DOI 10.1111/1574-6941.12420; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Opik M, 2010, NEW PHYTOL, V188, P223, DOI 10.1111/j.1469-8137.2010.03334.x; Osborne OG, 2018, NEW PHYTOL, V217, P1254, DOI 10.1111/nph.14850; Owen KJ, 2010, CROP PASTURE SCI, V61, P399, DOI 10.1071/CP09345; Pellegrino E, 2015, SOIL BIOL BIOCHEM, V84, P210, DOI 10.1016/j.soilbio.2015.02.020; R Core Team, 2021, R LANGUAGE ENV STAT; Requena N, 2001, APPL ENVIRON MICROB, V67, P495, DOI 10.1128/AEM.67.2.495-498.2001; Rillig MC, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01625; RILLIG MC, 2019, LETT EXPLORING AGRIC, V223, P517, DOI DOI 10.1111/NPH.15744; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Rua MA, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0698-9; Saks U, 2014, BOTANY, V92, DOI 10.1139/cjb-2013-0058; Sawers RJH, 2018, NEW PHYTOL, V220, P1135, DOI 10.1111/nph.15152; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Smith SE, 2015, APPL SOIL ECOL, V96, P68, DOI 10.1016/j.apsoil.2015.07.002; Spatafora JW, 2016, MYCOLOGIA, V108, P1028, DOI 10.3852/16-042; Sumner ME, 1994, COMMUN SOIL SCI PLAN, V25, P859, DOI 10.1080/00103629409369085; Thirkell TJ, 2017, J ECOL, V105, P921, DOI 10.1111/1365-2745.12788; Thirkell TJ, 2020, GLOBAL CHANGE BIOL, V26, P1725, DOI 10.1111/gcb.14851; Uibopuu A, 2009, SOIL BIOL BIOCHEM, V41, P2141, DOI 10.1016/j.soilbio.2009.07.026; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Van Geel M, 2016, AGRON SUSTAIN DEV, V36, DOI 10.1007/s13593-016-0373-y; Vasar M, 2017, MYCORRHIZA, V27, P761, DOI 10.1007/s00572-017-0791-y; Verbruggen E, 2012, PLANT SOIL, V350, P43, DOI 10.1007/s11104-011-0828-5; Verbruggen E, 2010, NEW PHYTOL, V186, P968, DOI 10.1111/j.1469-8137.2010.03230.x; Williams A, 2011, SOIL BIOL BIOCHEM, V43, P339, DOI 10.1016/j.soilbio.2010.10.021; Zhang SJ, 2019, NEW PHYTOL, V222, P543, DOI 10.1111/nph.15570; Zhu YG, 2001, PLANT SOIL, V237, P249, DOI 10.1023/A:1013343811110	58	12	12	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2020	15	5							e0233878	10.1371/journal.pone.0233878	http://dx.doi.org/10.1371/journal.pone.0233878			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1WS	32470094	Green Published, gold			2022-12-26	WOS:000537552800203
J	Alexander, JAN; Radaeva, M; King, DT; Chambers, HF; Cherkasov, A; Chatterjee, SS; Strynadka, NCJ				Alexander, J. Andrew N.; Radaeva, Mariia; King, Dustin T.; Chambers, Henry F.; Cherkasov, Artem; Chatterjee, Som S.; Strynadka, Natalie C. J.			Structural analysis of avibactam-mediated activation of the bla and mec divergons in methicillin-resistant Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibiotic resistance; avibactam; beta-lactam antibiotics; beta-lactamase; BlaR1; diazabicyclooctane; methicillin-resistant Staphylococcus aureus (MRSA); MecR1; X-ray crystallography; sensor domain; antibiotic resistance; antibiotics; crystal structure; drug action; gene expression; infectious disease; molecular docking; Staphylococcus aureus (S. aureus); beta-lactam	BETA-LACTAM SENSOR; BINDING PROTEIN 2A; IN-VITRO ACTIVITY; CEFTAROLINE-AVIBACTAM; CRYSTAL-STRUCTURE; STRUCTURE REFINEMENT; DOMAIN; MECHANISM; INSIGHTS; RECEPTOR	Methicillin-resistantStaphylococcus aureus(MRSA) infections cause significant mortality and morbidity globally. MRSA resistance to beta-lactam antibiotics is mediated by two divergons that control levels of a beta-lactamase, PC1, and a penicillin-binding protein poorly acylated by beta-lactam antibiotics, PBP2a. Expression of genes encoding these proteins is controlled by two integral membrane proteins, BlaR1 and MecR1, which both have an extracellular beta-lactam-binding sensor domain. Here, we solved the X-ray crystallographic structures of the BlaR1 and MecR1 sensor domains in complex with avibactam, a diazabicyclooctane beta-lactamase inhibitor at 1.6-2.0 angstrom resolution. Additionally, we show thatS. aureusSF8300, a clinically relevant strain from the USA300 clone of MRSA, responds to avibactam by up-regulating the expression of theblaZandpbp2aantibiotic-resistance genes, encoding PC1 and PBP2a, respectively. The BlaR1-avibactam structure of the carbamoyl-enzyme intermediate revealed that avibactam is bound to the active-site serine in two orientations similar to 180 degrees to each other. Although a physiological role of the observed alternative pose remains to be validated, our structural results hint at the presence of a secondary sulfate-binding pocket that could be exploited in the design of future inhibitors of BlaR1/MecR1 sensor domains or the structurally similar class D beta-lactamases. The MecR1-avibactam structure adopted a singular avibactam orientation similar to one of the two states observed in the BlaR1-avibactam structure. Given avibactam up-regulates expression ofblaZandpbp2aantibiotic resistance genes, we suggest further consideration and research is needed to explore what effects administering beta-lactam-avibactam combinations have on treating MRSA infections.	[Alexander, J. Andrew N.; King, Dustin T.; Strynadka, Natalie C. J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada; [Alexander, J. Andrew N.; King, Dustin T.; Strynadka, Natalie C. J.] Univ British Columbia, Ctr Blood Res, Vancouver, BC, Canada; [Radaeva, Mariia; Cherkasov, Artem] Univ British Columbia, Vancouver Prostate Ctr, Vancouver, BC, Canada; [Chambers, Henry F.] San Francisco Gen Hosp, Dept Med, Div Infect Dis, San Francisco, CA 94110 USA; [Chatterjee, Som S.] Univ Maryland, Sch Dent, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA; [Chatterjee, Som S.] Inst Marine & Environm Technol, Baltimore, MD 21202 USA	University of British Columbia; University of British Columbia; University of British Columbia; San Francisco General Hospital Medical Center; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology	Strynadka, NCJ (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada.; Strynadka, NCJ (corresponding author), Univ British Columbia, Ctr Blood Res, Vancouver, BC, Canada.; Chatterjee, SS (corresponding author), Univ Maryland, Sch Dent, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA.; Chatterjee, SS (corresponding author), Inst Marine & Environm Technol, Baltimore, MD 21202 USA.	schatterjee@umaryland.edu; ncjs@mail.ubc.ca		King, Dustin/0000-0003-1775-2885; Chatterjee, Som/0000-0002-7138-4449; Alexander, J. Andrew/0000-0002-8759-1389	Canadian Institutes of Health Research (CIHR); Howard Hughes Medical Institutes International Scholar program; National Institutes of Health [2R01AI100291, R21AI142501]; Tier 1 Canada Research Chair; CIHR Vanier scholarship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institutes International Scholar program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tier 1 Canada Research Chair(Canada Research Chairs); CIHR Vanier scholarship(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (CIHR) and the Howard Hughes Medical Institutes International Scholar program (to N. C. J. S.), National Institutes of Health Grants 2R01AI100291 (to S. S. C. and H. F. C.) and R21AI142501 (to S. S. C. and H. F. C.), a Tier 1 Canada Research Chair (to N. C. J. S.) and a CIHR Vanier scholarship (to J. A. N. A.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Antunes NT, 2014, ANTIMICROB AGENTS CH, V58, P2119, DOI 10.1128/AAC.02522-13; Basuino L, 2018, J ANTIMICROB CHEMOTH, V73, P1177, DOI 10.1093/jac/dkx531; Belluzo BS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55923-z; Birck C, 2004, J AM CHEM SOC, V126, P13945, DOI 10.1021/ja044742u; Bonnefoy A, 2004, J ANTIMICROB CHEMOTH, V54, P410, DOI 10.1093/jac/dkh358; Borbulevych O, 2011, J BIOL CHEM, V286, P31466, DOI 10.1074/jbc.M111.252189; Bush K, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a025247; Castanheira M, 2012, ANTIMICROB AGENTS CH, V56, P4779, DOI 10.1128/AAC.00817-12; Challagundla L, 2018, MBIO, V9, DOI [10.1128/mBio.02016-17, 10.1128/mbio.02016-17]; Docquier JD, 2018, DRUG RESIST UPDATE, V36, P13, DOI 10.1016/j.drup.2017.11.002; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Ehmann DE, 2012, P NATL ACAD SCI USA, V109, P11663, DOI 10.1073/pnas.1205073109; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans BA, 2014, CLIN MICROBIOL REV, V27, P241, DOI 10.1128/CMR.00117-13; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fishovitz J, 2014, IUBMB LIFE, V66, P572, DOI 10.1002/iub.1289; Garcia-Castellanos R, 2004, J BIOL CHEM, V279, P17888, DOI 10.1074/jbc.M313123200; Golemi D, 2001, P NATL ACAD SCI USA, V98, P14280, DOI 10.1073/pnas.241442898; Gonzalez-Bello C, 2020, J MED CHEM, V63, P1859, DOI 10.1021/acs.jmedchem.9b01279; Goto J, 2008, J CHEM INF MODEL, V48, P583, DOI 10.1021/ci700352q; HACKBARTH CJ, 1993, ANTIMICROB AGENTS CH, V37, P1144, DOI 10.1128/AAC.37.5.1144; HERZBERG O, 1987, SCIENCE, V236, P694, DOI 10.1126/science.3107125; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; June CM, 2016, PROTEIN SCI, V25, P2152, DOI 10.1002/pro.3040; Jurrus E, 2018, PROTEIN SCI, V27, P112, DOI 10.1002/pro.3280; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karlowsky JA, 2013, ANTIMICROB AGENTS CH, V57, P5600, DOI 10.1128/AAC.01485-13; Kerff F, 2003, BIOCHEMISTRY-US, V42, P12835, DOI 10.1021/bi034976a; King DT, 2015, ACS INFECT DIS, V1, P175, DOI 10.1021/acsinfecdis.5b00007; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumarasiri M, 2012, J BIOL CHEM, V287, P8232, DOI 10.1074/jbc.M111.333179; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lee AS, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.33; Lim D, 2002, NAT STRUCT BIOL, V9, P870, DOI 10.1038/nsb858; Livermore DM, 2017, J ANTIMICROB CHEMOTH, V72, P3342, DOI 10.1093/jac/dkx298; Lovering AL, 2012, ANNU REV BIOCHEM, V81, P451, DOI 10.1146/annurev-biochem-061809-112742; Mallalieu NL, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.02229-19; Marrero A, 2006, J MOL BIOL, V361, P506, DOI 10.1016/j.jmb.2006.06.046; Mazuet C, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.04.011; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miossec Christine, 2013, Infect Drug Resist, V6, P235, DOI 10.2147/IDR.S53874; Mosley F. F., 2016, P T, V41, P479; Otero LH, 2013, P NATL ACAD SCI USA, V110, P16808, DOI 10.1073/pnas.1300118110; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P24, DOI 10.1128/AAC.01512-08; Sader HS, 2013, ANTIMICROB AGENTS CH, V57, P1982, DOI 10.1128/AAC.02436-12; Santillana E, 2007, P NATL ACAD SCI USA, V104, P5354, DOI 10.1073/pnas.0607557104; Schroder EC, 2016, ANTIMICROB AGENTS CH, V60, P6155, DOI 10.1128/AAC.01277-16; Schrodinger Release 2019-1, 2019, DESM MOL DYN SYST DE; Stachyra T, 2010, ANTIMICROB AGENTS CH, V54, P5132, DOI 10.1128/AAC.00568-10; Staude MW, 2015, BIOCHEMISTRY-US, V54, P1600, DOI 10.1021/bi501463k; Szarecka A, 2011, PROTEIN ENG DES SEL, V24, P801, DOI 10.1093/protein/gzr041; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Thumanu K, 2006, P NATL ACAD SCI USA, V103, P10630, DOI 10.1073/pnas.0601971103; Thurlow LR, 2012, FEMS IMMUNOL MED MIC, V65, P5, DOI 10.1111/j.1574-695X.2012.00937.x; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wilke MS, 2004, J BIOL CHEM, V279, P47278, DOI 10.1074/jbc.M407054200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Zhang HZ, 2001, SCIENCE, V291, P1962, DOI 10.1126/science.1055144	63	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2020	295	32					10870	10884		10.1074/jbc.RA120.013029	http://dx.doi.org/10.1074/jbc.RA120.013029			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE7BV	32518158	hybrid, Green Published			2022-12-26	WOS:000562757100001
J	Myka, KK; Marians, KJ				Myka, Kamila K.; Marians, Kenneth J.			Two components of DNA replication-dependent LexA cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage response; DNA replication; enzyme degradation; E; coli; gene regulation; SOS response; proteolytic cleavage; single-stranded DNA; LexA; Escherichia coli (E; coli)	SINGLE-STRANDED-DNA; POLYMERASE-III HOLOENZYME; COLI RECA PROTEIN; ESCHERICHIA-COLI; LEADING-STRAND; BINDING-PROTEIN; LESION BYPASS; SSB PROTEIN; DUPLEX DNA; SOS	Induction of the SOS response, a cellular system triggered by DNA damage in bacteria, depends on DNA replication for the generation of the SOS signal, ssDNA. RecA binds to ssDNA, forming filaments that stimulate proteolytic cleavage of the LexA transcriptional repressor, allowing expression of > 40 gene products involved in DNA repair and cell cycle regulation. Here, using a DNA replication system reconstitutedin vitroin tandem with a LexA cleavage assay, we studied LexA cleavage during DNA replication of both undamaged and base-damaged templates. Only a ssDNA?RecA filament supported LexA cleavage. Surprisingly, replication of an undamaged template supported levels of LexA cleavage like that induced by a template carrying two site-specific cyclobutane pyrimidine dimers. We found that two processes generate ssDNA that could support LexA cleavage. 1) During unperturbed replication, single-stranded regions formed because of stochastic uncoupling of the leading-strand DNA polymerase from the replication fork DNA helicase, and 2) on the damaged template, nascent leading-strand gaps were generated by replisome lesion skipping. The two pathways differed in that RecF stimulated LexA cleavage during replication of the damaged template, but not normal replication. RecF appears to facilitate RecA filament formation on the leading-strand ssDNA gaps generated by replisome lesion skipping.	[Myka, Kamila K.; Marians, Kenneth J.] Mem Sloan Kettering Canc Ctr, Mol Biol Program, Sloan Kettering Inst, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Marians, KJ (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Biol Program, Sloan Kettering Inst, 1275 York Ave, New York, NY 10021 USA.	kmarians@sloankettering.edu		Myka, Kamila/0000-0002-6122-2817	NIH [R35 GM126907]; Cancer Center Support Grant [NCI P30CA008748]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant	These studies were supported by NIH grant R35 GM126907 (to K. J. M.) and Cancer Center Support Grant NCI P30CA008748 (to K. J. M.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adikesavan AK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002244; Antony E, 2019, SEMIN CELL DEV BIOL, V86, P102, DOI 10.1016/j.semcdb.2018.03.017; Bell JC, 2016, TRENDS BIOCHEM SCI, V41, P491, DOI 10.1016/j.tibs.2016.04.002; Bell JC, 2012, NATURE, V491, P274, DOI 10.1038/nature11598; BOBST EV, 1985, FEBS LETT, V181, P133, DOI 10.1016/0014-5793(85)81128-5; Bork JM, 2001, EMBO J, V20, P7313, DOI 10.1093/emboj/20.24.7313; BURGERS PMJ, 1982, J BIOL CHEM, V257, P1474; Butala M, 2011, NUCLEIC ACIDS RES, V39, P6546, DOI 10.1093/nar/gkr265; CHASE JW, 1974, J BIOL CHEM, V249, P4553; Courcelle J, 2001, GENETICS, V158, P41; CRAIG NL, 1980, NATURE, V283, P26, DOI 10.1038/283026a0; Culyba MJ, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007405; del Val E, 2019, BIOCHEM SOC T, V47, P1511, DOI 10.1042/BST20190558; Fernandez de Henestrosa AR, 2000, MOL MICROBIOL, V35, P1560, DOI 10.1046/j.1365-2958.2000.01826.x; Gabbai CB, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.613257; Giese KC, 2008, J MOL BIOL, V377, P148, DOI 10.1016/j.jmb.2007.12.025; Graham JE, 2017, CELL, V169, P1201, DOI 10.1016/j.cell.2017.05.041; Hegde SP, 1996, P NATL ACAD SCI USA, V93, P14468, DOI 10.1073/pnas.93.25.14468; Henrikus SS, 2019, NUCLEIC ACIDS RES, V47, P2946, DOI 10.1093/nar/gkz003; Hiasa H, 1996, J BIOL CHEM, V271, P21529, DOI 10.1074/jbc.271.35.21529; Higuchi K, 2003, GENES CELLS, V8, P437, DOI 10.1046/j.1365-2443.2003.00646.x; HILL TM, 1990, P NATL ACAD SCI USA, V87, P2481, DOI 10.1073/pnas.87.7.2481; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; Honda M, 2006, J BIOL CHEM, V281, P18549, DOI 10.1074/jbc.M512658200; HORII T, 1981, CELL, V27, P515, DOI 10.1016/0092-8674(81)90393-7; Indiani C, 2013, FRONT BIOSCI-LANDMRK, V18, P312, DOI 10.2741/4102; Joo C, 2006, CELL, V126, P515, DOI 10.1016/j.cell.2006.06.042; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; KITANI T, 1985, J MOL BIOL, V184, P45, DOI 10.1016/0022-2836(85)90042-7; Kovacic L, 2013, NUCLEIC ACIDS RES, V41, P9901, DOI 10.1093/nar/gkt744; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P81, DOI 10.1016/0022-2836(87)90629-2; LADUCA RJ, 1986, J BIOL CHEM, V261, P7550; LAVERY PE, 1988, J MOL BIOL, V203, P861, DOI 10.1016/0022-2836(88)90112-X; LITTLE JW, 1984, P NATL ACAD SCI-BIOL, V81, P1375, DOI 10.1073/pnas.81.5.1375; LITTLE JW, 1991, BIOCHIMIE, V73, P411, DOI 10.1016/0300-9084(91)90108-D; LU C, 1987, J MOL BIOL, V196, P497, DOI 10.1016/0022-2836(87)90027-1; Luo Y, 2001, CELL, V106, P585, DOI 10.1016/S0092-8674(01)00479-2; Marceau AH, 2011, EMBO J, V30, P4236, DOI 10.1038/emboj.2011.305; Marians KJ, 2018, ANNU REV BIOCHEM, V87, P217, DOI 10.1146/annurev-biochem-062917-011921; Marians KJ, 1995, METHOD ENZYMOL, V262, P507; Maslowska KH, 2019, ENVIRON MOL MUTAGEN, V60, P368, DOI 10.1002/em.22267; McHenry CS, 2011, ANNU REV BIOCHEM, V80, P403, DOI 10.1146/annurev-biochem-061208-091655; McInerney P, 2004, J BIOL CHEM, V279, P21543, DOI 10.1074/jbc.M401649200; McInerney P, 2007, J BIOL CHEM, V282, P25903, DOI 10.1074/jbc.M703777200; Mohana-Borges R, 2000, J BIOL CHEM, V275, P4708, DOI 10.1074/jbc.275.7.4708; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; Morimatsu K, 2012, J BIOL CHEM, V287, P35621, DOI 10.1074/jbc.M112.397034; Neher SB, 2003, GENE DEV, V17, P1084, DOI 10.1101/gad.1078003; Pages V, 2003, SCIENCE, V300, P1300, DOI 10.1126/science.1083964; Park MS, 2009, J BIOL CHEM, V284, P31473, DOI 10.1074/jbc.M109.050310; PUGH BF, 1988, J MOL BIOL, V203, P479, DOI 10.1016/0022-2836(88)90014-9; PUGH BF, 1987, J BIOL CHEM, V262, P1326; Raychaudhury P, 2019, J BIOL CHEM, V294, P852, DOI 10.1074/jbc.RA118.005726; Reuven NB, 1999, J BIOL CHEM, V274, P31763, DOI 10.1074/jbc.274.45.31763; Roy R, 2009, NATURE, V461, P1092, DOI 10.1038/nature08442; Ryzhikov M, 2011, NUCLEIC ACIDS RES, V39, P6305, DOI 10.1093/nar/gkr199; Sakai A, 2009, J BIOL CHEM, V284, P3264, DOI 10.1074/jbc.M807220200; Sambrook J., 2001, MOL CLONING LAB MANU; SASSANFAR M, 1990, J MOL BIOL, V212, P79, DOI 10.1016/0022-2836(90)90306-7; Simmons LAJF, 2008, ECOSAL ESCHERICHIA C, V5, P4; Spenkelink LM, 2019, NUCLEIC ACIDS RES, V47, P4111, DOI 10.1093/nar/gkz090; Tang MJ, 1999, P NATL ACAD SCI USA, V96, P8919, DOI 10.1073/pnas.96.16.8919; UMEZU K, 1993, P NATL ACAD SCI USA, V90, P3875, DOI 10.1073/pnas.90.9.3875; UMEZU K, 1994, J BIOL CHEM, V269, P30005; Webb BL, 1997, CELL, V91, P347, DOI 10.1016/S0092-8674(00)80418-3; WILLIAMS KR, 1984, J BIOL CHEM, V259, P1804; Wu HL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05306-z; Xu LW, 2003, MOL CELL, V11, P817, DOI 10.1016/S1097-2765(03)00061-3; Yeeles JTP, 2013, MOL CELL, V52, P855, DOI 10.1016/j.molcel.2013.10.020; Yeeles JTP, 2011, SCIENCE, V334, P235, DOI 10.1126/science.1209111; ZECHNER EL, 1992, J BIOL CHEM, V267, P4054; Zhang APP, 2010, NATURE, V466, P883, DOI 10.1038/nature09200	72	4	4	4	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2020	295	30					10368	10379		10.1074/jbc.RA120.014224	http://dx.doi.org/10.1074/jbc.RA120.014224			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MW0BV	32513870	Green Published, hybrid			2022-12-26	WOS:000556713400020
J	Pietrocola, G; Pellegrini, A; Alfeo, MJ; Marchese, L; Foster, TJ; Speziale, P				Pietrocola, Giampiero; Pellegrini, Angelica; Alfeo, Mariangela J.; Marchese, Loredana; Foster, Timothy J.; Speziale, Pietro			The iron-regulated surface determinant B (IsdB) protein fromStaphylococcus aureusacts as a receptor for the host protein vitronectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Staphylococcus aureus; plasma; extracellular matrix protein; adhesion; cell invasion; innate immunity; virulence factor; integrin; vitronectin (Vn); iron-regulated surface determinant B (IsdB); S; aureus	CLUMPING FACTOR-B; HUMAN PLASMA VITRONECTIN; STAPHYLOCOCCUS-AUREUS; ADHESIVE PROPERTIES; BINDING REGION; CELL-WALL; FACTOR-I; AUTOLYSIN; COMPLEMENT; INTERNALIZATION	Staphylococcus aureusis an important bacterial pathogen that can cause a wide spectrum of diseases in humans and other animals.S. aureusexpresses a variety of virulence factors that promote infection with this pathogen. These include cell-surface proteins that mediate adherence of the bacterial cells to host extracellular matrix components, such as fibronectin and fibrinogen. Here, using immunoblotting, ELISA, and surface plasmon resonance analysis, we report that the iron-regulated surface determinant B (IsdB) protein, besides being involved in heme transport, plays a novel role as a receptor for the plasma and extracellular matrix protein vitronectin (Vn). Vn-binding activity was expressed by staphylococcal strains grown under iron starvation conditions when Isd proteins are expressed. Recombinant IsdB bound Vn dose dependently and specifically. Both near-iron transporter motifs NEAT(1)and NEAT(2)of IsdB individually bound Vn in a saturable manner, withK(D)values in the range of 16?18 nm. Binding of Vn to IsdB was specifically blocked by heparin and reduced at high ionic strength. Furthermore, IsdB-expressing bacterial cells bound significantly higher amounts of Vn from human plasma than did anisdBmutant. Adherence to and invasion of epithelial and endothelial cells by IsdB-expressingS. aureuscells was promoted by Vn, and an ?(v)?(3)integrin-blocking mAb or cilengitide inhibited adherence and invasion by staphylococci, suggesting that Vn acts as a bridge between IsdB and host ?(v)?(3)integrin.	[Pietrocola, Giampiero; Pellegrini, Angelica; Alfeo, Mariangela J.; Marchese, Loredana; Speziale, Pietro] Univ Pavia, Dept Mol Med, Unit Biochem, Pavia, Italy; [Foster, Timothy J.] Trinity Coll Dublin, Dept Microbiol, Dublin, Ireland	University of Pavia; Trinity College Dublin	Pietrocola, G; Speziale, P (corresponding author), Univ Pavia, Dept Mol Med, Unit Biochem, Pavia, Italy.	giampiero.pietrocola@unipv.it; pspeziale@unipv.it		Alfeo, Mariangela Jessica/0000-0002-4600-1901; PIETROCOLA, GIAMPIERO/0000-0002-7069-8155	FFABR 2018, "Fondo di finanziamento per le attivita base di ricerca," Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)	FFABR 2018, "Fondo di finanziamento per le attivita base di ricerca," Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)	This research was funded by FFABR 2018, "Fondo di finanziamento per le attivita base di ricerca," Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) to G. P.	Akiyama Steven K, 2013, Curr Protoc Cell Biol, V60, DOI 10.1002/0471143030.cb1006s60; Andrade MA, 2002, GENOME BIOL, V3; Attia AS, 2006, INFECT IMMUN, V74, P1597, DOI 10.1128/IAI.74.3.1597-1611.2006; Bagnoli F, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00016; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Bergmann S, 2009, J CELL SCI, V122, P256, DOI 10.1242/jcs.035600; Bowden CFM, 2018, J BIOL CHEM, V293, P177, DOI 10.1074/jbc.M117.806562; BOYD NAM, 1993, J CLIN PATHOL, V46, P1042, DOI 10.1136/jcp.46.11.1042; Brown M, 2009, CLIN VACCINE IMMUNOL, V16, P1095, DOI 10.1128/CVI.00085-09; Buommino E, 2014, FRONT BIOSCI-LANDMRK, V19, P408, DOI 10.2741/4215; Bur S, 2013, J INVEST DERMATOL, V133, P2004, DOI 10.1038/jid.2013.87; Chauhan AK, 2006, CLIN EXP IMMUNOL, V145, P398, DOI 10.1111/j.1365-2249.2006.03135.x; Clarke SR, 2007, CELL HOST MICROBE, V1, P199, DOI 10.1016/j.chom.2007.04.005; Clarke SR, 2004, MOL MICROBIOL, V51, P1509, DOI 10.1111/j.1365-2958.2003.03938.x; Claro T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018748; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Dryla A, 2003, MOL MICROBIOL, V49, P37, DOI 10.1046/j.1365-2958.2003.03542.x; Eidhin DN, 1998, MOL MICROBIOL, V30, P245; Farrand AJ, 2015, INFECT IMMUN, V83, P3578, DOI 10.1128/IAI.00397-15; Foster TJ, 2019, TRENDS MICROBIOL, V27, P927, DOI 10.1016/j.tim.2019.06.007; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Fowler VG, 2013, JAMA-J AM MED ASSOC, V309, P1368, DOI 10.1001/jama.2013.3010; Ganesh VK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000226; Geoghegan JA, 2010, J BIOL CHEM, V285, P6208, DOI 10.1074/jbc.M109.062208; Gianquinto E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54970-w; Grigg JC, 2010, J INORG BIOCHEM, V104, P341, DOI 10.1016/j.jinorgbio.2009.09.012; Habermann BF, 1993, CURR OPIN CELL BIOL, V5, P864, DOI 10.1016/0955-0674(93)90036-P; Hair PS, 2008, J INFECT DIS, V198, P125, DOI 10.1086/588825; Hair PS, 2010, INFECT IMMUN, V78, P1717, DOI 10.1128/IAI.01065-09; Hammer ND, 2011, ANNU REV MICROBIOL, V65, P129, DOI 10.1146/annurev-micro-090110-102851; Hare SA, 2017, BBA-PROTEINS PROTEOM, V1865, P422, DOI 10.1016/j.bbapap.2017.01.006; Heilbronner S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006246; Heilmann C, 2003, MICROBIOL-SGM, V149, P2769, DOI 10.1099/mic.0.26527-0; Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x; Higgins J, 2006, FEMS MICROBIOL LETT, V258, P290, DOI 10.1111/j.1574-6968.2006.00229.x; Hirschhausen N, 2010, CELL MICROBIOL, V12, P1746, DOI 10.1111/j.1462-5822.2010.01506.x; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Hussain M, 2015, INT J MED MICROBIOL, V305, P129, DOI 10.1016/j.ijmm.2014.11.010; Hynes RO, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a004903; IZUMI M, 1989, BIOCHIM BIOPHYS ACTA, V990, P101, DOI 10.1016/S0304-4165(89)80019-4; Johnson MB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03614-y; Josse J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02433; Kim HK, 2010, VACCINE, V28, P6382, DOI 10.1016/j.vaccine.2010.02.097; Kohler TP, 2014, J BIOL CHEM, V289, P4070, DOI 10.1074/jbc.M113.521229; KOST C, 1992, J BIOL CHEM, V267, P12098; Kuklin NA, 2006, INFECT IMMUN, V74, P2215, DOI 10.1128/IAI.74.4.2215-2223.2006; Leavesley DI, 2013, IUBMB LIFE, V65, P807, DOI 10.1002/iub.1203; Liang OD, 1997, FEBS LETT, V407, P169, DOI 10.1016/S0014-5793(97)00330-X; Lynn GW, 2005, BIOCHEMISTRY-US, V44, P565, DOI 10.1021/bi048347s; Maresso AW, 2006, BIOMETALS, V19, P193, DOI 10.1007/s10534-005-4863-7; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; McDevitt D, 1997, EUR J BIOCHEM, V247, P416, DOI 10.1111/j.1432-1033.1997.00416.x; Meenan NAG, 2007, J BIOL CHEM, V282, P25893, DOI 10.1074/jbc.M703063200; Miajlovic H, 2010, MICROBIOL-SGM, V156, P920, DOI 10.1099/mic.0.036673-0; MILIS L, 1993, CLIN EXP IMMUNOL, V92, P114; Mulcahy ME, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003092; Naba A, 2016, MATRIX BIOL, V49, P10, DOI 10.1016/j.matbio.2015.06.003; Newton SMC, 2005, MOL MICROBIOL, V55, P927, DOI 10.1111/j.1365-2958.2004.04436.x; O'Brien LM, 2002, CELL MICROBIOL, V4, P759, DOI 10.1046/j.1462-5822.2002.00231.x; O'Halloran DP, 2015, INFECT IMMUN, V83, P1598, DOI 10.1128/IAI.03122-14; PATEL AH, 1987, INFECT IMMUN, V55, P3103, DOI 10.1128/IAI.55.12.3103-3110.1987; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Perkins S, 2001, J BIOL CHEM, V276, P44721, DOI 10.1074/jbc.M106741200; Pilpa RM, 2006, J MOL BIOL, V360, P435, DOI 10.1016/j.jmb.2006.05.019; Preissner KT, 1998, THROMB RES, V89, P1, DOI 10.1016/S0049-3848(97)00298-3; Ross CL, 2012, J BIOL CHEM, V287, P34856, DOI 10.1074/jbc.M112.371054; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SaraviaOtten P, 1997, J BACTERIOL, V179, P5259, DOI 10.1128/jb.179.17.5259-5263.1997; Schvartz I, 1999, INT J BIOCHEM CELL B, V31, P539, DOI 10.1016/S1357-2725(99)00005-9; SEIFFERT D, 1995, FEBS LETT, V368, P155, DOI 10.1016/0014-5793(95)00630-R; Seiffert D, 1997, J BIOL CHEM, V272, P13705, DOI 10.1074/jbc.272.21.13705; Singh B, 2010, MOL MICROBIOL, V78, P545, DOI 10.1111/j.1365-2958.2010.07373.x; Skaar EP, 2004, MICROBES INFECT, V6, P390, DOI 10.1016/j.micinf.2003.12.008; Skaar EP, 2006, J BACTERIOL, V188, P1071, DOI 10.1128/JB.188.3.1071-1080.2006; Speziale P, 2008, NAT PROTOC, V3, P525, DOI 10.1038/nprot.2008.12; STANLEY KK, 1986, FEBS LETT, V199, P249, DOI 10.1016/0014-5793(86)80489-6; STOCKMANN A, 1993, J BIOL CHEM, V268, P22874; Stranger-Jones YK, 2006, P NATL ACAD SCI USA, V103, P16942, DOI 10.1073/pnas.0606863103; Toida T, 1997, BIOCHEM J, V322, P499, DOI 10.1042/bj3220499; Tong SYC, 2015, CLIN MICROBIOL REV, V28, P603, DOI 10.1128/CMR.00134-14; Tribelli PM, 2020, CELL MICROBIOL, V22, DOI 10.1111/cmi.13111; Vazquez V, 2011, J BIOL CHEM, V286, P29797, DOI 10.1074/jbc.M110.214981; Viela F, 2019, MBIO, V10, DOI 10.1128/mBio.00555-19; Visai L, 2009, MICROBIOL-SGM, V155, P667, DOI 10.1099/mic.0.025684-0; Vitry P, 2017, MBIO, V8, DOI 10.1128/mBio.01748-17; Walsh EJ, 2004, J BIOL CHEM, V279, P50691, DOI 10.1074/jbc.M408713200; Zapotoczna M, 2013, CELL MICROBIOL, V15, P1026, DOI 10.1111/cmi.12097; Zapotoczna M, 2012, J BACTERIOL, V194, P6453, DOI 10.1128/JB.01195-12; Zhuang P, 1996, J BIOL CHEM, V271, P14333, DOI 10.1074/jbc.271.24.14333; Zoll S, 2012, J BACTERIOL, V194, P3789, DOI 10.1128/JB.00331-12	90	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2020	295	29					10008	10022		10.1074/jbc.RA120.013510	http://dx.doi.org/10.1074/jbc.RA120.013510			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MR1DY	32499371	Green Published, hybrid			2022-12-26	WOS:000553333300019
J	Asresie, MB; Fekadu, GA; Dagnew, GW				Asresie, Melash Belachew; Fekadu, Gedefaw Abeje; Dagnew, Gizachew Worku			Contraceptive use among women with no fertility intention in Ethiopia	PLOS ONE			English	Article							UNMET NEED; UNINTENDED PREGNANCY; HEALTH; TRENDS	Introduction Ethiopia is one of the Sub-Saharan African countries with high unintended pregnancy rate. Every woman in Ethiopia experiences at least one unintended birth. Although there were some studies about contraceptive use among all women in Ethiopia, evidence about contraceptive use among women with no fertility intention was limited. Therefore, this analysis was performed to assess the prevalence of contraceptive use and associated factors among fecund, married reproductive-age women who intended no more children. Methods We used the 2016 Ethiopian Demography and Health Survey (EDHS) data collected through a two-stage stratified cluster sampling technique. EDHS was a community based, cross-sectional study conducted from January 18, 2016, to June 27, 2016. A total of 2,859 fecund married reproductive age women with no desire to have more children were included in this study. Both descriptive and logistic regression analysis were performed using STATA V.14. A 95% confidence interval was used to declare statistical significance. Results Contraceptive use among fecund married reproductive-age women who want no more children was 51.1% (95%CI: 47.0-55.24%). Visit by health workers at home (AOR = 1.37, 95%CI: 1.02, 1.83), living in Addis Ababa (AOR = 3.38 95%CI: 1.76, 6.37) and having better wealth index (middle (AOR = 1.76, 95%CI: 1.25, 2.47) and being rich (AOR = 1.96, 95%CI: 1.40, 2.74)) were found positively associated with contraceptive use. On the other hand, living in the Somali region (AOR = 0.10, 95%CI: 0.01, 0.85), and being Muslim (AOR = 0.45, 95%CI: 0.30, 0.67) were found negatively associated with contraceptive use. Conclusion Contraceptive use among fecund married reproductive-age women with no fertility intention was low compared to their demand. Therefore, to improve contraceptive use, the provision of family planning counseling and information should be strengthened. Further intervention is needed to narrow disparities in contraceptive use among regions and different population groups.	[Asresie, Melash Belachew; Fekadu, Gedefaw Abeje; Dagnew, Gizachew Worku] Bahir Dar Univ, Sch Publ Hlth, Dept Reprod Hlth & Populat Studies, Coll Med & Hlth Sci, Bahir Dar, Ethiopia	Bahir Dar University	Asresie, MB (corresponding author), Bahir Dar Univ, Sch Publ Hlth, Dept Reprod Hlth & Populat Studies, Coll Med & Hlth Sci, Bahir Dar, Ethiopia.	Kalleab1@gmail.com	Dagnew, Gizachew Worku/ABE-7194-2021	Dagnew, Gizachew Worku/0000-0003-2043-3041; Asresie, Melash Belachew/0000-0002-4173-0646				Adebowale S. A., 2013, African Population Studies, V27, P127, DOI 10.11564/27-2-435; Adebowale SA, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-40; Ahmed S, 2012, LANCET, V380, P111, DOI 10.1016/S0140-6736(12)60478-4; Alkema L, 2013, LANCET, V381, P1642, DOI 10.1016/S0140-6736(12)62204-1; Alsaleem MA, 2018, SAUDI MED J, V39, P1109, DOI 10.15537/smj.2018.11.22817; [Anonymous], 2009, HEMATOL ONCOL CLIN N, V23, pviii, DOI 10.1016/j.hoc.2008.11.006; [Anonymous], 2011, J PEDIAT HLTH CARE, V25, pA9; [Anonymous], STESASERA414 UN POP; [Anonymous], 2004, EJIR, V10, P43; Apanga PA, 2015, PAN AFR MED J, V20, DOI 10.11604/pamj.2015.20.10.5301; Arbab A., 2011, PREVALENCE AWARENESS; Austin A, 2015, CONTRACEPTION, V91, P31, DOI 10.1016/j.contraception.2014.10.002; Avong H. N., 2012, Research on Humanities and Social Sciences, V2, P82; Babalola S, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4934-z; BONGAARTS J, 1995, STUD FAMILY PLANN, V26, P57, DOI 10.2307/2137932; Calhoun LM, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-48; Casterline JB, 2003, INT FAM PLAN PERSPEC, V29, P158, DOI 10.2307/3181044; Cleland J., 1994, DETERMINANTS REPROD, V72, P1; Crissman HP, 2012, STUD FAMILY PLANN, V43, P201, DOI 10.1111/j.1728-4465.2012.00318.x; Dahal GP, 2008, INT FAM PLAN PERSPEC, V34, P6, DOI 10.1363/ifpp.34.006.08; Decker Martha, 2011, Afr J Reprod Health, V15, P68; Endriyas M, 2017, CONTRACEP REPROD MED, V2, DOI 10.1186/s40834-016-0036-z; Ethiopian Mederal Ministery of Health, 2015, HSTP HLTH SECT TRANS; FMOH, 2006, HLTH HLTH REL IND ET; Genet E, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0038-3; Gipson JD, 2008, STUD FAMILY PLANN, V39, P18, DOI 10.1111/j.1728-4465.2008.00148.x; Haq Iqramul, 2017, Med Sci (Basel), V5, DOI 10.3390/medsci5040031; Hossain MB, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5098-1; ICF, 2016, CSACEA EDHS SURV 201; Kabir A., 2001, J MED SCI, V1, P296, DOI [10.3923/jms.2001.296.301, DOI 10.3923/JMS.2001.296.301]; Kesetebirhan A, 2011, NATL GUIDELINE FAMIL; Khalil SN, 2018, MIDDLE EAST FERTIL S, V23, P31, DOI 10.1016/j.mefs.2017.07.004; Lakew Y, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-52; Liu L, 2008, POP STUD-J DEMOG, V62, P191, DOI 10.1080/00324720801897796; MacQuarrie KLD, 2014, UNMET NEED FAMILY PL; Mohan P., 2007, ETHIOPIA HLTH SECTOR; Musa A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3292-6; National Institute of population Research and training (NIPORT), 2009, BANGL DEM HLTH SURV; Omran A.R., 2012, FAMILY PLANNING LEGA; Osmani AK, 2015, NAGOYA J MED SCI, V77, P551; Oye-Adeniran Boniface A, 2006, Afr J Reprod Health, V10, P90; Retherford RD, 1997, MEDIA EXPOSURE INCRE; Singh S, 2009, ADDING IT COSTS BENE; Singh S, 2010, STUD FAMILY PLANN, V41, P241, DOI 10.1111/j.1728-4465.2010.00250.x; Speizer IS, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0729-3; Tadele A, 2019, CONTRACEP REPROD MED, V4, DOI 10.1186/s40834-019-0087-z; Tani KM, 2015, LAW HIST REV, V33, P1, DOI 10.1017/S073824801400056X; Tekelab T, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0208-z; Viswan SP, 2017, INT J WOMENS HEALTH, V9, P581, DOI 10.2147/IJWH.S133760; Withers M, 2010, J BIOSOC SCI, V42, P549, DOI 10.1017/S0021932010000052; Worku SA, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4180-9; World Health Organization, 2019, FAM PLANN CONTR WHO	52	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234474	10.1371/journal.pone.0234474	http://dx.doi.org/10.1371/journal.pone.0234474			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MA6QL	32525935	Green Published, gold			2022-12-26	WOS:000542036800028
J	Pyart, R; Aggett, J; Goodland, A; Jones, H; Prichard, A; Pugh, J; Thomas, N; Roberts, G				Pyart, Rhodri; Aggett, Justine; Goodland, Annwen; Jones, Hayley; Prichard, Alison; Pugh, Julia; Thomas, Nerys; Roberts, Gareth			Exploring the choices and outcomes of older patients with advanced kidney disease	PLOS ONE			English	Article							RENAL REPLACEMENT THERAPY; SHARED DECISION-MAKING; OF-LIFE CARE; CONSERVATIVE MANAGEMENT; ELDERLY-PATIENTS; COMPARATIVE SURVIVAL; DIALYSIS PATIENTS; FRAILTY; COMORBIDITY; EDUCATION	A lack of data on patient choices and outcomes at the time of pre-dialysis planning limits meaningful shared decision making, particularly in older frailer patients. In this large retrospective cohort study of patients aged over 70 seen by the pre-dialysis clinic (2004-2016) of a large single centre in the United Kingdom (1,216 patients), age, sex, comorbidity, poverty and frailty were used to predict choice of renal replacement therapy (RRT) over maximum conservative management (MCM). The impact of patient choice of RRT versus MCM was used to predict survival from the time of choice using multivariable Cox proportional hazards regression. Older age, female sex, greater poverty and greater frailty were associated with choosing MCM, whilst comorbidity had no significant impact on choice. At 5 years of follow up, 49% of all patients had died without receiving RRT. Over 70% of the patients choosing MCM died with better kidney function than the median level at which those starting RRT initiated treatment. Frailty and age were better predictors of survival than comorbidity and in patients with at least moderate frailty, RRT offered no survival benefit over MCM. In conclusion, analysing outcomes from the time of choice may improve shared decision making. Frailty should be routinely assessed and collected and further work may help predict which patients are unlikely to survive or progress to end stage renal disease and may not need to be burdened with making a pre-dialysis choice.	[Pyart, Rhodri; Aggett, Justine; Goodland, Annwen; Jones, Hayley; Prichard, Alison; Pugh, Julia; Thomas, Nerys; Roberts, Gareth] Univ Hosp Wales, Dept Nephrol & Transplantat, Cardiff, Wales	Cardiff University	Pyart, R (corresponding author), Univ Hosp Wales, Dept Nephrol & Transplantat, Cardiff, Wales.	rhodri.pyart@wales.nhs.uk						Alfaadhel TA, 2015, CLIN J AM SOC NEPHRO, V10, P832, DOI 10.2215/CJN.07760814; [Anonymous], 2017, MEDICINE, V96, pe6504; Benzeval M., 2014, DOES MONEY INFLUENCE; Berger JR, 2012, CLIN J AM SOC NEPHRO, V7, P1039, DOI 10.2215/CJN.10411011; Brennan F, 2017, CLIN J AM SOC NEPHRO, V12, P1001, DOI 10.2215/CJN.09740916; Brown MA, 2015, CLIN J AM SOC NEPHRO, V10, P260, DOI 10.2215/CJN.03330414; Carson RC, 2009, CLIN J AM SOC NEPHRO, V4, P1611, DOI 10.2215/CJN.00510109; CHARLSON ME, 1987, J CHRON DIS, V40, P31, DOI 10.1016/0021-9681(87)90094-4; Couchoud CG, 2015, KIDNEY INT, V88, P1178, DOI 10.1038/ki.2015.245; Davison SN, 2010, CLIN J AM SOC NEPHRO, V5, P195, DOI 10.2215/CJN.05960809; Devoe DJ, 2016, AM J KIDNEY DIS, V68, P422, DOI 10.1053/j.ajkd.2016.02.053; Di Micco L, 2009, NEPHROL DIAL TRANSPL, V24, P3434, DOI 10.1093/ndt/gfp281; Farrington K, 2011, NEPHRON CLIN PRACT, V118, pC189, DOI 10.1159/000328069; Gilg J, 2017, NEPHRON, V137, P11, DOI 10.1159/000481363; Hemmelgarn BR, 2003, AM J KIDNEY DIS, V42, P125, DOI 10.1016/S0272-6386(03)00415-3; Hole B, 2016, SEMIN DIALYSIS, V29, P491, DOI 10.1111/sdi.12535; Hussain JA, 2013, PALLIATIVE MED, V27, P829, DOI 10.1177/0269216313484380; Johansen KL, 2013, SEMIN DIALYSIS, V26, P690, DOI 10.1111/sdi.12126; Kalantar-Zadeh K, 2017, NEPHROL DIAL TRANSPL, V32, P91, DOI 10.1093/ndt/gfw357; Koncicki HM, 2016, AM J KIDNEY DIS, V67, P688, DOI 10.1053/j.ajkd.2015.09.032; McAdams-DeMarco MA, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-224; Methven S, 2017, NEPHRON, V137, P117, DOI 10.1159/000481367; Morton RL, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c112; Morton RL, 2016, CLIN J AM SOC NEPHRO, V11, P2195, DOI 10.2215/CJN.11861115; Murtagh FEM, 2007, NEPHROL DIAL TRANSPL, V22, P1955, DOI 10.1093/ndt/gfm153; Murtagh FEM, 2016, CLIN J AM SOC NEPHRO, V11, P1909, DOI 10.2215/CJN.04840516; National Assembly for Wales Communities EaLGC, 2015, INQ POV WAL POV IN; Nee R, 2017, AM J NEPHROL, V45, P464, DOI 10.1159/000475767; Noordzij M, 2012, NEPHROL DIAL TRANSPL, V27, P3385, DOI 10.1093/ndt/gfs031; O'Connor NR, 2012, J PALLIAT MED, V15, P228, DOI 10.1089/jpm.2011.0207; O'Hare AM, 2007, J AM SOC NEPHROL, V18, P2758, DOI 10.1681/ASN.2007040422; Pugh J, 2016, CLIN KIDNEY J, V9, P324, DOI 10.1093/ckj/sfv150; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Rosansky SJ, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0617-3; Statistics for Wales, 2014, WELSH IND MULT DEPR; Sy J, 2017, CURR OPIN NEPHROL HY, V26, P537, DOI 10.1097/MNH.0000000000000364; Thamer M, 2015, AM J KIDNEY DIS, V66, P1024, DOI 10.1053/j.ajkd.2015.05.014; van de Pol MHJ, 2016, PATIENT EDUC COUNS, V99, P1069, DOI 10.1016/j.pec.2015.12.014; Van den Bosch J, 2015, PATIENT PREFER ADHER, V9, P1279, DOI 10.2147/PPA.S81284; van Loon I N., 2017, FRAILTY SCREENING TO; Verberne WR, 2016, CLIN J AM SOC NEPHRO, V11, P633, DOI 10.2215/CJN.07510715; Vetrano DL, 2019, J GERONTOLOGY A; Williams AW, 2012, CLIN J AM SOC NEPHRO, V7, P1664, DOI 10.2215/CJN.04970512	43	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2020	15	6							e0234309	10.1371/journal.pone.0234309	http://dx.doi.org/10.1371/journal.pone.0234309			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC0EC	32520955	gold, Green Published			2022-12-26	WOS:000542969500034
J	Weinberg, F; Han, MKL; Dahmke, IN; Del Campo, A; de Jonge, N				Weinberg, Florian; Han, Mitchell Kim Liong; Dahmke, Indra Navina; Del Campo, Aranzazu; de Jonge, Niels			Anti-correlation of HER2 and focal adhesion complexes in the plasma membrane	PLOS ONE			English	Article							BREAST-CANCER; ERBB2; KINASE; RESISTANCE; INTEGRINS; PROTEINS; SINGLE; CELLS	Excess presence of the human epidermal growth factor receptor 2 (HER2) as well as of the focal adhesion protein complexes are associated with increased proliferation, migratory, and invasive behavior of cancer cells. A cross-regulation between HER2 and integrin signaling pathways has been found, but the exact mechanism remains elusive. Here, we investigated whether HER2 colocalizes with focal adhesion complexes on breast cancer cells overexpressing HER2. For this purpose, vinculin or talin green fluorescent protein (GFP) fusion proteins, both key constituents of focal adhesions, were expressed in breast cancer cells. HER2 was either extracellularly or intracellularly labeled with fluorescent quantum dots nanoparticles (QDs). The cell-substrate interface was analyzed at the location of the focal adhesions by means of total internal reflection fluorescent microscopy or correlative fluorescence- and scanning transmission electron microscopy. Expression of HER2 at the cell-substrate interface was only observed upon intracellular labeling, and was heterogeneous with both HER2-enriched and -low regions. In contrast to an expected enrichment of HER2 at focal adhesions, an anti-correlated expression pattern was observed for talin and HER2. Our findings suggest a spatial anti-correlation between HER2 and focal adhesion complexes for adherent cells.	[Weinberg, Florian; Han, Mitchell Kim Liong; Dahmke, Indra Navina; Del Campo, Aranzazu; de Jonge, Niels] INM Leibniz Inst New Mat, Saarbrucken, Germany; [Del Campo, Aranzazu] Univ Saarland, Dept Chem, Saarbrucken, Germany; [de Jonge, Niels] Univ Saarland, Dept Phys, Saarbrucken, Germany	Leibniz Institut fur Neue Materialien (INM); Saarland University; Saarland University	de Jonge, N (corresponding author), INM Leibniz Inst New Mat, Saarbrucken, Germany.; de Jonge, N (corresponding author), Univ Saarland, Dept Phys, Saarbrucken, Germany.	niels.dejonge@leibniz-inm.de	de Jonge, Niels/B-5677-2008	de Jonge, Niels/0000-0002-3969-6821	Else Kroner-Fresenius-Stiftung; Deutsche Forschungsgemeinschaft [SFB1027]	Else Kroner-Fresenius-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Else Kroner-Fresenius-Stiftung (FW), and the Deutsche Forschungsgemeinschaft SFB1027 projects B6 (MKLH, ADC), and C7 (IND, NdJ).	Burridge K, 2016, EXP CELL RES, V343, P14, DOI 10.1016/j.yexcr.2015.10.029; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; da Silva EC, 2019, CANCERS, V11, DOI 10.3390/cancers11050692; Dahmke IN, 2017, ACS NANO, V11, P11108, DOI 10.1021/acsnano.7b05258; De Pascalis C, 2017, MOL BIOL CELL, V28, P1833, DOI 10.1091/mbc.E17-03-0134; Eke I, 2015, SEMIN CANCER BIOL, V31, P65, DOI 10.1016/j.semcancer.2014.07.009; Falcioni R, 1997, EXP CELL RES, V236, P76, DOI 10.1006/excr.1997.3695; Fazekas Z, 2008, CYTOM PART A, V73A, P209, DOI 10.1002/cyto.a.20489; Giepmans BNG, 2005, NAT METHODS, V2, P743, DOI 10.1038/NMETH791; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Hanker AB, 2017, CANCER RES, V77, P3280, DOI 10.1158/0008-5472.CAN-16-2808; Hou J, 2016, ONCOTARGET, V7, P45186, DOI 10.18632/oncotarget.9870; Ivaska J, 2011, ANNU REV CELL DEV BI, V27, P291, DOI 10.1146/annurev-cellbio-092910-154017; Jeong J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174849; Lal S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131842; Lazaro G, 2013, ENDOCR-RELAT CANCER, V20, P691, DOI 10.1530/ERC-13-0019; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Toscani AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174230; Mocanu MM, 2005, CANCER LETT, V227, P201, DOI 10.1016/j.canlet.2005.01.028; Palomeras S, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-019-1160-x; Peckys DB, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500165; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Wang SZE, 2006, CANCER RES, V66, P9591, DOI 10.1158/0008-5472.CAN-06-2071; Wang SE, 2009, CANCER RES, V69, P475, DOI 10.1158/0008-5472.CAN-08-2649; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; Yoon SO, 2006, CANCER RES, V66, P2732, DOI 10.1158/0008-5472.CAN-05-2941	26	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2020	15	6							e0234430	10.1371/journal.pone.0234430	http://dx.doi.org/10.1371/journal.pone.0234430			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ0RE	32511274	Green Published, gold			2022-12-26	WOS:000540938100027
J	Trujillo-Pisanty, I; Conover, K; Solis, P; Palacios, D; Shizgal, P				Trujillo-Pisanty, Ivan; Conover, Kent; Solis, Pavel; Palacios, Daniel; Shizgal, Peter			Dopamine neurons do not constitute an obligatory stage in the final common path for the evaluation and pursuit of brain stimulation reward	PLOS ONE			English	Article							MEDIAL FOREBRAIN-BUNDLE; INTRACRANIAL SELF-STIMULATION; VENTRAL TEGMENTAL AREA; NUCLEUS-ACCUMBENS; NEURAL SUBSTRATE; HYPOTHALAMIC-STIMULATION; SUBJECTIVE MAGNITUDE; CONDUCTION-VELOCITY; OPERANT PERFORMANCE; REFRACTORY PERIOD	The neurobiological study of reward was launched by the discovery of intracranial self-stimulation (ICSS). Subsequent investigation of this phenomenon provided the initial link between reward-seeking behavior and dopaminergic neurotransmission. We re-evaluated this relationship by psychophysical, pharmacological, optogenetic, and computational means. In rats working for direct, optical activation of midbrain dopamine neurons, we varied the strength and opportunity cost of the stimulation and measured time allocation, the proportion of trial time devoted to reward pursuit. We found that the dependence of time allocation on the strength and cost of stimulation was similar formally to that observed when electrical stimulation of the medial forebrain bundle served as the reward. When the stimulation is strong and cheap, the rats devote almost all their time to reward pursuit; time allocation falls off as stimulation strength is decreased and/or its opportunity cost is increased. A 3D plot of time allocation versus stimulation strength and cost produces a surface resembling the corner of a plateau (the "reward mountain"). We show that dopamine-transporter blockade shifts the mountain along both the strength and cost axes in rats working for optical activation of midbrain dopamine neurons. In contrast, the same drug shifted the mountain uniquely along the opportunity-cost axis when rats worked for electrical MFB stimulation in a prior study. Dopamine neurons are an obligatory stage in the dominant model of ICSS, which positions them at a key nexus in the final common path for reward seeking. This model fails to provide a cogent account for the differential effect of dopamine transporter blockade on the reward mountain. Instead, we propose that midbrain dopamine neurons and neurons with non-dopaminergic, MFB axons constitute parallel limbs of brain-reward circuitry that ultimately converge on the final-common path for the evaluation and pursuit of rewards.	[Trujillo-Pisanty, Ivan; Conover, Kent; Solis, Pavel; Palacios, Daniel; Shizgal, Peter] Concordia Univ, Ctr Studies Behav Neurobiol, Montreal, PQ, Canada; [Trujillo-Pisanty, Ivan] Univ Washington, Dept Pharmacol, Dept Anesthesiol & Pain Med, Ctr Neurobiol Addict Pain & Emot, Seattle, WA 98195 USA	Concordia University - Canada; University of Washington; University of Washington Seattle	Shizgal, P (corresponding author), Concordia Univ, Ctr Studies Behav Neurobiol, Montreal, PQ, Canada.	peter.shizgal@concordia.ca	Core, Vector/CAF-4832-2022	Shizgal, Peter/0000-0003-4265-0792	Natural Sciences and Engineering Research Council of Canada [s RGPIN 308-11, RGPIN-2016-06703]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	PS; Natural Sciences and Engineering Research Council of Canada grants #s RGPIN 308-11,RGPIN-2016-06703; https://www.nserc-crsng.gc.ca The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamantidis AR, 2011, J NEUROSCI, V31, P10829, DOI 10.1523/JNEUROSCI.2246-11.2011; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anderson RM, 1996, BRAIN RES, V718, P83, DOI 10.1016/0006-8993(96)00038-8; Arvanitogiannis A, 2008, BEHAV NEUROSCI, V122, P1126, DOI 10.1037/a0012679; BAUM WM, 1969, J EXP ANAL BEHAV, V12, P861, DOI 10.1901/jeab.1969.12-861; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; BIELAJEW C, 1982, BRAIN RES, V237, P107, DOI 10.1016/0006-8993(82)90560-1; BIELAJEW C, 1986, J NEUROSCI, V6, P919; Breton YA, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00284; Breton YA, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00125; Breton YA, 2009, BEHAV BRAIN RES, V202, P77, DOI 10.1016/j.bbr.2009.03.019; Budygin EA, 2000, NEUROSCI LETT, V281, P9, DOI 10.1016/S0304-3940(00)00813-2; Carlezon WA, 2007, NAT PROTOC, V2, P2987, DOI 10.1038/nprot.2007.441; Cheer JF, 2005, P NATL ACAD SCI USA, V102, P19150, DOI 10.1073/pnas.0509607102; Cheer JF, 2007, NEURON, V54, P237, DOI 10.1016/j.neuron.2007.03.021; CONOVER KL, 1994, BEHAV NEUROSCI, V108, P537, DOI 10.1037/0735-7044.108.3.537; Cossette MP, 2016, BEHAV BRAIN RES, V297, P345, DOI 10.1016/j.bbr.2015.10.029; Cossette MP, 2019, ANATOMICAL COMPUTATI; Covey DP, 2019, CELL REP, V27, P481, DOI 10.1016/j.celrep.2019.03.055; Cragg SJ, 1997, J NEUROPHYSIOL, V77, P863, DOI 10.1152/jn.1997.77.2.863; CROW TJ, 1970, LIFE SCI, V9, P375, DOI 10.1016/0024-3205(70)90190-6; Davis GL, 2018, BEHAV BRAIN RES, V337, P61, DOI 10.1016/j.bbr.2017.09.043; de Jong JW, 2019, NEURON, V101, P133, DOI 10.1016/j.neuron.2018.11.005; Dreyer JK, 2016, J NEUROSCI, V36, P98, DOI 10.1523/JNEUROSCI.2326-15.2016; EDMONDS DE, 1977, J COMP PHYSIOL PSYCH, V91, P962, DOI 10.1037/h0077391; Efron B., 1994, INTRO BOOTSTRAP; Ehrich JM, 2014, NEUROPSYCHOPHARMACOL, V39, P3036, DOI 10.1038/npp.2014.157; ESPOSITO RU, 1978, PHARMACOL BIOCHEM BE, V8, P437, DOI 10.1016/0091-3057(78)90082-5; Farassat N, 2019, IN VIVO FUNCTIONAL D, P624700; Faumont S, 2012, CURR OPIN NEUROBIOL, V22, P580, DOI 10.1016/j.conb.2012.05.005; Fiorillo CD, 2011, NEUROSCIENCE, V197, P162, DOI 10.1016/j.neuroscience.2011.09.037; FORGIE ML, 1993, BEHAV NEUROSCI, V107, P506, DOI 10.1037/0735-7044.107.3.506; Forster GL, 2000, EUR J NEUROSCI, V12, P3596, DOI 10.1046/j.1460-9568.2000.00250.x; GALLISTEL CR, 1981, PSYCHOL REV, V88, P228, DOI 10.1037/0033-295X.88.3.228; GALLISTEL CR, 1991, BEHAV NEUROSCI, V105, P913, DOI 10.1037/0735-7044.105.6.913; GALLISTEL CR, 1978, J COMP PHYSIOL PSYCH, V92, P977, DOI 10.1037/h0077513; Gallistel CR, 1976, BRAIN STIMULATION RE, P97; GERMAN DC, 1974, BRAIN RES, V73, P381, DOI 10.1016/0006-8993(74)90666-0; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; HATTORI T, 1991, J COMP NEUROL, V309, P391, DOI 10.1002/cne.903090308; Hernandez G, 2012, J NEUROSCI, V32, P11032, DOI 10.1523/JNEUROSCI.1051-12.2012; HERRNSTE.RJ, 1974, J EXP ANAL BEHAV, V21, P159, DOI 10.1901/jeab.1974.21-159; Herrnstein RJ, 1970, J EXP ANAL BEHAV, V13, P243, DOI 10.1901/jeab.1970.13-243; HERRNSTEIN RJ, 1961, J EXP ANAL BEHAV, V4, P267, DOI 10.1901/jeab.1961.4-267; HEYMAN GM, 1994, J EXP ANAL BEHAV, V61, P505, DOI 10.1901/jeab.1994.61-505; Hills TT, 2015, TRENDS COGN SCI, V19, P46, DOI 10.1016/j.tics.2014.10.004; Hills TT, 2006, COGNITIVE SCI, V30, P3, DOI 10.1207/s15516709cog0000_50; HODOS W, 1961, SCIENCE, V134, P943, DOI 10.1126/science.134.3483.943; HUSTON JP, 1973, BRAIN RES, V50, P467, DOI 10.1016/0006-8993(73)90753-1; HUSTON JP, 1974, PHYSIOL BEHAV, V12, P433, DOI 10.1016/0031-9384(74)90121-8; Ilango A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00155; Ilango A, 2014, J NEUROSCI, V34, P817, DOI 10.1523/JNEUROSCI.1703-13.2014; JOHNSON PI, 1994, BRAIN RES, V646, P73, DOI 10.1016/0006-8993(94)90059-0; Keller CM, 2011, PSYCHOPHARMACOLOGY, V215, P513, DOI 10.1007/s00213-011-2301-9; KILLEEN P, 1972, J EXP ANAL BEHAV, V17, P489, DOI 10.1901/jeab.1972.17-489; Lammel S, 2014, NEUROPHARMACOLOGY, V76, P351, DOI 10.1016/j.neuropharm.2013.03.019; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; LEON M, 1992, BEHAV BRAIN RES, V52, P183, DOI 10.1016/S0166-4328(05)80229-3; MAEDA H, 1980, BRAIN RES, V197, P365, DOI 10.1016/0006-8993(80)91122-1; MARK TA, 1993, BEHAV NEUROSCI, V107, P389, DOI 10.1037/0735-7044.107.2.389; MATTHEWS G, 1977, J COMP PHYSIOL PSYCH, V91, P858, DOI 10.1037/h0077373; McDowell JJ, 2005, J EXP ANAL BEHAV, V84, P111, DOI 10.1901/jeab.2005.59-04; MILIARESSIS E, 1986, PHYSIOL BEHAV, V37, P85, DOI 10.1016/0031-9384(86)90388-4; Mingote S, 2015, J NEUROSCI, V35, P16259, DOI 10.1523/JNEUROSCI.1674-15.2015; MURASUGI CM, 1993, J NEUROSCI, V13, P1719; Murray B, 1996, PHYSIOL BEHAV, V59, P427, DOI 10.1016/0031-9384(95)02077-2; Nguyen MN, 2010, PLOS ONE, V5, pe9907; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; Owesson-White CA, 2012, J NEUROCHEM, V121, P252, DOI 10.1111/j.1471-4159.2012.07677.x; Parker KE, 2019, CELL, V178, P653, DOI 10.1016/j.cell.2019.06.034; Patriarchi T, 2018, SCIENCE, V360, P1420, DOI 10.1126/science.aat4422; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; PFAFFMANN C, 1977, ANN NY ACAD SCI, V290, P18, DOI 10.1111/j.1749-6632.1977.tb39713.x; Rice ME, 2008, BRAIN RES REV, V58, P303, DOI 10.1016/j.brainresrev.2008.02.004; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; ROMPRE PP, 1986, BRAIN RES, V364, P338, DOI 10.1016/0006-8993(86)90846-2; Sewards TV, 2004, BRAIN RES BULL, V62, P271, DOI 10.1016/j.brainresbull.2003.10.004; SHIZGAL P, 1989, BRAIN RES, V499, P234, DOI 10.1016/0006-8993(89)90771-3; SHIZGAL P, 1980, J COMP PHYSIOL PSYCH, V94, P227, DOI 10.1037/h0077668; Shizgal P, 1997, CURR OPIN NEUROBIOL, V7, P198, DOI 10.1016/S0959-4388(97)80008-6; Shizgal P, 2012, VIDEO INTRO MOUNTAIN; SIMMONS JM, 1994, BEHAV NEUROSCI, V108, P151, DOI 10.1037/0735-7044.108.1.151; Solomon RB, 2015, BEHAV BRAIN RES, V292, P327, DOI 10.1016/j.bbr.2015.06.008; Solomon RB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182120; Sonnenschein B, 2003, BEHAV NEUROSCI, V117, P978, DOI 10.1037/0735-7044.117.5.978; Sparta DR, 2012, NAT PROTOC, V7, P12, DOI 10.1038/nprot.2011.413; Sun FM, 2018, CELL, V174, P481, DOI 10.1016/j.cell.2018.06.042; Tian J, 2016, NEURON, V91, P1374, DOI 10.1016/j.neuron.2016.08.018; Treadway MT, 2011, NEUROSCI BIOBEHAV R, V35, P537, DOI 10.1016/j.neubiorev.2010.06.006; Trujillo-Pisanty I, 2014, PSYCHOPHARMACOLOGY, V231, P1351, DOI 10.1007/s00213-013-3328-x; Trujillo-Pisanty I, 2015, METHODSX, V2, P263, DOI 10.1016/j.mex.2015.05.003; Trujillo-Pisanty I, 2011, J NEUROSCI, V31, P5426, DOI 10.1523/JNEUROSCI.0079-11.2011; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; WISE RA, 1980, PHARMACOL BIOCHEM BE, V13, P213, DOI 10.1016/S0091-3057(80)80033-5; Wise RA, 1996, ANNU REV NEUROSCI, V19, P319, DOI 10.1146/annurev.ne.19.030196.001535; WISE RA, 1978, BRAIN RES, V152, P215, DOI 10.1016/0006-8993(78)90253-6; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028; YEOMANS JS, 1975, PHYSIOL BEHAV, V15, P593, DOI 10.1016/S0031-9384(75)80035-7; YEOMANS JS, 1979, PHYSIOL BEHAV, V22, P911, DOI 10.1016/0031-9384(79)90336-6; Zaborszky L., 2006, NEUROANATOMICAL TRAC; Zald DH, 2017, ANNU REV CLIN PSYCHO, V13, P471, DOI 10.1146/annurev-clinpsy-032816-044957	102	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0226722	10.1371/journal.pone.0226722	http://dx.doi.org/10.1371/journal.pone.0226722			45	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MA6QB	32502210	gold, Green Published, Green Submitted			2022-12-26	WOS:000542035700002
J	Ghrayeb, H; Elias, M; Nashashibi, J; Youssef, A; Manal, M; Mahagna, L; Refaat, M; Schwartz, N; Elias, A				Ghrayeb, Hanin; Elias, Mazen; Nashashibi, Jeries; Youssef, Awni; Manal, Mari; Mahagna, Liala; Refaat, Masalha; Schwartz, Naama; Elias, Adi			Appetite and ghrelin levels in iron deficiency anemia and the effect of parenteral iron therapy: A longitudinal study	PLOS ONE			English	Article							NUTRITIONAL ASSESSMENT QUESTIONNAIRE; GASTRIC-ACID; SCREENING TOOL; LEPTIN; CHILDREN; RESISTANCE; INSULIN; SERUM; MALNUTRITION; GROWTH	Background Iron deficiency anemia (IDA) is associated with decreased appetite. The ghrelin hormone is one of the major regulators of appetite. Objectives To evaluate appetite and ghrelin levels in patients with IDA, and to investigate the change in appetite and ghrelin following intravenous iron therapy. Methods A total of 56 IDA patients and 51 controls were included in the study. Both appetite and ghrelin were assessed at baseline and following intravenous iron therapy. These were assessed at corresponding time intervals in the control group. Appetite was assessed by the SNAQ score (Simplified Nutritional Appetite Questionnaire) and fasting ghrelin levels were assessed by acylated ghrelin (AG), unacylated ghrelin (UAG) and their respective ratio AG/UAG. Results IDA patients had significantly lower SNAQ scores, yet higher AG levels and higher AG/UAG ratios compared to healthy controls; the mean SNAQ scores were 12.56 +/- 3.45 and 16.1 +/- 2, respectively (P<0.01); the median AG levels were 57.5 pg/ml and 43 pg/ml respectively (P = 0.007); and the median AG/UAG ratios were 0.48 and 0.25 respectively (P = 0.04). On multivariate linear regression analysis, IDA remained independently associated with decreased SNAQ score (beta = -0.524, P<0.001) and increased acylated ghrelin (beta = 0.289, P = 0.013). After IDA was treated, SNAQ scores increased significantly by a mean of 2 points. AG and AG/UAG ratios decreased significantly by a mean of -18.44 pg/ml and -0.2 respectively. The control group showed no significant change in SNAQ scores or ghrelin at corresponding time intervals. Conclusions IDA patients have a reduced appetite and paradoxically elevated ghrelin hormone activity compared to healthy controls. Treating IDA enhances appetite and lowers ghrelin levels. Future studies are needed to explore the mechanism of this paradoxical ghrelin activity.	[Ghrayeb, Hanin; Elias, Mazen] Emek Med Ctr, Dept Internal Med c, Afula, Israel; [Ghrayeb, Hanin; Elias, Mazen] Technion Israel Inst Technol, Rapaport Fac Med, Haifa, Israel; [Nashashibi, Jeries] Rambam Hlth Care Campus, Dept Internal Med D, Haifa, Israel; [Youssef, Awni] Bar Ilan Univ, Azrieli Fac Med, Fac Med, Safed, Israel; [Manal, Mari] Nazareth Tower Out Patients Clin Ambulatory, Clalit, Nazareth, Israel; [Mahagna, Liala; Refaat, Masalha] HaEmek Med Ctr, Endocrine Lab, Afula, Israel; [Schwartz, Naama] HaEmek Med Ctr, Clin Res Unit, Afula, Israel; [Elias, Adi] Rambam Hlth Care Campus, Dept Internal Med B, Haifa, Israel	Emek Medical Center; Technion Israel Institute of Technology; Rambam Health Care Campus; Bar Ilan University; Emek Medical Center; Emek Medical Center; Rambam Health Care Campus	Elias, A (corresponding author), Rambam Hlth Care Campus, Dept Internal Med B, Haifa, Israel.	adi.elias@gmail.com		elias, adi/0000-0002-2634-8086				Akarsu S, 2007, J PEDIAT HEMATOL ONC, V29, P384, DOI 10.1097/MPH.0b013e3180645170; Al Massadi O, 2011, PEPTIDES, V32, P2301, DOI 10.1016/j.peptides.2011.08.020; Astrup A, 2019, INT J OBESITY, V43, P219, DOI 10.1038/s41366-018-0143-9; Atalayer D, 2013, PROG NEURO-PSYCHOPH, V40, P70, DOI 10.1016/j.pnpbp.2012.08.011; Auerbach M, 2020, UPTODATE; Auerbach M, 2016, AM J HEMATOL, V91, P31, DOI 10.1002/ajh.24201; Auerbach M, 2010, HEMATOL-AM SOC HEMAT, P338, DOI 10.1182/asheducation-2010.1.338; Barazzoni R, 2007, J CLIN ENDOCR METAB, V92, P3935, DOI 10.1210/jc.2006-2527; Briggs DI, 2010, ENDOCRINOLOGY, V151, P4745, DOI 10.1210/en.2010-0556; Camaschella C, 2019, BLOOD, V133, P30, DOI 10.1182/blood-2018-05-815944; Campillos M, 2010, NUCLEIC ACIDS RES, V38, pW360, DOI 10.1093/nar/gkq371; Cui HX, 2017, NAT REV ENDOCRINOL, V13, P338, DOI 10.1038/nrendo.2016.222; Delhanty PJ, 2013, ENDOCR DEV, V25, P112, DOI 10.1159/000346059; Delhanty PJD, 2012, EUR J ENDOCRINOL, V167, P601, DOI 10.1530/EJE-12-0456; Dogan A, 2013, J CLIN LAB ANAL, V27, P81, DOI 10.1002/jcla.21566; Gao Y, 2015, J CLIN INVEST, V125, P3681, DOI 10.1172/JCI81860; Garcia JM, 2005, J CLIN ENDOCR METAB, V90, P2920, DOI 10.1210/jc.2004-1788; Germain N, 2010, J CLIN ENDOCR METAB, V95, P3057, DOI 10.1210/jc.2009-2196; Isguven P, 2007, ENDOCR J, V54, P985, DOI 10.1507/endocrj.K07-031; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; Korbonits M, 2004, FRONT NEUROENDOCRIN, V25, P27, DOI 10.1016/j.yfrne.2004.03.002; Kruizenga HM, 2005, CLIN NUTR, V24, P75, DOI 10.1016/j.clnu.2004.07.015; Kuppens RJ, 2015, ENDOCRINE, V50, P633, DOI 10.1007/s12020-015-0614-x; Lam JR, 2017, GASTROENTEROLOGY, V152, P821, DOI 10.1053/j.gastro.2016.11.023; LAWLESS JW, 1994, J NUTR, V124, P645, DOI 10.1093/jn/124.5.645; Lockie SH, 2015, PSYCHONEUROENDOCRINO, V62, P114, DOI 10.1016/j.psyneuen.2015.08.004; Luo QQ, 2018, ANN NUTR METAB, V72, P37, DOI 10.1159/000484698; Masuda Y, 2000, BIOCHEM BIOPH RES CO, V276, P905, DOI 10.1006/bbrc.2000.3568; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Milman N, 2011, ANN HEMATOL, V90, P1247, DOI 10.1007/s00277-011-1279-z; Nakai Y, 2003, EUR J ENDOCRINOL, V149, pR1, DOI 10.1530/eje.0.149R001; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Otto B, 2001, EUR J ENDOCRINOL, V145, pR5; Pan WW, 2018, NAT REV NEUROSCI, V19, P95, DOI 10.1038/nrn.2017.168; Rabito EI, 2017, NUTR CLIN PRACT, V32, P526, DOI 10.1177/0884533617692527; Shimizu Y, 2003, CLIN CANCER RES, V9, P774; SKIKNE BS, 1981, GASTROENTEROLOGY, V81, P1068; Stoltzfus RJ, 2004, J NUTR, V134, P348, DOI 10.1093/jn/134.2.348; Tanaka M, 2003, PSYCHONEUROENDOCRINO, V28, P829, DOI 10.1016/S0306-4530(02)00066-5; Terawaki K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173113; Topaloglu AK, 2001, NUTRITION, V17, P657, DOI 10.1016/S0899-9007(01)00570-6; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; Wilasco MIA, 2012, REGUL PEPTIDES, V173, P21, DOI 10.1016/j.regpep.2011.08.013; Wilson MMG, 2005, AM J CLIN NUTR, V82, P1074, DOI 10.1093/ajcn/82.5.1074; Wynne K, 2005, J ENDOCRINOL, V184, P291, DOI 10.1677/joe.1.05866; Yakabi K, 2008, WORLD J GASTROENTERO, V14, P6334, DOI 10.3748/wjg.14.6334; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017	47	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0234209	10.1371/journal.pone.0234209	http://dx.doi.org/10.1371/journal.pone.0234209			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497136	Green Published, gold			2022-12-26	WOS:000542035200017
J	Held, BW; Salomon, CE; Blanchette, RA				Held, Benjamin W.; Salomon, Christine E.; Blanchette, Robert A.			Diverse subterranean fungi of an underground iron ore mine	PLOS ONE			English	Article							ROT FUNGI; BROWN-ROT; DECAY; WOOD; IDENTIFICATION; SOILS; PHYLOGENY; REGION; AGENT	Mines and caves are unusual ecosystems containing unique fungi and are greatly understudied compared to other environments. The Soudan Mine in Tower, MN, an iron ore mine that closed in 1963 after operating for 80 years, was sampled to explore fungal diversity and to investigate taxa that tolerate heavy metals for potential bioprocessing technologies or as sources of bioactive molecules for drug discovery and possible biocontrol for white-nose syndrome (WNS) of bats. The mine is 714 m deep, has 18 levels and contains large quantities of wooden timbers, in contrast to many other oligotrophic subterranean environments. Fungi were cultured from samples and the ITS region was sequenced for identification and phylogenetic analysis. Results show Ascomycota are the dominant fungi followed by Basidiomycota and Mucoromycota. Out of 164 identified taxa, 108 belong to the Ascomycota and 26 and 31 to Basidiomycota and Mucoromycota, respectively. There are also 46 taxa that do not match (<97% BLAST GenBank identity) sequenced fungal species. Examples of the most commonly isolated Ascomycota include Scytalidium sp., Mariannaea comptospora, Hypocrea pachybasidioides, Oidiodendron griseum and Pochonia bulbillosa; Basidiomycota include Postia sp., Sistotrema brinkmannii, Calocera sp., Amylocorticiellum sp.; Mucoromycota include Mortierella parvispora, M. gamsii, M. hyaline, M. basiparvispora and Mortierella sp. Unusual growth forms were also found including large quantities of black rhizomorphs of Armillaria sinapina and white mycelial cords of Postia sp. mycelium, as well as Pseudogymnoascus species growing over large areas of mine walls and ceiling. The mine environment is a relatively extreme environment for fungi, with the presence of high levels of heavy metals, complete darkness and poor nutrient availability. Several genera are similar to those isolated in other extreme environments but phylogenetic analyses show differences in species between these environments. Results indicate this subterranean environment hosts a wide diversity of fungi, many of them not found in above ground environments.	[Held, Benjamin W.; Blanchette, Robert A.] Univ Minnesota, Dept Plant Pathol, Minneapolis, MN 55455 USA; [Salomon, Christine E.] Univ Minnesota, Ctr Drug Design, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Held, BW (corresponding author), Univ Minnesota, Dept Plant Pathol, Minneapolis, MN 55455 USA.	bheld@umn.edu		Blanchette, Robert A./0000-0003-2819-6511; Salomon, Christine/0000-0003-4976-598X	Minnesota Environment and Natural Resources Trust Fund; USFW [F15AP01056]; Minnesota Agricultural Experiment Station; National Institute of Food and Agriculture, U.S. Department of Agriculture Hatch project [1901-11031-21367-AES0022081]	Minnesota Environment and Natural Resources Trust Fund; USFW; Minnesota Agricultural Experiment Station; National Institute of Food and Agriculture, U.S. Department of Agriculture Hatch project	Funding was provided by the Minnesota Environment and Natural Resources Trust Fund as recommended by the Legislative-Citizen Commission on Minnesota Resources (LCCMR) (CS), USFW grant F15AP01056 (CS), and the Minnesota Agricultural Experiment Station with funds from the National Institute of Food and Agriculture, U.S. Department of Agriculture Hatch project 1901-11031-21367-AES0022081 (RB)	Alfredsen G, 2005, INT RES GROUP WOOD P; Anderson JB, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.2233; Arenz BA, 2014, ANTARCTIC TERRESTRIA; Arenz BE, 2006, SOIL BIOL BIOCHEM, V38, P3057, DOI 10.1016/j.soilbio.2006.01.016; Bastian F, 2010, MICROBIOL-SGM, V156, P644, DOI 10.1099/mic.0.036160-0; Blanchette RA, 2004, APPL ENVIRON MICROB, V70, P1328, DOI 10.1128/AEM.70.3.1328-1335.2004; Blanchette RA, 2016, FUNGAL ECOL, V23, P58, DOI 10.1016/j.funeco.2016.06.001; Burford Euan P., 2003, Mycologist, V17, P98, DOI 10.1017/S0269915X03003112; Burgaud G, 2009, ENVIRON MICROBIOL, V11, P1588, DOI 10.1111/j.1462-2920.2009.01886.x; Cartwright K., 1958, DECAY TIMBER ITS PRE; CEASE KR, 1989, WOOD SCI TECHNOL, V23, P151, DOI 10.1021/es00179a602; Cordero RJB, 2017, FUNGAL BIOL REV, V31, P99, DOI 10.1016/j.fbr.2016.12.003; Cui ZJ, 2017, J ENVIRON CHEM ENG, V5, P3616, DOI 10.1016/j.jece.2017.07.021; DAHLQUIST RL, 1978, APPL SPECTROSC, V32, P1, DOI 10.1366/000370278774331828; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Domsch KH, 2007, COMPENDIUM SOIL FUNG; Egar P, 2001, INVESTIGATION ELEVAT; Eger P, 2009, REVITALIZING ENV PRO; El-Elimat T, 2015, J ANTIBIOT, V68, P191, DOI 10.1038/ja.2014.125; Emerson JK, 2007, ACTA CHIROPTEROL, V9, P261, DOI 10.3161/1733-5329(2007)9[261:COGPBF]2.0.CO;2; ERBISCH FH, 1979, MYCOLOGIA, V71, P652, DOI 10.2307/3759079; ESLYN WE, 1983, FOREST PROD J, V33, P19; FAIRBAIRN N, 1983, CAN J BOT, V61, P2147, DOI 10.1139/b83-232; Gabriel CR., 2013, CAVE MICROBIOMES NOV, P85, DOI DOI 10.1007/978-1-4614-5206-5_; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; GEIGERT J, 1973, TETRAHEDRON, V29, P2343, DOI 10.1016/S0040-4020(01)93360-5; Ginns J., 1982, OPERA BOT, V61, P1; Goh YK, 2016, BIOCONTROL SCI TECHN, V26, P1352, DOI 10.1080/09583157.2016.1202192; Gorfer M, 2009, MYCOL RES, V113, P1377, DOI 10.1016/j.mycres.2009.09.005; Hershey OS, 2018, ECOL STUD-ANAL SYNTH, V235, P69, DOI 10.1007/978-3-319-98852-8_5; Hujslova M, 2010, MYCOL PROG, V9, P1, DOI 10.1007/s11557-009-0611-7; Humbolt A von, 1793, FLORAE FRIBERGENSIS; Karunasekera H, 2019, INT BIODETER BIODEGR, V137, P147, DOI 10.1016/j.ibiod.2018.12.001; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; LISTER M, 1674, PHILOS T ROY SOC LON, V8, P6179; Liu HP, 2002, J ECON ENTOMOL, V95, P675, DOI 10.1603/0022-0493-95.4.675; Lorch JM, 2013, MYCOLOGIA, V105, P237, DOI 10.3852/12-207; Mamani LDG, 2019, BIOTECHNOL RES INNOV; Man BY, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01158; Mattsson J, 2010, AGARICA, V29, P5; Micalizzi EW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179770; Munter R. C., 1981, DEV ATOMIC PLASMA SP, P653; MUNTER RC, 1984, COMMUN SOIL SCI PLAN, V15, P1285, DOI 10.1080/00103628409367559; NANNFELDT J. A., 1953, SVENSK BOT TIDSKR, V47, P177; Nonaka K, 2013, MYCOLOGIA, V105, P1202, DOI 10.3852/12-132; Novakova A, 2015, FOREST PATHOL, V45, P373, DOI 10.1111/efp.12177; Ogorek R, 2017, GEOMICROBIOL J, V34, P823, DOI 10.1080/01490451.2017.1280860; Okuda Toru, 2000, Mycoscience, V41, P411, DOI 10.1007/BF02463957; PENGRA RM, 1969, J BACTERIOL, V97, P1056, DOI 10.1128/JB.97.3.1056-1061.1969; Potvin LR, 2012, MYCORRHIZA, V22, P631, DOI 10.1007/s00572-012-0440-4; RIZZO DM, 1992, CAN J BOT, V70, P1515, DOI 10.1139/b92-190; Rusman Y, 2015, J NAT PROD, V78, P1456, DOI 10.1021/acs.jnatprod.5b00204; Schmidt O, 2007, MYCOL PROG, V6, P261, DOI 10.1007/s11557-007-0534-0; Schmidt O, 2011, FUNDAMENTALS OF MOLD GROWTH IN INDOOR ENVIRONMENTS AND STRATEGIES FOR HEALTHY LIVING, P117; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; SEIFERT KA, 1983, MYCOLOGIA, V75, P1011, DOI 10.2307/3792657; Shen LL, 2019, PERSOONIA, V42, P101, DOI 10.3767/persoonia.2019.42.05; SIGLER L, 1990, MYCOLOGIA, V82, P399, DOI 10.2307/3759916; STILLWELL MA, 1973, CAN J MICROBIOL, V19, P597, DOI 10.1139/m73-098; Torrini G, 2015, ZOOTAXA, V3937, P533, DOI 10.11646/zootaxa.3937.3.6; Vanderwolf KJ, 2019, DIVERSITY-BASEL, V11, DOI 10.3390/d11120222; Vanderwolf KJ, 2013, INT J SPELEOL, V42, P77, DOI 10.5038/1827-806X.42.1.9; Toledo AV, 2017, PHYSIOL MOL PLANT P, V99, P2, DOI 10.1016/j.pmpp.2017.04.004; Vaughan MJ, 2015, MICROB ECOL, V70, P175, DOI 10.1007/s00248-014-0560-9; Visagie CM, 2019, FUNGAL SYST EVOL; Wagner L, 2013, PERSOONIA, V30, P77, DOI 10.3767/003158513X666268; Weinstein RN, 2000, MYCOLOGIA, V92, P222, DOI 10.2307/3761554; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; Wilson MB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178968; ZABEL RA, 1985, WOOD FIBER SCI, V17, P75; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zhang Z-F, 2018, FRONT MICROBIOL, P9, DOI [10.3389/fmicb.2018.00009, DOI 10.3389/FMICB.2018.00009]	73	11	11	5	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0234208	10.1371/journal.pone.0234208	http://dx.doi.org/10.1371/journal.pone.0234208			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497073	Green Published, gold			2022-12-26	WOS:000542035200020
J	Hou, H; Lyu, YL; Jiang, J; Wang, M; Zhang, RR; Liew, CC; Wang, BG; Cheng, CM				Hou, Hong; Lyu, Yali; Jiang, Jing; Wang, Min; Zhang, Ruirui; Liew, Choong-Chin; Wang, Binggao; Cheng, Changming			Peripheral blood transcriptome identifies high-risk benign and malignant breast lesions	PLOS ONE			English	Article							CANCER RISK; RAPAMYCIN; SURVIVAL; PATHWAY; WOMEN; EXPRESSION; PROMOTES; TARGET	Background Peripheral blood transcriptome profiling is a potentially important tool for disease detection. We utilize this technique in a case-control study to identify candidate transcriptomic biomarkers able to differentiate women with breast lesions from normal controls. Methods Whole blood samples were collected from 50 women with high-risk breast lesions, 57 with breast cancers and 44 controls (151 samples). Blood gene expression profiling was carried out using microarray hybridization. We identified blood gene expression signatures using AdaBoost, and constructed a predictive model differentiating breast lesions from controls. Model performance was then characterized by AUC sensitivity, specificity and accuracy. Biomarker biological processes and functions were analyzed for clues to the pathogenesis of breast lesions. Results Ten gene biomarkers were identified (YWHAQ, BCLAF1, WSB1, PBX2, DDIT4, LUC7L3, FKBP1A, APP, HERC2P2, FAM126B). A ten-gene panel predictive model showed discriminatory power in the test set (sensitivity: 100%, specificity: 84.2%, accuracy: 93.5%, AUC: 0.99). These biomarkers were involved in apoptosis, TGF-beta signaling, adaptive immune system regulation, gene transcription and post-transcriptional protein modification. Conclusion A promising method for the detection of breast lesions is reported. This study also sheds light on breast cancer/immune system interactions, providing clues to new targets for breast cancer immune therapy.	[Hou, Hong; Wang, Binggao] Qingdao Cent Hosp, Qingdao Canc Hosp, Qingdao, Shandong, Peoples R China; [Lyu, Yali; Wang, Min; Zhang, Ruirui; Cheng, Changming] Huaxia Bangfu Technol Inc, Beijing, Peoples R China; [Jiang, Jing] Qingdao Lianchi Matern & Infant Hosp, Qingdao, Shandong, Peoples R China; [Liew, Choong-Chin] Golden Hlth Diagnost Inc, Wuxi, Jiangsu, Peoples R China; [Liew, Choong-Chin] Univ Toronto, Late Dept Clin Pathol & Lab Med, Toronto, ON, Canada; [Liew, Choong-Chin] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA	University of Toronto; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Wang, BG (corresponding author), Qingdao Cent Hosp, Qingdao Canc Hosp, Qingdao, Shandong, Peoples R China.; Cheng, CM (corresponding author), Huaxia Bangfu Technol Inc, Beijing, Peoples R China.	wbgqd1965@163.com; cmcheng2005@163.com			Huaxia Bangfu Technology Incorporated	Huaxia Bangfu Technology Incorporated	Huaxia Bangfu Technology Incorporated [http://www.hxjdyl.com/en/gongsijieshao.html] sponsored this research. Changming Cheng, Yali Lyu, Min Wang, Ruirui Zhang are employees of Huaxia Bangfu Technology Inc. Choong-Chin Liew was a consultant of Huaxia Bangfu Technology Inc. The funder provided support in the form of salaries for authors [C. Cheng, Y. Lyu, M. Wang, R. Zhang], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abay Mebrahtu, 2018, BMC Res Notes, V11, P622, DOI 10.1186/s13104-018-3731-9; [Anonymous], 2017, CANCER DISCOV, V7, P6, DOI DOI 10.15829/1560-4071-2017-6-7-85; [Anonymous], 2012, REGEN MED S3, V7, pS14; Archange C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002475; Bhushan L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022484; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Boughey JC, 2010, J CLIN ONCOL, V28, P3591, DOI 10.1200/JCO.2010.28.0784; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cao J, 2015, CANCER RES, V75, P4839, DOI 10.1158/0008-5472.CAN-15-0711; Chao Samuel, 2015, Microarrays (Basel), V4, P671, DOI 10.3390/microarrays4040671; Chao S, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-44; Chen QR, 2006, GENE CHROMOSOME CANC, V45, P856, DOI 10.1002/gcc.20349; Degnim AC, 2007, J CLIN ONCOL, V25, P2671, DOI 10.1200/JCO.2006.09.0217; Dennis MD, 2013, CELL SIGNAL, V25, P2709, DOI 10.1016/j.cellsig.2013.08.038; Dentice M, 2005, NAT CELL BIOL, V7, P698, DOI 10.1038/ncb1272; Dhandhukia JP, 2017, THERANOSTICS, V7, P3856, DOI 10.7150/thno.19981; Eloy JO, 2017, ANTI-CANCER AGENT ME, V17, P48, DOI 10.2174/1871520616666160526103432; Fang R, 2019, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01879; Ferlay J, 2019, INT J CANCER, V144, P1941, DOI 10.1002/ijc.31937; Han M, 2008, CLIN CANCER RES, V14, P455, DOI 10.1158/1078-0432.CCR-07-1801; Hartmann LC, 2014, CANCER PREV RES, V7, P211, DOI 10.1158/1940-6207.CAPR-13-0222; Hidalgo M, 2000, ONCOGENE, V19, P6680, DOI 10.1038/sj.onc.1204091; Jamshidi M, 2013, INT J CANCER, V132, P2044, DOI 10.1002/ijc.27884; Jorgensen KJ, 2017, ANN INTERN MED, V166, P313, DOI 10.7326/M16-0270; Khatua S, 2003, CANCER RES, V63, P1865; Lecomte S, 2017, CELL COMMUN SIGNAL, V15, DOI 10.1186/s12964-017-0182-1; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; Liew CC, 1999, Patent No. [US20110003298A1, 20110003298]; Linos E, 2008, JNCI-J NATL CANCER I, V100, P1352, DOI 10.1093/jnci/djn305; Malaspina A, 2000, J NEUROCHEM, V75, P2511, DOI 10.1046/j.1471-4159.2000.0752511.x; Malmartel A, 2019, EUR J OBSTET GYN R B, V237, P1, DOI 10.1016/j.ejogrb.2019.04.003; Marshall KW, 2010, INT J CANCER, V126, P1177, DOI 10.1002/ijc.24910; Mercado CL, 2014, RADIOL CLIN N AM, V52, P481, DOI 10.1016/j.rcl.2014.02.008; Morrow M, 2015, NAT REV CLIN ONCOL, V12, P227, DOI 10.1038/nrclinonc.2015.8; Obayashi T, 2019, NUCLEIC ACIDS RES, V47, pD55, DOI 10.1093/nar/gky1155; OGAWA M, 1993, BLOOD, V81, P2844; Okadome T, 1996, J BIOL CHEM, V271, P21687, DOI 10.1074/jbc.271.36.21687; Osman I, 2006, CLIN CANCER RES, V12, P3374, DOI 10.1158/1078-0432.CCR-05-2081; Ozkaya AB, 2017, BIOCHEM CELL BIOL, V95, P289, DOI 10.1139/bcb-2016-0037; Pinto JA, 2016, NPJ GENOM MED, V1, DOI 10.1038/npjgenmed.2015.15; Pinto JA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01207-3; Poujade FA, 2018, BRIT J CANCER, V118, P1229, DOI 10.1038/s41416-018-0056-3; Salsman J, 2017, SCI REP-UK, V7, DOI 10.1038/srep45038; Schon K, 2018, BREAST CANCER RES TR, V167, P417, DOI 10.1007/s10549-017-4531-y; SEHGAL SN, 1995, THER DRUG MONIT, V17, P660, DOI 10.1097/00007691-199512000-00019; Shi JN, 2018, ONCOL LETT, V15, P9802, DOI 10.3892/ol.2018.8577; Shou WN, 1998, NATURE, V391, P489, DOI 10.1038/35146; Sun L, 2018, B WORLD HEALTH ORGAN, V96, P568, DOI 10.2471/BLT.18.207944; Sung H, 2016, INT J CANCER, V139, P527, DOI 10.1002/ijc.30095; Sung HN, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv107; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Vourtsis A, 2019, EUR RADIOL, V29, P1762, DOI 10.1007/s00330-018-5668-8; Wang YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042899; Yap YS, 2019, JAMA ONCOL, V5, P1489, DOI 10.1001/jamaoncol.2019.0620; Youlden Danny R., 2014, Cancer Biology Medicine, V11, P101, DOI 10.7497/j.issn.2095-3941.2014.02.005; Zhiquan Q., 2017, ADABOOST LLP BOOSTIN	56	9	9	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0233713	10.1371/journal.pone.0233713	http://dx.doi.org/10.1371/journal.pone.0233713			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497068	Green Published, gold			2022-12-26	WOS:000542035200069
J	Wang, HP; Lu, ZW; Bao, YM; Yang, YH; de Groot, R; Dai, WK; de Jonge, MI; Zheng, YJ				Wang, Heping; Lu, Zhiwei; Bao, Yaomin; Yang, Yonghong; de Groot, Ronald; Dai, Wenkui; de Jonge, Marien I.; Zheng, Yuejie			Clinical diagnostic application of metagenomic next-generation sequencing in children with severe nonresponding pneumonia	PLOS ONE			English	Article							SPECIMENS; PATHOGENS; SAMPLES	Pneumonia is one of the most important causes of morbidity and mortality in children. Identification and characterization of pathogens that cause infections are crucial for accurate treatment and accelerated recovery. However, in most cases, the causative agent cannot be identified, which is partly due to the limited spectrum of pathogens covered by current diagnostics based on nucleic acid amplification. Therefore, in this study, we explored the application of metagenomic next-generation sequencing (mNGS) for the diagnosis of children with severe pneumonia. From April to July 2017, 32 hospitalized children with severe nonresponding pneumonia in Shenzhen Children's Hospital were included in this study. Blood tests were conducted immediately after hospitalization to assess cell counts and inflammatory markers, oropharyngeal swabs were collected to identify common pathogens by qPCR and culture. After bronchoscopy, bronchoalveolar lavage fluid (BALF) samples were collected for further pathogen identification using standardized diagnostic tests and mNGS. Blood tests were normal in 3 of the 32 children. In 9 oropharyngeal swabs, bacterial pathogens were detected, in 5 of these Mycoplasma pneumoniae was detected. Adenovirus was detected in 5 BALF samples, using the Direct Immunofluorescence Assay (DFA). In 15 cases, no common pathogens were found in BALF samples, using the current standard diagnostic tests, while in all 32 BALFs, pathogens were identified using mNGS, including adenovirus, Mycoplasma pneumoniae, Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, cytomegalovirus and bocavirus. This study shows that, with mNGS, the sensitivity of detection of the causative pathogens in children with severe nonresponding pneumonia is significantly improved. In addition, mNGS gives more strain specific information, helps to identify new pathogens and could potentially help to trace and control outbreaks. In this study, we have shown that it is possible to have the results within 24 hours, making the application of mNGS feasible for clinical diagnostics.	[Wang, Heping; Lu, Zhiwei; Bao, Yaomin; Yang, Yonghong; Zheng, Yuejie] Shenzhen Childrens Hosp, Dept Resp Dis, Shenzhen, Peoples R China; [Wang, Heping; de Groot, Ronald; de Jonge, Marien I.] Radboud Univ Nijmegen Med Ctr, Radboud Ctr Infect Dis, Sect Pediat Infect Dis, Lab Med Immunol, Nijmegen, Netherlands; [Dai, Wenkui] City Univ Hong Kong, Dept Comp Sci, Hong Kong, Peoples R China	Radboud University Nijmegen; City University of Hong Kong	Zheng, YJ (corresponding author), Shenzhen Childrens Hosp, Dept Resp Dis, Shenzhen, Peoples R China.; de Jonge, MI (corresponding author), Radboud Univ Nijmegen Med Ctr, Radboud Ctr Infect Dis, Sect Pediat Infect Dis, Lab Med Immunol, Nijmegen, Netherlands.	yuejiez@sina.com; marien.dejonge@radboudumc.nl	de Jonge, Marien I./P-5869-2015	de Jonge, Marien I./0000-0003-2812-5895; Wang, Heping/0000-0002-9527-1334	Key Medical Disciplines Building Project of Shenzhen [SZXJ2017005]; Sanming Project of Medicine in Shenzhen [SZSM201512030]; Shenzhen Science and Technology Project [JCYJ20170303155012371]	Key Medical Disciplines Building Project of Shenzhen; Sanming Project of Medicine in Shenzhen; Shenzhen Science and Technology Project	This work was supported by the Key Medical Disciplines Building Project of Shenzhen [SZXJ2017005], Sanming Project of Medicine in Shenzhen [SZSM201512030] and Shenzhen Science and Technology Project [JCYJ20170303155012371].	Graf EH, 2016, J CLIN MICROBIOL, V54, P1000, DOI 10.1128/JCM.03060-15; Grant LR, 2012, CLIN INFECT DIS, V54, pS140, DOI [10.1093/cid/cir1069, 10.1093/cid/cir1073]; Jain S, 2015, NEW ENGL J MED, V372, P835, DOI 10.1056/NEJMoa1405870; Jia JP, 2016, ALZHEIMERS DEMENT, V12, P446, DOI 10.1016/j.jalz.2015.06.1892; Kakuya F, 2017, J PEDIATR-US, V189, P218, DOI 10.1016/j.jpeds.2017.06.038; Kim C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021610; Langelier C, 2018, AM J RESP CRIT CARE, V197, P524, DOI 10.1164/rccm.201706-1097LE; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Lu ZW, 2017, GENES-BASEL, V8, DOI 10.3390/genes8120380; Noguchi S, 2014, INTERNAL MED, V53, P47, DOI 10.2169/internalmedicine.53.0971; Pendleton KM, 2017, AM J RESP CRIT CARE, V196, P1610, DOI 10.1164/rccm.201703-0537LE; Schlaberg R, 2017, ARCH PATHOL LAB MED, V141, P776, DOI 10.5858/arpa.2016-0539-RA; Doan T, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0344-6; Wang HP, 2015, INT J CLIN EXP MED, V8, P15011; Wilson MR, 2014, NEW ENGL J MED, V370, P2408, DOI 10.1056/NEJMoa1401268; Xie LY, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1037-0; Yang J, 2011, J CLIN MICROBIOL, V49, P3463, DOI 10.1128/JCM.00273-11; Zamli KZ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195675; Zoll J, 2015, J CLIN VIROL, V66, P6, DOI 10.1016/j.jcv.2015.02.010	19	19	21	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0232610	10.1371/journal.pone.0232610	http://dx.doi.org/10.1371/journal.pone.0232610			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497137	Green Published, gold			2022-12-26	WOS:000542035200054
J	Huang, MZ; Yick, KI; Ng, SP; Yip, J; Cheung, RTH				Huang, Meizhen; Yick, Kit-Iun; Ng, Sun-pui; Yip, Joanne; Cheung, Roy Tsz-hei			The effect of support surface and footwear condition on postural sway and lower limb muscle action of the older women	PLOS ONE			English	Article							SHOE CHARACTERISTICS; TEXTURED SURFACES; HEALTHY; BALANCE; STABILITY; FALLS; CIRCUMSTANCES; REPEATABILITY; CONSEQUENCES; ORTHOSES	Background Diminished somatosensory function is a critical age-related change which is related to postural instability in the older population. Footwear is a cost-effective way to modulate the postural stability by altering sensorimotor inputs via mechanoreceptors on the plantar surface of the feet. Compared to insoles with indentions in the entire surface, we innovatively developed a textured insole with site-specific nodulous protrudous. This study thus aimed to investigate the immediate effect of the nodulous insole and supporting surface condition on static postural stability and lower limb muscle activation for healthy older women. Methods This is a single-session study with repeated measurements. Twenty-three healthy older women stood on the firm (i.e., concrete floor) and foam surfaces with their eyes open in the three footwear conditions, namely barefoot, plain shoes and shoes with an innovative textured insole, for 30 seconds. Static postural sway and muscle activation of biceps femoris (BF), vastus lateralis (VL), tibialis anterior (TA), and lateral gastrocnemius (LG) of the dominant leg were measured during each testing condition. Results Compared to a firm surface, standing on the foam could significantly increase the body sway and lower limb muscle activation (p<0.05). When standing on the foam, compared to barefoot, wearing footwear significantly decreased the VL and TA muscle activation and minimize the postural sway in medial-lateral and anterior-posterior direction, while the influence is larger for the shoes with nodulous insloe compared to the plain shoes. No significant differences between the footwear conditions for static stability and muscle activation were observed on firm surface condition. Conclusions For older women, footwear could improve the postural stability in the unstable surface, particularly the footwear with nodulous insole, with the underlying mechanism as enhancing the mechanoreceptors on the plantar surface of the feet.	[Huang, Meizhen; Cheung, Roy Tsz-hei] Hong Kong Polytech Univ, Dept Rehabil Sci, Gait & Mot Anal Lab, Hung Hom, Hong Kong, Peoples R China; [Huang, Meizhen] Univ Maryland, Sch Med, Dept Phys Therapy & Rehabil Sci, Baltimore, MD 21201 USA; [Yick, Kit-Iun; Yip, Joanne] Hong Kong Polytech Univ, Inst Text & Clothing, Hung Hom, Hong Kong, Peoples R China; [Ng, Sun-pui] Hong Kong Polytech Univ, Coll Profess & Continuing Educ, Hong Kong, Peoples R China; [Cheung, Roy Tsz-hei] Western Sydney Univ, Sch Hlth Sci, Campbelltown, NSW, Australia	Hong Kong Polytechnic University; University System of Maryland; University of Maryland Baltimore; Hong Kong Polytechnic University; Hong Kong Polytechnic University; University of Sydney; Western Sydney University	Yick, KI (corresponding author), Hong Kong Polytech Univ, Inst Text & Clothing, Hung Hom, Hong Kong, Peoples R China.	tcyick@polyu.edu.hk	Yip, Joanne/P-6942-2014; HUANG, MEIZHEN/P-9652-2019; Yick, Kit Lun/P-8043-2014	Yip, Joanne/0000-0002-3270-4702; HUANG, MEIZHEN/0000-0002-4009-7332; Yick, Kit Lun/0000-0002-9043-1781; NG, Sun-Pui/0000-0002-7529-9129	Innovation and Technology Fund (ITF) [ITS/359/14]; Innovation and Technology Commission (AiDesign Lab Project)	Innovation and Technology Fund (ITF); Innovation and Technology Commission (AiDesign Lab Project)	The work is supported by funding from the Innovation and Technology Fund (ITF) (ITS/359/14) and the Innovation and Technology Commission (AiDesign Lab Project).	Aboutorabi A, 2016, PROSTHET ORTHOT INT, V40, P170, DOI 10.1177/0309364615588342; Bacsi AM, 2005, EXP BRAIN RES, V160, P22, DOI 10.1007/s00221-004-1982-2; Bisson EJ, 2014, EXP BRAIN RES, V232, P837, DOI 10.1007/s00221-013-3795-7; Brognara L, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10020069; Chesnin KJ, 2000, GAIT POSTURE, V12, P128, DOI 10.1016/S0966-6362(00)00071-0; Collins S, 2010, DISABIL REHABIL, V32, P2019, DOI 10.3109/09638281003797406; Debbi Eytan M, 2012, Foot (Edinb), V22, P269, DOI 10.1016/j.foot.2012.07.001; Feng YZ, 2009, J VASC SURG, V50, P675, DOI 10.1016/j.jvs.2009.05.017; Fransson PA, 2007, EUR J APPL PHYSIOL, V101, P81, DOI 10.1007/s00421-007-0476-x; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Hatton AL, 2013, J AM PODIAT MED ASSN, V103, P516, DOI 10.7547/1030516; Hatton AL, 2011, AGE AGEING, V40, P363, DOI 10.1093/ageing/afr026; Hatton AL, 2009, J ELECTROMYOGR KINES, V19, P957, DOI 10.1016/j.jelekin.2008.04.012; Hermens HJ, 1999, EUROPEAN RECOMMENDAT, V8, P13, DOI [10.1016/S1050-6411(00)00027-4, DOI 10.1016/S1050-6411(00)00027-4]; Hill K, 1999, AUST NZ J PUBL HEAL, V23, P41, DOI 10.1111/j.1467-842X.1999.tb01203.x; Hoffman M, 1998, J ATHL TRAINING, V33, P319; Holt GR, 2014, SOUTH MED J, V107, P407, DOI 10.14423/SMJ.0000000000000131; Huang MZ, 2019, SCAND J MED SCI SPOR, V29, P816, DOI 10.1111/sms.13408; Kennedy PM, 2002, J PHYSIOL-LONDON, V538, P995, DOI 10.1113/jphysiol.2001.013087; Kenny RP, 2019, GAIT POSTURE; Landry SC, 2010, GAIT POSTURE, V32, P215, DOI 10.1016/j.gaitpost.2010.04.018; Lopez DL, 2015, GERIATR NURS, V36, P458, DOI 10.1016/j.gerinurse.2015.07.003; Loram ID, 2009, MED SCI SPORT EXER, V41, P198, DOI 10.1249/MSS.0b013e318183c0ed; Lord SR, 1996, J AM GERIATR SOC, V44, P429, DOI 10.1111/j.1532-5415.1996.tb06416.x; Iglesias MEL, 2012, GERIATR NURS, V33, P264, DOI 10.1016/j.gerinurse.2012.01.007; Maki BE, 1999, J GERONTOL A-BIOL, V54, pM281, DOI 10.1093/gerona/54.6.M281; Manning WG, 2001, J HEALTH ECON, V20, P461, DOI 10.1016/S0167-6296(01)00086-8; Melzer I, 2004, AGE AGEING, V33, P602, DOI 10.1093/ageing/afh218; Menz HB, 2001, J AM GERIATR SOC, V49, P1651, DOI 10.1111/j.1532-5415.2001.49275.x; Menz HB, 2006, J GERONTOL A-BIOL, V61, P866, DOI 10.1093/gerona/61.8.866; Murley GS, 2009, GAIT POSTURE, V29, P172, DOI 10.1016/j.gaitpost.2008.08.015; Nachreiner NM, 2007, J WOMENS HEALTH, V16, P1437, DOI 10.1089/jwh.2006.0245; Nigg BM, 2001, CLIN J SPORT MED, V11, P2, DOI 10.1097/00042752-200101000-00002; Palluel E, 2008, AGE, V30, P53, DOI 10.1007/s11357-008-9047-2; Perrin PP, 1997, GERONTOLOGY, V43, P223; Price C, 2016, GAIT POSTURE, V46, P69, DOI 10.1016/j.gaitpost.2016.01.026; Putti AB, 2007, GAIT POSTURE, V25, P401, DOI 10.1016/j.gaitpost.2006.05.010; Qiu F, 2012, GAIT POSTURE, V35, P630, DOI 10.1016/j.gaitpost.2011.12.013; Raymakers JA, 2005, GAIT POSTURE, V21, P48, DOI 10.1016/j.gaitpost.2003.11.006; Rodriguez-Sanz D, 2018, DM-DIS MON, V64, P64, DOI 10.1016/j.disamonth.2017.08.001; Shaffer SW, 2007, PHYS THER, V87, P193, DOI 10.2522/ptj.20060083; Stevens Judy A, 2014, Inj Epidemiol, V1, DOI 10.1186/2197-1714-1-5; Talbot LA, 2005, BIOMED PUBLIC HLTH, V5, P1, DOI DOI 10.1186/1471-2458-5-86; WOLFSON L, 1994, J GERONTOL, V49, pM160, DOI 10.1093/geronj/49.4.M160; Wu G, 1997, EXP BRAIN RES, V114, P163, DOI 10.1007/PL00005616; Zehr EP, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-33	46	6	6	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2020	15	6							e0234140	10.1371/journal.pone.0234140	http://dx.doi.org/10.1371/journal.pone.0234140			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LW6ZP	32492058	gold, Green Published			2022-12-26	WOS:000539293000049
J	Rasmussen, GHF; Kristiansen, M; Arroyo-Morales, M; Voigt, M; Madeleine, P; Calvo-Lobo, C; Calvo-Lobo, C; Calvo-Lobo, C				Rasmussen, G. H. F.; Kristiansen, M.; Arroyo-Morales, M.; Voigt, M.; Madeleine, P.; Calvo-Lobo, Cesar; Calvo-Lobo, Cesar; Calvo-Lobo, Cesar			Absolute and relative reliability of pain sensitivity and functional outcomes of the affected shoulder among women with pain after breast cancer treatment	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; INTRACLASS CORRELATION-COEFFICIENT; CLINICAL PRESSURE PAIN; MUSCLE STRENGTH; EXERCISE THERAPY; RANGE; THRESHOLD; MOTION; KNEE; IMPAIRMENTS	Objective Breast cancer survivors (BCS) are often characterized by decreased pressure pain thresholds (PPT), range of motion (ROM) and strength in and around the shoulder affected by the treatment. This intra-rater reliability study was to establish the relative and absolute reliability of PPT's, active ROM and maximal isokinetic muscle strength (MIMS) of the affected shoulder in BCS with persistent pain after treatment. Methods Twenty-one BCS participated in the study. The PPTs of 17 locations and pain intensity were assessed using a pressure algometer and a numeric rating scale. The ROM was measured using a universal goniometer and MIMS was measured using an isokinetic dynamometer. Relative reliability was estimated using intra class correlation coefficient (ICC), and absolute reliability using standard error of measurement (SEM). Minimum detectable change (MDC) was calculated from SEM. Results The ICCs for PPTs ranged from 0.88-0.97, with SEM values ranging from 12.0 to 28.2 kPa and MDC ranging from 33.2 to 78.2 kPa. The ICCs for ROM ranged from 0.66-0.97, with SEM values ranging from 3.0 to 7.5 degrees and MDC ranging from 8.4 to 20.8 degrees. Finally, ICCs for MIMS ranged from 0.62-0.92, with SEM values ranging from 0.03 to 0.07 Nm/Kg FFM and MDC ranging from 0.09 to 0.19 Nm/kg FFM. Conclusion The results of this study indicate that PPTs, ROM and MIMS can be measured reliably on the affected shoulder in BCS with pain after treatment. This offer the possibility of using these measures to assess the effectiveness of interventions in this population.	[Rasmussen, G. H. F.; Kristiansen, M.; Voigt, M.; Madeleine, P.] Aalborg Univ, Dept Hlth Sci & Technol, Sport Sci Performance & Technol, Aalborg, Denmark; [Arroyo-Morales, M.] Univ Granada, Fac Hlth Sci, Dept Phys Therapy, Granada, Spain	Aalborg University; University of Granada	Rasmussen, GHF (corresponding author), Aalborg Univ, Dept Hlth Sci & Technol, Sport Sci Performance & Technol, Aalborg, Denmark.	ghfr@hst.aau.dk	Madeleine, Pascal/AAD-3201-2021	Kristiansen, Mathias/0000-0003-2372-2543; Fogh Rasmussen, Gorm Henrik/0000-0001-6916-3121	Danish Cancer Society [R204-A12469]	Danish Cancer Society(Danish Cancer Society)	GHFR, PM, MK and MV received a grant (grant nr. R204-A12469) from the Danish Cancer Society (URL: https://www.cancer.dk/). The grant covered salary and equipment expenses. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adsuar JC, 2013, ARCH PHYS MED REHAB, V94, P444, DOI 10.1016/j.apmr.2012.08.198; Alburquerque-Sendin F, 2018, J PAIN RES, V11, P215, DOI 10.2147/JPR.S135769; Andersen KG, 2015, CLIN J PAIN, V31, P794, DOI 10.1097/AJP.0000000000000156; Anonymous, 2014, Journal of Cetacean Research and Management, V15, P1; [Anonymous], 2010, BMC MUSCULOSKEL DIS, V11, P11; [Anonymous], 2018, DIABETES CARE S1, V4, pS4, DOI 10.2337/dc18-Srev01; [Anonymous], 2015, BMJ, V2015, ph1887; [Anonymous], 2013, CLIN DIABETOLOGY, V2, pA12; Balaguier R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160866; Binderup AT, 2008, 2008 ANNUAL IEEE STUDENT PAPER CONFERENCE, P126; Binderup AT, 2010, EUR J PAIN, V14, P705, DOI 10.1016/j.ejpain.2009.11.001; Blomqvist L, 2004, ACTA ONCOL, V43, P280, DOI 10.1080/02841860410026170; Box RC, 2002, BREAST CANCER RES TR, V75, P35, DOI 10.1023/A:1016571204924; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brown LE, 2001, J EXERC PHYSL ONLINE, V4, DOI DOI 10.4236/JEP.2013.46A001; Bujang MA, 2017, ARCH OROFAC SCI, V12, P1; Caro-Moran E, 2016, PAIN MED, V17, P1942, DOI 10.1093/pm/pnw064; Cho Ok-Hee, 2006, Nurs Health Sci, V8, P140, DOI 10.1111/j.1442-2018.2006.00271.x; Delanian S, 2012, RADIOTHER ONCOL, V105, P273, DOI 10.1016/j.radonc.2012.10.012; Dougherty J, 2015, J MANIP PHYSIOL THER, V38, P218, DOI 10.1016/j.jmpt.2014.11.006; Farooq MN, 2016, PAK J MED SCI, V32, P457, DOI 10.12669/pjms.322.8747; Fernandez-de-las-Penas C, 2009, CEPHALALGIA, V29, P670, DOI 10.1111/j.1468-2982.2008.01831.x; GAJDOSIK RL, 1987, PHYS THER, V67, P1867, DOI 10.1093/ptj/67.12.1867; Gartner R, 2009, JAMA-J AM MED ASSOC, V302, P1985, DOI 10.1001/jama.2009.1568; Gottrup H, 2000, PAIN, V87, P275, DOI 10.1016/S0304-3959(00)00291-8; Habets Bas, 2018, BMC Res Notes, V11, P15, DOI 10.1186/s13104-018-3128-9; Harrington S, 2011, J CANCER SURVIV, V5, P167, DOI 10.1007/s11764-010-0168-0; Hayes K, 2001, AUST J PHYSIOTHER, V47, P289, DOI 10.1016/S0004-9514(14)60274-9; Hidding JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096748; Hwang JH, 2008, YONSEI MED J, V49, P443, DOI 10.3349/ymj.2008.49.3.443; Jaric S, 2002, SPORTS MED, V32, P615, DOI 10.2165/00007256-200232100-00002; Jensen MP, 1999, PAIN, V83, P157, DOI 10.1016/S0304-3959(99)00101-3; Jung BF, 2003, PAIN, V104, P1, DOI 10.1016/S0304-3959(03)00241-0; Karki A, 2005, J REHABIL MED, V37, P180, DOI 10.1080/16501970410024181; Klassen O, 2017, J CACHEXIA SARCOPENI, V8, P305, DOI 10.1002/jcsm.12165; Kottner J, 2011, J CLIN EPIDEMIOL, V64, P96, DOI 10.1016/j.jclinepi.2010.03.002; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Levy EW, 2012, BREAST CANCER RES TR, V134, P315, DOI 10.1007/s10549-012-2061-1; Leysen L, 2019, PAIN PRACT, V19, P183, DOI 10.1111/papr.12732; Mancini ML, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00051; McCaffery M, 1989, PAIN, V0, P1989; McNeely ML, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005211.pub2; Muir Susan W, 2010, N Am J Sports Phys Ther, V5, P98; Nie HL, 2005, EUR J PAIN, V9, P653, DOI 10.1016/j.ejpain.2004.12.009; Norkin CC., 2003, MEASUREMENT JOINT MO; Pelfort X, 2015, ORTHOP TRAUMATOL-SUR, V101, P559, DOI 10.1016/j.otsr.2015.03.016; Pratheep NS, 2018, SCAND J PAIN, V18, P229, DOI 10.1515/sjpain-2018-0017; Riekki R, 2004, EXP DERMATOL, V13, P364, DOI 10.1111/j.0906-6705.2004.00164.x; Rietman J, 2004, DISABIL REHABIL, V26, P78, DOI 10.1080/09638280310001629642; Sabari JS, 1998, ARCH PHYS MED REHAB, V79, P647, DOI 10.1016/S0003-9993(98)90038-7; Schneider S, 2012, PAIN, V153, P813, DOI 10.1016/j.pain.2012.01.001; Schuck P, 2003, INT J REHABIL RES, V26, P85, DOI 10.1097/00004356-200306000-00002; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Skou ST, 2015, J GERIATR PHYS THER, V38, P141, DOI 10.1519/JPT.0000000000000028; Tatham B, 2013, PHYSIOTHER CAN, V65, P321, DOI 10.3138/ptc.2012-06; van Meeteren J, 2002, J REHABIL MED, V34, P91, DOI 10.1080/165019702753557890; Vangsgaard S, 2015, MUSCLE NERVE, V52, P1066, DOI 10.1002/mus.24645; Walton D, 2011, J ORTHOP SPORT PHYS, V41, P644, DOI 10.2519/jospt.2011.3666; Walton DM, 2014, PHYS THER, V94, P827, DOI 10.2522/ptj.20130369; Wang K, 2018, BREAST, V42, P113, DOI 10.1016/j.breast.2018.08.105; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Wingate M, 2014, MMWR SURVEILL SUMM, V63; Yang H, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/580397	63	6	6	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2020	15	6							e0234118	10.1371/journal.pone.0234118; 10.1371/journal.pone.0234118.r001; 10.1371/journal.pone.0234118.r002; 10.1371/journal.pone.0234118.r003; 10.1371/journal.pone.0234118.r004	http://dx.doi.org/10.1371/journal.pone.0234118; 10.1371/journal.pone.0234118.r001; 10.1371/journal.pone.0234118.r002; 10.1371/journal.pone.0234118.r003; 10.1371/journal.pone.0234118.r004			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LW6ZP	32492064	Green Published, gold			2022-12-26	WOS:000539293000003
J	Reyes, S; Rimkus, CD; Lozoff, B; Biswal, BB; Peirano, P; Algarin, C				Reyes, Sussanne; Rimkus, Carolina de Medeiros; Lozoff, Betsy; Biswal, Bharat B.; Peirano, Patricio; Algarin, Cecilia			Assessing cognitive control and the reward system in overweight young adults using sensitivity to incentives and white matter integrity	PLOS ONE			English	Article							IRON-DEFICIENCY ANEMIA; BODY-MASS INDEX; INHIBITORY CONTROL; OBESITY; FOOD; BEHAVIOR; MICROSTRUCTURE; AGE; ABNORMALITIES; METAANALYSIS	Cognitive control and incentive sensitivity are related to overeating and obesity. Optimal white matter integrity is relevant for an efficient interaction among reward-related brain regions. However, its relationship with sensitivity to incentives remains controversial. The aim of this study was to assess the incentive sensitivity and its relationship to white matter integrity in normal-weight and overweight groups. Seventy-six young adults participated in this study: 31 were normal-weight (body mass index [BMI] 18.5 to < 25.0 kg/m(2), 14 females) and 45 were overweight (BMI. 25.0 kg/m(2), 22 females). Incentive sensitivity was assessed using an antisaccade task that evaluates the effect of incentives (neutral, reward, and loss avoidance) on cognitive control performance. Diffusion tensor imaging studies were performed to assess white matter integrity. The relationship between white matter microstructure and incentive sensitivity was investigated through tract-based spatial statistics. Behavioral antisaccade results showed that normal-weight participants presented higher accuracy (78.0 vs. 66.7%, p = 0.01) for loss avoidance incentive compared to overweight participants. Diffusion tensor imaging analysis revealed a positive relationship between fractional anisotropy and loss avoidance accuracy in the normal-weight group (p < 0.05). No relationship reached significance in the overweight group. These results support the hypothesis that white matter integrity is relevant for performance in an incentivized antisaccade task.	[Reyes, Sussanne; Peirano, Patricio; Algarin, Cecilia] Univ Chile, Inst Nutr & Food Technol INTA, Lab Sleep & Funct Neurobiol, Santiago, Chile; [Rimkus, Carolina de Medeiros] Univ Sao Paulo, Fac Med, Dept Radiol & Oncol, Lab Med Invest LIM 44, Sao Paulo, SP, Brazil; [Lozoff, Betsy] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Biswal, Bharat B.] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA	Universidad de Chile; Universidade de Sao Paulo; University of Michigan System; University of Michigan; New Jersey Institute of Technology	Algarin, C (corresponding author), Univ Chile, Inst Nutr & Food Technol INTA, Lab Sleep & Funct Neurobiol, Santiago, Chile.	calgarin@inta.uchile.cl	Rimkus, Carolina/AAP-6742-2021	Rimkus, Carolina/0000-0002-3866-1299; Reyes, Sussanne/0000-0001-7351-1176	Chilean National Fund for Scientific and Technological Development (FONDECYT) [11160671]; National Institutes of Health [NIH HD33487]	Chilean National Fund for Scientific and Technological Development (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported grants from the Chilean National Fund for Scientific and Technological Development (FONDECYT; No. 11160671) and National Institutes of Health (NIH HD33487). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Algarin C, 2003, PEDIATR RES, V53, P217, DOI 10.1203/01.PDR.0000047657.23156.55; Algarin C, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00054; Algarin C, 2013, DEV MED CHILD NEUROL, V55, P453, DOI 10.1111/dmcn.12118; Amador N, 2000, J NEUROPHYSIOL, V84, P2166, DOI 10.1152/jn.2000.84.4.2166; Balodis IM, 2013, BIOL PSYCHIAT, V73, P877, DOI 10.1016/j.biopsych.2013.01.014; Benton D, 2016, INT J OBESITY, V40, pS12, DOI 10.1038/ijo.2016.9; Bessette KL, 2019, BIOL PSYCHIAT-COGN N, V4, P233, DOI 10.1016/j.bpsc.2018.09.007; Birdsill AC, 2017, HUM BRAIN MAPP, V38, P3337, DOI 10.1002/hbm.23576; Burman OHP, 2008, BIOL LETTERS, V4, P330, DOI 10.1098/rsbl.2008.0113; Camara E, 2009, FRONT NEUROSCI-SWITZ, V3, P350, DOI 10.3389/neuro.01.034.2009; Chaddock-Heyman L, 2013, BIOL PSYCHOL, V94, P109, DOI 10.1016/j.biopsycho.2013.05.008; Chahal R, 2018, NEUROIMAGE, V181, P659, DOI 10.1016/j.neuroimage.2018.07.050; Chaim TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110199; Chen PHA, 2017, COGN NEUROSCI-UK, V8, P162, DOI 10.1080/17588928.2016.1235556; Chen VCH, 2018, NEUROPSYCH DIS TREAT, V14, P3199, DOI 10.2147/NDT.S180569; Chung T, 2015, DEV COGN NEUROS-NETH, V16, P93, DOI 10.1016/j.dcn.2015.05.004; Cremers LGM, 2016, NEUROBIOL AGING, V39, P108, DOI 10.1016/j.neurobiolaging.2015.11.021; Fandino J, 2010, COMPR PSYCHIAT, V51, P110, DOI 10.1016/j.comppsych.2009.03.011; Geier CF, 2010, CEREB CORTEX, V20, P1613, DOI 10.1093/cercor/bhp225; Geier CF, 2013, HORM BEHAV, V64, P333, DOI 10.1016/j.yhbeh.2013.02.008; Geier CF, 2012, CHILD DEV, V83, P1262, DOI 10.1111/j.1467-8624.2012.01771.x; Gitelman DR, 2002, BEHAV RES METH INS C, V34, P605, DOI 10.3758/BF03195488; Goh S, 2011, DEV COGN NEUROS-NETH, V1, P305, DOI 10.1016/j.dcn.2011.03.001; Horstmann A, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00058; Hu YM, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00532; Koch K, 2014, HUM BRAIN MAPP, V35, P1469, DOI 10.1002/hbm.22284; Kube J, 2018, BRAIN IMAGING BEHAV, V12, P1431, DOI 10.1007/s11682-017-9786-8; Kullmann S, 2015, OBES REV, V16, P273, DOI 10.1111/obr.12248; Kullmann S, 2016, NEUROIMAGE, V125, P36, DOI 10.1016/j.neuroimage.2015.10.006; Leong JK, 2018, NEUROIMAGE, V178, P435, DOI 10.1016/j.neuroimage.2018.05.055; Li PP, 2018, BEHAV BRAIN RES, V339, P249, DOI 10.1016/j.bbr.2017.11.005; Li W, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.436; Lindgren E, 2018, FRONT BIOSCI-LANDMRK, V23, P811, DOI 10.2741/4618; Lou BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108180; Lozoff B, 2003, PEDIATRICS, V112, P846; Luna B, 2013, CURR DIR PSYCHOL SCI, V22, P94, DOI 10.1177/0963721413478416; Lyn R, 2019, CURR OBES REP, V8, P504, DOI 10.1007/s13679-019-00358-w; Mandviwala T, 2016, CURR ATHEROSCLER REP, V18, DOI 10.1007/s11883-016-0575-4; Marques-Iturria I, 2015, NEUROIMAGE, V111, P100, DOI 10.1016/j.neuroimage.2015.02.012; Ministry of Health Chile, 2017, NAT HLTH SURV 1 RES; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Mori S, 2009, CURR OPIN NEUROL, V22, P362, DOI 10.1097/WCO.0b013e32832d954b; Olivo G, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00075; Olson EA, 2009, J COGNITIVE NEUROSCI, V21, P1406, DOI 10.1162/jocn.2009.21107; Papageorgiou I, 2017, MAGN RESON IMAGING, V37, P116, DOI 10.1016/j.mri.2016.11.018; Paschke LM, 2015, NEUROIMAGE, V111, P549, DOI 10.1016/j.neuroimage.2015.02.047; Paulsen DJ, 2015, DEV COGN NEUROS-NETH, V11, P105, DOI 10.1016/j.dcn.2014.09.003; Repple J, 2018, PSYCHONEUROENDOCRINO, V91, P179, DOI 10.1016/j.psyneuen.2018.03.007; Reyes S, 2015, PEDIATR RES, V78, P152, DOI 10.1038/pr.2015.82; Riederer JW, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00271; Rotge JY, 2017, OBES REV, V18, P936, DOI 10.1111/obr.12549; Schmahmann JD, 2008, ANN NY ACAD SCI, V1142, P266, DOI 10.1196/annals.1444.017; Shott ME, 2015, INT J OBESITY, V39, P214, DOI 10.1038/ijo.2014.121; Shulman GL, 2010, J NEUROSCI, V30, P3640, DOI 10.1523/JNEUROSCI.4085-09.2010; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stanek KM, 2011, OBESITY, V19, P500, DOI 10.1038/oby.2010.312; Thakkar KN, 2016, HUM BRAIN MAPP, V37, P2811, DOI 10.1002/hbm.23209; Thijssen E, 2015, RHEUMATOLOGY, V54, P588, DOI 10.1093/rheumatology/keu464; Verdejo-Roman J, 2017, NEUROIMAGE, V146, P293, DOI 10.1016/j.neuroimage.2016.11.011; Verdejo-Roman J, 2017, HUM BRAIN MAPP, V38, P666, DOI 10.1002/hbm.23407; Volkow ND, 2013, OBES REV, V14, P2, DOI 10.1111/j.1467-789X.2012.01031.x; Volkow ND, 2017, NAT REV NEUROSCI, V18, P741, DOI 10.1038/nrn.2017.130; Volkow ND, 2011, TRENDS COGN SCI, V15, P37, DOI 10.1016/j.tics.2010.11.001; Voss MW, 2013, HUM BRAIN MAPP, V34, P2972, DOI 10.1002/hbm.22119; Waller R, 2017, NEUROIMAGE-CLIN, V14, P201, DOI 10.1016/j.nicl.2017.01.014; Wang J, 2016, CANCER EPIDEMIOL, V42, P1, DOI 10.1016/j.canep.2016.02.010; Wang Q, 2013, ACM T INFORM SYST, V31, DOI 10.1145/2414782.2414787; World Health Organization, 2018, OB OV; Xu JS, 2012, HUM BRAIN MAPP, V33, P994, DOI 10.1002/hbm.21275	73	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2020	15	6							e0233915	10.1371/journal.pone.0233915	http://dx.doi.org/10.1371/journal.pone.0233915			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MT4VF	32484819	gold, Green Published			2022-12-26	WOS:000554969700022
J	Tomecek, D; Androvicova, R; Fajnerova, I; Dechterenko, F; Rydlo, J; Horacek, J; Lukavsky, J; Tintera, J; Hlinka, J				Tomecek, David; Androvicova, Renata; Fajnerova, Iveta; Dechterenko, Filip; Rydlo, Jan; Horacek, Jiri; Lukavsky, Jiri; Tintera, Jaroslav; Hlinka, Jaroslav			Personality reflection in the brain's intrinsic functional architecture remains elusive	PLOS ONE			English	Article							CLUSTER-SIZE INFERENCE; GLOBAL SIGNAL; NOISE CORRECTION; SPATIAL EXTENT; RANDOM-FIELD; ANTICORRELATIONS; EXTROVERSION; AGREEABLENESS; NEUROTICISM; NETWORKS	In the last years, there has been a considerable increase of research into the neuroimaging correlates of inter-individual temperament and character variability-an endeavour for which the term `personality neuroscience' was coined. Among other neuroimaging modalities and approaches, substantial work focuses on functional connectivity in resting state (rs-FC) functional magnetic resonance imaging data. In the current paper, we set out to independently query the questions asked in a highly cited study that reported a range of functional connectivity correlates of personality dimensions assessed by the widely used `Big Five' Personality Inventory. Using a larger sample (84 subjects) and an equivalent data analysis pipeline, we obtained widely disagreeing results compared to the original study. Overall, the results were in line with the hypotheses of no relation between functional connectivity and personality, when more precise permutation-based multiple testing procedures were applied. The results demonstrate that as with other neuroimaging studies, great caution should be applied when interpreting the findings, among other reasons due to multiple testing problem involved at several levels in many neuroimaging studies. Of course, the current study results can not ultimately disprove the existence of some link between personality and brain's intrinsic functional architecture, but clearly shows that its form is very likely different and much more subtle and elusive than was previously reported.	[Tomecek, David; Androvicova, Renata; Fajnerova, Iveta; Rydlo, Jan; Horacek, Jiri; Lukavsky, Jiri; Tintera, Jaroslav; Hlinka, Jaroslav] Natl Inst Mental Hlth, Klecany, Czech Republic; [Dechterenko, Filip; Lukavsky, Jiri] Czech Acad Sci, Inst Psychol, Prague, Czech Republic; [Rydlo, Jan; Tintera, Jaroslav] Inst Clin & Expt Med, Dept Radiol, Prague, Czech Republic; [Tomecek, David; Hlinka, Jaroslav] Czech Acad Sci, Inst Comp Sci, Prague, Czech Republic; [Tomecek, David] Czech Tech Univ, Fac Elect Engn, Prague, Czech Republic; [Androvicova, Renata] Charles Univ Prague, Fac Med 3, Prague, Czech Republic	National Institute of Mental Health - Czech Republic; Czech Academy of Sciences; Institute of Psychology of the Czech Academy of Sciences; Institute for Clinical & Experimental Medicine (IKEM); Czech Academy of Sciences; Institute of Computer Science of the Czech Academy of Sciences; Czech Technical University Prague; Charles University Prague	Hlinka, J (corresponding author), Natl Inst Mental Hlth, Klecany, Czech Republic.; Hlinka, J (corresponding author), Czech Acad Sci, Inst Comp Sci, Prague, Czech Republic.	hlinka@cs.cas.cz	Dechterenko, Filip/H-2532-2014; Horacek, Jiri/M-7054-2019; Tomecek, David/C-5893-2019; Androvičová, Renáta/AAZ-4910-2020; Fajnerova, Iveta/AAF-1617-2020; Hlinka, Jaroslav/E-1787-2013	Dechterenko, Filip/0000-0003-0472-915X; Horacek, Jiri/0000-0003-0114-7306; Tomecek, David/0000-0001-7038-0529; Androvičová, Renáta/0000-0002-1099-0891; Fajnerova, Iveta/0000-0002-7399-3029; Hlinka, Jaroslav/0000-0003-1402-1470; Rydlo, Jan/0000-0001-7116-3614; Tintera, Jaroslav/0000-0002-0685-7174	Czech Science Foundation [13-23940S]; Ministry of Education, Youth and Sports under the NPU I program [LO1611]; Institute of Psychology [RVO: 68081740]; Institute of Computer Science of the Czech Academy of Sciences [RVO:67985807]	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports under the NPU I program; Institute of Psychology; Institute of Computer Science of the Czech Academy of Sciences(Czech Academy of Sciences)	This study was supported by the Czech Science Foundation (https://gacr.cz/en/) project No. 13-23940S (JHo, JL, JT, JHl) and project Nr. LO1611 with a financial support from the Ministry of Education, Youth and Sports (http://www.msmt.cz/?lang=2) under the NPU I program, and by the long-term strategic development financing of the Institute of Psychology (RVO: 68081740) and Institute of Computer Science (RVO:67985807) of the Czech Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelstein JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027633; Aghajani M, 2014, COGN AFFECT BEHAV NE, V14, P836, DOI 10.3758/s13415-013-0224-0; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Birn RM, 2013, NEUROIMAGE, V83, P550, DOI 10.1016/j.neuroimage.2013.05.099; Bjornebekk A, 2013, NEUROIMAGE, V65, P194, DOI 10.1016/j.neuroimage.2012.10.009; Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; Chang C, 2009, NEUROIMAGE, V47, P1448, DOI 10.1016/j.neuroimage.2009.05.012; Costa P.T., 2008, SAGE HDB PERSONALITY, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9, 10.4135/9781849200479.N9]; Costa P. T., 1989, NEO PI NEO FFI MAN S; DeYoung CG, 2005, J PERS, V73, P825, DOI 10.1111/j.1467-6494.2005.00330.x; DeYoung CG, 2010, PSYCHOL SCI, V21, P820, DOI 10.1177/0956797610370159; DeYoung CG, 2009, CAMBRIDGE HANDBOOK OF PERSONALITY PSYCHOLOGY, P323; DIGMAN JM, 1990, ANNU REV PSYCHOL, V41, P417, DOI 10.1146/annurev.psych.41.1.417; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Glatard T, 2015, FRONT NEUROINFORM, V9, DOI 10.3389/fninf.2015.00012; Graziano WG, 2007, J PERS SOC PSYCHOL, V93, P583, DOI 10.1037/0022-3514.93.4.583; Haas BW, 2007, BEHAV NEUROSCI, V121, P249, DOI 10.1037/0735-7044.121.2.249; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Hayasaka S, 2003, NEUROIMAGE, V20, P2343, DOI 10.1016/j.neuroimage.2003.08.003; Kruggel F, 1999, NEUROIMAGE, V10, P530, DOI 10.1006/nimg.1999.0490; Li Jingguang, 2010, Commun Integr Biol, V3, P295; Lucas RE, 2000, J PERS SOC PSYCHOL, V79, P452, DOI 10.1037//0022-3514.79.3.452; Mischel W, 2004, ANNU REV PSYCHOL, V55, P1, DOI 10.1146/annurev.psych.55.042902.130709; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nettle D, 2008, EUR J PERSONALITY, V22, P323, DOI 10.1002/per.672; Petersson KM, 1999, PHILOS T R SOC B, V354, P1261, DOI 10.1098/rstb.1999.0478; Poline JB, 1997, NEUROIMAGE, V5, P83, DOI 10.1006/nimg.1996.0248; Roels SP, 2015, J NEUROSCI METH, V240, P37, DOI 10.1016/j.jneumeth.2014.10.024; Sampaio A, 2014, BRAIN STRUCT FUNCT, V219, P1913, DOI 10.1007/s00429-013-0610-y; Servaas MN, 2015, NEUROPSYCHOPHARMACOL, V40, P296, DOI 10.1038/npp.2014.169; Suslow T, 2010, NEUROSCIENCE, V167, P111, DOI 10.1016/j.neuroscience.2010.01.038; Wei LQ, 2014, HUM BRAIN MAPP, V35, P331, DOI 10.1002/hbm.22176; Wei LQ, 2011, BRAIN RES, V1419, P68, DOI 10.1016/j.brainres.2011.08.060; Weisberg YJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00178; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Wright CI, 2006, CEREB CORTEX, V16, P1809, DOI 10.1093/cercor/bhj118; Xu JS, 2012, NEUROIMAGE, V59, P800, DOI 10.1016/j.neuroimage.2011.07.040	41	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2020	15	6							e0232570	10.1371/journal.pone.0232570	http://dx.doi.org/10.1371/journal.pone.0232570			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MT4VF	32484832	Green Published, Green Submitted, gold			2022-12-26	WOS:000554969700004
J	Escobar, C; Borras, X; Freire, RB; Gonzalez-Juanatey, C; Morillas, M; Munoz, AV; Gomez-Doblas, JJ				Escobar, Carlos; Borras, Xavier; Bover Freire, Ramon; Gonzalez-Juanatey, Carlos; Morillas, Miren; Valle Munoz, Alfonso; Jose Gomez-Doblas, Juan			A Delphi consensus on the management of oral anticoagulation in patients with nonvalvular atrial fibrillation in Spain: ACOPREFERENCE study	PLOS ONE			English	Article							STROKE PREVENTION; BLEEDING RISK; WARFARIN; CARE; DABIGATRAN; SCORE; IDARUCIZUMAB; METAANALYSIS; GUIDELINES; MORTALITY	Objective To evaluate the level of agreement between cardiologists regarding the management of oral anticoagulation (OAC) in patients with non-valvular atrial fibrillation (NVAF) in Spain. Materials and methods A two-round Delphi study was performed using an online survey. In round 1, panel members rated their level of agreement with the questionnaire items on a 9-point Likert scale. Item selection was based on acceptance by >= 66.6% of panellists and the agreement of the scientific committee. In round 2, the same panellists evaluated those items that did not meet consensus in round 1. Results A total of 238 experts participated in round 1; of these, 217 completed the round 2 survey. In round 1, 111 items from 4 dimensions (Thromboembolic and bleeding risk evaluation for treatment decision-making: 18 items; Choice of OAC: 39 items; OAC in specific cardiology situations: 12 items; Patient participation and education: 42 items) were evaluated. Consensus was reached for 92 items (83%). Over 80% of the experts agreed with the use of DOACs as the initial anticoagulant treatment when OAC is indicated. Panellists recommended the use of DOACs in patients at high risk of thromboembolic complications (CHA(2)DS(2)-VASc >= 3) (83%), haemorrhages (HAS-BLED >= 3) (89%) and poor quality of anticoagulation control (SAMe-TT2R2 > 2) (76%), patients who fail to achieve an optimal therapeutic range after 3 months on VKA treatment (93%), and those who are to undergo cardioversion (80%). Panellists agreed that the efficacy and safety profile of each DOAC (98%), the availability of a specific reversal agent (72%) and patient's preference (85%) should be considered when prescribing a DOAC. A total of 97 items were ultimately accepted after round 2. Conclusions This Delphi panel study provides expert-based recommendations that may offer guidance on clinical decision-making for the management of OAC in NVAF. The importance of patient education and involvement has been highlighted.	[Escobar, Carlos] Hosp Univ La Paz, Cardiol Dept, Madrid, Spain; [Borras, Xavier] Hosp Santa Creu & Sant Pau, Cardiol Dept, Barcelona, Spain; [Bover Freire, Ramon] Hosp Clin San Carlos, Cardiol Dept, CIBERCV, Madrid, Spain; [Gonzalez-Juanatey, Carlos] Hosp Univ Lucus Augusti, Cardiol Dept, Lugo, Spain; [Morillas, Miren] Hosp Galdakao, Cardiol Dept, Galdakao, Bizkaia, Spain; [Valle Munoz, Alfonso] Hosp Marina Salud, Cardiol Dept, Alicante, Spain; [Jose Gomez-Doblas, Juan] Hosp Univ Virgen de la Victoria, Cardiol Dept, CIBERCV, Malaga, Spain	Hospital Universitario La Paz; Hospital of Santa Creu i Sant Pau; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Hospital Clinico San Carlos; Hospital Universitario Lucus Augusti-Lugo; Galdakao Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Universidad de Malaga	Escobar, C (corresponding author), Hosp Univ La Paz, Cardiol Dept, Madrid, Spain.	escobar_cervantes_carlos@hotmail.com		Valle, Alfonso/0000-0001-9460-1066; Escobar, Carlos/0000-0001-5584-4735	Boehringer Ingelheim	Boehringer Ingelheim(Boehringer Ingelheim)	This study was funded by Boehringer Ingelheim. Boehringer Ingelheim participated in the study design and decision to publish, but this company had no role in data collection and analysis or in preparation of the manuscript. No additional external funding received for this study.	Agencia Espanola de Medicamentos y Productos Sanitarios. Informes de Posicionamiento Terape u- tico, 2016, INF POS TER CRIT REC; Anguita Sanchez M, 2015, REV ESP CARDIOL, V68, P761, DOI [10.1016/j.rec.2014.11.019, DOI 10.1016/J.REC.2014.11.019]; Apostolakis S, 2012, J AM COLL CARDIOL, V60, P861, DOI 10.1016/j.jacc.2012.06.019; Ball J, 2013, INT J CARDIOL, V167, P1807, DOI 10.1016/j.ijcard.2012.12.093; Barrios V, 2015, REV ESP CARDIOL, V68, P769, DOI 10.1016/j.rec.2015.04.017; Barrios V, 2012, REV ESP CARDIOL, V65, P47, DOI [10.1016/j.recesp.2011.08.008, 10.1016/j.rec.2011.09.004]; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Camm AJ, 2012, EUR HEART J, V33; Cinza-Sanjurjo S, 2015, REV ESP CARDIOL, V68, P753, DOI 10.1016/j.rec.2014.04.018; Connolly SJ, 2011, NEW ENGL J MED, V364, P806, DOI 10.1056/NEJMoa1007432; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Di Fusco SA, 2017, MONALDI ARCH CHEST D, V87, P49, DOI 10.4081/monaldi.2017.805; Fang MC, 2007, AM J MED, V120, P700, DOI 10.1016/j.amjmed.2006.07.034; Feuring M, 2016, EXPERT OPIN DRUG DIS, V11, P717, DOI 10.1080/17460441.2016.1188077; Friberg L, 2012, CIRCULATION, V125, P2298, DOI 10.1161/CIRCULATIONAHA.111.055079; Gallagher AM, 2011, THROMB HAEMOSTASIS, V106, P968, DOI 10.1160/TH11-05-0353; Gallego P, 2014, AM J MED, V127, P1083, DOI 10.1016/j.amjmed.2014.05.023; Gallego P, 2013, THROMB HAEMOSTASIS, V110, P1189, DOI 10.1160/TH13-07-0556; Garcia DA, 2010, THROMB HAEMOSTASIS, V104, P1099, DOI 10.1160/TH10-07-0491; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Glund S, 2015, LANCET, V386, P680, DOI 10.1016/S0140-6736(15)60732-2; Greinacher A, 2015, THROMB HAEMOSTASIS, V113, P931, DOI 10.1160/TH14-11-0982; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; James D, 2015, NURSE RES, V22, P35, DOI 10.7748/nr.22.3.35.e1297; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI [10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.022, 10.1161/CIR.0000000000000142, 10.1016/j.jacc.2014.03.021]; Gomez-Doblas JJ, 2014, REV ESP CARDIOL, V67, P259, DOI [10.1016/j.rec.2013.07.014, 10.1016/j.recesp.2013.07.015]; Keeney S, 2006, J ADV NURS, V53, P205, DOI 10.1111/j.1365-2648.2006.03716.x; Kirchhof P, 2016, EUROPACE, V18, DOI [10.1016/j.rec.2016.11.033, 10.1093/europace/euw295, 10.5603/KP.2016.0172]; Levy JH, 2013, ANESTHESIOLOGY, V118, P1466, DOI 10.1097/ALN.0b013e318289bcba; Lip GYH, 2015, EUR HEART J, V36, P3265, DOI 10.1093/eurheartj/ehv415; Lip GYH, 2015, JAMA-J AM MED ASSOC, V313, P1950, DOI 10.1001/jama.2015.4369; Moreno-Arribas J, 2016, J CARDIOVASC PHARM T, V21, P150, DOI 10.1177/1074248415596426; Nuno R, 2012, HEALTH POLICY, V105, P55, DOI 10.1016/j.healthpol.2011.10.006; Olesen JB, 2012, THROMB HAEMOSTASIS, V107, P1172, DOI 10.1160/TH12-03-0175; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; POLLACK CV, 2015, NEW ENGL J MED, V373, P511, DOI DOI 10.1056/NEJMOA1502000; RAND/UCLA T, APPR METH US MAN; Abumuaileq RRY, 2015, EUROPACE, V17, P711, DOI 10.1093/europace/euu353; Roldan I MF, 2016, PROPUESTA MODIFICACI; Roldan V, 2015, AM J MED, V128, P1237, DOI 10.1016/j.amjmed.2015.05.036; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Schaefer JK, 2016, ANN HEMATOL, V95, P437, DOI 10.1007/s00277-015-2566-x; Verheugt FWA, 2015, LANCET, V386, P303, DOI 10.1016/S0140-6736(15)60245-8; Yeh CH, 2015, ARTERIOSCL THROM VAS, V35, P1056, DOI 10.1161/ATVBAHA.115.303397; Yeh CH, 2012, CIRC RES, V111, P1069, DOI 10.1161/CIRCRESAHA.112.276741; Yeh JS, 2016, AM HEALTH DRUG BENEF, V9, P42	48	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0231565	10.1371/journal.pone.0231565	http://dx.doi.org/10.1371/journal.pone.0231565			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MJ2AA	32479502	Green Published, gold			2022-12-26	WOS:000547893500003
J	Eun, S; Lee, J; Song, EM; De Rosa, A; Lee, JH; Park, K				Eun, Seulgi; Lee, Jeungchan; Song, Eun-Mo; De Rosa, Alexandra; Lee, Jun-Hwan; Park, Kyungmo			Brain functional connectivity changes by low back extension pain model in low back pain patients	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; DEFAULT-MODE; NUCLEUS-ACCUMBENS; CLINICAL PAIN; HEAD MOTION; NETWORK; FMRI; FLUCTUATIONS; PERCEPTION; DIAGNOSIS	Purpose Low back pain (LBP) is a common ailment in most developed countries. Because most cases of LBP are known as 'non-specific', it has been challenging to develop experimental pain models of LBP which reproduce patients' clinical pain. In addition, previous models have limited applicability in a steady-pain-state neuroimaging environment. Thus, this study aims to devise a low back pain model with a simple methodology to induce experimental LBP, which has similar pain properties to patients' clinical pain, and to apply the model in a steady-pain-state neuroimaging study. Methods Our low back extension (LBE) pain model was tested on 217 LBP patients outside the magnetic resonance imaging (MRI) scanner to determine the reproducibility of endogenous pain and the similarity to their own clinical pain (STUDY1), and applied in a steady-pain-state functional MRI study (47 LBP patients and 23 healthy controls) to determine its applicability (induced head motions and brain functional connectivity changes; STUDY2). Results By the LBE pain model, 68.2% of the LBP patients reported increased LBP with high similarity of sensations to their own clinical pain (STUDY1), and the head motions were statistically similar to and correlated with those in resting state (STUDY2). Furthermore, the LBE model altered brain functional connectivity by decreasing the default-mode and the sensorimotor networks, and increasing the salience network, which was significantly associated with the intensity of the induced pain. Conversely, the healthy controls showed increased somatosensory network (but not of the cognitive pain processing). Conclusion Our investigations suggest that our LBE pain model, which increased LBP with high similarity to the LBP patients' own pain sensation and induced patient-specific brain responses with acceptable head motion, could be applied to neuroimaging studies investigating brain responses to different levels of endogenous LBP.	[Eun, Seulgi; Park, Kyungmo] Kyung Hee Univ, Dept Biomed Engn, Yongin, South Korea; [Eun, Seulgi] Inst Basic Sci, Ctr Neurosci Imaging Res, Suwon, South Korea; [Lee, Jeungchan] Harvard Med Sch, Athinoula A Martinos Ctr Biomed Imaging, Massachusetts Gen Hosp, Dept Radiol, Charlestown, MA USA; [Song, Eun-Mo] Kyung Hee Univ, Coll Korean Med, Dept Korean Rehabil Med, Seoul, South Korea; [De Rosa, Alexandra] MIT, Dept Biol, Cambridge, MA USA; [Lee, Jun-Hwan] Korea Inst Oriental Med, Clin Med Div, Daejeon, South Korea; [Lee, Jun-Hwan] Univ Sci & Technol UST, Korean Med Life Sci, Campus Korea Inst Oriental Med, Daejeon, South Korea	Kyung Hee University; Institute for Basic Science - Korea (IBS); Harvard University; Massachusetts General Hospital; Kyung Hee University; Massachusetts Institute of Technology (MIT); Korea Institute of Oriental Medicine (KIOM); Korea Institute of Oriental Medicine (KIOM); University of Science & Technology (UST)	Park, K (corresponding author), Kyung Hee Univ, Dept Biomed Engn, Yongin, South Korea.	saenim@khu.ac.kr	Lee, Jeungchan/AAA-9955-2021	LEE, JEUNGCHAN/0000-0002-4424-175X; park, kyungmo/0000-0002-7689-8967; Eun, Seulgi/0000-0002-2595-9408	KP: Korea Institute of Oriental Medicine [K19052]	KP: Korea Institute of Oriental Medicine	This work was funded by KP: Korea Institute of Oriental Medicine (grant number K19052).	Alshelh Z, 2018, NEUROIMAGE-CLIN, V17, P222, DOI 10.1016/j.nicl.2017.10.019; Apkarian AV, 2001, NEUROSCI LETT, V299, P57, DOI 10.1016/S0304-3940(01)01504-X; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Baliki MN, 2006, J NEUROSCI, V26, P12165, DOI 10.1523/JNEUROSCI.3576-06.2006; Baliki MN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106133; Baliki MN, 2010, NEURON, V66, P149, DOI 10.1016/j.neuron.2010.03.002; Baliki MN, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-47; Beckmann C. F, 2009, OHBM; Benarroch EE, 2016, NEUROLOGY, V87, P1720, DOI 10.1212/WNL.0000000000003243; Birn RM, 2008, NEUROIMAGE, V40, P644, DOI 10.1016/j.neuroimage.2007.11.059; Caparelli EC, 2003, NEUROIMAGE, V20, P1411, DOI 10.1016/S1053-8119(03)00339-2; Cavanaugh JM, 1996, J BIOMECH, V29, P1117, DOI 10.1016/0021-9290(96)00023-1; Chang C, 2009, NEUROIMAGE, V44, P857, DOI 10.1016/j.neuroimage.2008.09.029; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dafny N, 1996, NEUROSCIENCE, V70, P449, DOI 10.1016/0306-4522(95)00358-4; Deville WLJM, 2000, SPINE, V25, P1140, DOI 10.1097/00007632-200005010-00016; Eland David C., 2002, Journal of the American Osteopathic Association, V102, P130; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Huettel SA, 2014, FUNCTIONAL MAGNETIC RESONANCE IMAGING, THIRD EDITION, P271; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kobayashi Yoshitaka, 2009, Spine (Phila Pa 1976), V34, P2431, DOI 10.1097/BRS.0b013e3181b1fb76; Koes BW, 2006, BMJ-BRIT MED J, V332, P1430, DOI 10.1136/bmj.332.7555.1430; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; Kregel J, 2015, SEMIN ARTHRITIS RHEU, V45, P229, DOI 10.1016/j.semarthrit.2015.05.002; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; KUSLICH SD, 1991, ORTHOP CLIN N AM, V22, P181; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Loggia ML, 2013, PAIN, V154, P24, DOI 10.1016/j.pain.2012.07.029; Lorenz J, 2003, BRAIN, V126, P1079, DOI 10.1093/brain/awg102; Makary MM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18870-1; Martino M, 2016, P NATL ACAD SCI USA, V113, P4824, DOI 10.1073/pnas.1517558113; Misaggi B, 2009, EUR SPINE J, V18, pS49, DOI 10.1007/s00586-009-0987-8; Nickerson LD, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00115; O'Sullivan P, 2005, MANUAL THER, V10, P242, DOI 10.1016/j.math.2005.07.001; Ong WY, 2018, MOL NEUROBIOL; PETERS ML, 1992, J PSYCHOSOM RES, V36, P47, DOI 10.1016/0022-3999(92)90113-G; Peters SK, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00104; Petersen-Felix Steen, 2002, Best Pract Res Clin Anaesthesiol, V16, P667, DOI 10.1053/bean.2002.0258; Pijnenburg M, 2015, BRAIN CONNECT, V5, P303, DOI 10.1089/brain.2014.0309; PROCACCI P, 1979, PAIN, V6, P123, DOI 10.1016/0304-3959(79)90120-9; Pruim RHR, 2015, NEUROIMAGE, V112, P267, DOI 10.1016/j.neuroimage.2015.02.064; Rebain Richard, 2002, Spine (Phila Pa 1976), V27, pE388, DOI 10.1097/00007632-200209010-00025; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Seminowicz DA, 2017, J PAIN, V18, P1027, DOI 10.1016/j.jpain.2017.03.008; Seto E, 2001, NEUROIMAGE, V14, P284, DOI 10.1006/nimg.2001.0829; Sharma Harish A, 2011, J Pain Res, V4, P401, DOI 10.2147/JPR.S24393; SIKORSKI JM, 1985, SPINE, V10, P571, DOI 10.1097/00007632-198507000-00012; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Wasan AD, 2011, ANESTHESIOLOGY, V115, P364, DOI 10.1097/ALN.0b013e318220e880; Winters MV, 2004, PHYS THER, V84, P800, DOI 10.1093/ptj/84.9.800; YANG JC, 1985, PSYCHOSOM MED, V47, P461, DOI 10.1097/00006842-198509000-00006; Zhang SS, 2014, NEURAL REGEN RES, V9, P135, DOI 10.4103/1673-5374.125341	56	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0233858	10.1371/journal.pone.0233858	http://dx.doi.org/10.1371/journal.pone.0233858			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MJ2AA	32479547	gold, Green Published			2022-12-26	WOS:000547893500034
J	Van Orden, MJ; Newsom, S; Rajan, R				Van Orden, Mason J.; Newsom, Sydney; Rajan, Rakhi			CRISPR type II-A subgroups exhibit phylogenetically distinct mechanisms for prespacer insertion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CRISPR adaptation; type II-A; prespacer integration; Cas1; Cas2; streptococcus; leader-repeat junction; spacer; microbial adaptive immunity; integrase; gene tagging; CRISPR; Cas; Streptococcus; biotechnology; DNA-protein interaction; host defense; protein complex; viral DNA; CRISPR adaptive immunity; type II-A CRISPR	SPACER ACQUISITION; ADAPTATION; SEQUENCES; SYSTEM; PHAGE; PAM; INTEGRATION; RESISTANCE; MUTATIONS; DIVERSITY	CRISPR-Cas is an adaptive immune system that protects prokaryotes against foreign nucleic acids. Prokaryotes gain immunity by acquiring short pieces of the invading nucleic acid termed prespacers and inserting them into their CRISPR array. In type II-A systems, Cas1 and Cas2 proteins insert prespacers always at the leader-repeat junction of the CRISPR array. Among type II-A CRISPR systems, three distinct groups (G1, G2, and G3) exist according to the extent of DNA sequence conservation at the 3 ' end of the leader. However, the mechanisms by which these conserved motifs interact with their cognate Cas1 and Cas2 proteins remain unclear. Here, we performedin vitrointegration assays, finding that for G1 and G2, the insertion site is recognized through defined mechanisms, at least in members examined to date, whereas G3 exhibits no sequence-specific insertion. G1 first recognized a 12-bp sequence at the leader-repeat junction and performed leader-side insertion before proceeding to spacer-side insertion. G2 recognized the full repeat sequence and could perform independent leader-side or spacer-side insertions, although the leader-side insertion was faster than spacer-side. The prespacer morphology requirements for Cas1-Cas2 varied, with G1 stringently requiring a 5-nucleotide 3 ' overhang and G2 being able to insert many forms of prespacers with variable efficiencies. These results highlight the intricacy of protein-DNA sequence interactions within the seemingly similar type II-A integration complexes and provide mechanistic insights into prespacer insertion. These interactions can be fine-tuned to expand the Cas1-Cas2 toolset for inserting small DNAs into diverse DNA targets.	[Van Orden, Mason J.; Newsom, Sydney; Rajan, Rakhi] Univ Oklahoma, Dept Chem & Biochem, Stephenson Life Sci Res Ctr, Price Family Fdn Inst Struct Biol, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Rajan, R (corresponding author), Univ Oklahoma, Dept Chem & Biochem, Stephenson Life Sci Res Ctr, Price Family Fdn Inst Struct Biol, Norman, OK 73019 USA.	r-rajan@ou.edu			Oklahoma Center for the Advancement of Science and Technology Project [HR17-124]; National Institutes of Health [P20GM103640]	Oklahoma Center for the Advancement of Science and Technology Project; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Oklahoma Center for the Advancement of Science and Technology Project HR17-124 and in part by National Institutes of Health Grant P20GM103640. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arslan Z, 2014, NUCLEIC ACIDS RES, V42, P7884, DOI 10.1093/nar/gku510; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carey Michael F, 2013, Cold Spring Harb Protoc, V2013, P738, DOI 10.1101/pdb.prot076505; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Heler R, 2017, MOL CELL, V65, P168, DOI 10.1016/j.molcel.2016.11.031; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Hynes AP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5399; Ivancic-Bace I, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1213; Ka D, 2018, NUCLEIC ACIDS RES, V46, P9805, DOI 10.1093/nar/gky702; Kieper SN, 2018, CELL REP, V22, P3377, DOI 10.1016/j.celrep.2018.02.103; Kim JG, 2019, NUCLEIC ACIDS RES, V47, P8632, DOI 10.1093/nar/gkz677; Lee H, 2018, MOL CELL, V70, P48, DOI 10.1016/j.molcel.2018.03.003; Li Mamie Z, 2012, Methods Mol Biol, V852, P51, DOI 10.1007/978-1-61779-564-0_5; Lopez-Sanchez MJ, 2012, MOL MICROBIOL, V85, P1057, DOI 10.1111/j.1365-2958.2012.08172.x; McGinn J, 2019, NAT REV MICROBIOL, V17, P7, DOI 10.1038/s41579-018-0071-7; McGinn J, 2016, MOL CELL, V64, P616, DOI 10.1016/j.molcel.2016.08.038; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Nunez JK, 2016, MOL CELL, V62, P824, DOI 10.1016/j.molcel.2016.04.027; Nunez JK, 2015, NATURE, V527, P535, DOI 10.1038/nature15760; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Paez-Espino D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2440; Rollie C, 2020, NATURE, V578, P149, DOI 10.1038/s41586-020-1936-2; Rollie C, 2018, NUCLEIC ACIDS RES, V46, P1007, DOI 10.1093/nar/gkx1232; Sanozky-Dawes R, 2015, MICROBIOL-SGM, V161, P1752, DOI 10.1099/mic.0.000129; Schmidt F, 2018, NATURE, V562, P380, DOI 10.1038/s41586-018-0569-1; Shiimori M, 2018, MOL CELL, V70, P814, DOI 10.1016/j.molcel.2018.05.002; Shipman SL, 2017, NATURE, V547, P345, DOI 10.1038/nature23017; Sternberg SH, 2016, MOL CELL, V61, P797, DOI 10.1016/j.molcel.2016.01.030; Sun CL, 2013, ENVIRON MICROBIOL, V15, P463, DOI 10.1111/j.1462-2920.2012.02879.x; Van Orden MJ, 2017, PEERJ, V5, DOI 10.7717/peerj.3161; Wang JY, 2015, CELL, V163, P840, DOI 10.1016/j.cell.2015.10.008; Wei YZ, 2015, NUCLEIC ACIDS RES, V43, P1749, DOI 10.1093/nar/gku1407; Wei YZ, 2015, GENE DEV, V29, P356, DOI 10.1101/gad.257550.114; Wilkins MR, 1999, METH MOL B, V112, P531; Wilkinson M, 2019, MOL CELL, V75, P90, DOI 10.1016/j.molcel.2019.04.020; Wright AV, 2016, NAT STRUCT MOL BIOL, V23, P876, DOI 10.1038/nsmb.3289; Xiao YB, 2017, NATURE, V550, P137, DOI 10.1038/nature24020; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216	44	3	4	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2020	295	32					10956	10968		10.1074/jbc.RA120.013554	http://dx.doi.org/10.1074/jbc.RA120.013554			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE7BV	32513871	Green Published, hybrid			2022-12-26	WOS:000562757100007
J	Watkins, CL; Kempf, BJ; Beaucourt, S; Barton, DJ; Peersen, OB				Watkins, Colleen L.; Kempf, Brian J.; Beaucourt, Stephanie; Barton, David J.; Peersen, Olve B.			Picornaviral polymerase domain exchanges reveal a modular basis for distinct biochemical activities of viral RNA-dependent RNA polymerases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA-dependent RNA polymerase (RdRP); poliovirus; coxsackievirus; viral polymerase; RNA-protein interaction; enzyme kinetics; virus; protein engineering; viral replication; conformational change	POLIOVIRUS POLYMERASE; STRUCTURAL BASIS; REPLICATION; FIDELITY; RECOMBINATION; MECHANISM; CATALYSIS; EXPLORER; COMPLEX; SURFACE	Picornaviral RNA-dependent RNA polymerases (RdRPs) have low replication fidelity that is essential for viral fitness and evolution. Their global fold consists of the classical "cupped right hand" structure with palm, fingers, and thumb domains, and these RdRPs also possess a unique contact between the fingers and thumb domains. This interaction restricts movements of the fingers, and RdRPs use a subtle conformational change within the palm domain to close their active sites for catalysis. We have previously shown that this core RdRP structure and mechanism provide a platform for polymerases to fine-tune replication rates and fidelity to optimize virus fitness. Here, we further elucidated the structural basis for differences in replication rates and fidelity among different viruses by generating chimeric RdRPs from poliovirus and coxsackievirus B3. We designed these chimeric polymerases by exchanging the fingers, pinky finger, or thumb domains. The results of biochemical, rapid-quench, and stopped-flow assays revealed that differences in biochemical activity map to individual modular domains of this polymerase. We found that the pinky finger subdomain is a major regulator of initiation and that the palm domain is the major determinant of catalytic rate and nucleotide discrimination. We further noted that thumb domain interactions with product RNA regulate translocation and that the palm and thumb domains coordinately control elongation complex stability. Several RdRP chimeras supported the growth of infectious poliovirus, providing insights into enterovirus species-specific protein-protein interactions required for virus replication.	[Watkins, Colleen L.; Peersen, Olve B.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Kempf, Brian J.; Barton, David J.] Univ Colorado, Sch Med, Dept Immunol & Microbiol, Aurora, CO USA; [Beaucourt, Stephanie] Inst Pasteur, CNRS UMR 3569, Paris, France	Colorado State University; University of Colorado System; University of Colorado Anschutz Medical Campus; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Peersen, OB (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.	Olve.Peersen@ColoState.edu		Peersen, Olve/0000-0001-6208-2660; Beaucourt, Stephanie/0000-0001-9394-6425	National Institutes of Health [AI059130, AI042189]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants AI059130 (to O. B. P.) and AI042189 (to D. J. B.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andino R, 2015, VIROLOGY, V479, P46, DOI 10.1016/j.virol.2015.03.022; [Anonymous], **DATA OBJECT**, DOI DOI 10.5281/ZENODO.3361874; Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5126, DOI 10.1021/bi035212y; Arnold JJ, 2000, J BIOL CHEM, V275, P5329, DOI 10.1074/jbc.275.8.5329; Bell YC, 1999, J VIROL, V73, P9413, DOI 10.1128/JVI.73.11.9413-9421.1999; Cameron CE, 2009, CURR OPIN STRUC BIOL, V19, P768, DOI 10.1016/j.sbi.2009.10.012; Campagnola G, 2015, J VIROL, V89, P275, DOI 10.1128/JVI.01574-14; Cornell CT, 2002, VIROLOGY, V298, P200, DOI 10.1006/viro.2002.1481; Dubankova A, 2019, J STRUCT BIOL, V208, P92, DOI 10.1016/j.jsb.2019.08.004; Ferrer-Orta C, 2004, J BIOL CHEM, V279, P47212, DOI 10.1074/jbc.M405465200; Ferrero D, 2018, SUBCELL BIOCHEM, V88, P39, DOI 10.1007/978-981-10-8456-0_3; Gnadig NF, 2012, P NATL ACAD SCI USA, V109, pE2294, DOI 10.1073/pnas.1204022109; Gong P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060272; Gong P, 2010, P NATL ACAD SCI USA, V107, P22505, DOI 10.1073/pnas.1007626107; Gong P, 2009, ANAL BIOCHEM, V391, P45, DOI 10.1016/j.ab.2009.04.035; Hansen JL, 1997, STRUCTURE, V5, P1109, DOI 10.1016/S0969-2126(97)00261-X; Hobdey SE, 2010, J VIROL, V84, P8072, DOI 10.1128/JVI.02147-09; Hobson SD, 2001, EMBO J, V20, P1153, DOI 10.1093/emboj/20.5.1153; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Karr JP, 2016, BIOCHEMISTRY-US, V55, P3995, DOI 10.1021/acs.biochem.6b00467; Kempf BJ, 2019, J VIROL, V93, DOI 10.1128/JVI.00652-19; Kempf BJ, 2016, J VIROL, V90, P8410, DOI 10.1128/JVI.00078-16; Korboukh VK, 2014, J BIOL CHEM, V289, P29531, DOI 10.1074/jbc.M114.592303; Kortus MG, 2012, J MOL BIOL, V417, P263, DOI 10.1016/j.jmb.2012.01.049; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Lyle JM, 2002, SCIENCE, V296, P2218, DOI 10.1126/science.1070585; McCrone JT, 2018, CURR OPIN VIROL, V28, P20, DOI 10.1016/j.coviro.2017.10.008; McDonald S, 2016, J BIOL CHEM, V291, P13999, DOI 10.1074/jbc.M116.726596; Moustafa IM, 2014, J BIOL CHEM, V289, P36229, DOI 10.1074/jbc.M114.616193; Peck KM, 2018, J VIROL, V92, DOI 10.1128/JVI.01031-17; Peersen OB, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11080745; Peersen OB, 2017, VIRUS RES, V234, P4, DOI 10.1016/j.virusres.2017.01.026; Pfeiffer JK, 2003, P NATL ACAD SCI USA, V100, P7289, DOI 10.1073/pnas.1232294100; Shen HJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002851; Shen MQ, 2008, J BIOL CHEM, V283, P875, DOI 10.1074/jbc.M707907200; Shi JJ, 2019, BIOCHEMISTRY-US, V58, P3735, DOI 10.1021/acs.biochem.9b00497; Shu B, 2016, P NATL ACAD SCI USA, V113, pE4005, DOI 10.1073/pnas.1602591113; Smithee S, 2015, J VIROL, V89, P11761, DOI 10.1128/JVI.01308-15; Spagnolo JF, 2010, RNA, V16, P382, DOI 10.1261/rna.1955410; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; Steitz TA, 2006, EMBO J, V25, P3458, DOI 10.1038/sj.emboj.7601211; Tellez AB, 2011, J MOL BIOL, V412, P737, DOI 10.1016/j.jmb.2011.07.053; Temiakov D, 2004, CELL, V116, P381, DOI 10.1016/S0092-8674(04)00059-5; Thompson A. A., 2006, HAMLET; Thompson AA, 2004, EMBO J, V23, P3462, DOI 10.1038/sj.emboj.7600357; Thompson AA, 2007, J MOL BIOL, V366, P1459, DOI 10.1016/j.jmb.2006.11.070; Wang J, 2013, J MOL BIOL, V425, P2529, DOI 10.1016/j.jmb.2013.04.007; Woodman A, 2019, J VIROL, V93, DOI 10.1128/JVI.02057-18; Wu JQ, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010024; Xiao YH, 2016, CELL HOST MICROBE, V19, P493, DOI 10.1016/j.chom.2016.03.009; Yang XR, 2012, STRUCTURE, V20, P1519, DOI 10.1016/j.str.2012.06.012; Yang XR, 2010, BIOCHEMISTRY-US, V49, P9361, DOI 10.1021/bi100833r; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5	54	1	1	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2020	295	31					10624	10637		10.1074/jbc.RA120.013906	http://dx.doi.org/10.1074/jbc.RA120.013906			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB3HM	32493771	Green Published, hybrid			2022-12-26	WOS:000560405600010
J	Esch, A; Masiarz, A; Mossner, S; Moll, JM; Grotzinger, J; Schroder, J; Scheller, J; Floss, DM				Esch, Alessandra; Masiarz, Anna; Mossner, Sofie; Moll, Jens M.; Grotzinger, Joachim; Schroder, Jutta; Scheller, Jurgen; Floss, Doreen M.			Deciphering site 3 interactions of interleukin 12 and interleukin 23 with their cognate murine and human receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						IL-12; IL-23; IL-12Rbeta1; IL-23R; IL-12Rbeta2; STAT; ERK; signal transduction; innate immunity; protein?protein interaction; interleukin; receptr; mitogen-activated protein kinase (MAPK); STAT3	IL-12 P40 HOMODIMER; CYTOKINE IL-23; BINDING-SITES; FAMILY; EXPRESSION; DISTINCT; SUBUNIT; COMPLEX; PROTEIN; CELLS	Interleukin (IL)?12 and IL-23 belong to the IL-12 type family and are composite cytokines, consisting of the common ? subunit p40 and the specific cytokine ? subunit p35 and p19, respectively. IL-12 signals via the IL-12R?1?IL-12R?2 receptor complex, and IL-23 uses also IL-12R?1 but engages IL-23R as second receptor. Importantly, binding of IL-12 and IL-23 to IL-12R?1 is mediated by p40, and binding to IL-12R?2 and IL-23R is mediated by p35 and p19, respectively. Previously, we have identified a W157A substitution at site 3 of murine IL-23p19 that abrogates binding to murine IL-23R. Here, we demonstrate that the analogous Y185R site 3 substitution in murine and Y189R site 3 substitution in human IL-12p35 abolishes binding to IL-12R?2 in a cross-species manner. Although Trp(157)is conserved between murine and human IL-23p19 (Trp(156)in the human ortholog), the site 3 W156A substitution in hIL-23p19 did not affect signaling of cells expressing human IL-12R?1 and IL-23R, suggesting that the interface of murine IL-23p19 required for binding to IL-23R is different from that in the human ortholog. Hence, we introduced additional hIL-23p19 substitutions within its binding interface to hIL-23R and found that the combined site 3 substitutions of W156A and L160E, which become buried at the complex interface, disrupt binding of hIL-23p19 to hIL-23R. In summary, we have identified substitutions in IL-12p35 and IL-23p19 that disrupt binding to their cognate receptors IL-12R?2 and IL-23R in a murine/human cross-species manner.	[Esch, Alessandra; Masiarz, Anna; Mossner, Sofie; Moll, Jens M.; Schroder, Jutta; Scheller, Jurgen; Floss, Doreen M.] Heinrich Heine Univ, Med Fac, Inst Biochem & Mol Biol 2, Dusseldorf, Germany; [Grotzinger, Joachim] Univ Kiel, Med Fac, Inst Biochem, Kiel, Germany; [Schroder, Jutta] Pharmaceut Res Associates GmbH, Mannheim, Germany	Heinrich Heine University Dusseldorf; University of Kiel	Floss, DM (corresponding author), Heinrich Heine Univ, Med Fac, Inst Biochem & Mol Biol 2, Dusseldorf, Germany.	doreen.floss@uni-duesseldorf.de	Scheller, Jürgen/K-5290-2015		Deutsche Forschungsgemeinschaft [SFB1116]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB1116 (to J. S.).	Althoff K, 2001, BIOCHEM J, V353, P663, DOI 10.1042/0264-6021:3530663; Barton VA, 1999, J BIOL CHEM, V274, P5755, DOI 10.1074/jbc.274.9.5755; Beyer BM, 2008, J MOL BIOL, V382, P942, DOI 10.1016/j.jmb.2008.08.001; Bloch Y, 2018, IMMUNITY, V48, P45, DOI 10.1016/j.immuni.2017.12.008; Ciapponi L, 1995, J BIOL CHEM, V270, P31249, DOI 10.1074/jbc.270.52.31249; Collison LW, 2008, IMMUNOL REV, V226, P248, DOI 10.1111/j.1600-065X.2008.00704.x; Collison LW, 2012, NAT IMMUNOL, V13, P290, DOI 10.1038/ni.2227; Cosmi L, 2014, CYTOM PART A, V85A, P36, DOI 10.1002/cyto.a.22348; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Floss DM, 2016, MOL BIOL CELL, V27, P2301, DOI 10.1091/mbc.E14-12-1645; Floss DM, 2015, CYTOKINE GROWTH F R, V26, P569, DOI 10.1016/j.cytogfr.2015.07.005; Floss DM, 2013, J BIOL CHEM, V288, P19386, DOI 10.1074/jbc.M112.432153; Garbers C, 2012, CYTOKINE GROWTH F R, V23, P85, DOI 10.1016/j.cytogfr.2012.04.001; GILLESSEN S, 1995, EUR J IMMUNOL, V25, P200, DOI 10.1002/eji.1830250133; Ha SJ, 1999, J IMMUNOL, V163, P2902; Jones LL, 2011, IMMUNOL RES, V51, P5, DOI 10.1007/s12026-011-8209-y; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Ketteler R, 2002, GENE THER, V9, P477, DOI 10.1038/sj.gt.3301653; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; LING P, 1995, J IMMUNOL, V154, P116; MATTNER F, 1993, EUR J IMMUNOL, V23, P2202, DOI 10.1002/eji.1830230923; Murakami M, 2019, IMMUNITY, V50, P812, DOI 10.1016/j.immuni.2019.03.027; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; Rose-John S, 2015, CYTOKINE GROWTH F R, V26, P471, DOI 10.1016/j.cytogfr.2015.07.011; Russell TD, 2003, J IMMUNOL, V171, P6866, DOI 10.4049/jimmunol.171.12.6866; Sayago C, 2018, ACS MED CHEM LETT, V9, P912, DOI 10.1021/acsmedchemlett.8b00255; SCHOENHAUT DS, 1992, J IMMUNOL, V148, P3433; Schroder J, 2015, J BIOL CHEM, V290, P359, DOI 10.1074/jbc.M114.617597; Shimozato O, 2006, IMMUNOLOGY, V117, P22, DOI 10.1111/j.1365-2567.2005.02257.x; Suthaus J, 2010, MOL BIOL CELL, V21, P2797, DOI 10.1091/mbc.E10-03-0240; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Wang X, 1999, EUR J IMMUNOL, V29, P2007, DOI 10.1002/(SICI)1521-4141(199906)29:06<2007::AID-IMMU2007>3.0.CO;2-0; Wojno EDT, 2019, IMMUNITY, V50, P851, DOI 10.1016/j.immuni.2019.03.011; Wu CY, 2000, J IMMUNOL, V165, P6221, DOI 10.4049/jimmunol.165.11.6221; Yoon C, 2000, EMBO J, V19, P3530, DOI 10.1093/emboj/19.14.3530	42	7	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2020	295	30					10478	10492		10.1074/jbc.RA120.013935	http://dx.doi.org/10.1074/jbc.RA120.013935			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MW0BV	32518162	Green Published, hybrid			2022-12-26	WOS:000556713400029
J	Zhang, F; Wang, SW; Zhu, JY				Zhang, Fan; Wang, Shuwen; Zhu, Jiyue			ETS variant transcription factor 5 and c-Myc cooperate in derepressing the human telomerase gene promoter via composite ETS/E-box motifs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ETS variant transcription factor 5 (ETV5); c-Myc; gene regulation; human telomerase gene (hTERT); transcription; MYC proto-oncogene bHLH transcription factor; chromatin; epigenetics; Ets-related molecule (ERM); gene transcription; telomerase reverse transcriptase (TERT); transcription regulation; ETS transcription factor family; telomerase; telomere	MUTANT TERT PROMOTER; HTERT GENE; DIRECT ACTIVATION; FACTOR-BINDING; MUTATIONS; POLYMORPHISM; REPRESSION; EXPRESSION; ERM; TRANSACTIVATION	The human telomerase gene (hTERT) is repressed in most somatic cells. How transcription factors activate the hTERT promoter in its repressive chromatin environment is unknown. Here, we report that the ETS family protein ETS variant transcription factor 5 (ETV5) mediates epidermal growth factor (EGF)-induced hTERT expression in MCF10A cells. This activation required MYC proto-oncogene bHLH transcription factor (c-Myc) and depended on the chromatin state of the hTERT promoter. Using chromatinized bacterial artificial chromosome (BAC) reporters in human fibroblasts, we found that ETV5 and c-Myc/MYC-associated factor X (MAX) synergistically activate the hTERT promoter via two identical, but inverted, composite Ets/E-box motifs enclosing the core promoter. Mutations of Ets or E-box sites in either DNA motif abolished the activation and reduced or eliminated the synergism. ETV5 and c-Myc facilitated each other's binding to the hTERT promoter. ETV5 bound to the hTERT promoter in both telomerase-negative and -positive cells, but it activated the repressed hTERT promoter and altered histone modifications only in telomerase-negative cells. The synergistic ETV5/c-Myc activation disappeared when hTERT promoter repression became relieved because of the loss of distal regulatory elements in chimeric human/mouse BAC reporters. Our results suggest that the binding of c-Myc and ETS family proteins to the Ets/E-box motifs derepresses the hTERT promoter by inducing an active promoter configuration, providing a mechanistic insight into hTERT activation during tumorigenesis.	[Zhang, Fan; Wang, Shuwen; Zhu, Jiyue] Washington State Univ, Coll Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Spokane, WA 99202 USA	Washington State University	Zhu, JY (corresponding author), Washington State Univ, Coll Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Spokane, WA 99202 USA.	jiyue.zhu@wsu.edu	zhu, ji/HDM-1538-2022	ZHANG, FAN/0000-0002-7186-6317	National Institutes of Health [R01GM071725]; Spokane County Health Sciences and Service Authority	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spokane County Health Sciences and Service Authority	This work was supported by National Institutes of Health Grant R01GM071725 (to J. Z.) and the Spokane County Health Sciences and Service Authority. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baert JL, 2007, ONCOGENE, V26, P415, DOI 10.1038/sj.onc.1209801; Baillat D, 2009, BIOCHEM BIOPH RES CO, V378, P213, DOI 10.1016/j.bbrc.2008.11.035; Barthel FP, 2017, NAT GENET, V49, P349, DOI 10.1038/ng.3781; Bell RJA, 2015, SCIENCE, V348, P1036, DOI 10.1126/science.aab0015; Bojovic BB, 2001, J BIOL CHEM, V276, P4509, DOI 10.1074/jbc.M005509200; Bullock M, 2019, THYROID, V29, P1623, DOI 10.1089/thy.2018.0314; Chen C, 2005, NATURE, V436, P1030, DOI 10.1038/nature03894; Cheng D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46160-5; Cheng D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16764-w; Cheng D, 2017, FASEB J, V31, P1165, DOI 10.1096/fj.201601111R; Cheng D, 2015, J BIOL CHEM, V290, P30193, DOI 10.1074/jbc.M115.662221; Chiba K, 2017, SCIENCE, V357, P1416, DOI 10.1126/science.aao0535; Chiba K, 2015, ELIFE, V4, DOI 10.7554/eLife.07918; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; Cooper CDO, 2015, J BIOL CHEM, V290, P13692, DOI 10.1074/jbc.M115.646737; Cooper CDO, 2014, BIOCHEM SOC T, V42, P130, DOI 10.1042/BST20130227; Degerny C, 2008, BBA-GENE REGUL MECH, V1779, P183, DOI 10.1016/j.bbagrm.2008.01.002; Fitzsimmons D, 2009, J MOL BIOL, V392, P452, DOI 10.1016/j.jmb.2009.07.028; Garvie CW, 2002, J BIOL CHEM, V277, P45529, DOI 10.1074/jbc.M206327200; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Hsu CP, 2006, EUR J CANCER, V42, P1466, DOI 10.1016/j.ejca.2006.02.014; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Ko E, 2016, ONCOTARGET, V7, P684, DOI 10.18632/oncotarget.6331; Kyo S, 2000, NUCLEIC ACIDS RES, V28, P669, DOI 10.1093/nar/28.3.669; Kyo S, 2008, CANCER SCI, V99, P1528, DOI 10.1111/j.1349-7006.2008.00878.x; Labussiere M, 2014, BRIT J CANCER, V111, P2024, DOI 10.1038/bjc.2014.538; Li YH, 2015, NAT CELL BIOL, V17, P1327, DOI 10.1038/ncb3240; Liu YR, 2003, DEV BIOL, V261, P10, DOI 10.1016/S0012-1606(03)00359-2; Maida Y, 2002, ONCOGENE, V21, P4071, DOI 10.1038/sj.onc.1205509; Makowski MM, 2016, PROTEOMICS, V16, P417, DOI 10.1002/pmic.201500327; Malhotra Sanandan, 2018, Non-Coding RNA, V4, P1, DOI 10.3390/ncrna4010001; Muzza M, 2015, MOL CELL ENDOCRINOL, V399, P288, DOI 10.1016/j.mce.2014.10.019; Nencha U, 2016, J NEURO-ONCOL, V126, P441, DOI 10.1007/s11060-015-1999-3; Oh S, 2012, BBA-REV CANCER, V1826, P1, DOI 10.1016/j.bbcan.2012.02.002; Rachakonda PS, 2013, P NATL ACAD SCI USA, V110, P17426, DOI 10.1073/pnas.1310522110; Saha D, 2017, J BIOL CHEM, V292, P15205, DOI 10.1074/jbc.M117.792077; Schlesser HN, 2008, BIOL REPROD, V78, P483, DOI 10.1095/biolreprod.107.062935; Sjottem E, 1997, J MOL BIOL, V267, P490, DOI 10.1006/jmbi.1997.0893; Takahashi A, 2003, CANCER RES, V63, P8338; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Vageli D, 2009, ONCOL RES, V17, P413, DOI 10.3727/096504009788912507; Varadi V, 2009, CANCER GENET CYTOGEN, V190, P71, DOI 10.1016/j.cancergencyto.2008.12.006; Wang SW, 2010, MOL BIOL CELL, V21, P821, DOI 10.1091/mbc.E09-06-0456; Wang SW, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp511; Wang SW, 2009, MOL BIOTECHNOL, V42, P110, DOI 10.1007/s12033-009-9142-3; Wang SW, 2004, J BIOL CHEM, V279, P55401, DOI 10.1074/jbc.M411352200; Wang SW, 2003, J BIOL CHEM, V278, P18842, DOI 10.1074/jbc.M209544200; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Wu X, 2011, BIOL REPROD, V85, P1114, DOI 10.1095/biolreprod.111.091793; Xu DK, 2008, J BIOL CHEM, V283, P23567, DOI 10.1074/jbc.M800790200; Xu DW, 2001, P NATL ACAD SCI USA, V98, P3826, DOI 10.1073/pnas.071043198; Zhang F, 2016, GENES-BASEL, V7, DOI 10.3390/genes7070030; Zhang Z, 2017, P NATL ACAD SCI USA, V114, P3903, DOI 10.1073/pnas.1621177114; Zhao YJ, 2014, NUCLEIC ACIDS RES, V42, P10385, DOI 10.1093/nar/gku721; Zhao Yuanjun, 2011, Int J Biochem Mol Biol, V2, P199	55	4	4	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2020	295	29					10062	10075		10.1074/jbc.RA119.012130	http://dx.doi.org/10.1074/jbc.RA119.012130			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MR1DY	32518154	Green Published, hybrid			2022-12-26	WOS:000553333300023
J	Gehlen, M; Dalla Costa, ER; Rossetti, MLR; Silva, DR				Gehlen, Mirela; Dalla Costa, Elis Regina; Rosa Rossetti, Maria Lucia; Silva, Denise Rossato			Macrophage migration inhibitory factor-173 G>C single nucleotide polymorphism and its association with active pulmonary tuberculosis	PLOS ONE			English	Article							HUMAN GENETIC SUSCEPTIBILITY; RISK; MIF; LOCUS	Purpose The establishment of candidate genes associated with susceptibility to TB is a challenge especially due to divergent frequencies among different populations. The objective of this study was to evaluate the association between macrophage migration inhibitory factor (MIF) -173 G>C single nucleotide polymorphism (SNP) and susceptibility to pulmonary TB in a population of southern Brazil. Methods Case-control study. Patients > 18 years old, diagnosed with pulmonary TB were included. The control group consisted of blood donors and household contacts, not relatives, healthy and > 18 years old. MIF -173 G>C SNPs were genotyped using real-time PCR using a TaqMan SNP Genotyping assay. Results 174 patients and 166 controls were included. There were no statistically significant differences between cases and controls regarding genotype prevalence (p>0.05). Comparing patients with normal genotype (GG) with those with at least one C allele, there was also no statistically significant difference (p = 0.135). Also, there was no statistically significant difference comparing the homozygous for the mutation (CC) with the other patients (GG and CG) (p = 0.864). Conclusions We did not find association between MIF -173 G>C polymorphism and susceptibility to pulmonary TB.	[Gehlen, Mirela; Silva, Denise Rossato] Univ Fed Rio Grande do Sul UFRGS, Programa Posgrad Ciencias Pneumol, Porto Alegre, RS, Brazil; [Dalla Costa, Elis Regina] Secretaria Estadual Saude Rio Grande do Su CDCT S, Ctr Desenvolvimento Cient & Tecnol, Porto Alegre, RS, Brazil; [Rosa Rossetti, Maria Lucia] Univ Luterana Brasil ULBRA, Programa Posgrad Biol Mol & Celular Aplicada Saud, Canoas, RS, Brazil; [Silva, Denise Rossato] Univ Fed Rio Grande do Sul UFRGS, Fac Med, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Luterana do Brasil; Universidade Federal do Rio Grande do Sul	Silva, DR (corresponding author), Univ Fed Rio Grande do Sul UFRGS, Programa Posgrad Ciencias Pneumol, Porto Alegre, RS, Brazil.; Silva, DR (corresponding author), Univ Fed Rio Grande do Sul UFRGS, Fac Med, Porto Alegre, RS, Brazil.	denise.rossato@terra.com.br	Rossetti, Maria Lucia/ABH-1935-2020	Rossetti, Maria Lucia/0000-0002-9672-9394; Rossato Silva, Denise/0000-0003-0230-2734; Gehlen, Mirela/0000-0002-6847-0194	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - National Council for Scientific and Technological Development); Fundo de Incentivo a Pesquisa do Hospital de Clinicas de Porto Alegre [FIPE-HCPA 2016-0599]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundo de Incentivo a Pesquisa do Hospital de Clinicas de Porto Alegre	DRS was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - National Council for Scientific and Technological Development), and Fundo de Incentivo a Pesquisa do Hospital de Clinicas de Porto Alegre (FIPE-HCPA 2016-0599).	Bacher M, 1996, P NATL ACAD SCI USA, V93, P7849, DOI 10.1073/pnas.93.15.7849; Bellamy R, 2005, CLIN CHEST MED, V26, P233, DOI 10.1016/j.ccm.2005.02.006; Bellamy R, 2000, P NATL ACAD SCI USA, V97, P8005, DOI 10.1073/pnas.140201897; COMSTOCK GW, 1978, AM REV RESPIR DIS, V117, P621; Conde MB, 2009, J BRAS PNEUMOL, V35, P1018, DOI 10.1590/S1806-37132009001000011; Cooke GS, 2008, AM J RESP CRIT CARE, V178, P203, DOI 10.1164/rccm.200710-1554OC; Dissanayeke SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006698; Donn R, 2002, ARTHRITIS RHEUM-US, V46, P2402, DOI 10.1002/art.10492; El Sahly HM, 2004, SCAND J INFECT DIS, V36, P106, DOI 10.1080/00365540310018860; Gomez LM, 2007, TISSUE ANTIGENS, V70, P28, DOI 10.1111/j.1399-0039.2007.00843.x; Hashemil M, 2015, EXCLI J, V14, P117, DOI 10.17179/excli2014-636; Hill AVS, 2001, ANNU REV GENOM HUM G, V2, P373, DOI 10.1146/annurev.genom.2.1.373; Illescas O, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00055; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2010, GEOLOGYOFTHEPHILIPPI; Kibiki GS, 2007, CLIN IMMUNOL, V123, P60, DOI 10.1016/j.clim.2006.12.004; Kuai SG, 2016, INFECT DIS-NOR, V48, P222, DOI 10.3109/23744235.2015.1107188; Liu AH, 2016, INFECT GENET EVOL, V39, P219, DOI 10.1016/j.meegid.2015.12.003; Liu W, 2004, INT J TUBERC LUNG D, V8, P428; Mahasirimongkol S, 2009, GENES IMMUN, V10, P77, DOI 10.1038/gene.2008.81; Mahasirimongkol S, 2012, J HUM GENET, V57, P363, DOI 10.1038/jhg.2012.35; Malik S, 2005, P NATL ACAD SCI USA, V102, P12183, DOI 10.1073/pnas.0503368102; Martinez A, 2007, HUM IMMUNOL, V68, P744, DOI 10.1016/j.humimm.2007.06.007; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Ministerio da Saude, 2018, B EPIDEMIOLOGICO; Moller M, 2010, TUBERCULOSIS, V90, P71, DOI 10.1016/j.tube.2010.02.002; Nishihira J, 2000, J INTERF CYTOK RES, V20, P751, DOI 10.1089/10799900050151012; o A, 2013, DTSCH ARZTEBL, V110, pA; Png E, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-5; RAVIGLIONE MC, 1995, JAMA-J AM MED ASSOC, V273, P220, DOI 10.1001/jama.273.3.220; Sadki K, 2010, J GENET GENOMICS, V37, P257, DOI 10.1016/S1673-8527(09)60044-8; Scientific Working Group on Serious Adverse Events in Loa Loa endemic areas, 2003, FILARIA J S2, V2, pS2; Toscano A, 2012, SOCIOL REV, V60, P64, DOI 10.1111/j.1467-954X.2012.02117.x; Tosh K, 2006, P NATL ACAD SCI USA, V103, P10364, DOI 10.1073/pnas.0603340103; van de Vosse E, 2004, LANCET INFECT DIS, V4, P739, DOI 10.1016/S1473-3099(04)01203-4; Vannberg FO, 2011, IMMUNOL REV, V240, P105, DOI 10.1111/j.1600-065X.2010.00996.x; Vasilca V, 2019, ROUM ARCH MICROBIOL, V63, P209; Velez DR, 2009, HUM GENET, V126, P643, DOI 10.1007/s00439-009-0713-y; Yim JJ, 2010, RESPIROLOGY, V15, P241, DOI 10.1111/j.1440-1843.2009.01690.x	38	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234565	10.1371/journal.pone.0234565	http://dx.doi.org/10.1371/journal.pone.0234565			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525926	gold, Green Published			2022-12-26	WOS:000542036800043
J	Sirri, L; Guerra, E; Linnert, S; Smith, ES; Reid, V; Parise, E				Sirri, Louah; Guerra, Ernesto; Linnert, Szilvia; Smith, Eleanor S.; Reid, Vincent; Parise, Eugenio			Infants' conceptual representations of meaningful verbal and nonverbal sounds	PLOS ONE			English	Article							WORDS; LANGUAGE; SPEECH; TIME; PREDICTION; GROWTH	In adults, words are more effective than sounds at activating conceptual representations. We aimed to replicate these findings and extend them to infants. In a series of experiments using an eye tracker object recognition task, suitable for both adults and infants, participants heard either a word (e.g. cow) or an associated sound (e.g. mooing) followed by an image illustrating a target (e.g. cow) and a distracter (e.g. telephone). The results showed that adults reacted faster when the visual object matched the auditory stimulus and even faster in the word relative to the associated sound condition. Infants, however, did not show a similar pattern of eye-movements: only eighteen-month-olds, but not 9- or 12-month-olds, were equally fast at recognizing the target object in both conditions. Looking times, however, were longer for associated sounds, suggesting that processing sounds elicits greater allocation of attention. Our findings suggest that the advantage of words over associated sounds in activating conceptual representations emerges at a later stage during language development.	[Sirri, Louah] Manchester Metropolitan Univ, Dept Educ, Manchester, Lancs, England; [Sirri, Louah; Linnert, Szilvia; Reid, Vincent; Parise, Eugenio] Univ Lancaster, Dept Psychol, Lancaster, England; [Guerra, Ernesto] Univ Chile, Inst Educ, Santiago, Chile; [Guerra, Ernesto] Univ Chile, Ctr Adv Res Educ, Santiago, Chile; [Smith, Eleanor S.] Univ Cambridge, Dept Expt Psychol, Cambridge, England; [Reid, Vincent] Univ Waikato, Sch Psychol, Waikato, New Zealand	Manchester Metropolitan University; Lancaster University; Universidad de Chile; Universidad de Chile; University of Cambridge; University of Waikato	Sirri, L (corresponding author), Manchester Metropolitan Univ, Dept Educ, Manchester, Lancs, England.; Sirri, L (corresponding author), Univ Lancaster, Dept Psychol, Lancaster, England.	l.sirri@mmu.ac.uk	Parise, Eugenio/ABD-9940-2021; Parise, Eugenio/ABC-3974-2021	Parise, Eugenio/0000-0003-4836-6370; Parise, Eugenio/0000-0003-4836-6370; Guerra, Ernesto/0000-0001-7403-5271; Linnert, Szilvia/0000-0003-1178-6427; Reid, Vincent/0000-0002-2774-6975; Sirri, Louah/0000-0001-5951-8320	Economic and Social Research Council [ES/L008955/1]; Basal Funds for Centers of Excellence (CONICYT Associative Research Program) [FB0003]; ESRC [ES/L008955/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Basal Funds for Centers of Excellence (CONICYT Associative Research Program); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was funded by the: -Economic and Social Research Council (ES/L008955/1) International Centre for Language and Communication Development (LuCiD) -LS, SL, VR, EP. -Basal Funds for Centers of Excellence (Project FB0003 -from the CONICYT Associative Research Program) -EG.	Baayen R. H., 2008, ANAL LINGUISTIC DATA, DOI [10.1017/CBO9780511801686, DOI 10.1017/CBO9780511801686]; BALLAS JA, 1987, ENVIRON BEHAV, V19, P91, DOI 10.1177/0013916587191005; Ballas JA, 1991, HUM PERFORM, V4, P199, DOI DOI 10.1207/S15327043HUP0403_3; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Barr DJ, 2008, J MEM LANG, V59, P457, DOI 10.1016/j.jml.2007.09.002; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bergelson E, 2012, P NATL ACAD SCI USA, V109, P3253, DOI 10.1073/pnas.1113380109; Boutonnet B, 2015, J NEUROSCI, V35, P9329, DOI 10.1523/JNEUROSCI.5111-14.2015; Chen YC, 2018, PSYCHON B REV, V25, P1138, DOI 10.3758/s13423-017-1324-6; Chen YC, 2011, J EXP PSYCHOL HUMAN, V37, P1554, DOI 10.1037/a0024329; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; Cummings A, 2009, LANG LEARN DEV, V5, P172, DOI 10.1080/15475440902754086; Dahan D, 2001, LANG COGNITIVE PROC, V16, P507, DOI 10.1080/01690960143000074; Edmiston P, 2015, COGNITION, V143, P93, DOI 10.1016/j.cognition.2015.06.008; Ferguson B, 2017, J CHILD LANG, V44, P527, DOI 10.1017/S0305000916000568; Fernald A, 2006, DEV PSYCHOL, V42, P98, DOI 10.1037/0012-1649.42.1.98; Fernald A, 2001, CHILD DEV, V72, P1003, DOI 10.1111/1467-8624.00331; Gelman SA, 2017, P NATL ACAD SCI USA, V114, P7900, DOI 10.1073/pnas.1621073114; Hendrickson K, 2019, DEVELOPMENTAL SCI, V22, DOI 10.1111/desc.12746; Hills TT, 2009, COGNITION, V112, P381, DOI 10.1016/j.cognition.2009.06.002; Huettig F, 2019, BRAIN RES, V1706, P196, DOI 10.1016/j.brainres.2018.11.013; Huettig F, 2016, LANG COGN NEUROSCI, V31, P19, DOI 10.1080/23273798.2015.1072223; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lupyan G, 2019, LANG COGN NEUROSCI, V34, P1319, DOI 10.1080/23273798.2017.1404114; Lupyan G, 2012, J EXP PSYCHOL GEN, V141, P170, DOI 10.1037/a0024904; MATIN E, 1993, PERCEPT PSYCHOPHYS, V53, P372, DOI 10.3758/BF03206780; Mirman D., 2014, GROWTH CURVE ANAL VI; Mirman D, 2008, J MEM LANG, V59, P475, DOI 10.1016/j.jml.2007.11.006; Parise E, 2012, PSYCHOL SCI, V23, P728, DOI 10.1177/0956797612438734; R Core Team, 2021, R LANGUAGE ENV STAT; SASLOW MG, 1967, J OPT SOC AM, V57, P1024, DOI 10.1364/JOSA.57.001024; Toon J, 2020, COGNITIVE SCI, V44, DOI 10.1111/cogs.12810; Waxman SR, 2009, TRENDS COGN SCI, V13, P258, DOI 10.1016/j.tics.2009.03.006	33	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2020	15	6							e0233968	10.1371/journal.pone.0233968	http://dx.doi.org/10.1371/journal.pone.0233968			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LZ0RE	32512583	Green Published, Green Accepted, gold			2022-12-26	WOS:000540938100018
J	Xuan, R; Chao, TL; Wang, AL; Zhang, FH; Sun, P; Liu, S; Guo, MS; Wang, GZ; Ji, ZB; Wang, JM; Cheng, M				Xuan, Rong; Chao, Tianle; Wang, Aili; Zhang, Fuhong; Sun, Ping; Liu, Shuang; Guo, Maosen; Wang, Guizhi; Ji, Zhibin; Wang, Jianmin; Cheng, Ming			Characterization of microRNA profiles in the mammary gland tissue of dairy goats at the late lactation, dry period and late gestation stages	PLOS ONE			English	Article							HIPPO SIGNALING PATHWAY; EXPRESSION; GENE; DIFFERENTIATION; PROLACTIN; GROWTH; CELLS; IDENTIFICATION; PROLIFERATION; METASTASIS	MicroRNAs (miRNAs) play an important role in regulating mammary gland development and lactation. We previously analyzed miRNA expression profiles in Laoshan dairy goat mammary glands at the early (20 d postpartum), peak (90 d postpartum) and late lactation (210 d postpartum) stages. To further enrich and clarify the miRNA expression profiles during the lactation physiological cycle, we sequenced miRNAs in the mammary gland tissues of Laoshan dairy goats at three newly selected stages: the late lactation (240 d postpartum), dry period (300 d postpartum) and late gestation (140 d after mating) stages. We obtained 4038 miRNAs and 385 important miRNA families, including mir-10, let-7 and mir-9. We also identified 754 differentially expressed miRNAs in the mammary gland tissue at the 3 different stages and 6 groups of miRNA clusters that had unique expression patterns. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses showed that GO terms such as mammary gland development (GO:0030879) and mammary gland morphogenesis (GO:0060443) and important signaling pathways, including the insulin signaling pathway (chx04910), hippo signaling pathway (chx04390) and estrogen signaling pathway (chx04915), were enriched. We screened miRNAs and potential target genes that may be involved in the regulation of lactation, mammary gland growth and differentiation, cell apoptosis, and substance transport and synthesis and detected the expression patterns of important genes at the three stages. These miRNAs and critical target genes may be important factors for mammary gland development and lactation regulation and potentially valuable molecular markers, which may provide a theoretical reference for further investigation of mammary gland physiology.	[Xuan, Rong; Chao, Tianle; Wang, Aili; Zhang, Fuhong; Sun, Ping; Liu, Shuang; Guo, Maosen; Wang, Guizhi; Ji, Zhibin; Wang, Jianmin] Shandong Agr Univ, Coll Anim Sci & Vet Med, Shandong Prov Key Lab Anim Biotechnol & Dis Contr, Tai An, Shandong, Peoples R China; [Cheng, Ming] Qingdao Res Inst Husb & Vet, Qingdao, Shandong, Peoples R China	Key Laboratory of Animal Biotechnology & Disease Control & Prevention of Shandong Province; Shandong Agricultural University	Ji, ZB; Wang, JM (corresponding author), Shandong Agr Univ, Coll Anim Sci & Vet Med, Shandong Prov Key Lab Anim Biotechnol & Dis Contr, Tai An, Shandong, Peoples R China.	zbji916@sdau.edu.cn; wangjm@sdau.edu.cn	WANG, Jianmin/M-2002-2016	WANG, Jianmin/0000-0001-5678-8202; Xuan, Rong/0000-0001-5548-432X; tianle, chao/0000-0001-9721-0634	National Natural Science Foundation of China [31672401]; Shandong Provincial Natural Science Foundation of China [ZR2014CM029]; Project of Shandong Province Higher Educational Science and Technology Program of China [J14LF07]; Shandong Provincial Modern Agriculture Industry Technology System [SDAIT-10]; Funds of Shandong "Double Tops" Program [SYL2017YSTD12]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation of China(Natural Science Foundation of Shandong Province); Project of Shandong Province Higher Educational Science and Technology Program of China; Shandong Provincial Modern Agriculture Industry Technology System; Funds of Shandong "Double Tops" Program	This research was funded by National Natural Science Foundation of China (31672401), Shandong Provincial Natural Science Foundation of China (ZR2014CM029), A Project of Shandong Province Higher Educational Science and Technology Program of China (J14LF07), Shandong Provincial Modern Agriculture Industry Technology System (SDAIT-10), Funds of Shandong "Double Tops" Program (SYL2017YSTD12).	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Alsaweed M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152610; [Anonymous], 2017, DIABETES CARE S1, V39, pS33; [Anonymous], 2012, REGEN MED S3, V7, pS14; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Arnold D, 2002, ANTIVIR RES, V53, P153, DOI 10.1016/S0166-3542(01)00197-8; Avril-Sassen S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-548; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boutinaud M, 2017, J DAIRY SCI, V100, P9787, DOI 10.3168/jds.2017-12783; Busk PK, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-29; Cai XY, 2017, J DAIRY SCI, V100, P1971, DOI 10.3168/jds.2016-11461; Capuco AV, 1997, J DAIRY SCI, V80, P477, DOI 10.3168/jds.S0022-0302(97)75960-5; Chen D, 2018, ANIM SCI J, V89, P1355, DOI 10.1111/asj.13062; Clark S, 2017, J DAIRY SCI, V100, P10026, DOI 10.3168/jds.2017-13287; Collier RJ, 2012, ANIMAL, V6, P403, DOI 10.1017/S1751731111002461; Crisa A, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0881-7; DJIANE J, 1977, ENDOCRINOLOGY, V100, P1348, DOI 10.1210/endo-100-5-1348; Dong F, 2013, INT J GENOMICS, V2013, DOI 10.1155/2013/917342; Enciu AM, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/7801202; FLINT DJ, 1984, J ENDOCRINOL, V103, P213, DOI 10.1677/joe.0.1030213; Forrester E, 2005, CANCER RES, V65, P2296, DOI 10.1158/0008-5472.CAN-04-3272; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gao HF, 2019, CANCER MANAG RES, V11, P3171, DOI 10.2147/CMAR.S195424; Gao SY, 2018, INT J CLIN EXP PATHO, V11, P1347; Giroud M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28613; Harris RC, 2003, EXP CELL RES, V284, P2, DOI 10.1016/S0014-4827(02)00105-2; Hong LJ, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00661; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang S, 2003, MOL CELL, V11, P1491, DOI 10.1016/S1097-2765(03)00180-1; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010, IARC MONOG EVAL CARC, V96, P1; Inman JL, 2015, DEVELOPMENT, V142, P1028, DOI 10.1242/dev.087643; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Ji ZB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12297-4; Ji ZB, 2013, ASIAN AUSTRAL J ANIM, V26, P309, DOI 10.5713/ajas.2012.12422; Ji ZB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049463; Jiang PP, 2010, P NATL ACAD SCI USA, V107, P6765, DOI 10.1073/pnas.1001814107; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kanai Y, 2013, MOL ASPECTS MED, V34, P108, DOI 10.1016/j.mam.2013.01.001; KNIGHT CH, 1984, Q J EXP PHYSIOL CMS, V69, P331, DOI 10.1113/expphysiol.1984.sp002809; Le Guillou S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045727; Li JR, 2015, BIOMED PHARMACOTHER, V75, P159, DOI 10.1016/j.biopha.2015.07.013; Lin SM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-306; Liu B, 2018, EXP MOL MED, V50, DOI 10.1038/emm.2017.311; Liu F, 2014, ONCOGENE, V33, P4813, DOI 10.1038/onc.2013.428; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lombard AP, 2016, MOL CARCINOGEN, V55, P757, DOI 10.1002/mc.22319; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lv C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01059-5; Manavalan TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062334; Mapes J, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006654; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; MUKHERJEE AS, 1973, NATURE, V246, P159, DOI 10.1038/246159a0; Muraoka-Cook RS, 2008, J MAMMARY GLAND BIOL, V13, P235, DOI 10.1007/s10911-008-9080-x; O'Leary KA, 2017, STEM CELL REP, V9, P1167, DOI 10.1016/j.stemcr.2017.08.011; Oakes SR, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1411; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Porstner M, 2015, EUR J IMMUNOL, V45, P1206, DOI 10.1002/eji.201444637; Puppel K, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9121070; Qasba PK, 1997, CRIT REV BIOCHEM MOL, V32, P255, DOI 10.3109/10409239709082574; Risso D, 2014, NAT BIOTECHNOL, V32, P896, DOI 10.1038/nbt.2931; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; Rougvie AE, 2001, NAT REV GENET, V2, P690, DOI 10.1038/35088566; Rui T, 2020, BIOMARK RES, V8, DOI 10.1186/s40364-020-0186-7; STRANGE R, 1992, DEVELOPMENT, V115, P49; Takada S, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl653; Tanaka T, 2009, DIFFERENTIATION, V77, P181, DOI 10.1016/j.diff.2008.10.001; Tang RX, 2016, BRIT J CANCER, V115, P243, DOI 10.1038/bjc.2016.186; Theill LE, 2002, ANNU REV IMMUNOL, V20, P795, DOI 10.1146/annurev.immunol.20.100301.064753; Tome M, 2011, CELL DEATH DIFFER, V18, P985, DOI 10.1038/cdd.2010.167; Tu JJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep41304; Viswanathan SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006143; Wang SZ, 2019, ONCOL LETT, V18, P1475, DOI 10.3892/ol.2019.10403; Wang YM, 2018, CELL REP, V25, P1304, DOI 10.1016/j.celrep.2018.10.001; Xiao ZQ, 2017, ONCOL REP, V38, P167, DOI 10.3892/or.2017.5651; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yu CX, 2018, THYROID, V28, P1627, DOI 10.1089/thy.2017.0626; Zhao L, 2004, J BIOL CHEM, V279, P44093, DOI 10.1074/jbc.M313131200	80	16	16	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2020	15	6							e0234427	10.1371/journal.pone.0234427	http://dx.doi.org/10.1371/journal.pone.0234427			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ0RE	32511270	Green Published, gold			2022-12-26	WOS:000540938100035
J	de Jalon, LG; Limousin, JM; Richard, F; Gessler, A; Peter, M; Hattenschwiler, S; Milcu, A; Ibanez, I; Ibanez, I; Ibanez, I				Garcia de Jalon, Laura; Limousin, Jean-Marc; Richard, Franck; Gessler, Arthur; Peter, Martina; Hattenschwiler, Stephan; Milcu, Alexandru; Ibanez, Ines; Ibanez, Ines; Ibanez, Ines			Microhabitat and ectomycorrhizal effects on the establishment, growth and survival ofQuercus ilexL. seedlings under drought	PLOS ONE			English	Article							QUERCUS-ILEX; RAINFALL INTERCEPTION; TREE; SOIL; ECOSYSTEM; COMMUNITIES; RECRUITMENT; MECHANISMS; NETWORKS; DYNAMICS	The success of tree recruitment in Mediterranean holm oak (Quercus ilex) forests is threatened by the increasing intensity, duration and frequency of drought periods. Seedling germination and growth are modulated by complex interactions between abiotic (microhabitat conditions) and biotic factors (mycorrhiza association) that may mitigate the impacts of climate change on tree recruitment. To better understand and anticipate these effects, we conducted a germination experiment in a long-term precipitation reduction (PR) field experiment where we monitored seedling establishment and survival, micro-habitat conditions and ectomycorrhizal (ECM) colonization by different mycelia exploration types during the first year of seedling growth. We hypothesized that (i) the PR treatment decreases seedling survival relative to the control with ambient conditions, (ii) microhabitat conditions of water and light availability are better predictors of seedling survival than the PR treatment, (iii) the PR treatment will favour the development of ECM exploration types with drought-resistance traits such as differentiated rhizomorphs. Contrary to our first hypothesis, seedling survival was lower in control plots with overall higher soil moisture. Micro-habitat light and soil moisture conditions were better predictors of seedling survival and growth than the plot-level PR treatment, confirming our second hypothesis. Furthermore, in line with our third hypothesis, we found that ECM with longer extramatrical mycelia were more abundant in the PR treatment plots and were positively correlated to survival, which suggests a potential role of this ECM exploration type in seedling survival and recruitment. Although summer drought was the main cause of seedling mortality, our study indicates that drier conditions in spring can increase seedling survival, presumably through a synergistic effect of drought adapted ECM species and less favourable conditions for root pathogens.	[Garcia de Jalon, Laura; Limousin, Jean-Marc; Richard, Franck; Hattenschwiler, Stephan; Milcu, Alexandru] Univ Paul Valery Montpellier 3, Univ Montpellier, CEFE, CNRS,EPHE,IRD, Montpellier, France; [Gessler, Arthur; Peter, Martina] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland; [Milcu, Alexandru] CNRS, Ecotron Europeen Montpellier UPS 3248, Montferrier Sur Lez, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Centre National de la Recherche Scientifique (CNRS)	de Jalon, LG (corresponding author), Univ Paul Valery Montpellier 3, Univ Montpellier, CEFE, CNRS,EPHE,IRD, Montpellier, France.	laura.garciadejalon@gmail.com	Gessler, Arthur/C-7121-2008; Peter, Martina/G-2284-2018; Milcu, Alexandru/X-6267-2018	Gessler, Arthur/0000-0002-1910-9589; Peter, Martina/0000-0002-6365-6889; Milcu, Alexandru/0000-0002-2889-1234	ANR (Agence Nationale de la Recherche, France) [ANR-16-CE32-0002]; research infrastructure AnaEE-France [ANR-11-INBS-0001]; Allenvi through the SOERE F-ORE-T	ANR (Agence Nationale de la Recherche, France)(French National Research Agency (ANR)); research infrastructure AnaEE-France; Allenvi through the SOERE F-ORE-T	AM received ANR (Agence Nationale de la Recherche, France) -funded TRANSfER project (ANR-16-CE32-0002). https://anr.fr/en/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge Patrick Schevin, Quentin Lassus, and Adrien Millan for helping with the field work. The authors are also indebted to Jean-Marc Ourcival who designed and maintained the long-term rainfall exclusion experiment in Puechabon throughout the years, and to David Degueldre, Thierry Matthieu, Pauline Durbin and Karim Piquemal for their help. The Puechabon experimental site belongs to the OSU OREME (UMS 3282) and is annually supported by the research infrastructure AnaEE-France (ANR-11-INBS-0001) and by Allenvi through the SOERE F-ORE-T.	Agerer R, 2001, MYCORRHIZA, V11, P107, DOI 10.1007/s005720100108; Bakker MR, 2006, PLANT SOIL, V286, P37, DOI 10.1007/s11104-006-9024-4; Bates D, 2014, ARXIV14065823; Bingham MA, 2012, ECOSYSTEMS, V15, P188, DOI 10.1007/s10021-011-9502-2; Blom JM, 2009, MYCORRHIZA, V20, P25, DOI 10.1007/s00572-009-0256-z; BRASIER CM, 1993, PLANT PATHOL, V42, P140, DOI 10.1111/j.1365-3059.1993.tb01482.x; Bzdyk RM, 2019, FORESTS, V10, DOI 10.3390/f10010030; Carnicer J, 2011, P NATL ACAD SCI USA, V108, P1474, DOI 10.1073/pnas.1010070108; Castro J, 2004, J ECOL, V92, P266, DOI 10.1111/j.0022-0477.2004.00870.x; Corcobado T, 2014, AGR FOREST METEOROL, V192, P1, DOI 10.1016/j.agrformet.2014.02.007; David TS, 2006, HYDROL PROCESS, V20, P2713, DOI 10.1002/hyp.6062; di Pietro M, 2007, MYCORRHIZA, V17, P547, DOI 10.1007/s00572-007-0113-x; Egerton-Warburton LM, 2007, ECOL MONOGR, V77, P527, DOI 10.1890/06-1772.1; FRANCO AC, 1988, ECOLOGY, V69, P1731, DOI 10.2307/1941151; Garrett KA, 2006, ANNU REV PHYTOPATHOL, V44, P489, DOI 10.1146/annurev.phyto.44.070505.143420; Gavinet J, 2019, NEW PHYTOL, V223, P1267, DOI 10.1111/nph.15860; Gavinet J, 2016, FOREST ECOL MANAG, V381, P289, DOI 10.1016/j.foreco.2016.09.045; Genney DR, 2006, NEW PHYTOL, V170, P381, DOI 10.1111/j.1469-8137.2006.01669.x; Gentilesca T, 2017, IFOREST, V10, P796, DOI 10.3832/ifor2317-010; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Gomez-Aparicio L, 2008, OIKOS, V117, P1683, DOI 10.1111/j.1600-0706.2008.16814.x; Gomez-Aparicio L, 2005, J ECOL, V93, P1194, DOI 10.1111/j.1365-2745.2005.01047.x; Gomez-Aparicio L, 2004, ECOL APPL, V14, P1128, DOI 10.1890/03-5084; Gonzalez-Rodriguez V, 2011, ANN FOREST SCI, V68, P637, DOI 10.1007/s13595-011-0057-3; Gonzalez-Rodriguez V, 2011, ACTA OECOL, V37, P1, DOI 10.1016/j.actao.2010.10.006; HERRERA CM, 1994, ECOL MONOGR, V64, P315, DOI 10.2307/2937165; Homet P, 2019, AGR FOREST METEOROL, V276, DOI 10.1016/j.agrformet.2019.06.004; Joet T, 2016, ANN BOT-LONDON, V117, P165, DOI 10.1093/aob/mcv139; Khan M. L., 2001, Tropical Ecology, V42, P117; Lehto T, 2011, MYCORRHIZA, V21, P71, DOI 10.1007/s00572-010-0348-9; Limousin JM, 2008, J HYDROL, V357, P57, DOI 10.1016/j.jhydrol.2008.05.001; MARX DH, 1973, PHYTOPATHOLOGY, V63, P18, DOI 10.1094/Phyto-63-18; Matias L, 2012, OECOLOGIA, V169, P833, DOI 10.1007/s00442-011-2234-3; Milcu A, 2016, ECOLOGY, DOI [10.1101/080119, DOI 10.1101/080119]; Montecchio L, 2004, PHYTOPATHOL MEDITERR, V43, P26; Niinemets U, 2006, ECOL MONOGR, V76, P521, DOI 10.1890/0012-9615(2006)076[0521:TTSDAW]2.0.CO;2; Perez-Ramos IM, 2010, ECOLOGY, V91, P3057, DOI 10.1890/09-2313.1; Perez-Ramos IM, 2013, PERSPECT PLANT ECOL, V15, P106, DOI 10.1016/j.ppees.2012.12.005; Querejeta JI, 2003, OECOLOGIA, V134, P55, DOI 10.1007/s00442-002-1078-2; Quero JL, 2007, AM J BOT, V94, P1795, DOI 10.3732/ajb.94.11.1795; Richard F, 2011, ANN FOREST SCI, V68, P57, DOI 10.1007/s13595-010-0007-5; Richard F, 2009, FEMS MICROBIOL ECOL, V68, P14, DOI 10.1111/j.1574-6941.2009.00646.x; Rodriguez-Calcerrada J, 2010, NEW FOREST, V39, P245, DOI 10.1007/s11056-009-9168-1; Gomez FJR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41804-y; Sack L, 2003, PLANT ECOL, V168, P139, DOI 10.1023/A:1024423820136; Sanchez ME, 2002, FOREST PATHOL, V32, P5, DOI 10.1046/j.1439-0329.2002.00261.x; Sanchez-Humanes B, 2011, FORESTRY, V84, P73, DOI 10.1093/forestry/cpq045; Shahin O, 2013, SYMBIOSIS, V61, P1, DOI 10.1007/s13199-013-0252-0; Simard Suzanne W., 2012, Fungal Biology Reviews, V26, P39, DOI 10.1016/j.fbr.2012.01.001; Therneau T., 2015, PACKAGE SURVIVAL ANA; Urbieta IR, 2008, CAN J FOREST RES, V38, P2382, DOI 10.1139/X08-089; VALIENTEBANUET A, 1991, J ECOL, V79, P961, DOI 10.2307/2261091; Zuur Alain F., 2009, P1; 2014, SCIENCE, V346	54	12	12	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0229807	10.1371/journal.pone.0229807	http://dx.doi.org/10.1371/journal.pone.0229807			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502167	Green Published, gold, Green Submitted			2022-12-26	WOS:000542035700050
J	Katam, R; Shokri, S; Murthy, N; Singh, SK; Suravajhala, P; Khan, MN; Bahmani, M; Sakata, K; Reddy, KR				Katam, Ramesh; Shokri, Sedigheh; Murthy, Nitya; Singh, Shardendu K.; Suravajhala, Prashanth; Khan, Mudassar Nawaz; Bahmani, Mahya; Sakata, Katsumi; Reddy, Kambham Raja			Proteomics, physiological, and biochemical analysis of cross tolerance mechanisms in response to heat and water stresses in soybean	PLOS ONE			English	Article							OXIDATIVE STRESS; SEED COMPOSITION; HIGH-TEMPERATURE; LEAF PROTEOME; DROUGHT; PROTEINS; GROWTH; PEROXIDASE; ASCORBATE; SEEDLINGS	Water stress (WS) and heat stress (HS) have a negative effect on soybean plant growth and crop productivity. Changes in the physiological characteristics, proteome, and specific metabolites investigated on molecular and cellular functions were studied in two soybean cultivars exposed to different heat and water stress conditions independently and in combination. Leaf protein composition was studied using 2-DE and complemented with MALDI TOF mass spectrometry. While the two cultivars displayed genetic variation in response to water and heat stress, thirty-nine proteins were significantly altered in their relative abundance in response to WS, HS and combined WS+HS in both cultivars. A majority of these proteins were involved in metabolism, response to heat and photosynthesis showing significant cross-tolerance mechanisms. This study revealed that MED37C, a probable mediator of RNA polymerase transcription II protein, has potential interacting partners in Arabidopsis and signified the marked impact of this on the PI-471938 cultivar. Elevated activities in antioxidant enzymes indicate that the PI-471938 cultivar can restore the oxidation levels and sustain the plant during the stress. The discovery of this plant's development of cross-stress tolerance could be used as a guide to foster ongoing genetic modifications in stress tolerance.	[Katam, Ramesh; Shokri, Sedigheh; Murthy, Nitya] Florida A&M Univ, Dept Biol Sci, Tallahassee, FL 32307 USA; [Shokri, Sedigheh] Tarbiat Modares Univ, Coll Agr, Dept Hort Sci, Tehran, Iran; [Murthy, Nitya] Univ Pikeville, Kentucky Coll Optometry, Pikeville, KY USA; [Singh, Shardendu K.; Reddy, Kambham Raja] Mississippi State Univ, Mississippi State, MS 39762 USA; [Suravajhala, Prashanth] Biocluesorg, Hyderabad, India; [Suravajhala, Prashanth] Birla Inst Sci Res, Dept Biotechnol & Bioinformat, Jaipur, Rajasthan, India; [Khan, Mudassar Nawaz] Univ Agr, Inst Biotechnol & Genet Engn, Peshawar, Pakistan; [Bahmani, Mahya] Univ Tehran, Coll Agr Sci & Engn, Dept Agron & Plant Breeding, Tehran, Iran; [Sakata, Katsumi] Maebashi Inst Technol, Dept Life Sci & Informat, Maebashi, Gunma, Japan; [Bahmani, Mahya] Edith Cowan Univ, Sch Sci, Dept Biol, Perth, WA, Australia	State University System of Florida; Florida A&M University; Tarbiat Modares University; Mississippi State University; Agricultural University Peshawar; University of Agriculture Faisalabad; University of Tehran; Edith Cowan University	Katam, R (corresponding author), Florida A&M Univ, Dept Biol Sci, Tallahassee, FL 32307 USA.; Reddy, KR (corresponding author), Mississippi State Univ, Mississippi State, MS 39762 USA.	Ramesh.katam@famu.edu; krreddy@pss.msstate.edu	Reddy, Kambham Raja/ABE-6551-2020; Khan, Mudassar Nawaz Nawaz/AAY-8017-2021; Reddy, K. R./A-2339-2008; Suravajhala, Prashanth N/E-8270-2011; Katam, Ramesh/ABD-4806-2021	Reddy, Kambham Raja/0000-0002-7906-7755; Khan, Mudassar Nawaz Nawaz/0000-0001-7127-2239; Suravajhala, Prashanth N/0000-0002-8535-278X; Bahmani, Mahya/0000-0002-7337-4412	National Science Foundation [1156900]	National Science Foundation(National Science Foundation (NSF))	RK, and NM acknowledges the financial support from National Science Foundation Grant number 1156900 to carry out analysis of this research.	Ahmad Y., 2012, MOL CELL PROTEOMICS, V11, P1, DOI [10.1074/mcp.M111.013680, DOI 10.1074/mcp.M111.013680]; Ahsan N, 2010, J PROTEOME RES, V9, P4189, DOI 10.1021/pr100504j; Akram NA, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00613; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Ara N, 2013, INT J MOL SCI, V14, P24008, DOI 10.3390/ijms141224008; Ashoub A, 2015, PLANT MOL BIOL, V87, P459, DOI 10.1007/s11103-015-0291-4; Bai YL, 2018, PLANT J, V93, P781, DOI 10.1111/tpj.13800; Bhaskara GB, 2017, PLANT CELL, V29, P169, DOI 10.1105/tpc.16.00847; Blodner C, 2005, J PLANT PHYSIOL, V162, P549, DOI 10.1016/j.jplph.2004.09.005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruce TJA, 2007, PLANT SCI, V173, P603, DOI 10.1016/j.plantsci.2007.09.002; CAKMAK I, 1992, PLANT PHYSIOL, V98, P1222, DOI 10.1104/pp.98.4.1222; Carrera CS, 2017, CROP SCI, V57, P3179, DOI 10.2135/cropsci2017.04.0214; Djanaguiraman M, 2013, J AGRON CROP SCI, V199, P171, DOI 10.1111/jac.12005; Doherty MK, 2009, J PROTEOME RES, V8, P104, DOI 10.1021/pr800641v; Durr C, 2018, CROP PASTURE SCI, V69, P374, DOI 10.1071/CP17397; Ergo VV, 2018, ENVIRON EXP BOT, V148, P1, DOI 10.1016/j.envexpbot.2017.12.023; Etemadi N, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1799-6; Food and Agriculture Organization of the United Nations, CROP STAT REP WORLD; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Haslbeck M, 2015, J MOL BIOL, V427, P1537, DOI 10.1016/j.jmb.2015.02.002; Hewitt EJ, 1966, SAND WATER CULTURE M, P479; Hildebrandt TM, 2015, MOL PLANT, V8, P1563, DOI 10.1016/j.molp.2015.09.005; Hossain MA, 2018, PROTOPLASMA, V255, P399, DOI 10.1007/s00709-017-1150-8; Huang BR, 2008, J INTEGR PLANT BIOL, V50, P1230, DOI 10.1111/j.1744-7909.2008.00735.x; Huang H, 2012, J PROTEOMICS, V75, P1247, DOI 10.1016/j.jprot.2011.10.036; Hughes D., 2013, BRENNERS ENCY GENETI, VSecond, P466, DOI [10.1016/b978-0-12-374984-0.00468-x, DOI 10.1016/B978-0-12-374984-0.00468-X]; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; Jumrani K, 2018, PHYSIOL MOL BIOL PLA, V24, P37, DOI 10.1007/s12298-017-0480-5; Kadam S, 2012, FUNCT INTEGR GENOMIC, V12, P447, DOI 10.1007/s10142-012-0276-1; KAR M, 1976, PLANT PHYSIOL, V57, P315, DOI 10.1104/pp.57.2.315; Katam R, 2016, J PROTEOMICS, V143, P209, DOI 10.1016/j.jprot.2016.05.031; Katam Ramesh, 2015, J Proteomics Bioinform, V8, P217; Katam R, 2010, J PROTEOME RES, V9, P2236, DOI 10.1021/pr901009n; Kidokoro S, 2015, PLANT J, V81, P505, DOI 10.1111/tpj.12746; Komatsu S, 2012, J PROTEOMICS, V77, P531, DOI 10.1016/j.jprot.2012.09.032; Komatsu S, 2009, J PROTEOMICS, V72, P325, DOI 10.1016/j.jprot.2008.10.001; Kosova K, 2015, INT J MOL SCI, V16, P20913, DOI 10.3390/ijms160920913; Kosova K, 2011, J PROTEOMICS, V74, P1301, DOI 10.1016/j.jprot.2011.02.006; Kosti I, 2016, SCI REP-UK, V6, DOI 10.1038/srep24799; Le Gall Hyacinthe, 2015, Plants-Basel, V4, P112, DOI 10.3390/plants4010112; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Liu Y, 2017, J PROTEOME RES, V16, P2393, DOI 10.1021/acs.jproteome.6b01045; Lupwayi N. Z., 2011, African Journal of Plant Science, V5, P1; Mishra P, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00217; Mohammadi PP, 2012, J PROTEOMICS, V75, P1906, DOI 10.1016/j.jprot.2011.12.041; Mourtzinis S, 2015, NAT PLANTS, V1, P1, DOI [10.1038/NPLANTS.2014.26, 10.1038/nplants.2014.26]; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Niinemets U, 2010, FOREST ECOL MANAG, V260, P1623, DOI 10.1016/j.foreco.2010.07.054; Ozener O, 2014, FUEL, V115, P875, DOI 10.1016/j.fuel.2012.10.081; Parry MAJ, 2005, ANN APPL BIOL, V147, P211, DOI 10.1111/j.1744-7348.2005.00032.x; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pettigrew WT, 2018, PHYSIOL PLANTARUM, V162, P2; Qin J, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-12; Ray D, 2016, HEAT SHOCK PROTEINS, V10, P123, DOI 10.1007/978-3-319-46340-7_7; Reddy K. Raja, 2001, Biotronics, V30, P27; Rejeb Ines Ben, 2014, Plants (Basel), V3, P458, DOI 10.3390/plants3040458; Ren C, 2009, CROP SCI, V49, P1010, DOI 10.2135/cropsci2008.05.0247; Rodriguez VM, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0535-0; Rollins JA, 2013, J EXP BOT, V64, P3201, DOI 10.1093/jxb/ert158; Sadok W, 2012, CROP SCI, V52, P1261, DOI 10.2135/cropsci2011.11.0622; Sarkar NK, 2013, CELL STRESS CHAPERON, V18, P427, DOI 10.1007/s12192-012-0395-6; Saxton AM, 1998, PROCEEDINGS OF THE TWENTY-THIRD ANNUAL SAS USERS GROUP INTERNATIONAL CONFERENCE, P1243; SGHERRI CLM, 1995, PHYSIOL PLANTARUM, V93, P25, DOI 10.1034/j.1399-3054.1995.930105.x; Shi WJ, 2017, J EXP BOT, V68, P5233, DOI 10.1093/jxb/erx344; Singh SK, 2010, J PHOTOCH PHOTOBIO B, V100, P135, DOI 10.1016/j.jphotobiol.2010.05.013; Spargo JT, 2011, NUTR CYCL AGROECOSYS, V90, P253, DOI 10.1007/s10705-011-9426-4; Stastna M, 2012, PROTEOMICS, V12, P2937, DOI 10.1002/pmic.201200161; Su LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054237; Tairo E.V., 2013, AM J RECOMMUNICATI, V1, P159; Tanaka N, 2005, MOL CELL PROTEOMICS, V4, P796, DOI 10.1074/mcp.M400211-MCP200; Thomas JMG, 2009, J AGRON CROP SCI, V195, P148, DOI 10.1111/j.1439-037X.2008.00348.x; Tozzi ES, 2013, PLANT CELL ENVIRON, V36, P1423, DOI 10.1111/pce.12070; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; Vasanthaiah HKN, 2008, ELECTRON J BIOTECHN, V11, DOI 10.2225/vol11-issue3-fulltext-5; Waditee-Sirisattha R, 2017, ARCH MICROBIOL, V199, P29, DOI 10.1007/s00203-016-1271-z; Wang XL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101706; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Weng MY, 2015, PAK J BOT, V47, P49; Wu G, 2008, CURR MICROBIOL, V57, P18, DOI 10.1007/s00284-008-9145-5; Xu XP, 2015, FOOD CHEM, V172, P105, DOI 10.1016/j.foodchem.2014.09.035; Yildiztugay E, 2011, PLANT PHYSIOL BIOCH, V49, P816, DOI 10.1016/j.plaphy.2011.01.021; Zandalinas SI, 2018, PHYSIOL PLANTARUM, V162, P2, DOI 10.1111/ppl.12540; Zandalinas SI, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00953; Zhang J, 2016, S AFR J BOT, V105, P279, DOI 10.1016/j.sajb.2016.04.011; Zhao D, 2003, PLANT CELL ENVIRON, V26, P771, DOI 10.1046/j.1365-3040.2003.01019.x; Zhao FY, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01471; Zhou R, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-0974-x	91	15	17	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0233905	10.1371/journal.pone.0233905	http://dx.doi.org/10.1371/journal.pone.0233905			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502194	Green Published, gold			2022-12-26	WOS:000542035700011
J	Lu, GS; LaRowe, DE; Fike, DA; Druschel, GK; Gilhooly, WP; Price, RE; Amend, JP				Lu, Guang-Sin; LaRowe, Douglas E.; Fike, David A.; Druschel, Gregory K.; Gilhooly, William P., III; Price, Roy E.; Amend, Jan P.			Bioenergetic characterization of a shallow-sea hydrothermal vent system: Milos Island, Greece	PLOS ONE			English	Article							PARTIAL MOLAL PROPERTIES; HIGH-PRESSURES; THERMODYNAMIC PROPERTIES; DEEP-SEA; TRANSPORT-PROPERTIES; AEGEAN SEA; VULCANO ISLAND; METABOLIC REACTIONS; GEOCHEMICAL ENERGY; TEMPERATURES	Shallow-sea hydrothermal systems, like their deep-sea and terrestrial counterparts, can serve as relatively accessible portals into the microbial ecology of subsurface environments. In this study, we determined the chemical composition of 47 sediment porewater samples along a transect from a diffuse shallow-sea hydrothermal vent to a non-thermal background area in Paleochori Bay, Milos Island, Greece. These geochemical data were combined with thermodynamic calculations to quantify potential sources of energy that may support in situ chemolithotrophy. The Gibbs energies (Delta G(r)) of 730 redox reactions involving 23 inorganic H-, O-, C-, N-, S-, Fe-, Mn-, and As-bearing compounds were calculated. Of these reactions, 379 were exergonic at one or more sampling locations. The greatest energy yields were from anaerobic CO oxidation with NO2- (-136 to -162 kJ/mol e(-)), followed by reactions in which the electron acceptor/donor pairs were O-2/CO, NO3-/CO, and NO2-/H2S. When expressed as energy densities (where the concentration of the limiting reactant is taken into account), a different set of redox reactions are the most exergonic: in sediments affected by hydrothermal input, sulfide oxidation with a range of electron acceptors or nitrite reduction with different electron donors provide 85 similar to 245 J per kg of sediment, whereas in sediments less affected or unaffected by hydrothermal input, various S-0 oxidation reactions and aerobic respiration reactions with several different electron donors are most energy-yielding (80 similar to 95 J per kg of sediment). A model that considers seawater mixing with hydrothermal fluids revealed that there is up to similar to 50 times more energy available for microorganisms that can use S-0 or H2S as electron donors and NO2- or O-2 as electron acceptors compared to other reactions. In addition to revealing likely metabolic pathways in the near-surface and subsurface mixing zones, thermodynamic calculations like these can help guide novel microbial cultivation efforts to isolate new species.	[Lu, Guang-Sin; LaRowe, Douglas E.; Amend, Jan P.] Univ Southern Calif, Dept Earth Sci, Los Angeles, CA 90007 USA; [Fike, David A.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; [Druschel, Gregory K.; Gilhooly, William P., III] Indiana Univ Purdue Univ, Dept Earth Sci, Indianapolis, IN 46202 USA; [Price, Roy E.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA; [Amend, Jan P.] Univ Southern Calif, Dept Biol Sci, Los Angeles, CA 90007 USA	University of Southern California; Washington University (WUSTL); Indiana University System; Indiana University-Purdue University Indianapolis; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Southern California	Amend, JP (corresponding author), Univ Southern Calif, Dept Earth Sci, Los Angeles, CA 90007 USA.; Amend, JP (corresponding author), Univ Southern Calif, Dept Biol Sci, Los Angeles, CA 90007 USA.	janamend@usc.edu	Fike, David/D-3634-2011	Fike, David/0000-0003-2848-0328	NSF [MGG-1061476, OCE-0939564]; USC Zumberge Fund Individual Grant; NASA Astrobiology Institute grant [NNA13AA92A]; NASA-NSF Origins of Life Ideas Lab program [NNN13D466T, 80NSSC20K0228]; Alfred P. Sloan Foundation through the Deep Carbon Observatory; C-DEBI [529]	NSF(National Science Foundation (NSF)); USC Zumberge Fund Individual Grant; NASA Astrobiology Institute grant; NASA-NSF Origins of Life Ideas Lab program; Alfred P. Sloan Foundation through the Deep Carbon Observatory(Alfred P. Sloan Foundation); C-DEBI	Financial assistance was provided by the NSF through grant awards MGG-1061476 (to DAF, JPA, GKD) and OCE-0939564 (to JPA) as well as the USC Zumberge Fund Individual Grant, the NASA Astrobiology Institute grant NNA13AA92A (to DEL and JPA), the NASA-NSF Origins of Life Ideas Lab program under grant NNN13D466T (to DEL) and grant 80NSSC20K0228 (to DEL and REP), the Alfred P. Sloan Foundation through the Deep Carbon Observatory (all to DEL), and the C-DEBI contribution number 529 to JPA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerman NH, 2011, GEOBIOLOGY, V9, P436, DOI 10.1111/j.1472-4669.2011.00291.x; ALBAREDE F, 1981, EARTH PLANET SC LETT, V55, P229, DOI 10.1016/0012-821X(81)90102-3; Amend JP, 2019, ENVIRON MICROBIOL, V21, P3539, DOI 10.1111/1462-2920.14778; Amend JP, 2003, GEOBIOLOGY, V1, P37, DOI 10.1046/j.1472-4669.2003.00006.x; Amend JP, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0255; Amend JP, 2011, GEOCHIM COSMOCHIM AC, V75, P5736, DOI 10.1016/j.gca.2011.07.041; Amend JP, 2001, FEMS MICROBIOL REV, V25, P175, DOI 10.1016/S0168-6445(00)00062-0; [Anonymous], 2013, CLIN TRANSL GASTROEN, V4, pe39; [Anonymous], 2005, EFSA J, V224, P1; Baker ET, 2004, GEOPHYS MONOGR SER, V148, P245, DOI 10.1029/148GM10; Bayraktarov E, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00111; Beaulieu S. E., 2015, INTERRIDGE GLOBAL DA; Berenguer J., 2011, ENCY ASTROBIOLOGY, P1666, DOI DOI 10.1007/978-3-642-11274-4_1583; Boettger J, 2013, CHEM GEOL, V337, P11, DOI 10.1016/j.chemgeo.2012.10.053; Branch G.M., 1981, BIOL LIMPETS PHYS FA; BRICKER O, 1965, AM MINERAL, V50, P1296; Brinkhoff T, 1999, APPL ENVIRON MICROB, V65, P3843; BROCK T. D., 1970, Annual review of ecology and systematics., V1, P191, DOI 10.1146/annurev.es.01.110170.001203; CORLISS JB, 1979, SCIENCE, V203, P1073, DOI 10.1126/science.203.4385.1073; Dahle H, 2015, ISME J, V9, P1593, DOI 10.1038/ismej.2014.247; Dando PR, 2000, PHYS CHEM EARTH PT B, V25, P1, DOI 10.1016/S1464-1909(99)00112-4; Dando PR, 1998, CAH BIOL MAR, V39, P369; DANDO PR, 1995, CONT SHELF RES, V15, P913, DOI 10.1016/0278-4343(95)80002-U; DANIEL RM, 1992, ORIGINS LIFE EVOL B, V22, P33, DOI 10.1007/BF01808017; de Fommervault OP, 2015, J GEOPHYS RES-OCEANS, V120, P8528, DOI 10.1002/2015JC011103; Eecke HCV, 2013, ENV MICROBIOL REP, V5, P665, DOI 10.1111/1758-2229.12065; Garrison TS, 2018, ESSENTIALS OCEANOGRA, P71; Gilhooly WP, 2014, GEOCHEM T, V15, DOI 10.1186/s12932-014-0012-y; Giovanelli D., 2017, REFERENCE MODULE EAR; Giovannelli D, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00184; Godelitsas A, 2015, MAR CHEM, V177, P687, DOI 10.1016/j.marchem.2015.09.004; Haar L, 1984, NBS NRC STEAM TABLES; HELGESON HC, 1969, AM J SCI, V267, P729, DOI 10.2475/ajs.267.7.729; HELGESON HC, 1981, AM J SCI, V281, P1249, DOI 10.2475/ajs.281.10.1249; HEM JD, 1982, WATER RESOUR RES, V18, P563, DOI 10.1029/WR018i003p00563; Hentscher M, 2012, GEOCHEM T, V13, DOI 10.1186/1467-4866-13-2; Hill T., 2012, FREE ENERGY TRANSDUC; Houghton JL, 2019, MAR CHEM, V208, P83, DOI 10.1016/j.marchem.2018.11.002; Inskeep WP, 2005, GEOBIOLOGY, V3, P297, DOI 10.1111/j.1472-4669.2006.00059.x; JANNASCH HW, 1985, PROC R SOC SER B-BIO, V225, P277, DOI 10.1098/rspb.1985.0062; Jochimsen B, 1997, EXTREMOPHILES, V1, P67, DOI 10.1007/s007920050016; JOHNSON JW, 1992, COMPUT GEOSCI-UK, V18, P899, DOI 10.1016/0098-3004(92)90029-Q; Jolivet L, 2013, TECTONOPHYSICS, V597, P1, DOI 10.1016/j.tecto.2012.06.011; Karageorgis A, 1998, J MARINE SYST, V16, P269, DOI 10.1016/S0924-7963(97)00020-1; Kuever J, 2002, CAH BIOL MAR, V43, P413; LaRowe D, 2020, ENERGY LIMITS LIFE S; LaRowe D, MICROBIAL LIFE DEEP, P279; Larowe DE, 2007, GEOBIOLOGY, V5, P153, DOI 10.1111/j.1472-4669.2007.00099.x; LaRowe DE, 2014, GEOCHIM COSMOCHIM AC, V124, P72, DOI 10.1016/j.gca.2013.09.005; LUTZ RA, 1993, REV GEOPHYS, V31, P211, DOI 10.1029/93RG01280; Madigan MT, 2017, BROCK BIOL MICROORGA, DOI [10.3390/microorganisms5020034, DOI 10.3390/MICROORGANISMS5020034]; McCollom TM, 1997, GEOCHIM COSMOCHIM AC, V61, P4375, DOI 10.1016/S0016-7037(97)00241-X; McKay L, 2016, ENV MICROBIOL REP, V8, P150, DOI 10.1111/1758-2229.12365; Osburn MR, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00610; PALMER MR, 1992, EARTH PLANET SC LETT, V109, P37, DOI 10.1016/0012-821X(92)90072-4; Pehlivanoglou K, 2001, GEO-MAR LETT, V21, P75; Philips Sarah, 2002, Re/Views in Environmental Science and Bio/Technology, V1, P115, DOI 10.1023/A:1020892826575; Price RE, 2005, CHEM GEOL, V224, P122, DOI 10.1016/j.chemgeo.2005.07.017; Price RE, 2015, CHEM GEOL, V407, P21, DOI 10.1016/j.chemgeo.2015.04.011; Price RE, 2013, CHEM GEOL, V348, P15, DOI 10.1016/j.chemgeo.2012.06.007; Reece JB, 2013, CAMPBELL BIOL; Renner J, HYDROTHERMAL CONVECT; Rinehart J.S, 1980, GEYSERS GEOTHERMAL E; Rogers KL, 2005, GEOBIOLOGY, V3, P319, DOI 10.1111/j.1472-4669.2006.00064.x; Rogers KL, 2006, GEOCHIM COSMOCHIM AC, V70, P6180, DOI 10.1016/j.gca.2006.08.046; Schulte MD, 2001, GEOCHIM COSMOCHIM AC, V65, P3919, DOI 10.1016/S0016-7037(01)00717-7; SEGERER AH, 1993, ORIGINS LIFE EVOL B, V23, P77, DOI 10.1007/BF01581992; SENGERS JMHL, 1983, J PHYS CHEM REF DATA, V12, P1, DOI 10.1063/1.555676; Shibuya T, 2016, GEOCHIM COSMOCHIM AC, V175, P1, DOI 10.1016/j.gca.2015.11.021; Shock E. L., 2005, GEOTHERMAL BIOL GEOC, P95; SHOCK EL, 1992, J CHEM SOC FARADAY T, V88, P803, DOI 10.1039/ft9928800803; SHOCK EL, 1990, GEOCHIM COSMOCHIM AC, V54, P915, DOI 10.1016/0016-7037(90)90429-O; SHOCK EL, 1988, GEOCHIM COSMOCHIM AC, V52, P2009, DOI 10.1016/0016-7037(88)90181-0; SHOCK EL, 1989, GEOCHIM COSMOCHIM AC, V53, P2157, DOI 10.1016/0016-7037(89)90341-4; Shock EL, 2010, GEOCHIM COSMOCHIM AC, V74, P4005, DOI 10.1016/j.gca.2009.08.036; Sievert SM, 2000, INT J SYST EVOL MICR, V50, P1229, DOI 10.1099/00207713-50-3-1229; Sievert SM, 1999, APPL ENVIRON MICROB, V65, P3834; Spear JR, 2005, P NATL ACAD SCI USA, V102, P2555, DOI 10.1073/pnas.0409574102; Spear JR, 2005, GEOTHERMAL BIOL GEOC, P113; Sverjensky DA, 1997, GEOCHIM COSMOCHIM AC, V61, P1359, DOI 10.1016/S0016-7037(97)00009-4; TANGER JC, 1988, AM J SCI, V288, P19, DOI 10.2475/ajs.288.1.19; Tarasov VG, 2005, CHEM GEOL, V224, P5, DOI 10.1016/j.chemgeo.2005.07.021; Valsami-Jones E, 2005, J VOLCANOL GEOTH RES, V148, P130, DOI 10.1016/j.jvolgeores.2005.03.018; Varnavas SP, 2005, CHEM GEOL, V224, P40, DOI 10.1016/j.chemgeo.2005.07.013; Waring G.A., 1965, THERMAL SPRINGS US O; Windman T, 2007, ASTROBIOLOGY, V7, P873, DOI 10.1089/ast.2007.0127; ZHANG XY, 2015, FRONT MICROBIOL, V6, DOI DOI 10.3389/FMICB.2015.00006	87	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0234175	10.1371/journal.pone.0234175	http://dx.doi.org/10.1371/journal.pone.0234175			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502166	Green Published, gold			2022-12-26	WOS:000542035700039
J	Yang, X; Wisuthiphaet, N; Young, GM; Nitin, N				Yang, Xu; Wisuthiphaet, Nicharee; Young, Glenn M.; Nitin, Nitin			Rapid detection ofEscherichia coliusing bacteriophage-induced lysis and image analysis	PLOS ONE			English	Article							PROPIDIUM MONOAZIDE; PHAGE; SCATTERING; PATHOGENS; VIRUSES; FOOD	Rapid detection of bacterial pathogens is a critical unmet need for both food and environmental samples such as irrigation water. As a part of the Food safety Modernization Act (FSMA), The Produce Safety rule has established several requirements for testing for the presence of genericEscherichia coliin water, but the current method available for testing (EPA M1603) demands specified multiple colony verification and highly trained personnel to perform these tests. The purpose of the study was to assess a phage induced bacterial lysis using quantitative image analysis to achieve rapid detection ofE.coliat low concentrations within 8 hours. This study aimed to develop a simple yet highly sensitive and specific approach to detect target bacteria in complex matrices. In the study,E.colicells were first enriched in tryptic soy broth (TSB), followed by T7 phage induced lysis, concentration, staining and fluorescent imaging. Image analysis was conducted including image pre-processing, image segmentation and quantitatively analysis of cellular morphological features (area, eccentricity and full width at half maximum). Challenge experiments using realistic matrices, including simulated fresh produce wash water, coconut water and spinach wash water, demonstrated the method can be applied for use in situations that occur in food processing facilities. The results indicatedE.colicells that are lysed by T7 phages demonstrated significantly (P < 0.05) higher extracellular DNA release, altered cellular shape (from rod to circular) and diffused fluorescent signal intensity. Using this biosensing strategy, a sensitivity to detectEscherichia coliat 10 CFU/ml within 8 hours was achieved, both in laboratory medium and in complex matrices. The proposed phage based biosensing strategy enables rapid detection of bacteria and is applicable to analysis of food systems. Furthermore, the steps involved in this assay can be automated to enable detection of target bacteria in food facilities without extensive resources.	[Yang, Xu; Wisuthiphaet, Nicharee; Young, Glenn M.; Nitin, Nitin] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA; [Nitin, Nitin] Univ Calif Davis, Dept Biol & Agr Engn, Davis, CA 95616 USA; [Yang, Xu] Calif State Polytech Univ Pomona, Nutr & Food Sci Dept, Pomona, CA 91768 USA	University of California System; University of California Davis; University of California System; University of California Davis; California State University System; California State Polytechnic University Pomona	Nitin, N (corresponding author), Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA.; Nitin, N (corresponding author), Univ Calif Davis, Dept Biol & Agr Engn, Davis, CA 95616 USA.	nnitin@ucdavis.edu		Nitin, Nitin/0000-0003-4839-4566	USDA-NIFA Program Enhancing Food Safety through Improved Processing Technologies [A4131, 2015-68003-23411]	USDA-NIFA Program Enhancing Food Safety through Improved Processing Technologies	This project was funded by USDA-NIFA Program Enhancing Food Safety through Improved Processing Technologies (A4131) with grant no. 2015-68003-23411. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbana TE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205020; Altan A, 2011, J FOOD SCI, V76, pE212, DOI 10.1111/j.1750-3841.2010.01994.x; Anany H, 2018, ANAL BIOANAL CHEM, V410, P1217, DOI 10.1007/s00216-017-0597-y; Bae E, 2007, APPL OPTICS, V46, P3639, DOI 10.1364/AO.46.003639; Baggesen DL, 2010, EUROSURVEILLANCE, DOI [10.2807/ese.15.04.19471-en, DOI 10.2807/ESE.15.04.19471-EN]; Banada PP, 2007, BIOSENS BIOELECTRON, V22, P1664, DOI 10.1016/j.bios.2006.07.028; BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; Blahuta J, 2011, RECENT RESEARCHES CO; Brovko LY, 2012, ADV FOOD NUTR RES, V67, P241, DOI 10.1016/B978-0-12-394598-3.00006-X; Chen JH, 2017, ACS SENSORS, V2, P484, DOI 10.1021/acssensors.7b00021; CHEN SY, 2011, APPL ENVIRON MICROB, V77, P4008, DOI DOI 10.1128/AEM.00354-11; Cortesi M, 2017, J BIOL ENG, V11, DOI 10.1186/s13036-017-0050-y; Edgar R, 2006, P NATL ACAD SCI USA, V103, P4841, DOI 10.1073/pnas.0601211103; Elizaquivel P, 2012, FOOD MICROBIOL, V30, P316, DOI 10.1016/j.fm.2011.10.008; EPA/US EPA (US Environmental Protection Agency), 2007, 7473 EPAUS; FDA, 2015, FIN ENV IMP STAT EIS; HENNES KP, 1995, LIMNOL OCEANOGR, V40, P1050, DOI 10.4319/lo.1995.40.6.1050; Jackson AA, 2016, ANALYST, V141, P5543, DOI [10.1039/C6AN00479B, 10.1039/c6an00479b]; Kim H, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00537; Kostyuchenko VA, 2003, NAT STRUCT BIOL, V10, P688, DOI 10.1038/nsb970; Kostyuchenko VA, 2005, NAT STRUCT MOL BIOL, V12, P810, DOI 10.1038/nsmb975; Laube T, 2014, APPL MICROBIOL BIOT, V98, P1795, DOI 10.1007/s00253-013-5434-4; Lee SH, 2006, LETT APPL MICROBIOL, V42, P259, DOI 10.1111/j.1472-765X.2006.01840.x; Li JW, 2019, ANAL BIOANAL CHEM, V411, P6067, DOI 10.1007/s00216-019-01991-z; Loessner MJ, 2005, CURR OPIN MICROBIOL, V8, P480, DOI 10.1016/j.mib.2005.06.002; Mukhopadhyay A, 2007, J MICROBIOL METH, V68, P193, DOI 10.1016/j.mimet.2006.07.009; Nanduri JR, 2009, COMPUT FLUIDS, V38, P1026, DOI 10.1016/j.compfluid.2008.01.027; Otsu N., 1979, IEEE T SYST MAN CYB, DOI [10.1109/tsmc.1979.4310068, DOI 10.1109/TSMC.1979.4310068]; Parish ME, 2005, J FOOD PROTECT, V68, P2196, DOI 10.4315/0362-028X-68.10.2196; Patel A, 2007, NAT PROTOC, V2, P269, DOI 10.1038/nprot.2007.6; Ravindran PB, 2016, AUSTRALAS PHYS ENG S, V39, P677, DOI 10.1007/s13246-016-0463-9; Sharp NJ, 2015, J FOOD PROTECT, V78, P963, DOI 10.4315/0362-028X.JFP-14-534; Tilton L, 2019, ANAL LETT, V52, P2203, DOI 10.1080/00032719.2019.1604726; Turnbull L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11220; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; Wisuthiphaet N, 2019, AMB EXPRESS, V9, DOI 10.1186/s13568-019-0776-7; Yong JWH, 2009, MOLECULES, V14, P5144, DOI 10.3390/molecules14125144	37	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0233853	10.1371/journal.pone.0233853	http://dx.doi.org/10.1371/journal.pone.0233853			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502212	Green Published, gold			2022-12-26	WOS:000542035700052
J	Newnham, JP; White, SW; Lee, HS; Arrese, CA; Watts, JC; Pedretti, MK; Dickinson, JE; Doherty, DA				Newnham, John P.; White, Scott W.; Lee, Han-Shin; Arrese, Catherine A.; Watts, Jared C.; Pedretti, Michelle K.; Dickinson, Jan E.; Doherty, Dorota A.			The elements of success in a comprehensive state-wide program to safely reduce the rate of preterm birth	PLOS ONE			English	Article							COUNTRIES; TRENDS; WOMEN; CARE	Background In 2014, a whole-of-population and multi-faceted preterm birth prevention program was introduced in Western Australia with the single aim of safely lowering the rate of preterm birth. The program included new clinical guidelines, print and social media, and a dedicated new clinic. In the first full calendar year the rate of preterm birth fell by 7.6% and the reduction extended from the 28-31 week gestational age group upwards. Objective The objective of this study was to evaluate outcomes in greater depth and to also include the first three years of the program. Study design This was a prospective population-based cohort study of perinatal outcomes in singleton pregnancies before and after commencement of the program. Results There was a significant reduction in preterm birth in the tertiary center which extended from 28 weeks gestation onwards and was ongoing. In non-tertiary centers there was an initial reduction, but this was not sustained past the first year. The greatest reduction was observed in pregnancies classified at first attendance as low risk. No benefit was observed in the private sector, but a significant reduction was seen in the remote region of the Kimberley where the program was first launched and vaginal progesterone had been made free-of-charge. Conclusion Preterm birth rates can be safely reduced by a multi-faceted and whole-of-population program but the effectiveness requires continuing effort and will be greatest where the strategies are most targeted.	[Newnham, John P.; White, Scott W.; Lee, Han-Shin; Dickinson, Jan E.] King Edward Mem Hosp, Maternal Fetal Med Serv, Perth, WA, Australia; [Newnham, John P.; White, Scott W.; Arrese, Catherine A.; Pedretti, Michelle K.; Dickinson, Jan E.; Doherty, Dorota A.] Univ Western Australia, Div Obstet & Gynaecol, Perth, WA, Australia; [Watts, Jared C.] WA Country Hlth Serv, Dept Obstet & Gynaecol, Kimberley, WA, Australia; [Watts, Jared C.] Univ Western Australia, Rural Clin Sch Western Australia, Broome, WA, Australia; [Pedretti, Michelle K.] King Edward Mem Hosp, Dept Ultrasound, Perth, WA, Australia	King Edward Memorial Hospital; University of Western Australia; University of Western Australia; King Edward Memorial Hospital; University of Western Australia	Newnham, JP (corresponding author), King Edward Mem Hosp, Maternal Fetal Med Serv, Perth, WA, Australia.; Newnham, JP (corresponding author), Univ Western Australia, Div Obstet & Gynaecol, Perth, WA, Australia.	john.newnham@uwa.edu.au		Pedretti, Michelle/0000-0001-8241-6162; Dickinson, Jan/0000-0003-3928-3290; White, Scott/0000-0002-7235-6407; Doherty, Dorota/0000-0002-5507-9065	National Health and Medical Research Council of Australia [APP1151853]; Women and Infants Research Foundation of Western Australia; Channel 7 Telethon	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Women and Infants Research Foundation of Western Australia; Channel 7 Telethon	This study was supported by the National Health and Medical Research Council of Australia (Partnership Grant APP1151853 to JPN, DAD, www.nhmrc.gov.au), the Women and Infants Research Foundation of Western Australia (to JPN, DAD, www.wirf.com.au), Channel 7 Telethon (to JPN, DAD, www.telethon7.com) and private philanthropy. None of the study sponsors had any role in the design, data collection, analysis, interpretation of data, writing of the manuscript or decision to submit the paper for publication.	Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Chang HH, 2013, LANCET, V381, P223, DOI 10.1016/S0140-6736(12)61856-X; Clark S. L., 2010, AM J OBSTET GYNECOL, V203, pe1, DOI 10.1016/j.ajog.2010.05.036; Crump C, 2019, LANCET CHILD ADOLESC, V3, P408, DOI 10.1016/S2352-4642(19)30108-7; Hutchinson MJ, 2019, 33 DEP HLTH; Jarde A, 2019, BJOG-INT J OBSTET GY, V126, P556, DOI 10.1111/1471-0528.15566; Kildea S, 2019, ECLINICALMEDICINE, V12, P43, DOI 10.1016/j.eclinm.2019.06.001; Kildea SV, 2017, WOMEN BIRTH, V30, P398, DOI 10.1016/j.wombi.2017.03.003; Newnham JP, 2017, AM J OBSTET GYNECOL, V216, P434, DOI 10.1016/j.ajog.2016.11.1037; Newnham JP, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00066; Newnham JP, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00584; Perla RJ, 2011, BMJ QUAL SAF, V20, P46, DOI 10.1136/bmjqs.2009.037895; Romero R, 2018, AM J OBSTET GYNECOL, V218, P161, DOI 10.1016/j.ajog.2017.11.576; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Sandall J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004667.pub4; SMFM Consult Series #39, 2016, AM J OBSTET GYNECOL, V214, pB9; Tracy SK, 2013, LANCET, V382, P1723, DOI 10.1016/S0140-6736(13)61406-3; White SW, 2019, SEMIN FETAL NEONAT M, V24, P33, DOI 10.1016/j.siny.2018.10.006	18	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0234033	10.1371/journal.pone.0234033	http://dx.doi.org/10.1371/journal.pone.0234033			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497072	Green Published, gold			2022-12-26	WOS:000542035200006
J	Chhabra, R; Nanjundan, M				Chhabra, Ravneet; Nanjundan, Meera			Lysophosphatidic acid reverses Temsirolimus-induced changes in lipid droplets and mitochondrial networks in renal cancer cells	PLOS ONE			English	Article							CARCINOMA; AUTOPHAGY; MTOR; INHIBITION; EXPRESSION; LIPOLYSIS	Increased cytoplasmic lipid droplets (LDs) and elevated AKT/mTOR signaling are characteristics of clear cell renal cell carcinoma (ccRCC). Lysophosphatidic acid (LPA), a potent lipid mitogen generated via autotaxin (elevated in ccRCC), can modulate tumor progression but its role in altering chemotherapeutic sensitivity to mTOR inhibitors is unclear and thus is the focus of the studies presented herein. Using malignant (A-498, 769-P and 786-O) and normal immortalized kidney (HK-2) cell lines, we investigated their cellular responsiveness to Temsirolimus (TEMS, mTOR inhibitor) in the absence or presence of LPA by monitoring alterations in AKT/mTOR pathway mediators (via western blotting), LDs (using LipidTOX and real-time PCR to assess transcript changes in modulators of LD biogenesis/turnover), mitochondrial networks (via immunofluorescence staining for TOM20 and TOM70), as well as cellular viability. We identified that TEMS reduced cellular viability in all renal cell lines, with increased sensitivity in the presence of an autophagy inhibitor. TEMS also altered activation of AKT/mTOR pathway mediators, abundance of LDs, and fragmentation of mitochondrial networks. We observed that these effects were antagonized by LPA. In HK-2 cells, LPA markedly increased LD size and abundance, coinciding with phospho-MAPK and phospho-S6 activation, increased diacylglycerol O-acetyltransferase 2 (DGAT2) mRNA (which produces triacylglycerides), and survival. Inhibiting MAPK partially antagonized LPA-induced LD changes. Collectively, we have identified that LPA can reverse the effects of TEMS by increasing LDs in a MAPK-dependent manner; these results suggest that LPA may contribute to the pathogenesis and chemotherapeutic resistance of ccRCC.	[Chhabra, Ravneet; Nanjundan, Meera] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Nanjundan, M (corresponding author), Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA.	mnanjund@usf.edu			National Cancer Institute [NCI] [R03 CA212696]	National Cancer Institute [NCI](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute [NCI R03 CA212696] awarded to Meera Nanjundan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Valdes-Rives SA, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/9173090; Aon MA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00282; Bauckman KA, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.87; Beloribi-Djefaflia S, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2015.49; Benesch MGK, 2015, J LIPID RES, V56, P1134, DOI 10.1194/jlr.M057661; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chakravarthi BVSK, 2016, AM J PATHOL, V186, P1724, DOI 10.1016/j.ajpath.2016.02.023; Du WN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01965-8; Dutta P, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2053-3; Eskelinen EL, 2019, INT J BIOCHEM CELL B, V111, P1, DOI 10.1016/j.biocel.2019.03.010; Fei WH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002201; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Genc GE, 2019, BIOCHEM CELL BIOL, V97, P387, DOI 10.1139/bcb-2018-0164; Haas NB, 2019, CLIN CANCER RES, V25, P2080, DOI 10.1158/1078-0432.CCR-18-2204; Hakimi AA, 2013, NAT GENET, V45, P849, DOI 10.1038/ng.2708; Hashimoto S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10656; Jiang L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11842-5; Lancet Global Health, 2019, LANCET GLOBAL HLTH, V7, pe1; Li J, 2014, CELL METAB, V19, P373, DOI 10.1016/j.cmet.2014.01.001; Li LJ, 2013, CANCER CELL, V24, P738, DOI 10.1016/j.ccr.2013.10.025; Liotti A, 2018, J CELL PHYSIOL, V233, P7367, DOI 10.1002/jcp.26572; Lotze MT, 2013, CANCER J, V19, P341, DOI 10.1097/PPO.0b013e31829da0d6; Maycotte P, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317698391; Monzon FA, 2011, MODERN PATHOL, V24, P1470, DOI 10.1038/modpathol.2011.107; Mooberry LK, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00466; Morita M, 2017, MOL CELL, V67, P922; Motzer RJ, 2017, J NATL COMPR CANC NE, V15, P804, DOI 10.6004/jnccn.2017.0100; Navarro-Tito N, 2010, INT J BIOCHEM CELL B, V42, P306, DOI 10.1016/j.biocel.2009.11.010; Poklepovic A, 2014, AUTOPHAGY, V10, P1478, DOI 10.4161/auto.29428; Porta C, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00064; Rambold AS, 2015, DEV CELL, V32, P678, DOI 10.1016/j.devcel.2015.01.029; Rangwala R, 2014, AUTOPHAGY, V10, P1391, DOI 10.4161/auto.29119; Rapaport D, 2003, EMBO REP, V4, P948, DOI 10.1038/sj.embor.embor937; Rathmell WK, 2008, EXPERT REV ANTICANC, V8, P63, DOI 10.1586/14737140.8.1.63; Riaz A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020215; Ricketts CJ, 2018, CELL REP, V23, P3698, DOI 10.1016/j.celrep.2018.06.032; Rockfield S, 2019, ONCOGENESIS, V8, DOI 10.1038/s41389-019-0154-y; Rockfield S, 2018, ONCOTARGET, V9, P5344, DOI 10.18632/oncotarget.23747; Rodrik-Outmezguine VS, 2011, CANCER DISCOV, V1, P248, DOI 10.1158/2159-8290.CD-11-0085; Rohwedder A, 2014, J CELL SCI, V127, P3104, DOI 10.1242/jcs.145854; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Saito K, 2016, SCI REP-UK, V6, DOI 10.1038/srep28932; Sathe A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190854; Smith DM, 2010, CELL DEATH DIFFER, V17, P1867, DOI 10.1038/cdd.2010.53; Soliman GA, 2010, LIPIDS, V45, P1089, DOI 10.1007/s11745-010-3488-y; Su SC, 2013, CLIN CANCER RES, V19, P6461, DOI 10.1158/1078-0432.CCR-13-1284; Tang WW, 2006, J BIOCHEM MOL BIOL, V39, P626; Umezu-Goto M, 2004, J CELL BIOCHEM, V92, P1115, DOI 10.1002/jcb.20113; Voss MH, 2011, HEMATOL ONCOL CLIN N, V25, P835, DOI 10.1016/j.hoc.2011.04.008; Xu AH, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0836-7; Xu M, 2017, ONCOTARGET, V8, P66154, DOI 10.18632/oncotarget.19825; Yang JJ, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01315; Yu SX, 2008, JNCI-J NATL CANCER I, V100, P1630, DOI 10.1093/jnci/djn378; 2014, REG ANESTH PAIN MED, V9	54	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2020	15	6							e0233887	10.1371/journal.pone.0233887	http://dx.doi.org/10.1371/journal.pone.0233887			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LW6ZP	32492043	gold, Green Published			2022-12-26	WOS:000539293000034
J	Gilholm, P; Mengersen, K; Thompson, H				Gilholm, Patricia; Mengersen, Kerrie; Thompson, Helen			Identifying latent subgroups of children with developmental delay using Bayesian sequential updating and Dirichlet process mixture modelling	PLOS ONE			English	Article							CLUSTER-ANALYSIS; PROFILE REGRESSION; MOTOR DEVELOPMENT; DESIGN; HETEROGENEITY; PREDICTORS; SIBLINGS; LANGUAGE; SPECTRUM; INFANTS	Identifying children who are at-risk for developmental delay, so that these children can have access to interventions as early as possible, is an important and challenging problem in developmental research. This research aimed to identify latent subgroups of children with developmental delay, by modelling and clustering developmental milestones. The main objectives were to (a) create a developmental profile for each child by modelling milestone achievements, from birth to three years of age, across multiple domains of development, and (b) cluster the profiles to identify groups of children who show similar deviations from typical development. The ensemble methodology used in this research consisted of three components: (1) Bayesian sequential updating was used to model the achievement of milestones, which allows for updated predictions of development to be made in real time; (2) a measure was created that indicated how far away each child deviated from typical development for each functional domain, by calculating the area between each child's obtained sequence of posterior means and a sequence of posterior means representing typical development; and (3) Dirichlet process mixture modelling was used to cluster the obtained areas. The data used were 348 binary developmental milestone measurements, collected from birth to three years of age, from a small community sample of young children (N = 79). The model identified nine latent groups of children with similar features, ranging from no delays in all functional domains, to large delays in all domains. The performance of the Dirichlet process mixture model was validated with two simulation studies.	[Gilholm, Patricia; Mengersen, Kerrie; Thompson, Helen] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld, Australia; [Gilholm, Patricia; Mengersen, Kerrie] Queensland Univ Technol, Ctr Excellence Math & Stat Frontiers, Australian Res Council, Brisbane, Qld, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Gilholm, P (corresponding author), Queensland Univ Technol, Sch Math Sci, Brisbane, Qld, Australia.; Gilholm, P (corresponding author), Queensland Univ Technol, Ctr Excellence Math & Stat Frontiers, Australian Res Council, Brisbane, Qld, Australia.	p.gilholm@qut.edu.au	Gilholm, Trish/AAA-7392-2022; Mengersen, Kerrie/AHC-4096-2022; Thompson, Mery/J-1143-2012	Gilholm, Trish/0000-0001-8135-1520; Thompson, Mery/0000-0001-7006-3646	Australian Technology Network of Universities Industry Doctoral Training Centre scholarship; QUT; Developing Foundation	Australian Technology Network of Universities Industry Doctoral Training Centre scholarship; QUT; Developing Foundation	Work by PG was supported by an Australian Technology Network of Universities Industry Doctoral Training Centre scholarship, co-funded by QUT and the Developing Foundation. The Developing Foundation played a role in data collection. The funders had no role in study design, analysis, decision to publish or the preparation of the manuscript.	Andrews G, 2009, PSYCHOL MED, V39, P2013, DOI 10.1017/S0033291709990274; Bailey DB, 2004, PEDIATRICS, V113, P887, DOI 10.1542/peds.113.4.887; Berry SM, 2010, CH CRC BIOSTAT SER, P1, DOI 10.1201/EBK1439825488; Burns Y, 2004, EARLY HUM DEV, V80, P19, DOI 10.1016/j.earlhumdev.2004.05.003; Cai CY, 2014, J R STAT SOC C-APPL, V63, P159, DOI 10.1111/rssc.12039; Chen DC, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0518-1; Collins L.M., 2010, LATENT CLASS LATENT, V718; Dahl DB, 2006, BAYESIAN INFERENCE FOR GENE EXPRESSION AND PROTEOMICS, P201; Eldred K, 2010, PHYS THER, V90, P1510, DOI 10.2522/ptj.20090308; Favaro S, 2013, STAT SCI, V28, P335, DOI 10.1214/13-STS422; Fraley C, 2007, J CLASSIF, V24, P155, DOI [10.1007/s00357-007-0004-5, 10.1007/s00357-007-0004-z]; Fritsch A, 2009, BAYESIAN ANAL, V4, P367, DOI 10.1214/09-BA414; Fruhwirth-Schnatter S., 2006, FINITE MIXTURE MARKO, DOI [10.1007/978-0-387-35768-3, DOI 10.1007/978-0-387-35768-3]; Gilholm P., 2019, BAYESIAN SEQUENTIAL; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hastie DI, 2015, STAT COMPUT, V25, P1023, DOI 10.1007/s11222-014-9471-3; Hurn M, 2003, J COMPUT GRAPH STAT, V12, P55, DOI 10.1198/1061860031329; Ishwaran H, 2001, J AM STAT ASSOC, V96, P161, DOI 10.1198/016214501750332758; Ishwaran H, 2002, J COMPUT GRAPH STAT, V11, P508, DOI 10.1198/106186002411; Johnson C P, 1997, Pediatr Rev, V18, P224, DOI 10.1542/pir.18-7-224; Jones EJH, 2014, NEUROSCI BIOBEHAV R, V39, P1, DOI 10.1016/j.neubiorev.2013.12.001; Kalli M, 2011, STAT COMPUT, V21, P93, DOI 10.1007/s11222-009-9150-y; Karalunas SL, 2014, JAMA PSYCHIAT, V71, P1015, DOI 10.1001/jamapsychiatry.2014.763; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Kim SH, 2016, J CHILD PSYCHOL PSYC, V57, P93, DOI 10.1111/jcpp.12448; Kruschke J.K., 2014, DOING BAYESIAN DATA, DOI DOI 10.1016/B978-0-12-405888-0.09999-2; Landa RJ, 2012, J CHILD PSYCHOL PSYC, V53, P986, DOI 10.1111/j.1469-7610.2012.02558.x; Liverani S, 2015, J STAT SOFTW, V64, P1; Maatta S, 2012, J SPEECH LANGUAGE HE; Marquand Andre F, 2016, Biol Psychiatry Cogn Neurosci Neuroimaging, V1, P433; McLachlan G., 2000, WILEY SER PROB STAT; Medvedovic M, 2004, BIOINFORMATICS, V20, P1222, DOI 10.1093/bioinformatics/bth068; Muller P, 2004, STAT SCI, V19, P95, DOI 10.1214/088342304000000017; Murray GK, 2006, J CHILD PSYCHOL PSYC, V47, P25, DOI 10.1111/j.1469-7610.2005.01450.x; Nishimura T, 2016, INT J EPIDEMIOL, V45, P543, DOI 10.1093/ije/dyv363; OFLAHERTY B, 1992, J APPL BEHAV ANAL, V25, P585, DOI 10.1901/jaba.1992.25-585; Oravecz Z, 2016, BIG DATA COGNITIVE S, V13; Papaspiliopoulos O, 2008, NOTE POSTERIOR SAMPL; Papaspiliopoulos O, 2008, BIOMETRIKA, V95, P169, DOI 10.1093/biomet/asm086; Petty K., 2015, DEV MILESTONES YOUNG; Pickles A, 2014, J CHILD PSYCHOL PSYC, V55, P1354, DOI 10.1111/jcpp.12269; Porteous I, 2012, ARXIV12066845; Prior M, 1998, J CHILD PSYCHOL PSYC, V39, P893, DOI 10.1017/S0021963098002807; R Core Team, 2021, R LANGUAGE ENV STAT; Reynolds A.P., 2006, J MATH MODEL ALGORIT, V5, P475, DOI [DOI 10.1007/S10852-005-9022-1, 10.1007/s10852-005-9022-1]; Rodriguez A, 2011, ELECTRON J STAT, V5, P981, DOI 10.1214/11-EJS634; Rutter M, 2006, J CHILD PSYCHOL PSYC, V47, P276, DOI 10.1111/j.1469-7610.2006.01614.x; Ruzich E, 2016, AUTISM RES, V9, P658, DOI 10.1002/aur.1544; Sacco R, 2012, AUTISM RES, V5, P137, DOI 10.1002/aur.1226; Sacrey LAR, 2018, AUTISM RES, V11, P539, DOI 10.1002/aur.1920; Scarborough AA, 2009, J DEV BEHAV PEDIATR, V30, P489, DOI 10.1097/DBP.0b013e3181c35df6; Schaefer J.L., 1997, ANAL INCOMPLETE MULT, DOI 10.1201/9781439821862; Schieve LA, 2016, ANN EPIDEMIOL, V26, P267, DOI 10.1016/j.annepidem.2016.02.012; Schuurman NK, 2016, MULTIVAR BEHAV RES, V51, P185, DOI 10.1080/00273171.2015.1065398; SETHURAMAN J, 1994, STAT SINICA, V4, P639; Shahbaba B, 2009, J MACH LEARN RES, V10, P1829; Shen Jess J, 2007, AMIA Annu Symp Proc, P666; Sonnander K, 1999, DEV MED CHILD NEUROL, V41, P195, DOI 10.1017/S0012162299000389; Teh Y.W., 2010, ENCY MACHINE LEARNIN, P280, DOI [10.1007/978-0-387-30164-8_219, DOI 10.1007/978-0-387-30164-8_219]; Ukoumunne OC, 2012, CHILD CARE HLTH DEV, V38, P341, DOI 10.1111/j.1365-2214.2011.01234.x; van Havre Z, 2016, ARXIV160201915; Walker SG, 2007, COMMUN STAT-SIMUL C, V36, P45, DOI 10.1080/03610910601096262; White N., 2015, DIRICHLET PROCESS MI; White N, 2012, J APPL STAT, V39, P2363, DOI 10.1080/02664763.2012.710897; Wiggins LD, 2017, J AUTISM DEV DISORD, V47, P3634, DOI 10.1007/s10803-017-3280-4; Yin GS, 2012, J R STAT SOC C-APPL, V61, P219, DOI 10.1111/j.1467-9876.2011.01006.x; Yu KZ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185417; Zhou X, 2008, CLIN TRIALS, V5, P181, DOI 10.1177/1740774508091815	70	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2020	15	6							e0233542	10.1371/journal.pone.0233542	http://dx.doi.org/10.1371/journal.pone.0233542			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MT4VF	32484833	Green Published, gold			2022-12-26	WOS:000554969700009
J	Hwang, HS; Lee, MH; Kim, HA				Hwang, Hyun Sook; Lee, Mi Hyun; Kim, Hyun Ah			TGF-beta 1-induced expression of collagen type II and ACAN is regulated by 4E-BP1, a repressor of translation	FASEB JOURNAL			English	Article						4E-BP1; cartilage matrix; osteoarthritis; protein translation; TGF-beta 1	MESENCHYMAL STEM-CELLS; TGF-BETA; PROTEIN-SYNTHESIS; SMAD3 GENE; CHONDROCYTE; MTOR; MECHANISMS; INHIBITOR; DIFFERENTIATION; CHONDROGENESIS	Eukaryotic initiation factor 4E (eIF4E)-binding protein 1 (4E-BP1) binds eIF4E and represses protein translation by displacing it from the mRNA. In this study, we investigated the influence of 4E-BP1 translational apparatus on the regulation of transforming growth factor-beta 1 (TGF-beta 1)-induced anabolic signaling in chondrocytes. The level of 4E-BP1 expression was significantly higher in human OA cartilage than normal cartilage. TGF-beta 1 increased total protein synthesis, including aggrecan (ACAN) and collagen type II (Col II), together with activation of Akt/mTOR signaling pathway. mTOR silencing significantly suppressed ACAN and Col II expressions through decreasing TGF-beta 1-induced phosphorylation of 4E-BP1. On the contrary, 4E-BP1 knockdown promoted total protein synthesis but suppressed Col II and ACAN expressions with decreased expression of Smad2/3 and Smad4 and increased expression of inhibitory Smad6 and Smad7. TGF-beta 1 suppressed the interaction of 4E-BP1 and eIF4E and subsequently enhanced protein synthesis. Furthermore, 4E-BP1 regulated translation levels of inhibitory Smads, which decreased the accumulation of nuclear Smad2/3 complexes on the promoter of ACAN and Col II genes, subsequently affecting transcription of ACAN and Col II. These results demonstrated that TGF-beta 1-modulated phosphorylation of 4EBP1 plays a role in the expression of Col II and ACAN through differential alteration of Smad signaling pathway.	[Hwang, Hyun Sook; Lee, Mi Hyun; Kim, Hyun Ah] Hallym Univ, Dept Internal Med, Div Rheumatol, Sacred Heart Hosp, 896 Pyungchon, Anyang 14068, Kyunggi, South Korea; [Hwang, Hyun Sook; Lee, Mi Hyun; Kim, Hyun Ah] Hallym Univ, Inst Skeletal Aging, Chunchon, South Korea	Hallym University; Hallym University	Kim, HA (corresponding author), Hallym Univ, Dept Internal Med, Div Rheumatol, Sacred Heart Hosp, 896 Pyungchon, Anyang 14068, Kyunggi, South Korea.	kimha@hallym.ac.kr			National Research Foundation of Korea [2017R1A2B2001881]; Hallym University Research Fund	National Research Foundation of Korea(National Research Foundation of Korea); Hallym University Research Fund	The National Research Foundation of Korea, Grant/Award Number: 2017R1A2B2001881; Hallym University Research Fund	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Aref-Eshghi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097786; Avdulov S, 2004, CANCER CELL, V5, P553, DOI 10.1016/j.ccr.2004.05.024; Azar R, 2008, CELL MOL LIFE SCI, V65, P3110, DOI 10.1007/s00018-008-8418-2; Bhat M, 2015, NAT REV DRUG DISCOV, V14, P261, DOI 10.1038/nrd4505; Chen CG, 2012, ARTHRITIS RHEUM-US, V64, P3278, DOI 10.1002/art.34566; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Estrada KD, 2013, DEV BIOL, V382, P375, DOI 10.1016/j.ydbio.2013.08.021; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Furumatsu T, 2013, J BIOMECH, V46, P1508, DOI 10.1016/j.jbiomech.2013.03.028; Gingras AC, 2001, GENE DEV, V15, P2852; Hwang HS, 2019, OSTEOARTHR CARTILAGE, V27, P833, DOI 10.1016/j.joca.2019.01.006; Iwai T, 2008, J BIOL CHEM, V283, P27154, DOI 10.1074/jbc.M801175200; Jiang LY, 2013, RHEUMATOL INT, V33, P1763, DOI 10.1007/s00296-012-2593-z; Katsara O, 2017, ARTHRITIS RHEUMATOL, V69, P586, DOI 10.1002/art.39947; Lang CH, 2007, AM J PHYSIOL-ENDOC M, V293, pE453, DOI 10.1152/ajpendo.00204.2007; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee MC, 2015, BONE JOINT J, V97B, P924, DOI 10.1302/0301-620X.97B7.35852; Li C, 2014, BIOCHEM BIOPH RES CO, V450, P646, DOI 10.1016/j.bbrc.2014.06.030; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Lu J, 2017, MOL THER, V25, P2676, DOI 10.1016/j.ymthe.2017.08.009; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Mercer PF, 2016, THORAX, V71, P701, DOI 10.1136/thoraxjnl-2015-207429; Qin XY, 2016, CELL CYCLE, V15, P781, DOI 10.1080/15384101.2016.1151581; Qureshi HY, 2007, CELL SIGNAL, V19, P1643, DOI 10.1016/j.cellsig.2007.02.007; REDINI F, 1991, BIOCHIM BIOPHYS ACTA, V1093, P196, DOI 10.1016/0167-4889(91)90123-F; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; Ruoff R, 2016, P NATL ACAD SCI USA, V113, P7545, DOI 10.1073/pnas.1605451113; Schaeffer V, 2010, AM J NEPHROL, V31, P189, DOI 10.1159/000268954; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Valdes AM, 2010, ARTHRITIS RHEUM-US, V62, P2347, DOI 10.1002/art.27530; van de Laar IMBH, 2011, NAT GENET, V43, P121, DOI 10.1038/ng.744; van der Kraan PM, 2009, OSTEOARTHR CARTILAGE, V17, P1539, DOI 10.1016/j.joca.2009.06.008; van der Kraan PM, 2017, NAT REV RHEUMATOL, V13, P155, DOI 10.1038/nrrheum.2016.219; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang LF, 2006, J BIOL CHEM, V281, P24293, DOI 10.1074/jbc.M603566200; Watanabe H, 2001, J BIOL CHEM, V276, P14466, DOI 10.1074/jbc.M005724200; Whitaker AT, 2017, BIOL OPEN, V6, P358, DOI 10.1242/bio.021436; Woodcock HV, 2019, NAT COMMUN, V10, DOI [10.1038/s41467-020-18621-3, 10.1038/s41467-018-07858-8]; Xia P, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0733-9; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Yoon HJ, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0599-x; Zhen GH, 2013, NAT MED, V19, P704, DOI 10.1038/nm.3143	44	5	5	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9531	9546		10.1096/fj.201903003R	http://dx.doi.org/10.1096/fj.201903003R		JUN 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32485037				2022-12-26	WOS:000538169700001
J	Awad, AM; Nag, A; Pham, NVB; Bradley, MC; Jabassini, N; Nathaniel, J; Clarke, CF				Awad, Agape M.; Nag, Anish; Pham, Nguyen V. B.; Bradley, Michelle C.; Jabassini, Nour; Nathaniel, Juan; Clarke, Catherine F.			Intragenic suppressor mutations of the COQ8 protein kinase homolog restore coenzyme Q biosynthesis and function in Saccharomyces cerevisiae	PLOS ONE			English	Article							UBIQUINONE BIOSYNTHESIS; NEPHROTIC SYNDROME; CEREBELLAR-ATAXIA; DEFICIENCY; MITOCHONDRIA; POLYPEPTIDE; METABOLISM; COMPLEX; ADCK3; CYCLE	Saccharomyces cerevisiae Coq8 is a member of the ancient UbiB atypical protein kinase family. Coq8, and its orthologs UbiB, ABC1, ADCK3, and ADCK4, are required for the biosynthesis of coenzyme Q in yeast, E. coli, A. thaliana, and humans. Each Coq8 ortholog retains nine highly conserved protein kinase-like motifs, yet its functional role in coenzyme Q biosynthesis remains mysterious. Coq8 may function as an ATPase whose activity is stimulated by coenzyme Q intermediates and phospholipids. A key yeast point mutant expressing Coq8-A197V was previously shown to result in a coenzyme Q-less, respiratory deficient phenotype. The A197V substitution occurs in the crucial Ala-rich protein kinase-like motif I of yeast Coq8. Here we show that long-term cultures of mutants expressing Coq8-A197V produce spontaneous revertants with the ability to grow on medium containing a non-fermentable carbon source. Each revertant is shown to harbor a secondary intragenic suppressor mutation within the COQ8 gene. The intragenic suppressors restore the synthesis of coenzyme Q. One class of the suppressors fully restores the levels of coenzyme Q and key Coq polypeptides necessary for the maintenance and integrity of the high-molecular mass CoQ synthome (also termed complex Q), while the other class provides only a partial rescue. Mutants harboring the first class of suppressors grow robustly under respiratory conditions, while mutants containing the second class grow more slowly under these conditions. Our work provides insight into the function of this important yet still enigmatic Coq8 family.	[Awad, Agape M.; Nag, Anish; Pham, Nguyen V. B.; Bradley, Michelle C.; Jabassini, Nour; Nathaniel, Juan; Clarke, Catherine F.] Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA; [Awad, Agape M.; Nag, Anish; Pham, Nguyen V. B.; Bradley, Michelle C.; Jabassini, Nour; Nathaniel, Juan; Clarke, Catherine F.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clarke, CF (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.	cathy@chem.ucla.edu		Clarke, Catherine/0000-0002-6426-3833	National Science Foundation [MCB-1330803]; Whitcome Predoctoral Individual Fellowship	National Science Foundation(National Science Foundation (NSF)); Whitcome Predoctoral Individual Fellowship	This work was supported by the National Science Foundation, Grant MCB-1330803 to C.F.C. and Whitcome Predoctoral Individual Fellowship to M.C.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar-Fabra M, 2018, ESSAYS BIOCHEM, V62, P377, DOI 10.1042/EBC20170107; Allan CM, 2015, J BIOL CHEM, V290, P7517, DOI 10.1074/jbc.M114.633131; Ashraf S, 2013, J CLIN INVEST, V123, P5179, DOI 10.1172/JCI69000; Awad AM, 2018, ESSAYS BIOCHEM, V62, P361, DOI 10.1042/EBC20170106; Awad AM, 2017, J BIOL CHEM, V292, P14851, DOI 10.1074/jbc.M117.798397; Belogrudov GI, 2001, ARCH BIOCHEM BIOPHYS, V392, P48, DOI 10.1006/abbi.2001.2448; Bentinger M, 2007, MITOCHONDRION, V7, pS41, DOI 10.1016/j.mito.2007.02.006; Bentinger M, 2010, BIOCHEM BIOPH RES CO, V396, P74, DOI 10.1016/j.bbrc.2010.02.147; Black MH, 2019, SCIENCE, V364, P787, DOI 10.1126/science.aaw7446; BRANDT U, 1994, CRIT REV BIOCHEM MOL, V29, P165, DOI 10.3109/10409239409086800; Burke D., 2000, METHODS YEAST GENETI; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; Conrad M, 2014, FEMS MICROBIOL REV, V38, P254, DOI 10.1111/1574-6976.12065; Crane FL, 1985, COENZYME Q, P1; Do TQ, 2001, J BIOL CHEM, V276, P18161, DOI 10.1074/jbc.M100952200; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisenberg-Bord Michal, 2019, Contact (Thousand Oaks), V2, p2515256418825409, DOI 10.1177/2515256418825409; Fonseca LV, 2018, HUM MUTAT, V39, P406, DOI 10.1002/humu.23376; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; Gogl G, 2019, TRENDS BIOCHEM SCI, V44, P300, DOI 10.1016/j.tibs.2018.12.002; He CWH, 2014, BBA-MOL CELL BIOL L, V1841, P630, DOI 10.1016/j.bbalip.2013.12.017; Heeringa SF, 2011, J CLIN INVEST, V121, P2013, DOI 10.1172/JCI45693; HERSKOWITZ I, 1991, METHOD ENZYMOL, V194, P132; Hsieh EJ, 2007, ARCH BIOCHEM BIOPHYS, V463, P19, DOI 10.1016/j.abb.2007.02.016; Hsieh EJ, 2004, BIOCHEM BIOPH RES CO, V317, P648, DOI 10.1016/j.bbrc.2004.03.096; Hsu AY, 2000, BBA-MOL CELL BIOL L, V1484, P287, DOI 10.1016/S1388-1981(00)00019-6; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024; Luna-Sanchez M, 2017, EMBO MOL MED, V9, P78, DOI 10.15252/emmm.201606345; Martin-Montalvo A, 2011, BIOCHEM J, V440, P107, DOI 10.1042/BJ20101422; Martinis J, 2014, PLANT J, V77, P269, DOI 10.1111/tpj.12385; Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022; Nguyen TP, 2014, BIOCHIM BIOPHYS ACTA; Niemi NM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11047-6; Reidenbach AG, 2018, CELL CHEM BIOL, V25, P154, DOI 10.1016/j.chembiol.2017.11.001; Ryan OW, 2014, ELIFE, V3, DOI 10.7554/eLife.03703; Stefely JA, 2017, TRENDS BIOCHEM SCI, V42, P824, DOI 10.1016/j.tibs.2017.06.008; Stefely JA, 2016, MOL CELL, V63, P608, DOI 10.1016/j.molcel.2016.06.030; Stefely JA, 2015, MOL CELL, V57, P83, DOI 10.1016/j.molcel.2014.11.002; Subramanian K, 2019, J CELL BIOL, V218, P1352, DOI 10.1083/jcb.201808044; Tauche A, 2008, FEMS YEAST RES, V8, P1263, DOI 10.1111/j.1567-1364.2008.00436.x; Tran UC, 2006, J BIOL CHEM, V281, P16401, DOI 10.1074/jbc.M513267200; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; van Wijk KJ, 2017, ANNU REV PLANT BIOL, V68, P253, DOI 10.1146/annurev-arplant-043015-111737; Vazquez-Fonseca L, 2019, J CLIN MED, V8, DOI 10.3390/jcm8091374; Vogtle FN, 2009, CELL, V139, P428, DOI 10.1016/j.cell.2009.07.045; Wang Y, 2019, TRENDS ENDOCRIN MET, V30, P929, DOI 10.1016/j.tem.2019.08.009; Wang Y, 2013, CRIT REV BIOCHEM MOL, V48, P69, DOI 10.3109/10409238.2012.741564; Xie LTX, 2012, J BIOL CHEM, V287, P23571, DOI 10.1074/jbc.M112.360354; Xie LTX, 2011, BBA-MOL CELL BIOL L, V1811, P348, DOI 10.1016/j.bbalip.2011.01.009	54	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0234192	10.1371/journal.pone.0234192	http://dx.doi.org/10.1371/journal.pone.0234192			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MJ2AA	32479562	Green Published, gold			2022-12-26	WOS:000547893500058
J	Spivak, JL; Merchant, A; Williams, DM; Rogers, O; Zhao, WK; Duffield, A; Resar, LS; Moliterno, AR; Zhao, ZZJ				Spivak, Jerry L.; Merchant, Akil; Williams, Donna M.; Rogers, Ophelia; Zhao, Wanke; Duffield, Amy; Resar, Linda S.; Moliterno, Alison R.; Zhao, Zhizhuang J.			Thrombopoietin is required for full phenotype expression in a JAK2(V617F) transgenic mouse model of polycythemia vera	PLOS ONE			English	Article							CELL-SURFACE LOCALIZATION; C-MPL; HEMATOPOIETIC STEM; MUTANT CALRETICULIN; MYELOPROLIFERATIVE NEOPLASM; BLOOD THROMBOPOIETIN; JANUS KINASES; RECEPTOR; THROMBOCYTOSIS; ERYTHROPOIETIN	The myeloproliferative neoplasms, polycythemia vera, essential thrombocytosis and primary myelofibrosis are hematopoietic stem cell disorders and share driver mutations that either directly activate the thrombopoietin receptor, MPL, or activate it indirectly through gain-of-function mutations in the gene for JAK2, its cognate tyrosine kinase. Paradoxically, MPL surface expression in hematopoietic stem cells is also reduced in the myeloproliferative neoplasms due to abnormal post-translational glycosylation and premature destruction of JAK2, suggesting that the myeloproliferative neoplasms are disorders of MPL processing since MPL is the only hematopoietic growth factor receptor in hematopoietic stem cells. To examine this possibility, we genetically manipulated MPL expression and maturation in a JAK2(V617F) transgenic mouse model of polycythemia vera. Elimination of MPL expression completely abrogated the polycythemia vera phenotype in this JAK2(V617F) transgenic mouse model, which could only be partially restored by expression of one MPL allele. Most importantly, elimination of thrombopoietin gene expression abrogated the polycythemia vera phenotype in this JAK2(V617F) transgenic mouse model, which could be completely restored by expression of a single thrombopoietin allele. These data indicate that polycythemia vera is in part a thrombopoietin-dependent disorder and that targeting the MPL-thrombopoietin axis could be an effective, nonmyelotoxic therapeutic strategy in this disorder.	[Spivak, Jerry L.; Williams, Donna M.; Rogers, Ophelia; Resar, Linda S.; Moliterno, Alison R.] Johns Hopkins Univ, Sch Med, Dept Med, Hematol Div, Baltimore, MD 21205 USA; [Merchant, Akil] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Blood & Marrow Transplant Program, Los Angeles, CA 90048 USA; [Zhao, Wanke; Zhao, Zhizhuang J.] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; [Duffield, Amy] Johns Hopkins Univ, Sch Med, Dept Pathol, Hematol Pathol, Baltimore, MD 21205 USA	Johns Hopkins University; Cedars Sinai Medical Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Johns Hopkins University	Spivak, JL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Hematol Div, Baltimore, MD 21205 USA.	jlspivak@jhmi.edu		Spivak, Jerry/0000-0003-0169-5388; Duffield, Amy/0000-0003-2018-1964	National Cancer Institute [CA108671]; National Heart, Lung and Blood Institute [HL145750]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	JLS, National Cancer Institute CA108671 https://www.cancer.gov/contact; JLS, ARM, LR National Heart, Lung and Blood Institute HL145750 www.nhlbi.nih.gov.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki M, 2016, BLOOD, V127, P1307, DOI 10.1182/blood-2015-09-671172; Ballmaier M, 2009, BRIT J HAEMATOL, V146, P3, DOI 10.1111/j.1365-2141.2009.07706.x; Borge OJ, 1996, BLOOD, V88, P2859, DOI 10.1182/blood.V88.8.2859.bloodjournal8882859; Chachoua I, 2016, BLOOD, V127, P1325, DOI 10.1182/blood-2015-11-681932; Cleyrat C, 2014, TRAFFIC, V15, P961, DOI 10.1111/tra.12185; Desai D, 2018, BLOOD, V132, DOI 10.1182/blood-2018-99-117142; deSauvage FJ, 1996, J EXP MED, V183, P651, DOI 10.1084/jem.183.2.651; Ding F, 2004, BLOOD, V103, P4198, DOI 10.1182/blood-2003-10-3471; Ding JM, 2009, BLOOD, V114, P3325, DOI 10.1182/blood-2008-04-149047; Dupont S, 2007, BLOOD, V110, P1013, DOI 10.1182/blood-2006-10-054940; El-Harith EHA, 2009, BRIT J HAEMATOL, V144, P185, DOI 10.1111/j.1365-2141.2008.07430.x; Elf S, 2018, BLOOD, V131, P782, DOI 10.1182/blood-2017-08-800896; Favale F, 2016, BLOOD, V128, P3146, DOI [10.1182/blood-2016-06722058, 10.1182/blood-2016-06-722058]; Geddis AE, 2011, PEDIATR BLOOD CANCER, V57, P199, DOI 10.1002/pbc.22927; Goncalves F, 1997, BLOOD, V89, P3544, DOI 10.1182/blood.V89.10.3544.3544_3544_3553; Gurney A L, 1996, Stem Cells, V14 Suppl 1, P116; GURNEY AL, 1994, SCIENCE, V265, P1445, DOI 10.1126/science.8073287; Horikawa Y, 1997, BLOOD, V90, P4031, DOI 10.1182/blood.V90.10.4031; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Klampfl T, 2013, NEW ENGL J MED, V369, P2379, DOI 10.1056/NEJMoa1311347; Kohlscheen S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131866; KOURY MJ, 1990, SCIENCE, V248, P378, DOI 10.1126/science.2326648; KUTER DJ, 1995, BLOOD, V85, P2720, DOI 10.1182/blood.V85.10.2720.bloodjournal85102720; Lannutti BJ, 2009, BLOOD, V113, P1778, DOI 10.1182/blood-2007-11-124859; Levin J, 2001, BLOOD, V98, P1019, DOI 10.1182/blood.V98.4.1019; Li J, 2018, BLOOD, V131, P649, DOI 10.1182/blood-2017-09-806356; Li JZ, 2000, BRIT J HAEMATOL, V111, P943; Marty C, 2009, J BIOL CHEM, V284, P11781, DOI 10.1074/jbc.M808703200; Moliterno AR, 2004, P NATL ACAD SCI USA, V101, P11444, DOI 10.1073/pnas.0404241101; Moliterno AR, 1999, BLOOD, V94, P2555, DOI 10.1182/blood.V94.8.2555.420k14_2555_2561; Moliterno AR, 1998, NEW ENGL J MED, V338, P572, DOI 10.1056/NEJM199802263380903; Mullally A, 2010, CANCER CELL, V17, P584, DOI 10.1016/j.ccr.2010.05.015; Murone MM, 1998, STEM CELLS, V16, P1, DOI 10.1002/stem.160001; Nangalia J, 2013, NEW ENGL J MED, V369, P2391, DOI 10.1056/NEJMoa1312542; Pecquet C, 2012, BLOOD, V119, P4625, DOI 10.1182/blood-2011-08-372524; Pietras EM, 2015, CELL STEM CELL, V17, P35, DOI 10.1016/j.stem.2015.05.003; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Posthuma HLA, 2010, BLOOD, V116, P3375, DOI 10.1182/blood-2010-06-290718; PRCHAL JF, 1974, NEW ENGL J MED, V290, P1382; Qian H, 2007, CELL STEM CELL, V1, P671, DOI 10.1016/j.stem.2007.10.008; Royer Y, 2005, J BIOL CHEM, V280, P27251, DOI 10.1074/jbc.M501376200; Sangkhae V, 2014, BLOOD, V124, P3956, DOI 10.1182/blood-2014-07-587238; Seiki Y, 2013, HAEMATOLOGICA, V98, P901, DOI 10.3324/haematol.2012.066217; Shimoda K, 1997, BLOOD, V90, P597, DOI 10.1182/blood.V90.2.597.597_597_604; Shirai T, 2019, BLOOD ADV, V3, P3080, DOI 10.1182/bloodadvances.2019000250; SOUYRI M, 1990, CELL, V63, P1137, DOI 10.1016/0092-8674(90)90410-G; Spivak J, 2015, BLOOD, V126, P484; SPIVAK JL, 1991, BLOOD, V77, P1228; Tiedt R, 2009, BLOOD, V113, P1768, DOI 10.1182/blood-2008-03-146084; Vainchenker W, 2008, SEMIN CELL DEV BIOL, V19, P385, DOI 10.1016/j.semcdb.2008.07.002; Verstovsek S, 2012, NEW ENGL J MED, V366, P799, DOI 10.1056/NEJMoa1110557; Villeval JL, 1997, BLOOD, V90, P4369; VILLEVAL JL, 1992, LEUKEMIA, V6, P107; Wang JC, 1998, AM J MED, V104, P451, DOI 10.1016/S0002-9343(98)00090-4; Wang JC, 1997, LEUKEMIA, V11, P1827, DOI 10.1038/sj.leu.2400846; Wang XL, 2016, BLOOD, V127, P3398, DOI 10.1182/blood-2015-10-674465; Wang XL, 2014, BLOOD, V124, P2987, DOI 10.1182/blood-2014-02-558015; WENDLING F, 1986, VIROLOGY, V149, P242, DOI 10.1016/0042-6822(86)90125-X; Wiestner A, 1998, NAT GENET, V18, P49, DOI 10.1038/ng0198-49; Williams DM, 2007, EXP HEMATOL, V35, P1641, DOI 10.1016/j.exphem.2007.08.010; Xing S, 2008, BLOOD, V111, P5109, DOI 10.1182/blood-2007-05-091579; Yan XQ, 1996, BLOOD, V88, P402, DOI 10.1182/blood.V88.2.402.bloodjournal882402; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020	63	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0232801	10.1371/journal.pone.0232801	http://dx.doi.org/10.1371/journal.pone.0232801			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MJ2AA	32479500	Green Published, gold			2022-12-26	WOS:000547893500007
J	Yao, KL; Yang, Q; Li, YJ; Lan, T; Yu, H; Yu, Y				Yao, Keli; Yang, Qin; Li, Yajuan; Lan, Ting; Yu, Hong; Yu, Yang			MicroRNA-9 mediated the protective effect of ferulic acid on hypoxic-ischemic brain damage in neonatal rats	PLOS ONE			English	Article							UP-REGULATION; INJURY; EXPRESSION; ACHE; ACTIVATION; CELLS; MODEL	Neonatal hypoxic-ischemic brain damage (HIBD) is prone to cognitive and memory impairments, and there is no effective clinical treatment until now. Ferulic acid (FA) is found within members of the genus Angelica, reportedly shows protective effects on neuronal damage. However, the protective effects of FA on HIBD remains unclear. In this study, using the Morris water maze task, we herein found that the impairment of spatial memory formation in adult rats exposed to HIBD was significantly reversed by FA treatment and the administration of LNA-miR-9. The expression of miRNA-9 was detected by RT-PCR analyses, and the results shown that miRNA-9 was significantly increased in the hippocampus of neonatal rats following HIBD and in the PC12 cells following hypoxic-ischemic injury, while FA and LNA-miR-9 both inhibited the expression of miRNA-9, suggesting that the therapeutic effect of FA was mainly attributed to the inhibition of miRNA-9 expression. Indeed, the silencing of miR-9 by LNA-miR-9 or FA similarly attenuated neuronal damage and cerebral atrophy in the rat hippocampus after HIBD, which was consistent with the restored expression levels of brain-derived neurotrophic factor (BDNF). Therefore, our findings indicate that FA treatment may protect against neuronal death through the inhibition of miRNA-9 induction in the rat hippocampus following hypoxic-ischemic damage.	[Yao, Keli; Yang, Qin; Li, Yajuan; Lan, Ting; Yu, Hong; Yu, Yang] Southwest Med Univ, Sch Basic Med Sci, Dept Histol & Embryol, Luzhou, Sichuan, Peoples R China	Southwest Medical University	Yu, H; Yu, Y (corresponding author), Southwest Med Univ, Sch Basic Med Sci, Dept Histol & Embryol, Luzhou, Sichuan, Peoples R China.	759227112@qq.com; yupng80@swmu.edu.cn		Yao, Keli/0000-0001-6170-0535	Science and Technology Bureau of LuZhou City [2017LZXNYD-J30]	Science and Technology Bureau of LuZhou City	This work was supported by the Science and Technology Bureau of LuZhou City (2017LZXNYD-J30).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander M, 2014, BEHAV BRAIN RES, V259, P85, DOI 10.1016/j.bbr.2013.10.038; Bhalala OG, 2013, NAT REV NEUROL, V9, P328, DOI 10.1038/nrneurol.2013.67; Bumrungpert A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060713; Cai HX, 2017, MOL THER, V25, P1448, DOI 10.1016/j.ymthe.2017.03.020; Chang F, 2014, MOL MED REP, V9, P1917, DOI 10.3892/mmr.2014.2013; Coolen M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00220; Cui H, 2013, J CRANIOFAC SURG, V24, P2147, DOI 10.1097/SCS.0b013e3182a243f3; Dajas-Bailador F, 2012, NAT NEUROSCI, V15, P697, DOI 10.1038/nn.3082; Dilenge ME, 2001, J CHILD NEUROL, V16, P781, DOI 10.1177/08830738010160110201; Ding X, 2015, NEUROSCI LETT, V591, P75, DOI 10.1016/j.neulet.2015.02.026; Doman SE, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00304; Douglas-Escobar M, 2015, JAMA PEDIATR, V169, P397, DOI 10.1001/jamapediatrics.2014.3269; Duran-Carabali LE, 2018, MOL NEUROBIOL, V55, P3627, DOI 10.1007/s12035-017-0604-5; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Ezhuthupurakkal PB, 2018, NANOMED-NANOTECHNOL, V14, P415, DOI 10.1016/j.nano.2017.11.003; Furukawa S, 2011, REPROD SCI, V18, P172, DOI 10.1177/1933719110385129; Jalili-Baleh L, 2017, EUR J MED CHEM, V139, P280, DOI 10.1016/j.ejmech.2017.07.072; Lehtonen L, 2017, SEMIN FETAL NEONAT M, V22, P153, DOI 10.1016/j.siny.2017.02.006; Li B, 2003, J NEUROSCI, V23, P11244; Li B, 2017, PROG NEUROBIOL, V159, P50, DOI 10.1016/j.pneurobio.2017.10.006; Li SH, 2016, J MOL NEUROSCI, V60, P71, DOI 10.1007/s12031-016-0793-9; Li William A, 2017, Neurol Res, P1, DOI 10.1080/01616412.2017.1327505; Liu EYL, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00059; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Madelaine R, 2017, CELL REP, V20, P1533, DOI 10.1016/j.celrep.2017.07.051; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Mhillaj E, 2018, MOL NEUROBIOL, V55, P905, DOI 10.1007/s12035-017-0381-1; Moon JM, 2013, J CEREBR BLOOD F MET, V33, P1976, DOI 10.1038/jcbfm.2013.157; Otaegi G, 2011, J NEUROSCI, V31, P809, DOI 10.1523/JNEUROSCI.4330-10.2011; Pandareesh MD, 2013, CELL MOL NEUROBIOL, V33, P875, DOI 10.1007/s10571-013-9952-5; Pers YM, 2013, NAT REV RHEUMATOL, V9, P76, DOI 10.1038/nrrheum.2012.236; Radhakrishnan B, 2016, J EXP NEUROSCI, V10, P101, DOI 10.4137/JEN.S32843; Rehman SU, 2019, MOL NEUROBIOL, V56, P2774, DOI 10.1007/s12035-018-1280-9; Ren ZK, 2017, INT J MOL MED, V40, P1444, DOI 10.3892/ijmm.2017.3127; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Roese-Koerner B, 2016, STEM CELL REP, V7, P207, DOI 10.1016/j.stemcr.2016.06.008; Shah TA, 2017, PEDIATR RES, V81, P654, DOI 10.1038/pr.2016.271; Sun J, 2014, MOL MED REP, V10, P3047, DOI 10.3892/mmr.2014.2577; Wang Y, 2016, J PHARMACOL EXP THER, V357, P591, DOI 10.1124/jpet.115.230359; Xu L, 2016, CHEM-BIOL INTERACT, V259, P282, DOI 10.1016/j.cbi.2016.08.003; Yan BC, 2013, J NEUROL SCI, V330, P111, DOI 10.1016/j.jns.2013.04.023; Yu CL, 2016, MOL NEUROBIOL, V53, P6489, DOI 10.1007/s12035-015-9555-x; Yu Y, 2018, J NEUROSCI, V38, P8345, DOI 10.1523/JNEUROSCI.0128-18.2018; Zhang YX, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1374-y; Zhao JX, 2013, J TRADIT CHIN MED, V33, P253, DOI 10.1016/S0254-6272(13)60135-1	45	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2020	15	5							e0228825	10.1371/journal.pone.0228825	http://dx.doi.org/10.1371/journal.pone.0228825			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1WS	32470970	Green Published, Green Submitted, gold			2022-12-26	WOS:000537552800012
J	Fadel, L; Reho, B; Volko, J; Bojcsuk, D; Kolostyak, Z; Nagy, G; Muller, G; Simandi, Z; Hegedus, E; Szabo, G; Toth, K; Nagy, L; Vamosi, G				Fadel, Lina; Reho, Balint; Volko, Julianna; Bojcsuk, Dora; Kolostyak, Zsuzsanna; Nagy, Gergely; Mueller, Gabriele; Simandi, Zoltan; Hegedus, Eva; Szabo, Gabor; Toth, Katalin; Nagy, Laszlo; Vamosi, Gyorgy			Agonist binding directs dynamic competition among nuclear receptors for heterodimerization with retinoid X receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear receptors; nuclear transport; heterodimerization; retinoic acid receptor (RAR); retinoid X receptor (RXR); peroxisome proliferator?activated receptor (PPAR); vitamin D receptor (VDR); transcription factor; confocal microscopy; nuclear receptor; dimerization; retinoid; vitamin D; transcription regulation; ChIP sequencing (ChIP-seq)	VITAMIN-D-RECEPTOR; LOCALIZATION SIGNAL; DNA-BINDING; PPAR-GAMMA; LIGAND; REVEALS; DIMERIZATION; MECHANISMS; PROTEIN; CELLS	Retinoid X receptor (RXR) plays a pivotal role as a transcriptional regulator and serves as an obligatory heterodimerization partner for at least 20 other nuclear receptors (NRs). Given a potentially limiting/sequestered pool of RXR and simultaneous expression of several RXR partners, we hypothesized that NRs compete for binding to RXR and that this competition is directed by specific agonist treatment. Here, we tested this hypothesis on three NRs: peroxisome proliferator-activated receptor gamma (PPAR?), vitamin D receptor (VDR), and retinoic acid receptor alpha (RAR?). The evaluation of competition relied on a nuclear translocation assay applied in a three-color imaging model system by detecting changes in heterodimerization between RXR? and one of its partners (NR1) in the presence of another competing partner (NR2). Our results indicated dynamic competition between the NRs governed by two mechanisms. First, in the absence of agonist treatment, there is a hierarchy of affinities between RXR? and its partners in the following order: RAR? > PPAR? > VDR. Second, upon agonist treatment, RXR? favors the liganded partner. We conclude that recruiting RXR? by the liganded NR not only facilitates a stimulus-specific cellular response but also might impede other NR pathways involving RXR?.	[Fadel, Lina; Reho, Balint; Volko, Julianna; Hegedus, Eva; Szabo, Gabor; Vamosi, Gyorgy] Univ Debrecen, Fac Med, Doctoral Sch Mol Med, Dept Biophys & Cell Biol, Debrecen, Hungary; [Bojcsuk, Dora; Kolostyak, Zsuzsanna; Nagy, Gergely; Simandi, Zoltan; Nagy, Laszlo] Univ Debrecen, Fac Med, Doctoral Sch Mol Cell & Immune Biol, Dept Biochem & Mol Biol, Debrecen, Hungary; [Mueller, Gabriele; Toth, Katalin] German Canc Res Ctr, Biophys Macromol, Heidelberg, Germany; [Nagy, Laszlo] Johns Hopkins Univ, Sch Med, Dept Med & Biol Chem, Inst Fundamental Biomed Res,Johns Hopkins All Chi, St Petersburg, FL 33701 USA	University of Debrecen; University of Debrecen; Helmholtz Association; German Cancer Research Center (DKFZ); Johns Hopkins University	Vamosi, G (corresponding author), Univ Debrecen, Fac Med, Doctoral Sch Mol Med, Dept Biophys & Cell Biol, Debrecen, Hungary.; Nagy, L (corresponding author), Univ Debrecen, Fac Med, Doctoral Sch Mol Cell & Immune Biol, Dept Biochem & Mol Biol, Debrecen, Hungary.; Nagy, L (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med & Biol Chem, Inst Fundamental Biomed Res,Johns Hopkins All Chi, St Petersburg, FL 33701 USA.	lnagy@jhmi.edu; vamosig@med.unideb.hu	SIMANDI, Zoltan/A-9619-2012; Nagy, Gergely/F-7670-2017	SIMANDI, Zoltan/0000-0001-8894-1259; FADEL, LINA/0000-0002-4980-542X; Nagy, Gergely/0000-0002-3273-731X	Stipendium Hungaricum Scholarship by the Tempus Public Foundation [273478]; Marie Curie Initial Training Networks (ITN) [NR-NET FP7-PEOPLE-2013-ITN-606806]; National Research, Development, and Innovation Office [NN129371, KKP129909, K124298, GINOP-2.3.2-15-2016-00026, GINOP-2.3.3-15-2016-00003]; German Academic Exchange Service; Tempus Public Foundation [273478]	Stipendium Hungaricum Scholarship by the Tempus Public Foundation; Marie Curie Initial Training Networks (ITN); National Research, Development, and Innovation Office; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Tempus Public Foundation	This work was supported by the Stipendium Hungaricum Scholarship by the Tempus Public Foundation (to L. F.), NR-NET FP7-PEOPLE-2013-ITN-606806 Marie Curie Initial Training Networks (ITN) (to L. N. and L. F.), the National Research, Development, and Innovation Office grants NN129371, KKP129909, K124298, GINOP-2.3.2-15-2016-00026, and GINOP-2.3.3-15-2016-00003 (to G. V. and L. N.), the German Academic Exchange Service, and the Tempus Public Foundation no. 273478 (to G. V. and K. T).	Alaynick WA, 2008, MITOCHONDRION, V8, P329, DOI 10.1016/j.mito.2008.02.001; Alimirah F, 2012, EXP CELL RES, V318, P2490, DOI 10.1016/j.yexcr.2012.07.020; Barik S, 1993, Methods Mol Biol, V15, P277, DOI 10.1385/0-89603-244-2:277; Brazda P, 2014, MOL CELL BIOL, V34, P1234, DOI 10.1128/MCB.01097-13; Brazda P, 2011, J CELL SCI, V124, P3631, DOI 10.1242/jcs.086082; Burris TP, 2013, PHARMACOL REV, V65, P710, DOI 10.1124/pr.112.006833; Chan LSA, 2009, PPAR RES, V2009, DOI 10.1155/2009/925309; Chatagnon A, 2015, NUCLEIC ACIDS RES, V43, P4833, DOI 10.1093/nar/gkv370; Chen Y, 2003, P NATL ACAD SCI USA, V100, P15492, DOI 10.1073/pnas.2533045100; Chen ZP, 1998, J MOL BIOL, V275, P55, DOI 10.1006/jmbi.1997.1413; Daniel B, 2018, IMMUNITY, V49, P615, DOI 10.1016/j.immuni.2018.09.005; Dash AK, 2017, EXP CELL RES, V360, P337, DOI 10.1016/j.yexcr.2017.09.024; Dawson MI, 2012, BBA-MOL CELL BIOL L, V1821, P21, DOI 10.1016/j.bbalip.2011.09.014; Dong D, 1998, BIOCHEMISTRY-US, V37, P10691, DOI 10.1021/bi980561r; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Feige JN, 2005, J BIOL CHEM, V280, P17880, DOI 10.1074/jbc.M500786200; Georgiadi A, 2012, ADV NUTR, V3, P127, DOI 10.3945/an.111.001602; Giner XC, 2015, FASEB J, V29, P4256, DOI 10.1096/fj.14-259804; Gocek Elzbieta, 2012, Leuk Res Treatment, V2012, P713243, DOI 10.1155/2012/713243; Gonnord P, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aal1253; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; GUIOCHONMANTEL A, 1991, EMBO J, V10, P3851, DOI 10.1002/j.1460-2075.1991.tb04954.x; Hanel A, 2020, J MOL ENDOCRINOL, V64, pR45, DOI 10.1530/JME-19-0246; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hendrix J, 2011, NUCLEIC ACIDS RES, V39, P1310, DOI 10.1093/nar/gkq933; Huang PX, 2010, ANNU REV PHYSIOL, V72, P247, DOI 10.1146/annurev-physiol-021909-135917; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Hunter J, 1996, MOL CELL ENDOCRINOL, V116, P213, DOI 10.1016/0303-7207(95)03717-9; Ide T, 2003, MOL ENDOCRINOL, V17, P1255, DOI 10.1210/me.2002-0191; Jankevics H, 2005, BIOCHEMISTRY-US, V44, P11676, DOI 10.1021/bi050744v; Johansson S, 2001, J BONE MINER RES, V16, P1899, DOI 10.1359/jbmr.2001.16.10.1899; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Khorasanizadeh S, 2001, TRENDS BIOCHEM SCI, V26, P384, DOI 10.1016/S0968-0004(01)01800-X; Kumar S, 2006, MOL CELL ENDOCRINOL, V246, P147, DOI 10.1016/j.mce.2005.11.028; le Maire A, 2012, CURR TOP MED CHEM, V12, P505, DOI 10.2174/156802612799436687; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lionnet T, 2010, COLD SH Q B, V75, P113, DOI 10.1101/sqb.2010.75.057; Maruvada P, 2003, J BIOL CHEM, V278, P12425, DOI 10.1074/jbc.M202752200; Michigami T, 1999, J BIOL CHEM, V274, P33531, DOI 10.1074/jbc.274.47.33531; Mikuni S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091855; Nagy L, 2004, TRENDS BIOCHEM SCI, V29, P317, DOI 10.1016/j.tibs.2004.04.006; Neema S, 2015, PEDIATR DERMATOL, V32, pE151, DOI 10.1111/pde.12614; Nielsen R, 2014, METHOD ENZYMOL, V537, P261, DOI 10.1016/B978-0-12-411619-1.00014-8; Pawlak M, 2012, CURR TOP MED CHEM, V12, P486, DOI 10.2174/156802612799436641; Philippe L, 2020, P NATL ACAD SCI USA, V117, P5319, DOI 10.1073/pnas.1912864117; Prufer K, 2002, MOL ENDOCRINOL, V16, P1738, DOI 10.1210/me.2001-0345; Prufer K, 2000, J BIOL CHEM, V275, P41114, DOI 10.1074/jbc.M003791200; Rastinejad F, 2000, EMBO J, V19, P1045, DOI 10.1093/emboj/19.5.1045; Reho B, 2020, ANAL CHEM, V92, P2207, DOI 10.1021/acs.analchem.9b04902; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Savatier J, 2010, BIOCHEMISTRY-US, V49, P772, DOI 10.1021/bi9013006; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; Shulman AI, 2005, NEW ENGL J MED, V353, P604, DOI 10.1056/NEJMra043590; Simandi Z, 2018, MOL CELL ENDOCRINOL, V471, P51, DOI 10.1016/j.mce.2017.07.033; Sinha S, 2018, ADV APPL MICROBIOL, V103, P103, DOI 10.1016/bs.aambs.2018.01.005; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tyagi RK, 1998, MOL ENDOCRINOL, V12, P1684, DOI 10.1210/me.12.11.1684; Vamosi G, 2004, P NATL ACAD SCI USA, V101, P11082, DOI 10.1073/pnas.0403916101; Vamosi G, 2008, BIOPHYS J, V94, P2859, DOI 10.1529/biophysj.107.120766; van Royen ME, 2013, CYTOM PART A, V83, P806, DOI 10.1002/cyto.a.22284; Vivat-Hannah V, 2003, MOL CELL BIOL, V23, P7678, DOI 10.1128/MCB.23.21.7678-7688.2003; Wagstaff KM, 2009, TRAFFIC, V10, P1188, DOI 10.1111/j.1600-0854.2009.00937.x; Wang B, 2018, NAT REV ENDOCRINOL, V14, P452, DOI 10.1038/s41574-018-0037-x; WELSHONS WV, 1988, MOL CELL ENDOCRINOL, V57, P169, DOI 10.1016/0303-7207(88)90072-X; Wood RJ, 2008, NUTR REV, V66, P40, DOI 10.1111/j.1753-4887.2007.00004.x; Yasmin R, 2005, J BIOL CHEM, V280, P40152, DOI 10.1074/jbc.M507708200; Zhao CY, 2010, J ENDOCRINOL, V204, P233, DOI 10.1677/JOE-09-0271	68	14	14	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2020	295	29					10045	10061		10.1074/jbc.RA119.011614	http://dx.doi.org/10.1074/jbc.RA119.011614			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MR1DY	32513869	hybrid, Green Published			2022-12-26	WOS:000553333300022
J	Hargrove, TY; Wawrzak, Z; Guengerich, FP; Lepesheva, GI				Hargrove, Tatiana Y.; Wawrzak, Zdzislaw; Guengerich, F. Peter; Lepesheva, Galina, I			A requirement for an active proton delivery network supports a compound I-mediated C?C bond cleavage in CYP51 catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome P450; enzyme mechanism; enzyme catalysis; X-ray crystallography; conformational change; C?C bond cleavage; compound I; CYP51; sterol 14?-demethylase; sterol biosynthesis; proton relay; cytochrome P450 mechanism; X-ray structure; deformylation; hydroxylation; structural biology; proton relay	STEROL 14-ALPHA-DEMETHYLASE; STRUCTURAL BASIS; PEROXO-IRON; CYTOCHROME-P450; MECHANISM; OXYGEN; HYDROXYLATION; ALANINE; AROMATIZATION; BIOSYNTHESIS	CYP51 enzymes (sterol 14?-demethylases) are cytochromes P450 that catalyze multistep reactions. The CYP51 reaction occurs in all biological kingdoms and is essential in sterol biosynthesis. It removes the 14?-methyl group from cyclized sterol precursors by first forming an alcohol, then an aldehyde, and finally eliminating formic acid with the introduction of a ?14?15 double bond in the sterol core. The first two steps are typical hydroxylations, mediated by an electrophilic compound I mechanism. The third step, C?C bond cleavage, has been proposed to involve either compound I (i.e.FeO3+) or, alternatively, a proton transfer-independent nucleophilic ferric peroxo anion (compound 0,i.e.(Fe3+O2?)). Here, using comparative crystallographic and biochemical analyses of WT human CYP51 (CYP51A1) and its D231A/H314A mutant, whose proton delivery network is destroyed (as evidenced in a 1.98-? X-ray structure in complex with lanosterol), we demonstrate that deformylation of the 14?-carboxaldehyde intermediate requires an active proton relay network to drive the catalysis. These results indicate a unified, compound I-based mechanism for all three steps of the CYP51 reaction, as previously established for CYP11A1 and CYP19A1. We anticipate that our approach can be applied to mechanistic studies of other P450s that catalyze multistep reactions, such as C?C bond cleavage.	[Hargrove, Tatiana Y.; Guengerich, F. Peter; Lepesheva, Galina, I] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Wawrzak, Zdzislaw] Northwestern Univ, Synchrotron Res Ctr, Life Sci Collaborat Access Team, Argonne, IL USA; [Lepesheva, Galina, I] Vanderbilt Univ, Ctr Struct Biol, 221 Kirkland Hall, Nashville, TN 37235 USA	Vanderbilt University; Northwestern University; Vanderbilt University	Lepesheva, GI (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA.; Lepesheva, GI (corresponding author), Vanderbilt Univ, Ctr Struct Biol, 221 Kirkland Hall, Nashville, TN 37235 USA.	galina.i.lepesheva@vanderbilt.edu			National Institutes of Health [R01 GM067871, R01 GM118122]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The study was supported by National Institutes of Health grants R01 GM067871 (G. I. L.) and R01 GM118122 (F. P. G.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AKHTAR M, 1976, J CHEM SOC CHEM COMM, P854, DOI 10.1039/c39760000854; AKHTAR M, 1994, BIOCHEMISTRY-US, V33, P4410, DOI 10.1021/bi00180a039; AKHTAR M, 1982, BIOCHEM J, V201, P569, DOI 10.1042/bj2010569; CASPI E, 1986, J AM CHEM SOC, V108, P1847, DOI 10.1021/ja00268a023; Davydov R, 2015, BIOCHEMISTRY-US, V54, P7089, DOI 10.1021/acs.biochem.5b00903; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Follmer AH, 2019, J AM CHEM SOC, V141, P2678, DOI 10.1021/jacs.8b13079; Friggeri L, 2019, J MED CHEM, V62, P10391, DOI 10.1021/acs.jmedchem.9b01485; Gonzalez E, 2018, J BIOL CHEM, V293, P541, DOI 10.1074/jbc.RA117.000504; Gregory MC, 2013, J AM CHEM SOC, V135, P16245, DOI 10.1021/ja4086403; Guengerich FP, 2018, CHEM REV, V118, P6573, DOI 10.1021/acs.chemrev.8b00031; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; Hargrove TY, 2018, J BIOL CHEM, V293, P19344, DOI 10.1074/jbc.RA118.005850; Hargrove TY, 2016, J LIPID RES, V57, P1552, DOI 10.1194/jlr.M069229; IMAI M, 1989, P NATL ACAD SCI USA, V86, P7823, DOI 10.1073/pnas.86.20.7823; Khatri Y, 2014, FEBS LETT, V588, P3117, DOI 10.1016/j.febslet.2014.06.050; Lepesheva GI, 2007, BBA-GEN SUBJECTS, V1770, P467, DOI 10.1016/j.bbagen.2006.07.018; Lepesheva GI, 2018, PARASITOLOGY, V145, P1820, DOI 10.1017/S0031182018000562; Lepesheva GI, 2011, BBA-PROTEINS PROTEOM, V1814, P88, DOI 10.1016/j.bbapap.2010.06.006; Lepesheva GI, 2004, BIOCHEMISTRY-US, V43, P10789, DOI 10.1021/bi048967t; Lepesheva GI, 1999, BBA-PROTEIN STRUCT M, V1434, P31, DOI 10.1016/S0167-4838(99)00156-9; Mak PJ, 2018, J AM CHEM SOC, V140, P7324, DOI 10.1021/jacs.8b03901; Mak PJ, 2015, P NATL ACAD SCI USA, V112, P15856, DOI 10.1073/pnas.1519376113; Mak PJ, 2014, J AM CHEM SOC, V136, P4825, DOI 10.1021/ja500054c; MARTINIS SA, 1989, J AM CHEM SOC, V111, P9252, DOI 10.1021/ja00208a031; Newcomb M, 2003, J AM CHEM SOC, V125, P6064, DOI 10.1021/ja0343858; Ogliaro F, 2002, J AM CHEM SOC, V124, P2806, DOI 10.1021/ja0171963; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; Sen K, 2010, J AM CHEM SOC, V132, P10293, DOI 10.1021/ja906192b; Sen K, 2009, J PHYS CHEM B, V113, P8170, DOI 10.1021/jp902932p; Shyadehi AZ, 1996, J BIOL CHEM, V271, P12445, DOI 10.1074/jbc.271.21.12445; Tripathi S, 2013, SCIENCE, V340, P1227, DOI 10.1126/science.1235797; Vaz ADN, 1996, P NATL ACAD SCI USA, V93, P4644, DOI 10.1073/pnas.93.10.4644; Vidakovic M, 1998, BIOCHEMISTRY-US, V37, P9211, DOI 10.1021/bi980189f; Wang JB, 2020, J AM CHEM SOC, V142, P2068, DOI 10.1021/jacs.9b13061; Yoshimoto FK, 2016, J AM CHEM SOC, V138, P12124, DOI 10.1021/jacs.6b04437; Yoshimoto FK, 2016, J BIOL CHEM, V291, P17143, DOI 10.1074/jbc.M116.732966; Yoshimoto FK, 2014, J AM CHEM SOC, V136, P15016, DOI 10.1021/ja508185d; Zhu QH, 2017, BIOCHEMISTRY-US, V56, P5786, DOI 10.1021/acs.biochem.7b00766	41	11	11	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2020	295	29					9998	10007		10.1074/jbc.RA120.014064	http://dx.doi.org/10.1074/jbc.RA120.014064			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MR1DY	32493730	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000553333300018
J	Pires, S; Alves, J; Dia, I; Gomez, LF				Pires, Silvia; Alves, Joana; Dia, Ibrahima; Gomez, Lara F.			Susceptibility of mosquito vectors of the city of Praia, Cabo Verde, to Temephos andBacillus thuringiensisvarisraelensis	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS-ISRAELENSIS; PIPIENS-QUINQUEFASCIATUS DIPTERA; AEGYPTI L. DIPTERA; WEST-NILE-VIRUS; CULEX-PIPIENS; AEDES-AEGYPTI; INSECTICIDE RESISTANCE; FIELD POPULATIONS; CAPE-VERDE; MICROBIAL LARVICIDES	Many vector-borne diseases circulate in the Republic of Cabo Verde. These include malaria during the colonization of the archipelago by the Portuguese explorers and several arboviruses such as yellow fever (now eradicated), dengue and zika. To control these vector-borne diseases, an integrated vector control program was implemented. The main targeted mosquito vectors areAedes aegyptiandAnopheles arabiensis, and in a lesser extent the potential arbovirus vectorCulex pipienss.l. The main control strategy is focused on mosquito aquatic stages using diesel oil and Temephos. This latter has been applied in Cabo Verde since 1979. Its continuous use was followed by the emergence of resistance in mosquito populations. We investigated the current susceptibility to Temephos of the three potential mosquito vectors of Cabo Verde through bioassays tests. Our results showed various degrees of susceptibility with 24h post-exposure mortality rates ranging from 43.1% to 90.9% using WHO diagnostic doses. A full susceptibility was however observed withBacillus thurigiensisvarisraelensiswith mortality rates from 99.6% to 100%.	[Pires, Silvia; Gomez, Lara F.] Univ Jean Piaget Cabo Verde, Unidade Ciencias Nat Vida & Ambiente, Praia, Cape Verde; [Alves, Joana] Minist Saude, Inst Nacl Saude Publ, Praia, Cape Verde; [Dia, Ibrahima] Inst Pasteur, Unite Entomol Med, Dakar, Senegal	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar	Gomez, LF (corresponding author), Univ Jean Piaget Cabo Verde, Unidade Ciencias Nat Vida & Ambiente, Praia, Cape Verde.	lara.ferrero.gomez@gmail.com	Alves, Joana/GXF-4738-2022	Ferrero Gomez, Maria Lara/0000-0001-8166-3663				Abai MR, 2016, J ARTHROPOD-BORNE DI, V10, P510; Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Afrane YA, 2004, ACTA TROP, V89, P125, DOI 10.1016/j.actatropica.2003.06.001; Alsheikh Adel A, 2016, J Egypt Soc Parasitol, V46, P209; Alves JB, THESIS; Alves J, 2010, J VECTOR ECOL, V35, P307, DOI 10.1111/j.1948-7134.2010.00087.x; Alves J, 2010, BLOOD CELL MOL DIS, V44, P62, DOI 10.1016/j.bcmd.2009.09.008; Amraoui F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036757; [Anonymous], 2008, MEDWAVE, V8, pe1717, DOI 10.5867/medwave.2008.09.1717; Antonio-Nkondjio C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-154; Araujo AP, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-297; Diniz DFA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1276-5; Arslan A, 2016, J VECTOR DIS, V53, P136; Azrag RS, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2350-1; Barbosa RMR, 2010, J MED ENTOMOL, V47, P345, DOI 10.1603/ME09241; Ben Cheikh H, 1998, J MED ENTOMOL, V35, P251, DOI 10.1093/jmedent/35.3.251; BENCHEIKH H, 1993, J AM MOSQUITO CONTR, V9, P335; Beserra EB, 2007, NEOTROP ENTOMOL, V36, P303, DOI 10.1590/S1519-566X2007000200019; Bourguet D, 1996, J ECON ENTOMOL, V89, P1060, DOI 10.1093/jee/89.5.1060; Braga IA, 2004, MEM I OSWALDO CRUZ, V99, P199, DOI 10.1590/S0074-02762004000200015; Cambournac F. J. C., 1984, Anais do Instituto de Higiene e Medicina Tropical, V10, P23; CAMBOURNAC F J C, 1982, Parassitologia (Rome), V24, P265; Chandre F, 1997, J MED ENTOMOL, V34, P664, DOI 10.1093/jmedent/34.6.664; Chediak M, 2016, MEM I OSWALDO CRUZ, V111, P311, DOI 10.1590/0074-02760150409; Consoli R.A.G.B., 1994, PRINCIPAIS MOSQUITOS, DOI [DOI 10.7476/9788575412909, 10.7476/9788575412909]; Cruz DN, 2015, THESIS; da Cruz DL, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2757-3; Dambach P, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-371; David JP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-174; Diniz MMCDL, 2014, REV SAUDE PUBL, V48, P775, DOI 10.1590/S0034-8910.2014048004649; DePina AJ, 2019, TROP MED HEALTH, V47, DOI 10.1186/s41182-018-0127-4; Djenontin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087934; El Ouali Lalami A, 2014, Bull Soc Pathol Exot, V107, P194, DOI 10.1007/s13149-014-0361-x; FAILLOUX AB, 1994, J MED ENTOMOL, V31, P639, DOI 10.1093/jmedent/31.5.639; Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013; da Moura AJF, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0706-8; Fillinger U, 2009, B WORLD HEALTH ORGAN, V87, P655, DOI 10.2471/BLT.08.055632; Franco A, 1955, LISBOA ANN I MED TRO, V12, P369; Franco L, 2010, EUROSURVEILLANCE, V15, P5; Garelli Fernando M, 2011, PLoS Negl Trop Dis, V5, pe991, DOI 10.1371/journal.pntd.0000991; Goindin D, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0254-x; Gomes A.deC., 1998, INF EPIDEMIOL GICO S, V7, P49, DOI [10.5123/s0104-16731998000300006, DOI 10.5123/S0104-16731998000300006]; Gomez LF, 2015, 14 CURSO INT DENGUE; Gueye CS, 2016, MALARIA J, V15, DOI 10.1186/s12936-015-1054-z; Gunasekaran K, 2004, ACTA TROP, V92, P109, DOI 10.1016/j.actatropica.2004.04.008; Gunathilaka N, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0726-z; Hardy Margaret C, 2014, Insects, V5, P227, DOI 10.3390/insects5010227; Harwood JF, 2015, J MED ENTOMOL, V52, P663, DOI 10.1093/jme/tjv043; Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a; Huang YJS, 2017, INSECTS, V8, DOI 10.3390/insects8010021; Inforpress (Cabo Verde), 2018, INFORPRESS CABO VERD; Initial Aldemir A., 2009, J AM MOSQUITO CONTR, V25, P113, DOI [10.2987/08-5836.1, DOI 10.2987/08-5836.1]; Jaenisch Thomas, 2014, Emerg Infect Dis, V20, DOI 10.3201/eid2010.140487; Jornal da Noite (Cabo Verde), 2016, JORNAL NOITE CABO VE; Kahindi SC, 2008, J AM MOSQUITO CONTR, V24, P538, DOI 10.2987/5734.1; Kasai S, 2007, J MED ENTOMOL, V44, P822, DOI 10.1603/0022-2585(2007)44[822:IRIPVM]2.0.CO;2; Kioulos I, 2014, PEST MANAG SCI, V70, P623, DOI 10.1002/ps.3595; KROEGER A, 1995, ACTA TROP, V60, P47, DOI 10.1016/0001-706X(95)00101-J; Kulma K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058322; Le Gonidec E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004755; Li Ju-Lin, 2014, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V26, P67; Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5; Liu HQ, 2004, J MED ENTOMOL, V41, P408, DOI 10.1603/0022-2585-41.3.408; Loke SR, 2010, TROP BIOMED, V27, P493; Majambere S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-76; Melo-Santos MAV, 2010, ACTA TROP, V113, P180, DOI 10.1016/j.actatropica.2009.10.015; Menéndez Díaz Zulema, 2012, Rev Cubana Med Trop, V64, P324; Ministerio da Saude (Cabo Verde), 2007, POL NAC SAUD CAB VER; Ministerio da Saude (Cabo Verde), 2015, MAN LUT INT VET; Ministerio da Saude (Cabo Verde), 2011, REL EST 2010; Ministerio da Saude (Cabo Verde), 2009, PLAN ESTR PREEL PAL; Ministerio da Saude e da Seguranca Social (Cabo Verde), 2016, INF VIR ZIK ZIKV AN; Ministerio da Saude e da Seguranca Social (Cabo Verde), 2017, B INF EV CAS PAL CAB; Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625; Nartey R, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-116; PATTERSON KD, 1988, INT J AFR HIST STUD, V21, P291, DOI 10.2307/219938; Pocquet N, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-299; Ponlawat A, 2005, J MED ENTOMOL, V42, P821, DOI 10.1603/0022-2585(2005)042[0821:ISOAAA]2.0.CO;2; Pruszynski CA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170079; RAYMOND M, 1994, J EVOLUTION BIOL, V7, P315, DOI 10.1046/j.1420-9101.1994.7030315.x; Reid MC, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1162-4; Ribeiro H, 1980, MOSQUITOS CABO VERDE, P141; Rocha HDR, 2015, ACTA TROP, V152, P66, DOI 10.1016/j.actatropica.2015.08.013; Ridde V, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0120-2; Rubert A, 2016, MED SANTE TROP, V26, P423, DOI 10.1684/mst.2016.0634; Russell TL, 2003, J ECON ENTOMOL, V96, P1786, DOI 10.1603/0022-0493-96.6.1786; Rydzanicz K, 2010, J AM MOSQUITO CONTR, V26, P295, DOI 10.2987/09-5980.1; s NA, 2018, LANCET INFECT DIS, V18, pe228; Sant'Anna JF, 1920, ANOFELINEOS PORTUGAL, V4, P78; Santiago Magazine (Cabo Verde), 2017, SANTIAGO MAGAZI 0830; Santos ME, 2007, HIST CONCISA CABO VE; Setha T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004973; Sharma SK, 2008, J AM MOSQUITO CONTR, V24, P410, DOI 10.2987/5704.1; Shililu JI, 2003, J AM MOSQUITO CONTR, V19, P251; Simonsen PE, 2013, PARASITOL RES, V112, P35, DOI 10.1007/s00436-012-3226-x; Sivan A, 2015, PARASITOL RES, V114, P4693, DOI 10.1007/s00436-015-4717-3; Skovmand O, 1999, J MED ENTOMOL, V36, P62, DOI 10.1093/jmedent/36.1.62; Snow RW, 2012, ADV PARASIT, V78, P169, DOI 10.1016/B978-0-12-394303-3.00010-4; Strode C, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044578, 10.1371/journal.pone.0039439]; Suter T, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2364-5; Tchicaya ES, 2009, J AM MOSQUITO CONTR, V25, P382, DOI 10.2987/08-5809.1; Thomas MB, 2018, BIOCONTROL, V63, P61, DOI 10.1007/s10526-017-9815-y; To Setha, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P261; Toma L, 2011, PEST MANAG SCI, V67, P100, DOI 10.1002/ps.2039; Townson H, 2005, B WORLD HEALTH ORGAN, V83, P942; Vasquez MI, 2009, J MED ENTOMOL, V46, P881, DOI 10.1603/033.046.0421; Vazeille M, 2013, VECTOR-BORNE ZOONOT, V13, P37, DOI 10.1089/vbz.2012.0982; Vythilingan I., 2016, MOSQUITOES PUBLIC HL; Weaver SC, 2013, TRENDS MICROBIOL, V21, P360, DOI 10.1016/j.tim.2013.03.003; Weill M, 2001, J AM MOSQUITO CONTR, V17, P238; WHO, 2005, GUID LAB FIELD TEST; WHO, 2017, VECT BORN DIS FACT S; WHO, 2009, DENG FEV CAP VERD CI; Wirth MC, 1999, J AM MOSQUITO CONTR, V15, P315; Yap HH, 2002, J AM MOSQUITO CONTR, V18, P52; YEBAKIMA A, 1995, J MED ENTOMOL, V32, P77, DOI 10.1093/jmedent/32.2.77; Yebakima A, 2004, J MED ENTOMOL, V41, P718, DOI 10.1603/0022-2585-41.4.718; Zayed ABB, 2006, J AM MOSQUITO CONTR, V22, P473, DOI 10.2987/8756-971X(2006)22[473:UOBAMA]2.0.CO;2; Zhakhongirov Sh. M., 2004, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, P28; Zhang Q, 2017, INSECT SCI, V24, P714, DOI 10.1111/1744-7917.12401; 2019, NEW DISTRICTS, V20, P1	122	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2020	15	6							e0234242	10.1371/journal.pone.0234242	http://dx.doi.org/10.1371/journal.pone.0234242			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC0EC	32520941	Green Published, gold			2022-12-26	WOS:000542969500039
J	Ali, L; Grey, E; Singh, D; Mohammed, A; Tripathi, V; Gobin, J; Ramnarine, I				Ali, Lauren; Grey, Elisabeth; Singh, Delezia; Mohammed, Azad; Tripathi, Vrijesh; Gobin, Judith; Ramnarine, Indar			An evaluation of the public's Knowledge, Attitudes and Practices (KAP) in Trinidad and Tobago regarding sharks and shark consumption	PLOS ONE			English	Article							HEAVY-METALS; CONSERVATION; PERCEPTIONS; FISHERIES	There is a global lack of data concerning shark consumption trends, consumer attitudes, and public knowledge regarding sharks. This is the case in Trinidad and Tobago, where shark is a popular culinary delicacy. A Knowledge, Attitudes, and Practices (KAP) survey was conducted in Trinidad and Tobago. Six hundred and seven questionnaires were administered. Univariate and stepwise multivariate logistic regressions were performed to test the association between KAP and demographic categories. The response rate was 93.4% with 567 questionnaires returned (473 from Trinidad and 94 from Tobago). Two hundred and seventeen (38.3%) participants were knowledgeable, 422 (74.4%) displayed attitudes in favour of shark conservation and sustainable use, and 270 (47.6%) displayed practices promoting shark conservation and sustainable use. Island (AOR = 2.81, CI = 1.78, 4.46) and tertiary education (AOR = 2.31, CI = 1.20, 4.46) significantly influenced knowledge level. Gender (AOR = 1.50, CI = 1.02, 2.20) and island (AOR = 0.56, CI = 0.35, 0.90) significantly influenced attitude. Gender (COR = 1.59, CI = 1.14, 2.22) was significantly associated with practices. Over 70% of respondents ate shark, and 54.7% ate shark infrequently enough to avoid risks from heavy metal toxicity. Our results may be useful to develop public awareness and practice improvement initiatives in order to improve KAP regarding shark meat consumption.	[Ali, Lauren; Singh, Delezia; Mohammed, Azad; Gobin, Judith; Ramnarine, Indar] Univ West Indies, Fac Sci & Technol, Dept Life Sci, St Augustine, Trinidad Tobago; [Grey, Elisabeth] Univ West Indies, Fac Sci & Technol, Dept Chem, St Augustine, Trinidad Tobago; [Tripathi, Vrijesh] Univ West Indies, Fac Sci & Technol, Dept Math & Stat, St Augustine, Trinidad Tobago	University West Indies Mona Jamaica; University West Indies Saint Augustine; University West Indies Mona Jamaica; University West Indies Saint Augustine; University West Indies Mona Jamaica; University West Indies Saint Augustine	Ali, L (corresponding author), Univ West Indies, Fac Sci & Technol, Dept Life Sci, St Augustine, Trinidad Tobago.	lauren.cv.ali@gmail.com	; Singh, Delezia/I-5231-2016	Tripathi, V/0000-0003-4212-2658; Ali, Lauren/0000-0003-1581-9126; Singh, Delezia/0000-0001-5318-8711				Acuna-Marrero D, 2018, MAR POLICY, V91, P122, DOI 10.1016/j.marpol.2018.02.018; Adam G, 2016, MARINE POLLUTION B; Ahmad NI, 2016, FOOD NUTR RES, V60, DOI 10.3402/fnr.v60.32697; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2014, J MODERN POWER SYSTE, V2, P272; [Anonymous], 2013, PRINCIPLES PRIDE SCI; [Anonymous], 2003, BRIT MED B, V68, P167; [Anonymous], 2014, MOSAIC; [Anonymous], 2014, DIABETOL KLIN SA, V3, pA1; Browne-Nunez C., 2008, Human Dimensions of Wildlife, V13, P47, DOI 10.1080/10871200701812936; Castro-Gonzalez MI, 2008, ENVIRON TOXICOL PHAR, V26, P263, DOI 10.1016/j.etap.2008.06.001; Chan A, 2006, SHARK FISHERIES TRIN, P205; Clarke S, 2004, FISH FISH, V5, P53, DOI 10.1111/j.1467-2960.2004.00137.x; Clarke S, 2008, AQUAT LIVING RESOUR, V21, P373, DOI 10.1051/alr:2008060; DAVIDSON AR, 1985, J PERS SOC PSYCHOL, V49, P1184, DOI 10.1037/0022-3514.49.5.1184; De Beer J, 2012, LEG ISS ECON INTEGR, V39, P51; Dent F, 2015, 590 FAO, V2015, pI; Drymon JM, 2017, MAR POLICY, V81, P153, DOI 10.1016/j.marpol.2017.03.001; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; Ferraro PJ, 2001, CONSERV BIOL, V15, P990, DOI 10.1046/j.1523-1739.2001.015004990.x; Fishermen Investment Trust, 2013, SFFAO201330 FISH INV; Giglio VJ, 2018, MAR POLICY, V89, P142, DOI 10.1016/j.marpol.2017.12.020; Jacobson S.K., 2009, COMMUNICATION SKILLS; Jones S, 2018, ECCB2018 5 EUR C CON; Kalogeropoulos N, 2012, FOOD CHEM TOXICOL, V50, P3702, DOI 10.1016/j.fct.2012.07.012; Kassahun CW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170040; Kollmuss A., 2002, ENVIRON EDUC RES, V8, P239, DOI [10.1080/1350462022014540, DOI 10.1080/1350462022014540, 10.1080/13504620220145401, DOI 10.1080/13504620220145401]; Manika D, 2019, STUD HIGH EDUC, V44, P1691, DOI 10.1080/03075079.2018.1474456; Marcus RR, 2001, HUM ECOL, V29, P381, DOI 10.1023/A:1013189720278; Ministry of Health and Long- Term Care Ontario, 2004, CANADA COMMUNICABLE, V15, P117; Ministry of Planning and Sustainable Development Central Statistical Office, 2012, THE NOTICE ON ISSUIN, P5; Mohammed A, 2017, MAR POLLUT BULL, V119, P214, DOI 10.1016/j.marpolbul.2017.04.025; Myrick JG, 2014, SCI COMMUN, V36, P544, DOI 10.1177/1075547014547159; Neupane P.A, 2010, THESIS; O'Donnell K, 2019, THESIS; Otto S, 2017, GLOBAL ENVIRON CHANG, V47, P88, DOI 10.1016/j.gloenvcha.2017.09.009; Parimi Neeta, 2004, BMC Fam Pract, V5, P28, DOI 10.1186/1471-2296-5-28; Pepin-Neff C, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12407; Sabbagh SM, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12010040; Siegel L, 2018, AUST J ENVIRON EDUC, V34, P189, DOI 10.1017/aee.2018.32; Smith S, 1976, CULTURE NATALITY FAM; Soga M, 2016, FRONT ECOL ENVIRON, V14, P94, DOI 10.1002/fee.1225; Southgate HED, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00371; Stycos JM, WFS SCI REPORTS, V48; Thorndike AN, 2014, AM J PREV MED, V46, P143, DOI 10.1016/j.amepre.2013.10.002; Tsoi KH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163406; Verissimo D, 2018, SOC MARK Q, V24, P18, DOI 10.1177/1524500417734806; Vimalavathini R, 2008, INT J DIABETES DEV C, V28, P86, DOI 10.4103/0973-3930.44079; Wallace LE, 2020, PERS SOC PSYCHOL B, V46, P709, DOI 10.1177/0146167219873492; Warner L. A., 2017, Journal of Agricultural Education, V58, P313; Wood S, 2019, ADVOCACY COMMUNICATI	51	3	3	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2020	15	6							e0234499	10.1371/journal.pone.0234499	http://dx.doi.org/10.1371/journal.pone.0234499			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LZ1GC	32516322	Green Published, gold			2022-12-26	WOS:000540977000022
J	Bandy, A; Almaeen, AH				Bandy, Altaf; Almaeen, Abdulrahman Hamdan			Pathogenic spectrum of blood stream infections and resistance pattern in Gram-negative bacteria from Aljouf region of Saudi Arabia	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE; ANTIMICROBIAL RESISTANCE; ACINETOBACTER-BAUMANNII; ESCHERICHIA-COLI; BETA-LACTAMASES; MOLECULAR CHARACTERIZATION; ANTIBIOTIC-RESISTANCE; CARBAPENEM; ENTEROBACTERIACEAE; EPIDEMIOLOGY	Background The pathogenic spectrum of bloodstream infections (BSIs) varies across regions. Monitoring the pathogenic profile and antimicrobial resistance is a prerequisite for effective therapy, infection control and for strategies aimed to counter antimicrobial resistance. The pathogenic spectrum of BSIs in blood cultures was analysed, focusing on the resistance patterns of Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae, in Aljouf region. Methods This descriptive cross-sectional study analysed the culture reports of all non-duplicate blood samples collected from January 1 to December 31, 2019. Antibiograms of A. baumannii, E. coli, and K. pneumoniae were analysed for antibiotic resistance. The frequency and percentages of multi-drug, extensively-drug, pan-drug and carbapenem resistance were calculated. Results Of the 222 bloodstream infections, 62.2% and 36.4% were caused by gram-negative and gram-positive bacteria, respectively. Most BSIs occurred in patients aged >= 60 years (59.5%). Among the 103 isolates of the studied Gram-negative bacteria (GNB), 47.6%, 38.8%, and 2.9% were multi-drug, extensively drug and pan-drug resistant respectively. 46% of K. pneumoniae isolates were carbapenemase producers. Resistance to gentamycin, 1(st)-4(th) generation cephalosporins, and carbapenems was observed for A. baumannii. More than 70% of E. coli isolates were resistant to 3(rd)- and 4(th)-generation cephalosporins. Klebsiella pneumoniae presented a resistance rate of >60% to imipenems. Conclusions Gram-negative bacteria dominate BSIs, with carbapenem-resistant K. pneumoniae most frequently detected in this region. Resistant GNB infections make it challenging to treat geriatric patients. Regional variations in antimicrobial resistance should be continually monitored.	[Bandy, Altaf] Jouf Univ, Dept Family & Community Med, Coll Med, Sakaka, Saudi Arabia; [Almaeen, Abdulrahman Hamdan] Jouf Univ, Dept Pathol, Coll Med, Sakaka, Saudi Arabia	Al Jouf University; Al Jouf University	Bandy, A (corresponding author), Jouf Univ, Dept Family & Community Med, Coll Med, Sakaka, Saudi Arabia.	ahbandy@ju.edu.sa	BANDY, ALTAF/AAI-1032-2020; Bandy, Altaf/AAO-9012-2020; Almaeen, Abdulrahman/AAZ-4790-2021	Bandy, Altaf/0000-0003-4125-8094; Hamdan A. Almaeen, Abdulrahman/0000-0001-9267-2637				Abdalhamid B, 2017, J MED MICROBIOL, V66, P1286, DOI 10.1099/jmm.0.000504; Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Al-Abdely Hail M, 2017, J Infect Prev, V18, P25, DOI 10.1177/1757177416669424; Al-Agamy MH, 2018, J INFECT PUBLIC HEAL, V11, P64, DOI 10.1016/j.jiph.2017.03.010; Al-Obeid S, 2015, J CHEMOTHERAPY, V27, P156, DOI 10.1179/1973947815Y.0000000019; Al-Tawfiq Jaffar A., 2007, Journal of Infection and Chemotherapy, V13, P230, DOI 10.1007/s10156-007-0532-9; Al-Zahrani IA, 2018, SAUDI MED J, V39, P23, DOI 10.15537/smj.2018.1.21094; Alagesan Murali, 2015, Germs, V5, P65, DOI 10.11599/germs.2015.1073; Almaghrabi MK, 2018, CAN J INFECT DIS MED, V2018, DOI 10.1155/2018/9182747; Alotaibi FE, 2017, J INFECT PUBLIC HEAL, V10, P667, DOI 10.1016/j.jiph.2017.05.004; Aly MM, 2016, EUR J CLIN MICROBIOL, V35, P1759, DOI 10.1007/s10096-016-2723-8; Alyamani EJ, 2017, ANN CLIN MICROB ANTI, V16, DOI 10.1186/s12941-016-0177-6; Andrew B, 2017, INT J MICROBIOL, V2017, DOI 10.1155/2017/3183076; [Anonymous], 2017, J BONE MINER RES, V32; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; Balkhy HH, 2012, EUR J CLIN MICROBIOL, V31, P1901, DOI 10.1007/s10096-011-1519-0; Dortet L, 2012, CLIN MICROBIOL INFEC, V18, pE144, DOI 10.1111/j.1469-0691.2012.03796.x; Farah SM, 2019, SAUDI MED J, V40, P252, DOI 10.15537/smj.2019.3.23947; Gagliotti C, 2011, EUROSURVEILLANCE, V16, P20; Gopalakrishnan Ram, 2010, J Assoc Physicians India, V58 Suppl, P25; Goto M, 2013, CLIN MICROBIOL INFEC, V19, P501, DOI 10.1111/1469-0691.12195; Hassan H, 2014, J INFECT DEV COUNTR, V8, P282, DOI 10.3855/jidc.3809; Hassan MI, 2013, J INFECT DEV COUNTR, V7, P618, DOI 10.3855/jidc.2919; Hattori H, 2018, AM J INFECT CONTROL, V46, pE75, DOI 10.1016/j.ajic.2018.06.019; Huet B, 2019, INT J MULTIMED INF R, V8, P1, DOI 10.1007/s13735-019-00168-9; Hussein K, 2013, J HOSP INFECT, V83, P307, DOI 10.1016/j.jhin.2012.10.012; Ibrahim ME, 2019, CAN J INFECT DIS MED, V2019, DOI 10.1155/2019/6054694; Ibrahim ME, 2019, ANN CLIN MICROB ANTI, V18, DOI 10.1186/s12941-018-0301-x; Ibrahim Mutasim E, 2013, Oman Med J, V28, P116, DOI 10.5001/omj.2013.30; Jairoun A., 2014, ADV ENVIRON BIOL, V8, P675; Keihanian F, 2018, INFECT DRUG RESIST, V11, P1723, DOI 10.2147/IDR.S169176; Khan MA, 2016, JMID, V6, P121, DOI 10.5799/jmid.vi.328980; Khan MA, 2019, J INFECT DEV COUNTR, V13, P334, DOI 10.3855/jidc.11056; Khoja AT, 2018, SAUDI PHARM J, V26, P292, DOI 10.1016/j.jsps.2017.11.008; Kofteridis DP, 2014, J INFECT CHEMOTHER, V20, P293, DOI 10.1016/j.jiac.2013.11.007; Kreidl P, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223467; Lee H, 2018, EUROSURVEILLANCE, V23, P17, DOI 10.2807/1560-7917.ES.2018.23.42.1800047; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Maragakis LL, 2008, CLIN INFECT DIS, V46, P1254, DOI 10.1086/529198; Marie MA, 2013, MICROBIOL IMMUNOL, V57, P805, DOI 10.1111/1348-0421.12104; Musicha P, 2017, LANCET INFECT DIS, V17, P1042, DOI 10.1016/S1473-3099(17)30394-8; Ozbak HA, 2018, EPIDEMIOLOGY BLOODST; Patel J.B., 2016, M100S26 CLSI S, V40, P1; Revelas Angela, 2012, Niger Med J, V53, P59, DOI 10.4103/0300-1652.103543; Ryu S, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0373-6; Saeed W. M., 2018, African Journal of Microbiology Research, V12, P321, DOI 10.5897/ajmr2018.8836; Saeidinia A, 2016, IRAN J PARASITOL, V11, P527; Selim SA, 2013, P WORLD ACAD SCI ENG; Shrivastava S.R., 2018, J MED SOC, V32, P76, DOI [10.4103/jms.jms_25_17, DOI 10.4103/JMS.JMS_25_17]; Tzouvelekis LS, 2012, CLIN MICROBIOL REV, V25, P682, DOI 10.1128/CMR.05035-11; Uslan DZ, 2007, ARCH INTERN MED, V167, P834, DOI 10.1001/archinte.167.8.834; Yahav D, 2016, VIRULENCE, V7, P341, DOI 10.1080/21505594.2015.1132142; Zhang XL, 2015, J ANTIBIOT, V68, P115, DOI 10.1038/ja.2014.119; Zowawi HM, 2015, SCI REP-UK, V5, DOI 10.1038/srep15082; Zowawi HM, 2013, CLIN MICROBIOL REV, V26, P361, DOI 10.1128/CMR.00096-12	56	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2020	15	6							e0233704	10.1371/journal.pone.0233704	http://dx.doi.org/10.1371/journal.pone.0233704			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ1GC	32516308	gold, Green Published			2022-12-26	WOS:000540977000012
J	Boubred, F; Pauly, V; Romain, F; Fond, G; Boyer, L				Boubred, Farid; Pauly, Vanessa; Romain, Fanny; Fond, Guillaume; Boyer, Laurent			The role of neighbourhood socioeconomic status in large for gestational age	PLOS ONE			English	Article							HEALTH-CARE; PREPREGNANCY OBESITY; BIRTH OUTCOMES; INCREASED RISK; MATERNAL AGE; FETAL-GROWTH; WEIGHT-GAIN; PREGNANCY; ASSOCIATION; POPULATION	Objective To determine whether neighbourhood socioeconomic status (SES) was associated with large for gestational age (LGA) while considering key sociodemographic and clinical confounding factors. Setting and patient All singleton infants whose parents were living in the city of Marseilles, France, between 2013 and 2016. Method Population-based study based on new-born hospital birth admission charts from the French National Uniform Hospital Discharge Data Set Database. LGA infants were compared to appropriate-for-gestational-age (AGA) infants. Multiple generalized logistic model analysis was used to examine factors associated with LGA. Results A total of 43,309 singleton infants were included, and 4,747 (11%) were born LGA. LGA infants were more likely to have metabolic and respiratory diseases and to be admitted to the neonatal intensive care unit. Multiparity, advanced maternal age, obesity and diabetes were associated with an increased risk of LGA. Lower neighbourhood SES was associated with LGA (aOR = 1.24, 95% CI: 1.14; 1.36; p<0.0001) independent of age, diabetes, obesity, maternal smoking and multiparity. The strength of this association increased with maternal age, reaching an aOR of 1.50 (95% CI: 1.26; 1.78; p<0.0001) for women > 35 years old. Conclusion Neighbourhood SES could be considered an important factor for clinicians to better identify mothers at risk of having LGA births in addition to well-known risk factors such as maternal diabetes, obesity and age. The intensification of the association between SES and LGA with increasing maternal age suggests that neighbourhood disadvantage may act on LGA cumulatively over time.	[Boubred, Farid] AMU, Hosp Univ La Concept, APHM, Neonatal Unit,C2 VN, Marseille, France; [Pauly, Vanessa; Romain, Fanny; Fond, Guillaume; Boyer, Laurent] APHM, Publ Hlth & Med Informat Dept, Marseille, France; [Pauly, Vanessa; Fond, Guillaume; Boyer, Laurent] AMU, EA 3279, CEReSS Hlth Serv Res & Qual Life Ctr, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite	Boyer, L (corresponding author), APHM, Publ Hlth & Med Informat Dept, Marseille, France.; Boyer, L (corresponding author), AMU, EA 3279, CEReSS Hlth Serv Res & Qual Life Ctr, Marseille, France.	laurent.boyer@ap-hm.fr	Boyer, Laurent/E-5728-2016; Fond, Guillaume/D-7646-2011	Boyer, Laurent/0000-0003-1229-6622; Fond, Guillaume/0000-0003-3249-2030; Boubred, Farid/0000-0003-3039-2036				Ananth CV, 2002, SEMIN PERINATOL, V26, P260, DOI 10.1053/sper.2002.34772; Bocquier A, 2013, EUR J PUBLIC HEALTH, V23, P540, DOI 10.1093/eurpub/cks059; Boudemaghe T, 2017, INT J EPIDEMIOL, V46, P392, DOI 10.1093/ije/dyw359; Bowers K, 2013, DIABETOLOGIA, V56, P1263, DOI 10.1007/s00125-013-2881-5; Breart G, 2003, EUR J OBSTET GYN R B, V111, pS45, DOI 10.1016/j.ejogrb.2003.09.005; Chen SF, 2015, INT J ENV RES PUB HE, V12, P11178, DOI 10.3390/ijerph120911178; Chiavaroli V, 2016, ITAL J PEDIATR, V42, DOI 10.1186/s13052-016-0254-7; Clayborne ZM, 2017, SOC SCI MED, V175, P143, DOI 10.1016/j.socscimed.2016.12.041; Delpisheh A, 2008, J WOMENS HEALTH, V17, P965, DOI 10.1089/jwh.2007.0511; Delpisheh A, 2006, WOMENS HEALTH, V2, P389, DOI 10.2217/17455057.2.3.389; Ehrenberg HM, 2004, AM J OBSTET GYNECOL, V191, P964, DOI 10.1016/j.ajog.2004.05.052; Esakoff TF, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.02.035; Eurostat, 2010, EUROPEAN PERINATAL H; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Goldstein RF, 2017, JAMA-J AM MED ASSOC, V317, P2207, DOI 10.1001/jama.2017.3635; Gonthier C, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1310-z; Gustafsson PE, 2014, AM J PUBLIC HEALTH, V104, P904, DOI 10.2105/AJPH.2013.301707; Haugen M, 2014, BMC PREGNANCY CHILDB, V14, P201, DOI DOI 10.1186/1471-2393-14-201; Henriksen T, 2008, ACTA OBSTET GYN SCAN, V87, P134, DOI 10.1080/00016340801899289; Hoffman MC, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.10.862; Howell EA, 2018, CLIN OBSTET GYNECOL, V61, P387, DOI 10.1097/GRF.0000000000000349; Jacobsson B, 2004, OBSTET GYNECOL, V104, P727, DOI 10.1097/01.AOG.0000140682.63746.be; Johnsson IW, 2015, PEDIATR OBES, V10, P77, DOI 10.1111/ijpo.230; Jones NL, 2019, AM J PUBLIC HEALTH, V109, pS48, DOI [10.2105/AJPH.2018.304738, 10.2105/ajph.2018.304738]; Joseph KS, 2007, CAN MED ASSOC J, V177, P583, DOI 10.1503/cmaj.061198; Kenny LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056583; Kullgren JT, 2010, J COMMUN HEALTH, V35, P240, DOI 10.1007/s10900-010-9230-0; Martin Joyce A, 2018, Natl Vital Stat Rep, V67, P1; Metcalfe A, 2011, PAEDIATR PERINAT EP, V25, P236, DOI 10.1111/j.1365-3016.2011.01192.x; Michels N, 2018, EUR J NUTR, V57, P951, DOI 10.1007/s00394-017-1380-8; Mitanchez D, 2015, BEST PRACT RES CL OB, V29, P256, DOI 10.1016/j.bpobgyn.2014.08.004; Mullett MD, 2014, J PEDIATR-US, V164, P78, DOI 10.1016/j.jpeds.2013.08.064; Ncube CN, 2016, SOC SCI MED, V153, P156, DOI 10.1016/j.socscimed.2016.02.014; Nohr EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008444; OCDE, 2013, MOR INCL GROWTH METR; Orskou J, 2001, ACTA OBSTET GYN SCAN, V80, P931; Rey G, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-33; Rodwin VG, 2003, AM J PUBLIC HEALTH, V93, P31, DOI 10.2105/AJPH.93.1.31; Schimmel MS, 2015, ARCH GYNECOL OBSTET, V291, P793, DOI 10.1007/s00404-014-3469-0; Scifres CM, 2015, OBSTET GYNECOL, V126, P978, DOI 10.1097/AOG.0000000000001097; Shankardass K, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-96; Sundquist J, 2011, ARCH DIS CHILD, V96, P380, DOI 10.1136/adc.2009.180042; Surkan PJ, 2004, OBSTET GYNECOL, V104, P720, DOI 10.1097/01.AOG.0000141442.59573.cd; Tutlam NT, 2017, MATERN CHILD HLTH J, V21, P1643, DOI 10.1007/s10995-016-2256-x; Wang LF, 2015, J PERINATOL, V35, P985, DOI 10.1038/jp.2015.119; Warnecke RB, 2008, AM J PUBLIC HEALTH, V98, P1608, DOI 10.2105/AJPH.2006.102525; Weissmann-Brenner A, 2012, ACTA OBSTET GYN SCAN, V91, P844, DOI 10.1111/j.1600-0412.2012.01412.x; Wentz AE, 2014, HEALTH PLACE, V30, P98, DOI 10.1016/j.healthplace.2014.08.010; Wildman K, 2003, EUR J OBSTET GYN R B, V111, pS53, DOI 10.1016/j.ejogrb.2003.09.006; World Health Organization, MAT NEWB CHILD AD HL; 2013, PIBA, V36, P56	51	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0233416	10.1371/journal.pone.0233416	http://dx.doi.org/10.1371/journal.pone.0233416			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MA6QB	32502147	Green Published, gold			2022-12-26	WOS:000542035700061
J	Herhold, HW; Davis, SR; Grimaldi, DA				Herhold, Hollister W.; Davis, Steven R.; Grimaldi, David A.			Transcriptomes reveal expression of hemoglobins throughout insects and other Hexapoda	PLOS ONE			English	Article							GLOBIN GENE; EVOLUTIONARY HISTORY; RESPIRATORY PROTEINS; MORPHOLOGY; PHYLOGENY; DIVERSIFICATION; PREDICTION; HEMIPTERA; THUMMI; SYSTEM	Insects have long been thought to largely not require hemoglobins, with some notable exceptions like the red hemolymph of chironomid larvae. The tubular, branching network of tracheae in hexapods is traditionally considered sufficient for their respiration. Where hemoglobins do occur sporadically in plants and animals, they are believed to be either convergent, or because they are ancient in origin and their expression is lost in many clades. Our comprehensive analysis of 845 Hexapod transcriptomes, totaling over 38 Gbases, revealed the expression of hemoglobins in all 32 orders of hexapods, including the 29 recognized orders of insects. Discovery and identification of 1333 putative hemoglobins were achieved with target-gene BLAST searches of the NCBI TSA database, verifying functional residues, secondary- and tertiary-structure predictions, and localization predictions based on machine learning. While the majority of these hemoglobins are intracellular, extracellular ones were recovered in 38 species. Gene trees were constructed via multiple-sequence alignments and phylogenetic analyses. These indicate duplication events within insects and a monophyletic grouping of hemoglobins outside other globin clades, for which we propose the term insectahemoglobins. These hemoglobins are phylogenetically adjacent and appear structurally convergent with the clade of chordate myoglobins, cytoglobins, and hemoglobins. Their derivation and co-option from early neuroglobins may explain the widespread nature of hemoglobins in various kingdoms and phyla. These results will guide future work involving genome comparisons to transcriptome results, experimental investigations of gene expression, cell and tissue localization, and gas binding properties, all of which are needed to further illuminate the complex respiratory adaptations in insects.	[Herhold, Hollister W.; Davis, Steven R.; Grimaldi, David A.] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA	American Museum of Natural History (AMNH)	Herhold, HW (corresponding author), Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA.	hherhold@amnh.org	Davis, Steven/GQI-0883-2022	Herhold, Hollister/0000-0002-6377-4711; Davis, Steven/0000-0001-5353-1591				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2017, LANCET ONCOL, V18, P1, DOI 10.1016/S1470-2045(16)30642-8; Armenteros JJA, 2017, BIOINFORMATICS, V33, P3387, DOI 10.1093/bioinformatics/btx431; BERGTROM G, 1977, INSECT BIOCHEM, V7, P313, DOI 10.1016/0020-1790(77)90031-2; Blank M, 2012, MOL BIOL EVOL, V29, P3553, DOI 10.1093/molbev/mss164; BRAUNITZER G, 1968, H-S Z PHYSIOL CHEM, V349, P1789; Bruan V, 1968, H-S Z PHYSIOL CHEM, V349, P197; Burmester T, 1999, MOL BIOL EVOL, V16, P1809, DOI 10.1093/oxfordjournals.molbev.a026093; Burmester T, 2006, FEBS J, V273, P468, DOI 10.1111/j.1742-4658.2005.05073.x; Burmester T, 2007, J INSECT PHYSIOL, V53, P285, DOI 10.1016/j.jinsphys.2006.12.006; Burmester T, 2007, INSECT MOL BIOL, V16, P133, DOI 10.1111/j.1365-2583.2006.00706.x; Burmester T, 2018, J INSECT PHYSIOL, V106, P224, DOI 10.1016/j.jinsphys.2017.06.003; Burmester T, 2015, INTEGR COMP BIOL, V55, P792, DOI 10.1093/icb/icv079; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Dewilde S, 1998, J BIOL CHEM, V273, P32467, DOI 10.1074/jbc.273.49.32467; Dunlop JA, 2003, NATURE, V425, P916, DOI 10.1038/425916a; ENGLISH DS, 1969, J EMBRYOL EXP MORPH, V22, P465; Flogel U, 2001, P NATL ACAD SCI USA, V98, P4276; Franz-Guess S, 2016, ARTHROPOD STRUCT DEV, V45, P440, DOI 10.1016/j.asd.2016.08.004; Franz-Guess S, 2016, ARTHROPOD STRUCT DEV, V45, P452, DOI 10.1016/j.asd.2016.08.003; Freitas TAK, 2005, J INORG BIOCHEM, V99, P23, DOI 10.1016/j.jinorgbio.2004.10.024; Giribet G, 2019, CURR BIOL, V29, pR592, DOI 10.1016/j.cub.2019.04.057; Gleixner E, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-34; Gonzalez-Escobedo G, 2011, NAT REV MICROBIOL, V9, P9, DOI 10.1038/nrmicro2490; Hankeln T, 2002, J BIOL CHEM, V277, P29012, DOI 10.1074/jbc.M204009200; Hankeln T, 1998, J MOL EVOL, V46, P589, DOI 10.1007/PL00006339; Hankeln T, 2006, J INSECT PHYSIOL, V52, P701, DOI 10.1016/j.jinsphys.2006.03.010; Hetz SK, 2005, NATURE, V433, P516, DOI 10.1038/nature03106; Hoffmann FG, 2012, MOL BIOL EVOL, V29, P1735, DOI 10.1093/molbev/mss018; Hoffmann FG, 2012, MOL BIOL EVOL, V29, P303, DOI 10.1093/molbev/msr207; Hoogewijs D, 2012, MOL BIOL EVOL, V29, P1105, DOI 10.1093/molbev/msr246; Hourdez S, 2000, BIOL BULL-US, V199, P95, DOI 10.2307/1542868; Huerta-Cepas J, 2016, MOL BIOL EVOL, V33, P1635, DOI 10.1093/molbev/msw046; Hungerford H. B., 1922, Canadian Entomologist, V54, P262; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jones E., SCIPY OPEN SOURCE SC; Kamenz C, 2008, B AM MUS NAT HIST, P1; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kawaoka S, 2009, GENE, V431, P33, DOI 10.1016/j.gene.2008.11.004; KEILIN D, 1946, BIOCHEM J, V40, P855, DOI 10.1042/bj0400855; Kuwada T, 2007, GENE, V398, P29, DOI 10.1016/j.gene.2007.02.049; Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531; Lechauve C, 2013, J BIOL CHEM, V288, P6957, DOI 10.1074/jbc.M112.407601; Leitch I, 1916, J PHYSIOL-LONDON, V50, P370; Lu SN, 2020, NUCLEIC ACIDS RES, V48, pD265, DOI 10.1093/nar/gkz991; Maddison W.P., 2018, MESQUITE MODULAR SYS; MILLER PL, 1964, NATURE, V201, P1052, DOI 10.1038/2011052a0; Misof B, 2014, SCIENCE, V346, P763, DOI 10.1126/science.1257570; Mitter C, 2017, ANNU REV ENTOMOL, V62, P265, DOI 10.1146/annurev-ento-031616-035125; Natarajan C, 2016, SCIENCE, V354, P336, DOI 10.1126/science.aaf9070; National Center for Biotechnology Information, 2018, NCBI TRANSCR SHOTG A; National Center for Biotechnology Information, 2019, NONR NR DAT; OSMULSKI PA, 1986, COMP BIOCHEM PHYS B, V85, P701, DOI 10.1016/0305-0491(86)90166-5; OSMULSKI PA, 1992, BIOCHEM BIOPH RES CO, V187, P570, DOI 10.1016/0006-291X(92)91232-F; Pause I, 1918, ZOOL JB, V36, P1; Pesce A, 2005, PROTEIN SCI, V14, P3057, DOI 10.1110/ps.051742605; Peters RS, 2017, CURR BIOL, V27, P1013, DOI 10.1016/j.cub.2017.01.027; Project Jupyter, 2019, JUPYTERLAB; Python Software Foundation, 2019, PYTHON LANGUAGE REFE; R Core Team, 2021, R LANGUAGE ENV STAT; R Studio Team, 2016, RSTUDIO INT DEV ENV; Ramirez MJ, 2000, J ARACHNOL, V28, P149, DOI 10.1636/0161-8202(2000)028[0149:RSMATP]2.0.CO;2; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Scheer D, 1934, ARCH HYDROBIOL, V23, P391; Schmidt C, 2001, ACTA ZOOL-STOCKHOLM, V82, P315, DOI 10.1046/j.1463-6395.2001.00092.x; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Suzek BE, 2015, BIOINFORMATICS, V31, P926, DOI 10.1093/bioinformatics/btu739; THOMPSON P, 1968, J BIOL CHEM, V243, P4463; Tichy H, 1968, MOL GENET, P248; Vinogradov SN, 2005, P NATL ACAD SCI USA, V102, P11385, DOI 10.1073/pnas.0502103102; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wawrowski A, 2012, INSECT BIOCHEM MOLEC, V42, P603, DOI 10.1016/j.ibmb.2012.04.007; Weber RE, 2001, PHYSIOL REV, V81, P569, DOI 10.1152/physrev.2001.81.2.569; WELLS RMG, 1981, J COMP PHYSIOL, V142, P515, DOI 10.1007/BF00688984; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; Yadav R, 2016, DEV DYNAM, V245, P1048, DOI 10.1002/dvdy.24436; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	80	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0234272	10.1371/journal.pone.0234272	http://dx.doi.org/10.1371/journal.pone.0234272			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502196	gold, Green Published			2022-12-26	WOS:000542035700006
J	Husaini, Y; Tsai, VWW; Manandhar, R; Zhang, HP; Lee-Ng, KKM; Lebhar, H; Marquis, CP; Brown, DA; Breit, SN				Husaini, Yasmin; Tsai, Vicky Wang-Wei; Manandhar, Rakesh; Zhang, Hong Ping; Lee-Ng, Ka Ki Michelle; Lebhar, Helene; Marquis, Christopher P.; Brown, David A.; Breit, Samuel N.			Growth differentiation factor-15 slows the growth of murine prostate cancer by stimulating tumor immunity	PLOS ONE			English	Article							MACROPHAGE-INHIBITORY CYTOKINE-1; WEIGHT-LOSS; EXPRESSION; RECEPTOR; MIC-1/GDF15; CACHEXIA; PATHWAY; OBESITY; GDF15; MIC-1	Growth Differentiation Factor-15 (GDF15) is a divergent TGF-beta superfamily cytokine that is overexpressed by most cancers and is induced by anticancer therapy. Transgenic and induced animal models suggest that it protects from cancer development but the mechanisms are uncertain. We investigated the role of immunity in GDF15 induced reduction in prostate cancer (PCa) growth. The C57BL/6 transgenic TRAMP prostate cancer prone mice were bred with mice that were immunodeficient and/or systemically overexpressed GDF15. We developed a novel orthotopic TRAMP PCa model in which primary TRAMP tumor cells were implanted into prostates of mice to reduce the study time. These mice were administered recombinant mouse GDF15, antibody to CD8, PD1 or their respective controls. We found that GDF15 induced protection from tumor growth was reversed by lack of adaptive immunity. Flow cytometric evaluation of lymphocytes within these orthotopic tumors showed that GDF15 overexpression was associated with increased CD8 T cell numbers and an increased number and proportion of recently activated CD8(+)CD11c(+) T cells and a reduced proportion of "exhausted" CD8(+)PD1(+) T cells. Further, depletion of CD8 T cells in tumor bearing mice abolished the GDF15 induced protection from tumor growth. Infusion of GDF15 into mice bearing orthotopic TRAMP tumor, substantially reduced tumor growth that was further reduced by concurrent PD1 antibody administration. GDF15 overexpression or recombinant protein protects from TRAMP tumor growth by modulating CD8 T cell mediated antitumor immunity and augments the positive effects of anti-PD1 blockers.	[Husaini, Yasmin; Tsai, Vicky Wang-Wei; Manandhar, Rakesh; Zhang, Hong Ping; Lee-Ng, Ka Ki Michelle; Brown, David A.; Breit, Samuel N.] St Vincents Hosp, St Vincents Ctr Appl Med Res, Sydney, NSW, Australia; [Husaini, Yasmin; Tsai, Vicky Wang-Wei; Manandhar, Rakesh; Zhang, Hong Ping; Lee-Ng, Ka Ki Michelle; Brown, David A.; Breit, Samuel N.] Univ New South Wales, Sydney, NSW, Australia; [Lebhar, Helene; Marquis, Christopher P.] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Brown, David A.] New South Wales Hlth Pathol, Inst Pathol & Clin Res, Wesmead, NSW, Australia; [Brown, David A.] Westmead Hosp, Westmead Inst Med Res, Wesmead, NSW, Australia; [Brown, David A.] Univ Sydney, Wesmead, NSW, Australia	St Vincents Hospital Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney; Westmead Institute for Medical Research; University of Sydney	Breit, SN (corresponding author), St Vincents Hosp, St Vincents Ctr Appl Med Res, Sydney, NSW, Australia.; Breit, SN (corresponding author), Univ New South Wales, Sydney, NSW, Australia.	s.breit@amr.org.au		Brown, David/0000-0003-1382-9419	National Health and Medical Research Council (NHMRC) of Australia [568762]; Cancer Council NSW [400932, 1042661]; St. Vincent's Clinic Foundation	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council NSW(Cancer Council New South Wales); St. Vincent's Clinic Foundation	This work was financially supported by grants from the National Health and Medical Research Council (NHMRC) of Australia to SNB (568762, https://www.nhmrc.gov.au/), Cancer Council NSW to SNB (400932 and 1042661, https://www.cancercouncil.com.au/) and St. Vincent's Clinic Foundation grant to SNB and YH (https://www.stvincentsclinic.com.au/svcportal/research-grants).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ager CR, 2017, CANCER IMMUNOL RES, V5, P676, DOI 10.1158/2326-6066.CIR-17-0049; Baek SJ, 2006, GASTROENTEROLOGY, V131, P1553, DOI 10.1053/j.gastro.2006.09.015; Bauskin AR, 2005, CANCER RES, V65, P2330, DOI 10.1158/0008-5472.CAN-04-3827; Bauskin AR, 2010, J INTERF CYTOK RES, V30, P389, DOI 10.1089/jir.2009.0052; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Breit SN, 2017, TRENDS MOL MED, V23, P1065, DOI 10.1016/j.molmed.2017.10.005; Brown DA, 2003, CLIN CANCER RES, V9, P2642; Brown DA, 2002, BIOTECHNIQUES, V33, P118, DOI 10.2144/02331rr03; Brown DA, 2012, CANCER EPIDEM BIOMAR, V21, P337, DOI 10.1158/1055-9965.EPI-11-0786; Cekanova M, 2009, CANCER PREV RES, V2, P450, DOI 10.1158/1940-6207.CAPR-09-0057; Chiaverotti T, 2008, AM J PATHOL, V172, P236, DOI 10.2353/ajpath.2008.070602; Danta M, 2017, ALIMENT PHARM THER, V46, P347, DOI 10.1111/apt.14156; Emmerson PJ, 2017, NAT MED, V23, P1215, DOI 10.1038/nm.4393; Fairlie WD, 2000, GENE, V254, P67, DOI 10.1016/S0378-1119(00)00295-X; Gevariya N, 2019, PROSTATE, V79, P9, DOI 10.1002/pros.23706; Gingrich JR, 1996, CANCER RES, V56, P4096; Hsu JY, 2017, NATURE, V550, P255, DOI 10.1038/nature24042; Husaini Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115189; Husaini Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043833; Johnen H, 2007, NAT MED, V13, P1333, DOI 10.1038/nm1677; Kis E, 2006, INT J RADIAT ONCOL, V66, P1506, DOI 10.1016/j.ijrobp.2006.08.004; Lerner L, 2016, J CACHEXIA SARCOPENI, V7, P467, DOI 10.1002/jcsm.12077; Lindmark F, 2004, JNCI-J NATL CANCER I, V96, P1248, DOI 10.1093/jnci/djh227; Macia L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034868; Mehta RS, 2015, GASTROENTEROLOGY, V149, P614, DOI 10.1053/j.gastro.2015.05.038; Miyazaki T, 2018, ONCOGENESIS, V7, DOI 10.1038/s41389-017-0022-6; Moritake T, 2012, INT J RADIAT ONCOL, V84, pE95, DOI 10.1016/j.ijrobp.2012.02.013; Moynihan KD, 2016, NAT MED; Mullican SE, 2017, NAT MED, V23, P1150, DOI 10.1038/nm.4392; Okamura H, 2015, VITRO J CACHEX SARCO, V6, P25; Okazaki R, 2006, RADIAT RES, V165, P125, DOI 10.1667/RR3492.1; Olsen OE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187349; Patel SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061848; Sharpe Richard, 2007, ST DAVID WALES CULT, V24, p[107, 132]; Tsai VW, 2018, INT J OBESITY, V42, P561, DOI 10.1038/ijo.2017.258; Tsai VWW, 2016, INT J OBESITY, V40, P193, DOI 10.1038/ijo.2015.242; Tsai VWW, 2018, CELL METAB, V28, P353, DOI 10.1016/j.cmet.2018.07.018; Tucker JD, 2014, INT J RADIAT ONCOL, V88, P933, DOI 10.1016/j.ijrobp.2013.11.248; Vlkova V, 2014, ONCOTARGET, V5, P6923, DOI 10.18632/oncotarget.2222; Wang JY, 2015, PATHOL RES PRACT, V211, P845, DOI 10.1016/j.prp.2015.08.004; Yang H, 2003, MOL CANCER THER, V2, P1023; Yang LD, 2017, NAT MED, V23, P1158, DOI 10.1038/nm.4394; Zimmers TA, 2010, J CANCER RES CLIN, V136, P571, DOI 10.1007/s00432-009-0691-4	43	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0233846	10.1371/journal.pone.0233846	http://dx.doi.org/10.1371/journal.pone.0233846			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502202	gold, Green Published			2022-12-26	WOS:000542035700037
J	Zhang, R; Gehlen, J; Kawalia, A; Melissari, MT; Dakal, TC; Menon, AM; Hofele, J; Riedhammer, K; Waffenschmidt, L; Fabian, J; Breuer, K; Kalanithy, J; Hilger, AC; Sharma, A; Holscher, A; Boemers, TM; Pauly, M; Leutner, A; Fuchs, J; Seitz, G; Ludwikowski, BM; Gomez, B; Hubertus, J; Heydweiller, A; Kurz, R; Leonhardt, J; Kosch, F; Holland-Cunz, S; Munsterer, O; Ure, B; Schmiedeke, E; Neser, J; Degenhardt, P; Marzheuser, S; Kleine, K; Schafer, M; Spychalski, N; Deffaa, OJ; Gosemann, JH; Lacher, M; Heilmann-Heimbach, S; Zwink, N; Jenetzky, E; Ludwig, M; Grote, P; Schumacher, J; Thiele, H; Reutter, H				Zhang, Rong; Gehlen, Jan; Kawalia, Amit; Melissari, Maria-Theodora; Dakal, Tikam Chand; Menon, Athira M.; Hoefele, Julia; Riedhammer, Korbinian; Waffenschmidt, Lea; Fabian, Julia; Breuer, Katinka; Kalanithy, Jeshurun; Hilger, Alina Christine; Sharma, Amit; Hoelscher, Alice; Boemers, Thomas M.; Pauly, Markus; Leutner, Andreas; Fuchs, Joerg; Seitz, Guido; Ludwikowski, Barbara M.; Gomez, Barbara; Hubertus, Jochen; Heydweiller, Andreas; Kurz, Ralf; Leonhardt, Johannes; Kosch, Ferdinand; Holland-Cunz, Stefan; Muensterer, Oliver; Ure, Beno; Schmiedeke, Eberhard; Neser, Joerg; Degenhardt, Petra; Maerzheuser, Stefanie; Kleine, Katharina; Schaefer, Mattias; Spychalski, Nicole; Deffaa, Oliver J.; Gosemann, Jan-Hendrik; Lacher, Martin; Heilmann-Heimbach, Stefanie; Zwink, Nadine; Jenetzky, Ekkehart; Ludwig, Michael; Grote, Phillip; Schumacher, Johannes; Thiele, Holger; Reutter, Heiko			Human exome and mouse embryonic expression data implicate ZFHX3, TRPS1, and CHD7 in human esophageal atresia	PLOS ONE			English	Article							TRACHEOESOPHAGEAL FISTULA; CHARGE; MUTATIONS; SPECTRUM; DBNSFP	Introduction Esophageal atresia with or without tracheoesophageal fistula (EA/TEF) occurs approximately 1 in 3.500 live births representing the most common malformation of the upper digestive tract. Only half a century ago, EA/TEF was fatal among affected newborns suggesting that the steady birth prevalence might in parts be due to mutationalde novoevents in genes involved in foregut development. Methods To identify mutationalde novoevents in EA/TEF patients, we surveyed the exome of 30 case-parent trios. Identified and confirmedde novovariants were prioritized usingin silicoprediction tools. To investigate the embryonic role of genes harboring prioritizedde novovariants we performed targeted analysis of mouse transcriptome data of esophageal tissue obtained at the embryonic day (E) E8.5, E12.5, and postnatal. Results In total we prioritized 14 novelde novovariants in 14 different genes (APOL2,EEF1D,CHD7,FANCB,GGT6,KIAA0556,NFX1,NPR2,PIGC,SLC5A2,TANC2,TRPS1,UBA3, andZFHX3) and eight rarede novovariants in eight additional genes (CELSR1,CLP1,GPR133,HPS3,MTA3,PLEC,STAB1, andPPIP5K2). Through personal communication during the project, we identified an additional EA/TEF case-parent trio with a rarede novovariant inZFHX3.In silicoprediction analysis of the identified variants and comparative analysis of mouse transcriptome data of esophageal tissue obtained at E8.5, E12.5, and postnatal prioritizedCHD7,TRPS1, andZFHX3as EA/TEF candidate genes. Re-sequencing ofZFHX3in additional 192 EA/TEF patients did not identify further putative EA/TEF-associated variants. Conclusion Our study suggests that rare mutationalde novoevents in genes involved in foregut development contribute to the development of EA/TEF.	[Zhang, Rong; Waffenschmidt, Lea; Fabian, Julia; Breuer, Katinka; Kalanithy, Jeshurun; Hilger, Alina Christine; Heilmann-Heimbach, Stefanie; Schumacher, Johannes; Reutter, Heiko] Univ Bonn, Med Fac Bonn, Inst Human Genet, Bonn, Germany; [Gehlen, Jan; Schumacher, Johannes] Univ Hosp Marburg, Inst Human Genet, Marburg, Germany; [Kawalia, Amit; Thiele, Holger] Univ Cologne, Cologne Ctr Genom, Cologne, Germany; [Melissari, Maria-Theodora; Grote, Phillip] Goethe Univ Frankfurt, Ctr Mol Med, Inst Cardiovasc Regenerat, Frankfurt, Germany; [Dakal, Tikam Chand; Menon, Athira M.] Mohanlal Sukhadia Univ Udaipur, Dept Biotechnol, Udaipur, Rajasthan, India; [Hoefele, Julia; Riedhammer, Korbinian] Tech Univ Munich, Sch Med, Inst Human Genet, Klinikum Rechts Isar, Munich, Germany; [Riedhammer, Korbinian] Tech Univ Munich, Sch Med, Dept Nephrol, Klinikum Rechts Isar, Munich, Germany; [Sharma, Amit] Univ Hosp Bonn, Dept Pediat, Clin Pediat, Bonn, Germany; [Hoelscher, Alice] Univ Hosp Bonn, Dept Neurol, Bonn, Germany; [Hoelscher, Alice] Univ Hosp Bonn, Dept Ophthalmol, Bonn, Germany; [Boemers, Thomas M.; Pauly, Markus] Univ Hosp Cologne, Dept Pediat Surg & Urol, Cologne, Germany; [Leutner, Andreas] Asklepios Childrens Hosp St Augustin, Dept Pediat Surg, St Augustin, Germany; [Fuchs, Joerg] Med Ctr Dortmund, Dept Pediat Surg, Dortmund, Germany; [Seitz, Guido] Univ Tubingen, Dept Pediat Surg Childrens Hosp, Tubingen, Germany; [Ludwikowski, Barbara M.] Univ Marburg, Dept Pediat Surg, Marburg, Germany; [Gomez, Barbara; Hubertus, Jochen] Med Ctr Children & Adolescents AUF DER BULT, Dept Pediat Surg & Pediat Urol, Hannover, Germany; [Heydweiller, Andreas] Ludwig Maximilians Univ Munchen, Dept Pediat Surg, Dr von Hauner Childrens Hosp, Munich, Germany; [Kurz, Ralf; Leonhardt, Johannes] Univ Hosp Bonn, Dept Pediat Surg, Bonn, Germany; [Kosch, Ferdinand] Childrens Hosp Braunschweig, Dept Pediat Surg, Braunschweig, Germany; [Holland-Cunz, Stefan] Stadt Klinikum Karlsruhe, Dept Pediat Surg, Karlsruhe, Germany; [Muensterer, Oliver] Univ Childrens Hosp Basel UKBB, Dept Pediat Surg, Basel, Switzerland; [Ure, Beno] Univ Med Mainz, Dept Pediat Surg, Mainz, Germany; [Schmiedeke, Eberhard] Hannover Med Sch, Ctr Pediat Surg Hannover, Hannover, Germany; [Neser, Joerg] Klinikum Bremen Mitte, Clin Paediat Surg & Paediat Urol, Bremen, Germany; [Degenhardt, Petra] Gen Hosp, Dept Pediat Surg, Chemnitz, Germany; [Maerzheuser, Stefanie] Ernst von Bergmann Hosp, Dept Pediat Surg, Potsdam, Germany; [Kleine, Katharina] Charite, Dept Pediat Surg, Campus Virchow Clin, Berlin, Germany; [Schaefer, Mattias] Evangel Krankenhaus, Dept Pediat Surg, Oberhausen, Germany; [Spychalski, Nicole] Cnopfsche Kinderklin, Dept Pediat Surg & Urol, Nurnberg, Germany; [Deffaa, Oliver J.; Gosemann, Jan-Hendrik; Lacher, Martin] Univ Leipzig, Dept Pediat Surg, Leipzig, Germany; [Heilmann-Heimbach, Stefanie] Univ Bonn, Life & Brain Ctr, Dept Genom, Bonn, Germany; [Zwink, Nadine; Jenetzky, Ekkehart] Johannes Gutenberg Univ Mainz, Dept Child & Adolescent Psychiat & Psychotherapy, Mainz, Germany; [Jenetzky, Ekkehart] Witten Herdecke Univ, Inst Integrat Med, Herdecke, Germany; [Ludwig, Michael] Univ Bonn, Dept Clin Chem & Clin Pharmacol, Bonn, Germany; [Reutter, Heiko] Univ Hosp Bonn, Sect Neonatol & Pediat Intens Care, Clin Pediat, Bonn, Germany	University of Bonn; University Hospital of Giessen & Marburg; University of Cologne; Goethe University Frankfurt; Mohanlal Sukhadia University; Technical University of Munich; Technical University of Munich; University of Bonn; University of Bonn; University of Bonn; University of Cologne; Eberhard Karls University of Tubingen; Philipps University Marburg; University of Munich; University of Bonn; Municipal Hospital Karlsruhe; University of Basel; Johannes Gutenberg University of Mainz; Hannover Medical School; Klinikum Bremen-Mitte; Landstuhl Regional Medical Center; Klinikum Ernst von Bergmann; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leipzig University; University of Bonn; Johannes Gutenberg University of Mainz; University of Bonn; University of Bonn	Reutter, H (corresponding author), Univ Bonn, Med Fac Bonn, Inst Human Genet, Bonn, Germany.; Reutter, H (corresponding author), Univ Hosp Bonn, Sect Neonatol & Pediat Intens Care, Clin Pediat, Bonn, Germany.	reutter@uni-bonn.de	Hubertus, Jochen/AAW-7790-2021; Thiele, Holger/ABE-6792-2020; Sharma, Amit/W-4209-2019	Hubertus, Jochen/0000-0003-3206-6170; Thiele, Holger/0000-0002-0169-998X; Sharma, Amit/0000-0002-2216-5389; Melissari, Maria Theodora/0000-0001-5154-2801; Hilger, Alina Christine/0000-0002-0354-7584; Hoefele, Julia/0000-0002-7917-7129; Degenhardt, Petra/0000-0001-7506-9457; Jenetzky, Ekkehart/0000-0001-5415-8784; Muensterer, Oliver/0000-0003-2790-4395; Riedhammer, Korbinian Maria/0000-0002-7503-5801; Grote, Phillip/0000-0002-9254-1458	University of Bonn, BONFOR [O-149.0115.1]; German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [BE 3910/6-1, RE 1723/4-1, Exc147-2]; Else-Kroner-Fresenius-Stiftung (EKFS) [2014_A14]; DFG [215828658]; German Federal Ministry of Education and Research [FKZ 031A532-0331A540, 031L0101-0310108]	University of Bonn, BONFOR; German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); Else-Kroner-Fresenius-Stiftung (EKFS); DFG(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	F.K. was supported by a stipend of the University of Bonn, BONFOR (O-149.0115.1; https://www.medfak.uni-bonn.de/de/forschung/foerderung/interne-foerderung/bonfor).H.R., J.S., M.L., and P.G. are supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) (BE 3910/6-1, RE 1723/4-1, Exc147-2; https://www.dfg.de/).H.R., J. S., H.T, and E.J. are further supported by a grant of the Else-Kroner-Fresenius-Stiftung (EKFS, 2014_A14; https://www.ekfs.de/).The Exome analysis was performed on CHEOPS, a high performance computer cluster of the regional data center (RRZK) of the University of Cologne, funded by the DFG (215828658). The transcriptome analysis were performed on the de.NBI cloud, a national infrastructure supported by the German Federal Ministry of Education and Research (FKZ 031A532-0331A540 and 031L0101-0310108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brosens E, 2016, EUR J HUM GENET, V24, P1715, DOI 10.1038/ejhg.2016.86; DAVID TJ, 1975, J MED GENET, V12, P1, DOI 10.1136/jmg.12.1.1; DEPAEPE A, 1993, ARCH DIS CHILD, V68, P743, DOI 10.1136/adc.68.6.743; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; Genevieve D, 2007, CLIN GENET, V71, P392, DOI 10.1111/j.1399-0004.2007.00798.x; Janssen N, 2012, HUM MUTAT, V33, P1149, DOI 10.1002/humu.22086; Jongmans MCJ, 2006, J MED GENET, V43, P306, DOI 10.1136/jmg.2005.036061; Kawalia A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126321; KUTIYANAWALA M, 1992, J PEDIATR SURG, V27, P558, DOI 10.1016/0022-3468(92)90445-D; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu XM, 2016, HUM MUTAT, V37, P235, DOI 10.1002/humu.22932; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Love Michael I, 2015, F1000Res, V4, P1070, DOI 10.12688/f1000research.7035.1; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maas SM, 2015, EUR J MED GENET, V58, P279, DOI 10.1016/j.ejmg.2015.03.002; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Motoyama J, 1998, NAT GENET, V20, P54, DOI 10.1038/1711; Pedersen RN, 2012, ARCH DIS CHILD, V97, P227, DOI 10.1136/archdischild-2011-300597; QUAN L, 1973, J PEDIATR-US, V82, P104, DOI 10.1016/S0022-3476(73)80024-1; Ramu A, 2013, NAT METHODS, V10, P985, DOI 10.1038/nmeth.2611; Thisse B, 2004, ZFIN DIRECT DATA SUB; Torfs CP, 1995, TERATOLOGY, V52, P220, DOI 10.1002/tera.1420520408; van Bokhoven H, 2005, NAT GENET, V37, P465, DOI 10.1038/ng1546; Williamson KA, 2006, HUM MOL GENET, V15, P1413, DOI 10.1093/hmg/ddl064; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Zhang R, 2017, BIRTH DEFECTS RES, V109, P1063, DOI 10.1002/bdr2.1042	28	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0234246	10.1371/journal.pone.0234246	http://dx.doi.org/10.1371/journal.pone.0234246			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502225	Green Published, gold			2022-12-26	WOS:000542035700024
J	Li, C; Ge, SH; Zhou, JL; Peng, J; Chen, JY; Dong, SH; Feng, XF; Su, N; Zhang, LL; Zhong, YB; Deng, LB; Tang, XL				Li, Can; Ge, Shanghua; Zhou, Jialu; Peng, Jie; Chen, Jiayu; Dong, Shuhui; Feng, Xiaofang; Su, Ning; Zhang, Lunli; Zhong, Yuanbin; Deng, Libin; Tang, Xiaoli			Exploration of the effects of the CYCLOPS gene RBM17 in hepatocellular carcinoma	PLOS ONE			English	Article							COMPLEX; MICROTUBULES; PHENOTYPE; INCENP	Background Hepatocellular carcinoma (HCC) is one of the most lethal and malignant tumours worldwide. New therapeutic targets for HCC are urgently needed. CYCLOPS (copy number alterations yielding cancer liabilities owing to partial loss) genes have been noted to be associated with cancer-targeted therapies. Therefore, we intended to explore the effects of the CYCLOPS geneRBM17on HCC oncogenesis to determine if it could be further used for targeted therapy. Methods We collected data on 12 types of cancer from the Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) queries for comparison with adjacent non-tumour tissues.RBM17expression levels, clinicopathological factors and survival times were analysed. RNAseq data were downloaded from the Encyclopaedia of DNA Elements database for molecular mechanism exploration. Two representative HCC cell models were built to observe the proliferation capacity of HCC cells whenRBM17expression was inhibited by shRBM17. Cell cycle progression and apoptosis were also examined to investigate the pathogenesis ofRBM17. Results Based on 6,136 clinical samples,RBM17was markedly overexpressed in most cancers, especially HCC. Moreover, data from 442 patients revealed that highRBM17expression levels were related to a worse prognosis. Overexpression ofRBM17was related to the iCluster1 molecular subgroup, TNM stage, and histologic grade. Pathway analysis of RNAseq data suggested thatRBM17was involved in mitosis. Further investigation revealed that the proliferation rates of HepG2 (P = 0.003) and SMMC-7721 (P = 0.030) cells were significantly reduced whenRBM17was knocked down. In addition,RBM17knockdown also arrested the progression of the cell cycle, causing cells to halt at the G2/M phase. Increased apoptosis rates were also foundin vitro. Conclusion These results suggest thatRBM17is a potential therapeutic target for HCC treatment.	[Li, Can] Nanchang Univ, Queen Mary Sch, Med Coll, Nanchang, Jiangxi, Peoples R China; [Ge, Shanghua; Peng, Jie; Su, Ning; Deng, Libin] Nanchang Univ, Sch Publ Hlth, Jiangxi Prov Key Lab Prevent Med, Nanchang, Jiangxi, Peoples R China; [Zhou, Jialu] Nanchang Univ, Clin Coll 2, Med Coll, Nanchang, Jiangxi, Peoples R China; [Chen, Jiayu; Dong, Shuhui; Feng, Xiaofang] Nanchang Univ, Clin Coll 4, Med Coll, Nanchang, Jiangxi, Peoples R China; [Zhang, Lunli; Zhong, Yuanbin] Nanchang Univ, Dept Infect Dis, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China; [Zhang, Lunli; Zhong, Yuanbin] Nanchang Univ, Key Lab Liver Regenerat Med Jiangxi Prov, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China; [Deng, Libin; Tang, Xiaoli] Nanchang Univ, Coll Basic Med Sci, Nanchang, Jiangxi, Peoples R China	Nanchang University; Nanchang University; Nanchang University; Nanchang University; Nanchang University; Nanchang University; Nanchang University	Tang, XL (corresponding author), Nanchang Univ, Coll Basic Med Sci, Nanchang, Jiangxi, Peoples R China.	xltangmail@163.com		Li, Can/0000-0002-9087-2632; Peng, Jie/0000-0002-5278-3989	National Natural Science Foundation of China [81660041]; Natural Science Foundation of Jiangxi Province [20171BAB205109, 20192BAB205059, 20161BCD40015]; Nanchang University innovation and entrepreneurship training program for college students [20190402308]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangxi Province(Natural Science Foundation of Jiangxi Province); Nanchang University innovation and entrepreneurship training program for college students	1. The National Natural Science Foundation of China (81660041 to Libin Deng). Libin Deng played a role in study design and decision to publish. 2. The Natural Science Foundation of Jiangxi Province (20171BAB205109 to Xiaoli Tang). Xiaoli Tang played a role in study design and decision to publish. 3. The Natural Science Foundation of Jiangxi Province (20192BAB205059 to Yuanbin Zhong). Yuanbin Zhong played a role in study design and preparation of the manuscript. 4. The Natural Science Foundation of Jiangxi Province (20161BCD40015 to Lunli Zhang). Lunli Zhang played a role in decision to publish. 5. The Nanchang University innovation and entrepreneurship training program for college students (20190402308 to Can Li).Can Li played a role in data collection and analysis, and preparation of manuscript.	[Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; Baralle FE, 2017, NAT REV MOL CELL BIO, V18, P437, DOI 10.1038/nrm.2017.27; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Caisse nationale de l'assurance maladie des travailleurs salaries, 2008, POINTS REPERE, V23, P1; Chen XL, 2019, LAT AM J PHARM, V38, P518; Corsini L, 2007, NAT STRUCT MOL BIOL, V14, P620, DOI 10.1038/nsmb1260; Coskun M, 2017, EXP CLIN TRANSPLANT, V15, P36, DOI 10.6002/ect.TOND16.L10; Das M, 2012, SCIENCE, V337, P239, DOI 10.1126/science.1218377; Di Bisceglie AM, 2002, J VASC INTERV RADIOL, V13, pS169, DOI 10.1016/S1051-0443(07)61783-7; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; Fan YJ, 2018, AM J HUM GENET, V103, P448, DOI 10.1016/j.ajhg.2018.07.019; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Golyan FF, 2020, CLIN TRANSL ONCOL, V22, P681, DOI 10.1007/s12094-019-02174-z; Han YF, 2018, ONCOL LETT, V15, P5680, DOI 10.3892/ol.2018.8012; Kim E, 2014, BIOCHEM BIOPH RES CO, V449, P399, DOI 10.1016/j.bbrc.2014.05.063; Kornberg A, 2014, ISRN Hepatol, V2014, P706945, DOI 10.1155/2014/706945; Kudo M, 2017, ONCOLOGY-BASEL, V93, P135, DOI 10.1159/000481244; Liu TH, 2017, CELL CYCLE, V16, P861, DOI 10.1080/15384101.2017.1304339; Liu YH, 2015, NATURE, V520, P697, DOI 10.1038/nature14418; Lu JL, 2018, BIOCHEM BIOPH RES CO, V505, P20, DOI 10.1016/j.bbrc.2018.09.056; Maio A De, 2018, PROCESSING PROTEINS, V25, P726; Miller JA, 2017, ELIFE, V6, DOI 10.7554/eLife.31126; MS G AK2 K SM R-K IR K MA G TM P, 2016, HEPATOCELLULAR CARCI, P74; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; Nijhawan D, 2012, CELL, V150, P842, DOI 10.1016/j.cell.2012.07.023; NOVICK P, 1989, GENETICS, V121, P659; Parker AL, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00153; Roquette R, 2017, GEOSPATIAL HEALTH, V12, P23, DOI 10.4081/gh.2017.504; Samejima K, 2015, J BIOL CHEM, V290, P21460, DOI 10.1074/jbc.M115.645317; Sampath J, 2003, AM J PATHOL, V163, P1781, DOI 10.1016/S0002-9440(10)63538-9; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Wheelock MS, 2017, J CELL BIOL, V216, P925, DOI 10.1083/jcb.201609061; Zhu RX, 2016, GUT LIVER, V10, P332, DOI 10.5009/gnl15257	34	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0234062	10.1371/journal.pone.0234062	http://dx.doi.org/10.1371/journal.pone.0234062			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497093	Green Published, gold			2022-12-26	WOS:000542035200086
J	Sayyed, RZ; Bhamare, HM; Sapna; Marraiki, N; Elgorban, AM; Syed, A; El-Enshasy, HA; Dailin, DJ				Sayyed, R. Z.; Bhamare, H. M.; Sapna; Marraiki, Najat; Elgorban, Abdallah M.; Syed, Asad; El-Enshasy, Hesham Ali; Dailin, Daniel J.			Tree bark scrape fungus: A potential source of laccase for application in bioremediation of non-textile dyes	PLOS ONE			English	Article							ENHANCED PRODUCTION; PURIFICATION; DECOLORIZATION; REMOVAL; STRAIN; PH	Although laccase has been recognized as a wonder molecule and green enzyme, the use of low yielding fungal strains, poor production, purification, and low enzyme kinetics have hampered its large-scale application. Thus,this study aims to select high yielding fungal strains and optimize the production, purification, and kinetics of laccase ofAspergillussp. HB_RZ4. The results obtained indicated thatAspergillussp. HB_RZ4 produced a significantly large amount of laccase under meso-acidophilic shaking conditions in a medium containing glucose and yeast extract. A 25 mu M CuSO(4)was observed to enhance the enzyme yield. The enzyme was best purified on a Sephadex G-100 column. The purified enzyme resembled laccase ofA.flavus. The kinetics of the purified enzyme revealed high substrate specificity and good velocity of reaction,using ABTS as a substrate. The enzyme was observed to be stable over various pH values and temperatures. The peptide structure of the purified enzyme was found to resemble laccase ofA.kawachiiIFO 4308. The fungus was observed to decolorize various dyes independent of the requirement of a laccase mediator system.Aspergillussp. HB_RZ4 was observed to be a potent natural producer of laccase, and it decolorized the dyes even in the absence of a laccase mediator system. Thus, it can be used for bioremediation of effluent that contains non-textile dyes.	[Sayyed, R. Z.] PSGVP Mandals Arts Sci & Commerce Coll, Dept Microbiol, Shahada, India; [Bhamare, H. M.] SSVP Sansths Late Karmveer Dr PR Ghogrey Sci Coll, Dept Biotechnol, Dhule, India; [Sapna] ICAR Natl Bur Plant Genet Resources, New Delhi, India; [Marraiki, Najat; Elgorban, Abdallah M.; Syed, Asad] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh, Saudi Arabia; [Elgorban, Abdallah M.] King Saud Univ, Ctr Excellence Biotechnol Res, Riyadh, Saudi Arabia; [El-Enshasy, Hesham Ali; Dailin, Daniel J.] Univ Teknol Malaysia UTM, Inst Bioprod Dev, Skudai, Johor Bahru, Malaysia; [El-Enshasy, Hesham Ali; Dailin, Daniel J.] Univ Teknol Malaysia UTM, Fac Engn, Sch Chem & Energy Engn, Skudai, Johor Bahru, Malaysia; [El-Enshasy, Hesham Ali] City Sci Res & Technol Applicat, Alexandria, Egypt	Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources; King Saud University; King Saud University; Universiti Teknologi Malaysia; Universiti Teknologi Malaysia; Egyptian Knowledge Bank (EKB); City of Scientific Research & Technological Applications (SRTA-City)	Sayyed, RZ (corresponding author), PSGVP Mandals Arts Sci & Commerce Coll, Dept Microbiol, Shahada, India.	sayyedrz@gmail.com	Sayyed, R Z/Q-4313-2016; Elgorban, Abdallah M./C-6000-2013; Syed, Asad/A-7828-2012; El Enshasy, Hesham Ali/D-3733-2014	Sayyed, R Z/0000-0002-1553-1213; Elgorban, Abdallah M./0000-0003-3664-7853; Syed, Asad/0000-0002-2824-7721; El Enshasy, Hesham Ali/0000-0002-9712-2033	Deanship of Scientific Research at King Saud University [RG-1436-025]; MOE, Malaysia [R.J130000.7846.4J262]; UTM-RMC, Malaysia [R.J130000.7846.4J262]; MOHE-HICOE fund, Malaysia [R.J130000.7846.4J262]	Deanship of Scientific Research at King Saud University(King Saud University); MOE, Malaysia; UTM-RMC, Malaysia; MOHE-HICOE fund, Malaysia	The authors extend their sincere appreciation to the Deanship of Scientific Research at King Saud University and MOE, UTM-RMC, and MOHE-HICOE fund, Malaysia for supporting this research through the Research Group Project NO RG-1436-025 and No.R.J130000.7846.4J262, respectively.	Afreen S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175144; Al Ghazo AT, 2020, IEEE T SYST MAN CY-S, V50, P3488, DOI 10.1109/TSMC.2019.2915940; Bagewadi Zabin K., 2017, Journal of Genetic Engineering and Biotechnology, V15, P139, DOI 10.1016/j.jgeb.2017.01.007; Bayburt C, 2020, INT J ENVIRON SCI TE, V17, P945, DOI 10.1007/s13762-019-02519-9; Bhamare HM., 2018, ENV SUSTAIN, V1, P159, DOI [10.1007/s42398-018-0015-1, DOI 10.1007/S42398-018-0015-1]; Bukh C, 2010, J INORG BIOCHEM, V104, P1029, DOI 10.1016/j.jinorgbio.2010.05.010; Chen MY, 2019, WATER RES, V166, DOI 10.1016/j.watres.2019.115040; Collins PJ, 1996, APPL ENVIRON MICROB, V62, P4563, DOI 10.1128/AEM.62.12.4563-4567.1996; Copete LS, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0192-2; Cruz YWG, 2020, ENVIRON TECHNOL, V41, P1837, DOI 10.1080/09593330.2018.1551428; de Salas F, 2019, GREEN CHEM, V21, P5374, DOI 10.1039/c9gc02475a; Eggert C, 1996, APPL ENVIRON MICROB, V62, P1151, DOI 10.1128/AEM.62.4.1151-1158.1996; Finnie C, 2006, PLANT SCI, V170, P808, DOI 10.1016/j.plantsci.2005.11.012; Forootanfar H, 2016, J ENVIRON HEALTH SCI, V14, DOI 10.1186/s40201-016-0248-9; Frtges L, 2019, CHEMBIOCHEM, V20, P1928, DOI 10.1002/cbic.201900041; Gatica J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01233; Ghosh Priyanka, 2017, Acta Biologica Szegediensis, V61, P25; Gu YH, 2020, J POROUS MAT, V27, P73, DOI 10.1007/s10934-019-00786-y; Haugland JO, 2019, WATER ENVIRON RES, V91, P281, DOI 10.1002/wer.1006; Ike PTL, 2019, ENVIRON SCI POLLUT R, P1, DOI 10.1007/s11356-019-04197-z; Japanese Gastr Canc Assoc, 2021, GASTRIC CANCER, V24, P1, DOI [10.1007/s10120-020-01042-y, 10.1007/s10120-016-0622-4]; Jeon SJ, 2017, J MICROBIOL BIOTECHN, V27, P1120, DOI 10.4014/jmb.1701.01004; Kiiskinen LL, 2004, J APPL MICROBIOL, V97, P640, DOI 10.1111/j.1365-2672.2004.02348.x; Kumar Rajesh, 2016, Journal of Genetic Engineering and Biotechnology, V14, P125, DOI 10.1016/j.jgeb.2016.05.006; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu CJ, 2020, J MEMBRANE SCI, V593, DOI 10.1016/j.memsci.2019.117399; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma SX, 2018, J BASIC MICROB, V58, P68, DOI 10.1002/jobm.201700212; Mann J, 2015, INT BIODETER BIODEGR, V99, P138, DOI 10.1016/j.ibiod.2015.01.010; Neto SLM, 2009, BRAZ ARCH BIOL TECHN, V52, P1075, DOI 10.1590/S1516-89132009000500003; Olajuyigbe FM, 2017, INT J BIOL MACROMOL, V94, P535, DOI 10.1016/j.ijbiomac.2016.10.037; Ozer A, 2020, APPL BIOCHEM BIOTECH, V190, P721, DOI 10.1007/s12010-019-03122-x; Patel H, 2014, 3 BIOTECH, V4, P77, DOI 10.1007/s13205-013-0129-1; Permana D, 2019, BIOTECHNOL J, V14, DOI 10.1002/biot.201800531; Piao MY, 2019, MATERIALS, V12, DOI 10.3390/ma12050704; Rajeswari M., 2016, AFR J BIOTECHNOL, V15, P1813, DOI DOI 10.5897/AJB2016.15509; Ramirez-Cavazos LI, 2014, J ZHEJIANG UNIV-SC B, V15, P343, DOI 10.1631/jzus.B1300246; Rehan A. M., 2016, ANN AGR SCI, V61, P145, DOI [10.1016/j.aoas.2015.11.007, DOI 10.1016/J.AOAS.2015.11.007]; Revankar MS, 2006, PROCESS BIOCHEM, V41, P581, DOI 10.1016/j.procbio.2005.07.019; Rodakiewicz-Nowak J., 2002, J MOL CATAL B-ENZYM, V11, P1; Senthivelan T., 2019, Biotechnology Reports, V23, pe00344, DOI 10.1016/j.btre.2019.e00344; Shin SK, 2019, INT J BIOL MACROMOL, V129, P181, DOI 10.1016/j.ijbiomac.2019.02.027; Siddiqui RA, 2015, INT J BIOASSAYS, V4, P3841; Sivakumar R., 2010, INT J ENG SCI TECHNO, V2, P7133, DOI DOI 10.1134/S0003683808060100; Sivam S, 2008, PROCESS BIOCHEM, V43, P736, DOI [10.1016/j.procbio.2008.02.017, DOI 10.1016/J.PROCBIO.2008.02.017]; Sorrentio I, 2019, CHIMERA APPL MICROBI, P1; Thakur K, 2015, J MOL CATAL B-ENZYM, V122, P289, DOI 10.1016/j.molcatb.2015.10.002; Tinoco R, 2001, LETT APPL MICROBIOL, V32, P331, DOI 10.1046/j.1472-765X.2001.00913.x; Vantamuri AB, 2016, 3 BIOTECH, V189, P1; Viswanath B., 2008, DYN BIOCH PROCESS BI, V2, P19; Waghmode TR, 2019, J HAZARD MATER, V371, P115, DOI 10.1016/j.jhazmat.2019.03.004; Wang P, 2008, J ENVIRON SCI, V20, P1519, DOI 10.1016/S1001-0742(08)62559-0; Wu MH, 2018, FEBS OPEN BIO, V8, P1230, DOI 10.1002/2211-5463.12459; Xin FX, 2011, APPL BIOCHEM BIOTECH, V163, P235, DOI 10.1007/s12010-010-9033-x; Yang S, 2013, BIORESOURCE TECHNOL, V141, P97, DOI 10.1016/j.biortech.2013.01.173; Zhang LL, 2019, ANGEW CHEM INT EDIT, V58, P4562, DOI 10.1002/anie.201814069; Zou YL, 2019, CATAL LETT, V149, P2706, DOI 10.1007/s10562-019-02732-8; 2014, REG ANESTH PAIN MED, V9	58	8	9	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0229968	10.1371/journal.pone.0229968	http://dx.doi.org/10.1371/journal.pone.0229968			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497077	Green Published, Green Submitted, gold			2022-12-26	WOS:000542035200088
J	Mendes, HW; Taktek, M; Duret, T; Ekker, M				Weinschutz Mendes, Hellen; Taktek, Mariam; Duret, Thomas; Ekker, Marc			Expression of dlx genes in the normal and regenerating brain of adult zebrafish	PLOS ONE			English	Article							GANGLIONIC EMINENCES; CELL-PROLIFERATION; BASAL FOREBRAIN; HOMEOBOX GENES; DISTAL-LESS; NEUROGENESIS; MIGRATION; EVOLUTION; ENHANCER; ORIGIN	Dysfunctions in the GABAergic system lead to various pathological conditions and impaired inhibitory function is one of the causes behind neuropathies characterized by neuronal hyper excitability. TheDlxhomeobox genes are involved in the development of nervous system, neural crest, branchial arches and developing appendages.Dlxgenes also take part in neuronal migration and differentiation during development, more precisely, in the migration and differentiation of GABAergic neurons. Functional analysis ofdlxgenes has mainly been carried out in developing zebrafish embryos and larvae, however information regarding the expression and roles of these genes in the adult zebrafish brain is still lacking. The extensive neurogenesis that takes place in the adult zebrafish brain, makes them a good model for the visualization of mechanisms involvingdlxgenes during adulthood in physiological conditions and during regeneration of the nervous system. We have identified the adult brain regions where transcripts ofdlx1a,dlx2a,dlx5aanddlx6agenes are normally found and have confirmed that within telencephalic domains, there is high overlapping expression of the fourdlxparalogs with a marker for GABAergic neurons. Co-localization analyses carried with the Tg(dlx6a-1.4kbdlx5a/dlx6a:GFP) reporter line have also shown that in some areas of the diencephalon, cells expressing thedlx5a/6abigene may have a neural stem cell identity. Furthermore, investigations in a response to stab wound lesions, have demonstrated a possible participation of thedlx5a/6abigene, most likely ofdlx5a, during regeneration of the adult zebrafish brain. These observations suggest a possible participation ofdlx-expressing cells during brain regeneration in adult zebrafish and also provide information on the role ofdlxgenes under normal physiological conditions in adults.	[Weinschutz Mendes, Hellen; Taktek, Mariam; Ekker, Marc] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Duret, Thomas] Univ Poitiers, Fac Sci Fondamentales & Appl, Poitiers, France; [Weinschutz Mendes, Hellen] Yale Univ, Yale Child Study Ctr, New Haven, CT USA	University of Ottawa; Universite de Poitiers; Yale University	Ekker, M (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.	mekker@uottawa.ca		Weinschutz Mendes, Hellen/0000-0002-4282-6498	Natural Sciences and Engineering Research Council of Canada [121795]; Canadian Institutes of Health Research [MOP-137082]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by grants from the Natural Sciences and Engineering Research Council of Canada (grant #121795) and by the Canadian Institutes of Health Research (grant #MOP-137082). We, the authors, declare no competing interests.	Adolf B, 2006, DEV BIOL, V295, P278, DOI 10.1016/j.ydbio.2006.03.023; AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anderson SA, 1997, NEURON, V19, P27, DOI 10.1016/S0896-6273(00)80345-1; [Anonymous], 2011, NAT BIOTECHNOL, V29, P681, DOI 10.1038/nbt.1935; Becker CG, 2008, RESTOR NEUROL NEUROS, V26, P71; Brill MS, 2008, J NEUROSCI, V28, P6439, DOI 10.1523/JNEUROSCI.0700-08.2008; Castro DS, 2011, NOVEL FUNCTION PRONE, P930; Darbandi SF, 2016, DEV BIOL, V420, P32, DOI 10.1016/j.ydbio.2016.10.015; Eisenstat DD, 1999, J COMP NEUROL, V414, P217, DOI 10.1002/(SICI)1096-9861(19991115)414:2<217::AID-CNE6>3.0.CO;2-I; Ellies DL, 1997, GENOMICS, V45, P580, DOI 10.1006/geno.1997.4978; Endo T, 2007, DEV GROWTH DIFFER, V49, P121, DOI 10.1111/j.1440-169x.2007.00914.x; Ghanem N, 2003, GENOME RES, V13, P533, DOI 10.1101/gr.716103; Ghanem N, 2007, J NEUROSCI, V27, P5012, DOI 10.1523/JNEUROSCI.4725-06.2007; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Kaslin J, 2008, PHILOS T R SOC B, V363, P101, DOI 10.1098/rstb.2006.2015; Kishimoto N, 2012, DIS MODEL MECH, V5, P200, DOI 10.1242/dmm.007336; Kizil C, 2012, DEV NEUROBIOL, V72, P429, DOI 10.1002/dneu.20918; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; Lam CS, 2009, GFAP NESTIN REPORTER, P475; Leker RR, 2007, STROKE, V38, P153, DOI 10.1161/01.STR.0000252156.65953.a9; Long QM, 1997, DEVELOPMENT, V124, P4105; MacDonald RB, 2013, DEV BIOL, V381, P276, DOI 10.1016/j.ydbio.2013.05.025; MacDonald RB, 2010, DEV DYNAM, V239, P2298, DOI 10.1002/dvdy.22365; Machluf Y, 2011, ANN NY ACAD SCI, V1220, P93, DOI 10.1111/j.1749-6632.2010.05945.x; Martin SC, 1998, J COMP NEUROL, V396, P253; McNeill RS, 2014, JOVE-J VIS EXP, DOI [10.3791/51763, 10.3791/51753]; Nagpal J, 2019, CELL TISSUE RES, V375, P5, DOI 10.1007/s00441-018-2900-4; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Petryniak MA, 2007, NEURON, V55, P417, DOI 10.1016/j.neuron.2007.06.036; Pleasure SJ, 2000, NEURON, V28, P727, DOI 10.1016/S0896-6273(00)00149-5; Saino-Saito S, 2003, J COMP NEUROL, V461, P18, DOI 10.1002/cne.10611; Sarfo FS, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-202; Schmidt R, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-3; Solek CM, 2017, DEV BIOL, V427, P131, DOI 10.1016/j.ydbio.2017.04.019; Stock DW, 1996, P NATL ACAD SCI USA, V93, P10858, DOI 10.1073/pnas.93.20.10858; Sullivan-Brown J, 2011, NAT PROTOC, V6, P46, DOI 10.1038/nprot.2010.165; Sumiyama Kenta, 2003, Journal of Structural and Functional Genomics, V3, P151, DOI 10.1023/A:1022682505914; Viales RR, 2015, STEM CELLS, V33, P892, DOI 10.1002/stem.1883; Zerucha T, 2000, J NEUROSCI, V20, P709, DOI 10.1523/JNEUROSCI.20-02-00709.2000; Zerucha T, 2000, BIOCHEM CELL BIOL, V78, P593, DOI 10.1139/bcb-78-5-593; Zhang XB, 2015, J NEUROSCI, V35, P14966, DOI 10.1523/JNEUROSCI.0293-15.2015; Zupanc GKH, 1999, EXP NEUROL, V160, P78, DOI 10.1006/exnr.1999.7182	43	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0229549	10.1371/journal.pone.0229549	http://dx.doi.org/10.1371/journal.pone.0229549			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497078	Green Submitted, Green Published, gold			2022-12-26	WOS:000542035200063
J	Osuka, K; Watanabe, Y; Usuda, N; Iwami, K; Miyachi, S; Takayasu, M				Osuka, Koji; Watanabe, Yasuo; Usuda, Nobuteru; Iwami, Kenichiro; Miyachi, Shigeru; Takayasu, Masakazu			Expression of high mobility group B1 and toll-like receptor-nuclear factor kappa B signaling pathway in chronic subdural hematomas	PLOS ONE			English	Article							CEREBRAL ISCHEMIA-REPERFUSION; ENDOTHELIAL-CELLS; GENE-EXPRESSION; IL-6 SECRETION; ACTIVATION; LIPOPOLYSACCHARIDE; HMGB1; INTERLEUKIN-6; RECURRENCE; INCREASES	Chronic subdural hematoma (CSDH) is an angiogenic and inflammatory disease. Toll-like receptors (TLRs) transduce intracellular signals, resulting in the activation of nuclear factor kappa B (NF-kappa B), which leads to the production of inflammatory cytokines. High-mobility group box 1 (HMGB1) functions as a mediator of inflammatory responses through TLRs. In this study, we examined the expression of HMGB1 and components of the Toll-like receptor and NF-kappa B signaling pathways in the outer membrane of CSDH. Eight patients whose outer membrane was successfully obtained during trepanation surgery were included in this study. The expression of TLR4, myeloid differentiation factor 88 (MyD88), interleukin-1 receptor-associated kinase 4 (IRAK4), TNF receptor-associated factor 6 (TRAF6), TGF beta-activated kinase 1 (Tak1), interferon regulatory factors 3 (IRF3), I kappa B kinase beta (IKK beta), IKK gamma, I kappa B epsilon, I kappa B alpha, NF-kappa B/p65 and beta-actin was examined by Western blot analysis. The expression of TLR4, NF-kappa B/ p65 and interleukin-6 (IL-6) was also examined by immunohistochemistry. The concentrations of HMGB1 and IL-6 in CSDH fluids were measured using ELISA kits. Above-mentioned molecules were detected in all cases. In addition, TLR4, NF-kappa B/ p65 and IL-6 were localized in the endothelial cells of vessels within CSDH outer membranes. The concentrations of HMGB1 and IL-6 in CSDH fluids were significantly higher than that in the CSF and serum. There existed a correlation between the concentrations of HMGB1 and IL-6 in CSDH fluids. Our data suggest that HMGB1 in CSDH fluids produces the inflammatory cytokine IL-6 in endothelial cells through the Toll-like receptor and NF-kappa B signaling pathways. Anti-HMGB1 therapy might be a useful method to treat the growth of CSDH.	[Osuka, Koji; Iwami, Kenichiro; Miyachi, Shigeru; Takayasu, Masakazu] Aichi Med Univ Nagakute, Dept Neurol Surg, Nagakute, Aichi, Japan; [Watanabe, Yasuo] Showa Pharmaceut Univ, High Technol Res Ctr, Pharmacol, Machida, Tokyo, Japan; [Usuda, Nobuteru] Fujita Hlth Univ, Dept Anat 2, Sch Med, Toyoake, Aichi, Japan	Aichi Medical University; Showa Pharmaceutical University; Fujita Health University	Osuka, K (corresponding author), Aichi Med Univ Nagakute, Dept Neurol Surg, Nagakute, Aichi, Japan.	kosuka@aichi-med-u.ac.jp		Watanabe, Yasuo/0000-0003-2232-0091	 [17K10853]		Japanese Grant-in-Aid for Scientific Research (C), Grant Number 17K10853 (K.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama M, 2015, J NEUROTRAUM, V32, P1064, DOI 10.1089/neu.2014.3594; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Chen KB, 2011, SPINE, V36, P2122, DOI 10.1097/BRS.0b013e318203941c; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Cronin JG, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092718; Denk A, 2001, J BIOL CHEM, V276, P28451, DOI 10.1074/jbc.M102698200; Frati A, 2004, J NEUROSURG, V100, P24, DOI 10.3171/jns.2004.100.1.0024; Gao Y, 2009, BIOMED PHARMACOTHER, V63, P442, DOI 10.1016/j.biopha.2008.06.028; Gottipati S, 2008, CELL SIGNAL, V20, P269, DOI 10.1016/j.cellsig.2007.08.009; Hanafy KA, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-83; Hong HJ, 2009, SURG NEUROL, V71, P5; Hong HJ, 2009, SURG NEUROL, V71, P161, DOI 10.1016/j.surneu.2008.01.023; Jin JJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-23; JIRIK FR, 1989, J IMMUNOL, V142, P144; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kobayashi S, 2003, BIOCHEM BIOPH RES CO, V308, P306, DOI 10.1016/S0006-291X(03)01362-7; Lan L, 2013, INT J MOL MED, V31, P75, DOI 10.3892/ijmm.2012.1184; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Liu K, 2007, FASEB J, V21, P3904, DOI 10.1096/fj.07-8770com; MARUO N, 1992, ENDOCRINOLOGY, V131, P710, DOI 10.1210/en.131.2.710; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Okuma Y, 2012, ANN NEUROL, V72, P373, DOI 10.1002/ana.23602; Osuka K, 2017, NEUROSURGERY, V80, P571, DOI 10.1093/neuros/nyw100; Osuka K, 2016, WORLD NEUROSURG, V91, P376, DOI 10.1016/j.wneu.2016.04.025; Osuka K, 2013, NEUROSCI LETT, V534, P166, DOI 10.1016/j.neulet.2012.11.011; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Shin WH, 2015, SCI REP-UK, V5, DOI 10.1038/srep14764; Stanisic M, 2012, INFLAMM RES, V61, P845, DOI 10.1007/s00011-012-0476-0; STERPETTI AV, 1993, SURGERY, V114, P911; Sun L, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-1008-1; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; Wang LN, 2010, NEUROSCI LETT, V471, P152, DOI 10.1016/j.neulet.2010.01.030; Yokoyama T, 2006, LIVER INT, V26, P467, DOI 10.1111/j.1478-3231.2006.01254.x; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82	39	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0233643	10.1371/journal.pone.0233643	http://dx.doi.org/10.1371/journal.pone.0233643			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MJ2AA	32479555	gold, Green Published			2022-12-26	WOS:000547893500019
J	Semerdjieva, I; Petrova, G; Yankova-Tsvetkova, E; Doncheva, T; Kostova, N; Nikolova, R; Zheljazkov, VD				Semerdjieva, Ivanka; Petrova, Galya; Yankova-Tsvetkova, Elina; Doncheva, Tsvetelina; Kostova, Nadezhda; Nikolova, Rozalia; Zheljazkov, Valtcho D.			Genetic diversity, reproductive capacity and alkaloids content in three endemic Alkanna species	PLOS ONE			English	Article							TINCTORIA ROOT EXTRACTS; PYRROLIZIDINE ALKALOIDS; BORAGINACEAE; SYSTEMATICS; LITHOSPERMEAE; PLANTS; ITS1	The Balkans endemic species Alkanna primuliflora Griseb., A. stribrnyi Velen., and A. graeca Boiss. & Spruner have limited distribution in the Balkan Peninsula and a large variation in the morphological characteristics. The populations of the three Alkanna species in the Bulgarian flora are small and fragmented. There are no previous reports on the chemical profile or on the embryology of these species. The hypothesis was that the limited distribution of A. primuliflora, A. stribrnyi, and A. graeca was due to their reproductive capacity and genetic diversity. Furthermore, we hypothesized that the three species will contain pyrrolizidine alkaloids (PAs), as other species of the genus Alkanna (Boraginaceae), but they would have differential alkaloids composition. The population genetic structure and differentiation showed a clear distinction between species and revealed average levels of genetic diversity among the natural populations of the three Alkanna species. The embryological investigation observed stability of the processes in the male and female generative spheres and high viability of mature pollen and embryo of the three species. The normal formation of male and female gametophytes without deviations or degenerative processes, and observed levels of genetic diversity between Alkanna individuals are important in maintaining the size and resilience of the Alkanna populations. Eight alkaloids were identified by GC-MS in A. primuliflora and A. graeca and six alkaloids in A. stribrnyi. The main pyrrolizidine alkaloids (PAs) in all investigated species was triangularine. A. primuliflora and A. graeca showed similar chemical composition that comprised 9-angeloylretronecine, 7-tigloylretronecine, 9-tigloylretronecine, triangularicine, dihydroxytriangularine, dihydroxytriangularicine, whereas, in A. stribrnyi 9-tigloylretronecine, triangularicine and dihydroxytriangularicine were not found. This is the first report on the presence of PAs in A. primuliflora, A. stribrnyi and A. graeca. Besides, this is the first report on the embryology of these endemic species. The results contribute to the knowledge of the three endemic Alkanna species and will facilitate policy-making and defining new strategies for their conservation.	[Semerdjieva, Ivanka] Agr Univ, Fac Agron, Dept Bot & Agrometeorol, Plovdiv, Bulgaria; [Petrova, Galya] New Bulgarian Univ Sofia, Dept Nat Sci, Sofia, Bulgaria; [Yankova-Tsvetkova, Elina; Nikolova, Rozalia] Bulgarian Acad Sci, Inst Biodivers & Ecosyst Res, Dept Plant & Fungal Divers & Resources, Sofia, Bulgaria; [Doncheva, Tsvetelina; Kostova, Nadezhda] Bulgarian Acad Sci, Inst Organ Chem, Ctr Phytochem, Sofia, Bulgaria; [Zheljazkov, Valtcho D.] Oregon State Univ, Dept Crop & Soil Sci, Corvallis, OR 97331 USA	Agrarian University; New Bulgarian University; Bulgarian Academy of Sciences; Bulgarian Academy of Sciences; Oregon State University	Zheljazkov, VD (corresponding author), Oregon State Univ, Dept Crop & Soil Sci, Corvallis, OR 97331 USA.	Valtcho.Jeliazkov@oregonstate.edu	Semerdjieva, Ivanka/AAD-4355-2019	Semerdjieva, Ivanka/0000-0001-6015-7403	"Program for young scientists and post-doctoral students" of the Bulgarian Academy of Sciences in Sofia, Bulgaria; Oregon State University, United States	"Program for young scientists and post-doctoral students" of the Bulgarian Academy of Sciences in Sofia, Bulgaria; Oregon State University, United States	IS received financial support by the "Program for young scientists and post-doctoral students" of the Bulgarian Academy of Sciences in Sofia, Bulgaria. VDZ received financial support from Oregon State University, United States.	Aguilar R, 2006, ECOL LETT, V9, P968, DOI 10.1111/j.1461-0248.2006.00927.x; Akcin Oznur Ergen, 2004, Turkish Journal of Botany, V28, P591; Assimopoulou AN, 2005, PHYTOTHER RES, V19, P141, DOI 10.1002/ptr.1645; Assimopoulu AN, 2004, FOOD CHEM, V87, P433, DOI 10.1016/j.foodchem.2003.12.017; Bremer K, 2004, SYST BIOL, V53, P496, DOI 10.1080/10635150490445913; Clayton W, 1978, FLOWERING PLANTS WOR, P285; Davis G. L., 1966, SYSTEMATIC EMBRYOLOG; Doyle J. J., 1987, PHYTOCHEM B, P11; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; EAST E. M., 1940, PROC AMER PHIL SOC, V82, P449; Edgar JA, 2002, J AGR FOOD CHEM, V50, P2719, DOI 10.1021/jf0114482; El-Shazly A, 1998, BIOCHEM SYST ECOL, V26, P619, DOI 10.1016/S0305-1978(98)00028-3; El-Shazly A., 2014, Diversity, V6, P188, DOI 10.3390/d6020188; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Franklin-Tong VE, 2003, PHILOS T R SOC B, V358, P1025, DOI 10.1098/rstb.2003.1287; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hilger HH, 2004, ANN BOT-LONDON, V94, P201, DOI 10.1093/aob/mch132; Hojsgaard D, 2014, CRIT REV PLANT SCI, V33, P414, DOI 10.1080/07352689.2014.898488; HUIZING HJ, 1981, PLANT SYST EVOL, V137, P127, DOI 10.1007/BF00983210; KELLEY RB, 1992, PHYTOCHEMISTRY, V31, P2369, DOI 10.1016/0031-9422(92)83282-4; Khan UA, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0646-z; Kozuharov S., 1972, FLORA EUROPAEA, V3, P95; Langstrom E, 2002, PLANT SYST EVOL, V234, P137, DOI 10.1007/s00606-002-0195-z; LEWIS D., 1958, HEREDITY, V12, P233, DOI 10.1038/hdy.1958.26; Mattocks A.R., 1986, CHEM TOXICOLOGY PYRR; Metcalfe C.R., 1979, ANATOMY DICOTYLEDONS, P65; Moreira R, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061668; Tung NH, 2013, ANTI-CANCER DRUG, V24, P1058, DOI 10.1097/CAD.0000000000000017; Tung NH, 2013, PHYTOTHER RES, V27, P66, DOI 10.1002/ptr.4680; Papageorgiou VP, 2008, CURR MED CHEM, V15, P3248, DOI 10.2174/092986708786848532; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peters J., 2000, TETRAZOLIUM TESTING; Petrova G, 2014, PLANT SYST EVOL, V300, P29, DOI 10.1007/s00606-013-0857-z; Poddubnaya-Arnoldi V.A., 1976, CYTOEMBRYOLOGY ANGIO; Pritchard JK, 2000, GENETICS, V155, P945; Riedl H., 1978, FLORA IRANICA, V48, P1; RODER E, 1983, PLANTA MED, V49, P57, DOI 10.1055/s-2007-969812; ROEDER E, 1984, PHYTOCHEMISTRY, V23, P2125, DOI 10.1016/S0031-9422(00)85007-4; Roeder E., 1992, Fitoterapia, V63, P405; ROMEIS B, 1948, MIKROSKOPISCHE TECHN; Singh RJ., 2003, PLANT CYTOGENETICS; Strid A., 1991, MOUNTAIN FLORA GREEC, V2, P39; Sundara R.S., 2000, PRACTICAL MANUAL PLA; TETENYI P, 1974, Acta Botanica Academiae Scientiarum Hungaricae, V20, P159; Thiers B., 2012, VIRTUAL HERBARIUM; Thomas DC, 2008, TAXON, V57, P79, DOI 10.2307/25065950; Weigend M, 2009, MOL PHYLOGENET EVOL, V52, P755, DOI 10.1016/j.ympev.2009.05.013; Wolff K, 1997, MOL ECOL, V6, P365, DOI 10.1046/j.1365-294X.1997.00201.x	48	1	2	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0233516	10.1371/journal.pone.0233516	http://dx.doi.org/10.1371/journal.pone.0233516			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MJ2AA	32479498	gold, Green Published			2022-12-26	WOS:000547893500012
J	Tefera, YG; Alemayehu, M; Mekonnen, GB				Tefera, Yonas Getaye; Alemayehu, Mekuriaw; Mekonnen, Gashaw Binega			Prevalence and determinants of polypharmacy in cardiovascular patients attending outpatient clinic in Ethiopia University Hospital	PLOS ONE			English	Article							DRUG-USE; UNITED-STATES; OLDER-ADULTS; DISEASE; PEOPLE; CRITERIA	Background While there are advances in medicine and pharmaceutical care, the burden of medication use has also grown with polypharmacy. In this regard, cardiovascular patients are subjected to polypharmacy for a longer period. Objective The present study aimed to assess the prevalence and predictors of polypharmacy in cardiovascular outpatients attending the University of Gondar Comprehensive specialized hospital, northwest Ethiopia. Methods A hospital-based cross-sectional study was employed at the University of Gondar Comprehensive Specialized Hospital from March 30-May 30, 2019. The unique medical registration number of 424 patients was selected by using systematic random sampling to trace the medical chart and followed with an interview to explore the factors related to polypharmacy. All the Statistical analysis was carried out using Statistical Package for Social Sciences (SPSS) version 22. Bivariable and multivariable logistic regressions were used to identify the predictors of polypharmacy in cardiovascular patients. Result The mean age of the respondents was 56.83 +/- 15.27 years. The mean number of medications per patient was 3.3 +/- 1.6. The prevalence of polypharmacy was 24.8% in cardiovascular outpatients while cardiovascular specific polypharmacy was 9.2%. Elderly (aged >= 65 years and above) patients were nearly two times more likely to had polypharmacy prescriptions with AOR: 1.97; 95% CI: 1.08-3.61; p = 0.027. Patients with abnormal weight (underweight AOR: 4.51; 95% CI: 1.42-14.30; p = 0.010, overweight AOR: 3.78; 95% CI: 1.83-7.83; p<0.001 and obese AOR: 5.1; 95% CI: 2.04-12.75 p<0.001) are more likely to have polypharmacy. Having a family history of CVD increase the likelihood of polypharmacy more than double; AOR: 2.40; 95% CI: 1.17-4.93; p = 0.017. A unit increase in Charlson comorbidity index score resulted in a nearly threefold likelihood of polypharmacy with AOR: 2.83; 95% CI 1.91-3.89; p<0.001. Conclusion One out of four cardiovascular patients attending the outpatient clinic was on polypharmacy. The elderly age, abnormal body mass index (non-normal weight), family history of cardiovascular diseases and increasing Charlson morbidity index were the predictors of polypharmacy in cardiovascular patients. Clinicians should ensure the relevance of all prescribed medications and pharmaceutical care targeting at the prevention of inappropriate polypharmacy would be pivotal to reduce polypharmacy associated burdens.	[Tefera, Yonas Getaye] Univ Gondar, Coll Med & Hlth Sci, Sch Pharm, Dept Clin Pharm, Gondar, Ethiopia; [Alemayehu, Mekuriaw; Mekonnen, Gashaw Binega] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Gondar, Ethiopia	University of Gondar; University of Gondar	Tefera, YG (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Sch Pharm, Dept Clin Pharm, Gondar, Ethiopia.	yonas1get@gmail.com	mekonnen, Gashaw Binega/AAO-3178-2020	mekonnen, Gashaw Binega/0000-0002-2650-8668; Tefera, Yonas Getaye/0000-0002-9205-9442	University of Gondar	University of Gondar	Funding was received from University of Gondar to conduct this study.	Abebe SM, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015496; Abolhassani N, 2018, J CLIN EPIDEMIOL, V101, P1, DOI 10.1016/j.jclinepi.2018.05.002; Admassie E, 2013, J ADV PHARM TECHNOL, V4, P183, DOI 10.4103/2231-4040.121412; Al-Arifi MN, 2014, INT J REC SCI RES, V5, P1053; Appleton SC, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-58; Ashwell M, 2005, INT J FOOD SCI NUTR, V56, P303, DOI 10.1080/09637480500195066; Austin SR, 2015, MED CARE, V53, pE65, DOI 10.1097/MLR.0b013e318297429c; Baron-Franco B, 2017, BR J GEN PRACT; Betre M, 1997, E AFR MED J, V74, P376; Bjerrum L, 1998, EUR J CLIN PHARMACOL, V54, P197, DOI 10.1007/s002280050445; Castioni J, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2793-z; Chao C-T, 2015, MEDICINE, V94; Charlesworth CJ, 2015, J GERONTOL A-BIOL, V70, P989, DOI 10.1093/gerona/glv013; Cooper JA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009235; Derington CG, 2019, HYPERTENSION, V74, P267, DOI 10.1161/HYPERTENSIONAHA.119.12907; Fick DM, 2003, ARCH INTERN MED, V163, P2716, DOI 10.1001/archinte.163.22.2716; Fried TR, 2014, J AM GERIATR SOC, V62, P2261, DOI 10.1111/jgs.13153; Gu Qiuping, 2010, NCHS Data Brief, P1; Guthrie B, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0322-7; Haider SI, 2009, J AM GERIATR SOC, V57, P62, DOI 10.1111/j.1532-5415.2008.02040.x; Hovstadius Bo, 2009, BMC Clin Pharmacol, V9, P11, DOI 10.1186/1472-6904-9-11; Jyrkka J, 2009, DRUG AGING, V26, P493, DOI 10.2165/00002512-200926060-00006; Kantor ED, 2015, JAMA-J AM MED ASSOC, V314, P1818, DOI 10.1001/jama.2015.13766; KIM H, 2014, PLOS ONE, V9; Lafeber M, 2012, EUR J PREV CARDIOL, V19, P1234, DOI 10.1177/1741826711428066; Laslett LJ, 2012, J AM COLL CARDIOL, V60, pS1, DOI 10.1016/j.jacc.2012.11.002; Lopez-Jaramillo P, 2018, THER ADV CARDIO DIS, V12, P169, DOI 10.1177/1753944718764588; Maher RL, 2014, EXPERT OPIN DRUG SAF, V13, P57, DOI 10.1517/14740338.2013.827660; Moen J, 2009, ANN PHARMACOTHER, V43, P1978, DOI 10.1345/aph.1M354; Moges B, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-155; Mohammed MA, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018880; Mohammed MA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010035; Moriarty F, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008656; O'Mahony D, 2015, AGE AGEING, V44, P213, DOI 10.1093/ageing/afu145; Pache B, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1515-x; Pappa E, 2011, EUR J CLIN PHARMACOL, V67, P185, DOI 10.1007/s00228-010-0940-0; Rawle MJ, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0795-2; Tefera YG, 2019, PHARMACOL RES PERSPE, V7, DOI 10.1002/prp2.474; Tefera YG, 2017, VASC HEALTH RISK MAN, V13, P143, DOI 10.2147/VHRM.S131259; Tegegn HG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214191; Tseng HM, 2016, QUAL LIFE RES, V25, P1295, DOI 10.1007/s11136-015-1177-2; Veehof LJG, 2000, FAM PRACT, V17, P261, DOI 10.1093/fampra/17.3.261; Volpe M, 2010, FUND CLIN PHARMACOL, V24, P9, DOI 10.1111/j.1472-8206.2009.00757.x; Walckiers D, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0095-7	44	8	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0234000	10.1371/journal.pone.0234000	http://dx.doi.org/10.1371/journal.pone.0234000			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MJ2AA	32479516	gold, Green Published			2022-12-26	WOS:000547893500045
J	Varshney, M; Parel, JT; Raizada, N; Sarin, SK				Varshney, Mohit; Parel, Jithin Thomas; Raizada, Neeraj; Sarin, Shiv Kumar			Initial psychological impact of COVID-19 and its correlates in Indian Community: An online (FEEL-COVID) survey	PLOS ONE			English	Article							MENTAL-HEALTH; SOCIAL DESIRABILITY; OUTBREAK; STIGMA	Background The pandemic of Corona Virus (COVID-19) hit India recently; and the associated uncertainty is increasingly testing psychological resilience of the masses. When the global focus has mostly been on testing, finding a cure and preventing transmission; people are going through a myriad of psychological problems in adjusting to the current lifestyles and fear of the disease. Since there is a severe dearth of researches on this issue, we decided to conduct an online survey to evaluate its psychological impact. Methods From 26th to 29th March an online survey (FEEL-COVID) was conducted using principles of snowballing, and by invitation through text messages to participate. The survey collected data on socio-demographic and clinical variables related to COVID-19 (based on the current knowledge); along with measuring psychological impact with the help of Impact of Event-revised (IES-R) scale. Results There were a total of 1106 responses from around 64 cities in the country. Out of these 453 responses had at least one item missing; and were excluded from the analysis. The mean age of the respondents was around 41 years with a male female ratio of 3:1 and around 22% respondents were health care professionals. Overall approximately one third of respondents had significant psychological impact (IES-R score > 24). Higher psychological impact was predicted with younger age, female gender and comorbid physical illness. Presence of physical symptoms and contact history predicted higher psychological impact, but did not reach statistical significance. Conclusion During the initial stages of COVID-19 in India, almost one-third respondents had a significant psychological impact. This indicates a need for more systematic and longitudinal assessment of psychological needs of the population, which can help the government in formulating holistic interventions for affected individuals.	[Varshney, Mohit] Inst Liver & Biliary Sci ILBS, Dept Psychiat, New Delhi, India; [Parel, Jithin Thomas] Inst Liver & Biliary Sci LBS, Coll Nursing, New Delhi, India; [Raizada, Neeraj] Inst Liver & Biliary Sci ILBS, Dept Epidemiol & Clin Res, New Delhi, India; [Sarin, Shiv Kumar] Inst Liver & Biliary Sci ILBS, Dept Hepatol, New Delhi, India	Institute of Liver & Biliary Sciences (ILBS); Institute of Liver & Biliary Sciences (ILBS); Institute of Liver & Biliary Sciences (ILBS); Institute of Liver & Biliary Sciences (ILBS)	Varshney, M (corresponding author), Inst Liver & Biliary Sci ILBS, Dept Psychiat, New Delhi, India.	mkvarshney@ilbs.in	, Polly/AAX-2742-2020	THOMAS PAREL, JITHIN/0000-0003-1046-0759; Raizada, Neeraj/0000-0003-2116-332X				American Psychiatric Association, 2020, NEW POLL COVID 19 IM; Banerjee D., 2020, NAT INDIA, V26; Banerjee D, 2020, ASIAN J PSYCHIATR, V50, DOI 10.1016/j.ajp.2020.102014; Beck JG, 2008, J ANXIETY DISORD, V22, P187, DOI 10.1016/j.janxdis.2007.02.007; Cascella M, 2020, STATPEARLS; Chaturvedi Santosh K, 2020, J Psychosoc Rehabil Ment Health, V7, P1, DOI 10.1007/s40737-020-00162-z; Dong L, 2020, EMERG INFECT DIS, V26, P1616, DOI 10.3201/eid2607.200407; European Centre for Disease Prevention and Control (ECDC), 2019, NOV COR DIS 2019 COV; Galante O, 2016, AM J RESP CRIT CARE, V193, P100, DOI 10.1164/rccm.201506-1239LE; Goyal K, 2020, ASIAN J PSYCHIATR, V49, DOI 10.1016/j.ajp.2020.101989; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00597-2020; Hall RCW, 2008, GEN HOSP PSYCHIAT, V30, P446, DOI 10.1016/j.genhosppsych.2008.05.003; Henderson C, 2012, CAN J PSYCHIAT, V57, P152, DOI 10.1177/070674371205700304; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Kanwar A, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx052; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Lim GY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21243-x; Liu XH, 2012, COMPR PSYCHIAT, V53, P15, DOI 10.1016/j.comppsych.2011.02.003; Malinauskiene Vilija, 2016, Acta Med Litu, V23, P185, DOI 10.6001/actamedica.v23i3.3384; Michaels PJ, 2013, J MENT HEALTH, V22, P218, DOI 10.3109/09638237.2012.734652; Patel A, 2020, INITIAL PUBLIC HLTH, V69, P7; PTI, 2020, DECCAN HERALD; Rajkumar RP, 2020, ASIAN J PSYCHIATR, V52, DOI 10.1016/j.ajp.2020.102066; Shah K, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.7405; Shereen MA, 2020, J ADV RES, V24, P91, DOI 10.1016/j.jare.2020.03.005; Sonderskov KM, 2020, ACTA NEUROPSYCHIATR, V32, P226, DOI 10.1017/neu.2020.15; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072459; WHO, 2020, DIS CONS COVID 19 OU; WHO, 2020, WHO COR COVID 19 DAS; Xiang YT, 2020, LANCET PSYCHIAT, V7, P228, DOI 10.1016/S2215-0366(20)30046-8; Yao H, 2020, ASIAN J PSYCHIATR, V50, DOI 10.1016/j.ajp.2020.102015; Yao H, 2020, LANCET PSYCHIAT, V7, pE21, DOI 10.1016/S2215-0366(20)30090-0	32	125	129	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2020	15	5							e0233874	10.1371/journal.pone.0233874	http://dx.doi.org/10.1371/journal.pone.0233874			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LU1WS	32470088	Green Published, gold			2022-12-26	WOS:000537552800201
J	Nibbering, P; Petersen, BL; Motawia, MS; Jorgensen, B; Ulvskov, P; Niittyla, T				Nibbering, Pieter; Petersen, Bent L.; Motawia, Mohammed Saddik; Jorgensen, Bodil; Ulvskov, Peter; Niittyla, Totte			Golgi-localized exo-beta 1,3-galactosidases involved in cell expansion and root growth in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoside hydrolase 43; Golgi; glycosylation; arabinogalactan proteins; Arabidopsis; roots; cell expansion; plant cell wall; exo-beta 13-galactosidase; comprehensive microarray polymer profiling (CoMPP) microarray; cell wall; Arabidopsis thaliana; glycoside hydrolase; glycosidase; glycoprotein biosynthesis; arabinogalactan protein; exo-beta 1; 3-galactosidase	HYDROLASE FAMILY 43; ARABINOGALACTAN-PROTEINS; CELLULOSE BIOSYNTHESIS; II ARABINOGALACTAN; PLANT-GROWTH; WALL; IDENTIFICATION; PECTIN; POLYSACCHARIDE; ARABINOXYLAN	Plant arabinogalactan proteins (AGPs) are a diverse group of cell surface- and wall-associated glycoproteins. Functionally important AGP glycans are synthesized in the Golgi apparatus, but the relationships among their glycosylation levels, processing, and functionalities are poorly understood. Here, we report the identification and functional characterization of two Golgi-localized exo-beta-1,3-galactosidases from the glycosyl hydrolase 43 (GH43) family inArabidopsis thaliana. GH43 loss-of-function mutants exhibited root cell expansion defects in sugar-containing growth media. This root phenotype was associated with an increase in the extent of AGP cell wall association, as demonstrated by Yariv phenylglycoside dye quantification and comprehensive microarray polymer profiling of sequentially extracted cell walls. Characterization of recombinant GH43 variants revealed that the exo-beta-1,3-galactosidase activity of GH43 enzymes is hindered by beta-1,6 branches on beta-1,3-galactans. In line with this steric hindrance, the recombinant GH43 variants did not release galactose from cell wall-extracted glycoproteins or AGP-rich gum arabic. These results indicate that the lack of exo-beta-1,3-galactosidase activity alters cell wall extensibility in roots, a phenotype that could be explained by the involvement of galactosidases in AGP glycan biosynthesis.	[Nibbering, Pieter; Niittyla, Totte] Swedish Univ Agr Sci, Umea Plant Sci Ctr, Dept Forest Genet & Plant Physiol, S-90183 Umea, Sweden; [Petersen, Bent L.; Motawia, Mohammed Saddik; Jorgensen, Bodil; Ulvskov, Peter] Univ Copenhagen, Dept Plant & Environm Sci, DK-1871 Frederiksberg C, Denmark	Swedish University of Agricultural Sciences; Umea University; University of Copenhagen	Niittyla, T (corresponding author), Swedish Univ Agr Sci, Umea Plant Sci Ctr, Dept Forest Genet & Plant Physiol, S-90183 Umea, Sweden.	totte.niittyla@slu.se	Ulvskov, Peter/I-1228-2014; Petersen, Bent Larsen/H-9437-2014	Ulvskov, Peter/0000-0003-3776-818X; Niittyla, Totte/0000-0001-8029-1503; Petersen, Bent Larsen/0000-0002-2004-9077	Swedish Foundation for Strategic Research (Value Tree); Bio4-Energy (Swedish Programme for Renewable Energy); Swedish Research Council for Sustainable Development (Formas); UPSC Centre for Forest Biotechnology - VINNOVA	Swedish Foundation for Strategic Research (Value Tree); Bio4-Energy (Swedish Programme for Renewable Energy); Swedish Research Council for Sustainable Development (Formas)(Swedish Research Council Formas); UPSC Centre for Forest Biotechnology - VINNOVA	This work was supported by The Swedish Foundation for Strategic Research (Value Tree), Bio4-Energy (Swedish Programme for Renewable Energy), the UPSC Centre for Forest Biotechnology funded by VINNOVA, and the Swedish Research Council for Sustainable Development (Formas).	AKIYAMA Y, 1984, AGR BIOL CHEM TOKYO, V48, P235, DOI 10.1080/00021369.1984.10866126; [Anonymous], 2013, BIOPROTOCOL, DOI DOI 10.21769/BioProtoc.918; Bashline L, 2014, MOL PLANT, V7, P586, DOI 10.1093/mp/ssu018; Basu D, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0670-7; Basu D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125624; BENFEY PN, 1993, DEVELOPMENT, V119, P57; Cosgrove DJ, 2014, CURR OPIN PLANT BIOL, V22, P122, DOI 10.1016/j.pbi.2014.11.001; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Dilokpimol A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-90; Du H, 1996, TRENDS CELL BIOL, V6, P411, DOI 10.1016/S0962-8924(96)20036-4; Ellis M, 2010, PLANT PHYSIOL, V153, P403, DOI 10.1104/pp.110.156000; French AP, 2008, NAT PROTOC, V3, P619, DOI 10.1038/nprot.2008.31; Gandla ML, 2015, PHYTOCHEMISTRY, V112, P210, DOI 10.1016/j.phytochem.2014.06.002; Geldner N, 2009, PLANT J, V59, P169, DOI 10.1111/j.1365-313X.2009.03851.x; Geshi N, 2013, PLANT J, V76, P128, DOI 10.1111/tpj.12281; Gille S, 2013, MOL PLANT, V6, P1369, DOI 10.1093/mp/sst029; Grebe M, 2003, CURR BIOL, V13, P1378, DOI 10.1016/S0960-9822(03)00538-4; Gu Y, 2010, P NATL ACAD SCI USA, V107, P12866, DOI 10.1073/pnas.1007092107; Gunl M, 2011, PLANT CELL, V23, P4025, DOI 10.1105/tpc.111.089193; Gunl M, 2011, PLANTA, V233, P707, DOI 10.1007/s00425-010-1330-7; Haque A, 2005, BIOSCI BIOTECH BIOCH, V69, P2170, DOI 10.1271/bbb.69.2170; Harholt J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035846; Harholt J, 2010, PLANT PHYSIOL, V153, P384, DOI 10.1104/pp.110.156588; HAUSER MT, 1995, DEVELOPMENT, V121, P1237; Hernandez-Gomez MC, 2015, FEBS LETT, V589, P2297, DOI 10.1016/j.febslet.2015.07.009; Hijazi May, 2014, Front Plant Sci, V5, P395, DOI 10.3389/fpls.2014.00395; Ichinose H, 2005, J BIOL CHEM, V280, P25820, DOI 10.1074/jbc.M501024200; Ichinose H, 2006, APPL ENVIRON MICROB, V72, P3515, DOI 10.1128/AEM.72.5.3515-3523.2006; Jiang DH, 2012, J STRUCT BIOL, V180, P447, DOI 10.1016/j.jsb.2012.08.005; Jones L, 1997, PLANT PHYSIOL, V113, P1405, DOI 10.1104/pp.113.4.1405; Jordan DB, 2013, APPL MICROBIOL BIOT, V97, P4415, DOI 10.1007/s00253-012-4475-4; Kaji E, 2010, TETRAHEDRON LETT, V51, P1570, DOI 10.1016/j.tetlet.2010.01.048; KEEGSTRA K, 1973, PLANT PHYSIOL, V51, P188, DOI 10.1104/pp.51.1.188; Kitazawa K, 2013, PLANT PHYSIOL, V161, P1117, DOI 10.1104/pp.112.211722; Knoch E, 2013, PLANT J, V76, P1016, DOI 10.1111/tpj.12353; Kotake T, 2009, BIOSCI BIOTECH BIOCH, V73, P2303, DOI 10.1271/bbb.90433; KOVAC P, 1984, CARBOHYD RES, V128, P101, DOI 10.1016/0008-6215(84)85088-0; KOVAC P, 1985, CARBOHYD RES, V142, P158, DOI 10.1016/S0008-6215(00)90746-8; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; Liebminger E, 2009, PLANT CELL, V21, P3850, DOI 10.1105/tpc.109.072363; Marcus SE, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-60; McCleary BV, 2015, CARBOHYD RES, V407, P79, DOI 10.1016/j.carres.2015.01.017; Mewis K, 2016, APPL ENVIRON MICROB, V82, P1686, DOI 10.1128/AEM.03453-15; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Moller IE, 2012, JOVE-J VIS EXP, DOI 10.3791/4238; Nguema-Ona E, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00499; Ogawa-Ohnishi M, 2015, PLANT J, V81, P736, DOI 10.1111/tpj.12764; Oikawa A, 2013, TRENDS PLANT SCI, V18, P49, DOI 10.1016/j.tplants.2012.07.002; Parsons HT, 2019, PLANT CELL, V31, P2010, DOI 10.1105/tpc.19.00081; Parsons HT, 2012, PLANT PHYSIOL, V159, P12, DOI 10.1104/pp.111.193151; Peaucelle A, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00121; PENNELL RI, 1991, PLANT CELL, V3, P1317, DOI 10.1105/tpc.3.12.1317; Ralet MC, 2010, PLANTA, V231, P1373, DOI 10.1007/s00425-010-1116-y; Rende U, 2017, NEW PHYTOL, V214, P796, DOI 10.1111/nph.14392; Rose JKC, 2010, PLANT PHYSIOL, V153, P433, DOI 10.1104/pp.110.154872; Ruprecht C, 2017, PLANT PHYSIOL, V175, P1094, DOI 10.1104/pp.17.00737; Sanchez-Rodriguez C, 2012, PLANT CELL, V24, P589, DOI 10.1105/tpc.111.094672; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Schindelman G, 2001, GENE DEV, V15, P1115, DOI 10.1101/gad.879101; Showalter AM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00814; Showalter AM, 2010, PLANT PHYSIOL, V153, P485, DOI 10.1104/pp.110.156554; SHOWALTER AM, 1993, PLANT CELL, V5, P9, DOI 10.1105/tpc.5.1.9; SMALLWOOD M, 1994, PLANT J, V5, P237, DOI 10.1046/j.1365-313X.1994.05020237.x; Smallwood M, 1996, PLANTA, V198, P452, DOI 10.1007/BF00620063; Suzuki T, 2017, PLANT PHYSIOL, V173, P183, DOI 10.1104/pp.16.01385; Tan L, 2004, J BIOL CHEM, V279, P13156, DOI 10.1074/jbc.M311864200; Tan L, 2013, PLANT CELL, V25, P270, DOI 10.1105/tpc.112.107334; Tan L, 2010, J BIOL CHEM, V285, P24575, DOI 10.1074/jbc.M109.100149; Tryfona T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093291; Tryfona T, 2012, PLANT PHYSIOL, V160, P653, DOI 10.1104/pp.112.202309; Tryfona T, 2010, CARBOHYD RES, V345, P2648, DOI 10.1016/j.carres.2010.09.018; Uemura T, 2004, CELL STRUCT FUNCT, V29, P49, DOI 10.1247/csf.29.49; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; Verhertbruggen Y, 2009, CARBOHYD RES, V344, P1858, DOI 10.1016/j.carres.2008.11.010; Wang T, 2015, PLANT PHYSIOL, V168, P871, DOI 10.1104/pp.15.00665; Wang T, 2012, BIOCHEMISTRY-US, V51, P9846, DOI 10.1021/bi3015532; Wu YY, 2010, J BIOL CHEM, V285, P13638, DOI 10.1074/jbc.M110.102715; Xue H, 2017, PLANT J, V91, P613, DOI 10.1111/tpj.13591; Yapo BM, 2011, POLYM REV, V51, P391, DOI 10.1080/15583724.2011.615962; Yates EA, 1996, GLYCOBIOLOGY, V6, P131, DOI 10.1093/glycob/6.2.131	80	9	9	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2020	295	31					10581	10592		10.1074/jbc.RA120.013878	http://dx.doi.org/10.1074/jbc.RA120.013878			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB3HM	32493777	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000560405600007
J	Watanabe, K; Taketomi, Y; Miki, Y; Kugiyama, K; Murakami, M				Watanabe, Kazuhiro; Taketomi, Yoshitaka; Miki, Yoshimi; Kugiyama, Kiyotaka; Murakami, Makoto			Group V secreted phospholipase A(2) plays a protective role against aortic dissection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aortic dissection; animal model; phospholipase A2; phospholipid metabolism; fatty acid; lipidomics; lysyl oxidase; extracellular matrix; cardiovascular disorder; aortopathy; phospholipase; gene knockout; cardiovascular disease	ARACHIDONIC-ACID RELEASE; LYSYL OXIDASE; ENDOTHELIAL-CELLS; INFLAMMATORY RESPONSES; ANEURYSM FORMATION; PATHOGENIC ROLE; ATHEROSCLEROSIS; EXPRESSION; APOE(-/-); SPLA(2)	Aortic dissection is a life-threatening aortopathy involving separation of the aortic wall, whose underlying mechanisms are still incompletely understood. Epidemiological evidence suggests that unsaturated fatty acids improve cardiovascular health. Here, using quantitative RT-PCR, histological analyses, magnetic cell sorting and flow cytometry assays, and MS-based lipidomics, we show that the activity of a lipid-metabolizing enzyme, secreted phospholipase A(2) group V (sPLA(2)-V), protects against aortic dissection by endogenously mobilizing vasoprotective lipids. Global and endothelial cell-specific sPLA(2)-V-deficient mice frequently developed aortic dissection shortly after infusion of angiotensin II (AT-II). We observed that in the AT-II-treated aorta, endothelial sPLA(2)-V mobilized oleic and linoleic acids, which attenuated endoplasmic reticulum stress, increased the expression of lysyl oxidase, and thereby stabilized the extracellular matrix in the aorta. Of note, dietary supplementation with oleic or linoleic acid reversed the increased susceptibility of sPLA(2)-V-deficient mice to aortic dissection. These findings reveal an unexplored functional link between sPLA(2)-driven phospholipid metabolism and aortic stability, possibly contributing to the development of improved diagnostic and/or therapeutic strategies for preventing aortic dissection.	[Watanabe, Kazuhiro; Kugiyama, Kiyotaka] Univ Yamanashi, Fac Med, Dept Internal Med 2, Chuo Ku, Yamanashi, Japan; [Watanabe, Kazuhiro; Taketomi, Yoshitaka; Miki, Yoshimi; Murakami, Makoto] Tokyo Metropolitan Inst Med Sci, Lipid Metab Project, Tokyo, Japan; [Taketomi, Yoshitaka; Miki, Yoshimi; Murakami, Makoto] Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Lab Microenvironm & Metab Hlth Sci, Tokyo, Japan; [Kugiyama, Kiyotaka; Murakami, Makoto] Japan Agcy Med Res & Dev, AMED CREST, Tokyo, Japan; [Murakami, Makoto] Japan Agcy Med Res & Dev, FORCE, Tokyo, Japan	University of Yamanashi; Tokyo Metropolitan Institute of Medical Science; University of Tokyo	Kugiyama, K (corresponding author), Univ Yamanashi, Fac Med, Dept Internal Med 2, Chuo Ku, Yamanashi, Japan.; Murakami, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Lipid Metab Project, Tokyo, Japan.; Murakami, M (corresponding author), Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Lab Microenvironm & Metab Hlth Sci, Tokyo, Japan.; Kugiyama, K; Murakami, M (corresponding author), Japan Agcy Med Res & Dev, AMED CREST, Tokyo, Japan.; Murakami, M (corresponding author), Japan Agcy Med Res & Dev, FORCE, Tokyo, Japan.	kugiyama@yamanashi.ac.jp; makmurak@m.u-tokyo.ac.jp		Miki, Yoshimi/0000-0002-8587-0333	AMED-CREST Grant from the Japan Agency for Medical Research and Development [JP18gm0710006]; FORCE Grant from the Japan Agency for Medical Research and Development [JP19gm4010005]; Japan Society for the Promotion of Science KAKENHI Grants [JP15H05905, JP16H02613, JP18H05025, 25860591, 16K19436, 19K07502]	AMED-CREST Grant from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); FORCE Grant from the Japan Agency for Medical Research and Development; Japan Society for the Promotion of Science KAKENHI Grants(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by AMED-CREST Grant JP18gm0710006 and FORCE Grant JP19gm4010005 from the Japan Agency for Medical Research and Development (to M. M.) and Japan Society for the Promotion of Science KAKENHI Grants JP15H05905, JP16H02613, and JP18H05025 (to M. M.) and 25860591, 16K19436, and 19K07502 (to K. W.).	Ait-Oufella H, 2013, ARTERIOSCL THROM VAS, V33, P466, DOI 10.1161/ATVBAHA.112.300309; Balsinde J, 2000, J BIOL CHEM, V275, P4783, DOI 10.1074/jbc.275.7.4783; Bernatchez PN, 2001, BRIT J PHARMACOL, V134, P197, DOI 10.1038/sj.bjp.0704215; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bostrom MA, 2007, ARTERIOSCL THROM VAS, V27, P600, DOI 10.1161/01.ATV.0000257133.60884.44; Boyanovsky B, 2009, ARTERIOSCL THROM VAS, V29, P532, DOI 10.1161/ATVBAHA.108.183038; Boyanoysky BB, 2012, AM J PATHOL, V181, P1088, DOI 10.1016/j.ajpath.2012.05.037; Chen CA, 2018, LIFE SCI, V209, P9, DOI 10.1016/j.lfs.2018.07.050; CHEN J, 1994, J BIOL CHEM, V269, P2365; Chu IM, 2012, ONCOGENE, V31, P2017, DOI 10.1038/onc.2011.382; Coady Michael A., 1999, Cardiology Clinics, V17, P637, DOI 10.1016/S0733-8651(05)70106-5; Degousee N, 2002, J BIOL CHEM, V277, P5061, DOI 10.1074/jbc.M109083200; Estruch R, 2018, NEW ENGL J MED, V378, DOI [10.1056/NEJMoa1800389, 10.1056/nejmoa1800389]; Fraser H, 2009, J CARDIOVASC PHARM, V53, P60, DOI 10.1097/FJC.0b013e318195bfbc; Getz GS, 2016, ARTERIOSCL THROM VAS, V36, P1734, DOI 10.1161/ATVBAHA.116.306874; Getz GS, 2016, J LIPID RES, V57, P758, DOI 10.1194/jlr.R067249; Ghesquiere SAI, 2005, J LIPID RES, V46, P201, DOI 10.1194/jlr.M400253-JLR200; Guasch-Ferre M, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-78; Guo DC, 2016, CIRC RES, V118, P928, DOI 10.1161/CIRCRESAHA.115.307130; Han WK, 2003, J BIOL CHEM, V278, P24153, DOI 10.1074/jbc.M300424200; Ishiyama J, 2011, J LIPID RES, V52, P299, DOI 10.1194/jlr.m007104; Khan NS, 2015, HYPERTENSION, V65, P784, DOI 10.1161/HYPERTENSIONAHA.114.04803; Kikawada E, 2007, BLOOD, V110, P561, DOI 10.1182/blood-2006-10-052258; Kimura T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04051; Kugiyama K, 2000, AM J CARDIOL, V86, P718, DOI 10.1016/S0002-9149(00)01069-9; Kugiyama K, 1999, CIRCULATION, V100, P1280, DOI 10.1161/01.CIR.100.12.1280; Kurihara T, 2012, CIRCULATION, V126, P3070, DOI 10.1161/CIRCULATIONAHA.112.097097; Lee VS, 2016, P NATL ACAD SCI USA, V113, P8759, DOI 10.1073/pnas.1601442113; Lopez-Sagaseta J, 2012, BLOOD, V119, P2914, DOI 10.1182/blood-2011-05-353409; Luchtefeld M, 2007, ATHEROSCLEROSIS, V194, P62, DOI 10.1016/j.atherosclerosis.2006.09.024; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Maki JM, 2005, AM J PATHOL, V167, P927, DOI 10.1016/S0002-9440(10)61183-2; Mallat Z, 2005, J AM COLL CARDIOL, V46, P1249, DOI 10.1016/j.jacc.2005.06.056; Martin R, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020396; Martinez-Gonzalez MA, 2019, CIRC RES, V124, P779, DOI 10.1161/CIRCRESAHA.118.313348; Masuda S, 2005, BBA-MOL CELL BIOL L, V1736, P200, DOI 10.1016/j.bbalip.2005.08.014; Miki Y, 2013, J EXP MED, V210, P1217, DOI 10.1084/jem.20121887; MURAKAMI M, 1993, J BIOL CHEM, V268, P839; Murakami M, 2001, J BIOL CHEM, V276, P10083, DOI 10.1074/jbc.M007877200; Murakami M, 1998, J BIOL CHEM, V273, P14411, DOI 10.1074/jbc.273.23.14411; Murakami M, 2015, J LIPID RES, V56, P1248, DOI 10.1194/jlr.R058123; Murase R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12434-z; Mussa FF, 2016, JAMA-J AM MED ASSOC, V316, P754, DOI 10.1001/jama.2016.10026; NAKAMURA H, 1995, J CLIN INVEST, V95, P1062, DOI 10.1172/JCI117752; Nicholls SJ, 2014, JAMA-J AM MED ASSOC, V311, P252, DOI 10.1001/jama.2013.282836; Nienaber CA, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.53, 10.1038/nrdp.2016.71]; Nienaber CA, 2015, LANCET, V385, P800, DOI 10.1016/S0140-6736(14)61005-9; Ohta S, 2013, J IMMUNOL, V190, P5927, DOI 10.4049/jimmunol.1203202; Ovchinnikova OA, 2014, J INTERN MED, V276, P525, DOI 10.1111/joim.12228; Qiang GF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11378; RAO GN, 1994, BIOCHEM J, V299, P197, DOI 10.1042/bj2990197; Ren WH, 2016, SCI REP-UK, V6, DOI 10.1038/srep28149; Rodriguez C, 2002, ARTERIOSCL THROM VAS, V22, P1409, DOI 10.1161/01.ATV.0000033818.21748.99; Rodriguez C, 2008, CARDIOVASC RES, V79, P7, DOI 10.1093/cvr/cvn102; Rosengren B, 2006, ARTERIOSCL THROM VAS, V26, P1579, DOI 10.1161/01.ATV.0000221231.56617.67; Rousseau M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116812; Saraff K, 2003, ARTERIOSCL THROM VAS, V23, P1621, DOI 10.1161/01.ATV.0000085631.76095.64; Sato H, 2014, CELL METAB, V20, P119, DOI 10.1016/j.cmet.2014.05.002; Sawada H, 1999, EUR J BIOCHEM, V263, P826, DOI 10.1046/j.1432-1327.1999.00565.x; Son BK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7994; Sonoki K, 2008, BRIT J PHARMACOL, V153, P1399, DOI 10.1038/bjp.2008.12; Sonoki K, 2012, J CARDIOVASC PHARM, V60, P367, DOI 10.1097/FJC.0b013e3182646ccc; Taketomi Y, 2013, NAT IMMUNOL, V14, P554, DOI 10.1038/ni.2586; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Trachet B, 2017, CARDIOVASC RES, V113, P1230, DOI 10.1093/cvr/cvx128; Voloshenyuk TG, 2011, CYTOKINE, V55, P90, DOI 10.1016/j.cyto.2011.03.024; Watanabe K, 2012, AM J PHYSIOL-HEART C, V302, pH95, DOI 10.1152/ajpheart.00695.2011; Yamaguchi M, 2018, MUCOSAL IMMUNOL, V11, P615, DOI 10.1038/mi.2017.99; Yamamoto K, 2017, METHOD ENZYMOL, V583, P101, DOI 10.1016/bs.mie.2016.09.007; Yamamoto K, 2015, J EXP MED, V212, P1901, DOI 10.1084/jem.20141904; Yamamoto K, 2011, J BIOL CHEM, V286, P11616, DOI 10.1074/jbc.M110.206714; Yano T, 2011, CARDIOVASC RES, V90, P335, DOI 10.1093/cvr/cvq399; Zack M, 2011, ATHEROSCLEROSIS, V214, P58, DOI 10.1016/j.atherosclerosis.2010.08.054	73	7	8	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2020	295	30					10092	10111		10.1074/jbc.RA120.013753	http://dx.doi.org/10.1074/jbc.RA120.013753			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MW0BV	32482892	Green Published, hybrid			2022-12-26	WOS:000556713400001
J	de Krijger, I; van der Torre, J; Peuscher, MH; Eder, M; Jacobs, JJL				de Krijger, Inge; van der Torre, Jaco; Peuscher, Marieke H.; Eder, Mathias; Jacobs, Jacqueline J. L.			H3K36 dimethylation by MMSET promotes classical non-homologous end-joining at unprotected telomeres	ONCOGENE			English	Article							DNA-DAMAGE RESPONSE; HISTONE H3; HOMOLOGOUS RECOMBINATION; LYSINE 36; DYSFUNCTIONAL TELOMERES; MAMMALIAN TELOMERES; REPAIR; 53BP1; CHROMATIN; METHYLATION	The epigenetic environment plays an important role in DNA damage recognition and repair, both at DNA double-strand breaks and at deprotected telomeres. To increase understanding on how DNA damage responses (DDR) at deprotected telomeres are regulated by modification and remodeling of telomeric chromatin we screened 38 methyltransferases for their ability to promote telomere dysfunction-induced genomic instability. As top hit we identified MMSET, a histone methyltransferase (HMT) causally linked to multiple myeloma and Wolf-Hirschhorn syndrome. We show that MMSET promotes non-homologous end-joining (NHEJ) at deprotected telomeres through Ligase4-dependent classical NHEJ, and does not contribute to Ligase3-dependent alternative NHEJ. Moreover, we show that this is dependent on the catalytic activity of MMSET, enabled by its SET-domain. Indeed, in absence of MMSET H3K36-dimethylation (H3K36me2) decreases, both globally and at subtelomeric regions. Interestingly, the level of MMSET-dependent H3K36me2 directly correlates with NHEJ-efficiency. We show that MMSET depletion does not impact on recognition of deprotected telomeres by the DDR-machinery or on subsequent recruitment of DDR-factors acting upstream or at the level of DNA repair pathway choice. Our data are most consistent with an important role for H3K36me2 in more downstream steps of the DNA repair process. Moreover, we find additional H3K36me2-specific HMTs to contribute to NHEJ at deprotected telomeres, further emphasizing the importance of H3K36me2 in DNA repair.	[de Krijger, Inge; van der Torre, Jaco; Peuscher, Marieke H.; Eder, Mathias; Jacobs, Jacqueline J. L.] Netherlands Canc Inst, Div Oncogen, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Jacobs, JJL (corresponding author), Netherlands Canc Inst, Div Oncogen, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	j.jacobs@nki.nl	Jacobs, Jacqueline/ABA-5652-2020	Jacobs, Jacqueline/0000-0002-7704-4795; Peuscher, Marieke/0000-0001-9410-4350; van der Torre, Jaco/0000-0002-5405-3824				Arnoult N, 2015, NAT STRUCT MOL BIOL, V22, P859, DOI 10.1038/nsmb.3092; Aymard F, 2014, NAT STRUCT MOL BIOL, V21, P366, DOI 10.1038/nsmb.2796; Bartocci C, 2014, CELL REP, V7, P1320, DOI 10.1016/j.celrep.2014.04.002; Benetti R, 2007, NAT GENET, V39, P243, DOI 10.1038/ng1952; Bennett RL, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a026708; Bergemann AD, 2005, TRENDS GENET, V21, P188, DOI 10.1016/j.tig.2005.01.008; Blackford AN, 2017, MOL CELL, V66, P801, DOI 10.1016/j.molcel.2017.05.015; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Boersma V, 2015, NATURE, V521, P537, DOI 10.1038/nature14216; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Cao LL, 2016, ONCOGENE, V35, P301, DOI 10.1038/onc.2015.81; Carvalho S, 2014, ELIFE, V3, DOI 10.7554/eLife.02482; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Celli GB, 2006, NAT CELL BIOL, V8, P885, DOI 10.1038/ncb1444; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Chesi M, 1998, BLOOD, V92, P3025, DOI 10.1182/blood.V92.9.3025.421k53_3025_3034; Clouaire T, 2015, NUCLEUS-PHILA, V6, P107, DOI 10.1080/19491034.2015.1010946; Clouaire T, 2018, MOL CELL, V72, P250, DOI 10.1016/j.molcel.2018.08.020; Coussens NP, 2018, J BIOL CHEM, V293, P13750, DOI 10.1074/jbc.RA118.004274; de Lange T, 2010, COLD SH Q B, V75, P167, DOI 10.1101/sqb.2010.75.017; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; Di Virgilio M, 2013, SCIENCE, V339, P711, DOI 10.1126/science.1230624; Dimitrova N, 2009, MOL CELL BIOL, V29, P5552, DOI 10.1128/MCB.00476-09; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Fnu S, 2011, P NATL ACAD SCI USA, V108, P540, DOI 10.1073/pnas.1013571108; Fortuny A, 2018, CHROMOSOMA, V127, P291, DOI 10.1007/s00412-018-0669-6; Fradet-Turcotte A, 2013, NATURE, V499, P50, DOI 10.1038/nature12318; Nguyen HV, 2017, P NATL ACAD SCI USA, V114, pE10560, DOI 10.1073/pnas.1701366114; Hajdu I, 2011, P NATL ACAD SCI USA, V108, P13130, DOI 10.1073/pnas.1110081108; Hartlerode AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049211; Hsiao KY, 2013, J MOL CELL BIOL, V5, P157, DOI 10.1093/jmcb/mjs066; Hsu HL, 2000, GENE DEV, V14, P2807, DOI 10.1101/gad.844000; Hudlebusch HR, 2011, CLIN CANCER RES, V17, P2919, DOI 10.1158/1078-0432.CCR-10-1302; Jacquet K, 2016, MOL CELL, V62, P409, DOI 10.1016/j.molcel.2016.03.031; Jha DK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4965; Jiang WX, 2015, MOL CELL, V58, P172, DOI 10.1016/j.molcel.2015.02.024; Kassambara A, 2009, BIOCHEM BIOPH RES CO, V379, P840, DOI 10.1016/j.bbrc.2008.12.093; Kim JY, 2008, MOL CELL BIOL, V28, P2023, DOI 10.1128/MCB.02130-07; Konishi A, 2008, GENE DEV, V22, P1221, DOI 10.1101/gad.1634008; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Lauring J, 2008, BLOOD, V111, P856, DOI 10.1182/blood-2007-05-088674; Li Y, 2009, J BIOL CHEM, V284, P34283, DOI 10.1074/jbc.M109.034462; Luijsterburg MS, 2016, MOL CELL, V61, P547, DOI 10.1016/j.molcel.2016.01.019; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Marango J, 2008, BLOOD, V111, P3145, DOI 10.1182/blood-2007-06-092122; Martinez-Garcia E, 2011, BLOOD, V117, P211, DOI 10.1182/blood-2010-07-298349; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Nimura K, 2009, NATURE, V460, P287, DOI 10.1038/nature08086; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; Pai CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5091; Pei HD, 2013, J IMMUNOL, V190, P756, DOI 10.4049/jimmunol.1201811; Pei HD, 2011, NATURE, V470, P124, DOI 10.1038/nature09658; Peuscher MH, 2011, NAT CELL BIOL, V13, P1139, DOI 10.1038/ncb2326; Pfister SX, 2014, CELL REP, V7, P2006, DOI 10.1016/j.celrep.2014.05.026; Popovic R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004566; Porro A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6379; Ribes-Zamora A, 2013, CELL REP, V5, P194, DOI 10.1016/j.celrep.2013.08.040; Sallmyr A, 2018, J BIOL CHEM, V293, P10536, DOI 10.1074/jbc.TM117.000375; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; Shah MY, 2016, ONCOGENE, V35, P5905, DOI 10.1038/onc.2016.116; Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X; Stec I, 1998, HUM MOL GENET, V7, P1071, DOI 10.1093/hmg/7.7.1071; Symington LS, 2016, CRIT REV BIOCHEM MOL, V51, P195, DOI 10.3109/10409238.2016.1172552; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tang JB, 2013, NAT STRUCT MOL BIOL, V20, P317, DOI 10.1038/nsmb.2499; Todoerti K, 2005, BRIT J HAEMATOL, V131, P214, DOI 10.1111/j.1365-2141.2005.05741.x; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tuzon CT, 2014, CELL REP, V8, P429, DOI 10.1016/j.celrep.2014.06.013; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Zhang JF, 2019, CANCER DISCOV, V9, P1306, DOI 10.1158/2159-8290.CD-18-0083; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	73	9	9	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 18	2020	39	25					4814	4827		10.1038/s41388-020-1334-0	http://dx.doi.org/10.1038/s41388-020-1334-0			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LZ3HT	32472076	Green Published, hybrid			2022-12-26	WOS:000541119400003
J	Liu, Q; Sun, CY; Han, JZ; Li, L; Wang, KY; Wang, YF; Chen, J; Zhao, MZ; Wang, Y; Zhang, MP				Liu, Qian; Sun, Chunyu; Han, Jiazhuang; Li, Li; Wang, Kangyu; Wang, Yanfang; Chen, Jing; Zhao, Mingzhu; Wang, Yi; Zhang, Meiping			Identification, characterization and functional differentiation of theNAC gene family and its roles in response to cold stress in ginseng,Panax ginseng CA Meyer	PLOS ONE			English	Article							NAC TRANSCRIPTION FACTOR; GENOME-WIDE ANALYSIS; EXPRESSION ANALYSIS; TOLERANCE; ARABIDOPSIS; OVEREXPRESSION; DEHYDRATION; GINSENG	TheNACgene family is one of the important plant-specific transcription factor families involved in variety of physiological processes. It has been found in several plant species; however, little is known about the gene family in ginseng,Panax ginsengC.A. Meyer. Here we report identification and systematic analysis of this gene family in ginseng. A total of 89NACgenes, designatedPgNAC01toPgNAC89, are identified. These genes are alternatively spliced into 251 transcripts at fruiting stage of a four-year-old ginseng plant. The genes of this gene family have five conserved motifs and are clustered into 11 subfamilies, all of which are shared with the genes of theNACgene families identified in the dicot and monocot model plant species, Arabidopsis and rice. This result indicates that thePgNACgene family is an ancient and evolutionarily inactive gene family. Gene ontology (GO) analysis shows that the functions of thePgNACgene family have been substantially differentiated; nevertheless, over 86% thePgNACtranscripts remain functionally correlated. Finally, five of thePgNACgenes,PgNAC05-2,PgNAC41-2,PgNAC48,PgNAC56-1, andPgNAC59, are identified to be involved in plant response to cold stress, suggesting that this gene family plays roles in response to cold stress in ginseng. These results, therefore, provide new insights into functional differentiation and evolution of a gene family in plants and gene resources necessary to comprehensively determine the functions of thePgNACgene family in response to cold and other abiotic stresses in ginseng.	[Liu, Qian; Sun, Chunyu; Han, Jiazhuang; Li, Li; Wang, Kangyu; Wang, Yanfang; Chen, Jing; Zhao, Mingzhu; Wang, Yi; Zhang, Meiping] Jilin Agr Univ, Coll Life Sci, Changchun, Jilin, Peoples R China; [Liu, Qian; Sun, Chunyu; Han, Jiazhuang; Li, Li; Wang, Kangyu; Wang, Yanfang; Chen, Jing; Zhao, Mingzhu; Wang, Yi; Zhang, Meiping] Res Ctr Ginseng Genet Resources Dev & Utilizat, Changchun, Jilin, Peoples R China	Jilin Agricultural University	Wang, Y; Zhang, MP (corresponding author), Jilin Agr Univ, Coll Life Sci, Changchun, Jilin, Peoples R China.; Wang, Y; Zhang, MP (corresponding author), Res Ctr Ginseng Genet Resources Dev & Utilizat, Changchun, Jilin, Peoples R China.	wz_jlau@163.com; meiping.zhang@jlau.edu.cn			China 863 Project [2013AA102604-3]; Bureau of Science and Technology of Jilin Province [20170101010JC, 20180414077GH, 20180101027JC, 20190201264JC, 20190201171JC]; Education Department of Jilin Province [JJKH20200318KJ, JJKH20200320KJ]; Development and Reform Commission of Jilin Province [2016C064, 2018C047-3]	China 863 Project(National High Technology Research and Development Program of China); Bureau of Science and Technology of Jilin Province; Education Department of Jilin Province; Development and Reform Commission of Jilin Province	This work was supported by an award from the China 863 Project (2013AA102604-3), the Bureau of Science and Technology of Jilin Province (20170101010JC, 20180414077GH, 20180101027JC, 20190201264JC, and 20190201171JC), the Education Department of Jilin Province (JJKH20200318KJ and JJKH20200320KJ), and the Development and Reform Commission of Jilin Province (2016C064 and 2018C047-3).	Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2013, GASTROENTEROL HEP S3, P1, DOI DOI 10.1017/S1743923X12000670; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bray MA, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/giw014; Chen J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226055; Chen X, 2014, PLANT CELL PHYSIOL, V55, P604, DOI 10.1093/pcp/pct204; Le DT, 2011, DNA RES, V18, P263, DOI 10.1093/dnares/dsr015; Feng HL, 2013, PLANT PHYSIOL BIOCH, V73, P309, DOI 10.1016/j.plaphy.2013.09.014; Gao L, 2019, NAT GENET, V51, P1044, DOI 10.1038/s41588-019-0410-2; Jayakodi M, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1282-9; Kim NH, 2018, PLANT BIOTECHNOL J, V16, P1904, DOI 10.1111/pbi.12926; Kuk YI, 2003, CROP SCI, V43, P2109, DOI 10.2135/cropsci2003.2109; Lee S, 2012, PLANT J, V70, P831, DOI 10.1111/j.1365-313X.2012.04932.x; Li XD, 2016, J PLANT PHYSIOL, V204, P54, DOI 10.1016/j.jplph.2016.06.024; Lin YP, 2018, MOL GENET GENOMICS, V293, P845, DOI 10.1007/s00438-018-1425-6; Liu H, 2018, PLANT SCI, V271, P9, DOI 10.1016/j.plantsci.2018.03.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma J, 2014, SCI HORTIC-AMSTERDAM, V165, P82, DOI 10.1016/j.scienta.2013.11.005; Nakashima K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00170; Nakashima K, 2012, BBA-GENE REGUL MECH, V1819, P97, DOI 10.1016/j.bbagrm.2011.10.005; Nuruzzaman M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00248; Nuruzzaman M, 2010, GENE, V465, P30, DOI 10.1016/j.gene.2010.06.008; Oh JY, 2014, J GINSENG RES, V38, P270, DOI 10.1016/j.jgr.2014.04.004; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; Parvin Shohana, 2009, Journal of Ginseng Research, V33, P249; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Qu YT, 2016, ENVIRON EXP BOT, V129, P67, DOI 10.1016/j.envexpbot.2015.12.012; Ramaswamy Manimekalai, 2017, Agri Gene, V3, P1, DOI 10.1016/j.aggene.2016.10.003; Saidi MN, 2017, PLANT PHYSIOL BIOCH, V112, P117, DOI 10.1016/j.plaphy.2016.12.028; Shao HB, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00902; Singh AK, 2013, DNA RES, V20, P403, DOI 10.1093/dnares/dst019; Souer E, 1996, CELL, V85, P159, DOI 10.1016/S0092-8674(00)81093-4; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Theocharidis A, 2009, NAT PROTOC, V4, P1535, DOI 10.1038/nprot.2009.177; Tian Y, 2011, TRANSGENIC RES, V20, P857, DOI 10.1007/s11248-010-9463-9; Wang KY, 2015, SCI REP-UK, V5, DOI 10.1038/srep18283; Wang Y, 2018, PLANT GENOME-US, V11, DOI 10.3835/plantgenome2017.11.0106; Wu J, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0882-5; Xu ZY, 2013, PLANT CELL, V25, P4708, DOI 10.1105/tpc.113.119099; Yin R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181596; Zhang MP, 2010, NUCLEIC ACIDS RES, V38, P6513, DOI 10.1093/nar/gkq524; Zhang MP, 2020, SCI REPORTS; Zhang YJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199262; Zhao X, 2016, GENE, V586, P158, DOI 10.1016/j.gene.2016.04.028; Zhu GR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139794; Zhu L, 2020, MOL GENET GENOMICS, V295, P877, DOI 10.1007/s00438-020-01658-w	49	4	6	17	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234423	10.1371/journal.pone.0234423	http://dx.doi.org/10.1371/journal.pone.0234423			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525906	gold, Green Published			2022-12-26	WOS:000542036800075
J	Kubo, N; Yokobori, T; Takahashi, R; Ogawa, H; Gombodorj, N; Ohta, N; Ohno, T; Saeki, H; Shirabe, K; Asao, T				Kubo, Norio; Yokobori, Takehiko; Takahashi, Ryo; Ogawa, Hiroomi; Gombodorj, Navchaa; Ohta, Naoya; Ohno, Tatsuya; Saeki, Hiroshi; Shirabe, Ken; Asao, Takayuki			An abdominal spacer that does not require surgical removal and allows drainage of abdominal fluids in patients undergoing carbon ion radiotherapy	PLOS ONE			English	Article							SARCOMA; THERAPY	Abdominal spacers are useful for maintaining the distance between the target tumors and surrounding tissues, such as the gastrointestinal tract, in patients treated with carbon ion radiotherapy. Surgical intervention to remove the spacers is sometimes necessary because of abdominal infections triggered by long-term spacer placement or intestinal perforation. Therefore, spacers that do not require surgical removal and provide effective drainage against abdominal infections are urgently needed. This study aimed to develop a spacer that could be removed non-surgically and one that provides the therapeutic effect of drainage in patients who receive carbon ion radiotherapy for abdominal tumors. A novel fan-shaped spacer was constructed from a film drain that was folded along the trigger line. Simple withdrawal of the trigger line caused the film drain to fold and the holding lines to become free. We performed laparoscopy-assisted insertion with pneumoperitoneum and blind removal of the spacer fourteen times using a porcine model. Saline in the abdominal cavity was effectively aspirated using the spacer. Our novel fan-shaped spacer could be removed safely without surgery and was able to drain fluid effectively from the abdominal cavity.	[Kubo, Norio; Shirabe, Ken] Gunma Univ, Grad Sch Med, Dept Hepatobiliary & Pancreat Surg, Maebashi, Gunma, Japan; [Yokobori, Takehiko; Gombodorj, Navchaa] Gunma Univ, Div Integrated Oncol Res, Initiat Adv Res GIAR, Maebashi, Gunma, Japan; [Yokobori, Takehiko] Gunma Univ, Dept Innovat Canc Immunotherapy, Maebashi, Gunma, Japan; [Yokobori, Takehiko; Takahashi, Ryo; Ogawa, Hiroomi; Saeki, Hiroshi] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, Maebashi, Gunma, Japan; [Ohta, Naoya] Gunma Univ, Div Elect & Informat, Grad Sch Engn, Kiryu, Gunma, Japan; [Ohno, Tatsuya] Gunma Univ, Heavy Ion Med Ctr, Maebashi, Gunma, Japan; [Asao, Takayuki] Gunma Univ, Big Data Ctr Integrat Anal, Initiat Adv Res, Maebashi, Gunma, Japan	Gunma University; Gunma University; Gunma University; Gunma University; Gunma University; Gunma University; Gunma University	Kubo, N (corresponding author), Gunma Univ, Grad Sch Med, Dept Hepatobiliary & Pancreat Surg, Maebashi, Gunma, Japan.	nkubo@gunma-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [18K07665]; Research Grant of the Princess Takamatsu Cancer Research Fund; Suzuken Memorial Foundation; Pancreas Research Foundation of Japan	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research Grant of the Princess Takamatsu Cancer Research Fund; Suzuken Memorial Foundation; Pancreas Research Foundation of Japan(Pancreas Research Foundation of Japan)	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS); grant number 18K07665 to TY. The work was also supported in part by Research Grant of the Princess Takamatsu Cancer Research Fund, Suzuken Memorial Foundation, and Pancreas Research Foundation of Japan.	Emile SH, 2017, GASTROENT RES PRACT, V2017, DOI 10.1155/2017/6253898; Habl G, 2016, INT J RADIAT ONCOL, V95, P435, DOI 10.1016/j.ijrobp.2016.02.025; Ishikawa H, 2006, INT J RADIAT ONCOL, V66, P1084, DOI 10.1016/j.ijrobp.2006.06.056; Jingu K, 2012, INT J RADIAT ONCOL, V82, P2125, DOI 10.1016/j.ijrobp.2010.08.043; Rucinski A, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-134; Schorghofer A, 2019, RADIAT ONCOL, V14, DOI 10.1186/s13014-019-1248-6; Shiba S, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00702; Sugahara S, 2012, RADIOTHER ONCOL, V105, P226, DOI 10.1016/j.radonc.2012.09.010	8	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2020	15	6							e0234471	10.1371/journal.pone.0234471	http://dx.doi.org/10.1371/journal.pone.0234471			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC0EC	32520972	Green Published, gold			2022-12-26	WOS:000542969500018
J	Yu, SY; Yu, XT; Sun, LL; Zheng, YW; Chen, LL; Xu, H; Jin, J; Lan, Q; Chen, CC; Li, M				Yu, Shuye; Yu, Xiaoting; Sun, Lili; Zheng, Yanwen; Chen, Lili; Xu, Hui; Jin, Jing; Lan, Qing; Chen, Clark C.; Li, Ming			GBP2 enhances glioblastoma invasion through Stat3/fibronectin pathway	ONCOGENE			English	Article							BINDING PROTEIN-1; CELL-ADHESION; GENOMIC ANALYSIS; DRUG-RESISTANCE; BREAST-CANCER; FIBRONECTIN; PROLIFERATION; PROMOTES; GROWTH; LANDSCAPE	Guanylate-binding protein 2 (GBP2) is an interferon-inducible large GTPase which is crucial to the protective immunity against microorganisms. However, its biological function in cancer remains largely unknown. Glioblastoma multiforme (GBM) is the most common and deadly brain tumor in adults. Here we show that GBP2 expression is highly elevated in GBM tumor and cell lines, particularly in those of the mesenchymal subtype. High GBP2 expression is associated with poor prognosis. GBP2 overexpression significantly promotes GBM cell migration and invasion in vitro, and GBP2 silencing by RNA interference exhibits opposite effects. We further show that fibronectin (FN1) is dramatically induced by GBP2 expression at both mRNA and protein levels, and FN1 is essential for GBP2-promoted GBM invasiveness. Inhibition of Stat3 pathway prevents GBP2-promoted FN1 induction and cell invasion. Consistently, GBP2 dramatically promotes GBM tumor growth and invasion in mice and significantly reduces the survival time of the mice with tumor. Taken together, these findings establish the role of GBP2/Stat3/FN1 signaling cascade in GBM invasion and suggest GBP2 may serve as a potential therapeutic target for inhibiting GBM invasion.	[Yu, Shuye; Sun, Lili; Zheng, Yanwen; Chen, Lili; Li, Ming] Soochow Univ, Affiliated Hosp 2, Cent Lab, Suzhou, Jiangsu, Peoples R China; [Xu, Hui; Jin, Jing; Lan, Qing; Li, Ming] Soochow Univ, Affiliated Hosp 2, Dept Neurosurg, Suzhou, Jiangsu, Peoples R China; [Yu, Xiaoting] Soochow Univ, Affiliated Hosp 2, Dept Oncol, Suzhou, Jiangsu, Peoples R China; [Chen, Clark C.; Li, Ming] Univ Minnesota, Sch Med, Dept Neurosurg, Minneapolis, MN 55455 USA; [Yu, Shuye] Songlingzhen Hlth Ctr, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; University of Minnesota System; University of Minnesota Twin Cities	Li, M (corresponding author), Soochow Univ, Affiliated Hosp 2, Cent Lab, Suzhou, Jiangsu, Peoples R China.; Li, M (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Neurosurg, Suzhou, Jiangsu, Peoples R China.; Li, M (corresponding author), Univ Minnesota, Sch Med, Dept Neurosurg, Minneapolis, MN 55455 USA.	li001705@umn.edu	Sun, lili/GQH-2057-2022	Li, Ming/0000-0002-2540-1738	National Natural Sciences Foundation of China [81572480]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported with a grant from the National Natural Sciences Foundation of China (81572480). We thank Drs. Frank Furnari and Benjamin Purow for the gift of cell lines.	Behnan J, 2019, BRAIN, V142, P847, DOI 10.1093/brain/awz044; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Britzen-Laurent N, 2013, CARCINOGENESIS, V34, P153, DOI 10.1093/carcin/bgs310; Caffo M, 2004, ACTA NEUROCHIR, V146, P1113, DOI 10.1007/s00701-004-0344-y; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Fei M, 2013, INT J HEMATOL, V98, P446, DOI 10.1007/s12185-013-1435-4; Fukumoto M, 2014, CANCER SCI, V105, P1351, DOI 10.1111/cas.12489; Godoy P, 2014, BREAST CANCER-TOKYO, V21, P491, DOI 10.1007/s12282-012-0404-8; Gong J, 2017, MOL MED REP, V16, P143, DOI 10.3892/mmr.2017.6610; Guenzi E, 2001, EMBO J, V20, P5568, DOI 10.1093/emboj/20.20.5568; Guimaraes DP, 2009, INT J CANCER, V124, P272, DOI 10.1002/ijc.23944; Han SW, 2006, CANCER RES, V66, P315, DOI 10.1158/0008-5472.CAN-05-2367; Hazlehurst LA, 2006, CANCER RES, V66, P2338, DOI 10.1158/0008-5472.CAN-05-3256; Iwamaru A, 2007, ONCOGENE, V26, P2435, DOI 10.1038/sj.onc.1210031; Lan Q, 2016, ONCOTARGET, V7, P9680, DOI 10.18632/oncotarget.7109; Lau J, 2015, CANCER RES, V75, P4302, DOI 10.1158/0008-5472.CAN-14-3331; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Li L, 2015, DISCOV MED, V20, P369; Li M, 2011, J EXP MED, V208, P2657, DOI 10.1084/jem.20111102; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Nakagawa Y, 2014, INT J ONCOL, V44, P1376, DOI 10.3892/ijo.2014.2265; Natesh K, 2015, NEOPLASIA, V17, P225, DOI 10.1016/j.neo.2015.01.001; Olszewski MA, 2006, J INTERF CYTOK RES, V26, P328, DOI 10.1089/jir.2006.26.328; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Quintero M, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3726-2; SAWAYA R, 1985, NEUROSURGERY, V16, P161, DOI 10.1227/00006123-198502000-00006; Sengupta S, 2010, NEOPLASIA, V12, P837, DOI 10.1593/neo.10662; Tipton AR, 2016, BIOCHEM BIOPH RES CO, V478, P1617, DOI 10.1016/j.bbrc.2016.08.169; Tretina K, 2019, J EXP MED, V216, P482, DOI 10.1084/jem.20182031; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vestal DJ, 2011, J INTERF CYTOK RES, V31, P89, DOI 10.1089/jir.2010.0102; Weinlander K, 2008, FASEB J, V22, P4168, DOI 10.1096/fj.08-107524; Xu H, 2018, BIOCHEM BIOPH RES CO, V495, P446, DOI 10.1016/j.bbrc.2017.11.050; Yu Q, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00130; Zhang J, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.559	35	30	30	3	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 2	2020	39	27					5042	5055		10.1038/s41388-020-1348-7	http://dx.doi.org/10.1038/s41388-020-1348-7		JUN 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ME5NL	32518375				2022-12-26	WOS:000539201700002
J	Kakinda, M; Matovu, JKB				Kakinda, Michael; Matovu, Joseph K. B.			A yield and cost comparison of tuberculosis contact investigation and intensified case finding in Uganda	PLOS ONE			English	Article							HOUSEHOLD CONTACTS; HIV; INFECTION; KAMPALA; PEOPLE	Introduction Resource constraints in Low and Middle-Income Countries (LMICs) limit tuberculosis (TB) contact investigation despite evidence its benefits could outweigh costs, with increased efficiency when compared with intensified case finding (ICF). However, there is limited data on yield and cost per TB case identified. We compared yield and cost per TB case identified for ICF and Tuberculosis-Contact Investigation (TB-CI) in Uganda. Methods A retrospective cohort study based on data from 12 Ugandan hospitals was done between April and September 2017. Two methods of TB case finding (i.e. ICF and TB-CI) were compared. Regarding ICF, patients either self-reported their signs and symptoms or were prompted by health care workers, while TB-CI was done by home-visiting and screening contacts of TB patients. Patients who were presumed to have tuberculosis were requested to produce a sample for examination. TB yield was defined as a ratio of diagnoses to tests, and this was computed per method of diagnosis. The cost per TB case identified (medical, personnel, transportation and training) for each diagnosis method were computed using the activity-based approach, from the health care perspective. Cost data were analyzed using Windows Excel. Results 454 index TB cases and 2,707 of their household contacts were investigated. Thirty-one per cent of contacts (840/2707) were found to be presumptive TB cases. A total of 7,685 tests were done, 6,967 for ICF and 718 for TB-CI. The yields were 18.62% (1297/6967) and 5.29% (38/718) for ICF and TB-CI, respectively. It cost US$ 120.60 to diagnose a case of TB using ICF compared to US$ 877.57 for TB-CI. Conclusion The yield of TB-CI was found to be four-times lower and seven-times costlier compared to ICF. These findings suggest that ICF can improve TB case detection at a low cost, particularly in high TB prevalent settings.	[Kakinda, Michael] Minist Hlth, Kampala, Uganda; [Matovu, Joseph K. B.] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Matovu, Joseph K. B.] Busitema Univ, Fac Hlth Sci, Mbale, Uganda	Makerere University	Kakinda, M (corresponding author), Minist Hlth, Kampala, Uganda.	michaelkakinda@gmail.com	Kakinda, Michael/GNW-6001-2022	KAKINDA, MICHAEL/0000-0002-4638-1318	USAID [AD617-A10-00007-00]	USAID(United States Agency for International Development (USAID))	The study did receive funding from USAID through a cooperative agreement AD617-A10-00007-00 awarded to URC/SUSTAIN. The funds were awarded to hospitals to support TB contact investigation. The corresponding author was paid a salary during this time with URC/SUSTAIN. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors acknowledge support from Prof Anna Vassall from London School of Hygiene and Tropical Medicine (LSHTM) who made very valuable input into the costing data. We would also like to thank the URC-SUSTAIN team, especially Dr(s) John Paul Otuba and Pamela Ddongo for their support and technical advice in developing the various tools as well as Dr James Okello for this input during the writing.	Borgdorff MW, 2013, INT J TUBERC LUNG D, V17, P285, DOI 10.5588/ijtld.12.0806; Currie CSM, 2003, AIDS, V17, P2501, DOI 10.1097/00002030-200311210-00013; Datiko DG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009158; Deery CB, 2014, INT J TUBERC LUNG D, V18, P534, DOI 10.5588/ijtld.13.0587; Dhingra V.K., 2004, INDIAN J MED, V29, P44; Dodd PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029130; Eang MT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-469; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Gold MR, 1996, COST EFFECTIVENESS H; Guwatudde D, 2003, AM J EPIDEMIOL, V158, P887, DOI 10.1093/aje/kwg227; Haddix CA, 2003, PREVENTION EFFECTIVE; Hsiang E, 2016, INT J TUBERC LUNG D, V20, P1212, DOI 10.5588/ijtld.16.0200; Hwang TJ, 2011, INT J TUBERC LUNG D, V15, P1620, DOI 10.5588/ijtld.11.0222; Kranzer K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001281; Mauch V, 2013, INT J TUBERC LUNG D, V17, P381, DOI 10.5588/ijtld.12.0368; Ministry of Health, 2016, PRES DIR HLTH SERV I; Ministry of Public Service, 2016, SAL STRUCT CIV SERV; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; Mupere E, 2013, INT J TUBERC LUNG D, V17, P207, DOI 10.5588/ijtld.12.0160; Murray CJL, 1998, P NATL ACAD SCI USA, V95, P13881, DOI 10.1073/pnas.95.23.13881; Nair D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162090; National Medical Stores, 2019, MED ORD FORMS; Nishikiori N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-97; Office of the United Nations Resident Coordinator, 2019, UPD SCHED RAT ALL GO; Sekandi JN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117009; Shapiro A, 2011, SCOPING M DEV GUIDEL; Suggaravetsiri P, 2003, INT J TUBERC LUNG D, V7, pS424; Tlale L, 2016, PAN AFR MED J, V24, DOI 10.11604/pamj.2016.24.229.7004; UNAIDS/WHO, 2000, GUID 2 GEN HIV SURV; WHO, 2009, GLOB TUB CONTR 2009; World Health Organization, 2013, SYST SCREEN ACT TUB	31	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2020	15	6							e0234418	10.1371/journal.pone.0234418	http://dx.doi.org/10.1371/journal.pone.0234418			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ0RE	32511264	gold, Green Submitted, Green Published			2022-12-26	WOS:000540938100016
J	Muangpat, P; Suwannaroj, M; Yimthin, T; Fukruksa, C; Sitthisak, S; Chantratita, N; Vitta, A; Thanwisai, A				Muangpat, Paramaporn; Suwannaroj, Manawat; Yimthin, Thatcha; Fukruksa, Chamaiporn; Sitthisak, Sutthirat; Chantratita, Narisara; Vitta, Apichat; Thanwisai, Aunchalee			Antibacterial activity of Xenorhabdus and Photorhabdus isolated from entomopathogenic nematodes against antibiotic-resistant bacteria	PLOS ONE			English	Article							RHABDITIDA STEINERNEMATIDAE; LUMINESCENS; IDENTIFICATION; BIOSYNTHESIS; DERIVATIVES; PHYLOGENY; SEQUENCES; COMPOUND; SYMBIONT; STILBENE	XenorhabdusandPhotorhabdus, symbiotically associated with entomopathogenic nematodes (EPNs), produce a range of antimicrobial compounds. The objective of this study is to identifyXenorhabdusandPhotorhabdusand their EPNs hosts, which were isolated from soil samples from Saraburi province, and study their antibacterial activity against 15 strains of drug-resistant bacteria. Fourteen isolates (6.1%), consisting of sixXenorhabdusisolates and eightPhotorhabdusisolates, were obtained from 230 soil samples. Based on the BLASTN search incorporating the phylogenetic analysis of a partialrecAgene, all six isolates ofXenorhabduswere found to be identical and closely related toX.stockiae. Five isolates ofPhotorhabduswere found to be identical and closely related toP.luminescenssubsp.akhurstii. Two isolates ofPhotorhabduswere found to be identical and closely related toP.luminescenssubsp.hainanensis. The remaining isolate ofPhotorhabduswas found to be identical toP.asymbioticasubsp.australis. The bacterial extracts fromP.luminescenssubsp.akhurstiishowed strong inhibition the growth ofS.aureusstrain PB36 (MSRA) by disk diffusion, minimal inhibitory concentration, and minimal bactericidal concentration assay. The combination between each extract fromXenorhabdus/Photorhabdusand oxacillin or vancomycin againstS.aureusstrain PB36 (MRSA) exhibited no interaction on checkerboard assay. Moreover, killing curve assay ofP.luminescenssubsp.akhurstiiextracts againstS.aureusstrain PB36 exhibited a steady reduction of 10(5)CFU/ml to 10(3)CFU/ml within 30 min. This study demonstrates thatXenorhabdusandPhotorhabdus, showed antibacterial activity. This finding may be useful for further research on antibiotic production.	[Muangpat, Paramaporn; Suwannaroj, Manawat; Fukruksa, Chamaiporn; Sitthisak, Sutthirat; Vitta, Apichat; Thanwisai, Aunchalee] Naresuan Univ, Fac Med Sci, Dept Microbiol & Parasitol, Phitsanulok, Thailand; [Yimthin, Thatcha; Chantratita, Narisara] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand; [Vitta, Apichat; Thanwisai, Aunchalee] Naresuan Univ, Fac Med Sci, Ctr Excellence Med Biotechnol CEMB, Phitsanulok, Thailand; [Vitta, Apichat; Thanwisai, Aunchalee] Naresuan Univ, Fac Sci, Ctr Excellent Biodivers, Phitsanulok, Thailand	Naresuan University; Mahidol University; Naresuan University; Naresuan University	Thanwisai, A (corresponding author), Naresuan Univ, Fac Med Sci, Dept Microbiol & Parasitol, Phitsanulok, Thailand.; Thanwisai, A (corresponding author), Naresuan Univ, Fac Med Sci, Ctr Excellence Med Biotechnol CEMB, Phitsanulok, Thailand.; Thanwisai, A (corresponding author), Naresuan Univ, Fac Sci, Ctr Excellent Biodivers, Phitsanulok, Thailand.	aunchaleet@nu.ac.th	Sitthisak, Sutthirat/AAF-9383-2020; Sitthisak, Sutthirat/ABF-4922-2021; Vitta, Apichat/HHZ-5460-2022	Sitthisak, Sutthirat/0000-0003-4992-7635; Vitta, Apichat/0000-0002-2483-0100	National Research Council of Thailand through Naresuan University [R2562B083]	National Research Council of Thailand through Naresuan University	This work was supported by The National Research Council of Thailand through Naresuan University (Grant Number R2562B083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BJ, 2006, BIOL CONTROL, V37, P32, DOI 10.1016/j.biocontrol.2005.11.008; BEDDING RA, 1975, NEMATOLOGICA, V21, P109, DOI 10.1163/187529275X00419; Bhat AH, 2017, J NEMATOL, V49, P92; Bock CH, 2014, J PEST SCI, V87, P155, DOI 10.1007/s10340-013-0519-5; Bode HB, 2009, CURR OPIN CHEM BIOL, V13, P224, DOI 10.1016/j.cbpa.2009.02.037; Chen G., 1996, THESIS; Cheypratub P, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/3438453; Chokshi A, 2019, J GLOB INFECT DIS, V11, P36, DOI 10.4103/jgid.jgid_110_18; Cimen H, 2014, ZOOTAXA, V3821, P337, DOI 10.11646/zootaxa.3821.3.3; Derzelle S, 2002, APPL ENVIRON MICROB, V68, P3780, DOI 10.1128/AEm.68.8.3780-3789.2002; Food and Drug Administration, 2018, ANN FOOD DRUG ADM BL; Grundmann F, 2014, J NAT PROD, V77, P779, DOI 10.1021/np4007525; Guo L, 2020, FOODBORNE PATHOG DIS, V17, P396, DOI 10.1089/fpd.2019.2713; Hominick WM, 1997, J HELMINTHOL, V71, P271, DOI 10.1017/S0022149X00016096; Hu KJ, 2006, BIOORGAN MED CHEM, V14, P4677, DOI 10.1016/j.bmc.2006.01.025; KAYA HK, 1993, ANNU REV ENTOMOL, V38, P181, DOI 10.1146/annurev.en.38.010193.001145; Phan KL, 2014, NEMATOLOGY, V16, P761, DOI 10.1163/15685411-00002806; la Buscato E, 2013, CHEMMEDCHEM, V8, P919, DOI 10.1002/cmdc.201300057; LI JX, 1995, APPL ENVIRON MICROB, V61, P4329, DOI 10.1128/AEM.61.12.4329-4333.1995; Li YS, 2014, FEMS MICROBIOL LETT, V356, P23, DOI 10.1111/1574-6968.12474; Malan AP, 2014, J HELMINTHOL, V88, P139, DOI 10.1017/S0022149X12000806; Maneesakorn Patchareewan, 2010, International Journal of Nematology, V20, P27; MCINERNEY BV, 1991, J NAT PROD, V54, P785, DOI 10.1021/np50075a006; Muangpat P, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01142; Mulani MS, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00539; Nthenga I, 2014, NEMATOLOGY, V16, P475, DOI 10.1163/15685411-00002780; Paphitou NI, 2013, INT J ANTIMICROB AG, V42, pS25, DOI 10.1016/j.ijantimicag.2013.04.007; Park HB, 2016, MOLECULES, V21, DOI 10.3390/molecules21070824; Queenan K, 2016, INT J ANTIMICROB AG, V48, P422, DOI 10.1016/j.ijantimicag.2016.06.014; Reimer D, 2009, CHEMBIOCHEM, V10, P1997, DOI 10.1002/cbic.200900187; Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452; Roe VA, 2018, J MIDWIFERY WOM HEAL, V53, P216; Seier-Petersen MA, 2014, J ANTIMICROB CHEMOTH, V69, P343, DOI 10.1093/jac/dkt370; Shapiro-Ilan D. I., 2014, MASS PRODUCTION BENE, P321, DOI [10.1016/B978-0-12-391453-8.00010-8, DOI 10.1016/B978-0-12-391453-8.00010-8]; Shi DS, 2017, J AGR FOOD CHEM, V65, P60, DOI 10.1021/acs.jafc.6b04303; Stock SP, 2001, J PARASITOL, V87, P877, DOI 10.2307/3285148; Sun YW, 2019, TOXINS, V11, DOI 10.3390/toxins11120685; Tailliez P, 2006, INT J SYST EVOL MICR, V56, P2805, DOI 10.1099/ijs.0.64287-0; Tailliez P, 2010, INT J SYST EVOL MICR, V60, P1921, DOI 10.1099/ijs.0.014308-0; Teethaisong Y, 2014, J BIOMED SCI, V21, DOI 10.1186/s12929-014-0090-2; Thanwisai A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043835; Ullah I, 2015, J MICROBIOL, V53, P127, DOI 10.1007/s12275-015-4632-4; Vitta A, 2017, SE ASIAN J TROP MED, V48, P18; WHITE G. F., 1927, SCIENCE, V66, P302, DOI 10.1126/science.66.1709.302-a; Zhang X, 2014, FEMS MICROBIOL LETT, V350, P48, DOI 10.1111/1574-6968.12321; Zihadi MAH, 2019, J ADV VET ANIM RES, V6, P247, DOI 10.5455/javar.2019.f340	46	5	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0234129	10.1371/journal.pone.0234129	http://dx.doi.org/10.1371/journal.pone.0234129			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502188	Green Published, gold			2022-12-26	WOS:000542035700015
J	Chen, RJ; Lin, JH				Chen, Rongjun; Lin, Jinhui			Identification of feature risk pathways of smoking-induced lung cancer based on SVM	PLOS ONE			English	Article							EXPRESSION; HISTORY; METAANALYSIS; RECURRENCE; PREDICTION; PROGNOSIS; MUTATION; DATABASE; BIOLOGY; GENES	Objective The present study aims to explore the role of smoking factors in the risk of lung cancer and screen the feature risk pathways of smoking-induced lung cancer. Methods The expression profiles of the patient data from GEO database were standardized, and differentially expressed genes (DEGs) were analyzed by limma algorithm. Samples and genes were analyzed by Unsupervised hierarchical clustering method, while GO and KEGG enrichment analyses were performed on DEGs. The data of the protein-protein interaction (PPI) network were downloaded from the BioGrid and HPRD databases, and the DEGs were mapped into the PPI network to identify the interaction relationship. The enriched significant pathways were used to calculate the anomaly score and RFE method was used to optimize the feature sets. The model was trained using the support vector machine (SVM) and the predicted results were plotted into ROC curves. The AUC value was calculated to evaluate the predictive performance of the SVM model. Results A total of 1923 DEGs were obtained, of which 826 were down-regulated and 1097 were up-regulated. Unsupervised hierarchical clustering analysis showed that the diagnosis accuracy of lung cancer smokers was 74%, and that of non-lung cancer smokers was 75%. Five optimal feature pathway sets were obtained by screening, the clinical diagnostic ability of which was detected by SVM model with the accuracy improved to 84%. The diagnostic accuracy was 90% after combining clinical information. Conclusion We verified that five signaling pathways combined with clinical information could be used as a feature risk pathway for identifying lung cancer smokers and non-lung cancer smokers and increased the diagnostic accuracy.	[Chen, Rongjun] Anji Third Peoples Hosp, Dept Surg, Huzhou, Zhejiang, Peoples R China; [Lin, Jinhui] Taizhou Municipal Hosp, Dept Radiol, Taizhou, Zhejiang, Peoples R China	Taizhou University	Lin, JH (corresponding author), Taizhou Municipal Hosp, Dept Radiol, Taizhou, Zhejiang, Peoples R China.	linjh_doc@163.com						Alberg AJ, 2013, CHEST, V143, pE1, DOI 10.1378/chest.12-2345; Bishara AJ, 2012, PSYCHOL METHODS, V17, P399, DOI 10.1037/a0028087; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chapman AM, 2016, LUNG CANCER, V102, P122, DOI 10.1016/j.lungcan.2016.10.010; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chen Xin, 2009, Journal of Bioinformatics and Computational Biology, V7, P645, DOI 10.1142/S0219720009004291; Gadgeel SM, 2006, CLIN LUNG CANCER, V7, P369; Gibbons DL, 2014, MOL CANCER RES, V12, P3, DOI 10.1158/1541-7786.MCR-13-0539; Hamilton G, 2015, WIEN MED WOCHENSCHR, V165, P379, DOI 10.1007/s10354-015-0381-6; He XN, 2018, ONCOL REP, V39, P929, DOI 10.3892/or.2018.6197; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang MW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0161501; Huang SJ, 2018, CANCER GENOM PROTEOM, V15, P41, DOI 10.21873/cgp.20063; Igawa S, 2016, ONCOLOGY-BASEL, V91, P41, DOI 10.1159/000446438; Lee PN, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-385; Liu TG, 2015, J THEOR BIOL, V366, P8, DOI 10.1016/j.jtbi.2014.11.010; Ma SY, 2015, J HAZARD MATER, V283, P591, DOI 10.1016/j.jhazmat.2014.10.011; Matsuura Kuniomi, 2006, Osaka City Medical Journal, V52, P1; Mou WJ, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0059-8; Murie C, 2014, J BIOMOL SCREEN, V19, P661, DOI 10.1177/1087057113516003; Ni D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34945-z; Petushkova NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103950; Su JL, 2017, ACTA OTO-LARYNGOL, V137, P557, DOI 10.1080/00016489.2016.1247984; Wang YG, 2014, PATHOL ONCOL RES, V20, P611, DOI 10.1007/s12253-013-9739-5; Wei D, 2015, HEART LUNG CIRC, V24, P780, DOI 10.1016/j.hlc.2015.03.021; Xu GR, 2017, GENE, V604, P33, DOI 10.1016/j.gene.2016.12.016	26	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0233445	10.1371/journal.pone.0233445	http://dx.doi.org/10.1371/journal.pone.0233445			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497048	gold, Green Published			2022-12-26	WOS:000542035200033
J	Oakley-Cogan, A; Tebbett, SB; Bellwood, DR				Oakley-Cogan, Arun; Tebbett, Sterling B.; Bellwood, David R.			Habitat zonation on coral reefs: Structural complexity, nutritional resources and herbivorous fish distributions	PLOS ONE			English	Article							COMMUNITY STRUCTURE; SPATIAL PATTERNS; EPILITHIC ALGAL; BODY-SIZE; PREDATION; RISK; ASSEMBLAGES; VARIABLES; MORTALITY; ABUNDANCE	Distinct zonation of community assemblages among habitats is a ubiquitous feature of coral reefs. The distribution of roving herbivorous fishes (parrotfishes, surgeonfishes and rabbitfishes) is a particularly clear example, with the abundance of these fishes generally peaking in shallow-water, high-energy habitats, regardless of the biogeographic realm. Yet, our understanding of the factors which structure this habitat partitioning, especially with regards to different facets of structural complexity and nutritional resource availability, is limited. To address this issue, we used three-dimensional photogrammetry and structure-from-motion technologies to describe five components of structural complexity (rugosity, coral cover, verticality, refuge density and field-of-view) and nutritional resource availability (grazing surface area) among habitats and considered how these factors are related to herbivorous fish distributions. All complexity metrics (including coral cover) were highest on the slope and crest. Nutritional resource availability differed from this general pattern and peaked on the outer-flat. Unexpectedly, when compared to the distribution of herbivorous fishes, none of the complexity metrics had a marked influence in the models. However, grazing surface area was a strong predictor of both the abundance and biomass of herbivorous fishes. The strong relationship between grazing surface area and herbivorous fish distributions indicates that nutritional resource availability may be one of the primary factors driving the distribution of roving herbivorous fishes. The lack of a relationship between complexity and herbivorous fishes, and a strong affinity of herbivorous fishes for low-complexity, algal turf-dominated outer-flat habitats, offers some cautious optimism that herbivory may be sustained on future, low-complexity, algal turf-dominated reef configurations.	[Oakley-Cogan, Arun; Tebbett, Sterling B.; Bellwood, David R.] James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia; [Bellwood, David R.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia	James Cook University; James Cook University	Oakley-Cogan, A (corresponding author), James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia.	arun.oakleycogan@my.jcu.edu.au	Tebbett, Sterling B./J-9420-2019	Tebbett, Sterling B./0000-0002-9372-7617; Oakley-Cogan, Arun/0000-0002-2694-2501	Australian Research Council [CE140100020, FL190100062]	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council (DRB: grant number CE140100020 and FL190100062, URL: http://www.arc.gov.au/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Adam TC, 2018, MAR ECOL PROG SER, V597, P207, DOI 10.3354/meps12600; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; [Anonymous], 2016, J LARGE SCALE RES FA, V2, pA49; [Anonymous], 2018, 2017 CHIN WEBS SEC S, V1, P4; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bejarano S, 2017, FUNCT ECOL, V31, P1312, DOI 10.1111/1365-2435.12828; Bellwood DR, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3046; Bellwood DR, 2018, ECOL EVOL, V8, P4108, DOI 10.1002/ece3.3967; Bellwood DR, 2017, BIOL REV, V92, P878, DOI 10.1111/brv.12259; Bellwood DR, 2001, CORAL REEFS, V20, P139, DOI 10.1007/s003380100156; Beukers JS, 1998, OECOLOGIA, V114, P50, DOI 10.1007/s004420050419; BOUCHONNAVARO Y, 1981, MAR BIOL, V63, P79, DOI 10.1007/BF00394665; Brandl SJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14556; Brokovich E, 2005, AQUAT CONSERV, V15, pS45, DOI 10.1002/aqc.695; Brooks ME, 2017, R J, V9, P378, DOI 10.32614/RJ-2017-066; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Bureau of Meteorology, 2018, LUC OFFSH QUEENSL TI; Carlson PM, 2017, MAR ECOL PROG SER, V577, P165, DOI 10.3354/meps12258; Catano LB, 2016, J ANIM ECOL, V85, P146, DOI 10.1111/1365-2656.12440; Choat JH, 2002, MAR BIOL, V140, P613, DOI 10.1007/s00227-001-0715-3; Clements KD, 2017, BIOL J LINN SOC, V120, P729, DOI 10.1111/bij.12914; Connolly SR, 2005, SCIENCE, V309, P1363, DOI 10.1126/science.1113281; Darling ES, 2017, CORAL REEFS, V36, P561, DOI 10.1007/s00338-017-1539-z; Done T.J., 1983, Australian Institute of Marine Science Contribution, P107; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Duran A, 2018, MAR BIOL, V165, DOI 10.1007/s00227-018-3411-2; Eurich JG, 2018, MAR ECOL PROG SER, V587, P201, DOI 10.3354/meps12458; Eurich JG, 2018, J EXP MAR BIOL ECOL, V506, P155, DOI 10.1016/j.jembe.2018.06.009; Ferrari R, 2018, ECOGRAPHY, V41, P1077, DOI 10.1111/ecog.02580; Ferrari R, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8020113; Fox J., 2012, PACKAGE CAR; Fox RJ, 2008, CORAL REEFS, V27, P605, DOI 10.1007/s00338-008-0359-6; Fox RJ, 2007, MAR ECOL PROG SER, V339, P49, DOI 10.3354/meps339049; Friedlander AM, 2007, MAR ECOL PROG SER, V351, P221, DOI 10.3354/meps07112; Friedlander AM, 1998, J EXP MAR BIOL ECOL, V224, P1, DOI 10.1016/S0022-0981(97)00164-0; Fulton CJ, 2005, P ROY SOC B-BIOL SCI, V272, P827, DOI 10.1098/rspb.2004.3029; Garpe KC, 2003, HYDROBIOLOGIA, V498, P191, DOI 10.1023/A:1026217201408; Gonzalez-Rivero M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14272-5; Gordon SE, 2016, CORAL REEFS, V35, P285, DOI 10.1007/s00338-015-1374-z; GOREAU TF, 1959, ECOLOGY, V40, P67, DOI 10.2307/1929924; Gotanda KM, 2009, BEHAV ECOL SOCIOBIOL, V63, P1563, DOI 10.1007/s00265-009-0750-5; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Graham NAJ, 2013, CORAL REEFS, V32, P315, DOI 10.1007/s00338-012-0984-y; Graham NAJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101204; Harrison XA, 2015, PEERJ, V3, DOI 10.7717/peerj.1114; Henderson J, 2013, INT J NAUT ARCHAEOL, V42, P243, DOI 10.1111/1095-9270.12016; Hixon MA, 2005, ECOLOGY, V86, P2847, DOI 10.1890/04-1455; HIXON MA, 1993, ECOL MONOGR, V63, P77, DOI 10.2307/2937124; Hoey AS, 2009, ECOSYSTEMS, V12, P1316, DOI 10.1007/s10021-009-9291-z; Holbrook SJ, 2002, MAR FRESHWATER RES, V53, P1045, DOI 10.1071/MF02063; Holmes TH, 2006, MAR ECOL PROG SER, V317, P203, DOI 10.3354/meps317203; Hopley D, 2007, GEOMORPHOLOGY OF THE GREAT BARRIER REEF: DEVELOPMENT, DIVERSITY, AND CHANGE, P1, DOI 10.1017/CBO9780511535543; Januchowski-Hartley FA, 2012, MAR ECOL PROG SER, V469, P113, DOI 10.3354/meps09971; Johansen JL, 2008, MAR ECOL PROG SER, V360, P219, DOI 10.3354/meps07482; JONES GP, 1988, J EXP MAR BIOL ECOL, V123, P115, DOI 10.1016/0022-0981(88)90164-5; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Kerry JT, 2012, CORAL REEFS, V31, P415, DOI 10.1007/s00338-011-0859-7; Khan JA, 2016, CORAL REEFS, V35, P411, DOI 10.1007/s00338-015-1387-7; Khan JA, 2017, CORAL REEFS, V36, P1123, DOI 10.1007/s00338-017-1604-7; Kleypas JA, 2001, INT J EARTH SCI, V90, P426, DOI 10.1007/s005310000125; KLUMPP DW, 1989, J EXP MAR BIOL ECOL, V131, P1, DOI 10.1016/0022-0981(89)90008-7; Lara EN, 1998, J FISH BIOL, V53, P209, DOI 10.1111/j.1095-8649.1998.tb01028.x; Lee SC, 2006, OIKOS, V112, P442, DOI 10.1111/j.0030-1299.2006.14247.x; Leon JX, 2015, GEOMORPHOLOGY, V242, P21, DOI 10.1016/j.geomorph.2015.01.030; LEWIS SM, 1985, J EXP MAR BIOL ECOL, V87, P215, DOI 10.1016/0022-0981(85)90206-0; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; LUCKHURST BE, 1978, MAR BIOL, V49, P317, DOI 10.1007/BF00455026; Marley SA, 2017, HYDROBIOLOGIA, V792, P243, DOI 10.1007/s10750-016-3061-7; McClure EC, 2019, DIVERSITY-BASEL, V11, DOI 10.3390/d11020023; McCook LJ, 1999, CORAL REEFS, V18, P357, DOI 10.1007/s003380050213; MCCORMICK MI, 1994, MAR ECOL PROG SER, V112, P87, DOI 10.3354/meps112087; Mihalitsis M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184679; Nash KL, 2013, ECOSYSTEMS, V16, P478, DOI 10.1007/s10021-012-9625-0; Pinca S, 2012, FISH FISH, V13, P361, DOI 10.1111/j.1467-2979.2011.00425.x; Pizarro O, 2017, ECOL EVOL, V7, P1770, DOI 10.1002/ece3.2701; Purcell SW, 2001, CORAL REEFS, V20, P117, DOI 10.1007/s003380100150; R Core Team, 2021, R LANGUAGE ENV STAT; Rasher DB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15679-w; Richardson LE, 2017, ENVIRON BIOL FISH, V100, P193, DOI 10.1007/s10641-016-0571-0; Ripple WJ, 2003, FOREST ECOL MANAG, V184, P299, DOI 10.1016/S0378-1127(03)00154-3; Rizzari JR, 2014, OIKOS, V123, P829, DOI 10.1111/oik.01318; Robinson JPW, 2020, FUNCT ECOL, V34, P240, DOI 10.1111/1365-2435.13457; Robinson JPW, 2019, GLOBAL CHANGE BIOL, V25, P2739, DOI 10.1111/gcb.14704; Robinson JPW, 2019, NAT ECOL EVOL, V3, P183, DOI 10.1038/s41559-018-0715-z; Roff G, 2019, ECOL MONOGR, V89, DOI 10.1002/ecm.1336; Russ GR, 2018, J FISH BIOL, V93, P887, DOI 10.1111/jfb.13809; Russ GR, 2017, MAR ECOL-EVOL PERSP, V38, DOI 10.1111/maec.12442; Russ GR, 2017, MAR BIOL, V164, DOI 10.1007/s00227-016-3056-y; Russ GR, 2015, MAR BIOL, V162, P2029, DOI 10.1007/s00227-015-2728-3; Russ GR, 2003, CORAL REEFS, V22, P63, DOI 10.1007/s00338-003-0286-5; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sivrikaya F, 2014, POL J ENVIRON STUD, V23, P187; Taylor BM, 2018, ECOLOGY, V99, P642, DOI 10.1002/ecy.2127; Tebbett SB, 2020, J ECOL, V108, P70, DOI 10.1111/1365-2745.13235; Tebbett SB, 2018, MAR ENVIRON RES, V141, P255, DOI 10.1016/j.marenvres.2018.09.011; Tebbett SB, 2018, CORAL REEFS, V37, P929, DOI 10.1007/s00338-018-1718-6; Tebbett SB, 2017, CORAL REEFS, V36, P803, DOI 10.1007/s00338-017-1571-z; Tebbett SB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169479; Tootell JS, 2016, OECOLOGIA, V181, P13, DOI 10.1007/s00442-015-3418-z; Vehtari A, 2017, STAT COMPUT, V27, P1433, DOI 10.1007/s11222-016-9709-3; Wilson SK, 2007, MAR BIOL, V151, P1069, DOI 10.1007/s00227-006-0538-3; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Wismer S, 2019, SCI TOTAL ENVIRON, V650, P1487, DOI 10.1016/j.scitotenv.2018.09.114; Wismer S, 2009, MAR ECOL PROG SER, V376, P45, DOI 10.3354/meps07790; Wu Shuhong, 2006, Recent Pat Antiinfect Drug Discov, V1, P241, DOI 10.2174/157489106777452665; Zuur A. F., 2013, BEGINNERS GUIDE GLM	106	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0233498	10.1371/journal.pone.0233498	http://dx.doi.org/10.1371/journal.pone.0233498			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497043	gold, Green Accepted, Green Published			2022-12-26	WOS:000542035200096
J	Pantigoso, HA; Yuan, J; He, YH; Quo, QG; Vollmer, C; Vivanco, JM				Pantigoso, Hugo A.; Yuan, Jun; He, Yanhui; Quo, Qinggang; Vollmer, Charlie; Vivanco, Jorge M.			Role of root exudates on assimilation of phosphorus in young and old Arabidopsis thaliana plants	PLOS ONE			English	Article							ORGANIC ANION EXUDATION; WHITE LUPIN; SOIL-PHOSPHORUS; RHIZOSPHERE; PHOSPHATE; DEFICIENCY; CITRATE; ACID; SEED; AVAILABILITY	The role of root exudates has long been recognized for its potential to improve nutrient use efficiency in cropping systems. However, studies addressing the variability of root exudates involved in phosphorus solubilization across plant developmental stages remain scarce. Here, we grew Arabidopsis thaliana seedlings in sterile liquid culture with a low, medium, or high concentration of phosphate and measured the composition of the root exudate at seedling, vegetative, and bolting stages. The exudates changed in response to the incremental addition of phosphorus, starting from the vegetative stage. Specific metabolites decreased in relation to phosphate concentration supplementation at specific stages of development. Some of those metabolites were tested for their phosphate solubilizing activity, and 3-hydroxypropionic acid, malic acid, and nicotinic acid were able to solubilize calcium phosphate from both solid and liquid media. In summary, our data suggest that plants can release distinct compounds to deal with phosphorus deficiency needs influenced by the phosphorus nutritional status at varying developmental stages.	[Pantigoso, Hugo A.; He, Yanhui; Quo, Qinggang; Vivanco, Jorge M.] Colorado State Univ, Dept Hort & Landscape Architecture, Ctr Rhizosphere Biol, Ft Collins, CO 80523 USA; [Yuan, Jun] Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Organ Solid Waste, Jiangsu Prov Key Lab Organ Solid Waste Utilizat, Nanjing, Peoples R China; [He, Yanhui] Shihezi Univ, Sch Chem & Chem Engn, Key Lab Green Proc Chem Engn Xinjiang Bingtuan, Shihezi, Peoples R China; [Quo, Qinggang] Hebei Acad Agr & Forestry Sci, Inst Plant Protect, Baoding, Peoples R China; [Vollmer, Charlie] Colorado State Univ, Dept Stat, Ft Collins, CO 80523 USA	Colorado State University; Nanjing Agricultural University; Shihezi University; Hebei Academy of Agricultural & Forestry Sciences; Colorado State University	Vivanco, JM (corresponding author), Colorado State Univ, Dept Hort & Landscape Architecture, Ctr Rhizosphere Biol, Ft Collins, CO 80523 USA.	J.Vivanco@colostate.edu	Yuan, Jun/AAT-9457-2020; Yuan, Jun/P-4658-2014; He, Yanhui/ABF-8579-2020	Yuan, Jun/0000-0002-8265-0239; He, Yanhui/0000-0002-7721-0976; Pantigoso Guevara, Hugo Alejandro/0000-0002-7121-7253	National Postdoctoral Program for Innovative Talents [BX201600075]; Natural Science Foundation of Jiangsu Province [BK20170724]; China Scholarship Council [201709505007]	National Postdoctoral Program for Innovative Talents; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); China Scholarship Council(China Scholarship Council)	J. Y. was supported by National Postdoctoral Program for Innovative Talents (BX201600075) and Natural Science Foundation of Jiangsu Province (BK20170724), Y. H. was supported by China Scholarship Council (No. 201709505007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1983, EC BOOKS CURRENT SEL, V9, P29; [Anonymous], 2017, EXPERT OPIN THER PAT, V27, P1, DOI DOI 10.1017/S0959270917000065; Awasthi A, 2019, TRENDS BIOTECHNOL, V37, P569, DOI 10.1016/j.tibtech.2019.03.002; AWONAIKE KO, 1991, SOIL SCI SOC AM J, V55, P81, DOI 10.2136/sssaj1991.03615995005500010014x; Bates TR, 2001, PLANT SOIL, V236, P243, DOI 10.1023/A:1012791706800; BOLLAND MDA, 1988, AUST J EXP AGR, V28, P765, DOI 10.1071/EA9880765; BRAUM SM, 1995, PLANT SOIL, V176, P95, DOI 10.1007/BF00017679; Carvalhais LC, 2011, J PLANT NUTR SOIL SC, V174, P3, DOI 10.1002/jpln.201000085; Chaparro JM, 2014, ISME J, V8, P790, DOI 10.1038/ismej.2013.196; Chaparro JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055731; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; El-Bassiouny H. M. S., 2005, International Journal of Agriculture and Biology, V7, P653; Fiehn O, 2008, PLANT J, V53, P691, DOI 10.1111/j.1365-313X.2007.03387.x; FOHSE D, 1988, PLANT SOIL, V110, P101, DOI 10.1007/BF02143545; FUJIOKA S, 1986, PLANT CELL PHYSIOL, V27, P109; Gerke J, 2015, J PLANT NUTR SOIL SC, V178, P351, DOI 10.1002/jpln.201400590; Gilbert N, 2009, NATURE, V461, P716, DOI 10.1038/461716a; Giles CD, 2017, PLANT SOIL, V412, P43, DOI 10.1007/s11104-016-2884-3; Grant CA, 2001, CAN J PLANT SCI, V81, P211, DOI 10.4141/P00-093; Gunatilaka AAL, 2006, J NAT PROD, V69, P509, DOI 10.1021/np058128n; Hasan MM, 2016, CELL MOL BIOL LETT, V21, DOI 10.1186/s11658-016-0008-y; He Y, 2019, J APPL MICROBIOL, V127, P196, DOI 10.1111/jam.14273; Heydari MM, 2019, J PLANT NUTR, V42, P1, DOI 10.1080/01904167.2018.1509996; Hinsinger P, 2001, PLANT SOIL, V237, P173, DOI 10.1023/A:1013351617532; Hocking PJ, 2004, PLANT SOIL, V258, P135, DOI 10.1023/B:PLSO.0000016544.18563.86; Johnson JF, 1996, PLANT PHYSIOL, V112, P31, DOI 10.1104/pp.112.1.31; Jones DL, 1998, PLANT SOIL, V205, P25, DOI 10.1023/A:1004356007312; Keerthisinghe G, 1998, PLANT CELL ENVIRON, V21, P467, DOI 10.1046/j.1365-3040.1998.00300.x; Li L, 2007, P NATL ACAD SCI USA, V104, P11192, DOI 10.1073/pnas.0704591104; Lickfett T, 1999, EUR J AGRON, V11, P293, DOI 10.1016/S1161-0301(99)00038-6; LIPTON DS, 1987, PLANT PHYSIOL, V85, P315, DOI 10.1104/pp.85.2.315; Lynch JP, 2007, AUST J BOT, V55, P493, DOI 10.1071/BT06118; Marschner H., 1998, Soil chemistry and ecosystem health., P191; Marschner H, 1995, MINERAL NUTR HIGHER, P483, DOI DOI 10.1016/B978-012473542-2/50015-8; MARTI HR, 1991, J PLANT NUTR, V14, P1177, DOI 10.1080/01904169109364276; MARTI HR, 1991, J PLANT NUTR, V14, P1165, DOI 10.1080/01904169109364275; Mitchell-Olds T, 2006, NATURE, V441, P947, DOI 10.1038/nature04878; Nadeem M, 2012, PLANT SOIL, V357, P13, DOI 10.1007/s11104-011-1111-5; Nadeem M, 2011, PLANT SOIL, V346, P231, DOI 10.1007/s11104-011-0814-y; Nautiyal CS, 1999, FEMS MICROBIOL LETT, V170, P265, DOI 10.1111/j.1574-6968.1999.tb13383.x; Neumann G, 1999, PLANTA, V208, P373, DOI 10.1007/s004250050572; O'Banion BS, 2020, MOL PLANT MICROBE IN, V33, P124, DOI 10.1094/MPMI-04-19-0115-CR; Oburger E, 2018, RHIZOSPHERE-NETH, V6, P116, DOI 10.1016/j.rhisph.2018.06.004; Oburger E, 2013, ENVIRON EXP BOT, V87, P235, DOI 10.1016/j.envexpbot.2012.11.007; Paredes SH, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003962; Rolfe SA, 2019, CURR OPIN MICROBIOL, V49, P73, DOI 10.1016/j.mib.2019.10.003; Romheld V, 2000, RHIZOSPHERE, P57; Rose TJ, 2008, EUR J AGRON, V28, P371, DOI 10.1016/j.eja.2007.11.003; Ryan PR, 2001, ANNU REV PLANT PHYS, V52, P527, DOI 10.1146/annurev.arplant.52.1.527; Sattari SZ, 2012, P NATL ACAD SCI USA, V109, P6348, DOI 10.1073/pnas.1113675109; Schwarz M, 2004, PHYTOCHEMISTRY, V65, P2239, DOI 10.1016/j.phytochem.2004.06.035; Singer AC, 2003, TRENDS BIOTECHNOL, V21, P123, DOI 10.1016/S0167-7799(02)00041-0; Strom L, 2005, SOIL BIOL BIOCHEM, V37, P2046, DOI 10.1016/j.soilbio.2005.03.009; Tawaraya K, 2014, SOIL SCI PLANT NUTR, V60, P679, DOI 10.1080/00380768.2014.945390; Veneklaas EJ, 2003, PLANT SOIL, V248, P187, DOI 10.1023/A:1022367312851; Vengavasi K, 2018, PLANT PHYSIOL BIOCH, V124, P1, DOI 10.1016/j.plaphy.2018.01.002; Venturi V, 2016, TRENDS PLANT SCI, V21, P187, DOI 10.1016/j.tplants.2016.01.005; Voges MJEEE, 2019, P NATL ACAD SCI USA, V116, P12558, DOI 10.1073/pnas.1820691116; Wang YL, 2020, PLANT SOIL, V447, P135, DOI 10.1007/s11104-019-03972-8; Wei YQ, 2016, BIORESOURCE TECHNOL, V221, P139, DOI 10.1016/j.biortech.2016.09.038; Weisskopf L, 2006, PLANT CELL ENVIRON, V29, P919, DOI 10.1111/j.1365-3040.2005.01473.x; White PJ, 2012, PLANT SOIL, V357, P1, DOI 10.1007/s11104-012-1128-4; Yang H, 2007, PLANT BIOTECHNOL J, V5, P735, DOI 10.1111/j.1467-7652.2007.00281.x; Yuan J, 2015, SOIL BIOL BIOCHEM, V89, P206, DOI 10.1016/j.soilbio.2015.07.009; Zhang FS, 1997, PLANT SOIL, V196, P261, DOI 10.1023/A:1004214410785; Zhu J, 2018, SCI TOTAL ENVIRON, V612, P522, DOI 10.1016/j.scitotenv.2017.08.095	67	12	12	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2020	15	6							e0234216	10.1371/journal.pone.0234216	http://dx.doi.org/10.1371/journal.pone.0234216			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LW6ZP	32492072	Green Published, gold			2022-12-26	WOS:000539293000032
J	Hemati, Z; Haghkhah, M; Derakhshandeh, A; Chaubey, KK; Singh, SV				Hemati, Zahra; Haghkhah, Masoud; Derakhshandeh, Abdollah; Chaubey, Kundan Kumar; Singh, Shoor Vir			Novel recombinant Mce-truncated protein based ELISA for the diagnosis of Mycobacterium avium subsp. paratuberculosis infection in domestic livestock	PLOS ONE			English	Article							INDIGENOUS MILK ELISA; BOVINE-JOHNES-DISEASE; BISON-TYPE; SERO-PREVALENCE; IMMUNOGENICITY; EXPRESSION; STRAINS; TUBERCULOSIS; POPULATION; EPITOPES	Johne's disease (JD) is an infectious wasting condition of ruminants caused by Mycobacterium avium subsp. paratuberculosis (MAP) in domestic livestock of every country that has been investigated. Controlling JD is problematic due to the lack of sensitive, specific, efficient, and cost-effective diagnostic tests. A major challenge in the development of diagnostics like ELISA is the selection of an ideal antigen/(s) that is pathogen-specific and allows sensitive recognition. Therefore, the purpose of this study was to identify and use Mce-truncated protein-based ELISA assay for the diagnosis of MAP infection with high sensitivity and specificity. In silico epitope prediction by epitope mapping throughout the whole length of MAP2191 protein revealed that C-terminal portion of this protein presented potential T- and B-cell epitopes. Therefore, a novel Mce-truncated protein encoded by the selected region of MAP2191 gene was expressed, purified with Ni-NTA gel matrix and confirmed by SDS PAGE and western blot. A profiling ELISA assay was developed to evaluate sera from MAP infected and non-infected ruminant species for antibodies against Mce-truncated protein to infer the immunogenicity of this protein in the host. Using this Mce protein-based ELISA, 251 goats, 53 sheep, 117 buffaloes, and 33 cattle serum samples were screened and 49.4, 51.0, 69.2, and 54.6% animals, respectively, were found positive. Comparing with i-ELISA, the new Mce-based ELISA kit showed a relatively higher specificity but suffered from slightly reduced sensitivity. Mce-based ELISA excluded apparently false positive results of i-ELISA. Mce protein was found to be antigenic and Mce-ELISA test could be employed as a diagnostic test for JD in domestic livestock in view of the a relatively higher specificity and accuracy. The antigenic potential of Mce antigen can also be exploited for the development of a new vaccine for the control of MAP infection.	[Hemati, Zahra; Haghkhah, Masoud; Derakhshandeh, Abdollah] Shiraz Univ, Sch Vet Med, Dept Pathobiol, Shiraz, Iran; [Chaubey, Kundan Kumar; Singh, Shoor Vir] Cent Inst Res Goats, Anim Hlth Div, Mathura, Uttar Pradesh, India; [Hemati, Zahra] ShahreKord Univ, Sch Vet Med, Dept Pathobiol, Shahrekord, Iran; [Chaubey, Kundan Kumar; Singh, Shoor Vir] GLA Univ, Inst Appl Sci & Humanities, Dept Biotechnol, Mathura, Uttar Pradesh, India	Shiraz University; Indian Council of Agricultural Research (ICAR); ICAR - Central Institute for Research on Goats; Shahrekord University; GLA University	Haghkhah, M (corresponding author), Shiraz Univ, Sch Vet Med, Dept Pathobiol, Shiraz, Iran.	mhaghkha@shirazu.ac.ir	Hemati, Zahra/ABD-7499-2021; Derakhshandeh, Abdollah/B-5387-2015; Haghkhah, Masoud/AAX-6977-2021; Haghkhah, Masoud/W-9910-2018	Hemati, Zahra/0000-0002-8343-8483; Derakhshandeh, Abdollah/0000-0002-1878-1103; Haghkhah, Masoud/0000-0001-7266-4082; Chaubey, Kundan/0000-0002-5940-4638	Shiraz University [94GCU3M1304]; Iran National Science Foundation (INSF) [97004189]; ICAR_CIRG; Mathura; ICMR; DST_SERB New Delhi	Shiraz University; Iran National Science Foundation (INSF)(Iran National Science Foundation (INSF)); ICAR_CIRG; Mathura; ICMR(Indian Council of Medical Research (ICMR)); DST_SERB New Delhi	This work was financially supported partially by a grant from Shiraz University (94GCU3M1304) and also Iran National Science Foundation (INSF) (No. 97004189), different institutions in India (ICAR_CIRG, Mathura, ICMR and DST_SERB New Delhi).	Acharya KR, 2017, INT J FOOD MICROBIOL, V257, P1, DOI 10.1016/j.ijfoodmicro.2017.06.005; Ahlstrom C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1387-6; Ahmad S, 2005, SCAND J IMMUNOL, V62, P16, DOI 10.1111/j.1365-3083.2005.01639.x; Alexander DC, 2009, J BACTERIOL, V191, P1018, DOI 10.1128/JB.01340-08; Forrellad MA, 2014, TUBERCULOSIS, V94, P170, DOI 10.1016/j.tube.2013.12.005; Bannantine JP, 2011, CLIN VACCINE IMMUNOL, V18, P105, DOI 10.1128/CVI.00297-10; Biet F, 2008, VACCINE, V26, P257, DOI 10.1016/j.vaccine.2007.10.059; Carlos P, 2015, J THEOR BIOL, V384, P1, DOI 10.1016/j.jtbi.2015.08.003; Casali N, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-60; Castellanos E, 2012, VET MICROBIOL, V159, P60, DOI 10.1016/j.vetmic.2012.03.010; Castellanos E, 2009, APPL ENVIRON MICROB, V75, P676, DOI 10.1128/AEM.01683-08; Chaubey KK, 2015, ASIAN J ANIM VET ADV, V10, P567, DOI DOI 10.3923/AJAVA.2015.567.576; Chaubey KK, 2019, INDIAN J EXP BIOL, V57, P967; Chaubey KK, 2018, SMALL RUMINANT RES, V165, P24, DOI 10.1016/j.smallrumres.2018.06.005; Chaubey KK, 2018, INDIAN J EXP BIOL, V56, P279; Chaubey KK, 2017, VET QUART, V37, P282, DOI 10.1080/01652176.2017.1397301; Checkley AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026434; Collins MT, 2002, CLIN DIAGN LAB IMMUN, V9, P1367, DOI 10.1128/CDLI.9.6.1367-1371.2002; Faisal SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070171; Ghosh P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031947; Gumber S, 2009, VET MICROBIOL, V137, P290, DOI 10.1016/j.vetmic.2009.01.012; Gupta S, 2017, INDIAN J BIOTECHNOL, V228, P234; Gurung RB, 2012, CLIN VACCINE IMMUNOL, V19, P855, DOI 10.1128/CVI.00114-12; Hemati Z, 2019, VET QUART, V39, P65, DOI 10.1080/01652176.2019.1641764; Hemati Z, 2018, MOL BIOL RES COMMUN, V7, P165, DOI 10.22099/mbrc.2018.30979.1354; Hou JY, 2002, INFECT IMMUN, V70, P3714, DOI 10.1128/IAI.70.7.3714-3726.2002; Hughes V, 2008, CLIN VACCINE IMMUNOL, V15, P1824, DOI 10.1128/CVI.00099-08; Huntley JF, 2005, INFECT IMMUN, V73, P6877, DOI 10.1128/IAI.73.10.6877-6884.2005; Kuenstner JT, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00208; Kumar A, 2005, FEMS IMMUNOL MED MIC, V43, P185, DOI 10.1016/j.femsim.2004.08.013; Li LL, 2005, P NATL ACAD SCI USA, V102, P12344, DOI 10.1073/pnas.0505662102; Mohn WW, 2008, J BIOL CHEM, V283, P35368, DOI 10.1074/jbc.M805496200; Mukartal SY, 2017, COGENT FOOD AGR, V3, DOI 10.1080/23311932.2017.1298391; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Perkowski EF, 2016, MOL MICROBIOL, V100, P90, DOI 10.1111/mmi.13303; Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514; Rana A, 2015, J MOL RECOGNIT, V28, P506, DOI 10.1002/jmr.2458; Sechi LA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00096; Semret M, 2005, J CLIN MICROBIOL, V43, P3704, DOI 10.1128/JCM.43.8.3704-3712.2005; Senaratne RH, 2008, J MED MICROBIOL, V57, P164, DOI 10.1099/jmm.0.47454-0; Sevilla I, 2005, REV SCI TECH OIE, V24, P1061, DOI 10.20506/rst.24.3.1634; Sharma G, 2008, RES VET SCI, V84, P30, DOI 10.1016/j.rvsc.2007.03.014; Singh AV, 2009, INDIAN J EXP BIOL, V47, P379; Singh SV, 2008, COMP IMMUNOL MICROB, V31, P419, DOI 10.1016/j.cimid.2007.06.002; Singh SV, 2007, SMALL RUMINANT RES, V70, P89, DOI 10.1016/j.smallrumres.2005.11.019; Singh SV, 2014, TRANSBOUND EMERG DIS, V61, P43, DOI 10.1111/tbed.12216; Singh S. V., 2013, Research Opinions in Animal and Veterinary Sciences, V3, P401; Singh SV, 2011, COMP IMMUNOL MICROB, V34, P267, DOI 10.1016/j.cimid.2010.12.004; Singh S. V., 2007, Indian Journal of Microbiology, V47, P251, DOI 10.1007/s12088-007-0046-2; Singh SV, 2016, INDIAN J BIOTECHNOL, V15, P511; Tenzer S, 2005, CELL MOL LIFE SCI, V62, P1025, DOI 10.1007/s00018-005-4528-2; Timms VJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1889-2; Uchiya K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071831; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; Wu CW, 2006, J BACTERIOL, V188, P711, DOI 10.1128/JB.188.2.711-723.2006; Xu GX, 2007, MOL CELL BIOCHEM, V302, P1, DOI 10.1007/s11010-006-9395-0; Yadav D, 2008, COMP IMMUNOL MICROB, V31, P373, DOI 10.1016/j.cimid.2007.06.007; Zhang F, 2011, MOL CELL BIOCHEM, V352, P1, DOI 10.1007/s11010-011-0733-5; Zhu XC, 2008, MICROBES INFECT, V10, P1274, DOI 10.1016/j.micinf.2008.07.025	60	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0233695	10.1371/journal.pone.0233695	http://dx.doi.org/10.1371/journal.pone.0233695			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MJ2AA	32479551	gold, Green Published			2022-12-26	WOS:000547893500022
J	Olander, ER; Janzen, D; Villmann, C; Jensen, AA				Olander, Emma Rie; Janzen, Dieter; Villmann, Carmen; Jensen, Anders A.			Comparison of biophysical properties of alpha 1 beta 2 and alpha 3 beta 2 GABA(A) receptors in whole-cell patch-clamp electrophysiological recordings	PLOS ONE			English	Article							KINETIC-PROPERTIES; DESENSITIZATION; SUBTYPES; CURRENTS	In the present study we have characterized the biophysical properties of wild-type (WT) alpha 1 beta 2 and alpha 3 beta 2 GABA(A) receptors and probed the molecular basis for the observed differences. The activation and desensitization behavior and the residual currents of the receptors expressed in HEK293 cells were determined in whole-cell patch clamp recordings. Kinetic parameters of alpha 1 beta 2 and alpha 3 beta 2 activation differed significantly, with alpha 1 beta 2 and alpha 3 beta 2 exhibiting rise times (10-90%) of 24 +/- 2 ms and 51 +/- 7 ms, respectively. In contrast, the two receptors exhibited largely comparable desensitization behavior with decay currents that could be fitted to exponential functions with two or three components. Most notably, the two receptor compositions displayed different degrees of desentization, with the residual currents of alpha 1 beta 2 and alpha 3 beta 2 constituting 34 +/- 2% and 21 +/- 2% of the peak current, respectively. The respective contributions of the extracellular domains and the transmembrane/intracellular domains of the alpha-subunit to these physiological profiles were next assessed in recordings from cells expressing alpha beta 2 receptors comprising chimeric alpha-subunits. The rise times displayed by alpha 1(ECD)/alpha 3(TMD)beta 2 and alpha 3(ECD)/alpha 1(TMD)beta 2 receptors were intermediate to those of WT alpha 1 beta 2 and WT alpha 3 beta 2, and the distribution of the different components of the current decays exhibited by the two chimeric receptors followed the same pattern as the two WT receptors. The residual current exhibited by alpha 1(ECD)/alpha 3(TMD)beta 2 (23 +/- 3%) was similar to that of alpha 3 beta 2 but significantly different from that of alpha 1 beta 2, whereas the residual current displayed by alpha 3(ECD)/alpha 1(TMD)beta 2 (27 +/- 2%) was intermediate to and did not differ significantly from either of the WT receptors. This points to molecular differences in the transmembrane/intracellular domains of the alpha-subunit as the main determinants of the observed differences in receptor physiology between alpha 1 beta 2 and alpha 3 beta 2 receptors.	[Olander, Emma Rie; Janzen, Dieter; Villmann, Carmen] Julius Maximilians Univ Wurzburg, Inst Clin Neurobiol, Wurzburg, Germany; [Olander, Emma Rie; Jensen, Anders A.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark	University of Wurzburg; University of Copenhagen	Villmann, C (corresponding author), Julius Maximilians Univ Wurzburg, Inst Clin Neurobiol, Wurzburg, Germany.; Jensen, AA (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark.	villmann_c@ukw.de; aaj@sund.ku.dk	Jensen, Anders/AAJ-3335-2020; Janzen, Dieter/J-2978-2017	Jensen, Anders/0000-0002-7927-5052; Janzen, Dieter/0000-0001-7258-9043	Novo Nordisk Foundation; Augustinus Foundation	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Augustinus Foundation	A.A.J. Novo Nordisk Foundation URL: https://novonordiskfonden.dk/en/Augustinus Foundation URL: https://augustinusfonden.dk/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by funding from Novo Nordisk Foundation and the Augustinus Foundation. Dr. P.J. Whiting is thanked for the GABAAR subunits cDNAs.	Barberis A, 2007, EUR J NEUROSCI, V25, P2726, DOI 10.1111/j.1460-9568.2007.05530.x; Bianchi MT, 2002, J PHYSIOL-LONDON, V544, P3, DOI 10.1113/jphysiol.2002.020255; Braat S, 2015, NEURON, V86, P1119, DOI 10.1016/j.neuron.2015.03.042; Chen XM, 2017, NEUROPHARMACOLOGY, V125, P243, DOI 10.1016/j.neuropharm.2017.07.027; Chua HC, 2017, ADV PHARMACOL, V79, P1, DOI 10.1016/bs.apha.2017.03.003; Gielen M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7829; Haas KF, 1999, J PHYSIOL-LONDON, V514, P27, DOI 10.1111/j.1469-7793.1999.027af.x; Hegazy NH, 2019, BIOL CHEM, V400, P1205, DOI 10.1515/hsz-2019-0112; Jensen AA, 2010, J BIOL CHEM, V285, P10141, DOI 10.1074/jbc.M109.079319; Jones MV, 1996, TRENDS NEUROSCI, V19, P96, DOI 10.1016/S0166-2236(96)80037-3; JONES MV, 1995, NEURON, V15, P181, DOI 10.1016/0896-6273(95)90075-6; Karlsson U, 2011, J GEN PHYSIOL, V138, P609, DOI 10.1085/jgp.201110674; Laverty D, 2019, NATURE, V565, P516, DOI 10.1038/s41586-018-0833-4; Meiselbach H, 2014, J BIOL CHEM, V289, P29135, DOI 10.1074/jbc.M114.559138; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Picton AJ, 2007, BRAIN RES, V1165, P40, DOI 10.1016/j.brainres.2007.06.050; Rudolph U, 2014, ANNU REV PHARMACOL, V54, P483, DOI 10.1146/annurev-pharmtox-011613-135947; Soderhielm PC, 2018, BIOCHEM PHARMACOL, V158, P339, DOI 10.1016/j.bcp.2018.08.019; Stephens DN, 2017, GENES BRAIN BEHAV, V16, P149, DOI 10.1111/gbb.12321; Wang CH, 2018, J NEUROSCI, V38, P2818, DOI 10.1523/JNEUROSCI.0674-16.2018; Zhu ST, 2018, NATURE, V559, P67, DOI 10.1038/s41586-018-0255-3	23	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0234080	10.1371/journal.pone.0234080	http://dx.doi.org/10.1371/journal.pone.0234080			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MJ2AA	32479525	gold, Green Published			2022-12-26	WOS:000547893500051
J	Tengeler, AC; Gart, E; Wiesmann, M; Arnoldussen, IAC; van Duyvenvoorde, W; Hoogstad, M; Dederen, PJ; Verweij, V; Geenen, B; Kozicz, T; Kleemann, R; Morrison, MC; Kiliaan, AJ				Tengeler, Anouk C.; Gart, Eveline; Wiesmann, Maximilian; Arnoldussen, Ilse A. C.; van Duyvenvoorde, Wim; Hoogstad, Marloes; Dederen, Pieter J.; Verweij, Vivienne; Geenen, Bram; Kozicz, Tamas; Kleemann, Robert; Morrison, Martine C.; Kiliaan, Amanda J.			Propionic acid and not caproic acid, attenuates nonalcoholic steatohepatitis and improves (cerebro) vascular functions in obese Ldlr(-/-).Leiden mice	FASEB JOURNAL			English	Article						cerebral vasoreactivity; cognition; liver fibrosis; neuroimaging; obesity	CHAIN FATTY-ACIDS; DIET-INDUCED OBESITY; COGNITIVE IMPAIRMENT; SOCIAL-BEHAVIOR; BRAIN STRUCTURE; INSULIN; MODEL; RATS; QUANTIFICATION; METABOLISM	The obesity epidemic increases the interest to elucidate impact of short-chain fatty acids on metabolism, obesity, and the brain. We investigated the effects of propionic acid (PA) and caproic acid (CA) on metabolic risk factors, liver and adipose tissue pathology, brain function, structure (by MRI), and gene expression, during obesity development in Ldlr(-/-).Leiden mice. Ldlr(-/-).Leiden mice received 16 weeks either a high-fat diet (HFD) to induce obesity, or chow as reference group. Next, obese HFD-fed mice were treated 12 weeks with (a) HFD + CA (CA), (b) HFD + PA (PA), or (c) a HFD-control group. PA reduced the body weight and systolic blood pressure, lowered fasting insulin levels, and reduced HFD-induced liver macrovesicular steatosis, hypertrophy, inflammation, and collagen content. PA increased the amount of glucose transporter type 1-positive cerebral blood vessels, reverted cerebral vasoreactivity, and HFD-induced effects in microstructural gray and white matter integrity of optic tract, and somatosensory and visual cortex. PA and CA also reverted HFD-induced effects in functional connectivity between visual and auditory cortex. However, PA mice were more anxious in open field, and showed reduced activity of synaptogenesis and glutamate regulators in hippocampus. Therefore, PA treatment should be used with caution even though positive metabolic, (cerebro) vascular, and brain structural and functional effects were observed.	[Tengeler, Anouk C.; Wiesmann, Maximilian; Arnoldussen, Ilse A. C.; Hoogstad, Marloes; Dederen, Pieter J.; Verweij, Vivienne; Geenen, Bram; Kozicz, Tamas; Kleemann, Robert; Kiliaan, Amanda J.] Radboud Univ Nijmegen, Dept Anat, Donders Inst Brain Cognit & Behav, Preclin Imaging Ctr,Med Ctr, Nijmegen, Netherlands; [Gart, Eveline; van Duyvenvoorde, Wim; Morrison, Martine C.] Netherlands Org Appl Sci Res TNO, Dept Metab Hlth Res, Leiden, Netherlands; [Gart, Eveline; Morrison, Martine C.] Wageningen Univ, Human & Anim Physiol, Wageningen, Netherlands; [Kozicz, Tamas] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA; [Kleemann, Robert] Leiden Univ, Dept Vasc Surg, Med Ctr, Leiden, Netherlands	Radboud University Nijmegen; Wageningen University & Research; Mayo Clinic; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kiliaan, AJ (corresponding author), Radboud Univ Nijmegen, Dept Anat, Donders Inst Brain Cognit & Behav, Preclin Imaging Ctr PRIME,Med Ctr, Geert Grootepl Noord 21, NL-6525 EZ Nijmegen, Netherlands.	Amanda.Kiliaan@radboudumc.nl	Gart, Eveline/AFI-8480-2022; Geenen, Bram/D-9659-2016; Morrison, Martine C./C-3168-2014; Wiesmann, Maximilian/AAW-1627-2021; Kiliaan, Amanda J/D-8778-2012; Gart, Eveline/AAF-4105-2022	Gart, Eveline/0000-0002-7713-2381; Geenen, Bram/0000-0001-7838-3097; Morrison, Martine C./0000-0003-4996-943X; Wiesmann, Maximilian/0000-0002-1412-398X; Gart, Eveline/0000-0002-7713-2381	TNO Early Research Program 'Body Brain Interactions'	TNO Early Research Program 'Body Brain Interactions'	We thank the bio-technicians at TNO Metabolic Health Research and at the Animal Research Facility of the Radboud university medical center for taking excellent care of the mice. We also thank Andor Veltien, Sjaak van Asten, and Tim Emmerzaal for their great scientific support. This study was supported by the TNO Early Research Program 'Body Brain Interactions'.	Akpa MM, 2010, LIPIDS, V45, P997, DOI 10.1007/s11745-010-3465-5; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Arnoldussen IAC, 2017, INT J OBESITY, V41, P935, DOI 10.1038/ijo.2017.52; Arnoldussen IAC, 2016, J NUTR BIOCHEM, V30, P177, DOI 10.1016/j.jnutbio.2015.12.011; Bartolomaeus H, 2019, CIRCULATION, V139, P1407, DOI 10.1161/CIRCULATIONAHA.118.036652; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bindels LB, 2012, BRIT J CANCER, V107, P1337, DOI 10.1038/bjc.2012.409; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Burhans MS, 2019, COMPR PHYSIOL, V9, P1, DOI 10.1002/cphy.c170040; Chambers E, 2015, P NUTR SOC, V74; Chambers Edward S, 2018, Curr Nutr Rep, V7, P198, DOI 10.1007/s13668-018-0248-8; Choeiri C, 2002, NEUROSCIENCE, V111, P19, DOI 10.1016/S0306-4522(01)00619-4; Daikhin Y, 2000, J NUTR, V130, p1026S, DOI 10.1093/jn/130.4.1026S; de Mello AH, 2018, LIFE SCI, V192, P26, DOI 10.1016/j.lfs.2017.11.019; de Montgolfier O, 2019, GEROSCIENCE, V41, P511, DOI 10.1007/s11357-019-00070-6; De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016; DEMIGNE C, 1995, BRIT J NUTR, V74, P209, DOI 10.1079/BJN19950124; den Besten G, 2015, DIABETES, V64, P2398, DOI 10.2337/db14-1213; Deng J, 2014, CARDIOVASC RES, V103, P473, DOI 10.1093/cvr/cvu154; Deutsch C, 2009, MICROVASC RES, V78, P100, DOI 10.1016/j.mvr.2009.04.004; Emmerzaal TL, 2018, J ALZHEIMERS DIS, V66, P75, DOI 10.3233/JAD-180337; Foley KA, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087072, 10.1371/journal.pone.0108413]; Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9; Galarraga M, 2012, J LIPID RES, V53, P2791, DOI 10.1194/jlr.D023788; Giles JM, 2018, J AM ASS LAB ANIM SC; Harsan LA, 2010, NMR BIOMED, V23, P884, DOI 10.1002/nbm.1496; Hurr C, 2017, EXP PHYSIOL, V102, P1300, DOI 10.1113/EP086446; Jais A, 2016, CELL, V165, P882, DOI 10.1016/j.cell.2016.03.033; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; Janssen CIF, 2015, J NUTR BIOCHEM, V26, P24, DOI 10.1016/j.jnutbio.2014.08.002; Jennings JR, 2009, NEUROIMAGE, V47, P914, DOI 10.1016/j.neuroimage.2009.04.072; Kilkenny C, 2012, VET CLIN PATH, V41, P27, DOI 10.1111/j.1939-165X.2012.00418.x; Kitade H, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040387; Li M, 2018, EUR J PHARMACOL, V831, P52, DOI 10.1016/j.ejphar.2018.05.003; Liang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075290; Liang WF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0109757, 10.1371/journal.pone.0090827]; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; Lopez OL, 2003, ARCH NEUROL-CHICAGO, V60, P1394, DOI 10.1001/archneur.60.10.1394; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; MacFabe DF, 2007, BEHAV BRAIN RES, V176, P149, DOI 10.1016/j.bbr.2006.07.025; MacFabe DF, 2011, BEHAV BRAIN RES, V217, P47, DOI 10.1016/j.bbr.2010.10.005; Rodriguez MM, 2015, SCI REP-UK, V5, DOI 10.1038/srep14600; Medic N, 2019, INT J OBESITY, V43, P523, DOI 10.1038/s41366-018-0269-9; Morrison MC, 2018, HEPATOL COMMUN, V2, P1513, DOI 10.1002/hep4.1270; Mulder P, 2016, INT J OBESITY, V40, P675, DOI 10.1038/ijo.2015.226; Natarajan N, 2016, PHYSIOL GENOMICS, V48, P826, DOI 10.1152/physiolgenomics.00089.2016; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Ou XW, 2015, J MAGN RESON IMAGING, V42, P1205, DOI 10.1002/jmri.24912; Pannacciulli N, 2006, NEUROIMAGE, V31, P1419, DOI 10.1016/j.neuroimage.2006.01.047; Patrone V, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00200; Paxinos G, 2001, PAXINOS FRANKLINS MO, V4th; Pernold K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211063; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Renna NF, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/808353; Rial SA, 2018, MOLECULES, V23, DOI 10.3390/molecules23092315; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sekar S, 2013, PSYCHOPHARMACOLOGY, V227, P479, DOI 10.1007/s00213-013-2966-3; Seravalle G, 2017, PHARMACOL RES, V122, P1, DOI 10.1016/j.phrs.2017.05.013; Shams S, 2019, DEV PSYCHOBIOL, V61, P688, DOI 10.1002/dev.21825; Shultz SR, 2008, NEUROPHARMACOLOGY, V54, P901, DOI 10.1016/j.neuropharm.2008.01.013; Sorop O, 2017, CARDIOVASC RES, V113, P1035, DOI 10.1093/cvr/cvx093; Takai A, 2020, BMC GASTROENTEROL, V20, DOI 10.1186/s12876-020-01194-2; Tedelind S, 2007, WORLD J GASTROENTERO, V13, P2826, DOI 10.3748/wjg.v13.i20.2826; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Uranga RM, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00513; van Bloemendaal L, 2016, METAB BRAIN DIS, V31, P621, DOI 10.1007/s11011-016-9792-3; Vani K, 2017, J HISTOCHEM CYTOCHEM, V65, P463, DOI 10.1369/0022155417714208; Wagner J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221455; Wah DTO, 2019, PHYSIOL BEHAV, V199, P35, DOI 10.1016/j.physbeh.2018.11.003; Wiesmann M, 2017, J CEREBR BLOOD F MET, V37, P2396, DOI 10.1177/0271678X16667364; Wiesmann M, 2017, THERANOSTICS, V7, P1277, DOI 10.7150/thno.18509; Wiesmann M, 2017, THERANOSTICS, V7, P493, DOI 10.7150/thno.17559; WRIGHT RS, 1990, P SOC EXP BIOL MED, V195, P26, DOI 10.3181/00379727-195-43113; Wu H, 2016, NEUROSCIENCE, V322, P221, DOI 10.1016/j.neuroscience.2016.02.043; Xu H, 2016, J ENDOCRINOL, V229, P133, DOI 10.1530/JOE-15-0409; Zerbi V, 2014, J NEUROSCI, V34, P13963, DOI 10.1523/JNEUROSCI.0684-14.2014; Zerbi V, 2014, NEUROBIOL AGING, V35, P600, DOI 10.1016/j.neurobiolaging.2013.09.038	79	16	16	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9575	9593		10.1096/fj.202000455R	http://dx.doi.org/10.1096/fj.202000455R		MAY 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32472598	Green Published			2022-12-26	WOS:000538118400001
J	Pessina, F; Frosini, M; Marcolongo, P; Fusi, F; Saponara, S; Gamberucci, A; Valoti, M; Giustarini, D; Fiorenzani, P; Gorelli, B; Francardi, V; Botta, M; Dreassi, E				Pessina, Federica; Frosini, Maria; Marcolongo, Paola; Fusi, Fabio; Saponara, Simona; Gamberucci, Alessandra; Valoti, Massimo; Giustarini, Daniela; Fiorenzani, Paolo; Gorelli, Beatrice; Francardi, Valeria; Botta, Maurizio; Dreassi, Elena			Antihypertensive, cardio- and neuro-protective effects of Tenebrio molitor (Coleoptera: Tenebrionidae) defatted larvae in spontaneously hypertensive rats	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; MILL. BARK EXTRACT; BLOOD-PRESSURE; INHIBITORY PEPTIDE; CAPTOPRIL; LANGENDORFF; FRACTIONS; INSECTS; SLICES; THIOLS	In pre-hypertension, moderate control of blood pressure (BP) can be obtained by a nutritional approach. The effects of a diet enriched with defatted larvae of the mealworm Tenebrio molitor(Coleoptera: Tenebrionidae) (TM) endowed with ACE inhibitory activity was studied in both spontaneously hypertensive rats (SHR) and in the age-matched normotensive Wistar Kyoto strain. These were fed for 4 weeks with standard laboratory rodent chow supplemented with or without TM or captopril. In SHR, the TM diet caused a significant reduction in BP, heart rate and coronary perfusion pressure, as well as an increase in red blood cell glutathione/glutathione disulphide ratio. Rat brain slices of SHR were more resistant to oxidative stress and contained lower levels of inflammatory cytokines, while vascular and liver enzyme-activities were not affected. These results suggest that TM can be considered a new functional food that can lower BP in vivo and thus control cardiovascular-associated risk factors such as hypertension.	[Pessina, Federica; Marcolongo, Paola; Gamberucci, Alessandra] Univ Siena, Dipartimento Med Mol & Sviluppo, Siena, Italy; [Frosini, Maria; Saponara, Simona; Valoti, Massimo; Gorelli, Beatrice] Univ Siena, Dipartimento Sci Vita, Siena, Italy; [Fusi, Fabio; Giustarini, Daniela; Botta, Maurizio; Dreassi, Elena] Univ Siena, Dipartimento Biotecnol Chim & Farm, Siena, Italy; [Fiorenzani, Paolo] Univ Siena, Dipartimento Sci Med Chirurg & Neurosci, Siena, Italy; [Francardi, Valeria] Consiglio Ric Agr & Anal Econ Agr, Ctr Ric Difesa & Certificaz CREA DC, Florence, Italy; [Botta, Maurizio] Lead Discovery Siena Srl, Siena, Italy	University of Siena; University of Siena; University of Siena; University of Siena; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA)	Frosini, M (corresponding author), Univ Siena, Dipartimento Sci Vita, Siena, Italy.	maria.frosini@unisi.it	Saponara, Simona/I-7315-2019; Marcolongo, Paola/AAG-5260-2019; Giustarini, Daniela/AAV-6629-2021; Dreassi, Elena/B-5728-2012	Saponara, Simona/0000-0002-3831-8669; Marcolongo, Paola/0000-0001-9330-8570; Dreassi, Elena/0000-0001-8987-940X; FROSINI, MARIA/0000-0002-4452-8128; PESSINA, Federica/0000-0003-3310-3738	Tuscan Regional Administration's Call for Research Projects in the Nutraceutical Industry [4741, 5418]; Lead Discovery Siena Srl	Tuscan Regional Administration's Call for Research Projects in the Nutraceutical Industry; Lead Discovery Siena Srl	This research was carried out under the project "INSECT CARD" funded by the Tuscan Regional Administration's Call for Research Projects in the Nutraceutical Industry. Executive Decrees No. 4741 of 21 October 2014 and No. 5418 of 17 November 2014, PI Valeria Francardi. Lead Discovery Siena Srl provided support in the form of research materials. The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1985, World Health Organ Tech Rep Ser, V724, P1; [Anonymous], 1984, Arch Intern Med, V144, P1947; [Anonymous], 1995, OFFICIAL METHODS ANA; Brizi C, 2016, J CELL BIOCHEM, V117, P510, DOI 10.1002/jcb.25302; Cito A, 2017, J INSECTS FOOD FEED, V3, P231, DOI [10.3920/JIFF2017.0017, 10.3920/jiff2017.0017]; Cito A, 2017, POTENTIAL BENEFICIAL, P125; Connell BJ, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/319230; Contartese A, 2012, PHARMACOL RES, V66, P555, DOI 10.1016/j.phrs.2012.08.003; Dai CH, 2013, EUR FOOD RES TECHNOL, V236, P681, DOI 10.1007/s00217-013-1923-z; DINICOLANTONIO R, 1984, CLIN EXP PHARMACOL P, V11, P237; Doring HJ, 1987, ISOLATED PERFUSED HE; Dragoni S, 2007, J PHARM PHARM SCI, V10, P473, DOI 10.18433/J37P4J; EIKENBURG DC, 1984, HYPERTENSION, V6, P660, DOI 10.1161/01.HYP.6.5.660; Finke MD, 2015, ZOO BIOL, V34, P554, DOI 10.1002/zoo.21246; Gangwar A, 2014, INDIAN J PHARMACOL, V46, P351, DOI 10.4103/0253-7613.132207; Giustarini D, 2016, J CHROMATOGR B, V1019, P51, DOI 10.1016/j.jchromb.2016.02.009; GOLIK A, 1995, CLIN CHIM ACTA, V240, P89, DOI 10.1016/0009-8981(95)06121-3; Gomez-Roso M, 2009, BRIT J PHARMACOL, V158, P1911, DOI 10.1111/j.1476-5381.2009.00491.x; Han SR, 2016, REGUL TOXICOL PHARM, V77, P206, DOI 10.1016/j.yrtph.2016.03.006; Han SR, 2016, TOX RESEARCH, V32, P175, DOI 10.5487/TR.2016.32.2.175; Han SR, 2014, TOX RESEARCH, V30, P121, DOI 10.5487/TR.2014.30.2.121; Haspula D, 2018, AUTON NEUROSCI-BASIC, V210, P10, DOI 10.1016/j.autneu.2018.01.002; Hodges Romilly E, 2015, J Nutr Metab, V2015, P760689, DOI 10.1155/2015/760689; Iadecola C, 2008, CELL METAB, V7, P476, DOI 10.1016/j.cmet.2008.03.010; Ji BY, 2017, BIOMED PHARMACOTHER, V94, P1057, DOI 10.1016/j.biopha.2017.08.042; KOIKE H, 1980, HYPERTENSION, V2, P299, DOI 10.1161/01.HYP.2.3.299; Kolwicz SC, 2007, J APPL PHYSIOL, V102, P628, DOI 10.1152/japplphysiol.00449.2006; Kondziella D, 2008, PHYSIOL RES, V57, P487, DOI 10.33549/physiolres.931189; Lee W, 2017, FOOD CHEM TOXICOL, V109, P19, DOI 10.1016/j.fct.2017.08.026; LEVENS NR, 1981, ENDOCRINOLOGY, V108, P536, DOI 10.1210/endo-108-2-536; LUSCHER TF, 1986, HYPERTENSION, V8, P344, DOI 10.1161/01.HYP.8.4.344; Maron BA, 2009, ANNU REV MED, V60, P39, DOI 10.1146/annurev.med.60.041807.123308; Masson GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094927; Materson BJ, 2017, J AM SOC HYPERTENS, V11, P704, DOI 10.1016/j.jash.2017.09.005; Moriarty-Craige SE, 2004, ANNU REV NUTR, V24, P481, DOI 10.1146/annurev.nutr.24.012003.132208; Padilha GD, 2018, NUTRIENTS, V10, DOI 10.3390/nu10070828; PANZA JA, 1995, CIRCULATION, V91, P1732, DOI 10.1161/01.CIR.91.6.1732; Pessina F, 2018, BIOCHEM PHARMACOL, V155, P434, DOI 10.1016/j.bcp.2018.07.026; Reule S, 2012, CURR HYPERTENS REP, V14, P478, DOI 10.1007/s11906-012-0306-3; Ricci L, 2009, EUR J PHARMACOL, V621, P26, DOI 10.1016/j.ejphar.2009.08.017; Rumpold BA, 2013, MOL NUTR FOOD RES, V57, P802, DOI 10.1002/mnfr.201200735; Santulli C, 2017, J CELL BIOCHEM, V118, P839, DOI 10.1002/jcb.25760; Saponara S, 2016, BRIT J PHARMACOL, V173, P292, DOI 10.1111/bph.13369; Saponara S, 2007, EUR J PHARMACOL, V563, P160, DOI 10.1016/j.ejphar.2007.02.001; Selaledi L, 2020, TROP ANIM HEALTH PRO, V52, P7, DOI 10.1007/s11250-019-02033-7; Seo M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030518; Skrzypiec-Spring Monika, 2007, Journal of Pharmacological and Toxicological Methods, V55, P113, DOI 10.1016/j.vascn.2006.05.006; Su Q, 2016, TOXICOL LETT, V241, P152, DOI 10.1016/j.toxlet.2015.10.019; Sun Li, 2006, Shengli Xuebao, V58, P318; Touyz RM, 2011, HYPERTENS RES, V34, P5, DOI 10.1038/hr.2010.201; Wang ZL, 2011, AGR SCI CHINA, V10, P463, DOI 10.1016/S1671-2927(11)60026-6; Yi LY, 2016, EUR FOOD RES TECHNOL, V242, P1285, DOI 10.1007/s00217-015-2632-6; Yi LY, 2013, FOOD CHEM, V141, P3341, DOI 10.1016/j.foodchem.2013.05.115; Yuan YV, 1998, J NUTR, V128, P1620, DOI 10.1093/jn/128.10.1620; Zhao X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147791	55	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2020	15	5							e0233788	10.1371/journal.pone.0233788	http://dx.doi.org/10.1371/journal.pone.0233788			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1WS	32470081	Green Published, gold			2022-12-26	WOS:000537552800177
J	Yang, J; Naik, N; Patel, JS; Wylie, CS; Gu, WZ; Huang, J; Ytreberg, FM; Naik, MT; Weinreich, DM; Rubenstein, BM				Yang, Jordan; Naik, Nandita; Patel, Jagdish Suresh; Wylie, Christopher S.; Gu, Wenze; Huang, Jessie; Ytreberg, F. Marty; Naik, Mandar T.; Weinreich, Daniel M.; Rubenstein, Brenda M.			Predicting the viability of beta-lactamase: How folding and binding free energies correlate with beta-lactamase fitness	PLOS ONE			English	Article							PROTEIN-STRUCTURE; MOLECULAR-DYNAMICS; ACTIVE-SITE; STABILITY; MUTAGENESIS; EVOLUTION; MUTATIONS; INTERFACE; EFFICIENT; THERMODYNAMICS	One of the long-standing holy grails of molecular evolution has been the ability to predict an organism's fitness directly from its genotype. With such predictive abilities in hand, researchers would be able to more accurately forecast how organisms will evolve and how proteins with novel functions could be engineered, leading to revolutionary advances in medicine and biotechnology. In this work, we assemble the largest reported set of experimental TEM-1 beta-lactamase folding free energies and use this data in conjunction with previously acquired fitness data and computational free energy predictions to determine how much of the fitness of beta-lactamase can be directly predicted by thermodynamic folding and binding free energies. We focus upon beta-lactamase because of its long history as a model enzyme and its central role in antibiotic resistance. Based upon a set of 21 beta-lactamase single and double mutants expressly designed to influence protein folding, we first demonstrate that modeling software designed to compute folding free energies such as FoldX and PyRo-setta can meaningfully, although not perfectly, predict the experimental folding free energies of single mutants. Interestingly, while these techniques also yield sensible double mutant free energies, we show that they do so for the wrong physical reasons. We then go on to assess how well both experimental and computational folding free energies explain single mutant fitness. We find that folding free energies account for, at most, 24% of the variance in beta-lactamase fitness values according to linear models and, somewhat surprisingly, complementing folding free energies with computationally-predicted binding free energies of residues near the active site only increases the folding-only figure by a few percent. This strongly suggests that the majority of beta-lactamase's fitness is controlled by factors other than free energies. Overall, our results shed a bright light on to what extent the community is justified in using thermodynamic measures to infer protein fitness as well as how applicable modern computational techniques for predicting free energies will be to the large data sets of multiply-mutated proteins forthcoming.	[Yang, Jordan; Gu, Wenze; Rubenstein, Brenda M.] Brown Univ, Dept Chem, Providence, RI 02912 USA; [Naik, Nandita; Wylie, Christopher S.; Weinreich, Daniel M.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Patel, Jagdish Suresh; Ytreberg, F. Marty] Univ Idaho, Inst Modeling Collaborat & Innovat, Moscow, ID 83843 USA; [Patel, Jagdish Suresh] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Huang, Jessie] Wellesley Coll, Dept Chem, Wellesley, MA 02181 USA; [Ytreberg, F. Marty] Univ Idaho, Dept Phys, Moscow, ID USA; [Naik, Mandar T.] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA	Brown University; Brown University; Idaho; University of Idaho; Idaho; University of Idaho; Wellesley College; Idaho; University of Idaho; Brown University	Rubenstein, BM (corresponding author), Brown Univ, Dept Chem, Providence, RI 02912 USA.	brenda_rubenstein@brown.edu	Weinreich, Dan/AAZ-6606-2021	Yang, Jordan/0000-0001-8679-4347; Naik, Mandar/0000-0002-7016-572X	National Science Foundation EPSCoR Track-II award [OIA1736253]; Center for Modeling Complex Interactions - NIGMS [P20 GM104420]; Office of Nuclear Energy of the U.S. DOE; Nuclear Science User Facilities [DE-AC07-05ID14517]; EPSCOR [1736253]; Center for Modeling Complex Interactions Information	National Science Foundation EPSCoR Track-II award; Center for Modeling Complex Interactions - NIGMS; Office of Nuclear Energy of the U.S. DOE(United States Department of Energy (DOE)); Nuclear Science User Facilities; EPSCOR(National Science Foundation (NSF)NSF - Office of the Director (OD)); Center for Modeling Complex Interactions Information	JY, NN, JSP, WG, JH, MY, MTN, DMW, and B MR were funded by National Science Foundation EPSCoR Track-II award number OIA1736253. JSP was additionally supported by the Center for Modeling Complex Interactions sponsored by the NIGMS under award number P20 GM104420. Computer resources employed by JY, JH, WG, and BMR were provided by the Brown Center for Computation and Visualization (CCV) and JSP and MY employed resources provided by the high-performance computing center at Idaho National Laboratory, which is supported by the Office of Nuclear Energy of the U.S. DOE and the Nuclear Science User Facilities under Contract No. DE-AC07-05ID14517. EPSCOR Grant Information: https://www.nsf.gov/awardsearch/showAward? AWD_ID=1736253 Center for Modeling Complex Interactions Information: http://grantome.com/grant/NIH/P20-GM104420-04 No, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford RF, 2017, J CHEM THEORY COMPUT, V13, P3031, DOI 10.1021/acs.jctc.7b00125; Allen M. P., 1989, COMPUTER SIMULATION, DOI DOI 10.1093/OSO/9780198803195.001.0001; Araya CL, 2012, P NATL ACAD SCI USA, V109, P16858, DOI 10.1073/pnas.1209751109; Arnold FH, 1998, ACCOUNTS CHEM RES, V31, P125, DOI 10.1021/ar960017f; Ash J, 2017, J CHEM INF MODEL, V57, P1286, DOI 10.1021/acs.jcim.7b00048; Audagnotto M, 2017, COMPUT STRUCT BIOTEC, V15, P307, DOI 10.1016/j.csbj.2017.03.004; Bava KA, 2004, NUCLEIC ACIDS RES, V32, pD120, DOI 10.1093/nar/gkh082; BAXTER J, 1981, J OPER RES SOC, V32, P815, DOI 10.2307/2581397; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Bershtein S, 2013, MOL CELL, V49, P133, DOI 10.1016/j.molcel.2012.11.004; Bloom JD, 2005, P NATL ACAD SCI USA, V102, P606, DOI 10.1073/pnas.0406744102; Bloom JD, 2007, GENETICS, V175, P255, DOI 10.1534/genetics.106.061754; Blum C, 2008, STUD COMPUT INTELL, V114, P1, DOI 10.1007/978-3-540-78295-7; Bowman GR, 2015, P NATL ACAD SCI USA, V112, P2734, DOI 10.1073/pnas.1417811112; Broom A, 2017, J BIOL CHEM, V292, P14349, DOI 10.1074/jbc.M117.784165; Brunk E, 2018, P NATL ACAD SCI USA, V115, P11096, DOI 10.1073/pnas.1811971115; Buss O, 2018, COMPUT STRUCT BIOTEC, V16, P25, DOI 10.1016/j.csbj.2018.01.002; Chaudhury S, 2010, BIOINFORMATICS, V26, P689, DOI 10.1093/bioinformatics/btq007; Dehouck Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-151; DELAIRE M, 1992, J BIOL CHEM, V267, P20600; Deng ZF, 2012, J MOL BIOL, V424, P150, DOI 10.1016/j.jmb.2012.09.014; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Dror RO, 2012, ANNU REV BIOPHYS, V41, P429, DOI 10.1146/annurev-biophys-042910-155245; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Eyre-Walker A, 2007, NAT REV GENET, V8, P610, DOI 10.1038/nrg2146; Firnberg E, 2014, MOL BIOL EVOL, V31, P1581, DOI 10.1093/molbev/msu081; FONZE E, 1995, ACTA CRYSTALLOGR D, V51, P682, DOI 10.1107/S0907444994014496; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Freire E., 1995, DNA REPAIR MUTAGENES, P191; Frenkel D., 2001, UNDERSTANDING MOL SI, V1, DOI DOI 10.1016/B978-012267351-1/50003-; Fukunishi H, 2002, J CHEM PHYS, V116, P9058, DOI 10.1063/1.1472510; Gaillard T, 2018, J CHEM INF MODEL, V58, P1697, DOI 10.1021/acs.jcim.8b00312; Gibson RM, BIOCH J, P613; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Gur E, 2011, NAT REV MICROBIOL, V9, P839, DOI 10.1038/nrmicro2669; Hampton R.E., 2014, INTRO BIOLOGICAL STA; Hart KM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12965; HERZBERG O, 1987, SCIENCE, V236, P694, DOI 10.1126/science.3107125; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Huang PS, 2016, NATURE, V537, P320, DOI 10.1038/nature19946; Jack BR, 2019, TRANSCRIPT DEGRADATI; JACOB F, 1990, BIOCHEM J, V271, P399, DOI 10.1042/bj2710399; Jacquier H, 2013, P NATL ACAD SCI USA, V110, P13067, DOI 10.1073/pnas.1215206110; Johnson CM, 2013, ARCH BIOCHEM BIOPHYS, V531, P100, DOI 10.1016/j.abb.2012.09.008; Kasson PM, 2009, J AM CHEM SOC, V131, P11338, DOI 10.1021/ja904557w; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Knies JL, 2017, MOL BIOL EVOL, V34, P1040, DOI 10.1093/molbev/msx053; Kumar MDS, 2006, NUCLEIC ACIDS RES, V34, pD204, DOI 10.1093/nar/gkj103; Lazaridis T, 2000, CURR OPIN STRUC BIOL, V10, P139, DOI 10.1016/S0959-440X(00)00063-4; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; Liberles DA, 2012, PROTEIN SCI, V21, P769, DOI 10.1002/pro.2071; Maguid S, 2006, J MOL EVOL, V63, P448, DOI 10.1007/s00239-005-0209-x; Miler CR, 2016, PEERJ, V4, DOI 10.7717/peerj.1674; Miller CJ, 2014, PLOS ONE, V9, P1, DOI DOI 10.1371/J0URNAL.P0NE.0095061.EC0LLECTI0N; Mirny LA, 1999, J MOL BIOL, V291, P177, DOI 10.1006/jmbi.1999.2911; Morin RB, 2014, BIOL B LACTAM ANTIBI; Naganathan AN, 2019, CURR OPIN STRUC BIOL, V54, P1, DOI 10.1016/j.sbi.2018.09.004; Orencia MC, 2001, NAT STRUCT BIOL, V8, P238, DOI 10.1038/84981; Pandini A, 2007, PROTEIN ENG DES SEL, V20, P285, DOI 10.1093/protein/gzm021; Patel JS, 2018, J CHEM THEORY COMPUT, V14, P991, DOI 10.1021/acs.jctc.7b00660; Paterson JT, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215458; Petrosino JF, 1996, J BACTERIOL, V178, P1821, DOI 10.1128/jb.178.7.1821-1828.1996; Potapov V, 2009, PROTEIN ENG DES SEL, V22, P553, DOI 10.1093/protein/gzp030; Powers ET, 2012, CELL REP, V1, P265, DOI 10.1016/j.celrep.2012.02.011; Rajasekaran N, 2017, J PHYS CHEM LETT, V8, P4779, DOI 10.1021/acs.jpclett.7b02021; Rajasekaran N, 2017, BIOCHEMISTRY-US, V56, P294, DOI 10.1021/acs.biochem.6b00798; Ramanathan R, 2015, J PHYS CHEM B, V119, P7944, DOI 10.1021/acs.jpcb.5b03176; Rutherford SL, 2003, NAT REV GENET, V4, P263, DOI 10.1038/nrg1041; Schasfoort RBM, 2017, HANDBOOK OF SURFACE PLASMON RESONANCE, 2ND EDITION, P1; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Shapovalov MV, 2011, STRUCTURE, V19, P844, DOI 10.1016/j.str.2011.03.019; Silander OK, 2007, PLOS BIOL, V5, P922, DOI 10.1371/journal.pbio.0050094; Siloto RMP, 2012, BIOCATAL AGRIC BIOTE, V1, P181, DOI 10.1016/j.bcab.2012.03.010; Soskine M, 2010, NAT REV GENET, V11, P572, DOI 10.1038/nrg2808; Stec B, 2005, ACTA CRYSTALLOGR D, V61, P1072, DOI 10.1107/S0907444905014356; Stiffler MA, 2015, CELL, V160, P882, DOI 10.1016/j.cell.2015.01.035; Stojanoski V, 2016, BIOCHEMISTRY-US, V55, P2479, DOI 10.1021/acs.biochem.6b00056; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Van Durme J, 2011, BIOINFORMATICS, V27, P1711, DOI 10.1093/bioinformatics/btr254; VanWart AT, 2012, J CHEM THEORY COMPUT, V8, P2949, DOI 10.1021/ct300377a; Wackerly D., 2014, MATH STAT APPL; Walsh C., 2003, ANTIBIOTICS ACTIONS; Weinreich DM, 2013, CURR OPIN GENET DEV, V23, P700, DOI 10.1016/j.gde.2013.10.007; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Weinreich DM, 2005, EVOLUTION, V59, P1165; Wylie CS, 2011, P NATL ACAD SCI USA, V108, P9916, DOI 10.1073/pnas.1017572108; Zaccolo M, 1999, J MOL BIOL, V285, P775, DOI 10.1006/jmbi.1998.2262	92	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2020	15	5							e0233509	10.1371/journal.pone.0233509	http://dx.doi.org/10.1371/journal.pone.0233509			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1WS	32470971	gold, Green Published, Green Submitted			2022-12-26	WOS:000537552800085
J	Kang, HE; Bian, JF; Kane, SJ; Kim, S; Selwyn, V; Crowell, J; Bartz, JC; Telling, GC				Kang, Hae-Eun; Bian, Jifeng; Kane, Sarah J.; Kim, Sehun; Selwyn, Vanessa; Crowell, Jenna; Bartz, Jason C.; Telling, Glenn C.			Incomplete glycosylation during prion infection unmasks a prion protein epitope that facilitates prion detection and strain discrimination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						N-linked glycosylation; prions; prion disease; protein misfolding; monoclonal antibody; neurodegeneration; Creutzfeldt-Jakob disease; PRC7; bovine spongiform encephalopathy; chronic wasting disease; prion; prion strains	BOVINE SPONGIFORM ENCEPHALOPATHY; PRPSC FORMATION; HOST PRP; SCRAPIE; DISEASE; GLYCOPROTEIN; CONFORMATION; TRANSMISSION; VARIANT; BRAIN	The causative factors underlying conformational conversion of cellular prion protein (PrP (c)) into its infectious counterpart (PrPSc) during prion infection remain undetermined, in part because of a lack of monoclonal antibodies (mAbs) that can distinguish these conformational isoforms. Here we show that the anti-PrP mAb PRC7 recognizes an epitope that is shielded from detection when glycans are attached to Asn-196. We observed that whereas PrP (c) is predisposed to full glycosylation and is therefore refractory to PRC7 detection, prion infection leads to diminished PrP(Sc)glycosylation at Asn-196, resulting in an unshielded PRC7 epitope that is amenable to mAb recognition upon renaturation. Detection of PRC7-reactive PrP(Sc)in experimental and natural infections with various mouse-adapted scrapie strains and with prions causing deer and elk chronic wasting disease and transmissible mink encephalopathy uncovered that incomplete PrP(Sc)glycosylation is a consistent feature of prion pathogenesis. We also show that interrogating the conformational properties of the PRC7 epitope affords a direct means of distinguishing different prion strains. Because the specificity of our approach for prion detection and strain discrimination relies on the extent to whichN-linked glycosylation shields or unshields PrP epitopes from antibody recognition, it dispenses with the requirement for additional standard manipulations to distinguish PrP(Sc)from PrP (c), including evaluation of protease resistance. Our findings not only highlight an innovative and facile strategy for prion detection and strain differentiation, but are also consistent with a mechanism of prion replication in which structural instability of incompletely glycosylated PrP contributes to the conformational conversion of PrP (c) to PrPSc.	[Kang, Hae-Eun; Bian, Jifeng; Kane, Sarah J.; Kim, Sehun; Selwyn, Vanessa; Crowell, Jenna; Telling, Glenn C.] Colorado State Univ, Prion Res Ctr PRC, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Selwyn, Vanessa; Telling, Glenn C.] Colorado State Univ, Program Cell & Mol Biol, Ft Collins, CO 80523 USA; [Bartz, Jason C.] Creighton Univ, Dept Med Microbiol & Immunol, Omaha, NE 68178 USA	Colorado State University; Colorado State University; Creighton University	Telling, GC (corresponding author), Colorado State Univ, Prion Res Ctr PRC, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.; Telling, GC (corresponding author), Colorado State Univ, Program Cell & Mol Biol, Ft Collins, CO 80523 USA.	glenn.telling@colostate.edu		Bian, Jifeng/0000-0001-6838-9938; Bartz, Jason/0000-0003-4081-7886	National Institutes of Health [RO1NS040334, RO1NS109376, RO1NS103763, PO0011877A]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants RO1NS040334, RO1NS109376, RO1NS103763, and PO0011877A. The content is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health.	Angers R, 2014, P NATL ACAD SCI USA, V111, P11169, DOI 10.1073/pnas.1404739111; Angers RC, 2010, SCIENCE, V328, P1154, DOI 10.1126/science.1187107; Asante EA, 2015, NATURE, V522, P478, DOI 10.1038/nature14510; Babelhadj B, 2018, EMERG INFECT DIS, V24, P1029, DOI 10.3201/eid2406.172007; Bartz JC, 2000, J VIROL, V74, P5542, DOI 10.1128/JVI.74.12.5542-5547.2000; Benestad Sylvie L, 2018, Handb Clin Neurol, V153, P135, DOI 10.1016/B978-0-444-63945-5.00008-8; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; Bian JF, 2019, P NATL ACAD SCI USA, V116, P12478, DOI 10.1073/pnas.1903947116; Bian JF, 2017, P NATL ACAD SCI USA, V114, P1141, DOI 10.1073/pnas.1611891114; Bian JF, 2014, P NATL ACAD SCI USA, V111, P6028, DOI 10.1073/pnas.1322377111; Bian JF, 2010, J VIROL, V84, P8322, DOI 10.1128/JVI.00633-10; Biasini E, 2008, J NEUROCHEM, V105, P2190, DOI 10.1111/j.1471-4159.2008.05306.x; BRUCE M, 1994, PHILOS T R SOC B, V343, P405, DOI 10.1098/rstb.1994.0036; Camacho MV, 2019, LAB INVEST, V99, P1741, DOI 10.1038/s41374-019-0282-1; Cancellotti E, 2005, J BIOL CHEM, V280, P42909, DOI 10.1074/jbc.M509557200; Cancellotti E, 2007, BBA-MOL BASIS DIS, V1772, P673, DOI 10.1016/j.bbadis.2006.10.013; Cancellotti E, 2010, J VIROL, V84, P3464, DOI 10.1128/JVI.02374-09; Capellari Sabina, 2000, Journal of Alzheimer's Disease, V2, P27; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; DeArmond SJ, 1997, NEURON, V19, P1337, DOI 10.1016/S0896-6273(00)80424-9; Green KM, 2008, J GEN VIROL, V89, P598, DOI 10.1099/vir.0.83168-0; Green KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000139; Hanson SR, 2009, P NATL ACAD SCI USA, V106, P3131, DOI 10.1073/pnas.0810318105; HARRIS DA, 1993, BIOCHEMISTRY-US, V32, P1009, DOI 10.1021/bi00055a003; Kang HE, 2012, J BIOL CHEM, V287, P37219, DOI 10.1074/jbc.M112.395921; Katorcha E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004366; Khalili-Shirazi A, 2005, J GEN VIROL, V86, P2635, DOI 10.1099/vir.0.80375-0; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Korth C, 2000, J GEN VIROL, V81, P2555, DOI 10.1099/0022-1317-81-10-2555; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Matsunaga Y, 2001, PROTEINS, V44, P110, DOI 10.1002/prot.1077; Mays CE, 2014, J CLIN INVEST, V124, P847, DOI 10.1172/JCI72241; Mitra N, 2006, TRENDS BIOCHEM SCI, V31, P156, DOI 10.1016/j.tibs.2006.01.003; Moudjou M, 2004, J VIROL, V78, P9270, DOI 10.1128/JVI.78.17.9270-9276.2004; Moudjou M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29116; Nazor KE, 2005, EMBO J, V24, P2472, DOI 10.1038/sj.emboj.7600717; Neuendorf E, 2004, J BIOL CHEM, V279, P53306, DOI 10.1074/jbc.M410796200; Nishina KA, 2006, BIOCHEMISTRY-US, V45, P14129, DOI 10.1021/bi061526k; PAN KM, 1992, PROTEIN SCI, V1, P1343, DOI 10.1002/pro.5560011014; Pan T, 2002, J NEUROCHEM, V81, P1092, DOI 10.1046/j.1471-4159.2002.00909.x; Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201; Piro JR, 2009, J VIROL, V83, P5321, DOI 10.1128/JVI.02502-08; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; Prusiner S. B., 1998, LES PRIX NOBEL, P268; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; ROGERS M, 1990, Glycobiology, V1, P101, DOI 10.1093/glycob/1.1.101; Rudd PM, 1999, P NATL ACAD SCI USA, V96, P13044, DOI 10.1073/pnas.96.23.13044; Rudd PM, 2001, BIOCHEMISTRY-US, V40, P3759, DOI 10.1021/bi002625f; Russelakis-Carneiro M, 2002, J BIOL CHEM, V277, P36872, DOI 10.1074/jbc.M202229200; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Sandberg MK, 2011, NATURE, V470, P540, DOI 10.1038/nature09768; Spagnolli G, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007864; STAHL N, 1993, BIOCHEMISTRY-US, V32, P1991, DOI 10.1021/bi00059a016; TARABOULOS A, 1992, P NATL ACAD SCI USA, V89, P7620, DOI 10.1073/pnas.89.16.7620; Tattum MH, 2010, TRANSFUSION, V50, P2619, DOI 10.1111/j.1537-2995.2010.02731.x; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Tuzi NL, 2008, PLOS BIOL, V6, P872, DOI 10.1371/journal.pbio.0060100; Wadsworth JDF, 2004, SCIENCE, V306, P1793, DOI 10.1126/science.1103932; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Wiseman FK, 2015, J VIROL, V89, P4738, DOI 10.1128/JVI.02296-14; Yadavalli R, 2004, J BIOL CHEM, V279, P21948, DOI 10.1074/jbc.M400793200	63	9	9	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2020	295	30					10420	10433		10.1074/jbc.RA120.012796	http://dx.doi.org/10.1074/jbc.RA120.012796			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MW0BV	32513872	hybrid, Green Published			2022-12-26	WOS:000556713400024
J	Caliri, AW; Tommasi, S; Bates, SE; Besaratinia, A				Caliri, Andrew W.; Tommasi, Stella; Bates, Steven E.; Besaratinia, Ahmad			Spontaneous and photosensitization-induced mutations in primary mouse cells transitioning through senescence and immortalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; immortalization; mouse embryonic fibroblasts (MEF); mutagenesis; oncogenesis; oxidative stress; senescence; reactive oxygen species (ROS); transversion; DNA mismatch repair; DNA damage; photodynamic therapy; 8-oxoguanine (8-oxoG)	FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE; METHYLENE-BLUE; ESCHERICHIA-COLI; ERRONEOUS INCORPORATION; OXIDATIVE MUTAGENESIS; SUBSTRATE-SPECIFICITY; GENETIC INSTABILITY; CELLULAR SENESCENCE; IONIZING-RADIATION; SINGLET OXYGEN	To investigate the role of oxidative stress?induced DNA damage and mutagenesis in cellular senescence and immortalization, here we profiled spontaneous and methylene blue plus light?induced mutations in thecIIgene from ? phage in transgenic mouse embryonic fibroblasts during the transition from primary culture through senescence and immortalization. Consistent with detection of characteristic oxidized guanine lesions (8-oxodG) in the treated cells, we observed significantly increased relativecIImutant frequency in the treated pre-senescent cells which was augmented in their immortalized counterparts. The predominant mutation type in the treated pre-senescent cells was G:C?T:A transversion, whose frequency was intensified in the treated immortalized cells. Conversely, the prevailing mutation type in the treated immortalized cells was A:T?C:G transversion, with a unique sequence-context specificity,i.e.flanking purines at the 5? end of the mutated nucleotide. This mutation type was also enriched in the treated pre-senescent cells, although to a lower extent. The signature mutation of G:C?T:A transversions in the treated cells accorded with the well-established translesion synthesis bypass caused by 8-oxodG, and the hallmark A:T?C:G transversions conformed to the known replication errors because of oxidized guanine nucleosides (8-OHdGTPs). The distinctive features of photosensitization-induced mutagenesis in the immortalized cells, which were present at attenuated levels, in spontaneously immortalized cells provide insights into the role of oxidative stress in senescence bypass and immortalization. Our results have important implications for cancer biology because oxidized purines in the nucleoside pool can significantly contribute to genetic instability in DNA mismatch repair?defective human tumors.	[Caliri, Andrew W.; Tommasi, Stella; Besaratinia, Ahmad] Univ Southern Calif, USC Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90007 USA; [Bates, Steven E.] Beckman Res Inst City Hope, Dept Canc Biol, Duarte, CA USA	University of Southern California; City of Hope; Beckman Research Institute of City of Hope	Besaratinia, A (corresponding author), Univ Southern Calif, USC Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90007 USA.	besarati@med.usc.edu		Tommasi, Stella/0000-0001-6897-4985; Besaratinia, Ahmad/0000-0001-7231-228X	NIDCR, National Institutes of Health [1R01DE026043]; University of California Tobacco-Related Disease Research Program [TRDRP-26IR-0015, TRDRP-28IR0058, TRDRP-26IP-0051]	NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); University of California Tobacco-Related Disease Research Program(University of California System)	This work was supported by NIDCR, National Institutes of Health Grant 1R01DE026043 (to A. B.) and University of California Tobacco-Related Disease Research Program Grants TRDRP-26IR-0015 and TRDRP-28IR0058 (to A. B.) and TRDRP-26IP-0051 (to S. T.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agilent Technologies, SEL CII MUT DET SYST; Besaratinia A, 2008, FASEB J, V22, P2379, DOI 10.1096/fj.07-105437; Besaratinia A, 2018, JOVE-J VIS EXP, DOI 10.3791/57510; Besaratinia A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010262; Besaratinia A, 2011, FASEB J, V25, P3079, DOI 10.1096/fj.11-187336; BOITEUX S, 1992, BIOCHEMISTRY-US, V31, P106, DOI 10.1021/bi00116a016; BOITEUX S, 1987, EMBO J, V6, P3177, DOI 10.1002/j.1460-2075.1987.tb02629.x; Busuttil RA, 2003, AGING CELL, V2, P287, DOI 10.1046/j.1474-9728.2003.00066.x; Cadet J, 2006, PHOTOCHEM PHOTOBIOL, V82, P1219, DOI 10.1562/2006-06-09-IR-914; CHENG KC, 1992, J BIOL CHEM, V267, P166; Coste F, 2004, J BIOL CHEM, V279, P44074, DOI 10.1074/jbc.M405928200; DUNCAN BK, 1980, NATURE, V287, P560, DOI 10.1038/287560a0; EPE B, 1989, CARCINOGENESIS, V10, P2019, DOI 10.1093/carcin/10.11.2019; FLOYD RA, 1989, ARCH BIOCHEM BIOPHYS, V273, P106, DOI 10.1016/0003-9861(89)90167-7; FURUICHI M, 1994, GENOMICS, V24, P485, DOI 10.1006/geno.1994.1657; Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Henderson PT, 2003, BIOCHEMISTRY-US, V42, P9257, DOI 10.1021/bi0347252; HERSKOWITZ I, 1980, ANNU REV GENET, V14, P399, DOI 10.1146/annurev.ge.14.120180.002151; Hidaka K, 2008, DNA REPAIR, V7, P497, DOI 10.1016/j.dnarep.2007.12.005; Inoue M, 1998, J BIOL CHEM, V273, P11069, DOI 10.1074/jbc.273.18.11069; Jakubczak JL, 1996, P NATL ACAD SCI USA, V93, P9073, DOI 10.1073/pnas.93.17.9073; Jones PA, 2016, NAT REV GENET, V17, P630, DOI 10.1038/nrg.2016.93; KAMIYA H, 1995, NUCLEIC ACIDS RES, V23, P2893, DOI 10.1093/nar/23.15.2893; Kasai H, 2002, FREE RADICAL BIO MED, V33, P450, DOI 10.1016/S0891-5849(02)00818-3; Kucab JE, 2019, CELL, V177, P821, DOI 10.1016/j.cell.2019.03.001; Lambert LB, 2005, MUTAT RES-REV MUTAT, V590, P1, DOI 10.1016/j.mrrev.2005.04.002; Maitra A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3873; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; Mellish KJ, 2002, PHOTOCHEM PHOTOBIOL, V75, P392, DOI 10.1562/0031-8655(2002)075<0392:IVPAOA>2.0.CO;2; MICHAELS ML, 1992, P NATL ACAD SCI USA, V89, P7022, DOI 10.1073/pnas.89.15.7022; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; National Research Council, 2011, GUIDE CARE USE LAB A; Nohmi T, 2005, MUTAT RES-FUND MOL M, V591, P60, DOI 10.1016/j.mrfmmm.2005.03.033; Odell A, 2010, AGING-US, V2, P160, DOI 10.18632/aging.100129; Olivier M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04482; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; PAVLOV YI, 1994, BIOCHEMISTRY-US, V33, P4695, DOI 10.1021/bi00181a029; Russo MT, 2004, MOL CELL BIOL, V24, P465, DOI 10.1128/MCB.24.1.465-474.2004; Sakai A, 2006, GENES CELLS, V11, P767, DOI 10.1111/j.1365-2443.2006.00982.x; SAKUMI K, 1993, J BIOL CHEM, V268, P23524; Shimizu M, 2003, EMBO REP, V4, P269, DOI 10.1038/sj.embor.embor765; Shimizu M, 2007, BIOCHEMISTRY-US, V46, P5515, DOI 10.1021/bi062238r; Singh R, 2009, RAPID COMMUN MASS SP, V23, P151, DOI 10.1002/rcm.3866; TAJIRI T, 1995, MUTAT RES-DNA REPAIR, V336, P257, DOI 10.1016/0921-8777(94)00062-B; Tan XZ, 1999, CARCINOGENESIS, V20, P2287, DOI 10.1093/carcin/20.12.2287; TCHOU J, 1994, J BIOL CHEM, V269, P15318; Tommasi S, 2013, NUCLEIC ACIDS RES, V41, P182, DOI 10.1093/nar/gks1051; TUDEK B, 1993, MOL GEN GENET, V236, P433, DOI 10.1007/BF00277144; TUITE EM, 1993, J PHOTOCH PHOTOBIO B, V21, P103, DOI 10.1016/1011-1344(93)80173-7; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Whibley C, 2010, J BIOL CHEM, V285, P11326, DOI 10.1074/jbc.M109.064444; White PA, 2019, MUTAT RES-GEN TOX EN, V847, DOI 10.1016/j.mrgentox.2019.04.002; WOOD ML, 1990, BIOCHEMISTRY-US, V29, P7024, DOI 10.1021/bi00482a011; Yamada M, 2006, J BACTERIOL, V188, P4992, DOI 10.1128/JB.00281-06	56	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2020	295	29					9974	9985		10.1074/jbc.RA120.014465	http://dx.doi.org/10.1074/jbc.RA120.014465			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MR1DY	32487750	Green Published, hybrid			2022-12-26	WOS:000553333300016
J	Bednarek, M				Bednarek, Monika			Invisible or high-risk: Computer-assisted discourse analysis of references to Aboriginal and Torres Strait Islander people(s) and issues in a newspaper corpus about diabetes	PLOS ONE			English	Article							HEALTH; RACISM; MEDIA; JOURNALISM; URBAN	This article employs computer-assisted methods to analyse references to Aboriginal and Torres Strait Islander people(s) and issues in a newspaper corpus about diabetes. The objectives are to identify both the frequency and quality of social representation. The dataset consisted of 694 items from 12 Australian newspapers in a five-year period (2013-2017). The quantitative analysis focused on frequency (raw/normalised) and range (number/percentage of texts). The qualitative analysis focused on the identification of semantic prosody (co-occurrence with negative/positive words and phrases) and on selective social actor analysis. The qualitative analysis also compared choices made by the press to language practices recommended in relevant reporting guidelines. Key results include that references to Aboriginal and Torres Strait Islander people(s) or matters appear to be extremely rare. In addition, newspapers' language choices only partially align with guidelines. References that do occur can be classified into four categories: a) references to [groups of] people and other references to identity; b) names of services, institutions, professions, roles etc; c) non-human nouns related to health; d) non-human nouns related to culture. Qualitative analysis of the word COMMUNITY suggests that newspapers for the most part do recognise the existence of different communities at a national level. However, analysis of all references to [groups of] people shows that the vast majority occur in contexts to do with negativity, therefore having a negative semantic prosody. More specifically, there is a strong association with mentions of a higher risk, likelihood, or incidence of having or developing diabetes (or complications/effects). In sum, Aboriginal and Torres Strait Islander people(s) and issues lack in visibility in Australian diabetes coverage, and are associated with deficit framing, which can be disempowering. To change the discourse would require both an increased visibility as well as changing the deficit lens.	[Bednarek, Monika] Univ Sydney, Dept Linguist, Sydney, NSW, Australia; [Bednarek, Monika] Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia	University of Sydney; University of Sydney	Bednarek, M (corresponding author), Univ Sydney, Dept Linguist, Sydney, NSW, Australia.; Bednarek, M (corresponding author), Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia.	Monika.Bednarek@sydney.edu.au		Bednarek, Monika Anja/0000-0001-7819-5424	University of Sydney Research Accelerator Prize	University of Sydney Research Accelerator Prize	This research was funded through a University of Sydney Research Accelerator Prize. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich R, 2007, SOC SCI MED, V64, P125, DOI 10.1016/j.socscimed.2006.08.034; [Anonymous], 2018, REP AB TORR STRAIT I; [Anonymous], 2019, PREV TREAT CARDIO CE, V19, P1, DOI [DOI 10.5230/jgc.2019.19.e8, DOI 10.1186/s12877-019-1185-0]; Arkles R, 2020, DEMENTIA-LONDON, V19, P397, DOI 10.1177/1471301218776761; Australian Bureau of Statistics, 2017, UNDERSTANDING DIABET; Bailey J, 2016, AUST NZ J PUBL HEAL, V40, P493, DOI 10.1111/1753-6405.12563; Baker P., 2013, DISCOURSE ANAL MEDIA; Bednarek M., 2017, DISCOURSE NEWS VALUE, DOI DOI 10.1093/ACPROF:OSO/9780190653934.001.0001; Bednarek M, 2019, GUIDE DIABETES NEWS; Bednarek M, 2020, HEALTH PROMOT J AUST, V31, P497, DOI 10.1002/hpja.295; Bednarek M, 2008, CORPUS LINGUIST LING, V4, P119, DOI 10.1515/CLLT.2008.006; Bell Allan, 1991, LANGUAGE NEWS MEDIA; Bond C, 2019, INDIGENOUSX; Brough M., 1999, AUSTR J COMMUNICATIO, V26, P89; Browne J, 2018, AUST NZ J PUBL HEAL, V42, P277, DOI 10.1111/1753-6405.12790; Bullimore K., 1999, ASIA PAC MEDIA EDUC, V6, P72; Burrow S, 2016, REV DIABETES ABORIGI; Davies Mark, 2013, CORPUS NEWS WEB NOW; Deen CR, 2017, AUST NZ J PUBL HEAL, V41, P649, DOI 10.1111/1753-6405.12711; Diabetes Australia, 2011, NEW LANG DIAB IMPR C; ENTMAN RM, 1993, J COMMUN, V43, P51, DOI 10.1111/j.1460-2466.1993.tb01304.x; Gollust SE, 2009, SOC SCI MED, V69, P1091, DOI 10.1016/j.socscimed.2009.07.009; Gounder F, 2018, J APPL COMMUN RES, V46, P93, DOI 10.1080/00909882.2017.1409907; Grant Stan., 2016, TALKING MY COUNTRY; Islam Salwa, 2016, BMC Obes, V3, P30, DOI 10.1186/s40608-016-0109-1; Larson A, 2007, AUST NZ J PUBL HEAL, V31, P322, DOI 10.1111/j.1753-6405.2007.00079.x; Louw Bill, 1993, TEXT TECHNOLOGY HONO, P157, DOI DOI 10.1075/Z.64.11LOU; McCallum K, 2013, CRIT ARTS, V27, P332, DOI 10.1080/02560046.2013.800667; McCallum K, 2011, AUST ABORIG STUD, P21; MCCOMBS ME, 1972, PUBLIC OPIN QUART, V36, P176, DOI 10.1086/267990; Nartey M, 2019, CORPORA, V14, P203, DOI 10.3366/cor.2019.0169; Nguyen HD, 2016, INTERN MED J, V46, P1252, DOI 10.1111/imj.13123; NHMRC, 2003, VAL ETH GUID ETH CON; Oscar J, 2019, GUARDIAN; Priest NC, 2011, MED J AUSTRALIA, V194, P546; Public Health Association Australia [Internet], 2017, AB TORR STRAIT ISL G; Pulver Jackson L, 2013, MJA INSIGHT; Pyett P, 2008, HEALTH PROMOT J AUST, V19, P179, DOI 10.1071/HE08179; SCOTT M., 2018, WORDSMITH TOOLS VERS; Sweet MA, 2014, MED J AUSTRALIA, V200, P626, DOI 10.5694/mja14.00528; Thomas DP, 2017, AUST NZ J PUBL HEAL, V41, P650, DOI 10.1111/1753-6405.12712; Tong A, 2008, AM J KIDNEY DIS, V52, P159, DOI 10.1053/j.ajkd.2008.02.304; van Leeuwen Theo, 2008, DISCOURSE PRACTICE N; Wu KH, 2017, 2017 IEEE LIFE SCIENCES CONFERENCE (LSC), P55; Ziersch AM, 2011, SOC SCI MED, V73, P1045, DOI 10.1016/j.socscimed.2011.06.058; Zinn J. O., 2020, UK RISK CORPUS APPRO	46	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234486	10.1371/journal.pone.0234486	http://dx.doi.org/10.1371/journal.pone.0234486			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MA6QL	32525909	Green Published, gold			2022-12-26	WOS:000542036800049
J	Irahara, M; Yamamoto-Hanada, K; Yang, LM; Saito-Abe, M; Sato, M; Inuzuka, Y; Toyokuni, K; Nishimura, K; Ishikawa, F; Miyaji, Y; Fukuie, T; Narita, M; Ohya, Y				Irahara, Makoto; Yamamoto-Hanada, Kiwako; Yang, Limin; Saito-Abe, Mayako; Sato, Miori; Inuzuka, Yusuke; Toyokuni, Kenji; Nishimura, Koji; Ishikawa, Fumi; Miyaji, Yumiko; Fukuie, Tatsuki; Narita, Masami; Ohya, Yukihiro			Impact of swimming school attendance in 3-year-old children with wheeze and rhinitis at age 5 years: A prospective birth cohort study in Tokyo	PLOS ONE			English	Article							POOL ATTENDANCE; RESPIRATORY HEALTH; ALLERGIC DISEASES; ASTHMA; CHILDHOOD; INFANT; ADOLESCENTS; RISKS; WATER	Background In Japan, swimming school attendance is promoted as a form of therapy or as a prophylactic measure against asthma in young children. However, the putative beneficial effects have not been sufficiently verified. Objective The aim of the present study was to clarify whether or not swimming school attendance at age 3 years affects the onset and/or improvement of wheeze and rhinitis at age 5 years. Methods This study was a single-center, prospective, general, longitudinal cohort study (T-CHILD Study). Between November 2003 and December 2005, 1776 pregnant women were enrolled, and their offspring were followed up until age 5 years. Swimming school attendance at age 3 years and the presence of wheeze and/or rhinitis in the previous one year were examined using the International Study of Asthma and Allergies in Childhood (ISAAC) questionnaire. The relationship between swimming school attendance and wheeze and/or rhinitis was analyzed using multivariable logistic regression analysis. Results Data on the 1097 children were analyzed. At age 3 years, 126 (11.5%) children attended a swimming school, and at age 5 years, the prevalence of wheeze was 180 (16.4%) while that of rhinitis was 387 (35.3%). Swimming school attendance at age 3 showed no significant relationship with the development of either wheeze (aOR 0.83, 95% CI (0.43-1.60) or rhinitis (aOR 0.80, 95% CI (0.43-1.60) at age 5. Conclusions Swimming school attendance at age 3 years showed neither a preventive nor therapeutic effect on wheeze or rhinitis at age 5 years. There is thus no scientific evidence yet that swimming school attendance has a positive impact on the development of childhood wheeze or rhinitis.	[Irahara, Makoto; Yamamoto-Hanada, Kiwako; Yang, Limin; Saito-Abe, Mayako; Sato, Miori; Inuzuka, Yusuke; Toyokuni, Kenji; Nishimura, Koji; Ishikawa, Fumi; Miyaji, Yumiko; Fukuie, Tatsuki; Narita, Masami; Ohya, Yukihiro] Natl Ctr Child Hlth & Dev, Allergy Ctr, Tokyo, Japan	National Center for Child Health & Development - Japan	Yamamoto-Hanada, K (corresponding author), Natl Ctr Child Hlth & Dev, Allergy Ctr, Tokyo, Japan.	yamamoto-k@ncchd.go.jp	Yamamoto-Hanada, Kiwako/GQH-6445-2022; Yamamoto-Hanada, Kiwako/AAR-3094-2020	Yamamoto-Hanada, Kiwako/0000-0003-1288-9620; Yamamoto-Hanada, Kiwako/0000-0003-1288-9620; Irahara, Makoto/0000-0001-7007-445X	National Center for Child Health and Development [20A-1]	National Center for Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Yukihifo Ohya got the Grant of National Center for Child Health and Development (20A-1) related to this study.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 2018, ENVIRON HEALTH-GLOB, V17, DOI 10.1186/s12940-018-0383-0; Andersson M, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0023-x; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; BENNETT HJ, 1983, PEDIATRICS, V72, P125; Bernard A, 2008, EUR RESPIR J, V32, P979, DOI 10.1183/09031936.00114807; Bernard A, 2007, PEDIATRICS, V119, P1095, DOI 10.1542/peds.2006-3333; Bernard A, 2009, PEDIATRICS, V124, P1110, DOI 10.1542/peds.2009-0032; Blaiss MS, 2018, ANN ALLERG ASTHMA IM, V121, P43, DOI 10.1016/j.anai.2018.03.028; Borse NNGJ., 2008, CDC CHILDHOOD INJURY; Bougault V, 2010, CLIN EXP ALLERGY, V40, P1238, DOI 10.1111/j.1365-2222.2010.03551.x; Bougault V, 2009, SPORTS MED, V39, P295, DOI 10.2165/00007256-200939040-00003; Carbonnelle S, 2002, BIOMARKERS, V7, P464, DOI 10.1080/13547500210166612; Chua KL, 2009, WORLD ALLERGY ORGAN, V2, P77, DOI 10.1097/WOX.0b013e3181a7c288; Directer of Health Service Bureau in Ministry of Health, HYG STAND SWIMM POOL; Ferro MA, 2014, ACTA PAEDIATR, V103, pE32, DOI 10.1111/apa.12429; Font-Ribera L, 2014, RESP MED, V108, P1056, DOI 10.1016/j.rmed.2014.04.018; Font-Ribera L, 2011, AM J RESP CRIT CARE, V183, P582, DOI 10.1164/rccm.201005-0761OC; GOLDBERG GN, 1982, PEDIATRICS, V70, P599; Halterman JS, 2004, J ASTHMA, V41, P645, DOI 10.1081/JAS-200026410; HUANG SW, 1989, J ASTHMA, V26, P117, DOI 10.3109/02770908909073240; Kanikowska A, 2018, ANN AGR ENV MED, V25, P651, DOI 10.26444/aaem/79810; La Grutta S, 2014, PEDIAT ALLERG IMM-UK, V25, P450, DOI 10.1111/pai.12242; Narita Tomoko, 2013, KENKYUKIYO NAGOYA RY, V35, P89; Sasaki M, 2019, ALLERGY, V74, P1572, DOI 10.1111/all.13773; Seys SF, 2015, INT J HYG ENVIR HEAL, V218, P386, DOI 10.1016/j.ijheh.2015.03.001; Surda P, 2018, ALLERGY, V73, P1022, DOI 10.1111/all.13359; Valeriani F, 2017, PEDIATR INT, V59, P614, DOI 10.1111/ped.13230; Villanueva CM, 2012, ANN I SUPER SANITA, V48, P387, DOI 10.4415/ANN_12_04_06; Voisin C, 2010, EUR RESPIR J, V36, P41, DOI 10.1183/09031936.00118009; Weisel CP, 2009, ENVIRON HEALTH PERSP, V117, P500, DOI 10.1289/ehp.11513; Yamamoto-Hanada K, 2017, ANN ALLERG ASTHMA IM, V119, P54, DOI 10.1016/j.anai.2017.05.013; Yamamoto-Hanada K, 2016, ALLERGOL INT, V65, P327, DOI 10.1016/j.alit.2016.02.012; Yang LM, 2018, PEDIAT ALLERG IMM-UK, V29, P606, DOI 10.1111/pai.12917; Yilmaz OF, 2019, RESP PHYSIOL NEUROBI, V259, P129, DOI 10.1016/j.resp.2018.09.002	34	3	3	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2020	15	6							e0234161	10.1371/journal.pone.0234161	http://dx.doi.org/10.1371/journal.pone.0234161			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ1GC	32516323	gold, Green Published			2022-12-26	WOS:000540977000025
J	Easterling, KA; Pitra, NJ; Morcol, TB; Aquino, JR; Lopes, LG; Bussey, KC; Matthews, PD; Bass, HW				Easterling, Katherine A.; Pitra, Nicholi J.; Morcol, Taylan B.; Aquino, Jenna R.; Lopes, Lauren G.; Bussey, Kristin C.; Matthews, Paul D.; Bass, Hank W.			Identification of tandem repeat families from long-read sequences ofHumulus lupulus	PLOS ONE			English	Article							HOP HUMULUS-LUPULUS; SEX-CHROMOSOMES; DNA; L.; ELEMENTS; GENOME	Hop (Humulus lupulusL.) is known for its use as a bittering agent in beer and has a rich history of cultivation, beginning in Europe and now spanning the globe. There are five wild varieties worldwide, which may have been introgressed with cultivated varieties. As a dioecious species, its obligate outcrossing, non-Mendelian inheritance, and genomic structural variability have confounded directed breeding efforts. Consequently, understanding the hop genome represents a considerable challenge, requiring additional resources. In order to facilitate investigations into the transmission genetics of hop, we report here a tandem repeat discovery pipeline developed using k-mer filtering and dot plot analysis of PacBio long-read sequences from the hop cultivar Apollo. From this we identified 17 new and distinct tandem repeat sequence families, which represent candidates for FISH probe development. For two of these candidates, HuluTR120 and HuluTR225, we produced oligonucleotide FISH probes from conserved regions of and demonstrated their utility by staining meiotic chromosomes from wild hop, var.neomexicanusto address, for example, questions about hop transmission genetics. Collectively, these tandem repeat sequence families represent new resources suitable for development of additional cytogenomic tools for hop research.	[Easterling, Katherine A.; Aquino, Jenna R.; Lopes, Lauren G.; Bussey, Kristin C.; Bass, Hank W.] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA; [Easterling, Katherine A.; Pitra, Nicholi J.; Morcol, Taylan B.; Matthews, Paul D.] SS Steiner Inc, Hopsteiner, New York, NY USA; [Morcol, Taylan B.] CUNY, Lehman Coll, Dept Biol Sci, Bronx, NY USA; [Morcol, Taylan B.] CUNY, Grad Ctr, New York, NY USA	State University System of Florida; Florida State University; City University of New York (CUNY) System; Lehman College (CUNY); City University of New York (CUNY) System	Bass, HW (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	bass@bio.fsu.edu		Morcol, Taylan/0000-0003-4593-5486; Bass, Hank/0000-0003-0522-0881; Pitra, Nicholi/0000-0001-8642-5138	Hopsteiner Doctoral Research Fellowship (FSU OMNI Award) [0000030675]; FSU Planning Grant (Florida State University OMNI Award) [0000032134]; Hopsteiner	Hopsteiner Doctoral Research Fellowship (FSU OMNI Award); FSU Planning Grant (Florida State University OMNI Award); Hopsteiner	This work was supported by a Hopsteiner Doctoral Research Fellowship to KAE (FSU OMNI Award ID: 0000030675) and an FSU Planning Grant to HWB (Florida State University OMNI Award ID: 0000032134). The funder, Hopsteiner, provided support in the form of full or partial salaries for authors KAE, NJP, TBM, and PDM. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Bass HW, 1997, J CELL BIOL, V137, P5, DOI 10.1083/jcb.137.1.5; Belyayev A, 2018, PLANT SYST EVOL, V304, P387, DOI 10.1007/s00606-017-1483-y; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Birchler J. A., 2008, Tropical Plant Biology, V1, P34, DOI 10.1007/s12042-007-9001-y; BLOOM WL, 1974, CHROMOSOMA, V49, P61; Bolton JL, 2019, CHEM RES TOXICOL, V32, P222, DOI 10.1021/acs.chemrestox.8b00345; DENNIS ES, 1984, J MOL EVOL, V20, P341, DOI 10.1007/BF02104740; Divashuk MG, 2011, CYTOGENET GENOME RES, V134, P213, DOI 10.1159/000328831; Divashuk MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085118; Dodsworth S, 2015, SYST BIOL, V64, P112, DOI 10.1093/sysbio/syu080; Easterling KA, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01501; Garrido-Ramos MA, 2017, GENES-BASEL, V8, DOI 10.3390/genes8090230; Gluncic M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks721; Grabowska-Joachimiak A, 2006, ACTA SOC BOT POL, V75, P207, DOI 10.5586/asbp.2006.024; Higgins JD, 2014, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00546; Hill ST, 2017, DATABASE-OXFORD, DOI 10.1093/database/bax009; Hollister JD, 2019, NEW PHYTOL, V224, P1372, DOI 10.1111/nph.16053; HOLSINGER KE, 1984, AM NAT, V124, P48, DOI 10.1086/284251; Howe Elizabeth S, 2013, Methods Mol Biol, V990, P53, DOI 10.1007/978-1-62703-333-6_6; Kapustova V, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102483; Karlov GI, 2003, EUPHYTICA, V132, P185, DOI 10.1023/A:1024646818324; Kavalier AR, 2011, J AGR FOOD CHEM, V59, P4783, DOI 10.1021/jf1049084; Majtanova Z, 2019, PEERJ, V7, DOI 10.7717/peerj.7347; Mlinarec J, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00613; Moir M, 2000, J AM SOC BREW CHEM, V58, P131; Murakami A, 2006, GENET RESOUR CROP EV, V53, P1553, DOI 10.1007/s10722-005-7765-1; Natsume S, 2015, PLANT CELL PHYSIOL, V56, P428, DOI 10.1093/pcp/pcu169; Neve R.A., 1991, HOPS; Noe L, 2005, NUCLEIC ACIDS RES, V33, pW540, DOI 10.1093/nar/gki478; Novak P, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx257; Novak P, 2013, BIOINFORMATICS, V29, P792, DOI 10.1093/bioinformatics/btt054; Novak P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-378; Ososki AL, 2003, PHYTOTHER RES, V17, P845, DOI 10.1002/ptr.1364; Raskina O, 2008, CYTOGENET GENOME RES, V120, P351, DOI 10.1159/000121084; Reeves PA, 2011, SYST BIOL, V60, P45, DOI 10.1093/sysbio/syq056; Seibt KM, 2018, BIOINFORMATICS, V34, P3575, DOI 10.1093/bioinformatics/bty395; Sevim V, 2016, BIOINFORMATICS, V32, P1921, DOI 10.1093/bioinformatics/btw101; Shephard HL, 2000, NEW, DOI [10.1046/j.1469-8137.2000.00771.x/full, DOI 10.1046/J.1469-8137.2000.00771.X/FULL]; SINOTO YOSHITO, 1929, PROC IMP ACAD [TOKYO], V5, P46; Siragusa GR, 2008, J ANTIMICROB CHEMOTH, V61, P853, DOI 10.1093/jac/dkn024; Su HD, 2019, PLANT CELL, V31, P2035, DOI 10.1105/tpc.19.00133; Szymanski M, 2002, NUCLEIC ACIDS RES, V30, P176, DOI 10.1093/nar/30.1.176; Tembrock Luke R., 2016, Journal of the Botanical Research Institute of Texas, V10, P11; Vondrak T, 2020, PLANT J, V101, P484, DOI 10.1111/tpj.14546; Weiss-Schneeweiss H, 2015, REGNUM VEG, V158, P155; Winge O, 1929, HEREDITAS, V12, P53; Yan DD, 2019, FOOD CHEM, V275, P15, DOI 10.1016/j.foodchem.2018.09.082; Zhang D, 2017, PLANT GENOME-US, V10, DOI 10.3835/plantgenome2017.04.0032; Zonneveld BJM, 2005, ANN BOT-LONDON, V96, P229, DOI 10.1093/aob/mci170; Zuccolo A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r48	50	2	2	5	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0233971	10.1371/journal.pone.0233971	http://dx.doi.org/10.1371/journal.pone.0233971			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502183	Green Published, Green Submitted, gold			2022-12-26	WOS:000542035700073
J	Park, J; Yoon, H; Shin, CM; Park, YS; Kim, N; Lee, DH				Park, Jihye; Yoon, Hyuk; Shin, Cheol Min; Park, Young Soo; Kim, Nayoung; Lee, Dong Ho			Higher levels of disease-related knowledge reduce medical acceleration in patients with inflammatory bowel disease	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; HEALTH-CARE COSTS; ULCERATIVE-COLITIS; CLINICAL-OUTCOMES; TOP-DOWN; STEP-UP; CROHNS; NONADHERENCE; THERAPY; KOREA	Background and aims The disease-related knowledge levels in patients with inflammatory bowel disease (IBD) are important because it could affect the self-management ability and adaptive coping strategies. We set out to determine whether higher levels of disease-related knowledge reduce medical acceleration. Methods We evaluated the levels of disease-related knowledge in all patients at the time of enrollment for SNUBH IBD cohort using the validated IBD-KNOW questionnaire. Clinical data were prospectively collected and the factors related to step-up therapy were analyzed. Step-up therapy was defined as the new use of corticosteroids, immunomodulators, or biologics after the enrollment. Results Between April 2017 and January 2019, 298 patients were enrolled (mean age, 39.8 years; males, 69.5%); 193 patients (64.8%) had ulcerative colitis and 105 (35.2%) had Crohn's disease. The mean disease duration was 35.8 months. During the mean follow-up of 14.7 months, 90 patients (30.2%) underwent step-up therapy and 208 (69.8%) underwent continuous therapy. The prevalence of continuous therapy increased with increasing IBD-KNOW scores (p for trend = 0.019). Cox proportional hazards analysis revealed that high IBD-KNOW scores (>= 16) (hazards ratio [HR]: 0.498, 95% confidence interval [CI]: 0.276-0.897, p = 0.020) was negatively associated with the step-up therapy. Conclusions Higher disease-related knowledge could reduce the requirement of step-up therapy in IBD. The IBD-KNOW score was independently predictive of step-up therapy.	[Park, Jihye; Yoon, Hyuk; Shin, Cheol Min; Park, Young Soo; Kim, Nayoung; Lee, Dong Ho] Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam, South Korea	Seoul National University (SNU)	Yoon, H (corresponding author), Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam, South Korea.	bodnsoul@hanmail.net		Shin, Cheol Min/0000-0003-2265-9845				Cerveny P, 2007, INFLAMM BOWEL DIS, V13, P1244, DOI 10.1002/ibd.20189; Chang JY, 2018, DIGEST DIS SCI, V63, P3041, DOI 10.1007/s10620-018-5193-2; Colombara F, 2015, INFLAMM BOWEL DIS, V21, P615, DOI 10.1097/MIB.0000000000000304; Danion P, 2018, INFLAMM BOWEL DIS, V24, P943, DOI 10.1093/ibd/izx073; Eaden JA, 1999, AM J GASTROENTEROL, V94, P3560, DOI 10.1111/j.1572-0241.1999.01536.x; Eaden JA, 2002, POSTGRAD MED J, V78, P615, DOI 10.1136/pmj.78.924.615; Elkjaer M, 2010, GUT, V59, P1652, DOI 10.1136/gut.2010.220160; Hou JK, 2015, WORLD J GASTROENTERO, V21, P6001, DOI 10.3748/wjg.v21.i19.6001; Jung YS, 2017, DIGEST DIS SCI, V62, P2102, DOI 10.1007/s10620-017-4640-9; Kennedy A, 2003, HEALTH SOC CARE COMM, V11, P64, DOI 10.1046/j.1365-2524.2003.00399.x; Kim JY, 2020, J CLIN GASTROENTEROL, V54, P720, DOI 10.1097/MCG.0000000000001283; Kim JW, 2018, J GASTROEN HEPATOL, V33, P847, DOI 10.1111/jgh.14027; McDonald HP, 2002, JAMA-J AM MED ASSOC, V288, P2868, DOI 10.1001/jama.288.22.2868; Moradkhani A, 2011, DIGEST DIS SCI, V56, P2972, DOI 10.1007/s10620-011-1714-y; Ng SC, 2017, LANCET, V390, P2769, DOI 10.1016/S0140-6736(17)32448-0; Park SH, 2019, J CROHNS COLITIS, V13, P1410, DOI 10.1093/ecco-jcc/jjz081; Pillai N, 2019, J CROHNS COLITIS, V13, P744, DOI 10.1093/ecco-jcc/jjz003; Quan H, 2003, INFLAMM BOWEL DIS, V9, P356, DOI 10.1097/00054725-200311000-00003; Robinson A, 2001, LANCET, V358, P976, DOI 10.1016/S0140-6736(01)06105-0; Rogler G, 2013, DIGEST DIS, V31, P83, DOI 10.1159/000347190; Shen B, 2017, NAT REV GASTRO HEPAT, V14, P693, DOI 10.1038/nrgastro.2017.139; Sood A, 2001, Indian J Gastroenterol, V20, P6; Tiao DK, 2017, INFLAMM BOWEL DIS, V23, P257, DOI 10.1097/MIB.0000000000001194; van der Have M, 2016, J CROHNS COLITIS, V10, P549, DOI 10.1093/ecco-jcc/jjw002; Waters BM, 2005, CAN J GASTROENTEROL, V19, P235, DOI 10.1155/2005/250504; Whelan T, 2004, JAMA-J AM MED ASSOC, V292, P435, DOI 10.1001/jama.292.4.435; Yoon H, 2019, KOREAN J INTERN MED, V34, P81, DOI 10.3904/kjim.2017.104; Yu H, 2018, ALIMENT PHARM THER, V47, P364, DOI 10.1111/apt.14430	28	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0233654	10.1371/journal.pone.0233654	http://dx.doi.org/10.1371/journal.pone.0233654			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502199	Green Published, gold			2022-12-26	WOS:000542035700055
J	Garst-Orozco, J; Malik, R; Lanz, TA; Weber, ML; Xi, HL; Arion, D; Enwright, JF; Lewis, DA; O'Donnell, P; Sohal, VS; Buhl, DL				Garst-Orozco, Jonathan; Malik, Ruchi; Lanz, Thomas A.; Weber, Mark L.; Xi, Hualin; Arion, Dominique; Enwright, John F., III; Lewis, David A.; O'Donnell, Patricio; Sohal, Vikaas S.; Buhl, Derek L.			GluN2D-mediated excitatory drive onto medial prefrontal cortical PV plus fast-spiking inhibitory interneurons	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; GENE-EXPRESSION; GABA NEURONS; SCHIZOPHRENIA; CORTEX; DYSFUNCTION; BRAIN; OSCILLATIONS; CHALLENGE; RECEPTORS	Deficits in fast-spiking inhibitory interneurons (FSINs) within the dorsolateral prefrontal cortex (dlPFC) are hypothesized to underlie cognitive impairment associated with schizophrenia. Though representing a minority of interneurons, this key cell type coordinates broad neural network gamma-frequency oscillations, associated with cognition and cognitive flexibility. Here we report expression of GluN2D mRNA selectively in parvalbumin positive cells of human postmortem dlPFC tissue, but not pyramidal neurons, with little to no GluN2C expression in either cell type. In acute murine mPFC slices the GluN2C/D selective positive allosteric modulator (PAM), CIQ(+), increased the intrinsic excitability as well as enhanced NMDAR-mediated EPSCs onto FSINs. This increase in intrinsic excitability with GluN2C/D PAM was also observed in the Dlx 5/6+/- FSIN developmental deficit model with reported FSIN hypoexcitability. Together these data speak to selective modulation of FSINs by a GluN2D PAM, providing a potential mechanism to counter the FSIN-deficit seen in schizophrenia.	[Garst-Orozco, Jonathan; Lanz, Thomas A.; Weber, Mark L.; Xi, Hualin; O'Donnell, Patricio; Buhl, Derek L.] Pfizer Neurosci Res Unit, Cambridge, MA 02139 USA; [Malik, Ruchi; Sohal, Vikaas S.] Dept Psychiat, San Francisco, CA USA; [Malik, Ruchi; Sohal, Vikaas S.] UCSF Weill Inst Neu Rosci, San Francisco, CA USA; [Malik, Ruchi; Sohal, Vikaas S.] Univ Calif San Francisco, Ctr Integrat Neurosci, San Francisco, CA 94143 USA; [Malik, Ruchi; Sohal, Vikaas S.] Univ Calif San Francisco, Sloan Swartz Ctr Theoret Neurobiol, San Francisco, CA 94143 USA; [Arion, Dominique; Enwright, John F., III; Lewis, David A.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA; [Lewis, David A.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Garst-Orozco, Jonathan] Catenion, Boston, MA 02116 USA; [Lanz, Thomas A.] Pfizer Inc, Global Pathol & Investigat Toxicol, Groton, CT USA; [Xi, Hualin] Rgenta Therapeut Inc, Cambridge, MA USA; [O'Donnell, Patricio; Buhl, Derek L.] Takeda, Cambridge, MA USA	Pfizer; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pfizer	Garst-Orozco, J (corresponding author), Pfizer Neurosci Res Unit, Cambridge, MA 02139 USA.; Garst-Orozco, J (corresponding author), Catenion, Boston, MA 02116 USA.	jgarstor@gmail.com	Lewis, David A/G-4053-2014; Buhl, Derek/AAV-3911-2021; Malik, Ruchi/J-1941-2019	Lewis, David A/0000-0002-3225-6778; Malik, Ruchi/0000-0003-0611-8790; Lanz, Thomas/0000-0003-2483-3122; O'Donnell, Patricio/0000-0001-7788-624X	CDMRP [TS150059]; NIMH R01 [MH106507]; NARSAD Young Investigator Award	CDMRP(United States Department of Defense); NIMH R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NARSAD Young Investigator Award(NARSAD)	At the time of this study, Pfizer, Inc. provided support in the form of salaries for JGO, TAL, MLW, HX, POD, and DLB, and provided funding grants to the laboratories of DAL and VSS. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. CDMRP (TS150059) to VSS and RM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NIMH R01 (MH106507) to VSS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NARSAD Young Investigator Award (Leichtung Family Investigator, BBRF) to RM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are listed in the `author contribution' section.	AKBARIAN S, 1995, ARCH GEN PSYCHIAT, V52, P258, DOI 10.1001/archpsyc.1995.03950160008002; [Anonymous], 2006, THEOL STUD, V67, P3, DOI 10.1177/004056390606700101; Arion D, 2015, MOL PSYCHIATR, V20, P1397, DOI 10.1038/mp.2014.171; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Cho KKA, 2015, NEURON, V85, P1332, DOI 10.1016/j.neuron.2015.02.019; Chung DW, 2016, AM J PSYCHIAT, V173, P1131, DOI 10.1176/appi.ajp.2016.16010025; Curley AA, 2012, J PHYSIOL-LONDON, V590, P715, DOI 10.1113/jphysiol.2011.224659; Enwright JF, 2018, MOL PSYCHIATR, V23, P1606, DOI 10.1038/mp.2017.216; Erreger K, 2007, MOL PHARMACOL, V72, P907, DOI 10.1124/mol.107.037333; Fett AKJ, 2011, NEUROSCI BIOBEHAV R, V35, P573, DOI 10.1016/j.neubiorev.2010.07.001; Gonzalez-Burgos G, 2008, SCHIZOPHRENIA BULL, V34, P944, DOI 10.1093/schbul/sbn070; Green Michael F, 2014, Schizophr Res Cogn, V1, pe1; Grunze HCR, 1996, J NEUROSCI, V16, P2034; Hagino Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013722; Hanson E, 2019, J NEUROSCI, V39, P3611, DOI 10.1523/JNEUROSCI.1392-18.2019; Hashimoto T, 2003, J NEUROSCI, V23, P6315; Hemager N, 2018, JAMA PSYCHIAT, V75, P844, DOI 10.1001/jamapsychiatry.2018.1415; Jackson ME, 2004, P NATL ACAD SCI USA, V101, P8467, DOI 10.1073/pnas.0308455101; LAHTI AC, 1995, NEUROPSYCHOPHARMACOL, V13, P9, DOI 10.1016/0893-133X(94)00131-I; Lisman JE, 2008, TRENDS NEUROSCI, V31, P234, DOI 10.1016/j.tins.2008.02.005; Meechan DW, 2009, P NATL ACAD SCI USA, V106, P16434, DOI 10.1073/pnas.0905696106; Meyer U, 2008, BRAIN BEHAV IMMUN, V22, P469, DOI 10.1016/j.bbi.2007.09.012; Miller MN, 2011, DEV NEUROBIOL, V71, P62, DOI 10.1002/dneu.20811; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Moore H, 2006, BIOL PSYCHIAT, V60, P253, DOI 10.1016/j.biopsych.2006.01.003; Morris HM, 2008, CEREB CORTEX, V18, P1575, DOI 10.1093/cercor/bhm186; Mullasseril P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1085; Murray AJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep16778; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Perszyk RE, 2016, MOL PHARMACOL, V90, P689, DOI 10.1124/mol.116.105130; Riebe I, 2016, EUR J NEUROSCI, V43, P169, DOI 10.1111/ejn.13128; Sapkota K, 2016, J PHARMACOL EXP THER, V356, P702, DOI 10.1124/jpet.115.230391; Shen SB, 2008, J NEUROSCI, V28, P10893, DOI 10.1523/JNEUROSCI.3299-08.2008; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Volk DW, 2001, AM J PSYCHIAT, V158, P256, DOI 10.1176/appi.ajp.158.2.256; Volk DW, 2000, ARCH GEN PSYCHIAT, V57, P237, DOI 10.1001/archpsyc.57.3.237; von Engelhardt J, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00095; Wang YL, 2010, J NEUROSCI, V30, P5334, DOI 10.1523/JNEUROSCI.5963-09.2010; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; Young JW, 2015, J PSYCHOPHARMACOL, V29, P178, DOI 10.1177/0269881114555252	41	13	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0233895	10.1371/journal.pone.0233895	http://dx.doi.org/10.1371/journal.pone.0233895			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497062	Green Published, gold			2022-12-26	WOS:000542035200091
J	Akamatsu, MA; Sakihara, VA; Carvalho, BP; Abrantes, AD; Takano, MAS; Adami, EA; Yonehara, FS; Carneiro, PD; Rico, S; Schanoski, A; Meros, M; Simpson, A; Phan, T; Fox, CB; Ho, PL				Akamatsu, Milena Apetito; Sakihara, Vitor Anselmo; Carvalho, Bianca Pereira; Abrantes, Aline de Paiva; Takano, Maria A. Sakauchi; Adami, Eduardo Alfredo; Yonehara, Fernando Seiji; Carneiro, Patricia dos Santos; Rico, Stefanni; Schanoski, Alessandra; Meros, Mauricio; Simpson, Adrian; Phan, Tony; Fox, Christopher B.; Ho, Paulo Lee			Preparedness against pandemic influenza: Production of an oil-in-water emulsion adjuvant in Brazil	PLOS ONE			English	Article							TECHNOLOGY-TRANSFER; VACCINE PRODUCTION; IMMUNOGENICITY; SAFETY; VIRUS; CHALLENGES; H7N9	Increasing pandemic influenza vaccine manufacturing capacity is considered strategic by WHO. Adjuvant use is key in this strategy in order to spare the vaccine doses and by increasing immune protection. We describe here the production and stability studies of a squalene based oil-in-water emulsion, adjuvant IB160, and the immune response of the H7N9 vaccine combined with IB160. To qualify the production of IB160 we produced 10 consistency lots of IB160 and the average results were: pH 6.4 +/- 0.05; squalene 48.8 +/-.0.03 mg/ml; osmolality 47.6 +/- 6.9 mmol/kg; Z-average 157 +/- 2 nm, with polydispersity index (PDI) of 0.085 +/- 0.024 and endotoxin levels <0.5 EU/mL. The emulsion particle size was stable for at least six months at 25 degrees C and 24 months at 4-8 degrees C. Two doses of H7N9 vaccine formulated at 7.5 mu g/dose or 15 mu g/dose with adjuvant IB160 showed a significant increase of hemagglutination inhibition (HAI) titers in sera of immunized BALB/c mice when compared to control sera from animals immunized with the H7N9 antigens without adjuvant. Thus the antigen-sparing capacity of IB160 can potentially increase the production of the H7N9 pandemic vaccine and represents an important achievement for preparedness against pandemic influenza and a successful North (IDRI) to South (Butantan Institute) technology transfer for the production of the adjuvant emulsion IB160.	[Akamatsu, Milena Apetito; Sakihara, Vitor Anselmo; Carvalho, Bianca Pereira; Abrantes, Aline de Paiva; Takano, Maria A. Sakauchi; Ho, Paulo Lee] Inst Butantan, Serv Bacteriol, Div BioInd, Sao Paulo, Brazil; [Adami, Eduardo Alfredo] Inst Butantan, Div BioInd, Lab Influenza, Sao Paulo, Brazil; [Yonehara, Fernando Seiji; Carneiro, Patricia dos Santos] Inst Butantan, Controle Qualidade, Sao Paulo, Brazil; [Rico, Stefanni; Schanoski, Alessandra] Inst Butantan, Lab Bacteriol, Sao Paulo, Brazil; [Meros, Mauricio] Inst Butantan, Div BioInd, Sao Paulo, Brazil; [Simpson, Adrian; Phan, Tony; Fox, Christopher B.] Infect Dis Res Inst, Seattle, WA USA	Instituto Butantan; Instituto Butantan; Instituto Butantan; Instituto Butantan; Instituto Butantan	Akamatsu, MA; Ho, PL (corresponding author), Inst Butantan, Serv Bacteriol, Div BioInd, Sao Paulo, Brazil.	milena.akarnatsu@butantan.gov.br; paulo.ho@butantan.gov.br	Akamatsu, Milena Apetito/V-8084-2017	Akamatsu, Milena Apetito/0000-0002-8193-3448	U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority - BARDA [IDSEP140022, IDSEP130015]; World Health Organization -WHO [SPHQ13LOA-316]; Brazilian agency: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP [2015/25055-8]; Brazilian agency: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -CNPq [306992/2014-0]; Brazilian agency: Fundacao Butantan for Laboratory maintenance	U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority - BARDA; World Health Organization -WHO(World Health Organization); Brazilian agency: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian agency: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian agency: Fundacao Butantan for Laboratory maintenance	This project has been funded in whole or in part with Federal funds from the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority - BARDA (Grant no. IDSEP140022 and IDSEP130015), received by CF; an Institutional Grant to Butantan Institute from World Health Organization -WHO (grant SPHQ13LOA-316) and Brazilian agencies: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP (grant no. 2015/25055-8) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -CNPq (grant no. 306992/2014-0) to PLH and Fundacao Butantan for Laboratory maintenance. There was no additional external funding received for this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the U.S. Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansaldi F, 2010, VACCINE, V28, P4123, DOI 10.1016/j.vaccine.2010.04.030; Baldwin SL, 2009, VACCINE, V27, P5956, DOI 10.1016/j.vaccine.2009.07.081; Banzhoff A, 2008, INFLUENZA OTHER RESP, V2, P243, DOI 10.1111/j.1750-2659.2008.00059.x; Bart SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008761; De Donato S, 1999, VACCINE, V17, P3094, DOI 10.1016/S0264-410X(99)00138-3; De Franco M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002862; Duan YQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099322; Fang JH, 2000, RAMACHANDRAN RADHAKR, V42, P211; Fox CB, 2013, VACCINE, V31, P1633, DOI 10.1016/j.vaccine.2012.10.048; Houser K, 2015, CELL HOST MICROBE, V17, P295, DOI 10.1016/j.chom.2015.02.012; Khurana S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000624; Leroux-Roels I, 2010, VACCINE, V28, P849, DOI 10.1016/j.vaccine.2009.10.017; Levine AC, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1671-z; Lim WS, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2290-z; Lurie N, 2013, NEW ENGL J MED, V368, P1251, DOI 10.1056/NEJMsb1209510; Martin JT, 1997, BIOLOGICALS, V25, P209, DOI 10.1006/biol.1997.0086; Minutello M, 1999, VACCINE, V17, P99, DOI 10.1016/S0264-410X(98)00185-6; Miyaki C, 2011, VACCINE, V29, pA12, DOI 10.1016/j.vaccine.2011.04.127; Miyaki C, 2010, VACCINE, V28, P2505, DOI 10.1016/j.vaccine.2010.01.044; Oshitani H, 2008, EMERG INFECT DIS, V14, P875, DOI 10.3201/eid1406.070839; Ott G, 2000, METH MOLEC MED, V42, P211; Podda A, 2001, VACCINE, V19, P2673, DOI 10.1016/S0264-410X(00)00499-0; Precioso AR, 2011, VACCINE, V29, P8974, DOI 10.1016/j.vaccine.2011.09.040; Rojek AM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0760-x; Salk JE, 1944, J IMMUNOL, V49, P87; Schultze V, 2008, VACCINE, V26, P3209, DOI 10.1016/j.vaccine.2008.03.093; Scorza FB, 2017, VACCINE, V35, P5397, DOI 10.1016/j.vaccine.2017.03.094; Stavaru C, 2016, HUM VACC IMMUNOTHER, V12, P1009, DOI 10.1080/21645515.2015.1111495; Tregoning JS, 2018, HUM VACC IMMUNOTHER, V14, P550, DOI 10.1080/21645515.2017.1415684; Tsai TF, 2011, SCAND J INFECT DIS, V43, P702, DOI 10.3109/00365548.2011.580777; Usach I, 2019, ADV THER, V36, P2986, DOI 10.1007/s12325-019-01101-6; Ventura R, 2013, VACCINE, V31, P1641, DOI 10.1016/j.vaccine.2012.07.074; Whitehead J, 2016, CLIN TRIALS, V13, P31, DOI 10.1177/1740774515617740; Wong SS, 2015, J INFECT DIS, V212, P542, DOI 10.1093/infdis/jiv099; World Health Organization, 2009, PAND INFL PREP RESP; World Health Organization (WHO), 2005, WHO TECHN REP SER, V927, P99; World Health Organization (WHO), 1959, STUD GROUP REQ BIOL; World Health Organization (WHO), 2013, SER DET AV INF A H7N; World Health Organization (WHO), 2015, 8 M INT PARTN PROSP; Wu XX, 2018, CELL PHYSIOL BIOCHEM, V46, P633, DOI 10.1159/000488631; Zheng D, 2019, HUM VACC IMMUNOTHER, V15, P80, DOI 10.1080/21645515.2018.1515454	42	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2020	15	6							e0233632	10.1371/journal.pone.0233632	http://dx.doi.org/10.1371/journal.pone.0233632			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LW6ZP	32492039	Green Published, gold			2022-12-26	WOS:000539293000018
J	Christoff, AP; Sereia, AFR; Cruz, GNF; de Bastiani, DC; Silva, VL; Hernandes, C; Nascente, APM; dos Reis, AA; Viessi, RG; Marques, ADP; Braga, BS; Raduan, TPL; Martino, MD; de Menezes, FG; de Oliveira, LFV				Christoff, Ana Paula; Sereia, Aline Fernanda Rodrigues; Cruz, Giuliano Netto Flores; de Bastiani, Daniela Carolina; Silva, Vanessa Leitner; Hernandes, Camila; Nascente, Ana Paula Metran; dos Reis, Ana Andrea; Viessi, Renata Goncalves; Marques, Andrea dos Santos Pereira; Braga, Bianca Silva; Raduan, Telma Priscila Lovizio; Martino, Marines Dalla Valle; de Menezes, Fernando Gatti; de Oliveira, Luiz Felipe Valter			One year cross-sectional study in adult and neonatal intensive care units reveals the bacterial and antimicrobial resistance genes profiles in patients and hospital surfaces	PLOS ONE			English	Article							CLINICAL MICROBIOLOGY; CONTAMINATED SURFACES; INFECTION-CONTROL; TRANSMISSION; COLONIZATION; EPIDEMIOLOGY; PATHOGENS; BIOFILMS; PIPELINE; BRAZIL	Several studies have shown the ubiquitous presence of bacteria in hospital surfaces, staff, and patients. Frequently, these bacteria are related to HAI (healthcare-associated infections) and carry antimicrobial resistance (AMR). These HAI-related bacteria contribute to a major public health issue by increasing patient morbidity and mortality during or after hospital stay. Bacterial high-throughput amplicon gene sequencing along with identification of AMR genes, as well as whole genome sequencing (WGS), are biotechnological tools that allow multiple-sample screening for a diversity of bacteria. In this paper, we used these methods to perform a one-year cross sectional profiling of bacteria and AMR genes in adult and neonatal intensive care units (ICU and NICU) in a Brazilian public, tertiary hospital. Our results showed high abundances of HAI-related bacteria such as S. epidermidis, S. aureus, K. pneumoniae, A. baumannii complex, E. coli, E. faecalis, and P. aeruginosa in patients and hospital surfaces. Most abundant AMR genes detected throughout ICU and NICU were mecA, bla(CTX-M-1 group), bla(SHV-like), and bla(KPC-like). We found that NICU environment and patients were more widely contaminated with pathogenic bacteria than ICU. Patient samples, despite the higher bacterial load, have lower bacterial diversity than environmental samples in both units. Finally, we also identified contamination hotspots in the hospital environment showing constant frequencies of bacterial and AMR contamination throughout the year. Whole genome sequencing (WGS), 16S rRNA oligotypes, and AMR identification allowed a high-resolution characterization of the hospital microbiome profile.	[Christoff, Ana Paula; Sereia, Aline Fernanda Rodrigues; Cruz, Giuliano Netto Flores; de Bastiani, Daniela Carolina; Silva, Vanessa Leitner; de Oliveira, Luiz Felipe Valter] BiomeHub, Florianopolis, SC, Brazil; [Hernandes, Camila; Nascente, Ana Paula Metran; dos Reis, Ana Andrea; Viessi, Renata Goncalves; Marques, Andrea dos Santos Pereira; Braga, Bianca Silva; Raduan, Telma Priscila Lovizio; Martino, Marines Dalla Valle; de Menezes, Fernando Gatti] Albert Einstein Israelite Hosp, Sao Paulo, Brazil	Hospital Israelita Albert Einstein	de Oliveira, LFV (corresponding author), BiomeHub, Florianopolis, SC, Brazil.	felipe@biomehub.com	Christoff, Ana Paula/L-3887-2013	Christoff, Ana Paula/0000-0002-0264-6177; Reis, AlessanRSS/0000-0001-8486-7469				Adams RI, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0108-3; Alp E, 2015, J INFECT DEV COUNTR, V9, P1040, DOI 10.3855/jidc.6832; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amir A, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00199-16; [Anonymous], 2014, LANCET INFECT DIS, V14, P1, DOI 10.1016/S1473-3099(13)70368-2; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Beyaert R, 2018, CELL HOST MICROBE, V23, P283, DOI 10.1016/j.chom.2018.02.007; Bokulich NA, 2013, J CLIN MICROBIOL, V51, P2617, DOI 10.1128/JCM.00898-13; Brooks B, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-1; Calfee DP, 2012, ANNU REV MED, V63, P359, DOI 10.1146/annurev-med-081210-144458; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Cave R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45886-6; Chng KR, 2019, CARTOGRAPHY OPPORTUN, DOI [10.1101/644740, DOI 10.1101/644740]; Christoff AP, 2019, EXP BIOL MED, V244, P534, DOI 10.1177/1535370218821857; Coil D, 2015, BIOINFORMATICS, V31, P587, DOI 10.1093/bioinformatics/btu661; Crofts TS, 2017, NAT REV MICROBIOL, V15, P422, DOI 10.1038/nrmicro.2017.28; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; De Oliveira LFV, 2020, EQUIVOLUMETRIC PROTO, DOI [10.3389/fmicb.2021.638231, DOI 10.3389/FMICB.2021.638231]; Deurenberg RH, 2017, J BIOTECHNOL, V243, P16, DOI 10.1016/j.jbiotec.2016.12.022; Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226; Freitas FTM, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/S095026881900092X, 10.1017/s095026881900092x]; Gasparrini AJ, 2019, NAT MICROBIOL, V4, P2285, DOI 10.1038/s41564-019-0550-2; Goyal S, 2019, AM J INFECT CONTROL, V47, P994, DOI 10.1016/j.ajic.2019.01.012; Guzman-Blanco M, 2009, INT J ANTIMICROB AG, V34, P304, DOI 10.1016/j.ijantimicag.2009.06.005; Hartmann EM, 2016, ENVIRON SCI TECHNOL, V50, P9807, DOI 10.1021/acs.est.6b00262; Hewitt KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054703; Hota B, 2004, CLIN INFECT DIS, V39, P1182, DOI 10.1086/424667; Hothorn T, 2008, J STAT SOFTW, V28, P1; Hu H, 2015, J HOSP INFECT, V91, P35, DOI 10.1016/j.jhin.2015.05.016; Kaas RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104984; Knight R, 2018, NAT REV MICROBIOL, V16, P410, DOI 10.1038/s41579-018-0029-9; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Lax S, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah6500; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Madan JC, 2012, ARCH DIS CHILD-FETAL, V97, pF456, DOI 10.1136/fetalneonatal-2011-301373; Marotz CA, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0426-3; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Sampaio JLM, 2016, BRAZ J MICROBIOL, V47, P31, DOI 10.1016/j.bjm.2016.10.002; Minich JJ, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00218-17; Mora M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01573; Naccache SN, 2014, GENOME RES, V24, P1180, DOI 10.1101/gr.171934.113; Oberauner L, 2013, SCI REP-UK, V3, DOI 10.1038/srep01413; Otter JA, 2013, AM J INFECT CONTROL, V41, pS6, DOI 10.1016/j.ajic.2012.12.004; Otter JA, 2011, INFECT CONT HOSP EP, V32, P687, DOI 10.1086/660363; Peters L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215666; Pettigrew MM, 2016, ANN EPIDEMIOL, V26, P342, DOI 10.1016/j.annepidem.2016.02.007; Pittet D, 2008, J HOSP INFECT, V68, P285, DOI 10.1016/j.jhin.2007.12.013; Poza M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044105; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Ravi A, 2019, MICROB GENOMICS, V5, DOI 10.1099/mgen.0.000293; Ribeiro LF, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00240; Richter M, 2016, BIOINFORMATICS, V32, P929, DOI 10.1093/bioinformatics/btv681; Rocha FR, 2016, MICROB DRUG RESIST, V22, P301, DOI 10.1089/mdr.2015.0180; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Russotto V, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-015-0120-5; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Soto-Giron MJ, 2016, APPL ENVIRON MICROB, V82, P2872, DOI 10.1128/AEM.03529-15; Weber DJ, 2013, CURR OPIN INFECT DIS, V26, P338, DOI 10.1097/QCO.0b013e3283630f04; Weber DJ, 2010, AM J INFECT CONTROL, V38, pS25, DOI 10.1016/j.ajic.2010.04.196; Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330; Zhang HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006108	63	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2020	15	6							e0234127	10.1371/journal.pone.0234127	http://dx.doi.org/10.1371/journal.pone.0234127			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LW6ZP	32492060	Green Published, Green Submitted, gold			2022-12-26	WOS:000539293000017
J	Cao, JF; Chen, LC; Wu, CY; Zhang, ZB				Cao, Jianfang; Chen, Lichao; Wu, Chenyan; Zhang, Zibang			CM-supplement network model for reducing the memory consumption during multilabel image annotation	PLOS ONE			English	Article								With the rapid development of the Internet and the increasing popularity of mobile devices, the availability of digital image resources is increasing exponentially. How to rapidly and effectively retrieve and organize image information has been a hot issue that urgently must be solved. In the field of image retrieval, image auto-annotation remains a basic and challenging task. Targeting the drawbacks of the low accuracy rate and high memory resource consumption of current multilabel annotation methods, this study proposed a CM-supplement network model. This model combines the merits of cavity convolutions, Inception modules and a supplement network. The replacement of common convolutions with cavity convolutions enlarged the receptive field without increasing the number of parameters. The incorporation of Inception modules enables the model to extract image features at different scales with less memory consumption than before. The adoption of the supplement network enables the model to obtain the negative features of images. After 100 training iterations on the PASCAL VOC 2012 dataset, the proposed model achieved an overall annotation accuracy rate of 94.5%, which increased by 10.0 and 1.1 percentage points compared with the traditional convolution neural network (CNN) and double-channel CNN (DCCNN). After stabilization, this model achieved an accuracy of up to 96.4%. Moreover, the number of parameters in the DCCNN was more than 1.5 times that of the CM-supplement network. Without increasing the amount of memory resources consumed, the proposed CM-supplement network can achieve comparable or even better annotation effects than a DCCNN.	[Cao, Jianfang] Xinzhou Teachers Univ, Dept Comp Sci & Technol, Xinzhou, Peoples R China; [Cao, Jianfang; Chen, Lichao; Wu, Chenyan; Zhang, Zibang] Taiyuan Univ Sci & Technol, Sch Comp Sci & Technol, Taiyuan, Peoples R China	Xinzhou Teachers University; Taiyuan University of Science & Technology	Cao, JF (corresponding author), Xinzhou Teachers Univ, Dept Comp Sci & Technol, Xinzhou, Peoples R China.; Cao, JF (corresponding author), Taiyuan Univ Sci & Technol, Sch Comp Sci & Technol, Taiyuan, Peoples R China.	caojianfangcn@163.com			Natural Science Foundation of Shanxi Province [201701D21059]; Key Research Base Project of Humanities and Social Sciences in Colleges and universities of Shanxi Province [20190130]; Art and Science Planning Project of Shanxi Province [2017F06]; Platform and Personnel Specialty of Xinzhou [20180601]; Education Science Planning Project of the 13th Five-year Plan of the Key Discipline Project of Shanxi province [GH-17059]	Natural Science Foundation of Shanxi Province(Natural Science Foundation of Shanxi Province); Key Research Base Project of Humanities and Social Sciences in Colleges and universities of Shanxi Province; Art and Science Planning Project of Shanxi Province; Platform and Personnel Specialty of Xinzhou; Education Science Planning Project of the 13th Five-year Plan of the Key Discipline Project of Shanxi province	This work was supported by the Natural Science Foundation of Shanxi Province [grant number 201701D21059], the Key Research Base Project of Humanities and Social Sciences in Colleges and universities of Shanxi Province (20190130), the Art and Science Planning Project of Shanxi Province [grant number 2017F06], the Platform and Personnel Specialty of Xinzhou (20180601) and the Education Science Planning Project of the 13th Five-year Plan of the Key Discipline Project of Shanxi province [grant number GH-17059]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alham NK, 2014, NEURAL COMPUT APPL, V24, P367, DOI 10.1007/s00521-012-1237-2; Alkaoud M., 2014, INT J IMAGE GRAPHICS, V2, P59, DOI DOI 10.12720/joig.2.1.59-63; Bahrololoum A, 2017, PATTERN RECOGN, V61, P169, DOI 10.1016/j.patcog.2016.07.034; Cao JF, 2019, COMPUTATIONAL INTELL, V2019, P1; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Everingham M, 2010, INT J COMPUT VISION, V88, P303, DOI 10.1007/s11263-009-0275-4; Guillaumin M, 2009, IEEE I CONF COMP VIS, P309, DOI 10.1109/ICCV.2009.5459266; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; Jeon J., 2003, P ACM SIGIR C RES DE, P119; Jing XY, 2016, IEEE T IMAGE PROCESS, V25, P2712, DOI 10.1109/TIP.2016.2549459; Ke X, 2013, COMPUT ELECTR ENG, V39, P945, DOI 10.1016/j.compeleceng.2012.09.017; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; [黎健成 Li Jiancheng], 2016, [计算机科学, Computer Science], V43, P41; Li Y, 2018, NEUROCOMPUTING, V301, P11, DOI 10.1016/j.neucom.2018.01.084; Li Zhi-Xin, 2011, Journal of Software, V22, P801, DOI 10.3724/SP.J.1001.2011.03742; Liu Z, 2018, EXPERT SYST APPL, V104, P168, DOI 10.1016/j.eswa.2018.03.014; Makadia A, 2008, LECT NOTES COMPUT SC, V5304, P316, DOI 10.1007/978-3-540-88690-7_24; Makadia A, 2010, INT J COMPUT VISION, V90, P88, DOI 10.1007/s11263-010-0338-6; Moran S, 2014, INT J MULTIMED INF R, V3, P209, DOI 10.1007/s13735-014-0063-y; Murthy VN, 2015, ICMR'15: PROCEEDINGS OF THE 2015 ACM INTERNATIONAL CONFERENCE ON MULTIMEDIA RETRIEVAL, P603, DOI 10.1145/2671188.2749391; [邱泽宇 Qiu Zeyu], 2014, [计算机学报, Chinese Journal of Computers], V37, P1390; Szegedy C, 2015, PROC CVPR IEEE, P1, DOI 10.1109/CVPR.2015.7298594; Verma Y, 2017, INT J COMPUT VISION, V121, P126, DOI 10.1007/s11263-016-0927-0; Verma Y, 2012, LECT NOTES COMPUT SC, V7574, P836, DOI 10.1007/978-3-642-33712-3_60; [王强 Wang Qiang], 2018, [计算机辅助设计与图形学学报, Journal of Computer-Aided Design & Computer Graphics], V30, P385; Wu BY, 2015, PATTERN RECOGN, V48, P2279, DOI 10.1016/j.patcog.2015.01.022; Wu B, 2018, NEURAL COMPUT, V30, P1647, DOI [10.1162/NECO_a_01077, 10.1162/neco_a_01077]; Zeng ZQ, 2016, NEUROCOMPUTING, V215, P150, DOI 10.1016/j.neucom.2015.07.162; Zhang Bo, 2017, Journal of Software, V28, P292, DOI 10.13328/j.cnki.jos.005047; Zhang XF, 2015, IEEE T MED IMAGING, V34, P496, DOI 10.1109/TMI.2014.2361481; Zhu SH, 2015, ELECTRON LETT, V51, P905, DOI 10.1049/el.2015.0258; Zurowietz M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207498	33	0	0	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0234014	10.1371/journal.pone.0234014	http://dx.doi.org/10.1371/journal.pone.0234014			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MJ2AA	32479515	Green Published, gold			2022-12-26	WOS:000547893500046
J	Sanjo, H; Yao, T; Katagiri, K; Sato, T; Matsumura, T; Komeya, M; Yamanaka, H; Yao, M; Matsuhisa, A; Asayama, Y; Ikeda, K; Kano, K; Aoki, J; Arita, M; Ogawa, T				Sanjo, Hiroyuki; Yao, Tatsuma; Katagiri, Kumiko; Sato, Takuya; Matsumura, Takafumi; Komeya, Mitsuru; Yamanaka, Hiroyuki; Yao, Masahiro; Matsuhisa, Akio; Asayama, Yuta; Ikeda, Kazutaka; Kano, Kuniyuki; Aoki, Junken; Arita, Makoto; Ogawa, Takehiko			Antioxidant vitamins and lysophospholipids are critical for inducing mouse spermatogenesis under organ culture conditions	FASEB JOURNAL			English	Article						ascorbic acid; chemically defined medium; glutathione; lysophospholipids; meiosis; organ culture; spermatogenesis; testis; alpha-tocopherol	FOLLICLE-STIMULATING-HORMONE; LYSOPHOSPHATIDIC ACID; SPERM PRODUCTION; E-DEFICIENCY; SERUM; PHOSPHOLIPIDS; MATURATION; FERTILITY; TURNOVER; TISSUES	In vitro mouse spermatogenesis using a classical organ culture method became possible by supplementing basal culture medium with only the product of bovine serum albumin purified by chromatography (AlbuMAX), which indicated that AlbuMAX contained every chemical factor necessary for mouse spermatogenesis. However, since the identity of these factors was unclear, improvements in culture media and our understanding of the nutritional and signal substances required for spermatogenesis were hindered. In the present study, chemically defined media (CDM) without AlbuMAX was used to evaluate each supplementary factor and their combinations for the induction of spermatogenesis. Similar to in vivo conditions, retinoic acid, triiodothyronine (T-3), and testosterone (T) were needed. Based on differences in spermatogenic competence between AlbuMAX, fetal bovine serum, and adult bovine serum, we identified alpha-tocopherol, which strongly promoted spermatogenesis when combined with ascorbic acid and glutathione. Differences were also observed in the abilities of lipids extracted from AlbuMAX using two different methods to induce spermatogenesis. This led to the identification of lysophospholipids, particularly lysophosphatidylcholine, lysophosphatidic acid, and lysophosphatidylserine, as important molecules for spermatogenesis. New CDM formulated based on these results induced and promoted spermatogenesis as efficiently as AlbuMAX-containing medium. In vitro spermatogenesis with CDM may provide a unique experimental system for research on spermatogenesis that cannot be performed in in vivo experiments.	[Sanjo, Hiroyuki; Komeya, Mitsuru; Yamanaka, Hiroyuki; Yao, Masahiro; Ogawa, Takehiko] Yokohama City Univ, Grad Sch Med, Dept Urol, Yokohama, Kanagawa, Japan; [Sanjo, Hiroyuki; Katagiri, Kumiko; Sato, Takuya; Matsumura, Takafumi; Ogawa, Takehiko] Yokohama City Univ, Inst Mol Med & Life Sci, Lab Biopharmaceut & Regenerat Sci, Assoc Med Sci, Yokohama, Kanagawa, Japan; [Yao, Tatsuma; Matsuhisa, Akio; Asayama, Yuta] Fuso Pharmaceut Ind Ltd, Res & Dev Ctr, Osaka, Japan; [Ikeda, Kazutaka; Arita, Makoto] RIKEN Ctr Integrat Med Sci, Lab Metabolom, Yokohama, Kanagawa, Japan; [Ikeda, Kazutaka; Arita, Makoto] Yokohama City Univ, Grad Sch Med Life Sci, Cellular & Mol Epigenet Lab, Yokohama, Kanagawa, Japan; [Ikeda, Kazutaka] Kazusa DNA Res Inst, Kisarazu, Japan; [Kano, Kuniyuki; Aoki, Junken] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi, Japan; [Arita, Makoto] Keio Univ, Grad Sch Pharmaceut Sci, Div Physiol Chem & Metab, Tokyo, Japan	Yokohama City University; Yokohama City University; Fuso Pharmaceutical Industries, Ltd.; RIKEN; Yokohama City University; Kazusa DNA Research Institute; Tohoku University; Keio University	Ogawa, T (corresponding author), Yokohama City Univ, Assoc Med Sci, Lab Biopharmaceut & Regenerat Sci, Inst Mol Med & Life Sci,Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	ogawa@yokohama-cu.ac.jp	Sato, Takuya/F-8251-2017	Sato, Takuya/0000-0002-6198-2234; Yao, Tatsuma/0000-0002-0974-0625; Kano, Kuniyuki/0000-0002-4539-5750; Arita, Makoto/0000-0001-9902-0463	MEXT \ Japan Science and Technology Agency (JST) [18H05546, 15H05897]; Japan Agency for Medical Research and Development (AMED)	MEXT \ Japan Science and Technology Agency (JST); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	MEXT vertical bar Japan Science and Technology Agency (JST), Grant/Award Number: 18H05546 and 15H05897; Japan Agency for Medical Research and Development (AMED)	Aikawa S, 2015, J BIOCHEM, V157, P81, DOI 10.1093/jb/mvu077; Aoyagi R, 2017, J LIPID RES, V58, P2229, DOI 10.1194/jlr.D077123; Arkoun B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116660; Baker DL, 2001, ANAL BIOCHEM, V292, P287, DOI 10.1006/abio.2001.5063; Bensoussan K, 1998, J ANDROL, V19, P266; BETTGER WJ, 1981, P NATL ACAD SCI-BIOL, V78, P5588, DOI 10.1073/pnas.78.9.5588; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BURTON GW, 1982, LANCET, V2, P327; Carr AC, 1999, AM J CLIN NUTR, V69, P1086; CHESSEBEUF M, 1984, IN VITRO CELL DEV B, V20, P780; Dierich A, 1998, P NATL ACAD SCI USA, V95, P13612, DOI 10.1073/pnas.95.23.13612; Dumont L, 2016, MOL HUM REPROD, V22, P819, DOI 10.1093/molehr/gaw063; GALLAHER WR, 1973, BIOCHEM BIOPH RES CO, V52, P1252, DOI 10.1016/0006-291X(73)90635-9; Gohbara A, 2010, BIOL REPROD, V83, P261, DOI 10.1095/biolreprod.110.083899; Hishikawa D, 2014, J LIPID RES, V55, P799, DOI 10.1194/jlr.R046094; Holsberger DR, 2005, BIOL REPROD, V73, P396, DOI 10.1095/biolreprod.105.041426; ISCOVE NN, 1980, EXP CELL RES, V126, P121, DOI 10.1016/0014-4827(80)90476-0; Isoler-Alcaraz J, 2017, REPROD BIOL ENDOCRIN, V15, DOI 10.1186/s12958-017-0305-y; Kanatsu-Shinohara M, 2011, BIOL REPROD, V84, P97, DOI 10.1095/biolreprod.110.086462; Kihara Y, 2015, EXP CELL RES, V333, P171, DOI 10.1016/j.yexcr.2014.11.020; Komeya M, 2018, REPROD MED BIOL, V17, P407, DOI 10.1002/rmb2.12225; Komeya M, 2016, SCI REP-UK, V6, DOI 10.1038/srep21472; Kubota H, 2004, BIOL REPROD, V71, P722, DOI 10.1095/biolreprod.104.029207; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; Martinovitch P. N., 1937, Nature London, V139, P413, DOI 10.1038/139413a0; Mason KE, 1933, AM J ANAT, V52, P153, DOI 10.1002/aja.1000520202; Moudgal NR, 1998, HUM REPROD, V13, P916, DOI 10.1093/humrep/13.4.916; Nakamura N, 2017, BIRTH DEFECTS RES, V109, P465, DOI 10.1002/bdr2.1002; Nakanishi T, 1999, FEBS LETT, V449, P277, DOI 10.1016/S0014-5793(99)00433-0; Nakanishi T, 2001, DEV BIOL, V237, P222, DOI 10.1006/dbio.2001.0353; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; NIKI E, 1987, CHEM PHYS LIPIDS, V44, P227, DOI 10.1016/0009-3084(87)90052-1; Niki E, 2004, ACCOUNTS CHEM RES, V37, P45, DOI 10.1021/ar030069m; Ohta H, 2009, BIOL REPROD, V80, P511, DOI 10.1095/biolreprod.108.073270; Okudaira M, 2014, J LIPID RES, V55, P2178, DOI 10.1194/jlr.D048439; Olcott HS, 1937, J AM CHEM SOC, V59, P1008, DOI 10.1021/ja01285a013; PACKER JE, 1979, NATURE, V278, P737, DOI 10.1038/278737a0; Packer L., 1997, Vitamin C in health and disease., P95; PASTERNA.CA, 1970, BIOCHEM J, V119, P481, DOI 10.1042/bj1190481; Sanjo H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192884; Sato T, 2013, NAT PROTOC, V8, P2098, DOI 10.1038/nprot.2013.138; Sato T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1478; Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850; Sharpe Richard M., 1994, P1363; SINGH J, 1995, ENDOCRINOLOGY, V136, P5311, DOI 10.1210/en.136.12.5311; Wang RS, 2009, ENDOCR REV, V30, P119, DOI 10.1210/er.2008-0025; WARREN L, 1968, J CELL BIOL, V37, P729, DOI 10.1083/jcb.37.3.729; Wauthier E, 2008, METHOD CELL BIOL, V86, P137, DOI 10.1016/S0091-679X(08)00008-3; WINKLER BS, 1994, FREE RADICAL BIO MED, V17, P333, DOI 10.1016/0891-5849(94)90019-1; Ye XQ, 2008, BIOL REPROD, V79, P328, DOI 10.1095/biolreprod.108.068783; Yokonishi Tetsuhiro, 2016, Reproductive Medicine and Biology, V15, P21, DOI 10.1007/s12522-015-0218-4; Yokonishi Tetsuhiro, 2013, Methods Mol Biol, V927, P479	53	7	7	3	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9480	9497		10.1096/fj.202000245R	http://dx.doi.org/10.1096/fj.202000245R		MAY 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32474967				2022-12-26	WOS:000538126800001
J	Otiang, E; Campbell, ZA; Thumbi, SM; Njagi, LW; Nyaga, PN; Palmer, GH				Otiang, Elkanah; Campbell, Zoe A.; Thumbi, Samuel M.; Njagi, Lucy W.; Nyaga, Philip N.; Palmer, Guy H.			Mortality as the primary constraint to enhancing nutritional and financial gains from poultry: A multi-year longitudinal study of smallholder farmers in western Kenya	PLOS ONE			English	Article							LIVESTOCK; HEALTH; BIAS	Background Chickens are a widely held economic and nutritional asset in rural Africa and are frequently managed by women. Despite potential benefits of larger flock sizes, the average number of chickens kept at the household level is reported to be low. Whether this reflects decision making to maximize benefits per unit labor by voluntary reduction of chicken numbers by consumption or sale versus involuntary losses due to mortality is a significant gap in knowledge relevant to improving smallholder household welfare. Methods In a 4-year longitudinal study of 1,908 smallholder households in rural western Kenya, the number of chickens owned by quarterly census at each household was determined. Households reported gains and losses of chicken over the immediate previous quarter. Gains were classified as on-farm or off-farm; losses were classified as voluntary (sales, gifts, consumption) or involuntary (mortality, unclassified loss). Results The mean number of chickens owned over the 16 quarters was 10, consistent with prior cross-sectional data. Involuntary losses represented 70% of total off-take, while voluntary off-take represented the remaining 30%. Mortality composed 60% of total reported off-take and accounted for most of the involuntary losses. Household consumption, sales, and gifts represented 18%, 9%, and 3% of off-take, respectively. Conclusion The overwhelming majority of off-take can be classified as involuntary off-take, principally due to mortality, that does not reflect the owner's decision to maximize value through nutritional gain, income, or social capital. This strongly suggests that there is substantial opportunity to enhance the value of chickens as an asset, both nutritional and income generating, for smallholder households living at poverty level. Our findings suggest that programs emphasizing community level poultry vaccination and feed supplementation are much more likely to be effective than those solely focused on providing chickens.	[Otiang, Elkanah; Thumbi, Samuel M.; Njagi, Lucy W.; Nyaga, Philip N.; Palmer, Guy H.] Univ Nairobi, Nairobi, Kenya; [Otiang, Elkanah; Thumbi, Samuel M.] Kenya Med Res Ctr, Kisumu, Kenya; [Otiang, Elkanah; Thumbi, Samuel M.; Palmer, Guy H.] Washington State Univ Global Hlth Kenya, Nairobi, Kenya; [Campbell, Zoe A.; Thumbi, Samuel M.; Palmer, Guy H.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Campbell, Zoe A.] Int Livestock Res Inst, Nairobi, Kenya	University of Nairobi; Washington State University; CGIAR; International Livestock Research Institute (ILRI)	Palmer, GH (corresponding author), Univ Nairobi, Nairobi, Kenya.; Palmer, GH (corresponding author), Washington State Univ Global Hlth Kenya, Nairobi, Kenya.; Palmer, GH (corresponding author), Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.	gpalmer@wsu.edu		Palmer, Guy/0000-0001-5679-4709	Paul G. Allen School for Global Animal Health Washington State University	Paul G. Allen School for Global Animal Health Washington State University	Funding was provided by the Paul G. Allen School for Global Animal Health Washington State University. There is no specific grant number. https://globalhealth.wsu.edu Neither the late Paul G. Allen or his Foundation had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alders R, 2002, ACIAR MONOGRAPH, V87; Alders RG, 2009, WORLD POULTRY SCI J, V65, P181, DOI 10.1017/S0043933909000117; Althubaiti A, 2016, J MULTIDISCIP HEALTH, V9, P211, DOI 10.2147/JMDH.S104807; Campbell ZA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220963; Campbell ZA, 2019, VACCINE, V37, P11, DOI 10.1016/j.vaccine.2018.11.058; Campbell ZA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206058; Earnshaw J, 2008, PHARMACOECONOMICS, V26, P725, DOI 10.2165/00019053-200826090-00002; Farrell D, 2013, ROLE POULTRY HUMAN N; Fisher H, 2014, ACIAR IMPACT ASSESSM, P1; FISHER RJ, 1993, J CONSUM RES, V20, P303, DOI 10.1086/209351; Kingori A. M., 2010, International Journal of Poultry Science, V9, P309; Kitalyi A.J., 1998, VILLAGE CHICKEN PROD; Kristjanson P, 2012, FOOD SECUR, V4, P381, DOI 10.1007/s12571-012-0194-z; Kryger K.N., 2010, SMALL HOLDER POULTRY; Lesnoff M., 2009, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V62, P49; Lindahl JF, 2019, TROP ANIM HEALTH PRO, V51, P213, DOI 10.1007/s11250-018-1679-3; Magothe TM, 2012, WORLD POULTRY SCI J, V68, P119, DOI 10.1017/S0043933912000128; Mosites E, 2016, J NUTR, V146, P1118, DOI 10.3945/jn.115.225961; Mpenda FN, 2019, J APPL POULTRY RES, V28, P1, DOI 10.3382/japr/pfy063; Msami H, 2007, FAO POULTRY SECTOR C, DOI [10.1093/acprof:oso/9780190498511.003.0001, DOI 10.1093/ACPROF:OSO/9780190498511.003.0001]; Nyaga P, 2008, FAO POULTRY SECTOR C; Okitoi LO., 2006, J AGR RURAL DEV TROP, V39, P179; Olwande PO, 2010, TROP ANIM HEALTH PRO, V42, P283, DOI 10.1007/s11250-009-9418-4; Randolph TF, 2007, J ANIM SCI, V85, P2788, DOI 10.2527/jas.2007-0467; Thornton P. K., 2004, Responding to the livestock revolution: the role of globalisation and implications for poverty alleviation, P37; Thumbi SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120761; Valdivia C., 2001, Agriculture and Human Values, V18, P27, DOI 10.1023/A:1007613031102; Wilson K. R, 2021, GENDER PLACE CULT, V28, P1196	28	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2020	15	5							e0233691	10.1371/journal.pone.0233691	http://dx.doi.org/10.1371/journal.pone.0233691			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1WS	32470070	Green Published, gold			2022-12-26	WOS:000537552800137
J	Dierschke, SK; Toro, AL; Miller, WP; Sunilkumar, S; Dennis, MD				Dierschke, Sadie K.; Toro, Allyson L.; Miller, William P.; Sunilkumar, Siddharth; Dennis, Michael D.			Diabetes enhances translation of Cd40 mRNA in murine retinal Muller glia via a 4E-BP1/2-dependent mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diabetes; retina; cluster of differentiation 40 (CD40); O-GlcNAcylation; eukaryotic translation initiation factor 4E-binding protein 1 (eIF4EBP1); mRNA translation; post-translational modification; inflammation; thiamet G; Muller cell	NITRIC-OXIDE SYNTHASE; O-GLCNAC MODIFICATION; CAP-INDEPENDENT TRANSLATION; PROTEIN-SYNTHESIS; SECONDARY STRUCTURE; AQUEOUS-HUMOR; UP-REGULATION; EXPRESSION; CELLS; GLCNACYLATION	Activation of the immune costimulatory molecule cluster of differentiation 40 (CD40) in Muller glia has been implicated in the initiation of diabetes-induced retinal inflammation. Results from previous studies support that CD40 protein expression is elevated in Muller glia of diabetic mice; however, the mechanisms responsible for this increase have not been explored. Here, we evaluated the hypothesis that diabetes augments translation of theCd40mRNA. Mice receiving thiamet G (TMG), an inhibitor of theO-GlcNAc hydrolaseO-GlcNAcase, exhibited enhanced retinal proteinO-GlcNAcylation and increasedCd40mRNA translation. TMG administration also promotedCd40mRNA association with Muller cell-specific ribosomes isolated from the retina of RiboTag mice. Similar effects onO-GlcNAcylation andCd40mRNA translation were also observed in the retina of a mouse model of type 1 diabetes. In cultured cells, TMG promoted sequestration of the cap-binding protein eIF4E (eukaryotic translation in initiation factor 4E) by 4E-BP1 (eIF4E-binding protein 1) and enhanced cap-independentCd40mRNA translation as assessed by a bicistronic reporter that contained the 5 '-UTR of theCd40mRNA. Ablation of 4E-BP1/2 prevented the increase inCd40mRNA translation in TMG-exposed cells, and expression of a 4E-BP1 variant that constitutively sequesters eIF4E promoted reporter activity. Extending on the cell culture results, we found that in contrast to WT mice, diabetic 4E-BP1/2-deficient mice did not exhibit enhanced retinalCd40mRNA translation and failed to up-regulate expression of the inflammatory marker nitric-oxide synthase 2. These findings support a model wherein diabetes-inducedO-GlcNAcylation of 4E-BP1 promotesCd40mRNA translation in Muller glia.	[Dierschke, Sadie K.; Toro, Allyson L.; Miller, William P.; Sunilkumar, Siddharth; Dennis, Michael D.] Penn State Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Dennis, Michael D.] Penn State Coll Med, Dept Ophthalmol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Dennis, MD (corresponding author), Penn State Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA.; Dennis, MD (corresponding author), Penn State Coll Med, Dept Ophthalmol, Hershey, PA 17033 USA.	mdennis@psu.edu	Sunilkumar, Siddharth/AAS-5916-2021	Sunilkumar, Siddharth/0000-0003-3271-932X; MILLER, WILLIAM PHILLIP/0000-0003-0157-6389; Dennis, Michael/0000-0002-0645-6864	American Diabetes Association Pathway to Stop Diabetes Grant [1-14-INI-04]; NEI, National Institutes of Health [R01 EY029702]	American Diabetes Association Pathway to Stop Diabetes Grant; NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by American Diabetes Association Pathway to Stop Diabetes Grant 1-14-INI-04 and NEI, National Institutes of Health Grant R01 EY029702 (to M. D. D.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barber AJ, 2000, INVEST OPHTH VIS SCI, V41, P3561; Ben Lamine L, 2020, EXP CLIN ENDOCR DIAB, V128, P319, DOI 10.1055/a-0647-6860; Benveniste EN, 2004, BRAIN BEHAV IMMUN, V18, P7, DOI 10.1016/j.bbi.2003.09.001; Boeri D, 2001, DIABETES, V50, P1432, DOI 10.2337/diabetes.50.6.1432; Cipollone F, 2005, DIABETOLOGIA, V48, P1216, DOI 10.1007/s00125-005-1750-2; Coughlin BA, 2017, VISION RES, V139, P93, DOI 10.1016/j.visres.2017.03.013; Dai WW, 2018, BBA-MOL BASIS DIS, V1864, P3568, DOI 10.1016/j.bbadis.2018.09.006; Dela Justina V, 2017, INFLAMMATION, V40, P1773, DOI 10.1007/s10753-017-0620-7; Dennis MD, 2015, J BIOL CHEM, V290, P3865, DOI 10.1074/jbc.M114.623058; Dennis MD, 2013, DIABETES, V62, P2204, DOI 10.2337/db12-1453; Dennis MD, 2011, J BIOL CHEM, V286, P34286, DOI 10.1074/jbc.M111.259457; Dierschke SK, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.2.24; Dierschke SK, 2019, J BIOL CHEM, V294, P5508, DOI 10.1074/jbc.RA119.007494; Donovan K, 2014, INVEST OPHTH VIS SCI, V55, P7862, DOI 10.1167/iovs.14-14048; Du YP, 2002, J NEUROCHEM, V80, P771, DOI 10.1046/j.0022-3042.2001.00737.x; El-Asrar AM, 2001, AM J OPHTHALMOL, V132, P551, DOI 10.1016/S0002-9394(01)01127-8; Giraud S, 2001, J BIOL CHEM, V276, P5668, DOI 10.1074/jbc.M005928200; Gurel Z, 2013, MOL VIS, V19, P1047; Henn V, 2001, BLOOD, V98, P1047, DOI 10.1182/blood.V98.4.1047; Holcik M, 2000, TRENDS GENET, V16, P469, DOI 10.1016/S0168-9525(00)02106-5; Jacobson EM, 2005, ENDOCRINOLOGY, V146, P2684, DOI 10.1210/en.2004-1617; James LR, 2002, DIABETES, V51, P1146, DOI 10.2337/diabetes.51.4.1146; Khidekel N, 2007, NAT CHEM BIOL, V3, P339, DOI 10.1038/nchembio881; Kim SJ, 2016, CURR EYE RES, V41, P249, DOI 10.3109/02713683.2015.1006372; Kimball SR, 1997, AM J PHYSIOL-CELL PH, V272, pC754, DOI 10.1152/ajpcell.1997.272.2.C754; Kimball SR, 1998, J BIOL CHEM, V273, P30945, DOI 10.1074/jbc.273.47.30945; Kneass ZT, 2005, J BIOL CHEM, V280, P14579, DOI 10.1074/jbc.M414066200; KOZAK M, 1989, MOL CELL BIOL, V9, P5134, DOI 10.1128/MCB.9.11.5134; Krick S, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00708; Kwok CK, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a032284; Leal EC, 2007, INVEST OPHTH VIS SCI, V48, P5257, DOI 10.1167/iovs.07-0112; Li Y, 2019, INT J MOL MED, V44, P363, DOI 10.3892/ijmm.2019.4238; Lieth E, 1998, DIABETES, V47, P815, DOI 10.2337/diabetes.47.5.815; Lopez-Lastra M, 2005, BIOL RES, V38, P121, DOI 10.4067/S0716-97602005000200003; Lund PJ, 2016, J IMMUNOL, V197, P3086, DOI 10.4049/jimmunol.1502031; Mazumder B, 2010, J IMMUNOL, V184, P3311, DOI 10.4049/jimmunol.0903778; Miller WP, 2017, J BIOL CHEM, V292, P1591, DOI 10.1074/jbc.M116.760868; Miller WP, 2016, INVEST OPHTH VIS SCI, V57, P1327, DOI 10.1167/iovs.15-18719; Nandi A, 2006, ANAL CHEM, V78, P452, DOI 10.1021/ac051207j; PELLETIER J, 1985, CELL, V40, P515, DOI 10.1016/0092-8674(85)90200-4; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Portillo JAC, 2017, DIABETES, V66, P483, DOI 10.2337/db16-0051; Portillo JAC, 2014, INVEST OPHTH VIS SCI, V55, P8590, DOI 10.1167/iovs.14-15340; Portillo JAC, 2014, DIABETOLOGIA, V57, P2222, DOI 10.1007/s00125-014-3321-x; Portillo JAC, 2008, J IMMUNOL, V181, P8719, DOI 10.4049/jimmunol.181.12.8719; Roesch K, 2008, J COMP NEUROL, V509, P225, DOI 10.1002/cne.21730; Rubsam A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19040942; Rungger-Brandle E, 2000, INVEST OPHTH VIS SCI, V41, P1971; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schrufer TL, 2010, DIABETES, V59, P2107, DOI 10.2337/db10-0148; Semeraro F, 2019, DIABETES METAB, V45, P517, DOI 10.1016/j.diabet.2019.04.002; Sundstrom JM, 2018, INVEST OPHTH VIS SCI, V59, P2264, DOI 10.1167/iovs.17-23678; Swamy M, 2016, NAT IMMUNOL, V17, P712, DOI 10.1038/ni.3439; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Teo CF, 2010, NAT CHEM BIOL, V6, P338, DOI 10.1038/nchembio.338; Urbancic M, 2019, CLIN OPHTHALMOL, V13, P829, DOI 10.2147/OPTH.S206769; Vujosevic S, 2016, ACTA OPHTHALMOL, V94, P56, DOI 10.1111/aos.12812; Vujosevic S, 2015, INVEST OPHTH VIS SCI, V56, P3913, DOI 10.1167/iovs.15-16554; Wang MH, 2014, ADV EXP MED BIOL, V801, P333, DOI 10.1007/978-1-4614-3209-8_42; Wang MH, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-173; WATANABE T, 1994, BRAIN RES, V655, P128, DOI 10.1016/0006-8993(94)91606-3; Weingarten-Gabbay S, 2016, SCIENCE, V351, DOI 10.1126/science.aad4939; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Wu JL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01677-z; Xu HP, 2017, VISION RES, V139, P39, DOI 10.1016/j.visres.2017.04.013; Yellin MJ, 1997, ARTHRITIS RHEUM, V40, P124, DOI 10.1002/art.1780400117; Zhang Y, 2017, BIOCHEM BIOPH RES CO, V484, P79, DOI 10.1016/j.bbrc.2017.01.068; Zheng L, 2007, DIABETOLOGIA, V50, P1987, DOI 10.1007/s00125-007-0734-9	69	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2020	295	31					10831	10841		10.1074/jbc.RA120.013711	http://dx.doi.org/10.1074/jbc.RA120.013711			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB3HM	32475820	Green Published, hybrid			2022-12-26	WOS:000560405600025
J	Okino, N; Li, MB; Qu, QJ; Nakagawa, T; Hayashi, Y; Matsumoto, M; Ishibashi, Y; Ito, M				Okino, Nozomu; Li, Mengbai; Qu, Qingjun; Nakagawa, Tomoko; Hayashi, Yasuhiro; Matsumoto, Mitsufumi; Ishibashi, Yohei; Ito, Makoto			Two bacterial glycosphingolipid synthases responsible for the synthesis of glucuronosylceramide and alpha-galactosylceramide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycolipid; glycosyltransferase; bacteria; sphingolipid; ceramide; bacterial metabolism; innate immunity; alpha-galactosylceramide; glucuronosylceramide; invariant natural killer T cells	ZYMOMONAS-MOBILIS; NKT CELLS; QUANTITATIVE-ANALYSIS; SEQUENCE ALIGNMENT; GENOME SEQUENCE; SPHINGOLIPIDS; ACTIVATION; BIOLOGY; AGELASPHINS; ATTACHMENT	Bacterial glycosphingolipids such as glucuronosylceramide and galactosylceramide have been identified as ligands for invariant natural killer T cells and play important roles in host defense. However, the glycosphingolipid synthases required for production of these ceramides have not been well-characterized. Here, we report the identification and characterization of glucuronosylceramide synthase (ceramide UDP-glucuronosyltransferase [Cer-GlcAT]) in Zymomonas mobilis, a Gram-negative bacterium whose cellular membranes contain glucuronosylceramide. On comparing the gene sequences that encode the diacylglycerol GlcAT in bacteria and plants, we found a homologous gene that is widely distributed in the orderSphingomonadalesin theZ. mobilisgenome. We first cloned the gene and expressed it inEscherichia coli, followed by protein purification using nickel-Sepharose affinity and gel filtration chromatography. Using the highly enriched enzyme, we observed that it has high glycosyltransferase activity with UDP-glucuronic acid and ceramide as sugar donor and acceptor substrate, respectively. Cer-GlcAT deletion resulted in a loss of glucuronosylceramide and increased the levels of ceramide phosphoglycerol, which was expressed in WT cells only at very low levels. Furthermore, we found sequences homologous to Cer-GlcAT inSphingobium yanoikuyaeandBacteroides fragilis, which have been reported to produce glucuronosylceramide and alpha-galactosylceramide, respectively. We expressed the two homologs of thecer-glcatgene inE. coliand found that each gene encodes Cer-GlcAT and Cer-galactosyltransferase, respectively. These results contribute to the understanding of the roles of bacterial glycosphingolipids in host-bacteria interactions and the function of bacterial glycosphingolipids in bacterial physiology.	[Okino, Nozomu; Li, Mengbai; Qu, Qingjun; Nakagawa, Tomoko; Hayashi, Yasuhiro; Ishibashi, Yohei; Ito, Makoto] Kyushu Univ, Dept Biosci & Biotechnol, Grad Sch Bioresource & Bioenvironm Sci, Nishi Ku, Fukuoka, Japan; [Ito, Makoto] Kyushu Univ, Innovat Bioarchitecture Ctr, Grad Sch Bioresource & Bioenvironm Sci, Nishi Ku, Fukuoka, Japan; [Matsumoto, Mitsufumi] Elect Power Dev Co Ltd, Wakamatsu Inst, Wakamatsu Ku, Kitakyushu, Fukuoka, Japan; [Hayashi, Yasuhiro] Teikyo Univ, Fac Pharma Sci, Itabashi Ku, Tokyo, Japan	Kyushu University; Kyushu University; Teikyo University	Okino, N (corresponding author), Kyushu Univ, Dept Biosci & Biotechnol, Grad Sch Bioresource & Bioenvironm Sci, Nishi Ku, Fukuoka, Japan.	nokino@agr.kyushu-u.ac.jp	Okino, Nozomu/AAY-2635-2021		Japan Society for the Promotion of Science KAKENHI [JP15K06976, JP19H02888]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants, JP15K06976 and JP19H02888 (to N. O.).	An DD, 2014, CELL, V156, P123, DOI 10.1016/j.cell.2013.11.042; An DD, 2011, P NATL ACAD SCI USA, V108, P4666, DOI 10.1073/pnas.1001501107; BARATTI JC, 1986, BIOTECHNOL ADV, V4, P95, DOI 10.1016/0734-9750(86)90006-6; BEACHEY EH, 1981, J INFECT DIS, V143, P325, DOI 10.1093/infdis/143.3.325; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Brenac L, 2019, MOL MICROBIOL, V112, P1564, DOI 10.1111/mmi.14380; Brennan PJ, 2013, NAT REV IMMUNOL, V13, P101, DOI 10.1038/nri3369; BRINGER S, 1984, ARCH MICROBIOL, V139, P376, DOI 10.1007/BF00408383; Brown LCW, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001610; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; COSTELLO CE, 1990, METHOD ENZYMOL, V193, P738, DOI 10.1016/0076-6879(90)93448-T; Degroote S, 2004, SEMIN CELL DEV BIOL, V15, P375, DOI 10.1016/j.semcdb.2004.03.007; Geiger O, 2010, PROG LIPID RES, V49, P46, DOI 10.1016/j.plipres.2009.08.002; Glaeser S. P., 2014, PROKARYOTES ALPHAPRO, P641; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Hoelzl G, 2007, PROG LIPID RES, V46, P225, DOI 10.1016/j.plipres.2007.05.001; Ikushiro H, 2001, J BIOL CHEM, V276, P18249, DOI 10.1074/jbc.M101550200; Ishibashi Y, 2007, J BIOL CHEM, V282, P11386, DOI 10.1074/jbc.M608445200; Jin DC, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00569-16; KARLSSON KA, 1989, ANNU REV BIOCHEM, V58, P309, DOI 10.1146/annurev.bi.58.070189.001521; Karlsson OP, 1997, J BIOL CHEM, V272, P929, DOI 10.1074/jbc.272.2.929; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; KAWASAKI S, 1994, J BACTERIOL, V176, P284, DOI 10.1128/JB.176.2.284-290.1994; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kohlgruber AC, 2016, IMMUNOGENETICS, V68, P649, DOI 10.1007/s00251-016-0944-8; Kuraku S, 2013, NUCLEIC ACIDS RES, V41, pW22, DOI 10.1093/nar/gkt389; Li YR, 2017, ANAL CHIM ACTA, V986, P82, DOI 10.1016/j.aca.2017.07.039; Lin JN, 2010, J MICROBIOL IMMUNOL, V43, P35, DOI 10.1016/S1684-1182(10)60005-9; Lingwood CA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004788; Marbjerg LH, 2015, J CLIN MICROBIOL, V53, P1028, DOI 10.1128/JCM.03069-14; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Mattner J, 2008, CELL HOST MICROBE, V3, P304, DOI 10.1016/j.chom.2008.03.009; McEwen-Smith RM, 2015, CURR OPIN IMMUNOL, V34, P116, DOI 10.1016/j.coi.2015.03.004; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Miller TR, 2010, J BACTERIOL, V192, P6101, DOI 10.1128/JB.01030-10; Moreau RA, 1997, CURR MICROBIOL, V35, P124, DOI 10.1007/s002849900224; MORITA M, 1995, J MED CHEM, V38, P2176, DOI 10.1021/jm00012a018; Naka T, 2003, BBA-MOL CELL BIOL L, V1635, P83, DOI 10.1016/j.bbalip.2003.10.010; NATORI T, 1993, TETRAHEDRON LETT, V34, P5591, DOI 10.1016/S0040-4039(00)73889-5; NATORI T, 1994, TETRAHEDRON, V50, P2771, DOI 10.1016/S0040-4020(01)86991-X; Nichols FC, 2004, J LIPID RES, V45, P2317, DOI 10.1194/jlr.M400278-JLR200; Okazaki Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2512; Olsen I, 2001, ANAEROBE, V7, P103, DOI 10.1006/anae.2001.0376; Robinson O, 2016, MOL BIOL EVOL, V33, P2163, DOI 10.1093/molbev/msw080; Semeniuk A, 2014, J BIOL CHEM, V289, P10104, DOI 10.1074/jbc.M113.519298; Seo JS, 2005, NAT BIOTECHNOL, V23, P63, DOI 10.1038/nbt1045; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sohlenkamp C, 2016, FEMS MICROBIOL REV, V40, P133, DOI 10.1093/femsre/fuv008; Stankeviciute G, 2019, MBIO, V10, DOI 10.1128/mBio.00107-19; SWINGS J, 1977, BACTERIOL REV, V41, P1; TAHARA Y, 1994, BIOSCI BIOTECH BIOCH, V58, P586, DOI 10.1271/bbb.58.586; von Gerichten J, 2019, J LIPID RES, V60, P1892, DOI 10.1194/jlr.RA119000236; von Gerichten J, 2017, J LIPID RES, V58, P1247, DOI 10.1194/jlr.D076190	55	2	2	0	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2020	295	31					10709	10725		10.1074/jbc.RA120.013796	http://dx.doi.org/10.1074/jbc.RA120.013796			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB3HM	32518167	hybrid, Green Published			2022-12-26	WOS:000560405600016
J	Cheng, NX; Liu, C; Li, YL; Gao, SJ; Han, YC; Wang, XN; Du, J; Zhang, CC				Cheng, Naixuan; Liu, Chang; Li, Yulin; Gao, Shijuan; Han, Ying-Chun; Wang, Xiaonan; Du, Jie; Zhang, Congcong			MicroRNA-223-3p promotes skeletal muscle regeneration by regulating inflammation in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						muscle regeneration; inflammation; miR-223-3p; macrophage; cytokines; epigenetics; muscle satellite stem cell; small noncoding RNA; cytokine; interleukin-6 (IL-6)	PROGENITOR-CELL PROLIFERATION; INTERLEUKIN-6; RESOLUTION; MIR-223; PATHWAY; ATROPHY; SYSTEMS; GROWTH	After injury, the coordinated balance of pro- and anti-inflammatory factors in the microenvironment contribute to skeletal muscle regeneration. However, the underlying molecular mechanisms regulating this balance remain incompletely understood. In this study, we examined the roles of microRNAs (miRNAs) in inflammation and muscle regeneration. miRNA-Seq transcriptome analysis of mouse skeletal muscle revealed that miR-223-3p is upregulated in the early stage of muscle regeneration after injury. miR-223-3p knockout resulted in increased inflammation, impaired muscle regeneration, and increased interstitial fibrosis. Mechanistically, we found that myeloid-derived miR-223-3p suppresses the target gene interleukin-6 (Il6), associated with the maintenance of the proinflammatory macrophage phenotype during injury. Administration of IL-6-neutralizing antibody in miR-223-3p-knockout muscle could rescue the impaired regeneration ability and reduce the fibrosis. Together, our results reveal that miR-223-3p improves muscle regeneration by regulating inflammation, indicating that miRNAs can participate in skeletal muscle regeneration by controlling the balance of pro- and anti-inflammatory factors in the skeletal muscle microenvironment.	[Cheng, Naixuan] Capital Med Univ, Sch Basic Med Sci, Beijing, Peoples R China; [Cheng, Naixuan; Liu, Chang; Li, Yulin; Gao, Shijuan; Han, Ying-Chun; Wang, Xiaonan; Du, Jie; Zhang, Congcong] Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China; [Wang, Xiaonan] Emory Univ, Dept Med, Renal Div, Atlanta, GA 30322 USA	Capital Medical University; Capital Medical University; Emory University	Du, J; Zhang, CC (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China.	jiedu@ccmu.edu.cn; zcc861210@163.com	Li, yulin/AGZ-5611-2022	HAN, YINGCHUN/0000-0002-9490-3205; Li, Yulin/0000-0001-7909-0763	National Natural Science Foundation of China [81430050, 81790622, 81871758]; Beijing Hospitals Authority Youth Programme [QML20190604]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Hospitals Authority Youth Programme	This work was supported by the National Natural Science Foundation of China (grant no. 81430050, 81790622 to J. D., 81871758 to C. Z.) and Beijing Hospitals Authority Youth Programme (QML20190604).	Belizario JE, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2197-2; Bonetto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022538; Brauer RB, 2003, TRANSPL INT, V16, P37, DOI 10.1111/j.1432-2277.2003.tb00221.x; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen YX, 2012, PHYSIOL GENOMICS, V44, P1042, DOI 10.1152/physiolgenomics.00052.2012; Chu MP, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004878; Dorhoi A, 2013, J CLIN INVEST, V123, P4836, DOI 10.1172/JCI67604; Dort J, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/4761427; Forbes SJ, 2014, NAT MED, V20, P857, DOI 10.1038/nm.3653; Giannakis N, 2019, NAT IMMUNOL, V20, P626, DOI 10.1038/s41590-019-0356-7; Gilicze AB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/870267; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kharraz Y, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/491497; Lerner L, 2015, J CACHEXIA SARCOPENI, V6, P317, DOI 10.1002/jcsm.12033; Li GH, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.479; Li M, 2017, GUT, V66, P705, DOI 10.1136/gutjnl-2016-311861; Madaro L, 2018, NAT CELL BIOL, V20, P917, DOI 10.1038/s41556-018-0151-y; Miller A, 2017, ONCOGENE, V36, P3059, DOI 10.1038/onc.2016.437; Mok GF, 2017, SEMIN CELL DEV BIOL, V72, P67, DOI 10.1016/j.semcdb.2017.10.032; Mounier R, 2013, CELL METAB, V18, P251, DOI 10.1016/j.cmet.2013.06.017; Munoz-Canoves P, 2013, FEBS J, V280, P4131, DOI 10.1111/febs.12338; Neudecker V, 2017, J EXP MED, V214, P1737, DOI 10.1084/jem.20160462; Nie M, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.165; Perdiguero E, 2011, J CELL BIOL, V195, P307, DOI 10.1083/jcb.201104053; Perry TE, 2009, CARDIOVASC RES, V84, P317, DOI 10.1093/cvr/cvp215; Sciorati C, 2016, CELL DEATH DIFFER, V23, P927, DOI 10.1038/cdd.2015.171; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Steensberg A, 2001, J PHYSIOL-LONDON, V537, P633, DOI 10.1111/j.1469-7793.2001.00633.x; Tidball JG, 2017, NAT REV IMMUNOL, V17, P165, DOI 10.1038/nri.2016.150; Tidball JG, 2014, DEVELOPMENT, V141, P1184, DOI 10.1242/dev.098285; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Torres LFC, 2019, ATHEROSCLEROSIS, V286, P20, DOI 10.1016/j.atherosclerosis.2019.04.227; Tsujinaka T, 1996, J CLIN INVEST, V97, P244, DOI 10.1172/JCI118398; Ulbing M, 2017, BONE, V95, P115, DOI 10.1016/j.bone.2016.11.016; Ying W, 2015, J CLIN INVEST, V125, P4149, DOI 10.1172/JCI81656; Yuan XY, 2018, J LEUKOCYTE BIOL, V104, P515, DOI 10.1002/JLB.3MR0218-079R; Zhang CC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01526-z; Zhang CC, 2013, J BIOL CHEM, V288, P1489, DOI 10.1074/jbc.M112.419788; Zhang J, 2019, J BIOL CHEM, V294, P15672, DOI 10.1074/jbc.RA119.008795; Zhao Y, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8090988; Zhuang GQ, 2012, CIRCULATION, V125, P2892, DOI 10.1161/CIRCULATIONAHA.111.087817	41	24	24	2	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2020	295	30					10212	10223		10.1074/jbc.RA119.012263	http://dx.doi.org/10.1074/jbc.RA119.012263			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MW0BV	32493731	Green Published, hybrid			2022-12-26	WOS:000556713400010
J	Walker, KW; Foltz, IN; Wang, TN; Salimi-Moosavi, H; Bailis, JM; Lee, F; An, P; Smith, S; Bruno, R; Wang, ZL				Walker, Kenneth W.; Foltz, Ian N.; Wang, Tina; Salimi-Moosavi, Hossein; Bailis, Julie M.; Lee, Fei; An, Phillip; Smith, Stephen; Bruno, Richele; Wang, Zhulun			The serum protein transthyretin as a platform for dimerization and tetramerization of antibodies and Fab fragments to enable target clustering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; Fab; transthyretin; engineering; dimer; tetramer; target; clustering; tetravalent; octavalent; antibody engineering; dimerization; pharmacokinetics cancer; cancer therapy; protein engineering; target clustering; tetramerization	DEATH RECEPTOR 5; MONOCLONAL-ANTIBODIES; AGONIST ANTIBODY; AMG 655; CONATUMUMAB; APOPTOSIS; IGM; TRANSPORT; CANCER; INTERNALIZATION	Transthyretin (TTR) is an abundant homotetrameric serum protein and was selected here for engineering higher-valency molecules because of its compact size, simple structure, and natural propensity to tetramerize. To demonstrate this utility, we fused TTR to the C terminus of conatumumab, an antibody that targets tumor necrosis factor?related apoptosis-inducing ligand receptor 2, as heavy chains to form antibody dimers and Fab heavy chains to form Fab tetramers. Moreover, we used constant heavy domain 3 heterodimerization substitutions to create TTR-mediated conatumumab tetramers. The conatumumab?TTR fusions displayed substantially enhanced potency in cell-based assays, as well as in murine tumor xenograft models. We conclude that antibody?TTR fusions may provide a powerful platform for multimerizing antibody and Fab fragments to enhance the capabilities of human therapeutics that benefit from target clustering and higher-order antigen-binding valency.	[Walker, Kenneth W.; Salimi-Moosavi, Hossein; An, Phillip; Smith, Stephen; Bruno, Richele] Amgen Inc, Amgen Res, Thousand Oaks, CA 91320 USA; [Foltz, Ian N.; Wang, Tina] Amgen British Columbia, Amgen Res, Burnaby, BC, Canada; [Bailis, Julie M.; Lee, Fei; Wang, Zhulun] Amgen Inc, Amgen Res, San Francisco, CA USA	Amgen; Amgen	Walker, KW (corresponding author), Amgen Inc, Amgen Res, Thousand Oaks, CA 91320 USA.	kennethw@amgen.com						Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Baxendale HE, 2008, CLIN EXP IMMUNOL, V151, P51, DOI 10.1111/j.1365-2249.2007.03535.x; BLANER WS, 1989, ENDOCR REV, V10, P308, DOI 10.1210/edrv-10-3-308; CHANOINE JP, 1992, ENDOCRINOLOGY, V130, P933, DOI 10.1210/en.130.2.933; Chuntharapai A, 2001, J IMMUNOL, V166, P4891, DOI 10.4049/jimmunol.166.8.4891; Connors LH, 2003, AMYLOID, V10, P160, DOI 10.3109/13506120308998998; de Jong RN, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002344; Dubuisson A, 2017, ANTIBODIES, V6, DOI 10.3390/antib6040016; EPISKOPOU V, 1993, P NATL ACAD SCI USA, V90, P2375, DOI 10.1073/pnas.90.6.2375; Fleming CE, 2009, PROG NEUROBIOL, V89, P266, DOI 10.1016/j.pneurobio.2009.07.007; Florio M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11505; Graves JD, 2014, CANCER CELL, V26, P177, DOI 10.1016/j.ccr.2014.04.028; Hammarstrom P, 2001, BIOCHEMISTRY-US, V40, P11453, DOI 10.1021/bi010673+; Hanala Sherif, 2012, MAbs, V4, P555, DOI 10.4161/mabs.21449; Herbst RS, 2010, CLIN CANCER RES, V16, P5883, DOI 10.1158/1078-0432.CCR-10-0631; Hofmeister JK, 2000, BLOOD CELL MOL DIS, V26, P133, DOI 10.1006/bcmd.2000.0287; Jefferis R, 2012, WOODH PUB SER BIOMED, P197; Johnson SM, 2012, J MOL BIOL, V421, P185, DOI 10.1016/j.jmb.2011.12.060; Jones Peter C., 2016, Critical Reviews in Oncogenesis, V21, P75, DOI 10.1615/CritRevOncog.2016016881; Kaetzel CS, 2005, IMMUNOL REV, V206, P83, DOI 10.1111/j.0105-2896.2005.00278.x; Kaplan-Lefko PJ, 2010, CANCER BIOL THER, V9, P618, DOI 10.4161/cbt.9.8.11264; Kaveri SV, 2012, J IMMUNOL, V188, P939, DOI 10.4049/jimmunol.1102107; Kindler HL, 2012, ANN ONCOL, V23, P2834, DOI 10.1093/annonc/mds142; Krishna M, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00021; Liu FT, 2015, BIOMED PHARMACOTHER, V70, P41, DOI 10.1016/j.biopha.2014.12.024; Liz MA, 2010, IUBMB LIFE, V62, P429, DOI 10.1002/iub.340; Mader A, 2013, ABB, V4, P38; Marshall MJE, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01245; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Nazarian AA, 2015, J BIOMOL SCREEN, V20, P519, DOI 10.1177/1087057114561405; Niraula TN, 2002, J MOL BIOL, V320, P333, DOI 10.1016/S0022-2836(02)00425-4; Obici L, 2014, EXPERT OPIN INV DRUG, V23, P1239, DOI 10.1517/13543784.2014.922541; Odani-Kawabata N, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-221; PALHA JA, 1994, J BIOL CHEM, V269, P33135; Palha JA, 2002, CLIN CHEM LAB MED, V40, P1292, DOI 10.1515/CCLM.2002.223; Papadopoulos KP, 2015, CANCER CHEMOTH PHARM, V75, P887, DOI 10.1007/s00280-015-2712-0; Paz-Ares L, 2013, J THORAC ONCOL, V8, P329, DOI 10.1097/JTO.0b013e31827ce554; Pedersen MW, 2010, CANCER RES, V70, P588, DOI 10.1158/0008-5472.CAN-09-1417; Pirko I, 2004, FASEB J, V18, P1577, DOI 10.1096/fj.04-2026fje; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Reichert JM, 2006, NAT REV DRUG DISCOV, V5, P191, DOI 10.1038/nrd1987; Schneider H, 2019, CHEMBIOCHEM, V20, P3006, DOI 10.1002/cbic.201900251; Shen CG, 2019, THERANOSTICS, V9, P210, DOI 10.7150/thno.28434; SJOBRING U, 1991, J BIOL CHEM, V266, P399; SOPRANO DR, 1985, J BIOL CHEM, V260, P1793; Sousa JC, 2007, NEUROBIOL AGING, V28, P713, DOI 10.1016/j.neurobiolaging.2006.03.015; Szymanska M, 2016, J CELL MOL MED, V20, P1999, DOI 10.1111/jcmm.12899; Terp MG, 2013, J IMMUNOL, V191, P4165, DOI 10.4049/jimmunol.1301274; Vollmers H. Peter, 2002, Human Antibodies, V11, P131; Walker KW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217061; Warrington AE, 2007, J NEUROSCI RES, V85, P967, DOI 10.1002/jnr.21217; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wilson NS, 2011, CANCER CELL, V19, P101, DOI 10.1016/j.ccr.2010.11.012; Wycoff KL, 2005, CURR PHARM DESIGN, V11, P2429, DOI 10.2174/1381612054367508; Yang YL, 2019, MABS-AUSTIN, V11, P996, DOI 10.1080/19420862.2019.1625662; Zhang QH, 2003, BIOCHEMISTRY-US, V42, P8756, DOI 10.1021/bi030077a	56	1	1	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2020	295	30					10446	10455		10.1074/jbc.RA120.013135	http://dx.doi.org/10.1074/jbc.RA120.013135			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MW0BV	32518163	Green Published, hybrid			2022-12-26	WOS:000556713400026
J	Islam, MZ; Arifuzzaman, M; Banik, S; Hossain, MA; Ferdous, J; Khalequzzaman, M; Pittendrigh, BR; Tomita, M; Ali, MP				Islam, M. Z.; Arifuzzaman, M.; Banik, S.; Hossain, M. A.; Ferdous, J.; Khalequzzaman, M.; Pittendrigh, B. R.; Tomita, M.; Ali, M. P.			Mapping QTLs underpin nutrition components in aromatic rice germplasm	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; STAGE DROUGHT STRESS; GRAIN-YIELD; GENETIC DIVERSITY; IDENTIFICATION; ENVIRONMENT; SELECTION; ELEMENTS; IRON	As rice is an important staple food globally, research for development and enhancement of its nutritional value it is an imperative task. Identification of nutrient enriched rice germplasm and exploiting them for breeding programme is the easiest way to develop better quality rice. In this study, we analyzed 113 aromatic rice germplasm in order to identify quantitative trait loci (QTL) underpinning nutrition components and determined by measuring the normal frequency distribution for Fe, Zn, amylose, and protein content in those rice germplasm. Comparatively, the germplasm Radhuni pagal, Kalobakri, Thakurbhog (26.6 ppm) and Hatisail exhibited the highest mean values for Fe (16.9 ppm), Zn (34.1 ppm), amylose (26.6 ppm) and protein content (11.0 ppm), respectively. Moreover, a significant linear relationship (R-2= 0.693) was observed between Fe and Zn contents. Cluster analysis based on Mahalanobis D(2)distances revealed four major clusters of 113 rice germplasm, with cluster III containing a maximum 37 germplasm and a maximum inter-cluster distance between clusters III and IV. The 45 polymorphic SSRs and four trait associations exhibited eight significant quantitative trait loci (QTL) located on eight different chromosomes using composite interval mapping (CIM). The highly significant QTL (variance 7.89%, LOD 2.02) for protein content (QTL.pro.1) was observed on chromosome 1 at 94.9cM position. Also, four QTLs for amylose content were observed with the highly significantQTL.amy.8located on chromosome 8 exhibiting 7.2% variance with LOD 1.83. Only one QTL (QTL.Fe.9) for Fe content was located on chromosome 9 (LOD 1.24), and two (QTL.Zn.4andQTL.Zn.5) for Zn on chromosome 4 (LOD 1.71) and 5 (LOD 1.18), respectively. Overall, germplasm from clusters III and IV might offer higher heterotic response with the identified QTLs playing a significant role in any rice biofortification breeding program and released with development of new varieties.	[Islam, M. Z.; Khalequzzaman, M.] Bangladesh Rice Res Inst BRRI, Genet Resources & Seed Div, Gazipur, Bangladesh; [Arifuzzaman, M.] Hajee Mohammad Danesh Sci & Technol Univ, Dept Genet & Plant Breeding, Dinajpur, Bangladesh; [Banik, S.] Bangladesh Rice Res Inst BRRI, Grain Qual & Nutr Div, Gazipur, Bangladesh; [Hossain, M. A.] Bangladesh Rice Res Inst, Reg Stn, Gazipur, Bangladesh; [Ferdous, J.] Bangladesh Rice Res Inst BRRI, Biotechnol Div, Gazipur, Bangladesh; [Pittendrigh, B. R.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Tomita, M.] Shizuoka Univ, Res Inst Green Sci & Technol, Green Biol Res Div, Genet & Genome Engn Lab, Shizuoka, Shizuoka, Japan; [Ali, M. P.] Bangladesh Rice Res Inst BRRI, Entomolgy Div, Gazipur, Bangladesh	Bangladesh Rice Research Institute (BRRI); Bangladesh Rice Research Institute (BRRI); Bangladesh Rice Research Institute (BRRI); Bangladesh Rice Research Institute (BRRI); Michigan State University; Shizuoka University; Bangladesh Rice Research Institute (BRRI)	Islam, MZ (corresponding author), Bangladesh Rice Res Inst BRRI, Genet Resources & Seed Div, Gazipur, Bangladesh.; Tomita, M (corresponding author), Shizuoka Univ, Res Inst Green Sci & Technol, Green Biol Res Div, Genet & Genome Engn Lab, Shizuoka, Shizuoka, Japan.; Ali, MP (corresponding author), Bangladesh Rice Res Inst BRRI, Entomolgy Div, Gazipur, Bangladesh.	zahid.grs@gmail.com; tomita.montonori@shizuoka.ac.jp; panna_ali@yahoo.com	Tomita, Motonori/ABF-2683-2020; ALI, PANNA/P-1625-2017; Arifuzzaman, Md/ABF-6399-2021	Tomita, Motonori/0000-0003-1466-023X; ALI, PANNA/0000-0001-8197-7064; Arifuzzaman, Md/0000-0003-2786-8339	National Agricultural Technology Project (NATP): Phase-1 in Bangladesh; Bangladesh Agricultural Research Council (BARC), Farmgate, Dhaka [12]	National Agricultural Technology Project (NATP): Phase-1 in Bangladesh; Bangladesh Agricultural Research Council (BARC), Farmgate, Dhaka	National Agricultural Technology Project (NATP): Phase-1 in Bangladesh. Financed by Bangladesh Agricultural Research Council (BARC), Farmgate, Dhaka. Grant No. 12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.". Lead author MZ Islam received fellowship from this grant. M. Khalequzzaman received project award". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadikhah A, 2008, INT J PLANT PROD, V2, P297; Akond Z, 2019, BIOINFORMATION, V15, P90, DOI 10.6026/97320630015090; [Anonymous], 2014, INT J MATH SCI, V2014, P9; [Anonymous], 2018, CANC DISCOV, V8, pOF6; [Anonymous], 1995, METHODS ANAL; [Anonymous], 2016, THE TOTAL AUDIENCE R; [Anonymous], 2004, FLORIDA STATUTES, V25; Bernier J, 2007, CROP SCI, V47, P507, DOI 10.2135/cropsci2006.07.0495; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Bouis HE, 2003, P NUTR SOC, V62, P403, DOI 10.1079/PNS2003262; Bouis HE, 2010, CROP SCI, V50, pS20, DOI 10.2135/cropsci2009.09.0531; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Charles B., 1997, PERKIN ELMER CORP, V3, P2; CHURCHILL GA, 1994, GENETICS, V138, P963; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Courtois B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078037; Gande N. K., 2014, African Journal of Biotechnology, V13, P657; Ghimire KH, 2012, FIELD CROP RES, V131, P88, DOI 10.1016/j.fcr.2012.02.028; Gramene, GRAM PORT 2017; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HarvestPlus, 2014, BIOF PROGR BRIEFS 20; Heffelfinger C, 2017, BIOINFORMATICS, V33, P2224, DOI 10.1093/bioinformatics/btx177; Islam M. Z., 2013, ECO FRIENDLY AGRIL J, V6, P243; JULIANO BO, 1971, CEREAL SCI TODAY, V16, P334; Kumar A, 2014, J EXP BOT, V65, P6265, DOI 10.1093/jxb/eru363; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Nordborg M, 2002, TRENDS GENET, V18, P83, DOI 10.1016/S0168-9525(02)02557-X; Norton GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089685; Palanog AD, 2014, FIELD CROP RES, V161, P46, DOI 10.1016/j.fcr.2014.01.004; Pandian SS, 2011, AUST J CROP SCI, V5, P1737; Prasad AS, 2004, MET IONS BIOL SYST, V41, P103; R Core Team, 2019, R LANGUAGE ENV STAT; RAO A V, 1981, Indian Journal of Genetics and Plant Breeding, V41, P179; Rohlf F.J., 2002, NTSYS PC NUMERICAL T; Sabar M, 2019, BREEDING SCI, V69, P169, DOI 10.1270/jsbbs.18068; Semba RD, 2012, J NUTR, V142, p143S, DOI 10.3945/jn.110.137745; Shahidullah SM, 2009, AFR J BIOTECHNOL, V8, P1238; Singh R. K., 2000, P107; SINGH S K, 1987, Indian Journal of Genetics and Plant Breeding, V47, P11; Stangoulis J, 2010, 19 WORLD C SOIL SCI; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; Suwarto, 2011, RICE SCI, V18, P75, DOI 10.1016/S1672-6308(11)60011-5; Swamy BPM, 2016, RICE, V9, DOI 10.1186/s12284-016-0122-5; Swamy BPM, 2011, RICE SCI, V18, P178, DOI 10.1016/S1672-6308(11)60025-5; Swamy T, 2012, WOODHEAD PUBL SER EN, P149; Venuprasad R, 2009, EUPHYTICA, V167, P261, DOI 10.1007/s10681-009-9898-3; Vikram P, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-89; Wang XQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17347-5; Wessells KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050568; White PJ, 2005, TRENDS PLANT SCI, V10, P586, DOI 10.1016/j.tplants.2005.10.001; ZENG ZB, 1994, GENETICS, V136, P1457; Zheng K., 1995, IRRI DISCUSSION PAPE	59	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234395	10.1371/journal.pone.0234395	http://dx.doi.org/10.1371/journal.pone.0234395			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525930	gold, Green Published			2022-12-26	WOS:000542036800020
J	Li, BR; Dai, C; Wang, LJ; Deng, HL; Li, YY; Guan, Z; Ni, HH				Li, Bingrui; Dai, Chan; Wang, Lijun; Deng, Hailong; Li, Yingying; Guan, Zheng; Ni, Haihong			A novel drug repurposing approach for non-small cell lung cancer using deep learning	PLOS ONE			English	Article							GENE-EXPRESSION; SIMILARITY; ALGORITHM	Drug repurposing is an attractive and pragmatic way offering reduced risks and development time in the complicated process of drug discovery. In the past, drug repurposing has been largely accidental and serendipitous. The most successful examples so far have not involved a systematic approach. Nowadays, remarkable advances in drugs, diseases and bioinformatic knowledge are offering great opportunities for designing novel drug repurposing approach through comprehensive understanding of drug information. In this study, we introduced a novel drug repurposing approach based on transcriptomic data and chemical structures using deep learning. One strong candidate for repurposing has been identified. Pimozide is an anti-dyskinesia agent that is used for the suppression of motor and phonic tics in patients with Tourette's Disorder. However, our pipeline proposed it as a strong candidate for treating non-small cell lung cancer. The cytotoxicity of pimozide against A549 cell lines has been validated.	[Li, Bingrui; Dai, Chan; Wang, Lijun; Deng, Hailong; Li, Yingying; Guan, Zheng; Ni, Haihong] Beijing Deep Intelligent Pharma Technol Co Ltd, Beijing, Peoples R China		Li, YY; Guan, Z; Ni, HH (corresponding author), Beijing Deep Intelligent Pharma Technol Co Ltd, Beijing, Peoples R China.	yyli285@iccas.ac.cn; guanzheng828@hotmail.com; nihaihong@dip-ai.com		Li, Yingying/0000-0001-8675-8151	Beijing Deep Intelligent Pharma Technologies Co., Ltd.	Beijing Deep Intelligent Pharma Technologies Co., Ltd.	Beijing Deep Intelligent Pharma Technologies Co., Ltd. provided support for this study in the form of salaries for authors: BRL, CD, LJW, HLD, ZG, YYL, and HNN. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aliper A, 2016, MOL PHARMACEUT, V13, P2524, DOI 10.1021/acs.molpharmaceut.6b00248; Ankerst M, 1999, SIGMOD RECORD, VOL 28, NO 2 - JUNE 1999, P49; [Anonymous], 2015, NUCLEIC ACIDS RES, V43, pD204; Aoki K, 2007, PLANT CELL PHYSIOL, V48, P381, DOI 10.1093/pcp/pcm013; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Bajusz D, 2015, J CHEMINFORMATICS, V7, DOI 10.1186/s13321-015-0069-3; BLUM AL, 1992, NEURAL NETWORKS, V5, P117, DOI 10.1016/S0893-6080(05)80010-3; Brambilla E, 2009, EUR RESPIR J, V33, P1485, DOI 10.1183/09031936.00014009; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Chen WQ, 2015, THORAC CANCER, V6, P209, DOI 10.1111/1759-7714.12169; Fortney K, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004068; Glorot X., 2010, P 13 INT C ARTIFICIA, V9, P249, DOI DOI 10.1.1/207.2059; Goncalves JM, 2019, CLIN EXP PHARMACOL P, V46, P116, DOI 10.1111/1440-1681.13049; Hira Zena M., 2015, Advances in Bioinformatics, V2015, P198363, DOI 10.1155/2015/198363; Hodos RA, 2016, WIRES SYST BIOL MED, V8, P186, DOI 10.1002/wsbm.1337; Iskar M, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.20; Jung M, 2009, EUR J MED CHEM, V44, P3120, DOI 10.1016/j.ejmech.2009.03.007; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Kutalik Z, 2008, NAT BIOTECHNOL, V26, P531, DOI 10.1038/nbt1397; Maggiora G, 2014, J MED CHEM, V57, P3186, DOI 10.1021/jm401411z; Moridi M, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-3165-y; Nair V., 2010, ICML; Obayashi T, 2019, NUCLEIC ACIDS RES, V47, pD55, DOI 10.1093/nar/gky1155; Oprea TI, 2015, ASSAY DRUG DEV TECHN, V13, P299, DOI 10.1089/adt.2015.29011.tiodrrr; Pammolli F, 2011, NAT REV DRUG DISCOV, V10, P428, DOI 10.1038/nrd3405; Pantziarka P, 2016, ECANCERMEDICALSCIENC, V10, DOI 10.3332/ecancer.2016.680; Patterson DE, NEIGHBORHOOD BEHAV U, P0022; Proudfoot JR, 2002, BIOORG MED CHEM LETT, V12, P1647, DOI 10.1016/S0960-894X(02)00244-5; Pushpakom S, 2019, NAT REV DRUG DISCOV, V18, P41, DOI 10.1038/nrd.2018.168; Radi M, 2007, J MED CHEM, V50, P2249, DOI 10.1021/jm0612923; RUBINSTEIN LV, 1990, J NATL CANCER I, V82, P1113, DOI 10.1093/jnci/82.13.1113; Rung J, 2013, NAT REV GENET, V14, P89, DOI 10.1038/nrg3394; Shabana KM, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S17-S5; Skinnider MA, 2017, J CHEMINFORMATICS, V9, DOI 10.1186/s13321-017-0234-y; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sukhatme V, 2015, ECANCERMEDICALSCIENC, V9, DOI 10.3332/ecancer.2015.568; Toschi L, 2005, Future Oncol, V1, P7, DOI 10.1517/14796694.1.1.7; Wager S, 2018, J AM STAT ASSOC, V113, P1228, DOI 10.1080/01621459.2017.1319839; Wermuth CG, 2006, DRUG DISCOV TODAY, V11, P348, DOI 10.1016/j.drudis.2006.02.006; Wu Z, 2012, 2012 IEEE 6 INT C SY; Xue HQ, 2018, INT J BIOL SCI, V14, P1232, DOI 10.7150/ijbs.24612; Zeng XX, 2019, BIOINFORMATICS, V35, P5191, DOI 10.1093/bioinformatics/btz418; Zhang JD, 2009, BIOINFORMATICS, V25, P1470, DOI 10.1093/bioinformatics/btp167; Zhang T, 1997, DATA MIN KNOWL DISC, V1, P141, DOI 10.1023/A:1009783824328; Zhao K, 2019, METHODS MOL BIOL, V1903, P219, DOI 10.1007/978-1-4939-8955-3_13; Zhavoronkov A, 2019, AGEING RES REV, V49, P49, DOI 10.1016/j.arr.2018.11.003	47	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0233112	10.1371/journal.pone.0233112	http://dx.doi.org/10.1371/journal.pone.0233112			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525938	gold, Green Published			2022-12-26	WOS:000542036800041
J	Sae-Lee, C; De Biasi, J; Robinson, N; Barrow, TM; Mathers, JC; Koutsidis, G; Byun, HM				Sae-Lee, Chanachai; De Biasi, Julien; Robinson, Natassia; Barrow, Timothy M.; Mathers, John C.; Koutsidis, Georgios; Byun, Hyang-Min			DNA methylation patterns of LINE-1 and Alu for pre-symptomatic dementia in type 2 diabetes	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; COGNITIVE IMPAIRMENT; ACID SUPPLEMENTATION; PROTEIN-KINASE; INCREASED RISK; HUMAN GENOME; HOMOCYSTEINE; FOLATE; BLOOD; GENE	The identification of early markers of dementia is important for higher-risk populations such as those with type 2 diabetes (T2D). Retrotransposons, including long interspersed nuclear element 1 (LINE-1) andAlu, comprise similar to 40% of the human genome. Although dysregulation of these retrotransposons can induce aberrant gene regulation and genomic instability, their role in the development of pre-symptomatic dementia (PSD) among T2D patients is unknown. Here, we examined locus-specific changes in LINE-1 andAlumethylation in PSD and the potential to offset these changes via supplementation with folate and vitamin B-12. We interrogated DNA methylation patterns corresponding to 22,352 probes for LINE-1 andAluelements using publicly-available Illumina Infinium 450K methylation datasets from i) an 18-month prospective study in 28 T2D patients (GSE62003) and ii) an intervention study in which 44 individuals were supplemented with folic acid (400 mu g/day) and vitamin B-12(500 mu g/day) over two years (GSE74548). We identified 714 differentially methylated positions (DMP) mapping to retrotransposons in T2D patients who developed PSD in comparison to those who did not (P-FDR< 0.05), comprised of 2.4% (228 probes) of all LINE-1 probes and 3.8% (486 probes) of allAluprobes. These loci were enriched in genes with functions related to Alzheimer's disease and cognitive decline, includingGNB5,GNG7andPKN3(p < 0.05). In older individuals supplemented with folate/vitamin B-12, 85 (11.9%) PSD retrotransposon loci showed significant changes in methylation (p < 0.05): participants with theMTHFRCC genotype predominantly showed hypermethylation at these loci, while hypomethylation was observed more frequently in those with the TT genotype. In T2D patients, LINE-1 andAluelements are differentially methylated in PSD in a locus-specific manner and may offer clinical utility in monitoring risk of dementia. Further work is required to examine the potential for dietary supplementation in lowering the risk of PSD.	[Sae-Lee, Chanachai; Mathers, John C.; Byun, Hyang-Min] Newcastle Univ, Populat Hlth Sci Inst, Newcastle Upon Tyne, Tyne & Wear, England; [Sae-Lee, Chanachai] Mahidol Univ, Siriraj Hosp, Fac Med, Res Div, Bangkok, Thailand; [De Biasi, Julien; Koutsidis, Georgios] Northumbria Univ, Fac Hlth & Life Sci, Dept Appl Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Robinson, Natassia] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England; [Barrow, Timothy M.] Univ Sunderland, Fac Hlth Sci & Wellbeing, Sunderland, England	Newcastle University - UK; Mahidol University; Northumbria University; Newcastle University - UK; University of Sunderland	Sae-Lee, C (corresponding author), Newcastle Univ, Populat Hlth Sci Inst, Newcastle Upon Tyne, Tyne & Wear, England.; Sae-Lee, C (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Res Div, Bangkok, Thailand.	c.sae-lee2@ncl.ac.uk	Byun, Hyang-Min/X-2843-2018	Byun, Hyang-Min/0000-0002-6278-3165; Robinson, Natassia/0000-0001-8408-101X; Barrow, Timothy/0000-0003-4551-3857; Sae-Lee, Chanachai/0000-0001-7758-7653				Awad N, 2004, J CLIN EXP NEUROPSYC, V26, P1044, DOI 10.1080/13803390490514875; Ayarpadikannan Selvam, 2014, Genomics & Informatics, V12, P98, DOI 10.5808/GI.2014.12.3.98; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Barrow TM, 2021, HAEMATOLOGICA, V106, P98, DOI 10.3324/haematol.2019.228478; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Beeri MS, 2014, ALZHEIMERS DEMENT, V10, P769, DOI 10.1016/j.jalz.2014.06.002; Bernstein I, 2010, EPIGENETICS-US, V5, P750, DOI 10.4161/epi.5.8.13105; Brands AMA, 2005, DIABETES CARE, V28, P726, DOI 10.2337/diacare.28.3.726; Byun HM, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003218; Byun HM, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-28; Byun HM, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-13; Byun HM, 2009, HUM MOL GENET, V18, P4808, DOI 10.1093/hmg/ddp445; Choi SH, 2009, INT J CANCER, V125, P723, DOI 10.1002/ijc.24384; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Corsi S, 2020, CLIN EPIGENETICS, V12, DOI 10.1186/s13148-020-00825-5; Daskalos A, 2009, INT J CANCER, V124, P81, DOI 10.1002/ijc.23849; de la Monte Suzanne M, 2008, J Diabetes Sci Technol, V2, P1101; Deininger P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-236; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1422, DOI 10.1001/archneur.57.10.1422; Duncan TM, 2013, MOL NUTR FOOD RES, V57, P628, DOI 10.1002/mnfr.201200125; Erichsen L, 2018, SAUDI J BIOL SCI, V25, P1220, DOI 10.1016/j.sjbs.2018.02.005; Erwin JA, 2016, NAT NEUROSCI, V19, P1583, DOI 10.1038/nn.4388; Faeh D, 2006, SWISS MED WKLY, V136, P745; Fransquet PD, 2018, ALZHEIMERS DEMENT, V14, P81, DOI 10.1016/j.jalz.2017.10.002; Frappart PO, 2008, DNA REPAIR, V7, P1051, DOI 10.1016/j.dnarep.2008.03.007; Guo CW, 2018, CELL REP, V23, P2874, DOI 10.1016/j.celrep.2018.05.004; Guo LQ, 2017, ENVIRON RES, V153, P73, DOI 10.1016/j.envres.2016.11.017; Hankey GJ, 1999, LANCET, V354, P407, DOI 10.1016/S0140-6736(98)11058-9; Janson J, 2004, DIABETES, V53, P474, DOI 10.2337/diabetes.53.2.474; Jimenez-Garza O, 2017, FOOD CHEM TOXICOL, V109, P669, DOI 10.1016/j.fct.2017.08.019; JONES PA, 1986, CANCER RES, V46, P461; Kawamata T, 1998, J NEUROSCI, V18, P7402; Kines KJ, 2012, FRONT BIOSCI-LANDMRK, V17, P1329, DOI 10.2741/3990; Koestler DC, 2012, CANCER EPIDEM BIOMAR, V21, P1293, DOI 10.1158/1055-9965.EPI-12-0361; Kok DEG, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0154-5; Konkel MK, 2015, GENOME BIOL EVOL, V7, P2608, DOI 10.1093/gbe/evv167; Kovalska M, 2018, NEUROCHEM RES, V43, P1766, DOI 10.1007/s11064-018-2592-x; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lardenoije R, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0755-5; Larsen PA, 2018, CHROMOSOME RES, V26, P93, DOI 10.1007/s10577-018-9573-4; Leenders F, 2004, EMBO J, V23, P3303, DOI 10.1038/sj.emboj.7600345; Lisanti S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079044; Lunnon K, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2014.12.023; Malinow MR, 1997, ARTERIOSCL THROM VAS, V17, P1157, DOI 10.1161/01.ATV.17.6.1157; Mandal PK, 2013, HUM MOL GENET, V22, P3730, DOI 10.1093/hmg/ddt225; Marsit C, 2013, ADV EXP MED BIOL, V754, P233, DOI 10.1007/978-1-4419-9967-2_12; Medstrand P, 2002, GENOME RES, V12, P1483, DOI 10.1101/gr.388902; Meneilly GS, 2018, CAN J DIABETES, V42, P579, DOI 10.1016/j.jcjd.2018.10.006; Mills RE, 2007, TRENDS GENET, V23, P183, DOI 10.1016/j.tig.2007.02.006; Nelen WLDM, 1998, J NUTR, V128, P1336, DOI 10.1093/jn/128.8.1336; Niculescu MD, 2002, J NUTR, V132, p2333S, DOI 10.1093/jn/132.8.2333S; Ott A, 1999, NEUROLOGY, V53, P1937, DOI 10.1212/WNL.53.9.1937; Pirouzpanah S, 2015, J MOL MED, V93, P917, DOI 10.1007/s00109-015-1268-0; Pornthanakasem W, 2008, NUCLEIC ACIDS RES, V36, P3667, DOI 10.1093/nar/gkn261; Quadri P, 2004, AM J CLIN NUTR, V80, P114; Raut JR, 2019, CANCERS, V11, DOI 10.3390/cancers11070912; Richards KL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004941; Sae-Lee C, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201800092; Scarpa S, 2006, J ALZHEIMERS DIS, V9, P407; Schwindinger WF, 2003, J BIOL CHEM, V278, P6575, DOI 10.1074/jbc.M211132200; Shamseldin HE, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1061-6; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Shenoy V, 2014, INDIAN J CLIN BIOCHE, V29, P339, DOI 10.1007/s12291-013-0373-5; Stewart R, 1999, DIABETIC MED, V16, P93, DOI 10.1046/j.1464-5491.1999.00027.x; Strachan MWJ, 1997, DIABETES CARE, V20, P438, DOI 10.2337/diacare.20.3.438; Thauerer B, 2014, CURR NEUROPHARMACOL, V12, P213, DOI 10.2174/1570159X11666131225000518; van de Haar HJ, 2016, RADIOLOGY, V281, P527, DOI 10.1148/radiol.2016152244; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; van Wijngaarden JP, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-80; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wolff EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000917; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Zhang JH, 2011, J NEUROCHEM, V119, P544, DOI 10.1111/j.1471-4159.2011.07457.x; Zhang L, 2017, PAK J PHARM SCI, V30, P1445	74	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234578	10.1371/journal.pone.0234578	http://dx.doi.org/10.1371/journal.pone.0234578			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525932	Green Published, Green Accepted, gold			2022-12-26	WOS:000542036800055
J	Botham, JL; Haddad, CR; Gryzenhout, M; Swart, VR; Bredenhand, E				Botham, Jason L.; Haddad, Charles R.; Gryzenhout, Marieka; Swart, Vaughn R.; Bredenhand, Emile			High genetic diversity of spider species in a mosaic montane grassland landscape	PLOS ONE			English	Article							WATER CRABS DECAPODA; BALLOONING SPIDERS; AERIAL DISPERSAL; SITE SELECTION; FAUNISTIC DIVERSITY; SEQUENCE ALIGNMENT; ARACHNIDA ARANEAE; HABITAT STRUCTURE; SUBSOCIAL SPIDER; POPULATION	Gene flow and genetic variation were examined within and among populations of five of the most common spider species in shrublands of the mountainous Golden Gate Highlands National Park (GGHNP), South Africa. These species included three active hunters, Dendryphantes purcelli Peckham & Peckham, 1903 (Salticidae), Pherecydes tuberculatus O.P.-Cambridge, 1883 (Thomisidae) and Philodromus browningi Lawrence, 1952 (Philodromidae), and two web-builders, Neoscona subfusca (C.L. Koch, 1837) (Araneidae) and a Theridion Walckenaer, 1802 species (Theridiidae). A total of 249 spiders (57 D. purcelli, 69 N. subfusca, 34 P. browningi, 56 P. tuberculatus and 33 Theridion sp.) were collected and analysed from six shrubland localities in the park. Analyses of sequence variation of the mitochondrial cytochrome oxidase c subunit I (COI) gene for each species revealed relatively low nucleotide diversity (pi < 0.0420) but high genetic diversity (Hd > 0.6500) within populations for all species, except P. tuberculatus. Genetic differentiation was also noted to differ between species, with only P. tuberculatus indicating very large divergence (Fst > 0.2500). These results were reflected by gene flow, with D. purcelli, N. subfusca and the Theridion sp. estimated as experiencing more than one disperser per generation. Overall, highest gene flow was found in the two web-building species, indicating possible high dispersal ability of these spiders in the GGHNP. Additionally, constructed phylogenies indicated possible cryptic speciation occurring in the majority of the investigated species. Our current results indicate that the five investigated spider species were able to maintain gene flow between shrubland populations within the GGHNP to some degree, despite the mountainous landscape. However, further analyses incorporating additional molecular markers are needed to properly determine the extent of genetic diversity and gene flow of these species within the GGHNP.	[Botham, Jason L.; Haddad, Charles R.; Swart, Vaughn R.] Univ Free State, Dept Zool & Entomol, Bloemfontein, Free State, South Africa; [Gryzenhout, Marieka] Univ Free State, Dept Genet, Bloemfontein, Free State, South Africa; [Bredenhand, Emile] Univ Free State, Dept Zool & Entomol, Qwaqwa Campus, Phuthaditjhaba, Free State, South Africa	University of the Free State; University of the Free State; University of the Free State	Botham, JL (corresponding author), Univ Free State, Dept Zool & Entomol, Bloemfontein, Free State, South Africa.	jason.botham@yahoo.com		Gryzenhout, Marieka/0000-0002-9224-4277	Afromontane Research Unit; Masonic Charitable Foundation [LCAS94]	Afromontane Research Unit; Masonic Charitable Foundation	This study was funded by the Afromontane Research Unit (E.B.), with partial supplementation from the Masonic Charitable Foundation (J.L.B., Grant no. LCAS94). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06747-2; Agnarsson I, 2013, J EVOLUTION BIOL, V26, P27, DOI 10.1111/jeb.12022; Agnarsson I, 2010, MOL ECOL, V19, P3052, DOI 10.1111/j.1365-294X.2010.04681.x; Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; [Anonymous], 2016, NAT MATER, V15, P1, DOI 10.1038/nmat4533; [Anonymous], 2014, ED Manag, V26, P1; [Anonymous], 2015, URBAN RAPID RAIL TRA; Ashfaq M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217086; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bailly X, 2004, BIOL J LINN SOC, V82, P69, DOI 10.1111/j.1095-8312.2004.00316.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bell JR, 2005, B ENTOMOL RES, V95, P69, DOI 10.1079/BER2004350; Bertola LD, 2011, J BIOGEOGR, V38, P1356, DOI 10.1111/j.1365-2699.2011.02500.x; Bilde T, 2002, ANIM BEHAV, V64, P447, DOI 10.1006/anbe.2002.3076; Blandenier G., 1998, P177; Blandenier G, 2013, J ARACHNOL, V41, P126, DOI 10.1636/P12-48; Blandenier Gilles, 2009, Bulletin of the British Arachnological Society, V14, P308; Bond JE, 2001, MOL ECOL, V10, P899, DOI 10.1046/j.1365-294X.2001.01233.x; Bonte D, 2003, P ROY SOC B-BIOL SCI, V270, P1601, DOI 10.1098/rspb.2003.2432; Bonte D, 2004, ECOGRAPHY, V27, P343, DOI 10.1111/j.0906-7590.2004.03844.x; Brandt Y, 1998, ISR J ZOOL, V44, P201; Brown JH, 2001, OECOLOGIA, V126, P321, DOI 10.1007/s004420000536; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; Buskirk R.E., 1981, P281; Cambridge O. P., 1883, Proceedings of the Zoological Society, P352; Candek K, 2020, ZOOL SCR, V49, P210, DOI 10.1111/zsc.12405; CCDB, 2019, CCDB PROT; CCDB, 2019, CCDB PRIM SETS; Cho M, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004405; Clark DJ, 1977, ANN MUSEE ROYAL AFRI, V220, P87; COKENDOLPHER J C, 1979, Journal of the Kansas Entomological Society, V52, P723; Commission Decision, 2001, OFFICIAL J EUROPEAN, VL47, P1; Corcobado G, 2012, FUNCT ECOL, V26, P794, DOI 10.1111/j.1365-2435.2012.01996.x; Cumming MS, 2004, J ZOOL, V262, P1, DOI 10.1017/S0952836903004461; Daniels SR, 2003, BIOL J LINN SOC, V78, P129, DOI 10.1046/j.1095-8312.2003.00143.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DEAN DA, 1985, J ARACHNOL, V13, P111; Dippenaar-Schoeman A. S., 2006, Koedoe, V49, P85; Dippenaar-Schoeman A. S., 2010, 1 ATLAS SPIDERS S AF; Dippenaar-Schoeman Anna S., 2003, Koedoe, V46, P91; DIPPENAARSCHOEMAN AS, 1980, J ENTOMOL SOC S AFR, V43, P327; Duffey Eric, 1998, P187; Duncan SI, 2010, MOL ECOL, V19, P810, DOI 10.1111/j.1365-294X.2010.04523.x; Evans TA, 1997, AUST J ECOL, V22, P107, DOI 10.1111/j.1442-9993.1997.tb00646.x; Evans TA, 2002, MOL ECOL, V11, P2307, DOI 10.1046/j.1365-294X.2002.01623.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Follner K., 1995, P 15 EUR C AR, P66; Foord S. F., 2011, Transactions of the Royal Society of South Africa, V66, P170, DOI 10.1080/0035919X.2011.639406; Foord SH, 2011, CHANGING DIVERSITY IN CHANGING ENVIRONMENT, P163; Fourie R, 2013, KOEDOE, V55, DOI 10.4102/koedoe.v55i1.1113; Frankham R., 2002, INTRO CONSERVATION G, DOI 10.1017/CBO9780511808999; Franzini P. Z. N., 2013, INT J MODERN BIOL RE, V1, P21, DOI DOI 10.4102/SATNT.V31I1.339; Fraser DJ, 2004, MOL ECOL, V13, P67, DOI 10.1046/j.1365-294X.2003.02038.x; Galtier N, 2004, SYST BIOL, V53, P38, DOI 10.1080/10635150490264680; Garb JE, 2009, MOL ECOL, V18, P1746, DOI 10.1111/j.1365-294X.2009.04125.x; Gertsch W. J., 1939, Bulletin of the American Museum of Natural History, V76, P277; Gillespie Rosemary G., 1998, P41; Grab SW, 2011, KOEDOE, V53, DOI 10.4102/koedoe.v53i1.985; GRASSHOFF M, 1986, Koninklijk Museum voor Midden-Afrika Tervuren Belgie Annalen Zoologische Wetenschappen, V250, P1; Grasshoff M, 2007, FAUNA ARAB SER, V23, P151; GREENSTONE MH, 1990, OECOLOGIA, V84, P164, DOI 10.1007/BF00318267; GREENSTONE MH, 1987, J ARACHNOL, V15, P163; Grobler JP, 2003, BIOCHEM SYST ECOL, V31, P1023, DOI 10.1016/S0305-1978(03)00076-0; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haddad C. R., 2013, Transactions of the Royal Society of South Africa, V68, P97, DOI 10.1080/0035919X.2013.773267; Haddad CR, 2011, AFR INVERTEBR, V52, P51, DOI 10.5733/afin.052.0105; Hodge MA, 1997, ETHOLOGY, V103, P815; HOMANN H, 1975, Z MORPHOL TIERE, V80, P181; HUMPHREY JAC, 1987, OECOLOGIA, V73, P469, DOI 10.1007/BF00385267; Jackson ST, 2015, P NATL ACAD SCI USA, V112, P4915, DOI 10.1073/pnas.1403664111; Johannesen J, 1999, HEREDITY, V82, P677, DOI 10.1046/j.1365-2540.1999.00528.x; Johannesen J, 2012, BEHAV ECOL SOCIOBIOL, V66, P1387, DOI 10.1007/s00265-012-1394-4; Johannesen J, 2009, MOL ECOL, V18, P2812, DOI 10.1111/j.1365-294X.2009.04238.x; KASTON BJ, 1965, AM MIDL NAT, V73, P336, DOI 10.2307/2423458; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Keyghobadi N, 2007, CAN J ZOOL, V85, P1049, DOI 10.1139/Z07-095; Kruger AC, 2010, WIND STRUCT, V13, P37; Kuntner M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098907; Kuraku S, 2013, NUCLEIC ACIDS RES, V41, pW22, DOI 10.1093/nar/gkt389; Lachmuth S, 2010, MOL ECOL, V19, P3952, DOI 10.1111/j.1365-294X.2010.04797.x; Lagerholm VK, 2017, BIOL J LINN SOC, V121, P1, DOI 10.1093/biolinnean/blw020; Larrivee M, 2011, ECOL ENTOMOL, V36, P144, DOI 10.1111/j.1365-2311.2010.01255.x; LAWRENCE R. F., 1952, ANN NATAL MUS, V12, P183; Lee JW, 2004, ZOOL STUD, V43, P112; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; LEVI HERBERT W., 1962, BULL MUS COMP ZOOL HARVARD UNIV, V127, P1; Liu J, 2016, MOL PHYLOGENET EVOL, V94, P658, DOI 10.1016/j.ympev.2015.09.023; Lubin Y, 2007, ADV STUD BEHAV, V37, P83, DOI 10.1016/S0065-3454(07)37003-4; MADER HJ, 1984, BIOL CONSERV, V29, P81, DOI 10.1016/0006-3207(84)90015-6; Masta SE, 2000, EVOLUTION, V54, P1699; McNett BJ, 2000, ECOL ENTOMOL, V25, P423, DOI 10.1046/j.1365-2311.2000.00279.x; MORSE DH, 1992, J ARACHNOL, V20, P217; Mucina Ladislav, 2006, V19, P2; Murphy MA, 2010, MOL ECOL, V19, P3634, DOI 10.1111/j.1365-294X.2010.04723.x; Neethling Jan A., 2013, Transactions of the Royal Society of South Africa, V68, P123, DOI 10.1080/0035919X.2013.806374; Pagacz S, 2016, J MAMMAL, V97, P1164, DOI 10.1093/jmammal/gyw066; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Peckham GW, 1903, T WISC ACAD SCI, V14, P173; Peres EA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121543; Phiri EE, 2016, INVERTEBR SYST, V30, P60, DOI 10.1071/IS15035; PLAGENS MJ, 1986, ENVIRON ENTOMOL, V15, P1225, DOI 10.1093/ee/15.6.1225; Postiglioni R., 2019, SYST BIODIVERS, V17, P635, DOI [10.1080/14772000.2019.1689197, DOI 10.1080/14772000.2019.1689197]; Qiong L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172948; Ramirez MG, 1996, J ARACHNOL, V24, P1; Ramirez MG, 1999, HEREDITY, V83, P580, DOI 10.1038/sj.hdy.6885630; Reed DH, 2011, CONSERV GENET, V12, P331, DOI 10.1007/s10592-009-9995-9; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; RIECHERT SE, 1993, BEHAV ECOL SOCIOBIOL, V32, P355; ROFF DA, 1991, AM ZOOL, V31, P205; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Rubio G.D., 2018, SPECIES, V19, P117; Ruch J, 2009, BIOL J LINN SOC, V98, P851, DOI 10.1111/j.1095-8312.2009.01322.x; Rushton S.P., 1987, Bulletin of the British Arachnological Society, V7, P165; RUTTAN LM, 1990, BEHAV ECOL SOCIOBIOL, V27, P169, DOI 10.1007/BF00180300; Sanchez-Montes G, 2018, J BIOGEOGR, V45, P318, DOI 10.1111/jbi.13132; Schafer MA, 2001, HEREDITY, V86, P94, DOI 10.1046/j.1365-2540.2001.00815.x; SCHEIDLER M, 1990, ZOOL ANZ, V225, P333; Settepani V, 2014, J EVOLUTION BIOL, V27, P2850, DOI 10.1111/jeb.12520; Shochat E, 2004, ECOL APPL, V14, P268, DOI 10.1890/02-5341; Simon E., 1895, HIST NATURELLE ARAIG, V1, P761, DOI DOI 10.5962/BHL.TITLE.51973; SLATKIN M, 1989, EVOLUTION, V43, P1349, DOI 10.1111/j.1558-5646.1989.tb02587.x; Smith JM, 1999, EVOLUTIONARY GENETIC; South African National Parks (SANParks), 2013, GOLD GAT HIGHL NAT P; Tanikawa A, 2018, CONSERV GENET, V19, P255, DOI 10.1007/s10592-017-0996-9; Taru Phillip, 2013, S. Afr. j. sci., V109, P1; Tennessen JA, 2008, COPEIA, P558, DOI 10.1643/CG-06-038; TOLBERT W W, 1977, Psyche (Cambridge), V84, P13, DOI 10.1155/1977/52152; Vandergast AG, 2004, MOL ECOL, V13, P1729, DOI 10.1111/j.1365-294X.2004.02179.x; Vilchis-Nestor CA, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.9501; von der Heyden S, 2009, AFR J MAR SCI, V31, P263, DOI 10.2989/AJMS.2009.31.2.14.886; WADE MJ, 1988, EVOLUTION, V42, P995, DOI 10.1111/j.1558-5646.1988.tb02518.x; Walter A, 2005, J ARACHNOL, V33, P516, DOI 10.1636/04-78.1; Weiss KM, 2000, THEOR POPUL BIOL, V57, P187, DOI 10.1006/tpbi.2000.1460; WEYMAN GS, 1995, J ARACHNOL, V23, P75; WEYMAN GS, 1993, ETHOL ECOL EVOL, V5, P279, DOI 10.1080/08927014.1993.9523016; Williams Stephen E, 2008, PLoS Biol, V6, P2621, DOI 10.1371/journal.pbio.0060325; World Spider Catalog, 2019, WORLD SPIDER CATALOG; Zalewski A, 2009, MOL ECOL, V18, P1601, DOI 10.1111/j.1365-294X.2009.04131.x	138	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2020	15	6							e0234437	10.1371/journal.pone.0234437	http://dx.doi.org/10.1371/journal.pone.0234437			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ0RE	32511281	Green Published, gold			2022-12-26	WOS:000540938100008
J	Lin, RR; Zhan, M; Yang, LH; Wang, H; Shen, H; Huang, S; Huang, XC; Xu, SW; Zhang, ZJ; Li, WJ; Liu, Q; Shi, YS; Chen, W; Yu, JX; Wang, J				Lin, Ruirong; Zhan, Ming; Yang, Linhua; Wang, Hui; Shen, Hui; Huang, Shuai; Huang, Xince; Xu, Sunwang; Zhang, Zijie; Li, Weijian; Liu, Qiang; Shi, Yongsheng; Chen, Wei; Yu, Jianxiu; Wang, Jian			Deoxycholic acid modulates the progression of gallbladder cancer through N-6-methyladenosine-dependent microRNA maturation	ONCOGENE			English	Article							BILE-ACIDS; CHOLANGIOCYTE PROLIFERATION; NUCLEAR-RNA; MESSENGER; METABOLISM; APOPTOSIS; N6-METHYLADENOSINE; INFLAMMATION; ACTIVATION; ENDOCRINE	Bile acids (BAs), well-defined signaling molecules with diverse metabolic functions, play important roles in cellular processes associated with many cancers. As one of the most common BAs, deoxycholic acid (DCA) is originally synthesized in the liver, stored in the gallbladder, and processed in the gut. DCA plays crucial roles in various tumors; however, functions and molecular mechanisms of DCA in gallbladder cancer (GBC) still remain poorly characterized. Here, we analyzed human GBC samples and found that DCA was significantly downregulated in GBC, and reduced levels of DCA was associated with poor clinical outcome in patients with GBC. DCA treatment impeded tumor progression by halting cell proliferation. DCA decreased miR-92b-3p expression in an m(6)A-dependent posttranscriptional modification manner by facilitating dissociation of METTL3 from METTL3-METTL14-WTAP complex, which increased the protein level of the phosphatase and tensin homolog, a newly identified target of miR-92b-3p, and subsequently inactivated the PI3K/AKT signaling pathway. Our findings revealed that DCA might function as a tumor suppressive factor in GBC at least by interfering with miR-92b-3p maturation, and suggested that DCA treatment could provide a new therapeutic strategy for GBC.	[Lin, Ruirong; Zhan, Ming; Yang, Linhua; Wang, Hui; Shen, Hui; Huang, Shuai; Huang, Xince; Xu, Sunwang; Zhang, Zijie; Li, Weijian; Chen, Wei; Wang, Jian] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Biliary Pancreat Surg, Shanghai 200127, Peoples R China; [Liu, Qiang; Shi, Yongsheng] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Pathol, Shanghai 200127, Peoples R China; [Yu, Jianxiu] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Tumor Microenvironm & Inflammat, Dept Biochem & Mol Cell Biol, Shanghai 200025, Peoples R China; [Yu, Jianxiu; Wang, Jian] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Basic Clin Res Ctr, Shanghai 200127, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Biliary Pancreat Surg, Shanghai 200127, Peoples R China.; Yu, JX (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Tumor Microenvironm & Inflammat, Dept Biochem & Mol Cell Biol, Shanghai 200025, Peoples R China.; Yu, JX; Wang, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Basic Clin Res Ctr, Shanghai 200127, Peoples R China.	Jianxiu.Yu@gmail.com; dr_wangjian@126.com	Liu, Qiang/HHZ-3181-2022	Zhang, ZiJie/0000-0002-2513-3091; Wang, Jian/0000-0002-5335-8845; Lin, Ruirong/0000-0003-1675-8724	National Natural Science Foundation of China [81974370, 81773184, 81472240]; Shanghai Outstanding Academic Leaders Plan (2016); High-Level Collaborative Innovation Team Incentive Program of Shanghai Municipal Education Commission (2018)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Outstanding Academic Leaders Plan (2016); High-Level Collaborative Innovation Team Incentive Program of Shanghai Municipal Education Commission (2018)	The authors acknowledge the grants from National Natural Science Foundation of China (81974370, 81773184, and 81472240 to JW), Shanghai Outstanding Academic Leaders Plan (2016 to JW), and High-Level Collaborative Innovation Team Incentive Program of Shanghai Municipal Education Commission (2018 to JW).	Alarcon CR, 2015, NATURE, V519, P482, DOI 10.1038/nature14281; Alpini G, 1997, AM J PHYSIOL-GASTR L, V273, pG518, DOI 10.1152/ajpgi.1997.273.2.G518; Alpini G, 1999, GASTROENTEROLOGY, V116, P179, DOI 10.1016/S0016-5085(99)70242-8; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Bokar JA, 1997, RNA, V3, P1233; Broeders EPM, 2015, CELL METAB, V22, P418, DOI 10.1016/j.cmet.2015.07.002; Chavez-Talavera O, 2017, GASTROENTEROLOGY, V152, P1679, DOI 10.1053/j.gastro.2017.01.055; Chen MN, 2018, HEPATOLOGY, V67, P2254, DOI 10.1002/hep.29683; Cheng L, 2019, J CELL BIOCHEM, V120, P17405, DOI 10.1002/jcb.29005; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Du YZ, 2018, NUCLEIC ACIDS RES, V46, P5195, DOI 10.1093/nar/gky156; Gafar AA, 2016, PEERJ, V4, DOI 10.7717/peerj.2445; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Goldberg AA, 2011, ONCOTARGET, V2, P761; Graf D, 2002, GASTROENTEROLOGY, V122, P1411, DOI 10.1053/gast.2002.32976; Hohenester S, 2010, J HEPATOL, V53, P918, DOI 10.1016/j.jhep.2010.05.015; Horowitz NS, 2007, GYNECOL ONCOL, V107, P344, DOI 10.1016/j.ygyno.2007.07.072; Hou JJ, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1082-3; Houten SM, 2006, EMBO J, V25, P1419, DOI 10.1038/sj.emboj.7601049; Huang J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1919; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; Hundal R, 2014, CLIN EPIDEMIOL, V6, P99, DOI 10.2147/CLEP.S37357; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Jonsson AL, 2017, NAT REV CARDIOL, V14, P79, DOI 10.1038/nrcardio.2016.183; Keitel V, 2008, WORLD J GASTROENTERO, V14, P5620, DOI 10.3748/wjg.14.5620; Kim DH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12179; Konig A, 2014, J HEPATOL, V61, P867, DOI 10.1016/j.jhep.2014.05.018; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; Kovacs P, 2019, CANCERS, V11, DOI 10.3390/cancers11091255; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Li K, 2019, FLOW MEAS INSTRUM, V69, DOI 10.1016/j.flowmeasinst.2019.101590; Li TG, 2014, PHARMACOL REV, V66, P948, DOI 10.1124/pr.113.008201; Lin SB, 2015, NAT REV CANCER, V15, P321, DOI 10.1038/nrc3932; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Liu RP, 2014, HEPATOLOGY, V60, P908, DOI 10.1002/hep.27085; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Miko E, 2018, BBA-BIOENERGETICS, V1859, P958, DOI 10.1016/j.bbabio.2018.04.002; Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4; Pan T, 2013, TRENDS BIOCHEM SCI, V38, P204, DOI 10.1016/j.tibs.2012.12.006; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Pols TWH, 2011, CELL METAB, V14, P747, DOI 10.1016/j.cmet.2011.11.006; Pols TWH, 2011, J HEPATOL, V54, P1263, DOI 10.1016/j.jhep.2010.12.004; Rolo AP, 2004, TOXICOL SCI, V79, P196, DOI 10.1093/toxsci/kfh078; Shapiro H, 2018, J EXP MED, V215, P383, DOI 10.1084/jem.20171965; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Stinton LM, 2012, GUT LIVER, V6, P172, DOI 10.5009/gnl.2012.6.2.172; Sun Y, 2019, THER ADV MED ONCOL, V11, DOI 10.1177/1758835919855859; Tang W, 2019, CLIN CANCER RES, V25, P5972, DOI 10.1158/1078-0432.CCR-19-0094; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; Wang X, 2016, NATURE, V534, P575, DOI 10.1038/nature18298; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang XD, 2015, 2015 5TH INTERNATIONAL CONFERENCE ON ELECTRIC UTILITY DEREGULATION AND RESTRUCTURING AND POWER TECHNOLOGIES (DRPT 2015), P161, DOI 10.1109/DRPT.2015.7432219; Wang YQ, 2017, HEPATOLOGY, V65, P2005, DOI 10.1002/hep.29076; Wistuba II, 2004, NAT REV CANCER, V4, P695, DOI 10.1038/nrc1429; Wolpin BM, 2010, NEW ENGL J MED, V362, P1335, DOI 10.1056/NEJMe1001183; Xiao W, 2016, MOL CELL, V61, P507, DOI 10.1016/j.molcel.2016.01.012; Xu SW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13420-x; Zhang JL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09712-x; Zhang W, 2020, J CELL BIOCHEM, V121, P1998, DOI 10.1002/jcb.29434; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	62	27	27	4	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 25	2020	39	26					4983	5000		10.1038/s41388-020-1349-6	http://dx.doi.org/10.1038/s41388-020-1349-6		JUN 2020	18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	MQ2YO	32514152	hybrid, Green Published			2022-12-26	WOS:000538969800001
J	Yin, FL; Xia, XY; Song, N; Zhu, LY; Wu, JH				Yin, Fulian; Xia, Xinyu; Song, Nan; Zhu, Lingyao; Wu, Jianhong			Quantify the role of superspreaders -opinion leaders- on COVID-19 information propagation in the Chinese Sina-microblog	PLOS ONE			English	Article							RUMOR SPREADING MODEL; EPIDEMIC MODEL	Backgroud Effective communication of accurate information through social media constitutes an important component of public health interventions in modern time, when traditional public health approaches such as contact tracing, quarantine and isolation are among the few options for the containing the disease spread in the population. The success of control of COVID-19 outbreak started from Wuhan, the capital city of Hubei Province of China relies heavily on the resilience of residents to follow public health interventions which induce substantial interruption of social-economic activities, and evidence shows that opinion leaders have been playing significant roles in the propagation of epidemic information and public health policy and implementations. Methods We design a mathematical model to quantify the roles of information superspreaders in single specific information which outbreaks rapidly and usually has a short duration period, and to examine the information propagation dynamics in the Chinese Sina-microblog. Our opinion-leader susceptible-forwarding-immune (OL-SFI) model is formulated to track the temporal evolution of forwarding quantities generated by opinion leaders and normal users. Results Data fitting from the real data of COVID-19 obtained from Chinese Sina-microblog can identify the different contact rates and forwarding probabilities (and hence calculate the basic information forwarding reproduction number of superspreaders), and can be used to evaluate the roles of opinion leaders in different stages of the information propagation and the outbreak unfolding. Conclusions The parameterized model can be used to nearcast the information propagation trend, and the model-based sensitivity analysis can help to explore important factors for the roles of opinion leaders.	[Yin, Fulian; Xia, Xinyu; Song, Nan; Zhu, Lingyao] Commun Univ China, Coll Informat & Commun Engn, Beijing, Peoples R China; [Wu, Jianhong] York Univ, Fields CQAM Lab Math Publ Hlth, Lab Ind & Appl Math, Toronto, ON, Canada	Communication University of China; York University - Canada	Wu, JH (corresponding author), York Univ, Fields CQAM Lab Math Publ Hlth, Lab Ind & Appl Math, Toronto, ON, Canada.	wujhhida@hotmail.com	Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507; Wu, Jianhong Wu/0000-0002-3037-7154	National Natural Science Foundation of China [61801440]; Natural Science and Engineering Research Council of Canada; Canada Research Chair Program; Fundamental Research Funds for the Central Universities; High-quality and Cutting-edge Disciplines Construction Project for Universities in Beijing (Internet Information, Communication University of China)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair Program(Canada Research Chairs); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); High-quality and Cutting-edge Disciplines Construction Project for Universities in Beijing (Internet Information, Communication University of China)	The authors acknowledge the National Natural Science Foundation of China (Grant numbers: 61801440), the Natural Science and Engineering Research Council of Canada, the Canada Research Chair Program (JWu), the Fundamental Research Funds for the Central Universities and the High-quality and Cutting-edge Disciplines Construction Project for Universities in Beijing (Internet Information, Communication University of China); grateful to all study participants for their contribution to this research and also thank the tireless efforts of our data collectors: Jiale Wu, Meiqi Ji and Xueying Shao and Hongyu Pang. These fundings are used to pay for the data collection and experiments in this paper.	Abbas UL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000875; [Anonymous], 2009, NAT PHOTONICS, V3, P361; [Anonymous], 2013, MOD HEALTHC, V43, P38; Barrat A, 2008, DYNAMICAL PROCESSES, P189; CHAN KK, 1990, J ADVERTISING, V19, P53, DOI 10.1080/00913367.1990.10673192; Chen FH, 2006, J MATH BIOL, V53, P253, DOI 10.1007/s00285-006-0006-1; DALEY DJ, 1964, NATURE, V204, P1118, DOI 10.1038/2041118a0; Feng XM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38792-4; Hethcote HW, 1984, GONORRHOEA TRANSMISS, P32; Hospodarske noviny, 2011, HN ZPRAV; Hu YH, 2018, PHYSICA A, V502, P331, DOI 10.1016/j.physa.2018.02.096; KEMPER JT, 1980, MATH BIOSCI, V48, P111, DOI 10.1016/0025-5564(80)90018-8; KERMACK WO, 1991, B MATH BIOL, V53, P33, DOI 10.1016/S0092-8240(05)80040-0; Li F, 2011, DECIS SUPPORT SYST, V51, P190, DOI 10.1016/j.dss.2010.12.007; LI MY, 1995, MATH BIOSCI, V125, P155, DOI 10.1016/0025-5564(95)92756-5; Liu J, 2014, LECT NOTES ARTIF INT, V8722, P69, DOI 10.1007/978-3-319-10554-3_7; Liu Y, 2016, PHYSICA A, V463, P202, DOI 10.1016/j.physa.2016.07.022; Lu ZH, 2003, ACTA MATH SCI, V23, P440, DOI 10.1016/S0252-9602(17)30486-1; Lyons B., 2005, J CONSUMER BEHAVIOUR, V4, P319, DOI [DOI 10.1002/CB.22, https://doi.org/10.1002/cb.22]; Ma N, 2014, EXPERT SYST APPL, V41, P1357, DOI 10.1016/j.eswa.2013.08.033; Park CS, 2013, COMPUT HUM BEHAV, V29, P1641, DOI 10.1016/j.chb.2013.01.044; Stone L, 2000, MATH COMPUT MODEL, V31, P207, DOI 10.1016/S0895-7177(00)00040-6; Su Q, 2015, PHYSICA A, V419, P55, DOI 10.1016/j.physa.2014.10.042; Wang YQ, 2013, COMMUN THEOR PHYS, V59, P510, DOI 10.1088/0253-6102/59/4/21; Xiao DM, 2007, MATH BIOSCI, V208, P419, DOI 10.1016/j.mbs.2006.09.025; Yin FL, 2019, MATH BIOSCI ENG, V16, P5380, DOI 10.3934/mbe.2019268; Zhang N, 2014, PHYSICA A, V415, P333, DOI 10.1016/j.physa.2014.07.023; Zhang Y, 2015, DISCRETE DYN NAT SOC, V2015, DOI 10.1155/2015/204395; Zhao YY, 2018, INFORM SCIENCES, V426, P131, DOI 10.1016/j.ins.2017.10.031	30	7	7	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2020	15	6							e0234023	10.1371/journal.pone.0234023	http://dx.doi.org/10.1371/journal.pone.0234023			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ0RE	32511260	Green Published, gold			2022-12-26	WOS:000540938100041
J	Slade, SC; Bruce, C; McGinley, JL; Bloem, BR; Morris, ME				Slade, Susan C.; Bruce, Christopher; McGinley, Jennifer L.; Bloem, Bastiaan R.; Morris, Meg E.			Patient and care partner views on exercise and structured physical activity for people with Progressive Supranuclear Palsy	PLOS ONE			English	Article							PARKINSON DISEASE; QUALITATIVE RESEARCH; THERAPY; FALLS; MOTIVATORS; DIAGNOSIS; SYMPTOMS; BARRIERS; CRITERIA; BURDEN	Introduction Progressive Supranuclear Palsy (PSP) is a debilitating form of atypical Parkinsonism. People living with PSP experience movement disorders affecting walking, balance and eye movements. The role of exercise in optimising movement remains unclear. Aims To identify beliefs about exercise and structured physical activity through the experience of people with PSP. Methods Using a phenomenological theoretical framework, qualitative methods were employed to obtain the views of people living with PSP, and their care partners, by in-depth interviews. Questions derived from a systematic review and expert opinions guided the interviews which were audio-recorded, transcribed and de-identified. Two researchers independently conducted thematic analysis and reached consensus on emerging themes. Results There were 16 participants. Four themes were identified: (i) there are beliefs and preferences about exercise and physical activity that can impact on engagement; (ii) difficulty coping with disease progression impacts activities; (iii) facilitators to exercise include individual preferences, access to facilities and expert advice; and (iv) perceived barriers include beliefs about limited exercise options, falls risk, cost, transport and access to credible information. Discussion People living with PSP want early guidance about the condition and the role of exercise. It is important to quickly enable people to have access to evidence and resources supporting exercise and structured physical activities. Consideration of individual preferences and access to expert advice facilitate engagement. Individual barriers need to be identified and solutions found. Conclusion People living with PSP are amenable to exercise, especially early in the disease process. Clear guidelines are warranted to document which exercises, and physical activities are most beneficial.	[Slade, Susan C.; Morris, Meg E.] La Trobe Univ, SHE Coll, La Trobe Ctr Sport & Exercise Med Res, Sch Allied Hlth Human Serv & Sport, Bundoora, Vic, Australia; [Bruce, Christopher] La Trobe Univ, SHE Coll, Discipline Occupat Therapy, Sch Allied Hlth Human Serv & Sport, Bundoora, Vic, Australia; [McGinley, Jennifer L.] Univ Melbourne, Physiotherapy, Parkville, Vic, Australia; [Bloem, Bastiaan R.] Radboud Univ Nijmegen, Radboudumc Ctr Expertise Parkinson & Movement Dis, Donders Inst Brain Cognit & Behav, Dept Neurol,Med Ctr, Nijmegen, Netherlands; [Morris, Meg E.] Victorian Rehabil Ctr Healthscope, Healthscope, Glen Waverley, Australia	La Trobe University; La Trobe University; University of Melbourne; Radboud University Nijmegen	Slade, SC (corresponding author), La Trobe Univ, SHE Coll, La Trobe Ctr Sport & Exercise Med Res, Sch Allied Hlth Human Serv & Sport, Bundoora, Vic, Australia.	s.slade2@latrobe.edu.au	Bloem, Bastiaan/H-8013-2014	Bloem, Bastiaan/0000-0002-6371-3337; Bruce, Christopher/0000-0003-4084-0832; Morris, Meg/0000-0002-0114-4175; McGinley, Jennifer/0000-0003-3775-9267	Parkinson's Victoria (Argyrou Family Foundation); La Trobe University, Australia	Parkinson's Victoria (Argyrou Family Foundation); La Trobe University, Australia	Funding was awarded to Dr Susan Slade from Parkinson's Victoria (the Argyrou Family Foundation) and La Trobe University, Australia.	Afshari M, 2017, J PARKINSON DIS, V7, P703, DOI 10.3233/JPD-171173; Ali F, 2019, MOVEMENT DISORD, V34, P1144, DOI 10.1002/mds.27619; Anderson L, 2016, COCHRANE DB SYST REV, DOI [10.1016/j.jacc.2015.10.044, 10.1002/14651858.CD001800.pub3]; ASHOK C, 2013, INT J PHYSIOTHER RES, P41; Bluett B, 2015, EXPERT OPIN ORPHAN D, V3, P253, DOI 10.1517/21678707.2015.1018180; Boxer AL, 2017, LANCET NEUROL, V16, P552, DOI 10.1016/S1474-4422(17)30157-6; Burton E, 2017, J SPORT SCI, V35, P1523, DOI 10.1080/02640414.2016.1223334; Canning CG, 2015, NEUROLOGY, V84, P304, DOI 10.1212/WNL.0000000000001155; Carroll LM, 2017, ARCH PHYS MED REHAB, V98, P631, DOI 10.1016/j.apmr.2016.12.006; Davies K, 2017, J SOC WORK, V17, P3, DOI 10.1177/1468017316637222; Ebersbach G, 2015, NAT REV NEUROL, V11, P9, DOI 10.1038/nrneurol.2014.231; Eime RM, 2017, AUST NZ J PUBL HEAL, V41, P248, DOI 10.1111/1753-6405.12647; Ellis T, 2018, J PARKINSON DIS, V8, pS95, DOI 10.3233/JPD-181489; Ellis T, 2011, PHYS THER, V91, P1838, DOI 10.2522/ptj.20100390; Fiorenzato E, 2019, J NEURAL TRANSM, V126, P1437, DOI 10.1007/s00702-019-02065-1; Fransen M, 2014, COCHRANE DATABASE SY, P4; Fransen Marlene, 2015, COCHRANE DATABASE SY, V1; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Grimm MJ, 2019, MOVEMENT DISORD, V34, P1228, DOI 10.1002/mds.27666; Hoglinger GU, 2017, MOVEMENT DISORD, V32, P853, DOI 10.1002/mds.26987; Huberman A.M., 2004, QUALITATIVE DATA ANA; Intiso D, 2018, PM&R, V10, P636, DOI 10.1016/j.pmrj.2017.12.011; Inuzuka Y, 2019, MOV DISORD, V34; Kelly DH, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-57; Mak MK, 2017, NAT REV NEUROL, V13, P689, DOI 10.1038/nrneurol.2017.128; Martinez-Martin P, 2015, PARKINSONISM RELAT D, V21, P629, DOI 10.1016/j.parkreldis.2015.03.024; McCormack GR, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-125; Miyata H., 2009, INT J QUAL METH, V8, P64, DOI [10.1177/160940690900800106, DOI 10.1177/160940690900800106]; Moore T, 2014, MOV DISORD CLIN PRAC, V1, P188, DOI 10.1002/mdc3.12037; Morris ME, 1996, BRAIN, V119, P551, DOI 10.1093/brain/119.2.551; Morris ME, 2017, J PHYSIOTHER, V63, P94, DOI 10.1016/j.jphys.2017.02.015; Morris ME, 2015, NEUROREHAB NEURAL RE, V29, P777, DOI 10.1177/1545968314565511; Morris ME, 2010, PHYS THER, V90, P280, DOI 10.2522/ptj.20090091; Murphy AT., 2015, J AGING SCI, V3, P1; Nieuwboer A, 2007, J NEUROL NEUROSUR PS, V78, P134, DOI 10.1136/jnnp.200X.097923; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Rocha PA, 2017, COMPLEMENT THER MED, V34, P1, DOI 10.1016/j.ctim.2017.07.006; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Schenkman M, 2018, JAMA NEUROL, V75, P219, DOI 10.1001/jamaneurol.2017.3517; Schmotz C, 2017, J GERIATR PSYCH NEUR, V30, P267, DOI 10.1177/0891988717720300; Shanahan J, 2017, ARCH PHYS MED REHAB, V98, P1744, DOI 10.1016/j.apmr.2017.02.017; Slade SC, 2019, BMC NEUROL, V19, DOI 10.1186/s12883-019-1539-4; Slade SC, 2020, CLIN REHABIL, V34, P23, DOI 10.1177/0269215519877235; Slade SC, 2009, AUST J PHYSIOTHER, V55, P115, DOI 10.1016/S0004-9514(09)70041-8; Smith JA, 2015, BRIT J PAIN, V9, P41, DOI 10.1177/2049463714541642; Soundy Andrew, 2014, ScientificWorldJournal, V2014, P613592, DOI 10.1155/2014/613592; Stamelou M, 2019, MOVEMENT DISORD, V34, P1284, DOI 10.1002/mds.27788; Stamelou M, 2013, CURR OPIN NEUROL, V26, P401, DOI 10.1097/WCO.0b013e3283632da6; Stamelou M, 2010, BRAIN, V133, P1578, DOI 10.1093/brain/awq115; Starks H, 2007, QUAL HEALTH RES, V17, P1372, DOI 10.1177/1049732307307031; Strauss Anselm, 1997, BASICS QUALITATIVE R; Thorne S., 2004, INT J QUAL METH, V3, P1, DOI [DOI 10.1177/160940690400300101, 10.1177/160940690400300101]; Thumm PC, 2018, GAIT POSTURE, V62, P384, DOI 10.1016/j.gaitpost.2018.03.041; Tilley Erica, 2016, JBI Database System Rev Implement Rep, V14, P148, DOI 10.11124/JBISRIR-2016-2002352; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; van der Kolk NM, 2019, LANCET NEUROL, V18, P998, DOI 10.1016/S1474-4422(19)30285-6; van Nimwegen M, 2011, J NEUROL, V258, P2214, DOI 10.1007/s00415-011-6097-7; Wiblin L, 2019, J MOV DISORD, V12, P177, DOI 10.14802/jmd.19015; Wiblin L, 2017, PARKINSONS DIS-US, V2017, DOI 10.1155/2017/5283259; Ypinga JHL, 2018, LANCET NEUROL, V17, P153, DOI 10.1016/S1474-4422(17)30406-4	60	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0234265	10.1371/journal.pone.0234265	http://dx.doi.org/10.1371/journal.pone.0234265			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MA6QB	32502214	Green Published, gold			2022-12-26	WOS:000542035700075
J	Baeza-Raja, B; Goodyear, A; Liu, X; Lam, K; Yamamoto, L; Li, YW; Dodson, GS; Takeuchi, T; Kisseleva, T; Brenner, DA; Dabbagh, K				Baeza-Raja, Bernat; Goodyear, Andrew; Liu, Xiao; Lam, Kevin; Yamamoto, Lynn; Li, Yingwu; Dodson, G. Steven; Takeuchi, Toshi; Kisseleva, Tatiana; Brenner, David A.; Dabbagh, Karim			Pharmacological inhibition of P2RX7 ameliorates liver injury by reducing inflammation and fibrosis	PLOS ONE			English	Article							ACETAMINOPHEN-INDUCED HEPATOTOXICITY; IL-1 RECEPTOR ANTAGONIST; P2X7 RECEPTOR; IL-1-BETA RELEASE; P2X(7) RECEPTOR; HEPATIC RECRUITMENT; CELLS EXPRESS; ATP; STEATOHEPATITIS; ACTIVATION	Extracellular adenosine triphosphate (eATP) released by damaged cells, and its purinergic receptors, comprise a crucial signaling network after injury. Purinergic receptor P2X7 (P2RX7), a major driver of NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome activation and IL-1 beta processing, has been shown to play a role in liver injury in murine diet- and chemically-induced liver injury models. It is unclear, however, whether P2RX7 plays a role in non-alcoholic steatohepatitis (NASH) and which cell type is the main target of P2RX7 pharmacological inhibition. Here, we report that P2RX7 is expressed by infiltrating monocytes and resident Kupffer cells in livers from NASH-affected individuals. Using primary isolated human cells, we demonstrate that P2RX7 expression in CD14(+) monocytes and Kupffer cells primarily mediates IL-1 beta release. In addition, we show that pharmacological inhibition of P2RX7 in monocytes and Kupffer cells, blocks IL-1 beta release, reducing hepatocyte caspase 3/7 activity, IL-1 beta-mediated CCL2 and CCL5 chemokine gene expression and secretion, and hepatic stellate cell (HSC) procollagen secretion. Consequently, in a chemically-induced nonhuman primate model of liver fibrosis, treatment with a P2RX7 inhibitor improved histological characteristics of NASH, protecting from liver inflammation and fibrosis. Taken together, these findings underscore the critical role of P2RX7 in the pathogenesis of NASH and implicate P2RX7 as a promising therapeutic target for the management of this disease.	[Baeza-Raja, Bernat; Goodyear, Andrew; Yamamoto, Lynn; Li, Yingwu; Dodson, G. Steven; Takeuchi, Toshi; Dabbagh, Karim] Second Genome Inc, San Francisco, CA 94080 USA; [Liu, Xiao; Lam, Kevin; Kisseleva, Tatiana] Univ Calif San Diego, Dept Surg, La Jolla, CA 92093 USA; [Brenner, David A.] Univ Calif San Diego, Dept Med, La Jolla, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Baeza-Raja, B (corresponding author), Second Genome Inc, San Francisco, CA 94080 USA.	bernat@secondgenome.com		Lam, Kevin/0000-0001-7073-0429	Second Genome, Inc. [94080]; National Institutes of Health [R01 DK101737, U01 AA022614, R01 DK099205, P50AA011999]	Second Genome, Inc.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Second Genome, Inc. (341 Allerton Ave., South San Francisco, CA, 94080, USA; 1 (650) 440-4606; www.secondgenome.com). The sponsor has been involved in study design, data collection, and analysis, decision to publish, and preparation of the manuscript. This work was also supported by the National Institutes of Health R01 DK101737, U01 AA022614, R01 DK099205, P50AA011999 to T.K. and D.A.B.	Ajmera V, 2017, HEPATOLOGY, V65, P65, DOI 10.1002/hep.28776; [Anonymous], 2014, LANCET INFECT DIS, V14, P1, DOI 10.1016/S1473-3099(13)70368-2; Arulkumaran N, 2011, EXPERT OPIN INV DRUG, V20, P897, DOI 10.1517/13543784.2011.578068; Savio LEB, 2020, J CELL SCI, V133, DOI 10.1242/jcs.237560; Savio LEB, 2017, J HEPATOL, V67, P716, DOI 10.1016/j.jhep.2017.05.021; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Berres ML, 2010, J CLIN INVEST, V120, P4129, DOI 10.1172/JCI41732; Bianco F, 2005, J IMMUNOL, V174, P7268, DOI 10.4049/jimmunol.174.11.7268; Buell G, 1998, BLOOD, V92, P3521, DOI 10.1182/blood.V92.10.3521.422k50_3521_3528; Cc J, 2013, AM J PHYSIOL-ENDOC M, V305, pE964; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Chatterjee S, 2012, FREE RADICAL BIO MED, V52, P1666, DOI 10.1016/j.freeradbiomed.2012.02.010; Chen Y, 2009, J HEPATOL, V51, P510, DOI 10.1016/j.jhep.2009.04.026; Colomar A, 2003, J BIOL CHEM, V278, P30732, DOI 10.1074/jbc.M304534200; Csak T, 2011, HEPATOLOGY, V54, P133, DOI 10.1002/hep.24341; Dambach DM, 2002, HEPATOLOGY, V35, P1093, DOI 10.1053/jhep.2002.33162; Di Virgilio F, 2017, IMMUNITY, V47, P15, DOI 10.1016/j.immuni.2017.06.020; Diehl AM, 2017, NEW ENGL J MED, V377, P2063, DOI 10.1056/NEJMra1503519; Ding K, 2014, EXP TOXICOL PATHOL, V66, P257, DOI 10.1016/j.etp.2014.03.003; Dixon LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056100; Dixon LJ, 2012, LAB INVEST, V92, P713, DOI 10.1038/labinvest.2012.45; Fausther Michel, 2012, Wiley Interdiscip Rev Membr Transp Signal, V1, P341; Ferrari BD, 1997, PURINERGIC MODULATIO, V185, P22; Ferrari D, 1996, J IMMUNOL, V156, P1531; Ferrari D, 1997, J IMMUNOL, V159, P1451; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9; Gieling RG, 2009, AM J PHYSIOL-GASTR L, V296, pG1324, DOI 10.1152/ajpgi.90564.2008; Grahames CBA, 1999, BRIT J PHARMACOL, V127, P1915, DOI 10.1038/sj.bjp.0702732; Guillot A, 2019, HEPATOL COMMUN, V3, P730, DOI 10.1002/hep4.1356; Haukeland JW, 2006, J HEPATOL, V44, P1167, DOI 10.1016/j.jhep.2006.02.011; Heymann F, 2016, NAT REV GASTRO HEPAT, V13, P88, DOI 10.1038/nrgastro.2015.200; Hoque R, 2012, AM J PHYSIOL-GASTR L, V302, pG1171, DOI 10.1152/ajpgi.00352.2011; Huang CS, 2014, MOL MED REP, V9, P57, DOI 10.3892/mmr.2013.1807; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; Kakimi K, 2001, J EXP MED, V194, P1755, DOI 10.1084/jem.194.12.1755; Kamari Y, 2011, J HEPATOL, V55, P1086, DOI 10.1016/j.jhep.2011.01.048; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Karmakar M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10555; Kazankov K, 2018, NAT REV GASTRO HEPAT, P1, DOI 10.1038/nrgastro.2017.155; Kazankov K, 2019, NAT REV GASTRO HEPAT, V16, P145, DOI 10.1038/s41575-018-0082-x; Kirovski G, 2010, INT J CLIN EXP PATHO, V3, P675; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Laliberte RE, 1997, J LEUKOCYTE BIOL, V62, P227, DOI 10.1002/jlb.62.2.227; Lebeaupin C, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.248; Lee YA, 2015, GUT, V64, P1337, DOI 10.1136/gutjnl-2014-306842corr1; Marra F, 1998, AM J PATHOL, V152, P423; Marra F, 2014, GASTROENTEROLOGY, V147, P577, DOI 10.1053/j.gastro.2014.06.043; Mitchell C, 2009, AM J PATHOL, V174, P1766, DOI 10.2353/ajpath.2009.080632; Miura K, 2012, AM J PHYSIOL-GASTR L, V302, pG1310, DOI 10.1152/ajpgi.00365.2011; Miura K, 2010, GASTROENTEROLOGY, V139, P323, DOI 10.1053/j.gastro.2010.03.052; Mridha AR, 2017, J HEPATOL, V66, P1037, DOI 10.1016/j.jhep.2017.01.022; Noureddin M, 2016, EXPERT OPIN EMERG DR, V21, P343, DOI 10.1080/14728214.2016.1220533; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Perregaux DG, 2000, J IMMUNOL, V165, P4615, DOI 10.4049/jimmunol.165.8.4615; Petrasek J, 2012, J CLIN INVEST, V122, P3476, DOI 10.1172/JCI60777; Petrasek J, 2011, GASTROENTEROLOGY, V140, P697, DOI 10.1053/j.gastro.2010.08.020; Pizzirani C, 2007, BLOOD, V109, P3856, DOI 10.1182/blood-2005-06-031377; Qu Y, 2009, J IMMUNOL, V182, P5052, DOI 10.4049/jimmunol.0802968; Ratziu V, 2019, CONTEMP CLIN TRIALS, V84, DOI 10.1016/j.cct.2019.06.017; Schwabe RF, 2003, AM J PHYSIOL-GASTR L, V285, pG949, DOI 10.1152/ajpgi.00215.2003; Seki E, 2015, J HEPATO-BIL-PAN SCI, V22, P512, DOI 10.1002/jhbp.245; Seki E, 2015, HEPATOLOGY, V61, P1066, DOI 10.1002/hep.27332; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Seki E, 2009, HEPATOLOGY, V50, P185, DOI 10.1002/hep.22952; Shang LS, 2018, J GASTROENTEROL, V53, P6, DOI 10.1007/s00535-017-1404-4; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Szabo G, 2015, CLIN RES HEPATOL GAS, V39, pS18, DOI 10.1016/j.clinre.2015.06.012; Szabo G, 2015, NAT REV GASTRO HEPAT, V12, P387, DOI 10.1038/nrgastro.2015.94; Tacke F, 2014, J HEPATOL, V60, P1090, DOI 10.1016/j.jhep.2013.12.025; Tilg H, 2016, HEPATOLOGY, V64, P955, DOI 10.1002/hep.28456; Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38; Verma G, 2010, APOPTOSIS, V15, P864, DOI 10.1007/s10495-010-0498-4; Wree A, 2014, J MOL MED, V92, P1069, DOI 10.1007/s00109-014-1170-1; Zannetti C, 2016, J IMMUNOL, V197, P356, DOI 10.4049/jimmunol.1502301; Zhang Jinyu, 2016, J Clin Cell Immunol, V7	77	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2020	15	6							e0234038	10.1371/journal.pone.0234038	http://dx.doi.org/10.1371/journal.pone.0234038			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LW6ZP	32492075	gold, Green Published			2022-12-26	WOS:000539293000004
J	Zahra, R; Furqan, M; Ullah, R; Mithani, A; Saleem, RSZ; Faisal, A				Zahra, Rida; Furqan, Muhammad; Ullah, Rahim; Mithani, Aziz; Saleem, Rahman Shah Zaib; Faisal, Amir			A cell-based high-throughput screen identifies inhibitors that overcome P-glycoprotein (Pgp)-mediated multidrug resistance	PLOS ONE			English	Article							OVARIAN-CANCER; IN-VITRO; DRUG-RESISTANCE; BREFELDIN-A; MDR1 GENE; EXPRESSION; CYTOTOXICITY; REVERSES; BINDING; GROWTH	Multidrug resistance (MDR) to chemotherapeutic drugs remains one of the major impediments to the treatment of cancer. Discovery and development of drugs that can prevent and reverse the acquisition of multidrug resistance constitute a foremost challenge in cancer therapeutics. In this work, we screened a library of 1,127 compounds with known targets for their ability to overcome Pgp-mediated multidrug resistance in cancer cell lines. We identified four compounds (CHIR-124, Elesclomol, Tyrphostin-9 and Brefeldin A) that inhibited the growth of two pairs of parental and Pgp-overexpressing multidrug-resistant cell lines with similar potency irrespective of their Pgp status. Mechanistically, CHIR-124 (a potent inhibitor of Chk1 kinase) inhibited Pgp activity in both multidrug-resistant cell lines (KB-V1 and A2780-Pac-Res) as determined through cell-based Pgp-efflux assays. Other three inhibitors on the contrary, were effective in Pgp-overexpressing resistant cells without increasing the cellular accumulation of a Pgp substrate, indicating that they overcome resistance by avoiding efflux through Pgp. None of these compounds modulated the expression of Pgp in resistant cell lines. PIK-75, a PI3 Kinase inhibitor, was also determined to inhibit Pgp activity, despite being equally potent in only one of the two pairs of resistant and parental cell lines. Strong binding of both CHIR-124 and PIK-75 to Pgp was predicted through docking studies and both compounds inhibited Pgp in a biochemical assay. The inhibition of Pgp causes accumulation of these compounds in the cells where they can modulate the function of their target proteins and thereby inhibit cell proliferation. In conclusion, we have identified compounds with various cellular targets that overcome multidrug resistance in Pgp-overexpressing cell lines through mechanisms that include Pgp inhibition and efflux evasion. These compounds, therefore, can avoid challenges associated with the co-administration of Pgp inhibitors with chemotherapeutic or targeted drugs such as additive toxicities and differing pharmacokinetic properties.	[Zahra, Rida; Furqan, Muhammad; Ullah, Rahim; Mithani, Aziz; Faisal, Amir] Lahore Univ Management Sci, Syed Babar Ali Sch Sci & Engn, Dept Biol, Lahore, Pakistan; [Saleem, Rahman Shah Zaib] Lahore Univ Management Sci, Syed Babar Ali Sch Sci & Engn, Dept Chem & Chem Engn, Lahore, Pakistan	Lahore University of Management Sciences; Lahore University of Management Sciences	Faisal, A (corresponding author), Lahore Univ Management Sci, Syed Babar Ali Sch Sci & Engn, Dept Biol, Lahore, Pakistan.	amir.faisal@lums.edu.pk		Faisal, Amir/0000-0002-7376-8286; Mithani, Aziz/0000-0002-2214-3526	Lahore University of Management Sciences [STG-BIO-1009]	Lahore University of Management Sciences	Authors thank Lahore University of Management Sciences (LUMS) for providing start up grant (STG-BIO-1009) to Amir Faisal.	Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Amin ML, 2013, DRUG TARGET INSIGHT, V7, P27, DOI 10.4137/DTI.S12519; Ando T, 2000, LEUKEMIA, V14, P1915, DOI 10.1038/sj.leu.2401914; Ansbro MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060334; Baer MR, 2002, BLOOD, V100, P1224, DOI 10.1182/blood.V100.4.1224.h81602001224_1224_1232; Bark H, 2010, CANCER CHEMOTH PHARM, V65, P1131, DOI 10.1007/s00280-009-1121-7; Binkhathlan Z, 2013, CURR CANCER DRUG TAR, V13, P326, DOI 10.2174/15680096113139990076; Boucher P, 2002, J BIOL CHEM, V277, P15507, DOI 10.1074/jbc.M200428200; Brewer FK, 2014, MOL PHARMACOL, V86, P716, DOI 10.1124/mol.114.095414; Chen T, 2015, CANCER BIOL THER, V16, P106, DOI 10.4161/15384047.2014.987062; Chen ZL, 2016, CANCER LETT, V370, P153, DOI 10.1016/j.canlet.2015.10.010; Chou TC, 1998, P NATL ACAD SCI USA, V95, P15798, DOI 10.1073/pnas.95.26.15798; DALTON WS, 1995, CANCER, V75, P815, DOI 10.1002/1097-0142(19950201)75:3<815::AID-CNCR2820750311>3.0.CO;2-R; Eccles SA, 2008, CANCER RES, V68, P2850, DOI 10.1158/0008-5472.CAN-07-5256; ERMOLAYEVA E, 1995, APPL ENVIRON MICROB, V61, P3385, DOI 10.1128/AEM.61.9.3385-3390.1995; Follit CA, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.170; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Hasinoff BB, 2015, BIOCHEM PHARMACOL, V93, P266, DOI 10.1016/j.bcp.2014.12.008; Hegedus T, 2002, BBA-MOL BASIS DIS, V1587, P318, DOI 10.1016/S0925-4439(02)00095-9; Hu J, 2015, ONCOTARGET, V6, P44643, DOI 10.18632/oncotarget.5989; Hung TH, 2015, CANCER GENE THER, V22, P262, DOI 10.1038/cgt.2015.15; Kasibhatla S, 2007, CANCER RES, V67, P5865, DOI 10.1158/0008-5472.CAN-07-0127; Kim AE, 1998, J PHARMACOL EXP THER, V286, P1439; Kim HJ, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1543-z; Kirshner JR, 2008, MOL CANCER THER, V7, P2319, DOI 10.1158/1535-7163.MCT-08-0298; Limtrakul P, 2005, J CHEMOTHERAPY, V17, P86, DOI 10.1179/joc.2005.17.1.86; Lin X, 2012, NEOPLASMA, V59, P248, DOI 10.4149/neo_2012_032; LYALL RM, 1989, J BIOL CHEM, V264, P14503; Manzoor S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21642-0; Mechetner E, 1998, CLIN CANCER RES, V4, P389; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; Ng IOL, 2000, AM J CLIN PATHOL, V113, P355, DOI 10.1309/AC1M-4TY4-U0TN-EN7T; Penson RT, 2004, GYNECOL ONCOL, V93, P98, DOI 10.1016/j.ygyno.2003.11.053; Pusztai L, 2005, CANCER-AM CANCER SOC, V104, P682, DOI 10.1002/cncr.21227; REEVE JG, 1989, BRIT J CANCER, V60, P339, DOI 10.1038/bjc.1989.282; Sawada K, 2007, CANCER RES, V67, P1670, DOI 10.1158/0008-5472.CAN-06-1147; Srivalli KMR, 2012, BRAZ J PHARM SCI, V48, P353, DOI 10.1590/S1984-82502012000300002; Susa M, 2010, J BIOMOL SCREEN, V15, P287, DOI 10.1177/1087057109359422; Szakacs G, 2004, CANCER CELL, V6, P129, DOI 10.1016/j.ccr.2004.06.026; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Szewczyk P, 2015, ACTA CRYSTALLOGR D, V71, P732, DOI 10.1107/S1399004715000978; Talekar M, 2012, PHARM RES-DORDR, V29, P2874, DOI 10.1007/s11095-012-0793-6; Tanabe KM, 2005, INTERACTIONS PATUPIL; Tiedt R, 2011, CANCER RES, V71, P5255, DOI 10.1158/0008-5472.CAN-10-4433; Tiwari AK, 2011, CURR PHARM BIOTECHNO, V12, P570; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tse AN, 2007, CLIN CANCER RES, V13, P591, DOI 10.1158/1078-0432.CCR-06-1424; Wang EJ, 2002, ANTIMICROB AGENTS CH, V46, P160, DOI 10.1128/AAC.46.1.160-165.2002; Wei N, 2011, CANCER CHEMOTH PHARM, V67, P1017, DOI 10.1007/s00280-010-1397-7; Wojtowicz K, 2016, ONCOL REP, V35, P2896, DOI 10.3892/or.2016.4656; Wu Q, 2014, CANCER LETT, V347, P159, DOI 10.1016/j.canlet.2014.03.013; Zhou Q, 2017, ONCOTARGET, V8; Zhou WJ, 2012, BRIT J PHARMACOL, V166, P1669, DOI 10.1111/j.1476-5381.2012.01849.x	53	7	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2020	15	6							e0233993	10.1371/journal.pone.0233993	http://dx.doi.org/10.1371/journal.pone.0233993			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MT4VF	32484843	Green Published, gold			2022-12-26	WOS:000554969700025
J	Waiswa, P; Higgins, BV; Mubiri, P; Kirumbi, L; Butrick, E; Merai, R; Sloan, NL; Walker, D				Waiswa, Peter; Higgins, Brennan, V; Mubiri, Paul; Kirumbi, Leah; Butrick, Elizabeth; Merai, Rikita; Sloan, Nancy L.; Walker, Dilys		Preterm Birth Initiative Kenya	Pregnancy outcomes in facility deliveries in Kenya and Uganda: A large cross-sectional analysis of maternity registers illuminating opportunities for mortality prevention	PLOS ONE			English	Article							NEONATAL DEATHS; GESTATIONAL-AGE; TRENDS	Introduction As facility-based deliveries increase globally, maternity registers offer a promising way of documenting pregnancy outcomes and understanding opportunities for perinatal mortality prevention. This study aims to contribute to global quality improvement efforts by characterizing facility-based pregnancy outcomes in Kenya and Uganda including maternal, neonatal, and fetal outcomes at the time of delivery and neonatal discharge outcomes using strengthened maternity registers. Methods Cross sectional data were collected from strengthened maternity registers at 23 facilities over 18 months. Data strengthening efforts included provision of supplies, training on standard indicator definitions, and monthly feedback on completeness. Pregnancy outcomes were classified as live births, early stillbirths, late stillbirths, or spontaneous abortions according to birth weight or gestational age. Discharge outcomes were assessed for all live births. Outcomes were assessed by country and by infant, maternal, and facility characteristics. Maternal mortality was also examined. Results Among 50,981 deliveries, 91.3% were live born and, of those, 1.6% died before discharge. An additional 0.5% of deliveries were early stillbirths, 3.6% late stillbirths, and 4.7% spontaneous abortions. There were 64 documented maternal deaths (0.1%). Preterm and low birthweight infants represented a disproportionate number of stillbirths and pre-discharge deaths, yet very few were born at <= 1500g or < 28w. More pre-discharge deaths and stillbirths occurred after maternal referral and with cesarean section. Half of maternal deaths occurred in women who had undergone cesarean section. Conclusion Maternity registers are a valuable data source for understanding pregnancy outcomes including those mothers and infants at highest risk of perinatal mortality. Strengthened register data in Kenya and Uganda highlight the need for renewed focus on improving care of pre-term and low birthweight infants and expanding access to emergency obstetric care. Registers also permit enumeration of pregnancy loss < 28 weeks. Documenting these earlier losses is an important step towards further mortality reduction for the most vulnerable infants.	[Waiswa, Peter; Mubiri, Paul] Makerere Univ, Coll Hlth Sci, Maternal Newborn & Child Hlth Ctr Excellence, Sch Publ Hlth, Kampala, Uganda; [Waiswa, Peter] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Higgins, Brennan, V] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Kirumbi, Leah] Kenya Govt Med Res Ctr, Ctr Clin Res, Nairobi, Kenya; [Butrick, Elizabeth; Merai, Rikita; Sloan, Nancy L.] Univ Calif San Francisco, Inst Global Hlth Sci, San Francisco, CA 94143 USA; [Walker, Dilys] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Walker, Dilys] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA	Makerere University; Karolinska Institutet; University of California System; University of California San Francisco; Kenya Medical Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Higgins, BV (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.	brennan.vail@ucsf.edu		Butrick, Elizabeth/0000-0002-0026-7464; Sloan, Nancy L/0000-0002-3381-7602	East Africa Preterm Birth Initiative - Bill & Melinda Gates Foundation [OPP1107312]	East Africa Preterm Birth Initiative - Bill & Melinda Gates Foundation	This study was supported by the East Africa Preterm Birth Initiative, a multi-year, multi-country effort generously funded by the Bill & Melinda Gates Foundation (OPP1107312, https://www.gatesfoundation.org/). The primary grantee is DW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	African Institute for Development Policy, 2017, REPR MAT NEON CHILD; Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; [Anonymous], 2015, TRENDS MAT MORT 1990; Ariff S, 2016, CLIN PERINATOL, V43, P593, DOI 10.1016/j.clp.2016.05.001; Campbell OMR, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001972; Chawanpaiboon S, 2019, LANCET GLOB HEALTH, V7, pE37, DOI 10.1016/S2214-109X(18)30451-0; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Government of Kenya, HEALTHC SYST KEN; IBM Corp, 2013, IBM SPSS STAT MAC VE; Kamath-Rayne BD, 2015, MATERN CHILD HLTH J, V19, P1853, DOI 10.1007/s10995-015-1699-9; Kassebaum NJ, 2016, LANCET, V388, P1775, DOI 10.1016/S0140-6736(16)31470-2; Keating R, 2019, E AFRICAN J APPL FEB; Kenya National Bureau of Statistics Ministry of Health National AIDS Control Council Kenya Medical Research Institute, 2015, KEN DEM HLTH SURV 20; Lawn J, 2000, HLTH NEWBORN REFEREN; Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Lawn JE, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S5; Loftin Ryan W, 2010, Rev Obstet Gynecol, V3, P10; Lynch CD, 2007, PAEDIATR PERINAT EP, V21, P86, DOI 10.1111/j.1365-3016.2007.00865.x; Mikkelsen L, 2015, LANCET, V386, P1395, DOI 10.1016/S0140-6736(15)60171-4; Montagu D, 2017, HEALTH POLICY PLANN, V32, P1146, DOI 10.1093/heapol/czx060; Morgan MC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207156; Neilson JP, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002253.pub3; Otieno P, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2696-2; Plotkin M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201238; Rosenberg RE, 2009, J HEALTH POPUL NUTR, V27, P332; Sankar MJ, 2016, J PERINATOL, V36, pS1, DOI 10.1038/jp.2016.27; Smith LK, 2018, LANCET, V392, P1639, DOI [10.1016/s0140-6736(18)31651-9, 10.1016/S0140-6736(18)31651-9]; Sobhy S, 2019, LANCET; StataCorp, 2015, STAT STAT SOFTW REL; Uganda Bureau of Statistics, 2017, UG BUR STAT 2017 NAT; Uganda Bureau of Statistics (UBOS) and ICF, 2018, UG DEM HLTH SURV 201; Uganda Ministry of Health, 2014, UG HOSP HLTH CTR 4 C; UNICEF, 2014, UND WOMB CAN LEAD DI; Wang HD, 2017, LANCET, V390, P1084, DOI 10.1016/S0140-6736(17)31833-0; WHO, 2013, MAT DEATH SURV RESP; World Health Organization, 2014, EV NEWB ACT PLAN END	38	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0233845	10.1371/journal.pone.0233845	http://dx.doi.org/10.1371/journal.pone.0233845			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MJ2AA	32479522	gold, Green Published			2022-12-26	WOS:000547893500033
J	Hollmann, V; Donath, TW; Grammel, F; Himmighofen, T; Zerahn, U; Leyer, I				Hollmann, Verena; Donath, Tobias W.; Grammel, Florian; Himmighofen, Tina; Zerahn, Ute; Leyer, Ilona			From nutrients to competition processes: Habitat specific threats to Arnica montana L. populations in Hesse, Germany	PLOS ONE			English	Article							SEEDLING EMERGENCE; PLANT DIVERSITY; ESTABLISHMENT; GRASSLAND; MANAGEMENT; DISPERSAL; RICHNESS; GROWTH; AVAILABILITY; BRYOPHYTES	Populations of Arnica montana, a characteristic species of nutrient poor grasslands in Central Europe, have been deteriorating over the last decades, especially in lowland regions. Population size has been declining and signs of sexual reproduction are scarce. To start a long-term regeneration program, we investigated the major habitat specific drivers for the decline in Hesse, Germany. Firstly, we conducted a field study to analyze habitat characteristics of 32 Hessian lowland sites, comparing those on which this species has become extinct during the last 15 years with sites of small and declining, as well as large, stable populations. We compared habitat traits focusing on soil parameters, nutrients, and vegetation characteristics. Secondly, we set up a greenhouse experiment to study the response of A. montana seedlings to competition and nutrient input to assess the effects of competition pressure and fertilization. The results show lower carbon-to-nitrogen ratios and higher Ellen berg nitrogen indicator values on sites with extinct populations compared to existing populations. Both pH and Ellenberg soil reaction indicator values were higher on sites with extinct populations. In the greenhouse, the combination of nitrogen addition and competition resulted in lower seedling numbers. While rosette size was not dependent on fertilization, growth was strongly enhanced in the plots lacking vegetation. Both studies suggest that soil nutrient enrichment followed by competition pressure diminishes the number of safe sites for A. montana seedling recruitment and establishment and negatively impacts the growth of existing rosettes, thus leading to the continuous decline of populations. There is an urgent need for actions to reduce unintentional nitrogen deposition in the remaining nutrient poor areas as well as to modify land use to withdraw nutrients from enriched soils in order to preserve the remaining A. montana populations and to create bare ground for the safekeeping and enhancement of self-sustainable populations.	[Hollmann, Verena; Grammel, Florian; Himmighofen, Tina; Leyer, Ilona] Hsch Geisenheim Univ, Dept Appl Ecol, Geisenheim, Germany; [Donath, Tobias W.] Univ Kiel, Inst Nat Resource Conservat, Dept Landscape Ecol, Kiel, Germany; [Zerahn, Ute] Justus Liebig Univ Giessen, Interdisciplinary Res Ctr, Inst Landscape Ecol & Resource Management, Giessen, Germany	University of Kiel; Justus Liebig University Giessen	Hollmann, V (corresponding author), Hsch Geisenheim Univ, Dept Appl Ecol, Geisenheim, Germany.	verenaholimann@hs-gm.de	Donath, Tobias W./B-2856-2012	Donath, Tobias W./0000-0003-1874-1096	Federal Environment Ministry (BMUB); Federal Research Ministry (BMBF) [01LC1316C]	Federal Environment Ministry (BMUB); Federal Research Ministry (BMBF)	This study was embedded within the project ArnikaHessen which was jointly funded by the Federal Environment Ministry (BMUB) and the Federal Research Ministry (BMBF), grant number 01LC1316C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the staff members of the Department of Soil Science and Plant Nutrition at Geisenheim University for conducting soil analyses, all student and other helpers for their aid with data acquisition in the field, greenhouse, and lab, Eva Mosner for help in data analyses, Loris Capria and Michael Dunn for proof-reading as well as the whole ArnikaHessen team for their support. Two anonymous reviewers helped to improve the paper substantially.	Pietri JCA, 2009, SOIL BIOL BIOCHEM, V41, P1396, DOI 10.1016/j.soilbio.2009.03.017; Andersson S, 2001, SOIL BIOL BIOCHEM, V33, P1181, DOI 10.1016/S0038-0717(01)00022-0; [Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], 1991, HDB LANDWIRTSCHAFTLI, V1; Asmus F, 1977, REPRODUKTION ORGANIS; Barker CG, 2004, BIOL CONSERV, V120, P41, DOI 10.1016/j.biocon.2004.01.024; Barrett SCH, 2015, P NATL ACAD SCI USA, V112, P8859, DOI 10.1073/pnas.1501712112; Blume H.-P., 2010, SCHEFFER SCHACHTSCHA, DOI 10. 1007/978-3-662-49960-3; Bobbink R, 2010, ECOL APPL, V20, P30, DOI 10.1890/08-1140.1; BOBBINK R, 2003, EMPIRICAL CRITICAL L, P43; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Borer ET, 2014, NATURE, V508, P517, DOI 10.1038/nature13144; Bundesamt fur Naturschutz, FLORAWEB DAT INF WIL; BYERS DL, 1992, HEREDITY, V68, P353, DOI 10.1038/hdy.1992.50; Colling G, 2002, J APPL ECOL, V39, P310, DOI 10.1046/j.1365-2664.2002.00714.x; Dammgen U, 2010, BEITRAGE ERSTELLUNG; Diekmann M, 2003, BASIC APPL ECOL, V4, P493, DOI 10.1078/1439-1791-00185; Donath TW, 2010, PLANT ECOL, V207, P257, DOI 10.1007/s11258-009-9670-8; DUECK TA, 1992, NEW PHYTOL, V122, P507, DOI 10.1111/j.1469-8137.1992.tb00080.x; Ellenberg H., 1991, INDICATOR VALUES PLA; Ellenberg H., 2010, OKOLOGISCHER DYNAMIS, V8104; ERIKSSON O, 1992, OIKOS, V63, P439, DOI 10.2307/3544970; FENNEMA F, 1992, WATER AIR SOIL POLL, V62, P325, DOI 10.1007/BF00480264; Finck P., 2017, ROTE LISTE GEFAHRDET; Freeland JR, 2012, MOL ECOLOGY; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; Himmighofen T, 2013, POPULATIONSGROE FITN; Hulber K, 2017, AGR ECOSYST ENVIRON, V243, P10, DOI 10.1016/j.agee.2017.04.002; Hulten E., 1986, ATLAS N EUROPEAN VAS, V1-3; Jacquemyn H, 2003, BIOL CONSERV, V111, P137, DOI 10.1016/S0006-3207(02)00256-2; Jeschke M, 2008, FLORA, V203, P557, DOI 10.1016/j.flora.2007.09.006; Kahmen S., 1998, JB NATURSCHUTZ HESSE, V3, P225; KEIZER PJ, 1985, J ECOL, V73, P493, DOI 10.2307/2260489; Kjeldahl Johan Z., 1883, ANAL CHEM, V22, P366, DOI DOI 10.1007/BF01338151; Klimek S, 2007, BIOL CONSERV, V134, P559, DOI 10.1016/j.biocon.2006.09.007; Leps J., 2014, MULTIVARIATE ANAL EC; Leyer I., 2008, MULTIVARIATE STAT OK; Li J, 2017, COATINGS, V7, DOI 10.3390/coatings7070094; Licht W., 2013, ZEIGERPFLANZEN ERKEN; Loydi A, 2015, PLANT BIOLOGY, V17, P667, DOI 10.1111/plb.12287; Ludwig G., 2007, VERANTWORTLICHKEIT D; Maskell LC, 2010, GLOBAL CHANGE BIOL, V16, P671, DOI 10.1111/j.1365-2486.2009.02022.x; Maurice T, 2012, PLANT ECOL, V213, P831, DOI 10.1007/s11258-012-0045-1; Metzing D, 2018, ROTE LISTE GEFAHRDET, V7; Oberdorfer E., 2001, PFLANZENSOZIOLOGISCH; PEGTEL DM, 1994, VEGETATIO, V114, P109; Peppler-Lisbach C, 2017, TUEXENIA, P201, DOI 10.14471/2017.37.001; Pribyl DW, 2010, GEODERMA, V156, P75, DOI 10.1016/j.geoderma.2010.02.003; RYSER P, 1993, J VEG SCI, V4, P195, DOI 10.2307/3236105; SCHWABE A, 1990, Carolinea, V48, P45; Silvertown J, 2006, ECOLOGY, V87, pS39, DOI 10.1890/0012-9658(2006)87[39:PATHOO]2.0.CO;2; Strykstra RJ, 1998, ACTA BOT NEERL, V47, P45; Umweltbundesamt, 2009, HINT STICKST; VANTOOREN BF, 1988, OIKOS, V53, P41, DOI 10.2307/3565661; Weise J, 2009, LANDESWEITES ARTENHI; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Zamfir M, 2000, OIKOS, V88, P603, DOI 10.1034/j.1600-0706.2000.880317.x	57	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2020	15	5							e0233709	10.1371/journal.pone.0233709	http://dx.doi.org/10.1371/journal.pone.0233709			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1WS	32470080	Green Published, gold			2022-12-26	WOS:000537552800145
J	Campecino, J; Lagishetty, S; Wawrzak, Z; Alfaro, VS; Lehnert, N; Reguera, G; Hu, J; Hegg, EL				Campecino, Julius; Lagishetty, Satyanarayana; Wawrzak, Zdzislaw; Alfaro, Victor Sosa; Lehnert, Nicolai; Reguera, Gemma; Hu, Jian; Hegg, Eric L.			Cytochrome c nitrite reductase from the bacterium Geobacter lovleyi represents a new NrfA subclass	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; crystal structure; cytochromecnitrite reductase; dissimilatory nitrate reduction to ammonium (DNRA); enzyme catalysis; Geobacter lovleyi; metalloenzyme; NrfA; phylogenetics; nitrogen cycle	6-ELECTRON REDUCTION; CRYSTAL-STRUCTURE; DNRA BACTERIA; BINDING; AMMONIA; PROTEIN; PURIFICATION; CALCIUM; DISTAL; HYDROXYLAMINE	Cytochromecnitrite reductase (NrfA) catalyzes the reduction of nitrite to ammonium in the dissimilatory nitrate reduction to ammonium (DNRA) pathway, a process that competes with denitrification, conserves nitrogen, and minimizes nutrient loss in soils. The environmental bacteriumGeobacter lovleyihas recently been recognized as a key driver of DNRA in nature, but its enzymatic pathway is still uncharacterized. To address this limitation, here we overexpressed, purified, and characterizedG. lovleyiNrfA. We observed that the enzyme crystallizes as a dimer but remains monomeric in solution. Importantly, its crystal structure at 2.55-angstrom resolution revealed the presence of an arginine residue in the region otherwise occupied by calcium in canonical NrfA enzymes. The presence of EDTA did not affect the activity ofG. lovleyiNrfA, and site-directed mutagenesis of this arginine reduced enzymatic activity to <3% of the WT levels. Phylogenetic analysis revealed four separate emergences of Arg-containing NrfA enzymes. Thus, the Ca2+-independent, Arg-containing NrfA fromG. lovleyirepresents a new subclass of cytochromecnitrite reductase. Most genera from the exclusive clades of Arg-containing NrfA proteins are also represented in clades containing Ca2+-dependent enzymes, suggesting convergent evolution.	[Campecino, Julius; Lagishetty, Satyanarayana; Hu, Jian; Hegg, Eric L.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Wawrzak, Zdzislaw] Northwestern Univ, Life Sci Collaborat Access Team, Synchrotron Res Ctr, Argonne, IL USA; [Alfaro, Victor Sosa; Lehnert, Nicolai] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Alfaro, Victor Sosa; Lehnert, Nicolai] Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA; [Reguera, Gemma] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Hu, Jian] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA	Michigan State University; Northwestern University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Michigan State University; Michigan State University	Hegg, EL (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	EricHegg@msu.edu	Reguera, Gemma/AAZ-5864-2020	Reguera, Gemma/0000-0003-4317-7933; Sosa Alfaro, Victor/0000-0001-8149-5137; Hegg, Eric/0000-0003-2055-5495; Campecino, Julius/0000-0003-0502-0177	U.S. Department of Energy, Office of Science, Basic Energy Sciences [DE-SC0017952, DE-SC0018173]	U.S. Department of Energy, Office of Science, Basic Energy Sciences(United States Department of Energy (DOE))	This work was supported by the U.S. Department of Energy, Office of Science, Basic Energy Sciences, under award no. DE-SC0017952 (to G. R. and E. L. H.) and award no. DE-SC0018173 (to N. L.).	Ali M, 2019, J AM CHEM SOC, V141, P13358, DOI 10.1021/jacs.9b03036; Angove HC, 2002, J BIOL CHEM, V277, P23374, DOI 10.1074/jbc.M200495200; Bamford VA, 2002, BIOCHEMISTRY-US, V41, P2921, DOI 10.1021/bi015765d; Borgstahl Gloria E O, 2007, Methods Mol Biol, V363, P109, DOI 10.1007/978-1-59745-209-0_6; Brooks SC, 2003, ENVIRON SCI TECHNOL, V37, P1850, DOI 10.1021/es0210042; Burgin AJ, 2007, FRONT ECOL ENVIRON, V5, P89, DOI 10.1890/1540-9295(2007)5[89:HWOTRO]2.0.CO;2; Bykov D, 2015, INORG CHEM, V54, P9303, DOI 10.1021/acs.inorgchem.5b01506; Castro HF, 2000, FEMS MICROBIOL ECOL, V31, P1, DOI 10.1016/S0168-6496(99)00071-9; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Christin PA, 2010, TRENDS GENET, V26, P400, DOI 10.1016/j.tig.2010.06.005; Clarke TA, 2008, METHOD ENZYMOL, V437, P63, DOI 10.1016/S0076-6879(07)37004-3; Clarke TA, 2008, BIOCHEMISTRY-US, V47, P3789, DOI 10.1021/bi702175w; Clarke TA, 2007, BIOCHEM J, V406, P19, DOI 10.1042/BJ20070321; Cunha CA, 2003, J BIOL CHEM, V278, P17455, DOI 10.1074/jbc.M211777200; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Einsle O, 2000, J BIOL CHEM, V275, P39608, DOI 10.1074/jbc.M006188200; Einsle O, 1999, NATURE, V400, P476, DOI 10.1038/22802; Einsle O, 2002, J AM CHEM SOC, V124, P11737, DOI 10.1021/ja0206487; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandes SO, 2012, SCI REP-UK, V2, DOI 10.1038/srep00419; Fuson K, 2014, STRUCTURE, V22, P104, DOI 10.1016/j.str.2013.10.001; Gao HC, 2010, MICROB BIOTECHNOL, V3, P455, DOI 10.1111/j.1751-7915.2010.00181.x; George SJ, 1999, BIOCHEM J, V344, P237, DOI 10.1042/0264-6021:3440237; HEINZ DW, 1995, EMBO J, V14, P3855, DOI 10.1002/j.1460-2075.1995.tb00057.x; Huygens D, 2007, SOIL BIOL BIOCHEM, V39, P2448, DOI 10.1016/j.soilbio.2007.04.013; Judd ET, 2012, BIOCHEMISTRY-US, V51, P10175, DOI 10.1021/bi3011708; KAJIE SI, 1986, EUR J BIOCHEM, V154, P457, DOI 10.1111/j.1432-1033.1986.tb09419.x; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lehnert N, 2018, NAT REV CHEM, V2, P278, DOI 10.1038/s41570-018-0041-7; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; LIU MC, 1988, ARCH BIOCHEM BIOPHYS, V262, P259, DOI 10.1016/0003-9861(88)90187-7; Lockwood CWJ, 2015, J AM CHEM SOC, V137, P3059, DOI 10.1021/ja512941j; Lukat P, 2008, BIOCHEMISTRY-US, V47, P2080, DOI 10.1021/bi7021415; Nobbmann Ulf, 2007, Biotechnol Genet Eng Rev, V24, P117; Ochoa WF, 2001, J MOL BIOL, V311, P837, DOI 10.1006/jmbi.2001.4910; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pereira IAC, 2000, BBA-PROTEIN STRUCT M, V1481, P119, DOI 10.1016/S0167-4838(00)00111-4; Pereira IC, 1996, BIOCHEM BIOPH RES CO, V224, P611, DOI 10.1006/bbrc.1996.1074; Putz M, 2018, SOIL BIOL BIOCHEM, V123, P97, DOI 10.1016/j.soilbio.2018.05.006; Reguera G, 2019, ADV MICROB PHYSIOL, V74, P1, DOI 10.1016/bs.ampbs.2019.02.007; Rey C, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0234; Roberts MF, 2018, CHEM REV, V118, P8435, DOI 10.1021/acs.chemrev.8b00208; Rodrigues ML, 2006, EMBO J, V25, P5951, DOI 10.1038/sj.emboj.7601439; SCHUMACHER W, 1994, BIOCHEM BIOPH RES CO, V205, P911, DOI 10.1006/bbrc.1994.2751; SCHUMACHER W, 1991, ARCH MICROBIOL, V156, P70, DOI 10.1007/BF00418190; Shi L, 2005, BIOTECHNIQUES, V38, P297, DOI 10.2144/05382PT01; Shi YH, 2019, FISH SHELLFISH IMMUN, V84, P502, DOI 10.1016/j.fsi.2018.10.036; Simon J, 2002, FEMS MICROBIOL REV, V26, P285, DOI 10.1111/j.1574-6976.2002.tb00616.x; Stach P, 2000, J INORG BIOCHEM, V79, P381, DOI 10.1016/S0162-0134(99)00248-2; Stetefeld Jorg, 2016, Biophys Rev, V8, P409, DOI 10.1007/s12551-016-0218-6; Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016; Sung Y, 2006, APPL ENVIRON MICROB, V72, P2775, DOI 10.1128/AEM.72.4.2775-2782.2006; Sutherland GRJ, 1997, BIOCHEMISTRY-US, V36, P8567, DOI 10.1021/bi970484k; Unno H, 2019, PROTEIN SCI, V28, P766, DOI 10.1002/pro.3592; van den Berg EM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01684; van den Berg EM, 2017, AMB EXPRESS, V7, DOI 10.1186/s13568-017-0398-x; van den Berg EM, 2015, ISME J, V9, P2153, DOI 10.1038/ismej.2015.26; Welsh A, 2014, APPL ENVIRON MICROB, V80, P2110, DOI 10.1128/AEM.03443-13; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Youngblut M, 2014, BIOCHEMISTRY-US, V53, P2136, DOI 10.1021/bi401705d; Youngblut M, 2012, J BIOL INORG CHEM, V17, P647, DOI 10.1007/s00775-012-0885-0; Zhu TT, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00004	63	8	8	6	27	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2020	295	33					11455	11465		10.1074/jbc.RA120.013981	http://dx.doi.org/10.1074/jbc.RA120.013981			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NG3YV	32518164	hybrid, Green Published			2022-12-26	WOS:000563922500008
J	Min, YQ; Ning, YJ; Wang, HL; Deng, F				Min, Yuan-Qin; Ning, Yun-Jia; Wang, Hualin; Deng, Fei			A RIG-I?like receptor directs antiviral responses to a bunyavirus and is antagonized by virus-induced blockade of TRIM25-mediated ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						innate immunity; retinoic acid-inducible gene I protein (RIG-I); tripartite motif-containing 25 (TRIM25); melanoma differentiation?associated protein 5 (MDA5); severe fever with thrombocytopenia syndrome virus (SFTSV); nonstructural protein (NSs); inclusion body (IB); immune evasion; virus-host interaction; virulence factor; virology; infectious disease; viral immunology	DOUBLE-STRANDED-RNA; THROMBOCYTOPENIA SYNDROME VIRUS; INNATE IMMUNE-RESPONSES; NF-KAPPA-B; SEVERE FEVER; PATTERN-RECOGNITION; DISEASE SEVERITY; ADAPTER PROTEIN; LIGASE RIPLET; PHLEBOVIRUS	The RIG-I?like receptors (RLRs) retinoic acid?inducible gene I protein (RIG-I) and melanoma differentiation?associated protein 5 (MDA5) are cytosolic pattern recognition receptors that recognize specific viral RNA products and initiate antiviral innate immunity. Severe fever with thrombocytopenia syndrome virus (SFTSV) is a highly pathogenic member of theBunyavirales. RIG-I, but not MDA5, has been suggested to sense some bunyavirus infections; however, the roles of RLRs in anti-SFTSV immune responses remain unclear. Here, we show that SFTSV infection induces an antiviral response accompanied by significant induction of antiviral and inflammatory cytokines and that RIG-I plays a main role in this induction by recognizing viral 5?-triphosphorylated RNAs and by signaling via the adaptor mitochondrial antiviral signaling protein. Moreover, MDA5 may also sense SFTSV infection and contribute to IFN induction, but to a lesser extent. We further demonstrate that the RLR-mediated anti-SFTSV signaling can be antagonized by SFTSV nonstructural protein (NSs) at the level of RIG-I activation. Protein interaction and MS-based analyses revealed that NSs interacts with the host protein tripartite motif?containing 25 (TRIM25), a critical RIG-I?activating ubiquitin E3 ligase, but not with RIG-I or Riplet, another E3 ligase required for RIG-I ubiquitination. NSs specifically trapped TRIM25 into viral inclusion bodies and inhibited TRIM25-mediated RIG-I-Lys-63?linked ubiquitination/activation, contributing to suppression of RLR-mediated antiviral signaling at its initial stage. These results provide insights into immune responses to SFTSV infection and clarify a mechanism of the viral immune evasion, which may help inform the development of antiviral therapeutics.	[Min, Yuan-Qin; Ning, Yun-Jia; Wang, Hualin; Deng, Fei] Chinese Acad Sci, Ctr Biosafety Megasci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Ning, YJ; Deng, F (corresponding author), Chinese Acad Sci, Ctr Biosafety Megasci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China.	nyj@wh.iov.cn; df@wh.iov.cn			National Natural Science Foundation of China [31700146, 31870162, 31621061, 31600144]; National Key Research and Development Program of China [2018YFA0507202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This work was supported by National Natural Science Foundation of China Grants 31700146, 31870162, 31621061, and 31600144 and National Key Research and Development Program of China Grant 2018YFA0507202.	Abudurexiti A, 2019, ARCH VIROL, V164, P1949, DOI 10.1007/s00705-019-04253-6; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Ban J, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10120716; Cadena C, 2019, CELL, V177, P1187, DOI 10.1016/j.cell.2019.03.017; Castanier C, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-44; Chan YK, 2016, NAT REV MICROBIOL, V14, P360, DOI 10.1038/nrmicro.2016.45; Chen H, 2013, J MOL CELL BIOL, V5, P111, DOI 10.1093/jmcb/mjt006; Chiang C, 2018, J VIROL, V92, DOI 10.1128/JVI.01737-17; Chow KT, 2018, ANNU REV IMMUNOL, V36, P667, DOI 10.1146/annurev-immunol-042617-053309; Deng BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041365; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Errett JS, 2015, VIROL SIN, V30, P163, DOI 10.1007/s12250-015-3604-5; Fan L, 2010, J VIROL, V84, P1785, DOI 10.1128/JVI.01362-09; Feng K, 2019, J BIOL CHEM, V294, P9503, DOI 10.1074/jbc.RA118.006563; Gack MU, 2008, P NATL ACAD SCI USA, V105, P16743, DOI 10.1073/pnas.0804947105; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gack MU, 2014, J VIROL, V88, P5213, DOI 10.1128/JVI.03370-13; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Gowen BB, 2006, J IMMUNOL, V177, P6301, DOI 10.4049/jimmunol.177.9.6301; Gupta S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006852; Habjan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002032; Hage A, 2019, J GEN VIROL, V100, P1641, DOI 10.1099/jgv.0.001341; Hayman TJ, 2019, IMMUNOL CELL BIOL, V97, P840, DOI 10.1111/imcb.12284; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Hou DH, 2013, J VIROL, V87, P829, DOI 10.1128/JVI.02329-12; Hu Y, 2017, J VIROL, V91, DOI 10.1128/JVI.02143-16; Ito T, 2005, SPRINGER SEMIN IMMUN, V26, P221, DOI 10.1007/s00281-004-0180-4; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Kell AM, 2015, VIROLOGY, V479, P110, DOI 10.1016/j.virol.2015.02.017; Kim KH, 2013, EMERG INFECT DIS, V19, P1892, DOI 10.3201/eid1911.130792; Lang XT, 2017, J EXP MED, V214, P459, DOI 10.1084/jem.20160592; Li DX, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.1; Li MMH, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006145; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lin HY, 2019, NAT IMMUNOL, V20, P812, DOI 10.1038/s41590-019-0379-0; Liu W, 2013, CLIN INFECT DIS, V57, P1292, DOI 10.1093/cid/cit530; Liu ZY, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav0163; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Martin-Vicente M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01187; Matsuno K, 2015, J VIROL, V89, P594, DOI 10.1128/JVI.02704-14; McFadden MJ, 2017, CURR OPIN VIROL, V22, P36, DOI 10.1016/j.coviro.2016.11.012; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Min YQ, 2020, ACS INFECT DIS, V6, P857, DOI 10.1021/acsinfecdis.9b00492; Moriyama M, 2018, J VIROL, V92, DOI 10.1128/JVI.00706-18; Mourya DT, 2014, J VIROL, V88, P3605, DOI 10.1128/JVI.02617-13; Ning YJ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01182; Ning YJ, 2018, PROTEIN CELL, V9, P389, DOI 10.1007/s13238-017-0471-x; Ning YJ, 2017, J BIOL CHEM, V292, P16722, DOI 10.1074/jbc.M117.805127; Ning YJ, 2015, J VIROL, V89, P4227, DOI 10.1128/JVI.00154-15; Ning YJ, 2014, J MOL CELL BIOL, V6, DOI 10.1093/jmcb/mju015; Okamoto M, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01942; Oshiumi H, 2010, CELL HOST MICROBE, V8, P496, DOI 10.1016/j.chom.2010.11.008; Oshiumi H, 2009, J BIOL CHEM, V284, P807, DOI 10.1074/jbc.M804259200; Park EK, 2007, INFLAMM RES, V56, P45, DOI 10.1007/s00011-007-6115-5; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Ren FL, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00599; Sanchez JG, 2016, CELL REP, V16, P1315, DOI 10.1016/j.celrep.2016.06.070; Santiago FW, 2014, J VIROL, V88, P4572, DOI 10.1128/JVI.03021-13; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Savage HM, 2013, AM J TROP MED HYG, V89, P445, DOI 10.4269/ajtmh.13-0209; Schlee M, 2016, NAT REV IMMUNOL, V16, P566, DOI 10.1038/nri.2016.78; Schlee M, 2013, IMMUNOBIOLOGY, V218, P1322, DOI 10.1016/j.imbio.2013.06.007; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Scholte FEM, 2017, CELL REP, V20, P2396, DOI 10.1016/j.celrep.2017.08.040; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shen S, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0093-2; Spengler JR, 2015, J VIROL, V89, P10219, DOI 10.1128/JVI.01643-15; Sun YL, 2012, J INFECT DIS, V206, P1085, DOI 10.1093/infdis/jis452; Takahashi T, 2014, J INFECT DIS, V209, P816, DOI 10.1093/infdis/jit603; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tang XY, 2013, J INFECT DIS, V207, P736, DOI 10.1093/infdis/jis748; Versteeg GA, 2010, CURR OPIN MICROBIOL, V13, P508, DOI 10.1016/j.mib.2010.05.009; Wagner H, 2004, TRENDS IMMUNOL, V25, P381, DOI 10.1016/j.it.2004.04.011; Wang H, 2011, J GEN VIROL, V92, P1199, DOI 10.1099/vir.0.029405-0; Wang J, 2014, EMERG INFECT DIS, V20, P1040, DOI 10.3201/eid2006.140003; Wang SR, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501535; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; Weber M, 2013, CELL HOST MICROBE, V13, P336, DOI 10.1016/j.chom.2013.01.012; Wu XD, 2014, J VIROL, V88, P3067, DOI 10.1128/JVI.03510-13; Xu BL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002369; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yamada S, 2018, J VIROL, V92, DOI [10.1128/JVI.02246-17, 10.1128/jvi.02246-17]; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zhang YZ, 2012, CLIN INFECT DIS, V54, P527, DOI 10.1093/cid/cir804; Zhang Yong-Zhen, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P209; Zheng XJ, 2017, J VIROL, V91, DOI [10.1128/jvi.00088-17, 10.1128/JVI.00088-17]	92	21	23	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9691	9711		10.1074/jbc.RA120.013973	http://dx.doi.org/10.1074/jbc.RA120.013973			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32471869	Green Published, hybrid			2022-12-26	WOS:000552758600034
J	Calhoun, PJ; Phan, AV; Taylor, JD; James, CC; Padget, RL; Zeitz, MJ; Smyth, JW				Calhoun, Patrick J.; Phan, Allen, V; Taylor, Jordan D.; James, Carissa C.; Padget, Rachel L.; Zeitz, Michael J.; Smyth, James W.			Adenovirus targets transcriptional and posttranslational mechanisms to limit gap junction function	FASEB JOURNAL			English	Article						adenovirus; connexin; gap junction; myocarditis; beta-catenin	BETA-CATENIN; INTERCELLULAR COMMUNICATION; ZONULA OCCLUDENS-1; CONNEXIN43 PHOSPHORYLATION; PROTEIN CONNEXIN-43; VIRAL MYOCARDITIS; IN-VITRO; EXPRESSION; CELLS; P53	Adenoviruses are responsible for a spectrum of pathogenesis including viral myocarditis. The gap junction protein connexin43 (Cx43, gene nameGJA1) facilitates rapid propagation of action potentials necessary for each heartbeat. Gap junctions also propagate innate and adaptive antiviral immune responses, but how viruses may target these structures is not understood. Given this immunological role of Cx43, we hypothesized that gap junctions would be targeted during adenovirus type 5 (Ad5) infection. We find reduced Cx43 protein levels due to decreasedGJA1mRNA transcripts dependent upon beta-catenin transcriptional activity during Ad5 infection, with early viral protein E4orf1 sufficient to induce beta-catenin phosphorylation. Loss of gap junction function occurs prior to reduced Cx43 protein levels with Ad5 infection rapidly inducing Cx43 phosphorylation events consistent with altered gap junction conductance. Direct Cx43 interaction with ZO-1 plays a critical role in gap junction regulation. We find loss of Cx43/ZO-1 complexing during Ad5 infection by co-immunoprecipitation and complementary studies in human induced pluripotent stem cell derived-cardiomyocytes reveal Cx43 gap junction remodeling by reduced ZO-1 complexing. These findings reveal specific targeting of gap junction function by Ad5 leading to loss of intercellular communication which would contribute to dangerous pathological states including arrhythmias in infected hearts.	[Calhoun, Patrick J.; James, Carissa C.; Padget, Rachel L.; Zeitz, Michael J.; Smyth, James W.] VTC, Fralin Biomed Res Inst, 2 Riverside Circle, Roanoke, VA 24016 USA; [Calhoun, Patrick J.; Smyth, James W.] Virginia Tech, Dept Biol Sci, Blacksburg, VA USA; [Phan, Allen, V; Taylor, Jordan D.; Smyth, James W.] Virginia Tech, Carillon Sch Med, Roanoke, VA USA; [James, Carissa C.; Padget, Rachel L.] Virginia Tech, Grad Program Translat Biol Med & Hlth, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Smyth, JW (corresponding author), VTC, Fralin Biomed Res Inst, 2 Riverside Circle, Roanoke, VA 24016 USA.	smythj@vtc.vt.edu		Smyth, James/0000-0003-4246-7904	American Heart Association [18PRE33960573] Funding Source: Medline; NHLBI NIH HHS [R01 HL132236, F31 HL140909, F31 HL152649] Funding Source: Medline	American Heart Association(American Heart Association); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640; Agullo-Pascual E, 2014, CARDIOVASC RES, V104, P371, DOI 10.1093/cvr/cvu195; Ai ZW, 2000, J CLIN INVEST, V105, P161, DOI 10.1172/JCI7798; Alonso F, 2010, CARDIOVASC RES, V87, P166, DOI 10.1093/cvr/cvq031; ARANY Z, 1994, CELL, V77, P799, DOI 10.1016/0092-8674(94)90127-9; Babica P, 2016, METHODS MOL BIOL, V1437, P133, DOI 10.1007/978-1-4939-3664-9_9; Barker RJ, 2002, CIRC RES, V90, P317, DOI 10.1161/hh0302.104471; Basu R, 2016, J VIROL, V90, P2586, DOI 10.1128/JVI.02420-15; Bauer A, 2000, EMBO J, V19, P6121, DOI 10.1093/emboj/19.22.6121; Beardslee MA, 1998, CIRC RES, V83, P629, DOI 10.1161/01.RES.83.6.629; BLAIR GE, 1989, VIRUS RES, V14, P339, DOI 10.1016/0168-1702(89)90026-9; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BONDESSON M, 1992, EMBO J, V11, P3347, DOI 10.1002/j.1460-2075.1992.tb05413.x; Bowles NE, 2003, J AM COLL CARDIOL, V42, P466, DOI 10.1016/S0735-1097(03)00648-X; BRACIALE TJ, 1987, IMMUNOL REV, V98, P95, DOI 10.1111/j.1600-065X.1987.tb00521.x; Bridges RG, 2016, MBIO, V7, DOI 10.1128/mBio.02184-15; Bruce AF, 2008, CARDIOVASC RES, V77, P757, DOI 10.1093/cvr/cvm083; Castellano P, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00122; Chandrasekaran A, 2019, J VIROL, V93, DOI 10.1128/JVI.00569-19; Chen Q, 2016, NATURE, V533, P493, DOI 10.1038/nature18268; Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028; Dennert R, 2008, EUR HEART J, V29, P2073, DOI 10.1093/eurheartj/ehn296; Dobner T, 1996, SCIENCE, V272, P1470, DOI 10.1126/science.272.5267.1470; Dunn CA, 2014, J CELL SCI, V127, P455, DOI 10.1242/jcs.142497; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FALLON RF, 1981, J CELL BIOL, V90, P521, DOI 10.1083/jcb.90.2.521; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fang L, 2016, CANCER RES, V76, P891, DOI 10.1158/0008-5472.CAN-15-1519; Ferrari R, 2014, CELL HOST MICROBE, V16, P663, DOI 10.1016/j.chom.2014.10.004; Fischer NO, 2001, J VIROL METHODS, V91, P157, DOI 10.1016/S0166-0934(00)00260-3; Frese KK, 2003, ONCOGENE, V22, P710, DOI 10.1038/sj.onc.1206151; Fung G, 2016, CIRC RES, V118, P496, DOI 10.1161/CIRCRESAHA.115.306573; Gauntt CJ, 1995, EUR HEART J, V16, P56, DOI 10.1093/eurheartj/16.suppl_O.56; Giepmans BNG, 2001, J BIOL CHEM, V276, P8544, DOI 10.1074/jbc.M005847200; Goldsmith KT, 1998, VIROLOGY, V248, P406, DOI 10.1006/viro.1998.9293; Green Maurice, 2006, Curr Protoc Microbiol, VChapter 14, DOI 10.1002/9780471729259.mc14c01s00; Gutstein DE, 2001, CIRC RES, V88, P333, DOI 10.1161/01.RES.88.3.333; Hale TK, 1999, J BIOL CHEM, V274, P23777, DOI 10.1074/jbc.274.34.23777; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Herve JC, 2012, BBA-BIOMEMBRANES, V1818, P1844, DOI 10.1016/j.bbamem.2011.12.009; Hsiao HJ, 2010, ARCH VIROL, V155, P1107, DOI 10.1007/s00705-010-0693-1; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; James CC, 2018, MOL BIOL CELL, V29, P797, DOI 10.1091/mbc.E17-06-0406; Jogler C, 2006, J VIROL, V80, P3549, DOI 10.1128/JVI.80.7.3549-3558.2006; Johansen D, 2011, CELL PHYSIOL BIOCHEM, V28, P103, DOI 10.1159/000331719; Kanagaratnam P, 2002, J AM COLL CARDIOL, V39, P116, DOI 10.1016/S0735-1097(01)01710-7; Kearney MT, 2001, POSTGRAD MED J, V77, P4, DOI 10.1136/pmj.77.903.4; Koester-Patzlaff C, 2007, BRAIN RES, V1184, P316, DOI 10.1016/j.brainres.2007.09.062; Kostin S, 2007, J CELL MOL MED, V11, P892, DOI 10.1111/j.1582-4934.2007.00063.x; Laird DW, 2005, BBA-BIOMEMBRANES, V1711, P172, DOI 10.1016/j.bbamem.2004.09.009; LAIRD DW, 1995, J CELL BIOL, V131, P1193, DOI 10.1083/jcb.131.5.1193; Lampe PD, 2000, J CELL BIOL, V149, P1503, DOI 10.1083/jcb.149.7.1503; Li MWM, 2009, P NATL ACAD SCI USA, V106, P10213, DOI 10.1073/pnas.0901700106; Liao CK, 2013, TOXICOLOGY, V314, P11, DOI 10.1016/j.tox.2013.08.001; Lim BK, 2008, J CLIN INVEST, V118, P2758, DOI 10.1172/JCI34777; Lisewski U, 2008, J EXP MED, V205, P2369, DOI 10.1084/jem.20080897; Ma B, 2015, J CELL SCI, V128, P2430, DOI 10.1242/jcs.168542; MARTINO TA, 1994, CIRC RES, V74, P182, DOI 10.1161/01.RES.74.2.182; McCarthy MK, 2016, VIROLOGY, V498, P57, DOI 10.1016/j.virol.2016.08.009; McCarthy MK, 2015, J VIROL, V89, P468, DOI 10.1128/JVI.02077-14; Moreno AP, 2007, PROG BIOPHYS MOL BIO, V94, P107, DOI 10.1016/j.pbiomolbio.2007.03.004; Nagasawa K, 2006, J CELL PHYSIOL, V208, P123, DOI 10.1002/jcp.20647; Neijssen J, 2005, NATURE, V434, P83, DOI 10.1038/nature03290; Nimlamool W, 2015, MOL BIOL CELL, V26, P2755, DOI 10.1091/mbc.E14-06-1105; O'Shea CC, 2005, CELL CYCLE, V4, P883, DOI 10.4161/cc.4.7.1791; OELZE I, 1995, J VIROL, V69, P4489, DOI 10.1128/JVI.69.7.4489-4494.1995; Oyamada M, 2013, BBA-BIOMEMBRANES, V1828, P118, DOI 10.1016/j.bbamem.2011.12.031; Pankuweit S, 2013, HEART FAIL REV, V18, P683, DOI 10.1007/s10741-012-9357-4; Park DJ, 2007, CELL COMMUN ADHES, V14, P211, DOI 10.1080/15419060701755958; Patel SJ, 2009, P NATL ACAD SCI USA, V106, P12867, DOI 10.1073/pnas.0809292106; Poelzing S, 2004, AM J PHYSIOL-HEART C, V287, pH1762, DOI 10.1152/ajpheart.00346.2004; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; RAYCHAUDHURI P, 1987, EMBO J, V6, P4073, DOI 10.1002/j.1460-2075.1987.tb02753.x; Rhett JM, 2011, MOL BIOL CELL, V22, P1516, DOI 10.1091/mbc.E10-06-0548; Richards TS, 2004, J CELL BIOL, V167, P555, DOI 10.1083/jcb.200404142; SARNOW P, 1982, CELL, V28, P387, DOI 10.1016/0092-8674(82)90356-7; Sato PY, 2011, CIRC RES, V109, P193, DOI 10.1161/CIRCRESAHA.111.247023; Savon C, 2008, J CLIN VIROL, V43, P152, DOI 10.1016/j.jcv.2008.05.012; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Segretain D, 2004, BIOCHIMIE, V86, P241, DOI 10.1016/j.biochi.2004.05.003; Sharma A, 2014, CIRC RES, V115, P556, DOI 10.1161/CIRCRESAHA.115.303810; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Singh D, 2005, J BIOL CHEM, V280, P30416, DOI 10.1074/jbc.M506799200; Sirnes S, 2009, BIOCHEM BIOPH RES CO, V382, P41, DOI 10.1016/j.bbrc.2009.02.141; Smyth JW, 2014, TRAFFIC, V15, P684, DOI 10.1111/tra.12169; Smyth JW, 2013, CELL REP, V5, P611, DOI 10.1016/j.celrep.2013.10.009; Solan JL, 2007, J CELL BIOL, V179, P1301, DOI 10.1083/jcb.200707060; Solan JL, 2007, J MEMBRANE BIOL, V217, P35, DOI 10.1007/s00232-007-9035-y; Solan JL, 2014, FEBS LETT, V588, P1423, DOI 10.1016/j.febslet.2014.01.049; Soria C, 2010, NATURE, V466, P1076, DOI 10.1038/nature09307; Spagnol G, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061562; Suomalainen M, 2001, EMBO J, V20, P1310, DOI 10.1093/emboj/20.6.1310; Tago K, 2000, GENE DEV, V14, P1741; Takemaru KI, 2003, NATURE, V422, P905, DOI 10.1038/nature01570; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Teodoro JG, 1997, J VIROL, V71, P3620, DOI 10.1128/JVI.71.5.3620-3627.1997; Teunissen BEJ, 2004, CARDIOVASC RES, V62, P246, DOI 10.1016/j.cardiores.2003.12.011; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; Toyofuku T, 1998, J BIOL CHEM, V273, P12725, DOI 10.1074/jbc.273.21.12725; UNWIN PNT, 1980, NATURE, V283, P545, DOI 10.1038/283545a0; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; van der Heyden MAG, 1998, J CELL SCI, V111, P1741; Vozzi C, 1999, J MOL CELL CARDIOL, V31, P991, DOI 10.1006/jmcc.1999.0937; Warn-Cramer BJ, 1998, J BIOL CHEM, V273, P9188, DOI 10.1074/jbc.273.15.9188; WarnCramer BJ, 1996, J BIOL CHEM, V271, P3779; Wei CJ, 2005, J BIOL CHEM, V280, P19925, DOI 10.1074/jbc.M412921200; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; YEW PR, 1994, GENE DEV, V8, P190, DOI 10.1101/gad.8.2.190; YEW PR, 1992, NATURE, V357, P82, DOI 10.1038/357082a0; Yousuf MA, 2016, BIOCHEMISTRY-US, V55, P5938, DOI 10.1021/acs.biochem.6b00858; Yue P, 2006, CELL PHYSIOL BIOCHEM, V17, P129, DOI 10.1159/000092074; Zeitz MJ, 2019, CELL REP, V27, P2737, DOI 10.1016/j.celrep.2019.04.114; Zemljic-Harpf AE, 2014, J CELL SCI, V127, P1104, DOI 10.1242/jcs.143743; Zhang F, 2005, CIRC RES, V96, P950, DOI 10.1161/01.RES.0000165867.95291.7b; Zhang SS, 2011, P NATL ACAD SCI USA, V108, P13576, DOI 10.1073/pnas.1106911108; Zhang YM, 2005, J VIROL, V79, P12125, DOI 10.1128/JVI.79.19.12125-12131.2005; Zhao LM, 2019, J MOL CELL CARDIOL, V135, P90, DOI 10.1016/j.yjmcc.2019.08.007; Zheng YT, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005415; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	120	3	3	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					9694	9712		10.1096/fj.202000667R	http://dx.doi.org/10.1096/fj.202000667R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32485054	Green Accepted, Bronze			2022-12-26	WOS:000546308400061
J	Mustafa, HMJ; Ayob, M; Albashish, D; Abu-Taleb, S				Mustafa, Hossam M. J.; Ayob, Masri; Albashish, Dheeb; Abu-Taleb, Sawsan			Solving text clustering problem using a memetic differential evolution algorithm	PLOS ONE			English	Article							PARTICLE SWARM OPTIMIZATION; CUCKOO OPTIMIZATION	The text clustering is considered as one of the most effective text document analysis methods, which is applied to cluster documents as a consequence of the expanded big data and online information. Based on the review of the related work of the text clustering algorithms, these algorithms achieved reasonable clustering results for some datasets, while they failed on a wide variety of benchmark datasets. Furthermore, the performance of these algorithms was not robust due to the inefficient balance between the exploitation and exploration capabilities of the clustering algorithm. Accordingly, this research proposes a Memetic Differential Evolution algorithm (MDETC) to solve the text clustering problem, which aims to address the effect of the hybridization between the differential evolution (DE) mutation strategy with the memetic algorithm (MA). This hybridization intends to enhance the quality of text clustering and improve the exploitation and exploration capabilities of the algorithm. Our experimental results based on six standard text clustering benchmark datasets (i.e. the Laboratory of Computational Intelligence (LABIC)) have shown that the MDETC algorithm outperformed other compared clustering algorithms based on AUC metric, F-measure, and the statistical analysis. Furthermore, the MDETC is compared with the state of art text clustering algorithms and obtained almost the best results for the standard benchmark datasets.	[Mustafa, Hossam M. J.; Ayob, Masri] Univ Kebangsaan Malaysia, Fac Informat Sci & Technol, Data Min & Optimizat Res Grp, Ctr Artificial Intelligence Technol, Bangi, Malaysia; [Albashish, Dheeb; Abu-Taleb, Sawsan] Al Balqa Appl Univ, Prince Abdullah bin Ghazi Fac Informat & Commun T, Dept Comp Sci, Salt, Jordan	Universiti Kebangsaan Malaysia; Al-Balqa Applied University	Mustafa, HMJ (corresponding author), Univ Kebangsaan Malaysia, Fac Informat Sci & Technol, Data Min & Optimizat Res Grp, Ctr Artificial Intelligence Technol, Bangi, Malaysia.	hasa.mustafa@gmail.com	Albashish, Dheeb/AAA-2100-2021; Abu Taleb, Sawsan/HGC-0042-2022	Albashish, Dheeb/0000-0003-1252-1607; Mustafa, Hossam/0000-0003-2015-7497	FRGS of Ministry of Higher Education, Malaysia [FRGS/1/2018/ICT02/UKM/01/1]	FRGS of Ministry of Higher Education, Malaysia	This work was supported by the FRGS of Ministry of Higher Education, Malaysia. Ref. No: FRGS/1/2018/ICT02/UKM/01/1.	Abbasi AA, 2007, COMPUT COMMUN, V30, P2826, DOI 10.1016/j.comcom.2007.05.024; Abualigah LM, 2018, APPL INTELL, V48, P4047, DOI 10.1007/s10489-018-1190-6; Abualigah LM, 2018, J COMPUT SCI-NETH, V25, P456, DOI 10.1016/j.jocs.2017.07.018; Abualigah LM, 2016, 2016 7 INT C COMP SC, P1, DOI [10.1109/CSIT.2016.7549464, DOI 10.1109/CSIT.2016.7549456]; Aggarwal C.C., 2012, MINING TEXT DATA, P77, DOI [DOI 10.1007/978-1-4614-3223-44, 10.1007/978-1-4614-3223-4, 10.1007/978-1-4614-3223-4_4, DOI 10.1007/978-1-4614-3223-4_4]; Akter R, 2013, IERI PROC, V4, P370, DOI 10.1016/j.ieri.2013.11.053; Ali MZ, 2017, IEEE T CYBERNETICS, V47, P2768, DOI 10.1109/TCYB.2016.2617301; Amiri E, 2016, APPL SOFT COMPUT, V41, P15, DOI 10.1016/j.asoc.2015.12.008; [Anonymous], 2012, P 16 CSI INT S ART I, DOI [10.1109/AISP.2012.6313708, DOI 10.1109/AISP.2012.6313708]; Bharti KK, 2016, SOFT COMPUT, V20, P1113, DOI 10.1007/s00500-014-1571-7; Bharti KK, 2014, PROC INT CONF EMERG, P337, DOI 10.1109/EAIT.2014.48; Bouyer A, 2018, APPL SOFT COMPUT, V67, P172, DOI 10.1016/j.asoc.2018.03.011; Cui XH, 2005, 2005 IEEE SWARM INTELLIGENCE SYMPOSIUM, P185; Devi S S, 2015, IJSRSET, V1, P145; Forsati R, 2015, NEUROCOMPUTING, V159, P9, DOI 10.1016/j.neucom.2015.02.048; Forsati R, 2013, INFORM SCIENCES, V220, P269, DOI 10.1016/j.ins.2012.07.025; Gupta T., 2014, INT J ADV RES COMPUT, V4, P491; Jaradat G, 2016, APPL SOFT COMPUT, V44, P45, DOI 10.1016/j.asoc.2016.01.002; Kang JY, 2012, ADV INTEL SOFT COMPU, V139, P247; Karol S, 2013, OPEN COMPUT SCI, V3, P69, DOI 10.2478/s13537-013-0104-2; Kheng CW, 2012, INT J SYST SCI, V43, P1193, DOI 10.1080/00207721.2011.617526; Lu YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056221; Manikandan P, 2014, ADV INTELL SYST, V236, P1275, DOI 10.1007/978-81-322-1602-5_133; Miller B. L., 1995, Complex Systems, V9, P193; Mohammed AJ, 2016, J INF COMMUN TECHNOL, V15, P57; Mustafa HMJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216906; Mustafa HMJ, 2019, J INF COMMUN TECHNOL, V18, P77; Nagarajan E, 2017, PROCEEDINGS OF THE 2017 INTERNATIONAL CONFERENCE ON BIG DATA ANALYTICS AND COMPUTATIONAL INTELLIGENCE (ICBDAC), P459, DOI 10.1109/ICBDACI.2017.8070884; Neri F, 2012, STUD COMPUT INTELL, V379, P3; Neri F, 2008, IEEE C EVOL COMPUTAT, P2135, DOI 10.1109/CEC.2008.4631082; Ramadan RM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193142; Rodriguez MZ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210236; Sabar NR, 2013, P 6 MULTIDISCIPLINAR, P549; Saida IB., 2014, GENETIC EVOLUTIONARY, P55, DOI [10.1007/978-3-319-01796-9_6, DOI 10.1007/978-3-319-01796-9_6]; Shokouhifar M, 2017, ENG APPL ARTIF INTEL, V60, P16, DOI 10.1016/j.engappai.2017.01.007; Sivanandam S., 2008, INTRO GENETIC ALGORI, DOI DOI 10.1007/978-3-540-73190-0; Song W, 2017, SOFT COMPUT, V21, P283, DOI 10.1007/s00500-014-1458-7; Song W, 2015, EXPERT SYST APPL, V42, P2517, DOI 10.1016/j.eswa.2014.11.003; Song W, 2009, EXPERT SYST APPL, V36, P9095, DOI 10.1016/j.eswa.2008.12.046; Sorensen K, 2006, COMPUT OPER RES, V33, P1214, DOI 10.1016/j.cor.2004.09.011; Wang H, 2017, KNOWL-BASED SYST, V118, P15, DOI 10.1016/j.knosys.2016.11.008; Wang X.L., 2016, J SOFTWARE, V27, P1, DOI DOI 10.1017/S0956536116000079; Wu TH, 2015, COMPUT OPER RES, V54, P52, DOI 10.1016/j.cor.2014.08.016; Wu W., 2013, CLUSTERING INFORM RE, V11, DOI [10.1007/978-1-4613-0227-8, DOI 10.1007/978-1-4613-0227-8]; Yassen Esam Taha, 2015, Journal of Theoretical and Applied Information Technology, V73, P43; Yassen ET, 2017, COMPUT IND ENG, V113, P382, DOI 10.1016/j.cie.2017.09.034; Zaw MM, 2015, WEB DOCUMENT CLUSTER, P263, DOI [10.1007/978-3-319-13826-8_14, DOI 10.1007/978-3-319-13826-8_14]; Zhou AM, 2011, SWARM EVOL COMPUT, V1, P32, DOI 10.1016/j.swevo.2011.03.001	48	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0232816	10.1371/journal.pone.0232816	http://dx.doi.org/10.1371/journal.pone.0232816			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525869	Green Published, gold			2022-12-26	WOS:000542036800032
J	Jiang, K; Liu, P; Xu, HZ; Liang, DP; Fang, K; Du, S; Cheng, W; Ye, LG; Liu, T; Zhang, XH; Gong, P; Shao, SJ; Wang, YF; Meng, SS				Jiang, Ke; Liu, Peng; Xu, Huizhe; Liang, Dapeng; Fang, Kun; Du, Sha; Cheng, Wei; Ye, Leiguang; Liu, Tong; Zhang, Xiaohong; Gong, Peng; Shao, Shujuan; Wang, Yifei; Meng, Songshu			SASH1 suppresses triple-negative breast cancer cell invasion through YAP-ARHGAP42-actin axis	ONCOGENE			English	Article							HIPPO PATHWAY; ACTIN CYTOSKELETON; YAP; GENE; COMPLEX; GROWTH; PHOSPHORYLATION; METASTASIS; INHIBITION; EXPRESSION	Triple-negative breast cancer (TNBC) is extremely aggressive and lacks effective therapy. SAM and SH3 domain containing1 (SASH1) has been implicated in TNBC as a candidate tumor suppressor; however, the mechanisms of action of SASH1 in TNBC remain underexplored. Here, we show that SASH1 was significantly downregulated in TNBC patients samples compared with other subtypes of breast cancer. Ectopic SASH1 expression inhibited, while depletion of SASH1 enhanced, the invasive phenotype of TNBC cells, accompanied by deregulated expression of MMP2 and MMP9. The functional effects of SASH1 depletion were confirmed in the chicken chorioallantoic membrane and mouse xenograft models. Mechanistically, SASH1 knockdown downregulated the phosphorylation levels of the Hippo kinase LATS1 and its effector YAP (Yes associated protein), thereby upregulating YAP accumulation together with its downstream target CYR61. Consistently, forced SASH1 expression exhibited opposite effects. Pharmacological inhibition of YAP or knockdown of YAP reversed the enhanced cell invasion of TNBC cells following SASH1 depletion. Furthermore, SASH1-induced YAP signaling was LATS1-dependent, which in reverse enhanced phosphorylation of SASH1. The SASH1 S407A mutant (phosphorylation deficient) failed to rescue the altered YAP signaling by SASH1 knockdown. Notably, SASH1 depletion upregulated ARHGAP42 levels via YAP-TEAD and the YAP-ARHGAP42-actin axis contributed to SASH1-regulated TNBC cell invasion. Therefore, our findings uncover a new mechanism for the tumor-suppressive activity of SASH1 in TNBC, which may serve as a novel target for therapeutic intervention.	[Jiang, Ke; Xu, Huizhe; Liang, Dapeng; Fang, Kun; Du, Sha; Cheng, Wei; Zhang, Xiaohong; Meng, Songshu] Dalian Med Univ, Inst Canc Stem Cell, Canc Ctr, Dalian 116044, Peoples R China; [Liu, Peng; Gong, Peng] Shenzhen Univ, Gen Hosp, Dept Gen Surg, Shenzhen 518055, Peoples R China; [Liu, Peng; Gong, Peng] Shenzhen Univ, Sch Med, Carson Int Canc Res Ctr, Shenzhen 518055, Peoples R China; [Ye, Leiguang] Harbin Med Univ, Canc Hosp, Dept Oncol, Harbin 150000, Peoples R China; [Liu, Tong] Harbin Med Univ, Canc Hosp, Dept Breast Surg, Harbin 150000, Peoples R China; [Shao, Shujuan] Dalian Med Univ, Key Lab Prote, Dalian 116044, Peoples R China; [Wang, Yifei] Dalian Med Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Dalian 116027, Peoples R China	Dalian Medical University; Shenzhen University; Shenzhen University; Harbin Medical University; Harbin Medical University; Dalian Medical University; Dalian Medical University	Meng, SS (corresponding author), Dalian Med Univ, Inst Canc Stem Cell, Canc Ctr, Dalian 116044, Peoples R China.; Shao, SJ (corresponding author), Dalian Med Univ, Key Lab Prote, Dalian 116044, Peoples R China.; Wang, YF (corresponding author), Dalian Med Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Dalian 116027, Peoples R China.	shaoshujuan2006@126.com; yly2000.312@163.com; ssmeng@dmu.edu.cn	chegn, maizy/GVU-3127-2022	Jiang, Ke/0000-0001-7959-7716	National Natural Science Foundation of China [81572707, 81772973, 81973646, 81402071]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank professors Bin Zhao, Huadong Pei, Shian Wu, Zengqiang Yuan and Alexander Hergovich for providing plasmids. The authors gratefully acknowledge the financial support from the National Natural Science Foundation of China (81572707 and 81772973 to SM, 81973646 to PG, 81402071 to DL).	BUBB MR, 1994, J BIOL CHEM, V269, P14869; Burgess JT, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.364; Burgess JT, 2016, ONCOTARGET, V7, P72807, DOI 10.18632/oncotarget.12020; Calses PC, 2019, TRENDS CANCER, V5, P297, DOI 10.1016/j.trecan.2019.04.001; Citron F, 2017, CLIN CANCER RES, V23, P3769, DOI 10.1158/1078-0432.CCR-16-2814; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Coumans Joelle V F, 2018, Biophys Rev, V10, P1323, DOI 10.1007/s12551-018-0445-0; Das Thakur M, 2010, CURR BIOL, V20, P657, DOI 10.1016/j.cub.2010.02.035; Fang Q, 2018, ONCOTARGET, V9, P2475, DOI 10.18632/oncotarget.23504; Franke FC, 2019, CELL MOL GASTROENTER, V7, P33, DOI 10.1016/j.jcmgh.2018.08.007; Gong XC, 2017, ONCOTARGETS THER, V10, P271, DOI 10.2147/OTT.S119244; Hiemer SE, 2014, J BIOL CHEM, V289, P13461, DOI 10.1074/jbc.M113.529115; Jagannathan R, 2016, MOL CELL BIOL, V36, P2526, DOI 10.1128/MCB.00136-16; Jiang K, 2016, ONCOTARGET, V7, P25652, DOI 10.18632/oncotarget.8357; Kim T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10186; Kumar MA, 2018, MOL CELL BIOCHEM, V442, P1, DOI 10.1007/s11010-017-3187-6; Lin SY, 2013, J BUON, V18, P891; Liu M, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0806-3; Liu X, 2018, CELL SIGNAL, V51, P243, DOI 10.1016/j.cellsig.2018.08.011; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Luo WF, 2017, J CELL SCI, V130, P2382, DOI 10.1242/jcs.197434; Ma SH, 2019, ANNU REV BIOCHEM, V88, P577, DOI 10.1146/annurev-biochem-013118-111829; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Martini M, 2011, INT J BIOCHEM CELL B, V43, P1630, DOI 10.1016/j.biocel.2011.07.012; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Porazinski S, 2015, NATURE, V521, P217, DOI 10.1038/nature14215; Qiao YT, 2017, CELL REP, V19, P1495, DOI 10.1016/j.celrep.2017.04.075; Rimkus C, 2006, BRIT J CANCER, V95, P1419, DOI 10.1038/sj.bjc.6603452; Shi PG, 2015, ACTA BIOCH BIOPH SIN, V47, P53, DOI 10.1093/abbs/gmu114; Shoji K, 2012, BIOCHEM BIOPH RES CO, V424, P52, DOI 10.1016/j.bbrc.2012.06.063; Stubblefield K, 2017, EXP CELL RES, V359, P384, DOI 10.1016/j.yexcr.2017.08.022; Sulaiman A, 2018, MOL ONCOL, V12, P423, DOI 10.1002/1878-0261.12167; Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519; Sun CY, 2017, INT J BIOCHEM CELL B, V89, P95, DOI 10.1016/j.biocel.2017.06.006; Yao Chuanbo, 2017, Yichuan, V39, P617, DOI 10.16288/j.yczz.17-100; Yu FX, 2014, EMBO J, V33, P942, DOI 10.1002/embj.201488329; Zeller C, 2003, ONCOGENE, V22, P2972, DOI 10.1038/sj.onc.1206474; Zhang ZZ, 2014, ACS MED CHEM LETT, V5, P993, DOI 10.1021/ml500160m; Zheng YG, 2019, DEV CELL, V50, P264, DOI 10.1016/j.devcel.2019.06.003; Zhou X, 2015, J CLIN INVEST, V125, P2123, DOI 10.1172/JCI79573	40	11	11	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 2	2020	39	27					5015	5030		10.1038/s41388-020-1356-7	http://dx.doi.org/10.1038/s41388-020-1356-7		JUN 2020	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ME5NL	32523092				2022-12-26	WOS:000539515400002
J	Liu, ZY; Zhang, WG; Pang, SW				Liu, Z. Y.; Zhang, W. G.; Pang, S. W.			Traversing behavior of tumor cells in three-dimensional platforms with different topography	PLOS ONE			English	Article							MIGRATION; CANCER; INVASION	Three-dimensional polydimethylsiloxane platforms were developed to mimic the extracellular matrix with blood vessels by having scaffolds with micropatterns, porous membrane and trenches. Precisely controlled physical dimensions, layouts, and topography as well as different surface chemical treatments were applied to study their influences on nasopharyngeal carcinoma cell (10-15 mu m in diameter) migration in mimicked platforms over 15-hour of time-lapse imaging. By placing the pores at different distance from the edges of the trenches, pores with different trench sidewall exposures and effective sizes were generated. Pores right next to the trench sidewalls showed the highest cell traversing probability, most likely related to the larger surface contact area with cells along the sidewalls. Straight grating oriented perpendicular to trenches below the top layer increased cell traversing probability. Pore shape as well as pore size influenced the cell traversing probability and cells could not traverse through pores that were 6 mu m or less in diameter, which is much smaller than the cell size. Trench depth of 15 mu m could induce more cells to traverse through the porous membrane, while shallower trenches impeded cell traversing and longer time was needed for cells to traverse because 3 and 6 mu m deep trenches were much smaller than cell size which required large cell deformation. Hydrophobic surface coating on the top layer and fibronectin in pores and trenches increased the cell traversing probability and reduced the pore size that cells could traverse from 8 to 6 mu m, which indicated that cells could have larger deformation with certain surface coatings.	[Liu, Z. Y.; Zhang, W. G.; Pang, S. W.] City Univ Hong Kong, Dept Elect Engn, Hong Kong, Peoples R China; [Liu, Z. Y.; Zhang, W. G.; Pang, S. W.] City Univ Hong Kong, Ctr Biosyst Neurosci & Nanotechnol, Hong Kong, Peoples R China	City University of Hong Kong; City University of Hong Kong	Pang, SW (corresponding author), City Univ Hong Kong, Dept Elect Engn, Hong Kong, Peoples R China.; Pang, SW (corresponding author), City Univ Hong Kong, Ctr Biosyst Neurosci & Nanotechnol, Hong Kong, Peoples R China.	pang@cityu.edu.hk	Pang, Stella/A-7770-2012	Pang, Stella/0000-0002-4330-0877; Zhang, Weiguan/0000-0002-3725-4130	Center for Biosystems, Neuroscience, and Nanotechnology (CBNN), City University of Hong Kong [9360148, 9380062]; University Grants Committee of Hong Kong [11247716, 11218017, 11213018, 11212519, C1013-15G]	Center for Biosystems, Neuroscience, and Nanotechnology (CBNN), City University of Hong Kong; University Grants Committee of Hong Kong	S. W. Pang, Z. Y. Liu, and W. G. Zhang were supported by the Center for Biosystems, Neuroscience, and Nanotechnology (CBNN), City University of Hong Kong (9360148, 9380062) and the University Grants Committee of Hong Kong (GRF Projects: 11247716, 11218017, 11213018, 11212519, and CRF project: C1013-15G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Elizondo MB, 2020, MED ENG PHYS, V75, P5, DOI 10.1016/j.medengphy.2019.11.004; Bashyam MD, 2002, CANCER, V94, P1821, DOI 10.1002/cncr.10362; Elkhatib N, 2017, SCIENCE, V356, DOI 10.1126/science.aal4713; Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gallego-Perez D, 2012, LAB CHIP, V12, P4424, DOI 10.1039/c2lc40726d; Harunaga JS, 2011, MATRIX BIOL, V30, P363, DOI 10.1016/j.matbio.2011.06.001; HASTON WS, 1982, J CELL BIOL, V92, P747, DOI 10.1083/jcb.92.3.747; Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lei KF, 2017, ACS APPL MATER INTER, V9, P13092, DOI 10.1021/acsami.7b03021; Li W, 2015, SCI REP-UK, V5, DOI 10.1038/srep08644; Lo KW, 2004, CANCER CELL, V5, P423, DOI 10.1016/S1535-6108(04)00119-9; Mak M, 2014, LAB CHIP, V14, P964, DOI 10.1039/c3lc51173a; Mak M, 2013, INTEGR BIOL-UK, V5, P1374, DOI 10.1039/c3ib40128f; Mak M, 2013, LAB CHIP, V13, P340, DOI 10.1039/c2lc41117b; Ng WT, 2014, ORAL ONCOL, V50, P549, DOI 10.1016/j.oraloncology.2013.06.003; Pathak A, 2011, INTEGR BIOL-UK, V3, P267, DOI 10.1039/c0ib00095g; Point Carbon, 2011, POINT CARBON, V6, P1; Pyrzynska K, 2019, SEP PURIF REV, V48, P65, DOI 10.1080/15422119.2018.1430589; Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682; Recknor JB, 2006, BIOMATERIALS, V27, P4098, DOI 10.1016/j.biomaterials.2006.03.029; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Tang QY, 2015, J BIOMED MATER RES A, V103, P2383, DOI 10.1002/jbm.a.35378; Tsang J, 2014, ORAL ONCOL, V50, P798, DOI 10.1016/j.oraloncology.2014.01.002; Tsao SW, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0270; Tsao SW, 2014, ORAL ONCOL, V50, P330, DOI 10.1016/j.oraloncology.2014.02.006; Ulrich TA, 2010, BIOMATERIALS, V31, P1875, DOI 10.1016/j.biomaterials.2009.10.047; Um E, 2017, LAB CHIP, V17, P4171, DOI 10.1039/c7lc00555e; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Wieringa P, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/27/275102; Wolf K, 2003, BLOOD, V102, P3262, DOI 10.1182/blood-2002-12-3791; Yu MC, 2002, SEMIN CANCER BIOL, V12, P421, DOI 10.1016/S1044579X02000858; Zhou SF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147801	34	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2020	15	6							e0234482	10.1371/journal.pone.0234482	http://dx.doi.org/10.1371/journal.pone.0234482			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC0EC	32520967	gold, Green Published			2022-12-26	WOS:000542969500042
J	Gomes, RS; Machado, R; de Almeida, CF; Chagas, RR; de Oliveira, RL; Delazari, FT; da Silva, DJH				Gomes, Ronaldo Silva; Machado Junior, Ronaldo; de Almeida, Cleverson Freitas; Chagas, Rafael Ravaneli; de Oliveira, Rebeca Lourenco; Delazari, Fabio Teixeira; da Silva, Derly Jose Henriques			Brazilian germplasm of winter squash (Cucurbita moschata D.) displays vast genetic variability, allowing identification of promising genotypes for agro-morphological traits	PLOS ONE			English	Article							INTERSPECIFIC HYBRIDIZATION; BIOACTIVE COMPOUNDS; LIPID FRACTIONS; FRUIT-QUALITY; MAXIMA DUCH.; HOME COOKING; OIL CONTENT; R-PACKAGE; PUMPKIN; CAROTENOIDS	Winter squash fruits (Cucurbita moschata D.) are among the best sources of vitamin A precursors and constitute sources of bioactive components such as phenolic compounds and flavonoids. Approximately 70% of C. moschata seed oil is made up of unsaturated fatty acids, with high levels of monounsaturated fatty acids and components such as vitamin E and carotenoids, which represent a promising nutritional aspect in the production of this vegetable. C. moschata germplasm expresses high genetic variability, especially in Brazil. We assessed 91 C. moschata accessions, from different regions of Brazil, and maintained at the Federal University of Vicosa (UFV) Vegetable Germplasm Bank, to identify early-flowering accessions with high levels of carotenoids in the fruit pulp and high yields of seed and seed oil. Results showed that the accessions have high variability in the number and mass of seeds per fruit, number of accumulated degree-days for flowering, total carotenoid content, and fruit productivity, which allowed selection for considerable gains in these characteristics. Analysis of the correlation between these characteristics provided information that will assist in selection to improve this crop. Cluster analysis resulted in the formation of 16 groups, confirming the variability of the accessions. Per se analysis identified accessions BGH-6749, BGH-5639, and BGH-219 as those with the earliest flowering. Accessions BGH-5455A and BGH-5598A had the highest carotenoid content, with averages greater than 170.00 mu g g(-1) of fresh mass. With a productivity of 0.13 t ha(-1), accessions BGH-5485A, BGH-4610A, and BGH-5472A were the most promising for seed oil production. These last two accessions corresponded to those with higher seed productivity, averaging 0.58 and 0.54 t ha(-1), respectively. This study confirms the high potential of this germplasm for use in breeding for promotion of earlier flowering and increase in total content of fruit pulp carotenoids and in seed and seed oil productivity.	[Gomes, Ronaldo Silva; Machado Junior, Ronaldo; de Almeida, Cleverson Freitas; Chagas, Rafael Ravaneli; de Oliveira, Rebeca Lourenco; da Silva, Derly Jose Henriques] Fed Univ Vicosa UFV, Agron Dept, Vicosa, MG, Brazil; [Delazari, Fabio Teixeira] Natl Serv Rural Learning SENAR, Campo Grande, MS, Brazil	Universidade Federal de Vicosa	Gomes, RS (corresponding author), Fed Univ Vicosa UFV, Agron Dept, Vicosa, MG, Brazil.	ronaldo.s.gomes@ufv.br	Gomes, Ronaldo Silva/AAL-9488-2020	Gomes, Ronaldo Silva/0000-0001-7896-0720	Coordination for the Improvement of Higher Education Personnel (CAPES) [001]; National Council of Technological and Scientific Development (CNPq)	Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	All the funding sources of support to this study corresponded to study scholarships received by the first author (Ronaldo Silva Gomes). The first scholarship corresponded to a master's scholarship (grant number 001), funded by the Coordination for the Improvement of Higher Education Personnel (CAPES). The second scholarship corresponded to a doctorate scholarship (doctorate-GD grant), funded by the National Council of Technological and Scientific Development (CNPq). There was no additional external funding received for this study.	Ara N, 2013, INT J MOL SCI, V14, P24008, DOI 10.3390/ijms141224008; Azevedo-Meleiro CH, 2007, J AGR FOOD CHEM, V55, P4027, DOI 10.1021/jf063413d; Barboza N, 2012, SCI HORTIC-AMSTERDAM, V134, P60, DOI 10.1016/j.scienta.2011.10.028; Bates D, 2013, J STAT SOFTW, V52, P1, DOI 10.18637/jss.v052.i05; Bergantin C, 2018, MOLECULES, V23, DOI 10.3390/molecules23112791; Bodenhofer U, 2011, BIOINFORMATICS, V27, P2463, DOI 10.1093/bioinformatics/btr406; Bohn T, 2019, P NUTR SOC, V78, P68, DOI 10.1017/S0029665118002641; Borges RME, 2011, HORTIC BRAS, V29, P461, DOI 10.1590/S0102-05362011000400003; Bouis HE, 2010, CROP SCI, V50, pS20, DOI 10.2135/cropsci2009.09.0531; Cruz CD, 2013, ACTA SCI-AGRON, V35, P271, DOI 10.4025/actasciagron.v35i3.21251; Cullis BR, 2006, J AGR BIOL ENVIR ST, V11, P381, DOI 10.1198/108571106X154443; Darrudi R, 2018, J APPL RES MED AROMA, V8, P60, DOI 10.1016/j.jarmap.2017.11.003; Dias FD, 2017, TREE GENET GENOMES, V13, DOI 10.1007/s11295-017-1205-1; Dillehay TD, 2007, SCIENCE, V316, P1890, DOI 10.1126/science.1141395; do Rego ER, 2011, GENET RESOUR CROP EV, V58, P909, DOI 10.1007/s10722-010-9628-7; FAO, 2010, 2 REP STAT WORLDS PL; FEDERER W. T., 1956, Hawaiian Planters' Record, V55, P191; Ferreira MG, 2016, HORTIC BRAS, V34, P537, DOI [10.1590/s0102-053620160413, 10.1590/S0102-053620160413]; Ferriol M, 2004, CROP SCI, V44, P653, DOI 10.2135/cropsci2004.6530; Filgueira FAR., 2013, NOVO MANUAL OLERICUL, V3; Fonseca M. A., 2015, Magistra, V27, P432; Food and Agriculture Organization of the United Nations- FAO STATE, 2019, FAO STATE; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Gammone MA, 2015, FOOD NUTR RES, V59, DOI 10.3402/fnr.v59.26762; Gomes R. C., 2017, THESIS; Ribeiro EMG, 2015, FOOD RES INT, V77, P620, DOI 10.1016/j.foodres.2015.08.038; Gomes RS, 2016, AFR J AGR RES, DOI [10.5897/AJAR2016.11267, DOI 10.5897/AJAR2016.11267]; de Albuquerque HYG, 2019, SCI AGR, V76, P328, DOI [10.1590/1678-992X-2017-0389, 10.1590/1678-992x-2017-0389]; Green A.S., 2016, SCI WORLD J, V2016, P7393620, DOI [10.1155/2016/7393620, DOI 10.1155/2016/7393620]; Gurmu Fekadu, 2018, South African Journal of Plant and Soil, V35, P179, DOI [10.1080/025.1862.2017.1354405, 10.1080/02571862.2017.1354405]; Hallauer AR, 2010, HANDB PLANT BREED, V6, P1, DOI 10.1007/978-1-4419-0766-0; Hashemi S, 2020, SCI HORTIC-AMSTERDAM, V259, DOI 10.1016/j.scienta.2019.108827; Heino M, 2014, STOCK IDENTIFICATION; Hernandez-Rosales HS, 2020, AM J BOT, V107, P510, DOI 10.1002/ajb2.1424; Hooper L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002137.pub3; Instituto Brasileiro de Geografia e Estatistica- IBGE: ProducAo Agricola Municipal, 2017, IBGE PROD AGR; Itle RA, 2009, HORTSCIENCE, V44, P633, DOI 10.21273/HORTSCI.44.3.633; de Carvalho LMJ, 2014, FOOD SCI TECH-BRAZIL, V34, P365, DOI 10.1590/fst.2014.0058; de Carvalho LMJ, 2012, FOOD RES INT, V47, P337, DOI 10.1016/j.foodres.2011.07.040; Jarret RL, 2013, PLANT GENET RESOUR-C, V11, P149, DOI 10.1017/S1479262112000512; Jayedi A, 2018, ADV NUTR, V9, P701, DOI 10.1093/advances/nmy040; Karaagac O, 2013, SCI HORTIC-AMSTERDAM, V149, P9, DOI 10.1016/j.scienta.2012.10.021; Krajnc AU, 2016, PHYTON-ANN REI BOT A, V56, P61, DOI 10.12905/0380.phyton56(1)2016-0061; Kumar V, 2018, CURR SCI INDIA, V115, P1550, DOI 10.18520/cs/v115/i8/1550-1556; Laurindo Renata Dias Freitas, 2017, Rev. Ceres, V64, P582, DOI 10.1590/0034-737x201764060004; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Leesberg, 2012, THE NEW HOLLSTEIN, V1, plvi; De Lima GKL, 2016, REV CAATINGA, V29, P257, DOI 10.1590/1983-21252016v29n130rc; Lima Neto I. S., 2013, THESIS U FEDERAL VIC; Marconi G, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01460; Maurya KN, 2019, IND CROP PROD, V139, DOI 10.1016/j.indcrop.2019.111557; Mohsin GM, 2017, INT J AGR RES INNOV; Moura M.C.C.L., 2003, THESIS U FEDERAL VIC; Moura Maria da C.C.L., 2005, Hortic. Bras., V23, P206, DOI 10.1590/S0102-05362005000200009; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; Mratinic E, 2011, CZECH J FOOD SCI, V29, P161, DOI 10.17221/203/2010-CJFS; Nagar A, 2018, AGR RES, V7, P225, DOI 10.1007/s40003-018-0329-3; Nakkanong K, 2012, J AGR FOOD CHEM, V60, P5936, DOI 10.1021/jf3007135; Nascimento I, 2018, CHIL J AGR RES, V78, P39, DOI 10.4067/S0718-58392018000100039; Oliveira EJ D, 2014, SCI AGR, DOI [10.1590/0103-9016-2014-0043, DOI 10.1590/0103-9016-2014-0043]; Patel S, 2013, MEDITERR J NUTR META, V6, P183, DOI 10.1007/s12349-013-0131-5; Piperno DR, 2003, SCIENCE, V299, P1054, DOI 10.1126/science.1080365; PP J, 2004, REV STAT APPL, V52, P93; Priori D, 2017, FOOD SCI TECH-BRAZIL, V37, P33, DOI [10.1590/1678-457x.05016, 10.1590/1678-457X.05016]; R Core Team, 2018, R LANG ENV STAT COMP; Raatz B, 2019, GENET RESOUR CROP EV, DOI 10.1007/s10722-019-00746-0(0123456789().,-volV)(01234567; Rana JC, 2015, EUPHYTICA, V205, P441, DOI 10.1007/s10681-015-1406-3; RESENDE MDV, 1995, REV ARVORE, V19, P479; Restrepo-Salazar Javier Alonso, 2019, Rev. Fac. Nac. Agron. Medellín, V72, P8983, DOI 10.15446/rfnam.v72n3.77320; Rodriguez-Amaya DB, 2008, J FOOD COMPOS ANAL, V21, P445, DOI 10.1016/j.jfca.2008.04.001; Saltzman A, 2013, GLOB FOOD SECUR-AGR, V2, P9, DOI 10.1016/j.gfs.2012.12.003; Velho LPS, 2017, PESQUI AGROPECU BRAS, V52, P328, DOI [10.1590/s0100-204x2017000500006, 10.1590/S0100-204X2017000500006]; Schmidt P, 2019, CROP SCI, V59, P525, DOI 10.2135/cropsci2018.06.0376; Silva D. J. H., 2001, Horticultura Brasileira, V19, P108; Silva TN, 2016, REV CIENC AGRON, V47, P351, DOI 10.5935/1806-6690.20160041; Singh N, 2018, INDIAN J AGR SCI, V88, P877; Skeaff CM, 2009, ANN NUTR METAB, V55, P173, DOI 10.1159/000229002; Sobreira F.M., 2013, THESIS U FEDERAL VIC; Torres LG, 2019, EUPHYTICA, V215, DOI 10.1007/s10681-019-2373-x; Uretsky J, 2017, HORTSCIENCE, V52, P1156, DOI 10.21273/HORTSCI12018-17; Valois ACC, 1996, GLOSSARIO RECURSOS G; Veronezi CM, 2015, NUTR FOOD SCI, V45, P164, DOI 10.1108/NFS-01-2014-0003; Veronezi CM, 2012, J FOOD SCI, V77, pC653, DOI 10.1111/j.1750-3841.2012.02736.x; Whitaker T. W., 1976, Evolution of crop plants., P64; Wright S, 1920, J AGRIC RES, V20, P0557; Wu JX, 2011, SCI HORTIC-AMSTERDAM, V128, P7, DOI 10.1016/j.scienta.2010.12.006; Wu T, 2008, SCI HORTIC-AMSTERDAM, V117, P219, DOI 10.1016/j.scienta.2008.04.002	87	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2020	15	6							e0230546	10.1371/journal.pone.0230546	http://dx.doi.org/10.1371/journal.pone.0230546			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ1GC	32516347	Green Published, Green Submitted, gold			2022-12-26	WOS:000540977000032
J	Lee, GO; Comina, G; Hernandez-Cordova, G; Naik, N; Gayoso, O; Ticona, E; Coronel, J; Evans, CA; Zimic, M; Paz-Soldan, VA; Gilman, RH; Oberhelman, R				Lee, Gwenyth O.; Comina, German; Hernandez-Cordova, Gustavo; Naik, Nehal; Gayoso, Oscar; Ticona, Eduardo; Coronel, Jorge; Evans, Carlton A.; Zimic, Mirko; Paz-Soldan, Valerie A.; Gilman, Robert H.; Oberhelman, Richard			Cough dynamics in adults receiving tuberculosis treatment	PLOS ONE			English	Article							DRUG-SUSCEPTIBILITY ASSAY; MICROSCOPIC-OBSERVATION; FREQUENCY; TRANSMISSION	Cough is a characteristic symptom of tuberculosis, is the main cause of transmission, and is used to assess treatment response. We aimed to identify the best measure of cough severity and characterize changes during initial tuberculosis therapy. We conducted a prospective cohort of recently diagnosed ambulatory adult patients with pulmonary tuberculosis in two tertiary hospitals in Lima, Peru. Pre-treatment and five times during the first two months of treatment, a vibrometer was used to capture 4-hour recordings of involuntary cough. A total of 358 recordings from 69 participants were analyzed using a computer algorithm. Total time spent coughing (seconds per hour) was a better predictor of microbiologic indicators of disease severity and treatment response than the frequency of cough episodes or cough power. Patients with prior tuberculosis tended to cough more than patients without prior tuberculosis, and patients with tuberculosis and diabetes coughed more than patients without diabetes co-morbidity. Cough characteristics were similar regardless of HIV co-infection and for drug-susceptible versus drug-resistant tuberculosis. Tuberculosis treatment response may be meaningfully assessed by objectively monitoring the time spent coughing. This measure demonstrated that cough was increased in patients with TB recurrence or co-morbid diabetes, but not because of drug resistance or HIV co-infection.	[Lee, Gwenyth O.; Comina, German; Hernandez-Cordova, Gustavo; Paz-Soldan, Valerie A.; Oberhelman, Richard] Tulane Univ, Dept Global Community Hlth & Behav Sci, New Orleans, LA 70118 USA; [Lee, Gwenyth O.] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Naik, Nehal] Virginia Commonwealth Univ, Sch Med, Richmond, VA USA; [Gayoso, Oscar] Hosp Nacl Cayetano Heredia, Pulmonol Dept, Lima, Peru; [Ticona, Eduardo] Univ Nacl Mayor San Marcos, Fac Med, San Marcos, Peru; [Ticona, Eduardo] Hosp Nacl Dos Mayo Lima, Serv Enfermedades Infecciosas & Trop, Lima, Peru; [Coronel, Jorge; Zimic, Mirko; Gilman, Robert H.] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Lab Invest & Desarrollo, Lab Invest Enfermedades Infecciosas, Lima, Peru; [Evans, Carlton A.; Paz-Soldan, Valerie A.; Gilman, Robert H.] Asociac Benef PRISMA, Lima, Peru; [Evans, Carlton A.] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Lab Res & Dev Innovat Hlth & Dev IFHAD, Lima, Peru; [Evans, Carlton A.] Imperial Coll London, Dept Infect Dis, London, England; [Zimic, Mirko] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Lab Bioinformat & Biol Mol, Lima, Peru; [Gilman, Robert H.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Program Global Dis Epidemiol & Control, Dept Int Hlth, Baltimore, MD USA	Tulane University; University of Michigan System; University of Michigan; Virginia Commonwealth University; Universidad Nacional Mayor de San Marcos; Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; Imperial College London; Universidad Peruana Cayetano Heredia; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Lee, GO (corresponding author), Tulane Univ, Dept Global Community Hlth & Behav Sci, New Orleans, LA 70118 USA.; Lee, GO (corresponding author), Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA.	golee@umich.edu		Hernandez-Cordova, Gustavo/0000-0001-5258-2952; Evans, Carlton/0000-0002-6873-5447; Comina, German/0000-0003-2114-0486; Paz-Soldan, Valerie/0000-0002-1065-4919; Ticona, Eduardo/0000-0002-6556-1082; Lee, Gwenyth/0000-0002-7889-3852	National Institutes of Health (NIH) [4D43TW009349-05]; National Institutes of Health Office of the Director, Fogarty International Center, Office of AIDS Research, National Cancer Center, National Heart, Blood, and Lung Institute; NIH Office of Research for Women's Health through the Fogarty Global Health Fellows Program Consortium of the University of North Carolina [R25TW009340]; NIH Office of Research for Women's Health through the Fogarty Global Health Fellows Program Consortium of the University of John Hopkins [R25TW009340]; NIH Office of Research for Women's Health through the Fogarty Global Health Fellows Program Consortium of the University of Morehouse [R25TW009340]; NIH Office of Research for Women's Health through the Fogarty Global Health Fellows Program Consortium of the University of Tulane [R25TW009340]; Wellcome Trust [057434/Z/99/Z, 070005/Z/02/Z, 078340/Z/05/Z, 105788/Z/14/Z, 201251/Z/16/Z]; Joint Global Health Trials consortium (MRC); Joint Global Health Trials consortium (DFID); Joint Global Health Trials consortium (Wellcome Trust) [MR/K007467/1]; STOP TB partnership's TB REACH initiative - Government of Canada; Bill & Melinda Gates Foundation [W5_PER_CDT1_PRISMA, OPP1118545]; charity IFHAD: Innovation For Health And Development; MRC [MR/K007467/1] Funding Source: UKRI	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Office of the Director, Fogarty International Center, Office of AIDS Research, National Cancer Center, National Heart, Blood, and Lung Institute; NIH Office of Research for Women's Health through the Fogarty Global Health Fellows Program Consortium of the University of North Carolina; NIH Office of Research for Women's Health through the Fogarty Global Health Fellows Program Consortium of the University of John Hopkins; NIH Office of Research for Women's Health through the Fogarty Global Health Fellows Program Consortium of the University of Morehouse; NIH Office of Research for Women's Health through the Fogarty Global Health Fellows Program Consortium of the University of Tulane; Wellcome Trust(Wellcome TrustEuropean Commission); Joint Global Health Trials consortium (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Joint Global Health Trials consortium (DFID); Joint Global Health Trials consortium (Wellcome Trust)(Wellcome Trust); STOP TB partnership's TB REACH initiative - Government of Canada; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); charity IFHAD: Innovation For Health And Development; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported from the National Institutes of Health (NIH), through Grant 4D43TW009349-05. Nehal Naik was supported by the National Institutes of Health Office of the Director, Fogarty International Center, Office of AIDS Research, National Cancer Center, National Heart, Blood, and Lung Institute, and the NIH Office of Research for Women's Health through the Fogarty Global Health Fellows Program Consortium comprised of the University of North Carolina, John Hopkins, Morehouse and Tulane (R25TW009340). CAE acknowledges funding from the Wellcome Trust (awards 057434/Z/99/Z, 070005/Z/02/Z, 078340/Z/05/Z, 105788/Z/14/Z and 201251/Z/16/Z); the Joint Global Health Trials consortium (MRC, DFID, & Wellcome Trust award MR/K007467/1); the STOP TB partnership's TB REACH initiative funded by the Government of Canada and the Bill & Melinda Gates Foundation (awards W5_PER_CDT1_PRISMA and OPP1118545); and the charity IFHAD: Innovation For Health And Development. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or any of the funders.	BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; Brignall K, 2008, LUNG, P186; Burnham K P, 2003, MODEL SELECT MULTIMO; Caviedes L, 2000, J CLIN MICROBIOL, V38, P1203, DOI 10.1128/JCM.38.3.1203-1208.2000; Comina G, UNIVERSAL SIMP UNPUB; Desiere S, 2015, EVAL PROGRAM PLANN, V49, P10, DOI 10.1016/j.evalprogplan.2014.11.002; Esmail H, 2018, LANCET RESP MED, V6, P244, DOI 10.1016/S2213-2600(18)30105-X; Fan J, 2014, ACOUST SOC, P1; Gil-Santana L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146876; Hsiao Cheng., 2003, ANAL PANEL DATA, VSecond; Larson S, 2012, PLOS ONE, V7; Lee KK, 2017, BMJ OPEN RESP RES, V4, P1; Ministerio de Salud del Peru, 2013, NORM TECN SAL AT INT; Moore DAJ, 2004, J CLIN MICROBIOL, V42, P4432, DOI 10.1128/JCM.42.10.4432-4437.2004; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; Paz-Soldan VA, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-290; PAZSOLDAN VA, 2014, FRONT PUBLIC HEALTH, V2, P1; Pleil JD, 2016, J BREATH RES, V10, DOI 10.1088/1752-7155/10/4/045001; Proano A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010365corr2; Proano A, 2018, CHEST, V153, P1358, DOI 10.1016/j.chest.2018.03.006; Proano A, 2017, CLIN INFECT DIS, V64, P1174, DOI 10.1093/cid/cix039; Schreiner M, 2012, PROGR OUT POVERTY SI; Sumner H, 2013, AM J RESP CRIT CARE, V187, P943, DOI 10.1164/rccm.201211-2000OC; Tiberi S, 2017, PRESSE MED, V46, pE23, DOI 10.1016/j.lpm.2017.01.017; Tracey BH, 2011, IEEE ENG MED BIO, P6017, DOI 10.1109/IEMBS.2011.6091487; Turner RD, 2018, INT J TUBERC LUNG D, V22, P863, DOI 10.5588/ijtld.17.0652; Turner RD, 2015, J INFECT DIS, V211, P1367, DOI 10.1093/infdis/jiu625; Vizel E, 2010, COUGH, V6, P1, DOI [10.1186/1745-9974-6-1, DOI 10.1186/1745-9974-6-1]; World Health Organization, 2013, SYST SCREEN ACT TUB; Yousaf N, 2013, EUR RESPIR J, V41, P241, DOI 10.1183/09031936.00089312	30	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2020	15	6							e0231167	10.1371/journal.pone.0231167	http://dx.doi.org/10.1371/journal.pone.0231167			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ0RE	32511248	Green Published, gold			2022-12-26	WOS:000540938100006
J	Portney, BA; Arad, M; Gupta, A; Brown, RA; Khatri, R; Lin, PN; Hebert, AM; Angster, KH; Silipino, LE; Meltzer, WA; Taylor, RJ; Zalzman, M				Portney, Benjamin A.; Arad, Michal; Gupta, Aditi; Brown, Robert A.; Khatri, Raju; Lin, Phyo Nay; Hebert, Andrea M.; Angster, Kristen H.; Silipino, Lorna E.; Meltzer, W. Alex; Taylor, Rodney J.; Zalzman, Michal			ZSCAN4 facilitates chromatin remodeling and promotes the cancer stem cell phenotype	ONCOGENE			English	Article							DEVELOPMENTAL REGULATORS; TELOMERE ELONGATION; GENOMIC STABILITY; NECK-CANCER; HEAD; PLURIPOTENCY; NANOG; EXPRESSION; CARCINOMA; POLYCOMB	Cancer stem cells (CSCs) are cells within tumors that maintain the ability to self-renew, drive tumor growth, and contribute to therapeutic resistance and cancer recurrence. In this study, we investigate the role of Zinc finger and SCAN domain containing 4 (ZSCAN4) in human head and neck squamous cell carcinoma (HNSCC). The murine Zscan4 is involved in telomere maintenance and genomic stability of mouse embryonic stem cells. Our data indicate that the human ZSCAN4 is enriched for, marks and is co-expressed with CSC markers in HNSCC. We show that transient ZSCAN4 induction for just 2 days increases CSC frequency both in vitro and in vivo and leads to upregulation of pluripotency and CSC factors. Importantly, we define for the first time the role of ZSCAN4 in altering the epigenetic profile and regulating the chromatin state. Our data show that ZSCAN4 leads to a functional histone 3 hyperacetylation at the promoters of OCT3/4 and NANOG, leading to an upregulation of CSC factors. Consistently, ZSCAN4 depletion leads to downregulation of CSC markers, decreased ability to form tumorspheres and severely affects tumor growth. Our study suggests that ZSCAN4 plays an important role in the maintenance of the CSC phenotype, indicating it is a potential therapeutic target in HNSCC.	[Portney, Benjamin A.; Arad, Michal; Gupta, Aditi; Brown, Robert A.; Khatri, Raju; Lin, Phyo Nay; Hebert, Andrea M.; Angster, Kristen H.; Meltzer, W. Alex; Zalzman, Michal] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Hebert, Andrea M.; Angster, Kristen H.; Silipino, Lorna E.; Taylor, Rodney J.; Zalzman, Michal] Univ Maryland, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Baltimore, MD 21201 USA; [Taylor, Rodney J.; Zalzman, Michal] Univ Maryland, Sch Med, Marlene & Stewart Greenbaum Canc Ctr, Baltimore, MD 21201 USA; [Zalzman, Michal] Univ Maryland, Sch Med, Ctr Stem Cell Biol & Regenerat Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Zalzman, M (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA.; Zalzman, M (corresponding author), Univ Maryland, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Baltimore, MD 21201 USA.; Zalzman, M (corresponding author), Univ Maryland, Sch Med, Marlene & Stewart Greenbaum Canc Ctr, Baltimore, MD 21201 USA.; Zalzman, M (corresponding author), Univ Maryland, Sch Med, Ctr Stem Cell Biol & Regenerat Med, Baltimore, MD 21201 USA.	MZalzman@som.umaryland.edu	Gupta, Aditi/HGD-9632-2022	Khatri, Raju/0000-0002-1381-8560; Zalzman, Michal/0000-0002-4689-2951; Lin, Phyo Nay/0000-0003-4041-629X	National Institutes of Health/NINDS grant [1R21 NS095088-01A1]; NIH/NIAMS [R01 AR070819]; National Institutes of Health/NIH/NIAMS grant [R01 AR070819]	National Institutes of Health/NINDS grant; NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health/NIH/NIAMS grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The molecular studies of ZSCAN4 were partially supported by the National Institutes of Health/NINDS grant number 1R21 NS095088-01A1 and NIH/NIAMS grant number R01 AR070819. MZ, RJT, BAP, were partially supported by the National Institutes of Health/NIH/NIAMS grant number R01 AR070819.	Adhikary G, 2015, CARCINOGENESIS, V36, P800, DOI 10.1093/carcin/bgv064; Adhikary G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084324; Ailles L, 2009, METHODS MOL BIOL, V568, P175, DOI 10.1007/978-1-59745-280-9_11; Akiyama T, 2015, DNA RES, V22, P307, DOI 10.1093/dnares/dsv013; Allegra E, 2014, ONCOLOGY-BASEL, V86, P199, DOI 10.1159/000358598; Allegra E, 2012, ONCOTARGETS THER, V5, P375, DOI 10.2147/OTT.S38694; Amano T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2966; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bibikova M, 2008, CELL STEM CELL, V2, P123, DOI 10.1016/j.stem.2008.01.005; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Carew JS, 2008, CANCER LETT, V269, P7, DOI 10.1016/j.canlet.2008.03.037; Chinn SB, 2015, HEAD NECK-J SCI SPEC, V37, P317, DOI 10.1002/hed.23600; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Dan JM, 2017, CELL REP, V20, P1936, DOI 10.1016/j.celrep.2017.07.070; Falco G, 2007, DEV BIOL, V307, P539, DOI 10.1016/j.ydbio.2007.05.003; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Hirata T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00208; Jiang J, 2013, CELL RES, V23, P92, DOI 10.1038/cr.2012.157; Joshi P, 2014, RAMBAM MAIMONIDES ME, V5, DOI 10.5041/RMMJ.10143; Joshua B, 2012, HEAD NECK-J SCI SPEC, V34, P42, DOI 10.1002/hed.21699; Lee K, 2014, CANCER BIOL THER, V15, P1094, DOI 10.4161/cbt.29220; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Liu AF, 2013, CHIN J CANCER, V32, P483, DOI 10.5732/cjc.012.10282; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lu YH, 2013, CANCER LETT, V340, P113, DOI 10.1016/j.canlet.2013.07.009; Marur S, 2016, MAYO CLIN PROC, V91, P386, DOI 10.1016/j.mayocp.2015.12.017; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Nakai-Futatsugi Y, 2016, STEM CELL REP, V6, P483, DOI 10.1016/j.stemcr.2016.02.010; Ohbo K, 1996, BLOOD, V87, P956, DOI 10.1182/blood.V87.3.956.bloodjournal873956; Okamoto A, 2009, ORAL ONCOL, V45, P633, DOI 10.1016/j.oraloncology.2008.10.003; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Plimack ER, 2007, J CLIN ONCOL, V25, P4519, DOI 10.1200/JCO.2007.12.6029; Portney BA, 2018, BIOCHEM BIOPH RES CO, V498, P72, DOI 10.1016/j.bbrc.2018.02.155; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Prince MEP, 2008, J CLIN ONCOL, V26, P2871, DOI 10.1200/JCO.2007.15.1613; Proctor E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055820; Sano D, 2007, CANCER METAST REV, V26, P645, DOI 10.1007/s10555-007-9082-y; Seiwert TY, 2005, BRIT J CANCER, V92, P1341, DOI 10.1038/sj.bjc.6602510; Sharov AA, 2003, PLOS BIOL, V1, P410, DOI 10.1371/journal.pbio.0000074; Siddique HR, 2012, STEM CELLS, V30, P372, DOI 10.1002/stem.1035; Spafford MF, 1996, ARCH OTOLARYNGOL, V122, P627; Su YJ, 2011, EMBO J, V30, P3186, DOI 10.1038/emboj.2011.211; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; van Vlerken LE, 2013, STEM CELL TRANSL MED, V2, P43, DOI 10.5966/sctm.2012-0036; Zalzman M, 2010, NATURE, V464, P858, DOI 10.1038/nature08882	51	8	8	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 25	2020	39	26					4970	4982		10.1038/s41388-020-1333-1	http://dx.doi.org/10.1038/s41388-020-1333-1		JUN 2020	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	MQ2YO	32507861	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000538701900001
J	Dabhi, PA; Thangakunam, B; Gupta, R; James, P; Thomas, N; Naik, D; Christopher, DJ				Dabhi, Pradipkumar Arvindbhai; Thangakunam, Balamugesh; Gupta, Richa; James, Prince; Thomas, Nihal; Naik, Dukhabandhu; Christopher, Devasahayam Jesudas			Screening for prevalence of current TB disease and latent TB infection in type 2 diabetes mellitus patients attending a diabetic clinic in an Indian tertiary care hospital	PLOS ONE			English	Article							TUBERCULOSIS-CONTROL; ACTIVE TUBERCULOSIS	Background Diabetes triples the risk of developing tuberculosis (TB). This study was designed to determine the prevalence of past and current TB disease and Latent TB infection (LTBI) in type 2 Diabetes Mellitus (NIDDM) patients. Design This was a prospective descriptive study on all NIDDM patients attending a Diabetic clinic. Detailed history, included details of previous history of TB (Past TB)and symptoms of active TB and a thorough physical exam was also done. When clinical suspicion of TB was present, appropriate investigations were carried out to diagnose 'Current TB'. Subsequently, 200 consecutive patients who were negative for Past and Current TB were screened for Latent TB infection (LTBI) by tuberculin skin test. Results Of 1000 NIDDM patients enrolled, 43(4.3%) had Past TB. Of remaining 957 patients, 50 were evaluated for New TB on the basis of suggestive symptoms and 10(1%) patients were confirmed to have Current TB. Risk factors for Past or Current TB 'DM-TB' in comparison with 'DM Only' group were; male sex (72% VS 57%; P = 0.033), manual laborer (28% VS 15%; P = 0.012), smoking (26% VS 14%; P = 0.015), alcohol consumption (23% VS 9%; P<0.001)& being on treatment with Insulin (40% VS 20%; P<0.001). There was a protective effect with being a home maker (17% VS 37%; P = 0.034&overweightstatus (53% VS 71%; P = 0.004). Of the 200 patient without Past or Current TB, who were screened for LTBI, 96(48%) patients were found to have LTBI. Male sex was the only significant risk factor for LTBI (72% VS 59%; P = 0.05). Conclusion Past and Current TB was substantial in patients attending a Diabetic Clinic. Active symptom screening for TB in these clinics could lead to increase in case detection and earlier diagnosis.	[Dabhi, Pradipkumar Arvindbhai; Thangakunam, Balamugesh; Gupta, Richa; Christopher, Devasahayam Jesudas] Christian Med Coll & Hosp, Dept Pulm Med, Vellore, Tamil Nadu, India; [James, Prince] Christian Med Coll & Hosp, Dept Resp Med, Vellore, Tamil Nadu, India; [Thomas, Nihal] Christian Med Coll & Hosp, Dept Endocrinol Diabet & Metab, Vellore, Tamil Nadu, India; [Naik, Dukhabandhu] Jawaharlal Inst Postgrad Med Educ & Res JIPMER, Dept Endocrinol, Pondicherry, India	Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Jawaharlal Institute of Postgraduate Medical Education & Research	Christopher, DJ (corresponding author), Christian Med Coll & Hosp, Dept Pulm Med, Vellore, Tamil Nadu, India.	djchris@cmcvellore.ac.in			Department of Biotechnology (India); National Institute for Allergy and Infectious Diseases (USA); National Institutes of Health (USA); Fluid Research grant CMC, Vellore	Department of Biotechnology (India)(Department of Biotechnology (DBT) India); National Institute for Allergy and Infectious Diseases (USA); National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fluid Research grant CMC, Vellore	This study was partly supported by the Department of Biotechnology (India) and National Institute for Allergy and Infectious Diseases & National Institutes of Health (USA). The support was administered by CRDF Global under the aegis of the RePORT India consortium. We also acknowledge part funding from Fluid Research grant CMC, Vellore.	[Anonymous], SCREEN PAT DIAB MELL; [Anonymous], 2012, GLOBAL TUBERCULOSIS, P1; [Anonymous], 2018, TB IND REP 2018; [Anonymous], 1999, EPIDEMIOLOGIC BASIS; Bobbio F, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027179; Development C., 2018, NAT GUID COLL CAR CO; Di Gennaro F, 2018, INT J ENV RES PUBLIC, V15; Di Gennaro F, 2019, LANCET GLOB HEALTH, V7, pE707, DOI 10.1016/S2214-109X(19)30173-1; Hassmiller K, 2007, IMPACT SMOKING POPUL; Jeon CY, 2010, TROP MED INT HEALTH, V15, P1300, DOI 10.1111/j.1365-3156.2010.02632.x; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Kumpatla S, 2013, PUBLIC HEALTH ACTION, V3, pS23, DOI 10.5588/pha.13.0035; Leow MKS, 2014, EXP CLIN ENDOCR DIAB, V122, P528, DOI 10.1055/s-0034-1377044; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Majumdar A, 2019, PUBLIC HEALTH ACTION, V9, P3, DOI 10.5588/pha.18.0048; Mansilla Bermejo M J, 1995, Aten Primaria, V16, P154; Martnez-Aguilar Gerardo, 2015, ASS RISK FACTORS LAT, V46, P221, DOI [10.1016/j.arcmed.2015.03.009, DOI 10.1016/J.ARCMED.2015.03.009]; Mave V, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2483-9; Ottmani SE, 2010, INT J TUBERC LUNG D, V14, P1513; Pizzol D, 2017, AFR HEALTH SCI, V17, P773, DOI 10.4314/ahs.v17i3.20; Pizzol D, 2016, TROP MED INT HEALTH, V21, P694, DOI 10.1111/tmi.12704; Restrepo BI, 2008, CLIN INFECT DIS, V47, P634, DOI 10.1086/590565; Ruslami R, 2010, TROP MED INT HEALTH, V15, P1289, DOI 10.1111/j.1365-3156.2010.02625.x; Sachdeva KS, 2012, INDIAN J MED RES, V135, P690; Sharma SK, 2005, INDIAN J MED RES, V121, P550; Snehalatha C, 2003, DIABETES CARE, V26, P1380, DOI 10.2337/diacare.26.5.1380; Stevenson CR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-234; Tandon N, 2018, LANCET GLOB HEALTH, V6, pE1352, DOI 10.1016/S2214-109X(18)30387-5; Webb EA, 2009, INT J TUBERC LUNG D, V13, P868	29	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0233385	10.1371/journal.pone.0233385; 10.1371/journal.pone.0233385.r001; 10.1371/journal.pone.0233385.r002; 10.1371/journal.pone.0233385.r003; 10.1371/journal.pone.0233385.r004	http://dx.doi.org/10.1371/journal.pone.0233385; 10.1371/journal.pone.0233385.r001; 10.1371/journal.pone.0233385.r002; 10.1371/journal.pone.0233385.r003; 10.1371/journal.pone.0233385.r004			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502176	Green Published, gold			2022-12-26	WOS:000542035700009
J	Kou, ZQ; Jia, J; Liu, XH; Luo, TT; Xin, XL; Gong, JL; Zhang, JF; Sun, DP; Jiang, FC; Gao, RQ				Kou, Zengqiang; Jia, Jing; Liu, Xiaohui; Luo, Tingting; Xin, Xueling; Gong, Jinling; Zhang, Jingfei; Sun, Dapeng; Jiang, Fachun; Gao, Ruqin			Epidemiological characteristics and spatial-temporal clusters of hand, foot, and mouth disease in Qingdao City, China, 2013-2018	PLOS ONE			English	Article							OUTBREAK; SURVEILLANCE; JAPAN; A6	Background Hand, foot, and mouth disease (HFMD) has become one of the most important infectious diseases recent years. Qingdao City has suffered from serious HFMD epidemic. This study aimed to describe epidemiological characteristics and investigate spatial-temporal distribution at town level in Qingdao City. Method The surveillance data of HFMD during 2013-2018 were collected from the National Notifiable Disease Surveillance System. The global Moran's I statistic was used to detect the spatial autocorrelation of HFMD cases by ArcGis 10.0 software. Purely spatial and spatial-temporal analysis was used to detect epidemic clusters by SatScan(TM) v9.6 software. Results The annual average incidence of HFMD cases in Qingdao City from 2013 to 2018 was 123.16 per 100000, while the incidence rate of children <= 5years old was 2879.80 per 100000. The majority (88.97%) of HFMD cases were aged within 0-5 years old and the males were 60.20%. Other enterovirus (EV), enteriovirus 71(EV71), and Coxsackievirus A16 (CA16) accounted for 48.75%, 30.91% and 20.34%. The seasonal peak was between May and October. HFMD had positive spatial autocorrelation at town level with global Moran's I from 0.19 to 0.31(P<0.001). Spatial-temporal cluster analysis detected six most likely clusters and three secondary clusters from 2013 to 2018. The most likely cluster was located in urban and urban-rural fringe areas. Conclusions Urban and urban-rural fringe areas were the major locations of the clusters with other EV as the dominant pathogen between May and October. The findings suggested that the prevention and control of HFMD in Qingdao City should be focus on these high-risk periods and locations which had important public health significance for the allocation of public health resources.	[Kou, Zengqiang; Sun, Dapeng] Shandong Ctr Dis Control & Prevent, Jinan, Peoples R China; [Jia, Jing; Liu, Xiaohui; Xin, Xueling; Gong, Jinling; Zhang, Jingfei; Jiang, Fachun; Gao, Ruqin] Qingdao Ctr Dis Control & Prevent, Qingdao Inst Prevent Med, Dept Acute Infect Dis, Qingdao, Shandong, Peoples R China; [Luo, Tingting] Qingdao Univ, Dept Publ Hlth, Med Coll, Qingdao, Shandong, Peoples R China	Qingdao University	Sun, DP (corresponding author), Shandong Ctr Dis Control & Prevent, Jinan, Peoples R China.; Jiang, FC; Gao, RQ (corresponding author), Qingdao Ctr Dis Control & Prevent, Qingdao Inst Prevent Med, Dept Acute Infect Dis, Qingdao, Shandong, Peoples R China.	792114402@qq.com; jfch88@126.com; 1573503375@qq.com	Zhang, Jing/HII-4294-2022					Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; [Anonymous], 2014, LANCET INFECT DIS, V14, P1, DOI 10.1016/S1473-3099(13)70368-2; [Anonymous], 2012, REGEN MED S3, V7, pS14; [Anonymous], 2016, ANNOUNCEMENT LICENSE; Blomqvist S, 2010, J CLIN VIROL, V48, P49, DOI 10.1016/j.jcv.2010.02.002; Chinese Center for Disease Control and Prevention(China CDC), 2008, NAT INC DEATH CAS NO; Chinese Center for Disease Control and Prevention(China CDC), 2011, NAT INC DEATH CAS NO; Chinese Center for Disease Control and Prevention(China CDC), 2010, NAT INC DEATH CAS NO; Chinese Center for Disease Control and Prevention(China CDC), 2009, NAT INC DEATH CAS NO; Flett K, 2012, EMERG INFECT DIS, V18, P1702, DOI 10.3201/eid1810.120813; Fujimoto T, 2002, MICROBIOL IMMUNOL, V46, P621, DOI 10.1111/j.1348-0421.2002.tb02743.x; Hosoya M, 2006, PEDIATR INFECT DIS J, V25, P691, DOI 10.1097/01.inf.0000227959.89339.c3; Hu XW, 2018, J INFECT PUBLIC HEAL, V11, P500, DOI 10.1016/j.jiph.2017.10.001; Jiang FC, 2016, EPIDEMIOL INFECT, V144, P2354, DOI 10.1017/S0950268816000601; Jiang XY, 2010, CRIT CARE, V14, pR66; Kar BR, 2013, INDIAN PEDIATR, V50, P139, DOI 10.1007/s13312-013-0033-0; Kulldorff M, 1997, AM J EPIDEMIOL, V146, P161; Kulldorff M., 2021, SATSCANTM USER GUIDE; Kulldorff M, COMMUNIACTIONS STATI, V26, P1481; Li JL, 2014, J INFECTION, V69, P299, DOI 10.1016/j.jinf.2014.04.001; Liu L, 2015, EPIDEMIOL INFECT, V143, P831, DOI 10.1017/S0950268814001587; Liu YD, 2013, PLANT SIGNAL BEHAV, V8, DOI [10.4161/psb.25079, 10.4161/psb.23864, 10.1371/journal.pone.0065361]; Mao LX, 2010, J CLIN VIROL, V49, P100, DOI 10.1016/j.jcv.2010.07.009; Park SK, 2010, J KOREAN MED SCI, V25, P677, DOI 10.3346/jkms.2010.25.5.677; Pfeiffer DU, 2008, Spatial Analysis in Epidemiology, P1, DOI 10.1093/acprof:oso/9780198509882.001.0001; Qiaoyun F, 2013, ARCH VIROL, V158, P895; Rubel RC, 2011, NAV WAR COLL REV, V64, P13; Samphutthanon R, 2014, INT J ENV RES PUB HE, V11, P312, DOI 10.3390/ijerph110100312; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Suguitan Jr AL, 2011, PLOS ONE, V6; The Ministry of Health of The People's Republic of China, CAP J PUBLIC HLTH, P146; Tseng FC, 2007, J MED VIROL, V79, P1850, DOI 10.1002/jmv.21006; Tu PV, 2005, EMERG INFECT DIS, V2007, P1733; Waldhor T, 1996, STAT MED, V15, P887, DOI 10.1002/(SICI)1097-0258(19960415)15:7/9<887::AID-SIM257>3.3.CO;2-5; Wang JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092745; Wang J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09196-z; Wang XF, 2018, IRAN J PUBIC HLTH, V47, P1235; Wang YR, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-539; Weng KF, 2010, MICROBES INFECT, V12, P505, DOI 10.1016/j.micinf.2010.03.006; Xing W, 2012, LANCET INFECT DIS, V14, P308; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Xu LL, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3509-7; Zhang WY, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-206; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu Q, 2011, BIOMED ENVIRON SCI, V24, P349, DOI 10.3967/0895-3988.2011.04.005	47	3	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0233914	10.1371/journal.pone.0233914	http://dx.doi.org/10.1371/journal.pone.0233914			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502174	Green Published, gold			2022-12-26	WOS:000542035700031
J	Anderson, ES; Russell, C; Basham, K; Montgomery, M; Lozier, H; Crocker, A; Zuluaga, M; White, DAE				Anderson, Erik S.; Russell, Carly; Basham, Kellie; Montgomery, Martha; Lozier, Helen; Crocker, Abigail; Zuluaga, Marisa; White, Douglas A. E.			High prevalence of injection drug use and blood-borne viral infections among patients in an urban emergency department	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HIV; PEOPLE; PREVENTION; INCREASES; CARE	Background The opioid epidemic has led to an increase in the number of persons who inject drugs, and this population accounts for 12% of new human immunodeficiency virus (HIV) and 60% of new hepatitis C virus (HCV) infections in the United States annually. While persons who inject drugs disproportionately utilize the emergency department (ED), accurate data is lacking on the prevalence and patterns of injection drug use, and prevalence of co-occurring HIV and HCV infections among ED patients. Objective The primary outcome was to assess the prevalence of injection drug use and co-occurring HIV and HCV infection among patients presenting to an urban ED. Methods This was a cross sectional study conducted at an urban ED, with an annual census of 65,000 visits. A closed-response questionnaire was developed based on publicly available validated surveys to assess patterns of injection drug use and HIV and HCV infection status, and administered by trained research assistants to all registered adult patients during 4-hour blocks of time. Results Of the 2,319 eligible patients, 2,200 (94.9%) consented and completed the survey. 241 (11.0%) had ever used injection drugs, 103 (4.7%) currently used injection drugs, and 138 (6.3%) formerly used injection drugs. White patients age 25 to 34 years and white patients age 55 to 64 years had the highest prevalence of current (25.6%) and former (27.1%) injection drug use, respectively. Persons who use injection drugs had a higher prevalence of HCV infection (52.7% vs. 3.4%) and HIV infection (6.2% vs. 1.8%) than the rest of the population. Conclusion A high prevalence of ED patients report injection drug use, and this population self-reports a high prevalence of HIV and HCV infection. Emergency departments are in a unique position to engage with this population with regards to substance use treatment and linkage to care for HIV and HCV infection.	[Anderson, Erik S.; Russell, Carly; Basham, Kellie; Montgomery, Martha; Lozier, Helen; Crocker, Abigail; Zuluaga, Marisa; White, Douglas A. E.] Highland Hosp, Alameda Hlth Syst, Dept Emergency Med, Oakland, CA 94602 USA		Anderson, ES (corresponding author), Highland Hosp, Alameda Hlth Syst, Dept Emergency Med, Oakland, CA 94602 USA.	esanderson@alamedahealthsystem.org		Anderson, Erik/0000-0001-7759-4327; Lozier, Helen/0000-0002-5717-1711	Gilead Sciences FOCUS Grant	Gilead Sciences FOCUS Grant	Authors ESA, CR, KB, HL, AC, and DAEW, received funding from Gilead Sciences FOCUS Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ES, 2017, CLIN INFECT DIS, V64, P1540, DOI 10.1093/cid/cix163; Banerjee G, 2016, ADDICTION, V111, P2021, DOI 10.1111/add.13491; Center for Disease Control, 2018, HIV SURV REP 2018, V29; Coffin PO, 2020, JAMA PSYCHIAT, V77, P246, DOI 10.1001/jamapsychiatry.2019.3655; D'Onofrio G, 2015, JAMA-J AM MED ASSOC, V313, P1636, DOI 10.1001/jama.2015.3474; Degenhardt L, 2017, LANCET GLOB HEALTH, V5, pE1192, DOI 10.1016/S2214-109X(17)30375-3; Fairbairn N, 2012, J EMERG MED, V43, P236, DOI 10.1016/j.jemermed.2011.05.020; Gebo KA, 2005, JAIDS-J ACQ IMM DEF, V40, P609, DOI 10.1097/01.qai.0000171727.55553.78; Global AIDS Update, GLOB AIDS UPD MIL GO; Tucker RDGY, 2014, ANAEROBE, V30, P108, DOI 10.1016/j.anaerobe.2014.09.005; Haukoos JS, 2013, ANN EMERG MED, V61, P353, DOI 10.1016/j.annemergmed.2012.10.031; Heinzerling KG, 2006, J URBAN HEALTH, V83, P176, DOI 10.1007/s11524-005-9021-6; Hsieh YH, 2018, J VIRAL HEPATITIS, V25, P1397, DOI 10.1111/jvh.12948; Hsieh YH, 2016, CLIN INFECT DIS, V62, P1059, DOI 10.1093/cid/ciw074; Karch Debra L, 2016, Open AIDS J, V10, P127, DOI 10.2174/1874613601610010127; Kerr T, 2005, J PUBLIC HEALTH-UK, V27, P62, DOI 10.1093/pubmed/fdh189; Lansky A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097596; Larney S, 2015, INT J DRUG POLICY, V26, P950, DOI 10.1016/j.drugpo.2015.07.010; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Martin NK, 2013, HEPATOLOGY, V58, P1598, DOI 10.1002/hep.26431; NIDA Clinical Trial Network, COMM DAT EL; Peters PJ, 2016, NEW ENGL J MED, V375, P229, DOI 10.1056/NEJMoa1515195; Tsui JI, 2009, DIGEST DIS SCI, V54, P2694, DOI 10.1007/s10620-008-0659-2; Wu LT, 2012, ANN EMERG MED, V60, P172, DOI 10.1016/j.annemergmed.2012.02.003; Zibbell JE, 2018, AM J PUBLIC HEALTH, V108, P175, DOI 10.2105/AJPH.2017.304132; Zibbell JE, 2015, MMWR-MORBID MORTAL W, V64, P453	26	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0233927	10.1371/journal.pone.0233927	http://dx.doi.org/10.1371/journal.pone.0233927			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MA6PX	32497108	Green Published, gold			2022-12-26	WOS:000542035200089
J	Holden, IK; Lillebaek, T; Andersen, PH; Wejse, C; Johansen, IS				Holden, Inge K.; Lillebaek, Troels; Andersen, Peter H.; Wejse, Christian; Johansen, Isik S.			Characteristics and predictors for tuberculosis related mortality in Denmark from 2009 through 2014: A retrospective cohort study	PLOS ONE			English	Article							RISK-FACTORS; DEATH; NETHERLANDS	Objectives Mortality from tuberculosis (TB) has been declining since 2000, nevertheless there is still a significant number of patients who die before or during TB treatment. The aims were to examine and describe predictors associated with TB related mortality. Methods Patients notified with TB from 2009 though 2014 in Denmark were included. Data were extracted from national registers and patient records were examined for clinical information and treatment outcome. Cox proportional hazards regression was used to examine TB related mortality. Results A total of 2131 cases were identified, 141 (6.6%) patients died before or during TB treatment. TB related mortality accounted for 104 cases (73.8%) and decreased significantly from 6.7% to 3.2% (p = .04) during the study period. Within 1 months of diagnosis, 49% of TB related deaths had occurred. The strongest risk factors present at time of diagnosis, associated with TB related mortality, were: age > 70 years, Charlson comorbidity index > 1, alcohol abuse, weight loss, anemia, and C-reactive protein > 100 mg/L (p < .05). Conclusion The majority of TB related deaths occurred soon after diagnosis, emphasizing that TB patients identified to have a high risk of mortality should be closely monitored before and during the intensive treatment period to improve their outcomes.	[Holden, Inge K.; Johansen, Isik S.] Odense Univ Hosp, Dept Infect Dis, Odense, Denmark; [Holden, Inge K.; Johansen, Isik S.] Mycobacterial Ctr Res Southern DenmarkMyCRESD, Odense, Denmark; [Lillebaek, Troels] Statens Serum Inst, Int Reference Lab Mycobacteriol, Copenhagen, Denmark; [Andersen, Peter H.] Statens Serum Inst, Dept Infect Dis Epidemiol & Prevent, Copenhagen, Denmark; [Wejse, Christian] Aarhus Univ Hosp, Dept Infect Dis, Aarhus, Denmark; [Johansen, Isik S.] Univ Southern Denmark, Dept Clin Res, Odense, Denmark	University of Southern Denmark; Odense University Hospital; Statens Serum Institut; Statens Serum Institut; Aarhus University; University of Southern Denmark	Holden, IK (corresponding author), Odense Univ Hosp, Dept Infect Dis, Odense, Denmark.; Holden, IK (corresponding author), Mycobacterial Ctr Res Southern DenmarkMyCRESD, Odense, Denmark.	lnge.Holden@rsyd.dk	Wejse, Christian/C-8468-2014; Holden, Inge Kristine/B-8050-2018	Wejse, Christian/0000-0002-2534-2942; Lillebaek, Troels/0000-0002-2601-2718; Holden, Inge Kristine/0000-0003-2540-7651; johansen, isik somuncu/0000-0002-2189-9823				Ai JW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.10; [Anonymous], 2014, KULTURPOETIK, V14, P5; Bang D, 2010, SCAND J INFECT DIS, V42, P288, DOI 10.3109/00365540903456282; Borgdorff MW, 1998, EUR RESPIR J, V11, P816, DOI 10.1183/09031936.98.11040816; Borgdorff MW, 2000, EUR RESPIR J, V16, P209, DOI 10.1034/j.1399-3003.2000.16b05.x; Cayla JACJ, 2014, INT J TUBERC LUNG D, V8, P458; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Christensen ASH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027900; Chung-Delgado K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119332; Danish Health Authority, 2014, ALCOHOL DANISH HEALT; DeRiemer K, 1999, INT J TUBERC LUNG D, V3, P488; Diel R, 2003, INT J TUBERC LUNG D, V7, P124; ECDC, 2018, TUB SURV MON EUR; European Centre for Disease Prevention and Control/WHO Regional Office for Europe, 2018, TUB SURV MON EUR 201; Floe A, 2018, THORAX, V73, P70, DOI 10.1136/thoraxjnl-2016-209240; Floyd K, 2018, LANCET RESP MED, V6, P299, DOI 10.1016/S2213-2600(18)30057-2; Hannah HA, 2017, PUBLIC HEALTH REP, V132, P366, DOI 10.1177/0033354917698117; Holden IK, 2019, PREDICTORS PULMONARY; Holden IK, 2019, EXTRAPULMONARY TUBER; HOLM J, 1946, PUBLIC HEALTH REP, V61, P1426, DOI 10.2307/4585854; Kattan JA, 2012, INT J TUBERC LUNG D, V16, P1657, DOI 10.5588/ijtld.12.0169; Kumari P, 2014, APPL BIOCHEM BIOTECH, V174, P2663, DOI 10.1007/s12010-014-1217-3; Lefebvre N, 2008, EUR RESPIR J, V31, P1256, DOI 10.1183/09031936.00131107; Lohse N, 2005, SCAND J INFECT DIS, V37, P338, DOI 10.1080/00365540510031692; Martineau AR, 2004, INT J TUBERC LUNG D, V8, P737; Nguyen LT, 2011, INT J TUBERC LUNG D, V15, P257; PablosMendez A, 1996, JAMA-J AM MED ASSOC, V276, P1223, DOI 10.1001/jama.276.15.1223; Pascopella L, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu090; Rajagopalan S, 2016, CLIN GERIATR MED, V32, P479, DOI 10.1016/j.cger.2016.02.006; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Sterling TR, 2006, INT J TUBERC LUNG D, V10, P542; Theron G, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0964-2; Thrane FD, 2020, SCAND J PUBLIC HEALT, V48, P870, DOI 10.1177/1403494819884433; World Health Organization, 2014, DEF REP FRAM TUB 201; XIE HJ, 1992, TUBERCLE LUNG DIS, V73, P77, DOI 10.1016/0962-8479(92)90059-S; YOSHIKAWA TT, 1992, J AM GERIATR SOC, V40, P178, DOI 10.1111/j.1532-5415.1992.tb01941.x; Zellweger JP, 1998, INT J TUBERC LUNG D, V2, P372	37	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0231821	10.1371/journal.pone.0231821	http://dx.doi.org/10.1371/journal.pone.0231821			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497102	Green Published, gold			2022-12-26	WOS:000542035200036
J	Jia, HL; Wang, XM; Shi, YH; Wu, XM; Wang, YQ; Liu, JN; Fang, ZH; Li, CY; Dong, KH				Jia, Huili; Wang, Xuemin; Shi, Yonghong; Wu, Xinming; Wang, Yunqi; Liu, Jianning; Fang, Zhihong; Li, Chunyan; Dong, Kuanhu			Overexpression ofMedicago sativa LEA4-4 can improve the salt, drought, and oxidation resistance of transgenic Arabidopsis	PLOS ONE			English	Article							GENE-EXPRESSION; LEA GENE; STRESS; PROTEINS; TOLERANCE; PROMOTER; CLONING; IDENTIFICATION; EMBRYOGENESIS; DEHYDRATION	Late embryogenesis abundant (LEA) proteins are widely involved in many adverse conditions among plants. In this study, we isolated aLEA4 gene from alfalfa (Medicago sativaL.) termedMsLEA4-4 via a homology cloning strategy.MsLEA4-4 encodes 166 amino acids, and the structural analysis showed that the gene contained five repeating TAQAAKEKTQQ amino acid motifs. There were a large number of alpha-helix inMsLEA4-4, and belongs to hydrophilic amino acid. Subcellular localization analysis showed thatMsLEA4-4 was localized in the nucleus. TheMsLEA4-4 promoter consisted of G-box and A-box elements, abscisic acid-responsive elements (ABREs), photo regulation and photoperiodic-controllingcis-acting elements, and endosperm expression motifs. TheMsLEA4-4 overexpressing inArabidopsisconferred late-germination phenotypes. Resistance of the overexpressed plants to abiotic stress significantly outperformed the wild-type (WT) plants. Under salt stress and abscisic acid treatment, with more lateral roots and higher chlorophyll content, the overexpressed plants has a higher survival rate measured against WT. Compared to those in the WT plants, the levels of soluble sugar and the activity of various antioxidant enzymes were elevated in the overexpressed plants, whereas the levels of proline and malondialdehyde were significantly reduced. The expression levels of several genes such asABF3,ABI5,NCED5, andNCED9 increased markedly in the overexpressed plants compared to the WT under osmotic stress.	[Jia, Huili; Dong, Kuanhu] Shanxi Agr Univ, Coll Anim Sci & Technol, Taigu, Shanxi, Peoples R China; [Jia, Huili; Shi, Yonghong; Wu, Xinming; Wang, Yunqi; Liu, Jianning; Fang, Zhihong; Li, Chunyan] Shanxi Acad Agr Sci, Anim Husb & Vet Inst, Taiyuan, Shanxi, Peoples R China; [Wang, Xuemin] Chinese Acad Agr Sci, Inst Anim Sci, Beijing, Peoples R China	Shanxi Agricultural University; Shanxi Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS	Dong, KH (corresponding author), Shanxi Agr Univ, Coll Anim Sci & Technol, Taigu, Shanxi, Peoples R China.	dongkuanhu@126.com			Special Funds for the Technical System of the Modern Agricultural Industry of China [CARS-34]; Species Resources Conservation of China [2130135]; Key Research and Development Projects of ShanXi [201703D211002-9-2]	Special Funds for the Technical System of the Modern Agricultural Industry of China; Species Resources Conservation of China; Key Research and Development Projects of ShanXi	The work was supported by a grant from the Special Funds for the Technical System of the Modern Agricultural Industry of China (CARS-34), by the Species Resources Conservation of China (2130135) and by the Key Research and Development Projects of ShanXi (201703D211002-9-2).	Zamora-Briseno JA, 2016, MOL BIOL REP, V43, P221, DOI 10.1007/s11033-016-3963-5; Alqarawi AA, 2018, PLANT BIOSYST, V152, P1263, DOI 10.1080/11263504.2018.1439117; Altunoglu YC, 2016, PLANT GROWTH REGUL, V80, P225, DOI 10.1007/s10725-016-0160-4; Anis MH, 2002, IEEE T VLSI SYST, V10, P71, DOI 10.1109/92.994977; Asad MAU, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020256; Baena-Gonzalez E, 2010, MOL PLANT, V3, P300, DOI 10.1093/mp/ssp113; Banerjee A, 2016, PLANT GROWTH REGUL, V79, P1, DOI 10.1007/s10725-015-0113-3; Barrera-Figueroa BE, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-132; Bielsa B, 2016, SCI HORTIC-AMSTERDAM, V213, P260, DOI 10.1016/j.scienta.2016.11.006; Bray EA, 2002, PLANT CELL ENVIRON, V25, P153, DOI 10.1046/j.1365-3040.2002.00746.x; Chang HC, 2019, BOT STUD, V60, DOI 10.1186/s40529-019-0264-z; Chen G, 2019, PLANT GROWTH REGUL, V88, P241, DOI 10.1007/s10725-019-00504-3; Dalal M, 2009, J BIOTECHNOL, V139, P137, DOI 10.1016/j.jbiotec.2008.09.014; Dhar S., 2019, PLANT GENE, V21, DOI [10.1016/j.plgene.2019.100218, DOI 10.1016/J.PLGENE.2019.100218]; Ditzer A, 2006, PLANT MOL BIOL, V61, P643, DOI 10.1007/s11103-006-0038-3; DURE L, 1981, PLANT PHYSIOL, V68, P187, DOI 10.1104/pp.68.1.187; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; Habora MEE, 2013, BREEDING SCI, V63, P68, DOI 10.1270/jsbbs.63.68; Hawkins C, 2018, CROP J, V6, P565, DOI 10.1016/j.cj.2018.01.006; Hesami A, 2020, COMMUN SOIL SCI PLAN, V51, P804, DOI 10.1080/00103624.2020.1729366; Huang XS, 2011, J EXP BOT, V62, P5191, DOI 10.1093/jxb/err229; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Jia CJ, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1047-x; Jiang JS, 2016, PLANT SCI, V249, P93, DOI 10.1016/j.plantsci.2016.05.004; Ke YT, 2016, PLANT MOL BIOL REP, V34, P1003, DOI 10.1007/s11105-016-0983-1; Lei YT, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1250-4; Li X, 2016, PLANT MOL BIOL REP, V34, P15, DOI 10.1007/s11105-015-0901-y; Li ZY, 2016, MOL BIOL REP, V43, P815, DOI 10.1007/s11033-016-4008-9; Liu GB, 2011, PLANT CELL PHYSIOL, V52, P994, DOI 10.1093/pcp/pcr052; Liu YL, 2015, INT J MOL SCI, V16, P26978, DOI 10.3390/ijms161126006; [刘志敏 Liu Zhimin], 2015, [草业科学, Pratacultural Science], V32, P382; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo D, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1630-4; Magwanga RO, 2018, BMC GENET, V19, DOI 10.1186/s12863-017-0596-1; Meier S, 2008, RICE, V1, P177, DOI 10.1007/s12284-008-9017-4; Min DH, 2012, PLANT MOL BIOL REP, V30, P1313, DOI 10.1007/s11105-012-0446-2; Nylander M, 2001, PLANT MOL BIOL, V45, P263, DOI 10.1023/A:1006469128280; Patro L, 2014, J PHOTOCH PHOTOBIO B, V137, P49, DOI 10.1016/j.jphotobiol.2014.03.018; Qu GZ, 2012, PLANT MOL BIOL REP, V30, P512, DOI 10.1007/s11105-011-0371-9; Rodriguez-Valentin R, 2014, PLANT MOL BIOL REP, V32, P198, DOI 10.1007/s11105-013-0641-9; Romo S, 2001, PLANT PHYSIOL BIOCH, V39, P1017, DOI 10.1016/S0981-9428(01)01318-3; Ryabova A, 2016, BIONANOSCIENCE, V6, P554, DOI 10.1007/s12668-016-0275-0; Singer SD, 2018, PLANT CELL ENVIRON, V41, P1955, DOI 10.1111/pce.13090; Soulages JL, 2003, PLANT PHYSIOL, V131, P963, DOI 10.1104/pp.015891; Toxopeus J, 2014, CELL STRESS CHAPERON, V19, P939, DOI 10.1007/s12192-014-0518-3; Wang YF, 2018, PLANT CELL TISS ORG, V132, P525, DOI 10.1007/s11240-017-1348-7; Wu YC, 2014, PROTOPLASMA, V251, P1191, DOI 10.1007/s00709-014-0626-z; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Xu ML, 2020, PLANT CELL PHYSIOL, V61, P775, DOI 10.1093/pcp/pcaa004; Yang C, 2019, MITOCHONDRIAL DNA B, V4, P603, DOI 10.1080/23802359.2018.1561225; Yang ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116283; Zeng X, 2018, GENE, V646, P136, DOI 10.1016/j.gene.2018.01.002; Zhang HF, 2020, J EXP BOT, V71, P188, DOI 10.1093/jxb/erz432; Zhang Z.-Z., 2009, EXPT COURSE TEA BIOC; Zhao Y, 2017, PLANT CELL TISS ORG, V130, P379, DOI 10.1007/s11240-017-1234-3; Zhou C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060976; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367; Zou YD, 2011, BIOTECHNOL LETT, V33, P1667, DOI 10.1007/s10529-011-0602-z; 2015, DRUG SAFETY UPDATE, V8, P1	59	8	8	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0234085	10.1371/journal.pone.0234085	http://dx.doi.org/10.1371/journal.pone.0234085			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497140	Green Published, gold			2022-12-26	WOS:000542035200071
J	Schoenecker, JG				Schoenecker, Jonathan G.		Childrens Orthopaedic Trauma	Defining the volume of consultations for musculoskeletal infection encountered by pediatric orthopaedic services in the United States	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS OSTEOMYELITIS; ACUTE HEMATOGENOUS OSTEOMYELITIS; METHICILLIN-RESISTANT; SEPTIC ARTHRITIS; TRANSIENT SYNOVITIS; CHILDREN; CARE; GUIDELINE; HIP; ALGORITHM	Objective Adequate resources are required to rapidly diagnose and treat pediatric musculoskeletal infection (MSKI). The workload MSKI consults contribute to pediatric orthopaedic services is unknown as prior epidemiologic studies are variable and negative work-ups are not included in national discharge databases. The hypothesis was tested that MSKI consults constitute a substantial volume of total consultations for pediatric orthopaedic services across the United States. Study design Eighteen institutions from the Children's ORthopaedic Trauma and Infection Consortium for Evidence-based Study (CORTICES) group retrospectively reviewed a minimum of 1 year of hospital data, reporting the total number of surgeons, total consultations, and MSKI-related consultations. Consultations were classified by the location of consultation (emergency department or inpatient). Culture positivity rate and pathogens were also reported. Results 87,449 total orthopaedic consultations and 7,814 MSKI-related consultations performed by 229 pediatric orthopaedic surgeons were reviewed. There was an average of 13 orthopaedic surgeons per site each performing an average of 154 consultations per year. On average, 9% of consultations were MSKI related and 37% of these consults yielded positive cultures. Finally, a weak inverse monotonic relationship was noted between percent culture positivity and percent of total orthopedic consults for MSKI. Conclusion At large, academic pediatric tertiary care centers, pediatric orthopaedic services consult on an average of similar to 3,000 'rule-out' MSKI cases annually. These patients account for nearly 1 in 10 orthopaedic consultations, of which 1 in 3 are culture positive. Considering that 2 in 3 consultations were culture negative, estimating resources required for pediatric orthopaedic consult services to work up and treat children based on culture positive administrative discharge data underestimates clinical need. Finally, ascertainment bias must be considered when comparing differences in culture rates from different institution's pediatric orthopaedics services, given the variability in when orthopaedic physicians become involved in a MSKI workup.	[Schoenecker, Jonathan G.; Childrens Orthopaedic Trauma] Vanderbilt Univ, Med Ctr, Monroe Carell Jr Childrens Hosp, Nashville, TN 37212 USA	Vanderbilt University	Schoenecker, JG (corresponding author), Vanderbilt Univ, Med Ctr, Monroe Carell Jr Childrens Hosp, Nashville, TN 37212 USA.	Jon.schoenecker@vumc.org		Sanborn, Ryan/0000-0003-1449-2926; Schoenecker, Jonathan/0000-0002-3097-5496; Li, Ying/0000-0002-0882-5926	Pediatric Orthopaedic Society of North America (POSNA)	Pediatric Orthopaedic Society of North America (POSNA)	Funding for the creation of this database was provided by the Pediatric Orthopaedic Society of North America (POSNA) through a directed research grant to JGS as a member of CORTICES. POSNA did not play a role in this investigation or have influence on the database curation, no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshryda S, 2016, PAEDIAT ORTHOPAEDICS; Arkader A, 2016, J AM ACAD ORTHOP SUR, V24, pE112, DOI 10.5435/JAAOS-D-15-00714; Arnold SR, 2006, J PEDIATR ORTHOPED, V26, P703, DOI 10.1097/01.bpo.0000242431.91489.b4; Athey AG, 2019, J PEDIATR ORTHOPED, V39, P90, DOI 10.1097/BPO.0000000000000879; Bacon M, 2016, ARCH DIS CHILD S, V101, pA36; Benvenuti M, 2017, ORTHOP CLIN N AM, V48, P181, DOI 10.1016/j.ocl.2016.12.009; Benvenuti MA, 2019, J PEDIATR ORTHOPED, V39, P153, DOI 10.1097/BPO.0000000000000880; Benvenuti MA, 2019, J PEDIATR ORTHOPED, V39, P158, DOI 10.1097/BPO.0000000000000884; Chira S, 2010, EPIDEMIOL INFECT, V138, P313, DOI 10.1017/S0950268809990483; Copley LAB, 2014, PEDIATR INFECT DIS J, V33, P35, DOI 10.1097/INF.0000000000000002; Copley LAB, 2013, J BONE JOINT SURG AM, V95A, P686, DOI 10.2106/JBJS.L.00037; Hawkshead JJ, 2009, J PEDIATR ORTHOPED, V29, P85, DOI 10.1097/BPO.0b013e3181901c3a; Hollmig ST, 2007, CHANGING EPIDEMIOLOG; Horn S D, 1984, Health Care Financ Rev, VSuppl, P33; IEZZONI LI, 1990, JAMA-J AM MED ASSOC, V264, P1426, DOI 10.1001/jama.264.11.1426; Ju KL, 2011, J BONE JOINT SURG AM, V93A, P1693, DOI [10.2106/JBJSJ.01154, 10.2106/JBJS.J.01154]; Kocher MS, 2004, J BONE JOINT SURG AM, V86A, P1629, DOI 10.2106/00004623-200408000-00005; Kocher MS, 2003, J BONE JOINT SURG AM, V85A, P994, DOI 10.2106/00004623-200306000-00002; Kocher MS, 1999, J BONE JOINT SURG AM, V81A, P1662, DOI 10.2106/00004623-199912000-00002; Lawson EH, 2012, ANN SURG, V256, P973, DOI 10.1097/SLA.0b013e31826b4c4f; Malcius D, 2005, PEDIATR SURG INT, V21, P356, DOI 10.1007/s00383-005-1432-7; Mignemi ME, 2018, J PEDIATR ORTHOPED, V38, P279, DOI 10.1097/BPO.0000000000000811; Mignemi ME, 2014, J PEDIATR ORTHOPED, V34, P316, DOI 10.1097/BPO.0000000000000106; Mongkolrattanothai K, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-112; Nguyen A, 2017, J PEDIATR ORTHOPED, V37, pE114, DOI 10.1097/BPO.0000000000000602; Orloski KA, 1992, SURVEILLANCE LYME DI; Perlman MH, 2000, J PEDIATR ORTHOPED, V20, P40, DOI 10.1097/00004694-200001000-00009; RCore Team, 2020, R LANG ENV STAT COMP; Riise OR, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-45; Saavedra-Lozano J, 2008, J PEDIATR ORTHOPED, V28, P569, DOI 10.1097/BPO.0b013e31817bb816; Sarkissian EJ, 2016, J PEDIATR ORTHOPED, V36, P323, DOI 10.1097/BPO.0000000000000439; Section J, 2015, J BONE JOINT SURG AM, V97A, P441, DOI 10.2106/JBJS.N.00477; Shrader MW, 2013, J PEDIATR ORTHOPED, V33, P759, DOI 10.1097/BPO.0b013e3182a11cf7; Spruiell MD, 2017, J PEDIATR INFECT DIS, V6, pE86, DOI 10.1093/jpids/pix014; Toivonen L, 2016, PEDIATR INFECT DIS J, V35, pE362, DOI 10.1097/INF.0000000000001304; Urrea M, 2003, PEDIATR INFECT DIS J, V22, P490, DOI 10.1097/00006454-200306000-00002; Zingg W, 2017, LANCET INFECT DIS, V17, P381, DOI 10.1016/S1473-3099(16)30517-5	37	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0234055	10.1371/journal.pone.0234055	http://dx.doi.org/10.1371/journal.pone.0234055			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497101	Green Published, gold			2022-12-26	WOS:000542035200080
J	Wan, YL; Wang, XF; Chen, Q; Lei, XY; Wang, Y; Chen, CD; Hu, HP				Wan, Yanli; Wang, Xifu; Chen, Quan; Lei, Xingyun; Wang, Yan; Chen, Chongde; Hu, Hongpu			A disease category feature database construction method of brain image based on deep convolutional neural network	PLOS ONE			English	Article							RETRIEVAL	Background Constructing a medical image feature database according to the category of disease can achieve a quick retrieval of images with similar pathological features. Therefore, this approach has important application values in the fields such as auxiliary diagnosis, teaching, research, and telemedicine. Methods Based on the deep convolutional neural network, an image classifier applicable to brain disease was designed to distinguish between the image features of the different brain diseases with similar anatomical structures. Through the extraction and analysis of visual features, the images were labelled with the corresponding semantic features of a specific disease category, which can establish an association between the visual features of brain images and the semantic features of the category of disease which will permit to construct a disease category feature database of brain images. Results Based on the similarity measurement and the matching strategy of high-dimensional visual feature, a high-precision retrieval of brain image with semantics category was achieved, and the constructed disease category feature database of brain image was tested and evaluated through large numbers of pathological image retrieval experiments, the accuracy and the effectiveness of the proposed approach was verified. Conclusion The disease category feature database of brain image constructed by the proposed approach achieved a quick and effective retrieval of images with similar pathological features, which is beneficial to the categorization and analysis of intractable brain diseases. This provides an effective application tool such as case-based image data management, evidence-based medicine and clinical decision support.	[Wan, Yanli; Chen, Quan; Lei, Xingyun; Wang, Yan; Chen, Chongde; Hu, Hongpu] Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Informat, Beijing, Peoples R China; [Wang, Xifu] Beijing Jiaotong Univ, Sch Traff & Transportat, Inst Syst Engn & Control, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Beijing Jiaotong University	Hu, HP (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Informat, Beijing, Peoples R China.	huhongpu416@126.com			National Natural Science Foundation of China [61971446, 61703436]; National Social Science Foundation of China [17BGL184]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Social Science Foundation of China	This work was supported by the National Natural Science Foundation of China (URLs: http://www.nsfc.gov.cn/and grant No: 61971446 and 61703436), and the National Social Science Foundation of China (URLs: http://www.npopss-cn.gov.cn/and grant No: 17BGL184). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akgul CB, 2011, J DIGIT IMAGING, V24, P208, DOI 10.1007/s10278-010-9290-9; Avni U, 2011, IEEE T MED IMAGING, V30, P733, DOI 10.1109/TMI.2010.2095026; Bar Y, 2015, I S BIOMED IMAGING, P294, DOI 10.1109/ISBI.2015.7163871; Camlica Z, 2015, INT CONF IMAG PROC, P550, DOI 10.1109/IPTA.2015.7367208; Herrera AGSD, 2016, CLEF WORKINGNOTES; Jiang ML, 2015, IEEE T BIO-MED ENG, V62, P783, DOI 10.1109/TBME.2014.2365494; Joe Yue-Hei Ng, 2015, 2015 IEEE Conference on Computer Vision and Pattern Recognition Workshops (CVPRW), P53, DOI 10.1109/CVPRW.2015.7301272; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Li Q, 2014, I C CONT AUTOMAT ROB, P844, DOI 10.1109/ICARCV.2014.7064414; Li X, 2020, IEEE T NANOBIOSCI, V19, P299, DOI 10.1109/TNB.2020.2971644; Mourao A, 2015, COMPUT MED IMAG GRAP, V39, P35, DOI 10.1016/j.compmedimag.2014.05.006; Muller H, 2004, INT J MED INFORM, V73, P1, DOI 10.1016/j.ijmedinf.2003.11.024; Pang SC, 2018, COMPUT METH PROG BIO, V158, P53, DOI 10.1016/j.cmpb.2018.02.003; Qayyum A, 2017, NEUROCOMPUTING, V266, P8, DOI 10.1016/j.neucom.2017.05.025; Sharmila G., 2014, IJRET INT J RES ENG, V03, P149; Shin HC, 2016, IEEE T MED IMAGING, V35, P1285, DOI 10.1109/TMI.2016.2528162; Sun QP, 2017, MED IMAGING 2017 IMA; Weltera P, 2012, COMPUT METH PROG BIO, V108, P589, DOI 10.1016/j.cmpb.2011.08.010; Zhang Q, 2017, NEURAL INFORM PROCES, P364; Zhao HY, 2019, MATH BIOSCI ENG, V16, P1709, DOI 10.3934/mbe.2019081	21	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0232791	10.1371/journal.pone.0232791	http://dx.doi.org/10.1371/journal.pone.0232791			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MJ2AA	32479504	Green Published, gold			2022-12-26	WOS:000547893500005
J	Chen, P; Liu, R; Huang, MM; Zhu, JL; Wei, D; Castellino, FJ; Dang, GH; Xie, F; Li, G; Cui, ZY; Liu, SG; Zhang, YL				Chen, Ping; Liu, Ran; Huang, Mengmeng; Zhu, Jinlu; Wei, Dong; Castellino, Francis J.; Dang, Guanghui; Xie, Fang; Li, Gang; Cui, Ziyin; Liu, Siguo; Zhang, Yueling			A unique combination of glycoside hydrolases in Streptococcus suis specifically and sequentially acts on host-derived alpha Gal-epitope glycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Streptococcus suis; glycoside hydrolase (GH); multifunctional enzyme; family 32 carbohydrate-binding module (CBM32); evolution; alpha Gal epitope; swine tracheal epithelial cells (STEC); endo-(beta 1; 4)-galactosidase; beta-acetylhexosaminidase; GalNagA; Streptococcus; substrate specificity; multifunctional enzyme; carbohydrate-binding protein; carbohydrate processing; enzyme catalysis; enzyme kinetics; host-pathogen interaction; erythrocyte	RABBIT ERYTHROCYTE-MEMBRANES; BETA-GALACTOSIDASE C; CARBOHYDRATE; ANTIBODY; DATABASE; POLYGLYCOSYLCERAMIDES; IMMUNOCHEMISTRY; GLYCOSYLATION; GLYCOPROTEINS; RECOGNITION	Infections by many bacterial pathogens rely on their ability to degrade host glycans by producing glycoside hydrolases (GHs). Here, we discovered a conserved multifunctional GH, SsGalNagA, containing a unique combination of two family 32 carbohydrate-binding modules (CBM), a GH16 domain and a GH20 domain, in the zoonotic pathogenStreptococcus suis05ZYH33. Enzymatic assays revealed that the SsCBM-GH16 domain displaysendo-(beta 1,4)-galactosidase activity specifically toward the host-derived alpha Gal epitope Gal(alpha 1,3)Gal(beta 1,4)Glc(NAc)-R, whereas the SsGH20 domain has a wide spectrum ofexo-beta-N-acetylhexosaminidase activities, includingexo-(beta 1,3)-N-acetylglucosaminidase activity, and employs this activity to act in tandem with SsCBM-GH16 on the alpha Gal-epitope glycan. Further, we found that the CBM32 domain adjacent to the SsGH16 domain is indispensable for SsGH16 catalytic activity. Surface plasmon resonance experiments uncovered that both CBM32 domains specifically bind to alpha Gal-epitope glycan, and together they had aK(D)of 3.5 mmtoward a pentasaccharide alpha Gal-epitope glycan. Cell-binding and alpha Gal epitope removal assays revealed that SsGalNagA efficiently binds to both swine erythrocytes and tracheal epithelial cells and removes the alpha Gal epitope from these cells, suggesting that SsGalNagA functions in nutrient acquisition or alters host signaling inS. suis. Both binding and removal activities were blocked by an alpha Gal-epitope glycan. SsGalNagA is the first enzyme reported to sequentially act on a glycan containing the alpha Gal epitope. These findings shed detailed light on the evolution of GHs and an important host-pathogen interaction.	[Chen, Ping; Liu, Ran; Huang, Mengmeng; Zhu, Jinlu; Wei, Dong; Dang, Guanghui; Xie, Fang; Li, Gang; Cui, Ziyin; Liu, Siguo; Zhang, Yueling] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Peoples R China; [Castellino, Francis J.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Castellino, Francis J.] Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; University of Notre Dame; University of Notre Dame	Liu, SG; Zhang, YL (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Peoples R China.	zhangyueling@caas.cn; zhang.yl@foxmail.com		Castellino, Francis/0000-0003-0317-9539; Xie, Fang/0000-0003-2041-2208	National Key R&D Program of China [2017YFD0500203]; National Natural Science Foundation of China [31772757, 31873016, 31672575]; Natural Science Foundation of Heilongjiang Province of China [C2017075, C2017078]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province)	This research was supported by grants from the National Key R&D Program of China (2017YFD0500203 to Y. Z.), the National Natural Science Foundation of China (31772757 to Y. Z.; 31873016 to F. X.; 31672575 to G. L.), and the Natural Science Foundation of Heilongjiang Province of China (C2017075 to Y. Z.; C2017078 to G. L.).	Alexander Nathan, 2011, IEEE Int Conf Comput Adv Bio Med Sci, V2011, P13, DOI 10.1109/ICCABS.2011.5729867; Byers HL, 1999, GLYCOBIOLOGY, V9, P469, DOI 10.1093/glycob/9.5.469; Cao YL, 2014, P NATL ACAD SCI USA, V111, P12901, DOI 10.1073/pnas.1407344111; Chen C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000315; Cuskin F, 2015, NATURE, V517, P165, DOI 10.1038/nature13995; DABROWSKI U, 1984, J BIOL CHEM, V259, P7648; Dalia AB, 2010, INFECT IMMUN, V78, P2108, DOI 10.1128/IAI.01125-09; EGGE H, 1985, J BIOL CHEM, V260, P4927; Feng YJ, 2014, VIRULENCE, V5, P477, DOI 10.4161/viru.28595; Ficko-Blean E, 2012, CURR OPIN STRUC BIOL, V22, P570, DOI 10.1016/j.sbi.2012.07.009; FINNE J, 1979, EUR J BIOCHEM, V102, P583, DOI 10.1111/j.1432-1033.1979.tb04275.x; Fittipaldi N, 2012, FUTURE MICROBIOL, V7, P259, DOI [10.2217/FMB.11.149, 10.2217/fmb.11.149]; FUSHUKU N, 1987, J BIOL CHEM, V262, P10086; Galili U, 2005, IMMUNOL CELL BIOL, V83, P674, DOI 10.1111/j.1440-1711.2005.01366.x; GALILI U, 1984, J EXP MED, V160, P1519, DOI 10.1084/jem.160.5.1519; GALILI U, 1985, J EXP MED, V162, P573, DOI 10.1084/jem.162.2.573; HANFLAND P, 1988, CARBOHYD RES, V178, P1, DOI 10.1016/0008-6215(88)80098-3; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; HENDRICKS SP, 1990, J BIOL CHEM, V265, P17621; Hobbs JK, 2018, FEBS LETT, V592, P3865, DOI 10.1002/1873-3468.13045; Huai GL, 2016, INT J MOL MED, V37, P11, DOI 10.3892/ijmm.2015.2397; Huang L, 2018, NUCLEIC ACIDS RES, V46, pD516, DOI 10.1093/nar/gkx894; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Khoury GA, 2011, SCI REP-UK, V1, DOI 10.1038/srep00090; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Macher BA, 2008, BBA-GEN SUBJECTS, V1780, P75, DOI 10.1016/j.bbagen.2007.11.003; Manfredi P, 2011, MOL MICROBIOL, V81, P1050, DOI 10.1111/j.1365-2958.2011.07750.x; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Ogawa H, 2000, J BIOL CHEM, V275, P19368, DOI 10.1074/jbc.M001888200; ORIOL R, 1993, TRANSPLANTATION, V56, P1433, DOI 10.1097/00007890-199312000-00031; Poole J, 2018, NAT REV MICROBIOL, V16, P440, DOI 10.1038/s41579-018-0007-2; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Ritchie GE, 2002, CHEM REV, V102, P305, DOI 10.1021/cr990294a; Robb M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006090; Russo D, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101732; STELLNER K, 1973, ARCH BIOCHEM BIOPHYS, V155, P464, DOI 10.1016/0003-9861(73)90138-0; Terrapon N, 2018, NUCLEIC ACIDS RES, V46, pD677, DOI 10.1093/nar/gkx1022; van Bueren AL, 2011, STRUCTURE, V19, P640, DOI 10.1016/j.str.2011.03.001; Viborg AH, 2019, J BIOL CHEM, V294, P15973, DOI 10.1074/jbc.RA119.010619; WATANABE K, 1979, J BIOL CHEM, V254, P3221; Watanabe S, 2011, GLYCOBIOLOGY, V21, P482, DOI 10.1093/glycob/cwq186; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Yu YF, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00974; Zakhour M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000504; Zhang YL, 2012, J BIOL CHEM, V287, P42093, DOI 10.1074/jbc.M112.417808	47	3	3	2	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2020	295	31					10638	10652		10.1074/jbc.RA119.011977	http://dx.doi.org/10.1074/jbc.RA119.011977			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB3HM	32518157	Green Published, hybrid			2022-12-26	WOS:000560405600011
J	Mathur, Y; Sreyas, S; Datar, PM; Sathian, MB; Hazra, AB				Mathur, Yamini; Sreyas, Sheryl; Datar, Prathamesh M.; Sathian, Manjima B.; Hazra, Amrita B.			CobT and BzaC catalyze the regiospecific activation and methylation of the 5-hydroxybenzimidazole lower ligand in anaerobic cobamide biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						vitamin B-12; cobamide; CobT; phosphoribosyltransferase; BzaC; methyltransferase; 5-hydroxybenzimidazole; 5-methoxybenzimidazole; 5; 6-dimethylbenzimidazole; Moorella thermoacetica; enzyme; microbiology; S-adenosylmethionine (SAM); substrate specificity; adenosylcobalamin (AdoCbl); benzimidazoles	COENZYME B-12 SYNTHESIS; EUBACTERIUM-LIMOSUM; 5,6-DIMETHYLBENZIMIDAZOLE MOIETY; PHOSPHORIBOSYLTRANSFERASE COBT; NICOTINATE MONONUCLEOTIDE; S-ADENOSYLMETHIONINE; SALMONELLA-ENTERICA; LAST STEP; VITAMIN-B-12; COBALAMIN	Vitamin B(12)and other cobamides are essential cofactors required by many organisms and are synthesized by a subset of prokaryotes via distinct aerobic and anaerobic routes. The anaerobic biosynthesis of 5,6-dimethylbenzimidazole (DMB), the lower ligand of vitamin B-12, involves five reactions catalyzed by thebzaoperon gene products, namely the hydroxybenzimidazole synthase BzaAB/BzaF, phosphoribosyltransferase CobT, and three methyltransferases, BzaC, BzaD, and BzaE, that conduct three distinct methylation steps. Of these, the methyltransferases that contribute to benzimidazole lower ligand diversity in cobamides remain to be characterized, and the precise role of thebzaoperon protein CobT is unclear. In this study, we used thebzaoperon from the anaerobic bacteriumMoorella thermoacetica(comprisingbzaA-bzaB-cobT-bzaC) to examine the role of CobT and investigate the activity of the first methyltransferase, BzaC. We studied the phosphoribosylation catalyzed byMtCobT and found that it regiospecifically activates 5-hydroxybenzimidazole (5-OHBza) to form the 5-OHBza-ribotide (5-OHBza-RP) isomer as the sole product. Next, we characterized the domains ofMtBzaC and reconstituted its methyltransferase activity with the predicted substrate 5-OHBza and with two alternative substrates, theMtCobT product 5-OHBza-RP and its riboside derivative 5-OHBza-R. Unexpectedly, we found that 5-OHBza-R is the most favoredMtBzaC substrate. Our results collectively explain the long-standing observation that the attachment of the lower ligand in anaerobic cobamide biosynthesis is regiospecific. In conclusion, we validateMtBzaC as a SAM:hydroxybenzimidazole-riboside methyltransferase (HBIR-OMT). Finally, we propose a new pathway for the synthesis and activation of the benzimidazolyl lower ligand in anaerobic cobamide biosynthesis.	[Mathur, Yamini; Hazra, Amrita B.] Indian Inst Sci Educ & Res, Dept Biol, Pune, Maharashtra, India; [Sreyas, Sheryl; Datar, Prathamesh M.; Sathian, Manjima B.; Hazra, Amrita B.] Indian Inst Sci Educ & Res, Dept Chem, Pune, Maharashtra, India; [Datar, Prathamesh M.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	Indian Institute of Science Education & Research (IISER) Pune; Indian Institute of Science Education & Research (IISER) Pune; University of Michigan System; University of Michigan	Hazra, AB (corresponding author), Indian Inst Sci Educ & Res, Dept Biol, Pune, Maharashtra, India.; Hazra, AB (corresponding author), Indian Inst Sci Educ & Res, Dept Chem, Pune, Maharashtra, India.	amrita@iiserpune.ac.in		B Sathian, Manjima/0000-0002-3630-3076; Datar, Prathamesh/0000-0003-1514-9767; Mathur, Yamini/0000-0002-4895-911X; Hazra, Amrita/0000-0003-1536-2509; sreyas, sheryl/0000-0002-9311-5864	Department of Science and Technology (DST), Ministry of Science and Technology, India -Science and Engineering Research Board Early Career Research Award [ECR/2016/000466]; Department of Biotechnology -Ramalingaswami Re-entry Fellowship; Council for Scientific and Industrial Research, India; National Science Foundation; DST-Kishor Vaigyanik Protsahan Yojana fellowship; DST-INSPIRE fellowships	Department of Science and Technology (DST), Ministry of Science and Technology, India -Science and Engineering Research Board Early Career Research Award; Department of Biotechnology -Ramalingaswami Re-entry Fellowship; Council for Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); National Science Foundation(National Science Foundation (NSF)); DST-Kishor Vaigyanik Protsahan Yojana fellowship; DST-INSPIRE fellowships	The work was supported by Department of Science and Technology (DST), Ministry of Science and Technology, India -Science and Engineering Research Board Early Career Research Award ECR/2016/000466 (to A. B. H.) and the Department of Biotechnology -Ramalingaswami Re-entry Fellowship (to A. B. H.). Y. M. is supported by a graduate research fellowship from the Council for Scientific and Industrial Research, India and was provided travel support by the National Science Foundation funded Indo-US Workshop on Cell Factories to present this work. S. S. was supported by a DST-Kishor Vaigyanik Protsahan Yojana fellowship, and M. B. S. and P. M. D. were supported by DST-INSPIRE fellowships.	Allen RH, 2008, AM J CLIN NUTR, V87, P1324, DOI 10.1093/ajcn/87.5.1324; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063; Botros HG, 2013, J PINEAL RES, V54, P46, DOI 10.1111/j.1600-079X.2012.01020.x; Bridwell-Rabb J, 2018, ANNU REV BIOCHEM, V87, P555, DOI 10.1146/annurev-biochem-062917-012500; Broderick JB, 2014, CHEM REV, V114, P4229, DOI 10.1021/cr4004709; Campbell GRO, 2006, P NATL ACAD SCI USA, V103, P4634, DOI 10.1073/pnas.0509384103; Chan CH, 2014, BBA-GEN SUBJECTS, V1840, P464, DOI 10.1016/j.bbagen.2013.09.038; Chan CH, 2011, MOL MICROBIOL, V81, P952, DOI 10.1111/j.1365-2958.2011.07741.x; Cheng JJ, 2007, MICROBIOL-SGM, V153, P375, DOI 10.1099/mic.0.2006/001362-0; Cheong CG, 2002, J BIOL CHEM, V277, P41120, DOI 10.1074/jbc.M203535200; Cheong CG, 1999, BIOCHEMISTRY-US, V38, P16125, DOI 10.1021/bi991752c; Cheong CG, 2001, J BIOL CHEM, V276, P37612, DOI 10.1074/jbc.M105390200; Chittim CL, 2018, BIOCHEMISTRY-US, V57, P2567, DOI 10.1021/acs.biochem.7b01277; Cornell KA, 1996, BIOCHEM BIOPH RES CO, V228, P724, DOI 10.1006/bbrc.1996.1723; Crofts TS, 2014, BIOCHEMISTRY-US, V53, P7805, DOI 10.1021/bi501147d; Crofts TS, 2013, CHEM BIOL, V20, P1265, DOI 10.1016/j.chembiol.2013.08.006; Danchin A, 2017, MICROB BIOTECHNOL, V10, P688, DOI 10.1111/1751-7915.12722; Degnan PH, 2014, CELL METAB, V20, P769, DOI 10.1016/j.cmet.2014.10.002; Ding W, 2010, MOL BIOSYST, V6, P1071, DOI 10.1039/b926358f; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FRIEDMAN.HC, 1965, J BIOL CHEM, V240, P406; Gagnon DM, 2018, J AM CHEM SOC, V140, P12798, DOI 10.1021/jacs.8b05686; Giedyk M, 2015, CHEM SOC REV, V44, P3391, DOI 10.1039/c5cs00165j; Goodacre NF, 2014, MBIO, V5, DOI 10.1128/mBio.00744-13; Gray MJ, 2010, MOL MICROBIOL, V77, P1429, DOI 10.1111/j.1365-2958.2010.07294.x; Gude S, 2020, CURR OPIN BIOTECH, V62, P58, DOI 10.1016/j.copbio.2019.08.005; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hazra AB, 2018, BIOCHEMISTRY-US, V57, P1748, DOI 10.1021/acs.biochem.7b01193; Hazra AB, 2015, P NATL ACAD SCI USA, V112, P10792, DOI 10.1073/pnas.1509132112; Hazra AB, 2013, CHEM BIOL, V20, P1275, DOI 10.1016/j.chembiol.2013.08.007; HORIG JA, 1978, J BIOL CHEM, V253, P7410; IRION E, 1965, BIOCHEMISTRY-US, V4, P2780, DOI 10.1021/bi00888a031; Jeter VL, 2019, BIOCHEMISTRY-US, V58, P951, DOI 10.1021/acs.biochem.8b01253; Keller S, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00584-17; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kozbial PZ, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-19; KRAUTLER B, 1988, EUR J BIOCHEM, V176, P461, DOI 10.1111/j.1432-1033.1988.tb14303.x; LAMM L, 1980, EUR J BIOCHEM, V109, P115, DOI 10.1111/j.1432-1033.1980.tb04775.x; LAMM L, 1982, EUR J BIOCHEM, V122, P569; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Maggio-Hall LA, 1999, P NATL ACAD SCI USA, V96, P11798, DOI 10.1073/pnas.96.21.11798; Maggio-Hall LA, 2004, MICROBIOL-SGM, V150, P1385, DOI 10.1099/mic.0.26952-0; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Mattes T. A., 2017, ENCY INORGANIC BIOIN, P1; Mattes TA, 2017, MOL MICROBIOL, V103, P269, DOI 10.1111/mmi.13555; Mehta AP, 2015, J AM CHEM SOC, V137, P10444, DOI 10.1021/jacs.5b03576; Miller Mark A., 2010, 2010 Gateway Computing Environments Workshop (GCE 2010), DOI 10.1109/GCE.2010.5676129; Moore SJ, 2012, BIOCHEM SOC T, V40, P581, DOI 10.1042/BST20120066; Petrossian T, 2009, EPIGENOMICS-UK, V1, P163, DOI 10.2217/EPI.09.3; RENZ P, 1993, EUR J BIOCHEM, V217, P1117, DOI 10.1111/j.1432-1033.1993.tb18344.x; Roth JR, 1996, ANNU REV MICROBIOL, V50, P137, DOI 10.1146/annurev.micro.50.1.137; Sandanaraj BS, 2018, CHEM-EUR J, V24, P16085, DOI 10.1002/chem.201802824; SCHERER P, 1984, ARCH MICROBIOL, V138, P354, DOI 10.1007/BF00410903; Schulze B, 1998, EUR J BIOCHEM, V254, P620, DOI 10.1046/j.1432-1327.1998.2540620.x; Seth EC, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00350; Shelton AN, 2019, ISME J, V13, P789, DOI 10.1038/s41396-018-0304-9; Siegrist J, 2015, CHEMBIOCHEM, V16, P2576, DOI 10.1002/cbic.201500410; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Struck AW, 2012, CHEMBIOCHEM, V13, P2642, DOI 10.1002/cbic.201200556; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; STUPPERICH E, 1990, FEMS MICROBIOL LETT, V87, P355, DOI 10.1016/0378-1097(90)90478-9; STUPPERICH E, 1991, EUR J BIOCHEM, V199, P299, DOI 10.1111/j.1432-1033.1991.tb16124.x; Taga ME, 2007, NATURE, V446, P449, DOI 10.1038/nature05611; Towns J, 2014, COMPUT SCI ENG, V16, P62, DOI 10.1109/MCSE.2014.80; Trzebiatowski JR, 1997, J BIOL CHEM, V272, P17662, DOI 10.1074/jbc.272.28.17662; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; VOGT JRA, 1988, EUR J BIOCHEM, V171, P655, DOI 10.1111/j.1432-1033.1988.tb13836.x; Warner JR, 2007, BIOCHEMISTRY-US, V46, P13211, DOI 10.1021/bi701069n; WURM R, 1975, EUR J BIOCHEM, V56, P427, DOI 10.1111/j.1432-1033.1975.tb02249.x; WURM R, 1980, FEMS MICROBIOL LETT, V7, P11, DOI 10.1111/j.1574-6941.1980.tb01566.x; Yang Jianyi, 2015, Curr Protoc Bioinformatics, V52, DOI 10.1002/0471250953.bi0508s52; Zayas CL, 2007, J BACTERIOL, V189, P2210, DOI 10.1128/JB.01665-06; Zhang J, 2016, ACS CHEM BIOL, V11, P583, DOI 10.1021/acschembio.5b00812; Zhang W, 2008, J AM CHEM SOC, V130, P6068, DOI 10.1021/ja800951e	76	4	4	5	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2020	295	31					10522	10534		10.1074/jbc.RA120.014197	http://dx.doi.org/10.1074/jbc.RA120.014197			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB3HM	32503839	Green Published, hybrid			2022-12-26	WOS:000560405600002
J	Tripathi, A; Liverani, E; Tsygankov, AY; Puri, S				Tripathi, Aparna; Liverani, Elisabetta; Tsygankov, Alexander Y.; Puri, Sumant			Iron alters the cell wall composition and intracellular lactate to affectCandida albicanssusceptibility to antifungals and host immune response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Candida albicans; iron; cell wall; lactic acid; mitochondrial membrane potential; ATP; mitogen-activated protein kinase (MAPK); signaling; cytokine; phagocytosis	ACTIVATED PROTEIN-KINASE; CANDIDA-ALBICANS; TRANSCRIPTIONAL RESPONSE; DRUG-RESISTANCE; LACTIC-ACIDOSIS; ADAPTATIONS; STRESS; CALCINEURIN; HOMEOSTASIS; INHIBITION	Fungal pathogenCandida albicanshas a complex cell wall consisting of an outer layer of mannans and an inner layer of ?-glucans and chitin. The fungal cell wall is the primary target for antifungals and is recognized by host immune cells. Environmental conditions such as carbon sources, pH, temperature, and oxygen tension can modulate the fungal cell wall architecture. Cellular signaling pathways, including the mitogen-activated protein kinase (MAPK) pathways, are responsible for sensing environmental cues and mediating cell wall alterations. Although iron has recently been shown to affect ?-1,3-glucan exposure on the cell wall, we report here that iron changes the composition of all majorC. albicanscell wall components. Specifically, high iron decreased the levels of mannans (including phosphomannans) and chitin; and increased ?-1,3-glucan levels. These changes increased the resistance ofC. albicansto cell wall-perturbing antifungals. Moreover, high iron cells exhibited adequate mitochondrial functioning; leading to a reduction in accumulation of lactate that signals through the transcription factor Crz1 to induce ?-1,3-glucan masking inC. albicans. We show here that iron-induced changes in ?-1,3-glucan exposure are lactate-dependent; and high iron causes ?-1,3-glucan exposure by preventing lactate-induced, Crz1-mediated inhibition of activation of the fungal MAPK Cek1. Furthermore, despite exhibiting enhanced antifungal resistance, high ironC. albicanscells had reduced survival upon phagocytosis by macrophages. Our results underscore the role of iron as an environmental signal in multiple signaling pathways that alter cell wall architecture inC. albicans, thereby affecting its survival upon exposure to antifungals and host immune response.	[Tripathi, Aparna; Puri, Sumant] Temple Univ, Kornberg Sch Dent, Dept Oral Hlth Sci, Oral Microbiome Res Lab, Philadelphia, PA 19122 USA; [Liverani, Elisabetta; Tsygankov, Alexander Y.] Temple Univ, Temple Univ Hosp, Sol Sherry Thrombosis Res Ctr, Sch Med, Philadelphia, PA 19122 USA; [Tsygankov, Alexander Y.] Temple Univ, Dept Microbiol & Immunol, Sch Med, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Puri, S (corresponding author), Temple Univ, Kornberg Sch Dent, Dept Oral Hlth Sci, Oral Microbiome Res Lab, Philadelphia, PA 19122 USA.	sumantpuri@temple.edu	Puri, Sumant/ABF-4209-2021; Liverani, Elisabetta/AAR-4132-2021	Liverani, Elisabetta/0000-0001-5540-0456; Puri, Sumant/0000-0002-5509-007X	NIDCR, National Institutes of Health [R03DE026451]	NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIDCR, National Institutes of Health Grant R03DE026451 (to S. P.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agoro R, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12020075; Alfatah M, 2017, SCI REP-UK, V7, DOI 10.1038/srep40281; Arana DM, 2009, MICROB BIOTECHNOL, V2, P308, DOI 10.1111/j.1751-7915.2008.00070.x; Ballou ER, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.238; Boorsma A, 2004, YEAST, V21, P413, DOI 10.1002/yea.1109; Bruno VM, 2005, MOL MICROBIOL, V56, P559, DOI 10.1111/j.1365-2958.2005.04562.x; Chen CB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002956; Chen CB, 2011, CELL HOST MICROBE, V10, P118, DOI 10.1016/j.chom.2011.07.005; Chen T, 2019, MBIO, V10, DOI 10.1128/mBio.01767-19; Csank C, 1998, INFECT IMMUN, V66, P2713, DOI 10.1128/IAI.66.6.2713-2721.1998; Davis SE, 2014, INFECT IMMUN, V82, P4405, DOI 10.1128/IAI.01612-14; DJEU JY, 1986, J IMMUNOL, V137, P2980; Dostal A, 2015, MBIO, V6, DOI 10.1128/mBio.01453-15; Du Chen, 2009, V499, P17, DOI 10.1007/978-1-60327-151-6_3; Ene IV, 2012, CELL MICROBIOL, V14, P1319, DOI 10.1111/j.1462-5822.2012.01813.x; FINCH CA, 1979, J CLIN INVEST, V64, P129, DOI 10.1172/JCI109431; FONZI WA, 1993, GENETICS, V134, P717; Fourie R, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00185; Frohner IE, 2009, MOL MICROBIOL, V71, P240, DOI 10.1111/j.1365-2958.2008.06528.x; Gerwien F, 2016, MBIO, V7, DOI [10.1128/mBio.01782-16, 10.1128/mbio.01782-16]; GOLDMAN RC, 1995, EUR J BIOCHEM, V227, P372, DOI 10.1111/j.1432-1033.1995.tb20399.x; Grad LI, 2005, P NATL ACAD SCI USA, V102, P18367, DOI 10.1073/pnas.0506939102; Grahl N, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005133; Graus MS, 2018, CELL REP, V24, P2432, DOI 10.1016/j.celrep.2018.07.088; Hall RA, 2013, MOL MICROBIOL, V90, P1147, DOI 10.1111/mmi.12426; HALLIWELL B, 1984, METHOD ENZYMOL, V105, P47; Harris M, 2009, MICROBIOL-SGM, V155, P1058, DOI 10.1099/mic.0.026120-0; Karababa M, 2006, MOL MICROBIOL, V59, P1429, DOI 10.1111/j.1365-2958.2005.05037.x; Klis FM, 2015, EUKARYOT CELL, V14, P1165, DOI 10.1128/EC.00142-15; Lan CY, 2004, MOL MICROBIOL, V53, P1451, DOI 10.1111/j.1365-2958.2004.04214.x; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI 10.1128/EC.3.5.1076-1087.2004; Lorenz MC, 2002, EUKARYOT CELL, V1, P657, DOI 10.1128/EC.1.5.657-662.2002; Ly N, 2017, MOL BIOL CELL, V28, P576, DOI 10.1091/mbc.E16-06-0432; Malavia D, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02238; Marcos CM, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00142; Misslinger M, 2018, METALLOMICS, V10, P1687, DOI 10.1039/c8mt00263k; Miwa T, 2004, EUKARYOT CELL, V3, P919, DOI 10.1128/EC.3.4.919-931.2004; Monge RA, 2006, MICROBIOL-SGM, V152, P905, DOI 10.1099/mic.0.28616-0; Mora-Montes HM, 2010, J BIOL CHEM, V285, P12087, DOI 10.1074/jbc.M109.081513; Muhlschlegel FA, 1997, MOL CELL BIOL, V17, P5960; Nunez G, 2018, J IMMUNOL, V201, P11, DOI 10.4049/jimmunol.1800325; OHIRA Y, 1983, P SOC EXP BIOL MED, V173, P213, DOI 10.3181/00379727-173-41633; Ostrosky-Zeichner L, 2003, EUR J CLIN MICROBIOL, V22, P651, DOI 10.1007/s10096-003-1014-3; Philpott CC, 2012, BBA-MOL CELL RES, V1823, P1509, DOI 10.1016/j.bbamcr.2012.01.012; Pradhan A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13298-9; Pradhan A, 2018, MBIO, V9, DOI [10.1128/mBio.01318-18, 10.1128/mbio.01318-18]; Prasad T, 2006, ANTIMICROB AGENTS CH, V50, P3597, DOI 10.1128/AAC.00653-06; Puri S, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.02152-18; Puri S, 2014, MOL MICROBIOL, V93, P291, DOI 10.1111/mmi.12659; Puri S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046020; Roman E, 2009, EUKARYOT CELL, V8, P1235, DOI 10.1128/EC.00081-09; Savage KA, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.02576-17;e02576, 10.1128/aac.02576-17, 10.1128/AAC.02576-17]; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Schatzman SS, 2020, J BIOL CHEM, V295, P570, DOI 10.1074/jbc.RA119.011084; Sherrington SL, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006403; Smith DA, 2004, MOL BIOL CELL, V15, P4179, DOI 10.1091/mbc.E04-03-0181; Sorgo AG, 2013, MICROBIOL-SGM, V159, P1673, DOI 10.1099/mic.0.065599-0; Srivastava VK, 2015, FEBS J, V282, P2142, DOI 10.1111/febs.13264; Sun LM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172228; Sutak R, 2008, TRENDS MICROBIOL, V16, P261, DOI 10.1016/j.tim.2008.03.005; Tursi SA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006315; Ueno K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024759; Waller RF, 2009, EUKARYOT CELL, V8, P19, DOI 10.1128/EC.00313-08; Warnatsch A, 2017, IMMUNITY, V46, P421, DOI 10.1016/j.immuni.2017.02.013; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Yang F, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00071-17; Yilmaz B, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11040098; Yoo J, 2018, NAT STRUCT MOL BIOL, V25, P217, DOI 10.1038/s41594-018-0031-y	69	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2020	295	29					10032	10044		10.1074/jbc.RA120.013413	http://dx.doi.org/10.1074/jbc.RA120.013413			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MR1DY	32503842	Green Published, hybrid			2022-12-26	WOS:000553333300021
J	DeRogatis, AM; Nguyen, LV; Bandivadekar, RR; Klasing, KC; Tell, LA				DeRogatis, Andrea M.; Nguyen, Leilani V.; Bandivadekar, Ruta R.; Klasing, Kirk C.; Tell, Lisa A.			Anti-microbial activity of whole blood and plasma collected from Anna's Hummingbirds (Calypte anna) against three different microbes	PLOS ONE			English	Article							CONSTITUTIVE IMMUNITY; CALIFORNIA; BIRDS; LIFE; WILD	Hummingbirds are essential pollinators in many ecosystems, making their conservation critical. As is the case with many species, hummingbirds are now facing a variety of challenges resulting from anthropogenic changes. As populations shift and species interactions change, disease is likely to pose a significant threat. There is a basic understanding of which pathogens currently affect a variety of hummingbird species, however there is a paucity of information about their immune systems capacity to kill pathogens and what specific factors may affect immunity. The objective of this study was to gain a basic understanding of the effect of age, sex, and molt on the constitutive innate immunity of hummingbirds. Anin vitroassay was used to assess the microbiocidal capacity of the whole blood of Anna's Hummingbirds (Calypte anna) against three different microbes:Escherichia coli(E.coli),Staphylococcus aureus(S.aureus) andCandida albicans(C.albicans). The effect of age, sex and molt on anti-microbial capacity varied based on the microbe type. After-hatch-year birds tended to have better anti-microbial capacity compared to hatch-year birds. Male birds had higher anti-microbial activity than female birds, although this was not observed againstC.albicans. Molting birds had a weaker antimicrobial activity againstE.coliandS.aureusthan birds that were not molting. These results represent an important first step towards defining the parameters of constitutive innate immunity of Anna's Hummingbirds as well as providing important knowledge about factors that should be considered when evaluating the health of wild populations.	[DeRogatis, Andrea M.; Klasing, Kirk C.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Nguyen, Leilani V.; Bandivadekar, Ruta R.; Tell, Lisa A.] Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Tell, LA (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA.	latell@ucdavis.edu		DeRogatis, Andrea/0000-0001-8994-0995	Karen C. Drayer Wildlife Health Center, School of Veterinary Medicine, University of California, Davis	Karen C. Drayer Wildlife Health Center, School of Veterinary Medicine, University of California, Davis	This project was supported by the Karen C. Drayer Wildlife Health Center, School of Veterinary Medicine, University of California, Davis (AMD, KCK, LAT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder URL is as follows: https://whc.vetmed.ucdavis.edu/research/grants/whc-fellowship.	Backus L, 2019, J WILDLIFE DIS, V55, P903, DOI 10.7589/2018-10-241; Bandivadekar RR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208057; BARTHOLOMEW GA, 1986, J EXP BIOL, V123, P191; Downs CJ, 2020, AM NAT, V195, P107, DOI 10.1086/706235; Girard J, 2011, J WILDLIFE DIS, V47, P603, DOI 10.7589/0090-3558-47.3.603; Godoy LA, 2014, J ORNITHOL, V155, P1, DOI 10.1007/s10336-013-0990-z; Godoy LA, 2013, J WILDLIFE DIS, V49, P978, DOI 10.7589/2012-09-230; Gonzalez AMM, 2015, GLOBAL ECOL BIOGEOGR, V24, P1212, DOI 10.1111/geb.12355; Graves EE, 2019, ENVIRON SCI POLLUT R, V26, P15458, DOI 10.1007/s11356-019-04903-x; Hegemann A, 2012, OECOLOGIA, V170, P605, DOI 10.1007/s00442-012-2339-3; Hoye BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016230; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; KRUGER K, 1982, COMP BIOCHEM PHYS A, V73, P679, DOI 10.1016/0300-9629(82)90275-4; Lee C, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2018.2295; Matson KD, 2005, DEV COMP IMMUNOL, V29, P275, DOI 10.1016/j.dci.2004.07.006; METEYER CU, 1992, J ZOO WILDLIFE MED, V23, P222; Mikoni NA, 2017, ECOL INDIC, V80, P96, DOI 10.1016/j.ecolind.2017.04.053; Millet S, 2007, DEV COMP IMMUNOL, V31, P188, DOI 10.1016/j.dci.2006.05.013; Ots I, 2001, P ROY SOC B-BIOL SCI, V268, P1175, DOI 10.1098/rspb.2001.1636; Pap PL, 2015, OECOLOGIA, V177, P147, DOI 10.1007/s00442-014-3108-2; RADWAN AI, 1972, AVIAN DIS, V16, P343, DOI 10.2307/1588799; Russell SM., 2001, N AM BANDERS MANUAL; Safra N, 2018, J WILDLIFE DIS, V54, P607, DOI 10.7589/2017-10-260; Sanz JJ, 2004, J ANIM ECOL, V73, P441, DOI 10.1111/j.0021-8790.2004.00815.x; Schmidt KL, 2015, PHYSIOL BIOCHEM ZOOL, V88, P183, DOI 10.1086/680599; SUAREZ RK, 1992, EXPERIENTIA, V48, P565, DOI 10.1007/BF01920240; Vannette RL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2601; Wiegel FW, 2004, IMMUNOL CELL BIOL, V82, P127, DOI 10.1046/j.0818-9641.2004.01229.x; Yamasaki YK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191323	29	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234239	10.1371/journal.pone.0234239	http://dx.doi.org/10.1371/journal.pone.0234239			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525884	Green Published, gold			2022-12-26	WOS:000542036800010
J	Muto, K; Yamamoto, I; Nagasu, M; Tanaka, M; Wada, K				Muto, Kaori; Yamamoto, Isamu; Nagasu, Miwako; Tanaka, Mikihito; Wada, Koji			Japanese citizens' behavioral changes and preparedness against COVID-19: An online survey during the early phase of the pandemic	PLOS ONE			English	Article								The Japanese government instituted countermeasures against COVID-19, a pneumonia caused by the new coronavirus, in January 2020. Seeking "people's behavioral changes," in which the government called on the public to take precautionary measures or exercise self-restraint, was one of the important strategies. The purpose of this study is to investigate how and from when Japanese citizens have changed their precautionary behavior under circumstances in which the government has only requested their cooperation. This study uses micro data from a cross-sectional survey conducted on an online platform of an online research company, based on quota sampling that is representative of the Japanese population. By the end of March 2020, a total of 11,342 respondents, aged from 20 to 64 years, were recruited. About 85 percent reported practising the social distancing measures recommended by the government including more females than males and more older than younger participants. Frequent handwashing is conducted by 86 percent of all participants, 92 percent of female, and 87.9 percent of over-40 participants. The most important event influencing these precautionary actions was the infection aboard theDiamond Princesscruise ship, which occurred in early February 2020 (23 percent). Information from the central and local governments, received by 60 percent of the participants, was deemed trustworthy by 50 percent. However, the results also showed that about 20 percent of the participants were reluctant to implement proper prevention measures. The statistical analysis indicated that the typical characteristics of those people were male, younger (under 30 years old), unmarried, from lower-income households, a drinking or smoking habit, and a higher extraversion score. To prevent the spread of infection in Japan, it is imperative to address these individuals and encourage their behavioural changes using various means to reach and influence them.	[Muto, Kaori] Univ Tokyo, Inst Med Sci, Tokyo, Japan; [Yamamoto, Isamu] Keio Univ, Fac Business & Commerce, Tokyo, Japan; [Nagasu, Miwako] Keio Univ, Fac Econ, Tokyo, Japan; [Tanaka, Mikihito] Waseda Univ, Fac Polit Sci & Econ, Tokyo, Japan; [Wada, Koji] Int Univ Hlth & Welf, Grad Sch Med & Publ Hlth, Tokyo, Japan	University of Tokyo; Keio University; Keio University; Waseda University; International University of Health & Welfare	Muto, K (corresponding author), Univ Tokyo, Inst Med Sci, Tokyo, Japan.	krmt@ims.u-tokyo.ac.jp		Yamamoto, Isamu/0000-0002-4936-613X				[Anonymous], 2013, J MED INTERNET RES, V15, pe212; Bay AR, 2019, JPN FORUM, V31, P556, DOI 10.1080/09555803.2019.1594341; Bucchi M., 2020, PUBLIC UNDERSTANDING; Denyer S, 2020, WASH POST; Gallup International Association, 2020, COR VAST SCAR MAJ WO; Geldsetzer P, 2020, ANN INTERN MED; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; IHME COVID-19 Health Service Utilization Forecasting Team, 2020, FOR COVID 19 IMP HOS; Japanese Ministry of Health Labor and Welfare (JMHLW), 2020, EXP M NOV COR DIS CO; Masuike H, 2020, NY TIMES NEWSPA 0326; Minister of Health Labour and Welfare Japan, COR DIS 2019 COVID 1; Ministry of Health Labor and Welfare, PREV MEAS COR DIS 20; National Institute for Infectious Diseases, 2020, FIELD BRIEF DIAM PRI; Wolf J, 2019, INT J EPIDEMIOL, V48, P1204, DOI 10.1093/ije/dyy253; World Health Organisation, 2020, WHO CHARACTERIZES CO; World Health Organization, WHO SIT REP 29 MARCH; Zhan SY, 2020, EMERG MICROBES INFEC, V9, P534, DOI 10.1080/22221751.2020.1732232	17	85	86	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2020	15	6							e0234292	10.1371/journal.pone.0234292	http://dx.doi.org/10.1371/journal.pone.0234292			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QL	32525881	gold, Green Published			2022-12-26	WOS:000542036800050
J	Monti, RP; Gibberd, A; Roy, S; Nunes, M; Lorenz, R; Leech, R; Ogawa, T; Kawanabe, M; Hyvarinen, A				Monti, Ricardo Pio; Gibberd, Alex; Roy, Sandipan; Nunes, Matthew; Lorenz, Romy; Leech, Robert; Ogawa, Takeshi; Kawanabe, Motoaki; Hyvarinen, Aapo			Interpretable brain age prediction using linear latent variable models of functional connectivity	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; INDIVIDUAL-DIFFERENCES; RESTING-STATE; FMRI; NETWORKS; CLASSIFICATION; VARIABILITY	Neuroimaging-driven prediction of brain age, defined as the predicted biological age of a subject using only brain imaging data, is an exciting avenue of research. In this work we seek to build models of brain age based on functional connectivity while prioritizing model interpretability and understanding. This way, the models serve to both provide accurate estimates of brain age as well as allow us to investigate changes in functional connectivity which occur during the ageing process. The methods proposed in this work consist of a two-step procedure: first, linear latent variable models, such as PCA and its extensions, are employed to learn reproducible functional connectivity networks present across a cohort of subjects. The activity within each network is subsequently employed as a feature in a linear regression model to predict brain age. The proposed framework is employed on the data from the CamCAN repository and the inferred brain age models are further demonstrated to generalize using data from two open-access repositories: the Human Connectome Project and the ATR Wide-Age-Range.	[Monti, Ricardo Pio] UCL, Gatsby Computat Neurosci Unit, London, England; [Gibberd, Alex] Univ Lancaster, Dept Math & Stat, Bailrigg, England; [Roy, Sandipan; Nunes, Matthew] Univ Bath, Dept Math Sci, Bath, Avon, England; [Lorenz, Romy] Univ Cambridge, MRC Cognit & Brain Sci Unit, Cambridge, England; [Lorenz, Romy] Stanford Univ, Dept Psychol, Stanford, CA USA; [Leech, Robert] Kings Coll London, Ctr Neuroimaging Sci, London, England; [Monti, Ricardo Pio; Kawanabe, Motoaki] RIKEN Ctr Adv Intelligence Project AIP, Kyoto, Japan; [Ogawa, Takeshi; Kawanabe, Motoaki] Adv Telecommun Res Inst Int ATR, Brain Informat Commun Res Lab Grp, Kyoto, Japan; [Hyvarinen, Aapo] Univ Paris Saclay, Inria, F-91190 Palaiseau, France; [Hyvarinen, Aapo] Univ Helsinki, Dept Comp Sci, Helsinki, Finland; [Hyvarinen, Aapo] Univ Helsinki, HIIT, Helsinki, Finland	University of London; University College London; Lancaster University; University of Bath; University of Cambridge; Stanford University; University of London; King's College London; RIKEN; Advanced Telecommunications Research Institute International; Inria; UDICE-French Research Universities; Universite Paris Saclay; University of Helsinki; Aalto University; University of Helsinki	Monti, RP (corresponding author), UCL, Gatsby Computat Neurosci Unit, London, England.; Monti, RP (corresponding author), RIKEN Ctr Adv Intelligence Project AIP, Kyoto, Japan.	ricardo.monti08@gmail.com		Monti, Ricardo Pio/0000-0002-7823-4961; Nunes, Matthew/0000-0002-4719-2690; Hyvarinen, Aapo/0000-0002-5806-4432; Lorenz, Romy/0000-0002-7742-3162; Leech, Robert/0000-0002-5801-6318; Roy, Sandipan/0000-0002-2898-0659; Gibberd, Alexander/0000-0003-0924-3837	Gatsby Charitable Foundation; CIFAR; MEXT [KAKENHI 18KK0284, 19H04924]; DATAIA convergence institute as part of the "Programme d'Investissement d'Avenir" [ANR-17-CONV-0003]	Gatsby Charitable Foundation; CIFAR(Canadian Institute for Advanced Research (CIFAR)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); DATAIA convergence institute as part of the "Programme d'Investissement d'Avenir"(French National Research Agency (ANR))	R.P.M. was supported by the Gatsby Charitable Foundation. A.H. was supported by a Fellowship from CIFAR, and from the DATAIA convergence institute as part of the "Programme d'Investissement d'Avenir", (ANR-17-CONV-0003) operated by Inria. M.K. was partially supported by MEXT Grant-in-Aid for Scientific Research (KAKENHI 18KK0284, 19H04924).	Abraham A, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00014; [Anonymous], 2004, LUMEN, V22, P165; Ashburner J, 2009, MAGN RESON IMAGING, V27, P1163, DOI 10.1016/j.mri.2009.01.006; Athreya A., 2017, J MACH LEARN RES, V18, P8393; Bennett CM, 2010, ANN NY ACAD SCI, V1191, P133, DOI 10.1111/j.1749-6632.2010.05446.x; Bishop Christopher M., 2006, PATTERN RECOGNITION; Calhoun VD, 2014, NEURON, V84, P262, DOI 10.1016/j.neuron.2014.10.015; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Chung K, 2016, IEEE HI ASS SYS ENGR, P1, DOI [10.1109/iWEM.2016.7505035, 10.1109/HASE.2016.48]; Cole JH, 2018, MOL PSYCHIATR, V23, P1385, DOI 10.1038/mp.2017.62; Cole JH, 2017, TRENDS NEUROSCI, V40, P681, DOI 10.1016/j.tins.2017.10.001; Cole JH, 2017, NEUROIMAGE, V163, P115, DOI 10.1016/j.neuroimage.2017.07.059; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; Cremers HR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184923; Damoiseaux JS, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.06.024; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Esposito F, 2005, NEUROIMAGE, V25, P193, DOI 10.1016/j.neuroimage.2004.10.042; Franke K, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00090; Franke K, 2010, NEUROIMAGE, V50, P883, DOI 10.1016/j.neuroimage.2010.01.005; Friedman L, 2006, NEUROIMAGE, V33, P471, DOI 10.1016/j.neuroimage.2006.07.012; Geerligs L, 2017, HUM BRAIN MAPP, V38, P4125, DOI 10.1002/hbm.23653; Geerligs L, 2015, J NEUROSCI, V35, P13949, DOI 10.1523/JNEUROSCI.1324-15.2015; Geerligs L, 2015, CEREB CORTEX, V25, P1987, DOI 10.1093/cercor/bhu012; Geerligs L, 2014, HUM BRAIN MAPP, V35, P319, DOI 10.1002/hbm.22175; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Grady C, 2016, NEUROBIOL AGING, V41, P159, DOI 10.1016/j.neurobiolaging.2016.02.020; Harman H.H, 1960, MODERN FACTOR ANAL; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Hirayama J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168180; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Hyvarinen A, 2016, NEURAL COMPUT, V28, P445, DOI 10.1162/NECO_a_00810; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; Kelly C, 2012, TRENDS COGN SCI, V16, P181, DOI 10.1016/j.tics.2012.02.001; Khemakhem I., 2019, ARXIV190704809; Koutsouleris N, 2014, SCHIZOPHRENIA BULL, V40, P1140, DOI 10.1093/schbul/sbt142; KSPJDCEMAA JB, 2015, ANN IND ACAD NEUROL, V18, pS59; Lancaster J, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00028; Leonardi N, 2013, NEUROIMAGE, V83, P937, DOI 10.1016/j.neuroimage.2013.07.019; Liem F., 2019, FUNCTIONAL CONNECTIV; Lim S, 2013, CEREB CORTEX, P1477; Lorenz R, 2019, BRAIN STIMUL, V12, P1484, DOI 10.1016/j.brs.2019.07.003; Lorenz R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03657-3; Monti R. P., 2019, ARXIV190409096; Monti R, 2015, 2015 INTERNATIONAL WORKSHOP ON PATTERN RECOGNITION IN NEUROIMAGING (PRNI) 2015, P1, DOI 10.1109/PRNI.2015.21; Monti RP, 2017, FRONT COMPUT NEUROSC, V11, DOI 10.3389/fncom.2017.00014; Monti RP, 2018, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, P300; Monti RP, 2017, ANN APPL STAT, V11, P2142, DOI 10.1214/17-AOAS1067; Monti RP, 2017, HUM BRAIN MAPP, V38, P202, DOI 10.1002/hbm.23355; Monti RP, 2014, NEUROIMAGE, V103, P427, DOI 10.1016/j.neuroimage.2014.07.033; Ogawa T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24981-0; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; POLDRACK R. A., 2011, HDB FUNCTIONAL MRI D, DOI DOI 10.1017/CBO9780511895029; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Raz N, 2006, NEUROSCI BIOBEHAV R, V30, P730, DOI 10.1016/j.neubiorev.2006.07.001; Salimi-Khorshidi G, 2014, NEUROIMAGE, V90, P449, DOI 10.1016/j.neuroimage.2013.11.046; Sasaki H., 2019, ARXIV191100265; Sigg C.D., 2008, P 25 INT C MACH LEAR, P960, DOI [DOI 10.1145/1390156.1390277, 10.1145/1390156.1390277]; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2019, NEUROIMAGE, V200, P528, DOI 10.1016/j.neuroimage.2019.06.017; Smith SM, 2012, NEUROIMAGE, V62, P1257, DOI 10.1016/j.neuroimage.2012.01.022; Sporns O, 2012, DISCOVERING HUMAN CO; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Wu T, 2009, NEUROSCI LETT, V460, P6, DOI 10.1016/j.neulet.2009.05.046; Zass R., 2007, ADV NEURAL INFORM PR, P1561; Zippo A. G., 2019, CHRONIC PAIN ALTERS; Zippo AG, 2020, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00462	68	8	8	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2020	15	6							e0232296	10.1371/journal.pone.0232296	http://dx.doi.org/10.1371/journal.pone.0232296			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC0EC	32520931	Green Published, Green Submitted, gold			2022-12-26	WOS:000542969500020
J	Palacio-Aguero, A; Diaz-Torrente, X; Dourado, DQS				Palacio-Aguero, Ana; Diaz-Torrente, Ximena; Quintiliano Scarpelli Dourado, Daiana			Relative handgrip strength, nutritional status and abdominal obesity in Chilean adolescents	PLOS ONE			English	Article							PHYSICAL-FITNESS; MUSCLE STRENGTH; SKELETAL-MUSCLE; SARCOPENIC OBESITY; METABOLIC SYNDROME; GRIP STRENGTH; BODY-FAT; HEALTH; CHILDREN; ASSOCIATION	Handgrip strength (HGS) is a well-established indicator of muscle strength and can help to identify risk of sarcopenic obesity in children. This study explores the relationship between adiposity and muscular strength in healthy Chilean adolescents. Adolescents (n = 491) aged 10-17 were selected from five schools in Santiago, Chile. HGS was determined by dynamometry. Anthropometry (weight, height, waist and mid arm circumference), physical activity and socioeconomic status were also measured. Relative HGS (RHGS) was calculated by dividing maximum HGS of the dominant hand by body-mass index (BMI) and low RHGS was categorized as <25(th)percentile by sex. Logistic regression was used to determine the relationship between two markers of adiposity (abdominal obesity category by waist circumference and nutritional status measured by BMI category) and low RHGS, adjusting for possible confounding variables. Participants were on average 13.6y (2.4), 32.8% were overweight or obese and 37.5% were at risk of or had abdominal obesity. RHGS was 1.25 kg/kg/m(2)overall, with a significant difference by sex (1.51 for boys versus 1.14 for girls). In adjusted analyses, boys and girls with risk of abdominal obesity, had 3.3 (1.6-6.6) and 4.1 (1.8-9.3) increased odds of low RHGS, respectively, compared to boys and girls with normal waist circumference. Those with abdominal obesity compared to normal WC, had 8.5 (3.4-21.4) and 6.5 (2.0-21.3) increased odds of low RHGS for boys and girls, respectively. We observed similar associations for BMI category. In our sample of healthy adolescents, higher adiposity related to greater odds of low muscle strength measured by dynamometry. Considering the demographic shift from a young to an aging population in many countries, along with the increasing prevalence of obesity beginning in childhood, understanding how adiposity relates to low muscle strength is of growing importance.	[Palacio-Aguero, Ana; Diaz-Torrente, Ximena; Quintiliano Scarpelli Dourado, Daiana] Univ Desarrollo, Escuela Nutr & Dietet, Fac Med Clin Alemana, Santiago, Chile	Universidad del Desarrollo	Dourado, DQS (corresponding author), Univ Desarrollo, Escuela Nutr & Dietet, Fac Med Clin Alemana, Santiago, Chile.	d.quintiliano@udd.cl	Dourado, Daiana/AAO-6746-2021	Dourado, Daiana/0000-0003-4317-4601; Diaz-Torrente, Ximena/0000-0003-0456-3399; Palacio Aguero, Ana/0000-0001-7808-6359				[Anonymous], 2017, INT J RES HUMANITIES, V46, P1; [Anonymous], 2012, DIABETES CARE S1, V35, pS12; Biolo G, 2014, CLIN NUTR, V33, P737, DOI 10.1016/j.clnu.2014.03.007; Bohannon RW, 2017, PEDIATR PHYS THER, V29, P118, DOI 10.1097/PEP.0000000000000366; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Cauley JA, 2015, J CLIN DENSITOM, V18, P499, DOI 10.1016/j.jocd.2015.04.013; CDC, 2007, ANTHR PROC MAN; Chulvi-Medrano I, 2018, RETOS-NUEV TEND EDUC, P298; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Deforche B, 2003, OBES RES, V11, P434, DOI 10.1038/oby.2003.59; Dodds RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113637; Ellis KJ, 1999, AM J EPIDEMIOL, V150, P939, DOI 10.1093/oxfordjournals.aje.a010102; Ervin RB, 2014, PEDIATRICS, V134, pE782, DOI 10.1542/peds.2014-0794; Faigenbaum AD, 2017, ACTA PAEDIATR, V106, P696, DOI 10.1111/apa.13797; Fess EE, 1992, CLIN ASSESSMENT RECO, V2nd; FORBES GB, 1964, PEDIATRICS, V34, P308; Frankenfield DC, 2001, NUTRITION, V17, P26, DOI 10.1016/S0899-9007(00)00471-8; GARCIA AW, 1995, J SCHOOL HEALTH, V65, P213, DOI 10.1111/j.1746-1561.1995.tb03365.x; Garcia-Hermoso A, 2021, J STRENGTH COND RES, V35, P260, DOI 10.1519/JSC.0000000000002631; Gomez-Campos R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201033; Goodpaster BH, 2000, J APPL PHYSIOL, V89, P104, DOI 10.1152/jappl.2000.89.1.104; Growth from Knowledge (GfK), LIF GROUPS SOC CHIL; Hogrel JY, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-176; Ibegbu AO, 2014, ANTHROPOLOGIST, V17, P921, DOI 10.1080/09720073.2014.11891508; Jackson AW, 2010, OBESITY, V18, P1988, DOI 10.1038/oby.2009.422; Amo-Setien FJ, 2020, J HAND THER, V33, P96, DOI 10.1016/j.jht.2018.10.005; Katzmarzyk PT, 2014, INT J OBESITY, V38, P753, DOI 10.1038/ijo.2013.170; Lafortuna CL, 2004, J ENDOCRINOL INVEST, V27, P854, DOI 10.1007/BF03346280; Lafortuna CL, 2014, CLIN PHYSIOL FUNCT I, V34, P47, DOI 10.1111/cpf.12062; Lang JJ, 2019, HEALTH PROMOT CHRON, V39, P104, DOI 10.24095/hpcdp.39.3.02; Lauretani F, 2003, J APPL PHYSIOL, V95, P1851, DOI 10.1152/japplphysiol.00246.2003; Leahy S, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027728; Liao K, 2016, M E J REHABIL HLTH, V3, P1; Liao KH, 2014, INT J OCCUP SAF ERGO, V20, P77, DOI 10.1080/10803548.2014.11077039; Serrano MDM, 2009, AN PEDIATR, V70, P340, DOI 10.1016/j.anpedi.2008.11.025; McLean RR, 2014, J GERONTOL A-BIOL, V69, P576, DOI 10.1093/gerona/glu012; MINSAL, GROWTH PATT NUTR EV; MINSAL, 2016 2017 NAT HLTH S; MINSAL, HLTH IND LIF EXP; Murai J, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0755-3; Ortega FB, 2008, INT J OBESITY, V32, pS49, DOI 10.1038/ijo.2008.183; Ortega FB, 2005, REV ESP CARDIOL, V58, P898, DOI 10.1016/S1885-5857(06)60372-1; Otero J, 2017, AM J HUM BIOL, V29, DOI 10.1002/ajhb.22896; Pagano AF, 2018, J CACHEXIA SARCOPENI, V9, P335, DOI 10.1002/jcsm.12259; Pan American Health Organization, 2015, 54 DIR COUNC 67 SESS; Peterson MD, 2016, AM J PREV MED, V50, P593, DOI 10.1016/j.amepre.2015.09.019; Ploegmakers JJW, 2013, J PHYSIOTHER, V59, P255, DOI 10.1016/S1836-9553(13)70202-9; Ramirez-Velez R, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010024; Ramirez-Velez R, 2017, SCI REP-UK, V7, DOI 10.1038/srep42622; Rioux BV, 2017, METAB SYNDR RELAT D, V15, P379, DOI 10.1089/met.2016.0147; Roubenoff R, 2004, OBES RES, V12, P887, DOI 10.1038/oby.2004.107; Ruiz JR, 2011, BRIT J SPORT MED, V45, P518, DOI 10.1136/bjsm.2010.075341; Sayer AA, 2007, QJM-INT J MED, V100, P707, DOI 10.1093/qjmed/hcm095; Seferian AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121799; Steffl M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177006; Stevens J, 2014, PEDIATR OBES, V9, P260, DOI 10.1111/j.2047-6310.2013.00175.x; Tomlinson DJ, 2016, BIOGERONTOLOGY, V17, P467, DOI 10.1007/s10522-015-9626-4; Tremblay Mark S, 2010, Health Rep, V21, P7; de Carvalho DHT, 2019, J GERONTOL A-BIOL, V74, P1105, DOI 10.1093/gerona/gly178; Volaklis KA, 2016, EUR J INTERN MED, V31, P35, DOI 10.1016/j.ejim.2016.04.001; Wu HM, 2019, METABOLISM, V93, P61, DOI 10.1016/j.metabol.2019.01.011; Yi D, 2018, DIABETES METAB SYNDR, V11, P227, DOI 10.2147/DMSO.S166875	62	10	10	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2020	15	6							e0234316	10.1371/journal.pone.0234316	http://dx.doi.org/10.1371/journal.pone.0234316			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC0EC	32520942	Green Published, gold			2022-12-26	WOS:000542969500005
J	Zhou, DB; Scott, AW; Linz, MO; Han, IC; Castanos, MV; Lynch, G; Romo, JSA; Linderman, RE; Carroll, J; Rosen, RB; Chui, TY				Zhou, Davis B.; Scott, Adrienne W.; Linz, Marguerite O.; Han, Ian C.; Castanos, Maria, V; Lynch, Giselle; Romo, Jorge S. Andrade; Linderman, Rachel E.; Carroll, Joseph; Rosen, Richard B.; Chui, Toco Y.			Interocular asymmetry of foveal avascular zone morphology and parafoveal capillary density in sickle cell retinopathy	PLOS ONE			English	Article							COHERENCE TOMOGRAPHY ANGIOGRAPHY; NATURAL-HISTORY; CLINICAL-TRIAL; DISEASE	Objectives To examine interocular asymmetry of foveal avascular zone (FAZ) and parafoveal capillary density metrics in sickle cell retinopathy (SCR) using optical coherence tomography angiography (OCT-A). Methods This cross-sectional, retrospective study evaluated SCR patients and unaffected controls who underwent 3x3mm macular OCT-A imaging using a spectral domain-OCT system. FAZ (area, perimeter, and acircularity index) and parafoveal capillary density metrics were computed for both eyes of each participant. In unaffected controls, interocular difference in FAZ and parafoveal capillary density metrics were evaluated using Bland-Altman plots. SCR patients with interocular difference outside the upper 97.5% and lower 2.5% limits of agreement from controls were defined as having interocular asymmetry. Area under receiver operating characteristic curve (AROC) was also performed to determine the ability of the absolute interocular difference to differentiate between subjects with SCR-including non-proliferative SCR (NP-SCR) and proliferative SCR (P-SCR)-and unaffected controls. Results Thirty-one patients with SCR (21 NP-SCR and 10 P-SCR) and 14 race-matched and age-matched controls were included for analysis. Interocular asymmetry was seen for all FAZ and parafoveal capillary density metrics in NP-SCR and P-SCR subjects. SCR subjects showed greater disease severity in the left-eye for FAZ and parafoveal capillary density metrics. Conclusions NP-SCR and P-SCR patients demonstrated quantifiable interocular asymmetry in FAZ and parafoveal capillary density metrics compared to unaffected subjects, with left-eye predominance in disease severity.	[Zhou, Davis B.; Castanos, Maria, V; Lynch, Giselle; Romo, Jorge S. Andrade; Rosen, Richard B.; Chui, Toco Y.] New York Eye & Ear Infirm Mt Sinai, Ophthalmol, New York, NY 10003 USA; [Zhou, Davis B.; Lynch, Giselle; Rosen, Richard B.; Chui, Toco Y.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Scott, Adrienne W.; Linz, Marguerite O.; Han, Ian C.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Retina Div, Baltimore, MD 21205 USA; [Han, Ian C.] Univ Iowa, Inst Vis Res, Dept Ophthalmol & Visual Sci, Iowa City, IA USA; [Linderman, Rachel E.; Carroll, Joseph] Med Coll Wisconsin, Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Carroll, Joseph] Med Coll Wisconsin, Ophthalmol & Visual Sci, Milwaukee, WI 53226 USA	New York Eye & Ear Infirmary of Mount Sinai; Icahn School of Medicine at Mount Sinai; Johns Hopkins University; Johns Hopkins Medicine; University of Iowa; Medical College of Wisconsin; Medical College of Wisconsin	Chui, TY (corresponding author), New York Eye & Ear Infirm Mt Sinai, Ophthalmol, New York, NY 10003 USA.; Chui, TY (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.	ychui@nyee.edu		Linderman, Rachel/0000-0003-2950-1311; Zhou, Davis/0000-0001-5712-4408; Han, Ian/0000-0002-2371-727X; Andrade Romo, Jorge/0000-0001-7463-0097; Chui, Toco YP/0000-0003-2060-3848	National Eye Institute of the National Institutes of Health [R01EY027301, R01EY024969]; New York Eye and Ear Infirmary Foundation; Marrus Family Foundation; Wise Family Foundation; Geraldine Violett Foundation; Edward N. AMP; Della L. Thome Memorial Foundation; Jorge N. Buxton Microsurgical Foundation	National Eye Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); New York Eye and Ear Infirmary Foundation; Marrus Family Foundation; Wise Family Foundation; Geraldine Violett Foundation; Edward N. AMP; Della L. Thome Memorial Foundation; Jorge N. Buxton Microsurgical Foundation	This study was funding by the National Eye Institute of the National Institutes of Health under award numbers R01EY027301 (TYC) and R01EY024969 (JC). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Additional funding was provided by the New York Eye and Ear Infirmary Foundation (RBR, TYC), the Marrus Family Foundation (RBR) < https://www.guidestar.org/profile/13-6279584 >, the Wise Family Foundation (RBR) < https://www.guidestar.org/profile/13-3861747 >, the Geraldine Violett Foundation (RBR), the Edward N. & Della L. Thome Memorial Foundation (JC) < https://hria.org/tmf/thomeamd >, the Jorge N. Buxton Microsurgical Foundation (MVC) < https://buxtoneye.com/thefoundation >, unrestricted contributions to the Johns Hopkins University Retina Division research fund (AWS), and private philanthropy from Gail C. and Howard Woolley, Baltimore, Maryland (AWS). The sponsors and funding organizations had no role in the design or conduct of this research.	Agemy SA, 2015, RETINA-J RET VIT DIS, V35, P2353, DOI 10.1097/IAE.0000000000000862; ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; ASDOURIAN GK, 1976, BRIT J OPHTHALMOL, V60, P431, DOI 10.1136/bjo.60.6.431; Cho MHE, 2011, RETINA-J RET VIT DIS, V31, P738, DOI 10.1097/IAE.0b013e3181f049ec; de Carlo Talisa E, 2015, Int J Retina Vitreous, V1, P5; Dogru M, 1998, EYE, V12, P929, DOI 10.1038/eye.1998.241; Downes SM, 2005, OPHTHALMOLOGY, V112, P1869, DOI 10.1016/j.ophtha.2005.05.026; Driss A, 2009, GENOM INSIGHTS, V2, P23; GOLDBERG MF, 1971, ARCH OPHTHALMOL-CHIC, V85, P428; GOLDBERG MF, 1971, AM J OPHTHALMOL, V71, P649, DOI 10.1016/0002-9394(71)90429-6; Han IC, 2017, AM J OPHTHALMOL, V177, P90, DOI 10.1016/j.ajo.2017.02.007; Han IC, 2015, JAMA OPHTHALMOL, V133, P1337, DOI 10.1001/jamaophthalmol.2015.2824; Hassell KL, 2010, AM J PREV MED, V38, pS512, DOI 10.1016/j.amepre.2009.12.022; Hedna VS, 2013, J CLIN NEUROL, V9, P97, DOI 10.3988/jcn.2013.9.2.97; Hernandez SAR, 2003, HYPERTENSION, V42, P56, DOI 10.1161/01.HYP.0000077983.66161.6F; Hou HY, 2018, AM J OPHTHALMOL, V190, P69, DOI 10.1016/j.ajo.2018.03.026; JAMPOL LM, 1983, OPHTHALMOLOGY, V90, P540; Jia YL, 2012, OPT EXPRESS, V20, P4710, DOI 10.1364/OE.20.004710; Jin J, 2018, J AAPOS, V22, P197, DOI [10.1016/j.jaapos.2017.12.019, DOI 10.1016/J.JAAP0S.2017.12.019]; Krawitz BD, 2017, VISION RES, V139, P177, DOI 10.1016/j.visres.2016.09.019; Krejza J, 2011, STROKE, V42, P81, DOI 10.1161/STROKEAHA.110.591818; Linderman R, 2017, TRANSL VIS SCI TECHN, V6, DOI 10.1167/tvst.6.3.16; Lynch G, 2018, BIOMED OPT EXPRESS, V9, P5982, DOI 10.1364/BOE.9.005982; Mehdizadeh Morteza, 2012, J Ophthalmic Vis Res, V7, P295; Menaa F, 2017, J MULTIDISCIP HEALTH, V10, P335, DOI 10.2147/JMDH.S90630; Minvielle W, 2016, AM J OPHTHALMOL, V164, P137, DOI 10.1016/j.ajo.2015.12.023; Naess Halvor, 2006, J Stroke Cerebrovasc Dis, V15, P241, DOI 10.1016/j.jstrokecerebrovasdis.2006.06.003; OBRIEN C, 1992, EYE, V6, P273, DOI 10.1038/eye.1992.51; Pinhas A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197062; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Romo JSA, 2019, TRANSL VIS SCI TECHN, V8, DOI 10.1167/tvst.8.3.1; Sayag D, 2008, EUR J OPHTHALMOL, V18, P248, DOI 10.1177/112067210801800213; Scott AW, 2016, SOUTH MED J, V109, P542, DOI 10.14423/SMJ.0000000000000525; Scripsema Nicole K, 2016, Invest Ophthalmol Vis Sci, V57, pOCT611, DOI 10.1167/iovs.15-18945	34	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2020	15	6							e0234151	10.1371/journal.pone.0234151	http://dx.doi.org/10.1371/journal.pone.0234151			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC0EC	32520956	Green Published, gold			2022-12-26	WOS:000542969500016
J	Murtskhvaladze, M; Tarkhnishvili, D; Anderson, CL; Kotorashvili, A				Murtskhvaladze, Marine; Tarkhnishvili, David; Anderson, Cort L.; Kotorashvili, Adam			Phylogeny of caucasian rock lizards (Darevskia) and other true lizards based on mitogenome analysis: Optimisation of the algorithms and gene selection	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; MOLECULAR PHYLOGENY; LACERTIDAE; SQUAMATA; DNA; EVOLUTION; REPTILIA; SEQUENCE; PATTERNS; HISTORY	We generated a phylogeny for Caucasian rock lizards (Darevskia), and included six other families of true lizards (Lacertini), based on complete mitochondrial genome analysis. Next-generation sequencing (NGS) of genomic DNA was used to obtain 16 new mitogenomes of Darevskia. These, along with 35 sequences downloaded from GenBank: genera Darevskia, Zootoca, Podarcis, Phoenicolacerta, Takydromus, Lacerta, and Eremias-were used in the analysis. All four analytical methods (Bayesian Inference, BI; Maximum Likelihood, ML; Maximum Parsimony, MP; and Neighbor-Joining, NJ) showed almost congruent intra-generic topologies for Darevskia and other lizard genera. However, ML and NJ methods on one side, and BI and MP methods on the other harvested conflicting phylogenies. The ML/NJ topology supports earlier published separation of Darevskia into three mitochondrial clades (Murphy, Fu, Macculloch, Darevsky, and Kupinova, 2000), but BI and MP topologies support that the basal branching occurred between D. parvula from the western Lesser Caucasus and the rest of Darevskia. All topologies altered the phylogenetic position of some individual species, including D. daghestanica, D. derjugini, and D. chlorogaster. Reanalysis after excluding four saturated genes from the data set, and excluding genus Eremias gives fully convergent topologies. The most basal branching for true lizards was between Far Eastern Takydromus and the Western Eurasian genera (BI). Comparing phylogenetic performance of individual genes relative to whole mitogenome data, concatenated 16S RNA (the least saturated gene in our analyses) and Cytochrome b genes generate a robust phylogeny that is fully congruent with that based on the complete mitogenome.	[Murtskhvaladze, Marine; Tarkhnishvili, David; Anderson, Cort L.] Ilia State Univ, Sch Nat Sci & Engn, Tbilisi, Georgia; [Murtskhvaladze, Marine; Kotorashvili, Adam] L Sakvarelidze Natl Ctr Dis Control & Publ Hlth, Tbilisi, Georgia	Ilia State University	Tarkhnishvili, D (corresponding author), Ilia State Univ, Sch Nat Sci & Engn, Tbilisi, Georgia.	david.tarkhnishvili@iliauni.edu.ge	Tarkhnishvili, David/G-9438-2013	Tarkhnishvili, David/0000-0003-1479-9880; Murtskhvaladze, Marine/0000-0002-4647-2287	Fulbright Scholar Program [PS00215196]; Shota Rustaveli National Science Foundation [217478]	Fulbright Scholar Program; Shota Rustaveli National Science Foundation	MM received scholarship (award #PS00215196) from Fulbright Scholar Program https://www.cies.org/; DT grant (award #217478) from Shota Rustaveli National Science Foundation https://www.rustaveli.org.ge The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadeh F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080563; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 2006, DNEASY BLOOD TISSUE; Arnold EN, 2007, ZOOTAXA; Arribas O.J., 1999, RUSSIAN J HERPETOLOG, V1, P1; Associated Press, 2014, BLOOMINGTON HER 0602, V6, pB5; Avise J.C., 2004, MOL MARKERS NATURAL, P401; Bohme MU, 2007, GENE, V394, P69, DOI 10.1016/j.gene.2007.02.006; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Bromham L, 2002, MOL BIOL EVOL, V19, P302, DOI 10.1093/oxfordjournals.molbev.a004083; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Darevsky I., 1967, ROCK LIZARDS CAUCASU; de Queiroz A, 2002, MOL PHYLOGENET EVOL, V22, P315, DOI 10.1006/mpev.2001.1074; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Du Y, 2016, MITOCHONDRIAL DNA A, V27, P1918, DOI 10.3109/19401736.2014.971286; Freitas S, 2016, MOL PHYLOGENET EVOL, V102, P117, DOI 10.1016/j.ympev.2016.05.035; Fu JZ, 1997, ZOOL J LINN SOC-LOND, V120, P463; Gabelaia M, 2018, BIOL J LINN SOC, V125, P709, DOI 10.1093/biolinnean/bly143; Garcia-Porta J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11943-x; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Godinho R, 2008, MOL ECOL, V17, P4670, DOI 10.1111/j.1365-294X.2008.03929.x; Grechko VV, 2006, GENOME, V49, P1297, DOI 10.1139/G06-089; Grechko VV, 1997, J MOL EVOL, V45, P332, DOI 10.1007/PL00006237; Greenbaum E, 2011, ZOOL J LINN SOC-LOND, V163, P913, DOI 10.1111/j.1096-3642.2011.00732.x; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Harris David James, 1999, Natura Croatica, V8, P161; Hedges SB, 2015, MOL BIOL EVOL, V32, P835, DOI 10.1093/molbev/msv037; Janke A, 2001, P ROY SOC B-BIOL SCI, V268, P623, DOI 10.1098/rspb.2000.1402; Kapli P, 2008, MOL PHYLOGENET EVOL, V49, P102, DOI 10.1016/j.ympev.2008.06.016; Kapli Paschalia, 2011, Basic and Applied Herpetology, V25, P97; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kolora R, 2017, MITOCHONDRIAL DNA A, V28, P116, DOI 10.3109/19401736.2015.1111349; Komissarov A, 2016, MITOCHONDRIAL DNA B, V1, P875, DOI 10.1080/23802359.2016.1253040; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kumazawa Y, 2007, GENE, V388, P19, DOI 10.1016/j.gene.2006.09.026; Lanfear R, 2017, MOL BIOL EVOL, V34, P772, DOI 10.1093/molbev/msw260; Liu P, 2016, MITOCHONDRIAL DNA A, V27, P1944, DOI 10.3109/19401736.2014.971299; Ma WW, 2016, MITOCHONDRIAL DNA B, V1, P214, DOI 10.1080/23802359.2016.1155091; Mayer W, 2007, MOL PHYLOGENET EVOL, V44, P1155, DOI 10.1016/j.ympev.2007.05.015; Meikejohn KA, 2014, MOL PHYLOGENET EVOL, V78, P314, DOI 10.1016/j.ympev.2014.06.003; Meiklejohn KA, 2016, SYST BIOL, V65, P612, DOI 10.1093/sysbio/syw014; Mendes J, 2016, MOL PHYLOGENET EVOL, V100, P254, DOI 10.1016/j.ympev.2016.04.016; Miller JM, 2012, J HERED, V103, P140, DOI 10.1093/jhered/esr104; MILLER KG, 1983, NATURE, V306, P250, DOI 10.1038/306250a0; Miya M, 2000, MOL PHYLOGENET EVOL, V17, P437, DOI 10.1006/mpev.2000.0839; Murphy RW, 2000, ZOOL J LINN SOC-LOND, V130, P527, DOI 10.1006/zjls.1999.0241; Nabholz B, 2010, MOL PHYLOGENET EVOL, V57, P466, DOI 10.1016/j.ympev.2010.06.009; Orti G, 1997, SYST BIOL, V46, P75, DOI 10.2307/2413637; Pagel M, 2008, PHILOS T R SOC B, V363, P3955, DOI 10.1098/rstb.2008.0178; Pereira SL, 2006, MOL BIOL EVOL, V23, P1731, DOI 10.1093/molbev/msl038; Podnar M, 2009, J ZOOL SYST EVOL RES, V47, P35, DOI 10.1111/j.1439-0469.2008.00515.x; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; Pyron RA, 2009, MOL PHYLOGENET EVOL, V52, P524, DOI 10.1016/j.ympev.2009.02.008; Qian LF, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4717-7; Qin PS, 2015, MITOCHONDR DNA, V26, P465, DOI 10.3109/19401736.2013.830299; Rambaut A., TRACER V 1 6; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Swofford D.L., 2002, PAUP4 PHYLOGENETIC A; Tarkhnishvili D., 2012, ADV ZOOL RES, V2, P79; Tarkhnishvili D, 2016, HERPETOL J, V26, P175; Tarkhnishvili D, 2013, BIOL J LINN SOC, V109, P876, DOI 10.1111/bij.12092; Tarkhnishvili D, 2010, BIOL J LINN SOC, V101, P447, DOI 10.1111/j.1095-8312.2010.01498.x; Tong QL, 2016, MITOCHONDRIAL DNA A, V27, P1654, DOI 10.3109/19401736.2014.958714; Tonini JFR, 2016, BIOL CONSERV, V204, P23, DOI 10.1016/j.biocon.2016.03.039; Utescher T, 2011, PALAEOGEOGR PALAEOCL, V304, P351, DOI 10.1016/j.palaeo.2010.09.031; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Wright AM, 2015, J EXP ZOOL PART B, V324, P504, DOI 10.1002/jez.b.22642; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Yu DN, 2013, MITOCHONDR DNA, V24, P3, DOI 10.3109/19401736.2012.710223; Zardoya R, 1996, P NATL ACAD SCI USA, V93, P5449, DOI 10.1073/pnas.93.11.5449; Zazanashvili N, 2004, HOTSPOTS REVISITED E, P148; Zheng YC, 2016, MOL PHYLOGENET EVOL, V94, P537, DOI 10.1016/j.ympev.2015.10.009; Zhou TH, 2016, MITOCHONDRIAL DNA A, V27, P4340, DOI 10.3109/19401736.2015.1089491; 2004, INFORM MANAGEMENT J, V38	77	14	14	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2020	15	6							e0233680	10.1371/journal.pone.0233680	http://dx.doi.org/10.1371/journal.pone.0233680			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ0RE	32511235	Green Published, gold			2022-12-26	WOS:000540938100020
J	Takahashi, K; Murayama, H; Tanaka, T; Takase, M; Suthutvoravut, U; Iijima, K				Takahashi, Kyo; Murayama, Hiroshi; Tanaka, Tomoki; Takase, Mai; Suthutvoravut, Unyaporn; Iijima, Katsuya			A qualitative study on the reasons for solitary eating habits of older adults living with family	PLOS ONE			English	Article								Eating alone while living with family members is a risk factor for mental health decline in old age. However, little is known as to why older adults choose to eat alone, even with family present. This study therefore aimed to explore reasons for older adults eating alone despite living with family members, using a qualitative approach. Fifteen people aged 65 years and older (11 men and 4 women) who were eating alone while living with family members were included in the study. These individuals were selected from the participants of the Kashiwa cohort study conducted in 2016. Individual interviews were conducted using an open-ended format. All interviews were recorded and transcribed. The data were further thematically analyzed using a qualitative software package, NVivo 11. We extracted six themes as reasons for eating alone and hypothesized interactions among these themes. The extracted themes were: "age-related changes," "solo-friendly environment," "family structure changes," "time lag for eating," "bad relationships with family members" and "routinization." To assess interactions, the themes were categorized as "background factors," "triggers," and "stabilizers." The aforementioned themes could lead to the development and sustained behavior of eating alone among older adults living with family members. As most themes describe conditions that are likely to remain static, it may not be realistic to encourage such individuals to begin eating with family members. The promotion of meals with neighbors or friends could be effective in alleviating the negative consequences of eating alone.	[Takahashi, Kyo] Dokkyo Med Univ, Sch Med, Dept Publ Hlth, Mibu, Tochigi, Japan; [Takahashi, Kyo; Murayama, Hiroshi; Tanaka, Tomoki; Takase, Mai; Suthutvoravut, Unyaporn; Iijima, Katsuya] Univ Tokyo, Inst Gerontol, Tokyo, Japan	Dokkyo Medical University; University of Tokyo	Takahashi, K (corresponding author), Dokkyo Med Univ, Sch Med, Dept Publ Hlth, Mibu, Tochigi, Japan.; Takahashi, K (corresponding author), Univ Tokyo, Inst Gerontol, Tokyo, Japan.	tkyo-tky@umin.ac.jp	Suthutvoravut, Unyaporn/HDM-4236-2022; Takahashi, Kyo/O-1581-2018	Takahashi, Kyo/0000-0003-2276-1049	Japan Society for the Promotion of Science (JSPS) KAKENHI [15K08728, 19K21579]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Japan Society for the Promotion of Science (JSPS) KAKENHI Grant-in-Aid for Scientific Research (https://www.jsps.go.jp/english/e-grants/index.html) [Grant numbers: 15K08728, 19K21579] to KI and KT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, JAPAN TIMES; [Anonymous], 2019, THE MAINICHI; Cabinet Office Japan, ANN REP AG SOC FY 20; Cheng SL, 2007, BRIT J SOCIOL, V58, P39, DOI 10.1111/j.1468-4446.2007.00138.x; Drewnowski A, 2001, J Nutr Health Aging, V5, P75; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hughes G, 2004, APPETITE, V43, P269, DOI 10.1016/j.appet.2004.06.002; Ishiguro K, 2014, ASIAN SOC WORK POLIC, V8, P275, DOI 10.1111/aswp.12032; Ishikawa M, 2018, J NUTR HEALTH AGING, V22, P341, DOI 10.1007/s12603-017-0930-3; Japan Ministry of Agriculture Forestry and Fisheries, SHOK PROM POL FY 201; Kuroda A, 2015, J AM MED DIR ASSOC, V16, P578, DOI 10.1016/j.jamda.2015.01.078; Ohara Y, 2020, ARCH GERONTOL GERIAT, V87, DOI 10.1016/j.archger.2020.104014; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Raymo JM, 2008, J POPUL RES, V25, P379, DOI 10.1007/BF03033896; Statistics Bureau of Japan, 2015, POP HOUS JAP 2015; Suthutvoravut U, 2019, J FRALITY AGING, V8, P198, DOI 10.14283/jfa.2019.22; Tani Y, 2018, J GERONTOL B-PSYCHOL, V73, P1330, DOI 10.1093/geronb/gbw211; Tani Y, 2015, APPETITE, V95, P1, DOI 10.1016/j.appet.2015.06.005; Wada T, 2004, ARCH GERONTOL GERIAT, V39, P15, DOI 10.1016/j.archger.2003.12.003; Wang XY, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0197-2; Warde A, 2007, ACTA SOCIOL, V50, P363, DOI 10.1177/0001699307083978; Wright L, 2006, J HUM NUTR DIET, V19, P23, DOI 10.1111/j.1365-277X.2006.00658.x; Yiengprugsawan Vasoontara, 2015, Glob J Health Sci, V7, P270, DOI 10.5539/gjhs.v7n4p270	23	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2020	15	6							e0234379	10.1371/journal.pone.0234379	http://dx.doi.org/10.1371/journal.pone.0234379			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ0RE	32511277	gold, Green Published			2022-12-26	WOS:000540938100009
J	Cavin, L; Buffetaut, E; Dutour, Y; Garcia, G; Le Loeuff, J; Mechin, A; Mechin, P; Tong, HY; Tortosa, T; Turini, T; Valentin, X				Cavin, Lionel; Buffetaut, Eric; Dutour, Yves; Garcia, Geraldine; Le Loeuff, Jean; Mechin, Annie; Mechin, Patrick; Tong, Haiyan; Tortosa, Thierry; Turini, Eric; Valentin, Xavier			The last known freshwater coelacanths: New Late Cretaceous mawsoniid remains (Osteichthyes: Actinistia) from Southern France	PLOS ONE			English	Article							SARCOPTERYGII ACTINISTIA; GONDWANAN AFFINITIES; SAUROPOD DINOSAURS; SUCCESSION; EUROPE; DIVERSITY; HISTORY; BASIN; BIRD	Coelacanths are iconic fishes represented today by a single marine genus. The group was a little bit more diversified in the Mesozoic, with representatives in marine and continental environments in the Late Cretaceous. Here we describe isolated skull bones of the last know freshwater coelacanths found in several fossil sites from the Early Campanian to the Early Maastrichtian of Southern France (in the Departments of Aude, Bouches-du-Rhone, Herault, and Var). The sample does not allow distinguishing different species, and all material is referred to Axelrodichthys megadromos Cavin, Valentin, Garcia originally described from the locality of Ventabren in Southern France. A reconstruction of the skull is proposed. Previously unrecognized features are described, including parts of the postparietal portion of the skull, of the suspensorium and of the mandible. The new data confirm the assignation of the species to the mawsoniids, and more specifically to Axelrodichthys. A cladistic analysis scoring new character states provides a similar topology than a previous analysis, i.e. A. megadromos is placed in a polytomy with Axelrodichthys araripensis and Lualabaea lerichei, two species from the Early Cretaceous of Brazil and from the Late Jurassic of the Democratic Republic of the Congo, respectively. A. megadromos appears to have been restricted to freshwater environments, to the contrary of oldest Western Gondwanan representatives of the family that were able to live in brackish and marine waters. A. megadromos is the last representative of the mawsoniids and its occurrence in Europe is probably the result of a dispersal event from Western Gondwana that happened somewhen in the Cretaceous. Based on the available data, the mawsoniids went extinct in the mid-Maastrichthian, i.e. before the end-Cretaceous mass extinction. But it is possible that the fossil record of this family, which has been only recently recognized in Late Cretaceous European deposits, will geographically and stratigraphically widen with further discoveries.	[Cavin, Lionel] Nat Hist Muesum, Dept Geol & Palaeontol, Geneva, Switzerland; [Buffetaut, Eric] PSL Res Univ, Lab Geol, Ecole Normale Super, CNRS,UMR 8538, Paris, France; [Buffetaut, Eric; Tong, Haiyan] Mahasarakham Univ, Palaeontol Res & Educ Ctr, Kantarawichai, Maha Sarakham, Thailand; [Dutour, Yves; Turini, Eric] Museum Hist Nat, Paris, France; [Garcia, Geraldine; Valentin, Xavier] Univ Poitiers, UMR CNRS 7262, Lab Paleontol Evolut Paleoecosyst & Paleoprimatol, Poitiers, France; [Le Loeuff, Jean] Musee Dinosaures, Esperaza, France; [Mechin, Annie; Mechin, Patrick] Musee Cruzy, Cruzy, France; [Tortosa, Thierry] Reserve Nat St Victoire, Dept Bouches du Rhone, Hotel Dept, Marseille, France; [Valentin, Xavier] Palaios, Morthemer Valdivienne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Mahasarakham University; Museum National d'Histoire Naturelle (MNHN); Universite de Poitiers	Cavin, L (corresponding author), Nat Hist Muesum, Dept Geol & Palaeontol, Geneva, Switzerland.	lionel.cavin@ville-ge.ch	Tortosa, Thierry/AAA-5522-2021; Cavin, Lionel/AAZ-8120-2021	Cavin, Lionel/0000-0001-9666-5864	PhD CIFRE grant [62/2008]; Swiss National Science Foundation grant: "Evolutionary pace in the coelacanth clade: New evidence from the Triassic of Switzerland'' [200021-172700]; French Ministry of Education and Communication [VR1013]; Bouches du Rhone department CD 13 proposals [MAPADGAC23112010-1, MAPADGAC16012014-1-AAPC]; ESCOTA Company; VINCI group; "collectivite territoriale departementale" of the Bouches-du-Rhone Department	PhD CIFRE grant; Swiss National Science Foundation grant: "Evolutionary pace in the coelacanth clade: New evidence from the Triassic of Switzerland''; French Ministry of Education and Communication; Bouches du Rhone department CD 13 proposals; ESCOTA Company; VINCI group; "collectivite territoriale departementale" of the Bouches-du-Rhone Department	TT received a PhD CIFRE 62/2008 grant LC received a Swiss National Science Foundation grant: "Evolutionary pace in the coelacanth clade: New evidence from the Triassic of Switzerland'' (200021-172700) G.G and X.V received a grant from the French Ministry of Education and Communication (research grant VR1013) to the Palaios association. - G.G and X.V received a grant from the Bouches du Rhone department CD 13 proposals MAPADGAC23112010-1 and MAPADGAC16012014-1-AAPC) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the "collectivite territoriale departementale" of the Bouches-du-Rhone Department for excavation permits, administrative ease and financial support for the excavations on the localities of Bouc-Bel-Air-Sousquiere and Velaux-La Bastide Neuve, and more specifically to the "Direction de l'Environnement, des Grands-Projets et de la Recherche" (M. Bourrelly), the "Direction des Forets et des Espaces Naturels" (G. Michel), the "Direction des Routes" (B. Ott), the "Service Departemental d'Incendie et de Secours" and former directors (S. Amico, N. Mouly). We are grateful to ESCOTA Company (P. Laroche, S. Maurice) and VINCI group (C. Caye) for excavation permits and financial support to the palaeontological research. We thank the team of the Museum d'Histoire Naturelle d'Aix-en-Provence (M. Berrabah, S. Berton, M. Desparoir and F. Perret) and the volunteers (B. Derville, T. Guiragossian) for prospection, excavation and preparation works. G.G and X.V. thank the Velaux Municipality, Pascal Godefroit (Brussels) and numerous volunteers during the field campaigns in 2009 and 2012. The "Association culturelle, archeologique et paleontologique de l'Ouest Biterrois" (ACAP) is thanked for its support during the excavations at Cruzy. We thank Camila Cupello (Rio de Jainero), Paulo M. Brito (Rio de Jainero), Yoshitaka Yabumoto (Kitakyushu) for their reviews, and Giorgio Carnevale (Torino) for editing this article.	[Anonymous], 2015, BMJ, V2015, ph1887; [Anonymous], 2017, KIDNEY INT S, V7, p[1, 1], DOI DOI 10.1016/j.kisu.2017.04.001; Babinot J.-F, 1983, GEOLOGIE, V10, P413; Buffetaut E, 1998, J GEOL SOC LONDON, V155, P1, DOI 10.1144/gsjgs.155.1.0001; Buffetaut E, 2001, CR ACAD SCI II A, V333, P357, DOI 10.1016/S1251-8050(01)01630-5; Buffetaut E, 2000, CR ACAD SCI II A, V331, P557, DOI 10.1016/S1251-8050(00)01451-8; BUFFETAUT E, 1988, CR ACAD SCI II, V306, P153; Buffetaut E, 1998, ORYCTOS, V1, P127; Buffetaut E., 2006, MESOZOIC CENOZOIC VE, P95; Buffetaut E, 2020, CRETAC RES; Buffetaut E., 2019, CARNETS NATURES, V6, P47; Buffetaut Eric, 2019, PALAEOVERTEBRATA, V42, pe3, DOI 10.18563/pv.42.1.e3; Buffetaut E, 1989, TERRA NOVA, V1, P69, DOI 10.1111/j.1365-3121.1989.tb00328.x; Fragoso LGC, 2019, HIST BIOL, V31, P1350, DOI 10.1080/08912963.2018.1454443; Cavin L, 2005, BIOL LETT-UK, V1, P176, DOI 10.1098/rsbl.2004.0287; Cavin L., 2004, MESOZOIC FISHES, P493; Cavin L., 2017, 250 MILLION YEARS EV; Cavin Lionel, 2019, Bulletin of the Kitakyushu Museum of Natural History and Human History Series A Natural History, P3; Cavin L, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00049; Cavin L, 2016, CRETACEOUS RES, V62, P65, DOI 10.1016/j.cretres.2016.02.002; Cavin Lionel, 1996, Revue de Paleobiologie, V15, P1; Cincotta A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134231; Csiki-Sava Z, 2015, ZOOKEYS, P1, DOI 10.3897/zookeys.469.8439; Cupello C, 2016, CRETACEOUS RES, V65, P10, DOI 10.1016/j.cretres.2016.04.009; De Carvalho MSS, 2008, GEOL SOC SPEC PUBL, V295, P109, DOI 10.1144/SP295.8; Diaz VD, 2018, CRETACEOUS RES, V91, P429, DOI 10.1016/j.cretres.2018.06.015; Diaz VD, 2012, P GEOLOGIST ASSOC, V123, P626, DOI 10.1016/j.pgeola.2012.04.002; Dutel H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049911; Fabre-Taxy S, 1951, FAUNES LAGUNAIRES CO, P42; Fondevilla V, 2019, EARTH-SCI REV, V191, P168, DOI 10.1016/j.earscirev.2019.01.007; Fondevilla V, 2016, CRETACEOUS RES, V57, P457, DOI 10.1016/j.cretres.2015.08.009; Forey P.L., 1998, HIST COELACANTH FISH; Garcia G., 2001, B SOC ETUDE SCI NATU, V19, P11; Garcia G, 1998, THESIS; Garcia G, 2010, B SOC GEOL FR, V181, P269, DOI 10.2113/gssgfbull.181.3.269; Gheerbrant E, 2006, PALAEOGEOGR PALAEOCL, V241, P224, DOI 10.1016/j.palaeo.2006.03.016; Gopinath T., 2019, SCI REP, V9, P1, DOI DOI 10.1038/s41598-018-37186-2; Gottfried M.D., 2004, RECENT ADV ORIGIN EA, P687; Grande L, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011114; Knoll F, 2019, PEERJ, P1; Laurent Y., 2001, Developments in Palaeontology and Stratigraphy, V19, P657; Le Loeuff J, 2005, LIFE O PAST, P115; Le Loeuff J., 2012, J STRATIGRAPHY, V36, P1; Le Loeuff Jean, 1995, P181; LELOEUFF J, 1995, CR ACAD SCI II A, V321, P693; LELOEUFF J, 1991, CRETACEOUS RES, V12, P93, DOI 10.1016/S0195-6671(05)80019-9; LELOUEFF J, 1994, GEOL MAG, V131, P625, DOI 10.1017/S0016756800012413; Maisey J.G., 1986, American Museum Novitates, P1; Martin JE, 2016, ZOOL J LINN SOC-LOND, V176, P607, DOI 10.1111/zoj.12331; Martin JE, 2010, J VERTEBR PALEONTOL, V30, P756, DOI 10.1080/02724631003758318; SCHWIMMER DR, 1994, GEOLOGY, V22, P503, DOI 10.1130/0091-7613(1994)022<0503:GFCOTL>2.3.CO;2; Smektala F, 2014, P GEOLOGIST ASSOC, V125, P567, DOI 10.1016/j.pgeola.2014.10.004; Szabo M., 2017, CENT EUR GEOL, V60, P230, DOI [10.1556/24.60.2017.009, DOI 10.1556/24.60.2017.009]; Tong Haiyan, 1998, American Museum Novitates, V3251, P1; Tortosa T, 2014, THESIS, V6; Tortosa T, 2014, ANN PALEONTOL, V100, P63, DOI 10.1016/j.annpal.2013.10.003; Vila B, 2012, PALAEOGEOGR PALAEOCL, V350, P19, DOI 10.1016/j.palaeo.2012.06.008; Vullo R, 2018, J VERTEBR PALEONTOL, V38, DOI 10.1080/02724634.2018.1502670; Wenz S., 1981, Annales de Paleontologie Vertebres, V67, P1; Yabumoto Y, 2002, PALEONTOL RES, V12, P329; Yabumoto Yoshitaka, 2005, Bulletin of the National Science Museum Series C (Geology & Paleontology), V31, P39	61	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0234183	10.1371/journal.pone.0234183	http://dx.doi.org/10.1371/journal.pone.0234183			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6QB	32502171	gold, Green Published			2022-12-26	WOS:000542035700051
J	Sanford, AM; Morley, JE; Berg-Weger, M; Lundy, J; Little, MO; Leonard, K; Malmstrom, TK				Sanford, Angela M.; Morley, John E.; Berg-Weger, Marla; Lundy, Janice; Little, Milta O.; Leonard, Kathleen; Malmstrom, Theodore K.			High prevalence of geriatric syndromes in older adults	PLOS ONE			English	Article							SCREENING TOOL; SARC-F; FRAILTY; SARCOPENIA; PHENOTYPE; PEOPLE; HEALTH; SCALE	Introduction The geriatric syndromes of frailty, sarcopenia, weight loss, and dementia are highly prevalent in elderly individuals across all care continuums. Despite their deleterious impact on quality of life, disability, and mortality in older adults, they are frequently under-recognized. At Saint Louis University, the Rapid Geriatric Assessment (RGA) was developed as a brief screening tool to identify these four geriatric syndromes. Materials and methods From 2015-2019, the RGA, comprised of the FRAIL, SARC-F, Simplified Nutritional Appetite Questionnaire (SNAQ), and Rapid Cognitive Screen (RCS) tools and a question on Advance Directives, was administered to 11,344 individuals >= 65 years of age across Missouri in community, office-based, hospital, Programs of All-Inclusive Care for the Elderly (PACE), and nursing home care settings. Standard statistical methods were used to calculate the prevalence of frailty, sarcopenia, weight loss, and dementia across the sample. Results Among the 11,344 individuals screened by the RGA, 41.0% and 30.4% met the screening criteria for pre-frailty and frailty respectively, 42.9% met the screening criteria for sarcopenia, 29.3% were anorectic and at risk for weight loss, and 28.1% screened positive for dementia. The prevalence of frailty, risk for weight loss, sarcopenia, and dementia increased with age and decreased when hospitalized patients and those in the PACE program or nursing home were excluded. Conclusions Using the RGA as a valid screening tool, the prevalence of one or more of the geriatric syndromes of frailty, sarcopenia, weight loss, and dementia in older adults across all care continuums is quite high. Management approaches exist for each of these syndromes that can improve outcomes. It is suggested that the brief RGA screening tool be administered to persons 65 and older yearly as part of the Medicare Annual Wellness Visit.	[Sanford, Angela M.; Morley, John E.; Leonard, Kathleen] St Louis Univ, Sch Med, Div Geriatr Med, St Louis, MO 63104 USA; [Berg-Weger, Marla] St Louis Univ, Sch Social Work, St Louis, MO 63103 USA; [Lundy, Janice] Perry Cty Mem Hosp, Dept Social Work & Geriatr Care Management, Perryville, MO USA; [Little, Milta O.] Duke Univ, Sch Med, Div Geriatr Med, Durham, NC USA; [Malmstrom, Theodore K.] St Louis Univ, Sch Med, Dept Psychiat & Behav Neurosci, St Louis, MO USA	Saint Louis University; Saint Louis University; Duke University; Saint Louis University	Sanford, AM (corresponding author), St Louis Univ, Sch Med, Div Geriatr Med, St Louis, MO 63104 USA.	angela.sanford@health.slu.edu		, Angela/0000-0002-7131-7924	Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) [U1QHP28716]; Geriatrics Workforce Enhancement Program	Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS); Geriatrics Workforce Enhancement Program	This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U1QHP28716 Geriatrics Workforce Enhancement Program. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS, or the U. S. Government. All authors received support from the above grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abete P, 2017, AGING CLIN EXP RES, V29, P913, DOI 10.1007/s40520-017-0793-9; Aprahamian I, 2017, J AM MED DIR ASSOC, V18, P592, DOI 10.1016/j.jamda.2017.01.009; Bell SP, 2016, J AM GERIATR SOC, V64, P715, DOI 10.1111/jgs.14035; Bulut EA, 2018, CLIN INTERV AGING, V13, P1899, DOI 10.2147/CIA.S180281; Cao L, 2014, J NUTR HEALTH AGING, V18, P277, DOI 10.1007/s12603-013-0410-3; Chong E, 2017, J AM GERIATR SOC, V19; Collard RM, 2012, J AM GERIATR SOC, V60, P1487, DOI 10.1111/j.1532-5415.2012.04054.x; Cruz-Jentoft AJ, 2014, AGE AGEING, V43, P748, DOI 10.1093/ageing/afu115; Gaugler J, 2019, ALZHEIMERS DEMENT, V15, P321, DOI 10.1016/j.jalz.2019.01.010; Irving G, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017902; Kwon Insu, 2019, J Exerc Nutrition Biochem, V23, P50, DOI 10.20463/jenb.2019.0023; Liang YJ, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-1018-6; Liguori I, 2018, CLIN INTERV AGING, V13, P913, DOI 10.2147/CIA.S149232; Malmstrom TK, 2015, J NUTR HEALTH AGING, V19, P741, DOI 10.1007/s12603-015-0564-2; Malmstrom TK, 2016, J CACHEXIA SARCOPENI, V7, P28, DOI 10.1002/jcsm.12048; Morley JE, 2012, J NUTR HEALTH AGING, V16, P601, DOI 10.1007/s12603-012-0084-2; Morley JE, 2017, CLIN GERIATR MED, V33, P431, DOI 10.1016/j.cger.2017.03.006; Morley JE, 2017, J AM MED DIR ASSOC, V18, P489, DOI 10.1016/j.jamda.2017.03.015; Morley JE, 2015, J AM MED DIR ASSOC, V16, P808, DOI 10.1016/j.jamda.2015.08.004; Okudur SK, 2019, J NUTR HEALTH AGING, V23, P68, DOI 10.1007/s12603-018-1107-4; Rolland Y, 2012, J AM MED DIR ASSOC, V13, P31, DOI 10.1016/j.jamda.2011.05.003; Sanchez E, 2011, HEART, V97, P1602, DOI 10.1136/hrt.2011.227504; Tkacheva ON, 2018, CLIN INTERV AGING, V13, P251, DOI 10.2147/CIA.S153389; Tuna F, 2019, J NUTR HEALTH AGING, V23, P617, DOI 10.1007/s12603-019-1212-z; Valentini A, 2018, CLIN INTERV AGING, V13, P1237, DOI 10.2147/CIA.S164174; Wilson MMG, 2005, AM J CLIN NUTR, V82, P1074, DOI 10.1093/ajcn/82.5.1074; Woo J, 2014, J AM MED DIR ASSOC, V15, P630, DOI 10.1016/j.jamda.2014.04.021; Woo J, 2012, J AM GERIATR SOC, V60, P1478, DOI 10.1111/j.1532-5415.2012.04074.x	28	34	35	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0233857	10.1371/journal.pone.0233857	http://dx.doi.org/10.1371/journal.pone.0233857			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MA6QB	32502177	Green Published, gold			2022-12-26	WOS:000542035700056
J	Tapera, R; Mbongwe, B; Mhaka-Mutepfa, M; Lord, A; Phaladze, NA; Zetola, NM				Tapera, Roy; Mbongwe, Bontle; Mhaka-Mutepfa, Magen; Lord, Andrew; Phaladze, Nthabiseng A.; Zetola, Nicola M.			The theory of planned behavior as a behavior change model for tobacco control strategies among adolescents in Botswana	PLOS ONE			English	Article							IMPLICIT ASSOCIATION TEST; FRIENDSHIP NETWORKS; PERCEIVED BARRIERS; EXTENDED THEORY; START SMOKING; INTENTIONS; ATTITUDES; PEER; ADHERENCE; CESSATION	Background Behavioral intentions (motivational factors), attitudes, subjective norm (social pressures), and perceived behavioral control promote or discourage smoking behavior among adolescents. Objective To assess students' behavioral intentions, attitudes, subjective norms and perceived behavioral control on smoking using the Theory of Planned Behavior. The prevalence of smoking among the adolescents is also calculated. Methods In this cross-sectional study, structured self-administered questionnaires were used to collect data from adolescents in primary and secondary schools. Data on demographics, behavioral intentions, attitudes, subjective norms, and perceived behavioral control towards smoking were collected. Pearson product moment correlations and logistic regression models were used to determine factors associated with current smoking. Results A total sample of 2554 (mean age = 15; Range = 12-18 years) students participated in the study. Twenty-nine percent (n = 728) of the students had tried smoking at least once. Smoking was predicted by attitudes, subjective norms, perceived behavioral control and intention.There was a strong association between having a parent or guardian, caregiver or close friend who smoked (p < 0.001) and being a smoker. The majority of students (57%) conveyed that adults talked to them about the harmful effects of cigarette smoking and 50% had discussed smoking concerns with their friends. Students who had positive attitudes towards smoking like "smoking makes you confident" were more likely to be current smokers (OR: 1.63, 95% CI: 1.03-2.59). The feeling or conviction that they could refuse a cigarette if offered was an impediment from smoking (OR: 0.18, 95% CI: 0.13-0.26). Conclusions Attitudes, subjective norms, and perceived behavioral control contributed significantly to the students' smoking. Right attitudes must be cultivated and behavioral control must be strengthened for early effective interventions to curtail smoking among adolescents.	[Tapera, Roy; Mbongwe, Bontle] Univ Botswana, Sch Publ Hlth, Dept Environm Hlth, Gaborone, Botswana; [Mhaka-Mutepfa, Magen] Univ Botswana, Fac Social Sci, Dept Psychol, Gaborone, Botswana; [Lord, Andrew] Good Business, London, England; [Phaladze, Nthabiseng A.] Univ Botswana, Sch Nursing, Gaborone, Botswana; [Zetola, Nicola M.] Univ Penn, Dept Radiat Oncol, Philadelphia, PA 19104 USA	University of Botswana; University of Botswana; University of Botswana; University of Pennsylvania	Tapera, R (corresponding author), Univ Botswana, Sch Publ Hlth, Dept Environm Hlth, Gaborone, Botswana.	ztapera@gmail.com	Mutepfa, Magen/V-1614-2019; Mbongwe, Bontle/AAF-9888-2021	Mutepfa, Magen/0000-0003-0838-817X; Tapera, Dr Roy/0000-0002-7242-8650; Mbongwe, Bontle/0000-0002-3839-1225	Bill and Melinda Gates Foundation [OPP1082662]; Ministry of Basic Education; University of Botswana Office of Research and Development	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Ministry of Basic Education; University of Botswana Office of Research and Development	This research was commissioned by Good Business (London) as part of a social marketing programme designed to prevent teenage girls from taking up smoking in Botswana. This was funded through a grant from the Bill and Melinda Gates Foundation Grant number OPP1082662. The funder had no role in the study design, collection, analysis and interpretation of the data; writing the report or the decision to submit the report for publication. The views expressed in this paper are therefore those of the authors and do not necessarily reflect the views of the funding body.; The research team acknowledges the support received from the Ministry of Basic Education as well as the University of Botswana Office of Research and Development.	Abiru N, 2020, DIABETOL INT, V11, P1, DOI 10.1007/s13340-019-00415-8; Abraham C, 2003, BRIT J SOC PSYCHOL, V42, P495, DOI 10.1348/014466603322595248; Ajzen I, 2004, HEALTH PSYCHOL, V23, P431, DOI 10.1037/0278-6133.23.4.431; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I., 2008, HDB CONSUMER PSYCHOL, P525; Ajzen I, 2011, PSYCHOL HEALTH, V26, P1113, DOI 10.1080/08870446.2011.613995; Bandura A, 1998, PSYCHOL HEALTH, V13, P623, DOI 10.1080/08870449808407422; Chassin L, 2002, J PEDIATR PSYCHOL, V27, P485, DOI 10.1093/jpepsy/27.6.485; Chen XG, 2006, J ADOLESCENT HEALTH, V38, P359, DOI 10.1016/j.jadohealth.2005.03.010; Cheng OY, 2019, AM J HEALTH BEHAV, V43, P569, DOI 10.5993/AJHB.43.3.11; Chuang YC, 2005, J EPIDEMIOL COMMUN H, V59, P568, DOI 10.1136/jech.2004.029041; Conner M, 2003, CURR PSYCHOL, V22, P252, DOI 10.1007/s12144-003-1020-8; CONRAD KM, 1992, BRIT J ADDICT, V87, P1711; Filippidis FT, 2015, EUR J PUBLIC HEALTH, V25, P814, DOI 10.1093/eurpub/ckv068; Fishbein, 2000, EUR REV SOC PSYCHOL, V11, P1, DOI [https://doi.org/10.1080/14792779943000116, DOI 10.1080/14792779943000116, 10.1080/14792779943000116]; Fishbein M, 2005, J HEALTH PSYCHOL, V10, P27, DOI 10.1177/1359105305048552; Fung XCC, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17010064; Gass R. H., 2015, PERSUASION SOCIAL IN; Gold GJ, 2011, J SOC PSYCHOL, V151, P382, DOI 10.1080/00224545.2011.563209; Guo Q, 2012, ADDICT BEHAV, V37, P273, DOI 10.1016/j.addbeh.2011.11.002; Gwaltney CJ, 2009, PSYCHOL ADDICT BEHAV, V23, P56, DOI 10.1037/a0013529; Harakeh Z, 2012, DRUG ALCOHOL DEPEN, V121, P220, DOI 10.1016/j.drugalcdep.2011.08.029; Hiemstra M, 2011, J ADOLESCENT HEALTH, V48, P597, DOI 10.1016/j.jadohealth.2010.09.011; Hirschi T., 1969, CAUSE OF DELINQUENCY; Hong T, 2011, WOMEN HEALTH, V51, P187, DOI 10.1080/03630242.2011.560241; Hou WL, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17030923; Huijding J, 2005, ADDICT BEHAV, V30, P949, DOI 10.1016/j.addbeh.2004.09.014; Hukkelberg SS, 2014, BRIT J HEALTH PSYCH, V19, P83, DOI 10.1111/bjhp.12034; Karimy Mahmood, 2015, Int J High Risk Behav Addict, V4, pe24715, DOI 10.5812/ijhrba.24715; Kobus K, 2003, ADDICTION, V98, P37, DOI 10.1046/j.1360-0443.98.s1.4.x; Lakon CM, 2015, J YOUTH ADOLESCENCE, V44, P1767, DOI 10.1007/s10964-014-0187-7; Lee Eunyoung, 2005, Taehan Kanho Hakhoe Chi, V35, P694; Lee HS, 2018, NICOTINE TOB RES, V20, P58, DOI 10.1093/ntr/ntw259; Lin CY, 2018, PREGNANCY HYPERTENS, V12, P84, DOI 10.1016/j.preghy.2018.04.001; Lin CY, 2017, EPILEPSY BEHAV, V74, P124, DOI 10.1016/j.yebeh.2017.06.011; Lin CY, 2017, EPILEPSY BEHAV, V68, P123, DOI 10.1016/j.yebeh.2017.01.010; Lin CY, 2016, EPILEPSY BEHAV, V61, P231, DOI 10.1016/j.yebeh.2016.05.030; Lin CY, 2019, J PSYCHOSOM OBST GYN, P8942; Maassen ITHM, 2004, HEALTH EDUC RES, V19, P551, DOI 10.1093/her/cyg077; Mohammadpoorasl A, 2012, INT J PREVENTIVE MED, V3, P880, DOI 10.4103/2008-7802.104860; Montano DE, 2002, HLTH BEHAV HLTH ED, P67; Nyagwui AE, 2012, THESIS; Nye FI, 2010, ENCY CRIMINOL THEORY, DOI [10.4135/9781412959193.n187, DOI 10.4135/9781412959193.N187]; Orlando M, 2004, J CONSULT CLIN PSYCH, V72, P400, DOI 10.1037/0022-006X.72.3.400; Robinson MD, 2005, BASIC APPL SOC PSYCH, V27, P201, DOI 10.1207/s15324834basp2703_2; Simons-Morton B, 2001, HEALTH EDUC BEHAV, V28, P95, DOI 10.1177/109019810102800109; Strong C, 2018, J SLEEP RES, V27, P23, DOI 10.1111/jsr.12566; Su XF, 2015, ADDICT BEHAV, V48, P44, DOI 10.1016/j.addbeh.2015.04.005; Swanson JE, 2001, COGNITION EMOTION, V15, P207, DOI 10.1080/0269993004200060; Topa G, 2010, SUBST ABUSE REHABIL, V23; Wang C, 2016, PSYCHOL ADDICT BEHAV, V30, P312, DOI 10.1037/adb0000163; WHO, 2019, TOB KEY FACTS, P1; WHO, 2014, TOB FREE YOUNG PEOPL; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; Wolff K, 2011, PSYCHOL HEALTH, V26, P1143, DOI 10.1080/08870441003763253; Xu XL, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3694-z	56	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2020	15	6							e0233462	10.1371/journal.pone.0233462	http://dx.doi.org/10.1371/journal.pone.0233462			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MA6QB	32502211	Green Published, gold			2022-12-26	WOS:000542035700008
J	Luo, MY; Hann, K; Zhang, GM; Pan, XH; Ma, QQ; Jiang, J; Chen, L; Xia, SC				Luo, Mingyu; Hann, Katrina; Zhang, Guomin; Pan, Xiaohong; Ma, Qiaoqin; Jiang, Jun; Chen, Lin; Xia, Shichang			HIV testing uptake and yield among sexual partners of HIV-positive men who have sex with men in Zhejiang Province, China, 2014-2016: A cross-sectional pilot study of a choice-based partner tracing and testing package	PLOS ONE			English	Article							NOTIFICATION; ATTITUDES; MSM	Background Measures to effectively expand tracing and testing to identify undiagnosed HIV infections are significant for the control of HIV/AIDS epidemic among men who have sex with men (MSM). We piloted a choice-based tracing and testing package aimed at improving partner tracing, uptake, and yield of HIV testing for sexual partners of newly diagnosed HIV-positive MSM. Methods This package was piloted in the cities of Hangzhou and Ningbo, Zhejiang province, China from June 2014 to June 2016. The package adopted four modes: couples' HIV counseling and testing (CHCT), information assisted partner notification (IAPN), assisted HIV self-testing (HIVST) and patient referral. Data regarding sociodemographic factors and sexual behaviors between HIV-positive MSM and their sexual partners, as well as tracing and testing outcomes of each mode, were collected. Results Among 2,495 newly diagnosed HIV-positive MSM, 446(18%) were enrolled as index cases (ICs) through two rounds of contact tracing. The ICs disclosed a total of 4,716 sexual partners, of whom 548 (12%) were reachable. The pilot study resulted in a testing uptake of 87% (478/548), and a yield of 16% (74/478) among sexual partners. The generalized linear mixed model showed that the odds of a reachable sexual partner enrolled via IAPN taking an HIV test were 290% greater than that of a partner traced via CHCT (95% CI: 1.6, 9.3). Conclusions A choice-based tracing and testing package can feasibly expand HIV testing uptake and case finding among sexual partners of HIV-positive MSM. IAPN may be an acceptable option to reach sexual partners for whom limited contact information is available.	[Luo, Mingyu; Pan, Xiaohong; Ma, Qiaoqin; Jiang, Jun; Chen, Lin; Xia, Shichang] Ctr Dis Control & Prevent Zhejiang Prov, Hangzhou, Peoples R China; [Hann, Katrina] Sustainable Hlth Syst, Freetown, Sierra Leone; [Zhang, Guomin] Chinese Ctr Dis Control & Prevent, Natl Immunizat Program, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention	Pan, XH; Ma, QQ (corresponding author), Ctr Dis Control & Prevent Zhejiang Prov, Hangzhou, Peoples R China.	xhpan@cdc.zj.cn; qqma@cdc.zj.cn	Hann, Katrina/L-2977-2016	Hann, Katrina/0000-0002-4913-6270	Key Project on Social Development among S&T Major Project of Zhejiang Province, China [2013C03047-1]; Zhejiang Provincial Medicine Science and Technology Plan [2015PYA004]; National Science and Technology Major Project of China [2017ZX10201101]; Training Project of Young Scientific and Technological Innovative Talents of Zhejiang Provincial Center of Disease Control and Prevention	Key Project on Social Development among S&T Major Project of Zhejiang Province, China; Zhejiang Provincial Medicine Science and Technology Plan; National Science and Technology Major Project of China; Training Project of Young Scientific and Technological Innovative Talents of Zhejiang Provincial Center of Disease Control and Prevention	This study was supported by Key Project on Social Development among S&T Major Project of Zhejiang Province, China (2013C03047-1), Zhejiang Provincial Medicine Science and Technology Plan (2015PYA004), National Science and Technology Major Project of China (2017ZX10201101), The Training Project of Young Scientific and Technological Innovative Talents of Zhejiang Provincial Center of Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, NAT NANOTECHNOL, V11, P1, DOI 10.1038/nnano.2015.333; [Anonymous], 2007, NEWSLETTER MOZART SO, P699; [Anonymous], 2012, LEGAL THEORY, V18, P1, DOI DOI 10.13419/j.cnki.aids.2012.01.005; [Anonymous], 2014, FRONTIERS ARCHITECTU, V3, P1, DOI DOI 10.1520/C1557-03R13.2; [Anonymous], 2010, ADV TECHNOLOGY LIB, V39, P4; beda A., 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/J0URNAL.P0NE.0127296; Benchimol EI, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001885; Carvalho C, 2013, HIV MED, V14, P15, DOI 10.1111/hiv.12058; China CDC, 2015, NAT GUID DET HIV AID; Dalal S, 2017, AIDS, V31, P1867, DOI 10.1097/QAD.0000000000001555; Estem KS, 2016, CURR HIV-AIDS REP, V13, P107, DOI 10.1007/s11904-016-0307-y; Fu XJ, 2016, INT J STD AIDS, V27, P821, DOI 10.1177/0956462416648827; Green N, 2017, AIDS, V31, P287, DOI 10.1097/QAD.0000000000001308; Guo W, 2009, CHINESE J AIDS STD; [霍俊丽 Huo Junli], 2015, [中华疾病控制杂志, Chinese Journal of Disease Control & Prevention], V19, P1260; Katz DA, 2012, ACCEPTABILITY EASE U, V2, P50; Kim SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171394; Kirby T, 2014, LANCET, V384, P1415, DOI 10.1016/S0140-6736(14)61849-3; Lampkin D, 2016, JAIDS-J ACQ IMM DEF, V72, P73, DOI 10.1097/QAI.0000000000000930; Li XiTing, 2015, Disease Surveillance, V30, P742; Li XF, 2012, SEX TRANSM INFECT, V88, P187, DOI 10.1136/sextrans-2011-050248; Lin H, 2012, BMC PUBLIC HLTH, V12; Maohe Yu, 2014, CHINESE J DIS CONTRO, V18, P1229; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; McDaid LM, 2011, SEX TRANSM INFECT, V87, P221, DOI 10.1136/sti.2010.044560; Mitchell JW, 2014, ARCH SEX BEHAV, V43, P161, DOI 10.1007/s10508-013-0211-0; 中国疾病预防控制中心, 2017, [中国艾滋病性病, Chinese JOurnal of Aids & STD], V23, P93; Pan XH, 2018, EMERG INFECT DIS, V24, P2141, DOI 10.3201/eid2412.180117; Phillips G, 2014, AIDS BEHAV, V18, P1630, DOI 10.1007/s10461-014-0760-9; Tao Tao, 2016, CHINESE J PUBLIC HLT, V32, P887; The World Health Organization, 2016, GUID HIV SELF TEST P; Tobin KE, 2014, SEX TRANSM DIS, V41, P221, DOI 10.1097/OLQ.0000000000000112; UNAIDS, 2019, MEN WHO HAV SEX MEN; van Aar F, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-114; Wagenaar BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032915; Wei CY, 2014, SEX TRANSM INFECT, V90, P469, DOI 10.1136/sextrans-2013-051460; Xu Yun, 2017, Disease Surveillance, V32, P118; Xu Zuhui, 2013, CHINESE J AIDS STD, V19, P406; Zhang J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04958-1; Zou HC, 2012, AIDS BEHAV, V16, P1717, DOI 10.1007/s10461-012-0225-y	40	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2020	15	6							e0232268	10.1371/journal.pone.0232268	http://dx.doi.org/10.1371/journal.pone.0232268			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA6PX	32497114	Green Published, gold			2022-12-26	WOS:000542035200015
J	Elliott, JM; Smith, AC; Hoggarth, MA; Albin, SR; Weber, KA; Haager, M; Fundaun, J; Wasielewski, M; Courtney, DM; Parrish, TB				Elliott, James M.; Smith, Andrew C.; Hoggarth, Mark A.; Albin, Stephanie R.; Weber, Ken A., II; Haager, Mat; Fundaun, Joel; Wasielewski, Marie; Courtney, D. Mark; Parrish, Todd B.			Muscle fat infiltration following whiplash: A computed tomography and magnetic resonance imaging comparison	PLOS ONE			English	Article							LOW-BACK-PAIN; LUMBAR PARAVERTEBRAL MUSCLES; CERVICAL EXTENSOR MUSCLES; C-SPINE RULE; SKELETAL-MUSCLE; PARASPINAL MUSCLES; PROGNOSTIC-FACTORS; TRUNK MUSCLE; INJURY; AGE	Here we present a secondary analysis from a parent database of 97 acutely injured participants enrolled in a prospective inception cohort study of whiplash recovery after motor vehicle collision (MVC). The purpose was to investigate the deep and superficial neck extensor muscles with peri-traumatic computed tomography (CT) and longitudinal measures of magnetic resonance imaging (MRI) in participants with varying levels of whiplash-related disability. Thirty-six underwent standard care imaging of the cervical spine with CT at a level-1 trauma designated emergency department. All 36 participants were assessed with MRI of the cervical spine at < 1-week, 2-weeks, 3-, and 12-months post-injury and classified into three groups using initial pain severity and percentage scores on the Neck Disability Index (recovered (NDI of 0-8%), mild (NDI of 10-28%), or severe (NDI. 30%)) at 3-months post MVC. CT muscle attenuation values were significantly correlated to muscle fat infiltration (MFI) on MRI at one-week post MVC. There was no significant difference in muscle attenuation across groups at the time of enrollment. A trend of lower muscle attenuation in the deep compared to the superficial extensors was observed in the severe group. MFI values in the deep muscles on MRI were significantly higher in the severe group when compared to the mild group at 1-year post MVC. This study provides further evidence that the magnitude of 1) deep MFI appears unique to those at risk of and eventually transitioning to chronic WAD and that 2) pre- or peri-traumatic muscular health, determined by CT muscle attenuation, may be contribute to our understanding of long-term recovery.	[Elliott, James M.] Univ Sydney, Fac Med & Hlth, Discipline Physiotherapy, St Leonards, NSW, Australia; [Elliott, James M.] Kolling Res Inst, Northern Sydney Local Hlth Dist, St Leonards, NSW, Australia; [Elliott, James M.; Hoggarth, Mark A.; Fundaun, Joel; Wasielewski, Marie] Northwestern Univ, Feinberg Sch Med, Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA; [Smith, Andrew C.; Albin, Stephanie R.; Haager, Mat] Regis Univ, Sch Phys Therapy, Denver, CO USA; [Hoggarth, Mark A.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Weber, Ken A., II; Parrish, Todd B.] Stanford Univ, Dept Anesthesiol Perioperat & Pain Med, Syst Neurosci & Pain Lab, Palo Alto, CA 94304 USA; [Courtney, D. Mark] Northwestern Univ, Dept Emergency Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Parrish, Todd B.] Northwestern Univ, Feinberg Sch Med, Dept Radiol, Chicago, IL 60611 USA	University of Sydney; Northwestern University; Feinberg School of Medicine; Regis University; Northwestern University; Stanford University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Elliott, JM (corresponding author), Univ Sydney, Fac Med & Hlth, Discipline Physiotherapy, St Leonards, NSW, Australia.; Elliott, JM (corresponding author), Kolling Res Inst, Northern Sydney Local Hlth Dist, St Leonards, NSW, Australia.; Elliott, JM (corresponding author), Northwestern Univ, Feinberg Sch Med, Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA.	jim.elliott@sydney.edu.au		Smith, Andrew/0000-0001-5020-8094; Hoggarth, Mark/0000-0001-6516-5840; Weber, Kenneth/0000-0002-0916-9174; Parrish, Todd/0000-0002-1184-1572; Courtney, D. Mark/0000-0002-0905-465X; Fundaun, Joel/0000-0001-6025-0077; Elliott, James/0000-0002-8890-6012	National Institutes of Health [NIH - R01-HD079076]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We disclose that the work in question was funded by the National Institutes of Health (NIH - R01-HD079076). Elliott, Parrish, Courtney, Hoggarth, Smith and Wasliewski were supported by this grant. Smith, Weber, and Elliott are supported by NIH R03HD094577, which is unrelated to this work.	Abbott R, 2018, SPINE J, V18, P717, DOI 10.1016/j.spinee.2017.08.233; Abbott R, 2015, J ORTHOP SPORT PHYS, V45, P281, DOI 10.2519/jospt.2015.5719; Anderson DE, 2013, J GERONTOL A-BIOL, V68, P317, DOI 10.1093/gerona/gls168; Antoun S, 2013, CANCER-AM CANCER SOC, V119, P3377, DOI 10.1002/cncr.28218; Aubrey J, 2014, ACTA PHYSIOL, V210, P489, DOI 10.1111/apha.12224; Baum T, 2016, J COMPUT ASSIST TOMO, V40, P447, DOI 10.1097/RCT.0000000000000374; Bonati U, 2017, ANN CLIN TRANSL NEUR, V4, P292, DOI 10.1002/acn3.406; Carroll LJ, 2009, J MANIP PHYSIOL THER, V32, pS97, DOI 10.1016/j.jmpt.2008.11.014; Craig A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011993; Crawford RJ, 2016, AM J NEURORADIOL, V37, P742, DOI 10.3174/ajnr.A4596; Crawford RJ, 2017, EUR SPINE J, V26, P3059, DOI 10.1007/s00586-017-5212-6; Crawford RJ, 2016, SCOLIOSIS SPINAL DIS, V11, DOI 10.1186/s13013-016-0080-0; Daffner Richard H, 2007, J Am Coll Radiol, V4, P762, DOI 10.1016/j.jacr.2007.08.006; Dixon W., 1984, RADIOLOGY, P153; Elliott C, 2017, HASTINGS CENT REP, V47, DOI 10.1002/hast.704; Elliott J, 2008, CLIN RADIOL, V63, P681, DOI 10.1016/j.crad.2007.11.011; Elliott J, 2006, SPINE, V31, pE847, DOI 10.1097/01.brs.0000240841.07050.34; Elliott J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021194; Elliott JM, 2018, SPINE J, V18, P1489, DOI 10.1016/j.spinee.2017.06.015; Elliott JM, 2015, SPINE, V40, pE694, DOI 10.1097/BRS.0000000000000891; Elliott JM, 2014, SPINE, V39, P39, DOI 10.1097/BRS.0000000000000033; Elliott JM, 2019, AM J EMERGENCY MED; Engelke K, 2018, J ORTHOP TRANSL, V15, P91, DOI 10.1016/j.jot.2018.10.004; Expert Panel on Neurological Imaging and Musculoskeletal Imaging:, 2019, J Am Coll Radiol, V16, pS264, DOI 10.1016/j.jacr.2019.02.002; Fatehi F, 2016, REV NEUROL-FRANCE, V172, P566, DOI 10.1016/j.neurol.2016.08.002; Fortin M, 2017, BIOMED ENG ONLINE, V16, DOI 10.1186/s12938-017-0350-y; Fortin M, 2017, SPINE, V42, P232, DOI 10.1097/BRS.0000000000001704; Fortin M, 2014, MED SCI SPORT EXER, V46, P893, DOI 10.1249/MSS.0000000000000179; Fortin M, 2013, PHYS THER, V93, P1540, DOI 10.2522/ptj.20130051; GAY JR, 1953, JAMA-J AM MED ASSOC, V152, P1698, DOI 10.1001/jama.1953.03690180020006; Giambini H, 2018, MUSCLE NERVE, V57, P129, DOI 10.1002/mus.25673; Goodpaster BH, 2000, J APPL PHYSIOL, V89, P104, DOI 10.1152/jappl.2000.89.1.104; Goubert D, 2017, SPINE J, V17, P1285, DOI 10.1016/j.spinee.2017.04.025; Hahn Myung Hoon, 2016, J Bone Metab, V23, P215, DOI 10.11005/jbm.2016.23.4.215; Hicks GE, 2005, J GERONTOL A-BIOL, V60, P1420, DOI 10.1093/gerona/60.11.1420; Ito S, 2005, EUR SPINE J, V14, P356, DOI 10.1007/s00586-004-0783-4; Ivancic PC, 2006, CLIN BIOMECH, V21, P213, DOI 10.1016/j.clinbiomech.2005.10.011; Ivancic PC, 2004, EUR SPINE J, V13, P61, DOI 10.1007/s00586-003-0590-3; Jull G, 2016, J ORTHOP SPORT PHYS, V46, P815, DOI 10.2519/jospt.2016.0112; Kamper SJ, 2008, PAIN, V138, P617, DOI 10.1016/j.pain.2008.02.019; Karlsson A, 2016, J ORTHOP SPORT PHYS, V46, P886, DOI 10.2519/jospt.2016.6553; Krogh S, 2018, J REHABIL MED, V50, P548, DOI 10.2340/16501977-2348; Kumar D, 2014, OSTEOARTHR CARTILAGE, V22, P226, DOI 10.1016/j.joca.2013.12.005; Lee S, 2005, J APPL PHYSIOL, V99, P1220, DOI 10.1152/japplphysiol.00053.2005; Lee SH, 2017, SPINE J, V17, P81, DOI 10.1016/j.spinee.2016.08.001; Lollert A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190784; Martin L, 2013, J CLIN ONCOL, V31, P1539, DOI 10.1200/JCO.2012.45.2722; Matsumoto M, 2013, INJURY, V44, P819, DOI 10.1016/j.injury.2012.12.001; Matsumoto M, 2012, INJURY, V43, P912, DOI 10.1016/j.injury.2012.01.017; Mhuiris AN, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1090-z; Morrow JM, 2016, LANCET NEUROL, V15, P65, DOI 10.1016/S1474-4422(15)00242-2; Nakashima H, 2015, SPINE, V40, P392, DOI 10.1097/BRS.0000000000000775; Osterland TB, 2019, CLIN J PAIN, V35, P304, DOI 10.1097/AJP.0000000000000683; Panacek EA, 2001, ANN EMERG MED, V38, P22, DOI 10.1067/mem.2001.116499; Pearson AM, 2004, SPINE, V29, P390, DOI 10.1097/01.BRS.0000090836.50508.F7; Pedler A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197438; Peterson G, 2016, ULTRASOUND MED BIOL, V42, P1090, DOI 10.1016/j.ultrasmedbio.2015.12.022; Ploumis A, 2011, BRIT J RADIOL, V84, P709, DOI 10.1259/bjr/58136533; Ranger TA, 2017, SPINE J, V17, P1729, DOI 10.1016/j.spinee.2017.07.002; Rasch A, 2009, J BONE JOINT SURG BR, V91B, P583, DOI 10.1302/0301-620X.91B5.21477; Reeder SB, 2012, J MAGN RESON IMAGING, V36, P1011, DOI 10.1002/jmri.23741; Schomacher J, 2012, CLIN NEUROPHYSIOL, V123, P1403, DOI 10.1016/j.clinph.2011.11.033; Sebro R, 2017, J COMPUT ASSIST TOMO, V41, P298, DOI [10.1097/RCT.0000000000000507, 10.1097/rct.0000000000000507]; Siegmund GP, 2009, TRAFFIC INJ PREV, V10, P101, DOI 10.1080/15389580802593269; Smith AC, 2017, SPINAL CORD, V55, P672, DOI 10.1038/sc.2017.18; Smith Andrew C, 2015, Spinal Cord Ser Cases, V1; Smith AC, 2014, MUSCLE NERVE, V50, P170, DOI 10.1002/mus.24255; Spitzer WO, 1995, SPINE S8, V20, P1, DOI DOI 10.1097/00007632-199504151-00001; Sterling M, 2019, BR J SPORTS MED; Stiell IG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4146; Stiell IG, 2003, NEW ENGL J MED, V349, P2510, DOI 10.1056/NEJMoa031375; Strudwick K, 2018, EMERG MED AUSTRALAS, V30, P754, DOI 10.1111/1742-6723.13131; Teichtahl AJ, 2015, SPINE J, V15, P1593, DOI 10.1016/j.spinee.2015.03.039; Treleaven J, 2017, J ORTHOP SPORT PHYS, V47, P492, DOI 10.2519/jospt.2017.7052; Valentin S, 2015, MANUAL THER, V20, P90, DOI 10.1016/j.math.2014.07.007; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Walton DM, 2013, J ORTHOP SPORT PHYS, V43, P31, DOI 10.2519/jospt.2013.4507; Wan Q, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20140546; Willcocks RJ, 2016, ANN NEUROL, V79, P535, DOI 10.1002/ana.24599; Winkelstein BA, 2000, SPINE, V25, P1238, DOI 10.1097/00007632-200005150-00007; Yoganandan N, 2002, ACCIDENT ANAL PREV, V34, P663, DOI 10.1016/S0001-4575(01)00066-5; Yoo YH, 2015, KOREAN J RADIOL, V16, P1086, DOI 10.3348/kjr.2015.16.5.1086	82	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2020	15	6							e0234061	10.1371/journal.pone.0234061	http://dx.doi.org/10.1371/journal.pone.0234061			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MT4VF	32484835	Green Published, gold			2022-12-26	WOS:000554969700032
J	Perez-Barberia, FJ; Garcia, AJ; Cappelli, J; Landete-Castillejos, T; Serrano, MP; Gallego, L				Perez-Barberia, F. J.; Garcia, A. J.; Cappelli, J.; Landete-Castillejos, T.; Serrano, M. P.; Gallego, L.			Heat stress reduces growth rate of red deer calf: Climate warming implications	PLOS ONE			English	Article							TEMPERATURE-HUMIDITY INDEX; BODY-SIZE; SEXUAL-DIMORPHISM; DAIRY-CATTLE; MULE DEER; THERMOREGULATION; POPULATION; ADAPTATION; PARAMETERS; RESPONSES	Climate models agree in predicting scenarios of global warming. In endothermic species heat stress takes place when they are upper their thermal neutral zone. Any physiological or behavioural mechanism to mitigate heat stress is at the cost of diverting energy from other physiological functions, with negative repercussions for individual fitness. Tolerance to heat stress differs between species, age classes and sexes, those with the highest metabolic rates being the most sensitive to stressing thermal environments. This is especially important during the first months of life, when most growth takes place. Red deer (Cervus elaphus) is supposedly well adapted to a wide range of thermal environments, based on its worldwide distribution range, but little is known about the direct effect that heat stress may have on calf growth. We assessed the effect that heat stress, measured by heat stress indices and physical environment variables (air temperature, relative air humidity, wind speed and solar radiation), have on calf and mother body weights from calf ' s birth to weaning. We used 9265 longitudinal weekly body weight records of calf and mother across 19 years in captive Iberian red deer. We hypothesised that (i) heat stress in hot environments has a negative effect on calf growth, especially in males, as they are more energetically demanding to produce than females; and that (ii) the body weight of the mother through lactation should be negatively affected by heat stress. Our results supported hypothesis (i) but not so clearly hypothesis (ii). By weaning (day 143) calves growing under low heat stress environment grew up to 1.2 kg heavier than those growing in high heat stress environment, and males were more affected by heat stress than females. The results have implications in animal welfare, geographical clines in body size and adaptation to climate change.	[Perez-Barberia, F. J.; Garcia, A. J.; Cappelli, J.; Landete-Castillejos, T.; Serrano, M. P.; Gallego, L.] Univ Castilla La Mancha, Game & Livestock Resources Unit, IREC, IDR, Albacete, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha	Perez-Barberia, FJ (corresponding author), Univ Castilla La Mancha, Game & Livestock Resources Unit, IREC, IDR, Albacete, Spain.	j.perezbarberia@gmail.com	Garcia Diaz, Andres Jose/A-9162-2012; Perez Barberia, Francisco Javier/M-9847-2017	Garcia Diaz, Andres Jose/0000-0002-4662-2185; Perez Barberia, Francisco Javier/0000-0001-7513-5418; Perez, Martina/0000-0003-4232-8461; Landete Castillejos, Tomas/0000-0001-9753-5295	Ministerio de Economia y Competitividad, Spain Project INCYDEN [RTC-2016-5327-2]; Junta de Comunidades de Castilla-La Mancha [SBPLY/19/180501/000115]	Ministerio de Economia y Competitividad, Spain Project INCYDEN; Junta de Comunidades de Castilla-La Mancha(Junta de Comunidades de Castilla-La Mancha)	This work was supported by Ministerio de Economia y Competitividad, Spain Project INCYDEN, RTC-2016-5327-2 and by Junta de Comunidades de Castilla-La Mancha SBPLY/19/180501/000115. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander LV, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P3; Anderson A.E., 1974, Wildlife Monogr, VNo. 39, P1; Annie, 2018, ASK EXPERTS DOES RIS; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 1999, WALKERS MAMMALS WORL; [Anonymous], 1962, ENERGY METABOLISM RU; [Anonymous], 2007, NUTR REQ SMALL RUM S, DOI DOI 10.17226/11654; ARMSTRONG DV, 1994, J DAIRY SCI, V77, P2044, DOI 10.3168/jds.S0022-0302(94)77149-6; BAKKEN GS, 1985, AM ZOOL, V25, P933; Ballon Philippe, 2012, Revue Forestiere Francaise (Nancy), V64, P305; Bohmanova J, 2007, J DAIRY SCI, V90, P1947, DOI 10.3168/jds.2006-513; BRIEF RS, 1971, AM IND HYG ASSOC J, V32, P11, DOI 10.1080/0002889718506401; Brunet M, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008249; Burbaite Lina, 2010, Acta Zoologica Lituanica, V20, P179, DOI 10.2478/v10043-010-0038-z; Carranza J., 2002, ATLAS MAMIFEROS TERR; Carranza J., 2010, EUROPEAN UNGULATES T; Clutton-Brock T.H., 1985, P51; Clutton-Brock T. H., 1991, MONOGRAPHS BEHAV ECO; CLUTTONBROCK TH, 1981, NATURE, V289, P487, DOI 10.1038/289487a0; Collier RJ, 2019, ANIM FRONT, V9, P12, DOI 10.1093/af/vfy031; Cook J., 1999, WILDL MONOGR, V61; Correa-Calderon A, 2004, INT J BIOMETEOROL, V48, P142, DOI 10.1007/s00484-003-0194-y; Das R, 2016, VET WORLD, V9, P260, DOI 10.14202/vetworld.2016.260-268; Davis S., 2003, NEB BEEF CATTLE REP; Dikmen S, 2009, J DAIRY SCI, V92, P109, DOI 10.3168/jds.2008-1370; Du Preez JH, 2000, ONDERSTEPOORT J VET, V67, P263; DUPREEZ JH, 1990, ONDERSTEPOORT J VET, V57, P77; Dussault C, 2004, ECOSCIENCE, V11, P321, DOI 10.1080/11956860.2004.11682839; Epstein Y, 2006, IND HEALTH, V44, P388, DOI 10.2486/indhealth.44.388; ERSKINE DJ, 1982, J MAMMAL, V63, P267, DOI 10.2307/1380636; Finocchiaro R, 2005, J DAIRY SCI, V88, P1855, DOI 10.3168/jds.S0022-0302(05)72860-5; Forchhammer MC, 1998, P ROY SOC B-BIOL SCI, V265, P341, DOI 10.1098/rspb.1998.0301; Freckleton RP, 2003, AM NAT, V161, P821, DOI 10.1086/374346; Gates D. M., 1980, BIOPHYSICAL ECOLOGY; GEIST V, 1987, CAN J ZOOL, V65, P1035, DOI 10.1139/z87-164; Geist V., 1998, DEER WORLD THEIR EVO; Hastie T., 1986, STAT SCI, V1, P297; HOLTER JB, 1975, CAN J ZOOL, V53, P679, DOI 10.1139/z75-082; Perez-Barberia FJ, 2020, SCI TOTAL ENVIRON, V714, DOI 10.1016/j.scitotenv.2020.136738; Kingma Boris, 2012, Front Biosci (Elite Ed), V4, P1975; Landete-Castillejos T, 2005, BEHAV ECOL SOCIOBIOL, V57, P267, DOI 10.1007/s00265-004-0848-8; LANGVATN R, 1986, HOLARCTIC ECOL, V9, P285; Mader TL, 2006, J ANIM SCI, V84, P712, DOI 10.2527/2006.843712x; Mangas Navas J., 2012, CUADERNOS TRASHUMANC; McLean J., 1987, ANIMAL HUMAN CALORIM; MERRILL EH, 1991, APPL ANIM BEHAV SCI, V29, P251, DOI 10.1016/0168-1591(91)90252-S; Miller G. R., 1998, Scottish Forestry, V52, P14; MOEN AN, 1968, J WILDLIFE MANAGE, V32, P338, DOI 10.2307/3798979; MOEN AN, 1968, ECOLOGY, V49, P676, DOI 10.2307/1935531; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Ostrowski S, 2003, J EXP BIOL, V206, P1471, DOI 10.1242/jeb.00275; Parker K.L., 1985, P161; PARKER KL, 1990, J RANGE MANAGE, V43, P73, DOI 10.2307/3899126; PARKER KL, 1984, CAN J ZOOL, V62, P1409, DOI 10.1139/z84-202; Perez-Barberia FJ, 2007, ECOL MONOGR, V77, P631, DOI 10.1890/06-2088.1; Perez-Barberia FJ, 2017, SCI TOTAL ENVIRON, V579, P1572, DOI 10.1016/j.scitotenv.2016.11.175; Perez-Barberia FJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142707; Perez-Barberia FJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134788; Perez-Barberia FJ, 2002, EVOLUTION, V56, P1276; Perez-Barberia FJ, 1998, ACTA VET HUNG, V46, P357; Perez-Gonzalez J, 2010, J WILDLIFE MANAGE, V74, P1701, DOI 10.2193/2009-130; Pinares-Patino C. S., 2014, TECHNICAL MANUAL RES; Pinheiro J., 2017, LINEAR NONLINEAR MIX, DOI DOI 10.1186/1742-9994-4-11; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; PUTMAN R, 1989, NATURAL HIST DEER; Putman R.J., 2011, UNGULATE MANAGEMENT; Reiss M.J., 1989, ALLOMETRY GROWTH REP; RINGBERG TM, 1981, CAN J ZOOL, V59, P1040, DOI 10.1139/z81-145; Rivrud IM, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.0442; Robbins C.T., 1987, P429; Rojas-Downing MM, 2017, CLIM RISK MANAG, V16, P145, DOI 10.1016/j.crm.2017.02.001; SAND H, 1995, OECOLOGIA, V102, P433, DOI 10.1007/BF00341355; SARGEANT GA, 1994, J MAMMAL, V75, P536, DOI 10.2307/1382578; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Sejian V, 2018, ANIMAL, V12, pS431, DOI 10.1017/S1751731118001945; SHANK CC, 1982, ECOLOGY, V63, P627, DOI 10.2307/1936781; Spiers DE, 2004, J THERM BIOL, V29, P759, DOI 10.1016/j.jtherbio.2004.08.051; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Storm DJ, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00141.1; Strickland JT., 1989, SPRINKLER FAN COOLIN; Tabachnick B.G., 2019, USING MULTIVARIATE S, V7th; Thom E.C., 1959, WEATHERWISE, V12, P57, DOI [10.1080/00431672.1959.9926960, DOI 10.1080/00431672.1959.9926960]; Torres-Porras J, 2009, WILDLIFE BIOL, V15, P213, DOI 10.2981/08-059; Turner L. W., 1992, Applied Engineering in Agriculture, V8, P251; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Wickham H., 2009, MEDIA, V35, P10, DOI 10.1007/978-0-387-98141-3; Wood S.N., 2017, GEN ADDITIVE MODELS; Wood SN, 2006, BIOMETRICS, V62, P1025, DOI 10.1111/j.1541-0420.2006.00574.x; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; YAMAMOTO S, 1994, AUST J AGR RES, V45, P1741, DOI 10.1071/AR9941741	90	9	9	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0233809	10.1371/journal.pone.0233809	http://dx.doi.org/10.1371/journal.pone.0233809			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MJ2AA	32480402	Green Published, gold			2022-12-26	WOS:000547893500029
J	Rowell-Cunsolo, TL; Hu, G				Rowell-Cunsolo, Tawandra L.; Hu, Gloria			Barriers to optimal antiretroviral therapy adherence among HIV-infected formerly incarcerated individuals in New York City	PLOS ONE			English	Article							MEDICATION ADHERENCE; SUBSTANCE USE; ART ADHERENCE; PRIMARY-CARE; HEALTH-CARE; PRISONERS; MEN; INTERVENTIONS; RELEASE; BEHAVIORS	In the United States (U.S.), the HIV infection rate is disproportionately high among incarcerated individuals. HIV-infected individuals typically receive antiretroviral therapy (ART) to suppress HIV and reduce the threat of transmission. Although HIV-infected individuals are generally ART-adherent while incarcerated, the public health benefits experienced during incarceration are often lost as HIV-infected individuals struggle to maintain optimal adherence post-incarceration. While the importance of maintaining adherence in the post-incarceration period has been acknowledged, research on barriers to ART adherence during this period is limited. To better understand post-release barriers to ART adherence, we conducted in-depth interviews with 20 HIV-infected formerly incarcerated individuals in New York City; we also followed up with 18 (90%) participants after three months to explore whether their adherence challenges changed over time. Viral load testing results from their most recent physician visit were also recorded at each interview. Interviews were transcribed using transcription software and reviewed for accuracy by a researcher. Thematic coding based on discussion guide prompts were then used to identify commonly mentioned barriers to adherence. The results identified four overarching themes that affected study participants' efforts to adhere to their ART regimen: medication burden, forgetfulness, mental health and emotional difficulties, and perceived conflict between substance use and medication adherence. These barriers were the most commonly cited and largely persisted at three-month follow-up. The results suggest that interventions addressing these challenges are essential for promoting ART adherence among HIV-infected formerly incarcerated individuals. Effective interventions may include mobile-based text messaging reminders and those that facilitate patient-provider communication. Additionally, interventions or programs that integrate substance use and mental health treatment into HIV-related care, along with other types of behavioral health support, may also be beneficial for this population. Such interventions should be a routine part of discharge planning and support for incarcerated individuals returning to the community.	[Rowell-Cunsolo, Tawandra L.] Columbia Univ, Sch Nursing, Social Welf Sci, New York, NY 10027 USA; [Hu, Gloria] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	Columbia University; Columbia University	Rowell-Cunsolo, TL (corresponding author), Columbia Univ, Sch Nursing, Social Welf Sci, New York, NY 10027 USA.	tr2301@cumc.columbia.edu		Graf, Gloria/0000-0003-3538-3673; Rowell-Cunsolo, Tawandra/0000-0003-3715-8998	National Institute of Mental Health [R25MH080665]; National Institute on Drug Abuse [K01DA036411]	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was support by a grant from the National Institute of Mental Health (Grant #R25MH080665; MPIs NE & EW, pilot award to TRC) and the National Institute on Drug Abuse (Grant #K01DA036411; PI: TRC). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram KM, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-0360; Al-Dakkak I, 2013, AIDS CARE, V25, P400, DOI 10.1080/09540121.2012.712667; Amico KR, 2009, AIDS BEHAV, V13, P66, DOI 10.1007/s10461-007-9311-y; Ances BM, 2007, SEMINARS NEUROLOGY, P333; Anderson N, 2014, CTS-CLIN TRANSL SCI, V7, P127, DOI 10.1111/cts.12156; [Anonymous], 2019, GUID US ANT AG AD AD; Association AP, 2012, POS STAT SEGR PRIS M; Bhatia R, 2012, J NEUROVIROL, V18, P247, DOI 10.1007/s13365-011-0073-y; Binswanger IA, 2012, ADDICT SCI CLIN PRAC, V7, DOI 10.1186/1940-0640-7-3; Bisson GP, 2008, PLOS MED, V5, P777, DOI 10.1371/journal.pmed.0050109; Blashill AJ, 2015, AIDS BEHAV, V19, P981, DOI 10.1007/s10461-014-0925-6; Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650; Carson EA, 2016, NCJ250229 DEP JUST B; Catz SL, 2000, HEALTH PSYCHOL, V19, P124, DOI 10.1037/0278-6133.19.2.124; Dennis AC, 2015, J ASSOC NURSE AIDS C, V26, P542, DOI 10.1016/j.jana.2015.06.001; Dolan Karen, 2015, POOR GET PRISON ALAR; Fazel S, 2006, ADDICTION, V101, P181, DOI 10.1111/j.1360-0443.2006.01316.x; Fazel S, 2017, ADDICTION, V112, P1725, DOI 10.1111/add.13877; Finitsis DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088166; Fontana L, 2007, J HEALTH CARE POOR U, V18, P699, DOI 10.1353/hpu.2007.0058; Gallant J, 2017, J INFECT DIS, V216, P1525, DOI 10.1093/infdis/jix518; Haas AD, 2016, CLIN INFECT DIS, V63, P1227, DOI 10.1093/cid/ciw500; Haley DF, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1253; Hall AK, 2015, ANNU REV PUBL HEALTH, V36, P393, DOI 10.1146/annurev-publhealth-031914-122855; High KP, 1999, J ACQUIRED IMMUNE DE, V60; Hinkin CH, 2002, NEUROLOGY, V59, P1944, DOI 10.1212/01.WNL.0000038347.48137.67; Horvath DJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00056; Johnson ME, 2015, J CORRECT HEALTH CAR, V21, P101, DOI 10.1177/1078345815572347; Jones KT, 2008, AIDS BEHAV, V12, P41, DOI 10.1007/s10461-007-9228-5; Krishna S, 2009, TELEMED J E-HEALTH, V15, P231, DOI 10.1089/tmj.2008.0099; Leaver CA, 2007, AIDS BEHAV, V11, pS85, DOI 10.1007/s10461-007-9246-3; Lester C., 2003, Health Education Journal, V62, P341, DOI 10.1177/001789690306200406; Mallik-Kane K, 2008, HLTH PRISONER REENTR; Mbuagbaw L., 2013, BMJ OPEN, V3; McArthur JC, 2004, J NEUROIMMUNOL, V157, P3, DOI 10.1016/j.jneuroim.2004.08.042; Mellins CA, 2009, AIDS CARE, V21, P168, DOI 10.1080/09540120802001705; Meyer JP, 2014, JAMA INTERN MED, V174, P721, DOI 10.1001/jamainternmed.2014.601; Mills EJ, 2007, CLIN INFECT DIS, V45, P916, DOI 10.1086/521249; Mimiaga MJ, 2013, AM J PUBLIC HEALTH, V103, P1457, DOI 10.2105/AJPH.2012.301162; Morrow KM, 2009, AIDS CARE, V21, P235, DOI 10.1080/09540120802017586; Murphy DA, 2000, AIDS PATIENT CARE ST, V14, P47, DOI 10.1089/108729100318127; Nel A, 2011, AIDS CARE, V23, P1360, DOI 10.1080/09540121.2011.565025; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2016, GUIDELINES USE ANTIR; Park LG, 2014, J ADV NURS, V70, P1932, DOI 10.1111/jan.12400; Policy WHOoNA, 2015, NAT HIV AIDS STRAT U; Power R, 2003, AIDS PATIENT CARE ST, V17, P245, DOI 10.1089/108729103321655890; Rabuy B., 2015, PRISON POLICY INITIA, V9; Rich JD, 2001, J URBAN HEALTH, V78, P279, DOI 10.1093/jurban/78.2.279; Sacktor N, 2002, J NEUROVIROL, V8, P136, DOI 10.1080/13550280290049615; Schneider JA, 2017, AIDS, V31, P159, DOI 10.1097/QAD.0000000000001269; Simoni JM, 2007, HEALTH PSYCHOL, V26, P488, DOI 10.1037/0278-6133.26.4.488; Springer SA, 2004, CLIN INFECT DIS, V38, P1754, DOI 10.1086/421392; Steadman HJ, 2009, PSYCHIAT SERV, V60, P761, DOI 10.1176/ps.2009.60.6.761; Stephenson BL, 2006, INT J STD AIDS, V17, P103, DOI 10.1258/095646206775455775; Stephenson BL, 2005, PUBLIC HEALTH REP, V120, P84, DOI 10.1177/003335490512000114; Swan H, 2015, J DRUG ISSUES, V45, P38, DOI 10.1177/0022042614542512; Taussig J, 2006, JAMA-J AM MED ASSOC, V296, P162; Thakkar J, 2016, JAMA INTERN MED, V176, P340, DOI 10.1001/jamainternmed.2015.7667; Turner BJ, 2002, J INFECT DIS, V185, pS143, DOI 10.1086/340197; Unni EJ, 2019, PATIENT PREFER ADHER, V13, P993, DOI 10.2147/PPA.S205359; Wilhelmsen NC, 2019, EUR J HOSP PHARM, V26, P187, DOI 10.1136/ejhpharm-2018-001725; Wilper AP, 2009, AM J PUBLIC HEALTH, V99, P666, DOI 10.2105/AJPH.2008.144279; Wohl DA, 2011, AIDS BEHAV, V15, P356, DOI 10.1007/s10461-010-9843-4	63	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0233842	10.1371/journal.pone.0233842	http://dx.doi.org/10.1371/journal.pone.0233842			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MJ2AA	32479552	gold, Green Published			2022-12-26	WOS:000547893500032
J	Saito, K; Viborg, AH; Sakamoto, S; Arakawa, T; Yamada, C; Fujita, K; Fushinobu, S				Saito, Keita; Viborg, Alexander Holm; Sakamoto, Shiho; Arakawa, Takatoshi; Yamada, Chihaya; Fujita, Kiyotaka; Fushinobu, Shinya			Crystal structure of beta-L-arabinobiosidase belonging to glycoside hydrolase family 121	PLOS ONE			English	Article							CARBOHYDRATE-BINDING MODULE; ALPHA-L-RHAMNOSIDASE; HYDROXYPROLINE ARABINOSIDES; SUBSTRATE RECOGNITION; L-ARABINOFURANOSIDASE; COMPLEX; PHOSPHORYLASE; REVEALS; SPECIFICITY; INHIBITION	Enzymes acting on alpha-L-arabinofuranosides have been extensively studied; however, the structures and functions of beta-L-arabinofuranosidases are not fully understood. Three enzymes and an ABC transporter in a gene cluster of Bifidobacterium longum JCM 1217 constitute a degradation and import system of beta-L-arabinooligosaccharides on plant hydroxyproline-rich glycoproteins. An extracellular beta-L-arabinobiosidase (HypBA2) belonging to the glycoside hydrolase (GH) family 121 plays a key role in the degradation pathway by releasing beta-1,2-linked arabinofuranose disaccharide (beta-Ara(2)) for the specific sugar importer. Here, we present the crystal structure of the catalytic region of HypBA2 as the first three-dimensional structure of GH121 at 1.85 angstrom resolution. The HypBA2 structure consists of a central catalytic (alpha/alpha)(6) barrel domain and two flanking (N- and C-terminal) beta-sandwich domains. A pocket in the catalytic domain appears to be suitable for accommodating the beta-Ara(2) disaccharide. Three acidic residues Glu383, Asp515, and Glu713, located in this pocket, are completely conserved among all members of GH121; site-directed mutagenesis analysis showed that they are essential for catalytic activity. The active site of HypBA2 was compared with those of structural homologs in other GH families: GH63 alpha-glycosidase, GH94 chitobiose phosphorylase, GH142 beta-L-arabinofuranosidase, GH78 alpha-L-rhamnosidase, and GH37 alpha,alpha-trehalase. Based on these analyses, we concluded that the three conserved residues are essential for catalysis and substrate binding. beta-L-Arabinobiosidase genes in GH121 are mainly found in the genomes of bifidobacteria and Xanthomonas species, suggesting that the cleavage and specific import system for the beta-Ara(2) disaccharide on plant hydroxyproline-rich glycoproteins are shared in animal gut symbionts and plant pathogens.	[Saito, Keita; Viborg, Alexander Holm; Arakawa, Takatoshi; Yamada, Chihaya; Fushinobu, Shinya] Univ Tokyo, Dept Biotechnol, Tokyo, Japan; [Sakamoto, Shiho; Fujita, Kiyotaka] Kagoshima Univ, Fac Agr, Kagoshima, Japan; [Arakawa, Takatoshi; Yamada, Chihaya; Fushinobu, Shinya] Univ Tokyo, Collaborat Res Inst Innovat Microbiol, Tokyo, Japan	University of Tokyo; Kagoshima University; University of Tokyo	Fushinobu, S (corresponding author), Univ Tokyo, Dept Biotechnol, Tokyo, Japan.; Fushinobu, S (corresponding author), Univ Tokyo, Collaborat Res Inst Innovat Microbiol, Tokyo, Japan.	asfushi@mail.ecc.u-tokyo.ac.jp	Arakawa, Takatoshi/K-9739-2013; Fushinobu, Shinya/E-4987-2011; Viborg, Alexander/AAI-4943-2021	Arakawa, Takatoshi/0000-0001-6496-5440; Fushinobu, Shinya/0000-0003-1346-6435; Fujita, Kiyotaka/0000-0002-3780-3750	Japan Society for the Promotion of Science [19H00929, 15H02443, 26660083, 24380053, 22780094]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-inAid for Scientific Research from the Japan Society for the Promotion of Science (to S.F., Nos. 19H00929, 15H02443, 26660083 and 24380053, and to K.F., No. 22780094). https://www.jsps.go.jp/english/index.html The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott W, 2018, GLYCOBIOLOGY, V28, P3, DOI 10.1093/glycob/cwx089; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AKIYAMA Y, 1980, AGR BIOL CHEM TOKYO, V44, P2487, DOI 10.1080/00021369.1980.10864347; ASHFORD D, 1982, BIOCHEM J, V201, P199, DOI 10.1042/bj2010199; Barker MK, 2013, J BIOL CHEM, V288, P13563, DOI 10.1074/jbc.M113.460436; Bianchetti CM, 2011, ACTA CRYSTALLOGR F, V67, P1345, DOI 10.1107/S1744309111032660; Boraston AB, 2007, BIOCHEMISTRY-US, V46, P11352, DOI 10.1021/bi701317g; Cardona F, 2009, CHEM-EUR J, V15, P1627, DOI 10.1002/chem.200801578; Cereija TB, 2019, IUCRJ, V6, P572, DOI 10.1107/S2052252519005372; Dawson NL, 2017, NUCLEIC ACIDS RES, V45, pD289, DOI 10.1093/nar/gkw1098; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ficko-Blean E, 2006, J BIOL CHEM, V281, P37748, DOI 10.1074/jbc.M606126200; Fujimoto Z, 2013, J BIOL CHEM, V288, P12376, DOI 10.1074/jbc.M113.460097; Fujita K, 2014, J BIOL CHEM, V289, P5240, DOI 10.1074/jbc.M113.528711; Fujita K, 2011, J BIOL CHEM, V286, P5143, DOI 10.1074/jbc.M110.190512; Garron ML, 2019, CURR OPIN CHEM BIOL, V53, P82, DOI 10.1016/j.cbpa.2019.08.004; Gibson RP, 2007, ANGEW CHEM INT EDIT, V46, P4115, DOI 10.1002/anie.200604825; Hidaka M, 2004, STRUCTURE, V12, P937, DOI 10.1016/j.str.2004.03.027; Hidaka M, 2006, BIOCHEM J, V398, P37, DOI 10.1042/BJ20060274; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Ito T, 2014, BIOCHEM BIOPH RES CO, V447, P32, DOI 10.1016/j.bbrc.2014.03.096; Ito T, 2013, J BIOL CHEM, V288, P11795, DOI 10.1074/jbc.M112.420109; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KIELISZEWSKI MJ, 1994, PLANT J, V5, P849, DOI 10.1046/j.1365-313X.1994.5060849.x; KIELISZEWSKI MJ, 1994, PLANT J, V5, P157, DOI 10.1046/j.1365-313X.1994.05020157.x; Kurakata Y, 2008, J MOL BIOL, V381, P116, DOI 10.1016/j.jmb.2008.05.061; LAMPORT DTA, 1971, PLANT PHYSIOL, V48, P454, DOI 10.1104/pp.48.4.454; LEMASTER DM, 1985, BIOCHEMISTRY-US, V24, P7263, DOI 10.1021/bi00346a036; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Luis AS, 2018, NAT MICROBIOL, V3, P210, DOI 10.1038/s41564-017-0079-1; Matsubayashi Y, 2014, ANNU REV PLANT BIOL, V65, P385, DOI 10.1146/annurev-arplant-050312-120122; Miyake M, 2020, FEBS J, V287, P5114, DOI 10.1111/febs.15315; Miyazaki T, 2016, J STRUCT BIOL, V196, P479, DOI 10.1016/j.jsb.2016.09.015; Miyazaki T, 2015, J STRUCT BIOL, V190, P21, DOI 10.1016/j.jsb.2015.02.006; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakamura M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201982; Nam YW, 2015, J BIOL CHEM, V290, P18281, DOI 10.1074/jbc.M115.664664; Ndeh D, 2017, NATURE, V544, P65, DOI 10.1038/nature21725; Nerinckx W, 2005, FEBS LETT, V579, P302, DOI 10.1016/j.febslet.2004.12.021; Pachl P, 2018, ACTA CRYSTALLOGR D, V74, P1078, DOI 10.1107/S2059798318013049; Sakanaka M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010071; Sakurama H, 2012, J BIOL CHEM, V287, P16709, DOI 10.1074/jbc.M111.333781; Shallom D, 2003, CURR OPIN MICROBIOL, V6, P219, DOI 10.1016/S1369-5274(03)00056-0; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Suzuki R, 2009, J BIOCHEM, V146, P389, DOI 10.1093/jb/mvp086; Tian W, 2018, NUCLEIC ACIDS RES, V46, pW363, DOI 10.1093/nar/gky473; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yamada C, 2017, CELL CHEM BIOL, V24, P515, DOI 10.1016/j.chembiol.2017.03.012; Zheng H, 2017, ACTA CRYSTALLOGR D, V73, P223, DOI 10.1107/S2059798317001061	52	5	5	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2020	15	6							e0231513	10.1371/journal.pone.0231513	http://dx.doi.org/10.1371/journal.pone.0231513			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MJ2AA	32479540	Green Published, Green Submitted, gold			2022-12-26	WOS:000547893500002
J	Gibney, PA; Chen, AQ; Schieler, A; Chen, JC; Xu, YF; Hendrickson, DG; McIsaac, RS; Rabinowitz, JD; Botstein, D				Gibney, Patrick A.; Chen, Anqi; Schieler, Ariel; Chen, Jonathan C.; Xu, Yifan; Hendrickson, David G.; McIsaac, R. Scott; Rabinowitz, Joshua D.; Botstein, David			A tps1 Delta persister-like state in Saccharomyces cerevisiae is regulated by MKT1	PLOS ONE			English	Article							TREHALOSE SYNTHASE; METABOLOMIC ANALYSIS; MOLECULAR-CLONING; YEAST GENE; CELL-CYCLE; GLUCOSE; GROWTH; MUTANTS; EXPRESSION; COMPLEX	Trehalose metabolism in yeast has been linked to a variety of phenotypes, including heat resistance, desiccation tolerance, carbon-source utilization, and sporulation. The relationships among the several phenotypes of mutants unable to synthesize trehalose are not understood, even though the pathway is highly conserved. One of these phenotypes is that tps1 Delta strains cannot reportedly grow on media containing glucose or fructose, even when another carbon source they can use (e.g. galactose) is present. Here we corroborate the recent observation that a small fraction of yeast tps1 Delta cells do grow on glucose, unlike the majority of the population. This is not due to a genetic alteration, but instead resembles the persister phenotype documented in many microorganisms and cancer cells undergoing lethal stress. We extend these observations to show that this phenomenon is glucose-specific, as it does not occur on another highly fermented carbon source, fructose. We further demonstrate that this phenomenon appears to be related to mitochondrial complex III function, but unrelated to inorganic phosphate levels in the cell, as had previously been suggested. Finally, we found that this phenomenon is specific to S288C-derived strains, and is the consequence of a variant in the MKT1 gene.	[Gibney, Patrick A.; Schieler, Ariel; Chen, Jonathan C.; Xu, Yifan; Rabinowitz, Joshua D.; Botstein, David] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Gibney, Patrick A.; Hendrickson, David G.; McIsaac, R. Scott; Botstein, David] Calico Life Sci LLC, San Francisco, CA 94080 USA; [Gibney, Patrick A.; Chen, Anqi] Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA; [Chen, Jonathan C.; Xu, Yifan; Rabinowitz, Joshua D.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Princeton University; Cornell University; Princeton University	Gibney, PA (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.; Gibney, PA (corresponding author), Calico Life Sci LLC, San Francisco, CA 94080 USA.; Gibney, PA (corresponding author), Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA.	pag235@cornell.edu	Rabinowitz, Joshua/GPP-4019-2022; Chen, Jonathan/GPG-0565-2022	Rabinowitz, Joshua/0000-0002-1247-4727; Chen, Jonathan/0000-0003-4346-0501	National Institute of General Medical Sciences Center for Quantitative Biology [GM071508]; National Institutes of Health [GM097852, GM046406]; Department of Energy [DE-SC0012461]; Calico Life Sciences LLC	National Institute of General Medical Sciences Center for Quantitative Biology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); Calico Life Sciences LLC	This research was supported by the National Institute of General Medical Sciences Center for Quantitative Biology to DB (GM071508), National Institutes of Health grant to DB (GM046406), Department of Energy grant to JR (DE-SC0012461), National Institutes of Health grant to PG (GM097852), and Calico Life Sciences LLC. Calico Life Sciences LLC provided support in the form of salaries for authors PAG, DGH, RSM, and DB. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILERA A, 1986, MOL GEN GENET, V204, P310, DOI 10.1007/BF00425515; Angustia J, 2014, EXPEDITION; Avonce N, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-109; Bell W, 1998, J BIOL CHEM, V273, P33311, DOI 10.1074/jbc.273.50.33311; Berthels NJ, 2008, APPL MICROBIOL BIOT, V77, P1083, DOI 10.1007/s00253-007-1231-2; BISSON LF, 1983, P NATL ACAD SCI-BIOL, V80, P1730, DOI 10.1073/pnas.80.6.1730; Blazquez MA, 1995, MOL GEN GENET, V249, P655, DOI 10.1007/BF00418035; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Cai JY, 1998, BBA-BIOENERGETICS, V1366, P139, DOI 10.1016/S0005-2728(98)00109-1; Chen H, 2006, GENE DEV, V20, P1150, DOI 10.1101/gad.1411806; Crutchfield CA, 2010, METHOD ENZYMOL, V470, P393, DOI 10.1016/S0076-6879(10)70016-1; Dawson CC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002121; Demogines A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000123; Deutschbauer AM, 2005, NAT GENET, V37, P1333, DOI 10.1038/ng1674; DEVIRGILIO C, 1993, EUR J BIOCHEM, V212, P315; Dimitrov LN, 2009, GENETICS, V183, P365, DOI 10.1534/genetics.109.104497; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Dorr T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000760; Ehrenreich IM, 2010, NATURE, V464, P1039, DOI 10.1038/nature08923; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Eleutherio E, 2015, CURR GENET, V61, P263, DOI 10.1007/s00294-014-0450-1; Gibney PA, 2015, P NATL ACAD SCI USA, V112, P6116, DOI 10.1073/pnas.1506289112; GONZALEZ MI, 1992, YEAST, V8, P183, DOI 10.1002/yea.320080304; Gourlay CW, 2006, MOL CELL BIOL, V26, P6487, DOI 10.1128/MCB.00117-06; Guillou V, 2004, FEMS YEAST RES, V4, P773, DOI 10.1016/j.femsyr.2004.05.005; Guthrie C, 2002, CELL, V2009, P600; Harms A, 2017, MBIO, V8, DOI 10.1128/mBio.01964-17; Hickman MJ, 2007, MOL CELL BIOL, V27, P7414, DOI 10.1128/MCB.00887-07; Hickman MJ, 2011, GENETICS, V188, P325, DOI 10.1534/genetics.111.128322; HOHMANN S, 1993, CURR GENET, V23, P281, DOI 10.1007/BF00310888; Hohmann S, 1996, MOL MICROBIOL, V20, P981, DOI 10.1111/j.1365-2958.1996.tb02539.x; HOHMANN S, 1994, CURR GENET, V26, P295, DOI 10.1007/BF00310492; Hohmann S, 1992, J BACTERIOL, DOI [10.1128/jb.174.12.4183-4188.1992, DOI 10.1128/JB.174.12.4183-4188.1992]; Iturriaga G, 2009, INT J MOL SCI, V10, P3793, DOI 10.3390/ijms10093793; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim HS, 2009, GENETICS, V183, P1141, DOI 10.1534/genetics.109.108068; Kim JH, 2013, BBA-GEN SUBJECTS, V1830, P5204, DOI 10.1016/j.bbagen.2013.07.025; LAGUNAS R, 1993, FEMS MICROBIOL LETT, V104, P229, DOI 10.1016/0378-1097(93)90598-V; Lemaire K, 2004, MOL CELL, V16, P293, DOI 10.1016/j.molcel.2004.10.004; Levy SF, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001325; Lewis JA, 2014, GENETICS, V198, P369, DOI 10.1534/genetics.114.167429; Lu W, 2008, J CHROMATOGR B, V871, P236, DOI 10.1016/j.jchromb.2008.04.031; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; LUYTEN K, 1995, EMBO J, V14, P1360, DOI 10.1002/j.1460-2075.1995.tb07122.x; Melamud E, 2010, ANAL CHEM, V82, P9818, DOI 10.1021/ac1021166; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; NAVON G, 1979, BIOCHEMISTRY-US, V18, P4487, DOI 10.1021/bi00588a006; NEVES MJ, 1995, CURR GENET, V27, P110, DOI 10.1007/BF00313424; Ozcan S, 1999, MICROBIOL MOL BIOL R; Peeters K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01019-z; Ramirez M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10690; Rolland F, 2002, FEMS YEAST RES, V2, P183, DOI 10.1111/j.1567-1364.2002.tb00084.x; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shi L, 2010, MOL BIOL CELL, V21, P1982, DOI 10.1091/mbc.E10-01-0056; SIKORSKI RS, 1989, GENETICS, V122, P19; Sinha H, 2006, PLOS GENET, V2, P140, DOI 10.1371/journal.pgen.0020013; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Springer M, 2003, PLOS BIOL, V1, P261, DOI 10.1371/journal.pbio.0000028; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Stucka R, 1993, FEMS MICROBIOL LETT, DOI [10.1111/j.1574-6968.1993.tb06038.x, DOI 10.1111/J.1574-6968.1993.TB06038.X]; Swinnen S, 2012, GENOME RES, V22, P975, DOI 10.1101/gr.131698.111; Tadauchi T, 2004, MOL CELL BIOL, V24, P3670, DOI 10.1128/MCB.24.9.3670-3681.2004; Tapia H, 2015, P NATL ACAD SCI USA, V112, P6122, DOI 10.1073/pnas.1506415112; THEVELEIN JM, 1995, TRENDS BIOCHEM SCI, V20, P3, DOI 10.1016/S0968-0004(00)88938-0; Tournu H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003447; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Heerden JH, 2014, SCIENCE, V343, P987, DOI 10.1126/science.1245114; VANAELST L, 1993, MOL MICROBIOL, V8, P927; VANAELST L, 1991, EMBO J, V10, P2095, DOI 10.1002/j.1460-2075.1991.tb07742.x; VANDEPOLL KW, 1977, MOL GEN GENET, V154, P61, DOI 10.1007/BF00265577; VUORIO OE, 1993, EUR J BIOCHEM, V216, P849, DOI 10.1111/j.1432-1033.1993.tb18207.x; Walther T, 2013, BIOCHEM J, V454, P227, DOI 10.1042/BJ20130587; WICKNER RB, 1987, J BACTERIOL, V169, P4941, DOI 10.1128/jb.169.11.4941-4945.1987	75	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2020	15	5							e0233779	10.1371/journal.pone.0233779	http://dx.doi.org/10.1371/journal.pone.0233779			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1WS	32470059	Green Published			2022-12-26	WOS:000537552800174
